Michael	B-Person
Pentella	E-Person
PhD	O
,	O
is	O
Director	O
of	O
the	O
Bureau	B-Organization
of	I-Organization
Laboratory	I-Organization
Sciences	E-Organization
at	O
the	O
Hinton	B-Organization
State	I-Organization
Laboratory	I-Organization
Institute	E-Organization
,	O
Commonwealth	O
of	O
Massachusetts	S-Location
.	O
He	O
previously	O
served	O
as	O
the	O
Associate	O
Director	O
of	O
the	O
Iowa	B-Organization
state	I-Organization
public	I-Organization
health	I-Organization
laboratory	E-Organization
and	O
as	O
Clinical	O
Associate	O
Professor	O
at	O
the	O
College	B-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
,	O
University	B-Organization
of	I-Organization
Iowa	E-Organization
.Dr.	O
has	O
more	O
than	O
30	O
years	O
of	O
experience	O
in	O
clinical	O
and	O
public	O
health	O
laboratories	O
and	O
is	O
board	O
certified	O
in	O
medical	O
microbiology	O
and	O
infection	O
control	O
.	O

This	O
last	O
weekend	O
,	O
at	O
the	O
AAAS	B-Activity
Annual	I-Activity
Meeting	E-Activity
in	O
Austin	S-Location
,	O
Texas	S-Location
,	O
Col	O
.	O

Calkins	S-Person
said	O
the	O
lack	O
of	O
larvae	O
could	O
show	O
that	O
the	O
infestation	O
was	O
small	O
and	O
isolated	O
,	O
and	O
located	O
away	O
from	O
traps	O
.	O

The	O
Chinese	B-Organization
government	E-Organization
has	O
been	O
criticised	O
by	O
the	O
United	B-Organization
States	I-Organization
government	E-Organization
,	O
UK	S-Organization
Minister	O
for	O
the	O
Cabinet	O
Office	O
Michael	B-Person
Gove	E-Person
,	O
and	O
others	O
for	O
its	O
handling	O
of	O
the	O
pandemic	O
.	O

On	O
29	O
August	O
,	O
a	O
9-year-old	O
Congolese	O
girl	O
became	O
the	O
fourth	O
individual	O
in	O
Uganda	S-Location
to	O
test	O
positive	O
for	O
EVD	S-Disease
when	O
she	O
crossed	O
from	O
the	O
DRC	S-Location
into	O
the	O
district	O
of	O
.	O

There	O
was	O
an	O
almost	O
20-fold	O
higher	O
mortality	O
in	O
some	O
countries	O
in	O
the	O
Americas	S-Location
than	O
in	O
.	O
The	O
model	O
attributed	O
148,000–249,000	O
respiratory	O
deaths	O
to	O
influenza	O
in	O
an	O
average	O
pre-pandemic	O
season	O
,	O
with	O
only	O
19%	O
in	O
persons	O
&lt;65	O
years	O
of	O
age	O
.	O

Bayles	S-Person
said	O
the	O
Los	B-Location
Alamos	E-Location
program	O
would	O
complement	O
an	O
existing	O
educational	O
pipeline	O
previously	O
established	O
between	O
other	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
laboratories	O
,	O
UNMC	S-Organization
and	O
the	O
University	B-Organization
of	I-Organization
Nebraska	E-Organization
at	O
.	O

It	O
and	O
several	O
others	O
across	O
the	O
country	O
are	O
part	O
of	O
the	O
$7	O
billion	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
a	O
government	O
repository	O
of	O
drugs	O
and	O
supplies	O
ready	O
for	O
deployment	O
in	O
a	O
bioterrorism	O
or	O
nuclear	O
attack	O
,	O
or	O
against	O
an	O
infectious	O
disease	O
outbreak	O
-	O
of	O
either	O
a	O
known	O
pathogen	O
or	O
some	O
unknown	O
threat	O
with	O
pandemic	O
potential	O
,	O
which	O
global	O
health	O
officials	O
dub	O
"	O
Disease	O
X	O
"	O
-	O
or	O
other	O
major	O
public	O
health	O
emergency	O
.	O

NBIC	S-Organization
acts	O
as	O
a	O
hub	O
where	O
different	O
components	O
can	O
plan	O
and	O
coordinate	O
responses	O
to	O
biothreats	O
.	O

On	O
9	O
June	O
,	O
the	O
flare-up	O
was	O
declared	O
over	O
,	O
and	O
the	O
country	O
Ebola	S-Disease
-free	O
,	O
due	O
to	O
the	O
passage	O
of	O
the	O
42-day	O
period	O
;	O
Liberia	S-Location
then	O
entered	O
a	O
90-day	O
period	O
of	O
heightened	O
surveillance	O
,	O
which	O
ended	O
on	O
7	O
September	O
2016	O
.	O

More	O
typically	O
,	O
the	O
surgical	O
procedure	O
is	O
temporarily	O
interrupted	O
so	O
that	O
can	O
assess	O
the	O
success	O
of	O
the	O
procedure	O
or	O
guide	O
subsequent	O
surgical	O
work	O
.	O

Symptoms	O
usually	O
last	O
4–6	O
days	O
.	O

The	O
CDC	S-Organization
defines	O
four	O
biosafety	O
levels	O
for	O
activities	O
involving	O
infectious	O
disease	O
work	O
with	O
experimental	O
animals	O
.	O

European	B-Organization
Commission-Public	I-Organization
Health	I-Organization
EU	I-Organization
coordination	E-Organization
on	O
.	O

Since	O
then	O
,	O
it	O
has	O
jumped	O
from	O
radical	O
personal	O
experimentation	O
to	O
TED	O
st	S-Organization
to	O
everyday	O
lifestyle	O
products	O
,	O
including	O
coffee	O
.	O

We	O
report	O
isolation	O
of	O
a	O
New	B-Location
Delhi	E-Location
metallo-β-lactamase-5–producing	O
carbapenem-resistant	B-Pathogen
Escherichia	I-Pathogen
coli	I-Pathogen
sequence	E-Pathogen
type	O
167	O
from	O
companion	O
animals	O
in	O
the	O
United	B-Location
States	E-Location
.	O
Reports	O
of	O
in	O
companion	O
animals	O
are	O
rare	O
.	O

The	O
has	O
stated	O
that	O
the	O
reported	O
numbers	O
"	O
vastly	O
underestimate	O
the	O
magnitude	O
of	O
the	O
outbreak"	O
,	O
estimating	O
there	O
may	O
be	O
three	O
times	O
as	O
many	O
cases	O
as	O
officially	O
reported.Note	O
3:	O
Date	O
is	O
the	O
"	O
as	O
of	O
"	O
date	O
from	O
the	O
reference	O
.	O

Thereafter	O
,	O
confronted	O
by	O
the	O
selection	O
pressures	O
of	O
population	O
immunity	O
,	O
these	O
pandemic	O
viruses	O
begin	O
to	O
drift	O
genetically	O
and	O
eventually	O
settle	O
into	O
a	O
pattern	O
of	O
annual	O
epidemic	O
recurrences	O
caused	O
by	O
the	O
drifted	O
virus	O
variants	O
.	O

The	O
OECD	S-Organization
study	O
already	O
emphasized	O
the	O
need	O
for	O
development	O
and	O
maintenance	O
of	O
data	O
management	O
systems	O
in	O
order	O
to	O
build	O
up	O
and	O
secure	O
a	O
stable	O
data	O
management	O
infrastructure	O
.	O

"	O
It	O
has	O
always	O
been	O
a	O
personal	O
priority	O
to	O
increase	O
care	O
access	O
for	O
members	O
of	O
the	O
Army	O
,	O
Navy	O
,	O
Air	O
Force	S-Organization
Marines	S-Organization
,	O
and	O
Coast	B-Organization
Guard	E-Organization
,	O
"	O
said	O
Joel	B-Person
Barthelemy	E-Person
,	O
CEO	O
of	O
GlobalMed	S-Organization
and	O
a	O
Marine	O
Corps	O
Reserve	O
Veteran.	O
"	O
The	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
is	O
a	O
huge	O
healthcare	O
provider	O
and	O
network	O
security	O
is	O
a	O
high	O
priority.	O
is	O
focused	O
on	O
every	O
aspect	O
of	O
security	O
and	O
compliance	O
throughout	O
our	O
vertically	O
integrated	O
software	O
applications	O
.	O

CT	S-Technology
data	O
sets	O
have	O
a	O
very	O
high	O
dynamic	O
range	O
which	O
must	O
be	O
reduced	O
for	O
display	O
or	O
printing	O
.	O

At	O
a	O
press	O
conference	O
in	O
September	O
1985	O
,	O
Rajneesh	S-Person
accused	O
several	O
of	O
his	O
followers	O
of	O
participation	O
in	O
this	O
and	O
other	O
crimes	O
,	O
including	O
an	O
aborted	O
plan	O
in	O
1985	O
to	O
assassinate	O
a	O
United	O
States	O
Attorney	O
,	O
and	O
he	O
asked	O
state	O
and	O
federal	O
authorities	O
to	O
investigate	O
.	O

As	O
most	O
large-scale	O
projects	O
are	O
expected	O
to	O
use	O
a	O
large	O
diversity	O
of	O
'omics'	O
data	O
,	O
systems	O
should	O
be	O
flexible	O
to	O
incorporate	O
as	O
much	O
'omics'	O
data	O
as	O
possible	O
via	O
mechanisms	O
to	O
integrate	O
the	O
specific	O
standard	O
formats	O
,	O
e.g.	O
the	O
SysMO-SEEK	S-Platform
Just	O
Enough	O
Results	O
Model	O
(JERM)	O
templates	O
(see	O
'	O
SysMO-SEEK	S-Platform
'	O
section)	O
.	O

The	O
leaders	O
pledged	O
to	O
assist	O
in	O
carrying	O
out	O
WHO	S-Organization
regulations	O
.	O

Other	O
nations	O
,	O
notably	O
France	O
and	O
Japan	O
,	O
had	O
begun	O
their	O
own	O
biological-weapons	O
programs	O
.	O

Although	O
the	O
pandemic	O
mortality	O
estimate	O
was	O
similar	O
in	O
magnitude	O
to	O
that	O
of	O
seasonal	B-Disease
influenza	E-Disease
,	O
a	O
marked	O
shift	O
toward	O
mortality	O
among	O
persons	O
less	O
than	O
65	O
years	O
of	O
age	O
occurred	O
,	O
so	O
that	O
many	O
more	O
life-years	O
were	O
lost	O
.	O

On	O
11	O
June	O
2019	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
the	O
virus	O
had	O
spread	O
to	O
Uganda	S-Location
.	O
A	O
5-year-old	O
Congolese	O
boy	O
entered	O
Uganda	S-Location
on	O
the	O
previous	O
Sunday	O
with	O
his	O
family	O
to	O
seek	O
medical	O
care	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
attributes	O
human	O
error	O
and	O
poor	O
technique	O
as	O
the	O
primary	O
cause	O
of	O
.	O

Thus	O
,	O
they	O
could	O
open	O
the	O
survey	O
,	O
agree	O
to	O
the	O
human	O
ethics	O
considerations	O
,	O
and	O
then	O
view	O
the	O
remaining	O
questions	O
.	O

The	O
commune	O
leadership	O
planned	O
to	O
sicken	O
and	O
incapacitate	O
voters	O
in	O
The	O
Dalles	S-Location
where	O
most	O
of	O
the	O
voters	O
resided	O
,	O
to	O
sway	O
the	O
election	O
.	O

Nancy	B-Person
Cox	E-Person
,	O
head	O
of	O
the	O
,	O
has	O
said	O
,	O
"	O
This	O
particular	O
paper	O
is	O
extremely	O
interesting	O
because	O
it	O
demonstrates	O
for	O
the	O
first	O
time	O
what	O
we	O
had	O
worried	O
about	O
at	O
the	O
very	O
onset	O
of	O
the	O
pandemic	O
,	O
and	O
that	O
is	O
that	O
this	O
particular	O
virus	O
,	O
when	O
introduced	O
into	O
pigs	O
,	O
could	O
reassort	O
with	O
the	O
resident	O
viruses	O
in	O
pigs	O
and	O
we	O
would	O
have	O
new	O
gene	O
constellations	O
.	O

In	O
addition	O
,	O
the	O
network	O
has	O
a	O
steering	O
committee	O
,	O
which	O
consists	O
of	O
members	O
who	O
have	O
authority	O
to	O
influence	O
the	O
work	O
in	O
each	O
agency	O
and	O
which	O
is	O
responsible	O
for	O
coordinating	O
the	O
network	O
and	O
ensuring	O
a	O
balance	O
in	O
the	O
type	O
of	O
projects	O
run	O
.	O

Just	O
as	O
DARPA	S-Organization
's	O
mission	O
is	O
to	O
devise	O
emerging	O
technologies	O
for	O
the	O
military	O
,	O
a	O
similar	O
organization	O
could	O
be	O
created	O
for	O
,	O
as	O
an	O
example	O
,	O
to	O
develop	O
diagnostic	O
tools	O
for	O
the	O
health	O
market	O
,	O
he	O
said	O
.	O

But	O
the	O
screening	O
methods	O
are	O
imperfect	O
,	O
and	O
they	O
only	O
cover	O
about	O
80%	O
of	O
orders	O
.	O

His	O
followers	O
believed	O
he	O
was	O
involved	O
in	O
every	O
important	O
decision	O
that	O
Sheela	S-Person
made	O
,	O
but	O
those	O
allegations	O
were	O
never	O
proven.	O
"	O
Rajneesh	S-Person
insisted	O
that	O
,	O
who	O
he	O
said	O
was	O
his	O
only	O
source	O
of	O
information	O
during	O
his	O
period	O
of	O
isolation	O
,	O
used	O
her	O
position	O
to	O
impose	O
"	O
a	O
fascist	O
state	O
"	O
on	O
the	O
commune	O
.	O

Forty	O
years	O
ago	O
,	O
on	O
April	O
2nd	O
,	O
1979	O
,	O
there	O
was	O
a	O
major	O
leak	O
of	O
deadly	O
anthrax	S-Pathogen
spores	O
from	O
the	O
Soviet	S-Organization
biological	O
warfare	O
facility	O
at	O
Military	B-Organization
Compound	I-Organization
19	E-Organization
on	O
the	O
edge	O
of	O
Sverdlovsk	S-Location
.	O
The	O
strain	O
of	O
the	O
pathogen	O
,	O
,	O
was	O
the	O
deadliest	O
.	O

The	O
technology	O
industry	O
,	O
in	O
particular	O
,	O
has	O
warned	O
of	O
delays	O
to	O
shipments	O
of	O
electronic	O
goods	O
.	O

These	O
include	O
the	O
agents	O
that	O
cause	O
the	O
Spanish	B-Pathogen
flu	E-Pathogen
smallpox	S-Pathogen
,	O
Sars	S-Pathogen
and	O
H5N1	S-Pathogen
or	O
.	O
And	O
a	O
small	O
part	O
of	O
this	O
research	O
involves	O
making	O
strains	O
of	O
these	O
pathogens	O
that	O
pose	O
even	O
more	O
danger	O
than	O
the	O
natural	O
types	O
,	O
increasing	O
their	O
transmissibility	O
,	O
lethality	O
or	O
resistance	O
to	O
vaccination	O
or	O
treatment	O
.	O

Prime	O
Minister	O
,	O
Head	O
of	O
Government	O
,	O
Philemon	B-Person
Yang	E-Person
chaired	O
the	O
inauguration	O
ceremony	O
of	O
the	O
Centre	O
that	O
is	O
yet	O
another	O
fruit	O
of	O
the	O
Cameroon	S-Organization
-	O
USA	S-Organization
health	O
cooperation	O
.	O

None	O
of	O
these	O
viral	O
descendants	O
,	O
however	O
,	O
approaches	O
the	O
pathogenicity	O
of	O
the	O
1918	O
parent	O
virus	O
.	O

The	O
cysts	O
were	O
capable	O
of	O
reaching	O
macroscopic	O
dimensions	O
,	O
up	O
to	O
one	O
centimeter	O
in	O
diameter	O
.	O

However	O
,	O
later	O
findings	O
suggested	O
that	O
there	O
may	O
have	O
been	O
several	O
previous	O
cases	O
,	O
and	O
it	O
was	O
reported	O
that	O
pigs	O
in	O
the	O
village	O
may	O
have	O
been	O
infected	O
with	O
Ebola	S-Disease
some	O
time	O
before	O
the	O
first	O
human	O
case	O
occurred	O
.	O

BASE	S-Platform
supports	O
the	O
most	O
popular	O
microarray	O
platforms	O
and	O
provides	O
data	O
analysis	O
functionality	O
amended	O
by	O
a	O
plug-in	O
system	O
which	O
also	O
allows	O
straightforward	O
integration	O
of	O
other	O
systems-like	O
in	O
'	O
XperimentR	S-Platform
'	O
section	O
.	O

Government	O
actions	O
in	O
the	O
early	O
stages	O
of	O
the	O
virus'	O
arrival	O
in	O
the	O
country	O
in	O
September	O
1918	O
are	O
believed	O
to	O
have	O
unintentionally	O
accelerated	O
its	O
spread	O
throughout	O
the	O
country	O
.	O

For	O
each	O
biosafety	O
level	O
,	O
there	O
are	O
specific	O
supervisory	O
qualifications	O
as	O
assurance	O
that	O
laboratory	O
workers	O
are	O
provided	O
appropriate	O
role	O
models	O
and	O
knowledgeable	O
mentors	O
.	O

These	O
biological	O
agents	O
are	O
lowering	O
the	O
political	O
threshold	O
for	O
the	O
use	O
of	O
biological	O
weapons	O
and	O
are	O
likely	O
to	O
have	O
tremendous	O
environmental	O
and	O
health	O
impacts	O
.	O

However	O
,	O
during	O
the	O
1785	O
siege	O
of	O
,	O
Tunisian	O
forces	O
flung	O
diseased	O
clothing	O
into	O
the	O
city	O
.	O

It	O
appoints	O
the	O
Director-General	O
every	O
five	O
years	O
and	O
votes	O
on	O
matters	O
of	O
policy	O
and	O
finance	O
of	O
WHO	S-Organization
,	O
including	O
the	O
proposed	O
budget	O
.	O

On	O
7	O
May	O
2009	O
,	O
the	O
WHO	S-Organization
stated	O
that	O
containment	O
was	O
not	O
feasible	O
and	O
that	O
countries	O
should	O
focus	O
on	O
mitigating	O
the	O
effect	O
of	O
the	O
virus	O
.	O

Retrieved	O
January	O
7	O
,	O
2009	O
.	O

On	O
24	O
April	O
,	O
the	O
Hong	B-Organization
Kong	I-Organization
Government	E-Organization
announced	O
an	O
HK$11.8 billion	O
relief	O
package	O
designed	O
to	O
assist	O
's	O
battered	O
tourism	O
,	O
entertainment	O
,	O
retail	O
,	O
and	O
catering	O
sectors	O
,	O
consisting	O
of	O
a	O
waiver	O
of	O
tourism-	O
and	O
transport-related	O
license	O
fees	O
,	O
and	O
HK$1 billion	O
allocated	O
for	O
tourism	O
promotion	O
overseas	O
.	O

By	O
contrast	O
,	O
the	O
DARPA	S-Organization
project	O
uses	O
"	O
horizontal	O
environmental	O
genetic	O
alteration	O
agents,	O
"	O
in	O
which	O
common	O
pests	O
are	O
the	O
agents	O
of	O
genetic	B-Technology
modification	E-Technology
.	O
The	O
insects	O
deliver	O
engineered	O
viruses	O
that	O
can	O
the	O
chromosomes	O
of	O
mature	O
plants	O
for	O
the	O
purpose	O
of	O
making	O
them	O
more	O
resistant	O
to	O
disease	O
and	O
drought	O
.	O

OSHA	S-Organization
Web	O
site	O
.	O

TOM	B-Person
FRIEDEN	E-Person
I	O
will	O
say	O
that	O
I'm	O
just	O
astonished	O
that	O
this	O
could	O
have	O
happened	O
here	O
.	O

Some	O
countries	O
have	O
passed	O
emergency	O
legislation	O
in	O
response	O
to	O
the	O
pandemic	O
.	O

Like	O
the	O
first	O
case	O
,	O
the	O
third	O
case	O
had	O
traveled	O
to	O
Guangdong	S-Location
and	O
transited	O
through	O
Hong	B-Location
Kong	E-Location
before	O
arriving	O
in	O
Taiwan	S-Location
.	O
Shortly	O
after	O
the	O
third	O
case	O
was	O
diagnosed	O
,	O
officials	O
from	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
in	O
the	O
United	B-Location
States	E-Location
traveled	O
to	O
Taiwan	S-Location
to	O
study	O
the	O
disease	O
.	O

The	O
billionaire	O
tech	O
investor	O
has	O
expressed	O
keen	O
interest	O
.	O

It	O
doesn't	O
matter	O
whether	O
this	O
is	O
from	O
insufficient	O
standards	O
,	O
inspections	O
,	O
operations	O
or	O
penalties	O
.	O

Senator	O
Jeff	B-Person
Sessions	E-Person
'	O
aide	O
on	O
Capitol	B-Location
Hill	E-Location
–	O
Watson	B-Person
Donald	E-Person
,	O
is	O
now	O
a	O
Senior	O
Director	O
at	O
.	O

The	O
first	O
is	O
the	O
"	O
small	O
molecule	O
"	O
approach	O
,	O
which	O
often	O
focuses	O
on	O
dietary	O
supplements	O
.	O

Nevertheless	O
,	O
undergraduates	O
in	O
biotechnology	O
and	O
medical	O
science	O
laboratories	O
at	O
Hadassah	B-Organization
Academic	I-Organization
College	E-Organization
in	O
Jerusalem	S-Location
take	O
this	O
lab	O
as	O
part	O
of	O
the	O
mandatory	O
curriculum	O
.	O

The	O
introduction	O
of	O
the	O
virus	O
to	O
South	B-Location
America	E-Location
was	O
largely	O
related	O
to	O
international	O
travel	O
by	O
the	O
more	O
affluent	O
.	O

In	O
fact	O
,	O
the	O
project	O
that	O
led	O
to	O
the	O
potential	O
exposure	O
was	O
a	O
project	O
to	O
try	O
to	O
figure	O
out	O
a	O
quicker	O
way	O
to	O
diagnose	O
anthrax	S-Pathogen
with	O
a	O
new	O
and	O
interesting	O
technology	O
.	O

"	O
The	O
newly	O
developed	O
petrocalin	S-Drug
captures	O
petrobactin	O
,	O
thereby	O
depriving	O
the	O
anthrax	S-Pathogen
pathogen	O
of	O
access	O
to	O
vital	O
iron	O
and	O
acting	O
as	O
a	O
protein	O
antibiotic,	O
"	O
says	O
Skerra	S-Person
.	O
"	O
In	O
collaboration	O
with	O
professor	O
Siegfried	B-Person
Scherer	E-Person
from	O
the	O
,	O
we	O
have	O
been	O
able	O
to	O
demonstrate	O
that	O
this	O
approach	O
works	O
in	O
bacterial	O
cultures.	O
"	O

Historically	O
,	O
governments	O
and	O
authorities	O
have	O
relied	O
on	O
quarantines	O
to	O
protect	O
their	O
populations	O
.	O

According	O
to	O
a	O
United	B-Organization
Nations	I-Organization
Economic	I-Organization
Commission	I-Organization
for	I-Organization
Latin	I-Organization
America	E-Organization
estimate	O
,	O
the	O
pandemic-induced	O
recession	O
could	O
leave	O
14–22 million	O
more	O
people	O
in	O
extreme	O
poverty	O
in	O
than	O
would	O
have	O
been	O
in	O
that	O
situation	O
without	O
the	O
pandemic	O
.	O

Severe	B-Disease
Acute	I-Disease
Respiratory	I-Disease
Syndrome	E-Disease
(	O
SARS	S-Disease
)	O
–	O
multi-country	O
outbreak	O
–	O
Update	O
6	O
.	O

He	O
added	O
that	O
the	O
scientists	O
were	O
"	O
jumping	O
to	O
far-reaching	O
conclusions	O
with	O
scant	O
information.	O
"	O

This	O
report	O
focuses	O
specifically	O
on	O
data	O
assets	O
identified	O
by	O
the	O
agencies	O
as	O
having	O
high	O
value	O
and	O
that	O
are	O
restricted	O
or	O
nonpublic	O
.	O

In	O
Europe	S-Location
disease	O
surveillance	O
is	O
beginning	O
to	O
be	O
organized	O
on	O
the	O
continent-wide	O
scale	O
needed	O
to	O
track	O
a	O
biological	O
emergency	O
.	O

In	O
a	O
few	O
hours	O
,	O
someone	O
found	O
that	O
the	O
filter	S-Equipment
was	O
missing	O
and	O
reinstalled	O
it	O
.	O

Rosenberg	S-Person
told	O
in	O
2016	O
,	O
"	O
Right	O
now	O
,	O
there	O
is	O
nothing	O
stopping	O
them	O
from	O
addressing	O
this	O
life-and-death	O
national	O
problem.	O
"	O

As	O
another	O
caller	O
said	O
,	O
this	O
is	O
the	O
envy	O
of	O
the	O
world	O
.	O

Prior	O
to	O
arrival	O
in	O
Sierra	B-Location
Leone	E-Location
a	O
set	O
of	O
laboratory	O
management	O
and	O
program	O
documents	O
were	O
prepared	O
based	O
on	O
the	O
BSL-3	S-Platform
documents	O
of	O
the	O
NIVDC	S-Organization
,	O
China	B-Organization
CDC	E-Organization
.	O
Those	O
documents	O
were	O
revised	O
after	O
we	O
arrived	O
at	O
the	O
SLE–CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
,	O
according	O
to	O
the	O
acute	O
situation	O
.	O

The	O
Indonesian	B-Organization
government	E-Organization
also	O
halted	O
the	O
importation	O
of	O
pigs	O
and	O
initiated	O
the	O
examination	O
of	O
pigs	O
in	O
Indonesia	S-Location
.	O
The	O
Egyptian	B-Organization
government	E-Organization
ordered	O
the	O
slaughter	O
of	O
all	O
pigs	O
in	O
on	O
29	O
April	O
.	O

Dr	O
.	O

Cutting-edge	O
tools	O
like	O
CRISPR/Cas9	S-Technology
and	O
DNA	O
synthesis	O
raise	O
important	O
ethical	O
questions	O
that	O
are	O
increasingly	O
urgent	O
to	O
answer	O
.	O

In	O
2005	O
,	O
the	O
Oregon	B-Organization
State	I-Organization
Land	I-Organization
Board	E-Organization
agreed	O
to	O
sell	O
of	O
Wasco	B-Location
County	E-Location
,	O
including	O
Rajneeshpuram	S-Location
,	O
to	O
the	O
Colorado-based	O
youth	O
ministry	O
Young	O
Life	O
.	O

Anthrax	S-Disease
is	O
a	O
disease	O
caused	O
by	O
bacteria	O
.	O

Is	O
your	O
work	O
in	O
creating	B-Technology
a	I-Technology
synthetic	I-Technology
bacterial	I-Technology
cell	E-Technology
"	O
creating	O
life	O
from	O
scratch"?	O

The	O
DMMSS	S-Scientific_research_project
program	O
has	O
begun	O
roll-to-roll	O
development	O
,	O
creating	O
samples	O
up	O
to	O
eight	O
inches	O
wide	O
.	O

Any	O
improperly	O
performed	O
operations	O
,	O
from	O
the	O
acceptance	O
of	O
specimens	O
to	O
PCR	S-Equipment
preparation	O
,	O
will	O
result	O
in	O
the	O
possibility	O
of	O
EVD	B-Incident
laboratory	I-Incident
infection	I-Incident
or	I-Incident
environmental	I-Incident
contamination	I-Incident
with	I-Incident
EBOV	I-Incident
RNA	E-Incident
,	O
making	O
test	O
results	O
unreliable	O
.	O

Although	O
gadolinium	O
agents	O
have	O
proved	O
useful	O
for	O
patients	O
with	O
renal	B-Disease
impairment	E-Disease
in	O
patients	O
with	O
severe	O
renal	B-Disease
failure	E-Disease
requiring	O
dialysis	S-Technology
there	O
is	O
a	O
risk	O
of	O
a	O
rare	O
but	O
serious	O
illness	O
,	O
nephrogenic	B-Disease
systemic	I-Disease
fibrosis	E-Disease
,	O
which	O
may	O
be	O
linked	O
to	O
the	O
use	O
of	O
certain	O
gadolinium-containing	O
agents	O
.	O

Biohacking	O
is	O
a	O
concept	O
that	O
gained	O
currency	O
in	O
popular	O
culture	O
over	O
the	O
past	O
decade	O
,	O
initially	O
as	O
an	O
apparently	O
earnest	O
approach	O
to	O
applying	O
the	O
tech-hacker	O
ethos	O
to	O
biology	O
.	O

The	O
salmonellosis	O
outbreak	O
was	O
also	O
discussed	O
in	O
the	O
media	O
within	O
the	O
context	O
of	O
the	O
.	O

Rickettsia	B-Pathogen
prowazekii	E-Pathogen
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
were	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
Russian	O
biodefense	O
categorization	O
,	O
but	O
was	O
included	O
in	O
the	O
second	O
highest	O
category	O
by	O
the	O
US	B-Organization
CDC	E-Organization
and	O
the	O
EU	S-Location
.	O
Influenza	O
virus	O
was	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
Russian	O
biodefense	O
categorization	O
,	O
but	O
was	O
included	O
in	O
the	O
second	O
highest	O
category	O
by	O
the	O
EU	S-Location
,	O
and	O
was	O
not	O
specifically	O
listed	O
by	O
.	O

These	O
could	O
arm	O
warheads	O
for	O
their	O
SS-18	O
intercontinental	O
missiles	O
to	O
target	O
American	O
cities	O
.	O

The	O
M33's	O
sub-munition	O
,	O
the	O
pipe-bomb-like	O
cylindrical	O
M114	O
bomb	O
,	O
was	O
also	O
completed	O
and	O
battle-ready	O
by	O
1952	O
.	O

A	O
40-year-old	O
woman	O
became	O
the	O
first	O
local	O
case	O
in	O
Shanghai	S-Location
.	O
A	O
Chinese	O
health	O
specialist	O
admitted	O
at	O
a	O
press	O
conference	O
of	O
not	O
informing	O
the	O
public	O
early	O
enough	O
about	O
the	O
outbreak	O
.	O

Other	O
studies	O
have	O
been	O
able	O
to	O
induce	O
transcription	O
of	O
Cas9	O
with	O
a	O
small	O
molecule	O
,	O
doxycycline	O
.	O

Bavarian	B-Organization
Nordic	E-Organization
partnered	O
with	O
the	O
U.S.	B-Organization
Biomedical	I-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
to	O
stockpile	O
Imvamune	S-Vaccine
,	O
a	O
smallpox	B-Vaccine
vaccine	E-Vaccine
to	O
protect	O
66	O
million	O
Americans	O
,	O
many	O
of	O
whom	O
have	O
weakened	O
immune	O
systems	O
and	O
do	O
not	O
respond	O
well	O
to	O
drugs	O
for	O
the	O
treatment	O
of	O
smallpox	S-Disease
currently	O
in	O
the	O
stockpile	O
.	O

That	O
means	O
that	O
a	O
big	O
amount	O
of	O
cartilage	O
and	O
a	O
thin	O
layer	O
of	O
compact	O
bone	O
can	O
cause	O
the	O
same	O
attenuation	O
in	O
a	O
voxel	O
as	O
hyperdense	O
cartilage	O
alone	O
.	O

Such	O
procedures	O
use	O
no	O
ferromagnetic	O
instruments	O
.	O

In	O
the	O
US	S-Location
,	O
it	O
can	O
take	O
10	O
years	O
for	O
a	O
new	O
drug	O
to	O
be	O
developed	O
and	O
approved	O
;	O
for	O
people	O
with	O
serious	O
health	O
conditions	O
,	O
that	O
wait	O
time	O
can	O
feel	O
cruelly	O
long.	O
claims	O
that's	O
part	O
of	O
why	O
he	O
wants	O
to	O
democratize	O
science	O
and	O
empower	O
people	O
to	O
experiment	O
on	O
themselves	O
.	O

The	O
peak	O
of	O
U.S.	S-Location
biological	O
weapons	O
delivery	O
system	O
development	O
came	O
during	O
the	O
1960s	O
.	O

The	O
mid-level	O
in	O
this	O
range	O
is	O
about	O
61 million	O
people	O
infected	O
with	O
.	O

If	O
initial	O
data	O
from	O
ZIK-101	S-Drug
are	O
supportive	O
,	O
will	O
work	O
to	O
progress	O
into	O
Phase	O
2	O
development	O
as	O
soon	O
as	O
possible	O
.	O

Ribosome	O
splitting	O
and	O
recycling:	O
for	O
example	O
,	O
drug-mediated	O
stalling	O
of	O
the	O
ribosome	O
by	O
lincomycin	S-Drug
and	O
erythromycin	S-Drug
unstalled	O
by	O
a	O
heat	O
shock	O
protein	O
found	O
in	O
,	O
which	O
is	O
an	O
homologous	O
of	O
HflX	O
from	O
other	O
bacteria	O
.	O

The	O
experiments	O
date	O
back	O
to	O
2007	O
when	O
an	O
unspecified	O
quantity	O
of	O
the	O
toxin	O
was	O
procured	O
to	O
the	O
Department	B-Organization
of	I-Organization
the	I-Organization
Army	E-Organization
by	O
the	O
same	O
company	O
–	O
.	O

Richard	B-Person
Preston	E-Person
tells	O
the	O
story	O
of	O
Sverdlovsk	S-Location
in	O
the	O
chapter	O
'	O
Invisible	B-Document
History	I-Document
(II)	E-Document
'	O
from	O
his	O
book	O
.	O

In	O
general	O
,	O
the	O
grade	O
order	O
of	O
most	O
biological	O
agents	O
of	O
laboratory	B-Document
biosafety	I-Document
category	I-Document
list	E-Document
and	O
biodefense	B-Document
category	I-Document
lists	E-Document
was	O
found	O
to	O
be	O
consistent	O
.	O

These	O
bombs	O
enabled	O
Japanese	O
soldiers	O
to	O
launch	O
biological	O
attacks	O
,	O
infecting	O
agriculture	O
,	O
reservoirs	O
,	O
wells	O
,	O
as	O
well	O
as	O
other	O
areas	O
with	O
anthrax	S-Pathogen
plague-carrier	B-Pathogen
fleas	E-Pathogen
,	O
typhoid	S-Pathogen
,	O
dysentery	S-Pathogen
,	O
cholera	S-Pathogen
or	O
other	O
deadly	O
pathogens	O
.	O

On	O
25	O
September	O
,	O
Peter	B-Person
Salama	E-Person
of	O
the	O
WHO	S-Organization
indicated	O
that	O
insecurity	O
is	O
obstructing	O
efforts	O
to	O
stop	O
the	O
virus	O
and	O
believed	O
a	O
combination	O
of	O
factors	O
could	O
establish	O
conditions	O
for	O
an	O
epidemic	O
.	O

DAD	S-Phenotype
	S-Phenotype
is	O
the	O
cause	O
of	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
()	O
and	O
severe	O
hypoxemia	O
.	O

Group	O
4	O
causes	O
severe	O
disease	O
and	O
is	O
defined	O
by	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
EU	S-Location
as	O
agents	O
for	O
which	O
no	O
effective	O
treatments	O
or	O
preventive	O
measures	O
are	O
available	O
.	O

Although	O
most	O
cases	O
are	O
mild	O
,	O
these	O
epidemics	O
still	O
cause	O
severe	O
illness	O
in	O
people	O
and	O
290,000–650,000	O
deaths	O
worldwide	O
every	O
year	O
.	O

Once	O
the	O
full	O
suspension	O
is	O
lifted	O
,	O
the	O
CDC	S-Organization
will	O
resume	O
inspections	O
on	O
a	O
regulatory	O
basis	O
as	O
mandated	O
by	O
the	O
federal	O
regulations	O
.	O

As	O
scientists	O
improve	O
their	O
ability	O
to	O
read	O
and	O
write	O
DNA	O
,	O
the	O
possibilities	O
continue	O
to	O
expand	O
.	O

1	O
.	O

According	O
to	O
studies	O
conducted	O
in	O
Australia	S-Location
and	O
Japan	S-Location
,	O
screening	O
individuals	O
for	O
influenza	O
symptoms	O
at	O
airports	O
during	O
the	O
was	O
not	O
an	O
effective	O
method	O
of	O
infection	O
control	O
.	O

Within	O
the	O
division	O
are	O
two	O
programs:	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
(	O
FSAP	S-Document
)	O
and	O
the	O
Import	B-Document
Permit	I-Document
Program	E-Document
.	O
The	O
FSAP	S-Document
is	O
run	O
jointly	O
with	O
an	O
office	O
within	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
,	O
regulating	O
agents	O
that	O
can	O
cause	O
disease	O
in	O
humans	O
,	O
animals	O
,	O
and	O
plants.	O
regulates	O
the	O
importation	O
of	O
"	O
infectious	O
biological	O
materials.	O
"	O

In	O
June	O
2010	O
,	O
scientists	O
from	O
Hong	B-Location
Kong	E-Location
reported	O
discovery	O
of	O
a	O
new	O
swine	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
:	O
a	O
hybrid	O
of	O
the	O
pandemic	O
H1N1	B-Pathogen
virus	E-Pathogen
and	O
viruses	O
previously	O
found	O
in	O
pigs	O
.	O

Synthetic	B-Organization
Genomics	I-Organization
Inc	E-Organization
(	O
SGI	S-Organization
)	O
is	O
a	O
privately	O
held	O
company	O
founded	O
to	O
apply	O
synthetic	O
genomic-driven	O
commercial	O
solutions	O
in	O
a	O
variety	O
of	O
global	O
challenges	O
including	O
energy	O
and	O
the	O
environment	O
.	O

ASM	O
members	O
are	O
now	O
obligated	O
to	O
discourage	O
any	O
use	O
of	O
microbiology	O
contrary	O
to	O
the	O
welfare	O
of	O
humankind	O
,	O
including	O
the	O
use	O
of	O
microbes	O
as	O
biological	O
weapons	O
and	O
will	O
call	O
to	O
the	O
attention	O
of	O
the	O
public	O
or	O
the	O
appropriate	O
authorities	O
misuses	O
of	O
microbiology	O
or	O
of	O
information	O
derived	O
from	O
microbiology	O
.	O

A	O
scientist	O
at	O
Texas	B-Organization
A&amp;M	I-Organization
in	I-Organization
College	I-Organization
Station-B	E-Organization
yron	O
stuck	O
himself	O
with	O
a	O
needle	O
while	O
injecting	O
a	O
mouse	O
that	O
was	O
previously	O
infected	O
wit	O
h	B-Pathogen
a	I-Pathogen
recombinant	I-Pathogen
strain	I-Pathogen
of	I-Pathogen
Borrelia	I-Pathogen
burgdor	E-Pathogen
feri	O
,	O
the	O
bacteria	O
that	O
cauease	O
,	O
in	O
February	O
2014	O
.	O

In	O
the	O
interwar	O
period	O
,	O
little	O
research	O
was	O
done	O
in	O
biological	O
warfare	O
in	O
both	O
Britain	O
and	O
the	O
United	O
States	O
at	O
first	O
.	O

According	O
to	O
them	O
,	O
"	O
we've	O
now	O
seen	O
several	O
cases	O
that	O
don't	O
have	O
any	O
symptoms	O
at	O
all	O
,	O
asymptomatic	O
cases	O
.	O

That's	O
why	O
events	O
like	O
this	O
should	O
never	O
happen	O
,	O
and	O
that's	O
why	O
I	O
will	O
do	O
everything	O
in	O
my	O
power	O
to	O
make	O
sure	O
that	O
nothing	O
like	O
this	O
happens	O
again	O
.	O

G.P.O.	O
,	O
2012	O
.	O

On	O
Friday	O
,	O
30	O
March	O
1979	O
a	O
technician	O
removed	O
a	O
clogged	O
filter	S-Equipment
while	O
drying	O
machines	O
were	O
temporarily	O
turned	O
off	O
.	O

A	O
December	O
2009	O
study	O
found	O
that	O
the	O
transmissibility	O
of	O
the	O
in	O
households	O
is	O
lower	O
than	O
that	O
seen	O
in	O
past	O
pandemics	O
.	O

For	O
a	O
start	O
,	O
there	O
are	O
few	O
large-scale	O
pharmaceutical	O
campaigns	O
.	O

It's	O
because	O
it's	O
the	O
truth.	O
"	O

Eshoo	S-Person
said	O
she	O
looks	O
forward	O
to	O
swift	O
consideration	O
and	O
approval	O
of	O
H.R.	B-Document
6378	E-Document
by	O
members	O
in	O
the	O
U.S.	B-Organization
Senate	E-Organization
"	O
so	O
that	O
it	O
can	O
be	O
signed	O
into	O
law	O
before	O
Sept.	O
30,	O
"	O
which	O
is	O
the	O
deadline	O
to	O
reauthorize	O
.	O

Then	O
,	O
around	O
the	O
1960s	O
,	O
most	O
likely	O
due	O
to	O
climate	O
change	O
or	O
human	O
activities	O
,	O
the	O
genetic	O
diversity	O
of	O
the	O
virus	O
dropped	O
rapidly	O
and	O
most	O
lineages	O
became	O
extinct	O
.	O

Furthermore	O
,	O
19	O
(10%)	O
laboratories	O
had	O
a	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
vaccination	O
programme	O
,	O
5	O
(6.	O
2%)	O
applied	O
BCG	B-Vaccine
vaccine	E-Vaccine
,	O
and	O
2	O
(1.	O
1%0)	O
vaccinated	O
the	O
staff	O
against	O
.	O

A	O
visual	O
representation	O
of	O
the	O
raw	O
data	O
obtained	O
is	O
called	O
a	O
sinogram	O
,	O
yet	O
it	O
is	O
not	O
sufficient	O
for	O
interpretation	O
.	O

Shigella	S-Pathogen
in	O
particular	O
is	O
estimated	O
to	O
cause	O
80	O
–165	O
million	O
cases	O
of	O
disease	O
worldwide	O
,	O
resulting	O
in	O
600,000	O
deaths	O
annually	O
and	O
is	O
particularly	O
prevalent	O
in	O
both	O
sub-	O
Saharan	S-Location
Africa	S-Location
and	O
.	O

Allegations	O
were	O
made	O
that	O
a	O
"	O
chemical	O
section	O
"	O
of	O
a	O
US	S-Location
clandestine	O
unit	O
hidden	O
within	O
Yokosuka	B-Location
naval	I-Location
base	E-Location
was	O
operational	O
during	O
the	O
Korean	O
War	O
,	O
and	O
then	O
worked	O
on	O
unspecified	O
projects	O
inside	O
the	O
from	O
1955	O
to	O
1959	O
,	O
before	O
returning	O
to	O
Japan	O
to	O
enter	O
the	O
private	O
sector	O
.	O

We	O
have	O
one	O
medicine	O
available	O
that	O
is	O
not	O
very	O
effective	O
,	O
especially	O
when	O
people	O
don't	O
come	O
to	O
the	O
hospital	O
early	O
.	O

In	O
the	O
United	B-Location
States	E-Location
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
is	O
charged	O
with	O
protecting	O
the	O
health	O
,	O
safety	O
and	O
security	O
of	O
Americans	O
.	O

Also	O
,	O
systems	O
like	O
ISA	O
software	O
suite	O
,	O
BASE	S-Platform
(e.g.	O
with	O
XperimentR	S-Platform
)	O
,	O
DIPSBC	S-Platform
or	O
Gaggle	S-Platform
(e.g.	O
with	O
)	O
have	O
been	O
integrated	O
with	O
other	O
data	O
management	O
solutions	O
.	O

Downloaded	O
Oct.22	O
,	O
2017	O
.	O

The	O
cross-sectoral	O
FBD	S-Platform
network	O
not	O
only	O
adopts	O
to	O
the	O
One	O
Health	O
concept	O
;	O
it	O
also	O
leads	O
to	O
improved	O
coordination	O
and	O
harmonization	O
between	O
laboratories	O
that	O
undoubtedly	O
will	O
save	O
resources	O
and	O
strengthen	O
national	O
biopreparedness	O
.	O

Belgian	O
nuns	O
serving	O
the	O
community	O
were	O
also	O
infected	O
,	O
and	O
two	O
of	O
them	O
died	O
,	O
along	O
with	O
Mayinga	B-Person
N'Seka	E-Person
,	O
a	O
Zairean	O
nurse	O
,	O
after	O
the	O
group	O
was	O
transported	O
to	O
Kinshasa	S-Organization
.	O
With	O
assistance	O
from	O
the	O
WHO	S-Organization
,	O
the	O
outbreak	O
was	O
eventually	O
contained	O
by	O
quarantining	O
local	O
villagers	O
in	O
their	O
communities	O
,	O
sterilizing	O
medical	O
equipment	O
,	O
and	O
providing	O
protective	O
clothing	O
to	O
medical	O
personnel	O
.	O

During	O
the	O
closing	O
stages	O
of	O
the	O
Rhodesian	O
Bush	O
War	O
,	O
the	O
Rhodesian	O
government	O
resorted	O
to	O
use	O
chemical	O
and	O
biological	O
warfare	O
agents	O
.	O

Infectious	O
disease	O
preparedness	O
work	O
focuses	O
predominantly	O
on	O
an	O
historical	O
list	O
of	O
pathogens	O
derived	O
from	O
biological	O
warfare	O
agents	O
,	O
political	O
considerations	O
,	O
and	O
recent	O
outbreaks	O
.	O

"	O
Use	O
antibiotics	O
only	O
when	O
needed	O
,	O
especially	O
not	O
in	O
'just	O
in	O
case'	O
scenarios,	O
"	O
emphasized	O
Dr	O
.	O

The	O
3	O
recurrences	O
in	O
1889–1892	O
,	O
however	O
,	O
were	O
spread	O
over	O
&gt;3	O
years	O
,	O
in	O
contrast	O
to	O
1918–1919	O
,	O
when	O
the	O
sequential	O
waves	O
seen	O
in	O
individual	O
countries	O
were	O
typically	O
compressed	O
into	O
≈8–9	O
months	O
.	O

TOM	B-Person
FRIEDEN	E-Person
In	O
terms	O
of	O
the	O
impact	O
of	O
the	O
moratorium	O
,	O
we're	O
going	O
to	O
assess	O
that	O
laboratory	O
by	O
laboratory	O
.	O

Within	O
the	O
past	O
few	O
years	O
,	O
epigenetic	O
marks	O
in	O
different	O
human	O
cells	O
have	O
been	O
closely	O
researched	O
and	O
certain	O
patterns	O
within	O
the	O
marks	O
have	O
been	O
found	O
to	O
correlate	O
with	O
everything	O
ranging	O
from	O
tumor	O
growth	O
to	O
brain	O
activity	O
.	O

First	O
,	O
without	O
killing	O
the	O
bacteria	O
,	O
the	O
technology	O
must	O
extract	O
and	O
isolate	O
them	O
from	O
complex	O
environments	O
such	O
as	O
soil	O
,	O
runoff	O
,	O
sewage	O
,	O
biofilms	O
,	O
and	O
medical	O
samples	O
,	O
where	O
numerous	O
strains	O
of	O
bacteria	O
live	O
together	O
.	O

What's	O
distressing	O
about	O
it	O
are	O
two	O
things	O
,	O
really	O
.	O

between	O
about	O
195,000	O
and	O
403,000	O
H1N1	S-Pathogen
hospitalizations	O
occurred	O
between	O
April	O
2009	O
and	O
10	O
April	O
2010	O
.	O

That	O
includes	O
mechanical	O
paitents	O
built	O
specific	O
to	O
trauma	O
injuries	O
,	O
which	O
can	O
bleed	O
–	O
and	O
bleed	O
out	O
–	O
and	O
offer	O
more	O
options	O
for	O
surgical	O
procedures	O
.	O

A	O
covert	O
military	O
research	O
and	O
development	O
program	O
continued	O
for	O
another	O
four	O
years	O
,	O
with	O
the	O
intent	O
of	O
resuming	O
agent	O
production	O
and	O
weapons	O
manufacture	O
after	O
the	O
end	O
of	O
UN	S-Organization
sanctions	O
.	O

Please	O
see	O
Additional	O
file	O
1	O
for	O
translations	O
of	O
the	O
abstract	O
into	O
the	O
six	O
official	O
working	O
languages	O
of	O
the	O
United	B-Organization
Nations	E-Organization

On	O
28	O
May	O
2013	O
,	O
a	O
report	O
by	O
the	O
Associated	B-Organization
Press	E-Organization
said	O
a	O
French	O
patient	O
died	O
of	O
the	O
novel	O
coronavirus	O
related	O
to	O
.	O
Fifty	O
percent	O
of	O
those	O
infected	O
have	O
died	O
.	O

Similarly	O
,	O
immunodeficiency	B-Pathogen
virus	E-Pathogen
and	O
were	O
categorized	O
according	O
to	O
the	O
highest	O
laboratory	O
biosafety	O
level	O
,	O
but	O
were	O
not	O
included	O
in	O
the	O
corresponding	O
biodefense	O
level	O
.	O

Like	O
the	O
VA	O
,	O
the	O
military's	O
health	O
facilities	O
cannot	O
accommodate	O
the	O
demand	O
for	O
care	O
by	O
all	O
active	O
duty	O
service	O
people	O
,	O
their	O
dependents	O
,	O
and	O
retirees	O
(many	O
of	O
whom	O
are	O
not	O
eligible	O
for	O
VA	O
services)	O
.	O

Once	O
the	O
program	O
begins	O
,	O
a	O
separate	O
independent	O
verification	O
and	O
validation	O
(IV&amp;V)	O
team	O
contractedARPA	O
will	O
work	O
with	O
performer	O
teams	O
to	O
provide	O
standardized	O
biological	O
samples	O
that	O
simulate	O
different	O
environments	O
and	O
include	O
mixtures	O
of	O
known	O
bacteria	O
.	O

Resistance	O
to	O
recently	O
developed	O
drugs	O
such	O
as	O
artemisinin	S-Drug
has	O
also	O
been	O
reported	O
.	O

On	O
9	O
April	O
2020	O
,	O
preliminary	O
results	O
found	O
that	O
15	O
percent	O
of	O
people	O
tested	O
in	O
Gangelt	S-Location
the	O
centre	O
of	O
a	O
major	O
infection	O
cluster	O
in	O
Germany	S-Location
,	O
tested	O
positive	O
for	O
antibodies	O
.	O

During	O
,	O
this	O
laboratory	O
did	O
phenomenal	O
work	O
sequencing	O
specimens	O
,	O
figuring	O
out	O
where	O
the	O
virus	O
was	O
going	O
.	O

However	O
,	O
they	O
are	O
giving	O
latitude	O
to	O
the	O
scientific	O
community	O
to	O
identify	O
which	O
pathogens	O
,	O
in	O
particular	O
,	O
labs	O
and	O
institutions	O
should	O
be	O
inventoried.	O
*How	O
is	O
this	O
enforceable*?	O
*What	O
are	O
the	O
consequences	O
for	O
non-compliance*?	O
In	O
short	O
,	O
its	O
not	O
enforceable	O
and	O
there	O
are	O
no	O
consequences	O
for	O
non-compliance	O
.	O

Along	O
with	O
laboratory	O
testing	O
,	O
chest	B-Technology
CT	I-Technology
scans	E-Technology
may	O
be	O
helpful	O
to	O
diagnose	O
in	O
individuals	O
with	O
a	O
high	O
clinical	O
suspicion	O
of	O
infection	O
but	O
are	O
not	O
recommended	O
for	O
routine	O
screening	O
.	O

Although	O
the	O
Japanese	O
effort	O
lacked	O
the	O
technological	O
sophistication	O
of	O
the	O
American	O
or	O
British	O
programs	O
,	O
it	O
far	O
outstripped	O
them	O
in	O
its	O
widespread	O
application	O
and	O
indiscriminate	O
brutality	O
.	O

Anthrax	S-Pathogen
is	O
of	O
course	O
the	O
first	O
choice	O
because	O
the	O
causative	O
agent	O
,	O
B.	B-Pathogen
anthracis	E-Pathogen
,	O
fulfils	O
nearly	O
all	O
of	O
these	O
specifications	O
(Fig.3)	O
.	O

It	O
spread	O
following	O
the	O
path	O
of	O
its	O
human	O
carriers	O
,	O
along	O
trade	O
routes	O
and	O
shipping	O
lines	O
.	O

First	O
,	O
can	O
the	O
bacteria	O
survive	O
and	O
establish	O
a	O
niche	O
in	O
a	O
host	O
organism?	O
Does	O
it	O
,	O
for	O
instance	O
,	O
adhere	O
to	O
the	O
host's	O
cell	O
membranes?	O
Second	O
,	O
can	O
the	O
bacteria	O
harm	O
its	O
host?	O
For	O
example	O
,	O
does	O
it	O
secrete	O
toxins	O
or	O
have	O
flagella	O
that	O
could	O
disrupt	O
the	O
host's	O
mucosal	O
tissue?	O
And	O
third	O
,	O
can	O
the	O
bacterium	O
protect	O
itself?	O
Does	O
it	O
inactivate	O
the	O
host's	O
protective	O
antibodies	O
or	O
resist	O
antibiotics?	O

The	O
updated	O
recommendations	O
were	O
based	O
on	O
preliminary	O
results	O
from	O
the	O
NIAID-ACTT	B-Scientific_research_project
study	E-Scientific_research_project
,	O
which	O
suggested	O
a	O
beneficial	O
effect	O
of	O
remdesivir	S-Drug
in	O
the	O
treatment	O
of	O
hospitalized	O
individuals	O
with	O
severe	O
.	O

Following	O
Nixon	S-Person
's	O
November	O
1969	O
order	O
,	O
scientists	O
at	O
Fort	B-Location
Detrick	E-Location
worked	O
on	O
one	O
toxin	O
,	O
Staphylococcus	B-Pathogen
enterotoxin	I-Pathogen
type	I-Pathogen
B	E-Pathogen
(	O
SEB	S-Pathogen
)	O
,	O
for	O
several	O
more	O
months	O
.	O

SGI	S-Organization
has	O
filed	O
13	O
patent	O
family	O
applications	O
on	O
the	O
unique	O
inventions	O
of	O
the	O
JCVI	S-Organization
team	O
.	O

When	O
categorized	O
into	O
types	O
,	O
most	O
of	O
the	O
initiatives	O
were	O
found	O
to	O
be	O
in	O
the	O
category	O
of	O
general	O
awareness	O
and	O
information	O
exchange	O
workshops	O
at	O
country	O
level	O
70.	O
68%	O
(n = 1295)	O
.	O

Yet	O
those	O
suits	O
ruptured	O
or	O
developed	O
holes	O
in	O
at	O
least	O
37	O
incidents	O
during	O
a	O
20-month	O
period	O
in	O
2013	O
and	O
2014	O
,	O
according	O
to	O
lab	O
incident	O
reports	O
obtained	O
by	O
USA	B-Organization
TODAY	E-Organization
under	O
the	O
federal	O
.	O

Dr	O
Paul	B-Person
Farmer	E-Person
stated:	O
"	O
Most	O
of	O
Ebola	S-Disease
's	O
victims	O
may	O
well	O
be	O
dying	O
from	O
other	O
causes:	O
women	O
in	O
childbirth	O
,	O
children	O
from	O
,	O
people	O
in	O
road	O
accidents	O
or	O
from	O
trauma	O
of	O
other	O
sorts.	O
"	O

All	O
told	O
,	O
since	O
President	O
urged	O
nations	O
to	O
contribute	O
to	O
the	O
response	O
,	O
countries	O
from	O
all	O
over	O
the	O
world	O
,	O
private	O
sector	O
stakeholders	O
,	O
international	O
organizations	O
,	O
and	O
multilateral	O
development	O
banks	O
have	O
pledged	O
more	O
than	O
$2	O
billion	O
to	O
end	O
the	O
epidemic	O
.	O

By	O
making	O
a	O
comparison	O
of	O
the	O
number	O
and	O
type	O
of	O
articles	O
published	O
by	O
Environmental	O
Biosafety	O
Research	O
(EBR)	O
with	O
those	O
from	O
other	O
journals	O
active	O
in	O
the	O
arena	O
of	O
GMO	S-Technology
biosafety	O
,	O
it	O
is	O
possible	O
to	O
shed	O
light	O
on	O
the	O
answer	O
to	O
the	O
question	O
posed	O
in	O
the	O
title	O
.	O

By	O
23	O
March	O
,	O
Iran	S-Location
was	O
experiencing	O
fifty	O
new	O
cases	O
every	O
hour	O
and	O
one	O
new	O
death	O
every	O
ten	O
minutes	O
due	O
to	O
coronavirus	S-Pathogen
.	O
According	O
to	O
a	O
WHO	S-Organization
official	O
,	O
there	O
may	O
be	O
five	O
times	O
more	O
cases	O
in	O
than	O
what	O
is	O
being	O
reported	O
.	O

Publication	O
S/1995/864	O
,	O
59.Zilinskas	O
,	O
R.A.	O
,	O
"	O
:	O
The	O
Past	O
as	O
Future?	O
"	O
,	O
Journal	O
of	O
the	O
American	O
Medical	O
Association	O
,	O
1997;278:418–424	O
,	O
60	O
.	O

Under	O
another	O
DTRA	S-Organization
project	O
"	O
Epidemiology	B-Scientific_research_project
and	I-Scientific_research_project
Ecology	I-Scientific_research_project
of	I-Scientific_research_project
Tularemia	I-Scientific_research_project
in	I-Scientific_research_project
Georgia	E-Scientific_research_project
"	O
(2013-2016)	O
6,148	O
ground	O
ticks	O
were	O
collected	O
;	O
5,871	O
were	O
collected	O
off	O
the	O
cattle	O
and	O
1,310	O
fleas	O
and	O
731	O
ticks	O
were	O
caught	O
.	O

There	O
is	O
no	O
medication	O
known	O
to	O
be	O
effective	O
at	O
preventing	O
COVID‑19	S-Disease
After	O
the	O
implementation	O
of	O
social	O
distancing	O
and	O
stay-at-home	O
orders	O
,	O
many	O
regions	O
have	O
been	O
able	O
to	O
sustain	O
an	O
effective	O
transmission	O
rate	O
("Rt")	O
of	O
less	O
than	O
one	O
,	O
meaning	O
the	O
disease	O
is	O
in	O
remission	O
in	O
those	O
areas	O
.	O

At	O
the	O
time	O
of	O
his	O
arrival	O
in	O
Japan	S-Location
he	O
had	O
no	O
knowledge	O
of	O
what	O
Unit	B-Organization
731	E-Organization
was	O
.	O

SECOA	S-International_exchange_and_cooperation
(	O
Solutions	B-International_exchange_and_cooperation
for	I-International_exchange_and_cooperation
Environmental	I-International_exchange_and_cooperation
Contrasts	I-International_exchange_and_cooperation
in	I-International_exchange_and_cooperation
Coastal	I-International_exchange_and_cooperation
Areas	E-International_exchange_and_cooperation
)	O
is	O
a	O
multi-national	O
research	O
project	O
examining	O
the	O
effects	O
of	O
human	O
mobility	O
on	O
urban	O
settlements	O
in	O
fragile	O
coastal	O
environments	O
.	O

Based	O
on	O
many	O
years	O
of	O
experience	O
in	O
Africa	S-Location
several	O
months	O
working	O
in	O
the	O
present	O
epidemic-	O
MSF	S-Organization
took	O
a	O
conservative	O
approach	O
.	O

On	O
23	O
September	O
2014	O
,	O
the	O
WHO	S-Organization
revised	O
their	O
previous	O
projection	O
,	O
stating	O
that	O
they	O
expected	O
the	O
number	O
of	O
Ebola	S-Disease
cases	O
in	O
Western	B-Location
Africa	E-Location
to	O
be	O
in	O
excess	O
of	O
20,000	O
by	O
2	O
November	O
2014	O
.	O

Broad,	B-Person
W.J	E-Person
.	O
and	O
Miller	B-Person
J	E-Person
.	O
(2002)	O
,	O
"	O
Traces	O
of	O
Terror:	O
The	O
Bioterror	O
Threat	O
;	O
Report	O
Provides	O
New	O
Details	O
of	O
"	O
,	O
The	O
New	O
York	O
Times	O
;	O
15	O
June	O
issue	O
.	O

The	O
State	B-Organization
Department	E-Organization
closely	O
with	O
U.S.	S-Location
and	O
West	B-Location
African	E-Location
diplomats	O
on	O
the	O
ground	O
,	O
and	O
our	O
counterparts	O
throughout	O
the	O
government	O
to	O
bring	O
the	O
full	O
range	O
of	O
U.S.	S-Location
resources	O
to	O
bear	O
.	O

Analyses	O
of	O
the	O
genetic	O
sequences	O
of	O
the	O
first	O
isolates	O
,	O
promptly	O
shared	O
on	O
the	O
GISAID	B-Platform
database	E-Platform
according	O
to	O
Nature	S-Organization
and	O
WHO	S-Organization
,	O
soon	O
determined	O
that	O
the	O
strain	O
contains	O
genes	O
from	O
five	O
different	O
flu	O
viruses:	O
North	B-Disease
American	I-Disease
swine	I-Disease
influenza	E-Disease
,	O
North	B-Disease
American	I-Disease
avian	I-Disease
influenza	E-Disease
,	O
human	O
influenza	O
,	O
and	O
two	O
swine	O
influenza	O
viruses	O
typically	O
found	O
in	O
Asia	S-Location
and	O
Europe	S-Location
.	O
Further	O
analysis	O
has	O
shown	O
that	O
several	O
proteins	O
of	O
the	O
virus	O
are	O
most	O
similar	O
to	O
strains	O
that	O
cause	O
mild	O
symptoms	O
in	O
humans	O
,	O
leading	O
virologist	O
to	O
suggest	O
on	O
1May	O
2009	O
,	O
that	O
the	O
initial	O
indications	O
are	O
that	O
the	O
virus	O
was	O
unlikely	O
to	O
cause	O
severe	O
symptoms	O
for	O
most	O
people	O
.	O

Antimicrobial	O
resistance	O
in	O
bacteria	O
.	O

It	O
was	O
less	O
severe	O
than	O
the	O
second	O
wave	O
but	O
still	O
much	O
more	O
deadly	O
than	O
the	O
initial	O
first	O
wave	O
.	O

The	O
report	O
identified	O
seven	O
experiments	O
of	O
concern	O
,	O
including	O
those	O
that	O
would	O
enhance	O
the	O
virulence	O
of	O
a	O
pathogen	O
and	O
demonstrate	O
how	O
to	O
render	O
a	O
vaccine	O
ineffective	O
.	O

Roger	B-Person
Wicker	E-Person
,	O
R-Mississippi	S-Organization
.	O
A	O
laboratory	O
in	O
Maryland	S-Location
confirmed	O
the	O
presence	O
of	O
ricin	S-Pathogen
after	O
initial	O
field	O
tests	O
indicated	O
the	O
poison	O
was	O
present	O
,	O
according	O
to	O
Senate	S-Organization
Sergeant-at-Arms	O
.	O

[Discussion	O
section	O
,	O
8th	O
paragraph]	O
.	O

In	O
the	O
United	B-Location
States	E-Location
half	O
of	O
CT	B-Technology
scans	E-Technology
are	O
contrast	B-Drug
CTs	E-Drug
using	O
intravenously	O
injected	O
radiocontrast	O
agents	O
.	O

Discussions	O
on	O
the	O
content	O
,	O
promulgation	O
,	O
and	O
adoption	O
of	O
codes	O
of	O
conduct	O
were	O
completed	O
in	O
December	O
2005	O
by	O
States	O
Party	O
to	O
the	O
Biological	B-International_exchange_and_cooperation
Weapons	I-International_exchange_and_cooperation
Convention	E-International_exchange_and_cooperation

In	O
its	O
statement	O
,	O
Vector	S-Organization
said	O
that	O
no	O
biohazard	O
material	O
was	O
being	O
stored	O
in	O
the	O
room	O
where	O
the	O
explosion	O
took	O
place	O
.	O

"	O
It	O
is	O
our	O
opinion	O
that	O
the	O
knowledge	O
to	O
be	O
gained	O
from	O
this	O
program	O
appears	O
very	O
limited	O
in	O
its	O
capacity	O
to	O
enhance	O
U.S.	O
agriculture	O
or	O
respond	O
to	O
national	O
emergencies,	O
"	O
the	O
authors	O
wrote	O
.	O

As	O
is	O
common	O
with	O
infections	O
,	O
there	O
is	O
a	O
delay	O
between	O
the	O
moment	O
a	O
person	O
is	O
first	O
infected	O
and	O
the	O
time	O
he	O
or	O
she	O
develops	O
symptoms	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	O
,	O
DHHS	O
,	O
DoT	S-Organization
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

ResistanceMap	S-Platform
is	O
a	O
website	O
by	O
the	O
licy	O
and	O
provides	O
data	O
on	O
antimicrobial	O
resistance	O
on	O
a	O
global	O
level	O
.	O

A	O
jet	O
aircraft	O
released	O
material	O
over	O
Victoria	S-Location
Texas	S-Location
,	O
that	O
was	O
monitored	O
in	O
the	O
.	O

The	O
committee	O
will	O
also	O
discuss	O
vaccines	O
for	O
human	B-Pathogen
papillomavirus	E-Pathogen
,	O
Japanese	B-Pathogen
encephalitis	E-Pathogen
and	O
.	O

The	O
subject	O
was	O
not	O
pursued	O
further	O
by	O
Sutton	S-Person
,	O
who	O
was	O
probably	O
unaware	O
of	O
's	O
activities	O
.	O

Martin	S-Person
,	O
James	B-Person
W.	E-Person
,	O
George	B-Person
W.	I-Person
Christopher	E-Person
and	O
Edward	B-Person
M.	I-Person
Eitzen	E-Person
(2007)	O
,	O
"	O
History	O
of	O
Biological	O
Weapons:	O
From	O
Poisoned	O
Darts	O
to	O
Intentional	O
Epidemics"	O
,	O
In:	O
Dembek,	B-Person
Zygmunt	I-Person
F.	E-Person
(2007)	O
,	O
Medical	O
Aspects	O
of	O
Biological	O
Warfare	O
,	O
(Series:	O
Textbooks	O
of	O
Military	O
Medicine)	O
,	O
Washington,	B-Location
DC	E-Location
:	O
,	O
pg	O
11	O
.	O

Some	O
results	O
(such	O
as	O
the	O
study)	O
have	O
received	O
substantial	O
press	O
coverage	O
without	O
first	O
passing	O
through	O
peer	O
review	O
.	O

Both	O
of	O
those	O
are	O
part	O
of	O
Dorsey	S-Person
routine	O
,	O
which	O
he	O
detailed	O
in	O
a	O
podcast	O
interview	O
.	O

Restriction	O
enzymes	O
changed	O
genetics	O
because	O
they	O
allow	O
scientists	O
to	O
cut	O
and	O
paste	O
pieces	O
of	O
DNA	O
,	O
although	O
it	O
took	O
two	O
more	O
scientists	O
to	O
realize	O
their	O
potential	O
.	O

In	O
1970	O
and	O
1972	O
,	O
Sand	B-Scientific_research_project
Fly	I-Scientific_research_project
Fever	E-Scientific_research_project
tests	O
were	O
performed	O
on	O
humans	O
according	O
to	O
a	O
declassified	O
US	B-Organization
Army	E-Organization
report	O
–	O
US	B-Organization
Army	E-Organization
Activities	O
in	O
the	O
US	S-Location
,	O
Biological	O
Warfare	O
Programs	O
,	O
1977	O
,	O
vol.II	O
,	O
p.	O
203	O
During	O
operation	O
Whitecoat	O
volunteers	O
were	O
exposed	O
to	O
bites	O
by	O
infected	O
sand	O
flies	O
.	O

Health	O
officials	O
use	O
the	O
virus'	O
clinical	O
name	O
--	O
H1N1	S-Pathogen
--	O
to	O
reflect	O
that	O
it's	O
actually	O
a	O
combination	O
of	O
several	O
different	O
types	O
of	O
and	O
to	O
reduce	O
confusion	O
about	O
whether	O
eating	O
pork	O
can	O
spread	O
the	O
virus.It	O
cannot	O
.	O

In	O
the	O
Pacific	S-Location
American	O
Samoa	S-Location
and	O
the	O
French	O
colony	O
of	O
New	B-Location
Caledonia	E-Location
also	O
succeeded	O
in	O
preventing	O
even	O
a	O
single	O
death	O
from	O
influenza	S-Disease
through	O
effective	O
quarantines	O
.	O

Rather	O
than	O
closing	O
schools	O
,	O
the	O
CDC	S-Organization
recommended	O
that	O
students	O
and	O
school	O
workers	O
with	O
flu	O
symptoms	O
should	O
stay	O
home	O
for	O
either	O
seven	O
days	O
total	O
,	O
or	O
until	O
24	O
hours	O
after	O
symptoms	O
subsided	O
,	O
whichever	O
was	O
longer	O
.	O

By	O
the	O
end	O
of	O
the	O
program	O
,	O
seeks	O
to	O
demonstrate	O
in	O
controlled	O
laboratory	O
conditions	O
the	O
suppression	O
of	O
viral	O
jump	O
to	O
a	O
new	O
species	O
.	O

Immediately	O
following	O
the	O
incident	O
in	O
Frist's	O
office	O
,	O
both	O
the	O
FBI	S-Organization
and	O
the	O
United	B-Organization
States	I-Organization
Capitol	I-Organization
Police	E-Organization
were	O
tasked	O
to	O
the	O
investigation	O
;	O
like	O
in	O
the	O
Fallen	B-Activity
Angel	I-Activity
investigation	E-Activity
,	O
the	O
FBI	S-Organization
was	O
the	O
lead	O
agency	O
.	O

In	O
terms	O
of	O
the	O
,	O
you'd	O
have	O
to	O
direct	O
that	O
question	O
to	O
them	O
.	O

EK	S-Person
and	O
MC	S-Person
conceived	O
the	O
idea	O
for	O
this	O
project	O
.	O

One	O
study	O
estimated	O
that	O
as	O
many	O
as	O
0.	O
4%	O
of	O
current	O
cancers	O
in	O
the	O
United	B-Location
States	E-Location
are	O
due	O
to	O
CTs	S-Technology
performed	O
in	O
the	O
past	O
and	O
that	O
this	O
may	O
increase	O
to	O
as	O
high	O
as	O
1.	O
5	O
to	O
2%	O
with	O
2007	O
rates	O
of	O
CT	S-Technology
use	O
;	O
however	O
,	O
this	O
estimate	O
is	O
disputed	O
,	O
as	O
there	O
is	O
not	O
a	O
consensus	O
about	O
the	O
existence	O
of	O
damage	O
from	O
low	O
levels	O
of	O
radiation	O
.	O

The	O
isomers	O
were	O
then	O
separated	O
via	O
reversed-phase	B-Technology
HPLC	E-Technology
The	O
optically	O
pure	O
compound	O
and	O
intermediate	O
a	O
are	O
reacted	O
with	O
trimethyl	O
phosphate	O
and	O
methylimidazole	O
to	O
obtain	O
a	O
diastereomer	O
mixture	O
of	O
remdesivir	S-Drug
.	O
In	O
the	O
end	O
,	O
optically	O
pure	O
can	O
be	O
obtained	O
through	O
chiral	O
resolution	O
methods	O
.	O

So	O
when	O
something	O
like	O
this	O
happens	O
here	O
,	O
I'm	O
deeply	O
concerned	O
about	O
it	O
.	O

The	O
meeting	O
-	O
sponsored	O
by	O
the	O
Nuclear	B-Organization
Threat	I-Organization
Initiative	E-Organization
(	O
NTI	S-Organization
)	O
,	O
Oxford	B-Organization
University	E-Organization
,	O
and	O
-	O
included	O
representatives	O
from	O
13	O
countries	O
with	O
expertise	O
in	O
life	O
sciences	O
and	O
bioengineering	O
,	O
biodefense	O
and	O
biosecurity	O
,	O
science	O
policy	O
,	O
public	O
health	O
,	O
infectious	O
diseases	O
,	O
and	O
catastrophic	O
risks	O
.	O

People	O
in	O
at-risk	O
groups	O
should	O
be	O
treated	O
with	O
antivirals	O
(	O
oseltamivir	S-Drug
or	O
zanamivir	S-Drug
)	O
as	O
soon	O
as	O
possible	O
when	O
they	O
first	O
experience	O
flu	O
symptoms	O
.	O

The	O
extremes	O
poles	O
are	O
simple	O
hyperlinks	O
connecting	O
resources	O
versus	O
full	O
integration	O
in	O
a	O
data	O
warehouse	O
structure	O
.	O

Drug-resistant	O
plague	S-Disease
a	O
'major	O
threat'	O
,	O
say	O
scientists	O
,	O
SciDev.Net	S-Person
.	O
A	O
further	O
outbreak	O
in	O
Madagascar	S-Location
was	O
reported	O
in	O
November	O
2014	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
not	O
the	O
only	O
biological	O
disaster	O
to	O
scar	O
human	O
history	O
.	O

CDC	S-Organization
announced	O
today	O
that	O
approximately	O
75	O
Atlanta-based	O
staff	O
are	O
being	O
monitored	O
or	O
provided	O
antibiotics	S-Drug
because	O
they	O
may	O
have	O
been	O
unintentionally	O
exposed	O
to	O
live	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
()	O
after	O
established	O
safety	O
practices	O
were	O
not	O
followed	O
.	O

Having	O
previously	O
gained	O
political	O
control	O
of	O
Antelope	S-Location
Oregon	S-Location
,	O
Rajneesh's	O
followers	O
,	O
who	O
were	O
based	O
in	O
nearby	O
Rajneeshpuram	S-Location
,	O
sought	O
election	O
to	O
two	O
of	O
the	O
three	O
seats	O
on	O
the	O
Wasco	B-Organization
County	I-Organization
Circuit	I-Organization
Court	E-Organization
that	O
were	O
up	O
for	O
election	O
in	O
November	O
1984	O
.	O

We	O
believe	O
that	O
collaboration	O
among	O
laboratories	O
will	O
be	O
central	O
when	O
it	O
comes	O
to	O
adapting	O
to	O
the	O
rapid	O
technical	O
development	O
that	O
is	O
now	O
ongoing	O
in	O
microbiology	O
laboratories	O
.	O

Ricin	S-Pathogen
,	O
a	O
substance	O
derived	O
from	O
castor	O
beans	O
that	O
has	O
been	O
used	O
in	O
bioterror	O
attacks	O
,	O
"	O
has	O
legitimate	O
lab	O
uses	O
in	O
very	O
small	O
quantities,	O
"	O
but	O
was	O
not	O
in	O
use	O
in	O
this	O
lab	O
,	O
the	O
memo	O
says	O
.	O

The	O
CFR	O
among	O
hospitalised	O
patients	O
,	O
based	O
on	O
the	O
three	O
intense-transmission	O
countries	O
,	O
was	O
between	O
57%	O
and	O
59%	O
in	O
January	O
2015	O
.	O

In	O
the	O
case	O
of	O
SARS-CoV-2	S-Pathogen
,	O
such	O
research	O
focuses	O
on	O
the	O
S-spike	O
protein	O
that	O
helps	O
the	O
virus	O
intrude	O
the	O
ACE2	O
enzyme	O
receptor	O
.	O

The	O
synthetic	B-Technology
genomics	I-Technology
research	E-Technology
at	O
JCVI	S-Organization
has	O
undergone	O
review	O
at	O
the	O
highest	O
levels	O
of	O
the	O
US	S-Location
government	O
.	O

Zilinskas	S-Person
,	O
Raymond	B-Person
A.	E-Person
(1999)	O
,	O
"	O
Iraq	S-Location
's	O
Biological	O
Warfare	O
Program:	O
The	O
Past	O
as	O
Future?	O
"	O
,	O
Chapter	O
8	O
in:	O
Lederberg	S-Person
,	O
Joshua	S-Person
(editor)	O
,	O
Biological	O
Weapons:	O
Limiting	O
the	O
Threat	O
(1999)	O
,	O
The	O
MIT	O
Press	O
,	O
pg	O
138	O
.	O

These	O
established	O
trends	O
can	O
then	O
be	O
observed	O
by	O
medical	O
epidemiologists	O
to	O
determine	O
if	O
there	O
are	O
any	O
disease	O
outbreaks	O
in	O
any	O
particular	O
locales	O
;	O
maps	O
of	O
disease	O
prevalence	O
can	O
then	O
be	O
created	O
rather	O
easily	O
.	O

In	O
Philadelphia	S-Location
for	O
example	O
,	O
4,597 people	O
died	O
in	O
the	O
week	O
ending	O
16 October	O
,	O
but	O
by	O
11 November	O
,	O
influenza	S-Disease
had	O
almost	O
disappeared	O
from	O
the	O
city	O
.	O

Because	O
of	O
the	O
Lead	B-Incident
contamination	I-Incident
in	I-Incident
Washington,	I-Incident
D.C.	I-Incident
drinking	I-Incident
water	E-Incident
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
conducted	O
an	O
investigation	O
,	O
that	O
uncovered	O
that	O
the	O
CDC	S-Organization
had	O
made	O
claims	O
in	O
a	O
report	O
that	O
had	O
indicated	O
there	O
was	O
no	O
risk	O
from	O
high	O
lead	O
levels	O
-	O
although	O
it	O
is	O
the	O
opposite	O
.	O

The	O
new	O
provisions	O
allowed	O
drivers	O
to	O
stay	O
on	O
duty	O
for	O
only	O
14	O
hours	O
,	O
thus	O
the	O
time	O
spent	O
waiting	O
could	O
eat	O
into	O
the	O
time	O
a	O
driver	O
spent	O
on	O
duty	O
.	O

No	O
geographic	O
or	O
chronologic	O
indication	O
exists	O
to	O
suggest	O
that	O
one	O
of	O
these	O
variants	O
was	O
the	O
precursor	O
of	O
the	O
other	O
,	O
nor	O
are	O
there	O
consistent	O
differences	O
between	O
the	O
case	O
histories	O
or	O
histopathologic	O
features	O
of	O
the	O
5	O
patients	O
infected	O
with	O
them	O
.	O

He	O
found	O
archival	O
evidence	O
that	O
a	O
respiratory	O
illness	O
that	O
struck	O
northern	O
China	S-Location
in	O
November	O
1917	O
was	O
identified	O
a	O
year	O
later	O
by	O
Chinese	O
health	O
officials	O
as	O
identical	O
to	O
the	O
.	O

To	O
create	O
a	O
T1-weighted	O
image	O
,	O
magnetization	O
is	O
allowed	O
to	O
recover	O
before	O
measuring	O
the	O
MR	O
signal	O
by	O
changing	O
the	O
repetition	O
time	O
(TR)	O
.	O

This	O
past	O
May	O
,	O
legislation	O
that	O
would	O
create	O
a	O
national	O
defense	O
strategy	O
was	O
introduced	O
in	O
the	O
Senate	S-Organization
,	O
coinciding	O
with	O
the	O
timing	O
of	O
ISIS-affiliated	O
terrorist	O
groups	O
get	O
closer	O
to	O
weaponizing	O
biological	O
agents	O
.	O

KATHERINE	B-Person
LYON	I-Person
DANIEL	E-Person
Good	O
morning	O
.	O

This	O
problem	O
stems	O
from	O
the	O
fact	O
that	O
the	O
population	O
difference	O
between	O
the	O
nuclear	O
spin	O
states	O
is	O
very	O
small	O
at	O
room	O
temperature	O
.	O

Between	O
1701	O
and	O
1750	O
,	O
thirty-seven	O
larger	O
and	O
smaller	O
epidemics	O
were	O
recorded	O
in	O
Constantinople	S-Location
,	O
and	O
an	O
additional	O
thirty-one	O
between	O
1751	O
and	O
1800	O
.	O

The	O
Marburg	B-Pathogen
virus	E-Pathogen
is	O
in	O
the	O
same	O
family	O
as	O
Ebola	S-Pathogen
and	O
causes	O
severe	O
hemorrhagic	B-Disease
fever	E-Disease
in	O
humans	O
.	O

In	O
January	O
2020	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organisation	E-Organization
recommended	O
2019-nCov	S-Disease
and	O
2019-nCoV	B-Disease
acute	I-Disease
respiratory	I-Disease
disease	E-Disease
as	O
interim	O
names	O
for	O
the	O
virus	O
and	O
disease	O
per	O
2015	O
guidance	O
and	O
international	O
guidelines	O
against	O
using	O
geographical	O
locations	O
(e.g	O
.	O

An	O
estimated	O
date	O
for	O
its	O
appearance	O
in	O
mammalian	O
hosts	O
has	O
been	O
put	O
at	O
the	O
period	O
1882–1913	O
.	O

Jacob	S-Person
told	O
us	O
.	O

"	O
It's	O
our	O
honor	O
and	O
duty	O
to	O
support	O
our	O
military	O
personnel	O
by	O
ensuring	O
they	O
have	O
access	O
to	O
safe	O
and	O
effective	O
medical	O
products	O
–	O
especially	O
products	O
that	O
meet	O
the	O
unique	O
needs	O
and	O
settings	O
in	O
which	O
soldiers	O
may	O
require	O
medical	O
treatment,	O
"	O
said	O
FDA	S-Organization
Commissioner	O
.	O

Higher	O
resolution	O
is	O
not	O
always	O
suitable	O
for	O
any	O
given	O
scenario	O
,	O
such	O
as	O
detection	O
of	O
small	O
.	O

Greg	B-Person
Bear	E-Person
makes	O
reference	O
to	O
the	O
Sverdlovsk	B-Incident
anthrax	I-Incident
leak	E-Incident
in	O
Quantico	S-Document
,	O
a	O
novel	O
about	O
genetically	O
engineered	O
pathogens	O
and	O
agents	O
trying	O
to	O
stop	O
their	O
release	O
.	O

The	O
company	O
has	O
been	O
awarded	O
a	O
$344.	O
4	O
million	O
federal	O
contract	O
(2006	O
–	O
2016)	O
and	O
another	O
$17.	O
3	O
million	O
contract	O
(2015	O
-2026)	O
by	O
.	O

Mansfield	S-Person
and	O
Lauterbur	S-Person
were	O
awarded	O
the	O
2003	O
Nobel	O
Prize	O
in	O
Physiology	O
or	O
Medicine	O
for	O
their	O
"	O
discoveries	O
concerning	O
"	O
.	O

All	O
manipulations	O
of	O
potentially	O
infectious	O
diagnostic	O
materials	O
,	O
isolates	O
,	O
and	O
naturally	O
or	O
experimentally	O
infected	O
animals	O
pose	O
a	O
high	O
risk	O
of	O
exposure	O
and	O
infection	O
to	O
laboratory	O
personnel	O
,	O
the	O
community	O
,	O
and	O
the	O
environment	O
.	O

Definitive	O
confirmation	O
of	O
the	O
role	O
of	O
Y.	B-Pathogen
pestis	E-Pathogen
arrived	O
in	O
2010	O
with	O
a	O
publication	O
in	O
PLOS	B-Organization
Pathogens	I-Organization
by	I-Organization
Haensch	E-Organization
et	O
al	O
.	O

The	O
package	O
also	O
includes	O
a	O
salaries	O
tax	O
rebate	O
and	O
reduced	O
rates	O
.	O

Orthogonal	B-Technology
CRISPR	I-Technology
experiments	E-Technology
are	O
often	O
recommended	O
to	O
confirm	O
the	O
results	O
of	O
a	O
experiment	O
.	O

The	O
would	O
be	O
scalable	O
to	O
cover	O
a	O
major	O
metropolitan	O
city	O
and	O
its	O
surrounding	O
region	O
.	O

As	O
of	O
this	O
printing	O
,	O
there	O
are	O
no	O
experiments	O
described	O
in	O
this	O
manual	O
,	O
which	O
specifically	O
utilize	O
BSL‐4	S-Platform
containment	O
.	O

This	O
putative	O
treatment	O
sounds	O
vampiric	O
,	O
yet	O
it's	O
gained	O
popularity	O
in	O
the	O
Silicon	B-Location
Valley	E-Location
area	O
,	O
where	O
people	O
have	O
actually	O
paid	O
$8,000	O
a	O
pop	O
to	O
participate	O
in	O
trials	O
.	O

We	O
will	O
continue	O
to	O
innovate	O
.	O

These	O
drugs	O
prevent	O
viruses	O
from	O
reproducing	O
by	O
inhibiting	O
essential	O
stages	O
of	O
the	O
virus's	O
replication	O
cycle	O
in	O
infected	O
cells	O
.	O

As	O
I	O
said	O
,	O
we	O
are	O
determined	O
to	O
get	O
to	O
zero	O
cases	O
,	O
and	O
long	O
after	O
this	O
epidemic	O
is	O
over	O
,	O
we	O
will	O
need	O
that	O
resolve	O
to	O
meet	O
new	O
challenges	O
wherever	O
and	O
however	O
they	O
arise	O
.	O

These	O
events	O
should	O
never	O
happen	O
.	O

One	O
of	O
the	O
two	O
,	O
a	O
physician	O
,	O
had	O
worked	O
with	O
patients	O
,	O
but	O
the	O
other	O
was	O
assisting	O
workers	O
to	O
get	O
in	O
and	O
out	O
of	O
their	O
protective	B-Equipment
gear	E-Equipment
while	O
wearing	O
herself	O
.	O

As	O
primates	O
in	O
the	O
area	O
were	O
not	O
found	O
to	O
be	O
infected	O
and	O
fruit	O
bats	O
do	O
not	O
live	O
near	O
the	O
location	O
of	O
the	O
initial	O
zoonotic	O
transmission	O
event	O
in	O
Meliandou	S-Location
,	O
it	O
is	O
suspected	O
that	O
the	O
index	O
case	O
occurred	O
after	O
a	O
child	O
had	O
contact	O
with	O
an	O
insectivorous	O
bat	O
from	O
a	O
colony	O
of	O
Angolan	O
free-tailed	O
bats	O
near	O
the	O
village	O
.	O

The	O
noticeable	O
general	O
trend	O
was	O
the	O
international	O
donor	O
interest	O
in	O
the	O
BMENA	S-Location
region	O
in	O
2001–2013	O
.	O

As	O
was	O
true	O
for	O
the	O
,	O
the	O
second	O
1891	O
recurrence	O
produced	O
of	O
the	O
most	O
deaths	O
.	O

For	O
example	O
,	O
Palestine	S-Organization
attends	O
meetings	O
of	O
the	O
.	O
Each	O
region	O
also	O
has	O
a	O
regional	O
office	O
.	O

This	O
isolate	O
belonged	O
to	O
sequence	O
type	O
167	O
(ST167)	O
.	O

Although	O
it	O
was	O
a	O
major	O
scientific	O
success	O
,	O
the	O
project	O
raised	O
lots	O
of	O
questions	O
about	O
how	O
synthetic	O
genomes	O
could	O
be	O
used	O
,	O
for	O
good	O
or	O
bad	O
,	O
and	O
what	O
the	O
political	O
and	O
societal	O
implications	O
were	O
.	O

This	O
council	O
could	O
help	O
identify	O
redundancies	O
and	O
gaps	O
in	O
our	O
biodefense	O
before	O
they	O
wind	O
up	O
costing	O
lives	O
and	O
wasting	O
dollars	O
.	O

It	O
caused	O
significant	O
mortality	O
,	O
with	O
the	O
case	O
fatality	O
rate	O
reported	O
which	O
was	O
initially	O
considerable	O
,	O
while	O
the	O
rate	O
among	O
hospitalised	O
patients	O
was	O
57–59%	O
,	O
the	O
final	O
numbers	O
28,616	O
people	O
,	O
including	O
11,310	O
deaths	O
,	O
for	O
a	O
case-fatality	O
rate	O
of	O
40%	O
.	O

The	O
disease	O
was	O
declared	O
eradicated	O
from	O
human	O
populations	O
in	O
1980	O
.	O

At	O
least	O
29	O
phase	B-Activity
II–IV	I-Activity
efficacy	I-Activity
trials	I-Activity
in	I-Activity
COVID‑19	E-Activity
were	O
concluded	O
in	O
March	O
2020	O
,	O
or	O
scheduled	O
to	O
provide	O
results	O
in	O
April	O
from	O
hospitals	O
in	O
.	O
There	O
are	O
more	O
than	O
300	O
active	O
clinical	O
trials	O
underway	O
as	O
of	O
April	O
2020	O
.	O

"	O
Our	O
aim	O
is	O
to	O
develop	O
rapid	O
and	O
reliable	O
diagnostic	O
methods	O
,	O
as	O
well	O
as	O
to	O
find	O
ways	O
to	O
reduce	O
the	O
risk	O
of	O
melioidosis	S-Pathogen
in	O
deployed	O
service	O
members,	O
"	O
said	O
.	O

These	O
proteins	O
protect	O
the	O
bacterial	O
cell	O
from	O
antibiotics	O
that	O
target	O
the	O
cell's	O
ribosomes	O
to	O
inhibit	O
protein	O
synthesis	O
.	O

Every	O
user	O
can	O
also	O
check	O
the	O
status	O
of	O
three	O
other	O
users	O
.	O

On	O
21	O
September	O
,	O
officials	O
of	O
the	O
DRC	S-Location
indicated	O
a	O
confirmed	O
case	O
of	O
EVD	S-Disease
at	O
Lake	B-Location
Albert	E-Location
,	O
an	O
entry	O
point	O
into	O
,	O
though	O
no	O
cases	O
were	O
then	O
confirmed	O
within	O
Ugandan	O
territory	O
.	O

The	O
Agenda	O
was	O
launched	O
on	O
a	O
bitterly	O
cold	O
and	O
snowy	O
day	O
,	O
when	O
roads	O
and	O
offices	O
across	O
Washington	S-Location
were	O
closed	O
.	O

It	O
was	O
instead	O
ordered	O
that	O
,	O
rather	O
than	O
1-2	O
aerial	O
sprayings	O
of	O
the	O
infected	O
communities	O
,	O
more	O
than	O
a	O
dozen	O
sprayings	O
would	O
be	O
necessary	O
over	O
a	O
period	O
of	O
months	O
.	O

Although	O
PREEMPT	S-Scientific_research_project
is	O
a	O
fundamental	O
research	O
program	O
,	O
is	O
aware	O
of	O
biosafety	O
and	O
biosecurity	O
sensitivities	O
that	O
could	O
arise	O
.	O

As	O
of	O
May	O
2020	O
this	O
pandemic	O
had	O
nearly	O
4	O
million	O
confirmed	O
cases	O
worldwide	O
,	O
and	O
over	O
270,000	O
associated	O
deaths	O
.	O

In	O
2000	O
,	O
the	O
FDA	S-Organization
announced	O
their	O
intention	O
to	O
revoke	O
approval	O
of	O
fluoroquinolone	O
use	O
in	O
poultry	O
production	O
because	O
of	O
substantial	O
evidence	O
linking	O
it	O
to	O
the	O
emergence	O
of	O
fluoroquinolone-resistant	B-Disease
Campylobacter	I-Disease
infections	E-Disease
in	O
humans	O
.	O

News	O
of	O
the	O
infection	O
will	O
stoke	O
concerns	O
about	O
its	O
spread	O
in	O
a	O
country	O
which	O
is	O
by	O
far	O
the	O
world's	O
largest	O
producer	O
of	O
pork	O
.	O

Most	O
infections	O
with	O
human	O
coronaviruses	O
are	O
mild	O
and	O
associated	O
with	O
common	B-Disease
colds	E-Disease
The	O
seven	O
coronaviruses	O
known	O
to	O
infect	O
humans	O
are	O
in	O
the	O
alpha	O
and	O
beta	O
genera	O
.	O

There	O
is	O
no	O
spinning	O
here,	O
"	O
and	O
further	O
stating	O
that	O
"	O
I	O
know	O
there	O
is	O
a	O
lot	O
of	O
pressure	O
on	O
WHO	S-Organization
when	O
we	O
appreciate	O
what	O
is	O
doing	O
but	O
because	O
of	O
pressure	O
we	O
should	O
not	O
fail	O
to	O
tell	O
the	O
truth	O
,	O
we	O
don't	O
say	O
anything	O
to	O
appease	O
anyone	O
.	O

Source:	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center	E-Organization
edited	O
.	O

Attending	O
experts	O
use	O
the	O
occasion	O
to	O
address	O
the	O
emergence	O
,	O
spread	O
and	O
control	O
of	O
these	O
diseases	O
,	O
covering	O
a	O
host	O
of	O
health	O
threats	O
that	O
affect	O
both	O
and	O
its	O
colleagues	O
in	O
the	O
international	O
scene	O
.	O

The	O
-	O
the	O
flu	B-Pathogen
strain	E-Pathogen
that	O
your	O
lab	O
thought	O
it	O
was	O
sending	O
isn't	O
identified	O
,	O
but	O
it	O
was	O
going	O
to	O
a	O
bsl-3	S-Platform
lab	O
.	O

The	O
genetically	B-Pathogen
engineered	I-Pathogen
'superbug'	E-Pathogen
lethal	O
and	O
resistant	O
to	O
environmental	O
influence	O
or	O
any	O
medical	O
treatment-is	O
only	O
a	O
small	O
part	O
of	O
this	O
story	O
.	O

Its	O
guide	O
RNA	O
targets	O
regulatory	O
DNA	O
sequences	O
called	O
promoters	O
that	O
immediately	O
precede	O
the	O
target	O
gene	O
.	O

Based	O
on	O
these	O
findings	O
,	O
SIGA	S-Organization
is	O
continuing	O
to	O
move	O
tecovirimat	S-Drug
forward	O
as	O
a	O
treatment	O
for	O
smallpox	S-Pathogen
.	O
"	O
Smallpox	S-Pathogen
is	O
both	O
highly	O
contagious	O
and	O
highly	O
lethal	O
and	O
there	O
is	O
growing	O
concern	O
that	O
smallpox	S-Pathogen
could	O
be	O
used	O
as	O
a	O
potential	O
bioweapon,	O
"	O
said	O
Phil	B-Person
Gomez	E-Person
,	O
PhD	O
,	O
SIGA	S-Organization
's	O
Chief	O
Executive	O
Officer	O
in	O
a	O
statement	O
from	O
the	O
company.	O
"	O
A	O
bioterror	O
attack	O
could	O
be	O
especially	O
damaging	O
because	O
the	O
majority	O
of	O
today's	O
population	O
is	O
not	O
immune	O
to	O
the	O
virus	O
,	O
as	O
routine	O
vaccination	O
ended	O
in	O
the	O
1970s	O
.	O

The	O
biological	O
and	O
chemical	O
weapons	O
developed	O
during	O
that	O
period	O
were	O
tested	O
at	O
the	O
Dugway	B-Location
Proving	I-Location
Grounds	I-Location
in	I-Location
Utah	E-Location
.	O
Soon	O
there	O
were	O
facilities	O
for	O
the	O
mass	O
production	O
of	O
anthrax	B-Pathogen
spores	E-Pathogen
,	O
brucellosis	S-Pathogen
,	O
and	O
,	O
although	O
the	O
war	O
was	O
over	O
before	O
these	O
weapons	O
could	O
be	O
of	O
much	O
operational	O
use	O
.	O

When	O
Edward	B-Person
Jenner	E-Person
invented	O
vaccines	O
and	O
when	O
Alexander	B-Person
Fleming	E-Person
discovered	O
,	O
they	O
were	O
harnessing	O
the	O
power	O
of	O
biotechnology	O
.	O

The	O
flu	O
that	O
winter	O
was	O
beyond	O
imagination	O
as	O
millions	O
were	O
infected	O
and	O
thousands	O
died	O
.	O

In	O
a	O
summary	O
by	O
the	O
GAO	S-Organization
the	O
Secretary	B-Organization
of	I-Organization
the	I-Organization
Army	E-Organization
has	O
gone	O
so	O
far	O
as	O
to	O
implement	O
a	O
,	O
but	O
the	O
organization	O
has	O
not	O
created	O
the	O
strategy	O
and	O
execution	O
for	O
managing	O
the	O
initiative	O
.	O

The	O
effectiveness	O
of	O
potential	O
treatments	O
for	O
any	O
disease	O
is	O
usually	O
assessed	O
in	O
a	O
randomised	O
controlled	O
trial	O
,	O
which	O
compares	O
the	O
outcome	O
of	O
those	O
who	O
received	O
treatment	O
to	O
those	O
who	O
received	O
a	O
placebo	O
(i.e.	O
dummy	O
treatment)	O
.	O

In	O
1949	O
,	O
Sulkin	S-Person
and	O
Pike	S-Person
published	O
the	O
first	O
serious	O
surveys	O
of	O
laboratory	O
associated	O
infections	O
.	O

All	O
personnel	O
authorized	O
to	O
enter	O
the	O
laboratory	O
must	O
be	O
well	O
trained	O
.	O

Basing	O
their	O
choice	O
on	O
"	O
the	O
person	O
or	O
persons	O
who	O
most	O
affected	O
the	O
news	O
and	O
our	O
lives	O
,	O
for	O
good	O
or	O
ill	O
,	O
and	O
embodied	O
what	O
was	O
important	O
about	O
the	O
year"	O
,	O
the	O
editors	O
of	O
Time	B-Organization
magazine	E-Organization
in	O
December	O
2014	O
named	O
the	O
Ebola	S-Disease
health	O
workers	O
as	O
Person	O
of	O
the	O
Year	O
.	O

Nevertheless	O
,	O
studies	O
suggest	O
that	O
many	O
people	O
are	O
still	O
able	O
to	O
purchase	O
these	O
drugs	O
without	O
official	O
recommendations	O
from	O
their	O
doctors	O
.	O

Y.	B-Pathogen
pestis	E-Pathogen
was	O
discovered	O
by	O
Alexandre	B-Person
Yersin	E-Person
,	O
a	O
pupil	O
of	O
Louis	B-Person
Pasteur	E-Person
,	O
during	O
an	O
epidemic	B-Incident
of	I-Incident
bubonic	I-Incident
plague	I-Incident
in	I-Incident
Hong	I-Incident
Kong	I-Incident
in	I-Incident
1894	E-Incident
;	O
Yersin	S-Person
also	O
proved	O
this	O
bacillus	S-Pathogen
was	O
present	O
in	O
rodents	O
and	O
suggested	O
the	O
rat	O
was	O
the	O
main	O
vehicle	O
of	O
transmission	O
.	O

Biotechnology	O
can	O
range	O
from	O
using	O
bacterial	O
strains	O
for	O
brewing	O
beer	O
to	O
editing	O
genes	O
using	O
CRISPR	S-Technology

Among	O
other	O
things	O
,	O
this	O
investigation	O
recommended	O
that	O
the	O
capacity	O
of	O
and	O
coordination	O
between	O
the	O
various	O
microbiology	O
laboratories	O
should	O
be	O
strengthened	O
,	O
in	O
order	O
to	O
ensure	O
a	O
diagnostic	O
service	O
that	O
is	O
sustainable	O
and	O
effective	O
in	O
the	O
event	O
of	O
any	O
crisis	O
generating	O
a	O
large	O
sample	O
load	O
.	O

Because	O
pigs	O
are	O
more	O
readily	O
infected	O
with	O
avian	O
viruses	O
than	O
are	O
humans	O
,	O
they	O
were	O
suggested	O
as	O
the	O
original	O
recipients	O
of	O
the	O
virus	O
,	O
passing	O
the	O
virus	O
to	O
humans	O
sometime	O
between	O
1913	O
and	O
1918	O
.	O

We've	O
already	O
begun	O
the	O
process	O
of	O
analyzing	O
the	O
entire	O
genetic	O
sequence	O
of	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
,	O
and	O
we'll	O
see	O
whether	O
any	O
of	O
the	O
remaining	O
four	O
vials	O
grow	O
.	O

CDC	S-Organization
also	O
reported	O
findings	O
of	O
an	O
internal	B-Document
CDC	I-Document
investigation	E-Document
on	O
the	O
H5N1	B-Incident
flu	I-Incident
lab	I-Incident
incident	E-Incident
,	O
and	O
actions	O
taken	O
in	O
response	O
to	O
findings	O
of	O
both	O
the	O
APHIS	S-Organization
and	O
CDC	S-Organization
investigations	O
into	O
the	O
.	O

The	O
Breeders	O
claimed	O
that	O
it	O
was	O
responsible	O
for	O
the	O
summer	O
release	O
of	O
the	O
medflies	O
as	O
retaliation	O
for	O
the	O
environmental	O
damage	O
caused	O
by	O
the	O
Malathion	O
aerial	O
spraying	O
by	O
the	O
state	O
.	O

He	O
reported	O
that	O
in	O
thirteen	O
studies	O
of	O
hospitalized	O
women	O
in	O
the	O
pandemic	O
,	O
the	O
death	O
rate	O
ranged	O
from	O
23%	O
to	O
71%	O
.	O

However	O
,	O
there	O
have	O
been	O
credible	O
concerns	O
that	O
some	O
countries	O
used	O
it	O
to	O
create	O
bioweapons	O
.	O

In	O
principle	O
,	O
rather	O
than	O
transporting	O
samples	O
to	O
a	O
different	O
laboratory	O
in	O
the	O
network	O
,	O
an	O
alternative	O
would	O
be	O
to	O
exchange	O
staff	O
,	O
as	O
the	O
network	O
members'	O
staff	O
are	O
now	O
familiar	O
with	O
the	O
methods	O
and	O
practices	O
used	O
in	O
the	O
other	O
laboratories	O
.	O

MRI	S-Technology
was	O
originally	O
called	O
NMRI	S-Technology
(	O
nuclear	B-Technology
magnetic	I-Technology
resonance	I-Technology
imaging	E-Technology
)	O
,	O
but	O
"	O
nuclear"	O
was	O
dropped	O
to	O
avoid	O
negative	O
associations	O
.	O

To	O
avoid	O
blundering	O
into	O
disaster	O
,	O
the	O
errors	O
of	O
the	O
past	O
should	O
be	O
acknowledged	O
.	O

We	O
are	O
anticipating	O
a	O
scenario	O
of	O
continued	O
intense	O
transmission"	O
.	O

Construction	O
work	O
lagged	O
behind	O
schedule	O
and	O
costs	O
are	O
higher	O
than	O
originally	O
estimated	O
.	O

According	O
to	O
Dr	O
.	O

The	O
Homeland	B-Organization
Security	I-Organization
Department	E-Organization
wants	O
a	O
way	O
to	O
tap	O
into	O
nationwide	O
medical	O
databases	O
to	O
help	O
detect	O
and	O
respond	O
to	O
"	O
nationally	O
significant	O
"	O
biological	O
events	O
.	O

MERS	B-Disease
coronavirus	E-Disease
.	O
Ebola	S-Disease
.	O
Hepatitis	B-Disease
E	E-Disease
.	O
Yellow	B-Disease
Fever	E-Disease
.	O
Lassa	S-Disease
.	O
.	O

Pathogenic	O
micro-organisms	O
,	O
although	O
they	O
represent	O
only	O
a	O
small	O
part	O
in	O
the	O
total	O
microbial	O
world	O
,	O
receive	O
much	O
attention	O
because	O
they	O
represent	O
a	O
threat	O
for	O
the	O
human	O
or	O
animal	O
health	O
,	O
or	O
for	O
the	O
agriculture	O
.	O

Tafari	B-Person
Makonnen	E-Person
(the	O
future	O
Haile	B-Person
Selassie	E-Person
,	O
Emperor	O
of	O
Ethiopia	S-Location
)	O
was	O
one	O
of	O
the	O
first	O
Ethiopians	O
who	O
contracted	O
influenza	S-Disease
but	O
survived	O
.	O

Movies	O
have	O
been	O
made	O
about	O
this	O
place	O
saving	O
the	O
world	O
.	O

As	O
they	O
fled	O
the	O
besieged	O
cities	O
these	O
civilians	O
,	O
the	O
British	O
hoped	O
,	O
would	O
carry	O
to	O
rebel	O
troops	O
.	O

In	O
the	O
U.S.	S-Location
about	O
28%	O
of	O
the	O
population	O
of	O
105	O
million	O
became	O
infected	O
,	O
and	O
500,000	O
to	O
850,000	O
died	O
(0.48	O
to	O
0.81	O
percent	O
of	O
the	O
population	O
)	O
.	O
influenza	S-Disease
-and-	O
pneumonia	S-Disease
-pandemic-nationwide-820000-850000/The	O
Great	O
Pandemic:	O
The	O
United	B-Location
States	E-Location
in	O
1918–1919	O
,	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
&amp;	I-Organization
Human	I-Organization
Serv	E-Organization
ices	O
.	O

In	O
his	O
speech	O
Nixon	O
called	O
his	O
move	O
"	O
unprecedented";	O
and	O
it	O
was	O
in	O
fact	O
the	O
first	O
review	O
of	O
the	O
U.S.	O
biological	O
warfare	O
program	O
since	O
1954	O
.	O

As	O
people	O
celebrated	O
Armistice	O
Day	O
with	O
parades	O
and	O
large	O
partiess	O
,	O
a	O
complete	O
disaster	O
from	O
the	O
public	O
health	O
standpoint	O
,	O
a	O
rebirth	O
of	O
the	O
epidemic	O
occurred	O
in	O
some	O
cities	O
.	O

Their	O
efforts	O
included	O
installing	O
hand-washing	O
stations	O
and	O
distributing	O
millions	O
of	O
bars	O
of	O
soap	O
and	O
chlorine	O
and	O
plans	O
for	O
taking	O
the	O
temperature	O
of	O
children	O
and	O
staff	O
at	O
the	O
school	O
gate	O
.	O

Reports	O
say	O
they	O
have	O
made	O
anthrax	S-Pathogen
more	O
deadly	O
still	O
through	O
genetic	O
engineering	O
.	O

It	O
is	O
a	O
United	O
States	O
federal	O
agency	O
,	O
under	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
and	O
is	O
headquartered	O
in	O
Atlanta	O
,	O
.	O

Belgium	S-Organization
recalled	O
100,000	O
unusable	O
masks	O
,	O
which	O
were	O
thought	O
to	O
be	O
from	O
China	S-Location
but	O
were	O
in	O
fact	O
from	O
Colombia	S-Location
.	O
The	O
Philippines	S-Organization
stopped	O
using	O
test	O
kits	O
donated	O
by	O
China	S-Location
due	O
to	O
their	O
40	O
percent	O
accuracy	O
.	O

The	O
MoU	S-Document
authorizes	O
the	O
FDA	S-Organization
and	O
the	O
Pentagon	S-Organization
to	O
work	O
toward	O
faster	O
deployment	O
of	O
medical	O
products	O
meant	O
to	O
diagnose	O
,	O
treat	O
or	O
prevent	O
life-threatening	O
conditions	O
affecting	O
service	O
members	O
,	O
including	O
those	O
caused	O
by	O
chemical	O
,	O
biological	O
,	O
radiological	O
or	O
nuclear	O
agents	O
.	O

Speaking	O
during	O
the	O
occasion	O
,	O
USA	S-Organization
Ambassador	O
to	O
Cameroon	S-Organization
,	O
Peter	B-Person
Henry	I-Person
Barlerin	E-Person
said	O
the	O
Centre	O
equipped	O
with	O
the	O
state-of-the	O
art	O
equipment	O
including	O
computers	O
,	O
was	O
constructed	O
by	O
the	O
USAbased	O
company	O
.	O

The	O
FDA	S-Organization
Fast	O
Track	O
designation	O
is	O
a	O
process	O
designed	O
to	O
facilitate	O
the	O
development	O
and	O
expedite	O
the	O
review	O
of	O
drugs	O
and	O
vaccines	O
for	O
serious	O
conditions	O
and	O
that	O
fill	O
an	O
unmet	O
medical	O
need	O
.	O

The	O
ring	O
trials	O
include	O
both	O
live	O
and	O
inactivated	O
samples	O
that	O
are	O
prepared	O
by	O
one	O
arranging	O
laboratory	O
and	O
sent	O
to	O
the	O
other	O
participating	O
agencies	O
.	O

There	O
are	O
also	O
a	O
variety	O
of	O
signal	O
amplification	O
schemes	O
based	O
on	O
chemical	O
exchange	O
that	O
increase	O
sensitivity	O
.	O

To	O
put	O
in	O
perspective	O
what	O
it	O
would	O
cost	O
today	O
to	O
fight	O
a	O
1918-like	O
influenza	B-Incident
pandemic	E-Incident
which	O
100	O
years	O
ago	O
killed	O
50	O
million	O
people	O
,	O
estimated	O
the	O
price	O
tag	O
at	O
$6	O
trillion	O
.	O

Now	O
DOIs	O
have	O
been	O
used	O
for	O
giving	O
credit	O
to	O
data	O
producers	O
,	O
e.g.	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Well	O
,	O
first	O
off	O
,	O
to	O
clarify	O
a	O
few	O
things	O
,	O
there	O
was	O
no	O
delay	O
in	O
the	O
anthrax	B-Incident
exposure	I-Incident
incident	E-Incident
when	O
that	O
was	O
-	O
came	O
to	O
light	O
,	O
the	O
same	O
day	O
I	O
was	O
notified	O
,	O
and	O
we	O
began	O
our	O
response	O
.	O

Myself	O
,	O
adapting	O
the	O
current	O
CRISPR/Cas9	B-Technology
technology	E-Technology
to	O
my	O
research	O
project	O
,	O
I	O
came	O
up	O
with	O
.	O

Representative	O
results	O
are	O
shown	O
in	O
Fig.1	O
.	O

However	O
,	O
emergency	O
supplemental	O
funding	O
has	O
been	O
depleted	O
,	O
he	O
added	O
,	O
and	O
the	O
H7N9	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
is	O
currently	O
circulating	O
in	O
China	S-Location
.	O
"	O
We	O
are	O
concerned	O
with	O
the	O
ominous	O
trends	O
that	O
we	O
are	O
seeing,	O
"	O
said	O
.	O

The	O
effects	O
of	O
different	O
water	O
temperatures	O
were	O
tested	O
by	O
bludgeoning	O
the	O
victim	O
to	O
determine	O
if	O
any	O
areas	O
were	O
still	O
frozen	O
.	O

The	O
Roadmap	O
assumes	O
that	O
a	O
rapid	O
escalation	O
of	O
the	O
complementary	O
strategies	O
in	O
intense	O
transmission	O
,	O
resource-constrained	O
areas	O
will	O
allow	O
the	O
comprehensive	O
application	O
of	O
more	O
standard	O
containment	O
strategies	O
within	O
three	O
months.	O
"	O
The	O
report	O
included	O
an	O
assumption	O
that	O
some	O
country	O
or	O
countries	O
would	O
pay	O
the	O
required	O
cost	O
of	O
their	O
plan	O
,	O
estimated	O
at	O
half	O
a	O
billion	O
US	O
dollars	O
.	O

It	O
was	O
revealed	O
around	O
this	O
time	O
that	O
the	O
accident	O
was	O
caused	O
by	O
the	O
non-replacement	O
of	O
a	O
filter	S-Equipment
on	O
an	O
exhaust	O
at	O
the	O
facility	O
,	O
and	O
though	O
the	O
problem	O
was	O
quickly	O
rectified	O
,	O
it	O
was	O
too	O
late	O
to	O
prevent	O
a	O
release	O
.	O

The	O
new	O
and	O
upcoming	O
GM	S-Technology
crops	O
carrying	O
multiple	O
stacked	O
traits	O
likely	O
to	O
be	O
commercialized	O
soon	O
warrant	O
sensitive	O
detection	O
methods	O
both	O
at	O
the	O
DNA	O
and	O
protein	O
levels	O
.	O

The	O
current	O
Director-General	O
is	O
Tedros	B-Person
Adhanom	E-Person
,	O
former	O
Health	O
Minister	O
and	O
Foreign	O
Minister	O
of	O
,	O
who	O
began	O
his	O
five-year	O
term	O
on	O
1	O
July	O
2017	O
.	O

12	O
.	O

Had	O
the	O
winds	O
been	O
blowing	O
in	O
the	O
direction	O
of	O
the	O
city	O
at	O
that	O
time	O
,	O
it	O
could	O
have	O
resulted	O
in	O
the	O
pathogen	O
being	O
spread	O
to	O
hundreds	O
of	O
thousands	O
of	O
people	O
.	O

But	O
out	O
of	O
the	O
large	O
amount	O
of	O
pesticides	O
used	O
,	O
it	O
is	O
also	O
estimated	O
that	O
less	O
than	O
0.	O
1%	O
of	O
those	O
antimicrobial	O
agents	O
,	O
actually	O
reach	O
their	O
targets	O
.	O

In	O
March	O
,	O
developed	O
a	O
tablet	O
that	O
could	O
be	O
cleaned	O
with	O
chlorine	O
;	O
it	O
is	O
charged	O
wirelessly	O
and	O
can	O
transmit	O
information	O
to	O
servers	O
outside	O
the	O
working	O
area	O
.	O

When	O
the	O
official	O
memo	O
is	O
released	O
,	O
or	O
if	O
we	O
or	O
AAU	S-Organization
receive	O
any	O
additional	O
information	O
,	O
we	O
will	O
keep	O
the	O
membership	O
informed	O
.	O

This	O
includes	O
at	O
least	O
five	O
viruses	O
that	O
are	O
considered	O
to	O
be	O
potential	O
biowarfare	O
agents	O
,	O
among	O
them	O
Ebola	B-Pathogen
virus	E-Pathogen
Marburg	B-Pathogen
virus	E-Pathogen
and	O
Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
.	O
The	O
first	O
two	O
in	O
particular	O
are	O
very	O
rare	O
viruses	O
that	O
might	O
be	O
difficult	O
to	O
acquire	O
by	O
potential	O
bioweaponeers-according	O
to	O
rumours	O
,	O
members	O
of	O
the	O
Japanese	B-Organization
cult	I-Organization
Aum	I-Organization
Shinrikyo	E-Organization
,	O
famous	O
for	O
the	O
nerve	B-Incident
gas	I-Incident
attack	I-Incident
on	I-Incident
the	I-Incident
Tokyo	I-Incident
subway	E-Incident
,	O
tried	O
unsuccessfully	O
to	O
get	O
their	O
hands	O
on	O
Ebola	B-Pathogen
virus	E-Pathogen
during	O
an	B-Incident
outbreak	I-Incident
in	I-Incident
former	I-Incident
Zaire	I-Incident
in	I-Incident
the	I-Incident
1990s	E-Incident
.	O
Using	O
the	O
method	O
that	O
has	O
been	O
published	O
for	O
polio	S-Disease
,	O
such	O
a	O
group	O
or	O
an	O
interested	O
state	O
could	O
theoretically	O
construct	O
in	O
the	O
laboratory	O
.	O

See:	O
J.	B-Person
F.	I-Person
C.	I-Person
Hecker	E-Person
,	O
Der	O
schwarze	O
Tod	O
im	O
vierzehnten	O
Jahrhundert	O
[The	O
in	O
the	O
Fourteenth	O
Century]	O
(Berlin	O
,	O
(Germany):	O
Friedr	O
.	O

Watercourses	O
at	O
several	O
sites	O
inside	O
the	O
Mozambique	S-Location
border	O
were	O
deliberately	O
contaminated	O
with	O
cholera	S-Pathogen
.	O
These	O
biological	O
attacks	O
had	O
little	O
impact	O
on	O
the	O
fighting	O
capability	O
of	O
ZANLA	S-Location
,	O
but	O
caused	O
considerable	O
distress	O
to	O
the	O
local	O
population	O
.	O

Universities	O
and	O
other	O
scientific	O
institutions	O
should	O
develop	O
procedures	O
to	O
monitor	O
scientific	O
activities	O
.	O

A	O
retrospective	O
cohort	O
study	O
in	O
China	S-Location
found	O
that	O
children	O
were	O
as	O
likely	O
to	O
be	O
infected	O
as	O
adults	O
.	O

The	O
system	O
was	O
expected	O
to	O
reduce	O
the	O
burden	O
on	O
general	O
practitioners	O
.	O

It	O
is	O
also	O
incumbent	O
on	O
the	O
community	O
to	O
review	O
their	O
biosafety	O
procedures	O
and	O
to	O
ensure	O
that	O
all	O
laboratories	O
have	O
a	O
culture	O
of	O
biosafety	O
compliance	O
that	O
is	O
critical	O
for	O
protecting	O
laboratory	O
workers	O
and	O
the	O
broader	O
public.	O
"	O

Frieden	S-Person
.	O
H5N1	S-Disease
,	O
is	O
this	O
the	O
same	O
H5N1	S-Disease
that	O
was	O
commonly	O
referred	O
to	O
as	O
bird	B-Disease
flu	E-Disease
or	O
?	O

However	O
,	O
bacteria	O
can	O
also	O
acquire	O
resistance	O
through	O
transformation	O
,	O
as	O
in	O
Streptococcus	B-Pathogen
pneumoniae	E-Pathogen
uptaking	O
of	O
naked	O
fragments	O
of	O
extracellular	O
DNA	O
that	O
contain	O
antibiotic	O
resistance	O
genes	O
to	O
streptomycin	S-Drug
,	O
through	O
transduction	O
,	O
as	O
in	O
the	O
bacteriophage-mediated	O
transfer	O
of	O
tetracycline	O
resistance	O
genes	O
between	O
strains	O
of	O
,	O
or	O
through	O
gene	O
transfer	O
agents	O
,	O
which	O
are	O
particles	O
produced	O
by	O
the	O
host	O
cell	O
that	O
resemble	O
bacteriophage	O
structures	O
and	O
are	O
capable	O
of	O
transferring	O
DNA	O
.	O

In	O
the	O
same	O
year	O
Endicott	S-Person
book	O
was	O
published	O
,	O
Kathryn	B-Person
Weathersby	E-Person
and	O
Milton	B-Person
Leitenberg	E-Person
of	O
the	O
Cold	O
War	O
International	O
History	O
Project	O
at	O
the	O
Woodrow	B-Location
Wilson	I-Location
Center	I-Location
in	I-Location
Washington	E-Location
released	O
a	O
cache	O
of	O
Soviet	O
and	O
Chinese	O
documents	O
that	O
claimed	O
to	O
have	O
revealed	O
that	O
the	O
biowarfare	O
allegation	O
was	O
an	O
elaborate	O
disinformation	O
campaign	O
by	O
the	O
communists	O
.	O

On	O
20	O
July	O
,	O
the	O
last	O
patients	O
were	O
discharged	O
,	O
Reuters	S-Organization
(20	O
July	O
2015).	O
"	O
Liberia	S-Location
:	O
Ebola	S-Disease
Patients	O
Discharged	O
,	O
Last	O
of	O
the	O
Country's	O
Latest	O
Wave"	O
.	O

To	O
create	O
a	O
T1-weighted	O
image	O
,	O
magnetization	O
is	O
allowed	O
to	O
recover	O
before	O
measuring	O
the	O
MR	O
signal	O
by	O
changing	O
the	O
repetition	O
time	O
(TR)	O
.	O

Initially	O
,	O
the	O
letter	O
was	O
dismissed	O
as	O
"	O
some	O
crank	O
trying	O
to	O
get	O
a	O
lot	O
of	O
publicity",Published	O
on	O
December	O
2	O
,	O
1989	O
,	O
Daily	O
News	O
of	O
Los	B-Location
Angeles	E-Location
(CA)	O
GROUP	O
CLAIMS	O
RESPONSIBILITY	O
FOR	O
MEDFLY	O
WOES	O
but	O
there	O
was	O
evidence	O
the	O
group	O
played	O
a	O
role	O
in	O
the	O
infestation	O
.	O

On	O
Wednesday	O
of	O
this	O
week	O
,	O
we	O
learned	O
of	O
another	O
event	O
at	O
CDC	S-Organization
Our	O
influenza	O
laboratory	O
was	O
preparing	O
a	O
less	O
harmful	O
strain	B-Pathogen
of	I-Pathogen
animal	I-Pathogen
influenza	E-Pathogen
for	O
shipment	O
to	O
a	O
partner	O
laboratory	O
.	O

Dr	O
.	O

The	O
committee	O
decided	O
that	O
the	O
conditions	O
for	O
a	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
()	O
had	O
not	O
at	O
present	O
been	O
met	O
.	O

The	O
advises	O
people	O
to	O
avoid	O
touching	O
the	O
eyes	O
,	O
nose	O
,	O
or	O
mouth	O
with	O
unwashed	O
hands	O
.	O

The	O
lower	O
value	O
of	O
700	O
million	O
is	O
more	O
than	O
the	O
500	O
million	O
people	O
estimated	O
to	O
have	O
been	O
infected	O
by	O
the	O
Spanish	B-Incident
flu	I-Incident
pandemic	E-Incident

Because	O
they	O
are	O
so	O
small	O
,	O
you	O
may	O
not	O
be	O
able	O
to	O
see	O
,	O
smell	O
,	O
or	O
taste	O
them	O
.	O

According	O
to	O
the	O
U.S.	B-Organization
Congress	I-Organization
Office	I-Organization
of	I-Organization
Technology	I-Organization
Assessment	E-Organization
8	O
countries	O
were	O
generally	O
reported	O
as	O
having	O
undeclared	O
offensive	O
biological	O
warfare	O
programs	O
in	O
1995:	O
China	S-Location
,	O
Iran	S-Location
,	O
Iraq	S-Location
,	O
Israel	S-Location
,	O
Libya	S-Location
,	O
North	B-Location
Korea	E-Location
,	O
Syria	S-Location
and	O
Taiwan	S-Location
.	O
Five	O
countries	O
had	O
admitted	O
to	O
having	O
had	O
offensive	O
weapon	O
or	O
development	O
programs	O
in	O
the	O
past:	O
United	B-Location
States	E-Location
,	O
Russia	S-Location
,	O
France	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
,	O
and	O
Canada	S-Location
.	O
Offensive	B-Scientific_research_project
BW	I-Scientific_research_project
programs	I-Scientific_research_project
in	I-Scientific_research_project
Iraq	E-Scientific_research_project
were	O
dismantled	O
by	O
Coalition	B-Organization
Forces	E-Organization
and	O
the	O
UN	S-Organization
after	O
the	O
first	O
Gulf	O
War	O
(1990–91)	O
,	O
although	O
an	O
Iraqi	B-Scientific_research_project
military	I-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
was	O
covertly	O
maintained	O
in	O
defiance	O
of	O
international	O
agreements	O
until	O
it	O
was	O
apparently	O
abandoned	O
during	O
1995	O
and	O
1996	O
.	O

The	O
earliest	O
known	O
person	O
with	O
symptoms	O
was	O
later	O
discovered	O
to	O
have	O
fallen	O
ill	O
on	O
1December	O
2019	O
,	O
and	O
that	O
person	O
did	O
not	O
have	O
visible	O
connections	O
with	O
the	O
later	O
wet	O
market	O
cluster	O
.	O

Tigers	O
and	O
lions	O
at	O
the	O
Bronx	B-Location
Zoo	I-Location
in	I-Location
New	I-Location
York	E-Location
United	B-Location
States	E-Location
,	O
tested	O
positive	O
for	O
the	O
virus	O
and	O
showed	O
symptoms	O
of	O
COVID‑19	S-Disease
,	O
including	O
a	O
dry	B-Phenotype
cough	E-Phenotype
and	O
.	O

A	O
US	B-Organization
Army	E-Organization
report	O
in	O
1981	O
compared	O
two	O
scenarios	O
–	O
16	O
simultaneous	O
attacks	O
on	O
a	O
city	O
by	O
mosquitoes	O
,	O
infected	O
with	O
Yellow	B-Disease
Fever	E-Disease
,	O
and	O
aerosol	O
attack	O
,	O
and	O
assesses	O
their	O
effectiveness	O
in	O
cost	O
and	O
casualties	O
.	O

What	O
has	O
changed	O
in	O
the	O
last	O
two	O
years	O
is	O
our	O
ability	O
to	O
detect	O
it	O
.	O

The	O
outbreak	O
has	O
been	O
blamed	O
for	O
several	O
instances	O
of	O
supply	O
shortages	O
,	O
stemming	O
from	O
globally	O
increased	O
usage	O
of	O
equipment	O
to	O
fight	O
outbreaks	O
,	O
panic	O
buying	O
(which	O
in	O
several	O
places	O
led	O
to	O
shelves	O
being	O
cleared	O
of	O
grocery	O
essentials	O
such	O
as	O
food	O
,	O
toilet	O
paper	O
,	O
and	O
bottled	O
water)	O
,	O
and	O
disruption	O
to	O
factory	O
and	O
logistic	O
operations	O
.	O

The	O
outbreak	O
at	O
the	O
Lanzhou	B-Organization
Veterinary	I-Organization
Research	I-Organization
Institute	E-Organization
was	O
first	O
uncovered	O
in	O
November	O
when	O
some	O
students	O
in	O
the	O
institute's	O
foot	O
and	O
mouth	O
disease	O
research	O
unit	O
noticed	O
that	O
large	O
numbers	O
of	O
their	O
lab	O
mice	O
were	O
infertile	O
,	O
according	O
to	O
The	O
Beijing	B-Organization
News	E-Organization
.	O
The	O
mice	O
tested	O
positive	O
for	O
,	O
as	O
did	O
four	O
students	O
.	O

Many	O
high-consequence	O
pathogens	O
are	O
rarely	O
,	O
or	O
have	O
never	O
been	O
,	O
encountered	O
in	O
real-life	O
situations	O
,	O
meaning	O
that	O
the	O
capacity	O
to	O
carry	O
out	O
the	O
relevant	O
methods	O
is	O
not	O
tested	O
on	O
a	O
regular	O
basis	O
.	O

Health	O
care	O
providers	O
taking	O
care	O
of	O
someone	O
who	O
may	O
be	O
infected	O
are	O
recommended	O
to	O
use	O
standard	O
precautions	O
,	O
contact	O
precautions	O
,	O
and	O
eye	O
protection	O
.	O

More	O
likely	O
and	O
more	O
alarming	O
are	O
weapons	O
for	O
new	O
types	O
of	O
conflicts	O
and	O
warfare	O
scenarios	O
,	O
namely	O
low-intensity	O
warfare	O
or	O
secret	O
operations	O
,	O
for	O
economic	O
warfare	O
or	O
for	O
sabotage	O
activities	O
.	O

Light	O
bulbs	O
containing	O
Bacillus	B-Pathogen
globigii	E-Pathogen
were	O
dropped	O
in	O
's	O
subway	O
system	O
;	O
the	O
result	O
was	O
strong	O
enough	O
to	O
affect	O
people	O
prone	O
to	O
illness	O
(also	O
known	O
as	O
Subway	O
Experiment)	O
.	O

A	O
description	O
is	O
given	O
of	O
a	O
configurable	O
metadata	O
system	O
designed	O
to	O
grow	O
as	O
the	O
project	O
evolves	O
.	O

Critics	O
have	O
said	O
the	O
WHO	S-Organization
handled	O
the	O
pandemic	O
inadequately	O
and	O
that	O
the	O
public	O
health	O
emergency	O
declaration	O
and	O
pandemic	O
classification	O
came	O
too	O
late	O
.	O

A	O
hazardous-materials	O
worker	O
sprays	O
his	O
colleagues	O
on	O
October	O
23	O
,	O
2001	O
,	O
after	O
emerging	O
from	O
an	O
anthrax	S-Disease
search	O
on	O
.	O

In	O
this	O
group	O
,	O
one	O
in	O
every	O
1,800	O
CT	B-Technology
scans	E-Technology
was	O
followed	O
by	O
an	O
excess	O
cancer	O
.	O

And	O
those	O
funds	O
would	O
be	O
deployed	O
rapidly	O
,	O
he	O
said	O
,	O
and	O
accountability	O
would	O
be	O
built	O
in	O
.	O

Risk	O
assessment	O
guidelines	O
include	O
the	O
pathogenicity	O
of	O
the	O
infectious	O
agent	O
,	O
the	O
method	O
of	O
transmission	O
,	O
worker-related	O
risk	O
factors	O
,	O
the	O
source	O
and	O
route	O
of	O
infection	O
,	O
and	O
the	O
design	O
of	O
the	O
laboratory	O
facility	O
.	O

&quot;We	O
have	O
a	O
tendency	O
in	O
this	O
country	O
to	O
react	O
to	O
things	O
after	O
they	O
occur,&quot	O
;	O
said	O
Blue	O
Ribbon	O
panel	O
co	O
-chairman	S-Person
Tom	O
Ridge	O
,	O
former	O
gonnsylvania	O
.	O

Scientists	O
at	O
the	O
center	O
are	O
developing	O
vaccines	O
for	O
swine	B-Pathogen
flu	E-Pathogen
HIV	S-Pathogen
,	O
and	O
Ebola	S-Pathogen
.	O
In	O
February	O
,	O
scientists	O
there	O
wrapped	O
up	O
clinical	O
trials	O
of	O
an	O
Ebola	B-Vaccine
vaccine	E-Vaccine
,	O
according	O
to	O
.	O

Sen	O
.	O

Arnold	S-Person
(2019)	O
estimates	O
at	O
least	O
12	O
million	O
dead.	O
,	O
"	O
Dearth	O
and	O
the	O
Modern	O
Empire:	O
The	O
1918–19	O
Influenza	O
Epidemic	O
in	O
India,	O
"	O
Transactions	O
of	O
the	O
Royal	O
Historical	O
Society	O
29	O
(2019):	O
181–200	O
.	O

They	O
also	O
expect	O
us	O
to	O
adhere	O
to	O
the	O
highest	O
standards	O
possible	O
.	O

Human-to-human	O
transmission	O
was	O
confirmed	O
by	O
the	O
and	O
Chinese	O
authorities	O
by	O
20	O
January	O
2020	O
.	O

Proponents	O
make	O
all	O
sorts	O
of	O
claims	O
about	O
the	O
capacity	O
of	O
biochar	O
to	O
sequester	O
carbon	O
,	O
for	O
which	O
there	O
is	O
little	O
scientific	O
basis	O
,	O
and	O
they	O
fail	O
to	O
consider	O
the	O
impacts	O
of	O
dramatically	O
increasing	O
the	O
demand	O
for	O
plant	O
matter.	O
"	O

Furthermore	O
,	O
expression	O
microarray	O
analysis	O
performed	O
on	O
whole	O
lung	O
tissue	O
of	O
mice	O
infected	O
with	O
the	O
1918	O
HA/NA	O
recombinant	O
showed	O
increased	O
upregulation	O
of	O
genes	O
involved	O
in	O
apoptosis	O
,	O
tissue	O
injury	O
,	O
and	O
oxidative	O
damage	O
.	O

Meanwhile	O
,	O
62	O
countries	O
said	O
they	O
were	O
collecting	O
data	O
on	O
antimicrobial	O
use	O
in	O
animals	O
,	O
and	O
64	O
have	O
limited	O
the	O
use	O
of	O
critically	O
important	O
antimicrobials	O
for	O
growth	O
promotion	O
in	O
animals	O
.	O

Because	O
pigs	O
are	O
more	O
readily	O
infected	O
with	O
avian	O
viruses	O
than	O
are	O
humans	O
,	O
they	O
were	O
suggested	O
as	O
the	O
original	O
recipients	O
of	O
the	O
virus	O
,	O
passing	O
the	O
virus	O
to	O
humans	O
sometime	O
between	O
1913	O
and	O
1918	O
.	O

The	O
Tanzanian	B-Person
Health	I-Person
Minister	I-Person
Ummy	I-Person
Mwalimu	E-Person
stated	O
on	O
3	O
October	O
2019	O
that	O
there	O
was	O
no	O
Ebola	B-Incident
outbreak	E-Incident
in	O
Tanzania	S-Location
.	O
The	O
WHO	S-Organization
were	O
provided	O
with	O
a	O
preparedness	O
update	O
on	O
18	O
October	O
which	O
outlined	O
a	O
range	O
of	O
actions	O
,	O
and	O
included	O
commentary	O
that	O
since	O
the	O
outbreak	O
commenced	O
,	O
there	O
had	O
been	O
"	O
29	O
alerts	O
of	O
Ebola	S-Disease
suspect	O
cases	O
reported	O
,	O
17	O
samples	O
tested	O
and	O
were	O
negative	O
for	O
(including	O
2	O
in	O
September	O
2019)"	O
.	O

Three	O
out	O
of	O
10	O
people	O
with	O
died	O
.	O

In	O
my	O
view	O
,	O
this	O
track	O
record	O
of	O
escapes	O
shows	O
that	O
even	O
the	O
highest	O
biosafety	O
level	O
(	O
BSL-4	S-Platform
is	O
insufficient	O
for	O
working	O
on	O
pathogens	O
that	O
pose	O
a	O
risk	O
of	O
global	O
pandemics	O
on	O
the	O
scale	O
of	O
the	O
Spanish	B-Disease
flu	E-Disease
or	O
worse	O
.	O

CDC	S-Organization
notified	O
potentially	O
exposed	O
personnel	O
as	O
soon	O
as	O
they	O
were	O
identified	O
and	O
referred	O
them	O
to	O
the	O
CDC	B-Organization
health	I-Organization
clinic	E-Organization
or	O
to	O
a	O
local	O
emergency	O
department	O
for	O
evaluation	O
and	O
preventive	O
care	O
.	O

Once	O
the	O
scan	O
data	O
has	O
been	O
acquired	O
,	O
the	O
data	O
must	O
be	O
processed	O
using	O
a	O
form	O
of	O
tomographic	O
reconstruction	O
,	O
which	O
produces	O
a	O
series	O
of	O
cross-sectional	O
images	O
.	O

For	O
instance	O
,	O
"	O
We	O
can	O
do	O
better	O
than	O
the	O
president's	O
way-too-slow	O
response	O
in	O
Puerto	B-Location
Rico	E-Location
and	O
the	O
Virgin	B-Location
Islands	E-Location
after	O
Hurricane	B-Incident
Maria	E-Incident
,	O
"	O
said.	O
"	O
The	O
storm	O
left	O
many	O
people	O
without	O
access	O
to	O
clean	O
water	O
,	O
health	O
care	O
and	O
electricity	O
for	O
months	O
.	O

Rapid	O
spread	O
resulted	O
from	O
an	O
overburdened	O
health	O
care	O
system	O
,	O
a	O
lack	O
of	O
testing	O
,	O
and	O
a	O
large	O
impoverished	O
population	O
,	O
many	O
of	O
whom	O
live	O
in	O
very	O
close	O
proximity	O
and	O
are	O
unable	O
to	O
socially	O
distance	O
or	O
stop	O
work	O
.	O

Lagos	S-Person
,	O
Marisa	S-Person
.	O
"	O
Medfly	O
sightings	O
in	O
Solano	B-Location
County	E-Location
spur	O
quick	O
action	O
to	O
kill	O
pest"	O
,	O
San	O
Francisco	O
Chronicle	O
,	O
September	O
14	O
,	O
2007	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

CAUTION:	O
&lt;organism	O
name&gt	O
;	O
is	B-Platform
a	I-Platform
Biosafety	I-Platform
L	E-Platform
pathogen	O
.	O

Lenzilumab	S-Drug
an	O
anti-GM-CSF	O
monoclonal	O
antibody	O
,	O
is	O
protective	O
in	O
murine	O
models	O
for	O
CAR	O
T	O
cell-induced	O
CRS	S-Disease
and	O
neurotoxicity	S-Disease
and	O
is	O
a	O
viable	O
therapeutic	O
option	O
due	O
to	O
the	O
observed	O
increase	O
of	O
pathogenic	O
GM-CSF	O
secreting	O
T-cells	O
in	O
hospitalised	O
patients	O
with	O
.	O

Daschle	S-Person
said	O
that	O
his	O
&quot;mounting	O
frustration	O
over	O
the	O
inactiongton	O
on	O
this	O
issue&quot	O
;	O
is	O
one	O
of	O
the	O
reasons	O
he	O
decided	O
to	O
serve	O
on	O
the	O
bipartisan	O
Blue	O
Ribbon	O
Study	O
Panel	O
on	O
Biodefense	O
.	O

UN	B-Organization
News	I-Organization
Centre	E-Organization
.	O
26	O
August	O
2015	O
.	O

There	O
was	O
no	O
major	O
structural	O
damage	O
in	O
the	O
incident	O
and	O
"	O
no	O
work	O
with	O
biological	O
materials	O
was	O
going	O
on	O
there"	O
,	O
the	O
Vektor	S-Organization
statement	O
said	O
.	O

There	O
are	O
about	O
70	O
armed	O
military	O
groups	O
,	O
among	O
them	O
the	O
Alliance	B-Organization
of	I-Organization
Patriots	E-Organization
for	O
a	O
Free	B-Location
and	I-Location
Sovereign	I-Location
Congo	E-Location
and	O
the	O
Mai-Mayi	B-Location
Nduma	E-Location
défense	O
du	O
Congo-Rénové	S-Organization
,	O
in	O
North	B-Location
Kivu	E-Location
.	O
The	O
armed	O
fighting	O
has	O
displaced	O
thousands	O
of	O
individuals	O
.	O

Western	B-Location
Africa	E-Location
On	O
8	O
August	O
2014	O
,	O
a	O
cordon	O
sanitaire	O
,	O
a	O
disease-fighting	O
practice	O
that	O
forcibly	O
isolates	O
affected	O
regions	O
,	O
was	O
established	O
in	O
the	O
triangular	O
area	O
where	O
Guinea	S-Location
,	O
Liberia	S-Location
,	O
and	O
are	O
separated	O
only	O
by	O
porous	O
borders	O
and	O
where	O
70	O
per	O
cent	O
of	O
the	O
known	O
cases	O
had	O
been	O
found	O
.	O

Appointment	O
of	O
Dr	O
.	O

Fit	O
test	O
must	O
be	O
done	O
for	O
all	O
staffs	O
that	O
use	O
the	O
N95	B-Equipment
mask	E-Equipment
.	O
When	O
leaving	O
the	O
lab	O
,	O
staff	O
should	O
remove	O
the	O
disposable	O
waterproof	O
clothing	O
and	O
replace	O
the	O
outer-layer	O
gloves	O
within	O
the	O
core	O
area	O
.	O

The	O
operating	O
procedures	O
and	O
routes	O
for	O
EBOV	S-Pathogen
detection	O
were	O
carefully	O
draw	O
up	O
.	O

During	O
the	O
mid-2010s	O
,	O
the	O
Mintz	O
Levin	O
law	O
firm	O
prosecuted	O
various	O
patent	O
applications	O
for	O
remdesivir	S-Drug
on	O
behalf	O
of	O
Gilead	B-Organization
Sciences	E-Organization
before	O
the	O
United	B-Organization
States	I-Organization
Patent	I-Organization
and	I-Organization
Trademark	I-Organization
Office	E-Organization
(	O
USPTO	S-Organization
)	O
.	O

Readers	O
are	O
strongly	O
urged	O
to	O
review	O
this	O
publication	O
prior	O
to	O
initiating	O
any	O
experiment	O
outlined	O
in	O
this	O
manual	O
.	O

As	O
a	O
response	O
to	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	E-Incident
Congress	O
passed	O
a	O
Continuing	B-Document
Appropriations	I-Document
Resolution	E-Document
allocating	O
$30,000,000	O
towards	O
's	O
efforts	O
to	O
fight	O
the	O
virus	O
.	O

The	O
economic	O
and	O
human	O
cost	O
of	O
antibiotic	O
resistance	O
is	O
already	O
enormous	O
.	O

The	O
smallpox	S-Pathogen
formulation-400	O
gr.	O
of	O
which	O
was	O
exploded	O
on	O
the	O
island-"got	O
her	O
"	O
and	O
she	O
became	O
infected	O
.	O

First	O
,	O
without	O
killing	O
the	O
bacteria	O
,	O
the	O
technology	O
must	O
extract	O
and	O
isolate	O
them	O
from	O
complex	O
environments	O
such	O
as	O
soil	O
,	O
runoff	O
,	O
sewage	O
,	O
biofilms	O
,	O
and	O
medical	O
samples	O
,	O
where	O
numerous	O
strains	O
of	O
bacteria	O
live	O
together	O
.	O

My	O
understanding	O
is	O
that	O
the	O
staff	O
were	O
not	O
the	O
same	O
staff	O
at	O
that	O
time	O
.	O

By	O
17	O
July	O
,	O
the	O
total	O
number	O
of	O
suspected	O
cases	O
in	O
the	O
country	O
stood	O
at	O
442	O
,	O
surpassing	O
those	O
in	O
Guinea	S-Location
and	O
Liberia	S-Location
.	O
By	O
20	O
July	O
,	O
additional	O
cases	O
of	O
the	O
disease	O
had	O
been	O
reported	O
by	O
the	O
media	O
in	O
the	O
Bo	B-Location
District	E-Location
,	O
while	O
the	O
first	O
case	O
in	O
Freetown	S-Location
,	O
's	O
capital	O
,	O
was	O
reported	O
in	O
late	O
July	O
.	O

On	O
28	O
October	O
,	O
an	O
additional	O
3	O
cases	O
were	O
reported	O
in	O
the	O
Forécariah	B-Location
Prefecture	E-Location
by	O
the	O
WHO	S-Organization
.	O
On	O
6	O
November	O
,	O
a	O
media	O
report	O
indicated	O
Tana	B-Location
village	E-Location
to	O
be	O
the	O
last	O
known	O
place	O
with	O
Ebola	S-Disease
in	O
the	O
country	O
,	O
and	O
on	O
11	O
November	O
,	O
WHO	S-Organization
indicated	O
that	O
no	O
Ebola	S-Disease
cases	O
were	O
reported	O
in	O
;	O
this	O
was	O
the	O
first	O
time	O
since	O
the	O
epidemic	O
began	O
,	O
that	O
no	O
cases	O
had	O
been	O
reported	O
in	O
any	O
country	O
.	O

One	O
of	O
the	O
biggest	O
dangers	O
of	O
infection	O
faced	O
by	O
medical	O
staff	O
requires	O
their	O
learning	O
how	O
to	O
properly	O
suit	O
up	O
and	O
remove	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment

As	O
of	O
2008	O
,	O
no	O
direct	O
connection	O
has	O
yet	O
been	O
found	O
between	O
the	O
First	O
case	O
and	O
the	O
Fallen	B-Incident
Angel	I-Incident
case	E-Incident
and	O
no	O
explanation	O
found	O
for	O
the	O
origin	O
of	O
the	O
ricin	S-Pathogen
in	O
Frist's	B-Location
office	E-Location
.	O
Ryan	S-Person
,	O
Jeffrey	B-Person
R	E-Person
.	O
and	O
Glarum	S-Person
,	O
.	O
Biosecurity	O
and	O
Bioterrorism:	O
Containing	O
and	O
Preventing	O
Biological	O
Threats	O
,	O
(Google	O
Books)	O
,	O
Butterworth-Heinemann	O
,	O
2008	O
,	O
p.	O
148	O
,	O
()	O
.	O

This	O
isn't	O
just	O
a	O
problem	O
in	O
the	O
United	B-Location
States	E-Location
but	O
a	O
global	O
emerging	O
threat	O
.	O

"	O
When	O
things	O
slip	O
from	O
headlines	O
--	O
and	O
anthrax	S-Disease
hasn't	O
been	O
in	O
the	O
headlines	O
for	O
quite	O
a	O
long	O
time	O
--	O
people	O
don't	O
necessarily	O
give	O
it	O
the	O
same	O
type	O
of	O
importance,	O
"	O
he	O
said.	O
"	O
This	O
threat	O
hasn't	O
gone	O
away	O
.	O

The	O
IACG	S-Organization
is	O
co-chaired	O
by	O
the	O
UN	S-Organization
Deputy	O
Secretary-General	O
and	O
the	O
Director	O
General	O
of	O
WHO	S-Organization
and	O
comprises	O
high	O
level	O
representatives	O
of	O
relevant	O
agencies	O
,	O
other	O
international	O
organizations	O
,	O
and	O
individual	O
experts	O
across	O
different	O
sectors	O
.	O

The	O
Chemical	B-Pathogen
Corps	E-Pathogen
developed	O
Flettner	O
rotor	O
bomblets	O
and	O
later	O
triangular	O
bomblets	O
for	O
wider	O
coverage	O
due	O
to	O
improved	O
glide	O
angles	O
over	O
Magnus-lift	O
spherical	O
bomblets	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
FDA	O
,	O
USDA	O
,	O
DHHS	O
,	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Following	O
the	O
cease	O
and	O
desist	O
letter	O
,	O
USAMRIID	S-Organization
registration	O
with	O
the	O
Federal	B-Scientific_research_project
Select	I-Scientific_research_project
Agent	I-Scientific_research_project
Program	E-Scientific_research_project
()	O
,	O
which	O
sets	O
regulations	O
for	O
laboratories	O
handling	O
dangerous	O
and	O
lethal	O
pathogens	O
,	O
was	O
suspended	O
.	O

The	O
MR	S-Technology
reports	O
change	O
in	O
gene	O
expression	O
with	O
positive	O
correlation	O
to	O
TaqMan	O
analysis	O
,	O
.	O

Anthrax	S-Pathogen
makes	O
a	O
good	O
weapon	O
because	O
it	O
can	O
be	O
released	O
quietly	O
and	O
without	O
anyone	O
knowing	O
.	O

In	O
2004	O
,	O
the	O
JCVI	S-Organization
's	O
Policy	O
team	O
,	O
along	O
with	O
the	O
Center	B-Organization
for	I-Organization
Strategic	I-Organization
&amp;	I-Organization
International	I-Organization
Studies	B-Organization
(	O
CSIS	S-Organization
)	O
and	O
the	O
Massachusetts	B-Organization
Institute	I-Organization
of	I-Organization
Technology	E-Organization
(MIT)	O
were	O
funded	O
by	O
tion	O
to	O
conduct	O
a	O
series	O
of	O
workshops	O
and	O
public	O
sessions	O
over	O
a	O
20-month	O
period	O
to	O
discuss	O
the	O
ethical	O
and	O
societal	O
implications	O
of	O
synthetic	O
genomics	O
.	O

They	O
did	O
not	O
recommend	O
closing	O
borders	O
or	O
restricting	O
travel	O
.	O

The	O
WHO	S-Organization
the	O
Chinese	B-Organization
National	I-Organization
Health	I-Organization
Commission	E-Organization
,	O
and	O
the	O
United	B-Organization
States'	I-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
have	O
published	O
recommendations	O
for	O
taking	O
care	O
of	O
people	O
who	O
are	O
hospitalised	O
with	O
COVID‑19	S-Disease
.	O
Intensivists	O
and	O
pulmonologists	O
in	O
the	O
U.S.	S-Location
have	O
compiled	O
treatment	O
recommendations	O
from	O
various	O
agencies	O
into	O
a	O
free	O
resource	O
,	O
the	O
.	O

Students	O
receive	O
Vero	O
cells	O
that	O
were	O
plated	O
in	O
96	O
well	O
plates	O
a	O
day	O
earlier	O
.	O

In	O
2018	O
,	O
Michael	B-Person
Worobey	E-Person
an	O
evolutionary	O
biology	O
professor	O
at	O
the	O
University	B-Organization
of	I-Organization
Arizona	E-Organization
who	O
is	O
examining	O
the	O
history	O
of	O
the	O
1918	B-Incident
pandemic	E-Incident
,	O
revealed	O
that	O
he	O
obtained	O
tissue	O
slides	O
created	O
by	O
William	B-Person
Rolland	E-Person
,	O
a	O
physician	O
who	O
reported	O
on	O
a	O
respiratory	B-Disease
illness	E-Disease
likely	O
to	O
be	O
the	O
virus	O
while	O
a	O
pathologist	O
in	O
the	O
British	O
military	O
during	O
World	B-Incident
War	I-Incident
One	E-Incident
.	O
Rolland	S-Person
had	O
authored	O
an	O
article	O
in	O
the	O
Lancet	S-Organization
during	O
1917	O
about	O
a	O
respiratory	O
illness	O
outbreak	O
beginning	O
in	O
1916	O
in	O
Étaples	S-Location
,	O
France	S-Location
.	O
PDF	O
version	O
here	O
Worobey	S-Person
traced	O
recent	O
references	O
to	O
that	O
article	O
to	O
family	O
members	O
who	O
had	O
retained	O
slides	O
that	O
Rolland	S-Person
had	O
prepared	O
during	O
that	O
time.	O
extracted	O
tissue	O
from	O
the	O
slides	O
to	O
potentially	O
reveal	O
more	O
about	O
the	O
origin	O
of	O
the	O
pathogen	O
.	O

Information	O
from	O
the	O
US	S-Location
federal	O
contracts	O
registry	O
shows	O
that	O
the	O
Pentagon	S-Organization
performs	O
tests	O
using	O
the	O
bacteria	O
stolen	O
from	O
Saddam	B-Person
Hussein	E-Person
's	O
bio-weapons	O
factory	O
in	O
.	O

Just	O
as	O
the	O
war	O
had	O
effected	O
the	O
course	O
of	O
influenza	O
,	O
influenza	O
affected	O
the	O
war	O
.	O

CRISPR	S-Technology
simplifies	O
the	O
creation	O
of	O
genetically	O
modified	O
organisms	O
for	O
research	O
which	O
mimic	O
disease	O
or	O
show	O
what	O
happens	O
when	O
a	O
gene	O
is	O
knocked	O
down	O
or	O
mutated.	O
may	O
be	O
used	O
at	O
the	O
germline	O
level	O
to	O
create	O
organisms	O
in	O
which	O
the	O
targeted	O
gene	O
is	O
changed	O
everywhere	O
(i.e.	O
in	O
all	O
cells/tissues/organs	O
of	O
a	O
multicellular	O
organism)	O
,	O
or	O
it	O
may	O
be	O
used	O
in	O
non-germline	O
cells	O
to	O
create	O
local	O
changes	O
that	O
only	O
affect	O
certain	O
cell	O
populations	O
within	O
the	O
organism	O
.	O

These	O
programs	O
became	O
immense	O
and	O
were	O
conducted	O
at	O
52	O
clandestine	O
sites	O
employing	O
over	O
50,000	O
people	O
.	O

I	O
urge	O
the	O
international	O
community	O
to	O
provide	O
this	O
support	O
on	O
the	O
most	O
urgent	O
basis	O
possible	O
.	O
"	O

As	O
a	O
result	O
,	O
DHS	S-Organization
may	O
miss	O
an	O
opportunity	O
to	O
leverage	O
resources	O
and	O
share	O
information	O
that	O
could	O
lead	O
to	O
greater	O
effectiveness	O
addressing	O
chemical	O
threats	O
,	O
said	O
.	O

The	O
official	O
names	O
COVID‑19	S-Disease
and	O
SARS-CoV-2	S-Disease
were	O
issued	O
by	O
the	O
WHO	S-Organization
on	O
11	O
February	O
2020	O
.	O

First	O
,	O
there	O
must	O
be	O
an	O
increased	O
awareness	O
of	O
bioterrorism	O
risks	O
among	O
scientists	O
and	O
the	O
scientific	O
leadership	O
.	O

However	O
,	O
the	O
components	O
BASE	S-Platform
,	O
OMERO	S-Platform
and	O
omixed	O
are	O
distributed	O
as	O
stand-alone	O
versions-but	O
without	O
functionality	O
.	O

CDC	S-Organization
analyses	O
demonstrate	O
that	O
the	O
number	O
of	O
U.S.	S-Location
jobs	O
at	O
risk	O
rapidly	O
goes	O
up	O
as	O
an	O
outbreak	O
spreads	O
from	O
a	O
single	O
country	O
to	O
multiple	O
countries	O
.	O

All	O
sterilised	O
waste	O
was	O
incinerated	O
.	O

Timeline	O
of	O
reported	O
cases	O
reflects	O
cases	O
that	O
were	O
not	O
able	O
to	O
have	O
a	O
laboratory	O
test	O
sample	O
prior	O
to	O
burial	O
as	O
probable	O
cases	O
.	O

In	O
1348–1349	O
,	O
the	O
disease	O
reached	O
Antioch	S-Location
.	O
The	O
city's	O
residents	O
fled	O
to	O
the	O
north	O
,	O
but	O
most	O
of	O
them	O
ended	O
up	O
dying	O
during	O
the	O
journey	O
.	O

Neither	O
case	O
involved	O
a	O
select	O
agent-a	O
pathogen	O
on	O
CDC	S-Organization
list	O
of	O
potential	O
agents	O
in	O
a	O
biological	O
attack.	O
(Although	O
Y.	B-Pathogen
pestis	E-Pathogen
is	O
on	O
the	O
list	O
,	O
the	O
strain	O
Casadaban	O
studied	O
was	O
excluded.	O
)	O
But	O
Schneewind	S-Person
also	O
directs	O
the	O
Great	B-Organization
Lakes	I-Organization
Regional	I-Organization
Center	I-Organization
of	I-Organization
Excellence	I-Organization
for	I-Organization
Biodefense	I-Organization
and	I-Organization
Emerging	I-Organization
Infectious	I-Organization
Diseases	I-Organization
Research	E-Organization
,	O
a	O
consortium	O
funded	O
by	O
the	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
to	O
study	O
select	O
agents	O
and	O
natural	O
threats	O
.	O

In	O
1998	O
,	O
it	O
became	O
public	O
that	O
the	O
US	B-Organization
Naval	I-Organization
Research	I-Organization
Laboratory	E-Organization
in	O
Washington	B-Location
DC	E-Location
was	O
developing	O
genetically	B-Pathogen
engineered	I-Pathogen
fungi	I-Pathogen
with	I-Pathogen
offensive	I-Pathogen
biowarfare	I-Pathogen
potential	E-Pathogen
.	O
They	O
isolated	O
natural	O
microorganisms	O
that	O
degrade	O
a	O
variety	O
of	O
materials	O
,	O
such	O
as	O
plastics	O
,	O
rubber	O
and	O
metals	O
,	O
and	O
used	O
genetic	B-Technology
engineering	E-Technology
to	O
make	O
them	O
more	O
powerful	O
and	O
focused-one	O
of	O
these	O
genetically	O
engineered	O
microbes	O
can	O
destroy	O
military	O
paints	O
in	O
72	O
hours	O
.	O

The	O
U.S.	S-Location
death	O
toll	O
is	O
expected	O
be	O
higher	O
when	O
the	O
CDC	S-Organization
releases	O
its	O
latest	O
figures	O
Friday	O
,	O
said	O
Anne	B-Person
Schuchat	E-Person
,	O
director	O
of	O
the	O
.	O

There	O
has	O
been	O
a	O
lot	O
of	O
speculation	O
about	O
a	O
government-wide	O
biosafety	O
stand	O
down	O
following	O
the	O
Department	B-Organization
of	I-Organization
Veterans	I-Organization
Affairs	E-Organization
sending	O
notices	O
to	O
its	O
own	O
research	O
institutions	O
on	O
the	O
topic	O
.	O

For	O
staff	O
,	O
there	O
are	O
areas	O
for	O
preparation	O
and	O
decontamination	O
.	O

A	O
total	O
restriction	O
on	O
both	O
human-approved	O
compounds	O
and	O
their	O
structural	O
derivatives	O
as	O
routine	O
feedstocks	O
in	O
animal	O
feed	O
,	O
agriculture	O
,	O
or	O
fisheries	O
must	O
be	O
enforced	O
.	O

Roy	B-Person
Cunningham	E-Person
a	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
entomologist	O
and	O
dean	O
of	O
the	O
state's	O
Medfly	O
scientific	O
advisory	O
panel	O
,	O
agreed	O
that	O
there	O
have	O
been	O
some	O
baffling	O
aspects	O
to	O
the	O
.	O

In	O
May	O
2014	O
,	O
Dutschke	S-Person
pleaded	O
guilty	O
and	O
was	O
sentenced	O
to	O
25	O
years	O
in	O
prison	O
.	O

Lane	B-Person
Stephenson	E-Person
the	O
university's	O
director	O
of	O
news	O
and	O
information	O
services	O
,	O
declined	O
to	O
answer	O
questions	O
about	O
the	O
lab	O
incidents	O
.	O

Risks:	O
Cas9	O
has	O
generated	O
nearly	O
as	O
much	O
controversy	O
as	O
it	O
has	O
excitement	O
,	O
because	O
genome	B-Technology
editing	E-Technology
carries	O
both	O
safety	O
issues	O
and	O
ethical	O
risks	O
.	O

The	O
last	O
naturally	O
occurring	O
infection	O
was	O
of	O
Variola	B-Pathogen
minor	E-Pathogen
in	O
in	O
1977	O
.	O

This	O
represented	O
a	O
significant	O
fall	O
in	O
outlay	O
compared	O
to	O
the	O
previous	O
2009–2010	O
budget	O
,	O
adjusting	O
to	O
take	O
account	O
of	O
previous	O
underspends	O
.	O

Genetic	B-Technology
Engineers	E-Technology
are	O
a	O
subculture	O
of	O
biohackers	O
as	O
one	O
of	O
the	O
most	O
accessible	O
forms	O
of	O
biohacking	O
is	O
through	O
engineering	O
microorganisms	O
or	O
plants	O
.	O

Supplies	O
depended	O
on	O
crops	O
of	O
the	O
plant	O
.	O

Also	O
,	O
to	O
demonstrate	O
the	O
broad	O
utility	O
of	O
the	O
platform	O
,	O
each	O
team	O
will	O
target	O
a	O
variety	O
of	O
viral	O
pathogens	O
including	O
influenza	S-Pathogen
,	O
chikungunya	S-Pathogen
,	O
MERS-CoV	S-Pathogen
,	O
and	O
,	O
among	O
others	O
.	O

Downloaded	O
Oct.22	O
,	O
2017	O
.	O

Rapid	O
spread	O
from	O
person-to-person	O
can	O
occur	O
through	O
speaking	O
,	O
breathing	O
or	O
touching	O
,	O
and	O
smallpox	S-Pathogen
also	O
can	O
be	O
transmitted	O
by	O
direct	O
contact	O
with	O
infected	O
fluids	O
and	O
contaminated	O
objects	O
.	O

Mashups	O
are	O
aggregations	O
of	O
multiple	O
web	O
services	O
,	O
e.g.	O
an	O
aggregation	O
of	O
microarray	O
data	O
with	O
interactions	O
from	O
the	O
human	B-Pathogen
immunodeficiency	I-Pathogen
virus	I-Pathogen
type	I-Pathogen
1	E-Pathogen
(	O
HIV-1	S-Pathogen
)	O
,	O
Human	B-Platform
Protein	I-Platform
Interaction	I-Platform
Database	E-Platform
for	O
investigation	O
of	O
the	O
HIV-1	S-Pathogen
.	O
Workflows	O
can	O
be	O
regarded	O
as	O
a	O
dedicated	O
type	O
of	O
mashup	O
.	O

No	O
known	O
mutations	O
correlated	O
with	O
high	O
pathogenicity	O
in	O
other	O
human	O
or	O
animal	O
viruses	O
have	O
been	O
found	O
in	O
the	O
1918	O
genome	O
,	O
but	O
ongoing	O
studies	O
to	O
map	O
virulence	O
factors	O
are	O
yielding	O
interesting	O
results	O
.	O

President	O
Jair	B-Person
Bolsonaro	E-Person
has	O
created	O
a	O
great	O
deal	O
of	O
controversy	O
referring	O
to	O
the	O
virus	O
as	O
a	O
"	O
little	O
flu	O
"	O
and	O
frequently	O
speaking	O
out	O
against	O
preventive	O
measures	O
such	O
as	O
lockdowns	O
and	O
quarantines	O
.	O

They	O
also	O
stockpiled	O
animal	O
manure	O
in	O
the	O
hope	O
of	O
spreading	O
illness	O
.	O

All	O
sterilised	O
waste	O
was	O
incinerated	O
.	O

In	O
May	O
,	O
2016	O
,	O
Kenyan	O
officials	O
apprehended	O
two	O
members	O
of	O
an	O
Islamic	O
extremist	O
group	O
in	O
motion	O
to	O
set	O
off	O
a	O
biological	O
bomb	O
containing	O
anthrax	S-Pathogen
.	O
,	O
the	O
believed	O
leader	O
of	O
the	O
group	O
,	O
who	O
was	O
a	O
medical	O
intern	O
,	O
was	O
arrested	O
along	O
with	O
his	O
wife	O
,	O
a	O
medical	O
student	O
.	O

The	O
initial	O
idea	O
of	O
having	O
more	O
or	O
less	O
identical	O
methods	O
in	O
all	O
4	O
laboratories	O
turned	O
out	O
to	O
be	O
unrealistic	O
,	O
as	O
the	O
different	O
agencies	O
are	O
responsible	O
for	O
different	O
sample	O
types-for	O
example	O
,	O
tissue	O
(human	O
and	O
animal)	O
,	O
food	O
,	O
feed	O
,	O
drinking	O
water	O
,	O
and	O
environmental	O
samples	O
.	O

In	O
that	O
case	O
,	O
a	O
tear	O
was	O
discovered	O
in	O
the	O
,	O
records	O
show	O
.	O

Although	O
in	O
1918	O
influenza	S-Disease
was	O
not	O
a	O
nationally	O
reportable	O
disease	O
and	O
diagnostic	O
criteria	O
for	O
influenza	S-Disease
and	O
pneumonia	S-Disease
were	O
vague	O
,	O
death	O
rates	O
from	O
influenza	S-Disease
and	O
pneumonia	S-Disease
in	O
the	O
United	B-Location
States	E-Location
had	O
risen	O
sharply	O
in	O
1915	O
and	O
1916	O
because	O
of	O
a	O
major	O
respiratory	O
disease	O
epidemic	O
beginning	O
in	O
December	O
1915	O
.	O

Frieden	S-Person
.	O
I'm	O
just	O
curious	O
what	O
kind	O
of	O
impact	O
the	O
moratorium	O
will	O
have	O
on	O
the	O
work	O
that	O
you're	O
doing	O
,	O
number	O
one	O
.	O

In	O
Italy	S-Location
,	O
the	O
population	O
of	O
Florence	S-Organization
was	O
reduced	O
from	O
110,000–120,000	O
inhabitants	O
in	O
1338	O
down	O
to	O
50,000	O
in	O
1351	O
.	O

In	O
2011	O
,	O
a	O
study	O
from	O
the	O
US	B-Platform
Flu	I-Platform
Vaccine	I-Platform
Effectiveness	I-Platform
Network	E-Platform
estimated	O
the	O
overall	O
effectiveness	O
of	O
all	O
pandemic	B-Vaccine
H1N1	I-Vaccine
vaccines	E-Vaccine
at	O
56%	O
.	O

In	O
August	O
they	O
published	O
a	O
road	O
map	O
to	O
guide	O
and	O
coordinate	O
the	O
international	O
response	O
to	O
the	O
outbreak	O
,	O
aiming	O
to	O
stop	O
ongoing	O
Ebola	S-Disease
transmission	O
worldwide	O
within	O
6–9	O
months	O
,	O
and	O
formally	O
designated	O
the	O
outbreak	O
as	O
a	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
.	O
This	O
is	O
a	O
legal	O
designation	O
used	O
only	O
twice	O
before	O
(for	O
the	O
2009	O
H1N1	S-Disease
(	O
swine	B-Disease
flu	E-Disease
)	O
pandemic	O
and	O
the	O
2014	O
resurgence	O
of	O
)	O
that	O
invokes	O
legal	O
measures	O
on	O
disease	O
prevention	O
,	O
surveillance	O
,	O
control	O
,	O
and	O
response	O
,	O
by	O
194	O
signatory	O
countries	O
.	O

This	O
danger	O
was	O
highlighted	O
last	O
year	O
by	O
a	O
worrying	O
article	O
in	O
Science:	O
a	O
research	O
team	O
at	O
the	O
State	B-Organization
University	I-Organization
of	I-Organization
New	I-Organization
York	I-Organization
in	I-Organization
Stony	I-Organization
Brook	E-Organization
chemically	O
synthesized	O
an	O
artificial	B-Pathogen
polio	I-Pathogen
virus	E-Pathogen
from	O
scratch	O
(	O
et	O
al.	O
,	O
2002)	O
.	O

Confirming	O
the	O
infection	O
as	O
the	O
fourth	O
Zika	S-Disease
case	O
in	O
the	O
U.S.	S-Location
,	O
the	O
Allegheny	B-Organization
County	I-Organization
Health	I-Organization
Department	E-Organization
(	O
ACHD	S-Organization
)	O
released	O
a	O
statement	O
calling	O
the	O
case	O
"	O
unique,"	O
as	O
the	O
infected	O
woman	O
contracted	O
the	O
virus	O
in	O
a	O
lab	O
,	O
not	O
through	O
mosquito-borne	O
or	O
sexual	O
transmission.	O
"	O
We	O
want	O
to	O
remind	O
residents	O
that	O
,	O
despite	O
this	O
rare	O
incident	O
,	O
there	O
is	O
still	O
no	O
current	O
risk	O
of	O
contracting	O
Zika	S-Disease
from	O
mosquitoes	O
in	O
Allegheny	B-Location
County	E-Location
,	O
"	O
ACHD	S-Organization
Director	O
added	O
in	O
the	O
statement	O
.	O

Retrieved	O
January	O
3	O
,	O
2009	O
.	O

In	O
response	O
to	O
the	O
incident	O
,	O
the	O
lab's	O
workers	O
were	O
retrained	O
and	O
protocols	O
revised	O
.	O

These	O
laboratories	O
included	O
51	O
(27%)	O
labs	O
from	O
government	O
,	O
75	O
(39%)	O
from	O
private	O
sectors	O
and	O
64	O
(34%)	O
labs	O
belong	O
to	O
organization	O
providing	O
health	O
care	O
services	O
.	O

We	O
found	O
the	O
Cartagena	B-Document
protocol	E-Document
to	O
be	O
a	O
catalyst	O
for	O
the	O
serious	O
initiatives	O
in	O
the	O
capacity-building	O
efforts	O
in	O
the	O
BMENA	S-Location
region	O
.	O

Grazing	O
livestock	O
,	O
such	O
as	O
cows	O
or	O
sheep	O
,	O
ingest	O
the	O
spores	O
and	O
become	O
infected	O
with	O
anthrax	S-Disease
.	O
Persons	O
who	O
work	O
with	O
these	O
livestock	O
animals	O
or	O
with	O
animal	O
products	O
may	O
become	O
infected	O
;	O
however	O
,	O
it	O
is	O
very	O
rare	O
for	O
anthrax	S-Disease
to	O
occur	O
in	O
animal	O
herds	O
in	O
today	O
.	O

The	O
lab	O
was	O
not	O
one	O
of	O
the	O
two	O
labs	O
involved	O
in	O
recent	O
incidents	O
;	O
those	O
two	O
labs	O
remain	O
closed	O
.	O

The	O
was	O
also	O
unsatisfied	O
with	O
the	O
operational	O
qualities	O
of	O
the	O
M114/US	O
bursting	O
bomblet	O
and	O
labeled	O
it	O
an	O
interim	O
item	O
until	O
the	O
Chemical	O
Corps	O
could	O
deliver	O
a	O
superior	O
weapon	O
.	O

That	O
division	O
works	O
on	O
viruses	O
like	O
smallpox	S-Pathogen
and	O
Ebola	S-Pathogen
,	O
which	O
can	O
only	O
be	O
studied	O
in	O
laboratories	O
of	O
the	O
highest	O
biosafety	O
and	O
biosecurity	O
ratings	O
,	O
.	O

The	O
European	B-Organization
Union	E-Organization
(	O
EU	S-Location
)	O
divided	O
biological	O
agents	O
into	O
four	O
risk	O
groups	O
and	O
in	O
2000	O
published	O
the	O
category	O
lists	O
in	O
Directive	B-Document
No.	I-Document
2000/54/EC	E-Document
"	O
on	O
the	O
protection	O
of	O
workers	O
from	O
risks	O
related	O
to	O
exposure	O
to	O
biological	O
agents	O
at	O
work	O
"	O
[6]	O
.	O

Local	O
citizens	O
in	O
Chechnya	S-Location
noticed	O
a	O
UAV	O
sprayer	O
near	O
the	O
Russian	S-Location
border	O
with	O
in	O
2017	O
.	O

The	O
occurrence	O
,	O
and	O
to	O
some	O
extent	O
the	O
severity	O
,	O
of	O
recurrent	O
annual	O
outbreaks	O
,	O
are	O
driven	O
by	O
viral	O
antigenic	O
drift	O
,	O
with	O
an	O
antigenic	O
variant	O
virus	O
emerging	O
to	O
become	O
dominant	O
approximately	O
every	O
2	O
to	O
3	O
years	O
.	O

Facing	O
the	O
unprecedented	O
threats	O
of	O
climate	O
change	O
,	O
many	O
researchers	O
believe	O
rDNA	O
and	O
GMOs	O
will	O
be	O
crucial	O
in	O
humanity's	O
efforts	O
to	O
adapt	O
to	O
rapid	O
environmental	O
changes	O
.	O

Anthrax	B-Pathogen
spores	E-Pathogen
are	O
easily	O
found	O
in	O
nature	O
,	O
can	O
be	O
produced	O
in	O
a	O
lab	O
,	O
and	O
can	O
last	O
for	O
a	O
long	O
time	O
in	O
the	O
environment	O
.	O

According	O
to	O
the	O
results	O
of	O
a	O
new	O
study	O
,	O
recently	O
published	O
in	O
the	O
NEJM	S-Document
,	O
twice-daily	O
dosing	O
of	O
600	O
mg	O
of	O
was	O
found	O
to	O
be	O
safe	O
in	O
humans	O
.	O

Biotechnology	O
is	O
nearly	O
as	O
old	O
as	O
humanity	O
itself	O
.	O

Epidemiologists	O
discovered	O
the	O
Jordan	S-Location
cases	O
.	O

LENA	B-Person
SUN	E-Person
Hi	O
,	O
Dr	O
.	O

World	O
Health	O
Day	O
falls	O
on	O
7	O
April	O
each	O
year	O
,	O
timed	O
to	O
match	O
the	O
anniversary	O
of	O
WHO	S-Organization
founding	O
.	O

He	O
later	O
said	O
he	O
regretted	O
that	O
stunt	O
because	O
it	O
could	O
lead	O
others	O
to	O
copy	O
him	O
and	O
"	O
people	O
are	O
going	O
to	O
get	O
hurt.	O
"	O
Yet	O
when	O
asked	O
whether	O
his	O
company	O
,	O
the	O
Odin	S-Organization
,	O
which	O
he	O
runs	O
out	O
of	O
his	O
garage	O
in	O
Oakland	S-Location
,	O
California	S-Location
,	O
was	O
going	O
to	O
stop	O
selling	O
kits	O
to	O
the	O
general	O
public	O
,	O
he	O
said	O
no	O
.	O

On	O
15	O
September	O
2019	O
,	O
some	O
slowdown	O
of	O
EVD	S-Disease
cases	O
was	O
noted	O
by	O
the	O
WHO	S-Organization
in	O
DRC	S-Location
,	O
however	O
contact	O
tracing	O
continued	O
to	O
be	O
below	O
100%	O
,	O
then	O
at	O
89%	O
.	O

The	O
death	O
toll	O
is	O
estimated	O
to	O
have	O
been	O
anywhere	O
from	O
17 million	O
to	O
50 million	O
,	O
and	O
possibly	O
as	O
high	O
as	O
100 million	O
,	O
making	O
it	O
one	O
of	O
the	O
deadliest	O
pandemics	O
in	O
human	O
history	O
.	O

The	O
Use	O
of	O
Research	O
Evidence	O
in	O
Two	O
International	O
Organizations'	O
Recommendations	O
about	O
Health	O
Systelicy	O
,	O
5(1)	O
,	O
pp.66–86	O
.	O

Plans	O
to	O
limit	O
travel	O
between	O
cities	O
were	O
announced	O
in	O
March	O
,	O
although	O
heavy	O
traffic	O
between	O
cities	O
ahead	O
of	O
the	O
Persian	O
New	O
Year	O
Nowruz	O
continued	O
.	O

Keasling	S-Person
took	O
the	O
set	O
of	O
genes	O
that	O
produce	O
the	O
artemisinin	S-Drug
precursor	O
in	O
the	O
plant	O
and	O
moved	O
the	O
pathway	O
-	O
along	O
with	O
other	O
required	O
genes	O
from	O
different	O
organisms	O
-	O
to	O
yeast	O
,	O
a	O
eukaryotic	O
single-celled	O
organism	O
that	O
is	O
easy	O
to	O
grow	O
in	O
the	O
lab	O
.	O

Inglesby	S-Person
is	O
Chair	O
of	O
the	O
Board	B-Organization
of	I-Organization
Scientific	I-Organization
Counselors	E-Organization
,	O
Office	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
,	O
CDC	S-Organization
,	O
and	O
he	O
is	O
Co-chair	O
of	O
the	O
National	O
Health	O
Security	O
Preparedness	O
Index	O
initiative	O
.	O

The	O
origin	O
of	O
the	O
"	O
Spanish	B-Incident
flu	E-Incident
name	O
stems	O
from	O
the	O
pandemic's	O
spread	O
to	O
Spain	S-Location
from	O
France	S-Location
in	O
November	O
1918	O
.	O

Mabalo	B-Person
Lokela	E-Person
the	O
headmaster	O
of	O
a	O
local	O
school	O
in	O
Yambuku	S-Location
,	O
was	O
the	O
first	O
case	O
of	O
the	O
1976	B-Incident
outbreak	I-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
in	O
Zaire	S-Location
.	O

The	O
research	O
-	O
to	O
which	O
Dr.	O
contributed	O
-	O
has	O
shown	O
that	O
it	O
may	O
be	O
possible	O
to	O
fight	O
certain	O
drug	O
resistant	O
bacteria	O
using	O
specific	O
antibiotic	O
combinations	O
.	O

Asprey	S-Person
glorifies	O
coconut	O
oil	O
and	O
demonizes	O
olive	O
oil	O
,	O
ignoring	O
the	O
wealth	O
of	O
randomized	O
trials	O
(the	O
highest	O
quality	O
of	O
evidence)	O
that	O
have	O
demonstrated	O
olive	O
oil	O
is	O
beneficial	O
for	O
health	O
.	O

2006:	O
The	O
organization	O
endorsed	O
the	O
world's	O
first	O
official	O
HIV/AIDS	S-Disease
Toolkit	O
for	O
Zimbabwe	S-Organization
,	O
which	O
formed	O
the	O
basis	O
for	O
global	O
prevention	O
,	O
treatment	O
,	O
and	O
support	O
the	O
plan	O
to	O
fight	O
the	O
pandemic	O
.	O

According	O
to	O
a	O
communication	O
from	O
FAO	S-Organization
when	O
developed	O
,	O
the	O
national	O
strategic	O
action	O
plan	O
will	O
support	O
the	O
against	O
four	O
action	O
packages	O
including	O
zoonotic	O
disease	O
,	O
biosecurity	O
and	O
biosafety	O
,	O
laboratory	O
system	O
,	O
and	O
workforce	O
and	O
capacity	O
development	O
.	O

He	O
became	O
ill	O
by	O
4	O
April	O
,	O
and	O
sought	O
remedy	O
at	O
a	O
clinic	O
in	O
on	O
7	O
April	O
.	O

One	O
area	O
of	O
partisan	O
dispute	O
related	O
to	O
CDC	S-Organization
funding	O
is	O
studying	O
gun	O
violence	O
.	O

The	O
US	S-Location
accepted	O
four	O
evacuees	O
and	O
three	O
were	O
flown	O
to	O
.	O

In	O
one	O
incident	O
,	O
Iranian	O
prisoners	O
of	O
war	O
are	O
said	O
to	O
have	O
been	O
tied	O
up	O
and	O
killed	O
by	O
bacteria	O
from	O
a	O
shell	O
detonated	O
nearby	O
.	O

In	O
the	O
world	O
of	O
infectious	O
diseases	O
,	O
being	O
busy	O
is	O
not	O
good	O
.	O

The	O
H1N1	B-Incident
outbreak	E-Incident
led	O
to	O
numerous	O
precautionary	O
school	O
closures	O
in	O
some	O
areas	O
.	O

Hannoun	S-Person
considered	O
several	O
alternative	O
hypotheses	O
of	O
origin	O
,	O
such	O
as	O
Spain	S-Location
,	O
Kansas	S-Location
,	O
and	O
,	O
as	O
being	O
possible	O
,	O
but	O
not	O
likely	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
strain	O
is	O
the	O
most	O
lethal	O
of	O
the	O
six	O
known	O
strains	O
(including	O
the	O
newly	O
discovered	O
Bombali	S-Location
strain)	O
;	O
it	O
is	O
fatal	O
in	O
up	O
to	O
90%	O
of	O
cases	O
.	O

Building	O
DNA	O
from	O
scratch	O
has	O
traditionally	O
been	O
too	O
expensive	O
and	O
inefficient	O
to	O
be	O
very	O
practical	O
,	O
but	O
in	O
2010	O
,	O
researchers	O
did	O
just	O
that	O
,	O
completely	O
synthesizing	O
the	O
genome	O
of	O
a	O
bacteria	O
and	O
injecting	O
it	O
into	O
a	O
living	O
cell	O
.	O

"	O
We're	O
talking	O
about	O
doing	O
things	O
now	O
to	O
enhance	O
the	O
civilian	O
emergency	O
medical	O
response	O
to	O
not	O
just	O
terrorism	O
,	O
but	O
all	O
types	O
of	O
disasters	O
and	O
public	O
health	O
emergencies,	O
"	O
Reilly	S-Person
said	O
.	O

America's	O
Struggle	O
with	O
Chemical-Biological	O
Weapons	O
,	O
(Google	O
Books)	O
,	O
Greenwood	O
Publishing	O
Group	O
,	O
2000	O
,	O
pp.	O
49–60	O
,	O
()	O
.	O

Students	O
use	O
PCR	S-Equipment
to	O
identify	O
an	O
hCMV	S-Pathogen
strain	O
.	O

As	O
part	O
of	O
the	O
larger	O
biodefense	O
strategy	O
,	O
the	O
coordination	O
team	O
will	O
engage	O
state	O
,	O
local	O
,	O
and	O
territorial	O
governments	O
,	O
along	O
with	O
private	O
and	O
international	O
partners	O
.	O

This	O
may	O
explain	O
why	O
the	O
1918	O
had	O
its	O
surprising	O
effect	O
on	O
younger	O
,	O
healthier	O
people	O
,	O
as	O
a	O
person	O
with	O
a	O
stronger	O
immune	O
system	O
would	O
potentially	O
have	O
a	O
stronger	O
overreaction	O
.	O

Crystal	B-Person
Watson	E-Person
DrPH	O
,	O
MPH	O
,	O
a	O
senior	O
scholar	O
at	O
the	O
Center	O
,	O
Senior	O
Analyst	O
Matthew	B-Person
Watson	E-Person
,	O
and	O
Senior	O
Scholar	O
Tara	B-Person
Kirk	I-Person
Sell	E-Person
,	O
PhD	O
,	O
MA	O
,	O
co-led	O
the	O
project	O
team	O
,	O
which	O
also	O
included	O
Caitlin	B-Person
Rivers	E-Person
,	O
PhD	O
,	O
MPH	O
;	O
Matthew	B-Person
Shearer	E-Person
,	O
MPH	O
;	O
former	O
Analyst	O
Christopher	B-Person
Hurtado	E-Person
,	O
MHS	O
;	O
former	O
Research	O
Assistant	O
Ashley	B-Person
Geleta	E-Person
,	O
MS	O
;	O
and	O
,	O
MD	O
,	O
the	O
Center's	O
director	O
.	O

Ebola	S-Disease
control	O
is	O
hindered	O
by	O
the	O
fact	O
that	O
current	O
diagnostic	O
tests	O
require	O
specialised	O
equipment	O
and	O
highly	O
trained	O
personnel	O
.	O

On	O
20	O
January	O
,	O
China	S-Location
reported	O
nearly	O
140	O
new	O
cases	O
in	O
one	O
day	O
,	O
including	O
two	O
people	O
in	O
Beijing	S-Location
and	O
one	O
in	O
Shenzhen	S-Location
.	O
Later	O
official	O
data	O
shows	O
6,174	O
people	O
had	O
already	O
developed	O
symptoms	O
by	O
then	O
,	O
and	O
more	O
may	O
have	O
been	O
infected	O
.	O

I	O
know	O
its	O
frustrating	O
for	O
all	O
of	O
us	O
.	O

As	O
part	O
of	O
the	O
United	B-Organization
Nations	E-Organization
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
supports	O
work	O
towards	O
the	O
Millennium	O
Development	O
Goals	O
.	O

With	O
this	O
correction	O
factor	O
,	O
approximately	O
21,000	O
total	O
cases	O
were	O
estimated	O
for	O
the	O
end	O
of	O
September	O
2014	O
in	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
alone	O
.	O

Personal	O
hygiene	O
and	O
a	O
healthy	O
lifestyle	O
and	O
diet	O
have	O
been	O
recommended	O
to	O
improve	O
immunity	O
.	O

Medflies	O
breed	O
rapidly	O
and	O
eat	O
fruit	O
with	O
a	O
voracious	O
appetite	O
.	O

Also	O
,	O
the	O
infrequency	O
with	O
which	O
vaccines	O
are	O
administered	O
among	O
the	O
general	O
population	O
since	O
the	O
eradication	O
of	O
the	O
disease	O
would	O
leave	O
most	O
people	O
unprotected	O
in	O
the	O
event	O
of	O
an	O
outbreak	O
.	O

In	O
fast-progressing	O
cases	O
,	O
mortality	O
was	O
primarily	O
from	O
pneumonia	S-Disease
by	O
virus-induced	O
pulmonary	B-Disease
consolidation	E-Disease
.	O
Slower-progressing	O
cases	O
featured	O
secondary	O
bacterial	B-Pathogen
pneumonia	E-Pathogen
,	O
and	O
possibly	O
neural	O
involvement	O
that	O
led	O
to	O
mental	B-Disease
disorders	E-Disease
in	O
some	O
cases	O
.	O

The	O
following	O
genes	O
were	O
found	O
in	O
all	O
7	O
isolates:	O
aac	O
3-IId	O
,	O
aac	O
(6′)-Ib-cr5	O
,	O
aadA2	O
,	O
aadA22	O
,	O
aadA5	O
,	O
blaCTX-M-15	O
,	O
blaNDM-5	O
,	O
blaOXA-1	O
,	O
blaTEM-1	O
,	O
ble	O
,	O
catB3	O
,	O
dfrA12	O
,	O
dfrA17	O
,	O
mph(A)	O
,	O
qacEdelta1	O
,	O
sul1	O
,	O
and	O
tet(A)	O
.	O

Lassa	B-Disease
fever	E-Disease
is	O
a	O
viral	O
hemorrhagic	B-Disease
disease	E-Disease
.	O
It	O
does	O
have	O
a	O
lower	O
case-fatality	O
ratio	O
than	O
things	O
like	O
,	O
but	O
it's	O
still	O
a	O
fairly	O
bad	O
disease	O
.	O

In	O
2020	O
,	O
a	O
trial	O
found	O
that	O
lopinavir/ritonavir	S-Drug
was	O
ineffective	O
in	O
the	O
treatment	O
of	O
severe	O
illness	O
.	O

Long-term	O
intervention	O
to	O
suppress	O
the	O
pandemic	O
has	O
considerable	O
social	O
and	O
economic	O
costs	O
.	O

Melinda	B-Person
Hamer	E-Person
,	O
chief	O
of	O
the	O
,	O
Md.	O
,	O
where	O
the	O
trial	O
is	O
being	O
conducted	O
.	O

For	O
instance	O
,	O
in	O
Europe	S-Location
in	O
2007	O
,	O
the	O
number	O
of	O
infections	O
by	O
multidrug-resistant	O
bacteria	O
was	O
400,000	O
with	O
25,000	O
attributable	O
deaths	O
.	O

The	O
remaining	O
individuals	O
had	O
previously	O
been	O
vaccinated	O
,	O
and	O
all	O
recovered	O
after	O
having	O
an	O
attenuated	O
form	O
of	O
the	O
disease.	O
(2002)	O
,	O
Op.cit	O
.	O

On	O
27	O
April	O
2009	O
,	O
the	O
European	B-Organization
Union	I-Organization
health	I-Organization
commissioner	E-Organization
advised	O
Europeans	O
to	O
postpone	O
nonessential	O
travel	O
to	O
the	O
United	B-Location
States	E-Location
or	O
Mexico	S-Location
.	O
This	O
followed	O
the	O
discovery	O
of	O
the	O
first	O
confirmed	O
case	O
in	O
Spain	S-Location
.	O
On	O
6May	O
2009	O
,	O
the	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Canada	E-Organization
announced	O
that	O
their	O
National	B-Organization
Microbiology	I-Organization
Laboratory	E-Organization
(	O
NML	S-Organization
)	O
had	O
mapped	O
the	O
genetic	O
code	O
of	O
the	O
swine	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
,	O
the	O
first	O
time	O
that	O
had	O
been	O
done.In	O
the	O
U.K.	S-Location
,	O
the	O
National	B-Organization
Health	I-Organization
Service	E-Organization
launched	O
a	O
website	O
,	O
the	O
,	O
allowing	O
patients	O
to	O
self-assess	O
and	O
get	O
an	O
authorisation	O
number	O
for	O
antiviral	O
medication	O
.	O

LISA	B-Person
SCHNIRRING	E-Person
Hi	O
.	O

The	O
move	O
is	O
designed	O
to	O
streamline	O
and	O
create	O
a	O
cohesive	O
leadership	O
structure	O
that	O
will	O
provide	O
swifter	O
responses	O
to	O
public	O
health	O
emergencies	O
.	O

Afghanistan	S-Location
is	O
one	O
of	O
25	O
countries	O
across	O
the	O
world	O
with	O
Pentagon	B-Organization
bio-laboratories	E-Organization
on	O
their	O
territory	O
.	O

Both	O
Ebola	S-Pathogen
and	O
are	O
part	O
of	O
the	O
Filoviridae	O
family	O
.	O

A	O
specific	O
measure	O
,	O
termed	O
the	O
computed	O
tomography	O
dose	O
index	O
(CTDI)	O
,	O
is	O
commonly	O
used	O
as	O
an	O
estimate	O
of	O
the	O
radiation	O
absorbed	O
dose	O
for	O
tissue	O
within	O
the	O
scan	O
region	O
,	O
and	O
is	O
automatically	O
computed	O
by	O
.	O

Rates	O
of	O
cardiovascular	O
symptoms	O
are	O
high	O
,	O
owing	O
to	O
the	O
systemic	B-Phenotype
inflammatory	I-Phenotype
response	E-Phenotype
and	O
immune	B-Phenotype
system	I-Phenotype
disorders	E-Phenotype
during	O
disease	O
progression	O
,	O
but	O
acute	B-Phenotype
myocardial	I-Phenotype
injuries	E-Phenotype
may	O
also	O
be	O
related	O
to	O
ACE2	O
receptors	O
in	O
the	O
heart	O
.	O

He	O
was	O
indicted	O
for	O
producing	O
and	O
using	O
the	O
deadly	O
toxin	O
as	O
a	O
weapon	O
,	O
and	O
using	O
the	O
mail	O
to	O
threaten	O
President	O
Obama	S-Person
,	O
Sen	O
.	O

The	O
Tuskegee	B-Scientific_research_project
Study	E-Scientific_research_project
was	O
initiated	O
in	O
1932	O
by	O
the	O
Public	B-Organization
Health	I-Organization
Service	E-Organization
.	O
The	O
took	O
over	O
the	O
study	O
in	O
1957	O
.	O

The	O
re-emergence	B-Incident
of	I-Incident
bioterrorism	E-Incident
as	O
a	O
threat	O
activity	O
of	O
individuals	O
or	O
small	O
groups	O
has	O
caused	O
a	O
heightened	O
awareness	O
of	O
biosecurity	O
and	O
improved	O
biosafety	O
.	O

On	O
16	O
March	O
,	O
Prime	O
Minister	O
Boris	B-Person
Johnson	E-Person
made	O
an	O
announcement	O
advising	O
against	O
all	O
non-essential	O
travel	O
and	O
social	O
contact	O
,	O
suggesting	O
people	O
work	O
from	O
home	O
where	O
possible	O
and	O
avoid	O
venues	O
such	O
as	O
pubs	O
,	O
restaurants	O
,	O
and	O
theatres	O
.	O

Computed	B-Technology
tomography	E-Technology
was	O
originally	O
known	O
as	O
the	O
"	O
EMI	B-Technology
scan	E-Technology
"	O
as	O
it	O
was	O
developed	O
in	O
the	O
early	O
1970s	O
at	O
a	O
research	O
branch	O
of	O
EMI	S-Organization
,	O
a	O
company	O
best	O
known	O
today	O
for	O
its	O
music	O
and	O
recording	O
business	O
.	O

The	O
state	O
turned	O
to	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
for	O
assistance	O
,	O
she	O
said	O
,	O
and	O
"	O
through	O
no	O
fault	O
of	O
yours	O
,	O
you	O
also	O
didn't	O
have	O
any	O
extra	O
money,	O
"	O
she	O
said	O
to	O
witness	O
Dr	O
.	O

We	O
want	O
to	O
talk	O
.	O

Prime	O
Minister	O
,	O
Head	O
of	O
Government	O
,	O
Philemon	B-Person
Yang	E-Person
chaired	O
the	O
inauguration	O
ceremony	O
of	O
the	O
Centre	O
that	O
is	O
yet	O
another	O
fruit	O
of	O
the	O
Cameroon	S-Organization
-	O
USA	S-Organization
health	O
cooperation	O
.	O

The	O
focus	O
of	O
the	O
probe	O
by	O
the	O
FBI	S-Organization
U.S.	B-Organization
Postal	I-Organization
Inspection	I-Organization
Service	E-Organization
(	O
USPIS	S-Organization
)	O
and	O
the	O
Department	B-Organization
of	I-Organization
Transportation's	I-Organization
Office	I-Organization
of	I-Organization
Inspector	I-Organization
General	E-Organization
fell	O
instantly	O
upon	O
the	O
individual	O
calling	O
him/herself	O
Fallen	B-Person
Angel	E-Person
in	O
the	O
two	O
letters	O
.	O

Besides	O
FMD	S-Pathogen
,	O
five	O
other	O
top-secret	O
biological	O
weapons	O
projects	O
were	O
commissioned	O
on	O
Plum	B-Location
Island	E-Location
.	O
Carroll	S-Person
,	O
Michael	B-Person
C.	E-Person
Lab	O
257:	O
The	O
Disturbing	O
Story	O
of	O
the	O
Government's	O
Secret	O
Plum	O
Island	O
Germ	O
Laboratory	O
,	O
(Google	O
Books)	O
,	O
HarperCollins	O
,	O
2004	O
,	O
pp.	O
45–48	O
,	O
()	O
.	O

Of	O
these	O
,	O
three-	O
anthrax	S-Pathogen
,	O
botulinum	S-Pathogen
and	O
aflatoxin	S-Pathogen
-had	O
proceeded	O
to	O
weaponization	O
for	O
deployment.	O
(1999)	O
,	O
Op.	O
cit.	O
,	O
pg	O
143	O
.	O

The	O
U.S.	B-Platform
Food	I-Platform
and	I-Platform
Drug	I-Platform
Administration	I-Platform
Veterinary	I-Platform
Laboratory	I-Platform
Information	I-Platform
and	I-Platform
Response	I-Platform
Network	E-Platform
identified	O
a	O
New	O
Delhi	O
metallo-beta-lactamase	O
gene	O
,	O
NDM-5	O
,	O
in	O
its	O
testing	O
.	O

The	O
virus	O
includes	O
a	O
sequence	O
encoding	O
a	O
modified	O
13‐galactosidase	O
and	O
the	O
simian	O
virus	O
40	O
nuclear	O
location	O
signal	O
,	O
nls‐LacZ	O
7	O
.	O

In	O
April	O
2015	O
,	O
Chinese	O
scientists	O
reported	O
results	O
of	O
an	O
attempt	O
to	O
alter	O
the	O
DNA	O
of	O
non-viable	O
human	O
embryos	O
using	O
CRISPR	S-Technology
to	O
correct	O
a	O
mutation	O
that	O
causes	O
beta	O
thalassemia	S-Disease
,	O
a	O
lethal	B-Disease
heritable	I-Disease
disorder	E-Disease
.	O
The	O
study	O
had	O
previously	O
been	O
rejected	O
by	O
both	O
Nature	O
and	O
Science	O
in	O
part	O
because	O
of	O
ethical	O
concerns	O
.	O

These	O
range	O
from	O
disposable	B-Equipment
gloves	E-Equipment
and	O
other	O
personnel	B-Equipment
protective	I-Equipment
equipment	E-Equipment
to	O
complex	O
or	O
other	O
containment	O
devices	O
.	O

Beam	O
hardening	O
This	O
can	O
give	O
a	O
"	O
cupped	O
appearance	O
"	O
when	O
grayscale	O
is	O
visualized	O
as	O
height	O
.	O

In	O
2003	O
the	O
Swedish	B-Organization
National	I-Organization
Board	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Welfare	E-Organization
started	O
an	O
exercise	O
to	O
map	O
microbiology	O
laboratories	O
and	O
regional	O
clinical	O
laboratories	O
across	O
,	O
looking	O
at	O
their	O
capacity	O
and	O
levels	O
of	O
coordination	O
from	O
the	O
perspective	O
of	O
biopreparedness	O
.	O

He	O
never	O
recovered	O
and	O
died	O
in	O
the	O
intensive	O
care	O
unit	O
on	O
4	O
March	O
.	O

Operation	B-Activity
Big	I-Activity
Buzz	E-Activity
1	O
million	O
A	O
.	O

He	O
had	O
returned	O
to	O
Taiwan	S-Location
via	O
Hong	B-Location
Kong	E-Location
on	O
23	O
February	O
and	O
reported	O
a	O
fever	S-Phenotype
two	O
days	O
later	O
.	O

SAN	B-Location
DIEGO	E-Location
Sept.	O
28	O
,	O
2018	O
/PRNewswire/	O
--	O
Mapp	B-Organization
Biopharmaceutical,	I-Organization
Inc	E-Organization
.	O
(	O
MappBio	S-Organization
)	O
,	O
announced	O
today	O
that	O
it	O
has	O
been	O
awarded	O
a	O
contract	O
(HHSO100201800024C)	O
of	O
$14.	O
8	O
million	O
with	O
options	O
for	O
an	O
additional	O
$32.	O
0	O
million	O
by	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
,	O
part	O
of	O
the	O
Office	B-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	I-Organization
at	I-Organization
the	I-Organization
U.S.	I-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
,	O
to	O
advance	O
through	O
a	O
Phase	O
1	O
clinical	O
trial	O
.	O

The	O
organization	O
develops	O
and	O
promotes	O
the	O
use	O
of	O
evidence-based	O
tools	O
,	O
norms	O
and	O
standards	O
to	O
support	O
member	O
states	O
to	O
inform	O
health	O
policy	O
options	O
.	O

The	O
Irish	B-Organization
Department	I-Organization
of	I-Organization
Health	E-Organization
published	O
a	O
National	B-Document
Action	I-Document
Plan	I-Document
on	I-Document
Antimicrobial	I-Document
Resistance	E-Document
in	O
October	O
2017	O
.	O

Medfly	O
infestations	O
are	O
not	O
without	O
precedent	O
,	O
both	O
in	O
California	S-Location
and	O
elsewhere	O
in	O
North	B-Location
America	E-Location
.	O
Between	O
1975	O
and	O
1993	O
the	O
state	B-Location
of	I-Location
California	E-Location
spent	O
more	O
than	O
$170	O
million	O
on	O
medfly	O
eradication	O
programs	O
meant	O
to	O
contain	O
12	O
different	O
infestations	O
.	O

Analysis	O
by	O
the	O
confirmed	O
that	O
the	O
bacteria	O
at	O
the	O
Rajneesh	O
laboratory	O
were	O
an	O
exact	O
match	O
to	O
those	O
that	O
sickened	O
individuals	O
who	O
had	O
eaten	O
at	O
local	O
restaurants	O
.	O

JOHN	B-Person
ROBERTS	E-Person
Yes	O
,	O
Dr	O
.	O

In	O
addition	O
,	O
Malathion	O
was	O
no	O
longer	O
used	O
alone	O
,	O
but	O
mixed	O
in	O
a	O
4:1	O
ratio	O
with	O
Nu-Lure0	O
bait	O
to	O
attract	O
insects	O
to	O
the	O
area	O
.	O

The	O
Blue	O
Ribbon	O
panel	O
also	O
just	O
released	O
a	O
new	O
special	O
report	O
on	O
biodefense	O
preparedness	O
at	O
the	O
local	O
level	O
.	O

Approximately	O
20-30%	O
of	O
people	O
who	O
present	O
with	O
COVID‑19	S-Disease
have	O
elevated	O
liver	B-Phenotype
enzymes	E-Phenotype
reflecting	O
.	O

Often	O
the	O
willingness	O
to	O
share	O
biological	O
data	O
is	O
limited	O
and	O
it	O
is	O
difficult	O
to	O
convince	O
researchers	O
to	O
share	O
raw	O
data	O
even	O
after	O
publication	O
.	O

However	O
,	O
they	O
concluded	O
,	O
Hussein	S-Person
had	O
perpetuated	O
ambiguity	O
regarding	O
a	O
possible	O
program	O
as	O
a	O
strategic	O
deterrent	O
against	O
Iran	S-Location
.	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
State	E-Organization
(2005)	O
,	O
[https://2009-2017.state.gov/documents/organization/52113.pdf	O
Adherence	B-Document
To	I-Document
and	I-Document
Compliance	I-Document
With	I-Document
Arms	I-Document
Control	E-Document
,	O
Nonproliferation	O
and	O
Disarmament	O
Agreements	O
and	O
Commitments]	O
,	O
Washington,	B-Location
DC	E-Location
.	O
Accessed	O
November	O
18	O
,	O
2008	O
.	O

The	O
complete	O
sensing	O
systems	O
must	O
also	O
discriminate	O
between	O
target	O
vehicles	O
and	O
other	O
sources	O
of	O
stimuli	O
,	O
such	O
as	O
debris	O
and	O
other	O
marine	O
organisms	O
,	O
to	O
limit	O
the	O
number	O
of	O
false	O
positives	O
.	O

On	O
10	O
June	O
,	O
the	O
government	B-Organization
of	I-Organization
Ontario	E-Organization
created	O
the	O
SARS	B-Organization
Commission	I-Organization
inquiry	E-Organization
in	O
order	O
to	O
"	O
investigate	O
the	O
recent	O
introduction	O
and	O
spread	O
of	O
"	O
in	O
the	O
province	O
.	O

Relman	S-Person
said	O
that	O
not	O
enough	O
is	O
known	O
about	O
the	O
state	O
of	O
safety	O
at	O
labs	O
that	O
perform	O
infectious	O
disease	O
research	O
but	O
emphasized	O
that	O
the	O
kinds	O
of	O
labs	O
drawing	O
concern	O
are	O
the	O
same	O
ones	O
the	O
public	O
needs	O
to	O
discover	O
important	O
new	O
treatments	O
and	O
vaccines.	O
"	O
We	O
have	O
to	O
find	O
some	O
happy	O
blend	O
of	O
minimized	O
risk	O
and	O
enhanced	O
benefit,	O
"	O
he	O
said	O
.	O

Such	O
categorization	O
of	O
risk	O
would	O
lead	O
to	O
the	O
formulation	O
of	O
appropriate	O
sets	O
of	O
safety	O
precautions	O
,	O
called	O
risk	O
management	O
.	O

For	O
example	O
,	O
in	O
2008	O
,	O
over	O
1000	O
novel	O
compounds	O
were	O
isolated	O
from	O
marine	O
micro-organisms	O
(Ref)	O
.	O

DARPA	S-Organization
will	O
host	O
a	O
Proposers	O
Day	O
on	O
Wednesday	O
,	O
February	O
28	O
,	O
2018	O
,	O
at	O
the	O
DARPA	B-Location
Conference	I-Location
Center	E-Location
in	O
Arlington	S-Location
,	O
.	O
More	O
information	O
is	O
available	O
at	O

Slovenia	S-Location
is	O
a	O
small	O
country	O
and	O
a	O
new	O
Member	O
State	O
.	O

As	O
of	O
Dec.	O
31	O
,	O
2017	O
,	O
the	O
CDC	S-Organization
had	O
obligated	O
$453.8	O
million	O
,	O
and	O
USAID	S-Organization
obligated	O
$245.5	O
million	O
in	O
support	O
of	O
the	O
U.S.	S-Location
commitment	O
to	O
GHSA	S-International_exchange_and_cooperation
,	O
with	O
the	O
funding	O
and	O
technical	O
assistance	O
helping	O
these	O
countries	O
design	O
and	O
implement	O
five-year	B-Document
GHSA	I-Document
plans	E-Document
to	O
address	O
specific	O
gaps	O
in	O
health	O
security	O
capability	O
across	O
the	O
.	O

It	O
occurs	O
because	O
conventional	O
sources	O
,	O
like	O
X-ray	B-Equipment
tubes	E-Equipment
emit	O
a	O
polychromatic	O
spectrum	O
.	O

Coronavirus	B-Disease
disease	I-Disease
2019	E-Disease
(	O
COVID-19	S-Disease
)	O
is	O
an	O
infectious	O
disease	O
caused	O
by	O
severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus	I-Pathogen
2	E-Pathogen
()	O
.	O

The	O
smallpox	S-Pathogen
test	O
is	O
said	O
to	O
have	O
occurred	O
on	O
July	O
30	O
,	O
1971	O
,	O
with	O
the	O
ship	O
sailing	O
nearby	O
between	O
July	O
29	O
and	O
July	O
31	O
.	O

Ventilators	B-Equipment
capable	I-Equipment
of	I-Equipment
pressure	I-Equipment
control	I-Equipment
modes	I-Equipment
and	I-Equipment
high	I-Equipment
PEEP	E-Equipment
are	O
needed	O
to	O
maximise	O
oxygen	O
delivery	O
while	O
minimising	O
the	O
risk	O
of	O
ventilator-associated	B-Phenotype
lung	I-Phenotype
injury	I-Phenotype
and	I-Phenotype
pneumothorax	E-Phenotype
.	O
High	B-Technology
PEEP	E-Technology
may	O
not	O
be	O
available	O
on	O
.	O

There	O
are	O
at	O
least	O
17,000	O
people	O
who	O
have	O
survived	O
infection	O
from	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
Western	B-Location
Africa	E-Location
;	O
some	O
of	O
them	O
have	O
reported	O
lingering	O
health	O
effects	O
.	O

"	O
Not	O
even	O
the	O
exposure	O
we	O
had	O
in	O
2001,	O
"	O
Adalja	S-Person
said.	O
"	O
We're	O
talking	O
about	O
the	O
Super	O
Bowl	O
or	O
something	O
like	O
that.	O
"	O

Contacts	O
have	O
now	O
been	O
established	O
with	O
national	O
agencies	O
of	O
the	O
other	O
Nordic	O
countries	O
,	O
with	O
an	O
aim	O
to	O
expanding	O
the	O
collaboration	O
,	O
broadening	O
the	O
network	O
,	O
finding	O
synergies	O
in	O
new	O
areas	O
,	O
strengthening	O
the	O
ability	O
to	O
share	O
resources	O
,	O
and	O
consolidating	O
long-term	O
financing	O
in	O
the	O
context	O
of	O
harmonized	O
European	S-Location
biopreparedness	O
.	O

COVID-19	S-Pathogen
also	O
poses	O
a	O
greater	O
risk	O
to	O
people	O
who	O
misuse	O
opioids	S-Drug
and	O
methamphetamines	S-Drug
,	O
insofar	O
as	O
their	O
drug	O
use	O
may	O
have	O
caused	O
.	O

In	O
September	O
and	O
October	O
1984	O
,	O
they	O
contaminated	O
the	O
salad	O
bars	O
of	O
10	O
local	O
restaurants	O
with	O
,	O
infecting	O
751 people	O
.	O

In	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
made	O
an	O
initial	O
CFR	O
estimate	O
of	O
53%	O
,	O
though	O
this	O
included	O
suspected	O
cases	O
.	O

The	O
researcher	O
,	O
Stanley	B-Person
Perlman	E-Person
was	O
put	O
on	O
probation	O
for	O
a	O
year	O
and	O
received	O
additional	O
monitoring	O
from	O
the	O
university	O
.	O

Although	O
there	O
is	O
general	O
agreement	O
that	O
the	O
source	O
of	O
Parker	S-Person
's	O
infection	O
was	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
grown	O
at	O
the	O
Medical	O
School	O
laboratory	O
,	O
how	O
contracted	O
the	O
disease	O
remains	O
unknown	O
.	O

The	O
largest	O
single	O
incident	O
of	O
fraudulent	O
marriages	O
,	O
the	O
most	O
massive	O
scheme	O
of	O
wiretapping	O
and	O
bugging	O
,	O
and	O
the	O
largest	O
mass	O
poisoning.	O
"	O
Looking	O
back	O
on	O
the	O
incident	O
,	O
stated	O
,	O
"	O
We	O
lost	O
our	O
innocence	O
over	O
this	O
..	O
.	O

In	O
the	O
past	O
year	O
she	O
came	O
under	O
pressure	O
from	O
the	O
Bulgarian	B-Organization
National	I-Organization
Security	I-Organization
Agency	E-Organization
and	O
was	O
fired	O
from	O
her	O
job	O
in	O
the	O
Bulgarian	B-Organization
newspaper	I-Organization
Trud	I-Organization
Daily	E-Organization
without	O
explanation	O
.	O

The	O
monitoring	O
data	O
provides	O
evidence	O
to	O
assess	O
policies	O
,	O
set	O
priorities	O
and	O
determine	O
where	O
to	O
act	O
immediately	O
and	O
where	O
resources	O
need	O
to	O
be	O
addressed	O
.	O

Additionally	O
,	O
HHS	S-Organization
Secretary	O
Alex	B-Person
Azar	E-Person
delivered	O
a	O
video	O
message	O
to	O
the	O
delegation	O
at	O
the	O
,	O
praising	O
the	O
organization	O
for	O
what	O
its	O
achieved	O
so	O
far	O
and	O
focusing	O
on	O
the	O
work	O
that	O
remains	O
.	O

The	O
first	O
attempt	O
to	O
establish	O
a	O
classification	O
for	O
pathogenic	O
micro-organisms	O
was	O
devised	O
in	O
the	O
USA	S-Location
by	O
the	O
United	B-Organization
States	I-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
.	O
They	O
published	O
in	O
1969	O
and	O
1974	O
a	O
description	O
of	O
four	O
classes	O
of	O
etiological	O
agents	O
(bacteria	O
,	O
fungi	O
and	O
viruses)	O
ranking	O
from	O
those	O
that	O
pose	O
no	O
or	O
minimal	O
hazard	O
(class	O
1)	O
to	O
those	O
responsible	O
for	O
very	O
serious	O
diseases	O
(class	O
4)	O
(	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
,	O
Office	B-Organization
of	I-Organization
Biosafety	E-Organization
.	O
Classification	O
of	O
Etiological	O
Agents	O
on	O
the	O
Basis	O
of	O
Hazard	O
,	O
4th	O
edition	O
.	O

In	O
this	O
article	O
,	O
I	O
would	O
like	O
to	O
discuss	O
the	O
potential	O
uses	O
and	O
their	O
urgency	O
in	O
the	O
race	O
to	O
improve	O
gene	B-Technology
editing	E-Technology

In	O
March	O
2015	O
,	O
the	O
CDC	S-Organization
interviewed	O
the	O
survivors	O
;	O
they	O
all	O
reported	O
having	O
had	O
at	O
least	O
one	O
adverse	O
symptom	O
during	O
their	O
recovery	O
period	O
.	O

A	O
review	O
of	O
US-funded	O
Ebola	B-Scientific_research_project
recovery	I-Scientific_research_project
projects	E-Scientific_research_project
in	O
Guinea	S-Location
,	O
Liberia	S-Location
,	O
and	O
Sierra	B-Location
Leone	E-Location
by	O
the	O
US	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
released	O
this	O
week	O
found	O
that	O
,	O
of	O
$1.6	O
billion	O
appropriated	O
by	O
Congress	S-Organization
in	O
2014	O
for	O
US	B-Organization
Agency	I-Organization
for	I-Organization
International	I-Organization
Development	E-Organization
()	O
in	O
the	O
hard-hit	O
region	O
,	O
$411.6	O
million	O
has	O
been	O
targeted	O
to	O
131	O
specific	O
projects	O
.	O

So	O
we	O
have	O
to	O
keep	O
at	O
it	O
,	O
even	O
when	O
success	O
seems	O
far	O
.	O

The	O
NIAID	B-Organization
IRF	E-Organization
is	O
a	O
biosafety	B-Platform
level	I-Platform
4	E-Platform
()	O
specialized	O
biocontainment	O
facility	O
supporting	O
basic	O
research	O
and	O
animal	O
studies	O
on	O
various	O
infectious	O
disease	O
agents	O
to	O
evaluate	O
therapeutics	O
,	O
vaccines	O
and	O
diagnostics	O
as	O
well	O
as	O
natural	O
history	O
and	O
pathogenesis	O
associated	O
with	O
these	O
agents	O
.	O

In	O
particular	O
,	O
smallpox	S-Pathogen
,	O
which	O
was	O
eradicated	O
more	O
than	O
20	O
years	O
ago	O
,	O
is	O
officially	O
only	O
stored	O
at	O
two	O
high-security	O
laboratories	O
in	O
the	O
USA	S-Location
and	O
Russia	S-Location
,	O
and	O
it	O
is	O
at	O
present	O
virtually	O
impossible	O
to	O
gain	O
access	O
to	O
these	O
virus	O
stocks	O
.	O

The	O
Communicable	O
Disease	O
Center	O
was	O
founded	O
July	O
1	O
,	O
1946	O
,	O
as	O
the	O
successor	O
to	O
the	O
World	B-Document
War	I-Document
II	I-Document
Malaria	I-Document
Control	I-Document
in	I-Document
War	I-Document
Areas	I-Document
program	E-Document
of	O
.	O

Frieden	S-Person
,	O
you	O
mentioned	O
that	O
there	O
will	O
be	O
some	O
disciplinary	O
action	O
taken	O
.	O

Old	O
and	O
discarded	O
,	O
or	O
even	O
rejected	O
,	O
antibiotics	O
should	O
be	O
re-investigated	O
,	O
re-purposed	O
and	O
used	O
as	O
needed	O
.	O

The	O
classification	O
of	O
biological	O
agents	O
is	O
a	O
basic	O
requirement	O
for	O
biosafety	O
and	O
the	O
development	O
of	O
biodefense	O
capabilities	O
.	O

The	O
virus	O
that	O
caused	O
the	O
outbreak	O
is	O
known	O
as	O
SARS‑CoV‑2	S-Pathogen
,	O
a	O
newly	O
discovered	O
virus	O
closely	O
related	O
to	O
bat	O
coronaviruses	O
,	O
pangolin	O
coronaviruses	O
,	O
and	O
SARS-CoV	S-Pathogen
.	O
The	O
scientific	O
consensus	O
is	O
that	O
has	O
a	O
natural	O
origin	O
.	O

October	O
1918	O
was	O
the	O
month	O
with	O
the	O
highest	O
fatality	O
rate	O
of	O
the	O
whole	O
pandemic	O
.	O

Proposers	O
will	O
also	O
be	O
required	O
to	O
address	O
potential	O
ethical	O
,	O
legal	O
,	O
and	O
societal	O
implications	O
of	O
the	O
research	O
.	O

The	O
anticipated	O
global	O
eradication	O
of	O
has	O
prompted	O
the	O
promulgation	O
of	O
new	O
biosafety	O
guidelines	O
for	O
future	O
laboratory	O
and	O
animal	O
work	O
.	O

After	O
the	O
September	O
identification	O
of	O
a	O
novel	O
CoV	B-Pathogen
strain	E-Pathogen
,	O
a	O
retroactive	O
analysis	O
of	O
the	O
hospital	O
workers	O
was	O
performed	O
.	O

Many	O
scholars	O
arguing	O
for	O
Y.	B-Pathogen
pestis	E-Pathogen
as	O
the	O
major	O
agent	O
of	O
the	O
pandemic	O
suggest	O
that	O
its	O
extent	O
and	O
symptoms	O
can	O
be	O
explained	O
by	O
a	O
combination	O
of	O
bubonic	B-Disease
plague	E-Disease
with	O
other	O
diseases	O
,	O
including	O
typhus	S-Disease
,	O
smallpox	S-Disease
and	O
respiratory	B-Disease
infections	E-Disease
.	O
In	O
addition	O
to	O
the	O
bubonic	O
infection	O
,	O
others	O
point	O
to	O
additional	O
septicaemic	O
(a	O
type	O
of	O
"	O
blood	O
poisoning")	O
and	O
pneumonic	O
(an	O
airborne	O
plague	O
that	O
attacks	O
the	O
lungs	O
before	O
the	O
rest	O
of	O
the	O
body)	O
forms	O
of	O
the	O
plague	S-Disease
,	O
which	O
lengthen	O
the	O
duration	O
of	O
outbreaks	O
throughout	O
the	O
seasons	O
and	O
help	O
account	O
for	O
its	O
high	O
mortality	O
rate	O
and	O
additional	O
recorded	O
symptoms	O
.	O

Jacob	S-Person
also	O
pointed	O
to	O
the	O
need	O
for	O
better	O
ways	O
of	O
determining	O
which	O
infections	O
require	O
antibiotics	O
and	O
when	O
it	O
is	O
safe	O
to	O
start	O
and	O
stop	O
this	O
type	O
of	O
treatment	O
.	O

Among	O
them	O
,	O
Genotyping	O
DNA	O
Samples	O
from	O
Lymphoma	S-Disease
cases	O
and	O
from	O
controls	O
(healthy	O
patients)	O
,	O
Breast	B-Disease
cancer	E-Disease
tissue	O
blocks	O
from	O
breast	B-Disease
cancer	E-Disease
patients	O
,	O
Saliva	O
samples	O
of	O
50	O
families	O
who	O
have	O
3	O
or	O
more	O
cases	O
of	O
UGI	B-Disease
cancer	E-Disease
,	O
Genotype	O
50	O
SNP'S	O
for	O
DNA	O
samples	O
from	O
the	O
Cancer	O
Hospital	O
,	O
Beijing	S-Location
,	O
Genotypes	O
from	O
3000	O
cases	O
of	O
gastric	B-Disease
cancer	E-Disease
and	O
3000	O
controls	O
(healthy	O
patients)	O
in	O
.	O

Researchers	O
performed	O
invasive	O
surgery	O
on	O
prisoners	O
,	O
removing	O
organs	O
to	O
study	O
the	O
effects	O
of	O
disease	O
on	O
the	O
human	O
body	O
.	O

That	O
,	O
Dr.	O
said	O
,	O
strengthened	O
the	O
idea	O
that	O
she	O
picked	O
up	O
the	O
virus	O
from	O
the	O
wind	O
rather	O
than	O
from	O
a	O
port	O
of	O
call	O
.	O

Rich	S-Person
is	O
a	O
grinder	O
-	O
a	O
biohacker	O
that	O
does	O
extreme	O
body	O
modification	O
.	O

During	O
the	O
hearing	O
,	O
Gottlieb	S-Person
said	O
lawmakers	O
might	O
think	O
about	O
how	O
animal	O
studies	O
could	O
support	O
the	O
development	O
of	O
medical	O
countermeasures	O
.	O

Shia	O
shrines	O
in	O
remained	O
open	O
to	O
pilgrims	O
until	O
16	O
March	O
.	O

Of	O
the	O
six	O
,	O
two	O
died	O
.	O

For	O
example	O
,	O
scientists	O
studying	O
tuberculosis	S-Disease
,	O
a	O
bacterial	O
disease	O
that	O
kills	O
almost	O
two	O
million	O
people	O
a	O
year	O
,	O
wanted	O
to	O
find	O
a	O
drug	O
that	O
turns	O
off	O
a	O
gene	O
called	O
EthR	O
.	O

We	O
do	O
research	O
to	O
figure	O
out	O
how	O
better	O
to	O
treat	O
people	O
if	O
they're	O
exposed	O
and	O
prevent	O
it	O
if	O
they're	O
exposed	O
and	O
how	O
better	O
to	O
prevent	O
it	O
through	O
vaccination	O
.	O

Through	O
national	O
programs	O
,	O
partnerships	O
and	O
the	O
support	O
of	O
volunteers	O
,	O
HSC	S-Organization
educates	O
people	O
of	O
all	O
ages	O
to	O
be	O
safer	O
in	O
and	O
around	O
their	O
homes	O
.	O

Margaret	B-Person
Chan	E-Person
,	O
Director-General	O
of	O
the	O
WHO	S-Organization
,	O
replied	O
stating	O
,	O
"	O
Without	O
question	O
,	O
the	O
BMJ	S-Organization
feature	O
and	O
editorial	O
will	O
leave	O
many	O
readers	O
with	O
the	O
impression	O
that	O
's	O
decision	O
to	O
declare	O
a	O
pandemic	O
was	O
at	O
least	O
partially	O
influenced	O
by	O
a	O
desire	O
to	O
boost	O
the	O
profits	O
of	O
the	O
pharmaceutical	O
industry	O
.	O

A	O
report	O
on	O
the	O
Japanese	O
use	O
of	O
plague	S-Pathogen
-infested	O
fleas	O
on	O
Changde	S-Location
was	O
made	O
widely	O
available	O
the	O
following	O
year	O
,	O
but	O
was	O
not	O
addressed	O
by	O
the	O
Allied	B-Organization
Powers	E-Organization
until	O
issued	O
a	O
public	O
warning	O
in	O
1943	O
condemning	O
the	O
attacks	O
.	O

Ultimately	O
,	O
the	O
performer	O
teams	O
will	O
be	O
evaluated	O
on	O
the	O
results	O
of	O
their	O
clinical	O
trial	O
and	O
their	O
ability	O
to	O
complete	O
the	O
end-to-end	O
process	O
within	O
60	O
days	O
from	O
the	O
time	O
the	O
pathogen-containing	O
sample	O
is	O
first	O
obtained	O
.	O

Adalja	S-Person
project	O
team	O
included	O
senior	O
scholar	O
Eric	B-Person
Toner	E-Person
,	O
MD	O
,	O
and	O
senior	O
analyst	O
.	O
To	O
formulate	O
the	O
findings	O
and	O
recommendations	O
in	O
their	O
report	O
,	O
they	O
reviewed	O
published	O
literature	O
and	O
reports	O
on	O
emerging	O
infectious	O
disease	O
characteristics	O
,	O
the	O
pathogenic	O
potential	O
of	O
microbes	O
,	O
and	O
other	O
related	O
topics	O
;	O
interviewed	O
more	O
than	O
120	O
technical	O
experts	O
from	O
academia	O
,	O
industry	O
,	O
and	O
government	O
;	O
and	O
convened	O
a	O
meeting	O
of	O
a	O
subset	O
of	O
those	O
experts	O
to	O
discuss	O
preliminary	O
analysis	O
of	O
the	O
information	O
the	O
team	O
had	O
gathered	O
.	O

MAR	B-Technology
techniques	E-Technology
include	O
spectral	O
imaging	O
,	O
where	O
CT	S-Technology
images	O
are	O
taken	O
with	O
photons	O
of	O
different	O
energy	O
levels	O
,	O
and	O
then	O
synthesized	O
into	O
monochromatic	O
images	O
with	O
special	O
software	O
such	O
as	O
GSI	S-Technology
()	O
.	O

These	O
included	O
rye	B-Pathogen
stem	I-Pathogen
rust	I-Pathogen
spores	E-Pathogen
(stored	O
at	O
Edgewood	B-Location
Arsenal	E-Location
,	O
1951–1957)	O
,	O
wheat	B-Pathogen
stem	I-Pathogen
rust	I-Pathogen
spores	E-Pathogen
(stored	O
at	O
the	O
same	O
facility	O
1962–1969)	O
,	O
and	O
the	O
causative	B-Pathogen
agent	I-Pathogen
of	I-Pathogen
rice	I-Pathogen
blast	E-Pathogen
(stored	O
at	O
1965–1966)	O
.	O

Whether	O
Asprey	S-Person
belongs	O
in	O
the	O
category	O
of	O
biohacker	O
,	O
is	O
unclear	O
.	O

One	O
day	O
,	O
Smith	S-Person
infected	O
the	O
bacteria	O
with	O
a	O
phage	S-Pathogen
called	O
P22	S-Pathogen
.	O
The	O
phage	O
DNA	O
was	O
quickly	O
cut	O
up.	O
was	O
able	O
to	O
isolate	O
the	O
enzyme	O
responsible	O
for	O
the	O
cutting	O
and	O
eventually	O
showed	O
that	O
the	O
enzyme	O
,	O
now	O
known	O
as	O
HindII	O
,	O
always	O
cuts	O
DNA	O
at	O
a	O
particular	O
sequence	O
of	O
nucleotides	O
.	O

The	O
Animal	B-Document
Rule	E-Document
for	O
example	O
,	O
which	O
enables	O
animal	O
efficacy	O
studies	O
to	O
substitute	O
for	O
efficacy	O
trials	O
in	O
humans	O
if	O
the	O
results	O
can	O
reasonably	O
be	O
extrapolated	O
to	O
the	O
expected	O
human	O
use	O
,	O
wrote	O
in	O
his	O
testimony	O
,	O
can	O
be	O
used	O
to	O
facilitate	O
the	O
development	O
and	O
availability	O
of	O
medical	O
countermeasures	O
.	O

And	O
that's	O
because	O
Ebola	S-Disease
,	O
unlike	O
other	O
disease-causing	O
agents	O
,	O
is	O
not	O
very	O
hardy	O
,	O
said	O
.	O

Because	O
14th-century	O
healers	O
and	O
governments	O
were	O
at	O
a	O
loss	O
to	O
explain	O
or	O
stop	O
the	O
disease	O
,	O
Europeans	O
turned	O
to	O
astrological	O
forces	O
,	O
earthquakes	O
,	O
and	O
the	O
poisoning	O
of	O
wells	O
by	O
Jews	S-Person
as	O
possible	O
reasons	O
for	O
outbreaks	O
.	O

The	O
outbreak	O
left	O
about	O
17,000	O
survivors	O
of	O
the	O
disease	O
,	O
many	O
of	O
whom	O
report	O
post-recovery	O
symptoms	O
termed	O
post-Ebola	B-Phenotype
syndrome	E-Phenotype
often	O
severe	O
enough	O
to	O
require	O
medical	O
care	O
for	O
months	O
or	O
even	O
years	O
.	O

Success	O
and	O
Failure	O
in	O
Arms	O
Control	O
Negotiations	O
,	O
(Google	O
Books)	O
,	O
Press	O
,	O
1989	O
,	O
p.	O
298	O
,	O
()	O
.	O

And	O
new	O
gene	O
editing	O
technologies	O
are	O
increasing	O
the	O
odds	O
that	O
a	O
hypothetical	O
bioweapon	O
targeted	O
at	O
a	O
certain	O
ethnicity	O
,	O
or	O
even	O
a	O
single	O
individual	O
like	O
a	O
world	O
leader	O
,	O
could	O
one	O
day	O
become	O
a	O
reality	O
.	O

Title	O
42	O
of	O
the	O
Code	O
of	O
Federal	O
Regulations	O
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
citation	B-Document
42	I-Document
CFR	I-Document
73	I-Document
to	I-Document
42	I-Document
CFR	I-Document
73.21	E-Document
by	O
accessing	O
the	O
(CFR)	O
website	O
.	O

For	O
example	O
,	O
many	O
,	O
including	O
scientists	O
at	O
SGI	S-Organization
,	O
are	O
already	O
using	O
available	O
sequencing	O
information	O
to	O
engineer	B-Technology
cells	I-Technology
that	I-Technology
can	I-Technology
produce	I-Technology
energy,	I-Technology
pharmaceuticals,	I-Technology
and	I-Technology
industrial	I-Technology
compounds,	I-Technology
and	I-Technology
sequester	I-Technology
carbon	I-Technology
dioxide	E-Technology
.	O
The	O
team	O
at	O
JCVI	S-Organization
is	O
already	O
working	O
on	O
their	O
ultimate	O
objective	O
,	O
which	O
has	O
been	O
to	O
synthesize	O
a	O
minimal	O
cell	O
that	O
has	O
only	O
the	O
machinery	O
necessary	O
for	O
independent	O
life	O
.	O

So	O
there	O
is	O
the	O
possibility	O
that	O
some	O
spores	O
were	O
transferred	O
to	O
other	O
laboratories	O
within	O
CDC	S-Organization
and	O
potentially	O
exposed	O
other	O
workers	O
.	O

Border	O
closures	O
,	O
job	O
losses	O
,	O
and	O
food	O
shortages	O
also	O
followed	O
in	O
the	O
wake	O
of	O
the	O
Ebola	B-Incident
outbreak	E-Incident
.	O
According	O
to	O
the	O
GAO	S-Organization
report	O
,	O
gross	O
domestic	O
product	O
declined	O
in	O
all	O
three	O
of	O
the	O
countries	O
in	O
2015	O
,	O
especially	O
in	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
has	O
promoted	O
the	O
first	O
running	O
from	O
16–22	O
November	O
2015	O
.	O

For	O
example	O
,	O
the	O
Agriculture	B-Document
Risk	I-Document
Protection	I-Document
Act	I-Document
of	I-Document
2000	E-Document
gives	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
the	O
authority	O
to	O
oversee	O
the	O
detection	O
,	O
control	O
,	O
eradication	O
,	O
suppression	O
,	O
prevention	O
,	O
or	O
retardation	O
of	O
the	O
spread	O
of	O
plant	O
pests	O
or	O
noxious	O
weeds	O
to	O
protect	O
the	O
agriculture	O
,	O
environment	O
,	O
and	O
economy	O
of	O
the	O
US	O
.	O

Although	O
most	O
symptoms	O
resolved	O
or	O
improved	O
over	O
time	O
,	O
only	O
one	O
survivor	O
reported	O
complete	O
resolution	O
of	O
all	O
symptoms	O
.	O

The	O
clerk	O
countered	O
this	O
attempt	O
by	O
enforcing	O
a	O
regulation	O
that	O
required	O
all	O
new	O
voters	O
to	O
submit	O
their	O
qualifications	O
when	O
registering	O
to	O
vote	O
.	O

Critically	O
,	O
these	O
jobs	O
are	O
at	O
risk	O
even	O
if	O
no	O
person	O
in	O
falls	O
ill	O
in	O
the	O
outbreak	O
.	O

We	O
will	O
hear	O
from	O
CDC	S-Organization
Director	O
Tom	B-Person
Frieden	E-Person
.	O
There	O
will	O
be	O
time	O
for	O
Q&amp;A	O
following	O
his	O
opening	O
remarks	O
.	O

As	O
of	O
March	O
2015	O
,	O
multiple	O
groups	O
had	O
announced	O
ongoing	O
research	O
with	O
the	O
intention	O
of	O
laying	O
the	O
foundations	O
for	O
applying	O
CRISPR	S-Technology
to	O
human	O
embryos	O
for	O
human	O
germline	O
engineering	O
,	O
including	O
labs	O
in	O
the	O
US	S-Location
,	O
China	S-Location
,	O
and	O
the	O
UK	S-Location
,	O
as	O
well	O
as	O
US	B-Organization
biotechnology	I-Organization
company	I-Organization
OvaScience	E-Organization
.	O
Scientists	O
,	O
including	O
a	O
CRISPR	S-Technology
co-discoverer	O
,	O
urged	O
a	O
worldwide	O
moratorium	O
on	O
applying	O
CRISPR	S-Technology
to	O
the	O
human	O
germline	O
,	O
especially	O
for	O
clinical	O
use	O
.	O

In	O
2010	O
,	O
the	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Science	E-Organization
conducted	O
a	O
study	O
that	O
said	O
the	O
probability	O
of	O
an	O
accidental	O
disease	O
release	O
of	O
the	O
foot-and-mouth	O
disease	O
from	O
the	O
facility	O
during	O
its	O
expected	O
50-year	O
lifespan	O
could	O
cause	O
more	O
than	O
$50	O
billion	O
in	O
economic	O
losses	O
to	O
farmers	O
.	O

Poor	O
financial	O
investment	O
in	O
antibiotic	O
research	O
has	O
exacerbated	O
the	O
situation	O
.	O

International	O
Many	O
countries	O
considered	O
imposing	O
travel	O
restrictions	O
to	O
or	O
from	O
the	O
region	O
.	O

Export	O
and	O
import	O
of	O
research	O
materials	O
is	O
becoming	O
increasingly	O
complex	O
and	O
nearly	O
always	O
requires	O
a	O
permit	O
.	O

Tularemia	S-Pathogen
is	O
one	O
of	O
the	O
bio-weapons	O
that	O
the	O
developed	O
in	O
the	O
past	O
.	O

The	O
network	O
has	O
,	O
so	O
far	O
,	O
involved	O
around	O
80	O
people	O
in	O
total	O
,	O
with	O
roughly	O
30	O
participants	O
each	O
year	O
.	O

Many	O
standard	O
data	O
formats	O
are	O
defined	O
in	O
xml	O
to	O
adequately	O
represent	O
metadata-systematic	O
descriptions	O
of	O
data	O
which	O
is	O
indispensable	O
to	O
compare	O
and	O
reproduce	O
.	O

In	O
some	O
areas	O
,	O
aid	O
organizations	O
have	O
had	O
to	O
stop	O
their	O
work	O
due	O
to	O
violence	O
.	O

From	O
this	O
point	O
of	O
view	O
,	O
pathogens	O
fall	O
into	O
two	O
basic	O
types:	O
primary	O
pathogens	O
that	O
cause	O
disease	O
among	O
at	O
least	O
a	O
portion	O
of	O
normal	O
individuals	O
,	O
and	O
opportunistic	O
pathogens	O
that	O
cause	O
disease	O
only	O
in	O
individuals	O
who	O
are	O
compromised	O
in	O
either	O
their	O
innate	O
or	O
humoral	O
immune	O
defences	O
.	O

Across	O
the	O
border	O
from	O
Goma	S-Location
in	O
the	O
country	O
of	O
Rwanda	S-Location
,	O
Ebola	S-Pathogen
simulation	O
drills	O
are	O
being	O
conducted	O
at	O
health	O
facilities	O
.	O

Her	O
parents	O
were	O
later	O
also	O
transferred	O
to	O
Catherine-de-Barnes	S-Location
.	O
The	O
next	O
day	O
,	O
poxvirus	B-Disease
infection	E-Disease
was	O
confirmed	O
by	O
Henry	B-Person
Bedson	E-Person
,	O
then	O
Head	O
of	O
the	O
Smallpox	B-Organization
laboratory	E-Organization
at	O
the	O
Medical	B-Organization
School	E-Organization
,	O
by	O
electron	B-Equipment
microscopy	E-Equipment
of	O
vesicle	O
fluid	O
,	O
which	O
Geddes	S-Person
had	O
sampled	O
from	O
Parker	S-Person
's	O
rash	S-Disease
.	O
(Samples	O
of	O
the	O
fluid	O
were	O
also	O
collected	O
by	O
a	O
Biomedical	O
Scientist	O
for	O
examination	O
at	O
the	O
Regional	B-Organization
Virus	I-Organization
Laboratory	E-Organization
,	O
which	O
was	O
in	O
East	B-Organization
Birmingham	I-Organization
Hospital	E-Organization
)	O
.	O

The	O
lab	O
of	O
James	B-Person
Crowe	I-Person
Jr	E-Person
.	O
,	O
director	O
of	O
the	O
Vanderbilt	B-Organization
Vaccine	I-Organization
Center	E-Organization
,	O
has	O
isolated	O
human	O
monoclonal	O
antibodies	O
for	O
a	O
number	O
of	O
pathogenic	O
viruses	O
,	O
while	O
Crowe	S-Person
himself	O
is	O
a	O
pioneer	O
of	O
the	O
rational	O
design	O
for	O
neutralizing	O
antibody	O
treatments	O
and	O
vaccines	O
.	O

The	O
American	B-Organization
Center	I-Organization
for	I-Organization
Science	I-Organization
in	I-Organization
the	I-Organization
Public	I-Organization
Interest	E-Organization
linked	O
a	O
total	O
of	O
35	O
food	O
borne	O
outbreaks	O
from	O
1973	O
through	O
2009	O
where	O
bacterial	O
resistance	O
to	O
antibiotics	O
was	O
implicated	O
,	O
showing	O
how	O
this	O
overuse	O
in	O
the	O
food	O
industry	O
has	O
and	O
will	O
continue	O
to	O
threaten	O
public	O
health	O
.	O

The	O
United	B-Location
States	E-Location
signed	O
the	O
Protocol	O
,	O
yet	O
50	O
years	O
passed	O
before	O
the	O
U.S.	B-Organization
Senate	E-Organization
voted	O
to	O
ratify	O
it.	O
also	O
refused	O
to	O
ratify	O
the	O
agreement	O
in	O
1925	O
.	O

Several	O
existing	O
medications	O
are	O
being	O
evaluated	O
for	O
the	O
treatment	O
of	O
COVID‑19	S-Pathogen
including	O
remdesivir	S-Drug
,	O
chloroquine	S-Drug
,	O
hydroxychloroquine	S-Drug
,	O
lopinavir/ritonavir	S-Drug
,	O
and	O
lopinavir/ritonavir	B-Drug
combined	I-Drug
with	I-Drug
interferon	I-Drug
beta	E-Drug
.	O
There	O
is	O
tentative	O
evidence	O
for	O
efficacy	O
by	O
remdesivir	S-Drug
,	O
as	O
of	O
March	O
2020	O
.	O

Nicholas	B-Person
D.	I-Person
Kristof	E-Person
New	B-Location
York	E-Location
Times	O
,	O
March	O
17	O
,	O
1995.	O
"	O
Unmasking	O
Horror:	O
A	O
special	O
report	O
.	O

Based	O
on	O
most	O
of	O
the	O
potential	O
exposure	O
scenarios	O
,	O
the	O
risk	O
of	O
infection	O
is	O
very	O
low	O
.	O

In	O
August	O
1991	O
,	O
the	O
UN	S-Organization
carried	O
out	O
its	O
first	O
inspection	O
of	O
Iraq	S-Location
's	O
BW	O
capabilities	O
in	O
the	O
aftermath	O
of	O
the	O
Gulf	O
War	O
.	O

The	O
JCVI	S-Organization
efforts	O
to	O
boot	O
up	O
M.	O
genitalium	O
synthetic	B-Technology
cell	E-Technology
have	O
yielded	O
new	O
understandings	O
about	O
the	O
peculiar	O
biology	O
of	O
this	O
simple	O
cell	O
that	O
we	O
believe	O
will	O
soon	O
result	O
in	O
our	O
booting	O
up	O
this	O
as	O
well	O
.	O

Sign	O
up	O
for	O
the	O
Future	B-Platform
Perfect	E-Platform
newsletter	O
.	O

The	O
virus	O
begins	O
its	O
attack	O
by	O
attaching	O
to	O
host	O
receptors	O
through	O
the	O
glycoprotein	O
(GP)	O
surface	O
peplomer	O
and	O
is	O
endocytosed	O
into	O
macropinosomes	O
in	O
the	O
host	O
cell	O
.	O

A	O
hospital-related	O
outbreak	O
in	O
Riyadh	S-Location
brought	O
the	O
total	O
in	O
Saudi	B-Location
Arabia	E-Location
to	O
1,115	O
cases	O
and	O
480	O
fatalities	O
as	O
of	O
18	O
August	O
2015	O
.	O

One	O
person	O
died	O
and	O
nine	O
were	O
infected	O
in	O
the	O
outbreak	O
which	O
was	O
first	O
reported	O
on	O
22	O
April	O
.	O

The	O
field	O
strength	O
of	O
the	O
magnet	O
is	O
measured	O
in	O
teslas	O
–	O
and	O
while	O
the	O
majority	O
of	O
systems	O
operate	O
at	O
1.5	O
T	O
,	O
commercial	O
systems	O
are	O
available	O
between	O
0.2	O
and	O
7	O
T	O
.	O

Recombinant	O
DNA	O
tools	O
allow	O
researchers	O
to	O
choose	O
a	O
protein	O
they	O
think	O
may	O
be	O
important	O
for	O
health	O
or	O
industry	O
,	O
and	O
then	O
remove	O
that	O
protein	O
from	O
its	O
original	O
context	O
.	O

With	O
the	O
additional	O
reported	O
cases	O
,	O
there	O
were	O
now	O
a	O
total	O
of	O
285	O
cases	O
with	O
83	O
deaths	O
in	O
the	O
Kingdom	O
.	O

The	O
M33's	O
sub-munition	O
,	O
the	O
pipe-bomb-like	O
cylindrical	O
M114	O
bomb	O
,	O
was	O
also	O
completed	O
and	O
battle-ready	O
by	O
1952	O
.	O

Southern	B-Organization
Research	I-Organization
Institute	E-Organization
lobbied	O
the	O
US	B-Organization
Congress	E-Organization
and	O
US	B-Organization
Department	I-Organization
of	I-Organization
State	E-Organization
for	O
"	O
issues	O
related	O
to	O
research	O
and	O
development	O
for	O
US	S-Location
intelligence	O
"	O
and	O
"	O
defense	O
related	O
research	O
and	O
development"	O
.	O

Misconceptions	O
are	O
circulating	O
about	O
how	O
to	O
prevent	O
infection	O
;	O
for	O
example	O
,	O
rinsing	O
the	O
nose	O
and	O
gargling	O
with	O
mouthwash	O
are	O
not	O
effective	O
.	O

Biohacking	O
is	O
a	O
fairly	O
new	O
practice	O
that	O
could	O
lead	O
to	O
major	O
changes	O
in	O
our	O
life	O
.	O

After	O
protracted	O
negotiations	O
between	O
the	O
two	O
governments	O
,	O
they	O
were	O
extradited	O
to	O
the	O
United	B-Location
States	E-Location
,	O
reaching	O
Portland	S-Location
on	O
February	O
6	O
,	O
1986	O
.	O

The	O
US	B-Organization
Air	I-Organization
Force	E-Organization
has	O
been	O
specifically	O
collecting	O
Russian	O
RNA	O
and	O
synovial	O
tissue	O
samples	O
,	O
raising	O
fears	O
in	O
Moscow	S-Location
of	O
a	O
covert	O
.	O

On	O
14	O
January	O
2016	O
,	O
after	O
all	O
the	O
previously	O
infected	O
countries	O
had	O
been	O
declared	O
Ebola	S-Disease
the	O
WHO	S-Organization
reported	O
that	O
"	O
all	O
known	O
chains	O
of	O
transmission	O
have	O
been	O
stopped	O
in	O
Western	B-Location
Africa	E-Location
"	O
,	O
but	O
cautioned	O
that	O
further	O
small	O
outbreaks	O
of	O
the	O
disease	O
could	O
occur	O
in	O
the	O
future	O
.	O

The	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
(	O
DTRA	S-Organization
)	O
,	O
which	O
runs	O
the	O
US	S-Location
military	O
program	O
at	O
the	O
Lugar	B-Organization
Center	E-Organization
in	O
Georgia	S-Location
,	O
is	O
alleged	O
to	O
have	O
already	O
performed	O
field	O
tests	O
with	O
an	O
unknown	O
substance	O
in	O
Chechnya	S-Location
,	O
Russia	S-Location
.	O
In	O
the	O
spring	O
of	O
2017	O
local	O
citizens	O
reported	O
on	O
a	O
drone	O
disseminating	O
white	O
powder	O
close	O
to	O
the	O
Russian	S-Location
border	O
with	O
Georgia	S-Location
.	O
Neither	O
the	O
Georgian	S-Organization
border	O
police	O
,	O
nor	O
the	O
US	S-Location
personnel	O
operating	O
on	O
the	O
Georgia	S-Location
-	O
border	O
,	O
commented	O
on	O
this	O
information	O
.	O

This	O
leaves	O
with	O
fewer	O
policy	O
barriers	O
to	O
the	O
use	O
of	O
this	O
technology	O
.	O

To	O
better	O
visualize	O
the	O
anatomy	O
,	O
post-processing	O
of	O
the	O
images	O
is	O
common	O
.	O

As	O
the	O
outbreak	O
progressed	O
,	O
the	O
media	O
reports	O
,	O
many	O
hospitals	O
,	O
short	O
on	O
both	O
staff	O
and	O
supplies	O
,	O
were	O
overwhelmed	O
and	O
closed	O
down	O
,	O
leading	O
some	O
health	O
experts	O
to	O
state	O
that	O
the	O
inability	O
to	O
treat	O
other	O
medical	O
needs	O
may	O
have	O
been	O
causing	O
"	O
an	O
additional	O
death	O
toll	O
[that	O
is]	O
likely	O
to	O
exceed	O
that	O
of	O
the	O
outbreak	O
itself"	O
.	O

But	O
I	O
do	O
want	O
to	O
end	O
with	O
just	O
summarizing	O
what	O
we	O
found	O
.	O

From	O
this	O
point	O
on	O
,	O
researchers	O
switched	O
their	O
focus	O
to	O
defensive	O
measures	O
such	O
as	O
developing	O
"	O
air-sniffing"	O
detectors	O
.	O

In	O
May	O
2014	O
,	O
an	O
animal	O
caretaker	O
also	O
was	O
potentially	O
exposed	O
to	O
leptospira	S-Pathogen
when	O
the	O
person	O
removed	O
their	O
and	O
rubbed	O
an	O
eye	O
prior	O
to	O
washing	O
their	O
hands	O
.	O

And	O
tenth	O
,	O
we're	O
looking	O
at	O
the	O
implications	O
for	O
select	O
agents	O
and	O
virulent	O
pathogens	O
more	O
broadly	O
,	O
not	O
just	O
within	O
CDC	S-Organization
but	O
throughout	O
the	O
scientific	O
community	O
including	O
in	O
our	O
regulatory	O
function	O
at	O
CDC	S-Organization
where	O
we	O
have	O
a	O
unit	O
called	O
the	O
.	O
Given	O
the	O
critical	O
nature	O
of	O
our	O
investigations	O
,	O
the	O
work	O
that	O
we	O
do	O
here	O
to	O
protect	O
Americans	O
,	O
it's	O
crucial	O
that	O
we	O
do	O
this	O
safely	O
and	O
that	O
we	O
protect	O
our	O
staff	O
while	O
we	O
do	O
it	O
.	O

Thereafter	O
,	O
confronted	O
by	O
the	O
selection	O
pressures	O
of	O
population	O
immunity	O
,	O
these	O
pandemic	O
viruses	O
begin	O
to	O
drift	O
genetically	O
and	O
eventually	O
settle	O
into	O
a	O
pattern	O
of	O
annual	O
epidemic	O
recurrences	O
caused	O
by	O
the	O
drifted	O
virus	O
variants	O
.	O

The	O
name	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
is	O
derived	O
from	O
Zaire	S-Location
and	O
the	O
taxonomic	O
suffix	O
ebolavirus	O
(which	O
denotes	O
an	O
ebolavirus	S-Pathogen
species	O
and	O
refers	O
to	O
the	O
Ebola	B-Location
River	E-Location
)	O
.	O

MRI	S-Technology
has	O
the	O
advantages	O
of	O
having	O
very	O
high	O
spatial	O
resolution	O
and	O
is	O
very	O
adept	O
at	O
morphological	O
imaging	O
and	O
functional	O
imaging	O
.	O

Their	O
issue	O
had	O
to	O
do	O
with	O
inventory	O
control	O
and	O
both	O
NIH	S-Organization
and	O
are	O
doing	O
comprehensive	O
work	O
to	O
look	O
at	O
inventory	O
control	O
in	O
all	O
of	O
their	O
laboratory	O
facilities	O
to	O
see	O
if	O
there	O
are	O
any	O
other	O
unexpected	O
items	O
out	O
there	O
.	O

The	O
December	B-Activity
2005	I-Activity
meeting	I-Activity
of	I-Activity
States	I-Activity
Party	I-Activity
to	I-Activity
the	I-Activity
Biological	I-Activity
Weapons	I-Activity
Convention	E-Activity
endorsed	O
codes	O
of	O
conduct	O
,	O
agreeing	O
that	O
they	O
can	O
make	O
a	O
significant	O
and	O
effective	O
contribution	O
,	O
in	O
conjunction	O
with	O
other	O
measures	O
,	O
to	O
combating	O
the	O
present	O
and	O
future	O
threats	O
posed	O
by	O
biological	O
weapons	O
and	O
bioterrorism	O
.	O

Extreme	O
poverty	O
,	O
dysfunctional	O
healthcare	O
systems	O
,	O
distrust	O
of	O
government	O
after	O
years	O
of	O
armed	O
conflict	O
,	O
and	O
the	O
delay	O
in	O
responding	O
for	O
several	O
months	O
,	O
all	O
contributed	O
to	O
the	O
failure	O
to	O
control	O
the	O
epidemic	O
.	O

Concerns	O
have	O
been	O
raised	O
that	O
off-target	O
effects	O
(editing	O
of	O
genes	O
besides	O
the	O
ones	O
intended)	O
may	O
confound	O
the	O
results	O
of	O
a	O
CRISPR	B-Technology
gene	I-Technology
editing	E-Technology
experiment	O
(i.e.	O
the	O
observed	O
phenotypic	O
change	O
may	O
not	O
be	O
due	O
to	O
modifying	O
the	O
target	O
gene	O
,	O
but	O
some	O
other	O
gene)	O
.	O

Over	O
time	O
,	O
as	O
the	O
virus	O
multiplies	O
and	O
mutates	O
,	O
variants	O
can	O
gain	O
the	O
ability	O
to	O
jump	O
between	O
species	O
.	O

There	O
were	O
no	O
exposures	O
as	O
a	O
result	O
of	O
that	O
incident	O
.	O

An	O
electron	B-Equipment
microscope	E-Equipment
image	O
of	O
coronavirus	O
particles	O
,	O
colorized	O
in	O
yellow	O
.	O

In	O
addition	O
,	O
the	O
lecture	O
covers	O
technical	O
aspects	O
of	O
cell	O
infection	O
by	O
animal	O
viruses	O
(e.g.	O
,	O
cell	O
confluence	O
,	O
replicative	O
cell	O
status	O
and	O
optimal	O
adsorption	O
conditions)	O
.	O

On	O
12	O
April	O
2010	O
,	O
Keiji	B-Person
Fukuda	E-Person
the	O
WHO	S-Organization
's	O
top	O
influenza	O
expert	O
,	O
stated	O
that	O
the	O
system	O
leading	O
to	O
the	O
declaration	O
of	O
a	O
pandemic	O
led	O
to	O
confusion	O
about	O
H1N1	S-Pathogen
circulating	O
around	O
the	O
world	O
and	O
he	O
expressed	O
concern	O
that	O
there	O
was	O
a	O
failure	O
to	O
communicate	O
in	O
regard	O
to	O
uncertainties	O
about	O
the	O
new	O
virus	O
,	O
which	O
turned	O
out	O
to	O
be	O
not	O
as	O
deadly	O
as	O
feared	O
.	O

These	O
agents	O
are	O
typically	O
found	O
in	O
nature	O
,	O
but	O
could	O
be	O
mutated	O
or	O
altered	O
to	O
increase	O
their	O
ability	O
to	O
cause	O
disease	O
,	O
make	O
them	O
resistant	O
to	O
current	O
medicines	O
,	O
or	O
to	O
increase	O
their	O
ability	O
to	O
be	O
spread	O
into	O
the	O
environment	O
.	O

Some	O
towns	O
required	O
a	O
signed	O
certificate	O
to	O
enter	O
and	O
railroads	O
would	O
not	O
accept	O
passengers	O
without	O
them	O
.	O

In	O
June	O
2010	O
,	O
Fiona	B-Person
Godlee	E-Person
editor-in-chief	O
of	O
the	O
BMJ	S-Organization
,	O
published	O
an	O
editorial	O
which	O
criticised	O
the	O
WHO	S-Organization
,	O
saying	O
that	O
an	O
investigation	O
had	O
disclosed	O
that	O
some	O
of	O
the	O
experts	O
advising	O
WHO	S-Organization
on	O
the	O
pandemic	O
had	O
financial	O
ties	O
with	O
drug	O
companies	O
which	O
were	O
producing	O
antivirals	O
and	O
vaccines	O
.	O

IARPA	S-Organization
will	O
also	O
carry	O
out	O
the	O
Ithildin	O
program	O
,	O
which	O
seeks	O
to	O
develop	O
a	O
mechanism	O
to	O
detect	O
the	O
presence	O
of	O
harmful	O
chemicals	O
at	O
minuscule	O
levels	O
.	O

That	O
evening	O
,	O
the	O
issued	O
a	O
notice	O
to	O
various	O
medical	O
institutions	O
on	O
"	O
the	O
treatment	O
of	O
pneumonia	O
of	O
unknown	O
cause"	O
.	O

By	O
infecting	O
just	O
a	O
few	O
animals	O
,	O
through	O
needle	O
injection	O
and	O
pouring	O
bacteria	O
cultures	O
on	O
animal	O
feed	O
,	O
German	O
operatives	O
hoped	O
to	O
spark	O
devastating	O
epidemics	O
.	O

Our	B-Platform
World	I-Platform
in	I-Platform
Data	E-Platform
states	O
that	O
as	O
of	O
25	O
March	O
2020	O
the	O
IFR	O
cannot	O
be	O
accurately	O
calculated	O
as	O
neither	O
the	O
total	O
number	O
of	O
cases	O
nor	O
the	O
total	O
deaths	O
,	O
is	O
known	O
.	O

Quick	O
bipartisan	O
action	O
is	O
the	O
best	O
response	O
,	O
Murray	S-Person
said	O
,	O
adding	O
that	O
hiring	O
freezes	O
and	O
funding	O
cuts	O
stand	O
to	O
leave	O
less	O
prepared	O
.	O

In	O
addition	O
,	O
the	O
agency	O
will	O
develop	O
plans	O
to	O
ensure	O
that	O
all	O
medically	O
important	O
drugs	O
used	O
in	O
animal	O
water	O
and	O
feed	O
have	O
defined	O
duration	O
of	O
use	O
.	O

Hence	O
the	O
variability	O
in	O
the	O
severity	O
of	O
illness	O
was	O
suspected	O
to	O
correlate	O
with	O
genetic	O
differences	O
in	O
the	O
victims	O
.	O

Shortly	O
after	O
EDV	S-Disease
emerged	O
in	O
West	B-Location
Africa	E-Location
in	O
2014	O
,	O
the	O
Chinese	B-Organization
government	E-Organization
offered	O
to	O
provide	O
large-scale	O
medical	O
aid	O
to	O
the	O
three	O
most	O
strongly	O
affected	O
countries	O
.	O

However	O
,	O
it	O
is	O
now	O
clear	O
that	O
natural-product	O
drug	O
discovery	O
efforts	O
to	O
date	O
have	O
generally	O
focused	O
on	O
readily	O
accessible	O
sources	O
(Ref)	O
.	O

On	O
12	O
May	O
2020	O
,	O
Gilead	S-Organization
announced	O
that	O
it	O
had	O
granted	O
non-exclusive	O
voluntary	O
licenses	O
to	O
five	O
generic	O
drug	O
companies	O
to	O
manufacture	O
remdesivir	S-Drug
for	O
distribution	O
to	O
127	O
countries	O
.	O

NDM-5–producing	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
have	O
been	O
reported	O
in	O
dogs	O
from	O
Finland	S-Location
,	O
South	B-Location
Korea	E-Location
,	O
and	O
Algeria	S-Location
(3–5)	O
.	O

Death	O
occurs	O
in	O
about	O
two	O
to	O
30	O
people	O
per	O
1,000,000	O
administrations	O
,	O
with	O
newer	O
agents	O
being	O
safer	O
.	O

CDC	S-Organization
budget	O
for	O
fiscal	O
year	O
2018	O
is	O
$11.9billion	O
.	O

According	O
to	O
the	O
categorization	O
of	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
the	O
EU	S-Location
,	O
group	O
1	O
represents	O
the	O
least	O
risk	O
,	O
while	O
group	O
4	O
represents	O
the	O
highest	O
risk	O
.	O

No	O
country	O
is	O
immune,	O
"	O
Dr	O
.	O

The	O
agency	O
will	O
conduct	O
the	O
Finding	B-Scientific_research_project
Engineering-Linked	I-Scientific_research_project
Indicators	E-Scientific_research_project
program	O
,	O
or	O
,	O
to	O
help	O
build	O
tools	O
that	O
could	O
detect	O
whether	O
an	O
organism	O
has	O
been	O
engineered	O
for	O
use	O
in	O
bioweapons	O
.	O

In	O
January	O
2015	O
,	O
Oxfam	S-Organization
a	O
UK-based	O
disaster	O
relief	O
organisation	O
,	O
indicated	O
that	O
a	O
"	O
Marshall	B-Activity
Plan	E-Activity
"	O
(a	O
reference	O
to	O
the	O
massive	O
plan	O
to	O
rebuild	O
Europe	S-Location
after	O
World	B-Incident
War II	E-Incident
)	O
was	O
needed	O
so	O
that	O
countries	O
could	O
begin	O
to	O
financially	O
assist	O
those	O
that	O
had	O
been	O
worst	O
hit	O
by	O
the	O
virus	O
.	O

The	O
initial	O
work	O
in	O
the	O
BSL-3	S-Platform
lab	O
occurred	O
on	O
June	O
5	O
,	O
2014	O
.	O

These	O
efforts	O
have	O
now	O
determined	O
the	O
complete	O
genomic	O
sequence	O
of	O
1	O
virus	O
and	O
partial	O
sequences	O
from	O
4	O
others	O
.	O

In	O
October	O
,	O
the	O
Liberian	O
ambassador	O
in	O
Washington	S-Location
was	O
reported	O
as	O
saying	O
that	O
he	O
feared	O
that	O
his	O
country	O
may	O
be	O
"	O
close	O
to	O
collapse"	O
;	O
by	O
24	O
October	O
,	O
all	O
15	O
counties	O
had	O
reported	O
cases	O
.	O

Unlike	O
with	O
many	O
other	O
chain	O
terminators	O
,	O
this	O
is	O
not	O
mediated	O
by	O
preventing	O
addition	O
of	O
the	O
immediately	O
subsequent	O
nucleotide	O
,	O
but	O
is	O
instead	O
delayed	O
,	O
occurring	O
after	O
five	O
additional	O
bases	O
have	O
been	O
added	O
to	O
the	O
growing	O
RNA	O
chain	O
.	O

The	O
CDC	S-Organization
implemented	O
their	O
National	B-Document
Action	I-Document
Plan	I-Document
for	I-Document
Combating	I-Document
Antibiotic	I-Document
Resistant	I-Document
Bacteria	E-Document
as	O
a	O
measure	O
against	O
the	O
spread	O
of	O
antibiotic	O
resistance	O
in	O
the	O
United	B-Location
States	E-Location
.	O
This	O
initiative	O
has	O
a	O
budget	O
of	O
$161million	O
and	O
includes	O
the	O
development	O
of	O
the	O
.	O

He	O
said	O
that	O
the	O
"	O
false	B-Activity
pandemic"	I-Activity
campaign	E-Activity
began	O
in	O
May	O
2009	O
in	O
,	O
when	O
a	O
hundred	O
or	O
so	O
"	O
normal"	O
reported	O
influenza	O
cases	O
were	O
declared	O
to	O
be	O
the	O
beginning	O
of	O
a	O
threatening	O
new	O
pandemic	O
,	O
although	O
he	O
said	O
there	O
was	O
little	O
scientific	O
evidence	O
for	O
it	O
.	O

This	O
study	O
was	O
supported	O
in	O
part	O
by	O
grant	O
FOA	O
PAR-17-141	O
and	O
performed	O
in	O
collaboration	O
with	O
the	O
US	B-Platform
Food	I-Platform
and	I-Platform
Drug	I-Platform
Administration	I-Platform
Veterinary	I-Platform
Laboratory	I-Platform
Investigation	I-Platform
and	I-Platform
Response	I-Platform
Network	E-Platform
(	O
FDA	B-Platform
Vet-LIRN	E-Platform
)	O
under	O
grant	O
1	O
U18	O
FD006669-01	O
.	O

Robert	B-Person
Peaty	E-Person
(1903–1989)	O
,	O
a	O
British	O
Major	O
in	O
the	O
Royal	B-Organization
Army	I-Organization
Ordnance	I-Organization
Corps	E-Organization
,	O
was	O
the	O
senior	O
ranking	O
allied	O
officer	O
.	O

Alternating	B-Technology
therapy	E-Technology
is	O
a	O
proposed	O
method	O
in	O
which	O
two	O
or	O
three	O
antibiotics	O
are	O
taken	O
in	O
a	O
rotation	O
versus	O
taking	O
just	O
one	O
antibiotic	O
such	O
that	O
bacteria	O
resistant	O
to	O
one	O
antibiotic	O
are	O
killed	O
when	O
the	O
next	O
antibiotic	O
is	O
taken	O
.	O

Mathematical	O
models	O
have	O
raised	O
the	O
possibility	O
that	O
anthrax	B-Pathogen
spores	E-Pathogen
if	O
aerosolized	O
,	O
can	O
spread	O
over	O
big	O
cities	O
and	O
"	O
result	O
in	O
a	O
mass-casualty	O
incident	O
involving	O
hundreds	O
of	O
thousands	O
of	O
illnesses	O
and	O
deaths,	O
"	O
according	O
to	O
previous	O
guidance	O
.	O

But	O
the	O
maintains	O
that	O
disease	O
prevention	O
is	O
an	O
element	O
of	O
judicious	O
use	O
.	O

,	O
patent	O
rights	O
to	O
CRISPR	S-Technology
were	O
contested	O
.	O

The	O
event	O
is	O
under	O
internal	O
investigation	O
by	O
CDC	S-Organization
was	O
reported	O
to	O
Secretary	O
of	O
Health	B-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
Sylvia	B-Person
Burwell	E-Person
,	O
and	O
reporting	O
to	O
the	O
internal	B-Activity
and	I-Activity
national	I-Activity
Select	I-Activity
Agent	I-Activity
Programs	E-Activity
has	O
been	O
initiated	O
.	O

The	O
is	O
a	O
group	O
of	O
partner	O
governments	O
,	O
development	O
agencies	O
,	O
civil	O
society	O
and	O
others	O
committed	O
to	O
improving	O
the	O
health	O
of	O
citizens	O
in	O
developing	O
countries	O
.	O

TX-treated	O
grain	O
was	O
grown	O
at	O
the	O
Arsenal	O
from	O
1962–1968	O
in	O
Sections	O
23–26	O
.	O

The	O
seven	O
survivors	O
,	O
he	O
added	O
,	O
had	O
received	O
routine	O
vaccinations	O
earlier	O
but	O
nonetheless	O
contracted	O
mild	O
to	O
serious	O
cases	O
of	O
the	O
disease	O
.	O

Knock-out	O
libraries	O
are	O
created	O
in	O
a	O
way	O
to	O
achieve	O
equal	O
representation	O
and	O
performance	O
across	O
all	O
expressed	O
gRNAs	O
and	O
carry	O
an	O
antibiotic	O
or	O
fluorescent	O
selection	O
marker	O
that	O
can	O
be	O
used	O
to	O
recover	O
transduced	O
cells	O
.	O

In	O
2022	O
,	O
the	O
new	O
International	B-Document
Statistical	I-Document
Classification	I-Document
of	I-Document
Diseases	I-Document
and	I-Document
Related	I-Document
Health	I-Document
Problems	E-Document
,	O
ICD-11	S-Document
,	O
will	O
attempt	O
to	O
enable	O
classifications	O
from	O
traditional	O
medicine	O
to	O
be	O
integrated	O
with	O
classifications	O
from	O
evidence-based	O
medicine	O
.	O

Toxins	O
such	O
as	O
ricin	S-Pathogen
,	O
tetrodotoxin	S-Pathogen
,	O
conotoxin	S-Pathogen
,	O
fungi	O
such	O
as	O
,	O
and	O
protozoa	O
such	O
as	O
Cryptosporidium	O
parvum	O
were	O
included	O
in	O
some	O
category	O
lists	O
,	O
but	O
are	O
not	O
listed	O
in	O
this	O
study	O
.	O

China	S-Location
is	O
struggling	O
to	O
contain	O
the	O
disease	O
,	O
which	O
has	O
spread	O
to	O
every	O
part	O
of	O
the	O
country	O
since	O
August	O
last	O
year	O
.	O

To	O
evaluate	O
the	O
immuno-reactivity	O
of	O
Travelan®	S-Drug
60	O
clinical	O
isolates	O
of	O
each	O
bacteria	O
,	O
Campylobacter	S-Pathogen
,	O
ETEC	S-Pathogen
,	O
and	O
Shigella	S-Pathogen
,	O
were	O
tested	O
by	O
a	O
Western	O
blot	O
analysis	O
.	O

Van	O
der	O
Kloot	O
2004	O
,	O
p.152	O
.	O

The	O
BMENA	B-Organization
Organization	I-Organization
for	I-Organization
Economic	I-Organization
Co-operation	I-Organization
and	I-Organization
Development	E-Organization
(	O
OECD	S-Organization
)	O
,	O
a	O
forum	O
in	O
which	O
BMENA	S-Location
governments	O
work	O
together	O
to	O
share	O
experiences	O
and	O
seek	O
solutions	O
to	O
common	O
economic	O
problems	O
,	O
can	O
perhaps	O
be	O
an	O
effective	O
forum	O
to	O
raise	O
the	O
concern	O
about	O
the	O
local	O
legislations	O
,	O
uses	O
,	O
and	O
transportation	O
of	O
in	O
the	O
region	O
.	O

By	O
1960	O
,	O
numerous	O
BW	O
research	O
facilities	O
existed	O
throughout	O
the	O
Soviet	B-Location
Union	E-Location
Although	O
the	O
USSR	S-Organization
also	O
signed	O
the	O
1972	B-Document
Biological	I-Document
Weapons	I-Document
Convention	E-Document
(	O
BWC	S-Document
)	O
,	O
the	O
Soviets	S-Organization
subsequently	O
augmented	O
their	O
biowarfare	O
programs	O
.	O

As	O
for	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
the	O
public	O
may	O
know	O
it	O
best	O
as	O
,	O
the	O
substance	O
injected	O
in	O
foreheads	O
to	O
erase	O
wrinkles	O
.	O

A	O
summary	O
of	O
joint	O
projects	O
,	O
each	O
lasting	O
between	O
1	O
and	O
3	O
years	O
,	O
is	O
listed	O
in	O
Table	O
2	O
.	O

Officials	O
also	O
urged	O
communities	O
,	O
businesses	O
,	O
and	O
individuals	O
to	O
make	O
contingency	O
plans	O
for	O
possible	O
school	O
closures	O
,	O
multiple	O
employee	O
absences	O
for	O
illness	O
,	O
surges	O
of	O
patients	O
in	O
hospitals	O
,	O
and	O
other	O
effects	O
of	O
potentially	O
widespread	O
outbreaks	O
.	O

Unlike	O
most	O
strains	O
of	O
influenza	O
,	O
the	O
Pandemic	B-Pathogen
H1N1/09	I-Pathogen
virus	E-Pathogen
does	O
not	O
disproportionately	O
infect	O
adults	O
older	O
than	O
60 years	O
;	O
this	O
was	O
an	O
unusual	O
and	O
characteristic	O
feature	O
of	O
the	O
H1N1	B-Incident
pandemic	E-Incident
.	O
Even	O
in	O
the	O
case	O
of	O
previously	O
healthy	O
people	O
,	O
a	O
small	O
percentage	O
develop	O
pneumonia	S-Disease
or	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
.	O

An	O
FBI	S-Organization
agent	O
testified	O
that	O
no	O
ricin	S-Pathogen
or	O
precursors	O
were	O
found	O
in	O
the	O
man's	O
home	O
,	O
nor	O
did	O
a	O
preliminary	O
forensic	O
analysis	O
of	O
his	O
computer	O
reveal	O
anything	O
related	O
to	O
.	O
The	O
defense	O
attorney	O
claimed	O
in	O
court	O
that	O
his	O
client	O
was	O
being	O
framed	O
,	O
possibly	O
by	O
a	O
man	O
with	O
whom	O
he	O
had	O
been	O
feuding	O
online	O
.	O

However	O
,	O
the	O
did	O
further	O
indicate	O
that	O
individuals	O
travelling	O
to	O
the	O
country	O
should	O
take	O
precaution	O
with	O
sick	O
people	O
and	O
body	O
fluids	O
.	O

In	O
February	O
2019	O
,	O
it	O
was	O
reported	O
that	O
attacks	O
at	O
treatment	O
centers	O
had	O
been	O
carried	O
out	O
in	O
Butembo	S-Location
and	O
Katwa	S-Location
.	O
The	O
motives	O
behind	O
the	O
attacks	O
were	O
unclear	O
.	O

A	O
scientist	O
at	O
Texas	B-Organization
A&amp;M	I-Organization
in	I-Organization
College	I-Organization
Station-B	E-Organization
yron	O
stuck	O
himself	O
with	O
a	O
needle	O
while	O
injecting	O
a	O
mouse	O
that	O
was	O
previously	O
infected	O
wit	O
h	B-Pathogen
a	I-Pathogen
recombinant	I-Pathogen
strain	I-Pathogen
of	I-Pathogen
Borrelia	I-Pathogen
burgdor	E-Pathogen
feri	O
,	O
the	O
bacteria	O
that	O
cauease	O
,	O
in	O
February	O
2014	O
.	O

PRESAGED	S-Technology
has	O
also	O
been	O
shown	O
to	O
provide	O
early	O
warning	O
on	O
exposure	O
to	O
entirely	O
novel	O
pathogens	O
(i.e.	O
,	O
pathogens	O
unavailable	O
for	O
algorithm	O
training)	O
,	O
suggesting	O
that	O
this	O
approach	O
will	O
be	O
robust	O
in	O
detecting	O
emergent	O
diseases	O
,	O
such	O
as	O
SARS	S-Disease
/	O
or	O
novel	O
flu	O
strains	O
,	O
well	O
before	O
new	O
training	O
data	O
are	O
available	O
.	O

For	O
a	O
complete	O
overview	O
,	O
those	O
cases	O
are	O
included	O
below	O
with	O
footnotes	O
and	O
supporting	O
sources	O
.	O

Neurologic	O
manifestations	O
include	O
seizure	S-Phenotype
stroke	S-Phenotype
,	O
encephalitis	S-Phenotype
,	O
and	O
Guillain–Barré	B-Phenotype
syndrome	E-Phenotype
(which	O
includes	O
)	O
.	O

The	O
fund­ing	O
from	O
these	O
gov­ern­ment	O
deals	O
will	O
al­so	O
sup­port	O
Spero	S-Organization
clin­i­cal	O
tri­als	O
of	O
SPR994	S-Drug
for	O
the	O
treat­ment	O
of	O
com­pli­cat­ed	O
,	O
the	O
com­pa­ny	O
said	O
.	O

Staff	O
who	O
were	O
not	O
potentially	O
exposed	O
to	O
aerosols	O
but	O
were	O
in	O
or	O
near	O
affected	O
laboratory	O
space	O
.	O

Inserting	O
an	O
while	O
wearing	O
three	O
pairs	O
of	O
gloves	O
and	O
goggles	O
that	O
may	O
be	O
fogged	O
is	O
difficult	O
,	O
and	O
once	O
in	O
place	O
,	O
the	O
IV	O
site	O
and	O
line	O
must	O
be	O
constantly	O
monitored	O
.	O

This	O
may	O
have	O
led	O
to	O
the	O
Little	O
Ice	O
Age	O
.	O

They	O
also	O
have	O
a	O
strong	O
resistance	O
to	O
cold	O
and	O
can	O
survive	O
even	O
in	O
the	O
sub-zero	O
temperatures	O
in	O
the	O
mountains	O
.	O

The	O
result	O
was	O
"	O
petrocalin,"	O
which	O
is	O
able	O
to	O
neutralize	O
the	O
pathogen's	O
siderophore	O
.	O

The	O
Black	B-Disease
Death	E-Disease
devastated	O
Europe	S-Location
.	O
In	O
those	O
six	O
years	O
,	O
between	O
a	O
quarter	O
and	O
half	O
of	O
all	O
Europeans	O
were	O
killed	O
.	O

Zilinskas	S-Person
,	O
Raymond	B-Person
A.	E-Person
(1999)	O
,	O
"	O
Iraq	S-Location
's	O
Biological	O
Warfare	O
Program:	O
The	O
Past	O
as	O
Future?	O
"	O
,	O
Chapter	O
8	O
in:	O
Lederberg	S-Person
,	O
Joshua	S-Person
(editor)	O
,	O
Biological	O
Weapons:	O
Limiting	O
the	O
Threat	O
(1999)	O
,	O
The	O
MIT	O
Press	O
,	O
pg	O
138	O
.	O

And	O
one	O
company	O
is	O
betting	O
that	O
organ	O
transplant	O
waiting	O
lists	O
can	O
be	O
eliminated	O
by	O
growing	O
human	O
organs	O
in	O
chimeric	O
pigs	O
.	O

And	O
one	O
company	O
is	O
betting	O
that	O
organ	O
transplant	O
waiting	O
lists	O
can	O
be	O
eliminated	O
by	O
growing	O
human	O
organs	O
in	O
chimeric	O
pigs	O
.	O

China	S-Location
National	B-Organization
Bureau	I-Organization
of	I-Organization
Statistics	E-Organization
says	O
the	O
country's	O
pig	O
population	O
has	O
fallen	O
by	O
nearly	O
40	O
million	O
to	O
375.	O
3	O
million	O
from	O
a	O
year	O
earlier	O
,	O
because	O
of	O
the	O
outbreak	O
.	O

In	O
the	O
first	O
outbreak	O
,	O
two	O
thirds	O
of	O
the	O
population	O
contracted	O
the	O
illness	O
and	O
most	O
patients	O
died	O
;	O
in	O
the	O
next	O
,	O
half	O
the	O
population	O
became	O
ill	O
but	O
only	O
some	O
died	O
;	O
by	O
the	O
third	O
,	O
a	O
tenth	O
were	O
affected	O
and	O
many	O
survived	O
;	O
while	O
by	O
the	O
fourth	O
occurrence	O
,	O
only	O
one	O
in	O
twenty	O
people	O
were	O
sickened	O
and	O
most	O
of	O
them	O
survived	O
.	O

It	O
is	O
unknown	O
what	O
amount	O
of	O
virus	O
on	O
surfaces	O
is	O
required	O
to	O
cause	O
infection	O
via	O
this	O
method	O
,	O
but	O
it	O
can	O
be	O
detected	O
for	O
up	O
to	O
four	O
hours	O
on	O
copper	O
,	O
up	O
to	O
one	O
day	O
on	O
cardboard	O
,	O
and	O
up	O
to	O
three	O
days	O
on	O
plastic	O
(polypropylene)	O
and	O
stainless	O
steel	O
(AISI	O
304)	O
.	O

The	O
Pan	B-Organization
American	I-Organization
Health	I-Organization
Organization	E-Organization
()	O
became	O
the	O
first	O
region	O
to	O
develop	O
and	O
pass	O
a	O
policy	O
on	O
research	O
for	O
health	O
approved	O
in	O
September	O
2009	O
.	O

Implementing	O
standardized	B-Technology
testing	I-Technology
for	I-Technology
cross-contamination	E-Technology
of	O
samples	O
before	O
they	O
are	O
transferred	O
to	O
other	O
locations	O
or	O
to	O
other	O
laboratories	O
within	O
.	O

A	O
cattle	O
producer	O
from	O
Brewster	S-Location
Kansas	S-Location
,	O
explained	O
why	O
was	O
a	O
bad	O
location	O
when	O
the	O
decision	O
was	O
announced	O
to	O
move	O
the	O
facility	O
.	O

Of	O
these	O
volunteers	O
,	O
452	O
were	O
chosen	O
to	O
participate	O
in	O
the	O
trial	O
and	O
subsequently	O
randomized	O
into	O
2	O
groups:	O
361	O
participants	O
were	O
assigned	O
to	O
receive	O
600	O
mg	O
of	O
twice-daily	O
for	O
14	O
days	O
,	O
while	O
the	O
other	O
91	O
participants	O
were	O
assigned	O
to	O
receive	O
a	O
matching	O
placebo	O
twice	O
daily	O
for	O
14	O
days	O
.	O

See	O
also:	O
Joseph	B-Person
Patrick	I-Person
Byrne	E-Person
The	O
Black	B-Disease
Death	E-Disease
(	O
Westport	S-Location
,	O
Connecticut	S-Location
:	O
Greenwood	B-Organization
Press	E-Organization
,	O
2004)	O
,	O
p.1	O
.	O

New	O
pathogens	O
continue	O
to	O
be	O
discovered	O
,	O
further	O
increasing	O
public	O
health	O
risks	O
and	O
costs	O
for	O
.	O

In	O
the	O
U.S	S-Location
a	O
greater	O
proportion	O
of	O
deaths	O
due	O
to	O
COVID-19	S-Disease
have	O
occurred	O
among	O
African	O
Americans	O
.	O

"	O
The	O
longer	O
it	O
takes	O
,	O
the	O
more	O
likely	O
there	O
will	O
be	O
a	O
failure	O
.	O

It	O
was	O
argued	O
that	O
the	O
names	O
were	O
overly	O
technical	O
(e.g.	O
"	O
H1N1	S-Pathogen
"	O
),	O
incorrectly	O
implying	O
that	O
the	O
disease	O
is	O
caused	O
by	O
contact	O
with	O
pigs	O
or	O
pig	O
products	O
,	O
or	O
provoking	O
stigmatization	O
against	O
certain	O
communities	O
(e.g.	O
"	O
Mexican").	O
Some	O
academics	O
of	O
the	O
time	O
asserted	O
there	O
is	O
nothing	O
wrong	O
with	O
such	O
names	O
,	O
while	O
research	O
published	O
years	O
later	O
(in	O
2013)	O
concluded	O
that	O
Mexican	O
Americans	O
and	O
Latino	O
Americans	O
had	O
indeed	O
been	O
stigmatized	O
due	O
to	O
the	O
frequent	O
use	O
of	O
term	O
"	O
"	O
in	O
the	O
news	O
media	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	S-Organization
DHHS	O
,	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Besides	O
working	O
on	O
the	O
joint	O
projects	O
,	O
all	O
members	O
of	O
the	O
network	O
meet	O
approximately	O
3	O
times	O
a	O
year	O
for	O
a	O
shared	O
workshop	O
,	O
including	O
progress	O
reports	O
and	O
seminars	O
.	O

Macenta	B-Location
Prefecture	E-Location
,	O
from	O
Korokpara	S-Location
,	O
registered	O
Guinea	S-Location
's	O
fifth	O
fatality	O
due	O
to	O
within	O
the	O
same	O
period	O
.	O

Whether	O
either	O
of	O
these	O
two	O
leads	O
to	O
the	O
same	O
benefit	O
for	O
people	O
who	O
are	O
critically	O
ill	O
is	O
not	O
known	O
.	O

To	O
mitigate	O
shortcomings	O
of	O
current	O
PPE	S-Equipment
DTRA	S-Organization
's	O
Dynamic	B-Scientific_research_project
Multifunctional	I-Scientific_research_project
Materials	I-Scientific_research_project
for	I-Scientific_research_project
a	I-Scientific_research_project
Second	I-Scientific_research_project
Skin	E-Scientific_research_project
(	O
DMMSS	S-Scientific_research_project
)	O
program	O
is	O
exploring	O
three	O
different	O
approaches	O
which	O
aim	O
to	O
develop	O
.	O
More	O
specifically	O
,	O
these	O
membranes	O
will	O
close	O
their	O
pores	O
in	O
response	O
to	O
chemical	O
agents	O
and	O
remain	O
open	O
when	O
not	O
exposed	O
.	O

The	O
Pentagon	S-Organization
and	O
other	O
agencies	O
must	O
be	O
able	O
to	O
adapt	O
to	O
a	O
wide	O
range	O
of	O
potential	O
threats	O
because	O
of	O
uncertainty	O
about	O
which	O
approaches	O
an	O
enemy	O
might	O
pursue	O
,	O
the	O
report	O
noted	O
.	O

Lessons	O
from	O
such	O
fields	O
could	O
be	O
applied	O
to	O
the	O
area	O
of	O
biodefense	O
collaboration	O
.	O

That	O
fails	O
to	O
account	O
for	O
the	O
most	O
serious	O
agents	O
not	O
currently	O
known	O
or	O
without	O
historical	O
precedent	O
,	O
write	O
scholars	O
from	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
in	O
a	O
new	O
report	O
on	O
the	O
traits	O
of	O
microorganisms	O
with	O
high	O
pandemic	O
potential	O
.	O

The	O
13	O
students	O
were	O
among	O
49	O
students	O
who	O
had	O
previously	O
worked	O
as	O
interns	O
at	O
the	O
Lanzhou	S-Location
institute	O
.	O

However	O
,	O
John	B-Person
Barry	E-Person
stated	O
in	O
his	O
2004	O
book	O
The	O
Great	O
Influenza	S-Disease
:	O
The	O
Epic	O
Story	O
of	O
the	O
Deadliest	O
Plague	O
In	O
History	O
that	O
researchers	O
have	O
found	O
no	O
evidence	O
to	O
support	O
this	O
position	O
.	O

Within	O
days	O
,	O
522 men	O
at	O
the	O
camp	O
had	O
reported	O
sick	O
.	O

Scanning	O
with	O
X	O
and	O
Y	O
gradient	O
coils	O
cause	O
a	O
selected	O
region	O
of	O
the	O
patient	O
to	O
experience	O
the	O
exact	O
magnetic	O
field	O
required	O
for	O
the	O
energy	O
to	O
be	O
absorbed	O
.	O

MRI	S-Technology
does	O
have	O
several	O
disadvantages	O
though	O
.	O

Heritable	O
modifications	O
could	O
have	O
unintended	O
and	O
far-reaching	O
consequences	O
for	O
human	O
evolution	O
,	O
genetically	O
(e.g.	O
gene-environment	O
interactions)	O
and	O
culturally	O
(e.g.	O
social	O
Darwinism)	O
.	O

Appropriate	O
and	O
approved	O
inactivation	O
procedures	O
,	O
consistent	O
with	O
recently	O
implemented	O
laboratory	O
safety	O
improvements	O
,	O
were	O
used	O
.	O

As	O
part	O
of	O
one	O
of	O
the	O
FBD	S-Platform
projects	O
,	O
interagency	O
audits	O
were	O
performed	O
on	O
quality	O
assurance	O
of	O
diagnostic	O
methods	O
and	O
biosafety	O
at	O
the	O
BSL-3	S-Platform
laboratories	O
,	O
using	O
relevant	O
parts	O
of	O
the	O
ISO	S-Organization
17025	O
and	O
CWA	S-Organization
15793:	O
.	O
These	O
audits	O
led	O
to	O
improved	O
practical	O
solutions	O
and	O
facilitated	O
the	O
harmonization	O
of	O
good	O
practice	O
between	O
the	O
laboratories	O
.	O

The	O
report	O
pointed	O
out	O
that	O
the	O
committee	O
responsible	O
for	O
checking	O
the	O
WHO	S-Organization
's	O
actions	O
during	O
the	O
outbreak	O
(i.e.	O
the	O
WHO	B-Organization
Ebola	I-Organization
Interim	I-Organization
Assessment	I-Organization
Panel	E-Organization
)	O
had	O
delayed	O
responses	O
due	O
to	O
worries	O
about	O
political	O
resistance	O
from	O
the	O
Western	O
African	O
leaders	O
,	O
economic	O
consequences	O
,	O
and	O
a	O
system	O
within	O
the	O
that	O
discouraged	O
open	O
debate	O
about	O
issues	O
such	O
as	O
emergency	O
declarations	O
.	O

Any	O
results	O
and	O
products	O
generated	O
in	O
a	O
project	O
are	O
jointly	O
owned	O
by	O
all	O
4	O
agencies	O
.	O

The	O
patient	O
in	O
the	O
first	O
confirmed	O
case	O
had	O
flu	O
symptoms	O
including	O
fever	S-Phenotype
and	O
upon	O
clinical	O
examination	O
on	O
30	O
March	O
and	O
the	O
second	O
on	O
28	O
March	O
.	O

Moreover	O
,	O
in	O
many	O
cases	O
there	O
are	O
no	O
commercial	O
or	O
standardized	O
methods	O
for	O
analyzing	O
such	O
agents	O
.	O

European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
()	O
.	O

Another	O
of	O
the	O
thirteen	O
WHO	S-Organization
priority	O
areas	O
is	O
aimed	O
at	O
the	O
prevention	O
and	O
reduction	O
of	O
"	O
disease,	O
disability	O
and	O
premature	O
deaths	O
from	O
chronic	O
noncommunicable	O
diseases	O
,	O
mental	O
disorders	O
,	O
violence	O
and	O
injuries	O
,	O
and	O
visual	O
impairment"	O
.	O

If	O
swallowed	O
,	O
it	O
may	O
cause	O
diarrhea	S-Disease
or	O
bloody	B-Disease
vomiting	E-Disease
.	O
If	O
inhaled	O
,	O
it	O
may	O
initially	O
look	O
like	O
a	O
bad	O
case	O
of	O
the	O
.	O

Biohacking	O
entered	O
the	O
San	B-Location
Francisco	E-Location
programmer	O
and	O
maker	O
communities	O
as	O
early	O
as	O
2005	O
,	O
through	O
simple	O
demonstrations	O
of	O
basic	O
experiments	O
.	O

Start-up	O
companies	O
could	O
use	O
this	O
opportunity	O
to	O
generate	O
effective	O
,	O
new	O
,	O
antibiotic	O
combinations	O
.	O

Epidemiologists	O
discovered	O
the	O
Jordan	S-Location
cases	O
.	O

The	O
other	O
four	O
programs	O
researched	O
included	O
RVF	S-Pathogen
,	O
rinderpest	S-Pathogen
,	O
African	B-Pathogen
swine	I-Pathogen
fever	E-Pathogen
,	O
plus	O
eleven	O
miscellaneous	O
exotic	O
animal	O
diseases	O
.	O

WHO	S-Organization
member	O
states	O
appoint	O
delegations	O
to	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
,	O
WHO	S-Organization
's	O
supreme	O
decision-making	O
body	O
.	O

Agathe	B-Person
Demarais	E-Person
of	O
the	O
Economist	B-Organization
Intelligence	I-Organization
Unit	E-Organization
has	O
forecast	O
that	O
markets	O
will	O
remain	O
volatile	O
until	O
a	O
clearer	O
image	O
emerges	O
on	O
potential	O
outcomes	O
.	O

For	O
example	O
,	O
all	O
laboratory	O
manipulations	O
should	O
be	O
performed	O
in	O
a	O
BSC	S-Equipment
or	O
other	O
enclosed	O
equipment	O
,	O
such	O
as	O
a	O
.	O
Secondary	O
barriers	O
for	O
this	O
level	O
include	O
controlled	O
access	O
to	O
the	O
laboratory	O
and	O
ventilation	O
requirements	O
that	O
minimize	O
the	O
release	O
of	O
infectious	O
aerosols	O
from	O
the	O
laboratory	O
.	O

When	O
completed	O
in	O
2022	O
or	O
perhaps	O
2023	O
,	O
the	O
$1.	O
25	O
billion	O
facility	O
will	O
replace	O
the	O
outmoded	O
Plum	B-Organization
Island	I-Organization
Disease	I-Organization
Center	E-Organization
which	O
is	O
located	O
on	O
a	O
rather	O
isolated	O
island	O
in	O
New	B-Location
York	I-Location
State	E-Location
.	O
The	O
fact	O
that	O
it's	O
being	O
built	O
by	O
the	O
tells	O
you	O
something	O
about	O
how	O
seriously	O
the	O
government	O
takes	O
potential	O
threats	O
from	O
animal	O
disease	O
outbreaks	O
caused	O
intentionally	O
or	O
unintentionally	O
.	O

Common	O
symptoms	O
include	O
fever	S-Phenotype
cough	S-Phenotype
,	O
fatigue	S-Phenotype
,	O
shortness	B-Phenotype
of	I-Phenotype
breath	E-Phenotype
,	O
and	O
.	O

To	O
help	O
avoid	O
shortages	O
of	O
these	O
drugs	O
,	O
the	O
U.S.	B-Organization
CDC	E-Organization
recommended	O
oseltamivir	S-Drug
treatment	O
primarily	O
for	O
people	O
hospitalised	O
with	O
pandemic	B-Disease
flu	E-Disease
;	O
people	O
at	O
risk	O
of	O
serious	O
flu	B-Disease
complications	E-Disease
due	O
to	O
underlying	O
medical	O
conditions	O
;	O
and	O
patients	O
at	O
risk	O
of	O
serious	O
flu	S-Disease
complications	O
.	O

The	O
Working	B-Organization
Party	I-Organization
on	I-Organization
Safety	I-Organization
in	I-Organization
Biotechnology	I-Organization
of	I-Organization
the	I-Organization
European	I-Organization
Federation	I-Organization
of	I-Organization
Biotechnology	E-Organization
also	O
worked	O
on	O
the	O
classification	O
of	O
micro-organisms	O
and	O
produced	O
a	O
system	O
that	O
is	O
directed	O
towards	O
the	O
use	O
of	O
micro-organisms	O
in	O
the	O
industry	O
.	O

The	O
second	O
approach	O
involves	O
developing	O
an	O
enzyme	O
embedded	O
copolymer	O
membrane	O
.	O

During	O
the	O
hearing	O
,	O
Gottlieb	S-Person
said	O
lawmakers	O
might	O
think	O
about	O
how	O
animal	O
studies	O
could	O
support	O
the	O
development	O
of	O
medical	O
countermeasures	O
.	O

For	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
(	O
ECDC	S-Organization
)	O
face	O
masks	O
"	O
...could	O
be	O
considered	O
especially	O
when	O
visiting	O
busy	O
closed	O
spaces...	O
"	O
but	O
"	O
...only	O
as	O
a	O
complementary	O
measure...	O
"	O
Several	O
countries	O
have	O
recommended	O
that	O
healthy	O
individuals	O
wear	O
face	O
masks	O
or	O
cloth	O
face	O
coverings	O
(like	O
scarves	O
or	O
bandanas)	O
at	O
least	O
in	O
certain	O
public	O
settings	O
,	O
including	O
China	S-Location
,	O
Hong	B-Location
Kong	E-Location
,	O
Spain	S-Location
,	O
Italy	S-Location
(Lombardy	O
region)	O
,	O
Russia	S-Location
,	O
and	O
.	O

ASPR	S-Organization
manages	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
,	O
Project	B-Scientific_research_project
BioShield	E-Scientific_research_project
and	O
the	O
Public	B-Organization
Health	I-Organization
Emergency	I-Organization
Medical	I-Organization
Countermeasures	I-Organization
Enterprise	E-Organization
,	O
among	O
others	O
that	O
receive	O
funding	O
support	O
under	O
.	O

CDC	S-Organization
scientists	O
worked	O
rapidly	O
to	O
analyze	O
the	O
contents	O
of	O
the	O
six	O
vials	O
labeled	O
as	O
variola	S-Disease
,	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
.	O
First	O
they	O
did	O
what's	O
called	O
PCR	S-Technology
,	O
a	O
chain	O
reaction	O
to	O
see	O
if	O
there	O
was	O
DNA	O
from	O
there	O
.	O

The	O
review	O
of	O
experiments	O
would	O
be	O
added	O
on	O
to	O
the	O
already	O
established	O
NIH	S-Organization
system	O
for	O
reviewing	O
recombinant	O
DNA	O
experiments	O
through	O
local	O
institutional	O
biosafety	O
committees	O
.	O

Other	O
measures	O
include	O
the	O
case	O
fatality	O
rate	O
(CFR)	O
,	O
which	O
reflects	O
the	O
percentage	O
of	O
diagnosed	O
people	O
who	O
die	O
from	O
a	O
disease	O
,	O
and	O
the	O
infection	O
fatality	O
rate	O
(IFR)	O
,	O
which	O
reflects	O
the	O
percentage	O
of	O
infected	O
(diagnosed	O
and	O
undiagnosed)	O
who	O
die	O
from	O
a	O
disease	O
.	O

No	O
proven	O
Ebola	B-Pathogen
virus	E-Pathogen
treatment	O
presently	O
exists	O
;	O
however	O
,	O
measures	O
can	O
be	O
taken	O
to	O
improve	O
a	O
patient's	O
chances	O
of	O
survival	O
.	O

In	O
light	O
of	O
this	O
concern	O
,	O
is	O
it	O
important	O
to	O
select	O
a	O
virus	O
that	O
poses	O
the	O
lowest	O
biosafety	O
risk	O
,	O
within	O
the	O
BSL2	S-Platform
guidelines	O
.	O

The	O
Lancet	O
published	O
a	O
14-page	O
call	O
for	O
action	O
focusing	O
on	O
the	O
UK	S-Location
and	O
stated	O
conditions	O
were	O
such	O
that	O
a	O
range	O
of	O
mental	O
health	O
issues	O
was	O
likely	O
to	O
become	O
more	O
common	O
.	O

By	O
September	O
24	O
,	O
1984	O
,	O
more	O
than	O
150 people	O
were	O
violently	O
ill	O
.	O

What's	O
new	O
in	O
this	O
mission	O
,	O
he	O
said	O
,	O
is	O
the	O
way	O
the	O
federal	B-Organization
government	E-Organization
will	O
look	O
at	O
biosurveillance	O
and	O
better	O
integration	O
of	O
big	O
data	O
.	O

As	O
can	O
be	O
seen	O
,	O
the	O
lab	O
received	O
higher	O
scores	O
than	O
the	O
college	O
average	O
on	O
each	O
of	O
the	O
three	O
criteria	O
and	O
students	O
expressed	O
greater	O
overall	O
satisfaction	O
from	O
the	O
laboratory	O
than	O
the	O
college	O
average	O
for	O
other	O
labs	O
at	O
Hadassah	B-Organization
Academic	I-Organization
College	E-Organization

Rebecca	B-Person
Moritz	E-Person
a	O
UW	B-Organization
lab	E-Organization
administrator	O
,	O
said	O
there	O
has	O
never	O
been	O
a	O
lab-acquired	O
infection	O
in	O
the	O
.	O

Based	O
on	O
these	O
reports	O
a	O
team	O
of	O
Western	O
inspectors	O
led	O
by	O
Meselson	S-Person
gained	O
access	O
to	O
the	O
region	O
in	O
1992	O
.	O

i	O
Select	O
agents	O
are	O
biological	O
agents	O
and	O
toxins	O
that	O
HHS	S-Organization
and	O
have	O
determined	O
have	O
the	O
potential	O
to	O
pose	O
a	O
severe	O
threat	O
to	O
public	O
health	O
and/or	O
animal	O
health	O
,	O
or	O
to	O
plant	O
health	O
;	O
or	O
to	O
agricultural	O
animal	O
or	O
plant	O
products	O
.	O

The	O
WHO	S-Organization
handling	O
of	O
the	O
epidemic	O
has	O
come	O
under	O
criticism	O
amidst	O
what	O
has	O
been	O
described	O
as	O
the	O
agency's	O
"	O
diplomatic	O
balancing	O
act	O
"	O
between	O
"	O
China	S-Location
and	O
China	S-Location
's	O
critics,	O
"	O
including	O
scrutiny	O
of	O
the	O
relationship	O
between	O
the	O
agency	O
and	O
Chinese	O
authorities	O
.	O

And	O
a	O
reminder	O
that	O
there	O
will	O
be	O
a	O
transcript	O
available	O
following	O
the	O
briefing	O
.	O

W	O
.	O

The	O
moratorium	O
was	O
lifted	O
in	O
2017	O
and	O
experiments	O
have	O
continued	O
.	O

The	O
CDC	S-Organization
estimated	O
that	O
as	O
much	O
as	O
40%	O
of	O
the	O
workforce	O
might	O
be	O
unable	O
to	O
work	O
at	O
the	O
peak	O
of	O
the	O
pandemic	O
due	O
to	O
the	O
need	O
for	O
many	O
healthy	O
adults	O
to	O
stay	O
home	O
and	O
care	O
for	O
an	O
ill	O
family	O
member	O
,	O
and	O
advised	O
that	O
individuals	O
should	O
have	O
steps	O
in	O
place	O
should	O
a	O
workplace	O
close	O
down	O
or	O
a	O
situation	O
arise	O
that	O
requires	O
working	O
from	O
home	O
.	O

In	O
1999	O
,	O
the	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
defined	O
and	O
published	O
three	O
groups	O
of	O
potential	O
bioterrorism	O
biological	O
agents	O
in	O
the	O
category	O
list	O
based	O
on	O
assessment	O
of	O
the	O
threat	O
level	O
of	O
biological	O
agents	O
[11]	O
,	O
[12]	O
.	O

Four	O
other	O
countries	O
(	O
Senegal	S-Location
,	O
Spain	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
and	O
the	O
United	B-Location
States	I-Location
of	I-Location
America	E-Location
)	O
also	O
reported	O
cases	O
imported	O
from	O
,	O
with	O
widespread	O
and	O
intense	O
transmission	O
.	O

Cas9	B-Technology
genomic	I-Technology
modification	E-Technology
has	O
allowed	O
for	O
the	O
quick	O
and	O
efficient	O
generation	O
of	O
transgenic	O
models	O
within	O
the	O
field	O
of	O
genetics	O
.	O

The	O
algorithm	O
robustly	O
predicts	O
the	O
probability	O
of	O
pathogen	O
exposure	O
,	O
without	O
regard	O
to	O
the	O
particular	O
pathogen	O
,	O
the	O
exposure	O
route	O
,	O
or	O
pathogen	O
dose	O
.	O

This	O
is	O
,	O
you	O
know	O
-	O
gives	O
-	O
make	O
you	O
reconsider	O
or	O
want	O
to	O
take	O
a	O
look	O
at	O
that	O
idea?	O
I	O
mean	O
,	O
basically	O
have	O
you	O
been	O
arrogant?	O
Sorry	O
to	O
ask	O
it	O
in	O
such	O
a	O
blunt	O
way	O
.	O

The	O
PRC	O
Health	O
Minister	O
also	O
claimed	O
that	O
the	O
disease	O
has	O
been	O
under	O
control	O
in	O
most	O
parts	O
of	O
mainland	O
China	S-Location
.	O
He	O
also	O
released	O
the	O
names	O
of	O
seven	O
drugs	O
which	O
he	O
claimed	O
to	O
be	O
effective	O
in	O
curing	O
SARS	S-Disease
.	O
WHO	O
officials	O
said	O
that	O
the	O
information	O
provided	O
by	O
the	O
PRC	S-Location
about	O
the	O
disease	O
has	O
been	O
"	O
very	O
detailed".	O
enforced	O
compulsory	O
quarantine	O
of	O
an	O
infected	O
person	O
.	O

For	O
those	O
being	O
treated	O
at	O
home	O
,	O
the	O
WHO	S-Organization
advised	O
informing	O
the	O
local	O
public	O
health	O
authority	O
and	O
acquiring	O
appropriate	O
training	O
and	O
equipment	O
.	O

As	O
we	O
absorb	O
those	O
lessons	O
and	O
learn	O
them	O
,	O
we	O
will	O
incorporate	O
them	O
into	O
our	O
regulatory	O
function	O
and	O
send	O
advice	O
out	O
to	O
any	O
laboratory	O
working	O
in	O
BSL-3	S-Platform
or	O
BSL-4	S-Platform
facilities	O
about	O
things	O
like	O
inactivation	O
procedures	O
.	O

Research	O
into	O
potential	O
treatments	O
started	O
in	O
January	O
2020	O
,	O
and	O
several	O
antiviral	O
drugs	O
are	O
in	O
clinical	O
trials	O
.	O

On	O
18	O
December	O
,	O
the	O
WHO	S-Organization
indicated	O
that	O
it	O
still	O
considered	O
Ebola	S-Disease
in	O
a	O
public	O
health	O
emergency	O
,	O
though	O
progress	O
had	O
been	O
made	O
.	O

On	O
23	O
October	O
2014	O
,	O
the	O
first	O
case	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
in	O
Mali	S-Location
was	O
confirmed	O
in	O
the	O
city	O
of	O
Kayes	S-Location
-a	O
two-year-old	O
girl	O
who	O
had	O
arrived	O
with	O
a	O
family	O
group	O
from	O
Guinea	S-Location
,	O
and	O
died	O
the	O
next	O
day	O
.	O

The	O
modern	O
field	O
of	O
biotechnology	O
was	O
born	O
when	O
scientists	O
first	O
manipulated	O
–	O
or	O
'recombined'	O
–	O
DNA	O
in	O
a	O
test	O
tube	O
,	O
and	O
today	O
almost	O
all	O
aspects	O
of	O
society	O
are	O
impacted	O
by	O
so-called	O
'rDNA'	O
.	O

This	O
system	O
provides	O
protection	O
of	O
bacteria	O
against	O
invading	O
foreign	O
DNA	O
,	O
such	O
as	O
transposons	O
,	O
bacteriophages	O
,	O
and	O
plasmids	O
.	O

On	O
July	O
22	O
,	O
1986	O
,	O
both	O
women	O
entered	O
Alford	B-Organization
pleas	E-Organization
for	O
the	O
Salmonella	B-Incident
attack	E-Incident
and	O
the	O
other	O
charges	O
,	O
and	O
received	O
sentences	O
ranging	O
from	O
three	O
to	O
twenty	O
years	O
,	O
to	O
be	O
served	O
concurrently	O
.	O

One	O
company	O
hopes	O
to	O
edit	O
pig	O
cells	O
using	O
DNA	O
synthesis	O
technology	O
so	O
that	O
their	O
organs	O
can	O
be	O
transplanted	O
into	O
humans	O
.	O

Iraq	S-Location
BW	O
facilities	O
included	O
its	O
main	O
biowarfare	O
research	O
center	O
at	O
Salman	B-Location
Pak	E-Location
(just	O
south	O
of	O
Baghdad	S-Location
)	O
,	O
the	O
main	O
bioweapons	O
production	O
facility	O
at	O
Al	B-Location
Hakum	E-Location
(the	O
"	O
Single-Cell	B-Organization
Protein	I-Organization
Production	I-Organization
Plant	E-Organization
"	O
)	O
and	O
the	O
viral	O
biowarfare	O
research	O
site	O
at	O
Al	B-Location
Manal	E-Location
(the	O
"	O
Foot	B-Organization
and	I-Organization
Mouth	I-Organization
Disease	I-Organization
Center	E-Organization
"	O
).	O
Block	S-Person
,	O
(2001	O
,	O
January–February)	O
.	O

Established	O
in	O
2003	O
,	O
the	O
mission	O
of	O
the	O
BioWatch	S-Document
program	O
is	O
to	O
provide	O
and	O
maintain	O
a	O
continuous	O
bio-terrorism	O
air	O
monitoring	O
system	O
in	O
large	O
metropolitan	O
areas	O
and	O
coordinate	O
with	O
state	O
and	O
local	O
public	O
health	O
communities	O
to	O
prepare	O
for	O
and	O
respond	O
to	O
a	O
bioterrorist	O
event	O
.	O

The	O
event	O
is	O
held	O
every	O
two	O
to	O
three	O
years	O
and	O
brings	O
out	O
more	O
than	O
1,500	O
public	O
health	O
professionals	O
from	O
around	O
the	O
world	O
for	O
the	O
International	B-Activity
Conference	I-Activity
on	I-Activity
Emerging	I-Activity
Infectious	I-Activity
Diseases	E-Activity
(	O
ICEID	S-Activity
)	O
.	O

The	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
for	O
example	O
,	O
suggested	O
in	O
its	O
2003	O
report	O
that	O
the	O
nature	O
of	O
dual-use	O
risks	O
and	O
the	O
responsibilities	O
of	O
scientists	O
should	O
be	O
outlined	O
and	O
added	O
to	O
the	O
codes	O
of	O
ethics	O
of	O
relevant	O
professional	O
societies	O
.	O

New	O
resistance	O
mechanisms	O
are	O
emerging	O
and	O
spreading	O
globally	O
,	O
threatening	O
our	O
ability	O
to	O
treat	O
common	O
infectious	O
diseases	O
.	O

Furthermore	O
,	O
there	O
is	O
no	O
provision	O
to	O
establish	O
an	O
independent	O
national	O
biosafety	O
decision-making	O
body(ies)	O
.	O

On	O
26	O
July	O
,	O
it	O
was	O
reported	O
that	O
the	O
country	O
of	O
Saudi	B-Location
Arabia	E-Location
would	O
not	O
allow	O
visas	O
from	O
the	O
DRC	S-Location
after	O
the	O
WHO	S-Organization
declared	O
it	O
an	O
international	O
emergency	O
due	O
to	O
EVD	S-Disease
.	O
On	O
1	O
August	O
,	O
the	O
country	O
of	O
Rwanda	S-Location
closed	O
its	O
border	O
with	O
the	O
DRC	S-Location
,	O
due	O
to	O
multiple	O
cases	O
in	O
the	O
city	O
of	O
which	O
borders	O
the	O
country	O
in	O
the	O
upper	O
Northwestern	O
region	O
.	O

This	O
because	O
it	O
is	O
public	O
health	O
oriented	O
emergency	O
centre	O
.	O

Surfaces	O
may	O
be	O
decontaminated	O
with	O
a	O
number	O
of	O
solutions	O
(within	O
one	O
minute	O
of	O
exposure	O
to	O
the	O
disinfectant	O
for	O
a	O
stainless	O
steel	O
surface)	O
,	O
including	O
62–71	O
percent	O
ethanol	O
,	O
50–100	O
percent	O
isopropanol	O
,	O
0.	O
1	O
percent	O
sodium	O
hypochlorite	O
,	O
0.	O
5	O
percent	O
hydrogen	O
peroxide	O
,	O
and	O
0.2–7.	O
5	O
percent	O
povidone-iodine	O
.	O

This	O
is	O
the	O
case	O
of	O
a	O
team	O
from	O
the	O
University	B-Organization
of	I-Organization
Pittsburgh	E-Organization
in	O
Pennsylvania	S-Location
,	O
and	O
the	O
Howard	B-Organization
Hughes	I-Organization
Medical	I-Organization
Institute	E-Organization
,	O
in	O
Chevy	B-Location
Chase	E-Location
,	O
.	O

Although	O
biosafety	O
measures	O
were	O
observed	O
by	O
researchers	O
voluntarily	O
,	O
the	O
establishment	O
of	O
national	O
biosafety	O
organizations	O
since	O
the	O
year	O
2000	O
built	O
a	O
great	O
capacity	O
to	O
deal	O
with	O
biosafety	O
issues	O
in	O
the	O
present	O
and	O
future	O
time	O
,	O
particularly	O
with	O
respect	O
to	O
food	O
and	O
agricultural	O
biotechnology	O
.	O

The	O
dispersal	O
of	O
this	O
pathogen	O
among	O
densely	O
populated	O
areas	O
is	O
said	O
to	O
carry	O
less	O
than	O
one	O
percent	O
mortality	O
rate	O
,	O
for	O
cutaneous	O
exposure	O
,	O
to	O
a	O
ninety	O
percent	O
or	O
higher	O
mortality	O
for	O
untreated	O
inhalational	O
infections	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
USDA	O
,	O
DHHS	O
,	O
DoT	O
,	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Both	O
zinc	O
finger	O
nucleases	O
and	O
TALENs	O
require	O
the	O
design	O
and	O
creation	O
of	O
a	O
custom	O
protein	O
for	O
each	O
targeted	O
DNA	O
sequence	O
,	O
which	O
is	O
a	O
much	O
more	O
difficult	O
and	O
time-consuming	O
process	O
than	O
that	O
of	O
designing	O
guide	O
RNAs	O
.	O

An	O
interesting	O
approach	O
toward	O
data	O
citation	O
is	O
the	O
signaling	O
gateway	O
molecule	O
pages	O
(SGMP)-a	O
database	O
providing	O
structured	O
data	O
about	O
signaling	O
proteins	O
.	O

The	O
bill	O
included	O
prison	O
sentences	O
ranging	O
from	O
16	O
months	O
to	O
three	O
years	O
,	O
and	O
fines	O
up	O
to	O
$10,000.	O
"	O
3	O
Pest	O
Bills	O
Pass	O
AG	O
Committee"	O
,	O
(login	O
required)	O
,	O
Fresno	S-Location
Bee	O
,	O
May	O
15	O
,	O
1990	O
,	O
accessed	O
February	O
23	O
,	O
2012	O
.	O

A	O
straightforward	O
approach	O
which	O
is	O
already	O
exercised	O
in	O
UK	S-Location
,	O
Canada	S-Location
and	O
USA	S-Location
(and	O
recommended	O
to	O
funding	O
partners	O
in	O
other	O
countries	O
,	O
e.g	O
.	O

Updated	O
October	O
29	O
,	O
2019	O
,	O
to	O
edit	O
the	O
program	O
manager	O
for	O
the	O
Biological	B-Organization
Technologies	I-Organization
Office	E-Organization

The	O
Nile	O
was	O
choked	O
with	O
corpses	O
despite	O
Cairo	S-Organization
having	O
a	O
medieval	O
hospital	O
,	O
the	O
late	O
13th	O
century	O
bimaristan	S-Location
of	O
the	O
Qalawun	O
complex	O
.	O

Clinical	O
similarities	O
led	O
contemporary	O
observers	O
to	O
conclude	O
initially	O
that	O
they	O
were	O
observing	O
the	O
same	O
disease	O
in	O
the	O
successive	O
waves	O
.	O

As	O
the	O
toxic	O
threat	O
constantly	O
evolves	O
,	O
warfighters	O
rely	O
on	O
PPE	S-Equipment
that	O
can	O
adapt	O
at	O
the	O
speed	O
of	O
relevancy	O
from	O
hostile	O
enemies	O
to	O
viruses	O
and	O
volatile	O
chemicals	O
.	O

By	O
19	O
November	O
2009	O
,	O
doses	O
of	O
vaccine	O
had	O
been	O
administered	O
in	O
over	O
16	O
countries	O
.	O

Boris	B-Person
Yeltsin	E-Person
,	O
a	O
local	O
official	O
at	O
this	O
time	O
,	O
helped	O
cover	O
up	O
the	O
accident	O
.	O

Biological	O
agents	O
are	O
attractive	O
to	O
terrorists	O
because	O
they	O
are	O
extremely	O
difficult	O
to	O
detect	O
and	O
do	O
not	O
cause	O
illness	O
for	O
several	O
hours	O
to	O
several	O
days	O
.	O

People	O
with	O
this	O
kind	O
of	O
infection	O
typically	O
have	O
diarrhea	S-Phenotype
,	O
fever	S-Phenotype
and	O
that	O
go	O
away	O
without	O
specific	O
treatment	O
within	O
4-7	O
days	O
.	O

When	O
the	O
war	O
ended	O
,	O
the	O
US	B-Organization
Army	E-Organization
quietly	O
enlisted	O
certain	O
members	O
of	O
Noborito	S-Organization
in	O
its	O
efforts	O
against	O
the	O
communist	O
camp	O
in	O
the	O
early	O
years	O
of	O
the	O
Cold	O
War	O
.	O

Gottlieb	S-Person
said	O
the	O
agency	O
is	O
currently	O
discussing	O
this	O
and	O
other	O
potential	O
payment	O
strategies	O
,	O
which	O
would	O
be	O
linked	O
to	O
the	O
promise	O
of	O
effective	O
stewardship	O
efforts	O
by	O
hospitals	O
and	O
drug	O
makers	O
,	O
with	O
the	O
Centers	B-Organization
for	I-Organization
Medicare	I-Organization
and	I-Organization
Medicaid	I-Organization
Services	E-Organization
.	O
In	O
addition	O
,	O
commercial	O
insurers	O
could	O
work	O
with	O
groups	O
like	O
the	O
Gates	B-Organization
Foundation	E-Organization
and	O
BARDA	S-Organization
(the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
)	O
to	O
develop	O
pilot	O
programs.	O
said	O
small	O
pilot	O
programs	O
with	O
private	O
insurers	O
are	O
the	O
most	O
likely	O
method	O
for	O
testing	O
these	O
alternative	O
payment	O
strategies	O
.	O

Some	O
fatal	O
cases	O
did	O
continue	O
into	O
March	O
1919	O
,	O
killing	O
one	O
player	O
in	O
the	O
.	O

The	O
term	O
sinogram	O
was	O
introduced	O
by	O
Paul	B-Person
Edholm	E-Person
and	O
in	O
1975	O
.	O

The	O
4th	B-Activity
Annual	I-Activity
Biodefense	I-Activity
World	I-Activity
Summit	E-Activity
will	O
be	O
held	O
June	O
27-29	O
,	O
2018	O
in	O
Bethesda	S-Location
,	O
.	O

Good	O
evening	O
and	O
thank	O
you	O
for	O
the	O
kind	O
introduction	O
.	O

In	O
Hungary	S-Location
,	O
the	O
parliament	O
voted	O
to	O
allow	O
the	O
prime	O
minister	O
,	O
Viktor	B-Person
Orbán	E-Person
,	O
to	O
rule	O
by	O
decree	O
indefinitely	O
,	O
suspend	O
parliament	O
as	O
well	O
as	O
elections	O
,	O
and	O
punish	O
those	O
deemed	O
to	O
have	O
spread	O
false	O
information	O
about	O
the	O
virus	O
and	O
the	O
government's	O
handling	O
of	O
the	O
crisis	O
.	O

Employees	O
in	O
these	O
groups	O
are	O
having	O
one-on-one	O
appointments	O
with	O
medical	O
staff	O
in	O
CDC's	B-Organization
occupational	I-Organization
health	I-Organization
clinic	E-Organization
who	O
are	O
reviewing	O
all	O
information	O
with	O
them	O
and	O
discussing	O
the	O
pros	O
and	O
cons	O
of	O
continuing	O
post-exposure	O
prophylaxis	O
as	O
part	O
of	O
shared	O
decision	O
making	O
.	O

The	O
NIH	S-Organization
said	O
that	O
"	O
it	O
appears	O
the	O
measures	O
taken	O
by	O
the	O
to	O
reduce	O
the	O
likelihood	O
of	O
these	O
events	O
have	O
not	O
been	O
effective	O
"	O
and	O
ordered	O
an	O
action	O
plan	O
to	O
address	O
engineering	O
controls	O
,	O
training	O
and	O
other	O
activities	O
to	O
reduce	O
the	O
risk	O
of	O
escapes	O
.	O

How	O
is	O
this	O
different	O
than	O
standard	O
molecular	B-Technology
biology/genetic	I-Technology
engineering	E-Technology
etc?	O

Ground	O
teams	O
took	O
five	O
samples	O
from	O
suspected	O
active	O
cases	O
and	O
two	O
tested	O
positive	O
for	O
the	O
Zaire	B-Pathogen
strain	I-Pathogen
of	I-Pathogen
the	I-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
the	O
ministry	O
said	O
in	O
a	O
statement	O
.	O

One	O
,	O
in	O
both	O
these	O
cases	O
,	O
I	O
wanted	O
to	O
understand	O
how	O
much	O
-	O
and	O
sorry	O
,	O
I'm	O
talking	O
about	O
the	O
cases	O
of	O
the	O
anthrax	S-Pathogen
and	O
influenza	O
case	O
-	O
how	O
much	O
of	O
it	O
was	O
just	O
dumb	O
luck	O
that	O
the	O
spores	O
were	O
able	O
to	O
get	O
out	O
into	O
the	O
general	O
public?	O
And	O
secondly	O
,	O
in	O
both	O
these	O
cases	O
,	O
there	O
seems	O
to	O
be	O
a	O
huge	O
lag	O
between	O
when	O
these	O
events	O
were	O
found	O
out	O
and	O
when	O
they	O
were	O
reported	O
.	O

Some	O
bioterrorism	O
agents	O
,	O
like	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
can	O
be	O
spread	O
from	O
person	O
to	O
person	O
and	O
some	O
,	O
like	O
anthrax	S-Pathogen
,	O
cannot	O
.	O

Once	O
polio	S-Disease
is	O
eradicated	O
,	O
and	O
I	O
am	O
confident	O
it	O
will	O
be	O
,	O
we'll	O
need	O
to	O
do	O
something	O
very	O
similar	O
with	O
the	O
virus	O
.	O

Consequently	O
,	O
in	O
2010	O
,	O
a	O
group	O
of	O
researchers	O
recommended	O
that	O
the	O
name	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
be	O
adopted	O
for	O
a	O
subclassification	O
within	O
the	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
,	O
with	O
the	O
corresponding	O
abbreviation	O
EBOV	S-Pathogen
.	O
Previous	O
abbreviations	O
for	O
the	O
virus	O
were	O
EBOV-Z	S-Pathogen
(for	O
"	O
Ebola	B-Pathogen
virus	I-Pathogen
Zaire	E-Pathogen
"	O
)	O
and	O
ZEBOV	S-Pathogen
(for	O
"	O
Zaire	B-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
"	O
or	O
"	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
"	O
).	O
In	O
2011	O
,	O
the	O
ICTV	S-Organization
explicitly	O
rejected	O
a	O
proposal	O
(2010.010bV)	O
to	O
recognize	O
this	O
name	O
,	O
as	O
ICTV	S-Organization
does	O
not	O
designate	O
names	O
for	O
subtypes	O
,	O
variants	O
,	O
strains	O
,	O
or	O
other	O
subspecies	O
level	O
groupings	O
.	O

This	O
excess	O
mortality	O
may	O
include	O
deaths	O
due	O
to	O
strained	O
healthcare	O
systems	O
and	O
bans	O
on	O
elective	O
surgery	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
has	O
promoted	O
the	O
first	O
running	O
from	O
16–22	O
November	O
2015	O
.	O

"	O
Black	B-Disease
death	E-Disease
was	O
not	O
used	O
to	O
describe	O
the	O
plague	S-Disease
pandemic	O
in	O
English	O
until	O
the	O
1750s	O
;	O
the	O
term	O
is	O
first	O
attested	O
in	O
1755	O
,	O
where	O
it	O
translated	O
.	O
From	O
p.	O
24:	O
"	O
Norway	S-Location
,	O
indeed	O
,	O
cannot	O
be	O
said	O
to	O
be	O
entirely	O
exempt	O
from	O
pestilential	O
distempers	O
,	O
for	O
the	O
Black-death	S-Disease
,	O
known	O
all	O
over	O
Europe	S-Location
by	O
its	O
terrible	O
ravages	O
,	O
from	O
the	O
years	O
1348	O
to	O
50	O
,	O
was	O
felt	O
here	O
as	O
in	O
other	O
parts	O
,	O
and	O
to	O
the	O
great	O
diminution	O
of	O
the	O
number	O
of	O
the	O
inhabitants.	O
"	O
This	O
expression	O
as	O
a	O
proper	O
name	O
for	O
the	O
pandemic	O
had	O
been	O
popularised	O
by	O
Swedish	O
and	O
Danish	O
chroniclers	O
in	O
the	O
15th	O
and	O
early	O
16th	O
centuries	O
,	O
and	O
in	O
the	O
16th	O
and	O
17th	O
centuries	O
was	O
the	O
transferred	O
to	O
other	O
languages	O
as	O
a	O
calque:	O
,	O
,	O
and	O
.The	O
German	O
physician	O
Justus	B-Person
Friedrich	I-Person
Karl	I-Person
Hecker	E-Person
(1795–1850)	O
cited	O
the	O
phrase	O
in	O
Icelandic	O
()	O
,	O
Danish	O
()	O
,	O
etc	O
.	O

A	O
Soviet	S-Organization
field	O
test	O
of	O
weaponized	O
caused	O
an	O
outbreak	O
in	O
1971	O
that	O
killed	O
two	O
children	O
and	O
a	O
young	O
woman	O
before	O
health	O
teams	O
disinfected	O
homes	O
,	O
quarantined	O
hundreds	O
of	O
people	O
and	O
administered	O
nearly	O
50,000	O
emergency	O
vaccine	O
shots	O
,	O
a	O
new	O
report	O
asserts	O
.	O

Federal	O
officials	O
,	O
most	O
notably	O
at	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
()	O
,	O
remarked	O
that	O
the	O
letters	O
did	O
not	O
have	O
the	O
hallmarks	O
of	O
international	O
terrorism	O
and	O
were	O
more	O
likely	O
produced	O
by	O
a	O
homegrown	O
criminal	O
.	O

Ebola	S-Disease
control	O
is	O
hindered	O
by	O
the	O
fact	O
that	O
current	O
diagnostic	O
tests	O
require	O
specialised	O
equipment	O
and	O
highly	O
trained	O
personnel	O
.	O

Contaminated	O
waste	O
,	O
the	O
records	O
said	O
,	O
was	O
stored	O
in	O
barrels	S-Equipment
with	O
locking	O
lids	O
.	O

On	O
31	O
December	O
2019	O
,	O
the	O
WHO	B-Organization
China	I-Organization
Country	I-Organization
Office	E-Organization
was	O
informed	O
of	O
cases	O
of	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
(unknown	O
cause)	O
detected	O
in	O
Wuhan	B-Location
City	E-Location
,	O
Hubei	B-Location
Province	I-Location
of	I-Location
China	E-Location
.	O
As	O
of	O
3	O
January	O
2020	O
,	O
a	O
total	O
of	O
44	O
patients	O
with	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
have	O
been	O
reported	O
to	O
WHO	S-Organization
by	O
the	O
national	O
authorities	O
in	O
China	S-Location
.	O
Of	O
the	O
44	O
cases	O
reported	O
,	O
11	O
are	O
severely	O
ill	O
,	O
while	O
the	O
remaining	O
33	O
patients	O
are	O
in	O
stable	O
condition	O
.	O

In	O
October	O
,	O
the	O
United	B-Organization
Nations	I-Organization
Security	I-Organization
Council	E-Organization
stressed	O
that	O
all	O
armed	O
hostility	O
should	O
come	O
to	O
a	O
stop	O
in	O
the	O
DRC	S-Location
,	O
to	O
better	O
fight	O
the	O
ongoing	O
EVD	S-Disease
outbreak	O
.	O

So	O
says	O
the	O
GHSA	S-International_exchange_and_cooperation
February	O
2018	O
report	O
,	O
"	O
Implementing	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
:	O
Progress	O
and	O
Impact	O
from	O
Investments,	O
"	O
which	O
notes	O
that	O
many	O
new	O
and	O
reemerging	O
pathogens	O
are	O
spreading	O
quickly	O
resulting	O
in	O
epidemics	O
and	O
outbreaks	O
having	O
the	O
potential	O
to	O
overwhelm	O
and	O
devastate	O
global	O
systems	O
across	O
health	O
care	O
,	O
financial	O
and	O
research	O
and	O
development	O
markets	O
.	O

What	O
measures	O
have	O
you	O
put	O
in	O
place	O
to	O
prevent	O
future	O
outbreaks	O
of	O
Lassa	B-Disease
fever	E-Disease

Eitzen	S-Person
Edward	B-Person
M.	E-Person
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
Borden	B-Organization
Institute	E-Organization
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	B-Location
Air	I-Location
Force	I-Location
Base	E-Location
.	O
Retrieved	O
January	O
5	O
,	O
2009	O
.	O

The	O
also	O
just	O
released	O
a	O
new	O
special	O
report	O
on	O
biodefense	O
preparedness	O
at	O
the	O
local	O
level	O
.	O

Meanwhile	O
the	O
new	O
sciences	O
of	O
the	O
infectious	O
agents	O
and	O
immunology	O
were	O
racing	O
to	O
come	O
up	O
with	O
a	O
vaccine	O
or	O
therapy	O
to	O
stop	O
the	O
epidemics	O
.	O

In	O
natural	O
evolutionary	O
competition	O
there	O
is	O
no	O
guarantee	O
that	O
we	O
will	O
find	O
ourselves	O
the	O
survivors.	O
"	O
(Ref)	O
.	O

France	S-Location
reported	O
its	O
first	O
death	O
from	O
near	O
the	O
end	O
of	O
May	O
2013	O
.	O

A	O
new	O
DARPA	S-Organization
program	O
called	O
Preventing	B-Scientific_research_project
Emerging	I-Scientific_research_project
Pathogenic	I-Scientific_research_project
Threats	E-Scientific_research_project
,	O
or	O
PREEMPT	S-Scientific_research_project
,	O
seeks	O
to	O
support	O
military	O
readiness	O
by	O
going	O
after	O
new	O
viral	O
infectious	O
diseases	O
at	O
the	O
source	O
,	O
animal	O
reservoirs-the	O
species	O
in	O
which	O
a	O
pathogen	O
lives	O
,	O
multiplies	O
,	O
and	O
potentially	O
evolves	O
into	O
a	O
strain	O
that	O
can	O
threaten	O
humans.	O
aims	O
to	O
advance	O
understanding	O
of	O
viruses	O
and	O
their	O
interaction	O
with	O
animals	O
,	O
insects	O
,	O
and	O
humans	O
,	O
and	O
deliver	O
new	O
,	O
proactive	O
interventions	O
to	O
reduce	O
the	O
risk	O
from	O
emerging	O
and	O
reemerging	O
pathogens	O
.	O

Since	O
December	O
,	O
22	O
students	O
and	O
faculty	O
members	O
of	O
Lanzhou	B-Organization
University	E-Organization
have	O
tested	O
positive	O
for	O
brucella	S-Pathogen
antibody	O
,	O
among	O
whom	O
six	O
had	O
been	O
to	O
the	O
institute	O
.	O

Not	O
a	O
single	O
journalist	O
has	O
been	O
allowed	O
onto	O
the	O
premises	O
since	O
1992	O
.	O

WardEnvironment	S-Organization
time	O
since	O
the	O
initial	O
outbreak	O
,	O
and	O
population	O
characteristics	O
,	O
such	O
as	O
age	O
,	O
sex	O
,	O
and	O
overall	O
health	O
.	O

Start-up	O
companies	O
could	O
use	O
this	O
opportunity	O
to	O
generate	O
effective	O
,	O
new	O
,	O
antibiotic	O
combinations	O
.	O

Two	O
laboratories	O
,	O
one	O
at	O
CDC	S-Organization
and	O
the	O
other	O
at	O
the	O
Michigan	B-Organization
Department	I-Organization
of	I-Organization
Community	I-Organization
Health	E-Organization
,	O
conducted	O
experiments	O
to	O
determine	O
the	O
effectiveness	O
of	O
the	O
formic	O
acid/acetonitrile	O
protein	O
extraction	O
procedure	O
for	O
inactivating	O
B.	B-Pathogen
anthracis	E-Pathogen
.	O
Both	O
laboratories	O
found	O
that	O
the	O
extraction	O
procedure	O
completely	O
inactivated	O
preparations	O
of	O
B.	B-Pathogen
anthracis	I-Pathogen
cells	E-Pathogen
after	O
10	O
minutes	O
.	O

The	O
publication	O
of	O
this	O
article	O
is	O
to	O
reach	O
a	O
wider	O
audience	O
and	O
for	O
proper	O
recognition	O
of	O
the	O
efforts	O
by	O
the	O
project	O
team	O
.	O

The	O
University	B-Organization
of	I-Organization
Oxford	I-Organization
Centre	I-Organization
for	I-Organization
Evidence-Based	I-Organization
Medicine	E-Organization
()	O
estimated	O
a	O
global	O
CFR	O
of	O
0.8	O
to	O
9.	O
6	O
percent	O
(last	O
revised	O
30	O
April)	O
and	O
IFR	O
of	O
0.10	O
to	O
0.	O
41	O
percent	O
(last	O
revised	O
2	O
May)	O
.	O

It	O
uses	O
eye	O
scanners	O
and	O
other	O
security	O
measures	O
to	O
restrict	O
access	O
.	O

This	O
genetic	O
perturbation	O
is	O
necessary	O
for	O
fully	O
understanding	O
gene	O
function	O
and	O
epigenetic	O
regulation	O
.	O

Liberia	S-Location
began	O
a	O
90-day	O
period	O
of	O
heightened	O
surveillance	O
,	O
scheduled	O
to	O
conclude	O
on	O
13	O
April	O
2016	O
,	O
but	O
on	O
1	O
April	O
,	O
it	O
was	O
reported	O
that	O
a	O
new	O
Ebola	O
fatality	O
had	O
occurred	O
,	O
and	O
on	O
3	O
April	O
,	O
a	O
second	O
case	O
was	O
reported	O
in	O
Monrovia	S-Location
.	O
On	O
4	O
April	O
,	O
it	O
was	O
reported	O
that	O
84	O
individuals	O
were	O
under	O
observation	O
due	O
to	O
contact	O
with	O
the	O
2	O
confirmed	O
Ebola	S-Disease
cases	O
.	O

Using	O
data	O
acquired	O
from	O
non-human	O
primates	O
at	O
USAMRIID	S-Organization
and	O
NIH-IRF	S-Organization
,	O
the	O
researchers	O
developed	O
and	O
tested	O
PRESAGED	S-Technology
for	O
several	O
exposure	O
methods	O
(intramuscular	O
,	O
aerosol	O
,	O
or	O
intratracheal	O
routes)	O
to	O
one	O
of	O
several	O
viral	O
hemorrhagic	B-Disease
fevers	E-Disease
,	O
including	O
,	O
or	O
the	O
bacterial	O
pathogen	O
,	O
Y.pestis	O
.	O

Information	O
obtained	O
from	O
the	O
US	S-Location
federal	O
contracts	O
registry	O
clarifies	O
some	O
of	O
the	O
military	O
activities	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
–	O
among	O
them	O
research	O
on	O
bio-	O
agents	O
(	O
anthrax	S-Disease
,	O
tularemia	S-Disease
)	O
and	O
viral	O
diseases	O
(e.g.	O
)	O
,	O
and	O
the	O
collection	O
of	O
biological	O
samples	O
for	O
future	O
experiments	O
.	O

Even	O
President	B-Person
Woodrow	I-Person
Wilson	E-Person
suffered	O
from	O
the	O
flu	O
in	O
early	O
1919	O
while	O
negotiating	O
the	O
crucial	O
treaty	O
of	O
Versailles	S-Document
to	O
end	O
the	O
World	B-Incident
War	I-Incident
(Tice)	E-Incident
.	O
Those	O
who	O
were	O
lucky	O
enough	O
to	O
avoid	O
infection	O
had	O
to	O
deal	O
with	O
the	O
public	O
health	O
ordinances	O
to	O
restrain	O
the	O
spread	O
of	O
the	O
disease	O
.	O

A	O
similar	O
approach	O
was	O
taken	O
to	O
model	O
long	O
QT	O
syndrome	O
in	O
cardiomyocytes	O
derived	O
from	O
pluripotent	O
stem	O
cells	O
.	O

Heading	O
the	O
collaborative	O
effort	O
for	O
the	O
University	B-Organization
of	I-Organization
Nebraska	E-Organization
is	O
Ken	B-Person
Bayles	E-Person
,	O
Ph.D.	O
,	O
professor	O
,	O
pathology/microbiology	O
for	O
UNMC	S-Organization
.	O
Mark	B-Person
Riley	E-Person
,	O
Ph.D.	O
,	O
associate	O
dean	O
for	O
research	O
for	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	I-Organization
College	I-Organization
of	I-Organization
Engineering	E-Organization
,	O
is	O
assisting	O
Bayles	S-Person
on	O
the	O
.	O

One	O
estimate	O
from	O
an	O
expert	O
at	O
Washington	B-Organization
University	E-Organization
in	O
St.	B-Location
Louis	E-Location
gave	O
a	O
$300+billion	O
impact	O
on	O
the	O
world's	O
supply	O
chain	O
that	O
could	O
last	O
up	O
to	O
two	O
years	O
.	O

This	O
review	O
examines	O
the	O
history	O
,	O
the	O
causes	O
,	O
and	O
the	O
methods	O
for	O
prevention	O
of	O
laboratory-associated	O
infections	O
.	O

The	O
CDC	S-Organization
offers	O
grants	O
that	O
help	O
many	O
organizations	O
each	O
year	O
advance	O
health	O
,	O
safety	O
and	O
awareness	O
at	O
the	O
community	O
level	O
throughout	O
the	O
United	B-Location
States	E-Location
.	O
The	O
awards	O
over	O
85	O
percent	O
of	O
its	O
annual	O
budget	O
through	O
these	O
grants	O
.	O

All	O
personnel	O
authorized	O
to	O
enter	O
the	O
laboratory	O
must	O
be	O
well	O
trained	O
.	O

The	O
experts	O
calculated	O
that	O
it	O
would	O
require	O
of	O
virus	O
fluid	O
to	O
have	O
been	O
aspirated	O
(meaning	O
,	O
in	O
this	O
context	O
,	O
removed	O
by	O
suction	O
of	O
fluid	O
and	O
cells	O
through	O
a	O
needle)	O
and	O
it	O
would	O
take	O
20,000	O
years	O
for	O
one	O
particle	O
to	O
travel	O
to	O
the	O
telephone	O
room	O
at	O
the	O
rate	O
the	O
fluid	O
was	O
aspirated	O
.	O

These	O
are	O
events	O
that	O
tell	O
us	O
that	O
we	O
have	O
a	O
problem	O
and	O
we're	O
going	O
to	O
fix	O
it	O
.	O

In	O
March	O
2015	O
,	O
it	O
was	O
reported	O
that	O
had	O
begun	O
to	O
diversify	O
away	O
from	O
mining	O
,	O
due	O
to	O
the	O
country's	O
recent	O
problems	O
.	O

severe	O
pneumonia:	O
diffuse	B-Phenotype
alveolar	I-Phenotype
damage	E-Phenotype
(	O
DAD	S-Phenotype
)	O
with	O
diffuse	O
alveolar	O
exudates	O
.	O

The	O
risk	O
of	O
transmission	O
is	O
increased	O
among	O
those	O
caring	O
for	O
people	O
infected	O
.	O

A	O
joint	O
gap-analysis	O
identified	O
the	O
need	O
to	O
improve	O
and	O
share	O
existing	O
methods	O
and	O
in	O
some	O
cases	O
to	O
develop	O
new	O
methods	O
(Table	O
2)	O
.	O

Several	O
countries	O
donated	O
masks	O
,	O
medical	O
equipment	O
or	O
money	O
to	O
China	S-Location
including	O
Japan	S-Location
,	O
Turkey	S-Organization
,	O
Russia	S-Location
,	O
Malaysia	S-Organization
,	O
Germany	S-Organization
,	O
and	O
Canada	S-Location
.	O
Mu	B-Person
Xuequan	E-Person
(editor)	O
,	O
21	O
countries	O
donate	O
medical	O
supplies	O
to	O
China	S-Location
:	O
spokesperson]	O
,	O
6	O
February	O
2020	O
,	O
Xinhua	B-Organization
News	I-Organization
Agency	E-Organization
The	O
U.S.	B-Organization
State	I-Organization
Department	E-Organization
said	O
on	O
7February	O
it	O
had	O
facilitated	O
the	O
transportation	O
of	O
nearly	O
17.8	O
tons	O
of	O
medical	O
supplies	O
to	O
China	S-Location
.	O
The	O
same	O
day	O
,	O
U.S.	S-Location
Secretary	O
of	O
State	O
Pompeo	S-Person
announced	O
a	O
$100 million	O
pledge	O
to	O
China	S-Location
and	O
other	O
countries	O
to	O
aid	O
their	O
fights	O
against	O
the	O
virus	O
,	O
though	O
on	O
21	O
March	O
China	S-Location
said	O
it	O
had	O
not	O
received	O
epidemic	O
funding	O
from	O
the	O
U.S.	S-Location
government	O
and	O
reiterated	O
that	O
on	O
3April	O
.	O

The	O
extremely	O
slow	O
growth	O
rate	O
of	O
this	O
organism	O
makes	O
experimentation	O
very	O
time	O
consuming	O
(this	O
organism's	O
slow	O
growth	O
also	O
compelled	O
us	O
to	O
resort	O
to	O
working	O
with	O
the	O
faster	O
growing	O
species	O
M.	O
mycoides	O
that	O
we	O
report	O
on	O
now)	O
.	O

Lieberman	S-Person
also	O
expressed	O
worry	O
that	O
a	O
terrorist	O
group	O
like	O
ISIS	O
could	O
develop	O
a	O
synthetic	O
influenza	O
strain	O
and	O
introduce	O
it	O
to	O
the	O
world	O
to	O
kill	O
civilians	O
.	O

Speaking	O
on	O
12	O
September	O
,	O
WHO	S-Organization
Director-General	O
,	O
Margaret	B-Person
Chan	E-Person
,	O
said:	O
"	O
In	O
the	O
three	O
hardest	O
hit	O
countries	O
,	O
Guinea	S-Location
,	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
,	O
the	O
number	O
of	O
new	O
cases	O
is	O
moving	O
far	O
faster	O
than	O
the	O
capacity	O
to	O
manage	O
them	O
in	O
the	O
Ebola	S-Disease
-specific	O
treatment	O
centres	O
.	O

In	O
the	O
1st	O
changing	O
room	O
,	O
staff	O
should	O
remove	O
the	O
remaining	O
inner	O
PPE	S-Equipment
and	O
change	O
into	O
their	O
own	O
clothes	O
.	O

Influenza	B-Pathogen
A	I-Pathogen
viruses	E-Pathogen
(	O
IAVs	S-Pathogen
)	O
,	O
particularly	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
H5N1	S-Pathogen
,	O
have	O
posed	O
a	O
substantial	O
threat	O
to	O
public	O
health	O
worldwide	O
.	O

Micro-organisms	B-Document
-	I-Document
Examination	I-Document
of	I-Document
various	I-Document
existing	I-Document
lists	I-Document
of	I-Document
animal	I-Document
pathogens	I-Document
and	I-Document
production	I-Document
of	I-Document
a	I-Document
report	E-Document
.	O
CR	O
12894	O
,	O
1997)	O
.	O

On	O
16	O
March	O
2020	O
,	O
the	O
first	B-Incident
clinical	I-Incident
trial	I-Incident
of	I-Incident
a	I-Incident
vaccine	I-Incident
started	I-Incident
with	I-Incident
four	I-Incident
volunteers	E-Incident
in	O
Seattle	S-Location
,	O
Washington	S-Location
,	O
.	O
The	O
vaccine	O
contains	O
a	O
harmless	O
genetic	O
code	O
copied	O
from	O
the	O
virus	O
that	O
causes	O
the	O
disease	O
.	O

The	O
WHO	S-Organization
also	O
helped	O
contain	O
the	O
last	O
European	O
outbreak	O
in	O
Yugoslavia	S-Location
in	O
1972	O
.	O

LENA	B-Person
SUN	E-Person
Do	O
you	O
know	O
whether	O
these	O
-	O
in	O
the	O
previous	O
incidents	O
when	O
those	O
-	O
aside	O
from	O
the	O
flu	O
one	O
,	O
the	O
other	O
three	O
incidents	O
,	O
what	O
happened	O
to	O
those	O
organisms	O
and	O
whether	O
there	O
were	O
any	O
exposures?	O

On	O
November	O
2019	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
prequalified	O
an	O
Ebola	S-Pathogen
vaccine	O
,	O
rVSV-ZEBOV	S-Vaccine
,	O
for	O
the	O
first	O
time	O
against	O
.	O
As	O
of	O
22	O
February	O
2020	O
,	O
a	O
total	O
of	O
297,275	O
people	O
have	O
been	O
vaccinated	O
since	O
the	O
start	O
of	O
the	O
outbreak	O
.	O

Based	O
on	O
a	O
lack	O
of	O
evidence	O
about	O
the	O
safety	O
of	O
the	O
vaccine	O
during	O
pregnancy	O
,	O
the	O
DRC	B-Organization
ministry	I-Organization
of	I-Organization
health	E-Organization
and	O
the	O
WHO	S-Organization
decided	O
to	O
cease	O
vaccinating	O
women	O
who	O
are	O
pregnant	O
or	O
lactating	O
.	O

There's	O
also	O
the	O
avian	B-Disease
flu	E-Disease
that	O
emerged	O
in	O
china	S-Location
a	O
few	O
years	O
ago	O
.	O

"	O
More	O
and	O
more	O
studies	O
suggest	O
'shorter	O
is	O
better,'	O
in	O
terms	O
of	O
how	O
long	O
to	O
treat	O
common	O
infections	O
,	O
but	O
we	O
need	O
more	O
evidence	O
for	O
many	O
of	O
the	O
more	O
complicated	O
infections,	O
"	O
Dr	O
.	O

At	O
BSL‐3	S-Platform
more	O
emphasis	O
is	O
placed	O
on	O
primary	O
and	O
secondary	O
barriers	O
to	O
protect	O
personnel	O
in	O
contiguous	O
areas	O
,	O
the	O
community	O
,	O
and	O
the	O
environment	O
from	O
exposure	O
to	O
potentially	O
infectious	O
aerosols	O
(see	O
Table	O
1)	O
.	O

Bacteriophagics	O
are	O
used	O
against	O
antibiotic	O
resistant	O
bacteria	O
in	O
Georgia	S-Location
(	O
George	B-Organization
Eliava	I-Organization
Institute	E-Organization
)	O
and	O
in	O
one	O
institute	O
in	O
Wrocław	S-Location
,	O
.	O
Bacteriophage	O
cocktails	O
are	O
common	O
drugs	O
sold	O
over	O
the	O
counter	O
in	O
pharmacies	O
in	O
eastern	O
countries	O
.	O

A	O
portion	O
has	O
been	O
preserved	O
and	O
is	O
open	O
to	O
visitors	O
as	O
a	O
.	O

Despite	O
the	O
official	O
termination	O
of	O
the	O
US	S-Location
bio-weapons	O
program	O
,	O
in	O
1982	O
USAMRIID	S-Organization
performed	O
an	O
experiment	O
if	O
sand	O
flies	O
and	O
mosquitoes	O
could	O
be	O
vectors	O
of	O
Rift	B-Pathogen
Valley	I-Pathogen
Virus	E-Pathogen
,	O
Dengue	S-Pathogen
,	O
Chikungunya	S-Pathogen
and	O
Eastern	B-Pathogen
Equine	I-Pathogen
Encephalitis	E-Pathogen
–	O
viruses	O
,	O
which	O
the	O
researched	O
for	O
their	O
potential	O
as	O
bio-weapons	O
.	O

Noting	O
the	O
agency's	O
role	O
in	O
overseeing	O
and	O
regulating	O
drug	O
development	O
,	O
safety	O
,	O
and	O
use	O
,	O
Gottlieb	S-Person
said	O
the	O
strategy	O
aims	O
to	O
combat	O
AMR	O
by	O
addressing	O
the	O
"	O
full	O
continuum	O
"	O
of	O
antibiotic	O
development	O
and	O
use	O
in	O
both	O
humans	O
and	O
animals	O
.	O

The	O
physiological	O
biosignal	O
features	O
provided	O
to	O
PRESAGED	S-Technology
during	O
the	O
primate	O
testing	O
were	O
collected	O
by	O
implanted	O
monitoring	O
devices	O
.	O

France	S-Location
Italy	S-Location
,	O
the	O
Netherlands	S-Location
,	O
Norway	S-Location
,	O
Switzerland	S-Location
,	O
and	O
received	O
two	O
patients	O
(and	O
five	O
who	O
were	O
exposed)	O
.	O

The	O
pharmaceutical	O
industry	O
has	O
little	O
incentive	O
to	O
invest	O
in	O
antibiotics	O
because	O
of	O
the	O
high	O
risk	O
and	O
because	O
the	O
potential	O
financial	O
returns	O
are	O
less	O
likely	O
to	O
cover	O
the	O
cost	O
of	O
development	O
than	O
for	O
other	O
pharmaceuticals	O
.	O

In	O
severe	O
cases	O
,	O
patients	O
generally	O
begin	O
to	O
deteriorate	O
around	O
three	O
to	O
five	O
days	O
after	O
symptom	O
onset	O
.	O

Emergency	O
hospitals	O
were	O
created	O
to	O
take	O
in	O
the	O
patients	O
from	O
and	O
those	O
arriving	O
sick	O
from	O
overseas	O
.	O

Carus	S-Person
Seth	S-Person
-	O
Counterproliferation	O
Research	O
,	O
National	B-Organization
Defense	I-Organization
University	E-Organization
,	O
Bioterrorism	O
and	O
Biocrimes:	O
The	O
Illicit	O
Use	O
of	O
biological	O
Agents	O
Since	O
1900	O
,	O
(Google	O
Books	O
link)	O
,	O
The	O
Minerva	O
Group	O
,	O
Inc.	O
,	O
2002	O
,	O
p.	O
173	O
,	O
()	O
.	O

These	O
antibodies	O
have	O
demonstrated	O
unprecedented	O
therapeutic	O
efficacy	O
in	O
non-human	O
primate	O
models	O
of	O
infection	O
with	O
only	O
a	O
single	O
dose	O
.	O

After	O
decades	O
of	O
basic	O
research	O
into	O
decoding	O
the	O
chemical	O
and	O
genetic	O
makeup	O
of	O
cells	O
,	O
biologists	O
in	O
the	O
mid-20th	O
century	O
launched	O
what	O
would	O
become	O
a	O
multi-decade	O
flurry	O
of	O
research	O
and	O
breakthroughs	O
.	O

In	O
the	O
same	O
press	O
release	O
,	O
DOH	S-Organization
also	O
announced	O
that	O
they	O
were	O
tracking	O
all	O
other	O
414	O
passengers	O
of	O
Etihad	B-Organization
Airways	E-Organization
Flight	O
424	O
(the	O
flight	O
the	O
OFW	O
took	O
from	O
Abu	B-Location
Dhabi	E-Location
,	O
UAE	S-Location
to	O
)	O
in	O
order	O
that	O
they	O
should	O
be	O
tested	O
.	O

An	O
example	O
of	O
this	O
type	O
of	O
exam	O
is	O
CT	B-Technology
pulmonary	I-Technology
angiogram	E-Technology
(	O
CTPA	S-Technology
)	O
used	O
to	O
diagnose	O
pulmonary	B-Disease
embolism	E-Disease
(	O
PE	S-Disease
)	O
.	O

The	O
risk	O
for	O
transmission	O
of	O
from	O
animals	O
to	O
persons	O
is	O
currently	O
poorly	O
understood	O
.	O

The	O
discovery	O
of	O
penicillin	S-Drug
in	O
1928	O
and	O
other	O
antibiotics	O
in	O
the	O
20th	O
century	O
proved	O
to	O
be	O
a	O
significant	O
medical	O
achievement	O
,	O
saving	O
millions	O
of	O
lives	O
and	O
significantly	O
reducing	O
the	O
burden	O
of	O
infectious	O
diseases	O
.	O

PacBio	S-Organization
sequencing	O
of	O
isolate	O
24213-18	O
was	O
supported	O
by	O
the	O
as	O
part	O
of	O
routine	O
work	O
.	O

GAO	S-Organization
was	O
asked	O
to	O
examine	O
DHS	S-Organization
programs	O
and	O
activities	O
to	O
prevent	O
and	O
protect	O
against	O
domestic	O
chemical	O
attacks	O
and	O
look	O
at	O
how	O
it	O
has	O
coordinated	O
all	O
of	O
its	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

That	O
includes	O
mechanical	O
paitents	O
built	O
specific	O
to	O
trauma	O
injuries	O
,	O
which	O
can	O
bleed	O
–	O
and	O
bleed	O
out	O
–	O
and	O
offer	O
more	O
options	O
for	O
surgical	O
procedures	O
.	O

Kadlec	S-Person
said	O
that	O
while	O
building	O
up	O
domestic	O
manufacturing	O
capacity	O
may	O
be	O
a	O
one-time	O
expenditure	O
,	O
it	O
costs	O
money	O
to	O
maintain	O
and	O
sustain	O
that	O
capacity	O
.	O

Even	O
if	O
there	O
are	O
sharing	O
policies	O
installed	O
,	O
the	O
practices	O
to	O
control	O
data	O
availability	O
vary	O
as	O
the	O
US	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
reports	O
for	O
the	O
field	O
of	O
climate	O
research	O
.	O

Stefan	B-Person
Kroll	E-Person
,	O
Kersten	B-Person
Krüger	E-Person
(2004)	O
.	O

The	O
cylinders	O
are	O
of	O
variable	O
length	O
,	O
typically	O
800 nm	O
,	O
but	O
sometimes	O
up	O
to	O
1000 nm	O
long	O
.	O

NAMRU-2	S-Organization
requires	O
contractor	O
services	O
to	O
support	O
the	O
development	O
,	O
performance	O
and	O
management	O
of	O
research	O
and	O
clinical	O
activities	O
in	O
collaboration	O
with	O
,	O
biotech	O
and	O
host-country	O
partners	O
.	O

Lokela	S-Person
was	O
initially	O
diagnosed	O
with	O
malaria	S-Disease
at	O
the	O
Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
and	O
given	O
quinine	S-Drug
.	O
However	O
,	O
Lokela	S-Person
returned	O
to	O
the	O
mission	O
hospital	O
on	O
1	O
September	O
with	O
a	O
high	B-Phenotype
fever	E-Phenotype
.	O
Rest	O
was	O
recommended	O
,	O
and	O
he	O
returned	O
home	O
to	O
his	O
village	O
of	O
Yalikonde	S-Location
,	O
about	O
one kilometer	O
from	O
the	O
mission	O
complex	O
.	O

The	O
initial	O
problem	O
the	O
WHO	S-Organization
team	O
faced	O
was	O
inadequate	O
reporting	O
of	O
smallpox	S-Disease
	S-Disease
cases	O
.	O

The	O
CDC	S-Organization
recommends	O
that	O
people	O
wash	O
hands	O
often	O
with	O
soap	O
and	O
water	O
for	O
at	O
least	O
twenty	O
seconds	O
,	O
especially	O
after	O
going	O
to	O
the	O
toilet	O
or	O
when	O
hands	O
are	O
visibly	O
dirty	O
;	O
before	O
eating	O
;	O
and	O
after	O
blowing	O
one's	O
nose	O
,	O
coughing	O
,	O
or	O
sneezing	O
.	O

Other	O
delivery	O
systems	O
researched	O
and	O
at	O
least	O
partially	O
developed	O
during	O
the	O
1950s	O
included	O
the	O
E77	O
balloon	O
bomb	O
and	O
the	O
E86	O
cluster	O
bomb	O
.	O

I	O
don't	O
think	O
it	O
would	O
be	O
practical,	O
"	O
Redlener	S-Person
said	O
.	O

On	O
30	O
April	O
,	O
the	O
US	S-Location
shut	O
down	O
a	O
special	O
Ebola	S-Disease
treatment	O
unit	O
in	O
Liberia	S-Location
.	O
The	O
last	O
known	O
case	O
of	O
Ebola	S-Disease
died	O
on	O
27	O
March	O
,	O
and	O
the	O
country	O
was	O
officially	O
declared	O
Ebola	S-Disease
-free	O
on	O
9	O
May	O
2015	O
,	O
after	O
42 days	O
without	O
any	O
further	O
cases	O
being	O
recorded	O
.	O

Bleeding	O
from	O
the	O
ears	O
and	O
petechial	O
hemorrhages	S-Phenotype
in	O
the	O
skin	O
also	O
occurred"	O
.	O

In	O
this	O
post	O
,	O
I	O
have	O
analysed	O
from	O
a	O
general	O
and	O
superficial	O
perspective	O
the	O
uses	O
and	O
potential	O
of	O
CRISPR/Cas9	S-Technology
without	O
entering	O
the	O
particularities	O
of	O
each	O
of	O
the	O
uses	O
.	O

Hilary	B-Person
Koprowski	E-Person
,	O
a	O
doctor	O
allegedly	O
performing	O
research	O
on	O
AIDS	S-Disease
and	O
Ebola	S-Disease
by	O
deceiving	O
and	O
infecting	O
Africans	O
with	O
a	O
faux	O
.	O
It	O
was	O
estimated	O
that	O
over	O
a	O
million	O
Africans	O
were	O
infected	O
from	O
1954	O
to	O
1957	O
.	O

HR	O
397.	O
:	O
U.S	O
.	O

Individual	O
scientists	O
have	O
also	O
expressed	O
support	O
for	O
codes	O
of	O
conduct	O
,	O
most	O
notably	O
Margaret	B-Person
Somerville	E-Person
and	O
who	O
published	O
their	O
own	O
code	O
of	O
ethics	O
for	O
the	O
life	O
sciences	O
in	O
a	O
March	O
2005	O
issue	O
of	O
Science	O
.	O

Third	O
and	O
finally	O
,	O
I'd	O
like	O
to	O
discuss	O
some	O
breaking	O
news	O
with	O
the	O
vials	B-Incident
of	I-Incident
smallpox	I-Incident
found	I-Incident
on	I-Incident
the	I-Incident
campus	I-Incident
of	I-Incident
the	I-Incident
NIH	I-Incident
in	I-Incident
Maryland	E-Incident
NIH	S-Organization
moved	O
swiftly	O
to	O
make	O
sure	O
that	O
the	O
specimens	O
were	O
secure	O
and	O
expert	O
staff	O
at	O
CDC	S-Organization
along	O
with	O
federal	O
partners	O
quickly	O
secured	O
and	O
retrieved	O
the	O
specimens	O
and	O
transported	O
them	O
earlier	O
this	O
week	O
here	O
in	O
Atlanta	S-Location
.	O
There	O
was	O
no	O
risk	O
to	O
workers	O
or	O
to	O
the	O
public	O
,	O
but	O
this	O
event	O
also	O
should	O
never	O
have	O
happened	O
.	O

Secretary	O
of	O
the	O
Army	O
,	O
including	O
the	O
Chief	O
of	O
Staff	O
of	O
the	O
Army	O
and	O
the	O
Army	O
Acquisition	O
Executive	O
,	O
as	O
well	O
as	O
McDonnell	S-Person
office	O
and	O
the	O
U.S.	B-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	I-Organization
Office	E-Organization
of	O
the	O
(ASPR)	O
,	O
he	O
said	O
.	O

There	O
is	O
variation	O
in	O
the	O
sharing-culture	O
in	O
dedicated	O
scientific	O
disciplines	O
.	O

The	O
issue	O
isn't	O
about	O
individuals	O
doing	O
the	O
wrong	O
thing	O
.	O

The	O
WHO	S-Organization
broad	O
mandate	O
includes	O
advocating	O
for	O
universal	O
healthcare	O
,	O
monitoring	O
public	O
health	O
risks	O
,	O
coordinating	O
responses	O
to	O
health	O
emergencies	O
,	O
and	O
promoting	O
human	O
health	O
and	O
well	O
being	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
has	O
a	O
vested	O
interest	O
in	O
outmaneuvering	O
infectious	O
disease	O
.	O

However	O
,	O
this	O
assertion	O
has	O
been	O
subsequently	O
challenged	O
,	O
including	O
when	O
the	O
University	B-Organization
of	I-Organization
Birmingham	E-Organization
was	O
acquitted	O
following	O
a	O
prosecution	O
for	O
breach	O
of	O
Health	B-Document
and	I-Document
Safety	I-Document
legislation	E-Document
connected	O
with	O
Parker	S-Person
's	O
death	O
.	O

Detection	O
and	O
resilience	O
strategies	O
in	O
combating	O
bioterrorism	O
.	O

It	O
was	O
established	O
in	O
1960	O
and	O
most	O
of	O
their	O
resulting	O
JASON	O
reports	O
are	O
classified	O
.	O

Once	O
a	O
vessel	O
has	O
been	O
"	O
straightened"	O
in	O
this	O
way	O
,	O
quantitative	O
measurements	O
of	O
length	O
and	O
cross	O
sectional	O
area	O
can	O
be	O
made	O
,	O
so	O
that	O
surgery	O
or	O
interventional	O
treatment	O
can	O
be	O
planned	O
.	O

In	O
1984	O
,	O
followers	O
of	O
the	O
Indian	O
guru	O
Bagwan	B-Person
Shree	I-Person
Rajneesh	E-Person
living	O
on	O
a	O
compound	O
in	O
rural	O
Oregon	S-Location
,	O
sprinkled	O
on	O
salad	O
bars	O
throughout	O
their	O
county	O
.	O

"	O
The	O
state	O
wants	O
to	O
bring	O
innovation	O
technology	O
into	O
each	O
region	O
in	O
a	O
way	O
that	O
will	O
stimulate	O
more	O
outside	O
investment	O
from	O
the	O
federal	O
government	O
and	O
private	O
sources,	O
"	O
Amler	S-Person
said	O
.	O

These	O
agents	O
and	O
toxins	O
are	O
all	O
on	O
the	O
federal	O
select	O
agent	O
list	O
,	O
which	O
means	O
they	O
must	O
be	O
registered	O
and	O
handled	O
only	O
by	O
approved	O
labs	O
.	O

And	O
it	O
demonstrated	O
that	O
it	O
was	O
not	O
mere	O
misanthropic	O
ideation	O
.	O

The	O
Tokyo	B-Organization
War	I-Organization
Crimes	I-Organization
Tribunal	E-Organization
heard	O
only	O
one	O
reference	O
to	O
Japanese	O
experiments	O
with	O
"	O
poisonous	O
serums	O
"	O
on	O
Chinese	O
civilians	O
.	O

Detectives	O
and	O
agents	O
focused	O
on	O
the	O
possibility	O
that	O
the	O
individual	O
responsible	O
for	O
the	O
2003	O
letters	O
was	O
also	O
responsible	O
for	O
the	O
contamination	O
at	O
the	O
Dirksen	O
building	O
.	O

In	O
April	O
2019	O
,	O
passive	O
surveillance	O
by	O
the	O
Veterinary	B-Platform
Laboratory	I-Platform
Information	I-Platform
and	I-Platform
Response	I-Platform
Network	I-Platform
of	I-Platform
the	I-Platform
US	I-Platform
Food	I-Platform
and	I-Platform
Drug	I-Platform
Administration	E-Platform
identified	O
the	O
blaNDM-5	O
gene	O
in	O
a	O
isolated	O
from	O
a	O
dog	O
in	O
July	O
2018	O
.	O

MRI	S-Technology
has	O
the	O
advantages	O
of	O
having	O
very	O
high	O
spatial	O
resolution	O
and	O
is	O
very	O
adept	O
at	O
morphological	O
imaging	O
and	O
functional	O
imaging	O
.	O

Consequently	O
,	O
in	O
2010	O
,	O
a	O
group	O
of	O
researchers	O
recommended	O
that	O
the	O
name	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
be	O
adopted	O
for	O
a	O
subclassification	O
within	O
the	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
,	O
with	O
the	O
corresponding	O
abbreviation	O
EBOV	S-Pathogen
.	O
Previous	O
abbreviations	O
for	O
the	O
virus	O
were	O
EBOV-Z	S-Pathogen
(for	O
"	O
Ebola	B-Pathogen
virus	I-Pathogen
Zaire	E-Pathogen
"	O
)	O
and	O
ZEBOV	S-Pathogen
(for	O
"	O
Zaire	B-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
"	O
or	O
"	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
"	O
).	O
In	O
2011	O
,	O
the	O
ICTV	S-Organization
explicitly	O
rejected	O
a	O
proposal	O
(2010.010bV)	O
to	O
recognize	O
this	O
name	O
,	O
as	O
ICTV	S-Organization
does	O
not	O
designate	O
names	O
for	O
subtypes	O
,	O
variants	O
,	O
strains	O
,	O
or	O
other	O
subspecies	O
level	O
groupings	O
.	O

In	O
2005	O
Rob	B-Person
Carlson	E-Person
wrote	O
in	O
an	O
article	O
in	O
Wired:	O
"	O
The	O
era	O
of	O
garage	O
biology	O
is	O
upon	O
us	O
.	O

When	O
the	O
proper	O
protocol	O
is	O
followed	O
,	O
Ebola	S-Pathogen
is	O
considerably	O
less	O
contagious	O
than	O
common	O
viruses	O
,	O
such	O
as	O
measles	S-Pathogen
or	O
the	O
,	O
he	O
said	O
.	O

In	O
August	O
1349	O
,	O
the	O
Jewish	O
communities	O
in	O
Mainz	S-Location
and	O
Cologne	S-Location
were	O
annihilated	O
.	O

CDC	S-Organization
will	O
provide	O
a	O
report	O
on	O
the	O
event	O
when	O
the	O
investigation	O
concludes	O
.	O

Antibiotics	O
are	O
powerless	O
against	O
influenza	S-Disease
and	O
other	O
illnesses	O
caused	O
by	O
viruses	O
.	O

Broad,	B-Person
W.J	E-Person
.	O
and	O
Miller	B-Person
J	E-Person
.	O
(2002)	O
,	O
"	O
Traces	O
of	O
Terror:	O
The	O
Bioterror	O
Threat	O
;	O
Report	O
Provides	O
New	O
Details	O
of	O
"	O
,	O
The	O
New	O
York	O
Times	O
;	O
15	O
June	O
issue	O
.	O

Wikipedia	S-Platform
is	O
already	O
the	O
world's	O
'Dr	O
Google	S-Platform
'	O
-	O
it's	O
time	O
for	O
doctors	O
and	O
researchers	O
to	O
make	O
it	O
better	O
Huffington	B-Organization
Post	E-Organization
.	O
.Oct.18	O
,	O
2016	O
.	O

Emerging	O
diseases	O
,	O
along	O
with	O
a	O
host	O
of	O
infections	O
and	O
illnesses	O
,	O
pose	O
challenges	O
across	O
the	O
world	O
,	O
marking	O
the	O
importance	O
of	O
such	O
conferences	O
as	O
ICEID	S-Activity
and	O
the	O
communal	O
effort	O
to	O
eliminate	O
those	O
threats	O
.	O

In	O
a	O
statement	O
,	O
the	O
institute	O
said	O
most	O
of	O
the	O
infected	O
people	O
are	O
not	O
experiencing	O
signs	O
of	O
brucellosis	S-Pathogen
,	O
the	O
illness	O
caused	O
by	O
the	O
bacterium	O
,	O
which	O
can	O
include	O
and	O
flu-like	O
symptoms	O
.	O

It	O
has	O
not	O
undergone	O
the	O
clinical	O
studies	O
needed	O
to	O
show	O
it	O
is	O
safe	O
and	O
effective	O
for	O
the	O
disease	O
.	O

As	O
a	O
result	O
,	O
the	O
government	O
received	O
criticism	O
for	O
the	O
perceived	O
lack	O
of	O
pace	O
and	O
intensity	O
in	O
its	O
response	O
to	O
concerns	O
faced	O
by	O
the	O
public	O
.	O

Although	O
officially	O
the	O
research	O
and	O
development	O
of	O
ethnic	O
bio-weapons	O
have	O
never	O
been	O
publicly	O
confirmed	O
,	O
documents	O
show	O
that	O
the	O
US	S-Location
collects	O
biological	O
material	O
from	O
certain	O
ethnic	O
groups	O
–	O
Russians	O
and	O
Chinese	O
.	O

Guinean	B-Organization
Red	I-Organization
Cross	E-Organization
teams	O
said	O
they	O
had	O
suffered	O
an	O
average	O
of	O
10	O
attacks	O
a	O
month	O
over	O
the	O
previous	O
year	O
;	O
MSF	S-Organization
reported	O
that	O
acceptance	O
of	O
education	O
remained	O
low	O
and	O
that	O
further	O
violence	O
against	O
their	O
workers	O
might	O
force	O
them	O
to	O
leave	O
.	O

For	O
moderate	B-Phenotype
kidney	I-Phenotype
failure	E-Phenotype
,	O
the	O
use	O
of	O
iodinated	O
contrast	O
should	O
be	O
avoided	O
;	O
this	O
may	O
mean	O
using	O
an	O
alternative	O
technique	O
instead	O
of	O
CT	S-Technology
.	O
Those	O
with	O
severe	B-Phenotype
kidney	I-Phenotype
failure	E-Phenotype
requiring	O
dialysis	O
require	O
less	O
strict	O
precautions	O
,	O
as	O
their	O
kidneys	O
have	O
so	O
little	O
function	O
remaining	O
that	O
any	O
further	O
damage	O
would	O
not	O
be	O
noticeable	O
and	O
the	O
dialysis	O
will	O
remove	O
the	O
contrast	O
agent	O
;	O
it	O
is	O
normally	O
recommended	O
,	O
however	O
,	O
to	O
arrange	O
as	O
soon	O
as	O
possible	O
following	O
contrast	O
administration	O
to	O
minimize	O
any	O
adverse	O
effects	O
of	O
the	O
contrast	O
.	O

The	O
investigation	O
will	O
determine	O
what	O
happened	O
and	O
recommend	O
appropriate	O
action	O
for	O
that	O
.	O

In	O
December	O
2017	O
,	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
in	O
the	O
United	B-Location
States	E-Location
announced	O
in	O
a	O
drug	O
safety	O
communication	O
that	O
new	O
warnings	O
were	O
to	O
be	O
included	O
on	O
all	O
gadolinium-based	O
contrast	O
agents	O
(GBCAs)	O
.	O

Leishenshan	B-Organization
Hospital	E-Organization
was	O
later	O
built	O
to	O
handle	O
additional	O
patients	O
.	O

Carl	B-Person
Zimmer	E-Person
for	O
the	O
.	O

Bioterrorism	O
is	O
the	O
deliberate	O
release	O
of	O
viruses	O
,	O
bacteria	O
,	O
toxins	O
or	O
other	O
harmful	O
agents	O
to	O
cause	O
illness	O
or	O
death	O
in	O
people	O
,	O
animals	O
,	O
or	O
plants	O
.	O

This	O
experiment	O
is	O
performed	O
in	O
a	O
traditional	O
lab	O
space	O
under	O
conditions	O
.	O

Dr	O
.	O

Source:	O
DTRA	S-Organization
,	O
adapted	O
.	O

The	O
general	O
public	O
must	O
be	O
made	O
aware	O
of	O
the	O
facts	O
concerning	O
the	O
critical	O
roles	O
that	O
bacteria	O
play	O
in	O
their	O
lives	O
and	O
well-being	O
,	O
the	O
precious	O
nature	O
of	O
antibiotics	O
and	O
the	O
concomitant	O
importance	O
of	O
using	O
them	O
prudently	O
.	O

The	O
disease	O
is	O
caused	O
by	O
the	O
Francisella	B-Pathogen
tularensis	I-Pathogen
bacterium	E-Pathogen
,	O
and	O
can	O
be	O
contracted	O
through	O
contact	O
with	O
fur	O
,	O
inhalation	O
,	O
ingestion	O
of	O
contaminated	O
water	O
or	O
insect	O
bites	O
.	O

Ebola	B-Disease
virus	I-Disease
disease	E-Disease
has	O
a	O
high	O
case	O
fatality	O
rate	O
(CFR)	O
,	O
which	O
in	O
past	O
outbreaks	O
varied	O
between	O
25%	O
and	O
90%	O
,	O
with	O
an	O
average	O
of	O
about	O
50%	O
.	O

We	O
don't	O
have	O
too	O
many	O
tools	O
in	O
our	O
arsenal	O
,	O
which	O
is	O
why	O
it's	O
vital	O
that	O
we	O
mobilize	O
the	O
entire	O
international	O
community	O
.	O

CRISPR-Cas9	S-Technology
can	O
be	O
used	O
to	O
edit	O
the	O
DNA	O
of	O
organisms	O
in	O
vivo	O
and	O
to	O
eliminate	O
individual	O
genes	O
or	O
even	O
entire	O
chromosomes	O
from	O
an	O
organism	O
at	O
any	O
point	O
in	O
its	O
development	O
.	O

The	O
papal	O
doctor	O
recognised	O
that	O
bloodletting	O
was	O
ineffective	O
(though	O
he	O
continued	O
to	O
prescribe	O
bleeding	O
for	O
members	O
of	O
the	O
Roman	B-Organization
Curia	E-Organization
,	O
whom	O
he	O
disliked)	O
,	O
and	O
claimed	O
that	O
all	O
true	O
cases	O
of	O
the	O
were	O
caused	O
by	O
astrological	O
factors	O
and	O
were	O
incurable	O
;	O
he	O
himself	O
was	O
never	O
able	O
to	O
effect	O
a	O
cure	O
.	O

Following	O
the	O
terrorist	B-Incident
attacks	I-Incident
of	I-Incident
9.	I-Incident
11	E-Incident
and	O
the	O
anthrax	B-Incident
mail	I-Incident
event	I-Incident
in	I-Incident
2001	E-Incident
,	O
the	O
European	B-Organization
Commission	E-Organization
formed	O
a	O
task	O
force	O
on	O
bioterrorism	O
,	O
which	O
became	O
operational	O
in	O
May	O
2002	O
.	O

Plus:	O
new	O
efforts	O
to	O
come	O
up	O
with	O
a	O
code	O
of	O
conduct	O
for	O
biohackers	O
,	O
from	O
legislation	O
to	O
self-regulation	O
.	O

Brooks	S-Person
who	O
supported	O
the	O
president's	O
SNS	S-Platform
control	O
shift	O
change	O
,	O
made	O
it	O
a	O
point	O
during	O
the	O
hearing	O
to	O
clarify	O
for	O
her	O
subcommittee	O
colleagues	O
that	O
the	O
discussion	O
draft	O
simply	O
sets	O
out	O
the	O
guideposts	O
for	O
the	O
CDC	S-Organization
-to-	O
ASPR	S-Organization
change	O
,	O
and	O
she	O
said	O
she	O
thought	O
that	O
was	O
an	O
important	O
aspect	O
for	O
the	O
bill	O
to	O
contain	O
.	O

The	O
BBC	S-Organization
programme	O
meets	O
the	O
people	O
who	O
are	O
inserting	O
technology	O
under	O
their	O
skin	O
,	O
adopting	O
extreme	O
diets	O
and	O
trying	O
to	O
change	O
their	O
DNA	O
.	O

The	O
second	O
recurrence	O
peaked	O
in	O
late	O
spring	O
1891	O
(more	O
than	O
a	O
year	O
after	O
the	O
first	O
pandemic	O
appearance)	O
and	O
the	O
third	O
in	O
early	O
1892	O
.	O

It	O
then	O
sends	O
the	O
killed	O
bacteria	O
to	O
a	O
lower-level	O
BSL-2	B-Organization
CDC	I-Organization
lab	E-Organization
for	O
genetic	O
analysis	O
,	O
rapidly	O
telling	O
clinicians	O
whether	O
their	O
patients	O
carry	O
multi-drug-resistant	O
(MDR)	O
strains	O
of	O
and	O
which	O
drugs	O
will	O
be	O
most	O
effective	O
.	O

Biotechnology	O
is	O
behind	O
blockbuster	O
drugs	O
for	O
treating	O
cancer	S-Disease
and	O
heart	B-Disease
disease	E-Disease
,	O
and	O
it's	O
being	O
deployed	O
in	O
cutting-edge	O
research	O
to	O
cure	O
Alzheimer's	S-Disease
and	O
reverse	O
aging	O
.	O

The	O
areas	O
of	O
responsibility	O
are	O
being	O
mapped	O
out	O
between	O
the	O
different	O
regulatory	O
agencies	O
(	O
Sparrow	S-Person
,	O
P.A.C.	S-Person
,	O
Irwin	S-Person
,	O
J.	S-Person
,	O
Dale	S-Person
,	O
P.	S-Person
,	O
Twyman	S-Person
,	O
R.M.	S-Person
,	O
and	O
Ma	S-Person
,	O
J.K.C.	S-Person
(2007)	O
.	O

The	O
4th	B-Activity
Annual	I-Activity
Biodefense	I-Activity
World	I-Activity
Summit	E-Activity
will	O
be	O
held	O
June	O
27-29	O
,	O
2018	O
in	O
Bethesda	S-Location
,	O
.	O

On	O
12	O
June	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
the	O
5-year-old	O
patient	O
had	O
died	O
,	O
while	O
2	O
more	O
cases	O
of	O
Ebola	S-Pathogen
infection	O
within	O
the	O
same	O
family	O
were	O
also	O
confirmed	O
.	O

Standard	O
data	O
formats	O
and	O
annotations	O
are	O
required	O
to	O
make	O
data	O
comparable	O
.	O

Because	O
of	O
the	O
relatively	O
higher	O
risk	O
of	O
working	O
with	O
animal	O
viruses	O
,	O
it	O
is	O
important	O
that	O
students	O
learn	O
the	O
subject	O
formally	O
in	O
their	O
undergraduate	O
studies	O
,	O
rather	O
than	O
on	O
the	O
job	O
when	O
they	O
encounter	O
the	O
need	O
to	O
work	O
with	O
viruses	O
.	O

In	O
2004	O
,	O
one	O
of	O
the	O
last	O
known	O
deaths	O
caused	O
by	O
the	O
SARS	S-Disease
(	O
severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
)‐associated	O
coronavirus	S-Pathogen
was	O
that	O
of	O
the	O
mother	O
of	O
a	O
researcher	O
who	O
had	O
acquired	O
SARS	S-Disease
in	O
a	O
laboratory	O
and	O
transmitted	O
it	O
to	O
her	O
(Normille	O
,	O
2004)	O
.	O

Hearing	O
before	O
the	O
Subcommittee	O
on	O
Emergency	O
Preparedness	O
,	O
Response	O
and	O
Communications	O
of	O
the	O
Committee	O
on	O
Homeland	O
Security	O
,	O
House	B-Organization
of	I-Organization
Representatives	E-Organization
,	O
One	O
Hundred	O
Twelfth	O
Congress	O
,	O
First	O
Session	O
,	O
April	O
13	O
,	O
2011	O
and	O
May	O
12	O
,	O
2011.	O
112	O
Cong.	O
,	O
1st	O
sess	O
.	O

Although	O
VIGIV	S-Drug
has	O
been	O
sold	O
to	O
foreign	O
governments	O
,	O
to	O
date	O
,	O
the	O
principal	O
customer	O
for	O
VIGIV	S-Drug
has	O
been	O
the	O
U.S.	B-Organization
government	E-Organization
,	O
specifically	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
.	O
"	O
We	O
anticipate	O
negotiating	O
a	O
follow-on	O
contract	O
for	O
the	O
continued	O
supply	O
of	O
VIGIV	S-Drug
"	O
into	O
the	O
U.S.	B-Platform
Strategic	I-Platform
National	I-Platform
Stockpile	E-Platform
,	O
company	O
executives	O
wrote	O
in	O
.	O

He	O
also	O
stated	O
that	O
the	O
blatant	O
mishandling	O
of	O
the	O
Ebola	B-Incident
virus	I-Incident
outbreak	E-Incident
in	O
2014	O
attested	O
to	O
the	O
government's	O
lack	O
of	O
preparation	O
.	O

The	O
filovirus	O
genome	O
contains	O
seven	O
genes	O
,	O
including	O
VP40	O
.	O

By	O
1971	O
,	O
it	O
notes	O
,	O
the	O
Soviet	B-Organization
Union	E-Organization
had	O
reported	O
no	O
outbreaks	O
of	O
the	O
disease	O
for	O
a	O
decade	O
.	O

Humphries	S-Person
,	O
of	O
the	O
Memorial	B-Organization
University	I-Organization
of	I-Organization
Newfoundland	E-Organization
in	O
St.	B-Location
John's	E-Location
,	O
based	O
his	O
conclusions	O
on	O
newly	O
unearthed	O
records	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Well	O
,	O
in	O
terms	O
of	O
the	O
individual	O
human	O
resources	O
and	O
personnel	O
actions	O
,	O
it	O
will	O
depend	O
on	O
the	O
investigation	O
.	O

"	O
But	O
despite	O
this	O
progress	O
,	O
we're	O
not	O
fully	O
prepared,	O
"	O
he	O
said	O
,	O
adding	O
that	O
gaps	O
have	O
left	O
the	O
United	B-Location
States	E-Location
vulnerable	O
to	O
terrorists	O
and	O
natural	O
threats	O
.	O

Another	O
theory	O
holds	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
mutated	O
extremely	O
rapidly	O
to	O
a	O
less	O
lethal	O
strain	O
.	O

The	O
schools	O
and	O
day	O
care	O
centers	O
were	O
told	O
to	O
close	O
for	O
14	O
days	O
as	O
investigators	O
tried	O
to	O
identify	O
the	O
source	O
of	O
the	O
infection	O
,	O
said	O
Tsang	S-Person
the	O
chief	O
executive	O
.	O

Previous	O
work	O
on	O
SARS-CoV	S-Pathogen
is	O
being	O
used	O
because	O
both	O
SARS-CoV	S-Pathogen
and	O
SARS-CoV-2	S-Pathogen
use	O
the	O
ACE2	O
receptor	O
to	O
enter	O
human	O
cells	O
.	O

Despite	O
the	O
jump	O
in	O
reported	O
cases	O
,	O
the	O
number	O
of	O
new	O
cases	O
was	O
on	O
the	O
decline	O
according	O
to	O
Tariq	B-Person
Madany	E-Person
,	O
head	O
of	O
the	O
medical	O
advisory	O
council	O
.	O

Their	O
new	O
technologies	O
could	O
preserve	O
the	O
men	O
on	O
the	O
front	O
and	O
ultimately	O
save	O
the	O
world	O
.	O

In	O
February	O
2008	O
,	O
the	O
Government	B-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
released	O
report	B-Document
GAO-08-366	E-Document
titled	O
,	O
"	O
Chemical	B-Document
and	I-Document
Biological	I-Document
Defense,	I-Document
DOD	I-Document
and	I-Document
VA	I-Document
Need	I-Document
to	I-Document
Improve	I-Document
Efforts	I-Document
to	I-Document
Identify	I-Document
and	I-Document
Notify	I-Document
Individuals	I-Document
Potentially	I-Document
Exposed	I-Document
during	I-Document
Chemical	I-Document
and	I-Document
Biological	I-Document
Tests.	E-Document
"	O
The	O
report	O
stated	O
that	O
tens	O
of	O
thousands	O
of	O
military	O
personnel	O
and	O
civilians	O
may	O
have	O
been	O
exposed	O
to	O
biological	O
and	O
chemical	O
substances	O
through	O
DOD	S-Organization
tests	O
.	O

Concrete	O
Revolutio	O
.	O

Analysis	O
suggested	O
that	O
an	O
outside	O
hand	O
played	O
a	O
role	O
in	O
the	O
dense	O
infestation	O
.	O

The	O
control	O
shift	O
was	O
first	O
announced	O
in	O
the	O
February	O
release	O
of	O
President	O
Donald	B-Person
Trump	E-Person
Fiscal	O
Year	O
2019	O
budget	O
proposal	O
,	O
which	O
underscores	O
the	O
move	O
as	O
an	O
enhancement	O
of	O
emergency	O
preparedness	O
and	O
health	O
security	O
that	O
consolidates	O
the	O
necessary	O
strategic	O
decision-making	O
around	O
the	O
development	O
and	O
procurement	O
of	O
medical	O
countermeasures	O
.	O

Biosensors	O
can	O
be	O
used	O
for	O
detecting	O
biological	O
and	O
chemical	O
warfare	O
agents	O
,	O
including	O
nerve	O
gases	O
and	O
.	O

At	O
the	O
same	O
time	O
,	O
numerous	O
trends	O
including	O
increased	O
interactions	O
between	O
human	O
,	O
animal	O
,	O
and	O
insect	O
populations	O
due	O
to	O
globalization	O
,	O
densification	O
of	O
livestock	O
production	O
,	O
and	O
rising	O
human	O
encroachment	O
into	O
animal	O
habitats	O
have	O
increased	O
the	O
threat	O
of	O
novel	O
pathogens	O
in	O
regions	O
where	O
troops	O
,	O
humanitarian	O
workers	O
,	O
and	O
peacekeepers	O
tend	O
to	O
deploy	O
.	O

Additionally	O
,	O
there	O
were	O
two	O
phase	O
III	O
studies	O
being	O
conducted	O
with	O
two	O
different	O
vaccines.	O
.	O

Philosophy	O
of	O
a	O
Knife	O
(2008)	O
,	O
Russia	S-Location
directed	O
by	O
.	O

In	O
2016	O
,	O
the	O
first	O
conference	O
to	O
focus	O
specifically	O
on	O
biohacking	O
was	O
announced	O
to	O
take	O
place	O
in	O
September	O
in	O
Oakland	S-Location
.	O

Bacteriophages	O
can	O
even	O
possess	O
the	O
ability	O
to	O
digest	O
the	O
biofilm	O
that	O
many	O
bacteria	O
develop	O
that	O
protect	O
them	O
from	O
antibiotics	O
in	O
order	O
to	O
effectively	O
infect	O
and	O
kill	O
bacteria	O
.	O

One	O
study	O
in	O
China	S-Location
found	O
5%	O
were	O
admitted	O
to	O
intensive	O
care	O
units	O
,	O
2.	O
3%	O
needed	O
mechanical	O
support	O
of	O
ventilation	O
,	O
and	O
1.4%	O
died	O
.	O

Beginning	O
in	O
1972	O
,	O
the	O
Soviet	B-Organization
Union	E-Organization
United	B-Location
States	E-Location
and	O
more	O
than	O
100	O
other	O
countries	O
signed	O
the	O
BWC	S-Document
.	O
The	O
United	B-Location
States	E-Location
ratified	O
the	O
Geneva	B-Document
Protocol	E-Document
in	O
1975.	O
"	O
Protocol	B-Document
for	I-Document
the	I-Document
Prohibition	I-Document
of	I-Document
the	I-Document
Use	I-Document
in	I-Document
War	I-Document
of	I-Document
Asphyxiating,	I-Document
Poisonous	I-Document
or	I-Document
Other	I-Document
Gases,	I-Document
and	I-Document
of	I-Document
Bacteriological	I-Document
Methods	I-Document
of	I-Document
Warfare	E-Document
"	O
,	O
via	O
,	O
April	O
29	O
,	O
1975	O
.	O

Liu	S-Person
is	O
believed	O
to	O
have	O
been	O
a	O
SARS	O
super-spreader:	O
23	O
other	O
Metropole	O
guests	O
developed	O
SARS	S-Disease
,	O
including	O
seven	O
from	O
the	O
ninth	O
floor	O
.	O

Since	O
there	O
are	O
few	O
suitable	O
testing	O
centres	O
in	O
Western	B-Location
Africa	E-Location
,	O
this	O
delays	O
diagnosis.	O
a	O
number	O
of	O
rapid	O
diagnostic	O
tests	O
were	O
under	O
trial	O
.	O

The	O
WHO	S-Organization
defines	O
group	O
3	O
as	O
the	O
causes	O
of	O
individual	O
infections	O
that	O
are	O
not	O
generally	O
spread	O
,	O
while	O
the	O
EU	S-Location
and	O
China	S-Location
define	O
group	O
3	O
as	O
agents	O
that	O
can	O
be	O
spread	O
throughout	O
the	O
population	O
.	O

Attackers	O
hurled	O
dead	O
horses	O
and	O
other	O
animals	O
by	O
catapult	O
at	O
the	O
castle	B-Location
of	I-Location
Thun	I-Location
L'Eveque	E-Location
in	O
Hainault	S-Location
,	O
in	O
what	O
is	O
now	O
.	O
The	O
defenders	O
reported	O
that	O
"	O
the	O
stink	O
and	O
the	O
air	O
were	O
so	O
abominable...they	O
could	O
not	O
long	O
endure	O
"	O
and	O
negotiated	O
a	O
truce	O
.	O

In	O
contrast	O
with	O
state-of-the-art	O
medical	O
countermeasures	O
,	O
which	O
typically	O
take	O
many	O
months	O
or	O
even	O
years	O
to	O
develop	O
,	O
produce	O
,	O
distribute	O
,	O
and	O
administer	O
,	O
the	O
envisioned	O
P3	B-Platform
platform	E-Platform
would	O
cut	O
response	O
time	O
to	O
weeks	O
and	O
stay	O
within	O
the	O
window	O
of	O
relevance	O
for	O
containing	O
an	O
outbreak	O
.	O

Another	O
study	O
,	O
which	O
was	O
released	O
in	O
August	O
2015	O
looked	O
at	O
the	O
health	O
difficulties	O
reported	O
by	O
survivors	O
.	O

A	O
2018	O
study	O
of	O
tissue	O
slides	O
and	O
medical	O
reports	O
led	O
by	O
evolutionary	O
biology	O
professor	O
Michael	B-Person
Worobey	E-Person
found	O
evidence	O
against	O
the	O
disease	O
being	O
spread	O
by	O
Chinese	O
workers	O
,	O
noting	O
that	O
workers	O
entered	O
through	O
other	O
routes	O
that	O
did	O
not	O
result	O
in	O
detectable	O
spread	O
,	O
making	O
them	O
unlikely	O
to	O
have	O
been	O
the	O
original	O
hosts	O
.	O

This	O
and	O
other	O
support	O
of	O
for	O
such	O
practices	O
has	O
been	O
criticized	O
by	O
the	O
science-based	O
medicine	O
community	O
as	O
it	O
has	O
generally	O
criticized	O
the	O
use	O
of	O
alternative	O
medicine	O
.	O

Specific	O
antiviral	O
drugs	O
are	O
used	O
to	O
treat	O
some	O
viral	O
infections	O
.	O

Henry	B-Person
Walke	E-Person
chief	O
of	O
the	O
.	O

Waste	O
from	O
the	O
BSL-2	S-Platform
lab	O
was	O
sterilised	O
directly	O
in	O
the	O
in	O
the	O
decontamination	O
room	O
.	O

Dr	O
.	O

Jill	B-Person
Taylor	E-Person
PhD	O
,	O
is	O
Director	O
of	O
the	O
Wadsworth	B-Organization
Center	E-Organization
,	O
the	O
state	O
of	O
New	B-Organization
York's	I-Organization
public	I-Organization
health	I-Organization
reference	I-Organization
laboratory	E-Organization
and	O
a	O
premier	O
institution	O
for	O
basic	O
and	O
directed	O
research	O
.	O

The	O
challenge	O
of	O
transporting	O
and	O
delivering	O
samples	O
containing	O
class	O
3	O
microorganisms	O
is	O
well	O
described	O
by	O
Mèrens	S-Person
et	O
al	O
.	O

In	O
another	O
study	O
,	O
small	O
molecules	O
were	O
shown	O
to	O
inhibit	O
infection	O
by	O
preventing	O
viral	O
envelope	O
glycoprotein	O
(GP)	O
from	O
binding	O
to	O
NPC1	O
.	O

Health	O
workers	O
change	O
garments	O
frequently	O
,	O
discarding	O
gear	O
that	O
has	O
barely	O
been	O
used	O
.	O

As	O
of	O
12	O
May	O
2013	O
,	O
two	O
more	O
deaths	O
had	O
been	O
reported	O
in	O
the	O
al-Ahsa	O
region	O
of	O
Saudi	B-Location
Arabia	E-Location
.	O
In	O
the	O
latest	O
cluster	O
of	O
infections	O
,	O
15	O
cases	O
had	O
been	O
confirmed	O
,	O
and	O
nine	O
of	O
those	O
patients	O
had	O
died	O
.	O

Remdesivir	S-Drug
requires	O
"	O
70	O
raw	O
materials	O
,	O
reagents	O
,	O
and	O
catalysts	O
"	O
to	O
make	O
,	O
and	O
approximately	O
"	O
25	O
chemical	O
steps.	O
"	O
Some	O
of	O
the	O
ingredients	O
are	O
extremely	O
dangerous	O
to	O
humans	O
,	O
especially	O
trimethylsilyl	O
cyanide	O
.	O

The	O
last	O
known	O
incident	O
of	O
using	O
plague	O
corpses	O
for	O
biological	O
warfare	O
occurred	O
in	O
1710	O
,	O
when	O
Russian	B-Organization
forces	E-Organization
attacked	O
the	O
Swedes	O
by	O
flinging	O
plague-infected	O
corpses	O
over	O
the	O
city	O
walls	O
of	O
Reval	S-Location
(	O
Tallinn	S-Location
)	O
.	O

Given	O
the	O
differences	O
across	O
the	O
region	O
,	O
local	O
solutions	O
are	O
important	O
.	O

For	O
instance	O
,	O
Spain	S-Organization
withdrew	O
58,000	O
Chinese-made	O
coronavirus	B-Equipment
testing	I-Equipment
kits	E-Equipment
with	O
an	O
accuracy	O
rate	O
of	O
30	O
percent	O
,	O
while	O
the	O
Netherlands	S-Organization
recalled	O
600,000	O
Chinese	O
face	O
masks	O
which	O
were	O
said	O
to	O
be	O
defective	O
,	O
yet	O
this	O
could	O
have	O
been	O
due	O
to	O
product	O
misuse	O
.	O

That	O
requires	O
a	O
second	O
protein	O
,	O
attached	O
to	O
Cas9	S-Technology
a	O
reverse	O
transcriptase	O
enzyme	O
,	O
which	O
can	O
make	O
a	O
new	O
DNA	O
strand	O
from	O
the	O
RNA	O
template	O
and	O
insert	O
it	O
at	O
the	O
nicked	O
site.New	O
"	O
Prime	O
Editing	O
"	O
Method	O
Makes	O
Only	O
Single-Stranded	O
DNA	O
Cuts.	O
,	O
The	O
Scientist.	O
21	O
October	O
2019	O
.	O

On	O
30	O
January	O
2015	O
,	O
the	O
IMF	S-Organization
reported	O
it	O
was	O
close	O
to	O
reaching	O
a	O
deal	O
on	O
debt	O
forgiveness	O
.	O

Local	O
transmission	O
of	O
the	O
disease	O
has	O
occurred	O
in	O
most	O
countries	O
across	O
all	O
six	O
WHO	S-Organization
regions	O
.	O

Bacteriophages	O
can	O
even	O
possess	O
the	O
ability	O
to	O
digest	O
the	O
biofilm	O
that	O
many	O
bacteria	O
develop	O
that	O
protect	O
them	O
from	O
antibiotics	O
in	O
order	O
to	O
effectively	O
infect	O
and	O
kill	O
bacteria	O
.	O

Historically	O
,	O
the	O
information	O
in	O
this	O
publication	O
has	O
been	O
advisory	O
is	O
nature	O
even	O
though	O
legislation	O
and	O
regulation	O
,	O
in	O
some	O
circumstances	O
,	O
have	O
overtaken	O
it	O
and	O
made	O
compliance	O
with	O
the	O
guidance	O
provided	O
mandatory	O
.	O

As	O
a	O
side-effect	O
,	O
data	O
can	O
be	O
easily	O
exported	O
to	O
the	O
ISA-Tab	O
format	O
.	O

This	O
special	O
technique	O
is	O
called	O
that	O
produces	O
a	O
sampling	O
of	O
the	O
lung	O
,	O
and	O
not	O
continuous	O
images	O
.	O

Jacobs	S-Person
,	O
.	O

Our	O
labs	O
,	O
our	O
lab	O
scientists	O
are	O
a	O
national	O
treasure	O
.	O

As	O
of	O
18	O
June	O
2019	O
,	O
275	O
contacts	O
have	O
been	O
vaccinated	O
per	O
the	O
.	O

The	O
first	O
confirmed	O
case	O
of	O
COVID-19	S-Disease
has	O
been	O
traced	O
back	O
to	O
1December	O
2019	O
in	O
Wuhan	S-Location
;	O
one	O
unconfirmed	O
report	O
suggests	O
the	O
earliest	O
case	O
was	O
on	O
17	O
November	O
.	O

As	O
companies	O
ramp	O
up	O
financing	O
,	O
doubts	O
as	O
to	O
whether	O
CRISPR	S-Technology
can	O
be	O
quickly	O
monetized	O
were	O
raised	O
.	O

The	O
key	O
questions	O
for	O
researchers	O
to	O
address	O
are	O
therefore:	O
These	O
questions	O
are	O
priorities	O
for	O
the	O
prevention	O
of	O
antibiotic	O
resistance	O
development	O
worldwide	O
;	O
in	O
order	O
to	O
support	O
the	O
research	O
necessary	O
to	O
track	O
new	O
threats	O
on	O
a	O
global	O
scale	O
,	O
international	O
funding	O
is	O
indispensable	O
.	O

ISA	O
software	O
suite	O
provides	O
the	O
framework	O
for	O
ISA-Tab	O
also	O
used	O
by	O
XperimentR	S-Platform
and	O
directly	O
connected	O
to	O
EBI	O
Array-Express	O
upload	O
.	O

Good	O
preparedness	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
PPE	S-Equipment
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
laboratory	O
sectioning	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

As	O
another	O
caller	O
said	O
,	O
this	O
is	O
the	O
envy	O
of	O
the	O
world	O
.	O

While	O
it	O
is	O
not	O
known	O
precisely	O
where	O
or	O
when	O
the	O
virus	O
originated	O
,	O
analyses	O
in	O
scientific	O
journals	O
have	O
suggested	O
that	O
the	O
H1N1	S-Pathogen
strain	O
responsible	O
for	O
the	O
first	O
evolved	O
in	O
September	O
2008	O
and	O
circulated	O
amongst	O
humans	O
for	O
several	O
months	O
,	O
before	O
being	O
formally	O
recognised	O
and	O
identified	O
as	O
a	O
novel	O
strain	O
of	O
influenza	O
.	O

On	O
11	O
August	O
2018	O
,	O
it	O
was	O
reported	O
that	O
seven	O
individuals	O
were	O
killed	O
in	O
Mayi-Moya	S-Location
due	O
to	O
a	O
military	O
group	O
,	O
about	O
24	O
miles	O
from	O
the	O
city	O
of	O
Beni	S-Location
where	O
there	O
were	O
several	O
cases	O
.	O

Whereas	O
methods	O
such	O
as	O
RNA	O
interference	O
(RNAi)	O
do	O
not	O
fully	O
suppress	O
gene	O
function	O
,	O
CRISPR	S-Technology
ZFNs	S-Technology
,	O
and	O
TALENs	S-Technology
provide	O
full	O
irreversible	O
gene	B-Technology
knockout	E-Technology
.	O
CRISPR	S-Technology
can	O
also	O
target	O
several	O
DNA	O
sites	O
simultaneously	O
simply	O
by	O
introducing	O
different	O
gRNAs	O
.	O

Thus	O
far	O
,	O
12	O
medical	O
countermeasures	O
have	O
been	O
approved	O
under	O
this	O
rule	O
,	O
including	O
inhalational	O
anthrax	S-Disease
therapeutics	O
and	O
a	O
,	O
he	O
said	O
.	O

The	O
CDC	S-Organization
is	O
organized	O
into	O
"	O
Centers,	B-Organization
Institutes,	I-Organization
and	I-Organization
Offices	E-Organization
"	O
(	O
CIOs	S-Organization
)	O
,	O
with	O
each	O
organizational	O
unit	O
implementing	O
the	O
agency's	O
activities	O
in	O
a	O
particular	O
area	O
of	O
expertise	O
while	O
also	O
providing	O
intra-agency	O
support	O
and	O
resource-sharing	O
for	O
cross-cutting	O
issues	O
and	O
specific	O
health	O
threats	O
.	O

In	O
,	O
nearly	O
12,000	O
perished	O
.	O

This	O
shows	O
how	O
serious	O
the	O
misuse	O
of	O
antimicrobials	O
specifically	O
antibiotics	O
in	O
livestock	O
is	O
,	O
and	O
why	O
it	O
can	O
in	O
many	O
ways	O
lead	O
to	O
antimicrobial	O
resistance	O
.	O

Once	O
the	O
blog	O
article	O
became	O
popular	O
,	O
the	O
CDC	S-Organization
announced	O
an	O
open	O
contest	O
for	O
YouTube	O
submissions	O
of	O
the	O
most	O
creative	O
and	O
effective	O
videos	O
covering	O
preparedness	O
for	O
a	O
zombie	O
apocalypse	O
(or	O
apocalypse	O
of	O
any	O
kind)	O
,	O
to	O
be	O
judged	O
by	O
the	O
"	O
".	O
Submissions	O
were	O
open	O
until	O
October	O
11	O
,	O
2011	O
.	O

The	O
UN	S-Organization
High	O
Commissioner	O
for	O
Human	O
Rights	O
has	O
demanded	O
economic	O
sanctions	O
to	O
be	O
eased	O
for	O
nations	O
most	O
affected	O
by	O
the	O
pandemic	O
,	O
including	O
Iran	S-Location
.	O
On	O
20	O
April	O
it	O
was	O
reported	O
that	O
Iran	S-Location
had	O
reopened	O
shopping	O
malls	O
and	O
other	O
shopping	O
areas	O
across	O
the	O
country	O
,	O
though	O
there	O
is	O
fear	O
of	O
a	O
second	O
wave	O
of	O
infection	O
due	O
to	O
this	O
move	O
.	O

The	O
possession	O
,	O
use	O
,	O
or	O
transfer	O
of	O
B.	B-Pathogen
anthracis	E-Pathogen
is	O
regulated	O
by	O
the	O
(DSAT)	O
,	O
located	O
in	O
.	O

For	O
instance	O
,	O
some	O
of	O
what	O
experts	O
learned	O
from	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	E-Incident
was	O
the	O
impact	O
of	O
such	O
outbreaks	O
on	O
the	O
health	O
care	O
workers	O
,	O
who	O
were	O
needed	O
to	O
care	O
for	O
the	O
sick	O
but	O
who	O
also	O
got	O
ill	O
;	O
many	O
also	O
died	O
.	O

Importantly	O
,	O
it	O
is	O
not	O
the	O
agent	O
of	O
contagious	B-Disease
caprine	I-Disease
pleuropneumonia	E-Disease
(	O
CCPP	S-Disease
)	O
.	O

Retrieved	O
September	O
2	O
,	O
2010	O
.	O

CRE	O
will	O
be	O
a	O
major	O
challenge	O
across	O
all	O
health	O
fields	O
as	O
these	O
organisms	O
become	O
more	O
prevalent	O
in	O
the	O
community	O
.	O

"	O
They're	O
going	O
to	O
have	O
to	O
open	O
up,	O
"	O
Mr	O
.	O

Although	O
the	O
Assyrians	O
knew	O
of	O
ergot	S-Pathogen
,	O
a	O
parasitic	O
fungus	O
of	O
rye	O
which	O
produces	O
when	O
ingested	O
,	O
there	O
is	O
no	O
evidence	O
that	O
they	O
poisoned	O
enemy	O
wells	O
with	O
the	O
fungus	O
,	O
as	O
has	O
been	O
claimed	O
.	O

Significant	O
increases	O
in	O
public	O
education	O
about	O
bacteria	O
and	O
antibiotic	O
resistance	O
are	O
vitally	O
important	O
.	O

Clinical	O
misuse	O
by	O
healthcare	O
professionals	O
is	O
another	O
cause	O
leading	O
to	O
increased	O
antimicrobial	O
resistance	O
.	O

Genetically	B-Technology
modified	E-Technology
(	O
GM	S-Technology
)	O
crops	O
are	O
increasingly	O
gaining	O
acceptance	O
but	O
concurrently	O
consumers'	O
concerns	O
are	O
also	O
increasing	O
.	O

This	O
type	O
of	O
cell	O
directed	O
approach	O
is	O
a	O
promising	O
horizon	O
to	O
reduce	O
the	O
exposition	O
to	O
long	O
treatments	O
with	O
high	O
toxic	O
not-specific	O
chemotherapy	O
drugs	O
.	O

Botulinum	B-Pathogen
Toxin	E-Pathogen
was	O
tested	O
as	O
a	O
bio-weapon	O
by	O
the	O
US	B-Organization
Army	E-Organization
in	O
the	O
past	O
,	O
as	O
well	O
as	O
Anthrax	S-Disease
,	O
Brucella	S-Pathogen
and	O
Tularemia	S-Disease
.	O
Although	O
the	O
US	B-Scientific_research_project
bio-weapons	I-Scientific_research_project
program	E-Scientific_research_project
was	O
officially	O
terminated	O
in	O
1969	O
documents	O
show	O
that	O
the	O
military	O
experiments	O
have	O
never	O
ended	O
.	O

That's	O
horrifying	O
,	O
but	O
it's	O
not	O
a	O
function	O
of	O
the	O
technology	O
itself	O
.	O

CDC	S-Organization
has	O
reported	O
the	O
incident	O
to	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
and	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
Animal	B-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Service	E-Organization
(	O
APHIS	S-Organization
)	O
.	O

"	O
But	O
by	O
same	O
token	O
it	O
will	O
be	O
important	O
and	O
challenging	O
to	O
make	O
sure	O
that	O
the	O
many	O
other	O
agencies	O
of	O
government	O
that	O
need	O
to	O
be	O
involved	O
in	O
preventing	O
and	O
preparing	O
for	O
biological	O
threats	O
stay	O
engaged	O
and	O
bring	O
their	O
full	O
capabilities	O
to	O
bear,	O
"	O
he	O
said	O
.	O

Neuromuscular	O
and	O
cardiac	O
complications	O
are	O
unusual	O
but	O
may	O
occur	O
.	O

All	O
work	O
in	O
the	O
affected	O
labs	O
was	O
suspended	O
for	O
decontamination	O
.	O

The	O
first	O
case	O
in	O
Nigeria	S-Location
was	O
a	O
Liberian-American	O
,	O
who	O
flew	O
from	O
Liberia	S-Location
to	O
Nigeria	S-Location
's	O
most	O
populated	O
city	O
of	O
on	O
20	O
July	O
2014	O
.	O

After	O
all	O
,	O
synthetic	O
cells	O
could	O
be	O
seen	O
as	O
a	O
new	O
form	O
of	O
engineered	O
life	O
.	O

Former	O
Senate	O
Majority	O
Leader	O
Tom	B-Person
Daschle	E-Person
and	O
member	O
of	O
the	O
panel	O
,	O
asked	O
the	O
experts	O
to	O
"	O
drill	O
down	O
on	O
the	O
whole	O
notion	O
of	O
a	O
public-private	O
partnership,	O
"	O
seeking	O
clarification	O
on	O
how	O
the	O
private	O
entities	O
they	O
represent	O
navigate	O
the	O
seemingly	O
endless	O
number	O
of	O
contacts	O
with	O
governments	O
and	O
companies	O
around	O
the	O
world	O
during	O
an	O
emergency	O
.	O

For	O
mammalian	O
applications	O
,	O
a	O
section	O
of	O
protein	O
is	O
added	O
.	O

Downloaded	O
Oct.22	O
,	O
2017	O
.	O

Still	O
,	O
there	O
are	O
concerns	O
that	O
rogue	O
scientists	O
or	O
bioterrorists	O
could	O
produce	O
weapons	O
with	O
rDNA	O
.	O

However	O
,	O
the	O
number	O
of	O
cases	O
jumped	O
to	O
more	O
than	O
100,000	O
in	O
the	O
year	O
of	O
the	O
Stalingrad	B-Incident
outbreak	E-Incident
.	O
German	O
Panzer	O
troops	O
fell	O
ill	O
in	O
such	O
significant	O
numbers	O
during	O
the	O
late	O
summer	O
of	O
1942	O
that	O
the	O
German	O
military	O
campaign	O
came	O
to	O
a	O
temporary	O
halt	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
primary	O
objective	O
in	O
natural	O
and	O
man-made	O
emergencies	O
is	O
to	O
coordinate	O
with	O
member	O
states	O
and	O
other	O
stakeholders	O
to	O
"	O
reduce	O
avoidable	O
loss	O
of	O
life	O
and	O
the	O
burden	O
of	O
disease	O
and	O
disability.	O
"	O

Proponents	O
make	O
all	O
sorts	O
of	O
claims	O
about	O
the	O
capacity	O
of	O
biochar	O
to	O
sequester	O
carbon	O
,	O
for	O
which	O
there	O
is	O
little	O
scientific	O
basis	O
,	O
and	O
they	O
fail	O
to	O
consider	O
the	O
impacts	O
of	O
dramatically	O
increasing	O
the	O
demand	O
for	O
plant	O
matter.	O
"	O

While	O
choosing	O
the	O
appropriate	O
virus	O
with	O
which	O
to	O
work	O
,	O
it	O
is	O
important	O
to	O
bear	O
in	O
mind	O
that	O
undergraduates	O
are	O
not	O
experienced	O
in	O
laboratory	O
work	O
.	O

2002:	O
The	O
Global	B-Organization
Fund	I-Organization
to	I-Organization
Fight	I-Organization
AIDS,	I-Organization
Tuberculosis	I-Organization
and	I-Organization
Malaria	E-Organization
was	O
drawn	O
up	O
to	O
improve	O
the	O
resources	O
available	O
.	O

The	O
report	O
was	O
written	O
with	O
the	O
aid	O
of	O
Kazakh	S-Location
officials	O
,	O
who	O
blame	O
Moscow	S-Organization
for	O
the	O
Aralsk	B-Incident
outbreak	E-Incident
.	O
The	O
document	O
,	O
a	O
draft	O
of	O
which	O
The	O
Times	O
obtained	O
,	O
is	O
to	O
be	O
made	O
public	O
late	O
this	O
month	O
or	O
early	O
in	O
July	O
.	O

Current	O
geese	O
include	O
a	O
data	O
matrix	O
viewer	O
,	O
Cytoscape	O
,	O
the	O
TIGR	O
microarray	O
experiment	O
viewer	O
,	O
a	O
R/Bioconductor	O
goose	O
,	O
a	O
simple	O
Bioinformatics	O
web	O
browser	O
and	O
Bioinformatics	B-Platform
Resource	I-Platform
Manager	E-Platform
(	O
BRM	S-Platform
)	O
which	O
adds	O
data	O
management	O
functionality	O
to	O
Gaggle	S-Platform
.	O
Gaggle	S-Platform
is	O
easily	O
extendible	O
to	O
new	O
applications	O
via	O
the	O
message	O
interface	O
based	O
on	O
the	O
four	O
data	O
types	O
.	O

To	O
propagate	O
the	O
virus	O
,	O
Vero	O
cells	O
were	O
infected	O
and	O
the	O
virus	O
was	O
harvested	O
from	O
the	O
cell	O
pellet	O
,	O
purified	O
on	O
a	O
10%	O
sucrose	O
cushion	O
(Sigma	O
Aldrich)	O
,	O
and	O
titrated	O
by	O
plaque	O
assay	O
on	O
Vero	O
cells	O
8	O
.	O

With	O
the	O
onset	O
of	O
hostilities	O
,	O
the	O
Ministry	B-Organization
of	I-Organization
Supply	E-Organization
finally	O
established	O
a	O
biological	O
weapons	O
programme	O
at	O
Porton	O
Down	O
,	O
headed	O
by	O
the	O
microbiologist	O
Paul	B-Person
Fildes	E-Person
.	O
The	O
research	O
was	O
championed	O
by	O
Winston	B-Person
Churchill	E-Person
and	O
soon	O
tularemia	S-Pathogen
,	O
anthrax	S-Pathogen
,	O
brucellosis	S-Pathogen
,	O
and	O
botulism	B-Pathogen
toxins	E-Pathogen
had	O
been	O
effectively	O
weaponized	O
.	O

Establishment	O
of	O
an	O
external	O
working	O
group	O
,	O
made	O
up	O
of	O
leading	O
scientists	O
,	O
which	O
will	O
be	O
part	O
of	O
the	O
Advisory	B-Organization
Committee	I-Organization
to	I-Organization
the	I-Organization
Director	I-Organization
of	I-Organization
CDC	E-Organization

Severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus2	E-Pathogen
(	O
SARS-CoV-2	S-Pathogen
)	O
is	O
a	O
novel	O
severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus	E-Pathogen
,	O
first	O
isolated	O
from	O
three	O
people	O
with	O
pneumonia	B-Disease
connected	I-Disease
to	I-Disease
the	I-Disease
cluster	I-Disease
of	I-Disease
acute	I-Disease
respiratory	I-Disease
illness	E-Disease
cases	O
in	O
Wuhan	S-Location
.	O
All	O
features	O
of	O
the	O
novel	O
SARS-CoV-2	S-Pathogen
virus	O
occur	O
in	O
related	O
in	O
nature	O
.	O

A	O
July	O
17	O
,	O
2014	O
report	O
drafted	O
by	O
the	O
Viral	B-Organization
Hemorrhagic	I-Organization
Fever	I-Organization
Consortium	E-Organization
accused	O
Metabiota	B-Organization
Inc.	E-Organization
of	O
failing	O
to	O
abide	O
by	O
an	O
existing	O
agreement	O
on	O
how	O
to	O
report	O
test	O
results	O
and	O
for	O
bypassing	O
the	O
Sierra	B-Person
Leonean	I-Person
scientists	E-Person
working	O
there	O
.	O

On	O
10	O
December	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
the	O
current	O
outbreak	O
had	O
affected	O
49	O
healthcare	O
workers	O
as	O
confirmed	O
cases	O
,	O
and	O
15	O
had	O
died	O
.	O

Guangzhou	S-Location
was	O
also	O
the	O
site	O
of	O
the	O
first	O
case	O
in	O
December	O
and	O
was	O
thought	O
to	O
be	O
the	O
origin	O
of	O
the	O
virus	O
in	O
the	O
original	O
outbreak	O
.	O

A	O
similar	O
outbreak	O
of	O
a	O
mysterious	O
respiratory	O
infection	O
was	O
reported	O
among	O
healthcare	O
workers	O
.	O

Here	O
are	O
nine	O
questions	O
that	O
can	O
help	O
you	O
make	O
sense	O
of	O
biohacking	O
.	O

In	O
the	O
1330s	O
,	O
many	O
natural	O
disasters	O
and	O
plagues	O
led	O
to	O
widespread	O
famine	O
,	O
starting	O
in	O
1331	O
,	O
with	O
a	O
deadly	O
plague	S-Disease
arriving	O
soon	O
after	O
.	O

For	O
example	O
,	O
disparity	O
is	O
noticeable	O
in	O
terms	O
of	O
number	O
of	O
initiatives	O
when	O
compared	O
with	O
the	O
per	O
capita	O
population	O
of	O
member	O
countries	O
.	O

Global	O
health	O
security	O
issues	O
will	O
continue	O
to	O
challenge	O
collaboration	O
between	O
sectors	O
,	O
laboratory	O
activities	O
,	O
and	O
technologies	O
in	O
the	O
coming	O
years	O
.	O

And	O
H.R.	B-Document
6378	E-Document
would	O
borrow	O
a	O
model	O
from	O
Brooks	S-Person
'	O
home	O
that	O
focuses	O
on	O
regional	O
hospital	O
preparedness	O
and	O
response	O
planning	O
,	O
if	O
enacted	O
,	O
and	O
would	O
focus	O
on	O
the	O
pre-	O
and	O
post-emergency	O
needs	O
of	O
special	O
populations	O
,	O
including	O
children	O
,	O
people	O
with	O
disabilities	O
and	O
senior	O
citizens	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We	O
have	O
undertaken	O
a	O
series	O
of	O
measures	O
over	O
the	O
past	O
few	O
years	O
to	O
strengthen	O
our	O
investigation	O
of	O
select	O
agent	O
laboratories	O
.	O

Livestock	O
in	O
the	O
same	O
area	O
also	O
died	O
of	O
anthrax	S-Pathogen
.	O
After	O
completing	O
their	O
investigation	O
,	O
the	O
team	O
concluded	O
the	O
outbreak	O
was	O
caused	O
by	O
a	O
release	O
of	O
an	O
aerosol	O
of	O
pathogen	O
at	O
the	O
military	O
facility	O
.	O

The	O
success	O
rate	O
(in	O
terms	O
of	O
number	O
of	O
research	O
proposals	O
funded	O
compared	O
to	O
the	O
total	O
number	O
of	O
research	O
proposals	O
submitted)	O
was	O
approximately	O
28%	O
.	O

The	O
contrast	O
agent	O
may	O
induce	O
contrast-induced	O
nephropathy	S-Disease
This	O
occurs	O
in	O
2	O
to	O
7%	O
of	O
people	O
who	O
receive	O
these	O
agents	O
,	O
with	O
greater	O
risk	O
in	O
those	O
who	O
have	O
preexisting	B-Phenotype
kidney	I-Phenotype
failure	E-Phenotype
,	O
preexisting	B-Phenotype
diabetes	E-Phenotype
,	O
or	O
reduced	B-Phenotype
intravascular	I-Phenotype
volume	E-Phenotype
.	O
People	O
with	O
mild	O
kidney	B-Phenotype
impairment	E-Phenotype
are	O
usually	O
advised	O
to	O
ensure	O
full	O
hydration	O
for	O
several	O
hours	O
before	O
and	O
after	O
the	O
injection	O
.	O

The	O
average	O
incubation	O
period	O
for	O
COVID‑19	S-Disease
is	O
five	O
to	O
six	O
days	O
but	O
commonly	O
ranges	O
from	O
one	O
to	O
14	O
days	O
,	O
with	O
approximately	O
10%	O
of	O
cases	O
exceeding	O
that	O
time	O
.	O

The	O
CIA	S-Organization
maintained	O
its	O
collection	O
of	O
biologicals	O
well	O
into	O
1975	O
when	O
it	O
became	O
the	O
subject	O
of	O
the	O
.	O

In	O
a	O
study	O
done	O
by	O
Tulane	B-Organization
University	E-Organization
the	O
Broad	B-Organization
Institute	E-Organization
and	O
Harvard	B-Organization
University	E-Organization
,	O
in	O
partnership	O
with	O
the	O
Sierra	B-Organization
Leone	I-Organization
Ministry	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Sanitation	E-Organization
,	O
researchers	O
provided	O
information	O
about	O
the	O
origin	O
and	O
transmission	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
that	O
set	O
the	O
Western	B-Incident
African	I-Incident
outbreak	E-Incident
apart	O
from	O
previous	O
ones	O
,	O
including	O
341	O
genetic	O
changes	O
in	O
the	O
virion	O
.	O

It	O
was	O
suspected	O
that	O
the	O
two	O
viruses	O
mixed	O
while	O
he	O
was	O
doing	O
his	O
research	O
.	O

You	O
talked	O
about	O
your	O
personal	O
reaction	O
earlier	O
.	O

The	O
shipment	O
and	O
receipt	O
of	O
diagnostic	O
specimens	O
(which	O
includes	O
most	O
nonpathogenic	O
research	O
materials)	O
and	O
infectious	O
substances	O
(most	O
cultures	O
of	O
pathogens)	O
is	O
regulated	O
internationally	O
by	O
the	O
International	B-Organization
Air	I-Organization
Transport	I-Organization
Association	E-Organization
(	O
IATA	S-Organization
)	O
.	O

The	O
center	O
does	O
some	O
of	O
its	O
work	O
at	O
a	O
major	O
biosafety	B-Platform
level-3	E-Platform
lab	O
on	O
the	O
campus	O
of	O
Argonne	B-Organization
National	I-Organization
Laboratory	E-Organization
,	O
one	O
of	O
a	O
dozen	O
such	O
regional	O
biocontainment	O
labs	O
built	O
partly	O
with	O
NIAID	S-Organization
funding	O
after	O
the	O
2001	O
attacks	O
.	O

DARPA	S-Organization
favors	O
proposals	O
that	O
employ	O
natural	O
organisms	O
,	O
but	O
proposers	O
are	O
able	O
to	O
suggest	O
modifications	O
.	O

The	O
virus	O
was	O
first	O
reported	O
in	O
two	O
U.S.	O
children	O
in	O
March	O
2009	O
,	O
but	O
health	O
officials	O
have	O
reported	O
that	O
it	O
apparently	O
infected	O
people	O
as	O
early	O
as	O
January	O
2009	O
in	O
Mexico	S-Location
The	O
outbreak	O
was	O
first	O
identified	O
in	O
Mexico	B-Location
City	E-Location
on	O
18	O
March	O
2009	O
;	O
immediately	O
after	O
the	O
outbreak	O
was	O
officially	O
announced	O
,	O
Mexico	S-Organization
notified	O
the	O
U.S.	S-Location
and	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
,	O
and	O
within	O
days	O
of	O
the	O
outbreak	O
Mexico	B-Location
City	E-Location
was	O
"	O
effectively	O
shut	O
down"	O
.	O

In	O
Sweden	S-Location
the	O
national	O
agencies	O
for	O
public	O
health	O
,	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
and	O
biodefense	O
and	O
security	O
each	O
has	O
its	O
own	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
,	O
to	O
which	O
samples	O
are	O
sent	O
for	O
analysis	O
from	O
around	O
the	O
country	O
(Figure	O
1	O
,	O
Table	O
1)	O
.	O

Transferring	O
purified	O
and	O
concentrated	O
antibodies	O
produced	O
by	O
the	O
immune	O
systems	O
of	O
those	O
who	O
have	O
recovered	O
from	O
COVID‑19	S-Disease
to	O
people	O
who	O
need	O
them	O
is	O
being	O
investigated	O
as	O
a	O
non-vaccine	O
method	O
of	O
passive	O
immunisation	O
.	O

Waste	O
from	O
the	O
BSL-3	S-Platform
lab	O
was	O
carefully	O
wrapped	O
in	O
a	O
biohazard	O
bag	O
and	O
sterilised	O
twice	O
,	O
the	O
first	O
round	O
of	O
sterilisation	O
was	O
performed	O
in	O
an	O
autoclave	O
in	O
BSL-3	S-Platform
laboratory	O
,	O
then	O
transferred	O
to	O
another	O
autoclave	O
in	O
the	O
decontamination	O
room	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
for	O
a	O
second	O
round	O
of	O
sterilisation	O
.	O

The	O
study	O
and	O
handling	O
of	O
biological	O
agents	O
carries	O
with	O
it	O
the	O
potential	O
for	O
the	O
infection	O
of	O
laboratory	O
personnel	O
and	O
environmental	O
effects	O
.	O

The	O
study	O
involved	O
scientists	O
placing	O
identical	O
oral	O
swab	O
samples	O
from	O
guinea	O
pigs	O
into	O
two	O
sets	O
of	O
tubes-one	O
set	O
of	O
tubes	O
for	O
live	O
virus	O
studies	O
and	O
one	O
set	O
of	O
tubes	O
for	O
studies	O
with	O
inactivated	O
material	O
.	O

One	O
source	O
of	O
resistance	O
is	O
that	O
many	O
current	O
HIV	S-Disease
drugs	O
,	O
including	O
NRTIs	S-Drug
and	O
NNRTIs	S-Drug
,	O
target	O
reverse	O
transcriptase	O
;	O
however	O
,	O
HIV-1	S-Pathogen
reverse	O
transcriptase	O
is	O
highly	O
error	O
prone	O
and	O
thus	O
mutations	O
conferring	O
resistance	O
arise	O
rapidly	O
.	O

In	O
addition	O
to	O
the	O
devastating	O
loss	O
of	O
lives	O
and	O
degradation	O
of	O
human	O
health	O
,	O
disease	O
outbreaks	O
such	O
as	O
this	O
ignite	O
fear	O
and	O
uncertainty	O
,	O
which	O
stress	O
infrastructures	O
and	O
halt	O
international	O
trade	O
.	O

The	O
death	O
toll	O
in	O
Russia	S-Location
has	O
been	O
estimated	O
at	O
450,000	O
,	O
though	O
the	O
epidemiologists	O
who	O
suggested	O
this	O
number	O
called	O
it	O
a	O
"	O
shot	O
in	O
the	O
dark"	O
.	O

In	O
the	O
early	O
1980s	O
,	O
five	O
German	O
firms	O
supplied	O
equipment	O
to	O
manufacture	O
botulin	B-Pathogen
toxin	E-Pathogen
and	O
mycotoxin	S-Pathogen
to	O
Iraq	O
.	O

Early	O
measures	O
announced	O
by	O
the	O
government	O
included	O
the	O
cancellation	O
of	O
concerts	O
and	O
other	O
cultural	O
events	O
,	O
sporting	O
events	O
,	O
Friday	O
prayers	O
,	O
and	O
closures	O
of	O
universities	O
,	O
higher	O
education	O
institutions	O
,	O
and	O
schools	O
.	O

Another	O
study	O
by	O
He	S-Person
et	O
al.	O
(2013)	O
used	O
a	O
simple	O
epidemic	O
model	O
incorporating	O
three	O
factors	O
to	O
infer	O
the	O
cause	O
of	O
the	O
three	O
waves	O
of	O
.	O
These	O
factors	O
were	O
school	O
opening	O
and	O
closing	O
,	O
temperature	O
changes	O
throughout	O
the	O
outbreak	O
,	O
and	O
human	O
behavioral	O
changes	O
in	O
response	O
to	O
the	O
outbreak	O
.	O

According	O
to	O
Homer's	O
epic	O
poems	O
about	O
the	O
legendary	O
Trojan	O
War	O
,	O
the	O
Iliad	O
and	O
the	O
Odyssey	O
,	O
spears	O
and	O
arrows	O
were	O
tipped	O
with	O
poison	O
.	O

Rich	S-Person
is	O
a	O
grinder	O
-	O
a	O
biohacker	O
that	O
does	O
extreme	O
body	O
modification	O
.	O

In	O
2017	O
the	O
Ukrainian	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
confirmed	O
a	O
further	O
90	O
new	O
cases	O
,	O
with	O
8	O
deaths	O
,	O
of	O
botulinum	B-Disease
toxin	I-Disease
poisoning	E-Disease
(one	O
of	O
the	O
most	O
poisonous	O
biological	O
substances	O
known)	O
.	O

The	O
first	O
,	O
detailing	O
the	O
number	O
of	O
plaques	O
relative	O
to	O
the	O
decrease	O
in	O
the	O
optical	O
density	O
of	O
the	O
bacteria	O
.	O

Mutations	O
in	O
the	O
mouse	O
hepatitis	O
virus	O
RNA	O
replicase	O
that	O
cause	O
partial	O
resistance	O
to	O
remdesivir	S-Drug
were	O
identified	O
in	O
2018	O
.	O

Risks:	O
Simply	O
reading	O
DNA	O
is	O
not	O
harmful	O
,	O
but	O
it	O
is	O
foundational	O
for	O
all	O
of	O
modern	O
biotechnology	O
.	O

At	O
the	O
siege	O
of	O
Thun-l'Évêque	S-Location
in	O
1340	O
,	O
during	O
the	O
Hundred	O
Years'	O
War	O
,	O
the	O
attackers	O
catapulted	O
decomposing	O
animals	O
into	O
the	O
besieged	O
area	O
.	O

It	O
is	O
not	O
totally	O
unexpected	O
as	O
99.	O
6%	O
of	O
the	O
seasonal	O
H1N1	B-Disease
flu	E-Disease
strains	O
tested	O
have	O
developed	O
resistance	O
to	O
oseltamivir	S-Drug
.	O
No	O
circulating	O
flu	O
has	O
yet	O
shown	O
any	O
resistance	O
to	O
zanamivir	S-Drug
()	O
,	O
the	O
other	O
available	O
anti-viral	O
.	O

On	O
29	O
March	O
2016	O
,	O
the	O
Director-General	O
of	O
WHO	S-Organization
terminated	O
the	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
status	O
of	O
the	O
.	O

TOM	B-Person
FRIEDEN	E-Person
:	O
Yes	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
reports	O
that	O
the	O
clinical	O
picture	O
in	O
severe	O
cases	O
is	O
strikingly	O
different	O
from	O
the	O
disease	O
pattern	O
seen	O
during	O
epidemics	O
of	O
seasonal	B-Disease
influenza	E-Disease
.	O
While	O
people	O
with	O
certain	O
underlying	O
medical	O
conditions	O
are	O
known	O
to	O
be	O
at	O
increased	O
risk	O
,	O
many	O
severe	O
cases	O
occur	O
in	O
previously	O
healthy	O
people	O
.	O

Just	O
recently	O
,	O
an	O
FDA	S-Organization
panel	O
recommended	O
a	O
gene	O
therapy	O
for	O
cancer	O
,	O
which	O
showed	O
dramatic	O
responses	O
for	O
patients	O
who	O
had	O
exhausted	O
every	O
other	O
treatment	O
.	O

One	O
notable	O
area	O
of	O
weakness	O
was	O
the	O
lack	O
of	O
action	O
on	O
AMR	O
in	O
the	O
environment	O
.	O

The	O
outbreak	O
spread	O
to	O
healthcare	O
workers	O
after	O
people	O
sought	O
medical	O
treatment	O
for	O
the	O
disease	O
.	O

Revaccination's	O
protection	O
lasts	O
longer	O
.	O

Currently	O
,	O
the	O
best-possible	O
tests	O
to	O
indicate	O
pathogen	O
exposure	O
are	O
invasive	O
,	O
labor-intensive	O
,	O
serially-sampled	O
blood-based	O
assays	O
,	O
which	O
may	O
give	O
only	O
6	O
to	O
12	O
hours	O
of	O
warning	O
.	O

A	O
1967	O
US	B-Organization
Army	E-Organization
report	O
"	O
Arthropods	B-Document
of	I-Document
medical	I-Document
importance	I-Document
in	I-Document
Asia	I-Document
and	I-Document
the	I-Document
European	I-Document
USSR	E-Document
"	O
lists	O
all	O
local	O
insects	O
,	O
their	O
distribution	O
and	O
the	O
diseases	O
that	O
they	O
carry	O
.	O

Meselson	S-Person
's	O
original	O
contention	O
for	O
many	O
years	O
had	O
been	O
that	O
the	O
outbreak	O
was	O
a	O
natural	O
one	O
and	O
that	O
the	O
authorities	O
were	O
not	O
lying	O
when	O
they	O
disclaimed	O
having	O
an	O
active	O
offensive	O
bio-warfare	O
program	O
,	O
but	O
the	O
information	O
uncovered	O
in	O
the	O
investigation	O
left	O
no	O
room	O
for	O
doubt	O
.	O

If	O
a	O
bacterial	O
cell	O
was	O
growing	O
in	O
the	O
light	O
,	O
the	O
gene	O
was	O
blocked	O
from	O
making	O
pigment	O
.	O

The	O
package	O
also	O
includes	O
a	O
salaries	O
tax	O
rebate	O
and	O
reduced	O
rates	O
.	O

Tumors	O
can	O
be	O
detected	O
by	O
the	O
swelling	O
and	O
anatomical	O
distortion	O
they	O
cause	O
,	O
or	O
by	O
surrounding	O
edema	O
.	O

The	O
late	O
Joshua	B-Person
Lederberg	E-Person
observed	O
that	O
"	O
barring	O
geno-suicide	O
,	O
human	O
domination	O
is	O
challenged	O
only	O
by	O
pathogenic	O
microbes	O
,	O
for	O
which	O
we	O
are	O
the	O
prey	O
,	O
they	O
are	O
the	O
predators	O
.	O

To	O
date	O
,	O
there	O
is	O
no	O
randomised	O
,	O
controlled	O
evidence	O
that	O
tocilizumab	S-Drug
is	O
an	O
efficacious	O
treatment	O
for	O
.	O

Liviu	S-Person
38	O
,	O
is	O
the	O
chief	O
executive	O
of	O
his	O
own	O
company	O
,	O
,	O
which	O
designed	O
the	O
implant	O
.	O

The	O
report	O
also	O
found	O
that	O
countries	O
with	O
larger	O
working	O
groups	O
(defined	O
as	O
including	O
at	O
least	O
four	O
sectors)	O
appear	O
to	O
have	O
made	O
more	O
progress	O
toward	O
several	O
GAP	S-Document
objectives	O
.	O

Antibody-dependent	O
enhancement	O
has	O
been	O
suggested	O
as	O
a	O
potential	O
challenge	O
for	O
vaccine	O
development	O
for	O
SARS-COV-2	S-Disease
but	O
this	O
is	O
controversial	O
.	O

We	O
define	O
the	O
requirements	O
for	O
a	O
data	O
management	O
system	O
in	O
the	O
area	O
of	O
systems	O
biology	O
and	O
systems	O
medicine	O
,	O
respectively	O
,	O
and	O
give	O
an	O
overview	O
of	O
data	O
management	O
solutions	O
which	O
have	O
been	O
successfully	O
employed	O
in	O
large-scale	O
projects	O
.	O

Also	O
Thursday	O
,	O
authorities	O
in	O
Hong	B-Location
Kong	E-Location
ordered	O
the	O
closure	O
of	O
all	O
elementary	O
schools	O
,	O
kindergartens	O
and	O
day	O
care	O
centers	O
in	O
the	O
city	O
after	O
12	O
students	O
were	O
found	O
to	O
be	O
infected	O
with	O
the	O
virus	O
.	O

Therapeutic	O
use	O
of	O
antibiotics	O
in	O
domestic	O
pets	O
should	O
be	O
by	O
veterinarian	O
prescription	O
only	O
.	O

The	O
researchers	O
searched	O
databases	O
containing	O
hundreds	O
of	O
millions	O
of	O
genetic	O
sequences	O
for	O
those	O
that	O
resembled	O
CRISPR	S-Technology
genes	O
.	O

In	O
public	O
health	O
,	O
there	O
are	O
often	O
no	O
quick	O
solutions	O
.	O

Movement	O
of	O
people	O
away	O
from	O
affected	O
areas	O
disturbed	O
agricultural	O
activities	O
.	O

The	O
outer	O
viral	O
envelope	O
of	O
the	O
virion	O
is	O
derived	O
by	O
budding	O
from	O
domains	O
of	O
host	O
cell	O
membrane	O
into	O
which	O
the	O
GP	O
spikes	O
have	O
been	O
inserted	O
during	O
their	O
biosynthesis	O
.	O

A	O
confirmed	O
case	O
in	O
Goma	S-Location
triggered	O
the	O
decision	O
by	O
the	O
WHO	S-Organization
to	O
convene	O
an	O
emergency	O
committee	O
for	O
the	O
fourth	O
time	O
,	O
and	O
on	O
17	O
July	O
2019	O
,	O
they	O
announced	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
(PHEIC)	O
,	O
the	O
highest	O
level	O
of	O
alarm	O
the	O
can	O
sound	O
.	O

For	O
symptoms	O
,	O
some	O
medical	O
professionals	O
recommend	O
paracetamol	S-Drug
(	O
acetaminophen	S-Drug
)	O
over	O
for	O
first-line	O
use	O
.	O

It	O
eventually	O
did	O
so	O
in	O
1980	O
.	O

Students	O
compare	O
their	O
findings	O
to	O
those	O
reported	O
by	O
Chou	S-Person
and	O
and	O
use	O
the	O
results	O
to	O
determine	O
the	O
strain	O
they	O
used	O
in	O
the	O
lab	O
.	O

It	O
was	O
involved	O
in	O
both	O
military	O
and	O
civilian	O
sectors	O
to	O
mobilize	O
all	O
forces	O
to	O
fight	O
Spanish	B-Disease
influenza	E-Disease
(	O
Crosby	S-Organization
,	O
1989)	O
.	O

Baker	S-Person
,	O
Eric	S-Person
.	O
"	O
'Maggot	O
bombs'	O
and	O
malaria"	O
,	O
Casper	O
Star-Tribune	O
,	O
via	O
the	O
Laramie	O
Boomerang	O
,	O
February	O
27	O
,	O
2006	O
,	O
accessed	O
December	O
25	O
,	O
2008	O
.	O

In	O
a	O
speech	O
delivered	O
at	O
the	O
nearby	O
Masonic	B-Location
temple	E-Location
,	O
Bush	O
compared	O
the	O
to	O
a	O
modern	O
"	O
DEW"	O
line	O
(referring	O
to	O
the	O
Cold	O
War	O
ballistic	O
missile	O
early	O
warning	O
system)	O
.	O

The	O
US	B-Organization
Army	E-Organization
report	O
lists	O
numerous	O
dissemination	O
techniques	O
including	O
by	O
.	O

"	O
By	O
working	O
across	O
the	O
aisle	O
,	O
Rep	O
.	O

And	O
newer	O
research	O
,	O
worryingly	O
,	O
has	O
found	O
that	O
C.	B-Pathogen
difficile	E-Pathogen
to	O
be	O
resilient	O
in	O
the	O
face	O
of	O
all	O
hospital	O
disinfectants	O
.	O

First	O
is	O
the	O
potential	O
exposure	O
to	O
anthrax	S-Pathogen
Today	O
,	O
we're	O
releasing	O
the	O
results	O
,	O
in	O
fact	O
,	O
our	O
full	O
internal	O
investigation	O
of	O
that	O
incident	O
as	O
well	O
as	O
the	O
steps	O
we're	O
taking	O
that	O
will	O
do	O
everything	O
humanly	O
possible	O
to	O
make	O
sure	O
that	O
nothing	O
like	O
that	O
happens	O
again	O
.	O

A	O
description	O
is	O
given	O
of	O
a	O
configurable	O
metadata	O
system	O
designed	O
to	O
grow	O
as	O
the	O
project	O
evolves	O
.	O

"	O
Nonetheless,	O
we	O
used	O
this	O
as	O
an	O
opportunity	O
to	O
bring	O
together	O
all	O
workers	O
for	O
a	O
refresher	O
training	O
on	O
existing	O
protocols,	O
"	O
Hooker	S-Person
wrote	O
.	O

The	O
economic	O
and	O
human	O
cost	O
of	O
antibiotic	O
resistance	O
is	O
already	O
enormous	O
.	O

PCR	S-Equipment
reactions	O
were	O
performed	O
in	O
a	O
real-time	O
PCR	B-Equipment
thermocycler	E-Equipment
on	O
the	O
bench	O
in	O
BSL-2	S-Platform
and	O
the	O
results	O
were	O
read	O
automatically	O
.	O

However	O
,	O
they	O
are	O
giving	O
latitude	O
to	O
the	O
scientific	O
community	O
to	O
identify	O
which	O
pathogens	O
,	O
in	O
particular	O
,	O
labs	O
and	O
institutions	O
should	O
be	O
inventoried.	O
*How	O
is	O
this	O
enforceable*?	O
*What	O
are	O
the	O
consequences	O
for	O
non-compliance*?	O
In	O
short	O
,	O
its	O
not	O
enforceable	O
and	O
there	O
are	O
no	O
consequences	O
for	O
non-compliance	O
.	O

This	O
EU	B-Document
legislation	E-Document
complements	O
the	O
agreement	O
on	O
cross-border	O
cooperation	O
to	O
combat	O
certain	O
contagious	O
human	O
diseases	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
for	O
more	O
information	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
is	O
a	O
zoonotic	O
pathogen	O
.	O

Following	O
the	O
infection	O
,	O
children	O
may	O
develop	O
paediatric	B-Disease
multisystem	I-Disease
inflammatory	I-Disease
syndrome	E-Disease
which	O
has	O
symptoms	O
similar	O
to	O
,	O
which	O
can	O
be	O
fatal	O
.	O

In	O
fact	O
,	O
much	O
of	O
the	O
Ebola	S-Pathogen
funding	O
for	O
the	O
GHSA	S-International_exchange_and_cooperation
-	O
which	O
primarily	O
went	O
to	O
the	O
-	O
is	O
due	O
to	O
expire	O
at	O
the	O
end	O
of	O
fiscal	O
year	O
(FY)	O
2019	O
,	O
she	O
added	O
.	O

The	O
number	O
of	O
lab-confirmed	O
deaths	O
reported	O
to	O
the	O
WHO	S-Organization
is	O
18,449	O
,	O
though	O
this	O
2009	O
H1N1	B-Incident
flu	I-Incident
pandemic	E-Incident
is	O
estimated	O
to	O
have	O
actually	O
caused	O
about	O
284,000	O
(range	O
from	O
150,000	O
to	O
575,000)	O
deaths	O
.	O

An	O
August	O
2014	O
study	O
found	O
that	O
nearly	O
two-thirds	O
of	O
Ebola	S-Disease
cases	O
in	O
were	O
believed	O
to	O
be	O
due	O
to	O
burial	O
practices	O
including	O
washing	O
of	O
the	O
body	O
of	O
one	O
who	O
had	O
died	O
.	O

A	O
University	B-Organization
of	I-Organization
Iowa	E-Organization
scientist	O
imported	O
a	O
strain	O
of	O
Middle	B-Disease
East	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
MERS	S-Disease
)	O
virus	O
from	O
Spain	S-Location
and	O
began	O
research	O
without	O
approval	O
from	O
the	O
university's	O
oversight	O
committee	O
and	O
in	O
a	O
BSL-2	S-Platform
facility	O
in	O
2013	O
,	O
as	O
opposed	O
to	O
the	O
university's	O
lab	O
as	O
required	O
.	O

A	B-Technology
typical	I-Technology
plain	I-Technology
film	I-Technology
X-ray	E-Technology
involves	O
radiation	O
dose	O
of	O
0.01	O
to	O
0.	O
15 mGy	O
,	O
while	O
a	O
typical	O
CT	S-Technology
can	O
involve	O
10–20 mGy	O
for	O
specific	O
organs	O
,	O
and	O
can	O
go	O
up	O
to	O
80 mGy	O
for	O
certain	O
specialized	O
scans	O
.	O

Two	O
hundred	O
and	O
thirty	O
students	O
from	O
six	O
different	O
virology	O
labs	O
evaluated	O
the	O
course	O
in	O
the	O
years	O
2015–2016	O
.	O

However	O
,	O
in	O
2015	O
the	O
United	B-Location
States	E-Location
had	O
a	O
significant	O
funding	O
spike	O
from	O
$433	O
million	O
allocated	O
to	O
$1.34	O
billion	O
with	O
supplemental	O
funds	O
to	O
fight	O
the	O
Ebola	B-Incident
outbreak	E-Incident
and	O
pay	O
for	O
costs	O
associated	O
with	O
related	O
GHSA	S-International_exchange_and_cooperation
efforts	O
,	O
according	O
to	O
Kates	S-Person
.	O
In	O
2016	O
,	O
there	O
was	O
another	O
small	O
jump	O
in	O
global	O
health	O
security	O
spending	O
to	O
$552	O
million	O
from	O
$407	O
million	O
allocated	O
due	O
to	O
the	O
Zika	B-Pathogen
virus	E-Pathogen
and	O
related	O
efforts	O
.	O

That	O
was	O
the	O
overarching	O
theme	O
of	O
a	O
daylong	O
discussion	O
among	O
more	O
than	O
70	O
experts	O
convened	O
by	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
on	O
30	O
July	O
2018	O
,	O
in	O
Washington,	B-Location
D.C.	E-Location
,	O
to	O
gather	O
stakeholder	O
input	O
on	O
the	O
forthcoming	O
U.S.	B-Document
Global	I-Document
Health	I-Document
Security	I-Document
Strategy	E-Document
.	O
Drafted	O
by	O
the	O
Trump	B-Organization
administration	E-Organization
and	O
due	O
to	O
Congress	S-Organization
this	O
fall	O
,	O
the	O
strategy	O
will	O
guide	O
continued	O
work	O
to	O
build	O
outbreak	O
detection	O
and	O
response	O
capabilities	O
in	O
nations	O
all	O
over	O
the	O
world	O
.	O

TOM	B-Person
FRIEDEN	E-Person
CDC	S-Organization
has	O
many	O
biocontainment	O
laboratories	O
.	O

On	O
1	O
August	O
,	O
just	O
after	O
the	O
Ebola	S-Disease
epidemic	O
had	O
been	O
declared	O
,	O
Doctors	O
Without	O
Borders/	O
Médecins	B-Organization
Sans	I-Organization
Frontières	E-Organization
(	O
MSF	S-Organization
)	O
arrived	O
in	O
Mangina	S-Location
,	O
the	O
point	O
of	O
origin	O
of	O
the	O
outbreak	O
,	O
to	O
mount	O
a	O
response	O
against	O
the	O
outbreak	O
.	O

And	O
this	O
was	O
in	O
the	O
context	O
of	O
a	O
clinical	O
trial	O
-	O
presumably	O
,	O
a	O
DIY	O
attempt	O
could	O
be	O
even	O
riskier	O
.	O

Fortunately	O
,	O
the	O
perceived	O
image	O
of	O
a	O
passive	O
Africa	S-Location
in	O
this	O
game	O
is	O
changing	O
rapidly	O
with	O
clear	O
positions	O
on	O
how	O
to	O
harness	O
modern	O
biotechnology	O
.	O

Therefore	O
,	O
appropriate	O
PPE	S-Equipment
and	O
good	O
practices	O
are	O
essential	O
for	O
protecting	O
medical	O
and	O
laboratory	O
staff	O
dealing	O
with	O
EVD	S-Disease
.	O
We	O
believe	O
that	O
adequate	O
preparation	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
,	O
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
sectioning	O
of	O
the	O
biosafety	O
laboratory	O
,	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

The	O
system	O
,	O
called	O
NY	B-Platform
Responds	E-Platform
electronically	O
connects	O
every	O
county	O
in	O
New	B-Location
York	E-Location
to	O
aid	O
in	O
disaster	O
response	O
and	O
recovery	O
.	O

"	O
When	O
we	O
ask	O
the	O
private	O
sector	O
to	O
take	O
on	O
research	O
and	O
development	O
efforts	O
like	O
vaccines…it's	O
part	O
of	O
building	O
a	O
resilient	O
country,	O
"	O
Ridge	S-Person
said	O
.	O

Advances	O
in	O
biotechnology	O
are	O
escalating	O
the	O
debate	O
,	O
from	O
questions	O
about	O
altering	O
life	O
to	O
creating	O
it	O
from	O
scratch	O
.	O

This	O
means	O
they	O
don't	O
have	O
a	O
membrane-bound	O
nucleus	O
;	O
instead	O
of	O
having	O
chromosomal	O
DNA	O
,	O
their	O
genetic	O
information	O
is	O
maintained	O
in	O
a	O
circular	O
plasmid	O
like	O
the	O
ones	O
Cohen	S-Person
studied	O
.	O

In	O
,	O
antibiotic-resistant	O
infections	O
are	O
responsible	O
for	O
$20	O
billion	O
per	O
year	O
in	O
excess	O
health	O
care	O
costs	O
,	O
$35	O
billion	O
per	O
year	O
in	O
societal	O
costs	O
and	O
8	O
million	O
additional	O
hospital	O
days	O
each	O
year	O
(REF)	O
.	O

In	O
1980	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
announced	O
the	O
eradication	O
of	O
smallpox	S-Disease
,	O
a	O
highly	O
contagious	O
and	O
incurable	O
disease	O
.	O

The	O
report	O
,	O
"	O
The	O
Characteristics	B-Document
of	I-Document
Pandemic	I-Document
Pathogens	E-Document
establishes	O
a	O
framework	O
for	O
identifying	O
naturally	O
occurring	O
microorganisms	O
that	O
pose	O
a	O
global	O
catastrophic	O
biological	O
risk	O
(GCBR)	O
and	O
makes	O
broad	O
recommendations	O
for	O
improving	O
GCBR	O
preparedness	O
efforts	O
.	O

Ellen	B-Person
Jorgensen	E-Person
a	O
molecular	O
biologist	O
who	O
co-founded	O
Genspace	S-Organization
and	O
Biotech	B-Organization
Without	I-Organization
Borders	E-Organization
,	O
two	O
Brooklyn	S-Location
-based	O
biology	O
labs	O
open	O
to	O
the	O
public	O
,	O
finds	O
antics	O
like	O
Zayner	S-Person
's	O
worrisome	O
.	O

During	O
each	O
review	O
,	O
an	O
assessment	O
of	O
the	O
event	O
,	O
contributing	O
factors	O
,	O
and	O
risk	O
mitigation	O
practices	O
was	O
completed	O
.	O

Entire	O
new	O
fields	O
,	O
such	O
as	O
personalized	O
medicine	O
,	O
owe	O
their	O
existence	O
to	O
.	O

In	O
June	O
2014	O
,	O
another	O
employee	O
in	O
a	O
different	O
BSL-3	S-Platform
lab	O
experienced	O
reduced	O
airflow	O
through	O
a	O
respirator	S-Equipment
while	O
taking	O
samples	O
from	O
ducks	O
involved	O
in	O
an	O
H5N1	B-Disease
avian	I-Disease
influenza	E-Disease
experiment	O
.	O

Coronavirus	S-Pathogen
:	O
Kidney	B-Phenotype
Damage	E-Phenotype
Caused	O
by	O
COVID-19	S-Disease
,	O
Johns	B-Organization
Hopkins	I-Organization
Medicine	E-Organization
,	O
updated	O
May	O
14	O
,	O
2020	O
.	O

"	O
Biotech	O
is	O
the	O
transformative	O
technology	O
of	O
the	O
21st	O
century	O
.	O

"	O
Yes,	O
that's	O
my	O
understanding,	O
"	O
Kadlec	S-Person
said	O
.	O

"	O
The	O
two	O
biggest	O
reasons	O
why	O
people	O
past	O
the	O
age	O
of	O
50	O
don't	O
live	O
past	O
74	O
are	O
heart	B-Disease
disease	E-Disease
and	O
cancer	S-Disease
.	O
In	O
modern	O
medicine	O
,	O
you	O
only	O
go	O
to	O
get	O
yourself	O
checked	O
if	O
you	O
show	O
symptoms,	O
"	O
said	O
Venter	S-Person
,	O
but	O
added	O
that	O
an	O
estimated	O
five	O
percent	O
of	O
people	O
have	O
that	O
they	O
are	O
not	O
aware	O
of	O
and	O
would	O
only	O
be	O
alerted	O
to	O
once	O
they	O
metastasize	O
or	O
grow	O
big	O
enough	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
is	O
the	O
leading	O
national	O
public	O
health	O
institute	O
of	O
the	O
United	O
States	O
.	O

The	O
CDC	S-Organization
is	O
integral	O
in	O
working	O
with	O
the	O
WHO	S-Organization
to	O
implement	O
the	O
International	B-Document
Health	I-Document
Regulations	E-Document
(	O
IHR	S-Document
)	O
,	O
a	O
legally	O
binding	O
agreement	O
between	O
196	O
countries	O
to	O
prevent	O
,	O
control	O
,	O
and	O
report	O
on	O
the	O
international	O
spread	O
of	O
disease	O
,	O
through	O
initiatives	O
including	O
the	O
Global	B-Activity
Disease	I-Activity
Detection	I-Activity
Program	E-Activity
()	O
.	O

Nursing	O
staff	O
,	O
who	O
were	O
mainly	O
women	O
,	O
celebrated	O
the	O
success	O
of	O
their	O
patient	O
care	O
and	O
did	O
not	O
associate	O
the	O
spread	O
of	O
the	O
disease	O
with	O
their	O
work	O
.	O

More	O
importantly	O
,	O
the	O
company	O
can	O
predict	O
diseases	O
through	O
genome	B-Technology
reading	E-Technology
and	O
advanced	O
detection	O
algorithms.	O
"	O
The	O
new	O
preventive	O
medicine	O
paradigm	O
is	O
turning	O
healthcare	O
on	O
its	O
head,	O
"	O
added	O
.	O

By	O
infecting	O
just	O
a	O
few	O
animals	O
,	O
through	O
needle	O
injection	O
and	O
pouring	O
bacteria	O
cultures	O
on	O
animal	O
feed	O
,	O
German	O
operatives	O
hoped	O
to	O
spark	O
devastating	O
epidemics	O
.	O

It's	O
method	O
of	O
transmission	O
makes	O
Ebola	S-Pathogen
less	O
contagious	O
than	O
airborne	O
viruses	O
,	O
and	O
therefore	O
easier	O
to	O
contain	O
,	O
provided	O
that	O
strict	O
protocols	O
for	O
containment	O
are	O
followed	O
,	O
de	B-Person
Bretton-Gordon	E-Person
said	O
.	O

"	O
The	O
work	O
completed	O
at	O
AFRIMS	S-Organization
is	O
the	O
first	O
of	O
three	O
research	O
projects	O
we	O
are	O
collaborating	O
on	O
with	O
the	O
US	B-Organization
DoD	E-Organization
.	O
We	O
hope	O
to	O
announce	O
the	O
study	O
results	O
from	O
the	O
Department	B-Organization
of	I-Organization
Enteric	I-Organization
Infections,	I-Organization
US	I-Organization
Naval	I-Organization
Medical	I-Organization
Research	I-Organization
Center	E-Organization
and	O
the	O
in	O
the	O
next	O
few	O
months	O
.	O

It	O
also	O
wants	O
to	O
promote	O
the	O
correct	O
usage	O
of	O
antibiotics	O
across	O
all	O
fields	O
in	O
order	O
to	O
prevent	O
further	O
instances	O
of	O
antibiotic	O
resistance	O
.	O

For	O
example	O
,	O
it	O
could	O
be	O
placed	O
in	O
letters	O
and	O
mailed	O
,	O
as	O
was	O
done	O
in	O
2001	O
,	O
or	O
it	O
could	O
be	O
put	O
into	O
food	O
or	O
water	O
.	O

Not	O
only	O
are	O
80%	O
of	O
antibiotics	O
sold	O
in	O
used	O
on	O
animals	O
,	O
but	O
90%	O
of	O
those	O
antibiotics	O
are	O
excreted	O
in	O
the	O
urine	O
and	O
stool	O
of	O
livestock	O
.	O

But	O
according	O
to	O
Jen	B-Person
Kates	E-Person
vice	O
president	O
and	O
director	O
of	O
global	B-Document
health	I-Document
and	I-Document
HIV	I-Document
policy	E-Document
at	O
the	O
Henry	B-Organization
J.	I-Organization
Kaiser	I-Organization
Family	I-Organization
Foundation	E-Organization
()	O
,	O
this	O
isn't	O
typical	O
global	O
health	O
security	O
funding	O
.	O

I	O
am	O
therefore	O
,	O
asking	O
if	O
you	O
will	O
undertake	O
the	O
appointment	O
of	O
an	O
appropriate	O
committee	O
to	O
survey	O
all	O
phases	O
of	O
this	O
matter	O
.	O

Their	O
goal	O
was	O
to	O
win	O
two	O
of	O
three	O
seats	O
on	O
the	O
Wasco	B-Organization
County	I-Organization
Circuit	I-Organization
Court	E-Organization
,	O
as	O
well	O
as	O
the	O
sheriff's	O
office	O
.	O

It	O
stated	O
that	O
"	O
this	O
Roadmap	O
assumes	O
that	O
in	O
many	O
areas	O
of	O
intense	O
transmission	O
the	O
actual	O
number	O
of	O
cases	O
may	O
be	O
two-	O
to	O
fourfold	O
higher	O
than	O
that	O
currently	O
reported	O
.	O

Due	O
to	O
the	O
lack	O
of	O
precedent	O
regarding	O
such	O
a	O
business	O
model	O
,	O
the	O
DIYbio	S-Activity
founders	O
see	O
this	O
as	O
an	O
opportunity	O
to	O
be	O
innovators	O
in	O
regulatory	O
and	O
safety	O
policy	O
.	O

Azar	S-Person
has	O
asked	O
to	O
lead	O
the	O
day-to-day	O
coordination	O
team	O
that	O
supports	O
the	O
steering	O
committee	O
.	O

It	O
is	O
not	O
clear	O
if	O
washing	O
hands	O
with	O
ash	O
if	O
soap	O
is	O
not	O
available	O
is	O
effective	O
at	O
reducing	O
the	O
spread	O
of	O
viral	O
infections	O
.	O

The	O
work	O
was	O
done	O
in	O
one	O
room	O
.	O

On	O
Vozrozhdeniya	B-Location
Island	E-Location
in	O
the	O
Aral	B-Location
Sea	E-Location
,	O
the	O
strongest	O
recipes	O
of	O
smallpox	S-Pathogen
were	O
tested	O
.	O

We	O
have	O
increased	O
people's	O
awareness	O
of	O
the	O
need	O
to	O
use	O
primary	O
health	O
care	O
services	O
.	O

Genetically	B-Technology
modified	E-Technology
(	O
GM	S-Technology
)	O
crops	O
are	O
increasingly	O
gaining	O
acceptance	O
but	O
concurrently	O
consumers'	O
concerns	O
are	O
also	O
increasing	O
.	O

Ebola	S-Disease
medics	O
'better	O
trained	O
in	O
Sierra	B-Location
Leone	E-Location
than	O
Spain	S-Location
'	O
The	O
Telegraph	S-Organization
,	O
by	O
Fiona	B-Person
Govan	E-Person
,	O
11	O
October	O
2014	O
Even	O
with	O
proper	O
isolation	B-Equipment
equipment	E-Equipment
available	O
,	O
working	O
conditions	O
such	O
as	O
lack	O
of	O
running	O
water	O
,	O
climate	O
control	O
,	O
and	O
flooring	O
have	O
made	O
direct	O
care	O
difficult	O
.	O

Components	O
of	O
this	O
manuscript	O
may	O
be	O
found	O
as	O
part	O
of	O
the	O
final	O
report	O
that	O
was	O
submitted	O
to	O
the	O
funding	O
agency	O
at	O
the	O
end	O
of	O
the	O
project	O
.	O

GHSA	S-Document
partners	O
include	O
44	O
nations	O
,	O
international	O
organizations	O
like	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
()	O
and	O
Interpol	O
,	O
nongovernmental	O
partners	O
,	O
and	O
private	O
stakeholders	O
.	O

It	O
provides	O
technical	O
assistance	O
to	O
countries	O
,	O
sets	O
international	O
health	O
standards	O
and	O
guidelines	O
,	O
and	O
collects	O
data	O
on	O
global	O
health	O
issues	O
through	O
the	O
World	B-Organization
Health	I-Organization
Survey	E-Organization
.	O
Its	O
flagship	O
publication	O
,	O
the	O
World	B-Document
Health	I-Document
Report	E-Document
,	O
provides	O
expert	O
assessments	O
of	O
global	O
health	O
topics	O
and	O
health	O
statistics	O
on	O
all	O
nations	O
.	O

However	O
,	O
New	B-Location
York	I-Location
City	E-Location
as	O
an	O
entity	O
has	O
numerous	O
organizations	O
and	O
strategies	O
that	O
effectively	O
serve	O
to	O
deter	O
and	O
respond	O
to	O
bioterrorism	O
as	O
it	O
comes	O
.	O

Around	O
45,000	O
were	O
tested	O
from	O
1960	O
to	O
1973	O
.	O

The	O
university	O
is	O
concerned	O
that	O
the	O
B.	B-Pathogen
cereus	E-Pathogen
accident	O
follows	O
the	O
2009	O
plague	O
infection	O
,	O
Gilliam	S-Person
said.	O
"	O
The	O
fact	O
that	O
there	O
have	O
been	O
two	O
serious	O
incidents	O
[involving]	O
individuals	O
,	O
we	O
take	O
that	O
very	O
seriously	O
.	O

The	O
first	O
2	O
infected	O
cases	O
involved	O
a	O
postgraduate	O
student	O
and	O
a	O
researcher	O
at	O
the	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Viral	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(abbrev.	O
:	O
Institute	B-Organization
of	I-Organization
Virology	E-Organization
)	O
of	O
the	O
;	O
an	O
additional	O
7	O
cases	O
were	O
diagnosed	O
,	O
which	O
were	O
linked	O
with	O
close	O
personal	O
contact	O
with	O
the	O
student	O
,	O
the	O
lab	O
or	O
with	O
a	O
nurse	O
who	O
treated	O
the	O
student.	O
.	O

Formed	O
an	O
external	O
laboratory	O
safety	O
working	O
group	O
,	O
under	O
the	O
Advisory	B-Organization
Committee	E-Organization
to	O
the	O
Director	O
,	O
composed	O
of	O
experts	O
in	O
biosafety	O
and	O
related	O
areas	O
to	O
review	O
and	O
provide	O
input	O
into	O
corrective	O
actions	O
and	O
safeguards	O
across	O
all	O
laboratories	O
.	O

I	O
think	O
people	O
have	O
had	O
a	O
narrow	O
vision	O
of	O
the	O
problem	O
.	O

"	O
The	O
Breeding	O
House	O
"	O
(1994)	O
,	O
Bruce	B-Person
Dickinson	E-Person
Segment	O
of	O
the	O
CD-single	O
Tears	O
of	O
the	O
Dragon	O
,	O
describing	O
the	O
atrocities	O
committed	O
by	O
and	O
the	O
immunity	O
granted	O
by	O
the	O
Americans	O
to	O
the	O
physicians	O
of	O
the	O
Unit	O
.	O

As	O
a	O
consequence	O
,	O
the	O
high	O
level	O
of	O
misinterpretation	O
was	O
responsible	O
for	O
a	O
low	O
comprehensive	O
knowledge	O
about	O
the	O
virus	O
;	O
82%	O
of	O
individuals	O
believed	O
that	O
Ebola	S-Disease
was	O
the	O
result	O
of	O
a	O
virus	O
(36.2%	O
thought	O
that	O
a	O
higher	O
power	O
had	O
caused	O
it)	O
.	O

An	O
estimated	O
500,000	O
laboratory	O
workers	O
in	O
the	O
United	B-Location
States	E-Location
are	O
at	O
risk	O
of	O
exposure	O
to	O
infectious	O
agents	O
that	O
cause	O
disease	O
ranging	O
from	O
inapparent	O
to	O
life-threatening	O
infections	O
,	O
but	O
the	O
precise	O
risk	O
to	O
a	O
given	O
worker	O
unknown	O
.	O

President	O
Richard	B-Person
M.	I-Person
Nixon	E-Person
issued	O
his	O
"	O
Statement	O
on	O
Chemical	O
and	O
Biological	O
Defense	O
Policies	O
and	O
Programs	O
"	O
on	O
November	O
25	O
,	O
1969	O
in	O
a	O
speech	O
from	O
Fort	B-Location
Detrick	E-Location
.	O
The	O
statement	O
ended	O
,	O
unconditionally	O
,	O
all	O
U.S.	S-Location
offensive	O
biological	O
weapons	O
programs	O
.	O

However	O
,	O
the	O
most	O
notorious	O
program	O
of	O
the	O
period	O
was	O
run	O
by	O
the	O
secret	O
Imperial	O
Japanese	O
Army	O
Unit	B-Organization
731	E-Organization
during	O
the	O
war	O
,	O
based	O
at	O
Pingfan	S-Location
in	O
Manchuria	S-Location
and	O
commanded	O
by	O
Lieutenant	O
General	O
Shirō	B-Person
Ishii	E-Person
.	O
This	O
unit	O
did	O
research	O
on	O
BW	O
,	O
conducted	O
often	O
fatal	O
human	O
experiments	O
on	O
prisoners	O
,	O
and	O
produced	O
biological	O
weapons	O
for	O
combat	O
use	O
.	O

News	O
of	O
the	O
infection	O
will	O
stoke	O
concerns	O
about	O
its	O
spread	O
in	O
a	O
country	O
which	O
is	O
by	O
far	O
the	O
world's	O
largest	O
producer	O
of	O
pork	O
.	O

Learning	O
from	O
failed	O
responses	O
,	O
such	O
as	O
during	O
the	O
2000	O
outbreak	O
in	O
Uganda	S-Location
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
established	O
its	O
Global	B-Platform
Outbreak	I-Platform
Alert	I-Platform
and	I-Platform
Response	I-Platform
Network	E-Platform
,	O
and	O
other	O
public	O
health	O
measures	O
were	O
instituted	O
in	O
areas	O
at	O
high	O
risk	O
.	O

McDonnell	S-Person
position	O
was	O
established	O
last	O
December	O
and	O
made	O
permanent	O
by	O
the	O
this	O
year	O
.	O

A	O
CDC	S-Organization
study	O
released	O
28	O
January	O
2013	O
,	O
estimated	O
that	O
the	O
Pandemic	B-Vaccine
H1N1	I-Vaccine
vaccine	E-Vaccine
saved	O
roughly	O
300	O
lives	O
and	O
prevented	O
about	O
a	O
million	O
illnesses	O
in	O
.	O
The	O
study	O
concluded	O
that	O
had	O
the	O
vaccination	O
program	O
started	O
two	O
weeks	O
earlier	O
,	O
close	O
to	O
60%	O
more	O
cases	O
could	O
have	O
been	O
prevented	O
.	O

U.S.	O
federal	O
health	O
inspectors	O
surveyed	O
323	O
hospitals	O
in	O
late	O
March	O
;	O
reporting	O
"	O
severe	O
shortages	O
"	O
of	O
test	O
supplies	O
,	O
"	O
widespread	O
shortages	O
"	O
of	O
personal	O
protective	O
equipment	O
(PPE)	O
,	O
and	O
other	O
strained	O
resources	O
due	O
to	O
extended	O
patient	O
stays	O
while	O
awaiting	O
test	O
results	O
.	O

Based	O
on	O
what	O
was	O
learned	O
during	O
the	O
lab	O
science	O
and	O
safety	O
reviews	O
earlier	O
this	O
year	O
,	O
CDC	S-Organization
has	O
taken	O
several	O
immediate	O
actions	O
in	O
this	O
incident	O
including	O
closure	O
of	O
the	O
laboratory	O
,	O
notification	O
of	O
staff	O
,	O
initiation	O
of	O
a	O
complete	O
internal	O
review	O
,	O
and	O
notifications	O
of	O
regulatory	O
oversight	O
agencies	O
.	O

The	O
finds	O
came	O
as	O
part	O
of	O
a	O
sweep	O
for	O
select	O
agents	O
at	O
NIH	S-Organization
and	O
other	O
federal	O
agencies	O
launched	O
after	O
six	O
vials	O
of	O
live	O
smallpox	S-Disease
dated	O
1954	O
were	O
found	O
in	O
July	O
in	O
a	O
cold	O
storage	O
room	O
in	O
an	O
FDA	S-Organization
lab	O
on	O
the	O
campus	O
.	O

The	O
aid	O
included	O
establishment	O
of	O
a	O
fixed	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratory	O
in	O
Freetown	S-Location
,	O
the	O
capital	O
city	O
of	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
project	O
began	O
on	O
20	O
November	O
2014	O
and	O
construction	O
was	O
completed	O
on	O
31	O
January	O
2015	O
.	O

The	O
DTRA	S-Organization
contractor	O
on	O
this	O
project	O
–	O
Lovelace	B-Scientific_research_project
Biomedical	I-Scientific_research_project
and	I-Scientific_research_project
Environmental	I-Scientific_research_project
Research	I-Scientific_research_project
Institute	E-Scientific_research_project
(	O
LBERI	S-Scientific_research_project
)	O
,	O
operates	O
an	O
Animal	O
Bio-safety	O
3	O
Level	O
(ABSL-3)	O
laboratory	O
which	O
has	O
Select	O
Agent	O
status	O
.	O

It	O
alone	O
accounts	O
for	O
more	O
than	O
half	O
of	O
the	O
world's	O
pig	O
population	O
.	O

Partners	O
work	O
together	O
to	O
put	O
international	O
principles	O
for	O
aid	O
effectiveness	O
and	O
development	O
co-operation	O
into	O
practice	O
in	O
the	O
health	O
sector	O
.	O

Smart	S-Person
,	O
Jeffery	B-Person
K.	E-Person
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
19	O
-	O
The	O
U.S	O
.	O

The	O
study	O
found	O
that	O
32	O
(16.	O
8%)	O
of	O
laboratories	O
appointed	O
biosafety	O
officers	O
.	O

NIH	S-Organization
notice	O
comes	O
in	O
the	O
wake	O
of	O
a	O
Monday	O
statement	O
from	O
the	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
()	O
,	O
which	O
represents	O
many	O
researchers	O
working	O
with	O
dangerous	O
pathogens	O
,	O
which	O
called	O
on	O
its	O
members	O
to	O
conduct	O
a	O
similar	O
inventory	O
.	O

Some	O
who	O
criticized	O
the	O
placement	O
decision	O
did	O
so	O
on	O
grounds	O
that	O
it	O
was	O
a	O
desire	O
to	O
reward	O
politicians	O
.	O

This	O
new	O
device	O
allows	O
for	O
the	O
use	O
of	O
portable	O
instruments	O
that	O
can	O
provide	O
immediate	O
diagnosis	O
.	O

Dr	O
.	O

The	O
improved	O
resolution	O
of	O
CT	S-Technology
has	O
permitted	O
the	O
development	O
of	O
new	O
investigations	O
,	O
which	O
may	O
have	O
advantages	O
;	O
compared	O
to	O
conventional	O
radiography	O
,	O
for	O
example	O
,	O
CT	O
angiography	O
avoids	O
the	O
invasive	O
insertion	O
of	O
a	O
catheter	O
.	O

Local	O
police	O
have	O
launched	O
an	O
investigation	O
into	O
"	O
infection	O
with	O
human	O
immunodeficiency	O
virus	O
and	O
other	O
incurable	O
diseases"	O
.	O

In	O
an	O
interview	O
,	O
Dr	O
.	O

Anthrax	S-Disease
is	O
one	O
of	O
the	O
bio	O
agents	O
weaponized	O
by	O
the	O
US	B-Organization
Army	E-Organization
in	O
the	O
past	O
.	O

Medical	O
researchers	O
viewed	O
the	O
results	O
through	O
fortified	O
glass	O
.	O

Initial	O
concerns	O
included	O
the	O
observation	O
that	O
while	O
WHO	S-Organization
relies	O
upon	O
data	O
provided	O
and	O
filtered	O
by	O
member	O
states	O
,	O
China	S-Location
has	O
had	O
a	O
"	O
historical	O
aversion	O
to	O
transparency	O
and	O
sensitivity	O
to	O
international	O
criticism"	O
.	O

The	O
began	O
an	O
investigation	O
to	O
determine	O
whether	O
it	O
had	O
"	O
frightened	O
people	O
unnecessarily"	O
.	O

Sen	O
.	O

Forest	O
Sea	O
(Pol	O
.	O

The	O
last	O
known	O
incident	O
of	O
using	O
plague	O
corpses	O
for	O
biological	O
warfare	O
occurred	O
in	O
1710	O
,	O
when	O
Russian	B-Organization
forces	E-Organization
attacked	O
the	O
Swedes	O
by	O
flinging	O
plague-infected	O
corpses	O
over	O
the	O
city	O
walls	O
of	O
Reval	S-Location
(	O
Tallinn	S-Location
)	O
.	O

There	O
is	O
as	O
yet	O
no	O
known	O
confirmed	O
medication	O
or	O
treatment	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
The	O
director	O
of	O
the	O
US	B-Organization
National	I-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
has	O
stated	O
that	O
the	O
scientific	O
community	O
is	O
still	O
in	O
the	O
early	O
stages	O
of	O
understanding	O
how	O
infection	O
with	O
the	O
can	O
be	O
treated	O
and	O
prevented	O
.	O

Recommended	O
measures	O
when	O
caring	O
for	O
those	O
who	O
are	O
infected	O
include	O
medical	O
isolation	O
via	O
the	O
proper	O
use	O
of	O
boots	O
,	O
gowns	O
,	O
gloves	O
,	O
masks	O
and	O
goggles	O
,	O
and	O
sterilizing	O
all	O
equipment	O
and	O
surfaces	O
.	O

NBIC	S-Organization
doesn't	O
intend	O
to	O
build	O
its	O
own	O
data	O
stream	O
,	O
but	O
rather	O
subscribe	O
to	O
an	O
existing	O
service	O
,	O
according	O
to	O
the	O
.	O

Heading	O
the	O
collaborative	O
effort	O
for	O
the	O
University	B-Organization
of	I-Organization
Nebraska	E-Organization
is	O
Ken	B-Person
Bayles	E-Person
,	O
Ph.D.	O
,	O
professor	O
,	O
pathology/microbiology	O
for	O
UNMC	S-Organization
.	O
Mark	B-Person
Riley	E-Person
,	O
Ph.D.	O
,	O
associate	O
dean	O
for	O
research	O
for	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	I-Organization
College	I-Organization
of	I-Organization
Engineering	E-Organization
,	O
is	O
assisting	O
Bayles	S-Person
on	O
the	O
.	O

With	O
such	O
a	O
treasure	O
trove	O
to	O
mine	O
and	O
the	O
active	O
involvement	O
and	O
wealth	O
of	O
experience	O
of	O
the	O
established	O
pharmaceutical	O
industry	O
(which	O
was	O
in	O
fact	O
founded	O
on	O
natural	O
product	O
development	O
in	O
the	O
1950s	O
–	O
70s)	O
the	O
target	O
would	O
be	O
attainable	O
.	O

The	O
recommended	O
volunteers	O
take	O
part	O
in	O
trials	O
of	O
the	O
effectiveness	O
and	O
safety	O
of	O
potential	O
treatments	O
.	O

The	O
bacteriophage	O
harbors	O
a	O
ts	O
mutation	O
in	O
the	O
gene	O
coding	O
for	O
the	O
Cl	O
repressor	O
(λc1857)	O
.	O

This	O
is	O
often	O
carried	O
out	O
by	O
granting	O
temporary	O
project	O
funding	O
to	O
stakeholders	O
who	O
are	O
involved	O
in	O
handling	O
crises	O
at	O
the	O
national	O
and	O
local	O
or	O
regional	O
levels	O
.	O

After	O
protracted	O
negotiations	O
between	O
the	O
two	O
governments	O
,	O
they	O
were	O
extradited	O
to	O
the	O
United	B-Location
States	E-Location
,	O
reaching	O
Portland	S-Location
on	O
February	O
6	O
,	O
1986	O
.	O

I'm	O
just	O
-	O
it's	O
said	O
that	O
the	O
lab	O
was	O
closed	O
for	O
now	O
until	O
the	O
investigation	O
is	O
complete	O
.	O

The	O
BSL-3	S-Platform
laboratory	O
is	O
connected	O
to	O
the	O
other	O
labs	O
through	O
two	O
transfer	O
windows	O
(a	O
"	O
clean"	O
transfer	O
window	O
and	O
a	O
"	O
dirty"	O
transfer	O
window)	O
.	O

When	O
the	O
slice	O
thickness	O
is	O
also	O
factored	O
in	O
,	O
the	O
unit	O
is	O
known	O
as	O
a	O
Voxel	O
,	O
which	O
is	O
a	O
three-dimensional	O
unit	O
.	O

CDC	S-Organization
also	O
performed	O
environmental	O
testing	O
of	O
the	O
affected	O
labs	O
before	O
they	O
were	O
decontaminated	O
;	O
preliminary	O
results	O
for	O
some	O
of	O
the	O
tests	O
are	O
negative	O
for	O
,	O
suggesting	O
that	O
contamination	O
or	O
release	O
was	O
unlikely	O
.	O

The	O
anthrax	B-Incident
attack	E-Incident
17	O
years	O
ago	O
on	O
Capitol	B-Location
Hill	E-Location
,	O
for	O
instance	O
,	O
found	O
the	O
federal	O
government	O
semi-prepared.	O
"	O
That	O
incident	O
shook	O
up	O
the	O
nation,	O
"	O
which	O
learned	O
it	O
could	O
have	O
done	O
a	O
better	O
job	O
in	O
preparing	O
to	O
respond	O
to	O
such	O
bioterrorism	O
,	O
said	O
.	O

These	O
are	O
the	O
dominant	O
type	O
of	O
scanners	O
on	O
the	O
market	O
because	O
they	O
have	O
been	O
manufactured	O
longer	O
and	O
offer	O
a	O
lower	O
cost	O
of	O
production	O
and	O
purchase	O
.	O

And	O
I'm	O
wondering	O
if	O
you're	O
rethinking	O
that	O
now	O
.	O

The	O
existence	O
of	O
the	O
virus	O
along	O
with	O
the	O
fact	O
that	O
administration	O
of	O
the	O
smallpox	B-Vaccine
vaccine	E-Vaccine
was	O
discontinued	O
in	O
the	O
general	O
population	O
(in	O
the	O
United	B-Location
States	E-Location
)	O
in	O
1972	O
presents	O
the	O
potential	O
for	O
a	O
serious	O
public	O
health	O
emergency	O
should	O
the	O
virus	O
reemerge	O
,	O
or	O
if	O
a	O
bioengineered	O
form	O
of	O
the	O
virus	O
was	O
used	O
for	O
a	O
mass	O
bioterrorism	O
attack	O
.	O

The	O
team	O
visited	O
Sverdlovsk	S-Location
in	O
June	O
1992	O
and	O
August	O
1993	O
and	O
included	O
Professor	O
.	O

SECOA	S-Scientific_research_project
(	O
Solutions	B-Scientific_research_project
for	I-Scientific_research_project
Environmental	I-Scientific_research_project
Contrasts	I-Scientific_research_project
in	I-Scientific_research_project
Coastal	I-Scientific_research_project
Areas	E-Scientific_research_project
)	O
is	O
a	O
multi-national	O
research	O
project	O
examining	O
the	O
effects	O
of	O
human	O
mobility	O
on	O
urban	O
settlements	O
in	O
fragile	O
coastal	O
environments	O
.	O

And	O
a	O
single	O
inoculation	O
of	O
MVA-VLP-LASV	B-Vaccine
vaccine	E-Vaccine
protected	O
mice	O
against	O
a	O
lethal	O
delivered	O
directly	O
into	O
the	O
brain	O
.	O

XperimentR	S-Platform
's	O
web	O
approach	O
is	O
only	O
feasible	O
for	O
smaller	O
projects	O
,	O
for	O
large-scale	O
projects	O
a	O
distribution	O
of	O
the	O
software	O
would	O
be	O
desirable	O
.	O

Experts	O
from	O
the	O
Observatory	S-Scientific_research_project
witnessed	O
this	O
during	O
a	O
trip	O
to	O
last	O
year	O
to	O
document	O
a	O
mass	O
vaccination	O
campaign	O
of	O
school	O
children	O
against	O
seasonal	O
influenza	O
,	O
also	O
covered	O
extensively	O
by	O
Taiwanese	O
media	O
.	O

By	O
the	O
end	O
of	O
the	O
year	O
,	O
18	O
people	O
had	O
been	O
infected	O
with	O
anthrax	S-Pathogen
five	O
people	O
had	O
died	O
of	O
the	O
inhaled	O
form	O
of	O
the	O
disease	O
,	O
and	O
hundreds	O
of	O
millions	O
more	O
were	O
struck	O
by	O
anxiety	O
of	O
the	O
unknown	O
.	O

Information	O
seminars	O
have	O
been	O
presented	O
at	O
meetings	O
where	O
these	O
groups	O
of	O
professionals	O
gather	O
.	O

Since	O
1999	O
,	O
Regional	O
directors	O
serve	O
for	O
a	O
once-renewable	O
five-year	O
term	O
,	O
and	O
typically	O
take	O
their	O
position	O
on	O
1	O
February	O
.	O

The	O
e-Bug	B-Platform
programme	E-Platform
that	O
has	O
been	O
launched	O
as	O
a	O
pan-European	O
effort	O
is	O
a	O
prime	O
example	O
of	O
what	O
can	O
be	O
done	O
to	O
educate	O
children	O
(and	O
their	O
parents)	O
of	O
the	O
necessity	O
for	O
the	O
entire	O
population	O
to	O
take	O
antibiotic	O
use	O
and	O
resistance	O
development	O
personally	O
(Ref)	O
.	O

+Major	O
Ebola	B-Incident
virus	I-Incident
outbreaks	E-Incident
by	O
country	O
and	O
by	O
date	O
–	O
to	O
most	O
recent	O
WHO	S-Organization
/	O
Gov	O
update-	O
14	O
January	O
2016Date	O
Total	O
Guinea	S-Location
Liberia	S-Location
Sierra	B-Location
Leone	E-Location
Sources	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
CasesDeaths	O
14	O
January	O
2016	O
28,542	O
11,299	O
3,806	O
2,535	O
10,675	O
4,809	O
14,061	O
3,955	O
23	O
December	O
2015	O
28,542	O
11,299	O
3,806	O
2,535	O
10,676	O
4,809	O
14,061	O
3,955	O
9	O
December	O
2015	O
28,542	O
11,2993,806	O
2,535	O
10,675	O
4,809	O
14,061	O
3,955	O
25	O
November	O
2015	O
28,539	O
11,298	O
3,806	O
2,535	O
10,672	O
4,808	O
14,061	O
3,955	O
11	O
November	O
2015	O
28,539	O
11,298	O
3,806	O
2,535	O
10,672	O
4,808	O
14,061	O
3,955	O
25	O
October	O
2015	O
28,539	O
11,298	O
3,800	O
2,534	O
10,672	O
4,808	O
14,061	O
3,955	O
11	O
October	O
2015	O
28,454	O
11,297	O
3,800	O
2,534	O
10,672	O
4,808	O
13,982	O
3,955	O
Note	O
1:	O
Cases	O
include	O
confirmed	O
,	O
probable	O
and	O
suspected	O
per	O
the	O
,	O
numbers	O
are	O
the	O
cumulative	O
figures	O
as	O
published	O
on	O
the	O
given	O
date	O
,	O
and	O
due	O
to	O
retrospective	O
revisions	O
,	O
differences	O
between	O
successive	O
weekly	O
totals	O
are	O
not	O
necessarily	O
the	O
number	O
of	O
new	O
cases	O
that	O
week	O
.	O

How	O
does	O
that	O
change?	O
What	O
are	O
you	O
doing	O
for	O
that?	O

PPE	S-Equipment
must	O
be	O
selected	O
carefully	O
for	O
the	O
work	O
to	O
be	O
performed	O
.	O

The	O
program	O
received	O
generous	O
support	O
from	O
the	O
Japanese	O
government	O
up	O
to	O
the	O
end	O
of	O
the	O
war	O
in	O
1945	O
.	O

J	B-Person
Miller	E-Person
,	O
S	B-Person
Engelberg	E-Person
,	O
and	O
W	B-Person
Broad	E-Person
(2001)	O
,	O
Germs:	O
Biological	O
Weapons	O
and	O
America's	O
Secret	O
War	O
,	O
New	B-Location
York	E-Location
,	O
NY	S-Location
:	O
Simon	O
&amp	O
;	O
Schust	O
er.	B-Organization
So	E-Organization
viet	O
defectors	O
,	O
including	O
Colo	O
nel	B-Person
Kanatjan	I-Person
Alib	E-Person
ekov	O
,	O
the	O
first	O
deputy	O
chief	O
of	O
Bioprep	S-Organization
arat	O
from	O
1988	O
to	O
1992	O
,	O
confirmed	O
that	O
the	O
program	O
had	O
been	O
massive	O
and	O
that	O
it	O
still	O
existed	O
.	O

It	O
has	O
also	O
caused	O
a	O
shortage	O
of	O
personal	O
protective	O
equipment	O
worldwide	O
,	O
with	O
the	O
warning	O
that	O
this	O
will	O
endanger	O
health	O
workers	O
.	O

On	O
17	O
March	O
2016	O
,	O
the	O
government	B-Organization
of	I-Organization
Guinea	E-Organization
reported	O
,	O
per	O
the	O
media	O
,	O
that	O
2	O
people	O
had	O
again	O
tested	O
positive	O
for	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
Korokpara	S-Location
,	O
it	O
was	O
also	O
reported	O
that	O
they	O
were	O
from	O
the	O
village	O
where	O
members	O
of	O
one	O
family	O
had	O
recently	O
died	O
from	O
vomiting	S-Phenotype
(and	O
diarrhea	S-Phenotype
)	O
.	O

Michael	B-Person
Bell	E-Person
to	O
be	O
Director	O
of	O
Laboratory	O
Safety	O
and	O
serve	O
as	O
the	O
single	O
point	O
of	O
accountability	O
to	O
improve	O
all	O
laboratory	O
safety	O
protocols	O
and	O
practices	O
and	O
procedures	O
.	O

Anthrax	S-Person
"	O
,	O
"	O
Chemical	B-Person
Sally	E-Person
"	O
),	O
who	O
was	O
trained	O
at	O
the	O
University	B-Organization
of	I-Organization
Missouri	E-Organization
-	O
helped	O
to	O
rebuild	O
Iraq's	B-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
in	O
the	O
mid-1990s	O
after	O
the	O
Gulf	O
War	O
.	O

Other	O
good	O
examples	O
are	O
the	O
annual	O
Antibiotic	B-Activity
Awareness	I-Activity
Day	E-Activity
in	O
Europe	S-Location
and	O
Canada	S-Location
(Ref)	O
and	O
the	O
CDC	S-Organization
program	O
"	O
Get	B-Activity
Smart:	I-Activity
Know	I-Activity
When	I-Activity
Antibiotics	I-Activity
Work	E-Activity
"	O
in	O
(Ref)	O
.	O

"	O
This	O
first-in-human	O
trial	O
of	O
the	O
NIH	B-Vaccine
vaccine	E-Vaccine
is	O
part	O
of	O
an	O
important	O
inter-agency	O
effort	O
by	O
the	O
US	S-Location
government	O
to	O
anticipate	O
and	O
counter	O
emerging	O
infectious	O
threats	O
to	O
the	O
Americans	O
,	O
both	O
military	O
and	O
civilian	O
,	O
at	O
home	O
and	O
abroad,	O
"	O
added	O
Dr	O
.	O

Riley	S-Person
said	O
the	O
collaboration	O
with	O
UNL	S-Organization
,	O
UNMC	S-Organization
and	O
Los	B-Organization
Alamos	E-Organization
is	O
in	O
its	O
"	O
infancy,"	O
but	O
he	O
noted	O
that	O
about	O
10	O
UNL	S-Organization
faculty	O
attended	O
the	O
Omaha	S-Location
symposium	O
and	O
that	O
more	O
faculty	O
would	O
like	O
to	O
become	O
engaged	O
.	O

SARS	S-Disease
broke	O
out	O
again	O
in	O
Beijing	S-Location
and	O
in	O
Anhui	B-Location
Province	E-Location
.	O
On	O
22	O
April	O
,	O
China	S-Location
announced	O
that	O
a	O
53-year-old	O
woman	O
had	O
died	O
on	O
19	O
April	O
,	O
its	O
first	O
SARS	S-Disease
death	O
since	O
June	O
.	O

In	O
general	O
,	O
higher	O
radiation	O
doses	O
result	O
in	O
higher-resolution	O
images	O
,	O
while	O
lower	O
doses	O
lead	O
to	O
increased	O
image	O
noise	O
and	O
unsharp	O
images	O
.	O

"	O
Given	O
the	O
recent	O
deadly	O
outbreak	O
of	O
Marburg	B-Pathogen
virus	E-Pathogen
in	O
Uganda	S-Location
,	O
there	O
is	O
a	O
critical	O
need	O
to	O
develop	O
a	O
safe	O
and	O
effective	O
vaccine	O
which	O
has	O
the	O
potential	O
to	O
protect	O
our	O
soldiers	O
and	O
the	O
public	O
from	O
this	O
serious	O
threat,	O
"	O
said	O
Lt.Col	O
.	O

The	O
disease	O
spread	O
fastest	O
through	O
the	O
higher	O
social	O
classes	O
among	O
the	O
indigenous	O
peoples	O
,	O
because	O
of	O
the	O
custom	O
of	O
gathering	O
oral	O
tradition	O
from	O
chiefs	O
on	O
their	O
deathbeds	O
;	O
many	O
community	O
elders	O
were	O
infected	O
through	O
this	O
process	O
.	O

Multiple	O
studies	O
have	O
shown	O
that	O
the	O
use	O
of	O
malaria	S-Disease
rapid	O
diagnostic	O
tests	O
without	O
reliable	O
tools	O
to	O
distinguish	O
other	O
causes	O
has	O
resulted	O
in	O
increased	O
antibiotic	O
use	O
.	O

How	O
do	O
we	O
determine	O
a	O
hard	O
limit	O
for	O
which	O
gene	O
surgery	O
to	O
undertake	O
,	O
and	O
under	O
what	O
circumstances	O
,	O
especially	O
given	O
that	O
the	O
surgery	O
itself	O
comes	O
with	O
the	O
risk	O
of	O
causing	O
genetic	O
damage?	O
Scholars	O
and	O
policymakers	O
have	O
wrestled	O
with	O
these	O
questions	O
for	O
many	O
years	O
,	O
and	O
there	O
is	O
some	O
guidance	O
in	O
documents	O
such	O
as	O
the	O
United	B-Organization
Nations	E-Organization
'	O
.	O

The	O
most	O
controversial	O
measures	O
involved	O
the	O
way	O
that	O
workdays	O
were	O
calculated	O
.	O

The	O
discovery	O
of	O
small	B-Disease
pox	E-Disease
on	O
the	O
campus	O
was	O
just	O
such	O
an	O
event	O
materials	O
used	O
by	O
long-departed	O
investigators	O
and	O
stored	O
for	O
a	O
future	O
use	O
that	O
never	O
evolved.	O
*Will	O
this	O
result	O
in	O
new	O
policy/regulations*?	O
That	O
is	O
not	O
currently	O
the	O
governments	O
intent	O
.	O

The	O
last	O
common	O
ancestor	O
of	O
human	O
strains	O
dates	O
to	O
between	O
February	O
1917	O
and	O
April	O
1918	O
.	O

This	O
has	O
led	O
to	O
speculation	O
that	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
originated	O
in	O
China	S-Location
,	O
as	O
the	O
lower	O
rates	O
of	O
flu	S-Disease
mortality	O
may	O
be	O
explained	O
by	O
the	O
Chinese	O
population's	O
previously	O
acquired	O
immunity	O
to	O
the	O
virus	O
.	O

Sen	O
.	O

The	O
under-counting	O
of	O
mild	O
cases	O
can	O
cause	O
the	O
mortality	O
rate	O
to	O
be	O
overestimated	O
.	O

Iran	S-Location
allocated	O
5trillion	O
rials	O
(equivalent	O
to	O
)	O
to	O
combat	O
the	O
virus	O
.	O

Wednesday	O
the	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
disclosed	O
one	O
of	O
its	O
labs	O
in	O
Utah	S-Location
mistakenly	O
sent	O
samples	O
of	O
live	O
anthrax	S-Pathogen
--	O
instead	O
of	O
killed	O
specimens	O
–	O
to	O
labs	O
across	O
the	O
USA	S-Location
plus	O
a	O
military	O
base	O
in	O
South	B-Location
Korea	E-Location
where	O
22	O
people	O
are	O
now	O
being	O
treated	O
with	O
antibiotics	S-Drug
because	O
of	O
their	O
potential	O
exposure	O
to	O
the	O
bioterror	O
pathogen	O
.	O

Antivirals	O
are	O
used	O
to	O
treat	O
HIV	S-Disease
hepatitis	B-Disease
B	E-Disease
,	O
hepatitis	B-Disease
C	E-Disease
,	O
influenza	S-Disease
,	O
herpes	O
viruses	O
including	O
varicella	B-Pathogen
zoster	I-Pathogen
virus	E-Pathogen
,	O
cytomegalovirus	S-Pathogen
and	O
.	O
With	O
each	O
virus	O
,	O
some	O
strains	O
have	O
become	O
resistant	O
to	O
the	O
administered	O
drugs	O
.	O

The	O
US	S-Location
Company	O
Metabiota	B-Organization
Inc.	E-Organization
has	O
been	O
awarded	O
$18.	O
4	O
million	O
federal	O
contracts	O
under	O
the	O
Pentagon's	B-Scientific_research_project
DTRA	I-Scientific_research_project
program	E-Scientific_research_project
in	O
Georgia	S-Location
and	O
for	O
scientific	O
and	O
technical	O
consulting	O
services	O
.	O

The	O
letter	O
had	O
a	O
Memphis	S-Location
Tennessee	S-Location
,	O
postmark	O
and	O
no	O
return	O
address	O
,	O
wrote	O
in	O
an	O
e-mail	O
to	O
senators	O
and	O
aides	O
.	O

The	O
outbreak	O
then	O
spread	O
to	O
Sierra	B-Location
Leone	E-Location
and	O
progressed	O
rapidly	O
.	O

The	O
outbreak	O
is	O
a	O
major	O
destabilising	O
threat	O
to	O
the	O
global	O
economy	O
.	O

Even	O
if	O
the	O
claim	O
is	O
a	O
hoax	O
,	O
he	O
said	O
,	O
the	O
letter	O
writer	O
has	O
committed	O
at	O
least	O
a	O
misdemeanor--"threatening	O
to	O
do	O
something	O
if	O
government	O
officials	O
don't	O
accede	O
to	O
their	O
demands	O
.	O

If	O
such	O
an	O
emergency	O
were	O
to	O
occur	O
in	O
the	O
United	B-Location
States	E-Location
,	O
and	O
other	O
federal	O
agencies	O
would	O
work	O
closely	O
with	O
local	O
and	O
state	O
partners	O
to	O
coordinate	O
a	O
response	O
.	O

On	O
23	O
March	O
,	O
it	O
was	O
reported	O
that	O
South	B-Location
Korea	E-Location
had	O
the	O
lowest	O
one-day	O
case	O
total	O
in	O
four	O
weeks	O
.	O

Internationalization	O
may	O
broaden	O
the	O
network	O
of	O
national	O
BSL-3	S-Platform
laboratories	O
to	O
find	O
synergies	O
in	O
new	O
areas	O
,	O
strengthen	O
the	O
ability	O
to	O
pool	O
and	O
share	O
resources	O
throughout	O
,	O
and	O
consolidate	O
a	O
longer-term	O
financing	O
regime	O
in	O
the	O
context	O
of	O
harmonized	O
European	O
biopreparedness	O
.	O

In	O
addition	O
,	O
theoretical	O
background	O
regarding	O
methods	O
for	O
the	O
detection	O
of	O
viruses	O
in	O
samples	O
is	O
given	O
during	O
this	O
lab	O
and	O
is	O
combined	O
with	O
information	O
on	O
the	O
importance	O
of	O
detection	O
in	O
the	O
serum	O
and	O
amniotic	O
fluids	O
of	O
pregnant	O
women	O
.	O

The	O
recommended	O
gear	O
is	O
a	O
PPE	B-Equipment
gown	E-Equipment
,	O
respirator	B-Equipment
or	I-Equipment
facemask	E-Equipment
,	O
eye	B-Equipment
protection	E-Equipment
,	O
and	O
.	O

In	O
2000	O
,	O
Michael	B-Person
Elowitz	E-Person
and	O
Stanislas	B-Person
Leibler	E-Person
at	O
developed	O
a	O
synthetic	O
cellular	O
circuit	O
with	O
three	O
genes5	O
.	O

Also	O
in	O
March	O
2020	O
,	O
Deutsche	B-Person
Telekom	E-Person
shared	O
aggregated	O
phone	O
location	O
data	O
with	O
the	O
German	B-Organization
federal	I-Organization
government	I-Organization
agency	E-Organization
,	O
Robert	B-Organization
Koch	I-Organization
Institute	E-Organization
,	O
to	O
research	O
and	O
prevent	O
the	O
spread	O
of	O
the	O
virus.	O
deployed	O
facial	O
recognition	O
technology	O
to	O
detect	O
quarantine	O
breakers	O
.	O

It	O
is	O
also	O
not	O
the	O
same	O
as	O
M.	B-Pathogen
mycoides	I-Pathogen
subspecies	I-Pathogen
mycoides	E-Pathogen
,	O
which	O
is	O
the	O
agent	O
of	O
contagious	B-Disease
bovine	I-Disease
pleuropneumonae	E-Disease
(	O
CBPP	S-Disease
or	O
lung	B-Disease
plague	E-Disease
in	O
cattle)	O
.	O

Change	O
gloves	O
if	O
they	O
are	O
directly	O
contaminated	O
.	O

Local	O
emergency	O
departments	O
were	O
notified	O
to	O
see	O
if	O
any	O
cases	O
of	O
brucellosis	S-Disease
had	O
been	O
reported	O
,	O
but	O
none	O
was	O
.	O

A	O
CNN	S-Organization
report	O
indicated	O
that	O
the	O
combination	O
of	O
s	O
large	O
elderly	O
population	O
and	O
inability	O
to	O
test	O
all	O
who	O
have	O
the	O
virus	O
to	O
date	O
may	O
be	O
contributing	O
to	O
the	O
high	O
fatality	O
rate	O
.	O

However	O
,	O
"	O
doctors	O
don't	O
know	O
if	O
there	O
was	O
any	O
fully	O
formed	O
(and	O
therefore	O
infectious)	O
virus	O
in	O
the	O
guy's	O
semen.	O
"	O
It	O
is	O
known	O
that	O
testes	O
are	O
protected	O
from	O
the	O
body's	O
immune	O
system	O
to	O
protect	O
the	O
developing	O
sperm	O
,	O
and	O
it	O
is	O
thought	O
that	O
this	O
same	O
protection	O
may	O
allow	O
the	O
virus	O
to	O
survive	O
in	O
the	O
testes	O
for	O
an	O
unknown	O
time	O
.	O

Assistant	O
Minister	O
Wesseh	S-Person
who	O
officially	O
opened	O
the	O
workshop	O
on	O
behalf	O
of	O
Agriculture	O
Minister	O
Mogana	B-Person
S.	I-Person
Flomo	E-Person
,	O
added	O
that	O
the	O
one	O
week	O
sitting	O
by	O
stakeholders	O
is	O
an	O
opportunity	O
to	O
put	O
in	O
place	O
an	O
Integrated	O
National	B-Document
Rabies	I-Document
Elimination	I-Document
Plan	E-Document
by	O
using	O
the	O
"	O
One	O
Health	O
"	O
Approach	O
that	O
will	O
be	O
in	O
the	O
heart	O
of	O
our	O
.	O

Other	O
notable	O
and	O
novel	O
elements	O
of	O
the	O
new	O
plan	O
include	O
a	O
stronger	O
emphasis	O
on	O
risk	O
assessment	O
and	O
the	O
priority	O
given	O
to	O
forecasting	O
and	O
modeling	O
,	O
Inglesby	S-Person
said	O
.	O

Brooks	S-Person
advanced	O
vital	O
improvements	O
to	O
our	O
federal	O
framework	O
for	O
emergency	O
preparedness	O
and	O
made	O
important	O
and	O
potentially	O
life-savings	O
reforms	O
to	O
modernize	O
our	O
readiness	O
,	O
enhance	O
federal	O
authorities	O
,	O
and	O
improve	O
information	O
sharing,	O
"	O
Rep.	O
said	O
.	O

What	O
the	O
events	O
of	O
the	O
past	O
couple	O
of	O
months	O
have	O
told	O
me	O
is	O
that	O
there's	O
a	O
problem	O
,	O
and	O
it's	O
a	O
symptom	O
of	O
a	O
broader	O
problem	O
of	O
laboratory	O
safety	O
.	O

Blake	B-Person
Bextine	E-Person
who	O
acts	O
as	O
program	O
manager	O
for	O
DARPA	S-Organization
's	O
project	O
,	O
wrote	O
in	O
a	O
statement	O
that	O
the	O
current	O
"	O
state-of-the-art	O
methods	O
and	O
technologies	O
for	O
protecting	O
staple	O
crops	O
,	O
and	O
especially	O
mature	O
plants,	O
"	O
are	O
not	O
up	O
to	O
the	O
challenge	O
of	O
responding	O
quickly	O
to	O
the	O
most	O
severe	O
threats	O
that	O
could	O
put	O
the	O
nation's	O
food	O
security	O
in	O
jeopardy	O
.	O

The	O
research	B-Organization
institutes	E-Organization
in	O
Harbin	S-Location
and	O
Lanzhou	S-Location
did	O
not	O
respond	O
to	O
's	O
questions	O
about	O
how	O
the	O
outbreak	O
occurred	O
,	O
or	O
their	O
lab's	O
safety	O
procedures	O
.	O

Critics	O
claimed	O
the	O
WHO	S-Organization
had	O
exaggerated	O
the	O
danger	O
,	O
spreading	O
"	O
fear	O
and	O
confusion	O
"	O
rather	O
than	O
"	O
immediate	O
information"	O
.	O

This	O
not	O
only	O
takes	O
a	O
great	O
deal	O
of	O
time	O
but	O
also	O
exposes	O
them	O
to	O
the	O
virus	O
because	O
,	O
for	O
those	O
wearing	O
protective	B-Equipment
clothing	E-Equipment
,	O
one	O
of	O
the	O
most	O
dangerous	O
moments	O
for	O
contracting	O
is	O
while	O
suits	O
are	O
being	O
removed	O
.	O

A	O
lengthy	O
partial	O
transcript	O
of	O
the	O
trial	O
proceedings	O
was	O
published	O
in	O
different	O
languages	O
the	O
following	O
year	O
by	O
a	O
Moscow	O
foreign	O
languages	O
press	O
,	O
including	O
an	O
English	O
language	O
edition	O
.	O

Mexico	S-Location
already	O
had	O
hundreds	O
of	O
non-lethal	O
cases	O
before	O
the	O
outbreak	O
was	O
officially	O
discovered	O
,	O
and	O
was	O
therefore	O
in	O
the	O
midst	O
of	O
a	O
"	O
silent	O
epidemic"	O
.	O

Given	O
the	O
system	O
,	O
there	O
was	O
an	O
obvious	O
need	O
to	O
develop	O
means	O
for	O
cross-sectoral	O
cooperation	O
between	O
national	O
laboratories	O
in	O
order	O
to	O
improve	O
the	O
country's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

The	O
index	O
case	O
of	O
the	O
new	O
flareup	O
was	O
reported	O
to	O
be	O
the	O
wife	O
of	O
a	O
patient	O
who	O
died	O
from	O
Ebola	S-Disease
in	O
Guinea	S-Location
;	O
she	O
had	O
travelled	O
to	O
after	O
the	O
funeral	O
but	O
succumbed	O
to	O
the	O
disease	O
.	O

Future	O
initiatives	O
fostering	O
private–public	O
partnership	O
are	O
strongly	O
recommended	O
for	O
successful	O
and	O
sustainable	O
outcomes	O
.	O

Female	O
prisoners	O
were	O
forced	O
to	O
become	O
pregnant	O
for	O
use	O
in	O
experiments	O
.	O

Of	O
course	O
,	O
work	O
like	O
this	O
is	O
not	O
free	O
,	O
so	O
it	O
was	O
also	O
important	O
to	O
pool	O
resources	O
with	O
the	O
international	O
community	O
.	O

An	O
agreement	O
was	O
signed	O
with	O
the	O
US	S-Location
and	O
UK	S-Organization
promising	O
to	O
end	O
bio-weapons	O
programs	O
and	O
convert	O
BW	O
facilities	O
to	O
benevolent	O
purposes	O
,	O
but	O
compliance	O
with	O
the	O
agreement	O
-	O
and	O
the	O
fate	O
of	O
the	O
bio-agents	O
and	O
facilities	O
-	O
is	O
still	O
mostly	O
undocumented	O
.	O

And	O
I've	O
established	O
a	O
high-level	O
working	O
group	O
chaired	O
by	O
Dr	O
.	O

For	O
example	O
,	O
documenting	O
the	O
inactivation	O
in	O
a	O
fail-safe	O
way	O
.	O

An	O
estimated	O
72 million	O
scans	O
were	O
performed	O
in	O
the	O
United	B-Location
States	E-Location
in	O
2007	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
biosafety	O
perception	O
and	O
practices	O
of	O
laboratory	O
technicians	O
during	O
routine	O
work	O
in	O
clinical	O
laboratories	O
of	O
.	O

In	O
many	O
nations	O
,	O
a	O
third	O
wave	O
occurred	O
in	O
early	O
1919	O
.	O

And	O
lately	O
,	O
we've	O
been	O
very	O
busy	O
.	O

Key	O
players	O
with	O
a	O
biopreparedness	O
perspective	O
in	O
's	O
crisis	O
management	O
system	O
were	O
identified	O
,	O
including	O
county	O
veterinarians	O
,	O
veterinarians	O
in	O
clinical	O
practice	O
,	O
food	O
inspectors	O
at	O
the	O
local	O
level	O
,	O
and	O
relevant	O
personnel	O
in	O
the	O
healthcare	O
sector	O
.	O

Of	O
note	O
,	O
their	O
published	O
finding	O
related	O
only	O
to	O
use	O
in	O
healthy	O
adults	O
with	O
influenza	O
but	O
not	O
in	O
patients	O
judged	O
to	O
be	O
at	O
high	O
risk	O
of	O
complications	O
(pregnant	O
women	O
,	O
children	O
under	O
five	O
and	O
those	O
with	O
underlying	O
medical	O
conditions)	O
,	O
and	O
uncertainty	O
over	O
its	O
role	O
in	O
reducing	O
complications	O
in	O
healthy	O
adults	O
still	O
left	O
it	O
as	O
a	O
useful	O
drug	O
for	O
reducing	O
the	O
duration	O
of	O
symptoms	O
.	O

The	O
CDC	S-Organization
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
obesity	O
and	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
International	O
Association	O
of	O
National	O
Public	O
Health	O
Institutes	O
.	O

Other	O
common	O
symptoms	O
include	O
cough	S-Phenotype
loss	B-Phenotype
of	I-Phenotype
appetite	E-Phenotype
,	O
fatigue	S-Phenotype
,	O
shortness	B-Phenotype
of	I-Phenotype
breath	E-Phenotype
,	O
sputum	B-Phenotype
production	E-Phenotype
,	O
and	O
muscle	B-Phenotype
and	I-Phenotype
joint	I-Phenotype
pains	E-Phenotype
.	O
Symptoms	O
such	O
as	O
nausea	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
and	O
have	O
been	O
observed	O
in	O
varying	O
percentages	O
.	O

Personal	O
hygiene	O
and	O
a	O
healthy	O
lifestyle	O
and	O
diet	O
have	O
been	O
recommended	O
to	O
improve	O
immunity	O
.	O

On	O
11	O
March	O
,	O
Carlo	B-Person
Urbani	E-Person
travelled	O
to	O
Bangkok	S-Location
,	O
Thailand	S-Location
,	O
to	O
attend	O
a	O
medical	O
conference	O
.	O

In	O
spite	O
of	O
the	O
end	O
of	O
civil	O
violence	O
since	O
2003	O
and	O
inflows	O
from	O
international	O
donors	O
,	O
the	O
reconstruction	O
of	O
Liberia	S-Location
had	O
been	O
very	O
slow	O
and	O
non-productive-water	O
delivery	O
systems	O
,	O
sanitation	O
facilities	O
and	O
centralised	O
electricity	O
were	O
practically	O
non-existent	O
,	O
even	O
in	O
.	O

Building	O
DNA	O
from	O
scratch	O
has	O
traditionally	O
been	O
too	O
expensive	O
and	O
inefficient	O
to	O
be	O
very	O
practical	O
,	O
but	O
in	O
2010	O
,	O
researchers	O
did	O
just	O
that	O
,	O
completely	O
synthesizing	O
the	O
genome	O
of	O
a	O
bacteria	O
and	O
injecting	O
it	O
into	O
a	O
living	O
cell	O
.	O

Here	O
,	O
we	O
present	O
strategies	O
worked	O
out	O
by	O
international	O
and	O
national	O
institutions	O
targeting	O
open	O
access	O
to	O
publicly	O
funded	O
research	O
data	O
via	O
incentives	O
or	O
obligations	O
to	O
share	O
data	O
.	O

WHO	S-Organization
collaborates	O
with	O
the	O
Global	B-Organization
Fund	I-Organization
to	I-Organization
fight	I-Organization
AIDS,	I-Organization
Tuberculosis	I-Organization
and	I-Organization
Malaria	E-Organization
,	O
UNITAID	S-Organization
,	O
and	O
the	O
United	B-Organization
States	I-Organization
President's	I-Organization
Emergency	I-Organization
Plan	I-Organization
for	I-Organization
AIDS	I-Organization
Relief	E-Organization
to	O
spearhead	O
and	O
fund	O
the	O
development	O
of	O
programs	O
.	O

Two-dimensional	B-Technology
CT	I-Technology
images	E-Technology
are	O
conventionally	O
rendered	O
so	O
that	O
the	O
view	O
is	O
as	O
though	O
looking	O
up	O
at	O
it	O
from	O
the	O
patient's	O
feet	O
.	O

The	O
report	O
also	O
raised	O
the	O
possibility	O
that	O
Metabiota	S-Organization
was	O
culturing	O
blood	O
cells	O
at	O
the	O
lab	O
,	O
something	O
the	O
report	O
said	O
was	O
dangerous	O
,	O
as	O
well	O
as	O
misdiagnosing	O
healthy	O
patients	O
.	O

Here	O
are	O
a	O
few	O
examples	O
of	O
how	O
things	O
can	O
go	O
wrong	O
.	O

So	O
called	O
dual	O
use	O
technologies	O
need	O
to	O
be	O
carefully	O
discussed	O
and	O
reviewed	O
both	O
at	O
the	O
government	O
level	O
(Federal	O
,	O
state	O
and	O
local)	O
both	O
in	O
and	O
globally	O
,	O
as	O
well	O
as	O
in	O
accessible	O
forums	O
for	O
bioethicists	O
,	O
educators	O
,	O
students	O
,	O
media	O
and	O
laypeople	O
to	O
learn	O
about	O
the	O
science	O
and	O
understand	O
these	O
risks	O
and	O
benefits	O
.	O

Details	O
of	O
the	O
experiments	O
were	O
known	O
only	O
to	O
Saddam	S-Person
and	O
an	O
inner	O
circle	O
of	O
senior	O
government	O
officials	O
and	O
Iraqi	O
scientists	O
educated	O
in	O
the	O
West.	O
…	O
The	O
facility	O
,	O
which	O
is	O
understood	O
to	O
have	O
been	O
built	O
by	O
German	O
engineers	O
in	O
the	O
1980s	O
,	O
has	O
been	O
at	O
the	O
centre	O
of	O
Iraq	S-Location
's	O
experiments	O
on	O
"	O
human	O
guinea	O
pigs	O
"	O
for	O
more	O
than	O
10	O
years	O
,	O
according	O
to	O
Israeli	O
military	O
sources	O
.	O

The	O
survey	O
was	O
kept	O
open	O
for	O
a	O
duration	O
of	O
10	O
working	O
days	O
,	O
and	O
responses	O
were	O
directly	O
downloaded	O
from	O
SM	S-Platform
and	O
analyzed/graphed	O
in	O
Microsoft	O
Excel	O
.	O

It	O
will	O
take	O
a	O
number	O
of	O
years	O
to	O
build	O
the	O
new	O
facility	O
and	O
have	O
it	O
certified	O
for	O
select-agent	O
research	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S	O
.	O

Significant	O
increases	O
in	O
public	O
education	O
about	O
bacteria	O
and	O
antibiotic	O
resistance	O
are	O
vitally	O
important	O
.	O

Secondly	O
,	O
at	O
the	O
receiving	O
end	O
,	O
if	O
USDA	S-Organization
discovered	O
that	O
what	O
they	O
had	O
was	O
contaminated	O
with	O
h5n1	S-Pathogen
,	O
was	O
it	O
not	O
also	O
incumbent	O
on	O
them	O
to	O
report	O
the	O
incident	O
on	O
May	O
23rd	O
when	O
they	O
found	O
out	O
that	O
this	O
was	O
going	O
on?	O
And	O
third	O
,	O
you	O
know	O
,	O
made	O
reference	O
to	O
the	O
gain	O
of	O
function	O
work	O
,	O
and	O
this	O
is	O
going	O
to	O
explode	O
that	O
issue	O
.	O

Although	O
resistant	O
to	O
several	O
antibiotics	O
,	O
the	O
afflicted	O
could	O
be	O
treated	O
with	O
alternative	O
agents	O
.	O

Chan	S-Person
,	O
director-general	O
of	O
the	O
,	O
said	O
the	O
virus	O
was	O
now	O
her	O
"	O
greatest	O
concern.	O
"	O

Among	O
the	O
Protocol's	O
provisions	O
was	O
a	O
ban	O
on	O
bacteriological	O
warfare	O
.	O

During	O
PRESAGED	S-Technology
development	O
,	O
all	O
of	O
the	O
test	O
subjects	O
did	O
eventually	O
display	O
overt	O
symptoms	O
of	O
disease	O
,	O
primarily	O
fever.	O
was	O
able	O
to	O
consistently	O
warn	O
of	O
possible	O
viral	O
or	O
bacterial	O
exposure	O
more	O
than	O
two	O
days	O
before	O
fever	O
developed	O
in	O
almost	O
all	O
animals	O
.	O

On	O
16	O
August	O
,	O
the	O
United	B-Location
Kingdom	E-Location
indicated	O
it	O
would	O
help	O
with	O
EVD	S-Disease
diagnosis	O
and	O
monitoring	O
in	O
the	O
.	O

The	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
is	O
developing	O
materials	O
to	O
provide	O
'second	O
skin'	O
protection	O
from	O
exposure	O
to	O
chemical	O
and	O
biological	O
agents	O
with	O
the	O
breathability	O
and	O
comfort	O
of	O
warfighters'	O
own	O
skin	O
.	O

That	O
plan	O
was	O
completed	O
in	O
May	O
1972	O
and	O
included	O
decontamination	O
of	O
facilities	O
at	O
Pine	B-Location
Bluff	E-Location
.	O
Other	O
agents	O
,	O
including	O
anti-crop	O
agents	O
such	O
as	O
wheat	B-Pathogen
stem	I-Pathogen
rust	E-Pathogen
,	O
were	O
stored	O
at	O
Beale	B-Location
Air	I-Location
Force	I-Location
Base	E-Location
and	O
Rocky	B-Location
Mountain	I-Location
Arsenal	E-Location
.	O
These	O
anti-crop	O
agents	O
,	O
along	O
with	O
agents	O
at	O
used	O
for	O
research	O
purposes	O
were	O
destroyed	O
in	O
March	O
1973	O
.	O

But	O
as	O
McDonnell	S-Person
pointed	O
out	O
last	O
week	O
,	O
a	O
new	O
plan	O
focused	O
on	O
big	O
data	O
and	O
distributed	O
sensors	O
is	O
needed	O
to	O
replace	O
a	O
slow	O
,	O
outmoded	O
program	O
that	O
he	O
called	O
unacceptable	O
.	O

Hence	O
,	O
the	O
title	O
of	O
Tuesday's	O
meeting	O
by	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
meeting	O
-	O
and	O
Starts:	O
Reactionary	O
Biodefense	O
,	O
he	O
said	O
.	O

To	O
do	O
this	O
,	O
we	O
have	O
used	O
a	O
unique	O
open	O
access	O
online	O
tool	O
,	O
the	O
Biosafety	B-Platform
Bibliographic	I-Platform
Database	E-Platform
(	O
BBD	S-Platform
)	O
that	O
has	O
been	O
provided	O
by	O
ICGEB	S-Organization
since	O
1990	O
.	O

Understanding	O
the	O
long-term	O
consequences	O
of	O
altering	O
genes	O
or	O
experimenting	O
in	O
other	O
ways	O
on	O
humans	O
can	O
be	O
difficult	O
without	O
traditional	O
,	O
controlled	O
experimentation	O
.	O

Treatment	O
,	O
in	O
the	O
case	O
of	O
acute	O
labyrinthitis	S-Disease
(inner	O
ear	O
disorder)	O
,	O
should	O
be	O
given	O
within	O
10	O
days	O
of	O
the	O
onset	O
of	O
symptoms	O
and	O
prochlorperazine	S-Drug
,	O
a	O
vestibular	O
sedative	O
,	O
may	O
be	O
administered	O
for	O
.	O

To	O
teach	O
safety	O
procedures	O
gradually	O
,	O
the	O
first	O
lab	O
focuses	O
on	O
counting	O
viruses	O
using	O
the	O
Plaque	O
Assay	O
method	O
.	O

Benefits:	O
Genome	O
editing	O
may	O
be	O
the	O
key	O
to	O
solving	O
currently	O
intractable	O
genetic	O
diseases	O
such	O
as	O
cystic	B-Disease
fibrosis	E-Disease
which	O
is	O
caused	O
by	O
a	O
single	O
genetic	O
defect	O
.	O

So	O
the	O
procedure	O
that	O
they	O
put	O
in	O
place	O
in	O
2006	O
was	O
appropriate	O
,	O
but	O
they	O
didn't	O
go	O
deep	O
enough	O
in	O
terms	O
of	O
outlining	O
,	O
all	O
right	O
,	O
how	O
do	O
we	O
make	O
sure	O
if	O
this	O
had	O
happened	O
,	O
that	O
we	O
don't	O
just	O
prevent	O
this	O
but	O
everything	O
like	O
this	O
from	O
happening	O
in	O
that	O
laboratory	O
.	O

Biotechnology	O
is	O
present	O
in	O
our	O
lives	O
before	O
we're	O
even	O
born	O
,	O
from	O
fertility	B-Technology
assistance	E-Technology
to	O
prenatal	B-Technology
screening	E-Technology
to	O
the	O
home	B-Technology
pregnancy	I-Technology
test	E-Technology
.	O
It	O
follows	O
us	O
through	O
childhood	O
,	O
with	O
immunizations	O
and	O
antibiotics	O
,	O
both	O
of	O
which	O
have	O
drastically	O
improved	O
life	O
expectancy	O
.	O

Both	O
incidents	O
were	O
reported	O
to	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization

The	O
same	O
year	O
Pentagon	S-Organization
biologists	O
studied	O
the	O
virus	O
in	O
Georgia	S-Location
under	O
the	O
DTRA	B-Scientific_research_project
project	E-Scientific_research_project
"	O
Epidemiology	B-Scientific_research_project
of	I-Scientific_research_project
febrile	I-Scientific_research_project
illnesses	I-Scientific_research_project
caused	I-Scientific_research_project
by	I-Scientific_research_project
Dengue	I-Scientific_research_project
viruses	I-Scientific_research_project
and	I-Scientific_research_project
other	I-Scientific_research_project
Arboviruses	I-Scientific_research_project
in	I-Scientific_research_project
Georgia	E-Scientific_research_project
"	O
.	O
The	O
project	O
included	O
tests	O
on	O
patients	O
with	O
fever	S-Phenotype
symptoms	O
and	O
the	O
collection	O
of	O
ticks	O
,	O
as	O
possible	O
vectors	O
of	O
for	O
laboratory	O
analysis	O
.	O

"	O
Further	O
spread	O
is	O
considered	O
inevitable,	O
"	O
Chan	S-Person
said	O
at	O
a	O
news	O
conference	O
at	O
WHO	B-Location
headquarters	E-Location
in	O
Geneva	S-Location
,	O
.	O
"	O
The	O
scientific	O
criteria	O
for	O
an	O
influenza	O
pandemic	O
have	O
been	O
met.	O
"	O

See	O
,	O
generally	O
,	O
Article	O
18	O
of	O
the	O
.	O

The	O
incident	O
was	O
the	O
first	O
and	O
is	O
the	O
single	O
largest	O
bioterrorist	O
attack	O
in	O
United	O
States	O
history	O
.	O

Biodefense:	O
Worldwide	O
Threats	O
and	O
Countermeasure	O
Efforts	O
for	O
the	O
Department	O
of	O
Defense	O
:	O
Hearing	O
Before	O
the	O
Subcommittee	O
on	O
Intelligence	O
,	O
Emerging	O
Threats	O
and	O
Capabilities	O
of	O
the	O
Committee	O
on	O
Armed	O
Services	O
,	O
,	O
One	O
Hundred	O
Thirteenth	O
Congress	O
,	O
First	O
Session	O
,	O
Hearing	O
Held	O
October	O
11	O
,	O
2013.	O
p.	O
34	O
.	O

This	O
provided	O
"	O
the	O
first	O
time	O
that	O
the	O
real	O
evolution	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
[could]	O
be	O
observed	O
in	O
humans.	O
"	O
The	O
research	O
showed	O
that	O
the	O
outbreak	B-Incident
in	I-Incident
Sierra	I-Incident
Leone	E-Incident
was	O
sparked	O
by	O
at	O
least	O
two	O
distinct	O
lineages	O
introduced	O
from	O
Guinea	S-Location
at	O
about	O
the	O
same	O
time	O
.	O

Real-time	B-Technology
MRI	E-Technology
refers	O
to	O
the	O
continuous	O
imaging	O
of	O
moving	O
objects	O
(such	O
as	O
the	O
heart)	O
in	O
real	O
time	O
.	O

During	O
the	O
planned	O
3.	O
5-year	O
PREEMPT	S-Scientific_research_project
program	O
,	O
DARPA	S-Organization
aims	O
to	O
identify	O
signatures	O
of	O
viral	O
fitness	O
and	O
the	O
potential	O
for	O
spillover	O
from	O
one	O
species	O
to	O
another	O
;	O
develop	O
risk	O
classifiers	O
and	O
predict	O
pathways	O
of	O
viral	O
adaptation	O
;	O
and	O
test	O
initial	O
intervention	O
approaches	O
.	O

The	O
genes	O
that	O
encode	O
carbapenemases	O
are	O
found	O
on	O
conjugative	O
plasmids	O
and	O
commonly	O
fall	O
in	O
the	O
following	O
classes:	O
KPC	O
(Klebsiella	O
pneumoniae	O
carbapenemase)	O
,	O
NDM	O
(New	O
Delhi	O
metallo-β-lactamase)	O
,	O
IMP	O
(imipenamase)	O
,	O
and	O
VIM	O
(Verona	O
integron-encoded	O
metallo-β-lactamase)	O
(1)	O
.	O

Ricin	S-Pathogen
is	O
an	O
extremely	O
toxic	O
plant	O
protein	O
that	O
can	O
cause	O
severe	O
allergic	O
reactions	O
,	O
and	O
exposure	O
to	O
small	O
quantities	O
can	O
be	O
fatal	O
.	O

He	O
said	O
that	O
if	O
the	O
Medfly	O
were	O
to	O
become	O
established	O
in	O
,	O
pesticide	O
use	O
by	O
farmers	O
and	O
homeowners	O
would	O
increase	O
.	O

Excessive	O
antibiotic	O
use	O
has	O
become	O
one	O
of	O
the	O
top	O
contributors	O
to	O
the	O
development	O
of	O
antibiotic	O
resistance	O
.	O

In	O
December	O
2017	O
,	O
The	O
Washington	B-Organization
Post	E-Organization
reported	O
that	O
the	O
Trump	S-Person
administration	O
had	O
issued	O
a	O
list	O
of	O
seven	O
words	O
that	O
were	O
forbidden	O
in	O
official	O
CDC	S-Organization
documentation	O
.	O

The	O
CDC	S-Organization
mission	O
and	O
role	O
in	O
implementing	O
the	O
PAHPRA	S-Document
,	O
Redd	S-Person
said	O
,	O
requires	O
that	O
provides	O
the	O
country's	O
common	O
defense	O
against	O
public	O
health	O
threats	O
,	O
including	O
infectious	O
diseases	O
,	O
terrorism	O
and	O
natural	O
disasters	O
.	O

Strategies	O
that	O
block	O
the	O
publication	O
of	O
certain	O
research	O
material	O
would	O
deter	O
the	O
free	O
flow	O
of	O
information	O
,	O
impede	O
careers	O
,	O
and	O
discourage	O
many	O
from	O
entering	O
the	O
research	O
field	O
.	O

On	O
20	O
October	O
2018	O
,	O
an	O
armed	O
rebel	O
group	O
in	O
the	O
DRC	S-Location
killed	O
some	O
13	O
civilians	O
and	O
took	O
12	O
children	O
as	O
hostages	O
in	O
Beni	S-Location
,	O
which	O
was	O
experiencing	O
one	O
of	O
the	O
worst	O
outbreaks	O
.	O

For	O
this	O
reason	O
,	O
most	O
essentially	O
map	O
the	O
location	O
of	O
water	O
and	O
fat	O
in	O
the	O
body	O
.	O

He	O
is	O
a	O
minority	O
voice	O
on	O
the	O
panel	O
on	O
that	O
point	O
.	O

The	O
2016	O
study	O
suggested	O
that	O
the	O
low	O
flu	O
mortality	O
rate	O
(an	O
estimated	O
1/1000)	O
found	O
among	O
the	O
Chinese	O
and	O
Southeast	O
Asian	O
workers	O
in	O
Europe	O
meant	O
that	O
the	O
deadly	O
could	O
not	O
have	O
originated	O
from	O
those	O
workers	O
.	O

The	O
type	O
of	O
respiratory	O
support	O
for	O
individuals	O
with	O
COVID‑19	S-Disease
related	O
respiratory	B-Phenotype
failure	E-Phenotype
is	O
being	O
actively	O
studied	O
for	O
people	O
in	O
the	O
hospital	O
,	O
with	O
some	O
evidence	O
that	O
intubation	O
can	O
be	O
avoided	O
with	O
a	O
high	O
flow	O
nasal	O
cannula	O
or	O
bi-level	O
positive	O
airway	O
pressure	O
.	O

Political	O
scientist	O
Andrew	B-Person
Price-Smith	E-Person
published	O
data	O
from	O
the	O
Austrian	O
archives	O
suggesting	O
the	O
influenza	S-Disease
began	O
in	O
in	O
early	O
1917	O
.	O

Conflicting	O
usability	O
requirements	O
of	O
two	O
groups	O
-	O
metadata	O
creators	O
and	O
metadata	O
users	O
-	O
are	O
identified	O
along	O
with	O
associated	O
limitations	O
of	O
current	O
metadata	O
standards	O
.	O

But	O
that	O
depends	O
on	O
what	O
we	O
do	O
as	O
a	O
society,	O
"	O
he	O
said	O
.	O

Furthermore	O
,	O
genetic	B-Technology
engineering	E-Technology
is	O
not	O
merely	O
a	O
theoretical	O
possibility	O
for	O
future	O
biowarfare:	O
it	O
has	O
already	O
been	O
applied	O
in	O
past	O
weapons	O
programmes	O
,	O
particularly	O
in	O
the	O
former	B-Location
Soviet	I-Location
Union	E-Location
.	O
One	O
example	O
is	O
the	O
USSR	S-Location
's	O
'	O
invisible	B-Disease
anthrax	E-Disease
'	O
,	O
resulting	O
from	O
the	O
introduction	O
of	O
an	O
alien	O
gene	O
into	O
that	O
altered	O
its	O
immunological	O
properties	O
(Pomerantsev	O
et	O
al.	O
,	O
1997)	O
.	O

The	O
pandemic	O
virus	O
is	O
a	O
type	O
of	O
swine	B-Disease
influenza	E-Disease
derived	O
originally	O
from	O
a	O
strain	O
which	O
lived	O
in	O
pigs	O
,	O
and	O
this	O
origin	O
gave	O
rise	O
to	O
the	O
common	O
name	O
of	O
"	O
swine	B-Disease
flu	E-Disease
"	O
.	O
This	O
term	O
is	O
widely	O
used	O
by	O
mass	O
media	O
,	O
though	O
the	O
Paris	S-Location
-based	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
as	O
well	O
as	O
industry	O
groups	O
such	O
as	O
the	O
U.S.	B-Organization
National	I-Organization
Pork	I-Organization
Board	E-Organization
,	O
the	O
American	B-Organization
Meat	I-Organization
Institute	E-Organization
,	O
and	O
the	O
Canadian	B-Organization
Pork	I-Organization
Council	E-Organization
objected	O
to	O
widespread	O
media	O
use	O
of	O
the	O
name	O
"	O
swine	B-Disease
flu	E-Disease
"	O
and	O
suggested	O
it	O
should	O
be	O
called	O
"	O
North	B-Disease
American	I-Disease
flu	E-Disease
"	O
instead	O
,	O
while	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
switched	O
its	O
designation	O
from	O
"	O
swine	B-Disease
influenza	E-Disease
"	O
to	O
"	O
influenza	B-Disease
A	I-Disease
(H1N1)	E-Disease
"	O
in	O
late	O
April	O
2009	O
.	O

Robert	B-Person
Kadlec	E-Person
MD	O
,	O
HHS	S-Organization
Assistant	O
Secretary	O
of	O
Preparedness	O
and	O
Response	O
(	O
ASPR	S-Organization
)	O
today	O
fleshed	O
out	O
more	O
details	O
about	O
the	O
presidential	O
directive	O
,	O
saying	O
leaders	O
from	O
every	O
federal	O
department	O
involved	O
in	O
biodefense	O
will	O
be	O
part	O
of	O
the	O
cabinet-level	O
steering	O
committee	O
and	O
will	O
be	O
led	O
by	O
HHS	S-Organization
Secretary	O
.	O

However	O
,	O
remdesivir	S-Drug
may	O
have	O
an	O
effect	O
on	O
the	O
time	O
it	O
takes	O
to	O
recover	O
from	O
the	O
virus	O
.	O

And	O
,	O
of	O
course	O
,	O
modern	O
civilization	O
would	O
hardly	O
be	O
imaginable	O
without	O
the	O
fermentation	O
processes	O
that	O
gave	O
us	O
beer	O
,	O
wine	O
,	O
and	O
cheese!	O

Pratt	S-Person
,	O
Robert	B-Person
J	E-Person
.	O
"	O
Invasive	O
Species	O
-	O
A	O
Threat	O
to	O
the	O
Homeland?	O
"	O
,	O
USAWC	B-Scientific_research_project
Strategy	I-Scientific_research_project
Research	I-Scientific_research_project
Project	E-Scientific_research_project
,	O
,	O
April	O
7	O
,	O
2003	O
,	O
accessed	O
February	O
21	O
,	O
2012	O
.	O

MPR	S-Organization
is	O
frequently	O
used	O
for	O
examining	O
the	O
spine	O
.	O

Each	O
virion	O
contains	O
one	O
molecule	O
of	O
linear	O
,	O
single-stranded	O
,	O
negative-sense	O
RNA	O
,	O
18,959	O
to	O
18,961	O
nucleotides	O
in	O
length	O
.	O

Thomas	B-Person
Inglesby	E-Person
MD	O
,	O
is	O
Chief	O
Executive	O
Officer	O
and	O
Director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
,	O
University	B-Organization
of	I-Organization
Pittsburgh	I-Organization
Medical	I-Organization
Center	E-Organization
.	O
His	O
work	O
is	O
internationally	O
recognized	O
in	O
the	O
fields	O
of	O
public	O
health	O
preparedness	O
,	O
pandemic	O
flu	O
and	O
epidemic	O
planning	O
,	O
and	O
biosecurity.Dr	O
.	O

There's	O
just	O
one	O
problem	O
-	O
President	O
's	O
trade	O
war	O
.	O

Before	O
hitting	O
age	O
30	O
,	O
he	O
was	O
diagnosed	O
with	O
high	O
risk	O
of	O
stroke	S-Disease
and	O
heart	B-Disease
attack	E-Disease
,	O
suffered	O
from	O
cognitive	B-Disease
dysfunction	E-Disease
,	O
and	O
weighed	O
300	O
pounds.	O
"	O
I	O
just	O
wanted	O
to	O
control	O
my	O
own	O
biology	O
because	O
I	O
was	O
tired	O
of	O
being	O
in	O
pain	O
and	O
having	O
,	O
"	O
he	O
told	O
me	O
.	O

Many	O
of	O
the	O
studies	O
weren't	O
done	O
in	O
humans	O
but	O
in	O
rats	O
and	O
mice	O
.	O

OPERATOR:	O
On	O
the	O
phone	O
lines	O
again	O
if	O
you'd	O
like	O
to	O
ask	O
a	O
question	O
,	O
just	O
press	O
star-1	O
.	O

1988:	O
The	O
Global	B-Activity
Polio	I-Activity
Eradication	I-Activity
Initiative	E-Activity
was	O
established	O
.	O

The	O
strong	O
link	O
between	O
increased	O
consumption	O
and	O
resistance	O
indicates	O
that	O
this	O
will	O
directly	O
mitigate	O
the	O
accelerating	O
spread	O
of	O
AMR	O
.	O

Because	O
the	O
only	O
1918	B-Pathogen
pandemic	I-Pathogen
virus	E-Pathogen
samples	O
we	O
have	O
yet	O
identified	O
are	O
from	O
second-wave	O
patients	O
,	O
nothing	O
can	O
yet	O
be	O
said	O
about	O
whether	O
the	O
first	O
(spring)	O
wave	O
,	O
or	O
for	O
that	O
matter	O
,	O
the	O
third	O
wave	O
,	O
represented	O
circulation	O
of	O
the	O
same	O
virus	O
or	O
variants	O
of	O
it	O
.	O

The	O
protagonist	O
of	O
the	O
operetta	O
was	O
a	O
stock	O
Don	B-Person
Juan	E-Person
type	O
.	O

Authorities	O
believe	O
the	O
current	O
infestation	O
began	O
in	O
Whittier	S-Location
where	O
a	O
Medfly	O
was	O
first	O
trapped	O
on	O
Sept.26	O
.	O

In	O
the	O
event	O
of	O
a	O
crisis	O
,	O
network	O
activation	O
relies	O
on	O
a	O
request	O
of	O
assistance	O
from	O
any	O
of	O
the	O
network	O
agencies	O
.	O

On	O
15	O
February	O
,	O
the	O
U.S.	S-Location
announced	O
it	O
would	O
evacuate	O
Americans	O
aboard	O
the	O
cruise	O
ship	O
Diamond	O
Princess	O
,	O
and	O
on	O
21	O
February	O
,	O
Canada	S-Location
evacuated	O
129	O
Canadian	O
passengers	O
from	O
the	O
ship	O
.	O

BioMart	O
is	O
an	O
example	O
of	O
a	O
data	O
warehouse	O
system	O
.	O

CAUTION:	O
Protocols	O
using	O
live	O
animals	O
must	O
first	O
be	O
reviewed	O
and	O
approved	O
by	O
an	O
Institutional	B-Organization
Animal	I-Organization
Care	I-Organization
and	I-Organization
Use	I-Organization
Committee	E-Organization
()	O
or	O
must	O
conform	O
to	O
governmental	O
regulations	O
regarding	O
the	O
care	O
and	O
use	O
of	O
laboratory	O
animals	O
.	O

Nonetheless	O
,	O
these	O
periods	O
need	O
to	O
be	O
justified	O
as	O
required	O
by	O
the	O
Wellcome	B-Organization
Trust	E-Organization
Mechanisms	O
to	O
give	O
credit	O
to	O
authors	O
of	O
data	O
are	O
an	O
additional	O
incentive	O
to	O
overcome	O
the	O
reluctance	O
of	O
sharing	O
data	O
.	O

In	O
a	O
1998	O
correspondence	O
letter	O
between	O
the	O
DOJ	S-Organization
and	O
Rabbi	B-Person
Abraham	I-Person
Cooper	E-Person
,	O
Eli	B-Person
Rosenbaum	E-Person
,	O
director	O
of	O
OSI	S-Organization
,	O
stated	O
that	O
this	O
was	O
due	O
to	O
two	O
factors.	O
(1)	O
While	O
most	O
documents	O
captured	O
by	O
the	O
US	S-Location
in	O
Europe	S-Location
were	O
microfilmed	O
before	O
being	O
returned	O
to	O
their	O
respective	O
governments	O
,	O
the	O
decided	O
to	O
not	O
microfilm	O
its	O
vast	O
collection	O
of	O
documents	O
before	O
returning	O
them	O
back	O
to	O
the	O
Japanese	O
government	O
.	O

Zilinskas	S-Person
said	O
of	O
the	O
Russians.	O
"	O
We	O
have	O
to	O
know	O
what	O
we're	O
defending	O
against.	O
"	O
He	O
added	O
that	O
the	O
Russians	O
undoubtedly	O
still	O
possessed	O
the	O
strain	O
.	O

Their	O
analysis	O
suggests	O
that	O
temporal	O
variations	O
in	O
transmission	O
rate	O
provide	O
the	O
best	O
explanation	O
,	O
and	O
the	O
variation	O
in	O
transmission	O
required	O
to	O
generate	O
these	O
three	O
waves	O
is	O
within	O
biologically	O
plausible	O
values	O
.	O

The	O
program	O
must	O
ensure	O
each	O
location	O
is	O
able	O
to	O
perform	O
daily	O
sample	O
collection	O
and	O
analysis	O
in	O
a	O
timely	O
manner	O
and	O
be	O
flexible	O
enough	O
to	O
provide	O
additional	O
coverage	O
for	O
large	O
special	O
security	O
or	O
other	O
high-risk	O
events	O
.	O

With	O
deaths	O
of	O
1,100	O
children	O
and	O
7,500	O
adults	O
18	O
to	O
64	O
,	O
these	O
figures	O
were	O
deemed	O
"	O
much	O
higher	O
than	O
in	O
a	O
usual	O
flu	O
season	O
"	O
during	O
the	O
pandemic	O
.	O

The	O
standard	O
test	O
for	O
current	O
infection	O
with	O
SARS-CoV-2	S-Pathogen
uses	O
RNA	B-Technology
testing	E-Technology
of	O
respiratory	O
secretions	O
collected	O
using	O
a	O
nasopharyngeal	O
swab	O
,	O
though	O
it	O
is	O
possible	O
to	O
test	O
other	O
samples	O
.	O

Different	O
types	O
of	O
Brucella	S-Pathogen
occur	O
in	O
many	O
mammals	O
species	O
,	O
but	O
infections	O
are	O
most	O
commonly	O
detected	O
in	O
farm	O
animals	O
such	O
as	O
goats	O
,	O
sheep	O
,	O
cattle	O
and	O
pigs	O
.	O

Individuals	O
responsible	O
for	O
performing	O
exams	O
are	O
called	O
radiographers	O
or	O
radiologic	O
technologists	O
.	O

The	O
city's	O
mayor	O
also	O
insisted	O
that	O
the	O
incident	O
does	O
not	O
pose	O
any	O
biological	O
or	O
any	O
other	O
threat	O
to	O
the	O
local	O
population	O
,	O
according	O
to	O
.	O

Outbreaks	O
have	O
occurred	O
in	O
prisons	O
due	O
to	O
crowding	O
and	O
an	O
inability	O
to	O
enforce	O
adequate	O
social	O
distancing	O
.	O

In	O
April	O
,	O
the	O
department	O
said	O
technology	O
upgrades	O
for	O
BioWatch	S-Document
would	O
better	O
address	O
a	O
wider	O
range	O
of	O
bioterrorism	O
threats	O
,	O
provide	O
real-time	O
data	O
across	O
,	O
and	O
enhance	O
information-sharing	O
between	O
operators	O
at	O
the	O
federal	O
,	O
state	O
and	O
local	O
levels	O
.	O

BASE	S-Platform
for	O
microarray	O
transcriptomics	O
or	O
for	O
a	O
combination	O
of	O
transcriptomics	O
,	O
metabolomics	O
and	O
proteomics	O
.	O

Another	O
important	O
safety	O
aspect	O
of	O
the	O
lab	O
is	O
a	O
low	O
student‐to‐instructor	O
ratio	O
.	O

(	O
CNN	S-Organization
Trump	S-Person
's	O
recent	O
declaration	O
that	O
is	O
no	O
longer	O
a	O
nuclear	O
threat	O
,	O
despite	O
a	O
lack	O
of	O
verifiable	O
proof	O
that	O
the	O
regime	O
will	O
put	O
an	O
end	O
to	O
its	O
nuclear	O
program	O
,	O
has	O
not	O
completely	O
quelled	O
national	O
security	O
concerns	O
about	O
nuclear	O
war	O
.	O

The	O
company's	O
second-generation	O
test	O
system	O
may	O
be	O
able	O
to	O
provide	O
results	O
the	O
same	O
day	O
that	O
the	O
test	O
is	O
started	O
.	O

A	O
total	O
of	O
1832	O
initiatives	O
of	O
biosafety/biosecurity	O
were	O
recorded	O
from	O
97	O
web	O
links	O
;	O
70.68%	O
(n = 1295)	O
initiatives	O
were	O
focused	O
on	O
raising	O
general	O
awareness	O
among	O
the	O
scientific	O
community	O
about	O
biosafety/biosecurity/biocontainment	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
works	O
to	O
provide	O
the	O
needed	O
health	O
and	O
well-being	O
evidence	O
through	O
a	O
variety	O
of	O
data	O
collection	O
platforms	O
,	O
including	O
the	O
World	B-Platform
Health	I-Platform
Survey	E-Platform
covering	O
almost	O
400,000	O
respondents	O
from	O
70	O
countries	O
,	O
and	O
the	O
Study	B-Platform
on	I-Platform
Global	I-Platform
Aging	I-Platform
and	I-Platform
Adult	I-Platform
Health	E-Platform
(	O
SAGE	S-Platform
)	O
covering	O
over	O
50,000	O
persons	O
over	O
50	O
years	O
old	O
in	O
23	O
countries	O
.	O

This	O
was	O
traced	O
to	O
the	O
inability	O
of	O
podocytes	O
to	O
form	O
microvilli	O
between	O
adjacent	O
cells	O
.	O

United	B-Organization
Nations	I-Organization
Security	I-Organization
Council	E-Organization
(1991)	O
,	O
Report	B-Document
of	I-Document
the	I-Document
Secretary-General	I-Document
on	I-Document
the	I-Document
Status	I-Document
of	I-Document
the	I-Document
Implementation	I-Document
of	I-Document
the	I-Document
Special	I-Document
Commission's	I-Document
Plan	I-Document
for	I-Document
the	I-Document
Ongoing	I-Document
Monitoring	I-Document
and	I-Document
Verification	I-Document
of	I-Document
Iraq's	I-Document
Compliance	I-Document
With	I-Document
Relevant	I-Document
Parts	I-Document
of	I-Document
Section	I-Document
C	I-Document
of	I-Document
Security	I-Document
Council	I-Document
Resolution	I-Document
687	E-Document
,	O
New	B-Location
York	E-Location
,	O
NY	S-Location
:	O
United	B-Organization
Nations	E-Organization
,	O
1995	O
.	O

The	O
study	O
was	O
part	O
of	O
a	O
larger	O
project	O
titled	O
"	O
Scientific	B-International_exchange_and_cooperation
Engagement:	I-International_exchange_and_cooperation
Defining	I-International_exchange_and_cooperation
Gaps	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Creating	I-International_exchange_and_cooperation
Opportunities	I-International_exchange_and_cooperation
for	I-International_exchange_and_cooperation
Cooperative	I-International_exchange_and_cooperation
Research	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Global	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
in	I-International_exchange_and_cooperation
the	I-International_exchange_and_cooperation
Broader	I-International_exchange_and_cooperation
Middle	I-International_exchange_and_cooperation
East	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
North	I-International_exchange_and_cooperation
Africa	I-International_exchange_and_cooperation
(BMENA)	I-International_exchange_and_cooperation
Region	E-International_exchange_and_cooperation
and	O
was	O
funded	O
by	O
the	O
American	B-Organization
Association	I-Organization
for	I-Organization
the	I-Organization
Advancement	I-Organization
of	I-Organization
Science	E-Organization
()	O
Grant	O
#	O
2492	O
–	O
Pat	O
–	O
ERC	O
.	O

Scientists	O
hope	O
these	O
advances	O
,	O
and	O
the	O
insights	O
they	O
enable	O
,	O
will	O
ultimately	O
make	O
it	O
easier	O
to	O
make	O
custom	O
cells	O
to	O
serve	O
as	O
medicines	O
or	O
even	O
bomb-sniffing	O
plants	O
.	O

US	O
response	O
would	O
include	O
the	O
.	O

During	O
1348	O
,	O
records	O
show	O
the	O
city	O
of	O
Mosul	S-Location
suffered	O
a	O
massive	O
epidemic	O
,	O
and	O
the	O
city	O
of	O
experienced	O
a	O
second	O
round	O
of	O
the	O
disease	O
.	O

It	O
seemed	O
logical	O
to	O
keep	O
the	O
center	O
and	O
its	O
research	O
in	O
an	O
isolated	O
setting	O
,	O
which	O
Plum	B-Location
Island	E-Location
provided	O
.	O

BioWatch	S-Document
currently	O
maintains	O
operational	O
laboratories	O
in	O
approximately	O
30	O
jurisdictions	O
across	O
the	O
country	O
.	O

Dr	O
.	O

Because	O
we	O
all	O
share	O
responsibility	O
for	O
making	O
sure	O
that	O
the	O
work	O
we	O
do	O
is	O
done	O
safely	O
and	O
securely	O
.	O

Remdesivir	S-Drug
was	O
originally	O
created	O
and	O
developed	O
by	O
Gilead	B-Organization
Sciences	E-Organization
in	O
2009	O
,	O
as	O
part	O
of	O
the	O
company's	O
research	O
and	O
development	O
program	O
for	O
hepatitis	B-Disease
C	E-Disease
.	O
It	O
did	O
not	O
work	O
against	O
hepatitis	B-Disease
C	E-Disease
as	O
hoped	O
,	O
but	O
was	O
then	O
repurposed	O
and	O
studied	O
as	O
a	O
potential	O
treatment	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
and	O
Marburg	B-Disease
virus	I-Disease
infections	E-Disease
.	O
According	O
to	O
the	O
Czech	B-Organization
News	I-Organization
Agency	E-Organization
,	O
this	O
new	O
line	O
of	O
research	O
was	O
carried	O
out	O
under	O
the	O
direction	O
of	O
scientist	O
Tomáš	B-Person
Cihlář	E-Person
.	O
Czech	B-Organization
News	I-Organization
Agency	E-Organization
,	O
"	O
Did	O
Czech	S-Location
scientists	O
create	O
the	O
cure	O
for	O
coronavirus	S-Pathogen
?	O
"	O
,	O
Aktuálně.cz	S-Person
,	O
5	O
February	O
2020	O
.	O

Benefits:	O
Simply	O
put	O
,	O
our	O
world	O
has	O
been	O
reshaped	O
by	O
rDNA	O
.	O

While	O
building	O
a	O
database	O
of	O
dangerous	O
bacterial	O
strains	O
will	O
be	O
helpful	O
for	O
surveillance	O
and	O
for	O
researchers	O
working	O
on	O
antibiotic	O
development	O
,	O
the	O
ultimate	O
goal	O
of	O
ARMADA	S-Scientific_research_project
is	O
to	O
translate	O
this	O
knowledge	O
into	O
clinical	O
action	O
,	O
in	O
real	O
time	O
,	O
through	O
the	O
development	O
of	O
rapid	O
diagnostic	O
tests	O
that	O
can	O
quickly	O
identify	O
these	O
dangerous	O
bacterial	O
strains	O
and	O
guide	O
appropriate	O
antibiotic	O
therapy	O
.	O

Robin	B-Person
Cook	E-Person
used	O
the	O
Sverdlovsk	B-Incident
anthrax	I-Incident
leak	E-Incident
as	O
a	O
plot	O
device	O
in	O
his	O
novel	O
Vector	S-Document
.	O
In	O
the	O
novel	O
,	O
a	O
Russian	O
immigrant	O
named	O
Yuri	B-Person
Davydov	E-Person
works	O
with	O
a	O
neo-Nazi	O
group	O
to	O
plan	O
an	O
anthrax	S-Pathogen
attack	O
on	O
New	B-Location
York	I-Location
City	E-Location
.	O
Yuri	S-Person
learned	O
to	O
develop	O
anthrax	O
while	O
he	O
was	O
working	O
at	O
the	O
Biopreparat	B-Equipment
facility	E-Equipment
in	O
Sverdlovsk	S-Location
.	O
The	O
character	O
was	O
present	O
when	O
the	O
leak	O
happened	O
and	O
his	O
mother	O
was	O
one	O
of	O
the	O
victims	O
.	O

So	O
you	O
see	O
the	O
response	O
to	O
Lassa	S-Disease
is	O
a	O
multi-pronged	O
attack	O
.	O

Frieden	S-Person
.	O
I	O
guess	O
my	O
question	O
is	O
the	O
report	O
actually	O
details	O
four	O
other	O
incidents	O
in	O
addition	O
to	O
the	O
last	O
month's	O
anthrax	O
release	O
.	O

The	O
standard	O
method	O
of	O
diagnosis	O
is	O
by	O
real-time	B-Technology
reverse	I-Technology
transcription	I-Technology
polymerase	I-Technology
chain	I-Technology
reaction	E-Technology
(	O
rRT-PCR	S-Technology
)	O
from	O
a	O
nasopharyngeal	B-Equipment
swab	E-Equipment
.	O
Chest	B-Technology
CT	I-Technology
imaging	E-Technology
may	O
also	O
be	O
helpful	O
for	O
diagnosis	O
in	O
individuals	O
where	O
there	O
is	O
a	O
high	O
suspicion	O
of	O
infection	O
based	O
on	O
symptoms	O
and	O
risk	O
factors	O
;	O
however	O
,	O
guidelines	O
do	O
not	O
recommend	O
using	O
for	O
routine	O
screening	O
.	O

PRESAGED	S-Technology
is	O
the	O
first	O
system	O
capable	O
of	O
giving	O
early	O
warning	O
of	O
incipient	O
disease	O
symptoms	O
(e.g.	O
,	O
fever)	O
.	O

Retrieved	O
22	O
January	O
2020	O
and	O
a	O
teacher	O
at	O
Shenzhen	B-Organization
Polytechnic	E-Organization
,	O
he	O
had	O
been	O
sick	O
for	O
approximately	O
one	O
month	O
before	O
his	O
death	O
,	O
but	O
he	O
was	O
originally	O
diagnosed	O
with	O
pneumonia	S-Disease
.Reported	O
on	O
CBS	S-Organization
's	O
The	O
Early	O
Show	O
Tatiana	B-Person
Morales	E-Person
:	O
American	O
Family	O
Affected	O
By	O
SARS	S-Disease
11	O
April	O
2003	O
,	O
CBS	B-Organization
News	E-Organization
.	O
Retrieved	O
22	O
January	O
2020	O
His	O
son	O
Michael	B-Person
"	O
Mickey"	I-Person
Salisbury	E-Person
was	O
with	O
him	O
in	O
China	S-Location
and	O
also	O
contracted	O
the	O
disease	O
,	O
but	O
he	O
survived	O
it	O
.	O

In	O
a	O
study	O
published	O
by	O
the	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
mapping	O
antimicrobial	O
consumption	O
in	O
livestock	O
globally	O
,	O
it	O
was	O
predicted	O
that	O
in	O
the	O
228	O
countries	O
studied	O
,	O
there	O
would	O
be	O
a	O
total	O
67%	O
increase	O
in	O
consumption	O
of	O
antibiotics	O
by	O
livestock	O
by	O
2030	O
.	O

Notably	O
,	O
the	O
disease	O
was	O
left	O
untreated	O
in	O
the	O
research	O
subjects	O
and	O
they	O
never	O
gave	O
their	O
informed	O
consent	O
to	O
serve	O
as	O
research	O
subjects	O
.	O

Thirteen	O
years	O
since	O
the	O
last	O
publicly	O
acknowledged	O
outbreak	O
from	O
a	O
BSL-4	S-Platform
facility	O
is	O
not	O
good	O
enough	O
.	O

In	O
late	O
2019	O
,	O
the	O
WHO	S-Organization
assigned	O
emergency	O
ICD-10	O
disease	O
codes	O
U07.	O
1	O
for	O
deaths	O
from	O
lab-confirmed	O
SARS-CoV-2	B-Disease
infection	E-Disease
and	O
U07.	O
2	O
for	O
deaths	O
from	O
clinically	O
or	O
epidemiologically	O
diagnosed	O
COVID‑19	S-Disease
without	O
lab-confirmed	O
infection	O
.	O

The	O
basic	O
reproduction	O
number	O
(the	O
average	O
number	O
of	O
other	O
individuals	O
whom	O
each	O
infected	O
individual	O
will	O
infect	O
,	O
in	O
a	O
population	O
which	O
has	O
no	O
immunity	O
to	O
the	O
disease)	O
for	O
the	O
2009	B-Pathogen
novel	I-Pathogen
H1N1	E-Pathogen
is	O
estimated	O
to	O
be	O
1.75	O
.	O

It	O
found	O
that	O
DHS	S-Organization
has	O
not	O
fully	O
integrated	O
and	O
coordinated	O
its	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

Over	O
the	O
course	O
of	O
its	O
history	O
,	O
the	O
Soviet	O
program	O
is	O
known	O
to	O
have	O
weaponized	O
and	O
stockpiled	O
the	O
following	O
eleven	O
bio-agentsCook	O
,	O
Michelle	B-Person
Stem	E-Person
and	O
Amy	B-Person
F.	I-Person
Woolf	E-Person
(April	O
10	O
,	O
2002)	O
,	O
Preventing	B-Document
Proliferation	I-Document
of	I-Document
Biological	I-Document
Weapons:	I-Document
U.S.	I-Document
Assistance	I-Document
to	I-Document
the	I-Document
Former	I-Document
Soviet	I-Document
States	E-Document
,	O
(Congressional	O
Research	O
Service	O
Report	O
for	O
Congress)	O
,	O
pg	O
3.	O
(and	O
to	O
have	O
pursued	O
basic	O
research	O
on	O
many	O
more):	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
(	O
anthrax	S-Pathogen
)	O
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
(	O
plague	S-Pathogen
)	O
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
(	O
tularemia	S-Pathogen
)	O
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
(	O
glanders	S-Pathogen
)	O
,	O
Brucella	B-Pathogen
sp.	E-Pathogen
(	O
brucellosis	S-Pathogen
)	O
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
(	O
Q-fever	S-Pathogen
)	O
,	O
Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
,	O
(	O
VEE	S-Pathogen
)	O
,	O
Botulinum	B-Pathogen
toxin	E-Pathogen
,	O
Staphylococcal	B-Pathogen
enterotoxin	I-Pathogen
B	E-Pathogen
,	O
Smallpox	S-Pathogen
,	O
and	O
.	O

Annotation	O
of	O
experiments	O
is	O
assisted	O
by	O
an	O
integrated	O
ontology	O
lookup	O
service	O
.	O

According	O
to	O
the	O
WHO	S-Organization
,	O
tests	O
indicated	O
that	O
the	O
flare-up	O
was	O
likely	O
due	O
to	O
contact	O
with	O
a	O
prior	O
Ebola	S-Disease
survivor's	O
infected	O
body	O
fluids	O
.	O

Essential	O
biosafety	O
equipment	O
was	O
also	O
investigated	O
and	O
only	O
14	O
(7.	O
35%)	O
labs	O
used	O
self	B-Equipment
needle	I-Equipment
device	E-Equipment
in	O
the	O
work	O
.	O

EBEN	B-Person
BROWN	E-Person
Thank	O
you	O
very	O
much	O
.	O

Additional	O
investigations	O
are	O
needed	O
in	O
the	O
context	O
of	O
transmission	O
between	O
humans	O
and	O
animals	O
.	O

Hoffman,	B-Person
S.J.	E-Person
,	O
Lavis,	B-Person
J.N	E-Person
.	O
&a	O
mp;	B-Person
Bennett	E-Person
,	O
S.	O
,	O
2009	O
.	O

Looking	O
ahead	O
,	O
the	O
epidemic	O
could	O
decimate	O
around	O
200	O
million	O
pigs	O
in	O
China	S-Location
according	O
to	O
a	O
grim	O
report	O
by	O
.	O

There	O
is	O
no	O
simple	O
solution	O
to	O
biosecurity	O
,	O
but	O
we	O
must	O
construct	O
a	O
system	O
of	O
checks	O
and	O
balances	O
needed	O
to	O
assure	O
that	O
the	O
growing	O
power	O
of	O
the	O
life	O
sciences	O
is	O
used	O
to	O
protect	O
life	O
,	O
not	O
to	O
destroy	O
it,	O
"	O
said	O
Dr	O
.	O

Adalja	S-Person
who	O
is	O
also	O
an	O
infectious	O
disease	O
doctor	O
,	O
said	O
the	O
2001	B-Incident
attacks	E-Incident
"	O
really	O
showed	O
how	O
unprepared	O
we	O
were.	O
"	O
But	O
they	O
also	O
led	O
to	O
a	O
surge	O
in	O
funding	O
and	O
initiatives	O
that	O
sought	O
to	O
make	O
the	O
more	O
resilient	O
to	O
future	O
attacks:	O
new	O
vaccines	O
,	O
new	O
medications	O
,	O
diagnostic	O
tests	O
and	O
emergency	O
hospital	O
plans	O
.	O

The	O
Soviet	B-Organization
Union	E-Organization
began	O
a	O
biological	O
weapons	O
program	O
in	O
the	O
1920s	O
.	O

All	O
these	O
biosafety	B-Equipment
cabinets	E-Equipment
were	O
either	O
level	O
-1	O
or	O
level	O
-2	O
,	O
no	O
laboratory	O
had	O
.	O

Mbalu	B-Person
Fonnie	E-Person
,	O
a	O
licensed	O
nurse-midwife	O
and	O
nursing	O
supervisor	O
at	O
the	O
Kenema	B-Organization
hospital	E-Organization
in	O
Sierra	B-Location
Leone	E-Location
,	O
with	O
over	O
30	O
years	O
of	O
experience	O
,	O
died	O
after	O
contracting	O
Ebola	S-Disease
while	O
caring	O
for	O
a	O
fellow	O
nurse	O
who	O
was	O
pregnant	O
and	O
had	O
the	O
disease	O
.	O

When	O
compared	O
to	O
the	O
control	O
,	O
researchers	O
found	O
that	O
the	O
antibodies	O
within	O
Immuron's	O
Travelan®	S-Drug
product	O
were	O
reactive	O
to	O
all	O
180	O
clinical	O
isolates	O
from	O
these	O
infected	O
individuals	O
.	O

Frieden	S-Person
.	O
In	O
terms	O
of	O
the	O
smallpox	S-Pathogen
vials	O
that	O
were	O
found	O
at	O
the	O
NIH	S-Organization
lab	O
,	O
you	O
said	O
you	O
were	O
planning	O
to	O
scour	O
those	O
labs	O
.	O

As	O
of	O
now	O
,	O
the	O
government	O
cannot	O
force	O
any	O
individual	O
or	O
institution	O
to	O
go	O
through	O
this	O
process	O
.	O

So	O
says	O
the	O
GHSA	S-International_exchange_and_cooperation
February	O
2018	O
report	O
,	O
"	O
Implementing	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
:	O
Progress	O
and	O
Impact	O
from	O
Investments,	O
"	O
which	O
notes	O
that	O
many	O
new	O
and	O
reemerging	O
pathogens	O
are	O
spreading	O
quickly	O
resulting	O
in	O
epidemics	O
and	O
outbreaks	O
having	O
the	O
potential	O
to	O
overwhelm	O
and	O
devastate	O
global	O
systems	O
across	O
health	O
care	O
,	O
financial	O
and	O
research	O
and	O
development	O
markets	O
.	O

The	O
humanitarian	O
crisis	O
and	O
deterioration	O
of	O
the	O
security	O
situation	O
is	O
expected	O
to	O
affect	O
any	O
response	O
to	O
the	O
outbreak	O
.	O

According	O
to	O
Deadly	O
Cultures:	O
Biological	O
Weapons	O
Since	O
1945	O
,	O
these	O
are	O
the	O
only	O
two	O
confirmed	O
uses	O
of	O
biological	O
weapons	O
for	O
terrorist	O
purposes	O
to	O
harm	O
humans	O
.	O

Federal	B-Organization
Coordination	I-Organization
Centre	I-Organization
for	I-Organization
Biotechnology	E-Organization
.	O
Classification	O
of	O
Organisms	O
according	O
to	O
the	O
Risk	O
presented	O
to	O
People	O
and	O
the	O
Environment	O
.	O

This	O
may	O
have	O
led	O
to	O
the	O
Little	O
Ice	O
Age	O
.	O

In	O
an	O
interview	O
,	O
Dr	O
.	O

The	O
key	O
questions	O
for	O
researchers	O
to	O
address	O
are	O
therefore:	O
These	O
questions	O
are	O
priorities	O
for	O
the	O
prevention	O
of	O
antibiotic	O
resistance	O
development	O
worldwide	O
;	O
in	O
order	O
to	O
support	O
the	O
research	O
necessary	O
to	O
track	O
new	O
threats	O
on	O
a	O
global	O
scale	O
,	O
international	O
funding	O
is	O
indispensable	O
.	O

In	O
his	O
section	O
of	O
the	O
draft	O
report	O
,	O
Dr	O
.	O

To	O
teach	O
safety	O
procedures	O
gradually	O
,	O
the	O
first	O
lab	O
focuses	O
on	O
counting	O
viruses	O
using	O
the	O
Plaque	O
Assay	O
method	O
.	O

During	O
those	O
thirteen	O
years	O
,	O
while	O
an	O
intense	O
debate	O
raged	O
within	O
the	O
international	O
scientific	O
and	O
intelligence	O
communities	O
on	O
whether	O
the	O
Russians	O
were	O
telling	O
the	O
truth	O
,	O
the	O
continued	O
its	O
offensive	O
biological	O
warfare	O
program	O
unabated	O
.	O

There	O
are	O
two	O
candidates	O
for	O
host	O
cell	O
entry	O
proteins	O
.	O

Along	O
with	O
Southern	B-Organization
Research	I-Organization
Institute	E-Organization
two	O
other	O
private	O
American	O
companies	O
operate	O
military	O
bio-labs	O
in	O
Ukraine	S-Location
–	O
Black&amp;Ve	S-Organization
atch	O
iota	O
.	O

Sections	O
of	O
the	O
NP	O
,	O
VP35	O
and	O
the	O
L	O
genes	O
from	O
filoviruses	O
have	O
been	O
identified	O
as	O
endogenous	O
in	O
the	O
genomes	O
of	O
several	O
groups	O
of	O
small	O
mammals	O
.	O

Some	O
outbreaks	O
,	O
such	O
as	O
food	B-Disease
poisoning	E-Disease
due	O
to	O
E.	B-Pathogen
coli	E-Pathogen
or	O
,	O
could	O
be	O
of	O
either	O
natural	O
or	O
deliberate	O
origin	O
.	O

The	O
research	O
team	O
is	O
working	O
toward	O
future	O
iterations	O
of	O
PRESAGED	S-Technology
that	O
will	O
include	O
using	O
the	O
algorithm	O
to	O
identify	O
specific	O
pathogens	O
,	O
moving	O
the	O
implementation	O
entirely	O
to	O
wearable	O
devices	O
,	O
and	O
making	O
alerts	O
to	O
users	O
over	O
their	O
phones	O
or	O
the	O
cloud	O
.	O

Shortly	O
after	O
the	O
E61/N	O
failed	O
to	O
make	O
standardization	O
,	O
tularemia	S-Pathogen
was	O
standardized	O
in	O
the	O
3.4	O
"	O
M143	O
bursting	O
spherical	O
bomblet	O
.	O

To	O
help	O
find	O
out	O
,	O
Spero	S-Organization
was	O
award­ed	O
$15.	O
7	O
mil­lion	O
in	O
fund­ing	O
from	O
the	O
Bio­med­ical	B-Organization
Ad­vanced	I-Organization
Re­search	I-Organization
and	I-Organization
De­vel­op­ment	I-Organization
Au­thor­i­ty	E-Organization
,	O
or	O
,	O
with	O
po­ten­tial	O
to	O
see	O
an	O
ad­di­tion­al	O
$28.	O
5	O
mil­lion	O
over	O
the	O
next	O
5	O
years	O
.	O

Saward	S-Person
provided	O
a	O
few	O
details	O
about	O
how	O
important	O
this	O
new	O
area	O
is	O
overall	O
to	O
the	O
company's	O
2018	O
financial	O
outlook	O
.	O

On	O
2	O
May	O
,	O
China	S-Location
announced	O
the	O
three	O
suspected	O
cases	O
as	O
genuine	O
cases	O
of	O
SARS	S-Disease
,	O
bringing	O
the	O
total	O
cases	O
in	O
a	O
recent	O
outbreak	O
to	O
nine.	O
189	O
people	O
were	O
released	O
from	O
quarantine	O
.	O

The	O
death-to-case	O
ratio	O
reflects	O
the	O
number	O
of	O
deaths	O
attributed	O
to	O
COVID-19	S-Disease
divided	O
by	O
the	O
number	O
of	O
diagnosed	O
cases	O
within	O
a	O
given	O
time	O
interval	O
.	O

After	O
its	O
repeated	O
sprayings	O
failed	O
to	O
eradicate	O
the	O
medfly	O
threat	O
,	O
California	S-Location
halted	O
its	O
Malathion	B-Activity
aerial	I-Activity
spraying	I-Activity
program	E-Activity
in	O
March	O
1990	O
,	O
three	O
months	O
after	O
the	O
threat	O
from	O
The	O
Breeders	O
was	O
received	O
.	O

Research	O
on	O
coronavirus	O
genomes	O
indicates	O
the	O
majority	O
of	O
COVID-19	S-Disease
cases	O
in	O
New	B-Location
York	E-Location
came	O
from	O
European	O
travellers	O
,	O
rather	O
than	O
directly	O
from	O
China	S-Location
or	O
any	O
other	O
Asian	S-Location
country	O
.	O

As	O
of	O
18	O
June	O
2019	O
,	O
275	O
contacts	O
have	O
been	O
vaccinated	O
per	O
the	O
.	O

In	O
PCR	S-Technology
a	O
scientist	O
heats	O
up	O
DNA	O
,	O
adds	O
loose	O
nucleotides	O
-	O
the	O
building	O
blocks	O
of	O
new	O
DNA	O
strands	O
-	O
and	O
then	O
cools	O
the	O
DNA	O
.	O

And	O
when	O
I	O
answered	O
them	O
,	O
they	O
still	O
didn't	O
quite	O
get	O
it	O
.	O

The	O
control	O
shift	O
was	O
first	O
announced	O
in	O
the	O
February	O
release	O
of	O
President	O
Donald	B-Person
Trump	E-Person
Fiscal	O
Year	O
2019	O
budget	O
proposal	O
,	O
which	O
underscores	O
the	O
move	O
as	O
an	O
enhancement	O
of	O
emergency	O
preparedness	O
and	O
health	O
security	O
that	O
consolidates	O
the	O
necessary	O
strategic	O
decision-making	O
around	O
the	O
development	O
and	O
procurement	O
of	O
medical	O
countermeasures	O
.	O

The	O
term	O
biohacker	O
is	O
now	O
ubiquitous	O
.	O

Tests	O
on	O
February	O
3	O
confirmed	O
that	O
the	O
substance	O
was	O
ricin	S-Pathogen
.	O
The	O
positive	O
test	O
results	O
were	O
indicated	O
by	O
six	O
of	O
eight	O
preliminary	O
tests	O
on	O
the	O
substance	O
.	O

I	O
suspected	O
the	O
reason	O
for	O
this	O
and	O
called	O
the	O
Chief	O
of	O
General	O
Staff	O
of	O
Ministry	B-Organization
of	I-Organization
Defense	E-Organization
and	O
requested	O
to	O
forbid	O
the	O
stop	O
of	O
the	O
Alma-Ata-Moscow	O
train	O
in	O
.	O
As	O
a	O
result	O
,	O
the	O
epidemic	O
around	O
the	O
country	O
was	O
prevented	O
.	O

Smokers	O
were	O
1.	O
4	O
times	O
more	O
likely	O
to	O
have	O
severe	O
symptoms	O
of	O
COVID‑19	S-Disease
and	O
approximately	O
2.	O
4	O
times	O
more	O
likely	O
to	O
require	O
intensive	O
care	O
or	O
die	O
compared	O
to	O
non-smokers	O
.	O

Cases	O
in	O
which	O
recovery	O
from	O
COVID‑19	S-Disease
was	O
followed	O
by	O
positive	O
tests	O
for	O
coronavirus	O
at	O
a	O
later	O
date	O
have	O
been	O
reported	O
.	O

Upon	O
activation	O
,	O
samples	O
may	O
be	O
shipped	O
to	O
the	O
assisting	O
agencies	O
that	O
will	O
assist	O
with	O
the	O
diagnostics	O
.	O

2000-2009:	O
The	O
academician	O
,	O
"	O
A.S.	S-Person
proposed	O
a	O
new	O
biological	O
warfare	O
program	O
,	O
called	O
the	O
"	O
Biological	B-Scientific_research_project
Shield	I-Scientific_research_project
of	I-Scientific_research_project
Russia	E-Scientific_research_project
"	O
to	O
president	O
Vladimir	B-Person
Putin	E-Person
.	O
The	O
program	O
reportedly	O
includes	O
institutes	O
of	O
the	O
.	O

For	O
example	O
,	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Variola	B-Pathogen
major	E-Pathogen
and	O
Marburg	B-Pathogen
virus	E-Pathogen
were	O
all	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
.	O

The	O
exercises	O
,	O
ring	O
trials	O
,	O
and	O
audits	O
carried	O
out	O
at	O
the	O
network	O
members'	O
various	O
laboratories	O
have	O
shed	O
light	O
on	O
some	O
areas	O
of	O
inconsistency	O
regarding	O
how	O
practices	O
are	O
handled	O
and	O
how	O
Swedish	O
biopreparedness	O
could	O
be	O
improved	O
.	O

In	O
one	O
study	O
,	O
44%	O
of	O
people	O
had	O
fever	S-Phenotype
when	O
they	O
presented	O
to	O
the	O
hospital	O
,	O
while	O
89%	O
went	O
on	O
to	O
develop	O
fever	S-Phenotype
at	O
some	O
point	O
during	O
their	O
hospitalization	O
.	O

In	O
Europe	S-Location
and	O
in	O
the	O
U.S.	S-Location
,	O
Palantir	B-Organization
Technologies	E-Organization
is	O
also	O
providing	O
tracking	O
services	O
.	O

Other	O
scientific	O
organizations	O
,	O
including	O
the	O
International	B-Organization
Centre	I-Organization
for	I-Organization
Genetic	I-Organization
Engineering	I-Organization
and	I-Organization
Biotechnology	E-Organization
the	O
International	B-Organization
Union	I-Organization
of	I-Organization
Biochemistry	I-Organization
and	I-Organization
Molecular	I-Organization
Biology	E-Organization
,	O
and	O
,	O
have	O
also	O
expressed	O
support	O
for	O
codes	O
of	O
conduct	O
.	O

Black	B-Organization
&amp;	I-Organization
Veatch	I-Organization
Special	I-Organization
Project	I-Organization
C	E-Organization
was	O
awarded	O
$198.	O
7	O
mill	O
ion	S-Organization
	S-Organization
DTRA	O
contracts	O
to	O
build	O
and	O
operate	O
bio-laboratories	O
in	B-Location
Ukr	E-Location
aine	O
(under	O
two	O
5-year	O
contracts	O
in	O
2008	O
and	O
2012	O
totaling	O
$128.	O
5	O
million)	O
,	O
as	O
well	O
as	O
in	B-Location
Ger	E-Location
ma	O
ny,	B-Location
Azerba	E-Location
ij	O
an,	B-Location
Came	E-Location
ro	O
on,	B-Location
Thai	E-Location
la	O
nd,	B-Location
Ethi	E-Location
op	O
ia,	B-Location
Vie	E-Location
tnam	O
enia	O
.	O

Biologist	O
Craig	B-Person
Venter	E-Person
and	O
a	O
group	O
of	O
scientists	O
that	O
included	O
-	O
the	O
discoverer	O
of	O
the	O
first	O
restriction	O
enzyme	O
-	O
did	O
just	O
that	O
in	O
2010	O
.	O

Systemic	O
inflammation	O
results	O
in	O
vasodilation	S-Phenotype
allowing	O
inflammatory	O
lymphocytic	O
and	O
monocytic	O
infiltration	O
of	O
the	O
lung	O
and	O
the	O
heart	O
.	O

After	O
mutating	O
,	O
the	O
viruses	O
became	O
capable	O
of	O
infecting	O
humans.	O
"	O

The	O
inactivated	O
samples	O
were	O
transferred	O
to	O
the	O
RNA	O
extraction	O
bench	O
for	O
either	O
manual	O
or	O
automatic	O
RNA	O
extraction	O
.	O

From	O
this	O
proof	O
of	O
concept	O
experiment	O
the	O
team	O
is	O
now	O
ready	O
to	O
build	O
more	O
complex	O
organisms	O
with	O
useful	O
properties	O
.	O

Amherst's	O
letter	O
Gen	O
.	O

These	O
beliefs	O
correlated	O
with	O
decreased	O
likelihood	O
of	O
seeking	O
healthcare	O
or	O
agreeing	O
to	O
vaccination	O
.	O

In	O
September	O
19	O
92,	B-Organization
Ru	E-Organization
ssia	O
signed	O
an	O
agreement	O
with	O
the	O
United	B-Organization
St	E-Organization
ates	O
and	B-Organization
Great	I-Organization
Bri	E-Organization
tain	O
promising	O
to	O
end	O
its	O
bio-weapons	O
program	O
and	O
to	O
convert	O
its	O
facilities	O
for	O
benevolent	O
scientific	O
and	O
medical	O
purpos	O
es.	B-Person
M	I-Person
Leiten	E-Person
berg	O
(2001)	O
,	O
Working	O
Paper:	O
Biological	O
Weapons	O
in	O
the	O
20th	O
Century:	O
A	O
Review	O
and	O
Analysis	O
,	O
College	O
Park	O
,	O
Md:	B-Organization
Center	I-Organization
for	I-Organization
International	I-Organization
and	I-Organization
Security	I-Organization
Studies	I-Organization
at	I-Organization
Mary	E-Organization
laland	O
;	O
2001	O
.	O

On	O
13	O
March	O
,	O
Trump	S-Person
declared	O
a	O
national	O
emergency	O
,	O
which	O
made	O
federal	O
funds	O
available	O
to	O
respond	O
to	O
the	O
crisis	O
.	O

There	O
are	O
mixed	O
results	O
as	O
of	O
3	O
April	O
2020	O
as	O
to	O
the	O
effectiveness	O
of	O
hydroxychloroquine	S-Drug
as	O
a	O
treatment	O
for	O
COVID‑19	S-Disease
,	O
with	O
some	O
studies	O
showing	O
little	O
or	O
no	O
improvement	O
.	O

The	O
motivations	O
for	O
DIY	B-Activity
biolog	E-Activity
include	O
(but	O
aren't	O
limited	O
to)	O
lowered	O
costs	O
,	O
entertainment	O
,	O
medicine	O
,	O
biohacking	O
,	O
life	O
extension	O
,	O
and	O
education	O
.	O

Dr	O
Peter	B-Person
Piot	E-Person
the	O
scientist	O
who	O
co-discovered	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
stated	O
that	O
the	O
outbreak	O
was	O
not	O
following	O
its	O
usual	O
linear	O
patterns	O
as	O
mapped	O
out	O
in	O
earlier	O
outbreaks-this	O
time	O
the	O
virus	O
was	O
"	O
hopping"	O
all	O
over	O
the	O
Western	B-Location
African	E-Location
epidemic	O
region	O
.	O

This	O
is	O
the	O
same	O
strain	O
that	O
was	O
involved	O
in	O
the	O
early	O
2018	O
outbreak	O
in	O
western	O
.	O

Noise	O
This	O
appears	O
as	O
grain	O
on	O
the	O
image	O
and	O
is	O
caused	O
by	O
a	O
low	O
signal	O
to	O
noise	O
ratio	O
.	O

Defecting	O
Soviet	O
bioweaponeers	O
such	O
as	O
Colonel	B-Person
Kanatjan	I-Person
Alibekov	E-Person
confirmed	O
that	O
the	O
program	O
had	O
been	O
massive	O
and	O
still	O
existed	O
.	O

One	O
of	O
the	O
Pentagon	S-Organization
bio-labs	O
is	O
located	O
in	O
Kharkiv	S-Location
which	O
was	O
blamed	O
for	O
the	O
deadly	O
a	O
year	O
ago	O
which	O
claimed	O
the	O
lives	O
of	O
364	O
Ukrainians	O
.	O

The	O
Netherlands	S-Organization
Spain	S-Organization
,	O
Turkey	S-Organization
,	O
Georgia	S-Organization
,	O
and	O
the	O
Czech	B-Organization
Republic	E-Organization
expressed	O
concerns	O
over	O
Chinese-made	O
masks	O
and	O
test	O
kits	O
.	O

UK	S-Location
was	O
the	O
first	O
country	O
in	O
Europe	S-Location
to	O
propose	O
a	O
classification	O
.	O

Oregon	O
Attorney	O
General	O
Dave	B-Person
Frohnmayer	E-Person
established	O
a	O
task	O
force	O
among	O
the	O
Wasco	B-Organization
County	I-Organization
Sheriff's	I-Organization
office	E-Organization
,	O
the	O
Oregon	B-Organization
State	I-Organization
Police	E-Organization
,	O
the	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
(	O
FBI	S-Organization
)	O
,	O
the	O
Immigration	B-Organization
and	I-Organization
Naturalization	I-Organization
Service	E-Organization
(	O
INS	S-Organization
)	O
and	O
the	O
National	B-Organization
Guard	E-Organization
that	O
set	O
up	O
headquarters	O
on	O
the	O
Ranch	O
to	O
investigate	O
the	O
allegations	O
.	O

PRESAGED	S-Technology
is	O
designed	O
to	O
run	O
on	O
data	O
collected	O
from	O
noninvasive	O
medical	O
sensors-for	O
example	O
,	O
wearable	B-Equipment
electrocardiographs	E-Equipment
(also	O
known	O
as	O
)	O
.	O

In	O
2006	O
,	O
Toyo	B-Person
Ishii	E-Person
-a	O
nurse	O
who	O
worked	O
at	O
the	O
school	O
during	O
the	O
war-revealed	O
that	O
she	O
had	O
helped	O
bury	O
bodies	O
and	O
pieces	O
of	O
bodies	O
on	O
the	O
school's	O
grounds	O
shortly	O
after	O
Japan	S-Location
's	O
surrender	O
in	O
1945	O
.	O

He	O
provides	O
data	O
that	O
the	O
viral	O
waves	O
hit	O
the	O
Central	B-Organization
Powers	E-Organization
before	O
the	O
Allied	O
powers	O
and	O
that	O
both	O
morbidity	O
and	O
mortality	O
in	O
Germany	S-Location
and	O
Austria	S-Location
were	O
considerably	O
higher	O
than	O
in	O
Britain	S-Location
and	O
.	O

Iran	S-Location
President	O
Hassan	B-Person
Rouhani	E-Person
wrote	O
a	O
public	O
letter	O
to	O
world	O
leaders	O
asking	O
for	O
help	O
on	O
14	O
March	O
2020	O
,	O
saying	O
they	O
were	O
struggling	O
to	O
fight	O
the	O
outbreak	O
due	O
to	O
a	O
lack	O
of	O
access	O
to	O
international	O
markets	O
from	O
the	O
United	B-Location
States	E-Location
sanctions	O
against	O
Iran	S-Location
.	O
Saudi	B-Organization
Arabia	E-Organization
,	O
which	O
launched	O
a	O
military	O
intervention	O
in	O
in	O
March	O
2015	O
,	O
declared	O
a	O
ceasefire	O
.	O

As	O
of	O
2004	O
,	O
several	O
European	O
countries	O
established	O
a	O
decline	O
of	O
antimicrobial	O
resistance	O
in	O
humans	O
through	O
limiting	O
the	O
use	O
of	O
antimicrobials	O
in	O
agriculture	O
and	O
food	O
industries	O
without	O
jeopardizing	O
animal	O
health	O
or	O
economic	O
cost	O
.	O

His	O
mother	O
,	O
sister	O
,	O
and	O
grandmother	O
,	O
per	O
media	O
reports	O
later	O
became	O
ill	O
with	O
similar	O
symptoms	O
and	O
also	O
died	O
;	O
people	O
infected	O
by	O
these	O
initial	O
cases	O
spread	O
the	O
disease	O
to	O
other	O
villages	O
.	O

Since	O
this	O
time	O
,	O
further	O
genomic	O
papers	O
have	O
further	O
confirmed	O
the	O
phylogenetic	O
placement	O
of	O
the	O
Y.	B-Pathogen
pestis	I-Pathogen
strain	E-Pathogen
responsible	O
for	O
the	O
Black	B-Disease
Death	E-Disease
as	O
both	O
the	O
ancestor	O
of	O
later	O
plague	S-Disease
epidemics	O
including	O
the	O
third	O
plague	S-Disease
pandemic	O
and	O
as	O
the	O
descendant	O
of	O
the	O
strain	O
responsible	O
for	O
the	O
Plague	S-Disease
of	O
Justinian	S-Location
.	O
In	O
addition	O
,	O
genomes	O
from	O
significantly	O
earlier	O
in	O
prehistory	O
have	O
been	O
recovered	O
.	O

Five	O
members	O
of	O
the	O
research	O
team	O
became	O
ill	O
and	O
died	O
from	O
before	O
the	O
study	O
was	O
published	O
in	O
August	O
2014	O
.	O

The	O
FBI	S-Organization
was	O
the	O
lead	O
agency	O
in	O
the	O
Fallen	B-Activity
Angel	I-Activity
investigation	E-Activity
.	O
Borenstein	S-Person
,	O
Seth	S-Person
,	O
and	O
Chatterjee	S-Person
,	O
Sumana	S-Person
.	O
"	O
Source	O
of	O
ricin	S-Pathogen
may	O
come	O
from	O
within	O
the	O
U.S.	S-Location
"	O
,	O
Knight-Ridder	O
Newspapers	O
,	O
via	O
kaleo.org	O
-	O
Ka	B-Person
Leo	E-Person
,	O
February	O
5	O
,	O
2004	O
,	O
accessed	O
May	O
6	O
,	O
2009	O
.	O

The	O
workshop	O
was	O
a	O
collaboration	O
with	O
the	O
African	B-Organization
Union	E-Organization
the	O
African	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
,	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention,	E-Organization
and	O
the	O
.	O

The	O
exact	O
reasons	O
for	O
this	O
sex-difference	O
are	O
not	O
known	O
,	O
but	O
genetic	O
and	O
behavioural	O
factors	O
could	O
be	O
a	O
reason	O
.	O

That's	O
why	O
we	O
put	O
in	O
systems	O
so	O
that	O
if	O
human	O
mistakes	O
occur	O
,	O
human	O
harm	O
will	O
not	O
occur	O
.	O

For	O
example	O
,	O
it	O
could	O
be	O
placed	O
in	O
letters	O
and	O
mailed	O
,	O
as	O
was	O
done	O
in	O
2001	O
,	O
or	O
it	O
could	O
be	O
put	O
into	O
food	O
or	O
water	O
.	O

In	O
August	O
2015	O
,	O
after	O
substantial	O
progress	O
in	O
reducing	O
the	O
scale	O
of	O
the	O
epidemic	O
,	O
the	O
WHO	S-Organization
held	O
a	O
meeting	O
to	O
work	O
out	O
a	O
"	O
Comprehensive	O
care	O
plan	O
for	O
Ebola	O
survivors	O
"	O
and	O
identify	O
research	O
needed	O
to	O
optimise	O
clinical	O
care	O
and	O
social	O
well-being	O
.	O

Potassium	O
cyanide	O
vials	O
were	O
issued	O
for	O
use	O
in	O
the	O
event	O
that	O
the	O
remaining	O
personnel	O
were	O
captured	O
.	O

That	O
was	O
the	O
overarching	O
theme	O
of	O
a	O
daylong	O
discussion	O
among	O
more	O
than	O
70	O
experts	O
convened	O
by	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
on	O
30	O
July	O
2018	O
,	O
in	O
Washington,	B-Location
D.C.	E-Location
,	O
to	O
gather	O
stakeholder	O
input	O
on	O
the	O
forthcoming	O
U.S.	B-Document
Global	I-Document
Health	I-Document
Security	I-Document
Strategy	E-Document
.	O
Drafted	O
by	O
the	O
Trump	B-Organization
administration	E-Organization
and	O
due	O
to	O
Congress	S-Organization
this	O
fall	O
,	O
the	O
strategy	O
will	O
guide	O
continued	O
work	O
to	O
build	O
outbreak	O
detection	O
and	O
response	O
capabilities	O
in	O
nations	O
all	O
over	O
the	O
world	O
.	O

Current	O
geese	O
include	O
a	O
data	O
matrix	O
viewer	O
,	O
Cytoscape	O
,	O
the	O
TIGR	O
microarray	O
experiment	O
viewer	O
,	O
a	O
R/Bioconductor	O
goose	O
,	O
a	O
simple	O
Bioinformatics	O
web	O
browser	O
and	O
Bioinformatics	B-Platform
Resource	I-Platform
Manager	E-Platform
(	O
BRM	S-Platform
)	O
which	O
adds	O
data	O
management	O
functionality	O
to	O
Gaggle	S-Platform
.	O
Gaggle	S-Platform
is	O
easily	O
extendible	O
to	O
new	O
applications	O
via	O
the	O
message	O
interface	O
based	O
on	O
the	O
four	O
data	O
types	O
.	O

We	O
are	O
essentially	O
the	O
reference	O
laboratory	O
for	O
the	O
world	O
.	O

The	O
most	O
authoritative	O
contemporary	O
account	O
is	O
found	O
in	O
a	O
report	O
from	O
the	O
medical	O
faculty	O
in	O
Paris	B-Person
to	I-Person
Philip	I-Person
VI	E-Person
of	O
France	S-Location
.	O
It	O
blamed	O
the	O
heavens	O
,	O
in	O
the	O
form	O
of	O
a	O
conjunction	O
of	O
three	O
planets	O
in	O
1345	O
that	O
caused	O
a	O
"	O
great	O
in	O
the	O
air	O
"	O
(miasma	O
theory)	O
.	O

A	O
total	O
number	O
of	O
190	O
laboratories	O
(labs)	O
were	O
surveyed	O
about	O
their	O
compliance	O
with	O
standard	O
biosafety	O
precautions	O
.	O

By	O
7	O
April	O
,	O
Liberia	S-Location
had	O
confirmed	O
3	O
new	O
cases	O
since	O
the	O
virus	O
resurfaced	O
and	O
a	O
total	O
of	O
97 contacts	O
,	O
including	O
15 healthcare	O
workers	O
,	O
were	O
being	O
monitored	O
.	O

Fever	S-Phenotype
is	O
the	O
most	O
common	O
symptom	O
,	O
although	O
some	O
older	O
people	O
and	O
those	O
with	O
other	O
health	O
problems	O
experience	O
fever	S-Phenotype
later	O
in	O
the	O
disease	O
.	O

On	O
8	O
August	O
2018	O
,	O
the	O
process	O
of	O
vaccination	O
began	O
with	O
rVSV-ZEBOV	B-Vaccine
Ebola	I-Vaccine
vaccine	E-Vaccine
While	O
several	O
studies	O
have	O
shown	O
the	O
vaccine	O
to	O
be	O
safe	O
and	O
protective	O
against	O
the	O
virus	O
,	O
additional	O
research	O
is	O
needed	O
before	O
it	O
can	O
be	O
licensed	O
.	O

Currently	O
,	O
40%	O
of	O
the	O
medically	O
important	O
antibiotics	O
approved	O
for	O
use	O
in	O
food-animals	O
have	O
at	O
least	O
one	O
indication	O
without	O
a	O
defined	O
duration	O
of	O
use	O
,	O
which	O
means	O
farmers	O
can	O
continuously	O
use	O
them	O
at	O
sub-therapeutic	O
doses	O
.	O

"	O
We	O
should	O
obviously	O
try	O
as	O
best	O
we	O
can	O
to	O
limit	O
the	O
use	O
of	O
these	O
drugs	O
to	O
only	O
when	O
they're	O
necessary,	O
"	O
William	B-Person
Flynn	E-Person
DVM	O
,	O
deputy	O
secretary	O
of	O
science	O
policy	O
at	O
the	O
Center	B-Organization
for	I-Organization
Veterinary	I-Organization
Medicine	E-Organization
,	O
said	O
in	O
a	O
panel	O
discussion	O
that	O
followed	O
's	O
remarks.	O
"	O
That's	O
sort	O
of	O
the	O
core	O
principle	O
,	O
that	O
we	O
make	O
sure	O
that	O
we're	O
only	O
using	O
these	O
medically	O
important	O
antibiotics	O
when	O
there's	O
an	O
actually	O
animal	O
health	O
issue	O
that's	O
being	O
addressed	O
.	O

The	O
regional	O
director	O
is	O
effectively	O
the	O
head	O
of	O
WHO	S-Organization
for	O
his	O
or	O
her	O
region	O
.	O

However	O
,	O
his	O
work	O
having	O
been	O
the	O
cause	O
of	O
any	O
disease	O
has	O
been	O
refuted	O
.	O

Relman	S-Person
served	O
as	O
vice-chair	O
of	O
a	O
2011	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
study	O
of	O
the	O
science	O
underlying	O
the	O
FBI	S-Organization
investigation	O
of	O
the	O
.	O

The	O
increasing	O
international	O
movement	O
of	O
people	O
,	O
animals	O
,	O
food	O
and	O
other	O
products	O
can	O
raise	O
the	O
potential	O
for	O
antimicrobial	O
resistance	O
to	O
spread	O
rapidly	O
around	O
the	O
world	O
.	O

All	O
materials	O
that	O
came	O
into	O
contact	O
with	O
clinical	O
samples	O
were	O
immediately	O
soaked	O
in	O
a	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
for	O
at	O
least	O
10	O
min	O
.	O

For	O
regulations	O
and	O
guidelines	O
applicable	O
outside	O
of	O
the	O
U.S	S-Location
,	O
please	O
refer	O
to	O
appendix	O
mca01b	O
and	O
Internet	O
Resources	O
.	O

Australian	O
aborigines	O
(Kooris)	O
have	O
always	O
maintained	O
that	O
the	O
British	O
deliberately	O
spread	O
smallpox	S-Pathogen
in	O
1789	O
,	O
Foley	S-Person
,	O
Dennis	S-Person
,	O
''	O
Repossession	O
of	O
our	O
Spirit:	O
Traditional	O
Owners	O
of	O
Northern	B-Location
Sydney	E-Location
,''	O
(2001)	O
.	O

Directed	O
against	O
China	S-Location
,	O
the	O
onslaught	O
was	O
spearheaded	O
by	O
a	O
notorious	O
division	O
of	O
the	O
Imperial	O
Army	O
called	O
.	O

On	O
6	O
March	O
2015	O
,	O
The	O
Department	B-Organization
of	I-Organization
Foreign	I-Organization
Affairs	E-Organization
confirmed	O
that	O
three	O
Filipino	O
female	O
healthcare	O
workers	O
in	O
Saudi	B-Location
Arabia	E-Location
were	O
infected	O
with	O
.	O

However	O
,	O
people	O
transferred	O
to	O
an	O
ICU	O
had	O
a	O
median	O
time	O
of	O
seven	O
days	O
between	O
hospitalisation	O
and	O
death	O
.	O

The	O
RODS	O
laboratory's	O
first	O
efforts	O
eventually	O
led	O
to	O
the	O
establishment	O
of	O
the	O
National	O
Retail	O
Data	O
Monitor	O
,	O
a	O
system	O
which	O
collects	O
data	O
from	O
20,000	O
retail	O
locations	O
nationwide	O
.	O

Los	B-Organization
Angeles	I-Organization
Police	E-Organization
Cmdr	O
.	O

The	O
complex	O
contained	O
various	O
factories	O
.	O

While	O
MRI	S-Technology
is	O
most	O
prominently	O
used	O
in	O
diagnostic	O
medicine	O
and	O
biomedical	O
research	O
,	O
it	O
also	O
may	O
be	O
used	O
to	O
form	O
images	O
of	O
non-living	O
objects	O
.	O

Tunisia	S-Location
was	O
the	O
eighth	O
country	O
to	O
be	O
affected	O
by	O
MERS-CoV	S-Pathogen
after	O
Jordan	S-Location
,	O
Saudi	B-Location
Arabia	E-Location
,	O
Qatar	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
,	O
France	S-Location
,	O
Germany	S-Location
,	O
and	O
the	O
.	O

In	O
a	O
conference	O
call	O
on	O
Thursday	O
,	O
Dr	O
.	O

On	O
22	O
March	O
,	O
it	O
was	O
reported	O
that	O
Russia	S-Location
had	O
sent	O
nine	O
military	O
planes	O
with	O
medical	O
equipment	O
to	O
Italy	S-Organization
.	O
,	O
there	O
were	O
217,185	O
confirmed	O
cases	O
,	O
30,201	O
deaths	O
,	O
and	O
99,023	O
recoveries	O
in	O
Italy	S-Location
,	O
with	O
the	O
majority	O
of	O
those	O
cases	O
occurring	O
in	O
the	O
Lombardy	S-Location
region	O
.	O

In	O
my	O
view	O
,	O
this	O
track	O
record	O
of	O
escapes	O
shows	O
that	O
even	O
the	O
highest	O
biosafety	O
level	O
(	O
BSL-4	S-Platform
is	O
insufficient	O
for	O
working	O
on	O
pathogens	O
that	O
pose	O
a	O
risk	O
of	O
global	O
pandemics	O
on	O
the	O
scale	O
of	O
the	O
Spanish	B-Disease
flu	E-Disease
or	O
worse	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

For	O
example	O
,	O
daptomycin	S-Drug
abandoned	O
by	O
one	O
company	O
for	O
reasons	O
of	O
toxicity	O
,	O
has	O
become	O
a	O
leading	O
treatment	O
for	O
serious	O
Gram-positive	O
infections	O
using	O
a	O
different	O
dosing	O
regime	O
(REF)	O
.	O

We	O
found	O
18%	O
of	O
total	O
initiatives	O
to	O
be	O
focused	O
on	O
biosafety	O
issues	O
related	O
to	O
LMOs	S-Technology
.	O
Although	O
these	O
are	O
encouraging	O
figures	O
,	O
the	O
BMENA	S-Location
region	O
is	O
the	O
most	O
water-scarce	O
and	O
dry	O
region	O
worldwide	O
.	O

What	O
matters	O
is	O
the	O
poor	O
track	O
record	O
in	O
the	O
field	O
,	O
made	O
worse	O
by	O
a	O
lack	O
of	O
transparency	O
and	O
accountability	O
.	O

With	O
this	O
in	O
mind	O
,	O
representatives	O
from	O
around	O
the	O
world	O
braved	O
a	O
Washington,	B-Location
DC	E-Location
snow	O
storm	O
to	O
launch	O
the	O
exactly	O
one	O
year	O
ago	O
today	O
.	O

Buildings	O
that	O
house	O
these	O
types	O
of	O
labs	O
simply	O
require	O
a	O
lot	O
of	O
maintenance	O
,	O
explained	O
Dr	O
.	O

Medical	O
experiments	O
were	O
conducted	O
on	O
a	O
large	O
scale	O
on	O
civilians	O
who	O
had	O
not	O
consented	O
to	O
participate	O
.	O

Confirmation	O
of	O
this	O
case	O
in	O
highlights	O
that	O
the	O
outbreak	O
has	O
spread	O
geographically	O
,	O
and	O
this	O
is	O
a	O
concern	O
.	O

This	O
will	O
be	O
difficult	O
,	O
given	O
that	O
industry's	O
search	O
for	O
novel	O
chemical	O
agents	O
acting	O
on	O
new	O
biological	O
targets	O
has	O
become	O
non-productive	O
.	O

That	O
means	O
people	O
shower	O
out	O
.	O

International	O
bodies	O
such	O
as	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
already	O
devote	O
some	O
of	O
their	O
resources	O
to	O
monitoring	O
epidemics	O
and	O
have	O
served	O
clearing-house	O
roles	O
in	O
historical	O
epidemics	O
.	O

Shublaq	S-Person
et	O
al.	O
discuss	O
privacy	O
issues	O
arising	O
from	O
the	O
expected	O
higher	O
frequency	O
of	O
sequencing	O
whole	O
genomes	O
of	O
individuals	O
due	O
to	O
the	O
continuously	O
decreasing	O
costs	O
of	O
the	O
technology	O
.	O

Individual	O
GP	O
molecules	O
appear	O
with	O
spacings	O
of	O
about	O
10 nm	O
.	O

He	O
was	O
referring	O
to	O
Dr	O
.	O

This	O
is	O
the	O
.	O

The	O
existing	O
building	O
,	O
which	O
went	O
into	O
service	O
in	O
2005	O
,	O
will	O
need	O
to	O
be	O
replaced	O
by	O
2023	O
or	O
so	O
to	O
avoid	O
major	O
disruptions	O
in	O
the	O
work	O
,	O
senior	O
agency	O
staff	O
told	O
.	O

Marine	O
organisms	O
are	O
highly	O
attuned	O
to	O
their	O
surroundings-their	O
survival	O
depends	O
on	O
it-and	O
a	O
new	O
program	O
out	O
of	O
DARPA	S-Organization
's	O
aims	O
to	O
tap	O
into	O
their	O
natural	O
sensing	O
capabilities	O
to	O
detect	O
and	O
signal	O
when	O
activities	O
of	O
interest	O
occur	O
in	O
strategic	O
waters	O
such	O
as	O
straits	O
and	O
littoral	O
regions	O
.	O

The	O
clustered	B-Technology
regularly	I-Technology
interspaced	I-Technology
short	I-Technology
palindrome	I-Technology
repeats	E-Technology
(	O
CRISPR	S-Technology
)/Cas9	O
system	O
is	O
a	O
new	O
gene-editing	O
technology	O
that	O
can	O
induce	O
double-strand	O
breaks	O
(DSBs)	O
,	O
single-strand	O
nicks	O
,	O
or	O
anywhere	O
guide	O
ribonucleic	O
acids	O
(RNAs)	O
can	O
bind	O
with	O
the	O
protospacer	O
adjacent	O
motif	O
sequence	O
.	O

Fine-grained	O
access	O
control	O
is	O
indispensable	O
when	O
multiple	O
groups	O
and	O
consortia	O
are	O
working	O
with	O
the	O
same	O
data	O
management	O
system	O
.	O

Laws	O
relating	O
to	O
biosafety	O
are	O
not	O
easily	O
accessible	O
and	O
there	O
are	O
few	O
federal	O
regulations	O
that	O
are	O
readily	O
available	O
for	O
a	O
potential	O
trainee	O
to	O
reference	O
outside	O
of	O
the	O
publications	O
recommended	O
in	O
.	O

The	O
research	O
also	O
indicated	O
the	O
virus	O
had	O
been	O
latent	O
in	O
pigs	O
for	O
several	O
months	O
prior	O
to	O
the	O
outbreak	O
,	O
suggesting	O
a	O
need	O
to	O
increase	O
agricultural	O
surveillance	O
to	O
prevent	O
future	O
outbreaks	O
.	O

It	O
has	O
also	O
caused	O
a	O
shortage	O
of	O
personal	O
protective	O
equipment	O
worldwide	O
,	O
with	O
the	O
warning	O
that	O
this	O
will	O
endanger	O
health	O
workers	O
.	O

Continuous	O
funding	O
and	O
an	O
ongoing	O
commitment	O
to	O
the	O
medical	O
countermeasures	O
enterprise	O
would	O
help	O
,	O
Kadlec	O
said	O
.	O

Some	O
medical	O
procedures	O
are	O
aerosol-generating	O
and	O
result	O
in	O
the	O
virus	O
being	O
transmitted	O
more	O
easily	O
than	O
normal	O
.	O

Early	O
genetic	B-Technology
engineering	E-Technology
made	O
possible	O
by	O
restriction	O
enzymes	O
didn't	O
involve	O
much	O
engineering	O
.	O

Sheela	S-Person
received	O
20	O
years	O
for	O
the	O
attempted	O
murder	O
of	O
Rajneesh's	O
physician	O
,	O
twenty	O
years	O
for	O
first-degree	O
assault	O
in	O
the	O
poisoning	O
of	O
Judge	O
Hulse	S-Person
,	O
ten	O
years	O
for	O
second-degree	O
assault	O
in	O
the	O
poisoning	O
of	O
Commissioner	O
Matthews	S-Person
,	O
four	O
and	O
a	O
half	O
years	O
for	O
her	O
role	O
in	O
the	O
attack	O
,	O
four	O
and	O
a	O
half	O
years	O
for	O
the	O
wiretapping	O
conspiracy	O
,	O
and	O
five	O
years'	O
probation	O
for	O
immigration	O
fraud	O
;	O
Puja	S-Person
received	O
fifteen	O
,	O
fifteen	O
,	O
seven	O
and	O
a	O
half	O
,	O
and	O
four	O
and	O
a	O
half	O
years	O
,	O
respectively	O
,	O
for	O
her	O
role	O
in	O
the	O
first	O
four	O
of	O
these	O
crimes	O
,	O
as	O
well	O
as	O
three	O
years'	O
probation	O
for	O
the	O
wiretapping	O
conspiracy	O
.	O

There	O
was	O
no	O
possible	O
exposure	O
outside	O
the	O
secure	O
laboratory	O
at	O
CDC	S-Organization
and	O
no	O
exposure	O
or	O
risk	O
to	O
the	O
public	O
.	O

William	O
Trent	O
,	O
the	O
militia	O
commander	O
,	O
sent	O
a	O
bill	O
to	O
the	O
British	O
Army	O
indicating	O
that	O
the	O
purpose	O
of	O
giving	O
the	O
blankets	O
was	O
"	O
to	O
Convey	O
the	O
Smallpox	O
to	O
the	O
Indians.	O
"	O
The	O
invoice's	O
approval	O
confirms	O
that	O
the	O
British	O
command	O
endorsed	O
Ecuyer	O
actions.Calloway	O
,	O
Scratch	O
of	O
a	O
Penn	O
,	O
73	O
.	O

Laboratory	O
science	O
is	O
critical	O
to	O
protect	O
America	S-Location
health	O
.	O

Ukraine	S-Organization
has	O
no	O
control	O
over	O
the	O
military	O
bio-laboratories	O
on	O
its	O
own	O
territory	O
.	O

Although	O
new	O
medications	O
may	O
take	O
until	O
2021	O
to	O
develop	O
,	O
several	O
of	O
the	O
medications	O
being	O
tested	O
are	O
already	O
approved	O
for	O
other	O
uses	O
or	O
are	O
already	O
in	O
advanced	O
testing	O
.	O

Most	O
of	O
the	O
biological	O
agents	O
in	O
the	O
biodefense	O
category	O
lists	O
of	O
the	O
US	B-Organization
CDC	E-Organization
EU	S-Location
and	O
Russia	S-Location
were	O
found	O
to	O
be	O
consistent	O
.	O

Blood	O
plasma	O
concentrations	O
of	O
remdesivir	S-Drug
are	O
expected	O
to	O
decrease	O
if	O
it	O
is	O
administered	O
together	O
with	O
cytochrome	O
P450	O
inducers	O
such	O
as	O
rifampicin	S-Drug
,	O
carbamazepine	S-Drug
,	O
phenobarbital	S-Drug
,	O
phenytoin	S-Drug
,	O
primidone	S-Drug
,	O
and	O
.	O

CRISPR-Cas	B-Technology
systems	E-Technology
can	O
also	O
be	O
employed	O
for	O
editing	O
of	O
micro-RNA	O
and	O
long-noncoding	O
RNA	O
genes	O
in	O
plants	O
.	O

As	O
a	O
side-effect	O
,	O
data	O
can	O
be	O
easily	O
exported	O
to	O
the	O
ISA-Tab	O
format	O
.	O

This	O
collaboration	O
between	O
the	O
National	B-Organization
Veterinary	I-Organization
Institute	E-Organization
and	O
the	O
National	B-Organization
Food	I-Organization
Agency	E-Organization
initially	O
focused	O
on	O
biopreparedness	O
and	O
the	O
deliberate	O
spread	O
of	O
pathogens	O
in	O
the	O
food	O
chain	O
.	O

The	O
group	O
agreed	O
to	O
initiate	O
an	O
international	O
forum	O
to	O
address	O
such	O
concerns	O
and	O
harmonize	O
regulations	O
across	O
countries	O
.	O

Doctors	O
in	O
wrote	O
506	O
annual	O
antibiotic	O
scripts	O
for	O
every	O
1,000	O
people	O
,	O
with	O
353	O
being	O
medically	O
necessary	O
.	O

In	O
Hungary	S-Location
,	O
the	O
parliament	O
voted	O
to	O
allow	O
the	O
prime	O
minister	O
,	O
Viktor	B-Person
Orbán	E-Person
,	O
to	O
rule	O
by	O
decree	O
indefinitely	O
,	O
suspend	O
parliament	O
as	O
well	O
as	O
elections	O
,	O
and	O
punish	O
those	O
deemed	O
to	O
have	O
spread	O
false	O
information	O
about	O
the	O
virus	O
and	O
the	O
government's	O
handling	O
of	O
the	O
crisis	O
.	O

Two	O
Chinese	O
agriculture	O
research	O
institutions	O
are	O
investigating	O
how	O
more	O
than	O
100	O
students	O
and	O
staff	O
became	O
infected	O
with	O
the	O
bacterium	O
Brucella	S-Pathogen
strains	O
of	O
which	O
are	O
typically	O
found	O
in	O
farm	O
animals	O
but	O
can	O
also	O
trigger	O
potentially	O
fatal	O
complications	O
in	O
people	O
.	O

These	O
programs	O
over	O
the	O
years	O
have	O
gained	O
the	O
trust	O
of	O
scientific	O
individuals	O
and	O
national	O
governments	O
;	O
these	O
programs	O
can	O
be	O
used	O
as	O
a	O
bridge	O
in	O
strengthening	O
regional	O
initiatives	O
.	O

They	O
assessed	O
the	O
presence	O
of	O
DNA/RNA	O
with	O
polymerase	B-Technology
chain	I-Technology
reaction	E-Technology
(	O
PCR	S-Technology
)	O
techniques	O
for	O
Y.	B-Pathogen
pestis	E-Pathogen
from	O
the	O
tooth	O
sockets	O
in	O
human	O
skeletons	O
from	O
mass	O
graves	O
in	O
northern	O
,	O
central	O
and	O
southern	O
Europe	O
that	O
were	O
associated	O
archaeologically	O
with	O
the	O
Black	O
Death	O
and	O
subsequent	O
resurgences	O
.	O

Developing	O
countermeasures	O
should	O
be	O
"	O
top	O
of	O
mind,	O
"	O
Burr	S-Person
added	O
,	O
saying	O
lawmakers	O
need	O
to	O
ensure	O
that	O
the	O
responsible	O
agencies	O
have	O
what	O
they	O
need	O
to	O
keep	O
pace	O
with	O
rapidly	O
changing	O
and	O
evolving	O
threats	O
.	O

David	B-Person
Nabarro	E-Person
have	O
defended	O
this	O
strategy	O
in	O
order	O
"	O
to	O
ensure	O
Beijing	S-Organization
's	O
co-operation	O
in	O
mounting	O
an	O
effective	O
global	O
response	O
to	O
the	O
outbreak"	O
.	O

On	O
10	O
December	O
,	O
the	O
health	O
commission	O
for	O
the	O
province	O
of	O
Heilongjiang	S-Location
confirmed	O
that	O
13	O
students	O
at	O
the	O
Harbin	B-Organization
Veterinary	I-Organization
Research	I-Organization
Institute	E-Organization
,	O
around	O
2,600	O
kilometres	O
to	O
the	O
northeast	O
of	O
Lanzhou	S-Location
,	O
also	O
had	O
the	O
infection	O
.	O

The	O
average	O
research	O
award	O
was	O
$485,985	O
(total	O
costs)	O
for	O
approximately	O
36	O
months	O
.	O

In	O
a	O
letter	O
to	O
the	O
university	O
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
said	O
the	O
incident	O
"	O
raises	O
several	O
questions	O
"	O
about	O
procedures	O
in	O
the	O
labs	O
.	O

Biosafety	O
Perspective	O
of	O
Clinical	O
Laboratory	O
Workers:	O
A	O
Profile	O
of	O
Pakistan	S-Location
Biosafety	O
during	O
lab	O
work	O
is	O
an	O
important	O
concern	O
in	O
developing	O
countries	O
.	O

Following	O
induction	O
,	O
the	O
bacteriophage	O
replicates	O
,	O
causes	O
lysis	O
,	O
and	O
releases	O
to	O
the	O
medium	O
.	O

At	O
the	O
time	O
of	O
the	O
outbreak	O
,	O
the	O
WHO	S-Organization
had	O
been	O
about	O
to	O
certify	O
that	O
had	O
been	O
eradicated	O
globally	O
.	O

His	O
decree	O
was	O
,	O
however	O
,	O
not	O
obeyed.	O
"	O
Leitenberg	S-Person
,	O
Milton	S-Person
and	O
Raymond	B-Person
A.	I-Person
Zilinskas	E-Person
(2012)	O
,	O
:	O
A	O
History	O
;	O
Cambridge	O
,	O
Massachusetts:	O
Harvard	O
University	O
Press	O
,	O
pg	O
14	O
.	O

Critically	O
,	O
these	O
jobs	O
are	O
at	O
risk	O
even	O
if	O
no	O
person	O
in	O
falls	O
ill	O
in	O
the	O
outbreak	O
.	O

In	O
large-scale	O
projects	O
,	O
often	O
heterogeneous	O
data	O
management	O
solutions	O
have	O
to	O
be	O
brought	O
together	O
.	O

Henderson	S-Person
suggested	O
that	O
a	O
natural	O
outbreak	O
might	O
have	O
carried	O
the	O
virus	O
to	O
Aralsk	S-Location
from	O
Afghanistan	S-Location
,	O
where	O
in	O
1971	O
was	O
still	O
endemic	O
.	O

In	O
principle	O
,	O
this	O
method	O
could	O
be	O
used	O
to	O
synthesize	O
other	O
viruses	O
with	O
similarly	O
short	O
DNA	O
sequences	O
.	O

The	O
International	B-Document
Regulations	E-Document
and	O
the	O
Codex	B-Document
guidelines	E-Document
regulate	O
the	O
biosafety	O
requirements	O
of	O
the	O
GM	S-Technology
crops	O
.	O

Many	O
planned	O
to	O
stockpile	O
medical	O
supplies	O
and	O
discuss	O
worst-case	O
scenarios	O
,	O
including	O
plans	O
to	O
provide	O
lessons	O
and	O
meals	O
for	O
low-income	O
children	O
in	O
case	O
elementary	O
and	O
secondary	O
schools	O
closed	O
.	O

In	O
regards	O
to	O
possible	O
EVD	S-Disease
cases	O
in	O
Tanzania	S-Location
,	O
the	O
WHO	S-Organization
stated	O
on	O
21	O
September	O
2019	O
that	O
"	O
to	O
date	O
,	O
the	O
clinical	O
details	O
and	O
the	O
results	O
of	O
the	O
investigation	O
,	O
including	O
laboratory	O
tests	O
performed	O
for	O
differential	O
diagnosis	O
of	O
these	O
patients	O
,	O
have	O
not	O
been	O
shared	O
with	O
WHO	S-Organization
.	O
The	O
insufficient	O
information	O
received	O
by	O
WHO	S-Organization
does	O
not	O
allow	O
for	O
a	O
formulation	O
of	O
a	O
hypotheses	O
regarding	O
the	O
possible	O
cause	O
of	O
the	O
illness"	O
.	O

At	O
,	O
we	O
have	O
laboratories	O
that	O
don't	O
test	O
for	O
human	O
specimens	O
,	O
but	O
they	O
also	O
need	O
to	O
have	O
quality	O
management	O
systems	O
in	O
place	O
.	O

Information	O
seminars	O
have	O
been	O
presented	O
at	O
meetings	O
where	O
these	O
groups	O
of	O
professionals	O
gather	O
.	O

And	O
while	O
leadership	O
on	O
the	O
issue	O
is	O
needed	O
,	O
he	O
thinks	O
the	O
solution	O
is	O
organization	O
rather	O
than	O
whomever	O
mans	O
it	O
.	O

In	O
November	O
2013	O
,	O
a	O
man	O
became	O
ill	O
with	O
after	O
tending	O
to	O
a	O
sick	O
camel	O
.	O

The	O
biggest	O
way	O
to	O
get	O
into	O
more	O
trouble	O
is	O
not	O
to	O
talk	O
about	O
something	O
when	O
you've	O
got	O
a	O
problem	O
.	O

The	O
DRC	B-Organization
Ministry	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
confirmed	O
that	O
the	O
new	O
Ebola	S-Pathogen
outbreak	O
is	O
caused	O
by	O
the	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
species	O
.	O

In	O
Bahia	S-Location
the	O
vaccination	O
campaign	O
began	O
on	O
19	O
February	O
with	O
a	O
targeted	O
population	O
of	O
3.	O
3	O
million	O
persons	O
in	O
eight	O
municipalities	O
.	O

One	O
possible	O
explanation	O
is	O
that	O
these	O
unusual	O
gene	O
segments	O
were	O
acquired	O
from	O
a	O
reservoir	O
of	O
influenza	B-Pathogen
virus	E-Pathogen
that	O
has	O
not	O
yet	O
been	O
identified	O
or	O
sampled	O
.	O

And	O
so	O
they	O
call	O
for	O
more	O
transparency	O
from	O
DARPA	S-Organization
in	O
addition	O
to	O
more	O
opportunities	O
for	O
public	O
discussion	O
of	O
this	O
new	O
strategy	O
.	O

The	O
gene	O
order	O
is	O
3′	O
–	O
leader	O
–	O
NP	O
–	O
VP35	O
–	O
VP40	O
–	O
GP/sGP	O
–	O
VP30	O
–	O
VP24	O
–	O
L	O
–	O
trailer	O
–	O
5′	O
;	O
with	O
the	O
leader	O
and	O
trailer	O
being	O
non-transcribed	O
regions	O
,	O
which	O
carry	O
important	O
signals	O
to	O
control	O
transcription	O
,	O
replication	O
,	O
and	O
packaging	O
of	O
the	O
viral	O
genomes	O
into	O
new	O
virions	O
.	O

A	O
total	O
of	O
1832	O
biosafety/biosecurity	O
initiatives	O
were	O
recorded	O
from	O
97	O
web	O
links	O
that	O
were	O
reviewed	O
,	O
after	O
removing	O
the	O
duplicate	O
,	O
60	O
web	O
links	O
(1–60)	O
were	O
used	O
for	O
analysis	O
.	O

In	O
Britain	S-Location
the	O
1950s	O
saw	O
the	O
weaponization	O
of	O
plague	S-Pathogen
,	O
brucellosis	S-Pathogen
,	O
tularemia	S-Pathogen
and	O
later	O
equine	B-Pathogen
encephalomyelitis	E-Pathogen
and	O
vaccinia	B-Pathogen
viruses	E-Pathogen
.	O
Trial	O
tests	O
at	O
sea	O
were	O
carried	O
out	O
including	O
Operation	O
Cauldron	O
off	O
in	O
1952	O
.	O

The	O
Defense	B-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
()	O
has	O
invested	O
$100	O
million	O
in	O
vaccines	O
production	O
from	O
tobacco	O
plants	O
.	O

The	O
burden	O
varied	O
greatly	O
among	O
countries	O
.	O

And	O
that's	O
because	O
Ebola	S-Disease
,	O
unlike	O
other	O
disease-causing	O
agents	O
,	O
is	O
not	O
very	O
hardy	O
,	O
said	O
.	O

Liu's	O
brother-in-law	O
,	O
who	O
sought	O
treatment	O
in	O
late	O
February	O
,	O
was	O
hospitalized	O
in	O
Kwong	B-Organization
Wah	I-Organization
Hospital	E-Organization
on	O
1	O
March	O
and	O
died	O
on	O
19	O
March	O
.	O

There	O
is	O
no	O
accredited	O
government/private	O
agency	O
available	O
in	O
India	O
to	O
undertake	O
validation	O
and	O
certification	O
of	O
biosafety	O
laboratories	O
.	O

Initially	O
,	O
the	O
usage	O
of	O
unsterilized	O
needles	O
in	O
a	O
hospital	O
was	O
connected	O
to	O
the	O
first	O
outbreak	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
.	O

In	O
April	O
2018	O
,	O
the	O
National	B-Organization
Archives	I-Organization
of	I-Organization
Japan	E-Organization
for	O
the	O
first	O
time	O
disclosed	O
a	O
nearly	O
complete	O
list	O
of	O
3607	O
people	O
who	O
worked	O
for	O
Unit	B-Organization
731	E-Organization
to	O
Dr	O
.	O

The	O
absence	O
of	O
RNA	O
in	O
the	O
laboratory	O
environmental	O
samples	O
in	O
this	O
study	O
reflects	O
the	O
importance	O
of	O
good	O
laboratory	O
practice	O
for	O
control	O
of	O
potential	O
contamination	O
with	O
viral	O
nucleic	O
acids	O
.	O

Recognition	O
that	O
prion	B-Disease
disease	E-Disease
agents	O
and	O
other	O
high-consequence	O
pathogens	O
require	O
safe	O
handling	O
and	O
thorough	O
destruction	O
during	O
terminal	O
decontamination	O
treatment	O
has	O
led	O
to	O
the	O
development	O
of	O
new	O
biosafety	O
guidelines	O
and	O
technologies	O
.	O

Then	O
there	O
are	O
some	O
of	O
the	O
more	O
radical	O
practices:	O
cryotherapy	S-Technology
(purposely	O
making	O
yourself	O
cold)	O
,	O
neurofeedback	S-Technology
(training	O
yourself	O
to	O
regulate	O
your	O
brain	O
waves)	O
,	O
near-infrared	B-Technology
saunas	E-Technology
(they	O
supposedly	O
help	O
you	O
escape	O
stress	O
from	O
electromagnetic	O
transmissions)	O
,	O
and	O
(which	O
are	O
meant	O
to	O
induce	O
a	O
meditative	O
state	O
through	O
sensory	O
deprivation)	O
,	O
among	O
others	O
.	O

DARPA	S-Organization
envisions	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
as	O
a	O
four-year	O
,	O
fundamental	O
research	O
program	O
.	O

Entire	O
fleets	O
were	O
ill	O
with	O
the	O
disease	O
and	O
men	O
on	O
the	O
front	O
were	O
too	O
sick	O
to	O
fight	O
.	O

Many	O
of	O
China	S-Location
's	O
nearly	O
300 million	O
rural	O
migrant	O
workers	O
have	O
been	O
stranded	O
at	O
home	O
in	O
inland	O
provinces	O
or	O
trapped	O
in	O
.	O

On	O
21	O
September	O
it	O
was	O
announced	O
that	O
Brother	B-Person
Manuel	I-Person
García	I-Person
Viejo	E-Person
,	O
another	O
Spanish	O
citizen	O
who	O
was	O
medical	O
director	O
at	O
the	O
San	B-Organization
Juan	I-Organization
de	I-Organization
Dios	I-Organization
Hospital	E-Organization
in	O
Lunsar	S-Location
,	O
had	O
been	O
evacuated	O
to	O
Spain	S-Location
from	O
after	O
being	O
infected	O
with	O
the	O
virus	O
.	O

The	O
economic	O
effects	O
were	O
being	O
felt	O
nationwide	O
in	O
Liberia	S-Location
,	O
such	O
as	O
the	O
termination	O
of	O
expansions	O
in	O
the	O
mining	O
business	O
.	O

Category	B-Pathogen
C	I-Pathogen
agents	E-Pathogen
are	O
emerging	O
pathogens	O
that	O
might	O
be	O
engineered	O
for	O
mass	O
dissemination	O
because	O
of	O
their	O
availability	O
,	O
ease	O
of	O
production	O
and	O
dissemination	O
,	O
high	O
mortality	O
rate	O
,	O
or	O
ability	O
to	O
cause	O
a	O
major	O
health	O
impact	O
.	O

The	O
first	O
outbreak	O
in	O
Constantinople	S-Location
lasted	O
a	O
year	O
,	O
but	O
the	O
plague	O
recurred	O
ten	O
times	O
before	O
1400	O
.	O

Brooks	S-Person
are	O
those	O
that	O
would	O
clarify	O
the	O
use	O
of	O
the	O
Public	O
Health	O
Emergency	O
Fund	O
;	O
codify	O
the	O
Public	B-Organization
Health	I-Organization
Emergency	I-Organization
Medical	I-Organization
Countermeasures	I-Organization
Enterprise	E-Organization
;	O
improve	O
the	O
ability	O
of	O
the	O
HHS	S-Organization
Secretary	O
to	O
fill	O
intermittent	O
federal	O
employee	O
vacancies	O
in	O
National	B-Platform
Disaster	I-Platform
Medical	I-Platform
System	E-Platform
;	O
prioritize	O
preparing	O
for	O
and	O
responding	O
to	O
cyber	O
threats	O
;	O
and	O
would	O
authorize	O
resources	O
for	O
the	O
development	O
of	O
medical	O
countermeasures	O
for	O
pandemic	O
influenza	O
and	O
emerging	O
infectious	O
diseases	O
within	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
()	O
.	O

The	O
programme	O
was	O
cancelled	O
in	O
1956	O
,	O
when	O
the	O
British	O
government	O
unilaterally	O
renounced	O
the	O
use	O
of	O
biological	O
and	O
chemical	O
weapons	O
.	O

Studies	O
of	O
outbreaks	O
in	O
the	O
late	O
twentieth	O
century	O
failed	O
to	O
find	O
a	O
correlation	O
between	O
the	O
disease	O
severity	O
and	O
the	O
genetic	O
nature	O
of	O
the	O
virus	O
.	O

This	O
study	O
was	O
part	O
of	O
a	O
larger	O
project	O
titled	O
"	O
Scientific	B-International_exchange_and_cooperation
Engagement	I-International_exchange_and_cooperation
Defining	I-International_exchange_and_cooperation
Gaps	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Creating	I-International_exchange_and_cooperation
Opportunities	I-International_exchange_and_cooperation
for	I-International_exchange_and_cooperation
Cooperative	I-International_exchange_and_cooperation
Research	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Global	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
in	I-International_exchange_and_cooperation
the	I-International_exchange_and_cooperation
Broader	I-International_exchange_and_cooperation
Middle	I-International_exchange_and_cooperation
East	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
North	I-International_exchange_and_cooperation
Africa	I-International_exchange_and_cooperation
Region	E-International_exchange_and_cooperation
"	O
to	O
assess	O
the	O
overall	O
impact	O
of	O
global	O
biosecurity	O
capacity-building	O
initiatives	O
undertaken	O
in	O
recent	O
years	O
in	O
the	O
region	O
and	O
to	O
then	O
apply	O
the	O
knowledge	O
gained	O
from	O
this	O
assessment	O
to	O
suggest	O
sustainable	O
ways	O
to	O
build	O
cooperative	O
regional	O
biosafety	O
opportunities	O
.	O

The	O
2016	O
study	O
suggested	O
that	O
the	O
low	O
flu	O
mortality	O
rate	O
(an	O
estimated	O
1/1000)	O
found	O
among	O
the	O
Chinese	O
and	O
Southeast	O
Asian	O
workers	O
in	O
Europe	O
meant	O
that	O
the	O
deadly	O
could	O
not	O
have	O
originated	O
from	O
those	O
workers	O
.	O

It	O
is	O
part	O
of	O
the	O
reference	O
lists	O
for	O
risk	O
classification	O
of	O
micro-organisms	O
that	O
have	O
been	O
published	O
in	O
the	O
Regional	O
Decrees	O
regulating	O
contained	O
use	O
activities	O
involving	O
pathogen	O
and/or	O
genetically	O
modified	O
organisms	O
.	O

In	O
addition	O
,	O
biosafety	B-Equipment
cabinet	E-Equipment
was	O
found	O
in	O
11	O
(5.	O
8%)	O
labs	O
,	O
autoclave	S-Equipment
in	O
28	O
(14.	O
7%)	O
,	O
and	O
incinerator	S-Equipment
in	O
only	O
2	O
(1.1%)	O
labs	O
.	O

For	O
instance	O
,	O
if	O
gene	O
therapy	O
in	O
humans	O
is	O
acceptable	O
to	O
cure	O
disease	O
,	O
where	O
do	O
you	O
draw	O
the	O
line?	O
Among	O
disease-associated	O
gene	O
mutations	O
,	O
some	O
come	O
with	O
virtual	O
certainty	O
of	O
premature	O
death	O
,	O
while	O
others	O
put	O
you	O
at	O
higher	O
risk	O
for	O
something	O
like	O
Alzheimer's	S-Disease
,	O
but	O
don't	O
guarantee	O
you'll	O
get	O
the	O
disease	O
.	O

A	O
hospital-related	O
outbreak	O
in	O
Riyadh	S-Location
brought	O
the	O
total	O
in	O
Saudi	B-Location
Arabia	E-Location
to	O
1,115	O
cases	O
and	O
480	O
fatalities	O
as	O
of	O
18	O
August	O
2015	O
.	O

Anthrax	S-Pathogen
cannot	O
be	O
spread	O
from	O
person	O
to	O
person	O
.	O

And	O
DNA	O
is	O
an	O
efficient	O
option	O
for	O
storing	O
data	O
,	O
as	O
researchers	O
recently	O
demonstrated	O
when	O
they	O
stored	O
a	O
movie	O
file	O
in	O
the	O
genome	O
of	O
a	O
cell	O
.	O

As	O
a	O
result	O
of	O
the	O
pandemic	O
,	O
many	O
countries	O
and	O
regions	O
imposed	O
quarantines	O
,	O
entry	O
bans	O
,	O
or	O
other	O
restrictions	O
,	O
either	O
for	O
citizens	O
,	O
recent	O
travellers	O
to	O
affected	O
areas	O
,	O
or	O
for	O
all	O
travellers	O
.	O

On	O
25	O
May	O
,	O
Brazil	S-Organization
exceeded	O
the	O
number	O
of	O
reported	O
cases	O
in	O
Russia	S-Location
when	O
they	O
reported	O
that	O
11,687	O
new	O
cases	O
had	O
been	O
confirmed	O
over	O
the	O
previous	O
24	O
hours	O
,	O
bringing	O
the	O
total	O
number	O
to	O
over	O
374,800	O
,	O
with	O
more	O
than	O
23,400	O
deaths	O
.	O

The	O
university	O
is	O
still	O
investigating	O
whether	O
she	O
acquired	O
the	O
infection	O
in	O
the	O
lab	O
,	O
said	O
University	B-Organization
of	I-Organization
Chicago	I-Organization
Medical	I-Organization
Center	E-Organization
spokesperson	O
Lorna	B-Person
Wong	E-Person
.	O
B.	B-Pathogen
cereus	E-Pathogen
is	O
not	O
contagious	O
as	O
long	O
as	O
standard	O
procedures	O
such	O
as	O
good	O
hand-washing	O
hygiene	O
are	O
followed	O
,	O
but	O
family	O
members	O
and	O
co-workers	O
were	O
screened	O
for	O
infection	O
risk	O
and	O
some	O
were	O
offered	O
precautionary	O
.	O

Supportive	O
treatments	O
may	O
be	O
useful	O
in	O
those	O
with	O
mild	O
symptoms	O
at	O
the	O
early	O
stage	O
of	O
infection	O
.	O

Applications	O
of	O
these	O
concepts	O
in	O
systems	O
biology	O
include	O
the	O
Systems	O
Biology	O
Ontology	O
which	O
adds	O
semantics	O
to	O
models	O
allowing	O
,	O
e.g.	O
to	O
give	O
understandable	O
names	O
to	O
reaction	O
rate	O
equations-and	O
the	O
tool	O
RightField	O
employing	O
ontologies	O
to	O
enhance	O
annotation	O
of	O
data	O
.	O

Bats	O
are	O
allegedly	O
the	O
reservoir	O
hosts	O
to	O
the	O
Ebola	B-Pathogen
Virus	E-Pathogen
,	O
Middle	B-Pathogen
East	I-Pathogen
Respiratory	I-Pathogen
Syndrome	E-Pathogen
(	O
MERS	S-Pathogen
)	O
and	O
other	O
deadly	O
diseases	O
.	O

The	O
much	O
more	O
apparent	O
horrors	O
of	O
chemical	O
warfare	O
led	O
,	O
in	O
1925	O
,	O
to	O
the	O
Geneva	B-Document
Protocol	E-Document
It	O
prohibits	O
the	O
use	O
of	O
chemical	O
and	O
biological	O
agents	O
,	O
but	O
not	O
research	O
and	O
development	O
of	O
these	O
agents	O
.	O

Further	O
,	O
the	O
laboratory	O
personnel	O
awareness	O
towards	O
biosafety	O
principles	O
implementation	O
was	O
very	O
low	O
too	O
.	O

Although	O
the	O
pathogen	O
responsible	O
for	O
anthrax	S-Disease
can	O
be	O
treated	O
with	O
,	O
the	O
toxin	O
which	O
it	O
releases	O
in	O
the	O
body	O
is	O
particularly	O
dangerous	O
.	O

As	O
of	O
today	O
,	O
the	O
CDC	S-Organization
has	O
about	O
35	O
public	O
health	O
events	O
of	O
international	O
importance	O
under	O
surveillance	O
all	O
around	O
the	O
world	O
,	O
she	O
said	O
,	O
adding	O
that	O
the	O
public	O
health	O
system	O
is	O
dependent	O
upon	O
other	O
nations	O
being	O
able	O
to	O
effectively	O
operate	O
their	O
own	O
systems	O
.	O

Even	O
though	O
the	O
CDC	S-Organization
and	O
USDA	S-Organization
have	O
partially	O
lifted	O
USAMRIID's	B-Document
suspension	E-Document
,	O
the	O
laboratory	O
still	O
needs	O
approval	O
from	O
Gen.	B-Person
John	I-Person
Murray	E-Person
,	O
commanding	O
general	O
of	O
the	O
Army	B-Organization
Futures	I-Organization
Command	E-Organization
,	O
before	O
it	O
can	O
start	O
work	O
,	O
said	O
.	O

"	O
The	O
political	O
stakes	O
in	O
the	O
Medfly	B-Incident
infestation	E-Incident
California	S-Location
Journal	O
,	O
April	O
1981	O
,	O
pp.	O
137-39	O
.	O

The	O
new	O
virus	O
was	O
first	O
isolated	O
in	O
late	O
April	O
by	O
American	O
and	O
Canadian	O
laboratories	O
from	O
samples	O
taken	O
from	O
people	O
with	O
flu	O
in	O
Mexico	S-Location
,	O
Southern	B-Location
California	E-Location
,	O
and	O
Texas	S-Location
.	O
Soon	O
the	O
earliest	O
known	O
human	O
case	O
was	O
traced	O
to	O
a	O
case	O
from	O
9March	O
2009	O
in	O
a	O
5-year-old	O
boy	O
in	O
La	B-Location
Gloria	E-Location
,	O
Mexico	S-Location
,	O
a	O
rural	O
town	O
in	O
Veracruz	S-Location
.	O
In	O
late	O
April	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
declared	O
its	O
first	O
ever	O
"	O
public	O
health	O
emergency	O
of	O
international	O
concern,	O
"	O
or	O
PHEIC	S-Incident
,	O
and	O
in	O
June	O
,	O
the	O
WHO	S-Organization
and	O
the	O
stopped	O
counting	O
cases	O
and	O
declared	O
the	O
outbreak	O
a	O
pandemic	O
.	O

Older	O
adults	O
and	O
those	O
with	O
underlying	O
medical	O
conditions	O
such	O
as	O
diabetes	S-Disease
heart	O
disease	O
,	O
respiratory	O
disease	O
,	O
hypertension	S-Disease
,	O
and	O
compromised	O
immune	O
systems	O
face	O
increased	O
risk	O
of	O
serious	O
illness	O
and	O
complications	O
and	O
have	O
been	O
advised	O
by	O
the	O
to	O
stay	O
home	O
as	O
much	O
as	O
possible	O
in	O
areas	O
of	O
community	O
outbreak	O
.	O

Members	O
were	O
charged	O
with	O
providing	O
expertise	O
and	O
reviewing	O
all	O
HHS	S-Organization
efforts	O
related	O
to	O
tick-borne	O
diseases	O
to	O
help	O
ensure	O
interagency	O
coordination	O
,	O
minimize	O
overlap	O
,	O
and	O
to	O
examine	O
research	O
priorities	O
.	O

In	O
January	O
2020	O
,	O
Gilead	S-Organization
began	O
laboratory	O
testing	O
of	O
remdesivir	S-Drug
against	O
SARS-CoV-2	S-Pathogen
,	O
stating	O
that	O
remdesivir	S-Drug
had	O
been	O
shown	O
to	O
be	O
active	O
against	O
severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
SARS	S-Disease
)	O
and	O
Middle	B-Disease
East	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
MERS	S-Disease
)	O
in	O
animal	O
models	O
.	O

As	O
of	O
30	O
April	O
2019	O
,	O
there	O
have	O
been	O
92	O
health	O
care	O
workers	O
in	O
the	O
DRC	S-Location
infected	O
with	O
,	O
of	O
which	O
33	O
have	O
died	O
.	O

As	O
of	O
2015	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
has	O
worked	O
within	O
the	O
UNAIDS	B-Platform
network	E-Platform
and	O
strives	O
to	O
involve	O
sections	O
of	O
society	O
other	O
than	O
health	O
to	O
help	O
deal	O
with	O
the	O
economic	O
and	O
social	O
effects	O
of	O
HIV/AIDS	S-Disease
.	O
In	O
line	O
with	O
UNAIDS	S-Organization
,	O
WHO	S-Organization
has	O
set	O
itself	O
the	O
interim	O
task	O
between	O
2009	O
and	O
2015	O
of	O
reducing	O
the	O
number	O
of	O
those	O
aged	O
15–24	O
years	O
who	O
are	O
infected	O
by	O
50%	O
;	O
reducing	O
new	O
HIV	S-Pathogen
infections	O
in	O
children	O
by	O
90%	O
;	O
and	O
reducing	O
-related	O
deaths	O
by	O
25%	O
.	O

Both	O
men	O
fell	O
ill	O
and	O
one	O
was	O
hospitalized	O
.	O

In	O
2014	O
,	O
the	O
Center	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
came	O
under	O
scrutiny	O
after	O
repeated	O
errors	O
led	O
to	O
scientists	O
being	O
exposed	O
to	O
Ebola	S-Pathogen
,	O
anthrax	S-Pathogen
,	O
and	O
the	O
flu	S-Pathogen
.	O
And	O
a	O
professor	O
in	O
the	O
Netherlands	S-Location
came	O
under	O
fire	O
in	O
2011	O
when	O
his	O
lab	O
engineered	O
a	O
deadly	O
,	O
airborne	O
version	O
of	O
the	O
virus	O
,	O
mentioned	O
above	O
,	O
and	O
attempted	O
to	O
publish	O
the	O
details	O
.	O

Restrictive	O
use	O
of	O
intellectual	O
property	O
(IP)	O
rights	O
and	O
privacy	O
are	O
identified	O
as	O
main	O
hurdles	O
for	O
open	O
access	O
to	O
public	O
research	O
data	O
.	O

Other	O
organizations	O
involved	O
in	O
the	O
design	O
and	O
production	O
of	O
biological	O
weapons	O
were	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Defense	E-Organization
,	O
Ministry	B-Organization
of	I-Organization
Agriculture	E-Organization
,	O
Ministry	B-Organization
of	I-Organization
Health	E-Organization
,	O
USSR	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
,	O
and	O
KGB	S-Organization
.	O
The	O
USSR	S-Organization
bioweapons	O
investment	O
rivaled	O
its	O
considerable	O
investment	O
in	O
nuclear	O
arms	O
.	O

+Major	O
Ebola	B-Incident
virus	I-Incident
outbreaks	E-Incident
by	O
country	O
and	O
by	O
date	O
–	O
to	O
most	O
recent	O
WHO	S-Organization
/	O
Gov	O
update-	O
14	O
January	O
2016Date	O
Total	O
Guinea	S-Location
Liberia	S-Location
Sierra	B-Location
Leone	E-Location
Sources	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
CasesDeaths	O
14	O
January	O
2016	O
28,542	O
11,299	O
3,806	O
2,535	O
10,675	O
4,809	O
14,061	O
3,955	O
23	O
December	O
2015	O
28,542	O
11,299	O
3,806	O
2,535	O
10,676	O
4,809	O
14,061	O
3,955	O
9	O
December	O
2015	O
28,542	O
11,2993,806	O
2,535	O
10,675	O
4,809	O
14,061	O
3,955	O
25	O
November	O
2015	O
28,539	O
11,298	O
3,806	O
2,535	O
10,672	O
4,808	O
14,061	O
3,955	O
11	O
November	O
2015	O
28,539	O
11,298	O
3,806	O
2,535	O
10,672	O
4,808	O
14,061	O
3,955	O
25	O
October	O
2015	O
28,539	O
11,298	O
3,800	O
2,534	O
10,672	O
4,808	O
14,061	O
3,955	O
11	O
October	O
2015	O
28,454	O
11,297	O
3,800	O
2,534	O
10,672	O
4,808	O
13,982	O
3,955	O
Note	O
1:	O
Cases	O
include	O
confirmed	O
,	O
probable	O
and	O
suspected	O
per	O
the	O
,	O
numbers	O
are	O
the	O
cumulative	O
figures	O
as	O
published	O
on	O
the	O
given	O
date	O
,	O
and	O
due	O
to	O
retrospective	O
revisions	O
,	O
differences	O
between	O
successive	O
weekly	O
totals	O
are	O
not	O
necessarily	O
the	O
number	O
of	O
new	O
cases	O
that	O
week	O
.	O

Laboratory	O
work	O
in	O
virology	O
requires	O
students	O
to	O
operate	O
under	O
biosafety	B-Platform
level	I-Platform
2	E-Platform
(	O
BSL2	S-Platform
)	O
conditions	O
(see	O
information	O
box)	O
.	O

Laboratory	O
wastewater	O
on	O
Fort	B-Location
Detrick	E-Location
is	O
chemically	O
disinfected	O
at	O
the	O
source	O
,	O
then	O
routed	O
to	O
the	O
,	O
where	O
it	O
is	O
held	O
in	O
these	O
storage	O
tanks	O
prior	O
to	O
entering	O
the	O
steam	O
sterilization	O
process	O
.	O

Many	O
high-consequence	O
pathogens	O
are	O
rarely	O
,	O
or	O
have	O
never	O
been	O
,	O
encountered	O
in	O
real-life	O
situations	O
,	O
meaning	O
that	O
the	O
capacity	O
to	O
carry	O
out	O
the	O
relevant	O
methods	O
is	O
not	O
tested	O
on	O
a	O
regular	O
basis	O
.	O

The	O
conditions	O
used	O
to	O
decide	O
when	O
the	O
fund	O
should	O
pay	O
out	O
to	O
disease-affected	O
countries	O
were	O
criticised	O
as	O
too	O
stringent	O
.	O

The	O
Eurovision	O
Song	O
Contest	O
,	O
which	O
was	O
due	O
to	O
be	O
held	O
in	O
the	O
Netherlands	S-Location
in	O
May	O
,	O
was	O
postponed	O
until	O
2021	O
.	O

Contact	O
tracing	O
is	O
an	O
essential	O
method	O
of	O
preventing	O
the	O
spread	O
of	O
the	O
disease	O
,	O
this	O
requires	O
effective	O
community	O
surveillance	O
so	O
that	O
a	O
possible	O
case	O
of	O
Ebola	S-Disease
can	O
be	O
registered	O
and	O
accurately	O
diagnosed	O
as	O
soon	O
as	O
possible	O
,	O
and	O
subsequently	O
finding	O
everyone	O
who	O
has	O
had	O
close	O
contact	O
with	O
the	O
case	O
and	O
tracking	O
them	O
for	O
21	O
days	O
.	O

Online	O
survey	O
results	O
confirmed	O
desktop	O
review	O
findings	O
;	O
however	O
,	O
the	O
response	O
rate	O
was	O
11%	O
.	O

Why	O
Would	O
Anthrax	S-Pathogen
Be	O
Used	O
as	O
a	O
Weapon?	O

Richard	B-Person
Burr	E-Person
(R-NC)	O
introduced	O
on	O
May	O
15	O
.	O

It	O
has	O
more	O
recently	O
been	O
used	O
for	O
preventive	O
medicine	O
or	O
screening	O
for	O
disease	O
,	O
for	O
example	O
CT	B-Technology
colonography	E-Technology
for	O
people	O
with	O
a	O
high	O
risk	O
of	O
colon	B-Disease
cancer	E-Disease
,	O
or	O
full-motion	B-Technology
heart	I-Technology
scans	E-Technology
for	O
people	O
with	O
high	O
risk	O
of	O
heart	B-Disease
disease	E-Disease
.	O
A	O
number	O
of	O
institutions	O
offer	O
for	O
the	O
general	O
population	O
although	O
this	O
practice	O
goes	O
against	O
the	O
advice	O
and	O
official	O
position	O
of	O
many	O
professional	O
organizations	O
in	O
the	O
field	O
primarily	O
due	O
to	O
the	O
radiation	O
dose	O
applied	O
.	O

Ironically	O
,	O
the	O
global	O
response	O
to	O
the	O
deadly	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
has	O
been	O
just	O
that	O
.	O

But	O
even	O
after	O
adjusting	O
age-specific	O
deaths	O
by	O
age-specific	O
clinical	O
attack	O
rates	O
(Figure	O
3	O
,	O
panel	O
B)	O
,	O
a	O
W-shaped	O
curve	O
with	O
a	O
case-fatality	O
peak	O
in	O
young	O
adults	O
remains	O
and	O
is	O
significantly	O
different	O
from	O
U-shaped	O
age-specific	O
case-fatality	O
curves	O
typically	O
seen	O
in	O
oth	O
er	B-Disease
influe	E-Disease
nza	O
years	O
,	O
e.g.	O
,	O
1928–1929	O
(Figure	O
3	O
,	O
panel	O
C)	O
.	O

This	O
is	O
because	O
the	O
construction	O
of	O
the	O
centre	O
was	O
funded	O
by	O
the	O
Defence	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
which	O
is	O
an	O
agency	O
within	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
founded	O
in	O
October	O
1	O
,	O
1998	O
.	O

According	O
to	O
Kenneth	B-Person
Alibek	E-Person
,	O
the	O
used	O
tularemia	S-Pathogen
weapon	O
had	O
been	O
developed	O
in	O
the	O
Kirov	B-Location
military	I-Location
facility	E-Location
.	O
It	O
was	O
suggested	O
by	O
some	O
,	O
however	O
,	O
that	O
the	O
outbreak	O
might	O
have	O
been	O
of	O
natural	O
origin	O
,	O
since	O
a	O
pulmonary	S-Phenotype
form	O
of	O
tularemia	S-Pathogen
has	O
also	O
been	O
noted	O
in	O
.	O

Governments	O
need	O
to	O
accept	O
and	O
embrace	O
some	O
of	O
these	O
new	O
trends	O
and	O
new	O
technologies	O
.	O

This	O
gives	O
a	O
temporal	O
resolution	O
of	O
20–30	O
ms	O
for	O
images	O
with	O
an	O
in-plane	O
resolution	O
of	O
1.5–2.0 mm	O
.	O

Many	O
other	O
pathogens	O
that	O
infect	O
animals	O
can	O
also	O
infect	O
humans:	O
these	O
are	O
called	O
zoonotic	O
agents	O
(	O
et	O
al.	O
,	O
2003)	O
.	O

Awards	O
totaling	O
$5,395,838	O
were	O
made	O
to	O
the	O
11	O
research	O
and	O
2	O
conference	O
proposals	O
that	O
were	O
highly	O
ranked	O
.	O

The	O
anthrax	S-Pathogen
was	O
in	O
a	O
powder	O
form	O
and	O
it	O
was	O
delivered	O
by	O
the	O
mail	O
.	O

First	O
,	O
the	O
US	B-Organization
national	I-Organization
council	E-Organization
on	O
research	O
requested	O
full	O
and	O
open	O
access	O
to	O
publicly	O
funded	O
research	O
data	O
.	O

Some	O
other	O
coronaviruses	O
circulating	O
in	O
people	O
are	O
capable	O
of	O
reinfection	O
after	O
roughly	O
a	O
year	O
.	O

However	O
,	O
it	O
has	O
developed	O
and	O
implemented	O
an	O
efficient	O
national	O
biosafety	O
system	O
.	O

The	O
overall	O
design	O
of	O
the	O
lab	O
is	O
shown	O
in	O
Table	O
1	O
.	O

In	O
October	O
2014	O
,	O
the	O
Associated	B-Organization
Press	E-Organization
reported	O
in	O
an	O
internal	O
draft	O
document	O
that	O
the	O
WHO	S-Organization
admitted	O
"	O
nearly	O
everyone	O
"	O
involved	O
in	O
the	O
Ebola	S-Disease
response	O
failed	O
to	O
notice	O
factors	O
that	O
turned	O
the	O
outbreak	O
into	O
the	O
largest	O
on	O
record	O
,	O
and	O
that	O
they	O
had	O
missed	O
chances	O
to	O
stop	O
the	O
spread	O
of	O
Ebola	S-Disease
due	O
to	O
"	O
incompetent	O
staff	O
,	O
bureaucracy	O
and	O
a	O
lack	O
of	O
reliable	O
information"	O
.	O

In	O
1422	O
,	O
during	O
the	O
siege	O
of	O
Karlstein	B-Location
Castle	E-Location
in	O
,	O
Hussite	O
attackers	O
used	O
catapults	O
to	O
throw	O
dead	O
(but	O
not	O
plague-infected)	O
bodies	O
and	O
2000	O
carriage-loads	O
of	O
dung	O
over	O
the	O
walls	O
.	O

The	O
design	O
of	O
the	O
facilities	O
made	O
them	O
hard	O
to	O
destroy	O
by	O
bombing	O
.	O

Watercourses	O
at	O
several	O
sites	O
inside	O
the	O
Mozambique	S-Location
border	O
were	O
deliberately	O
contaminated	O
with	O
cholera	S-Pathogen
.	O
These	O
biological	O
attacks	O
had	O
little	O
impact	O
on	O
the	O
fighting	O
capability	O
of	O
ZANLA	S-Location
,	O
but	O
caused	O
considerable	O
distress	O
to	O
the	O
local	O
population	O
.	O

The	O
key	O
to	O
sleep	O
is	O
to	O
save	O
the	O
last	O
hour	O
of	O
the	O
day	O
for	O
non-work-related	O
things	O
that	O
let	O
your	O
brain	O
cool	O
down	O
.	O

We	O
don't	O
,	O
but	O
as	O
I	O
said	O
,	O
we	O
don't	O
have	O
many	O
tools	O
against	O
Lassa	S-Disease
We	O
don't	O
have	O
a	O
vaccine	O
;	O
there's	O
no	O
magic	O
bullet	O
.	O

Sports	O
events	O
and	O
seasons	O
were	O
cancelled	O
.	O

Operation	B-Scientific_research_project
Big	I-Scientific_research_project
Itch	E-Scientific_research_project
,	O
in	O
1954	O
,	O
was	O
designed	O
to	O
test	O
munitions	O
loaded	O
with	O
uninfected	O
fleas	O
(Xenopsylla	O
cheopis)	O
.	O

"	O
Any	O
province	O
with	O
low	O
routine	O
immunisation	O
coverage	O
or	O
gaps	O
in	O
vaccination	O
coverage	O
during	O
the	O
outbreak	O
response	O
is	O
vulnerable	O
for	O
polio	B-Pathogen
virus	E-Pathogen
circulation	O
.	O

In	O
the	O
21	O
January	O
2015	O
WHO	S-Organization
road	O
map	O
update	O
,	O
it	O
was	O
reported	O
that	O
100%	O
of	O
districts	O
in	O
Sierra	B-Location
Leone	E-Location
and	O
71%	O
of	O
districts	O
in	O
had	O
a	O
list	O
of	O
key	O
religious	O
leaders	O
who	O
promoted	O
safe	O
and	O
dignified	O
burials	O
.	O

The	O
average	O
grade	O
of	O
these	O
three	O
reports	O
accounts	O
for	O
25%	O
of	O
the	O
final	O
lab	O
grade	O
.	O

Also	O
,	O
if	O
the	O
massive	O
decline	O
in	O
economic	O
activity	O
persisted	O
,	O
the	O
authors	O
suggested	O
a	O
focus	O
on	O
economic	O
recovery	O
in	O
addition	O
to	O
support	O
for	O
the	O
healthcare	O
system	O
.	O

The	O
European	B-Organization
Union	E-Organization
rejected	O
the	O
idea	O
of	O
suspending	O
the	O
Schengen	S-Location
free	O
travel	O
zone	O
and	O
introducing	O
border	O
controls	O
with	O
,	O
a	O
decision	O
which	O
has	O
been	O
criticised	O
by	O
some	O
European	O
politicians	O
.	O

On	O
1May	O
2020	O
,	O
the	O
United	B-Location
States	E-Location
gave	O
emergency	O
use	O
authorization	O
to	O
the	O
antiviral	B-Drug
remdesivir	E-Drug
for	O
people	O
hospitalized	O
with	O
severe	O
COVID‑19	S-Disease
.	O
Management	O
involves	O
the	O
treatment	O
of	O
symptoms	O
,	O
supportive	O
care	O
,	O
isolation	O
,	O
and	O
experimental	O
measures	O
.	O

A	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
report	O
is	O
touting	O
the	O
benefits	O
of	O
a	O
program	O
credited	O
with	O
expediting	O
detection	O
.	O

So	O
we'll	O
be	O
going	O
back	O
and	O
forth	O
between	O
the	O
phone	O
and	O
the	O
room	O
.	O

In	O
2003	O
,	O
the	O
WHO	S-Organization
denounced	O
the	O
Roman	B-Organization
Curia	E-Organization
's	O
health	O
department's	O
opposition	O
to	O
the	O
use	O
of	O
condoms	O
,	O
saying:	O
"	O
These	O
incorrect	O
statements	O
about	O
condoms	O
and	O
HIV	S-Pathogen
are	O
dangerous	O
when	O
we	O
are	O
facing	O
a	O
global	O
pandemic	O
which	O
has	O
already	O
killed	O
more	O
than	O
20 million	O
people	O
,	O
and	O
currently	O
affects	O
at	O
least	O
42 million.	O
"	O
,	O
the	O
Catholic	B-Organization
Church	E-Organization
remains	O
opposed	O
to	O
increasing	O
the	O
use	O
of	O
contraception	O
to	O
combat	O
HIV/AIDS	S-Disease
.	O
At	O
the	O
time	O
,	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
President	O
,	O
Guyana	S-Organization
's	O
Health	O
Minister	O
,	O
has	O
condemned	O
Pope	O
Benedict's	O
opposition	O
to	O
contraception	O
,	O
saying	O
he	O
was	O
trying	O
to	O
"	O
create	O
confusion	O
"	O
and	O
"	O
impede"	O
proven	O
strategies	O
in	O
the	O
battle	O
against	O
the	O
disease	O
.	O

Minks	O
at	O
two	O
farms	O
in	O
the	O
Netherlands	S-Location
also	O
tested	O
positive	O
for	O
.	O

But	O
trials	O
of	O
CRISPR/Cas9	S-Technology
in	O
human	O
cells	O
have	O
produced	O
troubling	O
results	O
,	O
with	O
mutations	O
showing	O
up	O
in	O
parts	O
of	O
the	O
genome	O
that	O
shouldn't	O
have	O
been	O
targeted	O
for	O
DNA	O
changes	O
.	O

There	O
was	O
no	O
possible	O
exposure	O
outside	O
the	O
secure	O
laboratory	O
at	O
CDC	S-Organization
and	O
no	O
exposure	O
or	O
risk	O
to	O
the	O
public	O
.	O

Second	O
,	O
I'm	O
appointing	O
a	O
single	O
point	O
of	O
accountability	O
,	O
Dr	O
.	O

The	O
authors	O
thank	O
all	O
the	O
present	O
and	O
previous	O
staff	O
and	O
members	O
of	O
the	O
FBD	S-Platform
network	O
and	O
Mr	O
.	O

A	O
second	O
or	O
fall	O
wave	O
spread	O
globally	O
from	O
September	O
to	O
November	O
1918	O
and	O
was	O
highly	O
fatal	O
.	O

Speaking	O
on	O
3	O
September	O
,	O
the	O
International	O
President	O
of	O
MSF	S-Organization
spoke	O
out	O
concerning	O
the	O
lack	O
of	O
assistance	O
from	O
United	B-Organization
Nations	E-Organization
(	O
UN	S-Organization
)	O
member	O
countries:	O
"	O
Six	O
months	O
into	O
the	O
worst	O
Ebola	B-Incident
epidemic	E-Incident
in	O
history	O
,	O
the	O
world	O
is	O
losing	O
the	O
battle	O
to	O
contain	O
it.	O
"	O
In	O
a	O
26	O
September	O
statement	O
,	O
the	O
WHO	S-Organization
stated	O
that	O
"	O
[t]he	O
Ebola	B-Incident
epidemic	E-Incident
ravaging	O
parts	O
of	O
is	O
the	O
most	O
severe	O
acute	O
public	O
health	O
emergency	O
seen	O
in	O
modern	O
times	O
"	O
and	O
its	O
Director-General	O
called	O
the	O
outbreak	O
"	O
the	O
largest	O
,	O
most	O
complex	O
and	O
most	O
severe	O
we've	O
ever	O
seen"	O
.	O

Besides	O
working	O
on	O
the	O
joint	O
projects	O
,	O
all	O
members	O
of	O
the	O
network	O
meet	O
approximately	O
3	O
times	O
a	O
year	O
for	O
a	O
shared	O
workshop	O
,	O
including	O
progress	O
reports	O
and	O
seminars	O
.	O

While	O
overall	O
trends	O
are	O
positive	O
,	O
a	O
modest	O
uptick	O
in	O
cases	O
in	O
Guinea	S-Location
Liberia	S-Location
,	O
and	O
Sierra	S-Location
Leone	O
in	O
late	O
January	O
should	O
serve	O
as	O
a	O
powerful	O
reminder	O
that	O
we	O
must	O
remain	O
vigilant	O
and	O
intensify	O
our	O
efforts	O
.	O

On	O
2	O
April	O
1979	O
,	O
spores	O
of	O
anthrax	O
were	O
accidentally	O
released	O
from	O
a	O
Soviet	S-Organization
military	O
research	O
facility	O
near	O
the	O
city	O
of	O
Sverdlovsk	S-Location
,	O
Russia	S-Location
(now	O
Yekaterinburg	S-Location
)	O
.	O

By	O
23	O
March	O
,	O
Iran	S-Location
was	O
experiencing	O
fifty	O
new	O
cases	O
every	O
hour	O
and	O
one	O
new	O
death	O
every	O
ten	O
minutes	O
due	O
to	O
coronavirus	S-Pathogen
.	O
According	O
to	O
a	O
WHO	S-Organization
official	O
,	O
there	O
may	O
be	O
five	O
times	O
more	O
cases	O
in	O
than	O
what	O
is	O
being	O
reported	O
.	O

Although	O
there	O
is	O
no	O
evidence	O
that	O
biological	O
weapons	O
were	O
used	O
by	O
the	O
United	B-Location
States	E-Location
China	S-Location
and	O
North	B-Location
Korea	E-Location
accused	O
the	O
US	S-Location
of	O
large-scale	O
field	O
testing	O
of	O
BW	O
against	O
them	O
during	O
the	O
Korean	O
War	O
(1950–1953)	O
.	O

Although	O
VIGIV	S-Drug
has	O
been	O
sold	O
to	O
foreign	O
governments	O
,	O
to	O
date	O
,	O
the	O
principal	O
customer	O
for	O
VIGIV	S-Drug
has	O
been	O
the	O
U.S.	B-Organization
government	E-Organization
,	O
specifically	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
.	O
"	O
We	O
anticipate	O
negotiating	O
a	O
follow-on	O
contract	O
for	O
the	O
continued	O
supply	O
of	O
VIGIV	S-Drug
"	O
into	O
the	O
U.S.	B-Platform
Strategic	I-Platform
National	I-Platform
Stockpile	E-Platform
,	O
company	O
executives	O
wrote	O
in	O
.	O

Heather	B-Person
Sheeley	E-Person
BA	O
(Hons)	O
,	O
MSc.	O
,	O
CBiol	O
MSB.	O
,	O
CMIOSH	O
,	O
FISTR	O
,	O
is	O
Corporate	O
BioSafety	O
Programme	O
Lead	O
,	O
Public	B-Organization
Health	I-Organization
England	E-Organization
.	O
She	O
has	O
more	O
than	O
20	O
years	O
of	O
experience	O
in	O
biological	O
laboratory	O
safety	O
and	O
general	O
safety	O
,	O
and	O
is	O
a	O
recognized	O
expert/specialist	O
in	O
biosafety	O
,	O
especially	O
in	O
the	O
areas	O
of	O
design	B-Technology
and	I-Technology
commissioning	I-Technology
of	I-Technology
high-containment	I-Technology
laboratories	E-Technology
.	O
She	O
is	O
a	O
past	O
President	O
of	O
the	O
European	B-Organization
Biosafety	I-Organization
Association	E-Organization
and	O
a	O
member	O
of	O
the	O
.	O

TOM	B-Person
FRIEDEN	E-Person
On	O
the	O
phone?	O

CT	B-Technology
VC	E-Technology
is	O
increasingly	O
being	O
used	O
in	O
the	O
UK	S-Technology
and	O
US	S-Technology
as	O
a	O
screening	O
test	O
for	O
colon	B-Disease
polyps	E-Disease
and	O
and	O
can	O
negate	O
the	O
need	O
for	O
a	O
colonoscopy	O
in	O
some	O
cases	O
.	O

Scott	B-Person
Becker	E-Person
executive	O
director	O
of	O
the	O
,	O
however	O
,	O
was	O
pleased	O
with	O
the	O
guidelines	O
,	O
which	O
include	O
many	O
of	O
his	O
group's	O
recommendations	O
,	O
including	O
the	O
call	O
for	O
greater	O
transparency	O
.	O

The	O
contractors	O
will	O
provide	O
the	O
FDA	S-Organization
with	O
"	O
indirect	O
access	O
"	O
to	O
a	O
network	O
of	O
electronic	O
health	O
records	O
and	O
other	O
data	O
of	O
U.S.	S-Location
patients	O
through	O
a	O
distributed	O
data	O
framework	O
and	O
build	O
a	O
data	O
infrastructure	O
to	O
help	O
the	O
agency	O
run	O
observational	O
studies	O
and	O
queries	O
related	O
to	O
-regulated	O
biologics	O
,	O
according	O
to	O
the	O
solicitation	O
.	O

The	O
Soviet	B-Organization
government	E-Organization
publicly	O
blamed	O
contaminated	O
meat	O
,	O
but	O
intelligence	O
sources	O
suspected	O
the	O
outbreak	O
was	O
linked	O
to	O
secret	O
weapons	O
work	O
at	O
a	O
nearby	O
army	O
lab	O
.	O

It	O
recommends	O
this	O
because	O
of	O
its	O
known	O
benefit	O
in	O
cytokine	B-Phenotype
storm	E-Phenotype
caused	O
by	O
a	O
specific	O
cancer	O
treatment	O
,	O
and	O
that	O
cytokine	O
storm	O
may	O
be	O
a	O
significant	O
contributor	O
to	O
mortality	O
in	O
severe	O
.	O

These	O
include	O
photoactivatable	O
CRISPR	S-Technology
systems	O
developed	O
by	O
fusing	O
light-responsive	O
protein	O
partners	O
with	O
an	O
activator	O
domain	O
and	O
a	O
dCas9	O
for	O
gene	O
activation	O
,	O
or	O
by	O
fusing	O
similar	O
light-responsive	O
domains	O
with	O
two	O
constructs	O
of	O
split-Cas9	O
,	O
or	O
by	O
incorporating	O
caged	O
unnatural	B-Equipment
amino	I-Equipment
acids	E-Equipment
into	O
Cas9	O
,	O
or	O
by	O
modifying	O
the	O
guide	O
RNAs	O
with	O
.	O

It	O
would	O
allow	O
them	O
to	O
get	O
access	O
to	O
the	O
DNA	O
of	O
controlled	O
pathogens	O
such	O
as	O
smallpox	S-Disease
(whose	O
genome	O
is	O
readily	O
available	O
online)	O
and	O
to	O
create	O
DNA	O
with	O
modifications	O
to	O
make	O
the	O
pathogen	O
more	O
dangerous	O
.	O

But	O
it	O
also	O
poses	O
a	O
threat	O
to	O
the	O
United	B-Location
States	E-Location
according	O
to	O
a	O
recent	O
study	O
group	O
report	O
released	O
June	O
19	O
.	O

The	O
new	O
Institute	B-Organization
for	I-Organization
Antimicrobial	I-Organization
Resistance	I-Organization
Research	I-Organization
and	I-Organization
Education	E-Organization
involves	O
cooperation	O
from	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	E-Organization
,	O
Iowa	B-Organization
State	I-Organization
University	E-Organization
,	O
the	O
University	B-Organization
of	I-Organization
Nebraska	I-Organization
Medical	I-Organization
Center	E-Organization
,	O
the	O
University	B-Organization
of	I-Organization
Iowa	E-Organization
,	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
and	I-Organization
Land-grant	I-Organization
Universities	E-Organization
and	O
the	O
Association	B-Organization
of	I-Organization
American	I-Organization
Veterinary	I-Organization
Medical	I-Organization
Colleges	E-Organization
.	O
Funding	O
is	O
being	O
provided	O
from	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	E-Organization
and	O
,	O
respectively	O
.	O

Despite	O
the	O
lack	O
of	O
review	O
,	O
the	O
biological	O
warfare	O
program	O
had	O
increased	O
in	O
cost	O
and	O
size	O
since	O
1961	O
;	O
when	O
ended	O
the	O
program	O
the	O
budget	O
was	O
$300	O
million	O
annually	O
.	O

Lymphocytic	O
infiltrates	O
have	O
also	O
been	O
reported	O
at	O
autopsy	O
.	O

So	O
when	O
someone	O
takes	O
antibiotics	O
for	O
the	O
wrong	O
illness	O
or	O
uses	O
too	O
many	O
too	O
often	O
,	O
this	O
kills	O
off	O
helpful	O
bacteria	O
that	O
populate	O
the	O
body	O
,	O
threatening	O
the	O
delicate	O
balance	O
upon	O
which	O
health	O
depends	O
.	O

This	O
chain	O
of	O
events	O
forms	O
a	O
possible	O
indirect	O
means	O
of	O
transmission	O
from	O
the	O
natural	O
host	O
to	O
animal	O
populations	O
.	O

National	O
authorities	O
report	O
that	O
all	O
patients	O
are	O
isolated	O
and	O
receiving	O
treatment	O
in	O
Wuhan	S-Location
medical	O
institutions	O
.	O

NIAID	S-Organization
is	O
seeking	O
input	O
from	O
stakeholders	O
throughout	O
the	O
scientific	O
research	O
community	O
and	O
the	O
general	O
public	O
regarding	O
the	O
proposed	O
framework	O
.	O

When	O
exposed	O
to	O
chemical	O
agents	O
,	O
these	O
membranes	O
expand	O
and	O
close	O
from	O
an	O
enzyme	O
reaction	O
with	O
the	O
chemical	O
agent	O
,	O
protecting	O
warfighters	O
wearing	O
the	O
garment	O
.	O

Synthesizing	B-Technology
DNA	E-Technology
has	O
the	O
advantage	O
of	O
offering	O
total	O
researcher	O
control	O
over	O
the	O
final	O
product	O
.	O

Ward	S-Person
,	O
Dan	S-Person
.	O
(May	O
2020).	O
"	O
Sampling	O
Bias:	O
Explaining	O
Variations	O
in	O
Age	O
Distributions	O
of	O
COVID-19	S-Disease
Cases	O
"	O
.	O

Previous	O
experiences	O
of	O
laboratory	O
networks	O
have	O
reported	O
on	O
the	O
importance	O
of	O
quality	O
assurance	O
management	O
programs	O
,	O
including	O
reference	O
material	O
and	O
well-designed	O
validation	O
parameters	O
as	O
a	O
basis	O
for	O
inter-agency	O
cooperation	O
.	O

Ecuador	S-Organization
has	O
also	O
been	O
overwhelmed	O
by	O
a	O
large	O
surge	O
in	O
April	O
even	O
though	O
it	O
is	O
believed	O
that	O
both	O
the	O
number	O
of	O
cases	O
and	O
the	O
number	O
of	O
deaths	O
are	O
being	O
grossly	O
under-reported	O
.	O

But	O
now	O
he	O
knows	O
,	O
said	O
Lillibridge	S-Person
director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Global	I-Organization
Health	I-Organization
and	I-Organization
Innovation	E-Organization
,	O
as	O
a	O
panelist	O
who	O
spoke	O
during	O
an	O
Oct.	O
9	S-Equipment
panel	O
meeting	O
at	O
the	O
Hudson	B-Organization
Institute	E-Organization
in	O
Washington	S-Location
,	O
D.C.	S-Location
,	O
held	O
by	O
the	O
on	O
Biodefense	O
.	O

10	O
.	O

In	O
March	O
,	O
China	S-Location
,	O
Cuba	S-Organization
and	O
Russia	S-Location
sent	O
medical	O
supplies	O
and	O
experts	O
to	O
help	O
Italy	S-Organization
deal	O
with	O
its	O
coronavirus	B-Incident
outbreak	E-Incident
;	O
China	S-Location
sent	O
three	O
medical	O
teams	O
and	O
donated	O
more	O
than	O
forty	O
tons	O
of	O
medical	O
supplies	O
to	O
Italy	S-Organization
.	O
Businessman	O
Jack	B-Person
Ma	E-Person
sent	O
1.	O
1 million	O
testing	O
kits	O
,	O
6 million	O
face	O
masks	O
,	O
and	O
60,000	O
protective	O
suits	O
to	O
Ethiopia	S-Organization
for	O
distribution	O
by	O
the	O
African	B-Organization
Union	E-Organization
.	O
He	O
later	O
sent	O
5,000	O
testing	O
kits	O
,	O
100,000	O
face	O
masks	O
and	O
5ventilators	O
to	O
.	O

At	O
a	O
meeting	O
in	O
Los	B-Location
Angeles	E-Location
on	O
Dec.	O
6	O
,	O
the	O
scientific	O
panel	O
questioned	O
whether	O
the	O
unexplained	O
patterns	O
of	O
infestation	O
might	O
lend	O
credence	O
to	O
a	O
letter	O
distributed	O
by	O
a	O
group	O
that	O
calls	O
itself	O
the	O
Breeders	S-Organization
.	O
In	O
the	O
letter	O
,	O
sent	O
to	O
newspapers	O
and	O
Los	B-Organization
Angeles	E-Organization
Mayor	O
,	O
the	O
group	O
claimed	O
to	O
be	O
spreading	O
Medflies	O
to	O
protest	O
California	O
agricultural	O
practices	O
.	O

The	O
WHA	S-Organization
convenes	O
annually	O
and	O
is	O
responsible	O
for	O
selecting	O
the	O
Director-General	O
,	O
setting	O
goals	O
and	O
priorities	O
,	O
and	O
approving	O
the	O
WHO	S-Organization
's	O
budget	O
and	O
activities	O
.	O

The	O
number	O
of	O
extra	O
hospital	O
days	O
was	O
2.5	O
million	O
.	O

The	O
reported	O
link	O
to	O
a	O
wholesale	O
fish	O
and	O
live	O
animal	O
market	O
could	O
indicate	O
an	O
exposure	O
link	O
to	O
animals	O
.	O

Officials	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
say	O
the	O
current	O
lab	O
building	O
in	O
Atlanta	S-Location
is	O
quickly	O
wearing	O
down	O
,	O
and	O
cannot	O
be	O
upgraded	O
without	O
shutting	O
down	O
the	O
facility	O
for	O
years	O
.	O

The	O
e-Bug	B-Platform
programme	E-Platform
that	O
has	O
been	O
launched	O
as	O
a	O
pan-European	O
effort	O
is	O
a	O
prime	O
example	O
of	O
what	O
can	O
be	O
done	O
to	O
educate	O
children	O
(and	O
their	O
parents)	O
of	O
the	O
necessity	O
for	O
the	O
entire	O
population	O
to	O
take	O
antibiotic	O
use	O
and	O
resistance	O
development	O
personally	O
(Ref)	O
.	O

Germany	S-Location
)	O
is	O
to	O
make	O
data	O
sharing	O
mandatory	O
in	O
order	O
to	O
receive	O
(full)	O
funding	O
.	O

Despite	O
diligent	O
investigations	O
since	O
2003	O
,	O
evidence	O
for	O
the	O
existence	O
of	O
additional	O
BW	O
stockpiles	O
in	O
Iraq	O
has	O
not	O
been	O
documented	O
.	O

Individual	O
GP	O
molecules	O
appear	O
with	O
spacings	O
of	O
about	O
10 nm	O
.	O

Development	O
and	O
testing	O
of	O
more	O
effective	O
vaccines	O
is	O
underway	O
.	O

Kirby	S-Person
,	O
.	O
"	O
The	O
CB	O
Battlefield	O
Legacy:	O
Understanding	O
the	O
Potential	O
Problem	O
of	O
Clustered	O
CB	O
Weapons	O
"	O
,	O
Army	O
Chemical	O
Review	O
,	O
pp.	O
25–29	O
,	O
July–December	O
2006	O
.	O

Through	O
GHSA	S-International_exchange_and_cooperation
and	O
CDC	S-Organization
-specific	O
programs	O
,	O
she	O
said	O
CDC	S-Organization
is	O
focused	O
on	O
building	O
strong	O
,	O
capable	O
systems	O
around	O
the	O
world	O
that	O
have	O
the	O
same	O
core	O
capabilities	O
as	O
those	O
of	O
the	O
United	B-Location
States	E-Location
.	O
But	O
based	O
on	O
CDC	S-Organization
and	O
assessments	O
,	O
known	O
as	O
joint	O
external	O
evaluations	O
(JEEs)	O
,	O
many	O
countries	O
still	O
have	O
significant	O
gaps	O
in	O
their	O
efforts	O
to	O
find	O
,	O
stop	O
and	O
prevent	O
epidemics	O
,	O
Schuchat	O
said	O
.	O

Because	O
of	O
the	O
technical	O
and	O
safety	O
issues	O
,	O
teaching	O
virology	O
in	O
a	O
practical	O
laboratory	O
setup	O
poses	O
various	O
challenges	O
.	O

The	O
most	O
common	O
bacteria	O
that	O
make	O
this	O
enzyme	O
are	O
gram-negative	O
such	O
as	O
Escherichia	B-Pathogen
coli	E-Pathogen
and	O
,	O
but	O
the	O
gene	O
for	O
NDM-1	O
can	O
spread	O
from	O
one	O
strain	O
of	O
bacteria	O
to	O
another	O
by	O
horizontal	O
gene	O
transfer	O
.	O

The	O
index	O
case	O
was	O
initially	O
reported	O
to	O
have	O
been	O
a	O
woman	O
from	O
Ikanamongo	B-Location
Village	E-Location
who	O
became	O
ill	O
with	O
symptoms	O
of	O
Ebola	S-Disease
after	O
she	O
had	O
butchered	O
a	O
bush	O
animal	O
.	O

The	O
United	B-Location
States	E-Location
biological	O
weapons	O
program	O
began	O
in	O
1943	O
and	O
was	O
discontinued	O
in	O
1969	O
.	O

And	O
we'll	O
just	O
have	O
to	O
make	O
sure	O
that	O
if	O
any	O
material	O
leaves	O
,	O
when	O
any	O
material	O
leaves	O
,	O
we	O
assure	O
that	O
it	O
actually	O
needs	O
to	O
leave	O
and	O
that	O
it	O
leaves	O
in	O
a	O
way	O
that's	O
absolutely	O
safe	O
.	O

But	O
that	O
could	O
change	O
.	O

The	O
presentation	O
will	O
provide	O
example	O
biohazard	O
protocol	O
reviews	O
and	O
accompanying	O
containment	O
measures	O
for	O
core	O
laboratories	O
at	O
Yale	B-Organization
University	E-Organization

Despite	O
scaling	O
back	O
the	O
initiative	O
,	O
the	O
CDC	S-Organization
will	O
continue	O
efforts	O
to	O
improve	O
the	O
detection	O
of	O
emerging	O
infectious	O
diseases	O
and	O
will	O
help	O
respond	O
to	O
emerging	O
threats	O
.	O

That's	O
what	O
should	O
have	O
been	O
done	O
a	O
couple	O
of	O
decades	O
ago	O
,	O
and	O
that's	O
what	O
will	O
be	O
done	O
now	O
,	O
and	O
we've	O
invited	O
representatives	O
from	O
the	O
will	O
witness	O
that	O
destruction	O
.	O

Though	O
it	O
draws	O
on	O
old	O
Soviet	S-Organization
studies	O
about	O
the	O
,	O
the	O
report	O
does	O
not	O
directly	O
tie	O
the	O
epidemic	O
to	O
weapon	O
tests	O
but	O
infers	O
a	O
link	O
through	O
circumstantial	O
evidence	O
and	O
the	O
perceived	O
weakness	O
of	O
alternative	O
theories	O
,	O
such	O
as	O
a	O
natural	O
epidemic	O
.	O

We	O
believe	O
that	O
collaboration	O
among	O
laboratories	O
will	O
be	O
central	O
when	O
it	O
comes	O
to	O
adapting	O
to	O
the	O
rapid	O
technical	O
development	O
that	O
is	O
now	O
ongoing	O
in	O
microbiology	O
laboratories	O
.	O

Returning	O
health	O
workers	O
There	O
was	O
concern	O
that	O
people	O
returning	O
from	O
affected	O
countries	O
,	O
such	O
as	O
health	O
workers	O
and	O
reporters	O
,	O
may	O
have	O
been	O
incubating	O
the	O
disease	O
and	O
become	O
infectious	O
after	O
arriving	O
.	O

Heather	B-Person
Sheeley	E-Person
BA	O
(Hons)	O
,	O
MSc.	O
,	O
CBiol	O
MSB.	O
,	O
CMIOSH	O
,	O
FISTR	O
,	O
is	O
Corporate	O
BioSafety	O
Programme	O
Lead	O
,	O
Public	B-Organization
Health	I-Organization
England	E-Organization
.	O
She	O
has	O
more	O
than	O
20	O
years	O
of	O
experience	O
in	O
biological	O
laboratory	O
safety	O
and	O
general	O
safety	O
,	O
and	O
is	O
a	O
recognized	O
expert/specialist	O
in	O
biosafety	O
,	O
especially	O
in	O
the	O
areas	O
of	O
design	B-Technology
and	I-Technology
commissioning	I-Technology
of	I-Technology
high-containment	I-Technology
laboratories	E-Technology
.	O
She	O
is	O
a	O
past	O
President	O
of	O
the	O
European	B-Organization
Biosafety	I-Organization
Association	E-Organization
and	O
a	O
member	O
of	O
the	O
.	O

By	O
the	O
early	O
1990s	O
,	O
75	O
years	O
of	O
research	O
had	O
failed	O
to	O
answer	O
a	O
most	O
basic	O
question	O
about	O
the	O
1918	B-Incident
pandemic	E-Incident
why	O
was	O
it	O
so	O
fatal?	O
No	O
virus	O
from	O
1918	O
had	O
been	O
isolated	O
,	O
but	O
all	O
of	O
its	O
apparent	O
descendants	O
caused	O
substantially	O
milder	O
human	O
disease	O
.	O

"	O
We	O
are	O
interested	O
in	O
technology	O
development	O
,	O
new	O
methods	O
of	O
analysis	O
and	O
modeling	O
,	O
and	O
in	O
translation	O
and	O
use	O
of	O
new	O
schemes	O
to	O
monitor	O
microbes	O
in	O
a	O
variety	O
of	O
environments	O
.	O

Next	O
question	O
comes	O
from	O
Betsy	B-Person
McKay	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

This	O
shows	O
how	O
serious	O
the	O
misuse	O
of	O
antimicrobials	O
specifically	O
antibiotics	O
in	O
livestock	O
is	O
,	O
and	O
why	O
it	O
can	O
in	O
many	O
ways	O
lead	O
to	O
antimicrobial	O
resistance	O
.	O

The	O
U.S.	B-Organization
Army	I-Organization
for	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
has	O
suspended	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
and	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
()	O
operations	O
while	O
conducting	O
repairs	O
to	O
its	O
waste	O
treatment	O
plant	O
.	O

Other	O
mechanisms	O
,	O
however	O
,	O
such	O
as	O
antibody-dependent	O
cellular	O
cytotoxicity	O
and/or	O
phagocytosis	O
,	O
may	O
be	O
possible	O
.	O

Every	O
pair	O
of	O
students	O
works	O
with	O
an	O
instructor	O
for	O
15–20	O
min	O
in	O
the	O
biological	O
hood	O
.	O

The	O
cult	O
also	O
had	O
enlisted	O
Ph.D.	O
scientists	O
to	O
launch	O
biological	O
attacks	O
.	O

Imperial	B-Organization
Japanese	I-Organization
Army	E-Organization
surgeon	O
Ken	B-Person
Yuasa	E-Person
suggests	O
that	O
the	O
practice	O
of	O
vivisection	O
on	O
human	O
subjects	O
was	O
widespread	O
even	O
outside	O
Unit	B-Organization
731	E-Organization
,	O
estimating	O
that	O
at	O
least	O
1,000	O
Japanese	O
personnel	O
were	O
involved	O
in	O
the	O
practice	O
in	O
.	O

A	O
third	O
strategy	O
is	O
that	O
of	O
the	O
nucleic	B-Vaccine
acid	I-Vaccine
vaccines	E-Vaccine
(	O
,	O
a	O
novel	O
technique	O
for	O
creating	O
a	O
vaccination)	O
.	O

And	O
it	O
will	O
continue	O
to	O
inspect	O
the	O
agency	O
until	O
the	O
full	O
suspension	O
is	O
lifted	O
,	O
said	O
.	O

In	O
contrast	O
with	O
state-of-the-art	O
medical	O
countermeasures	O
,	O
which	O
typically	O
take	O
many	O
months	O
or	O
even	O
years	O
to	O
develop	O
,	O
produce	O
,	O
distribute	O
,	O
and	O
administer	O
,	O
the	O
envisioned	O
P3	B-Platform
platform	E-Platform
would	O
cut	O
response	O
time	O
to	O
weeks	O
and	O
stay	O
within	O
the	O
window	O
of	O
relevance	O
for	O
containing	O
an	O
outbreak	O
.	O

Successful	B-Incident
in	I-Incident
vivo	I-Incident
genome	I-Incident
editing	I-Incident
using	I-Incident
CRISPR-Cas9	E-Incident
has	O
been	O
shown	O
in	O
numerous	O
model	O
organisms	O
,	O
including	O
Escherichia	O
coli	O
,	O
Saccharomyces	O
cerevisiae	O
,	O
Candida	O
albicans	O
,	O
Caenorhadbitis	O
elegans	O
,	O
Arabidopsis	O
spp.	O
,	O
Danio	B-Person
rerio	E-Person
,	O
and	O
.	O
Successes	O
have	O
been	O
achieved	O
in	O
the	O
study	O
of	O
basic	O
biology	O
,	O
in	O
the	O
creation	O
of	O
disease	O
models	O
,	O
and	O
in	O
the	O
experimental	O
treatment	O
of	O
disease	O
models	O
.	O

A	O
third	O
case	O
of	O
EVD	S-Disease
was	O
confirmed	O
in	O
Goma	S-Location
on	O
1	O
August	O
.	O

Ironically	O
,	O
the	O
global	O
response	O
to	O
the	O
deadly	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
has	O
been	O
just	O
that	O
.	O

Canada	S-Location
,	O
the	O
United	B-Location
States	E-Location
,	O
Japan	S-Location
,	O
India	S-Organization
,	O
Sri	B-Organization
Lanka	E-Organization
,	O
Australia	S-Organization
,	O
France	S-Location
,	O
Argentina	S-Organization
,	O
Germany	S-Organization
,	O
and	O
Thailand	S-Organization
were	O
among	O
the	O
first	O
to	O
plan	O
the	O
evacuation	O
of	O
their	O
citizens	O
.	O

On	O
6	O
July	O
2015	O
,	O
UN	B-Person
Secretary-General	I-Person
Ban	I-Person
Ki-moon	E-Person
announced	O
that	O
he	O
would	O
host	O
an	O
Ebola	S-Disease
recovery	O
conference	O
to	O
raise	O
funds	O
for	O
reconstruction	O
,	O
stating	O
that	O
the	O
three	O
countries	O
hardest	O
hit	O
by	O
Ebola	S-Disease
needed	O
about	O
$700	O
million	O
to	O
rebuild	O
their	O
health	O
services	O
over	O
a	O
two-year	O
period	O
.	O

1955:	O
The	O
malaria	S-Disease
eradication	O
programme	O
was	O
launched	O
,	O
although	O
it	O
was	O
later	O
altered	O
in	O
objective.	O
1955	O
saw	O
the	O
first	O
report	O
on	O
diabetes	B-Disease
mellitus	E-Disease
and	O
the	O
creation	O
of	O
the	O
.	O

Yet	O
the	O
defense	O
held	O
fast	O
,	O
and	O
the	O
siege	O
was	O
abandoned	O
after	O
five	O
months	O
.	O

The	O
same	O
approach	O
should	O
be	O
applied	O
to	O
antibiotic	O
resistance	O
;	O
a	O
new	O
generation	O
of	O
physician/scientists	O
with	O
modern	O
approaches	O
to	O
diagnostic/predictive	O
medicine	O
needs	O
to	O
be	O
trained	O
.	O

In	O
2007	O
Georgia	S-Organization
ended	O
its	O
policy	O
of	O
having	O
compulsory	O
annual	O
livestock	O
anthrax	B-Vaccine
vaccination	E-Vaccine
.	O
As	O
a	O
result	O
,	O
the	O
morbidity	O
rate	O
of	O
the	O
disease	O
reached	O
its	O
peak	O
in	O
2013	O
.	O

American	O
occupation	O
authorities	O
monitored	O
the	O
activities	O
of	O
former	O
unit	O
members	O
,	O
including	O
reading	O
and	O
censoring	O
their	O
mail.Kyodo	O
News	O
,	O
"	O
Occupation	O
censored	O
Unit	B-Organization
731	E-Organization
ex-members'	O
mail:	O
secret	O
paper"	O
,	O
Japan	S-Location
Times	O
,	O
February	O
10	O
,	O
2010	O
,	O
p.	O
3	O
.	O

CT	S-Technology
is	O
an	O
accurate	O
technique	O
for	O
diagnosis	O
of	O
.	O
Its	O
uses	O
include	O
diagnosis	O
and	O
staging	O
of	O
cancer	O
,	O
as	O
well	O
as	O
follow	O
up	O
after	O
cancer	O
treatment	O
to	O
assess	O
response	O
.	O

This	O
can	O
include	O
your	O
mood	O
,	O
productivity	O
,	O
or	O
attention	O
span	O
.	O

Bacillus	B-Pathogen
anthracis	E-Pathogen
spores	O
can	O
become	O
&amp;quot;activated&amp;quot	O
;	O
once	O
in	O
the	O
body	O
,	O
where	O
bacteria	O
can	O
multiply	O
and	O
release	O
toxins	O
,	O
according	O
the	O
CDC	O
.	O

Koizumi	S-Person
had	O
joined	O
a	O
secret	O
poison	O
gas	O
research	O
committee	O
in	O
1915	O
,	O
during	O
World	O
War	O
I	O
,	O
when	O
he	O
and	O
other	O
Imperial	O
Japanese	O
Army	O
officers	O
became	O
impressed	O
by	O
the	O
successful	O
German	O
use	O
of	O
chlorine	O
gas	O
at	O
the	O
Second	O
Battle	O
of	O
Ypres	S-Location
,	O
in	O
which	O
the	O
Allies	O
suffered	O
5,000	O
deaths	O
and	O
15,000	O
wounded	O
as	O
a	O
result	O
of	O
the	O
chemical	O
attack	O
.	O

Besides	O
the	O
military	O
experiments	O
at	O
the	O
Lugar	B-Organization
Center	E-Organization
in	O
Georgia	S-Location
,	O
Battelle	S-Organization
has	O
already	O
produced	O
bioterrorism	O
agents	O
at	O
the	O
Biosafety	O
Level	O
4	O
NBACC	S-Organization
Top	O
Secret	O
Laboratory	O
at	O
Fort	B-Location
Detrick	E-Location
in	O
the	O
US	S-Location
.	O
presentation	O
lists	O
16	O
research	O
priorities	O
for	O
the	O
lab	O
.	O

The	O
Mediterranean	B-Incident
fruit	I-Incident
fly	I-Incident
crisis	E-Incident
has	O
taken	O
an	O
odd	O
turn	O
with	O
law	O
enforcement	O
officials	O
tentatively	O
investigating	O
a	O
mysterious	O
letter	O
from	O
a	O
group	O
that	O
claims	O
to	O
be	O
breeding	O
and	O
spreading	O
the	O
pest	O
throughout	O
.	O

Both	B-Document
medications	I-Document
mentioned	I-Document
above	I-Document
for	I-Document
treatment,	I-Document
oseltamivir	I-Document
and	I-Document
zanamivir,	I-Document
have	I-Document
known	I-Document
side	I-Document
effects,	I-Document
including	I-Document
lightheadedness,	I-Document
chills,	I-Document
nausea,	I-Document
vomiting,	I-Document
loss	I-Document
of	I-Document
appetite,	I-Document
and	I-Document
trouble	I-Document
breathing.	I-Document
Children	I-Document
were	I-Document
reported	I-Document
to	I-Document
be	I-Document
at	I-Document
increased	I-Document
risk	I-Document
of	I-Document
self-injury	I-Document
and	I-Document
confusion	I-Document
after	I-Document
taking	I-Document
oseltamivir.	I-Document
The	I-Document
WHO	I-Document
warned	I-Document
against	I-Document
buying	I-Document
antiviral	I-Document
medications	I-Document
from	I-Document
online	I-Document
sources	I-Document
and	I-Document
estimate	I-Document
that	I-Document
half	I-Document
the	I-Document
drugs	I-Document
sold	I-Document
by	I-Document
online	I-Document
pharmacies	I-Document
without	I-Document
a	I-Document
physical	I-Document
address	I-Document
are	I-Document
counterfeit	E-Document

The	O
said	O
the	O
program	O
,	O
which	O
began	O
in	O
2010	O
,	O
identified	O
five	O
times	O
as	O
many	O
outbreaks	O
between	O
2010	O
and	O
2017	O
as	O
were	O
documented	O
in	O
the	O
decade	O
before	O
the	O
program	O
began	O
.	O

Screening	O
methods	O
included	O
mandatory	O
self-reporting	O
of	O
symptoms	O
by	O
new	O
international	O
arrivals	O
through	O
mobile	O
application	O
,	O
drive-through	O
testing	O
for	O
the	O
virus	O
with	O
the	O
results	O
available	O
the	O
next	O
day	O
,	O
and	O
increasing	O
testing	O
capability	O
to	O
allow	O
up	O
to	O
20,000	O
people	O
to	O
be	O
tested	O
every	O
day.	O
's	O
programme	O
is	O
considered	O
a	O
success	O
in	O
controlling	O
the	O
outbreak	O
without	O
quarantining	O
entire	O
cities	O
.	O

Establishment	O
of	O
an	O
external	O
group	O
on	O
biosafety	O
comprising	O
leading	O
scientists	O
and	O
biosafety	O
experts	O
,	O
which	O
will	O
advise	O
the	O
Biosafety	B-Organization
Working	I-Organization
Group	E-Organization
to	O
the	O
Director	O
.	O

The	O
Walter	B-Organization
Reed	I-Organization
Army	I-Organization
Institute	I-Organization
of	I-Organization
Research	E-Organization
(	O
WRAIR	S-Organization
)	O
this	O
week	O
administered	O
the	O
first	O
vaccine	O
in	O
a	O
Phase	O
1	O
clinical	O
trial	O
to	O
evaluate	O
the	O
safety	O
and	O
immunogenicity	O
of	O
a	O
candidate	O
in	O
healthy	O
adult	O
volunteers	O
.	O

The	O
most	O
authoritative	O
contemporary	O
account	O
is	O
found	O
in	O
a	O
report	O
from	O
the	O
medical	O
faculty	O
in	O
Paris	B-Person
to	I-Person
Philip	I-Person
VI	E-Person
of	O
France	S-Location
.	O
It	O
blamed	O
the	O
heavens	O
,	O
in	O
the	O
form	O
of	O
a	O
conjunction	O
of	O
three	O
planets	O
in	O
1345	O
that	O
caused	O
a	O
"	O
great	O
in	O
the	O
air	O
"	O
(miasma	O
theory)	O
.	O

Public	O
Health	O
Associate	O
Program	O
website	O
,	O
Cdc.	O
gov	O
;	O
retrieved	O
April	O
12	O
,	O
2014	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Our	O
report	O
outlines	O
all	O
prior	O
incidents	O
that	O
we're	O
currently	O
aware	O
of	O
dangerous	O
pathogens	O
leaving	O
a	O
CDC	S-Organization
lab	O
when	O
they	O
shouldn't	O
have	O
left	O
a	O
CDC	S-Organization
laboratory	O
.	O

A	O
number	O
of	O
people	O
who	O
had	O
become	O
infected	O
with	O
Ebola	S-Disease
were	O
medically	O
evacuated	O
for	O
treatment	O
in	O
isolation	O
wards	O
in	O
Europe	S-Location
or	O
the	O
US	S-Location
.	O
They	O
were	O
mostly	O
health	O
workers	O
with	O
one	O
of	O
the	O
NGOs	S-Organization
in	O
Western	B-Location
Africa	E-Location
.	O
With	O
the	O
exception	O
of	O
a	O
single	O
isolated	O
case	O
in	O
Spain	S-Location
,	O
no	O
secondary	O
infections	O
occurred	O
as	O
a	O
result	O
of	O
the	O
medical	O
evacuations	O
.	O

As	O
it	O
cools	O
,	O
an	O
enzyme	O
in	O
the	O
reaction	O
mix	O
attaches	O
the	O
loose	O
nucleotides	O
to	O
form	O
a	O
new	O
strand	O
of	O
DNA	O
to	O
make	O
each	O
single	O
strand	O
double	O
again	O
.	O

On	O
20	O
May	O
,	O
the	O
WHO	S-Organization
refused	O
to	O
lift	O
the	O
Tourism	B-Document
Warning	E-Document
for	O
Hong	B-Location
Kong	E-Location
and	O
Guangdong	S-Location
,	O
but	O
did	O
so	O
three	O
days	O
later	O
after	O
a	O
recount	O
of	O
the	O
number	O
of	O
SARS	S-Disease
patients	O
.	O

It	O
took	O
a	O
year	O
,	O
and	O
an	O
independent	O
police	O
investigation	O
,	O
to	O
discover	O
the	O
true	O
source	O
of	O
the	O
attack	O
.	O

Schools	O
and	O
universities	O
were	O
closed	O
,	O
and	O
the	O
worst-affected	O
areas	O
in	O
the	O
country	O
were	O
placed	O
under	O
quarantine	O
.	O

However	O
,	O
the	O
method	O
for	O
creating	O
polio	B-Pathogen
virus	E-Pathogen
artificially	O
cannot	O
be	O
directly	O
transferred	O
to	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
.	O
The	O
variola	O
genome	O
,	O
with	O
more	O
than	O
200,000	O
base	O
pairs	O
,	O
is	O
far	O
bigger	O
than	O
that	O
of	O
polio	O
,	O
and	O
even	O
if	O
it	O
were	O
possible	O
to	O
recreate	O
the	O
full	O
smallpox	S-Pathogen
sequence	O
in	O
vitro	O
,	O
it	O
could	O
not	O
easily	O
be	O
transformed	O
into	O
a	O
live	O
infectious	O
virus	O
particle	O
.	O

Only	O
rarely	O
do	O
pregnant	O
women	O
survive-a	O
midwife	O
who	O
worked	O
with	O
MSF	S-Organization
in	O
a	O
Sierra	B-Organization
Leone	I-Organization
treatment	I-Organization
centre	E-Organization
stated	O
that	O
she	O
knew	O
of	O
"	O
no	O
reported	O
cases	O
of	O
pregnant	O
mothers	O
and	O
unborn	O
babies	O
surviving	O
Ebola	S-Disease
in	O
Sierra	B-Location
Leone	E-Location
.	O
"	O
In	O
September	O
2015	O
,	O
the	O
WHO	S-Organization
issued	O
pregnancy	O
guidance	O
information	O
entitled	O
,	O
"	O
."	O

He	O
had	O
to	O
go	O
back	O
for	O
another	O
health	O
evaluation	O
while	O
still	O
completing	O
the	O
round	O
of	O
antibiotics	O
from	O
the	O
first	O
incident	O
.	O

Representative	O
results	O
are	O
shown	O
in	O
Fig.2	O
.	O

Brooks	S-Person
pointed	O
out	O
that	O
17	O
years	O
ago	O
,	O
anthrax	B-Incident
attacks	E-Incident
infected	O
more	O
than	O
17	O
people	O
in	O
,	O
killing	O
five	O
of	O
them	O
.	O

Hence	O
,	O
the	O
risk	O
of	O
work	O
related	O
accidents	O
is	O
high	O
10	O
,	O
11	O
.	O

"	O
Our	O
ideal	O
scenario	O
for	O
PALS	S-Scientific_research_project
is	O
to	O
leverage	O
a	O
wide	O
range	O
of	O
native	O
marine	O
organisms	O
,	O
with	O
no	O
need	O
to	O
train	O
,	O
house	O
,	O
or	O
modify	O
them	O
in	O
any	O
way	O
,	O
which	O
would	O
open	O
up	O
this	O
type	O
of	O
sensing	O
to	O
many	O
locations,	O
"	O
said	O
.	O

Although	O
the	O
disease	O
has	O
been	O
eliminated	O
in	O
the	O
wild	O
,	O
frozen	O
stocks	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
are	O
still	O
maintained	O
by	O
the	O
governments	O
of	O
the	O
United	B-Location
States	E-Location
and	O
Russia	S-Location
.	O
Disastrous	O
consequences	O
are	O
feared	O
if	O
rogue	O
politicians	O
or	O
terrorists	O
were	O
to	O
get	O
hold	O
of	O
the	O
smallpox	B-Pathogen
strains	E-Pathogen
.	O
(citation	O
needed)	O
Since	O
vaccination	O
programs	O
are	O
now	O
terminated	O
,	O
the	O
world	O
population	O
is	O
more	O
susceptible	O
to	O
than	O
ever	O
before	O
.	O

Accusations	O
have	O
continued	O
to	O
come	O
out	O
of	O
Havana	S-Location
charging	O
U.S.	S-Location
use	O
of	O
bio-weapons	O
on	O
the	O
island	O
,	O
after	O
the	O
official	O
end	O
of	O
the	O
US	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
in	O
1973	O
.	O

Private	O
vehicle	O
use	O
was	O
banned	O
in	O
the	O
city	O
.	O

He	O
has	O
also	O
attempted	O
"	O
Crispr	S-Technology
-	O
probably	O
the	O
most	O
extreme	O
and	O
controversial	O
kind	O
of	O
biohacking	O
,	O
a	O
technique	O
used	O
by	O
scientists	O
to	O
target	O
and	O
edit	O
your	O
genes	O
.	O

Modifications	O
to	O
CRISPR	S-Technology
have	O
been	O
made	O
to	O
minimize	O
the	O
possibility	O
of	O
off-target	O
effects	O
.	O

U.S	O
.	O

On	O
3	O
May	O
,	O
the	O
2003	O
FIFA	B-Activity
Women's	I-Activity
World	I-Activity
Cup	E-Activity
was	O
abruptly	O
moved	O
to	O
the	O
United	B-Location
States	E-Location
due	O
to	O
the	O
outbreak	O
.	O

However	O
,	O
any	O
nucleus	O
with	O
a	O
net	O
nuclear	O
spin	O
could	O
potentially	O
be	O
imaged	O
with	O
.	O
Such	O
nuclei	O
include	O
helium-3	O
,	O
lithium-7	O
,	O
carbon-13	O
,	O
fluorine-19	O
,	O
oxygen-17	O
,	O
sodium-23	O
,	O
phosphorus-31	O
and	O
xenon-129.	O
23Na	O
and	O
31P	O
are	O
naturally	O
abundant	O
in	O
the	O
body	O
,	O
so	O
they	O
can	O
be	O
imaged	O
directly	O
.	O

The	O
air	O
flow	O
in	O
laboratory	O
is	O
also	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

,	O
remdesivir	S-Drug
was	O
viewed	O
as	O
the	O
most	O
promising	O
treatment	O
for	O
COVID-19	S-Disease
,	O
and	O
was	O
included	O
among	O
four	O
treatments	O
under	O
evaluation	O
in	O
the	O
international	O
Solidarity	O
trial	O
and	O
European	O
Discovery	O
trial	O
.	O

Jordan	S-Location
appeared	O
to	O
be	O
the	O
hub	O
in	O
the	O
region	O
for	O
biosafety	O
,	O
biosecurity	O
,	O
and	O
biorisk	O
management	O
activities	O
with	O
(n = 179)	O
,	O
followed	O
by	O
Pakistan	S-Location
(n = 162)	O
,	O
Morocco	S-Location
(n = 109)	O
,	O
Iraq	S-Location
(n = 68)	O
,	O
Iran	S-Location
(n = 66)	O
,	O
and	O
(n = 60)	O
.	O

On	O
24	O
March	O
,	O
Chinese	O
Premier	O
Li	B-Person
Keqiang	E-Person
reported	O
that	O
the	O
spread	O
of	O
domestically	O
transmitted	O
cases	O
has	O
been	O
basically	O
blocked	O
and	O
the	O
outbreak	O
has	O
been	O
controlled	O
in	O
China	S-Location
.	O
The	O
same	O
day	O
travel	O
restrictions	O
were	O
eased	O
in	O
Hubei	S-Location
,	O
apart	O
from	O
Wuhan	S-Location
,	O
two	O
months	O
after	O
the	O
lockdown	O
was	O
imposed	O
.	O

Here	O
,	O
we	O
present	O
an	O
overview	O
on	O
the	O
production	O
of	O
crops	O
,	O
their	O
acceptabilities	O
,	O
detection	O
strategies	O
,	O
biosafety	O
issues	O
and	O
potential	O
impact	O
on	O
society	O
.	O

The	O
disease	O
affects	O
males	O
and	O
females	O
equally	O
and	O
the	O
majority	O
of	O
those	O
that	O
contract	O
Ebola	B-Disease
disease	E-Disease
are	O
between	O
15	O
and	O
45	O
years	O
of	O
age	O
.	O

Thus	O
in	O
2006	O
,	O
2	O
major	O
descendant	O
lineages	O
of	O
the	O
1918	B-Pathogen
H1N1	I-Pathogen
virus	E-Pathogen
as	O
well	O
as	O
2	O
additional	O
reassortant	O
lineages	O
,	O
persist	O
naturally:	O
a	O
human	O
epidemic/endemic	O
H1N1	S-Pathogen
lineage	O
,	O
a	O
porcine	O
enzootic	O
H1N1	S-Pathogen
lineage	O
(so-called	O
classic	O
swine	O
flu)	O
,	O
and	O
the	O
reassorted	O
human	O
H3N2	S-Pathogen
virus	O
lineage	O
,	O
which	O
like	O
the	O
human	O
H1N1	S-Pathogen
virus	O
,	O
has	O
led	O
to	O
a	O
porcine	O
H3N2	S-Pathogen
lineage	O
.	O

On	O
28	O
May	O
,	O
the	O
total	O
number	O
of	O
reported	O
cases	O
had	O
reached	O
281	O
,	O
with	O
186	O
deaths	O
.	O

CH2M	B-Organization
Hill	E-Organization
has	O
been	O
awarded	O
$341.	O
5	O
million	O
DTRA	O
contracts	O
under	O
the	O
Pentagon's	B-Scientific_research_project
program	E-Scientific_research_project
for	O
bio-laboratories	O
in	O
Georgia	S-Location
,	O
Uganda	S-Location
,	O
Tanzania	S-Location
,	O
Iraq	S-Location
,	O
Afghanistan	S-Location
,	O
South	B-Location
East	I-Location
Asia	E-Location
.	O
Half	O
of	O
this	O
sum	O
($161.	O
1	O
million)	O
,	O
being	O
allocated	O
to	O
The	O
,	O
under	O
the	O
Georgian	O
contract	O
.	O

When	O
associated	O
with	O
antibiotic	O
resistance	O
they	O
may	O
become	O
deadly	O
.	O

To	O
understand	O
our	O
vulnerability	O
,	O
and	O
to	O
determine	O
what	O
steps	O
must	O
be	O
taken	O
to	O
end	O
it	O
,	O
it	O
is	O
useful	O
to	O
ask	O
about	O
the	O
very	O
worst-case	O
scenarios	O
.	O

With	O
the	O
research	O
and	O
development	O
of	O
genetically	B-Technology
engineered	I-Technology
animals	E-Technology
(	O
GEAs	S-Technology
)	O
in	O
breeding	O
of	O
new	O
variety	O
,	O
xenotransplantation	S-Technology
,	O
bioreactor	O
and	O
disease	O
model	O
,	O
biosafety	O
issues	O
of	O
GEAs	S-Technology
have	O
attracted	O
widespread	O
attentions	O
worldwide	O
.	O

Classified	O
activities	O
were	O
moved	O
underground	O
,	O
and	O
several	O
new	O
laboratories	O
have	O
been	O
constructed	O
and	O
equipped	O
to	O
work	O
with	O
highly	O
dangerous	O
pathogens	O
.	O

On	O
14	O
April	O
2014	O
,	O
one	O
Filipino	O
paramedic	O
died	O
in	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
with	O
six	O
other	O
reported	O
to	O
be	O
infected	O
with	O
the	O
virus	O
.	O

The	O
LabKey	O
instance	O
Atlas	O
is	O
applied	O
in	O
a	O
large-scale	O
HIV	S-Pathogen
project	O
consisting	O
of	O
many	O
consortia.	O
provides	O
a	O
web	O
server	O
via	O
the	O
Tomcat	O
servlet	O
which	O
is	O
accessing	O
a	O
PostgreSQL	O
or	O
Microsoft	O
SQLServer	O
database	O
.	O

For	O
now	O
,	O
though	O
,	O
synthetic	O
cells	O
are	O
limited	O
to	O
lab	O
benches	O
.	O

Researchers	O
concluded	O
that	O
"	O
travel	O
restrictions	O
are	O
most	O
useful	O
in	O
the	O
early	O
and	O
late	O
phase	O
of	O
an	O
epidemic	O
"	O
and	O
"	O
restrictions	O
of	O
travel	O
from	O
unfortunately	O
came	O
too	O
late"	O
.	O

This	O
procedure	O
teaches	O
students	O
how	O
to	O
calculate	O
the	O
virus	O
concentration	O
in	O
the	O
stock	O
solution	O
and	O
use	O
it	O
for	O
calculation	O
of	O
the	O
MOI	O
in	O
following	O
experiments	O
.	O

The	O
samples	O
included	O
two	O
vials	O
of	O
plague	B-Pathogen
bacteria	E-Pathogen
(	O
Yersinia	B-Pathogen
pestis	E-Pathogen
)	O
;	O
two	O
vials	O
of	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
,	O
which	O
causes	O
the	O
tropical	B-Disease
disease	I-Disease
melioidosis	E-Disease
;	O
three	O
vials	O
of	O
tularemia	B-Pathogen
bacteria	E-Pathogen
;	O
two	O
vials	O
of	O
botulinum	B-Pathogen
toxin	E-Pathogen
;	O
and	O
a	O
sample	O
of	O
deadly	O
in	O
an	O
old	O
collection	O
dating	O
to	O
1914	O
.	O

Since	O
May	O
2015	O
,	O
most	O
of	O
the	O
cases	O
had	O
occurred	O
at	O
the	O
,	O
a	O
large	O
national	O
guard	O
hospital	O
.	O

But	O
,	O
many	O
other	O
types	O
of	O
CT	S-Technology
exist	O
,	O
such	O
as	O
positron	B-Technology
emission	I-Technology
tomography	E-Technology
(	O
PET	S-Technology
)	O
and	O
single-photon	B-Technology
emission	I-Technology
computed	I-Technology
tomography	E-Technology
(	O
SPECT	S-Technology
)	O
.	O

Some	O
countries	O
have	O
passed	O
emergency	O
legislation	O
in	O
response	O
to	O
the	O
pandemic	O
.	O

In	O
2010	O
,	O
Genspace	S-Organization
opened	O
the	O
first	O
community	O
biology	O
lab	O
,	O
Ten	O
months	O
later	O
it	O
was	O
followed	O
by	O
BioCurious	S-Organization
,	O
and	O
Victoria	B-Organization
Makerspace	E-Organization
.	O
Many	O
other	O
labs	O
and	O
organizations	O
followed	O
,	O
including	O
but	O
not	O
limited	O
to	O
Counter	B-Organization
Culture	I-Organization
Labs	E-Organization
in	O
Oakland	S-Location
,	O
CA	S-Location
,	O
Baltimore	B-Organization
Underground	I-Organization
Science	I-Organization
Space	E-Organization
in	O
Baltimore	S-Location
,	O
MD	S-Location
,	O
TheLab	B-Organization
in	I-Organization
Los	I-Organization
Angeles	E-Organization
,	O
CA	S-Location
and	O
Denver	B-Organization
Biolabs	E-Organization
in	O
Denver	S-Location
,	O
.	O

The	O
ASPR	B-Organization
office	E-Organization
,	O
created	O
in	O
2006	O
in	O
the	O
wake	O
of	O
Hurricane	B-Incident
Katrina	E-Incident
to	O
manage	O
emergency	O
responses	O
across	O
the	O
government	O
,	O
was	O
historically	O
focused	O
on	O
natural	O
disasters	O
and	O
threats	O
from	O
dirty	O
bombs	O
or	O
crude	O
biological	O
or	O
chemical	O
weapons	O
,	O
he	O
said	O
.	O

As	O
Tartars	O
launched	O
a	O
siege	O
of	O
Caffa	S-Location
a	O
port	O
on	O
the	O
Crimean	B-Location
peninsula	E-Location
in	O
the	O
Black	B-Location
Sea	E-Location
,	O
they	O
suffered	O
an	O
outbreak	B-Incident
of	I-Incident
plague	E-Incident
.	O
Before	O
abandoning	O
their	O
attack	O
,	O
they	O
sent	O
the	O
infected	O
bodies	O
of	O
their	O
comrades	O
over	O
the	O
walls	O
of	O
the	O
city	O
.	O

He	O
was	O
never	O
prosecuted	O
for	O
crimes	O
related	O
to	O
.	O

As	O
a	O
result	O
,	O
most	O
of	O
the	O
affected	O
employees	O
have	O
been	O
determined	O
to	O
have	O
no	O
increased	O
risk	O
of	O
exposure	O
and	O
are	O
therefore	O
being	O
advised	O
that	O
they	O
no	O
longer	O
need	O
to	O
take	O
antibiotics	S-Drug
and	O
vaccine	O
to	O
prevent	O
inhalation	O
anthrax	S-Pathogen
(	O
media	O
statement)	O
.	O

The	O
explains:	O
"	O
[I]nfluenza	O
is	O
infrequently	O
listed	O
on	O
death	O
certificates	O
of	O
people	O
who	O
die	O
from	O
flu-related	O
complications	O
"	O
and	O
hence	O
,	O
"	O
Only	O
counting	O
deaths	O
where	O
influenza	O
was	O
included	O
on	O
a	O
death	O
certificate	O
would	O
be	O
a	O
gross	O
underestimation	O
of	O
influenza's	O
true	O
impact.	O
"	O

Vektor	S-Organization
was	O
reportedly	O
a	O
biological	O
weapons	O
research	O
centre	O
.	O

Daschle	S-Person
said	O
that	O
his	O
"	O
mounting	O
frustration	O
over	O
the	O
inaction	O
in	O
Washington	S-Location
on	O
this	O
issue	O
"	O
is	O
one	O
of	O
the	O
reasons	O
he	O
decided	O
to	O
serve	O
on	O
the	O
bipartisan	O
.	O

For	O
15	O
years	O
,	O
the	O
CDC	S-Organization
had	O
direct	O
oversight	O
over	O
the	O
Tuskegee	B-Scientific_research_project
syphilis	I-Scientific_research_project
experiment	E-Scientific_research_project
.	O
In	O
the	O
study	O
,	O
which	O
lasted	O
from	O
1932	O
to	O
1972	O
,	O
a	O
group	O
of	O
African	O
American	O
men	O
(nearly	O
400	O
of	O
whom	O
had	O
syphilis	S-Disease
)	O
were	O
studied	O
to	O
learn	O
more	O
about	O
the	O
disease	O
.	O

The	O
initiative	O
,	O
funded	O
by	O
a	O
grant	O
from	O
the	O
Open	B-Scientific_research_project
Philanthropy	I-Scientific_research_project
Project	E-Scientific_research_project
,	O
is	O
a	O
new	O
project	O
of	O
the	O
.	O

There	O
is	O
evidence	O
that	O
live	O
Ebola	B-Pathogen
virus	E-Pathogen
can	O
be	O
isolated	O
in	O
seminal	O
fluids	O
of	O
convalescent	O
men	O
for	O
82	O
days	O
after	O
onset	O
of	O
symptoms	O
.	O

So	O
far	O
,	O
governments	O
and	O
agencies	O
have	O
established	O
corresponding	O
laws	O
and	O
regulations	O
to	O
regulate	O
research	O
and	O
application	O
of	O
GEAs	S-Technology
or	O
their	O
derived	O
products	O
.	O

The	O
percentage	O
of	O
these	O
parameters	O
was	O
low	O
when	O
compared	O
to	O
a	O
similar	O
study	O
in	O
Turkey	S-Location

He	O
died	O
on	O
19	O
February	O
2013	O
.	O

In	O
December	O
2015	O
,	O
an	B-Activity
International	I-Activity
Summit	I-Activity
on	I-Activity
Human	I-Activity
Gene	I-Activity
Editing	E-Activity
took	O
place	O
in	O
Washington	S-Location
under	O
the	O
guidance	O
of	O
David	B-Person
Baltimore	E-Person
.	O
Members	O
of	O
national	O
scientific	O
academies	O
of	O
the	O
US	S-Location
,	O
UK	S-Location
,	O
and	O
discussed	O
the	O
ethics	O
of	O
germline	O
modification	O
.	O

One	O
word	O
Asprey	S-Person
likes	O
to	O
use	O
a	O
lot	O
is	O
"	O
control,"	O
and	O
that	O
kind	O
of	O
language	O
is	O
typical	O
of	O
many	O
biohackers	O
,	O
who	O
often	O
talk	O
about	O
"	O
optimizing"	O
and	O
"	O
upgrading"	O
their	O
minds	O
and	O
bodies	O
.	O

The	O
United	B-Location
States	E-Location
biological	O
weapons	O
program	O
began	O
in	O
1943	O
and	O
was	O
discontinued	O
in	O
1969	O
.	O

Its	O
ability	O
to	O
modify	O
specific	O
DNA	O
sequences	O
makes	O
it	O
a	O
tool	O
with	O
potential	O
to	O
fix	O
disease-causing	O
mutations	O
.	O

Thus	O
,	O
to	O
benefit	O
from	O
GMOs	S-Technology
,	O
has	O
to	O
revise	O
its	O
biosafety	O
system	O
,	O
primarily	O
by	O
making	O
changes	O
to	O
some	O
provisions	O
of	O
the	O
law	O
in	O
a	O
way	O
that	O
balances	O
its	O
diverse	O
interests	O
of	O
conserving	O
biodiversity	O
,	O
protecting	O
the	O
environment	O
and	O
enhancing	O
competition	O
in	O
agricultural	O
and	O
other	O
economic	O
sectors	O
.	O

In	O
2015	O
a	O
panel	O
of	O
experts	O
looked	O
at	O
the	O
ways	O
of	O
preventing	O
small	O
outbreaks	O
from	O
becoming	O
large	O
epidemics	O
.	O

The	O
Truth	O
of	O
Unit	B-Organization
731	E-Organization
Elite	O
medical	O
students	O
and	O
human	O
experiments	O
(2017)	O
.	O

Biological	O
agent	O
classification	O
can	O
be	O
based	O
on	O
two	O
measures:	O
laboratory	O
biosafety	O
and	O
biodefense	O
considerations	O
.	O

The	O
Ministry	O
of	O
Education	O
of	O
Singapore	O
announced	O
that	O
all	O
primary	O
schools	O
,	O
secondary	O
schools	O
,	O
and	O
junior	O
colleges	O
were	O
to	O
be	O
shut	O
until	O
6	O
April	O
2003	O
.	O

It	O
was	O
revised	O
several	O
times	O
from	O
1975	O
to	O
1978	O
to	O
finally	O
end	O
up	O
with	O
three	O
categories	O
A	O
,	O
B	O
and	O
C	O
.	O

Only	O
last	O
week	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
released	O
a	O
report	O
reviewing	O
the	O
newest	O
data	O
on	O
antibiotic	O
resistance	O
.	O

The	O
International	B-Organization
Commission	I-Organization
on	I-Organization
Radiological	I-Organization
Protection	E-Organization
estimates	O
that	O
the	O
risk	O
to	O
a	O
fetus	O
being	O
exposed	O
to	O
10 mGy	O
(a	O
unit	O
of	O
radiation	O
exposure)	O
increases	O
the	O
rate	O
of	O
cancer	S-Disease
before	O
20	O
years	O
of	O
age	O
from	O
0.03%	O
to	O
0.	O
04%	O
(for	O
reference	O
a	O
pulmonary	O
angiogram	O
exposes	O
a	O
fetus	O
to	O
4 mGy)	O
.	O

This	O
threat	O
is	O
by	O
no	O
means	O
new	O
.	O

Toxins:	O
Botulinum	S-Pathogen
,	O
etc	O
.	O

On	O
17	O
August	O
the	O
country	O
marked	O
its	O
first	O
week	O
with	O
no	O
new	O
cases	O
,	O
and	O
one	O
week	O
later	O
the	O
last	O
patients	O
were	O
released	O
.	O

How	O
is	O
that	O
affecting	O
surveillance	O
in	O
over	O
the	O
summer?	O
I	O
know	O
that	O
it's	O
flu	O
season	O
in	O
different	O
parts	O
of	O
the	O
world	O
.	O

On	O
3	O
September	O
2018	O
,	O
WHO	S-Organization
stated	O
that	O
16	O
health	O
workers	O
had	O
contracted	O
the	O
virus	O
.	O

The	O
actual	O
origin	O
is	O
unknown	O
,	O
but	O
the	O
first	O
known	O
cases	O
of	O
infection	O
happened	O
in	O
China	S-Location
By	O
December	O
2019	O
,	O
the	O
spread	O
of	O
infection	O
was	O
almost	O
entirely	O
driven	O
by	O
human-to-human	O
transmission	O
.	O

The	O
American	O
peoples	O
got	O
by	O
far	O
the	O
worse	O
end	O
of	O
the	O
exchange	O
,	O
through	O
diseases	O
such	O
as	O
measles	S-Disease
,	O
influenza	S-Disease
and	O
,	O
especially	O
,	O
.	O

China	S-Location
is	O
,	O
however	O
,	O
trying	O
to	O
boost	O
pork	O
imports	O
from	O
another	O
big	O
producer	O
-	O
the	O
US	S-Location
-	O
to	O
make	O
up	O
for	O
its	O
lost	O
domestic	O
supply	O
.	O

What	O
the	O
Pentagon	S-Organization
is	O
now	O
doing	O
is	O
exactly	O
what	O
it	O
did	O
in	O
the	O
past	O
,	O
meaning	O
that	O
its	O
bio-weapons	O
program	O
was	O
never	O
terminated	O
.	O

Therefore	O
,	O
the	O
reliance	O
is	O
mostly	O
on	O
indigenous	O
experience	O
,	O
talent	O
and	O
expertise	O
available	O
,	O
which	O
is	O
in	O
short	O
supply	O
.	O

Another	O
new	O
element	O
is	O
that	O
the	O
national	O
security	O
advisor	O
is	O
the	O
lead	O
for	O
the	O
strategy	O
,	O
and	O
Inglesby	S-Person
said	O
the	O
president's	O
national	O
security	O
priorities	O
are	O
more	O
likely	O
to	O
get	O
more	O
attention	O
and	O
resources	O
.	O

For	O
2017	O
,	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
(	O
FAO	S-Organization
)	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
and	O
the	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
()	O
are	O
together	O
calling	O
for	O
responsible	O
use	O
of	O
antibiotics	O
in	O
humans	O
and	O
animals	O
to	O
reduce	O
the	O
emergence	O
of	O
antibiotic	O
resistance	O
.	O

Were	O
it	O
not	O
for	O
the	O
writings	O
of	O
Shearer	S-Person
and	O
his	O
colleagues	O
,	O
U.S.	O
public	O
health	O
officials	O
might	O
have	O
learned	O
of	O
Taiwanese	O
efforts	O
via	O
a	O
journal	O
article	O
published	O
months	O
after	O
the	O
vaccination	O
campaign	O
.	O

Although	O
the	O
pandemic	O
mortality	O
estimate	O
was	O
similar	O
in	O
magnitude	O
to	O
that	O
of	O
seasonal	B-Disease
influenza	E-Disease
,	O
a	O
marked	O
shift	O
toward	O
mortality	O
among	O
persons	O
less	O
than	O
65	O
years	O
of	O
age	O
occurred	O
,	O
so	O
that	O
many	O
more	O
life-years	O
were	O
lost	O
.	O

Using	O
stored	O
laboratory	O
samples	O
for	O
all	O
six	O
,	O
it	O
was	O
found	O
that	O
samples	O
from	O
the	O
two	O
patients	O
who	O
had	O
died	O
tested	O
positive	O
for	O
.	O

Zelicoff	S-Person
is	O
presenting	O
a	O
summary	O
of	O
the	O
Monterey	S-Location
study	O
is	O
one	O
of	O
a	O
series	O
that	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
holding	O
to	O
solicit	O
opinions	O
before	O
two	O
advisory	O
committees	O
decide	O
whether	O
to	O
change	O
recommendations	O
on	O
.	O

That	O
evolutionary	O
process	O
contains	O
natural	O
bottlenecks	O
that	O
could	O
be	O
exploited	O
to	O
impede	O
dangerous	O
mutations	O
.	O

The	O
overuse	O
of	O
many	O
pesticides	O
in	O
an	O
effort	O
to	O
have	O
a	O
higher	O
yield	O
of	O
crops	O
has	O
resulted	O
in	O
many	O
of	O
these	O
microbes	O
developing	O
a	O
tolerance	O
against	O
these	O
antimicrobial	O
agents	O
.	O

"	O
It's	O
not	O
just	O
this	O
bacteria	O
that	O
replicates	O
in	O
people	O
,	O
but	O
in	O
the	O
environment	O
,	O
it	O
has	O
this	O
spore	O
form	O
that	O
lasts	O
a	O
long	O
time	O
and	O
makes	O
it	O
easier	O
to	O
perhaps	O
use	O
as	O
a	O
weapon,	O
"	O
said	O
Dr	O
.	O

International	O
mail	O
between	O
some	O
countries	O
stopped	O
or	O
was	O
delayed	O
due	O
to	O
reduced	O
transportation	O
between	O
them	O
or	O
suspension	O
of	O
domestic	O
service	O
.	O

Concerns	O
have	O
been	O
raised	O
about	O
long-term	O
sequelae	O
of	O
the	O
disease	O
.	O

In	O
2009	O
,	O
Harvard	B-Organization
University	E-Organization
geneticist	O
George	B-Person
Church	E-Person
unveiled	O
a	O
technique	O
that	O
lets	O
researchers	O
design	O
millions	O
of	O
slightly	O
different	O
versions	O
of	O
a	O
strand	O
of	O
DNA	O
.	O

Biological	O
safety	O
is	O
a	O
relative	O
newcomer	O
to	O
the	O
field	O
of	O
occupational	O
safety	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Well	O
,	O
I	O
think	O
,	O
as	O
I	O
said	O
,	O
I	O
think	O
this	O
is	O
a	O
wake-up	O
call	O
.	O

In	O
2015	O
,	O
Yinong	B-Person
Yang	E-Person
successfully	O
deactivated	O
16	O
specific	O
genes	O
in	O
the	O
white	O
button	O
mushroom	O
to	O
make	O
them	O
non-browning	O
.	O

After	O
the	O
outbreak	O
began	O
in	O
Aralsk	S-Location
health	O
officials	O
scrambled	O
to	O
contain	O
the	O
disease	O
,	O
according	O
to	O
a	O
formally	O
secret	O
Soviet	S-Organization
report	O
reprinted	O
in	O
the	O
study	O
.	O

Ken	B-Person
Alibek	E-Person
was	O
the	O
First	O
Deputy	O
Director	O
of	O
Biopreparat	S-Organization
,	O
where	O
he	O
oversaw	O
a	O
program	O
for	O
biological	O
weapon	O
facilities	O
and	O
was	O
the	O
Soviet	B-Organization
Union	E-Organization
's	O
main	O
expert	O
on	O
anthrax	S-Disease
.	O
After	O
his	O
defection	O
to	O
the	O
US	S-Location
,	O
he	O
was	O
engaged	O
on	O
research	O
projects	O
.	O

In	O
1979	O
,	O
a	O
rare	O
outbreak	O
of	O
anthrax	B-Disease
disease	E-Disease
in	O
the	O
city	O
of	O
Sverdlovsk	S-Location
killed	O
nearly	O
70	O
people	O
.	O

But	O
terror	O
experts	O
say	O
impoverished	O
Russian	O
scientists	O
may	O
have	O
sold	O
the	O
virus	O
to	O
foreigners	O
.	O

Patterson	S-Person
and	O
Pyle	S-Person
in	O
their	O
study	O
'	O
The	O
1918	B-Incident
Influenza	I-Incident
Pandemic	E-Incident
'	O
tried	O
to	O
estimate	O
the	O
number	O
of	O
deaths	O
by	O
Spanish	O
influenza	S-Disease
in	O
China	S-Location
as	O
a	O
whole	O
.	O

In	O
fact	O
,	O
that's	O
before	O
eradication	O
was	O
undertaken	O
.	O

However	O
,	O
the	O
lab	O
used	O
a	O
procedure	O
that	O
did	O
not	O
adequately	O
inactivate	O
the	O
samples	O
.	O

Senate	B-Organization
HELP	I-Organization
Committee	E-Organization
Chairman	O
Lamar	B-Person
Alexander	E-Person
(R-TN)	O
wants	O
markup	O
action	O
to	O
take	O
place	O
on	O
June	O
20	O
for	O
,	O
as	O
well	O
as	O
for	O
a	O
slew	O
of	O
other	O
Senate	O
proposals	O
.	O

Viral	O
proteins	O
VP40	O
and	O
VP24	O
are	O
located	O
between	O
the	O
envelope	O
and	O
the	O
nucleocapsid	O
(see	O
following)	O
,	O
in	O
the	O
matrix	O
space	O
.	O

It	O
was	O
able	O
to	O
eradicate	O
viral	O
DNA	O
in	O
the	O
case	O
of	O
Epstein-Barr	B-Pathogen
virus	E-Pathogen
(	O
EBV	S-Pathogen
)	O
.	O

Cases	O
refer	O
to	O
the	O
number	O
of	O
people	O
who	O
have	O
been	O
tested	O
for	O
COVID-19	S-Disease
and	O
whose	O
test	O
has	O
been	O
confirmed	O
positive	O
according	O
to	O
official	O
protocols	O
.	O

1967:	O
The	O
WHO	S-Organization
launched	O
the	O
Special	B-Activity
Programme	I-Activity
for	I-Activity
Research	I-Activity
and	I-Activity
Training	I-Activity
in	I-Activity
Tropical	I-Activity
Diseases	E-Activity
and	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
voted	O
to	O
enact	O
a	O
resolution	O
on	O
,	O
with	O
a	O
focus	O
on	O
community-driven	O
care	O
.	O

But	O
,	O
the	O
viral	O
genome	O
alone	O
is	O
unlikely	O
to	O
provide	O
answers	O
to	O
some	O
critical	O
questions	O
.	O

NTI	S-Organization
was	O
founded	O
in	O
2001	O
by	O
former	O
U.S.Sen	O
.	O

The	O
project	O
had	O
two	O
components:	O
(a)	O
a	O
review	O
of	O
biosafety	O
and	O
biosecurity	O
initiatives	O
in	O
the	O
region	O
and	O
(b)	O
assessment	O
of	O
the	O
impact	O
of	O
these	O
initiatives	O
on	O
scientists	O
at	O
local/regional	O
levels	O
.	O

Although	O
most	O
common	O
in	O
medicine	O
,	O
CT	S-Technology
is	O
also	O
used	O
in	O
other	O
fields	O
,	O
such	O
as	O
nondestructive	O
materials	O
testing	O
.	O

Her	O
case	O
was	O
described	O
as	O
"	O
very	O
minor	O
"	O
and	O
she	O
was	O
subsequently	O
declared	O
free	O
from	O
infection	O
and	O
was	O
discharged	O
from	O
hospital	O
on	O
22	O
September	O
.	O

The	O
WHO	S-Organization
employs	O
8,500	O
people	O
in	O
147	O
countries	O
to	O
carry	O
out	O
its	O
principles	O
.	O

The	O
first	O
confirmed	O
death	O
was	O
in	O
Wuhan	S-Location
on	O
9	O
January	O
2020	O
.	O

But	O
can	O
they	O
be	O
trusted?	O
,	O
6May	O
2020	O
,	O
USA	B-Organization
Today	E-Organization
Despite	O
being	O
the	O
first	O
area	O
of	O
the	O
world	O
hit	O
by	O
the	O
outbreak	O
,	O
the	O
early	O
wide-scale	O
response	O
of	O
some	O
Asian	O
states	O
,	O
particularly	O
South	B-Location
Korea	E-Location
,	O
Taiwan	S-Location
,	O
and	O
has	O
allowed	O
them	O
to	O
fare	O
comparatively	O
well	O
.	O

Eligible	O
medicines	O
are	O
tested	O
by	O
the	O
to	O
check	O
if	O
,	O
and	O
for	O
how	O
long	O
,	O
the	O
expiration	O
date	O
can	O
be	O
extended	O
.	O

On	O
23	O
November	O
2018	O
,	O
it	O
was	O
reported	O
that	O
due	O
to	O
a	O
steady	O
increase	O
in	O
cases	O
,	O
it	O
is	O
expected	O
that	O
the	O
EVD	S-Disease
outbreak	O
in	O
DRC	S-Location
will	O
overtake	O
the	O
Uganda	B-Incident
2000	I-Incident
outbreak	E-Incident
of	O
425	O
total	O
cases	O
,	O
to	O
become	O
the	O
second	O
biggest	O
EVD	S-Disease
outbreak	O
behind	O
only	O
the	O
West	B-Incident
Africa	I-Incident
Ebola	I-Incident
virus	I-Incident
epidemic	E-Incident
.	O
According	O
to	O
the	O
available	O
statistics	O
,	O
women	O
are	O
being	O
infected	O
at	O
a	O
higher	O
rate	O
,	O
60%	O
,	O
than	O
their	O
male	O
counterparts	O
due	O
to	O
the	O
outbreak	O
,	O
a	O
report	O
issued	O
4	O
December	O
indicated	O
.	O

Preston	S-Person
,	O
Richard	S-Person
(2002)	O
.	O

The	O
Kivu	S-Location
Ebola	S-Disease
epidemic	O
began	O
on	O
1	O
August	O
2018	O
,	O
when	O
it	O
was	O
confirmed	O
that	O
four	O
cases	O
had	O
tested	O
positive	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
in	O
the	O
eastern	O
region	O
of	O
Kivu	S-Location
in	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
(	O
DRC	S-Location
)	O
.	O

The	O
Centre	O
has	O
key	O
missions	O
to	O
support	O
the	O
development	O
of	O
preparedness	O
and	O
response	O
plan	O
.	O

The	O
hospital	O
,	O
which	O
became	O
aware	O
of	O
the	O
infection	O
in	O
May	O
,	O
is	O
working	O
with	O
the	O
Philadelphia	B-Organization
Department	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
and	O
the	O
to	O
determine	O
the	O
source	O
of	O
the	O
infection	O
,	O
according	O
to	O
the	O
university	O
.	O

Many	O
nations	O
and	O
charitable	O
organisations	O
cooperated	O
to	O
realise	O
the	O
plan	O
,	O
and	O
a	O
situation	O
report	O
published	O
mid-December	O
indicated	O
that	O
the	O
international	O
community	O
was	O
on	O
track	O
to	O
meet	O
the	O
90-day	O
target	O
.	O

"	O
…When	O
it	O
comes	O
to	O
naturally	O
occurring	O
biological	O
threats	O
,	O
we	O
agree	O
with	O
Bill	B-Person
Gates	E-Person
whose	O
charitable	O
foundation	O
has	O
provided	O
funds	O
to	O
address	O
biological	O
outbreaks.	O
…	O
Naturally	O
occurring	O
pathogens	O
have	O
the	O
power	O
to	O
destroy	O
lives	O
and	O
economies.	O
…	O
We	O
call	O
upon	O
the	O
president	O
to	O
release	O
the	O
National	B-Document
Biodefense	I-Document
Strategy	E-Document
soon	O
and	O
ensure	O
that	O
his	O
next	O
budget	O
request	O
to	O
Congress	S-Organization
conforms	O
to	O
the	O
priorities	O
in	O
this	O
strategy	O
,	O
showing	O
how	O
money	O
requested	O
for	O
biodefense	O
programs	O
supports	O
the	O
National	B-Document
Strategy	E-Document
's	O
goals	O
and	O
objectives.	O
should	O
also	O
establish	O
a	O
new	O
,	O
government-wide	O
,	O
Biodefense	O
Coordination	O
Council	O
composed	O
of	O
senior	O
officials	O
from	O
responsible	O
departments	O
,	O
independent	O
agencies	O
,	O
and	O
independent	O
institutions	O
,	O
as	O
well	O
as	O
private	O
sector	O
and	O
state	O
,	O
local	O
,	O
tribal	O
,	O
and	O
territorial	O
representatives	O
.	O

Despite	O
this	O
,	O
antibiotic	O
prescribing	O
remains	O
high	O
with	O
variance	O
in	O
adherence	O
to	O
guidelines	O
.	O

Another	O
important	O
safety	O
aspect	O
of	O
the	O
lab	O
is	O
a	O
low	O
student‐to‐instructor	O
ratio	O
.	O

Saward	S-Person
also	O
shared	O
information	O
about	O
Emergent	S-Organization
's	O
new	O
mobile	O
manufacturing	O
units	O
on	O
Monday	O
as	O
a	O
speaker	O
during	O
the	O
Emerging	B-Activity
Viral	I-Activity
Diseases	I-Activity
and	I-Activity
Global	I-Activity
Preparedness	I-Activity
Symposium	E-Activity
held	O
at	O
the	O
Apotex	B-Location
Centre	E-Location
on	O
the	O
Bannatyne	B-Organization
Campus	I-Organization
of	I-Organization
Canada's	I-Organization
University	I-Organization
of	I-Organization
Manitoba	E-Organization
.	O
The	O
symposium	O
was	O
part	O
of	O
the	O
seminar	O
schedule	O
for	O
the	O
Department	B-Organization
of	I-Organization
Medical	I-Organization
Microbiology	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
at	O
the	O
university's	O
.	O

In	O
February	O
2016	O
,	O
British	O
scientists	O
were	O
given	O
permission	O
by	O
regulators	O
to	O
genetically	O
modify	O
human	O
embryos	O
by	O
using	O
and	O
related	O
techniques	O
.	O

Most	O
of	O
the	O
work	O
is	O
carried	O
out	O
with	O
a	O
replication	O
defective	O
,	O
nonreplicative	O
,	O
ecotropic‐	O
MulV	S-Pathogen
viral	O
vector	O
expressing	O
β‐galactosidase	O
7	O
,	O
12	O
.	O

This	O
advancement	O
is	O
significant	O
simply	O
because	O
it	O
enables	O
action	O
to	O
be	O
taken	O
in	O
four	O
to	O
six	O
hours	O
due	O
to	O
its	O
automatic	O
response	O
system	O
,	O
whereas	O
the	O
previous	O
system	O
required	O
aerosol	O
detectors	O
to	O
be	O
manually	O
transported	O
to	O
laboratories	O
.	O

To	O
date	O
,	O
many	O
studies	O
have	O
been	O
devoted	O
to	O
developing	O
targeted-	O
MRI	S-Technology
contrast	O
agents	O
to	O
achieve	O
molecular	O
imaging	O
by	O
MRI	S-Technology
.	O
Commonly	O
,	O
peptides	O
,	O
antibodies	O
,	O
or	O
small	O
ligands	O
,	O
and	O
small	O
protein	O
domains	O
,	O
such	O
as	O
HER-2	O
affibodies	O
,	O
have	O
been	O
applied	O
to	O
achieve	O
targeting	O
.	O

In	O
what	O
appears	O
to	O
be	O
a	O
related	O
move	O
,	O
NIH	S-Organization
issued	O
a	O
notice	O
urging	O
institutions	O
to	O
take	O
heed	O
of	O
the	O
recent	O
biosafety	O
incidents.	O
"	O
Recent	O
reports	O
of	O
lapses	O
in	O
biosafety	O
practices	O
involving	O
Federal	O
laboratories	O
have	O
served	O
to	O
remind	O
us	O
of	O
the	O
importance	O
of	O
constant	O
vigilance	O
over	O
our	O
implementation	O
of	O
biosafety	O
standards,	O
"	O
the	O
notice	O
states	O
.	O

"	O
After	O
devastating	O
the	O
Baltic	B-Location
nations	E-Location
and	O
eastern	O
Poland	S-Location
in	O
2014	O
,	O
African	O
swine	B-Disease
fever	E-Disease
emerged	O
in	O
the	O
Czech	B-Location
Republic	E-Location
and	O
near	O
Warsaw	S-Location
,	O
"	O
says	O
Lynn	B-Person
Morgan	E-Person
,	O
head	O
of	O
Europe	S-Location
at	O
global	O
research	O
firm	O
.	O

Biohacking	O
can	O
be	O
described	O
as	O
citizen	O
or	O
do-it-yourself	B-Activity
biology	E-Activity
For	O
many	O
"	O
biohackers,"	O
this	O
consists	O
of	O
making	O
small	O
,	O
incremental	O
diet	O
or	O
lifestyle	O
changes	O
to	O
make	O
small	O
improvements	O
in	O
your	O
health	O
and	O
well-being	O
.	O

Thanks	O
so	O
much	O
for	O
all	O
the	O
details	O
today	O
.	O

You	O
can	O
accomplish	O
much	O
more	O
as	O
a	O
whole	O
than	O
by	O
working	O
alone,	O
"	O
said	O
Los	B-Organization
Alamos	I-Organization
National	I-Organization
Laboratory	E-Organization
scientist	O
and	O
partnership	O
coordinator	O
,	O
Ph.D	O
.	O

Instead	O
,	O
the	O
government	O
is	O
seeking	O
voluntary	O
compliance	O
in	O
a	O
timely	O
manner	O
consistent	O
with	O
the	O
proper	O
management	O
of	O
pathogens	O
.	O

Develop	O
One	B-International_exchange_and_cooperation
Health	E-International_exchange_and_cooperation
nationwide	O
surveillance	O
of	O
AMR	O
and	O
the	O
use	O
of	O
antimicrobials	O
.	O

Medflies	O
were	O
found	O
in	O
traps	O
as	O
late	O
as	O
2007	O
in	O
Solano	B-Location
County	E-Location
,	O
California	S-Location
.	O
The	O
first	O
medflies	O
in	O
Florida	S-Location
turned	O
up	O
in	O
1929	O
and	O
they	O
have	O
been	O
a	O
constant	O
threat	O
to	O
the	O
citrus	O
crop	O
there	O
ever	O
since	O
.	O

It	O
says	O
that	O
in	O
September	O
,	O
NIH	S-Organization
and	O
other	O
federal	O
agencies	O
will	O
observe	O
National	O
Biosafety	O
Stewardship	O
Month	O
.	O

Only	O
last	O
week	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
released	O
a	O
report	O
reviewing	O
the	O
newest	O
data	O
on	O
antibiotic	O
resistance	O
.	O

WHO	S-Organization
addresses	O
government	O
health	O
policy	O
with	O
two	O
aims:	O
firstly	O
,	O
"	O
to	O
address	O
the	O
underlying	O
social	O
and	O
economic	O
determinants	O
of	O
health	O
through	O
policies	O
and	O
programmes	O
that	O
enhance	O
health	O
equity	O
and	O
integrate	O
pro-poor	O
,	O
gender-responsive	O
,	O
and	O
human	O
rights-based	O
approaches	O
"	O
and	O
secondly	O
"	O
to	O
promote	O
a	O
healthier	O
environment	O
,	O
intensify	O
primary	O
prevention	O
and	O
influence	O
public	O
policies	O
in	O
all	O
sectors	O
so	O
as	O
to	O
address	O
the	O
root	O
causes	O
of	O
environmental	O
threats	O
to	O
health"	O
.	O

The	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	S-Organization
is	O
the	O
leading	O
national	O
public	O
health	O
institute	O
of	O
the	O
.	O

For	O
more	O
than	O
two	O
decades	O
,	O
bioterrorism	O
experts	O
warned	O
that	O
America	S-Organization
may	O
be	O
vulnerable	O
to	O
attack	O
with	O
biological	O
weapons	O
.	O

They	O
have	O
highlighted	O
,	O
for	O
example	O
,	O
disparities	O
in	O
methods	O
,	O
diagnostic	O
equipment	O
,	O
QA	O
management	O
systems	O
,	O
the	O
transport	O
and	O
delivery	O
of	O
samples	O
,	O
and	O
inter-agency	O
communication	O
and	O
data	O
sharing	O
(Table	O
2)	O
.	O

The	O
researcher	O
became	O
infected	O
with	O
Bacillus	B-Pathogen
cereus	E-Pathogen
which	O
can	O
cause	O
food-borne	B-Disease
infections	E-Disease
,	O
while	O
working	O
on	O
a	O
project	O
headed	O
by	O
microbiologist	O
Olaf	B-Person
Schneewind	E-Person
,	O
according	O
to	O
the	O
university	O
.	O

Of	O
particular	O
note	O
,	O
Fluconazole-resistant	B-Pathogen
Candida	E-Pathogen
have	O
been	O
highlighted	O
as	O
a	O
growing	O
problem	O
by	O
the	O
CDC	S-Organization
.	O
More	O
than	O
20	O
species	O
of	O
Candida	O
can	O
cause	O
Candidiasis	B-Disease
infection	E-Disease
,	O
the	O
most	O
common	O
of	O
which	O
is	O
Candida	B-Pathogen
albicans	E-Pathogen
.	O
Candida	O
yeasts	O
normally	O
inhabit	O
the	O
skin	O
and	O
mucous	O
membranes	O
without	O
causing	O
infection	O
.	O

While	O
MRI	S-Technology
is	O
most	O
prominently	O
used	O
in	O
diagnostic	O
medicine	O
and	O
biomedical	O
research	O
,	O
it	O
also	O
may	O
be	O
used	O
to	O
form	O
images	O
of	O
non-living	O
objects	O
.	O

Similarly	O
,	O
immunodeficiency	B-Pathogen
virus	E-Pathogen
and	O
were	O
categorized	O
according	O
to	O
the	O
highest	O
laboratory	O
biosafety	O
level	O
,	O
but	O
were	O
not	O
included	O
in	O
the	O
corresponding	O
biodefense	O
level	O
.	O

Kanatjan	B-Person
Alibekov	E-Person
,	O
former	O
first	O
deputy	O
chief	O
for	O
Biopreparat	S-Scientific_research_project
(the	O
civilian	O
part	O
of	O
the	O
Soviet	O
biological	O
weapons	O
program)	O
,	O
the	O
anthrax	S-Pathogen
airborne	O
leak	O
had	O
been	O
caused	O
by	O
workers	O
at	O
the	O
military	O
facility	O
who	O
forgot	O
to	O
replace	O
a	O
filter	S-Equipment
in	O
an	O
exhaust	O
system	O
.	O

Adams	S-Person
noted	O
that	O
if	O
,	O
by	O
chance	O
,	O
the	O
Insect	B-Scientific_research_project
Allies	E-Scientific_research_project
technology	O
is	O
successful	O
,	O
"	O
it	O
will	O
be	O
entities	O
other	O
than	O
that	O
determine	O
if	O
and	O
how	O
the	O
technology	O
is	O
used.	O
"	O

While	O
scientists	O
are	O
still	O
working	O
out	O
the	O
limits	O
and	O
dangers	O
,	O
Rich	S-Person
is	O
experimenting	O
at	O
home	O
and	O
admits	O
if	O
he	O
gets	O
it	O
wrong	O
,	O
he	O
could	O
kill	O
himself	O
.	O

Topics	O
discussed	O
include	O
routine	O
precautions	O
when	O
working	O
with	O
biohazards	O
,	O
disinfectants	O
,	O
disposal	O
of	O
biohazards	O
,	O
biosafety	O
levels	O
(as	O
established	O
by	O
the	O
U.S.	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
and	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
)	O
,	O
animal	O
facilities	O
,	O
and	O
clinical	O
laboratories	O
.	O

However	O
,	O
later	O
tests	O
confirmed	O
that	O
the	O
initial	O
tests	O
did	O
not	O
indicate	O
a	O
false	O
positive	O
and	O
the	O
substance	O
was	O
indeed	O
ricin	S-Pathogen
By	O
the	O
end	O
of	O
March	O
2005	O
,	O
there	O
were	O
no	O
suspects	O
and	O
no	O
confirmed	O
source	O
for	O
the	O
ricin	S-Pathogen
found	O
in	O
Senator	B-Location
Frist's	I-Location
office	E-Location
.	O
Investigators	O
also	O
found	O
no	O
connection	O
to	O
the	O
Fallen	B-Incident
Angel	I-Incident
case	E-Incident
as	O
of	O
the	O
same	O
date.	O
"	O
Still	O
No	O
Suspects	O
in	O
Ricin	B-Incident
Case	E-Incident
on	O
Capitol	O
Hill	O
"	O
,	O
WTOP.com	O
,	O
March	O
31	O
,	O
2005	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

Historical	O
records	O
since	O
the	O
16th	O
century	O
suggest	O
that	O
new	O
influenza	O
pandemics	O
may	O
appear	O
at	O
any	O
time	O
of	O
year	O
,	O
not	O
necessarily	O
in	O
the	O
familiar	O
annual	O
winter	O
patterns	O
of	O
interpandemic	O
years	O
,	O
presumably	O
because	O
newly	O
shifted	O
influenza	S-Disease
viruses	O
behave	O
differently	O
when	O
they	O
find	O
a	O
universal	O
or	O
highly	O
susceptible	O
human	O
population	O
.	O

Special	O
munitions	O
for	O
the	O
United	B-Organization
States	I-Organization
Special	I-Organization
Forces	E-Organization
and	O
the	O
CIA	S-Organization
and	O
the	O
Big	B-Organization
Five	I-Organization
Weapons	E-Organization
for	O
the	O
military	O
were	O
destroyed	O
in	O
accordance	O
with	O
Nixon's	O
executive	O
order	O
to	O
end	O
the	O
offensive	O
program	O
.	O

The	O
Ebola	B-Pathogen
Virus	E-Pathogen
3D	O
model	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
prepared	O
by	O
Visual	B-Organization
Science	E-Organization
,	O
.	O

Viruses	O
such	O
as	O
Marburg	S-Pathogen
or	O
Congo‐Crimean	B-Pathogen
hemorrhagic	I-Pathogen
fever	E-Pathogen
are	O
manipulated	O
at	O
.	O

The	O
Sierra	B-Organization
Leone-China	I-Organization
Friendship	I-Organization
Biological	I-Organization
Safety	I-Organization
Laboratory	E-Organization
(	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
)	O
,	O
a	O
fixed	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
laboratory	O
in	O
the	O
capital	O
city	O
of	O
Sierra	B-Location
Leone	E-Location
,	O
was	O
established	O
by	O
the	O
Chinese	B-Organization
government	E-Organization
and	O
has	O
been	O
active	O
in	O
EBOV	S-Pathogen
detection	O
since	O
11	O
March	O
2015	O
.	O

CDC	S-Organization
is	O
conducting	O
additional	O
work	O
to	O
further	O
define	O
the	O
risk	O
of	O
anthrax	S-Pathogen
for	O
employees	O
potentially	O
exposed	O
because	O
best	O
safety	O
practices	O
were	O
not	O
followed	O
in	O
one	O
of	O
its	O
laboratories	O
in	O
early	O
June	O
.	O

Further	O
,	O
the	O
laboratory	O
personnel	O
awareness	O
towards	O
biosafety	O
principles	O
implementation	O
was	O
very	O
low	O
too	O
.	O

I	O
just	O
want	O
to	O
get	O
a	O
personal	O
reaction	O
here	O
,	O
Dr	O
.	O

An	O
article	O
published	O
in	O
JAMA	S-Organization
in	O
September	O
2010	O
challenged	O
previous	O
reports	O
and	O
stated	O
that	O
children	O
infected	O
in	O
the	O
2009	O
flu	B-Disease
pandemic	E-Disease
were	O
no	O
more	O
likely	O
to	O
be	O
hospitalised	O
with	O
complications	O
or	O
get	O
pneumonia	S-Disease
than	O
those	O
who	O
catch	O
seasonal	B-Pathogen
strains	E-Pathogen
.	O
Researchers	O
found	O
that	O
about	O
1.	O
5%	O
of	O
children	O
with	O
the	O
H1N1	B-Pathogen
swine	I-Pathogen
flu	I-Pathogen
strain	E-Pathogen
were	O
hospitalised	O
within	O
30	O
days	O
,	O
compared	O
with	O
3.	O
7%	O
of	O
those	O
sick	O
with	O
a	O
seasonal	B-Pathogen
strain	I-Pathogen
of	I-Pathogen
H1N1	E-Pathogen
and	O
3.	O
1%	O
with	O
an	O
.	O

The	O
material	O
mistakenly	O
transferred	O
during	O
procedures	O
for	O
this	O
study	O
was	O
on	O
a	O
sealed	O
plate	O
but	O
should	O
not	O
have	O
been	O
moved	O
from	O
the	O
BSL-4	S-Platform
laboratory	O
into	O
the	O
laboratory	O
.	O

The	O
role	O
of	O
non-governmental	O
organisations	O
and	O
other	O
interested	O
observers	O
-	O
civil	O
society	O
-	O
has	O
long	O
been	O
neglected	O
by	O
governments	O
in	O
the	O
quest	O
for	O
a	O
world	O
secure	O
from	O
the	O
threat	O
of	O
biological	O
weapons	O
or	O
bioterrorism	O
.	O

The	O
People's	B-Location
Republic	I-Location
of	I-Location
China	E-Location
notified	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
about	O
this	O
outbreak	B-Incident
on	I-Incident
10	I-Incident
February	I-Incident
2003	E-Incident
,	O
reporting	O
305	O
cases	O
including	O
105	O
health-care	O
workers	O
and	O
five	O
deaths	O
.	O

The	O
use	O
of	O
agents	O
that	O
do	O
not	O
cause	O
harm	O
to	O
humans	O
,	O
but	O
disrupt	O
the	O
economy	O
,	O
have	O
also	O
been	O
discussed	O
.	O

Now	O
I'd	O
like	O
to	O
describe	O
each	O
of	O
the	O
three	O
incidents	O
in	O
more	O
detail	O
,	O
and	O
we	O
can	O
provide	O
additional	O
detail	O
in	O
the	O
question/answer	O
if	O
you'd	O
like	O
.	O

These	O
events	O
should	O
never	O
have	O
happened	O
.	O

First	O
,	O
because	O
it	O
happened	O
in	O
our	O
influenza	O
laboratory	O
.	O

Examples	O
from	O
recent	O
outbreaks	O
such	O
as	O
H3N2	B-Pathogen
(flu)	E-Pathogen
Ebola	S-Pathogen
,	O
and	O
highlight	O
the	O
significant	O
lag	O
in	O
deployment	O
and	O
efficacy	O
of	O
life-saving	O
solutions	O
.	O

As	O
of	O
Dec.	O
31	O
,	O
2017	O
,	O
the	O
CDC	S-Organization
had	O
obligated	O
$453.8	O
million	O
,	O
and	O
USAID	S-Organization
obligated	O
$245.5	O
million	O
in	O
support	O
of	O
the	O
U.S.	S-Location
commitment	O
to	O
GHSA	S-International_exchange_and_cooperation
,	O
with	O
the	O
funding	O
and	O
technical	O
assistance	O
helping	O
these	O
countries	O
design	O
and	O
implement	O
five-year	B-Document
GHSA	I-Document
plans	E-Document
to	O
address	O
specific	O
gaps	O
in	O
health	O
security	O
capability	O
across	O
the	O
.	O

Yambuku	S-Location
is	O
a	O
small	O
village	O
in	O
Mongala	B-Location
Province	E-Location
in	O
northern	B-Location
Democratic	I-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
,	O
best	O
known	O
as	O
the	O
center	O
of	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
.	O
It	O
is	O
northeast	O
of	O
the	O
capital	O
city	O
of	O
.	O

Magnetic	B-Technology
resonance	I-Technology
spectroscopic	I-Technology
imaging	E-Technology
(	O
MRSI	S-Technology
)	O
combines	O
both	O
spectroscopic	O
and	O
imaging	O
methods	O
to	O
produce	O
spatially	O
localized	O
spectra	O
from	O
within	O
the	O
sample	O
or	O
patient	O
.	O

But	O
the	O
idea	O
of	O
Ebola	S-Pathogen
being	O
harvested	O
for	O
use	O
in	O
a	O
"	O
dirty	O
bomb	O
"	O
sounds	O
more	O
like	O
science	O
fiction	O
than	O
a	O
real	O
possibility	O
to	O
bioterrorism	O
experts	O
.	O

The	O
epicentre	O
of	O
the	O
current	O
crisis	O
is	O
China	S-Location
the	O
world's	O
biggest	O
producer	O
and	O
consumer	O
of	O
pork	O
.	O

Bacteria	O
and	O
fungi	O
are	O
germs	O
found	O
inside	O
and	O
outside	O
of	O
our	O
bodies	O
.	O

Contrast	O
media	O
used	O
for	O
X-ray	B-Technology
CT	E-Technology
as	O
well	O
as	O
for	O
plain	O
film	O
X-ray	O
,	O
are	O
called	O
radiocontrasts	O
.	O

By	O
5	O
September	O
,	O
Lokela	S-Person
was	O
in	O
a	O
critical	O
condition	O
with	O
profuse	O
bleeding	O
from	O
all	O
orifices	O
,	O
vomiting	S-Phenotype
,	O
acute	O
diarrhea	S-Phenotype
,	O
chest	B-Phenotype
pains	E-Phenotype
,	O
headache	S-Phenotype
,	O
fever	S-Phenotype
and	O
in	O
an	O
agitated	S-Phenotype
and	O
confused	S-Phenotype
state	O
.	O

Yet	O
those	O
suits	O
ruptured	O
or	O
developed	O
holes	O
in	O
at	O
least	O
37	O
incidents	O
during	O
a	O
20-month	O
period	O
in	O
2013	O
and	O
2014	O
,	O
according	O
to	O
lab	O
incident	O
reports	O
obtained	O
by	O
USA	B-Organization
TODAY	E-Organization
under	O
the	O
federal	O
.	O

Stericycle	S-Organization
and	O
are	O
two	O
national	O
leaders	O
in	O
medical	O
waste	O
and	O
pharmaceutical	O
disposal	O
in	O
the	O
United	O
States	O
.	O

The	O
National	B-Organization
Polio	I-Organization
Response	I-Organization
Emergency	I-Organization
Operations	I-Organization
Centre	E-Organization
is	O
currently	O
updating	O
its	O
risk	O
assessment	O
and	O
planning	O
the	O
enhancement	O
of	O
response	O
operations	O
,	O
including	O
possible	O
expansion	O
of	O
vaccination	O
to	O
the	O
entire	O
region	O
.	O

A	O
Foreword	O
by	O
the	O
Secretary	O
of	O
State	B-Organization
for	I-Organization
Social	I-Organization
Services	E-Organization
Patrick	B-Person
Jenkin	E-Person
,	O
noted	O
that	O
the	O
disputed	O
the	O
report's	O
findings	O
.	O

In	O
2014	O
34	O
people	O
became	O
infected	O
(among	O
which	O
a	O
4-year	O
old	O
child)	O
with	O
CCHF	S-Disease
.	O
3	O
of	O
which	O
died	O
.	O

In	O
November	O
2018	O
,	O
Jiankui	B-Person
He	E-Person
announced	O
that	O
he	O
had	O
edited	O
two	O
human	O
embryos	O
to	O
attempt	O
to	O
disable	O
the	O
gene	O
for	O
CCR5	O
,	O
which	O
codes	O
for	O
a	O
receptor	O
that	O
HIV	S-Disease
uses	O
to	O
enter	O
cells	O
.	O

Only	O
24	O
(12.	O
6%)	O
laboratories	O
had	O
separated	O
room	O
for	O
sampling	O
and	O
57	O
(30%)	O
had	O
special	O
room	O
for	O
patients	O
.	O

Riley	S-Person
said	O
the	O
collaboration	O
with	O
UNL	S-Organization
,	O
UNMC	S-Organization
and	O
Los	B-Organization
Alamos	E-Organization
is	O
in	O
its	O
"	O
infancy,"	O
but	O
he	O
noted	O
that	O
about	O
10	O
UNL	S-Organization
faculty	O
attended	O
the	O
Omaha	S-Location
symposium	O
and	O
that	O
more	O
faculty	O
would	O
like	O
to	O
become	O
engaged	O
.	O

MRI	S-Technology
is	O
used	O
industrially	O
mainly	O
for	O
routine	O
analysis	O
of	O
chemicals	O
.	O

They	O
can	O
be	O
divided	O
in	O
mono-	O
and	O
multi-material	O
methods	O
.	O

This	O
allows	O
for	O
the	O
introduction	O
of	O
targeted	O
DNA	O
damage	O
and	O
repair	O
.	O

During	O
the	O
following	O
three	O
weeks	O
,	O
eight	O
additional	O
cases	O
of	O
fever	S-Phenotype
and	O
rash	S-Phenotype
occurred	O
in	O
Aral	S-Location
.	O
Five	O
adults	O
ranging	O
in	O
age	O
from	O
23	O
to	O
60	O
,	O
and	O
three	O
children	O
(4	O
and	O
9	O
months	O
old	O
,	O
and	O
a	O
5-year-old)	O
were	O
diagnosed	O
with	O
smallpox	S-Pathogen
both	O
clinically	O
and	O
by	O
laboratory	O
testing	O
.	O

An	O
additional	O
284	O
cases	O
and	O
151	O
deaths	O
occurred	O
in	O
nearby	O
South	O
Sudan	S-Location
in	O
an	O
unrelated	O
outbreak	O
.	O

Antivirals	O
are	O
most	O
useful	O
if	O
given	O
within	O
48	O
hours	O
of	O
the	O
start	O
of	O
symptoms	O
and	O
may	O
improve	O
outcomes	O
in	O
hospitalised	O
patients	O
.	O

For	O
instance	O
,	O
in	O
Europe	S-Location
in	O
2007	O
,	O
the	O
number	O
of	O
infections	O
by	O
multidrug-resistant	O
bacteria	O
was	O
400,000	O
with	O
25,000	O
attributable	O
deaths	O
.	O

The	O
Soviet	B-Organization
Union	E-Organization
continued	O
the	O
development	O
and	O
mass	O
production	O
of	O
offensive	O
biological	O
weapons	O
,	O
despite	O
having	O
signed	O
the	O
1972	B-Document
BWC	E-Document
.	O
The	O
development	O
and	O
production	O
were	O
conducted	O
by	O
a	O
main	O
directorate	O
(	O
"	O
Biopreparat	S-Organization
"	O
)	O
along	O
with	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Defense	E-Organization
,	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Agriculture	E-Organization
,	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
,	O
the	O
USSR	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
,	O
the	O
,	O
and	O
other	O
state	O
organizations	O
.	O

The	O
antimicrobial	O
resistance	O
crisis	O
also	O
extends	O
to	O
the	O
food	O
industry	O
,	O
specifically	O
with	O
food	O
producing	O
animals	O
.	O

Details	O
on	O
these	O
findings	O
are	O
included	O
in	O
the	O
report	O
.	O

Yang's	O
white	O
button	O
mushroom	O
was	O
the	O
first	O
organism	O
genetically	O
modified	O
with	O
the	O
protein	O
system	O
to	O
pass	O
US	O
regulation	O
.	O

Developing	O
such	O
a	O
platform	O
will	O
require	O
overcoming	O
numerous	O
engineering	O
challenges	O
.	O

The	O
entertainment	O
industry	O
has	O
also	O
been	O
affected	O
,	O
with	O
many	O
music	O
groups	O
suspending	O
or	O
cancelling	O
concert	O
tours	O
.	O

The	O
Biological	B-Document
Agent	I-Document
Laboratory	I-Document
Biosafety	I-Document
Category	I-Document
Lists	E-Document
and	O
the	O
category	O
criteria	O
of	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
,	O
the	O
EU	S-Location
and	O
China	S-Location
as	O
well	O
as	O
the	O
Biological	B-Document
Agents	I-Document
Biodefense	I-Document
Category	I-Document
List	E-Document
and	O
criteria	O
of	O
the	O
CDC	S-Organization
,	O
the	O
European	B-Organization
Union	E-Organization
and	O
Russia	S-Location
were	O
obtained	O
via	O
internet	O
sites	O
and	O
publications	O
.	O

"	O
To	O
help	O
put	O
it	O
into	O
perspective	O
,	O
in	O
2014	O
,	O
Dr.	O
(	O
Yoshi	S-Person
Kawaoka	S-Person
went	O
into	O
two	O
of	O
the	O
containment	O
laboratories	O
over	O
1,500	O
times,	O
"	O
wrote	O
in	O
an	O
email.	O
"	O
And	O
spent	O
over	O
2,600	O
hours	O
working	O
inside	O
those	O
two	O
laboratories.	O
"	O

After	O
Dorsey	S-Person
endorsed	O
a	O
particular	O
near-infrared	O
sauna	O
sold	O
by	O
SaunaSpace	S-Organization
,	O
which	O
claims	O
its	O
product	O
boosts	O
cellular	O
regeneration	O
and	O
fights	O
aging	O
by	O
detoxing	O
your	O
body	O
,	O
the	O
company	O
experienced	O
a	O
surge	O
in	O
demand	O
.	O

Due	O
to	O
the	O
deteriorating	O
situation	O
in	O
North	O
Kivu	S-Location
and	O
surrounding	O
areas	O
,	O
the	O
WHO	S-Organization
raised	O
the	O
risk	O
assessment	O
at	O
the	O
national	O
and	O
regional	O
level	O
from	O
"	O
high"	O
to	O
"	O
very	O
high	O
"	O
in	O
September	O
2018	O
.	O

Wuhan	S-Location
city	O
,	O
with	O
a	O
population	O
of	O
19	O
million	O
,	O
is	O
the	O
capital	O
city	O
of	O
Hubei	B-Location
province	E-Location
,	O
with	O
a	O
population	O
of	O
58	O
million	O
people.	O
has	O
requested	O
further	O
information	O
on	O
the	O
laboratory	O
tests	O
performed	O
and	O
the	O
differential	O
diagnoses	O
considered	O
.	O

In	O
some	O
countries	O
,	O
including	O
Egypt	S-Organization
,	O
Turkey	S-Organization
,	O
and	O
Thailand	S-Organization
,	O
opposition	O
activists	O
and	O
government	O
critics	O
have	O
been	O
arrested	O
for	O
allegedly	O
spreading	O
fake	O
news	O
about	O
the	O
pandemic	O
.	O

The	O
private	O
company	O
performs	O
work	O
for	O
the	O
Pentagon's	B-Organization
DTRA	I-Organization
bio	I-Organization
laboratories	E-Organization
in	O
Afghanistan	S-Location
,	O
Armenia	S-Location
,	O
Georgia	S-Location
,	O
Uganda	S-Location
,	O
Tanzania	S-Location
,	O
Iraq	S-Location
,	O
Afghanistan	S-Location
and	O
Vietnam	S-Location
.	O
Battelle	S-Organization
conducts	O
research	O
,	O
development	O
,	O
testing	O
,	O
and	O
evaluation	O
using	O
both	O
highly	O
toxic	O
chemicals	O
and	O
highly	O
pathogenic	O
biological	O
agents	O
for	O
a	O
wide	O
range	O
of	O
US	B-Organization
government	I-Organization
agencies	E-Organization
.	O
It	O
has	O
been	O
awarded	O
some	O
$2	O
billion	O
federal	O
contracts	O
in	O
total	O
and	O
ranks	O
23	O
on	O
the	O
Top	O
100	O
contractors	O
list	O
.	O

Modern	O
medical	O
advances	O
are	O
unimaginable	O
without	O
the	O
ability	O
to	O
study	O
cells	O
and	O
proteins	O
with	O
rDNA	O
and	O
the	O
tools	O
used	O
to	O
make	O
it	O
,	O
such	O
as	O
PCR	S-Technology
which	O
helps	O
researchers	O
'copy	O
and	O
paste'	O
DNA	O
in	O
a	O
test	O
tube	O
.	O

Our	O
commitment	O
to	O
delivering	O
unmatched	O
performance	O
,	O
security	O
and	O
scalability	O
extends	O
beyond	O
our	O
government	O
clients	O
to	O
those	O
in	O
the	O
commercial	O
enterprise	O
space	O
,	O
giving	O
physician	O
groups	O
and	O
non-government	O
hospitals	O
an	O
added	O
measure	O
of	O
reassurance.	O
"	O
According	O
to	O
the	O
KPMG	O
survey	O
,	O
12	O
percent	O
of	O
survey	O
respondents	O
are	O
concerned	O
with	O
regulatory	O
compliance	O
and	O
risk/liability	O
.	O

The	O
subject	O
receives	O
an	O
intravenous	O
injection	O
of	O
radiocontrast	O
,	O
and	O
then	O
the	O
heart	O
is	O
scanned	O
using	O
a	O
high-speed	B-Equipment
CT	I-Equipment
scanner	E-Equipment
,	O
allowing	O
radiologists	O
to	O
assess	O
the	O
extent	O
of	O
occlusion	O
in	O
the	O
coronary	O
arteries	O
,	O
usually	O
in	O
order	O
to	O
diagnose	O
.	O

In	O
1989	O
,	O
as	O
many	O
flies	O
were	O
captured	O
as	O
had	O
been	O
captured	O
in	O
the	O
previous	O
fifteen	O
years	O
combined	O
.	O

This	O
is	O
typically	O
done	O
via	O
a	O
process	O
of	O
"	O
windowing",	O
which	O
maps	O
a	O
range	O
(the	O
"	O
window")	O
of	O
pixel	O
values	O
to	O
a	O
grayscale	O
ramp	O
.	O

These	O
factors	O
underscore	O
the	O
need	O
for	O
an	O
effective	O
smallpox	S-Pathogen
antiviral	O
therapy	O
,	O
and	O
we	O
believe	O
that	O
TPOXX	S-Drug
can	O
address	O
this	O
need.	O
"	O
Although	O
the	O
standard	O
smallpox	B-Vaccine
vaccine	E-Vaccine
is	O
still	O
available	O
,	O
in	O
the	O
untimely	O
event	O
of	O
an	O
outbreak	O
or	O
bioterrorist	O
attack	O
,	O
the	O
investigators	O
state	O
that	O
tecovirimat	S-Drug
could	O
be	O
used	O
as	O
an	O
"	O
an	O
important	O
stopgap	O
measure	O
until	O
the	O
standard	O
vaccine	O
can	O
be	O
effectively	O
deployed	O
,	O
while	O
complementing	O
the	O
protective	O
efficacy	O
of	O
the	O
vaccine	O
once	O
it	O
has	O
been	O
deployed.	O
"	O
The	O
US	S-Location
government's	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
funded	O
the	O
advanced	O
development	O
of	O
oral	O
tecovirimat	S-Drug
in	O
partnership	O
with	O
SIGA	S-Organization
.	O
Additionally	O
,	O
under	O
Project	B-Scientific_research_project
Bioshield	E-Scientific_research_project
,	O
SIGA	S-Organization
has	O
already	O
delivered	O
2	O
million	O
courses	O
of	O
oral	O
tecovirimat	S-Drug
to	O
the	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
.	O
FDA	S-Organization
NDA	S-Organization
acceptance	O
and	O
priority	O
review	O
of	O
tecovirimat	S-Drug
occurred	O
in	O
February	O
2018	O
and	O
was	O
swiftly	O
followed	O
by	O
unanimous	O
support	O
by	O
the	O
's	O
advisory	O
committee	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
USDA	O
,	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

The	O
new	O
strategy	O
,	O
spelled	O
out	O
in	O
a	O
36-page	O
document	O
,	O
covers	O
deliberate	O
attacks	O
,	O
accidental	O
releases	O
,	O
and	O
naturally	O
occurring	O
biological	O
threats	O
and	O
pivots	O
off	O
lessons	O
learned	O
during	O
the	O
2001	B-Incident
anthrax	I-Incident
attacks	E-Incident
the	O
2009	B-Incident
H1N1	I-Incident
flu	I-Incident
pandemic	E-Incident
,	O
and	O
.	O

A	O
flu	O
follow-up	O
study	O
done	O
in	O
September	O
2010	O
,	O
found	O
that	O
"	O
the	O
risk	O
of	O
most	O
serious	O
complications	O
was	O
not	O
elevated	O
in	O
adults	O
or	O
children.	O
"	O

Herodian	S-Person
3.9.	O
3–8	O
and	O
Dio	B-Person
Cassius	E-Person
68.	O
31–75	O
and	O
Epitome	S-Person
75.10	O
and	O
76.10	O
.	O

Hundreds	O
of	O
thousands	O
of	O
unwitting	O
people	O
are	O
systematically	O
exposed	O
to	O
dangerous	O
pathogens	O
and	O
other	O
incurable	O
diseases	O
.	O

Crisis	O
management	O
in	O
Sweden	S-Location
is	O
based	O
on	O
the	O
premise	O
that	O
procedures	O
will	O
be	O
performed	O
as	O
normal	O
;	O
this	O
also	O
includes	O
sample	O
flow	O
upon	O
suspicion	O
of	O
high-consequence	O
pathogens	O
.	O

This	O
suggestion	O
appears	O
reasonable	O
because	O
conflicting	O
sharing	O
policies	O
would	O
be	O
a	O
major	O
obstacle	O
for	O
research	O
in	O
international	O
consortia	O
.	O

Evaluation	O
forms	O
consist	O
of	O
8	O
criteria	O
to	O
be	O
scored	O
from	O
1	O
(not	O
satisfied)	O
to	O
5	O
(very	O
satisfied)	O
.	O

Yet	O
another	O
attack	O
reported	O
on	O
17	O
November	O
,	O
in	O
Beni	S-Location
by	O
an	O
armed	O
rebel	O
group	O
forced	O
the	O
cessation	O
of	O
EVD	S-Disease
containment	O
efforts	O
and	O
WHO	S-Organization
staff	O
to	O
evacuate	O
to	O
another	O
DRC	O
city	O
for	O
the	O
time	O
being.	O
continues	O
to	O
be	O
the	O
site	O
of	O
attacks	O
by	O
militant	O
groups	O
as	O
18	O
civilians	O
were	O
killed	O
on	O
6	O
December	O
.	O

Due	O
to	O
the	O
violence	O
,	O
international	O
aid	O
organizations	O
had	O
to	O
stop	O
their	O
work	O
in	O
the	O
two	O
communities	O
.	O

A	O
law	O
enforcement	O
source	O
said	O
more	O
tests	O
would	O
be	O
conducted	O
at	O
the	O
Army's	B-Organization
biomedical	I-Organization
research	I-Organization
laboratory	E-Organization
at	O
Fort	B-Location
Detrick	E-Location
,	O
.	O

In	O
bacteria	O
,	O
the	O
presence	O
of	O
Cas9	S-Technology
alone	O
is	O
enough	O
to	O
block	O
transcription	O
.	O

CT	S-Technology
is	O
regarded	O
as	O
a	O
moderate-	O
to	O
high-radiation	O
diagnostic	O
technique	O
.	O

There	O
are	O
currently	O
five	O
Goodwill	O
Ambassadors	O
(	O
Jet	B-Person
Li	E-Person
,	O
Nancy	B-Person
Brinker	E-Person
,	O
Peng	B-Person
Liyuan	E-Person
,	O
Yohei	B-Person
Sasakawa	E-Person
and	O
the	O
Vienna	B-Person
Philharmonic	I-Person
Orchestra	E-Person
)	O
and	O
a	O
further	O
ambassador	O
associated	O
with	O
a	O
partnership	O
project	O
()	O
.	O

Most	O
cases	O
of	O
COVID‑19	S-Disease
are	O
not	O
severe	O
enough	O
to	O
require	O
mechanical	O
ventilation	O
or	O
alternatives	O
,	O
but	O
a	O
percentage	O
of	O
cases	O
are	O
.	O

He	O
reports	O
that	O
since	O
January	O
there	O
have	O
been	O
42	O
attacks	O
on	O
health	O
facilities	O
and	O
85	O
health	O
workers	O
have	O
been	O
wounded	O
or	O
killed.	O
"	O
Every	O
time	O
we	O
have	O
managed	O
to	O
regain	O
control	O
over	O
the	O
virus	O
and	O
contain	O
its	O
spread	O
,	O
we	O
have	O
suffered	O
major	O
,	O
major	O
security	O
events	O
.	O

Historical	O
data	O
indicate	O
that	O
about	O
two-thirds	O
of	O
individuals	O
who	O
were	O
infected	O
with	O
the	O
virus	O
survived	O
;	O
however	O
,	O
there	O
was	O
no	O
treatment	O
for	O
the	O
infection.Until	O
now	O
.	O

Investments	O
in	O
global	O
health	O
security	O
programs	O
at	O
the	O
federal	O
level	O
directly	O
benefit	O
U.S.	S-Location
national	O
security	O
and	O
the	O
economy	O
by	O
helping	O
to	O
prevent	O
the	O
cross-border	O
spread	O
of	O
infectious	O
disease	O
outbreaks	O
in	O
other	O
countries	O
.	O

"	O
To	O
demonstrate	O
a	O
broad	O
utility	O
of	O
the	O
platform	O
,	O
we	O
developed	O
prophylactic	O
and	O
therapeutic	O
vaccines	O
for	O
other	O
infectious	O
diseases	O
as	O
well	O
as	O
cancer,	O
"	O
said	O
Basu	S-Person

"	O
It	O
has	O
always	O
been	O
a	O
personal	O
priority	O
to	O
increase	O
care	O
access	O
for	O
members	O
of	O
the	O
Army	O
,	O
Navy	O
,	O
Air	O
Force	S-Organization
Marines	S-Organization
,	O
and	O
Coast	B-Organization
Guard	E-Organization
,	O
"	O
said	O
Joel	B-Person
Barthelemy	E-Person
,	O
CEO	O
of	O
GlobalMed	S-Organization
and	O
a	O
Marine	O
Corps	O
Reserve	O
Veteran.	O
"	O
The	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
is	O
a	O
huge	O
healthcare	O
provider	O
and	O
network	O
security	O
is	O
a	O
high	O
priority.	O
is	O
focused	O
on	O
every	O
aspect	O
of	O
security	O
and	O
compliance	O
throughout	O
our	O
vertically	O
integrated	O
software	O
applications	O
.	O

The	O
system	O
is	O
intended	O
to	O
allow	O
governments	O
to	O
create	O
official	O
privacy-preserving	O
coronavirus	O
tracking	O
apps	O
,	O
with	O
the	O
eventual	O
goal	O
of	O
integration	O
of	O
this	O
functionality	O
directly	O
into	O
the	O
iOS	O
and	O
Android	O
mobile	O
platforms	O
.	O

Synthesizing	B-Technology
DNA	E-Technology
has	O
the	O
advantage	O
of	O
offering	O
total	O
researcher	O
control	O
over	O
the	O
final	O
product	O
.	O

In	O
October	O
2014	O
,	O
the	O
WHO	S-Organization
noted	O
that	O
exponential	O
increase	O
of	O
cases	O
continued	O
in	O
the	O
three	O
countries	O
with	O
the	O
most	O
intense	O
transmission	O
.	O

However	O
,	O
some	O
inconsistencies	O
were	O
identified	O
.	O

Baghdad	S-Location
has	O
suffered	O
severely	O
from	O
visitations	O
of	O
the	O
,	O
and	O
sometimes	O
two-thirds	O
of	O
its	O
population	O
has	O
been	O
wiped	O
out	O
.	O

During	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	I-Incident
in	I-Incident
West	I-Incident
Africa	E-Incident
the	O
CDC	S-Organization
helped	O
coordinate	O
the	O
return	O
of	O
two	O
infected	O
American	O
aid	O
workers	O
for	O
treatment	O
at	O
,	O
the	O
home	O
of	O
a	O
special	O
unit	O
to	O
handle	O
highly	O
infectious	O
diseases	O
.	O

Scientific	O
conferences	O
and	O
meetings	O
on	O
GMOs	S-Technology
and	O
other	O
biotechnology-related	O
topics	O
were	O
the	O
next	O
most	O
frequently	O
conducted	O
initiatives	O
at	O
18.	O
5%	O
(n = 339)	O
(see	O
Figure	O
2)	O
.	O

The	O
event	O
was	O
discovered	O
by	O
the	O
laboratory	O
scientists	O
yesterday	O
,	O
December	O
23	O
,	O
and	O
reported	O
to	O
leadership	O
within	O
an	O
hour	O
of	O
the	O
discovery	O
.	O

At	O
the	O
present	O
time	O
more	O
than	O
50%	O
of	O
the	O
antibiotics	O
produced	O
are	O
employed	O
as	O
animal	O
feeds	O
to	O
promote	O
growth	O
.	O

In	O
November	O
2012	O
,	O
Egyptian	O
virologist	O
Dr	O
.	O

In	O
December	O
2014	O
,	O
a	O
British	O
aid	O
worker	O
who	O
had	O
just	O
returned	O
from	O
Sierra	B-Location
Leone	E-Location
was	O
diagnosed	O
with	O
Ebola	S-Disease
.	O
She	O
was	O
treated	O
with	O
survivors'	O
blood	O
plasma	O
and	O
experimental	O
drugs	O
and	O
declared	O
free	O
of	O
disease	O
in	O
January	O
2015	O
.	O

In	O
June	O
2010	O
,	O
Fiona	B-Person
Godlee	E-Person
editor-in-chief	O
of	O
the	O
BMJ	S-Organization
,	O
published	O
an	O
editorial	O
which	O
criticised	O
the	O
WHO	S-Organization
,	O
saying	O
that	O
an	O
investigation	O
had	O
disclosed	O
that	O
some	O
of	O
the	O
experts	O
advising	O
WHO	S-Organization
on	O
the	O
pandemic	O
had	O
financial	O
ties	O
with	O
drug	O
companies	O
which	O
were	O
producing	O
antivirals	O
and	O
vaccines	O
.	O

Ebola's	O
toll	O
on	O
the	O
social	O
and	O
economic	O
fabric	O
of	O
is	O
undermining	O
political	O
stability	O
and	O
the	O
progress	O
that	O
this	O
region	O
has	O
made	O
after	O
decades	O
of	O
civil	O
war	O
.	O

On	O
22	O
March	O
,	O
the	O
media	O
reported	O
that	O
medical	O
authorities	O
in	O
Guinea	S-Location
had	O
quarantined	O
816	O
suspected	O
contacts	O
of	O
the	O
prior	O
cases	O
(more	O
than	O
100	O
individuals	O
were	O
considered	O
high-risk)	O
;	O
the	O
same	O
day	O
,	O
Liberia	S-Organization
ordered	O
its	O
border	O
with	O
Guinea	S-Location
closed	O
.	O

Pakistan	S-Organization
said	O
it	O
would	O
not	O
evacuate	O
citizens	O
from	O
.	O

Prepare	O
food	O
hygienically	O
,	O
following	O
the	O
WHO	B-Document
Five	I-Document
Keys	I-Document
to	I-Document
Safer	I-Document
Food	E-Document
(keep	O
clean	O
,	O
separate	O
raw	O
and	O
cooked	O
,	O
cook	O
thoroughly	O
,	O
keep	O
food	O
at	O
safe	O
temperatures	O
,	O
use	O
safe	O
water	O
and	O
raw	O
materials)	O
and	O
choose	O
foods	O
that	O
have	O
been	O
produced	O
without	O
the	O
use	O
of	O
antibiotics	O
for	O
growth	O
promotion	O
or	O
disease	O
prevention	O
in	O
healthy	O
animals	O
.	O

A	O
NHK	O
Documentary	O
broadcast	O
in	O
2017	O
,	O
including	O
paper	O
materials	O
,	O
recording	O
tapes	O
,	O
and	O
interviews	O
to	O
former	O
members	O
and	O
doctors	O
who	O
have	O
implemented	O
experiments	O
in	O
.	O

We	O
believe	O
that	O
the	O
ability	O
to	O
"	O
write	O
the	O
genetic	O
code	O
"	O
as	O
we	O
describe	O
synthetic	B-Technology
genomics	I-Technology
research	E-Technology
will	O
enable	O
a	O
better	O
understanding	O
of	O
the	O
fundamentals	O
of	O
living	O
cells	O
.	O

CDC	S-Organization
will	O
improve	O
its	O
response	O
to	O
future	O
internal	O
incidents	O
by	O
the	O
rapid	O
establishment	O
of	O
an	O
incident	O
command	O
structure	O
,	O
as	O
uses	O
for	O
external	O
events	O
.	O

For	O
example	O
,	O
Palestine	S-Organization
attends	O
meetings	O
of	O
the	O
.	O
Each	O
region	O
also	O
has	O
a	O
regional	O
office	O
.	O

The	O
Japanese	O
government	O
severely	O
restricted	O
sea	O
travel	O
to	O
and	O
from	O
the	O
home	O
islands	O
when	O
the	O
pandemic	O
struck	O
.	O

You	O
can	O
biohack	O
without	O
regular	O
blood	O
tests	O
.	O

The	O
Center	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
(	O
CDC	S-Organization
)	O
issued	O
a	O
travel	O
advisory	O
stating	O
that	O
persons	O
considering	O
travel	O
to	O
the	O
affected	O
areas	O
in	O
Asia	S-Location
(	O
Hong	B-Location
Kong	E-Location
,	O
Singapore	S-Location
,	O
Vietnam	S-Location
,	O
and	O
)	O
should	O
not	O
go	O
.	O

The	O
FBD	S-Platform
network	O
is	O
coordinated	O
by	O
a	O
steering	O
committee	O
that	O
consists	O
of	O
2	O
representatives	O
from	O
each	O
of	O
the	O
4	O
agencies	O
,	O
and	O
the	O
presidency	O
of	O
the	O
committee	O
is	O
rotating	O
.	O

Botulinum	B-Pathogen
neurotoxin	E-Pathogen
poses	O
a	O
major	O
bio-weapon	O
threat	O
because	O
of	O
its	O
extreme	O
potency	O
,	O
ease	O
of	O
production	O
and	O
transport	O
.	O

Greater	O
prevalence	O
of	O
lacking	O
health	O
insurance	O
and	O
care	O
and	O
of	O
underlying	O
conditions	O
such	O
as	O
diabetes	S-Disease
,	O
hypertension	S-Disease
and	O
also	O
increase	O
their	O
risk	O
of	O
death	O
.	O

Growth	O
in	O
the	O
regions	O
of	O
Guinea	S-Location
,	O
Liberia	S-Location
and	O
was	O
very	O
different	O
over	O
time	O
,	O
indicating	O
that	O
monitoring	O
the	O
outbreak	O
at	O
district	O
level	O
was	O
important	O
.	O

Adornato	S-Person
is	O
aiming	O
to	O
demonstrate	O
the	O
approach	O
and	O
its	O
advantages	O
in	O
realistic	O
environments	O
to	O
convey	O
military	O
utility	O
.	O

Cas9	O
can	O
be	O
easily	O
introduced	O
into	O
the	O
target	O
cells	O
along	O
with	O
sgRNA	O
via	O
plasmid	O
transfection	O
in	O
order	O
to	O
model	O
the	O
spread	O
of	O
diseases	O
and	O
the	O
cell's	O
response	O
to	O
and	O
defense	O
against	O
infection	O
.	O

European	O
data	O
is	O
from	O
the	O
EARS-Net	S-Platform
(	O
European	B-Platform
Antimicrobial	I-Platform
Resistance	I-Platform
Surveillance	I-Platform
Network	E-Platform
)	O
,	O
part	O
of	O
the	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
(	O
DHS	S-Organization
)	O
outdated	O
BioWatch	S-Document
Program	O
,	O
launched	O
in	O
2003	O
as	O
an	O
early	O
warning	O
system	O
for	O
potential	O
bioterrorist	O
attacks	O
in	O
the	O
United	B-Location
States	E-Location
,	O
is	O
being	O
replaced	O
,	O
a	O
federal	O
expert	O
told	O
members	O
of	O
the	O
on	O
Nov.	O
14	O
during	O
a	O
report	O
on	O
biosurveillance	O
and	O
biodetection	O
.	O

However	O
,	O
like	O
,	O
the	O
precise	O
ways	O
the	O
virus	O
spreads	O
are	O
unknown	O
.	O

Excelsior	O
Challenge	O
.	O

Apart	O
from	O
knock-out	O
there	O
are	O
also	O
knock-down	O
(	O
CRISPRi	S-Technology
and	O
activation	O
(	O
CRISPRa	S-Technology
)	O
libraries	O
,	O
which	O
using	O
the	O
ability	O
of	O
proteolytically	O
deactivated	O
Cas9-fusion	O
proteins	O
(dCas9)	O
to	O
bind	O
target	O
DNA	O
,	O
which	O
means	O
that	O
gene	O
of	O
interest	O
is	O
not	O
cut	O
but	O
is	O
over-expressed	O
or	O
repressed	O
.	O

Agents	O
in	O
group	O
3	O
cause	O
serious	O
disease	O
.	O

We	O
cannot	O
rule	O
out	O
possible	O
exposure	O
of	O
the	O
one	O
laboratory	O
technician	O
who	O
worked	O
with	O
the	O
material	O
in	O
the	O
laboratory	O
.	O

This	O
is	O
useful	O
to	O
highlight	O
structures	O
such	O
as	O
blood	O
vessels	O
that	O
otherwise	O
would	O
be	O
difficult	O
to	O
delineate	O
from	O
their	O
surroundings	O
.	O

Next	O
question	O
on	O
the	O
phone	O
lines	O
comes	O
from	O
Julie	B-Person
Steenhuysen	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

Walløe	S-Person
complains	O
that	O
all	O
of	O
these	O
authors	O
"	O
take	O
it	O
for	O
granted	O
that	O
Simond	S-Person
's	O
infection	O
model	O
,	O
black	O
rat	O
→	O
rat	O
flea	O
→	O
human	O
,	O
which	O
was	O
developed	O
to	O
explain	O
the	O
spread	O
of	O
plague	S-Disease
in	O
India	S-Location
,	O
is	O
the	O
only	O
way	O
an	O
epidemic	O
of	O
Yersinia	B-Pathogen
pestis	E-Pathogen
infection	O
could	O
spread"	O
,	O
whilst	O
pointing	O
to	O
several	O
other	O
possibilities	O
.	O

"	O
The	O
virus	O
is	O
not	O
stoppable,	O
"	O
she	O
said.	O
"	O
I	O
would	O
advise	O
them	O
to	O
maintain	O
vigilance	O
,	O
enhance	O
surveillance	O
and	O
be	O
prepared	O
for	O
the	O
arrival	O
of	O
the	O
novel	B-Pathogen
H1N1	E-Pathogen
in	O
their	O
country.	O
"	O

Questions	O
can	O
be	O
directed	O
to	O
404-639-3286	O
,	O
or	O
they	O
can	O
be	O
e-mailed	O
to	O
media@cdc.gov.Thank	O
youeden?	O

This	O
technology	O
can	O
achieve	O
precise	O
ablation	O
of	O
diseased	O
tissue	O
.	O

At	O
present	O
,	O
ICTV	S-Organization
does	O
not	O
officially	O
recognize	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
as	O
a	O
taxonomic	O
rank	O
,	O
but	O
rather	O
continues	O
to	O
use	O
and	O
recommend	O
only	O
the	O
species	O
designation	O
.	O

A	O
CT	S-Equipment
scan	O
can	O
be	O
used	O
for	O
detecting	O
both	O
acute	O
and	O
chronic	O
changes	O
in	O
the	O
lung	O
parenchyma	O
,	O
the	O
tissue	O
of	O
the	O
lungs	O
.	O

Universities	O
and	O
schools	O
around	O
the	O
country	O
were	O
also	O
closed	O
.	O

The	O
information	O
in	O
this	O
second-annual	O
report	O
,	O
which	O
focuses	O
on	O
activities	O
during	O
the	O
third	O
year	O
of	O
the	O
five-year	O
U.S.	B-Organization
government	E-Organization
GHSA	S-International_exchange_and_cooperation
commitment	O
,	O
highlights	O
how	O
U.S.	S-Location
and	O
other	O
partner	O
investments	O
in	O
the	O
GHSA	S-International_exchange_and_cooperation
have	O
continued	O
to	O
build	O
capacities	O
across	O
each	O
of	O
the	O
.	O

It	O
was	O
hailed	O
by	O
The	O
Washington	O
Post	O
as	O
"	O
the	O
most	O
important	O
innovation	O
in	O
the	O
synthetic	O
biology	O
space	O
in	O
nearly	O
30	O
years.	O
"	O
While	O
other	O
methods	O
take	O
months	O
or	O
years	O
to	O
edit	O
gene	O
sequences	O
,	O
speeds	O
that	O
time	O
up	O
to	O
weeks	O
.	O

The	O
reports	O
were	O
sourced	O
from	O
official	O
information	O
from	O
the	O
affected	O
countries'	O
health	O
ministries	O
.	O

3	O
.	O

More	O
questions	O
on	O
the	O
phone?	O

SIGMA+	O
seeks	O
to	O
develop	O
new	O
sensors	O
and	O
networks	O
that	O
alert	O
authorities	O
to	O
chemical	O
,	O
biological	O
,	O
and	O
explosives	O
threats	O
as	O
well	O
.	O

Referring	O
to	O
the	O
ASPR	S-Organization
as	O
the	O
national	O
security	O
mission	O
manager	O
for	O
HHS	S-Organization
,	O
Kadlec	S-Person
said	O
the	O
office	O
-	O
which	O
was	O
established	O
a	O
decade	O
ago	O
by	O
PAHPA	S-Document
-	O
consolidates	O
all	O
federal	O
non-military	O
public	O
health	O
and	O
medical	O
preparedness	O
and	O
response	O
functions	O
under	O
its	O
command	O
.	O

CRISPR-Cas	B-Technology
technology	E-Technology
has	O
been	O
proposed	O
as	O
a	O
treatment	O
for	O
multiple	O
human	O
diseases	O
,	O
especially	O
those	O
with	O
a	O
genetic	O
cause	O
.	O

Sierra	B-Location
Leone	E-Location
had	O
entered	O
a	O
90-day	O
period	O
of	O
enhanced	O
surveillance	O
that	O
was	O
scheduled	O
to	O
end	O
on	O
5	O
February	O
2016	O
,	O
when	O
,	O
on	O
14	O
January	O
,	O
a	O
new	O
Ebola	S-Disease
death	O
was	O
reported	O
in	O
the	O
Tonkolili	B-Location
District	E-Location
.	O
Prior	O
to	O
this	O
case	O
,	O
the	O
WHO	S-Organization
had	O
advised	O
that	O
"	O
we	O
still	O
anticipate	O
more	O
flare-ups	O
and	O
must	O
be	O
prepared	O
for	O
them	O
.	O

The	O
close	O
quarters	O
and	O
massive	O
troop	O
movements	O
of	O
hastened	O
the	O
pandemic	O
,	O
and	O
probably	O
both	O
increased	O
transmission	O
and	O
augmented	O
mutation	O
.	O

A	O
pneumonia	S-Disease
cluster	O
of	O
unknown	O
cause	O
was	O
observed	O
on	O
26	O
December	O
and	O
treated	O
by	O
the	O
doctor	O
Zhang	B-Person
Jixian	E-Person
in	O
Hubei	B-Organization
Provincial	I-Organization
Hospital	E-Organization
,	O
who	O
informed	O
the	O
Wuhan	B-Organization
Jianghan	I-Organization
CDC	E-Organization
on	O
27	O
December	O
.	O

Retrieved	O
March	O
4	O
,	O
2011	O
.	O

They	O
considered	O
the	O
fusobacteria	O
Leptotrichia	O
shahii	O
.	O

The	O
Hopkins	O
team	O
also	O
suggests	O
that	O
security	O
provisions	O
should	O
work	O
with	O
the	O
practices	O
of	O
biological	O
research	O
.	O

Working	O
on	O
their	O
bench	O
tops	O
,	O
students	O
add	O
the	O
blocking	O
solution	O
,	O
primary	O
and	O
secondary	O
antibodies	O
,	O
and	O
a	O
substrate	O
,	O
and	O
then	O
read	O
their	O
results	O
in	O
an	O
(lab4	O
,	O
Table	O
1)	O
.	O

A	O
number	O
of	O
laboratories	O
and	O
companies	O
have	O
developed	O
serological	B-Technology
tests	E-Technology
which	O
detect	O
antibodies	O
produced	O
by	O
the	O
body	O
in	O
response	O
to	O
infection	O
.	O

Oseltamivir	S-Drug
does	O
not	O
inhibit	O
SARS-CoV-2	S-Pathogen
in	O
vitro	O
and	O
has	O
no	O
known	O
role	O
in	O
treatment	O
.	O

Marines	S-Organization
and	O
recently	O
joined	O
forces	O
to	O
share	O
training	O
techniques	O
designed	O
to	O
enhance	O
chemical	O
and	O
biological	O
emergency	O
preparedness	O
.	O

In	O
Boston	S-Location
the	O
mission	O
seems	O
to	O
have	O
failed	O
;	O
the	O
infected	O
civilians	O
were	O
quarantined	O
and	O
thus	O
kept	O
from	O
Continental	O
soldiers	O
.	O

US	S-Location
conscientious	O
objectors	O
were	O
used	O
as	O
consenting	O
test	O
subjects	O
for	O
tularemia	S-Pathogen
in	O
a	O
program	O
known	O
as	O
.	O
There	O
were	O
also	O
many	O
unpublicized	O
tests	O
carried	O
out	O
in	O
public	O
places	O
with	O
bio-agent	O
simulants	O
during	O
the	O
Cold	O
War	O
.	O

Ukraine	S-Organization
has	O
no	O
control	O
over	O
the	O
military	O
bio-laboratories	O
on	O
its	O
own	O
territory	O
.	O

Please	O
visit	O
the	O
Biodefense	B-Activity
World	I-Activity
Summit	E-Activity
2018	O
website	O
for	O
more	O
information	O
and	O
registration	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

Fluroquinolones	O
have	O
been	O
banned	O
from	O
extra-label	O
use	O
in	O
food	O
animals	O
in	O
the	O
since	O
2007	O
.	O

Redberg	S-Person
,	O
Rita	B-Person
F.	E-Person
,	O
and	O
Smith-Bindman	S-Person
,	O
Rebecca	S-Person
.	O
"	O
We	O
Are	O
Giving	O
Ourselves	O
Cancer	O
"	O
,	O
New	O
York	O
Times	O
,	O
Jan.	O
30	O
,	O
2014	O
However	O
,	O
a	O
lumbar	O
spine	O
x-ray	O
has	O
a	O
similar	O
dose	O
as	O
a	O
head	O
CT	S-Technology
.	O
Articles	O
in	O
the	O
media	O
often	O
exaggerate	O
the	O
relative	O
dose	O
of	O
CT	S-Technology
by	O
comparing	O
the	O
lowest-dose	O
x-ray	B-Technology
techniques	E-Technology
(chest	O
x-ray)	O
with	O
the	O
highest-dose	B-Technology
CT	I-Technology
techniques	E-Technology
.	O
In	O
general	O
,	O
the	O
radiation	O
dose	O
associated	O
with	O
a	O
routine	O
abdominal	O
has	O
a	O
radiation	O
dose	O
similar	O
to	O
three	O
years	O
average	O
background	O
radiation	O
.	O

In	O
1998	O
,	O
the	O
virus	O
name	O
was	O
changed	O
to	O
"	O
Zaire	B-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
and	O
in	O
2002	O
to	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
.	O
However	O
,	O
most	O
scientific	O
articles	O
continued	O
to	O
refer	O
to	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
or	O
used	O
the	O
terms	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
and	O
"	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
"	O
in	O
parallel	O
.	O

Industrial	B-Technology
CT	I-Technology
scanning	E-Technology
has	O
been	O
utilized	O
in	O
many	O
areas	O
of	O
industry	O
for	O
internal	O
inspection	O
of	O
components	O
.	O

Warehouse	O
13	O
episode	O
"	O
The	O
40th	O
Floor	O
"	O
(2011)	O
.	O

In	O
November	O
2018	O
,	O
the	O
outbreak	O
became	O
the	O
biggest	O
Ebola	S-Disease
outbreak	O
in	O
the	O
DRC	S-Organization
's	O
history	O
,	O
and	O
by	O
November	O
,	O
it	O
had	O
become	O
the	O
second-largest	O
Ebola	S-Disease
outbreak	O
in	O
recorded	O
history	O
,	O
behind	O
only	O
the	O
2013–2016	B-Incident
Western	I-Incident
Africa	I-Incident
epidemic	E-Incident
.	O
On	O
3	O
May	O
2019	O
,	O
nine	O
months	O
into	O
the	O
outbreak	O
,	O
the	O
outbreak	O
death	O
toll	O
surpassed	O
1,000	O
.	O

It's	O
time	O
to	O
invest	O
more	O
in	O
research	O
that	O
will	O
take	O
us	O
to	O
a	O
vaccine	O
or	O
new	O
drugs	O
.	O

The	O
White	B-Organization
House	E-Organization
also	O
plans	O
to	O
hold	O
semi-annual	O
reviews	O
to	O
ensure	O
the	O
recommendations	O
are	O
implemented	O
.	O

William	B-Person
Close	E-Person
1995	O
Ebola	S-Pathogen
:	O
A	O
Documentary	O
Novel	O
of	O
Its	O
First	O
Explosion	O
and	O
2002	O
Ebola	S-Pathogen
:	O
Through	O
the	O
Eyes	O
of	O
the	O
People	O
focused	O
on	O
individuals'	O
reactions	O
to	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
in	O
.	O
At	O
Google	O
Books	O
.	O

Cornelius	O
Nepos	O
,	O
Hannibal	S-Person
11.5–6	O
.	O

Takashi	B-Person
Tsuchiya	E-Person
.	O
"	O
The	O
Imperial	O
Japanese	O
Experiments	O
in	O
China"	O
.	O

In	O
the	O
U.S.	S-Location
,	O
the	O
had	O
to	O
recruit	O
more	O
volunteers	O
to	O
contribute	O
to	O
the	O
new	O
cause	O
at	O
home	O
of	O
fighting	O
the	O
influenza	O
epidemic	O
.	O

climb	O
out	O
of	O
one	O
of	O
these	O
locking	O
medical	O
waste	O
barrels	O
,	O
which	O
contained	O
soiled	O
mouse	O
disposable	O
caging	O
,	O
bedding	O
and	O
uneaten	O
food	O
.	O

This	O
incident	O
was	O
the	O
first	O
known	O
bioterrorist	O
attack	O
in	O
the	O
United	B-Location
States	E-Location
in	O
the	O
20th	O
century.Past	O
U.S	O
.	O

It	O
is	O
also	O
applied	O
to	O
veterinary	O
radiology	O
for	O
diagnostic	O
purposes	O
.	O

Sudan	B-Pathogen
virus	E-Pathogen
is	O
from	O
the	O
same	O
family	O
of	O
viruses	O
as	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
a	O
strain	O
of	O
which	O
was	O
responsible	O
for	O
the	O
2013-2016	B-Incident
outbreak	I-Incident
in	I-Incident
West	I-Incident
Africa	E-Incident
and	O
the	O
current	O
outbreak	B-Incident
in	I-Incident
the	I-Incident
Democratic	I-Incident
Republic	I-Incident
of	I-Incident
the	I-Incident
Congo	E-Incident
.	O
Like	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
Sudan	B-Pathogen
virus	E-Pathogen
causes	O
disease	O
characterized	O
by	O
severe	O
hemorrhagic	B-Phenotype
fever	E-Phenotype
and	O
high	O
mortality.	O
"	O
This	O
contract	O
will	O
allow	O
us	O
to	O
advance	O
these	O
molecules	O
to	O
clinical	O
evaluation	O
and	O
to	O
be	O
better	O
prepared	O
for	O
future	O
outbreaks,	O
"	O
said	O
Dr.	O
,	O
Principal	O
Investigator	O
on	O
the	O
contract	O
.	O

Influenza	B-Pathogen
A	I-Pathogen
viruses	E-Pathogen
(	O
IAVs	S-Pathogen
)	O
,	O
particularly	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
H5N1	S-Pathogen
,	O
have	O
posed	O
a	O
substantial	O
threat	O
to	O
public	O
health	O
worldwide	O
.	O

TOM	B-Person
FRIEDEN	E-Person
The	O
broader	O
issue	O
-	O
and	O
it's	O
in	O
our	O
report	O
that	O
we	O
released	O
today	O
-	O
the	O
broader	O
issue	O
is	O
we	O
think	O
there	O
are	O
lessons	O
here	O
for	O
other	O
laboratories	O
.	O

Remdesivir	S-Drug
inhibits	O
SARS-CoV-2	S-Pathogen
in	O
vitro	O
.	O

This	O
was	O
partly	O
because	O
of	O
safety	O
concerns	O
;	O
the	O
wanted	O
as	O
few	O
laboratories	O
as	O
possible	O
handling	O
the	O
virus	O
.	O

At	O
the	O
same	O
time	O
,	O
he	O
said	O
he	O
will	O
be	O
able	O
to	O
advocate	O
most	O
effectively	O
for	O
the	O
program	O
to	O
give	O
it	O
greater	O
visibility	O
,	O
which	O
could	O
lead	O
to	O
more	O
funding	O
.	O

In	O
September	O
2014	O
,	O
it	O
was	O
estimated	O
that	O
the	O
affected	O
countries'	O
capacity	O
for	O
treating	O
Ebola	O
patients	O
was	O
insufficient	O
by	O
the	O
equivalent	O
of	O
2,122	O
beds	O
;	O
however	O
,	O
by	O
December	O
2014	O
there	O
were	O
enough	O
beds	O
to	O
treat	O
and	O
isolate	O
all	O
reported	O
cases	O
,	O
although	O
the	O
uneven	O
distribution	O
of	O
cases	O
was	O
resulting	O
in	O
serious	O
shortfalls	O
in	O
some	O
areas	O
.	O

Movies	O
have	O
been	O
made	O
about	O
this	O
place	O
saving	O
the	O
world	O
.	O

The	O
contract	O
is	O
on	O
behalf	O
of	O
the	O
U.S.	B-Organization
Naval	I-Organization
Medical	I-Organization
Research	I-Organization
Unit-No.	I-Organization
3	E-Organization
(	O
NAMRU-3	S-Organization
)	O
,	O
which	O
conducts	O
research	O
and	O
surveillance	O
to	O
support	O
military	O
personnel	O
deployed	O
to	O
Africa	S-Location
,	O
the	O
Middle	B-Location
East	E-Location
,	O
and	O
.	O

When	O
smallpox	S-Pathogen
was	O
eradicated	O
,	O
there	O
was	O
a	O
global	O
agreement	O
to	O
identify	O
any	O
existing	O
sample	O
and	O
to	O
either	O
destroy	O
it	O
or	O
send	O
it	O
to	O
one	O
of	O
two	O
laboratories	O
.	O

The	O
university	O
was	O
found	O
not	O
guilty	O
of	O
causing	O
's	O
death	O
.	O

The	O
Man	O
Who	O
Ended	O
History:	O
A	O
Documentary	O
(2011)	O
,	O
a	O
novella	O
published	O
in	O
The	O
Paper	O
Menagerie	O
book	O
by	O
American	O
writer	O
and	O
Chinese	O
translator	O
Ken	B-Person
Liu	E-Person
A	O
scientific	O
discovery	O
allows	O
a	O
victim's	O
descendant	O
to	O
go	O
back	O
in	O
time	O
to	O
witness	O
and	O
learn	O
the	O
truth	O
about	O
the	O
atrocities	O
committed	O
in	O
the	O
unit	O
.	O

Our	O
next	O
question	O
comes	O
from	O
Helen	B-Person
Branswell	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

However	O
,	O
the	O
uses	O
of	O
for	O
pharma	O
and	O
biotech	O
companies	O
are	O
almost	O
limitless	O
,	O
and	O
should	O
deserve	O
further	O
attention	O
from	O
funding	O
agencies	O
and	O
investors	O
as	O
well	O
as	O
media	O
.	O

In	O
the	O
fall	O
of	O
2001	O
,	O
these	O
warnings	O
took	O
on	O
a	O
new	O
urgency	O
.	O

Similarly	O
,	O
Green	S-Person
has	O
argued	O
that	O
greater	O
attention	O
is	O
needed	O
to	O
the	O
range	O
of	O
(especially	O
non-commensal)	O
animals	O
that	O
might	O
be	O
involved	O
in	O
the	O
transmission	O
of	O
.	O

The	O
outcome	O
of	O
the	O
infection	O
is	O
dependent	O
on	O
the	O
properties	O
of	O
the	O
pathogen	O
(virulence	O
,	O
invasiveness	O
,	O
toxic	O
or	O
allergenic	S-Disease
effects)	O
but	O
also	O
upon	O
the	O
host	O
immunity	O
status	O
.	O

This	O
image	O
weighting	O
is	O
useful	O
for	O
detecting	O
edema	S-Phenotype
and	O
inflammation	S-Phenotype
,	O
revealing	O
,	O
and	O
assessing	O
zonal	O
anatomy	O
in	O
the	O
prostate	O
and	O
uterus	O
.	O

Michael	B-Person
Pentella	E-Person
PhD	O
,	O
is	O
Director	O
of	O
the	O
Bureau	B-Organization
of	I-Organization
Laboratory	I-Organization
Sciences	E-Organization
at	O
the	O
Hinton	B-Organization
State	I-Organization
Laboratory	I-Organization
Institute	E-Organization
,	O
Commonwealth	O
of	O
Massachusetts	S-Location
.	O
He	O
previously	O
served	O
as	O
the	O
Associate	O
Director	O
of	O
the	O
Iowa	B-Organization
state	I-Organization
public	I-Organization
health	I-Organization
laboratory	E-Organization
and	O
as	O
Clinical	O
Associate	O
Professor	O
at	O
the	O
College	B-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
,	O
University	B-Organization
of	I-Organization
Iowa	E-Organization
.Dr.	O
has	O
more	O
than	O
30	O
years	O
of	O
experience	O
in	O
clinical	O
and	O
public	O
health	O
laboratories	O
and	O
is	O
board	O
certified	O
in	O
medical	O
microbiology	O
and	O
infection	O
control	O
.	O

Greece	S-Location
France	S-Location
and	O
have	O
high	O
prescribing	O
rates	O
of	O
more	O
than	O
28	O
DDD	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	S-Organization
established	O
an	O
(ELSW)	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
Federal	O
Select	O
Agent	O
Program	O
.	O

Because	O
of	O
increased	O
susceptibility	O
of	O
fetuses	O
to	O
radiation	O
exposure	O
,	O
the	O
radiation	O
dosage	O
of	O
a	O
CT	B-Phenotype
scan	E-Phenotype
is	O
an	O
important	O
consideration	O
in	O
the	O
choice	O
of	O
medical	O
imaging	O
in	O
pregnancy	O
.	O

The	O
main	O
obstacles	O
to	O
teaching	O
a	O
laboratory	O
course	O
on	O
animal	O
viruses	O
are	O
the	O
requirements	O
for	O
highly	O
trained	O
instructors	O
and	O
adequate	O
facilities	O
,	O
including	O
biological	O
hoods	O
in	O
aseptic	O
rooms	O
.	O

At	O
10pm	O
she	O
was	O
on	O
her	O
way	O
to	O
Catherine-de-Barnes	B-Organization
Isolation	I-Organization
Hospital	E-Organization
near	O
Solihull	S-Location
.	O
By	O
11pm	O
all	O
her	O
close	O
contacts	O
,	O
including	O
her	O
parents	O
,	O
were	O
placed	O
in	O
quarantine	O
.	O

Supply	O
could	O
now	O
change	O
with	O
demand	O
,	O
and	O
costs	O
dropped	O
.	O

Enhanced	O
Potential	O
Pandemic	O
Pathogens	O
(PPPs)	O
experiments	O
are	O
legal	O
in	O
the	O
.	O

On	O
10	O
July	O
,	O
it	O
was	O
announced	O
that	O
the	O
countries	O
most	O
affected	O
by	O
the	O
Ebola	B-Disease
epidemic	E-Disease
would	O
receive	O
$3.4	O
billion	O
to	O
rebuild	O
their	O
economies	O
.	O

The	O
Nuclear	B-Organization
Threat	I-Organization
Initiative	E-Organization
(	O
NTI	S-Organization
)	O
launched	O
an	O
advisory	O
group	O
for	O
its	O
recently	O
expanded	O
.	O

On	O
31	O
January	O
,	O
China	S-Location
announced	O
the	O
fourth	O
case	O
of	O
SARS	S-Disease
as	O
a	O
40-year-old	O
doctor	O
from	O
the	O
southern	O
city	O
of	O
Guangzhou	S-Location
,	O
and	O
gave	O
his	O
family	O
name	O
as	O
.	O
He	O
was	O
discharged	O
when	O
the	O
announcement	O
was	O
made	O
.	O

During	O
PRESAGED	S-Technology
development	O
,	O
all	O
of	O
the	O
test	O
subjects	O
did	O
eventually	O
display	O
overt	O
symptoms	O
of	O
disease	O
,	O
primarily	O
fever.	O
was	O
able	O
to	O
consistently	O
warn	O
of	O
possible	O
viral	O
or	O
bacterial	O
exposure	O
more	O
than	O
two	O
days	O
before	O
fever	O
developed	O
in	O
almost	O
all	O
animals	O
.	O

The	O
Soviet	B-Organization
Union	E-Organization
continued	O
research	O
and	O
production	O
of	O
offensive	O
biological	O
weapons	O
in	O
a	O
program	O
called	O
Biopreparat	S-Scientific_research_project
,	O
despite	O
having	O
signed	O
the	O
convention	O
.	O

Sheela's	O
Green	O
Card	O
was	O
revoked	O
;	O
she	O
moved	O
to	O
.	O

A	O
New	O
Gene	O
Editing	O
Tool	O
Could	O
Make	O
CRISPR	S-Technology
More	O
Precise	O
.	O

I	O
know	O
that	O
you've	O
said	O
this	O
,	O
but	O
each	O
team	O
there	O
was	O
,	O
I	O
guess	O
,	O
incident	O
,	O
why	O
were	O
there	O
-	O
how	O
could	O
this	O
have	O
happened	O
at	O
the	O
that	O
all	O
these	O
agents	O
were	O
released	O
in	O
the	O
last	O
decade?	O

Covert	S-Person
,	O
Norman	B-Person
M	E-Person
.	O
(2000)	O
,	O
"	O
A	O
History	O
of	O
Fort	B-Location
Detrick	E-Location
,	O
"	O
,	O
4th	O
Edition:	O
2000	O
.	O

A	O
male	O
and	O
female	O
,	O
one	O
infected	O
with	O
syphilis	O
,	O
would	O
be	O
brought	O
together	O
in	O
a	O
cell	O
and	O
forced	O
into	O
sex	O
with	O
each	O
other	O
.	O

There	O
is	O
a	O
higher	O
risk	O
of	O
mortality	O
in	O
those	O
who	O
are	O
female	O
,	O
elderly	O
or	O
in	O
poor	O
health	O
,	O
usually	O
secondary	O
to	O
either	O
anaphylaxis	S-Phenotype
or	O
.	O

President	O
Bush	S-Person
cited	O
the	O
non-cooperation	O
with	O
inspectors	O
as	O
a	O
major	O
justification	O
for	O
military	O
action	O
.	O

In	O
Europe	S-Location
where	O
more	O
gadolinium-containing	O
agents	O
are	O
available	O
,	O
a	O
classification	O
of	O
agents	O
according	O
to	O
potential	O
risks	O
has	O
been	O
released	O
.	O

New	O
trends	O
illustrate	O
a	O
greater	O
appreciation	O
of	O
a	O
strong	O
need	O
for	O
a	O
cooperative	O
partnership	O
.	O

However	O
,	O
at	O
a	O
congressional	O
hearing	O
on	O
19	O
November	O
,	O
the	O
Director	O
of	O
the	O
CDC	S-Organization
said	O
that	O
the	O
number	O
of	O
cases	O
was	O
no	O
longer	O
expected	O
to	O
exceed	O
1	O
million	O
,	O
moving	O
away	O
from	O
the	O
worst-case	O
scenario	O
that	O
had	O
been	O
previously	O
predicted	O
.	O

If	O
the	O
rate	O
is	O
less	O
than	O
1	O
,	O
the	O
infection	O
dies	O
out	O
;	O
if	O
it	O
is	O
greater	O
than	O
1	O
,	O
the	O
infection	O
continues	O
to	O
spread-with	O
exponential	O
growth	O
in	O
the	O
number	O
of	O
cases	O
.	O

According	O
to	O
a	O
September	O
2018	O
Lancet	O
survey	O
,	O
25%	O
of	O
respondents	O
in	O
Beni	S-Location
and	O
Butembo	S-Location
believed	O
the	O
outbreak	O
to	O
be	O
a	O
hoax	O
.	O

I	O
dare	O
to	O
suspect	O
that	O
direct	O
therapeutic	O
approaches	O
of	O
CRISPR/Cas9	S-Technology
are	O
probably	O
the	O
mainstream	O
of	O
investment	O
in	O
gene	O
therapy	O
,	O
especially	O
in	O
academia	O
.	O

Contaminated	O
waste	O
,	O
the	O
records	O
said	O
,	O
was	O
stored	O
in	O
barrels	S-Equipment
with	O
locking	O
lids	O
.	O

The	O
U.S.	S-Location
delegation	O
was	O
led	O
by	O
HHS	S-Organization
Deputy	O
Secretary	O
Eric	B-Person
Hargan	E-Person
,	O
who	O
reaffirmed	O
U.S.	S-Location
support	O
for	O
GHSA	S-International_exchange_and_cooperation
and	O
underscored	O
the	O
goal	O
to	O
prevent	O
,	O
detect	O
,	O
and	O
respond	O
to	O
infectious	O
diseases	O
.	O

This	O
was	O
done	O
by	O
infecting	O
salad	O
bars	O
in	O
11	O
restaurants	O
,	O
produce	O
in	O
grocery	O
stores	O
,	O
doorknobs	O
,	O
and	O
other	O
public	O
domains	O
with	O
Salmonella	B-Pathogen
typhimurium	I-Pathogen
bacteria	E-Pathogen
in	O
the	O
city	O
of	O
The	O
Dalles	S-Location
,	O
Oregon	S-Location
.	O
The	O
attack	O
infected	O
751	O
people	O
with	O
severe	O
food	B-Disease
poisoning	E-Disease
.	O
There	O
were	O
no	O
fatalities	O
.	O

Agri	O
News	O
editorialists	O
were	O
against	O
relocating	O
the	O
facility	O
from	O
Plum	B-Location
Island	E-Location
when	O
it	O
was	O
proposed	O
and	O
remain	O
skeptical	O
that	O
the	O
move	O
is	O
in	O
the	O
best	O
interest	O
of	O
farmers	O
.	O

Zilinskas	S-Person
(1997)	O
,	O
Op.cit.	O
.	O

For	O
the	O
time	O
being	O
,	O
insecticide-treated	O
mosquito	O
nets	O
and	O
insecticide	O
sprays	O
are	O
used	O
to	O
prevent	O
the	O
spread	O
of	O
,	O
as	O
are	O
antimalarial	O
drugs	O
–	O
particularly	O
to	O
vulnerable	O
people	O
such	O
as	O
pregnant	O
women	O
and	O
young	O
children	O
.	O

According	O
to	O
the	O
21	O
January	O
2015	O
WHO	S-Organization
Situation	O
Report	O
,	O
the	O
case	O
incidence	O
was	O
rapidly	O
decreasing	O
in	O
Sierra	B-Location
Leone	E-Location
.	O
However	O
,	O
in	O
February	O
and	O
March	O
reports	O
indicated	O
a	O
rise	O
again	O
in	O
the	O
number	O
of	O
cases	O
.	O

USAMRIID	S-Organization
can	O
also	O
resume	O
full	O
operational	O
status	O
as	O
part	O
of	O
the	O
,	O
which	O
is	O
a	O
network	O
of	O
three	O
laboratories	O
that	O
can	O
determine	O
what	O
an	O
unknown	O
material	O
is	O
.	O

The	O
should	O
prove	O
to	O
be	O
a	O
useful	O
starting	O
point	O
for	O
diverse	O
bibliometric	O
studies	O
of	O
publications	O
in	O
this	O
area	O
.	O

David	B-Person
Relman	E-Person
MD	O
,	O
is	O
Merigan	O
Professor	O
in	O
the	O
Departments	B-Organization
of	I-Organization
Medicine	I-Organization
and	I-Organization
Microbiology	I-Organization
and	I-Organization
Immunology	E-Organization
at	O
Stanford	B-Organization
University	E-Organization
and	O
Chief	O
of	O
Infectious	O
Diseases	O
at	O
the	O
VA	B-Platform
Palo	I-Platform
Alto	I-Platform
Health	I-Platform
Care	I-Platform
System	E-Platform
.	O
He	O
is	O
a	O
member	O
of	O
the	O
National	B-Organization
Science	I-Organization
Advisory	I-Organization
Board	I-Organization
for	I-Organization
Biosecurity	E-Organization
;	O
a	O
member	O
of	O
the	O
Science	O
,	O
Technology	B-Organization
and	I-Organization
Engineering	I-Organization
Advisory	I-Organization
Panel	I-Organization
for	I-Organization
Lawrence	I-Organization
Livermore	I-Organization
National	I-Organization
Laboratory	E-Organization
;	O
Chair	O
of	O
the	O
Forum	O
on	O
Microbial	O
Threats	O
at	O
the	O
Institute	O
of	O
Medicine	O
;	O
and	O
Immediate	O
Past	O
President	O
of	O
the	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
.Dr	O
.	O

For	O
instance	O
,	O
if	O
gene	O
therapy	O
in	O
humans	O
is	O
acceptable	O
to	O
cure	O
disease	O
,	O
where	O
do	O
you	O
draw	O
the	O
line?	O
Among	O
disease-associated	O
gene	O
mutations	O
,	O
some	O
come	O
with	O
virtual	O
certainty	O
of	O
premature	O
death	O
,	O
while	O
others	O
put	O
you	O
at	O
higher	O
risk	O
for	O
something	O
like	O
Alzheimer's	S-Disease
,	O
but	O
don't	O
guarantee	O
you'll	O
get	O
the	O
disease	O
.	O

Anthrax	S-Pathogen
is	O
one	O
of	O
the	O
few	O
biological	O
agents	O
that	O
federal	O
employees	O
have	O
been	O
vaccinated	O
for	O
.	O

In	O
addition	O
to	O
concern	O
for	O
transmission	O
from	O
human‐derived	O
material	O
,	O
research	O
materials	O
derived	O
from	O
animals	O
should	O
be	O
evaluated	O
for	O
the	O
presence	O
of	O
agents	O
capable	O
of	O
infecting	O
humans	O
.	O

Our	O
fight	O
against	O
this	O
outbreak	O
is	O
not	O
finished	O
until	O
we	O
get	O
to	O
zero	O
cases	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here:	O

Based	O
on	O
these	O
investigations	O
,	O
CDC	S-Organization
will	O
take	O
appropriate	O
action	O
in	O
the	O
laboratory	O
where	O
best	O
safety	O
practices	O
were	O
not	O
followed	O
,	O
as	O
well	O
as	O
any	O
actions	O
indicated	O
for	O
all	O
laboratories	O
that	O
work	O
with	O
dangerous	O
microbes	O
at	O
,	O
and	O
will	O
consider	O
broader	O
implications	O
for	O
laboratory	O
safety	O
.	O

In	O
that	O
case	O
,	O
a	O
tear	O
was	O
discovered	O
in	O
the	O
,	O
records	O
show	O
.	O

Parts	O
of	O
the	O
1981	O
US	B-Organization
Army	E-Organization
report	O
such	O
as	O
the	O
"	O
Mass	O
production	O
of	O
have	O
not	O
been	O
declassified	O
,	O
potentially	O
meaning	O
that	O
the	O
project	O
is	O
still	O
ongoing	O
.	O

"	O
We	O
will	O
have	O
to	O
scale	O
its	O
global	O
health	O
security	O
portfolio	O
to	O
focus	O
efforts	O
based	O
on	O
existing	O
resources,	O
"	O
wrote	O
Rebecca	B-Person
Martin	E-Person
PhD	O
,	O
director	O
of	O
the	O
CDC's	B-Organization
Center	I-Organization
for	I-Organization
Global	I-Organization
Health	E-Organization
in	O
an	O
email	O
to	O
U.S.	S-Location
and	O
overseas	O
leaders	O
in	O
its	O
,	O
according	O
to	O
The	O
Wall	O
Street	O
Journal.	O
"	O
Faced	O
with	O
this	O
anticipated	O
fiscal	O
reality	O
,	O
we	O
have	O
had	O
to	O
make	O
some	O
very	O
difficult	O
decisions.	O
"	O

Tularemia	S-Disease
also	O
known	O
as	O
Rabbit	B-Disease
Fever	E-Disease
,	O
is	O
classified	O
as	O
a	O
bioterrorism	O
agent	O
and	O
was	O
developed	O
in	O
the	O
past	O
as	O
such	O
by	O
the	O
US	S-Location
.	O
However	O
,	O
the	O
Pentagon	S-Organization
's	O
research	O
on	O
tularemia	S-Disease
continues	O
,	O
as	O
well	O
as	O
on	O
possible	O
vectors	O
of	O
the	O
bacteria	O
such	O
as	O
ticks	O
and	O
rodents	O
which	O
cause	O
the	O
disease	O
.	O

Some	O
experts	O
said	O
the	O
pattern	O
is	O
as	O
illogical	O
as	O
it	O
is	O
frustrating	O
.	O

Big	O
data	O
analytics	O
on	O
cellphone	O
data	O
,	O
facial	O
recognition	O
technology	O
,	O
mobile	O
phone	O
tracking	O
,	O
and	O
artificial	O
intelligence	O
are	O
used	O
to	O
track	O
infected	O
people	O
and	O
people	O
whom	O
they	O
contacted	O
in	O
South	B-Location
Korea	E-Location
Taiwan	S-Location
,	O
and	O
Singapore	S-Location
.	O
In	O
March	O
2020	O
,	O
the	O
Israeli	B-Organization
government	E-Organization
enabled	O
security	O
agencies	O
to	O
track	O
mobile	O
phone	O
data	O
of	O
people	O
supposed	O
to	O
have	O
coronavirus	O
.	O

The	O
State	B-Organization
Council	E-Organization
declared	O
a	O
day	O
of	O
mourning	O
to	O
begin	O
with	O
a	O
national	O
three-minute	O
moment	O
of	O
silence	O
on	O
4April	O
,	O
coinciding	O
with	O
Qingming	O
Festival	O
,	O
although	O
the	O
central	O
government	O
asked	O
families	O
to	O
pay	O
their	O
respects	O
online	O
in	O
observance	O
of	O
physical	O
distancing	O
to	O
avoid	O
a	O
renewed	O
COVID-19	B-Incident
outbreak	E-Incident
.	O
On	O
25	O
April	O
the	O
last	O
patients	O
were	O
discharged	O
in	O
Wuhan	S-Location
.	O
On	O
13	O
May	O
the	O
city	O
of	O
was	O
put	O
on	O
lockdown	O
,	O
sparking	O
fear	O
of	O
a	O
second	O
wave	O
of	O
infection	O
.	O

A	O
number	O
of	O
experimental	O
treatments	O
are	O
undergoing	O
clinical	O
trials	O
.	O

They	O
argued	O
that	O
between	O
4.0	O
and	O
9.	O
5	O
million	O
people	O
died	O
in	O
China	S-Location
,	O
but	O
this	O
total	O
was	O
based	O
purely	O
on	O
the	O
assumption	O
that	O
the	O
death	O
rate	O
there	O
was	O
1.0–2.	O
25	O
per	O
cent	O
in	O
1918	O
,	O
because	O
China	S-Location
was	O
a	O
poor	O
country	O
similar	O
to	O
Indonesia	S-Location
and	O
where	O
the	O
mortality	O
rate	O
was	O
of	O
that	O
order	O
.	O

The	O
system	O
not	O
only	O
monitors	O
infected	O
persons	O
,	O
but	O
attempts	O
to	O
discern	O
the	O
origin	O
of	O
the	O
outbreak	O
.	O

Based	O
on	O
an	O
internal	O
review	O
called	O
for	O
by	O
the	O
CDC	S-Organization
Director	O
,	O
the	O
report	O
released	O
today	O
concludes	O
that	O
the	O
scientists'	O
failure	O
to	O
follow	O
an	O
approved	O
,	O
written	O
study	O
plan	O
that	O
met	O
all	O
laboratory	O
safety	O
requirements	O
led	O
to	O
dozens	O
of	O
employees	O
being	O
potentially	O
exposed	O
.	O

It	O
will	O
ask	O
for	O
an	O
inventory	O
and	O
scrutiny	O
of	O
safety	O
practices	O
.	O

Biological	O
agent	O
biodefense	O
categorization	O
is	O
not	O
as	O
common	O
as	O
laboratory	O
biosafety	O
categorization	O
,	O
mainly	O
having	O
been	O
defined	O
by	O
the	O
US	B-Organization
CDC	E-Organization
the	O
EU	S-Location
and	O
Russia	S-Location
.	O
Unlike	O
laboratory	O
biosafety	O
criteria	O
,	O
not	O
all	O
agents	O
are	O
divided	O
into	O
four	O
groups	O
.	O

The	O
E99	O
was	O
the	O
first	O
workable	O
design	O
,	O
but	O
was	O
too	O
complex	O
to	O
be	O
manufactured	O
.	O

The	O
vaccine	O
had	O
also	O
reduced	O
mortality	O
among	O
those	O
who	O
were	O
infected	O
after	O
vaccination	O
.	O

But	O
more	O
will	O
be	O
needed	O
later	O
;	O
the	O
new	O
high	O
containment	O
continuity	O
laboratory	O
,	O
as	O
it	O
is	O
called	O
,	O
would	O
be	O
built	O
on	O
the	O
site	O
of	O
one	O
of	O
only	O
a	O
few	O
parking	O
facilities	O
on	O
the	O
CDC	S-Organization
main	O
campus	O
.	O

In	O
2016	O
,	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Laboratories	E-Organization
(APHL)	O
had	O
a	O
presentation	O
at	O
their	O
annual	O
meeting	O
focused	O
on	O
improving	O
biosafety	O
culture	O
.	O
This	O
same	O
year	O
,	O
issued	O
a	O
case	O
study	O
report	O
including	O
reviews	O
of	O
ten	O
different	O
nations’	O
current	O
biosafety	O
regulations	O
,	O
including	O
the	O
United	O
States	O
.	O

From	O
left	O
,	O
Ken	B-Person
Bayles	E-Person
Ph.D.	O
,	O
of	O
UNMC	S-Organization
;	O
Mark	B-Person
Riley	E-Person
,	O
Ph.D.	O
,	O
of	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	E-Organization
;	O
and	O
Harshini	B-Person
Mukundan	E-Person
,	O
Ph.D.	O
,	O
of	O
.	O

Total	O
commitment	O
at	O
all	O
levels	O
of	O
the	O
population	O
is	O
the	O
only	O
solution	O
.	O

Two	O
laboratories	O
,	O
one	O
at	O
CDC	S-Organization
and	O
the	O
other	O
at	O
the	O
Michigan	B-Organization
Department	I-Organization
of	I-Organization
Community	I-Organization
Health	E-Organization
,	O
conducted	O
experiments	O
to	O
determine	O
the	O
effectiveness	O
of	O
the	O
formic	O
acid/acetonitrile	O
protein	O
extraction	O
procedure	O
for	O
inactivating	O
B.	B-Pathogen
anthracis	E-Pathogen
.	O
Both	O
laboratories	O
found	O
that	O
the	O
extraction	O
procedure	O
completely	O
inactivated	O
preparations	O
of	O
B.	B-Pathogen
anthracis	I-Pathogen
cells	E-Pathogen
after	O
10	O
minutes	O
.	O

Some	O
of	O
Unit	B-Organization
731	E-Organization
satellite	O
(branch)	O
facilities	O
are	O
in	O
still	O
use	O
by	O
various	O
Chinese	O
industrial	O
companies	O
.	O

The	O
aim	O
of	O
FBD	S-Platform
was	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
laboratories	O
through	O
harmonization	O
.	O

The	O
second	O
patient	O
is	O
said	O
to	O
be	O
in	O
a	O
good	O
condition	O
.	O

Once	O
subjected	O
to	O
steam	O
sterilization	O
,	O
where	O
it	O
is	O
super-heated	O
to	O
about	O
250	O
degrees	O
Fahrenheit	O
for	O
20	O
minutes	O
,	O
the	O
liquid	O
can	O
then	O
be	O
treated	O
as	O
normal	O
wastewater	O
.	O

When	O
the	O
slice	O
thickness	O
is	O
also	O
factored	O
in	O
,	O
the	O
unit	O
is	O
known	O
as	O
a	O
Voxel	O
,	O
which	O
is	O
a	O
three-dimensional	O
unit	O
.	O

The	O
pandemic	O
reached	O
them	O
from	O
New	B-Location
Zealand	E-Location
,	O
which	O
was	O
too	O
slow	O
to	O
implement	O
measures	O
to	O
prevent	O
ships	O
,	O
such	O
as	O
the	O
SS	O
Talune	O
,	O
carrying	O
the	O
flu	S-Disease
from	O
leaving	O
its	O
ports	O
.	O

Let's	O
go	O
to	O
the	O
phone	O
.	O

Health	O
agencies	O
,	O
for	O
instance	O
,	O
would	O
be	O
able	O
to	O
respond	O
immediately	O
to	O
emergencies	O
rather	O
than	O
being	O
required	O
first	O
to	O
ask	O
for	O
federal	O
funding	O
.	O

While	O
reference	O
will	O
be	O
made	O
to	O
EU	S-Location
regulations	O
,	O
the	O
underlying	O
principles	O
of	O
biosafety	O
and	O
risk	O
assessment	O
are	O
generic	O
to	O
most	O
countries	O
.	O

The	O
agency	O
will	O
also	O
continue	O
its	O
global	O
vaccination	O
programs	O
and	O
keep	O
up	O
current	O
efforts	O
to	O
track	O
and	O
combat	O
HIV	S-Pathogen
,	O
tuberculosis	S-Disease
,	O
malaria	S-Disease
and	O
.	O

On	O
10	O
January	O
,	O
a	O
restaurant	O
worker	O
in	O
Guangdong	S-Location
was	O
confirmed	O
as	O
the	O
second	O
wild	O
source	O
SARS	S-Disease
since	O
the	O
outbreak	O
was	O
contained	O
.	O

On	O
10	O
April	O
,	O
Jim	B-Person
Hughes	E-Person
the	O
head	O
of	O
infectious	O
disease	O
at	O
the	O
CDC	S-Organization
,	O
confirming	O
the	O
warnings	O
of	O
Hong	O
Kong	O
health	O
officials	O
,	O
claimed	O
that	O
he	O
believed	O
that	O
SARS	S-Disease
could	O
no	O
longer	O
be	O
eradicated	O
in	O
the	O
Far	B-Location
East	E-Location
.	O
However	O
,	O
he	O
remained	O
hopeful	O
that	O
it	O
could	O
be	O
prevented	O
from	O
spreading	O
widely	O
in	O
North	B-Location
America	E-Location
.	O
Sars	B-Disease
illness	E-Disease
'not	O
under	O
control'	O
11	O
April	O
2003	O
,	O
bbc.co.uk	O
.	O

Though	O
the	O
program	O
was	O
successful	O
in	O
meeting	O
its	O
development	O
goals	O
,	O
the	O
lack	O
of	O
validation	O
on	O
the	O
infectivity	O
of	O
anthrax	S-Pathogen
stalled	O
standardization	O
.	O

SIGMA+	S-Scientific_research_project
will	O
use	O
a	O
common	O
network	O
infrastructure	O
and	O
mobile	O
sensing	O
strategy	O
,	O
a	O
concept	O
that	O
was	O
proven	O
effective	O
in	O
the	O
SIGMA	S-Scientific_research_project
program	O
.	O

An	O
agreement	O
was	O
signed	O
with	O
the	O
US	S-Location
and	O
UK	S-Organization
promising	O
to	O
end	O
bio-weapons	O
programs	O
and	O
convert	O
BW	O
facilities	O
to	O
benevolent	O
purposes	O
,	O
but	O
compliance	O
with	O
the	O
agreement	O
-	O
and	O
the	O
fate	O
of	O
the	O
bio-agents	O
and	O
facilities	O
-	O
is	O
still	O
mostly	O
undocumented	O
.	O

This	O
has	O
led	O
some	O
historians	O
to	O
label	O
the	O
a	O
"	O
forgotten	O
pandemic"	O
.	O

Some	O
of	O
the	O
key	O
uses	O
for	B-Technology
CT	I-Technology
scanning	E-Technology
have	O
been	O
flaw	O
detection	O
,	O
failure	O
analysis	O
,	O
metrology	O
,	O
assembly	O
analysis	O
,	O
image-based	O
finite	O
element	O
methods	O
and	O
reverse	O
engineering	O
applications.	O
is	O
also	O
employed	O
in	O
the	O
imaging	O
and	O
conservation	O
of	O
museum	O
artifacts	O
.	O

As	O
a	O
result	O
of	O
lapses	B-Incident
in	I-Incident
biosafety	I-Incident
practices	I-Incident
that	I-Incident
were	I-Incident
discovered/came	I-Incident
to	I-Incident
light	I-Incident
in	I-Incident
the	I-Incident
summer	I-Incident
of	I-Incident
2014	E-Incident
,	O
Assistant	O
to	O
the	O
President	O
for	O
Homeland	O
Security	O
and	O
Counterterrorism	O
Lisa	B-Person
Monaco	E-Person
and	O
Assistant	O
to	O
the	O
President	O
for	O
Science	O
and	O
Technology	O
John	B-Person
Holdren	E-Person
issued	O
on	O
August	O
18	O
,	O
2014	O
a	O
memorandum	O
,	O
entitled	O
,	O
"	O
Enhancing	B-Document
Biosafety	I-Document
and	I-Document
Biosecurity	I-Document
in	I-Document
the	I-Document
United	I-Document
States	E-Document
,	O
"	O
which	O
urged	O
all	O
Government	O
departments	O
and	O
agencies	O
that	O
work	O
with	O
infectious	O
agents	O
to	O
take	O
immediate	O
and	O
long-term	O
steps	O
to	O
enhance	O
safety	O
and	O
security	O
of	O
research	O
to	O
minimize	O
the	O
potential	O
for	O
future	O
incidents	O
.	O

You	O
talked	O
about	O
your	O
personal	O
reaction	O
earlier	O
.	O

They	O
can	O
be	O
divided	O
in	O
mono-	O
and	O
multi-material	O
methods	O
.	O

The	O
infrastructure	O
and	O
also	O
training	O
programs	O
for	O
researchers	O
have	O
to	O
be	O
funded	O
in	O
respect	O
to	O
a	O
long-term	O
horizon	O
in	O
order	O
to	O
preserve	O
data	O
and	O
to	O
make	O
it	O
available	O
for	O
possible	O
future	O
investigations	O
.	O

Flu	O
viruses	O
are	O
spread	O
mainly	O
from	O
person	O
to	O
person	O
through	O
coughing	S-Phenotype
or	O
by	O
people	O
with	O
influenza	O
.	O

To	O
create	O
a	O
T2-weighted	O
image	O
,	O
magnetization	O
is	O
allowed	O
to	O
decay	O
before	O
measuring	O
the	O
MR	O
signal	O
by	O
changing	O
the	O
echo	O
time	O
(TE)	O
.	O

N95	B-Equipment
respirators	E-Equipment
are	O
approved	O
for	O
industrial	O
settings	O
but	O
the	O
FDA	S-Organization
has	O
authorised	O
the	O
masks	O
for	O
use	O
under	O
an	O
emergency	O
use	O
authorization	O
(EUA)	O
.	O

The	O
experimental	O
Flettner	O
rotor	O
bomblet	O
was	O
also	O
developed	O
during	O
this	O
time	O
period	O
.	O

South	B-Location
Korea	E-Location
the	O
highest	O
level	O
of	O
alert	O
on	O
23	O
February	O
2020	O
.	O

In	O
addition	O
,	O
the	O
agency	O
will	O
develop	O
plans	O
to	O
ensure	O
that	O
all	O
medically	O
important	O
drugs	O
used	O
in	O
animal	O
water	O
and	O
feed	O
have	O
defined	O
duration	O
of	O
use	O
.	O

We	O
wish	O
that	O
research	O
of	O
this	O
type	O
and	O
organisms	O
of	O
this	O
type	O
didn't	O
have	O
to	O
be	O
studied	O
at	O
CDC	S-Organization
But	O
given	O
the	O
world	O
we	O
live	O
in	O
,	O
they	O
continue	O
to	O
spread	O
in	O
nature	O
and	O
make	O
people	O
sick	O
and	O
kill	O
them	O
.	O

The	O
past	O
10	O
years	O
have	O
seen	O
major	O
qualitative	O
breakthroughs	O
,	O
such	O
as	O
the	O
use	O
of	O
the	O
gene	O
editing	O
tool	O
Crispr	S-Technology
to	O
efficiently	O
insert	O
new	O
genetic	O
sequences	O
into	O
a	O
genome	O
,	O
and	O
the	O
use	O
of	O
to	O
efficiently	O
replace	O
populations	O
of	O
natural	O
organisms	O
in	O
the	O
wild	O
with	O
genetically	O
modified	O
versions	O
.	O

As	O
per	O
the	O
IRB	O
protocol	O
,	O
respondents	O
were	O
required	O
to	O
agree	O
to	O
take	O
the	O
survey	O
once	O
they	O
understood	O
any	O
potential	O
harm	O
by	O
participating	O
before	O
they	O
could	O
proceed	O
to	O
the	O
questions	O
within	O
.	O

While	O
researchers	O
might	O
see	O
the	O
engineering	B-Technology
of	I-Technology
a	I-Technology
supercharged	I-Technology
flu	I-Technology
virus	E-Technology
as	O
a	O
perfectly	O
reasonable	O
way	O
to	O
better	O
understand	O
and	O
thus	O
fight	O
the	O
flu	O
,	O
the	O
public	O
might	O
see	O
the	O
drawbacks	O
as	O
equally	O
obvious:	O
the	O
virus	O
could	O
escape	O
,	O
or	O
someone	O
could	O
weaponize	O
the	O
research	O
.	O

From	O
Italy	S-Location
the	O
disease	O
spread	O
northwest	O
across	O
Europe	S-Location
,	O
striking	O
France	S-Location
,	O
Spain	S-Location
(which	O
was	O
hit	O
due	O
to	O
the	O
heat	O
–	O
the	O
epidemic	O
raged	O
in	O
the	O
early	O
weeks	O
of	O
July)	O
,	O
Portugal	S-Location
and	O
England	S-Location
by	O
June	O
1348	O
,	O
then	O
spread	O
east	O
and	O
north	O
through	O
Germany	S-Location
,	O
Scotland	S-Location
and	O
Scandinavia	S-Location
from	O
1348	O
to	O
1350	O
.	O

Individual	O
scientists	O
have	O
also	O
expressed	O
support	O
for	O
codes	O
of	O
conduct	O
,	O
most	O
notably	O
Margaret	B-Person
Somerville	E-Person
and	O
who	O
published	O
their	O
own	O
code	O
of	O
ethics	O
for	O
the	O
life	O
sciences	O
in	O
a	O
March	O
2005	O
issue	O
of	O
Science	O
.	O

A	O
recuperation	O
in	O
the	O
economy	O
,	O
at	O
the	O
end	O
of	O
the	O
outbreak	O
,	O
was	O
expected	O
to	O
be	O
more	O
rapid	O
in	O
some	O
sectors	O
than	O
in	O
others	O
.	O

Castro	S-Person
et	O
al.	O
and	O
Smedley	S-Person
et	O
al.	O
assess	O
several	O
approaches	O
for	O
integration	O
of	O
functional	O
genomics	O
data	O
.	O

Another	O
study	O
showed	O
that	O
,	O
in	O
Guinea	S-Location
a	O
satisfactory	O
knowledge	O
had	O
not	O
altered	O
the	O
level	O
of	O
comprehensive	O
knowledge	O
about	O
the	O
virus	O
.	O

In	O
2014	O
,	O
incidents	O
with	O
Anthrax	O
and	O
Ebola	O
pathogens	O
in	O
CDC	O
laboratories	O
()	O
,	O
prompted	O
the	O
CDC	S-Organization
director	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
1918	O
sequences	O
have	O
too	O
few	O
amino	O
acid	O
differences	O
from	O
those	O
of	O
wild-bird	B-Pathogen
strains	E-Pathogen
to	O
have	O
spent	O
many	O
years	O
adapting	O
only	O
in	O
a	O
human	O
or	O
swine	O
intermediate	O
host	O
.	O

Ingestion	O
of	O
moldy	O
grains	O
that	O
are	O
contaminated	O
with	O
trichothecenes	S-Pathogen
has	O
been	O
associated	O
with	O
.	O

Estimates	O
of	O
victims	O
are	O
usually	O
extrapolated	O
from	O
figures	O
for	O
the	O
clergy	O
.	O

An	O
intrinsic	O
weakness	O
of	O
the	O
current	O
system	O
of	O
cross-sector	O
collaboration	O
is	O
that	O
it	O
is	O
not	O
underpinned	O
by	O
long-term	O
,	O
ongoing	O
financing	O
.	O

There	O
are	O
various	O
theories	O
of	O
why	O
the	O
Spanish	B-Disease
flu	E-Disease
was	O
"	O
forgotten".	O
The	O
rapid	O
pace	O
of	O
the	O
pandemic	O
,	O
which	O
,	O
for	O
example	O
,	O
killed	O
most	O
of	O
its	O
victims	O
in	O
the	O
United	B-Location
States	E-Location
within	O
less	O
than	O
nine	O
months	O
,	O
resulted	O
in	O
limited	O
media	O
coverage	O
.	O

That	O
means	O
that	O
a	O
big	O
amount	O
of	O
cartilage	O
and	O
a	O
thin	O
layer	O
of	O
compact	O
bone	O
can	O
cause	O
the	O
same	O
attenuation	O
in	O
a	O
voxel	O
as	O
hyperdense	O
cartilage	O
alone	O
.	O

That	O
model	O
doesn't	O
works	O
well	O
for	O
new	O
antibiotics	O
,	O
which	O
are	O
generally	O
kept	O
in	O
reserve	O
until	O
older	O
antibiotics	O
fail	O
.	O

Export	O
controls	O
on	O
biological	O
agents	O
are	O
not	O
applied	O
uniformly	O
providing	O
terrorists	O
a	O
route	O
for	O
acquisition	O
.	O

When	O
the	O
U.S.	B-Scientific_research_project
biological	I-Scientific_research_project
warfare	I-Scientific_research_project
program	E-Scientific_research_project
ended	O
in	O
1969	O
it	O
had	O
developed	O
six	O
mass-produced	O
,	O
battle-ready	O
biological	O
weapons	O
in	O
the	O
form	O
of	O
agents	O
that	O
cause	O
anthrax	S-Disease
,	O
tularemia	S-Disease
,	O
brucellosis	S-Disease
,	O
Q-fever	S-Disease
,	O
VEE	S-Disease
,	O
and	O
botulism	S-Disease
.	O
In	O
addition	O
staphylococcal	B-Pathogen
enterotoxin	I-Pathogen
B	E-Pathogen
was	O
produced	O
as	O
an	O
incapacitating	O
agent	O
.	O

The	O
act	O
also	O
required	O
the	O
departments	O
to	O
periodically	O
report	O
the	O
status	O
of	O
the	O
projects	O
to	O
Congress	S-Organization
and	O
for	O
the	O
GAO	S-Organization
to	O
conduct	O
oversight	O
on	O
the	O
use	O
of	O
the	O
funds	O
.	O

And	O
the	O
root	O
cause	O
fundamentally	O
was	O
that	O
the	O
scientists	O
failed	O
to	O
follow	O
a	O
scientifically	O
derived	O
and	O
reviewed	O
protocol	O
that	O
would	O
have	O
assured	O
that	O
anthrax	S-Pathogen
was	O
inactivated	O
and	O
that	O
the	O
material	O
was	O
confirmed	O
to	O
be	O
before	O
it	O
ever	O
left	O
the	O
lab	O
.	O

The	O
ensuing	O
outbreak	O
of	O
the	O
disease	O
resulted	O
in	O
approximately	O
100	O
deaths	O
,	O
although	O
the	O
exact	O
number	O
of	O
victims	O
remains	O
unknown	O
.	O

Avian	B-Disease
influenza	E-Disease
(	O
H7N9	S-Disease
)	O
.	O

The	O
Pentagon	S-Organization
funded	O
to	O
develop	O
new	O
technology	O
and	O
to	O
profit	O
from	O
vaccines	O
.	O

A	O
national	O
campaign	O
began	O
using	O
the	O
ready	O
rhetoric	O
of	O
war	O
to	O
fight	O
the	O
new	O
enemy	O
of	O
microscopic	O
proportions	O
.	O

It	O
has	O
been	O
cited	O
as	O
the	O
most	O
devastating	O
epidemic	O
in	O
recorded	O
world	O
history	O
.	O

Vero	O
cells	O
were	O
kindly	O
provided	O
by	O
Dr	O
A.	B-Person
Panet	E-Person
()	O
.	O

Biosafety	O
level	O
refers	O
to	O
the	O
stringency	O
of	O
biocontainment	O
precautions	O
deemed	O
necessary	O
by	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
for	O
laboratory	O
work	O
with	O
infectious	O
materials	O
.	O

This	O
new	O
CA	O
can	O
trace	O
cells	O
with	O
unique	O
mRNA	O
,	O
microRNA	O
and	O
virus	O
;	O
tissue	O
response	O
to	O
inflammation	O
in	O
living	O
brains	O
.	O

I	O
wanted	O
to	O
ask	O
about	O
-	O
you	O
had	O
mentioned	O
before	O
that	O
,	O
you	O
know	O
,	O
that	O
the	O
incident	O
that	O
happened	O
in	O
2006	O
was	O
the	O
same	O
lab	O
but	O
with	O
a	O
different	O
set	O
of	O
staff	O
.	O

Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
and	O
Yellow	B-Pathogen
fever	I-Pathogen
virus	E-Pathogen
were	O
included	O
in	O
risk	O
group	O
1	O
of	O
the	O
Chinese	O
biosafety	O
categorization	O
(equivalent	O
to	O
the	O
risk	O
group	O
4	O
according	O
to	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
EU	S-Location
)	O
,	O
but	O
were	O
included	O
in	O
risk	O
group	O
3	O
according	O
to	O
NIH	S-Organization
and	O
EU	S-Location
categorization	O
.	O

"	O
In	O
fact	O
there	O
have	O
been	O
stories	O
of	O
huge	O
volumes	O
of	O
US	S-Location
pork	O
being	O
shipped	O
to	O
already	O
despite	O
those	O
tariffs	O
being	O
in	O
place.	O
"	O

This	O
included	O
a	O
course	O
in	O
project	O
management	O
for	O
all	O
participants	O
,	O
an	O
FBD	B-Document
quality	I-Document
assurance	I-Document
(QA)	I-Document
manual	E-Document
,	O
and	O
a	O
protected	O
(Figure	O
3)	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
will	O
strengthen	O
the	O
results-based	O
planning	O
(collection	O
,	O
data	O
management,)	O
;	O
strengthen	O
resource	O
mobilization	O
and	O
financial	O
sustainability	O
of	O
the	O
national	O
action	O
plan	O
to	O
overcome	B-Incident
transmitted	I-Incident
rabies	E-Incident
advocate	O
for	O
the	O
national	O
ownership	O
of	O
the	O
and	O
improve	O
monitoring	O
,	O
evaluation	O
,	O
surveillance	O
and	O
research	O
on	O
rabies	O
prevention	O
as	O
well	O
as	O
control	O
and	O
eradication	O
.	O

Four	O
officials	O
were	O
disciplined	O
at	O
over	O
the	O
accident	O
.	O

A	O
review	O
of	O
the	O
incident	O
found	O
that	O
safety	O
protocols	O
were	O
followed	O
and	O
no	O
changes	O
were	O
needed	O
in	O
procedure	O
,	O
wrote	O
Mike	B-Person
Hooker	E-Person
,	O
a	O
spokesman	O
.	O

"	O
The	O
identification	O
of	O
this	O
case	O
underscores	O
the	O
importance	O
of	O
maintaining	O
high	O
levels	O
of	O
routine	O
vaccination	O
coverage	O
and	O
effective	O
surveillance	O
systems	O
for	O
early	O
detection,	O
"	O
said	O
Dr	O
Luo	B-Person
Dapeng	E-Person
WHO	S-Organization
representative	O
in	O
.	O

It	O
is	O
a	O
United	O
States	O
federal	O
agency	O
,	O
under	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
and	O
is	O
headquartered	O
in	O
,	O
Georgia	O
.	O

This	O
is	O
highlighted	O
by	O
the	O
new	O
confirmed	O
case	O
in	O
Enga	S-Location
,	O
"	O
said	O
David	B-Person
Mcloughlin	E-Person
,	O
UNICEF	S-Organization
representative	O
in	O
.	O

The	O
biological	O
military	O
laboratory	O
at	O
Fort	B-Location
Detrick	E-Location
that	O
had	O
its	O
high-level	O
research	O
stopped	O
by	O
the	O
earlier	O
this	O
year	O
due	O
to	O
safety	O
protocol	O
failures	O
announced	O
late	O
Friday	O
it	O
will	O
resume	O
operations	O
on	O
a	O
limited	O
scale	O
.	O

Another	O
case	O
,	O
a	O
Florida	S-Location
man	O
from	O
the	O
Orlando	S-Location
area	O
,	O
was	O
reported	O
,	O
and	O
a	O
third	O
Illinois	S-Location
man	O
was	O
at	O
that	O
point	O
asymptomatic	O
but	O
had	O
tested	O
positive	O
for	O
a	O
past	O
infection	O
with	O
the	O
healthcare	O
worker	O
from	O
Indiana	S-Location
.	O
The	O
latter	O
case	O
was	O
the	O
first	O
human-to-human	O
transmission	O
in	O
the	O
United	B-Location
States	E-Location
.	O
On	O
28	O
May	O
2014	O
,	O
the	O
CDC	S-Organization
announced	O
that	O
the	O
third	O
person	O
who	O
was	O
found	O
positive	O
for	O
the	O
virus	O
was	O
not	O
infected	O
.	O

Gloved	O
hands	O
sorting	O
through	O
mail	O
during	O
2001	B-Incident
anthrax	I-Incident
scare	E-Incident
anthrax	S-Pathogen
attack	O
could	O
take	O
many	O
forms	O
.	O

It	O
forecasts	O
that	O
China	S-Location
pork	O
output	O
will	O
fall	O
by	O
30%	O
this	O
year	O
,	O
creating	O
implications	O
for	O
global	O
commodity	O
markets	O
.	O

The	O
Home	B-Organization
Safety	I-Organization
Council	E-Organization
()	O
is	O
the	O
only	O
national	O
American	O
nonprofit	O
organization	O
solely	O
dedicated	O
to	O
preventing	O
home	O
related	O
injuries	O
that	O
result	O
in	O
nearly	O
20,000	O
deaths	O
and	O
21	O
million	O
medical	O
visits	O
on	O
average	O
each	O
year	O
.	O

DOIs	O
are	O
issued	O
by	O
the	O
International	B-Organization
DOI	I-Organization
Foundation	E-Organization
and	O
are	O
already	O
in	O
use	O
for	O
conventional	O
citations	O
.	O

A	O
summary	O
report	O
written	O
by	O
the	O
Center	O
provides	O
detailed	O
descriptions	O
of	O
each	O
of	O
these	O
major	O
recommendations	O
.	O

The	O
operation	O
led	O
to	O
a	O
surge	O
in	O
reports	O
of	O
cases	O
,	O
with	O
403 new	O
ones	O
reported	O
between	O
14 and 17	O
December	O
.	O

Medvedik	S-Person
pointed	O
out	O
that's	O
not	O
very	O
useful	O
for	O
treating	O
humans	O
-	O
we	O
want	O
to	O
be	O
able	O
to	O
treat	O
people	O
who	O
have	O
already	O
been	O
born	O
and	O
have	O
begun	O
to	O
age	O
.	O

In	O
Brazil	S-Location
the	O
yellow	B-Incident
fever	I-Incident
outbreak	E-Incident
continues	O
to	O
roll	O
on	O
with	O
some	O
numbers	O
not	O
seen	O
in	O
decades	O
.	O

As	O
principal	O
investigator	O
of	O
the	O
study	O
Schully	S-Person
collaborated	O
with	O
researchers	O
and	O
staff	O
from	O
NMRC	S-Organization
,	O
the	O
Menzies	B-Organization
School	I-Organization
of	I-Organization
Health	I-Organization
Research	E-Organization
in	O
Darwin	S-Location
,	O
and	O
The	O
.	O

Agents	O
with	O
a	O
close	O
or	O
identical	O
antigenic	O
relationship	O
to	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
agents	O
also	O
should	O
be	O
handled	O
at	O
this	O
level	O
.	O

On	O
20	O
October	O
2018	O
,	O
an	O
armed	O
rebel	O
group	O
in	O
the	O
DRC	S-Location
killed	O
some	O
13	O
civilians	O
and	O
took	O
12	O
children	O
as	O
hostages	O
in	O
Beni	S-Location
,	O
which	O
was	O
experiencing	O
one	O
of	O
the	O
worst	O
outbreaks	O
.	O

Individuals	O
responsible	O
for	O
performing	O
exams	O
are	O
called	O
radiographers	O
or	O
radiologic	O
technologists	O
.	O

This	O
created	O
a	O
shortage	O
of	O
physicians	O
,	O
especially	O
in	O
the	O
civilian	O
sector	O
as	O
many	O
had	O
been	O
lost	O
for	O
service	O
with	O
the	O
military	O
.	O

At	O
least	O
60%	O
of	O
the	O
population	O
of	O
Hamburg	S-Organization
and	O
Bremen	S-Organization
perished	O
,	O
and	O
a	O
similar	O
percentage	O
of	O
Londoners	O
may	O
have	O
died	O
from	O
the	O
disease	O
as	O
well	O
,	O
with	O
a	O
death	O
toll	O
of	O
approximately	O
62,000	O
between	O
1346	O
and	O
1353.	O
's	O
tax	O
records	O
suggest	O
that	O
80%	O
of	O
the	O
city's	O
population	O
died	O
within	O
four	O
months	O
in	O
1348	O
.	O

Project	B-Scientific_research_project
Clear	I-Scientific_research_project
Vision	E-Scientific_research_project
(1997	O
and	O
2000)	O
,	O
a	O
joint	O
investigation	O
by	O
the	O
CIA	S-Organization
and	O
the	O
Battelle	B-Organization
Memorial	I-Organization
Institute	E-Organization
,	O
under	O
a	O
contract	O
awarded	O
by	O
the	O
Agency	O
,	O
reconstructed	O
and	O
tested	O
a	O
Soviet-era	O
anthrax	S-Disease
bomblet	O
in	O
order	O
to	O
test	O
its	O
dissemination	O
characteristics	O
.	O

Where	O
appropriate	O
,	O
indicators	O
are	O
given	O
of	O
the	O
toxic	O
and	O
allergic	S-Disease
potential	O
of	O
these	O
agents	O
.	O

The	O
Division	B-Organization
of	I-Organization
Noncommunicable	I-Organization
Diseases	I-Organization
for	I-Organization
Promoting	I-Organization
Health	E-Organization
through	O
the	O
Life-course	O
Sexual	O
and	O
Reproductive	O
Health	O
has	O
published	O
the	O
magazine	O
,	O
Entre	B-Organization
Nous	E-Organization
,	O
across	O
since	O
1983	O
.	O

However	O
,	O
this	O
technique	O
is	O
susceptible	O
to	O
noise	O
and	O
other	O
factors	O
which	O
can	O
affect	O
the	O
linearity	O
of	O
the	O
voltage	O
to	O
x-ray	O
intensity	O
relationship	O
.	O

The	O
HA	O
receptor-binding	O
site	O
configuration	O
is	O
different	O
for	O
those	O
influenza	B-Pathogen
viruses	E-Pathogen
adapted	O
to	O
infect	O
birds	O
and	O
those	O
adapted	O
to	O
infect	O
humans	O
.	O

In	O
February	O
2003	O
,	O
Hong	B-Location
Kong	E-Location
SARS	S-Disease
index	O
patient	O
was	O
Liu	B-Person
Jianlun	E-Person
,	O
who	O
had	O
come	O
to	O
attend	O
a	O
family	O
wedding	O
gathering	O
;	O
Liu	S-Person
was	O
on	O
the	O
staff	O
at	O
Sun	B-Organization
Yat-Sen	I-Organization
Memorial	I-Organization
Hospital	E-Organization
in	O
and	O
had	O
treated	O
SARS	O
patients	O
.	O

With	O
the	O
focus	O
on	O
high-consequence	O
pathogens	O
the	O
impact	O
,	O
nonetheless	O
,	O
should	O
be	O
focused	O
on	O
a	O
known	O
group	O
of	O
labs.	O
*Where	O
does	O
this	O
directive	O
come	O
from*?	O
The	O
directive	O
would	O
come	O
from	O
the	O
Office	B-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	E-Organization
(	O
OSTP	S-Organization
)	O
,	O
through	O
the	O
research	O
agencies	O
,	O
via	O
a	O
memorandum	O
.	O

SysMO-SEEK	S-Platform
provides	O
the	O
most	O
elaborated	O
approach	O
for	O
automated	O
data	O
collection:	O
harvesters	O
are	O
automatically	O
looking	O
for	O
new	O
data	O
and	O
feeding	O
it	O
to	O
the	O
system	O
.	O

Therapeutics	O
such	O
as	O
Emergent	S-Organization
antibody	O
VIGIV	S-Drug
,	O
or	O
Vaccinia	B-Drug
Immune	I-Drug
Globulin	I-Drug
Intravenous	E-Drug
,	O
the	O
only	O
polyclonal	O
antibody	O
therapeutic	O
licensed	O
by	O
the	O
FDA	S-Organization
to	O
counteract	O
certain	O
complications	O
from	O
the	O
smallpox	S-Disease
vaccination	O
.	O

Data	O
management	O
plans	O
as	O
required	O
prerequisite	O
for	O
funding	O
in	O
Australia	S-Location
can	O
then	O
be	O
employed	O
to	O
control	O
the	O
delivery	O
of	O
data	O
assets	O
planned	O
.	O

The	O
American	O
people	O
depend	O
on	O
us	O
24/7	O
to	O
protect	O
them	O
.	O

For	O
symptoms	O
,	O
some	O
medical	O
professionals	O
recommend	O
paracetamol	S-Drug
(	O
acetaminophen	S-Drug
)	O
over	O
for	O
first-line	O
use	O
.	O

But	O
some	O
public	O
health	O
officials	O
and	O
members	O
of	O
Congress	S-Organization
in	O
both	O
parties	O
worry	O
the	O
move	O
will	O
disrupt	O
a	O
complex	O
process	O
that	O
relies	O
on	O
long-standing	O
relationships	O
between	O
the	O
federal	O
program	O
and	O
the	O
state	O
and	O
local	O
agencies	O
responsible	O
for	O
distributing	O
the	O
medicine	O
.	O

A	O
portion	O
has	O
been	O
preserved	O
and	O
is	O
open	O
to	O
visitors	O
as	O
a	O
.	O

The	O
head	O
of	O
the	O
NIAID	S-Organization
Anthony	B-Person
Fauci	E-Person
,	O
warned	O
that	O
if	O
caution	O
was	O
not	O
used	O
the	O
rate	O
of	O
infections	O
could	O
rebound	O
and	O
he	O
was	O
particularly	O
concerned	O
about	O
opening	O
the	O
schools	O
in	O
the	O
fall	O
.	O

In	O
a	O
trial	O
in	O
China	S-Location
over	O
February-March	O
2020	O
,	O
remdesivir	S-Drug
was	O
not	O
effective	O
in	O
reducing	O
the	O
time	O
for	O
improvement	O
from	O
or	O
deaths	O
,	O
and	O
caused	O
various	O
adverse	O
effects	O
,	O
requiring	O
the	O
investigators	O
to	O
terminate	O
the	O
trial	O
.	O

Biotechnology	O
is	O
nearly	O
as	O
old	O
as	O
humanity	O
itself	O
.	O

Because	O
of	O
this	O
,	O
the	O
precision	O
of	O
genome	B-Technology
editing	E-Technology
is	O
a	O
great	O
concern.	O
leads	O
to	O
irreversible	O
changes	O
to	O
the	O
genome	O
.	O

To	O
help	O
prepare	O
for	O
contingencies	O
,	O
University	B-Organization
of	I-Organization
Maryland	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
professor	O
of	O
pediatrics	O
James	B-Person
C.	I-Person
King	I-Person
Jr	E-Person
.	O
suggested	O
that	O
every	O
county	O
should	O
create	O
an	O
"	O
influenza	O
action	O
team	O
"	O
to	O
be	O
run	O
by	O
the	O
local	O
health	O
department	O
,	O
parents	O
,	O
and	O
school	O
administrators	O
.	O

The	O
executive	O
board	O
is	O
composed	O
of	O
members	O
technically	O
qualified	O
in	O
health	O
,	O
and	O
gives	O
effect	O
to	O
the	O
decisions	O
and	O
policies	O
of	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
In	O
addition	O
,	O
the	O
UN	S-Organization
observer	O
organizations	O
International	B-Organization
Committee	I-Organization
of	I-Organization
the	I-Organization
Red	I-Organization
Cross	E-Organization
and	O
International	B-Organization
Federation	I-Organization
of	I-Organization
Red	I-Organization
Cross	E-Organization
and	O
Red	B-Organization
Crescent	I-Organization
Societies	E-Organization
have	O
entered	O
into	O
"	O
official	O
relations	O
"	O
with	O
WHO	S-Organization
and	O
are	O
invited	O
as	O
observers	O
.	O

Brooks	S-Person
asked	O
if	O
there	O
have	O
been	O
any	O
problems	O
in	O
the	O
control	O
shift	O
as	O
the	O
offices	O
work	O
with	O
state	O
and	O
local	O
officials	O
.	O

During	O
the	O
height	O
of	O
the	O
crisis	O
,	O
Wikipedia	S-Platform
Ebola	S-Disease
page	O
received	O
2.	O
5	O
million	O
page	O
views	O
per	O
day	O
,	O
making	O
Wikipedia	S-Platform
one	O
of	O
the	O
world's	O
most	O
highly	O
used	O
sources	O
of	O
trusted	O
medical	O
information	O
regarding	O
the	O
disease	O
.	O

This	O
may	O
be	O
done	O
as	O
a	O
hobby	O
,	O
as	O
a	O
not-for-profit	O
endeavour	O
for	O
community	O
learning	O
and	O
open-science	O
innovation	O
,	O
or	O
for	O
profit	O
,	O
to	O
start	O
a	O
business	O
.	O

National	O
authorities	O
report	O
that	O
all	O
patients	O
are	O
isolated	O
and	O
receiving	O
treatment	O
in	O
Wuhan	S-Location
medical	O
institutions	O
.	O

In	O
case	O
of	O
symptoms	O
suggestive	O
of	O
respiratory	O
illness	O
either	O
during	O
or	O
after	O
travel	O
,	O
travellers	O
are	O
encouraged	O
to	O
seek	O
medical	O
attention	O
and	O
share	O
travel	O
history	O
with	O
their	O
healthcare	O
provider	O
.	O

Those	O
diagnosed	O
with	O
COVID‑19	S-Disease
or	O
who	O
believe	O
they	O
may	O
be	O
infected	O
are	O
advised	O
by	O
the	O
CDC	S-Organization
to	O
stay	O
home	O
except	O
to	O
get	O
medical	O
care	O
,	O
call	O
ahead	O
before	O
visiting	O
a	O
healthcare	O
provider	O
,	O
wear	O
a	O
face	O
mask	O
before	O
entering	O
the	O
healthcare	O
provider's	O
office	O
and	O
when	O
in	O
any	O
room	O
or	O
vehicle	O
with	O
another	O
person	O
,	O
cover	O
coughs	O
and	O
sneezes	O
with	O
a	O
tissue	O
,	O
regularly	O
wash	O
hands	O
with	O
soap	O
and	O
water	O
and	O
avoid	O
sharing	O
personal	O
household	O
items	O
.	O

The	O
air	O
flow	O
in	O
laboratory	O
is	O
also	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

Start-up	O
companies	O
could	O
use	O
this	O
opportunity	O
to	O
generate	O
effective	O
,	O
new	O
,	O
antibiotic	O
combinations	O
.	O

For	O
example	O
,	O
images	O
of	O
the	O
brain	O
are	O
commonly	O
viewed	O
with	O
a	O
window	O
extending	O
from	O
0	O
HU	O
to	O
80	O
HU	O
.	O

Treatment	O
with	O
Cas9	O
can	O
deplete	O
abundant	O
rRNA	O
while	O
increasing	O
pathogen	O
sensitivity	O
in	O
RNA-seq	O
libraries	O
.	O

Information	O
on	O
risk	O
assessment	O
for	O
specific	O
etiological	O
agents	O
may	O
be	O
found	O
in	O
the	O
Agent	O
Summary	O
Statements	O
of	O
the	O
CDC	S-Organization
NIH	S-Organization
publication	O
,	O
.	O

But	O
even	O
before	O
the	O
official	O
release	O
of	O
the	O
OSTP	B-Document
memo	E-Document
the	O
has	O
recommended	O
that	O
its	O
members	O
take	O
prudent	O
steps	O
to	O
know	O
which	O
cultures	O
they	O
possess	O
and	O
where	O
they	O
are	O
located	O
.	O

Researchers	O
recently	O
demonstrated	O
the	O
ability	O
to	O
birth	O
live	O
pig	O
specimens	O
after	O
removing	O
these	O
retroviruses	O
from	O
their	O
genome	O
using	O
for	O
the	O
first	O
time	O
.	O

A	O
method	O
of	O
dead-end	O
ultrafiltration	O
for	O
detection	O
of	O
high-consequence	O
pathogens	O
in	O
larger	O
volume	O
water	O
also	O
led	O
all	O
4	O
agencies	O
to	O
purchase	O
the	O
same	O
equipment	O
.	O

Remdesivir	S-Drug
is	O
the	O
international	O
nonproprietary	O
name	O
(INN)	O
while	O
the	O
development	O
code	O
name	O
was	O
.	O

Russian	O
Prime	O
Minister	O
Yegor	B-Person
Gaidar	E-Person
issued	O
a	O
decree	O
to	O
begin	O
demilitarization	O
of	O
Compound	B-Organization
19	E-Organization
in	O
1992	O
.	O

CT	S-Technology
data	O
sets	O
have	O
a	O
very	O
high	O
dynamic	O
range	O
which	O
must	O
be	O
reduced	O
for	O
display	O
or	O
printing	O
.	O

Under	O
the	O
DTRA	B-Scientific_research_project
project	E-Scientific_research_project
"	O
Virus	O
and	O
Other	O
Arboviruses	O
in	O
Georgia	S-Location
"	O
in	O
2014	O
the	O
never-before-seen	O
tropical	O
mosquito	O
Aedes	O
albopictus	O
was	O
detected	O
for	O
the	O
first	O
time	O
and	O
after	O
decades	O
(60	O
years)	O
the	O
existence	O
of	O
Aedes	O
Aegypti	O
mosquito	O
was	O
confirmed	O
in	O
.	O

Of	O
note	O
,	O
their	O
published	O
finding	O
related	O
only	O
to	O
use	O
in	O
healthy	O
adults	O
with	O
influenza	O
but	O
not	O
in	O
patients	O
judged	O
to	O
be	O
at	O
high	O
risk	O
of	O
complications	O
(pregnant	O
women	O
,	O
children	O
under	O
five	O
and	O
those	O
with	O
underlying	O
medical	O
conditions)	O
,	O
and	O
uncertainty	O
over	O
its	O
role	O
in	O
reducing	O
complications	O
in	O
healthy	O
adults	O
still	O
left	O
it	O
as	O
a	O
useful	O
drug	O
for	O
reducing	O
the	O
duration	O
of	O
symptoms	O
.	O

Using	O
a	O
big-data	O
approach	O
and	O
a	O
network	O
of	O
hospitals	O
and	O
clinical	O
laboratories	O
around	O
the	O
world	O
,	O
a	O
new	O
non-profit	O
initiative	O
aims	O
to	O
create	O
a	O
comprehensive	O
"	O
criminal	B-Platform
database"	I-Platform
of	I-Platform
antibiotic-resistant	I-Platform
bacterial	I-Platform
strains	E-Platform
that	O
can	O
be	O
recognized	O
by	O
their	O
genetic	O
fingerprint	O
.	O

These	O
are	O
only	O
the	O
tip	O
of	O
the	O
iceberg	O
in	O
terms	O
of	O
the	O
vast	O
reservoir	O
of	O
bioactive	O
compounds	O
available	O
in	O
nature	O
.	O

Russia	S-Location
chief	O
epidemiologist	O
believes	O
the	O
virus	O
could	O
potentially	O
mutate	O
further	O
given	O
the	O
similarity	O
between	O
pig	O
and	O
human	O
physiology	O
.	O

Stericycle	O
and	O
Daniels	B-Organization
Health	E-Organization
are	O
two	O
national	O
leaders	O
in	O
medical	O
waste	O
and	O
pharmaceutical	O
disposal	O
in	O
.	O

One	O
recent	O
advancement	O
is	O
the	O
commercialization	O
of	O
a	O
new	O
form	O
of	O
Tyvex™	B-Equipment
armor	E-Equipment
which	O
protects	O
first	O
responders	O
and	O
patients	O
from	O
chemical	O
and	O
biological	O
contaminants	O
.	O

Allegations	O
were	O
made	O
that	O
a	O
"	O
chemical	O
section	O
"	O
of	O
a	O
US	S-Location
clandestine	O
unit	O
hidden	O
within	O
Yokosuka	B-Location
naval	I-Location
base	E-Location
was	O
operational	O
during	O
the	O
Korean	O
War	O
,	O
and	O
then	O
worked	O
on	O
unspecified	O
projects	O
inside	O
the	O
from	O
1955	O
to	O
1959	O
,	O
before	O
returning	O
to	O
Japan	O
to	O
enter	O
the	O
private	O
sector	O
.	O

The	O
repository	O
includes	O
nearly	O
2,000	O
caches	O
of	O
nerve	O
agent	O
antidotes	O
,	O
known	O
as	O
Chempacks	O
,	O
that	O
are	O
stored	O
and	O
maintained	O
separately	O
from	O
the	O
warehouses	O
at	O
more	O
than	O
1,300	O
locations	O
around	O
the	O
country	O
where	O
they	O
can	O
be	O
accessed	O
quickly	O
.	O

More	O
than	O
36	O
million	O
people	O
a	O
year	O
around	O
the	O
world	O
die	O
from	O
hunger	O
and	O
malnutrition	S-Disease
.	O
Deficiencies	O
of	O
specific	O
nutrients	O
,	O
such	O
as	O
,	O
cause	O
many	O
of	O
these	O
deaths	O
.	O

A	O
workshop	O
will	O
be	O
organized	O
at	O
least	O
annually	O
,	O
hosted	O
by	O
each	O
country	O
in	O
turn	O
.	O

These	O
drugs	O
are	O
effective	O
but	O
infections	O
caused	O
by	O
resistant	O
parasites	O
have	O
been	O
reported	O
.	O

The	O
expectations	O
of	O
genome	B-Technology
editing	E-Technology
have	O
arisen	O
in	O
a	O
wide	O
variety	O
of	O
fields	O
encompassed	O
in	O
biomedicine	O
and	O
biotechnology	O
,	O
from	O
drug	O
discovery	O
to	O
food	O
engineering	O
and	O
generation	O
of	O
biofuels	O
.	O

Studies	O
of	O
outbreaks	O
in	O
the	O
late	O
twentieth	O
century	O
failed	O
to	O
find	O
a	O
correlation	O
between	O
the	O
disease	O
severity	O
and	O
the	O
genetic	O
nature	O
of	O
the	O
virus	O
.	O

The	O
expenditure	O
associated	O
with	O
these	O
infections	O
in	O
terms	O
of	O
extra	O
hospital	O
costs	O
and	O
productivity	O
losses	O
exceeded	O
€1.	O
5	O
billion	O
each	O
year	O
(Ref)	O
.	O

In	O
the	O
1980s	O
and	O
1990s	O
,	O
many	O
of	O
these	O
agents	O
were	O
genetically	O
altered	O
to	O
resist	O
heat	O
,	O
cold	O
,	O
and	O
antibiotics	O
.	O

I	O
have	O
two	O
quick	O
questions	O
.	O

Transport	O
materials	O
outside	O
of	O
the	O
laboratory	O
using	O
secondary	B-Equipment
containment	E-Equipment

The	O
and	O
the	O
have	O
formalized	O
the	O
framework	O
of	O
an	O
earlier	O
plan	O
to	O
accelerate	O
the	O
development	O
and	O
availability	O
of	O
emergency	O
medical	O
products	O
for	O
the	O
U.S.	S-Location

At	O
least	O
3,000	O
men	O
,	O
women	O
,	O
and	O
children-from	O
which	O
at	O
least	O
600	O
every	O
year	O
were	O
provided	O
by	O
the	O
KempeitaiYuki	B-Person
Tanaka	E-Person
Hidden	O
Horrors	O
,	O
Westviewpress	O
,	O
1996	O
,	O
p.	O
138	O
were	O
subjected	O
to	O
experimentation	O
conducted	O
by	O
Unit	B-Organization
731	E-Organization
at	O
the	O
camp	O
based	O
in	O
Pingfang	S-Location
alone	O
,	O
which	O
does	O
not	O
include	O
victims	O
from	O
other	O
medical	O
experimentation	O
sites	O
,	O
such	O
as	O
.	O

Overall	O
,	O
nearly	O
half	O
of	O
the	O
influenza-related	O
deaths	O
in	O
tmic	O
were	O
in	O
young	O
adults	O
20–40	O
years	O
of	O
age	O
,	O
a	O
phenomenon	O
unique	O
to	O
that	O
pandemic	O
year	O
.	O

The	O
lack	O
of	O
action	O
was	O
later	O
criticized	O
when	O
the	O
epidemic	O
could	O
not	O
be	O
ignored	O
in	O
the	O
winter	O
of	O
1918	O
(	O
BMJ	S-Organization
1918)	O
.	O

In	O
the	O
hardest	O
hit	O
areas	O
there	O
have	O
historically	O
been	O
only	O
one	O
or	O
two	O
doctors	O
available	O
to	O
treat	O
100,000 people	O
,	O
and	O
these	O
doctors	O
are	O
heavily	O
concentrated	O
in	O
urban	O
areas	O
.	O

Since	O
then	O
some	O
scholars	O
have	O
argued	O
that	O
the	O
British	O
committed	O
biological	O
warfare	O
in	O
1789	O
near	O
their	O
new	O
convict	O
settlement	O
at	O
.	O

There	O
is	O
no	O
medication	O
known	O
to	O
be	O
effective	O
at	O
preventing	O
COVID‑19	S-Disease
After	O
the	O
implementation	O
of	O
social	O
distancing	O
and	O
stay-at-home	O
orders	O
,	O
many	O
regions	O
have	O
been	O
able	O
to	O
sustain	O
an	O
effective	O
transmission	O
rate	O
("Rt")	O
of	O
less	O
than	O
one	O
,	O
meaning	O
the	O
disease	O
is	O
in	O
remission	O
in	O
those	O
areas	O
.	O

DW	S-Organization
talks	O
to	O
the	O
head	O
of	O
the	O
Nigeria	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
()	O
about	O
what	O
is	O
being	O
done	O
to	O
prevent	O
more	O
fatalities	O
.	O

The	O
CDC	O
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
obesity	S-Disease
and	O
diabetes	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
.	O

As	O
the	O
epidemic	O
progressed	O
,	O
one	O
virus	O
lineage	O
disappeared	O
from	O
patient	O
samples	O
,	O
while	O
a	O
third	O
one	O
appeared	O
.	O

It	O
set	O
the	O
stage	O
for	O
combining	O
not	O
just	O
a	O
few	O
genes	O
,	O
but	O
entire	O
pathways	O
that	O
can	O
make	O
a	O
compound	O
,	O
or	O
a	O
whole	O
genome	O
that	O
can	O
let	O
a	O
cell	O
divide	O
,	O
grow	O
,	O
copy	O
itself	O
and	O
interact	O
with	O
other	O
organisms	O
.	O

The	O
materials	O
are	O
all	O
either	O
destroyed	O
or	O
contained	O
,	O
and	O
there's	O
no	O
risk	O
from	O
it	O
.	O

Jacob	S-Person
explained	O
to	O
.	O

If	O
the	O
infection	O
is	O
recognized	O
too	O
late	O
,	O
it	O
is	O
often	O
lethal	O
.	O

Heterogeneous	O
data	O
are	O
integrated	O
via	O
overlapping	O
column	O
values	O
from	O
spread	O
sheet	O
formats	O
which	O
are	O
employed	O
to	O
import	O
high-throughput	O
data	O
.	O

Our	O
population	O
now	O
is	O
a	O
thousand	O
times	O
greater	O
than	O
it	O
was	O
for	O
most	O
of	O
human	O
history	O
,	O
so	O
there	O
are	O
vastly	O
more	O
opportunities	O
for	O
new	O
human	O
diseases	O
to	O
originate	O
.	O

At	O
this	O
week's	O
meeting	O
in	O
Indonesia	S-Location
,	O
GHSA	S-International_exchange_and_cooperation
launched	O
a	O
new	O
five-year	O
plan	O
called	O
,	O
which	O
seeks	O
to	O
guide	O
countries	O
in	O
evaluating	O
health	O
security	O
risks	O
and	O
addressing	O
gaps	O
.	O

According	O
to	O
Evgeni	B-Person
Sokurenko	E-Person
MD	O
,	O
PhD	O
,	O
ARMADA	S-Scientific_research_project
advisory	O
board	O
member	O
and	O
co-founder	O
of	O
ID	B-Organization
Genomics	E-Organization
,	O
ARMADA	S-Scientific_research_project
will	O
help	O
researchers	O
identify	O
the	O
important	O
bacterial	O
crime	O
families-the	O
clonal	B-Pathogen
groups	E-Pathogen
that	O
are	O
multidrug-resistant	O
,	O
spread	O
quickly	O
,	O
and	O
cause	O
severe	O
illness.	O
"	O
Just	O
based	O
on	O
certain	O
barcode	O
genes	O
,	O
we'll	O
get	O
an	O
idea	O
of	O
which	O
clonal	B-Pathogen
group	E-Pathogen
the	O
bacteria	O
belongs	O
to,	O
"	O
Sokurenko	S-Person
,	O
who's	O
also	O
a	O
professor	O
of	O
microbiology	O
at	O
the	O
University	B-Organization
of	I-Organization
Washington	E-Organization
School	O
of	O
Medicine	O
,	O
told	O
News	O
.	O

The	O
observed	O
mutation	O
rate	O
of	O
2.0	O
x	O
10−3	O
substitutions	O
per	O
site	O
per	O
year	O
is	O
as	O
fast	O
as	O
that	O
of	O
seasonal	O
influenza	O
.	O

In	O
April	O
,	O
an	O
epidemiologist	O
from	O
WHO	S-Organization
was	O
killed	O
and	O
two	O
health	O
workers	O
injured	O
in	O
a	O
militia	O
attack	O
on	O
Butembo	B-Organization
University	I-Organization
Hospital	E-Organization
in	O
Katwa	S-Location
.	O
In	O
May	O
,	O
's	O
health	O
emergencies	O
chief	O
said	O
insecurity	O
had	O
become	O
a	O
"	O
major	O
impediment	O
"	O
to	O
controlling	O
the	O
outbreak	O
.	O

EBEN	B-Person
BROWN	E-Person
Thank	O
you	O
.	O

And	O
I	O
think	O
it's	O
fair	O
to	O
raise	O
those	O
questions	O
.	O

An	O
example	O
for	O
integration	O
of	O
bioinformatics	O
data	O
from	O
various	O
databases	O
via	O
these	O
semantic	O
web	O
technologies	O
is	O
Bio2RDF	O
.	O

The	O
growing	O
threat	O
of	O
biological	O
weapons	O
,	O
American	O
Scientist	O
,	O
89:1	O
.	O

Focal	O
or	O
diffuse	O
disorders	O
of	O
the	O
liver	O
may	O
be	O
evaluated	O
using	O
diffusion-weighted	O
,	O
opposed-phase	O
imaging	O
and	O
dynamic	O
contrast	O
enhancement	O
sequences	O
.	O

On	O
21	O
October	O
2017	O
,	O
the	O
Director	O
General	O
Tedros	B-Person
Adhanom	I-Person
Ghebreyesus	E-Person
appointed	O
former	O
Zimbabwean	O
president	O
Robert	B-Person
Mugabe	E-Person
as	O
a	O
WHO	S-Organization
Goodwill	O
Ambassador	O
to	O
help	O
promote	O
the	O
fight	O
against	O
non-communicable	O
diseases	O
.	O

"	O
The	O
United	B-Location
States	E-Location
is	O
committed	O
to	O
working	O
with	O
31	O
countries	O
and	O
the	O
Caribbean	O
Community	O
toward	O
achieving	O
GHSA	S-International_exchange_and_cooperation
targets	O
across	O
the	O
11	O
Action	O
Packages,	O
"	O
according	O
to	O
the	O
report	O
,	O
and	O
in	O
July	O
2015	O
committed	O
to	O
investing	O
$1	O
billion	O
in	O
new	O
resources	O
across	O
several	O
countries	O
to	O
build	O
capacity	O
to	O
prevent	O
,	O
detect	O
and	O
respond	O
to	O
infectious	O
disease	O
outbreaks	O
.	O

This	O
blockage	O
starves	O
the	O
fleas	O
and	O
drives	O
them	O
to	O
aggressive	O
feeding	O
behaviour	O
and	O
attempts	O
to	O
clear	O
the	O
blockage	O
by	O
regurgitation	O
,	O
resulting	O
in	O
thousands	O
of	O
plague	B-Pathogen
bacteria	E-Pathogen
being	O
flushed	O
into	O
the	O
feeding	O
site	O
,	O
infecting	O
the	O
host	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
declared	O
the	O
outbreak	O
a	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
on	O
30	O
January	O
,	O
and	O
a	O
pandemic	O
on	O
11	O
March	O
.	O

This	O
project	O
has	O
been	O
funded	O
in	O
part	O
with	O
federal	O
funds	O
from	O
the	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
under	O
Contract	O
No	O
.	O

So	O
there	O
was	O
no	O
release	O
.	O

Consequently	O
,	O
during	O
modern	O
pandemics	O
,	O
health	O
officials	O
pay	O
attention	O
when	O
the	O
virus	O
reaches	O
places	O
with	O
social	O
upheaval	O
(looking	O
for	O
deadlier	O
strains	O
of	O
the	O
virus)	O
.	O

They	O
further	O
stated	O
,	O
that	O
if	O
the	O
disease	O
was	O
not	O
adequately	O
contained	O
it	O
could	O
become	O
native	O
in	O
Guinea	S-Location
,	O
Sierra	B-Location
Leone	E-Location
and	O
Liberia	S-Location
,	O
"	O
spreading	O
as	O
routinely	O
as	O
malaria	S-Disease
or	O
the	O
flu	S-Disease
"	O
,	O
and	O
according	O
to	O
an	O
editorial	O
in	O
the	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
,	O
eventually	O
to	O
other	O
parts	O
of	O
and	O
beyond	O
.	O

On	O
behalf	O
of	O
WRAIR	S-Organization
the	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Acquisition	I-Organization
Activity	E-Organization
(	O
USAMRAA	S-Organization
)	O
has	O
announced	O
intentions	O
to	O
negotiate	O
a	O
sole	O
source	O
contract	O
with	O
the	O
Southwest	B-Organization
Research	I-Organization
Institute	E-Organization
for	O
the	O
production	O
of	O
customized	O
subdermal	O
implants	O
with	O
a	O
specific	O
combination	O
of	O
a	O
drug	O
of	O
choice	O
and	O
ethylene-vinyl	O
acetate	O
(EVA)	O
copolymer	O
using	O
the	O
patented	O
technology	O
.	O

If	O
these	O
creations	O
somehow	O
get	O
to	O
the	O
hands	O
of	O
terrorists	O
,	O
it	O
could	O
prove	O
to	O
be	O
extremely	O
dangerous	O
worldwide	O
.	O

In	O
April	O
2016	O
,	O
Chinese	O
scientists	O
were	O
reported	O
to	O
have	O
made	O
a	O
second	O
unsuccessful	O
attempt	O
to	O
alter	O
the	O
DNA	O
of	O
non-viable	O
human	O
embryos	O
using	O
CRISPR	S-Technology
–	O
this	O
time	O
to	O
alter	O
the	O
CCR5	O
gene	O
to	O
make	O
the	O
embryo	O
resistant	O
to	O
infection	O
.	O

Much	O
more	O
alarming	O
,	O
from	O
an	O
arms-control	O
perspective	O
,	O
are	O
the	O
possibilities	O
of	O
developing	O
completely	O
novel	O
weapons	O
on	O
the	O
basis	O
of	O
knowledge	O
provided	O
by	O
biomedical	O
research-developments	O
that	O
are	O
already	O
taking	O
place	O
.	O

When	O
you	O
consider	O
the	O
viral	O
infectious	O
diseases	O
that	O
emerged	O
and	O
reemerged	O
around	O
the	O
world	O
in	O
2017	O
alone	O
,	O
what	O
many	O
of	O
them	O
have	O
in	O
common	O
is	O
that	O
they	O
originated	O
in	O
animals	O
and	O
spilled	O
over	O
into	O
humans	O
after	O
a	O
series	O
of	O
mutations	O
that	O
enable	O
the	O
pathogens	O
to	O
jump	O
species	O
.	O

Agents	O
with	O
a	O
close	O
or	O
identical	O
antigenic	O
relationship	O
to	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
agents	O
also	O
should	O
be	O
handled	O
at	O
this	O
level	O
.	O

The	O
CDC	S-Organization
is	O
also	O
a	O
lead	O
implementer	O
of	O
key	O
U.S.	S-Location
global	O
health	O
initiatives	O
such	O
as	O
the	O
President's	B-Activity
Emergency	I-Activity
Plan	I-Activity
for	I-Activity
AIDS	I-Activity
Relief	E-Activity
(	O
PEPFAR	S-Activity
)	O
and	O
.	O

A	O
2015	O
interview-based	O
evaluation	O
of	O
the	O
network	O
,	O
carried	O
out	O
by	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
concluded	O
that	O
the	O
4	O
partners	O
see	O
their	O
work	O
in	O
FBD	S-Platform
as	O
having	O
been	O
democratic	O
,	O
transparent	O
,	O
and	O
equal	O
.	O

This	O
method	O
might	O
be	O
useful	O
for	O
treating	O
genetic	O
disorders	O
caused	O
by	O
abnormal	O
numbers	O
of	O
chromosomes	O
,	O
such	O
as	O
Down	B-Disease
syndrome	E-Disease
and	O
.	O

Vero	O
cells	O
were	O
seeded	O
in	O
96‐well	O
plates	O
(1	O
×	O
104	O
cells	O
per	O
well)	O
in	O
DMEM	O
,	O
for	O
24	O
hr	O
and	O
then	O
infected	O
with	O
10−3–10−7	O
dilutions	O
of	O
HSV	S-Pathogen
in	O
50 μλ	O
DMEM	O
,	O
with	O
no	O
FCS	O
.	O

H.R.	B-Document
6378	E-Document
among	O
numerous	O
provisions	O
,	O
would	O
reauthorize	O
and	O
boost	O
funding	O
for	O
programs	O
under	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
(	O
HHS	S-Organization
)	O
to	O
develop	O
responses	O
to	O
pandemics	O
and	O
biological	O
threats	O
.	O

He	O
was	O
not	O
quarantined	O
and	O
there	O
were	O
at	O
least	O
twelve	O
further	O
cases	O
in	O
the	O
West	B-Location
Midlands	E-Location
,	O
five	O
of	O
whom	O
were	O
quarantined	O
in	O
Witton	B-Organization
Isolation	I-Organization
Hospital	E-Organization
in	O
Birmingham	S-Location
.	O
There	O
are	O
no	O
records	O
of	O
any	O
formal	O
enquiries	O
on	O
the	O
source	O
of	O
this	O
outbreak	O
despite	O
concerns	O
expressed	O
by	O
the	O
then	O
head	O
of	O
the	O
laboratory	O
,	O
.	O

Fine-grained	O
access	O
control	O
is	O
indispensable	O
when	O
multiple	O
groups	O
and	O
consortia	O
are	O
working	O
with	O
the	O
same	O
data	O
management	O
system	O
.	O

Working	O
like	O
genetic	B-Technology
scissors	E-Technology
the	O
Cas9	O
nuclease	O
opens	O
both	O
strands	O
of	O
the	O
targeted	O
sequence	O
of	O
DNA	O
to	O
introduce	O
the	O
modification	O
by	O
one	O
of	O
two	O
methods	O
.	O

Since	O
its	O
formation	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
QA	O
protocols	O
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

Other	O
international	O
policy	O
frameworks	O
produced	O
by	O
WHO	S-Organization
include	O
the	O
International	B-Document
Code	I-Document
of	I-Document
Marketing	I-Document
of	I-Document
Breast-milk	I-Document
Substitutes	E-Document
(adopted	O
in	O
1981)	O
,	O
Framework	B-Document
Convention	I-Document
on	I-Document
Tobacco	I-Document
Control	E-Document
(adopted	O
in	O
2003)	O
the	O
Global	B-Document
Code	I-Document
of	I-Document
Practice	I-Document
on	I-Document
the	I-Document
International	I-Document
Recruitment	I-Document
of	I-Document
Health	I-Document
Personnel	E-Document
(adopted	O
in	O
2010)	O
as	O
well	O
as	O
the	O
and	O
its	O
pediatric	O
counterpart	O
.	O

Cirincione	S-Person
,	O
,	O
et	O
al	O
.	O

He	O
would	O
not	O
disclose	O
the	O
type	O
of	O
tests	O
.	O

Following	O
induction	O
,	O
the	O
bacteriophage	O
replicates	O
,	O
causes	O
lysis	O
,	O
and	O
releases	O
to	O
the	O
medium	O
.	O

There	O
has	O
been	O
some	O
disagreement	O
about	O
the	O
value	O
of	O
wearing	O
face	B-Equipment
masks	E-Equipment
,	O
some	O
experts	O
fearing	O
that	O
masks	O
may	O
give	O
people	O
a	O
false	O
sense	O
of	O
security	O
and	O
should	O
not	O
replace	O
other	O
standard	O
precautions	O
.	O

The	O
authors	O
estimated	O
that	O
between	O
17%	O
and	O
70%	O
of	O
cases	O
in	O
were	O
unreported-far	O
fewer	O
than	O
had	O
been	O
estimated	O
in	O
prior	O
projections	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
sub-department	O
,	O
the	O
International	B-Organization
Agency	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Cancer	E-Organization
(	O
IARC	S-Organization
)	O
,	O
has	O
been	O
criticized	O
for	O
the	O
way	O
it	O
analyses	O
the	O
tendency	O
of	O
certain	O
substances	O
and	O
activities	O
to	O
cause	O
cancer	S-Disease
and	O
for	O
having	O
a	O
politically	O
motivated	O
bias	O
when	O
it	O
selects	O
studies	O
for	O
its	O
analysis	O
.	O

An	O
additional	O
cause	O
for	O
concern	O
is	O
the	O
apparent	O
ability	O
of	O
the	O
virus	O
to	O
"	O
hide"	O
in	O
a	O
recovered	O
survivor's	O
body	O
for	O
an	O
extended	O
period	O
of	O
time	O
and	O
then	O
become	O
active	O
months	O
or	O
years	O
later	O
,	O
either	O
in	O
the	O
same	O
individual	O
or	O
in	O
a	O
sexual	O
partner	O
.	O

The	O
classification	O
of	O
biological	O
agents	O
is	O
a	O
basic	O
requirement	O
for	O
both	O
biosafety	O
and	O
biodefense	O
.	O

Early	O
studies	O
on	O
animals	O
,	O
especially	O
on	O
something	O
as	O
complex	O
as	O
nutrition	O
,	O
should	O
never	O
be	O
extrapolated	O
to	O
humans	O
.	O

When	O
the	O
researchers	O
equipped	O
other	O
bacteria	O
with	O
these	O
genes	O
,	O
which	O
they	O
called	O
C2c2	O
,	O
they	O
found	O
that	O
the	O
organisms	O
gained	O
a	O
novel	O
defense	O
.	O

This	O
genetic	O
bottleneck	O
effect	O
has	O
implications	O
for	O
the	O
species'	O
ability	O
to	O
cause	O
in	O
human	O
hosts	O
.	O

Called	O
the	O
most	O
far-reaching	O
rule	O
changes	O
in	O
65	O
years	O
,	O
the	O
regulations	O
reduced	O
daily	O
allowed	O
driving	O
time	O
from	O
11	O
hours	O
to	O
10	O
.	O

A	O
domestic	O
cat	O
in	O
Liège,	B-Location
Belgium	E-Location
tested	O
positive	O
after	O
it	O
started	O
showing	O
symptoms	O
(diarrhoea	O
,	O
vomiting	O
,	O
shortness	O
of	O
breath)	O
a	O
week	O
later	O
than	O
its	O
owner	O
,	O
who	O
was	O
also	O
positive	O
.	O

Mashups	O
are	O
aggregations	O
of	O
multiple	O
web	O
services	O
,	O
e.g.	O
an	O
aggregation	O
of	O
microarray	O
data	O
with	O
interactions	O
from	O
the	O
human	B-Pathogen
immunodeficiency	I-Pathogen
virus	I-Pathogen
type	I-Pathogen
1	E-Pathogen
(	O
HIV-1	S-Pathogen
)	O
,	O
Human	B-Platform
Protein	I-Platform
Interaction	I-Platform
Database	E-Platform
for	O
investigation	O
of	O
the	O
HIV-1	S-Pathogen
.	O
Workflows	O
can	O
be	O
regarded	O
as	O
a	O
dedicated	O
type	O
of	O
mashup	O
.	O

From	O
this	O
point	O
on	O
,	O
researchers	O
switched	O
their	O
focus	O
to	O
defensive	O
measures	O
such	O
as	O
developing	O
"	O
air-sniffing"	O
detectors	O
.	O

In	O
another	O
FBD	S-Platform
project	O
,	O
the	O
outcomes	O
of	O
network	O
activities	O
were	O
disseminated	O
to	O
other	O
actors	O
working	O
in	O
the	O
field	O
of	O
biopreparedness	O
.	O

Since	O
he	O
had	O
not	O
added	O
any	O
foreign-species	O
(transgenic)	O
DNA	O
to	O
his	O
organism	O
,	O
the	O
mushroom	O
could	O
not	O
be	O
regulated	O
by	O
the	O
USDA	S-Organization
under	O
Section	O
340.2	O
.	O

In	O
that	O
vein	O
,	O
the	O
American	B-Organization
Society	I-Organization
of	I-Organization
Microbiology	E-Organization
is	O
calling	O
on	O
its	O
members	O
to	O
go	O
through	O
a	O
similar	O
inventory	O
exercise:	O
https://www.asm.org/index.php/publicpolicy-2/statements-testimony/99-policy/policy/93059-freezer-8-14	O
.	O

Using	O
2	O
pairs	O
may	O
reduce	O
the	O
risk	O
of	O
sharp	O
injuries	O
;	O
however	O
,	O
there	O
is	O
no	O
evidence	O
that	O
using	O
more	O
than	O
the	O
recommended	O
will	O
give	O
additional	O
protection	O
.	O

On	O
21	O
October	O
,	O
it	O
was	O
reported	O
that	O
she	O
had	O
been	O
diagnosed	O
with	O
meningitis	O
caused	O
by	O
the	O
virus	O
persisting	O
in	O
her	O
brain	O
.	O

Montserrado	S-Location
saw	O
a	O
47%	O
decline	O
in	O
employment	O
per	O
firm	O
in	O
contrast	O
to	O
what	O
was	O
obtained	O
prior	O
to	O
the	O
.	O

In	O
1982	O
,	O
the	O
company	O
filed	O
a	O
patent	O
for	O
the	O
process	O
and	O
the	O
technique	O
drastically	O
changed	O
the	O
production	O
of	O
insulin	O
,	O
which	O
had	O
previously	O
relied	O
on	O
slaughtered	O
animals	O
.	O

The	O
treaty	O
,	O
essentially	O
,	O
is	O
a	O
gentlemen's	O
agreement	O
amongst	O
members	O
backed	O
by	O
the	O
long-prevailing	O
thought	O
that	O
biological	O
warfare	O
should	O
not	O
be	O
used	O
in	O
battle	O
.	O

Since	O
the	O
mid-1980s	O
pharmaceutical	O
companies	O
have	O
invested	O
in	O
medications	O
for	O
cancer	O
or	O
chronic	O
disease	O
that	O
have	O
greater	O
potential	O
to	O
make	O
money	O
and	O
have	O
"	O
de-emphasized	O
or	O
dropped	O
development	O
of	O
antibiotics"	O
.	O

•	O
Mark	B-Person
Wrobel	E-Person
is	O
SIGMA	S-Scientific_research_project
program	O
manager	O
in	O
DSO	S-Organization
.	O
Launched	O
in	O
2014	O
,	O
SIGMA	S-Scientific_research_project
has	O
successfully	O
demonstrated	O
an	O
operationally	O
effective	O
,	O
continuous	O
radiation-monitoring	O
network	O
of	O
wearable	O
,	O
vehicle-mounted	O
,	O
and	O
stationary	O
radiation	O
detection	O
sensors	O
that	O
provide	O
coverage	O
across	O
a	O
large	O
city	O
or	O
region	O
.	O

The	O
basic	O
challenge	O
is	O
to	O
convince	O
the	O
participants	O
on	O
all	O
levels	O
(PI	O
to	O
technician)	O
of	O
the	O
necessity	O
to	O
share	O
experimental	O
data	O
and	O
reliably	O
use	O
data	O
management	O
systems	O
.	O

Country-level	O
analyses	O
of	O
the	O
local	O
capacity-building	O
needs	O
are	O
,	O
therefore	O
,	O
recommended	O
.	O

"	O
Our	O
aim	O
is	O
to	O
develop	O
rapid	O
and	O
reliable	O
diagnostic	O
methods	O
,	O
as	O
well	O
as	O
to	O
find	O
ways	O
to	O
reduce	O
the	O
risk	O
of	O
melioidosis	S-Pathogen
in	O
deployed	O
service	O
members,	O
"	O
said	O
.	O

However	O
,	O
some	O
inconsistencies	O
were	O
identified	O
,	O
such	O
as	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
which	O
were	O
categorized	O
according	O
to	O
the	O
highest	O
biodefense	O
level	O
,	O
but	O
were	O
not	O
included	O
in	O
the	O
corresponding	O
laboratory	O
biosafety	O
level	O
.	O

The	O
development	O
of	O
genetically	O
altered	O
strains	O
of	O
smallpox	S-Pathogen
was	O
presumably	O
conducted	O
in	O
the	O
Institute	O
under	O
the	O
leadership	O
of	O
Dr	O
.	O

Good	O
afternoon	O
,	O
Dr	O
.	O

And	O
Hamish	B-Person
de	I-Person
Bretton-Gordon	E-Person
COO	O
of	O
SecureBio	S-Organization
,	O
a	O
chemical	O
,	O
biological	O
,	O
radiological	O
and	O
nuclear	O
security	O
firm	O
in	O
the	O
United	B-Location
Kingdom	E-Location
,	O
said	O
that	O
claims	O
like	O
's	O
are	O
an	O
example	O
of	O
fear-mongering	O
.	O

New	O
study	O
results	O
on	O
SIGA	B-Technology
Technologies	E-Technology
small	O
molecule	O
antiviral	O
treatment	O
for	O
smallpox	S-Pathogen
(	O
tecovirimat	S-Drug
,	O
brand	O
name	O
TPOXX	S-Drug
)	O
indicate	O
that	O
the	O
oral	O
formulation	O
is	O
both	O
safe	O
for	O
humans	O
and	O
efficacious	O
in	O
animals	O
.	O

Visits	O
to	O
retailers	O
in	O
Europe	S-Location
and	O
Latin	B-Location
America	E-Location
declined	O
by	O
40	O
percent	O
.	O

Several	O
variants	O
of	O
CRISPR-Cas9	S-Technology
allow	O
gene	B-Technology
activation	E-Technology
or	O
genome	B-Technology
editing	E-Technology
with	O
an	O
external	O
trigger	O
such	O
as	O
light	O
or	O
small	O
molecules	O
.	O

And	O
second	O
,	O
because	O
it	O
happened	O
six	O
weeks	O
ago	O
,	O
and	O
I	O
learned	O
about	O
it	O
less	O
than	O
48	O
hours	O
ago	O
.	O

Fort	B-Location
Detrick	E-Location
officials	O
stated	O
they	O
have	O
notified	O
appropriate	O
local	O
,	O
state	O
and	O
federal	O
officials	O
of	O
the	O
situation	O
and	O
will	O
continue	O
to	O
work	O
with	O
regulatory	O
agencies	O
,	O
including	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
the	O
,	O
to	O
ensure	O
compliance	O
and	O
determine	O
the	O
necessary	O
next	O
steps	O
.	O

On	O
8	O
November	O
2012	O
,	O
in	O
an	O
article	O
published	O
in	O
the	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
Dr	O
.	O

Working	O
closely	O
with	O
our	O
DoD	O
threat	O
reduction	O
colleagues	O
,	O
we	O
are	O
also	O
making	O
sure	O
that	O
other	O
labs	O
in	O
West	B-Location
Africa	E-Location
that	O
store	O
Ebola	S-Pathogen
samples	O
identify	O
vulnerabilities	O
and	O
rapidly	O
implement	O
physical	O
security	O
measures	O
.	O

To	O
do	O
this	O
job	O
effectively	O
,	O
CDC	S-Organization
works	O
in	O
and	O
overseas	O
to	O
stop	O
outbreaks	O
where	O
they	O
occur	O
.	O

The	O
virus	O
killed	O
almost	O
200,00	O
in	O
October	O
of	O
1918	O
alone	O
.	O

After	O
the	O
September	O
identification	O
of	O
a	O
novel	O
CoV	B-Pathogen
strain	E-Pathogen
,	O
a	O
retroactive	O
analysis	O
of	O
the	O
hospital	O
workers	O
was	O
performed	O
.	O

For	O
example	O
,	O
unrestricted	O
DNA	O
synthesis	O
would	O
help	O
bad	O
actors	O
overcome	O
a	O
major	O
hurdle	O
in	O
creating	O
extremely	O
deadly	O
pathogens	O
.	O

Over	O
the	O
past	O
couple	O
of	O
decades	O
,	O
we've	O
implemented	O
the	O
Clinical	B-Platform
Laboratory	I-Platform
Improvement	I-Platform
System	E-Platform
,	O
CLIS	S-Platform
,	O
and	O
that	O
has	O
resulted	O
in	O
steady	O
improvements	O
in	O
laboratory	O
quality	O
and	O
safety	O
in	O
laboratories	O
that	O
test	O
for	O
human	O
specimens	O
.	O

Felipe	B-Person
Francisco	I-Person
Tuon	E-Person
coordinator	O
of	O
the	O
Laboratory	B-Organization
of	I-Organization
Emerging	I-Organization
Infectious	I-Organization
Diseases	E-Organization
at	O
the	O
Pontifical	B-Organization
Catholic	I-Organization
University	I-Organization
of	I-Organization
Paraná	E-Organization
in	O
Curitiba	S-Location
,	O
,	O
says	O
that	O
outbreaks	O
in	O
laboratories	O
are	O
usually	O
found	O
to	O
be	O
linked	O
to	O
insufficient	O
safety	O
precautions	O
.	O

People	O
are	O
managed	O
with	O
supportive	O
care	O
,	O
which	O
may	O
include	O
fluid	O
therapy	O
,	O
oxygen	O
support	O
,	O
and	O
supporting	O
other	O
affected	O
vital	O
organs	O
.	O

PCR	S-Equipment
reactions	O
were	O
performed	O
in	O
a	O
real-time	B-Equipment
PCR	E-Equipment
thermocycler	O
on	O
the	O
bench	O
in	O
BSL-2	S-Platform
and	O
the	O
results	O
were	O
read	O
automatically	O
.	O

Taking	O
off	O
PPE	S-Equipment
must	O
be	O
performed	O
carefully	O
to	O
avoid	O
contaminating	O
skin	O
or	O
street	O
clothes	O
.	O

Sheela	S-Person
said	O
that	O
[Rajneesh]	O
commented	O
that	O
it	O
was	O
best	O
not	O
to	O
hurt	O
people	O
,	O
but	O
if	O
a	O
few	O
died	O
not	O
to	O
worry.	O
"	O
In	O
Miller's	O
Germs:	O
Biological	O
Weapons	O
and	O
America's	O
Secret	O
War	O
,	O
this	O
statement	O
is	O
attributed	O
to	O
.	O
According	O
to	O
KD's	O
testimony	O
,	O
she	O
played	O
doubters	O
a	O
tape	O
of	O
Rajneesh's	O
muffled	O
voice	O
saying	O
,	O
"	O
if	O
it	O
was	O
necessary	O
to	O
do	O
things	O
to	O
preserve	O
[his]	O
vision	O
,	O
then	O
do	O
it,	O
"	O
and	O
interpreted	O
this	O
to	O
mean	O
that	O
murder	O
in	O
his	O
name	O
was	O
fine	O
,	O
telling	O
doubters	O
"	O
not	O
to	O
worry	O
"	O
if	O
a	O
few	O
people	O
had	O
to	O
die	O
.	O

As	O
scientists	O
improve	O
their	O
ability	O
to	O
read	O
and	O
write	O
DNA	O
,	O
the	O
possibilities	O
continue	O
to	O
expand	O
.	O

Looking	O
at	O
a	O
detailed	O
report	O
that	O
examined	O
the	O
funding	O
decrease	O
for	O
bioterrorism	O
in	O
fifty-one	O
American	O
cities	O
,	O
Dr	O
.	O

We	O
really	O
learned	O
to	O
be	O
more	O
suspicious	O
..	O
.	O

The	O
private	O
company	O
performs	O
work	O
for	O
the	O
Pentagon's	B-Organization
DTRA	I-Organization
bio	I-Organization
laboratories	E-Organization
in	O
Afghanistan	S-Location
,	O
Armenia	S-Location
,	O
Georgia	S-Location
,	O
Uganda	S-Location
,	O
Tanzania	S-Location
,	O
Iraq	S-Location
,	O
Afghanistan	S-Location
and	O
Vietnam	S-Location
.	O
Battelle	S-Organization
conducts	O
research	O
,	O
development	O
,	O
testing	O
,	O
and	O
evaluation	O
using	O
both	O
highly	O
toxic	O
chemicals	O
and	O
highly	O
pathogenic	O
biological	O
agents	O
for	O
a	O
wide	O
range	O
of	O
US	B-Organization
government	I-Organization
agencies	E-Organization
.	O
It	O
has	O
been	O
awarded	O
some	O
$2	O
billion	O
federal	O
contracts	O
in	O
total	O
and	O
ranks	O
23	O
on	O
the	O
Top	O
100	O
contractors	O
list	O
.	O

And	O
while	O
vibrating	O
,	O
she	O
uses	O
an	O
infrared	O
light	O
in	O
an	O
attempt	O
to	O
build	O
collagen	O
in	O
her	O
skin	O
.	O

Some	O
bore	O
swollen	B-Phenotype
buboes	E-Phenotype
on	O
their	O
necks	O
,	O
armpits	O
and	O
thighs	O
;	O
some	O
had	O
their	O
flesh	B-Phenotype
turn	I-Phenotype
black	I-Phenotype
from	I-Phenotype
haemorrhaging	I-Phenotype
beneath	I-Phenotype
the	I-Phenotype
skin	E-Phenotype
;	O
some	O
coughed	B-Phenotype
blood	E-Phenotype
from	O
the	O
necrotic	B-Disease
inflammation	E-Disease
of	O
their	O
throats	O
and	O
lungs	O
.	O

It	O
also	O
strives	O
to	O
"	O
ensure	O
improved	O
access	O
,	O
quality	O
and	O
use	O
of	O
medical	O
products	O
and	O
technologies"	O
.	O

According	O
to	O
a	O
2015	O
review	O
article	O
,	O
about	O
15	O
different	O
vaccines	O
were	O
in	O
preclinical	O
stages	O
of	O
development	O
,	O
including	O
DNA	O
vaccines	O
,	O
virus-like	O
particles	O
and	O
viral	O
vectors.	O
and	O
another	O
seven	O
as	O
yet	O
unheard-of	O
vaccines	O
were	O
being	O
developed	O
.	O

At	O
the	O
end	O
of	O
the	O
discussion	O
,	O
a	O
comprehensive	O
national	O
action	O
plan	O
for	O
rabies	S-Disease
prevention	O
and	O
control	O
is	O
expected	O
to	O
be	O
developed	O
to	O
carry	O
out	O
plan	O
activities	O
for	O
implementing	O
a	O
sustainable	O
long-term	O
program	O
.	O

So	O
you	O
see	O
the	O
response	O
to	O
Lassa	S-Disease
is	O
a	O
multi-pronged	O
attack	O
.	O

In	O
November	O
2018	O
,	O
the	O
DRC	S-Organization
gave	O
approval	O
to	O
start	O
clinical	O
trials	O
for	O
treatment	O
.	O

Shortly	O
after	O
the	O
E61/N	O
failed	O
to	O
make	O
standardization	O
,	O
tularemia	S-Pathogen
was	O
standardized	O
in	O
the	O
3.4	O
"	O
M143	O
bursting	O
spherical	O
bomblet	O
.	O

They	O
continue	O
to	O
circulate	O
endemically	O
and	O
epidemically	O
.	O

However	O
,	O
the	O
precise	O
ways	O
these	O
viruses	O
are	O
transmitted	O
to	O
humans	O
are	O
currently	O
unknown	O
.	O

The	O
problem	O
of	O
drug	O
resistance	O
in	O
has	O
driven	O
efforts	O
to	O
develop	O
vaccines	O
.	O

Both	O
the	O
U.S.	S-Location
bio-weapons	O
ban	O
and	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
restricted	O
any	O
work	O
in	O
the	O
area	O
of	O
biological	O
warfare	O
to	O
defensive	O
in	O
nature	O
.	O

A	O
total	O
restriction	O
on	O
both	O
human-approved	O
compounds	O
and	O
their	O
structural	O
derivatives	O
as	O
routine	O
feedstocks	O
in	O
animal	O
feed	O
,	O
agriculture	O
,	O
or	O
fisheries	O
must	O
be	O
enforced	O
.	O

In	O
response	O
to	O
the	O
threat	O
,	O
California	O
State	O
Senator	O
Ruben	B-Person
S.	I-Person
Ayala	E-Person
introduced	O
the	O
bill	O
SB1754	S-Document
in	O
the	O
Senate	B-Organization
Agriculture	I-Organization
and	I-Organization
Water	I-Organization
Resources	I-Organization
Committee	E-Organization
to	O
make	O
it	O
a	O
felony	O
for	O
any	O
person	O
to	O
import	O
Mediterranean	S-Location
fruit	O
flies	O
into	O
the	O
state,"Panel	O
OKS	O
Bill	O
Making	O
Medfly	O
Import	O
Felony"	O
,	O
(login	O
required)	O
,	O
Fresno	S-Location
Bee	O
,	O
March	O
7	O
,	O
1990	O
,	O
accessed	O
February	O
23	O
,	O
2012.	O
rather	O
than	O
the	O
misdemeanor	O
it	O
already	O
was	O
.	O

For	O
all	O
our	O
advances	O
in	O
medicine	O
,	O
humanity	O
remains	O
much	O
more	O
vulnerable	O
to	O
pandemics	O
than	O
we	O
would	O
like	O
to	O
believe	O
.	O

This	O
means	O
that	O
the	O
cut	O
DNA	O
could	O
be	O
joined	O
back	O
together	O
with	O
any	O
other	O
piece	O
of	O
DNA	O
that	O
had	O
the	O
same	O
sticky	O
end	O
.	O

On	O
18	O
October	O
,	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
raised	O
its	O
travelers'	O
alert	O
to	O
the	O
DRC	S-Location
from	O
a	O
level	O
1	O
to	O
level	O
2	O
for	O
all	O
U.S.travelers	O
.	O

•	O
Rebecca	B-Person
Martin	E-Person
is	O
director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Global	I-Organization
Health	E-Organization
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
(	O
CDC	S-Organization
)	O
.	O

CT	S-Equipment
scanning	O
of	O
the	O
head	O
is	O
typically	O
used	O
to	O
detect	O
infarction	S-Phenotype
,	O
tumors	S-Phenotype
,	O
calcifications	S-Phenotype
,	O
haemorrhage	S-Phenotype
,	O
and	O
bone	B-Phenotype
trauma	E-Phenotype
.	O
Of	O
the	O
above	O
,	O
hypodense	O
(dark)	O
structures	O
can	O
indicate	O
edema	O
and	O
infarction	O
,	O
hyperdense	O
(bright)	O
structures	O
indicate	O
calcifications	O
and	O
haemorrhage	O
and	O
bone	O
trauma	O
can	O
be	O
seen	O
as	O
disjunction	O
in	O
bone	O
windows	O
.	O

The	O
system	O
integrates	O
emergency	O
department	O
chief	O
complaints	O
with	O
data	O
from	O
health	O
clinics	O
and	O
social	O
media	O
to	O
uncover	O
outbreaks	O
that	O
do	O
not	O
correspond	O
with	O
known	O
illnesses	O
.	O

The	O
genetic	O
diversity	O
of	O
Ebolavirus	S-Pathogen
remained	O
constant	O
before	O
1900	O
.	O

PCR	S-Equipment
reactions	O
were	O
performed	O
in	O
a	O
real-time	B-Equipment
PCR	E-Equipment
thermocycler	O
on	O
the	O
bench	O
in	O
BSL-2	S-Platform
and	O
the	O
results	O
were	O
read	O
automatically	O
.	O

Similarly	O
,	O
a	O
gene	O
drive	O
,	O
despite	O
possibly	O
minimizing	O
the	O
spread	O
of	O
certain	O
diseases	O
,	O
has	O
the	O
potential	O
to	O
create	O
great	O
harm	O
since	O
it	O
is	O
intended	O
to	O
kill	O
or	O
modify	O
an	O
entire	O
species	O
.	O

Retrieved	O
22	O
January	O
2020	O
Later	O
it	O
reported	O
that	O
the	O
outbreak	O
in	O
had	O
peaked	O
in	O
mid-February	O
2003	O
.	O

Among	O
the	O
decisions	O
made	O
were	O
the	O
setting-up	O
of	O
a	O
ministerial-level	O
task	O
force	O
and	O
uniform	O
pre-departure	O
health	O
screening	O
in	O
airports	O
.	O

"	O
It	O
could	O
cause	O
a	O
large	O
number	O
of	O
horrific	O
deaths,	O
"	O
Walsh	S-Person
told	O
The	O
Sun	O
.	O

Severe	O
cases	O
are	O
most	O
common	O
in	O
older	O
adults	O
(those	O
older	O
than	O
60	O
years	O
,	O
and	O
especially	O
those	O
older	O
than	O
80	O
years)	O
.	O

Our	O
first	O
effort	O
is	O
to	O
understand	O
fully	O
what	O
happened	O
and	O
remediate	O
it	O
here	O
at	O
,	O
but	O
we	O
are	O
definitely	O
looking	O
at	O
the	O
implications	O
for	O
laboratories	O
around	O
the	O
country	O
and	O
around	O
the	O
world	O
.	O

The	O
primary	O
hazards	O
to	O
personnel	O
working	O
with	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
agents	O
are	O
respiratory	O
exposure	O
to	O
infectious	O
aerosols	O
,	O
mucous	O
membrane	O
or	O
broken	O
skin	O
exposure	O
to	O
infectious	O
droplets	O
,	O
and	O
autoinoculation	O
.	O

The	O
incident	O
is	O
being	O
investigated	O
by	O
a	O
team	O
from	O
the	O
US	B-Organization
Department	I-Organization
of	I-Organization
Agriculture's	I-Organization
Animal	I-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Service	E-Organization
.	O
In	O
addition	O
,	O
CDC's	B-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Associate	I-Organization
Director	I-Organization
for	I-Organization
Science	E-Organization
is	O
leading	O
an	O
internal	O
investigation	O
into	O
the	O
circumstances	O
surrounding	O
the	O
incident	O
.	O

He	O
chose	O
Darwin	S-Location
because	O
it	O
is	O
a	O
hyper-endemic	O
area	O
for	O
B.	B-Pathogen
pseudomallei	E-Pathogen
.	O
Because	O
of	O
its	O
environmental	O
habit	O
,	O
high	O
probability	O
of	O
infection	O
,	O
and	O
route	O
of	O
infection	O
,	O
poses	O
a	O
significant	O
danger	O
to	O
military	O
forces	O
deployed	O
to	O
such	O
areas	O
.	O

A	O
step	O
toward	O
making	O
a	O
difference	O
,	O
said	O
Lillibridge	S-Person
would	O
be	O
to	O
consolidate	O
biodefense	O
budgets	O
across	O
all	O
federal	O
agencies	O
and	O
departments	O
,	O
which	O
he	O
thinks	O
would	O
resolve	O
90	O
percent	O
of	O
the	O
country's	O
coordination	O
issues.	O
&quot;You	O
can't	O
build	O
the	O
pizza	O
if	O
you	O
hand	O
out	O
the	O
slices,&quot	O
;	O
he	O
said	O
,	O
referring	O
to	O
the	O
government's	O
disparate	O
biodefense	O
budgets	O
and	O
operations	O
.	O

"	O
We	O
are	O
pleased	O
to	O
see	O
that	O
Travelan®	S-Drug
a	O
product	O
that	O
has	O
achieved	O
significant	O
sales	O
growth	O
,	O
has	O
proven	O
its	O
reactivity	O
to	O
a	O
multitude	O
of	O
clinically	O
relevant	O
bacterium	O
strains	O
within	O
Southeast	B-Location
Asia	E-Location
including	O
ETEC	S-Pathogen
,	O
Campylobacter	S-Pathogen
and	O
.	O

The	O
regions	O
of	O
Hong	B-Location
Kong	E-Location
and	O
Macau	S-Location
instituted	O
several	O
measures	O
,	O
particularly	O
in	O
regard	O
to	O
schools	O
and	O
universities	O
.	O

The	O
stand-down	O
directive	O
is	O
expected	O
to	O
come	O
soon	O
from	O
the	O
White	B-Organization
House's	I-Organization
Office	I-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	E-Organization
(	O
OSTP	S-Organization
)	O
,	O
the	O
memo	O
states	O
,	O
and	O
be	O
delivered	O
to	O
labs	O
through	O
funding	O
agencies	O
.	O

Sabeti's	B-Person
team	E-Person
hopes	O
to	O
build	O
on	O
this	O
further	O
and	O
seeks	O
to	O
test	O
SHERLOCK	S-Platform
with	O
Nigerian	B-Person
collaborators	E-Person
,	O
as	O
a	O
means	O
of	O
addressing	O
their	O
recent	O
Lassa	B-Incident
fever	I-Incident
outbreak	E-Incident
.	O
The	O
recent	O
effort	O
was	O
led	O
by	O
Harvard	S-Organization
graduate	O
student	O
Catherine	B-Person
Freije	E-Person
and	O
postdoctoral	O
scientist	O
,	O
who	O
developed	O
a	O
simpler	O
method	O
for	O
an	O
enzyme	O
involved	O
in	O
the	O
platform	O
to	O
detect	O
its	O
target	O
directly	O
in	O
bodily	O
fluid	O
samples	O
.	O

In	O
1980	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
announced	O
the	O
eradication	O
of	O
smallpox	S-Disease
,	O
a	O
highly	O
contagious	O
and	O
incurable	O
disease	O
.	O

R0	O
can	O
vary	O
across	O
populations	O
and	O
is	O
not	O
to	O
be	O
confused	O
with	O
the	O
effective	O
reproduction	O
number	O
(commonly	O
just	O
called	O
R)	O
,	O
which	O
takes	O
into	O
account	O
effects	O
such	O
as	O
social	O
distancing	O
and	O
herd	O
immunity	O
.	O

Following	O
the	O
progression	O
of	O
the	O
outbreak	O
to	O
new	O
hotspot	O
countries	O
,	O
people	O
from	O
Italy	S-Location
(the	O
first	O
country	O
in	O
Europe	S-Location
to	O
experience	O
a	O
serious	O
outbreak	O
of	O
COVID-19	S-Disease
)	O
were	O
also	O
subjected	O
to	O
suspicion	O
and	O
xenophobia	O
,	O
as	O
were	O
people	O
from	O
hotspots	O
in	O
other	O
countries	O
.	O

This	O
could	O
strain	O
national	O
stockpiles	O
of	O
antibiotics	O
and	O
lead	O
to	O
a	O
shortage	O
of	O
the	O
vaccine	O
.	O

Curt	B-Person
Frodlund	E-Person
at	O
Utvecklingsprojekt	B-Organization
AB	E-Organization
for	O
his	O
inputs	O
on	O
project	O
management	O
.	O

ResistanceMap	S-Platform
is	O
a	O
website	O
by	O
the	O
licy	O
and	O
provides	O
data	O
on	O
antimicrobial	O
resistance	O
on	O
a	O
global	O
level	O
.	O

Her	O
case	O
was	O
described	O
as	O
"	O
very	O
minor	O
"	O
and	O
she	O
was	O
subsequently	O
declared	O
free	O
from	O
infection	O
and	O
was	O
discharged	O
from	O
hospital	O
on	O
22	O
September	O
.	O

The	O
leaders	O
pledged	O
to	O
assist	O
in	O
carrying	O
out	O
WHO	S-Organization
regulations	O
.	O

In	O
the	O
case	O
of	O
non-uniform	O
radiation	O
,	O
or	O
radiation	O
given	O
to	O
only	O
part	O
of	O
the	O
body	O
,	O
which	O
is	O
common	O
for	O
CT	B-Technology
examinations	E-Technology
using	O
the	O
local	O
equivalent	O
dose	O
alone	O
would	O
overstate	O
the	O
biological	O
risks	O
to	O
the	O
entire	O
organism	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Well	O
,	O
I	O
think	O
,	O
as	O
I	O
said	O
,	O
I	O
think	O
this	O
is	O
a	O
wake-up	O
call	O
.	O

The	O
budget	O
for	O
fiscal	O
year	O
1966	O
was	O
$38	O
million	O
.	O

These	O
tropical	O
mosquitoes	O
Aedes	O
Albopictus	O
having	O
never	O
been	O
seen	O
before	O
in	O
Georgia	S-Location
have	O
also	O
been	O
detected	O
in	O
neighboring	O
Russia	S-Location
(	O
Krasnodar)	S-Location
and	O
Turkey	S-Location
,	O
According	O
to	O
data	O
provided	O
by	O
the	O
,	O
Their	O
spread	O
is	O
unusual	O
for	O
this	O
part	O
of	O
the	O
world	O
.	O

In	O
addition	O
to	O
its	O
Atlanta	S-Location
headquarters	O
,	O
CDC	S-Organization
's	O
other	O
domestic	O
locations	O
are	O
Anchorage	S-Location
,	O
Fort	B-Location
Collins	E-Location
,	O
Hyattsville	S-Location
,	O
Research	B-Location
Triangle	I-Location
Park	E-Location
,	O
San	B-Location
Juan	I-Location
(Puerto	I-Location
Rico	E-Location
)	O
,	O
and	O
Washington	S-Location
,	O
D.C.	S-Location
,	O
while	O
NIOSH	S-Organization
operates	O
its	O
own	O
facilities	O
in	O
Cincinnati	S-Location
,	O
Morgantown	S-Location
,	O
Pittsburgh	S-Location
,	O
Spokane	S-Location
,	O
Denver	S-Location
,	O
and	O
Anchorage	S-Location
.	O
In	O
addition	O
,	O
CDC	S-Organization
operates	O
quarantine	O
facilities	O
in	O
20	O
cities	O
in	O
.	O

Certain	O
atomic	O
nuclei	O
are	O
able	O
to	O
absorb	O
radio	O
frequency	O
energy	O
when	O
placed	O
in	O
an	O
external	O
magnetic	O
field	O
;	O
the	O
resultant	O
evolving	O
spin	O
polarization	O
can	O
induce	O
an	O
RF	O
signal	O
in	O
a	O
radio	O
frequency	O
coil	O
and	O
thereby	O
be	O
detected	O
.	O

On	O
31	O
January	O
,	O
the	O
Trump	S-Person
administration	O
declared	O
a	O
public	O
health	O
emergency	O
,	O
and	O
restricted	O
entry	O
for	O
travellers	O
from	O
China	S-Location
who	O
were	O
not	O
citizens	O
.	O

They	O
further	O
stated	O
,	O
that	O
if	O
the	O
disease	O
was	O
not	O
adequately	O
contained	O
it	O
could	O
become	O
native	O
in	O
Guinea	S-Location
,	O
Sierra	B-Location
Leone	E-Location
and	O
Liberia	S-Location
,	O
"	O
spreading	O
as	O
routinely	O
as	O
malaria	S-Disease
or	O
the	O
flu	S-Disease
"	O
,	O
and	O
according	O
to	O
an	O
editorial	O
in	O
the	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
,	O
eventually	O
to	O
other	O
parts	O
of	O
and	O
beyond	O
.	O

I've	O
lost	O
sleep	O
over	O
it	O
,	O
and	O
I'm	O
working	O
around	O
the	O
clock	O
to	O
make	O
sure	O
we	O
do	O
everything	O
possible	O
to	O
resolve	O
it	O
.	O

He	O
says	O
that	O
the	O
is	O
unlikely	O
to	O
affect	O
their	O
activities	O
because	O
the	O
actions	O
are	O
recommendations	O
,	O
not	O
requirements	O
.	O

According	O
to	O
a	O
report	O
in	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
's	O
Mortality	O
and	O
Morbidity	O
Weekly	O
Report	O
,	O
Casadaban	S-Person
may	O
have	O
become	O
sick	O
because	O
he	O
had	O
hemochromatosis	S-Disease
,	O
or	O
an	O
overload	O
of	O
iron	S-Drug
in	O
the	O
body.The	O
Y.	B-Pathogen
pestis	I-Pathogen
strain	E-Pathogen
had	O
been	O
weakened	O
by	O
making	O
it	O
less	O
able	O
to	O
acquire	O
iron	S-Drug
,	O
and	O
the	O
excess	O
iron	S-Drug
in	O
Casadaban	S-Person
's	O
body	O
might	O
have	O
allowed	O
it	O
to	O
be	O
become	O
more	O
virulent	O
,	O
the	O
report	O
says	O
.	O

When	O
the	O
stockpile	O
was	O
established	O
,	O
CDC	S-Organization
was	O
the	O
only	O
major	O
public	O
health	O
agency	O
in	O
the	O
federal	O
government	O
.	O

Auster	S-Person
,	O
Bruce	B-Person
B	E-Person
.	O
"	O
Unmasking	O
an	O
Old	O
Lie	O
"	O
,	O
U.S.	S-Location
News	O
and	O
World	O
Report	O
,	O
November	O
16	O
,	O
1998	O
.	O

The	O
unintentional	O
exposure	O
was	O
discovered	O
June	O
13	O
when	O
the	O
original	O
bacterial	O
plates	O
were	O
gathered	O
for	O
disposal	O
and	O
B.	B-Pathogen
anthracis	E-Pathogen
colonies	O
(live	O
bacteria)	O
were	O
found	O
on	O
the	O
plates	O
.	O

Retroviruses	O
present	O
in	O
animal	O
genomes	O
could	O
harm	O
transplant	O
recipients	O
.	O

The	O
newly	O
approved	O
drug's	O
safety	O
was	O
established	O
with	O
tests	O
on	O
healthy	O
human	O
volunteers	O
who	O
reported	O
side	O
effects	O
that	O
include	O
headache	S-Disease
nausea	S-Disease
,	O
and	O
.	O

As	O
the	O
Swedish	O
national	O
BSL-3	S-Platform
laboratories	O
are	O
each	O
governed	O
by	O
their	O
own	O
QA	O
systems	O
and	O
diagnostic	O
methods	O
,	O
it	O
has	O
been	O
important	O
to	O
define	O
how	O
the	O
FBD	S-Platform
activities	O
relate	O
to	O
existing	O
ways	O
of	O
doing	O
things	O
.	O

Our	O
laboratories	O
are	O
the	O
reason	O
we	O
are	O
the	O
gold	O
standard	O
for	O
not	O
just	O
infectious	O
diseases	O
but	O
environmental	O
health	O
as	O
well	O
.	O

The	O
phenomenon	O
of	O
antimicrobial	O
resistance	O
caused	O
by	O
overuse	O
of	O
antibiotics	O
was	O
predicted	O
by	O
Alexander	B-Person
Fleming	E-Person
who	O
said	O
"	O
The	O
time	O
may	O
come	O
when	O
can	O
be	O
bought	O
by	O
anyone	O
in	O
the	O
shops	O
.	O

Assembling	O
a	O
living	O
cell	O
from	O
a	O
list	O
of	O
genes	O
would	O
be	O
like	O
assembling	O
a	O
jumbo	O
jet	O
from	O
a	O
list	O
of	O
mechanical	O
parts	O
.	O

Russia	S-Location
is	O
developing	O
a	O
nuclear-powered	O
cruise	O
missile	O
,	O
but	O
the	O
Russian	O
military	O
did	O
not	O
specify	O
the	O
technology	O
that	O
was	O
being	O
tested	O
at	O
.	O

Furthermore	O
,	O
there	O
is	O
no	O
provision	O
to	O
establish	O
an	O
independent	O
national	O
biosafety	O
decision-making	O
body(ies)	O
.	O

Books	O
have	O
been	O
written	O
.	O

Synthetic	B-Technology
genomics	E-Technology
is	O
different	O
in	O
that	O
scientists	O
start	O
with	O
digital	O
information	O
in	O
the	O
computer	O
,	O
which	O
allows	O
for	O
the	O
design	O
of	O
entire	O
synthetic	O
chromosomes	O
to	O
replace	O
existing	O
chromosomes	O
in	O
cells	O
.	O

10	O
.	O

The	O
CDC	S-Organization
is	O
asking	O
Congress	S-Organization
for	O
$350	O
million	O
for	O
the	O
lab	O
and	O
more	O
than	O
$50	O
million	O
for	O
related	O
work	O
.	O

Methods	O
to	O
control	O
the	O
spread	O
of	O
CRE	S-Pathogen
in	O
veterinary	O
medical	O
settings	O
have	O
not	O
yet	O
been	O
studied	O
;	O
these	O
studies	O
are	O
needed	O
to	O
limit	O
the	O
spread	O
of	O
these	O
pathogens	O
in	O
animal	O
populations	O
.	O

By	O
17	O
July	O
,	O
the	O
total	O
number	O
of	O
suspected	O
cases	O
in	O
the	O
country	O
stood	O
at	O
442	O
,	O
surpassing	O
those	O
in	O
Guinea	S-Location
and	O
Liberia	S-Location
.	O
By	O
20	O
July	O
,	O
additional	O
cases	O
of	O
the	O
disease	O
had	O
been	O
reported	O
by	O
the	O
media	O
in	O
the	O
Bo	B-Location
District	E-Location
,	O
while	O
the	O
first	O
case	O
in	O
Freetown	S-Location
,	O
's	O
capital	O
,	O
was	O
reported	O
in	O
late	O
July	O
.	O

In	O
1971	O
at	O
Stony	B-Organization
Brook	I-Organization
University	E-Organization
Paul	B-Person
Lauterbur	E-Person
applied	O
magnetic	O
field	O
gradients	O
in	O
all	O
three	O
dimensions	O
and	O
a	O
back-projection	O
technique	O
to	O
create	O
NMR	B-Technology
images	E-Technology
.	O
He	O
published	O
the	O
first	O
images	O
of	O
two	O
tubes	O
of	O
water	O
in	O
1973	O
in	O
the	O
journal	O
Nature	O
,	O
followed	O
by	O
the	O
picture	O
of	O
a	O
living	O
animal	O
,	O
a	O
clam	O
,	O
and	O
in	O
1974	O
by	O
the	O
image	O
of	O
the	O
thoracic	O
cavity	O
of	O
a	O
mouse	O
.	O

The	O
Ebola	B-Disease
epidemic	E-Disease
caused	O
an	O
increasing	O
demand	O
for	O
protective	B-Equipment
clothing	E-Equipment
.	O
A	O
full	O
set	O
of	O
protective	B-Equipment
clothing	E-Equipment
includes	O
a	O
suit	O
,	O
goggles	O
,	O
a	O
mask	O
,	O
socks	O
and	O
boots	O
,	O
and	O
an	O
apron	O
.	O

We	O
believe	O
that	O
collaboration	O
among	O
laboratories	O
will	O
be	O
central	O
when	O
it	O
comes	O
to	O
adapting	O
to	O
the	O
rapid	O
technical	O
development	O
that	O
is	O
now	O
ongoing	O
in	O
microbiology	O
laboratories	O
.	O

Patricia	B-Person
Olinger	E-Person
RBP††	O
,	O
is	O
Director	O
of	O
the	O
Environmental	B-Organization
Health	I-Organization
and	I-Organization
Safety	I-Organization
Office	E-Organization
(	O
EHSO	S-Organization
)	O
at	O
Emory	B-Organization
University	E-Organization
.	O
EHSO	S-Organization
has	O
university-wide	O
responsibility	O
for	O
developing	O
,	O
implementing	O
,	O
and	O
maintaining	O
environmental	O
health	O
and	O
safety	O
programs	O
to	O
control	O
occupational	O
exposures	O
and	O
to	O
oversee	O
the	O
implementation	O
of	O
the	O
mandated	O
federal/state	O
laws	O
,	O
regulations	O
,	O
and	O
guidelines	O
.	O

A	O
review	O
launched	O
in	O
August	O
2014	O
has	O
resulted	O
in	O
a	O
3-page	O
memo	O
(plus	O
184	O
pages	O
of	O
attachments	O
and	O
related	O
reports)	O
sent	O
today	O
to	O
federal	O
agencies	O
from	O
the	O
president's	O
science	O
adviser	O
,	O
John	B-Person
Holdren	E-Person
and	O
,	O
assistant	O
to	O
the	O
president	O
for	O
homeland	O
security	O
and	O
counterterrorism	O
.	O

After	O
returning	O
home	O
to	O
Aralsk	S-Location
,	O
she	O
infected	O
several	O
people	O
including	O
children	O
.	O

Additionally	O
,	O
cheese	O
lovers	O
may	O
be	O
interested	O
to	O
know	O
that	O
rDNA	O
provides	O
ingredients	O
for	O
a	O
majority	O
of	O
hard	O
cheeses	O
produced	O
in	O
the	O
West	O
.	O

Most	O
complications	O
have	O
occurred	O
among	O
previously	O
unhealthy	O
individuals	O
,	O
with	O
obesity	S-Disease
and	O
respiratory	O
disease	O
as	O
the	O
strongest	O
risk	O
factors	O
.	O

Investigations	O
indicated	O
that	O
the	O
deceased	O
was	O
a	O
female	O
student	O
from	O
Lunsar	S-Location
,	O
in	O
Port	B-Location
Loko	I-Location
District	E-Location
,	O
who	O
had	O
gone	O
to	O
Kambia	B-Location
District	E-Location
on	O
28	O
December	O
2015	O
before	O
returning	O
symptomatic	O
.	O

No	O
medication	O
or	O
vaccine	O
is	O
approved	O
to	O
treat	O
the	O
disease	O
.	O

The	O
WHO	S-Organization
stated	O
on	O
5January	O
that	O
cases	O
of	O
pneumonia	O
of	O
unknown	O
cause	O
had	O
been	O
reported	O
,	O
and	O
issued	O
technical	O
briefings	O
on	O
10	O
and	O
11	O
January	O
warning	O
of	O
risks	O
of	O
human-to-human	O
transmission	O
and	O
urging	O
precautions	O
due	O
to	O
the	O
similarity	O
to	O
earlier	O
SARS	S-Disease
and	O
MERS	S-Disease
outbreaks.	O
though	O
in	O
public	O
announcements	O
it	O
said	O
there	O
was	O
"	O
no	O
clear	O
evidence	O
of	O
human-to-human	O
transmission	O
"	O
as	O
late	O
as	O
14	O
January	O
.	O

The	O
CDC	S-Organization
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
and	O
diabetes	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
International	O
Association	O
of	O
National	O
Public	O
Health	O
Institutes	O
.	O

Italy	S-Location
was	O
particularly	O
badly	O
hit	O
by	O
the	O
plague	S-Disease
,	O
and	O
it	O
has	O
been	O
speculated	O
that	O
the	O
resulting	O
familiarity	O
with	O
death	O
caused	O
thinkers	O
to	O
dwell	O
more	O
on	O
their	O
lives	O
on	O
Earth	S-Location
,	O
rather	O
than	O
on	O
spirituality	O
and	O
the	O
afterlife	O
.	O

The	O
Center	B-Organization
of	I-Organization
Excellence	E-Organization
designation	O
comes	O
from	O
the	O
state's	O
economic	O
development	O
arm	O
,	O
Empire	O
State	O
Development	O
.	O

The	O
Pentagon	S-Organization
has	O
allegedly	O
performed	O
such	O
entomological	O
tests	O
in	O
Georgia	S-Location
and	O
.	O

In	O
the	O
1918–1919	B-Incident
pandemic	E-Incident
a	O
first	O
or	O
spring	O
wave	O
began	O
in	O
March	O
1918	O
and	O
spread	O
unevenly	O
through	O
the	O
United	B-Location
States	E-Location
,	O
Europe	S-Location
,	O
and	O
possibly	O
Asia	S-Location
over	O
the	O
next	O
6	O
months	O
(Figure	O
1)	O
.	O

Per	O
the	O
Swedish	B-Document
Constitution	E-Document
,	O
the	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Sweden	E-Organization
has	O
autonomy	O
that	O
prevents	O
political	O
interference	O
and	O
the	O
agency's	O
policy	O
favored	O
forgoing	O
a	O
lockdown	O
in	O
an	O
attempt	O
to	O
reach	O
herd	O
immunity	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
USDA	O
,	O
DHHS	O
,	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

In	O
2017	O
,	O
Doudna	S-Person
and	O
Charpentier	S-Person
were	O
awarded	O
the	O
Japan	O
Prize	O
in	O
Tokyo	O
,	O
Japan	O
for	O
their	O
revolutionary	O
invention	O
of	O
CRISPR-Cas9	S-Technology
.	O
In	O
2016	O
,	O
Charpentier	S-Person
,	O
Doudna	S-Person
,	O
and	O
won	O
the	O
Tang	O
Prize	O
in	O
Biopharmaceutical	O
Science	O
.	O

On	O
17	O
January	O
,	O
China	S-Location
announced	O
a	O
third	O
case	O
of	O
SARS	S-Disease
in	O
Guangzhou	S-Location
.	O
WHO	S-Organization
officials	O
urged	O
more	O
testing	O
to	O
bring	O
the	O
three	O
recently	O
announced	O
cases	O
into	O
line	O
with	O
their	O
standards	O
;	O
however	O
,	O
they	O
also	O
announced	O
SARS	B-Pathogen
virus	E-Pathogen
had	O
been	O
detected	O
by	O
a	O
team	O
in	O
civet	O
cages	O
at	O
the	O
restaurant	O
where	O
the	O
second	O
case	O
worked	O
and	O
in	O
civet	O
cages	O
in	O
the	O
market	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
.	O

In	O
recent	O
years	O
with	O
the	O
strengthening	O
of	O
the	O
discourse	O
surrounding	O
the	O
biological	O
risk	O
of	O
bioterrorist	O
nature	O
,	O
the	O
concept	O
of	O
biosafety	O
emerged	O
gradually	O
.	O

In	O
addition	O
,	O
these	O
bodies	O
synergize	O
and	O
harmonize	O
the	O
ethical	O
issues	O
related	O
to	O
the	O
release	O
and	O
use	O
of	O
GM	S-Technology
products	O
.	O

They	O
concluded	O
that	O
a	O
wide	O
consensus	O
exists	O
,	O
except	O
for	O
the	O
United	B-Location
Kingdom	E-Location
where	O
four	O
hazard	O
groups	O
of	O
animal	O
pathogens	O
,	O
in	O
addition	O
to	O
the	O
harmless	O
micro-organisms	O
,	O
are	O
distinguished	O
by	O
the	O
Ministry	B-Organization
of	I-Organization
Agriculture,	I-Organization
Fisheries	I-Organization
and	I-Organization
Food	E-Organization
()	O
.	O

Essential	O
biosafety	O
equipment	O
was	O
also	O
investigated	O
and	O
only	O
14	O
(7.	O
35%)	O
labs	O
used	O
self	B-Equipment
needle	I-Equipment
device	E-Equipment
in	O
the	O
work	O
.	O

Source:	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center	E-Organization
edited	O
.	O

In	O
July	O
2015	O
,	O
researchers	O
announced	O
that	O
a	O
vaccine	O
trial	O
in	O
Guinea	S-Location
had	O
been	O
completed	O
that	O
appeared	O
to	O
give	O
protection	O
from	O
the	O
virus	O
.	O

According	O
to	O
one	O
advocacy	O
group	O
,	O
"	O
... yet	O
the	O
IMF	S-Organization
,	O
which	O
has	O
made	O
a	O
$9	O
billion	O
surplus	O
from	O
its	O
lending	O
over	O
the	O
last	O
three	O
years	O
,	O
is	O
considering	O
offering	O
loans	O
,	O
not	O
debt	O
relief	O
and	O
grants	O
,	O
in	O
response"	O
.	O

In	O
South	B-Location
Africa	E-Location
it	O
is	O
estimated	O
that	O
about	O
300,000	O
people	O
amounting	O
to	O
6%	O
of	O
the	O
population	O
died	O
within	O
six	O
weeks	O
.	O

The	O
Black	B-Disease
Death	E-Disease
ravaged	O
much	O
of	O
the	O
Islamic	B-Location
world	E-Location
.	O
Plague	S-Disease
was	O
present	O
in	O
at	O
least	O
one	O
location	O
in	O
the	O
Islamic	O
world	O
virtually	O
every	O
year	O
between	O
1500	O
and	O
1850	O
.	O

Student	O
safety	O
and	O
personal	O
mentoring	O
are	O
fundamental	O
to	O
any	O
teaching	O
laboratory	O
for	O
science	O
undergraduates	O
.	O

Further	O
,	O
overall	O
future	O
prospects	O
are	O
also	O
highlighted	O
.	O

The	O
timing	O
and	O
spacing	O
of	O
epidemics	O
in	O
interpandemic	O
years	O
have	O
been	O
subjects	O
of	O
speculation	O
for	O
decades	O
.	O

All	O
sterilised	O
waste	O
was	O
incinerated	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
has	O
completed	O
additional	O
work	O
to	O
further	O
define	O
the	O
risk	O
of	O
anthrax	S-Pathogen
for	O
employees	O
potentially	O
exposed	O
because	O
best	O
safety	O
practices	O
were	O
not	O
followed	O
in	O
one	O
of	O
its	O
laboratories	O
in	O
early	O
June	O
.	O

Soldiers	O
with	O
a	O
mild	O
strain	O
stayed	O
where	O
they	O
were	O
,	O
while	O
the	O
severely	O
ill	O
were	O
sent	O
on	O
crowded	O
trains	O
to	O
crowded	O
field	O
hospitals	O
,	O
spreading	O
the	O
deadlier	O
virus	O
.	O

Prior	O
to	O
18	O
March	O
2020	O
,	O
the	O
British	B-Organization
government	E-Organization
did	O
not	O
impose	O
any	O
form	O
of	O
social	O
distancing	O
or	O
mass	O
quarantine	O
measures	O
on	O
its	O
citizens	O
.	O

To	O
date	O
,	O
none	O
of	O
the	O
samples	O
taken	O
from	O
laboratory	O
surfaces	O
in	O
the	O
potentially	O
affected	O
laboratories	O
have	O
been	O
positive	O
for	O
anthrax	S-Pathogen
Additional	O
investigations	O
on	O
the	O
procedure	O
used	O
to	O
treat	O
anthrax	S-Pathogen
before	O
it	O
was	O
transferred	O
to	O
lower-security	O
laboratories	O
have	O
been	O
reassuring	O
,	O
suggesting	O
that	O
while	O
it	O
is	O
not	O
impossible	O
that	O
viable	O
was	O
transferred	O
out	O
of	O
the	O
high-containment	O
laboratory	O
,	O
it	O
is	O
extremely	O
unlikely	O
that	O
this	O
happened	O
.	O

On	O
31	O
October	O
2013	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
confirmed	O
that	O
one	O
person	O
in	O
Oman	S-Location
had	O
MERS	S-Disease
.	O
The	O
WHO	S-Organization
said	O
"	O
the	O
patient	O
in	O
Oman	S-Location
is	O
a	O
68-year-old	O
man	O
from	O
region	O
who	O
became	O
ill	O
"	O
on	O
26	O
October	O
2013	O
.	O

LISA	B-Person
SCHNIRRING	E-Person
Thank	O
you	O
,	O
Dr	O
.	O

Had	O
the	O
winds	O
been	O
blowing	O
in	O
the	O
direction	O
of	O
the	O
city	O
at	O
that	O
time	O
,	O
it	O
could	O
have	O
resulted	O
in	O
the	O
pathogen	O
being	O
spread	O
to	O
hundreds	O
of	O
thousands	O
of	O
people	O
.	O

No	O
cure	O
currently	O
exists	O
,	O
although	O
vaccines	O
are	O
in	O
development	O
.	O

A	O
number	O
of	O
organisations	O
enrolled	O
local	O
people	O
to	O
conduct	O
public	O
awareness	O
campaigns	O
among	O
the	O
communities	O
in	O
Western	B-Location
Africa	E-Location
"	O
... what	O
we	O
mean	O
by	O
social	O
mobilization	O
is	O
to	O
try	O
to	O
convey	O
the	O
right	O
messages	O
,	O
in	O
terms	O
of	O
prevention	O
measures	O
,	O
adapted	O
to	O
the	O
local	O
context-adapted	O
to	O
the	O
cultural	O
practices	O
in	O
a	O
specific	O
area,	O
"	O
said	O
Vincent	B-Person
Martin	E-Person
,	O
FAO	S-Organization
's	O
representative	O
in	O
.	O

DARPA	S-Organization
will	O
hold	O
a	O
Proposers	O
Day	O
on	O
January	O
30	O
,	O
2018	O
,	O
in	O
Arlington	S-Location
,	O
Virginia	S-Location
,	O
to	O
provide	O
more	O
information	O
about	O
and	O
to	O
answer	O
questions	O
from	O
potential	O
proposers	O
.	O

Fractures	S-Disease
,	O
ligamentous	B-Disease
injuries	E-Disease
,	O
and	O
dislocations	S-Disease
can	O
easily	O
be	O
recognised	O
with	O
a	O
0.	O
2 mm	O
resolution	O
.	O

The	O
significance	O
of	O
this	O
program	O
should	O
not	O
be	O
overlooked	O
as	O
"	O
there	O
is	O
currently	O
enough	O
smallpox	B-Vaccine
vaccine	E-Vaccine
to	O
inoculate	O
every	O
United	B-Location
States	E-Location
citizen…	O
and	O
a	O
variety	O
of	O
therapeutic	O
drugs	O
to	O
treat	O
the	O
infected.	O
"	O
The	O
also	O
has	O
a	O
variety	O
of	O
laboratories	O
currently	O
working	O
to	O
increase	O
the	O
quantity	O
and	O
efficacy	O
of	O
countermeasures	O
that	O
comprise	O
the	O
national	O
stockpile	O
.	O

Locy	S-Person
,	O
Toni	S-Person
,	O
and	O
Johnson	S-Person
,	O
Kevin	S-Person
.	O
"	O
Feds	S-Organization
didn't	O
report	O
for	O
five	O
days"	O
,	O
USA	O
Today	O
,	O
February	O
4	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

In	O
California	S-Location
school	O
districts	O
and	O
universities	O
were	O
on	O
alert	O
and	O
worked	O
with	O
health	O
officials	O
to	O
launch	O
education	O
campaigns	O
.	O

In	O
a	O
press	O
release	O
on	O
19	O
April	O
,	O
DOH	S-Organization
announced	O
that	O
the	O
OFW	O
who	O
UAE	S-Location
doctors	O
found	O
positive	O
for	O
M	O
ERS-CoV	S-Pathogen
was	O
found	O
negative	O
for	O
the	O
virus	O
in	O
an	O
subsequent	O
test	O
by	O
Research	B-Organization
Institute	I-Organization
for	I-Organization
Tropical	I-Organization
Medicine	E-Organization
()	O
.	O

On	O
25	O
August	O
,	O
ASM	S-Organization
asked	O
its	O
members	O
to	O
check	O
what's	O
in	O
their	O
freezers	O
.	O

In	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
reported	O
an	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	E-Incident
in	O
the	O
Boende	B-Location
District	E-Location
,	O
part	O
of	O
the	O
northern	B-Location
Équateur	I-Location
province	E-Location
of	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
(	O
DRC	S-Location
)	O
,	O
where	O
13	O
people	O
were	O
reported	O
to	O
have	O
died	O
of	O
Ebola-like	B-Phenotype
symptoms	E-Phenotype
.	O
Genetic	B-Technology
sequencing	E-Technology
revealed	O
that	O
this	O
outbreak	O
was	O
caused	O
by	O
the	O
Zaire	B-Disease
Ebola	E-Disease
species	O
,	O
which	O
is	O
native	O
to	O
the	O
DRC	S-Location
;	O
there	O
have	O
been	O
seven	O
previous	O
Ebola	S-Disease
outbreaks	O
in	O
the	O
country	O
since	O
1976	O
.	O

The	O
general	O
objective	O
of	O
this	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
biosafety	O
precautions	O
adopted	O
in	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
State	O
.	O

The	O
US	B-Organization
Army	I-Organization
Chemical	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Command,	I-Organization
Biological	I-Organization
Weapons	I-Organization
Branch	E-Organization
studied	O
outdoor	O
mosquito	O
biting	O
activity	O
in	O
a	O
number	O
of	O
field	O
tests	O
at	O
Dugway	B-Organization
Proving	I-Organization
Ground	E-Organization
,	O
,	O
in	O
1960	O
.	O

Within	O
two	O
years	O
,	O
the	O
plague	S-Disease
had	O
spread	O
throughout	O
the	O
Islamic	O
world	O
,	O
from	O
Arabia	S-Location
across	O
North	B-Location
Africa	E-Location
.	O
The	O
pandemic	O
spread	O
westwards	O
from	O
Alexandria	S-Location
along	O
the	O
African	S-Location
coast	O
,	O
while	O
in	O
April	O
1348	O
Tunis	S-Location
was	O
infected	O
by	O
ship	O
from	O
Sicily	S-Location
.	O
Tunis	S-Location
was	O
then	O
under	O
attack	O
by	O
an	O
army	O
from	O
Morocco	S-Location
;	O
this	O
army	O
dispersed	O
in	O
1348	O
and	O
brought	O
the	O
contagion	O
with	O
them	O
to	O
Morocco	S-Location
,	O
whose	O
epidemic	O
may	O
also	O
have	O
been	O
seeded	O
from	O
the	O
Islamic	O
city	O
of	O
Almería	S-Location
in	O
.	O

Most	O
were	O
acquired	O
in	O
healthcare	O
settings	O
.	O

Although	O
the	O
Federal	O
Government	O
,	O
EPA	S-Organization
	S-Organization
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

Nearly	O
50,000	O
residents	O
of	O
Aralsk	S-Location
were	O
vaccinated	O
in	O
less	O
than	O
two	O
weeks	O
,	O
and	O
hundreds	O
were	O
placed	O
in	O
isolation	O
in	O
a	O
makeshift	O
facility	O
on	O
the	O
edge	O
of	O
town	O
where	O
they	O
could	O
receive	O
no	O
visitors	O
.	O

Federico	B-Person
Romero	E-Person
,	O
one	O
of	O
the	O
librettists	O
,	O
quipped	O
that	O
the	O
play's	O
most	O
popular	O
musical	O
number	O
,	O
Naples	O
Soldier	O
,	O
was	O
as	O
catchy	O
as	O
the	O
flu	O
.	O

And	O
a	O
reminder	O
that	O
there	O
will	O
be	O
a	O
transcript	O
available	O
following	O
the	O
briefing	O
.	O

The	O
experiments	O
date	O
back	O
to	O
2007	O
when	O
an	O
unspecified	O
quantity	O
of	O
the	O
toxin	O
was	O
procured	O
to	O
the	O
Department	B-Organization
of	I-Organization
the	I-Organization
Army	E-Organization
by	O
the	O
same	O
company	O
–	O
.	O

A	O
sharper	O
perspective	O
emerges	O
when	O
1918	O
age-specific	O
influenza	S-Disease
morbidity	O
rates	O
are	O
used	O
to	O
adjust	O
the	O
W-shaped	O
mortality	O
curve	O
(Figure	O
3	O
,	O
panels	O
,	O
A	O
,	O
B	O
,	O
and	O
C)	O
.	O

In	O
April	O
2012	O
,	O
six	O
hospital	O
workers	O
were	O
diagnosed	O
with	O
acute	B-Disease
respiratory	I-Disease
failure	E-Disease
of	O
unknown	O
origin	O
.	O

In	O
addition	O
to	O
the	O
loss	O
of	O
life	O
,	O
the	O
outbreak	O
had	O
a	O
number	O
of	O
significant	O
economic	O
impacts	O
.	O

Katsuo	B-Person
Nishiyama	E-Person
of	O
the	O
,	O
who	O
says	O
that	O
he	O
intends	O
to	O
publish	O
the	O
list	O
online	O
.	O

Other	O
publications	O
of	O
WHO	S-Organization
include	O
the	O
Bulletin	B-Document
of	I-Document
the	I-Document
World	I-Document
Health	I-Document
Organization	E-Document
,	O
the	O
Eastern	B-Document
Mediterranean	I-Document
Health	I-Document
Journal	E-Document
(overseen	O
by	O
EMRO	S-Organization
)	O
,	O
the	O
Human	B-Document
Resources	I-Document
for	I-Document
Health	E-Document
(published	O
in	O
collaboration	O
with	O
BioMed	B-Organization
Central	E-Organization
)	O
,	O
and	O
the	O
Pan	B-Document
American	I-Document
Journal	I-Document
of	I-Document
Public	I-Document
Health	E-Document
(overseen	O
by	O
)	O
.	O

That	O
contamination	O
zone	O
could	O
be	O
10	O
to	O
a	O
few	O
hundred	O
meters	O
depending	O
on	O
the	O
size	O
of	O
the	O
blast	O
and	O
other	O
factors	O
such	O
as	O
wind	O
speed	O
and	O
direction	O
,	O
and	O
whether	O
it	O
was	O
an	O
airborne	O
virus	O
.	O

In	O
a	O
February	O
meeting	O
,	O
the	O
CDC's	B-Organization
Advisory	I-Organization
Committee	I-Organization
on	I-Organization
Immunization	I-Organization
Practices	E-Organization
discussed	O
ways	O
to	O
stretch	O
out	O
doses	O
of	O
anthrax	B-Vaccine
vaccines	E-Vaccine
and	O
antibiotics	O
during	O
a	O
large-scale	O
event	O
,	O
for	O
which	O
noted	O
"	O
there's	O
not	O
an	O
imminent	O
threat.	O
"	O

A	O
workshop	O
will	O
be	O
organized	O
at	O
least	O
annually	O
,	O
hosted	O
by	O
each	O
country	O
in	O
turn	O
.	O

"	O
It's	O
great	O
to	O
hear	O
an	O
FDA	S-Organization
commissioner	O
acknowledging	O
that	O
there	O
is	O
a	O
need	O
for	O
economic	O
incentives…like	O
new	O
ways	O
of	O
paying	O
for	O
antibiotics	O
that	O
are	O
divorced	O
from	O
volume	O
of	O
use,	O
"	O
Gregory	B-Person
Daniel	E-Person
,	O
PhD	O
,	O
MPH	O
,	O
RPh	O
,	O
deputy	O
director	O
of	O
the	O
Duke-Margolis	B-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Policy	E-Organization
,	O
said	O
in	O
an	O
interview.	O
and	O
his	O
colleagues	O
last	O
year	O
authored	O
a	O
paper	O
that	O
proposed	O
a	O
new	O
reimbursement	O
model	O
for	O
antibiotics	O
that	O
would	O
combine	O
a	O
market	O
entry	O
reward	O
with	O
population-based	O
payments	O
from	O
insurance	O
companies.	O
"	O
This	O
is	O
very	O
much	O
in	O
line	O
with	O
our	O
version	O
of	O
a	O
new	O
payment	O
model,	O
"	O
he	O
said	O
.	O

Confronting	O
Gruesome	O
War	O
Atrocity	O
"	O
Vivisections	O
were	O
performed	O
on	O
prisoners	O
after	O
infecting	O
them	O
with	O
various	O
diseases	O
.	O

The	O
project's	O
stated	O
goal	O
was	O
to	O
assess	O
bio-agents	O
dissemination	O
characteristics	O
of	O
bomblets	O
.	O

Switching	O
to	O
Keasling	S-Person
's	O
method	O
for	O
production	O
is	O
likely	O
to	O
shave	O
30–60%	O
off	O
the	O
cost	O
of	O
the	O
drug	O
,	O
making	O
it	O
more	O
affordable	O
in	O
the	O
developing	O
countries	O
that	O
need	O
it	O
.	O

According	O
to	O
the	O
2005	O
Agreement	O
between	O
the	O
US	B-Organization
DoD	E-Organization
and	O
the	O
Ministry	B-Organization
of	I-Organization
Health	I-Organization
of	I-Organization
Ukraine	E-Organization
the	O
Ukrainian	B-Organization
government	E-Organization
is	O
prohibited	O
from	O
public	O
disclosure	O
of	O
sensitive	O
information	O
about	O
the	O
US	S-Location
program	O
and	O
Ukraine	S-Organization
is	O
obliged	O
to	O
transfer	O
to	O
the	O
US	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)	O
dangerous	O
pathogens	O
for	O
biological	O
research	O
.	O

In	O
November	O
,	O
WHO	S-Organization
released	O
a	O
protocol	O
for	O
the	O
safe	O
and	O
dignified	O
burial	O
of	O
people	O
who	O
die	O
from	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
It	O
encouraged	O
the	O
inclusion	O
of	O
family	O
and	O
clergy	O
,	O
and	O
gave	O
specific	O
instructions	O
for	O
Muslim	O
and	O
Christian	O
burials	O
.	O

Toxins:	O
Botulinum	S-Pathogen
,	O
etc	O
.	O

On	O
11	O
March	O
,	O
Prime	O
Minister	O
ordered	O
stoppage	O
of	O
nearly	O
all	O
commercial	O
activity	O
except	O
supermarkets	O
and	O
pharmacies	O
.	O

Europe	S-Location
has	O
also	O
been	O
affected	O
by	O
African	O
in	O
recent	O
years	O
,	O
which	O
can	O
be	O
carried	O
by	O
both	O
domesticated	O
pigs	O
and	O
wild	O
boars	O
.	O

Within	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
the	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
would	O
lose	O
18	O
percent	O
of	O
its	O
budget	O
.	O

The	O
specific	O
objectives	O
of	O
this	O
study	O
were:	O
1)	O
to	O
investigate	O
laboratory	O
biosafety	O
standards	O
practices	O
and	O
techniques	O
in	O
diagnostic	O
laboratories	O
;	O
2)	O
to	O
determine	O
the	O
awareness	O
of	O
laboratory	O
staff	O
towards	O
potential	O
hazards	O
.	O

One	O
hypothesis	O
is	O
that	O
the	O
virus	O
strain	O
originated	O
at	O
Fort	B-Location
Riley	E-Location
,	O
Kansas	S-Location
,	O
in	O
viruses	O
in	O
poultry	O
and	O
swine	O
which	O
the	O
fort	O
bred	O
for	O
food	O
;	O
the	O
soldiers	O
were	O
then	O
sent	O
from	O
Fort	B-Location
Riley	E-Location
around	O
the	O
world	O
,	O
where	O
they	O
spread	O
the	O
disease	O
.	O

The	O
worker	O
was	O
tested	O
for	O
dengue	B-Pathogen
virus	E-Pathogen
antibodies	O
after	O
the	O
bite	O
and	O
again	O
three	O
weeks	O
later	O
but	O
showed	O
no	O
signs	O
of	O
exposure	O
,	O
the	O
report	O
said	O
.	O

On	O
4	O
May	O
,	O
the	O
newly	O
infected	O
number	O
of	O
people	O
in	O
Hong	B-Location
Kong	E-Location
dropped	O
to	O
single	O
digits	O
.	O

Medical	O
societies	O
issue	O
guidelines	O
for	O
when	O
physicians	O
should	O
use	O
MRI	S-Technology
on	O
patients	O
and	O
recommend	O
against	O
overuse	O
.	O

The	O
spatial	O
resolution	O
is	O
much	O
lower	O
(limited	O
by	O
the	O
available	O
SNR)	O
,	O
but	O
the	O
spectra	O
in	O
each	O
voxel	O
contains	O
information	O
about	O
many	O
metabolites	O
.	O

However	O
,	O
Congress	O
directed	O
that	O
the	O
initialism	O
be	O
retained	O
because	O
of	O
its	O
name	O
recognition	O
.	O

Cole	S-Person
is	O
a	O
veterinary	O
microbiologist	O
and	O
a	O
lecturer	O
at	O
the	O
University	B-Organization
of	I-Organization
Pennsylvania	I-Organization
School	I-Organization
of	I-Organization
Veterinary	I-Organization
Medicine	E-Organization
,	O
,	O
PA	O
.	O

Working	O
on	O
their	O
bench	O
tops	O
,	O
students	O
add	O
the	O
blocking	O
solution	O
,	O
primary	O
and	O
secondary	O
antibodies	O
,	O
and	O
a	O
substrate	O
,	O
and	O
then	O
read	O
their	O
results	O
in	O
an	O
(lab4	O
,	O
Table	O
1)	O
.	O

In	O
South	B-Location
Africa	E-Location
it	O
is	O
estimated	O
that	O
about	O
300,000	O
people	O
amounting	O
to	O
6%	O
of	O
the	O
population	O
died	O
within	O
six	O
weeks	O
.	O

I'm	O
going	O
to	O
stop	O
there	O
.	O

These	O
plates	O
had	O
appeared	O
negative	O
for	O
B.	B-Pathogen
anthracis	E-Pathogen
at	O
the	O
time	O
samples	O
were	O
distributed	O
to	O
the	O
other	O
laboratories	O
.	O

BETSY	B-Person
MCKAY	E-Person
Okay.Thanks	O
.	O

WHO	S-Organization
established	O
a	O
network	O
of	O
consultants	O
who	O
assisted	O
countries	O
in	O
setting	O
up	O
surveillance	O
and	O
containment	O
activities	O
.	O

Croddy	S-Person
,	O
Eric	B-Person
C.	E-Person
and	O
Hart,	B-Person
C.	E-Person
Perez-Armendariz	B-Person
J.	E-Person
,	O
Chemical	O
and	O
Biological	O
Warfare	O
,	O
(Google	O
Books)	O
,	O
Springer	O
,	O
2002	O
,	O
pp.	O
30–31	O
,	O
()	O
.	O

CAUTION:	O
&lt;organism	O
name&gt	O
;	O
is	B-Platform
a	I-Platform
Biosafety	I-Platform
L	E-Platform
organism	O
.	O

Beckett	S-Person
(1983)	O
,	O
Weapons	O
of	O
Tomorrow	O
,	O
New	B-Location
York	E-Location
,	O
:	O
Plenum	O
Press	O
.	O

1953:	O
The	O
fifteenth	O
directorate	O
of	O
the	O
Red	B-Organization
Army	E-Organization
takes	O
responsibility	O
for	O
the	O
program	O
.	O

By	O
designing	O
2	O
or	O
3	O
experiments	O
that	O
intertwine	O
with	O
each	O
other	O
during	O
different	O
periods	O
of	O
the	O
lab	O
,	O
a	O
potential	O
bottle‐neck	O
problem	O
is	O
avoided	O
,	O
while	O
still	O
allowing	O
students	O
to	O
learn	O
invaluable	O
techniques	O
by	O
performing	O
the	O
experiments	O
themselves	O
in	O
an	O
individual	O
,	O
supervised	O
way	O
.	O

Note	O
2:	O
Data	O
are	O
from	O
reports	O
by	O
the	O
WHO	B-Organization
Global	I-Organization
Alert	I-Organization
and	I-Organization
Response	I-Organization
Unit	E-Organization
and	O
the	O
WHO	S-Organization
's	O
Regional	B-Organization
Office	I-Organization
for	I-Organization
Africa	E-Organization
.	O
All	O
numbers	O
are	O
correlated	O
with	O
UN	B-Organization
Office	I-Organization
for	I-Organization
the	I-Organization
Coordination	I-Organization
of	I-Organization
Humanitarian	I-Organization
Affairs	E-Organization
(	O
OCHA	S-Organization
)	O
,	O
if	O
available	O
.	O

The	O
impact	O
of	O
this	O
pandemic	O
was	O
not	O
limited	O
to	O
1918–1919	O
.	O

On	O
5	O
January	O
,	O
China	S-Location
confirmed	O
that	O
the	O
case	O
reported	O
in	O
December	O
was	O
a	O
case	O
of	O
wild	O
source	O
SARS	S-Disease
.	O
The	O
Philippines	S-Organization
announced	O
a	O
possible	O
case	O
in	O
a	O
person	O
just	O
returned	O
from	O
Hong	B-Location
Kong	E-Location
.	O
The	O
patient	O
was	O
later	O
determined	O
to	O
be	O
suffering	O
from	O
pneumonia	S-Disease
and	O
not	O
SARS	S-Disease
.	O
In	O
,	O
Asian	O
palm	O
civets	O
were	O
culled	O
in	O
markets	O
(the	O
civets	O
were	O
thought	O
to	O
be	O
a	O
reservoir	O
for	O
the	O
disease)	O
.	O

It	O
was	O
then	O
reacted	O
with	O
an	O
excess	O
of	O
trimethylsilyl	O
cyanide	O
in	O
dichloromethane	O
at	O
for	O
10	O
minutes	O
.	O

Thanks	O
for	O
joining	O
us	O
today	O
.	O

Recent	O
work	O
combining	O
open-source	O
hardware	O
of	O
microcontrollers	O
like	O
the	O
Arduino	S-Platform
and	O
,	O
very	O
low-cost	O
scientific	O
instruments	O
have	O
been	O
developed	O
.	O

Designer	O
diseases	O
can	O
be	O
engineered	O
to	O
target	O
a	O
certain	O
ethnic	O
group	O
,	O
meaning	O
that	O
they	O
can	O
be	O
used	O
as	O
ethnic	O
bio-weapons	O
.	O

He	O
implored	O
the	O
U.S.	O
government	O
to	O
take	O
the	O
proper	O
and	O
necessary	O
actions	O
to	O
implement	O
a	O
strategic	O
plan	O
of	O
action	O
to	O
save	O
as	O
many	O
lives	O
as	O
possible	O
and	O
to	O
safeguard	O
against	O
potential	O
chaos	O
and	O
confusion	O
.	O

By	O
mid-September	O
,	O
however	O
,	O
there	O
had	O
been	O
only	O
two	O
additional	O
cases	O
in	O
the	O
Mandima	B-Location
Health	I-Location
Zone	E-Location
,	O
and	O
only	O
sporadic	O
cases	O
were	O
being	O
reported	O
in	O
the	O
.	O

One	O
of	O
the	O
most	O
frequent	O
conversations	O
I	O
have	O
been	O
involved	O
in	O
is	O
about	O
correcting	O
life-threatening	O
disorders	O
in	O
human	O
embryos	O
.	O

As	O
the	O
epidemic	O
waned	O
,	O
following	O
international	O
control	O
efforts	O
,	O
the	O
edition	O
of	O
8	O
April	O
2015	O
of	O
the	O
WHO	S-Organization
Ebola	B-Document
Situation	I-Document
Reports	E-Document
stated	O
that	O
a	O
total	O
of	O
30	O
cases	O
were	O
reported	O
and	O
in	O
29	O
July	O
2015	O
,	O
the	O
WHO	S-Organization
weekly	O
update	O
reported	O
only	O
7	O
cases-the	O
lowest	O
in	O
more	O
than	O
a	O
year	O
.	O

The	O
processes	O
of	O
package	O
unwrapping	O
,	O
sample	O
registration	O
and	O
photographing	O
,	O
sample	O
aliquoting	O
,	O
EBOV	S-Pathogen
inactivation	O
,	O
and	O
a	O
blood	O
assay	O
for	O
malaria	S-Disease
(colloidal	O
gold	O
method)	O
were	O
performed	O
in	O
the	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
the	O
laboratory	O
.	O

This	O
collaboration	O
between	O
the	O
National	B-Organization
Veterinary	I-Organization
Institute	E-Organization
and	O
the	O
National	B-Organization
Food	I-Organization
Agency	E-Organization
initially	O
focused	O
on	O
biopreparedness	O
and	O
the	O
deliberate	O
spread	O
of	O
pathogens	O
in	O
the	O
food	O
chain	O
.	O

These	O
are	O
procedures	O
in	O
laboratory	O
procedures	O
.	O

On	O
17	O
March	O
2016	O
the	O
WHO	S-Organization
announced	O
that	O
the	O
Sierra	B-Location
Leone	E-Location
flare-up	O
was	O
over	O
,	O
and	O
that	O
no	O
other	O
chains	O
of	O
transmission	O
were	O
known	O
to	O
be	O
active	O
at	O
that	O
time	O
.	O

In	O
Europe	S-Location
,	O
of	O
those	O
infected	O
with	O
COVID‑19	S-Location
,	O
57%	O
were	O
men	O
;	O
of	O
those	O
infected	O
with	O
COVID‑19	S-Location
who	O
also	O
died	O
,	O
72%	O
were	O
men	O
.	O

The	O
most	O
common	O
reactions	O
from	O
these	O
agents	O
are	O
mild	O
,	O
including	O
nausea	S-Phenotype
,	O
vomiting	S-Phenotype
and	O
an	O
itching	B-Phenotype
rash	E-Phenotype
;	O
however	O
,	O
more	O
severe	O
reactions	O
may	O
occur	O
.	O

On	O
22	O
May	O
,	O
the	O
WHO	S-Organization
reported	O
another	O
rise	O
in	O
cases	O
,	O
per	O
media	O
reports	O
,	O
which	O
was	O
believed	O
to	O
have	O
been	O
due	O
to	O
funeral	O
transmissions	O
;	O
on	O
25	O
May	O
,	O
six	O
persons	O
were	O
placed	O
in	O
prison	O
isolation	O
after	O
they	O
were	O
found	O
travelling	O
with	O
the	O
corpse	O
of	O
an	O
individual	O
who	O
had	O
died	O
of	O
the	O
disease	O
,	O
on	O
1	O
June	O
,	O
it	O
was	O
reported	O
that	O
violent	O
protests	O
in	O
a	O
north	O
Guinean	O
town	O
at	O
the	O
border	O
with	O
Guinea-Bissau	S-Location
had	O
caused	O
the	O
to	O
withdraw	O
its	O
workers	O
.	O

Animal	O
and	O
plant	O
pathogens	O
which	O
are	O
known	O
not	O
to	O
affect	O
man	O
are	O
excluded	O
.	O

The	O
aims	O
to	O
build	O
this	O
foundational	O
work	O
into	O
an	O
entire	O
system	O
capable	O
of	O
halting	O
the	O
spread	O
of	O
any	O
viral	O
disease	O
outbreak	O
within	O
60	O
days	O
.	O

Prior	O
to	O
arrival	O
in	O
Sierra	B-Location
Leone	E-Location
a	O
set	O
of	O
laboratory	O
management	O
and	O
program	O
documents	O
were	O
prepared	O
based	O
on	O
the	O
BSL-3	S-Platform
documents	O
of	O
the	O
NIVDC	S-Organization
,	O
China	B-Organization
CDC	E-Organization
.	O
Those	O
documents	O
were	O
revised	O
after	O
we	O
arrived	O
at	O
the	O
SLE–CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
,	O
according	O
to	O
the	O
acute	O
situation	O
.	O

These	O
were	O
conducted	O
while	O
the	O
patients	O
were	O
alive	O
because	O
it	O
was	O
thought	O
that	O
the	O
death	O
of	O
the	O
subject	O
would	O
affect	O
the	O
results	O
.	O

Thinking	O
that	O
spread	O
of	O
the	O
virus	O
had	O
been	O
contained	O
,	O
closed	O
its	O
treatment	O
centres	O
in	O
May	O
,	O
leaving	O
only	O
a	O
skeleton	O
staff	O
to	O
handle	O
the	O
Macenta	O
region	O
.	O

Rapid	O
progress	O
in	O
the	O
application	O
of	O
biotechnological	O
methodologies	O
and	O
development	O
of	O
genetically	O
modified	O
crops	O
in	O
Iran	S-Location
necessitated	O
intensive	O
efforts	O
to	O
establish	O
proper	O
organizations	O
and	O
prepare	O
required	O
rules	O
and	O
regulations	O
at	O
the	O
national	O
level	O
to	O
ensure	O
safe	O
application	O
of	O
biotechnology	O
in	O
all	O
pertinent	O
aspects	O
.	O

In	O
the	O
Pacific	S-Location
American	O
Samoa	S-Location
and	O
the	O
French	O
colony	O
of	O
New	B-Location
Caledonia	E-Location
also	O
succeeded	O
in	O
preventing	O
even	O
a	O
single	O
death	O
from	O
influenza	S-Disease
through	O
effective	O
quarantines	O
.	O

But	O
there's	O
going	O
to	O
be	O
time	O
to	O
answer	O
questions	O
.	O

They	O
can	O
cause	O
diseases	O
of	O
plague	S-Disease
dimensions	O
with	O
serious	O
economic	O
and	O
environmental	O
consequences	O
.	O

So	O
though	O
we	O
wish	O
there's	O
parts	O
of	O
the	O
science	O
that	O
we	O
work	O
on	O
weren't	O
necessary	O
,	O
unfortunately	O
,	O
in	O
the	O
world	O
we	O
live	O
in	O
today	O
,	O
they	O
are	O
.	O

In	O
2009	O
,	O
U.S.	O
agricultural	O
officials	O
speculated	O
,	O
although	O
emphasizing	O
that	O
there	O
was	O
no	O
way	O
to	O
prove	O
their	O
hypothesis	O
,	O
that	O
"	O
contrary	O
to	O
the	O
popular	O
assumption	O
that	O
the	O
new	O
swine	B-Incident
flu	I-Incident
pandemic	E-Incident
arose	O
on	O
factory	O
farms	O
in	O
Mexico	S-Location
,	O
[the	O
virus]	O
most	O
likely	O
emerged	O
in	O
pigs	O
in	O
Asia	S-Location
,	O
but	O
then	O
traveled	O
to	O
North	B-Location
America	E-Location
in	O
a	O
human.	O
"	O
However	O
,	O
a	O
subsequent	O
report	O
by	O
researchers	O
at	O
the	O
Mount	B-Organization
Sinai	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
in	O
2016	O
found	O
that	O
the	O
2009	O
H1N1	B-Pathogen
virus	E-Pathogen
likely	O
originated	O
from	O
pigs	O
in	O
a	O
very	O
small	O
region	O
of	O
central	O
.	O

According	O
to	O
local	O
people	O
,	O
they	O
bite	O
and	O
cause	O
.	O
Their	O
breeding	O
habitats	O
are	O
house	O
drains	O
.	O

Unit	B-Organization
731	E-Organization
had	O
other	O
units	O
underneath	O
it	O
in	O
the	O
chain	O
of	O
command	O
;	O
there	O
were	O
several	O
other	O
units	O
under	O
the	O
auspice	O
of	O
Japan's	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
programs	E-Scientific_research_project
.	O
Most	O
or	O
all	O
Units	O
had	O
branch	O
offices	O
,	O
which	O
were	O
also	O
often	O
referred	O
to	O
as	O
"	O
Units".	O
The	O
term	O
can	O
refer	O
to	O
the	O
Harbin	O
complex	O
itself	O
,	O
or	O
it	O
can	O
refer	O
to	O
the	O
organization	O
and	O
its	O
branches	O
,	O
sub-Units	O
and	O
their	O
branches	O
.	O

Only	O
a	O
few	O
animals	O
serve	O
as	O
hosts	O
,	O
including	O
primates	O
,	O
bats	O
and	O
forest	O
antelope	O
,	O
and	O
none	O
of	O
these	O
are	O
particularly	O
easy	O
to	O
detain	O
.	O

This	O
occurs	O
more	O
commonly	O
when	O
a	O
thin	O
slice	O
thickness	O
is	O
used	O
.	O

According	O
to	O
a	O
2015	O
review	O
article	O
,	O
about	O
15	O
different	O
vaccines	O
were	O
in	O
preclinical	O
stages	O
of	O
development	O
,	O
including	O
DNA	O
vaccines	O
,	O
virus-like	O
particles	O
and	O
viral	O
vectors.	O
and	O
another	O
seven	O
as	O
yet	O
unheard-of	O
vaccines	O
were	O
being	O
developed	O
.	O

Smith	S-Person
was	O
studying	O
a	O
bacterium	O
,	O
Haemophilus	B-Pathogen
influenzae	E-Pathogen
,	O
and	O
the	O
small	O
viral	O
particles	O
called	O
phages	S-Pathogen
that	O
infect	O
bacterial	O
cells	O
.	O

Within	O
each	O
sector	O
,	O
local	O
and	O
regional	O
actors	O
handle	O
samples	O
and	O
communicate	O
with	O
national	O
resources	O
and	O
BSL-3	S-Platform
laboratories	O
.	O

Mortality	O
data	O
are	O
in	O
accord	O
.	O

Kidney	O
organoids	O
from	O
stem	O
cells	O
with	O
PKD	O
mutations	O
formed	O
large	O
,	O
translucent	O
cyst	O
structures	O
from	O
kidney	O
tubules	O
.	O

NDM-5–producing	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
have	O
been	O
reported	O
in	O
dogs	O
from	O
Finland	S-Location
,	O
South	B-Location
Korea	E-Location
,	O
and	O
Algeria	S-Location
(3–5)	O
.	O

Control	O
of	O
public	O
movement	O
was	O
applied	O
in	O
many	O
cities	O
,	O
and	O
an	O
estimated	O
760 million	O
people	O
(more	O
than	O
half	O
the	O
population)	O
faced	O
some	O
form	O
of	O
outdoor	O
restriction	O
.	O

The	O
use	O
of	O
RIDTs	S-Technology
has	O
been	O
questioned	O
by	O
researcher	O
Paul	B-Person
Schreckenberger	E-Person
of	O
the	O
Loyola	B-Organization
University	I-Organization
Health	I-Organization
System	E-Organization
,	O
who	O
suggests	O
that	O
rapid	O
tests	O
may	O
actually	O
pose	O
a	O
dangerous	O
public	O
health	O
risk	O
.	O

Have	O
you	O
heard	O
about	O
the	O
National	B-Organization
Bio	I-Organization
and	I-Organization
Agro-defense	I-Organization
facility	E-Organization
that's	O
under	O
construction	O
in	O
Manhattan	S-Location
,	O
Kansas	S-Location
,	O
which	O
is	O
home	O
to	O
?	O

In	O
September	O
2016	O
,	O
findings	O
were	O
published	O
suggesting	O
that	O
the	O
resurgence	O
in	O
Guinea	S-Location
was	O
caused	O
by	O
an	O
Ebola	S-Disease
survivor	O
who	O
,	O
after	O
eight	O
months	O
of	O
abstinence	O
,	O
had	O
sexual	O
relations	O
with	O
several	O
partners	O
,	O
including	O
the	O
first	O
victim	O
in	O
the	O
new	O
outbreak	O
.	O

The	O
lab	O
investigates	O
deadly	O
and	O
exotic	O
germs	O
like	O
Ebola	S-Disease
,	O
and	O
dangerous	O
new	O
forms	O
of	O
flu	O
.	O

The	O
existing	O
building	O
,	O
which	O
went	O
into	O
service	O
in	O
2005	O
,	O
will	O
need	O
to	O
be	O
replaced	O
by	O
2023	O
or	O
so	O
to	O
avoid	O
major	O
disruptions	O
in	O
the	O
work	O
,	O
senior	O
agency	O
staff	O
told	O
.	O

Public	O
Health	O
Service	O
and	O
Atlanta	S-Location
was	O
chosen	O
as	O
the	O
location	O
because	O
was	O
endemic	O
in	O
the	O
Southern	O
United	O
States	O
.	O

These	O
could	O
arm	O
warheads	O
for	O
their	O
SS-18	O
intercontinental	O
missiles	O
to	O
target	O
American	O
cities	O
.	O

Anatomical	O
imaging	O
of	O
the	O
bile	O
ducts	O
is	O
achieved	O
by	O
using	O
a	O
heavily	O
T2-weighted	O
sequence	O
in	O
magnetic	B-Technology
resonance	I-Technology
cholangiopancreatography	E-Technology
(	O
MRCP	S-Technology
)	O
.	O

It	O
occupies	O
a	O
surface	O
area	O
of	O
1813	O
metres	O
square	O
.	O

Masks	S-Equipment
were	O
not	O
generally	O
provided	O
by	O
airlines	O
and	O
the	O
CDC	S-Organization
did	O
not	O
recommend	O
that	O
airline	O
crews	O
wear	O
them	O
.	O

"	O
We	O
know	O
that	O
the	O
vaccine	O
works	O
well	O
in	O
the	O
vast	O
majority	O
of	O
cases,	O
"	O
Alan	B-Person
P.	I-Person
Zelicoff	E-Person
a	O
team	O
member	O
who	O
is	O
also	O
a	O
physician	O
and	O
smallpox	O
expert	O
at	O
the	O
,	O
said	O
in	O
an	O
interview.	O
"	O
What	O
the	O
new	O
data	O
strongly	O
suggests	O
is	O
that	O
we	O
have	O
much	O
more	O
work	O
to	O
do	O
on	O
new	O
vaccines	O
and	O
the	O
development	O
of	O
antiviral	O
drugs	O
,	O
none	O
of	O
which	O
are	O
available	O
today.	O
"	O

One	O
dispersion	O
test	O
involved	O
laboratory	O
personnel	O
disguised	O
as	O
passengers	O
spraying	O
harmless	O
bacteria	O
in	O
.	O

In	O
a	O
way	O
,	O
what	O
has	O
changed	O
is	O
our	O
ability	O
to	O
detect	O
an	O
illness	O
that	O
has	O
been	O
there	O
all	O
along	O
.	O

The	O
United	B-Location
States	E-Location
had	O
no	O
solid	O
proof	O
of	O
this	O
program	O
until	O
Dr	O
.	O

Scientific	O
conferences	O
and	O
meetings	O
on	O
GMOs	S-Technology
and	O
other	O
biotechnology-related	O
topics	O
were	O
the	O
next	O
most	O
frequently	O
conducted	O
initiatives	O
at	O
18.	O
5%	O
(n = 339)	O
(see	O
Figure	O
2)	O
.	O

George	B-Person
Poste	E-Person
chief	O
scientist	O
of	O
the	O
Complex	B-Organization
Adaptive	I-Organization
Systems	I-Organization
Initiative	E-Organization
and	O
former	O
director	O
of	O
the	O
Biodesign	B-Organization
Institute	I-Organization
at	I-Organization
Arizona	I-Organization
State	I-Organization
University	E-Organization
,	O
said	O
the	O
chief	O
road	O
block	O
to	O
creating	O
marketable	O
medical	O
countermeasures	O
is	O
the	O
federal	O
funding	O
cycle	O
.	O

My	O
question	O
is	O
what	O
were	O
the	O
security	O
protocols	O
that	O
were	O
put	O
in	O
place	O
following	O
that?	O
And	O
were	O
those	O
protocols	O
followed?	O
You'd	O
think	O
if	O
you	O
had	O
a	O
similar	O
incident	O
in	O
2006	O
,	O
you	O
wouldn't	O
be	O
in	O
the	O
position	O
that	O
you	O
find	O
yourself	O
in	O
today	O
.	O

"	O
The	O
concerns	O
are	O
that	O
the	O
facility	O
we've	O
been	O
in	O
now	O
is	O
beginning	O
to	O
show	O
signs	O
of	O
age,	O
"	O
said	O
Dr	O
.	O

CDC	S-Organization
today	O
released	O
the	O
findings	O
of	O
its	O
internal	O
investigation	O
into	O
the	O
and	O
the	O
subsequent	O
shipment	O
of	O
the	O
contaminated	O
culture	O
to	O
an	O
external	O
high-containment	O
laboratory	O
.	O

So	O
when	O
someone	O
takes	O
antibiotics	O
for	O
the	O
wrong	O
illness	O
or	O
uses	O
too	O
many	O
too	O
often	O
,	O
this	O
kills	O
off	O
helpful	O
bacteria	O
that	O
populate	O
the	O
body	O
,	O
threatening	O
the	O
delicate	O
balance	O
upon	O
which	O
health	O
depends	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	S-Organization
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Although	O
the	O
disease	O
has	O
been	O
eliminated	O
in	O
the	O
wild	O
,	O
frozen	O
stocks	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
are	O
still	O
maintained	O
by	O
the	O
governments	O
of	O
the	O
United	B-Location
States	E-Location
and	O
Russia	S-Location
.	O
Disastrous	O
consequences	O
are	O
feared	O
if	O
rogue	O
politicians	O
or	O
terrorists	O
were	O
to	O
get	O
hold	O
of	O
the	O
smallpox	B-Pathogen
strains	E-Pathogen
.	O
(citation	O
needed)	O
Since	O
vaccination	O
programs	O
are	O
now	O
terminated	O
,	O
the	O
world	O
population	O
is	O
more	O
susceptible	O
to	O
than	O
ever	O
before	O
.	O

Information	O
has	O
also	O
been	O
made	O
available	O
on	O
the	O
relevant	O
authorities'	O
websites	O
,	O
and	O
a	O
leaflet	O
has	O
been	O
produced	O
and	O
distributed	O
.	O

Iraqi	S-Organization
scientist	O
Nassir	B-Person
al-Hindawi	E-Person
was	O
described	O
by	O
United	B-Organization
Nations	E-Organization
inspectors	O
as	O
the	O
"	O
father	O
of	O
Iraq's	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
"	O
.	O
Two	O
of	O
the	O
leading	O
researchers	O
in	O
the	O
program	O
studied	O
in	O
Britain	S-Location
.	O
Rihab	B-Person
al-Taha	E-Person
(	O
"	O
Dr	O
.	O

And	O
number	O
two	O
,	O
you've	O
talked	O
a	O
lot	O
about	O
putting	O
new	O
procedures	O
in	O
place	O
.	O

This	O
case	O
,	O
however	O
,	O
had	O
no	O
relation	O
to	O
those	O
originating	O
from	O
Duncan	S-Location
.	O
recovered	O
and	O
was	O
released	O
from	O
hospital	O
on	O
11	O
November	O
.	O

When	O
the	O
U.S.	B-Scientific_research_project
biological	I-Scientific_research_project
warfare	I-Scientific_research_project
program	E-Scientific_research_project
ended	O
in	O
1969	O
it	O
had	O
developed	O
six	O
mass-produced	O
,	O
battle-ready	O
biological	O
weapons	O
in	O
the	O
form	O
of	O
agents	O
that	O
cause	O
anthrax	S-Disease
,	O
tularemia	S-Disease
,	O
brucellosis	S-Disease
,	O
Q-fever	S-Disease
,	O
VEE	S-Disease
,	O
and	O
botulism	S-Disease
.	O
In	O
addition	O
staphylococcal	B-Pathogen
enterotoxin	I-Pathogen
B	E-Pathogen
was	O
produced	O
as	O
an	O
incapacitating	O
agent	O
.	O

Google	O
Books	O
website	O
Retrieved	O
13	O
April	O
2020	O
.	O

The	O
first	O
confirmed	O
case	O
in	O
Butembo	S-Location
was	O
announced	O
on	O
4	O
September	O
,	O
the	O
same	O
day	O
that	O
it	O
was	O
announced	O
that	O
one	O
of	O
the	O
cases	O
registered	O
at	O
Beni	S-Location
had	O
actually	O
come	O
from	O
the	O
.	O

Statistical	O
analysis	O
then	O
identify	O
genes	O
that	O
are	O
significantly	O
likely	O
to	O
be	O
relevant	O
to	O
the	O
phenotype	O
of	O
interest	O
.	O

The	O
diseases	O
they	O
cultivated	O
as	O
weapons	O
were	O
glanders	S-Pathogen
and	O
,	O
both	O
known	O
to	O
ravage	O
populations	O
of	O
grazing	O
animals	O
in	O
natural	O
epidemics	O
.	O

Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories	E-Document
(	O
BMBL	S-Document
)	O
quickly	O
became	O
the	O
cornerstone	O
of	O
biosafety	O
practice	O
and	O
policy	O
in	O
the	O
United	B-Location
States	E-Location
upon	O
first	O
publication	O
in	O
1984	O
.	O

Forest	O
Sea	O
(Pol	O
.	O

In	O
some	O
countries	O
such	O
as	O
Brazil	S-Location
,	O
Russia	S-Location
,	O
India	S-Location
,	O
China	S-Location
,	O
and	O
it	O
is	O
predicted	O
that	O
a	O
99%	O
increase	O
will	O
occur	O
.	O

This	O
chapter	O
does	O
not	O
deal	O
with	O
plant	O
disease	O
agents	O
that	O
pose	O
no	O
risk	O
for	O
human	O
or	O
animal	O
health	O
.	O

Lastly	O
,	O
CRISPR/Cas9	S-Technology
applications	O
for	O
biotech	O
will	O
enhance	O
the	O
use	O
of	O
yet	O
under-used	O
production	O
systems	O
as	O
well	O
as	O
introducing	O
a	O
new	O
era	O
in	O
GMOs	O
.	O

Italy	S-Location
was	O
particularly	O
badly	O
hit	O
by	O
the	O
plague	S-Disease
,	O
and	O
it	O
has	O
been	O
speculated	O
that	O
the	O
resulting	O
familiarity	O
with	O
death	O
caused	O
thinkers	O
to	O
dwell	O
more	O
on	O
their	O
lives	O
on	O
Earth	S-Location
,	O
rather	O
than	O
on	O
spirituality	O
and	O
the	O
afterlife	O
.	O

During	O
World	O
War	O
II	O
,	O
Stalin	S-Person
was	O
forced	O
to	O
move	O
his	O
BW	O
operations	O
out	O
of	O
the	O
path	O
of	O
advancing	O
German	O
forcesKen	O
Alibek	S-Person
and	O
K	B-Person
Handelman	E-Person
(1999)	O
,	O
Biohazard:	O
The	O
Chilling	O
True	O
Story	O
of	O
the	O
Largest	O
Covert	O
Biological	O
Weapons	O
Program	O
in	O
the	O
World	O
Trade	O
From	O
the	O
Inside	O
by	O
the	O
Man	O
Who	O
Ran	O
It	O
,	O
New	B-Location
York	E-Location
,	O
:	O
Random	O
House	O
.	O

However	O
,	O
potential	O
victims	O
of	O
an	O
anthrax	S-Pathogen
attack	O
can	O
be	O
treated	O
with	O
antibiotics	S-Drug
even	O
several	O
days	O
after	O
an	O
infection	O
.	O

Although	O
the	O
term	O
"	O
computed	B-Technology
tomography	E-Technology
could	O
be	O
used	O
to	O
describe	O
positron	O
emission	O
tomography	O
or	O
single	B-Technology
photon	I-Technology
emission	I-Technology
computed	I-Technology
tomography	E-Technology
()	O
,	O
in	O
practice	O
it	O
usually	O
refers	O
to	O
the	O
computation	O
of	O
tomography	O
from	O
X-ray	O
images	O
,	O
especially	O
in	O
older	O
medical	O
literature	O
and	O
smaller	O
medical	O
facilities	O
.	O

The	O
streaks	O
can	O
be	O
reduced	O
using	O
newer	O
reconstruction	O
techniques	O
or	O
approaches	O
such	O
as	O
metal	B-Technology
artifact	I-Technology
reduction	E-Technology
(	O
MAR	S-Technology
)	O
.	O

Biological	O
agents	O
included	O
bacteria	O
(Rickettsia	O
,	O
Chlamydia)	O
,	O
viruses	O
,	O
toxins	O
,	O
fungi	O
and	O
protozoa	O
.	O

What	O
the	O
Pentagon	S-Organization
is	O
now	O
doing	O
is	O
exactly	O
what	O
it	O
did	O
in	O
the	O
past	O
,	O
meaning	O
that	O
its	O
bio-weapons	O
program	O
was	O
never	O
terminated	O
.	O

About	O
a	O
third	O
of	O
antibiotic	O
prescriptions	O
written	O
in	O
outpatient	O
settings	O
in	O
the	O
United	B-Location
States	E-Location
were	O
not	O
appropriate	O
in	O
2010	O
and	O
2011	O
.	O

Pixel	O
is	O
a	O
two	O
dimensional	O
unit	O
based	O
on	O
the	O
matrix	O
size	O
and	O
the	O
field	O
of	O
view	O
.	O

Influenza	S-Disease
and	O
pneumonia	S-Disease
death	O
rates	O
for	O
those	O
15–34	O
years	O
of	O
age	O
in	O
1918–1919	O
,	O
for	O
example	O
,	O
were	O
&gt;20	O
times	O
higher	O
than	O
in	O
previous	O
years	O
.	O

Some	O
commentators	O
have	O
expressed	O
concern	O
that	O
it	O
could	O
allow	O
governments	O
to	O
strengthen	O
their	O
grip	O
on	O
power	O
.	O

His	O
vaccination	O
history	O
is	O
unknown	O
due	O
to	O
unavailability	O
of	O
the	O
baby	O
clinic	O
book	O
,	O
and	O
his	O
travel	O
history	O
is	O
being	O
established	O
.	O

Has	O
there	O
been	O
any	O
review	O
of	O
this	O
work	O
by	O
the	O
US	S-Location
government?	O
Review	O
by	O
any	O
other	O
organizations?	O

As	O
a	O
result	O
of	O
these	O
two	O
incidents	O
,	O
CDC	S-Organization
is	O
issuing	O
,	O
effective	O
immediately	O
,	O
a	O
moratorium	O
on	O
the	O
movement	O
(i.e.	O
,	O
transfer	O
inside	O
or	O
outside	O
the	O
agency)	O
of	O
biological	O
materials	O
(i.e.	O
,	O
infectious	B-Pathogen
agents	E-Pathogen
,	O
active	O
or	O
inactivated	O
specimens)	O
from	O
BSL3	S-Platform
or	O
facilities	O
.	O

Bioinformatics	O
is	O
another	O
popular	O
target	O
for	O
do-it-yourself	B-Activity
biology	E-Activity
research	O
.	O

Some	O
countries	O
cancelled	O
flights	O
to	O
Mexico	S-Location
while	O
others	O
halted	O
trade	O
.	O

Next	O
question	O
comes	O
from	O
Sabriya	B-Person
Rice	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

For	O
joint	O
European	O
research	O
projects	O
,	O
harmonization	O
is	O
already	O
recommended	O
in	O
the	O
report	O
of	O
the	O
EU	S-Location
and	O
funded	O
project	O
'	O
PARSE.	B-International_exchange_and_cooperation
Insight	E-International_exchange_and_cooperation
':	O
'An	O
integrated	O
and	O
international	O
approach	O
is	O
desired	O
,	O
in	O
which	O
policies	O
are	O
geared	O
to	O
one	O
another	O
to	O
ensure	O
efficiency	O
and	O
rapid	O
development	O
of	O
policies'	O
.	O

Weathersby	S-Person
,	O
Kathryn	S-Person
,	O
&a	O
mp;	B-Person
Milton	I-Person
Leiten	E-Person
berg	O
,	O
"	O
New	O
Evidence	O
on	O
the	O
Korean	O
War"	O
,	O
Cold	O
War	O
International	O
History	O
Project	O
,	O
1998	O
.	O

This	O
incident	O
was	O
the	O
first	O
known	O
bioterrorist	O
attack	O
in	O
the	O
United	B-Location
States	E-Location
in	O
the	O
20th	O
century.Past	O
U.S	O
.	O

Another	O
point	O
to	O
be	O
addressed	O
is	O
whether	O
chronic	O
and	O
metachronic	O
can	O
be	O
performed	O
with	O
minimal	O
risks	O
to	O
maintain	O
"	O
correcting"	O
levels	O
throughout	O
a	O
patient's	O
life	O
.	O

On	O
22	O
November	O
,	O
the	O
final	O
case	O
related	O
to	O
the	O
imam	O
was	O
reported-a	O
friend	O
of	O
the	O
Pasteur	B-Organization
Clinic	E-Organization
nurse	O
who	O
had	O
died	O
from	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
On	O
12	O
December	O
,	O
the	O
last	O
case	O
in	O
treatment	O
recovered	O
and	O
was	O
discharged	O
,	O
"	O
so	O
there	O
are	O
no	O
more	O
people	O
sick	O
with	O
Ebola	S-Disease
in	O
Mali	S-Location
"	O
,	O
according	O
to	O
a	O
source	O
.	O

The	O
plants	O
then	O
start	O
producing	O
the	O
protein	O
that	O
will	O
be	O
used	O
for	O
vaccinations	O
.	O

and	O
officials	O
.	O

A	O
comparative	O
evaluation	O
of	O
ring	O
artefact	O
reduction	O
on	O
X-ray	O
tomography	O
images	O
showed	O
that	O
the	O
method	O
of	O
Sijbers	S-Person
and	O
can	O
effectively	O
suppress	O
ring	O
artefacts	O
.	O

In	O
2011	O
,	O
these	O
results	O
were	O
further	O
confirmed	O
with	O
genetic	O
evidence	O
derived	O
from	O
Black	B-Disease
Death	E-Disease
victims	O
in	O
the	O
East	B-Location
Smithfield	E-Location
burial	O
site	O
in	O
.	O
Schuenemann	O
et	O
al	O
.	O

The	O
virus	O
of	O
the	O
1918	B-Incident
pandemic	E-Incident
likely	O
expressed	O
an	O
antigenically	O
novel	O
subtype	O
to	O
which	O
most	O
humans	O
and	O
swine	O
were	O
immunologically	O
naive	O
in	O
1918	O
(,)	O
.	O

Kyasanur	B-Pathogen
Forest	I-Pathogen
Virus	E-Pathogen
and	O
Omsk	B-Pathogen
Hemorrhagic	I-Pathogen
fever	I-Pathogen
virus	E-Pathogen
were	O
included	O
in	O
risk	O
group	O
4	O
according	O
to	O
NIH	S-Organization
biosafety	O
categorization	O
,	O
but	O
were	O
included	O
in	O
risk	O
group	O
3	O
by	O
the	O
.	O

On	O
18	O
May	O
,	O
after	O
no	O
new	O
infections	O
had	O
been	O
reported	O
in	O
a	O
three-week	O
period	O
,	O
WHO	S-Organization
announced	O
China	S-Location
as	O
free	O
of	O
further	O
cases	O
of	O
,	O
but	O
stated	O
that	O
"	O
biosafety	O
concerns	O
remain"	O
.	O

The	O
Bio-safety	O
Level	O
3	O
Laboratory	O
is	O
accessible	O
only	O
to	O
US	S-Location
citizens	O
with	O
security	O
clearance	O
.	O

Researchers	O
recently	O
demonstrated	O
the	O
ability	O
to	O
birth	O
live	O
pig	O
specimens	O
after	O
removing	O
these	O
retroviruses	O
from	O
their	O
genome	O
using	O
for	O
the	O
first	O
time	O
.	O

By	O
late	O
April	O
,	O
around	O
300 million	O
people	O
were	O
under	O
lockdown	O
in	O
nations	O
of	O
Europe	S-Location
including	O
but	O
not	O
limited	O
to	O
Italy	S-Location
,	O
Spain	S-Location
,	O
France	S-Location
,	O
and	O
the	O
United	B-Location
Kingdom	E-Location
,	O
while	O
around	O
200 million	O
people	O
were	O
under	O
lockdown	O
in	O
Latin	B-Location
America	E-Location
.	O
Nearly	O
300 million	O
people	O
,	O
or	O
about	O
90	O
percent	O
of	O
the	O
population	O
,	O
were	O
under	O
some	O
form	O
of	O
lockdown	O
in	O
the	O
United	B-Location
States	E-Location
,	O
around	O
100 million	O
people	O
in	O
the	O
Philippines	S-Location
,	O
about	O
59 million	O
people	O
in	O
South	B-Location
Africa	E-Location
,	O
and	O
1.	O
3 billion	O
people	O
have	O
been	O
under	O
lockdown	O
in	O
.	O
On	O
21	O
May	O
100,000	O
new	O
infections	O
occurred	O
worldwide	O
,	O
the	O
most	O
since	O
the	O
start	O
of	O
the	O
pandemic	O
,	O
while	O
overall	O
5million	O
cases	O
were	O
surpassed	O
.	O

The	O
STCU	S-Organization
officially	O
supports	O
projects	O
of	O
scientists	O
previously	O
involved	O
in	O
the	O
Soviet	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
.	O
Over	O
the	O
past	O
20	O
years	O
the	O
has	O
invested	O
over	O
$285	O
million	O
in	O
funding	O
and	O
managing	O
some	O
1,850	O
projects	O
of	O
scientists	O
who	O
previously	O
worked	O
on	O
the	O
development	O
of	O
weapons	O
of	O
mass	O
destruction	O
.	O

Some	O
artists	O
have	O
explored	O
ways	O
to	O
continue	O
to	O
produce	O
and	O
share	O
work	O
over	O
the	O
internet	O
as	O
an	O
alternative	O
to	O
traditional	O
live	O
performance	O
,	O
such	O
as	O
live	O
streaming	O
concerts	O
or	O
creating	O
web-based	O
"	O
festivals"	O
for	O
artists	O
to	O
perform	O
,	O
distribute	O
,	O
and	O
publicise	O
their	O
work	O
.	O

Personalised	O
medicine	O
is	O
pushing	O
towards	O
the	O
generation	O
of	O
biological	O
compounds	O
and	O
antibody-based	O
therapies	O
.	O

Junior	O
colleges	O
were	O
to	O
reopen	O
on	O
9	O
April	O
,	O
secondary	O
schools	O
would	O
reopen	O
on	O
14	O
April	O
and	O
primary	O
schools	O
and	O
pre-schools	O
would	O
reopen	O
on	O
16	O
April	O
.	O

A	O
total	O
of	O
countries	O
and	O
territories	O
have	O
had	O
at	O
least	O
one	O
case	O
of	O
COVID-19	S-Disease
so	O
far	O
.	O

Accordingly	O
,	O
bacteria	O
produce	O
special	O
complexing	O
agents	O
called	O
siderophores	S-Drug
(	O
iron	S-Drug
carriers)	O
in	O
order	O
to	O
bind	O
the	O
few	O
available	O
iron	O
ions	O
and	O
subsequently	O
absorb	O
them	O
via	O
their	O
own	O
import	O
systems	O
.	O

They	O
can	O
create	O
bacteria	O
that	O
can	O
clean	O
up	O
oil	O
spills	O
,	O
rice	O
with	O
genes	O
that	O
keep	O
the	O
plant	O
infection-free	O
,	O
or	O
cells	O
that	O
can	O
churn	O
out	O
new	O
materials	O
.	O

Southern	B-Organization
Research	I-Organization
Institute	E-Organization
has	O
been	O
a	O
prime	O
subcontractor	O
under	O
the	O
DTRA	S-Organization
program	O
in	O
Ukraine	S-Location
since	O
2008	O
.	O

The	O
White	B-Organization
House	E-Organization
is	O
asking	O
federally	O
funded	O
labs	O
studying	O
infectious	O
agents	O
to	O
take	O
"	O
immediate	O
action	O
"	O
to	O
inventory	O
samples	O
and	O
review	O
safety	O
and	O
security	O
procedures	O
in	O
the	O
wake	O
of	O
several	O
high-profile	O
accidents	O
earlier	O
this	O
year	O
.	O

As	O
well	O
the	O
work	O
has	O
been	O
reviewed	O
by	O
independent	O
bioethics	O
groups	O
since	O
1997	O
.	O

On	O
April	O
21	O
,	O
2005	O
,	O
then–	O
CDC	S-Organization
Director	O
Julie	B-Person
Gerberding	E-Person
formally	O
announced	O
the	O
reorganization	O
of	O
to	O
"	O
confront	O
the	O
challenges	O
of	O
21st-century	O
health	O
threats"	O
.	O

In	O
occupied	O
Manchuria	S-Location
starting	O
around	O
1936	O
,	O
Japanese	O
scientists	O
used	O
scores	O
of	O
human	O
subjects	O
to	O
test	S-Equipment
the	O
lethality	O
of	O
various	O
disease	O
agents	O
,	O
including	O
anthrax	S-Pathogen
,	O
cholera	S-Pathogen
,	O
typhoid	S-Pathogen
,	O
and	O
.	O
As	O
many	O
as	O
10,000	O
people	O
were	O
killed	O
.	O

Jared	B-Person
B.	I-Person
Adams	E-Person
chief	O
of	O
communications	O
at	O
,	O
says	O
the	O
defense	O
agency	O
--	O
which	O
does	O
not	O
conduct	O
research	O
itself	O
but	O
instead	O
provides	O
financing	O
--	O
does	O
not	O
agree	O
with	O
some	O
of	O
the	O
claims	O
in	O
the	O
editorial	O
.	O

Skerra	S-Person
strategy	O
opens	O
up	O
a	O
new	O
avenue	O
of	O
treatment	O
for	O
anthrax	B-Disease
infections	E-Disease
by	O
effectively	O
suppressing	O
the	O
spread	O
of	O
the	O
bacterium	O
in	O
the	O
patient's	O
body	O
.	O

The	O
incidents	O
included	O
inadvertent	O
shipments	O
of	O
live	O
anthrax	S-Disease
samples	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
in	O
Atlanta	S-Location
and	O
the	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
,	O
and	O
the	O
discovery	O
of	O
old	O
vials	O
of	O
live	O
smallpox	S-Disease
on	O
the	O
campus	O
of	O
the	O
.	O
Accidents	O
at	O
universities	O
have	O
also	O
drawn	O
scrutiny	O
of	O
federal	O
oversight	O
of	O
labs	O
that	O
work	O
with	O
select	O
agents	O
,	O
a	O
list	O
of	O
risky	O
viruses	O
,	O
bacteria	O
,	O
and	O
toxins	O
that	O
could	O
potentially	O
be	O
used	O
to	O
cause	O
harm	O
.	O

The	O
International	B-Document
Regulations	E-Document
and	O
the	O
Codex	B-Document
guidelines	E-Document
regulate	O
the	O
biosafety	O
requirements	O
of	O
the	O
GM	S-Technology
crops	O
.	O

Resistance	O
to	O
HIV	S-Disease
antivirals	O
is	O
problematic	O
,	O
and	O
even	O
multi-drug	O
resistant	O
strains	O
have	O
evolved	O
.	O

CRISPR	S-Technology
screening	O
helps	O
scientist	O
to	O
create	O
a	O
systematic	O
and	O
high-throughput	O
genetic	O
perturbation	O
within	O
live	O
model	O
organisms	O
.	O

The	O
organization	O
relies	O
on	O
contributions	O
from	O
renowned	O
scientists	O
and	O
professionals	O
to	O
inform	O
its	O
work	O
,	O
such	O
as	O
the	O
WHO	B-Organization
Expert	I-Organization
Committee	I-Organization
on	I-Organization
Biological	I-Organization
Standardization	E-Organization
the	O
WHO	B-Organization
Expert	I-Organization
Committee	I-Organization
on	I-Organization
Leprosy	E-Organization
,	O
and	O
the	O
tice	O
.	O

Biohackers	O
want	O
to	O
make	O
their	O
bodies	O
and	O
brains	O
function	O
better	O
by	O
"	O
hacking"	O
their	O
biology	O
.	O

This	O
was	O
intended	O
for	O
delivery	O
by	O
the	O
MGM-29	O
Sergeant	O
missile	O
warhead	O
and	O
could	O
produce	O
50%	O
infection	O
over	O
a	O
area.Countermeasures	O
,	O
Chapter	O
6	O
–	O
An	O
Overview	O
of	O
Emerging	O
Missile	O
State	O
Countermeasures	O
,	O
p.	O
14	O
,	O
accessed	O
November	O
12	O
,	O
2008	O
.	O

Here	O
,	O
the	O
sources	O
say	O
,	O
experiments	O
with	O
biological	O
and	O
chemical	O
agents	O
were	O
carried	O
out	O
first	O
on	O
dogs	O
and	O
cats	O
,	O
then	O
on	O
Iranian	O
prisoners	O
.	O

Based	O
on	O
the	O
results	O
of	O
its	O
study	O
,	O
the	O
NIH	S-Organization
stopped	O
the	O
ACTT	O
trial	O
and	O
provided	O
to	O
participants	O
assigned	O
to	O
received	O
placebo	O
.	O

The	O
goal	O
of	O
PPE	S-Equipment
is	O
two‐fold:	O
(1)	O
PPE	S-Equipment
provides	O
a	O
barrier	O
to	O
possible	O
routes	O
of	O
entry	O
on	O
a	O
worker's	O
body	O
and	O
(2)	O
protects	O
street	O
clothing	O
and	O
shoes	O
so	O
that	O
laboratory	O
contaminants	O
are	O
not	O
inadvertently	O
taken	O
from	O
the	O
laboratory	O
into	O
a	O
nonresearch	O
area	O
,	O
such	O
as	O
a	O
worker's	O
home	O
.	O

The	O
switch	O
from	O
this	O
avian	O
receptor	O
configuration	O
requires	O
of	O
the	O
virus	O
only	O
1	O
amino	O
acid	O
change	O
,	O
and	O
the	O
HAs	O
of	O
all	O
5	O
sequenced	O
have	O
this	O
change	O
,	O
which	O
suggests	O
that	O
it	O
could	O
be	O
a	O
critical	O
step	O
in	O
human	O
host	O
adaptation	O
.	O

In	O
2016	O
,	O
the	O
Association	O
of	O
Public	O
Health	O
Laboratories	O
(	O
APHL	S-Organization
had	O
a	O
presentation	O
at	O
their	O
annual	O
meeting	O
focused	O
on	O
improving	O
biosafety	O
culture	O
.	O

A	O
follow-up	O
study	O
done	O
in	O
September	O
2010	O
showed	O
that	O
the	O
risk	O
of	O
serious	O
illness	O
resulting	O
from	O
the	O
2009	O
H1N1	B-Disease
flu	E-Disease
was	O
no	O
higher	O
than	O
that	O
of	O
the	O
yearly	O
seasonal	B-Disease
flu	E-Disease
.	O
For	O
comparison	O
,	O
the	O
WHO	S-Organization
estimates	O
that	O
250,000	O
to	O
500,000	O
people	O
die	O
of	O
annually	O
.	O

The	O
Working	B-Organization
Party	I-Organization
on	I-Organization
Safety	I-Organization
in	I-Organization
Biotechnology	I-Organization
of	I-Organization
the	I-Organization
European	I-Organization
Federation	I-Organization
of	I-Organization
Biotechnology	E-Organization
also	O
worked	O
on	O
the	O
classification	O
of	O
micro-organisms	O
and	O
produced	O
a	O
system	O
that	O
is	O
directed	O
towards	O
the	O
use	O
of	O
micro-organisms	O
in	O
the	O
industry	O
.	O

Bubonic	B-Disease
plague	E-Disease
Plague	S-Disease
is	O
a	O
disease	O
caused	O
by	O
the	O
Yersinia	B-Pathogen
pestis	I-Pathogen
bacterium	E-Pathogen
.	O
Rodents	O
are	O
the	O
normal	O
host	O
of	O
plague	S-Disease
,	O
and	O
the	O
disease	O
is	O
transmitted	O
to	O
humans	O
by	O
flea	O
bites	O
and	O
occasionally	O
by	O
aerosol	O
in	O
the	O
form	O
of	O
pneumonic	B-Disease
plague	E-Disease
.	O
The	O
disease	O
has	O
a	O
history	O
of	O
use	O
in	O
biological	O
warfare	O
dating	O
back	O
many	O
centuries	O
,	O
and	O
is	O
considered	O
a	O
threat	O
due	O
to	O
its	O
ease	O
of	O
culture	O
and	O
ability	O
to	O
remain	O
in	O
circulation	O
among	O
local	O
rodents	O
for	O
a	O
long	O
period	O
of	O
time	O
.	O

In	O
January	O
2015	O
,	O
the	O
media	O
stated	O
researchers	O
in	O
Guinea	S-Location
had	O
reported	O
mutations	O
in	O
the	O
virus	O
samples	O
that	O
they	O
were	O
looking	O
at	O
.	O

This	O
practice	O
has	O
been	O
ongoing	O
since	O
the	O
1950s	O
,	O
despite	O
efforts	O
to	O
prevent	O
such	O
non-prescription	O
use	O
by	O
regulatory	O
authorities	O
,	O
such	O
as	O
the	O
UN	S-Organization
and	O
.	O
Is	O
there	O
convincing	O
evidence	O
that	O
these	O
supplements	O
are	O
of	O
use	O
when	O
good	O
animal	O
husbandry	O
is	O
common	O
practice?	O
Appropriate	O
treatment	O
for	O
sick	O
animals	O
must	O
,	O
of	O
course	O
,	O
be	O
maintained	O
.	O

Antivirals	O
(	O
oseltamivir	S-Drug
or	O
)	O
were	O
recommended	O
for	O
those	O
with	O
more	O
severe	O
symptoms	O
or	O
those	O
in	O
an	O
at-risk	O
group	O
.	O

Kar	S-Person
said	O
that	O
until	O
the	O
actually	O
defines	O
appropriately	O
targeted	O
duration	O
of	O
use	O
for	O
these	O
drugs	O
(the	O
plan	O
says	O
that	O
won't	O
happen	O
until	O
2022	O
to	O
2023)	O
,	O
it's	O
hard	O
to	O
say	O
whether	O
the	O
agency	O
is	O
adequately	O
addressing	O
the	O
issue	O
.	O

Taking	O
over-the-counter	O
cold	O
medications	O
,	O
drinking	O
fluids	O
,	O
and	O
resting	O
may	O
help	O
alleviate	O
symptoms	O
.	O

A	O
more	O
critical	O
approach	O
including	O
social	O
and	O
political	O
dimensions	O
within	O
a	O
Foucauldian	O
perspective	O
is	O
needed	O
to	O
expand	O
the	O
scope	O
of	O
the	O
biosecurity	O
concept	O
up	O
to	O
biological	O
hazards	O
constructs	O
.	O

On	O
29	O
March	O
2016	O
,	O
the	O
Director-General	O
of	O
WHO	S-Organization
terminated	O
the	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
status	O
of	O
the	O
.	O

All	O
of	O
these	O
findings	O
beg	O
the	O
question:	O
where	O
did	O
the	O
come	O
from?	O

"	O
These	O
principles	O
emphasize	O
a	O
commitment	O
to	O
protecting	O
Americans	O
and	O
the	O
global	O
community	O
,	O
and	O
ensuring	O
a	O
system	O
designed	O
to	O
prevent	O
dangerous	O
actors	O
from	O
accessing	O
or	O
misusing	O
sensitive	S-Phenotype
biological	O
material,	O
"	O
they	O
wrote	O
in	O
a	O
blog	O
post	O
.	O

Magnetic	B-Technology
resonance	I-Technology
imaging	E-Technology
(	O
MRI	S-Technology
)	O
is	O
a	O
medical	O
imaging	O
technique	O
used	O
in	O
radiology	O
to	O
form	O
pictures	O
of	O
the	O
anatomy	O
and	O
the	O
physiological	O
processes	O
of	O
the	O
body	O
.	O

The	O
war	O
also	O
gave	O
science	O
greater	O
importance	O
as	O
governments	O
relied	O
on	O
scientists	O
,	O
now	O
armed	O
with	O
the	O
new	O
germ	O
theory	O
and	O
the	O
development	O
of	O
antiseptic	O
surgery	O
,	O
to	O
design	O
vaccines	O
and	O
reduce	O
mortalities	O
of	O
disease	O
and	O
battle	O
wounds	O
.	O

Two	O
of	O
those	O
five	O
areas	O
related	O
to	O
communicable	O
diseases:	O
the	O
first	O
,	O
to	O
reduce	O
the	O
"	O
health,	O
social	O
and	O
economic	O
burden	O
"	O
of	O
communicable	O
diseases	O
in	O
general	O
;	O
the	O
second	O
to	O
combat	O
HIV/AIDS	S-Disease
,	O
malaria	S-Disease
and	O
in	O
particular	O
.	O

Other	O
than	O
Parker's	B-Person
mother	E-Person
,	O
no	O
further	O
cases	O
occurred	O
.	O

He	O
also	O
serves	O
as	O
Director	O
,	O
Southeast	B-Organization
Regional	I-Organization
Center	I-Organization
of	I-Organization
Excellence	I-Organization
for	I-Organization
Emerging	I-Organization
Infections	I-Organization
and	I-Organization
Biodefense	E-Organization
,	O
and	O
Director	O
,	O
NC	B-Organization
Sexually	I-Organization
Transmitted	I-Organization
Diseases	I-Organization
Cooperative	I-Organization
Research	I-Organization
Center	E-Organization
.	O
His	O
interests	O
include	O
emerging	O
infections	O
and	O
biodefense	O
,	O
and	O
supporting	O
investigators	O
who	O
work	O
on	O
pathogens	O
including	O
dengue	B-Pathogen
viruses	E-Pathogen
,	O
alphaviruses	S-Pathogen
,	O
coronaviruses	S-Pathogen
,	O
Yersinia	S-Pathogen
,	O
and	O
tularemia	S-Pathogen
.	O
He	O
has	O
served	O
as	O
a	O
member	O
of	O
NIH's	B-Organization
Committee	I-Organization
on	I-Organization
Scientific	I-Organization
Boundaries	I-Organization
for	I-Organization
Review	E-Organization
,	O
as	O
a	O
member	O
of	O
the	O
IOM	B-Organization
Committee	I-Organization
on	I-Organization
Emerging	I-Organization
Microbial	I-Organization
Threats	I-Organization
to	I-Organization
Health	E-Organization
,	O
and	O
as	O
chair	O
of	O
the	O
committee	O
for	O
Investigators	O
in	O
Infectious	O
Diseases	O
Pathogenesis	O
.	O

Whether	O
you	O
are	O
talking	O
about	O
anthrax	S-Disease
avian	B-Disease
flu	E-Disease
,	O
or	O
Venezuelan	B-Disease
Equine	I-Disease
Encephalitis	E-Disease
,	O
we	O
need	O
a	O
global	O
capability	O
to	O
prevent	O
,	O
detect	O
and	O
rapidly	O
respond	O
to	O
biological	O
threats	O
no	O
matter	O
their	O
origin	O
.	O

WHO	S-Organization
Representatives	O
in	O
the	O
Region	O
termed	O
the	O
Americas	S-Location
are	O
referred	O
to	O
as	O
PAHO	S-Organization
/	O
WHO	S-Organization
Representatives	O
.	O

Also	O
,	O
countries	O
with	O
actively	O
functional	O
Biosafety	O
Associations	O
and	O
other	O
scientifically	O
related	O
associations	O
had	O
far	O
more	O
such	O
initiatives	O
than	O
those	O
without	O
such	O
associations	O
,	O
but	O
much	O
duplication	O
of	O
efforts	O
and	O
inefficiencies	O
of	O
scale	O
have	O
been	O
seen	O
over	O
the	O
past	O
decade	O
.	O

Questions	O
were	O
raised	O
about	O
detrimental	O
health	O
effects	O
after	O
experiments	O
in	O
San	B-Location
Francisco	E-Location
California	S-Location
,	O
were	O
followed	O
by	O
a	O
spike	O
in	O
hospital	O
visits	O
;	O
however	O
,	O
in	O
1977	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
determined	O
that	O
there	O
was	O
no	O
association	O
between	O
the	O
testing	O
and	O
the	O
occurrence	O
of	O
pneumonia	S-Disease
or	O
influenza	S-Disease
.	O
The	O
San	B-Location
Francisco	E-Location
test	O
involved	O
a	O
U.S.	B-Organization
Navy	E-Organization
ship	O
that	O
sprayed	O
Serratia	B-Pathogen
marcescens	E-Pathogen
from	O
the	O
bay	O
;	O
it	O
traveled	O
more	O
than	O
30	O
miles	O
.	O

The	O
pilot	O
survey	O
was	O
released	O
on	O
June	O
5	O
,	O
2013:	O
50	O
requests	O
to	O
participate	O
were	O
sent	O
out	O
,	O
with	O
25	O
participants	O
opening	O
the	O
request	O
,	O
and	O
23	O
agreeing	O
to	O
participate	O
.	O

In	O
February	O
2020	O
,	O
Chinese	O
researchers	O
found	O
that	O
there	O
is	O
only	O
one	O
amino	O
acid	O
difference	O
in	O
the	O
binding	O
domain	O
of	O
the	O
S	O
protein	O
between	O
the	O
coronaviruses	S-Pathogen
from	O
pangolins	O
and	O
those	O
from	O
humans	O
;	O
however	O
,	O
whole-genome	O
comparison	O
to	O
date	O
found	O
that	O
at	O
most	O
92%	O
of	O
genetic	O
material	O
was	O
shared	O
between	O
pangolin	B-Pathogen
coronavirus	E-Pathogen
and	O
,	O
which	O
is	O
insufficient	O
to	O
prove	O
pangolins	O
to	O
be	O
the	O
intermediate	O
host	O
.	O

One	O
of	O
the	O
people	O
died	O
.	O

Within	O
the	O
European	B-Organization
Union	E-Organization
(	O
EU	S-Location
)	O
,	O
the	O
European	B-Organization
Commission	E-Organization
has	O
launched	O
a	O
green	B-Document
paper	I-Document
on	I-Document
biopreparedness	E-Document
,	O
an	O
EU	B-Document
CBRN	I-Document
action	I-Document
plan	E-Document
,	O
and	O
EU	B-Document
legislation	E-Document
concerning	O
serious	O
cross-border	O
threats	O
to	O
health	O
.	O

However	O
,	O
it	O
has	O
developed	O
and	O
implemented	O
an	O
efficient	O
national	O
biosafety	O
system	O
.	O

On	O
27	O
March	O
2015	O
,	O
the	O
White	B-Organization
House	E-Organization
released	O
a	O
comprehensive	O
plan	O
to	O
address	O
the	O
increasing	O
need	O
for	O
agencies	O
to	O
combat	O
the	O
rise	O
of	O
antibiotic-resistant	O
bacteria	O
.	O

The	O
system	O
integrates	O
three	O
specialized	O
data	O
management	O
systems:	O
BASE	S-Platform
for	O
microarrays	O
,	O
OMERO	S-Platform
for	O
microscopy	O
imaging	O
data	O
and	O
Metabolomixed-based	O
on	O
the	O
open-source	O
system	O
omixed	O
-for	O
metabolomics	O
and	O
proteomics	O
data	O
.	O

NAMRU-3	S-Organization
is	O
the	O
only	O
laboratory	O
in	O
Africa	S-Location
with	O
an	O
animal	O
facility	O
accredited	O
by	O
the	O
American	B-Organization
Association	I-Organization
of	I-Organization
Accreditation	I-Organization
of	I-Organization
Laboratory	I-Organization
Animal	I-Organization
Care	E-Organization
.	O
It	O
is	O
the	O
largest	O
DOD	S-Organization
overseas	O
laboratory	O
,	O
with	O
bio-safety	O
level	O
3	O
bio-containment	O
space	O
and	O
field	O
and	O
hospital	O
study	O
sites	O
located	O
throughout	O
Egypt	S-Location
.	O
A	O
malaria	S-Disease
field	O
site	O
is	O
located	O
in	O
the	O
upper	O
east	O
region	O
of	O
northern	O
.	O

NBIC	S-Organization
is	O
only	O
considering	O
platforms	O
that	O
include	O
national-level	O
information	O
and	O
meet	O
federal	O
regulations	O
for	O
data	O
privacy	O
and	O
confidentiality	O
,	O
according	O
to	O
the	O
.	O

CIA	S-Organization
A	O
total	O
of	O
97	O
vials-including	O
those	O
with	O
labels	O
consistent	O
with	O
the	O
al	O
Hakam	O
cover	O
stories	O
of	O
single-cell	O
protein	O
and	O
bio-pesticides	O
,	O
as	O
well	O
as	O
strains	O
that	O
could	O
be	O
used	O
to	O
produce	O
BW	B-Drug
agents	E-Drug
were	O
recovered	O
from	O
a	O
scientist's	O
residence	O
in	O
in	O
2003	O
.	O

We	O
did	O
additional	O
experiments	O
to	O
replicate	O
in	O
a	O
worst-case	O
scenario	O
what	O
might	O
have	O
happened	O
in	O
that	O
process	O
.	O

Based	O
on	O
the	O
records	O
in	O
the	O
BBD	S-Platform
,	O
biosafety	O
research	O
activity	O
over	O
the	O
past	O
16-17	O
years	O
can	O
be	O
summarized	O
by	O
analyzing	O
basic	O
statistics	O
.	O

But	O
they	O
were	O
unable	O
to	O
determine	O
what	O
caused	O
the	O
release	O
or	O
what	O
specific	O
activities	O
were	O
conducted	O
at	O
the	O
facility	O
.	O

WRAIR	S-Organization
conducted	O
the	O
first	O
Ebola	B-Vaccine
vaccine	E-Vaccine
clinical	O
trial	O
in	O
Africa	S-Location
in	O
2009	O
,	O
testing	O
an	O
early	O
vaccine	O
candidate	O
also	O
developed	O
by	O
the	O
VRC	S-Drug
at	O
NIAID	S-Organization
.	O
During	O
the	O
2014	B-Incident
West	I-Incident
Africa	I-Incident
Ebola	I-Incident
outbreak	E-Incident
,	O
WRAIR	S-Organization
conceived	O
of	O
,	O
and	O
then	O
initiated	O
a	O
Phase	O
I	O
clinical	O
trial	O
of	O
the	O
VSV-EBOV	B-Vaccine
vaccine	E-Vaccine
candidate	O
over	O
a	O
period	O
of	O
just	O
11	O
weeks	O
at	O
its	O
CTC	S-Organization
.	O
WRAIR	S-Organization
has	O
conducted	O
six	O
studies	O
to	O
date	O
.	O

This	O
will	O
allow	O
active	O
duty	O
members	O
of	O
the	O
military	O
and	O
their	O
dependents	O
,	O
wherever	O
they	O
may	O
be	O
working	O
around	O
the	O
globe	O
,	O
to	O
access	O
the	O
same	O
quality	O
care	O
as	O
they	O
would	O
at	O
home	O
.	O

This	O
occurred	O
shortly	O
after	O
the	O
Surgeon	O
General	O
of	O
the	O
U.S.	B-Organization
Army	E-Organization
and	O
the	O
Journal	O
of	O
the	O
American	O
Medical	O
Association	O
both	O
recommended	O
very	O
large	O
doses	O
of	O
8	O
to	O
31 grams	O
of	O
aspirin	O
per	O
day	O
as	O
part	O
of	O
treatment	O
.	O

A	O
virus	O
can	O
change	O
itself	O
to	O
[become]	O
less	O
deadly	O
,	O
but	O
more	O
contagious	O
and	O
that's	O
something	O
we	O
are	O
afraid	O
of.	O
"	O
A	O
2015	O
study	O
suggested	O
that	O
accelerating	O
the	O
rate	O
of	O
mutation	O
of	O
the	O
could	O
make	O
the	O
virus	O
less	O
capable	O
of	O
infecting	O
humans	O
.	O

Thirdly	O
,	O
we	O
have	O
strengthened	O
our	O
surveillance	O
system	O
,	O
so	O
that	O
new	O
cases	O
are	O
identified	O
immediately	O
and	O
we	O
are	O
able	O
to	O
respond	O
quickly	O
.	O

The	O
potentially	O
infectious	O
samples	O
were	O
moved	O
and	O
used	O
for	O
experimentation	O
in	O
three	O
CDC	B-Organization
Roybal	I-Organization
campus	I-Organization
laboratories	E-Organization
not	O
equipped	O
to	O
handle	O
live	O
B.anthracis	S-Pathogen
.	O
Workers	O
,	O
believing	O
the	O
samples	O
were	O
inactivated	O
,	O
were	O
not	O
wearing	O
adequate	O
while	O
handling	O
the	O
material	O
.	O

However	O
,	O
bioterrorism	O
and	O
biowarfare	O
threats	O
are	O
not	O
unique	O
to	O
developed	O
countries	O
.	O

That	O
requires	O
a	O
second	O
protein	O
,	O
attached	O
to	O
Cas9	S-Technology
a	O
reverse	O
transcriptase	O
enzyme	O
,	O
which	O
can	O
make	O
a	O
new	O
DNA	O
strand	O
from	O
the	O
RNA	O
template	O
and	O
insert	O
it	O
at	O
the	O
nicked	O
site.New	O
"	O
Prime	O
Editing	O
"	O
Method	O
Makes	O
Only	O
Single-Stranded	O
DNA	O
Cuts	O
.	O

The	O
disease	O
may	O
take	O
a	O
mild	O
course	O
with	O
few	O
or	O
no	O
symptoms	O
,	O
resembling	O
other	O
common	O
upper	O
respiratory	O
diseases	O
such	O
as	O
the	O
common	O
.	O
Mild	O
cases	O
typically	O
recover	O
within	O
two	O
weeks	O
,	O
while	O
those	O
with	O
severe	O
or	O
critical	O
diseases	O
may	O
take	O
three	O
to	O
six	O
weeks	O
to	O
recover	O
.	O

"	O
When	O
things	O
slip	O
from	O
headlines	O
--	O
and	O
anthrax	S-Disease
hasn't	O
been	O
in	O
the	O
headlines	O
for	O
quite	O
a	O
long	O
time	O
--	O
people	O
don't	O
necessarily	O
give	O
it	O
the	O
same	O
type	O
of	O
importance,	O
"	O
he	O
said.	O
"	O
This	O
threat	O
hasn't	O
gone	O
away	O
.	O

All	O
medical	O
records	O
of	O
the	O
victims	O
were	O
removed	O
to	O
hide	O
serious	O
violations	O
of	O
the	O
that	O
had	O
come	O
in	O
effect	O
in	O
1975	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	O
established	O
an	O
External	B-Organization
Laboratory	I-Organization
Safety	I-Organization
Workgroup	E-Organization
(ELSW)	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
.	O

More	O
than	O
40	O
experts	O
from	O
nine	O
Central	O
African	O
nations	O
met	O
in	O
October	O
at	O
an	O
event	O
hosted	O
by	O
the	O
Nuclear	B-Organization
Threat	I-Organization
Initiative	E-Organization
(	O
NTI	S-Organization
)	O
and	O
the	O
Africa	B-Organization
Centres	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
to	O
advance	O
biosafety	O
and	O
biosecurity	O
in	O
the	O
region	O
.	O

Sometimes	O
people	O
may	O
become	O
infected	O
by	O
touching	O
something-such	O
as	O
a	O
surface	O
or	O
object-with	O
flu	O
viruses	O
on	O
it	O
and	O
then	O
touching	O
their	O
face	O
.	O

The	O
relies	O
on	O
3	O
fundamental	O
principles:	O
(1)	O
crises	O
should	O
be	O
managed	O
by	O
the	O
same	O
authorities	O
that	O
manage	O
the	O
relevant	O
activities	O
in	O
normal	O
times	O
;	O
(2)	O
crises	O
should	O
be	O
managed	O
primarily	O
at	O
the	O
local	O
level	O
;	O
and	O
(3)	O
crises	O
should	O
be	O
handled	O
using	O
normal	O
practices	O
.	O

Over	O
the	O
past	O
several	O
years	O
,	O
DARPA-funded	B-Person
researchers	E-Person
have	O
pioneered	O
RNA	B-Technology
vaccine	I-Technology
technology	E-Technology
,	O
a	O
medical	O
countermeasure	O
against	O
infectious	O
diseases	O
that	O
uses	O
coded	O
genetic	O
constructs	O
to	O
stimulate	O
production	O
of	O
viral	O
proteins	O
in	O
the	O
body	O
,	O
which	O
in	O
turn	O
can	O
trigger	O
a	O
protective	O
antibody	O
response	O
.	O

The	O
sentences	O
doled	O
out	O
to	O
the	O
Japanese	O
perpetrators	O
were	O
unusually	O
lenient	O
for	O
Soviet	S-Person
standards	O
,	O
and	O
all	O
but	O
one	O
of	O
the	O
defendants	O
returned	O
to	O
Japan	S-Location
by	O
the	O
1950s	O
(with	O
the	O
remaining	O
prisoner	O
committing	O
suicide	O
inside	O
his	O
cell)	O
.	O

The	O
long-established	O
practice	O
of	O
permitting	O
OTC	O
sales	O
of	O
antibiotics	O
(including	O
and	O
other	O
drugs)	O
to	O
lay	O
animal	O
owners	O
for	O
administration	O
to	O
their	O
own	O
animals	O
nonetheless	O
continued	O
in	O
all	O
states	O
.	O

On	O
July	O
24	O
,	O
2018	O
the	O
outbreak	O
was	O
declared	O
over	O
.	O

Combined	O
with	O
a	O
serum	O
ferritin	O
blood	O
test	O
to	O
identify	O
a	O
cytokine	B-Phenotype
storm	E-Phenotype
(also	O
called	O
cytokine	B-Phenotype
storm	I-Phenotype
syndrome	E-Phenotype
,	O
not	O
to	O
be	O
confused	O
with	O
)	O
,	O
it	O
is	O
meant	O
to	O
counter	O
such	O
developments	O
,	O
which	O
are	O
thought	O
to	O
be	O
the	O
cause	O
of	O
death	O
in	O
some	O
affected	O
people	O
.	O

"	O
The	O
next	O
epidemic	O
could	O
originate	O
on	O
the	O
computer	O
screen	O
of	O
a	O
terrorist	O
intent	O
on	O
using	O
genetic	O
engineering	O
to	O
create	O
a	O
synthetic	O
version	O
of	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
...	O
or	O
a	O
super	O
contagious	O
and	O
deadly	O
strain	O
of	O
the	O
flu	S-Disease
,	O
"	O
said	O
.	O

The	O
biological	O
weapons	O
facility	O
in	O
Sverdlovsk	S-Location
was	O
built	O
after	O
World	B-Incident
War	I-Incident
II	E-Incident
,	O
using	O
documentation	O
captured	O
in	O
Manchuria	S-Location
from	O
the	O
Japanese	O
germ	O
warfare	O
program	O
.	O

During	O
the	O
Chinese	B-Activity
New	I-Activity
Year	I-Activity
travel	E-Activity
period	O
,	O
authorities	O
instigated	O
a	O
City	B-Activity
of	I-Activity
Wuhan	I-Activity
lockdown	E-Activity
.	O
On	O
10	O
February	O
the	O
Chinese	B-Organization
government	E-Organization
launched	O
a	O
radical	O
campaign	O
described	O
by	O
paramount	O
leader	O
and	O
Chinese	B-Organization
Communist	I-Organization
Party	E-Organization
general	B-Person
secretary	I-Person
Xi	E-Person
as	O
a	O
"	O
people's	O
war	O
"	O
to	O
contain	O
the	O
viral	O
spread	O
.	O

The	O
symptoms	O
reported	O
among	O
the	O
patients	O
are	O
common	O
to	O
several	O
respiratory	O
diseases	O
,	O
and	O
pneumonia	S-Disease
is	O
common	O
in	O
the	O
winter	O
season	O
;	O
however	O
,	O
the	O
occurrence	O
of	O
44	O
cases	O
of	O
requiring	O
hospitalization	O
clustered	O
in	O
space	O
and	O
time	O
should	O
be	O
handled	O
prudently	O
.	O

Some	O
bore	O
swollen	B-Phenotype
buboes	E-Phenotype
on	O
their	O
necks	O
,	O
armpits	O
and	O
thighs	O
;	O
some	O
had	O
their	O
flesh	B-Phenotype
turn	I-Phenotype
black	I-Phenotype
from	I-Phenotype
haemorrhaging	I-Phenotype
beneath	I-Phenotype
the	I-Phenotype
skin	E-Phenotype
;	O
some	O
coughed	B-Phenotype
blood	E-Phenotype
from	O
the	O
necrotic	B-Disease
inflammation	E-Disease
of	O
their	O
throats	O
and	O
lungs	O
.	O

On	O
15	O
September	O
,	O
the	O
first	O
doctor	O
to	O
arrive	O
,	O
Mgoi	B-Person
Mushola	E-Person
,	O
prepared	O
a	O
report	O
in	O
which	O
he	O
noted	O
that	O
none	O
of	O
the	O
many	O
treatments	O
provided	O
met	O
with	O
success	O
.	O

The	O
virulence	O
of	O
the	O
comeback	O
would	O
depend	O
on	O
herd	O
immunity	O
and	O
the	O
extent	O
of	O
mutation	O
.	O

Sharp	B-Equipment
disposable	I-Equipment
containers	E-Equipment
were	O
found	O
in	O
84	O
(44.	O
2%)	O
labs	O
,	O
but	O
the	O
difference	O
between	O
government	O
,	O
private	O
and	O
organization	O
laboratories	O
was	O
not	O
significant	O
(P=0.149)	O
.	O

Jacob	S-Person

Others	O
have	O
disagreed	O
,	O
and	O
more	O
recent	O
research	O
has	O
suggested	O
the	O
strain	O
may	O
have	O
originated	O
in	O
a	O
nonhuman	O
,	O
mammalian	O
species	O
.	O

The	O
probable	O
bat-to-human	O
infection	O
may	O
have	O
been	O
among	O
people	O
processing	O
bat	O
carcasses	O
and	O
guano	O
in	O
the	O
production	O
of	O
traditional	O
Chinese	O
medicines	O
.	O

The	O
country	O
office	O
is	O
headed	O
by	O
a	O
WHO	S-Organization
Representative	O
(WR).	O
,	O
the	O
only	O
WHO	S-Organization
Representative	O
outside	O
Europe	S-Location
to	O
be	O
a	O
national	O
of	O
that	O
country	O
was	O
for	O
the	O
Libyan	B-Location
Arab	I-Location
Jamahiriya	E-Location
(	O
"	O
Libya	S-Location
"	O
);	O
all	O
other	O
staff	O
were	O
international	O
.	O

A	O
cytokine	B-Phenotype
storm	E-Phenotype
can	O
be	O
a	O
complication	O
in	O
the	O
later	O
stages	O
of	O
severe	O
COVID‑19	S-Disease
.	O
There	O
is	O
preliminary	O
evidence	O
that	O
hydroxychloroquine	S-Drug
may	O
be	O
useful	O
in	O
controlling	O
in	O
late-phase	O
severe	O
forms	O
of	O
the	O
disease	O
.	O

The	O
etiological	O
agents	O
have	O
been	O
extensively	O
cultured	O
and	O
studied	O
since	O
the	O
end	O
of	O
the	O
last	O
century	O
(isolation	O
of	O
pure	O
cultures)	O
.	O

They	O
routinely	O
tested	O
on	O
human	O
beings	O
(who	O
were	O
referred	O
to	O
internally	O
as	O
"	O
logs").	O
Additionally	O
,	O
the	O
biological	O
weapons	O
were	O
tested	O
in	O
the	O
field	O
on	O
cities	O
and	O
towns	O
in	O
China	S-Location
.	O
Estimates	O
of	O
those	O
killed	O
by	O
and	O
its	O
related	O
programs	O
range	O
up	O
to	O
half	O
a	O
million	O
people	O
.	O

These	O
results	O
suggest	O
that	O
the	O
conservative	O
NHP	O
model	O
would	O
be	O
an	O
appropriate	O
model	O
for	O
estimation	O
of	O
human	O
drug	O
exposure.A	O
total	O
of	O
851	O
human	O
volunteers	O
were	O
screened	O
for	O
the	O
safety	O
trial	O
.	O

According	O
to	O
a	O
university	O
spokesperson	O
,	O
the	O
researcher	O
developed	O
symptoms	O
on	O
June	O
1	O
,	O
and	O
returned	O
to	O
work	O
on	O
June	O
6	O
when	O
the	O
fever	S-Phenotype
abated	O
,	O
reported	O
.	O

Once	O
a	O
new	O
method	O
has	O
been	O
implemented	O
,	O
it	O
is	O
still	O
a	O
challenge	O
for	O
each	O
agency	O
to	O
maintain	O
the	O
relevant	O
competence	O
over	O
time	O
for	O
those	O
methods	O
that	O
are	O
infrequently	O
used	O
,	O
especially	O
in	O
slimmed	O
down	O
organizations	O
.	O

None	O
of	O
the	O
staff	O
who	O
was	O
potentially	O
exposed	O
has	O
become	O
ill	O
with	O
.	O

At	O
least	O
twelve	O
sitting	O
or	O
former	O
Iranian	O
politicians	O
and	O
government	O
officials	O
had	O
died	O
from	O
the	O
disease	O
by	O
17	O
March	O
.	O

The	O
discovery	O
resulted	O
in	O
more	O
than	O
a	O
dozen	O
staffers	O
undergoing	O
decontamination	O
as	O
well	O
as	O
the	O
closure	O
of	O
the	O
Dirksen,	B-Location
Hart,	I-Location
and	I-Location
Russell	I-Location
Senate	I-Location
Office	I-Location
Buildings	E-Location
.	O
"	O
Ricin	S-Pathogen
in	O
Frist's	B-Location
office	E-Location
closes	O
3	O
senate	O
buildings	O
"	O
,	O
Center	B-Organization
for	I-Organization
Infectious	I-Organization
Disease	I-Organization
Research	I-Organization
and	I-Organization
Policy	E-Organization
,	O
University	B-Organization
of	I-Organization
Minnesota	E-Organization
,	O
February	O
3	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

The	O
United	B-Location
States	E-Location
takes	O
biosafety	O
and	O
biosecurity	O
very	O
seriously	O
.	O

CHS	S-Organization
notes	O
that	O
the	O
Center	O
has	O
long	O
been	O
an	O
advocate	O
of	O
effective	O
global	O
health	O
security	O
policy	O
.	O

Those	O
who	O
get	O
very	O
ill	O
stay	O
home	O
,	O
and	O
those	O
mildly	O
ill	O
continue	O
with	O
their	O
lives	O
,	O
preferentially	O
spreading	O
the	O
mild	O
strain	O
.	O

Critics	O
criticised	O
the	O
G7	O
leaders	O
,	O
saying	O
they	O
were	O
not	O
committed	O
enough	O
in	O
the	O
fight	O
against	O
the	O
possibility	O
of	O
future	O
pandemics	O
.	O

One	O
of	O
the	O
few	O
things	O
known	O
for	O
certain	O
about	O
the	O
influenza	S-Disease
in	O
1918	O
and	O
for	O
some	O
years	O
after	O
was	O
that	O
it	O
was	O
,	O
except	O
in	O
the	O
laboratory	O
,	O
exclusively	O
a	O
disease	O
of	O
human	O
beings	O
.	O

This	O
gave	O
rise	O
to	O
the	O
name	O
.	O
Historical	O
and	O
epidemiological	O
data	O
are	O
inadequate	O
to	O
identify	O
with	O
certainty	O
the	O
pandemic's	O
geographic	O
origin	O
,	O
with	O
varying	O
views	O
as	O
to	O
its	O
location	O
.	O

It	O
often	O
is	O
aimed	O
at	O
producing	O
a	O
product	O
,	O
like	O
the	O
chairs	O
and	O
building	O
blocks	O
that	O
artist	O
Philip	B-Person
Ross	E-Person
makes	O
by	O
feeding	O
mushrooms	O
a	O
meal	O
of	O
sawdust	O
or	O
peanut	O
shavings	O
.	O

Other	O
rodent‐borne	O
diseases	O
have	O
been	O
transferred	O
to	O
humans	O
via	O
cell	O
lines	O
that	O
were	O
passaged	O
through	O
rodent	O
hosts	O
(	O
Baum	S-Person
et	O
al.	O
,	O
1966)	O
.	O

Calling	O
the	O
set	O
of	O
symptoms	O
"	O
post-Ebolavirus	B-Phenotype
disease	I-Phenotype
syndrome	E-Phenotype
the	O
research	O
found	O
symptoms	O
that	O
included	O
"	O
chronic	B-Phenotype
joint	I-Phenotype
and	I-Phenotype
muscle	I-Phenotype
pain	E-Phenotype
,	O
fatigue	S-Phenotype
,	O
anorexia	S-Phenotype
,	O
hearing	B-Phenotype
loss	E-Phenotype
,	O
blurred	B-Phenotype
vision	E-Phenotype
,	O
headache	S-Phenotype
,	O
sleep	B-Phenotype
disturbances	E-Phenotype
,	O
low	B-Phenotype
mood	E-Phenotype
and	O
"	O
,	O
and	O
suggested	O
the	O
"	O
implementation	O
of	O
specialised	O
health	O
services	O
to	O
treat	O
and	O
follow-up	O
survivors"	O
.	O

The	O
earliest	O
documented	O
incident	O
of	O
the	O
intention	O
to	O
use	O
biological	O
weapons	O
is	O
possibly	O
recorded	O
in	O
Hittite	O
texts	O
of	O
1500–1200	O
BC	O
,	O
in	O
which	O
victims	O
of	O
tularemia	S-Pathogen
were	O
driven	O
into	O
enemy	O
lands	O
,	O
causing	O
an	O
epidemic	O
.	O

So	O
at	O
this	O
point	O
,	O
we	O
don't	O
see	O
any	O
risk	O
to	O
keeping	O
the	O
lab	O
closed	O
until	O
we	O
have	O
a	O
full	O
assessment	O
of	O
what	O
happened	O
and	O
are	O
sure	O
that	O
we	O
can	O
prevent	O
future	O
occurrence.Yes?	O

After	O
WWII	O
,	O
the	O
Office	B-Organization
of	I-Organization
Special	I-Organization
Investigations	E-Organization
created	O
a	O
watchlist	O
of	O
suspected	O
Axis	O
collaborators	O
and	O
persecutors	O
that	O
are	O
banned	O
from	O
entering	O
the	O
United	B-Location
States	E-Location
.	O
While	O
they	O
have	O
added	O
over	O
60,000	O
names	O
to	O
the	O
watchlist	O
,	O
they	O
have	O
only	O
been	O
able	O
to	O
identify	O
under	O
100	O
Japanese	O
participants	O
.	O

Such	O
a	O
risk	O
to	O
humanity's	O
entire	O
future	O
is	O
known	O
as	O
an	O
existential	O
risk	O
.	O

Those	O
who	O
ignored	O
the	O
flu	O
ordinances	O
had	O
to	O
pay	O
steep	O
fines	O
enforced	O
by	O
extra	O
officers	O
(	O
Deseret	B-Organization
News	E-Organization
)	O
.	O

Some	O
prisoners	O
had	O
their	O
stomachs	O
surgically	O
removed	O
and	O
the	O
esophagus	O
reattached	O
to	O
the	O
intestines	O
.	O

The	O
future	O
of	O
genetically	O
engineered	O
foods	O
and	O
crops	O
in	O
BMENA	S-Location
region	O
will	O
depend	O
heavily	O
on	O
choices	O
governments	O
make	O
regarding	O
the	O
regulation	O
of	O
this	O
technology	O
;	O
therefore	O
,	O
coordinated	O
and	O
strong	O
regional	O
efforts	O
are	O
urgently	O
required	O
.	O

Photons	O
of	O
higher	O
photon	O
energy	O
levels	O
are	O
typically	O
attenuated	O
less	O
.	O

As	O
a	O
result	O
,	O
"	O
counties	O
have	O
access	O
to	O
a	O
new	O
technology	O
known	O
as	O
Mutualink	S-Technology
,	O
which	O
improves	O
interoperability	O
by	O
integrating	O
telephone	O
,	O
radio	O
,	O
video	O
,	O
and	O
file-sharing	O
into	O
one	O
application	O
to	O
allow	O
local	O
emergency	O
staff	O
to	O
share	O
real-time	O
information	O
with	O
the	O
state	O
and	O
other	O
counties.	O
"	O
The	O
State	B-Organization
Preparedness	I-Organization
Training	I-Organization
Center	E-Organization
in	O
Oriskany	S-Location
was	O
designed	O
by	O
the	O
State	O
Division	B-Organization
of	I-Organization
Homeland	I-Organization
Security,	I-Organization
and	I-Organization
Emergency	I-Organization
Services	E-Organization
(	O
DHSES	S-Organization
)	O
in	O
2006	O
.	O

One	O
exceptional	O
example	O
of	O
outstanding	O
community	O
spirit	O
are	O
the	O
human	B-Document
genome	I-Document
project's	I-Document
Bermuda	I-Document
principles	E-Document
with	O
the	O
requirement	O
to	O
upload	O
sequences	O
to	O
a	O
public	O
database	O
within	O
24	O
h	O
but	O
usually	O
the	O
willingness	O
to	O
share	O
systems	O
biology	O
data	O
is	O
not	O
that	O
high	O
(see	O
'Policies'	O
section).	O
et	O
al.	O
studied	O
reasons	O
why	O
researchers	O
do	O
not	O
want	O
to	O
share	O
and	O
give	O
a	O
detailed	O
description	O
that	O
emphasizes	O
lack	O
of	O
resources	O
and	O
lack	O
of	O
expertise	O
as	O
the	O
main	O
reasons	O
why	O
data	O
are	O
not	O
shared	O
easily	O
.	O

According	O
to	O
mask	O
manufacturer	O
3M	S-Organization
masks	S-Equipment
will	O
filter	O
out	O
particles	O
in	O
industrial	O
settings	O
,	O
but	O
"	O
there	O
are	O
no	O
established	O
exposure	O
limits	O
for	O
biological	O
agents	O
such	O
as	O
swine	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
"	O
.	O
However	O
,	O
despite	O
the	O
lack	O
of	O
evidence	O
of	O
effectiveness	O
,	O
the	O
use	O
of	O
such	O
masks	O
is	O
common	O
in	O
Asia	S-Location
.	O
They	O
are	O
particularly	O
popular	O
in	O
Japan	S-Location
,	O
where	O
cleanliness	O
and	O
hygiene	O
are	O
highly	O
valued	O
and	O
where	O
etiquette	O
obligates	O
those	O
who	O
are	O
sick	O
to	O
wear	O
to	O
avoid	O
spreading	O
disease	O
.	O

Essential	O
equipment	O
such	O
as	O
biosafety	B-Equipment
cabinet	E-Equipment
,	O
autoclave	S-Equipment
,	O
incinerator	O
and	O
screw	B-Equipment
caped	I-Equipment
container	I-Equipment
and	I-Equipment
bottles	E-Equipment
are	O
so	O
important	O
to	O
safe	O
work	O
area	O
.	O

As	O
the	O
leaders	O
of	O
Unit	B-Organization
731	E-Organization
saw	O
Japan	S-Location
's	O
defeat	O
on	O
the	O
horizon	O
,	O
they	O
burned	O
their	O
records	O
,	O
destroyed	O
their	O
facilities	O
,	O
and	O
fled	O
to	O
Tokyo	S-Location
.	O
Later	O
,	O
in	O
the	O
hands	O
of	O
,	O
they	O
brokered	O
a	O
deal	O
,	O
offering	O
details	O
of	O
their	O
work	O
in	O
exchange	O
for	O
immunity	O
to	O
war	O
crimes	O
prosecution	O
.	O

Indeed	O
,	O
today's	O
technical	O
possibilities	O
are	O
creating	O
a	O
new	O
interest	O
in	O
this	O
area	O
that	O
might	O
be	O
leading	O
to	O
a	O
new	O
biological	O
arms	O
race	O
.	O

"	O
People	O
have	O
very	O
short	O
memories	O
,	O
and	O
policymakers	O
do	O
as	O
well,	O
"	O
Adalja	S-Person
said	O
.	O

In	O
,	O
antibiotic-resistant	O
infections	O
are	O
responsible	O
for	O
$20	O
billion	O
per	O
year	O
in	O
excess	O
health	O
care	O
costs	O
,	O
$35	O
billion	O
per	O
year	O
in	O
societal	O
costs	O
and	O
8	O
million	O
additional	O
hospital	O
days	O
each	O
year	O
(REF)	O
.	O

Biotechnology	O
companies	O
are	O
working	O
to	O
limit	O
the	O
dark	O
side	O
of	O
the	O
democratisation	O
of	O
their	O
field	O
.	O

Plug-ins	O
provide	O
import/export	O
functionality	O
for	O
the	O
MAGE-TAB	O
format	O
for	O
data	O
deposit	O
in	O
EBIs	O
ArrayExpress	O
repository.	O
can	O
be	O
installed	O
with	O
some	O
IT	O
expertise	O
.	O

Benefits:	O
Sonia	B-Person
Vallabh	E-Person
had	O
just	O
graduated	O
from	O
law	O
school	O
when	O
her	O
mother	O
died	O
from	O
a	O
rare	O
and	O
fatal	O
genetic	O
disease	O
.	O

On	O
1May	O
the	O
CDC	S-Organization
presented	O
a	O
17-page	O
report	O
titled	O
"	O
Guidance	B-Document
for	I-Document
Implementing	I-Document
the	I-Document
Opening	I-Document
Up	I-Document
America	I-Document
Again	I-Document
Framework	E-Document
"	O
to	O
the	O
administration	O
.	O

I'm	O
going	O
to	O
go	O
to	O
people	O
who	O
haven't	O
asked	O
questions	O
yet	O
.	O

The	O
Global	B-Document
Health	I-Document
Security	I-Document
Agenda	E-Document
(	O
GHSA	S-Document
)	O
is	O
an	O
international	O
effort	O
to	O
accelerate	O
progress	O
toward	O
a	O
world	O
safe	O
and	O
secure	O
from	O
infectious	O
disease	O
threats	O
.	O

In	O
September	O
2018	O
,	O
the	O
WHO	S-Organization
's	O
Deputy	O
Director-	O
described	O
the	O
combination	O
of	O
military	O
conflict	O
and	O
civilian	O
distress	O
as	O
a	O
potential	O
"	O
perfect	O
storm	O
"	O
that	O
could	O
lead	O
to	O
a	O
rapid	O
worsening	O
of	O
the	O
outbreak	O
.	O

The	O
announcement	O
came	O
after	O
a	O
meeting	O
of	O
the	O
WHO's	B-Organization
Emergency	I-Organization
Committee	E-Organization
which	O
has	O
debated	O
since	O
April	O
whether	O
the	O
spread	O
of	O
a	O
novel	O
was	O
fast	O
and	O
widespread	O
enough	O
to	O
warrant	O
a	O
Phase	O
6	O
designation	O
.	O

Dr	O
.	O

Today	O
,	O
the	O
White	B-Organization
House	E-Organization
is	O
releasing	O
a	O
report	O
,	O
"	O
,"	O
that	O
clearly	O
shows	O
how	O
the	O
investments	O
made	O
by	O
taxpayers	O
to	O
improve	O
global	O
health	O
security	O
are	O
paying	O
dividends	O
.	O

Tourism	O
is	O
one	O
of	O
the	O
worst	O
affected	O
sectors	O
due	O
to	O
travel	O
bans	O
,	O
closing	O
of	O
public	O
places	O
including	O
travel	O
attractions	O
,	O
and	O
advice	O
of	O
governments	O
against	O
travel	O
.	O

Although	O
cellular	B-Disease
damage	E-Disease
is	O
not	O
clinically	O
apparent	O
in	O
many	O
cases	O
,	O
a	O
significant	O
proportion	O
of	O
infected	O
hosts	O
shows	O
signs	O
of	O
disease	O
or	O
eventually	O
dies	O
.	O

A	O
laboratory	O
information	O
management	O
system	O
comes	O
with	O
BASE	S-Platform
and	O
thus	O
a	O
complete	O
capture	O
of	O
all	O
data	O
concerning	O
the	O
experiment	O
is	O
enabled-needed	O
for	O
compliance	O
with	O
the	O
MIAME	S-Platform
standard	O
.	O

Iran	S-Location
became	O
a	O
centre	O
of	O
the	O
spread	O
of	O
the	O
virus	O
after	O
China	S-Location
during	O
February	O
.	O

Inspectors	O
from	O
the	O
U.N.	B-Organization
Special	I-Organization
Commission	E-Organization
(	O
UNSCOM	S-Organization
)	O
spent	O
frustrating	O
years	O
chasing	O
down	O
evidence	O
of	O
the	O
program	O
,	O
which	O
Iraq	S-Location
repeatedly	O
denied	O
existed	O
.	O

The	O
results	O
raised	O
suspicion	O
because	O
no	O
source	O
(e.g.	O
a	O
letter)	O
was	O
ever	O
found	O
for	O
the	O
ricin	S-Pathogen
.	O
It	O
was	O
possible	O
that	O
the	O
"	O
contamination"	O
was	O
from	O
paper	O
by-products	O
and	O
not	O
.	O
"	O
NBC:	O
Investigators	O
question	O
ricin	O
test	O
results"	O
,	O
NBC	O
News	O
,	O
February	O
18	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

The	O
2012–2013	O
WHO	S-Organization
budget	O
identified	O
5	O
areas	O
among	O
which	O
funding	O
was	O
distributed	O
.	O

Case	O
fatality	O
rates	O
in	O
Marburg	B-Incident
outbreaks	E-Incident
have	O
ranged	O
from	O
24%	O
to	O
88%	O
.	O

The	O
nucleic-acid-based	O
technologies	O
that	O
are	O
central	O
to	O
P3	S-Platform
research	O
,	O
particularly	O
those	O
focused	O
on	O
DNA	O
and	O
RNA	O
,	O
include	O
some	O
developed	O
under	O
DARPA	S-Organization
's	O
Autonomous	B-Scientific_research_project
Diagnostics	I-Scientific_research_project
to	I-Scientific_research_project
Enable	I-Scientific_research_project
Prevention	I-Scientific_research_project
and	I-Scientific_research_project
Therapeutics	E-Scientific_research_project
()	O
program	O
.	O

Medical	O
experiments	O
were	O
conducted	O
on	O
a	O
large	O
scale	O
on	O
civilians	O
who	O
had	O
not	O
consented	O
to	O
participate	O
.	O

In	O
2004	O
,	O
one	O
of	O
the	O
last	O
known	O
deaths	O
caused	O
by	O
the	O
SARS	S-Disease
(	O
severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
)‐associated	O
coronavirus	S-Pathogen
was	O
that	O
of	O
the	O
mother	O
of	O
a	O
researcher	O
who	O
had	O
acquired	O
SARS	S-Disease
in	O
a	O
laboratory	O
and	O
transmitted	O
it	O
to	O
her	O
(Normille	O
,	O
2004)	O
.	O

Let's	O
go	O
to	O
the	O
phone	O
.	O

Scientists	O
taking	O
this	O
tack	O
in	O
mouse	O
studies	O
usually	O
tinker	O
with	O
a	O
genome	O
in	O
embryo	O
,	O
meaning	O
that	O
new	O
mice	O
are	O
born	O
with	O
the	O
fix	O
already	O
in	O
place	O
.	O

PREEMPT	S-Scientific_research_project
aims	O
to	O
prevent	O
transmission	O
of	O
virus	O
from	O
a	O
reservoir	O
species	O
direct	O
to	O
humans	O
,	O
from	O
a	O
reservoir	O
species	O
to	O
traditional	O
vectors	O
,	O
such	O
as	O
mosquitos	O
,	O
that	O
spread	O
disease	O
,	O
and	O
from	O
a	O
reservoir	O
species	O
to	O
a	O
species	O
intermediate	O
to	O
humans-for	O
example	O
,	O
from	O
bats	O
to	O
pigs	O
.	O

Laura	B-Person
Saward	E-Person
Emergent	B-Organization
BioSolutions	E-Organization
senior	O
vice	O
president	O
and	O
Head	O
,	O
told	O
Homeland	O
Preparedness	O
News	O
.	O

The	O
most	O
recent	O
outbreak	O
occurred	O
in	O
in	O
2017	O
.	O

First	O
,	O
our	O
influenza	O
laboratory	O
is	O
a	O
superb	O
laboratory	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
released	O
a	O
report	O
today	O
that	O
reviews	O
the	O
early	O
June	O
incident	O
that	O
involved	O
the	O
unintentional	O
exposure	O
of	O
personnel	O
to	O
potentially	O
viable	O
anthrax	S-Pathogen
at	O
the	O
CDC's	B-Location
Roybal	I-Location
Campus	E-Location
.	O
The	O
report	O
identifies	O
factors	O
found	O
to	O
have	O
contributed	O
to	O
the	O
incident	O
;	O
and	O
highlights	O
actions	O
taken	O
by	O
the	O
agency	O
to	O
address	O
these	O
factors	O
and	O
prevent	O
future	O
incidents	O
.	O

Todd	B-Person
Kuiken	E-Person
of	O
the	O
Woodrow	B-Organization
Wilson	I-Organization
Center	E-Organization
proposes	O
that	O
through	O
safety	O
and	O
self-governance	O
,	O
DIY	O
biologists	O
won't	O
be	O
in	O
need	O
of	O
regulation.	O
has	O
proposed	O
that	O
safety	O
is	O
inherent	O
in	O
biohacking	O
and	O
that	O
accessibility	O
should	O
be	O
the	O
foremost	O
concern	O
as	O
there	O
is	O
large	O
underrepresentation	O
of	O
social	O
and	O
ethnic	O
minorities	O
in	O
biohacking	O
.	O

It	O
infects	O
only	O
mouse	O
cells	O
and	O
poses	O
a	O
low	O
safety	O
risk	O
.	O

Some	O
of	O
Unit	B-Organization
731	E-Organization
satellite	O
(branch)	O
facilities	O
are	O
in	O
still	O
use	O
by	O
various	O
Chinese	O
industrial	O
companies	O
.	O

There	O
are	O
2	O
types	O
of	O
selection:	O
negative	O
and	O
positive	O
.	O

The	O
crRNA	O
must	O
bind	O
only	O
where	O
editing	O
is	O
desired	O
.	O

Infusion‐related	O
reactions	O
.	O

It	O
depends	O
on	O
two	O
factors	O
for	O
its	O
specificity:	O
the	O
target	O
sequence	O
and	O
the	O
PAM	O
sequence	O
.	O

In	O
his	O
fingers	O
,	O
he	O
has	O
magnets	O
and	O
two	O
near-field	O
communication	O
(NFC)	O
chips	O
that	O
can	O
be	O
programmed	O
to	O
link	O
to	O
websites	O
or	O
open	O
car	O
doors	O
,	O
among	O
other	O
tasks	O
.	O

This	O
list	O
of	O
Ebola	S-Pathogen
outbreaks	O
records	O
the	O
known	O
occurrences	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
,	O
a	O
highly	O
infectious	O
and	O
acutely	O
lethal	O
viral	O
disease	O
that	O
has	O
afflicted	O
humans	O
and	O
animals	O
primarily	O
in	O
equatorial	B-Location
Africa	E-Location
.	O
The	O
pathogens	O
responsible	O
for	O
the	O
disease	O
are	O
the	O
five	O
ebolaviruses	S-Pathogen
recognized	O
by	O
the	O
International	B-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
:	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
,	O
Sudan	B-Pathogen
virus	E-Pathogen
(	O
SUDV	S-Pathogen
)	O
,	O
Reston	B-Pathogen
virus	E-Pathogen
(	O
RESTV	S-Pathogen
)	O
,	O
Taï	B-Pathogen
Forest	I-Pathogen
virus	E-Pathogen
(	O
TAFV	S-Pathogen
)	O
,	O
and	O
Bundibugyo	B-Pathogen
virus	E-Pathogen
(	O
BDBV	S-Pathogen
)	O
.	O

Prior	O
to	O
this	O
study	O
,	O
isolation	O
of	O
E	B-Pathogen
coli	I-Pathogen
ST1193	E-Pathogen
had	O
only	O
been	O
reported	O
at	O
a	O
few	O
hospitals	O
around	O
the	O
world	O
.	O

And	O
in-flu-enza	S-Disease

I	O
think	O
we	O
recognize	O
that	O
these	O
are	O
dangerous	O
agents	O
.	O

A	O
pandemic	O
involving	O
the	O
H1N1	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
was	O
declared	O
by	O
the	O
then	O
Director-General	O
Margaret	B-Person
Chan	E-Person
in	O
April	O
2009	O
.	O

Some	O
question	O
whether	O
altering	O
human	O
genes	O
means	O
"	O
playing	O
God,	O
"	O
and	O
if	O
so	O
,	O
whether	O
we	O
should	O
do	O
that	O
at	O
all	O
.	O

He	O
concluded	O
t	O
hat	B-Organization
the	I-Organization
Unite	E-Organization
d	O
States	O
did	O
,	O
in	O
fact	O
,	O
test	O
biological	O
weath	O
Korea	O
during	O
the	O
Korean	O
War	O
.	O

Lenzilumab	S-Drug
an	O
anti-GM-CSF	O
monoclonal	O
antibody	O
,	O
is	O
protective	O
in	O
murine	O
models	O
for	O
CAR	O
T	O
cell-induced	O
CRS	S-Disease
and	O
neurotoxicity	S-Disease
and	O
is	O
a	O
viable	O
therapeutic	O
option	O
due	O
to	O
the	O
observed	O
increase	O
of	O
pathogenic	O
GM-CSF	O
secreting	O
T-cells	O
in	O
hospitalised	O
patients	O
with	O
.	O

Ironically	O
,	O
the	O
global	O
response	O
to	O
the	O
deadly	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
has	O
been	O
just	O
that	O
.	O

The	O
main	O
functions	O
of	O
the	O
Board	O
are	O
to	O
carry	O
out	O
the	O
decisions	O
and	O
policies	O
of	O
the	O
Assembly	O
,	O
to	O
advise	O
it	O
and	O
to	O
facilitate	O
its	O
work	O
.	O

How	O
Dangerous	O
Is	O
Anthrax	S-Pathogen

Another	O
person	O
,	O
who	O
was	O
also	O
showing	O
symptoms	O
,	O
was	O
placed	O
in	O
isolation	O
after	O
he	O
had	O
close	O
contact	O
with	O
the	O
said	O
patient	O
;	O
eight	O
others	O
,	O
who	O
also	O
had	O
had	O
contact	O
with	O
the	O
patient	O
,	O
were	O
identified.	O
took	O
steps	O
to	O
track	O
all	O
the	O
people	O
with	O
whom	O
the	O
patient	O
had	O
had	O
contact	O
.	O

Biotechnology	O
is	O
present	O
in	O
our	O
lives	O
before	O
we're	O
even	O
born	O
,	O
from	O
fertility	B-Technology
assistance	E-Technology
to	O
prenatal	B-Technology
screening	E-Technology
to	O
the	O
home	B-Technology
pregnancy	I-Technology
test	E-Technology
.	O
It	O
follows	O
us	O
through	O
childhood	O
,	O
with	O
immunizations	O
and	O
antibiotics	O
,	O
both	O
of	O
which	O
have	O
drastically	O
improved	O
life	O
expectancy	O
.	O

Hence	O
the	O
variability	O
in	O
the	O
severity	O
of	O
illness	O
was	O
suspected	O
to	O
correlate	O
with	O
genetic	O
differences	O
in	O
the	O
victims	O
.	O

Both	O
individuals	O
then	O
sign	O
off	O
on	O
the	O
process	O
.	O

It	O
allows	O
large	O
numbers	O
of	O
small	O
organizations	O
and	O
individuals	O
to	O
participate	O
in	O
research	O
and	O
development	O
,	O
with	O
spreading	O
knowledge	O
a	O
higher	O
priority	O
than	O
turning	O
profits.	O
.	O

There	O
were	O
further	O
outbreaks	O
throughout	O
the	O
Late	O
Middle	O
Ages	O
,	O
and	O
with	O
other	O
contributing	O
factors	O
it	O
took	O
until	O
1500	O
for	O
the	O
European	O
population	O
to	O
regain	O
the	O
levels	O
of	O
1300	O
(Crisis	O
of	O
the	O
Late	O
Middle	O
Ages)	O
.	O

For	O
example	O
,	O
at	O
1.5	O
teslas	O
,	O
a	O
typical	O
field	O
strength	O
for	O
clinical	O
MRI	O
,	O
the	O
difference	O
between	O
high	O
and	O
low	O
energy	O
states	O
is	O
approximately	O
9	O
molecules	O
per	O
2	O
million	O
.	O

Smallpox	S-Disease
is	O
an	O
infectious	O
disease	O
unique	O
to	O
humans	O
,	O
caused	O
by	O
either	O
of	O
two	O
virus	O
variants	O
named	O
Variola	B-Pathogen
major	E-Pathogen
and	O
Variola	B-Pathogen
minor	E-Pathogen
.	O
The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
had	O
established	O
a	O
smallpox	B-Scientific_research_project
eradication	I-Scientific_research_project
programme	E-Scientific_research_project
and	O
,	O
by	O
1978	O
,	O
was	O
close	O
to	O
declaring	O
that	O
the	O
disease	O
had	O
been	O
eradicated	O
globally	O
.	O

The	O
survey	O
was	O
initially	O
released	O
as	O
a	O
pilot	O
,	O
using	O
Pakistan	S-Location
as	O
the	O
test	O
group	O
.	O

The	O
hospital	O
treated	O
thousands	O
of	O
victims	O
of	O
poison	O
gas	O
attacks	O
,	O
and	O
other	O
casualties	O
of	O
war	O
,	O
and	O
100,000 soldiers	O
passed	O
through	O
the	O
camp	O
every	O
day	O
.	O

In	O
1972	O
,	O
Herbert	B-Person
Boyer	E-Person
and	O
Stanley	B-Person
Cohen	E-Person
met	O
at	O
a	O
conference	O
about	O
plasmids	O
,	O
small	O
circles	O
of	O
DNA	O
that	O
can	O
move	O
between	O
cells	O
.	O

Spurred	O
by	O
several	O
accidents	O
at	O
federal	O
laboratories	O
involving	O
risky	O
pathogens	O
,	O
the	O
White	B-Organization
House	E-Organization
today	O
announced	O
a	O
sweeping	O
set	O
of	O
steps	O
aimed	O
at	O
shoring	O
up	O
biosafety	O
and	O
biosecurity	O
procedures	O
.	O

Genetically	B-Technology
modified	E-Technology
(	O
GM	S-Technology
)	O
crops	O
are	O
increasingly	O
gaining	O
acceptance	O
but	O
concurrently	O
consumers'	O
concerns	O
are	O
also	O
increasing	O
.	O

Robert	B-Person
Kadlec	E-Person
Assistant	B-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
at	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
()	O
,	O
for	O
instance	O
,	O
said	O
the	O
office	O
has	O
enough	O
domestic	O
vaccine	O
manufacturing	O
capacity	O
to	O
produce	O
bulk	O
vaccines	O
for	O
each	O
American	O
within	O
six	O
months	O
.	O

It	O
infects	O
only	O
mouse	O
cells	O
and	O
poses	O
a	O
low	O
safety	O
risk	O
.	O

The	O
number	O
of	O
lab-confirmed	O
deaths	O
reported	O
to	O
the	O
WHO	S-Organization
is	O
18,449	O
,	O
though	O
this	O
2009	O
H1N1	B-Incident
flu	I-Incident
pandemic	E-Incident
is	O
estimated	O
to	O
have	O
actually	O
caused	O
about	O
284,000	O
(range	O
from	O
150,000	O
to	O
575,000)	O
deaths	O
.	O

On	O
25	O
November	O
2019	O
,	O
it	O
was	O
reported	O
that	O
violence	O
had	O
broken	O
out	O
in	O
Beni	S-Location
once	O
more	O
,	O
to	O
such	O
a	O
degree	O
that	O
some	O
aid	O
agencies	O
had	O
evacuated	O
.	O

This	O
included	O
a	O
course	O
in	O
project	O
management	O
for	O
all	O
participants	O
,	O
an	O
FBD	B-Document
quality	I-Document
assurance	I-Document
(QA)	I-Document
manual	E-Document
,	O
and	O
a	O
(Figure	O
3)	O
.	O

She	O
had	O
also	O
visited	O
Bombali	B-Location
District	E-Location
to	O
consult	O
a	O
herbalist	O
,	O
and	O
had	O
later	O
gone	O
to	O
a	O
.	O

The	O
majority	O
(66.	O
7%)	O
claimed	O
there	O
are	O
no	O
separate	O
bins	O
for	O
sharps	O
,	O
so	O
they	O
throw	O
these	O
in	O
municipal	O
dustbins	O
.	O

WHO	S-Organization
Representatives	O
in	O
the	O
Region	O
termed	O
the	O
Americas	S-Location
are	O
referred	O
to	O
as	O
PAHO	S-Organization
/	O
WHO	S-Organization
Representatives	O
.	O

Dr	O
.	O

It	O
is	O
not	O
clear	O
why	O
the	O
Pentagon	S-Organization
choses	O
to	O
invest	O
in	O
vaccines	B-Vaccine
produced	I-Vaccine
from	I-Vaccine
tobacco	I-Vaccine
plants	E-Vaccine
amongst	O
all	O
other	O
plant	O
species	O
,	O
which	O
they	O
explored	O
.	O

In	O
response	O
to	O
the	O
incident	O
,	O
"	O
communication	O
systems	O
were	O
reviewed	O
,	O
updated	O
and	O
additional	O
emphasis	O
was	O
placed	O
on	O
timely	O
communication	O
between	O
staff	O
working	O
in	O
the	O
laboratory	O
and	O
the	O
University	B-Organization
Occupational	I-Organization
Health	E-Organization
physicians	O
in	O
order	O
to	O
help	O
everyone	O
involved	O
understand	O
the	O
material	O
being	O
used	O
and	O
the	O
signs	O
and	O
symptoms	O
of	O
infection,	O
"	O
wrote	O
,	O
a	O
university	O
spokesman	O
.	O

The	O
CDC	S-Organization
recommends	O
those	O
who	O
suspect	O
they	O
carry	O
the	O
virus	O
wear	O
a	O
simple	O
face	B-Equipment
mask	E-Equipment
.	O
Extracorporeal	B-Equipment
membrane	I-Equipment
oxygenation	E-Equipment
(	O
ECMO	S-Equipment
)	O
has	O
been	O
used	O
to	O
address	O
the	O
issue	O
of	O
,	O
but	O
its	O
benefits	O
are	O
still	O
under	O
consideration	O
.	O

Formed	O
an	O
external	O
laboratory	O
safety	O
working	O
group	O
,	O
under	O
the	O
Advisory	B-Organization
Committee	E-Organization
to	O
the	O
Director	O
,	O
composed	O
of	O
experts	O
in	O
biosafety	O
and	O
related	O
areas	O
to	O
review	O
and	O
provide	O
input	O
into	O
corrective	O
actions	O
and	O
safeguards	O
across	O
all	O
laboratories	O
.	O

MRI	B-Equipment
scanners	E-Equipment
use	O
strong	O
magnetic	O
fields	O
,	O
magnetic	O
field	O
gradients	O
,	O
and	O
radio	O
waves	O
to	O
generate	O
images	O
of	O
the	O
organs	O
in	O
the	O
body	O
.	O

Looming	O
large	O
over	O
such	O
catastrophies	O
is	O
the	O
constant	O
development	O
and	O
worldwide	O
spread	O
of	O
antibiotic	O
genes	O
.	O

A	O
prophylactic	O
treatment	O
that	O
protects	O
against	O
enteric	O
diseases	O
,	O
specifically	O
Shigella	S-Pathogen
is	O
a	O
high	O
priority	O
objective	O
for	O
the	O
US	B-Organization
Army	E-Organization
,	O
supported	O
under	O
Military	B-Scientific_research_project
Infectious	I-Scientific_research_project
Diseases	I-Scientific_research_project
Research	I-Scientific_research_project
Program	E-Scientific_research_project
,	O
and	O
for	O
use	O
in	O
endemic	O
areas	O
of	O
the	O
world	O
.	O

In	O
fact	O
,	O
the	O
use	O
of	O
anthrax	S-Pathogen
at	O
all	O
for	O
this	O
experiment	O
should	O
not	O
have	O
been	O
done	O
.	O

In	O
October	O
2014	O
,	O
a	O
safety	O
worker	O
at	O
Colorado	B-Organization
State	I-Organization
University	I-Organization
in	I-Organization
Fort	I-Organization
Collins	E-Organization
discovered	O
an	O
insect	O
bite	O
after	O
completing	O
a	O
laboratory	O
shift	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
isolate	O
,	O
complete	O
genome	O
,	O
GenBank	O
The	O
3′	O
terminus	O
is	O
not	O
polyadenylated	O
and	O
the	O
5′	O
end	O
is	O
not	O
capped	O
.	O

His	O
research	O
interests	O
include	O
infectious	O
diseases	O
of	O
dogs	O
and	O
cats	O
and	O
antimicrobial	O
stewardship	O
educational	O
strategies	O
in	O
veterinary	O
medicine	O
.	O

6	O
.	O

The	O
Open	B-Scientific_research_project
Insulin	I-Scientific_research_project
project	E-Scientific_research_project
aims	O
to	O
make	O
the	O
recombinant	B-Drug
protein	I-Drug
insulin	E-Drug
more	O
accessible	O
by	O
creating	O
an	O
open	O
source	O
protocol	O
for	O
expression	O
and	O
purification	O
.	O

Because	O
of	O
its	O
high	O
mortality	O
rate	O
(up	O
to	O
83	O
to	O
90	O
percent)	O
,	O
EBOV	S-Pathogen
is	O
also	O
listed	O
as	O
a	O
select	O
agent	O
,	O
World	B-Organization
Health	I-Organization
Organization	I-Organization
Risk	I-Organization
Group	E-Organization
4	O
Pathogen	O
(requiring	O
Biosafety	O
Level	O
4-equivalent	O
containment)	O
,	O
a	O
US	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
/	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	E-Organization
and	O
Infectious	O
Diseases	O
Category	O
A	O
Priority	O
Pathogen	O
,	O
US	B-Organization
CDC	E-Organization
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
and	O
Prevention	O
Category	O
A	O
Bioterrorism	O
Agent	O
,	O
and	O
a	O
Biological	O
Agent	O
for	O
Export	O
Control	O
by	O
the	O
.	O

As	O
of	O
September	O
2017	O
,	O
the	O
largest	O
number	O
of	O
projects	O
have	O
been	O
implemented	O
in	O
.	O

Hence	O
,	O
is	O
classified	O
as	O
a	O
direct-acting	O
antiviral	O
agent	O
that	O
works	O
as	O
a	O
delayed	O
chain	O
terminator	O
.	O

Thirty	O
microliters	O
of	O
the	O
E.	O
coli	O
culture	O
was	O
inoculated	O
into	O
3	O
ml	O
LB	O
at	O
a	O
starting	O
optical	O
density	O
of	O
0.	O
05	O
measured	O
at	O
590	O
nm	O
(OD590)	O
and	O
grown	O
at	O
the	O
same	O
conditions	O
to	O
an	O
optical	O
density	O
of	O
0.2	O
.	O

On	O
a	O
couple	O
of	O
occasions	O
,	O
samples	O
have	O
been	O
sent	O
between	O
the	O
agencies	O
,	O
for	O
example	O
,	O
when	O
there	O
have	O
been	O
problems	O
with	O
equipment	O
or	O
when	O
results	O
have	O
needed	O
to	O
be	O
confirmed	O
,	O
in	O
a	O
manner	O
that	O
would	O
not	O
have	O
been	O
possible	O
before	O
the	O
establishment	O
of	O
the	O
FBD	S-Platform
network	O
.	O

Although	O
resistant	O
to	O
several	O
antibiotics	O
,	O
the	O
afflicted	O
could	O
be	O
treated	O
with	O
alternative	O
agents	O
.	O

Soon	O
after	O
Lokela	S-Person
visit	O
,	O
a	O
number	O
of	O
other	O
cases	O
were	O
presented	O
at	O
the	O
Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
.	O
A	O
report	O
from	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
noted	O
that	O
"	O
almost	O
all	O
subsequent	O
infections	O
had	O
either	O
received	O
injections	O
at	O
the	O
hospital	O
or	O
had	O
had	O
close	O
contact	O
with	O
another	O
case.	O
"	O
Shortly	O
after	O
family	O
members	O
prepared	O
his	O
body	O
for	O
burial	O
,	O
in	O
accordance	O
with	O
local	O
customs	O
,	O
21	O
of	O
's	O
friends	O
and	O
relatives	O
fell	O
seriously	O
ill	O
and	O
18	O
later	O
died	O
.	O

But	O
unlike	O
most	O
other	O
steps	O
in	O
the	O
memo	O
,	O
this	O
one	O
does	O
not	O
come	O
with	O
a	O
deadline	O
for	O
implementation	O
.	O

Avian	B-Disease
influenza	E-Disease
(	O
H7N9	S-Disease
)	O
.	O

The	O
Chinese	B-Organization
Ministry	I-Organization
of	I-Organization
Foreign	I-Organization
Affairs	E-Organization
announced	O
on	O
26	O
March	O
that	O
entry	O
for	O
visa	O
or	O
residence	O
permit	O
holders	O
would	O
be	O
suspended	O
from	O
28	O
March	O
onwards	O
,	O
with	O
no	O
specific	O
details	O
on	O
when	O
this	O
policy	O
would	O
end	O
.	O

Operation	B-Scientific_research_project
Whitecoat	E-Scientific_research_project
involved	O
the	O
controlled	O
testing	O
of	O
many	O
serious	O
agents	O
on	O
military	O
personnel	O
who	O
had	O
consented	O
to	O
experimentation	O
,	O
and	O
who	O
understood	O
the	O
risks	O
involved	O
.	O

The	O
university	O
contacted	O
its	O
vendor	O
for	O
biohazard	O
waste	O
barrels	O
about	O
the	O
need	O
to	O
ensure	O
all	O
lids	O
can	O
lock	O
before	O
they	O
are	O
delivered	O
.	O

The	O
procedure	O
used	O
in	O
the	O
lab	O
may	O
not	O
have	O
fully	O
inactivated	O
the	O
samples	O
.	O

"	O
In	O
fact	O
there	O
have	O
been	O
stories	O
of	O
huge	O
volumes	O
of	O
US	S-Location
pork	O
being	O
shipped	O
to	O
already	O
despite	O
those	O
tariffs	O
being	O
in	O
place.	O
"	O

The	O
military	O
facility	O
remains	O
closed	O
for	O
inspection	O
.	O

Furthermore	O
,	O
the	O
interwave	O
periods	O
were	O
so	O
brief	O
as	O
to	O
be	O
almost	O
undetectable	O
in	O
some	O
locales	O
.	O

As	O
President	O
Trump	S-Person
has	O
said	O
,	O
"	O
We	O
cannot	O
have	O
prosperity	O
if	O
we	O
are	O
not	O
healthy.	O
"	O
The	O
report	O
details	O
how	O
GHSA	S-International_exchange_and_cooperation
support	O
enabled	O
countries	O
to	O
respond	O
to	O
and	O
contain	O
outbreaks	O
of	O
high-threat	O
diseases	O
,	O
including	O
dengue	B-Disease
fever	E-Disease
in	O
Burkina	B-Location
Faso	E-Location
and	O
the	O
Marburg	B-Pathogen
virus	E-Pathogen
in	O
.	O

On	O
May	O
16	O
,	O
2011	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
blog	O
published	O
an	O
article	O
instructing	O
the	O
public	O
on	O
what	O
to	O
do	O
to	O
prepare	O
for	O
a	O
zombie	O
invasion	O
.	O

On	O
12	O
April	O
2010	O
,	O
Keiji	B-Person
Fukuda	E-Person
the	O
WHO	S-Organization
's	O
top	O
influenza	O
expert	O
,	O
stated	O
that	O
the	O
system	O
leading	O
to	O
the	O
declaration	O
of	O
a	O
pandemic	O
led	O
to	O
confusion	O
about	O
H1N1	S-Pathogen
circulating	O
around	O
the	O
world	O
and	O
he	O
expressed	O
concern	O
that	O
there	O
was	O
a	O
failure	O
to	O
communicate	O
in	O
regard	O
to	O
uncertainties	O
about	O
the	O
new	O
virus	O
,	O
which	O
turned	O
out	O
to	O
be	O
not	O
as	O
deadly	O
as	O
feared	O
.	O

Enhanced	O
equipment	O
for	O
first	O
responders	O
.	O

Iraq	S-Location
is	O
known	O
to	O
have	O
unleashed	O
chemical	O
weapons	O
in	O
the	O
1980s	O
,	O
both	O
during	O
the	O
Iran	S-Location
-	O
Iraq	S-Location
war	O
and	O
against	O
rebellious	O
Kurds	O
in	O
northern	O
.	O
But	O
there	O
is	O
no	O
evidence	O
that	O
the	O
Iraqi	O
state	O
has	O
ever	O
used	O
its	O
biological	O
arsenal	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
operates	O
150	O
country	O
offices	O
in	O
six	O
different	O
regions	O
.	O

CDC	S-Organization
strives	O
to	O
protect	O
Americans	O
by	O
finding	O
and	O
ending	O
outbreaks	O
at	O
their	O
source	O
.	O

Two	O
of	O
the	O
Saudi	B-Location
Arabia	E-Location
cases	O
were	O
from	O
the	O
same	O
family	O
and	O
from	O
that	O
family	O
at	O
least	O
one	O
additional	O
person	O
presented	O
similar	O
symptoms	O
but	O
tested	O
negative	O
for	O
the	O
novel	O
coronavirus	O
.	O

Fifteen	O
of	O
the	O
quarantined	O
Amoy	B-Organization
Gardens	E-Organization
residents	O
at	O
Lei	B-Organization
Yue	I-Organization
Mun	I-Organization
Holiday	I-Organization
Camp	E-Organization
were	O
relocated	O
to	O
the	O
Sai	B-Organization
Kung	I-Organization
Outdoor	I-Organization
Recreation	I-Organization
Centre	E-Organization
after	O
an	O
overnight	O
protest	O
on	O
washroom	O
sharing	O
.	O

This	O
response	O
was	O
only	O
possible	O
because	O
of	O
the	O
extensive	O
preparations	O
undertaken	O
during	O
the	O
last	O
decade"	O
.	O

The	O
continent	O
of	O
Africa	S-Location
has	O
experienced	O
deforestation	O
in	O
several	O
areas	O
or	O
regions	O
;	O
this	O
may	O
contribute	O
to	O
recent	O
outbreaks	O
,	O
including	O
this	O
,	O
as	O
initial	O
cases	O
have	O
been	O
in	O
the	O
proximity	O
of	O
deforested	O
lands	O
where	O
fruit-eating	O
bats	O
natural	O
habitat	O
may	O
be	O
affected	O
,	O
though	O
100%	O
evidence	O
does	O
not	O
as	O
yet	O
exist	O
.	O

The	O
United	B-Organization
Nations	E-Organization
Secretary-General	O
has	O
established	O
IACG	S-Organization
to	O
improve	O
coordination	O
between	O
international	O
organizations	O
and	O
to	O
ensure	O
effective	O
global	O
action	O
against	O
this	O
threat	O
to	O
health	O
security	O
.	O

The	O
lab	O
adjoined	O
an	O
insectary	O
where	O
genetically	O
modified	O
mosquitoes	O
were	O
being	O
used	O
in	O
a	O
dengue	B-Pathogen
virus	E-Pathogen
experiment	O
,	O
according	O
to	O
an	O
incident	O
report	O
the	O
university	O
filed	O
with	O
the	O
.	O

According	O
to	O
a	O
just-updated	O
analysis	O
by	O
Pew	S-Person
antibiotic	O
resistance	O
project	O
,	O
there	O
are	O
only	O
11	O
antibiotics	O
currently	O
in	O
clinical	O
trials	O
to	O
address	O
the	O
bacterial	O
pathogens	O
deemed	O
the	O
biggest	O
threats	O
by	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
()	O
.	O

The	O
finds	O
came	O
as	O
part	O
of	O
a	O
sweep	O
for	O
select	O
agents	O
at	O
NIH	S-Organization
and	O
other	O
federal	O
agencies	O
launched	O
after	O
six	O
vials	O
of	O
live	O
smallpox	S-Disease
dated	O
1954	O
were	O
found	O
in	O
July	O
in	O
a	O
cold	O
storage	O
room	O
in	O
an	O
FDA	S-Organization
lab	O
on	O
the	O
campus	O
.	O

Quick	O
response	O
is	O
slowed	O
and	O
the	O
consequences	O
more	O
dire	O
when	O
systems	O
aren't	O
well-equipped	O
to	O
handle	O
outbreaks	O
.	O

Plasma	O
then	O
gets	O
collected	O
from	O
these	O
donors	O
and	O
is	O
used	O
to	O
create	O
therapeutics	O
that	O
are	O
administered	O
to	O
patients	O
suffering	O
from	O
diseases	O
like	O
anthrax	S-Disease
or	O
.	O

In	O
2014	O
The	O
Lugar	B-Organization
Center	E-Organization
was	O
equipped	O
with	O
an	O
insect	B-Equipment
facility	E-Equipment
and	O
launched	O
a	O
project	O
"	O
Raising	B-Scientific_research_project
Awareness	I-Scientific_research_project
about	I-Scientific_research_project
Barcoding	I-Scientific_research_project
of	I-Scientific_research_project
Sand	I-Scientific_research_project
Flies	I-Scientific_research_project
in	I-Scientific_research_project
Georgia	I-Scientific_research_project
and	I-Scientific_research_project
Caucasus	E-Scientific_research_project
"	O
.	O
The	O
project	O
covered	O
a	O
larger	O
geographic	O
area	O
outside	O
of	O
Georgia	S-Location
–	O
Caucasus	S-Location
.	O
In	O
2014-2015	O
Phlebotomine	O
sand	O
fly	O
species	O
were	O
collected	O
under	O
another	O
project	O
"	O
"	O
and	O
all	O
(female)	O
sand	O
flies	O
were	O
tested	O
to	O
determine	O
their	O
infectivity	O
rate	O
.	O

Other	O
good	O
examples	O
are	O
the	O
annual	O
Antibiotic	B-Activity
Awareness	I-Activity
Day	E-Activity
in	O
Europe	S-Location
and	O
Canada	S-Location
(Ref)	O
and	O
the	O
CDC	S-Organization
program	O
"	O
Get	B-Activity
Smart:	I-Activity
Know	I-Activity
When	I-Activity
Antibiotics	I-Activity
Work	E-Activity
"	O
in	O
(Ref)	O
.	O

If	O
so	O
,	O
an	O
incident	O
management	O
center	O
would	O
be	O
set	O
up	O
in	O
the	O
first	O
20-30	O
minutes	O
so	O
someone	O
in	O
range	O
could	O
take	O
a	O
sample	O
and	O
make	O
a	O
presumptive	O
analysis	O
so	O
that	O
people	O
could	O
start	O
making	O
high-risk	O
decisions	O
like	O
shutting	O
down	O
air	O
handling	O
systems	O
or	O
turning	O
off	O
trains	O
,	O
McDonnell	S-Person
explained	O
.	O

No	O
exhaustive	O
catalogue	O
of	O
GCBR	O
culprits	O
exists	O
,	O
leaving	O
the	O
health	O
security	O
community	O
to	O
rely	O
on	O
historical	O
examples	O
(e.g.	O
,	O
)	O
to	O
guide	O
their	O
preparedness	O
priorities	O
.	O

The	O
university	O
contacted	O
its	O
vendor	O
for	O
biohazard	O
waste	O
barrels	O
about	O
the	O
need	O
to	O
ensure	O
all	O
lids	O
can	O
lock	O
before	O
they	O
are	O
delivered	O
.	O

Investigators	O
believed	O
that	O
the	O
commune	O
had	O
previously	O
carried	O
out	O
similar	O
attacks	O
in	O
Salem	S-Location
,	O
Portland	S-Location
,	O
and	O
other	O
cities	O
in	O
Oregon	S-Location
.	O
According	O
to	O
court	O
testimony	O
,	O
the	O
plotters	O
boasted	O
that	O
they	O
had	O
attacked	O
a	O
nursing	O
home	O
and	O
a	O
salad	O
bar	O
at	O
the	O
Mid-Columbia	B-Organization
Medical	I-Organization
Center	E-Organization
,	O
but	O
no	O
such	O
attempts	O
were	O
ever	O
proven	O
in	O
court	O
.	O

NIH	S-Organization
officials	O
said	O
the	O
needle	O
used	O
for	O
collection	O
violated	O
a	O
university	O
policy	O
against	O
such	O
use	O
in	O
the	O
ABSL-3	B-Platform
lab	E-Platform
.	O
The	O
NIH	S-Organization
also	O
took	O
issue	O
with	O
using	O
the	O
researcher's	O
home	O
for	O
the	O
quarantine	O
,	O
contrary	O
to	O
a	O
previous	O
agreement	O
about	O
the	O
research	O
.	O

The	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
system	O
will	O
test	O
for	O
three	O
traits	O
of	O
pathogenicity	O
.	O

The	O
group	O
also	O
tried	O
to	O
introduce	O
pathogens	O
into	O
'	O
water	O
system	O
.	O

Referring	O
to	O
the	O
ASPR	S-Organization
as	O
the	O
national	O
security	O
mission	O
manager	O
for	O
HHS	S-Organization
,	O
Kadlec	S-Person
said	O
the	O
office	O
-	O
which	O
was	O
established	O
a	O
decade	O
ago	O
by	O
PAHPA	S-Document
-	O
consolidates	O
all	O
federal	O
non-military	O
public	O
health	O
and	O
medical	O
preparedness	O
and	O
response	O
functions	O
under	O
its	O
command	O
.	O

Japanese	O
discussions	O
of	O
Unit	B-Organization
731	E-Organization
activity	O
began	O
in	O
the	O
1950s	O
,	O
after	O
the	O
end	O
of	O
the	O
American	O
occupation	O
of	O
Japan	S-Location
.	O
In	O
1952	O
,	O
human	O
experiments	O
carried	O
out	O
in	O
Nagoya	B-Location
City	I-Location
Pediatric	I-Location
Hospital	E-Location
,	O
which	O
resulted	O
in	O
one	O
death	O
,	O
were	O
publicly	O
tied	O
to	O
former	O
members	O
of	O
Unit	B-Organization
731	E-Organization
.	O
日本弁護士連合会『人権白書昭和43年版』日本弁護士連合会、1968年、pp.	O
134–136;高杉晋吾『七三一部隊細菌戦の医師を追え』徳間書店、1982年、pp.	O
94–111	O
;	O
保護施設収容者に対する人権擁護に関する件(決議)	O
Later	O
in	O
that	O
decade	O
,	O
journalists	O
suspected	O
that	O
the	O
murders	O
attributed	O
by	O
the	O
government	O
to	O
Sadamichi	B-Person
Hirasawa	E-Person
were	O
actually	O
carried	O
out	O
by	O
members	O
of	O
Unit	B-Organization
731	E-Organization
.	O
In	O
1958	O
,	O
Japanese	O
author	O
published	O
the	O
book	O
The	O
Sea	O
and	O
Poison	O
about	O
human	O
experimentation	O
,	O
which	O
is	O
thought	O
to	O
have	O
been	O
based	O
on	O
a	O
real	O
incident	O
.	O

Muslim	O
religious	O
scholars	O
taught	O
that	O
the	O
plague	S-Disease
was	O
a	O
"	O
martyrdom	O
and	O
mercy	O
"	O
from	O
God	O
,	O
assuring	O
the	O
believer's	O
place	O
in	O
paradise	O
.	O

Safe	O
work	O
practices	O
and	O
the	O
use	O
of	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
must	O
be	O
included	O
in	O
the	O
procedures	O
.	O

Thus	O
,	O
during	O
a	O
crisis	O
,	O
each	O
sector	O
is	O
responsible	O
only	O
for	O
its	O
own	O
area	O
of	O
expertise	O
,	O
and	O
most	O
crises	O
are	O
managed	O
by	O
the	O
municipalities	O
responsible	O
at	O
a	O
local	O
level	O
.	O

For	O
example	O
,	O
getting	O
a	O
blood	O
test	O
before	O
and	O
after	O
taking	O
vitamin	B-Drug
B12	E-Drug
supplements	O
for	O
greater	O
cognitive	O
function	O
can	O
show	O
you	O
whether	O
the	O
supplements	O
have	O
affected	O
your	O
levels	O
.	O

According	O
to	O
The	O
Associated	B-Organization
Press	E-Organization
the	O
WHO	S-Organization
routinely	O
spends	O
about	O
$200 million	O
a	O
year	O
on	O
travel	O
expenses	O
,	O
more	O
than	O
it	O
spends	O
to	O
tackle	O
mental	O
health	O
problems	O
,	O
HIV/AIDS	S-Disease
,	O
Tuberculosis	S-Disease
and	O
Malaria	S-Disease
combined	O
.	O

Environmental	O
specimens	O
were	O
collected	O
with	O
swabs	O
,	O
including	O
(1)	O
the	O
surface	O
of	O
sample	O
acceptance	O
desk	O
,	O
(2)	O
the	O
temporary	O
storage	O
refrigerator	O
,	O
(3)	O
the	O
operation	O
platform	O
of	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(4)	O
the	O
RNA	O
extraction	O
bench	O
in	O
the	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(5)	O
the	O
autoclave	O
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(6)	O
the	O
centrifuge	O
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(7)	O
the	O
transfer	O
windows	O
in	O
the	O
BSL-3	S-Platform
lab	O
("clean	O
"	O
and	O
"	O
dirty"),	O
(8)	O
the	O
bench	O
in	O
the	O
preparation	O
room	O
(before	O
and	O
after	O
use)	O
,	O
(9)	O
the	O
operation	O
platform	O
of	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
the	O
BSL-2	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
and	O
(10)	O
the	O
real-time	O
PCR	S-Equipment
facility	O
in	O
(inside	O
and	O
outside)	O
.	O

Advances	O
in	O
semiconductor	O
technology	O
were	O
crucial	O
to	O
the	O
development	O
of	O
practical	O
MRI	S-Technology
which	O
requires	O
a	O
large	O
amount	O
of	O
computational	O
power	O
.	O

The	O
Johns	B-Organization
Hopkins	I-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
works	O
to	O
protect	O
people	O
from	O
epidemics	O
and	O
disasters	O
and	O
build	O
resilient	O
communities	O
through	O
innovative	O
scholarship	O
,	O
engagement	O
,	O
and	O
research	O
that	O
strengthens	O
the	O
organizations	O
,	O
systems	O
,	O
policies	O
,	O
and	O
programs	O
essential	O
to	O
preventing	O
and	O
responding	O
to	O
public	O
health	O
crises	O
.	O

In	O
another	O
FBD	S-Platform
project	O
,	O
the	O
outcomes	O
of	O
network	O
activities	O
were	O
disseminated	O
to	O
other	O
actors	O
working	O
in	O
the	O
field	O
of	O
biopreparedness	O
.	O

The	O
WHO	O
Assessment	O
Instrument	O
for	O
Mental	O
Health	O
Systems	O
(WHO-AIMS)	O
,	O
the	O
WHO	O
Quality	O
of	O
Life	O
Instrument	O
(WHOQOL)	O
,	O
and	O
the	O
Service	O
Availability	O
and	O
Readiness	O
Assessment	O
(SARA)	O
provide	O
guidance	O
for	O
data	O
collection.See	O
respectively:*	O
*	O
*	O
Collaborative	O
efforts	O
between	O
WHO	S-Organization
and	O
other	O
agencies	O
,	O
such	O
as	O
through	O
the	O
Health	B-Platform
Metrics	I-Platform
Network	E-Platform
,	O
also	O
aim	O
to	O
provide	O
sufficient	O
high-quality	O
information	O
to	O
assist	O
governmental	O
decision	O
making	O
.	O

In	O
August	O
1349	O
,	O
the	O
Jewish	O
communities	O
in	O
Mainz	S-Location
and	O
Cologne	S-Location
were	O
annihilated	O
.	O

The	O
first	O
edition	O
was	O
published	O
in	O
1983	O
,	O
second	O
edition	O
in	O
1993	O
,	O
and	O
the	O
third	O
and	O
latest	O
edition	O
was	O
published	O
in	O
2004	O
.	O

How	O
do	O
you	O
biohack	O
with	O
nootropics	S-Drug

"	O
The	O
SECURE	B-Document
Act	E-Document
addresses	O
the	O
need	O
for	O
a	O
public	O
health	O
workforce	O
that	O
is	O
trained	O
,	O
ready	O
and	O
sufficient	O
to	O
respond	O
to	O
large-scale	O
infectious	O
disease	O
outbreaks	O
,	O
and	O
other	O
threats	O
to	O
our	O
health	O
security,	O
"	O
the	O
society	O
said	O
in	O
a	O
June	O
5	O
statement	O
.	O

The	O
latter	O
are	O
composed	O
of	O
key	O
genes	O
from	O
the	O
1918	B-Pathogen
virus	E-Pathogen
,	O
updated	O
by	O
subsequently	O
incorporated	O
avian	O
influenza	S-Disease
genes	O
that	O
code	O
for	O
novel	O
surface	O
proteins	O
,	O
making	O
the	O
indeed	O
the	O
"	O
mother"	O
of	O
all	O
pandemics	O
.	O

And	O
the	O
root	O
cause	O
fundamentally	O
was	O
that	O
the	O
scientists	O
failed	O
to	O
follow	O
a	O
scientifically	O
derived	O
and	O
reviewed	O
protocol	O
that	O
would	O
have	O
assured	O
that	O
anthrax	S-Pathogen
was	O
inactivated	O
and	O
that	O
the	O
material	O
was	O
confirmed	O
to	O
be	O
before	O
it	O
ever	O
left	O
the	O
lab	O
.	O

Stationed	O
in	O
Harbin	S-Location

Barkan,	B-Person
O	E-Person
;	O
Weill,	B-Person
J	E-Person
;	O
Averbuch,	B-Person
A	E-Person
;	O
.	O
"	O
Adaptive	O
Compressed	O
Tomography	O
Sensing	O
"	O
.	O
In	O
Proceedings	O
of	O
the	O
IEEE	O
Conference	O
on	O
Computer	O
Vision	O
and	O
Pattern	O
Recognition	O
2013	O
(pp.	O
2195–2202)	O
.	O

Worldwide	O
antibiotic	O
resistance	O
is	O
not	O
completely	O
identified	O
,	O
but	O
poorer	O
countries	O
with	O
weaker	O
healthcare	O
systems	O
are	O
more	O
affected	O
.	O

This	O
page	O
provides	O
links	O
to	O
international	O
biosafety	O
guidelines	O
and	O
websites	O
.	O

Among	O
those	O
threats	O
are	O
bioterrorism	O
attacks	O
,	O
disease	O
outbreaks	O
and	O
environmental	O
catastrophes	O
.	O

DNA	B-Technology
sequencing	E-Technology
has	O
also	O
allowed	O
Sonia	S-Person
to	O
become	O
pregnant	O
,	O
since	O
doctors	O
cou	O
ld	B-Equipment
t	E-Equipment
est	O
her	O
eggs	O
for	O
ones	O
that	O
don't	O
have	O
the	O
mutation	O
.	O

A	O
method	O
of	O
for	O
detection	O
of	O
high-consequence	O
pathogens	O
in	O
larger	O
volume	O
water	O
also	O
led	O
all	O
4	O
agencies	O
to	O
purchase	O
the	O
same	O
equipment	O
.	O

Since	O
May	O
2015	O
,	O
most	O
of	O
the	O
cases	O
had	O
occurred	O
at	O
the	O
,	O
a	O
large	O
national	O
guard	O
hospital	O
.	O

On	O
23	O
July	O
,	O
a	O
World	B-Organization
Bank	E-Organization
poll	O
warned	O
that	O
"	O
we	O
are	O
not	O
ready	O
for	O
another	O
Ebola	B-Incident
outbreak	E-Incident
"	O
.	O
On	O
15	O
December	O
,	O
the	O
World	B-Organization
Bank	E-Organization
indicated	O
that	O
by	O
1	O
December	O
2015	O
,	O
it	O
had	O
marshalled	O
$1.62	O
billion	O
in	O
financing	O
for	O
the	O
response	O
.	O

Hence	O
,	O
the	O
risk	O
of	O
work	O
related	O
accidents	O
is	O
high	O
10	O
,	O
11	O
.	O

Its	O
applications	O
include	O
assessment	O
of	O
myocardial	B-Disease
ischemia	E-Disease
and	O
viability	O
,	O
cardiomyopathies	S-Disease
,	O
myocarditis	S-Disease
,	O
iron	B-Disease
overload	E-Disease
,	O
vascular	B-Disease
diseases	E-Disease
,	O
and	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

Compared	O
to	O
the	O
lowest	O
dose	O
x-ray	B-Technology
techniques	E-Technology
,	O
CT	B-Technology
scans	E-Technology
can	O
have	O
100	O
to	O
1,000	O
times	O
higher	O
dose	O
than	O
conventional	O
X-rays	O
.	O

The	O
Strategy	B-Document
for	I-Document
the	I-Document
Control	I-Document
of	I-Document
Antimicrobial	I-Document
Resistance	I-Document
in	I-Document
Ireland	E-Document
(	O
SARI	S-Document
)	O
,	O
Iaunched	O
in	O
2001	O
developed	O
Guidelines	B-Document
for	I-Document
Antimicrobial	I-Document
Stewardship	I-Document
in	I-Document
Hospitals	I-Document
in	I-Document
Ireland	E-Document
in	O
conjunction	O
with	O
the	O
Health	B-Organization
Protection	I-Organization
Surveillance	I-Organization
Centre	E-Organization
,	O
these	O
were	O
published	O
in	O
2009	O
.	O

The	O
percentage	O
of	O
these	O
parameters	O
was	O
low	O
when	O
compared	O
to	O
a	O
similar	O
study	O
in	O
Turkey	S-Location

According	O
to	O
the	O
director	O
of	O
the	O
NGO	B-Organization
Plan	I-Organization
International	E-Organization
in	O
Guinea	S-Location
,	O
"	O
The	O
poor	O
living	O
conditions	O
and	O
lack	O
of	O
water	O
and	O
sanitation	O
in	O
most	O
districts	O
of	O
Conakry	S-Location
pose	O
a	O
serious	O
risk	O
that	O
the	O
epidemic	O
escalates	O
into	O
a	O
crisis	O
.	O

A	O
recuperation	O
in	O
the	O
economy	O
,	O
at	O
the	O
end	O
of	O
the	O
outbreak	O
,	O
was	O
expected	O
to	O
be	O
more	O
rapid	O
in	O
some	O
sectors	O
than	O
in	O
others	O
.	O

As	O
of	O
February	O
2016	O
is	O
in	O
use	O
at	O
three	O
sites	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We	O
have	O
done	O
that	O
.	O

Medications	O
used	O
as	O
can	O
be	O
dangerous	O
unless	O
used	O
as	O
directed	O
by	O
a	O
medical	O
professional	O
.	O

Dr	O
.	O

More	O
drastic	O
actions	O
aimed	O
at	O
containing	O
the	O
outbreak	O
were	O
taken	O
in	O
China	S-Location
once	O
the	O
severity	O
of	O
the	O
outbreak	O
became	O
apparent	O
,	O
such	O
as	O
quarantining	O
entire	O
cities	O
and	O
imposing	O
strict	O
travel	O
bans	O
.	O

The	O
application	O
server	O
stores	O
metadata	O
in	O
a	O
dedicated	O
database	O
and	O
interfaces	O
to	O
the	O
user	O
web	O
browsers.	O
openBIS	S-Platform
employs	O
a	O
generic	O
metadata	O
model	O
based	O
on	O
controlled	O
vocabularies	O
.	O

In	O
2005	O
,	O
synthetic	O
biologist	O
Chris	B-Person
Voigt	E-Person
and	O
a	O
team	O
of	O
students	O
at	O
the	O
University	B-Organization
of	I-Organization
California	E-Organization
,	O
,	O
created	O
another	O
powerful	O
-	O
and	O
playful	O
-	O
illustration	O
of	O
what	O
it	O
means	O
to	O
program	O
biological	O
circuits	O
with	O
memory	O
.	O

The	O
name	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
is	O
derived	O
from	O
the	O
Ebola	B-Location
River	E-Location
-a	O
river	O
that	O
was	O
at	O
first	O
thought	O
to	O
be	O
in	O
close	O
proximity	O
to	O
the	O
area	O
in	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
,	O
previously	O
called	O
Zaire	S-Location
,	O
where	O
the	O
occurred-and	O
the	O
taxonomic	O
suffix	O
virus	O
.	O

For	O
the	O
RNA-Dependent	O
RNA	O
Polymerase	O
of	O
MERS-CoV	S-Pathogen
,	O
SARS-CoV-1	S-Pathogen
,	O
and	O
SARS-CoV-2	S-Pathogen
arrest	O
of	O
RNA	O
synthesis	O
occurs	O
after	O
incorporation	O
of	O
three	O
additional	O
nucleotides	O
.	O

Most	O
people	O
recover	O
without	O
medical	O
attention	O
,	O
although	O
ones	O
with	O
pre-existing	O
or	O
underlying	O
medical	O
conditions	O
are	O
more	O
prone	O
to	O
complications	O
and	O
may	O
benefit	O
from	O
further	O
treatments	O
.	O

The	O
WHO	S-Organization
recognized	O
the	O
spread	O
of	O
COVID-19	S-Disease
as	O
a	O
pandemic	O
on	O
11	O
March	O
2020	O
.	O

Over	O
the	O
past	O
year	O
,	O
the	O
Trump	B-Organization
Administration	E-Organization
has	O
strongly	O
championed	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
()	O
,	O
which	O
helps	O
build	O
health	O
security	O
capacity	O
around	O
the	O
world	O
to	O
prevent	O
the	O
spread	O
of	O
infectious	O
diseases	O
,	O
whether	O
naturally	O
occurring	O
,	O
accidental	O
,	O
or	O
deliberate	O
.	O

A	O
review	O
found	O
that	O
early	O
quarantine	O
with	O
other	O
public	O
health	O
measures	O
are	O
effective	O
in	O
limiting	O
the	O
pandemic	O
,	O
but	O
the	O
best	O
manner	O
of	O
adopting	O
and	O
relaxing	O
policies	O
are	O
uncertain	O
,	O
as	O
local	O
conditions	O
vary	O
.	O

Once	O
frozen	O
,	O
which	O
testimony	O
from	O
a	O
Japanese	O
officer	O
said	O
"	O
was	O
determined	O
after	O
the	O
'frozen	O
arms	O
,	O
when	O
struck	O
with	O
a	O
short	O
stick	O
,	O
emitted	O
a	O
sound	O
resembling	O
that	O
which	O
a	O
board	O
gives	O
when	O
it	O
is	O
struck'"	O
,	O
Kristof,	B-Pathogen
Nicholas	I-Pathogen
D	E-Pathogen
.	O
"	O
Unmasking	O
Horror	O
–	O
A	O
special	O
report.	O
;	O
Japan	S-Location
Confronting	O
Gruesome	O
War	O
Atrocity	O
"	O
The	O
Times(1995)	O
ice	O
was	O
chipped	O
away	O
and	O
the	O
area	O
doused	O
in	O
water	O
,	O
limbs	O
brought	O
close	O
to	O
fire	O
and	O
other	O
"	O
methods"	O
used	O
to	O
determine	O
the	O
effect	O
it	O
had	O
on	O
frostbite	O
.	O

In	O
addition	O
,	O
poisoned	O
food	O
and	O
candies	O
were	O
given	O
to	O
unsuspecting	O
victims	O
.	O

CDC	S-Organization
officials	O
have	O
established	O
two	O
potential	O
risk	O
groups	O
of	O
individuals:	O
staff	O
who	O
were	O
potentially	O
exposed	O
to	O
aerosols	O
in	O
affected	O
laboratory	O
space	O
;	O
and	O
staff	O
who	O
were	O
not	O
potentially	O
exposed	O
to	O
aerosols	O
but	O
were	O
in	O
or	O
near	O
affected	O
laboratory	O
space	O
.	O

How	O
you	O
count	O
them	O
depends	O
on	O
whether	O
you're	O
talking	O
about	O
rooms	O
or	O
investigators	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
today	O
released	O
a	O
series	O
of	O
updates	O
and	O
actions	O
taken	O
showing	O
its	O
progress	O
in	O
laboratory	O
safety	O
.	O

Thirteen	O
years	O
since	O
the	O
last	O
publicly	O
acknowledged	O
outbreak	O
from	O
a	O
BSL-4	S-Platform
facility	O
is	O
not	O
good	O
enough	O
.	O

The	O
assignment	O
serves	O
as	O
part	O
of	O
the	O
student's	O
final	O
grade	O
.	O

On	O
16	O
April	O
2014	O
,	O
an	O
Overseas	O
Filipino	O
Worker	O
(OFW)	O
who	O
returned	O
from	O
Al	B-Location
Ain	I-Location
City	E-Location
United	B-Location
Arab	I-Location
Emirates	E-Location
was	O
found	O
positive	O
for	O
MERS-CoV	S-Pathogen
at	O
the	O
Ninoy	B-Organization
Aquino	I-Organization
International	I-Organization
Airport	E-Organization
.	O
The	O
OFW	O
was	O
tested	O
for	O
the	O
virus	O
in	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
(	O
UAE	S-Location
)	O
but	O
immediately	O
travelled	O
to	O
Manila	S-Location
.	O
Doctors	O
from	O
UAE	S-Location
later	O
contacted	O
the	O
Philippines	B-Organization
Department	I-Organization
of	I-Organization
Health	E-Organization
(	O
DOH	S-Organization
)	O
confirming	O
the	O
condition	O
of	O
the	O
OFW	O
.	O

At	O
least	O
eight	O
individuals	O
helped	O
spread	O
the	O
bacteria	O
.	O

For	O
example	O
,	O
in	O
the	O
WHO	S-Organization
laboratory	O
biosafety	O
standard	O
,	O
the	O
third	O
risk	O
group	O
is	O
defined	O
as	O
,	O
"	O
not	O
ordinarily	O
spread	O
from	O
one	O
infected	O
individual	O
to	O
another"	O
,	O
but	O
the	O
EU	S-Location
criteria	O
states	O
that	O
,	O
"	O
it	O
may	O
present	O
a	O
risk	O
of	O
spreading	O
to	O
the	O
community"	O
.	O

As	O
of	O
,	O
approximately	O
deaths	O
had	O
been	O
attributed	O
to	O
COVID-19	S-Disease
.	O
In	O
China	S-Location
,	O
,	O
about	O
80	O
percent	O
of	O
deaths	O
were	O
recorded	O
in	O
those	O
aged	O
over	O
60	O
,	O
and	O
75	O
percent	O
had	O
pre-existing	O
health	O
conditions	O
including	O
cardiovascular	O
diseases	O
and	O
.	O

She	O
based	O
this	O
on	O
the	O
reported	O
symptoms	O
in	O
those	O
dying	O
from	O
the	O
flu	S-Disease
,	O
as	O
reported	O
in	O
the	O
post	O
mortem	O
reports	O
still	O
available	O
,	O
and	O
also	O
the	O
timing	O
of	O
the	O
big	O
"	O
death	O
spike	O
"	O
in	O
October	O
1918	O
.	O

The	O
plan	O
includes	O
risk	O
assessment	O
;	O
rules	O
for	O
personal	O
protective	O
equipment	O
;	O
validation	O
(including	O
observation	O
of	O
key	O
steps	O
by	O
a	O
second	O
,	O
highly	O
trained	O
and	O
certified	O
lab	O
technician)	O
that	O
the	O
heat-kill	S-Technology
process	O
was	O
conducted	O
correctly	O
and	O
that	O
any	O
living	O
organisms	O
were	O
killed	O
;	O
strict	O
limits	O
on	O
lab	O
access	O
;	O
medical	O
monitoring	O
of	O
lab	O
personnel	O
;	O
and	O
back-up	O
tests	O
.	O

The	O
stewardship	O
element	O
of	O
the	O
strategy	O
focuses	O
mainly	O
on	O
antibiotic	O
use	O
in	O
veterinary	O
settings	O
,	O
which	O
is	O
overseen	O
by	O
the	O
FDA	S-Organization
In	O
recent	O
years	O
the	O
agency	O
has	O
made	O
strides	O
in	O
this	O
area	O
through	O
the	O
implementation	O
of	O
two	O
Guidances	O
for	O
Industry	O
(	O
GFI	B-Document
#209	E-Document
and	O
GFI	B-Document
#213	E-Document
)	O
,	O
which	O
seek	O
to	O
end	O
the	O
use	O
of	O
medically	O
important	O
antibiotics	O
for	O
growth	O
promotion	O
in	O
food-producing	O
animals	O
and	O
brought	O
95%	O
of	O
medically	O
important	O
antibiotic	O
used	O
in	O
food-animal	O
water	O
and	O
feed	O
under	O
veterinary	O
supervision	O
.	O

In	O
April	O
2020	O
,	O
the	O
European	B-Organization
Medicines	I-Organization
Agency	E-Organization
(	O
EMA	S-Organization
)	O
provided	O
recommendations	O
on	O
compassionate	O
use	O
of	O
remdesivir	S-Drug
for	O
COVID‑19	S-Disease
in	O
the	O
.	O

The	O
strain	O
used	O
in	O
the	O
2001	B-Incident
anthrax	I-Incident
attack	E-Incident
was	O
identical	O
to	O
the	O
strain	O
used	O
by	O
the	O
.	O

The	O
space	O
will	O
be	O
able	O
to	O
simulate	O
the	O
types	O
of	O
disorienting	O
scenes	O
-	O
active	O
shooter	O
situations	O
,	O
fires	O
,	O
car	O
accidents	O
-	O
that	O
a	O
first	O
responder	O
or	O
physician	O
could	O
face	O
while	O
trying	O
to	O
provide	O
care	O
.	O

Nearly	O
all	O
systems'	O
functionality	O
can	O
be	O
increased	O
via	O
extensions	O
which	O
sometimes	O
can	O
be	O
taken	O
from	O
a	O
pool	O
of	O
existing	O
software	O
.	O

Selux	S-Organization
Universal	B-Technology
Synthetic	I-Technology
Amplifier	I-Technology
(USA)	I-Technology
technology	E-Technology
delivers	O
Antibiotic	B-Equipment
Susceptibility	I-Equipment
Testing	E-Equipment
()	O
results	O
in	O
4	O
hours	O
and	O
leverages	O
standard	O
equipment	O
to	O
make	O
adoption	O
easy	O
.	O

Epidemiologists	O
discovered	O
the	O
Jordan	S-Location
cases	O
.	O

With	O
the	O
military	O
patients	O
coming	O
home	O
from	O
the	O
war	O
with	O
battle	O
wounds	O
and	O
mustard	O
gas	O
burns	O
,	O
hospital	O
facilities	O
and	O
staff	O
were	O
taxed	O
to	O
the	O
limit	O
.	O

Following	O
a	O
case	O
in	O
Goma	S-Location
,	O
the	O
reconvening	O
of	O
a	O
fourth	O
review	O
was	O
announced	O
on	O
15	O
July	O
2019	O
.	O

In	O
less	O
than	O
two	O
weeks	O
,	O
approximately	O
50,000	O
residents	O
of	O
Aral	S-Location
were	O
vaccinated	O
.	O

CRISPR-Cas9	B-Technology
genome	I-Technology
editing	I-Technology
techniques	E-Technology
have	O
many	O
potential	O
applications	O
,	O
including	O
in	O
medicine	O
and	O
agriculture	O
.	O

These	O
audits	O
led	O
to	O
improved	O
practical	O
solutions	O
and	O
facilitated	O
the	O
harmonization	O
of	O
good	O
practice	O
between	O
the	O
laboratories	O
.	O

However	O
,	O
other	O
sources	O
suggest	O
that	O
the	O
Second	O
pandemic	O
did	O
indeed	O
reach	O
.	O

A	O
common	O
case	O
is	O
to	O
use	O
MRI	S-Technology
to	O
seek	O
a	O
cause	O
of	O
low	O
back	O
pain	O
;	O
the	O
,	O
for	O
example	O
,	O
recommends	O
against	O
this	O
procedure	O
as	O
unlikely	O
to	O
result	O
in	O
a	O
positive	O
outcome	O
for	O
the	O
patient	O
.	O

Frederick	B-Person
Sparling	E-Person
MD	O
,	O
is	O
Professor	O
of	O
Medicine	O
in	O
the	O
School	O
of	O
Medicine	O
at	O
the	O
University	O
of	O
North	O
Carolina	O
,	O
Chapel	O
Hill	O
.	O

Cells	O
of	O
interest	O
can	O
be	O
consequentially	O
infected	O
by	O
the	O
library	O
and	O
then	O
selected	O
according	O
to	O
the	O
phenotype	O
.	O

Its	O
drafting	O
process	O
,	O
led	O
by	O
the	O
country's	O
Environmental	B-Organization
Protection	I-Organization
Authority	E-Organization
,	O
was	O
judged	O
as	O
biased	O
,	O
focusing	O
only	O
on	O
protecting	O
the	O
environment	O
from	O
perceived	O
risks	O
,	O
giving	O
little	O
attention	O
to	O
potential	O
benefits	O
of	O
GMOs	S-Technology
.	O
Many	O
of	O
its	O
provisions	O
are	O
very	O
stringent	O
,	O
exceeding	O
those	O
of	O
,	O
while	O
others	O
cannot	O
be	O
fulfilled	O
by	O
applicants	O
,	O
collectively	O
rendering	O
the	O
emerged	O
biosafety	O
system	O
unworkable	O
.	O

General	O
Burgasov	S-Person
said	O
the	O
crew	O
member	O
on	O
the	O
research	O
ship	O
picked	O
up	O
the	O
virus	O
when	O
it	O
passed	O
within	O
15	O
kilometers	O
,	O
or	O
about	O
9	O
miles	O
,	O
of	O
an	O
off-limits	O
isle	O
.	O

The	O
serious	O
outbreaks	O
of	O
bacterial	O
infection	O
that	O
are	O
increasingly	O
being	O
reported	O
are	O
costly	O
in	O
many	O
respects	O
.	O

To	O
quickly	O
alert	O
officials	O
of	O
a	O
biological	O
terror	O
attack	O
,	O
such	O
as	O
the	O
release	O
of	O
anthrax	S-Pathogen
smallpox	S-Pathogen
or	O
plague	B-Pathogen
viruses	E-Pathogen
,	O
seeks	O
sensors	O
that	O
can	O
detect	O
,	O
in	O
real	O
time	O
,	O
traces	O
of	O
a	O
wide	O
range	O
of	O
pathogens	O
.	O

After	O
being	O
denied	O
building	O
permits	O
for	O
Rajneeshpuram	S-Location
the	O
commune	O
leadership	O
sought	O
to	O
gain	O
political	O
control	O
over	O
the	O
rest	O
of	O
the	O
county	O
by	O
influencing	O
the	O
November	O
1984	O
county	O
election	O
.	O

Singapore	S-Organization
provided	O
financial	O
support	O
for	O
those	O
infected	O
who	O
quarantined	O
themselves	O
and	O
imposed	O
large	O
fines	O
for	O
those	O
who	O
failed	O
to	O
do	O
so	O
.	O

Extreme	O
caution	O
should	O
be	O
taken	O
with	O
contaminated	O
needles	O
or	O
sharp	O
instruments	O
.	O

BRM	S-Platform
can	O
export	O
data	O
in	O
simple	O
file	O
formats	O
and	O
in	O
Cytoscape.	O
can	O
be	O
installed	O
straightforwardly	O
assisted	O
by	O
a	O
quick-start	O
guide	O
.	O

Joseph	B-Person
Lieberman	E-Person
of	O
the	O
experts	O
.	O

Among	O
them	O
,	O
44	O
were	O
positive	O
for	O
,	O
and	O
the	O
positive	O
rates	O
were	O
11.71	O
%	O
in	O
blood	O
samples	O
(41/350)	O
and	O
0.53	O
%	O
(3/563)	O
in	O
throat	O
swab	O
samples	O
.	O

Over	O
time	O
,	O
as	O
the	O
virus	O
multiplies	O
and	O
mutates	O
,	O
variants	O
can	O
gain	O
the	O
ability	O
to	O
jump	O
between	O
species	O
.	O

However	O
,	O
biosecurity	O
may	O
be	O
defined	O
as	O
the	O
security	O
of	O
life	O
and	O
therefore	O
affect	O
the	O
safety	O
devices	O
participating	O
in	O
the	O
government	O
of	O
bodies	O
and	O
power	O
over	O
life	O
.	O

Biosecurity	O
is	O
an	O
issue	O
area	O
that	O
will	O
only	O
grow	O
in	O
importance	O
in	O
the	O
coming	O
years	O
,	O
so	O
it	O
is	O
encouraging	O
to	O
see	O
so	O
much	O
interest	O
.	O

Pigs	O
in	O
the	O
Philippines	S-Location
have	O
been	O
reported	O
to	O
be	O
infected	O
with	O
Reston	B-Pathogen
virus	E-Pathogen
,	O
so	O
other	O
interim	O
or	O
amplifying	O
hosts	O
may	O
exist	O
.	O

In	O
addition	O
,	O
the	O
lab	O
contains	O
a	O
central	O
control	O
room	O
and	O
offices	O
on	O
the	O
left	O
side	O
,	O
and	O
a	O
decontamination	O
room	O
,	O
an	O
electricity	O
distribution	O
room	O
,	O
and	O
an	O
air	O
conditioning	O
engine	O
unit	O
on	O
the	O
right	O
side	O
.	O

But	O
,	O
since	O
a	O
man-made	O
gene	O
drive	O
has	O
never	O
been	O
tested	O
in	O
the	O
wild	O
,	O
it's	O
impossible	O
to	O
know	O
for	O
certain	O
the	O
impact	O
that	O
a	O
mosquito	O
extinction	O
could	O
have	O
on	O
the	O
environment	O
.	O

He	O
claimed	O
that	O
this	O
classification	O
did	O
not	O
take	O
into	O
account	O
the	O
extent	O
of	O
exposure:	O
for	O
example	O
,	O
red	O
meat	O
is	O
qualified	O
as	O
probably	O
carcinogenic	O
,	O
but	O
the	O
quantity	O
of	O
consumed	O
red	O
meat	O
at	O
which	O
it	O
could	O
become	O
dangerous	O
is	O
not	O
specified	O
.	O

Because	O
of	O
this	O
,	O
the	O
mean	O
energy	O
of	O
the	O
spectrum	O
increases	O
when	O
passing	O
the	O
object	O
,	O
often	O
described	O
as	O
getting	O
"	O
harder".	O
This	O
leads	O
to	O
an	O
effect	O
increasingly	O
underestimating	O
material	O
thickness	O
,	O
if	O
not	O
corrected	O
.	O

In	O
1954	O
,	O
an	O
existing	O
biological	O
weapons	O
test	O
site	O
originally	O
constructed	O
on	O
Vozrozhdeniya	B-Location
Island	E-Location
in	O
the	O
Aral	B-Location
Sea	E-Location
in	O
1948	O
was	O
greatly	O
expanded	O
by	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Defence	E-Organization
,	O
including	O
to	O
the	O
neighboring	O
Komsomolskiy	B-Location
Island	E-Location
,	O
and	O
named	O
Aralsk-7	S-Platform
.	O
Dembek	S-Person
,	O
Zygmunt	B-Person
F.	E-Person
,	O
Julie	B-Person
A.	I-Person
Pavlin	E-Person
,	O
and	O
Mark	B-Person
G	E-Person
.	O
Kortepeter	O
(2007)	O
,	O
"	O
Epidemiology	B-Document
of	I-Document
Biowarfare	I-Document
and	I-Document
Bioterrorism	E-Document
"	O
,	O
Chapter	O
3	O
of:	O
Dembek	S-Person
,	O
Zygmunt	B-Person
F	E-Person
.	O
(2007)	O
,	O
Medical	O
Aspects	O
of	O
Biological	O
Warfare	O
,	O
(Series:	O
Textbooks	O
of	O
Military	O
Medicine)	O
,	O
Washington,	B-Location
DC	E-Location
:	O
The	O
Borden	B-Organization
Institute	E-Organization
,	O
pp	O
51-52	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
more	O
commonly	O
known	O
as 	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
;	O
EBOV	S-Pathogen
)	O
,	O
is	O
one	O
of	O
six	O
known	O
species	O
within	O
the	O
genus	O
Ebolavirus	S-Pathogen
.	O
Four	O
of	O
the	O
six	O
known	O
ebolaviruses	S-Pathogen
,	O
including	O
EBOV	S-Pathogen
,	O
cause	O
a	O
severe	O
and	O
often	O
fatal	O
hemorrhagic	B-Disease
fever	E-Disease
in	O
humans	O
and	O
other	O
mammals	O
,	O
known	O
as	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
.	O

According	O
to	O
media	O
reports	O
,	O
the	O
concerned	O
market	O
in	O
was	O
closed	O
on	O
1	O
January	O
2020	O
for	O
environmental	O
sanitation	O
and	O
disinfection	O
.	O

Often	O
,	O
these	O
experiments	O
took	O
place	O
in	O
urban	O
areas	O
in	O
order	O
to	O
test	O
dispersion	O
methods	O
.	O

On	O
the	O
skin	O
,	O
the	O
bacteria	O
can	O
cause	O
blisters	S-Disease
and	O
ulcers	S-Disease
with	O
a	O
black	O
center	O
.	O

As	O
a	O
result	O
Tbilisi	S-Organization
has	O
been	O
infested	O
with	O
biting	O
flies	O
since	O
2015	O
.	O

Pressures	O
to	O
adapt	O
to	O
the	O
human	O
host	O
were	O
seen	O
at	O
this	O
time	O
,	O
however	O
,	O
no	O
phenotypic	O
changes	O
in	O
the	O
virus	O
(such	O
as	O
increased	O
transmission	O
,	O
increased	O
immune	O
evasion	O
by	O
the	O
virus)	O
were	O
seen	O
.	O

On	O
20	O
January	O
2020	O
,	O
the	O
first	O
known	O
case	O
of	O
COVID-19	S-Disease
was	O
confirmed	O
in	O
the	O
Pacific	B-Location
Northwest	E-Location
state	O
of	O
Washington	S-Location
in	O
a	O
man	O
who	O
had	O
returned	O
from	O
Wuhan	S-Location
on	O
15	O
January	O
.	O

The	O
mistake	O
was	O
realized	O
shortly	O
after	O
,	O
but	O
by	O
then	O
some	O
anthrax	S-Pathogen
spores	O
were	O
released	O
.	O

Deterioration	O
is	O
rapid	O
,	O
with	O
many	O
patients	O
progressing	O
to	O
respiratory	B-Disease
failure	E-Disease
within	O
24	O
hours	O
,	O
requiring	O
immediate	O
admission	O
to	O
an	O
intensive	O
care	O
unit	O
.	O

The	O
world	O
has	O
been	O
at	O
an	O
increased	O
level	O
of	O
alert	O
since	O
the	O
SARS	S-Disease
epidemic	O
in	O
Southeast	B-Location
Asia	E-Location
(caused	O
by	O
the	O
SARS	B-Pathogen
coronavirus	E-Pathogen
)	O
.	O

In	O
February	O
2017	O
the	O
US	B-Organization
Patent	I-Organization
Office	E-Organization
ruled	O
on	O
a	O
patent	O
interference	O
case	O
brought	O
by	O
University	B-Organization
of	I-Organization
California	E-Organization
with	O
respect	O
to	O
patents	O
issued	O
to	O
the	O
Broad	B-Organization
Institute	E-Organization
,	O
and	O
found	O
that	O
the	O
Broad	O
patents	O
,	O
with	O
claims	O
covering	O
the	O
application	O
of	O
CRISPR-Cas9	S-Technology
in	O
eukaryotic	O
cells	O
,	O
were	O
distinct	O
from	O
the	O
inventions	O
claimed	O
by	O
.	O

The	O
fact	O
is	O
that	O
an	O
continues	O
to	O
occur	O
in	O
nature	O
and	O
that	O
has	O
been	O
used	O
as	O
a	O
weapon	O
.	O

By	O
making	O
a	O
comparison	O
of	O
the	O
number	O
and	O
type	O
of	O
articles	O
published	O
by	O
Environmental	O
Biosafety	O
Research	O
(EBR)	O
with	O
those	O
from	O
other	O
journals	O
active	O
in	O
the	O
arena	O
of	O
GMO	S-Technology
biosafety	O
,	O
it	O
is	O
possible	O
to	O
shed	O
light	O
on	O
the	O
answer	O
to	O
the	O
question	O
posed	O
in	O
the	O
title	O
.	O

The	O
second	O
,	O
describing	O
the	O
infection	O
of	O
NIH3T3	O
cells	O
with	O
MulV	S-Pathogen
and	O
the	O
detection	O
of	O
HSV‐1	S-Pathogen
infected	O
Vero	O
cells	O
by	O
ELISA	S-Equipment
.	O
The	O
third	O
lab	O
report	O
documents	O
the	O
detection	O
of	O
by	O
molecular	O
methods	O
.	O

Healthcare-associated	O
spread	O
of	O
this	O
E.	B-Pathogen
coli	E-Pathogen
strain	O
in	O
the	O
veterinary	O
intensive	O
care	O
unit	O
emphasizes	O
the	O
need	O
to	O
rapidly	O
identify	O
and	O
characterize	O
carbapenem-resistant	O
isolates	O
from	O
animals	O
.	O

San	O
Francisco.	O
20	O
Dec.	O
2011	O
.	O

Studies	O
done	O
by	O
the	O
CDC	S-Organization
show	O
that	O
the	O
indication	O
for	O
treatment	O
of	O
antibiotics	O
,	O
choice	O
of	O
the	O
agent	O
used	O
,	O
and	O
the	O
duration	O
of	O
therapy	O
was	O
incorrect	O
in	O
up	O
to	O
50%	O
of	O
the	O
cases	O
studied	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We	O
have	O
undertaken	O
a	O
series	O
of	O
measures	O
over	O
the	O
past	O
few	O
years	O
to	O
strengthen	O
our	O
investigation	O
of	O
select	O
agent	O
laboratories	O
.	O

Despite	O
those	O
developments	O
,	O
investigators	O
were	O
not	O
yet	O
ready	O
to	O
declare	O
a	O
dead	O
end	O
to	O
the	O
investigation	O
.	O

Iraq	S-Location
BW	O
facilities	O
included	O
its	O
main	O
biowarfare	O
research	O
center	O
at	O
Salman	B-Location
Pak	E-Location
(just	O
south	O
of	O
Baghdad	S-Location
)	O
,	O
the	O
main	O
bioweapons	O
production	O
facility	O
at	O
Al	B-Location
Hakum	E-Location
(the	O
"	O
Single-Cell	B-Organization
Protein	I-Organization
Production	I-Organization
Plant	E-Organization
"	O
)	O
and	O
the	O
viral	O
biowarfare	O
research	O
site	O
at	O
Al	B-Location
Manal	E-Location
(the	O
"	O
Foot	B-Organization
and	I-Organization
Mouth	I-Organization
Disease	I-Organization
Center	E-Organization
"	O
).	O
Block	S-Person
,	O
(2001	O
,	O
January–February)	O
.	O

Pressure	O
to	O
allow	O
Taiwan	S-Location
to	O
participate	O
in	O
WHO	S-Organization
increased	O
as	O
a	O
result	O
of	O
the	O
2019–2020	B-Incident
coronavirus	I-Incident
pandemic	E-Incident
with	O
Taiwan	S-Location
's	O
exclusion	O
from	O
emergency	O
meetings	O
concerning	O
the	O
outbreak	O
bringing	O
a	O
rare	O
united	O
front	O
from	O
Taiwan	S-Location
's	O
diverse	O
political	O
parties	O
.	O

For	O
the	O
first	O
time	O
,	O
we	O
are	O
faced	O
with	O
science	O
fiction-like	O
scenarios,	O
"	O
said	O
Ellen	B-Person
Jorgensen	E-Person
co-founder	O
and	O
president	O
of	O
,	O
a	O
nonprofit	O
organisation	O
dedicated	O
to	O
promoting	O
citizen	O
science	O
and	O
access	O
to	O
biotechnology	O
.	O

None	O
of	O
the	O
staff	O
who	O
were	O
potentially	O
exposed	O
have	O
developed	O
to	O
date	O
.	O

Members	O
of	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
agreed	O
with	O
that	O
assessment	O
.	O

Other	O
plausible	O
factors	O
include	O
the	O
perceived	O
ineffectiveness	O
of	O
the	O
untested	O
delivery	O
and	O
dispersal	O
systems	O
,	O
the	O
probable	O
ineffectiveness	O
of	O
liquid	O
slurries	O
resulting	O
from	O
poor	O
aerosolization	O
,	O
and	O
the	O
potential	O
hazards	O
to	O
the	O
Iraqi	O
troops	O
themselves	O
,	O
as	O
they	O
lacked	O
the	O
protective	O
equipment	O
and	O
training	O
available	O
to	O
Coalition	O
forces	O
.	O

This	O
wasn't	O
the	O
FDA	S-Organization
first	O
foray	O
into	O
biohacking	O
.	O

A	O
week	O
after	O
the	O
terrorist	O
attacks	O
of	O
September	O
11th	O
,	O
a	O
letter	O
containing	O
anthrax	S-Pathogen
spores	O
was	O
mailed	O
to	O
Tom	B-Person
Brokaw	E-Person
at	O
NBC	O
News	O
in	O
New	B-Location
York	E-Location
.	O
Two	O
other	O
letters	O
with	O
nearly	O
identical	O
handwriting	O
,	O
venomous	O
messages	O
,	O
and	O
lethal	O
spores	O
arrived	O
at	O
the	O
offices	B-Location
of	I-Location
the	I-Location
New	I-Location
York	I-Location
Post	E-Location
and	O
Senator	O
Tom	B-Person
Daschle	E-Person
in	O
Washington	S-Location
,	O
.	O

Following	O
laboratory	O
safety	O
events	O
at	O
CDC	S-Organization
involving	O
select	O
agents	O
in	O
2014	O
,	O
CDC	S-Organization
conducted	O
comprehensive	O
internal	O
reviews	O
of	O
each	O
incident	O
.	O

The	O
majority	O
(62–85%)	O
were	O
attributed	O
to	O
persons	O
under	O
65	O
years	O
of	O
age	O
.	O

"	O
Because	O
of	O
the	O
FDA	S-Organization
statutory	O
responsibility	O
for	O
assuring	O
safe	O
and	O
effective	O
products	O
that	O
promote	O
and	O
protect	O
both	O
human	O
and	O
animal	O
health	O
,	O
we	O
have	O
a	O
unique	O
vantage	O
point	O
for	O
coordinating	O
all	O
of	O
these	O
aspects	O
of	O
a	O
product's	O
development	O
and	O
application	O
to	O
health,	O
"	O
said	O
.	O

Pathogenic	B-Pathogen
Fusarium	I-Pathogen
oxysporum	I-Pathogen
strains	E-Pathogen
developed	O
in	O
the	O
USA	S-Location
to	O
kill	O
coca	O
plants	O
were	O
scheduled	O
for	O
field	O
tests	O
in	O
in	O
2000	O
,	O
but	O
international	O
protests	O
halted	O
this	O
project	O
.	O

And	O
we'll	O
be	O
looking	O
at	O
what	O
the	O
implications	O
are	O
for	O
our	O
as	O
well	O
as	O
other	O
partners	O
.	O

Given	O
that	O
CDC	S-Organization
expert	O
protocols	O
were	O
not	O
followed	O
,	O
disciplinary	O
action(s)	O
will	O
be	O
taken	O
as	O
necessary	O
.	O

Print	O
.	O

The	O
disease	O
,	O
which	O
these	O
flies	O
carry	O
,	O
is	O
of	O
high	O
interest	O
to	O
the	O
Pentagon	S-Organization
In	O
2003	O
during	O
the	O
US	B-Incident
invasion	I-Incident
of	I-Incident
Iraq	E-Incident
American	O
soldiers	O
were	O
severely	O
bitten	O
by	O
sand	O
flies	O
and	O
contracted	O
Leishmoniasis	S-Disease
.	O
The	O
disease	O
is	O
native	O
to	O
Iraq	S-Location
and	O
Afghanistan	S-Location
and	O
if	O
left	O
untreated	O
the	O
acute	O
form	O
of	O
can	O
be	O
fatal	O
.	O

Data	O
from	O
1918	O
suggest	O
that	O
persons	O
infected	O
in	O
the	O
second	O
wave	O
may	O
have	O
been	O
protected	O
from	O
influenza	S-Disease
in	O
the	O
third	O
wave	O
.	O

Annualized	O
production	O
capacity	O
for	O
weaponized	O
smallpox	S-Pathogen
for	O
example	O
,	O
was	O
90	O
to	O
100	O
tons	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture's	I-Organization
National	I-Organization
Animal	I-Organization
Disease	I-Organization
Center	E-Organization
in	O
Ames	S-Location
,	O
Iowa	S-Location
.	O
In	O
separate	O
incidents	O
last	O
summer	O
,	O
workers	O
at	O
the	O
USDA's	B-Organization
National	I-Organization
Animal	I-Organization
Disease	I-Organization
Center	E-Organization
in	O
Ames	S-Location
,	O
Iowa	S-Location
,	O
were	O
potentially	O
exposed	O
to	O
,	O
a	O
dangerous	O
bacteria	O
,	O
because	O
they	O
didn't	O
follow	O
basic	O
safety	O
procedures	O
.	O

BASE	S-Platform
has	O
been	O
employed	O
in	O
many	O
projects	O
,	O
e.g.	O
.	O

Our	O
scientists	O
go	O
anywhere	O
in	O
the	O
world	O
at	O
a	O
moment's	O
notice	O
to	O
stop	O
an	O
outbreak	O
.	O

As	O
a	O
result	O
,	O
foreign	O
technology	O
owners	O
that	O
provide	O
highly	O
demanded	O
technologies	O
like	O
Bt	O
cotton	O
declined	O
to	O
work	O
with	O
Ethiopia	S-Organization
There	O
is	O
a	O
fear	O
that	O
the	O
emerged	O
biosafety	O
system	O
might	O
also	O
continue	O
to	O
suppress	O
domestic	O
genetic	O
engineering	O
research	O
and	O
development	O
.	O

The	O
decision	O
to	O
lock	O
down	O
the	O
medical	O
facility	O
was	O
protested	O
by	O
hospital	O
staff	O
.	O

In	O
August	O
1949	O
a	O
U.S.	B-Organization
Army	I-Organization
Special	I-Organization
Operations	I-Organization
Division	E-Organization
operating	O
out	O
of	O
Fort	B-Location
Detrick	E-Location
in	O
Maryland	S-Location
,	O
set	O
up	O
its	O
first	O
test	O
at	O
The	O
Pentagon	S-Organization
in	O
Washington	S-Location
,	O
D.C.	S-Location
Operatives	O
sprayed	O
harmless	O
bacteria	O
into	O
the	O
building's	O
air	O
conditioning	O
system	O
and	O
observed	O
as	O
the	O
microbes	O
spread	O
throughout	O
the	O
.	O

VSV-EBOV	S-Vaccine
was	O
approved	O
by	O
the	O
in	O
December	O
2019	O
.	O

In	O
February	O
2020	O
,	O
a	B-Activity
US	I-Activity
trial	E-Activity
showed	O
CRISPR	B-Technology
gene	I-Technology
editing	E-Technology
on	O
3	O
patients	O
.	O

On	O
November	O
6	O
,	O
2003	O
,	O
another	O
letter	O
,	O
described	O
as	O
"	O
nearly	O
identical	O
"	O
to	O
the	O
October	O
letter	O
,	O
was	O
discovered	O
.	O

Among	O
other	O
provisions	O
included	O
in	O
the	O
discussion	O
draft	O
,	O
according	O
to	O
a	O
summary	O
provided	O
by	O
Rep	O
.	O

The	O
report	O
also	O
noted	O
that	O
competent	O
governance	O
of	O
the	O
global	O
system	O
demanded	O
political	O
leadership	O
and	O
a	O
that	O
is	O
more	O
focused	O
and	O
appropriately	O
financed	O
and	O
whose	O
integrity	O
is	O
restored	O
through	O
the	O
application	O
of	O
adequate	O
reforms	O
and	O
leadership	O
.	O

The	O
word	O
"	O
tomography"	O
is	O
derived	O
from	O
the	O
Greek	O
tome	O
(slice)	O
and	O
graphein	O
(to	O
write)	O
.	O

The	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
states	O
that	O
500	O
micrograms	O
is	O
the	O
minimum	O
lethal	O
dose	O
of	O
ricin	S-Pathogen
in	O
humans	O
provided	O
that	O
exposure	O
is	O
from	O
injection	O
or	O
inhalation.	O
&lt;ref	O
name=facts&gt;Facts	O
About	S-Pathogen
Ri	O
cin	B-Organization
,	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prev	E-Organization
ention	O
,	O
March	O
5	O
,	O
2008	O
,	O
accessed	O
May	O
5	O
,	O
2009.	O
&ef&gt	O
;	O
Ricin	O
is	O
easily	O
purified	O
from	O
castor-oil	O
manufacturing	O
waste	O
.	O

It	O
apparently	O
sent	O
a	O
copy	O
of	O
the	O
letter	O
to	O
The	O
Fresno	O
Bee	O
as	O
well	O
.	O

The	O
most	O
sophisticated	O
biotechnology	O
may	O
be	O
no	O
match	O
for	O
Murphy's	O
Law	O
.	O

Medicago	S-Organization
,	O
co-owned	O
by	O
Philip	B-Organization
Morris	E-Organization
,	O
paid	O
$495,000	O
for	O
lobbying	O
the	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
,	O
the	O
Congress	S-Organization
and	O
The	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
for	O
"	O
funding	O
to	O
advance	O
technology	O
to	O
support	O
public	O
health	O
preparedness	O
applications"	O
.	O

On	O
10	O
June	O
,	O
the	O
government	B-Organization
of	I-Organization
Ontario	E-Organization
created	O
the	O
SARS	B-Organization
Commission	I-Organization
inquiry	E-Organization
in	O
order	O
to	O
"	O
investigate	O
the	O
recent	O
introduction	O
and	O
spread	O
of	O
"	O
in	O
the	O
province	O
.	O

With	O
the	O
use	O
of	O
heat	O
maps	O
,	O
it	O
was	O
determined	O
that	O
the	O
outbreak	O
did	O
not	O
uniformly	O
unfold	O
over	O
the	O
affected	O
community	O
areas	O
.	O

By	O
23	O
December	O
,	O
the	O
EVD	S-Disease
outbreak	O
had	O
spread	O
to	O
more	O
health	O
zones	O
,	O
and	O
at	O
that	O
time	O
18	O
such	O
areas	O
had	O
been	O
affected	O
.	O

Berndt	O
,	O
RM	O
and	O
CH	O
(1980)	O
,	O
UWA	O
Press	O
,	O
Perth.	O
but	O
this	O
possibility	O
has	O
only	O
been	O
raised	O
by	O
historians	O
from	O
the	O
1980s	O
when	O
Dr	O
Noel	B-Person
Butlin	E-Person
suggested	O
;	O
"	O
there	O
are	O
some	O
possibilities	O
that	O
...	O
disease	O
could	O
have	O
been	O
used	O
deliberately	O
as	O
an	O
exterminating	O
agent"	O
.	O

But	O
they	O
also	O
have	O
severe	O
implications	O
for	O
international	O
peace	O
and	O
security	O
because	O
they	O
open	O
up	O
tremendous	O
avenues	O
for	O
the	O
creation	O
of	O
new	O
biological	O
weapons	O
.	O

One	O
infamous	O
and	O
well-documented	O
case	O
occurred	O
in	O
1763	O
at	O
Fort	B-Location
Pitt	E-Location
on	O
the	O
Pennsylvania	S-Location
frontier	O
.	O

Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
inspectors	O
and	O
University	B-Organization
of	I-Organization
Michigan	E-Organization
officials	O
found	O
materials	O
labeled	O
as	O
Brucella	S-Pathogen
,	O
a	O
select	O
agent	O
,	O
outside	O
the	O
containment	O
area	O
in	O
April	O
2012	O
.	O

Many	O
decisions	O
are	O
made	O
at	O
regional	O
level	O
,	O
including	O
important	O
discussions	O
over	O
's	O
budget	O
,	O
and	O
in	O
deciding	O
the	O
members	O
of	O
the	O
next	O
assembly	O
,	O
which	O
are	O
designated	O
by	O
the	O
regions.	O
.	O

Mycobacterium	B-Pathogen
tuberculosis	E-Pathogen
,	O
Brucella	S-Pathogen
,	O
)	O
than	O
the	O
general	O
population	O
.	O

President	O
Trump	S-Person
expressed	O
surprise	O
and	O
disapproval	O
at	O
's	O
statements	O
saying	O
,	O
"	O
To	O
me	O
it's	O
not	O
an	O
acceptable	O
answer	O
,	O
especially	O
when	O
it	O
comes	O
to	O
schools.	O
"	O

Since	O
2012	O
,	O
an	O
outbreak	B-Incident
of	I-Incident
Middle	I-Incident
East	I-Incident
respiratory	I-Incident
syndrome	I-Incident
coronavirus	E-Incident
has	O
affected	O
several	O
countries	O
,	O
primarily	O
in	O
its	O
namesake	O
,	O
the	O
Middle	B-Location
East	E-Location
.	O
The	O
virus	O
,	O
which	O
causes	O
Middle	B-Disease
East	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
MERS	S-Disease
)	O
,	O
is	O
a	O
newly	O
emerged	O
betacoronavirus	O
that	O
was	O
first	O
identified	O
in	O
a	O
patient	O
from	O
in	O
April	O
2012	O
.	O

As	O
researchers	O
create	O
longer	O
and	O
longer	O
stretches	O
of	O
DNA	O
using	O
new	O
technologies	O
,	O
it	O
starts	O
to	O
seem	O
possible	O
to	O
build	O
an	O
entire	O
genome	O
,	O
which	O
is	O
the	O
set	O
of	O
all	O
the	O
genes	O
required	O
for	O
an	O
organism	O
to	O
function	O
.	O

These	O
findings	O
wouldn't	O
be	O
generalizable	O
to	O
the	O
rest	O
of	O
us	O
.	O

On	O
18	O
April	O
it	O
was	O
reported	O
that	O
schools	O
in	O
France	S-Location
had	O
to	O
close	O
again	O
after	O
reopening	O
,	O
due	O
to	O
case	O
flare-ups	O
.	O

With	O
current	O
labs	O
,	O
an	O
escape	O
of	O
a	O
pandemic	O
pathogen	O
is	O
only	O
a	O
matter	O
of	O
time	O
.	O

Postwar	O
reports	O
have	O
generally	O
regarded	O
the	O
data	O
as	O
"	O
crude	O
and	O
ineffective"	O
,	O
with	O
one	O
expert	O
even	O
deeming	O
it	O
"	O
amateurish".	O
Harris	S-Person
speculates	O
that	O
the	O
reason	O
scientists	O
generally	O
wanted	O
to	O
acquire	O
it	O
was	O
due	O
to	O
the	O
concept	O
of	O
forbidden	O
fruit	O
,	O
believing	O
that	O
lawful	O
and	O
ethical	O
prohibitions	O
could	O
affect	O
the	O
outcomes	O
of	O
their	O
research	O
.	O

Following	O
their	O
publication	O
a	O
public	O
information	O
campaign	O
''	O
was	O
launched	O
to	O
highlight	O
the	O
need	O
for	O
a	O
change	O
in	O
antibiotic	O
prescribing	O
.	O

The	O
EU	S-Location
and	O
NIH	S-Organization
laboratory	O
biosafety	O
categorization	O
lists	O
the	O
Equine	B-Pathogen
Morbilli	I-Pathogen
Virus	E-Pathogen
,	O
while	O
the	O
same	O
virus	O
is	O
designated	O
as	O
Hendra	B-Pathogen
virus	E-Pathogen
in	O
the	O
.	O
These	O
inconsistencies	O
could	O
impede	O
international	O
communication	O
and	O
delay	O
situation	O
management	O
.	O

Croddy	O
,	O
Weapons	O
of	O
Mass	O
Destruction	O
,	O
p.304	O
.	O

BSL-4	S-Platform
is	O
the	O
highest	O
biosafety	O
laboratory	O
containment	O
level	O
,	O
employing	O
precautions	O
such	O
as	O
airflow	O
systems	O
,	O
positive	O
pressure	O
suits	O
,	O
and	O
extensive	O
personnel	O
training	O
to	O
prevent	O
exposure	O
to	O
or	O
spread	O
of	O
potentially	O
lethal	O
select	O
agents	O
including	O
Marburg	B-Pathogen
virus	E-Pathogen
,	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
and	O
.	O

It	O
is	O
not	O
clear	O
whether	O
the	O
traditional	O
healer	O
was	O
infected	O
with	O
both	O
variants	O
,	O
or	O
if	O
perhaps	O
one	O
of	O
the	O
women	O
attending	O
the	O
funeral	O
was	O
independently	O
infected	O
.	O

Retrieved	O
January	O
7	O
,	O
2009	O
.	O

An	O
intrinsic	O
weakness	O
of	O
the	O
current	O
system	O
of	O
cross-sector	O
collaboration	O
is	O
that	O
it	O
is	O
not	O
underpinned	O
by	O
long-term	O
,	O
ongoing	O
financing	O
.	O

Hunt	S-Person
has	O
served	O
on	O
the	O
Planetary	B-Organization
Protection	I-Organization
Advisory	I-Organization
Committee	E-Organization
for	O
NASA	S-Organization
.	O
She	O
serves	O
on	O
the	O
Scientific	B-Organization
Advisory	I-Organization
Board	E-Organization
for	O
NIH's	B-Activity
National	I-Activity
Biosafety	I-Activity
and	I-Activity
Biocontainment	I-Activity
Training	I-Activity
Program	E-Activity
()	O
,	O
and	O
is	O
currently	O
Chairman	O
.	O

The	O
USPTO	S-Organization
granted	O
two	O
patents	O
on	O
remdesivir	S-Drug
to	O
Gilead	B-Organization
Sciences	E-Organization
on	O
April	O
9	O
,	O
2019:	O
one	O
for	O
filoviruses	S-Pathogen
,	O
and	O
one	O
which	O
covered	O
both	O
arenaviruses	S-Pathogen
and	O
.	O

From	O
this	O
perspective	O
,	O
genetic	O
engineering	O
is	O
a	O
step	O
taken	O
relatively	O
late	O
in	O
the	O
development	O
of	O
biowarfare	O
potential	O
,	O
which	O
most	O
probably	O
will	O
not	O
be	O
taken	O
before	O
the	O
first	O
,	O
essential	O
steps	O
are	O
solved	O
.	O

The	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
states	O
that	O
500	O
micrograms	O
is	O
the	O
minimum	O
lethal	O
dose	O
of	O
ricin	S-Pathogen
in	O
humans	O
provided	O
that	O
exposure	O
is	O
from	O
injection	O
or	O
inhalation.	O
&lt;ref	O
name=facts&gt;Facts	O
About	S-Pathogen
Ri	O
cin	B-Organization
,	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prev	E-Organization
ention	O
,	O
March	O
5	O
,	O
2008	O
,	O
accessed	O
May	O
5	O
,	O
2009.	O
&ef&gt	O
;	O
Ricin	O
is	O
easily	O
purified	O
from	O
castor-oil	O
manufacturing	O
waste	O
.	O

Article	O
VII	O
of	O
the	O
BWC	S-Document
commits	O
its	O
Parties	O
to	O
provide	O
assistance	O
to	O
any	O
other	O
Party	O
"	O
if	O
the	O
()	O
Security	O
Council	O
decides	O
that	O
such	O
Party	O
has	O
been	O
exposed	O
to	O
danger	O
as	O
a	O
result	O
of	O
violation	O
of	O
the	O
Convention.	O
"	O
The	O
problem	O
is	O
that	O
it	O
can	O
be	O
difficult	O
and	O
time	O
consuming	O
to	O
determine	O
whether	O
biological	O
weapons	O
have	O
been	O
used	O
,	O
particularly	O
compared	O
to	O
use	O
of	O
most	O
other	O
types	O
of	O
weapons	O
.	O

However	O
,	O
these	O
cases	O
are	O
believed	O
to	O
be	O
lingering	O
infection	O
rather	O
than	O
reinfection	O
,	O
or	O
false	O
positives	O
due	O
to	O
remaining	O
RNA	O
fragments	O
.	O

Cunningham	S-Person
asserted	O
that	O
the	O
"	O
Breeders"	O
"	O
logic	O
is	O
seriously	O
faulted	O
"	O
because	O
the	O
government	O
will	O
not	O
"	O
abandon	O
the	O
effort	O
"	O
to	O
use	O
aerial	O
applications	O
to	O
eradicate	O
the	O
pest	O
.	O

However	O
,	O
the	O
project	O
may	O
be	O
"	O
widely	O
perceived	O
as	O
an	O
effort	O
to	O
develop	O
biological	O
agents	O
for	O
hostile	O
purposes	O
and	O
their	O
means	O
of	O
delivery	O
,	O
which	O
--	O
if	O
true	O
--	O
would	O
constitute	O
a	O
breach	O
of	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
writes	O
Guy	B-Person
Reeves	E-Person
,	O
a	O
geneticist	O
at	O
the	O
,	O
and	O
his	O
co-authors	O
in	O
an	O
editorial	O
published	O
Thursday	O
in	O
the	O
journal	O
Science	O
.	O

By	O
19	O
June	O
2013	O
,	O
MERS	S-Disease
had	O
infected	O
at	O
least	O
60	O
people	O
with	O
cases	O
reported	O
in	O
Jordan	S-Location
,	O
Qatar	S-Location
,	O
Saudi	B-Location
Arabia	E-Location
,	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
(	O
UAE	S-Location
)	O
,	O
Tunisia	S-Location
,	O
Germany	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
(	O
UK	S-Location
)	O
,	O
France	S-Location
and	O
Italy	S-Location
,	O
with	O
a	O
death	O
toll	O
of	O
38	O
.	O

The	O
long-established	O
practice	O
of	O
permitting	O
OTC	O
sales	O
of	O
antibiotics	O
(including	O
and	O
other	O
drugs)	O
to	O
lay	O
animal	O
owners	O
for	O
administration	O
to	O
their	O
own	O
animals	O
nonetheless	O
continued	O
in	O
all	O
states	O
.	O

The	O
Geneva	B-Document
Protocol	E-Document
of	O
1925	O
prohibited	O
the	O
use	O
of	O
chemical	O
weapons	O
and	O
biological	O
weapons	O
,	O
but	O
said	O
nothing	O
about	O
experimentation	O
,	O
production	O
,	O
storage	O
,	O
or	O
transfer	O
;	O
later	O
treaties	O
did	O
cover	O
these	O
aspects	O
.	O

NAMRU-2	S-Organization
requires	O
contractor	O
services	O
to	O
support	O
the	O
development	O
,	O
performance	O
and	O
management	O
of	O
research	O
and	O
clinical	O
activities	O
in	O
collaboration	O
with	O
,	O
biotech	O
and	O
host-country	O
partners	O
.	O

Posted	O
by	O
NBC	O
News	O
Industry	O
experts	O
countered	O
that	O
the	O
2009	O
pandemic	O
had	O
led	O
to	O
"	O
unprecedented	O
collaboration	O
between	O
global	O
health	O
authorities	O
,	O
scientists	O
and	O
manufacturers	O
,	O
resulting	O
in	O
the	O
most	O
comprehensive	O
pandemic	O
response	O
ever	O
undertaken	O
,	O
with	O
a	O
number	O
of	O
vaccines	O
approved	O
for	O
use	O
three	O
months	O
after	O
the	O
pandemic	O
declaration	O
.	O

On	O
15	O
March	O
,	O
the	O
Iranian	B-Organization
government	E-Organization
reported	O
a	O
hundred	O
deaths	O
in	O
a	O
single	O
day	O
,	O
the	O
most	O
recorded	O
in	O
the	O
country	O
since	O
the	O
outbreak	O
began	O
.	O

Laboratory	O
wastewater	O
on	O
Fort	B-Location
Detrick	E-Location
is	O
chemically	O
disinfected	O
at	O
the	O
source	O
,	O
then	O
routed	O
to	O
the	O
,	O
where	O
it	O
is	O
held	O
in	O
these	O
storage	O
tanks	O
prior	O
to	O
entering	O
the	O
steam	O
sterilization	O
process	O
.	O

But	O
within	O
just	O
two	O
years	O
,	O
each	O
of	O
these	O
technologies	O
were	O
used	O
successfully	O
by	O
bright	O
students	O
participating	O
in	O
science	O
competitions	O
.	O

Each	O
100 μl	O
sample	O
is	O
decimal	O
diluted	O
from	O
10−1	O
to	O
10−7	O
and	O
3	O
prechosen	O
dilutions	O
from	O
each	O
time	O
point	O
were	O
prepared	O
for	O
plaque	O
assay	O
by	O
mixing	O
with	O
20 μl	O
0.	O
1 M	O
and	O
with	O
100 μl	O
of	O
E.	O
coli	O
strain	O
ER1647grown	O
overnight	O
in	O
Liquid	O
Broth	O
(LB)	O
medium	O
at	O
37°C	O
.	O

As	O
such	O
,	O
potential	O
vendors	O
must	O
be	O
able	O
to	O
provide	O
both	O
real-time	O
and	O
historical	O
data	O
on	O
an	O
array	O
of	O
topics	O
that	O
potentially	O
factor	O
into	O
epidemics	O
,	O
bioattacks	O
and	O
other	O
incidents	O
.	O

The	O
mosquitoes	O
survived	O
the	O
airdrop	O
and	O
actively	O
sought	O
out	O
human	O
blood	O
.	O

Tricky	O
Twenty-Two	O
,	O
a	O
novel	O
in	O
the	O
Stephanie	O
Plum	O
series	O
by	O
Janet	B-Person
Evanovich	E-Person
features	O
as	O
its	O
antagonist	O
a	O
deranged	O
biology	O
professor	O
who	O
is	O
obsessed	O
with	O
Unit	B-Organization
731	E-Organization
and	O
is	O
attempting	O
to	O
re-create	O
the	O
unit's	O
dispersals	O
.	O

In	O
late	O
August	O
,	O
MSF	S-Organization
called	O
the	O
situation	O
"	O
chaotic"	O
and	O
the	O
medical	O
response	O
"	O
inadequate."	O
They	O
reported	O
that	O
they	O
had	O
expanded	O
their	O
operations	O
,	O
but	O
couldn't	O
keep	O
up	O
with	O
the	O
rapidly	O
increasing	O
need	O
for	O
assistance	O
,	O
which	O
had	O
forced	O
them	O
to	O
reduce	O
the	O
level	O
of	O
care:	O
"	O
It	O
is	O
not	O
currently	O
possible	O
,	O
for	O
example	O
,	O
to	O
administer	O
intravenous	O
treatments.	O
"	O
Calling	O
the	O
situation	O
"	O
an	O
emergency	O
within	O
the	O
emergency"	O
,	O
MSF	S-Organization
reported	O
that	O
many	O
hospitals	O
had	O
shut	O
down	O
due	O
to	O
lack	O
of	O
staff	O
or	O
fears	O
of	O
the	O
virus	O
among	O
patients	O
and	O
staff	O
,	O
which	O
had	O
left	O
people	O
with	O
other	O
health	O
problems	O
without	O
any	O
care	O
at	O
all	O
.	O

Article	O
8	O
of	O
The	O
Rome	B-Document
Statute	I-Document
of	I-Document
The	I-Document
International	I-Document
Criminal	I-Document
Court	E-Document
(	O
ICC	S-Organization
)	O
defines	O
biological	O
experiments	O
as	O
war	O
crimes	O
.	O

PCDs	S-Equipment
have	O
several	O
potential	O
advantages	O
,	O
including	O
improving	O
signal	O
(and	O
contrast)	O
to	O
noise	O
ratios	O
,	O
reducing	O
doses	O
,	O
improving	O
spatial	O
resolution	O
,	O
and	O
through	O
use	O
of	O
several	O
energies	O
,	O
distinguishing	O
multiple	O
contrast	O
agents	O
.	O

The	O
rotation	O
between	O
different	O
work	O
stations	O
allows	O
for	O
experiments	O
that	O
continue	O
from	O
one	O
lab	O
to	O
the	O
next	O
,	O
providing	O
students	O
with	O
a	O
sense	O
of	O
an	O
ongoing	O
experiment	O
as	O
will	O
be	O
the	O
case	O
in	O
future	O
work	O
.	O

The	O
milder	O
forms	O
of	O
illness	O
in	O
all	O
3	O
waves	O
were	O
identical	O
and	O
typical	O
of	O
influenza	S-Disease
seen	O
in	O
the	O
1889	O
pandemic	O
and	O
in	O
prior	O
interpandemic	O
years	O
.	O

A	O
fourth	O
Ebola	S-Pathogen
Treatment	O
Center	O
(after	O
those	O
in	O
Mangina	S-Location
,	O
Beni	S-Location
and	O
Butembo	S-Location
)	O
was	O
inaugurated	O
in	O
September	O
in	O
Makeke	S-Location
in	O
the	O
Mandima	B-Location
Health	I-Location
Zone	I-Location
of	I-Location
Ituri	I-Location
Province	E-Location
.	O
Makeke	S-Location
is	O
less	O
than	O
five	O
kilometers	O
from	O
Mangina	S-Location
along	O
a	O
well-traveled	O
local	O
road	O
;	O
the	O
site	O
had	O
been	O
proposed	O
in	O
August	O
when	O
it	O
appeared	O
that	O
a	O
second	O
Ebola	S-Pathogen
Treatment	O
Center	O
would	O
be	O
needed	O
in	O
the	O
area	O
,	O
and	O
space	O
was	O
insufficient	O
in	O
Mangina	S-Location
itself	O
to	O
accommodate	O
one	O
.	O

That	O
report	O
said	O
Casadaban	S-Person
who	O
was	O
known	O
to	O
use	O
gloves	O
inconsistently	O
,	O
may	O
have	O
become	O
infected	O
through	O
dermal	O
exposure-possibly	O
the	O
same	O
exposure	O
route	O
as	O
the	O
researcher	O
infected	O
with	O
B.cereus	O
.	O

Its	O
principles	O
apply	O
to	O
both	O
natural	O
and	O
man-made	O
epidemics	O
(bioterrorism)	O
.	O

Some	O
countries	O
refer	O
mainly	O
to	O
the	O
biological	B-Document
agent	I-Document
biosafety	I-Document
category	I-Document
lists	E-Document
published	O
by	O
the	O
US	B-Organization
CDC	E-Organization
,	O
NIH	S-Organization
or	O
.	O

I've	O
been	O
covering	O
this	O
issue	O
for	O
a	O
while	O
.	O

Treatment	O
was	O
conducted	O
by	O
four	O
Belgian	O
nuns	O
,	O
a	O
priest	O
,	O
one	O
female	O
nurse	O
from	O
Zaire	S-Location
,	O
and	O
seven	O
male	O
Zaireians	O
.	O

A	O
$100,000	O
reward	O
was	O
offered	O
in	O
2004	O
by	O
the	O
investigating	O
the	O
case	O
,	O
but	O
to	O
date	O
the	O
reward	O
remains	O
unclaimed	O
.	O

Furthermore	O
,	O
19(10%)	O
laboratories	O
had	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
vaccination	O
programme	O
,	O
5	O
(6.	O
2%)	O
applied	O
BCG	B-Vaccine
vaccine	E-Vaccine
,	O
and	O
2	O
(1.	O
1%)	O
vaccinated	O
the	O
staff	O
against	O
.	O

On	O
22	O
February	O
,	O
the	O
Council	O
of	O
Ministers	O
announced	O
a	O
new	O
decree-law	O
to	O
contain	O
the	O
outbreak	O
,	O
including	O
quarantining	O
more	O
than	O
50,000	O
people	O
from	O
eleven	O
different	O
municipalities	O
in	O
northern	O
Italy	S-Location
Prime	O
Minister	O
said	O
,	O
"	O
In	O
the	O
outbreak	O
areas	O
,	O
entry	O
and	O
exit	O
will	O
not	O
be	O
provided	O
.	O

Besides	O
the	O
numerous	O
pathogens	O
that	O
afflict	O
human	O
beings	O
,	O
the	O
U.S.	S-Location
had	O
developed	O
an	O
arsenal	O
of	O
anti-agriculture	O
biological	O
agents	O
.	O

But	O
can	O
they	O
be	O
trusted?	O
,	O
6May	O
2020	O
,	O
USA	B-Organization
Today	E-Organization
Despite	O
being	O
the	O
first	O
area	O
of	O
the	O
world	O
hit	O
by	O
the	O
outbreak	O
,	O
the	O
early	O
wide-scale	O
response	O
of	O
some	O
Asian	O
states	O
,	O
particularly	O
South	B-Location
Korea	E-Location
,	O
Taiwan	S-Location
,	O
and	O
has	O
allowed	O
them	O
to	O
fare	O
comparatively	O
well	O
.	O

The	O
statement	O
also	O
expressed	O
support	O
for	O
efforts	O
to	O
establish	O
a	O
political	O
declaration	O
based	O
on	O
human	O
rights	O
,	O
equity	O
,	O
and	O
medical	O
science	O
that	O
sets	O
targets	O
related	O
to	O
ending	O
TB	S-Disease
The	O
statement	O
urged	O
the	O
inclusion	O
of	O
targets	O
for	O
finding	O
a	O
missing	O
4	O
million	O
cases	O
,	O
improving	O
treatment	O
and	O
prevention	O
and	O
increasing	O
investments	O
in	O
research	O
and	O
development	O
for	O
diagnostic	O
,	O
preventive	O
and	O
treatment	O
tools	O
.	O

Methods	O
for	O
predicting	O
the	O
use	O
of	O
biological	O
agents	O
in	O
urban	O
areas	O
as	O
well	O
as	O
assessing	O
the	O
area	O
for	O
the	O
hazards	O
associated	O
with	O
a	O
biological	O
attack	O
are	O
being	O
established	O
in	O
major	O
cities	O
.	O

These	O
are	O
only	O
the	O
tip	O
of	O
the	O
iceberg	O
in	O
terms	O
of	O
the	O
vast	O
reservoir	O
of	O
bioactive	O
compounds	O
available	O
in	O
nature	O
.	O

Strategies	O
for	O
preventing	O
transmission	O
of	O
the	O
disease	O
include	O
maintaining	O
overall	O
good	O
personal	O
hygiene	O
,	O
washing	O
hands	O
,	O
avoiding	O
touching	O
the	O
eyes	O
,	O
nose	O
,	O
or	O
mouth	O
with	O
unwashed	O
hands	O
,	O
and	O
coughing	O
or	O
sneezing	O
into	O
a	O
tissue	O
,	O
and	O
putting	O
the	O
tissue	O
directly	O
into	O
a	O
waste	O
container	O
.	O

Liberation	O
of	O
the	O
ribosome	O
from	O
the	O
drug	O
allows	O
further	O
translation	O
and	O
consequent	O
resistance	O
to	O
the	O
drug	O
.	O

Antibiotics	O
are	O
powerless	O
against	O
influenza	S-Disease
and	O
other	O
illnesses	O
caused	O
by	O
viruses	O
.	O

Real-time	B-Technology
MRI	E-Technology
is	O
likely	O
to	O
add	O
important	O
information	O
on	O
diseases	O
of	O
the	O
heart	O
and	O
the	O
joints	O
,	O
and	O
in	O
many	O
cases	O
may	O
make	O
MRI	S-Technology
examinations	O
easier	O
and	O
more	O
comfortable	O
for	O
patients	O
,	O
especially	O
for	O
the	O
patients	O
who	O
cannot	O
hold	O
their	O
breathings	O
or	O
who	O
have	O
.	O

For	O
evaluation	O
of	O
chronic	O
interstitial	O
processes	O
such	O
as	O
emphysema	S-Disease
,	O
and	O
fibrosis	S-Disease
,	O
thin	O
sections	O
with	O
high	O
spatial	O
frequency	O
reconstructions	O
are	O
used	O
;	O
often	O
scans	O
are	O
performed	O
both	O
on	O
inspiration	O
and	O
expiration	O
.	O

Joseph	B-Person
Kam	E-Person
Honorary	O
Clinical	O
Associate	O
Professor	O
at	O
the	O
Stanley	B-Organization
Ho	I-Organization
Centre	I-Organization
for	I-Organization
Emerging	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
CEID	S-Organization
)	O
told	O
CNN	S-Organization
that	O
rules	O
for	O
storing	O
viruses	O
are	O
very	O
strict	O
and	O
highly	O
dangerous	O
diseases	O
such	O
as	O
Ebola	S-Disease
and	O
would	O
be	O
stored	O
in	O
the	O
highest	O
"	O
Level	O
4	O
"	O
laboratory	O
.	O

Southern	B-Organization
Research	I-Organization
Institute	E-Organization
has	O
been	O
a	O
prime	O
subcontractor	O
under	O
the	O
DTRA	S-Organization
program	O
in	O
Ukraine	S-Location
since	O
2008	O
.	O

As	O
with	O
any	O
new	O
area	O
of	O
science	O
,	O
medicine	O
or	O
technology	O
,	O
synthetic	B-Technology
genomics	E-Technology
has	O
the	O
potential	O
to	O
be	O
used	O
for	O
great	O
societal	O
benefit	O
(biofuels	O
,	O
vaccines	O
and	O
pharmaceuticals	O
,	O
clean	O
water	O
,	O
bioremediation	O
,	O
etc)	O
,	O
but	O
it	O
could	O
also	O
be	O
used	O
for	O
negative	O
purposes	O
.	O

"	O
And	O
You	O
Will	O
Beg	O
for	O
Our	O
Secrets	O
"	O
(2016)	O
,	O
from	O
the	O
Anaal	B-Person
Nathrakh	E-Person
album	O
The	O
Whole	O
of	O
the	O
Law	O
,	O
refers	O
to	O
Unit	B-Organization
731	E-Organization
's	O
activities	O
and	O
the	O
amnesty	O
given	O
in	O
exchange	O
for	O
information	O
resulting	O
from	O
the	O
experiments	O
carried	O
out	O
.	O

China	S-Location
once	O
again	O
dismissed	O
concerns	O
over	O
Taiwanese	O
inclusion	O
with	O
the	O
Foreign	O
Minister	O
claiming	O
that	O
no-one	O
cares	O
more	O
about	O
the	O
health	O
and	O
wellbeing	O
of	O
the	O
Taiwanese	O
people	O
than	O
China	S-Location
's	O
central	O
government	O
.	O

MRI	B-Technology
scans	E-Technology
are	O
capable	O
of	O
producing	O
a	O
variety	O
of	O
chemical	O
and	O
physical	O
data	O
,	O
in	O
addition	O
to	O
detailed	O
spatial	O
images	O
.	O

The	O
reality	O
is	O
quite	O
the	O
opposite	O
,	O
as	O
it	O
can	O
be	O
a	O
challenge	O
for	O
the	O
government	O
to	O
convince	O
pharmaceutical	O
companies	O
to	O
develop	O
drugs	O
for	O
the	O
U.S.	S-Location
national	O
stockpile	O
that	O
are	O
not	O
also	O
commercially	O
viable	O
.	O

The	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
one	O
of	O
the	O
few	O
laboratories	O
in	O
the	O
country	O
that	O
can	O
handle	O
dangerous	O
pathogens	O
such	O
as	O
Ebola	S-Pathogen
,	O
will	O
begin	O
work	O
again	O
in	O
its	O
biosafety	B-Platform
level	I-Platform
3	I-Platform
and	I-Platform
biosafety	I-Platform
level	I-Platform
4	E-Platform
laboratories	O
,	O
said	O
Col.	B-Person
E.	I-Person
Darrin	I-Person
Cox	E-Person
,	O
commander	O
.	O

The	O
phrase	O
'	O
black	B-Disease
death	E-Disease
–	O
describing	O
Death	O
as	O
black	O
–	O
is	O
very	O
old	O
.	O

The	O
3	O
recurrences	O
in	O
1889–1892	O
,	O
however	O
,	O
were	O
spread	O
over	O
&gt;3	O
years	O
,	O
in	O
contrast	O
to	O
1918–1919	O
,	O
when	O
the	O
sequential	O
waves	O
seen	O
in	O
individual	O
countries	O
were	O
typically	O
compressed	O
into	O
≈8–9	O
months	O
.	O

Initial	O
scenarios	O
had	O
placed	O
expected	O
economic	O
losses	O
at	O
$25	O
billion	O
;	O
however	O
subsequent	O
World	B-Organization
Bank	E-Organization
estimates	O
were	O
much	O
lower	O
,	O
at	O
about	O
12%	O
of	O
the	O
combined	O
GDP	O
of	O
the	O
3	O
worst	O
hit	O
countries	O
.	O

Restricted	O
access	O
to	O
medical	O
care	O
and	O
medicine	O
has	O
pushed	O
biohackers	O
to	O
start	O
experimenting	O
in	O
medically	O
related	O
fields	O
.	O

For	O
example	O
,	O
in	O
the	O
TB	S-Disease
lab	O
when	O
heat	O
is	O
used	O
to	O
kill	O
a	O
pathogen	O
,	O
a	O
second	O
trained	O
lab	O
technician	O
will	O
witness	O
the	O
process	O
to	O
make	O
sure	O
the	O
right	O
temperature	O
is	O
used	O
for	O
the	O
right	O
amount	O
of	O
time	O
.	O

One	O
of	O
Ishii	S-Person
main	O
supporters	O
inside	O
the	O
army	O
was	O
Colonel	O
Chikahiko	B-Person
Koizumi	E-Person
,	O
who	O
later	O
became	O
Japan's	O
Health	O
Minister	O
from	O
1941	O
to	O
1945	O
.	O

Over	O
the	O
course	O
of	O
its	O
history	O
,	O
the	O
Soviet	O
program	O
is	O
known	O
to	O
have	O
weaponized	O
and	O
stockpiled	O
the	O
following	O
eleven	O
bio-agentsCook	O
,	O
Michelle	B-Person
Stem	E-Person
and	O
Amy	B-Person
F.	I-Person
Woolf	E-Person
(April	O
10	O
,	O
2002)	O
,	O
Preventing	B-Document
Proliferation	I-Document
of	I-Document
Biological	I-Document
Weapons:	I-Document
U.S.	I-Document
Assistance	I-Document
to	I-Document
the	I-Document
Former	I-Document
Soviet	I-Document
States	E-Document
,	O
(Congressional	O
Research	O
Service	O
Report	O
for	O
Congress)	O
,	O
pg	O
3.	O
(and	O
to	O
have	O
pursued	O
basic	O
research	O
on	O
many	O
more):	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
(	O
anthrax	S-Pathogen
)	O
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
(	O
plague	S-Pathogen
)	O
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
(	O
tularemia	S-Pathogen
)	O
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
(	O
glanders	S-Pathogen
)	O
,	O
Brucella	B-Pathogen
sp.	E-Pathogen
(	O
brucellosis	S-Pathogen
)	O
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
(	O
Q-fever	S-Pathogen
)	O
,	O
Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
,	O
(	O
VEE	S-Pathogen
)	O
,	O
Botulinum	B-Pathogen
toxin	E-Pathogen
,	O
Staphylococcal	B-Pathogen
enterotoxin	I-Pathogen
B	E-Pathogen
,	O
Smallpox	S-Pathogen
,	O
and	O
.	O

CT	S-Equipment
of	O
the	O
thyroid	O
plays	O
an	O
important	O
role	O
in	O
the	O
evaluation	O
of	O
thyroid	B-Disease
cancer	E-Disease
.	O
Creative	O
Commons	O
Attribution	O
4.	O
0	O
International	O
License	O
Also	O
,	O
CT	B-Technology
scans	E-Technology
often	O
incidentally	O
find	O
,	O
and	O
thereby	O
practically	O
becomes	O
the	O
first	O
investigation	O
modality	O
.	O

In	O
recent	O
years	O
,	O
the	O
WHO	S-Organization
work	O
has	O
involved	O
increasing	O
collaboration	O
with	O
external	O
bodies.	O
,	O
a	O
total	O
of	O
473	O
non-governmental	O
organizations	O
(NGO)	O
had	O
some	O
form	O
of	O
partnership	O
with	O
WHO	S-Organization
.	O
There	O
were	O
189	O
partnerships	O
with	O
international	O
NGOs	O
in	O
formal	O
"	O
official	O
relations	O
"	O
–	O
the	O
rest	O
being	O
considered	O
informal	O
in	O
character	O
.	O

But	O
Gentry	O
of	O
would	O
admit	O
him	O
to	O
the	O
club	O
.	O

This	O
would	O
apply	O
to	O
research	O
conducted	O
by	O
and	O
funded	O
by	O
federal	O
research	O
agencies	O
.	O

However	O
,	O
later	O
tests	O
confirmed	O
that	O
the	O
initial	O
tests	O
did	O
not	O
indicate	O
a	O
false	O
positive	O
and	O
the	O
substance	O
was	O
indeed	O
ricin	S-Pathogen
By	O
the	O
end	O
of	O
March	O
2005	O
,	O
there	O
were	O
no	O
suspects	O
and	O
no	O
confirmed	O
source	O
for	O
the	O
ricin	S-Pathogen
found	O
in	O
Senator	B-Location
Frist's	I-Location
office	E-Location
.	O
Investigators	O
also	O
found	O
no	O
connection	O
to	O
the	O
Fallen	B-Incident
Angel	I-Incident
case	E-Incident
as	O
of	O
the	O
same	O
date.	O
"	O
Still	O
No	O
Suspects	O
in	O
Ricin	B-Incident
Case	E-Incident
on	O
Capitol	O
Hill	O
"	O
,	O
WTOP.com	O
,	O
March	O
31	O
,	O
2005	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

Entomological	B-Incident
warfare	E-Incident
is	O
a	O
type	O
of	O
biological	B-Incident
warfare	E-Incident
that	O
uses	O
insects	O
to	O
transmit	O
diseases	O
.	O

He	O
found	O
archival	O
evidence	O
that	O
a	O
respiratory	O
illness	O
that	O
struck	O
northern	O
China	S-Location
in	O
November	O
1917	O
was	O
identified	O
a	O
year	O
later	O
by	O
Chinese	O
health	O
officials	O
as	O
identical	O
to	O
the	O
.	O

However	O
,	O
the	O
uses	O
of	O
for	O
pharma	O
and	O
biotech	O
companies	O
are	O
almost	O
limitless	O
,	O
and	O
should	O
deserve	O
further	O
attention	O
from	O
funding	O
agencies	O
and	O
investors	O
as	O
well	O
as	O
media	O
.	O

In	O
2022	O
,	O
the	O
new	O
International	B-Document
Statistical	I-Document
Classification	I-Document
of	I-Document
Diseases	I-Document
and	I-Document
Related	I-Document
Health	I-Document
Problems	E-Document
,	O
ICD-11	S-Document
,	O
will	O
attempt	O
to	O
enable	O
classifications	O
from	O
traditional	O
medicine	O
to	O
be	O
integrated	O
with	O
classifications	O
from	O
evidence-based	O
medicine	O
.	O

Their	O
target	O
was	O
livestock-the	O
horses	O
,	O
mules	O
,	O
sheep	O
,	O
and	O
cattle	O
being	O
shipped	O
from	O
neutral	O
countries	O
to	O
the	O
Allies	O
.	O

Researchers	O
presented	O
evidence	O
indicating	O
that	O
infected	O
people	O
that	O
lived	O
in	O
low	O
socioeconomic	O
areas	O
were	O
more	O
likely	O
to	O
transmit	O
the	O
virus	O
to	O
other	O
socioeconomic	O
status	O
(SES)	O
communities	O
,	O
in	O
contrast	O
to	O
individuals	O
in	O
higher	O
SES	O
areas	O
who	O
were	O
infected	O
as	O
well	O
.	O

The	O
researchers	O
suggested	O
that	O
this	O
information	O
could	O
help	O
to	O
assess	O
the	O
efficacy	O
of	O
proposed	O
treatments	O
more	O
accurately	O
in	O
non-randomised	O
clinical	O
trials	O
.	O

In	O
a	O
study	O
published	O
by	O
the	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
mapping	O
antimicrobial	O
consumption	O
in	O
livestock	O
globally	O
,	O
it	O
was	O
predicted	O
that	O
in	O
the	O
228	O
countries	O
studied	O
,	O
there	O
would	O
be	O
a	O
total	O
67%	O
increase	O
in	O
consumption	O
of	O
antibiotics	O
by	O
livestock	O
by	O
2030	O
.	O

Since	O
the	O
insertion	O
of	O
a	O
gene	O
into	O
the	O
host	O
genome	O
may	O
even	O
cause	O
copy	O
number	O
variation	O
,	O
this	O
may	O
be	O
uncovered	O
using	O
real	B-Equipment
time	I-Equipment
PCR	E-Equipment
Besides	O
,	O
assessing	O
the	O
exact	O
number	O
of	O
mRNA	O
transcripts	O
of	O
a	O
gene	O
,	O
correlation	O
between	O
the	O
template	O
activity	O
and	O
expressed	O
protein	O
may	O
be	O
established	O
.	O

WHO's	B-Document
Global	I-Document
Malaria	I-Document
Programme	E-Document
works	O
to	O
keep	O
track	O
of	O
malaria	S-Disease
cases	O
,	O
and	O
future	O
problems	O
in	O
malaria	O
control	O
schemes	O
.	O

In	O
October	O
,	O
the	O
WHO	S-Organization
and	O
non-profit	O
partners	O
launched	O
a	O
program	O
in	O
to	O
move	O
infected	O
people	O
out	O
of	O
their	O
homes	O
into	O
ad	O
hoc	O
centres	O
that	O
could	O
provide	O
rudimentary	O
care	O
.	O

While	O
this	O
first	O
bioterrorist	O
act	O
on	O
American	B-Location
soil	E-Location
went	O
almost	O
unnoticed	O
,	O
a	O
decade	O
later	O
the	O
work	O
of	O
another	O
cult	O
sparked	O
a	O
flurry	O
of	O
media	O
coverage	O
and	O
government	O
response	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

The	O
lack	O
of	O
harmful	O
effects	O
on	O
the	O
patient	O
and	O
the	O
operator	O
make	O
MRI	S-Technology
well-suited	O
for	O
interventional	O
radiology	O
,	O
where	O
the	O
images	O
produced	O
by	O
an	O
guide	O
minimally	O
invasive	O
procedures	O
.	O

So	O
is	O
buying	O
this	O
expensive	O
product	O
likely	O
to	O
improve	O
your	O
health?	O
We	O
can't	O
say	O
that	O
yet	O
.	O

"	O
I	O
don't	O
think	O
we've	O
done	O
anywhere	O
near	O
the	O
amount	O
of	O
work	O
necessary	O
to	O
create	O
the	O
medical	O
understanding	O
,	O
the	O
psychological	O
understanding	O
,	O
and	O
maybe	O
even	O
the	O
genetic	O
understanding	O
of	O
what	O
happens	O
to	O
people	O
who	O
are	O
exposed,	O
"	O
said	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	E-Organization
member	O
Tom	B-Person
Daschle	E-Person
,	O
a	O
former	O
majority	O
leader	O
in	O
the	O
.	O

In	O
a	O
previous	O
study	O
,	O
based	O
on	O
experiences	O
gained	O
during	O
46	O
years	O
of	O
collaborative	O
work	O
,	O
performed	O
across	O
diverse	O
laboratory	O
cultures	O
,	O
the	O
value	O
of	O
networks	O
has	O
been	O
summarized	O
as	O
having	O
achieved	O
enhanced	O
productivity	O
and	O
trust-greater	O
than	O
any	O
single	O
laboratory	O
could	O
achieve	O
.	O

The	O
same	O
year	O
,	O
the	O
PHS	S-Organization
transferred	O
its	O
San	B-Organization
Francisco	I-Organization
based	I-Organization
plague	I-Organization
laboratory	E-Organization
into	O
the	O
as	O
the	O
Epidemiology	O
Division	O
,	O
and	O
a	O
new	O
Veterinary	O
Diseases	O
Division	O
was	O
established	O
.	O

Adalja	S-Person
project	O
team	O
included	O
senior	O
scholar	O
Eric	B-Person
Toner	E-Person
,	O
MD	O
,	O
and	O
senior	O
analyst	O
.	O
To	O
formulate	O
the	O
findings	O
and	O
recommendations	O
in	O
their	O
report	O
,	O
they	O
reviewed	O
published	O
literature	O
and	O
reports	O
on	O
emerging	O
infectious	O
disease	O
characteristics	O
,	O
the	O
pathogenic	O
potential	O
of	O
microbes	O
,	O
and	O
other	O
related	O
topics	O
;	O
interviewed	O
more	O
than	O
120	O
technical	O
experts	O
from	O
academia	O
,	O
industry	O
,	O
and	O
government	O
;	O
and	O
convened	O
a	O
meeting	O
of	O
a	O
subset	O
of	O
those	O
experts	O
to	O
discuss	O
preliminary	O
analysis	O
of	O
the	O
information	O
the	O
team	O
had	O
gathered	O
.	O

Kommersant	S-Organization
described	O
the	O
facility	O
as	O
a	O
"	O
military	O
installation"	O
,	O
surrounded	O
by	O
a	O
barbed-wire	O
fence	O
and	O
armed	O
guards	O
in	O
watchtowers	O
.	O

They	O
believe	O
this	O
because	O
larvae	O
were	O
detected	O
there	O
,	O
indicating	O
the	O
existence	O
of	O
a	O
breeding	O
population	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
and	O
its	O
genus	O
were	O
both	O
originally	O
named	O
for	O
Zaire	S-Location
(now	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
)	O
,	O
the	O
country	O
where	O
it	O
was	O
first	O
described	O
,	O
and	O
was	O
at	O
first	O
suspected	O
to	O
be	O
a	O
new	O
"	O
strain"	O
of	O
the	O
closely	O
related	O
Marburg	B-Pathogen
virus	E-Pathogen
.	O
The	O
virus	O
was	O
renamed	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
in	O
2010	O
to	O
avoid	O
confusion	O
.	O

On	O
22	O
June	O
2010	O
,	O
the	O
CDC	S-Organization
announced	O
a	O
new	O
test	O
called	O
the	O
"	O
CDC	B-Technology
Influenza	I-Technology
2009	I-Technology
A	I-Technology
(H1N1)pdm	I-Technology
Real-Time	I-Technology
RT-PCR	I-Technology
Panel	E-Technology
(	O
IVD	S-Technology
)"	O
.	O

As	O
part	O
of	O
their	O
second‐year	O
requirements	O
,	O
students	O
take	O
a	O
course	O
and	O
lab	O
in	O
immunology	O
,	O
where	O
they	O
learn	O
about	O
in	O
theory	O
and	O
practice	O
.	O

However	O
,	O
federal	O
agencies	O
have	O
worked	O
for	O
years	O
with	O
health	O
departments	O
across	O
the	O
country	O
to	O
plan	O
and	O
prepare	O
for	O
an	O
anthrax	S-Pathogen
attack	O
.	O

CT	B-Technology
scanning	E-Technology
has	O
also	O
found	O
an	O
application	O
in	O
transport	O
security	O
(predominantly	O
airport	O
security	O
where	O
it	O
is	O
currently	O
used	O
in	O
a	O
materials	O
analysis	O
context	O
for	O
(explosive-detection	O
device)	O
and	O
is	O
also	O
under	O
consideration	O
for	O
automated	O
baggage/parcel	O
security	O
scanning	O
using	O
computer	O
vision	O
based	O
object	O
recognition	O
algorithms	O
that	O
target	O
the	O
detection	O
of	O
specific	O
threat	O
items	O
based	O
on	O
3D	O
appearance	O
(e.g.	O
guns	O
,	O
knives	O
,	O
liquid	O
containers)	O
.	O

The	O
Basics	O
of	O
MRI	S-Technology
Underlying	O
physics	O
and	O
technical	O
aspects	O
.	O

Similarities	O
between	O
a	O
reconstruction	O
of	O
the	O
virus	O
and	O
avian	O
viruses	O
,	O
combined	O
with	O
the	O
human	O
pandemic	O
preceding	O
the	O
first	O
reports	O
of	O
influenza	S-Disease
in	O
swine	O
,	O
led	O
researchers	O
to	O
conclude	O
the	O
virus	O
jumped	O
directly	O
from	O
birds	O
to	O
humans	O
,	O
and	O
swine	O
caught	O
the	O
disease	O
from	O
humans	O
.	O

As	O
of	O
7May	O
,	O
in	O
New	B-Location
York	I-Location
City	E-Location
with	O
a	O
population	O
of	O
8.	O
4 million	O
,	O
14,162	O
have	O
died	O
from	O
COVID-19	S-Disease
(0.	O
17%	O
of	O
the	O
population)	O
.	O

In	O
2006	O
a	O
ban	O
on	O
the	O
use	O
of	O
antibiotics	O
in	O
European	O
feed	O
,	O
with	O
the	O
exception	O
of	O
two	O
antibiotics	O
in	O
poultry	O
feeds	O
,	O
became	O
effective	O
.	O

But	O
Frieden	S-Person
said	O
overall	O
the	O
facility	O
has	O
performed	O
well	O
and	O
the	O
incidents	O
were	O
not	O
the	O
reason	O
for	O
the	O
replacement	O
plans	O
.	O

On	O
June	O
5th	O
of	O
this	O
year	O
,	O
a	O
laboratory	O
scientist	O
working	O
in	O
one	O
of	O
our	O
bioterrorism	O
response	O
laboratories	O
made	O
a	O
mistake	O
.	O

The	O
development	O
and	O
implementation	O
of	O
an	O
effective	O
national	O
biosafety	O
system	O
is	O
important	O
for	O
several	O
key	O
reasons:	O
to	O
ensure	O
safe	O
access	O
to	O
products	O
of	O
modern	O
biotechnology	O
,	O
to	O
build	O
public	O
confidence	O
,	O
to	O
encourage	O
the	O
growth	O
of	O
domestic	O
modern	O
biotechnology	O
,	O
and	O
to	O
comply	O
with	O
international	O
standards	O
and	O
agreements	O
.	O

Livestock	O
in	O
the	O
area	O
were	O
also	O
affected	O
.	O

In	O
1346	O
,	O
during	O
the	O
siege	O
of	O
Caffa	S-Location
(now	O
Feodossia	S-Location
,	O
Crimea	S-Location
)	O
the	O
attacking	O
Tartar	O
Forces	O
which	O
were	O
subjugated	O
by	O
the	O
Mongol	O
empire	O
under	O
Genghis	O
Khan	O
,	O
used	O
the	O
bodies	O
of	O
Mongol	O
warriors	O
of	O
the	O
Golden	O
Horde	O
who	O
had	O
died	O
of	O
plague	O
,	O
as	O
weapons	O
.	O

On	O
17	O
April	O
,	O
first	O
confirmed	O
case	O
of	O
SARS	S-Disease
from	O
India	S-Location
was	O
reported	O
.	O

These	O
conditions	O
created	O
by	O
,	O
together	O
with	O
the	O
current	O
social	O
attitudes	O
and	O
ideas	O
,	O
led	O
to	O
the	O
relatively	O
calm	O
response	O
of	O
the	O
public	O
and	O
application	O
of	O
scientific	O
ideas	O
.	O

The	O
recombination	O
of	O
its	O
surface	O
proteins	O
created	O
a	O
virus	O
novel	O
to	O
almost	O
everyone	O
and	O
a	O
loss	O
of	O
herd	O
immunity	O
.	O

On	O
1	O
August	O
2018	O
,	O
the	O
North	B-Location
Kivu	E-Location
health	O
division	O
notified	O
Congo	S-Organization
's	O
health	O
ministry	O
of	O
26	O
cases	O
of	O
hemorrhagic	B-Disease
fever	E-Disease
,	O
including	O
20	O
deaths	O
.	O

These	O
levels	O
will	O
produce	O
hyperventilation	O
in	O
33%	O
of	O
patients	O
,	O
as	O
well	O
as	O
in	O
3%	O
of	O
patients	O
.	O

Research	O
suggests	O
that	O
many	O
Ebola	S-Disease
infections	O
are	O
asymptomatic	O
,	O
meaning	O
that	O
some	O
infected	O
people	O
show	O
no	O
symptoms	O
of	O
the	O
disease	O
.	O

As	O
a	O
member	O
of	O
the	O
biohacking	O
movement	O
that	O
aims	O
to	O
encourage	O
individuals	O
and	O
smaller	O
organisations	O
to	O
study	O
biology	O
using	O
the	O
same	O
methods	O
as	O
traditional	O
research	O
institutions	O
,	O
Jorgensen	S-Person
advocates	O
democratising	O
biotechnology	O
at	O
the	O
local	O
level	O
through	O
community	O
laboratories	O
that	O
not	O
only	O
teach	O
the	O
technical	O
aspects	O
of	O
the	O
science	O
but	O
also	O
explain	O
how	O
to	O
contextualise	O
it	O
.	O

In	O
the	O
model	O
,	O
"	O
a	O
modern	O
day	O
'	O
Spanish	B-Incident
flu	E-Incident
'	O
event	O
would	O
result	O
in	O
additional	O
life	O
insurance	O
losses	O
of	O
between	O
US	S-Location
$15.3–27.8 billion	O
in	O
the	O
United	B-Location
States	E-Location
alone"	O
,	O
with	O
188,000–337,000 deaths	O
in	O
.	O

Universities	O
and	O
other	O
scientific	O
institutions	O
should	O
develop	O
procedures	O
to	O
monitor	O
scientific	O
activities	O
.	O

The	O
Association	B-Organization
for	I-Organization
Civil	I-Organization
Rights	I-Organization
in	I-Organization
Israel	E-Organization
,	O
however	O
,	O
said	O
the	O
move	O
was	O
"	O
a	O
dangerous	O
precedent	O
and	O
a	O
slippery	O
slope"	O
.	O

The	O
Cambridge	O
History	O
of	O
China	S-Location
:	O
Alien	O
regimes	O
and	O
border	O
states	O
,	O
907–1368	O
,	O
p.585	O
.	O

Epidemics	O
ravaged	O
cities	O
,	O
particularly	O
children.	O
Plagues	B-Disease
easily	O
spread	O
by	O
lice	O
,	O
unsanitary	O
drinking	O
water	O
,	O
armies	O
,	O
or	O
by	O
poor	O
sanitation	O
.	O

I	O
may	O
have	O
misunderstood	O
something	O
you	O
said	O
.	O

One	O
explanation	O
for	O
the	O
rapid	O
decline	O
in	O
the	O
lethality	O
of	O
the	O
disease	O
is	O
that	O
doctors	O
became	O
more	O
effective	O
in	O
prevention	O
and	O
treatment	O
of	O
the	O
pneumonia	S-Disease
that	O
developed	O
after	O
the	O
victims	O
had	O
contracted	O
the	O
virus	O
.	O

"	O
These	O
approvals	O
underscore	O
the	O
critical	O
role	O
the	O
Animal	B-Document
Rule	E-Document
and	O
animal	O
studies	O
can	O
play	O
in	O
advancing	O
medical	O
countermeasures	O
for	O
some	O
of	O
the	O
world's	O
most	O
challenging	O
threats,	O
"	O
said	O
.	O

Other	O
international	O
policy	O
frameworks	O
produced	O
by	O
WHO	S-Organization
include	O
the	O
International	B-Document
Code	I-Document
of	I-Document
Marketing	I-Document
of	I-Document
Breast-milk	I-Document
Substitutes	E-Document
(adopted	O
in	O
1981)	O
,	O
Framework	B-Document
Convention	I-Document
on	I-Document
Tobacco	I-Document
Control	E-Document
(adopted	O
in	O
2003)	O
the	O
Global	B-Document
Code	I-Document
of	I-Document
Practice	I-Document
on	I-Document
the	I-Document
International	I-Document
Recruitment	I-Document
of	I-Document
Health	I-Document
Personnel	E-Document
(adopted	O
in	O
2010)	O
as	O
well	O
as	O
the	O
and	O
its	O
pediatric	O
counterpart	O
.	O

Based	O
on	O
the	O
records	O
in	O
the	O
BBD	S-Platform
,	O
biosafety	O
research	O
activity	O
over	O
the	O
past	O
16-17	O
years	O
can	O
be	O
summarized	O
by	O
analyzing	O
basic	O
statistics	O
.	O

Presiding	O
judge	O
Koji	B-Person
Iwata	E-Person
ruled	O
that	O
the	O
Unit	B-Organization
731	E-Organization
,	O
on	O
the	O
orders	O
of	O
the	O
Imperial	B-Organization
Japanese	I-Organization
Army	E-Organization
headquarters	O
,	O
used	O
bacteriological	O
weapons	O
on	O
Chinese	O
civilians	O
between	O
1940	O
and	O
1942	O
,	O
spreading	O
diseases	O
including	O
plague	S-Disease
and	O
typhoid	S-Disease
in	O
the	O
cities	O
of	O
Quzhou	S-Location
,	O
Ningbo	S-Location
and	O
.	O
However	O
,	O
he	O
rejected	O
the	O
victims'	O
claims	O
for	O
compensation	O
on	O
the	O
grounds	O
that	O
they	O
had	O
already	O
been	O
settled	O
by	O
international	O
peace	O
treaties	O
.	O

Alongside	O
staggering	O
numbers	O
of	O
illnesses	O
and	O
deaths	O
from	O
the	O
virus	O
in	O
West	B-Location
Africa	E-Location
the	O
outbreak	O
stretched	O
thin	O
the	O
already	O
weak	O
healthcare	O
and	O
infrastructure	O
systems	O
in	O
the	O
three	O
countries	O
.	O

In	O
the	O
United	B-Location
States	E-Location
,	O
isolated	O
outbreaks	O
occurred	O
in	O
some	O
cities	O
including	O
Los	B-Location
Angeles	E-Location
,	O
New	B-Location
York	I-Location
City	E-Location
,	O
Memphis	S-Location
,	O
Nashville	S-Location
,	O
San	B-Location
Francisco	E-Location
and	O
.	O
Overall	O
American	O
mortality	O
rates	O
were	O
in	O
the	O
tens	O
of	O
thousands	O
during	O
the	O
first	O
six	O
months	O
of	O
1919	O
.	O

An	O
international	O
group	O
of	O
scientists	O
called	O
for	O
a	O
global	O
moratorium	O
on	O
genetically	O
editing	O
human	O
embryos	O
.	O

For	O
example	O
,	O
images	O
of	O
the	O
brain	O
are	O
commonly	O
viewed	O
with	O
a	O
window	O
extending	O
from	O
0	O
HU	O
to	O
80	O
HU	O
.	O

In	O
a	O
report	O
released	O
in	O
August	O
2014	O
,	O
researchers	O
tracked	O
the	O
spread	O
of	O
Ebola	S-Disease
in	O
Sierra	B-Location
Leone	E-Location
from	O
the	O
group	O
first	O
infected-13	O
women	O
who	O
had	O
attended	O
the	O
funeral	O
of	O
the	O
traditional	O
healer	O
,	O
where	O
they	O
contracted	O
the	O
disease-giving	O
them	O
a	O
unique	O
opportunity	O
to	O
track	O
how	O
the	O
virus	O
had	O
changed	O
.	O

Chemical	O
transfection	O
techniques	O
utilizing	O
lipids	O
have	O
also	O
been	O
used	O
to	O
introduce	O
sgRNAs	O
in	O
complex	O
with	O
Cas9	O
into	O
cells	O
.	O

In	O
addition	O
,	O
forensic	O
technologies	O
are	O
working	O
on	O
identifying	O
biological	O
agents	O
,	O
their	O
geographical	O
origins	O
and/or	O
their	O
initial	O
source	O
.	O

,	O
cases	O
have	O
been	O
reported	O
in	O
all	O
Asian	O
countries	O
except	O
for	O
Turkmenistan	S-Location
and	O
North	B-Location
Korea	E-Location
,	O
although	O
these	O
countries	O
likely	O
also	O
have	O
cases	O
.	O

The	O
combination	O
of	O
atovaquone	S-Drug
proguanil	S-Drug
and	O
in	O
subdermal	O
implant	O
form	O
will	O
be	O
tested	O
for	O
long-term	O
prophylactic	O
efficacy	O
to	O
replace	O
the	O
current	O
orally	O
administered	O
drug	O
regimens	O
.	O

WHO	S-Organization
established	O
a	O
network	O
of	O
consultants	O
who	O
assisted	O
countries	O
in	O
setting	O
up	O
surveillance	O
and	O
containment	O
activities	O
.	O

The	O
incident	O
originated	O
when	O
a	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
(	O
BSL3	S-Platform
)	O
laboratory	O
at	O
CDC	S-Organization
prepared	O
B.	B-Pathogen
anthracis	E-Pathogen
samples	O
for	O
use	O
at	O
lower	O
biosafety	O
levels	O
(i.e.	O
,	O
BSL	B-Platform
2	E-Platform
)	O
in	O
other	O
CDC	S-Organization
labs	O
where	O
live	O
bacteria	O
are	O
not	O
required	O
for	O
the	O
research	O
.	O

Forty‐eight	O
hours	O
postinfection	O
(lab3	O
,	O
Table	O
1)	O
,	O
students	O
fix	O
the	O
cells	O
and	O
stain	O
them	O
by	O
adding	O
X‐gal	O
.	O

Secret	O
agents	O
waged	O
this	O
campaign	O
in	O
Romania	S-Location
and	O
the	O
U.S.	S-Location
from	O
1915-1916	O
,	O
in	O
Argentina	S-Location
from	O
roughly	O
1916-1918	O
,	O
and	O
in	O
Spain	S-Location
and	O
(dates	O
and	O
details	O
are	O
obscure)	O
.	O

The	O
second	O
and	O
third	O
labs	O
focus	O
on	O
working	O
with	O
animal	O
viruses	O
,	O
including	O
cell	O
infection	O
and	O
viral	O
quantification	O
in	O
cell	O
cultures	O
.	O

Frieden	S-Person
.	O
You	O
and	O
I	O
have	O
known	O
each	O
other	O
for	O
a	O
long	O
time	O
.	O

"	O
Congress	O
and	O
the	O
president	O
are	O
ignoring	O
the	O
science	O
that	O
tells	O
us	O
this	O
research	O
facility	O
is	O
an	O
accident	O
waiting	O
to	O
happen,''	O
said	O
Mike	B-Person
Schultz	E-Person

All	O
inactivation	O
procedures	O
for	O
laboratories	O
working	O
with	O
select	O
agents	O
and	O
other	O
dangerous	O
pathogens	O
throughout	O
CDC	S-Organization
are	O
being	O
carefully	O
reviewed	O
and	O
will	O
be	O
updated	O
as	O
needed	O
.	O

Despite	O
these	O
gains	O
,	O
support	O
and	O
funding	O
for	O
these	O
programs	O
may	O
not	O
be	O
keeping	O
pace	O
with	O
an	O
intensifying	O
threat	O
,	O
Adalja	S-Person
said	O
.	O

From	O
these	O
discussions	O
emerged	O
a	O
priority	O
list	O
of	O
steps	O
that	O
need	O
to	O
be	O
taken	O
to	O
resolve	O
this	O
global	O
crisis	O
.	O

This	O
practice	O
has	O
been	O
ongoing	O
since	O
the	O
1950s	O
,	O
despite	O
efforts	O
to	O
prevent	O
such	O
non-prescription	O
use	O
by	O
regulatory	O
authorities	O
,	O
such	O
as	O
the	O
UN	S-Organization
and	O
.	O
Is	O
there	O
convincing	O
evidence	O
that	O
these	O
supplements	O
are	O
of	O
use	O
when	O
good	O
animal	O
husbandry	O
is	O
common	O
practice?	O
Appropriate	O
treatment	O
for	O
sick	O
animals	O
must	O
,	O
of	O
course	O
,	O
be	O
maintained	O
.	O

At	O
the	O
end	O
of	O
each	O
project	O
,	O
a	O
report	O
is	O
printed	O
and	O
made	O
available	O
as	O
a	O
PDF	O
on	O
the	O
web	O
page	O
of	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
with	O
a	O
summary	O
in	O
English	O
.	O

OPERATOR:	O
Next	O
question	O
comes	O
from	O
Eben	B-Person
Brown	E-Person
with	O
.	O
Go	O
ahead	O
with	O
your	O
question	O
.	O

Making	O
data	O
citable	O
via	O
DOIs	O
is	O
promoted	O
by	O
the	O
DataCite	S-Organization
organization	O
and	O
now	O
has	O
been	O
used	O
in	O
a	O
few	O
initial	O
cases	O
.	O

Shortly	O
thereafter	O
,	O
Tuberculosis	O
Control	O
was	O
transferred	O
(in	O
1960)	O
to	O
the	O
CDC	S-Organization
from	O
,	O
and	O
then	O
in	O
1963	O
the	O
Immunization	O
program	O
was	O
established	O
.	O

Thus	O
,	O
the	O
Nixon	S-Person
administration	O
became	O
the	O
world's	O
leading	O
anti-biological	O
weapons	O
voice	O
calling	O
for	O
an	O
international	O
treaty	O
.	O

Around	O
the	O
same	O
time	O
,	O
fresh	O
raw	O
materials	O
began	O
to	O
arrive	O
from	O
contract	O
manufacturers	O
reactivated	O
by	O
in	O
January	O
.	O

The	O
mission	O
of	O
CDC	S-Organization
expanded	O
beyond	O
its	O
original	O
focus	O
on	O
malaria	O
to	O
include	O
sexually	O
transmitted	O
diseases	O
when	O
the	O
Venereal	O
Disease	O
Division	O
of	O
the	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
(	O
PHS	S-Organization
)	O
was	O
transferred	O
to	O
the	O
in	O
1957	O
.	O

However	O
,	O
no	O
conclusive	O
evidence	O
of	O
exactly	O
how	O
the	O
virus	O
"	O
jumped"	O
to	O
humans	O
has	O
ever	O
been	O
provided	O
,	O
which	O
raises	O
suspicions	O
of	O
intentional	O
and	O
not	O
natural	O
infection	O
.	O

Takeda	B-Organization
Pharmaceutical	I-Organization
Company	I-Organization
Limited	E-Organization
announced	O
Monday	O
that	O
the	O
U.S.	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
has	O
granted	O
Fast	O
Track	O
designation	O
to	O
TAK-426	S-Drug
,	O
Takeda	S-Organization
's	O
purified	O
,	O
inactivated	O
,	O
alum-adjuvanted	O
,	O
whole	O
candidate	O
.	O

Throughout	O
that	O
decade	O
,	O
influenza	B-Disease
A	I-Disease
(H3N2)	E-Disease
was	O
the	O
predominant	O
virus	O
during	O
most	O
of	O
the	O
seasons	O
,	O
and	O
H3N2	B-Pathogen
influenza	I-Pathogen
viruses	E-Pathogen
are	O
typically	O
associated	O
with	O
higher	O
death	O
rates	O
.	O

Harmonized	O
,	O
quality-assured	O
,	O
up-to-date	O
diagnostic	O
methods	O
have	O
been	O
a	O
key	O
factor	O
in	O
enabling	O
cooperation	O
in	O
the	O
network	O
.	O

In	O
addition	O
to	O
the	O
accusations	O
of	O
propaganda	O
,	O
the	O
US	S-Location
also	O
asserted	O
that	O
the	O
trials	O
were	O
to	O
only	O
serve	O
as	O
a	O
distraction	O
from	O
the	O
Soviet	S-Organization
treatment	O
of	O
several	O
hundred	O
thousand	O
Japanese	O
prisoners	O
of	O
war	O
;	O
meanwhile	O
,	O
the	O
USSR	S-Organization
asserted	O
that	O
the	O
had	O
given	O
the	O
Japanese	O
diplomatic	O
leniency	O
in	O
exchange	O
for	O
information	O
regarding	O
their	O
human	O
experimentation	O
.	O

It	O
tested	O
several	O
delivery	O
systems	O
including	O
aerial	O
spray	O
tanks	O
and	O
drone	O
aircraft	O
.	O

In	O
late	O
2019	O
,	O
the	O
WHO	S-Organization
assigned	O
emergency	O
ICD-10	O
disease	O
codes	O
U07.	O
1	O
for	O
deaths	O
from	O
lab-confirmed	O
SARS-CoV-2	B-Disease
infection	E-Disease
and	O
U07.	O
2	O
for	O
deaths	O
from	O
clinically	O
or	O
epidemiologically	O
diagnosed	O
COVID‑19	S-Disease
without	O
lab-confirmed	O
infection	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	S-Organization
established	O
an	O
External	O
Laboratory	O
Safety	O
Workgroup	O
()	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
Federal	O
Select	O
Agent	O
Program	O
.	O

United	B-Organization
States.	I-Organization
Congress.	I-Organization
House.	I-Organization
Committee	I-Organization
on	I-Organization
Armed	I-Organization
Services.	I-Organization
Subcommittee	I-Organization
on	I-Organization
Intelligence	E-Organization
,	O
Emerging	O
Threats	O
and	O
Capabilities.	O
(11	O
October	O
2013)	O
.	O

Established	O
a	O
high-level	O
working	O
group	O
,	O
reporting	O
to	O
the	O
CDC	S-Organization
Director	O
,	O
to	O
,	O
among	O
other	O
duties	O
,	O
accelerate	O
improvements	O
in	O
laboratory	O
safety	O
,	O
review	O
and	O
approve	O
,	O
on	O
a	O
laboratory-by-laboratory	O
basis	O
,	O
resumed	O
transfer	O
of	O
biological	O
materials	O
outside	O
of	O
BSL3	S-Platform
and	O
BSL4	S-Platform
laboratories	O
,	O
and	O
serve	O
as	O
the	O
transition	O
group	O
for	O
the	O
single	O
point	O
of	O
accountability	O
on	O
laboratory	O
safety	O
called	O
for	O
in	O
the	O
review	O
of	O
the	O
potential	O
exposure	O
to	O
incident	O
.	O

On	O
20	O
September	O
2019	O
it	O
was	O
reported	O
that	O
a	O
second	O
vaccine	O
by	O
Johnson	B-Organization
&amp;	I-Organization
Joh	E-Organization
would	O
be	O
introduced	O
in	O
the	O
curr	O
ent	S-Disease
EVD	O
epidemic	O
in	O
DRC	O
.	O

The	O
Cuban	B-Organization
government	E-Organization
blamed	O
the	O
U.S.	S-Location
for	O
a	O
1981	B-Incident
outbreak	I-Incident
of	I-Incident
dengue	I-Incident
fever	E-Incident
that	O
sickened	O
more	O
than	O
300,000	O
.	O

"	O
Island	O
731	O
"	O
written	O
by	O
Jeremy	B-Person
Robinson	E-Person

According	O
to	O
guidelines	O
released	O
by	O
the	O
CDC	S-Organization
in	O
August	O
2015	O
,	O
updates	O
were	O
put	O
in	O
place	O
to	O
improve	O
the	O
doffing	O
method	O
to	O
make	O
the	O
steps	O
easier	O
,	O
and	O
affirm	O
the	O
importance	O
of	O
cleaning	O
the	O
floor	O
where	O
doffing	O
has	O
been	O
done	O
.	O

These	O
virus	O
strains	O
had	O
undergone	O
major	O
genetic	O
changes	O
for	O
which	O
the	O
population	O
did	O
not	O
possess	O
significant	O
immunity	O
.	O

CARITAS	B-Organization
DRC	E-Organization
CARE	B-Organization
International	E-Organization
,	O
Cooperazione	B-Organization
Internationale	E-Organization
(	O
COOPE	S-Organization
)	O
,	O
Catholic	B-Organization
Organization	I-Organization
for	I-Organization
Relief	I-Organization
and	I-Organization
Development	I-Organization
Aid	E-Organization
(	O
CORDAID/PAP-DRC	S-Organization
)	O
,	O
International	B-Organization
Rescue	I-Organization
Committee	E-Organization
(	O
IRC	S-Organization
)	O
,	O
Médecins	B-Organization
Sans	I-Organization
Frontières	E-Organization
(	O
MSF	S-Organization
)	O
,	O
Oxfam	S-Organization
,	O
International	B-Organization
Federation	I-Organization
of	I-Organization
Red	I-Organization
Cross	I-Organization
and	I-Organization
Red	I-Organization
Crescent	I-Organization
Societies	E-Organization
(	O
IFRC	S-Organization
)	O
,	O
International	B-Organization
Committee	I-Organization
of	I-Organization
the	I-Organization
Red	I-Organization
Cross	E-Organization
(	O
ICRC	S-Organization
)	O
,	O
and	O
.	O

Fit	O
test	O
must	O
be	O
done	O
for	O
all	O
staffs	O
that	O
use	O
the	O
N95	B-Equipment
mask	E-Equipment
.	O
When	O
leaving	O
the	O
BSL-3	S-Platform
lab	O
,	O
staff	O
should	O
remove	O
the	O
disposable	B-Equipment
waterproof	I-Equipment
clothing	E-Equipment
and	O
replace	O
the	O
within	O
the	O
core	O
area	O
.	O

The	O
same	O
year	O
,	O
operational	O
portions	O
of	O
the	O
facilities	O
at	O
Salman	B-Location
Pak	E-Location
and	O
Al	B-Location
Manal	E-Location
were	O
also	O
supposedly	O
destroyed	O
,	O
either	O
by	O
the	O
Iraqis	O
themselves	O
or	O
under	O
direct	O
supervision	O
.	O

The	O
Rhodesians	O
also	O
experimented	O
with	O
several	O
other	O
pathogens	O
and	O
toxins	O
for	O
use	O
in	O
their	O
counterinsurgency	O
.	O

Zayner	S-Person
the	O
biohacker	O
who	O
once	O
injected	O
himself	O
with	O
CRISPR	S-Technology
DNA	O
,	O
has	O
also	O
had	O
health	O
problems	O
for	O
years	O
,	O
and	O
some	O
of	O
his	O
biohacking	O
pursuits	O
have	O
been	O
explicit	O
attempts	O
to	O
cure	O
himself	O
.	O

Do	O
you	O
need	O
to	O
seek	O
more	O
,	O
you	O
know	O
,	O
third-party	O
oversight?	O
Could	O
you	O
just	O
talk	O
a	O
little	O
bit	O
about	O
that?	O

Annual	O
influenza	O
epidemics	O
are	O
estimated	O
to	O
affect	O
5–15%	O
of	O
the	O
global	O
population	O
.	O

The	O
mechanism	O
involves	O
the	O
binding	O
of	O
the	O
ribosomal	O
protection	O
proteins	O
to	O
the	O
ribosomes	O
of	O
the	O
bacterial	O
cell	O
,	O
which	O
in	O
turn	O
changes	O
its	O
conformational	O
shape	O
.	O

To	O
evaluate	O
's	O
performance	O
with	O
data	O
from	O
noninvasive	O
devices	O
,	O
which	O
would	O
be	O
practical	O
for	O
clinicians	O
and	O
public	O
health	O
workers	O
to	O
use	O
,	O
the	O
researchers	O
conducted	O
a	O
computer	O
simulation	O
using	O
a	O
dataset	O
that	O
included	O
only	O
ECG-derived	O
features	O
,	O
such	O
as	O
the	O
time	O
intervals	O
between	O
certain	O
peaks	O
of	O
the	O
ECG	O
waveform	O
.	O

They	O
probably	O
also	O
circulated	O
continuously	O
in	O
humans	O
,	O
undergoing	O
gradual	O
antigenic	O
drift	O
and	O
causing	O
annual	O
epidemics	O
,	O
until	O
the	O
1950s	O
.	O

Third	O
,	O
the	O
general	O
issue	O
of	O
inactivation	O
,	O
how	O
do	O
you	O
kill	O
bacteria	O
or	O
viruses	O
before	O
you	O
transfer	O
them	O
out	O
,	O
that	O
procedure	O
will	O
be	O
looked	O
at	O
every	O
laboratory	O
that	O
works	O
on	O
not	O
just	O
select	O
agents	O
but	O
any	O
dangerous	O
pathogen	O
at	O
CDC	S-Organization
and	O
if	O
needed	O
,	O
we	O
will	O
improve	O
it	O
.	O

The	O
studies	O
of	O
chloroquine	S-Drug
and	O
hydroxychloroquine	S-Drug
with	O
or	O
without	O
have	O
major	O
limitations	O
that	O
have	O
prevented	O
the	O
medical	O
community	O
from	O
embracing	O
these	O
therapies	O
without	O
further	O
study	O
.	O

Briefly	O
,	O
samples	O
from	O
patients	O
suspected	O
to	O
have	O
EVD	S-Disease
were	O
transferred	O
into	O
the	O
BSL-3	S-Platform
lab	O
in	O
a	O
specimen	O
container	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
,	O
after	O
decontamination	O
of	O
the	O
outside	O
of	O
the	O
container	O
with	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
.	O

For	O
example	O
,	O
six	O
separate	O
UNEP	S-Organization
-funded	O
biosafety	O
and	O
biosecurity	O
awareness	O
initiatives	O
were	O
recorded	O
from	O
individual	O
countries	O
between	O
January	O
2002	O
and	O
December	O
2003	O
,	O
including	O
Algeria	S-Location
,	O
Iraq	S-Location
,	O
Iran	S-Location
,	O
Turkey	S-Location
,	O
Egypt	S-Location
,	O
and	O
.	O
Such	O
duplication	O
can	O
best	O
be	O
avoided	O
in	O
the	O
future	O
by	O
working	O
more	O
closely	O
with	O
regional	O
groups	O
in	O
order	O
to	O
coordinate	O
efforts	O
and	O
focus	O
on	O
regional	O
needs	O
.	O

Recently	O
the	O
virus	O
has	O
been	O
reconstructed	O
from	O
the	O
tissue	O
of	O
a	O
dead	O
soldier	O
and	O
is	O
now	O
being	O
genetically	O
characterized	O
.	O

In	O
response	O
the	O
NAS	S-Organization
formed	O
a	O
committee	O
,	O
the	O
War	B-Document
Bureau	I-Document
of	I-Document
Consultants	E-Document
()	O
,	O
which	O
issued	O
a	O
report	O
on	O
the	O
subject	O
in	O
February	O
1942	O
.	O

Officials	O
and	O
investigators	O
from	O
a	O
number	O
of	O
different	O
state	O
and	O
federal	O
agencies	O
investigated	O
the	O
outbreak	O
.	O

In	O
Iran	S-Location
the	O
mortality	O
was	O
very	O
high:	O
according	O
to	O
an	O
estimate	O
,	O
between	O
902,400	O
and	O
2,431,000	O
,	O
or	O
8%	O
to	O
22%	O
of	O
the	O
total	O
population	O
died	O
.	O

Also	O
,	O
in	O
1918	O
those	O
5	O
to	O
14	O
years	O
of	O
age	O
accounted	O
for	O
a	O
disproportionate	O
number	O
of	B-Disease
influe	E-Disease
nza	O
cases	O
,	O
but	O
had	O
a	O
much	O
lower	O
death	O
rate	O
fr	O
om	B-Disease
influe	E-Disease
nza	O
ania	O
than	O
other	O
age	O
groups	O
.	O

Recently	O
,	O
the	O
US	B-Organization
Center	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
tracked	O
multistate	B-Incident
Salmonella	I-Incident
Heidelberg	I-Incident
infections	E-Incident
associated	O
with	O
contaminated	O
ground	O
turkey	O
that	O
sickened	O
more	O
than	O
130	O
people	O
in	O
32	O
different	O
states	O
.	O

One	O
theory	O
speculated	O
that	O
the	O
virus	O
was	O
spread	O
by	O
airborne	O
transmission	O
,	O
through	O
dried	O
up	O
U-shaped	O
P-traps	O
in	O
the	O
drainage	O
system	O
which	O
a	O
maritime	O
breeze	O
blew	O
into	O
the	O
estate's	O
balconies	O
and	O
stairwell	O
ventilation	O
.	O

As	O
the	O
alveolar	O
disease	O
progresses	O
,	O
respiratory	O
failure	O
might	O
develop	O
and	O
death	O
may	O
follow	O
.	O

Several	O
of	O
the	O
staff	O
at	O
the	O
laboratory	O
had	O
received	O
no	O
special	O
training	O
.	O

A	O
study	O
published	O
in	O
May	O
2015	O
discussed	O
the	O
case	O
of	O
Ian	B-Person
Crozier	E-Person
a	O
Zimbabwe	S-Location
-born	O
physician	O
and	O
American	O
citizen	O
who	O
became	O
infected	O
with	O
Ebola	S-Disease
while	O
he	O
was	O
working	O
at	O
an	O
Ebola	S-Disease
treatment	O
centre	O
in	O
Sierra	B-Location
Leone	E-Location
.	O
He	O
was	O
transported	O
to	O
the	O
US	S-Location
and	O
successfully	O
treated	O
at	O
Emory	B-Organization
University	I-Organization
Hospital	E-Organization
.	O
However	O
,	O
after	O
discharge	O
Crozier	S-Person
began	O
to	O
experience	O
symptoms	O
including	O
low	B-Phenotype
back	I-Phenotype
pain	E-Phenotype
,	O
bilateral	B-Phenotype
enthesitis	I-Phenotype
of	I-Phenotype
the	I-Phenotype
Achilles	I-Phenotype
tendon	E-Phenotype
,	O
paresthesias	S-Phenotype
involving	O
his	O
lower	O
legs	O
,	O
and	O
eye	B-Phenotype
pain	E-Phenotype
,	O
which	O
was	O
diagnosed	O
as	O
uveitis	S-Disease
.	O
His	O
eye	O
condition	O
worsened	O
and	O
a	O
specimen	O
of	O
aqueous	O
humor	O
obtained	O
from	O
his	O
eye	O
tested	O
positive	O
for	O
Ebola	S-Disease
.	O
The	O
authors	O
of	O
the	O
study	O
concluded	O
that	O
"	O
further	O
studies	O
to	O
investigate	O
the	O
mechanisms	O
responsible	O
for	O
the	O
ocular	O
persistence	O
of	O
and	O
the	O
possible	O
presence	O
of	O
the	O
virus	O
in	O
other	O
immune-privileged	O
sites	O
(e.g.	O
,	O
in	O
the	O
central	O
nervous	O
system	O
,	O
gonads	O
,	O
and	O
articular	O
cartilage)	O
are	O
warranted.	O
"	O

In	O
an	O
increasingly	O
populated	O
world	O
with	O
less	O
than	O
ever	O
resources	O
to	O
support	O
the	O
basic	O
needs	O
for	O
the	O
population	O
,	O
genome	B-Technology
editing	E-Technology
can	O
offer	O
increased	O
production	O
of	O
food	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
has	O
completed	O
additional	O
work	O
to	O
further	O
define	O
the	O
risk	O
of	O
anthrax	S-Pathogen
for	O
employees	O
potentially	O
exposed	O
because	O
best	O
safety	O
practices	O
were	O
not	O
followed	O
in	O
one	O
of	O
its	O
laboratories	O
in	O
early	O
June	O
.	O

They	O
created	O
a	O
living	O
photograph	O
using	O
engineered	O
bacteria	O
.	O

This	O
provided	O
"	O
the	O
first	O
time	O
that	O
the	O
real	O
evolution	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
[could]	O
be	O
observed	O
in	O
humans.	O
"	O
The	O
research	O
showed	O
that	O
the	O
outbreak	B-Incident
in	I-Incident
Sierra	I-Incident
Leone	E-Incident
was	O
sparked	O
by	O
at	O
least	O
two	O
distinct	O
lineages	O
introduced	O
from	O
Guinea	S-Location
at	O
about	O
the	O
same	O
time	O
.	O

An	O
accidental	O
release	O
of	O
an	O
infectious	O
disease	O
capable	O
of	O
devastating	O
agriculture	O
could	O
be	O
better	O
controlled	O
in	O
much-more	O
isolated	O
Plum	B-Location
Island	E-Location
than	O
in	O
the	O
college	O
town	O
of	O
Manhattan.	B-Location
Kansas	I-Location
State	E-Location
is	O
free	O
to	O
brag	O
that	O
it	O
is	O
the	O
"	O
''	O
for	O
biodefense	O
all	O
it	O
wants	O
,	O
but	O
it's	O
too	O
risky	O
to	O
move	O
the	O
federal	O
center	O
there	O
.	O

Environmental	O
risk	O
factors	O
,	O
such	O
as	O
air	O
,	O
water	O
and	O
soil	O
pollution	O
,	O
chemical	O
exposures	O
,	O
climate	O
change	O
,	O
and	O
ultraviolet	O
radiation	O
,	O
contribute	O
to	O
more	O
than	O
100	O
diseases	O
and	O
injuries	O
.	O

It	O
was	O
later	O
established	O
that	O
a	O
number	O
of	O
family	O
members	O
had	O
also	O
died	O
of	O
Ebola	S-Disease
.	O
The	O
family	O
had	O
returned	O
to	O
after	O
the	O
father's	O
funeral	O
via	O
public	O
bus	O
and	O
taxi-a	O
journey	O
of	O
more	O
than	O
.	O
All	O
contacts	O
were	O
followed	O
for	O
21 days	O
,	O
with	O
no	O
further	O
spread	O
of	O
the	O
disease	O
reported	O
.	O

I'll	O
end	O
today's	O
briefing	O
by	O
reiterating	O
an	O
important	O
point	O
I	O
started	O
with	O
.	O

Dry-type	O
biologicals	O
resemble	O
talcum	O
powder	O
,	O
and	O
can	O
be	O
disseminated	O
as	O
aerosols	O
using	O
gas	O
expulsion	O
devices	O
instead	O
of	O
a	O
burster	O
or	O
complex	O
sprayer	O
.	O

In	O
order	O
to	O
make	O
Ebola	S-Disease
into	O
a	O
biological	O
weapon	O
,	O
a	O
terrorist	O
organization	O
would	O
need	O
to	O
first	O
obtain	O
a	O
live	O
host	O
infected	O
with	O
the	O
virus	O
,	O
either	O
a	O
human	O
or	O
an	O
animal	O
.	O

The	O
agency	O
will	O
work	O
with	O
external	O
bioethics	O
advisors	O
to	O
ensure	O
efforts	O
funded	O
by	O
the	O
program	O
adhere	O
to	O
regulations	O
and	O
ethical	O
best	O
practices	O
.	O

CAUTION:	O
&lt;organism	O
name&gt	O
;	O
is	B-Platform
a	I-Platform
Biosafety	I-Platform
L	E-Platform
pathogen	O
.	O

Due	O
to	O
various	O
situations	O
surrounding	O
the	O
current	O
EVD	S-Disease
outbreak	O
,	O
indicated	O
on	O
13	O
November	O
,	O
that	O
the	O
viral	O
outbreak	O
would	O
last	O
at	O
least	O
six	O
months	O
.	O

Vaccination	O
usually	O
bars	O
the	O
crippling	O
illness	O
.	O

Kwik	S-Person

Between	O
1993	O
and	O
1995	O
,	O
Aum	O
Shinrikyo	O
tried	O
as	O
many	O
as	O
10	O
times	O
to	O
spray	O
botulinum	B-Pathogen
toxin	E-Pathogen
and	O
anthrax	S-Pathogen
in	O
downtown	O
.	O

In	O
the	O
summer	O
of	O
2017	O
60	O
people	O
with	O
Hepatitis	B-Disease
A	E-Disease
were	O
admitted	O
to	O
hospital	O
in	O
the	O
city	O
of	O
,	O
the	O
cause	O
of	O
this	O
outbreak	O
is	O
still	O
unknown	O
.	O

In	O
the	O
,	O
they	O
are	O
seated	O
alongside	O
the	O
other	O
NGOs	O
.	O

In	O
a	O
study	O
by	O
the	O
National	B-Organization
Health	I-Organization
Commission	E-Organization
(	O
NHC	S-Organization
)	O
of	O
China	S-Location
,	O
men	O
had	O
a	O
death	O
rate	O
of	O
2.	O
8%	O
while	O
women	O
had	O
a	O
death	O
rate	O
of	O
1.7%	O
.	O

Here	O
it	O
takes	O
20–25	O
minutes	O
to	O
take	O
off	O
a	O
protective	B-Equipment
suit	E-Equipment
and	O
must	O
be	O
done	O
with	O
two	O
trained	O
supervisors	O
who	O
watch	O
every	O
step	O
in	O
a	O
military	O
manner	O
to	O
ensure	O
no	O
mistakes	O
are	O
made	O
,	O
because	O
a	O
slip	O
up	O
can	O
easily	O
occur	O
and	O
of	O
course	O
can	O
be	O
fatal.	O
"	O
By	O
October	O
,	O
there	O
were	O
reports	O
that	O
were	O
beginning	O
to	O
be	O
in	O
short	O
supply	O
and	O
manufacturers	O
began	O
to	O
increase	O
their	O
production	O
,	O
but	O
the	O
need	O
to	O
find	O
better	O
types	O
of	O
suits	O
has	O
also	O
been	O
raised	O
.	O

The	O
name	O
of	O
Spanish	B-Disease
Flu	E-Disease
came	O
from	O
the	O
early	O
affliction	O
and	O
large	O
mortalities	O
in	O
Spain	S-Location
(	O
BMJ	S-Organization
,10/19/1918)	O
where	O
it	O
allegedly	O
killed	O
8	O
million	O
in	O
May	O
(	O
BMJ	S-Organization
,	O
7/13/1918)	O
.	O

Forty-five	O
people	O
received	O
hospital	O
treatment	O
;	O
all	O
survived	O
.	O

The	O
classifies	O
them	O
as	O
a	O
Category	O
A	O
agent:	O
one	O
that	O
poses	O
the	O
greatest	O
possible	O
threat	O
for	O
a	O
negative	O
impact	O
on	O
public	O
health	O
,	O
one	O
that	O
may	O
spread	O
across	O
a	O
large	O
area	O
or	O
need	O
public	O
awareness	O
and	O
requires	O
planning	O
to	O
protect	O
the	O
public's	O
health	O
.	O

His	O
testimony	O
tied	O
the	O
Noborito	B-Organization
Institute	E-Organization
to	O
the	O
infamous	O
,	O
which	O
participated	O
in	O
biomedical	O
research	O
.	O

Safety	O
officials	O
found	O
its	O
latch	O
was	O
broken	O
-	O
as	O
were	O
those	O
on	O
about	O
30%	O
of	O
the	O
barrels	O
,	O
records	O
say	O
.	O

The	O
first	O
smallpox	S-Pathogen
weapons	O
factory	O
in	O
the	O
Soviet	B-Location
Union	E-Location
was	O
established	O
in	O
1947	O
in	O
the	O
city	O
of	O
Zagorsk	S-Location
,	O
close	O
to	O
Moscow	S-Location
.	O
It	O
was	O
produced	O
by	O
injecting	O
small	O
amounts	O
of	O
the	O
virus	O
into	O
chicken	O
eggs	O
.	O

As	O
terminology	O
changed	O
to	O
deal	O
with	O
these	O
and	O
other	O
such	O
issues	O
,	O
further	O
criticism	O
was	O
made	O
that	O
the	O
situation	O
was	O
unnecessarily	O
confusing	O
.	O

Williams,	B-Person
Peter	E-Person
,	O
and	O
Wallace,	B-Person
David	E-Person
(1989).	O
.	O

Beyond	O
Guinea	S-Location
,	O
Liberia	S-Location
,	O
and	O
Sierra	B-Location
Leone	E-Location
–	O
the	O
three	O
most	O
impacted	O
countries	O
–	O
Ebola	S-Disease
spread	O
to	O
Mali	S-Location
,	O
Nigeria	S-Location
,	O
Senegal	S-Location
,	O
Spain	S-Location
,	O
the	O
,	O
and	O
of	O
course	O
,	O
our	O
own	O
country	O
.	O

In	O
the	O
most	O
common	O
hoax	O
scenario	O
,	O
no	O
biological	O
agents	O
are	O
employed	O
.	O

Per	O
media	O
reports	O
on	O
1April	O
,	O
has	O
received	O
requests	O
for	O
virus	O
testing	O
assistance	O
from	O
121	O
different	O
countries	O
.	O

Additionally	O
,	O
an	O
estimated	O
10	O
to	O
26	O
cases	O
had	O
prevented	O
fatality	O
through	O
treatment	O
supplied	O
to	O
over	O
30,000	O
individuals	O
.	O

The	O
CDC	S-Organization
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
and	O
diabetes	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
International	O
Association	O
of	O
National	O
Public	O
Health	O
Institutes	O
.	O

This	O
indicated	O
a	O
decline	O
in	O
the	O
Liberian	O
national	O
economy	O
during	O
the	O
outbreak	O
,	O
as	O
well	O
as	O
an	O
indication	O
that	O
the	O
county	B-Location
of	I-Location
Montserrado	E-Location
was	O
hardest	O
hit	O
economically	O
.	O

Also	O
,	O
there	O
appears	O
to	O
be	O
a	O
link	O
between	O
severe	O
A/H1N1	B-Disease
influenza	E-Disease
infection	O
and	O
pulmonary	B-Disease
embolism	E-Disease
.	O
In	O
one	O
report	O
,	O
five	O
out	O
of	O
14	O
patients	O
admitted	O
to	O
the	O
intensive	O
care	O
unit	O
with	O
severe	O
A/H1N1	B-Disease
infection	E-Disease
were	O
found	O
to	O
have	O
.	O

The	O
cost	O
of	O
the	O
undertaking	O
that	O
we	O
propose	O
will	O
be	O
infinitesimally	O
small	O
in	O
comparison	O
to	O
the	O
economic	O
and	O
human	O
cost	O
of	O
doing	O
nothing	O
.	O

Because	O
of	O
the	O
dangers	O
that	O
might	O
confront	O
this	O
country	O
from	O
potential	O
enemies	O
employing	O
what	O
may	O
be	O
broadly	O
described	O
as	O
biological	O
warfare	O
,	O
it	O
seems	O
advisable	O
that	O
investigations	O
be	O
initiated	O
to	O
survey	O
the	O
present	O
situation	O
and	O
the	O
future	O
possibilities	O
.	O

The	O
figure	O
to	O
the	O
right	O
is	O
one	O
of	O
the	O
synthesis	O
routes	O
of	O
remdesivir	S-Drug
invented	O
by	O
Chun	S-Person
and	O
coauthors	O
from	O
.	O
In	O
this	O
method	O
,	O
intermediate	O
a	O
is	O
firstly	O
prepared	O
from	O
L-alanine	O
and	O
phenyl	O
phosphorodichloridate	O
in	O
presence	O
of	O
triethylamine	O
and	O
dichloromethane	O
;	O
triple	O
benzyl-protected	O
ribose	O
is	O
oxidized	O
by	O
dimethyl	O
sulfoxide	O
with	O
acetic	O
anhydride	O
and	O
give	O
the	O
lactone	O
intermediate	O
b	O
;	O
pyrrolo[2,1-f]	O
[1,2,4]triazin-4-amine	O
is	O
brominated	O
,	O
and	O
the	O
amine	O
group	O
is	O
protected	O
by	O
excess	O
trimethylsilyl	O
chloride.	O
n-Butyllithium	O
undergoes	O
a	O
halogen-lithium	O
exchange	O
reaction	O
with	O
the	O
bromide	O
at	O
to	O
yield	O
the	O
intermediate	O
c	O
.	O

It	O
can	O
be	O
used	O
to	O
assess	O
the	O
structure	O
and	O
the	O
function	O
of	O
the	O
heart	O
.	O

The	O
Flettner	O
rotor	O
was	O
called	O
,	O
"	O
probably	O
one	O
of	O
the	O
better	O
devices	O
for	O
disseminating	O
microorganisms"	O
,	O
by	O
William	B-Person
C.	I-Person
Patrick	I-Person
III	E-Person
.	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
,	O
Office	B-Organization
of	I-Organization
Emergency	I-Organization
Preparedness	E-Organization
,	O
"	O
Proceedings	B-Document
of	I-Document
the	I-Document
Seminar	I-Document
Responding	I-Document
to	I-Document
the	I-Document
Consequences	I-Document
of	I-Document
Chemical	I-Document
and	I-Document
Biological	I-Document
Terrorism	E-Document
"	O
,	O
Uniformed	B-Organization
Services	I-Organization
University	I-Organization
of	I-Organization
Health	I-Organization
Sciences	E-Organization
,	O
,	O
Md	O
;	O
July	O
11–14	O
,	O
1995	O
,	O
p.	O
70	O
,	O
via	O
LSU	O
Law	O
Center's	O
Medical	O
and	O
Public	O
Health	O
Law	O
Site	O
.	O

While	O
modern	O
biotechnology	O
solutions	O
to	O
society's	O
problems	O
seem	O
much	O
more	O
sophisticated	O
than	O
airdropping	O
amphibians	O
into	O
Australia	S-Location
this	O
story	O
should	O
serve	O
as	O
a	O
cautionary	O
tale	O
.	O

This	O
can	O
result	O
in	O
a	O
number	O
of	O
pollution-related	O
diseases	O
.	O

Additional	O
testing	O
of	O
the	O
is	O
under	O
way	O
to	O
determine	O
if	O
the	O
material	O
in	O
the	O
vials	O
is	O
viable	O
(i.e.	O
,	O
can	O
grow	O
in	O
tissue	O
culture)	O
.	O

The	O
use	O
of	O
the	O
term	O
"	O
social	O
distancing	O
"	O
had	O
led	O
to	O
implications	O
that	O
people	O
should	O
engage	O
in	O
complete	O
social	O
isolation	O
,	O
rather	O
than	O
encouraging	O
them	O
to	O
stay	O
in	O
contact	O
through	O
alternative	O
means	O
.	O

An	O
envelope	O
that	O
tested	O
positive	O
for	O
the	O
deadly	O
poison	O
ricin	S-Pathogen
was	O
intercepted	O
Tuesday	O
afternoon	O
at	O
the	O
U.S.	B-Organization
Capitol's	I-Organization
off-site	I-Organization
mail	I-Organization
facility	E-Organization
in	O
,	O
congressional	O
and	O
law	O
enforcement	O
sources	O
tell	O
CNN	O
.	O

Very	O
little	O
data	O
were	O
available	O
for	O
initiatives	O
for	O
other	O
areas	O
of	O
significant	O
biosafety	O
concern	O
,	O
such	O
as	O
animal	O
health	O
sciences	O
,	O
chemical	O
industry	O
,	O
or	O
radiological	O
industry	O
.	O

On	O
14	O
February	O
,	O
violence	O
erupted	O
and	O
an	O
Ebola	S-Disease
treatment	O
centre	O
near	O
the	O
centre	O
of	O
the	O
country	O
was	O
destroyed	O
.	O

We	O
believe	O
that	O
the	O
key	O
factors	O
in	O
building	O
trust	O
among	O
FBD	S-Platform
network	O
members	O
have	O
been	O
joint	O
work	O
on	O
the	O
part	O
of	O
laboratory	O
personnel	O
,	O
significant	O
contribution	O
by	O
each	O
of	O
the	O
participating	O
agencies	O
,	O
and	O
common	O
ownership	O
of	O
results	O
.	O

Medflies	O
were	O
found	O
in	O
traps	O
as	O
late	O
as	O
2007	O
in	O
Solano	B-Location
County	E-Location
,	O
California	S-Location
.	O
The	O
first	O
medflies	O
in	O
Florida	S-Location
turned	O
up	O
in	O
1929	O
and	O
they	O
have	O
been	O
a	O
constant	O
threat	O
to	O
the	O
citrus	O
crop	O
there	O
ever	O
since	O
.	O

IARPA	S-Organization
Director	O
Jason	B-Person
Matheny	E-Person
told	O
in	O
an	O
interview	O
that	O
advances	O
in	O
biotechnology	O
present	O
growth	O
opportunities	O
for	O
medicine	O
,	O
agriculture	O
,	O
energy	O
and	O
materials	O
,	O
but	O
could	O
also	O
lead	O
to	O
the	O
creation	O
of	O
weapons	O
of	O
mass	O
destruction	O
.	O

At	O
the	O
present	O
time	O
more	O
than	O
50%	O
of	O
the	O
antibiotics	O
produced	O
are	O
employed	O
as	O
animal	O
feeds	O
to	O
promote	O
growth	O
.	O

For	O
example	O
,	O
sending	O
samples	O
and	O
metadata	O
requires	O
a	O
system	O
that	O
ensures	O
confidentiality	O
in	O
the	O
laboratory	O
receiving	O
it	O
.	O

Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
and	O
Yellow	B-Pathogen
fever	I-Pathogen
virus	E-Pathogen
were	O
included	O
in	O
risk	O
group	O
1	O
of	O
the	O
Chinese	O
biosafety	O
categorization	O
(equivalent	O
to	O
the	O
risk	O
group	O
4	O
according	O
to	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
EU	S-Location
)	O
,	O
but	O
were	O
included	O
in	O
risk	O
group	O
3	O
according	O
to	O
NIH	S-Organization
and	O
EU	S-Location
categorization	O
.	O

GS-441524	S-Drug
was	O
shown	O
in	O
2019	O
to	O
have	O
promise	O
for	O
treating	O
feline	B-Disease
infectious	I-Disease
peritonitis	E-Disease
caused	O
by	O
a	O
coronavirus	S-Pathogen
.	O
It	O
has	O
not	O
been	O
evaluated	O
or	O
approved	O
by	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
for	O
the	O
treatment	O
of	O
feline	B-Disease
coronavirus	E-Disease
or	O
feline	B-Disease
infectious	I-Disease
peritonitis	E-Disease
but	O
has	O
been	O
available	O
since	O
2019	O
through	O
websites	O
and	O
social	O
media	O
as	O
an	O
unregulated	O
black	O
market	O
substance	O
as	O
confirmed	O
by	O
the	O
.	O

This	O
Directive	O
refers	O
to	O
biological	O
agents	O
instead	O
of	O
micro-organisms	O
,	O
and	O
includes	O
those	O
which	O
have	O
been	O
genetically	O
modified	O
,	O
cell	O
cultures	O
and	O
human	O
endoparasites	O
,	O
which	O
may	O
be	O
able	O
to	O
provoke	O
any	O
infection	O
,	O
allergy	O
or	O
toxicity	O
.	O

On	O
8	O
August	O
2014	O
,	O
it	O
declared	O
the	O
outbreak	O
a	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
.	O

To	O
the	O
extent	O
researchers	O
do	O
propose	O
solutions	O
that	O
would	O
tune	O
organisms'	O
reporting	O
mechanisms	O
,	O
the	O
proposers	O
will	O
be	O
responsible	O
for	O
developing	O
appropriate	O
environmental	O
safeguards	O
to	O
support	O
future	O
deployment	O
.	O

In	O
Liberia	S-Location
,	O
a	O
mob	O
attacked	O
an	O
Ebola	S-Disease
isolation	O
centre	O
,	O
stealing	O
equipment	O
and	O
"	O
freeing"	O
patients	O
while	O
shouting	O
"	O
There's	O
no	O
Ebola	S-Disease
.	O
"	O
Red	B-Organization
Cross	E-Organization
staff	O
were	O
forced	O
to	O
suspend	O
operations	O
in	O
southeast	O
Guinea	S-Location
after	O
they	O
were	O
threatened	O
by	O
a	O
group	O
of	O
men	O
armed	O
with	O
knives	O
.	O

In	O
many	O
cases	O
,	O
hospitals	O
were	O
relatively	O
successful	O
in	O
making	O
sure	O
that	O
those	O
patients	O
most	O
severely	O
affected	O
by	O
the	O
influenza	O
strain	O
were	O
able	O
to	O
be	O
seen	O
,	O
treated	O
,	O
and	O
discharged	O
in	O
an	O
efficient	O
manner	O
.	O

Although	O
declared	O
to	O
be	O
eradicated	O
around	O
the	O
world	O
in	O
1980	O
,	O
the	O
virus	O
that	O
causes	O
smallpox-variola	S-Pathogen
virus-still	O
exists	O
.	O

More	O
than	O
1.25	O
million	O
deaths	O
resulted	O
from	O
the	O
extreme	O
incidence	O
of	O
plague	S-Disease
in	O
17th-century	O
.	O

Due	O
to	O
pressure	O
from	O
numerous	O
accounts	O
of	O
the	O
bio-warfare	O
attacks	O
,	O
Chiang	B-Person
Kai-shek	E-Person
sent	O
a	O
delegation	O
of	O
army	O
and	O
foreign	O
medical	O
personnel	O
in	O
November	O
1941	O
to	O
document	O
evidence	O
and	O
treat	O
the	O
afflicted	O
.	O

Researchers	O
in	O
also	O
published	O
some	O
of	O
their	O
results	O
in	O
peer-reviewed	O
journals	O
,	O
writing	O
as	O
though	O
the	O
research	O
had	O
been	O
conducted	O
on	O
non-human	O
primates	O
called	O
"	O
Manchurian	O
monkeys	O
"	O
or	O
"	O
long-tailed	O
monkeys"	O
.	O

Increases	O
in	O
levels	O
of	O
liver	O
enzymes	O
have	O
been	O
seen	O
in	O
people	O
who	O
have	O
received	O
remdesivir	S-Drug
which	O
may	O
be	O
a	O
sign	O
of	O
inflammation	O
or	O
damage	O
to	O
cells	O
in	O
the	O
liver	O
.	O

Native	O
American	O
tribes	O
were	O
particularly	O
hard	O
hit	O
.	O

That	O
didn't	O
keep	O
people	O
from	O
the	O
table	O
.	O

Non-therapeutic	O
use	O
of	O
antibiotics	O
must	O
be	O
discontinued	O
.	O

Google	O
Books	O
website	O
Retrieved	O
13	O
April	O
2020	O
.	O

On	O
22	O
March	O
2020	O
,	O
Germany	S-Organization
banned	O
public	O
gatherings	O
of	O
more	O
than	O
two	O
people	O
.	O

During	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	I-Incident
in	I-Incident
West	I-Incident
Africa	E-Incident
the	O
CDC	S-Organization
helped	O
coordinate	O
the	O
return	O
of	O
two	O
infected	O
American	O
aid	O
workers	O
for	O
treatment	O
at	O
,	O
the	O
home	O
of	O
a	O
special	O
unit	O
to	O
handle	O
highly	O
infectious	O
diseases	O
.	O

It's	O
all	O
part	O
of	O
his	O
quest	O
to	O
live	O
until	O
at	O
least	O
age	O
180	O
.	O

Emergent	B-Organization
BioSolutions	E-Organization
has	O
constructed	O
a	O
new	O
trench	O
from	O
where	O
the	O
Gaithersburg	S-Location
,	O
.	O
-based	O
global	O
life	O
sciences	O
company	O
will	O
launch	O
the	O
world's	O
next	O
line	O
of	O
defense	O
against	O
emerging	O
viral	O
diseases:	O
mobile	O
manufacturing	O
units	O
that	O
can	O
produce	O
hyperimmune	O
therapeutics	O
for	O
known	O
and	O
emerging	O
infectious	O
diseases	O
.	O

Lothar	B-Organization
Saloman	I-Organization
Life	I-Organization
Sciences	I-Organization
Test	I-Organization
Facility	E-Organization
()	O
where	O
bio-terrorism	O
agents	O
are	O
produced	O
and	O
aerosolized	O
.	O

Ribosome	O
splitting	O
and	O
recycling:	O
for	O
example	O
,	O
drug-mediated	O
stalling	O
of	O
the	O
ribosome	O
by	O
lincomycin	S-Drug
and	O
erythromycin	S-Drug
unstalled	O
by	O
a	O
heat	O
shock	O
protein	O
found	O
in	O
,	O
which	O
is	O
an	O
homologous	O
of	O
HflX	O
from	O
other	O
bacteria	O
.	O

The	O
"	O
red	B-Disease
mold	I-Disease
disease	E-Disease
"	O
of	O
wheat	O
and	O
barley	O
in	O
Japan	O
is	O
prevalent	O
in	O
the	O
region	O
that	O
faces	O
the	O
Pacific	O
Ocean	O
.	O

In	O
the	O
hands	O
of	O
terrorists	O
and	O
rogue	O
nation	O
states	O
,	O
however	O
,	O
these	O
capabilities	O
could	O
be	O
misused	O
to	O
concoct	O
chemical	O
,	O
biological	O
,	O
radiological	O
,	O
nuclear	O
,	O
and	O
high-yield	O
explosive	O
(CBRNE)	O
weapons	O
of	O
mass	O
destruction	O
(WMD)	O
in	O
small	O
quantities	O
and	O
in	O
form	O
factors	O
that	O
are	O
hard	O
to	O
detect	O
.	O

No	O
more	O
than	O
four	O
appear	O
to	O
have	O
been	O
involved	O
in	O
development	O
at	O
the	O
;	O
not	O
all	O
of	O
those	O
were	O
necessarily	O
aware	O
of	O
the	O
objectives	O
of	O
their	O
work	O
.	O

Although	O
an	O
initial	O
investigation	O
by	O
the	O
Oregon	B-Organization
Public	I-Organization
Health	I-Organization
Division	I-Organization
and	I-Organization
the	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
did	O
not	O
rule	O
out	O
deliberate	O
contamination	O
,	O
the	O
agents	O
and	O
contamination	O
were	O
only	O
confirmed	O
a	O
year	O
later	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	O
,	O
DHHS	S-Organization
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

William	B-Person
Booth	E-Person
said	O
the	O
letter	O
was	O
forwarded	O
to	O
the	O
department	O
from	O
Bradley's	O
office	O
and	O
turned	O
over	O
for	O
investigation	O
to	O
the	O
.	O

He	O
passed	O
the	O
disease	O
through	O
a	O
series	O
of	O
10	O
ferrets	O
,	O
which	O
are	O
commonly	O
used	O
as	O
a	O
model	O
for	O
how	O
influenza	O
affects	O
humans	O
.	O

The	O
work	O
to	O
create	O
the	O
first	O
self-replicating	O
,	O
synthetic	O
bacterial	O
cell	O
was	O
an	O
important	O
proof	O
of	O
concept	O
.	O

On	O
4	O
February	O
2016	O
the	O
last	O
known	O
case	O
tested	O
negative	O
for	O
a	O
second	O
consecutive	O
time	O
and	O
Sierra	B-Location
Leone	E-Location
commenced	O
another	O
42-day	O
countdown	O
towards	O
being	O
declared	O
Ebola	S-Disease
-free	O
.	O

For	O
this	O
reason	O
,	O
and	O
because	O
no	O
research	O
provides	O
supporting	O
evidence	O
that	O
intensive	O
surveillance	O
gives	O
better	O
outcomes	O
,	O
and	O
because	O
of	O
risks	O
associated	O
with	O
having	O
CT	S-Technology
scans	O
,	O
patients	O
should	O
not	O
receive	O
screening	O
in	O
excess	O
of	O
those	O
recommended	O
by	O
established	O
guidelines	O
.	O

The	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
was	O
signed	O
by	O
the	O
US	S-Location
,	O
UK	S-Organization
,	O
USSR	S-Organization
and	O
other	O
nations	O
,	O
as	O
a	O
ban	O
on	O
"	O
development,	O
production	O
and	O
stockpiling	O
of	O
microbes	O
or	O
their	O
poisonous	O
products	O
except	O
in	O
amounts	O
necessary	O
for	O
protective	O
and	O
peaceful	O
research	O
"	O
in	O
1972	O
.	O

In	O
2015	O
at	O
least	O
100	O
new	O
cases	O
were	O
registered	O
in	O
the	O
city	O
of	O
alone	O
.	O

The	O
"	O
Interagency	B-International_exchange_and_cooperation
Coordination	I-International_exchange_and_cooperation
Group	I-International_exchange_and_cooperation
on	I-International_exchange_and_cooperation
Antimicrobial	I-International_exchange_and_cooperation
Resistance	E-International_exchange_and_cooperation
stated	O
in	O
2018	O
that	O
"	O
the	O
spread	O
of	O
pathogens	O
through	O
unsafe	O
water	O
results	O
in	O
a	O
high	O
burden	O
of	O
gastrointestinal	O
disease	O
,	O
increasing	O
even	O
further	O
the	O
need	O
for	O
antibiotic	O
treatment.	O
"	O
IACG	S-Organization
(2018)	O
Reduce	O
unintentional	O
exposure	O
and	O
the	O
need	O
for	O
antimicrobials	O
,	O
and	O
optimize	O
their	O
use	O
IACG	B-Document
Discussion	I-Document
Paper	E-Document
,	O
Interagency	B-International_exchange_and_cooperation
Coordination	I-International_exchange_and_cooperation
Group	I-International_exchange_and_cooperation
on	I-International_exchange_and_cooperation
Antimicrobial	I-International_exchange_and_cooperation
Resistance	E-International_exchange_and_cooperation
,	O
public	O
consultation	O
process	O
at	O
WHO	S-Organization
,	O
Geneva	S-Location
,	O
This	O
is	O
particularly	O
a	O
problem	O
in	O
developing	O
countries	O
where	O
the	O
spread	O
of	O
infectious	O
diseases	O
caused	O
by	O
inadequate	O
WASH	O
standards	O
is	O
a	O
major	O
driver	O
of	O
antibiotic	O
demand	O
.	O

An	O
MRI	S-Technology
artifact	O
is	O
a	O
visual	O
artifact	O
,	O
that	O
is	O
,	O
an	O
anomaly	O
during	O
visual	O
representation	O
.	O

To	O
directly	O
and	O
efficiently	O
test	O
for	O
pathogenicity	O
,	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
aims	O
to	O
build	O
a	O
portable	O
platform	O
that	O
screens	O
many	O
unfamiliar	O
strains	O
of	O
bacteria	O
at	O
once	O
to	O
reveal	O
their	O
phenotypes	O
.	O

In	O
a	O
report	O
released	O
in	O
August	O
2014	O
,	O
researchers	O
tracked	O
the	O
spread	O
of	O
Ebola	S-Disease
in	O
Sierra	B-Location
Leone	E-Location
from	O
the	O
group	O
first	O
infected-13	O
women	O
who	O
had	O
attended	O
the	O
funeral	O
of	O
the	O
traditional	O
healer	O
,	O
where	O
they	O
contracted	O
the	O
disease-giving	O
them	O
a	O
unique	O
opportunity	O
to	O
track	O
how	O
the	O
virus	O
had	O
changed	O
.	O

"	O
We	O
can't	O
count	O
on	O
outracing	O
drug	O
resistance,	O
"	O
FDA	S-Organization
	S-Organization
,	O
MD	O
,	O
said	O
in	O
announcing	O
the	O
strategy.	O
"	O
But	O
we	O
can	O
use	O
stewardship	O
and	O
science	O
to	O
slow	O
its	O
pace	O
and	O
reduce	O
its	O
impact	O
on	O
human	O
and	O
animal	O
health.	O
"	O

Work	O
with	O
CDC	S-Organization
scientists	O
from	O
to	O
establish	O
a	O
peer-review	O
system	O
of	O
written	O
research	O
plans	O
to	O
foster	O
critical	O
thinking	O
on	O
how	O
to	O
optimize	O
workflows	O
in	O
protocols	O
and	O
minimize	O
error	O
.	O

Estimates	O
as	O
to	O
how	O
many	O
infected	O
people	O
died	O
vary	O
greatly	O
,	O
but	O
the	O
flu	O
is	O
regardless	O
considered	O
to	O
be	O
one	O
of	O
the	O
deadliest	O
pandemics	O
in	O
history	O
.	O

In	O
China	S-Location
xenophobia	O
and	O
racism	O
against	O
non-Chinese	O
residents	O
has	O
been	O
inflamed	O
by	O
the	O
pandemic	O
,	O
with	O
foreigners	O
described	O
as	O
"	O
foreign	O
garbage	O
"	O
and	O
targeted	O
for	O
"	O
disposal".	O
Some	O
black	O
people	O
were	O
evicted	O
from	O
their	O
homes	O
by	O
police	O
and	O
told	O
to	O
leave	O
China	S-Location
within	O
24	O
hours	O
,	O
due	O
to	O
disinformation	O
that	O
they	O
and	O
other	O
foreigners	O
were	O
spreading	O
the	O
virus	O
.	O

In	O
FY	O
2017	O
,	O
a	O
total	O
of	O
42	O
proposals	O
were	O
submitted	O
to	O
the	O
BRAG	S-Document
program	O
requesting	O
a	O
total	O
of	O
$19,129,634	O
.	O

In	O
Liberian	O
counties	O
that	O
were	O
less	O
affected	O
by	O
the	O
outbreak	O
,	O
the	O
number	O
of	O
individuals	O
employed	O
fell	O
by	O
24%	O
.	O

Meeting	O
this	O
goal	O
–	O
and	O
within	O
a	O
10	O
year	O
timeline	O
–	O
will	O
require	O
new	O
technology	O
and	O
an	O
explosion	O
in	O
manufacturing	O
capacity	O
.	O

The	O
window	O
used	O
for	O
display	O
must	O
be	O
matched	O
to	O
the	O
X-ray	O
density	O
of	O
the	O
object	O
of	O
interest	O
,	O
in	O
order	O
to	O
optimize	O
the	O
visible	O
detail	O
.	O

Joseph	B-Person
Lieberman	E-Person
co-chairman	O
of	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
,	O
noted	O
that	O
the	O
recently	O
released	O
national	O
biodefense	O
strategy	O
by	O
the	O
took	O
"	O
a	O
while	O
longer	O
than	O
we	O
hoped,	O
"	O
but	O
is	O
a	O
strong	O
document	O
and	O
a	O
significant	O
step	O
forward	O
that	O
the	O
panel	O
would	O
like	O
to	O
build	O
on	O
.	O

The	O
major	O
UK	S-Location
troop	O
staging	O
and	O
hospital	O
camp	O
in	O
Étaples	S-Location
in	O
France	S-Location
has	O
been	O
theorized	O
by	O
virologist	O
John	B-Person
Oxford	E-Person
as	O
being	O
at	O
the	O
center	O
of	O
the	O
Spanish	B-Incident
flu	E-Incident
.	O
His	O
study	O
found	O
that	O
in	O
late	O
1916	O
the	O
Étaples	S-Location
camp	O
was	O
hit	O
by	O
the	O
onset	O
of	O
a	O
new	O
disease	O
with	O
high	O
mortality	O
that	O
caused	O
symptoms	O
similar	O
to	O
the	O
flu	S-Disease
.	O
According	O
to	O
Oxford	S-Organization
,	O
a	O
similar	O
outbreak	O
occurred	O
in	O
March	O
1917	O
at	O
army	O
barracks	O
in	O
Aldershot	S-Location
,	O
and	O
military	O
pathologists	O
later	O
recognized	O
these	O
early	O
outbreaks	O
as	O
the	O
same	O
disease	O
as	O
the	O
1918	B-Disease
flu	E-Disease
.	O
The	O
overcrowded	O
camp	O
and	O
hospital was	O
an	O
ideal	O
environment	O
for	O
the	O
spread	O
of	O
a	O
respiratory	O
virus	O
.	O

The	O
first	B-Activity
clinical	I-Activity
trial	I-Activity
involving	I-Activity
CRISPR	E-Activity
started	O
in	O
2016	O
.	O

Thus	O
,	O
the	O
can	O
be	O
regarded	O
as	O
complementary	O
to	O
each	O
agency's	O
existing	O
management	O
systems	O
.	O

We	O
do	O
unannounced	O
inspections	O
.	O

Please	O
see	O
Additional	O
file	O
1	O
for	O
translations	O
of	O
the	O
abstract	O
into	O
the	O
six	O
official	O
working	O
languages	O
of	O
the	O
United	B-Organization
Nations	E-Organization

There	O
is	O
a	O
contending	O
belief	O
that	O
the	O
disease	O
actually	O
spread	O
to	O
the	O
Lev	B-Location
Berg	E-Location
from	O
Uyaly	S-Location
or	O
Komsomolsk-on-Ustyurt	S-Location
,	O
two	O
cities	O
in	O
what	O
is	O
now	O
where	O
the	O
ship	O
docked	O
.	O

People	O
who	O
inhale	O
an	O
infectious	O
aerosol	O
would	O
generally	O
experience	O
severe	O
respiratory	O
illness	O
,	O
including	O
life-threatening	B-Phenotype
pneumonia	E-Phenotype
and	O
,	O
if	O
they	O
are	O
not	O
treated	O
.	O

But	O
experts	O
agree	O
on	O
one	O
thing:	O
"	O
It's	O
hard	O
to	O
predict	O
the	O
future,	O
"	O
Walke	S-Person
said	O
,	O
"	O
but	O
we	O
certainly	O
are	O
in	O
a	O
much	O
better	O
place	O
than	O
we	O
were	O
in	O
2001.	O
"	O

Gaggle	S-Platform
is	O
an	O
open-source	O
Java	O
software	O
environment	O
developed	O
at	O
the	O
Institute	B-Organization
for	I-Organization
Systems	I-Organization
Biology	E-Organization
.	O
Gaggle	S-Platform
uses	O
only	O
four	O
data	O
types	O
(list	O
of	O
names	O
,	O
matrices	O
,	O
networks	O
and	O
associative	O
arrays)	O
to	O
integrate	O
various	O
data	O
resources	O
and	O
software	O
.	O

It	O
conducted	O
its	O
clandestine	O
activities	O
at	O
52	O
sites	O
and	O
employed	O
over	O
50,000	O
people	O
.	O

LISA	B-Person
SCHNIRRING	E-Person
Thank	O
you	O
,	O
Dr	O
.	O

Most	O
work	O
has	O
been	O
done	O
on	O
the	O
spread	O
of	O
the	O
plague	S-Disease
in	O
England	S-Location
,	O
and	O
even	O
estimates	O
of	O
overall	O
population	O
at	O
the	O
start	O
vary	O
by	O
over	O
100%	O
as	O
no	O
census	O
was	O
undertaken	O
in	O
England	S-Location
between	O
the	O
time	O
of	O
publication	O
of	O
the	O
Domesday	B-Document
Book	E-Document
of	O
1086	O
and	O
the	O
poll	O
tax	O
of	O
the	O
year	O
1377	O
.	O

Newspapers	O
were	O
therefore	O
free	O
to	O
report	O
the	O
epidemic's	O
effects	O
,	O
such	O
as	O
the	O
grave	O
illness	O
of	O
King	B-Person
Alfonso	I-Person
XIII	E-Person
,	O
and	O
these	O
widely-spread	O
stories	O
created	O
a	O
false	O
impression	O
of	O
as	O
especially	O
hard	O
hit	O
.	O

Similarly	O
,	O
evaluated	O
the	O
potential	O
bioterrorism	O
agents	O
and	O
identified	O
three	O
groups	O
of	O
potential	O
bioterrorism	O
agents	O
[15]	O
.	O

If	O
the	O
lifetime	O
risk	O
of	O
developing	O
cancer	O
is	O
40%	O
then	O
the	O
absolute	O
risk	O
rises	O
to	O
40.	O
05%	O
after	O
a	O
.	O

On	O
29	O
April	O
,	O
leaders	O
of	O
member	O
countries	O
of	O
ASEAN	S-Organization
and	O
the	O
PRC	S-Organization
premier	O
held	O
an	O
emergency	O
summit	O
in	O
Bangkok	S-Location
,	O
to	O
address	O
the	O
outbreak	O
.	O

South	B-Location
Korea	E-Location
introduced	O
what	O
was	O
considered	O
the	O
largest	O
and	O
best-organised	O
programme	O
in	O
the	O
world	O
to	O
screen	O
the	O
population	O
for	O
the	O
virus	O
,	O
isolate	O
any	O
infected	O
people	O
,	O
and	O
trace	O
and	O
quarantine	O
those	O
who	O
contacted	O
them	O
.	O

We	O
do	O
have	O
the	O
ability	O
to	O
answer	O
your	O
questions	O
going	O
forward	O
.	O

Another	O
13	O
cases	O
in	O
also	O
worked	O
in	O
the	O
institute	O
in	O
August	O
.	O

Study	O
setting:	O
The	O
study	O
was	O
conducted	O
in	O
Khartoum	S-Location
state	O
diagnostic	O
laboratories	O
.	O

The	O
mission	O
hospital's	O
reuse	O
of	O
unsterilized	O
needles	O
also	O
contributed	O
to	O
the	O
spread	O
of	O
infection	O
.	O

Experiments	O
can	O
range	O
from	O
using	O
plasmids	O
to	O
fluorescent	O
bacteria	O
,	O
controlling	O
gene	O
expression	O
using	O
light	O
in	O
bacteria	O
,	O
even	O
using	O
to	O
engineer	O
the	O
genome	O
of	O
bacteria	O
or	O
yeast	O
.	O

This	O
study	O
was	O
funded	O
by	O
small	O
grant	O
from	O
Eastern	B-Organization
Mediterranean	I-Organization
Office	I-Organization
of	I-Organization
The	I-Organization
World	I-Organization
Health	I-Organization
Organization	E-Organization

Individuals	O
who	O
receive	O
a	O
five-day	O
treatment	O
course	O
but	O
do	O
not	O
show	O
clinical	O
improvement	O
will	O
be	O
eligible	O
to	O
continue	O
receiving	O
remdesivir	S-Drug
	S-Drug
an	O
additional	O
five	O
days	O
.	O

University	B-Organization
of	I-Organization
California	E-Organization
campuses	O
stockpiled	O
supplies	O
,	O
from	O
paper	B-Equipment
masks	E-Equipment
and	O
hand	B-Equipment
sanitizer	E-Equipment
to	O
food	O
and	O
water	O
.	O

But	O
according	O
to	O
Jen	B-Person
Kates	E-Person
vice	O
president	O
and	O
director	O
of	O
global	B-Document
health	I-Document
and	I-Document
HIV	I-Document
policy	E-Document
at	O
the	O
Henry	B-Organization
J.	I-Organization
Kaiser	I-Organization
Family	I-Organization
Foundation	E-Organization
()	O
,	O
this	O
isn't	O
typical	O
global	O
health	O
security	O
funding	O
.	O

Two	O
analyses	O
published	O
recently	O
in	O
Health	O
Security	O
by	O
CDC	S-Organization
illustrate	O
the	O
potential	O
losses	O
to	O
America	S-Location
's	O
export	O
economy	O
from	O
an	O
overseas	O
disease	O
outbreak	O
.	O

Methods	O
to	O
control	O
genome	B-Technology
editing	I-Technology
with	I-Technology
small	I-Technology
molecules	E-Technology
include	O
an	O
allosteric	B-Technology
Cas9	E-Technology
,	O
with	O
no	O
detectable	O
background	O
editing	O
,	O
that	O
will	O
activate	O
binding	O
and	O
cleavage	O
upon	O
the	O
addition	O
of	O
4-hydroxytamoxifen	O
(4-HT)	O
,	O
4-HT	O
responsive	O
intein-linked	O
Cas9	O
,	O
or	O
a	O
Cas9	O
that	O
is	O
4-HT	O
responsive	O
when	O
fused	O
to	O
four	O
ERT2	O
domains	O
.	O

Why	O
Would	O
Anthrax	S-Pathogen
Be	O
Used	O
as	O
a	O
Weapon?	O

But	O
after	O
the	O
2006	O
episode	O
,	O
what	O
they	O
did	O
was	O
implement	O
a	O
procedure	O
for	O
one	O
particular	O
type	O
of	O
specimen	O
.	O

On	O
1	O
March	O
26-year-old	O
Esther	B-Person
Mok	E-Person
another	O
Metropole	O
guest	O
,	O
was	O
admitted	O
to	O
Tan	B-Organization
Tock	I-Organization
Seng	I-Organization
Hospital	E-Organization
after	O
visiting	O
Hong	B-Location
Kong	E-Location
,	O
starting	O
the	O
.	O
Although	O
she	O
recovered	O
,	O
various	O
family	O
members	O
did	O
not	O
.	O

The	O
size	O
and	O
scope	O
of	O
the	O
organization	O
also	O
needs	O
"	O
to	O
be	O
more	O
like	O
the	O
Manhattan	B-Scientific_research_project
Project	E-Scientific_research_project
rather	O
than	O
a	O
small	O
program	O
in	O
a	O
discreet	O
agency	O
or	O
department	O
;	O
it	O
should	O
be	O
over-arching,	O
"	O
he	O
said	O
.	O

On	O
31	O
December	O
2019	O
,	O
the	O
WHO	B-Organization
China	I-Organization
Country	I-Organization
Office	E-Organization
was	O
informed	O
of	O
cases	O
of	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
(unknown	O
cause)	O
detected	O
in	O
Wuhan	B-Location
City	E-Location
,	O
Hubei	B-Location
Province	I-Location
of	I-Location
China	E-Location
.	O
As	O
of	O
3	O
January	O
2020	O
,	O
a	O
total	O
of	O
44	O
patients	O
with	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
have	O
been	O
reported	O
to	O
WHO	S-Organization
by	O
the	O
national	O
authorities	O
in	O
China	S-Location
.	O
Of	O
the	O
44	O
cases	O
reported	O
,	O
11	O
are	O
severely	O
ill	O
,	O
while	O
the	O
remaining	O
33	O
patients	O
are	O
in	O
stable	O
condition	O
.	O

Neither	O
bacteria	O
was	O
weaponized	O
.	O

Each	O
treatment	O
centre	O
is	O
divided	O
into	O
a	O
number	O
of	O
distinct	O
and	O
rigorously	O
separate	O
areas	O
.	O

The	O
commune	O
decided	O
to	O
boycott	O
the	O
election	O
when	O
it	O
became	O
clear	O
that	O
those	O
brought	O
in	O
through	O
the	O
"	O
Share-a-Home"	O
program	O
would	O
not	O
be	O
allowed	O
to	O
vote	O
.	O

While	O
the	O
majority	O
of	O
cases	O
result	O
in	O
mild	O
symptoms	O
,	O
some	O
progress	O
to	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
likely	O
precipitated	O
by	O
a	O
cytokine	B-Phenotype
storm	E-Phenotype
,	O
multi-organ	B-Phenotype
failure	E-Phenotype
,	O
septic	B-Phenotype
shock	E-Phenotype
,	O
and	O
.	O

1946:	O
A	O
biological	O
weapons	O
facility	O
was	O
established	O
in	O
Sverdlovsk	S-Location

It	O
forecasts	O
that	O
China	S-Location
pork	O
output	O
will	O
fall	O
by	O
30%	O
this	O
year	O
,	O
creating	O
implications	O
for	O
global	O
commodity	O
markets	O
.	O

It	O
was	O
revised	O
several	O
times	O
from	O
1975	O
to	O
1978	O
to	O
finally	O
end	O
up	O
with	O
three	O
categories	O
A	O
,	O
B	O
and	O
C	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	I-Organization
Atlanta	E-Organization
was	O
chosen	O
as	O
the	O
location	O
because	O
was	O
endemic	O
in	O
the	O
Southern	O
United	O
States	O
.	O

Global	O
health	O
security	O
issues	O
will	O
continue	O
to	O
challenge	O
collaboration	O
between	O
sectors	O
,	O
laboratory	O
activities	O
,	O
and	O
technologies	O
in	O
the	O
coming	O
years	O
.	O

However	O
,	O
Congress	O
directed	O
that	O
the	O
initialism	O
be	O
retained	O
because	O
of	O
its	O
name	O
recognition	O
.	O

This	O
is	O
the	O
.	O

Based	O
on	O
information	O
provided	O
by	O
national	O
authorities	O
,	O
WHO	S-Organization
recommendations	O
on	O
public	O
health	O
measures	O
and	O
surveillance	O
of	O
influenza	S-Disease
and	O
severe	O
still	O
apply	O
.	O

The	O
five	O
suspected	O
cases	O
in	O
the	O
Mambasa	B-Organization
Health	I-Organization
Zone	E-Organization
proved	O
not	O
to	O
be	O
EVD	S-Disease
;	O
it	O
was	O
not	O
possible	O
to	O
confirm	O
the	O
one	O
probable	O
case	O
in	O
the	O
Musienene	B-Organization
Health	I-Organization
Zone	E-Organization
and	O
the	O
two	O
probable	O
cases	O
in	O
the	O
Butembo	B-Organization
Health	I-Organization
Zone	E-Organization
.	O
No	O
new	O
cases	O
had	O
been	O
recorded	O
in	O
any	O
of	O
those	O
health	O
zones	O
.	O

Drogin	S-Person
,	O
Bob	S-Person
.	O
"	O
High	O
school	O
mixes	O
algebra	O
,	O
homeland	O
security"	O
,	O
Times	O
,	O
June	O
10	O
,	O
2009	O
,	O
accessed	O
February	O
21	O
,	O
2012	O
.	O

Information	O
published	O
about	O
the	O
centre	O
specifies	O
that	O
,	O
"	O
it	O
is	O
a	O
central	O
location	O
used	O
by	O
the	O
and	O
related	O
ministries	O
to	O
collect	O
,	O
synthesise	O
,	O
and	O
analyse	O
bio	O
surveillance	O
data	O
,	O
collected	O
across	O
the	O
country	O
(situation	O
awareness	O
,	O
alert)	O
,	O
in	O
order	O
to	O
coor	O
dinate	O
resources	O
and	O
information	O
to	O
support	O
response	O
to	O
public	O
health	O
emergencies	O
or	O
events.	O
"	O
It	O
proposes	O
a	O
more	O
efficient	O
emergency	O
management	O
system	O
based	O
on	O
the	O
integration	O
of	O
resources	O
,	O
the	O
harmonisation	O
of	O
strategic	O
areas	O
of	O
intervention	O
,	O
unified	O
command	O
and	O
standardised	O
operating	O
procedures	O
for	O
incident	O
management	O
and	O
all	O
hazards	O
of	O
public	O
health	O
emergencies	O
.	O

An	O
investigation	O
to	O
determine	O
the	O
root	O
causes	O
that	O
led	O
to	O
contamination	O
of	O
H5N1	S-Pathogen
in	O
the	O
influenza	O
laboratory	O
.	O

In	O
Liberian	O
counties	O
that	O
were	O
less	O
affected	O
by	O
the	O
outbreak	O
,	O
the	O
number	O
of	O
individuals	O
employed	O
fell	O
by	O
24%	O
.	O

CDC	S-Organization
has	O
implemented	O
numerous	O
steps	O
over	O
the	O
past	O
few	O
years	O
to	O
enhance	O
its	O
laboratory	O
safety	O
program	O
,	O
including	O
standing	O
up	O
the	O
Office	B-Organization
of	I-Organization
the	I-Organization
Associate	I-Organization
Director	I-Organization
for	I-Organization
Laboratory	I-Organization
Science	I-Organization
and	I-Organization
Safety	E-Organization
,	O
reviewing	O
laboratory	O
safety	O
protocols	O
,	O
and	O
establishing	O
the	O
.	O
The	O
agency	O
has	O
implemented	O
rigorous	O
steps	O
to	O
minimize	O
these	O
risks	O
and	O
to	O
quickly	O
investigate	O
these	O
incidents	O
when	O
they	O
do	O
occur	O
including	O
this	O
recent	O
incident	O
.	O

Combining	O
a	O
laboratory	O
course	O
in	O
virology	O
with	O
the	O
in‐class	O
course	O
is	O
important	O
not	O
only	O
for	O
this	O
reason	O
but	O
also	O
because	O
students	O
should	O
be	O
familiar	O
with	O
BSL2	S-Platform
working	O
conditions	O
before	O
they	O
participate	O
in	O
any	O
work	O
involving	O
animal	O
viruses	O
.	O

EU	S-Location
determine	O
the	O
degree	O
of	O
threat	O
associated	O
with	O
biological	O
agents	O
according	O
to	O
the	O
formula	O
T = (B	O
*	O
M	O
*	O
A	O
*	O
D)-Tr+C	O
,	O
where	O
T	O
is	O
the	O
threat	O
level	O
,	O
B	O
is	O
the	O
base	O
score	O
,	O
M	O
is	O
the	O
mortality	O
rate	O
,	O
A	O
is	O
the	O
aerosol	O
spread	O
of	O
ability	O
,	O
D	O
is	O
the	O
ability	O
to	O
spread	O
between	O
people	O
,	O
Tr	O
is	O
drugs	O
and	O
vaccines	O
for	O
a	O
possible	O
response	O
and	O
C	O
is	O
the	O
production	O
potential	O
.	O

A	O
report	O
published	O
in	O
2016	O
in	O
the	O
Journal	O
of	O
the	O
Chinese	B-Organization
Medical	I-Organization
Association	E-Organization
found	O
evidence	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
had	O
been	O
circulating	O
in	O
the	O
European	O
armies	O
for	O
months	O
and	O
possibly	O
years	O
before	O
the	O
1918	O
pandemic	O
.	O

A	O
gene	O
from	O
the	O
protein	O
is	O
transferred	O
to	O
bacteria	O
,	O
whichis	O
used	O
to	O
infect	O
plants	O
.	O

These	O
materials	O
included	O
anthrax	S-Pathogen
,	O
West	B-Pathogen
Nile	I-Pathogen
virus	E-Pathogen
and	O
botulism	S-Pathogen
,	O
as	O
well	O
as	O
Brucella	B-Pathogen
melitensis	E-Pathogen
,	O
and	O
Clostridium	B-Pathogen
perfringens	E-Pathogen
.	O
Some	O
of	O
these	O
materials	O
were	O
used	O
for	O
,	O
while	O
others	O
were	O
used	O
for	O
vaccine	O
development	O
.	O

"	O
The	O
concept	O
is	O
to	O
design	O
a	O
unit	O
that	O
could	O
be	O
deployed	O
where	O
the	O
outbreak	O
is	O
,	O
collect	O
plasma	O
from	O
those	O
who	O
have	O
recovered	O
from	O
the	O
disease	O
,	O
and	O
convert	O
plasma	O
into	O
finished	O
product	O
that	O
is	O
ready	O
to	O
administer	O
right	O
in	O
the	O
truck,	O
"	O
Saward	S-Person
said	O
.	O

The	O
tests	O
are	O
performed	O
on	O
Kirtland	B-Organization
Air	I-Organization
Force	I-Organization
Base	E-Organization
(	O
Kirtland	S-Location
is	O
the	O
home	O
of	O
the	O
)	O
.	O

The	O
supervisor	O
of	O
the	O
next	O
shift	O
did	O
not	O
find	O
anything	O
unusual	O
in	O
the	O
logbook	O
and	O
turned	O
the	O
machines	O
on	O
.	O

Antimicrobial	O
resistance	O
threatens	O
the	O
world	O
as	O
we	O
know	O
it	O
,	O
and	O
can	O
lead	O
to	O
epidemics	O
of	O
enormous	O
proportions	O
if	O
preventive	O
actions	O
are	O
not	O
taken	O
.	O

Small	O
molecules	O
can	O
also	O
be	O
used	O
to	O
improve	O
homology	B-Technology
directed	I-Technology
repair	E-Technology
,	O
often	O
by	O
inhibiting	O
the	O
non-homologous	O
end	O
joining	O
pathway	O
.	O

In	O
addition	O
,	O
people	O
with	O
some	O
medical	O
implants	O
or	O
other	O
non-removable	O
metal	O
inside	O
the	O
body	O
may	O
be	O
unable	O
to	O
undergo	O
an	O
examination	O
safely	O
.	O

Though	O
the	O
program	O
was	O
successful	O
in	O
meeting	O
its	O
development	O
goals	O
,	O
the	O
lack	O
of	O
validation	O
on	O
the	O
infectivity	O
of	O
anthrax	S-Pathogen
stalled	O
standardization	O
.	O

In	O
March	O
2010	O
,	O
the	O
allegations	O
were	O
investigated	O
by	O
the	O
Al	O
Jazeera	O
English	O
news	O
program	O
People	O
&amp	O
;	O
Power	O
.	O

In	O
2012	O
,	O
a	O
Dutch	O
virologist	O
,	O
Ron	B-Person
Fouchier	E-Person
published	O
details	O
of	O
an	O
experiment	O
on	O
the	O
recent	O
H5N1	B-Pathogen
strain	I-Pathogen
of	I-Pathogen
bird	I-Pathogen
flu	E-Pathogen
.	O
This	O
strain	O
was	O
extremely	O
deadly	O
,	O
killing	O
an	O
estimated	O
60%	O
of	O
humans	O
it	O
infected	O
–	O
far	O
beyond	O
even	O
the	O
Spanish	B-Disease
flu	E-Disease
.	O
Yet	O
its	O
inability	O
to	O
pass	O
from	O
human	O
to	O
human	O
had	O
so	O
far	O
prevented	O
a	O
pandemic	O
.	O

I	O
suspected	O
the	O
reason	O
for	O
this	O
and	O
called	O
the	O
Chief	O
of	O
General	O
Staff	O
of	O
Ministry	B-Organization
of	I-Organization
Defense	E-Organization
and	O
requested	O
to	O
forbid	O
the	O
stop	O
of	O
the	O
Alma-Ata-Moscow	O
train	O
in	O
.	O
As	O
a	O
result	O
,	O
the	O
epidemic	O
around	O
the	O
country	O
was	O
prevented	O
.	O

The	O
spread	O
of	O
disease	O
was	O
significantly	O
more	O
rampant	O
in	O
areas	O
of	O
poverty	O
.	O

Second	O
,	O
the	O
system	O
must	O
sustain	O
the	O
bacteria	O
in	O
simulated	O
host	O
environments	O
long	O
enough	O
to	O
conduct	O
testing	O
.	O

"	O
In	O
the	O
end	O
,	O
we	O
will	O
see	O
that	O
there'll	O
be	O
some	O
sort	O
of	O
temporary	O
,	O
or	O
maybe	O
even	O
a	O
permanent	O
,	O
resolution	O
of	O
the	O
trade	O
dispute	O
to	O
try	O
and	O
get	O
that	O
pork	O
meat	O
and	O
other	O
animal	O
proteins	O
flowing	O
from	O
the	O
US	S-Location
to	O
,	O
"	O
he	O
says	O
.	O

This	O
theory	O
is	O
supported	O
by	O
research	O
in	O
2018	O
which	O
suggested	O
transmission	O
was	O
more	O
likely	O
by	O
body	O
lice	O
and	O
human	O
fleas	O
during	O
the	O
second	O
pandemic	O
.	O

RDFs	O
emerge	O
as	O
an	O
appropriate	O
method	O
to	O
improve	O
metadata	O
.	O

Additionally	O
,	O
people	O
with	O
COVID‑19	S-Disease
and	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
have	O
classical	O
serum	O
biomarkers	O
of	O
,	O
including	O
elevated	O
C-reactive	O
protein	O
(CRP)	O
,	O
lactate	O
dehydrogenase	O
(LDH)	O
,	O
D-dimer	O
,	O
and	O
ferritin	O
.	O

We're	O
concerned	O
about	O
what	O
is	O
the	O
framework	O
that	O
everyone's	O
using?	O
And	O
that	O
framework	O
includes	O
rapid	O
reporting	O
.	O

Antivirals	O
(	O
oseltamivir	S-Drug
or	O
)	O
were	O
recommended	O
for	O
those	O
with	O
more	O
severe	O
symptoms	O
or	O
those	O
in	O
an	O
at-risk	O
group	O
.	O

According	O
to	O
some	O
epidemiologists	O
,	O
periods	O
of	O
unfavourable	O
weather	O
decimated	O
plague-infected	O
rodent	O
populations	O
and	O
forced	O
their	O
fleas	O
onto	O
alternative	O
hosts	O
,	O
inducing	O
plague	S-Disease
outbreaks	O
which	O
often	O
peaked	O
in	O
the	O
hot	O
summers	O
of	O
the	O
Mediterranean	S-Location
,	O
as	O
well	O
as	O
during	O
the	O
cool	O
autumn	O
months	O
of	O
the	O
southern	O
Baltic	S-Location
states	O
.	O

Various	O
types	O
of	O
specialized	O
equipment	O
are	O
used	O
to	O
provide	O
primary	O
barriers	O
between	O
the	O
microorganism	O
and	O
the	O
laboratory	O
worker	O
.	O

This	O
collaboration	O
between	O
the	O
National	B-Organization
Veterinary	I-Organization
Institute	E-Organization
and	O
the	O
National	B-Organization
Food	I-Organization
Agency	E-Organization
initially	O
focused	O
on	O
biopreparedness	O
and	O
the	O
deliberate	O
spread	O
of	O
pathogens	O
in	O
the	O
food	O
chain	O
.	O

Vaccines	O
available	O
to	O
prevent	O
certain	O
types	O
of	O
STDs	S-Disease
include	O
vaccinations	O
for	O
hepatitis	B-Disease
A	E-Disease
and	O
hepatitis	B-Disease
B	E-Disease
as	O
well	O
as	O
.	O

The	O
order	O
in	O
which	O
boot	O
covers	O
are	O
removed	O
,	O
by	O
these	O
guidelines	O
,	O
indicates	O
their	O
removal	O
after	O
the	O
coverall	O
or	O
gown	O
.	O

The	O
case	O
is	O
the	O
third	O
in	O
the	O
country	O
,	O
following	O
confirmation	O
of	O
two	O
cases	O
from	O
Lae	S-Location
in	O
June	O
and	O
July	O
2018	O
.	O

Fewer	O
scanners	O
of	O
this	O
design	O
have	O
been	O
produced	O
when	O
compared	O
with	O
spinning	O
tube	O
types	O
,	O
mainly	O
due	O
to	O
the	O
higher	O
cost	O
associated	O
with	O
building	O
a	O
much	O
larger	O
X-ray	O
tube	O
and	O
detector	O
array	O
and	O
limited	O
anatomical	O
coverage	O
.	O

The	O
system	O
will	O
rely	O
on	O
big-data	O
analytics	O
to	O
determine	O
whether	O
further	O
inspection	O
is	O
warranted	O
.	O

Even	O
with	O
the	O
elimination	O
of	O
naturally	O
occurring	O
smallpox	S-Pathogen
the	O
Congress	O
made	O
it	O
a	O
priority	O
to	O
find	O
solutions	O
for	O
pathogens	O
that	O
could	O
be	O
used	O
as	O
weapons	O
.	O

The	O
IV&amp;V	O
team	O
will	O
also	O
evaluate	O
the	O
effectiveness	O
of	O
the	O
performers'	O
systems	O
following	O
demonstrations	O
.	O

Bacillus	B-Pathogen
subtilis	E-Pathogen
,	O
Naegleria	B-Pathogen
gruberi	E-Pathogen
,	O
infectious	B-Pathogen
canine	I-Pathogen
hepatitis	I-Pathogen
virus	E-Pathogen
,	O
and	O
exempt	B-Pathogen
organisms	E-Pathogen
under	O
the	O
are	O
representative	O
of	O
microorganisms	O
meeting	O
these	O
criteria	O
.	O

Apparently	O
,	O
the	O
porcine	O
H1N1	S-Pathogen
and	O
H3N2	S-Pathogen
lineages	O
uncommonly	O
infect	O
humans	O
,	O
and	O
the	O
human	O
H1N1	S-Pathogen
and	O
H3N2	S-Pathogen
lineages	O
have	O
both	O
been	O
associated	O
with	O
substantially	O
lower	O
rates	O
of	O
illness	O
and	O
death	O
than	O
the	O
virus	O
of	O
1918	O
.	O

The	O
mechanism	O
was	O
also	O
dependent	O
on	O
two	O
populations	O
of	O
rodents:	O
one	O
resistant	O
to	O
the	O
disease	O
,	O
which	O
act	O
as	O
hosts	O
,	O
keeping	O
the	O
disease	O
endemic	O
,	O
and	O
a	O
second	O
that	O
lack	O
resistance	O
.	O

In	O
July	O
2018	O
,	O
the	O
ECJ	S-Organization
ruled	O
that	O
gene	B-Technology
editing	I-Technology
for	I-Technology
plants	E-Technology
was	O
a	O
sub-category	O
of	O
GMO	S-Organization
foods	O
and	O
therefore	O
that	O
the	O
CRISPR	S-Technology
technique	O
would	O
henceforth	O
be	O
regulated	O
in	O
the	O
European	B-Organization
Union	E-Organization
by	O
their	O
rules	O
and	O
regulations	O
for	O
.	O

Furthermore	O
,	O
a	O
thorough	O
evaluation	O
of	O
a	O
DNA	O
extraction	O
robot	O
in	O
biosafety	B-Equipment
cabinets	E-Equipment
including	O
the	O
validation	O
of	O
the	O
extraction	O
process	O
using	O
a	O
broad	O
range	O
of	O
sample	O
types	O
(matrixes)	O
,	O
resulted	O
in	O
the	O
equipment's	O
being	O
implemented	O
at	O
all	O
4	O
agencies	O
.	O

There	O
is	O
no	O
evidence	O
that	O
any	O
of	O
the	O
vials	O
labeled	O
variola	S-Disease
has	O
been	O
breached	O
,	O
and	O
onsite	O
biosafety	O
personnel	O
have	O
not	O
identified	O
any	O
infectious	O
exposure	O
risk	O
to	O
lab	O
workers	O
or	O
the	O
public	O
.	O

Statistical	O
analysis	O
then	O
identify	O
genes	O
that	O
are	O
significantly	O
likely	O
to	O
be	O
relevant	O
to	O
the	O
phenotype	O
of	O
interest	O
.	O

When	O
an	O
individual	O
is	O
infected	O
the	O
pathophysiological	O
process	O
indicates	O
that	O
as	O
systemic	B-Phenotype
inflammation	E-Phenotype
sets	O
in	O
there	O
are	O
,	O
as	O
well	O
as	O
vascular	O
and	O
the	O
aforementioned	O
immune	O
system	O
issues	O
.	O

The	O
NIH	S-Organization
,	O
EU	S-Location
define	O
group	O
3	O
as	O
agents	O
for	O
which	O
effective	O
treatments	O
and	O
preventive	O
measures	O
are	O
available	O
.	O

Synthetic	O
biology	O
,	O
the	O
field	O
that	O
explores	O
the	O
engineering	O
and	O
creation	O
of	O
organisms	O
not	O
found	O
in	O
the	O
natural	O
world	O
,	O
can	O
benefit	O
society	O
when	O
it	O
comes	O
to	O
healthcare	O
and	O
other	O
fields	O
.	O

Badie	S-Person
,	O
Rick	S-Person
.	O
"	O
Medfly	O
Scare	O
Yet	O
Another	O
Challenge	O
For	O
Citrus	O
Industry	O
,	O
Very	O
Much	O
Alive	O
In	O
Lake"	O
,	O
Orlando	B-Person
Sentinel	E-Person
,	O
July	O
13	O
,	O
1997	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

A	O
USA	B-Organization
TODAY	I-Organization
Network	E-Organization
investigation	O
reveals	O
that	O
hundreds	O
of	O
lab	O
mistakes	O
,	O
safety	O
violations	O
and	O
near-miss	O
incidents	O
have	O
occurred	O
in	O
biological	O
laboratories	O
coast	O
to	O
coast	O
in	O
recent	O
years	O
,	O
putting	O
scientists	O
,	O
their	O
colleagues	O
and	O
sometimes	O
even	O
the	O
public	O
at	O
risk	O
.	O

The	O
virus	O
can	O
cause	O
acute	B-Phenotype
myocardial	I-Phenotype
injury	E-Phenotype
and	O
chronic	B-Phenotype
damage	E-Phenotype
to	O
the	O
cardiovascular	O
system	O
.	O

The	O
technology	O
industry	O
,	O
in	O
particular	O
,	O
has	O
warned	O
of	O
delays	O
to	O
shipments	O
of	O
electronic	O
goods	O
.	O

These	O
analyses	O
show	O
that	O
the	O
ability	O
to	O
rapidly	O
detect	O
and	O
control	O
disease	O
threats	O
in	O
other	O
countries	O
is	O
critical	O
to	O
economy	O
and	O
jobs	O
.	O

With	O
the	O
discovery	O
of	O
and	O
specifically	O
the	O
Cas9	O
nuclease	O
molecule	O
,	O
efficient	O
and	O
highly	O
selective	O
editing	O
is	O
now	O
a	O
reality	O
.	O

However	O
,	O
DOIs	O
can	O
be	O
minted	O
external	O
to	O
the	O
data	O
management	O
systems	O
and	O
refer	O
to	O
data	O
objects	O
inside	O
them	O
,	O
e.g.	O
to	O
persistent	O
URIs	O
as	O
provided	O
by	O
the	O
.	O

In	O
addition	O
,	O
the	O
lab	O
contains	O
a	O
central	O
control	O
room	O
and	O
offices	O
on	O
the	O
left	O
side	O
,	O
and	O
a	O
decontamination	O
room	O
,	O
an	O
electricity	O
distribution	O
room	O
,	O
and	O
an	O
air	O
conditioning	O
engine	O
unit	O
on	O
the	O
right	O
side	O
.	O

And	O
third	O
,	O
it	O
must	O
run	O
and	O
evaluate	O
a	O
gauntlet	O
of	O
physical	O
and	O
chemical	O
tests	O
on	O
the	O
bacteria-the	O
biological	O
equivalent	O
of	O
the	O
game	O
"	O
Twenty	O
Questions"-to	O
determine	O
their	O
pathogenicity	O
.	O

Redberg	S-Person
,	O
Rita	B-Person
F.	E-Person
,	O
and	O
Smith-Bindman	S-Person
,	O
Rebecca	S-Person
.	O
"	O
We	O
Are	O
Giving	O
Ourselves	O
Cancer	O
"	O
,	O
New	O
York	O
Times	O
,	O
Jan.	O
30	O
,	O
2014	O
However	O
,	O
a	O
lumbar	O
spine	O
x-ray	O
has	O
a	O
similar	O
dose	O
as	O
a	O
head	O
CT	S-Technology
.	O
Articles	O
in	O
the	O
media	O
often	O
exaggerate	O
the	O
relative	O
dose	O
of	O
CT	S-Technology
by	O
comparing	O
the	O
lowest-dose	O
x-ray	B-Technology
techniques	E-Technology
(chest	O
x-ray)	O
with	O
the	O
highest-dose	B-Technology
CT	I-Technology
techniques	E-Technology
.	O
In	O
general	O
,	O
the	O
radiation	O
dose	O
associated	O
with	O
a	O
routine	O
abdominal	O
has	O
a	O
radiation	O
dose	O
similar	O
to	O
three	O
years	O
average	O
background	O
radiation	O
.	O

Additionally	O
,	O
individuals	O
travelling	O
to	O
the	O
country	O
should	O
avoid	O
contact	O
with	O
animals	O
.	O

Lycopene	O
is	O
a	O
bright	O
red	O
compound	O
found	O
in	O
tomatoes	O
and	O
is	O
studied	O
for	O
its	O
potential	O
to	O
prevent	O
some	O
types	O
of	O
cancer.	O
's	O
research	O
showed	O
that	O
cells	O
can	O
be	O
selected	O
for	O
any	O
trait	O
a	O
researcher	O
wishes	O
to	O
screen	O
for	O
,	O
not	O
just	O
lycopene	O
production	O
.	O

Embargo	O
periods	O
can	O
be	O
employed	O
to	O
retain	O
the	O
release	O
of	O
data	O
for	O
a	O
defined	O
period	O
of	O
time-to	O
enable	O
the	O
author	O
to	O
prepare	O
a	O
manuscript	O
or	O
file	O
for	O
a	O
patent	O
,	O
etc	O
.	O

The	O
DTRA	S-Organization
contractors	O
,	O
working	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
in	O
Georgia	S-Location
,	O
CH2M	B-Organization
Hill	E-Organization
and	O
Battelle	S-Organization
have	O
also	O
been	O
contracted	O
for	O
the	O
program	O
in	O
Afghanistan	S-Organization
.	O
CH2M	B-Organization
Hill	E-Organization
has	O
been	O
awarded	O
a	O
$10.4	O
million	O
contract	O
(2013-2017)	O
.	O

Sea	O
life	O
,	O
however	O
,	O
offers	O
a	O
potential	O
new	O
advantage	O
.	O

They	O
were	O
charged	O
with	O
attempting	O
to	O
murder	O
Rajneesh's	O
personal	O
physician	O
,	O
first-degree	O
assault	O
for	O
poisoning	O
Judge	O
William	B-Person
Hulse	E-Person
,	O
second-degree	O
assault	O
for	O
poisoning	O
The	O
Dalles	O
Commissioner	O
Raymond	B-Person
Matthews	E-Person
,	O
and	O
product	O
tampering	O
for	O
the	O
poisonings	O
in	O
The	O
Dalles	S-Location
,	O
as	O
well	O
as	O
wiretapping	O
and	O
immigration	O
offenses	O
.	O

One	O
other	O
question	O
for	O
Dr.	O
.	O

"	O
And	O
You	O
Will	O
Beg	O
for	O
Our	O
Secrets	O
"	O
(2016)	O
,	O
from	O
the	O
Anaal	B-Person
Nathrakh	E-Person
album	O
The	O
Whole	O
of	O
the	O
Law	O
,	O
refers	O
to	O
Unit	B-Organization
731	E-Organization
's	O
activities	O
and	O
the	O
amnesty	O
given	O
in	O
exchange	O
for	O
information	O
resulting	O
from	O
the	O
experiments	O
carried	O
out	O
.	O

Howard	B-Person
Taylor	I-Person
Ricketts	E-Person
acquired	O
typhus	S-Disease
and	O
died	O
while	O
studying	O
the	O
disease	O
using	O
a	O
primitive	O
containment	O
device	O
.	O

Wicker	S-Person
the	O
junior	O
senator	O
from	O
,	O
has	O
been	O
assigned	O
a	O
protective	O
detail	O
,	O
according	O
to	O
a	O
law	O
enforcement	O
source	O
.	O

The	O
project	O
team	O
noted	O
their	O
list	O
is	O
not	O
exhaustive	O
or	O
an	O
endorsement	O
of	O
specific	O
companies	O
.	O

The	O
phenomenon	O
that	O
one	O
part	O
of	O
the	O
detector	O
cannot	O
differentiate	O
between	O
different	O
tissues	O
is	O
called	O
the	O
"	O
Partial	O
Volume	O
Effect"	O
.	O

This	O
may	O
be	O
avoided	O
since	O
the	O
original	O
criteria	O
that	O
method	O
development	O
should	O
be	O
relevant	O
for	O
all	O
sectors	O
has	O
been	O
abandoned	O
.	O

Pharmaceutical	O
companies	O
should	O
provide	O
their	O
stocks	O
for	O
this	O
purpose	O
(retaining	O
rights	O
to	O
other	O
applications)	O
.	O

The	O
Blue	O
Ribbon	O
panel	O
also	O
just	O
released	O
a	O
new	O
special	O
report	O
on	O
biodefense	O
preparedness	O
at	O
the	O
local	O
level	O
.	O

Viral	O
proteins	O
VP40	O
and	O
VP24	O
are	O
located	O
between	O
the	O
envelope	O
and	O
the	O
nucleocapsid	O
(see	O
following)	O
,	O
in	O
the	O
matrix	O
space	O
.	O

Axial	O
images	O
through	O
the	O
spine	O
will	O
only	O
show	O
one	O
vertebral	O
body	O
at	O
a	O
time	O
and	O
cannot	O
reliably	O
show	O
the	O
intervertebral	O
discs	O
.	O

Sergei	B-Person
Popov	E-Person
With	O
Biowarriors:	O
"	O
,	O
(2001)	O
NOVA	O
Online	O
.	O

The	O
second	O
candidate	O
is	O
TIM-1	O
(a.k.a.HAVCR1)	O
.	O

Detection	O
has	O
two	O
primary	O
technological	O
factors	O
.	O

Scientists	O
offer	O
several	O
possible	O
explanations	O
for	O
the	O
high	O
mortality	O
rate	O
of	O
the	O
1918	B-Incident
influenza	I-Incident
pandemic	E-Incident
.	O
Some	O
analyses	O
have	O
shown	O
the	O
virus	O
to	O
be	O
particularly	O
deadly	O
because	O
it	O
triggers	O
a	O
cytokine	O
storm	O
,	O
which	O
ravages	O
the	O
stronger	O
immune	O
system	O
of	O
young	O
adults	O
.	O

A	O
Proposers	O
Day	O
is	O
scheduled	O
for	O
March	O
7	O
,	O
2018	O
in	O
Arlington	S-Location
.	O
Details	O
and	O
registration	O
instructions	O
are	O
available	O
here:	O
https://go.usa.gov/xnFub	O
.	O

In	O
the	O
September	O
2014	O
incident	O
,	O
an	O
animal	O
caretaker	O
in	O
a	O
BSL-3	S-Platform
lab	O
noticed	O
decreased	O
airflow	O
to	O
their	O
respirator	O
and	O
discovered	O
that	O
a	O
hose	O
had	O
separated	O
from	O
its	O
coupling	O
.	O

In	O
urban	O
centres	O
,	O
the	O
greater	O
the	O
population	O
before	O
the	O
outbreak	O
,	O
the	O
longer	O
the	O
duration	O
of	O
the	O
period	O
of	O
abnormal	O
mortality	O
.	O

In	O
1968	O
,	O
Hamilton	B-Person
Smith	E-Person
,	O
a	O
molecular	O
biologist	O
at	O
the	O
Johns	B-Organization
Hopkins	I-Organization
University	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
in	O
Baltimore	S-Location
,	O
made	O
a	O
chance	O
discovery	O
that	O
shaped	O
the	O
world	O
of	O
genetics	O
for	O
decades	O
to	O
come	O
.	O

On	O
14	O
April	O
2014	O
,	O
one	O
Filipino	O
paramedic	O
died	O
in	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
with	O
six	O
other	O
reported	O
to	O
be	O
infected	O
with	O
the	O
virus	O
.	O

For	O
those	O
who	O
do	O
not	O
,	O
the	O
time	O
between	O
the	O
onset	O
of	O
symptoms	O
and	O
death	O
usually	O
ranges	O
from6	O
to	O
41	O
days	O
,	O
typically	O
about	O
14	O
days	O
.	O

The	O
authors	O
concluded	O
that	O
this	O
new	O
research	O
,	O
together	O
with	O
prior	O
analyses	O
from	O
the	O
south	O
of	O
France	S-Location
and	O
Germany	S-Location
,	O
"	O
ends	O
the	O
debate	O
about	O
the	O
cause	O
of	O
the	O
Black	B-Disease
Death	E-Disease
,	O
and	O
unambiguously	O
demonstrates	O
that	O
Y.	B-Pathogen
pestis	E-Pathogen
was	O
the	O
causative	O
agent	O
of	O
the	O
epidemic	O
plague	S-Disease
that	O
devastated	O
Europe	S-Location
during	O
the	O
Middle	O
Ages"	O
.	O

Members	O
of	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
agreed	O
with	O
that	O
assessment	O
.	O

Homer	S-Person
used	O
it	O
in	O
the	O
Odyssey	O
to	O
describe	O
the	O
monstrous	O
Scylla	O
,	O
with	O
her	O
mouths	O
"	O
full	O
of	O
black	B-Disease
Death	E-Disease
"	O
()	O
.	O

A	O
Broad	O
Agency	O
Announcement	O
(BAA)	O
solicitation	O
for	O
the	O
first	O
phase	O
of	O
the	O
program	O
is	O
expected	O
to	O
be	O
available	O
in	O
March	O
on	O
FedBizOpps	O
here:	O
http://go.usa.gov/3W53j	O
.	O

This	O
design	O
necessitates	O
the	O
use	O
of	O
a	O
variety	O
of	O
experimental	O
methods	O
.	O

The	O
same	O
scientific	O
advances	O
in	O
biotechnology	O
,	O
genetics	O
,	O
and	O
medicine	O
that	O
are	O
intended	O
to	O
improve	O
life	O
could	O
also	O
be	O
used	O
to	O
develop	O
biological	O
weapons	O
capable	O
of	O
causing	O
mass	O
destruction	O
,	O
according	O
to	O
researchers	O
from	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Bloomberg	I-Organization
School	I-Organization
of	I-Organization
Public	I-Organization
Health's	I-Organization
Center	I-Organization
for	I-Organization
Civilian	I-Organization
Biodefense	I-Organization
Strategies	E-Organization
They	O
urge	O
governments	O
and	O
the	O
scientific	O
community	O
to	O
adopt	O
a	O
system	O
of	O
checks	O
and	O
balances	O
to	O
prevent	O
the	O
misappropriation	O
of	O
scientific	O
discoveries	O
and	O
technology	O
.	O

Escherichia	B-Pathogen
coli	I-Pathogen
lysogenic	I-Pathogen
for	I-Pathogen
λc1857	E-Pathogen
were	O
grown	O
with	O
gentle	O
shaking	O
in	O
Liquid	O
Broth	O
(LB)	O
medium	O
at	O
30°C	O
for	O
overnight	O
.	O

The	O
virus	O
completes	O
a	O
set	O
of	O
steps	O
when	O
infecting	O
each	O
individual	O
cell	O
.	O

Water	O
has	O
an	O
attenuation	O
of	O
0	O
Hounsfield	O
units	O
(HU)	O
,	O
while	O
air	O
is	O
−1,000 HU	O
,	O
cancellous	O
bone	O
is	O
typically	O
+400 HU	O
,	O
and	O
cranial	O
bone	O
can	O
reach	O
2,000 HU	O
or	O
more	O
(os	O
temporale)	O
and	O
can	O
cause	O
artifacts	O
.	O

The	O
WHO	S-Organization
and	O
NIH	S-Organization
do	O
not	O
oppose	O
the	O
use	O
of	O
non-steroidal	B-Drug
anti-inflammatory	I-Drug
drugs	E-Drug
(	O
NSAIDs	S-Drug
)	O
such	O
as	O
ibuprofen	S-Drug
for	O
symptoms	O
,	O
and	O
the	O
FDA	S-Organization
says	O
currently	O
there	O
is	O
no	O
evidence	O
that	O
NSAIDs	S-Drug
worsen	O
symptoms	O
.	O

Hence	O
,	O
NPC1	O
was	O
shown	O
to	O
be	O
critical	O
to	O
entry	O
of	O
this	O
filovirus	O
,	O
because	O
it	O
mediates	O
infection	O
by	O
binding	O
directly	O
to	O
viral	O
GP	O
.	O

A	O
Wisconsin	S-Location
study	O
published	O
in	O
the	O
Journal	B-Organization
of	I-Organization
the	I-Organization
American	I-Organization
Medical	I-Organization
Association	E-Organization
in	O
September	O
2010	O
,	O
reported	O
that	O
findings	O
showed	O
that	O
the	O
2009	B-Disease
H1N1	I-Disease
flu	E-Disease
was	O
no	O
more	O
severe	O
than	O
the	O
seasonal	B-Disease
flu	E-Disease
.	O
"	O
The	O
risk	O
of	O
most	O
serious	O
complications	O
was	O
not	O
elevated	O
in	O
adults	O
or	O
children"	O
,	O
the	O
study's	O
authors	O
wrote.	O
"	O
Children	O
were	O
disproportionately	O
affected	O
by	O
2009	B-Disease
H1N1	E-Disease
infection	O
,	O
but	O
the	O
perceived	O
severity	O
of	O
symptoms	O
and	O
risk	O
of	O
serious	O
outcomes	O
were	O
not	O
increased.	O
"	O
Children	O
infected	O
in	O
the	O
2009	B-Incident
H1N1	I-Incident
flu	I-Incident
pandemic	E-Incident
were	O
no	O
more	O
likely	O
to	O
be	O
hospitalized	O
with	O
complications	O
or	O
get	O
pneumonia	S-Disease
than	O
those	O
who	O
catch	O
seasonal	O
strains	O
.	O

For	O
example	O
,	O
the	O
news	O
department	O
at	O
the	O
journal	O
Science	S-Organization
produced	O
an	O
article	O
with	O
the	O
humorous	O
title	O
"	O
Swine	B-Disease
Flu	E-Disease
Names	O
Evolving	O
Faster	O
Than	O
Itself"	O
.	O

And	O
just	O
as	O
the	O
American	O
people	O
depend	O
on	O
CDC	S-Organization
to	O
protect	O
their	O
health	O
,	O
our	O
workers	O
should	O
be	O
able	O
to	O
depend	O
on	O
us	O
to	O
protect	O
their	O
health	O
.	O

For	O
details	O
of	O
the	O
event	O
,	O
including	O
registration	O
requirements	O
,	O
visit:	O

However	O
,	O
developing	O
these	O
devices	O
on	O
a	O
much	O
greater	O
scale	O
for	O
biosecurity	O
purposes	O
may	O
mean	O
creating	O
and	O
funding	O
specific	O
federal	O
agencies	O
to	O
promote	O
commercialization	O
,	O
according	O
to	O
expert	O
testimony	O
on	O
Wednesday	O
during	O
a	O
meeting	O
of	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization

The	O
Trump	B-Organization
Administration	E-Organization
today	O
released	O
a	O
new	O
National	B-Document
Biodefense	I-Document
Strategy	E-Document
,	O
along	O
with	O
an	O
order	O
from	O
President	O
Donald	B-Person
Trump	E-Person
that	O
directs	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
()	O
to	O
take	O
the	O
coordinating	O
lead	O
and	O
establishes	O
a	O
cabinet-level	O
biodefense	O
steering	O
committee	O
.	O

It's	O
been	O
a	O
deplorable	O
situation	O
that	O
we've	O
had	O
this	O
number	O
of	O
deaths	O
within	O
the	O
first	O
few	O
weeks	O
of	O
January	O
.	O

To	O
avoid	O
blundering	O
into	O
disaster	O
,	O
the	O
errors	O
of	O
the	O
past	O
should	O
be	O
acknowledged	O
.	O

To	O
achieve	O
molecular	O
imaging	O
of	O
disease	O
biomarkers	O
using	O
MRI	S-Technology
targeted	O
MRI	S-Technology
contrast	O
agents	O
with	O
high	O
specificity	O
and	O
high	O
relaxivity	O
(sensitivity)	O
are	O
required	O
.	O

Other	O
scientific	O
organizations	O
,	O
including	O
the	O
International	B-Organization
Centre	I-Organization
for	I-Organization
Genetic	I-Organization
Engineering	I-Organization
and	I-Organization
Biotechnology	E-Organization
the	O
International	B-Organization
Union	I-Organization
of	I-Organization
Biochemistry	I-Organization
and	I-Organization
Molecular	I-Organization
Biology	E-Organization
,	O
and	O
,	O
have	O
also	O
expressed	O
support	O
for	O
codes	O
of	O
conduct	O
.	O

It	O
is	O
recommended	O
that	O
such	O
patients	O
receive	O
both	O
.	O

Successful	O
public/private	O
partnership	O
models	O
that	O
currently	O
exist	O
include	O
the	O
International	B-Organization
Council	I-Organization
for	I-Organization
the	I-Organization
Life	I-Organization
Sciences	E-Organization
(a	O
U.S.	S-Location
-based	O
non-profit	O
agency)	O
,	O
working	O
in	O
collaboration	O
with	O
the	O
Royal	B-Organization
Scientific	I-Organization
Society	I-Organization
of	I-Organization
Jordan	E-Organization
(	O
RSS	S-Organization
)	O
,	O
the	O
Biosafety	B-Organization
and	I-Organization
Biosecurity	I-Organization
International	I-Organization
Consortium	E-Organization
(	O
BBIC	S-Organization
,	O
a	O
network	O
of	O
concerned	O
individuals	O
from	O
22	O
countries	O
in	O
the	O
region)	O
,	O
and	O
the	O
Moroccan	B-Organization
Biosafety	I-Organization
Association	E-Organization
()	O
that	O
have	O
developed	O
successful	O
sustainable	O
projects	O
since	O
2005	O
.	O

Until	O
Sanders	S-Person
finally	O
threatened	O
the	O
Japanese	O
with	O
bringing	O
the	O
Soviets	S-Organization
into	O
the	O
picture	O
,	O
little	O
information	O
about	O
biological	O
warfare	O
was	O
being	O
shared	O
with	O
the	O
Americans	O
.	O

These	O
should	O
be	O
disposed	O
of	O
as	O
biohazardous	O
waste	O
.	O

AFP	O
News	O
Agency	O
(11	O
April	O
2020)	O
.	O

When	O
an	O
infected	O
person	O
sneezes	S-Phenotype
or	O
coughs	S-Phenotype
,	O
more	O
than	O
half	O
a	O
million	O
virus	O
particles	O
can	O
spread	O
to	O
those	O
nearby	O
.	O

Micro-organisms	O
-	O
Further	O
examination	O
of	O
organisms	O
in	O
support	O
of	O
the	O
classification	O
carried	O
out	O
under	O
directive	O
90/679/EEC	O
.	O

"	O
We	O
hope	O
policymakers	O
and	O
practitioners	O
consider	O
our	O
recommendations	O
in	O
their	O
work	O
to	O
strengthen	O
health	O
sector	O
resilience	O
and	O
fortify	O
pandemic	O
preparedness,	O
"	O
said	O
Adalja	S-Person

The	O
three	O
most	O
popular	O
types	O
are	O
nutrigenomics	O
,	O
DIY	B-Activity
biology	E-Activity
and	O
grinder	O
.	O

SARS	S-Disease
in	O
India	S-Location
Sars	S-Disease
spreads	O
to	O
India	S-Location
On	O
19	O
April	O
,	O
Premier	O
of	O
the	O
People's	B-Organization
Republic	I-Organization
of	I-Organization
China	E-Organization
Wen	B-Person
Jiabao	E-Person
announced	O
that	O
there	O
would	O
be	O
severe	O
consequences	O
for	O
local	O
officials	O
who	O
did	O
not	O
report	O
SARS	S-Disease
cases	O
in	O
a	O
timely	O
and	O
accurate	O
manner	O
,	O
signaling	O
a	O
major	O
change	O
in	O
policy.	O
had	O
also	O
been	O
gaining	O
prominence	O
in	O
the	O
mainland	O
Chinese	O
media	O
;	O
by	O
late	O
April	O
,	O
it	O
had	O
jumped	O
from	O
virtual	O
invisibility	O
onto	O
the	O
front	O
page	O
,	O
with	O
daily	O
reports	O
from	O
all	O
provinces	O
on	O
new	O
cases	O
and	O
measures	O
.	O

33	O
people	O
became	O
infected	O
with	O
CCHF	S-Disease
3	O
of	O
them	O
died	O
in	O
.	O

The	O
rules	O
took	O
effect	O
with	O
a	O
60-day	O
grace	O
period	O
and	O
were	O
aimed	O
at	O
reducing	O
fatigue	O
related	O
accidents	O
and	O
fatalities	O
.	O

On	O
Friday	O
,	O
July	O
13	O
,	O
the	O
FDA	S-Organization
announced	O
the	O
approval	O
of	O
the	O
drug	O
tecovirimat	S-Drug
or	O
TPOXX	S-Drug
,	O
which	O
was	O
deemed	O
effective	O
following	O
successful	O
trials	O
on	O
animals	O
infected	O
with	O
viruses	O
related	O
to	O
the	O
one	O
that	O
causes	O
.	O

NHEJ	S-Technology
can	O
often	O
result	O
in	O
random	O
deletions	O
or	O
insertions	O
at	O
the	O
repair	O
site	O
,	O
which	O
may	O
disrupt	O
or	O
alter	O
gene	O
functionality	O
.	O

rVSV-ZEBOV	S-Vaccine
received	O
regulatory	O
approval	O
in	O
2019	O
.	O

When	O
people	O
read	O
the	O
obituaries	O
,	O
they	O
saw	O
the	O
war	O
or	O
postwar	O
deaths	O
and	O
the	O
deaths	O
from	O
the	O
influenza	S-Disease
side	O
by	O
side	O
.	O

It	O
also	O
elects	O
and	O
advises	O
an	O
Executive	B-Organization
Board	E-Organization
made	O
up	O
of	O
34	O
health	O
specialists	O
.	O

Biotechnology	O
is	O
a	O
broad	O
term	O
referring	O
to	O
the	O
study	O
of	O
biological	O
processes	O
to	O
inform	O
technological	O
advancement	O
.	O

Did	O
you	O
have	O
a	O
question?	O
On	O
the	O
phone?	O

Financial	O
cutbacks	O
have	O
limited	O
the	O
tracking	O
of	O
disease	O
outbreaks	O
.	O

BSL‐4	S-Platform
practices	O
,	O
safety	O
equipment	O
,	O
and	O
facility	O
design	O
and	O
construction	O
are	O
applicable	O
for	O
work	O
with	O
dangerous	O
and	O
exotic	O
agents	O
that	O
pose	O
a	O
high	O
individual	O
risk	O
of	O
life‐threatening	O
disease	O
,	O
which	O
may	O
be	O
transmitted	O
via	O
the	O
aerosol	O
route	O
,	O
and	O
for	O
which	O
there	O
is	O
no	O
available	O
vaccine	O
or	O
therapy	O
.	O

The	O
last	O
naturally	O
occurring	O
infection	O
was	O
of	O
Variola	B-Pathogen
minor	E-Pathogen
in	O
in	O
1977	O
.	O

By	O
the	O
end	O
of	O
1346	O
,	O
reports	O
of	O
plague	S-Disease
had	O
reached	O
the	O
seaports	O
of	O
Europe	S-Location
:	O
"	O
India	S-Location
was	O
depopulated	O
,	O
Tartary	S-Location
,	O
Mesopotamia	S-Location
,	O
Syria	S-Location
,	O
Armenia	S-Location
were	O
covered	O
with	O
dead	O
bodies".	O
cited	O
by	O
,	O
p.	O
15	O
.	O

Within	O
each	O
sector	O
,	O
local	O
and	O
regional	O
actors	O
handle	O
samples	O
and	O
communicate	O
with	O
national	O
resources	O
and	O
BSL-3	S-Platform
laboratories	O
.	O

It	O
has	O
been	O
speculated	O
that	O
this	O
operation	O
may	O
have	O
been	O
responsible	O
for	O
the	O
advent	O
of	O
the	O
Black	B-Incident
Death	E-Incident
in	O
.	O
At	O
the	O
time	O
,	O
the	O
attackers	O
thought	O
that	O
the	O
stench	O
was	O
enough	O
to	O
kill	O
them	O
,	O
though	O
it	O
was	O
the	O
disease	O
that	O
was	O
deadly	O
.	O

Since	O
that	O
time	O
,	O
there	O
have	O
been	O
many	O
reports	O
of	O
laboratory‐acquired	O
infection	O
,	O
with	O
many	O
more	O
cases	O
probably	O
having	O
gone	O
unreported	O
.	O

Persons	O
&lt;35	O
years	O
of	O
age	O
in	O
1918	O
had	O
a	O
disproportionately	O
hi	O
gh	B-Disease
influe	E-Disease
nza	O
incidence	O
(Figure	O
3	O
,	O
panel	O
A)	O
.	O

Johnson	S-Person
,	O
John	S-Person
.	O
"	O
Invasion	O
by	O
Medfly	O
Defies	O
Logic	O
,	O
Scientists	O
Say	O
Infestation:	O
Experts	O
discover	O
peculiar	O
patterns	O
in	O
the	O
spread	O
of	O
the	O
stubborn	O
fruit	O
fly"	O
,	O
Los	O
Angeles	O
Times	O
,	O
December	O
30	O
,	O
1989	O
,	O
accessed	O
February	O
21	O
,	O
2012	O
.	O

By	O
making	O
a	O
comparison	O
of	O
the	O
number	O
and	O
type	O
of	O
articles	O
published	O
by	O
Environmental	O
Biosafety	O
Research	O
(EBR)	O
with	O
those	O
from	O
other	O
journals	O
active	O
in	O
the	O
arena	O
of	O
GMO	S-Technology
biosafety	O
,	O
it	O
is	O
possible	O
to	O
shed	O
light	O
on	O
the	O
answer	O
to	O
the	O
question	O
posed	O
in	O
the	O
title	O
.	O

On	O
February	O
18	O
,	O
2005	O
,	O
Court	O
TV	O
aired	O
an	O
episode	O
of	O
about	O
the	O
incident	O
,	O
entitled:	O
"	O
'Bio-Attack'	O
–	O
Oregon	S-Location
Cult	O
Poisonings"	O
.	O

We	O
think	O
that	O
it	O
is	O
prudent	O
,	O
as	O
is	O
being	O
proposed	O
by	O
HHS	S-Organization
to	O
require	O
DNA	O
synthesis	O
companies	O
to	O
screen	O
synthesis	O
requests	O
against	O
harmful	O
agents	O
.	O

A	O
method	O
of	O
for	O
detection	O
of	O
high-consequence	O
pathogens	O
in	O
larger	O
volume	O
water	O
also	O
led	O
all	O
4	O
agencies	O
to	O
purchase	O
the	O
same	O
equipment	O
.	O

Telehealth	O
is	O
proving	O
to	O
be	O
a	O
cost-effective	O
solution	O
.	O

Members	O
of	O
the	O
Monterey	O
team	O
said	O
the	O
blowing	O
of	O
germs	O
in	O
the	O
wind	O
suggested	O
that	O
a	O
contemporary	O
threat	O
could	O
be	O
harder	O
to	O
combat	O
and	O
contain	O
.	O

The	O
exercises	O
,	O
ring	O
trials	O
,	O
and	O
audits	O
carried	O
out	O
at	O
the	O
network	O
members'	O
various	O
laboratories	O
have	O
shed	O
light	O
on	O
some	O
areas	O
of	O
inconsistency	O
regarding	O
how	O
practices	O
are	O
handled	O
and	O
how	O
Swedish	O
biopreparedness	O
could	O
be	O
improved	O
.	O

Some	O
of	O
the	O
various	O
chemical	O
defense	O
programs	O
were	O
recently	O
consolidated	O
under	O
the	O
new	O
Countering	B-Organization
Weapons	I-Organization
of	I-Organization
Mass	I-Organization
Destruction	I-Organization
(CWMD)	I-Organization
Office	E-Organization
.	O
However	O
,	O
several	O
agency's	O
components	O
,	O
including	O
Customs	B-Organization
and	I-Organization
Border	I-Organization
Protection	E-Organization
and	O
the	O
,	O
still	O
run	O
their	O
own	O
programs	O
.	O

To	O
do	O
this	O
,	O
the	O
team	O
wrote	O
one	O
bacteria's	O
entire	O
genome	O
into	O
a	O
digital	O
computer	O
file	O
and	O
then	O
translated	O
the	O
file	O
into	O
small	O
pieces	O
of	O
DNA	O
.	O

Supportive	O
treatments	O
may	O
be	O
useful	O
in	O
those	O
with	O
mild	O
symptoms	O
at	O
the	O
early	O
stage	O
of	O
infection	O
.	O

NHEJ	S-Technology
can	O
often	O
result	O
in	O
random	O
deletions	O
or	O
insertions	O
at	O
the	O
repair	O
site	O
,	O
which	O
may	O
disrupt	O
or	O
alter	O
gene	O
functionality	O
.	O

Nationalism	O
pervaded	O
as	O
people	O
accepted	O
government	O
authority	O
.	O

And	O
there	O
was	O
a	O
lack	O
of	O
scientific	O
knowledge	O
in	O
this	O
laboratory	O
about	O
inactivation	O
because	O
there	O
were	O
articles	O
in	O
the	O
published	O
literature	O
that	O
indicated	O
that	O
this	O
was	O
not	O
a	O
perfect	O
method	O
to	O
inactivate	O
anthrax	S-Pathogen
.	O
This	O
laboratory	O
is	O
closed	O
,	O
and	O
it	O
will	O
remain	O
closed	O
with	O
respect	O
to	O
what	O
we	O
call	O
select	O
agents	O
which	O
are	O
the	O
most	O
dangerous	O
microbes	O
until	O
it	O
is	O
completely	O
reviewed	O
and	O
until	O
Dr.	O
and	O
his	O
group	O
recommends	O
to	O
me	O
and	O
I	O
approve	O
its	O
reopening	O
under	O
different	O
conditions	O
that	O
we'll	O
do	O
everything	O
humanly	O
possible	O
to	O
assure	O
that	O
nothing	O
like	O
this	O
happens	O
again	O
.	O

This	O
decreases	O
the	O
risk	O
of	O
health	O
services	O
being	O
overwhelmed	O
and	O
provides	O
more	O
time	O
for	O
vaccines	O
and	O
treatments	O
to	O
be	O
developed	O
.	O

Many	O
medical	O
advances	O
are	O
dependent	O
on	O
the	O
ability	O
to	O
fight	O
infections	O
using	O
antibiotics	O
,	O
including	O
joint	O
replacements	O
,	O
organ	B-Technology
transplants	E-Technology
cancer	O
therapy	O
,	O
and	O
treatment	O
of	O
chronic	O
diseases	O
like	O
diabetes	S-Disease
,	O
asthma	S-Disease
,	O
and	O
.	O

On	O
February	O
2	O
,	O
2004	O
in	O
a	B-Location
mail	I-Location
room	I-Location
serving	I-Location
Senator	I-Location
Bill	I-Location
Frist	I-Location
in	I-Location
the	I-Location
Dirksen	I-Location
Senate	I-Location
Office	I-Location
Building	E-Location
a	O
white	O
powdery	O
substance	O
was	O
found	O
on	O
a	O
sorting	O
machine.	O
"	O
Frist:	O
Ricin	S-Pathogen
confirmed	O
but	O
no	O
illness	O
reported"	O
,	O
CNN.com	O
,	O
February	O
4	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

There	O
has	O
also	O
been	O
a	O
new	O
generation	O
of	O
Self-Contained	B-Equipment
Breathing	I-Equipment
Apparatuses	E-Equipment
(	O
SCBA	S-Equipment
)	O
which	O
has	O
been	O
recently	O
made	O
more	O
robust	O
against	O
bioterrorism	O
agents	O
.	O

Alteration	O
of	O
metabolic	O
pathway:	O
for	O
example	O
,	O
some	O
sulfonamide-resistant	O
bacteria	O
do	O
not	O
require	O
para-aminobenzoic	O
acid	O
(PABA)	O
,	O
an	O
important	O
precursor	O
for	O
the	O
synthesis	O
of	O
folic	B-Drug
acid	E-Drug
and	O
nucleic	O
acids	O
in	O
bacteria	O
inhibited	O
by	O
sulfonamides	O
,	O
instead	O
,	O
like	O
mammalian	O
cells	O
,	O
they	O
turn	O
to	O
using	O
preformed	O
.	O

He	O
was	O
hospitalized	O
by	O
9	O
April	O
and	O
died	O
on	O
13	O
April	O
.	O

This	O
increases	O
the	O
risk	O
,	O
as	O
many	O
major	O
diseases	O
originate	O
in	O
animals	O
before	O
crossing	O
over	O
to	O
humans	O
.	O

In	O
addition	O
,	O
the	O
costs	O
of	O
employing	O
are	O
relatively	O
low	O
.	O

In	O
September	O
2014	O
,	O
the	O
United	B-Organization
Nations	I-Organization
Security	I-Organization
Council	E-Organization
declared	O
the	O
Ebola	B-Incident
virus	I-Incident
outbreak	E-Incident
in	O
Western	B-Location
Africa	E-Location
"	O
a	O
threat	O
to	O
international	O
peace	O
and	O
security	O
"	O
and	O
unanimously	O
adopted	O
a	O
resolution	O
urging	O
UN	S-Organization
member	O
states	O
to	O
provide	O
more	O
resources	O
to	O
fight	O
the	O
outbreak	O
.	O

Medications	O
to	O
prevent	O
blood	B-Disease
clotting	E-Disease
have	O
been	O
suggested	O
for	O
treatment	O
,	O
and	O
anticoagulant	O
therapy	O
with	O
low	O
molecular	O
weight	O
heparin	O
appears	O
to	O
be	O
associated	O
with	O
better	O
outcomes	O
in	O
severe	O
COVID‐19	O
showing	O
signs	O
of	O
coagulopathy	S-Phenotype
()	O
.	O

The	O
system	O
,	O
called	O
NY	B-Platform
Responds	E-Platform
electronically	O
connects	O
every	O
county	O
in	O
New	B-Location
York	E-Location
to	O
aid	O
in	O
disaster	O
response	O
and	O
recovery	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
biosafety	O
perception	O
and	O
practices	O
of	O
laboratory	O
technicians	O
during	O
routine	O
work	O
in	O
clinical	O
laboratories	O
of	O
.	O

A	O
self-identified	O
biohacker	O
,	O
she	O
told	O
me	O
people	O
shouldn't	O
buy	O
Zayner	S-Person
's	O
kits	O
,	O
not	O
just	O
because	O
they	O
don't	O
work	O
half	O
the	O
time	O
(she's	O
a	O
professional	O
and	O
even	O
she	O
couldn't	O
get	O
it	O
to	O
work)	O
,	O
but	O
because	O
CRISPR	S-Technology
is	O
such	O
a	O
new	O
technology	O
that	O
scientists	O
aren't	O
yet	O
sure	O
of	O
all	O
the	O
risks	O
involved	O
in	O
using	O
it	O
.	O

As	O
best	O
as	O
is	O
known	O
,	O
all	O
of	O
these	O
allegations	O
are	O
deliberate	O
,	O
fraudulent	O
concoctions	O
.	O

That's	O
why	O
it's	O
important	O
that	O
we	O
have	O
protocols	O
in	O
place	O
that	O
are	O
rigorously	O
reviewed	O
.	O

Assessed	O
contributions	O
were	O
kept	O
the	O
same	O
.	O

Each	O
regional	O
office	O
is	O
headed	O
by	O
a	O
director	O
,	O
who	O
is	O
elected	O
by	O
the	O
Regional	O
Committee	O
.	O

HELEN	B-Person
BRANSWELL	E-Person
Hi	O
.	O

According	O
to	O
the	O
report	O
,	O
HHS	S-Organization
a	O
consistent	O
,	O
transparent	O
,	O
and	O
standardized	O
protocol	O
for	O
interagency	O
data	O
sharing	O
.	O

"	O
What's	O
at	O
stake	O
here	O
is	O
that	O
these	O
labs	O
deal	O
with	O
very	O
dangerous	O
biological	O
materials	O
,	O
in	O
this	O
case	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
that	O
could	O
potentially	O
cause	O
anthrax	S-Disease
,	O
which	O
as	O
you	O
recall	O
from	O
the	O
post-	O
9/11	B-Incident
attacks	E-Incident
in	O
Washington	S-Location
and	O
other	O
places	O
,	O
could	O
potentially	O
be	O
disastrous,	O
"	O
said	O
.	O

The	O
capabilities	O
we	O
gained	O
then	O
are	O
now	O
helping	O
us	O
to	O
fight	O
the	O
Ebola	S-Pathogen
outbreak	O
.	O

The	O
system	O
works	O
by	O
tracking	O
the	O
symptoms	O
of	O
those	O
taken	O
into	O
the	O
emergency	O
department-based	O
on	O
the	O
location	O
of	O
the	O
hospital	O
to	O
which	O
they	O
are	O
taken	O
and	O
their	O
home	O
address-and	O
assessing	O
any	O
patterns	O
in	O
symptoms	O
.	O

Even	O
though	O
he	O
was	O
evacuated	O
to	O
Hong	B-Location
Kong	E-Location
,	O
he	O
died	O
on	O
13	O
March	O
.	O

Three	O
years	O
ago	O
more	O
than	O
100	O
people	O
in	O
the	O
same	O
city	O
became	O
infected	O
with	O
.	O
Both	O
diseases	O
are	O
alleged	O
to	O
have	O
spread	O
through	O
contaminated	O
drinking	O
water	O
.	O

For	O
example	O
,	O
North	B-Location
Korea	E-Location
is	O
rumored	O
to	O
have	O
assembled	O
an	O
arsenal	O
containing	O
"	O
anthrax	S-Disease
,	O
botulism	S-Disease
,	O
hemorrhagic	B-Disease
fever	E-Disease
,	O
plague	S-Disease
,	O
smallpox	S-Disease
,	O
typhoid	S-Disease
,	O
and	O
yellow	B-Disease
fever	E-Disease
,	O
"	O
ready	O
in	O
case	O
of	O
attack	O
.	O

Inglesby	S-Person
said	O
another	O
encouraging	O
element	O
of	O
the	O
plan	O
includes	O
a	O
commitment	O
to	O
working	O
with	O
other	O
countries	O
to	O
strengthen	O
the	O
capacity	O
to	O
fight	O
infectious	O
diseases.	O
"	O
I	O
would	O
have	O
liked	O
to	O
see	O
specific	O
mention	O
to	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
by	O
name	O
,	O
but	O
it	O
is	O
very	O
heartening	O
to	O
see	O
the	O
international	O
commitment	O
to	O
capacity	O
building	O
for	O
epidemic	O
response,	O
"	O
he	O
said	O
,	O
noting	O
that	O
the	O
release	O
of	O
a	O
is	O
expected	O
next	O
month	O
,	O
which	O
might	O
include	O
more	O
details	O
about	O
those	O
activities	O
.	O

Rajneesh	S-Person
left	O
Oregon	S-Location
by	O
plane	O
on	O
October	O
27	O
,	O
1985	O
,	O
and	O
was	O
arrested	O
when	O
he	O
landed	O
in	O
Charlotte	S-Location
,	O
North	B-Location
Carolina	E-Location
,	O
and	O
charged	O
with	O
35	O
counts	O
of	O
deliberate	O
violations	O
of	O
immigration	O
laws	O
.	O

As	O
of	O
June	O
2007	O
,	O
the	O
BBD	S-Platform
contained	O
6694	O
records	O
pertaining	O
to	O
scientific	O
publications	O
(full	O
references	O
and	O
abstracts)	O
,	O
and	O
appearing	O
in	O
international	O
and	O
national	O
scientific	O
periodicals	O
and	O
books	O
.	O

Scientists	O
have	O
long	O
been	O
able	O
to	O
change	O
and/or	O
modify	O
single	O
genes	O
or	O
small	O
sets	O
of	O
genes	O
.	O

However	O
,	O
by	O
2012	O
,	O
research	O
showed	O
that	O
as	O
many	O
as	O
579,000	O
people	O
could	O
have	O
been	O
killed	O
by	O
the	O
disease	O
,	O
as	O
only	O
those	O
fatalities	O
confirmed	O
by	O
laboratory	O
testing	O
were	O
included	O
in	O
the	O
original	O
number	O
,	O
and	O
meant	O
that	O
many	O
without	O
access	O
to	O
health	O
facilities	O
went	O
uncounted	O
.	O

The	O
initial	O
idea	O
of	O
having	O
more	O
or	O
less	O
identical	O
methods	O
in	O
all	O
4	O
laboratories	O
turned	O
out	O
to	O
be	O
unrealistic	O
,	O
as	O
the	O
different	O
agencies	O
are	O
responsible	O
for	O
different	O
sample	O
types-for	O
example	O
,	O
tissue	O
(human	O
and	O
animal)	O
,	O
food	O
,	O
feed	O
,	O
drinking	O
water	O
,	O
and	O
environmental	O
samples	O
.	O

However	O
,	O
in	O
2007	O
,	O
Christopher	B-Person
Warren	E-Person
demonstrated	O
that	O
the	O
British	O
smallpox	S-Pathogen
may	O
have	O
been	O
still	O
viable	O
.	O

On	O
14	O
October	O
,	O
her	O
condition	O
was	O
listed	O
as	O
"	O
critical"	O
and	O
58 individuals	O
were	O
being	O
monitored	O
and	O
25	O
received	O
an	O
experimental	O
vaccination	O
,	O
being	O
close	O
contacts	O
.	O

Once	O
subjected	O
to	O
steam	O
sterilization	O
,	O
where	O
it	O
is	O
super-heated	O
to	O
about	O
250	O
degrees	O
Fahrenheit	O
for	O
20	O
minutes	O
,	O
the	O
liquid	O
can	O
then	O
be	O
treated	O
as	O
normal	O
wastewater	O
.	O

Infusion‐related	O
reactions	O
.	O

Medvedik	S-Person
dismissed	O
that	O
concern	O
,	O
arguing	O
that	O
a	O
lot	O
of	O
interventions	O
that	O
could	O
lengthen	O
our	O
lives	O
,	O
like	O
supplements	O
,	O
wouldn't	O
be	O
expensive	O
to	O
produce.	O
"	O
There's	O
no	O
reason	O
why	O
that	O
stuff	O
can't	O
be	O
dirt-cheap	O
.	O

It	O
was	O
less	O
severe	O
than	O
the	O
second	O
wave	O
but	O
still	O
much	O
more	O
deadly	O
than	O
the	O
initial	O
first	O
wave	O
.	O

Remdesivir	S-Drug
requires	O
"	O
70	O
raw	O
materials	O
,	O
reagents	O
,	O
and	O
catalysts	O
"	O
to	O
make	O
,	O
and	O
approximately	O
"	O
25	O
chemical	O
steps.	O
"	O
Some	O
of	O
the	O
ingredients	O
are	O
extremely	O
dangerous	O
to	O
humans	O
,	O
especially	O
trimethylsilyl	O
cyanide	O
.	O

The	O
publication	O
of	O
this	O
article	O
is	O
to	O
reach	O
a	O
wider	O
audience	O
and	O
for	O
proper	O
recognition	O
of	O
the	O
efforts	O
by	O
the	O
project	O
team	O
.	O

Considering	O
the	O
extreme	O
danger	O
that	O
smallpox	S-Pathogen
poses	O
to	O
a	O
now	O
largely	O
unvaccinated	O
human	O
population	O
,	O
it	O
seems	O
at	O
least	O
questionable	O
to	O
make	O
the	O
smallpox	S-Pathogen
sequence	O
available	O
on	O
.	O

Larry	B-Person
Zeitlin	E-Person
President	O
,	O
added	O
,	O
"	O
This	O
award	O
is	O
a	O
credit	O
to	O
the	O
productivity	O
and	O
success	O
of	O
the	O
interdisciplinary	O
interinstitutional	O
team	O
,	O
and	O
also	O
highlights	O
the	O
great	O
potential	O
of	O
monoclonal	O
antibodies	O
to	O
address	O
even	O
the	O
most	O
challenging	O
of	O
infectious	O
disease	O
threats	O
to	O
public	O
health.	O
"	O

After	O
a	O
third	O
new	O
case	O
was	O
confirmed	O
on	O
2	O
July	O
,	O
and	O
it	O
was	O
discovered	O
that	O
all	O
3	O
new	O
cases	O
had	O
shared	O
a	O
meal	O
of	O
dog	O
meat	O
,	O
researchers	O
looked	O
at	O
the	O
possibility	O
that	O
the	O
meat	O
may	O
have	O
been	O
involved	O
in	O
the	O
transfer	O
of	O
the	O
virus	O
.	O

On	O
a	O
CNN	O
news	O
broadcast	O
in	O
2011	O
,	O
the	O
CNN	O
chief	O
medical	O
correspondent	O
,	O
Dr	O
.	O

That's	O
horrifying	O
,	O
but	O
it's	O
not	O
a	O
function	O
of	O
the	O
technology	O
itself	O
.	O

With	O
a	O
total	O
number	O
of	O
almost	O
272,000	O
cases	O
,	O
Brazil	S-Organization
became	O
the	O
country	O
with	O
the	O
third-highest	O
number	O
of	O
cases	O
,	O
following	O
Russia	S-Location
and	O
the	O
United	B-Location
States	E-Location
.	O
On	O
22	O
May	O
,	O
citing	O
especially	O
the	O
rapid	O
increase	O
of	O
infections	O
in	O
Brazil	S-Location
,	O
the	O
WHO	S-Organization
declared	O
South	B-Location
America	E-Location
to	O
currently	O
be	O
the	O
epicentre	O
of	O
the	O
pandemic	O
.	O

It	O
also	O
elects	O
and	O
advises	O
an	O
Executive	B-Organization
Board	E-Organization
made	O
up	O
of	O
34	O
health	O
specialists	O
.	O

Andrija	B-Person
Štampar	E-Person
was	O
the	O
Assembly	S-Organization
's	O
first	O
president	O
,	O
and	O
G.	B-Person
Brock	I-Person
Chisholm	E-Person
was	O
appointed	O
Director-General	O
of	O
WHO	S-Organization
,	O
having	O
served	O
as	O
Executive	O
Secretary	O
during	O
the	O
planning	O
stages	O
.	O

Genetic	B-Technology
engineering	E-Technology
also	O
helps	O
scientists	O
discover	O
new	O
ways	O
to	O
make	O
bacteria	O
produce	O
energy	O
from	O
raw	O
materials	O
.	O

The	O
only	O
agent	O
the	O
U.S.	S-Location
tested	O
was	O
the	O
toxin	O
ricin	S-Pathogen
,	O
a	O
product	O
of	O
the	O
castor	O
plant.The	O
U.S.	S-Location
conducted	O
tests	O
concerning	O
two	O
methods	O
of	O
ricin	S-Pathogen
dissemination:	O
the	O
first	O
,	O
which	O
involved	O
adhering	O
the	O
toxin	O
to	O
shrapnel	O
for	O
delivery	O
by	O
artillery	O
shell	O
,	O
was	O
successful	O
;	O
the	O
second	O
,	O
delivering	O
an	O
aerosol	O
cloud	O
of	O
ricin	S-Pathogen
,	O
was	O
proven	O
less	O
successful	O
in	O
these	O
tests	O
.	O

On	O
17	O
April	O
,	O
the	O
UAE	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
reported	O
another	O
fatality	O
and	O
four	O
additional	O
cases	O
,	O
including	O
the	O
Filipino	O
medical	O
worker	O
who	O
travelled	O
to	O
the	O
on	O
16	O
April	O
.	O

At	O
a	O
meeting	O
in	O
Los	B-Location
Angeles	E-Location
on	O
Dec.	O
6	O
,	O
the	O
scientific	O
panel	O
questioned	O
whether	O
the	O
unexplained	O
patterns	O
of	O
infestation	O
might	O
lend	O
credence	O
to	O
a	O
letter	O
distributed	O
by	O
a	O
group	O
that	O
calls	O
itself	O
the	O
Breeders	S-Organization
.	O
In	O
the	O
letter	O
,	O
sent	O
to	O
newspapers	O
and	O
Los	B-Organization
Angeles	E-Organization
Mayor	O
,	O
the	O
group	O
claimed	O
to	O
be	O
spreading	O
Medflies	O
to	O
protest	O
California	O
agricultural	O
practices	O
.	O

No	O
repeat	O
attacks	O
or	O
hoaxes	O
subsequently	O
occurred	O
,	O
and	O
a	O
detailed	O
account	O
of	O
the	O
incident	O
and	O
investigation	O
was	O
published	O
in	O
JAMA	S-Organization
in	O
1997	O
.	O

To	O
date	O
,	O
the	O
network's	O
activities	O
have	O
focused	O
primarily	O
on	O
high-consequence	O
bacteria	O
,	O
and	O
only	O
a	O
few	O
projects	O
have	O
involved	O
emerging	O
viruses	O
.	O

Zelicoff	S-Person
(2002)	O
,	O
Op.cit.	O
,	O
Op.cit	O
.	O

Only	O
24	O
(12.	O
6%)	O
laboratories	O
had	O
separated	O
room	O
for	O
sampling	O
and	O
57	O
(30%)	O
had	O
special	O
room	O
for	O
patients	O
.	O

APHIS	S-Organization
began	O
conducting	O
an	O
independent	O
investigation	O
at	O
on	O
June	O
24	O
.	O

Cas9	O
is	O
an	O
accurate	O
method	O
of	O
treating	O
diseases	O
due	O
to	O
the	O
targeting	O
of	O
the	O
Cas9	O
enzyme	O
only	O
affecting	O
certain	O
cell	O
types	O
.	O

Viral	O
sequence	O
data	O
now	O
suggest	O
that	O
the	O
entire	O
1918	B-Pathogen
virus	E-Pathogen
was	O
novel	O
to	O
humans	O
in	O
,	O
or	O
shortly	O
before	O
,	O
1918	O
,	O
and	O
that	O
it	O
thus	O
was	O
not	O
a	O
reassortant	O
virus	O
produced	O
from	O
old	O
existing	O
strains	O
that	O
acquired	O
1	O
or	O
more	O
new	O
genes	O
,	O
such	O
as	O
those	O
causing	O
the	O
1957	B-Incident
and	I-Incident
1968	I-Incident
pandemics	E-Incident
.	O
On	O
the	O
contrary	O
,	O
the	O
1918	B-Pathogen
virus	E-Pathogen
appears	O
to	O
be	O
an	O
avianlike	O
influenza	B-Pathogen
virus	E-Pathogen
derived	O
in	O
toto	O
from	O
an	O
unknown	O
source	O
(,)	O
,	O
as	O
its	O
8	O
genome	O
segments	O
are	O
substantially	O
different	O
from	O
contemporary	O
avian	O
influenza	S-Disease
genes	O
.	O

Anthrax	S-Pathogen
was	O
used	O
in	O
a	O
series	O
of	O
attacks	O
by	O
a	O
microbiologist	O
at	O
the	O
US	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infection	I-Organization
Disease	E-Organization
on	O
the	O
offices	O
of	O
several	O
United	B-Location
States	E-Location
Senators	O
in	O
late	O
2001	O
.	O

He	O
returned	O
to	O
the	O
hospital	O
by	O
ambulance	O
on	O
28	O
September	O
and	O
was	O
placed	O
in	O
isolation	O
and	O
tested	O
for	O
Ebola	S-Disease
.	O
He	O
died	O
on	O
8	O
October	O
.	O

Brooks	S-Person
,	O
said	O
H.R.	B-Document
6378	E-Document
updates	O
the	O
original	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
Act	E-Document
(	O
PAHPA	S-Document
)	O
,	O
which	O
was	O
signed	O
into	O
law	O
by	O
President	O
in	O
2006	O
.	O

Investigations	O
have	O
shown	O
that	O
there	O
are	O
hundreds	O
of	O
unreported	O
biosafety	O
accidents	O
,	O
with	O
laboratories	O
self-policing	O
the	O
handling	O
of	O
biohazardous	O
materials	O
and	O
lack	O
of	O
reporting	O
.	O

On	O
30	O
January	O
,	O
the	O
declared	O
the	O
coronavirus	O
a	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
.	O

Data	O
management	O
plans	O
as	O
required	O
prerequisite	O
for	O
funding	O
in	O
Australia	S-Location
can	O
then	O
be	O
employed	O
to	O
control	O
the	O
delivery	O
of	O
data	O
assets	O
planned	O
.	O

To	O
reduce	O
the	O
spread	O
,	O
the	O
WHO	S-Organization
recommended	O
raising	O
community	O
awareness	O
of	O
the	O
risk	O
factors	O
for	O
Ebola	S-Disease
infection	O
and	O
the	O
protective	O
measures	O
individuals	O
can	O
take	O
.	O

Political	O
pressure	O
from	O
China	S-Location
has	O
led	O
to	O
Taiwan	S-Location
being	O
barred	O
from	O
membership	O
of	O
the	O
WHO	S-Organization
and	O
other	O
UN-affiliated	O
organizations	O
,	O
and	O
in	O
2017	O
to	O
2020	O
the	O
WHO	S-Organization
refused	O
to	O
allow	O
Taiwanese	O
delegates	O
to	O
attend	O
the	O
annual	O
assembly	O
.	O

In	O
April	O
,	O
there	O
were	O
riots	O
in	O
some	O
Paris	S-Location
suburbs	O
.	O

Medical	O
researchers	O
viewed	O
the	O
results	O
through	O
fortified	O
glass	O
.	O

The	O
world	O
is	O
in	O
the	O
early	O
stages	O
of	O
what	O
may	O
be	O
the	O
most	O
deadly	O
pandemic	O
of	O
the	O
past	O
100	O
years	O
.	O

Dr	O
.	O

Such	O
weapons	O
,	O
designed	O
for	O
new	O
types	O
of	O
conflicts	O
and	O
warfare	O
scenarios	O
,	O
secret	O
operations	O
or	O
sabotage	O
activities	O
,	O
are	O
not	O
mere	O
science	O
fiction	O
,	O
but	O
are	O
increasingly	O
becoming	O
a	O
reality	O
that	O
we	O
have	O
to	O
face	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
,	O
DHHS	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

In	O
2003	O
,	O
the	O
WHO	S-Organization
denounced	O
the	O
Roman	B-Organization
Curia	E-Organization
's	O
health	O
department's	O
opposition	O
to	O
the	O
use	O
of	O
condoms	O
,	O
saying:	O
"	O
These	O
incorrect	O
statements	O
about	O
condoms	O
and	O
HIV	S-Pathogen
are	O
dangerous	O
when	O
we	O
are	O
facing	O
a	O
global	O
pandemic	O
which	O
has	O
already	O
killed	O
more	O
than	O
20 million	O
people	O
,	O
and	O
currently	O
affects	O
at	O
least	O
42 million.	O
"	O
,	O
the	O
Catholic	B-Organization
Church	E-Organization
remains	O
opposed	O
to	O
increasing	O
the	O
use	O
of	O
contraception	O
to	O
combat	O
HIV/AIDS	S-Disease
.	O
At	O
the	O
time	O
,	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
President	O
,	O
Guyana	S-Organization
's	O
Health	O
Minister	O
,	O
has	O
condemned	O
Pope	O
Benedict's	O
opposition	O
to	O
contraception	O
,	O
saying	O
he	O
was	O
trying	O
to	O
"	O
create	O
confusion	O
"	O
and	O
"	O
impede"	O
proven	O
strategies	O
in	O
the	O
battle	O
against	O
the	O
disease	O
.	O

The	O
introduction	O
of	O
Bacillus	B-Pathogen
thuringiensis	E-Pathogen
(Bt)	O
genes	O
into	O
the	O
plants	O
has	O
raised	O
issues	O
related	O
to	O
its	O
risk	O
assessment	O
and	O
biosafety	O
.	O

The	O
program	O
also	O
purified	O
biological	O
toxins	O
,	O
such	O
as	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
ricin	S-Pathogen
and	O
aflatoxin	S-Pathogen
.	O
After	O
1995	O
,	O
it	O
was	O
learned	O
that	O
,	O
in	O
all	O
,	O
Iraq	S-Location
had	O
produced	O
19,000	O
liters	O
of	O
concentrated	O
botulinum	B-Pathogen
toxin	E-Pathogen
(nearly	O
10,000	O
liters	O
filled	O
into	O
munitions)	O
,	O
8,500	O
liters	O
of	O
concentrated	O
anthrax	S-Pathogen
(6,500	O
liters	O
filled	O
into	O
munitions)	O
and	O
2,200	O
liters	O
of	O
aflatoxin	S-Pathogen
(1,580	O
liters	O
filled	O
into	O
munitions).Woods	O
,	O
Op.cit.	O
,	O
pg	O
8	O
In	O
total	O
,	O
the	O
program	O
grew	O
a	O
half	O
million	O
liters	O
of	O
biological	O
agents.	O
,	O
Op.cit	O
.	O

Other	O
organizations	O
involved	O
in	O
the	O
design	O
and	O
production	O
of	O
biological	O
weapons	O
were	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Defense	E-Organization
,	O
Ministry	B-Organization
of	I-Organization
Agriculture	E-Organization
,	O
Ministry	B-Organization
of	I-Organization
Health	E-Organization
,	O
USSR	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	E-Organization
,	O
and	O
KGB	S-Organization
.	O
The	O
USSR	S-Organization
bioweapons	O
investment	O
rivaled	O
its	O
considerable	O
investment	O
in	O
nuclear	O
arms	O
.	O

On	O
12	O
June	O
2019	O
,	O
in	O
Uganda	S-Location
a	O
5-year-old	O
boy	O
became	O
the	O
first	O
cross-border	O
victim	O
of	O
Ebola	S-Pathogen
,	O
with	O
two	O
more	O
people	O
testing	O
positive	O
for	O
Ebola	S-Pathogen
.	O
This	O
shows	O
the	O
spread	O
of	O
Ebola	S-Pathogen
to	O
neighboring	O
countries	O
because	O
of	O
rebel	O
attacks	O
and	O
community	O
resistance	O
hampering	O
virus	O
containment	O
work	O
in	O
eastern	O
.	O
In	O
late	O
2019	O
and	O
in	O
April	O
2020	O
,	O
attacks	O
and	O
protests	O
continued	O
to	O
disrupt	O
epidemic	O
response	O
work	O
.	O

Even	O
with	O
a	O
tear	O
,	O
the	O
lab	O
said	O
,	O
the	O
positive	O
air	O
pressure	O
within	O
the	O
suit	O
would	O
keep	O
pathogens	O
from	O
entering	O
.	O

She	O
has	O
experience	O
in	O
the	O
design	O
of	O
high	O
containment	O
laboratories	O
and	O
has	O
coordinated	O
and	O
managed	O
the	O
since	O
1992	O
.	O

Most	O
of	O
humanity	O
felt	O
the	O
effects	O
of	O
this	O
strain	O
of	O
the	O
influenza	O
virus	O
.	O

The	O
majority	O
of	O
people	O
who	O
catch	O
the	O
infection	O
recover	O
,	O
but	O
many	O
are	O
left	O
with	O
large	O
scars	O
from	O
the	O
rash	S-Disease
There	O
are	O
those	O
who	O
become	O
blind	O
from	O
the	O
infection	O
.	O

Dr	O
.	O

In	O
this	O
article	O
,	O
I	O
would	O
like	O
to	O
discuss	O
the	O
potential	O
uses	O
and	O
their	O
urgency	O
in	O
the	O
race	O
to	O
improve	O
gene	B-Technology
editing	E-Technology

This	O
testing	O
could	O
take	O
up	O
to	O
2	O
weeks	O
.	O

As	O
the	O
outbreak	O
progressed	O
,	O
the	O
media	O
reports	O
,	O
many	O
hospitals	O
,	O
short	O
on	O
both	O
staff	O
and	O
supplies	O
,	O
were	O
overwhelmed	O
and	O
closed	O
down	O
,	O
leading	O
some	O
health	O
experts	O
to	O
state	O
that	O
the	O
inability	O
to	O
treat	O
other	O
medical	O
needs	O
may	O
have	O
been	O
causing	O
"	O
an	O
additional	O
death	O
toll	O
[that	O
is]	O
likely	O
to	O
exceed	O
that	O
of	O
the	O
outbreak	O
itself"	O
.	O

BSL‐1	S-Platform
represents	O
a	O
basic	O
level	O
of	O
containment	O
that	O
relies	O
on	O
standard	O
microbiological	O
practices	O
with	O
no	O
special	O
primary	O
or	O
secondary	O
barriers	O
recommended	O
,	O
other	O
than	O
a	O
sink	O
for	O
hand	O
washing	O
.	O

With	O
regard	O
to	O
Ebola	S-Disease
and	O
economic	O
activity	O
in	O
the	O
country	O
of	O
Liberia	S-Location
,	O
a	O
study	O
found	O
that	O
8%	O
of	O
automotive	O
firms	O
,	O
8%	O
of	O
construction	O
firms	O
,	O
15%	O
of	O
food	O
businesses	O
and	O
30%	O
of	O
restaurants	O
had	O
closed	O
due	O
to	O
the	O
Ebola	B-Incident
outbreak	E-Incident
.	O
Montserrado	B-Location
county	E-Location
experienced	O
up	O
to	O
20%	O
firm	O
closure	O
.	O

So	O
multiple	O
redundant	O
checks	O
to	O
prevent	O
infection	O
with	O
flu	O
.	O

Margaret	B-Person
Chan	E-Person
,	O
Director-General	O
of	O
the	O
WHO	S-Organization
,	O
replied	O
stating	O
,	O
"	O
Without	O
question	O
,	O
the	O
BMJ	S-Organization
feature	O
and	O
editorial	O
will	O
leave	O
many	O
readers	O
with	O
the	O
impression	O
that	O
's	O
decision	O
to	O
declare	O
a	O
pandemic	O
was	O
at	O
least	O
partially	O
influenced	O
by	O
a	O
desire	O
to	O
boost	O
the	O
profits	O
of	O
the	O
pharmaceutical	O
industry	O
.	O

The	O
Iranian	B-Organization
Parliament	E-Organization
was	O
shut	O
down	O
,	O
with	O
23	O
of	O
its	O
290	O
members	O
reported	O
to	O
have	O
had	O
tested	O
positive	O
for	O
the	O
virus	O
on	O
3March	O
.	O

Household	O
quarantine	O
of	O
potentially	O
exposed	O
individuals	O
was	O
enacted	O
,	O
and	O
hundreds	O
were	O
isolated	O
in	O
a	O
makeshift	O
facility	O
at	O
the	O
edge	O
of	O
the	O
city	O
.	O

Forty‐eight	O
hours	O
postinfection	O
,	O
the	O
lab	O
technicians	O
fix	O
the	O
cells	O
with	O
formaldehyde	O
(in	O
a	O
chemical	O
hood)	O
and	O
wash	O
the	O
cells	O
to	O
prepare	O
them	O
for	O
immunocytology	O
.	O

Mortality	O
is	O
higher	O
in	O
men	O
in	O
studies	O
conducted	O
in	O
China	S-Location
and	O
Italy	S-Location
.	O
The	O
higher	O
risk	O
for	O
men	O
appears	O
in	O
their	O
50s	O
,	O
and	O
begins	O
to	O
taper	O
off	O
only	O
at	O
90	O
.	O

The	O
website	O
can	O
display	O
data	O
for	O
a	O
25-mile	O
radius	O
from	O
a	O
location	O
.	O

In	O
1998	O
,	O
the	O
virus	O
name	O
was	O
changed	O
to	O
"	O
Zaire	B-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
and	O
in	O
2002	O
to	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
.	O
However	O
,	O
most	O
scientific	O
articles	O
continued	O
to	O
refer	O
to	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
or	O
used	O
the	O
terms	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
and	O
"	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
"	O
in	O
parallel	O
.	O

In	O
China	S-Location
,	O
approximately	O
30%	O
of	O
people	O
in	O
hospital	O
with	O
COVID‑19	S-Disease
are	O
eventually	O
admitted	O
to	O
.	O

With	O
a	O
view	O
to	O
initiating	O
a	O
Nordic	O
network	O
for	O
cross-sector	O
collaboration	O
,	O
one	O
FBD	S-Platform
project	O
established	O
contact	O
with	O
the	O
corresponding	O
agencies	O
in	O
the	O
other	O
Nordic	O
countries	O
(	O
Denmark	S-Organization
,	O
Finland	S-Organization
,	O
Iceland	S-Organization
,	O
and	O
Norway	S-Organization
)	O
.	O

And	O
to	O
work	O
with	O
them	O
means	O
to	O
have	O
a	O
special	O
responsibility	O
to	O
protect	O
both	O
the	O
workers	O
and	O
the	O
public	O
.	O

Minimum	B-Equipment
Information	I-Equipment
About	I-Equipment
a	I-Equipment
Microarray	I-Equipment
Experiment	E-Equipment
(	O
MIAME	S-Equipment
)	O
for	O
microarray	O
transciptomics	O
and	O
MIAPE	O
for	O
proteomics.	O
'Omics'	O
might	O
also	O
profit	O
from	O
other	O
existing	O
omics'	O
standards	O
,	O
e.g.	O
lipidomics	O
from	O
metabolomics	O
.	O

We	O
report	O
isolation	O
of	O
a	O
New	B-Location
Delhi	E-Location
metallo-β-lactamase-5–producing	O
carbapenem-resistant	B-Pathogen
Escherichia	I-Pathogen
coli	I-Pathogen
sequence	E-Pathogen
type	O
167	O
from	O
companion	O
animals	O
in	O
the	O
United	B-Location
States	E-Location
.	O
Reports	O
of	O
in	O
companion	O
animals	O
are	O
rare	O
.	O

The	O
plan	O
includes	O
new	O
procedures	O
to	O
document	O
correct	O
use	O
of	O
the	O
protocol	O
as	O
well	O
as	O
new	O
oversight	O
of	O
individuals	O
using	O
the	O
protocol	O
.	O

In	O
a	O
conference	O
call	O
on	O
Thursday	O
,	O
Dr	O
.	O


Taipei	B-Organization
City	I-Organization
Bureau	I-Organization
of	I-Organization
Health	E-Organization
director	O
Chiu	B-Person
Shu-ti	E-Person
resigned	O
from	O
Ma	B-Person
Ying-jeou	E-Person
's	O
mayoral	O
administration	O
on	O
25	O
May	O
.	O

A	O
total	O
of	O
282	O
people	O
had	O
died	O
from	O
MERS	S-Disease
.	O
The	O
numbers	O
represented	O
a	O
jump	O
of	O
113	O
cases	O
and	O
92	O
deaths	O
.	O

BSCs	O
should	O
also	O
be	O
used	O
for	O
the	O
initial	O
processing	O
of	O
clinical	O
specimens	O
when	O
the	O
nature	O
of	O
the	O
test	O
requested	O
or	O
other	O
information	O
suggests	O
the	O
likely	O
presence	O
of	O
an	O
agent	O
readily	O
transmissible	O
by	O
infectious	O
aerosols	O
(e.g.	O
,	O
M.	B-Pathogen
tuberculosis	E-Pathogen
)	O
,	O
or	O
when	O
the	O
use	O
of	O
a	O
(Class	O
II)	O
is	O
indicated	O
to	O
protect	O
the	O
integrity	O
of	O
the	O
specimen	O
.	O

Yet	O
those	O
suits	O
ruptured	O
or	O
developed	O
holes	O
in	O
at	O
least	O
37	O
incidents	O
during	O
a	O
20-month	O
period	O
in	O
2013	O
and	O
2014	O
,	O
according	O
to	O
lab	O
incident	O
reports	O
obtained	O
by	O
USA	B-Organization
TODAY	E-Organization
under	O
the	O
federal	O
.	O

But	O
fewer	O
people	O
may	O
be	O
keeping	O
an	O
eye	O
on	O
another	O
,	O
potentially	O
bigger	O
danger:	O
anthrax	S-Pathogen

The	O
Japanese	B-Organization
government	E-Organization
until	O
then	O
had	O
never	O
officially	O
acknowledged	O
the	O
atrocities	O
committed	O
by	O
-rejected	O
the	O
request.The	O
Economist	O
,	O
"	O
Deafening	O
silence"	O
,	O
24	O
February	O
2011	O
,	O
p.	O
48	O
.	O

The	O
White	B-Organization
House	E-Organization
has	O
been	O
criticised	O
for	O
downplaying	O
the	O
threat	O
and	O
controlling	O
the	O
messaging	O
by	O
directing	O
health	O
officials	O
and	O
scientists	O
to	O
coordinate	O
public	O
statements	O
and	O
publications	O
related	O
to	O
the	O
virus	O
with	O
the	O
office	O
of	O
Vice-President	O
Mike	B-Person
Pence	E-Person
.	O
On	O
14	O
April	O
,	O
President	O
Trump	S-Person
halted	O
funding	O
to	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
saying	O
they	O
had	O
mismanaged	O
the	O
pandemic	O
.	O

Therefore	O
,	O
governments	O
,	O
funding	O
agencies	O
and	O
the	O
Organization	B-Organization
for	I-Organization
Economic	I-Organization
Cooperation	I-Organization
and	I-Organization
Development	E-Organization
OECD	S-Organization
)	O
commissioned	O
studies	O
concerning	O
the	O
best	O
practice	O
to	O
handle	O
publicly	O
funded	O
research	O
data	O
.	O

It	O
expected	O
the	O
most	O
severe	O
losses	O
in	O
the	O
three	O
affected	O
countries	O
,	O
with	O
a	O
wider	O
impact	O
across	O
the	O
broader	O
Western	B-Location
African	I-Location
region	E-Location
.	O
On	O
13	O
April	O
2015	O
,	O
the	O
World	B-Organization
Bank	E-Organization
said	O
that	O
they	O
would	O
soon	O
announce	O
a	O
major	O
new	O
effort	O
to	O
rebuild	O
the	O
economies	O
of	O
the	O
three	O
hardest-hit	O
countries	O
.	O

The	O
Feinstein	B-Organization
Institute	I-Organization
of	I-Organization
Northwell	I-Organization
Health	E-Organization
announced	O
in	O
March	O
.	O

Carus	S-Person
Seth	S-Person
-	O
Counterproliferation	O
Research	O
,	O
National	B-Organization
Defense	I-Organization
University	E-Organization
,	O
Bioterrorism	O
and	O
Biocrimes:	O
The	O
Illicit	O
Use	O
of	O
biological	O
Agents	O
Since	O
1900	O
,	O
(Google	O
Books	O
link)	O
,	O
The	O
Minerva	O
Group	O
,	O
Inc.	O
,	O
2002	O
,	O
p.	O
173	O
,	O
()	O
.	O

The	O
Holy	B-Organization
See	E-Organization
also	O
attends	O
as	O
an	O
observer	O
,	O
as	O
does	O
the	O
.	O

Last	O
year	O
,	O
specialists	O
from	O
the	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
used	O
Bacillus	S-Pathogen
,	O
a	O
type	O
of	O
probiotic	O
bacteria	O
,	O
to	O
fight	O
one	O
of	O
the	O
most	O
dangerous	O
bacterial	O
strains	O
on	O
the	O
block:	O
methicillin	B-Pathogen
resistant	I-Pathogen
Staphylococcus	I-Pathogen
aureus	E-Pathogen
,	O
better	O
known	O
as	O
.	O
So	O
far	O
,	O
their	O
experiments	O
in	O
mouse	O
models	O
have	O
yielded	O
promising	O
results	O
.	O

Nootropics	S-Drug
are	O
huge	O
in	O
Silicon	B-Location
Valley	E-Location
.	O
Many	O
venture	O
capital-funded	O
firms	O
are	O
focused	O
on	O
.	O
There's	O
even	O
a	O
huge	O
Reddit	O
community	O
based	O
around	O
this	O
biohack	O
.	O

Harbel	S-Location
Margibi	B-Location
County	E-Location
–	O
Animal	O
and	O
Human	O
health	O
experts	O
are	O
brainstorming	O
at	O
the	O
Farmington	B-Location
Hotel	E-Location
in	O
Margibi	B-Location
County	E-Location
to	O
develop	O
a	O
national	O
strategic	O
action	O
plan	O
for	O
rabies	S-Disease
prevention	O
and	O
control	O
in	O
.	O

DTRA	S-Organization
has	O
full	O
access	O
to	O
the	O
Russia	S-Location
-	O
Georgia	S-Location
border	O
,	O
granted	O
under	O
a	O
military	O
program	O
called	O
"	O
Georgia	B-Scientific_research_project
Land	I-Scientific_research_project
Border	I-Scientific_research_project
Security	I-Scientific_research_project
Project	E-Scientific_research_project
"	O
.	O
The	O
activities	O
,	O
related	O
to	O
the	O
project	O
have	O
been	O
outsourced	O
to	O
a	O
private	O
American	O
company	O
–	O
Parsons	B-Organization
Government	I-Organization
Services	I-Organization
International	E-Organization
.	O
DTRA	S-Organization
has	O
previously	O
contracted	O
Parsons	S-Organization
for	O
similar	O
border	O
security	O
projects	O
in	O
Lebanon	S-Location
,	O
Jordan	S-Location
,	O
Libya	S-Location
and	O
Syria	S-Location
.	O
Parsons	S-Organization
have	O
been	O
awarded	O
a	O
$9.	O
2	O
million	O
contract	O
under	O
the	O
Pentagon	B-Scientific_research_project
border	I-Scientific_research_project
security	I-Scientific_research_project
project	E-Scientific_research_project
on	O
the	O
Russia	S-Location
-	O
border	O
.	O

In	O
May	O
,	O
2016	O
,	O
Kenyan	O
officials	O
apprehended	O
two	O
members	O
of	O
an	O
Islamic	O
extremist	O
group	O
in	O
motion	O
to	O
set	O
off	O
a	O
biological	O
bomb	O
containing	O
anthrax	S-Pathogen
.	O
,	O
the	O
believed	O
leader	O
of	O
the	O
group	O
,	O
who	O
was	O
a	O
medical	O
intern	O
,	O
was	O
arrested	O
along	O
with	O
his	O
wife	O
,	O
a	O
medical	O
student	O
.	O

In	O
the	O
early	O
stages	O
there	O
were	O
just	O
a	O
few	O
researchers	O
on	O
the	O
team	O
but	O
it	O
has	O
grown	O
over	O
the	O
years	O
to	O
include	O
approximately	O
24	O
.	O

Proposals	O
are	O
solicited	O
to	O
support	O
standard	O
research	O
projects	O
or	O
conference	O
proposals	O
that	O
bring	O
together	O
stakeholders	O
to	O
discuss	O
and	O
evaluate	O
science-based	O
data	O
relevant	O
to	O
environmental	O
risk	O
assessments	O
or	O
risk	O
management	O
related	O
to	O
biotechnology-developed	O
organisms	O
.	O

In	O
June	O
2010	O
,	O
a	O
team	O
at	O
the	O
Mount	B-Organization
Sinai	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
reported	O
the	O
2009	B-Vaccine
flu	I-Vaccine
pandemic	I-Vaccine
vaccine	E-Vaccine
provided	O
some	O
cross-protection	O
against	O
the	O
strain	O
.	O

Only	O
a	O
few	O
countries	O
have	O
this	O
disease	O
,	O
just	O
a	O
small	O
cluster	O
in	O
West	B-Location
Africa	E-Location
mostly	O
in	O
Sierra	B-Location
Leone	E-Location
but	O
also	O
Liberia	S-Location
and	O
Guinea	S-Location
.	O
And	O
also	O
a	O
significant	O
number	O
in	O
.	O
Because	O
of	O
the	O
limited	O
geographical	O
spread	O
,	O
we	O
don't	O
think	O
this	O
disease	O
gets	O
the	O
attention	O
it	O
deserves	O
,	O
for	O
the	O
mortality	O
that	O
it	O
causes	O
.	O

After	O
returning	O
home	O
to	O
Aralsk	S-Location
,	O
she	O
infected	O
several	O
people	O
including	O
children	O
.	O

The	O
US	O
military	O
has	O
specialized	O
units	O
,	O
which	O
can	O
respond	O
to	O
a	O
bioterrorism	O
event	O
;	O
among	O
them	O
are	O
the	O
United	B-Organization
States	I-Organization
Marine	I-Organization
Corps'	I-Organization
Chemical	I-Organization
Biological	I-Organization
Incident	I-Organization
Response	I-Organization
Force	E-Organization
and	O
the	O
U.S.	B-Organization
Army's	I-Organization
20th	I-Organization
Support	I-Organization
Command	E-Organization
(	O
CBRNE	S-Organization
)	O
,	O
which	O
can	O
detect	O
,	O
identify	O
,	O
and	O
neutralize	O
threats	O
,	O
and	O
decontaminate	O
victims	O
exposed	O
to	O
bioterror	O
agents	O
.	O

This	O
assignment	O
requires	O
students	O
to	O
review	O
their	O
work	O
and	O
to	O
manifest	O
their	O
ability	O
to	O
design	O
the	O
quantitative	O
aspects	O
of	O
an	O
experiment	O
.	O

The	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
()	O
added	O
concerns	O
about	O
the	O
misuse	O
of	O
biological	O
research	O
to	O
its	O
code	O
of	O
ethics	O
in	O
April	O
2005	O
.	O

The	O
three-day	O
conference	O
includes	O
panel	O
sessions	O
,	O
presentations	O
,	O
and	O
scientific	O
and	O
public	O
health	O
exhibitors	O
.	O

Of	O
the	O
six	O
,	O
two	O
died	O
.	O

Once	O
the	O
virus	O
is	O
removed	O
from	O
its	O
host	O
,	O
it	O
requires	O
a	O
very	O
particular	O
environment	O
in	O
which	O
to	O
survive	O
,	O
including	O
relatively	O
high	O
temperatures	O
and	O
humidity	O
,	O
he	O
said	O
.	O

Parker's	B-Person
mother	E-Person
contracted	O
smallpox	S-Disease
on	O
7	O
September	O
,	O
despite	O
having	O
been	O
vaccinated	O
against	O
the	O
disease	O
on	O
24	O
August	O
.	O

In	O
the	O
same	O
year	O
Endicott	S-Person
book	O
was	O
published	O
,	O
Kathryn	B-Person
Weathersby	E-Person
and	O
Milton	B-Person
Leitenberg	E-Person
of	O
the	O
Cold	O
War	O
International	O
History	O
Project	O
at	O
the	O
Woodrow	B-Location
Wilson	I-Location
Center	I-Location
in	I-Location
Washington	E-Location
released	O
a	O
cache	O
of	O
Soviet	O
and	O
Chinese	O
documents	O
that	O
claimed	O
to	O
have	O
revealed	O
that	O
the	O
biowarfare	O
allegation	O
was	O
an	O
elaborate	O
disinformation	O
campaign	O
by	O
the	O
communists	O
.	O

Doing	O
so	O
saves	O
lives	O
and	O
protects	O
the	O
lifeblood	O
of	O
the	O
economy	O
,	O
which	O
also	O
saves	O
American	O
jobs	O
.	O

In	O
addition	O
,	O
they	O
agreed	O
to	O
nominate	O
representatives	O
of	O
the	O
region	O
to	O
participate	O
in	O
the	O
.	O

The	O
OFW	O
together	O
with	O
four	O
of	O
his	O
family	O
members	O
who	O
fetched	O
him	O
at	O
the	O
airport	O
were	O
quarantined	O
.	O

Pharma-Planta	S-Scientific_research_project
:	O
Road	O
testing	O
the	O
developing	O
regulatory	O
guidelines	O
for	O
plant-made	B-Drug
pharmaceuticals	E-Drug
.	O
Transgenic	S-Organization
Res.	O
,	O
2007)	O
,	O
with	O
specific	O
guidelines	O
currently	O
being	O
drawn	O
up	O
for	O
the	O
regulation	O
of	O
.	O

"	O
We	O
are	O
at	O
a	O
critical	O
time,	O
"	O
Kates	S-Person
said	O
during	O
a	O
March	O
12	O
KFF	S-Organization
event	O
to	O
take	O
stock	O
thus	O
far	O
of	O
the	O
's	O
support	O
of	O
global	O
health	O
security	O
.	O

Our	O
next	O
question	O
comes	O
from	O
Helen	B-Person
Branswell	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

Promoting	O
trust	O
between	O
funders	O
,	O
regional	O
scientists	O
,	O
and	O
cooperative	O
partners	O
,	O
and	O
improving	O
open	O
communication	O
about	O
intentions	O
and	O
objectives	O
for	O
the	O
bioengagement	O
activity	O
(i.e.	O
,	O
transparency)	O
in	O
the	O
region	O
is	O
of	O
utmost	O
importance	O
.	O

Trump	S-Person
in	O
his	O
presidential	O
directive	O
today	O
also	O
directs	O
his	O
national	O
security	O
advisor	O
to	O
annually	O
review	O
biological	O
threats	O
and	O
prioritize	O
biodefense	O
actions	O
,	O
which	O
he	O
said	O
will	O
better	O
enable	O
the	O
government	O
to	O
anticipate	O
,	O
prevent	O
,	O
prepare	O
for	O
,	O
and	O
respond	O
to	O
biological	O
incidents	O
.	O

The	O
US	B-Organization
Army	E-Organization
performed	O
27	O
field	O
tests	O
with	O
such	O
biological	O
simulants	O
,	O
involving	O
the	O
public	O
domain	O
from1949	O
to	O
1968	O
,	O
when	O
President	O
officially	O
announced	O
the	O
end	O
of	O
the	O
program	O
.	O

On	O
12	O
March	O
,	O
WHO	S-Organization
issued	O
a	O
global	O
alert	O
about	O
a	O
new	O
infectious	O
disease	O
of	O
unknown	O
origin	O
in	O
both	O
Vietnam	S-Location
and	O
Hong	B-Location
Kong	E-Location
.	O
On	O
15	O
March	O
,	O
WHO	S-Organization
issued	O
a	O
heightened	O
global	O
health	O
alert	O
about	O
a	O
mysterious	O
pneumonia	S-Disease
with	O
a	O
case	O
definition	O
of	O
SARS	S-Disease
after	O
cases	O
in	O
Singapore	S-Location
and	O
Canada	S-Location
were	O
also	O
identified	O
.	O

In	O
1982	O
,	O
the	O
company	O
filed	O
a	O
patent	O
for	O
the	O
process	O
and	O
the	O
technique	O
drastically	O
changed	O
the	O
production	O
of	O
insulin	O
,	O
which	O
had	O
previously	O
relied	O
on	O
slaughtered	O
animals	O
.	O

After	O
being	O
denied	O
building	O
permits	O
for	O
Rajneeshpuram	S-Location
the	O
commune	O
leadership	O
sought	O
to	O
gain	O
political	O
control	O
over	O
the	O
rest	O
of	O
the	O
county	O
by	O
influencing	O
the	O
November	O
1984	O
county	O
election	O
.	O

It	O
was	O
revealed	O
around	O
this	O
time	O
that	O
the	O
accident	O
was	O
caused	O
by	O
the	O
non-replacement	O
of	O
a	O
filter	S-Equipment
on	O
an	O
exhaust	O
at	O
the	O
facility	O
,	O
and	O
though	O
the	O
problem	O
was	O
quickly	O
rectified	O
,	O
it	O
was	O
too	O
late	O
to	O
prevent	O
a	O
release	O
.	O

Escherichia	B-Pathogen
coli	E-Pathogen
lysogenic	O
strain	O
bearing	O
bacteriophages	O
λ	O
cI857	O
,	O
carrying	O
a	O
temperature‐sensitive	O
repressor	O
mutation	O
6	O
and	O
host	O
strain	O
ER1647	O
(Novagen	O
corp)	O
were	O
grown	O
in	O
Liquid	O
Broth	O
(LB)	O
medium	O
contained	O
1%	O
Trypton	O
(Bactlab	O
‐	O
Becton	O
Dickinson)	O
,	O
0.	O
5%	O
NaCl	O
,	O
and	O
0.	O
5%	O
yeast	O
extract	O
(Bactlab	O
‐	O
Becton	O
Dickinson)	O
.	O

Most	O
genetic	O
alterations	O
that	O
people	O
know	O
about	O
today	O
are	O
through	O
engineering	O
of	O
crops	O
,	O
which	O
involves	O
adding	O
or	O
altering	O
less	O
than	O
10	O
genes	O
out	O
of	O
the	O
tens	O
of	O
thousands	O
that	O
are	O
contained	O
in	O
most	O
organisms	O
or	O
plants	O
.	O

The	O
International	B-Organization
Biosafety	I-Organization
Working	I-Organization
Group	E-Organization
()	O
maintains	O
a	O
compendium	O
(see	O
Internet	O
Resources)	O
,	O
which	O
provides	O
a	O
listing	O
of	O
currently	O
identified	O
permit	O
requirements	O
.	O

The	O
contributing	O
international	O
organizations	O
are	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
(FAO)	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
,	O
and	O
the	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
()	O
.	O

The	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
has	O
a	O
list	O
of	O
such	O
agencies	O
and	O
links	O
to	O
their	O
websites	O
,	O
along	O
with	O
links	O
to	O
publications	O
and	O
guidance	O
documents	O
to	O
assist	O
in	O
risk	O
assessment	O
,	O
lab	O
design	O
and	O
adherence	O
to	O
laboratory	O
exposure	O
control	O
plans	O
.	O

Other	O
notable	O
and	O
novel	O
elements	O
of	O
the	O
new	O
plan	O
include	O
a	O
stronger	O
emphasis	O
on	O
risk	O
assessment	O
and	O
the	O
priority	O
given	O
to	O
forecasting	O
and	O
modeling	O
,	O
Inglesby	S-Person
said	O
.	O

And	O
some	O
warn	O
of	O
unethical	O
uses	O
of	O
,	O
fearing	O
a	O
rise	O
of	O
'designer	O
babies'	O
if	O
parents	O
are	O
allowed	O
to	O
choose	O
their	O
children's	O
traits	O
,	O
even	O
though	O
there	O
are	O
currently	O
no	O
straightforward	O
links	O
between	O
one's	O
genes	O
and	O
their	O
intelligence	O
,	O
appearance	O
,	O
etc	O
.	O

If	O
a	O
patient	O
is	O
alert	O
and	O
is	O
not	O
vomiting	S-Phenotype
oral	B-Technology
rehydration	I-Technology
therapy	E-Technology
may	O
be	O
instituted	O
,	O
but	O
patients	O
who	O
are	O
vomiting	S-Phenotype
or	O
are	O
delirious	S-Phenotype
must	O
be	O
hydrated	O
with	O
.	O

On	O
9	O
September	O
,	O
Jonas	B-Person
Schmidt-Chanasit	E-Person
of	O
the	O
Bernhard	B-Organization
Nocht	I-Organization
Institute	E-Organization
for	O
Tropical	B-Organization
Medicine	E-Organization
in	O
Germany	S-Location
,	O
controversially	O
announced	O
that	O
the	O
containment	O
fight	O
in	O
Sierra	B-Location
Leone	E-Location
and	O
had	O
already	O
been	O
"	O
lost"	O
and	O
that	O
the	O
disease	O
would	O
"	O
burn	O
itself	O
out"	O
.	O

All	O
UN	S-Organization
member	O
states	O
are	O
eligible	O
for	O
WHO	S-Organization
membership	O
,	O
and	O
,	O
according	O
to	O
the	O
WHO	S-Organization
website	O
,	O
"	O
other	O
countries	O
may	O
be	O
admitted	O
as	O
members	O
when	O
their	O
application	O
has	O
been	O
approved	O
by	O
a	O
simple	O
majority	O
vote	O
of	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
"	O
.	O
The	O
is	O
attended	O
by	O
delegations	O
from	O
all	O
member	O
states	O
,	O
and	O
determines	O
the	O
policies	O
of	O
the	O
organization	O
.	O

Towards	O
the	O
end	O
of	O
the	O
first	O
world	O
war	O
,	O
a	O
devastating	O
strain	O
of	O
influenza	S-Disease
known	O
as	O
the	O
1918	B-Disease
flu	E-Disease
or	O
Spanish	B-Disease
flu	E-Disease
,	O
spread	O
to	O
six	O
continents	O
,	O
and	O
even	O
remote	O
.	O
About	O
a	O
third	O
of	O
the	O
world's	O
population	O
were	O
infected	O
and	O
between	O
3%	O
and	O
6%	O
were	O
killed	O
.	O

Senate	S-Organization
Majority	O
Leader	O
Harry	B-Person
Reid	E-Person
said	O
he	O
was	O
told	O
the	O
letter	O
was	O
addressed	O
to	O
the	O
office	O
of	O
Sen	O
.	O

As	O
the	O
Swedish	S-Location
national	O
BSL-3	S-Platform
laboratories	O
are	O
each	O
governed	O
by	O
their	O
own	O
QA	B-Platform
systems	E-Platform
and	O
diagnostic	O
methods	O
,	O
it	O
has	O
been	O
important	O
to	O
define	O
how	O
the	O
FBD	S-Platform
activities	O
relate	O
to	O
existing	O
ways	O
of	O
doing	O
things	O
.	O

There	O
are	O
2	O
types	O
of	O
selection:	O
negative	O
and	O
positive	O
.	O

Mechanical	B-Technology
ventilation	E-Technology
becomes	O
more	O
complex	O
as	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
develops	O
in	O
COVID‑19	S-Disease
and	O
oxygenation	O
becomes	O
increasingly	O
difficult	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
currently	O
estimate	O
that	O
$20	O
billion	O
in	O
direct	O
health	O
care	O
costs	O
and	O
$35	O
billion	O
in	O
lost	O
productivity	O
can	O
be	O
attributed	O
annually	O
to	O
drug-resistant	O
superbugs	O
.	O

It	O
may	O
shorten	O
the	O
time	O
it	O
takes	O
to	O
recover	O
from	O
the	O
infection	O
.	O

The	O
following	O
day	O
,	O
confirmed	O
its	O
first	O
new	O
case	O
since	O
September	O
2015	O
.	O

A	O
nurse	O
and	O
a	O
doctor	O
who	O
had	O
treated	O
the	O
imam	O
subsequently	O
fell	O
ill	O
with	O
Ebola	S-Disease
and	O
died	O
.	O

Postal	O
workers	O
started	O
handling	O
mail	O
at	O
a	O
site	O
off	O
Capitol	B-Location
Hill	E-Location
after	O
the	O
2001	B-Incident
anthrax	I-Incident
attacks	E-Incident
that	O
targeted	O
then-Majority	O
Leader	O
Tom	B-Person
Daschle	E-Person
and	O
Vermont	S-Location
Sen	O
.	O

Most	O
recently	O
in	O
December	O
of	O
2008	O
,	O
JCVI	S-Organization
received	O
funding	O
from	O
the	O
Alfred	B-Organization
P.	I-Organization
Sloan	I-Organization
Foundation	E-Organization
to	O
examine	O
ethical	O
and	O
societal	O
concerns	O
that	O
are	O
associated	O
with	O
the	O
developing	O
science	O
of	O
.	O
The	O
ongoing	O
research	O
is	O
intended	O
to	O
inform	O
the	O
scientific	O
community	O
as	O
well	O
as	O
educate	O
our	O
policymakers	O
and	O
journalists	O
so	O
that	O
they	O
may	O
engage	O
in	O
informed	O
discussions	O
on	O
the	O
topic	O
.	O

Genome	B-Equipment
editing	I-Equipment
tools	E-Equipment
are	O
also	O
used	O
to	O
make	O
lab	O
models	O
of	O
diseases	O
,	O
cells	O
that	O
store	O
memories	O
,	O
and	O
tools	O
that	O
can	O
detect	O
epidemic	O
viruses	O
like	O
Zika	S-Disease
or	O
Ebola	S-Disease
.	O
And	O
as	O
described	O
above	O
,	O
if	O
a	O
gene	O
drive	O
,	O
which	O
uses	O
Cas9	O
,	O
is	O
deployed	O
effectively	O
,	O
we	O
could	O
eliminate	O
diseases	O
such	O
as	O
,	O
which	O
kills	O
nearly	O
half	O
a	O
million	O
people	O
each	O
year	O
.	O

This	O
and	O
other	O
support	O
of	O
for	O
such	O
practices	O
has	O
been	O
criticized	O
by	O
the	O
science-based	O
medicine	O
community	O
as	O
it	O
has	O
generally	O
criticized	O
the	O
use	O
of	O
alternative	O
medicine	O
.	O

Mechanical	B-Technology
ventilation	E-Technology
becomes	O
more	O
complex	O
as	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
develops	O
in	O
COVID‑19	S-Disease
and	O
oxygenation	O
becomes	O
increasingly	O
difficult	O
.	O

According	O
to	O
WKTV	O
,	O
"	O
This	O
is	O
the	O
fourth	O
year	O
of	O
the	O
Excelsior	B-Activity
Challenge	E-Activity
,	O
a	O
training	O
exercise	O
designed	O
for	O
police	O
and	O
first	O
responders	O
to	O
become	O
familiar	O
with	O
techniques	O
and	O
practices	O
should	O
a	O
real	O
incident	O
occur.	O
"	O
The	O
event	O
was	O
held	O
over	O
three	O
days	O
and	O
hosted	O
by	O
the	O
State	B-Organization
Preparedness	I-Organization
Training	I-Organization
Center	E-Organization
in	O
Oriskany	S-Location
,	O
New	B-Location
York	E-Location
.	O
Participants	O
included	O
bomb	O
squads	O
,	O
canine	O
handlers	O
,	O
tactical	O
team	O
officers	O
and	O
emergency	O
medical	O
services	O
.	O

Betrayal	O
of	O
Trust:	O
The	O
Collapse	O
of	O
Global	O
Public	O
Health	O
,	O
(Google	O
Books)	O
,	O
Oxford	O
University	O
Press	O
,	O
2003	O
,	O
p.	O
340-41	O
,	O
()	O
.	O

Commonly	O
,	O
agents	O
included	O
in	O
a	O
high	O
laboratory	O
biosafety	O
category	O
(such	O
as	O
Variola	B-Pathogen
major	E-Pathogen
,	O
Ebola	B-Pathogen
virus	E-Pathogen
and	O
Marburg	B-Pathogen
virus	E-Pathogen
)	O
were	O
categorized	O
accordingly	O
at	O
the	O
higher	O
biological	O
defense	O
level	O
and	O
those	O
categorized	O
at	O
lower	O
laboratory	O
biosafety	O
levels	O
(such	O
as	O
Salmonella	S-Pathogen
and	O
Shigella	S-Pathogen
)	O
were	O
also	O
included	O
categorized	O
at	O
lower	O
biodefense	O
levels	O
.	O

These	O
scientists	O
support	O
further	O
low-level	O
research	O
on	O
CRISPR	S-Technology
and	O
do	O
not	O
see	O
as	O
developed	O
enough	O
for	O
any	O
clinical	O
use	O
in	O
making	O
heritable	O
changes	O
to	O
humans	O
.	O

The	O
official	O
policy	O
of	O
the	O
United	B-Location
States	E-Location
was	O
first	O
to	O
deter	O
the	O
use	O
of	O
bio-weapons	O
against	O
and	O
secondarily	O
to	O
retaliate	O
if	O
deterrence	O
failed	O
.	O

Many	O
of	O
his	O
subjects	O
did	O
not	O
;	O
estimates	O
for	O
fatalities	O
in	O
the	O
capital	O
city	O
,	O
Addis	B-Location
Ababa	E-Location
,	O
range	O
from	O
5,000	O
to	O
10,000	O
,	O
or	O
higher	O
.	O

Primary	O
influenza	B-Disease
pneumonia	E-Disease
occurs	O
most	O
commonly	O
in	O
adults	O
and	O
may	O
progress	O
rapidly	O
to	O
acute	O
lung	O
injury	O
requiring	O
mechanical	B-Equipment
ventilation	E-Equipment
.	O
Secondary	O
bacterial	B-Disease
infection	E-Disease
is	O
more	O
common	O
in	O
children	O
.	O

Some	O
deaths	O
resulted	O
from	O
.	O

This	O
range	O
of	O
experimental	O
methods	O
gives	O
students	O
a	O
broad	O
perspective	O
on	O
working	O
with	O
viruses	O
.	O

On	O
26	O
April	O
,	O
Wu	B-Person
Yi	E-Person
was	O
named	O
Zhang	B-Person
Wenkang	E-Person
's	O
replacement	O
as	O
PRC	S-Organization
health	O
minister	O
.	O

Non-therapeutic	O
use	O
of	O
antibiotics	O
must	O
be	O
discontinued	O
.	O

Examples	O
of	O
positive	O
remarks	O
included	O
"	O
practical	O
course	O
that	O
contributed	O
a	O
lot	O
to	O
understanding	O
the	O
theoretical	O
one,	O
"	O
"	O
I	O
learned	O
a	O
lot	O
from	O
the	O
lab	O
,	O
gave	O
me	O
a	O
lot	O
of	O
knowledge,	O
"	O
"	O
very	O
enriching,	O
"	O
"	O
the	O
course	O
helped	O
me	O
understand	O
the	O
material.	O
"	O
Critical	O
commentary	O
centered	O
primarily	O
on	O
the	O
fact	O
that	O
the	O
amount	O
of	O
work	O
required	O
of	O
the	O
students	O
was	O
disproportionate	O
to	O
the	O
number	O
of	O
course	O
credits	O
,	O
as	O
can	O
be	O
seen	O
in	O
these	O
examples:	O
"	O
The	O
course	O
requires	O
a	O
lot	O
and	O
the	O
number	O
of	O
credit	O
units	O
is	O
not	O
enough	O
compared	O
to	O
the	O
time	O
and	O
effort	O
invested	O
in	O
it,	O
"	O
"	O
The	O
course	O
requirements	O
are	O
3	O
times	O
higher	O
than	O
the	O
number	O
of	O
credit	O
units.	O
"	O
The	O
number	O
of	O
laboratory	O
credit	O
units	O
is	O
determined	O
by	O
the	O
Council	B-Organization
for	I-Organization
Higher	I-Organization
Education	E-Organization
and	O
cannot	O
be	O
changed	O
by	O
the	O
college	O
despite	O
student	O
frustration	O
.	O

These	O
claims	O
are	O
controversial	O
as	O
it	O
is	O
argued	O
that	O
any	O
smallpox	B-Pathogen
virus	E-Pathogen
brought	O
to	O
New	B-Location
South	I-Location
Wales	E-Location
probably	O
would	O
have	O
been	O
sterilised	O
by	O
heat	O
and	O
humidity	O
encountered	O
during	O
the	O
voyage	O
of	O
the	O
First	B-Organization
Fleet	E-Organization
from	O
England	S-Location
and	O
incapable	O
of	O
biological	O
warfare	O
.	O

In	O
November	O
2013	O
,	O
a	O
University	B-Organization
of	I-Organization
Wisconsin	E-Organization
researcher	O
in	O
an	O
ABSL-3	S-Platform
punctured	O
skin	O
with	O
a	O
needle	O
loaded	O
with	O
.	O
The	O
researcher	O
was	O
quarantined	O
for	O
seven	O
days	O
in	O
an	O
empty	O
home	O
,	O
according	O
to	O
incident	O
reports	O
.	O

In	O
1996	O
the	O
state	O
began	O
utilizing	O
sterile	O
medflies	O
in	O
its	O
eradication	O
program	O
and	O
between	O
1996	O
and	O
2007	O
the	O
state	O
experienced	O
five	O
infestations	O
.	O

Tens	O
of	O
millions	O
fell	O
gravely	O
ill	O
,	O
their	O
bodies	O
succumbing	O
to	O
the	O
disease	O
in	O
different	O
ways	O
.	O

This	O
is	O
done	O
by	O
slowing	O
the	O
infection	O
rate	O
to	O
decrease	O
the	O
risk	O
of	O
health	O
services	O
being	O
overwhelmed	O
,	O
allowing	O
for	O
better	O
treatment	O
of	O
current	O
cases	O
,	O
and	O
delaying	O
additional	O
cases	O
until	O
effective	O
treatments	O
or	O
a	O
vaccine	O
become	O
available	O
.	O

What's	O
preferable	O
,	O
he	O
said	O
,	O
would	O
be	O
a	O
fund	O
containing	O
roughly	O
$2.	O
5	O
billion	O
to	O
$3.	O
5	O
billion	O
,	O
based	O
on	O
the	O
costs	O
associated	O
with	O
fighting	O
previous	O
pandemics	O
,	O
and	O
the	O
fund	O
would	O
be	O
managed	O
by	O
the	O
HHS	S-Organization
Secretary	O
,	O
who	O
would	O
distribute	O
funds	O
across	O
or	O
to	O
states	O
.	O

But	O
even	O
if	O
there	O
were	O
clear	O
regulations	O
governing	O
all	O
biohacking	O
activities	O
,	O
there	O
would	O
be	O
no	O
straightforward	O
way	O
to	O
stop	O
people	O
from	O
pursuing	O
them	O
behind	O
closed	O
doors.	O
"	O
This	O
technology	O
is	O
available	O
and	O
implementable	O
anywhere	O
,	O
there's	O
no	O
physical	O
means	O
to	O
control	O
access	O
to	O
it	O
,	O
so	O
what	O
would	O
regulating	O
that	O
mean?	O
"	O
Carlson	S-Person
said	O
.	O

Senior	O
officials	O
at	O
the	O
United	B-Organization
Nations	E-Organization
estimated	O
in	O
April	O
2020	O
that	O
an	O
additional	O
130 million	O
people	O
could	O
starve	O
,	O
for	O
a	O
total	O
of	O
265 million	O
by	O
the	O
end	O
of	O
2020	O
.	O

And	O
this	O
summer	O
,	O
a	O
London	S-Location
museum	O
is	O
displaying	O
something	O
rather	O
less	O
fragrant:	O
cheese	O
made	O
from	O
celebrities	O
.	O

Lillibridge	S-Person
also	O
suggested	O
that	O
the	O
United	B-Location
States	E-Location
take	O
a	O
second	O
look	O
at	O
revitalizing	O
components	O
of	O
the	O
.	O
&quot;We	O
need	O
more	O
neutral	O
ways	O
to	O
get	O
into	O
regions	O
of	O
the	O
world,&quot	O
;	O
he	O
said	O
.	O

The	O
"	O
Interagency	B-International_exchange_and_cooperation
Coordination	I-International_exchange_and_cooperation
Group	I-International_exchange_and_cooperation
on	I-International_exchange_and_cooperation
Antimicrobial	I-International_exchange_and_cooperation
Resistance	E-International_exchange_and_cooperation
stated	O
in	O
2018	O
that	O
"	O
the	O
spread	O
of	O
pathogens	O
through	O
unsafe	O
water	O
results	O
in	O
a	O
high	O
burden	O
of	O
gastrointestinal	O
disease	O
,	O
increasing	O
even	O
further	O
the	O
need	O
for	O
antibiotic	O
treatment.	O
"	O
IACG	S-Organization
(2018)	O
Reduce	O
unintentional	O
exposure	O
and	O
the	O
need	O
for	O
antimicrobials	O
,	O
and	O
optimize	O
their	O
use	O
IACG	B-Document
Discussion	I-Document
Paper	E-Document
,	O
Interagency	B-International_exchange_and_cooperation
Coordination	I-International_exchange_and_cooperation
Group	I-International_exchange_and_cooperation
on	I-International_exchange_and_cooperation
Antimicrobial	I-International_exchange_and_cooperation
Resistance	E-International_exchange_and_cooperation
,	O
public	O
consultation	O
process	O
at	O
WHO	S-Organization
,	O
Geneva	S-Location
,	O
This	O
is	O
particularly	O
a	O
problem	O
in	O
developing	O
countries	O
where	O
the	O
spread	O
of	O
infectious	O
diseases	O
caused	O
by	O
inadequate	O
WASH	O
standards	O
is	O
a	O
major	O
driver	O
of	O
antibiotic	O
demand	O
.	O

He	O
also	O
stated	O
that	O
the	O
blatant	O
mishandling	O
of	O
the	O
Ebola	B-Incident
virus	I-Incident
outbreak	E-Incident
in	O
2014	O
attested	O
to	O
the	O
government's	O
lack	O
of	O
preparation	O
.	O

Biodefense	O
is	O
often	O
considered	O
as	O
a	O
sensitive	O
field	O
,	O
and	O
it	O
may	O
be	O
simpler	O
to	O
collaborate	O
well	O
in	O
other	O
scientific	O
areas	O
such	O
as	O
cancer	S-Disease
or	O
research	O
.	O

USAID	S-Organization
published	O
an	O
open	O
competitive	O
bidding	O
for	O
proposals	O
that	O
address	O
the	O
challenge	O
of	O
developing	O
"	O
... new	O
practical	O
and	O
cost-effective	O
solutions	O
to	O
improve	O
infection	O
treatment	O
and	O
control	O
that	O
can	O
be	O
rapidly	O
deployed	O
;	O
1)	O
to	O
help	O
health	O
care	O
workers	O
provide	O
better	O
care	O
and	O
2)	O
transform	O
our	O
ability	O
to	O
combat	O
Ebola	S-Disease
"	O
.	O
On	O
12	O
December	O
2014	O
,	O
announced	O
the	O
result	O
of	O
the	O
first	O
selection	O
in	O
a	O
press	O
release	O
.	O

The	O
report	O
recommends	O
a	O
multi-pronged	O
response	O
to	O
address	O
these	O
diseases	O
that	O
affect	O
more	O
than	O
300,000	O
Americans	O
each	O
year	O
.	O

In	O
2014	O
,	O
WHO	S-Organization
released	O
the	O
Global	B-Document
Atlas	I-Document
of	I-Document
Palliative	I-Document
Care	I-Document
at	I-Document
the	I-Document
End	I-Document
of	I-Document
Life	E-Document
in	O
a	O
joint	O
publication	O
with	O
the	O
Worldwide	B-Organization
Hospice	I-Organization
Palliative	I-Organization
Care	I-Organization
Alliance	E-Organization
,	O
an	O
affiliated	O
NGO	O
working	O
collaboratively	O
with	O
the	O
WHO	S-Organization
to	O
promote	O
palliative	O
care	O
in	O
national	O
and	O
international	O
health	O
policy	O
.	O

Other	O
advisory	O
group	O
members	O
include	O
John	B-Person
Brownstein	E-Person
chief	O
innovation	O
officer	O
at	O
Boston	B-Organization
Children's	I-Organization
Hospital	E-Organization
;	O
Gerald	B-Person
Fink	E-Person
,	O
member	O
of	O
the	O
Whitehead	B-Organization
Institute	E-Organization
and	O
professor	O
of	O
genetics	O
at	O
MIT	S-Organization
;	O
Tore	B-Person
Godal	E-Person
,	O
special	O
advisor	O
on	O
global	O
health	O
,	O
Ministry	B-Organization
of	I-Organization
Foreign	I-Organization
Affairs,	I-Organization
Norway	E-Organization
;	O
John-Erik	B-Person
Stig	I-Person
Hansen	E-Person
,	O
director	O
of	O
the	O
Centre	B-Organization
for	I-Organization
Biosecurity	I-Organization
and	I-Organization
Biopreparedness,	I-Organization
Denmark	E-Organization
;	O
and	O
Renee	B-Person
Wegrzyn	E-Person
,	O
program	O
manager	O
,	O
Biological	B-Organization
Technologies	I-Organization
Office	I-Organization
(BTO),	I-Organization
Defense	I-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
()	O
.	O

The	O
US	B-Organization
Army	E-Organization
performed	O
27	O
field	O
tests	O
with	O
such	O
biological	O
simulants	O
,	O
involving	O
the	O
public	O
domain	O
from1949	O
to	O
1968	O
,	O
when	O
President	O
officially	O
announced	O
the	O
end	O
of	O
the	O
program	O
.	O

It	O
became	O
the	O
National	B-Organization
Communicable	I-Organization
Disease	I-Organization
Center	E-Organization
(	O
NCDC	S-Organization
)	O
effective	O
July	O
1	O
,	O
1967	O
.	O

The	O
maximum	O
gathering	O
size	O
recommended	O
by	O
U.S.	B-Organization
government	E-Organization
bodies	O
and	O
health	O
organisations	O
was	O
swiftly	O
reduced	O
from	O
250	O
people	O
(if	O
there	O
was	O
no	O
known	O
COVID-19	S-Disease
spread	O
in	O
a	O
region)	O
to	O
50	O
people	O
,	O
and	O
later	O
to	O
10	O
.	O

It	O
could	O
be	O
disseminated	O
via	O
aerosol	O
,	O
or	O
by	O
contamination	O
of	O
water	O
and/	O
or	O
food	O
supplies	O
.	O

This	O
results	O
in	O
the	O
transfer	O
of	O
resistant	O
bacterial	O
strains	O
into	O
the	O
food	O
that	O
humans	O
eat	O
,	O
causing	O
potentially	O
fatal	O
transfer	O
of	O
disease	O
.	O

Russia	S-Location
and	O
Taiwan	S-Location
said	O
they	O
would	O
quarantine	O
visitors	O
with	O
who	O
come	O
from	O
areas	O
where	O
the	O
flu	O
was	O
present	O
.	O

After	O
an	O
investigation	O
,	O
the	O
lab's	O
licence	O
was	O
renewed	O
–	O
only	O
for	O
another	O
leak	O
to	O
occur	O
two	O
weeks	O
later	O
.	O

Macenta	B-Location
Prefecture	E-Location
,	O
from	O
Korokpara	S-Location
,	O
registered	O
Guinea	S-Location
's	O
fifth	O
fatality	O
due	O
to	O
within	O
the	O
same	O
period	O
.	O

SARS-CoV-2	S-Disease
may	O
also	O
cause	O
through	O
affecting	O
the	O
brainstem	O
as	O
other	O
coronaviruses	O
have	O
been	O
found	O
to	O
invade	O
the	O
central	O
nervous	O
system	O
(CNS)	O
.	O

Cutting	O
and	O
repairing	O
a	O
cell's	O
DNA	O
is	O
not	O
risk-free	O
,	O
and	O
errors	O
in	O
the	O
process	O
could	O
make	O
a	O
disease	O
worse	O
,	O
not	O
better	O
.	O

About	O
1.5%	O
of	O
children	O
with	O
the	O
H1N1	B-Disease
swine	I-Disease
flu	E-Disease
strain	O
were	O
hospitalized	O
within	O
30	O
days	O
,	O
compared	O
with	O
3.7%	O
of	O
those	O
sick	O
with	O
a	O
seasonal	O
strain	O
of	O
H1N1	S-Pathogen
and	O
3.1%	O
with	O
an	O
.	O

Phages	O
destroy	O
bacterial	O
cell	O
walls	O
and	O
membrane	O
through	O
the	O
use	O
of	O
lytic	O
proteins	O
which	O
kill	O
bacteria	O
by	O
making	O
many	O
holes	O
from	O
the	O
inside	O
out	O
.	O

The	O
1889	O
pandemic	O
,	O
for	O
example	O
,	O
began	O
in	O
the	O
late	O
spring	O
of	O
1889	O
and	O
took	O
several	O
months	O
to	O
spread	O
throughout	O
the	O
world	O
,	O
peaking	O
in	O
northern	B-Location
Europe	E-Location
and	O
the	O
United	B-Location
States	E-Location
late	O
in	O
1889	O
or	O
early	O
in	O
1890	O
.	O

The	O
appointment	O
attracted	O
widespread	O
condemnation	O
and	O
criticism	O
in	O
WHO	S-Organization
member	O
states	O
and	O
international	O
organizations	O
due	O
to	O
Robert	B-Person
Mugabe	E-Person
's	O
poor	O
record	O
on	O
human	O
rights	O
and	O
presiding	O
over	O
a	O
decline	O
in's	O
public	O
health	O
.	O

Three	O
lab	O
reports	O
are	O
required	O
by	O
the	O
end	O
of	O
the	O
course	O
.	O

As	O
the	O
battle	O
against	O
the	O
Mediterranean	B-Incident
fruit	I-Incident
fly	E-Incident
enters	O
a	O
new	O
year	O
and	O
aerial	O
pesticide	O
spraying	O
covers	O
still	O
more	O
neighborhoods	O
in	O
,	O
state	O
and	O
federal	O
officials	O
remain	O
baffled	O
by	O
several	O
aspects	O
of	O
a	O
stubborn	O
infestation	O
.	O

Weathersby	S-Person
,	O
Kathryn	S-Person
,	O
&a	O
mp;	B-Person
Milton	I-Person
Leiten	E-Person
berg	O
,	O
"	O
New	O
Evidence	O
on	O
the	O
Korean	O
War"	O
,	O
Cold	O
War	O
International	O
History	O
Project	O
,	O
1998	O
.	O

Guidelines	O
for	O
returning	O
workers	O
were	O
issued	O
by	O
a	O
number	O
of	O
agencies	O
,	O
including	O
the	O
CDC	S-Organization
MSF	S-Organization
,	O
Public	B-Organization
Health	I-Organization
England	E-Organization
,	O
and	O
.	O

F.	B-Pathogen
Tularensis	E-Pathogen
is	O
a	O
highly	O
infectious	O
bacterium	O
and	O
has	O
the	O
potential	O
to	O
be	O
weaponized	O
for	O
use	O
through	O
aerosol	O
attacks	O
.	O

Retrieved	O
January	O
3	O
,	O
2009	O
.	O

Planning	O
may	O
involve	O
the	O
development	O
of	O
biological	O
identification	O
systems	O
.	O

The	O
Material	O
Safety	O
Data	O
Sheets	O
for	O
Infectious	O
Substances	O
,	O
housed	O
and	O
maintained	O
by	O
the	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Canada	E-Organization

Gaggle	S-Platform
is	O
an	O
open-source	O
Java	O
software	O
environment	O
developed	O
at	O
the	O
Institute	B-Organization
for	I-Organization
Systems	I-Organization
Biology	E-Organization
.	O
Gaggle	S-Platform
uses	O
only	O
four	O
data	O
types	O
(list	O
of	O
names	O
,	O
matrices	O
,	O
networks	O
and	O
associative	O
arrays)	O
to	O
integrate	O
various	O
data	O
resources	O
and	O
software	O
.	O

There	O
is	O
no	O
available	O
vaccine	O
,	O
but	O
various	O
agencies	O
are	O
actively	O
developing	O
vaccine	O
candidates	O
.	O

Previously	O
the	O
headquarters	O
were	O
in	O
an	O
unincorporated	O
area	O
,	O
statistically	O
in	O
the	O
Druid	B-Location
Hills	I-Location
census-designated	I-Location
place	E-Location
.CDC	O
Home	O
Page	O
,	O
cdc.gov	O
;	O
retrieved	O
November	O
19	O
,	O
2008.	O
"	O
1600	O
Clifton	O
Rd	O
.	O

The	O
laboratory	O
consequently	O
kept	O
possession	O
of	O
the	O
transgenic	O
rabbit	O
which	O
it	O
had	O
created	O
and	O
funded	O
and	O
the	O
"	O
transgenic	O
art	O
"	O
was	O
never	O
exhibited	O
at	O
the	O
Digital	B-Activity
Avignon	I-Activity
festival	E-Activity
[2000]	O
as	O
intended	O
.	O

Saudi	S-Organization
officials	O
expressed	O
great	O
concern	O
that	O
millions	O
of	O
Muslims	O
from	O
around	O
the	O
world	O
would	O
potentially	O
be	O
exposed	O
to	O
the	O
virus	O
during	O
the	O
autumn	O
Hajj	S-Activity
,	O
or	O
pilgrimage	O
to	O
.	O

Scott	B-Person
Becker	E-Person
executive	O
director	O
of	O
the	O
,	O
however	O
,	O
was	O
pleased	O
with	O
the	O
guidelines	O
,	O
which	O
include	O
many	O
of	O
his	O
group's	O
recommendations	O
,	O
including	O
the	O
call	O
for	O
greater	O
transparency	O
.	O

Bioterrorism	O
and	O
biowarfare	O
poses	O
an	O
enormous	O
threat	O
to	O
humankind	O
.	O

However	O
,	O
the	O
components	O
BASE	S-Platform
,	O
OMERO	S-Platform
and	O
omixed	O
are	O
distributed	O
as	O
stand-alone	O
versions-but	O
without	O
functionality	O
.	O

Bush	O
Administration	O
and	O
Gerberding-"diminished	O
the	O
influence	O
of	O
national	O
centers	O
under	O
[their]	O
umbrella"	O
,	O
and	O
were	O
ordered	O
cut	O
under	O
the	O
Obama	O
Administration	O
in	O
2009	O
.	O

1967:	O
The	O
WHO	S-Organization
intensified	O
the	O
global	O
smallpox	S-Disease
eradication	O
by	O
contributing	O
$2.	O
4 million	O
annually	O
to	O
the	O
effort	O
and	O
adopted	O
a	O
new	O
disease	O
surveillance	O
method	O
.	O

The	O
OFW	O
together	O
with	O
four	O
of	O
his	O
family	O
members	O
who	O
fetched	O
him	O
at	O
the	O
airport	O
were	O
quarantined	O
.	O

This	O
request	O
is	O
deliberately	O
more	O
about	O
best	O
practices	O
in	O
lab	O
management	O
than	O
it	O
is	O
about	O
imposing	O
new	O
regulations	O
on	O
the	O
community	O
.	O

Nearly	O
a	O
century	O
after	O
the	O
Spanish	B-Incident
flu	E-Incident
struck	O
in	O
1918–1920	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
called	O
on	O
scientists	O
,	O
national	O
authorities	O
and	O
the	O
media	O
to	O
follow	O
best	O
practices	O
in	O
naming	O
new	O
human	O
infectious	O
diseases	O
to	O
minimize	O
unnecessary	O
negative	O
effects	O
on	O
nations	O
,	O
economies	O
and	O
people	O
.	O

These	O
outbreaks	O
probably	O
lessened	O
the	O
significance	O
of	O
the	O
influenza	S-Disease
pandemic	O
for	O
the	O
public	O
.	O

Just	O
how	O
bad	O
could	O
a	O
pandemic	O
be?	O
In	O
science	O
fiction	O
,	O
we	O
sometimes	O
encounter	O
the	O
idea	O
of	O
a	O
pandemic	O
so	O
severe	O
that	O
it	O
could	O
cause	O
the	O
end	O
of	O
civilisation	O
,	O
or	O
even	O
of	O
humanity	O
itself	O
.	O

Of	O
the	O
62	O
completed	O
projects	O
,	O
39	O
were	O
done	O
according	O
to	O
original	O
time	O
frames	O
and	O
budgeted	O
costs	O
,	O
with	O
extensions	O
given	O
for	O
23	O
.	O

Additionally	O
,	O
CDC	S-Organization
has	O
found	O
that	O
1.	O
6	O
million	O
American	S-Organization
jobs	O
across	O
a	O
variety	O
of	O
sectors	O
are	O
threatened	O
by	O
these	O
overseas	O
outbreaks	O
of	O
infectious	O
diseases	O
,	O
said	O
.	O

An	O
increasing	O
number	O
of	O
vaccines	O
and	O
drugs	O
are	O
the	O
direct	O
products	O
of	O
rDNA	O
.	O

In	O
1918	O
,	O
persons	O
&gt;75	O
years	O
h	O
ad	B-Disease
lower	E-Disease
influpneumonia	O
case-fatality	O
rates	O
than	O
they	O
had	O
during	O
the	O
prepandemic	O
period	O
of	O
1911–1917	O
.	O

It	O
was	O
later	O
known	O
as	O
computed	B-Technology
axial	I-Technology
tomography	E-Technology
(	O
CAT	B-Technology
or	I-Technology
CT	I-Technology
scan	E-Technology
)	O
and	O
.	O

However	O
,	O
potential	O
applications	O
include	O
functional	O
imaging	O
and	O
imaging	O
of	O
organs	O
poorly	O
seen	O
on	O
1H	B-Technology
MRI	E-Technology
(e.g.	O
,	O
lungs	O
and	O
bones)	O
or	O
as	O
alternative	O
contrast	O
agents	O
.	O

Several	O
measures	O
are	O
used	O
to	O
quantify	O
mortality	O
.	O

In	O
1989	O
,	O
a	O
sudden	O
invasion	B-Incident
of	I-Incident
Mediterranean	I-Incident
fruit	I-Incident
flies	E-Incident
(Ceratitis	O
capitata	O
,	O
"	O
medflies")	O
appeared	O
in	O
California	S-Location
and	O
began	O
devastating	O
crops	O
.	O

The	O
complex	O
contained	O
various	O
factories	O
.	O

"	O
The	O
work	O
completed	O
at	O
AFRIMS	S-Organization
is	O
the	O
first	O
of	O
three	O
research	O
projects	O
we	O
are	O
collaborating	O
on	O
with	O
the	O
US	B-Organization
DoD	E-Organization
.	O
We	O
hope	O
to	O
announce	O
the	O
study	O
results	O
from	O
the	O
Department	B-Organization
of	I-Organization
Enteric	I-Organization
Infections,	I-Organization
US	I-Organization
Naval	I-Organization
Medical	I-Organization
Research	I-Organization
Center	E-Organization
and	O
the	O
in	O
the	O
next	O
few	O
months	O
.	O

She	O
has	O
extensive	O
experience	O
and	O
expertise	O
in	O
public	O
health	O
and	O
laboratory	O
research	O
,	O
particularly	O
related	O
to	O
the	O
prevention	O
and	O
control	O
of	O
infectious	O
diseases	O
.	O

In	O
2000	O
,	O
Michael	B-Person
Wagner	E-Person
,	O
the	O
codirector	O
of	O
the	O
RODS	B-Organization
laboratory	E-Organization
,	O
and	O
,	O
a	O
subcontractor	O
,	O
conceived	O
the	O
idea	O
of	O
obtaining	O
live	O
data	O
feeds	O
from	O
"	O
non-traditional"	O
(non-health-care)	O
data	O
sources	O
.	O

MRI	S-Technology
can	O
detect	O
health	O
problems	O
or	O
confirm	O
a	O
diagnosis	O
,	O
but	O
medical	O
societies	O
often	O
recommend	O
that	O
MRI	S-Technology
not	O
be	O
the	O
first	O
procedure	O
for	O
creating	O
a	O
plan	O
to	O
diagnose	O
or	O
manage	O
a	O
patient's	O
complaint	O
.	O

The	O
processes	O
of	O
package	O
unwrapping	O
,	O
sample	O
registration	O
and	O
photographing	O
,	O
sample	O
aliquoting	O
,	O
EBOV	B-Technology
inactivation	E-Technology
,	O
and	O
a	B-Technology
blood	I-Technology
assay	I-Technology
for	I-Technology
malaria	E-Technology
(	O
colloidal	B-Technology
gold	I-Technology
method	E-Technology
)	O
were	O
performed	O
in	O
the	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
the	O
laboratory	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

According	O
to	O
Kenneth	B-Person
Alibek	E-Person
,	O
the	O
used	O
tularemia	S-Pathogen
weapon	O
had	O
been	O
developed	O
in	O
the	O
Kirov	B-Location
military	I-Location
facility	E-Location
.	O
It	O
was	O
suggested	O
by	O
some	O
,	O
however	O
,	O
that	O
the	O
outbreak	O
might	O
have	O
been	O
of	O
natural	O
origin	O
,	O
since	O
a	O
pulmonary	S-Phenotype
form	O
of	O
tularemia	S-Pathogen
has	O
also	O
been	O
noted	O
in	O
.	O

Approximately	O
of	O
could	O
be	O
produced	O
in	O
a	O
few	O
days	O
.	O

They	O
obtained	O
search	O
warrants	O
and	O
subpoenas	O
;	O
50	O
investigators	O
entered	O
the	O
Ranch	O
on	O
October	O
2	O
,	O
1985	O
.	O

Emergent	S-Organization
has	O
programs	O
in	O
partnership	O
with	O
governments	O
,	O
non-government	O
organizations	O
,	O
industry	O
,	O
and	O
the	O
academia	O
,	O
and	O
this	O
mobile	O
manufacturing	O
unit	O
is	O
one	O
opportunity	O
to	O
leverage	O
these	O
relationships,	O
"	O
she	O
said	O
.	O

And	O
I	O
will	O
say	O
that	O
we	O
have	O
a	O
lot	O
to	O
cover	O
.	O

For	O
more	O
complex	O
anatomies	O
and	O
procedures	O
,	O
such	O
as	O
heart	O
valve	O
interventions	O
,	O
a	O
true	O
3D	O
reconstruction	O
or	O
a	O
3D	O
print	O
is	O
created	O
based	O
on	O
these	O
images	O
to	O
gain	O
a	O
deeper	O
understanding	O
.	O

The	O
National	B-Organization
Center	I-Organization
for	I-Organization
Emerging	I-Organization
and	I-Organization
Zoonotic	I-Organization
Infectious	I-Organization
Diseases	E-Organization
would	O
be	O
cut	O
by	O
$65	O
million	O
,	O
or	O
11	O
percent	O
.	O

CDC	S-Organization
Scientific	O
Data	O
,	O
Surveillance	O
,	O
Health	O
Statistics	O
,	O
and	O
Laboratory	O
Information	O
.	O

Private	O
vehicle	O
use	O
was	O
banned	O
in	O
the	O
city	O
.	O

"	O
Towards	B-Document
more	I-Document
consistent	I-Document
estimates	I-Document
of	I-Document
Aboriginal	I-Document
de-population	I-Document
in	I-Document
the	I-Document
early	I-Document
colonial	I-Document
Australia	E-Document
by	O
Jack	B-Person
Carmody	E-Person
and	O
,	O
presented	O
to	O
Asia-Pacific	O
Economic	O
&amp	O
;	O
Business	O
History	O
conference	O
in	O
Hamilton	O
(University	O
of	O
Waikato)	O
13–15	O
February	O
2014	O
.	O

This	O
problem	O
stems	O
from	O
the	O
fact	O
that	O
the	O
population	O
difference	O
between	O
the	O
nuclear	O
spin	O
states	O
is	O
very	O
small	O
at	O
room	O
temperature	O
.	O

This	O
year	O
,	O
the	O
event's	O
main	O
themes	O
included	O
mold	O
exposure	O
and	O
the	O
need	O
for	O
personal	O
protective	O
equipment	O
as	O
learned	O
from	O
the	O
fatalities	O
of	O
Hurricane	B-Incident
Harvey.	E-Incident
Conference	O
participants	O
also	O
focused	O
on	O
deaths	O
due	O
to	O
infections	O
in	O
alcohol	S-Drug
,	O
opioid	S-Drug
and	O
illegal	O
drug	O
use	O
;	O
advancement	O
and	O
lasting	O
concerns	O
in	O
the	O
eradication	O
of	O
polio	S-Disease
,	O
measles	S-Disease
,	O
and	O
rubella	S-Disease
;	O
the	O
infectious	O
causes	O
of	O
child	O
mortality	O
;	O
and	O
addressing	O
the	O
,	O
among	O
others	O
.	O

The	O
Federal	B-Organization
government	E-Organization
hopes	O
that	O
a	O
systematic	O
stand-down	O
and	O
thorough	O
inventory	O
will	O
allow	O
institutions	O
to	O
identify	O
orphaned	O
pathogens	O
and	O
conduct	O
orderly	O
disposals	O
of	O
the	O
materials	O
.	O

Bioengineering	O
can	O
play	O
a	O
role	O
in	O
creating	O
successful	O
bacteriophages	O
.	O

Speaking	O
at	O
the	O
opening	O
of	O
the	O
discussion	O
,	O
FAO	S-Organization
Representative	O
in	O
Liberia	S-Location
Ms	O
.	O

The	O
Chinese	B-Organization
government	E-Organization
said	O
product	O
instructions	O
might	O
not	O
have	O
been	O
followed	O
,	O
and	O
that	O
some	O
products	O
were	O
not	O
purchased	O
directly	O
from	O
certified	O
companies	O
.	O

During	O
the	O
Khabarovsk	O
War	O
Crime	O
Trials	O
the	O
accused	O
,	O
such	O
as	O
Major	O
General	O
Kiyashi	B-Person
Kawashima	E-Person
testified	O
that	O
as	O
early	O
as	O
1941	O
some	O
40	O
members	O
of	O
Unit	B-Organization
731	E-Organization
air-dropped	O
plague-contaminated	O
fleas	O
on	O
.	O
These	O
operations	O
caused	O
epidemic	O
plague	O
outbreaks	O
.	O

The	O
drop	O
in	O
cases	O
was	O
believed	O
to	O
be	O
related	O
to	O
an	O
integrated	O
strategy	O
combining	O
isolation	O
and	O
treatment	O
with	O
community	O
behaviour	O
change	O
,	O
including	O
safe	O
burial	O
practices	O
,	O
case	O
finding	O
and	O
contact	O
tracing.	O
,	O
leader	O
of	O
the	O
Safe	O
&amp	O
;	O
Diginified	O
Burial	O
Practices	O
Team	O
during	O
the	O
crisis	O
,	O
was	O
awarded	O
the	O
Florence	O
Nightingale	O
Medal	O
in	O
2017	O
for	O
her	O
work	O
during	O
the	O
crisis	O
.	O

Details	O
of	O
the	O
experiments	O
were	O
known	O
only	O
to	O
Saddam	S-Person
and	O
an	O
inner	O
circle	O
of	O
senior	O
government	O
officials	O
and	O
Iraqi	O
scientists	O
educated	O
in	O
the	O
West.	O
…	O
The	O
facility	O
,	O
which	O
is	O
understood	O
to	O
have	O
been	O
built	O
by	O
German	O
engineers	O
in	O
the	O
1980s	O
,	O
has	O
been	O
at	O
the	O
centre	O
of	O
Iraq	S-Location
's	O
experiments	O
on	O
"	O
human	O
guinea	O
pigs	O
"	O
for	O
more	O
than	O
10	O
years	O
,	O
according	O
to	O
Israeli	O
military	O
sources	O
.	O

Online	O
version	O
of	O
the	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories	I-Document
(BMBL),	I-Document
5th	I-Document
Ed	E-Document

There	O
are	O
several	O
advantages	O
that	O
CT	S-Technology
has	O
over	O
traditional	O
2D	B-Technology
medical	I-Technology
radiography	E-Technology
.	O
First	O
,	O
CT	S-Technology
completely	O
eliminates	O
the	O
superimposition	O
of	O
images	O
of	O
structures	O
outside	O
the	O
area	O
of	O
interest	O
.	O

Early	O
measures	O
announced	O
by	O
the	O
government	O
included	O
the	O
cancellation	O
of	O
concerts	O
and	O
other	O
cultural	O
events	O
,	O
sporting	O
events	O
,	O
Friday	O
prayers	O
,	O
and	O
closures	O
of	O
universities	O
,	O
higher	O
education	O
institutions	O
,	O
and	O
schools	O
.	O

Fetal	O
survival	O
and	O
damage	O
to	O
mother's	O
reproductive	O
organs	O
were	O
objects	O
of	O
interest	O
.	O

He	O
said	O
that	O
he	O
believed	O
they	O
had	O
poisoned	O
a	O
county	O
commissioner	O
and	O
Judge	O
William	B-Person
Hulse	E-Person
,	O
and	O
that	O
they	O
may	O
have	O
been	O
responsible	O
for	O
the	O
salmonellosis	B-Incident
outbreak	E-Incident
in	O
.	O
He	O
invited	O
state	O
and	O
federal	O
law	O
enforcement	O
officials	O
to	O
the	O
Ranch	O
to	O
investigate	O
.	O

It	O
will	O
provide	O
training	O
for	O
disaster	O
and	O
terror	O
situations	O
,	O
as	O
well	O
as	O
focus	O
research	O
on	O
responses	O
to	O
chemical	O
and	O
biological	O
terror	O
threats	O
.	O

Many	O
other	O
countries	O
are	O
reviewing	O
and	O
discussing	O
this	O
area	O
of	O
science	O
and	O
as	O
such	O
numerous	O
reports	O
and	O
reviews	O
have	O
also	O
been	O
conducted	O
.	O

Both	O
MERS-CoV	S-Pathogen
and	O
SARS-CoV	S-Pathogen
()	O
are	O
betacoronaviruses	O
.	O

Around	O
1950	O
the	O
Chemical	B-Organization
Corps	E-Organization
also	O
initiated	O
a	O
program	O
to	O
weaponize	O
tularemia	S-Pathogen
(UL)	O
.	O

According	O
to	O
international	O
medical	O
geneticists	O
led	O
by	O
Mark	B-Person
Achtman	E-Person
that	O
analysed	O
the	O
global	O
sequence	O
variation	O
of	O
the	O
bacterium	O
,	O
all	O
three	O
of	O
the	O
great	O
waves	O
of	O
the	O
plague	S-Disease
had	O
their	O
bacterium	O
"	O
evolved	O
in	O
or	O
near	O
China	S-Location
"	O
.	O
The	O
analysis	O
also	O
found	O
that	O
"	O
sylvatic	O
cycles	O
of	O
disease	O
depend	O
on	O
transmission	O
by	O
flea	O
vectors	O
"	O
and	O
"	O
the	O
likely	O
origin	O
of	O
the	O
plague	S-Disease
in	O
has	O
nothing	O
to	O
do	O
with	O
its	O
people	O
or	O
crowded	O
cities"	O
.	O

The	O
multi-user	O
open-source	O
system	O
uses	O
a	O
MySQL	O
or	O
PostgreSQL	O
relational	O
database	O
,	O
an	O
integrated	O
File	O
transfer	O
protocol	O
server	O
for	O
batch	O
data	O
transfer	O
and	O
a	O
Tomcat	O
servlet	O
attached	O
to	O
a	O
web	O
server	O
for	O
dissemination	O
of	O
data	O
.	O

Although	O
the	O
laboratory	O
generation	O
of	O
the	O
mutant	O
influenza	O
virus	O
H5N1	S-Pathogen
with	O
airborne	O
transmissibility	O
among	O
mammals	O
,	O
which	O
has	O
been	O
considered	O
as	O
a	O
dual-use	O
research	O
,	O
may	O
benefit	O
the	O
development	O
of	O
effective	O
vaccines	O
and	O
therapeutics	O
against	O
the	O
emerging	O
infectious	O
agents	O
,	O
it	O
may	O
also	O
pose	O
threats	O
to	O
national	O
biosecurity	O
,	O
laboratory	O
biosafety	O
,	O
and/or	O
public	O
health	O
.	O

What	O
Might	O
an	O
Anthrax	S-Pathogen
Attack	O
Look	O
Like?	O

It	O
also	O
called	O
for	O
the	O
inclusion	O
of	O
child-specific	O
targets	O
and	O
targets	O
addressing	O
antimicrobial	O
resistance	O
.	O

After	O
two	O
months	O
of	O
being	O
Ebola	S-Disease
a	O
new	O
case	O
was	O
confirmed	O
on	O
20	O
November	O
2015	O
,	O
when	O
a	O
15-year-old	O
boy	O
was	O
diagnosed	O
with	O
the	O
virus	O
and	O
two	O
family	O
members	O
subsequently	O
tested	O
positive	O
as	O
well	O
.	O

For	O
example	O
,	O
too	O
many	O
antibiotics	O
are	O
being	O
prescribed	O
unnecessarily	O
to	O
humans	O
in	O
the	O
United	B-Location
States	E-Location
CDC	S-Organization
estimates	O
about	O
47	O
million	O
antibiotic	O
courses	O
are	O
prescribed	O
for	O
infections	O
that	O
don't	O
need	O
antibiotics	O
,	O
like	O
for	O
colds	S-Disease
and	O
the	O
flu	S-Disease
,	O
in	O
doctors'	O
offices	O
and	O
emergency	O
departments	O
each	O
year	O
.	O

A	O
preliminary	O
study	O
in	O
the	O
U.S.	S-Location
found	O
38%	O
under-utilization	O
of	O
cardiac	O
care	O
units	O
as	O
compared	O
to	O
normal	O
.	O

It	O
also	O
means	O
that	O
cells	O
can	O
act	O
as	O
sensors	O
of	O
factors	O
in	O
the	O
environment	O
.	O

Public	O
Health	O
Service	O
and	O
Atlanta	O
was	O
chosen	O
as	O
the	O
location	O
because	O
malaria	S-Disease
was	O
endemic	O
in	O
the	O
.	O

Pseudomallei	O
was	O
studied	O
by	O
the	O
US	O
as	O
a	O
potential	O
bioweapon	O
in	O
the	O
past	O
.	O

While	O
theoretical	O
concerns	O
have	O
been	O
raised	O
about	O
ACE	B-Drug
inhibitors	E-Drug
and	O
angiotensin	B-Drug
receptor	I-Drug
blockers	E-Drug
,	O
as	O
of	O
19	O
March	O
2020	O
,	O
these	O
are	O
not	O
sufficient	O
to	O
justify	O
stopping	O
these	O
medications	O
.	O

"	O
We	O
have	O
more	O
information	O
about	O
how	O
the	O
vaccine	O
works	O
,	O
how	O
effective	O
is	O
it	O
is	O
...	O
if	O
there	O
was	O
an	O
event	O
that	O
required	O
a	O
massive	O
vaccination	O
of	O
thousands	O
or	O
even	O
hundreds	O
of	O
thousands	O
of	O
people,	O
"	O
Walke	S-Person
said	O
.	O

In	O
addition	O
to	O
the	O
use	O
of	O
bursting	O
bomblets	O
for	O
creating	O
biological	O
aerosols	O
,	O
the	O
Chemical	B-Organization
Corps	E-Organization
started	O
investigating	O
aerosol-generating	O
bomblets	O
in	O
the	O
1950s	O
.	O

The	O
success	O
rate	O
(in	O
terms	O
of	O
number	O
of	O
research	O
proposals	O
funded	O
compared	O
to	O
the	O
total	O
number	O
of	O
research	O
proposals	O
submitted)	O
was	O
approximately	O
28%	O
.	O

Meanwhile	O
,	O
the	O
UK's	B-Platform
National	I-Platform
Health	I-Platform
Service	E-Platform
website	O
states	O
that:	O
"	O
Many	O
global	O
outbreaks	O
of	O
infectious	O
illnesses	O
(pandemics)	O
that	O
have	O
occurred	O
in	O
recent	O
history	O
are	O
thought	O
to	O
have	O
been	O
caused	O
by	O
viruses	O
previously	O
only	O
found	O
in	O
animals	O
.	O

Twenty-two	O
people	O
,	O
including	O
12	O
mail	O
handlers	O
,	O
got	O
,	O
and	O
five	O
of	O
these	O
22	O
people	O
died	O
.	O

However	O
,	O
both	O
are	O
commonly	O
found	O
in	O
goat	O
herds	O
worldwide	O
,	O
and	O
are	O
often	O
isolated	O
from	O
goats	O
in	O
the	O
US	S-Location
.	O
The	O
organisms	O
typically	O
cause	O
mild	O
mastitis	S-Disease
and	O
polyarthritis	S-Disease
in	O
some	O
goats	O
.	O

In	O
those	O
beyond	O
48	O
hours	O
who	O
are	O
moderately	O
or	O
severely	O
ill	O
,	O
antivirals	O
may	O
still	O
be	O
beneficial	O
.	O

We	O
want	O
to	O
talk	O
.	O

The	O
national	O
security	O
of	O
the	O
U.S.	S-Location
has	O
a	O
vested	O
interest	O
in	O
containing	O
the	O
virus	O
in	O
Africa	S-Location
,	O
but	O
the	O
U.S.	S-Location
lacks	O
a	O
coordinated	O
team	O
,	O
a	O
central	O
structure	O
to	O
meet	O
such	O
biodefense	O
goals,e	O
said	O
.	O

They	O
assembled	O
a	O
DNA	O
strand	O
one	O
million	O
base	O
pairs	O
long	O
and	O
put	O
it	O
into	O
a	O
bacterial	O
cell3	O
.	O

The	O
forum	O
is	O
also	O
gear	O
at	O
developing	O
a	O
multi-sectoral	O
national	O
strategic	O
action	O
plan	O
for	O
stakeholders	O
to	O
support	O
rabies	S-Disease
control	O
capacities	O
.	O

Official	O
publications	O
from	O
the	O
WHO	S-Organization
reported	O
the	O
earliest	O
onset	O
of	O
symptoms	O
as	O
8December	O
2019	O
.	O

Of	O
particular	O
note	O
,	O
Fluconazole-resistant	B-Pathogen
Candida	E-Pathogen
have	O
been	O
highlighted	O
as	O
a	O
growing	O
problem	O
by	O
the	O
CDC	S-Organization
.	O
More	O
than	O
20	O
species	O
of	O
Candida	O
can	O
cause	O
Candidiasis	B-Disease
infection	E-Disease
,	O
the	O
most	O
common	O
of	O
which	O
is	O
Candida	B-Pathogen
albicans	E-Pathogen
.	O
Candida	O
yeasts	O
normally	O
inhabit	O
the	O
skin	O
and	O
mucous	O
membranes	O
without	O
causing	O
infection	O
.	O

The	O
curve	O
of	O
influenza	S-Disease
deaths	O
by	O
age	O
at	O
death	O
has	O
historically	O
,	O
for	O
at	O
least	O
150	O
years	O
,	O
been	O
U-shaped	O
(Figure	O
2)	O
,	O
exhibiting	O
mortality	O
peaks	O
in	O
the	O
very	O
young	O
and	O
the	O
very	O
old	O
,	O
with	O
a	O
comparatively	O
low	O
frequency	O
of	O
deaths	O
at	O
all	O
ages	O
in	O
between	O
.	O

The	O
other	O
official	O
global	O
public	O
health	O
campaigns	O
marked	O
by	O
WHO	S-Organization
are	O
World	O
Tuberculosis	S-Disease
Day	O
,	O
World	O
Immunization	O
Week	O
,	O
World	O
Malaria	S-Disease
Day	O
,	O
World	O
No	O
Tobacco	O
Day	O
,	O
World	O
Blood	O
Donor	O
Day	O
,	O
World	O
Hepatitis	S-Disease
Day	O
,	O
and	O
World	O
Day	O
.	O

"	O
Protecting	O
public	O
health	O
requires	O
a	O
concerted	O
effort	O
from	O
all	O
sectors	O
.	O

When	O
Nixon	S-Person
ended	O
the	O
U.S.	B-Scientific_research_project
bio-weapons	I-Scientific_research_project
program	E-Scientific_research_project
in	O
1969	O
he	O
also	O
announced	O
that	O
he	O
would	O
resubmit	O
the	O
Geneva	B-Document
Protocol	E-Document
to	O
the	O
U.S.	B-Organization
Senate	E-Organization
.	O
This	O
was	O
a	O
move	O
Nixon	S-Person
was	O
considering	O
as	O
early	O
as	O
July	O
1969	O
.	O

Three	O
private	O
American	O
companies	O
work	O
at	O
the	O
US	S-Location
bio-laboratory	O
in	O
Tbilisi	S-Location
–	O
CH2M	B-Organization
Hill	E-Organization
,	O
Battelle	S-Organization
and	O
Metabiota	S-Organization
.	O
In	O
addition	O
to	O
the	O
Pentagon	S-Organization
,	O
these	O
private	O
contractors	O
perform	O
biological	O
research	O
for	O
the	O
and	O
various	O
other	O
government	O
agencies	O
.	O

However	O
,	O
overgrowth	O
of	O
Candida	O
can	O
lead	O
to	O
.	O
Some	O
Candida	O
strains	O
are	O
becoming	O
resistant	O
to	O
first-line	O
and	O
second-line	O
antifungal	O
agents	O
such	O
as	O
azoles	O
and	O
echinocandins	O
.	O

To	O
perform	O
a	O
study	O
,	O
the	O
person	O
is	O
positioned	O
within	O
an	O
MRI	B-Equipment
scanner	E-Equipment
that	O
forms	O
a	O
strong	O
magnetic	O
field	O
around	O
the	O
area	O
to	O
be	O
imaged	O
.	O

In	O
the	O
first	O
outbreak	O
,	O
two	O
thirds	O
of	O
the	O
population	O
contracted	O
the	O
illness	O
and	O
most	O
patients	O
died	O
;	O
in	O
the	O
next	O
,	O
half	O
the	O
population	O
became	O
ill	O
but	O
only	O
some	O
died	O
;	O
by	O
the	O
third	O
,	O
a	O
tenth	O
were	O
affected	O
and	O
many	O
survived	O
;	O
while	O
by	O
the	O
fourth	O
occurrence	O
,	O
only	O
one	O
in	O
twenty	O
people	O
were	O
sickened	O
and	O
most	O
of	O
them	O
survived	O
.	O

On	O
30	O
January	O
,	O
the	O
declared	O
the	O
coronavirus	O
a	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
.	O

Within	O
the	O
European	B-Organization
Union	E-Organization
(	O
EU	S-Location
)	O
,	O
the	O
European	B-Organization
Commission	E-Organization
has	O
launched	O
a	O
green	O
paper	O
on	O
biopreparedness	O
,	O
an	O
EU	B-Document
CBRN	I-Document
action	I-Document
plan	E-Document
,	O
and	O
EU	B-Document
legislation	E-Document
concerning	O
serious	O
cross-border	O
threats	O
to	O
health	O
.	O

Attackers	O
hurled	O
dead	O
horses	O
and	O
other	O
animals	O
by	O
catapult	O
at	O
the	O
castle	B-Location
of	I-Location
Thun	I-Location
L'Eveque	E-Location
in	O
Hainault	S-Location
,	O
in	O
what	O
is	O
now	O
.	O
The	O
defenders	O
reported	O
that	O
"	O
the	O
stink	O
and	O
the	O
air	O
were	O
so	O
abominable...they	O
could	O
not	O
long	O
endure	O
"	O
and	O
negotiated	O
a	O
truce	O
.	O

The	O
worker	O
was	O
put	O
on	O
an	O
antiviral	O
medication	O
for	O
10	O
days	O
and	O
told	O
to	O
monitor	O
for	O
,	O
but	O
no	O
infection	O
resulted	O
,	O
the	O
records	O
say	O
.	O

In	O
addition	O
,	O
61,731	O
passengers	O
and	O
2,430	O
cargo	O
shipments	O
were	O
searched	O
entering	O
through	O
airports	O
,	O
but	O
no	O
larvae	O
were	O
discovered	O
.	O

The	O
Oregonian	O
ran	O
a	O
20-part	O
series	O
on	O
Rajneesh	S-Person
movement	O
,	O
beginning	O
in	O
June	O
1985	O
,	O
which	O
included	O
an	O
investigation	O
into	O
the	O
Salmonella	B-Incident
incident	E-Incident
.	O
As	O
a	O
result	O
of	O
a	O
follow-up	O
investigation	O
,	O
The	O
Oregonian	O
learned	O
that	O
Leslie	B-Person
L.	I-Person
Zaitz	E-Person
,	O
one	O
of	O
their	O
investigative	O
journalists	O
,	O
had	O
been	O
placed	O
as	O
number	O
three	O
on	O
a	O
top-ten	O
hit	O
list	O
by	O
Sheela	S-Person
's	O
group	O
.	O

He	O
was	O
interviewed	O
by	O
the	O
Imperial	B-Organization
War	I-Organization
Museum	E-Organization
in	O
1981	O
,	O
and	O
the	O
audio	O
recording	O
tape	O
reels	O
are	O
in	O
the	O
's	O
archives	O
.	O

And	O
although	O
one's	O
own	O
DNA	O
information	O
has	O
traditionally	O
been	O
considered	O
personal	O
and	O
private	O
,	O
containing	O
information	O
about	O
your	O
ancestors	O
,	O
family	O
,	O
and	O
medical	O
conditions	O
,	O
governments	O
and	O
corporations	O
increasingly	O
include	O
a	O
person's	O
DNA	O
signature	O
in	O
the	O
information	O
they	O
collect	O
.	O

The	O
military	O
facility	O
remains	O
closed	O
for	O
inspection	O
.	O

The	O
WHO	S-Organization
additionally	O
uses	O
"	O
the	O
COVID‑19	B-Pathogen
virus	E-Pathogen
"	O
and	O
"	O
"	O
in	O
public	O
communications	O
.	O

It	O
was	O
confirmed	O
that	O
the	O
virus	O
spread	O
via	O
droplets	O
,	O
but	O
this	O
later	O
outbreak	O
made	O
officials	O
question	O
the	O
possibility	O
that	O
the	O
virus	O
could	O
be	O
spread	O
through	O
the	O
air	O
.	O

LOS	B-Location
ALAMOS,	I-Location
N.M.	E-Location
May	O
8	O
,	O
2018-A	O
partnership	O
involving	O
the	O
University	B-Organization
of	I-Organization
Nebraska	E-Organization
and	O
will	O
boost	O
educational	O
opportunities	O
for	O
students	O
seeking	O
careers	O
in	O
the	O
biodefense	O
field	O
.	O

It	O
is	O
essential	O
that	O
antibiotic	O
discovery	O
and	O
production	O
be	O
maintained	O
on	O
a	O
scale	O
that	O
is	O
appropriate	O
to	O
our	O
increasing	O
requirements	O
.	O

I	O
want	O
to	O
make	O
clear	O
in	O
this	O
incident	O
,	O
all	O
of	O
the	O
materials	O
were	O
handled	O
in	O
what's	O
called	O
enhanced	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
facilities	O
.	O

The	O
category	O
lists	O
and	O
criteria	O
published	O
by	O
the	O
US	B-Organization
CDC	E-Organization
NIH	S-Organization
,	O
EU	S-Location
or	O
China	S-Location
have	O
certain	O
inconsistencies	O
.	O

Founded	O
in	O
1974	O
,	O
the	O
Center	B-Organization
for	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	E-Organization
was	O
once	O
known	O
for	O
developing	O
biological	O
weapons	O
research	O
during	O
the	O
.	O
It	O
is	O
now	O
one	O
of	O
the	O
world's	O
largest	O
research	O
centers	O
developing	O
vaccines	O
and	O
tools	O
for	O
diagnosing	O
and	O
treating	O
infectious	O
diseases	O
.	O

By	O
September	O
2014	O
,	O
Médecins	B-Organization
Sans	I-Organization
Frontières/Doctors	I-Organization
Without	I-Organization
Borders	E-Organization
(	O
MSF	S-Organization
)	O
,	O
the	O
non-governmental	O
organisation	O
with	O
the	O
largest	O
working	O
presence	O
in	O
the	O
affected	O
countries	O
,	O
had	O
grown	O
increasingly	O
critical	O
of	O
the	O
international	O
response	O
.	O

"	O
People	O
have	O
very	O
short	O
memories	O
,	O
and	O
policymakers	O
do	O
as	O
well,	O
"	O
Adalja	S-Person
said	O
.	O

So	O
,	O
biosafety	O
precautions	O
in	O
diagnostic	O
laboratories	O
become	O
a	O
crucial	O
issue	O
that	O
should	O
be	O
followed	O
.	O

A	O
further	O
study	O
has	O
also	O
presented	O
evidence	O
that	O
NPC1	O
is	O
the	O
critical	O
receptor	O
mediating	O
infection	O
via	O
its	O
direct	O
binding	O
to	O
the	O
viral	O
GP	O
,	O
and	O
that	O
it	O
is	O
the	O
second	O
"	O
lysosomal"	O
domain	O
of	O
NPC1	O
that	O
mediates	O
this	O
binding	O
.	O

The	O
rest	O
of	O
this	O
article	O
discusses	O
medical-imaging	B-Technology
X-ray	I-Technology
CT	E-Technology
;	O
industrial	O
applications	O
of	O
are	O
discussed	O
at	O
industrial	O
computed	O
tomography	O
scanning	O
.	O

It	O
will	O
also	O
enable	O
us	O
to	O
direct	O
cells	O
and	O
organisms	O
to	O
perform	O
jobs	O
,	O
such	O
as	O
creating	O
clean	O
water	O
or	O
new	O
biofuels	O
that	O
natural	O
species	O
cannot	O
currently	O
do	O
to	O
the	O
needed	O
scale	O
and	O
efficiencies	O
.	O

In	O
addition	O
,	O
the	O
US	B-Organization
CDC	E-Organization
takes	O
into	O
account	O
the	O
need	O
for	O
special	O
public	O
health	O
response	O
measures	O
,	O
the	O
EU	S-Location
takes	O
into	O
account	O
the	O
epidemiological	O
situation	O
and	O
disease	O
susceptibility	O
factors	O
and	O
Russia	S-Location
takes	O
into	O
account	O
the	O
dose	O
required	O
for	O
.	O

The	O
major	O
part	O
of	O
the	O
outbreak	O
lasted	O
about	O
8	O
months	O
,	O
since	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
declared	O
SARS	S-Disease
contained	O
on	O
5	O
July	O
2003	O
.	O

But	O
the	O
few	O
data	O
bearing	O
on	O
protection	O
during	O
the	O
second	O
and	O
third	O
waves	O
after	O
infection	O
in	O
the	O
first	O
wave	O
are	O
inconclusive	O
and	O
do	O
little	O
to	O
resolve	O
the	O
question	O
of	O
whether	O
the	O
first	O
wave	O
was	O
caused	O
by	O
the	O
same	O
virus	O
or	O
whether	O
major	O
genetic	O
evolutionary	O
events	O
were	O
occurring	O
even	O
as	O
the	O
pandemic	O
exploded	O
and	O
progressed	O
.	O

It	O
has	O
a	O
high	O
affinity	O
for	O
common	O
and	O
scavenges	O
them	O
,	O
allowing	O
them	O
to	O
be	O
removed	O
via	O
the	O
kidneys	O
.	O

Subsequent	O
research	O
indicates	O
that	O
descendants	O
of	O
the	O
still	O
persists	O
enzootically	O
in	O
pigs	O
.	O

Regarding	O
the	O
topic	O
of	O
animals	O
,	O
Dr	O
.	O

On	O
1	O
August	O
2018	O
,	O
the	O
tenth	O
Ebola	B-Incident
outbreak	E-Incident
was	O
declared	O
in	O
the	O
,	O
only	O
a	O
few	O
days	O
after	O
the	O
prior	O
outbreak	O
in	O
the	O
same	O
country	O
had	O
been	O
declared	O
over	O
on	O
24	O
July	O
.	O

"	O
The	O
goal	O
is	O
to	O
design	O
a	O
mobile	O
lab	O
that	O
can	O
be	O
used	O
to	O
protect	O
health	O
and	O
infrastructure	O
during	O
outbreaks	O
of	O
Zika	S-Disease
MERS	S-Disease
,	O
or	O
other	O
diseases	O
around	O
the	O
world,	O
"	O
she	O
added	O
.	O

Most	O
germs	O
are	O
harmless	O
,	O
and	O
some	O
can	O
even	O
be	O
helpful	O
to	O
humans	O
,	O
but	O
some	O
can	O
cause	O
infections	O
,	O
like	O
strep	B-Disease
throat	E-Disease
and	O
.	O

DARPA	S-Organization
program	O
seeks	O
to	O
prevent	O
these	O
cross-species	O
jumps	O
by	O
predicting	O
viral	O
evolution	O
and	O
transmission	O
pathways	O
and	O
proactively	O
intervening	O
to	O
prevent	O
the	O
jump	O
to	O
humans	O
.	O

Speaking	O
to	O
an	O
audience	O
at	O
the	O
Pew	B-Organization
Charitable	I-Organization
Trusts	E-Organization
in	O
Washington,	B-Location
DC	E-Location
,	O
Gottlieb	S-Person
praised	O
efforts	O
to	O
stimulate	O
antibiotic	O
research	O
and	O
development	O
,	O
highlighting	O
the	O
Generating	B-Document
New	I-Document
Antibiotics	I-Document
Now	I-Document
(GAIN)	I-Document
Act	E-Document
and	O
the	O
.	O
But	O
he	O
said	O
these	O
"	O
push"	O
incentives	O
,	O
designed	O
to	O
get	O
product	O
research	O
and	O
development	O
off	O
the	O
ground	O
,	O
are	O
not	O
enough	O
to	O
stem	O
the	O
tide	O
of	O
pharmaceutical	O
companies	O
that	O
are	O
dropping	O
antibiotic-development	O
programs	O
.	O

Critics	O
have	O
said	O
the	O
WHO	S-Organization
handled	O
the	O
pandemic	O
inadequately	O
and	O
that	O
the	O
public	O
health	O
emergency	O
declaration	O
and	O
pandemic	O
classification	O
came	O
too	O
late	O
.	O

Also	O
,	O
if	O
the	O
massive	O
decline	O
in	O
economic	O
activity	O
persisted	O
,	O
the	O
authors	O
suggested	O
a	O
focus	O
on	O
economic	O
recovery	O
in	O
addition	O
to	O
support	O
for	O
the	O
healthcare	O
system	O
.	O

On	O
5February	O
,	O
the	O
Chinese	O
foreign	O
ministry	O
said	O
21	O
countries	O
(including	O
Belarus	S-Organization
,	O
Pakistan	S-Organization
,	O
Trinidad	S-Organization
and	O
Tobago	S-Organization
,	O
Egypt	S-Organization
,	O
and	O
Iran	S-Location
)	O
had	O
sent	O
aid	O
to	O
China	S-Location
,	O
and	O
Bill	S-Person
and	O
Melinda	B-Person
Gates	E-Person
announced	O
a	O
$100 million	O
donation	O
to	O
the	O
WHO	S-Organization
to	O
fund	O
vaccine	O
research	O
and	O
treatment	O
efforts	O
and	O
protect	O
"	O
at-risk	O
populations	O
in	O
Africa	S-Location
and	O
South	B-Location
Asia	E-Location
"	O
.	O
Interaksyon	S-Person
said	O
the	O
Chinese	B-Organization
government	E-Organization
had	O
donated	O
200,000	O
masks	O
to	O
the	O
Philippines	S-Organization
on	O
6February	O
after	O
Philippine	O
senator	O
Richard	B-Person
Gordon	E-Person
shipped	O
3.16 million	O
masks	O
to	O
Wuhan	S-Location
.	O
On	O
19	O
February	O
,	O
the	O
Singapore	B-Organization
Red	I-Organization
Cross	E-Organization
announced	O
it	O
would	O
send	O
$2.26 million	O
worth	O
of	O
aid	O
to	O
.	O

"	O
If	O
we	O
are	O
able	O
to	O
predict	O
how	O
viruses	O
might	O
mutate	O
and	O
spread	O
,	O
and	O
take	O
steps	O
to	O
prevent	O
those	O
mutations	O
from	O
impacting	O
humans	O
,	O
then	O
we'll	O
vastly	O
diminish	O
the	O
possibility	O
of	O
future	O
viral	O
pandemics,	O
"	O
said	O
Gimlett	S-Person

This	O
ranges	O
from	O
arteries	O
serving	O
the	O
brain	S-Phenotype
to	O
those	O
bringing	O
blood	O
to	O
the	O
lungs	O
,	O
kidneys	O
,	O
arms	O
and	O
legs	O
.	O

A	O
subset	O
of	O
select	O
agents	O
and	O
toxins	O
have	O
been	O
designated	O
as	O
Tier	O
1	O
because	O
these	O
biological	O
agents	O
and	O
toxins	O
present	O
the	O
greatest	O
risk	O
of	O
deliberate	O
misuse	O
with	O
significant	O
potential	O
for	O
mass	O
casualties	O
or	O
devastating	O
effect	O
to	O
the	O
economy	O
,	O
critical	O
infrastructure	O
,	O
or	O
public	O
confidence	O
,	O
and	O
pose	O
a	O
severe	O
threat	O
to	O
public	O
health	O
and	O
safety	O
.	O

Unit	B-Organization
731	E-Organization
-	O
Did	O
the	O
Emperor	O
Know?	O
.	O

Copyright	O
2018	O
The	O
Associated	B-Organization
Press	E-Organization
All	O
rights	O
reserved	O
.	O

Resilience	O
is	O
a	O
multifaceted	O
issue	O
as	O
well	O
,	O
as	O
addressed	O
by	O
OHA	S-Organization
One	O
way	O
in	O
which	O
this	O
is	O
ensured	O
is	O
through	O
exercises	O
that	O
establish	O
preparedness	O
;	O
programs	O
like	O
the	O
Anthrax	B-Activity
Response	I-Activity
Exercise	I-Activity
Series	E-Activity
exist	O
to	O
ensure	O
that	O
,	O
regardless	O
of	O
the	O
incident	O
,	O
all	O
emergency	O
personnel	O
will	O
be	O
aware	O
of	O
the	O
role	O
they	O
must	O
fill	O
.	O

There	O
were	O
many	O
attacks	O
against	O
Jewish	O
communities	O
.	O

Cohen	S-Person
was	O
studying	O
how	O
to	O
transfer	O
plasmids	O
from	O
one	O
cell	O
to	O
another.	O
was	O
studying	O
restriction	O
enzymes	O
and	O
had	O
found	O
that	O
enzymes	O
such	O
as	O
HindII	O
leave	O
behind	O
'sticky	O
ends'	O
when	O
they	O
cut	O
DNA	O
.	O

Voluntary	O
contributions	O
will	O
account	O
for	O
$3,015 million	O
(76%)	O
,	O
of	O
which	O
$800 million	O
is	O
regarded	O
as	O
highly	O
or	O
moderately	O
flexible	O
funding	O
,	O
with	O
the	O
remainder	O
tied	O
to	O
particular	O
programmes	O
or	O
objectives	O
.	O

The	O
use	O
of	O
such	O
a	O
virus	O
,	O
be	O
it	O
inactive	O
or	O
dead	O
,	O
aims	O
to	O
elicit	O
a	O
prompt	O
immune	O
response	O
of	O
the	O
human	O
body	O
to	O
a	O
new	O
infection	O
with	O
COVID‑19	S-Pathogen
.	O
A	O
second	O
strategy	O
,	O
subunit	O
vaccines	O
,	O
aims	O
to	O
create	O
a	O
vaccine	O
that	O
sensitises	O
the	O
immune	O
system	O
to	O
certain	O
subunits	O
of	O
the	O
virus	O
.	O

SGI	S-Organization
intends	O
to	O
provide	O
licenses	O
to	O
its	O
.	O

Genitals	O
of	O
female	O
prisoners	O
that	O
were	O
infected	O
with	O
syphilis	S-Disease
were	O
called	O
"	O
jam	O
filled	O
buns	O
"	O
by	O
guards	O
.	O

Over	O
three	O
years	O
,	O
it	O
took	O
the	O
lives	O
of	O
roughly	O
3%	O
of	O
the	O
world's	O
people	O
.	O

Liberation	O
of	O
the	O
ribosome	O
from	O
the	O
drug	O
allows	O
further	O
translation	O
and	O
consequent	O
resistance	O
to	O
the	O
drug	O
.	O

Emergency	B-Organization
Response	I-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Database	E-Organization
.	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Occupational	I-Organization
Safety	I-Organization
and	I-Organization
Health	E-Organization
.	O
Accessed	O
April	O
20	O
,	O
2009	O
.	O

The	O
RF	O
signal	O
may	O
be	O
processed	O
to	O
deduce	O
position	O
information	O
by	O
looking	O
at	O
the	O
changes	O
in	O
RF	O
level	O
and	O
phase	O
caused	O
by	O
varying	O
the	O
local	O
magnetic	O
field	O
using	O
gradient	O
coils	O
.	O

Recommendations	O
for	O
wearing	O
masks	O
have	O
been	O
a	O
subject	O
of	O
debate	O
.	O

Since	O
he	O
had	O
not	O
added	O
any	O
foreign-species	O
(transgenic)	O
DNA	O
to	O
his	O
organism	O
,	O
the	O
mushroom	O
could	O
not	O
be	O
regulated	O
by	O
the	O
USDA	S-Organization
under	O
Section	O
340.2	O
.	O

He	O
also	O
said	O
the	O
U.S.	S-Location
would	O
not	O
participate	O
in	O
a	O
global	O
effort	O
with	O
the	O
WHO	S-Organization
to	O
develop	O
a	O
vaccine	O
and	O
drugs	O
to	O
combat	O
the	O
virus	O
.	O

The	O
disease	O
was	O
declared	O
eradicated	O
from	O
human	O
populations	O
in	O
1980	O
.	O

Occasional	O
Paper	O
No.9	O
.	O

On	O
18	O
March	O
2020	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
announced	O
the	O
launch	O
of	O
a	O
trial	O
that	O
would	O
include	O
one	O
group	O
treated	O
with	O
.	O
Other	O
clinical	O
trials	O
are	O
underway	O
or	O
planned	O
.	O

Foot-and-mouth	S-Disease
was	O
considered	O
a	O
highest-category	O
pathogen	O
,	O
and	O
required	O
the	O
highest	O
level	O
of	O
biosecurity	O
.	O

Vials	O
of	O
bioterror	O
bacteria	O
have	O
gone	O
missing	O
.	O

ASPR	S-Organization
manages	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
,	O
Project	B-Scientific_research_project
BioShield	E-Scientific_research_project
and	O
the	O
Public	B-Organization
Health	I-Organization
Emergency	I-Organization
Medical	I-Organization
Countermeasures	I-Organization
Enterprise	E-Organization
,	O
among	O
others	O
that	O
receive	O
funding	O
support	O
under	O
.	O

In	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
for	O
instance	O
,	O
the	O
UN	S-Organization
is	O
supervising	O
the	O
overall	O
response	O
to	O
the	O
Ebola	S-Disease
crisis	O
,	O
the	O
first	O
time	O
Lillibridge	S-Person
said	O
he's	O
seen	O
it	O
become	O
operational.	O
investment	O
in	O
such	O
responses	O
would	O
benefit	O
the	O
nation	O
,	O
he	O
said	O
.	O

Included	O
in	O
the	O
recommendations	O
of	O
the	O
changes	O
needed	O
to	O
fight	O
future	O
outbreaks	O
is	O
the	O
creation	O
of	O
a	O
U.N.	B-Organization
Security	I-Organization
Council	I-Organization
health	I-Organization
committee	E-Organization
to	O
expedite	O
political	O
attention	O
to	O
health	O
issues	O
and	O
the	O
establishment	O
of	O
a	O
global	O
fund	O
to	O
finance	O
and	O
accelerate	O
the	O
development	O
of	O
outbreak-relevant	O
drugs	O
and	O
treatment	O
.	O

Nimble	O
strategies	O
are	O
needed	O
because	O
of	O
the	O
fast	O
pace	O
of	O
technological	O
change	O
.	O

The	O
devastating	O
impact	O
of	O
this	O
loss	O
is	O
still	O
being	O
felt	O
years	O
after	O
the	O
outbreak	O
ended	O
,	O
said	O
.	O

On	O
17	O
January	O
,	O
China	S-Location
announced	O
a	O
third	O
case	O
of	O
SARS	S-Disease
in	O
Guangzhou	S-Location
.	O
WHO	S-Organization
officials	O
urged	O
more	O
testing	O
to	O
bring	O
the	O
three	O
recently	O
announced	O
cases	O
into	O
line	O
with	O
their	O
standards	O
;	O
however	O
,	O
they	O
also	O
announced	O
SARS	B-Pathogen
virus	E-Pathogen
had	O
been	O
detected	O
by	O
a	O
team	O
in	O
civet	O
cages	O
at	O
the	O
restaurant	O
where	O
the	O
second	O
case	O
worked	O
and	O
in	O
civet	O
cages	O
in	O
the	O
market	O
.	O

I	O
know	O
that	O
you've	O
said	O
this	O
,	O
but	O
each	O
team	O
there	O
was	O
,	O
I	O
guess	O
,	O
incident	O
,	O
why	O
were	O
there	O
-	O
how	O
could	O
this	O
have	O
happened	O
at	O
the	O
that	O
all	O
these	O
agents	O
were	O
released	O
in	O
the	O
last	O
decade?	O

Little	O
did	O
the	O
U.S.	O
team	O
know	O
,	O
however	O
,	O
that	O
spies	O
were	O
in	O
nearby	O
waters	O
,	O
collecting	O
samples	O
of	O
the	O
agents	O
tested	O
.	O

This	O
must	O
stop	O
.	O

In	O
May	O
2018	O
,	O
Center	O
authors	O
published	O
,	O
The	O
,	O
which	O
established	O
a	O
framework	O
for	O
identifying	O
naturally	O
occurring	O
microorganisms	O
that	O
could	O
be	O
GCBRs	O
and	O
made	O
broad	O
recommendations	O
for	O
improving	O
GCBR	O
preparedness	O
efforts	O
.	O

The	O
labeling	O
of	O
GM	S-Technology
crops	O
and	O
their	O
products	O
are	O
mandatory	O
if	O
the	O
genetically	B-Technology
modified	I-Technology
organism	E-Technology
(	O
GMO	S-Technology
)	O
content	O
exceeds	O
the	O
levels	O
of	O
a	O
recommended	O
threshold	O
.	O

We	O
put	O
a	O
premium	O
on	O
flexibility	O
and	O
speed	O
so	O
we	O
could	O
rapidly	O
respond	O
to	O
developments	O
in	O
the	O
outbreak	O
.	O

Persons	O
&lt;35	O
years	O
of	O
age	O
in	O
1918	O
had	O
a	O
disproportionately	O
hi	O
gh	B-Disease
influe	E-Disease
nza	O
incidence	O
(Figure	O
3	O
,	O
panel	O
A)	O
.	O

There's	O
a	O
problem	O
,	O
they	O
fixed	O
that	O
problem	O
.	O

Based	O
on	O
the	O
quality	O
assurance	O
requirement	O
,	O
contamination	O
of	O
the	O
laboratory	O
region	O
with	O
EBOV	S-Pathogen
RNA	O
should	O
be	O
evaluated	O
by	O
real-time	B-Equipment
RT-PCR	E-Equipment
every	O
2	O
months	O
,	O
so	O
the	O
first	O
evaluation	O
had	O
been	O
done	O
at	O
the	O
end	O
of	O
the	O
mission	O
.	O

All	O
of	O
them	O
died	O
.	O

William	B-Person
Booth	E-Person
said	O
the	O
letter	O
was	O
forwarded	O
to	O
the	O
department	O
from	O
Bradley's	O
office	O
and	O
turned	O
over	O
for	O
investigation	O
to	O
the	O
.	O

Subsequently	O
,	O
three	O
months	O
after	O
"	O
The	O
Breeders	O
"	O
announced	O
the	O
medfly	O
release	O
,	O
the	O
state	O
ended	O
its	O
decade-long	O
Malathion	B-Scientific_research_project
program	E-Scientific_research_project
and	O
sought	O
alternate	O
ways	O
to	O
handle	O
destructive	O
insects	O
.	O

Forty-five	O
people	O
received	O
hospital	O
treatment	O
;	O
all	O
survived	O
.	O

With	O
this	O
correction	O
factor	O
,	O
approximately	O
21,000	O
total	O
cases	O
were	O
estimated	O
for	O
the	O
end	O
of	O
September	O
2014	O
in	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
alone	O
.	O

GAO	S-Organization
was	O
asked	O
to	O
examine	O
DHS	S-Organization
programs	O
and	O
activities	O
to	O
prevent	O
and	O
protect	O
against	O
domestic	O
chemical	O
attacks	O
and	O
look	O
at	O
how	O
it	O
has	O
coordinated	O
all	O
of	O
its	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

A	O
GAO	S-Organization
report	O
in	O
November	O
2016	O
looked	O
at	O
USAID	S-Organization
expenditures	O
for	O
the	O
Ebola	S-Pathogen
response	O
that	O
occurred	O
before	O
passed	O
the	O
response	O
funding	O
package	O
.	O

The	O
public	O
health	O
implications	O
of	O
the	O
pandemic	O
therefore	O
remain	O
in	O
doubt	O
even	O
as	O
we	O
now	O
grapple	O
with	O
the	O
feared	O
emergence	O
of	O
a	O
pandemic	O
caused	O
by	O
H5N1	S-Pathogen
or	O
other	O
virus	O
.	O

As	O
a	O
result	O
,	O
the	O
US	B-Organization
State	I-Organization
Department	E-Organization
issued	O
a	O
travel	O
alert	O
about	O
China	S-Location
's	O
anti-flu	O
measures	O
and	O
warned	O
travellers	O
against	O
travelling	O
to	O
China	S-Location
if	O
ill	O
.	O

Since	O
the	O
beginning	O
of	O
the	O
antibiotic	O
era	O
,	O
antibiotics	O
have	O
been	O
used	O
to	O
treat	O
a	O
wide	O
range	O
of	O
disease	O
.	O

Lists	O
of	O
animal	O
pathogens	O
that	O
necessitate	O
quarantine	O
or	O
sanitary	O
measures	O
have	O
been	O
developed	O
on	O
a	O
national	O
basis	O
,	O
but	O
all	O
are	O
inspired	O
from	O
the	O
lists	O
produced	O
by	O
the	O
"	O
Office	B-Organization
International	I-Organization
des	I-Organization
Epizooties	E-Organization
(	O
OIE	S-Organization
)	O
,	O
World	B-Organization
Organization	I-Organization
of	I-Organization
Animal	I-Organization
Health	E-Organization
.	O
OIE	S-Organization
periodically	O
releases	O
lists	O
(Lists	O
A	O
and	O
B)	O
of	O
pathogenic	O
micro-organisms	O
that	O
cause	O
diseases	O
in	O
animal	O
,	O
some	O
of	O
them	O
being	O
also	O
zoonotic	O
pathogens	O
(such	O
as	O
Mycobacterium	B-Pathogen
bovis	E-Pathogen
,	O
rabies	B-Pathogen
virus	E-Pathogen
,	O
Japanese	B-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
)	O
.	O

On	O
a	O
couple	O
of	O
occasions	O
,	O
samples	O
have	O
been	O
sent	O
between	O
the	O
agencies	O
,	O
for	O
example	O
,	O
when	O
there	O
have	O
been	O
problems	O
with	O
equipment	O
or	O
when	O
results	O
have	O
needed	O
to	O
be	O
confirmed	O
,	O
in	O
a	O
manner	O
that	O
would	O
not	O
have	O
been	O
possible	O
before	O
the	O
establishment	O
of	O
the	O
FBD	S-Platform
network	O
.	O

Emphasis	O
is	O
placed	O
on	O
building	O
a	O
culture	O
of	O
risk	O
assessment-based	O
safety	O
through	O
competency	O
training	O
designed	O
to	O
enhance	O
understanding	O
and	O
recognition	O
of	O
potential	O
biological	O
hazards	O
as	O
well	O
as	O
methods	O
for	O
controlling	O
these	O
hazards	O
.	O

Global	O
stock	O
markets	O
fell	O
on	O
24	O
February	O
due	O
to	O
a	O
significant	O
rise	O
in	O
the	O
number	O
of	O
COVID-19	S-Disease
cases	O
outside	O
China	S-Location
.	O
On	O
27	O
February	O
,	O
due	O
to	O
mounting	O
worries	O
about	O
the	O
coronavirus	O
outbreak	O
,	O
U.S.	S-Location
stock	O
indexes	O
posted	O
their	O
sharpest	O
falls	O
since	O
2008	O
,	O
with	O
the	O
Dow	O
falling	O
1,191	O
points	O
(the	O
largest	O
one-day	O
drop	O
since	O
the	O
financial	O
crisis	O
of	O
2007–08)	O
and	O
all	O
three	O
major	O
indexes	O
ending	O
the	O
week	O
down	O
more	O
than	O
10	O
percent	O
.	O

The	O
project	O
organizers	O
have	O
many	O
applications	O
in	O
mind	O
,	O
from	O
bringing	O
back	O
wooly	O
mammoths	O
to	O
growing	O
human	O
organs	O
in	O
pigs	O
.	O

TOM	B-Person
FRIEDEN	E-Person
One	O
of	O
the	O
issues	O
,	O
which	O
Dr	O
.	O

Pat	B-Person
Mooney	E-Person
executive	O
director	O
of	O
ETC	B-International_exchange_and_cooperation
Group	E-International_exchange_and_cooperation
,	O
is	O
a	O
critic	O
of	O
biohacking	O
who	O
argues	O
that-using	O
a	O
laptop	O
computer	O
,	O
published	O
gene	O
sequence	O
information	O
,	O
and	O
mail-order	O
synthetic	O
DNA-just	O
about	O
anyone	O
has	O
the	O
potential	O
to	O
construct	O
genes	O
or	O
entire	O
genomes	O
from	O
scratch	O
(including	O
those	O
of	O
the	O
lethal	O
pathogens)	O
in	O
the	O
near-future	O
.	O

The	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
is	O
developing	O
a	O
strategic	O
framework	O
to	O
advance	O
tuberculosis	S-Disease
()	O
research	O
and	O
development	O
for	O
the	O
next	O
five	O
years	O
and	O
beyond	O
.	O

The	O
capabilities	O
we	O
gained	O
then	O
are	O
now	O
helping	O
us	O
to	O
fight	O
the	O
Ebola	S-Pathogen
outbreak	O
.	O

But	O
late	O
last	O
year	O
,	O
a	O
former	O
top	O
official	O
in	O
the	O
Soviet	B-Scientific_research_project
germ	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
spoke	O
of	O
the	O
incident	O
in	O
an	O
interview	O
with	O
a	O
newspaper	O
,	O
and	O
Kazakh	O
officials	O
have	O
recently	O
been	O
investigating	O
the	O
outbreak's	O
origins	O
.	O

The	O
inactivated	O
samples	O
were	O
transferred	O
to	O
the	O
RNA	O
extraction	O
bench	O
for	O
either	O
manual	O
or	O
automatic	O
RNA	O
extraction	O
.	O

Such	O
a	O
bioweapon	O
must	O
fulfil	O
a	O
variety	O
of	O
demands:	O
it	O
needs	O
to	O
be	O
produced	O
in	O
large	O
amounts	O
,	O
it	O
must	O
act	O
fast	O
,	O
it	O
must	O
be	O
environmentally	O
robust	O
,	O
and	O
the	O
disease	O
must	O
be	O
treatable	O
,	O
or	O
a	O
vaccine	O
must	O
be	O
available	O
,	O
to	O
allow	O
the	O
protection	O
of	O
one's	O
own	O
soldiers	O
.	O

In	O
December	O
2014	O
,	O
it	O
was	O
reported	O
that	O
the	O
iron	O
ore	O
mining	O
company	O
,	O
African	B-Organization
Minerals	E-Organization
had	O
started	O
the	O
shutdown	O
of	O
its	O
Sierra	B-Location
Leone	E-Location
operations	O
because	O
it	O
was	O
running	O
low	O
on	O
income	O
.	O

Emergent	B-Organization
BioSolutions	E-Organization
has	O
a	O
30-year	O
history	O
in	O
biologics	O
manufacturing	O
and	O
has	O
developed	O
and	O
manufactured	O
plasma-derived	O
products	O
called	O
hyperimmunes	O
,	O
explained	O
,	O
which	O
basically	O
are	O
products	O
having	O
extra-large	O
amounts	O
of	O
certain	O
antibodies	O
in	O
the	O
serum	O
.	O

In	O
September	O
2009	O
,	O
the	O
CDC	S-Organization
reported	O
that	O
the	O
H1N1	B-Disease
flu	E-Disease
"	O
seems	O
to	O
be	O
taking	O
a	O
heavier	O
toll	O
among	O
chronically	O
ill	O
children	O
than	O
the	O
seasonal	B-Disease
flu	E-Disease
usually	O
does"	O
.	O

For	O
patients	O
,	O
there	O
is	O
a	O
triage	O
area	O
,	O
and	O
low-	O
and	O
high-risk	O
care	O
wards	O
.	O

According	O
to	O
historian	O
John	B-Person
M.	I-Person
Barry	E-Person
the	O
most	O
vulnerable	O
of	O
all –	O
"	O
those	O
most	O
likely	O
,	O
of	O
the	O
most	O
likely"	O
,	O
to	O
die –	O
were	O
pregnant	O
women	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
reporting	O
today	O
that	O
a	O
small	O
amount	O
of	O
material	O
from	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
experiment	O
that	O
was	O
securely	O
transported	O
from	O
a	O
Select‐Agent‐approved	O
BSL‐4	S-Platform
lab	O
to	O
a	O
Select‐Agent‐approved	O
BSL‐2	S-Platform
lab	O
may	O
have	O
contained	O
live	O
virus	O
.	O

Rothschild	B-Person
J.H.	E-Person
(1964)	O
,	O
Tomorrow's	O
Weapons:	O
Chemical	O
and	O
Biological	O
,	O
New	O
York	O
,	O
New	O
York:	O
McGraw-Hill	O
.	O

On	O
29	O
April	O
,	O
WHO	S-Organization
reported	O
that	O
Liberia	S-Location
had	O
discharged	O
the	O
last	O
patient	O
and	O
had	O
begun	O
the	O
42-day	O
countdown	O
to	O
be	O
declared	O
Ebola	S-Disease
-free	O
once	O
more	O
.	O

DSAT	S-Organization
in	O
collaboration	O
with	O
the	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
,	O
is	O
actively	O
investigating	O
the	O
history	O
of	O
how	O
these	O
samples	O
were	O
originally	O
prepared	O
and	O
subsequently	O
stored	O
in	O
the	O
laboratory	O
.	O

On	O
31	O
July	O
2015	O
,	O
the	O
WHO	S-Organization
announced	O
"	O
an	O
extremely	O
promising	O
development	O
"	O
in	O
the	O
search	O
for	O
an	O
effective	O
vaccine	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
While	O
the	O
vaccine	O
had	O
shown	O
high	O
efficacy	O
in	O
individuals	O
,	O
more	O
conclusive	O
evidence	O
was	O
needed	O
regarding	O
its	O
capacity	O
to	O
protect	O
populations	O
through	O
herd	O
immunity	O
.	O

A	O
search	O
of	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
()	O
laboratories	O
for	O
forgotten	O
infectious	O
agents	O
has	O
turned	O
up	O
a	O
handful	O
of	O
dangerous	O
bacteria	O
and	O
toxins	O
in	O
labs	O
not	O
approved	O
to	O
handle	O
them	O
,	O
according	O
toThe	O
Washington	O
Post	O
,	O
which	O
broke	O
the	O
story	O
late	O
Friday	O
.	O

Once	O
removed	O
,	O
the	O
protein	O
can	O
be	O
studied	O
in	O
a	O
species	O
that's	O
simple	O
to	O
manipulate	O
,	O
such	O
as	O
E.	B-Pathogen
coli	I-Pathogen
bacteria	E-Pathogen
This	O
lets	O
researchers	O
reproduce	O
it	O
in	O
vast	O
quantities	O
,	O
engineer	O
it	O
for	O
improved	O
properties	O
,	O
and/or	O
transplant	O
it	O
into	O
a	O
new	O
species	O
.	O

This	O
area	O
came	O
under	O
the	O
spotlight	O
of	O
the	O
international	O
media	O
after	O
the	O
use	O
of	O
psychoactive	O
substances	O
in	O
the	O
Moscow	B-Incident
hostage	I-Incident
crisis	I-Incident
last	I-Incident
year	E-Incident
causing	O
the	O
death	O
of	O
more	O
than	O
170	O
people	O
.	O

As	O
New	B-Location
York	E-Location
Times	O
reporter	O
Judith	B-Person
Miller	E-Person
notes	O
in	O
NOVA's	O
"	O
Bioterror,"	O
the	O
-laced	O
letters	O
sparked	O
"	O
mass	O
disruption	O
"	O
rather	O
than	O
"	O
mass	O
destruction.	O
"	O

The	O
effectiveness	O
was	O
based	O
on	O
European	O
and	O
Asian	O
studies	O
and	O
expert	O
opinion	O
.	O

CHICAGO	S-Location
(Reuters)	O
-	O
The	O
White	B-Organization
House	E-Organization
issued	O
a	O
187-page	O
report	O
on	O
Thursday	O
designed	O
to	O
improve	O
biosafety	O
following	O
a	O
series	O
of	O
safety	O
breaches	O
at	O
federal	O
laboratories	O
charged	O
with	O
handling	O
dangerous	O
pathogens	O
such	O
as	O
anthrax	S-Pathogen
,	O
bird	B-Pathogen
flu	E-Pathogen
and	O
.	O

In	O
another	O
experiment	O
,	O
15	O
Kurdish	O
prisoners	O
were	O
tied	O
up	O
in	O
a	O
field	O
while	O
shells	O
containing	O
,	O
a	O
mild	O
virus	O
,	O
were	O
dropped	O
from	O
a	O
light	O
aircraft	O
.	O

Pixel	O
values	O
of	O
0	O
and	O
lower	O
,	O
are	O
displayed	O
as	O
black	O
;	O
values	O
of	O
80	O
and	O
higher	O
are	O
displayed	O
as	O
white	O
;	O
values	O
within	O
the	O
window	O
are	O
displayed	O
as	O
a	O
grey	O
intensity	O
proportional	O
to	O
position	O
within	O
the	O
window	O
.	O

Re-assessing	O
current	O
use	O
of	O
BSL-3	S-Platform
enhanced	O
space	O
to	O
ensure	O
that	O
work	O
done	O
on	O
Select	O
Agents	O
and	O
non-Select	O
Agents	O
is	O
separated	O
by	O
an	O
appropriate	O
amount	O
of	O
time	O
to	O
reduce	O
the	O
chances	O
that	O
cross-contamination	O
can	O
occur	O
.	O

All	O
synthetic	B-Technology
genomics	E-Technology
work	O
to	O
date	O
,	O
both	O
at	O
the	O
and	O
elsewhere	O
has	O
focused	O
on	O
microorganisms	O
.	O

Sen	O
.	O

A	O
more	O
legible	O
copy	O
of	O
the	O
poem	O
appears	O
in:	O
Emile	O
Littré	O
(1841)	O
"	O
Opuscule	O
relatif	O
à	O
la	B-Disease
peste	E-Disease
de	O
1348	O
,	O
composé	O
par	O
un	O
contemporain	O
"	O
(Work	O
concerning	O
the	O
of	O
1348	O
,	O
composed	O
by	O
a	O
contemporary)	O
,	O
Bibliothèque	O
de	O
l'école	O
des	O
chartes	O
,	O
2	O
(2)	O
:	O
201–43	O
;	O
see	O
especially	O
p.	O
228	O
.	O

She	O
has	O
been	O
an	O
active	O
and	O
contributing	O
member	O
of	O
the	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
(	O
ABSA	S-Organization
)	O
for	O
more	O
than	O
20	O
years	O
,	O
a	O
member	O
of	O
the	O
ABSA	S-Organization
Curriculum	O
and	O
professional	O
Development	O
core	O
,	O
Education	O
and	O
Training	O
,	O
and	O
a	O
member	O
of	O
the	O
ABSA	S-Organization
Trans-Federal	O
BSL3	S-Platform
certification	O
Taskforce	O
.	O

These	O
combinations	O
of	O
practices	O
,	O
safety	O
equipment	O
,	O
and	O
facilities	O
are	O
designated	O
Animal	O
Biosafety	O
Levels	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
and	O
provide	O
increasing	O
levels	O
of	O
protection	O
to	O
personnel	O
and	O
the	O
environment	O
.	O

DARPA	S-Organization
wants	O
to	O
insert	O
an	O
additional	O
47th	O
artificial	O
chromosome	O
into	O
human	O
cells	O
.	O

Within	O
a	O
week	O
of	O
the	O
original	O
request	O
,	O
the	O
center's	O
equipment	O
was	O
in	O
place	O
–	O
lightning	O
speed	O
by	O
government	O
standards	O
.	O

In	O
1348–1349	O
,	O
the	O
disease	O
reached	O
Antioch	S-Location
.	O
The	O
city's	O
residents	O
fled	O
to	O
the	O
north	O
,	O
but	O
most	O
of	O
them	O
ended	O
up	O
dying	O
during	O
the	O
journey	O
.	O

Roger	B-Person
Wicker	E-Person
of	O
Mississippi	S-Location
and	O
Lee	B-Organization
County	E-Organization
Judge	O
.	O

Those	O
in	O
the	O
nuclear	O
industry	O
in	O
the	O
United	O
States	O
are	O
limited	O
to	O
doses	O
of	O
50 mSv	O
a	O
year	O
and	O
100 mSv	O
every	O
5	O
years	O
.	O

Children	O
in	O
city	O
dwellings	O
were	O
more	O
affected	O
by	O
the	O
spread	O
of	O
disease	O
than	O
the	O
children	O
of	O
the	O
wealthy	O
.	O

Several	O
companies	O
formed	O
to	O
develop	O
related	O
drugs	O
and	O
research	O
tools	O
.	O

In	O
general	O
,	O
these	O
agents	O
have	O
proved	O
safer	O
than	O
the	O
iodinated	O
contrast	O
agents	O
used	O
in	O
X-ray	B-Technology
radiography	E-Technology
or	O
CT	S-Technology
.	O
Anaphylactoid	O
reactions	O
are	O
rare	O
,	O
occurring	O
in	O
approx.0.03–0.1%	O
.	O

Synthetic	B-Technology
biology	E-Technology
also	O
provides	O
ways	O
to	O
make	O
drugs	O
for	O
diseases	O
such	O
as	O
cancer	O
and	O
infections	O
more	O
cheaply	O
than	O
traditional	O
methods	O
,	O
as	O
we	O
saw	O
in	O
the	O
case	O
of	O
artemisinin	S-Drug
.	O
It	O
also	O
offers	O
ways	O
of	O
discovering	O
new	O
drugs	O
.	O

According	O
to	O
a	O
partially	O
declassified	O
1981	O
US	B-Organization
Army	E-Organization
report	O
,	O
American	S-Organization
bio	O
warfare	O
scientists	O
carried	O
out	O
a	O
number	O
of	O
experiments	O
on	O
insects	O
.	O

By	O
19	O
June	O
2013	O
,	O
MERS	S-Disease
had	O
infected	O
at	O
least	O
60	O
people	O
with	O
cases	O
reported	O
in	O
Jordan	S-Location
,	O
Qatar	S-Location
,	O
Saudi	B-Location
Arabia	E-Location
,	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
(	O
UAE	S-Location
)	O
,	O
Tunisia	S-Location
,	O
Germany	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
(	O
UK	S-Location
)	O
,	O
France	S-Location
and	O
Italy	S-Location
,	O
with	O
a	O
death	O
toll	O
of	O
38	O
.	O

Bradley	B-Person
A.	I-Person
Thayer	E-Person
,	O
Lianchao	B-Person
Han	E-Person
,	O
China	S-Location
and	O
the	O
's	O
chief:	O
Hold	O
them	O
both	O
accountable	O
for	O
pandemic	O
,	O
The	O
Hill	O
,	O
17	O
March	O
2020	O
.	O

Data	O
can	O
be	O
integrated	O
via	O
view	O
summaries	O
based	O
on	O
cross-reference	O
identifiers	O
shared	O
by	O
multiple	O
tables	O
.	O

Often	O
,	O
these	O
are	O
the	O
ones	O
that	O
are	O
tried	O
and	O
true	O
,	O
debugged	O
over	O
centuries	O
of	O
experimentation	O
.	O

There	O
are	O
other	O
weaponizable	O
microbes	O
,	O
including	O
smallpox	S-Pathogen
and	O
tularemia	S-Pathogen
,	O
that	O
experts	O
are	O
concerned	O
about	O
.	O

Online	O
version	O
of	O
the	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories	I-Document
(BMBL),	I-Document
5th	I-Document
Ed	E-Document

Even	O
the	O
federal	O
government	O
doesn't	O
know	O
where	O
they	O
all	O
are	O
,	O
the	O
has	O
warned	O
for	O
years	O
.	O

This	O
allowed	O
the	O
public	O
health	O
departments	O
to	O
easily	O
step	O
in	O
and	O
implement	O
their	O
restrictive	O
measures	O
.	O

Over	O
the	O
course	O
of	O
the	O
15	O
years	O
it	O
has	O
taken	O
to	O
construct	O
the	O
first	O
self-replicating	O
synthetic	O
bacterial	O
cell	O
,	O
the	O
team	O
at	O
JCVI	S-Organization
has	O
had	O
to	O
develop	O
new	O
tools	O
and	O
technologies	O
to	O
enable	O
this	O
feat	O
.	O

Since	O
its	O
formation	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
QA	B-Document
protocols	E-Document
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

Bioengagement	O
programs	O
can	O
greatly	O
benefit	O
by	O
incorporating	O
such	O
efforts	O
into	O
mainstream	O
national	O
health	O
and	O
science	O
programs	O
,	O
such	O
as	O
global	O
aid	O
programs	O
focused	O
on	O
public	O
health:	O
malaria	S-Disease
soil	B-Disease
and	I-Disease
water	I-Disease
parasitism	E-Disease
,	O
tuberculosis	S-Disease
,	O
vector-borne	B-Pathogen
viruses	E-Pathogen
,	O
and	O
HIV	S-Pathogen
/	O
.	O

"	O
Regarding	O
other	O
aspects	O
of	O
your	O
inquiry	O
,	O
we	O
think	O
the	O
information	O
provided	O
in	O
response	O
to	O
your	O
earlier	O
FOI	O
request	O
is	O
sufficient,	O
"	O
Stephenson	S-Person
said	O
in	O
an	O
email	O
.	O

The	O
first	O
death	O
outside	O
of	O
China	S-Location
occurred	O
on	O
1February	O
in	O
the	O
Philippines	S-Location
,	O
and	O
the	O
first	O
death	O
outside	O
Asia	S-Location
was	O
in	O
on	O
14	O
February	O
.	O

On	O
12	O
November	O
2014	O
,	O
Mali	S-Organization
reported	O
deaths	O
from	O
Ebola	S-Disease
in	O
an	O
outbreak	O
unconnected	O
with	O
the	O
first	O
case	O
in	O
Kayes	S-Location
.	O
The	O
first	O
probable	O
case	O
was	O
an	O
imam	O
who	O
had	O
fallen	O
ill	O
on	O
17	O
October	O
in	O
Guinea	S-Location
and	O
was	O
transferred	O
to	O
the	O
Pasteur	B-Organization
Clinic	E-Organization
in	O
Mali	S-Location
's	O
capital	O
city	O
,	O
Bamako	S-Location
,	O
for	O
treatment	O
.	O

On	O
11	O
March	O
,	O
the	O
WHO	S-Organization
declared	O
the	O
.	O

He	O
chose	O
Darwin	S-Location
because	O
it	O
is	O
a	O
hyper-endemic	O
area	O
for	O
B.	B-Pathogen
pseudomallei	E-Pathogen
.	O
Because	O
of	O
its	O
environmental	O
habit	O
,	O
high	O
probability	O
of	O
infection	O
,	O
and	O
route	O
of	O
infection	O
,	O
poses	O
a	O
significant	O
danger	O
to	O
military	O
forces	O
deployed	O
to	O
such	O
areas	O
.	O

Ten	O
of	O
the	O
22	O
people	O
who	O
died	O
and	O
22	O
of	O
44	O
cases	O
reported	O
were	O
in	O
Saudi	B-Location
Arabia	E-Location
.	O
An	O
unconfirmed	O
case	O
in	O
another	O
Saudi	S-Location
citizen	O
,	O
for	O
which	O
no	O
clinical	O
information	O
was	O
available	O
,	O
was	O
also	O
reported	O
around	O
this	O
time	O
.	O

This	O
cost	O
far	O
exceeded	O
the	O
investments	O
that	O
could	O
have	O
prevented	O
the	O
uncontrolled	O
expansion	O
of	O
the	O
in	O
the	O
first	O
place	O
.	O

The	O
name	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
is	O
derived	O
from	O
the	O
Ebola	B-Location
River	E-Location
-a	O
river	O
that	O
was	O
at	O
first	O
thought	O
to	O
be	O
in	O
close	O
proximity	O
to	O
the	O
area	O
in	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
,	O
previously	O
called	O
Zaire	S-Location
,	O
where	O
the	O
occurred-and	O
the	O
taxonomic	O
suffix	O
virus	O
.	O

The	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
and	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
()	O
collect	O
data	O
on	O
antibiotic	O
use	O
in	O
humans	O
and	O
in	O
a	O
more	O
limited	O
fashion	O
in	O
animals	O
.	O

Subpleural	O
dominance	O
,	O
crazy	O
paving	O
(lobular	O
septal	O
thickening	O
with	O
variable	O
alveolar	O
filling)	O
,	O
and	O
consolidation	O
may	O
appear	O
as	O
the	O
disease	O
progresses	O
.	O

According	O
to	O
government	O
officials	O
,	O
the	O
virus	O
was	O
brought	O
into	O
the	O
estate	O
by	O
an	O
infected	O
kidney	O
patient	O
(the	O
type	O
of	O
kidney	O
illness	O
was	O
not	O
specified)	O
after	O
discharge	O
from	O
Prince	B-Organization
of	I-Organization
Wales	I-Organization
Hospital	E-Organization
who	O
visited	O
his	O
elder	O
brother	O
living	O
on	O
the	O
seventh	O
floor	O
.	O

This	O
system	O
,	O
which	O
was	O
never	O
very	O
satisfactory	O
,	O
was	O
superseded	O
in	O
1984	O
by	O
a	O
numerical	O
classification	O
(	O
Advisory	B-Organization
Committee	I-Organization
on	I-Organization
Dangerous	I-Organization
Pathogens	E-Organization
)	O
which	O
parallels	O
that	O
of	O
.	O

Unenriched	O
sequencing	O
libraries	O
often	O
have	O
abundant	O
undesired	O
sequences	O
.	O

In	O
that	O
vein	O
,	O
the	O
American	B-Organization
Society	I-Organization
of	I-Organization
Microbiology	E-Organization
is	O
calling	O
on	O
its	O
members	O
to	O
go	O
through	O
a	O
similar	O
inventory	O
exercise:	O
https://www.asm.org/index.php/publicpolicy-2/statements-testimony/99-policy/policy/93059-freezer-8-14	O
.	O

Here	O
,	O
we	O
present	O
an	O
overview	O
on	O
the	O
production	O
of	O
crops	O
,	O
their	O
acceptabilities	O
,	O
detection	O
strategies	O
,	O
biosafety	O
issues	O
and	O
potential	O
impact	O
on	O
society	O
.	O

One	O
crew	O
member	O
of	O
the	O
Lev	O
Berg	O
contracted	O
smallpox	S-Pathogen
as	O
the	O
ship	O
passed	O
within	O
15 km	O
(9	O
miles)	O
of	O
the	O
island	O
.	O

A	O
living	O
cell	O
has	O
thousands	O
of	O
genes	O
,	O
and	O
circuits	O
on	O
that	O
scale	O
are	O
currently	O
beyond	O
the	O
reach	O
of	O
.	O
We	O
have	O
a	O
list	O
of	O
parts	O
-	O
the	O
genes	O
and	O
their	O
regulators	O
-	O
but	O
we	O
don't	O
know	O
how	O
they	O
all	O
interact	O
.	O

The	O
processes	O
of	O
package	O
unwrapping	O
,	O
sample	O
registration	O
and	O
photographing	O
,	O
sample	O
aliquoting	O
,	O
EBOV	B-Technology
inactivation	E-Technology
,	O
and	O
a	B-Technology
blood	I-Technology
assay	I-Technology
for	I-Technology
malaria	E-Technology
(	O
colloidal	B-Technology
gold	I-Technology
method	E-Technology
)	O
were	O
performed	O
in	O
the	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
the	O
laboratory	O
.	O

"	O
How	O
do	O
you	O
create	O
incentives	O
in	O
the	O
private	O
sector	O
to	O
develop	O
medical	O
countermeasures	O
when	O
there	O
may	O
not	O
be	O
a	O
market	O
unless	O
there	O
is	O
a	O
crisis?	O
"	O
asked	O
co-chair	O
of	O
the	O
panel	O
and	O
former	O
U.S.Sen	O
.	O

Members	O
of	O
the	O
Monterey	S-Organization
team	O
said	O
federal	O
officials	O
grew	O
wary	O
this	O
week	O
when	O
told	O
of	O
the	O
impending	O
report	O
out	O
of	O
fear	O
that	O
it	O
would	O
undermine	O
the	O
national	O
push	O
for	O
300	O
million	O
doses	O
of	O
,	O
the	O
production	O
of	O
which	O
is	O
due	O
to	O
be	O
completed	O
late	O
this	O
year	O
.	O

Mycobacterium	B-Pathogen
tuberculosis	E-Pathogen
,	O
St.	B-Pathogen
Louis	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
,	O
and	O
are	O
representative	O
of	O
the	O
microorganisms	O
assigned	O
to	O
this	O
level	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
more	O
commonly	O
known	O
as 	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
;	O
EBOV	S-Pathogen
)	O
,	O
is	O
one	O
of	O
six	O
known	O
species	O
within	O
the	O
genus	O
Ebolavirus	S-Pathogen
.	O
Four	O
of	O
the	O
six	O
known	O
ebolaviruses	S-Pathogen
,	O
including	O
EBOV	S-Pathogen
,	O
cause	O
a	O
severe	O
and	O
often	O
fatal	O
hemorrhagic	B-Disease
fever	E-Disease
in	O
humans	O
and	O
other	O
mammals	O
,	O
known	O
as	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
.	O

TIM1	O
is	O
expressed	O
in	O
tissues	O
known	O
to	O
be	O
seriously	O
impacted	O
by	O
EBOV	S-Pathogen
lysis	O
(trachea	O
,	O
cornea	O
,	O
and	O
conjunctiva)	O
.	O

It	O
apparently	O
sent	O
a	O
copy	O
of	O
the	O
letter	O
to	O
The	O
Fresno	O
Bee	O
as	O
well	O
.	O

Health	O
officials	O
were	O
concerned	O
because	O
the	O
child	O
had	O
not	O
recently	O
travelled	O
or	O
been	O
exposed	O
to	O
someone	O
with	O
Ebola	S-Disease
and	O
the	O
WHO	S-Organization
stated	O
that	O
"	O
we	O
believe	O
that	O
this	O
is	O
probably	O
again	O
,	O
somehow	O
,	O
someone	O
who	O
has	O
come	O
in	O
contact	O
with	O
a	O
virus	O
that	O
had	O
been	O
persisting	O
in	O
an	O
individual	O
,	O
who	O
had	O
suffered	O
the	O
disease	O
months	O
ago.	O
"	O
Two	O
staff	O
of	O
the	O
CDC	S-Organization
were	O
sent	O
to	O
the	O
country	O
to	O
help	O
ascertain	O
the	O
cause	O
of	O
the	O
new	O
cases	O
.	O

On	O
25	O
March	O
2014	O
,	O
the	O
WHO	S-Organization
reported	O
an	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
in	O
four	O
southeastern	O
districts	O
of	O
Guinea	S-Location
with	O
a	O
total	O
of	O
86	O
suspected	O
cases	O
,	O
including	O
59	O
deaths	O
,	O
and	O
MSF	S-Organization
assisted	O
the	O
Ministry	B-Organization
of	I-Organization
Health	E-Organization
by	O
establishing	O
Ebola	B-Organization
treatment	I-Organization
centres	E-Organization
in	O
the	O
epicentre	O
of	O
the	O
outbreak	O
.	O

The	O
worker	O
was	O
put	O
on	O
an	O
antiviral	O
medication	O
for	O
10	O
days	O
and	O
told	O
to	O
monitor	O
for	O
,	O
but	O
no	O
infection	O
resulted	O
,	O
the	O
records	O
say	O
.	O

In	O
October	O
,	O
WHO	S-Organization
and	O
the	O
UN	B-Organization
Mission	I-Organization
for	I-Organization
Ebola	I-Organization
Emergency	I-Organization
Response	E-Organization
announced	O
a	O
comprehensive	O
90-day	O
plan	O
to	O
control	O
and	O
reverse	O
the	O
Ebola	B-Disease
epidemic	E-Disease
.	O
The	O
ultimate	O
goal	O
was	O
to	O
have	O
capacity	O
in	O
place	O
for	O
the	O
isolation	O
of	O
100%	O
of	O
Ebola	S-Disease
cases	O
and	O
the	O
safe	O
burial	O
of	O
100%	O
of	O
casualties	O
by	O
1	O
January	O
2015	O
(the	O
90-day	O
target)	O
.	O

This	O
type	O
of	O
artifact	O
commonly	O
occurs	O
in	O
the	O
posterior	O
fossa	O
of	O
the	O
brain	O
,	O
or	O
if	O
there	O
are	O
metal	O
implants	O
.	O

While	O
the	O
specific	O
form	O
of	O
the	O
biological	O
bomb	O
was	O
classified	O
until	O
some	O
years	O
after	O
the	O
Korean	O
War	O
,	O
in	O
the	O
various	O
exhibits	O
of	O
biological	O
weapons	O
that	O
Korea	S-Location
alleged	O
were	O
dropped	O
on	O
their	O
country	O
nothing	O
resembled	O
an	O
M114	O
bomblet	O
.	O

The	O
principles	O
and	O
practices	O
of	O
biosurveillance	O
,	O
a	O
new	O
interdisciplinary	O
science	O
,	O
were	O
defined	O
and	O
described	O
in	O
the	O
Handbook	O
of	O
Biosurveillance	O
,	O
edited	O
by	O
Michael	B-Person
Wagner	E-Person
Andrew	B-Person
Moore	E-Person
and	O
,	O
and	O
published	O
in	O
2006	O
.	O

The	O
findings	O
indicate	O
a	O
need	O
for	O
continued	O
engagement	O
across	O
agencies	O
to	O
ensure	O
success	O
in	O
building	O
a	O
cohesive	O
data	O
strategy	O
.	O

Photon	B-Technology
counting	I-Technology
computed	I-Technology
tomography	E-Technology
is	O
a	O
CT	S-Technology
technique	O
currently	O
under	O
development	O
.	O

Enthusiasts	O
argue	O
that	O
fear	O
of	O
potential	O
hazards	O
should	O
be	O
met	O
with	O
increased	O
research	O
and	O
education	O
rather	O
than	O
closing	O
the	O
door	O
on	O
the	O
profound	O
positive	O
impacts	O
that	O
distributed	O
biological	O
technology	O
will	O
have	O
on	O
human	O
health	O
,	O
the	O
environment	O
,	O
and	O
the	O
standard	O
of	O
living	O
around	O
the	O
world	O
.	O

It	O
oversees	O
the	O
implementation	O
of	O
the	O
International	B-Document
Health	I-Document
Regulations	E-Document
and	O
publishes	O
a	O
series	O
of	O
medical	O
classifications	O
;	O
of	O
these	O
,	O
three	O
are	O
over-reaching	O
"	O
reference	O
classifications":	O
the	O
International	B-Document
Statistical	I-Document
Classification	I-Document
of	I-Document
Diseases	E-Document
(	O
ICD	S-Document
)	O
,	O
the	O
International	B-Document
Classification	I-Document
of	I-Document
Functioning,	I-Document
Disability	I-Document
and	I-Document
Health	E-Document
(	O
ICF	S-Document
)	O
and	O
the	O
International	B-Document
Classification	I-Document
of	I-Document
Health	I-Document
Interventions	E-Document
(	O
ICHI	S-Document
)	O
.	O

However	O
,	O
such	O
antibody	O
surveys	O
can	O
be	O
unreliable	O
due	O
to	O
a	O
selection	O
bias	O
in	O
who	O
volunteers	O
to	O
take	O
the	O
tests	O
,	O
and	O
due	O
to	O
false	O
positives	O
.	O

In	O
addition	O
to	O
that	O
,	O
Harding	S-Person
and	O
Byers	S-Person
indicated	O
that	O
45%	O
to	O
51%	O
of	O
laboratories	O
associated	O
infections	O
took	O
place	O
in	O
clinical	O
,	O
diagnostics	O
and	O
research	O
laboratories	O
.	O

Antiviral	O
medication	O
may	O
be	O
tried	O
in	O
people	O
with	O
severe	O
disease	O
.	O

On	O
the	O
other	O
hand	O
,	O
positive	O
selection	O
gives	O
a	O
collection	O
of	O
growth-advantage	O
acquired	O
populations	O
by	O
random	O
mutagenesis	O
.	O

These	O
results	O
suggest	O
the	O
implementation	O
of	O
this	O
algorithm	O
with	O
ECG-based	O
devices	O
,	O
such	O
as	O
.	O

Denial	O
in	O
some	O
affected	O
countries	O
also	O
made	O
containment	O
efforts	O
difficult	O
.	O

As	O
the	O
outbreak	O
unfolded	O
,	O
global	O
health	O
officials	O
also	O
warned	O
that	O
Ebola	S-Pathogen
survivors	O
would	O
face	O
long-term	O
health	O
and	O
socioeconomic	O
challenges	O
,	O
which	O
prompted	O
and	O
other	O
countries	O
to	O
retool	O
some	O
of	O
their	O
response	O
plans	O
.	O

The	O
overall	O
shape	O
of	O
the	O
virions	O
after	O
purification	O
and	O
visualization	O
(e.g.	O
,	O
by	O
ultracentrifugation	S-Technology
and	O
,	O
respectively)	O
varies	O
considerably	O
;	O
simple	O
cylinders	O
are	O
far	O
less	O
prevalent	O
than	O
structures	O
showing	O
reversed	O
direction	O
,	O
branches	O
,	O
and	O
loops	O
(e.g.	O
,	O
U-	O
,	O
shepherd's	O
crook-	O
,	O
9-	O
,	O
or	O
eye	O
bolt-shapes	O
,	O
or	O
other	O
or	O
circular/coiled	O
appearances)	O
,	O
the	O
origin	O
of	O
which	O
may	O
be	O
in	O
the	O
laboratory	O
techniques	O
applied	O
.	O

PlasmidFinder	O
(https://cge.cbs.dtu.dk/services/PlasmidFinderExternal	O
Link)	O
analysis	O
confirmed	O
the	O
presence	O
of	O
an	O
IncFII	O
plasmid	O
in	O
all	O
isolates	O
.	O

Since	O
its	O
discovery	O
in	O
2012	O
,	O
the	O
use	O
of	O
the	O
CRISPR/Cas9	S-Technology
system	O
to	O
edit	O
genomes	O
has	O
raised	O
the	O
expectations	O
for	O
the	O
cure	O
of	O
untreatable	O
disorders	O
.	O

,	O
SAGE	B-Organization
Labs	E-Organization
(part	O
of	O
Horizon	B-Organization
Discovery	I-Organization
group	E-Organization
)	O
had	O
exclusive	O
rights	O
from	O
one	O
of	O
those	O
companies	O
to	O
produce	O
and	O
sell	O
genetically	O
engineered	O
rats	O
and	O
non-exclusive	O
rights	O
for	O
mouse	O
and	O
rabbit	O
models.	O
,	O
Thermo	B-Organization
Fisher	I-Organization
Scientific	E-Organization
had	O
licensed	O
intellectual	O
property	O
from	O
ToolGen	S-Organization
to	O
develop	O
.	O

Records	O
of	O
the	O
;	O
retrieved	O
October	O
4	O
,	O
2009	O
.	O

Tom	B-Person
Inglesby	E-Person
MD	O
,	O
director	O
of	O
the	O
,	O
said	O
today	O
that	O
he	O
was	O
impressed	O
by	O
the	O
scope	O
of	O
the	O
effort.	O
"	O
It's	O
the	O
first	O
national	O
strategy	O
that	O
encompasses	O
natural	O
,	O
deliberate	O
,	O
and	O
accidental	O
biological	O
threats	O
,	O
and	O
that	O
addresses	O
threats	O
to	O
humans	O
,	O
animals	O
,	O
and	O
plants.	O
"	O

To	O
assure	O
effective	O
work	O
,	O
a	O
set	O
of	O
network	O
tools	O
was	O
developed	O
.	O

For	O
example	O
,	O
most	O
gloves	O
are	O
suitable	O
for	O
creating	O
a	O
barrier	O
against	O
biological	O
agents	O
,	O
but	O
they	O
may	O
not	O
be	O
compatible	O
with	O
research	O
chemicals	O
.	O

This	O
indicated	O
a	O
decline	O
in	O
the	O
Liberian	O
national	O
economy	O
during	O
the	O
outbreak	O
,	O
as	O
well	O
as	O
an	O
indication	O
that	O
the	O
county	B-Location
of	I-Location
Montserrado	E-Location
was	O
hardest	O
hit	O
economically	O
.	O

With	O
good	O
microbiological	O
techniques	O
,	O
these	O
agents	O
can	O
be	O
used	O
safely	O
in	O
activities	O
conducted	O
on	O
the	O
open	O
bench	O
,	O
provided	O
the	O
potential	O
for	O
producing	O
splashes	O
or	O
aerosols	O
is	O
low	O
.	O

In	O
the	O
UK	S-Location
the	O
Health	B-Organization
and	I-Organization
Safety	I-Organization
Executive	E-Organization
()	O
also	O
issued	O
general	O
guidance	O
for	O
employers	O
.	O

A	O
major	O
Russian	O
research	O
centre	O
studying	O
lethal	O
viruses	O
including	O
Ebola	S-Pathogen
and	O
says	O
there	O
was	O
no	O
biological	O
contamination	O
from	O
an	O
explosion	O
and	O
fire	O
in	O
one	O
of	O
its	O
buildings	O
.	O

At	O
the	O
annual	O
World	B-Activity
Health	I-Activity
Assembly	E-Activity
in	O
2015	O
,	O
Director-General	O
Margaret	O
Chan	S-Person
announced	O
a	O
$100 million	O
Contingency	O
Fund	O
for	O
rapid	O
response	O
to	O
future	O
emergencies	O
,	O
of	O
which	O
it	O
had	O
received	O
$26.9 million	O
by	O
April	O
2016	O
(for	O
2017	O
disbursement).	O
has	O
budgeted	O
an	O
additional	O
$494 million	O
for	O
its	O
Health	O
Emergencies	O
Programme	O
in	O
2016–17	O
,	O
for	O
which	O
it	O
had	O
received	O
$140 million	O
by	O
April	O
2016	O
.	O

In	O
2014	O
,	O
there	O
were	O
similar	O
breaches	O
by	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
involving	O
anthrax	S-Pathogen
and	O
bird	B-Pathogen
flu	E-Pathogen
,	O
and	O
the	O
discovery	O
of	O
vials	O
of	O
smallpox	S-Pathogen
from	O
the	O
1950s	O
in	O
a	O
storage	O
closet	O
in	O
an	O
unsecured	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	I-Organization
lab	E-Organization
on	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
's	O
campus	O
in	O
Bethesda	S-Location
,	O
.	O

Title	O
42	O
of	O
the	O
Code	O
of	O
Federal	O
Regulations	O
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
citation	B-Document
42	I-Document
CFR	I-Document
73	I-Document
to	I-Document
42	I-Document
CFR	I-Document
73.21	E-Document
by	O
accessing	O
the	O
US	O
Code	O
of	O
Federal	O
Regulations	O
()	O
website	O
.	O

World	B-Activity
Antibiotic	I-Activity
Awareness	I-Activity
Week	E-Activity
has	O
been	O
held	O
every	O
November	O
since	O
2015	O
.	O

Tests	O
results	O
are	O
available	O
in	O
four	O
hours	O
and	O
are	O
96%	O
accurate	O
.	O

Geneticists	O
quickly	O
picked	O
up	O
on	O
the	O
technique	O
,	O
transferring	B-Technology
animal	I-Technology
and	I-Technology
plant	I-Technology
genes	I-Technology
into	I-Technology
bacteria	I-Technology
using	I-Technology
plasmids	I-Technology
and	I-Technology
restriction	I-Technology
enzymes	E-Technology
.	O
This	O
was	O
the	O
beginning	O
of	O
.	O

EUI	B-Person
HOAI-TRAN	E-Person
Hi	O
,	O
Dr	O
.	O

Enormous	O
additional	O
knowledge	O
and	O
insights	O
could	O
be	O
extracted	O
from	O
existing	O
projects	O
if	O
their	O
data	O
were	O
publicly	O
available	O
.	O

In	O
2017	O
,	O
the	O
organization	O
launched	O
an	O
international	O
competition	O
to	O
redesign	O
and	O
extend	O
its	O
headquarters	O
.	O

Guillemin	S-Person
Biological	O
Weapons	O
,	O
pp.71–73	O
.	O

There	O
is	O
no	O
single	O
best	O
approach	O
in	O
the	O
development	O
and	O
implementation	O
of	O
a	O
national	O
biosafety	O
system	O
and	O
each	O
country	O
is	O
faced	O
with	O
unique	O
challenges	O
.	O

Make	O
sure	O
we	O
wear	O
gloves	O
all	O
the	O
time	O
when	O
we're	O
managing	O
patients	O
and	O
using	O
tests	O
for	O
.	O

TOM	B-Person
FRIEDEN	E-Person
I	O
asked	O
the	O
same	O
question	O
.	O

The	O
laboratory	O
worker's	O
complete	O
isolation	O
from	O
aerosolized	O
infectious	O
materials	O
is	O
accomplished	O
primarily	O
by	O
working	O
in	O
a	O
Class	B-Equipment
III	I-Equipment
BSC	E-Equipment
or	O
in	O
a	O
full‐body	O
,	O
air‐supplied	O
,	O
positive‐pressure	O
personnel	O
suit	O
.	O

Blood	O
tests	O
can	O
be	O
used	O
,	O
but	O
these	O
require	O
two	O
blood	O
samples	O
taken	O
two	O
weeks	O
apart	O
,	O
and	O
the	O
results	O
have	O
little	O
immediate	O
value	O
.	O

The	O
Antibiotic	B-Scientific_research_project
Resistance	I-Scientific_research_project
Monitoring,	I-Scientific_research_project
Analysis	I-Scientific_research_project
and	I-Scientific_research_project
Diagnostics	I-Scientific_research_project
Alliance	E-Scientific_research_project
(	O
ARMADA	S-Scientific_research_project
)	O
will	O
create	O
this	O
global	B-Platform
biobank	I-Platform
of	I-Platform
bacterial	I-Platform
strains	E-Platform
by	O
collecting	O
bacterial	O
isolates	O
from	O
hospitals	O
,	O
doctor's	O
offices	O
,	O
clinical	O
labs	O
,	O
and	O
veterinary	O
sources	O
and	O
then	O
analyzing	O
them	O
to	O
understand	O
their	O
resistance	O
profiles	O
,	O
their	O
genetic	O
identity	O
,	O
and	O
their	O
epidemiological	O
history	O
.	O

Kac-claiming	O
that	O
his	O
rabbit	O
was	O
the	O
first	O
GFP	O
bunny	O
created	O
in	O
the	O
name	O
of	O
Art-used	O
this	O
dispute	O
to	O
popularize	O
the	O
issue	O
as	O
one	O
of	O
disguised	O
censorship	O
by	O
launching	O
a	O
"	O
Free	B-Activity
Alba	E-Activity
"	O
campaign	O
.	O

The	O
usual	O
tariff	O
rate	O
for	O
US	S-Location
pork	O
exports	O
to	O
is	O
12%	O
,	O
but	O
an	O
additional	O
tariff	O
of	O
50%	O
was	O
added	O
last	O
year	O
due	O
to	O
their	O
spat	O
,	O
making	O
American	O
pork	O
significantly	O
more	O
expensive	O
for	O
Chinese	O
consumers	O
.	O

In	O
2017	O
,	O
spending	O
returned	O
to	O
$402	O
million	O
and	O
in	O
2018	O
,	O
$353	O
million	O
has	O
been	O
requested	O
.	O

The	O
intermediate	O
b	O
is	O
then	O
added	O
to	O
a	O
solution	O
containing	O
intermediate	O
c	O
dropwise	O
.	O

Pixels	O
in	O
an	O
image	O
obtained	O
by	O
CT	B-Technology
scanning	E-Technology
are	O
displayed	O
in	O
terms	O
of	O
relative	O
radiodensity	O
.	O

The	O
first	O
confirmed	O
case	O
in	O
Butembo	S-Location
was	O
announced	O
on	O
4	O
September	O
,	O
the	O
same	O
day	O
that	O
it	O
was	O
announced	O
that	O
one	O
of	O
the	O
cases	O
registered	O
at	O
Beni	S-Location
had	O
actually	O
come	O
from	O
the	O
.	O

There	O
are	O
several	O
theories	O
about	O
where	O
the	O
very	O
first	O
case	O
(the	O
so-called	O
patient	O
zero)	O
originated	O
.	O

It's	O
very	O
important	O
to	O
have	O
a	O
culture	O
of	O
safety	O
that	O
says	O
if	O
you've	O
got	O
a	O
problem	O
,	O
talk	O
about	O
it	O
.	O

And	O
that's	O
going	O
to	O
require	O
careful	O
review	O
of	O
what	O
actually	O
happened	O
and	O
a	O
careful	O
consideration	O
for	O
what	O
will	O
be	O
effective	O
at	O
improving	O
laboratory	O
safety	O
around	O
the	O
country	O
and	O
around	O
the	O
world	O
.	O

As	O
of	O
now	O
,	O
the	O
government	O
cannot	O
force	O
any	O
individual	O
or	O
institution	O
to	O
go	O
through	O
this	O
process	O
.	O

Ricin	S-Pathogen
:	O
Biotoxin	O
.	O

When	O
called	O
upon	O
by	O
a	O
governmental	O
body	O
,	O
EIS	S-Organization
officers	O
may	O
embark	O
on	O
short-term	O
epidemiological	O
assistance	O
assignments	O
,	O
or	O
"	O
Epi-Aids",	O
to	O
provide	O
technical	O
expertise	O
in	O
containing	O
and	O
investigating	O
disease	O
outbreaks	O
.	O

The	O
published	O
the	O
59-page	O
report	O
on	O
Mar	O
28	O
.	O

On	O
12	O
November	O
,	O
she	O
was	O
released	O
from	O
hospital	O
after	O
making	O
a	O
full	O
recovery	O
.	O

New	O
software	O
technology	O
can	O
significantly	O
reduce	O
the	O
required	O
radiation	O
dose	O
.	O

On	O
10	O
September	O
,	O
it	O
was	O
reported	O
that	O
the	O
student	O
had	O
recovered	O
but	O
health	O
officials	O
continued	O
to	O
monitor	O
his	O
contacts	O
for	O
21	O
days	O
.	O

We	O
do	O
not	O
know	O
if	O
or	O
when	O
another	O
anthrax	S-Pathogen
attack	O
might	O
occur	O
.	O

The	O
aim	O
of	O
Prof.	B-Person
Skerra	E-Person
from	O
the	O
Department	B-Organization
of	I-Organization
Biological	I-Organization
Chemistry	E-Organization
was	O
to	O
disable	O
this	O
anthrax	S-Pathogen
siderophore	O
,	O
thereby	O
inhibiting	O
the	O
reproduction	O
of	O
the	O
anthrax	S-Pathogen
pathogen	O
.	O

But	O
we	O
will	O
not	O
give	O
up	O
.	O

Approximately	O
twelve	O
people	O
were	O
involved	O
in	O
the	O
plots	O
to	O
employ	O
biological	O
agents	O
,	O
and	O
at	O
least	O
eleven	O
were	O
involved	O
in	O
planning	O
them	O
.	O

An	O
acute	B-Phenotype
cardiac	I-Phenotype
injury	E-Phenotype
was	O
found	O
in	O
12%	O
of	O
infected	O
people	O
admitted	O
to	O
the	O
hospital	O
in	O
Wuhan,	B-Location
China	E-Location
,	O
and	O
is	O
more	O
frequent	O
in	O
severe	O
disease	O
.	O

The	O
emergence	O
of	O
human	B-Pathogen
immunodeficiency	I-Pathogen
virus	E-Pathogen
and	O
hantavirus	S-Pathogen
,	O
the	O
continuing	O
problem	O
of	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
,	O
and	O
the	O
reemergence	O
of	O
have	O
renewed	O
interest	O
in	O
biosafety	O
for	O
the	O
employees	O
of	O
laboratories	O
and	O
health	O
care	O
facilities	O
.	O

BRM	S-Platform
is	O
integrating	O
user	O
data	O
with	O
functional	O
annotation	O
and	O
interaction	O
data	O
from	O
public	O
resources	O
.	O

The	O
plant-based	B-Vaccine
vaccine	E-Vaccine
production	O
method	O
works	O
by	O
isolating	O
a	O
specific	O
antigen	O
protein	O
that	O
triggers	O
a	O
human	O
immune	O
response	O
from	O
the	O
targeted	O
virus	O
.	O

The	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
(	O
ASM	S-Organization
)	O
is	O
"	O
supportive	O
of	O
efforts	O
to	O
ensure	O
"	O
biosafety	O
,	O
the	O
group	O
said	O
in	O
a	O
comment	O
to	O
ScienceInsider	O
.	O

Delta	O
(2000)	O
.	O

The	O
Zika	B-Pathogen
virus	E-Pathogen
has	O
spread	O
in	O
recent	O
years	O
to	O
more	O
than	O
84	O
countries	O
,	O
territories	O
or	O
subnational	O
areas	O
,	O
including	O
the	O
U.S	S-Location
.	O
There	O
is	O
currently	O
no	O
vaccine	O
or	O
medicine	O
for	O
.	O

Retrieved	O
January	O
7	O
,	O
2009	O
.	O

However	O
,	O
there	O
was	O
a	O
very	O
precise	O
indication	O
from	O
their	O
reported	O
locations	O
during	O
working	O
hours	O
,	O
that	O
all	O
of	O
the	O
victims	O
had	O
been	O
directly	O
downwind	O
at	O
the	O
time	O
of	O
the	O
release	O
of	O
the	O
spores	O
via	O
aerosol	O
.	O

The	O
cost	O
of	O
the	O
undertaking	O
that	O
we	O
propose	O
will	O
be	O
infinitesimally	O
small	O
in	O
comparison	O
to	O
the	O
economic	O
and	O
human	O
cost	O
of	O
doing	O
nothing	O
.	O

In	O
addition	O
,	O
the	O
Swedish	B-Organization
Defence	I-Organization
Research	I-Organization
Agency	E-Organization
is	O
the	O
national	O
authority	O
for	O
research	O
and	O
expertise	O
in	O
defense	O
and	O
security	O
(Table	O
1	O
,	O
Figure	O
2)	O
.	O

CRISPR-Cas	B-Technology
technology	E-Technology
has	O
been	O
proposed	O
as	O
a	O
treatment	O
for	O
multiple	O
human	O
diseases	O
,	O
especially	O
those	O
with	O
a	O
genetic	O
cause	O
.	O

Ricin	S-Pathogen
is	O
a	O
white	O
powder	O
that	O
can	O
be	O
produced	O
as	O
a	O
liquid	O
or	O
a	O
crystal	O
.	O

The	O
mechanism	O
was	O
also	O
dependent	O
on	O
two	O
populations	O
of	O
rodents:	O
one	O
resistant	O
to	O
the	O
disease	O
,	O
which	O
act	O
as	O
hosts	O
,	O
keeping	O
the	O
disease	O
endemic	O
,	O
and	O
a	O
second	O
that	O
lack	O
resistance	O
.	O

On	O
July	O
22	O
,	O
1986	O
,	O
both	O
women	O
entered	O
Alford	B-Organization
pleas	E-Organization
for	O
the	O
Salmonella	B-Incident
attack	E-Incident
and	O
the	O
other	O
charges	O
,	O
and	O
received	O
sentences	O
ranging	O
from	O
three	O
to	O
twenty	O
years	O
,	O
to	O
be	O
served	O
concurrently	O
.	O

The	O
trial	O
of	O
those	O
captured	O
Japanese	O
perpetrators	O
was	O
held	O
in	O
Khabarovsk	S-Location
in	O
December	O
1949	O
.	O

,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
and	O
respective	O
governments	O
reported	O
a	O
total	O
of	O
28,646	O
suspected	O
cases	O
and	O
11,323	O
deaths	O
(39.5%)	O
,	O
though	O
the	O
believes	O
that	O
this	O
substantially	O
understates	O
the	O
magnitude	O
of	O
the	O
outbreak	O
.	O

By	O
1960	O
,	O
numerous	O
BW	O
research	O
facilities	O
existed	O
throughout	O
the	O
Soviet	B-Location
Union	E-Location
Although	O
the	O
USSR	S-Organization
also	O
signed	O
the	O
1972	B-Document
Biological	I-Document
Weapons	I-Document
Convention	E-Document
(	O
BWC	S-Document
)	O
,	O
the	O
Soviets	S-Organization
subsequently	O
augmented	O
their	O
biowarfare	O
programs	O
.	O

Dilger	S-Person
eventually	O
fled	O
to	O
Madrid	S-Location
,	O
Spain	S-Location
,	O
where	O
he	O
died	O
during	O
the	O
Influenza	B-Incident
Pandemic	I-Incident
of	I-Incident
1918	E-Incident
.	O
In	O
1916	O
,	O
the	O
Russians	O
arrested	O
a	O
German	O
agent	O
with	O
similar	O
intentions	O
.	O

Phage	B-Technology
therapy	E-Technology
relies	O
on	O
the	O
use	O
of	O
naturally-occurring	O
bacteriophages	O
to	O
infect	O
and	O
lyse	O
bacteria	O
at	O
the	O
site	O
of	O
infection	O
in	O
a	O
host	O
.	O

Taylor	S-Person
has	O
served	O
and	O
held	O
leadership	O
positions	O
on	O
committees	O
of	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Laboratories	E-Organization
.	O
She	O
is	O
a	O
member	O
of	O
the	O
Board	B-Organization
of	I-Organization
Scientific	I-Organization
Counselors	E-Organization
,	O
Office	B-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
,	O
CDC	S-Organization
,	O
and	O
is	O
co-chair	O
of	O
the	O
board's	O
.	O

Most	O
of	O
the	O
work	O
is	O
carried	O
out	O
with	O
a	O
replication	O
defective	O
,	O
nonreplicative	O
,	O
ecotropic‐	O
MulV	S-Pathogen
viral	O
vector	O
expressing	O
β‐galactosidase	O
7	O
,	O
12	O
.	O

The	O
Plum	B-Location
Island	E-Location
location	O
has	O
housed	O
some	O
of	O
the	O
world's	O
most	O
lethal	O
bacteria	O
and	O
viruses	O
for	O
the	O
past	O
five	O
decades	O
without	O
trouble	O
.	O

Tom	B-Person
Clancy	E-Person
1996	O
novel	O
,	O
Executive	O
Orders	O
,	O
involves	O
a	O
Middle	B-Location
Eastern	E-Location
terrorist	O
attack	O
on	O
the	O
United	B-Location
States	E-Location
using	O
an	O
airborne	O
form	O
of	O
a	O
deadly	O
Ebola	B-Pathogen
virus	E-Pathogen
named	O
"	O
".	O

In	O
addition	O
,	O
the	O
letter	O
had	O
no	O
delivery	O
address	O
and	O
no	O
postmark.	O
"	O
Fallen	B-Person
Angel	E-Person
Focus	O
of	O
"	O
,	O
redorbit.com	O
,	O
February	O
5	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

"	O
The	O
U.S.	B-Organization
government	E-Organization
should	O
pay	O
close	O
attention	O
to	O
this	O
rapidly	O
progressing	O
field	O
,	O
just	O
as	O
it	O
did	O
to	O
advances	O
in	O
chemistry	O
and	O
physics	O
during	O
the	O
Cold	B-Incident
War	E-Incident
era,	O
"	O
said	O
Michael	B-Person
Imperiale	E-Person
,	O
a	O
professor	O
of	O
microbiology	O
and	O
immunology	O
at	O
the	O
,	O
and	O
the	O
chair	O
of	O
the	O
committee	O
that	O
conducted	O
the	O
study	O
.	O

The	O
World	B-Organization
Bank	E-Organization
estimated	O
that	O
the	O
overall	O
economic	O
impact	O
of	O
the	O
Ebola	B-Incident
crisis	E-Incident
in	O
Guinea	S-Location
,	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
was	O
approximately	O
$2.8	O
billion	O
.	O

In	O
addition	O
,	O
biosafety	B-Equipment
cabinet	E-Equipment
was	O
found	O
in	O
11	O
(5.	O
8%)	O
labs	O
,	O
autoclave	S-Equipment
in	O
28	O
(14.	O
7%)	O
,	O
and	O
incinerator	S-Equipment
in	O
only	O
2	O
(1.1%)	O
labs	O
.	O

Remote	O
working	O
measures	O
were	O
instituted	O
in	O
several	O
Chinese	O
regions	O
.	O

Gary	B-Person
Cohen	E-Person
,	O
is	O
executive	O
vice	O
president	O
,	O
global	O
health	O
,	O
of	O
Becton	B-Organization
Dickinson	I-Organization
and	I-Organization
Co.	E-Organization
()	O
.	O

The	O
Fast	O
Track	O
process	O
allows	O
more	O
frequent	O
interactions	O
with	O
the	O
,	O
rolling	O
reviews	O
of	O
the	O
Biologic	O
License	O
Application	O
(BLA)	O
,	O
and	O
eligibility	O
for	O
a	O
priority	O
review	O
if	O
relevant	O
criteria	O
are	O
met	O
.	O

The	O
WHO	S-Organization
also	O
came	O
under	O
fire	O
for	O
refusing	O
to	O
send	O
Dr	O
.	O

Bell	S-Person
will	O
look	O
at	O
in	O
terms	O
of	O
our	O
laboratory	O
.	O

The	O
agency	O
maintains	O
staff	O
in	O
more	O
than	O
60	O
countries	O
,	O
including	O
some	O
from	O
the	O
U.S.	S-Location
but	O
even	O
more	O
from	O
the	O
countries	O
in	O
which	O
it	O
operates	O
.	O

By	O
1351	O
,	O
60	O
major	O
and	O
150	O
smaller	O
Jewish	O
communities	O
had	O
been	O
destroyed.	O
"	O
Jewish	O
History	O
1340–1349	O
"	O
.	O
During	O
this	O
period	O
many	O
Jews	O
relocated	O
to	O
Poland	S-Location
,	O
where	O
they	O
received	O
a	O
warm	O
welcome	O
from	O
.	O

The	O
announcement	O
came	O
after	O
a	O
further	O
laboratory	O
analysis	O
by	O
indicating	O
that	O
the	O
person	O
was	O
never	O
infected	O
with	O
the	O
virus	O
.	O

The	O
Soviet	B-Organization
Union	E-Organization
began	O
a	O
biological	O
weapons	O
program	O
in	O
the	O
1920s	O
.	O

Similar	O
to	O
the	O
situation	O
in	O
malaria	S-Disease
therapy	O
,	O
where	O
successful	O
treatments	O
based	O
on	O
ancient	O
recipes	O
have	O
been	O
found	O
,	O
there	O
has	O
already	O
been	O
some	O
success	O
in	O
finding	O
and	O
testing	O
ancient	O
drugs	O
and	O
other	O
treatments	O
that	O
are	O
effective	O
against	O
AMR	O
bacteria	O
.	O

There	O
are	O
some	O
international	O
guidelines	O
available	O
,	O
but	O
there	O
are	O
no	O
national	O
guidelines	O
or	O
reference	O
standards	O
available	O
in	O
on	O
certification	O
and	O
validation	O
of	O
biosafety	O
laboratories	O
.	O

Carlo	B-Person
Urbani	E-Person
,	O
a	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
infectious	O
disease	O
specialist	O
,	O
was	O
among	O
the	O
staff	O
who	O
examined	O
Chen	S-Person
.	O
observed	O
that	O
other	O
hospital	O
staff	O
were	O
already	O
falling	O
ill	O
and	O
realized	O
that	O
he	O
was	O
dealing	O
with	O
a	O
new	O
and	O
dangerous	O
disease	O
.	O

The	O
following	O
member	O
countries	O
as	O
per	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
definition	O
of	O
BMENA	O
region	O
were	O
included	O
in	O
the	O
study:	O
Afghanistan	S-Location
,	O
Algeria	S-Location
,	O
Bahrain	S-Location
,	O
Egypt	S-Location
,	O
Iran	S-Location
,	O
Iraq	S-Location
,	O
Israel	S-Location
,	O
Jordan	S-Location
,	O
Kuwait	S-Location
,	O
Lebanon	S-Location
,	O
Libya	S-Location
,	O
Mauritania	S-Location
,	O
Morocco	S-Location
,	O
Oman	S-Location
,	O
Palestine	S-Location
,	O
Pakistan	S-Location
,	O
Qatar	S-Location
,	O
Saudi	S-Location
,	O
Sudan	S-Location
,	O
Syria	S-Location
,	O
Tunisia	S-Location
,	O
Turkey	S-Location
,	O
United	B-Location
Arab	I-Location
Emirates	E-Location
(	O
UAE	S-Location
)	O
,	O
and	O
.	O
Members	O
of	O
biosafety	O
associations	O
of	O
these	O
countries	O
were	O
invited	O
by	O
the	O
study	O
country	O
coordinators	O
to	O
participate	O
in	O
the	O
survey	O
.	O

Furthermore	O
,	O
most	O
past	O
epidemics	O
had	O
occurred	O
in	O
remote	O
regions	O
,	O
but	O
this	O
outbreak	O
spread	O
to	O
large	O
urban	O
areas	O
,	O
which	O
had	O
increased	O
the	O
number	O
of	O
contacts	O
an	O
infected	O
person	O
might	O
have	O
and	O
made	O
transmission	O
harder	O
to	O
track	O
and	O
break	O
.	O

Bell	S-Person
to	O
be	O
the	O
single	O
point	O
of	O
accountability	O
for	O
laboratory	O
safety	O
at	O
-	O
in	O
fact	O
,	O
what	O
we	O
need	O
to	O
ensure	O
is	O
that	O
safety	O
is	O
a	O
laser-like	O
focus	O
for	O
every	O
single	O
level	O
of	O
the	O
organization	O
.	O

However	O
,	O
it	O
killed	O
a	O
much	O
lower	O
percentage	O
of	O
the	O
world's	O
population	O
than	O
the	O
Black	O
Death	O
,	O
which	O
lasted	O
for	O
many	O
more	O
years	O
.	O

As	O
of	O
June	O
2019	O
,	O
pregnant	O
and	O
lactating	O
women	O
are	O
now	O
also	O
being	O
vaccinated	O
.	O

It	O
had	O
around	O
4,500	O
containers	O
to	O
be	O
used	O
to	O
raise	O
fleas	O
,	O
six	O
cauldrons	O
to	O
produce	O
various	O
chemicals	O
,	O
and	O
around	O
1,800	O
containers	O
to	O
produce	O
biological	O
agents	O
.	O

Researchers	O
often	O
used	O
broom	O
handles	O
to	O
corral	O
the	O
wayward	O
mice	O
that	O
had	O
previously	O
been	O
infected	O
with	O
a	O
variety	O
of	O
pathogens	O
.	O

In	O
terms	O
of	O
the	O
culture	O
of	O
safety	O
,	O
while	O
we're	O
appointing	O
Dr	O
.	O

Crimean-Congo	B-Disease
hemorrhagic	I-Disease
fever	E-Disease
(	O
CCHF	S-Disease
)	O
is	O
caused	O
by	O
infection	O
through	O
a	O
tick-borne	B-Pathogen
virus	E-Pathogen
(	O
Nairovirus	S-Pathogen
)	O
.	O

PPE	S-Equipment
must	O
be	O
put	O
on	O
(donned)	O
in	O
the	O
laboratory	O
and	O
removed	O
(doffed)	O
prior	O
to	O
leaving	O
the	O
work	O
area	O
.	O

Several	O
Ebola	B-Vaccine
vaccine	E-Vaccine
candidates	O
had	O
been	O
developed	O
in	O
the	O
decade	O
prior	O
to	O
2014	O
and	O
had	O
been	O
shown	O
to	O
protect	O
nonhuman	O
primates	O
against	O
infection	O
,	O
but	O
none	O
had	O
yet	O
been	O
approved	O
for	O
clinical	O
use	O
in	O
humans	O
.	O

But	O
officials	O
will	O
not	O
ask	O
labs	O
to	O
suspend	O
research	O
for	O
any	O
specific	O
period	O
of	O
time	O
,	O
or	O
focus	O
only	O
on	O
studies	O
involving	O
"	O
high-consequence"	O
pathogens	O
,	O
a	O
source	O
familiar	O
with	O
the	O
matter	O
tells	O
ScienceInsider	O
.	O

The	O
first	O
self-replicating	O
synthetic	O
bacteria	O
cell	O
constructed	O
by	O
scientists	O
at	O
the	O
has	O
more	O
than	O
1	O
million	O
base	O
pairs	O
of	O
DNA	O
,	O
almost	O
1,000	O
genes	O
,	O
and	O
involved	O
the	O
complete	O
replacement	O
of	O
genetic	O
material	O
in	O
the	O
cell	O
.	O

In	O
December	O
2008	O
,	O
research	O
by	O
Yoshihiro	B-Person
Kawaoka	E-Person
of	O
the	O
University	B-Organization
of	I-Organization
Wisconsin	E-Organization
linked	O
the	O
presence	O
of	O
three	O
specific	O
genes	O
(termed	O
PA	O
,	O
PB1	O
,	O
and	O
PB2)	O
and	O
a	O
nucleoprotein	O
derived	O
from	O
1918	B-Disease
flu	E-Disease
samples	O
to	O
the	O
ability	O
of	O
the	O
flu	S-Disease
virus	O
to	O
invade	O
the	O
lungs	O
and	O
cause	O
.	O
The	O
combination	O
triggered	O
similar	O
symptoms	O
in	O
animal	O
testing	O
.	O

On	O
9	O
December	O
,	O
a	O
study	O
indicated	O
that	O
a	O
single	O
individual	O
introduced	O
the	O
virus	O
into	O
,	O
causing	O
the	O
most	O
cases	O
of	O
the	O
disease	O
in	O
that	O
country	O
.	O

Thus	O
,	O
to	O
benefit	O
from	O
GMOs	O
,	O
has	O
to	O
revise	O
its	O
biosafety	O
system	O
,	O
primarily	O
by	O
making	O
changes	O
to	O
some	O
provisions	O
of	O
the	O
law	O
in	O
a	O
way	O
that	O
balances	O
its	O
diverse	O
interests	O
of	O
conserving	O
biodiversity	O
,	O
protecting	O
the	O
environment	O
and	O
enhancing	O
competition	O
in	O
agricultural	O
and	O
other	O
economic	O
sectors	O
.	O

However	O
,	O
officials	O
in	O
the	O
Carter	B-Organization
administration	E-Organization
suspected	O
the	O
outbreak	O
was	O
caused	O
by	O
an	O
accidental	O
release	O
of	O
anthrax	S-Pathogen
spores	O
from	O
a	O
suspected	O
Soviet	S-Organization
biological	O
weapons	O
facility	O
located	O
in	O
the	O
city	O
.	O

The	O
five	O
suspected	O
cases	O
in	O
the	O
Mambasa	B-Organization
Health	I-Organization
Zone	E-Organization
proved	O
not	O
to	O
be	O
EVD	S-Disease
;	O
it	O
was	O
not	O
possible	O
to	O
confirm	O
the	O
one	O
probable	O
case	O
in	O
the	O
Musienene	B-Organization
Health	I-Organization
Zone	E-Organization
and	O
the	O
two	O
probable	O
cases	O
in	O
the	O
Butembo	B-Organization
Health	I-Organization
Zone	E-Organization
.	O
No	O
new	O
cases	O
had	O
been	O
recorded	O
in	O
any	O
of	O
those	O
health	O
zones	O
.	O

DARRALL	B-Person
JOHNSON	E-Person
Just	O
a	O
question	O
for	O
Dr.Bell	O
.	O

Out	O
of	O
an	O
abundance	O
of	O
caution	O
,	O
CDC	S-Organization
is	O
taking	O
aggressive	O
steps	O
to	O
protect	O
the	O
health	O
of	O
all	O
involved	O
,	O
including	O
providing	O
protective	O
courses	O
of	O
antibiotics	S-Drug
for	O
potentially	O
exposed	O
staff	O
.	O

At	O
least	O
since	B-Incident
2001	I-Incident
and	I-Incident
the	I-Incident
Amerithrax	I-Incident
anthrax	I-Incident
letters	E-Incident
the	O
USA	S-Location
has	O
had	O
a	O
significant	O
focus	O
on	O
biosecurity	O
and	O
the	O
related	O
subject	O
of	O
biosafety	O
.	O

As	O
of	O
2007	O
in	O
the	O
United	B-Location
States	E-Location
a	O
proportion	O
of	O
are	O
performed	O
unnecessarily	O
.	O

In	O
March	O
,	O
and	O
again	O
in	O
April	O
,	O
there	O
were	O
reports	O
that	O
Iran	S-Location
was	O
under-reporting	O
cases	O
and	O
deaths	O
.	O

The	O
same	O
year	O
,	O
the	O
PHS	S-Organization
transferred	O
its	O
San	B-Organization
Francisco	I-Organization
based	I-Organization
plague	I-Organization
laboratory	E-Organization
into	O
the	O
as	O
the	O
Epidemiology	O
Division	O
,	O
and	O
a	O
new	O
Veterinary	O
Diseases	O
Division	O
was	O
established	O
.	O

The	O
seat	O
of	O
the	O
organization	O
is	O
in	O
Geneva	S-Location
Switzerland	S-Location
.	O
It	O
was	O
designed	O
by	O
Swiss	O
architect	O
and	O
inaugurated	O
in	O
1966	O
.	O

For	O
45	O
minutes	O
each	O
morning	O
,	O
the	O
veteran	O
hockey	O
player	O
Duncan	B-Person
Keith	E-Person
ritually	O
goes	O
upstairs	O
to	O
what	O
he	O
calls	O
his	O
"	O
lab,"	O
where	O
he	O
has	O
"	O
a	O
bunch	O
of	O
little	O
things	O
that	O
I	O
do	O
to	O
stay	O
healthy.	O
"	O
This	O
,	O
according	O
to	O
an	O
interview	O
this	O
week	O
in	O
The	O
New	B-Organization
York	I-Organization
Times	E-Organization
,	O
includes	O
dousing	O
himself	O
with	O
infrared	O
light	O
,	O
lying	O
for	O
eight	O
minutes	O
on	O
a	O
mat	O
that	O
"	O
has	O
electromagnetic	O
currents,	O
"	O
and	O
taking	O
supplement	O
pills	O
such	O
as	O
glutathione	S-Drug
and	O
vitamin	B-Drug
C	E-Drug
,	O
and	O
liquid	O
herbs	O
such	O
as	O
.	O

Before	O
hitting	O
age	O
30	O
,	O
he	O
was	O
diagnosed	O
with	O
high	O
risk	O
of	O
stroke	S-Disease
and	O
heart	B-Disease
attack	E-Disease
,	O
suffered	O
from	O
cognitive	B-Disease
dysfunction	E-Disease
,	O
and	O
weighed	O
300	O
pounds.	O
"	O
I	O
just	O
wanted	O
to	O
control	O
my	O
own	O
biology	O
because	O
I	O
was	O
tired	O
of	O
being	O
in	O
pain	O
and	O
having	O
,	O
"	O
he	O
told	O
me	O
.	O

In	O
addition	O
,	O
another	O
important	O
restriction	O
of	O
bioweapons	O
might	O
be	O
overcome	O
by	O
genetic	B-Technology
engineering	E-Technology
techniques	O
in	O
the	O
future	O
.	O

In	O
addition	O
,	O
a	O
British	O
report	O
found	O
that	O
people	O
often	O
failed	O
to	O
complete	O
a	O
full	O
course	O
of	O
the	O
drug	O
or	O
took	O
the	O
medication	O
when	O
not	O
needed	O
.	O

SysMO-SEEK	S-Platform
was	O
developed	O
to	O
be	O
integrated	O
with	O
other	O
data	O
management	O
systems	O
via	O
a	O
software	O
architecture	O
using	O
web	O
interfaces	O
for	O
the	O
adaptation	O
of	O
external	O
systems	O
.	O

The	O
incident	O
did	O
not	O
appear	O
to	O
have	O
posed	O
a	O
safety	O
risk	O
since	O
the	O
virus	O
was	O
handled	O
solely	O
under	O
laboratory	O
conditions	O
appropriate	O
for	O
containment	O
of	O
HPAI	B-Pathogen
H5N1	I-Pathogen
virus	E-Pathogen
(	O
biosafety	B-Platform
level	I-Platform
3	I-Platform
with	I-Platform
enhancements	E-Platform
or	O
)	O
,	O
and	O
were	O
shipped	O
with	O
proper	O
permits	O
and	O
packaging	O
.	O

Warren	O
proposed	O
that	O
the	O
British	O
had	O
no	O
choice	O
as	O
they	O
were	O
confronted	O
with	O
dire	O
circumstances	O
when	O
,	O
among	O
other	O
factors	O
,	O
they	O
ran	O
out	O
of	O
ammunition	O
for	O
their	O
muskets	O
.	O

That	O
training	O
will	O
incorporate	O
some	O
of	O
the	O
simulators	O
owned	O
by	O
New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
They	O
look	O
like	O
mannequins	O
or	O
crash	O
test	O
dummies	O
but	O
are	O
far	O
more	O
complex	O
.	O

Simple	O
interventions	O
,	O
such	O
as	O
written	O
information	O
explaining	O
the	O
futility	O
of	O
antibiotics	O
for	O
common	O
infections	O
such	O
as	O
upper	B-Disease
respiratory	I-Disease
tract	I-Disease
infections	E-Disease
have	O
been	O
shown	O
to	O
reduce	O
antibiotic	O
prescribing	O
.	O

The	O
center	O
needed	O
to	O
be	O
updated	O
,	O
but	O
it	O
could	O
have	O
been	O
done	O
in	O
Plum	B-Location
Island	E-Location
with	O
less	O
risk	O
exposure	O
to	O
farmers	O
.	O

A	O
number	O
of	O
problems	O
have	O
been	O
reported	O
over	O
the	O
years	O
in	O
the	O
building	O
,	O
including	O
a	O
2009	O
decontamination	O
shower	O
failure	O
and	O
a	O
2015	O
fire	O
in	O
a	O
lower-level	O
lab	O
.	O

Cohen	S-Person
was	O
studying	O
how	O
to	O
transfer	O
plasmids	O
from	O
one	O
cell	O
to	O
another.	O
was	O
studying	O
restriction	O
enzymes	O
and	O
had	O
found	O
that	O
enzymes	O
such	O
as	O
HindII	O
leave	O
behind	O
'sticky	O
ends'	O
when	O
they	O
cut	O
DNA	O
.	O

As	O
little	O
as	O
500	O
micrograms	O
--	O
an	O
amount	O
the	O
size	O
of	O
the	O
head	O
of	O
a	O
pin	O
--	O
can	O
kill	O
an	O
adult	O
.	O

The	O
mosquito	O
tests	O
were	O
known	O
as	O
Operation	B-Scientific_research_project
Big	I-Scientific_research_project
Buzz	E-Scientific_research_project
.	O
Novick	S-Person
,	O
Lloyd	S-Person
and	O
Marr	S-Person
,	O
John	B-Person
S	E-Person
.	O
Public	O
Health	O
Issues	O
Disaster	O
Preparedness	O
,	O
(Google	O
Books)	O
,	O
Jones	S-Person
&a	O
mp;	B-Person
Bart	E-Person
lett	O
Publishers	O
,	O
2001	O
,	O
p.87	O
,	O
.The	O
U.S.	O
engaged	O
in	O
at	O
least	O
two	O
other	O
EW	O
testing	O
programs	O
,	O
Operation	O
Drop	O
Kick	O
Day	O
.	O

Urgent	O
pleas	O
for	O
assistance	O
were	O
sent	O
out	O
on	O
12	O
September	O
.	O

An	O
official	O
government	O
inquiry	O
into	O
Parker	S-Person
death	O
was	O
conducted	O
by	O
a	O
panel	O
led	O
by	O
microbiologist	O
R.A.	B-Person
Shooter	E-Person
,	O
and	O
comprising	O
Dr	O
Christopher	B-Person
Booth	E-Person
,	O
Prof	O
.	O

On	O
12	O
February	O
,	O
it	O
was	O
reported	O
that	O
13	O
individuals	O
had	O
been	O
isolated	O
due	O
to	O
their	O
contact	O
with	O
a	O
suspected	O
Ebola	S-Pathogen
case	O
in	O
;	O
the	O
lab	O
results	O
came	O
back	O
negative	O
several	O
hours	O
later	O
.	O

Mortality	B-Platform
Medical	I-Platform
Data	I-Platform
System	E-Platform

Most	O
systems	O
allow	O
granting	O
read/write	O
permissions	O
to	O
users	O
,	O
groups	O
and	O
the	O
general	O
public	O
.	O

Other	O
terms	O
are	O
also	O
associated	O
with	O
the	O
do-it-yourself	B-Activity
biology	E-Activity
community	O
.	O

Included	O
among	O
those	O
prosecuted	O
for	O
war	O
crimes	O
,	O
including	O
germ	O
warfare	O
,	O
was	O
General	O
Otozō	B-Person
Yamada	E-Person
,	O
the	O
commander-in-chief	O
of	O
the	O
million-man	O
Kwantung	B-Organization
Army	E-Organization
occupying	O
.	O

To	O
integrate	O
applications	O
,	O
the	O
Gaggle	S-Platform
boss	O
relays	O
messages	O
of	O
these	O
basic	O
data	O
types	O
between	O
'geese'	O
(software	O
adapted	O
to	O
Gaggle	S-Platform
)	O
.	O

Other	O
reported	O
side	O
effects	O
include	O
gastrointestinal	O
distress	O
,	O
elevated	O
transaminase	O
levels	O
in	O
the	O
blood	O
(liver	O
enzymes)	O
,	O
and	O
infusion	O
site	O
reactions	O
.	O

Opinion	O
in	O
Africa	S-Location
over	O
the	O
use	O
of	O
genetically	O
modified	O
crops	O
for	O
food	O
has	O
been	O
divided	O
,	O
honed	O
by	O
more	O
than	O
a	O
decade	O
of	O
arguments	O
in	O
Europe	S-Location
and	O
elsewhere	O
.	O

The	O
development	O
and	O
spread	O
of	O
antibiotic	O
resistance	O
in	O
bacteria	O
is	O
a	O
universal	O
threat	O
to	O
both	O
humans	O
and	O
animals	O
that	O
is	O
generally	O
not	O
preventable	O
,	O
but	O
can	O
nevertheless	O
be	O
controlled	O
and	O
must	O
be	O
tackled	O
in	O
the	O
most	O
effective	O
ways	O
possible	O
.	O

The	O
incident	O
was	O
treated	O
as	O
a	O
criminal	O
probe	O
with	O
investigators	O
looking	O
carefully	O
for	O
any	O
connection	O
between	O
the	O
ricin	S-Pathogen
found	O
at	O
Dirksen	S-Location
and	O
the	O
"	O
Fallen	B-Incident
Angel"	I-Incident
cases	E-Incident
.	O
Johnston	S-Person
,	O
David	S-Person
,	O
and	O
Hulse	S-Person
,	O
.	O

There	O
is	O
variation	O
in	O
the	O
sharing-culture	O
in	O
dedicated	O
scientific	O
disciplines	O
.	O

On	O
27	O
May	O
,	O
the	O
Taichung	B-Organization
City	I-Organization
Government	E-Organization
,	O
led	O
by	O
mayor	O
Jason	B-Person
Hu	E-Person
,	O
established	O
a	O
command	O
center	O
in	O
central	O
Taiwan	S-Location
to	O
handle	O
SARS	S-Disease
.	O
The	O
Department	B-Organization
of	I-Organization
Health	E-Organization
worked	O
with	O
several	O
hospitals	O
in	O
Taiwan	S-Location
to	O
expand	O
medical	O
facilities	O
and	O
treatment	O
for	O
patients	O
.	O

In	O
addition	O
,	O
in	O
2004	O
the	O
Swedish	B-Organization
Laboratory	I-Organization
for	I-Organization
Food	I-Organization
Safety	I-Organization
and	I-Organization
Biopreparedness	E-Organization
was	O
established	O
.	O

Although	O
it	O
would	O
be	O
comforting	O
to	O
consider	O
laboratory‐acquired	O
infection	O
an	O
artifact	O
of	O
a	O
less	O
sophisticated	O
time	O
in	O
biomedical	O
research	O
,	O
recent	O
examples	O
refute	O
this	O
.	O

A	O
corporate	O
mailroom	O
employee	O
in	O
New	B-Location
York	E-Location
City	O
uses	O
gloves	O
while	O
sifting	O
through	O
letters	O
in	O
October	O
2001	O
.	O

However	O
,	O
this	O
appears	O
to	O
have	O
been	O
false	O
because	O
subsequently	O
806	O
cases	O
of	O
infection	O
and	O
34	O
deaths	O
were	O
reported	O
.	O

There	O
is	O
limited	O
information	O
to	O
determine	O
the	O
overall	O
risk	O
of	O
this	O
reported	O
cluster	O
of	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
.	O

Sharing	O
of	O
such	O
information	O
is	O
especially	O
crucial	O
during	O
an	O
emergent	O
pandemic	O
as	O
in	O
April	O
2009	O
,	O
when	O
the	O
genetic	O
sequences	O
of	O
the	O
initial	O
viruses	O
were	O
rapidly	O
and	O
openly	O
shared	O
via	O
the	O
GISAID	B-Organization
Initiative	E-Organization
within	O
days	O
of	O
identification	O
,	O
playing	O
a	O
key	O
role	O
in	O
facilitating	O
an	O
early	O
response	O
to	O
the	O
evolving	O
pandemic	O
.	O

Staphylococcus	B-Pathogen
aureus	E-Pathogen
,	O
including	O
methicillin-resistant	O
strains	O
,	O
is	O
an	O
important	O
cause	O
of	O
secondary	O
bacterial	B-Disease
pneumonia	E-Disease
with	O
a	O
high	O
mortality	O
rate	O
;	O
Streptococcus	B-Pathogen
pneumoniae	E-Pathogen
is	O
the	O
second	O
most	O
important	O
cause	O
of	O
secondary	O
for	O
children	O
and	O
primary	O
for	O
adults	O
.	O

It	O
is	O
now	O
known	O
that	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
can	O
be	O
transmitted	O
sexually	O
.	O

SARS‑CoV‑2	S-Pathogen
is	O
closely	O
related	O
to	O
SARS‑CoV	S-Pathogen
,	O
and	O
is	O
thought	O
to	O
have	O
a	O
zoonotic	O
origin.	O
genetically	O
clusters	O
with	O
the	O
genus	O
Betacoronavirus	O
,	O
and	O
is	O
96	O
percent	O
identical	O
at	O
the	O
whole	O
genome	O
level	O
to	O
other	O
bat	O
coronavirus	O
samples	O
and	O
92	O
percent	O
identical	O
to	O
pangolin	O
coronavirus	O
.	O

"	O
But	O
despite	O
this	O
progress	O
,	O
we're	O
not	O
fully	O
prepared,	O
"	O
he	O
said	O
,	O
adding	O
that	O
gaps	O
have	O
left	O
the	O
United	B-Location
States	E-Location
vulnerable	O
to	O
terrorists	O
and	O
natural	O
threats	O
.	O

The	O
extent	O
of	O
Iraq's	B-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
between	O
1998	O
when	O
UNSCOM	S-Organization
left	O
Iraq	S-Location
and	O
the	O
U.S.	S-Location
Coalition	O
invasion	O
in	O
March	O
2003	O
remains	O
unknown	O
.	O

Dominica	B-Person
(Dee)	I-Person
Zimmerman	E-Person
is	O
a	O
Biosafety	O
Officer	O
and	O
Director	O
of	O
the	O
Environmental	B-Organization
Health	I-Organization
and	I-Organization
Biosafety	I-Organization
Regulations	I-Organization
and	I-Organization
Requirements	I-Organization
Core	E-Organization
in	O
the	O
Environmental	O
Health	O
and	O
Safety	O
,	O
Biological	O
and	O
Chemical	O
Safety	O
Program	O
for	O
the	O
University	B-Organization
of	I-Organization
Texas	I-Organization
Medical	I-Organization
Branch	E-Organization
(	O
UTMB	S-Organization
)	O
in	O
Galveston	S-Location
.	O
She	O
has	O
more	O
than	O
28	O
years	O
of	O
safety	O
experience	O
at	O
UTMB	S-Organization
and	O
6	O
years	O
of	O
experience	O
as	O
laboratory	O
coordinator	O
and	O
division	O
safety	O
liaison	O
with	O
the	O
University	B-Organization
of	I-Organization
Puerto	I-Organization
Rico	E-Organization
,	O
Division	O
of	O
Marine	O
Ecology	O
.	O

In	O
the	O
article	O
,	O
they	O
noted	O
four	O
respiratory	O
human	O
coronaviruses	O
(HCoV)	O
known	O
to	O
be	O
endemic:	O
229E	S-Pathogen
,	O
OC43	S-Pathogen
,	O
NL63	S-Pathogen
,	O
and	O
.	O

There	O
were	O
further	O
outbreaks	O
throughout	O
the	O
Late	O
Middle	O
Ages	O
,	O
and	O
with	O
other	O
contributing	O
factors	O
it	O
took	O
until	O
1500	O
for	O
the	O
European	O
population	O
to	O
regain	O
the	O
levels	O
of	O
1300	O
(Crisis	O
of	O
the	O
Late	O
Middle	O
Ages)	O
.	O

We	O
do	O
not	O
yet	O
know	O
where	O
Covid-19	S-Pathogen
came	O
from	O
,	O
though	O
it	O
is	O
very	O
similar	O
to	O
found	O
in	O
bats	O
and	O
pangolins	O
.	O

The	O
term	O
biohacking	O
is	O
also	O
used	O
by	O
the	O
grinder	O
body	O
modification	O
community	O
,	O
which	O
is	O
considered	O
related	O
but	O
distinct	O
from	O
the	O
.	O
The	O
term	O
biopunk	O
emphasizes	O
the	O
techno-progressive	O
,	O
political	O
,	O
and	O
artistic	O
elements	O
of	O
the	O
movement	O
.	O

"	O
If	O
successful	O
,	O
SIGMA+	S-Scientific_research_project
will	O
demonstrate	O
that	O
automated	O
,	O
distributed	O
networks	O
of	O
sensors	O
,	O
combined	O
with	O
automated	O
intelligence	O
analytics	O
and	O
insights	O
from	O
social	O
science	O
,	O
can	O
be	O
deployed	O
and	O
practically	O
scaled	O
to	O
significantly	O
increase	O
the	O
probability	O
of	O
interdicting	O
CBRNE	O
WMD	O
attacks,	O
"	O
said	O
.	O

The	O
old	O
radiocontrast	O
agents	O
caused	O
anaphylaxis	S-Phenotype
in	O
1%	O
of	O
cases	O
while	O
the	O
newer	O
,	O
lower-osmolar	O
agents	O
cause	O
reactions	O
in	O
0.01–0.	O
04%	O
of	O
cases	O
.	O

manifesting	O
,	O
in	O
slower	O
growth	O
rate	O
.	O

Warehouse	O
13	O
episode	O
"	O
The	O
40th	O
Floor	O
"	O
(2011)	O
.	O

OPERATOR:	O
Our	O
next	O
question	O
comes	O
from	O
Donald	B-Person
McNeil	E-Person
from	O
the	O
;	O
you	O
may	O
ask	O
your	O
question	O
.	O

Encapsidated	O
,	O
negative-sense	O
genomic	O
ssRNA	O
is	O
used	O
as	O
a	O
template	O
for	O
the	O
synthesis	O
(3'-5')	O
of	O
polyadenylated	O
,	O
monocistronic	O
mRNAs	O
and	O
,	O
using	O
the	O
host	O
cell's	O
ribosomes	O
,	O
tRNA	O
molecules	O
,	O
etc.	O
,	O
the	O
mRNA	O
is	O
translated	O
into	O
individual	O
viral	O
proteins	O
.	O

Beginning	O
on	O
15	O
March	O
,	O
many	O
businesses	O
closed	O
or	O
reduced	O
hours	O
and	O
schools	O
across	O
the	O
country	O
were	O
shutting	O
down	O
.	O

However	O
,	O
some	O
inconsistencies	O
were	O
identified	O
,	O
such	O
as	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
which	O
were	O
categorized	O
according	O
to	O
the	O
highest	O
biodefense	O
level	O
,	O
but	O
were	O
not	O
included	O
in	O
the	O
corresponding	O
laboratory	O
biosafety	O
level	O
.	O

Horizon	O
Scientific	O
Press	O
;	O
2007	O
Without	O
the	O
creation	O
of	O
new	O
and	O
stronger	O
antibiotics	O
an	O
era	O
where	O
common	O
infections	O
and	O
minor	O
injuries	O
can	O
kill	O
,	O
and	O
where	O
complex	O
procedures	O
such	O
as	O
surgery	O
and	O
chemotherapy	O
become	O
too	O
risky	O
,	O
is	O
a	O
very	O
real	O
possibility	O
.	O

WHO	S-Organization
works	O
to	O
"	O
reduce	O
morbidity	O
and	O
mortality	O
and	O
improve	O
health	O
during	O
key	O
stages	O
of	O
life	O
,	O
including	O
pregnancy	O
,	O
childbirth	O
,	O
the	O
neonatal	O
period	O
,	O
childhood	O
and	O
adolescence	O
,	O
and	O
improve	O
sexual	O
and	O
reproductive	O
health	O
and	O
promote	O
active	O
and	O
healthy	O
aging	O
for	O
all	O
individuals"	O
.	O

But	O
molecular	O
biologist	O
Richard	B-Person
Ebright	E-Person
of	O
Rutgers	B-Organization
University	E-Organization
in	O
Piscataway	S-Location
,	O
New	B-Location
Jersey	E-Location
,	O
calls	O
the	O
memo	O
"	O
very	O
thin	O
gruel.	O
"	O
A	O
longtime	O
critic	O
of	O
biodefense	O
labs	O
,	O
Ebright	S-Person
notes	O
that	O
most	O
select	O
agent	O
work	O
takes	O
place	O
at	O
academic	O
or	O
other	O
nonfederal	O
labs	O
.	O

We'll	O
use	O
that	O
for	O
certainly	O
events	O
when	O
we	O
need	O
to	O
.	O

We	O
believe	O
that	O
the	O
key	O
factors	O
in	O
building	O
trust	O
among	O
FBD	S-Platform
network	O
members	O
have	O
been	O
joint	O
work	O
on	O
the	O
part	O
of	O
laboratory	O
personnel	O
,	O
significant	O
contribution	O
by	O
each	O
of	O
the	O
participating	O
agencies	O
,	O
and	O
common	O
ownership	O
of	O
results	O
.	O

As	O
of	O
September	O
2017	O
,	O
the	O
largest	O
number	O
of	O
projects	O
have	O
been	O
implemented	O
in	O
.	O

Clinical	O
improvement	O
was	O
observed	O
in	O
patients	O
treated	O
with	O
compassionate-use	O
remdesivir	O
.	O

You	O
don't	O
need	O
nootropics	S-Drug
to	O
biohack	O
.	O

An	O
important	O
part	O
of	O
each	O
centre	O
is	O
an	O
arrangement	O
for	O
safe	O
burial	O
or	O
cremation	O
of	O
bodies	O
,	O
required	O
to	O
prevent	O
further	O
infection	O
.	O

The	O
center	O
has	O
long	O
been	O
viewed	O
with	O
suspicion	O
in	O
Russia	S-Location
,	O
with	O
some	O
officials	O
,	O
including	O
FSB	S-Organization
chief	O
,	O
alleging	O
that	O
it	O
was	O
involved	O
in	O
bioweapons	O
research	O
.	O

However	O
,	O
today	O
what	O
I	O
want	O
to	O
talk	O
about	O
are	O
three	O
laboratory	O
incidents	O
that	O
raise	O
serious	O
and	O
troubling	O
questions	O
.	O

A	O
March	O
2019	O
,	O
paper	O
by	O
Tariq	S-Person
et	O
al.	O
indicated	O
(rho = −0.37	O
,	O
p &lt; 0.	O
001)	O
oscillating	O
around	O
0.	O
9	O
for	O
mean	O
R	O
.	O

Another	O
idea	O
is	O
to	O
pilot	O
concepts	O
for	O
awarding	O
a	O
"	O
seal	O
of	O
approval	O
"	O
among	O
researchers	O
and	O
institutions	O
to	O
develop	O
incentives	O
for	O
responsible	O
science	O
and	O
disincentives	O
for	O
irresponsible	O
behavior	O
.	O

Some	O
estimates	O
place	O
this	O
number	O
at	O
30%	O
.	O

On	O
Friday	O
,	O
July	O
13	O
,	O
the	O
FDA	S-Organization
announced	O
the	O
approval	O
of	O
the	O
drug	O
tecovirimat	S-Drug
or	O
TPOXX	S-Drug
,	O
which	O
was	O
deemed	O
effective	O
following	O
successful	O
trials	O
on	O
animals	O
infected	O
with	O
viruses	O
related	O
to	O
the	O
one	O
that	O
causes	O
.	O

LIT	B-Organization
Verlag	I-Organization
Berlin	E-Organization
.	O
Among	O
many	O
other	O
culprits	O
of	O
contagiousness	O
,	O
malnutrition	O
,	O
even	O
if	O
distantly	O
,	O
also	O
contributed	O
to	O
such	O
an	O
immense	O
loss	O
in	O
European	O
population	O
,	O
since	O
it	O
weakened	O
immune	O
systems	O
.	O

The	O
WHO	S-Organization
guidelines	O
advise	O
to	O
distinguish	O
non-inflammatory	B-Disease
arthralgia	E-Disease
from	O
inflammatory	B-Disease
arthritis	E-Disease
.	O
With	O
regard	O
to	O
ocular	O
problems	O
,	O
sensitivity	B-Phenotype
to	I-Phenotype
light	E-Phenotype
and	O
have	O
been	O
indicated	O
among	O
survivors	O
.	O

For	O
example	O
,	O
in	O
2008	O
,	O
over	O
1000	O
novel	O
compounds	O
were	O
isolated	O
from	O
marine	O
micro-organisms	O
(Ref)	O
.	O

An	O
especially	O
virulent	B-Pathogen
strain	E-Pathogen
(codenamed	O
India-1967	S-Pathogen
or	O
India-1	S-Pathogen
)	O
was	O
brought	O
from	O
India	S-Location
in	O
1967	O
by	O
a	O
special	O
Soviet	S-Organization
medical	O
team	O
that	O
was	O
sent	O
to	O
to	O
help	O
eradicate	O
the	O
virus	O
.	O

No	O
deaths	O
are	O
known	O
to	O
have	O
resulted	O
from	O
this	O
program	O
.	O

At	O
the	O
conclusion	O
of	O
the	O
war	O
,	O
Soviet	S-Organization
troops	O
invading	O
Manchuria	S-Location
captured	O
many	O
Unit	B-Organization
731	E-Organization
Japanese	O
scientists	O
and	O
learned	O
of	O
their	O
extensive	O
human	O
experimentation	O
through	O
captured	O
documents	O
and	O
prisoner	O
interrogations	O
.	O

In	O
general	O
,	O
the	O
grade	O
order	O
of	O
most	O
biological	O
agents	O
of	O
laboratory	B-Document
biosafety	I-Document
category	I-Document
list	E-Document
and	O
biodefense	B-Document
category	I-Document
lists	E-Document
was	O
found	O
to	O
be	O
consistent	O
.	O

The	O
material	O
mistakenly	O
transferred	O
during	O
procedures	O
for	O
this	O
study	O
was	O
on	O
a	O
sealed	O
plate	O
but	O
should	O
not	O
have	O
been	O
moved	O
from	O
the	O
BSL-4	S-Platform
laboratory	O
into	O
the	O
laboratory	O
.	O

Biological	O
agents	O
can	O
be	O
spread	O
through	O
the	O
air	O
,	O
water	O
,	O
or	O
in	O
food	O
.	O

One	O
of	O
the	O
many	O
different	O
strategies	O
developed	O
since	O
the	O
early	O
2000s	O
is	O
based	O
on	O
radial	B-Technology
FLASH	I-Technology
MRI	E-Technology
,	O
and	O
iterative	O
reconstruction	O
.	O

These	O
researchers	O
report	O
that	O
they	O
were	O
able	O
to	O
successfully	O
treat	O
a	O
severe	O
liver	B-Disease
infection	E-Disease
in	O
a	O
15-year-old	O
using	O
bacteriophages	O
that	O
ate	O
the	O
specific	O
bacteria	O
that	O
had	O
been	O
causing	O
serious	O
harm	O
.	O

In	O
addition	O
,	O
a	O
Japanese	O
journalist	O
claims	O
to	O
have	O
seen	O
similar	O
evidence	O
of	O
a	O
Soviet	O
disinformation	O
campaign	O
and	O
that	O
the	O
evidence	O
supporting	O
its	O
occurrence	O
was	O
faked	O
.	O

The	O
10	O
countries	O
where	O
global	B-International_exchange_and_cooperation
health	I-International_exchange_and_cooperation
security	E-International_exchange_and_cooperation
will	O
remain	O
are:	O
India	S-Organization
,	O
Thailand	S-Organization
,	O
Vietnam	S-Organization
,	O
Kenya	S-Organization
,	O
Uganda	S-Organization
,	O
Liberia	S-Organization
,	O
Nigeria	S-Organization
,	O
Senegal	S-Organization
,	O
Jordan	S-Organization
and	O
Guatemala	S-Organization
.	O
The	O
hopes	O
funding	O
for	O
preventive	O
work	O
in	O
the	O
other	O
39	O
countries	O
would	O
transition	O
to	O
outside	O
or	O
private	O
companies	O
.	O

Yersinia	B-Pathogen
pestis	E-Pathogen
is	O
also	O
responsible	O
for	O
an	O
epidemic	O
that	O
began	O
in	O
southern	O
China	S-Location
in	O
1865	O
,	O
eventually	O
spreading	O
to	O
India	S-Location
.	O
The	O
investigation	O
of	O
the	O
pathogen	O
that	O
caused	O
the	O
19th-century	O
plague	S-Disease
was	O
begun	O
by	O
teams	O
of	O
scientists	O
who	O
visited	O
Hong	B-Location
Kong	E-Location
in	O
1894	O
,	O
among	O
whom	O
was	O
the	O
French-Swiss	O
bacteriologist	O
,	O
after	O
whom	O
the	O
pathogen	O
was	O
named	O
.	O

There	O
is	O
no	O
short	O
answer	O
to	O
the	O
question	O
of	O
how	O
synthetic	B-Technology
biology	E-Technology
should	O
be	O
regulated	O
.	O

The	O
also	O
recommends	O
that	O
individuals	O
wash	O
hands	O
often	O
with	O
soap	O
and	O
water	O
for	O
at	O
least	O
20	O
seconds	O
,	O
especially	O
after	O
going	O
to	O
the	O
toilet	O
or	O
when	O
hands	O
are	O
visibly	O
dirty	O
,	O
before	O
eating	O
and	O
after	O
blowing	O
one's	O
nose	O
,	O
coughing	O
or	O
sneezing	O
.	O

The	O
U.S.	B-Organization
Army	I-Organization
for	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
has	O
suspended	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
and	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
()	O
operations	O
while	O
conducting	O
repairs	O
to	O
its	O
waste	O
treatment	O
plant	O
.	O

While	O
the	O
first	O
true	O
vaccine	O
for	O
smallpox	S-Pathogen
was	O
not	O
invented	O
until	O
1796	O
,	O
the	O
practice	O
of	O
deliberately	O
inoculating	O
people	O
with	O
a	O
mild	O
form	O
of	O
the	O
disease	O
was	O
established	O
decades	O
earlier	O
.	O

In	O
1964	O
,	O
research	O
programs	O
studied	O
Enterotoxin	B-Pathogen
type	I-Pathogen
B	E-Pathogen
,	O
which	O
can	O
cause	O
food	B-Disease
poisoning	E-Disease
.	O
New	O
research	O
initiatives	O
also	O
included	O
prophylaxis	O
,	O
the	O
preventive	O
treatment	O
of	O
diseases	O
.	O

As	O
of	O
2007	O
in	O
the	O
United	B-Location
States	E-Location
a	O
proportion	O
of	O
are	O
performed	O
unnecessarily	O
.	O

To	O
evaluate	O
the	O
immuno-reactivity	O
of	O
Travelan®	S-Drug
60	O
clinical	O
isolates	O
of	O
each	O
bacteria	O
,	O
Campylobacter	S-Pathogen
,	O
ETEC	S-Pathogen
,	O
and	O
Shigella	S-Pathogen
,	O
were	O
tested	O
by	O
a	O
Western	O
blot	O
analysis	O
.	O

This	O
is	O
typically	O
done	O
via	O
a	O
process	O
of	O
"	O
windowing",	O
which	O
maps	O
a	O
range	O
(the	O
"	O
window")	O
of	O
pixel	O
values	O
to	O
a	O
grayscale	O
ramp	O
.	O

The	O
increased	O
use	O
of	O
CT	S-Equipment
scans	O
has	O
been	O
the	O
greatest	O
in	O
two	O
fields:	O
screening	O
of	O
adults	O
(screening	O
CT	S-Equipment
of	O
the	O
lung	O
in	O
smokers	O
,	O
virtual	O
colonoscopy	O
,	O
CT	S-Equipment
cardiac	O
screening	O
,	O
and	O
whole-body	O
CT	S-Equipment
in	O
asymptomatic	O
patients)	O
and	O
CT	S-Equipment
imaging	O
of	O
children	O
.	O

Slovenia	S-Organization
is	O
a	O
small	O
country	O
and	O
a	O
new	O
Member	O
State	O
.	O

The	O
1950s	O
to	O
1970s	O
represented	O
the	O
golden	O
age	O
of	O
antibiotic	O
discovery	O
,	O
where	O
countless	O
new	O
classes	O
of	O
antibiotics	O
were	O
discovered	O
to	O
treat	O
previously	O
incurable	O
diseases	O
such	O
as	O
tuberculosis	S-Disease
and	O
.	O
However	O
,	O
since	O
that	O
time	O
the	O
discovery	O
of	O
new	O
classes	O
of	O
antibiotics	O
has	O
been	O
almost	O
nonexistent	O
,	O
and	O
represents	O
a	O
situation	O
that	O
is	O
especially	O
problematic	O
considering	O
the	O
resiliency	O
of	O
bacteria	O
shown	O
over	O
time	O
and	O
the	O
continued	O
misuse	O
and	O
overuse	O
of	O
antibiotics	O
in	O
treatment	O
.	O

Many	O
diseases	O
have	O
a	O
basis	O
in	O
our	O
DNA	O
,	O
and	O
until	O
recently	O
,	O
doctors	O
had	O
very	O
few	O
tools	O
to	O
address	O
the	O
root	O
causes	O
.	O

Primary	O
hazards	O
to	O
personnel	O
working	O
with	O
these	O
agents	O
relate	O
to	O
accidental	O
percutaneous	O
or	O
mucous	O
membrane	O
exposures	O
,	O
or	O
ingestion	O
of	O
infectious	O
materials	O
.	O

Considering	O
the	O
extreme	O
danger	O
that	O
smallpox	S-Pathogen
poses	O
to	O
a	O
now	O
largely	O
unvaccinated	O
human	O
population	O
,	O
it	O
seems	O
at	O
least	O
questionable	O
to	O
make	O
the	O
smallpox	S-Pathogen
sequence	O
available	O
on	O
.	O

The	O
CDC	S-Organization
advisory	O
committee	O
is	O
expected	O
to	O
revisit	O
these	O
measures	O
and	O
vote	O
on	O
options	O
at	O
its	O
meeting	O
Wednesday	O
.	O

Clearly	O
suggesting	O
that	O
the	O
WHO	S-Organization
is	O
free	O
to	O
do	O
as	O
it	O
sees	O
fit	O
on	O
nuclear	O
,	O
radiation	O
and	O
other	O
matters	O
which	O
relate	O
to	O
health	O
.	O

The	O
unprecedented	O
infestation	O
has	O
required	O
that	O
232	O
square	O
miles	O
of	O
primarily	O
residential	O
neighborhoods	O
in	O
Los	B-Location
Angeles	E-Location
and	O
Orange	S-Location
counties	O
receive	O
one	O
or	O
two	O
aerial	O
sprays	O
of	O
malathion	S-Drug
from	O
low-flying	O
helicopters	O
.	O

"	O
Emerging	O
infectious	O
diseases	O
affect	O
developing	O
countries	O
,	O
but	O
they	O
also	O
affect	O
wealthy	O
countries	O
.	O

It	O
allows	O
large	O
numbers	O
of	O
small	O
organizations	O
and	O
individuals	O
to	O
participate	O
in	O
research	O
and	O
development	O
,	O
with	O
spreading	O
knowledge	O
a	O
higher	O
priority	O
than	O
turning	O
profits.	O
.	O

With	O
the	O
aid	O
of	O
Anticalin®	B-Technology
technology	E-Technology
,	O
which	O
was	O
developed	O
by	O
his	O
department	O
,	O
he	O
and	O
his	O
team	O
were	O
able	O
to	O
reconstruct	O
the	O
body's	O
own	O
siderocalin	O
.	O

The	O
first	O
isolate	O
,	O
E.	B-Pathogen
coli	I-Pathogen
24213-18	E-Pathogen
was	O
sequenced	O
by	O
using	O
a	O
Pacific	B-Equipment
Biosciences	I-Equipment
Sequel	I-Equipment
Sequencer	E-Equipment
comExternal	O
Link)	O
and	O
uploaded	O
to	O
GenBank	S-Platform
(BioSample	O
SAMN11230749)	O
.	O

Additionally	O
,	O
cheese	O
lovers	O
may	O
be	O
interested	O
to	O
know	O
that	O
rDNA	O
provides	O
ingredients	O
for	O
a	O
majority	O
of	O
hard	O
cheeses	O
produced	O
in	O
the	O
West	O
.	O

In	O
February	O
the	O
Institute	B-Organization
for	I-Organization
Disease	I-Organization
Modeling	E-Organization
estimated	O
the	O
IFR	O
as	O
0.	O
94%	O
(95%	O
confidence	O
interval	O
0.37–2.	O
9)	O
,	O
based	O
on	O
data	O
from	O
China	S-Location
.	O
The	O
University	B-Organization
of	I-Organization
Oxford's	I-Organization
Centre	I-Organization
for	I-Organization
Evidence-Based	I-Organization
Medicine	E-Organization
()	O
estimated	O
a	O
global	O
CFR	O
of	O
0.8	O
to	O
9.	O
6	O
percent	O
(last	O
revised	O
30	O
April)	O
and	O
IFR	O
of	O
0.	O
10	O
percent	O
to	O
0.	O
41	O
percent	O
(last	O
revised	O
2May)	O
,	O
acknowledging	O
that	O
this	O
will	O
vary	O
between	O
populations	O
due	O
to	O
differences	O
in	O
demographics	O
.	O

This	O
isolate	O
belonged	O
to	O
sequence	O
type	O
167	O
(ST167)	O
.	O

between	O
about	O
8,870	O
and	O
18,300	O
2009	B-Disease
H1N1	E-Disease
deaths	O
occurred	O
between	O
April	O
2009	O
and	O
10	O
April	O
2010	O
.	O

US	S-Location
oil	O
prices	O
turn	O
negative	O
as	O
demand	O
dries	O
up	O
,	O
,	O
21	O
April	O
2020	O
.	O

Symptoms	O
included	O
eye	B-Phenotype
pain	E-Phenotype
,	O
blurred	B-Phenotype
vision	E-Phenotype
,	O
hearing	B-Phenotype
loss	E-Phenotype
,	O
difficulty	B-Phenotype
swallowing	E-Phenotype
,	O
difficulty	B-Phenotype
sleeping	E-Phenotype
,	O
arthralgias	S-Phenotype
,	O
,	O
and	O
"	O
various	O
constitutional	O
symptoms	O
controlling	O
for	O
age	O
and	O
sex"	O
.	O

The	O
plant-based	B-Vaccine
vaccine	E-Vaccine
production	O
method	O
works	O
by	O
isolating	O
a	O
specific	O
antigen	O
protein	O
that	O
triggers	O
a	O
human	O
immune	O
response	O
from	O
the	O
targeted	O
virus	O
.	O

A	O
report	O
published	O
in	O
2016	O
in	O
the	O
Journal	O
of	O
the	O
Chinese	B-Organization
Medical	I-Organization
Association	E-Organization
found	O
evidence	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
had	O
been	O
circulating	O
in	O
the	O
European	O
armies	O
for	O
months	O
and	O
possibly	O
years	O
before	O
the	O
1918	O
pandemic	O
.	O

By	O
testing	O
the	O
accuracy	O
and	O
specificity	O
of	O
commercially	O
available	O
systems	O
used	O
by	O
first	O
responders	O
,	O
the	O
hope	O
is	O
that	O
all	O
biologically	O
harmful	O
powders	O
can	O
be	O
rendered	O
ineffecti	O
ve.	B-Organization
United	I-Organization
States.Cong.H	E-Organization
ourity	O
.	O

The	O
same	O
report	O
predicted	O
that	O
total	O
cases	O
,	O
including	O
unreported	O
cases	O
,	O
could	O
reach	O
1.	O
4	O
million	O
in	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
by	O
the	O
end	O
of	O
January	O
2015	O
if	O
no	O
improvement	O
in	O
intervention	O
or	O
community	O
behaviour	O
occurred	O
.	O

Usually	O
in-house	O
solutions	O
are	O
developed	O
,	O
and	O
the	O
total	O
number	O
of	O
staff	O
working	O
in	O
this	O
field	O
is	O
limited	O
.	O

Human	O
infections	O
most	O
commonly	O
result	O
from	O
the	O
ingestion	O
of	O
undercooked	O
meat	O
or	O
raw	O
milk	O
-	O
but	O
the	O
bacteria	O
can	O
also	O
enter	O
the	O
body	O
through	O
the	O
lungs	O
or	O
skin	O
wounds.	O
are	O
not	O
typically	O
transmitted	O
from	O
person	O
to	O
person	O
.	O

"	O
How	O
do	O
you	O
create	O
incentives	O
in	O
the	O
private	O
sector	O
to	O
develop	O
medical	O
countermeasures	O
when	O
there	O
may	O
not	O
be	O
a	O
market	O
unless	O
there	O
is	O
a	O
crisis?	O
"	O
asked	O
co-chair	O
of	O
the	O
panel	O
and	O
former	O
U.S.Sen	O
.	O

While	O
DIPSBC	S-Platform
has	O
the	O
BioModels	O
database	O
indexed	O
by	O
its	O
search	O
engine	O
and	O
the	O
potential	O
of	O
Gaggle	S-Platform
to	O
integrate	O
modeling	O
is	O
demonstrated	O
in	O
preliminary	O
versions	O
of	O
the	O
Systems	O
biology	O
knowledgebase	O
Kbase	O
framework	O
-	O
SysMO-SEEK	S-Platform
provides	O
the	O
highest	O
level	O
of	O
modeling	O
support	O
in	O
the	O
systems	O
compared:	O
integration	O
of	O
JWS-Online	O
,	O
functionality	O
to	O
link	O
data	O
and	O
models	O
and	O
to	O
plot	O
experimental	O
and	O
simulated	O
data	O
coherently	O
.	O

At	O
the	O
end	O
of	O
1969	O
,	O
likely	O
prompted	O
by	O
Vietnam	O
War	O
protests	O
,	O
President	O
Richard	B-Person
Nixon	E-Person
terminated	O
the	O
offensive	O
biological	O
warfare	O
program	O
and	O
ordered	O
all	O
stockpiled	O
weapons	O
destroyed	O
.	O

This	O
would	O
apply	O
to	O
research	O
conducted	O
by	O
and	O
funded	O
by	O
federal	O
research	O
agencies	O
.	O

After	O
two	O
months	O
of	O
being	O
Ebola	S-Disease
a	O
new	O
case	O
was	O
confirmed	O
on	O
20	O
November	O
2015	O
,	O
when	O
a	O
15-year-old	O
boy	O
was	O
diagnosed	O
with	O
the	O
virus	O
and	O
two	O
family	O
members	O
subsequently	O
tested	O
positive	O
as	O
well	O
.	O

Viral	O
infectious	O
diseases	O
often	O
arise	O
in	O
animals	O
.	O

Since	O
1980s	O
,	O
laboratories	O
have	O
applied	O
fundamental	O
guidelines	O
in	O
activities	O
associated	O
with	O
blood	O
borne	O
pathogens	O
.	O

Established	O
a	O
review	O
group	O
,	O
under	O
the	O
direction	O
of	O
CDC	S-Organization
Associate	O
Director	O
for	O
Science	O
,	O
to	O
look	O
at	O
the	O
systems	O
,	O
procedures	O
,	O
and	O
personnel	O
issues	O
leading	O
to	O
this	O
event	O
and	O
means	O
of	O
preventing	O
similar	O
events	O
in	O
the	O
future	O
.	O

While	O
experts	O
have	O
studied	O
the	O
mortality	O
rates	O
of	O
different	O
treatment	O
settings	O
,	O
and	O
given	O
the	O
wide	O
differences	O
in	O
variables	O
that	O
affected	O
outcomes	O
,	O
adequate	O
information	O
had	O
not	O
yet	O
been	O
gathered	O
to	O
make	O
a	O
definitive	O
statement	O
about	O
what	O
constituted	O
optimal	O
care	O
in	O
the	O
setting	O
.	O

The	O
ASPR	B-Organization
office	E-Organization
needs	O
to	O
change	O
to	O
meet	O
these	O
threats.	O
"	O
The	O
decision	O
to	O
move	O
the	O
stockpile	O
,	O
I	O
think	O
,	O
was	O
just	O
a	O
natural	O
one,	O
"	O
said	O
.	O

The	O
density	O
of	O
ACE2	O
in	O
each	O
tissue	O
correlates	O
with	O
the	O
severity	O
of	O
the	O
disease	O
in	O
that	O
tissue	O
and	O
some	O
have	O
suggested	O
decreasing	O
ACE2	O
activity	O
might	O
be	O
protective	O
,	O
though	O
another	O
view	O
is	O
that	O
increasing	O
ACE2	O
using	O
could	O
be	O
protective	O
.	O

They	O
infect	O
the	O
cells	O
with	O
different	O
titrations	O
of	O
HSV‐1	S-Pathogen
virus	O
in	O
a	O
biological	O
hood	O
under	O
the	O
same	O
conditions	O
described	O
in	O
the	O
second	O
lab	O
settings	O
(lab3	O
,	O
Table	O
1)	O
.	O

Approximately	O
of	O
could	O
be	O
produced	O
in	O
a	O
few	O
days	O
.	O

In	O
2011	O
,	O
the	O
NDM-5	O
carbapenemase	O
was	O
described	O
in	O
an	O
isolate	O
of	O
E.	B-Pathogen
coli	I-Pathogen
(ST648)	E-Pathogen
from	O
a	O
human	O
in	O
the	O
United	B-Location
Kingdom	E-Location
who	O
was	O
previously	O
hospitalized	O
in	O
Goa	S-Location
,	O
India	S-Location
(6)	O
.	O

Despite	O
those	O
developments	O
,	O
investigators	O
were	O
not	O
yet	O
ready	O
to	O
declare	O
a	O
dead	O
end	O
to	O
the	O
investigation	O
.	O

Commonly	O
,	O
agents	O
included	O
in	O
a	O
high	O
laboratory	O
biosafety	O
category	O
(such	O
as	O
Variola	B-Pathogen
major	E-Pathogen
,	O
Ebola	B-Pathogen
virus	E-Pathogen
and	O
Marburg	B-Pathogen
virus	E-Pathogen
)	O
were	O
categorized	O
accordingly	O
at	O
the	O
higher	O
biological	O
defense	O
level	O
and	O
those	O
categorized	O
at	O
lower	O
laboratory	O
biosafety	O
levels	O
(such	O
as	O
Salmonella	S-Pathogen
and	O
Shigella	S-Pathogen
)	O
were	O
also	O
included	O
categorized	O
at	O
lower	O
biodefense	O
levels	O
.	O

In	O
the	O
summer	O
of	O
2017	O
60	O
people	O
with	O
Hepatitis	B-Disease
A	E-Disease
were	O
admitted	O
to	O
hospital	O
in	O
the	O
city	O
of	O
,	O
the	O
cause	O
of	O
this	O
outbreak	O
is	O
still	O
unknown	O
.	O

The	O
kits	O
included	O
protective	O
clothing	O
,	O
hydration	O
items	O
,	O
medicines	O
,	O
and	O
disinfectant	O
,	O
among	O
other	O
items	O
.	O

XperimentR	S-Platform
's	O
web	O
approach	O
is	O
only	O
feasible	O
for	O
smaller	O
projects	O
,	O
for	O
large-scale	O
projects	O
a	O
distribution	O
of	O
the	O
software	O
would	O
be	O
desirable	O
.	O

In	O
,	O
there	O
is	O
evidence	O
that	O
the	O
ban	O
has	O
led	O
to	O
a	O
lower	O
prevalence	O
of	O
antibiotic	O
resistance	O
in	O
(nonhazardous)	O
animal	O
bacterial	O
populations	O
.	O

So	O
the	O
procedure	O
that	O
they	O
put	O
in	O
place	O
in	O
2006	O
was	O
appropriate	O
,	O
but	O
they	O
didn't	O
go	O
deep	O
enough	O
in	O
terms	O
of	O
outlining	O
,	O
all	O
right	O
,	O
how	O
do	O
we	O
make	O
sure	O
if	O
this	O
had	O
happened	O
,	O
that	O
we	O
don't	O
just	O
prevent	O
this	O
but	O
everything	O
like	O
this	O
from	O
happening	O
in	O
that	O
laboratory	O
.	O

At	O
HHS	S-Organization
there	O
already	O
is	O
such	O
a	O
fund	O
,	O
according	O
to	O
Kadlec	S-Person
,	O
who	O
said	O
it	O
currently	O
has	O
$57,000	O
in	O
it	O
.	O

"	O
They	O
were	O
able	O
to	O
vaccinate	O
thousands	O
of	O
children	O
in	O
four	O
hours,	O
"	O
said	O
Matthew	B-Person
Shearer	E-Person
Observatory	S-Scientific_research_project
project	O
manager	O
,	O
about	O
that	O
country's	O
equivalent	O
to	O
the	O
.	O

"	O
This	O
outbreak	O
did	O
not	O
have	O
enough	O
cases	O
,	O
thank	O
God	O
,	O
to	O
clarify	O
"	O
hints	O
that	O
the	O
strain	O
was	O
unusually	O
potent	O
,	O
Dr	O
.	O

Hall	S-Person
noted	O
that	O
even	O
full-scale	O
production	O
doesn't	O
mean	O
there	O
will	O
be	O
an	O
immunization	O
campaign	O
.	O

The	O
1918	B-Incident
influenza	I-Incident
pandemic	E-Incident
had	O
another	O
unique	O
feature	O
,	O
the	O
simultaneous	O
(or	O
nearly	O
simultaneous)	O
infection	O
of	O
humans	O
and	O
swine	O
.	O

Thank	O
you	O
for	O
taking	O
my	O
question	O
.	O

A	O
lack	O
of	O
does	O
not	O
verify	O
someone	O
is	O
disease	O
free	O
.	O

The	O
Geneva	B-Document
Protocol	E-Document
had	O
encountered	O
opposition	O
in	O
the	O
U.S.	B-Organization
Senate	E-Organization
,	O
in	O
part	O
due	O
to	O
strong	O
lobbying	O
against	O
it	O
by	O
the	O
Chemical	B-Organization
Warfare	I-Organization
Service	E-Organization
,	O
and	O
it	O
was	O
never	O
brought	O
to	O
the	O
floor	O
for	O
a	O
vote	O
when	O
originally	O
introduced	O
.	O

The	O
peak	O
and	O
ultimate	O
duration	O
of	O
the	O
outbreak	O
are	O
uncertain	O
and	O
may	O
differ	O
by	O
location	O
.	O

Schools	O
,	O
universities	O
,	O
and	O
colleges	O
have	O
been	O
closed	O
either	O
on	O
a	O
nationwide	O
or	O
local	O
basis	O
in	O
countries	O
,	O
affecting	O
approximately	O
percent	O
of	O
the	O
world's	O
student	O
population	O
.	O

Case-fatality	O
rates	O
were	O
&gt;2.	O
5%	O
,	O
compared	O
to	O
&lt;0.	O
1%	O
in	O
luenza	O
pandemics	O
(,)	O
.	O

An	O
international	O
conference	O
held	O
this	O
week	O
in	O
Atlanta	S-Location
hosted	O
by	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
and	O
the	O
,	O
sought	O
to	O
provide	O
a	O
space	O
for	O
the	O
exchange	O
of	O
information	O
related	O
to	O
infectious	O
diseases	O
.	O

Follow	O
all	O
appropriate	O
guidelines	O
for	O
the	O
use	O
and	O
handling	O
of	O
pathogenic	O
microorganisms	O
.	O

Iran's	B-Organization
Health	I-Organization
Ministry	E-Organization
announced	O
the	O
cancellation	O
of	O
Friday	O
prayers	O
in	O
areas	O
affected	O
by	O
the	O
outbreak	O
and	O
shrines	O
were	O
later	O
closed	O
,	O
while	O
Saudi	B-Organization
Arabia	E-Organization
banned	O
the	O
entry	O
of	O
foreign	O
pilgrims	O
as	O
well	O
as	O
its	O
residents	O
to	O
holy	O
sites	O
in	O
Mecca	S-Location
and	O
.	O

The	O
WHO	S-Organization
has	O
recommended	O
healthy	O
people	O
wear	O
masks	S-Equipment
only	O
if	O
they	O
are	O
at	O
high	O
risk	O
,	O
such	O
as	O
those	O
who	O
are	O
caring	O
for	O
a	O
person	O
with	O
COVID-19	S-Disease
.	O
China	S-Location
and	O
the	O
United	B-Location
States	E-Location
,	O
among	O
other	O
countries	O
,	O
have	O
encouraged	O
the	O
use	O
of	O
face	B-Equipment
masks	E-Equipment
or	O
cloth	O
face	O
coverings	O
more	O
generally	O
by	O
members	O
of	O
the	O
public	O
to	O
limit	O
the	O
spread	O
of	O
the	O
virus	O
by	O
asymptomatic	O
individuals	O
as	O
a	O
precautionary	O
principle	O
.	O

Students	O
titrate	O
bacteriophage	O
Lambda	O
after	O
the	O
induction	O
of	O
a	O
lysogenic	O
E.	B-Pathogen
coli	E-Pathogen
harboring	O
a	O
temperature‐sensitive	O
(ts)	O
mutant	O
,	O
Lambda	O
prophage	O
.	O

On	O
28	O
February	O
,	O
WHO	S-Organization
officials	O
said	O
the	O
coronavirus	S-Pathogen
threat	O
assessment	O
at	O
the	O
global	O
level	O
would	O
be	O
raised	O
from	O
"	O
high"	O
to	O
"	O
very	O
high"	O
,	O
its	O
highest	O
level	O
of	O
alert	O
and	O
risk	O
assessment	O
.	O

1947:	O
The	O
WHO	S-Organization
established	O
an	O
epidemiological	B-Platform
information	I-Platform
service	E-Platform
via	O
telex	O
,	O
and	O
by	O
1950	O
a	O
mass	O
tuberculosis	S-Disease
inoculation	O
drive	O
using	O
the	O
was	O
under	O
way	O
.	O

In	O
March	O
2013	O
,	O
the	O
Saudi	B-Organization
Arabia	I-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
reported	O
the	O
death	O
of	O
a	O
39-year-old	O
man	O
,	O
the	O
15th	O
case	O
and	O
9th	O
death	O
reported	O
to	O
WHO	S-Organization
.	O
On	O
2	O
May	O
2013	O
,	O
the	O
Saudi	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
announced	O
five	O
people	O
died	O
and	O
two	O
other	O
people	O
were	O
in	O
critical	O
condition	O
with	O
confirmed	O
cases	O
of	O
a	O
SARS	S-Disease
-like	O
virus	O
.	O

Carried	O
by	O
twelve	O
Genoese	O
galleys	O
,	O
plague	S-Disease
arrived	O
by	O
ship	O
in	O
Sicily	S-Location
in	O
October	O
1347;Michael	O
of	O
Piazza	O
(Platiensis)	O
Bibliotheca	O
scriptorum	O
qui	O
res	O
in	O
Sicilia	S-Location
gestas	O
retulere	O
Vol	O
1	O
,	O
p.	O
562	O
,	O
cited	O
in	O
Ziegler	S-Person
,	O
1998	O
,	O
p.40.	O
the	O
plague	O
spread	O
rapidly	O
all	O
over	O
the	O
island	O
.	O

The	O
Fiscal	B-Document
Year	I-Document
2019	I-Document
President's	I-Document
Budget	E-Document
proposes	O
additional	O
resources	O
for	O
,	O
and	O
emphasizes	O
the	O
importance	O
of	O
strengthening	O
countries'	O
ability	O
to	O
prevent	O
,	O
detect	O
,	O
and	O
respond	O
to	O
infectious	O
disease	O
threats	O
.	O

Thus	O
,	O
to	O
benefit	O
from	O
GMOs	O
,	O
has	O
to	O
revise	O
its	O
biosafety	O
system	O
,	O
primarily	O
by	O
making	O
changes	O
to	O
some	O
provisions	O
of	O
the	O
law	O
in	O
a	O
way	O
that	O
balances	O
its	O
diverse	O
interests	O
of	O
conserving	O
biodiversity	O
,	O
protecting	O
the	O
environment	O
and	O
enhancing	O
competition	O
in	O
agricultural	O
and	O
other	O
economic	O
sectors	O
.	O

A	O
specific	O
distinction	O
was	O
made	O
between	O
somatic	O
cells	O
,	O
where	O
the	O
effects	O
of	O
edits	O
are	O
limited	O
to	O
a	O
single	O
individual	O
,	O
and	O
germline	O
cells	O
,	O
where	O
genome	O
changes	O
can	O
be	O
inherited	O
by	O
descendants	O
.	O

The	O
virus	O
was	O
isolated	O
in	O
contaminated	O
drinking	O
water	O
.	O

This	O
paper	O
describes	O
the	O
setting	O
up	O
of	O
a	O
SECOA	S-Scientific_research_project
metadata	O
repository	O
for	O
non-specialist	O
researchers	O
such	O
as	O
environmental	O
scientists	O
and	O
tourism	O
experts	O
.	O

Their	O
attempts	O
to	O
influence	O
the	O
election	O
included	O
the	O
"	O
Share-a-Home"	O
program	O
,	O
in	O
which	O
they	O
transported	O
thousands	O
of	O
homeless	O
people	O
to	O
Rajneeshpuram	S-Location
and	O
attempted	O
to	O
register	O
them	O
to	O
vote	O
to	O
inflate	O
the	O
constituency	O
of	O
voters	O
for	O
the	O
group's	O
candidates	O
.	O

On	O
4May	O
,	O
it	O
was	O
announced	O
that	O
the	O
Nightingale	B-Organization
Hospital	E-Organization
in	O
London	S-Location
would	O
be	O
placed	O
on	O
standby	O
and	O
remaining	O
patients	O
transferred	O
to	O
other	O
facilities	O
.	O

Some	O
people	O
mistakenly	O
believe	O
that	O
taking	O
any	O
kind	O
of	O
antibiotics	O
acts	O
as	O
a	O
sort	O
of	O
panacea	O
,	O
and	O
they	O
use	O
these	O
drugs	O
to	O
treat	O
illnesses	O
such	O
as	O
influenza	S-Disease
However	O
,	O
antibiotics	O
can	O
only	O
target	O
and	O
kill	O
bacteria	O
and	O
thus	O
only	O
treat	O
bacterial	O
infections	O
.	O

BSL‐1	S-Platform
is	O
appropriate	O
for	O
working	O
with	O
microorganisms	O
that	O
are	O
not	O
known	O
to	O
cause	O
disease	O
in	O
healthy	O
humans	O
.	O

They	O
concluded	O
that	O
"	O
the	O
salicylate	O
[	O
aspirin	S-Drug
poisoning	O
hypothesis	O
[was]	O
difficult	O
to	O
sustain	O
as	O
the	O
primary	O
explanation	O
for	O
the	O
unusual	O
virulence	O
of	O
the	O
1918–1919	B-Incident
influenza	I-Incident
pandemic	E-Incident
"	O
.	O
In	O
response	O
,	O
Starko	S-Person
said	O
there	O
was	O
anecdotal	O
evidence	O
of	O
aspirin	S-Drug
use	O
in	O
India	S-Location
and	O
argued	O
that	O
even	O
if	O
aspirin	S-Drug
over-prescription	O
had	O
not	O
contributed	O
to	O
the	O
high	O
Indian	O
mortality	O
rate	O
,	O
it	O
could	O
still	O
have	O
been	O
a	O
factor	O
for	O
high	O
rates	O
in	O
areas	O
where	O
other	O
exacerbating	O
factors	O
present	O
in	O
played	O
less	O
of	O
a	O
role	O
.	O

Medfly	O
sightings	O
occurred	O
in	O
Florida	S-Location
in	O
1997	O
and	O
2010	O
.	O

Coalition	O
troops	O
trained	O
with	O
protective	O
gear	O
and	O
stockpiled	O
the	O
antibiotic	O
ciprofloxacin	S-Drug
for	O
use	O
as	O
post-exposure	O
prophylaxis	O
against	O
anthrax	S-Pathogen
.	O
Approximately	O
150,000	O
US	S-Location
troops	O
received	O
the	O
U.S.	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
–licensed	O
anthrax	S-Pathogen
vaccine	O
(	O
BioThrax	S-Vaccine
)	O
,	O
and	O
8,000	O
received	O
a	O
botulinum	B-Vaccine
toxoid	I-Vaccine
vaccine	E-Vaccine
also	O
approved	O
by	O
the	O
FDA	O
as	O
an	O
investigational	O
new	O
drug	O
.	O

The	O
report	O
led	O
to	O
lobbying	O
by	O
the	O
sugar	O
industry	O
against	O
the	O
recommendation	O
,	O
to	O
which	O
the	O
WHO	S-Organization
/	O
responded	O
by	O
including	O
the	O
following	O
statement	O
in	O
the	O
report:	O
"	O
The	O
Consultation	O
recognized	O
that	O
a	O
population	O
goal	O
for	O
free	O
sugars	O
of	O
less	O
than	O
10%	O
of	O
total	O
energy	O
is	O
controversial"	O
.	O

PREEMPT	S-Scientific_research_project
aims	O
to	O
prevent	O
transmission	O
of	O
virus	O
from	O
a	O
reservoir	O
species	O
direct	O
to	O
humans	O
,	O
from	O
a	O
reservoir	O
species	O
to	O
traditional	O
vectors	O
,	O
such	O
as	O
mosquitos	O
,	O
that	O
spread	O
disease	O
,	O
and	O
from	O
a	O
reservoir	O
species	O
to	O
a	O
species	O
intermediate	O
to	O
humans-for	O
example	O
,	O
from	O
bats	O
to	O
pigs	O
.	O

Partly	O
because	O
of	O
this	O
lack	O
of	O
definition	O
,	O
and	O
largely	O
because	O
of	O
a	O
broader	O
understanding	O
of	O
the	O
capabilities	O
of	O
the	O
life	O
sciences	O
,	O
many	O
topics	O
have	O
begun	O
to	O
fall	S-Incident
under	O
the	O
heading	O
of	O
biosecurity	O
.	O

Tom	B-Person
Inglesy	E-Person
the	O
CEO	O
and	O
director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
at	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Bloomberg	I-Organization
School	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
and	O
an	O
internationally	O
recognized	O
expert	O
on	O
public	O
health	O
preparedness	O
,	O
pandemic	O
and	O
emerging	O
infectious	O
disease	O
said	O
in	O
2017	O
that	O
the	O
lack	O
of	O
an	O
internationally	O
standardized	O
approval	O
process	O
that	O
could	O
be	O
used	O
to	O
guide	O
countries	O
in	O
conducting	O
public	O
health	O
experiments	O
for	O
resurrecting	O
a	O
disease	O
that	O
has	O
already	O
been	O
eradicated	O
increases	O
the	O
risk	O
that	O
the	O
disease	O
could	O
be	O
used	O
in	O
bioterrorism	O
.	O

Ever	O
the	O
public	O
stuntman	O
,	O
he	O
invited	O
a	O
journalist	O
to	O
document	O
the	O
procedure	O
.	O

The	O
incumbent	O
contractor	O
is	O
Vysnova	B-Organization
Partners	I-Organization
Inc	E-Organization
and	O
the	O
legacy	O
contract	O
number	O
is	O
W911QY-16-D-0058	O
.	O

The	O
meeting	O
participants	O
came	O
up	O
with	O
several	O
ideas	O
to	O
prevent	O
,	O
mitigate	O
,	O
and	O
manage	O
high-impact	O
biothreats	O
.	O

A	O
follow-up	O
study	O
done	O
in	O
September	O
2010	O
showed	O
that	O
the	O
risk	O
of	O
serious	O
illness	O
resulting	O
from	O
the	O
2009	O
H1N1	B-Disease
flu	E-Disease
was	O
no	O
higher	O
than	O
that	O
of	O
the	O
yearly	O
seasonal	B-Disease
flu	E-Disease
.	O
For	O
comparison	O
,	O
the	O
WHO	S-Organization
estimates	O
that	O
250,000	O
to	O
500,000	O
people	O
die	O
of	O
annually	O
.	O

In	O
fact	O
,	O
with	O
the	O
aid	O
of	O
former	O
Soviet	S-Organization
experts	O
and	O
inspectors	O
kept	O
at	O
bay	O
,	O
the	O
Iraqi	O
arsenal	O
is	O
likely	O
growing	O
in	O
power	O
.	O

Development	O
of	O
the	O
spherical	O
E120	O
bomblet	O
took	O
place	O
in	O
the	O
early	O
1960sCountermeasures	O
,	O
Chapter	O
6	O
–	O
An	O
Overview	O
of	O
Emerging	O
Missile	O
State	O
Countermeasures	O
,	O
p.	O
14	O
.	O

Almost	O
all	O
of	O
them	O
died	O
within	O
a	O
week	O
.	O

The	O
U.S.	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
has	O
recommended	O
that	O
the	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
's	O
Countering	B-Organization
Weapons	I-Organization
of	I-Organization
Mass	I-Organization
Destruction	I-Organization
Office	E-Organization
develop	O
a	O
plan	O
to	O
help	O
coordinate	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

Good	O
preparedness	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
PPE	S-Equipment
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
laboratory	O
sectioning	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

The	O
first	O
isolate	O
,	O
E.	B-Pathogen
coli	I-Pathogen
24213-18	E-Pathogen
was	O
sequenced	O
by	O
using	O
a	O
Pacific	B-Equipment
Biosciences	I-Equipment
Sequel	I-Equipment
Sequencer	E-Equipment
comExternal	O
Link)	O
and	O
uploaded	O
to	O
GenBank	S-Platform
(BioSample	O
SAMN11230749)	O
.	O

Despite	O
the	O
high	O
morbidity	O
and	O
mortality	O
rates	O
that	O
resulted	O
from	O
the	O
epidemic	O
,	O
the	O
Spanish	B-Disease
flu	E-Disease
began	O
to	O
fade	O
from	O
public	O
awareness	O
over	O
the	O
decades	O
until	O
the	O
arrival	O
of	O
news	O
about	O
bird	B-Disease
flu	E-Disease
and	O
other	O
pandemics	O
in	O
the	O
1990s	O
and	O
2000s	O
.	O

The	O
CRISPR	B-Technology
edits	E-Technology
are	O
not	O
always	O
perfect	O
and	O
the	O
cuts	O
can	O
end	O
up	O
in	O
the	O
wrong	O
place	O
.	O

The	O
current	O
Director-General	O
is	O
Dr.	O
,	O
who	O
was	O
appointed	O
on	O
1	O
July	O
2017	O
.	O

First	O
,	O
I've	O
issued	O
a	O
moratorium	O
on	O
CDC	S-Organization
transferring	O
any	O
biological	O
samples	O
out	O
of	O
any	O
BSL-3	S-Platform
or	O
BSL-4	S-Platform
laboratory	O
either	O
within	O
CDC	S-Organization
or	O
outside	O
of	O
CDC	S-Organization
until	O
we	O
have	O
given	O
a	O
lab-by-lab	O
assessment	O
and	O
allow	O
that	O
process	O
to	O
resume	O
.	O

Although	O
most	O
common	O
in	O
medicine	O
,	O
CT	S-Technology
is	O
also	O
used	O
in	O
other	O
fields	O
,	O
such	O
as	O
nondestructive	O
materials	O
testing	O
.	O

Contact	O
tracing	O
is	O
a	O
way	O
of	O
identifying	O
those	O
who	O
have	O
been	O
in	O
direct	O
contact	O
with	O
an	O
infected	O
individual	O
and	O
are	O
thus	O
at	O
higher	O
risk	O
of	O
becoming	O
infected	O
or	O
infecting	O
others	O
.	O

On	O
27	O
August	O
this	O
patient's	O
9-year-old	O
brother	O
developed	O
a	O
rash	S-Phenotype
and	O
fever	S-Phenotype
,	O
his	O
pediatrician	O
prescribed	O
tetracycline	S-Drug
and	O
,	O
and	O
he	O
recovered	O
.	O

Olivet	B-Person
Buck	E-Person
to	O
Germany	S-Location
for	O
experimental	O
treatment	O
after	O
she	O
contracted	O
Ebola	S-Disease
per	O
the	O
government	O
of	O
Sierra	B-Location
Leone	E-Location
's	O
request	O
.	O

Anthrax	S-Disease
is	O
caused	O
by	O
a	O
bacterium	O
--	O
--	O
that	O
can	O
persist	O
in	O
soil	O
,	O
water	O
and	O
,	O
most	O
infamously	O
,	O
long	O
journeys	O
through	O
the	O
mail	O
system	O
.	O

And	O
third	O
,	O
I've	O
directed	O
that	O
appropriate	O
disciplinary	O
action	O
be	O
taken	O
for	O
any	O
staff	O
member	O
at	O
who	O
knowingly	O
violated	O
protocols	O
or	O
who	O
failed	O
to	O
appropriately	O
report	O
a	O
lab	O
incident	O
.	O

Primary	O
barriers	O
such	O
as	O
BSCs	S-Equipment
(Class	O
I	O
or	O
II	O
;	O
see	O
appendix	O
a	O
should	O
be	O
used	O
when	O
performing	O
procedures	O
that	O
might	O
cause	O
splashing	O
,	O
spraying	O
,	O
or	O
splattering	O
of	O
droplets	O
.	O

The	O
GAO	S-Organization
study	O
came	O
about	O
in	O
response	O
to	O
concerns	O
about	O
recent	O
chemical	O
attacks	O
abroad	O
and	O
the	O
threats	O
against	O
the	O
West	O
by	O
the	O
Islamic	B-Organization
State	I-Organization
of	I-Organization
Iraq	I-Organization
and	I-Organization
Syria	E-Organization
()	O
.	O

By	O
August	O
,	O
when	O
the	O
second	O
wave	O
began	O
in	O
France	S-Location
,	O
Sierra	B-Location
Leone	E-Location
,	O
and	O
the	O
,	O
the	O
virus	O
had	O
mutated	O
to	O
a	O
much	O
more	O
deadly	O
form	O
.	O

Dengue	S-Disease
,	O
a	O
vector-borne	O
disease	O
usually	O
carried	O
by	O
mosquitoes	O
,	O
killed	O
158	O
people	O
that	O
year	O
in	O
Cuba	S-Location
,	O
including	O
101	O
children	O
under	O
15	O
.	O

He	O
said	O
he	O
managed	O
to	O
acquire	O
over	O
100,000	O
pages	O
of	O
documents	O
about	O
the	O
research	O
done	O
at	O
the	O
Richard	B-Organization
Lugar	I-Organization
Center	I-Organization
for	I-Organization
Public	I-Organization
Health	E-Organization
.	O
The	O
biomedical	O
facility	O
was	O
opened	O
near	O
capital	O
,	O
Tbilisi	S-Organization
in	O
2011	O
and	O
is	O
officially	O
part	O
of	O
a	O
network	O
of	O
labs	O
studying	O
various	O
infectious	O
diseases	O
.	O

The	O
generator	O
,	O
water	O
supplying	O
unit	O
and	O
incineration	O
units	O
are	O
located	O
outside	O
the	O
building	O
.	O

The	O
second	O
recurrence	O
peaked	O
in	O
late	O
spring	O
1891	O
(more	O
than	O
a	O
year	O
after	O
the	O
first	O
pandemic	O
appearance)	O
and	O
the	O
third	O
in	O
early	O
1892	O
.	O

And	O
I	O
expect	O
that	O
as	O
well	O
.	O

So	O
it's	O
a	O
coning	O
down	O
and	O
a	O
stepping	O
up	O
of	O
security	O
within	O
that	O
procedure	O
.	O

The	O
CDC	S-Organization
also	O
operates	O
a	O
number	O
of	O
notable	O
training	O
and	O
fellowship	O
programs	O
,	O
including	O
those	O
indicated	O
below	O
.	O

Methods	O
for	O
predicting	O
the	O
use	O
of	O
biological	O
agents	O
in	O
urban	O
areas	O
as	O
well	O
as	O
assessing	O
the	O
area	O
for	O
the	O
hazards	O
associated	O
with	O
a	O
biological	O
attack	O
are	O
being	O
established	O
in	O
major	O
cities	O
.	O

As	O
a	O
result	O
of	O
this	O
work	O
,	O
it	O
was	O
recommended	O
that	O
"	O
should	O
be	O
further	O
developed	O
as	O
a	O
potential	O
treatment.	O
"	O

Established	O
a	O
Laboratory	B-Organization
Safety	I-Organization
Review	I-Organization
Board	E-Organization
to	O
rigorously	O
review	O
and	O
approve	O
every	O
protocol	O
for	O
the	O
transfer	O
of	O
biological	O
materials	O
out	O
of	O
high-containment	O
labs	O
.	O

In	O
a	O
previous	O
study	O
,	O
based	O
on	O
experiences	O
gained	O
during	O
46	O
years	O
of	O
collaborative	O
work	O
,	O
performed	O
across	O
diverse	O
laboratory	O
cultures	O
,	O
the	O
value	O
of	O
networks	O
has	O
been	O
summarized	O
as	O
having	O
achieved	O
enhanced	O
productivity	O
and	O
trust-greater	O
than	O
any	O
single	O
laboratory	O
could	O
achieve	O
.	O

This	O
is	O
because	O
outside	O
the	O
human	O
body	O
,	O
the	O
virus	O
is	O
killed	O
by	O
household	O
soap	O
,	O
which	O
bursts	O
its	O
protective	O
bubble	O
.	O

BSL‐4	S-Platform
practices	O
,	O
safety	O
equipment	O
,	O
and	O
facility	O
design	O
and	O
construction	O
are	O
applicable	O
for	O
work	O
with	O
dangerous	O
and	O
exotic	O
agents	O
that	O
pose	O
a	O
high	O
individual	O
risk	O
of	O
life‐threatening	O
disease	O
,	O
which	O
may	O
be	O
transmitted	O
via	O
the	O
aerosol	O
route	O
,	O
and	O
for	O
which	O
there	O
is	O
no	O
available	O
vaccine	O
or	O
therapy	O
.	O

A	O
second	O
change	O
that	O
greatly	O
augments	O
virus	O
binding	O
to	O
the	O
human	O
receptor	O
may	O
also	O
occur	O
,	O
but	O
only	O
3	O
of	O
5	O
1918	O
HA	O
sequences	O
have	O
it	O
.	O

Laboratory	O
personnel	O
must	O
not	O
launder	O
labcoats	O
or	O
other	O
reusable	O
at	O
home	O
.	O

The	O
FDA	S-Organization
in	O
the	O
approved	O
the	O
first	O
point-of-care	O
test	O
on	O
21	O
March	O
2020	O
for	O
use	O
at	O
the	O
end	O
of	O
that	O
month	O
.	O

Some	O
children	O
grew	O
up	O
inside	O
the	O
walls	O
of	O
Unit	B-Organization
731	E-Organization
infected	O
with	O
syphilis	S-Disease
.	O
A	O
Youth	O
Corps	O
member	O
deployed	O
to	O
train	O
at	O
Unit	B-Organization
731	E-Organization
recalled	O
viewing	O
a	O
batch	O
of	O
subjects	O
that	O
would	O
undergo	O
testing:	O
"	O
one	O
was	O
a	O
Chinese	O
woman	O
holding	O
an	O
infant	O
,	O
one	O
was	O
a	O
White	O
Russian	O
woman	O
with	O
a	O
daughter	O
of	O
four	O
or	O
five	O
years	O
of	O
age	O
,	O
and	O
the	O
last	O
was	O
a	O
White	O
Russian	O
woman	O
with	O
a	O
boy	O
of	O
about	O
six	O
or	O
seven.	O
"	O
The	O
children	O
of	O
these	O
women	O
were	O
tested	O
in	O
ways	O
similar	O
to	O
their	O
parents	O
,	O
with	O
specific	O
emphasis	O
on	O
determining	O
how	O
longer	O
infection	O
periods	O
affected	O
the	O
effectiveness	O
of	O
treatments	O
.	O

For	O
non-believers	O
,	O
it	O
was	O
a	O
punishment	O
.	O

Additionally	O
,	O
other	O
recommendations	O
specific	O
for	O
clinical	O
laboratories	O
may	O
be	O
obtained	O
from	O
the	O
Clinical	B-Organization
Laboratory	I-Organization
Standards	I-Organization
Institute	E-Organization
(formerly	O
known	O
as	O
the	O
U.S.	B-Document
National	I-Document
Committee	I-Document
for	I-Document
Clinical	I-Document
Laboratory	I-Document
Standards	E-Document
;	O
,	O
2005)	O
.	O

Critics	O
have	O
lambasted	O
the	O
Trump	S-Person
administration	O
for	O
proposing	O
budget	O
cuts	O
to	O
public	O
health	O
programs	O
,	O
including	O
the	O
.	O

Field	O
laboratories	O
were	O
established	O
to	O
confirm	O
cases	O
,	O
instead	O
of	O
shipping	O
samples	O
to	O
South	B-Location
Africa	E-Location
.	O
Outbreaks	O
are	O
also	O
closely	O
monitored	O
by	O
the	O
.	O

And	O
that's	O
why	O
we	O
do	O
work	O
to	O
make	O
sure	O
that	O
we	O
could	O
diagnose	O
it	O
effectively	O
throughout	O
the	O
U.S	S-Location
.	O
,	O
we	O
do	O
research	O
to	O
figure	O
out	O
how	O
to	O
diagnose	O
it	O
more	O
rapidly	O
.	O

In	O
the	O
U.S.	S-Location
and	O
other	O
countries	O
around	O
the	O
world	O
,	O
pharmacies	O
are	O
not	O
permitted	O
to	O
sell	O
antibiotics	O
to	O
people	O
who	O
are	O
unable	O
to	O
produce	O
a	O
prescription	O
.	O

Other	O
working	O
groups	O
are	O
handling	O
matters	O
involving	O
personnel	O
issues	O
,	O
such	O
as	O
negotiating	O
the	O
numbers	O
of	O
people	O
being	O
transferred	O
to	O
ASPR	S-Organization
from	O
CDC	S-Organization
who	O
are	O
working	O
at	O
the	O
local	O
level	O
,	O
said	O
.	O

It	O
is	O
essential	O
that	O
antibiotic	O
discovery	O
and	O
production	O
be	O
maintained	O
on	O
a	O
scale	O
that	O
is	O
appropriate	O
to	O
our	O
increasing	O
requirements	O
.	O

Howard	B-Person
Taylor	I-Person
Ricketts	E-Person
acquired	O
typhus	S-Disease
and	O
died	O
while	O
studying	O
the	O
disease	O
using	O
a	O
primitive	O
containment	O
device	O
.	O

Of	O
these	O
volunteers	O
,	O
452	O
were	O
chosen	O
to	O
participate	O
in	O
the	O
trial	O
and	O
subsequently	O
randomized	O
into	O
2	O
groups:	O
361	O
participants	O
were	O
assigned	O
to	O
receive	O
600	O
mg	O
of	O
twice-daily	O
for	O
14	O
days	O
,	O
while	O
the	O
other	O
91	O
participants	O
were	O
assigned	O
to	O
receive	O
a	O
matching	O
placebo	O
twice	O
daily	O
for	O
14	O
days	O
.	O

So	O
many	O
questions	O
I'd	O
like	O
to	O
ask	O
.	O

While	O
it	O
might	O
be	O
capable	O
of	O
infecting	O
goats	O
,	O
and	O
could	O
potentially	O
cause	O
disease	O
,	O
this	O
has	O
not	O
been	O
tested	O
.	O

The	O
need	O
for	O
animal	O
work	O
involving	O
high-risk	O
or	O
high-consequence	O
pathogens	O
and	O
for	O
arthropod-borne	O
diseases	O
has	O
stimulated	O
renewed	O
interest	O
in	O
animal	O
biosafety	O
matters	O
,	O
particularly	O
for	O
work	O
in	O
containment	O
.	O

When	O
they	O
are	O
exposed	O
to	O
light	O
,	O
say	O
,	O
or	O
pollution	O
or	O
certain	O
chemicals	O
,	O
cells	O
can	O
retain	O
a	O
memory	O
of	O
that	O
and	O
can	O
give	O
a	O
signal	O
to	O
let	O
people	O
know	O
.	O

In	O
2008	O
,	O
the	O
DIYbio	B-Organization
organization	E-Organization
was	O
founded	O
by	O
Jason	B-Person
Bobe	E-Person
and	O
and	O
its	O
first	O
meeting	O
held	O
.	O

Avian	B-Disease
influenza	E-Disease
(	O
H7N9	S-Disease
)	O
.	O

The	O
and	O
the	O
have	O
formalized	O
the	O
framework	O
of	O
an	O
earlier	O
plan	O
to	O
accelerate	O
the	O
development	O
and	O
availability	O
of	O
emergency	O
medical	O
products	O
for	O
the	O
U.S.	S-Location

In	O
October	O
1940	O
,	O
the	O
Japanese	O
dropped	O
paper	O
bags	O
filled	O
with	O
plague-infested	O
fleas	O
over	O
the	O
cities	O
of	O
Ningbo	S-Location
and	O
Quzhou	S-Location
in	O
.	O
Other	O
attacks	O
involved	O
contaminating	O
wells	O
and	O
distributing	O
poisoned	O
foods	O
.	O

Polytechnics	O
and	O
universities	O
were	O
not	O
affected	O
.	O

Lamar	B-Person
Alexander	E-Person
(R-TN)	O
,	O
chairman	O
of	O
the	O
.	O

Guangzhou	S-Location
was	O
also	O
the	O
site	O
of	O
the	O
first	O
case	O
in	O
December	O
and	O
was	O
thought	O
to	O
be	O
the	O
origin	O
of	O
the	O
virus	O
in	O
the	O
original	O
outbreak	O
.	O

Four	O
of	O
the	O
six	O
samples	O
that	O
were	O
sent	O
for	O
analysis	O
to	O
the	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Biological	I-Organization
Research	E-Organization
in	O
Kinshasa	S-Location
came	O
back	O
positive	O
for	O
and	O
an	O
outbreak	O
was	O
declared	O
on	O
that	O
date	O
.	O

They	O
have	O
highlighted	O
,	O
for	O
example	O
,	O
disparities	O
in	O
methods	O
,	O
diagnostic	O
equipment	O
,	O
QA	O
management	O
systems	O
,	O
the	O
transport	O
and	O
delivery	O
of	O
samples	O
,	O
and	O
inter-agency	O
communication	O
and	O
data	O
sharing	O
(Table	O
2)	O
.	O

A	O
majority	O
of	O
these	O
products	O
are	O
used	O
to	O
help	O
defend	O
against	O
the	O
spread	O
of	O
infectious	O
diseases	O
,	O
and	O
hopefully	O
protect	O
public	O
health	O
.	O

In	O
particular	O
,	O
Gruinard	B-Location
Island	E-Location
in	O
Scotland	S-Location
,	O
during	O
a	O
series	O
of	O
extensive	O
tests	O
,	O
was	O
contaminated	O
with	O
for	O
the	O
next	O
48	O
years	O
.	O

Many	O
places	O
have	O
also	O
worked	O
to	O
increase	O
testing	O
capacity	O
and	O
trace	O
contacts	O
of	O
infected	O
persons	O
.	O

Metabiota	S-Organization
has	O
been	O
awarded	O
a	O
$18.	O
4	O
million	O
federal	O
contract	O
under	O
the	O
program	O
in	O
Georgia	S-Location
and	O
Ukraine	S-Location
.	O
This	O
US	S-Location
company	O
was	O
also	O
contracted	O
to	O
perform	O
work	O
for	O
the	O
DTRA	S-Organization
before	O
and	O
during	O
the	O
Ebola	B-Incident
crisis	E-Incident
in	O
West	B-Location
Africa	E-Location
,	O
the	O
company	O
was	O
awarded	O
$3.	O
1	O
million	O
(2012-2015)	O
for	O
work	O
in	O
.	O

Increasing	O
capacity	O
and	O
adapting	O
healthcare	O
for	O
the	O
needs	O
of	O
COVID-19	S-Disease
patients	O
is	O
described	O
by	O
the	O
WHO	S-Organization
as	O
a	O
fundamental	O
outbreak	O
response	O
measure	O
.	O

If	O
I	O
could	O
talk	O
for	O
a	O
minute	O
about	O
how	O
to	O
improve	O
performance	O
.	O

The	O
risk	O
for	O
someone	O
who	O
is	O
40	O
years	O
old	O
is	O
half	O
that	O
of	O
someone	O
who	O
is	O
20	O
years	O
old	O
with	O
substantially	O
less	O
risk	O
in	O
the	O
elderly	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
identify	O
and	O
assess	O
the	O
impact	O
of	O
capacity-building	O
biosafety	O
initiatives	O
and	O
programs	O
that	O
have	O
taken	O
place	O
in	O
broader	B-Location
Middle	I-Location
East	I-Location
and	I-Location
North	I-Location
Africa	E-Location
(	O
BMENA	S-Location
)	O
region	O
between	O
2001	O
and	O
2013	O
,	O
and	O
to	O
highlight	O
gaps	O
that	O
require	O
further	O
development	O
.	O

The	O
results	O
were	O
slower	O
but	O
the	O
test	O
was	O
judged	O
a	O
success	O
;	O
the	O
prisoners	O
fell	O
ill	O
within	O
a	O
week	O
.	O

After	O
over	O
two	O
decades	O
of	O
fighting	O
smallpox	S-Disease
,	O
the	O
declared	O
in	O
1979	O
that	O
the	O
disease	O
had	O
been	O
eradicated	O
–	O
the	O
first	O
disease	O
in	O
history	O
to	O
be	O
eliminated	O
by	O
human	O
effort	O
.	O

Gilead	B-Organization
Sciences	E-Organization
subsequently	O
discovered	O
that	O
remdesivir	S-Drug
had	O
antiviral	O
activity	O
in	O
vitro	O
against	O
multiple	O
filoviruses	S-Pathogen
,	O
pneumoviruses	S-Pathogen
,	O
paramyxoviruses	S-Pathogen
,	O
and	O
.	O

On	O
25	O
March	O
2014	O
,	O
the	O
WHO	S-Organization
indicated	O
that	O
Guinea's	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
had	O
reported	O
an	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
in	O
four	O
southeastern	O
districts	O
,	O
and	O
that	O
suspected	O
cases	O
in	O
the	O
neighbouring	O
countries	O
of	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
were	O
being	O
investigated	O
.	O

Two	O
more	O
questions	O
.	O

The	O
GAO	S-Organization
said	O
it	O
found	O
a	O
number	O
of	O
discrepancies	O
between	O
the	O
contractor's	O
project	O
inventory	O
and	O
USAID	S-Organization
's	O
data	O
that	O
the	O
agency	O
couldn't	O
explain	O
with	O
certainty	O
.	O

EBEN	B-Person
BROWN	E-Person
Thank	O
you	O
.	O

On	O
26	O
September	O
,	O
he	O
fell	O
ill	O
and	O
sought	O
medical	O
treatment	O
,	O
but	O
was	O
sent	O
home	O
with	O
antibiotics	O
.	O

The	O
CDC	S-Organization
runs	O
a	O
program	O
that	O
protects	O
the	O
public	O
from	O
rare	O
and	O
dangerous	O
substances	O
such	O
as	O
anthrax	S-Pathogen
and	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
The	O
program	O
,	O
called	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
,	O
calls	O
for	O
inspections	O
of	O
labs	O
in	O
the	O
U.S.	S-Location
that	O
work	O
with	O
dangerous	O
pathogens..	O
"	O
CDC's	O
Select	O
Agents	O
Program	O
protects	O
against	O
bioterror	O
threats	O
"	O
,	O
BioPrepWatch	O
,	O
February	O
10	O
,	O
2014	O
;	O
accessed	O
October	O
17	O
,	O
2014	O
.	O

We	O
can	O
say	O
with	O
certainty	O
that	O
the	O
novel	O
coronavirus	O
,	O
named	O
Covid-19	S-Pathogen
does	O
not	O
pose	O
such	O
a	O
risk	O
.	O

And	O
we	O
do	O
have	O
a	O
question	O
from	O
Miriam	B-Person
Falco	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

In	O
addition	O
to	O
those	O
undergoing	O
invasive	O
mechanical	O
ventilation	O
,	O
the	O
compassionate	O
use	O
recommendations	O
cover	O
the	O
treatment	O
of	O
hospitalized	O
individuals	O
requiring	O
supplemental	O
oxygen	O
,	O
non-invasive	O
ventilation	O
,	O
high-flow	O
oxygen	O
devices	O
or	O
ECMO	S-Technology
(	O
extracorporeal	B-Technology
membrane	I-Technology
oxygenation	E-Technology
)	O
.	O

Synthetic	B-Technology
biology	E-Technology
the	O
field	O
that	O
revolves	O
around	O
figuring	O
out	O
how	O
to	O
combine	O
genes	O
in	O
new	O
and	O
interesting	O
ways	O
,	O
requires	O
an	O
understanding	O
of	O
biology	O
,	O
creative	O
engineering	O
skills	O
and	O
computing	O
expertise	O
.	O

Two	O
days	O
ago	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
reported	O
that	O
the	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
has	O
sickened	O
188	O
people	O
and	O
killed	O
118	O
in	O
the	O
northeastern	O
region	O
of	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
.	O
Lillibridge	S-Person
noted	O
that	O
Ebola	S-Disease
continues	O
to	O
spread	O
in	O
what	O
is	O
considered	O
a	O
conflict	O
zone	O
,	O
making	O
it	O
nearly	O
impossible	O
for	O
to	O
sufficiently	O
access	O
the	O
stricken	O
population	O
there	O
.	O

Currently	O
there	O
is	O
no	O
system	O
providing	O
embargo	O
periods-but	O
SysMO-SEEK	S-Platform
provides	O
services	O
to	O
publish	O
data	O
at	O
the	O
end	O
of	O
projects	O
.	O

Sabeti's	B-Person
team	E-Person
hopes	O
to	O
build	O
on	O
this	O
further	O
and	O
seeks	O
to	O
test	O
SHERLOCK	S-Platform
with	O
Nigerian	B-Person
collaborators	E-Person
,	O
as	O
a	O
means	O
of	O
addressing	O
their	O
recent	O
Lassa	B-Incident
fever	I-Incident
outbreak	E-Incident
.	O
The	O
recent	O
effort	O
was	O
led	O
by	O
Harvard	S-Organization
graduate	O
student	O
Catherine	B-Person
Freije	E-Person
and	O
postdoctoral	O
scientist	O
,	O
who	O
developed	O
a	O
simpler	O
method	O
for	O
an	O
enzyme	O
involved	O
in	O
the	O
platform	O
to	O
detect	O
its	O
target	O
directly	O
in	O
bodily	O
fluid	O
samples	O
.	O

Of	O
349	O
with	O
documented	O
chest	O
x-rays	O
on	O
admission	O
,	O
29%	O
had	O
evidence	O
of	B-Disease
pneumo	E-Disease
nia	O
,	O
but	O
bacterial	O
co-infection	O
was	O
uncommon	O
.	O

"	O
On	O
this	O
hyperimmune	O
platform	O
,	O
we	O
have	O
successfully	O
developed	O
and	O
manufactured	O
FDA	S-Organization
products	O
such	O
as	O
treatments	O
for	O
inhalation	B-Disease
anthrax	E-Disease
and	O
complications	O
from	O
smallpox	S-Disease
vaccination,	O
"	O
said	O
.	O

Full	O
training	O
for	O
wearing	O
protective	O
body	O
clothing	O
can	O
take	O
10	O
to	O
14	O
days	O
.	O

Biosecurity	O
has	O
also	O
been	O
raised	O
to	O
a	O
place	O
of	O
prominence	O
in	O
security	O
discussions	O
throughout	O
much	O
of	O
the	O
rest	O
of	O
the	O
globe	O
,	O
largely	O
through	O
the	O
mechanisms	O
of	O
the	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
and	O
related	O
groups	O
,	O
but	O
also	O
through	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
and	O
the	O
implementation	O
of	O
the	O
,	O
which	O
is	O
scheduled	O
for	O
2012	O
.	O

At	O
the	O
time	O
,	O
Fort	B-Organization
Detrick	E-Organization
and	O
USAMRIID	S-Organization
were	O
under	O
different	O
leadership.	O
assumed	O
command	O
on	O
July	O
23	O
,	O
days	O
after	O
the	O
cease	O
and	O
desist	O
letter	O
.	O

The	O
Outbreak	B-Scientific_research_project
Observatory	E-Scientific_research_project
aims	O
to	O
change	O
that	O
.	O

The	O
Assembly	O
elects	O
34	O
members	O
,	O
technically	O
qualified	O
in	O
the	O
field	O
of	O
health	O
,	O
to	O
the	O
Executive	O
Board	O
for	O
three-year	O
terms	O
.	O

When	O
the	O
slice	O
thickness	O
is	O
also	O
factored	O
in	O
,	O
the	O
unit	O
is	O
known	O
as	O
a	O
Voxel	O
,	O
which	O
is	O
a	O
three-dimensional	O
unit	O
.	O

In	O
2015	O
,	O
it	O
was	O
the	O
winner	O
of	O
that	O
award	O
.	O

"	O
Herald"	B-Incident
events	E-Incident
in	O
1915	O
,	O
1916	O
,	O
and	O
possibly	O
even	O
in	O
early	O
1918	O
,	O
if	O
they	O
occurred	O
,	O
would	O
be	O
difficult	O
to	O
identify	O
.	O

In	O
contrast	O
,	O
age-specific	O
death	O
rates	O
in	O
the	O
1918	B-Incident
pandemic	E-Incident
exhibited	O
a	O
distinct	O
pattern	O
that	O
has	O
not	O
been	O
documented	O
before	O
or	O
since:	O
a	O
"	O
W-shaped"	O
curve	O
,	O
similar	O
to	O
the	O
familiar	O
U-shaped	O
curve	O
but	O
with	O
the	O
addition	O
of	O
a	O
third	O
(middle)	O
distinct	O
peak	O
of	O
deaths	O
in	O
young	O
adults	O
≈20–40	O
years	O
of	O
age	O
.	O

Different	O
types	O
of	O
safe	O
and	O
appropriate	O
personnel	B-Equipment
protection	I-Equipment
equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
are	O
used	O
in	O
different	O
zones	O
of	O
the	O
laboratory	O
,	O
and	O
it	O
fully	O
meets	O
the	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
laboratory	O
standards	O
of	O
the	O
.	O

NMR	S-Technology
can	O
also	O
be	O
used	O
for	O
imaging	O
in	O
other	O
NMR	S-Technology
applications	O
,	O
such	O
as	O
spectroscopy	O
.	O

Surveillance	O
is	O
used	O
to	O
determine	O
if	O
influenza	O
activity	O
is	O
increasing	O
or	O
decreasing	O
,	O
but	O
cannot	O
be	O
used	O
to	O
ascertain	O
how	O
many	O
people	O
have	O
become	O
ill	O
with	O
influenza.	O
"	O
For	O
example	O
,	O
as	O
of	O
late	O
June	O
,	O
influenza	O
surveillance	O
information	O
showed	O
the	O
U.S.	S-Location
had	O
nearly	O
28,000	O
laboratory-confirmed	O
cases	O
including	O
3,065	O
hospitalizations	O
and	O
127	O
deaths	O
.	O

WHO	S-Organization
collaborates	O
with	O
the	O
Global	B-Organization
Fund	I-Organization
to	I-Organization
fight	I-Organization
AIDS,	I-Organization
Tuberculosis	I-Organization
and	I-Organization
Malaria	E-Organization
,	O
UNITAID	S-Organization
,	O
and	O
the	O
United	B-Organization
States	I-Organization
President's	I-Organization
Emergency	I-Organization
Plan	I-Organization
for	I-Organization
AIDS	I-Organization
Relief	E-Organization
to	O
spearhead	O
and	O
fund	O
the	O
development	O
of	O
programs	O
.	O

The	O
same	O
studies	O
described	O
similar	O
results	O
regarding	O
NPC1's	O
role	O
in	O
virus	O
entry	O
for	O
Marburg	B-Pathogen
virus	E-Pathogen
,	O
a	O
related	O
filovirus	O
.	O

The	O
project	O
team	O
noted	O
their	O
list	O
is	O
not	O
exhaustive	O
or	O
an	O
endorsement	O
of	O
specific	O
companies	O
.	O

The	O
confirmed	O
this	O
demand	O
in	O
its	O
guidelines	O
arguing	O
that	O
open	O
access	O
to	O
data	O
enables	O
'testing	O
of	O
new	O
or	O
alternative	O
hypotheses	O
and	O
methods	O
of	O
analysis'	O
and	O
'exploration	O
of	O
topics	O
not	O
envisioned	O
by	O
the	O
initial	O
investigator'	O
.	O

In	O
,	O
it	O
is	O
consent	O
'that	O
all	O
funded	O
research	O
be	O
made	O
openly	O
available	O
for	O
future	O
use	O
and	O
ensure	O
this	O
is	O
a	O
condition	O
attached	O
to	O
future	O
funding	O
decisions'	O
at	O
the	O
latest	O
2016	O
.	O

At	O
least	O
21	O
people	O
died	O
from	O
Lassa	B-Disease
fever	E-Disease
in	O
Nigeria	O
last	O
month	O
.	O

In	O
October	O
2017	O
,	O
the	O
WHO	S-Organization
issued	O
guidelines	O
recommending	O
that	O
medically	O
important	O
antibiotics	O
be	O
used	O
only	O
to	O
treat	O
sick	O
animals	O
,	O
arguing	O
that	O
the	O
widespread	O
use	O
of	O
these	O
drugs	O
for	O
growth	O
promotion	O
and	O
disease	O
prevention	O
in	O
animals	O
contributes	O
to	O
the	O
spread	O
of	O
AMR	O
.	O

Ebola	B-Disease
virus	I-Disease
disease	E-Disease
,	O
in	O
particular	O
,	O
has	O
caused	O
high	S-Phenotype
fatality	O
rates	O
ranging	O
from	O
25–90%	O
with	O
a	O
50%	O
average	O
.	O

Total	O
commitment	O
at	O
all	O
levels	O
of	O
the	O
population	O
is	O
the	O
only	O
solution	O
.	O

Rapid	O
progress	O
in	O
the	O
application	O
of	O
biotechnological	O
methodologies	O
and	O
development	O
of	O
genetically	O
modified	O
crops	O
in	O
Iran	S-Location
necessitated	O
intensive	O
efforts	O
to	O
establish	O
proper	O
organizations	O
and	O
prepare	O
required	O
rules	O
and	O
regulations	O
at	O
the	O
national	O
level	O
to	O
ensure	O
safe	O
application	O
of	O
biotechnology	O
in	O
all	O
pertinent	O
aspects	O
.	O

I	O
just	O
wanted	O
to	O
ask	O
specifically	O
about	O
your	O
flu	O
lab	O
.	O

In	O
the	O
1980s	O
,	O
the	O
Soviet	B-Organization
Ministry	I-Organization
of	I-Organization
Agriculture	E-Organization
successfully	O
developed	O
variants	O
of	O
foot-and-mouth	B-Disease
disease	I-Disease
and	I-Disease
rinderpest	I-Disease
against	I-Disease
cows	E-Disease
,	O
African	B-Disease
swine	I-Disease
fever	I-Disease
for	I-Disease
pigs	E-Disease
,	O
and	O
psittacosis	B-Disease
to	I-Disease
kill	I-Disease
chicken	E-Disease
.	O
These	O
agents	O
were	O
prepared	O
to	O
be	O
sprayed	O
down	O
from	O
tanks	O
attached	O
to	O
airplanes	O
over	O
hundreds	O
of	O
miles	O
.	O

While	O
no	O
DIYbio	B-Scientific_research_project
project	E-Scientific_research_project
to	O
date	O
has	O
involved	O
harmful	O
agents	O
,	O
the	O
fear	O
remains	O
in	O
the	O
minds	O
of	O
both	O
regulators	O
and	O
laypersons	O
.	O

But	O
often	O
,	O
these	O
data	O
are	O
inaccessible	O
for	O
future	O
research	O
projects	O
or	O
data	O
are	O
stored	O
in	O
proprietary	O
data	O
formats	O
that	O
are	O
not	O
interoperable	O
standard	O
formats	O
.	O

Masateru	B-Person
Saito	E-Person
"	O
civilian	O
employee	O
"	O

Saying	O
that	O
new	O
information	O
had	O
been	O
discovered	O
in	O
the	O
case	O
,	O
authorities	O
who	O
had	O
placed	O
his	O
house	O
under	O
surveillance	O
arrested	O
Dutschke	S-Person
in	O
the	O
early	O
hours	O
of	O
April	O
27	O
.	O

Reilly	S-Person
provides	O
,	O
which	O
is	O
not	O
based	O
on	O
protocols	O
but	O
principles	O
,	O
can	O
make	O
sure	O
we	O
don't	O
repeat	O
the	O
same	O
mistakes	O
over	O
again,	O
"	O
he	O
added	O
.	O

The	O
same	O
year	O
,	O
operational	O
portions	O
of	O
the	O
facilities	O
at	O
Salman	B-Location
Pak	E-Location
and	O
Al	B-Location
Manal	E-Location
were	O
also	O
supposedly	O
destroyed	O
,	O
either	O
by	O
the	O
Iraqis	O
themselves	O
or	O
under	O
direct	O
supervision	O
.	O

The	O
laboratory	O
was	O
decontaminated	O
for	O
a	O
second	O
time	O
,	O
and	O
is	O
now	O
closed	O
and	O
transfers	O
from	O
the	O
lab	O
have	O
been	O
stopped	O
while	O
the	O
review	O
is	O
taking	O
place	O
.	O

This	O
procedure	O
teaches	O
students	O
how	O
to	O
calculate	O
the	O
virus	O
concentration	O
in	O
the	O
stock	O
solution	O
and	O
use	O
it	O
for	O
calculation	O
of	O
the	O
MOI	O
in	O
following	O
experiments	O
.	O

This	O
genetic	O
bottleneck	O
effect	O
has	O
implications	O
for	O
the	O
species'	O
ability	O
to	O
cause	O
in	O
human	O
hosts	O
.	O

Nitazoxanide	S-Drug
has	O
been	O
recommended	O
for	O
further	O
in	O
vivo	O
study	O
after	O
demonstrating	O
low	O
concentration	O
inhibition	O
of	O
.	O

The	O
majority	O
of	O
these	O
deaths	O
occurred	O
in	O
Africa	S-Location
and	O
Southeast	B-Location
Asia	E-Location
.	O
Experts	O
,	O
including	O
the	O
,	O
have	O
agreed	O
that	O
an	O
estimated	O
284,500	O
people	O
were	O
killed	O
by	O
the	O
disease	O
,	O
much	O
higher	O
than	O
the	O
initial	O
death	O
toll	O
.	O

These	O
levels	O
will	O
produce	O
hyperventilation	O
in	O
33%	O
of	O
patients	O
,	O
as	O
well	O
as	O
in	O
3%	O
of	O
patients	O
.	O

Japanese	O
discussions	O
of	O
Unit	B-Organization
731	E-Organization
activity	O
began	O
in	O
the	O
1950s	O
,	O
after	O
the	O
end	O
of	O
the	O
American	O
occupation	O
of	O
Japan	S-Location
.	O
In	O
1952	O
,	O
human	O
experiments	O
carried	O
out	O
in	O
Nagoya	B-Location
City	I-Location
Pediatric	I-Location
Hospital	E-Location
,	O
which	O
resulted	O
in	O
one	O
death	O
,	O
were	O
publicly	O
tied	O
to	O
former	O
members	O
of	O
Unit	B-Organization
731	E-Organization
.	O
日本弁護士連合会『人権白書昭和43年版』日本弁護士連合会、1968年、pp.	O
134–136;高杉晋吾『七三一部隊細菌戦の医師を追え』徳間書店、1982年、pp.	O
94–111	O
;	O
保護施設収容者に対する人権擁護に関する件(決議)	O
Later	O
in	O
that	O
decade	O
,	O
journalists	O
suspected	O
that	O
the	O
murders	O
attributed	O
by	O
the	O
government	O
to	O
Sadamichi	B-Person
Hirasawa	E-Person
were	O
actually	O
carried	O
out	O
by	O
members	O
of	O
Unit	B-Organization
731	E-Organization
.	O
In	O
1958	O
,	O
Japanese	O
author	O
published	O
the	O
book	O
The	O
Sea	O
and	O
Poison	O
about	O
human	O
experimentation	O
,	O
which	O
is	O
thought	O
to	O
have	O
been	O
based	O
on	O
a	O
real	O
incident	O
.	O

Is	O
your	O
work	O
in	O
creating	B-Technology
a	I-Technology
synthetic	I-Technology
bacterial	I-Technology
cell	E-Technology
"	O
creating	O
life	O
from	O
scratch"?	O

As	O
a	O
result	O
of	O
the	O
bioterrorism	O
investigation	O
,	O
law	O
enforcement	O
officials	O
discovered	O
that	O
there	O
had	O
been	O
an	O
aborted	O
plot	O
by	O
Rajneeshees	O
to	O
murder	O
Charles	B-Person
Turner	E-Person
,	O
a	O
former	O
United	O
States	O
Attorney	O
for	O
.	O

There	O
is	O
still	O
work	O
to	O
be	O
done	O
.	O

He	O
believes	O
that	O
because	O
there	O
have	O
been	O
no	O
significant	O
instances	O
of	O
bioterrorism	O
since	O
the	O
,	O
the	O
government	O
has	O
allowed	O
itself	O
to	O
become	O
complacent	O
making	O
the	O
country	O
that	O
much	O
more	O
vulnerable	O
to	O
unsuspecting	O
attacks	O
,	O
thereby	O
further	O
endangering	O
the	O
lives	O
of	O
U.S.citizens	O
.	O

Will	O
today's	O
income	O
inequality	O
,	O
combined	O
with	O
biotechnology	O
tools	O
and	O
talk	O
of	O
'designer	O
babies'	O
,	O
lead	O
to	O
tomorrow's	O
permanent	O
underclass	O
of	O
people	O
who	O
couldn't	O
afford	O
genetic	O
enhancement?	O

Another	O
good	O
development	O
is	O
that	O
the	O
plan	O
spells	O
the	O
day-to-day	O
coordination	O
and	O
execution	O
by	O
the	O
HHS	S-Organization
secretary	O
,	O
which	O
builds	O
in	O
top-level	O
accountability	O
and	O
clearly	O
assigned	O
responsibility	O
,	O
according	O
to	O
.	O

In	O
February	O
2017	O
the	O
US	B-Organization
Patent	I-Organization
Office	E-Organization
ruled	O
on	O
a	O
patent	O
interference	O
case	O
brought	O
by	O
University	B-Organization
of	I-Organization
California	E-Organization
with	O
respect	O
to	O
patents	O
issued	O
to	O
the	O
Broad	B-Organization
Institute	E-Organization
,	O
and	O
found	O
that	O
the	O
Broad	O
patents	O
,	O
with	O
claims	O
covering	O
the	O
application	O
of	O
CRISPR-Cas9	S-Technology
in	O
eukaryotic	O
cells	O
,	O
were	O
distinct	O
from	O
the	O
inventions	O
claimed	O
by	O
.	O

Multidrug	O
resistance	O
in	O
fungi	O
is	O
increasing	O
because	O
of	O
the	O
widespread	O
use	O
of	O
antifungal	O
drugs	O
to	O
treat	O
infections	O
in	O
immunocompromised	O
individuals	O
.	O

But	O
considering	O
the	O
rapid	O
development	O
of	O
molecular	O
biology	O
,	O
it	O
is	O
only	O
a	O
question	O
of	O
time	O
before	O
the	O
artificial	O
synthesis	O
of	O
agents	O
or	O
new	O
combinations	O
of	O
agents	O
becomes	O
possible	O
.	O

The	O
CDC	S-Organization
used	O
names	O
like	O
"	O
novel	B-Disease
influenza	I-Disease
A	I-Disease
(H1N1)	E-Disease
"	O
or	O
"	O
2009	B-Disease
H1N1	I-Disease
flu	E-Disease
"	O
.	O
The	O
Netherlands	B-Organization
National	I-Organization
Institute	I-Organization
for	I-Organization
Public	I-Organization
Health	I-Organization
and	I-Organization
the	I-Organization
Environment	E-Organization
used	O
the	O
term	O
"	O
Pig	B-Disease
Flu	E-Disease
"	O
early	O
on	O
.	O

"	O
It	O
is	O
our	O
opinion	O
that	O
the	O
knowledge	O
to	O
be	O
gained	O
from	O
this	O
program	O
appears	O
very	O
limited	O
in	O
its	O
capacity	O
to	O
enhance	O
U.S.	O
agriculture	O
or	O
respond	O
to	O
national	O
emergencies,	O
"	O
the	O
authors	O
wrote	O
.	O

There	O
is	O
no	O
specific	O
test	O
for	O
exposure	O
and	O
no	O
antidote	O
once	O
exposed	O
.	O

As	O
biohacking	O
starts	O
to	O
appear	O
more	O
often	O
in	O
headlines	O
-	O
and	O
,	O
recently	O
,	O
in	O
a	O
fascinating	O
Netflix	S-Organization
series	O
called	O
Unnatural	O
Selection	O
-	O
it's	O
worth	O
getting	O
clear	O
on	O
some	O
of	O
the	O
fundamentals	O
.	O

Only	O
one	O
manufacturer	O
(	O
Imatron	S-Organization
,	O
later	O
acquired	O
by	O
)	O
ever	O
produced	O
scanners	O
of	O
this	O
design	O
.	O

Epidemics	O
,	O
that	O
may	O
have	O
included	O
the	O
plague	O
,	O
killed	O
an	O
estimated	O
25 million	O
across	O
Asia	S-Location
during	O
the	O
fifteen years	O
before	O
it	O
reached	O
in	O
1347	O
.	O

The	O
Country	B-Platform
Health	I-Platform
Intelligence	I-Platform
Portal	E-Platform
()	O
,	O
has	O
also	O
been	O
developed	O
to	O
provide	O
an	O
access	O
point	O
to	O
information	O
about	O
the	O
health	O
services	O
that	O
are	O
available	O
in	O
different	O
countries	O
.	O

Resistance	O
to	O
interventions	O
by	O
health	O
officials	O
among	O
the	O
Guinean	S-Location
population	O
remained	O
greater	O
than	O
in	O
Sierra	B-Location
Leone	E-Location
and	O
Liberia	S-Location
,	O
per	O
media	O
reports	O
,	O
raising	O
concerns	O
over	O
its	O
impact	O
on	O
ongoing	O
efforts	O
to	O
halt	O
the	O
epidemic	O
;	O
in	O
mid-March	O
,	O
there	O
were	O
95	O
new	O
cases	O
and	O
on	O
28	O
March	O
,	O
and	O
a	O
45-day	O
"	O
health	O
emergency	O
"	O
was	O
declared	O
in	O
5	O
regions	O
of	O
the	O
country	O
.	O

Complete	O
management	O
and	O
program	O
documents	O
were	O
created	O
for	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
,	O
and	O
it	O
was	O
divided	O
into	O
four	O
zones	O
(the	O
green	O
,	O
yellow	O
,	O
brown	O
,	O
and	O
red	O
zones)	O
based	O
on	O
the	O
risk	O
assessment	O
.	O

Proposers	O
will	O
also	O
be	O
required	O
to	O
address	O
potential	O
ethical	O
,	O
legal	O
,	O
and	O
societal	O
implications	O
of	O
the	O
research	O
.	O

SHERLOCK	S-Platform
has	O
also	O
been	O
updated	O
to	O
better	O
distinguish	O
between	O
related	O
viral	O
species	O
,	O
allowing	O
it	O
to	O
identify	O
mutations	O
.	O

Their	O
use	O
in	O
recent	O
clinical	O
trials	O
for	O
the	O
treatment	O
of	O
adrenoleukodystrophy	S-Disease
,	O
β-thalassemia	S-Disease
,	O
Wiskott-Aldrich-	B-Disease
Syndrome	E-Disease
and	O
metachromatic	B-Disease
leukodystrophy	E-Disease
underlined	O
their	O
efficacy	O
for	O
therapies	O
especially	O
in	O
case	O
of	O
hereditary	O
diseases	O
.	O

The	O
rotation	O
between	O
different	O
work	O
stations	O
allows	O
for	O
experiments	O
that	O
continue	O
from	O
one	O
lab	O
to	O
the	O
next	O
,	O
providing	O
students	O
with	O
a	O
sense	O
of	O
an	O
ongoing	O
experiment	O
as	O
will	O
be	O
the	O
case	O
in	O
future	O
work	O
.	O

In	O
May	O
2009	O
,	O
the	O
Chinese	B-Organization
government	E-Organization
confined	O
21	O
U.S.	O
students	O
and	O
three	O
teachers	O
to	O
their	O
hotel	O
rooms	O
.	O

One	O
of	O
the	O
unfortunate	O
consequences	O
of	O
working	O
with	O
etiological	O
agents	O
is	O
the	O
potential	O
for	O
acquiring	O
a	O
laboratory-associated-infection	S-Disease
(	O
LAI	S-Disease
)	O
.	O

Each	O
regional	O
committee	O
of	O
the	O
WHO	S-Organization
consists	O
of	O
all	O
the	O
Health	O
Department	O
heads	O
,	O
in	O
all	O
the	O
governments	O
of	O
the	O
countries	O
that	O
constitute	O
the	O
Region	O
.	O

All	O
of	O
these	O
technologies	O
combine	O
to	O
form	O
what	O
seems	O
like	O
a	O
relatively	O
strong	O
deterrent	O
to	O
bioterrorism	O
.	O

A	O
patient's	O
electrolytes	O
must	O
be	O
closely	O
monitored	O
to	O
determine	O
correct	O
fluid	O
administration	O
,	O
for	O
which	O
many	O
areas	O
did	O
not	O
have	O
access	O
to	O
the	O
required	O
laboratory	O
services	O
.	O

According	O
to	O
medieval	O
historian	O
Philip	B-Person
Daileader	E-Person
it	O
is	O
likely	O
that	O
over	O
four	O
years	O
,	O
45–50%	O
of	O
the	O
European	O
population	O
died	O
of	O
the	O
plague	O
.	O

In	O
,	O
one	O
official	O
estimated	O
that	O
7%	O
of	O
the	O
native	O
population	O
died	O
.	O

This	O
viral	O
genome	O
codes	O
for	O
seven	O
structural	O
proteins	O
and	O
one	O
non-structural	O
protein	O
.	O

The	O
report	O
we're	O
releasing	O
today	O
,	O
though	O
,	O
looks	O
at	O
the	O
root	O
cause	O
of	O
this	O
incident	O
.	O

The	O
GAO	S-Organization
said	O
USAID	S-Organization
and	O
other	O
government	O
agencies	O
have	O
reviewed	O
a	O
draft	O
of	O
its	O
report	O
,	O
and	O
that	O
has	O
agreed	O
with	O
the	O
recommendations	O
.	O

Each	O
region	O
has	O
a	O
regional	O
committee	O
,	O
which	O
generally	O
meets	O
once	O
a	O
year	O
,	O
normally	O
in	O
the	O
autumn	O
.	O

The	O
U.S.	B-Organization
Navy	E-Organization
is	O
awarding	O
funding	O
to	O
the	O
Noguchi	B-Organization
Memorial	I-Organization
Institute	I-Organization
for	I-Organization
Medical	I-Organization
Research	E-Organization
in	O
Ghana	S-Location
in	O
support	O
of	O
infectious	O
disease	O
research	O
in	O
.	O

The	O
need	O
for	O
animal	O
work	O
involving	O
high-risk	O
or	O
high-consequence	O
pathogens	O
and	O
for	O
arthropod-borne	O
diseases	O
has	O
stimulated	O
renewed	O
interest	O
in	O
animal	O
biosafety	O
matters	O
,	O
particularly	O
for	O
work	O
in	O
containment	O
.	O

The	O
"	O
NIH	B-Document
Guidelines	I-Document
for	I-Document
Research	I-Document
Involving	I-Document
Recombinant	I-Document
DNA	I-Document
Molecules	E-Document
()	O
.	O

Thomas	B-Person
Inglesby	E-Person
,	O
a	O
biosecurity	O
expert	O
at	O
the	O
UPMC	B-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
in	O
Baltimore	S-Location
,	O
Maryland	S-Location
,	O
calls	O
the	O
"	O
a	O
welcome	O
development	O
…	O
the	O
memo	O
should	O
prompt	O
a	O
lot	O
of	O
activity	O
that	O
can	O
improve	O
safety	O
"	O
at	O
both	O
government	O
and	O
extramural	O
labs	O
.	O

Public	O
health	O
,	O
when	O
threatened	O
not	O
by	O
Obamacare	S-Document
but	O
by	O
exposure	O
to	O
infectious	O
diseases	O
,	O
natural	O
disasters	O
or	O
chemical	O
,	O
biological	O
,	O
radiological	O
or	O
nuclear	O
(CBRN)	O
agents	O
,	O
is	O
an	O
area	O
where	O
members	O
of	O
have	O
been	O
able	O
to	O
build	O
bipartisanship	O
.	O

The	O
system	O
was	O
originally	O
conceived	O
for	O
microarrays	O
in	O
a	O
MIAME	S-Platform
compliant	O
fashion	O
but	O
has	O
been	O
extended	O
to	O
sequencing	O
techniques	O
using	O
MGED	S-Organization
ontologies	O
for	O
annotation-in	O
the	O
lack	O
of	O
a	O
broadly	O
accepted	O
standard	O
for	O
sequencing	O
data	O
.	O

Upon	O
admission	O
,	O
most	O
patients	O
need	O
immediate	O
respiratory	O
support	O
with	O
.	O

The	O
plague	S-Disease
was	O
somewhat	O
more	O
uncommon	O
in	O
parts	O
of	O
Europe	S-Location
with	O
less	O
developed	O
trade	O
with	O
their	O
neighbours	O
,	O
including	O
the	O
majority	O
of	O
the	O
Basque	B-Location
Country	E-Location
,	O
isolated	O
parts	O
of	O
Belgium	S-Location
and	O
the	O
,	O
and	O
isolated	O
Alpine	O
villages	O
throughout	O
the	O
continent	O
.	O

He	O
tries	O
to	O
do	O
two	O
hours	O
of	O
meditation	O
a	O
day	O
and	O
eats	O
only	O
one	O
meal	O
(dinner)	O
on	O
weekdays	O
;	O
on	O
weekends	O
,	O
he	O
doesn't	O
eat	O
at	O
all.	O
(Critics	O
worry	O
that	O
his	O
dietary	O
habits	O
sound	O
a	O
bit	O
like	O
an	O
eating	O
disorder	O
,	O
or	O
that	O
they	O
might	O
unintentionally	O
influence	O
others	O
to	O
develop	O
a	O
disorder.	O
)	O
He	O
also	O
kicks	O
off	O
each	O
morning	O
with	O
an	O
ice	O
bath	O
before	O
walking	O
the	O
5	O
miles	O
to	O
.	O

JULIE	B-Person
STEENHUYSEN	E-Person
Yeah	O
,	O
I	O
have	O
just	O
a	O
quick	O
follow-up	O
.	O

By	O
using	O
genetic	B-Technology
engineering	E-Technology
biological	O
researchers	O
have	O
already	O
developed	O
new	O
weapons	O
that	O
are	O
much	O
more	O
effective	O
than	O
their	O
natural	O
counterparts	O
.	O

As	O
the	O
Swedish	S-Location
national	O
BSL-3	S-Platform
laboratories	O
work	O
under	O
different	O
ministries	O
,	O
there	O
is	O
no	O
central	O
command	O
structure	O
to	O
which	O
all	O
laboratories	O
are	O
connected	O
,	O
in	O
contrast	O
to	O
,	O
for	O
example	O
,	O
the	O
,	O
which	O
is	O
overseen	O
by	O
a	O
program	O
leader	O
.	O

By	O
28	O
October	O
2009	O
,	O
about	O
600	O
schools	O
in	O
had	O
been	O
temporarily	O
closed	O
,	O
affecting	O
over	O
126,000	O
students	O
in	O
19	O
states	O
.	O

Nigeria	S-Location
was	O
the	O
first	O
country	O
in	O
western	O
to	O
successfully	O
curtail	O
the	O
virus	O
,	O
and	O
its	O
procedures	O
have	O
served	O
as	O
a	O
model	O
for	O
other	O
countries	O
to	O
follow	O
.	O

On	O
23	O
March	O
2020	O
,	O
voluntarily	O
suspended	O
access	O
for	O
compassionate	O
use	O
(excepting	O
cases	O
of	O
critically	O
ill	O
children	O
and	O
pregnant	O
women)	O
,	O
for	O
reasons	O
related	O
to	O
supply	O
,	O
citing	O
the	O
need	O
to	O
continue	O
to	O
provide	O
the	O
agent	O
for	O
testing	O
in	O
clinical	O
trials	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

In	O
early	O
December	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
at	O
a	O
national	O
level	O
there	O
were	O
enough	O
beds	O
in	O
treatment	O
facilities	O
to	O
treat	O
and	O
isolate	O
all	O
reported	O
Ebola	S-Disease
cases	O
,	O
although	O
their	O
uneven	O
distribution	O
was	O
resulting	O
in	O
serious	O
shortfalls	O
in	O
some	O
areas	O
.	O

The	O
absence	O
of	O
in	O
the	O
laboratory	O
environmental	O
samples	O
in	O
this	O
study	O
reflects	O
the	O
importance	O
of	O
good	O
laboratory	O
practice	O
for	O
control	O
of	O
potential	O
contamination	O
with	O
viral	O
nucleic	O
acids	O
.	O

Making	O
data	O
citable	O
via	O
DOIs	O
is	O
promoted	O
by	O
the	O
DataCite	S-Organization
organization	O
and	O
now	O
has	O
been	O
used	O
in	O
a	O
few	O
initial	O
cases	O
.	O

To	O
date	O
,	O
Gottlieb	S-Person
explained	O
,	O
inconsistencies	O
in	O
the	O
reporting	O
of	O
antibiotic	O
susceptibility	O
test	O
results	O
across	O
different	O
institutions	O
has	O
made	O
it	O
difficult	O
to	O
track	O
resistance	O
.	O

The	O
term	O
"	O
computed	B-Technology
tomography	E-Technology
(	O
CT	S-Technology
)	O
is	O
often	O
used	O
to	O
refer	O
to	O
X-ray	B-Technology
CT	E-Technology
because	O
it	O
is	O
the	O
most	O
commonly	O
known	O
form	O
.	O

The	O
community	O
labs	O
she's	O
helped	O
to	O
build	O
,	O
Genspace	S-Organization
and	O
Biotech	B-Organization
Without	I-Organization
Borders	E-Organization
,	O
offer	O
classes	O
on	O
using	O
technology	O
to	O
edit	O
a	O
genome	O
-	O
but	O
participants	O
work	O
on	O
the	O
genome	O
of	O
yeast	O
,	O
never	O
on	O
their	O
own	O
bodies	O
.	O

Smallpox	S-Pathogen
Smallpox	S-Pathogen
is	O
a	O
highly	O
contagious	O
virus	O
.	O

British	O
Television	O
South	O
documentary	O
first	O
broadcast	O
on	O
13	O
August	O
1985	O
.	O

The	O
1996	B-Document
Dickey	I-Document
Amendment	E-Document
states	O
"	O
none	O
of	O
the	O
funds	O
made	O
available	O
for	O
injury	O
prevention	O
and	O
control	O
at	O
the	O
n	O
may	O
be	O
used	O
to	O
advocate	O
or	O
promote	O
gun	O
control"	O
.	O

Auster	S-Person
,	O
Bruce	B-Person
B	E-Person
.	O
"	O
Unmasking	O
an	O
Old	O
Lie	O
"	O
,	O
U.S.	S-Location
News	O
and	O
World	O
Report	O
,	O
November	O
16	O
,	O
1998	O
.	O

Being	O
acellular	O
,	O
viruses	O
such	O
as	O
Ebola	S-Pathogen
do	O
not	O
replicate	O
through	O
any	O
type	O
of	O
cell	O
division	O
;	O
rather	O
,	O
they	O
use	O
a	O
combination	O
of	O
host-	O
and	O
virally	O
encoded	O
enzymes	O
,	O
alongside	O
host	O
cell	O
structures	O
,	O
to	O
produce	O
multiple	O
copies	O
of	O
themselves	O
.	O

Sokurenko	S-Person
also	O
envisions	O
that	O
diagnostic	O
tests	O
will	O
be	O
able	O
to	O
feed	O
information	O
back	O
into	O
the	O
database	O
and	O
keep	O
it	O
constantly	O
updated	O
.	O

To	O
counteract	O
these	O
tendencies	O
,	O
recommends	O
incorporating	O
open	O
access	O
to	O
research	O
data	O
into	O
IP	O
right	O
(IPR)	O
legislation	O
.	O

Initial	O
estimates	O
of	O
the	O
basic	O
reproduction	O
number	O
(R0)	O
for	O
COVID-19	S-Disease
in	O
January	O
were	O
between	O
1.4	O
and	O
2.	O
5	O
,	O
but	O
a	O
subsequent	O
analysis	O
has	O
concluded	O
that	O
it	O
may	O
be	O
about	O
5.	O
7	O
(with	O
a	O
95	O
percent	O
confidence	O
interval	O
of	O
3.8	O
to	O
8.9)	O
.	O

But	O
officials	O
will	O
not	O
ask	O
labs	O
to	O
suspend	O
research	O
for	O
any	O
specific	O
period	O
of	O
time	O
,	O
or	O
focus	O
only	O
on	O
studies	O
involving	O
"	O
high-consequence"	O
pathogens	O
,	O
a	O
source	O
familiar	O
with	O
the	O
matter	O
tells	O
ScienceInsider	O
.	O

In	O
Sweden	S-Location
the	O
national	O
agencies	O
for	O
public	O
health	O
,	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
and	O
biodefense	O
and	O
security	O
each	O
has	O
its	O
own	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
,	O
to	O
which	O
samples	O
are	O
sent	O
for	O
analysis	O
from	O
around	O
the	O
country	O
(Figure	O
1	O
,	O
Table	O
1)	O
.	O

The	O
bill	O
also	O
would	O
renew	O
these	O
health-readiness	O
programs	O
but	O
would	O
change	O
how	O
some	O
of	O
the	O
federal	O
funds	O
get	O
spent	O
,	O
according	O
to	O
a	O
summary	O
provided	O
by	O
Rep	O
.	O

Some	O
commentators	O
believed	O
this	O
move	O
was	O
intended	O
to	O
protect	O
Chinese	B-Organization
Communist	I-Organization
Party	E-Organization
general	O
secretary	O
Xi	B-Person
Jinping	E-Person
from	O
the	O
controversy	O
.	O
The	O
U.S.	B-Organization
intelligence	O
community	O
says	O
China	S-Location
intentionally	O
under-reported	O
its	O
number	O
of	O
cases	O
.	O

On	O
27	O
September	O
a	O
new	O
42-day	O
countdown	O
began	O
to	O
declare	O
the	O
country	O
Ebola	S-Disease
-free	O
,	O
which	O
eventually	O
occurred	O
on	O
7	O
November	O
2015	O
;	O
thereafter	O
,	O
the	O
country	O
increased	O
its	O
vigilance	O
on	O
the	O
border	O
.	O

The	O
patient	O
who	O
had	O
contracted	O
the	O
virus	O
was	O
from	O
the	O
Middle	B-Location
East	E-Location
and	O
was	O
referred	O
to	O
the	O
RITM	S-Organization
on	O
4	O
July	O
2015	O
.	O

Therapeutic	O
use	O
of	O
antibiotics	O
in	O
domestic	O
pets	O
should	O
be	O
by	O
veterinarian	O
prescription	O
only	O
.	O

Title	O
42	O
of	O
the	O
Code	O
of	O
Federal	O
Regulations	O
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
citation	O
42	O
CFR	O
73	O
to	O
42	O
CFR	O
73.21	O
by	O
accessing	O
the	O
US	B-Document
Code	I-Document
of	I-Document
Federal	I-Document
Regulations	E-Document
()	O
website	O
.	O

Second	O
,	O
earlier	O
this	O
week	O
,	O
we	O
learned	O
about	O
an	O
incident	O
in	O
CDC	S-Organization
's	O
influenza	O
laboratory	O
.	O

On	O
February	O
5	O
,	O
2002	O
,	O
George	B-Person
W.	I-Person
Bush	E-Person
visited	O
the	O
RODS	B-Organization
laboratory	E-Organization
and	O
used	O
it	O
as	O
a	O
model	O
for	O
a	O
$300	O
million	O
spending	O
proposal	O
to	O
equip	O
all	O
50	O
states	O
with	O
biosurveillance	O
systems	O
.	O

The	O
criminal	O
has	O
not	O
been	O
captured	O
to	O
date	O
.	O

The	O
procedure	O
used	O
by	O
CDC	S-Organization
to	O
deactivate	O
the	O
bacteria	O
in	O
this	O
incident	O
had	O
been	O
examined	O
previously	O
for	O
effectiveness	O
.	O

The	O
circuits	O
we	O
have	O
created	O
from	O
scratch	O
are	O
small	O
and	O
are	O
made	O
up	O
of	O
only	O
a	O
handful	O
of	O
genes	O
.	O

The	O
history	O
of	O
biological	O
warfare	O
is	O
nearly	O
as	O
old	O
as	O
the	O
history	O
of	O
warfare	O
itself	O
.	O

In	O
2016	O
,	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Laboratories	E-Organization
()	O
had	O
a	O
presentation	O
at	O
their	O
annual	O
meeting	O
focused	O
on	O
improving	O
biosafety	O
culture	O
.	O

Typical	B-Equipment
CT	I-Equipment
scanners	E-Equipment
use	O
energy	O
integrating	O
detectors	O
;	O
photons	O
are	O
measured	O
as	O
a	O
voltage	O
on	O
a	O
capacitor	O
which	O
is	O
proportional	O
to	O
the	O
x-rays	O
detected	O
.	O

For	O
2017	O
,	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
(	O
FAO	S-Organization
)	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
and	O
the	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
()	O
are	O
together	O
calling	O
for	O
responsible	O
use	O
of	O
antibiotics	O
in	O
humans	O
and	O
animals	O
to	O
reduce	O
the	O
emergence	O
of	O
antibiotic	O
resistance	O
.	O

Many	O
governments	O
have	O
mandated	O
or	O
recommended	O
self-quarantine	O
for	O
entire	O
populations	O
living	O
in	O
affected	O
areas	O
.	O

Biological	O
agents	O
are	O
attractive	O
to	O
terrorists	O
because	O
they	O
are	O
extremely	O
difficult	O
to	O
detect	O
and	O
do	O
not	O
cause	O
illness	O
for	O
several	O
hours	O
to	O
several	O
days	O
.	O

Although	O
the	O
JASON	B-Document
Reports	E-Document
are	O
classified	O
,	O
another	O
US	B-Organization
Air	I-Organization
Force	E-Organization
study	O
titled	O
Biotechnology:	O
Genetically	B-Scientific_research_project
Engineered	I-Scientific_research_project
Pathogens	E-Scientific_research_project
,	O
sheds	O
some	O
light	O
on	O
what	O
the	O
secretive	O
JASON	B-Organization
group	E-Organization
has	O
researched	O
–	O
5	O
groups	O
of	O
genetically	O
engineered	O
pathogens	O
that	O
can	O
be	O
used	O
as	O
bio-weapons	O
.	O

The	O
CDC	S-Organization
advisory	O
committee	O
is	O
expected	O
to	O
revisit	O
these	O
measures	O
and	O
vote	O
on	O
options	O
at	O
its	O
meeting	O
Wednesday	O
.	O

JOHN	B-Person
ROBERTS	E-Person
Everybody	O
on	O
the	O
phone	O
was	O
asking	O
two	O
questions	O
so	O
i	O
thought	O
I	O
might	O
try	O
to	O
get	O
a	O
second	O
one	O
in	O
.	O

And	O
after	O
he	O
injected	O
himself	O
with	O
CRISPR	S-Technology
,	O
the	O
FDA	S-Organization
released	O
a	O
notice	O
saying	O
the	O
sale	O
of	O
DIY	O
gene-editing	O
kits	O
for	O
use	O
on	O
humans	O
is	O
illegal.	O
disregarded	O
the	O
warning	O
and	O
continued	O
to	O
sell	O
his	O
wares	O
.	O

WHO	S-Organization
–	O
working	O
with	O
donor	O
agencies	O
and	O
national	O
governments	O
–	O
can	O
improve	O
their	O
use	O
of	O
and	O
their	O
reporting	O
about	O
their	O
use	O
of	O
research	O
evidence	O
.	O

It	O
was	O
pushed	O
forward	O
by	O
a	O
small	O
group	O
,	O
mostly	O
healthy	O
,	O
wealthy-ish	O
men	O
,	O
certain	O
that	O
they	O
could	O
find	O
shortcuts	O
to	O
anything	O
,	O
including	O
themselves	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
Atlanta	O
was	O
chosen	O
as	O
the	O
location	O
because	O
malaria	O
was	O
endemic	O
in	O
the	O
.	O

Currently	O
there	O
are	O
over	O
4000	O
antimicrobial	O
pesticides	O
registered	O
with	O
the	O
EPA	S-Organization
and	O
sold	O
to	O
market	O
,	O
showing	O
the	O
widespread	O
use	O
of	O
these	O
agents	O
.	O

Radiocontrasts	O
for	O
are	O
,	O
in	O
general	O
,	O
iodine-based	O
.	O

The	O
US	B-Organization
Army	E-Organization
regularly	O
produces	O
deadly	O
viruses	O
,	O
bacteria	O
and	O
toxins	O
in	O
direct	O
violation	O
of	O
the	O
UN	B-Document
Convention	E-Document
on	O
the	O
prohibition	O
of	O
Biological	O
Weapons	O
.	O

Their	O
feedback	O
also	O
ensures	O
that	O
in	O
the	O
future	O
,	O
"	O
we	O
have	O
clear	O
procedures	O
,	O
resources	O
,	O
and	O
support	O
in	O
place	O
to	O
keep	O
Americans	O
safe,	O
"	O
said	O
.	O

On	O
10	O
April	O
2020	O
Google	S-Organization
and	O
Apple	S-Organization
jointly	O
announced	O
an	O
initiative	O
for	O
privacy-preserving	O
contact	O
tracing	O
based	O
on	O
Bluetooth	O
technology	O
and	O
cryptography	O
.	O

Michael	B-Person
Skeels	E-Person
Director	O
of	O
the	O
Oregon	B-Organization
State	I-Organization
Public	I-Organization
Health	I-Organization
Laboratory	E-Organization
at	O
the	O
time	O
,	O
said	O
that	O
the	O
incident	O
provoked	O
such	O
a	O
large	O
public	O
health	O
investigation	O
because	O
"	O
it	O
was	O
the	O
largest	O
food-related	O
outbreak	O
in	O
the	O
U.S.	O
in	O
1984"	O
.	O

Misinformation	O
about	O
the	O
virus	O
has	O
spread	O
through	O
social	O
media	O
and	O
the	O
mass	O
media	O
and	O
there	O
have	O
been	O
incidents	O
of	O
xenophobia	O
and	O
discrimination	O
against	O
Chinese	O
people	O
and	O
against	O
those	O
perceived	O
as	O
being	O
Chinese	O
or	O
as	O
being	O
from	O
areas	O
with	O
high	O
infection	O
rates	O
.	O

On	O
22	O
September	O
2014	O
,	O
the	O
Nigerian	O
health	O
ministry	O
announced	O
,	O
"	O
As	O
of	O
today	O
,	O
there	O
is	O
no	O
case	O
of	O
Ebola	S-Disease
in	O
Nigeria	S-Location
.	O
"	O
According	O
to	O
the	O
,	O
20 cases	O
and	O
8 deaths	O
were	O
confirmed	O
,	O
including	O
the	O
imported	O
case	O
,	O
who	O
also	O
died.	O
4	O
of	O
the	O
dead	O
were	O
health	O
workers	O
who	O
had	O
cared	O
for	O
the	O
index	O
case	O
.	O

For	O
example	O
,	O
daptomycin	S-Drug
abandoned	O
by	O
one	O
company	O
for	O
reasons	O
of	O
toxicity	O
,	O
has	O
become	O
a	O
leading	O
treatment	O
for	O
serious	O
using	O
a	O
different	O
dosing	O
regime	O
(REF)	O
.	O

It's	O
important	O
to	O
deliver	O
thousands	O
of	O
unique	O
sgRNAs-containing	O
vectors	O
to	O
a	O
single	O
vessel	O
of	O
cells	O
by	O
viral	O
transduction	O
at	O
low	O
multiplicity	O
of	O
infection	O
(MOI	O
,	O
typically	O
at	O
0.1-0.6)	O
,	O
it	O
prevents	O
the	O
probability	O
that	O
an	O
individual	O
cell	O
clone	O
will	O
get	O
more	O
than	O
one	O
type	O
of	O
sgRNA	O
otherwise	O
it	O
can	O
lead	O
to	O
incorrect	O
assignment	O
of	O
genotype	O
to	O
phenotype	O
.	O

Jesse	B-Person
Jacob	E-Person
-	O
a	O
specialist	O
in	O
bacteria	O
resistant	O
to	O
multiple	O
drugs	O
,	O
from	O
the	O
Emory	B-Organization
Antibiotic	I-Organization
Resistance	I-Organization
Center	E-Organization
at	O
the	O
Emory	B-Organization
University	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
,	O
in	O
Atlanta	S-Location
,	O
GA	S-Location
-	O
has	O
told	O
.	O

These	O
universities	O
have	O
previously	O
worked	O
together	O
in	O
one	O
of	O
the	O
institute's	O
forebears	O
-	O
the	O
Antimicrobial	B-Scientific_research_project
Resistance	I-Scientific_research_project
Consortium	E-Scientific_research_project
a	O
research	O
initiative	O
focused	O
on	O
similar	O
ends	O
.	O

As	O
this	O
process	O
is	O
repeated	O
over	O
and	O
over	O
,	O
the	O
number	O
of	O
matching	O
DNA	O
strands	O
grows	O
exponentially	O
.	O

Diagnostic	O
guidelines	O
released	O
by	O
Zhongnan	B-Organization
Hospital	I-Organization
of	I-Organization
Wuhan	I-Organization
University	E-Organization
suggested	O
methods	O
for	O
detecting	O
infections	O
based	O
upon	O
clinical	O
features	O
and	O
epidemiological	O
risk	O
.	O

The	O
high	O
ratio	O
of	O
haemorrhagic	B-Disease
smallpox	E-Disease
cases	O
in	O
this	O
outbreak	O
,	O
combined	O
with	O
the	O
rate	O
of	O
infectivity	O
and	O
the	O
testimony	O
of	O
General	O
Burgasov	S-Person
,	O
has	O
led	O
to	O
the	O
understanding	O
that	O
an	O
enhanced	O
weaponized	O
strain	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
was	O
released	O
from	O
Aralsk-7	S-Platform
in	O
1971	O
.	O

Based	O
on	O
a	O
review	O
of	O
all	O
aspects	O
of	O
the	O
June	O
incident	O
,	O
CDC	S-Organization
concluded	O
that	O
while	O
it	O
is	O
not	O
impossible	O
that	O
staff	O
members	O
were	O
exposed	O
to	O
viable	O
B.	B-Pathogen
anthracis	E-Pathogen
,	O
it	O
is	O
extremely	O
unlikely	O
that	O
this	O
occurred	O
.	O

The	O
appointment	O
attracted	O
widespread	O
condemnation	O
and	O
criticism	O
in	O
WHO	S-Organization
member	O
states	O
and	O
international	O
organizations	O
due	O
to	O
Robert	B-Person
Mugabe	E-Person
's	O
poor	O
record	O
on	O
human	O
rights	O
and	O
presiding	O
over	O
a	O
decline	O
in's	O
public	O
health	O
.	O

The	O
grand	O
prize	O
winner	O
,	O
the	O
Computational	B-Organization
Epidemiology	I-Organization
Lab	I-Organization
at	I-Organization
Boston	I-Organization
Children's	I-Organization
Hospital	E-Organization
will	O
receive	O
$150,000	O
.	O

The	O
following	O
genes	O
were	O
found	O
in	O
all	O
7	O
isolates:	O
aac	O
3-IId	O
,	O
aac	O
(6′)-Ib-cr5	O
,	O
aadA2	O
,	O
aadA22	O
,	O
aadA5	O
,	O
blaCTX-M-15	O
,	O
blaNDM-5	O
,	O
blaOXA-1	O
,	O
blaTEM-1	O
,	O
ble	O
,	O
catB3	O
,	O
dfrA12	O
,	O
dfrA17	O
,	O
mph(A)	O
,	O
qacEdelta1	O
,	O
sul1	O
,	O
and	O
tet(A)	O
.	O

The	O
sievert	O
unit	O
,	O
in	O
the	O
context	O
of	O
CT	B-Technology
scans	E-Technology
does	O
not	O
correspond	O
to	O
the	O
actual	O
radiation	O
dose	O
that	O
the	O
scanned	O
body	O
part	O
absorbs	O
but	O
to	O
another	O
radiation	O
dose	O
of	O
another	O
scenario	O
,	O
the	O
whole	O
body	O
absorbing	O
the	O
other	O
radiation	O
dose	O
and	O
the	O
other	O
radiation	O
dose	O
being	O
of	O
a	O
magnitude	O
,	O
estimated	O
to	O
have	O
the	O
same	O
probability	O
to	O
induce	O
cancer	O
as	O
the	O
CT	B-Technology
scan	E-Technology
.The	O
Measurement	O
,	O
Reporting	O
,	O
and	O
Management	O
of	O
Radiation	O
Dose	O
in	O
CT	S-Technology
"	O
It	O
is	O
a	O
single	O
dose	O
parameter	O
that	O
reflects	O
the	O
risk	O
of	O
a	O
nonuniform	O
exposure	O
in	O
terms	O
of	O
an	O
equivalent	O
whole-body	O
exposure.	O
"	O
Thus	O
,	O
as	O
is	O
shown	O
in	O
the	O
table	O
above	O
,	O
the	O
actual	O
radiation	O
that	O
is	O
absorbed	O
by	O
a	O
scanned	O
body	O
part	O
is	O
often	O
much	O
larger	O
than	O
the	O
effective	O
dose	O
suggests	O
.	O

Within	O
two	O
weeks	O
of	O
the	O
incident	O
,	O
investigators	O
were	O
questioning	O
the	O
validity	O
of	O
the	O
positive	O
ricin	O
tests	O
at	O
the	O
Senate	O
building	O
.	O

Based	O
on	O
the	O
results	O
of	O
some	O
of	O
this	O
follow-up	O
work	O
,	O
most	O
of	O
the	O
impacted	S-Phenotype
employees	O
have	O
been	O
determined	O
to	O
have	O
no	O
increased	O
risk	O
of	O
exposure	O
as	O
a	O
result	O
of	O
this	O
incident	O
,	O
and	O
therefore	O
are	O
being	O
advised	O
that	O
they	O
no	O
longer	O
need	O
to	O
take	O
antibiotics	S-Drug
and	O
vaccine	O
to	O
prevent	O
inhalation	O
.	O

One	O
of	O
the	O
big	O
arguments	O
made	O
for	O
-	O
in	O
defense	O
of	O
gain	O
of	O
function	O
work	O
on	O
flu	O
was	O
that	O
this	O
work	O
is	O
done	O
very	O
safely	O
and	O
that	O
labs	O
know	O
how	O
to	O
do	O
this	O
very	O
safely	O
.	O

One	O
study	O
from	O
22	O
April	O
found	O
that	O
people	O
with	O
COVID‑19	S-Disease
and	O
had	O
lower	O
all-cause	O
mortality	O
when	O
on	O
these	O
medications	O
.	O

Moreover	O
,	O
examination	O
of	O
mortality	O
data	O
from	O
the	O
1920s	O
suggests	O
that	O
within	O
a	O
few	O
years	O
after	O
1918	O
,	O
influenza	S-Disease
epidemics	O
had	O
settled	O
into	O
a	O
pattern	O
of	O
annual	O
epidemicity	O
associated	O
with	O
strain	O
drifting	O
and	O
substantially	O
lowered	O
death	O
rates	O
.	O

After	O
completion	O
of	O
this	O
testing	O
,	O
the	O
samples	O
will	O
be	O
destroyed	O
.	O

Adalja	S-Person
who	O
is	O
also	O
an	O
infectious	O
disease	O
doctor	O
,	O
said	O
the	O
2001	B-Incident
attacks	E-Incident
"	O
really	O
showed	O
how	O
unprepared	O
we	O
were.	O
"	O
But	O
they	O
also	O
led	O
to	O
a	O
surge	O
in	O
funding	O
and	O
initiatives	O
that	O
sought	O
to	O
make	O
the	O
more	O
resilient	O
to	O
future	O
attacks:	O
new	O
vaccines	O
,	O
new	O
medications	O
,	O
diagnostic	O
tests	O
and	O
emergency	O
hospital	O
plans	O
.	O

Mariatou	B-Person
Njie	E-Person
said:	O
"	O
This	O
workshop	O
is	O
timely	O
and	O
relevant	O
for	O
to	O
join	O
the	O
global	O
eradication	O
efforts	O
through	O
proper	O
prevention	O
and	O
control	O
strategy"	O
.	O

Even	O
diseases	O
caused	O
by	O
many	O
mutations	O
,	O
like	O
cancer	S-Disease
,	O
or	O
caused	O
by	O
a	O
virus	O
,	O
like	O
HIV/AIDS	S-Disease
,	O
could	O
be	O
treated	O
using	O
genome	O
editing	O
.	O

It	O
appoints	O
the	O
Director-General	O
every	O
five	O
years	O
and	O
votes	O
on	O
matters	O
of	O
policy	O
and	O
finance	O
of	O
WHO	S-Organization
,	O
including	O
the	O
proposed	O
budget	O
.	O

The	O
subjects'	O
physiological	O
data	O
were	O
standardized	O
to	O
remove	O
the	O
effects	O
of	O
daily	O
rhythms	O
,	O
aggregated	O
to	O
reduce	O
short-term	O
fluctuations	O
in	O
data	O
,	O
and	O
then	O
provided	O
to	O
a	O
supervised	O
binary	O
classification	O
machine	O
learning	O
algorithm	O
.	O

A	O
CT	B-Technology
scan	E-Technology
or	O
computed	B-Technology
tomography	I-Technology
scan	E-Technology
(formerly	O
computerized	B-Technology
axial	I-Technology
tomography	I-Technology
scan	E-Technology
,	O
or	O
CAT	B-Technology
scan	E-Technology
)	O
is	O
a	O
medical	O
imaging	O
procedure	O
that	O
uses	O
computer-processed	O
combinations	O
of	O
many	O
X-ray	O
measurements	O
taken	O
from	O
different	O
angles	O
to	O
produce	O
cross-sectional	O
(tomographic)	O
images	O
(virtual	O
"	O
slices")	O
of	O
specific	O
areas	O
of	O
a	O
scanned	O
object	O
,	O
allowing	O
the	O
user	O
to	O
see	O
inside	O
the	O
object	O
without	O
cutting	O
.	O

The	O
CDC	S-Organization
works	O
with	O
other	O
organizations	O
around	O
the	O
world	O
to	O
address	O
global	O
health	O
challenges	O
and	O
contain	O
disease	O
threats	O
at	O
their	O
source	O
.	O

ZMapp	S-Drug
and	O
have	O
been	O
discontinued	O
.	O

The	O
survey	O
results	O
were	O
analyzed	O
as	O
ordinal	O
data	O
,	O
responses	O
to	O
various	O
survey	O
questions	O
were	O
recorded	O
as	O
ordered	O
categories	O
(excellent	O
to	O
poor)	O
.	O

Having	O
a	O
rotating	O
presidency	O
has	O
fostered	O
trust	O
and	O
commitment	O
from	O
all	O
agencies	O
involved	O
.	O

DHS	S-Organization
manages	O
several	O
programs	O
to	O
protect	O
against	O
domestic	O
attacks	O
using	O
chemical	O
agents	O
.	O

The	O
aim	O
of	O
the	O
network	O
is	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
to	O
improve	O
Sweden	S-Location
's	O
biopreparedness	O
,	O
in	O
line	O
with	O
recommendations	O
from	O
the	O
EU	S-Location
and	O
WHO	S-Organization
.	O
Since	O
forming	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
quality	O
assurance	O
protocols	O
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

The	O
topics	O
most	O
commonly	O
addressed	O
in	O
these	O
awareness	O
sessions	O
included	O
basic	O
biosafety	O
,	O
biosecurity	O
,	O
biocontainment	O
,	O
and	O
biorisk	O
management	O
in	O
biomedical	O
and	O
biotechnology	O
laboratories	O
.	O

Now	O
,	O
the	O
institute	O
will	O
help	O
coordinate	O
and	O
implement	O
recommendations	O
for	O
universities	O
and	O
veterinary	O
medical	O
colleges	O
throughout	O
.	O

Azar	S-Person
discussed	O
the	O
need	O
for	O
a	O
"	O
culture	O
of	O
preparedness	O
"	O
to	O
combat	O
these	O
threats	O
.	O

The	O
American	B-Organization
Medical	I-Organization
Association	E-Organization
the	O
American	B-Organization
Psychological	I-Organization
Association	E-Organization
and	O
the	O
American	B-Organization
Academy	I-Organization
of	I-Organization
Pediatrics	E-Organization
sent	O
a	O
letter	O
to	O
the	O
leaders	O
of	O
the	O
Senate	B-Organization
Appropriations	I-Organization
Committee	E-Organization
in	O
2013	O
asking	O
them	O
"	O
to	O
support	O
at	O
least	O
$10million	O
within	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
in	O
FY	O
2014	O
along	O
with	O
sufficient	O
new	O
funding	O
at	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
to	O
support	O
research	O
into	O
the	O
causes	O
and	O
prevention	O
of	O
gun	O
violence	O
.	O

He	O
says	O
that	O
China	S-Location
cannot	O
import	O
enough	O
pigs	O
to	O
make	O
up	O
the	O
shortfall	O
.	O

On	O
3	O
April	O
,	O
a	O
WHO	O
team	O
of	O
international	O
scientists	O
landed	O
in	O
Guangzhou	S-Location
from	O
Beijing	S-Location
to	O
discuss	O
with	O
officials	O
,	O
but	O
the	O
team	O
was	O
yet	O
to	O
inspect	O
any	O
suspected	O
origin	O
or	O
any	O
medical	O
facilities	O
on	O
the	O
progress	O
of	O
infection	O
control	O
.	O

The	O
fabrication	O
methods	O
and	O
device	O
characteristics	O
were	O
described	O
at	O
the	O
50th	O
Electronic	O
Materials	O
Conference	O
in	O
Santa	B-Location
Barbara	E-Location
on	O
June	O
25	O
,	O
2008	O
.	O

Some	O
outbreaks	O
,	O
such	O
as	O
food	B-Disease
poisoning	E-Disease
due	O
to	O
E.	B-Pathogen
coli	E-Pathogen
or	O
,	O
could	O
be	O
of	O
either	O
natural	O
or	O
deliberate	O
origin	O
.	O

Joseph	B-Person
Kanabrocki	E-Person
PhD	O
,	O
CBSP	O
,	O
is	O
Associate	O
Vice	O
President	O
for	O
Research	O
Safety	O
and	O
Professor	O
of	O
Microbiology	O
,	O
University	B-Organization
of	I-Organization
Chicago	E-Organization
.	O
In	O
this	O
capacity	O
,	O
Dr	O
.	O

climb	O
out	O
of	O
one	O
of	O
these	O
locking	O
medical	O
waste	O
barrels	O
,	O
which	O
contained	O
soiled	O
mouse	O
disposable	O
caging	O
,	O
bedding	O
and	O
uneaten	O
food	O
.	O

The	O
importance	O
of	O
detecting	O
different	O
viral	O
strains	O
in	O
research	O
and	O
clinic	O
is	O
discussed	O
.	O

"	O
If	O
our	O
Insect	B-Organization
allies	I-Organization
research	I-Organization
institutions	E-Organization
succeed	O
and	O
move	O
to	O
apply	O
their	O
work	O
in	O
the	O
future	O
,	O
they	O
will	O
need	O
to	O
go	O
through	O
the	O
standard	O
regulatory	O
process	O
for	O
approval,	O
"	O
he	O
said	O
.	O

In	O
May	O
2019	O
,	O
the	O
reported	O
that	O
since	O
January	O
there	O
had	O
been	O
42	O
attacks	O
on	O
health	O
facilities	O
and	O
85	O
health	O
workers	O
had	O
been	O
wounded	O
or	O
killed	O
.	O

Cuba	S-Organization
also	O
accused	O
the	O
of	O
spreading	O
human	O
and	O
animal	O
disease	O
on	O
their	O
island	O
nation	O
.	O

The	O
potentially	O
infectious	O
samples	O
were	O
moved	O
and	O
used	O
for	O
experimentation	O
in	O
three	O
CDC	B-Organization
Roybal	I-Organization
campus	I-Organization
laboratories	E-Organization
not	O
equipped	O
to	O
handle	O
live	O
B.anthracis	S-Pathogen
.	O
Workers	O
,	O
believing	O
the	O
samples	O
were	O
inactivated	O
,	O
were	O
not	O
wearing	O
adequate	O
while	O
handling	O
the	O
material	O
.	O

Hence	O
,	O
students	O
work	O
with	O
it	O
only	O
after	O
gaining	O
experience	O
with	O
the	O
MulV	S-Pathogen
vector	O
under	O
conditions	O
and	O
personal	O
supervision	O
.	O

MIKE	B-Person
STOBBE	E-Person
And	O
could	O
you	O
say	O
how	O
many	O
BSL-3	B-Organization
and	I-Organization
-4	I-Organization
labs	E-Organization
there	O
are	O
,	O
and	O
are	O
they	O
all	O
in	O
,	O
or	O
where	O
are	O
they?	O

The	O
most	O
common	O
mechanism	O
of	O
horizontal	O
gene	O
transfer	O
is	O
the	O
transferring	O
of	O
plasmids	O
carrying	O
antibiotic	O
resistance	O
genes	O
between	O
bacteria	O
of	O
the	O
same	O
or	O
different	O
species	O
via	O
conjugation	O
.	O

In	O
Chile	S-Location
and	O
Australia	S-Location
,	O
two	O
countries	O
with	O
many	O
flu	S-Disease
cases	O
,	O
she	O
said	O
H1N1	S-Pathogen
appears	O
to	O
be	O
the	O
dominant	O
strain	O
,	O
"	O
crowding	O
out	O
"	O
the	O
seasonal	O
virus	O
.	O

Belgium	S-Organization
recalled	O
100,000	O
unusable	O
masks	O
,	O
which	O
were	O
thought	O
to	O
be	O
from	O
China	S-Location
but	O
were	O
in	O
fact	O
from	O
Colombia	S-Location
.	O
The	O
Philippines	S-Organization
stopped	O
using	O
test	O
kits	O
donated	O
by	O
China	S-Location
due	O
to	O
their	O
40	O
percent	O
accuracy	O
.	O

In	O
addition	O
,	O
it	O
will	O
cover	O
studies	O
involving	O
any	O
kind	O
of	O
pathogen	O
,	O
not	O
just	O
the	O
most	O
dangerous	O
agents	O
.	O

In	O
2003	O
,	O
the	O
DOD	S-Organization
reported	O
it	O
had	O
identified	O
5,842	O
military	O
personnel	O
and	O
estimated	O
350	O
civilians	O
as	O
being	O
potentially	O
exposed	O
during	O
the	O
testing	O
,	O
known	O
as	O
.	O

During	O
the	O
height	O
of	O
the	O
crisis	O
,	O
Wikipedia	S-Platform
Ebola	S-Disease
page	O
received	O
2.	O
5	O
million	O
page	O
views	O
per	O
day	O
,	O
making	O
Wikipedia	S-Platform
one	O
of	O
the	O
world's	O
most	O
highly	O
used	O
sources	O
of	O
trusted	O
medical	O
information	O
regarding	O
the	O
disease	O
.	O

The	O
Oxford	O
Textbook	O
of	O
Clinical	O
Research	O
Ethics	O
,	O
pp	O
,	O
35	O
,	O
42	O
.	O

Efforts	O
have	O
also	O
been	O
taken	O
to	O
ensure	O
that	O
these	O
medical	O
countermeasures	O
can	O
be	O
disseminated	O
effectively	O
in	O
the	O
event	O
of	O
a	O
bioterrorist	O
attack	O
.	O

It	O
is	O
thought	O
to	O
have	O
originated	O
in	O
China	S-Location
in	O
a	O
rare	O
genetic	O
shift	O
of	O
the	O
influenza	O
virus	O
.	O

Some	O
954	O
contacts	O
were	O
successfully	O
followed	O
up	O
on	O
18	O
August	O
,	O
however	O
,	O
Mandima	B-Organization
Health	I-Organization
Zone	E-Organization
indicated	O
resistance	O
;	O
as	O
a	O
consequence	O
,	O
contacts	O
were	O
not	O
followed	O
up	O
there	O
per	O
the	O
.	O

H1N1	S-Pathogen
viruses	O
descended	O
from	O
the	O
1918	O
strain	O
,	O
as	O
well	O
as	O
viruses	O
,	O
have	O
now	O
been	O
cocirculating	O
worldwide	O
for	O
29	O
years	O
and	O
show	O
little	O
evidence	O
of	O
imminent	O
extinction	O
.	O

Table	O
1	O
provides	O
a	O
summary	O
of	O
recommended	O
biosafety	O
levels	O
for	O
infectious	O
agents	O
.	O

Collaboration	O
agreements	O
were	O
signed	O
by	O
the	O
4	O
agencies	O
in	O
2008	O
and	O
renewed	O
in	O
2014	O
.	O

Medications	O
to	O
prevent	O
blood	B-Disease
clotting	E-Disease
have	O
been	O
suggested	O
for	O
treatment	O
,	O
and	O
anticoagulant	O
therapy	O
with	O
low	O
molecular	O
weight	O
heparin	O
appears	O
to	O
be	O
associated	O
with	O
better	O
outcomes	O
in	O
severe	O
COVID‐19	O
showing	O
signs	O
of	O
coagulopathy	S-Phenotype
()	O
.	O

&quot;I	O
don't	O
think	O
we've	O
done	O
anywhere	O
near	O
the	O
amount	O
of	O
work	O
necessary	O
to	O
create	O
the	O
medical	O
understanding	O
,	O
the	O
psychological	O
understanding	O
,	O
and	O
maybe	O
even	O
the	O
genetic	O
understanding	O
of	O
what	O
happens	O
to	O
people	O
who	O
are	O
exposed,&quot	O
;	O
said	O
Blue	O
Ribbon	O
Study	O
Pan	O
el	B-Person
member	I-Person
T	E-Person
Daschle	O
,	O
a	O
former	O
majority	O
leadU.S.Senate	O
.	O

Yes	O
,	O
thank	O
you	O
for	O
taking	O
my	O
question.Dr	O
.	O

The	O
coffin	O
was	O
found	O
to	O
be	O
split	O
and	O
the	O
cadaver	O
badly	O
decomposed	O
;	O
nonetheless	O
,	O
samples	O
of	O
lung	O
and	O
brain	O
tissue	O
were	O
taken	O
.	O

These	O
individuals	O
are	O
being	O
advised	O
to	O
continue	O
post-exposure	O
prophylaxis	O
(	O
antibiotics	S-Drug
and	O
vaccine)	O
.	O

In	O
1918	O
,	O
the	O
cause	O
of	O
human	O
influenza	S-Disease
and	O
its	O
links	O
to	O
avian	O
and	O
swine	B-Disease
influenza	E-Disease
were	O
unknown	O
.	O

One	O
of	O
the	O
most	O
direct	O
routes	O
to	O
informing	O
scientific	O
debates	O
is	O
through	O
the	O
timely	O
publication	O
of	O
relevant	O
research	O
results	O
.	O

On	O
11	O
June	O
2019	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
the	O
virus	O
had	O
spread	O
to	O
Uganda	S-Location
.	O
A	O
5-year-old	O
Congolese	O
boy	O
entered	O
Uganda	S-Location
on	O
the	O
previous	O
Sunday	O
with	O
his	O
family	O
to	O
seek	O
medical	O
care	O
.	O

One	O
hour	O
postinfection	O
,	O
10%	O
FCS	O
and	O
DMEM	O
were	O
added	O
to	O
achieve	O
a	O
total	O
volume	O
of	O
100 μl	O
,	O
and	O
cells	O
were	O
incubated	O
for	O
a	O
further	O
48	O
hr	O
at	O
37°C	O
in	O
5%	O
CO2	O
.	O

Supply	O
could	O
now	O
change	O
with	O
demand	O
,	O
and	O
costs	O
dropped	O
.	O

He	O
urged	O
to	O
classify	O
the	O
situation	O
as	O
a	O
PHEIC	O
,	O
to	O
facilitate	O
the	O
release	O
of	O
international	O
aid	O
.	O

NANCY	B-Person
SNYDERMAN	E-Person
And	O
on	O
a	O
secondary	O
note	O
very	O
quickly	O
,	O
the	O
whole	O
idea	O
of	O
keeping	O
smallpox	S-Pathogen
,	O
keeping	O
anthrax	S-Pathogen
cultures	O
,	O
would	O
you	O
talk	O
for	O
a	O
second	O
about	O
bioterrorism	O
and	O
why	O
certain	O
materials	O
are	O
kept	O
at	O
the	O
?	O

Researchers	O
at	O
MIT	B-Organization
Lincoln	I-Organization
Laboratory	E-Organization
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	I-Organization
Integrated	I-Organization
Research	I-Organization
Facility	E-Organization
(	O
NIH-IRF	S-Organization
)	O
,	O
and	O
the	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
()	O
are	O
developing	O
a	O
technology	O
that	O
may	O
provide	O
those	O
early	O
warnings	O
.	O

More	O
than	O
600,000	O
doses	O
of	O
oral	O
polio	B-Vaccine
vaccine	E-Vaccine
have	O
already	O
been	O
distributed	O
in	O
for	O
supplemental	O
immunisation	O
activities	O
.	O

Although	O
the	O
investigation	O
continues	O
,	O
early	O
reports	O
show	O
that	O
one	O
of	O
its	O
Roybal	O
campus	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
(	O
BSL3	S-Platform
)	O
labs	O
was	O
preparing	O
B.	B-Pathogen
anthracis	E-Pathogen
samples	O
for	O
research	O
in	O
other	O
labs	O
at	O
lower	O
biosafety	O
levels	O
to	O
yield	O
new	O
means	O
of	O
detecting	O
dangerous	O
pathogens	O
in	O
environmental	O
samples	O
.	O

On	O
25	O
March	O
,	O
Hong	B-Organization
Kong	I-Organization
authorities	E-Organization
stated	O
that	O
nine	O
tourists	O
had	O
contracted	O
the	O
disease	O
from	O
a	O
mainland	O
Chinese	O
man	O
who	O
had	O
boarded	O
the	O
same	O
plane	O
on	O
15	O
March	O
,	O
Air	B-Organization
China	E-Organization
Flight	O
112	O
to	O
Beijing	S-Location
.	O
The	O
started	O
to	O
enforce	O
compulsory	O
quarantine	O
of	O
any	O
infected	O
person	O
.	O

A	O
massive	O
effort	O
is	O
underway	O
to	O
ensure	O
robust	O
prevention	O
,	O
surveillance	O
and	O
response	O
capacity	O
across	O
all	O
three	O
countries	O
by	O
the	O
end	O
of	O
March.	O
"	O
On	O
16	O
January	O
aid	O
workers	O
reported	O
that	O
a	O
woman	O
had	O
died	O
of	O
the	O
virus	O
and	O
that	O
she	O
may	O
have	O
exposed	O
several	O
individuals	O
;	O
the	O
government	O
later	O
announced	O
that	O
100	O
people	O
had	O
been	O
quarantined	O
.	O

The	O
target	O
sequence	O
is	O
20	O
bases	O
long	O
as	O
part	O
of	O
each	O
locus	O
in	O
the	O
crRNA	O
array	O
.	O

Pathogens	O
developed	O
by	O
the	O
organization	O
would	O
be	O
used	O
in	O
open-air	O
trials	O
.	O

Although	O
the	O
laboratory	O
generation	O
of	O
the	O
mutant	O
influenza	O
virus	O
H5N1	S-Pathogen
with	O
airborne	O
transmissibility	O
among	O
mammals	O
,	O
which	O
has	O
been	O
considered	O
as	O
a	O
dual-use	O
research	O
,	O
may	O
benefit	O
the	O
development	O
of	O
effective	O
vaccines	O
and	O
therapeutics	O
against	O
the	O
emerging	O
infectious	O
agents	O
,	O
it	O
may	O
also	O
pose	O
threats	O
to	O
national	O
biosecurity	O
,	O
laboratory	O
biosafety	O
,	O
and/or	O
public	O
health	O
.	O

Cooperation	O
can	O
benefit	O
each	O
other	O
,	O
including	O
further	O
discussions	O
into	O
the	O
making	O
or	O
revision	O
of	O
biological	B-Document
agent	I-Document
category	I-Document
lists	E-Document

The	O
documents	O
are	O
comprised	O
of	O
four	O
layers	O
,	O
including	O
the	O
management	O
manual	O
(30	O
files	O
,	O
describe	O
the	O
quality	O
management	O
system	O
documentation)	O
,	O
program	O
documents	O
(50	O
files	O
,	O
describe	O
the	O
function	O
of	O
quality	O
requirement	O
allocation)	O
,	O
standard	O
operation	O
procedures	O
(SOP)	O
(20	O
files	O
,	O
describe	O
the	O
operation	O
procedures	O
,	O
inspection	O
standard	O
,	O
etc.	O
)	O
,	O
and	O
working	O
manual	O
(29	O
files	O
,	O
describe	O
the	O
records	O
of	O
operation	O
results)	O
.	O

This	O
topic	O
last	O
updated:	O
Dec	O
04	O
,	O
2017	O
.	O

Multivariate	O
analyses	O
showed	O
that	O
physician-recorded	O
obesity	O
on	O
admission	O
and	O
pulmonary	O
conditions	O
other	O
th	O
an	B-Disease
ast	E-Disease
hma	O
or	B-Disease
chronic	I-Disease
obstructive	I-Disease
pulmonary	I-Disease
dise	E-Disease
as	O
e	B-Disease
(C	E-Disease
OPD)	O
were	O
associated	O
with	O
a	O
severe	O
outcome	O
,	O
as	O
were	O
radiologically	O
confirmnia	O
and	O
a	O
raised	O
C-reactive	O
protein	O
(CRP)	O
level	O
(≥	O
.	O

Los	B-Organization
Angeles	I-Organization
Police	I-Organization
Department	E-Organization
Detective	O
,	O
who	O
with	O
his	O
partner	O
is	O
conducting	O
the	O
investigation	O
,	O
said	O
it	O
is	O
in	O
its	O
"	O
embryo	O
stage	O
"	O
and	O
that	O
tests	O
will	O
be	O
conducted	O
on	O
the	O
letter's	O
stationery	O
and	O
envelope	O
.	O

The	O
affected	O
area	O
has	O
about	O
one	O
million	O
uprooted	O
people	O
and	O
shares	O
borders	O
with	O
Rwanda	S-Location
and	O
,	O
with	O
cross	O
border	O
movement	O
because	O
of	O
trade	O
activities	O
.	O

The	O
e-Bug	B-Scientific_research_project
programme	E-Scientific_research_project
that	O
has	O
been	O
launched	O
as	O
a	O
pan-European	O
effort	O
is	O
a	O
prime	O
example	O
of	O
what	O
can	O
be	O
done	O
to	O
educate	O
children	O
(and	O
their	O
parents)	O
of	O
the	O
necessity	O
for	O
the	O
entire	O
population	O
to	O
take	O
antibiotic	O
use	O
and	O
resistance	O
development	O
personally	O
(Ref)	O
.	O

In	O
the	O
influenza	B-Incident
episode	E-Incident
,	O
we	O
will	O
certainly	O
try	O
to	O
understand	O
what	O
went	O
into	O
that	O
delay	O
because	O
we	O
think	O
that's	O
very	O
unusual	O
behavior	O
for	O
CDC	S-Organization
and	O
not	O
acceptable	O
behavior	O
.	O

We	O
wish	O
to	O
emphasize	O
that	O
the	O
5th	O
edition	O
of	O
the	O
remains	O
an	O
advisory	O
document	O
recommending	O
best	O
practices	O
for	O
the	O
safe	O
conduct	O
of	O
work	O
in	O
biomedical	O
and	O
clinical	O
laboratories	O
from	O
a	O
biosafety	O
perspective	O
,	O
and	O
is	O
not	O
intended	O
as	O
a	O
regulatory	O
document	O
though	O
we	O
recognize	O
that	O
it	O
will	O
be	O
used	O
that	O
way	O
by	O
some	O
.	O

On	O
2	O
September	O
2014	O
,	O
WHO	S-Organization
Director-General	O
Margaret	B-Person
Chan	E-Person
advised	O
against	O
this	O
,	O
saying	O
that	O
they	O
were	O
not	O
justified	O
and	O
that	O
they	O
would	O
prevent	O
medical	O
experts	O
from	O
entering	O
the	O
affected	O
areas	O
.	O

According	O
to	O
the	O
same	O
report	O
,	O
the	O
median	O
time	O
between	O
the	O
onset	O
of	O
symptoms	O
and	O
death	O
was	O
ten	O
days	O
,	O
with	O
five	O
being	O
spent	O
hospitalised	O
.	O

On	O
16	O
April	O
2014	O
,	O
an	O
Overseas	O
Filipino	O
Worker	O
(OFW)	O
who	O
returned	O
from	O
Al	B-Location
Ain	I-Location
City	E-Location
United	B-Location
Arab	I-Location
Emirates	E-Location
was	O
found	O
positive	O
for	O
MERS-CoV	S-Pathogen
at	O
the	O
Ninoy	B-Organization
Aquino	I-Organization
International	I-Organization
Airport	E-Organization
.	O
The	O
OFW	O
was	O
tested	O
for	O
the	O
virus	O
in	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
(	O
UAE	S-Location
)	O
but	O
immediately	O
travelled	O
to	O
Manila	S-Location
.	O
Doctors	O
from	O
UAE	S-Location
later	O
contacted	O
the	O
Philippines	B-Organization
Department	I-Organization
of	I-Organization
Health	E-Organization
(	O
DOH	S-Organization
)	O
confirming	O
the	O
condition	O
of	O
the	O
OFW	O
.	O

The	O
U.S.	S-Location
answer	O
to	O
this	O
risk	O
is	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)	O
,	O
a	O
modern	O
partnership	O
building	O
and	O
strengthening	O
capacity	O
to	O
thwart	O
disease	O
threats	O
where	O
they	O
start.	O
leverages	O
a	O
multisectoral	O
approach	O
with	O
government	O
and	O
private	O
sector	O
engagement	O
,	O
new	O
technology	O
and	O
expertise	O
to	O
elevate	O
health	O
security	O
as	O
a	O
component	O
of	O
our	O
national	O
security	O
.	O

This	O
bioterrorist	O
attack	O
inevitably	O
prompted	O
seven	O
cases	O
of	O
cutaneous	B-Disease
anthrax	E-Disease
and	O
eleven	O
cases	O
of	O
inhalation	B-Disease
anthrax	E-Disease
,	O
with	O
five	O
leading	O
to	O
deaths	O
.	O

On	O
31	O
January	O
2020	O
,	O
Italy	S-Location
had	O
its	O
first	O
confirmed	O
cases	O
,	O
two	O
tourists	O
from	O
China	S-Location
.	O
As	O
of	O
13	O
March	O
2020	O
,	O
the	O
WHO	S-Organization
considered	O
Europe	S-Location
the	O
active	O
centre	O
of	O
the	O
pandemic	O
.	O

We	O
suggest	O
that	O
the	O
classification	O
of	O
biological	O
agents	O
based	O
on	O
laboratory	O
biosafety	O
should	O
reduce	O
the	O
number	O
of	O
inconsistencies	O
and	O
contradictions	O
.	O

The	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
the	O
only	O
other	O
center	O
in	O
the	O
world	O
approved	O
and	O
known	O
to	O
have	O
live	O
samples	O
of	O
the	O
deadly	O
.	O

Biotechnol.	O
30	O
,	O
541-552	O
,	O
1989)	O
,	O
the	O
European	B-Organization
Committee	I-Organization
for	I-Organization
Standardization	E-Organization
(European	O
Committee	O
for	O
Standardization,Technical	O
Committee	O
233	O
-	O
Biotechnology	O
,	O
Working	O
group	O
1	O
.	O

Among	O
them	O
,	O
Genotyping	O
DNA	O
Samples	O
from	O
Lymphoma	S-Disease
cases	O
and	O
from	O
controls	O
(healthy	O
patients)	O
,	O
Breast	B-Disease
cancer	E-Disease
tissue	O
blocks	O
from	O
breast	B-Disease
cancer	E-Disease
patients	O
,	O
Saliva	O
samples	O
of	O
50	O
families	O
who	O
have	O
3	O
or	O
more	O
cases	O
of	O
UGI	B-Disease
cancer	E-Disease
,	O
Genotype	O
50	O
SNP'S	O
for	O
DNA	O
samples	O
from	O
the	O
Cancer	O
Hospital	O
,	O
Beijing	S-Location
,	O
Genotypes	O
from	O
3000	O
cases	O
of	O
gastric	B-Disease
cancer	E-Disease
and	O
3000	O
controls	O
(healthy	O
patients)	O
in	O
.	O

The	O
advisory	O
group	O
provides	O
strategic	O
guidance	O
on	O
the	O
program's	O
effort	O
to	O
reduce	O
global	O
biological	O
risks	O
.	O

Diplomatic	O
relations	O
between	O
Japan	S-Location
and	O
South	B-Location
Korea	E-Location
worsened	O
due	O
to	O
the	O
pandemic	O
.	O

The	O
majority	O
of	O
fatalities	O
,	O
from	O
both	O
the	O
war	O
and	O
the	O
epidemic	O
,	O
were	O
among	O
young	O
adults	O
.	O

In	O
a	O
2009	O
paper	O
published	O
in	O
the	O
journal	O
Clinical	O
Infectious	O
Diseases	O
,	O
Karen	B-Person
Starko	E-Person
proposed	O
that	O
aspirin	S-Drug
poisoning	O
contributed	O
substantially	O
to	O
the	O
fatalities	O
.	O

Source:	O
Adapted	O
from	O
original	O
by	O
Dorothy	B-Person
Ryan	E-Person
,	O
edited	O
for	O
context	O
and	O
format	O
by	O
Global	O
Biodefense	O
.	O

As	O
the	O
infestation	O
spread	O
across	O
the	O
Los	B-Location
Angeles	I-Location
Basin	E-Location
to	O
parts	O
of	O
Brea	S-Location
,	O
La	B-Location
Habra	E-Location
and	O
Fullerton	S-Location
in	O
,	O
however	O
,	O
scientists	O
did	O
not	O
find	O
nearly	O
as	O
many	O
larvae	O
.	O

The	O
major	O
part	O
of	O
the	O
outbreak	O
lasted	O
about	O
8	O
months	O
,	O
since	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
declared	O
SARS	S-Disease
contained	O
on	O
5	O
July	O
2003	O
.	O

Late	O
last	O
month	O
,	O
a	O
researcher	O
who	O
worked	O
in	O
the	O
same	O
general	O
lab	O
area	O
was	O
hospitalized	O
with	O
a	O
skin	O
infection	O
caused	O
by	O
a	O
common	O
bacterium	O
being	O
studied	O
in	O
her	O
lab	O
.	O

The	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	I-Organization
(NIAID)	I-Organization
Integrated	I-Organization
Research	I-Organization
Facility	E-Organization
(	O
IRF	S-Organization
)	O
is	O
part	O
of	O
the	O
National	B-Organization
Interagency	I-Organization
Biodefense	I-Organization
Campus	E-Organization
based	O
at	O
Fort	B-Location
Detrick	E-Location
,	O
.	O

Please	O
see	O
the	O
BRAG	S-Document
request	O
for	O
applications	O
for	O
details	O
.	O

This	O
was	O
subsequently	O
replaced	O
by	O
a	O
series	O
of	O
simple	O
checkpoints	O
for	O
hand-washing	O
and	O
measuring	O
body	O
temperature	O
on	O
major	O
roads	O
throughout	O
the	O
region	O
,	O
manned	O
either	O
by	O
local	O
volunteers	O
or	O
by	O
the	O
military	O
.	O

Another	O
biohack	O
that	O
definitely	O
falls	O
in	O
the	O
"	O
don't	O
try	O
this	O
at	O
home	O
"	O
category:	O
fecal	O
transplants	O
,	O
or	O
transferring	O
stool	O
from	O
a	O
healthy	O
donor	O
into	O
the	O
gastrointestinal	O
tract	O
of	O
an	O
unhealthy	O
recipient	O
.	O

The	O
assignment	O
of	O
Personal	B-Equipment
Protective	I-Equipment
Equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
is	O
considered	O
to	O
be	O
the	O
"	O
last	O
resort	O
"	O
for	O
preventing	O
and	O
protecting	O
against	O
hazard	O
exposures	O
.	O

In	O
1351	O
or	O
1352	O
,	O
the	O
Rasulid	B-Location
sultan	E-Location
of	O
the	O
Yemen	S-Location
,	O
al-Mujahid	B-Person
Ali	E-Person
,	O
was	O
released	O
from	O
Mamluk	O
captivity	O
in	O
Egypt	S-Location
and	O
carried	O
the	O
plague	S-Disease
with	O
him	O
on	O
his	O
return	O
home	O
.	O

2000:	O
The	O
Stop	O
TB	S-Disease
Partnership	O
was	O
created	O
along	O
with	O
the	O
.	O

An	O
increased	O
international	O
donor	O
interest	O
was	O
noted	O
in	O
the	O
BMENA	S-Location
region	O
for	O
biosafety	O
and	O
biosecurity	O
initiatives	O
post	O
2000	O
;	O
80%	O
of	O
the	O
initiatives	O
reviewed	O
were	O
funded	O
by	O
international	O
donor/scientific	O
agencies	O
such	O
as	O
the	O
United	B-Organization
Nations	I-Organization
WHO	I-Organization
and	I-Organization
the	I-Organization
Environment	I-Organization
Programme	E-Organization
(	O
UNEP	S-Organization
)	O
,	O
the	O
International	B-Organization
Council	I-Organization
for	I-Organization
Life	I-Organization
Scientists	E-Organization
(	O
ICLS	S-Organization
)	O
,	O
and	O
CRDF	B-Organization
Global	E-Organization
.	O
United	B-Location
States	E-Location
sponsored/funded	O
biosafety	O
activities	O
organized	O
in	O
2001–2013	O
in	O
the	O
BMENA	S-Location
region	O
included	O
the	O
Department	B-Organization
of	I-Organization
State	I-Organization
Cooperative	I-Organization
Biosafety	I-Organization
Engagement	I-Organization
Program	E-Organization
(	O
CBEP	S-Organization
)	O
and	O
the	O
American	B-Organization
Association	I-Organization
for	I-Organization
the	I-Organization
Advancement	I-Organization
of	I-Organization
Science-Center	I-Organization
for	I-Organization
Science,	I-Organization
Technology,	I-Organization
and	I-Organization
Security	I-Organization
Policy	E-Organization
()	O
.	O

Eitzen	S-Person
Edward	B-Person
M.	E-Person
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
Borden	B-Organization
Institute	E-Organization
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	B-Location
Air	I-Location
Force	I-Location
Base	E-Location
.	O
Retrieved	O
January	O
5	O
,	O
2009	O
.	O

Rajneesh	S-Person
left	O
Oregon	S-Location
by	O
plane	O
on	O
October	O
27	O
,	O
1985	O
,	O
and	O
was	O
arrested	O
when	O
he	O
landed	O
in	O
Charlotte	S-Location
,	O
North	B-Location
Carolina	E-Location
,	O
and	O
charged	O
with	O
35	O
counts	O
of	O
deliberate	O
violations	O
of	O
immigration	O
laws	O
.	O

Again	O
,	O
the	O
cause	O
was	O
likely	O
an	O
unauthorized	O
or	O
untested	O
procedure	O
to	O
inactivate	O
the	O
virus	O
.	O

In	O
fact	O
,	O
does	O
not	O
necessarily	O
have	O
a	O
central	O
role	O
in	O
the	O
early	O
stages	O
of	O
a	O
biowarfare	O
programme	O
.	O

COVID-19	S-Pathogen
also	O
poses	O
a	O
greater	O
risk	O
to	O
people	O
who	O
misuse	O
opioids	S-Drug
and	O
methamphetamines	S-Drug
,	O
insofar	O
as	O
their	O
drug	O
use	O
may	O
have	O
caused	O
.	O

For	O
instance	O
,	O
an	O
envelope	O
with	O
powder	O
in	O
it	O
that	O
says	O
,	O
"	O
You've	O
just	O
been	O
exposed	O
to	O
anthrax	S-Pathogen
"	O
Such	O
hoaxes	O
already	O
showed	O
to	O
produce	O
a	O
large	O
psychological	O
impact	O
on	O
the	O
population	O
.	O

Under	O
current	O
United	O
States	O
law	O
,	O
bio-agents	O
which	O
have	O
been	O
declared	O
by	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
or	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
to	O
have	O
the	O
"	O
potential	O
to	O
pose	O
a	O
severe	O
threat	O
to	O
public	O
health	O
and	O
safety	O
"	O
are	O
officially	O
defined	O
as	O
"	O
select	O
agents.	O
"	O
The	O
CDC	S-Organization
categorizes	O
these	O
agents	O
(A	O
,	O
B	O
or	O
C)	O
and	O
administers	O
the	O
Select	B-Scientific_research_project
Agent	I-Scientific_research_project
Program	E-Scientific_research_project
,	O
which	O
regulates	O
the	O
laboratories	O
which	O
may	O
possess	O
,	O
use	O
,	O
or	O
transfer	O
select	O
agents	O
within	O
the	O
United	B-Location
States	E-Location
.	O
As	O
with	O
US	O
attempts	O
to	O
categorize	O
harmful	O
recreational	O
drugs	O
,	O
designer	O
viruses	O
are	O
not	O
yet	O
categorized	O
and	O
has	O
been	O
shown	O
to	O
achieve	O
high	O
mortality	O
and	O
human-communication	O
in	O
a	O
laboratory	O
setting	O
.	O

A	O
variety	O
of	O
techniques	O
are	O
used	O
,	O
depending	O
on	O
the	O
suspected	O
abnormality	O
.	O

The	O
radiation	O
used	O
in	O
CT	S-Technology
scans	O
can	O
damage	O
body	O
cells	O
,	O
including	O
DNA	O
molecules	O
,	O
which	O
can	O
lead	O
to	O
radiation-induced	O
cancer	O
.	O

How	O
do	O
you	O
biohack	O
with	O
nootropics	S-Drug

Fifth	O
,	O
I've	O
ordered	O
an	O
investigation	O
to	O
determine	O
the	O
root	O
causes	O
that	O
led	O
to	O
contamination	B-Incident
of	I-Incident
H5N1	I-Incident
in	I-Incident
the	I-Incident
influenza	I-Incident
laboratory	E-Incident
.	O
Sixth	O
,	O
I've	O
reported	O
the	O
incident	O
through	O
the	O
proper	O
channels	O
-	O
or	O
CDC	S-Organization
has	O
reported	O
the	O
incident	O
through	O
the	O
proper	O
channels	O
to	O
the	O
select	O
agent	O
oversight	O
body	O
,	O
the	O
agriculture	B-Organization
department	E-Organization
's	O
inspection	O
service	O
which	O
is	O
known	O
as	O
.	O

These	O
involved	O
identifying	O
people	O
who	O
had	O
at	O
least	O
two	O
of	O
the	O
following	O
symptoms	O
in	O
addition	O
to	O
a	O
history	O
of	O
travel	O
to	O
Wuhan	S-Location
or	O
contact	O
with	O
other	O
infected	O
people:	O
fever	S-Phenotype
,	O
imaging	O
features	O
of	O
pneumonia	S-Disease
,	O
normal	B-Phenotype
or	I-Phenotype
reduced	I-Phenotype
white	I-Phenotype
blood	I-Phenotype
cell	I-Phenotype
count	E-Phenotype
,	O
or	O
.	O

In	O
addition	O
,	O
Ling	S-Person
and	O
Poste	S-Person
told	O
the	O
panel	O
that	O
the	O
funding	O
for	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
()	O
,	O
which	O
is	O
responsible	O
for	O
the	O
procurement	O
and	O
creation	O
of	O
countermeasures	O
against	O
bioterrorism	O
,	O
should	O
be	O
doubled	O
to	O
just	O
under	O
a	O
billion	O
dollars	O
and	O
would	O
decrease	O
costs	O
for	O
the	O
commercial	O
sector	O
.	O

In	O
addition	O
to	O
those	O
undergoing	O
invasive	O
mechanical	O
ventilation	O
,	O
the	O
compassionate	O
use	O
recommendations	O
cover	O
the	O
treatment	O
of	O
hospitalized	O
individuals	O
requiring	O
supplemental	O
oxygen	O
,	O
non-invasive	O
ventilation	O
,	O
high-flow	O
oxygen	O
devices	O
or	O
ECMO	S-Technology
(	O
extracorporeal	B-Technology
membrane	I-Technology
oxygenation	E-Technology
)	O
.	O

The	O
JCVI	S-Organization
team	O
is	O
still	O
working	O
to	O
boot	O
up	O
this	O
first	O
synthetic	O
bacterial	O
genome	O
.	O

Some	O
experts	O
said	O
they	O
are	O
a	O
little	O
surprised	O
CDC	S-Organization
is	O
talking	O
about	O
replacing	O
the	O
high-containment	O
lab	O
so	O
soon	O
.	O

And	O
what	O
about	O
ways	O
that	O
biotechnology	O
may	O
contribute	O
to	O
inequality	O
in	O
society?	O
Early	O
work	O
in	O
gene	B-Technology
surgery	E-Technology
will	O
no	O
doubt	O
be	O
expensive	O
–	O
for	O
example	O
,	O
Novartis	O
plans	O
to	O
charge	O
$475,000	O
for	O
a	O
one-time	O
treatment	O
of	O
their	O
recently	O
approved	O
cancer	O
therapy	O
,	O
a	O
drug	O
which	O
,	O
in	O
trials	O
,	O
has	O
rescued	O
patients	O
facing	O
certain	O
death	O
.	O

Some	O
people	O
find	O
little	O
reassurance	O
that	O
nobody	O
was	O
sickened	O
in	O
the	O
CDC	S-Organization
accidents	O
or	O
in	O
the	O
historically	O
low	O
numbers	O
of	O
serious	O
infections	O
among	O
lab	O
workers	O
generally	O
,	O
or	O
that	O
infections	O
spreading	O
into	O
communities	O
surrounding	O
labs	O
have	O
been	O
rarer	O
still	O
.	O

And	O
our	O
farming	O
practices	O
have	O
created	O
vast	O
numbers	O
of	O
animals	O
living	O
in	O
unhealthy	O
conditions	O
within	O
close	O
proximity	O
to	O
humans	O
.	O

Many	O
informal	O
horizontal	O
links	O
have	O
been	O
created	O
,	O
and	O
this	O
has	O
expanded	O
the	O
communication	O
between	O
agencies	O
at	O
all	O
levels	O
.	O

On	O
surfaces	O
the	O
amount	O
of	O
active	O
virus	O
decreases	O
over	O
time	O
until	O
it	O
can	O
no	O
longer	O
cause	O
infection	O
,	O
and	O
surfaces	O
are	O
thought	O
not	O
to	O
be	O
the	O
main	O
way	O
the	O
virus	O
spreads	O
.	O

Results	O
from	O
the	O
global	B-Organization
polio	I-Organization
laboratory	I-Organization
at	I-Organization
the	I-Organization
United	I-Organization
States	I-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
confirmed	O
that	O
the	O
new	O
case	O
is	O
genetically	O
linked	O
to	O
the	O
other	O
two	O
cases	O
from	O
.	O

By	O
negative	O
selection	O
dead	O
or	O
slow	O
growing	O
cells	O
are	O
efficiently	O
detected	O
.	O

Such	O
individuals	O
are	O
monitored	O
for	O
up	O
to	O
21	O
days	O
in	O
the	O
case	O
of	O
EVD	S-Disease

In	O
the	O
US	S-Location
an	O
anthrax	O
vaccine	O
,	O
Anthrax	B-Vaccine
Vaccine	I-Vaccine
Adsorbed	E-Vaccine
(	O
AVA	S-Vaccine
)	O
exists	O
and	O
requires	O
five	O
injections	O
for	O
stable	O
use	O
.	O

The	O
TB	S-Disease
lab's	O
plan	O
was	O
reviewed	O
and	O
approved	O
by	O
each	O
member	O
of	O
the	O
internal	O
working	O
group	O
;	O
by	O
Mike	B-Person
Bell	E-Person
,	O
M.D.	O
,	O
CDC	S-Organization
's	O
new	O
Director	O
of	O
Laboratory	O
Safety	O
;	O
and	O
by	O
Dr.	O
.	O

And	O
bingo	O
,	O
here	O
we	O
are.	O
"	O
Pigs	O
have	O
been	O
termed	O
the	O
mixing	O
vessel	O
of	O
flu	O
because	O
they	O
can	O
be	O
infected	O
both	O
by	O
avian	O
flu	O
viruses	O
,	O
which	O
rarely	O
directly	O
infect	O
people	O
,	O
and	O
by	O
human	O
viruses	O
.	O

In	O
Germany	S-Location
,	O
an	O
epidemic	O
of	O
infections	O
due	O
to	O
contaminated	O
vegetables	O
affected	O
up	O
to	O
5000	O
people	O
with	O
more	O
than	O
50	O
deaths	O
.	O

Other	O
basic	O
steps	O
to	O
mastering	O
this	O
biohack:	O
no	O
phones	O
in	O
bed	O
,	O
no	O
caffeine	O
or	O
prescription	O
amphetamines	S-Drug
before	O
bed	O
,	O
no	O
alcohol	O
before	O
bed	O
because	O
it	O
messes	O
with	O
sleep	O
cycles	O
.	O

Initially	O
called	O
an	O
"	O
outbreak",	O
widespread	O
H1N1	S-Pathogen
infection	O
was	O
first	O
recognized	O
in	O
the	O
state	O
of	O
Veracruz	S-Location
,	O
Mexico	S-Location
,	O
with	O
evidence	O
that	O
the	O
virus	O
had	O
been	O
present	O
for	O
months	O
before	O
it	O
was	O
officially	O
called	O
an	O
"	O
epidemic".	O
The	O
Mexican	B-Organization
government	E-Organization
closed	O
most	O
of	O
Mexico	B-Location
City	E-Location
's	O
public	O
and	O
private	O
facilities	O
in	O
an	O
attempt	O
to	O
contain	O
the	O
spread	O
of	O
the	O
virus	O
;	O
however	O
,	O
it	O
continued	O
to	O
spread	O
globally	O
,	O
and	O
clinics	O
in	O
some	O
areas	O
were	O
overwhelmed	O
by	O
infected	O
people	O
.	O

The	O
bottom	O
line	O
,	O
however	O
,	O
is	O
that	O
decisions	O
to	O
raise	O
the	O
level	O
of	O
pandemic	O
alert	O
were	O
based	O
on	O
clearly	O
defined	O
virological	O
and	O
epidemiological	O
criteria	O
.	O

As	O
a	O
result	O
,	O
was	O
reporting	O
only	O
the	O
most	O
serious	O
cases	O
which	O
showed	O
more	O
severe	O
signs	O
different	O
from	O
those	O
of	O
normal	O
flu	O
,	O
possibly	O
leading	O
to	O
a	O
skewed	O
initial	O
estimate	O
of	O
the	O
case	O
fatality	O
rate	O
.	O

"	O
We	O
have	O
a	O
tendency	O
in	O
this	O
country	O
to	O
react	O
to	O
things	O
after	O
they	O
occur,	O
"	O
said	O
Blue	B-Organization
Ribbon	I-Organization
panel	E-Organization
co-chairman	O
Tom	B-Person
Ridge	E-Person
,	O
former	O
governor	O
of	O
.	O

The	O
topics	O
most	O
commonly	O
addressed	O
in	O
these	O
awareness	O
sessions	O
included	O
basic	O
biosafety	O
,	O
biosecurity	O
,	O
biocontainment	O
,	O
and	O
biorisk	O
management	O
in	O
biomedical	O
and	O
biotechnology	O
laboratories	O
.	O

Over	O
the	O
next	O
six	O
to	O
eight	O
months	O
,	O
McDonnell	S-Person
said	O
the	O
partnership	O
will	O
have	O
five	O
different	O
technologies	O
deployed	O
in	O
12	O
different	O
locations	O
across	O
the	O
United	B-Location
States	E-Location
to	O
begin	O
collecting	O
data	O
into	O
the	O
DHS	B-Organization
U.S.	I-Organization
Customs	I-Organization
and	I-Organization
Border	I-Organization
Protection	E-Organization
's	O
National	B-Organization
Targeting	I-Organization
Center	E-Organization
,	O
which	O
works	O
24-7-365	O
to	O
monitor	O
and	O
detect	O
global	O
threats	O
to	O
.	O
via	O
human	O
travelers	O
or	O
cargo	O
.	O

Senator	O
Ayala's	O
proposal	O
became	O
law	O
June	O
22	O
,	O
1990	O
,	O
and	O
added	O
Section	O
6306	O
to	O
the	O
.	O

However	O
,	O
the	O
Mycoplasmas	O
the	O
JCVI	S-Organization
team	O
is	O
working	O
with	O
-	O
wild	O
type	O
M.	B-Pathogen
mycoides	I-Pathogen
subspecies	I-Pathogen
capri	E-Pathogen
and	O
Mycoplasma	B-Pathogen
capricolum	I-Pathogen
subspecies	I-Pathogen
capricolum	E-Pathogen
are	O
not	O
dangerous	O
to	O
humans	O
.	O

Gilead	S-Organization
stated	O
they	O
were	O
donating	O
1.	O
5	O
million	O
vials	O
for	O
emergency	O
use	O
and	O
estimated	O
,	O
as	O
of	O
April	O
2020	O
,	O
they	O
had	O
enough	O
for	O
140,000	O
treatment	O
courses	O
and	O
expect	O
to	O
have	O
500,000	O
courses	O
by	O
October	O
2020	O
,	O
and	O
one	O
million	O
courses	O
by	O
the	O
end	O
of	O
2020	O
.	O

The	O
United	B-Organization
States	I-Organization
Army	I-Organization
Chemical	I-Organization
Corps	E-Organization
then	O
initiated	O
a	O
crash	O
program	O
to	O
weaponize	O
anthrax	S-Pathogen
(N)	O
in	O
the	O
E61	O
1/2-lb	O
hour-glass	O
bomblet	O
.	O

Health	O
agencies	O
have	O
issued	O
detailed	O
instructions	O
for	O
proper	O
self-isolation	O
.	O

There	O
are	O
also	O
a	O
variety	O
of	O
signal	O
amplification	O
schemes	O
based	O
on	O
chemical	O
exchange	O
that	O
increase	O
sensitivity	O
.	O

Those	O
constructs	O
bearing	O
the	O
1918	O
HA	O
and	O
NA	O
are	O
all	O
highly	O
pathogenic	O
in	O
mice	O
.	O

KATHERINE	B-Person
LYON	I-Person
DANIEL	E-Person
Good	O
morning	O
.	O

Sheela	S-Person
received	O
20	O
years	O
for	O
the	O
attempted	O
murder	O
of	O
Rajneesh's	O
physician	O
,	O
twenty	O
years	O
for	O
first-degree	O
assault	O
in	O
the	O
poisoning	O
of	O
Judge	O
Hulse	S-Person
,	O
ten	O
years	O
for	O
second-degree	O
assault	O
in	O
the	O
poisoning	O
of	O
Commissioner	O
Matthews	S-Person
,	O
four	O
and	O
a	O
half	O
years	O
for	O
her	O
role	O
in	O
the	O
attack	O
,	O
four	O
and	O
a	O
half	O
years	O
for	O
the	O
wiretapping	O
conspiracy	O
,	O
and	O
five	O
years'	O
probation	O
for	O
immigration	O
fraud	O
;	O
Puja	S-Person
received	O
fifteen	O
,	O
fifteen	O
,	O
seven	O
and	O
a	O
half	O
,	O
and	O
four	O
and	O
a	O
half	O
years	O
,	O
respectively	O
,	O
for	O
her	O
role	O
in	O
the	O
first	O
four	O
of	O
these	O
crimes	O
,	O
as	O
well	O
as	O
three	O
years'	O
probation	O
for	O
the	O
wiretapping	O
conspiracy	O
.	O

In	O
1979	O
,	O
a	O
rare	O
outbreak	O
of	O
anthrax	B-Disease
disease	E-Disease
in	O
the	O
city	O
of	O
Sverdlovsk	S-Location
killed	O
nearly	O
70	O
people	O
.	O

The	O
contributing	O
international	O
organizations	O
are	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
(FAO)	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
,	O
and	O
the	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
()	O
.	O

Kadlec	S-Person
called	O
the	O
plan's	O
coordination	O
of	O
federal	O
activities	O
and	O
budgets	O
across	O
a	O
full	O
range	O
of	O
biodefense	O
sectors	O
and	O
activities	O
"	O
a	O
monumental	O
step	O
forward.	O
"	O

Subramaniam	O
et	O
al.	O
provide	O
information	O
about	O
lipidomics	O
data	O
management.	O
'Omics'-specific	O
analysis	O
and	O
visualization	O
functionality	O
are	O
optional	O
requirements	O
.	O

Additionally	O
,	O
Ling	S-Person
serves	O
as	O
Professor	O
of	O
Neurology	O
and	O
Attending	O
Physician	O
,	O
Neuro	O
Critical	O
Care	O
at	O
Johns	B-Organization
Hopkins	I-Organization
Hospital	E-Organization
and	O
is	O
founding	O
director	O
of	O
the	O
Biological	B-Organization
Technologies	I-Organization
Office	E-Organization
in	O
the	O
Defense	B-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
(	O
DARPA	S-Organization
)	O
.	O

Some	O
countries	O
(like	O
Belgium	S-Location
)	O
include	O
deaths	O
from	O
suspected	O
cases	O
of	O
,	O
regardless	O
of	O
whether	O
the	O
person	O
was	O
tested	O
,	O
resulting	O
in	O
higher	O
numbers	O
compared	O
to	O
countries	O
that	O
include	O
only	O
test-confirmed	O
cases	O
.	O

The	O
policy	O
team	O
at	O
JCVI	S-Organization
has	O
been	O
funded	O
to	O
conduct	O
an	O
already	O
completed	O
study	O
on	O
the	O
options	O
for	O
governance	O
of	O
this	O
field	O
as	O
well	O
as	O
an	O
ongoing	O
study	O
of	O
the	O
societal	O
issues	O
this	O
work	O
raises	O
.	O

"	O
The	O
longer	O
it	O
takes	O
,	O
the	O
more	O
likely	O
there	O
will	O
be	O
a	O
failure	O
.	O

While	O
those	O
infected	O
by	O
EVD	S-Disease
gain	O
immunity	O
,	O
it	O
has	O
been	O
suggested	O
to	O
have	O
a	O
finite	O
duration	O
.	O

Prior	O
to	O
this	O
outbreak	O
,	O
it	O
was	O
believed	O
that	O
human-to-human	O
transmission	O
occurred	O
only	O
via	O
direct	O
contact	O
with	O
blood	O
or	O
bodily	O
fluids	O
from	O
an	O
infected	O
person	O
who	O
is	O
showing	O
symptoms	O
of	O
infection	O
,	O
by	O
contact	O
with	O
the	O
body	O
of	O
a	O
person	O
who	O
had	O
died	O
of	O
Ebola	S-Disease
or	O
by	O
contact	O
with	O
objects	O
recently	O
contaminated	O
with	O
the	O
body	O
fluids	O
of	O
an	O
actively	O
ill	O
infected	O
person	O
.	O

Estimates	O
are	O
that	O
700,000	O
to	O
several	O
million	O
deaths	O
result	O
per	O
year	O
.	O

For	O
instance	O
,	O
in	O
Europe	S-Location
in	O
2007	O
,	O
the	O
number	O
of	O
infections	O
by	O
multidrug-resistant	O
bacteria	O
was	O
400,000	O
with	O
25,000	O
attributable	O
deaths	O
.	O

On	O
29	O
March	O
it	O
was	O
reported	O
that	O
beginning	O
1April	O
all	O
new	O
overseas	O
arrivals	O
will	O
be	O
quarantined	O
for	O
two	O
weeks	O
.	O

The	O
reality	O
is	O
quite	O
the	O
opposite	O
,	O
as	O
it	O
can	O
be	O
a	O
challenge	O
for	O
the	O
government	O
to	O
convince	O
pharmaceutical	O
companies	O
to	O
develop	O
drugs	O
for	O
the	O
U.S.	S-Location
national	O
stockpile	O
that	O
are	O
not	O
also	O
commercially	O
viable	O
.	O

Despite	O
those	O
considerations	O
,	O
officials	O
with	O
the	O
NIH	S-Organization
called	O
the	O
escapes	O
"	O
concerning."	O
Several	O
of	O
the	O
mice	O
were	O
infected	O
with	O
either	O
SARS	S-Disease
or	O
the	O
.	O

Investigators	O
found	O
a	O
copy	O
of	O
The	O
Anarchist	O
Cookbook	O
,	O
and	O
literature	O
on	O
the	O
manufacture	O
and	O
usage	O
of	O
explosives	O
and	O
military	O
bio-warfare	O
.	O

Most	O
of	O
the	O
biosecurity	O
concerns	O
in	O
synthetic	O
biology	O
,	O
however	O
,	O
are	O
focused	O
on	O
the	O
role	O
of	O
DNA	O
synthesis	O
and	O
the	O
risk	O
of	O
producing	O
genetic	O
material	O
of	O
lethal	O
viruses	O
(e.g.	O
1918	B-Incident
Spanish	I-Incident
flu	E-Incident
polio	S-Incident
)	O
in	O
the	O
lab	O
.	O

XperimentR	S-Platform
lets	O
users	O
describe	O
experimental	O
metadata	O
via	O
a	O
graphical	O
representation	O
based	O
on	O
the	O
ISA-Tab	O
structure	O
.	O

In	O
a	O
related	O
announcement	O
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
()	O
said	O
today	O
that	O
September	O
will	O
be	O
"	O
National	O
Biosafety	O
Stewardship	O
Month,	O
"	O
and	O
urged	O
its	O
laboratories	O
and	O
grantee	O
institutions	O
to	O
take	O
heed	O
of	O
the	O
recent	O
biosafety	O
incidents.	O
"	O
Recent	O
reports	O
of	O
lapses	O
in	O
biosafety	O
practices	O
involving	O
Federal	O
laboratories	O
have	O
served	O
to	O
remind	O
us	O
of	O
the	O
importance	O
of	O
constant	O
vigilance	O
over	O
our	O
implementation	O
of	O
biosafety	O
standards,	O
"	O
the	O
notice	O
states	O
.	O

It	O
was	O
first	O
identified	O
in	O
December	O
2019	O
in	O
Wuhan	S-Location
,	O
and	O
has	O
since	O
spread	O
globally	O
,	O
resulting	O
in	O
an	O
ongoing	O
pandemic	O
.	O

Based	O
on	O
these	O
investigations	O
,	O
CDC	S-Organization
will	O
take	O
appropriate	O
action	O
in	O
the	O
individual	O
laboratory	O
,	O
as	O
well	O
as	O
any	O
actions	O
indicated	O
for	O
all	O
laboratories	O
which	O
work	O
with	O
dangerous	O
microbes	O
at	O
,	O
and	O
will	O
consider	O
broader	O
implications	O
for	O
laboratory	O
safety	O
.	O

Thirty	O
members	O
of	O
these	O
various	O
associations	O
from	O
each	O
country	O
were	O
identified	O
by	O
random	O
selection	O
to	O
receive	O
the	O
survey	O
questionnaire	O
via	O
email	O
.	O

First	O
,	O
we	O
had	O
the	O
potential	O
exposure	O
to	O
anthrax	S-Pathogen
at	O
CDC	S-Organization
's	O
laboratory	O
.	O

Eight	O
laboratory	O
workers	O
received	O
post‐exposure	O
treatment	O
;	O
none	O
developed	O
.	O
These	O
recent	O
events	O
highlight	O
the	O
continuing	O
possibility	O
of	O
the	O
occurrence	O
of	O
laboratory‐acquired	O
infections	O
due	O
to	O
simple	O
and	O
preventable	O
laboratory	O
errors	O
.	O

In	O
1918-19	O
this	O
deadly	O
influenza	O
pandemic	O
erupted	O
during	O
the	O
final	O
stages	O
of	O
World	B-Incident
War	I-Incident
I	E-Incident
Nations	O
were	O
already	O
attempting	O
to	O
deal	O
with	O
the	O
effects	O
and	O
costs	O
of	O
the	O
war	O
.	O

However	O
,	O
potential	O
victims	O
of	O
an	O
anthrax	S-Pathogen
attack	O
can	O
be	O
treated	O
with	O
antibiotics	S-Drug
even	O
several	O
days	O
after	O
an	O
infection	O
.	O

The	O
stockpile	O
program	O
was	O
created	O
in	O
1999	O
under	O
President	O
Bill	B-Person
Clinton	E-Person
to	O
respond	O
to	O
terrorist	O
events	O
,	O
including	O
the	O
first	O
World	B-Incident
Trade	I-Incident
Center	I-Incident
bombing	E-Incident
,	O
the	O
sarin	B-Incident
gas	I-Incident
attack	I-Incident
on	I-Incident
the	I-Incident
Tokyo	I-Incident
subway	E-Incident
and	O
the	O
.	O
The	O
original	O
goal	O
was	O
to	O
be	O
ready	O
for	O
chemical	O
,	O
biological	O
,	O
radiological	O
and	O
nuclear	O
threats	O
.	O

In	O
1998	O
,	O
it	O
became	O
public	O
that	O
the	O
US	B-Organization
Naval	I-Organization
Research	I-Organization
Laboratory	E-Organization
in	O
Washington	B-Location
DC	E-Location
was	O
developing	O
genetically	B-Pathogen
engineered	I-Pathogen
fungi	I-Pathogen
with	I-Pathogen
offensive	I-Pathogen
biowarfare	I-Pathogen
potential	E-Pathogen
.	O
They	O
isolated	O
natural	O
microorganisms	O
that	O
degrade	O
a	O
variety	O
of	O
materials	O
,	O
such	O
as	O
plastics	O
,	O
rubber	O
and	O
metals	O
,	O
and	O
used	O
genetic	B-Technology
engineering	E-Technology
to	O
make	O
them	O
more	O
powerful	O
and	O
focused-one	O
of	O
these	O
genetically	O
engineered	O
microbes	O
can	O
destroy	O
military	O
paints	O
in	O
72	O
hours	O
.	O

In	O
August	O
2014	O
,	O
healthcare	O
workers	O
represented	O
nearly	O
10	O
per	O
cent	O
of	O
cases	O
and	O
fatalities-significantly	O
impairing	O
the	O
capacity	O
to	O
respond	O
to	O
an	O
outbreak	O
in	O
an	O
area	O
already	O
facing	O
severe	O
shortages	O
.	O

In	O
a	O
final	O
point	O
,	O
George	B-Person
Poste	E-Person
accomplished	O
scientist	O
and	O
ex	O
officio	O
of	O
the	O
panel	O
,	O
questioned	O
whether	O
was	O
prepared	O
to	O
provide	O
enough	O
generic	O
medications	O
during	O
a	O
national	O
emergency	O
when	O
85	O
percent	O
of	O
these	O
drugs	O
are	O
manufactured	O
overseas	O
.	O

In	O
2001	O
,	O
for	O
example	O
,	O
a	O
public	O
health	O
laboratory	O
worker	O
in	O
the	O
U.S.	S-Location
acquired	O
cutaneous	B-Disease
anthrax	E-Disease
due	O
to	O
an	O
unauthorized	O
switch	O
in	O
disinfectants	O
(MMWR	O
,	O
2002)	O
.	O

During	O
the	O
1950s	O
the	O
United	B-Location
States	E-Location
conducted	O
a	O
series	O
of	O
field	O
tests	O
using	O
entomological	O
weapons	O
.	O

All	O
influenza	S-Disease
A	O
pandemics	O
since	O
that	O
time	O
,	O
and	O
indeed	O
almost	O
all	O
cases	O
of	O
influenza	O
A	O
worldwide	O
(excepting	O
human	O
infections	O
from	O
avian	O
viruses	O
such	O
as	O
H5N1	S-Pathogen
and	O
H7N7	S-Pathogen
)	O
,	O
have	O
been	O
caused	O
by	O
descendants	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
,	O
including	O
"	O
drifted"	O
H1N1	S-Pathogen
viruses	O
and	O
reassorted	O
H2N2	S-Pathogen
and	O
H3N2	S-Pathogen
viruses	O
.	O

The	O
new	O
and	O
upcoming	O
GM	S-Technology
crops	O
carrying	O
multiple	O
stacked	O
traits	O
likely	O
to	O
be	O
commercialized	O
soon	O
warrant	O
sensitive	O
detection	O
methods	O
both	O
at	O
the	O
DNA	O
and	O
protein	O
levels	O
.	O

The	O
centre	O
is	O
a	O
two-storey	O
building	O
with	O
a	O
maximum	O
capacity	O
of	O
116	O
people	O
at	O
a	O
time	O
.	O

The	O
International	B-Organization
Commission	I-Organization
on	I-Organization
Radiological	I-Organization
Protection	E-Organization
estimates	O
that	O
the	O
risk	O
to	O
a	O
fetus	O
being	O
exposed	O
to	O
10 mGy	O
(a	O
unit	O
of	O
radiation	O
exposure)	O
increases	O
the	O
rate	O
of	O
cancer	S-Disease
before	O
20	O
years	O
of	O
age	O
from	O
0.03%	O
to	O
0.	O
04%	O
(for	O
reference	O
a	O
pulmonary	O
angiogram	O
exposes	O
a	O
fetus	O
to	O
4 mGy)	O
.	O

The	O
WHO	S-Organization
responded	O
by	O
stating	O
that	O
they	O
take	O
their	O
duty	O
to	O
provide	O
independent	O
advice	O
seriously	O
and	O
guarded	O
against	O
interference	O
from	O
outside	O
interests	O
.	O

Before	O
I	O
discuss	O
the	O
details	O
,	O
I'll	O
give	O
you	O
my	O
perspective	O
which	O
is	O
plain	O
and	O
simple	O
.	O

WHO	S-Organization
created	O
the	O
,	O
which	O
brings	O
together	O
other	O
networks	O
that	O
are	O
involved	O
in	O
policy	O
making	O
and	O
the	O
dissemination	O
of	O
guidelines	O
.	O

The	O
reconstruction	O
assumes	O
that	O
the	O
X-ray	O
attenuation	O
within	O
each	O
voxel	O
is	O
homogeneous	O
;	O
this	O
may	O
not	O
be	O
the	O
case	O
at	O
sharp	O
edges	O
.	O

Keep	O
biohazard	O
waste	O
in	O
covered	O
containers	O
free	O
from	O
leaks	O
.	O

The	O
interleukin-6	B-Drug
receptor	I-Drug
antagonist	E-Drug
was	O
approved	O
by	O
the	O
FDA	S-Organization
to	O
undergo	O
a	O
phase	B-Activity
III	I-Activity
clinical	I-Activity
trial	E-Activity
assessing	O
the	O
its	O
effectiveness	O
on	O
COVID‑19	S-Disease
based	O
on	O
retrospective	O
case	O
studies	O
for	O
the	O
treatment	O
of	O
steroid-refractory	O
cytokine	O
release	O
syndrome	O
induced	O
by	O
a	O
different	O
cause	O
,	O
CAR	B-Technology
T	I-Technology
cell	I-Technology
therapy	E-Technology
,	O
in	O
2017	O
.	O

Traps	O
caught	O
14	O
rats	O
before	O
the	O
nest	O
was	O
dismantled	O
and	O
disinfected	O
with	O
bleach	O
.	O

On	O
7	O
August	O
2018	O
,	O
the	O
DRC	B-Organization
Ministry	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
indicated	O
that	O
the	O
total	O
count	O
had	O
climbed	O
to	O
almost	O
90	O
cases	O
,	O
and	O
The	O
Uganda	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
issued	O
an	O
alert	O
for	O
extra	O
surveillance	O
as	O
the	O
outbreak	O
was	O
just	O
away	O
from	O
its	O
border	O
.	O

The	O
planned	O
NATO	S-Organization
"	O
Defender	B-Activity
2020	E-Activity
"	O
military	O
exercise	O
in	O
Germany	S-Location
,	O
Poland	S-Location
,	O
and	O
the	O
Baltic	B-Location
states	E-Location
,	O
the	O
largest	O
NATO	S-Organization
war	O
exercise	O
since	O
the	O
end	O
of	O
the	O
Cold	B-Incident
War	E-Incident
,	O
will	O
be	O
held	O
on	O
a	O
reduced	O
scale	O
.	O

Proper	O
hand	O
hygiene	O
after	O
any	O
cough	O
or	O
sneeze	O
is	O
encouraged	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Next	O
question	O
on	O
the	O
phone?	O

For	O
example	O
,	O
sending	O
samples	O
and	O
metadata	O
requires	O
a	O
system	O
that	O
ensures	O
confidentiality	O
in	O
the	O
laboratory	O
receiving	O
it	O
.	O

WHO	S-Organization
has	O
been	O
moving	O
toward	O
acceptance	O
and	O
integration	O
of	O
traditional	O
medicine	O
and	O
traditional	O
Chinese	O
medicine	O
.	O

In	O
one	O
incident	O
,	O
Iranian	O
prisoners	O
of	O
war	O
are	O
said	O
to	O
have	O
been	O
tied	O
up	O
and	O
killed	O
by	O
bacteria	O
from	O
a	O
shell	O
detonated	O
nearby	O
.	O

Beyond	O
voluntariness-making	O
data	O
management	O
and	O
sharing	O
a	O
condition	O
of	O
funding	O
,	O
using	O
data	O
management	O
plans	O
and	O
controlling	O
these-are	O
efficient	O
mechanisms	O
to	O
get	O
publicly	O
funded	O
data	O
shared	O
and	O
are	O
on	O
the	O
road	O
map	O
in	O
some	O
countries	O
.	O

But	O
in	O
Boston	S-Location
,	O
and	O
perhaps	O
also	O
Quebec	S-Location
,	O
the	O
British	O
may	O
have	O
forced	O
smallpox	S-Pathogen
on	O
civilians	O
.	O

Their	O
proposed	O
solution	O
,	O
Pandemic	O
Pulse	O
,	O
integrates	O
Twitter	O
and	O
Google	O
Search	O
data	O
with	O
infectious	O
disease	O
monitoring	O
tools	O
Flu	B-Equipment
Near	I-Equipment
You	E-Equipment
and	O
.	O

To	O
meet	O
this	O
challenge	O
DARPA	S-Organization
today	O
announced	O
its	O
SIGMA+	S-Scientific_research_project
program	O
,	O
an	O
expansion	O
of	O
the	O
existing	O
program	O
,	O
which	O
detects	O
radiological	O
and	O
nuclear	O
materials	O
.	O

The	O
same	O
approach	O
should	O
be	O
applied	O
to	O
antibiotic	O
resistance	O
;	O
a	O
new	O
generation	O
of	O
physician/scientists	O
with	O
modern	O
approaches	O
to	O
diagnostic/predictive	O
medicine	O
needs	O
to	O
be	O
trained	O
.	O

Some	O
bioterrorism	O
agents	O
,	O
like	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
can	O
be	O
spread	O
from	O
person	O
to	O
person	O
and	O
some	O
,	O
like	O
anthrax	S-Pathogen
,	O
cannot	O
.	O

Furthermore	O
,	O
we	O
urge	O
Members	O
to	O
oppose	O
any	O
efforts	O
to	O
reduce	O
,	O
eliminate	O
,	O
or	O
condition	O
funding	O
related	O
to	O
gun	O
violence	O
prevention	O
research.	O
"	O
Congress	O
maintained	O
the	O
ban	O
in	O
subsequent	O
budgets	O
.	O

They're	O
scattered	O
across	O
the	O
country	O
from	O
the	O
heart	O
of	O
New	B-Location
York	I-Location
City	E-Location
to	O
a	O
valley	O
in	O
Montana	S-Location
;	O
from	O
an	O
area	O
near	O
Seattle's	B-Location
Space	I-Location
Needle	E-Location
to	O
just	O
a	O
few	O
blocks	O
from	O
restaurant	O
and	O
shopping	O
district	O
.	O

All	O
documents	O
were	O
reviewed	O
and	O
issued	O
by	O
the	O
.	O

It	O
is	O
also	O
worth	O
noting	O
that	O
,	O
while	O
an	O
individual	O
could	O
conceivably	O
do	O
harm	O
with	O
sufficient	O
skill	O
and	O
intent	O
,	O
there	O
exist	O
biology	O
labs	O
throughout	O
the	O
world	O
with	O
greater	O
access	O
to	O
the	O
technology	O
,	O
skill	O
and	O
funding	O
to	O
accomplish	O
a	O
bioweapons	O
project	O
.	O

Television	O
.	O

This	O
will	O
be	O
an	O
important	O
opportunity	O
to	O
uphold	O
and	O
widen	O
the	O
contacts	O
between	O
people	O
in	O
this	O
field	O
,	O
to	O
share	O
knowledge	O
and	O
experience	O
from	O
outbreaks	O
,	O
and	O
to	O
discuss	O
how	O
to	O
improve	O
current	O
methods	O
and	O
strategies	O
for	O
quality	O
assurance	O
.	O

New	O
environmental	O
,	O
as	O
well	O
as	O
biomechanical	O
and	O
biochemical	O
sensing	O
methods	O
for	O
detecting	O
threats	O
could	O
provide	O
system	O
sensitivity	O
10	O
times	O
greater	O
than	O
the	O
state-of-the-art	O
,	O
which	O
would	O
enable	O
detection	O
of	O
a	O
wider	O
range	O
of	O
biological	O
attacks	O
days	O
earlier	O
,	O
maximizing	O
the	O
effectiveness	O
of	O
countermeasures	O
and	O
prophylaxis	O
.	O

Depletion	O
or	O
enrichment	O
of	O
sgRNAs	O
is	O
detected	O
and	O
compared	O
to	O
the	O
original	O
sgRNA	O
library	O
,	O
annotated	O
with	O
the	O
target	O
gene	O
that	O
sgRNA	O
corresponds	O
to	O
.	O

Hearing	O
loss	O
has	O
been	O
reported	O
in	O
Ebola	S-Disease
survivors	O
25%	O
of	O
the	O
time	O
.	O

The	O
Lugar	B-Organization
Center	E-Organization
is	O
the	O
Pentagon	B-Organization
bio	I-Organization
laboratory	E-Organization
in	O
Georgia	S-Location
.	O
It	O
is	O
located	O
just	O
17	O
km	O
away	O
from	O
the	O
US	B-Organization
Vaziani	I-Organization
military	I-Organization
airbase	E-Organization
in	O
the	O
capital	O
Tbilisi	S-Location
.	O
Tasked	O
with	O
the	O
military	O
program	O
are	O
biologists	O
from	O
the	O
US	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Unit-Georgia	E-Organization
(	O
USAMRU-G	S-Organization
)	O
along	O
with	O
private	O
contractors	O
.	O

As	O
worldwide	O
oil	O
supplies	O
diminish	O
and	O
the	O
cost	O
of	O
gas	O
increases	O
,	O
everyone	O
is	O
affected	O
.	O

The	O
sustained	O
increase	O
in	O
demand	O
for	O
within	O
health	O
systems	O
has	O
led	O
to	O
concerns	O
about	O
cost	O
effectiveness	O
and	O
overdiagnosis	O
.	O

The	O
BioTesting	B-Organization
Division	I-Organization
at	I-Organization
Dugway	I-Organization
Proving	I-Organization
Ground	E-Organization
is	O
working	O
to	O
regain	O
its	O
certification	O
as	O
a	O
covered	O
facility	O
under	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
to	O
possess	O
BSAT	O
in	O
.	O

Internationalization	O
may	O
broaden	O
the	O
network	O
of	O
national	O
BSL-3	S-Platform
laboratories	O
to	O
find	O
synergies	O
in	O
new	O
areas	O
,	O
strengthen	O
the	O
ability	O
to	O
pool	O
and	O
share	O
resources	O
throughout	O
,	O
and	O
consolidate	O
a	O
longer-term	O
financing	O
regime	O
in	O
the	O
context	O
of	O
harmonized	O
European	O
biopreparedness	O
.	O

Some	O
people	O
find	O
little	O
reassurance	O
that	O
nobody	O
was	O
sickened	O
in	O
the	O
CDC	S-Organization
accidents	O
or	O
in	O
the	O
historically	O
low	O
numbers	O
of	O
serious	O
infections	O
among	O
lab	O
workers	O
generally	O
,	O
or	O
that	O
infections	O
spreading	O
into	O
communities	O
surrounding	O
labs	O
have	O
been	O
rarer	O
still	O
.	O

The	O
inclusion	O
of	O
the	O
"	O
Taiwan	S-Location
region	O
"	O
in	O
the	O
WHO	S-Organization
's	O
daily	O
situation	O
reports	O
,	O
which	O
resulted	O
in	O
Taiwan	S-Location
receiving	O
the	O
same	O
WHO	S-Organization
"	O
very	O
high	O
"	O
risk	O
rating	O
as	O
the	O
mainland	O
despite	O
only	O
a	O
having	O
a	O
relatively	O
small	O
number	O
of	O
cases	O
on	O
the	O
ROC-governed	O
island	O
has	O
led	O
to	O
protests	O
by	O
Taiwan	S-Location
who	O
says	O
that	O
the	O
rating	O
has	O
led	O
to	O
it	O
receiving	O
travel	O
bans	O
as	O
a	O
result	O
.	O

On	O
31	O
March	O
,	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
sent	O
a	O
five-person	O
team	O
to	O
assist	O
in	O
the	O
response	O
to	O
the	O
outbreak	O
.	O

In	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
published	O
a	O
road	O
map	O
of	O
the	O
steps	O
required	O
to	O
bring	O
the	O
epidemic	O
under	O
control	O
and	O
to	O
prevent	O
further	O
transmission	O
of	O
the	O
disease	O
within	O
;	O
the	O
coordinated	O
international	O
response	O
worked	O
towards	O
realising	O
this	O
plan	O
.	O

Frieden	S-Person
,	O
your	O
report	O
details	O
that	O
there	O
was	O
a	O
similar	O
incident	O
involving	O
the	O
bioterror	B-Organization
rapid	I-Organization
response	I-Organization
lab	E-Organization
and	O
in	O
2006	O
.	O

On	O
22	O
September	O
2012	O
,	O
the	O
Saudi	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
(	O
MOH	S-Organization
)	O
announced	O
that	O
the	O
two	O
cases	O
involving	O
citizens	O
,	O
caused	O
by	O
what	O
they	O
termed	O
a	O
"	O
rare	O
pattern	O
of	O
coronavirus,	O
"	O
had	O
both	O
proven	O
fatal	O
.	O

Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
was	O
a	O
remote	O
Catholic	O
hospital	O
and	O
had	O
no	O
doctors	O
and	O
no	O
laboratory	O
facilities	O
to	O
aid	O
in	O
diagnosis	O
.	O

In	O
November	O
,	O
when	O
Mali	S-Location
experienced	O
an	O
unexpected	O
uptick	O
of	O
Ebola	S-Pathogen
cases	O
,	O
we	O
responded	O
to	O
an	O
urgent	O
request	O
to	O
stand	O
up	O
an	O
Emergency	B-Organization
Operations	I-Organization
Center	E-Organization
in	O
by	O
quickly	O
redirecting	O
funds	O
for	O
this	O
initiative	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

The	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
and	I-Document
Advancing	I-Document
Innovation	I-Document
Act	E-Document
of	O
2018	O
,	O
H.R.	B-Document
6378	E-Document
,	O
introduced	O
by	O
Brooks	S-Person
on	O
July	O
16	O
with	O
original	O
cosponsors	O
U.S.	S-Location
Reps	O
.	O

Despite	O
the	O
variety	O
of	O
methods	O
and	O
the	O
large	O
number	O
of	O
students	O
,	O
students	O
receive	O
personal	O
supervision	O
that	O
can	O
only	O
be	O
achieved	O
using	O
the	O
unique	O
work	O
station	O
design	O
that	O
was	O
developed	O
for	O
this	O
lab	O
.	O

Therefore	O
,	O
traceability	O
of	O
the	O
transgene	O
and	O
its	O
protein	O
expression	O
in	O
crops	O
is	O
an	O
important	O
issue	O
that	O
needs	O
to	O
be	O
addressed	O
on	O
a	O
priority	O
basis	O
.	O

Officials	O
from	O
the	O
U.S.	B-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	I-Organization
Department	E-Organization
attended	O
the	O
Fifth	B-Activity
Global	I-Activity
Health	I-Activity
Security	I-Activity
Agenda	I-Activity
(GHSA)	I-Activity
Ministerial	I-Activity
Meeting	E-Activity
in	O
Indonesia	S-Location
this	O
week	O
to	O
reaffirm	O
support	O
for	O
the	O
initiative	O
and	O
commit	O
additional	O
funding	O
.	O

For	O
example	O
,	O
the	O
Agriculture	B-Document
Risk	I-Document
Protection	I-Document
Act	I-Document
of	I-Document
2000	E-Document
gives	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
the	O
authority	O
to	O
oversee	O
the	O
detection	O
,	O
control	O
,	O
eradication	O
,	O
suppression	O
,	O
prevention	O
,	O
or	O
retardation	O
of	O
the	O
spread	O
of	O
plant	O
pests	O
or	O
noxious	O
weeds	O
to	O
protect	O
the	O
agriculture	O
,	O
environment	O
,	O
and	O
economy	O
of	O
the	O
US	O
.	O

Carter	S-Person
,	O
April	O
,	O
(Stockholm	O
International	O
Peace	O
Research	O
Institute)	O
.	O

An	O
estimated	O
one	O
third	O
of	O
the	O
world's	O
population	O
(or	O
≈500	O
million	O
persons)	O
were	O
infected	O
and	O
had	O
clinically	O
apparent	O
illnesses	O
(,)	O
during	O
the	O
1918–1919	B-Incident
influenza	I-Incident
pandemic	E-Incident
The	O
disease	O
was	O
exceptionally	O
severe	O
.	O

A	O
research	O
ship	O
[the	O
Lev	O
Berg]	O
of	O
the	O
Aral	S-Location
fleet	O
came	O
to	O
within	O
15	O
km	O
of	O
the	O
island	O
(it	O
was	O
forbidden	O
to	O
come	O
any	O
closer	O
than	O
40 km)	O
.	O

Dilger	S-Person
set	O
up	O
a	O
laboratory	O
in	O
his	O
home	O
in	O
Chevy	B-Location
Chase	E-Location
,	O
Maryland	S-Location
.	O
He	O
used	O
stevedores	O
working	O
the	O
docks	O
in	O
Baltimore	S-Location
to	O
infect	O
horses	O
with	O
glanders	S-Disease
while	O
they	O
were	O
waiting	O
to	O
be	O
shipped	O
to	O
Britain	S-Location
.	O
Dilger	S-Person
was	O
under	O
suspicion	O
as	O
being	O
a	O
German	O
agent	O
,	O
but	O
was	O
never	O
arrested	O
.	O

On	O
27	O
December	O
,	O
China	S-Location
announced	O
the	O
first	O
suspected	O
case	O
of	O
SARS	S-Disease
in	O
six	O
months	O
in	O
Guangdong	S-Location
in	O
an	O
individual	O
who	O
was	O
not	O
a	O
researcher	O
.	O

The	O
medical	O
director	O
of	O
a	O
hospital	O
in	O
Liberia	S-Location
reported	O
that	O
he	O
was	O
seeing	O
health	O
problems	O
in	O
patients	O
who	O
had	O
been	O
in	O
recovery	O
for	O
as	O
long	O
as	O
nine	O
months	O
.	O

The	O
report	O
infers	O
from	O
circumstantial	O
evidence	O
that	O
the	O
outbreak	O
was	O
triggered	O
by	O
airborne	O
viruses	O
from	O
a	O
germ	O
warfare	O
test	O
on	O
an	O
island	O
in	O
the	O
Aral	B-Location
Sea	E-Location
The	O
viruses	O
infected	O
a	O
crew	O
member	O
on	O
a	O
research	O
vessel	O
that	O
is	O
said	O
to	O
have	O
come	O
within	O
nine	O
miles	O
of	O
the	O
island	O
,	O
and	O
she	O
in	O
turn	O
spread	O
the	O
virus	O
to	O
others	O
in	O
the	O
city	O
of	O
Aralsk	S-Location
.	O
Although	O
some	O
experts	O
think	O
the	O
Aralsk	B-Incident
outbreak	E-Incident
may	O
have	O
had	O
natural	O
causes	O
,	O
a	O
former	O
general	O
in	O
the	O
Soviet	B-Scientific_research_project
germ	I-Scientific_research_project
warfare	I-Scientific_research_project
program	E-Scientific_research_project
told	O
a	O
newspaper	O
it	O
had	O
been	O
caused	O
by	O
field-testing	O
of	O
germs	O
.	O

A	O
CNN	S-Organization
report	O
indicated	O
that	O
the	O
combination	O
of	O
s	O
large	O
elderly	O
population	O
and	O
inability	O
to	O
test	O
all	O
who	O
have	O
the	O
virus	O
to	O
date	O
may	O
be	O
contributing	O
to	O
the	O
high	O
fatality	O
rate	O
.	O

The	O
Rhodesians	O
also	O
experimented	O
with	O
several	O
other	O
pathogens	O
and	O
toxins	O
for	O
use	O
in	O
their	O
counterinsurgency	O
.	O

Others	O
have	O
disagreed	O
,	O
and	O
more	O
recent	O
research	O
has	O
suggested	O
the	O
strain	O
may	O
have	O
originated	O
in	O
a	O
nonhuman	O
,	O
mammalian	O
species	O
.	O

The	O
Flettner	O
rotor	O
was	O
called	O
,	O
"	O
probably	O
one	O
of	O
the	O
better	O
devices	O
for	O
disseminating	O
microorganisms"	O
,	O
by	O
William	B-Person
C.	I-Person
Patrick	I-Person
III	E-Person
.	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
,	O
Office	B-Organization
of	I-Organization
Emergency	I-Organization
Preparedness	E-Organization
,	O
"	O
Proceedings	B-Document
of	I-Document
the	I-Document
Seminar	I-Document
Responding	I-Document
to	I-Document
the	I-Document
Consequences	I-Document
of	I-Document
Chemical	I-Document
and	I-Document
Biological	I-Document
Terrorism	E-Document
"	O
,	O
Uniformed	B-Organization
Services	I-Organization
University	I-Organization
of	I-Organization
Health	I-Organization
Sciences	E-Organization
,	O
,	O
Md	O
;	O
July	O
11–14	O
,	O
1995	O
,	O
p.	O
70	O
,	O
via	O
LSU	O
Law	O
Center's	O
Medical	O
and	O
Public	O
Health	O
Law	O
Site	O
.	O

In	O
2014	O
,	O
incidents	B-Incident
with	I-Incident
Anthrax	I-Incident
and	I-Incident
Ebola	I-Incident
pathogens	I-Incident
in	I-Incident
CDC	I-Incident
laboratories	E-Incident
()	O
,	O
prompted	O
the	O
director	O
Tom	O
Frieden	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

DNA	O
is	O
cut	O
with	O
the	O
restriction	O
enzymes	O
RsaI	O
and	O
HinfI	O
and	O
the	O
fragments	O
are	O
separated	O
by	O
an	O
8%	O
polyacrylamide	O
gel	O
electrophoresis	O
that	O
allows	O
the	O
separation	O
and	O
detection	O
of	O
fragments	O
ranging	O
from	O
60	O
to	O
200 bp.	O
hCMV	S-Pathogen
strains	O
can	O
be	O
differentiated	O
based	O
on	O
the	O
pattern	O
of	O
restriction	O
fragments	O
formed	O
by	O
RsaI	O
and	O
HinfI	O
.	O

The	O
Public	B-Organization
Health	I-Organization
Emergency	I-Organization
Operations	I-Organization
Centre	E-Organization
is	O
a	O
welcome	O
relief	O
to	O
Cameroon	S-Location
that	O
from	O
time	O
to	O
time	O
have	O
cholera	S-Disease
attacks	O
and	O
other	O
pandemics	O
.	O

The	O
cells	O
undergoing	O
the	O
can	O
also	O
be	O
removed	O
and	O
reintroduced	O
to	O
provide	O
amplified	O
effects	O
of	O
the	O
therapy	O
.	O

On	O
5May	O
,	O
official	O
figures	O
revealed	O
that	O
Britain	S-Organization
had	O
the	O
worst	O
COVID-19	S-Disease
death	O
toll	O
in	O
Europe	S-Location
,	O
prompting	O
calls	O
for	O
an	O
inquiry	O
into	O
the	O
handling	O
of	O
the	O
pandemic	O
.	O

Military	O
leaders	O
,	O
however	O
,	O
have	O
learned	O
that	O
,	O
as	O
a	O
military	O
asset	O
,	O
bioterrorism	O
has	O
some	O
important	O
limitations	O
;	O
it	O
is	O
difficult	O
to	O
use	O
a	O
bioweapon	O
in	O
a	O
way	O
that	O
only	O
affects	O
the	O
enemy	O
and	O
not	O
friendly	O
forces	O
.	O

The	O
outbreak	O
is	O
in	O
the	O
northwestern	O
town	O
of	O
Bikoro	S-Location

Much	O
of	O
this	O
was	O
focused	O
on	O
the	O
information	O
contained	O
in	O
his	O
work	O
.	O

In	O
May	O
2018	O
,	O
the	O
WHO	S-Organization
denied	O
access	O
to	O
its	O
annual	O
assembly	O
by	O
Taiwanese	O
media	O
reportedly	O
due	O
to	O
demands	O
from	O
China	S-Location
.	O
Later	O
in	O
May	O
172	O
members	O
of	O
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
wrote	O
to	O
the	O
Director	O
General	O
of	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
to	O
argue	O
for	O
Taiwan	S-Location
's	O
inclusion	O
as	O
an	O
observer	O
at	O
the	O
WHA	S-Organization
.	O
The	O
United	B-Location
States	E-Location
,	O
Japan	S-Location
,	O
Germany	S-Organization
,	O
and	O
Australia	S-Organization
all	O
support	O
Taiwan	S-Location
's	O
inclusion	O
in	O
.	O

All	O
GHSA	S-International_exchange_and_cooperation
member	O
countries	O
participate	O
in	O
one	O
or	O
more	O
Action	O
Packages	O
and	O
may	O
choose	O
to	O
fulfill	O
commitments	O
by	O
building	O
capacity	O
at	O
a	O
national	O
,	O
regional	O
and/or	O
global	O
level	O
,	O
according	O
to	O
.	O

Within	O
two	O
years	O
,	O
the	O
plague	S-Disease
had	O
spread	O
throughout	O
the	O
Islamic	O
world	O
,	O
from	O
Arabia	S-Location
across	O
North	B-Location
Africa	E-Location
.	O
The	O
pandemic	O
spread	O
westwards	O
from	O
Alexandria	S-Location
along	O
the	O
African	S-Location
coast	O
,	O
while	O
in	O
April	O
1348	O
Tunis	S-Location
was	O
infected	O
by	O
ship	O
from	O
Sicily	S-Location
.	O
Tunis	S-Location
was	O
then	O
under	O
attack	O
by	O
an	O
army	O
from	O
Morocco	S-Location
;	O
this	O
army	O
dispersed	O
in	O
1348	O
and	O
brought	O
the	O
contagion	O
with	O
them	O
to	O
Morocco	S-Location
,	O
whose	O
epidemic	O
may	O
also	O
have	O
been	O
seeded	O
from	O
the	O
Islamic	O
city	O
of	O
Almería	S-Location
in	O
.	O

For	O
the	O
United	B-Location
States	E-Location
2016	O
budget	O
,	O
U.S.	S-Location
president	O
Barack	B-Person
Obama	E-Person
proposed	O
to	O
nearly	O
double	O
the	O
amount	O
of	O
federal	O
funding	O
to	O
"	O
combat	O
and	O
prevent	O
"	O
antibiotic	O
resistance	O
to	O
more	O
than	O
$1.2 billion.President's	O
2016	O
Budget	O
Proposes	O
Historic	O
Investment	O
to	O
Combat	O
Antibiotic-Resistant	O
Bacteria	O
to	O
Protect	O
Public	O
Health	O
The	O
White	B-Organization
House,	I-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Press	I-Organization
Secretary	E-Organization
,	O
27	O
January	O
2015	O
Many	O
international	O
funding	O
agencies	O
like	O
USAID	S-Organization
,	O
DFID	S-Organization
,	O
SIDA	S-Organization
and	O
tion	O
have	O
pledged	O
money	O
for	O
developing	O
strategies	O
to	O
counter	O
antimicrobial	O
resistance	O
.	O

Molecular	B-Technology
biology	E-Technology
and	O
genetic	B-Technology
engineering	E-Technology
are	O
still	O
in	O
their	O
infancy	O
,	O
and	O
more	O
technical	O
possibilities	O
will	O
arise	O
in	O
the	O
years	O
to	O
come-for	O
military	O
abuse	O
too	O
(	O
Fraser	S-Person
&a	O
mp;	B-Person
D	E-Person
ando	O
,	O
2001)	O
.	O

The	O
weaponized	O
threat	O
comes	O
mainly	O
in	O
the	O
form	O
of	O
pneumonic	B-Disease
plague	E-Disease
(infection	O
by	O
inhalation)	O
It	O
was	O
the	O
disease	O
that	O
caused	O
the	O
Black	B-Disease
Death	E-Disease
in	O
.	O

How	O
does	O
that	O
change?	O
What	O
are	O
you	O
doing	O
for	O
that?	O

Shortly	O
after	O
EDV	B-Incident
emerged	I-Incident
in	I-Incident
West	I-Incident
Africa	I-Incident
in	I-Incident
2014	E-Incident
,	O
the	O
Chinese	O
government	O
offered	O
to	O
provide	O
large-scale	O
medical	O
aid	O
to	O
the	O
three	O
most	O
strongly	O
affected	O
countries	O
.	O

On	O
23	O
April	O
2020	O
,	O
NASA	S-Organization
reported	O
building	O
,	O
in	O
37	O
days	O
,	O
a	O
ventilator	S-Equipment
which	O
is	O
currently	O
undergoing	O
further	O
testing.	O
is	O
seeking	O
fast-track	O
approval	O
.	O

An	O
effort	O
to	O
recreate	O
the	O
1918	O
flu	O
strain	O
(a	O
subtype	O
of	O
avian	O
strain	O
H1N1	S-Pathogen
was	O
a	O
collaboration	O
among	O
the	O
Armed	B-Organization
Forces	I-Organization
Institute	I-Organization
of	I-Organization
Pathology	E-Organization
,	O
the	O
USDA	B-Organization
ARS	I-Organization
Southeast	I-Organization
Poultry	I-Organization
Research	I-Organization
Laboratory	E-Organization
,	O
and	O
Mount	B-Organization
Sinai	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
in	O
New	B-Location
York	I-Location
City	E-Location
.	O
The	O
effort	O
resulted	O
in	O
the	O
announcement	O
(on	O
5	O
October	O
2005)	O
that	O
the	O
group	O
had	O
successfully	O
determined	O
the	O
virus's	O
genetic	O
sequence	O
,	O
using	O
historic	O
tissue	O
samples	O
recovered	O
by	O
pathologist	O
Johan	B-Person
Hultin	E-Person
from	O
an	O
Inuit	O
female	O
flu	O
victim	O
buried	O
in	O
the	O
Alaskan	O
permafrost	O
and	O
samples	O
preserved	O
from	O
American	O
soldiers	O
Roscoe	B-Person
Vaughan	E-Person
and	O
.	O

Now	O
,	O
though	O
,	O
some	O
agencies	O
seem	O
to	O
think	O
they	O
ought	O
to	O
take	O
action	O
.	O

In	O
the	O
year	O
following	O
the	O
attack	O
,	O
there	O
were	O
seizures	O
of	O
postal	O
shipments	O
which	O
sought	O
to	O
intercept	O
medfly	O
larvae	O
.	O

An	O
Australian	O
study	O
of	O
10.	O
9 million	O
people	O
reported	O
that	O
the	O
increased	O
incidence	O
of	O
cancer	S-Disease
after	O
CT	B-Incident
scan	I-Incident
exposure	I-Incident
in	I-Incident
this	I-Incident
cohort	E-Incident
was	O
mostly	O
due	O
to	O
irradiation	O
.	O

In	O
1972	O
,	O
the	O
U.S.	S-Location
and	O
more	O
than	O
100	O
nations	O
sign	O
the	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
,	O
the	O
world's	O
first	O
treaty	O
banning	O
an	O
entire	O
class	O
of	O
weapons	O
.	O

Their	O
new	O
technologies	O
could	O
preserve	O
the	O
men	O
on	O
the	O
front	O
and	O
ultimately	O
save	O
the	O
world	O
.	O

The	O
United	B-Location
States	E-Location
ended	O
routine	O
in	O
1972	O
and	O
the	O
immunity	O
of	O
those	O
vaccinated	O
before	O
then	O
is	O
believed	O
to	O
have	O
waned	O
over	O
time	O
.	O

Yet	O
,	O
strong	O
relationships	O
may	O
not	O
usurp	O
state	O
legislation	O
.	O

During	O
the	O
planned	O
3.	O
5-year	O
PREEMPT	S-Scientific_research_project
program	O
,	O
DARPA	S-Organization
aims	O
to	O
identify	O
signatures	O
of	O
viral	O
fitness	O
and	O
the	O
potential	O
for	O
spillover	O
from	O
one	O
species	O
to	O
another	O
;	O
develop	O
risk	O
classifiers	O
and	O
predict	O
pathways	O
of	O
viral	O
adaptation	O
;	O
and	O
test	O
initial	O
intervention	O
approaches	O
.	O

In	O
addition	O
,	O
the	O
lab	O
contains	O
a	O
central	O
control	O
room	O
and	O
offices	O
on	O
the	O
left	O
side	O
,	O
and	O
a	O
decontamination	O
room	O
,	O
an	O
electricity	O
distribution	O
room	O
,	O
and	O
an	O
air	O
conditioning	O
engine	O
unit	O
on	O
the	O
right	O
side	O
.	O

Investing	O
in	O
global	O
health	O
security	O
also	O
saves	O
lives	O
here	O
in	O
the	O
U.S.	S-Location
and	O
across	O
the	O
globe	O
,	O
she	O
added	O
,	O
and	O
produces	O
economic	O
benefits	O
,	O
as	O
well	O
.	O

It	O
is	O
undergoing	O
a	O
phase2	B-Activity
non-randomised	I-Activity
trial	E-Activity
at	O
the	O
national	O
level	O
in	O
after	O
showing	O
positive	O
results	O
in	O
people	O
with	O
severe	O
disease	O
.	O

Nevertheless	O
,	O
studies	O
suggest	O
that	O
many	O
people	O
are	O
still	O
able	O
to	O
purchase	O
these	O
drugs	O
without	O
official	O
recommendations	O
from	O
their	O
doctors	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here:	O
http://go.usa.gov/cuTXR	O
.	O

With	O
such	O
a	O
treasure	O
trove	O
to	O
mine	O
and	O
the	O
active	O
involvement	O
and	O
wealth	O
of	O
experience	O
of	O
the	O
established	O
pharmaceutical	O
industry	O
(which	O
was	O
in	O
fact	O
founded	O
on	O
natural	O
product	O
development	O
in	O
the	O
1950s	O
–	O
70s)	O
the	O
target	O
would	O
be	O
attainable	O
.	O

On	O
24	O
April	O
it	O
was	O
reported	O
that	O
one	O
of	O
the	O
more	O
promising	O
vaccine	O
trials	O
had	O
begun	O
in	O
England	S-Location
the	O
government	O
has	O
pledged	O
,	O
in	O
total	O
,	O
more	O
than	O
50 million	O
pounds	O
towards	O
research	O
.	O

Of	O
the	O
nearly	O
6,000	O
people	O
vaccinated	O
,	O
none	O
had	O
contracted	O
Ebola	S-Disease
after	O
a	O
ten-day	O
period	O
while	O
in	O
the	O
group	O
not	O
vaccinated	O
23	O
cases	O
developed	O
.	O

There	O
was	O
significant	O
criticism	O
of	O
the	O
WHO	S-Organization
from	O
some	O
aid	O
agencies	O
because	O
its	O
response	O
was	O
perceived	O
as	O
slow	O
and	O
insufficient	O
,	O
especially	O
during	O
the	O
early	O
stages	O
of	O
the	O
outbreak	O
.	O

However	O
,	O
it	O
is	O
now	O
clear	O
that	O
natural-product	O
drug	O
discovery	O
efforts	O
to	O
date	O
have	O
generally	O
focused	O
on	O
readily	O
accessible	O
sources	O
(Ref)	O
.	O

The	O
first	O
super-spreader	O
,	O
Zhou	B-Person
Zuofen	E-Person
a	O
fishmonger	O
,	O
checked	O
in	O
to	O
the	O
Sun	B-Organization
Yat-sen	I-Organization
Memorial	I-Organization
Hospital	E-Organization
in	O
on	O
31	O
January	O
,	O
where	O
he	O
infected	O
30	O
nurses	O
and	O
doctors	O
.	O

There	O
was	O
knowledge	O
of	O
Tai	B-Pathogen
Forest	I-Pathogen
virus	E-Pathogen
in	O
Côte	B-Location
d'Ivoire	E-Location
,	O
which	O
had	O
resulted	O
in	O
one	O
human	O
transmission	O
in	O
1994	O
.	O

By	O
19	O
November	O
2009	O
,	O
doses	O
of	O
vaccine	O
had	O
been	O
administered	O
in	O
over	O
16	O
countries	O
.	O

To	O
mitigate	O
shortcomings	O
of	O
current	O
PPE	S-Equipment
DTRA	S-Organization
's	O
Dynamic	B-Scientific_research_project
Multifunctional	I-Scientific_research_project
Materials	I-Scientific_research_project
for	I-Scientific_research_project
a	I-Scientific_research_project
Second	I-Scientific_research_project
Skin	E-Scientific_research_project
(	O
DMMSS	S-Scientific_research_project
)	O
program	O
is	O
exploring	O
three	O
different	O
approaches	O
which	O
aim	O
to	O
develop	O
.	O
More	O
specifically	O
,	O
these	O
membranes	O
will	O
close	O
their	O
pores	O
in	O
response	O
to	O
chemical	O
agents	O
and	O
remain	O
open	O
when	O
not	O
exposed	O
.	O

Resistance	O
to	O
antivirals	O
is	O
thus	O
acquired	O
through	O
mutations	O
in	O
the	O
genes	O
that	O
encode	O
the	O
protein	O
targets	O
of	O
the	O
drugs	O
.	O

Some	O
of	O
the	O
Unit	B-Organization
731	E-Organization
personnel	O
were	O
imprisoned	O
by	O
the	O
Soviets	O
,	O
and	O
may	O
have	O
been	O
a	O
potential	O
source	O
of	O
information	O
on	O
Japanese	O
weaponization	O
.	O

A	O
report	O
in	O
The	O
Lancet	S-Organization
on	O
24	O
January	O
indicated	O
human	O
transmission	O
,	O
strongly	O
recommended	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
for	O
health	O
workers	O
,	O
and	O
said	O
testing	O
for	O
the	O
virus	O
was	O
essential	O
due	O
to	O
its	O
"	O
pandemic	O
potential"	O
.	O

It	O
is	O
simply	O
not	O
acceptable	O
that	O
so	O
many	O
people	O
die	O
of	O
this	O
disease	O
.	O

If	O
that	O
is	O
true	O
,	O
it	O
raises	O
the	O
worrisome	O
possibility	O
that	O
a	O
smallpox	S-Pathogen
attack	O
might	O
be	O
carried	O
out	O
with	O
plumes	O
of	O
germs	O
that	O
could	O
infect	O
large	O
numbers	O
of	O
people	O
simultaneously	O
.	O

Environmental	O
specimens	O
were	O
collected	O
with	O
swabs	O
,	O
including	O
(1)	O
the	O
surface	O
of	O
sample	O
acceptance	O
desk	O
,	O
(2)	O
the	O
temporary	O
storage	O
refrigerator	O
,	O
(3)	O
the	O
operation	O
platform	O
of	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(4)	O
the	O
RNA	O
extraction	O
bench	O
in	O
the	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(5)	O
the	O
autoclave	S-Equipment
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(6)	O
the	O
centrifuge	S-Equipment
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(7)	O
the	O
transfer	O
windows	O
in	O
the	O
BSL-3	S-Platform
lab	O
("clean	O
"	O
and	O
"	O
dirty"),	O
(8)	O
the	O
bench	O
in	O
the	O
preparation	O
room	O
(before	O
and	O
after	O
use)	O
,	O
(9)	O
the	O
operation	O
platform	O
of	O
biosafety	O
cabinet	O
in	O
the	O
BSL-2	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
and	O
(10)	O
the	O
real-time	B-Equipment
PCR	I-Equipment
facility	E-Equipment
in	O
(inside	O
and	O
outside)	O
.	O

Apart	O
from	O
regional	O
,	O
country	O
and	O
liaison	O
offices	O
,	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
has	O
also	O
established	O
other	O
institutions	O
for	O
promoting	O
and	O
carrying	O
on	O
research	O
.	O

The	O
2009	O
swine	B-Incident
flu	I-Incident
pandemic	E-Incident
was	O
an	O
influenza	O
pandemic	O
that	O
lasted	O
for	O
about	O
19	O
months	O
,	O
from	O
January	O
2009	O
to	O
August	O
2010	O
,	O
and	O
the	O
second	O
of	O
two	O
pandemics	O
involving	O
H1N1	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
(the	O
first	O
being	O
the	O
1918–1919	O
Spanish	B-Incident
flu	I-Incident
pandemic	E-Incident
which	O
lasted	O
about	O
15	O
months)	O
.	O

The	O
first	O
super-spreader	O
,	O
Zhou	B-Person
Zuofen	E-Person
a	O
fishmonger	O
,	O
checked	O
in	O
to	O
the	O
Sun	B-Organization
Yat-sen	I-Organization
Memorial	I-Organization
Hospital	E-Organization
in	O
on	O
31	O
January	O
,	O
where	O
he	O
infected	O
30	O
nurses	O
and	O
doctors	O
.	O

On	O
the	O
human	O
side	O
,	O
the	O
agency	O
will	O
work	O
with	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
other	O
stakeholders	O
to	O
improve	O
the	O
collection	O
and	O
reporting	O
of	O
AMR	O
data	O
.	O

The	O
case	O
is	O
the	O
third	O
in	O
the	O
country	O
,	O
following	O
confirmation	O
of	O
two	O
cases	O
from	O
Lae	S-Location
in	O
June	O
and	O
July	O
2018	O
.	O

Under	O
the	O
DTRA	B-Scientific_research_project
project	E-Scientific_research_project
"	O
Virus	O
and	O
Other	O
Arboviruses	O
in	O
Georgia	S-Location
"	O
in	O
2014	O
the	O
never-before-seen	O
tropical	O
mosquito	O
Aedes	O
albopictus	O
was	O
detected	O
for	O
the	O
first	O
time	O
and	O
after	O
decades	O
(60	O
years)	O
the	O
existence	O
of	O
Aedes	O
Aegypti	O
mosquito	O
was	O
confirmed	O
in	O
.	O

Through	O
these	O
tools	O
,	O
researchers	O
can	O
identify	O
protective	O
antibodies	O
from	O
recovering	O
patients	O
and	O
then	O
manufacture	O
genetic	O
constructs	O
capable	O
of	O
instructing	O
a	O
patient's	O
body	O
to	O
produce	O
similar	O
protective	O
antibodies	O
.	O

But	O
because	O
of	O
that	O
,	O
workers	O
in	O
other	O
laboratories	O
who	O
received	O
materials	O
that	O
that	O
laboratory	O
prepared	O
may	O
have	O
been	O
exposed	O
to	O
.	O
While	O
we've	O
assessed	O
the	O
event	O
,	O
we've	O
learned	O
more	O
about	O
what	O
happened	O
.	O

Belgium	S-Organization
has	O
also	O
issued	O
an	O
official	O
classification	O
of	O
animal	O
pathogens	O
.	O

In	O
addition	O
to	O
that	O
,	O
awareness	O
of	O
laboratory	O
personnel	O
towards	O
biosafety	O
principles	O
implementation	O
was	O
very	O
low	O
too	O
.	O

The	O
first	O
is	O
the	O
"	O
small	O
molecule	O
"	O
approach	O
,	O
which	O
often	O
focuses	O
on	O
dietary	O
supplements	O
.	O

In	O
the	O
21	O
January	O
2015	O
WHO	S-Organization
road	O
map	O
update	O
,	O
it	O
was	O
reported	O
that	O
100%	O
of	O
districts	O
in	O
Sierra	B-Location
Leone	E-Location
and	O
71%	O
of	O
districts	O
in	O
had	O
a	O
list	O
of	O
key	O
religious	O
leaders	O
who	O
promoted	O
safe	O
and	O
dignified	O
burials	O
.	O

To	O
penetrate	O
the	O
cell	O
,	O
the	O
viral	O
membrane	O
fuses	O
with	O
vesicle	O
membrane	O
,	O
and	O
the	O
nucleocapsid	O
is	O
released	O
into	O
the	O
cytoplasm	O
.	O

Hadassah	B-Organization
Academic	I-Organization
College	E-Organization
holds	O
anonymous	O
student	O
evaluations	O
for	O
every	O
course	O
.	O

For	O
effective	O
military	O
use	O
it	O
was	O
dried	O
to	O
a	O
powder	O
that	O
could	O
be	O
dispersed	O
as	O
aerosols	O
.	O

Detectives	O
and	O
agents	O
focused	O
on	O
the	O
possibility	O
that	O
the	O
individual	O
responsible	O
for	O
the	O
2003	O
letters	O
was	O
also	O
responsible	O
for	O
the	O
contamination	O
at	O
the	O
Dirksen	O
building	O
.	O

This	O
allows	O
bends	O
in	O
a	O
vessel	O
to	O
be	O
"	O
straightened"	O
so	O
that	O
the	O
entire	O
length	O
can	O
be	O
visualised	O
on	O
one	O
image	O
,	O
or	O
a	O
short	O
series	O
of	O
images	O
.	O

One	O
of	O
their	O
current	O
subjects	O
is	O
reportedly	O
.	O
Its	O
virulence	O
and	O
antibiotic	O
resistance	O
have	O
been	O
dramatically	O
increased	O
using	O
genetic	O
engineering	O
.	O

However	O
,	O
as	O
of	O
late	O
2015	O
,	O
while	O
the	O
large-scale	O
epidemic	O
had	O
ended	O
,	O
according	O
to	O
media	O
reports	O
,	O
sporadic	O
new	O
cases	O
were	O
still	O
being	O
recorded	O
,	O
frustrating	O
hopes	O
that	O
the	O
epidemic	O
could	O
be	O
declared	O
over	O
.	O

Tocilizumab	S-Drug
has	O
been	O
included	O
in	O
treatment	O
guidelines	O
by	O
China's	B-Organization
National	I-Organization
Health	I-Organization
Commission	E-Organization
after	O
a	O
small	O
study	O
was	O
completed	O
.	O

DNA	O
is	O
made	O
up	O
of	O
four	O
building	O
blocks	O
,	O
or	O
bases	O
,	O
and	O
DNA	O
sequencing	O
is	O
the	O
process	O
of	O
determining	O
the	O
order	O
of	O
those	O
bases	O
in	O
a	O
strand	O
of	O
DNA	O
.	O

The	O
participants	O
believe	O
that	O
if	O
the	O
appropriate	O
actions	O
are	O
taken	O
on	O
a	O
worldwide	O
scale	O
,	O
the	O
odds	O
can	O
be	O
changed	O
.	O

A	O
key	O
event	O
in	O
the	O
spread	O
of	O
the	O
disease	O
in	O
the	O
country	O
was	O
the	O
annual	O
assembly	O
of	O
the	O
Christian	B-Organization
Open	I-Organization
Door	I-Organization
Church	E-Organization
between	O
17	O
and	O
24	O
February	O
in	O
,	O
which	O
was	O
attended	O
by	O
about	O
2,500	O
people	O
,	O
at	O
least	O
half	O
of	O
whom	O
are	O
believed	O
to	O
have	O
contracted	O
the	O
virus	O
.	O

Production	O
of	O
cluster	O
bomb	O
submunitions	O
began	O
to	O
shift	O
from	O
cylindrical	O
to	O
spherical	O
bomblets	O
,	O
which	O
had	O
a	O
larger	O
coverage	O
area	O
.	O

In	O
the	O
US	S-Location
the	O
FBI	B-Organization
Weapons	I-Organization
of	I-Organization
Mass	I-Organization
Destruction	I-Organization
Directorate	E-Organization
has	O
worked	O
with	O
the	O
American	B-Organization
Association	I-Organization
for	I-Organization
the	I-Organization
Advancement	I-Organization
of	I-Organization
Science's	I-Organization
National	I-Organization
Science	I-Organization
Advisory	I-Organization
Board	I-Organization
for	I-Organization
Biosecurity	E-Organization
to	O
convene	O
a	O
series	O
of	O
meetings	O
to	O
discuss	O
biosecurity	O
,	O
which	O
have	O
included	O
discussions	O
of	O
amateur	O
biologists	O
and	O
ways	O
to	O
manage	O
the	O
risks	O
to	O
society	O
it	O
poses	O
.	O

Waste	O
from	O
the	O
BSL-2	S-Platform
lab	O
was	O
sterilised	O
directly	O
in	O
the	O
in	O
the	O
decontamination	O
room	O
.	O

However	O
,	O
administration	O
of	O
IV	B-Equipment
fluids	E-Equipment
is	O
difficult	O
in	O
the	O
African	S-Location
environment	O
.	O

In	O
reality	O
,	O
this	O
gives	O
BWC	S-Document
member-states	O
wide	O
latitude	O
to	O
conduct	O
biological	O
weapons	O
research	O
because	O
the	O
BWC	S-Document
contains	O
no	O
provisions	O
for	O
monitoring	O
or	O
enforcement	O
.	O

The	O
December	B-Activity
2005	I-Activity
meeting	I-Activity
of	I-Activity
States	I-Activity
Party	I-Activity
to	I-Activity
the	I-Activity
Biological	I-Activity
Weapons	I-Activity
Convention	E-Activity
endorsed	O
codes	O
of	O
conduct	O
,	O
agreeing	O
that	O
they	O
can	O
make	O
a	O
significant	O
and	O
effective	O
contribution	O
,	O
in	O
conjunction	O
with	O
other	O
measures	O
,	O
to	O
combating	O
the	O
present	O
and	O
future	O
threats	O
posed	O
by	O
biological	O
weapons	O
and	O
bioterrorism	O
.	O

So	O
much	O
you've	O
covered	O
,	O
I'll	O
ask	O
you	O
one	O
question	O
.	O

Some	O
states	O
have	O
different	O
emergency	O
pharmacy	O
laws	O
,	O
which	O
complicate	O
things	O
during	O
a	O
disaster	O
,	O
Roszak	S-Person
said	O
,	O
who	O
added	O
she	O
wasn't	O
sure	O
of	O
what	O
efforts	O
exist	O
to	O
streamline	O
these	O
laws	O
across	O
state	O
lines	O
.	O

MIRIAM	B-Person
FALCO	E-Person
Hi	O
,	O
Dr.Frieden	S-Person
.	O
Thank	O
you	O
for	O
taking	O
these	O
questions	O
.	O

Both	O
men	O
fell	O
ill	O
and	O
one	O
was	O
hospitalized	O
.	O

For	O
instance	O
,	O
some	O
of	O
what	O
experts	O
learned	O
from	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	E-Incident
was	O
the	O
impact	O
of	O
such	O
outbreaks	O
on	O
the	O
health	O
care	O
workers	O
,	O
who	O
were	O
needed	O
to	O
care	O
for	O
the	O
sick	O
but	O
who	O
also	O
got	O
ill	O
;	O
many	O
also	O
died	O
.	O

On	O
1	O
April	O
,	O
the	O
U.S.	B-Organization
government	E-Organization
called	O
back	O
non-essential	O
personnel	O
in	O
their	O
consulate	O
office	O
in	O
Hong	B-Location
Kong	E-Location
and	O
Guangzhou	S-Location
.	O
The	O
also	O
advised	O
US	O
citizens	O
not	O
to	O
travel	O
to	O
the	O
region	O
.	O

Therefore	O
,	O
appropriate	O
PPE	S-Equipment
and	O
good	O
practices	O
are	O
essential	O
for	O
protecting	O
medical	O
and	O
laboratory	O
staff	O
dealing	O
with	O
EVD	S-Disease
.	O
We	O
believe	O
that	O
adequate	O
preparation	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
,	O
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
sectioning	O
of	O
the	O
biosafety	O
laboratory	O
,	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

By	O
17	O
March	O
,	O
the	O
epidemic	O
had	O
been	O
confirmed	O
in	O
all	O
fifty	O
states	O
and	O
in	O
the	O
District	B-Location
of	I-Location
Columbia	E-Location
.	O
On	O
26	O
March	O
,	O
had	O
more	O
confirmed	O
cases	O
than	O
any	O
other	O
country	O
.	O

The	O
Action	O
Packages	O
have	O
been	O
identified	O
and	O
agreed	O
upon	O
by	O
GHSA	S-International_exchange_and_cooperation
member	O
countries	O
to	O
provide	O
focus	O
and	O
structure	O
to	O
priority	O
technical	O
areas	O
that	O
will	O
help	O
achieve	O
the	O
overall	O
GHSA	S-International_exchange_and_cooperation
goal	O
to	O
prevent	O
,	O
detect	O
and	O
respond	O
to	O
infectious	O
disease	O
outbreaks	O
.	O

The	O
system	O
integrates	O
three	O
specialized	O
data	O
management	O
systems:	O
BASE	S-Platform
for	O
microarrays	O
,	O
OMERO	S-Platform
for	O
microscopy	O
imaging	O
data	O
and	O
Metabolomixed-based	O
on	O
the	O
open-source	O
system	O
omixed	O
-for	O
metabolomics	O
and	O
proteomics	O
data	O
.	O

Indeed	O
,	O
the	O
insights	O
into	O
the	O
nature	O
of	O
infectious	O
diseases	O
gained	O
by	O
Louis	B-Person
Pasteur	E-Person
and	O
Robert	B-Person
Koch	E-Person
in	O
the	O
nineteenth	O
century	O
did	O
not	O
actually	O
represent	O
a	O
great	O
breakthrough	O
in	O
the	O
use	O
of	O
infectious	O
organisms	O
as	O
biological	O
weapons	O
.	O

Deadly	O
Arsenals	O
,	O
p.	O
212	O
.	O

No	O
proven	O
Ebola	B-Pathogen
virus	E-Pathogen
treatment	O
presently	O
exists	O
;	O
however	O
,	O
measures	O
can	O
be	O
taken	O
to	O
improve	O
a	O
patient's	O
chances	O
of	O
survival	O
.	O

But	O
Avinash	B-Person
Kar	E-Person
a	O
senior	O
attorney	O
with	O
the	O
Natural	B-Organization
Resources	I-Organization
Defense	I-Organization
Council	E-Organization
,	O
expressed	O
concern	O
that	O
the	O
details	O
on	O
these	O
objectives	O
,	O
which	O
are	O
contained	O
in	O
the	O
FDA	S-Organization
's	O
newly	O
released	O
5-year	O
plan	O
to	O
support	O
antibiotic	O
stewardship	O
in	O
veterinary	O
settings	O
,	O
are	O
lacking-particularly	O
on	O
duration	O
limits.	O
"	O
We	O
don't	O
have	O
any	O
details	O
on	O
what	O
this	O
is	O
going	O
to	O
look	O
like,	O
"	O
said.	O
"	O
What	O
is	O
a	O
reasonable	O
duration	O
limit?	O
"	O

By	O
incorporating	O
long	O
term	O
release	O
of	O
-approved	O
antimalarial	O
drugs	O
in	O
a	O
drug	O
matrix	O
of	O
EVA	O
,	O
drug	O
rods	O
can	O
be	O
implanted	O
in	O
service	O
members	O
,	O
which	O
frees	O
the	O
deployed	O
service	O
members	O
from	O
adhering	O
to	O
a	O
daily	O
oral	O
drug	O
dosing	O
schedule	O
and	O
should	O
protect	O
from	O
malaria	O
for	O
the	O
entire	O
deployment	O
after	O
implant	O
insertion	O
.	O

However	O
,	O
the	O
number	O
of	O
cases	O
jumped	O
to	O
more	O
than	O
100,000	O
in	O
the	O
year	O
of	O
the	O
Stalingrad	B-Incident
outbreak	E-Incident
.	O
German	O
Panzer	O
troops	O
fell	O
ill	O
in	O
such	O
significant	O
numbers	O
during	O
the	O
late	O
summer	O
of	O
1942	O
that	O
the	O
German	O
military	O
campaign	O
came	O
to	O
a	O
temporary	O
halt	O
.	O

"	O
We	O
will	O
leverage	O
this	O
DHS	B-Organization
big	I-Organization
data	I-Organization
center	E-Organization
that's	O
been	O
built	O
up	O
over	O
the	O
years	O
and	O
literally	O
tracks	O
every	O
container	O
,	O
commodity	O
and	O
person	O
moving	O
and	O
coming	O
into	O
the	O
United	B-Location
States	E-Location
,	O
"	O
said	O
McDonnell	S-Person
,	O
noting	O
that	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
,	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Transportation	E-Organization
and	O
the	O
also	O
will	O
be	O
involved	O
.	O

When	O
an	O
individual	O
is	O
infected	O
the	O
pathophysiological	O
process	O
indicates	O
that	O
as	O
systemic	B-Phenotype
inflammation	E-Phenotype
sets	O
in	O
there	O
are	O
,	O
as	O
well	O
as	O
vascular	O
and	O
the	O
aforementioned	O
immune	O
system	O
issues	O
.	O

In	O
a	O
report	O
released	O
on	O
23	O
September	O
2014	O
,	O
the	O
CDC	S-Organization
analysed	O
the	O
impact	O
of	O
under-reporting	O
,	O
which	O
required	O
correction	O
of	O
case	O
numbers	O
by	O
a	O
factor	O
of	O
up	O
to	O
2.5	O
.	O

SGI	S-Organization
has	O
funded	O
the	O
work	O
at	O
JCVI	S-Organization
in	O
exchange	O
for	O
exclusive	O
intellectual	O
property	O
rights	O
.	O

Initially	O
,	O
the	O
usage	O
of	O
unsterilized	O
needles	O
in	O
a	O
hospital	O
was	O
connected	O
to	O
the	O
first	O
outbreak	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
.	O

Here	O
,	O
Joint	B-Organization
Information	I-Organization
Systems	I-Organization
Committee	E-Organization
(	O
JISC	S-Organization
)	O
reports	O
provide	O
more	O
detail	O
.	O

The	O
employee	O
was	O
given	O
an	O
antiviral	O
medication	O
;	O
no	O
infection	O
resulted	O
,	O
the	O
records	O
say	O
.	O

The	O
type	O
of	O
respiratory	O
support	O
for	O
individuals	O
with	O
COVID‑19	S-Disease
related	O
respiratory	B-Phenotype
failure	E-Phenotype
is	O
being	O
actively	O
studied	O
for	O
people	O
in	O
the	O
hospital	O
,	O
with	O
some	O
evidence	O
that	O
intubation	O
can	O
be	O
avoided	O
with	O
a	O
high	O
flow	O
nasal	O
cannula	O
or	O
bi-level	O
positive	O
airway	O
pressure	O
.	O

In	O
the	O
news	O
conference	O
chaired	O
by	O
Gao	B-Person
Qiang	E-Person
several	O
hours	O
earlier	O
,	O
the	O
PRC	S-Organization
admitted	O
that	O
in	O
there	O
were	O
more	O
than	O
300	O
cases	O
,	O
as	O
opposed	O
to	O
the	O
previous	O
figure	O
of	O
only	O
37	O
.	O

Unit	B-Organization
731	E-Organization
presents	O
a	O
special	O
problem	O
,	O
since	O
unlike	O
Nazi	O
human	O
experimentation	O
which	O
the	O
United	B-Location
States	E-Location
publicly	O
condemned	O
,	O
the	O
activities	O
of	O
are	O
known	O
to	O
the	O
general	O
public	O
only	O
from	O
the	O
testimonies	O
of	O
willing	O
former	O
unit	O
members	O
,	O
and	O
testimony	O
cannot	O
be	O
employed	O
to	O
determine	O
indemnity	O
in	O
this	O
way	O
.	O

However	O
,	O
interpreting	O
these	O
results	O
at	O
the	O
country	O
level	O
is	O
most	O
challenging	O
and	O
complicated	O
because	O
of	O
the	O
diversity	O
of	O
the	O
population	O
strata	O
,	O
cultures	O
,	O
socioeconomic	O
statuses	O
,	O
availability	O
of	O
funds	O
,	O
and	O
development	O
needs	O
of	O
study	O
countries	O
.	O

The	O
proper	O
use	O
of	O
infrastructure	O
for	O
water	O
,	O
sanitation	O
and	O
hygiene	O
(WASH)	O
can	O
result	O
in	O
a	O
47–72	O
percent	O
decrease	O
of	O
diarrhea	S-Phenotype
cases	O
treated	O
with	O
antibiotics	O
depending	O
on	O
the	O
type	O
of	O
intervention	O
and	O
its	O
effectiveness	O
.	O

Most	O
of	O
the	O
cases	O
were	O
linked	O
to	O
apartments	O
with	O
a	O
north-western	O
orientation	O
which	O
shared	O
the	O
same	O
sewage	O
pipe	O
.	O

Dan	B-Person
Jernigan	E-Person
head	O
of	O
the	O
's	O
influenza	O
branch	O
.	O

The	O
benefactor	O
behind	O
the	O
"	O
gift"	O
was	O
Robert	B-Person
W.Woodruff	E-Person
,	O
chairman	O
of	O
the	O
board	O
of	O
.	O

Dr	O
.	O

Brazil	S-Organization
and	O
New	B-Organization
Zealand	E-Organization
also	O
evacuated	O
their	O
own	O
nationals	O
and	O
some	O
other	O
people	O
.	O

And	O
third	O
,	O
it	O
must	O
run	O
and	O
evaluate	O
a	O
gauntlet	O
of	O
physical	O
and	O
chemical	O
tests	O
on	O
the	O
bacteria-the	O
biological	O
equivalent	O
of	O
the	O
game	O
"	O
Twenty	O
Questions"-to	O
determine	O
their	O
pathogenicity	O
.	O

On	O
22	O
April	O
it	O
was	O
reported	O
that	O
two	O
Californians	O
had	O
died	O
from	O
the	O
virus	O
(not	O
,	O
as	O
previously	O
thought	O
,	O
influenza)	O
on	O
6and	O
17	O
February	O
,	O
three	O
weeks	O
before	O
the	O
first	O
official	O
COVID-19	S-Disease
death	O
in	O
the	O
U.S.	S-Location
had	O
been	O
acknowledged	O
.	O

I'd	O
like	O
to	O
really	O
outline	O
what	O
has	O
happened	O
in	O
recent	O
months	O
,	O
give	O
the	O
details	O
,	O
give	O
what	O
happened	O
,	O
why	O
it	O
happened	O
and	O
what	O
we	O
are	O
doing	O
about	O
it	O
.	O

Zelicoff	S-Person
says	O
the	O
fact	O
that	O
the	O
Soviet	B-Organization
Union	E-Organization
never	O
reported	O
the	O
to	O
world	O
health	O
authorities	O
"	O
suggests	O
a	O
sinister	O
source.	O
"	O

A	O
2012	O
review	O
did	O
not	O
find	O
an	O
association	O
between	O
medical	O
radiation	O
and	O
cancer	O
risk	O
in	O
children	O
noting	O
however	O
the	O
existence	O
of	O
limitations	O
in	O
the	O
evidences	O
over	O
which	O
the	O
review	O
is	O
based	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here:	O

The	O
same	O
report	O
predicted	O
that	O
total	O
cases	O
,	O
including	O
unreported	O
cases	O
,	O
could	O
reach	O
1.	O
4	O
million	O
in	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
by	O
the	O
end	O
of	O
January	O
2015	O
if	O
no	O
improvement	O
in	O
intervention	O
or	O
community	O
behaviour	O
occurred	O
.	O

Nixon's	O
statement	O
confined	O
all	O
biological	O
weapons	O
research	O
to	O
defensive-only	O
and	O
ordered	O
the	O
destruction	O
of	O
the	O
existing	O
U.S.	O
biological	O
arsenal.Mauroni	O
,	O
Albert	O
J	O
.	O

Preliminary	O
data	O
from	O
an	O
international	O
multi-center	O
,	O
placebo	O
controlled	O
double-blind	O
randomized	O
controlled	O
trial	O
carried	O
out	O
by	O
the	O
U.S.	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
suggests	O
that	O
remdesivir	S-Drug
is	O
effective	O
in	O
reducing	O
the	O
recovery	O
time	O
from	O
15	O
to	O
11	O
days	O
in	O
people	O
hospitalized	O
with	O
COVID‑19	S-Disease
.	O
On	O
29	O
April	O
2020	O
,	O
based	O
on	O
results	O
of	O
the	O
ACTT	O
trial	O
,	O
the	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
announced	O
that	O
remdesivir	S-Drug
was	O
better	O
than	O
a	O
placebo	O
in	O
reducing	O
time	O
to	O
recovery	O
for	O
people	O
hospitalized	O
with	O
advanced	O
COVID‑19	S-Disease
and	O
lung	O
involvement	O
.	O

Following	O
upon	O
the	O
success	O
of	O
the	O
Image	B-Activity
Gently	I-Activity
campaign	E-Activity
the	O
American	B-Organization
College	I-Organization
of	I-Organization
Radiology	E-Organization
,	O
the	O
Radiological	B-Organization
Society	I-Organization
of	I-Organization
North	I-Organization
America	E-Organization
,	O
the	O
American	B-Organization
Association	I-Organization
of	I-Organization
Physicists	I-Organization
in	I-Organization
Medicine	E-Organization
and	O
the	O
American	B-Organization
Society	I-Organization
of	I-Organization
Radiologic	I-Organization
Technologists	E-Organization
have	O
launched	O
a	O
similar	O
campaign	O
to	O
address	O
this	O
issue	O
in	O
the	O
adult	O
population	O
called	O
.	O

One	O
of	O
the	O
things	O
that	O
may	O
happen	O
-	O
and	O
this	O
is	O
just	O
a	O
hypothesis	O
-	O
is	O
that	O
when	O
most	O
people	O
hear	O
about	O
or	O
another	O
deadly	O
organism	O
,	O
they	O
think	O
,	O
you	O
know	O
,	O
this	O
is	O
something	O
that	O
is	O
,	O
of	O
course	O
,	O
terrifying	O
,	O
and	O
it	O
is	O
.	O

,	O
CDC	S-Organization
staff	O
numbered	O
approximately	O
15,000	O
(including	O
6,000	O
contractors	O
and	O
840	O
Commissioned	O
Corps	O
officers)	O
in	O
170	O
occupations	O
.	O

About	O
Mapp	B-Organization
Biopharmaceutical	E-Organization
MappBio	S-Organization
com)	O
was	O
founded	O
in	O
2003	O
to	O
develop	O
novel	O
pharmaceuticals	O
for	O
the	O
prevention	O
and	O
treatment	O
of	O
infectious	O
diseases	O
,	O
focusing	O
on	O
unmet	O
needs	O
in	O
global	O
health	O
and	O
biodefense	O
.	O

Tumpej	B-Person
TM	E-Person
et	O
al.	O
2005	O
.	O

The	O
victim's	O
son-in-law	O
is	O
also	O
reported	O
to	O
have	O
been	O
infected	O
.	O

"	O
There's	O
little	O
down	O
time	O
to	O
reflect	O
on	O
what	O
happened,	O
"	O
said	O
Jennifer	B-Person
Nuzzo	E-Person
director	O
of	O
the	O
,	O
about	O
officials	O
who	O
can	O
be	O
in	O
the	O
midst	O
of	O
addressing	O
a	O
response	O
to	O
outbreaks	O
.	O

However	O
,	O
most	O
of	O
the	O
early	O
initiatives	O
were	O
focused	O
on	O
national	O
frameworks	O
for	O
biotechnology	O
,	O
aspects	O
such	O
as	O
control	O
GMOs	S-Technology
and	O
living	B-Technology
modified	I-Technology
organisms	E-Technology
(	O
LMOs	S-Technology
)	O
,	O
and	O
environmental	O
effects	O
of	O
agricultural	O
products	O
,	O
such	O
as	O
Bt	O
Cotton	O
,	O
perhaps	O
because	O
of	O
its	O
wider	O
impact	O
at	O
the	O
global	O
level	O
.	O

"	O
We	O
will	O
have	O
to	O
scale	O
its	O
global	O
health	O
security	O
portfolio	O
to	O
focus	O
efforts	O
based	O
on	O
existing	O
resources,	O
"	O
wrote	O
Rebecca	B-Person
Martin	E-Person
PhD	O
,	O
director	O
of	O
the	O
CDC's	B-Organization
Center	I-Organization
for	I-Organization
Global	I-Organization
Health	E-Organization
in	O
an	O
email	O
to	O
U.S.	S-Location
and	O
overseas	O
leaders	O
in	O
its	O
,	O
according	O
to	O
The	O
Wall	O
Street	O
Journal.	O
"	O
Faced	O
with	O
this	O
anticipated	O
fiscal	O
reality	O
,	O
we	O
have	O
had	O
to	O
make	O
some	O
very	O
difficult	O
decisions.	O
"	O

Within	O
each	O
sector	O
,	O
local	O
and	O
regional	O
actors	O
handle	O
samples	O
and	O
communicate	O
with	O
national	O
resources	O
and	O
BSL-3	S-Platform
laboratories	O
.	O

The	O
term	O
hacker	O
is	O
used	O
in	O
the	O
original	O
sense	O
of	O
finding	O
new	O
and	O
clever	O
ways	O
to	O
do	O
things	O
.	O

In	O
some	O
countries	O
,	O
including	O
Egypt	S-Organization
,	O
Turkey	S-Organization
,	O
and	O
Thailand	S-Organization
,	O
opposition	O
activists	O
and	O
government	O
critics	O
have	O
been	O
arrested	O
for	O
allegedly	O
spreading	O
fake	O
news	O
about	O
the	O
pandemic	O
.	O

Spread	O
of	O
NDM-5–positive	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
has	O
occurred	O
globally	O
and	O
included	O
reports	O
of	O
ST167	O
in	O
persons	O
in	O
Europe	S-Location
and	O
(8,9)	O
.	O

In	O
comparison	O
with	O
the	O
Biological	B-Document
Agent	I-Document
Biosafety	I-Document
Category	I-Document
Lists	E-Document
the	O
development	O
of	O
Biological	B-Document
Agent	I-Document
Biodefense	I-Document
Category	I-Document
lists	E-Document
requires	O
the	O
consideration	O
of	O
more	O
factors	O
.	O

Although	O
there's	O
a	O
lot	O
of	O
research	O
on	O
the	O
long-term	O
health	O
outcomes	O
of	O
fasting	O
in	O
animals	O
-	O
and	O
much	O
of	O
it	O
is	O
promising	O
-	O
the	O
research	O
literature	O
on	O
humans	O
is	O
much	O
thinner	O
.	O

According	O
to	O
the	O
Brazil	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
,	O
846	O
confirmed	O
cases	O
and	O
260	O
deaths	O
were	O
reported	O
in	O
the	O
period	O
from	O
July	O
1	O
,	O
2017	O
to	O
March	O
6	O
of	O
this	O
year	O
.	O

In	O
contrast	O
to	O
the	O
hardiness	O
of	O
anthrax	B-Pathogen
bacteria	E-Pathogen
the	O
Ebola	B-Pathogen
virus	E-Pathogen
is	O
sensitive	O
to	O
climactic	O
conditions	O
,	O
like	O
exposure	O
to	O
sunlight	O
and	O
extreme	O
temperatures	O
,	O
said	O
.	O

US	S-Location
conscientious	O
objectors	O
were	O
used	O
as	O
consenting	O
test	O
subjects	O
for	O
tularemia	S-Pathogen
in	O
a	O
program	O
known	O
as	O
.	O
There	O
were	O
also	O
many	O
unpublicized	O
tests	O
carried	O
out	O
in	O
public	O
places	O
with	O
bio-agent	O
simulants	O
during	O
the	O
Cold	O
War	O
.	O

In	O
"	O
the	O
largest	O
quarantine	O
in	O
human	O
history"	O
,	O
a	O
cordon	O
sanitaire	O
on	O
23	O
January	O
stopped	O
travel	O
in	O
and	O
out	O
of	O
Wuhan	S-Location
,	O
then	O
extended	O
to	O
fifteen	O
Hubei	S-Location
cities	O
affecting	O
about	O
57 million	O
people	O
.	O

These	O
universities	O
have	O
previously	O
worked	O
together	O
in	O
one	O
of	O
the	O
institute's	O
forebears	O
-	O
the	O
Antimicrobial	B-Scientific_research_project
Resistance	I-Scientific_research_project
Consortium	E-Scientific_research_project
a	O
research	O
initiative	O
focused	O
on	O
similar	O
ends	O
.	O

CRISPR-Cas9	B-Technology
genome	I-Technology
editing	E-Technology
is	O
carried	O
out	O
with	O
a	O
Type	O
II	O
CRISPR	O
system	O
.	O

This	O
strain	O
was	O
planned	O
to	O
be	O
used	O
to	O
arm	O
warheads	O
for	O
the	O
SS-18	O
ICBM	O
,	O
which	O
would	O
target	O
American	O
cities	O
,	O
among	O
other	O
targets	O
.	O

The	O
Chinese	O
experience	O
with	O
testing	O
has	O
shown	O
the	O
accuracy	O
is	O
only	O
60	O
to	O
70%	O
.	O

This	O
knowledge	O
should	O
be	O
initiated	O
in	O
schools	O
.	O

This	O
initiative	O
has	O
been	O
endorsed	O
and	O
applied	O
by	O
a	O
growing	O
list	O
of	O
various	O
professional	O
medical	O
organizations	O
around	O
the	O
world	O
and	O
has	O
received	O
support	O
and	O
assistance	O
from	O
companies	O
that	O
manufacture	O
equipment	O
used	O
in	O
Radiology	O
.	O

This	O
study	O
indicated	O
that	O
the	O
standards	O
biosafety	O
precautions	O
adopted	O
by	O
the	O
diagnostics	O
laboratories	O
in	O
Khartoum	S-Location
state	O
was	O
very	O
low	O
.	O

What	O
gave	O
the	O
1918	B-Pathogen
virus	E-Pathogen
the	O
unprecedented	O
ability	O
to	O
generate	O
rapidly	O
successive	O
pandemic	O
waves	O
is	O
unclear	O
.	O

Several	O
national	O
and	O
local	O
governments	O
have	O
made	O
wearing	O
mandatory	O
.	O

After	O
the	O
lethal	O
second	O
wave	O
struck	O
in	O
late	O
1918	O
,	O
new	O
cases	O
dropped	O
abruptly –	O
almost	O
to	O
nothing	O
after	O
the	O
peak	O
in	O
the	O
second	O
wave	O
.	O

The	O
idea	O
,	O
the	O
source	O
says	O
,	O
is	O
to	O
provide	O
flexibility	O
and	O
acknowledge	O
that	O
researchers	O
know	O
best	O
how	O
to	O
address	O
biosafety	O
issues	O
within	O
their	O
labs	O
.	O

As	O
a	O
member	O
of	O
the	O
biohacking	O
movement	O
that	O
aims	O
to	O
encourage	O
individuals	O
and	O
smaller	O
organisations	O
to	O
study	O
biology	O
using	O
the	O
same	O
methods	O
as	O
traditional	O
research	O
institutions	O
,	O
Jorgensen	S-Person
advocates	O
democratising	O
biotechnology	O
at	O
the	O
local	O
level	O
through	O
community	O
laboratories	O
that	O
not	O
only	O
teach	O
the	O
technical	O
aspects	O
of	O
the	O
science	O
but	O
also	O
explain	O
how	O
to	O
contextualise	O
it	O
.	O

What	O
is	O
being	O
done	O
to	O
protect	O
CDC	S-Organization
workers?	O

Recent	O
themes	O
have	O
been	O
vector-borne	O
diseases	O
(2014)	O
,	O
healthy	O
ageing	O
(2012)	O
and	O
drug	O
resistance	O
(2011)	O
.	O

The	O
study	O
was	O
commissioned	O
by	O
the	O
Defense	B-Organization
Department	E-Organization
with	O
the	O
aim	O
of	O
developing	O
a	O
framework	O
to	O
guide	O
an	O
assessment	O
of	O
the	O
security	O
concerns	O
related	O
to	O
advances	O
in	O
synthetic	O
biology	O
,	O
evaluate	O
the	O
levels	O
of	O
concern	O
warranted	O
for	O
such	O
advances	O
and	O
identify	O
options	O
to	O
mitigate	O
threats	O
.	O

A	O
new	O
class	O
of	O
gene	O
targeting	O
MR	O
contrast	O
agents	O
(CA)	O
has	O
been	O
introduced	O
to	O
show	O
gene	O
action	O
of	O
unique	O
mRNA	O
and	O
gene	O
transcription	O
factor	O
proteins	O
.	O

Biotechnology	O
is	O
behind	O
blockbuster	O
drugs	O
for	O
treating	O
cancer	S-Disease
and	O
heart	B-Disease
disease	E-Disease
,	O
and	O
it's	O
being	O
deployed	O
in	O
cutting-edge	O
research	O
to	O
cure	O
Alzheimer's	S-Disease
and	O
reverse	O
aging	O
.	O

She	O
said	O
H.R.	B-Document
6378	E-Document
reflects	O
extensive	O
feedback	O
from	O
stakeholders	O
across	O
the	O
full	O
range	O
of	O
medical	O
and	O
public	O
health	O
preparedness	O
and	O
response	O
,	O
who	O
offered	O
suggestions	O
on	O
how	O
the	O
nation	O
might	O
best	O
address	O
threats	O
more	O
cohesively	O
.	O

The	O
last	O
common	O
ancestor	O
of	O
human	O
strains	O
dates	O
to	O
between	O
February	O
1917	O
and	O
April	O
1918	O
.	O

Workers	O
preparing	O
food	O
at	O
the	O
affected	O
restaurants	O
had	O
fallen	O
ill	O
before	O
most	O
patrons	O
had	O
.	O

Abcellera	S-Organization
Biologics	O
Inc	O
.	O

To	O
comply	O
with	O
these	O
regulations	O
,	O
several	O
laboratory	O
networks	O
have	O
been	O
established	O
.	O

Symptoms	O
of	O
COVID-19	S-Disease
can	O
be	O
relatively	O
non-specific	O
;	O
the	O
two	O
most	O
common	O
symptoms	O
are	O
fever	S-Phenotype
(88	O
percent)	O
and	O
dry	B-Phenotype
cough	E-Phenotype
(68	O
percent)	O
.	O

Bedson	S-Person
misled	O
the	O
WHO	S-Organization
about	O
the	O
volume	O
of	O
work	O
handled	O
by	O
the	O
laboratory	O
,	O
telling	O
them	O
that	O
it	O
had	O
progressively	O
declined	O
since	O
1973	O
,	O
when	O
in	O
fact	O
it	O
had	O
risen	O
substantially	O
as	O
tried	O
to	O
finish	O
his	O
work	O
before	O
the	O
laboratory	O
closed	O
.	O

This	O
vaccination	O
strategy	O
is	O
considered	O
optimal	O
to	O
protect	O
both	O
first-line	O
health	O
workers	O
and	O
general	O
populations	O
in	O
areas	O
where	O
outbreaks	O
occur	O
.	O

On	O
December	O
8	O
,	O
1989	O
,	O
the	O
state	O
retreated	O
from	O
its	O
position	O
that	O
the	O
12	O
outbreaks	O
since	O
August	O
each	O
represented	O
"	O
isolated	O
infestations	O
"	O
that	O
could	O
be	O
easily	O
eradicated	O
after	O
a	O
panel	O
of	O
scientific	O
advisers	O
suggested	O
it	O
was	O
not	O
possible	O
.	O

The	O
first	O
known	O
case	O
may	O
trace	O
back	O
to	O
1December	O
2019	O
in	O
Wuhan	S-Location
Hubei	S-Location
,	O
China	S-Location
.	O
Over	O
the	O
next	O
month	O
,	O
the	O
number	O
of	O
coronavirus	O
cases	O
in	O
Hubei	S-Location
gradually	O
increased	O
.	O

Outbreaks	O
of	O
the	O
recurred	O
at	O
various	O
locations	O
around	O
the	O
world	O
until	O
the	O
early	O
19th	O
century	O
.	O

This	O
study	O
was	O
investigating	O
the	O
compliance	O
of	O
diagnostics	O
laboratory	O
to	O
standard	O
biosafety	O
precautions	O
.	O

In	O
July	O
2017	O
,	O
Robert	B-Person
C.	I-Person
Hutchinson	E-Person
,	O
former	O
agent	O
at	O
the	O
,	O
called	O
for	O
a	O
"	O
whole-of-government"	O
response	O
to	O
the	O
next	O
global	O
health	O
threat	O
,	O
which	O
he	O
described	O
as	O
including	O
strict	O
security	O
procedures	O
at	O
our	O
borders	O
and	O
proper	O
execution	O
of	O
government	O
preparedness	O
plans	O
.	O

CDC	S-Organization
will	O
continue	O
to	O
provide	O
support	O
during	O
the	O
Ebola	S-Disease
epidemic	O
through	O
its	O
research	O
and	O
diagnostic	O
lab	O
work	O
.	O

On	O
29	O
July	O
,	O
a	O
sharp	O
decline	O
in	O
cases	O
was	O
reported	O
,	O
with	O
only	O
a	O
single	O
case	O
,	O
per	O
media	O
reports	O
left	O
by	O
the	O
end	O
of	O
the	O
week	O
,	O
the	O
number	O
of	O
cases	O
eventually	O
plateaued	O
at	O
1	O
or	O
2	O
cases	O
per	O
week	O
after	O
the	O
beginning	O
of	O
August	O
.	O

However	O
,	O
the	O
FBI	S-Organization
said	O
additional	O
testing	O
is	O
needed	O
as	O
field	O
and	O
preliminary	O
tests	O
produce	O
inconsistent	O
results	O
.	O

When	O
I	O
asked	O
Carlson	S-Person
he	O
refused	O
to	O
buy	O
the	O
premise	O
of	O
the	O
question	O
.	O

Since	O
the	O
start	O
of	O
the	O
Pentagon	S-Scientific_research_project
project	O
in	O
2014	O
flies	O
similar	O
to	O
those	O
in	O
Georgia	S-Location
have	O
appeared	O
in	O
neighboring	O
Dagestan	S-Location
(	O
Russia	S-Location
)	O
.	O

The	O
Truth	O
of	O
Unit	B-Organization
731	E-Organization
Elite	O
medical	O
students	O
and	O
human	O
experiments	O
(2017)	O
.	O

Furthermore	O
,	O
if	O
the	O
use	O
of	O
vaccines	O
increases	O
,	O
there	O
is	O
evidence	O
that	O
antibiotic	O
resistant	O
strains	O
of	O
pathogens	O
will	O
decrease	O
;	O
the	O
need	O
for	O
antibiotics	O
will	O
naturally	O
decrease	O
as	O
vaccines	O
prevent	O
infection	O
before	O
it	O
occurs	O
.	O

And	O
to	O
work	O
with	O
them	O
means	O
to	O
have	O
a	O
special	O
responsibility	O
to	O
protect	O
both	O
the	O
workers	O
and	O
the	O
public	O
.	O

On	O
6	O
March	O
,	O
the	O
Italian	B-Organization
College	I-Organization
of	I-Organization
Anaesthesia,	I-Organization
Analgesia,	I-Organization
Resuscitation	I-Organization
and	I-Organization
Intensive	I-Organization
Care	E-Organization
(	O
SIAARTI	S-Organization
)	O
published	O
medical	O
ethics	O
recommendations	O
regarding	O
triage	O
protocols	O
.	O

But	O
according	O
to	O
the	O
,	O
"	O
though	O
a	O
study	O
of	O
middle-aged	O
and	O
older	O
Finnish	O
men	O
indicates	O
that	O
their	O
health	O
benefited	O
from	O
saunas	O
,	O
there	O
have	O
been	O
no	O
major	O
studies	O
conducted	O
of	O
"	O
this	O
type	O
of	O
sauna	O
,	O
which	O
directs	O
incandescent	O
light	O
at	O
your	O
body	O
.	O

The	O
prisoners	O
were	O
secured	O
to	O
a	O
bed	O
in	O
a	O
purpose-built	O
chamber	O
,	O
into	O
which	O
lethal	O
agents	O
,	O
including	O
anthrax	S-Pathogen
were	O
sprayed	O
from	O
a	O
high-velocity	O
device	O
mounted	O
in	O
the	O
ceiling	O
.	O

The	O
workshop	O
was	O
a	O
collaboration	O
with	O
the	O
African	B-Organization
Union	E-Organization
the	O
African	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
,	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention,	E-Organization
and	O
the	O
.	O

Non-therapeutic	O
use	O
of	O
antibiotics	O
must	O
be	O
discontinued	O
.	O

The	O
BSL-3	S-Platform
laboratory	O
is	O
connected	O
to	O
the	O
other	O
labs	O
through	O
two	O
transfer	O
windows	O
(a	O
"	O
clean"	O
transfer	O
window	O
and	O
a	O
"	O
dirty"	O
transfer	O
window)	O
.	O

Due	O
to	O
the	O
outcry	O
,	O
the	O
following	O
day	O
the	O
appointment	O
was	O
revoked	O
.	O

The	O
major	O
components	O
of	O
an	O
MRI	B-Equipment
scanner	E-Equipment
are	O
the	O
main	O
magnet	O
,	O
which	O
polarizes	O
the	O
sample	O
,	O
the	O
shim	O
coils	O
for	O
correcting	O
shifts	O
in	O
the	O
homogeneity	O
of	O
the	O
main	O
magnetic	O
field	O
,	O
the	O
gradient	O
system	O
which	O
is	O
used	O
to	O
localize	O
the	O
region	O
to	O
be	O
scanned	O
and	O
the	O
RF	O
system	O
,	O
which	O
excites	O
the	O
sample	O
and	O
detects	O
the	O
resulting	O
signal	O
.	O

The	O
CDC	S-Organization
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
obesity	O
and	O
diabetes	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
.	O

Lila	B-Person
Thulin	E-Person
,	O
The	O
Smithsonian	O
Magazine.	O
21	O
October	O
2019	O
.	O

It	O
further	O
recommends	O
using	O
an	O
alcohol-based	O
hand	O
sanitiser	O
with	O
at	O
least	O
60%	O
alcohol	O
,	O
but	O
only	O
when	O
soap	O
and	O
water	O
are	O
not	O
readily	O
available	O
.	O

The	O
generator	O
,	O
water	O
supplying	O
unit	O
and	O
incineration	O
units	O
are	O
located	O
outside	O
the	O
building	O
.	O

In	O
October	O
2017	O
,	O
the	O
WHO	S-Organization
issued	O
guidelines	O
recommending	O
that	O
medically	O
important	O
antibiotics	O
be	O
used	O
only	O
to	O
treat	O
sick	O
animals	O
,	O
arguing	O
that	O
the	O
widespread	O
use	O
of	O
these	O
drugs	O
for	O
growth	O
promotion	O
and	O
disease	O
prevention	O
in	O
animals	O
contributes	O
to	O
the	O
spread	O
of	O
AMR	O
.	O

Contrary	O
to	O
the	O
official	O
Soviet	S-Organization
report	O
,	O
he	O
said	O
,	O
she	O
told	O
him	O
that	O
she	O
never	O
disembarked	O
from	O
the	O
ship	O
,	O
the	O
Lev	O
Berg	O
,	O
before	O
returning	O
to	O
the	O
home	B-Location
port	I-Location
of	I-Location
Aralsk	E-Location
.	O

They	O
may	O
be	O
wondering	O
whether	O
we're	O
doing	O
what	O
we	O
need	O
to	O
do	O
to	O
keep	O
our	O
workers	O
and	O
our	O
communities	O
safe	O
.	O

The	O
plague	S-Disease
was	O
somewhat	O
more	O
uncommon	O
in	O
parts	O
of	O
Europe	S-Location
with	O
less	O
developed	O
trade	O
with	O
their	O
neighbours	O
,	O
including	O
the	O
majority	O
of	O
the	O
Basque	B-Location
Country	E-Location
,	O
isolated	O
parts	O
of	O
Belgium	S-Location
and	O
the	O
,	O
and	O
isolated	O
Alpine	O
villages	O
throughout	O
the	O
continent	O
.	O

As	O
of	O
2013	O
,	O
the	O
CDC	S-Organization
Biosafety	B-Platform
Level	I-Platform
4	I-Platform
laboratories	E-Platform
are	O
among	O
the	O
few	O
that	O
exist	O
in	O
the	O
world	O
,	O
and	O
serve	O
as	O
one	O
of	O
only	O
two	O
official	O
repositories	O
of	O
smallpox	S-Pathogen
in	O
the	O
world	O
.	O

The	O
plan	O
also	O
includes	O
efforts	O
to	O
improve	O
the	O
data	O
on	O
antibiotic	O
sales	O
,	O
use	O
,	O
and	O
resistance	O
in	O
food-producing	O
animals	O
,	O
provide	O
more	O
outreach	O
and	O
education	O
on	O
the	O
judicious	O
use	O
of	O
antibiotics	O
in	O
farms	O
animals	O
,	O
encourage	O
the	O
development	O
of	O
alternative	O
therapies	O
for	O
sick	O
animals	O
,	O
and	O
promote	O
stewardship	O
in	O
companion	O
animals	O
.	O

It	O
encodes	O
seven	O
structural	O
proteins:	O
nucleoprotein	O
(NP)	O
,	O
polymerase	O
cofactor	O
(VP35)	O
,	O
(VP40)	O
,	O
GP	O
,	O
transcription	O
activator	O
(VP30)	O
,	O
VP24	O
,	O
and	O
RNA-dependent	O
RNA	O
polymerase	O
(L)	O
.	O

In	O
"	O
the	O
largest	O
quarantine	O
in	O
human	O
history"	O
,	O
a	O
cordon	O
sanitaire	O
on	O
23	O
January	O
stopped	O
travel	O
in	O
and	O
out	O
of	O
Wuhan	S-Location
,	O
then	O
extended	O
to	O
fifteen	O
Hubei	S-Location
cities	O
affecting	O
about	O
57 million	O
people	O
.	O

It	O
expected	O
the	O
most	O
severe	O
losses	O
in	O
the	O
three	O
affected	O
countries	O
,	O
with	O
a	O
wider	O
impact	O
across	O
the	O
broader	O
Western	B-Location
African	I-Location
region	E-Location
.	O
On	O
13	O
April	O
2015	O
,	O
the	O
World	B-Organization
Bank	E-Organization
said	O
that	O
they	O
would	O
soon	O
announce	O
a	O
major	O
new	O
effort	O
to	O
rebuild	O
the	O
economies	O
of	O
the	O
three	O
hardest-hit	O
countries	O
.	O

Common	O
interests	O
among	O
the	O
agencies	O
define	O
the	O
scope	O
of	O
the	O
projects	O
.	O

MERS	B-Disease
coronavirus	E-Disease
.	O
Ebola	S-Disease
.	O
Hepatitis	B-Disease
E	E-Disease
.	O
Yellow	B-Disease
Fever	E-Disease
.	O
Lassa	S-Disease
.	O
.	O

Twenty-nine	O
individuals	O
in	O
group	O
one	O
are	O
being	O
advised	O
to	O
continue	O
taking	O
antibiotics	S-Drug
out	O
of	O
an	O
abundance	O
of	O
caution	O
.	O

An	O
omnibus	O
spending	O
bill	O
passed	O
by	O
Congress	S-Organization
earlier	O
this	O
year	O
included	O
3	O
years	O
of	O
"	O
bridge"	O
funding	O
for	O
GHSA	S-International_exchange_and_cooperation
work	O
at	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
;	O
the	O
bill	O
also	O
directed	O
the	O
White	B-Organization
House	E-Organization
to	O
create	O
a	O
.	O

The	O
ability	O
of	O
to	O
bind	O
and	O
potentially	O
neutralise	O
these	O
bacteria	O
,	O
highlights	O
the	O
broad-spectrum	O
recognition	O
of	O
surface	O
antigens	O
on	O
potentially	O
debilitating	O
and	O
even	O
life-threatening	O
bacteria	O
.	O

TIM-1	O
was	O
shown	O
to	O
bind	O
to	O
the	O
receptor	O
binding	O
domain	O
of	O
the	O
EBOV	S-Pathogen
glycoprotein	O
,	O
to	O
increase	O
the	O
receptivity	O
of	O
Vero	O
cells	O
.	O

The	O
third	O
example	O
is	O
not	O
about	O
biological	O
weapons	O
but	O
new	O
types	O
of	O
chemical	O
,	O
or	O
rather	O
biochemical	O
,	O
weapons	O
.	O

In	O
comparison	O
to	O
LTR-driven	O
vectors	O
,	O
which	O
were	O
employed	O
in	O
the	O
first	O
clinical	O
trials	O
,	O
lentiviral	O
vectors	O
present	O
with	O
some	O
favorable	O
features	O
like	O
the	O
ability	O
to	O
transduce	O
also	O
non-dividing	O
cells	O
and	O
a	O
potentially	O
safer	O
insertion	O
profile	O
.	O

On	O
5	O
October	O
2018	O
,	O
the	O
Nobel	O
Peace	O
Prize	O
was	O
awarded	O
to	O
Denis	B-Person
Mukwege	E-Person
who	O
tends	O
to	O
the	O
female	O
victims	O
of	O
the	O
ongoing	O
internal	O
armed	O
conflict	O
in	O
the	O
.	O

On	O
the	O
same	O
day	O
,	O
Yombe	B-Person
Ngongo	E-Person
,	O
a	O
patient	O
at	O
the	O
hospital	O
receiving	O
treatment	O
for	O
anemia	S-Disease
,	O
checked	O
out	O
of	O
the	O
hospital	O
and	O
returned	O
to	O
her	O
village	O
.	O

"	O
Health	O
security	O
preparedness	O
needs	O
to	O
be	O
adaptable	O
to	O
new	O
threats	O
and	O
not	O
exclusively	O
wedded	O
to	O
historical	O
notions,	O
"	O
said	O
Amesh	B-Person
Adalja	E-Person
MD	O
,	O
project	O
lead	O
and	O
senior	O
scholar	O
at	O
the	O
Center.	O
"	O
A	O
more	O
active-minded	O
approach	O
to	O
this	O
problem	O
will	O
,	O
in	O
the	O
end	O
,	O
help	O
guard	O
against	O
a	O
GCBR	O
event	O
occurring.	O
"	O

Availability	O
of	O
effective	O
treatment	O
.	O

A	O
2009	O
review	O
by	O
the	O
U.S.	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
concluded	O
that	O
the	O
has	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
seasonal	O
vaccine	O
.	O

The	O
CDC	O
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
obesity	O
and	O
diabetes	S-Disease
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
diverged	O
from	O
its	O
ancestors	O
between	O
1960–1976	O
.	O

It	O
was	O
the	O
second	O
outbreak	O
of	O
Ebola	S-Disease
,	O
occurring	O
shortly	O
after	O
the	O
earlier	O
1976	O
outbreak	O
in	O
Sudan	S-Location
,	O
and	O
was	O
the	O
first	O
known	O
outbreak	O
of	O
Ebola	S-Disease
.	O
In	O
total	O
,	O
280	O
of	O
the	O
318	O
cases	O
of	O
Ebola	S-Disease
in	O
resulted	O
in	O
death	O
,	O
a	O
mortality	O
rate	O
of	O
88%	O
.	O

Williams,	B-Person
Peter	E-Person
,	O
and	O
Wallace,	B-Person
David	E-Person
(1989).	O
.	O

In	O
West	B-Location
Africa	E-Location
and	O
around	O
the	O
world	O
,	O
the	O
plays	O
a	O
central	O
role	O
in	O
reducing	O
threats	O
from	O
dangerous	O
pathogens	O
.	O

This	O
is	O
a	O
new	O
area	O
for	O
research	O
;	O
little	O
is	O
known	O
about	O
the	O
.	O
"	O

SARS-CoV-2	S-Pathogen
is	O
closely	O
related	O
to	O
the	O
original	O
SARS-CoV	S-Pathogen
.	O
It	O
is	O
thought	O
to	O
have	O
an	O
animal	O
(zoonotic)	O
origin	O
.	O

Social	O
distancing	O
strategies	O
aim	O
to	O
reduce	O
contact	O
of	O
infected	O
persons	O
with	O
large	O
groups	O
by	O
closing	O
schools	O
and	O
workplaces	O
,	O
restricting	O
travel	O
,	O
and	O
cancelling	O
large	O
public	O
gatherings	O
.	O

Ebola	B-Disease
virus	I-Disease
disease	E-Disease
is	O
caused	O
by	O
four	O
of	O
five	O
viruses	O
classified	O
in	O
the	O
genus	O
Ebolavirus	O
.	O

In	O
2017	O
,	O
the	O
organization	O
launched	O
an	O
international	O
competition	O
to	O
redesign	O
and	O
extend	O
its	O
headquarters	O
.	O

Mycobacterium	B-Pathogen
tuberculosis	E-Pathogen
,	O
Brucella	S-Pathogen
,	O
)	O
than	O
the	O
general	O
population	O
.	O

The	O
plants	O
then	O
start	O
producing	O
the	O
protein	O
that	O
will	O
be	O
used	O
for	O
vaccinations	O
.	O

Retrieved	O
September	O
2	O
,	O
2010	O
.	O

In	O
,	O
0.	O
57%	O
of	O
the	O
population	O
has	O
died	O
.	O

Lillibridge	S-Person
who	O
experienced	O
firsthand	O
the	O
anthrax	S-Pathogen
events	O
of	O
2001	O
,	O
addressed	O
these	O
and	O
other	O
future	O
biological	O
challenges	O
during	O
one	O
of	O
several	O
panels	O
held	O
during	O
Tuesday's	O
meeting	O
to	O
review	O
the	O
state	O
of	O
biodefense	O
.	O

Many	O
algorithms	O
exist	O
to	O
correct	O
for	O
this	O
artifact	O
.	O

"	O
We	O
haven't	O
updated	O
the	O
recommendations	O
for	O
vaccines	O
since	O
2010	O
,	O
and	O
since	O
that	O
time	O
now	O
,	O
eight	O
years	O
later	O
,	O
we	O
have	O
more	O
information	O
about	O
the	O
vaccine,	O
"	O
Walke	S-Person
said	O
.	O

Bioterrorism	O
may	O
be	O
favored	O
because	O
biological	O
agents	O
are	O
relatively	O
easy	O
and	O
inexpensive	O
to	O
obtain	O
,	O
can	O
be	O
easily	O
disseminated	O
,	O
and	O
can	O
cause	O
widespread	O
fear	O
and	O
panic	O
beyond	O
the	O
actual	O
physical	O
damage	O
.	O

On	O
7	O
February	O
70 individuals	O
were	O
released	O
from	O
quarantine	O
,	O
and	O
on	O
8	O
February	O
the	O
last	O
Ebola	S-Disease
patient	O
was	O
also	O
released	O
.	O

Furthermore	O
,	O
we	O
urge	O
Members	O
to	O
oppose	O
any	O
efforts	O
to	O
reduce	O
,	O
eliminate	O
,	O
or	O
condition	O
funding	O
related	O
to	O
gun	O
violence	O
prevention	O
research.	O
"	O
Congress	O
maintained	O
the	O
ban	O
in	O
subsequent	O
budgets	O
.	O

What	O
is	O
being	O
done	O
to	O
protect	O
CDC	S-Organization
workers?	O

One	O
of	O
those	O
incidents	O
was	O
in	O
2006	O
from	O
the	O
same	O
laboratory	O
that	O
was	O
involved	O
in	O
the	O
work	O
that	O
we	O
described	O
now	O
.	O

Suspension	O
of	O
work	O
activities	O
and	O
sports	O
events	O
has	O
already	O
been	O
ordered	O
in	O
those	O
areas.	O
"	O

Many	O
viruses	O
encode	O
their	O
genetic	O
information	O
in	O
RNA	O
rather	O
than	O
DNA	O
that	O
they	O
repurpose	O
to	O
make	O
new	O
viruses	O
.	O

Flies	O
from	O
the	O
Phlebotomine	O
family	O
carry	O
dangerous	O
parasites	O
in	O
their	O
saliva	O
which	O
they	O
transmit	O
through	O
a	O
bite	O
to	O
humans	O
.	O

A	O
database	O
was	O
created	O
according	O
to	O
the	O
type	O
of	O
initiatives	O
each	O
study	O
country	O
in	O
the	O
region	O
had	O
,	O
the	O
scope	O
of	O
the	O
activity	O
,	O
institute(s)	O
involved	O
,	O
and	O
type	O
of	O
funding/donors	O
,	O
etc	O
.	O

As	O
for	O
the	O
recent	O
Zika	B-Incident
virus	I-Incident
outbreak	I-Incident
in	I-Incident
the	I-Incident
United	I-Incident
States	E-Incident
greater	O
on-the-ground	O
reporting	O
of	O
the	O
response	O
,	O
even	O
during	O
periods	O
where	O
case	O
reports	O
were	O
fewer	O
,	O
could	O
have	O
swayed	O
lawmakers	O
to	O
fund	O
outbreak	O
efforts	O
more	O
consistently	O
,	O
said	O
.	O

A	O
report	O
published	O
in	O
2016	O
in	O
the	O
Journal	O
of	O
the	O
Chinese	B-Organization
Medical	I-Organization
Association	E-Organization
found	O
evidence	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
had	O
been	O
circulating	O
in	O
the	O
European	O
armies	O
for	O
months	O
and	O
possibly	O
years	O
before	O
the	O
1918	B-Incident
pandemic	E-Incident
.	O
Political	O
scientist	O
Andrew	B-Person
Price-Smith	E-Person
published	O
data	O
from	O
the	O
Austrian	O
archives	O
suggesting	O
the	O
influenza	S-Disease
began	O
in	O
in	O
early	O
1917	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

In	O
China	S-Location
"	O
Pathogenic	B-Document
microbiology	I-Document
laboratory	I-Document
biosafety	I-Document
regulations	E-Document
"	O
,	O
which	O
were	O
published	O
by	O
the	O
State	B-Organization
Council	E-Organization
in	O
2004	O
[7]	O
,	O
divided	O
pathogenic	O
microorganisms	O
into	O
four	O
groups	O
,	O
with	O
group	O
1	O
defined	O
as	O
the	O
highest	O
risk	O
,	O
in	O
contrast	O
to	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
the	O
EU	S-Location
,	O
which	O
defined	O
group	O
4	O
as	O
the	O
highest	O
risk	O
.	O

Although	O
it	O
was	O
initially	O
thought	O
that	O
two	O
injections	O
would	O
be	O
required	O
,	O
clinical	O
trials	O
showed	O
that	O
the	O
new	O
vaccine	O
protected	O
adults	O
"	O
with	O
only	O
one	O
dose	O
instead	O
of	O
two;	O
"	O
thus	O
the	O
limited	O
vaccine	O
supplies	O
would	O
go	O
twice	O
as	O
far	O
as	O
had	O
been	O
predicted	O
.	O

,	O
cases	O
have	O
been	O
reported	O
in	O
all	O
Asian	O
countries	O
except	O
for	O
Turkmenistan	S-Location
and	O
North	B-Location
Korea	E-Location
,	O
although	O
these	O
countries	O
likely	O
also	O
have	O
cases	O
.	O

In	O
his	O
section	O
of	O
the	O
draft	O
report	O
,	O
Dr	O
.	O

In	O
contrast	O
,	O
age-specific	O
death	O
rates	O
in	O
the	O
1918	B-Incident
pandemic	E-Incident
exhibited	O
a	O
distinct	O
pattern	O
that	O
has	O
not	O
been	O
documented	O
before	O
or	O
since:	O
a	O
"	O
W-shaped"	O
curve	O
,	O
similar	O
to	O
the	O
familiar	O
U-shaped	O
curve	O
but	O
with	O
the	O
addition	O
of	O
a	O
third	O
(middle)	O
distinct	O
peak	O
of	O
deaths	O
in	O
young	O
adults	O
≈20–40	O
years	O
of	O
age	O
.	O

Kirby	S-Person
,	O
.	O
"	O
The	O
CB	O
Battlefield	O
Legacy:	O
Understanding	O
the	O
Potential	O
Problem	O
of	O
Clustered	O
CB	O
Weapons	O
"	O
,	O
Army	O
Chemical	O
Review	O
,	O
pp.	O
25–29	O
,	O
July–December	O
2006	O
.	O

Today	O
,	O
access	O
to	O
highly	O
virulent	O
agents	O
and	O
strains	O
is	O
increasingly	O
regulated	O
and	O
restricted	O
.	O

On	O
22	O
January	O
,	O
the	O
WHO	S-Organization
issued	O
Clinical	B-Document
Care	I-Document
for	I-Document
survivors	I-Document
of	I-Document
Ebola	I-Document
Virus	I-Document
Disease:	I-Document
interim	I-Document
guidance	E-Document
.	O
The	O
guidance	O
covers	O
specific	O
issues	O
like	O
musculoskeletal	B-Phenotype
pain	E-Phenotype
,	O
which	O
is	O
reported	O
in	O
up	O
to	O
75%	O
of	O
survivors	O
.	O

The	O
phenomenon	O
that	O
one	O
part	O
of	O
the	O
detector	O
cannot	O
differentiate	O
between	O
different	O
tissues	O
is	O
called	O
the	O
"	O
Partial	O
Volume	O
Effect"	O
.	O

The	O
WHO	S-Organization
has	O
a	O
Framework	B-Platform
Convention	I-Platform
on	I-Platform
Tobacco	I-Platform
implementation	I-Platform
database	E-Platform
which	O
is	O
one	O
of	O
the	O
few	O
mechanisms	O
to	O
help	O
enforce	O
compliance	O
with	O
the	O
FCTC	S-Document
.	O
However	O
,	O
there	O
have	O
been	O
reports	O
of	O
numerous	O
discrepancies	O
between	O
it	O
and	O
national	O
implementation	O
reports	O
on	O
which	O
it	O
was	O
built	O
.	O

In	O
1993	O
,	O
Claude	B-Person
Hannoun	E-Person
the	O
leading	O
expert	O
on	O
the	O
1918	O
flu	O
at	O
the	O
Pasteur	B-Organization
Institute	E-Organization
,	O
asserted	O
the	O
precursor	O
virus	O
was	O
likely	O
to	O
have	O
come	O
from	O
China	S-Location
.	O
It	O
then	O
mutated	O
in	O
the	O
United	B-Location
States	E-Location
near	O
Boston	S-Location
and	O
from	O
there	O
spread	O
to	O
Brest	S-Location
,	O
France	S-Location
,	O
Europe	S-Location
's	O
battlefields	O
,	O
the	O
rest	O
of	O
Europe	S-Location
,	O
and	O
the	O
rest	O
of	O
the	O
world	O
,	O
with	O
Allied	O
soldiers	O
and	O
sailors	O
as	O
the	O
main	O
disseminators	O
.	O

Last	O
year	O
,	O
the	O
US	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
announced	O
its	O
approval	O
of	O
the	O
first	O
drug	O
to	O
treat	O
.	O
The	O
contagious	O
disease	O
was	O
eradicated	O
in	O
1980	O
thanks	O
to	O
vaccination	O
efforts	O
,	O
but	O
there	O
are	O
concerns	O
that	O
it	O
could	O
be	O
used	O
in	O
a	O
bioterror	O
attack	O
.	O

Dr	O
.	O

Travel	O
restrictions	O
were	O
enacted	O
in	O
and	O
outside	O
of	O
Hubei	S-Location
.	O
Public	O
transport	O
was	O
modified	O
,	O
and	O
museums	O
throughout	O
China	S-Location
were	O
temporarily	O
closed	O
.	O

CRISPR-Cas-based	B-Technology
"	O
RNA-guided	I-Technology
nucleases"	E-Technology
can	O
be	O
used	O
to	O
target	O
virulence	O
factors	O
,	O
genes	O
encoding	O
antibiotic	O
resistance	O
,	O
and	O
other	O
medically	O
relevant	O
sequences	O
of	O
interest	O
.	O

Pulses	O
of	O
radio	O
waves	O
excite	O
the	O
nuclear	O
spin	O
energy	O
transition	O
,	O
and	O
magnetic	O
field	O
gradients	O
localize	O
the	O
polarization	O
in	O
space	O
.	O

DNA	O
is	O
cut	O
with	O
the	O
restriction	O
enzymes	O
RsaI	O
and	O
HinfI	O
and	O
the	O
fragments	O
are	O
separated	O
by	O
an	O
8%	O
polyacrylamide	O
gel	O
electrophoresis	O
that	O
allows	O
the	O
separation	O
and	O
detection	O
of	O
fragments	O
ranging	O
from	O
60	O
to	O
200 bp.	O
hCMV	S-Pathogen
strains	O
can	O
be	O
differentiated	O
based	O
on	O
the	O
pattern	O
of	O
restriction	O
fragments	O
formed	O
by	O
RsaI	O
and	O
HinfI	O
.	O

WHO	S-Organization
also	O
reported	O
that	O
every	O
district	O
had	O
access	O
to	O
a	O
laboratory	O
to	O
confirm	O
cases	O
of	O
Ebola	S-Disease
within	O
24	O
hours	O
of	O
sample	O
collection	O
,	O
and	O
that	O
all	O
three	O
countries	O
had	O
reported	O
that	O
more	O
than	O
80%	O
of	O
registered	O
contacts	O
associated	O
with	O
known	O
cases	O
of	O
were	O
being	O
traced	O
,	O
although	O
contact	O
tracing	O
was	O
still	O
a	O
challenge	O
in	O
areas	O
of	O
intense	O
transmission	O
and	O
those	O
with	O
community	O
resistance	O
.	O

Some	O
critical	O
issues	O
concerning	O
biosafety	O
are	O
lack	O
of	O
training	O
,	O
exceeding	O
workload	O
,	O
working	O
too	O
fast	O
,	O
deciding	O
not	O
to	O
follow	O
safe	O
practices	O
,	O
and	O
skepticism	O
about	O
biohazards	O
.	O

Afterward	O
,	O
members	O
of	O
Sheela	S-Person
's	O
team	O
spread	O
Salmonella	S-Pathogen
on	O
produce	O
in	O
grocery	O
stores	O
and	O
on	O
doorknobs	O
and	O
urinal	O
handles	O
in	O
the	O
county	O
courthouse	O
,	O
but	O
these	O
actions	O
did	O
not	O
produce	O
the	O
desired	O
effects	O
.	O

It	O
is	O
unknown	O
(as	O
of	O
April	O
2020)	O
if	O
past	O
infection	O
provides	O
effective	O
and	O
long-term	O
immunity	O
in	O
people	O
who	O
recover	O
from	O
the	O
disease	O
.	O

Three	O
Hong	B-Location
Kong	E-Location
television	O
reporters	O
who	O
visited	O
SARS	S-Location
-related	O
sites	O
in	O
Guangzhou	S-Location
were	O
declared	O
free	O
of	O
the	O
disease	O
.	O

Health	O
officials	O
were	O
concerned	O
because	O
the	O
child	O
had	O
not	O
recently	O
travelled	O
or	O
been	O
exposed	O
to	O
someone	O
with	O
Ebola	S-Disease
and	O
the	O
WHO	S-Organization
stated	O
that	O
"	O
we	O
believe	O
that	O
this	O
is	O
probably	O
again	O
,	O
somehow	O
,	O
someone	O
who	O
has	O
come	O
in	O
contact	O
with	O
a	O
virus	O
that	O
had	O
been	O
persisting	O
in	O
an	O
individual	O
,	O
who	O
had	O
suffered	O
the	O
disease	O
months	O
ago.	O
"	O
Two	O
staff	O
of	O
the	O
CDC	S-Organization
were	O
sent	O
to	O
the	O
country	O
to	O
help	O
ascertain	O
the	O
cause	O
of	O
the	O
new	O
cases	O
.	O

In	O
India	S-Location
the	O
mortality	O
rate	O
was	O
extremely	O
high	O
at	O
around	O
50	O
deaths	O
from	O
influenza	O
per	O
1,000	O
people	O
(	O
Brown	S-Person
)	O
.	O

The	O
lung	O
picture	O
resembled	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
).In	O
11.	O
8%	O
of	O
the	O
deaths	O
reported	O
by	O
the	O
National	B-Organization
Health	I-Organization
Commission	I-Organization
of	I-Organization
China	E-Organization
,	O
heart	B-Disease
damage	E-Disease
was	O
noted	O
by	O
elevated	O
levels	O
of	O
troponin	O
or	O
cardiac	B-Disease
arrest	E-Disease
.	O
According	O
to	O
March	O
data	O
from	O
the	O
,	O
89%	O
of	O
those	O
hospitalised	O
had	O
preexisting	O
conditions	O
.	O

Australian	O
Government	O
has	O
aligned	O
with	O
the	O
Global	B-Organization
Action	I-Organization
Plan	E-Organization
(	O
GAP	S-Organization
)	O
,	O
World	B-Organization
Health	I-Organization
Organisation	E-Organization
(	O
WHO	S-Organization
)	O
,	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
(	O
OIE	S-Organization
)	O
,	O
and	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organisation	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
()	O
on	O
responding	O
to	O
antimicrobial	O
resistance	O
.	O

Taiwan	S-Location
's	O
main	O
opposition	O
party	O
,	O
the	O
KMT	S-Organization
,	O
expressed	O
their	O
anger	O
at	O
being	O
excluded	O
arguing	O
that	O
disease	O
respects	O
neither	O
politics	O
nor	O
geography	O
.	O

It	O
causes	O
muscles	B-Phenotype
paralyses	E-Phenotype
,	O
and	O
ultimately	O
death	O
if	O
not	O
treated	O
immediately	O
.	O

115	O
Botulism	S-Disease
cases	O
,	O
with	O
12	O
deaths	O
,	O
were	O
reported	O
in	O
in	O
2016	O
.	O

Fourth	O
,	O
I've	O
begun	O
the	O
process	O
of	O
establishing	O
an	O
external	O
advisory	O
group	O
that	O
will	O
be	O
part	O
of	O
the	O
advisory	O
committee	O
to	O
the	O
director	O
,	O
and	O
I	O
will	O
issue	O
invitations	O
to	O
the	O
leading	O
scientists	O
of	O
that	O
group	O
by	O
the	O
end	O
of	O
next	O
week	O
.	O

In	O
a	O
March	O
9	O
,	O
2017	O
interview	O
with	O
CNBC	O
,	O
former	O
U.S	O
.	O

On	O
31	O
October	O
2013	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
confirmed	O
that	O
one	O
person	O
in	O
Oman	S-Location
had	O
MERS	S-Disease
.	O
The	O
WHO	S-Organization
said	O
"	O
the	O
patient	O
in	O
Oman	S-Location
is	O
a	O
68-year-old	O
man	O
from	O
region	O
who	O
became	O
ill	O
"	O
on	O
26	O
October	O
2013	O
.	O

The	O
University	B-Organization
of	I-Organization
Oxford	I-Organization
Centre	I-Organization
for	I-Organization
Evidence-Based	I-Organization
Medicine	E-Organization
()	O
estimated	O
a	O
global	O
CFR	O
of	O
0.8	O
to	O
9.	O
6	O
percent	O
(last	O
revised	O
30	O
April)	O
and	O
IFR	O
of	O
0.10	O
to	O
0.	O
41	O
percent	O
(last	O
revised	O
2	O
May)	O
.	O

The	O
United	B-Location
States	E-Location
which	O
has	O
been	O
instrumental	O
in	O
launching	O
the	O
GHSA	S-International_exchange_and_cooperation
and	O
in	O
helping	O
to	O
build	O
the	O
capacity	O
of	O
countries	O
to	O
prevent	O
,	O
detect	O
and	O
respond	O
to	O
emergent	O
health	O
threats	O
,	O
now	O
faces	O
a	O
major	O
funding	O
challenge	O
,	O
she	O
said	O
,	O
pointing	O
to	O
historical	O
funding	O
data	O
dating	O
back	O
to	O
2006	O
showing	O
that	O
,	O
on	O
average	O
,	O
the	O
nation	O
spent	O
about	O
$400	O
million	O
annually	O
on	O
global	O
health	O
security	O
activities	O
.	O

In	O
Iran	S-Location
the	O
mortality	O
was	O
very	O
high:	O
according	O
to	O
an	O
estimate	O
,	O
between	O
902,400	O
and	O
2,431,000	O
,	O
or	O
8%	O
to	O
22%	O
of	O
the	O
total	O
population	O
died	O
.	O

"	O
There	O
are	O
some	O
peculiar	O
things	O
happening,	O
"	O
said	O
Caroll	B-Person
Calkins	E-Person
a	O
researcher	O
in	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture's	I-Organization
Insect	I-Organization
Behavior	I-Organization
Unit	E-Organization
in	O
Gainesville	S-Location
,	O
.	O

OSTP	S-Organization
had	O
anticipated	O
issuing	O
the	O
memorandum	O
last	O
week	O
but	O
that	O
action	O
is	O
delayed	O
to	O
allow	O
for	O
additional	O
consultation	O
with	O
the	O
Federal	O
agencies.	O
anticipates	O
the	O
memo	O
will	O
be	O
released	O
soon	O
,	O
at	O
which	O
point	O
labs	O
and	O
institutions	O
may	O
be	O
contacted	O
by	O
multiple	O
agencies	O
about	O
the	O
stand-down	O
.	O

In	O
April	O
,	O
an	O
epidemiologist	O
from	O
WHO	S-Organization
was	O
killed	O
and	O
two	O
health	O
workers	O
injured	O
in	O
a	O
militia	O
attack	O
on	O
Butembo	B-Organization
University	I-Organization
Hospital	E-Organization
in	O
Katwa	S-Location
.	O
In	O
May	O
,	O
's	O
health	O
emergencies	O
chief	O
said	O
insecurity	O
had	O
become	O
a	O
"	O
major	O
impediment	O
"	O
to	O
controlling	O
the	O
outbreak	O
.	O

"	O
Herald"	B-Incident
events	E-Incident
in	O
1915	O
,	O
1916	O
,	O
and	O
possibly	O
even	O
in	O
early	O
1918	O
,	O
if	O
they	O
occurred	O
,	O
would	O
be	O
difficult	O
to	O
identify	O
.	O

South	B-Location
Korea	E-Location
criticised	O
Japan	S-Location
's	O
"	O
ambiguous	O
and	O
passive	O
quarantine	O
efforts	O
"	O
after	O
Japan	S-Location
announced	O
anyone	O
coming	O
from	O
South	B-Location
Korea	E-Location
would	O
be	O
placed	O
in	O
quarantine	O
for	O
two	O
weeks	O
at	O
government-designated	O
sites	O
.	O

According	O
to	O
WHO	S-Organization
,	O
health	O
care	O
workers	O
are	O
to	O
be	O
accompanied	O
by	O
military	O
personnel	O
for	O
protection	O
and	O
ring	O
vaccination	O
may	O
not	O
be	O
possible	O
.	O

Both	O
issues	O
are	O
a	O
problem	O
for	O
using	O
the	O
technology	O
in	O
medicine	O
.	O

This	O
would	O
be	O
the	O
first	O
time	O
since	O
1976	O
that	O
an	O
outbreak	O
has	O
not	O
been	O
able	O
to	O
be	O
curbed	O
.	O

The	O
specific	O
objectives	O
of	O
this	O
study	O
were:	O
1)	O
to	O
investigate	O
laboratory	O
biosafety	O
standards	O
practices	O
and	O
techniques	O
in	O
diagnostic	O
laboratories	O
;	O
2)	O
to	O
determine	O
the	O
awareness	O
of	O
laboratory	O
staff	O
towards	O
potential	O
hazards	O
.	O

Seneca	B-Person
the	I-Person
Younger	E-Person
may	O
have	O
been	O
the	O
first	O
to	O
describe	O
an	O
epidemic	O
as	O
'	O
black	B-Disease
death	E-Disease
'	O
,	O
()	O
but	O
only	O
in	O
reference	O
to	O
the	O
acute	O
lethality	O
and	O
dark	O
prognosis	O
of	O
disease	O
.	O

Irwin	B-Person
Redlener	E-Person
director	O
of	O
Columbia	B-Organization
University's	I-Organization
National	I-Organization
Center	I-Organization
for	I-Organization
Disaster	I-Organization
Preparedness	E-Organization
,	O
noted	O
that	O
"	O
the	O
ability	O
to	O
weaponize	O
is	O
out	O
there	O
.	O

In	O
these	O
formulations	O
,	O
the	O
antimicrobial	O
activity	O
arises	O
from	O
ethanol	O
or	O
isopropanol	O
.	O

Ricin	S-Pathogen
is	O
an	O
extremely	O
toxic	O
plant	O
protein	O
that	O
can	O
cause	O
severe	O
allergic	O
reactions	O
,	O
and	O
exposure	O
to	O
small	O
quantities	O
can	O
be	O
fatal	O
.	O

Compliance	O
with	O
the	O
agreement	O
,	O
as	O
well	O
as	O
the	O
fate	O
of	O
the	O
former	O
Soviet	S-Organization
bio-agents	O
and	O
facilities	O
,	O
is	O
still	O
mostly	O
undocumented	O
.	O

His	O
death	O
was	O
announced	O
on	O
25	O
September	O
.	O

Criticism	O
centered	O
on	O
how	O
these	O
names	O
may	O
confuse	O
or	O
mislead	O
the	O
public	O
.	O

In	O
the	O
1990s	O
,	O
Boris	B-Person
Yeltsin	E-Person
admitted	O
to	O
an	O
offensive	O
bio-weapons	O
program	O
as	O
well	O
as	O
to	O
the	O
true	O
nature	O
of	O
the	O
Sverdlovsk	B-Incident
biological	I-Incident
weapons	I-Incident
accident	I-Incident
of	I-Incident
1979	E-Incident
,	O
which	O
had	O
resulted	O
in	O
the	O
deaths	O
of	O
at	O
least	O
64	O
people	O
.	O

Behavioral	B-Platform
Risk	I-Platform
Factor	I-Platform
Surveillance	I-Platform
System	E-Platform
()	O
,	O
the	O
world's	O
largest	O
,	O
ongoing	O
telephone	O
health-survey	O
system	O
.	O

An	O
unassociated	O
cluster	O
of	O
COVID-19	S-Disease
cases	O
was	O
later	O
detected	O
,	O
starting	O
with	O
16	O
confirmed	O
cases	O
in	O
on	O
21	O
February	O
.	O

React	O
based	O
in	O
Sweden	S-Location
has	O
produced	O
informative	O
material	O
on	O
AMR	O
for	O
the	O
general	O
public	O
.	O

However	O
,	O
at	O
no	O
point	O
in	O
the	O
PALS	S-Scientific_research_project
program	O
will	O
test	O
modified	O
organisms	O
outside	O
of	O
contained	O
,	O
biosecure	O
facilities	O
.	O

Pathogenic	O
micro-organisms	O
,	O
although	O
they	O
represent	O
only	O
a	O
small	O
part	O
in	O
the	O
total	O
microbial	O
world	O
,	O
receive	O
much	O
attention	O
because	O
they	O
represent	O
a	O
threat	O
for	O
the	O
human	O
or	O
animal	O
health	O
,	O
or	O
for	O
the	O
agriculture	O
.	O

The	O
state	O
will	O
provide	O
a	O
$500,000	O
initial	O
grant	O
to	O
New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
to	O
help	O
launch	O
the	O
center	O
.	O

This	O
vector	O
poses	O
a	O
higher	O
safety	O
risk	O
.	O

Sudan	B-Pathogen
virus	E-Pathogen
is	O
from	O
the	O
same	O
family	O
of	O
viruses	O
as	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
a	O
strain	O
of	O
which	O
was	O
responsible	O
for	O
the	O
2013-2016	B-Incident
outbreak	I-Incident
in	I-Incident
West	I-Incident
Africa	E-Incident
and	O
the	O
current	O
outbreak	B-Incident
in	I-Incident
the	I-Incident
Democratic	I-Incident
Republic	I-Incident
of	I-Incident
the	I-Incident
Congo	E-Incident
.	O
Like	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
Sudan	B-Pathogen
virus	E-Pathogen
causes	O
disease	O
characterized	O
by	O
severe	O
hemorrhagic	B-Phenotype
fever	E-Phenotype
and	O
high	O
mortality.	O
"	O
This	O
contract	O
will	O
allow	O
us	O
to	O
advance	O
these	O
molecules	O
to	O
clinical	O
evaluation	O
and	O
to	O
be	O
better	O
prepared	O
for	O
future	O
outbreaks,	O
"	O
said	O
Dr.	O
,	O
Principal	O
Investigator	O
on	O
the	O
contract	O
.	O

Funding	O
organizations	O
such	O
as	O
the	O
therefore	O
have	O
developed	O
data	O
sharing	O
policies	O
and	O
request	O
commitment	O
to	O
data	O
management	O
and	O
sharing	O
in	O
grant	O
applications	O
.	O

Consequently	O
,	O
the	O
WHO	S-Organization
reports	O
that	O
it	O
is	O
being	O
used	O
under	O
a	O
ring	O
vaccination	O
strategy	O
with	O
what	O
is	O
known	O
as	O
"	O
compassionate	O
use	O
"	O
to	O
protect	O
persons	O
at	O
highest	O
risk	O
of	O
the	O
Ebola	S-Pathogen
outbreak	O
,	O
i.e.	O
contacts	O
of	O
those	O
infected	O
,	O
contacts	O
of	O
those	O
contacts	O
,	O
and	O
front-line	O
medical	O
personnel	O
.	O

But	O
there's	O
still	O
a	O
long	O
way	O
to	O
go	O
in	O
terms	O
of	O
preparedness	O
,	O
Redlener	S-Person
said	O
,	O
adding	O
that	O
no	O
city	O
is	O
fully	O
prepared	O
.	O

Officials	O
also	O
urged	O
communities	O
,	O
businesses	O
,	O
and	O
individuals	O
to	O
make	O
contingency	O
plans	O
for	O
possible	O
school	O
closures	O
,	O
multiple	O
employee	O
absences	O
for	O
illness	O
,	O
surges	O
of	O
patients	O
in	O
hospitals	O
,	O
and	O
other	O
effects	O
of	O
potentially	O
widespread	O
outbreaks	O
.	O

Some	O
Atlanta	S-Location
staff	O
were	O
being	O
monitored	O
and	O
provided	O
or	O
prescribed	O
antibiotics	S-Drug
because	O
they	O
may	O
have	O
been	O
unintentionally	O
exposed	O
to	O
live	O
anthrax	S-Pathogen
bacteria	O
after	O
established	O
safety	O
practices	O
were	O
not	O
followed	O
during	O
a	O
laboratory	O
procedure	O
(	O
)	O
This	O
broad	O
action	O
was	O
taken	O
out	O
of	O
an	O
abundance	O
of	O
caution	O
,	O
and	O
the	O
agency	O
began	O
immediate	O
work	O
to	O
better	O
determine	O
employees'	O
potential	O
risk	O
by	O
administering	O
a	O
detailed	O
epidemiologic	O
questionnaire	O
to	O
those	O
believed	O
to	O
be	O
affected	O
to	O
learn	O
more	O
about	O
their	O
whereabouts	O
and	O
their	O
specific	O
work	O
during	O
the	O
time	O
of	O
potential	O
exposure	O
–	O
June	O
6	O
to	O
June	O
13	O
.	O

"	O
This	O
new	O
treatment	O
affords	O
us	O
an	O
additional	O
option	O
should	O
smallpox	S-Pathogen
ever	O
be	O
used	O
as	O
a	O
bioweapon,	O
"	O
Scott	B-Person
Gottlieb	E-Person
,	O
M.D	O
,	O
the	O
FDA	S-Organization
commissioner	O
,	O
says	O
in	O
a	O
statement.	O
"	O
This	O
is	O
the	O
first	O
product	O
to	O
be	O
awarded	O
a	O
Material	O
Threat	O
Medical	O
Countermeasure	O
priority	O
review	O
voucher	O
.	O

High-profile	O
lab	O
accidents	O
last	O
year	O
with	O
anthrax	S-Disease
Ebola	S-Disease
and	O
bird	B-Disease
flu	E-Disease
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
the	O
discovery	O
of	O
forgotten	O
vials	O
of	O
deadly	O
smallpox	B-Pathogen
virus	E-Pathogen
at	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
raised	O
widespread	O
concerns	O
about	O
lab	O
safety	O
and	O
security	O
nationwide	O
and	O
whether	O
current	O
oversight	O
is	O
adequate	O
to	O
protect	O
workers	O
and	O
the	O
public	O
.	O

The	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	I-Incident
(EVD)	I-Incident
in	I-Incident
West	I-Incident
Africa	I-Incident
between	I-Incident
2014	I-Incident
and	I-Incident
2015	E-Incident
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
,	O
and	O
the	O
countries	O
most	O
strongly	O
affected	O
were	O
Sierra	B-Location
Leone	E-Location
,	O
Guinea	S-Location
,	O
and	O
.	O

As	O
one	O
of	O
my	O
colleagues	O
put	O
it	O
to	O
me	O
,	O
40	O
years	O
ago	O
,	O
"	O
test	B-Technology
tube	I-Technology
babies	E-Technology
seemed	O
unnatural	O
,	O
a	O
freak-show	O
curiosity	O
;	O
now	O
in	O
vitro	O
fertilization	O
has	O
achieved	O
mainstream	O
acceptance	O
.	O

"	O
We	O
will	O
leverage	O
this	O
DHS	B-Organization
big	I-Organization
data	I-Organization
center	E-Organization
that's	O
been	O
built	O
up	O
over	O
the	O
years	O
and	O
literally	O
tracks	O
every	O
container	O
,	O
commodity	O
and	O
person	O
moving	O
and	O
coming	O
into	O
the	O
United	B-Location
States	E-Location
,	O
"	O
said	O
McDonnell	S-Person
,	O
noting	O
that	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
,	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Transportation	E-Organization
and	O
the	O
also	O
will	O
be	O
involved	O
.	O

Although	O
some	O
drugs	O
,	O
such	O
as	O
insulin	S-Drug
can	O
be	O
produced	O
in	O
bacteria	O
by	O
inserting	O
a	O
single	O
gene	O
,	O
others	O
require	O
a	O
whole	O
series	O
of	O
genes	O
.	O

H.R.	B-Document
5998	E-Document
according	O
to	O
the	O
congressional	O
record	O
,	O
would	O
amend	O
the	O
Public	B-Document
Health	I-Document
Service	I-Document
Act	E-Document
to	O
reauthorize	O
a	O
loan	O
repayment	O
program	O
under	O
which	O
health	O
professionals	O
agree	O
to	O
conduct	O
prevention	O
activities	O
,	O
as	O
employees	O
of	O
the	O
CDC	S-Organization
and	O
the	O
,	O
in	O
consideration	O
of	O
the	O
federal	O
government	O
agreeing	O
to	O
make	O
payments	O
on	O
the	O
principal	O
and	O
interest	O
of	O
their	O
educational	O
loans	O
,	O
among	O
other	O
purposes	O
.	O

Adherence	O
To	O
and	O
Compliance	O
With	O
Arms	O
Control	O
,	O
Nonproliferation	O
and	O
Disarmament	O
Agreements	O
and	O
Commitments]	O
,	O
Washington,	B-Location
DC	E-Location
:	O
;	O
2005	O
.	O

Lillibridge	S-Person
who	O
experienced	O
firsthand	O
the	O
anthrax	B-Incident
events	I-Incident
of	I-Incident
2001	E-Incident
,	O
addressed	O
these	O
and	O
other	O
future	O
biological	O
challenges	O
during	O
one	O
of	O
several	O
panels	O
held	O
during	O
Tuesday's	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
meeting	O
to	O
review	O
the	O
state	O
of	O
biodefense	O
.	O

For	O
now	O
,	O
many	O
of	O
the	O
benefits	O
of	O
biotechnology	O
are	O
concrete	O
while	O
many	O
of	O
the	O
risks	O
remain	O
hypotheticals	O
,	O
but	O
it	O
is	O
better	O
to	O
be	O
proactive	O
and	O
cognizant	O
of	O
the	O
risks	O
than	O
to	O
wait	O
for	O
something	O
to	O
go	O
wrong	O
first	O
and	O
then	O
attempt	O
to	O
address	O
the	O
damage	O
.	O

How	O
do	O
we	O
determine	O
a	O
hard	O
limit	O
for	O
which	O
gene	O
surgery	O
to	O
undertake	O
,	O
and	O
under	O
what	O
circumstances	O
,	O
especially	O
given	O
that	O
the	O
surgery	O
itself	O
comes	O
with	O
the	O
risk	O
of	O
causing	O
genetic	O
damage?	O
Scholars	O
and	O
policymakers	O
have	O
wrestled	O
with	O
these	O
questions	O
for	O
many	O
years	O
,	O
and	O
there	O
is	O
some	O
guidance	O
in	O
documents	O
such	O
as	O
the	O
United	B-Organization
Nations	E-Organization
'	O
.	O

Dr	O
.	O

This	O
huge	O
death	O
toll	O
resulted	O
from	O
an	O
extremely	O
high	O
infection	O
rate	O
of	O
up	O
to	O
50%	O
and	O
the	O
extreme	O
severity	O
of	O
the	O
symptoms	O
,	O
suspected	O
to	O
be	O
caused	O
by	O
cytokine	B-Disease
storms	E-Disease
Symptoms	O
in	O
1918	O
were	O
unusual	O
,	O
initially	O
causing	O
influenza	S-Disease
to	O
be	O
misdiagnosed	O
as	O
dengue	S-Disease
,	O
cholera	S-Disease
,	O
or	O
typhoid	S-Disease
.	O
One	O
observer	O
wrote	O
,	O
"	O
One	O
of	O
the	O
most	O
striking	O
of	O
the	O
complications	O
was	O
hemorrhage	S-Phenotype
from	O
mucous	O
membranes	O
,	O
especially	O
from	O
the	O
nose	O
,	O
stomach	O
,	O
and	O
intestine	O
.	O

In	O
New	B-Location
Zealand	E-Location
the	O
killed	O
an	O
estimated	O
6,400 Pakeha	O
and	O
2,500 indigenous	O
Maori	O
in	O
six	O
weeks	O
,	O
with	O
Māori	O
dying	O
at	O
eight	O
times	O
the	O
rate	O
of	O
Pakeha	O
.	O

The	O
1976	B-Incident
outbreak	I-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
in	O
Zaire	S-Location
(which	O
was	O
the	O
name	O
,	O
at	O
that	O
time	O
,	O
of	O
the	O
country	O
now	O
known	O
as	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
)	O
began	O
in	O
late	O
August	O
.	O

DONALD	B-Person
MCNEIL	E-Person
But	O
there's	O
no	O
effort	O
to	O
extend	O
it	O
even	O
by	O
request	O
to	O
other	O
agencies	O
or	O
to	O
any	O
private	O
labs	O
to	O
make	O
them	O
look	O
at	O
their	O
procedures	O
before	O
samples	O
are	O
shipped?	O
I	O
mean	O
,	O
this	O
obviously	O
is	O
related	O
to	O
the	O
gain	O
of	O
function	O
work	O
that's	O
going	O
on	O
around	O
the	O
country	O
.	O

The	O
major	O
issue	O
with	O
self-medication	O
is	O
the	O
lack	O
of	O
knowledge	O
of	O
the	O
public	O
on	O
the	O
dangerous	O
effects	O
of	O
antimicrobial	O
resistance	O
,	O
and	O
how	O
they	O
can	O
contribute	O
to	O
it	O
through	O
mistreating	O
or	O
misdiagnosing	O
themselves	O
.	O

Economic	O
recovery	O
had	O
been	O
observed	O
at	O
the	O
beginning	O
of	O
the	O
fourteenth century	O
.	O

Oregon	S-Location
Attorney	O
General	O
David	B-Person
B.	I-Person
Frohnmayer	E-Person
set	O
up	O
an	O
interagency	O
task	O
force	O
,	O
composed	O
of	O
Oregon	B-Organization
State	I-Organization
Police	E-Organization
and	O
the	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
,	O
and	O
executed	O
search	O
warrants	O
in	O
Rajneeshpuram	S-Location
.	O
A	O
sample	O
of	O
bacteria	O
matching	O
the	O
contaminant	O
that	O
had	O
sickened	O
the	O
town	O
residents	O
was	O
found	O
in	O
a	O
Rajneeshpuram	B-Location
medical	I-Location
laboratory	E-Location
.	O
Two	O
leading	O
officials	O
were	O
convicted	O
on	O
charges	O
of	O
attempted	O
murder	O
and	O
served	O
29 months	O
of	O
20-year	O
sentences	O
in	O
a	O
minimum-security	O
federal	O
prison	O
.	O

Two	O
British-trained	O
scientists	O
have	O
been	O
identified	O
as	O
leading	O
figures	O
in	O
the	O
programme.	O
…	O
According	O
to	O
Israeli	O
military	O
intelligence	O
sources	O
,	O
10	O
Iranian	O
prisoners	O
of	O
war	O
were	O
taken	O
to	O
a	O
location	O
near	O
Iraq	S-Location
's	O
border	O
with	O
Saudi	B-Location
Arabia	E-Location
.	O
They	O
were	O
lashed	O
to	O
posts	O
and	O
left	O
helpless	O
as	O
an	O
anthrax	S-Pathogen
bomb	O
was	O
exploded	O
by	O
remote	O
control	O
15	O
yards	O
away	O
.	O

For	O
vascular	B-Technology
imaging	E-Technology
curved-plane	O
reconstruction	O
can	O
be	O
performed	O
.	O

France	S-Location
reported	O
its	O
first	O
death	O
from	O
near	O
the	O
end	O
of	O
May	O
2013	O
.	O

China	S-Location
has	O
done	O
many	O
good	O
things	O
to	O
slow	O
down	O
the	O
virus	O
.	O

First	O
,	O
is	O
all	O
in	O
one	O
plasmid	O
,	O
where	O
sgRNA	O
and	O
Cas9	O
are	O
produced	O
simultaneously	O
in	O
a	O
transfected	O
cell	O
.	O

However	O
,	O
US	S-Location
medical	O
scientists	O
in	O
occupied	O
Japan	S-Location
undertook	O
extensive	O
research	O
on	O
insect	O
vectors	O
,	O
with	O
the	O
assistance	O
of	O
former	O
staff	O
,	O
as	O
early	O
as	O
1946	O
.	O

Are	O
you	O
also	O
planning	O
to	O
scour	O
any	O
labs	O
or	O
campuses	O
that	O
may	O
have	O
any	O
unsecured	O
samples	O
or	O
like	O
that?	O

The	O
1889	O
pandemic	O
,	O
for	O
example	O
,	O
began	O
in	O
the	O
late	O
spring	O
of	O
1889	O
and	O
took	O
several	O
months	O
to	O
spread	O
throughout	O
the	O
world	O
,	O
peaking	O
in	O
northern	B-Location
Europe	E-Location
and	O
the	O
United	B-Location
States	E-Location
late	O
in	O
1889	O
or	O
early	O
in	O
1890	O
.	O

The	O
added	O
lifetime	O
risk	O
of	O
developing	O
cancer	S-Disease
by	O
a	O
single	O
abdominal	O
of	O
8	O
mSv	O
is	O
estimated	O
to	O
be	O
0.	O
05%	O
,	O
or	O
1	O
one	O
in	O
2,000	O
.	O

Comparison	O
of	O
the	O
biological	B-Document
agent	I-Document
category	I-Document
lists	E-Document
revealed	O
that	O
the	O
laboratory	O
biosafety	O
risk	O
groups	O
of	O
most	O
biological	O
agents	O
in	O
NIH	S-Organization
,	O
EU	S-Location
and	O
China	S-Location
are	O
consistent	O
,	O
although	O
some	O
inconsistencies	O
were	O
identified	O
(Table	O
2	O
,	O
Table	O
3)	O
.	O

In	O
ancient	O
times	O
,	O
warring	O
parties	O
poisoned	O
wells	O
or	O
used	O
arrowheads	O
with	O
natural	O
toxins	O
.	O

Mongol	O
invaders	O
catapulted	O
plague	S-Pathogen
victims	O
into	O
besieged	O
cities	O
,	O
probably	O
causing	O
the	O
first	B-Incident
great	I-Incident
plague	I-Incident
epidemic	I-Incident
in	I-Incident
Europe	E-Incident
,	O
and	O
British	O
settlers	O
distributed	O
smallpox	S-Pathogen
-infected	O
blankets	O
to	O
native	O
Americans	O
.	O

This	O
area	O
came	O
under	O
the	O
spotlight	O
of	O
the	O
international	O
media	O
after	O
the	O
use	O
of	O
psychoactive	O
substances	O
in	O
the	O
Moscow	B-Incident
hostage	I-Incident
crisis	I-Incident
last	I-Incident
year	E-Incident
causing	O
the	O
death	O
of	O
more	O
than	O
170	O
people	O
.	O

On	O
11	O
May	O
2020	O
,	O
the	O
Committee	B-Organization
for	I-Organization
Medicinal	I-Organization
Products	I-Organization
for	I-Organization
Human	I-Organization
Use	I-Organization
of	I-Organization
the	I-Organization
European	I-Organization
Medicines	I-Organization
Agency	E-Organization
(	O
EMA	S-Organization
)	O
recommended	O
expanding	O
the	O
compassionate	O
use	O
of	O
remdesivir	S-Drug
to	O
those	O
not	O
on	O
mechanical	O
ventilation	O
.	O

Some	O
have	O
suggested	O
that	O
the	O
epidemic	O
originated	O
in	O
the	O
United	B-Location
States	E-Location
Historian	O
Alfred	B-Person
W.	I-Person
Crosby	E-Person
stated	O
in	O
2003	O
that	O
the	O
flu	S-Disease
originated	O
in	O
Kansas	S-Location
,	O
and	O
popular	O
author	O
John	B-Person
M.	I-Person
Barry	E-Person
described	O
a	O
January	O
1918	O
outbreak	O
in	O
Haskell	B-Location
County	E-Location
,	O
,	O
as	O
the	O
point	O
of	O
origin	O
in	O
his	O
2004	O
article	O
.	O

Please	O
see	O
the	O
for	O
more	O
detail	O
on	O
this	O
work	O
.	O

The	O
agency's	O
Health	B-Organization
Affairs	I-Organization
and	I-Organization
Countering	I-Organization
Weapons	I-Organization
of	I-Organization
Mass	I-Organization
Destruction	I-Organization
offices	E-Organization
will	O
assist	O
in	O
assessing	O
the	O
value	O
of	O
potential	O
platforms	O
.	O

Is	O
it	O
possible	O
that	O
a	O
poorly-adapted	O
virus	O
was	O
already	O
beginning	O
to	O
spread	O
in	O
1915	O
,	O
causing	O
some	O
serious	O
illnesses	O
but	O
not	O
yet	O
sufficiently	O
fit	O
to	O
initiate	O
a	O
pandemic?	O

Financial	O
support	O
has	O
been	O
contributed	O
by	O
the	O
governments	O
of	O
the	O
US	S-Location
and	O
the	O
UK	S-Location
,	O
among	O
others	O
.	O

It	O
was	O
then	O
reacted	O
with	O
an	O
excess	O
of	O
trimethylsilyl	O
cyanide	O
in	O
dichloromethane	O
at	O
for	O
10	O
minutes	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
was	O
first	O
identified	O
as	O
a	O
possible	O
new	O
"	O
strain"	O
of	O
Marburg	B-Pathogen
virus	E-Pathogen
in	O
1976	O
.	O

The	O
updated	O
recommendations	O
were	O
based	O
on	O
preliminary	O
results	O
from	O
the	O
NIAID-ACTT	B-Scientific_research_project
study	E-Scientific_research_project
,	O
which	O
suggested	O
a	O
beneficial	O
effect	O
of	O
remdesivir	S-Drug
in	O
the	O
treatment	O
of	O
hospitalized	O
individuals	O
with	O
severe	O
.	O

Among	O
the	O
individuals	O
in	O
Japan	S-Location
after	O
its	O
1945	O
surrender	O
was	O
Lieutenant	O
Colonel	O
Murray	B-Person
Sanders	E-Person
,	O
who	O
arrived	O
in	O
Yokohama	S-Location
via	O
the	O
American	O
ship	O
Sturgess	O
in	O
September	O
1945	O
.	O

It's	O
not	O
the	O
little	O
mistake	O
that	O
we're	O
concerned	O
about	O
in	O
this	O
instance	O
.	O

In	O
fact	O
,	O
the	O
most	O
exciting	O
biotechnology	O
advances	O
of	O
recent	O
times	O
are	O
occurring	O
at	O
the	O
microscopic	O
level	O
(and	O
smaller!)	O
within	O
the	O
membranes	O
of	O
cells	O
.	O

The	O
technology	O
for	O
plant-made	B-Drug
pharmaceuticals	E-Drug
(	O
PMPs	S-Drug
)	O
has	O
progressed	O
significantly	O
over	O
the	O
last	O
few	O
years	O
,	O
with	O
the	O
first	O
commercial	O
products	O
for	O
human	O
use	O
expected	O
to	O
reach	O
the	O
market	O
by	O
2009	O
(see	O
Note	O
1)	O
.	O

From	O
this	O
point	O
of	O
view	O
,	O
pathogens	O
fall	O
into	O
two	O
basic	O
types:	O
primary	O
pathogens	O
that	O
cause	O
disease	O
among	O
at	O
least	O
a	O
portion	O
of	O
normal	O
individuals	O
,	O
and	O
opportunistic	O
pathogens	O
that	O
cause	O
disease	O
only	O
in	O
individuals	O
who	O
are	O
compromised	O
in	O
either	O
their	O
innate	O
or	O
humoral	O
immune	O
defences	O
.	O

Sponsored	O
by	O
the	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
the	O
research	O
aims	O
to	O
provide	O
both	O
effective	O
individual	O
patient	O
care	O
resulting	O
from	O
early	O
treatment	O
and	O
faster	O
,	O
more	O
confident	O
implementation	O
of	O
public	O
health	O
measures	O
,	O
such	O
as	O
isolation	O
,	O
to	O
improve	O
overall	O
population	O
health	O
by	O
blunting	O
epidemics	O
.	O

HR	O
397.	O
:	O
U.S	O
.	O

Atlanta	O
,	O
GA	O
30333	O
,	O
USA	O
"	O
Compare	O
this	O
to	O
the	O
CDP	O
map:	O
"	O
2010	O
CENSUS	O
-	O
CENSUS	O
BLOCK	O
MAP:	O
Druid	O
Hills	O
CDP	O
,	O
GA.	O
"	O
.	O
Retrieved	O
on	O
June	O
1	O
,	O
2017	O
.	O

In	O
2017	O
,	O
spending	O
returned	O
to	O
$402	O
million	O
and	O
in	O
2018	O
,	O
$353	O
million	O
has	O
been	O
requested	O
.	O

In	O
2015	O
,	O
Yinong	B-Person
Yang	E-Person
successfully	O
deactivated	O
16	O
specific	O
genes	O
in	O
the	O
white	O
button	O
mushroom	O
to	O
make	O
them	O
non-browning	O
.	O

That's	O
where	O
research	O
on	O
dangerous	O
avian	O
influenza	O
viruses	O
like	O
H5N1	S-Pathogen
and	O
is	O
conducted	O
.	O

Earlier	O
experience	O
pinpoints	O
mutual	O
trust	O
between	O
partners	O
as	O
a	O
cornerstone	O
for	O
a	O
successful	O
network	O
.	O

The	O
project	O
had	O
two	O
components:	O
(a)	O
a	O
review	O
of	O
biosafety	O
and	O
biosecurity	O
initiatives	O
in	O
the	O
region	O
and	O
(b)	O
assessment	O
of	O
the	O
impact	O
of	O
these	O
initiatives	O
on	O
scientists	O
at	O
local/regional	O
levels	O
.	O

A	O
1999	O
empirical	O
analysis	O
in	O
the	O
journal	O
Emerging	O
Infectious	O
Diseases	O
published	O
by	O
the	O
described	O
six	O
motivational	O
factors	O
associated	O
with	O
bioterrorism	O
,	O
including:	O
charismatic	O
leadership	O
,	O
no	O
outside	O
constituency	O
,	O
apocalyptic	O
ideology	O
,	O
loner	O
or	O
splinter	O
group	O
,	O
sense	O
of	O
paranoia	O
and	O
grandiosity	O
,	O
and	O
defensive	O
aggression	O
.	O

Saudi	O
Health	O
Minister	O
Abdullah	B-Person
Al-Rabia	E-Person
said	O
"	O
that	O
authorities	O
had	O
so	O
far	O
detected	O
no	O
cases	O
among	O
the	O
pilgrims	O
"	O
of	O
MERS	S-Disease
.	O
However	O
,	O
the	O
Spanish	B-Organization
government	E-Organization
,	O
in	O
November	O
2013	O
,	O
reported	O
a	O
woman	O
in	O
Spain	S-Location
,	O
who	O
had	O
recently	O
traveled	O
to	O
for	O
the	O
Islamic	O
pilgrimage	O
,	O
contracted	O
the	O
disease	O
.	O

According	O
to	O
the	O
2012	O
West	B-Organization
Desert	I-Organization
Test	I-Organization
Center	E-Organization
Report	O
,	O
the	O
military	O
facility	O
performs	O
tests	O
with	O
Botulinum	B-Pathogen
Neurotoxin	E-Pathogen
Aerosol	O
,	O
as	O
well	O
as	O
with	O
aerosolized	O
Anthrax	S-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
and	O
Venezuelan	B-Pathogen
Equine	I-Pathogen
Encephalitis	I-Pathogen
Virus	E-Pathogen
()	O
.	O

But	O
could	O
the	O
next	O
pandemic?	O
To	O
find	O
out	O
,	O
and	O
to	O
put	O
the	O
current	O
outbreak	O
into	O
greater	O
context	O
,	O
let	O
us	O
turn	O
to	O
the	O
past	O
.	O

The	O
cause	O
of	O
the	O
CCHF	B-Incident
outbreak	E-Incident
in	O
Georgia	S-Location
is	O
still	O
unknown	O
.	O

Nigeria	S-Location
was	O
the	O
first	O
African	S-Location
country	O
to	O
be	O
declared	O
Ebola	S-Disease
free	O
.	O

Four	O
or	O
five	O
unit	O
members	O
,	O
dressed	O
in	O
white	O
laboratory	O
clothing	O
completely	O
covering	O
the	O
body	O
with	O
only	O
eyes	O
and	O
mouth	O
visible	O
,	O
rest	O
covered	O
,	O
handled	O
the	O
tests	O
.	O

N95	B-Equipment
respirators	E-Equipment
are	O
approved	O
for	O
industrial	O
settings	O
but	O
the	O
FDA	S-Organization
has	O
authorised	O
the	O
masks	O
for	O
use	O
under	O
an	O
emergency	O
use	O
authorization	O
(EUA)	O
.	O

The	O
food	O
you	O
eat	O
and	O
the	O
pets	O
you	O
love?	O
You	O
can	O
thank	O
our	O
distant	O
ancestors	O
for	O
kickstarting	O
the	O
agricultural	O
revolution	O
,	O
using	O
artificial	O
selection	O
for	O
crops	O
,	O
livestock	O
,	O
and	O
other	O
domesticated	O
animals	O
.	O

This	O
paper	O
describes	O
the	O
setting	O
up	O
of	O
a	O
SECOA	S-International_exchange_and_cooperation
metadata	O
repository	O
for	O
non-specialist	O
researchers	O
such	O
as	O
environmental	O
scientists	O
and	O
tourism	O
experts	O
.	O

The	O
New	O
York	O
Times	O
Company	O
,	O
26	O
Oct.	O
2011	O
.	O

Despite	O
the	O
high	O
morbidity	O
and	O
mortality	O
rates	O
that	O
resulted	O
from	O
the	O
epidemic	O
,	O
the	O
Spanish	B-Disease
flu	E-Disease
began	O
to	O
fade	O
from	O
public	O
awareness	O
over	O
the	O
decades	O
until	O
the	O
arrival	O
of	O
news	O
about	O
bird	B-Disease
flu	E-Disease
and	O
other	O
pandemics	O
in	O
the	O
1990s	O
and	O
2000s	O
.	O

That's	O
what	O
Amler	S-Person
described	O
as	O
"	O
the	O
fog	O
of	O
war,	O
"	O
and	O
he	O
said	O
it	O
inevitably	O
leads	O
to	O
mistakes.	O
"	O
But	O
the	O
kind	O
of	O
training	O
Dr	O
.	O

Based	O
on	O
the	O
results	O
of	O
some	O
of	O
this	O
follow-up	O
work	O
,	O
most	O
of	O
the	O
impacted	S-Phenotype
employees	O
have	O
been	O
determined	O
to	O
have	O
no	O
increased	O
risk	O
of	O
exposure	O
as	O
a	O
result	O
of	O
this	O
incident	O
,	O
and	O
therefore	O
are	O
being	O
advised	O
that	O
they	O
no	O
longer	O
need	O
to	O
take	O
antibiotics	S-Drug
and	O
vaccine	O
to	O
prevent	O
inhalation	O
.	O

The	O
synthetic	B-Pathogen
M.	I-Pathogen
mycoides	I-Pathogen
organism	E-Pathogen
has	O
14	O
genes	O
deleted	O
or	O
inactivated	O
,	O
including	O
genes	O
that	O
are	O
predicted	O
to	O
be	O
critical	O
to	O
virulence	O
.	O

IDSA	S-Organization
also	O
presented	O
a	O
statement	O
in	O
collaboration	O
with	O
the	O
Global	B-Organization
Health	I-Organization
Council	E-Organization
,	O
the	O
Elizabeth	B-Organization
Glaser	I-Organization
Pediatric	I-Organization
AIDS	I-Organization
Foundation	E-Organization
,	O
the	O
Global	B-Organization
Health	I-Organization
Technologies	I-Organization
Coalition	E-Organization
,	O
and	O
Partners	B-Organization
in	I-Organization
Health	E-Organization
commending	O
work	O
to	O
prepare	O
for	O
the	O
upcoming	O
.	O

CDC	S-Organization
continues	O
its	O
internal	O
review	O
to	O
determine	O
why	O
validated	O
procedures	O
were	O
not	O
used	O
by	O
the	O
lab	O
.	O

The	O
death-to-case	O
ratio	O
reflects	O
the	O
number	O
of	O
deaths	O
divided	O
by	O
the	O
number	O
of	O
diagnosed	O
cases	O
within	O
a	O
given	O
time	O
interval	O
.	O

This	O
subset	O
of	O
emerging	O
technologies	O
and	O
their	O
potential	O
application	O
are	O
the	O
focus	O
of	O
a	O
new	O
report	O
,	O
Technologies	B-Document
to	I-Document
Address	I-Document
Global	I-Document
Catastrophic	I-Document
Biological	I-Document
Risks	E-Document
by	O
a	O
team	O
of	O
researchers	O
at	O
the	O
.	O
The	O
study	O
is	O
among	O
the	O
first	O
to	O
assess	O
technologies	O
for	O
the	O
purpose	O
of	O
reducing	O
GCBRs-a	O
special	O
category	O
of	O
risk	O
defined	O
previously	O
by	O
the	O
Center	O
as	O
threats	O
from	O
biological	O
agents	O
that	O
could	O
lead	O
to	O
sudden	O
,	O
extraordinary	O
,	O
widespread	O
disaster	O
beyond	O
the	O
collective	O
capability	O
of	O
national	O
and	O
international	O
organizations	O
and	O
the	O
private	O
sector	O
to	O
control	O
.	O

He	O
returned	O
to	O
the	O
hospital	O
by	O
ambulance	O
on	O
28	O
September	O
and	O
was	O
placed	O
in	O
isolation	O
and	O
tested	O
for	O
Ebola	S-Disease
.	O
He	O
died	O
on	O
8	O
October	O
.	O

Reviewing	O
and	O
providing	O
input	O
into	O
corrective	O
actions	O
for	O
CDC	S-Organization
laboratories	O
.	O

And	O
it	O
was	O
not	O
done	O
as	O
it	O
was	O
supposed	O
to	O
have	O
been	O
done	O
.	O

The	O
2003	O
ricin	S-Pathogen
letters	O
refers	O
to	O
two	O
ricin-laden	S-Pathogen
letters	O
found	O
on	O
two	O
separate	O
occasions	O
between	O
October	O
and	O
November	O
2003	O
.	O

At	O
the	O
end	O
of	O
1969	O
,	O
likely	O
prompted	O
by	O
Vietnam	O
War	O
protests	O
,	O
President	O
Richard	B-Person
Nixon	E-Person
terminated	O
the	O
offensive	O
biological	O
warfare	O
program	O
and	O
ordered	O
all	O
stockpiled	O
weapons	O
destroyed	O
.	O

China	S-Location
is	O
struggling	O
to	O
contain	O
the	O
disease	O
,	O
which	O
has	O
spread	O
to	O
every	O
part	O
of	O
the	O
country	O
since	O
August	O
last	O
year	O
.	O

Saddam	B-Person
Hussein	E-Person
(1937–2006)	O
initiated	O
an	O
extensive	O
biological	O
weapons	O
(BW)	O
program	O
in	O
Iraq	S-Location
in	O
the	O
early	O
1980s	O
,	O
in	O
violation	O
of	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
(	O
BWC	S-Document
)	O
of	O
1972	O
.	O

Work	O
on	O
delivery	O
systems	O
for	O
the	O
U.S.	S-Location
bioweapons	O
arsenal	O
led	O
to	O
the	O
first	O
mass-produced	O
biological	O
weapon	O
in	O
1952	O
,	O
the	O
M33	O
cluster	O
bomb.Croddy	O
,	O
Weapons	O
of	O
Mass	O
Destruction	O
,	O
p.	O
75	O
.	O

Projects	O
in	O
FBD	S-Platform
have	O
principally	O
been	O
funded	O
through	O
grants	O
from	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
,	O
2:4	O
Krisberedskap	O
.	O

In	O
both	O
incidents	O
,	O
there	O
is	O
no	O
risk	O
that	O
agents	O
were	O
released	O
outside	O
of	O
CDC	S-Organization
.	O
In	O
terms	O
of	O
the	O
influenza	O
work	O
,	O
it	O
was	O
all	O
done	O
in	O
a	O
highly	O
contained	O
environment	O
,	O
both	O
here	O
and	O
at	O
the	O
USDA	S-Organization
laboratory	O
,	O
and	O
our	O
understanding	O
is	O
there	O
is	O
no	O
risk	O
of	O
it	O
having	O
either	O
exposed	O
workers	O
or	O
gotten	O
out	O
into	O
the	O
community	O
,	O
and	O
that's	O
certainly	O
the	O
case	O
with	O
the	O
as	O
well	O
.	O

He	O
had	O
inadvertently	O
produced	O
the	O
first	O
description	O
of	O
.	O

According	O
to	O
the	O
biological	O
agents	O
laboratory	O
biosafety	O
categorization	O
criteria	O
shown	O
in	O
Table	O
1	O
(for	O
ease	O
of	O
comparison	O
,	O
the	O
category	O
order	O
of	O
is	O
reversed)	O
,	O
agents	O
in	O
group	O
1	O
do	O
not	O
generally	O
cause	O
human	O
disease	O
,	O
while	O
those	O
in	O
group	O
2	O
cause	O
disease	O
that	O
is	O
not	O
serious	O
and	O
for	O
which	O
effective	O
treatments	O
and	O
preventive	O
measures	O
are	O
available	O
.	O

It	O
has	O
been	O
reported	O
that	O
Russia	O
made	O
smallpox	S-Pathogen
available	O
to	O
Iraq	O
in	O
the	O
beginning	O
of	O
the	O
1990s	O
.	O

As	O
shown	O
in	O
Fig.	O
1	O
,	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
mainly	O
consists	O
of	O
a	O
BSL-3	S-Platform
laboratory	O
with	O
negative	O
pressure	O
,	O
a	O
BSL-2	S-Platform
laboratory	O
,	O
a	O
PCR	S-Equipment
preparation	O
room	O
,	O
a	O
storage	O
room	O
and	O
two	O
sets	O
of	O
dressing	O
rooms	O
(including	O
two	O
1st	O
changing	O
rooms	O
,	O
two	O
shower	O
rooms	O
and	O
one	O
2nd	O
changing	O
room)	O
.	O

However	O
,	O
this	O
assertion	O
has	O
been	O
subsequently	O
challenged	O
,	O
including	O
when	O
the	O
University	B-Organization
of	I-Organization
Birmingham	E-Organization
was	O
acquitted	O
following	O
a	O
prosecution	O
for	O
breach	O
of	O
Health	B-Document
and	I-Document
Safety	I-Document
legislation	E-Document
connected	O
with	O
Parker	S-Person
's	O
death	O
.	O

In	O
Canada	S-Location
,	O
50,000	O
died.	O
"	O
A	O
deadly	O
virus	O
rages	O
through	O
out	O
Canada	S-Location
at	O
the	O
end	O
of	O
the	O
First	B-Incident
World	E-Incident
Watory	O
.	O

As	O
of	O
,	O
countries	O
that	O
publicised	O
their	O
testing	O
data	O
have	O
typically	O
performed	O
many	O
tests	O
equal	O
to	O
percent	O
of	O
their	O
population	O
,	O
while	O
no	O
country	O
has	O
tested	O
samples	O
equal	O
to	O
more	O
than	O
percent	O
of	O
its	O
population	O
.	O

In	O
October	O
2015	O
,	O
the	O
United	B-Organization
States	I-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
announced	O
preclinical	O
results	O
that	O
remdesivir	S-Drug
had	O
blocked	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
Rhesus	O
monkeys	O
.	O

In	O
a	O
trial	O
in	O
China	S-Location
over	O
February-March	O
2020	O
,	O
remdesivir	S-Drug
was	O
not	O
effective	O
in	O
reducing	O
the	O
time	O
for	O
improvement	O
from	O
or	O
deaths	O
,	O
and	O
caused	O
various	O
adverse	O
effects	O
,	O
requiring	O
the	O
investigators	O
to	O
terminate	O
the	O
trial	O
.	O

Diet	O
,	O
nutrition	O
and	O
the	O
prevention	O
of	O
chronic	O
diseases	O
.	O

The	O
GAO	S-Organization
said	O
it	O
looked	O
at	O
the	O
contractor's	O
evaluation	O
plan	O
and	O
found	O
some	O
incomplete	O
or	O
unclear	O
elements	O
,	O
which	O
have	O
since	O
been	O
addressed	O
by	O
USAID	S-Organization
and	O
the	O
contractor	O
.	O

Melioidosis	S-Pathogen
has	O
the	O
potential	O
to	O
be	O
developed	O
as	O
a	O
biological	O
weapon	O
,	O
hence	O
,	O
it	O
is	O
classed	O
as	O
a	O
category	O
B	O
.	O

What	O
if	O
we	O
could	O
engineer	O
humans	O
with	O
sonar	O
,	O
like	O
that	O
used	O
by	O
bats	O
,	O
to	O
help	O
us	O
navigate	O
in	O
the	O
dark?	O
What	O
if	O
we	O
had	O
genes	O
that	O
enabled	O
us	O
to	O
get	O
energy	O
from	O
sunlight	O
,	O
like	O
plants	O
do?	O
Pamela	B-Person
Silver	E-Person
group	O
at	O
has	O
inserted	O
cyanobacteria	O
,	O
the	O
microbes	O
responsible	O
for	O
nearly	O
half	O
the	O
world's	O
photosynthesis	O
,	O
into	O
zebrafish	O
embryos	O
as	O
a	O
first	O
step	O
towards	O
achieving	O
that	O
goal	O
.	O

Discussions	O
about	O
shifting	O
to	O
Phase	O
6	O
have	O
been	O
under	O
way	O
for	O
weeks	O
.	O

"	O
Biology,	O
medicine	O
,	O
agriculture	O
,	O
and	O
other	O
life	O
sciences	O
were	O
always	O
considered	O
the	O
'good'	O
sciences	O
,	O
but	O
like	O
Persephone	O
they	O
could	O
be	O
used	O
to	O
bring	O
death	O
and	O
destruction	O
in	O
the	O
form	O
of	O
biological	O
weapons,	O
"	O
explained	O
lead	O
author	O
Gigi	B-Person
Kwik	E-Person
PhD	O
,	O
a	O
fellow	O
with	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Center	I-Organization
for	I-Organization
Civilian	I-Organization
Biodefense	I-Organization
Strategies	E-Organization
and	O
assistant	O
scientist	O
in	O
the	O
.	O

In	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
for	O
instance	O
,	O
the	O
UN	S-Organization
is	O
supervising	O
the	O
overall	O
response	O
to	O
the	O
Ebola	S-Disease
crisis	O
,	O
the	O
first	O
time	O
said	O
he's	O
seen	O
it	O
become	O
operational.U.S.	O
investment	O
in	O
such	O
responses	O
would	O
benefit	O
the	O
nation	O
,	O
he	O
said	O
.	O

It	O
has	O
done	O
this	O
mainly	O
through	O
carrying	O
out	O
joint	O
projects	O
,	O
which	O
have	O
included	O
activities	O
such	O
as	O
ring	O
trials	O
(analysis	O
of	O
spiked	O
samples	O
for	O
detection	O
of	O
high-consequence	O
pathogens)	O
,	O
exercises	O
,	O
and	O
audits	O
.	O

The	O
delays	O
in	O
obtaining	O
data	O
and	O
absence	O
of	O
basic	O
information	O
(which	O
would	O
usefully	O
include:	O
sex	O
,	O
age	O
,	O
other	O
medical	O
conditions	O
and	O
smoking	O
status)	O
were	O
noted	O
and	O
decried	O
by	O
Dr	O
.	O

The	O
architect	O
firm	O
that	O
worked	O
on	O
it	O
,	O
HDR	B-Organization
Inc.	E-Organization
,	O
predicted	O
the	O
building	O
would	O
serve	O
the	O
for	O
50	O
years	O
.	O

The	O
base	O
score	O
includes	O
the	O
current	O
prevalence	O
in	O
Europe	S-Location
and	O
also	O
refers	O
to	O
.	O
Ability	O
to	O
spread	O
among	O
people	O
includes	O
the	O
number	O
of	O
susceptible	O
people	O
.	O

Kadlec	S-Person
likened	O
's	O
financial	O
resources	O
on	O
hand	O
to	O
operating	O
with	O
half	O
an	O
aircraft	O
carrier	O
to	O
complete	O
its	O
mission	O
of	O
protecting	O
the	O
nation's	O
more	O
than	O
320	O
million	O
people	O
.	O

Frieden	S-Person
.	O
I	O
guess	O
my	O
question	O
is	O
the	O
report	O
actually	O
details	O
four	O
other	O
incidents	O
in	O
addition	O
to	O
the	O
last	O
month's	O
anthrax	O
release	O
.	O

The	O
total	O
numbers	O
outside	O
China	S-Location
quickly	O
passed	O
's	O
.	O

Because	O
PRESAGED	S-Technology
detects	O
a	O
subject's	O
physical	O
response	O
to	O
the	O
pathogen	O
and	O
does	O
not	O
recognize	O
biomarkers	O
for	O
the	O
pathogen	O
itself	O
,	O
currently	O
does	O
not	O
differentiate	O
or	O
identify	O
the	O
viruses	O
or	O
bacteria	O
.	O

Develop	O
One	B-International_exchange_and_cooperation
Health	E-International_exchange_and_cooperation
nationwide	O
surveillance	O
of	O
AMR	O
and	O
the	O
use	O
of	O
antimicrobials	O
.	O

The	O
report	O
we're	O
releasing	O
today	O
,	O
though	O
,	O
looks	O
at	O
the	O
root	O
cause	O
of	O
this	O
incident	O
.	O

Some	O
Muslim	O
doctors	O
cautioned	O
against	O
trying	O
to	O
prevent	O
or	O
treat	O
a	O
disease	O
sent	O
by	O
God	O
.	O

And	O
when	O
information	O
does	O
make	O
it	O
to	O
the	O
public	O
,	O
it	O
is	O
often	O
when	O
"	O
things	O
go	O
wrong,	O
"	O
Nuzzo	S-Person
said	O
.	O

Like	O
some	O
other	O
biohackers	O
with	O
an	O
anti-establishment	O
streak	O
,	O
he's	O
irritated	O
by	O
federal	O
officials'	O
purported	O
sluggishness	O
in	O
greenlighting	O
all	O
sorts	O
of	O
medical	O
treatments	O
.	O

The	O
COVID‑19	B-Organization
Clinical	I-Organization
Research	I-Organization
Coalition	E-Organization
has	O
goals	O
to	O
1)	O
facilitate	O
rapid	O
reviews	O
of	O
clinical	O
trial	O
proposals	O
by	O
ethics	O
committees	O
and	O
national	O
regulatory	O
agencies	O
,	O
2)	O
fast-track	O
approvals	O
for	O
the	O
candidate	O
therapeutic	O
compounds	O
,	O
3)	O
ensure	O
standardised	O
and	O
rapid	O
analysis	O
of	O
emerging	O
efficacy	O
and	O
safety	O
data	O
and	O
4)	O
facilitate	O
sharing	O
of	O
clinical	O
trial	O
outcomes	O
before	O
publication	O
.	O

However	O
,	O
in	O
an	O
account	O
by	O
a	O
man	O
who	O
worked	O
as	O
a	O
junior	O
uniformed	O
civilian	O
employee	O
of	O
the	O
Imperial	B-Organization
Japanese	I-Organization
Army	E-Organization
in	O
Unit	B-Organization
731	E-Organization
,	O
the	O
project	O
was	O
internally	O
called	O
"	O
Holzklotz	S-Scientific_research_project
"	O
,	O
which	O
is	O
a	O
German	O
word	O
for	O
log	O
.	O

As	O
a	O
result	O
,	O
the	O
pipeline	O
for	O
new	O
antibiotics	O
has	O
dwindled	O
.	O

5	O
.	O

Since	O
then	O
,	O
scientists	O
have	O
made	O
bigger	O
and	O
bigger	O
genomes	O
,	O
and	O
recently	O
,	O
the	O
launched	O
with	O
the	O
intention	O
of	O
tackling	O
perhaps	O
the	O
ultimate	O
goal:	O
chemically	O
fabricating	O
an	O
entire	O
human	O
genome	O
.	O

The	O
agreement	O
can	O
be	O
extended	O
to	O
fund	O
additional	O
work	O
up	O
to	O
a	O
total	O
of	O
approximately	O
$36	O
million	O
through	O
2023	O
.	O

Death	O
rates	O
then	O
dipped	O
slightly	O
in	O
1917	O
.	O

As	O
a	O
result	O
,	O
foreign	O
technology	O
owners	O
that	O
provide	O
highly	O
demanded	O
technologies	O
like	O
Bt	O
cotton	O
declined	O
to	O
work	O
with	O
Ethiopia	S-Location
There	O
is	O
a	O
fear	O
that	O
the	O
emerged	O
biosafety	O
system	O
might	O
also	O
continue	O
to	O
suppress	O
domestic	O
genetic	O
engineering	O
research	O
and	O
development	O
.	O

Second	O
,	O
is	O
a	O
two-vector	O
system:	O
sgRNA	O
and	O
Cas9	O
plasmids	O
are	O
delivered	O
separetly	O
.	O

On	O
17	O
December	O
2014	O
,	O
a	O
team	O
at	O
Johns	B-Organization
Hopkins	I-Organization
University	E-Organization
developed	O
a	O
prototype	O
breakaway	B-Equipment
hazmat	I-Equipment
suit	E-Equipment
,	O
and	O
was	O
awarded	O
a	O
grant	O
from	O
the	O
USAID	S-Organization
to	O
develop	O
it	O
.	O

Shortening	O
of	O
the	O
scanning	O
time	O
to	O
around	O
1	O
second	O
,	O
eliminating	O
the	O
strict	O
need	O
for	O
the	O
subject	O
to	O
remain	O
still	O
or	O
be	O
sedated	O
,	O
is	O
one	O
of	O
the	O
main	O
reasons	O
for	O
the	O
large	O
increase	O
in	O
the	O
pediatric	O
population	O
(especially	O
for	O
the	O
diagnosis	O
of	O
appendicitis)	O
.	O

Kioyashi	B-Person
Mineoi	E-Person
"	O
civilian	O
employee	O
"	O

Developing	O
countries	O
should	O
also	O
have	O
biodefense	O
biological	O
agent	O
lists	O
.	O

Historical	O
records	O
since	O
the	O
16th	O
century	O
suggest	O
that	O
new	O
influenza	O
pandemics	O
may	O
appear	O
at	O
any	O
time	O
of	O
year	O
,	O
not	O
necessarily	O
in	O
the	O
familiar	O
annual	O
winter	O
patterns	O
of	O
interpandemic	O
years	O
,	O
presumably	O
because	O
newly	O
shifted	O
influenza	S-Disease
viruses	O
behave	O
differently	O
when	O
they	O
find	O
a	O
universal	O
or	O
highly	O
susceptible	O
human	O
population	O
.	O

After	O
months	O
of	O
claiming	O
the	O
situation	O
was	O
under	O
control	O
,	O
Beijing	S-Location
is	O
now	O
warning	O
that	O
pork	O
prices	O
in	O
could	O
rise	O
by	O
more	O
than	O
70%	O
in	O
the	O
second	O
half	O
of	O
this	O
year	O
.	O

Koizumi	S-Person
had	O
joined	O
a	O
secret	O
poison	O
gas	O
research	O
committee	O
in	O
1915	O
,	O
during	O
World	O
War	O
I	O
,	O
when	O
he	O
and	O
other	O
Imperial	O
Japanese	O
Army	O
officers	O
became	O
impressed	O
by	O
the	O
successful	O
German	O
use	O
of	O
chlorine	O
gas	O
at	O
the	O
Second	O
Battle	O
of	O
Ypres	S-Location
,	O
in	O
which	O
the	O
Allies	O
suffered	O
5,000	O
deaths	O
and	O
15,000	O
wounded	O
as	O
a	O
result	O
of	O
the	O
chemical	O
attack	O
.	O

The	O
officially	O
announced	O
it	O
as	O
a	O
PHEIC	O
on	O
17	O
July	O
2019	O
,	O
and	O
as	O
of	O
12	O
February	O
2020	O
,	O
it	O
continues	O
to	O
be	O
a	O
PHEIC	O
.	O

In	O
,	O
there	O
is	O
evidence	O
that	O
the	O
ban	O
has	O
led	O
to	O
a	O
lower	O
prevalence	O
of	O
antibiotic	O
resistance	O
in	O
(nonhazardous)	O
animal	O
bacterial	O
populations	O
.	O

Pixel	O
is	O
a	O
two	O
dimensional	O
unit	O
based	O
on	O
the	O
matrix	O
size	O
and	O
the	O
field	O
of	O
view	O
.	O

According	O
to	O
the	O
WHO	S-Organization
director-general	O
Tedros	B-Person
Adhanom	E-Person
,	O
demand	O
for	O
personal	O
protection	O
equipment	O
has	O
risen	O
a	O
hundredfold	O
,	O
leading	O
to	O
prices	O
up	O
to	O
twenty	O
times	O
the	O
normal	O
price	O
and	O
also	O
delays	O
in	O
the	O
supply	O
of	O
medical	O
items	O
of	O
four	O
to	O
six	O
months	O
.	O

In	O
envisioning	O
a	O
smallpox	S-Pathogen
attack	O
,	O
terrorism	O
experts	O
consider	O
person-to-person	O
contact	O
a	O
main	O
threat	O
.	O

In	O
Liberia	S-Location
the	O
disease	O
was	O
reported	O
in	O
both	O
Lofa	S-Location
and	O
Nimba	S-Location
counties	O
in	O
late	O
March	O
2014	O
.	O

The	O
FDA	S-Organization
approved	O
long-term	O
drug	O
delivery	O
platform	O
,	O
ProNeura	S-Technology
,	O
is	O
a	O
matrix	O
of	O
EVA	O
which	O
is	O
readily	O
available	O
to	O
modify	O
this	O
drug	O
administration	O
schedule	O
.	O

To	O
enhance	O
the	O
sensitivity	O
of	O
the	O
contrast	O
agents	O
,	O
these	O
targeting	O
moieties	O
are	O
usually	O
linked	O
to	O
high	O
payload	O
MRI	S-Technology
contrast	O
agents	O
or	O
MRI	S-Technology
contrast	O
agents	O
with	O
high	O
relaxivities	O
.	O

It	O
is	O
transmitted	O
by	O
ticks	O
and	O
direct	O
contact	O
between	O
animals	O
and	O
there	O
is	O
no	O
vaccine	O
.	O

In	O
a	O
further	O
parallel	O
,	O
the	O
corpses	O
of	O
"	O
sacrificed"	O
subjects	O
were	O
disposed	O
of	O
by	O
incineration	O
.	O

Moreover	O
,	O
some	O
adaptive	O
mutations	O
can	O
propagate	O
not	O
only	O
through	O
inheritance	O
but	O
also	O
through	O
horizontal	O
gene	O
transfer	O
.	O

In	O
some	O
areas	O
,	O
the	O
was	O
not	O
reported	O
on	O
,	O
the	O
only	O
mention	O
being	O
that	O
of	O
advertisements	O
for	O
medicines	O
claiming	O
to	O
cure	O
it	O
.	O

Secondly	O
,	O
at	O
the	O
receiving	O
end	O
,	O
if	O
USDA	S-Organization
discovered	O
that	O
what	O
they	O
had	O
was	O
contaminated	O
with	O
h5n1	S-Pathogen
,	O
was	O
it	O
not	O
also	O
incumbent	O
on	O
them	O
to	O
report	O
the	O
incident	O
on	O
May	O
23rd	O
when	O
they	O
found	O
out	O
that	O
this	O
was	O
going	O
on?	O
And	O
third	O
,	O
you	O
know	O
,	O
made	O
reference	O
to	O
the	O
gain	O
of	O
function	O
work	O
,	O
and	O
this	O
is	O
going	O
to	O
explode	O
that	O
issue	O
.	O

Experiments	O
can	O
range	O
from	O
using	O
plasmids	O
to	O
fluorescent	O
bacteria	O
,	O
controlling	O
gene	O
expression	O
using	O
light	O
in	O
bacteria	O
,	O
even	O
using	O
to	O
engineer	O
the	O
genome	O
of	O
bacteria	O
or	O
yeast	O
.	O

Other	O
anthrax	O
vaccines	O
also	O
exist	O
.	O

Of	O
the	O
65	O
ongoing	O
projects	O
,	O
USAID	S-Organization
expects	O
to	O
implement	O
46	O
within	O
original	O
time	O
frames	O
but	O
has	O
extended	O
19	O
.	O

Although	O
it	O
was	O
initially	O
thought	O
that	O
two	O
injections	O
would	O
be	O
required	O
,	O
clinical	O
trials	O
showed	O
that	O
the	O
new	O
vaccine	O
protected	O
adults	O
"	O
with	O
only	O
one	O
dose	O
instead	O
of	O
two;	O
"	O
thus	O
the	O
limited	O
vaccine	O
supplies	O
would	O
go	O
twice	O
as	O
far	O
as	O
had	O
been	O
predicted	O
.	O

A	O
dimensional	O
analysis	O
was	O
used	O
to	O
contextualize	O
the	O
concept	O
.	O

In	O
Liberia	S-Location
the	O
disease	O
was	O
reported	O
in	O
four	O
counties	O
by	O
mid-April	O
2014	O
and	O
cases	O
in	O
Liberia	S-Location
's	O
capital	O
Monrovia	S-Location
were	O
reported	O
in	O
mid-June	O
.	O

On	O
8	O
April	O
2015	O
,	O
the	O
reported	O
a	O
total	O
of	O
only	O
30	O
confirmed	O
cases	O
,	O
and	O
the	O
weekly	O
update	O
for	O
29	O
July	O
reported	O
only	O
seven	O
new	O
cases	O
.	O

Some	O
studies	O
estimated	O
that	O
the	O
actual	O
number	O
of	O
cases	O
including	O
asymptomatic	O
and	O
mild	O
cases	O
could	O
be	O
700	O
million	O
to	O
1.	O
4	O
billion	O
people-or	O
11	O
to	O
21	O
percent	O
of	O
the	O
global	O
population	O
of	O
6.	O
8	O
billion	O
at	O
the	O
time	O
.	O

It	O
also	O
reviews	O
reports	O
of	O
the	O
Executive	O
Board	O
and	O
decides	O
whether	O
there	O
are	O
areas	O
of	O
work	O
requiring	O
further	O
examination	O
.	O

GlobalMed	S-Organization
is	O
the	O
first	O
provider	O
of	O
HIPAA	S-Document
-compliant	O
clinical	O
video	O
collaboration	O
to	O
obtain	O
an	O
ATO	O
.	O

Yes	O
,	O
you	O
read	O
that	O
right:	O
The	O
cheese	O
was	O
created	O
with	O
bacteria	O
harvested	O
from	O
the	O
armpits	O
,	O
toes	O
,	O
bellybuttons	O
,	O
and	O
nostrils	O
of	O
famous	O
people	O
.	O

Non-pharmaceutical	O
interventions	O
that	O
may	O
manage	O
the	O
outbreak	O
include	O
personal	O
preventive	O
measures	O
such	O
as	O
hand	O
hygiene	O
,	O
wearing	O
face	B-Equipment
masks	E-Equipment
and	O
self-quarantine	O
;	O
community	O
measures	O
aimed	O
at	O
physical	O
distancing	O
such	O
as	O
closing	O
schools	O
and	O
cancelling	O
mass	O
gathering	O
events	O
;	O
community	O
engagement	O
to	O
encourage	O
acceptance	O
and	O
participation	O
in	O
such	O
interventions	O
;	O
as	O
well	O
as	O
environmental	O
measures	O
such	O
surface	O
cleaning	O
.	O

The	O
index	O
case	O
is	O
believed	O
to	O
have	O
been	O
the	O
death	O
and	O
unsafe	O
burial	O
of	O
a	O
65-year-old	O
woman	O
on	O
25	O
July	O
in	O
the	O
town	O
of	O
Mangina	S-Location
soon	O
afterwards	O
seven	O
members	O
of	O
her	O
immediate	O
family	O
died	O
.	O

DOE	O
OSH	O
technical	O
reference	O
chapter	O
on	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment

Although	O
biosafety	O
measures	O
were	O
observed	O
by	O
researchers	O
voluntarily	O
,	O
the	O
establishment	O
of	O
national	O
biosafety	O
organizations	O
since	O
the	O
year	O
2000	O
built	O
a	O
great	O
capacity	O
to	O
deal	O
with	O
biosafety	O
issues	O
in	O
the	O
present	O
and	O
future	O
time	O
,	O
particularly	O
with	O
respect	O
to	O
food	O
and	O
agricultural	O
biotechnology	O
.	O

severe	O
pneumonia:	O
diffuse	B-Phenotype
alveolar	I-Phenotype
damage	E-Phenotype
(	O
DAD	S-Phenotype
)	O
with	O
diffuse	O
alveolar	O
exudates	O
.	O

"	O
I	O
think	O
a	O
vaccination	O
program	O
would	O
be	O
a	O
nightmare	O
.	O

The	O
aim	O
of	O
this	O
article	O
is	O
to	O
describe	O
the	O
design	O
and	O
implementation	O
of	O
a	O
virology	O
laboratory	O
,	O
with	O
emphasis	O
on	O
student	O
safety	O
,	O
for	O
biotechnology	O
undergraduates	O
.	O

In	O
terms	O
of	O
health	O
services	O
,	O
WHO	S-Organization
looks	O
to	O
improve	O
"	O
governance,	O
financing	O
,	O
staffing	O
and	O
management	O
"	O
and	O
the	O
availability	O
and	O
quality	O
of	O
evidence	O
and	O
research	O
to	O
guide	O
policy	O
.	O

Bonfante	S-Person
,	O
Jordan	S-Person
.	O
"	O
Medfly	O
Madness"	O
,	O
Time	O
Magazine	O
,	O
January	O
8	O
,	O
1990	O
,	O
accessed	O
December	O
25	O
,	O
2008	O
.	O

"	O
State	O
officials	O
have	O
probably	O
noticed	O
an	O
increase	O
as	O
well	O
as	O
an	O
unusual	O
distribution	O
of	O
Medfly	O
infestation	O
in	O
Los	B-Location
Angeles	I-Location
County	E-Location
since	O
March	O
,	O
1989,	O
"	O
the	O
letter	O
stated	O
.	O

And	O
just	O
as	O
it	O
signed	O
the	O
treaty	O
,	O
the	O
fired	O
up	O
its	O
offensive	O
program	O
.	O

The	O
web	O
interface	O
provides	O
visualization	O
and	O
retrieval	O
functionality	O
.	O
is	O
designed	O
to	O
allow	O
extensions	O
and	O
integration	O
of	O
workflows	O
with	O
minimal	O
effort	O
and	O
provides	O
interfaces	O
for	O
the	O
integration	O
of	O
relevant	O
community	O
tools	O
.	O

A	O
joint	O
gap-analysis	O
identified	O
the	O
need	O
to	O
improve	O
and	O
share	O
existing	O
methods	O
and	O
in	O
some	O
cases	O
to	O
develop	O
new	O
methods	O
(Table	O
2)	O
.	O

In	O
response	O
to	O
increased	O
concern	O
by	O
the	O
public	O
and	O
the	O
ongoing	O
progress	O
of	O
best	O
practices	O
,	O
The	O
Alliance	O
for	O
Radiation	O
Safety	O
in	O
Pediatric	O
Imaging	O
was	O
formed	O
within	O
the	O
Society	B-Organization
for	I-Organization
Pediatric	I-Organization
Radiology	E-Organization
In	O
concert	O
with	O
The	O
American	B-Organization
Society	I-Organization
of	I-Organization
Radiologic	I-Organization
Technologists	E-Organization
,	O
The	O
American	B-Organization
College	I-Organization
of	I-Organization
Radiology	E-Organization
and	O
The	O
American	B-Organization
Association	I-Organization
of	I-Organization
Physicists	I-Organization
in	I-Organization
Medicine	E-Organization
,	O
the	O
Society	B-Organization
for	I-Organization
Pediatric	I-Organization
Radiology	E-Organization
developed	O
and	O
launched	O
the	O
which	O
is	O
designed	O
to	O
maintain	O
high	O
quality	O
imaging	O
studies	O
while	O
using	O
the	O
lowest	O
doses	O
and	O
best	O
radiation	O
safety	O
practices	O
available	O
on	O
pediatric	O
patients	O
.	O

2009	B-Incident
influenza	I-Incident
A	I-Incident
(H1N1)	I-Incident
pandemic	E-Incident
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
()	O
.	O

WHO	S-Organization
facilitates	O
technical	O
partnerships	O
through	O
the	O
Technical	B-Organization
Advisory	I-Organization
Committee	I-Organization
on	I-Organization
HIV	E-Organization
,	O
which	O
they	O
created	O
to	O
develop	O
guidelines	O
and	O
policies	O
.	O

"	O
The	O
thing	O
about	O
Ebola	S-Pathogen
is	O
that	O
it's	O
not	O
easy	O
to	O
work	O
with,	O
"	O
said.	O
"	O
It	O
would	O
be	O
difficult	O
to	O
weaponize.	O
"	O

"	O
CWMD,	O
including	O
biodefense	O
,	O
is	O
a	O
top	O
priority	O
of	O
this	O
administration	O
.	O

In	O
addition	O
,	O
he	O
participated	O
in	O
the	O
2012	O
External	O
Review	O
of	O
CDC	S-Organization
's	O
Vivarium	O
Facility	O
.	O

They	O
each	O
received	O
61,000	O
yuan	O
(US$8,740)	O
in	O
compensation	O
.	O

Populations	O
of	O
chimpanzees	O
and	O
gorillas	O
living	O
in	O
the	O
wild	O
are	O
also	O
endangered	O
by	O
.	O

But	O
since	O
then	O
,	O
the	O
world	O
has	O
changed	O
,	O
with	O
many	O
more	O
unpredictable	O
threats	O
.	O

The	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
conducts	O
global	O
biosurveillance	O
through	O
several	O
programs	O
,	O
including	O
the	O
Global	B-Platform
Emerging	I-Platform
Infections	I-Platform
Surveillance	I-Platform
and	I-Platform
Response	I-Platform
System	E-Platform
.	O
Pellerin	S-Person
,	O
Cheryl	S-Person
.	O
"	O
"	O
American	O
Forces	O
Press	O
Service	O
,	O
27	O
October	O
2011	O
.	O

He	O
warned	O
staff	O
that	O
he	O
was	O
very	O
sick	O
and	O
to	O
put	O
him	O
in	O
isolation	O
.	O

Some	O
of	O
the	O
infected	O
have	O
been	O
reported	O
to	O
develop	O
protective	O
antibodies	O
,	O
so	O
acquired	O
immunity	O
is	O
presumed	O
likely	O
,	O
based	O
on	O
the	O
behaviour	O
of	O
other	O
coronaviruses	O
.	O

Staff	O
who	O
have	O
returned	O
from	O
deployments	O
to	O
Western	B-Location
Africa	E-Location
say	O
the	O
clothing	O
is	O
so	O
heavy	O
that	O
it	O
can	O
be	O
worn	O
for	O
only	O
about	O
40	O
minutes	O
at	O
a	O
stretch	O
.	O

Further	O
,	O
overall	O
future	O
prospects	O
are	O
also	O
highlighted	O
.	O

This	O
stage	O
introduces	O
working	O
techniques	O
with	O
viruses	O
while	O
teaching	O
students	O
the	O
principles	O
of	O
plaque	O
counting	O
.	O

Scientists	O
at	O
the	O
IRF	S-Organization
focus	O
intensively	O
on	O
developing	O
prevention	O
and	O
treatment	O
options	O
that	O
will	O
be	O
directly	O
relevant	O
to	O
naturally	O
occurring	O
or	O
deliberately	O
introduced	O
human	O
diseases	O
.	O

Various	O
types	O
of	O
specialized	O
equipment	O
are	O
used	O
to	O
provide	O
primary	O
barriers	O
between	O
the	O
microorganism	O
and	O
the	O
laboratory	O
worker	O
.	O

They	O
conclude	O
that	O
two	O
infants	O
and	O
a	O
young	O
woman	O
,	O
none	O
of	O
whom	O
had	O
been	O
vaccinated	O
,	O
died	O
from	O
a	O
rare	O
hemorrhagic	O
form	O
of	O
.	O
Seven	O
survivors	O
who	O
had	O
been	O
vaccinated	O
contracted	O
mild	O
to	O
serious	O
cases	O
of	O
the	O
disease	O
.	O

He	O
also	O
serves	O
as	O
Director	O
,	O
Southeast	B-Organization
Regional	I-Organization
Center	I-Organization
of	I-Organization
Excellence	I-Organization
for	I-Organization
Emerging	I-Organization
Infections	I-Organization
and	I-Organization
Biodefense	E-Organization
,	O
and	O
Director	O
,	O
NC	B-Organization
Sexually	I-Organization
Transmitted	I-Organization
Diseases	I-Organization
Cooperative	I-Organization
Research	I-Organization
Center	E-Organization
.	O
His	O
interests	O
include	O
emerging	O
infections	O
and	O
biodefense	O
,	O
and	O
supporting	O
investigators	O
who	O
work	O
on	O
pathogens	O
including	O
dengue	B-Pathogen
viruses	E-Pathogen
,	O
alphaviruses	S-Pathogen
,	O
coronaviruses	S-Pathogen
,	O
Yersinia	S-Pathogen
,	O
and	O
tularemia	S-Pathogen
.	O
He	O
has	O
served	O
as	O
a	O
member	O
of	O
NIH's	B-Organization
Committee	I-Organization
on	I-Organization
Scientific	I-Organization
Boundaries	I-Organization
for	I-Organization
Review	E-Organization
,	O
as	O
a	O
member	O
of	O
the	O
IOM	B-Organization
Committee	I-Organization
on	I-Organization
Emerging	I-Organization
Microbial	I-Organization
Threats	I-Organization
to	I-Organization
Health	E-Organization
,	O
and	O
as	O
chair	O
of	O
the	O
committee	O
for	O
Investigators	O
in	O
Infectious	O
Diseases	O
Pathogenesis	O
.	O

The	O
Aral	B-Location
Sea	I-Location
island	I-Location
of	I-Location
Vozrozhdeniye	E-Location
housed	O
the	O
main	O
outdoor	O
testing	O
area	O
of	O
the	O
program	O
to	O
make	O
germ	O
weapons	O
.	O

European	O
writers	O
contemporary	O
with	O
the	O
plague	O
described	O
the	O
disease	O
in	O
Latin	O
as	O
or	O
;	O
;	O
.	O
In	O
English	O
prior	O
to	O
the	O
18th	O
century	O
,	O
the	O
event	O
was	O
called	O
the	O
"	O
pestilence"	O
or	O
"	O
great	O
pestilence"	O
,	O
"	O
the	O
plague	S-Disease
or	O
the	O
"	O
great	O
death"	O
.	O

Biosafety	B-Platform
Level	I-Platform
2	E-Platform
recommendations	O
and	O
OSHA	S-Organization
requirements	O
focus	O
on	O
the	O
prevention	O
of	O
percutaneous	O
and	O
mucous	O
membrane	O
exposures	O
to	O
clinical	O
material	O
.	O

Projections	O
of	O
future	O
cases	O
should	O
also	O
reflect	O
the	O
possibility	O
that	O
deforestation	O
might	O
have	O
a	O
hand	O
in	O
terms	O
of	O
the	O
more	O
recent	O
Ebola	B-Incident
outbreaks	E-Incident
It	O
has	O
been	O
suggested	O
that	O
due	O
to	O
the	O
clearing	O
of	O
forest	O
for	O
commercial	O
use	O
,	O
various	O
types	O
of	O
bats	O
namely	O
fruit	O
bats	O
may	O
be	O
taken	O
out	O
of	O
their	O
natural	O
habitat	O
and	O
therefore	O
into	O
closer	O
and	O
potential	O
contact	O
with	O
civilisation	O
.	O

The	O
U.S.	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
has	O
recently	O
released	O
its	O
findings	O
regarding	O
how	O
effective	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
has	O
been	O
with	O
addressing	O
the	O
lapses	O
made	O
at	O
the	O
laboratory	O
at	O
Dugway	B-Location
Proving	I-Location
Ground	E-Location
,	O
Utah	S-Location
,	O
and	O
whether	O
systemic	O
oversight	O
changes	O
regarding	O
biosecurity	O
have	O
since	O
been	O
implemented	O
across	O
facilities	O
.	O

Italy	S-Location
,	O
Iran	S-Location
,	O
South	B-Location
Korea	E-Location
,	O
and	O
Japan	S-Location
reported	O
surging	O
cases	O
.	O

Typical	B-Equipment
CT	I-Equipment
scanners	E-Equipment
use	O
energy	O
integrating	O
detectors	O
;	O
photons	O
are	O
measured	O
as	O
a	O
voltage	O
on	O
a	O
capacitor	O
which	O
is	O
proportional	O
to	O
the	O
x-rays	O
detected	O
.	O

The	O
should	O
prove	O
to	O
be	O
a	O
useful	O
starting	O
point	O
for	O
diverse	O
bibliometric	O
studies	O
of	O
publications	O
in	O
this	O
area	O
.	O

Moreover	O
,	O
in	O
many	O
cases	O
there	O
are	O
no	O
commercial	O
or	O
standardized	O
methods	O
for	O
analyzing	O
such	O
agents	O
.	O

On	O
20	O
January	O
,	O
China	S-Location
reported	O
nearly	O
140	O
new	O
cases	O
in	O
one	O
day	O
,	O
including	O
two	O
people	O
in	O
Beijing	S-Location
and	O
one	O
in	O
Shenzhen	S-Location
.	O
Later	O
official	O
data	O
shows	O
6,174	O
people	O
had	O
already	O
developed	O
symptoms	O
by	O
then	O
,	O
and	O
more	O
may	O
have	O
been	O
infected	O
.	O

To	O
that	O
end	O
,	O
the	O
Department	B-Organization
of	I-Organization
State	E-Organization
has	O
trained	O
and	O
equipped	O
over	O
1,200	O
Liberian	O
police	O
officers	O
,	O
over	O
2,000	O
Sierra	O
Leonean	O
police	O
officers	O
,	O
and	O
several	O
hundred	O
Guinean	O
police	O
officers	O
to	O
safely	O
and	O
effectively	O
perform	O
key	O
security-related	O
duties	O
during	O
the	O
crisis	O
.	O

Virgin	O
female	O
Aedes	O
aegypti	O
mosquitoes	O
,	O
which	O
had	O
been	O
starved	O
,	O
were	O
tested	O
upon	O
troops	O
out	O
in	O
the	O
open	O
air	O
.	O

Pathogens	O
studied	O
included	O
the	O
biological	O
agents	O
causing	O
a	O
myriad	O
of	O
diseases	O
such	O
as	O
anthrax	S-Disease
,	O
glanders	S-Disease
,	O
brucellosis	S-Disease
,	O
melioidosis	S-Disease
,	O
Venezuelan	B-Disease
equine	I-Disease
encephalitis	E-Disease
,	O
Q	B-Disease
fever	E-Disease
,	O
,	O
and	O
other	O
plant	O
and	O
animal	O
pathogens	O
.	O

On	O
19	O
March	O
,	O
Italy	S-Organization
overtook	O
China	S-Location
as	O
the	O
country	O
with	O
the	O
most	O
coronavirus-related	O
deaths	O
in	O
the	O
world	O
after	O
reporting	O
3,405	O
fatalities	O
from	O
the	O
pandemic	O
.	O

PREEMPT	S-Scientific_research_project
will	O
have	O
two	O
technical	O
thrusts:	O
development	O
of	O
multiscale	O
models	O
and	O
test	O
beds	O
to	O
quantify	O
the	O
imminent	O
emergence	O
and	O
reemergence	O
of	O
human	O
pathogens	O
;	O
and	O
development	O
of	O
new	O
,	O
scalable	O
approaches	O
to	O
preventing	O
pathogen	O
spillover	O
and	O
transmission	O
from	O
animals	O
and	O
vectors	O
into	O
humans	O
.	O

To	O
uncover	O
chemical	O
and	O
explosives	O
threats	O
,	O
SIGMA+	S-Scientific_research_project
seeks	O
unprecedented	O
long-range	O
detection	O
of	O
hundreds	O
of	O
chemicals	O
at	O
trace	O
levels	O
to	O
help	O
authorities	O
identify	O
bomb-making	O
safe	O
houses	O
in	O
large	O
urban	O
areas	O
,	O
for	O
example	O
.	O

On	O
24	O
May	O
,	O
a	O
new	O
cluster	O
of	O
about	O
20	O
suspected	O
patients	O
was	O
reported	O
in	O
Toronto	S-Location
By	O
29	O
May	O
,	O
more	O
than	O
7,000	O
people	O
were	O
instructed	O
to	O
quarantine	O
themselves	O
in	O
Canada	S-Location
by	O
authorities	O
seeking	O
to	O
control	O
the	O
potential	O
spread	O
of	O
the	O
.	O

They	O
might	O
experiment	O
on	O
organisms	O
in	O
makeshift	O
labs	O
in	O
their	O
garages	O
.	O

What	O
is	O
almost	O
certain	O
,	O
though	O
,	O
is	O
that	O
this	O
arsenal	O
still	O
exists	O
in	O
2001	O
.	O

The	O
work	O
that	O
we	O
do	O
in	O
public	O
health	O
is	O
often	O
not	O
easy	O
.	O

On	O
30	O
March	O
,	O
Hong	B-Organization
Kong	I-Organization
authorities	E-Organization
quarantined	O
estate	O
E	O
of	O
the	O
Amoy	B-Organization
Gardens	E-Organization
housing	O
estate	O
due	O
to	O
a	O
massive	O
(200+	O
cases)	O
outbreak	O
in	O
the	O
building	O
.	O

The	O
CDC	S-Organization
held	O
its	O
first	O
briefing	O
on	O
SARS	S-Disease
and	O
said	O
that	O
14	O
suspected	O
SARS	S-Disease
cases	O
were	O
being	O
investigated	O
in	O
the	O
US.	S-Location
On	O
20	O
March	O
,	O
WHO	S-Organization
reported	O
that	O
several	O
hospitals	O
in	O
Vietnam	S-Location
and	O
Hong	B-Location
Kong	E-Location
were	O
operating	O
with	O
half	O
the	O
usual	O
staff	O
because	O
many	O
workers	O
stayed	O
home	O
out	O
of	O
fear	O
of	O
getting	O
infected.	O
raised	O
the	O
concern	O
that	O
substandard	O
care	O
of	O
the	O
infected	O
patients	O
might	O
contribute	O
to	O
the	O
spread	O
of	O
the	O
disease	O
.	O

Many	O
others	O
lie	O
somewhere	O
in	O
between	O
.	O

Often	O
,	O
these	O
experiments	O
took	O
place	O
in	O
urban	O
areas	O
in	O
order	O
to	O
test	O
dispersion	O
methods	O
.	O

Add	O
to	O
that	O
the	O
fact	O
that	O
people	O
need	O
to	O
be	O
comfortable	O
doing	O
this	O
.	O

On	O
26	O
October	O
,	O
the	O
WHO	S-Organization
indicated	O
that	O
half	O
of	O
confirmed	O
cases	O
were	O
not	O
showing	O
any	O
symptom	O
,	O
thus	O
making	O
diagnosis	O
more	O
difficult	O
.	O

In	O
the	O
chapter	O
titled:	O
"	O
Influencing	O
An	O
Election:	O
America's	O
First	O
Modern	O
Bioterrorist	O
Attack	O
"	O
in	O
his	O
2006	O
book	O
Terrorism	O
on	O
American	O
Soil:	O
A	O
Concise	O
History	O
of	O
Plots	O
and	O
Perpetrators	O
from	O
the	O
Famous	O
to	O
the	O
Forgotten	O
,	O
author	O
Joseph	B-Person
T.	I-Person
McCann	E-Person
concludes:	O
"	O
In	O
every	O
respect	O
,	O
the	O
carried	O
out	O
by	O
the	O
cult	O
members	O
was	O
a	O
major	O
bioterrorist	O
attack	O
that	O
fortunately	O
failed	O
to	O
achieve	O
its	O
ultimate	O
goal	O
and	O
resulted	O
in	O
no	O
fatalities.	O
"	O

Gerontologist	O
Aubrey	B-Person
de	I-Person
Grey	E-Person
claims	O
people	O
will	O
be	O
able	O
to	O
live	O
to	O
age	O
1,000	O
.	O

PCDs	S-Equipment
have	O
only	O
recently	O
become	O
feasible	O
in	O
CT	B-Equipment
scanners	E-Equipment
due	O
to	O
improvements	O
in	O
detector	O
technologies	O
that	O
can	O
cope	O
with	O
the	O
volume	O
and	O
rate	O
of	O
data	O
required	O
.	O

On	O
2	O
January	O
2019	O
,	O
it	O
was	O
reported	O
that	O
refugee	O
movement	O
from	O
the	O
DRC	S-Location
to	O
Uganda	S-Location
had	O
increased	O
after	O
the	O
presidential	O
elections	O
.	O

Viruses	O
such	O
as	O
Marburg	S-Pathogen
or	O
Congo‐Crimean	B-Pathogen
hemorrhagic	I-Pathogen
fever	E-Pathogen
are	O
manipulated	O
at	O
.	O

The	O
instructors	O
are	O
all	O
graduate	O
students	O
,	O
experienced	O
with	O
cell	O
culture	O
techniques	O
and	O
handling	O
of	O
viruses	O
.	O

Bavarian	B-Organization
Nordic	E-Organization
partnered	O
with	O
the	O
U.S.	B-Organization
Biomedical	I-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
to	O
stockpile	O
Imvamune	S-Vaccine
,	O
a	O
smallpox	B-Vaccine
vaccine	E-Vaccine
to	O
protect	O
66	O
million	O
Americans	O
,	O
many	O
of	O
whom	O
have	O
weakened	O
immune	O
systems	O
and	O
do	O
not	O
respond	O
well	O
to	O
drugs	O
for	O
the	O
treatment	O
of	O
smallpox	S-Disease
currently	O
in	O
the	O
stockpile	O
.	O

To	O
start	O
with	O
,	O
let's	O
set	O
aside	O
the	O
risks	O
from	O
malicious	O
intent	O
,	O
and	O
consider	O
only	O
the	O
risks	O
that	O
can	O
arise	O
from	O
well-intentioned	O
research	O
.	O

They're	O
popular	O
mainly	O
because	O
they're	O
easy	O
to	O
get	O
and	O
your	O
body	O
can	O
metabolize	O
them	O
in	O
a	O
few	O
hours	O
or	O
less	O
for	O
quick	O
results	O
.	O

In	O
addition	O
,	O
forensic	O
technologies	O
are	O
working	O
on	O
identifying	O
biological	O
agents	O
,	O
their	O
geographical	O
origins	O
and/or	O
their	O
initial	O
source	O
.	O

This	O
experiment	O
is	O
performed	O
in	O
a	O
traditional	O
lab	O
space	O
under	O
conditions	O
.	O

Sequence	O
analysis	O
alone	O
does	O
not	O
offer	O
clues	O
to	O
the	O
pathogenicity	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
A	O
series	O
of	O
experiments	O
are	O
under	O
way	O
to	O
model	O
virulence	O
in	O
vitro	O
and	O
in	O
animal	O
models	O
by	O
using	O
viral	O
constructs	O
containing	O
1918	O
genes	O
produced	O
by	O
reverse	O
genetics	O
.	O

In	O
2016	O
,	O
researchers	O
demonstrated	O
that	O
CRISPR	S-Technology
from	O
an	O
ordinary	O
mouth	O
bacterium	O
could	O
be	O
used	O
to	O
edit	O
RNA	O
.	O

He	O
said	O
that	O
the	O
girls	O
still	O
carried	O
functional	O
copies	O
of	O
CCR5	O
along	O
with	O
disabled	O
CCR5	O
(mosaicism)	O
and	O
were	O
still	O
vulnerable	O
to	O
.	O
The	O
work	O
was	O
widely	O
condemned	O
as	O
unethical	O
,	O
dangerous	O
,	O
and	O
premature	O
.	O

People	O
&amp	O
;	O
Power:	O
Dirty	O
little	O
sec	O
rets	B-Person
by	I-Person
Diarmuid	E-Person
Al	O
Jazeera	O
English	O
,	O
2010-03-10	O
In	O
this	O
program	O
,	O
Pr	O
ofessor	B-Person
Mori	E-Person
Masataka	O
investigated	O
historical	O
artifacts	O
in	O
the	O
form	O
of	O
bomb	O
casin	O
gs	S-Organization
from	O
US	O
biological	O
weapons	O
,	O
contemporary	O
documentary	O
evidence	O
and	O
eyewitness	O
testimonies	O
.	O

Such	O
organisms	O
are	O
not	O
known	O
to	O
consistently	O
cause	O
disease	O
in	O
healthy	O
adult	O
humans	O
,	O
and	O
are	O
of	O
minimal	O
potential	O
hazard	O
to	O
laboratory	O
personnel	O
and	O
the	O
environment	O
.	O

The	O
physician	O
to	O
the	O
Avignon	B-Organization
Papacy	E-Organization
Raimundo	B-Person
Chalmel	I-Person
de	I-Person
Vinario	E-Person
()	O
,	O
observed	O
the	O
decreasing	O
mortality	O
rate	O
of	O
successive	O
outbreaks	O
of	O
plague	S-Disease
in	O
1347-8	O
,	O
1362	O
,	O
1371	O
,	O
and	O
1382	O
in	O
his	O
1382	O
treatise	O
On	O
Epidemics	O
()	O
.	O

In	O
early	O
November	O
,	O
a	O
WHO	S-Organization
consultant	O
reported:	O
"	O
Many	O
of	O
the	O
survivors	O
are	O
discharged	O
with	O
the	O
so-called	O
Post-Ebola	B-Phenotype
Syndrome	E-Phenotype
.	O
We	O
want	O
to	O
ascertain	O
whether	O
these	O
medical	O
conditions	O
are	O
due	O
to	O
the	O
disease	O
itself	O
,	O
the	O
treatment	O
given	O
or	O
chlorine	O
used	O
during	O
disinfection	O
of	O
the	O
patients	O
.	O

MPR	S-Organization
is	O
frequently	O
used	O
for	O
examining	O
the	O
spine	O
.	O

For	O
example	O
,	O
daptomycin	S-Drug
abandoned	O
by	O
one	O
company	O
for	O
reasons	O
of	O
toxicity	O
,	O
has	O
become	O
a	O
leading	O
treatment	O
for	O
serious	O
using	O
a	O
different	O
dosing	O
regime	O
(REF)	O
.	O

We	O
have	O
hundreds	O
of	O
laboratories	O
at	O
.	O
And	O
making	O
sure	O
that	O
we	O
have	O
a	O
culture	O
of	O
safety	O
in	O
each	O
and	O
every	O
one	O
of	O
those	O
is	O
critically	O
important	O
.	O

The	O
agency's	O
Associate	O
Director	O
for	O
Science	O
Dr	O
.	O

And	O
we	O
have	O
a	O
graphic	O
that	O
we	O
can	O
provide	O
you	O
,	O
which	O
describes	O
the	O
movement	O
of	O
that	O
isolate	O
and	O
when	O
it	O
got	O
contaminated	O
and	O
when	O
it	O
was	O
then	O
destroyed	O
.	O

Livestock	O
in	O
the	O
area	O
were	O
also	O
affected	O
.	O

This	O
is	O
referred	O
to	O
as	O
multiplanar	O
reformatted	O
imaging	O
.	O

Summaries	O
of	O
the	O
pandemic	O
.	O

The	O
impact	O
of	O
the	O
coronavirus	S-Pathogen
outbreak	O
was	O
worldwide	O
.	O

Algeria	S-Organization
experienced	O
2	O
cases	O
and	O
1	O
fatality	O
.	O

By	O
29	O
July	O
,	O
the	O
had	O
given	O
10,500	O
tons	O
of	O
maize	O
and	O
rice	O
seed	O
to	O
the	O
3	O
hardest-hit	O
countries	O
to	O
help	O
them	O
to	O
rebuild	O
their	O
agricultural	O
systems	O
.	O

Further	O
,	O
the	O
teams	O
are	O
tasked	O
with	O
developing	O
technologies	O
to	O
deliver	O
antibodies	O
using	O
nucleic	O
acid	O
technology	O
,	O
and	O
achieve	O
sufficient	O
serum	O
concentrations	O
of	O
the	O
antibodies	O
for	O
protection	O
against	O
the	O
pathogen	O
within	O
three	O
days	O
after	O
administration	O
.	O

The	O
BRAG	S-Document
program	O
supports	O
applied	O
and	O
fundamental	O
research	O
to	O
help	O
federal	O
regulators	O
evaluate	O
the	O
effects	O
of	O
GE	O
organisms	O
on	O
their	O
environment	O
.	O

Using	O
third-generation	O
sequencing	O
technology	O
,	O
investigators	O
were	O
able	O
to	O
sequence	O
samples	O
as	O
quickly	O
as	O
48	O
hours	O
.	O

To	O
prevent	O
the	O
hostile	O
exploitation	O
of	O
biology	O
now	O
and	O
forever	O
,	O
a	O
bundle	O
of	O
measures	O
must	O
be	O
taken	O
,	O
from	O
strengthention	O
to	O
building	O
an	O
awareness	O
in	O
the	O
scientific	O
community	O
about	O
the	O
possibilities	O
and	O
dangers	O
of	O
abuse	O
.	O

Anthrax	S-Pathogen
also	O
could	O
be	O
released	O
into	O
the	O
air	O
from	O
a	O
truck	O
,	O
building	O
,	O
or	O
plane	O
.	O

While	O
the	O
inherent	O
danger	O
of	O
antimicrobial	O
resistance	O
is	O
growing	O
,	O
increasing	O
the	O
threat	O
of	O
a	O
global	O
public	O
health	O
crisis	O
,	O
a	O
new	O
national	O
institute	O
to	O
address	O
the	O
threat	O
has	O
been	O
created	O
through	O
a	O
partnership	O
between	O
universities	O
in	O
Nebraska	S-Location
and	O
.	O

Annotation	O
of	O
experiments	O
is	O
assisted	O
by	O
an	O
integrated	O
ontology	O
lookup	O
service	O
.	O

During	O
this	O
time	O
,	O
he	O
kept	O
a	O
secret	O
diary	O
.	O

The	O
CDCs	O
of	O
developing	O
country	O
should	O
play	O
an	O
important	O
role	O
in	O
this	O
process	O
and	O
cooperate	O
with	O
other	O
related	O
departments	O
and	O
organizations	O
.	O

Aedes	O
Albopictus	O
is	O
a	O
vector	O
of	O
many	O
viral	O
pathogens	O
,	O
Yellow	B-Pathogen
fever	I-Pathogen
virus	E-Pathogen
Dengue	S-Pathogen
,	O
Chikungunya	S-Pathogen
and	O
.	O

"	O
Further	O
spread	O
is	O
considered	O
inevitable,	O
"	O
Chan	S-Person
said	O
at	O
a	O
news	O
conference	O
at	O
WHO	B-Location
headquarters	E-Location
in	O
Geneva	S-Location
,	O
.	O
"	O
The	O
scientific	O
criteria	O
for	O
an	O
influenza	O
pandemic	O
have	O
been	O
met.	O
"	O

The	O
proposal	O
is	O
part	O
of	O
a	O
wide-reaching	O
plan	O
that	O
was	O
released	O
Thursday	O
by	O
the	O
White	B-Organization
House	E-Organization
and	O
that	O
includes	O
other	O
broader	O
ideas	O
to	O
reform	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
.	O
HHS	S-Organization
would	O
be	O
renamed	O
the	O
"	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Public	I-Organization
Welfare	E-Organization
"	O
and	O
absorb	O
some	O
food	O
assistance	O
programs	O
currently	O
run	O
by	O
the	O
.	O

When	O
utilized	O
for	O
genome	B-Technology
editing	E-Technology
,	O
this	O
system	O
includes	O
Cas9	O
,	O
crRNA	O
,	O
and	O
tracrRNA	O
along	O
with	O
an	O
optional	O
section	O
of	O
DNA	O
repair	O
template	O
that	O
is	O
utilized	O
in	O
either	O
non-homologous	B-Technology
end	I-Technology
joining	E-Technology
(	O
NHEJ	S-Technology
)	O
or	O
homology	B-Technology
directed	I-Technology
repair	E-Technology
()	O
.	O

Veterans	O
who	O
took	O
part	O
believe	O
they	O
were	O
also	O
exposed	O
to	O
Agent	O
Orange	O
.	O

To	O
create	O
a	O
T2-weighted	O
image	O
,	O
magnetization	O
is	O
allowed	O
to	O
decay	O
before	O
measuring	O
the	O
MR	O
signal	O
by	O
changing	O
the	O
echo	O
time	O
(TE)	O
.	O

This	O
topic	O
last	O
updated:	O
Dec	O
04	O
,	O
2017	O
.	O

Meanwhile	O
,	O
of	O
the	O
more	O
than	O
28,600	O
total	O
Ebola	S-Pathogen
cases	O
CDC	S-Organization
reported	O
in	O
Liberia	S-Location
,	O
New	B-Location
Guinea	E-Location
and	O
Sierra	B-Location
Leone	E-Location
during	O
that	O
outbreak	O
,	O
more	O
than	O
11,300	O
people	O
in	O
those	O
nations	O
died	O
,	O
according	O
to	O
the	O
agency	O
.	O

The	O
report	O
is	O
part	O
of	O
an	O
ongoing	O
effort	O
to	O
build	O
and	O
implement	O
an	O
enterprise-wide	O
data	O
strategy	O
at	O
HHS	S-Organization
Creating	O
a	O
data-driven	O
department	O
requires	O
implementing	O
a	O
cohesive	O
data	O
governance	O
structure	O
as	O
well	O
as	O
a	O
platform	O
to	O
encourages	O
data	O
sharing	O
,	O
acknowledge	O
data	O
as	O
an	O
asset	O
,	O
and	O
design	O
policy	O
around	O
evidence	O
.	O

SIGMA+	O
seeks	O
to	O
develop	O
new	O
sensors	O
and	O
networks	O
that	O
alert	O
authorities	O
to	O
chemical	O
,	O
biological	O
,	O
and	O
explosives	O
threats	O
as	O
well	O
.	O

In	O
addition	O
to	O
the	O
agents	O
that	O
were	O
ready	O
to	O
be	O
used	O
,	O
the	O
U.S.	S-Location
program	O
conducted	O
research	O
into	O
the	O
weaponization	O
of	O
more	O
than	O
20	O
other	O
agents	O
.	O

On	O
16	O
August	O
2019	O
,	O
it	O
was	O
reported	O
that	O
the	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
had	O
spread	O
to	O
a	O
third	O
province	O
–	O
South	B-Location
Kivu	E-Location
–	O
via	O
two	O
new	O
cases	O
who	O
had	O
travelled	O
from	O
Beni	S-Location
,	O
North	B-Location
Kivu	E-Location
.	O
By	O
August	O
22	O
,	O
the	O
number	O
of	O
cases	O
in	O
had	O
risen	O
to	O
four	O
,	O
including	O
one	O
person	O
at	O
a	O
health	O
facility	O
visited	O
by	O
the	O
first	O
case	O
.	O

Their	O
first	O
report	O
which	O
was	O
published	O
in	O
the	O
New	O
England	O
Journal	O
of	O
Medicine	O
in	O
1993	O
,	O
entitled	O
"	O
Gun	B-Document
Ownership	I-Document
as	I-Document
a	I-Document
Risk	I-Document
Factor	I-Document
for	I-Document
Homicide	I-Document
in	I-Document
the	I-Document
Home	E-Document
"	O
reported	O
that	O
the	O
"	O
mere	O
presence	O
of	O
a	O
gun	O
in	O
a	O
home	O
increased	O
the	O
risk	O
of	O
a	O
firearm-related	O
death	O
by	O
2.7	O
percent	O
,	O
and	O
suicide	O
fivefold-a	O
"	O
huge"	O
increase.	O
"	O
In	O
response	O
,	O
the	O
NRA	S-Organization
launched	O
a	O
"	O
campaign	B-Activity
to	I-Activity
shut	I-Activity
down	I-Activity
the	I-Activity
Injury	I-Activity
Center	E-Activity
.	O
"	O
Doctors	O
for	O
Responsible	B-Organization
Gun	I-Organization
Ownership	I-Organization
and	I-Organization
Doctors	E-Organization
for	O
joined	O
the	O
pro-gun	O
effort	O
and	O
by	O
1995	O
,	O
politicians	O
also	O
supported	O
the	O
pro-gun	O
initiative	O
.	O

The	O
fatality	O
ratio	O
we've	O
tried	O
to	O
keep	O
as	O
low	O
as	O
possible	O
,	O
but	O
there	O
is	O
no	O
magic	O
bullet	O
for	O
Lassa	S-Pathogen
I	O
think	O
it's	O
time	O
to	O
raise	O
this	O
internationally	O
,	O
and	O
bring	O
in	O
the	O
resources	O
that	O
we	O
need	O
to	O
support	O
the	O
country	O
in	O
addressing	O
this	O
disease	O
.	O

The	O
would	O
be	O
scalable	O
to	O
cover	O
a	O
major	O
metropolitan	O
city	O
and	O
its	O
surrounding	O
region	O
.	O

The	O
survey	O
was	O
initially	O
released	O
as	O
a	O
pilot	O
,	O
using	O
Pakistan	S-Location
as	O
the	O
test	O
group	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

Ministries	O
and	O
funding	O
agencies	O
of	O
other	O
countries	O
could	O
adapt	O
these	O
policies	O
as	O
a	O
template	O
.	O

So	O
every	O
time	O
we	O
collect	O
a	O
sample	O
,	O
we	O
have	O
to	O
fly	O
it	O
across	O
many	O
kilometers	O
to	O
the	O
three	O
labs	O
that	O
have	O
that	O
capacity	O
.	O

In	O
2014	O
,	O
the	O
Center	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
came	O
under	O
scrutiny	O
after	O
repeated	O
errors	O
led	O
to	O
scientists	O
being	O
exposed	O
to	O
Ebola	S-Pathogen
,	O
anthrax	S-Pathogen
,	O
and	O
the	O
flu	S-Pathogen
.	O
And	O
a	O
professor	O
in	O
the	O
Netherlands	S-Location
came	O
under	O
fire	O
in	O
2011	O
when	O
his	O
lab	O
engineered	O
a	O
deadly	O
,	O
airborne	O
version	O
of	O
the	O
virus	O
,	O
mentioned	O
above	O
,	O
and	O
attempted	O
to	O
publish	O
the	O
details	O
.	O

As	O
of	O
mid-October	O
the	O
transmission	O
of	O
the	O
virus	O
had	O
significantly	O
reduced	O
;	O
it	O
was	O
by	O
then	O
confined	O
to	O
the	O
Mandima	S-Location
region	O
near	O
where	O
the	O
outbreak	O
began	O
,	O
and	O
was	O
only	O
affecting	O
27	O
health	O
zones	O
in	O
the	O
(down	O
from	O
a	O
peak	O
of	O
207)	O
.	O

There	O
are	O
a	O
number	O
of	O
reasons	O
for	O
this	O
including:	O
legal	O
concerns	O
,	O
financial	O
incentives	O
,	O
and	O
desire	O
by	O
the	O
public	O
.	O

No	O
country	O
has	O
divulged	O
outdoor	O
tests	O
of	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
which	O
causes	O
and	O
usually	O
kills	O
one	O
in	O
three	O
unvaccinated	O
people	O
.	O

Of	O
the	O
early	O
cluster	O
of	O
cases	O
reported	O
that	O
month	O
,	O
two-thirds	O
were	O
found	O
to	O
have	O
a	O
link	O
with	O
the	O
market	O
.	O

In	O
fact	O
,	O
when	O
I	O
joined	O
CDC	S-Organization
in	O
1990	O
,	O
I	O
did	O
an	O
investigation	O
of	O
laboratory	B-Incident
cross-contamination	I-Incident
in	I-Incident
community	I-Incident
hospitals	I-Incident
and	I-Incident
academic	I-Incident
medical	I-Incident
centers	I-Incident
throughout	I-Incident
New	I-Incident
York	I-Incident
City	E-Incident
.	O
And	O
we	O
found	O
that	O
about	O
3	O
percent	O
of	O
all	O
cultures	O
were	O
cross-contaminated	O
,	O
which	O
was	O
really	O
quite	O
terrifying	O
because	O
it	O
meant	O
that	O
somewhere	O
in	O
those	O
laboratories	O
,	O
tuberculosis	S-Disease
has	O
been	O
floating	O
around	O
.	O

Sierra	B-Location
Leone	E-Location
begins	O
42-day	O
countdown	O
to	O
be	O
declared	O
free	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
transmission	O
.	O

Racism	O
and	O
xenophobia	O
towards	O
South	O
Asians	O
and	O
Southeast	O
Asians	O
increased	O
in	O
the	O
Arab	O
states	O
of	O
the	O
Persian	B-Location
Gulf	E-Location
.	O
South	B-Location
Korea	E-Location
's	O
LGBTQ	B-Organization
community	E-Organization
was	O
blamed	O
by	O
some	O
for	O
the	O
spread	O
of	O
COVID-19	S-Disease
in	O
.	O

Together	O
,	O
these	O
events	O
I'm	O
sure	O
have	O
many	O
people	O
asking	O
and	O
questioning	O
government	O
labs	O
.	O

The	O
sustained	O
increase	O
in	O
demand	O
for	O
within	O
health	O
systems	O
has	O
led	O
to	O
concerns	O
about	O
cost	O
effectiveness	O
and	O
overdiagnosis	O
.	O

In	O
2005	O
,	O
Jay	B-Person
Keasling	E-Person
at	O
the	O
Lawrence	B-Organization
Berkeley	I-Organization
National	I-Organization
Laboratory	E-Organization
in	O
California	S-Location
put	O
a	O
group	O
of	O
genes	O
into	O
yeast	O
to	O
produce	O
a	O
precursor	O
to	O
a	O
drug	O
that	O
treats	O
malaria2	S-Disease
.	O
The	O
drug	O
,	O
artemisinin	S-Drug
,	O
is	O
the	O
most	O
effective	O
antimalarial	O
medication	O
available	O
,	O
but	O
it	O
could	O
previously	O
only	O
be	O
harvested	O
from	O
a	O
herb	O
called	O
Artemisia	O
annua	O
.	O

Salisbury	S-Person
's	O
death	O
led	O
to	O
more	O
open	O
admissions	O
by	O
the	O
Chinese	B-Organization
government	E-Organization
about	O
the	O
spread	O
of	O
.	O

All	O
of	O
this	O
work	O
is	O
being	O
used	O
to	O
gain	O
better	O
information	O
to	O
advise	O
employees	O
about	O
their	O
need	O
to	O
take	O
antibiotics	S-Drug
to	O
prevent	O
anthrax	S-Disease
.	O
None	O
of	O
the	O
samples	O
taken	O
from	O
laboratory	O
surfaces	O
in	O
the	O
potentially	O
affected	O
laboratories	O
have	O
been	O
positive	O
for	O
anthrax	S-Pathogen
.	O
Additional	O
investigations	O
on	O
the	O
procedure	O
used	O
to	O
treat	O
anthrax	S-Pathogen
before	O
it	O
was	O
transferred	O
to	O
lower-security	O
laboratories	O
have	O
been	O
reassuring	O
,	O
suggesting	O
that	O
while	O
it	O
is	O
not	O
impossible	O
that	O
viable	O
was	O
transferred	O
out	O
of	O
the	O
high-containment	O
laboratory	O
,	O
it	O
is	O
extremely	O
unlikely	O
that	O
this	O
happened	O
.	O

Depletion	O
or	O
enrichment	O
of	O
sgRNAs	O
is	O
detected	O
and	O
compared	O
to	O
the	O
original	O
sgRNA	O
library	O
,	O
annotated	O
with	O
the	O
target	O
gene	O
that	O
sgRNA	O
corresponds	O
to	O
.	O

In	O
2011	O
,	O
the	O
NDM-5	O
carbapenemase	O
was	O
described	O
in	O
an	O
isolate	O
of	O
E.	B-Pathogen
coli	I-Pathogen
(ST648)	E-Pathogen
from	O
a	O
human	O
in	O
the	O
United	B-Location
Kingdom	E-Location
who	O
was	O
previously	O
hospitalized	O
in	O
Goa	S-Location
,	O
India	S-Location
(6)	O
.	O

On	O
10	O
May	O
2019	O
,	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
indicated	O
that	O
the	O
outbreak	O
could	O
well	O
surpass	O
the	O
epidemic	O
given	O
time	O
.	O

This	O
will	O
be	O
an	O
important	O
opportunity	O
to	O
uphold	O
and	O
widen	O
the	O
contacts	O
between	O
people	O
in	O
this	O
field	O
,	O
to	O
share	O
knowledge	O
and	O
experience	O
from	O
outbreaks	O
,	O
and	O
to	O
discuss	O
how	O
to	O
improve	O
current	O
methods	O
and	O
strategies	O
for	O
quality	O
assurance	O
.	O

What	O
measures	O
have	O
you	O
put	O
in	O
place	O
to	O
prevent	O
future	O
outbreaks	O
of	O
Lassa	B-Disease
fever	E-Disease

WHO	S-Organization
promotes	O
the	O
development	O
of	O
capacities	O
in	O
member	O
states	O
to	O
use	O
and	O
produce	O
research	O
that	O
addresses	O
their	O
national	O
needs	O
,	O
including	O
through	O
the	O
Evidence-Informed	B-Platform
Policy	I-Platform
Network	E-Platform
(	O
EVIPNet	S-Platform
)	O
.	O

Artifacts	O
can	O
be	O
classified	O
as	O
patient-related	O
,	O
signal	O
processing-dependent	O
and	O
hardware	O
(machine)-related	O
.	O

The	O
Iraqis	O
claimed	O
to	O
have	O
destroyed	O
their	O
biological	O
arsenal	O
immediately	O
after	O
the	O
1991	O
war	O
,	O
but	O
they	O
did	O
not	O
provide	O
confirmatory	O
evidence	O
.	O

We	O
evaluated	O
antimicrobial	O
use	O
;	O
5/6	O
animals	O
received	O
&gt;4	O
antimicrobial	O
drugs	O
before	O
specimen	O
submission	O
.	O

The	O
unintentional	O
exposure	O
was	O
discovered	O
June	O
13	O
when	O
the	O
original	O
bacterial	O
plates	O
were	O
gathered	O
for	O
disposal	O
and	O
B.	B-Pathogen
anthracis	E-Pathogen
colonies	O
(live	O
bacteria)	O
were	O
found	O
on	O
the	O
plates	O
.	O

Details	O
on	O
these	O
findings	O
are	O
included	O
in	O
the	O
report	O
.	O

Histopathological	O
examinations	O
of	O
post-mortem	O
lung	O
samples	O
show	O
diffuse	O
alveolar	O
damage	O
with	O
.	O

This	O
modification	O
inhibits	O
transcription	O
.	O

A	O
study	O
conducted	O
by	O
He	S-Person
et	O
al.	O
(2011)	O
used	O
a	O
mechanistic	O
modeling	O
approach	O
to	O
study	O
the	O
three	O
waves	O
of	O
.	O
They	O
examined	O
the	O
factors	O
that	O
underlie	O
variability	O
in	O
temporal	O
patterns	O
and	O
their	O
correlation	O
to	O
patterns	O
of	O
mortality	O
and	O
morbidity	O
.	O

The	O
role	O
of	O
non-governmental	O
organisations	O
and	O
other	O
interested	O
observers	O
-	O
civil	O
society	O
-	O
has	O
long	O
been	O
neglected	O
by	O
governments	O
in	O
the	O
quest	O
for	O
a	O
world	O
secure	O
from	O
the	O
threat	O
of	O
biological	O
weapons	O
or	O
bioterrorism	O
.	O

But	O
that	O
request	O
appears	O
to	O
come	O
at	O
the	O
expense	O
of	O
other	O
global	O
health	O
security	O
initiatives	O
,	O
Kates	S-Person
said	O
,	O
in	O
this	O
case	O
global	O
HIV	S-Pathogen
-related	O
funding	O
,	O
which	O
seems	O
to	O
go	O
down	O
about	O
the	O
same	O
amount	O
as	O
funding	O
increases	O
.	O

Literature	O
search	O
was	O
conducted	O
by	O
NA	S-Person
and	O
AH	S-Person
,	O
and	O
was	O
reviewed	O
and	O
analyzed	O
by	O
EK	S-Person
,	O
JC	S-Person
,	O
AE-G	S-Person
,	O
KT	S-Person
,	O
and	O
MC	S-Person
.	O
The	O
survey	O
software	O
was	O
developed	O
by	O
HG	S-Person
.	O
analyzed	O
survey	O
results	O
and	O
overall	O
developed	O
the	O
manuscript	O
.	O

Fleeing	O
merchants	O
unwittingly	O
carried	O
it	O
back	O
to	O
Italy	S-Location
.	O
From	O
there	O
,	O
it	O
spread	O
to	O
France	S-Location
,	O
Spain	S-Location
and	O
England	S-Location
.	O
Then	O
up	O
as	O
far	O
as	O
Norway	S-Location
and	O
across	O
the	O
rest	O
of	O
Europe	S-Location
–	O
all	O
the	O
way	O
to	O
Moscow	S-Location
.	O
Within	O
six	O
years	O
,	O
the	O
had	O
taken	O
the	O
continent	O
.	O

It	O
is	O
now	O
known	O
that	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
can	O
be	O
transmitted	O
sexually	O
.	O

Five	O
years	O
later	O
,	O
a	O
convention	B-Document
for	I-Document
the	I-Document
plague	E-Document
was	O
signed	O
.	O

On	O
18	O
January	O
,	O
the	O
African	B-Location
Union	E-Location
indicated	O
that	O
presidential	O
election	O
results	O
announcements	O
should	O
be	O
suspended	O
in	O
the	O
DRC	S-Location
,	O
and	O
have	O
furthermore	O
decided	O
not	O
to	O
travel	O
to	O
the	O
.	O

SM	S-Platform
offers	O
state-of-the-art	O
features	O
in	O
both	O
survey	O
design	O
and	O
delivery	O
capabilities	O
.	O

Glenn	B-Person
Cross	E-Person
.	O
Dirty	O
War:	O
Rhodesia	O
and	O
Chemical	O
Biological	O
Warfare	O
,	O
1975	O
to	O
1980.	O
:	O
Helion	O
&amp	O
;	O
Company	O
(2017)	O
.	O

Officials	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
say	O
the	O
current	O
lab	O
building	O
in	O
Atlanta	S-Location
is	O
quickly	O
wearing	O
down	O
,	O
and	O
cannot	O
be	O
upgraded	O
without	O
shutting	O
down	O
the	O
facility	O
for	O
years	O
.	O

The	O
launched	O
an	O
investigation	O
but	O
concluded	O
that	O
the	O
outbreak	O
was	O
natural	O
.	O

The	O
CDC	S-Organization
's	O
website	O
has	O
information	O
on	O
various	O
infectious	O
(and	O
noninfectious)	O
diseases	O
,	O
including	O
smallpox	S-Disease
,	O
,	O
and	O
others	O
.	O

Margaret	B-Person
Chan	E-Person
and	O
in	O
Pro-Med	S-Organization
comments	O
on	O
numerous	O
briefings	O
.	O

You	O
may	O
ask	O
your	O
question	O
.	O

Coronary	B-Technology
CT	I-Technology
angiography	E-Technology
(	O
CTA	S-Technology
):	O
the	O
use	O
of	O
CT	S-Equipment
to	O
assess	O
the	O
coronary	O
arteries	O
of	O
the	O
heart	O
.	O

Ebright	S-Person
is	O
also	O
disappointed	O
that	O
oversight	O
of	O
select	O
agents	O
will	O
remain	O
with	O
the	O
CDC	S-Organization
and	O
rather	O
than	O
an	O
independent	O
federal	O
agency	O
that	O
does	O
not	O
perform	O
select	O
agent	O
work	O
.	O

The	O
key	O
elements	O
of	O
this	O
system	O
are	O
administrative	O
procedure	O
,	O
risk	O
assessment	O
,	O
enforcement	O
,	O
and	O
public	O
participation	O
and	O
information	O
.	O

On	O
3	O
June	O
2014	O
,	O
Saudi	B-Organization
Arabia	E-Organization
revised	O
the	O
country's	O
total	O
cases	O
of	O
MERS	S-Disease
to	O
date	O
to	O
688	O
cases	O
after	O
re-examining	O
the	O
data	O
as	O
part	O
of	O
an	O
effort	O
to	O
better	O
understand	O
the	O
disease	O
.	O

It	O
is	O
anticipated	O
that	O
given	O
how	O
little	O
is	O
known	O
about	O
human	O
biology	O
that	O
no	O
applications	O
of	O
this	O
work	O
will	O
or	O
should	O
be	O
attempted	O
in	O
humans	O
.	O

Ecotropic	O
defective	O
MulV	S-Pathogen
vector	O
expressing	O
the	O
LacZ	O
gene	O
(β‐Galactozidase)	O
was	O
produced	O
from	O
NIH3T3	O
Packaging	O
cells	O
5	O
.	O

Moreover	O
,	O
in	O
many	O
cases	O
there	O
are	O
no	O
commercial	O
or	O
standardized	O
methods	O
for	O
analyzing	O
such	O
agents	O
.	O

The	O
second	O
patient	O
was	O
a	O
49-year-old	O
Qatari	O
man	O
who	O
had	O
visited	O
Saudi	B-Location
Arabia	E-Location
before	O
falling	O
ill	O
.	O

The	O
Wuhan	B-Organization
Municipal	I-Organization
Health	I-Organization
Commission	E-Organization
made	O
the	O
first	O
public	O
announcement	O
of	O
a	O
of	O
unknown	O
cause	O
on	O
31	O
December	O
,	O
confirming	O
27	O
cases-enough	O
to	O
trigger	O
an	O
investigation	O
.	O

Mona	B-Person
Siddiqui	E-Person
,	O
a	O
small	O
team	O
of	O
HHS	S-Organization
staff	O
interviewed	O
agency	O
leadership	O
and	O
staff	O
from	O
eleven	O
HHS	S-Organization
agencies	O
,	O
including	O
at	O
the	O
NIH	S-Organization
,	O
CDC	S-Organization
,	O
FDA	S-Organization
,	O
CMS	S-Organization
,	O
and	O
,	O
about	O
the	O
challenges	O
and	O
opportunities	O
in	O
sharing	O
data	O
between	O
agencies	O
.	O

The	O
countries	O
most	O
strongly	O
affected	O
were	O
Guinea	S-Location
,	O
Liberia	S-Location
,	O
and	O
Sierra	B-Location
Leone	E-Location
,	O
accounting	O
for	O
99	O
%	O
of	O
EVD	S-Disease
cases	O
worldwide	O
.	O

According	O
to	O
a	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
(	O
ECDC	S-Organization
)	O
publication	O
,	O
on	O
April	O
2014	O
,	O
had	O
a	O
total	O
of	O
3	O
cases	O
with	O
1	O
fatality	O
.	O

Everything	O
we	O
know	O
today	O
suggests	O
there	O
was	O
no	O
human	O
exposure	O
.	O

When	O
Europeans	O
reached	O
the	O
Americas	S-Location
in	O
1492	O
,	O
the	O
two	O
populations	O
exposed	O
each	O
other	O
to	O
completely	O
novel	O
diseases	O
.	O

In	O
April	O
2012	O
,	O
six	O
hospital	O
workers	O
were	O
diagnosed	O
with	O
acute	B-Disease
respiratory	I-Disease
failure	E-Disease
of	O
unknown	O
origin	O
.	O

Cases	O
dwindled	O
to	O
zero	O
by	O
17	O
February	O
2020	O
,	O
but	O
after	O
52	O
days	O
without	O
a	O
case	O
,	O
surveillance	O
and	O
response	O
teams	O
on	O
the	O
ground	O
confirmed	O
three	O
new	O
cases	O
of	O
Ebola	S-Disease
in	O
health	O
zone	O
in	O
mid-April	O
.	O

In	O
January	O
1919	O
a	O
third	O
wave	O
of	O
the	O
Spanish	B-Disease
Flu	E-Disease
hit	O
Australia	S-Location
,	O
then	O
spread	O
quickly	O
through	O
Europe	S-Location
and	O
the	O
United	B-Location
States	E-Location
,	O
where	O
it	O
lingered	O
through	O
the	O
Spring	O
and	O
until	O
June	O
1919	O
.	O

The	O
Working	B-Organization
Group	E-Organization
is	O
administered	O
by	O
HHS	S-Organization
.	O
Its	O
14	O
members	O
represent	O
a	O
variety	O
of	O
stakeholders	O
,	O
including	O
providers	O
,	O
scientists	O
and	O
researchers	O
,	O
patients	O
and	O
family	O
members	O
,	O
patient	O
advocates	O
and	O
federal	O
members	O
.	O

As	O
the	O
saying	O
goes	O
,	O
knowledge	O
is	O
power	O
,	O
and	O
the	O
misuse	O
of	O
DNA	O
information	O
could	O
have	O
dire	O
consequences	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
the	O
second	O
disaster	O
affecting	O
Europe	S-Location
during	O
the	O
Late	O
Middle	O
Ages	O
(the	O
first	O
one	O
being	O
the	O
Great	O
Famine)	O
and	O
is	O
estimated	O
to	O
have	O
killed	O
30%	O
to	O
60%	O
of	O
Europe	S-Location
's	O
population	O
.	O

Large	O
next-generation	O
sequencing	O
data	O
are	O
currently	O
managed	O
in	O
openBIS	S-Platform
and	O
MIMAS	S-Platform
.	O
provides	O
an	O
archiving	O
solution	O
for	O
large	O
data	O
.	O

Did	O
we	O
have	O
a	O
question	O
in	O
the	O
room?	O

The	O
WHO	S-Organization
officially	O
commended	O
the	O
Senegalese	B-Organization
government	E-Organization
,	O
and	O
in	O
particular	O
the	O
President	B-Person
Macky	I-Person
Sall	E-Person
and	O
the	O
Minister	O
of	O
Health	O
,	O
Dr	O
Awa	B-Person
Coll-Seck	E-Person
,	O
for	O
their	O
response	O
in	O
quickly	O
isolating	O
the	O
patient	O
and	O
tracing	O
and	O
following	O
up	O
74	O
contacts	O
,	O
as	O
well	O
as	O
for	O
their	O
public	O
awareness	O
campaign	O
.	O

The	O
efficiency	O
of	O
Cas9-endonuclease	O
and	O
the	O
ease	O
by	O
which	O
genes	O
can	O
be	O
targeted	O
led	O
to	O
the	O
development	O
of	O
CRISPR-knockout	B-Platform
(KO)	I-Platform
libraries	E-Platform
both	O
for	O
mouse	O
and	O
human	O
cells	O
,	O
which	O
can	O
cover	O
either	O
specific	O
gene	O
sets	O
of	O
interest	O
or	O
the	O
whole-genome	O
.	O

And	O
in	O
terms	O
of	O
the	O
gain	O
of	O
function	O
studies	O
,	O
I	O
think	O
whatever	O
you	O
think	O
about	O
gain	O
of	O
function	O
studies	O
and	O
dual	O
use	O
research	O
of	O
concern	O
;	O
I	O
think	O
it's	O
clearly	O
the	O
case	O
that	O
these	O
incidents	O
indicate	O
that	O
we	O
need	O
to	O
really	O
ensure	O
that	O
whatever	O
work	O
is	O
done	O
needs	O
to	O
be	O
done	O
safely	O
and	O
securely	O
.	O

By	O
mid-May	O
reports	O
of	O
new	O
cases	O
began	O
to	O
level	O
off	O
and	O
most	O
states	O
began	O
to	O
open	O
restaurants	O
and	O
other	O
places	O
of	O
business	O
,	O
placing	O
limits	O
to	O
the	O
numbers	O
of	O
people	O
allowed	O
in	O
the	O
establishment	O
at	O
the	O
same	O
time	O
.	O

Health	O
workers	O
change	O
garments	O
frequently	O
,	O
discarding	O
gear	O
that	O
has	O
barely	O
been	O
used	O
.	O

Additional	O
analysis	O
and	O
visualization	O
functionality	O
with	O
respect	O
to	O
different	O
'omics'	O
can	O
be	O
a	O
useful	O
option	O
and	O
is	O
adequately	O
realized	O
by	O
BASE	S-Platform
for	O
transcriptomics/microarrays	O
and	O
XperimentR	S-Platform
bundling	O
BASE	S-Platform
,	O
Metabolomixed	O
and	O
for	O
transcriptomics	O
,	O
metabolomics	O
and	O
proteomics	O
.	O

Initial	O
genetic	O
testing	O
of	O
patient	O
samples	O
on	O
27	O
December	O
2019	O
indicated	O
the	O
presence	O
of	O
a	O
SARS	S-Disease
-like	O
coronavirus	O
.	O

It	O
had	O
a	O
group	O
of	O
genes	O
that	O
resembled	O
genes	O
,	O
but	O
with	O
important	O
differences	O
.	O

This	O
test	O
uses	O
real-time	O
which	O
detects	O
presence	O
of	O
viral	O
RNA	O
fragments	O
.	O

The	O
Occupational	B-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Administration	E-Organization
(OSHA)	O
regulations	O
in	O
.	O

The	O
influenza	B-Incident
pandemic	I-Incident
of	I-Incident
1918-1919	E-Incident
killed	O
more	O
people	O
than	O
the	O
Great	B-Incident
War	E-Incident
,	O
known	O
today	O
as	O
World	B-Incident
War	I-Incident
I	E-Incident
(	O
WWI	S-Incident
)	O
,	O
at	O
somewhere	O
between	O
20	O
and	O
40	O
million	O
people	O
.	O

Last	O
month	O
,	O
five	O
nuclear	O
engineers	O
and	O
two	O
military	O
personnel	O
died	O
when	O
an	O
"	O
isotope-fuel"	O
engine	O
blew	O
up	O
at	O
the	O
Nyonoksa	S-Location
naval	O
test	O
range	O
,	O
in	O
.	O
There	O
was	O
a	O
low-level	O
release	O
of	O
radiation	O
,	O
officials	O
said	O
.	O

Retrieved	O
22	O
January	O
2020	O
and	O
a	O
teacher	O
at	O
Shenzhen	B-Organization
Polytechnic	E-Organization
,	O
he	O
had	O
been	O
sick	O
for	O
approximately	O
one	O
month	O
before	O
his	O
death	O
,	O
but	O
he	O
was	O
originally	O
diagnosed	O
with	O
pneumonia	S-Disease
.Reported	O
on	O
CBS	S-Organization
's	O
The	O
Early	O
Show	O
Tatiana	B-Person
Morales	E-Person
:	O
American	O
Family	O
Affected	O
By	O
SARS	S-Disease
11	O
April	O
2003	O
,	O
CBS	B-Organization
News	E-Organization
.	O
Retrieved	O
22	O
January	O
2020	O
His	O
son	O
Michael	B-Person
"	O
Mickey"	I-Person
Salisbury	E-Person
was	O
with	O
him	O
in	O
China	S-Location
and	O
also	O
contracted	O
the	O
disease	O
,	O
but	O
he	O
survived	O
it	O
.	O

The	O
majority	O
of	O
deaths	O
were	O
from	O
bacterial	O
pneumonia	S-Disease
,	O
a	O
common	O
secondary	O
infection	O
associated	O
with	O
influenza	S-Disease
.	O
The	O
virus	O
also	O
killed	O
people	O
directly	O
by	O
causing	O
massive	O
hemorrhages	S-Phenotype
and	O
in	O
the	O
lungs	O
.	O

In	O
March	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organisation	E-Organization
initiated	O
the	O
"	O
"	O
to	O
assess	O
the	O
treatment	O
effects	O
of	O
four	O
existing	O
antiviral	O
compounds	O
with	O
the	O
most	O
promise	O
of	O
efficacy	O
.	O

In	O
Europe	S-Location
where	O
more	O
gadolinium-containing	O
agents	O
are	O
available	O
,	O
a	O
classification	O
of	O
agents	O
according	O
to	O
potential	O
risks	O
has	O
been	O
released	O
.	O

The	O
risk	O
group	O
of	O
each	O
micro-organisms	O
are	O
based	O
on	O
the	O
pathogenicity	O
mechanisms	O
,	O
host	O
range	O
,	O
epidemiological	O
criteria	O
,	O
and	O
availability	O
of	O
an	O
effective	O
therapy	O
.	O

Dutschke	S-Person
was	O
out	O
on	O
$25,000	O
bail	O
for	O
unrelated	O
state	O
criminal	O
charges	O
of	O
April	O
1	O
,	O
2013	O
.	O

There	O
were	O
only	O
two	O
incinerators	S-Equipment
the	O
first	O
one	O
of	O
them	O
belonging	O
to	O
government	O
laboratory	O
and	O
the	O
second	O
is	O
a	O
private	O
laboratory	O
.	O

Although	O
the	O
KGB	S-Organization
had	O
confiscated	O
hospital	O
and	O
other	O
records	O
after	O
the	O
incident	O
,	O
the	O
Western	O
scientists	O
were	O
able	O
to	O
track	O
where	O
all	O
the	O
victims	O
had	O
been	O
at	O
the	O
time	O
of	O
the	O
anthrax	S-Pathogen
release	O
.	O

Multinuclear	B-Technology
imaging	E-Technology
holds	O
the	O
potential	O
to	O
chart	O
the	O
distribution	O
of	O
lithium	O
in	O
the	O
human	O
brain	O
,	O
this	O
element	O
finding	O
use	O
as	O
an	O
important	O
drug	O
for	O
those	O
with	O
conditions	O
such	O
as	O
.	O

For	O
areas	O
where	O
commercial	O
hand	O
sanitisers	O
are	O
not	O
readily	O
available	O
,	O
the	O
WHO	S-Organization
provides	O
two	O
formulations	O
for	O
local	O
production	O
.	O

Furthermore	O
,	O
there	O
is	O
no	O
provision	O
to	O
establish	O
an	O
independent	O
national	O
biosafety	O
decision-making	O
body(ies)	O
.	O

"	O
But	O
as	O
we	O
consider	O
this	O
legislation	O
,	O
we	O
must	O
remember	O
that	O
there	O
is	O
more	O
to	O
be	O
done	O
to	O
bolster	O
America	S-Organization
public	O
health	O
security,	O
"	O
Rep.	O
said	O
.	O

The	O
percentage	O
who	O
received	O
CT	S-Equipment
,	O
however	O
,	O
varied	O
markedly	O
by	O
the	O
emergency	O
physician	O
who	O
saw	O
them	O
from	O
1.8%	O
to	O
25%	O
.	O

On	O
5	O
April	O
2016	O
,	O
it	O
was	O
reported	O
via	O
the	O
media	O
,	O
that	O
there	O
had	O
been	O
9	O
new	O
cases	O
of	O
Ebola	S-Disease
since	O
the	O
virus	O
resurfaced	O
,	O
out	O
of	O
which	O
8	O
were	O
fatal	O
;	O
on	O
1	O
June	O
,	O
after	O
the	O
stipulated	O
waiting	O
period	O
,	O
the	O
WHO	S-Organization
again	O
declared	O
Guinea	S-Location
-free	O
,	O
after	O
which	O
the	O
country	O
entered	O
a	O
90-day	O
period	O
of	O
heightened	O
surveillance	O
that	O
was	O
concluded	O
on	O
30	O
August	O
2016	O
.	O

Except	O
in	O
extraordinary	O
circumstances	O
(e.g.	O
,	O
suspected	O
hemorrhagic	B-Disease
fever	E-Disease
the	O
initial	O
processing	O
of	O
clinical	O
specimens	O
and	O
serological	O
identification	O
of	O
isolates	O
can	O
be	O
done	O
safely	O
at	O
Biosafety	B-Platform
Level	I-Platform
2	E-Platform
(see	O
above)	O
,	O
the	O
recommended	O
level	O
for	O
work	O
with	O
blood‐borne	O
pathogens	O
such	O
as	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
and	O
HIV	S-Pathogen
.	O
The	O
containment	O
elements	O
described	O
in	O
BSL‐2	S-Platform
are	O
consistent	O
with	O
the	O
OSHA	S-Organization
standard	O
,	O
Occupational	B-Document
Exposure	I-Document
to	I-Document
Bloodborne	I-Document
Pathogens	E-Document
(	O
Richmond	S-Location
,	O
1994)	O
from	O
the	O
Occupational	B-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Administration	E-Organization
(	O
OSHA	S-Organization
;	O
see	O
Internet	O
Resources)	O
.	O

The	O
CDC	S-Organization
programs	O
address	O
more	O
than	O
400	O
diseases	O
,	O
health	O
threats	O
,	O
and	O
conditions	O
that	O
are	O
major	O
causes	O
of	O
death	O
,	O
disease	O
,	O
and	O
disability	O
.	O

Print	O
.	O

The	O
clandestine	O
CIA	S-Organization
-Battelle	O
operation	O
was	O
omitted	O
from	O
the	O
US	B-Document
Biological	I-Document
Weapons	I-Document
Convention	I-Document
declarations	E-Document
submitted	O
to	O
the	O
.	O

The	O
lab	O
adjoined	O
an	O
insectary	O
where	O
genetically	O
modified	O
mosquitoes	O
were	O
being	O
used	O
in	O
a	O
dengue	B-Pathogen
virus	E-Pathogen
experiment	O
,	O
according	O
to	O
an	O
incident	O
report	O
the	O
university	O
filed	O
with	O
the	O
.	O

As	O
shown	O
in	O
Fig.	O
1	O
,	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
mainly	O
consists	O
of	O
a	O
BSL-3	S-Platform
laboratory	O
with	O
negative	O
pressure	O
,	O
a	O
BSL-2	S-Platform
laboratory	O
,	O
a	O
PCR	S-Equipment
preparation	O
room	O
,	O
a	O
storage	O
room	O
and	O
two	O
sets	O
of	O
dressing	O
rooms	O
(including	O
two	O
1st	O
changing	O
rooms	O
,	O
two	O
shower	O
rooms	O
and	O
one	O
2nd	O
changing	O
room)	O
.	O

During	O
a	O
congressional	O
hearing	O
last	O
week	O
,	O
lawmakers	O
expressed	O
concern	O
that	O
a	O
change	O
could	O
risk	O
the	O
government's	O
ability	O
to	O
deliver	O
lifesaving	O
medical	O
supplies	O
to	O
what	O
public	O
health	O
officials	O
call	O
"	O
the	O
last	O
mile	O
"	O
-	O
to	O
people	O
in	O
need	O
during	O
a	O
disaster	O
.	O

Significant	O
quantities	O
of	O
these	O
nucleic	O
acid	O
"	O
blueprints"	O
can	O
be	O
rapidly	O
manufactured	O
compared	O
to	O
existing	O
antibody	O
production	O
methods	O
.	O

"	O
Chemical	O
and	O
Biological	O
Weapons:	O
Possession	O
and	O
Programs	O
Past	O
and	O
Present"	O
,	O
James	B-Organization
Martin	I-Organization
Center	I-Organization
for	I-Organization
Nonproliferation	I-Organization
Studies	E-Organization
Middlebury	O
College	O
,	O
April	O
9	O
,	O
2002	O
.	O

Kar	S-Person
said	O
that	O
until	O
the	O
actually	O
defines	O
appropriately	O
targeted	O
duration	O
of	O
use	O
for	O
these	O
drugs	O
(the	O
plan	O
says	O
that	O
won't	O
happen	O
until	O
2022	O
to	O
2023)	O
,	O
it's	O
hard	O
to	O
say	O
whether	O
the	O
agency	O
is	O
adequately	O
addressing	O
the	O
issue	O
.	O

By	O
24	O
April	O
,	O
889,309	O
cases	O
had	O
been	O
confirmed	O
and	O
50,256	O
people	O
had	O
died	O
.	O

Students	O
learn	O
different	O
methods	O
for	O
counting	O
the	O
number	O
of	O
infective	O
units	O
per	O
milliliter	O
for	O
different	O
types	O
of	O
viruses	O
and	O
differentiate	O
between	O
infective	O
and	O
noninfective	O
viruses	O
before	O
choosing	O
the	O
appropriate	O
counting	O
method	O
.	O

The	O
United	B-Organization
States	I-Organization
Army	I-Organization
Chemical	I-Organization
Corps	E-Organization
then	O
initiated	O
a	O
crash	O
program	O
to	O
weaponize	O
anthrax	S-Pathogen
(N)	O
in	O
the	O
E61	O
1/2-lb	O
hour-glass	O
bomblet	O
.	O

The	O
development	O
and	O
spread	O
of	O
antibiotic	O
resistance	O
in	O
bacteria	O
is	O
a	O
universal	O
threat	O
to	O
both	O
humans	O
and	O
animals	O
that	O
is	O
generally	O
not	O
preventable	O
,	O
but	O
can	O
nevertheless	O
be	O
controlled	O
and	O
must	O
be	O
tackled	O
in	O
the	O
most	O
effective	O
ways	O
possible	O
.	O

Over	O
8,000	O
people	O
from	O
29	O
different	O
countries	O
and	O
territories	O
were	O
infected	O
,	O
and	O
at	O
least	O
774	O
died	O
worldwide	O
.	O

For	O
instance	O
,	O
in	O
Europe	S-Location
in	O
2007	O
,	O
the	O
number	O
of	O
infections	O
by	O
multidrug-resistant	O
bacteria	O
was	O
400,000	O
with	O
25,000	O
attributable	O
deaths	O
.	O

Four	O
days	O
later	O
,	O
on	O
4	O
June	O
2014	O
,	O
the	O
Ministry	B-Organization
of	I-Organization
Health	E-Organization
reported	O
that	O
3	O
more	O
people	O
including	O
a	O
doctor	O
and	O
a	O
nurse	O
who	O
came	O
in	O
contact	O
with	O
the	O
deceased	O
patient	O
were	O
suspected	O
to	O
have	O
contracted	O
the	O
disease	O
.	O

Authorities	O
have	O
not	O
determined	O
the	O
source	O
of	O
the	O
infection	O
,	O
said	O
Hong	B-Location
Kong	E-Location
Chief	O
Executive	O
Donald	B-Person
Tsang	E-Person
.	O
This	O
makes	O
it	O
the	O
first	O
cluster	O
of	O
cases	O
in	O
the	O
city	O
without	O
a	O
link	O
to	O
someone	O
who	O
had	O
traveled	O
overseas	O
.	O

In	O
the	O
United	O
Kingdom	O
the	O
preoccupation	O
was	O
mainly	O
in	O
withstanding	O
the	O
anticipated	O
conventional	O
bombing	O
attacks	O
that	O
would	O
be	O
unleashed	O
in	O
the	O
event	O
of	O
war	O
with	O
Germany	O
.	O

Policymakers	O
and	O
industry	O
can	O
help	O
tackle	O
resistance	O
by:	O
fostering	O
innovation	O
and	O
research	O
and	O
development	O
of	O
new	O
tools	O
;	O
and	O
promoting	O
cooperation	O
and	O
information	O
sharing	O
among	O
all	O
stakeholders	O
.	O

"	O
Contrary	O
to	O
popular	O
myth	O
--	O
probably	O
from	O
the	O
film	O
'Outbreak'	O
--	O
Ebola	S-Pathogen
is	O
not	O
airborne	O
,	O
and	O
relies	O
on	O
transmission	O
through	O
the	O
consumption	O
of	O
contaminated	O
meat	O
and	O
direct	O
contact	O
with	O
infected	O
bodily	O
fluid,	O
"	O
said	O
.	O

Although	O
the	O
Federal	B-Organization
Government	E-Organization
EPA	O
&aDOT	O
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

It	O
can	O
also	O
occur	O
when	O
the	O
power	O
supplied	O
to	O
the	O
X-ray	B-Equipment
tube	E-Equipment
is	O
insufficient	O
to	O
penetrate	O
the	O
anatomy	O
.	O

UN	O
officials	O
working	O
on	O
the	O
ground	O
also	O
criticised	O
the	O
travel	O
restrictions	O
,	O
saying	O
the	O
solution	O
was	O
"	O
not	O
in	O
travel	O
restrictions	O
but	O
in	O
ensuring	O
that	O
effective	O
preventive	O
and	O
curative	O
health	O
measures	O
are	O
put	O
in	O
place".	O
also	O
spoke	O
out	O
against	O
the	O
closure	O
of	O
international	O
borders	O
,	O
calling	O
them	O
"	O
another	O
layer	O
of	O
collective	O
irresponsibility	O
"	O
and	O
added:	O
"	O
The	O
international	O
community	O
must	O
ensure	O
that	O
those	O
who	O
try	O
to	O
contain	O
the	O
outbreak	O
can	O
enter	O
and	O
leave	O
the	O
affected	O
countries	O
if	O
need	O
be.	O
"	O

While	O
genome	B-Technology
editing	E-Technology
in	O
eukaryotic	O
cells	O
has	O
been	O
possible	O
using	O
various	O
methods	O
since	O
the	O
1980s	O
,	O
the	O
methods	O
employed	O
had	O
proved	O
to	O
be	O
inefficient	O
and	O
impractical	O
to	O
implement	O
on	O
a	O
large	O
scale	O
.	O

Tom	B-Person
Frieden	E-Person
in	O
early	O
July	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
declared	O
a	O
public	O
health	O
emergency	O
of	O
international	O
concern	O
(PHEIC)	O
on	O
30	O
January	O
2020	O
and	O
a	O
pandemic	O
on	O
11	O
March	O
2020	O
.	O

One	O
of	O
the	O
primary	O
reasons	O
for	O
the	O
spread	O
of	O
the	O
disease	O
is	O
the	O
low-quality	O
,	O
functioning	O
health	O
systems	O
in	O
the	O
parts	O
of	O
Africa	S-Location
where	O
the	O
disease	O
occurs	O
.	O

Clearly	O
their	O
study	O
was	O
not	O
based	O
on	O
any	O
local	O
Chinese	O
statistical	O
data	O
.	O

MERS-CoV	S-Pathogen
is	O
one	O
of	O
the	O
viruses	O
that	O
have	O
been	O
engineered	O
by	O
the	O
US	S-Location
and	O
studied	O
by	O
the	O
Pentagon	S-Organization
,	O
as	O
well	O
as	O
Influenza	S-Disease
and	O
SARS	S-Disease
.	O
Confirmation	O
of	O
this	O
practice	O
is	O
Obama	S-Person
's	O
2014	O
temporary	O
ban	O
on	O
government	O
funding	O
for	O
such	O
"	O
dual-use"	O
research	O
.	O

By	O
11 March	O
1918	O
,	O
the	O
virus	O
had	O
reached	O
Queens	S-Location
,	O
.	O
Failure	O
to	O
take	O
preventive	O
measures	O
in	O
March/April	O
was	O
later	O
criticised	O
.	O

However	O
,	O
at	O
a	O
congressional	O
hearing	O
on	O
19	O
November	O
,	O
the	O
Director	O
of	O
the	O
CDC	S-Organization
said	O
that	O
the	O
number	O
of	O
cases	O
was	O
no	O
longer	O
expected	O
to	O
exceed	O
1	O
million	O
,	O
moving	O
away	O
from	O
the	O
worst-case	O
scenario	O
that	O
had	O
been	O
previously	O
predicted	O
.	O

How	O
we	O
train	O
staff	O
and	O
how	O
we	O
make	O
sure	O
that	O
new	O
staff	O
are	O
trained	O
,	O
that	O
people	O
learn	O
from	O
past	O
incidents	O
and	O
that	O
procedures	O
are	O
in	O
place	O
that	O
are	O
clear	O
,	O
understandable	O
,	O
easy	O
to	O
follow	O
and	O
that	O
training	O
is	O
then	O
assessed	O
and	O
repeated	O
as	O
necessary	O
.	O

The	O
characteristic	O
"	O
threadlike"	O
structure	O
is	O
,	O
however	O
,	O
a	O
more	O
general	O
morphologic	O
characteristic	O
of	O
filoviruses	O
(alongside	O
their	O
GP-decorated	O
viral	O
envelope	O
,	O
RNA	O
nucleocapsid	O
,	O
etc.	O
)	O
.	O

As	O
a	O
founding	O
director	O
of	O
the	O
nation's	O
first	O
bioterrorism	O
preparedness	O
program	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
in	O
1999	O
,	O
Dr	O
.	O

Frieden	S-Person
.	O
I'm	O
just	O
curious	O
what	O
kind	O
of	O
impact	O
the	O
moratorium	O
will	O
have	O
on	O
the	O
work	O
that	O
you're	O
doing	O
,	O
number	O
one	O
.	O

Who	O
would	O
administer	O
it?	O
Who	O
would	O
pay	O
for	O
it?	O
Who	O
would	O
manufacture	O
it?	O
The	O
cost	O
of	O
complications	O
that	O
may	O
occur	O
.	O

Considerable	O
research	O
into	O
BW	O
was	O
undertaken	O
throughout	O
the	O
Cold	S-Phenotype
War	O
era	O
by	O
the	O
US	S-Location
,	O
UK	S-Location
and	O
,	O
and	O
probably	O
other	O
major	O
nations	O
as	O
well	O
,	O
although	O
it	O
is	O
generally	O
believed	O
that	O
such	O
weapons	O
were	O
never	O
used	O
.	O

According	O
to	O
the	O
rules	O
for	O
taxon	O
naming	O
established	O
by	O
the	O
International	B-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
(	O
ICTV	S-Organization
)	O
,	O
the	O
name	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
is	O
always	O
to	O
be	O
capitalized	O
,	O
italicized	O
,	O
and	O
to	O
be	O
preceded	O
by	O
the	O
word	O
"	O
species".	O
The	O
names	O
of	O
its	O
members	O
()	O
are	O
to	O
be	O
capitalized	O
,	O
are	O
not	O
italicized	O
,	O
and	O
used	O
without	O
articles	O
.	O

In	O
September	O
and	O
October	O
1984	O
,	O
they	O
contaminated	O
the	O
salad	O
bars	O
of	O
10	O
local	O
restaurants	O
with	O
,	O
infecting	O
751 people	O
.	O

In	O
an	O
interview	O
with	O
Homeland	O
Preparedness	O
News	O
,	O
Bob	B-Person
Stallman	E-Person
,	O
assistant	O
director	O
at	O
the	O
,	O
said	O
,	O
"	O
We're	O
constantly	O
seeing	O
what's	O
happening	O
around	O
the	O
world	O
and	O
we	O
tailor	O
our	O
training	O
courses	O
and	O
events	O
for	O
those	O
types	O
of	O
real-world	O
events.	O
"	O

Palestine	S-Organization
is	O
an	O
observer	O
as	O
a	O
"	O
national	O
liberation	O
movement	O
"	O
recognized	O
by	O
the	O
League	B-Organization
of	I-Organization
Arab	I-Organization
States	E-Organization
under	O
United	B-Organization
Nations	E-Organization
Resolution	O
3118	O
.	O

The	O
WHO	S-Organization
estimates	O
that	O
12.	O
6 million	O
people	O
died	O
as	O
a	O
result	O
of	O
living	O
or	O
working	O
in	O
an	O
unhealthy	O
environment	O
in	O
2012	O
–	O
this	O
accounts	O
for	O
nearly	O
1	O
in	O
4	O
of	O
total	O
global	O
deaths	O
.	O

Compared	O
to	O
the	O
lowest	O
dose	O
x-ray	B-Technology
techniques	E-Technology
,	O
CT	B-Technology
scans	E-Technology
can	O
have	O
100	O
to	O
1,000	O
times	O
higher	O
dose	O
than	O
conventional	O
X-rays	O
.	O

Caruba	S-Person
,	O
.	O
"	O
A	O
New	O
Terrorism	O
Comes	O
of	O
Age"	O
,	O
Conservative	O
Monitor	O
,	O
May	O
2001	O
,	O
accessed	O
February	O
23	O
,	O
2012	O
.	O

There	O
were	O
many	O
attacks	O
against	O
Jewish	O
communities	O
.	O

The	O
definitions	O
of	O
the	O
four	O
Risk	O
Groups	O
are	O
given	O
in	O
the	O
NIH	S-Organization
Guidelines	O
on	O
Recombinant	O
DNA	O
and	O
Gene	O
Transfer	O
,	O
Section	O
II-A-1	O
.	O

Hence	O
,	O
the	O
left	O
side	O
of	O
the	O
image	O
is	O
to	O
the	O
patient's	O
right	O
and	O
vice	O
versa	O
,	O
while	O
anterior	O
in	O
the	O
image	O
also	O
is	O
the	O
patient's	O
anterior	O
and	O
vice	O
versa	O
.	O

The	O
CDC	S-Organization
implemented	O
their	O
National	B-Document
Action	I-Document
Plan	I-Document
for	I-Document
Combating	I-Document
Antibiotic	I-Document
Resistant	I-Document
Bacteria	E-Document
as	O
a	O
measure	O
against	O
the	O
spread	O
of	O
antibiotic	O
resistance	O
in	O
the	O
United	B-Location
States	E-Location
.	O
This	O
initiative	O
has	O
a	O
budget	O
of	O
$161million	O
and	O
includes	O
the	O
development	O
of	O
the	O
.	O

The	O
Soviet	S-Organization
BW	O
effort	O
became	O
a	O
huge	O
program	O
,	O
comprising	O
various	O
institutions	O
under	O
different	O
ministries	O
along	O
with	O
commercial	O
facilities	O
and	O
collectively	O
known	O
as	O
Biopreparat	S-Organization
after	O
1973	O
.	O

Zelicoff	S-Person
said	O
,	O
were	O
all	O
unvaccinated	O
and	O
developed	O
the	O
disease's	O
rare	O
hemorrhagic	S-Phenotype
form	O
.	O

A	O
growing	O
number	O
of	O
infections	O
–	O
such	O
as	O
pneumonia	S-Disease
tuberculosis	S-Disease
,	O
gonorrhoea	S-Disease
,	O
and	O
–	O
are	O
becoming	O
harder	O
to	O
treat	O
as	O
the	O
antibiotics	O
used	O
to	O
treat	O
them	O
become	O
less	O
effective	O
.	O

The	O
book	O
received	O
mostly	O
positive	O
reviews	O
,	O
out	O
of	O
a	O
collection	O
of	O
20	O
reviews	O
cited	O
,	O
2	O
were	O
negative	O
,	O
calling	O
it	O
"	O
bad	O
history	O
"	O
and	O
"	O
appalling",	O
while	O
others	O
praised	O
the	O
authors	O
,	O
"	O
Endicott	S-Person
and	O
is	O
far	O
and	O
away	O
the	O
most	O
authoritative	O
work	O
on	O
the	O
subject	O
"	O
and	O
"	O
the	O
most	O
impressive	O
,	O
expertly	O
researched	O
and	O
,	O
as	O
far	O
as	O
the	O
official	O
files	O
allow	O
,	O
the	O
best-documented	O
case	O
for	O
the	O
prosecution	O
yet	O
made"	O
.	O

Some	O
people	O
in	O
the	O
community	O
are	O
altruistically	O
motivated	O
.	O

By	O
contrast	O
,	O
Governor	O
John	B-Person
Martin	I-Person
Poyer	E-Person
prevented	O
the	O
flu	S-Disease
from	O
reaching	O
neighboring	O
American	O
by	O
imposing	O
a	O
blockade	O
.	O

Fasting	O
has	O
gone	O
mainstream	O
,	O
but	O
because	O
it's	O
done	O
so	O
ahead	O
of	O
the	O
science	O
,	O
it	O
falls	O
into	O
the	O
"	O
proceed	O
with	O
caution	O
"	O
category	O
.	O

However	O
,	O
in	O
2007	O
,	O
Christopher	B-Person
Warren	E-Person
demonstrated	O
that	O
the	O
British	O
smallpox	S-Pathogen
may	O
have	O
been	O
still	O
viable	O
.	O

In	O
CDC	S-Organization
initial	O
years	O
,	O
more	O
than	O
six	O
and	O
a	O
half	O
million	O
homes	O
were	O
sprayed	O
,	O
mostly	O
with	O
.	O

Jeffrey	B-Person
Amherst	E-Person
in	O
a	O
letter	O
dated	O
16	O
July	O
1763	O
,	O
approved	O
the	O
plan	O
to	O
spread	O
to	O
Delaware	O
Indians	O
.	O

The	O
US	S-Location
personnel	O
in	O
work	O
under	O
diplomatic	O
cover	O
.	O

The	O
initial	O
distribution	O
of	O
the	O
drug	O
in	O
the	O
U.S.	S-Location
was	O
tripped	O
up	O
by	O
seemingly	O
capricious	O
decision-making	O
and	O
finger-pointing	O
,	O
resulting	O
in	O
over	O
a	O
week	O
of	O
confusion	O
and	O
frustration	O
among	O
health	O
care	O
providers	O
and	O
patients	O
alike	O
.	O

The	O
anthrax	S-Pathogen
attack	O
17	O
years	O
ago	O
on	O
Capitol	B-Organization
Hill	E-Organization
,	O
for	O
instance	O
,	O
found	O
the	O
federal	O
government	O
semi-prepared.	O
&quot;That	O
incident	O
shook	O
up	O
the	O
nation,&quot	O
;	O
which	O
learned	O
it	O
could	O
have	O
done	O
a	O
better	O
job	O
in	O
preparing	O
to	O
respond	O
to	O
such	O
biotism	O
,	O
Ridge	O
said	O
.	O

The	O
media	O
revisited	O
the	O
incident	O
during	O
the	O
2001	B-Incident
anthrax	I-Incident
attacks	E-Incident
in	O
the	O
United	B-Location
States	E-Location
.	O
The	O
2001	O
publication	O
of	O
Judith	B-Person
Miller	E-Person
's	O
Germs:	O
Biological	O
Weapons	O
and	O
America's	O
Secret	O
War	O
,	O
which	O
contained	O
an	O
analysis	O
and	O
detailed	O
description	O
of	O
the	O
events	O
,	O
also	O
brought	O
discussion	O
of	O
the	O
incident	O
back	O
into	O
the	O
news	O
.	O

On	O
the	O
same	O
day	O
,	O
Yombe	B-Person
Ngongo	E-Person
,	O
a	O
patient	O
at	O
the	O
hospital	O
receiving	O
treatment	O
for	O
anemia	S-Disease
,	O
checked	O
out	O
of	O
the	O
hospital	O
and	O
returned	O
to	O
her	O
village	O
.	O

However	O
,	O
it	O
is	O
now	O
clear	O
that	O
natural-product	O
drug	O
discovery	O
efforts	O
to	O
date	O
have	O
generally	O
focused	O
on	O
readily	O
accessible	O
sources	O
(Ref)	O
.	O

"	O
Without	O
such	O
tools	O
,	O
it	O
is	O
difficult	O
to	O
generate	O
the	O
data	O
necessary	O
to	O
support	O
regulatory	O
decision	O
making,	O
"	O
Gottlieb	S-Person
wrote	O
in	O
his	O
written	O
testimony	O
.	O

Like	O
other	O
RNA	O
viruses	O
,	O
mutates	O
rapidly	O
,	O
both	O
within	O
a	O
person	O
during	O
the	O
progression	O
of	O
disease	O
and	O
in	O
the	O
reservoir	O
among	O
the	O
local	O
human	O
population	O
.	O

A	O
study	O
at	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
published	O
in	O
May	O
2009	O
found	O
that	O
children	O
had	O
no	O
preexisting	O
immunity	O
to	O
the	O
new	O
strain	O
but	O
that	O
adults	O
,	O
particularly	O
those	O
older	O
than	O
60	O
,	O
had	O
some	O
degree	O
of	O
immunity	O
.	O

The	O
information	O
gathered	O
in	O
this	O
portal	O
is	O
used	O
by	O
the	O
countries	O
to	O
set	O
priorities	O
for	O
future	O
strategies	O
or	O
plans	O
,	O
implement	O
,	O
monitor	O
,	O
and	O
evaluate	O
it	O
.	O

Retrieved	O
21	O
September	O
2019	O
.	O

Ed	B-Person
Yong	E-Person
,	O
a	O
British	O
science	O
journalist	O
,	O
has	O
criticized	O
the	O
agency	O
and	O
its	O
"	O
confusing"	O
category	O
system	O
for	O
misleading	O
the	O
public	O
.	O

Today	O
,	O
biofuels	O
-	O
organic	O
fuels	O
derived	O
from	O
microorganisms	O
,	O
plants	O
and	O
animals	O
-	O
represent	O
just	O
3%	O
of	O
global	O
fuel	O
consumption	O
for	O
road	O
transport	O
.	O

Ken	B-Person
Alibek	E-Person
and	O
.	O
Biohazard:	O
The	O
Chilling	O
True	O
Story	O
of	O
the	O
Largest	O
Covert	O
Biological	O
Weapons	O
Program	O
in	O
the	O
World	O
–	O
Told	O
from	O
Inside	O
by	O
the	O
Man	O
Who	O
Ran	O
it.1999	O
.	O

CIA	S-Organization
A	O
total	O
of	O
97	O
vials-including	O
those	O
with	O
labels	O
consistent	O
with	O
the	O
al	O
Hakam	O
cover	O
stories	O
of	O
single-cell	O
protein	O
and	O
bio-pesticides	O
,	O
as	O
well	O
as	O
strains	O
that	O
could	O
be	O
used	O
to	O
produce	O
BW	B-Drug
agents	E-Drug
were	O
recovered	O
from	O
a	O
scientist's	O
residence	O
in	O
in	O
2003	O
.	O

Bell	S-Person
will	O
look	O
at	O
in	O
terms	O
of	O
our	O
laboratory	O
.	O

Sometimes	O
people	O
may	O
become	O
infected	O
by	O
touching	O
something-such	O
as	O
a	O
surface	O
or	O
object-with	O
flu	O
viruses	O
on	O
it	O
and	O
then	O
touching	O
their	O
face	O
.	O

In	O
May	O
1955	O
over	O
300,000	O
yellow	B-Pathogen
fever	E-Pathogen
mosquitoes	O
(Aedes	O
aegypti)	O
were	O
dropped	O
over	O
parts	O
of	O
the	O
U.S.	B-Location
state	I-Location
of	I-Location
Georgia	E-Location
to	O
determine	O
if	O
the	O
air-dropped	O
mosquitoes	O
could	O
survive	O
to	O
take	O
meals	O
from	O
humans	O
.	O

These	O
involved	O
identifying	O
people	O
who	O
had	O
at	O
least	O
two	O
of	O
the	O
following	O
symptoms	O
in	O
addition	O
to	O
a	O
history	O
of	O
travel	O
to	O
Wuhan	S-Location
or	O
contact	O
with	O
other	O
infected	O
people:	O
fever	S-Phenotype
,	O
imaging	O
features	O
of	O
pneumonia	S-Disease
,	O
normal	B-Phenotype
or	I-Phenotype
reduced	I-Phenotype
white	I-Phenotype
blood	I-Phenotype
cell	I-Phenotype
count	E-Phenotype
,	O
or	O
.	O

The	O
lab	O
is	O
housed	O
in	O
a	O
400,000-square-foot	O
concrete	O
building	O
located	O
in	O
the	O
heart	O
of	O
the	O
CDC	S-Organization
main	O
campus	O
.	O

The	O
latest	O
threat	O
comes	O
from	O
African	B-Disease
swine	I-Disease
fever	E-Disease
a	O
highly	O
contagious	O
virus	O
with	O
no	O
known	O
cure	O
,	O
and	O
a	O
near	O
zero	O
survival	O
rate	O
for	O
infected	O
pigs	O
.	O

The	O
DTRA	S-Organization
has	O
launched	O
a	O
number	O
of	O
projects	O
on	O
Tularemia	S-Disease
along	O
with	O
other	O
especially	O
dangerous	O
pathogens	O
in	O
.	O
Especially	O
Dangerous	O
Pathogens	O
(EDPs)	O
,	O
or	O
select	O
agents	O
,	O
represent	O
a	O
major	O
concern	O
for	O
the	O
public	O
health	O
globally	O
.	O

The	O
database	O
was	O
launched	O
on	O
Human	O
Rights	O
Day	O
,	O
and	O
is	O
part	O
of	O
WHO	S-Organization
's	O
QualityRights	O
initiative	O
,	O
which	O
aims	O
to	O
end	O
human	O
rights	O
violations	O
against	O
people	O
with	O
mental	O
health	O
conditions	O
.	O

Do-it-yourself	B-Activity
biology	E-Activity
(	O
DIY	B-Activity
biology	E-Activity
,	O
)	O
is	O
a	O
growing	O
biotechnological	O
social	O
movement	O
in	O
which	O
individuals	O
,	O
communities	O
,	O
and	O
small	O
organizations	O
study	O
biology	O
and	O
life	O
science	O
using	O
the	O
same	O
methods	O
as	O
traditional	O
research	O
institutions	O
.	O

Once	O
a	O
live	O
host	O
was	O
captured	O
,	O
it	O
would	O
need	O
to	O
be	O
transported	O
to	O
what	O
de	B-Person
Bretton-Gordon	E-Person
called	O
a	O
"	O
suitably	O
equipped	O
"	O
laboratory	O
,	O
in	O
order	O
to	O
extract	O
the	O
virus	O
.	O

Genitals	O
of	O
female	O
prisoners	O
that	O
were	O
infected	O
with	O
syphilis	S-Disease
were	O
called	O
"	O
jam	O
filled	O
buns	O
"	O
by	O
guards	O
.	O

The	O
lab	O
is	O
and	O
has	O
been	O
certified	O
under	O
Clinical	B-Technology
Laboratory	I-Technology
Improvement	I-Technology
Amendments	E-Technology
(	O
CLIA	S-Technology
)	O
federal	O
standards	O
,	O
and	O
the	O
lab's	O
testing	O
results	O
and	O
quality-control	O
is	O
reviewed	O
in	O
real	O
time	O
by	O
a	O
CLIA	S-Technology
technical	O
supervisor	O
.	O

On	O
19	O
May	O
,	O
it	O
was	O
reported	O
that	O
the	O
country	O
had	O
in	O
the	O
week	O
of	O
12–19	O
May	O
the	O
highest	O
per	O
capita	O
deaths	O
in	O
,	O
6.	O
25	O
deaths	O
per	O
million	O
per	O
day	O
.	O

However	O
,	O
new	O
information	O
about	O
the	O
1918	B-Pathogen
virus	E-Pathogen
is	O
emerging	O
,	O
for	O
example	O
,	O
sequencing	O
of	O
the	O
entire	O
genome	O
from	O
archival	O
autopsy	O
tissues	O
.	O

One	O
of	O
the	O
Pentagon	S-Organization
bio-labs	O
is	O
located	O
in	O
Kharkiv	S-Location
which	O
was	O
blamed	O
for	O
the	O
deadly	O
a	O
year	O
ago	O
which	O
claimed	O
the	O
lives	O
of	O
364	O
Ukrainians	O
.	O

Another	O
common	O
cause	O
of	O
death	O
is	O
complications	O
related	O
to	O
the	O
kidneys	O
.	O

Frequencies	O
of	O
the	O
responses	O
were	O
generated	O
as	O
percentages	O
of	O
excellent	O
,	O
good	O
,	O
average	O
,	O
and	O
poor	O
categories	O
of	O
resource	O
availability	O
.	O

Records	O
obtained	O
by	O
the	O
USA	B-Organization
TODAY	I-Organization
Network	E-Organization
show	O
hundreds	O
of	O
incidents	O
have	O
occurred	O
in	O
labs	O
across	O
the	O
country	O
in	O
recent	O
years	O
.	O

Dilyana	B-Person
Gaytandzhieva	E-Person
is	O
a	O
Bulgarian	O
investigative	O
journalist	O
and	O
Middle	B-Organization
East	E-Organization
Correspondent	O
.	O

As	O
a	O
positive	O
control	O
Vero	O
cells	O
were	O
infected	O
with	O
10−3	O
dilution	O
of	O
HSV	S-Pathogen
with	O
10 μM	O
of	O
(Sigma	O
Aldrich)	O
,	O
a	O
known	O
anti‐HSV	O
agent	O
.	O

These	O
established	O
trends	O
can	O
then	O
be	O
observed	O
by	O
medical	O
epidemiologists	O
to	O
determine	O
if	O
there	O
are	O
any	O
disease	O
outbreaks	O
in	O
any	O
particular	O
locales	O
;	O
maps	O
of	O
disease	O
prevalence	O
can	O
then	O
be	O
created	O
rather	O
easily	O
.	O

For	O
more	O
data	O
on	O
2008	O
,	O
click	O
on	O
the	O
"	O
2008"	O
link	O
.	O

Sweden	S-Organization
differed	O
from	O
most	O
other	O
European	O
countries	O
in	O
that	O
it	O
mostly	O
remained	O
open	O
.	O

The	O
announcement	O
included	O
language	O
that	O
indicated	O
the	O
Nixon	S-Person
administration	O
was	O
moving	O
toward	O
an	O
international	O
agreement	O
on	O
an	O
outright	O
ban	O
on	O
bio-weapons	O
.	O

About	O
keeping	O
over	O
environment	O
free	O
and	O
not	O
attractive	O
to	O
rats	O
.	O

Infusion‐related	O
reactions	O
have	O
been	O
seen	O
during	O
a	O
remdesivir	S-Drug
infusion	O
or	O
around	O
the	O
time	O
remdesivir	S-Drug
was	O
given	O
.	O

For	O
additional	O
details	O
visit:	O

Potentially	O
exposed	O
staff	O
are	O
being	O
offered	O
antibiotics	S-Drug
and	O
vaccinations	O
to	O
prevent	O
possible	O
anthrax	B-Disease
infection	E-Disease
.	O
No	O
staff	O
have	O
shown	O
symptoms	O
of	O
anthrax	S-Pathogen
or	O
tested	O
positive	O
for	O
.	O

Biological	B-Scientific_research_project
Weapons	I-Scientific_research_project
Program-Japan	I-Scientific_research_project
Federation	I-Scientific_research_project
of	I-Scientific_research_project
American	I-Scientific_research_project
Scientists	E-Scientific_research_project
This	O
research	O
led	O
to	O
the	O
development	O
of	O
the	O
defoliation	O
bacilli	O
bomb	O
and	O
the	O
flea	O
bomb	O
used	O
to	O
spread	O
bubonic	B-Pathogen
plague	E-Pathogen
.	O
Review	O
of	O
the	O
studies	O
on	O
Germ	O
Warfare	O
Tien-wei	O
Wu	O
A	O
Preliminary	O
Review	O
of	O
Studies	O
of	O
Japanese	O
Biological	O
Warfare	O
and	O
Unit	B-Organization
731	E-Organization
in	O
the	O
United	B-Location
States	E-Location
Some	O
of	O
these	O
bombs	O
were	O
designed	O
with	O
porcelain	O
shells	O
,	O
an	O
idea	O
proposed	O
by	O
in	O
1938	O
.	O

In	O
1971	O
the	O
first	B-Incident
serious	I-Incident
outbreak	I-Incident
of	I-Incident
African	I-Incident
Swine	I-Incident
Fever	E-Incident
in	O
the	O
Western	O
Hemisphere	O
occurred	O
in	O
Cuba	S-Location
.	O
The	O
Cuban	O
government	O
alleged	O
that	O
U.S.	S-Location
covert	O
biological	O
warfare	O
was	O
responsible	O
for	O
this	O
outbreak	O
,	O
which	O
led	O
to	O
the	O
preemptive	O
slaughter	O
of	O
500,000	O
pigs	O
.	O

According	O
to	O
DPR	S-Organization
intelligence	O
information	O
the	O
US	B-Organization
bio	I-Organization
lab	E-Organization
in	O
leaked	O
the	O
deadly	O
virus	O
.	O

If	O
oseltamivir	S-Drug
(	O
Tamiflu	S-Drug
)	O
is	O
unavailable	O
or	O
cannot	O
be	O
used	O
,	O
zanamivir	S-Drug
()	O
is	O
recommended	O
as	O
a	O
substitute	O
.	O

Therapeutic	O
use	O
of	O
antibiotics	O
in	O
domestic	O
pets	O
should	O
be	O
by	O
veterinarian	O
prescription	O
only	O
.	O

President	O
Donald	B-Person
Trump	E-Person
promoted	O
his	O
first	O
budget	O
around	O
keeping	O
America	O
safe	O
.	O

Other	O
good	O
examples	O
are	O
the	O
annual	O
Antibiotic	B-Activity
Awareness	I-Activity
Day	E-Activity
in	O
Europe	S-Location
and	O
Canada	S-Location
(Ref)	O
and	O
the	O
CDC	S-Organization
program	O
"	O
Get	B-Scientific_research_project
Smart:	I-Scientific_research_project
Know	I-Scientific_research_project
When	I-Scientific_research_project
Antibiotics	I-Scientific_research_project
Work	E-Scientific_research_project
"	O
in	O
(Ref)	O
.	O

In	O
2016	O
,	O
the	O
United	B-Organization
States	I-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
approved	O
a	O
clinical	O
trial	O
in	O
which	O
CRISPR	S-Technology
would	O
be	O
used	O
to	O
alter	O
T	O
cells	O
extracted	O
from	O
people	O
with	O
different	O
kinds	O
of	O
and	O
then	O
administer	O
those	O
engineered	O
T	O
cells	O
back	O
to	O
the	O
same	O
people	O
.	O

Debra	B-Person
Hunt	E-Person
DrPH	O
,	O
CBSP†	O
,	O
is	O
the	O
Director	O
of	O
Biological	O
Safety	O
within	O
the	O
Occupational	B-Organization
and	I-Organization
Environmental	I-Organization
Safety	I-Organization
Office	E-Organization
at	O
Duke	B-Organization
University	E-Organization
,	O
with	O
responsibilities	O
in	O
the	O
University	O
,	O
the	O
Medical	O
Center	O
,	O
and	O
Duke	B-Platform
Health	I-Platform
System	E-Platform
.	O
She	O
is	O
also	O
an	O
Assistant	O
Professor	O
in	O
the	O
university's	O
Department	B-Organization
of	I-Organization
Community	I-Organization
and	I-Organization
Family	I-Organization
Medicine	E-Organization
,	O
Division	B-Organization
of	I-Organization
Occupational	I-Organization
Medicine	E-Organization
.	O
She	O
serves	O
on	O
the	O
Duke	B-Organization
University	I-Organization
Institutional	I-Organization
Biosafety	I-Organization
Committee	E-Organization
,	O
the	O
Duke	B-Organization
University	I-Organization
Safety	I-Organization
Committee	E-Organization
,	O
and	O
is	O
the	O
designated	O
"	O
Responsible	O
Official	O
"	O
for	O
Duke	B-Scientific_research_project
University's	I-Scientific_research_project
Select	I-Scientific_research_project
Agent	I-Scientific_research_project
Program	E-Scientific_research_project
.	O
She	O
is	O
a	O
Certified	O
Biological	O
Safety	O
Professional	O
(CBSP)	O
and	O
a	O
Past-President	O
of	O
the	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
.	O

CRISPR	S-Technology
may	O
revive	O
the	O
concept	O
of	O
transplanting	O
animal	O
organs	O
into	O
people	O
.	O

"	O
Congress	O
and	O
the	O
president	O
are	O
ignoring	O
the	O
science	O
that	O
tells	O
us	O
this	O
research	O
facility	O
is	O
an	O
accident	O
waiting	O
to	O
happen,''	O
said	O
Mike	B-Person
Schultz	E-Person

There	O
have	O
been	O
several	O
films	O
about	O
the	O
atrocities	O
of	O
Unit	B-Organization
731	E-Organization

The	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
Biosafety	O
Guidelines	O
Web	O
site	O
.	O

An	O
ongoing	O
US	O
military	O
research	O
project	O
that	O
is	O
exploring	O
a	O
new	O
biotechnology	B-Technology
to	I-Technology
genetically	I-Technology
modify	I-Technology
mature	I-Technology
crops	E-Technology
has	O
some	O
scientists	O
worried	O
.	O

In	O
the	O
worst	O
affected	O
areas	O
,	O
mortality	O
has	O
been	O
several	O
times	O
higher	O
than	O
average	O
.	O

This	O
review	O
will	O
be	O
done	O
in	O
conjunction	O
with	O
the	O
internal	O
investigation	O
and	O
in	O
coordination	O
with	O
the	O
working	O
group	O
.	O

However	O
,	O
recent	O
compressed	O
sensing-based	O
software	O
algorithms	O
(e.g.	O
,	O
)	O
have	O
been	O
proposed	O
to	O
achieve	O
super-resolution	O
without	O
requiring	O
such	O
high	O
field	O
strengths	O
.	O

Additionally	O
,	O
an	O
estimated	O
10	O
to	O
26	O
cases	O
had	O
prevented	O
fatality	O
through	O
treatment	O
supplied	O
to	O
over	O
30,000	O
individuals	O
.	O

Apart	O
from	O
regional	O
,	O
country	O
and	O
liaison	O
offices	O
,	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
has	O
also	O
established	O
other	O
institutions	O
for	O
promoting	O
and	O
carrying	O
on	O
research	O
.	O

Despite	O
the	O
potentially	O
deadly	O
nature	O
of	O
the	O
poison	O
,	O
no	O
one	O
was	O
exposed	O
to	O
,	O
injured	O
by	O
,	O
or	O
killed	O
by	O
the	O
ricin	S-Pathogen
"	O
FBI	S-Organization
offers	O
$100,000	O
reward	O
in	O
ricin	B-Incident
case	E-Incident
"	O
,	O
CNN.com	O
,	O
January	O
9	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

Surgical	B-Equipment
masks	E-Equipment
are	O
recommended	O
for	O
those	O
who	O
may	O
be	O
infected	O
,	O
as	O
wearing	O
this	O
type	O
of	O
can	O
limit	O
the	O
volume	O
and	O
travel	O
distance	O
of	O
expiratory	O
droplets	O
dispersed	O
when	O
talking	O
,	O
sneezing	O
,	O
and	O
coughing	O
.	O

This	O
phenomenon	O
can	O
be	O
used	O
to	O
select	O
against	O
resistant	O
bacteria	O
using	O
an	O
approach	O
termed	O
collateral	O
sensitivity	O
cycling	O
,	O
which	O
has	O
recently	O
been	O
found	O
to	O
be	O
relevant	O
in	O
developing	O
treatment	O
strategies	O
for	O
chronic	O
infections	O
caused	O
by	O
Pseudomonas	B-Pathogen
aeruginosa	E-Pathogen

Today	O
,	O
there	O
is	O
not	O
one	O
single	O
bed	O
available	O
for	O
the	O
treatment	O
of	O
an	O
Ebola	S-Disease
patient	O
in	O
the	O
entire	O
country	O
of	O
Liberia	S-Location
.	O
"	O
According	O
to	O
a	O
WHO	S-Organization
report	O
released	O
on	O
19	O
September	O
,	O
Sierra	B-Location
Leone	E-Location
was	O
meeting	O
only	O
35%	O
of	O
its	O
need	O
for	O
patient	O
beds	O
,	O
while	O
for	O
it	O
was	O
just	O
20%	O
.	O

In	O
Calgary,	B-Location
Canada	E-Location
12.	O
1%	O
of	O
people	O
who	O
present	O
to	O
the	O
emergency	O
with	O
an	O
urgent	O
complaint	O
received	O
a	O
CT	B-Technology
scan	E-Technology
,	O
most	O
commonly	O
either	O
of	O
the	O
head	O
or	O
of	O
the	O
abdomen	O
.	O

The	O
WHO	S-Organization
has	O
a	O
Framework	B-Platform
Convention	I-Platform
on	I-Platform
Tobacco	I-Platform
implementation	I-Platform
database	E-Platform
which	O
is	O
one	O
of	O
the	O
few	O
mechanisms	O
to	O
help	O
enforce	O
compliance	O
with	O
the	O
FCTC	S-Document
.	O
However	O
,	O
there	O
have	O
been	O
reports	O
of	O
numerous	O
discrepancies	O
between	O
it	O
and	O
national	O
implementation	O
reports	O
on	O
which	O
it	O
was	O
built	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
has	O
described	O
the	O
combination	O
of	O
military	O
conflict	O
and	O
civilian	O
distress	O
as	O
a	O
potential	O
"	O
perfect	O
storm	O
"	O
that	O
could	O
lead	O
to	O
a	O
rapid	O
worsening	O
of	O
the	O
outbreak	O
.	O

The	O
agency's	O
National	B-Organization
Biosurveillance	I-Organization
Integration	I-Organization
Center	E-Organization
on	O
Thursday	O
began	O
looking	O
for	O
groups	O
to	O
provide	O
nationwide	O
information	O
on	O
medical	O
interventions	O
,	O
food	O
safety	O
,	O
wildlife	O
health	O
,	O
travel	O
itineraries	O
and	O
other	O
health-related	O
topics	O
.	O

Seroepidemiologic	O
studies	O
soon	O
linked	O
both	O
of	O
these	O
viruses	O
to	O
the	O
1918	O
pandemic	O
.	O

Editor	O
Nancy	B-Person
Gibbs	E-Person
said:	O
"	O
The	O
rest	O
of	O
the	O
world	O
can	O
sleep	O
at	O
night	O
because	O
a	O
group	O
of	O
men	O
and	O
women	O
are	O
willing	O
to	O
stand	O
and	O
fight	O
.	O

All	O
animals	O
overlapped	O
with	O
&gt;1	O
other	O
affected	O
animal	O
.	O

TOM	B-Person
FRIEDEN	E-Person
No	O
,	O
the	O
moratorium	O
that	O
we	O
are	O
implementing	O
applies	O
specifically	O
to	O
CDC	S-Organization
.	O
I've	O
discussed	O
this	O
with	O
both	O
NIH	S-Organization
and	O
FDA	S-Organization
leadership	O
.	O

At	O
the	O
nexus	O
of	O
the	O
country's	O
biopreparedness	O
is	O
the	O
CDC	S-Organization
which	O
has	O
activated	O
an	O
emergency	O
response	O
,	O
or	O
"	O
incident	B-Platform
management	I-Platform
system	E-Platform
,	O
"	O
67	O
times	O
over	O
the	O
past	O
16	O
years	O
for	O
a	O
variety	O
of	O
infectious	O
threats	O
including	O
.	O
After	O
September	O
11	O
,	O
the	O
agency	O
also	O
began	O
systematically	O
collecting	O
information	O
from	O
emergency	O
departments	O
,	O
looking	O
for	O
any	O
patterns	O
of	O
a	O
bioterrorism	O
attack	O
.	O

So	O
I'm	O
upset.I'm	O
angry	O
.	O

Environmental	O
specimens	O
were	O
collected	O
with	O
swabs	O
,	O
including	O
(1)	O
the	O
surface	O
of	O
sample	O
acceptance	O
desk	O
,	O
(2)	O
the	O
temporary	O
storage	O
refrigerator	O
,	O
(3)	O
the	O
operation	O
platform	O
of	O
biosafety	B-Equipment
cabinet	E-Equipment
in	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(4)	O
the	O
RNA	O
extraction	O
bench	O
in	O
the	O
BSL-3	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
,	O
(5)	O
the	O
autoclave	S-Equipment
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(6)	O
the	O
centrifuge	S-Equipment
in	O
the	O
BSL-3	S-Platform
lab	O
(inside	O
and	O
outside)	O
,	O
(7)	O
the	O
transfer	O
windows	O
in	O
the	O
BSL-3	S-Platform
lab	O
("clean	O
"	O
and	O
"	O
dirty"),	O
(8)	O
the	O
bench	O
in	O
the	O
preparation	O
room	O
(before	O
and	O
after	O
use)	O
,	O
(9)	O
the	O
operation	O
platform	O
of	O
biosafety	O
cabinet	O
in	O
the	O
BSL-2	S-Platform
lab	O
(before	O
and	O
after	O
use)	O
and	O
(10)	O
the	O
real-time	B-Equipment
PCR	I-Equipment
facility	E-Equipment
in	O
(inside	O
and	O
outside)	O
.	O

This	O
bioterrorist	O
attack	O
inevitably	O
prompted	O
seven	O
cases	O
of	O
cutaneous	B-Disease
anthrax	E-Disease
and	O
eleven	O
cases	O
of	O
inhalation	B-Disease
anthrax	E-Disease
,	O
with	O
five	O
leading	O
to	O
deaths	O
.	O

Former	O
members	O
of	O
Unit	B-Organization
731	E-Organization
secretly	O
continue	O
their	O
experiments	O
on	O
humans	O
under	O
control	O
of	O
a	O
covert	O
agency	O
.	O

However	O
,	O
no	O
conclusive	O
evidence	O
of	O
exactly	O
how	O
the	O
virus	O
"	O
jumped"	O
to	O
humans	O
has	O
ever	O
been	O
provided	O
,	O
which	O
raises	O
suspicions	O
of	O
intentional	O
and	O
not	O
natural	O
infection	O
.	O

On	O
16	O
March	O
2019	O
,	O
the	O
director	O
of	O
the	O
CDC	S-Organization
indicated	O
that	O
the	O
outbreak	O
in	O
the	O
DRC	S-Location
could	O
last	O
another	O
year	O
,	O
additionally	O
indicating	O
that	O
vaccine	O
supplies	O
could	O
run	O
out	O
.	O

But	O
if	O
it	O
was	O
growing	O
in	O
the	O
dark	O
,	O
the	O
synthetic	O
circuit	O
turned	O
on	O
the	O
pigment-producing	O
gene	O
.	O

The	O
pandemic	O
has	O
disrupted	O
global	O
food	O
supplies	O
and	O
threatens	O
to	O
trigger	O
a	O
new	O
food	O
crisis	O
.	O

The	O
E99	O
was	O
the	O
first	O
workable	O
design	O
,	O
but	O
was	O
too	O
complex	O
to	O
be	O
manufactured	O
.	O

Resistant	O
strains	O
of	O
the	O
HIV	B-Pathogen
virus	E-Pathogen
emerge	O
rapidly	O
if	O
only	O
one	O
antiviral	O
drug	O
is	O
used	O
.	O

In	O
researching	O
the	O
incident	O
,	O
Dr	O
.	O

Indeed	O
,	O
we	O
know	O
only	O
from	O
the	O
massive	O
biowarfare	O
programme	O
in	O
the	O
former	O
that	O
pathogens	O
have	O
been	O
genetically	O
modified	O
to	O
increase	O
their	O
effectiveness	O
as	O
bioweapons	O
,	O
but	O
there	O
may	O
have	O
been	O
other	O
,	O
so	O
far	O
undetected	O
,	O
attempts	O
elsewhere	O
.	O

So	O
we	O
have	O
to	O
keep	O
at	O
it	O
,	O
even	O
when	O
success	O
seems	O
far	O
.	O

On	O
23	O
September	O
2014	O
,	O
the	O
WHO	S-Organization
revised	O
their	O
previous	O
projection	O
,	O
stating	O
that	O
they	O
expected	O
the	O
number	O
of	O
Ebola	S-Disease
cases	O
in	O
Western	B-Location
Africa	E-Location
to	O
be	O
in	O
excess	O
of	O
20,000	O
by	O
2	O
November	O
2014	O
.	O

From	O
these	O
discussions	O
emerged	O
a	O
priority	O
list	O
of	O
steps	O
that	O
need	O
to	O
be	O
taken	O
to	O
resolve	O
this	O
global	O
crisis	O
.	O

He	O
implored	O
the	O
U.S.	O
government	O
to	O
take	O
the	O
proper	O
and	O
necessary	O
actions	O
to	O
implement	O
a	O
strategic	O
plan	O
of	O
action	O
to	O
save	O
as	O
many	O
lives	O
as	O
possible	O
and	O
to	O
safeguard	O
against	O
potential	O
chaos	O
and	O
confusion	O
.	O

Symptoms	O
usually	O
last	O
4–6	O
days	O
.	O

These	O
patients	O
will	O
need	O
medical	O
care	O
for	O
months	O
and	O
maybe	O
years.	O
"	O
A	O
physician	O
from	O
the	O
Kenema	B-Organization
hospital	E-Organization
in	O
reported	O
similar	O
health	O
difficulties	O
.	O

These	O
companies	O
do	O
not	O
currently	O
have	O
these	O
assurances	O
because	O
much	O
of	O
this	O
federal	O
research	O
funding	O
is	O
allocated	O
on	O
an	O
annual	O
basis	O
,	O
dissuading	O
companies	O
from	O
taking	O
risks	O
in	O
drug	O
development	O
,	O
said	O
.	O

Appointed	O
to	O
head	O
the	O
office	O
in	O
May	O
,	O
he	O
has	O
rapidly	O
moved	O
to	O
make	O
requested	O
changes	O
.	O

The	O
Aral	B-Incident
smallpox	I-Incident
incident	E-Incident
was	O
a	O
July	O
30	O
,	O
1971	O
outbreak	O
of	O
the	O
viral	O
disease	O
which	O
occurred	O
as	O
a	O
result	O
of	O
a	O
field	O
test	O
at	O
a	O
Soviet	B-Location
biological	I-Location
weapons	I-Location
(BW)	I-Location
facility	E-Location
on	O
an	O
island	O
in	O
the	O
Aral	B-Location
Sea	E-Location
.	O
The	O
incident	O
sickened	O
ten	O
people	O
,	O
of	O
whom	O
three	O
died	O
,	O
and	O
came	O
to	O
widespread	O
public	O
notice	O
only	O
in	O
2002	O
.	O

One	O
worker	O
was	O
injured	O
in	O
the	O
incident	O
and	O
is	O
being	O
treated	O
in	O
intensive	O
care	O
for	O
burns	O
,	O
Russia	S-Location
reported	O
.	O

Depending	O
on	O
the	O
disease	O
outbreak	O
scenario	O
explored	O
,	O
the	O
number	O
of	O
U.S.	S-Location
jobs	O
at	O
risk	O
jumps	O
from	O
about	O
1,400	O
to	O
more	O
than	O
1.3	O
million	O
.	O

As	O
in	O
the	O
other	O
examples	O
,	O
the	O
revolution	O
in	O
biomedicine	O
created	O
new	O
desires	O
in	O
the	O
East	O
and	O
the	O
West	O
,	O
and	O
there	O
are	O
already	O
new	O
weapons	O
under	O
development	O
that	O
violate	O
international	O
treaties	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	S-Organization
established	O
an	O
External	O
Laboratory	O
Safety	O
Workgroup	O
()	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
Federal	O
Select	O
Agent	O
Program	O
.	O

The	O
health	O
and	O
safety	O
of	O
CDC	S-Organization
staff	O
is	O
a	O
top	O
priority	O
for	O
the	O
agency	O
,	O
and	O
CDC	S-Organization
is	O
taking	O
aggressive	O
steps	O
to	O
monitor	O
and	O
protect	O
the	O
health	O
of	O
all	O
involved	O
,	O
including	O
dispensing	O
or	O
prescribing	O
protective	O
courses	O
of	O
antibiotics	S-Drug
and	O
vaccinations	O
to	O
potentially	O
exposed	O
staff	O
.	O

We	O
conducted	O
this	O
study	O
to	O
evaluate	O
biosafety	O
precautions	O
which	O
adopted	O
by	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
state	O
.	O

But	O
the	O
idea	O
that	O
Ebola	S-Disease
could	O
be	O
used	O
as	O
a	O
biological	O
weapon	O
should	O
be	O
viewed	O
with	O
heavy	O
skepticism	O
,	O
according	O
to	O
bioterrorism	O
experts	O
.	O

The	O
Division	B-Organization
of	I-Organization
Noncommunicable	I-Organization
Diseases	I-Organization
for	I-Organization
Promoting	I-Organization
Health	E-Organization
through	O
the	O
Life-course	O
Sexual	O
and	O
Reproductive	O
Health	O
has	O
published	O
the	O
magazine	O
,	O
Entre	B-Organization
Nous	E-Organization
,	O
across	O
since	O
1983	O
.	O

Before	O
and	O
after	O
1918	O
,	O
most	O
influenza	S-Disease
pandemics	O
developed	O
in	O
Asia	S-Location
and	O
spread	O
from	O
there	O
to	O
the	O
rest	O
of	O
the	O
world	O
.	O

Modeling	O
support	O
distinguishes	O
dedicated	O
systems	O
biology	O
data	O
management	O
systems	O
from	O
general	O
purpose	O
bioinformatics	O
systems	O
which	O
nevertheless	O
might	O
cover	O
most	O
features	O
needed	O
for	O
systems	O
biology	O
data	O
management	O
.	O

Just	O
a	O
few	O
years	O
later	O
,	O
in	O
2002	O
,	O
several	O
research	O
proposals	O
by	O
the	O
US	S-Location
military	O
that	O
were	O
clearly	O
offensive	O
in	O
nature	O
became	O
public	O
.	O

A	O
report	O
in	O
The	O
Lancet	S-Organization
on	O
24	O
January	O
indicated	O
human	O
transmission	O
,	O
strongly	O
recommended	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
for	O
health	O
workers	O
,	O
and	O
said	O
testing	O
for	O
the	O
virus	O
was	O
essential	O
due	O
to	O
its	O
"	O
pandemic	O
potential"	O
.	O

In	O
1993	O
,	O
Claude	B-Person
Hannoun	E-Person
the	O
leading	O
expert	O
on	O
the	O
1918	B-Incident
flu	E-Incident
at	O
the	O
Pasteur	B-Organization
Institute	E-Organization
,	O
asserted	O
the	O
precursor	O
virus	O
was	O
likely	O
to	O
have	O
come	O
from	O
China	S-Location
.	O
It	O
then	O
mutated	O
in	O
the	O
United	B-Location
States	E-Location
near	O
Boston	S-Location
and	O
from	O
there	O
spread	O
to	O
Brest	S-Location
,	O
France	S-Location
,	O
Europe	S-Location
's	O
battlefields	O
,	O
the	O
rest	O
of	O
Europe	S-Location
,	O
and	O
the	O
rest	O
of	O
the	O
world	O
,	O
with	O
Allied	O
soldiers	O
and	O
sailors	O
as	O
the	O
main	O
disseminators	O
.	O

Annex	O
III	O
of	O
the	O
Directive	O
gives	O
a	O
list	O
of	O
biological	O
agents	O
which	O
are	O
known	O
to	O
infect	O
humans	O
.	O

On	O
28	O
May	O
2013	O
,	O
the	O
Saudi	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
reported	O
five	O
more	O
cases	O
of	O
MERS-CoV	S-Pathogen
.	O
The	O
cases	O
had	O
been	O
"	O
recorded	O
among	O
citizens	O
in	O
the	O
Eastern	O
Region	O
,	O
ranging	O
in	O
age	O
from	O
73	O
to	O
85	O
years	O
,	O
but	O
they	O
have	O
all	O
chronic	O
diseases.	O
"	O
With	O
this	O
announcement	O
,	O
the	O
unofficial	O
global	O
case	O
count	O
reached	O
49	O
while	O
the	O
death	O
toll	O
stood	O
at	O
24	O
according	O
to	O
the	O
.	O
As	O
of	O
26	O
June	O
34	O
deaths	O
have	O
been	O
recorded	O
in	O
the	O
kingdom	O
.	O

In	O
October	O
of	O
2007	O
the	O
group	O
published	O
their	O
findings	O
in	O
a	O
report	O
,	O
outlining	O
options	O
for	O
the	O
field	O
and	O
its	O
researchers	O
moving	O
forward	O
.	O

"	O
Neither	O
of	O
those	O
two	O
critical	O
elements	O
is	O
visible	O
in	O
the	O
plans	O
that	O
were	O
released	O
today,	O
"	O
Kar	S-Person
said	O
.	O

BARDA	S-Organization
funding	O
will	O
support	O
necessary	O
work	O
for	O
the	O
company	O
to	O
apply	O
for	O
U.S.	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
()	O
approval	O
.	O

And	O
then	O
going	O
into	O
secondary	O
things	O
like	O
increasing	O
the	O
laboratory	O
capacity	O
for	O
the	O
diagnosis	O
of	O
.	O

Michael	B-Person
Bell	E-Person
,	O
who's	O
with	O
us	O
this	O
morning	O
,	O
to	O
be	O
Director	O
of	O
Laboratory	O
Safety	O
for	O
CDC	S-Organization
and	O
to	O
oversee	O
implementation	O
of	O
the	O
recommendations	O
that	O
I'll	O
be	O
talking	O
to	O
you	O
about	O
later	O
and	O
to	O
report	O
directly	O
to	O
me	O
.	O

In	O
a	O
milestone	O
move	O
,	O
the	O
United	B-Organization
States	I-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
approves	O
the	O
first	O
ever	O
drug	O
that	O
treats	O
the	O
infectious	O
and	O
potentially	O
lethal	O
.	O

Galleys	O
from	O
Kaffa	S-Location
reached	O
Genoa	S-Location
and	O
Venice	S-Location
in	O
January	O
1348	O
,	O
but	O
it	O
was	O
the	O
outbreak	O
in	O
Pisa	S-Location
a	O
few	O
weeks	O
later	O
that	O
was	O
the	O
entry	O
point	O
to	O
northern	O
Italy	S-Location
.	O
Towards	O
the	O
end	O
of	O
January	O
,	O
one	O
of	O
the	O
galleys	O
expelled	O
from	O
Italy	S-Location
arrived	O
in	O
Marseilles	S-Location
.	O
De	O
Smet	O
,	O
Vol	O
II	O
,	O
,	O
p.15	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	I-Organization
and	I-Organization
International	I-Organization
Atomic	I-Organization
Energy	I-Organization
Agency	E-Organization
(	O
IAEA	S-Organization
)	O
of	O
the	O
have	O
also	O
been	O
working	O
in	O
this	O
area	O
and	O
have	O
ongoing	O
projects	O
designed	O
to	O
broaden	O
best	O
practices	O
and	O
lower	O
patient	O
radiation	O
dose	O
.	O

For	O
example	O
,	O
daptomycin	S-Drug
abandoned	O
by	O
one	O
company	O
for	O
reasons	O
of	O
toxicity	O
,	O
has	O
become	O
a	O
leading	O
treatment	O
for	O
serious	O
Gram-positive	O
infections	O
using	O
a	O
different	O
dosing	O
regime	O
(REF)	O
.	O

The	O
current	O
population	O
in	O
is	O
more	O
than	O
84,000,000	O
people	O
.	O

In	O
the	O
1990s	O
,	O
Boris	B-Person
Yeltsin	E-Person
admitted	O
to	O
an	O
offensive	O
bio-weapons	O
program	O
as	O
well	O
as	O
to	O
the	O
true	O
nature	O
of	O
the	O
Sverdlovsk	B-Incident
biological	I-Incident
weapons	I-Incident
accident	I-Incident
of	I-Incident
1979	E-Incident
,	O
which	O
had	O
resulted	O
in	O
the	O
deaths	O
of	O
at	O
least	O
64	O
people	O
.	O

Cam­bridge	S-Location
Mass­a­chu­setts	S-Location
start­up	O
is	O
join­ing	O
forces	O
with	O
US	O
de­fense	O
or­ga­ni­za­tions	O
to	O
see	O
if	O
their	O
in­ves­ti­ga­tion­al	O
an­tibi­ot­ic	O
could	O
be	O
use­ful	O
against	O
biode­fense	O
threats	O
.	O

Following	O
the	O
confirmation	O
of	O
Ebola	S-Pathogen
crossing	O
into	O
Uganda	S-Location
,	O
a	O
third	O
review	O
by	O
the	O
WHO	S-Organization
on	O
14	O
June	O
2019	O
,	O
concluded	O
that	O
while	O
the	O
outbreak	O
was	O
a	O
health	O
emergency	O
in	O
the	O
DRC	S-Location
and	O
the	O
region	O
,	O
it	O
does	O
not	O
meet	O
all	O
the	O
three	O
criteria	O
for	O
a	O
PHEIC	O
.	O

A	O
joint	O
gap-analysis	O
identified	O
the	O
need	O
to	O
improve	O
and	O
share	O
existing	O
methods	O
and	O
in	O
some	O
cases	O
to	O
develop	O
new	O
methods	O
(Table	O
2)	O
.	O

Indeed	O
,	O
numerous	O
instances	O
of	O
chemical	O
or	O
biological	O
weapon	O
use	O
have	O
been	O
recorded	O
,	O
including	O
,	O
which	O
left	O
5	O
dead	O
after	O
the	O
toxic	O
cells	O
were	O
sent	O
through	O
the	O
mail	O
.	O

In	O
retrospect	O
,	O
even	O
the	O
rapid	O
progressions	O
from	O
uncomplicated	O
influenza	S-Disease
infections	O
to	O
fatal	O
,	O
a	O
hallmark	O
of	O
the	O
1918–1919	O
fall	O
and	O
winter	O
waves	O
,	O
had	O
been	O
noted	O
in	O
the	O
relatively	O
few	O
severe	O
spring	O
wave	O
cases	O
.	O

The	O
MR	O
signal	O
produces	O
a	O
spectrum	O
of	O
resonances	O
that	O
corresponds	O
to	O
different	O
molecular	O
arrangements	O
of	O
the	O
isotope	O
being	O
"	O
excited".	O
This	O
signature	O
is	O
used	O
to	O
diagnose	O
certain	O
metabolic	O
disorders	O
,	O
especially	O
those	O
affecting	O
the	O
brain	O
,	O
and	O
to	O
provide	O
information	O
on	O
metabolism	O
.	O

But	O
in	O
Quebec	S-Location
,	O
smallpox	S-Pathogen
swept	O
through	O
the	O
,	O
helping	O
to	O
prompt	O
a	O
retreat	O
.	O

The	O
provincial	O
health	O
and	O
agricultural	O
authorities	O
and	O
the	O
municipal	O
government	O
of	O
Lanzhou	S-Location
said	O
in	O
a	O
joint	O
report	O
that	O
the	O
infections	O
were	O
caused	O
by	O
the	O
use	O
of	O
expired	O
disinfectant	O
at	O
a	O
nearby	O
factory	O
that	O
produces	O
animal	O
between	O
July	O
24	O
and	O
Aug.20	O
.	O

And	O
Americans	O
should	O
know	O
that	O
we're	O
implementing	O
the	O
highest	O
levels	O
of	O
safety	O
and	O
security	O
in	O
our	O
laboratories	O
and	O
throughout	O
our	O
work	O
.	O

They	O
also	O
said	O
that	O
they	O
were	O
concerned	O
about	O
further	O
risk	O
to	O
already	O
overworked	O
staff	O
.	O

The	O
virus	O
uses	O
a	O
special	O
surface	O
glycoprotein	O
called	O
a	O
"	O
spike"	O
(peplomer)	O
to	O
connect	O
to	O
ACE2	O
and	O
enter	O
the	O
host	O
cell	O
.	O

On	O
the	O
other	O
hand	O
,	O
in	O
the	O
quarter	O
century	O
after	O
the	O
Black	B-Disease
Death	E-Disease
in	O
,	O
it	O
is	O
clear	O
many	O
labourers	O
,	O
artisans	O
,	O
and	O
craftsmen	O
,	O
those	O
living	O
from	O
money-wages	O
alone	O
,	O
did	O
suffer	O
a	O
reduction	O
in	O
real	O
incomes	O
owing	O
to	O
rampant	O
inflation	O
.	O

China	S-Location
includes	O
in	O
this	O
group	O
biological	O
agents	O
that	O
have	O
not	O
been	O
identified	O
in	O
.	O

The	O
virus	O
is	O
thought	O
to	O
be	O
natural	O
and	O
has	O
an	O
animal	O
origin	O
,	O
through	O
spillover	O
infection	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
Atlanta	O
was	O
chosen	O
as	O
the	O
location	O
because	O
malaria	O
was	O
endemic	O
in	O
the	O
.	O

The	O
introduction	O
of	O
Bacillus	B-Pathogen
thuringiensis	E-Pathogen
(	O
Bt	S-Pathogen
)	O
genes	O
into	O
the	O
plants	O
has	O
raised	O
issues	O
related	O
to	O
its	O
risk	O
assessment	O
and	O
biosafety	O
.	O

The	O
study	O
found	O
that	O
32	O
(16.	O
	S-Equipment
of	O
labs	O
appointed	O
biosafety	O
officers	O
,	O
while	O
75	O
(39.	O
5%)	O
working	O
in	O
these	O
laboratories	O
indicated	O
that	O
they	O
attended	O
biosafety	O
training	O
previously	O
.	O

The	O
way	O
that	O
experiment	O
was	O
used	O
was	O
basically	O
a	O
worst-case	O
scenario	O
experiment	O
.	O

In	O
Taiwan	O
,	O
administrators	O
and	O
staff	O
of	O
Taipei	B-Organization
Municipal	I-Organization
Hospital's	I-Organization
Hoping	I-Organization
branch	E-Organization
faced	O
disciplinary	O
action	O
from	O
the	O
Taipei	B-Organization
City	I-Organization
Government	E-Organization
.	O
The	O
Control	B-Organization
Yuan	E-Organization
also	O
launched	O
an	O
investigation	O
into	O
the	O
hospital's	O
closure	O
.	O

Political	O
scientist	O
Andrew	B-Person
Price-Smith	E-Person
published	O
data	O
from	O
the	O
Austrian	O
archives	O
suggesting	O
the	O
influenza	S-Disease
began	O
in	O
in	O
early	O
1917	O
.	O

CRISPR	B-Technology
gene	I-Technology
editing	E-Technology
is	O
a	O
genetic	O
engineering	O
technique	O
in	O
molecular	O
biology	O
by	O
which	O
the	O
genomes	O
of	O
living	O
organisms	O
may	O
be	O
modified	O
.	O

The	O
company	O
has	O
been	O
awarded	O
a	O
5-year	O
contract	O
for	O
field	O
tests	O
with	O
biological	O
simulants	O
at	O
.	O

In	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
for	O
instance	O
,	O
the	O
UN	S-Organization
is	O
supervising	O
the	O
overall	O
response	O
to	O
the	O
Ebola	S-Disease
crisis	O
,	O
the	O
first	O
time	O
Lillibridge	S-Person
said	O
he's	O
seen	O
it	O
become	O
operational.	O
investment	O
in	O
such	O
responses	O
would	O
benefit	O
the	O
nation	O
,	O
he	O
said	O
.	O

The	O
work	O
that	O
we	O
do	O
in	O
public	O
health	O
is	O
often	O
not	O
easy	O
.	O

In	O
a	O
1998	O
correspondence	O
letter	O
between	O
the	O
DOJ	S-Organization
and	O
Rabbi	B-Person
Abraham	I-Person
Cooper	E-Person
,	O
Eli	B-Person
Rosenbaum	E-Person
,	O
director	O
of	O
OSI	S-Organization
,	O
stated	O
that	O
this	O
was	O
due	O
to	O
two	O
factors.	O
(1)	O
While	O
most	O
documents	O
captured	O
by	O
the	O
US	S-Location
in	O
Europe	S-Location
were	O
microfilmed	O
before	O
being	O
returned	O
to	O
their	O
respective	O
governments	O
,	O
the	O
decided	O
to	O
not	O
microfilm	O
its	O
vast	O
collection	O
of	O
documents	O
before	O
returning	O
them	O
back	O
to	O
the	O
Japanese	O
government	O
.	O

"	O
We	O
have	O
a	O
tendency	O
in	O
this	O
country	O
to	O
react	O
to	O
things	O
after	O
they	O
occur,	O
"	O
said	O
Blue	B-Organization
Ribbon	I-Organization
panel	E-Organization
co-chairman	O
Tom	B-Person
Ridge	E-Person
,	O
former	O
governor	O
of	O
.	O

Flies	O
from	O
the	O
Phlebotomine	O
family	O
carry	O
dangerous	O
parasites	O
in	O
their	O
saliva	O
which	O
they	O
transmit	O
through	O
a	O
bite	O
to	O
humans	O
.	O

Broad	B-Organization
Institute	I-Organization
of	I-Organization
MIT	E-Organization
and	O
Harvard	S-Organization
researchers	O
have	O
created	O
a	O
new	O
tool	O
that	O
better	O
prepares	O
the	O
CRISPR	S-Technology
-based	O
diagnostic	O
tool	O
,	O
,	O
for	O
rapid	O
response	O
to	O
viral	O
outbreaks	O
.	O

Retesting	O
of	O
prior	O
samples	O
found	O
a	O
person	O
in	O
France	S-Location
who	O
had	O
the	O
virus	O
on	O
27	O
December	O
2019	O
and	O
a	O
person	O
in	O
who	O
died	O
from	O
the	O
disease	O
on	O
6February	O
2020	O
.	O

On	O
1	O
August	O
2013	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
announced	O
three	O
new	O
MERS-CoV	S-Pathogen
cases	O
in	O
that	O
Saudi	B-Location
Arabia	E-Location
,	O
all	O
of	O
them	O
in	O
women	O
,	O
two	O
of	O
whom	O
were	O
healthcare	O
workers.	O
"	O
With	O
the	O
three	O
new	O
cases	O
,	O
Saudi	B-Organization
Arabia	E-Organization
's	O
posted	O
MERS	S-Disease
tally	O
increases	O
to	O
74	O
cases	O
with	O
39	O
deaths	O
.	O

Cairo	S-Organization
suffered	O
more	O
than	O
fifty	O
plague	S-Disease
epidemics	O
within	O
150	O
years	O
from	O
the	O
plague's	O
first	O
appearance	O
,	O
with	O
the	O
final	O
outbreak	O
of	O
the	O
second	O
pandemic	O
there	O
in	O
the	O
1840s	O
.	O

Anderson	S-Person
,	O
.	O
"	O
Medfly	O
fighters	O
win	O
their	O
battle	O
the	O
hard	O
way"	O
,	O
(Google	O
Books	O
link)	O
,	O
New	O
Scientist	O
,	O
Vol.	O
95	O
,	O
No	O
.	O

Simulations	O
for	O
Great	B-Location
Britain	E-Location
and	O
the	O
show	O
that	O
mitigation	O
(slowing	O
but	O
not	O
stopping	O
epidemic	O
spread)	O
and	O
suppression	O
(reversing	O
epidemic	O
growth)	O
have	O
major	O
challenges	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
loss	O
of	O
human	O
life	O
was	O
not	O
limited	O
to	O
Ebola	S-Disease
victims	O
alone	O
.	O

These	O
and	O
other	O
labs	O
study	O
viruses	O
or	O
toxins	O
to	O
better	O
understand	O
the	O
threats	O
they	O
pose	O
and	O
to	O
try	O
to	O
find	O
cures	O
,	O
but	O
their	O
work	O
could	O
set	O
off	O
a	O
public	O
health	O
emergency	O
if	O
a	O
deadly	O
material	O
is	O
released	O
or	O
mishandled	O
as	O
a	O
result	O
of	O
human	O
error	O
.	O

Also	O
,	O
only	O
5	O
(2.	O
6%)	O
laboratories	O
had	O
waste	B-Equipment
container	I-Equipment
chemical	I-Equipment
materials	E-Equipment
and	O
4	O
(2.	O
1)	O
had	O
.	O

In	O
the	O
1st	O
changing	O
room	O
,	O
staff	O
should	O
remove	O
the	O
remaining	O
inner	O
PPE	S-Equipment
and	O
change	O
into	O
their	O
own	O
clothes	O
.	O

According	O
to	O
a	O
university	O
spokesperson	O
,	O
the	O
researcher	O
developed	O
symptoms	O
on	O
June	O
1	O
,	O
and	O
returned	O
to	O
work	O
on	O
June	O
6	O
when	O
the	O
fever	S-Phenotype
abated	O
,	O
reported	O
.	O

All	O
told	O
,	O
since	O
President	O
urged	O
nations	O
to	O
contribute	O
to	O
the	O
response	O
,	O
countries	O
from	O
all	O
over	O
the	O
world	O
,	O
private	O
sector	O
stakeholders	O
,	O
international	O
organizations	O
,	O
and	O
multilateral	O
development	O
banks	O
have	O
pledged	O
more	O
than	O
$2	O
billion	O
to	O
end	O
the	O
epidemic	O
.	O

Therapies	O
based	O
on	O
CRISPR–Cas3	B-Technology
gene	I-Technology
editing	I-Technology
technology	E-Technology
delivered	O
by	O
engineered	O
bacteriophages	O
could	O
be	O
used	O
to	O
destroy	O
targeted	O
DNA	O
in	O
pathogens	O
.	O

Black	B-Organization
&amp;	I-Organization
Veatch	I-Organization
Special	I-Organization
Project	I-Organization
C	E-Organization
was	O
awarded	O
$198.	O
7	O
mill	O
ion	S-Organization
	S-Organization
DTRA	O
contracts	O
to	O
build	O
and	O
operate	O
bio-laboratories	O
in	B-Location
Ukr	E-Location
aine	O
(under	O
two	O
5-year	O
contracts	O
in	O
2008	O
and	O
2012	O
totaling	O
$128.	O
5	O
million)	O
,	O
as	O
well	O
as	O
in	B-Location
Ger	E-Location
ma	O
ny,	B-Location
Azerba	E-Location
ij	O
an,	B-Location
Came	E-Location
ro	O
on,	B-Location
Thai	E-Location
la	O
nd,	B-Location
Ethi	E-Location
op	O
ia,	B-Location
Vie	E-Location
tnam	O
enia	O
.	O

Governments	O
need	O
to	O
accept	O
and	O
embrace	O
some	O
of	O
these	O
new	O
trends	O
and	O
new	O
technologies	O
.	O

Bats	O
drop	O
partially	O
eaten	O
fruit	O
and	O
pulp	O
,	O
then	O
land	O
mammals	O
such	O
as	O
gorillas	O
and	O
duikers	O
feed	O
on	O
this	O
fallen	O
fruit	O
.	O

Post	O
election	O
tensions	O
continued	O
when	O
it	O
was	O
reported	O
that	O
the	O
government	O
had	O
cut-off	O
internet	O
connections	O
for	O
the	O
population	O
,	O
as	O
the	O
vote	O
results	O
were	O
yet	O
to	O
be	O
released	O
.	O

Other	O
aspects	O
included	O
bioterrorism	O
and	O
means	O
to	O
combat	O
it	O
,	O
as	O
well	O
as	O
bioethics	O
and	O
dual	O
use	O
research	O
of	O
concern	O
and	O
other	O
ethical	O
dilemmas	O
.	O

RODS	S-Platform
is	O
designed	O
to	O
collect	O
data	O
from	O
many	O
data	O
sources	O
and	O
use	O
them	O
to	O
perform	O
signal	O
detection	O
,	O
that	O
is	O
,	O
to	O
detect	O
a	O
possible	O
bioterrorism	O
event	O
at	O
the	O
earliest	O
possible	O
moment	O
.	O

The	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
(	O
EVD	S-Disease
)	O
in	O
West	B-Location
Africa	E-Location
between	O
2014	O
and	O
2015	O
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
,	O
and	O
the	O
countries	O
most	O
strongly	O
affected	O
were	O
Sierra	B-Location
Leone	E-Location
,	O
Guinea	S-Location
,	O
and	O
.	O

The	O
U.S.	B-Organization
CDC	E-Organization
does	O
not	O
recommend	O
use	O
of	O
face	B-Equipment
masks	E-Equipment
or	O
respirators	S-Equipment
in	O
non-health	O
care	O
settings	O
,	O
such	O
as	O
schools	O
,	O
workplaces	O
,	O
or	O
public	O
places	O
,	O
with	O
a	O
few	O
exceptions:	O
people	O
who	O
are	O
ill	O
with	O
the	O
virus	O
when	O
around	O
other	O
people	O
,	O
and	O
people	O
who	O
are	O
at	O
risk	O
for	O
severe	O
illness	O
while	O
caring	O
for	O
someone	O
with	O
the	O
flu	O
.	O

Engineers	O
are	O
using	O
genes	O
and	O
proteins	O
as	O
building	O
blocks	O
to	O
create	O
new	O
kinds	O
of	O
cell	O
and	O
new	O
functions	O
for	O
cells	O
.	O

The	O
BWC	S-Document
for	O
those	O
of	O
you	O
who	O
don't	O
know	O
,	O
is	O
a	O
legally	O
binding	O
treaty	O
that	O
bans	O
the	O
development	O
,	O
stockpiling	O
,	O
acquisition	O
,	O
retention	O
,	O
and	O
production	O
of	O
biological	O
agents	O
and	O
toxins	O
in	O
types	O
and	O
in	O
quantities	O
that	O
have	O
no	O
justification	O
for	O
protective	O
or	O
peaceful	O
purposes	O
.	O

While	O
Germany	S-Organization
dabbled	O
with	O
biological	O
weapons	O
in	O
World	O
War	O
I	O
,	O
the	O
Japanese	O
military	O
practiced	O
biowarfare	O
on	O
a	O
mass	O
scale	O
in	O
the	O
years	O
leading	O
up	O
to	O
and	O
throughout	O
World	O
War	O
II	O
.	O

Medfly	O
sightings	O
occurred	O
in	O
Florida	S-Location
in	O
1997	O
and	O
2010	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here:	O
http://go.usa.gov/cuTXR	O
.	O

Adherence	B-Document
To	I-Document
and	I-Document
Compliance	I-Document
With	I-Document
Arms	I-Document
Control,	I-Document
Nonproliferation	I-Document
and	I-Document
Disarmament	I-Document
Agreements	I-Document
and	I-Document
Commitments	E-Document
,	O
Washington,	B-Location
DC	E-Location
:	O
US	B-Organization
Department	I-Organization
of	I-Organization
State	E-Organization
;	O
2005	O
.	O

Our	O
colleagues	O
at	O
the	O
Association	B-Organization
of	I-Organization
American	I-Organization
Universities	E-Organization
(	O
AAU	S-Organization
)	O
discussed	O
the	O
subject	O
with	O
senior	O
Administration	O
officials	O
on	O
Tuesday	O
,	O
August	O
26	O
,	O
and	O
received	O
permission	O
to	O
provide	O
additional	O
information	O
to	O
clarify	O
the	O
issue	O
under	O
consideration	O
by	O
the	O
Federal	B-Organization
government	E-Organization
for	O
the	O
research	O
community	O
.	O

6	O
.	O

As	O
part	O
of	O
the	O
'next	O
generation'	O
of	O
genetically	B-Technology
modified	E-Technology
(	O
GM	S-Technology
)	O
crops	O
,	O
PMPs	S-Drug
will	O
be	O
subject	O
to	O
additional	O
biosafety	O
considerations	O
and	O
are	O
set	O
to	O
challenge	O
the	O
complex	O
and	O
overlapping	O
regulations	O
that	O
currently	O
govern	O
GM	S-Technology
plants	O
,	O
plant	O
biologics	O
(see	O
Note	O
2)	O
and	O
'conventional'	O
pharmaceutical	O
production	O
.	O

Previous	O
experiences	O
of	O
laboratory	O
networks	O
have	O
reported	O
on	O
the	O
importance	O
of	O
quality	O
assurance	O
management	O
programs	O
,	O
including	O
reference	O
material	O
and	O
well-designed	O
validation	O
parameters	O
as	O
a	O
basis	O
for	O
inter-agency	O
cooperation	O
.	O

This	O
genetic	O
perturbation	O
is	O
necessary	O
for	O
fully	O
understanding	O
gene	O
function	O
and	O
epigenetic	O
regulation	O
.	O

More	O
than	O
2.	O
8	O
million	O
antibiotic-resistant	O
infections	O
occur	O
in	O
the	O
United	B-Location
States	E-Location
each	O
year	O
,	O
and	O
more	O
than	O
35,000	O
people	O
die	O
as	O
a	O
result	O
.	O

The	O
alert	O
included	O
a	O
rare	O
emergency	O
travel	O
advisory	O
to	O
international	O
travelers	O
,	O
healthcare	O
professionals	O
,	O
and	O
health	O
authorities	O
.	O

According	O
to	O
the	O
Brazil	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
,	O
846	O
confirmed	O
cases	O
and	O
260	O
deaths	O
were	O
reported	O
in	O
the	O
period	O
from	O
July	O
1	O
,	O
2017	O
to	O
March	O
6	O
of	O
this	O
year	O
.	O

Infections	O
by	O
fungi	O
are	O
a	O
cause	O
of	O
high	O
morbidity	O
and	O
mortality	O
in	O
immunocompromised	O
persons	O
,	O
such	O
as	O
those	O
with	O
HIV/AIDS	S-Disease
tuberculosis	S-Disease
or	O
receiving	O
chemotherapy	O
.	O

The	O
argument	O
for	O
the	O
Observatory	S-Scientific_research_project
is	O
that	O
anecdotal	O
information	O
gathered	O
from	O
outbreaks	O
as	O
they	O
occur	O
will	O
not	O
only	O
,	O
as	O
a	O
feedback	O
loop	O
,	O
improve	O
minute-to-minute	O
preparedness	O
,	O
but	O
it	O
could	O
shape	O
public	O
policy	O
and	O
public	O
perception	O
.	O

Unit	B-Organization
731	E-Organization
had	O
branches	O
in	O
Linkou	S-Location
(Branch	O
162)	O
,	O
Mudanjiang	S-Location
,	O
Hailin	S-Location
(Branch	O
643)	O
,	O
Sunwu	S-Location
(Branch	O
673)	O
,	O
Toan	S-Location
and	O
(Branch	O
543)	O
.	O

Officials	O
say	O
that	O
although	O
the	O
cases	O
of	O
the	O
current	O
monitoring	O
period	O
have	O
been	O
higher	O
than	O
the	O
past	O
seasons	O
,	O
the	O
yellow	B-Pathogen
fever	I-Pathogen
virus	E-Pathogen
now	O
circulates	O
in	O
metropolitan	O
regions	O
of	O
the	O
country	O
with	O
the	O
largest	O
population	O
,	O
reaching	O
32.	O
5	O
million	O
people	O
who	O
live	O
in	O
areas	O
that	O
have	O
never	O
had	O
a	O
recommendation	O
of	O
vaccine	O
.	O

A	O
massive	O
public	O
health	O
response	O
to	O
the	O
smallpox	B-Incident
cases	I-Incident
in	I-Incident
Aral	E-Incident
ensued	O
once	O
the	O
disease	O
was	O
recognized	O
.	O

These	O
books	O
purported	O
to	O
reveal	O
the	O
"	O
true"	O
operations	O
of	O
,	O
but	O
falsely	O
attributed	O
unrelated	O
photos	O
to	O
the	O
Unit	O
,	O
which	O
raised	O
questions	O
about	O
their	O
accuracy	O
.	O

Gerstein	S-Person
formerly	O
served	O
in	O
the	O
Science	B-Organization
and	I-Organization
Technology	I-Organization
Directorate	I-Organization
of	I-Organization
the	I-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
from	O
2011	O
to	O
2014	O
.	O

As	O
to	O
why	O
it	O
took	O
six	O
weeks	O
for	O
that	O
to	O
be	O
made	O
apparent	O
to	O
us	O
,	O
I	O
can	O
think	O
of	O
no	O
valid	O
explanation	O
.	O

Then	O
there	O
are	O
some	O
of	O
the	O
more	O
radical	O
practices:	O
cryotherapy	S-Technology
(purposely	O
making	O
yourself	O
cold)	O
,	O
neurofeedback	S-Technology
(training	O
yourself	O
to	O
regulate	O
your	O
brain	O
waves)	O
,	O
near-infrared	B-Technology
saunas	E-Technology
(they	O
supposedly	O
help	O
you	O
escape	O
stress	O
from	O
electromagnetic	O
transmissions)	O
,	O
and	O
(which	O
are	O
meant	O
to	O
induce	O
a	O
meditative	O
state	O
through	O
sensory	O
deprivation)	O
,	O
among	O
others	O
.	O

The	O
OECD	S-Organization
study	O
was	O
initiated	O
by	O
science	O
and	O
technology	O
ministers	O
and	O
has	O
been	O
recommended	O
for	O
adoption	O
by	O
the	O
executing	O
entities	O
.	O

Since	O
there	O
are	O
few	O
suitable	O
testing	O
centres	O
in	O
Western	B-Location
Africa	E-Location
,	O
this	O
delays	O
diagnosis.	O
a	O
number	O
of	O
rapid	O
diagnostic	O
tests	O
were	O
under	O
trial	O
.	O

Since	O
December	O
,	O
22	O
students	O
and	O
faculty	O
members	O
of	O
Lanzhou	B-Organization
University	E-Organization
have	O
tested	O
positive	O
for	O
brucella	S-Pathogen
antibody	O
,	O
among	O
whom	O
six	O
had	O
been	O
to	O
the	O
institute	O
.	O

The	O
BSL-3	B-Organization
Clinical	I-Organization
TB	I-Organization
Lab	E-Organization
uses	O
a	O
"	O
heat	B-Technology
kill	E-Technology
"	O
process	O
to	O
inactivate	O
tuberculosis	O
bacteria	O
isolated	O
from	O
patients	O
.	O

In	O
late	O
August	O
of	O
this	O
year	O
,	O
livestock	O
in	O
the	O
southeast	O
of	O
France	S-Location
became	O
infected	O
with	O
anthrax	S-Disease
--	O
the	O
most	O
serious	O
outbreak	O
in	O
20	O
years	O
,	O
according	O
to	O
the	O
French	O
media	O
.	O

The	O
Table	O
1	O
.	O

The	O
exact	O
role	O
of	O
the	O
board	O
in	O
the	O
process	O
has	O
been	O
a	O
subject	O
of	O
debate	O
,	O
but	O
the	O
practical	O
effect	O
has	O
always	O
been	O
small	O
.	O

Some	O
observers	O
have	O
accused	O
the	O
WHO	S-Organization
of	O
being	O
unable	O
to	O
risk	O
antagonizing	O
the	O
Chinese	O
government	O
,	O
as	O
otherwise	O
the	O
agency	O
would	O
not	O
have	O
been	O
able	O
stay	O
informed	O
on	O
the	O
domestic	O
state	O
of	O
the	O
outbreak	O
and	O
influence	O
response	O
measures	O
there	O
,	O
after	O
which	O
there	O
would	O
have	O
"	O
likely	O
have	O
been	O
a	O
raft	O
of	O
articles	O
criticizing	O
the	O
WHO	S-Organization
for	O
needlessly	O
offending	O
China	S-Location
at	O
a	O
time	O
of	O
crisis	O
and	O
hamstringing	O
its	O
own	O
ability	O
to	O
operate.	O
"	O
Through	O
this	O
,	O
experts	O
such	O
as	O
Dr	O
.	O

As	O
researchers	O
Hoffman	S-Person
and	O
Rizvi	S-Person
report	O
"	O
As	O
of	O
July	O
4	O
,	O
2012	O
,	O
361	O
(32·7%)	O
of	O
1104	O
countries'	O
responses	O
were	O
misreported:	O
33	O
(3·0%)	O
were	O
clear	O
errors	O
(e.g.	O
,	O
database	O
indicated	O
"	O
yes"	O
when	O
report	O
indicated	O
"	O
no"),	O
270	O
(24·5%)	O
were	O
missing	O
despite	O
countries	O
having	O
submitted	O
responses	O
,	O
and	O
58	O
(5·3%)	O
were	O
,	O
in	O
our	O
opinion	O
,	O
misinterpreted	O
by	O
staff"	O
.	O

The	O
initial	O
idea	O
of	O
having	O
more	O
or	O
less	O
identical	O
methods	O
in	O
all	O
4	O
laboratories	O
turned	O
out	O
to	O
be	O
unrealistic	O
,	O
as	O
the	O
different	O
agencies	O
are	O
responsible	O
for	O
different	O
sample	O
types-for	O
example	O
,	O
tissue	O
(human	O
and	O
animal)	O
,	O
food	O
,	O
feed	O
,	O
drinking	O
water	O
,	O
and	O
environmental	O
samples	O
.	O

Modern	O
medical	O
advances	O
are	O
unimaginable	O
without	O
the	O
ability	O
to	O
study	O
cells	O
and	O
proteins	O
with	O
rDNA	O
and	O
the	O
tools	O
used	O
to	O
make	O
it	O
,	O
such	O
as	O
PCR	S-Technology
which	O
helps	O
researchers	O
'copy	O
and	O
paste'	O
DNA	O
in	O
a	O
test	O
tube	O
.	O

Meselson	S-Person
's	O
original	O
contention	O
for	O
many	O
years	O
had	O
been	O
that	O
the	O
outbreak	O
was	O
a	O
natural	O
one	O
and	O
that	O
the	O
authorities	O
were	O
not	O
lying	O
when	O
they	O
disclaimed	O
having	O
an	O
active	O
offensive	O
bio-warfare	O
program	O
,	O
but	O
the	O
information	O
uncovered	O
in	O
the	O
investigation	O
left	O
no	O
room	O
for	O
doubt	O
.	O

An	O
international	O
group	O
of	O
scientists	O
called	O
for	O
a	O
global	O
moratorium	O
on	O
genetically	O
editing	O
human	O
embryos	O
.	O

With	O
a	O
focus	O
on	O
security	O
and	O
simplicity	O
,	O
designs	O
,	O
builds	O
,	O
manufactures	O
and	O
deploys	O
fully	O
integrated	O
,	O
evidence-based	O
hardware	O
and	O
software	O
telehealth	O
solutions	O
that	O
enable	O
medical	O
groups	O
,	O
healthcare	O
enterprises	O
and	O
government	O
entities	O
to	O
improve	O
patient	O
outcomes	O
while	O
lowering	O
cost	O
.	O

Its	O
parent	O
program	O
was	O
officially	O
known	O
as	O
the	O
.	O
Originally	O
set	O
up	O
under	O
the	O
Kempeitai	O
military	O
police	O
of	O
the	O
Empire	B-Organization
of	I-Organization
Japan	E-Organization
Unit	B-Organization
731	E-Organization
was	O
taken	O
over	O
and	O
commanded	O
until	O
the	O
end	O
of	O
the	O
war	O
by	O
General	O
Shirō	B-Person
Ishii	E-Person
,	O
a	O
combat	O
medic	O
officer	O
in	O
the	O
Kwantung	B-Organization
Army	E-Organization
.	O
The	O
facility	O
itself	O
was	O
built	O
in	O
1935	O
as	O
a	O
replacement	O
for	O
the	O
Zhongma	B-Location
Fortress	E-Location
,	O
and	O
to	O
expand	O
the	O
capabilities	O
for	O
Ishii	O
and	O
his	O
team	O
.	O

Kwik	S-Person
and	O
her	O
colleagues	O
,	O
recent	O
advances	O
in	O
aerosol	B-Technology
technology	E-Technology
,	O
microbiology	O
,	O
and	O
genetics	O
are	O
areas	O
of	O
concern	O
.	O

Iraq	S-Location
officially	O
acknowledged	O
that	O
it	O
had	O
worked	O
with	O
several	O
species	O
of	O
bacterial	O
pathogen	O
,	O
including	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Clostridium	B-Pathogen
botulinum	E-Pathogen
and	O
Clostridium	B-Pathogen
perfringens	E-Pathogen
(	O
gas	B-Pathogen
gangrene	E-Pathogen
)	O
and	O
several	O
viruses	O
(including	O
enterovirus	B-Pathogen
17	I-Pathogen
[human	I-Pathogen
conjunctivitis	E-Pathogen
]	O
,	O
rotavirus	S-Pathogen
and	O
camelpox	S-Pathogen
)	O
.	O

However	O
,	O
as	O
millions	O
of	O
are	O
performed	O
globally	O
each	O
year	O
,	O
fatalities	O
are	O
extremely	O
rare	O
.	O

GHSA	S-International_exchange_and_cooperation
which	O
launched	O
in	O
2014	O
,	O
is	O
a	O
worldwide	O
effort	O
to	O
combat	O
infectious	O
disease	O
threats	O
and	O
elevate	O
global	O
health	O
security	O
as	O
a	O
worldwide	O
priority	O
.	O

So	O
we	O
need	O
to	O
do	O
a	O
lot	O
of	O
work	O
ourselves	O
,	O
which	O
we	O
are	O
,	O
such	O
as	O
increasing	O
access	O
to	O
primary	O
health	O
care	O
,	O
making	O
sure	O
we're	O
able	O
to	O
diagnose	O
other	O
causes	O
of	O
fever	O
like	O
malaria	S-Pathogen
to	O
rule	O
them	O
out	O
.	O

New	B-Technology
iterative	I-Technology
tomographic	I-Technology
reconstruction	I-Technology
algorithms	E-Technology
(e.g.	O
,	O
iterative	O
Sparse	O
Asymptotic	O
Minimum	O
Variance)	O
could	O
offer	O
superresolution	O
without	O
requiring	O
higher	O
radiation	O
dose	O
.	O

The	O
IMF	S-Organization
has	O
been	O
criticised	O
for	O
its	O
lack	O
of	O
assistance	O
in	O
the	O
efforts	O
to	O
combat	O
the	O
epidemic	O
.	O

WHO	S-Organization
Leader	O
Outlines	O
Changes	O
in	O
Response	O
to	O
Ebola	B-Disease
Epidemic	E-Disease
.	O
.	O
and	O
on	O
23	O
March	O
,	O
she	O
stated	O
that	O
"	O
the	O
world	O
remains	O
woefully	O
ill-prepared	O
to	O
respond	O
to	O
outbreaks	O
that	O
are	O
both	O
severe	O
and	O
sustained.	O
"	O

Briefly	O
,	O
samples	O
from	O
patients	O
suspected	O
to	O
have	O
EVD	S-Disease
were	O
transferred	O
into	O
the	O
BSL-3	S-Platform
lab	O
in	O
a	O
specimen	O
container	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
,	O
after	O
decontamination	O
of	O
the	O
outside	O
of	O
the	O
container	O
with	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
.	O

Despite	O
the	O
events	O
of	O
40	O
years	O
ago	O
,	O
the	O
facility	O
still	O
exists	O
,	O
with	O
its	O
work	O
moved	O
underground	O
.	O

The	O
WHO	S-Organization
defines	O
antimicrobial	O
resistance	O
as	O
a	O
microorganism's	O
resistance	O
to	O
an	O
antimicrobial	O
drug	O
that	O
was	O
once	O
able	O
to	O
treat	O
an	O
infection	O
by	O
that	O
microorganism	O
.	O

Many	O
high-consequence	O
pathogens	O
are	O
rarely	O
,	O
or	O
have	O
never	O
been	O
,	O
encountered	O
in	O
real-life	O
situations	O
,	O
meaning	O
that	O
the	O
capacity	O
to	O
carry	O
out	O
the	O
relevant	O
methods	O
is	O
not	O
tested	O
on	O
a	O
regular	O
basis	O
.	O

The	O
grinder	O
ethic	O
can	O
be	O
especially	O
dangerous	O
.	O

During	O
next	O
week's	O
PAHPA	S-Document
hearing	O
,	O
the	O
senators	O
will	O
hear	O
from	O
non-governmental	O
witnesses	O
,	O
Sen.	O
said	O
.	O

GCBRs	O
are	O
events	O
in	O
which	O
biological	O
agents	O
could	O
lead	O
to	O
a	O
sudden	O
,	O
extraordinary	O
,	O
widespread	O
disaster	O
beyond	O
the	O
collective	O
capability	O
of	O
national	O
and	O
international	O
governments	O
and	O
the	O
private	O
sector	O
to	O
control	O
.	O

HHS	S-Organization
spokesman	O
said	O
Thursday	O
that	O
no	O
decision	O
has	O
been	O
made	O
on	O
full-scale	O
production	O
because	O
there	O
is	O
no	O
need	O
yet	O
to	O
make	O
that	O
decision	O
.	O

Self-isolation	O
at	O
home	O
has	O
been	O
recommended	O
for	O
those	O
diagnosed	O
with	O
COVID-19	S-Disease
and	O
those	O
who	O
suspect	O
they	O
have	O
been	O
infected	O
.	O

The	O
lobbying	O
activities	O
coincided	O
with	O
the	O
start	O
of	O
the	O
Pentagon	S-Organization
projects	O
on	O
bio-labs	O
in	O
and	O
other	O
former	O
Soviet	O
states	O
.	O

The	O
Iranian	O
government	O
has	O
been	O
heavily	O
affected	O
by	O
the	O
virus	O
,	O
with	O
about	O
two	O
dozen	O
parliament	O
members	O
and	O
fifteen	O
current	O
or	O
former	O
political	O
figures	O
infected	O
.	O

The	O
importance	O
of	O
detecting	O
different	O
viral	O
strains	O
in	O
research	O
and	O
clinic	O
is	O
discussed	O
.	O

How	O
serious	O
is	O
the	O
North	B-Location
Korean	E-Location
threat?	O

The	O
epidemic	O
there	O
killed	O
the	O
13	O
year-old	O
son	O
of	O
the	O
Byzantine	O
emperor	O
,	O
John	B-Person
VI	I-Person
Kantakouzenos	E-Person
,	O
who	O
wrote	O
a	O
description	O
of	O
the	O
disease	O
modelled	O
on	O
Thucydides	S-Person
's	O
account	O
of	O
the	O
5th	B-Incident
century	I-Incident
BCE	I-Incident
Plague	I-Incident
of	I-Incident
Athens	E-Incident
,	O
but	O
noting	O
the	O
spread	O
of	O
the	O
by	O
ship	O
between	O
maritime	O
cities	O
.	O

In	O
early	O
March	O
,	O
the	O
Italian	O
government	O
criticised	O
the	O
European	B-Organization
Union	E-Organization
lack	O
of	O
solidarity	O
with	O
coronavirus-affected	O
Italy-	O
Maurizio	B-Person
Massari	E-Person
,	O
Italy	S-Organization
's	O
ambassador	O
to	O
the	O
EU	S-Location
,	O
said	O
"	O
only	O
China	S-Location
responded	O
bilaterally"	O
,	O
not	O
the	O
EU	S-Location
.	O
On	O
22	O
March	O
,	O
after	O
a	O
phone	O
call	O
with	O
Italian	O
Prime	O
Minister	O
Giuseppe	B-Person
Conte	E-Person
,	O
Russian	O
president	O
Vladimir	B-Person
Putin	E-Person
had	O
the	O
Russian	O
army	O
send	O
military	O
medics	O
,	O
disinfection	O
vehicles	O
,	O
and	O
other	O
medical	O
equipment	O
to	O
Italy	S-Organization
.	O
President	O
of	O
Lombardy	S-Organization
Attilio	B-Person
Fontana	E-Person
and	O
Italian	O
Foreign	O
Minister	O
Luigi	B-Person
Di	I-Person
Maio	E-Person
expressed	O
their	O
gratitude	O
for	O
the	O
aid	O
.	O

One	O
theory	O
that	O
has	O
been	O
advanced	O
is	O
that	O
the	O
devastation	O
in	O
Florence	S-Location
caused	O
by	O
the	O
Black	B-Disease
Death	E-Disease
,	O
which	O
hit	O
Europe	S-Location
between	O
1348	O
and	O
1350	O
,	O
resulted	O
in	O
a	O
shift	O
in	O
the	O
world	O
view	O
of	O
people	O
in	O
14th-century	O
Italy	S-Location
and	O
led	O
to	O
the	O
Renaissance	O
.	O

The	O
maximum	O
gathering	O
size	O
recommended	O
by	O
U.S.	B-Organization
government	E-Organization
bodies	O
and	O
health	O
organisations	O
was	O
swiftly	O
reduced	O
from	O
250	O
people	O
(if	O
there	O
was	O
no	O
known	O
COVID-19	S-Disease
spread	O
in	O
a	O
region)	O
to	O
50	O
people	O
,	O
and	O
later	O
to	O
10	O
.	O

We	O
have	O
also	O
witnessed	O
extraordinary	O
resolve	O
and	O
courage	O
in	O
the	O
health	O
workers	O
in	O
who	O
–	O
in	O
the	O
face	O
of	O
mortal	O
danger	O
–	O
continued	O
to	O
treat	O
the	O
sick	O
.	O

Subsequent	O
pandemics	O
have	O
had	O
many	O
fewer	O
fatalities	O
due	O
to	O
the	O
development	O
of	O
antibiotic	O
medicines	O
which	O
can	O
treat	O
.	O

Corina	S-Person
can	O
also	O
be	O
found	O
walking	O
the	O
freezing	O
cold	O
streets	O
of	O
Berlin	S-Location
with	O
bare	O
legs	O
.	O

In	O
September	O
2014	O
,	O
the	O
estimated	O
R0	O
were	O
1.	O
71	O
(95% CI	O
,	O
1.44	O
to	O
2.	O
01)	O
for	O
Guinea	S-Location
1.	O
83	O
(95% CI	O
,	O
1.72	O
to	O
1.	O
94)	O
for	O
Liberia	S-Location
,	O
and	O
2.	O
02	O
(95% CI	O
,	O
1.79	O
to	O
2.	O
26)	O
for	O
.	O

CRVS	S-Platform
()	O
to	O
provide	O
monitoring	O
of	O
vital	O
events	O
(birth	O
,	O
death	O
,	O
wedding	O
,	O
divorce)	O
.	O

It	O
is	O
hard	O
to	O
bend	O
these	O
criteria	O
,	O
no	O
matter	O
what	O
the	O
motive"	O
.	O

Because	O
the	O
1918	O
gene	O
segments	O
have	O
more	O
synonymous	O
changes	O
from	O
known	O
sequences	O
of	O
wild	B-Pathogen
bird	I-Pathogen
strains	E-Pathogen
than	O
expected	O
,	O
they	O
are	O
unlikely	O
to	O
have	O
emerged	O
directly	O
from	O
an	O
avian	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
similar	O
to	O
those	O
that	O
have	O
been	O
sequenced	O
so	O
far	O
.	O

Between	O
April	O
2013	O
and	O
September	O
2014	O
,	O
eight	O
individual	O
mouse	O
escapes	O
were	O
reported	O
at	O
the	O
University	B-Organization
of	I-Organization
North	I-Organization
Carolina-Chapel	I-Organization
Hill	E-Organization

The	O
Japanese	O
defense	O
counsel	O
argued	O
that	O
the	O
claim	O
was	O
vague	O
and	O
uncorroborated	O
and	O
it	O
was	O
dismissed	O
by	O
the	O
tribunal	O
president	O
,	O
Sir	O
William	B-Person
Webb	E-Person
,	O
for	O
lack	O
of	O
evidence	O
.	O

Some	O
parts	O
needed	O
at	O
the	O
CDC	S-Organization
lab	O
are	O
no	O
longer	O
made	O
and	O
engineers	O
determined	O
a	O
new	O
building	O
is	O
necessary	O
because	O
of	O
the	O
complexity	O
of	O
the	O
systems	O
,	O
said	O
Dr.	O
,	O
who	O
oversees	O
much	O
of	O
the	O
lab	O
work	O
involving	O
dangerous	O
germs	O
.	O

Even	O
if	O
DARPA	S-Organization
funding	O
for	O
this	O
project	O
were	O
withdrawn	O
,	O
it	O
would	O
not	O
close	O
the	O
"	O
Pandora's	O
box	O
"	O
that	O
this	O
new	O
technology	O
represents	O
,	O
they	O
wrote	O
.	O

A	O
fourth	O
case	O
was	O
identified	O
on	O
23	O
October	O
2014	O
,	O
when	O
Craig	B-Person
Spencer	E-Person
an	O
American	O
physician	O
who	O
had	O
returned	O
to	O
the	O
United	B-Location
States	E-Location
after	O
treating	O
Ebola	S-Disease
patients	O
in	O
Western	B-Location
Africa	E-Location
,	O
tested	O
positive	O
for	O
the	O
virus	O
.	O

And	O
just	O
as	O
the	O
American	O
people	O
depend	O
on	O
CDC	S-Organization
to	O
protect	O
their	O
health	O
,	O
our	O
workers	O
should	O
be	O
able	O
to	O
depend	O
on	O
us	O
to	O
protect	O
their	O
health	O
.	O

Remdesivir	S-Drug
is	O
the	O
international	O
nonproprietary	O
name	O
(INN)	O
while	O
the	O
development	O
code	O
name	O
was	O
.	O

Over	O
a	O
dozen	O
"	O
public	O
health	O
insiders	O
,	O
including	O
current	O
and	O
former	O
CDC	S-Organization
senior	O
leaders	O
"	O
told	O
The	O
Trace	O
interviewers	O
that	O
CDC	S-Organization
senior	O
leaders	O
took	O
an	O
overly	O
cautious	O
stance	O
in	O
their	O
interpretation	O
of	O
the	O
Dickey	B-Document
amendment	E-Document
.	O
They	O
could	O
have	O
done	O
much	O
more	O
.	O

14	O
.	O

DARPA	S-Organization
will	O
hold	O
a	O
Proposers	O
Day	O
on	O
March	O
2	O
,	O
2018	O
,	O
in	O
Arlington	S-Location
,	O
Virginia	S-Location
,	O
to	O
provide	O
more	O
information	O
about	O
and	O
to	O
answer	O
questions	O
from	O
potential	O
proposers	O
.	O

In	O
2015	O
,	O
between	O
11	O
March	O
and	O
20	O
April	O
,	O
a	O
total	O
of	O
913	O
specimens	O
were	O
received	O
in	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
including	O
350	O
blood	O
specimens	O
and	O
563	O
throat	O
swabs	O
.	O

Parker's	B-Person
mother	E-Person
contracted	O
smallpox	S-Disease
on	O
7	O
September	O
,	O
despite	O
having	O
been	O
vaccinated	O
against	O
the	O
disease	O
on	O
24	O
August	O
.	O

To	O
overcome	O
the	O
inevitable	O
challenges	O
of	O
steering	O
cross-sector	O
collaboration	O
,	O
a	O
formal	O
agreement	O
between	O
directors	O
general	O
of	O
the	O
4	O
agencies	O
consolidates	O
the	O
FBD	S-Platform
network	O
.	O

Methods	O
to	O
control	O
the	O
spread	O
of	O
CRE	S-Pathogen
in	O
veterinary	O
medical	O
settings	O
have	O
not	O
yet	O
been	O
studied	O
;	O
these	O
studies	O
are	O
needed	O
to	O
limit	O
the	O
spread	O
of	O
these	O
pathogens	O
in	O
animal	O
populations	O
.	O

However	O
,	O
New	B-Location
York	I-Location
City	E-Location
as	O
an	O
entity	O
has	O
numerous	O
organizations	O
and	O
strategies	O
that	O
effectively	O
serve	O
to	O
deter	O
and	O
respond	O
to	O
bioterrorism	O
as	O
it	O
comes	O
.	O

By	O
shining	O
a	O
pattern	O
of	O
light	O
and	O
dark	O
onto	O
the	O
cells	O
,	O
the	O
team	O
of	O
scientists	O
created	O
a	O
matching	O
pattern	O
in	O
the	O
growing	O
bacteria	O
.	O

Symptoms	O
usually	O
begin	O
with	O
a	O
sudden	O
influenza-like	O
illness	O
characterised	O
by	O
feeling	B-Phenotype
tired	E-Phenotype
,	O
and	O
pain	B-Phenotype
in	I-Phenotype
the	I-Phenotype
muscles	I-Phenotype
and	I-Phenotype
joints	E-Phenotype
.	O
Later	O
symptoms	O
may	O
include	O
headache	S-Phenotype
,	O
nausea	S-Phenotype
,	O
and	O
abdominal	B-Phenotype
pain	E-Phenotype
;	O
this	O
is	O
often	O
followed	O
by	O
severe	O
vomiting	S-Phenotype
and	O
diarrhoea	S-Phenotype
.	O
In	O
past	O
outbreaks	O
,	O
it	O
has	O
been	O
noted	O
that	O
some	O
patients	O
bleed	B-Phenotype
internally	I-Phenotype
and/or	I-Phenotype
externally	E-Phenotype
;	O
however	O
data	O
published	O
in	O
October	O
2014	O
showed	O
that	O
this	O
had	O
been	O
a	O
rare	O
symptom	O
in	O
the	O
Western	B-Incident
African	I-Incident
outbreak	E-Incident
.	O
Another	O
study	O
published	O
in	O
October	O
2014	O
suggested	O
that	O
a	O
person's	O
genetic	O
makeup	O
may	O
play	O
a	O
major	O
role	O
in	O
determining	O
how	O
an	O
infected	O
person's	O
body	O
reacts	O
to	O
the	O
disease	O
,	O
with	O
some	O
infected	O
people	O
experiencing	O
mild	O
or	O
no	O
symptoms	O
while	O
others	O
progress	O
to	O
a	O
very	O
severe	O
stage	O
that	O
includes	O
.	O

In	O
August	O
,	O
a	O
well-known	O
Nigerian	O
physician	O
,	O
Ameyo	B-Person
Adadevoh	E-Person
,	O
died	O
.	O

Streaks	O
are	O
often	O
seen	O
around	O
materials	O
that	O
block	O
most	O
X-rays	O
,	O
such	O
as	O
metal	O
or	O
bone	O
.	O

Both	O
the	O
fish	O
and	O
the	O
cyanobacteria	O
grew	O
well	O
in	O
the	O
experiment	O
.	O

Ms	O
.	O

Of	O
the	O
eight	O
Millennium	O
Development	O
Goals	O
,	O
three	O
–	O
reducing	O
child	O
mortality	O
by	O
two-thirds	O
,	O
to	O
reduce	O
maternal	O
deaths	O
by	O
three-quarters	O
,	O
and	O
to	O
halt	O
and	O
begin	O
to	O
reduce	O
the	O
spread	O
of	O
HIV/AIDS	S-Disease
–	O
relate	O
directly	O
to	O
's	O
scope	O
;	O
the	O
other	O
five	O
inter-relate	O
and	O
affect	O
world	O
health	O
.	O

That	O
means	O
that	O
a	O
lot	O
of	O
biohacking	O
pursuits	O
exist	O
in	O
a	O
legal	O
gray	O
zone:	O
frowned	O
upon	O
by	O
bodies	O
like	O
the	O
FDA	S-Organization
but	O
not	O
yet	O
outright	O
illegal	O
,	O
or	O
not	O
enforced	O
as	O
such	O
.	O

The	O
European	B-Organization
Biosafety	I-Organization
Association	E-Organization
homepage	O
.	O

The	O
test	O
is	O
typically	O
done	O
on	O
respiratory	O
samples	O
obtained	O
by	O
a	O
nasopharyngeal	B-Equipment
swab	E-Equipment
;	O
however	O
,	O
a	B-Equipment
nasal	I-Equipment
swab	E-Equipment
or	O
sputum	O
sample	O
may	O
also	O
be	O
used	O
.	O

The	O
illness	O
is	O
characterized	O
with	O
a	O
high	O
temperature	B-Phenotype
of	I-Phenotype
about	I-Phenotype
39°C	E-Phenotype
hematemesis	S-Phenotype
,	O
diarrhea	B-Phenotype
with	I-Phenotype
blood	E-Phenotype
,	O
,	O
prostration	O
with	O
"	O
heavy"	O
articulations	O
,	O
and	O
rapid	O
evolution	O
death	O
after	O
a	O
mean	O
of	O
three	O
days	O
.	O

However	O
,	O
technologists	O
such	O
Joy	O
have	O
warned	O
of	O
the	O
potential	O
power	O
which	O
genetic	O
engineering	O
might	O
place	O
in	O
the	O
hands	O
of	O
future	O
bio-terrorists	O
.	O

Therapeutics	O
such	O
as	O
Emergent	S-Organization
antibody	O
VIGIV	S-Drug
,	O
or	O
Vaccinia	B-Drug
Immune	I-Drug
Globulin	I-Drug
Intravenous	E-Drug
,	O
the	O
only	O
polyclonal	O
antibody	O
therapeutic	O
licensed	O
by	O
the	O
FDA	S-Organization
to	O
counteract	O
certain	O
complications	O
from	O
the	O
smallpox	S-Disease
vaccination	O
.	O

Rapid	O
developments	O
in	O
biotechnology	O
,	O
genetics	O
and	O
genomics	O
are	O
undoubtedly	O
creating	O
a	O
variety	O
of	O
environmental	O
,	O
ethical	O
,	O
political	O
and	O
social	O
challenges	O
for	O
advanced	O
societies	O
.	O

They	O
are	O
usually	O
caused	O
by	O
the	O
variations	O
in	O
the	O
response	O
from	O
individual	O
elements	O
in	O
a	O
two	B-Equipment
dimensional	I-Equipment
X-ray	I-Equipment
detector	E-Equipment
due	O
to	O
defect	O
or	O
miscalibration	O
.	O

And	O
if	O
there's	O
a	O
failure	O
,	O
we	O
lose	O
an	O
essential	O
line	O
of	O
defense	O
"	O
against	O
disease	O
threats	O
,	O
said	O
the	O
CDC	S-Organization
former	O
director	O
,	O
Dr.	O
.	O

However	O
,	O
the	O
facility	O
continued	O
its	O
work	O
.	O

We	O
compared	O
and	O
analyzed	O
the	O
Biological	B-Document
Agent	I-Document
Laboratory	I-Document
Biosafety	I-Document
Category	I-Document
list	E-Document
and	O
the	O
defining	O
criteria	O
according	O
to	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
,	O
the	O
European	B-Organization
Union	E-Organization
(	O
EU	S-Location
)	O
and	O
China	S-Location
.	O
We	O
also	O
compared	O
and	O
analyzed	O
the	O
Biological	B-Document
Agent	I-Document
Biodefense	I-Document
Category	I-Document
list	E-Document
and	O
the	O
defining	O
criteria	O
according	O
to	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
of	O
the	O
United	B-Location
States	E-Location
,	O
the	O
EU	S-Location
and	O
.	O
The	O
results	O
show	O
some	O
inconsistencies	O
among	O
or	O
between	O
the	O
two	O
types	O
of	O
category	O
lists	O
and	O
criteria	O
.	O

Three	O
of	O
the	O
agencies-the	O
National	B-Organization
Veterinary	I-Organization
Institute	E-Organization
the	O
National	B-Organization
Food	I-Organization
Agency	E-Organization
,	O
and	O
the	O
Public	B-Organization
Health	I-Organization
Agency	E-Organization
of	O
Sweden	S-Location
-have	O
designated	O
responsibility	O
for	O
expertise	O
and	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
(risk	O
class	O
3	O
microorganisms)	O
within	O
their	O
sectors	O
.	O

On	O
9	O
April	O
,	O
James	B-Person
Earl	I-Person
Salisbury	E-Person
died	O
of	O
SARS	S-Disease
at	O
a	O
hospital	O
in	O
Hong	B-Location
Kong	E-Location
.	O
An	O
American	O
Mormon"Church	O
Member	O
Dies	O
of	O
SARS	S-Disease
"	O
,	O
11	O
April	O
2003	O
,	O
lds.org	O
.	O

We	O
are	O
especially	O
interested	O
in	O
connections	O
of	O
students	O
at	O
the	O
graduate	O
and	O
undergraduate	O
levels,	O
"	O
said	O
Riley	S-Person
who	O
is	O
professor	O
of	O
biological	O
systems	O
engineering	O
at	O
.	O

In	O
2001	O
,	O
anti-communist	O
histor	O
ian	B-Person
Herbert	I-Person
Romers	E-Person
tein	O
suppor	O
ted	B-Person
Weathe	E-Person
rsby	O
and	B-Person
Leiten	E-Person
berg	O
,	O
criticiz	O
ing	B-Person
Endi	E-Person
cott's	O
research	O
for	O
using	O
evidence	O
provided	O
by	O
ment	O
.	O

Additionally	O
,	O
the	O
outbreak	O
coincided	O
with	O
the	O
deaths	O
and	O
media	O
focus	O
on	O
the	O
First	B-Incident
World	I-Incident
War	E-Incident
Another	O
explanation	O
involves	O
the	O
age	O
group	O
affected	O
by	O
the	O
disease	O
.	O

And	O
this	O
summer	O
,	O
a	O
London	S-Location
museum	O
is	O
displaying	O
something	O
rather	O
less	O
fragrant:	O
cheese	O
made	O
from	O
celebrities	O
.	O

He	O
has	O
been	O
chair	O
or	O
a	O
member	O
of	O
several	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	I-Organization
committees	E-Organization
,	O
and	O
he	O
has	O
served	O
in	O
an	O
advisory	O
capacity	O
to	O
the	O
Defense	B-Organization
Science	I-Organization
Board	E-Organization
,	O
the	O
Departments	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
and	O
Homeland	B-Organization
Security	E-Organization
,	O
and	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
.Dr	O
.	O

From	O
here	O
the	O
logical	O
progression	O
is	O
into	O
the	O
realm	O
of	O
's	O
specific	O
strategies	O
to	O
prevent	O
bioterrorism	O
.	O

In	O
the	O
Four	O
Corners	O
area	O
,	O
there	O
were	O
3,293	O
registered	O
deaths	O
among	O
Native	O
Americans	O
.	O

Photon	B-Technology
counting	I-Technology
computed	I-Technology
tomography	E-Technology
is	O
a	O
CT	S-Technology
technique	O
currently	O
under	O
development	O
.	O

According	O
to	O
Jorgensen	S-Person
most	O
biohackers	O
are	O
safety-conscious	O
,	O
not	O
the	O
sorts	O
of	O
people	O
interested	O
in	O
engineering	O
a	O
pandemic	O
.	O

The	O
"	O
Spanish"	B-Incident
influenza	I-Incident
pandemic	I-Incident
of	I-Incident
1918–1919	E-Incident
which	O
caused	O
≈50	O
million	O
deaths	O
worldwide	O
,	O
remains	O
an	O
ominous	O
warning	O
to	O
public	O
health	O
.	O

Operation	B-Activity
Big	I-Activity
Buzz	E-Activity
1	O
million	O
A	O
.	O

The	O
Nordic	O
workshop	O
in	O
2016	O
was	O
funded	O
by	O
the	O
Nordic	B-Organization
Working	I-Organization
Group	I-Organization
for	I-Organization
Microbiology	I-Organization
and	I-Organization
Animal	I-Organization
Health	I-Organization
and	I-Organization
Welfare	E-Organization
(	O
NMDD	S-Organization
)	O
.	O

Its	O
name	O
was	O
Enza	S-Disease

This	O
method	O
relies	O
on	O
the	O
periodic	O
and	O
isolated	O
occurrence	O
of	O
DNA	O
damage	O
at	O
the	O
target	O
site	O
in	O
order	O
for	O
the	O
repair	O
to	O
commence	O
.	O

Other	O
countries	O
also	O
adopted	O
a	O
variety	O
of	O
measures	O
aimed	O
at	O
limiting	O
the	O
spread	O
of	O
the	O
virus	O
.	O

On	O
16	O
April	O
2014	O
,	O
Malaysia	S-Organization
reported	O
its	O
first	O
MERS-COV	S-Pathogen
related	O
death	O
.	O

Biological	O
Warfare	O
and	O
Biological	O
Defense	O
Programs	O
,	O
(PDF:	O
p.430	O
[p.	O
6	O
in	O
PDF])	O
,	O
Borden	O
Institute	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Air	O
University	O
.	O

The	O
team	O
used	O
a	O
modified	O
version	O
of	O
DARPA	S-Organization
Heilmeier	O
Catechism	O
to	O
standardize	O
the	O
process	O
of	O
evaluating	O
each	O
technology	O
and	O
formulating	O
guidance	O
for	O
funding	O
decisions	O
.	O

Fourteen	O
companion	O
dogs	O
and	O
one	O
cat	O
that	O
had	O
been	O
infected	O
with	O
carbapenem-resistant	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
(	O
CRE	S-Pathogen
)	O
were	O
treated	O
at	O
the	O
teaching	O
hospital.	O
is	O
a	O
family	O
of	O
bacteria	O
that	O
can	O
cause	O
difficult-to-treat	O
infections	O
.	O

The	O
major	O
components	O
of	O
an	O
MRI	B-Equipment
scanner	E-Equipment
are	O
the	O
main	O
magnet	O
,	O
which	O
polarizes	O
the	O
sample	O
,	O
the	O
shim	O
coils	O
for	O
correcting	O
shifts	O
in	O
the	O
homogeneity	O
of	O
the	O
main	O
magnetic	O
field	O
,	O
the	O
gradient	O
system	O
which	O
is	O
used	O
to	O
localize	O
the	O
region	O
to	O
be	O
scanned	O
and	O
the	O
RF	O
system	O
,	O
which	O
excites	O
the	O
sample	O
and	O
detects	O
the	O
resulting	O
signal	O
.	O

All	O
forms	O
involved	O
fever	S-Phenotype
,	O
exhaustion	S-Phenotype
and	O
an	O
intolerable	O
from	O
the	O
material	O
that	O
exuded	O
from	O
the	O
body	O
.	O

Pseudomallei	O
was	O
studied	O
by	O
the	O
US	O
as	O
a	O
potential	O
bioweapon	O
in	O
the	O
past	O
.	O

Largely	O
because	O
of	O
its	O
sunny	O
Mediterranean	O
climate	O
and	O
widespread	O
irrigation	O
,	O
California	S-Location
is	O
the	O
world's	O
fifth	O
largest	O
supplier	O
of	O
food	O
and	O
agriculture	O
commodities	O
.	O

"	O
The	O
detection	O
of	O
the	O
case	O
is	O
a	O
result	O
of	O
our	O
enhanced	O
surveillance	O
system	O
put	O
in	O
place	O
in	O
all	O
provinces	O
in	O
response	O
to	O
the	O
confirmed	O
polio	S-Disease
cases	O
in	O
Morobe	B-Location
Province	E-Location
,	O
"	O
said	O
Pascoe	B-Person
Kase	E-Person
,	O
Secretary	O
of	O
the	O
.	O

Sentinel	O
for	O
Health:	O
A	O
History	O
of	O
the	O
Centers	O
for	O
Disease	O
Control	O
.	O

In	O
the	O
emergency	O
department	O
in	O
the	O
United	B-Location
States	E-Location
,	O
is	O
done	O
in	O
15%	O
of	O
people	O
who	O
present	O
with	O
injuries	O
as	O
of	O
2007	O
(up	O
from	O
6%	O
in	O
1998)	O
.	O

The	O
Ukrainian	B-Organization
government	E-Organization
stopped	O
supplying	O
antitoxin	O
in	O
2014	O
and	O
no	O
in	O
stock	O
were	O
available	O
during	O
the	O
2016-2017	O
outbreak	O
.	O

Lyme	B-Pathogen
disease	E-Pathogen
alone	O
is	O
estimated	O
to	O
affect	O
more	O
than	O
300,000	O
Americans	O
each	O
year	O
,	O
with	O
the	O
number	O
of	O
cases	O
having	O
doubled	O
since	O
2004	O
.	O

More	O
and	O
more	O
,	O
germs	O
are	O
sharing	O
their	O
resistance	O
with	O
one	O
another	O
,	O
making	O
it	O
harder	O
for	O
us	O
to	O
keep	O
up	O
.	O

We	O
can	O
bolster	O
that	O
and	O
make	O
use	O
of	O
this	O
series	O
of	O
events	O
to	O
make	O
sure	O
that	O
in	O
the	O
future	O
;	O
there	O
is	O
much	O
less	O
likelihood	O
of	O
this	O
happening	O
again	O
.	O

Plague	S-Disease
repeatedly	O
struck	O
the	O
cities	O
of	O
North	B-Location
Africa	E-Location
.	O
Algiers	S-Organization
lost	O
30,000–50,000	O
inhabitants	O
to	O
it	O
in	O
1620–1621	O
,	O
and	O
again	O
in	O
1654–1657	O
,	O
1665	O
,	O
1691	O
,	O
and	O
1740–1742	O
.	O

As	O
of	O
,	O
more	O
than	O
cases	O
have	O
been	O
reported	O
across	O
countries	O
and	O
territories	O
,	O
resulting	O
in	O
more	O
than	O
deaths	O
.	O

A	O
full	O
program	O
description	O
will	O
be	O
made	O
available	O
in	O
a	O
forthcoming	O
Broad	O
Agency	O
Announcement	O
.	O

CRISPRs	S-Technology
are	O
much	O
easier	O
to	O
design	O
because	O
the	O
process	O
requires	O
synthesizing	O
only	O
a	O
short	O
RNA	O
sequence	O
,	O
a	O
procedure	O
that	O
is	O
already	O
widely	O
used	O
for	O
many	O
other	O
molecular	O
biology	O
techniques	O
(e.g.	O
creating	O
oligonucleotide	O
primers)	O
.	O

For	O
example	O
,	O
a	O
team	O
of	O
researchers	O
from	O
the	O
University	B-Organization
of	I-Organization
Sheffield	E-Organization
and	O
the	O
Rutherford	B-Organization
Appleton	I-Organization
Laboratory	E-Organization
,	O
in	O
Didcot	S-Location
-	O
both	O
in	O
the	O
United	B-Location
Kingdom	E-Location
-	O
started	O
developing	O
a	O
new	O
compound	O
earlier	O
this	O
year	O
that	O
they	O
hope	O
will	O
be	O
able	O
to	O
effectively	O
target	O
bacteria	O
,	O
particularly	O
strains	O
of	O
,	O
that	O
are	O
resistant	O
to	O
multiple	O
drugs	O
.	O

As	O
part	O
of	O
an	O
ongoing	O
effort	O
to	O
be	O
prepared	O
,	O
the	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
will	O
review	O
on	O
Wednesday	O
its	O
recommendations	O
for	O
mass	O
vaccination	O
in	O
the	O
event	O
of	O
an	O
.	O

Although	O
the	O
source	O
of	O
infection	O
was	O
traced	O
,	O
the	O
mode	O
and	O
cause	O
of	O
transmission	O
was	O
not	O
.	O

But	O
fewer	O
people	O
may	O
be	O
keeping	O
an	O
eye	O
on	O
another	O
,	O
potentially	O
bigger	O
danger:	O
anthrax	S-Pathogen

Follow	O
all	O
appropriate	O
guidelines	O
for	O
the	O
use	O
and	O
handling	O
of	O
infected	O
animals	O
.	O

A	O
workshop	O
will	O
be	O
organized	O
at	O
least	O
annually	O
,	O
hosted	O
by	O
each	O
country	O
in	O
turn	O
.	O

Suppression	O
can	O
be	O
preferred	O
but	O
needs	O
to	O
be	O
maintained	O
for	O
as	O
long	O
as	O
the	O
virus	O
is	O
circulating	O
in	O
the	O
human	O
population	O
(or	O
until	O
a	O
vaccine	O
becomes	O
available)	O
,	O
as	O
transmission	O
otherwise	O
quickly	O
rebounds	O
when	O
measures	O
are	O
relaxed	O
.	O

Our	O
labs	O
,	O
our	O
lab	O
scientists	O
are	O
a	O
national	O
treasure	O
.	O

Septicaemic	B-Disease
plague	E-Disease
is	O
the	O
least	O
common	O
of	O
the	O
three	O
forms	O
,	O
with	O
a	O
mortality	O
rate	O
near	O
100%	O
.	O

Heather	B-Person
Dewey-Hagborg	E-Person
is	O
an	O
information	O
artist	O
and	O
biohacker	O
who	O
uses	O
genomic	O
DNA	O
left	O
behind	O
by	O
people	O
as	O
a	O
starting	O
point	O
for	O
creating	O
lifelike	O
,	O
computer-generated	O
,	O
3-D	O
portraits	O
.	O

Many	O
of	O
the	O
law's	O
provisions	O
are	O
set	O
to	O
expire	O
in	O
September	O
.	O

Nearly	O
all	O
systems'	O
functionality	O
can	O
be	O
increased	O
via	O
extensions	O
which	O
sometimes	O
can	O
be	O
taken	O
from	O
a	O
pool	O
of	O
existing	O
software	O
.	O

Known	O
as	O
"	O
Spanish	B-Disease
Flu	E-Disease
"	O
or	O
"	O
"	O
the	O
influenza	O
of	O
1918-1919	O
was	O
a	O
global	O
disaster	O
.	O

Increased	O
citation	O
rates	O
are	O
a	O
profound	O
argument	O
for	O
sharing	O
publication	O
data	O
.	O

Founded	O
in	O
2002	O
by	O
a	O
Marine	O
Corps	O
Reserve	O
Veteran	O
still	O
serving	O
as	O
CEO	O
,	O
GlobalMed	S-Organization
is	O
proud	O
to	O
be	O
a	O
Veteran	O
Owned	O
Small	O
Business	O
(VOSB)	O
.	O

The	O
National	B-Organization
Polio	I-Organization
Response	I-Organization
Emergency	I-Organization
Operations	I-Organization
Centre	E-Organization
is	O
currently	O
updating	O
its	O
risk	O
assessment	O
and	O
planning	O
the	O
enhancement	O
of	O
response	O
operations	O
,	O
including	O
possible	O
expansion	O
of	O
vaccination	O
to	O
the	O
entire	O
region	O
.	O

A	O
UN	B-Organization
Crisis	I-Organization
Management	I-Organization
Team	E-Organization
was	O
activated	O
,	O
allowing	O
coordination	O
of	O
the	O
entire	O
United	B-Organization
Nations	E-Organization
,	O
which	O
the	O
WHO	S-Organization
stated	O
will	O
allow	O
them	O
to	O
"	O
focus	O
on	O
the	O
health	O
response	O
while	O
the	O
other	O
agencies	O
can	O
bring	O
their	O
expertise	O
to	O
bear	O
on	O
the	O
wider	O
social	O
,	O
economic	O
and	O
developmental	O
implications	O
of	O
the	O
outbreak"	O
.	O

Robert	B-Person
Leggiadro	E-Person
a	O
physician	O
in	O
New	B-Location
York	E-Location
with	O
a	O
background	O
in	O
infectious	O
disease	O
and	O
bioterrorism	O
,	O
told	O
Live	O
Science	O
that	O
although	O
Ebola	S-Pathogen
is	O
listed	O
by	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
as	O
a	O
possible	O
bioterrorism	O
agent	O
,	O
that	O
doesn't	O
necessarily	O
mean	O
the	O
virus	O
could	O
be	O
used	O
in	O
a	O
bomb	O
.	O

Most	O
scientific	O
and	O
medical	O
research	O
poses	O
a	O
negligible	O
risk	O
of	O
harms	O
at	O
the	O
scale	O
we	O
are	O
considering	O
.	O

Harbel	S-Location
Margibi	B-Location
County	E-Location
–	O
Animal	O
and	O
Human	O
health	O
experts	O
are	O
brainstorming	O
at	O
the	O
Farmington	B-Location
Hotel	E-Location
in	O
Margibi	B-Location
County	E-Location
to	O
develop	O
a	O
national	O
strategic	O
action	O
plan	O
for	O
rabies	S-Disease
prevention	O
and	O
control	O
in	O
.	O

This	O
testing	O
could	O
take	O
up	O
to	O
2	O
weeks	O
.	O

The	O
second	O
smallpox	S-Pathogen
store	O
resides	O
at	O
the	O
State	B-Organization
Research	I-Organization
Center	I-Organization
of	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	I-Organization
VECTOR	E-Organization
in	O
the	O
Russian	B-Location
Federation	E-Location
.	O
The	O
CDC	S-Organization
revealed	O
in	O
2014	O
that	O
it	O
had	O
discovered	O
several	O
misplaced	O
smallpox	S-Pathogen
samples	O
and	O
also	O
that	O
lab	O
workers	O
had	O
potentially	O
been	O
infected	O
with	O
.	O

The	O
United	B-Organization
States	I-Organization
Government	E-Organization
remains	O
a	O
strong	O
supporter	O
of	O
GHSA	S-International_exchange_and_cooperation
and	O
continues	O
to	O
demonstrate	O
leadership	O
through	O
our	O
engagement	O
in	O
multilateral	O
efforts	O
and	O
bilateral	O
capacity	O
building	O
programs	O
.	O

Public	B-Organization
Health	I-Organization
England	E-Organization
reported	O
that	O
the	O
total	O
number	O
of	O
antibiotic	O
resistant	O
infections	O
in	O
rose	O
by	O
9%	O
from	O
55,812	O
in	O
2017	O
to	O
60,788	O
in	O
2018	O
,	O
but	O
antibiotic	O
consumption	O
had	O
fallen	O
by	O
9%	O
from	O
20.0	O
to	O
18.	O
2	O
defined	O
daily	O
doses	O
per	O
1,000	O
inhabitants	O
per	O
day	O
between	O
2014	O
and	O
2018	O
.	O

Primary	O
hazards	O
to	O
personnel	O
working	O
with	O
these	O
agents	O
relate	O
to	O
autoinoculation	O
,	O
ingestion	O
,	O
and	O
exposure	O
to	O
infectious	O
aerosols	O
.	O

Botulinum	B-Pathogen
toxin	E-Pathogen
The	O
neurotoxin	B-Pathogen
Botulinum	E-Pathogen
is	O
the	O
deadliest	O
toxin	O
known	O
to	O
man	O
,	O
and	O
is	O
produced	O
by	O
the	O
bacterium	B-Pathogen
Clostridium	I-Pathogen
botulinum	E-Pathogen
.	O
Botulism	S-Pathogen
causes	O
death	O
by	O
respiratory	B-Disease
failure	E-Disease
and	O
.	O
Furthermore	O
,	O
the	O
toxin	O
is	O
readily	O
available	O
worldwide	O
due	O
to	O
its	O
cosmetic	O
applications	O
in	O
injections	O
.	O

HELEN	B-Person
BRANSWELL	E-Person
Hi	O
.	O

The	O
development	O
of	O
reliable	O
,	O
effective	O
biological	O
weapons	O
requires	O
an	O
intense	O
and	O
resource-demanding	O
research	O
programme	O
that	O
must	O
,	O
step	O
by	O
step	O
,	O
solve	O
increasingly	O
complex	O
problems:	O
the	O
procurement	O
of	O
virulent	O
strains	O
of	O
suitable	O
agents	O
,	O
the	O
mass	O
production	O
of	O
the	O
agents	O
without	O
loss	O
of	O
pathogenicity	O
,	O
and	O
the	O
development	O
of	O
an	O
effective	O
means	O
of	O
delivery	O
.	O

According	O
to	O
a	O
partially	O
declassified	O
1981	O
US	B-Organization
Army	E-Organization
report	O
,	O
American	S-Organization
bio	O
warfare	O
scientists	O
carried	O
out	O
a	O
number	O
of	O
experiments	O
on	O
insects	O
.	O

Problems	O
he	O
was	O
seeing	O
included	O
chronic	B-Phenotype
pain	E-Phenotype
,	O
sometimes	O
so	O
severe	O
that	O
walking	O
was	O
difficult	O
;	O
eye	O
problems	O
,	O
including	O
uveitis	S-Disease
;	O
and	O
headaches	S-Phenotype
as	O
the	O
most	O
common	O
physical	O
symptoms.	O
"	O
They're	O
still	O
very	O
severe	O
and	O
impacting	O
their	O
life	O
every	O
day	O
.	O

R0	O
can	O
vary	O
across	O
populations	O
and	O
is	O
not	O
to	O
be	O
confused	O
with	O
the	O
effective	O
reproduction	O
number	O
(commonly	O
just	O
called	O
R)	O
,	O
which	O
takes	O
into	O
account	O
effects	O
such	O
as	O
social	O
distancing	O
and	O
herd	O
immunity	O
.	O

The	O
CDC	S-Organization
and	O
other	O
U.S.	B-Organization
governmental	I-Organization
agencies	E-Organization
used	O
the	O
summer	O
lull	O
to	O
take	O
stock	O
of	O
the	O
United	B-Location
States	E-Location
response	O
to	O
H1N1	B-Disease
flu	E-Disease
and	O
attempt	O
to	O
patch	O
any	O
gaps	O
in	O
the	O
public	O
health	O
safety	O
net	O
before	O
flu	O
season	O
started	O
in	O
early	O
autumn	O
.	O

HDTRA1-13-C-0018	O
;	O
the	O
Department	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services'	I-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(U19AI109711	O
,	O
U19AI109762	O
,	O
HHSN2722011000221)	O
and	O
Office	B-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
,	O
and	O
,	O
under	O
Contract	O
No	O
.	O

Dave	B-Person
Asprey	E-Person
a	O
biohacker	O
who	O
created	O
the	O
supplement	O
company	O
,	O
told	O
me	O
that	O
for	O
him	O
,	O
biohacking	O
is	O
"	O
the	O
art	O
and	O
science	O
of	O
changing	O
the	O
environment	O
around	O
you	O
and	O
inside	O
you	O
so	O
that	O
you	O
have	O
full	O
control	O
over	O
your	O
own	O
biology.	O
"	O
He's	O
very	O
game	O
to	O
experiment	O
on	O
his	O
body:	O
He	O
has	O
stem	O
cells	O
injected	O
into	O
his	O
joints	O
,	O
takes	O
dozens	O
of	O
supplements	O
daily	O
,	O
bathes	O
in	O
infrared	O
light	O
,	O
and	O
much	O
more	O
.	O

In	O
the	O
House	S-Organization
the	O
Brooks-Eshoo	O
discussion	O
draft	O
most	O
notably	O
addresses	O
the	O
control	O
shift	O
of	O
the	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
(	O
SNS	S-Platform
)	O
from	O
the	O
CDC	S-Organization
to	O
the	O
ASPR	S-Organization
.	O
Such	O
language	O
isn't	O
included	O
in	O
the	O
bill	O
regarding	O
the	O
federal	O
government's	O
$7-billion	O
storehouse	O
of	O
drugs	O
,	O
supplies	O
and	O
vaccines	O
that	O
are	O
on	O
standby	O
for	O
deployment	O
in	O
the	O
event	O
of	O
a	O
pandemic	O
,	O
infectious	O
disease	O
outbreak	O
,	O
bioterror	O
attack	O
,	O
or	O
chemical	O
accident	O
-	O
whatever	O
large-scale	O
public	O
health	O
emergency	O
that	O
might	O
affect	O
massive	O
numbers	O
of	O
people	O
.	O

During	O
this	O
period	O
,	O
State	O
and	O
Defense	O
developed	O
substantial	O
expertise	O
in	O
training	O
scientific	O
and	O
laboratory	O
personnel	O
in	O
biosafety	O
and	O
biosecurity	O
best	O
practices	O
,	O
securing	O
collections	O
of	O
pathogens	O
such	O
as	O
Ebola	S-Pathogen
and	O
anthrax	S-Pathogen
,	O
and	O
improving	O
disease	O
detection	O
systems	O
.	O

The	O
Government	O
envisions	O
a	O
single	O
award	O
ID/IQ	O
contract	O
,	O
in	O
which	O
Task	O
Orders	O
will	O
be	O
issued	O
for	O
specific	O
services	O
.	O

The	O
United	B-Location
States	E-Location
will	O
seek	O
agreement	O
on	O
measures	O
to	O
improve	O
national	O
implementation	O
of	O
the	O
Convention's	O
prohibitions	O
on	O
biological	O
weapons	O
and	O
improve	O
coordination	O
of	O
international	O
assistance	O
in	O
the	O
event	O
of	O
outbreaks	O
of	O
infectious	O
disease	O
,	O
whether	O
caused	O
naturally	O
–	O
as	O
in	O
the	O
case	O
of	O
–	O
or	O
intentionally	O
.	O

Image	O
Caption:	O
The	O
potential	O
threats	O
posed	O
by	O
unfamiliar	O
bacteria	O
can	O
evade	O
state-of-the-art	O
forensics	O
technology	O
,	O
which	O
requires	O
existing	O
knowledge	O
of	O
a	O
bacterium's	O
function	O
or	O
biochemical	O
makeup	O
.	O

The	O
EBOV	S-Pathogen
genome	O
is	O
a	O
single-stranded	O
RNA	O
approximately	O
19,000	O
nucleotides	O
long	O
.	O

The	O
head	O
of	O
Unit	B-Organization
731	E-Organization
,	O
Shiro	B-Person
Ishii	E-Person
,	O
was	O
granted	O
immunity	O
from	O
war	O
crimes	O
prosecution	O
in	O
exchange	O
for	O
providing	O
information	O
to	O
the	O
United	B-Location
States	E-Location
on	O
the	O
Unit's	O
activities	O
.	O

The	O
development	O
and	O
implementation	O
of	O
an	O
effective	O
national	O
biosafety	O
system	O
is	O
important	O
for	O
several	O
key	O
reasons:	O
to	O
ensure	O
safe	O
access	O
to	O
products	O
of	O
modern	O
biotechnology	O
,	O
to	O
build	O
public	O
confidence	O
,	O
to	O
encourage	O
the	O
growth	O
of	O
domestic	O
modern	O
biotechnology	O
,	O
and	O
to	O
comply	O
with	O
international	O
standards	O
and	O
agreements	O
.	O

Practically	O
,	O
preparation	O
of	O
a	O
national	O
biotechnology	O
strategic	O
plan	O
in	O
the	O
country	O
coincided	O
with	O
development	O
of	O
a	O
national	O
biosafety	O
framework	O
that	O
was	O
the	O
basis	O
for	O
the	O
drafted	O
biosafety	O
law	O
.	O

We	O
must	O
take	O
advantage	O
of	O
the	O
bridge	O
funding	O
provided	O
in	O
the	O
administration's	O
budget	O
to	O
ensure	O
the	O
men	O
and	O
women	O
of	O
are	O
able	O
to	O
hunt	O
disease	O
threats	O
across	O
the	O
globe	O
,	O
to	O
save	O
lives	O
and	O
to	O
protect	O
American	O
jobs	O
by	O
ensuring	O
strong	O
economies	O
.	O

We've	O
looked	O
carefully	O
at	O
the	O
factors	O
that	O
led	O
to	O
that	O
mistake	O
.	O

With	O
false	O
rumors	O
being	O
spread	O
by	O
word-of-mouth	O
and	O
social	O
media	O
,	O
residents	O
remain	O
mistrustful	O
and	O
fearful	O
of	O
health	O
care	O
workers	O
.	O

The	O
End	O
of	O
Europe	S-Location
's	O
Middle	O
Ages:	O
The	O
Black	B-Organization
Death	I-Organization
University	I-Organization
of	I-Organization
Calgary	E-Organization
website.	O
(Retrieved	O
on	O
April	O
5	O
,	O
2007)	O
However	O
,	O
this	O
does	O
not	O
fully	O
explain	O
why	O
the	O
Renaissance	O
occurred	O
specifically	O
in	O
Italy	S-Location
in	O
the	O
14th	O
century	O
.	O

The	O
basic	O
challenge	O
is	O
to	O
convince	O
the	O
participants	O
on	O
all	O
levels	O
(PI	O
to	O
technician)	O
of	O
the	O
necessity	O
to	O
share	O
experimental	O
data	O
and	O
reliably	O
use	O
data	O
management	O
systems	O
.	O

In	O
October	O
2014	O
,	O
a	O
World	B-Organization
Bank	E-Organization
report	O
estimated	O
overall	O
economic	O
impacts	O
of	O
between	O
$3.8	O
billion	O
and	O
$32.6	O
billion	O
,	O
depending	O
on	O
the	O
extent	O
of	O
the	O
outbreak	O
and	O
speed	O
of	O
containment	O
.	O

Institutional	B-Organization
Review	I-Organization
Board	E-Organization
approval	O
was	O
obtained	O
through	O
the	O
Aga	B-Organization
Khan	I-Organization
University	E-Organization
in	O
Karachi	S-Location
,	O
.	O
Survey	O
subjects	O
were	O
identified	O
by	O
the	O
country	O
coordinators	O
.	O

The	O
Home	B-Organization
Safety	I-Organization
Council	E-Organization
is	O
a	O
501(c)(3)	O
charitable	O
organization	O
located	O
in	O
.	O

To	O
comply	O
with	O
these	O
regulations	O
,	O
several	O
European	O
laboratory	O
networks	O
have	O
been	O
established	O
.	O

Medical	B-Technology
imaging	E-Technology
as	O
of	O
2007	O
accounted	O
for	O
half	O
of	O
the	O
radiation	B-Incident
exposure	E-Incident
of	O
those	O
in	O
the	O
United	B-Location
States	E-Location
with	O
CT	S-Technology
scans	O
making	O
up	O
two	O
thirds	O
of	O
this	O
amount	O
.	O

The	O
catch?	O
All	O
of	O
these	O
bacteria	O
infect	O
people	O
who	O
have	O
recently	O
received	O
medical	O
attention	O
and	O
who	O
,	O
usually	O
,	O
are	O
still	O
in	O
the	O
hospital	O
.	O

If	O
you've	O
watched	O
HBO	S-Organization
,	O
then	O
you're	O
already	O
familiar	O
with	O
young	O
blood	O
transfusions	O
.	O

There	O
will	O
be	O
new	O
diseases	O
.	O

Many	O
different	O
artifacts	O
can	O
occur	O
during	O
magnetic	B-Technology
resonance	I-Technology
imaging	E-Technology
()	O
,	O
some	O
affecting	O
the	O
diagnostic	O
quality	O
,	O
while	O
others	O
may	O
be	O
confused	O
with	O
pathology	O
.	O

On	O
17	O
August	O
2018	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
"	O
contacts"	O
numbered	O
about	O
1,500	O
individuals	O
,	O
however	O
there	O
could	O
be	O
more	O
in	O
certain	O
conflict	O
zones	O
in	O
the	O
DRC	S-Location
that	O
can	O
not	O
be	O
reached	O
.	O

Officials	O
with	O
USAMRIID	S-Organization
declined	O
to	O
be	O
interviewed	O
.	O

Scott	B-Person
Gottlieb	E-Person
commissioner	O
of	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
()	O
,	O
pointed	O
out	O
that	O
for	O
many	O
threats	O
there	O
is	O
not	O
yet	O
adequate	O
regulatory	O
science	O
foundation	O
,	O
such	O
as	O
animal	O
models	O
that	O
support	O
medical	O
countermeasure	O
development	O
or	O
sufficient	O
biomarkers	O
to	O
enable	O
the	O
extrapolation	O
of	O
data	O
generated	O
in	O
animal	O
models	O
to	O
humans	O
.	O

The	O
convention	O
bound	O
its	O
signatories	O
to	O
a	O
far	O
more	O
stringent	O
set	O
of	O
regulations	O
than	O
had	O
been	O
envisioned	O
by	O
the	O
1925	O
.	O
By	O
1996	O
,	O
137	O
countries	O
had	O
signed	O
the	O
treaty	O
;	O
however	O
it	O
is	O
believed	O
that	O
since	O
the	O
signing	O
of	O
the	O
Convention	O
the	O
number	O
of	O
countries	O
capable	O
of	O
producing	O
such	O
weapons	O
has	O
increased	O
.	O

The	O
fire	O
was	O
caused	O
by	O
the	O
explosion	O
of	O
a	O
gas	O
canister	O
during	O
refurbishment	O
work	O
at	O
the	O
Vektor	B-Organization
centre	E-Organization
in	O
Koltsovo	S-Location
,	O
a	O
town	O
near	O
Novosibirsk	S-Location
in	O
.	O

The	O
Al	B-Drug
Hakum	E-Drug
facility	O
began	O
mass	O
production	O
of	O
weapons-grade	O
anthrax	S-Pathogen
in	O
1989	O
,	O
eventually	O
producing	O
8,000	O
liters	O
or	O
more	O
(the	O
8,000	O
liter	O
figure	O
is	O
based	O
on	O
declared	O
amounts)	O
.	O

The	O
program	O
was	O
aimed	O
at	O
rebuilding	O
WHO	S-Organization
capacity	O
for	O
direct	O
action	O
,	O
which	O
critics	O
said	O
had	O
been	O
lost	O
due	O
to	O
budget	O
cuts	O
in	O
the	O
previous	O
decade	O
that	O
had	O
left	O
the	O
organization	O
in	O
an	O
advisory	O
role	O
dependent	O
on	O
member	O
states	O
for	O
on-the-ground	O
activities	O
.	O

His	O
use	O
of	O
the	O
phrase	O
is	O
not	O
connected	O
unambiguously	O
with	O
the	O
and	O
appears	O
to	O
refer	O
to	O
the	O
fatal	O
outcome	O
of	O
disease	O
.	O

There	O
is	O
no	O
single	O
best	O
approach	O
in	O
the	O
development	O
and	O
implementation	O
of	O
a	O
national	O
biosafety	O
system	O
and	O
each	O
country	O
is	O
faced	O
with	O
unique	O
challenges	O
.	O

Leishmaniasis	S-Disease
is	O
caused	O
by	O
protozoa	O
and	O
is	O
an	O
important	O
public	O
health	O
problem	O
worldwide	O
,	O
especially	O
in	O
sub-tropical	O
and	O
tropical	O
countries	O
.	O

But	O
they	O
exist	O
.	O

At	O
Google	O
Books	O
.	O

Furthermore	O
,	O
there	O
is	O
no	O
provision	O
to	O
establish	O
an	O
independent	O
national	O
biosafety	O
decision-making	O
body(ies)	O
.	O

The	O
OFW	O
,	O
who	O
was	O
working	O
as	O
a	O
nurse	O
in	O
the	O
UAE	S-Location
,	O
had	O
contact	O
with	O
a	O
Filipino	O
paramedic	O
who	O
had	O
died	O
recently	O
in	O
the	O
said	O
country	O
.	O

Because	O
investigations	O
into	O
LAI	S-Disease
showed	O
that	O
certain	O
micro-organisms	O
were	O
more	O
likely	O
to	O
be	O
involved	O
than	O
the	O
others	O
,	O
several	O
attempts	O
have	O
been	O
made	O
to	O
classify	O
human	O
and	O
animal	O
pathogens	O
according	O
to	O
the	O
risks	O
they	O
present	O
to	O
the	O
health	O
of	O
laboratory	O
workers	O
and	O
to	O
the	O
human	O
and	O
animal	O
community	O
should	O
they	O
escape	O
from	O
the	O
laboratory	O
.	O

Furthermore	O
,	O
as	O
we	O
mentioned	O
above	O
with	O
regard	O
to	O
the	O
smallpox	S-Pathogen
genome	O
sequence	O
,	O
it	O
might	O
also	O
be	O
necessary	O
to	O
apply	O
restrictions	O
to	O
certain	O
research	O
and/or	O
publications	O
.	O

In	O
smaller	O
projects	O
,	O
data	O
management	O
is	O
often	O
realized	O
via	O
a	O
wiki	O
or	O
similar	O
content	O
management	O
systems-systems	O
managing	O
arbitrary	O
contents	O
of	O
web	O
pages	O
.	O

Fire	B-Equipment
alarm	I-Equipment
system	E-Equipment
was	O
found	O
in	O
2	O
(1.	O
1%)	O
laboratories	O
,	O
fire	B-Equipment
extinguisher	E-Equipment
in	O
39	O
(20.	O
5%)	O
laboratories	O
,	O
and	O
fire	O
emergency	O
exit	O
found	O
in	O
14	O
(7.	O
4%)	O
laboratories	O
.	O

The	O
Aral	B-Incident
smallpox	I-Incident
incident	E-Incident
was	O
a	O
July	O
30	O
,	O
1971	O
outbreak	O
of	O
the	O
viral	O
disease	O
which	O
occurred	O
as	O
a	O
result	O
of	O
a	O
field	O
test	O
at	O
a	O
Soviet	B-Location
biological	I-Location
weapons	I-Location
(BW)	I-Location
facility	E-Location
on	O
an	O
island	O
in	O
the	O
Aral	B-Location
Sea	E-Location
.	O
The	O
incident	O
sickened	O
ten	O
people	O
,	O
of	O
whom	O
three	O
died	O
,	O
and	O
came	O
to	O
widespread	O
public	O
notice	O
only	O
in	O
2002	O
.	O

CDC	S-Organization
believes	O
that	O
other	O
staff	O
,	O
family	O
and	O
friends	O
are	O
not	O
at	O
risk	O
.	O

Yang's	O
white	O
button	O
mushroom	O
was	O
the	O
first	O
organism	O
genetically	O
modified	O
with	O
the	O
protein	O
system	O
to	O
pass	O
US	O
regulation	O
.	O

Before	O
synthetic	B-Technology
biology	E-Technology
genetic	O
engineering	O
was	O
largely	O
just	O
genetics	O
.	O

Countless	O
examples	O
from	O
the	O
daily	O
work	O
of	O
molecular	O
biologists	O
could	O
be	O
presented	O
here	O
,	O
not	O
least	O
the	O
introduction	O
of	O
antibiotic	O
resistance	O
into	O
bacterial	O
pathogens	O
,	O
which	O
today	O
is	O
routine	O
work	O
in	O
almost	O
any	O
microbiology	O
laboratory	O
.	O

The	O
physician	O
to	O
the	O
Avignon	B-Organization
Papacy	E-Organization
Raimundo	B-Person
Chalmel	I-Person
de	I-Person
Vinario	E-Person
()	O
,	O
observed	O
the	O
decreasing	O
mortality	O
rate	O
of	O
successive	O
outbreaks	O
of	O
plague	S-Disease
in	O
1347-8	O
,	O
1362	O
,	O
1371	O
,	O
and	O
1382	O
in	O
his	O
1382	O
treatise	O
On	O
Epidemics	O
()	O
.	O

The	O
use	O
of	O
these	O
items	O
is	O
appropriate	O
even	O
during	O
research	O
of	O
minimal	O
biosafety	O
concern	O
.	O

Division	O
1:	O
Research	O
on	O
bubonic	B-Pathogen
plague	E-Pathogen
cholera	S-Pathogen
,	O
anthrax	S-Pathogen
,	O
typhoid	S-Pathogen
and	O
using	O
live	O
human	O
subjects	O
.	O

On	O
29	O
December	O
2014	O
,	O
Pauline	B-Person
Cafferkey	E-Person
a	O
British	O
aid	O
worker	O
who	O
had	O
just	O
returned	O
to	O
Glasgow	S-Location
from	O
Sierra	B-Location
Leone	E-Location
,	O
was	O
diagnosed	O
with	O
Ebola	S-Disease
.	O
She	O
was	O
treated	O
and	O
declared	O
to	O
be	O
free	O
of	O
infection	O
and	O
released	O
from	O
hospital	O
on	O
24	O
January	O
2015	O
.	O

Increasing	O
the	O
alert	O
to	O
Phase	O
6	O
does	O
not	O
mean	O
that	O
the	O
disease	O
is	O
deadlier	O
or	O
more	O
dangerous	O
than	O
before	O
,	O
just	O
that	O
it	O
has	O
spread	O
to	O
more	O
countries	O
,	O
the	O
WHO	S-Organization
said	O
.	O

The	O
study	O
found	O
that	O
32	O
(16.	O
	S-Equipment
of	O
labs	O
appointed	O
biosafety	O
officers	O
,	O
while	O
75	O
(39.	O
5%)	O
working	O
in	O
these	O
laboratories	O
indicated	O
that	O
they	O
attended	O
biosafety	O
training	O
previously	O
.	O

Cas9	O
proteins	O
select	O
the	O
correct	O
location	O
on	O
the	O
host's	O
genome	O
by	O
utilizing	O
the	O
sequence	O
to	O
bond	O
with	O
base	O
pairs	O
on	O
the	O
host	O
DNA	O
.	O

Based	O
on	O
the	O
quality	O
assurance	O
requirement	O
,	O
contamination	O
of	O
the	O
laboratory	O
region	O
with	O
EBOV	B-Pathogen
RNA	E-Pathogen
should	O
be	O
evaluated	O
by	O
real-time	O
RT-PCR	S-Equipment
every	O
2	O
months	O
,	O
so	O
the	O
first	O
evaluation	O
had	O
been	O
done	O
at	O
the	O
end	O
of	O
the	O
mission	O
.	O

The	O
group	O
threatened	O
to	O
spread	O
the	O
infestation	O
into	O
the	O
farm-rich	O
San	B-Location
Joaquin	I-Location
Valley	E-Location
if	O
aerial	O
spraying	O
is	O
not	O
stopped	O
in	O
the	O
area	O
.	O

Highly	O
contagious	O
,	O
it	O
is	O
caused	O
by	O
the	O
variola	B-Pathogen
virus	E-Pathogen
.	O
Symptoms	O
include	O
fever	S-Phenotype
and	O
a	O
distinctive	O
that	O
spreads	O
all	O
over	O
the	O
body	O
.	O

Thereafter	O
,	O
many	O
funding	O
organizations	O
,	O
journals	O
and	O
scientific	O
institutions-e.g	O
.	O

Spores	O
of	O
weaponized	O
anthrax	S-Pathogen
were	O
accidentally	O
released	O
from	O
a	O
military	O
facility	O
near	O
the	O
city	O
of	O
Sverdlovsk	S-Location
in	O
1979	O
.	O

The	O
clinical	O
isolates	O
were	O
collected	O
from	O
infected	O
patients	O
located	O
in	O
Bhutan	S-Location
,	O
Cambodia	S-Location
,	O
Nepal	S-Location
and	O
Thailand	S-Location
between	O
1993	O
and	O
2016	O
,	O
allowing	O
researchers	O
to	O
measure	O
the	O
impact	O
of	O
Travelan®	S-Drug
antibodies	O
on	O
recent	O
infectious	O
bacterial	O
strains	O
in	O
the	O
field	O
.	O

In	O
2011	O
,	O
28	O
students	O
and	O
staff	O
at	O
an	O
agricultural	O
university	O
also	O
in	O
Heilongjiang	B-Location
province	E-Location
,	O
were	O
infected	O
with	O
from	O
goats	O
.	O

The	O
infected	O
individual	O
was	O
a	O
69-year-old	O
Greek	O
male	O
who	O
had	O
returned	O
to	O
Greece	S-Location
on	O
17	O
April	O
from	O
.	O
People	O
with	O
close	O
contact	O
with	O
the	O
infected	O
man	O
were	O
identified	O
and	O
were	O
being	O
followed	O
up	O
.	O

On	O
17	O
December	O
President	B-Person
Koroma	E-Person
of	O
Sierra	B-Location
Leone	E-Location
launched	O
"	O
"	O
and	O
workers	O
went	O
door-to-door	O
in	O
the	O
capital	O
city	O
looking	O
for	O
possible	O
cases	O
.	O

A	O
gene	O
from	O
the	O
protein	O
is	O
transferred	O
to	O
bacteria	O
,	O
whichis	O
used	O
to	O
infect	O
plants	O
.	O

Although	O
biosafety	O
measures	O
were	O
observed	O
by	O
researchers	O
voluntarily	O
,	O
the	O
establishment	O
of	O
national	O
biosafety	O
organizations	O
since	O
the	O
year	O
2000	O
built	O
a	O
great	O
capacity	O
to	O
deal	O
with	O
biosafety	O
issues	O
in	O
the	O
present	O
and	O
future	O
time	O
,	O
particularly	O
with	O
respect	O
to	O
food	O
and	O
agricultural	O
biotechnology	O
.	O

Maintaining	O
and	O
improving	O
the	O
diagnostics	O
for	O
those	O
rare	O
pathogens	O
that	O
require	O
analysis	O
by	O
BSL-3	B-Platform
and	I-Platform
-4	E-Platform
laboratories	O
is	O
resource-intensive	O
.	O

The	O
existence	O
of	O
the	O
facility	O
was	O
in	O
direct	O
violation	O
of	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
and	O
it	O
was	O
only	O
after	O
the	O
fall	O
of	O
the	O
Soviet	B-Organization
Union	E-Organization
that	O
the	O
incident	O
was	O
investigated	O
by	O
an	O
international	O
team	O
of	O
inspectors	O
.	O

A	O
specific	O
distinction	O
was	O
made	O
between	O
somatic	O
cells	O
,	O
where	O
the	O
effects	O
of	O
edits	O
are	O
limited	O
to	O
a	O
single	O
individual	O
,	O
and	O
germline	O
cells	O
,	O
where	O
genome	O
changes	O
can	O
be	O
inherited	O
by	O
descendants	O
.	O

Frieden	S-Person
,	O
you	O
were	O
talking	O
about	O
the	O
need	O
to	O
address	O
,	O
you	O
know	O
,	O
the	O
problem	O
more	O
fundamentally	O
rather	O
than	O
just	O
the	O
symptoms	O
.	O

As	O
an	O
explanation	O
for	O
the	O
universally	O
high	O
mortality	O
rate	O
,	O
this	O
hypothesis	O
was	O
questioned	O
in	O
a	O
letter	O
to	O
the	O
journal	O
published	O
in	O
April	O
2010	O
by	O
Andrew	B-Person
Noymer	E-Person
and	O
Daisy	B-Person
Carreon	E-Person
of	O
the	O
University	B-Organization
of	I-Organization
California	E-Organization
,	O
Irvine	S-Person
,	O
and	O
Niall	B-Person
Johnson	E-Person
of	O
the	O
Australian	B-Organization
Commission	I-Organization
on	I-Organization
Safety	I-Organization
and	I-Organization
Quality	I-Organization
in	I-Organization
Health	I-Organization
Care	E-Organization
.	O
They	O
questioned	O
the	O
universal	O
applicability	O
of	O
the	O
aspirin	S-Drug
theory	O
,	O
given	O
the	O
high	O
mortality	O
rate	O
in	O
countries	O
such	O
as	O
India	S-Location
,	O
where	O
there	O
was	O
little	O
or	O
no	O
access	O
to	O
aspirin	S-Drug
at	O
the	O
time	O
,	O
compared	O
to	O
the	O
death	O
rate	O
in	O
places	O
where	O
was	O
plentiful	O
.	O

Wilgoren	S-Person
,	O
Debbi	S-Person
and	O
Shear	S-Person
,	O
Michael	B-Person
D	E-Person
.	O
"	O
Obama	S-Person
Chooses	O
NYC	B-Person
Health	I-Person
Chief	E-Person
to	O
Head	O
CDC	S-Organization
"	O
,	O
The	O
Washington	O
Post	O
,	O
May	O
16	O
,	O
2009.Etheridge	O
,	O
Elizabeth	O
W	O
.	O

On	O
16 September	O
2008	O
,	O
the	O
body	O
of	O
British	O
politician	O
and	O
diplomat	O
Sir	B-Person
Mark	I-Person
Sykes	E-Person
was	O
exhumed	O
to	O
study	O
the	O
RNA	O
of	O
the	O
flu	S-Disease
virus	O
in	O
efforts	O
to	O
understand	O
the	O
genetic	O
structure	O
of	O
modern	O
H5N1	B-Disease
bird	I-Disease
flu	E-Disease
.	O
had	O
been	O
buried	O
in	O
1919	O
in	O
a	O
lead	O
coffin	O
which	O
scientists	O
hoped	O
had	O
helped	O
preserve	O
the	O
virus	O
.	O

On	O
23	O
July	O
,	O
a	O
World	B-Organization
Bank	E-Organization
poll	O
warned	O
that	O
"	O
we	O
are	O
not	O
ready	O
for	O
another	O
Ebola	B-Incident
outbreak	E-Incident
"	O
.	O
On	O
15	O
December	O
,	O
the	O
World	B-Organization
Bank	E-Organization
indicated	O
that	O
by	O
1	O
December	O
2015	O
,	O
it	O
had	O
marshalled	O
$1.62	O
billion	O
in	O
financing	O
for	O
the	O
response	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
identify	O
and	O
assess	O
the	O
impact	O
of	O
capacity-building	O
biosafety	O
initiatives	O
and	O
programs	O
that	O
have	O
taken	O
place	O
in	O
broader	B-Location
Middle	I-Location
East	I-Location
and	I-Location
North	I-Location
Africa	E-Location
(	O
BMENA	S-Location
)	O
region	O
between	O
2001	O
and	O
2013	O
,	O
and	O
to	O
highlight	O
gaps	O
that	O
require	O
further	O
development	O
.	O

The	O
WHO	S-Organization
said	O
on	O
11	O
March	O
2020	O
the	O
pandemic	O
could	O
be	O
controlled	O
.	O

As	O
biohackers	O
traverse	O
uncharted	O
territory	O
,	O
regulators	O
are	O
scrambling	O
to	O
catch	O
up	O
with	O
them	O
.	O

When	O
he	O
coined	O
the	O
term	O
in	O
1919	O
,	O
the	O
agriculturalist	O
Karl	B-Person
Ereky	E-Person
described	O
'biotechnology'	O
as	O
"	O
all	O
lines	O
of	O
work	O
by	O
which	O
products	O
are	O
produced	O
from	O
raw	O
materials	O
with	O
the	O
aid	O
of	O
living	O
things.	O
"	O
In	O
modern	O
biotechnology	O
,	O
researchers	O
modify	O
DNA	O
and	O
proteins	O
to	O
shape	O
the	O
capabilities	O
of	O
living	O
cells	O
,	O
plants	O
,	O
and	O
animals	O
into	O
something	O
useful	O
for	O
humans	O
.	O

Reevaluation	O
and	O
improvement	O
of	O
inactivation	O
procedures	O
in	O
all	O
BSL-3	S-Platform
and	O
labs	O
.	O

Contact	O
tracing	O
is	O
a	O
way	O
of	O
identifying	O
those	O
who	O
have	O
been	O
in	O
direct	O
contact	O
with	O
an	O
infected	O
individual	O
and	O
are	O
thus	O
at	O
higher	O
risk	O
of	O
becoming	O
infected	O
or	O
infecting	O
others	O
.	O

It	O
was	O
additionally	O
found	O
that	O
although	O
the	O
Shooter	B-Organization
Inquiry	E-Organization
noted	O
the	O
poor	O
state	O
of	O
the	O
duct	O
sealing	O
in	O
the	O
laboratory	O
,	O
this	O
was	O
caused	O
after	O
the	O
outbreak	O
by	O
engineers	O
fumigating	O
the	O
laboratory	O
and	O
ducts	O
.	O

The	O
second	O
wave	O
caused	O
simultaneous	O
outbreaks	O
in	O
the	O
Northern	O
and	O
Southern	O
Hemispheres	O
from	O
September	O
to	O
November	O
.	O

The	O
Shooter	B-Organization
Inquiry	E-Organization
found	O
that	O
Parker	S-Person
was	O
accidentally	O
exposed	O
to	O
a	O
strain	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
that	O
had	O
been	O
grown	O
in	O
a	O
research	O
laboratory	O
on	O
the	O
floor	O
below	O
her	O
workplace	O
at	O
the	O
University	B-Organization
of	I-Organization
Birmingham	I-Organization
Medical	I-Organization
School	E-Organization
.	O
Shooter	S-Organization
concluded	O
that	O
the	O
mode	O
of	O
transmission	O
was	O
most	O
likely	O
airborne	O
through	O
a	O
poorly	O
maintained	O
service	O
duct	O
between	O
the	O
two	O
floors	O
.	O

What	O
if	O
we	O
could	O
engineer	O
humans	O
with	O
sonar	O
,	O
like	O
that	O
used	O
by	O
bats	O
,	O
to	O
help	O
us	O
navigate	O
in	O
the	O
dark?	O
What	O
if	O
we	O
had	O
genes	O
that	O
enabled	O
us	O
to	O
get	O
energy	O
from	O
sunlight	O
,	O
like	O
plants	O
do?	O
Pamela	B-Person
Silver	E-Person
group	O
at	O
has	O
inserted	O
cyanobacteria	O
,	O
the	O
microbes	O
responsible	O
for	O
nearly	O
half	O
the	O
world's	O
photosynthesis	O
,	O
into	O
zebrafish	O
embryos	O
as	O
a	O
first	O
step	O
towards	O
achieving	O
that	O
goal	O
.	O

Next	O
question	O
on	O
the	O
phone	O
comes	O
from	O
Danny	B-Person
Al-Faruque	E-Person
with	O
newspaper	O
.	O

The	O
Walter	B-Organization
Reed	I-Organization
Army	I-Organization
Institute	I-Organization
of	I-Organization
Research	E-Organization
(	O
WRAIR	S-Organization
)	O
this	O
week	O
administered	O
the	O
first	O
vaccine	O
in	O
a	O
Phase	O
1	O
clinical	O
trial	O
to	O
evaluate	O
the	O
safety	O
and	O
immunogenicity	O
of	O
a	O
candidate	O
in	O
healthy	O
adult	O
volunteers	O
.	O

An	O
anthrax	B-Vaccine
vaccine	E-Vaccine
does	O
exist	O
but	O
requires	O
many	O
injections	O
for	O
stable	O
use	O
.	O

DAD	S-Phenotype
	S-Phenotype
is	O
the	O
cause	O
of	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
()	O
and	O
severe	O
hypoxemia	O
.	O

In	O
September	O
,	O
in	O
the	O
town	O
of	O
Womey	S-Location
in	O
,	O
suspicious	O
inhabitants	O
wielding	O
machetes	O
murdered	O
at	O
least	O
eight	O
aid	O
workers	O
and	O
dumped	O
their	O
bodies	O
in	O
a	O
latrine	O
.	O

There	O
were	O
five	O
"	O
intensive	O
searches	O
"	O
of	O
cargo	O
and	O
baggage	O
as	O
it	O
arrived	O
at	O
Los	B-Location
Angeles	I-Location
Airport	E-Location
and	O
that	O
tested	O
positive	O
for	O
medfly	O
larvae	O
.	O

On	O
27	O
June	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
stated	O
that	O
the	O
world	O
population	O
should	O
be	O
SARS	S-Disease
-free	O
within	O
the	O
next	O
two	O
to	O
three	O
weeks	O
,	O
but	O
warned	O
the	O
disease	O
could	O
emerge	O
in	O
next	O
winter	O
.	O

On	O
20	O
January	O
,	O
the	O
Chinese	B-Organization
National	I-Organization
Health	I-Organization
Commission	E-Organization
confirmed	O
human-to-human	O
transmission	O
of	O
the	O
virus	O
.	O

The	O
exact	O
language	O
of	O
the	O
OSTP	B-Document
memo	E-Document
is	O
not	O
yet	O
known	O
.	O

There	O
is	O
limited	O
information	O
to	O
determine	O
the	O
overall	O
risk	O
of	O
this	O
reported	O
cluster	O
of	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
.	O

A	O
report	O
published	O
in	O
2016	O
in	O
the	O
Journal	B-Organization
of	I-Organization
the	I-Organization
Chinese	I-Organization
Medical	I-Organization
Association	E-Organization
found	O
no	O
evidence	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
was	O
imported	O
to	O
Europe	O
via	O
Chinese	O
and	O
Southeast	O
Asian	O
soldiers	O
and	O
workers	O
and	O
instead	O
found	O
evidence	O
of	O
its	O
circulation	O
in	O
Europe	O
before	O
the	O
pandemic	O
.	O

Bacterial	O
agents:	O
Anthrax	S-Pathogen
Brucella	S-Pathogen
,	O
,	O
etc	O
.	O

Also	O
,	O
a	O
WHO	O
team	O
that	O
travelled	O
to	O
Beijing	S-Location
was	O
not	O
allowed	O
to	O
visit	O
for	O
several	O
weeks	O
.	O

The	O
first	O
round	O
of	O
fixed	O
laboratory	O
team	O
from	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Viral	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
NIVDC	S-Organization
)	O
,	O
Chinese	B-Organization
Center	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
China	B-Organization
CDC	E-Organization
)	O
arrived	O
in	O
on	O
8	O
February	O
2015	O
.	O

He	O
fell	O
ill	O
during	O
the	O
flight	O
and	O
told	O
a	O
friend	O
waiting	O
at	O
Bangkok	S-Location
not	O
to	O
touch	O
him	O
,	O
to	O
call	O
an	O
ambulance	O
and	O
take	O
him	O
to	O
a	O
hospital	O
.	O

No	O
.	O

This	O
same	O
year	O
,	O
The	O
UPMC	O
Center	O
for	O
Health	O
Security	O
issued	O
a	O
case	O
study	O
report	O
including	O
reviews	O
of	O
ten	O
different	O
nations’	O
current	O
biosafety	O
regulations	O
,	O
including	O
the	O
United	O
States	O
.	O

I	O
think	O
from	O
our	O
perspective	O
,	O
that	O
may	O
be	O
through	O
treating	O
a	O
disease	O
,	O
controlling	O
a	O
disease	O
,	O
or	O
preventing	O
a	O
disease.	O
"	O

Adrianna	B-Person
Rodriguez	E-Person
,	O
These	O
countries	O
have	O
no	O
reports	O
of	O
coronavirus	O
cases	O
.	O

Dr	O
.	O

It	O
uses	O
a	O
molecular	O
biology	O
technique	O
to	O
detect	O
influenza	B-Pathogen
A	I-Pathogen
viruses	E-Pathogen
and	O
specifically	O
the	O
2009	O
H1N1	B-Pathogen
virus	E-Pathogen
.	O
The	O
new	O
test	O
will	O
replace	O
the	O
previous	O
real-time	O
RT-PCR	S-Technology
diagnostic	O
test	O
used	O
during	O
the	O
2009	O
H1N1	B-Disease
pandemic	E-Disease
,	O
which	O
received	O
an	O
emergency	O
use	O
authorization	O
from	O
the	O
in	O
April	O
2009	O
.	O

Furthermore	O
,	O
following	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
"	O
Animal	O
Rule	O
"	O
interpreted	O
for	O
smallpox	S-Pathogen
therapeutics	O
by	O
an	O
expert	O
advisory	O
committee	O
,	O
the	O
investigators	O
on	O
the	O
study	O
found	O
that	O
the	O
minimum	O
dose	O
of	O
tecovirimat	S-Vaccine
needed	O
to	O
achieve	O
over	O
90%	O
survival	O
in	O
a	O
monkeypox/nonhuman	O
primate	O
(NHP)	O
model	O
was	O
10	O
mg/kg	O
for	O
14	O
days	O
.	O

Neurologic	O
manifestations	O
include	O
seizure	S-Phenotype
stroke	S-Phenotype
,	O
encephalitis	S-Phenotype
,	O
and	O
Guillain–Barré	B-Phenotype
syndrome	E-Phenotype
(which	O
includes	O
)	O
.	O

The	O
university	O
suspended	O
Perlman	S-Person
's	O
work	O
while	O
he	O
gained	O
permission	O
to	O
do	O
the	O
research	O
and	O
reported	O
the	O
non-compliance	O
to	O
the	O
.	O

AMR	O
is	O
a	O
global	O
concern	O
,	O
which	O
requires	O
every	O
country	O
to	O
have	O
an	O
action	O
against	O
it	O
.	O

After	O
we've	O
monitored	O
growth	O
and	O
sequenced	O
the	O
genome	O
,	O
we	O
will	O
destroy	O
the	O
vials	O
and	O
all	O
of	O
the	O
culture	O
material	O
from	O
these	O
materials	O
.	O

Magnetic	B-Technology
resonance	I-Technology
angiography	E-Technology
(	O
MRA	S-Technology
)	O
generates	O
pictures	O
of	O
the	O
arteries	O
to	O
evaluate	O
them	O
for	O
stenosis	O
(abnormal	O
narrowing)	O
or	O
aneurysms	S-Disease
(vessel	O
wall	O
dilatations	O
,	O
at	O
risk	O
of	O
rupture)	O
.	O

In	O
this	O
method	O
,	O
the	O
tissue	O
is	O
now	O
excited	O
inferiorly	O
,	O
while	O
the	O
signal	O
is	O
gathered	O
in	O
the	O
plane	O
immediately	O
superior	O
to	O
the	O
excitation	O
plane-thus	O
imaging	O
the	O
venous	O
blood	O
that	O
recently	O
moved	O
from	O
the	O
excited	O
plane	O
.	O

"	O
If	O
our	O
Insect	B-Organization
allies	I-Organization
research	I-Organization
institutions	E-Organization
succeed	O
and	O
move	O
to	O
apply	O
their	O
work	O
in	O
the	O
future	O
,	O
they	O
will	O
need	O
to	O
go	O
through	O
the	O
standard	O
regulatory	O
process	O
for	O
approval,	O
"	O
he	O
said	O
.	O

Given	O
the	O
hundreds	O
of	O
tons	O
of	O
anthrax	S-Pathogen
the	O
could	O
produce	O
,	O
the	O
release	O
of	O
just	O
a	O
small	O
amount	O
of	O
spores	O
was	O
fortunate	O
.	O

And	O
that's	O
why	O
it's	O
important	O
the	O
staff	O
feel	O
comfortable	O
coming	O
forward	O
if	O
there's	O
a	O
problem	O
.	O

The	O
issue	O
,	O
Gottlieb	S-Person
explained	O
,	O
is	O
a	O
problem	O
with	O
the	O
current	O
reimbursement	O
scheme	O
for	O
drugs	O
,	O
in	O
which	O
profits	O
are	O
driven	O
by	O
sales	O
.	O

COVID-19	S-Disease
was	O
confirmed	O
to	O
have	O
spread	O
to	O
South	B-Location
Korea	E-Location
on	O
20	O
January	O
2020	O
from	O
China	S-Location
.	O
The	O
nation's	O
health	O
agency	O
reported	O
a	O
significant	O
increase	O
in	O
confirmed	O
cases	O
on	O
20	O
February	O
,	O
largely	O
attributed	O
to	O
a	O
gathering	O
in	O
Daegu	S-Location
of	O
the	O
Shincheonji	B-Organization
Church	I-Organization
of	I-Organization
Jesus	E-Organization
.	O
Shincheonji	O
devotees	O
visiting	O
Daegu	S-Location
from	O
were	O
suspected	O
to	O
be	O
the	O
origin	O
of	O
the	O
outbreak.	O
,	O
among	O
9,336	O
followers	O
of	O
the	O
church	O
,	O
1,261	O
or	O
about	O
13	O
percent	O
reported	O
symptoms	O
.	O

When	O
the	O
League	B-Organization
of	I-Organization
Nations	E-Organization
was	O
formed	O
in	O
1920	O
,	O
they	O
established	O
the	O
Health	B-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
League	I-Organization
of	I-Organization
Nations	E-Organization
.	O
After	O
World	B-Incident
War	I-Incident
II	E-Incident
,	O
the	O
United	B-Organization
Nations	E-Organization
absorbed	O
all	O
the	O
other	O
health	O
organizations	O
,	O
to	O
form	O
the	O
.	O

Two	O
visiting	O
Wasco	B-Location
County	E-Location
commissioners	O
were	O
infected	O
via	O
glasses	O
of	O
water	O
containing	O
Salmonella	S-Pathogen
bacteria	O
during	O
a	O
visit	O
to	O
Rajneeshpuram	S-Location
on	O
August	O
29	O
,	O
1984	O
.	O

Based	O
on	O
the	O
quality	O
assurance	O
requirement	O
,	O
contamination	O
of	O
the	O
laboratory	O
region	O
with	O
EBOV	S-Pathogen
RNA	O
should	O
be	O
evaluated	O
by	O
real-time	B-Equipment
RT-PCR	E-Equipment
every	O
2	O
months	O
,	O
so	O
the	O
first	O
evaluation	O
had	O
been	O
done	O
at	O
the	O
end	O
of	O
the	O
mission	O
.	O

Iran	S-Location
allocated	O
5trillion	O
rials	O
(equivalent	O
to	O
)	O
to	O
combat	O
the	O
virus	O
.	O

Article	O
8	O
of	O
The	O
Rome	B-Document
Statute	I-Document
of	I-Document
The	I-Document
International	I-Document
Criminal	I-Document
Court	E-Document
(	O
ICC	S-Organization
)	O
defines	O
biological	O
experiments	O
as	O
war	O
crimes	O
.	O

On	O
26	O
September	O
,	O
he	O
fell	O
ill	O
and	O
sought	O
medical	O
treatment	O
,	O
but	O
was	O
sent	O
home	O
with	O
antibiotics	O
.	O

The	O
secret	O
program	O
was	O
code-named	O
"	O
".	O

SGMP	O
does	O
not	O
implement	O
DOI	O
services	O
directly	O
for	O
data	O
objects	O
but	O
for	O
review	O
articles	O
about	O
signaling	O
proteins	O
.	O

Of	O
these	O
,	O
six	O
to	O
eleven	O
percent	O
are	O
done	O
in	O
children	O
,	O
an	O
increase	O
of	O
seven	O
to	O
eightfold	O
from	O
1980	O
.	O

New	O
trends	O
illustrate	O
a	O
greater	O
appreciation	O
of	O
a	O
strong	O
need	O
for	O
a	O
cooperative	O
partnership	O
.	O

From	O
the	O
onset	O
of	O
the	O
U.S.	O
biological	O
weapons	O
program	O
in	O
1943	O
through	O
the	O
end	O
of	O
World	O
War	O
II	O
the	O
United	O
States	O
spent	O
$400	O
million	O
on	O
biological	O
weapons	O
,	O
mostly	O
on	O
research	O
and	O
development	O
.	O

In	O
2015	O
it	O
was	O
discovered	O
that	O
a	O
U.S.	S-Location
laboratory	O
spent	O
more	O
than	O
a	O
decade	O
inadvertently	O
sending	O
the	O
bacteria	O
that	O
causes	O
to	O
194	O
laboratories	O
worldwide	O
.	O

Nolin	S-Person
,	O
Robert	S-Person
.	O
"	O
Medflies	O
found	O
in	O
"	O
,	O
Sun-Sentinel	O
,	O
June	O
15	O
,	O
2010	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

The	O
main	O
limitation	O
of	O
this	O
type	O
is	O
the	O
bulk	O
and	O
inertia	O
of	O
the	O
equipment	O
(	O
X-ray	B-Equipment
tube	I-Equipment
assembly	E-Equipment
and	O
on	O
the	O
opposite	O
side	O
of	O
the	O
circle)	O
which	O
limits	O
the	O
speed	O
at	O
which	O
the	O
equipment	O
can	O
spin	O
.	O

On	O
5	O
August	O
2014	O
,	O
the	O
Brothers	B-Organization
Hospitallers	I-Organization
of	I-Organization
Saint	I-Organization
John	I-Organization
of	I-Organization
God	E-Organization
confirmed	O
that	O
Brother	B-Person
Miguel	I-Person
Pajares	E-Person
,	O
who	O
had	O
been	O
volunteering	O
in	O
Liberia	S-Location
,	O
had	O
become	O
infected	O
.	O

Clinical	O
testing	O
will	O
take	O
place	O
over	O
the	O
summer	O
,	O
said	O
.	O

Other	O
African	O
countries	O
that	O
were	O
not	O
directly	O
affected	O
by	O
the	O
virus	O
also	O
reported	O
adverse	O
effects	O
on	O
tourism	O
.	O

However	O
,	O
US	S-Location
medical	O
scientists	O
in	O
occupied	O
Japan	S-Location
undertook	O
extensive	O
research	O
on	O
insect	O
vectors	O
,	O
with	O
the	O
assistance	O
of	O
former	O
staff	O
,	O
as	O
early	O
as	O
1946	O
.	O

Governments	O
worldwide	O
have	O
set	O
targets	O
for	O
biofuel	O
production	O
by	O
2050	O
.	O

Total	O
deaths	O
were	O
estimated	O
at	O
≈50	O
million	O
(–)	O
and	O
were	O
arguably	O
as	O
high	O
as	O
100	O
million	O
.	O

On	O
19	O
March	O
,	O
it	O
was	O
also	O
reported	O
by	O
the	O
media	O
that	O
another	O
individual	O
had	O
died	O
due	O
to	O
the	O
virus	O
at	O
the	O
treatment	O
centre	O
in	O
Nzerekore	S-Location
,	O
consequently	O
,	O
the	O
country's	O
government	O
quarantined	O
an	O
area	O
around	O
the	O
home	O
where	O
the	O
cases	O
took	O
place	O
.	O

"	O
In	O
the	O
end	O
,	O
we	O
will	O
see	O
that	O
there'll	O
be	O
some	O
sort	O
of	O
temporary	O
,	O
or	O
maybe	O
even	O
a	O
permanent	O
,	O
resolution	O
of	O
the	O
trade	O
dispute	O
to	O
try	O
and	O
get	O
that	O
pork	O
meat	O
and	O
other	O
animal	O
proteins	O
flowing	O
from	O
the	O
US	S-Location
to	O
,	O
"	O
he	O
says	O
.	O

OPERATOR:	O
On	O
the	O
phone	O
lines	O
if	O
you'd	O
like	O
to	O
ask	O
a	O
question	O
,	O
just	O
press	O
star-1	O
at	O
this	O
time	O
.	O

The	O
gene	O
order	O
is	O
3′	O
–	O
leader	O
–	O
NP	O
–	O
VP35	O
–	O
VP40	O
–	O
GP/sGP	O
–	O
VP30	O
–	O
VP24	O
–	O
L	O
–	O
trailer	O
–	O
5′	O
;	O
with	O
the	O
leader	O
and	O
trailer	O
being	O
non-transcribed	O
regions	O
,	O
which	O
carry	O
important	O
signals	O
to	O
control	O
transcription	O
,	O
replication	O
,	O
and	O
packaging	O
of	O
the	O
viral	O
genomes	O
into	O
new	O
virions	O
.	O

By	O
mid-September	O
,	O
however	O
,	O
there	O
had	O
been	O
only	O
two	O
additional	O
cases	O
in	O
the	O
Mandima	B-Location
Health	I-Location
Zone	E-Location
,	O
and	O
only	O
sporadic	O
cases	O
were	O
being	O
reported	O
in	O
the	O
.	O

The	O
physiological	O
biosignal	O
features	O
provided	O
to	O
PRESAGED	S-Technology
during	O
the	O
primate	O
testing	O
were	O
collected	O
by	O
implanted	O
monitoring	O
devices	O
.	O

When	O
the	O
United	O
States	O
entered	O
the	O
war	O
,	O
mounting	O
British	O
pressure	O
for	O
the	O
creation	O
of	O
a	O
similar	O
research	O
program	O
for	O
an	O
Allied	O
pooling	O
of	O
resources	O
led	O
to	O
the	O
creation	O
of	O
a	O
large	O
industrial	O
complex	O
at	O
Fort	B-Location
Detrick	E-Location
Maryland	S-Location
in	O
1942	O
under	O
the	O
direction	O
of	O
George	O
W	O
.	O

As	O
for	O
the	O
Soviet	S-Organization
one	O
,	O
too	O
little	O
was	O
known	O
,	O
he	O
said	O
,	O
to	O
assess	O
its	O
effectiveness	O
among	O
citizens	O
in	O
the	O
1971	O
outbreak	O
.	O

However	O
,	O
they	O
remain	O
widely	O
used	O
in	O
companion	O
and	O
exotic	O
animals	O
.	O

But	O
that	O
depends	O
on	O
what	O
we	O
do	O
as	O
a	O
society,	O
"	O
he	O
said	O
.	O

However	O
,	O
we	O
found	O
that	O
most	O
of	O
the	O
efforts	O
had	O
been	O
at	O
the	O
individual	O
country	O
level	O
and	O
not	O
at	O
a	O
regional	O
level	O
,	O
resulting	O
in	O
some	O
duplication	O
of	O
efforts	O
.	O

Progress	O
has	O
been	O
slow	O
due	O
to	O
a	O
range	O
of	O
reasons	O
including	O
cost	O
and	O
regulation	O
.	O

UNSCOM	S-Organization
inspectors	O
at	O
downed	O
Scud	O
missle	O
During	O
Operation	O
Desert	O
Storm	O
,	O
the	O
feared	O
that	O
Scud	O
missiles	O
might	O
contain	O
biological	O
agents	O
.	O

Small	O
outbreaks	O
occurred	O
in	O
Nigeria	S-Location
and	O
Mali	S-Location
,	O
and	O
secondary	O
infections	O
of	O
medical	O
workers	O
occurred	O
in	O
the	O
United	B-Location
States	E-Location
and	O
Spain	S-Location
.	O
In	O
addition	O
,	O
isolated	O
cases	O
were	O
recorded	O
in	O
Senegal	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
and	O
.	O

Afterward	O
,	O
members	O
of	O
Sheela	S-Person
's	O
team	O
spread	O
Salmonella	S-Pathogen
on	O
produce	O
in	O
grocery	O
stores	O
and	O
on	O
doorknobs	O
and	O
urinal	O
handles	O
in	O
the	O
county	O
courthouse	O
,	O
but	O
these	O
actions	O
did	O
not	O
produce	O
the	O
desired	O
effects	O
.	O

And	O
that's	O
why	O
Dr	O
.	O

MIKE	B-Person
STOBBE	E-Person
Thank	O
you	O
.	O

*Update	O
,	O
27	O
August	O
,	O
3:18	O
p.m.	O
:	O
This	O
article	O
was	O
updated	O
to	O
include	O
a	O
comment	O
from	O
Ron	B-Person
Atlas	E-Person
and	O
to	O
clarify	O
the	O
source	O
of	O
today's	O
memo	O
.	O

Preparations	O
included	O
planning	O
a	O
second	O
influenza	O
vaccination	O
program	O
in	O
addition	O
to	O
the	O
one	O
for	O
,	O
and	O
improving	O
coordination	O
between	O
federal	O
,	O
state	O
,	O
and	O
local	O
governments	O
and	O
private	O
health	O
providers	O
.	O

He	O
would	O
not	O
disclose	O
the	O
type	O
of	O
tests	O
.	O

CAUTION:	O
&lt;organism	O
name&gt	O
;	O
is	B-Platform
a	I-Platform
Biosafety	I-Platform
L	E-Platform
organism	O
.	O

In	O
late	O
October	O
2014	O
,	O
a	O
publication	O
reported	O
a	O
study	O
of	O
the	O
response	O
to	O
a	O
mouse-adapted	O
strain	O
of	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
presented	O
by	O
a	O
genetically	O
diverse	O
population	O
of	O
mice	O
that	O
was	O
bred	O
to	O
have	O
a	O
range	O
of	O
responses	O
to	O
the	O
virus	O
that	O
includes	O
fatality	O
from	O
.	O

Part	O
of	O
managing	O
an	O
infectious	O
disease	O
outbreak	O
is	O
trying	O
to	O
delay	O
and	O
decrease	O
the	O
epidemic	O
peak	O
,	O
known	O
as	O
flattening	O
the	O
epidemic	O
curve	O
.	O

Men	O
in	O
lab	O
Weapons	O
production	O
at	O
Fort	B-Location
Detrick	E-Location
Maryland	S-Location
,	O
the	O
's	O
base	O
for	O
biowarfare	O
research	O
.	O

The	O
Country	B-Platform
Health	I-Platform
Intelligence	I-Platform
Portal	E-Platform
()	O
,	O
has	O
also	O
been	O
developed	O
to	O
provide	O
an	O
access	O
point	O
to	O
information	O
about	O
the	O
health	O
services	O
that	O
are	O
available	O
in	O
different	O
countries	O
.	O

Two	O
days	O
ago	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
reported	O
that	O
the	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
has	O
sickened	O
188	O
people	O
and	O
killed	O
118	O
in	O
the	O
northeastern	O
region	O
of	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
.	O
Lillibridge	S-Person
noted	O
that	O
Ebola	S-Disease
continues	O
to	O
spread	O
in	O
what	O
is	O
considered	O
a	O
conflict	O
zone	O
,	O
making	O
it	O
nearly	O
impossible	O
for	O
to	O
sufficiently	O
access	O
the	O
stricken	O
population	O
there	O
.	O

Corporations	O
encouraged	O
employees	O
to	O
work	O
from	O
home	O
.	O

According	O
to	O
the	O
same	O
report	O
some	O
300	O
individuals	O
may	O
have	O
been	O
exposed	O
to	O
via	O
an	O
infected	O
individual	O
.	O

Madam	B-Person
Njie	E-Person
maintained	O
that	O
remains	O
under-reported	O
but	O
neglected	O
zoonosis	O
with	O
cases	O
of	O
fatality	O
have	O
rated	O
almost	O
100%	O
in	O
humans	O
while	O
animals	O
account	O
for	O
59,000	O
deaths	O
every	O
year	O
globally	O
.	O

Biosafety	B-Platform
Level	I-Platform
2	E-Platform
is	O
also	O
appropriate	O
when	O
work	O
is	O
done	O
with	O
any	O
human‐derived	O
blood	O
,	O
body	O
fluids	O
,	O
tissues	O
,	O
or	O
primary	O
human	O
cell	O
lines	O
where	O
the	O
presence	O
of	O
an	O
infectious	O
agent	O
may	O
be	O
unknown	O
.	O

Extracellular	O
contrast	O
agents	O
are	O
used	O
widely	O
in	O
liver	B-Technology
MRI	E-Technology
,	O
and	O
newer	O
hepatobiliary	O
contrast	O
agents	O
also	O
provide	O
the	O
opportunity	O
to	O
perform	O
functional	O
biliary	O
imaging	O
.	O

In	O
2005	O
,	O
influenza	O
only	O
appeared	O
on	O
the	O
death	O
certificates	O
of	O
1,812	O
people	O
in	O
the	O
US	S-Location
The	O
average	O
annual	O
US	O
death	O
toll	O
from	O
flu	O
is	O
,	O
however	O
,	O
estimated	O
to	O
be	O
36,000	O
.	O

Dead	O
Mine	O
(2012)	O
,	O
Indonesia	S-Location
directed	O
by	O
Steven	B-Person
Sheil	E-Person
and	O
based	O
in	O
a	O
fictionalised	O
version	O
of	O
.	O

The	O
Pentagon	S-Organization
contractors	O
in	O
Afghanistan	S-Location
and	O
are	O
the	O
same	O
and	O
so	O
are	O
the	O
diseases	O
which	O
are	O
spreading	O
among	O
the	O
local	O
population	O
in	O
both	O
countries	O
.	O

BSL‐1	S-Platform
practices	O
,	O
safety	O
equipment	O
,	O
and	O
facility	O
design	O
and	O
construction	O
are	O
appropriate	O
for	O
undergraduate	O
and	O
secondary	O
educational	O
training	O
and	O
teaching	O
laboratories	O
,	O
and	O
for	O
other	O
laboratories	O
in	O
which	O
work	O
is	O
done	O
with	O
defined	O
and	O
characterized	O
strains	O
of	O
viable	O
microorganisms	O
not	O
known	O
to	O
consistently	O
cause	O
disease	O
in	O
healthy	O
adult	O
humans	O
.	O

Under	O
the	O
microscope	S-Equipment
the	O
bacteria	O
look	O
like	O
tiny	O
rods	O
.	O

Data	O
producers	O
can	O
grant	O
open	O
access	O
to	O
their	O
data	O
without	O
relinquishing	O
their	O
authorship	O
.	O

Difficulties	O
in	O
attempting	O
to	O
halt	O
transmission	O
have	O
also	O
included	O
the	O
multiple	O
disease	O
outbreaks	O
across	O
country	O
borders	O
.	O

At	O
this	O
point	O
,	O
most	O
respondents	O
stopped	O
participating	O
.	O

The	O
general	O
objective	O
of	O
this	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
biosafety	O
precautions	O
adopted	O
in	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
State	O
.	O

In	O
2008	O
,	O
a	O
new	O
contrast	O
agent	O
named	O
gadoxetate	O
,	O
brand	O
name	O
Eovist	O
(	O
US	S-Location
)	O
or	O
Primovist	O
()	O
,	O
was	O
approved	O
for	O
diagnostic	O
use:	O
This	O
has	O
the	O
theoretical	O
benefit	O
of	O
a	O
dual	O
excretion	O
path	O
.	O

A	O
2020	O
study	O
found	O
that	O
US	S-Location
cities	O
that	O
implemented	O
early	O
and	O
extensive	O
non-medical	O
measures	O
(quarantine	O
etc.	O
)	O
suffered	O
no	O
additional	O
adverse	O
economic	O
effects	O
due	O
to	O
implementing	O
those	O
measures	O
,	O
when	O
compared	O
with	O
cities	O
that	O
implemented	O
measures	O
late	O
or	O
not	O
at	O
all	O
.	O

As	O
of	O
June	O
2007	O
,	O
the	O
BBD	S-Platform
contained	O
6694	O
records	O
pertaining	O
to	O
scientific	O
publications	O
(full	O
references	O
and	O
abstracts)	O
,	O
and	O
appearing	O
in	O
international	O
and	O
national	O
scientific	O
periodicals	O
and	O
books	O
.	O

The	O
technique	O
achieved	O
a	O
strong	O
effect	O
by	O
targeting	O
multiple	O
constructs	O
to	O
slightly	O
different	O
locations	O
on	O
the	O
gene's	O
promoter	O
.	O

This	O
result	O
is	O
not	O
unexpected	O
as	O
bacterial	O
spores	O
are	O
typically	O
much	O
more	O
resistant	O
to	O
chemical	O
inactivation	O
than	O
bacterial	O
cells	O
.	O

Such	O
knowledge	O
is	O
vital	O
to	O
determine	O
whether	O
new	O
vaccines	O
or	O
drugs	O
might	O
be	O
needed	O
to	O
protect	O
against	O
that	O
strain's	O
falling	O
into	O
the	O
hands	O
of	O
terrorists	O
.	O

Now	O
,	O
it	O
is	O
increasingly	O
used	O
in	O
reference	O
to	O
the	O
prevention	O
and	O
infections	O
control	O
,	O
even	O
though	O
its	O
use	O
remains	O
marginal	O
.	O

Furthermore	O
,	O
a	O
thorough	O
evaluation	O
of	O
a	O
DNA	O
extraction	O
robot	O
in	O
biosafety	B-Equipment
cabinets	E-Equipment
including	O
the	O
validation	O
of	O
the	O
extraction	O
process	O
using	O
a	O
broad	O
range	O
of	O
sample	O
types	O
(matrixes)	O
,	O
resulted	O
in	O
the	O
equipment's	O
being	O
implemented	O
at	O
all	O
4	O
agencies	O
.	O

The	O
attenuation	O
of	O
metallic	O
implants	O
depends	O
on	O
the	O
atomic	O
number	O
of	O
the	O
element	O
used:	O
Titanium	O
usually	O
has	O
an	O
amount	O
of	O
+1000 HU	O
,	O
iron	O
steel	O
can	O
completely	O
extinguish	O
the	O
X-ray	O
and	O
is	O
,	O
therefore	O
,	O
responsible	O
for	O
well-known	O
line-artifacts	O
in	O
computed	B-Technology
tomograms	E-Technology
Artifacts	O
are	O
caused	O
by	O
abrupt	O
transitions	O
between	O
low-	O
and	O
high-density	O
materials	O
,	O
which	O
results	O
in	O
data	O
values	O
that	O
exceed	O
the	O
dynamic	O
range	O
of	O
the	O
processing	O
electronics	O
.	O

The	O
results	O
raised	O
suspicion	O
because	O
no	O
source	O
(e.g.	O
a	O
letter)	O
was	O
ever	O
found	O
for	O
the	O
ricin	S-Pathogen
.	O
It	O
was	O
possible	O
that	O
the	O
"	O
contamination"	O
was	O
from	O
paper	O
by-products	O
and	O
not	O
.	O
"	O
NBC:	O
Investigators	O
question	O
ricin	O
test	O
results"	O
,	O
NBC	O
News	O
,	O
February	O
18	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

Lillibridge	S-Person
also	O
suggested	O
that	O
the	O
United	B-Location
States	E-Location
take	O
a	O
second	O
look	O
at	O
revitalizing	O
components	O
of	O
the	O
.	O
"	O
We	O
need	O
more	O
neutral	O
ways	O
to	O
get	O
into	O
regions	O
of	O
the	O
world,	O
"	O
he	O
said	O
.	O

One	O
person	O
died	O
and	O
nine	O
were	O
infected	O
in	O
the	O
outbreak	O
which	O
was	O
first	O
reported	O
on	O
22	O
April	O
.	O

Vaccinations	O
started	O
on	O
7	O
November	O
,	O
and	O
by	O
13	O
June	O
2019	O
,	O
4,699	O
health	O
workers	O
at	O
165	O
sites	O
had	O
been	O
vaccinated	O
.	O

Alibek	S-Person
,	O
Op.	O
cit	O
.	O

On	O
14	O
September	O
2015	O
,	O
the	O
body	O
of	O
a	O
girl	O
who	O
had	O
died	O
in	O
Sierra	B-Location
Leone	E-Location
tested	O
positive	O
for	O
Ebola	S-Disease
and	O
it	O
was	O
suspected	O
that	O
she	O
may	O
have	O
contracted	O
the	O
disease	O
from	O
the	O
semen	O
of	O
an	O
Ebola	S-Disease
survivor	O
who	O
was	O
discharged	O
in	O
March	O
2015	O
.	O

On	O
11	O
August	O
2018	O
,	O
it	O
was	O
reported	O
that	O
seven	O
individuals	O
were	O
killed	O
in	O
Mayi-Moya	S-Location
due	O
to	O
a	O
military	O
group	O
,	O
about	O
24	O
miles	O
from	O
the	O
city	O
of	O
Beni	S-Location
where	O
there	O
were	O
several	O
cases	O
.	O

On	O
5	O
July	O
,	O
WHO	S-Organization
declared	O
the	O
SARS	B-Incident
outbreak	E-Incident
contained	O
and	O
removed	O
Taiwan	S-Location
from	O
the	O
list	O
of	O
affected	O
areas.	O
's	O
removal	O
from	O
the	O
list	O
signified	O
the	O
end	O
of	O
the	O
outbreak	O
.	O

Although	O
the	O
Federal	B-Organization
Government	E-Organization
EPA	O
&aDOT	O
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

In	O
1947	O
,	O
the	O
CDC	S-Organization
made	O
a	O
token	O
payment	O
of	O
$10	O
to	O
Emory	B-Organization
University	I-Organization
for	I-Organization
of	I-Organization
land	I-Organization
on	I-Organization
Clifton	I-Organization
Road	I-Organization
in	I-Organization
DeKalb	I-Organization
County	E-Organization
,	O
still	O
the	O
home	O
of	O
headquarters	O
as	O
of	O
2019	O
.	O

In	O
some	O
countries	O
such	O
as	O
Brazil	S-Location
,	O
Russia	S-Location
,	O
India	S-Location
,	O
China	S-Location
,	O
and	O
it	O
is	O
predicted	O
that	O
a	O
99%	O
increase	O
will	O
occur	O
.	O

The	O
severity	O
of	O
the	O
disease	O
in	O
humans	O
varies	O
widely	O
,	O
from	O
rapid	O
fatality	O
to	O
mild	O
illness	O
or	O
even	O
asymptomatic	O
response	O
.	O

Ironically	O
,	O
the	O
global	O
response	O
to	O
the	O
deadly	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
has	O
been	O
just	O
that	O
.	O

Approaches	O
based	O
on	O
voluntary	O
sharing	O
intend	O
to	O
reward	O
researchers	O
with	O
publication-like	O
citations	O
for	O
publishing	O
data	O
or	O
by	O
providing	O
attractive	O
data	O
management	O
systems	O
supporting	O
their	O
work	O
.	O

It	O
was	O
the	O
first	O
report	O
of	O
a	O
reassortment	O
of	O
the	O
pandemic	O
virus	O
,	O
which	O
in	O
humans	O
had	O
been	O
slow	O
to	O
evolve	O
.	O

Gear	O
meant	O
to	O
protect	O
lab	O
workers	O
from	O
lethal	O
viruses	O
such	O
as	O
Ebola	S-Disease
and	O
has	O
failed	O
,	O
repeatedly	O
.	O

Unprecedented	O
heavy	O
rainfall	O
in	O
the	O
Fort	B-Location
Detrick	E-Location
area	O
created	O
flooding	O
issues	O
in	O
the	O
Steam	B-Organization
Sterilization	I-Organization
Plant	E-Organization
()	O
.	O

In	O
June	O
2014	O
,	O
it	O
was	O
reported	O
that	O
local	O
authorities	O
did	O
not	O
have	O
the	O
resources	O
to	O
contain	O
the	O
disease	O
,	O
with	O
health	O
centres	O
closing	O
and	O
hospitals	O
becoming	O
overwhelmed	O
.	O

Several	O
factors	O
contribute	O
to	O
the	O
risk	O
of	O
infection	O
,	O
such	O
as	O
working	O
on	O
the	O
pathogen	O
without	O
bio-safety-level-3	O
conditions	O
which	O
recommend	O
closed	O
laboratory	O
safety	O
cabinets	O
,	O
masks	O
,	O
a	O
positive-pressure	O
ventilation	O
system	O
and	O
other	O
precautions	O
.	O

This	O
may	O
be	O
avoided	O
since	O
the	O
original	O
criteria	O
that	O
method	O
development	O
should	O
be	O
relevant	O
for	O
all	O
sectors	O
has	O
been	O
abandoned	O
.	O

When	O
her	O
engineered	O
plants	O
sense	O
explosive	O
chemicals	O
in	O
the	O
air	O
,	O
the	O
pathway	O
that	O
makes	O
chlorophyll	O
-	O
the	O
green	O
pigment	O
in	O
plants	O
-	O
is	O
blocked	O
.	O

Skeels	S-Person
found	O
glass	O
vials	O
containing	O
Salmonella	O
"	O
bactrol	O
disks	O
"	O
in	O
the	O
laboratory	O
of	O
a	O
Rajneeshpuram	O
medical	O
clinic	O
.	O

Some	O
designs	O
use	O
two	O
X-ray	O
sources	O
and	O
detector	O
arrays	O
offset	O
by	O
an	O
angle	O
,	O
as	O
a	O
technique	O
to	O
improve	O
temporal	O
resolution	O
.	O

According	O
to	O
the	O
Army	S-Organization
report	O
,	O
scientists	O
from	O
this	O
division	O
produce	O
and	O
test	O
aerosolized	O
bio-agents	O
at	O
Lothar	B-Organization
Saloman	I-Organization
Life	I-Organization
Sciences	I-Organization
Test	I-Organization
Facility	E-Organization
()	O
.	O

Speaking	O
during	O
the	O
occasion	O
,	O
USA	S-Organization
Ambassador	O
to	O
Cameroon	S-Organization
,	O
Peter	B-Person
Henry	I-Person
Barlerin	E-Person
said	O
the	O
Centre	O
equipped	O
with	O
the	O
state-of-the	O
art	O
equipment	O
including	O
computers	O
,	O
was	O
constructed	O
by	O
the	O
USAbased	O
company	O
.	O

The	O
problem	O
was	O
not	O
in	O
the	O
creation	O
of	O
the	O
materials	O
but	O
in	O
the	O
inventory	O
control	O
which	O
allowed	O
them	O
to	O
remain	O
unsecured	O
for	O
decades	O
.	O

The	O
idea	O
,	O
the	O
source	O
says	O
,	O
is	O
to	O
provide	O
flexibility	O
and	O
acknowledge	O
that	O
researchers	O
know	O
best	O
how	O
to	O
address	O
biosafety	O
issues	O
within	O
their	O
labs	O
.	O

One	O
of	O
the	O
unfortunate	O
consequences	O
of	O
working	O
with	O
etiological	O
agents	O
is	O
the	O
potential	O
for	O
acquiring	O
a	O
laboratory-associated-infection	S-Disease
(	O
LAI	S-Disease
)	O
.	O

This	O
could	O
strain	O
national	O
stockpiles	O
of	O
antibiotics	O
and	O
lead	O
to	O
a	O
shortage	O
of	O
the	O
vaccine	O
.	O

Most	O
transmissions	O
occur	O
soon	O
before	O
or	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

He	O
was	O
evacuated	O
to	O
Spain	S-Location
and	O
died	O
on	O
12	O
August	O
.	O

As	O
part	O
of	O
the	O
United	B-Organization
Nations	E-Organization
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
supports	O
work	O
towards	O
the	O
Millennium	O
Development	O
Goals	O
.	O

The	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
and	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
()	O
collect	O
data	O
on	O
antibiotic	O
use	O
in	O
humans	O
and	O
in	O
a	O
more	O
limited	O
fashion	O
in	O
animals	O
.	O

As	O
of	O
April	O
2020	O
,	O
the	O
U.S.	B-Organization
government	E-Organization
is	O
not	O
tracking	O
sex-related	O
data	O
of	O
COVID‑19	S-Disease
infections	O
.	O

Other	O
conditions	O
,	O
such	O
as	O
war	O
,	O
famine	O
,	O
and	O
weather	O
,	O
contributed	O
to	O
the	O
severity	O
of	O
the	O
.	O

The	O
technology	O
developed	O
by	O
GeoVax	S-Organization
an	O
Atlanta-based	O
clinical-stage	O
biotechnology	O
company	O
,	O
was	O
presented	O
on	O
Sunday	O
at	O
ASM	B-Activity
Microbe	E-Activity
,	O
the	O
ongoing	O
annual	O
meeting	O
of	O
the	O
.	O

"	O
The	O
identification	O
of	O
this	O
case	O
underscores	O
the	O
importance	O
of	O
maintaining	O
high	O
levels	O
of	O
routine	O
vaccination	O
coverage	O
and	O
effective	O
surveillance	O
systems	O
for	O
early	O
detection,	O
"	O
said	O
Dr	O
Luo	B-Person
Dapeng	E-Person
WHO	S-Organization
representative	O
in	O
.	O

In	O
another	O
statement	O
,	O
IDSA	S-Organization
joined	O
the	O
Global	B-Organization
Health	I-Organization
Council	E-Organization
,	O
the	O
American	B-Organization
Academy	I-Organization
of	I-Organization
Pediatrics	E-Organization
,	O
and	O
Management	B-Organization
Sciences	I-Organization
for	I-Organization
Health	E-Organization
in	O
recognizing	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
efforts	O
to	O
strengthen	O
its	O
role	O
in	O
public	O
health	O
preparedness	O
and	O
response	O
.	O

The	O
Unit	B-Organization
731	E-Organization
complex	O
covered	O
and	O
consisted	O
of	O
more	O
than	O
150	O
buildings	O
.	O

Autopsies	O
of	O
people	O
who	O
died	O
of	O
COVID‑19	S-Disease
have	O
found	O
diffuse	B-Phenotype
alveolar	I-Phenotype
damage	E-Phenotype
(	O
DAD	S-Phenotype
)	O
,	O
and	O
lymphocyte-containing	O
.	O

Changing	O
your	O
diet	O
or	O
habits	O
can	O
have	O
noticeable	O
effects	O
on	O
your	O
overall	O
sense	O
of	O
well-being	O
,	O
or	O
it	O
may	O
affect	O
specific	O
symptoms	O
you're	O
targeting	O
,	O
like	O
digestive	O
concerns	O
or	O
headaches	S-Phenotype

Most	O
advocacy	O
in	O
biohacking	O
is	O
about	O
the	O
safety	O
,	O
accessibility	O
and	O
future	O
legality	O
of	O
experimentation	O
.	O

The	O
CDC	O
also	O
conducts	O
research	O
and	O
provides	O
information	O
on	O
non-infectious	O
diseases	O
,	O
such	O
as	O
obesity	S-Disease
and	O
diabetes	O
,	O
and	O
is	O
a	O
founding	O
member	O
of	O
the	O
.	O

Still	O
,	O
"	O
[t]he	O
finding	O
of	O
these	O
agents	O
and	O
toxins	O
highlights	O
the	O
need	O
for	O
constant	O
vigilance	O
in	O
monitoring	O
laboratory	O
materials	O
in	O
compliance	O
with	O
federal	O
regulations	O
on	O
biosafety,	O
"	O
Collins	S-Person
wrote.	O
expects	O
to	O
issue	O
a	O
status	O
report	O
on	O
its	O
campuswide	O
inventory	O
in	O
early	O
October	O
.	O

The	O
current	O
chairman	O
of	O
the	O
executive	O
board	O
is	O
Dr.	O
.	O

Fort	B-Location
Detrick	E-Location
officials	O
stated	O
they	O
have	O
notified	O
appropriate	O
local	O
,	O
state	O
and	O
federal	O
officials	O
of	O
the	O
situation	O
and	O
will	O
continue	O
to	O
work	O
with	O
regulatory	O
agencies	O
,	O
including	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
the	O
,	O
to	O
ensure	O
compliance	O
and	O
determine	O
the	O
necessary	O
next	O
steps	O
.	O

But	O
that	O
request	O
appears	O
to	O
come	O
at	O
the	O
expense	O
of	O
other	O
global	O
health	O
security	O
initiatives	O
,	O
Kates	S-Person
said	O
,	O
in	O
this	O
case	O
global	O
HIV	S-Pathogen
-related	O
funding	O
,	O
which	O
seems	O
to	O
go	O
down	O
about	O
the	O
same	O
amount	O
as	O
funding	O
increases	O
.	O

In	O
April	O
2019	O
,	O
the	O
WHO	S-Organization
published	O
the	O
preliminary	O
results	O
of	O
its	O
research	O
,	O
in	O
association	O
with	O
the	O
DRC	S-Organization
's	O
Institut	B-Organization
National	I-Organization
pour	I-Organization
la	I-Organization
Recherche	I-Organization
Biomedicale	E-Organization
,	O
into	O
the	O
effectiveness	O
of	O
the	O
ring	O
vaccination	O
program	O
,	O
including	O
data	O
from	O
93,965	O
at-risk	O
people	O
who	O
had	O
been	O
vaccinated	O
.	O

On	O
24	O
August	O
2018	O
,	O
it	O
was	O
reported	O
that	O
an	O
Ebola	S-Disease
physician	O
had	O
been	O
in	O
contact	O
with	O
some	O
97	O
individuals	O
in	O
an	O
inaccessible	O
military	O
area	O
,	O
hence	O
those	O
97	O
contacts	O
could	O
not	O
be	O
diagnosed	O
.	O

Remdesivir	S-Drug
is	O
at	O
least	O
partially	O
metabolized	O
by	O
the	O
cytochrome	O
P450	O
enzymes	O
CYP2C8	O
,	O
CYP2D6	O
,	O
and	O
CYP3A4	O
.	O

Amesh	B-Person
Adalja	E-Person
a	O
senior	O
scholar	O
at	O
the	O
.	O
"	O
If	O
you	O
use	O
a	O
contagious	O
infectious	O
disease	O
,	O
you	O
really	O
could	O
create	O
havoc	O
on	O
a	O
different	O
scale.	O
"	O

The	O
two	O
BSL-2	S-Platform
labs	O
where	O
the	O
samples	O
were	O
sent	O
are	O
not	O
equipped	O
to	O
handle	O
live	O
anthrax	B-Pathogen
bacteria	E-Pathogen
.	O
Workers	O
in	O
the	O
labs	O
,	O
believing	O
the	O
samples	O
were	O
inactivated	O
,	O
were	O
not	O
wearing	O
adequate	O
personal	O
protective	O
equipment	O
needed	O
to	O
work	O
with	O
live	O
bacteria	O
while	O
handling	O
the	O
material	O
.	O

It	O
is	O
due	O
to	O
the	O
scanner	S-Equipment
being	O
unable	O
to	O
differentiate	O
between	O
a	O
small	O
amount	O
of	O
high-density	O
material	O
(e.g.	O
,	O
bone)	O
and	O
a	O
larger	O
amount	O
of	O
lower	O
density	O
(e.g.	O
,	O
cartilage)	O
.	O

In	O
a	O
speech	O
delivered	O
at	O
the	O
nearby	O
Masonic	B-Location
temple	E-Location
,	O
Bush	O
compared	O
the	O
to	O
a	O
modern	O
"	O
DEW"	O
line	O
(referring	O
to	O
the	O
Cold	O
War	O
ballistic	O
missile	O
early	O
warning	O
system)	O
.	O

This	O
testing	O
confirmed	O
and	O
identified	O
a	O
circular	O
IncFII	O
plasmid	O
of	O
139,547	O
bp	O
,	O
which	O
contained	O
the	O
blaNDM-5	O
gene	O
and	O
additional	O
resistance	O
genes:	O
tet(A)	O
,	O
aac(6′)-Ib-cr	O
,	O
aadA5	O
,	O
aadA2	O
,	O
blaOXA-1	O
,	O
blaCTX-M-15	O
,	O
catB3	O
,	O
dfrA17	O
,	O
dfrA12	O
,	O
sul1	O
(2	O
copies)	O
,	O
and	O
mph(A)	O
(3)	O
.	O

That	O
process	O
informed	O
the	O
team's	O
high-level	O
assessment	O
of	O
the	O
readiness	O
of	O
each	O
technology	O
(from	O
early	O
development	O
to	O
being	O
field-ready)	O
,	O
the	O
potential	O
impact	O
of	O
the	O
technology	O
on	O
GCBR	O
reduction	O
(from	O
low	O
to	O
high)	O
,	O
and	O
the	O
amount	O
of	O
financial	O
investment	O
that	O
would	O
be	O
needed	O
to	O
meaningfully	O
deploy	O
the	O
technology	O
(from	O
low	O
to	O
high)	O
.	O

Despite	O
its	O
importance	O
,	O
public	O
health	O
is	O
underfunded	O
worldwide	O
,	O
and	O
poorer	O
countries	O
remain	O
vulnerable	O
to	O
being	O
overwhelmed	O
by	O
outbreaks	O
.	O

More	O
than	O
70%	O
of	O
hospitalizations	O
in	O
the	O
U.S.	S-Location
have	O
been	O
people	O
with	O
such	O
underlying	O
conditions	O
,	O
according	O
to	O
the	O
.	O

You're	O
just	O
walking	O
in	O
water	O
in	O
your	O
boots	O
.	O

The	O
regional	O
divisions	O
of	O
WHO	S-Organization
were	O
created	O
between	O
1949	O
and	O
1952	O
,	O
and	O
are	O
based	O
on	O
article	O
44	O
of	O
the	O
WHO's	B-Document
constitution	E-Document
,	O
which	O
allowed	O
the	O
WHO	S-Organization
to	O
"	O
establish	O
a	O
[single]	O
regional	O
organization	O
to	O
meet	O
the	O
special	O
needs	O
of	O
[each	O
defined]	O
area"	O
.	O

However	O
,	O
this	O
requires	O
careful	O
record-keeping	O
by	O
properly	O
trained	O
and	O
equipped	O
staff	O
.	O

Alibekov	S-Person
says	O
if	O
the	O
wind	O
had	O
been	O
in	O
the	O
opposite	O
direction	O
that	O
day--toward	O
the	O
city	O
of	O
--the	O
death	O
rate	O
could	O
have	O
been	O
in	O
the	O
hundreds	O
of	O
thousands	O
.	O

Because	O
14th-century	O
healers	O
and	O
governments	O
were	O
at	O
a	O
loss	O
to	O
explain	O
or	O
stop	O
the	O
disease	O
,	O
Europeans	O
turned	O
to	O
astrological	O
forces	O
,	O
earthquakes	O
,	O
and	O
the	O
poisoning	O
of	O
wells	O
by	O
Jews	S-Person
as	O
possible	O
reasons	O
for	O
outbreaks	O
.	O

Full	O
details	O
will	O
be	O
made	O
available	O
in	O
a	O
forthcoming	O
Broad	B-Organization
Agency	I-Organization
Announcement	E-Organization

CDC	S-Organization
investigation	O
found	O
that	O
immediate	O
steps	O
were	O
taken	O
to	O
minimize	O
any	O
risk	O
to	O
CDC	S-Organization
lab	O
staff	O
and	O
that	O
this	O
incident	O
was	O
reported	O
to	O
appropriate	O
authorities	O
in	O
a	O
timely	O
manner	O
.	O

The	O
disease	O
bypassed	O
some	O
areas	O
,	O
with	O
the	O
most	O
isolated	O
areas	O
being	O
less	O
vulnerable	O
to	O
contagion	O
.	O

Estimates	O
of	O
the	O
number	O
of	O
people	O
infected	O
by	O
one	O
person	O
with	O
COVID-19	S-Pathogen
(the	O
R0)	O
have	O
varied	O
widely	O
.	O

CRISPR	S-Technology
may	O
revive	O
the	O
concept	O
of	O
transplanting	O
animal	O
organs	O
into	O
people	O
.	O

Now	O
,	O
on	O
July	O
7th	O
,	O
that's	O
when	O
-	O
earlier	O
this	O
week	O
-	O
six	O
weeks	O
after	O
it	O
should	O
have	O
been	O
reported	O
,	O
the	O
incident	O
was	O
reported	O
to	O
senior	O
leadership	O
.	O

Oversight	O
of	O
biological	O
research	O
labs	O
is	O
fragmented	O
,	O
often	O
secretive	O
and	O
largely	O
self-policing	O
,	O
the	O
investigation	O
found	O
.	O

Coronary	B-Technology
CT	I-Technology
calcium	I-Technology
scan	E-Technology
also	O
used	O
for	O
the	O
assessment	O
of	O
severity	O
of	O
coronary	B-Disease
artery	I-Disease
disease	E-Disease
.	O
Specifically	O
,	O
it	O
looks	O
for	O
calcium	B-Phenotype
deposits	I-Phenotype
in	I-Phenotype
the	I-Phenotype
coronary	I-Phenotype
arteries	E-Phenotype
that	O
can	O
narrow	O
arteries	O
and	O
increase	O
the	O
risk	O
of	O
heart	O
attack	O
.	O

The	O
German	B-Organization
Government	E-Organization
conducted	O
a	O
48-hour	O
weekend	O
hackathon	O
,	O
which	O
had	O
more	O
than	O
42,000	O
participants	O
.	O

B.	B-Pathogen
anthracis	E-Pathogen
is	O
a	O
select	O
agent	O
.	O

Next	O
question	O
comes	O
from	O
Nancy	B-Person
Snyderman	E-Person
with	O
.	O

Fouchier	S-Person
wanted	O
to	O
find	O
out	O
whether	O
(and	O
how)	O
H5N1	S-Pathogen
could	O
naturally	O
develop	O
this	O
ability	O
.	O

For	O
example	O
,	O
in	O
2008	O
,	O
over	O
1000	O
novel	O
compounds	O
were	O
isolated	O
from	O
marine	O
micro-organisms	O
(Ref)	O
.	O

Initial	O
scenarios	O
had	O
placed	O
expected	O
economic	O
losses	O
at	O
$25	O
billion	O
;	O
however	O
subsequent	O
World	B-Organization
Bank	E-Organization
estimates	O
were	O
much	O
lower	O
,	O
at	O
about	O
12%	O
of	O
the	O
combined	O
GDP	O
of	O
the	O
3	O
worst	O
hit	O
countries	O
.	O

The	O
people	O
who	O
were	O
involved	O
were	O
wearing	O
what	O
are	O
called	O
"	O
PAPRs	S-Equipment
"	O
or	O
positive	B-Equipment
air	I-Equipment
pressure	I-Equipment
respirators	E-Equipment
.	O
They	O
were	O
working	O
in	O
an	O
enhanced	O
facilities	O
.	O

The	O
lack	O
of	O
infected	O
ticks	O
and	O
animals	O
is	O
inexplicable	O
given	O
the	O
sharp	O
increase	O
of	O
human	O
cases	O
in	O
2014	O
,	O
meaning	O
that	O
the	O
outbreak	O
was	O
not	O
natural	O
and	O
the	O
virus	O
was	O
spread	O
intentionally	O
.	O

In	O
1348	O
,	O
the	O
plague	S-Disease
spread	O
so	O
rapidly	O
that	O
before	O
any	O
physicians	O
or	O
government	O
authorities	O
had	O
time	O
to	O
reflect	O
upon	O
its	O
origins	O
,	O
about	O
a	O
third	O
of	O
the	O
European	O
population	O
had	O
already	O
perished	O
.	O

For	O
guidelines	O
and	O
regulations	O
appropriate	O
to	O
locations	O
outsU.S.	O
,	O
please	O
refer	O
to	O
appendix	O
mca01b	O
and	O
Internet	O
Resources	O
.	O

While	O
the	O
capability	O
of	O
cutting	O
DNA	O
wasn't	O
unprecedented	O
,	O
Cas9	O
dusts	O
the	O
competition	O
with	O
its	O
effectiveness	O
and	O
ease	O
of	O
use	O
.	O

A	O
growing	O
list	O
of	O
infections	O
–	O
such	O
as	O
pneumonia	S-Disease
tuberculosis	S-Disease
,	O
blood	B-Disease
poisoning	E-Disease
,	O
,	O
and	O
foodborne	O
diseases	O
–	O
are	O
becoming	O
harder	O
,	O
and	O
sometimes	O
impossible	O
,	O
to	O
treat	O
as	O
antibiotics	O
become	O
less	O
effective	O
.	O

In	O
January	O
2020	O
,	O
it	O
was	O
reported	O
that	O
there	O
had	O
been	O
nearly	O
400	O
attacks	O
on	O
medical	O
workers	O
since	O
the	O
outbreak	O
began	O
in	O
2018	O
.	O

DARPA	S-Organization
will	O
hold	O
a	O
Proposers	O
Day	O
on	O
January	O
30	O
,	O
2018	O
,	O
in	O
Arlington	S-Location
,	O
Virginia	S-Location
,	O
to	O
provide	O
more	O
information	O
about	O
and	O
to	O
answer	O
questions	O
from	O
potential	O
proposers	O
.	O

UNICEF	S-Organization
,	O
USAID	S-Organization
and	O
Samaritan's	B-Organization
Purse	E-Organization
began	O
to	O
take	O
measures	O
to	O
provide	O
support	O
for	O
families	O
that	O
were	O
forced	O
to	O
care	O
for	O
patients	O
at	O
home	O
by	O
supplying	O
caregiver	O
kits	O
intended	O
for	O
interim	O
home-based	O
interventions	O
.	O

Traditional	B-Technology
genomic	I-Technology
models	E-Technology
such	O
as	O
Drosophila	O
melanogaster	O
,	O
one	O
of	O
the	O
first	O
model	O
organisms	O
,	O
have	O
seen	O
further	O
refinement	O
in	O
their	O
resolution	O
with	O
the	O
use	O
of	O
Cas9	O
.	O

A	O
CT	S-Equipment
scan	O
can	O
be	O
used	O
for	O
detecting	O
both	O
acute	O
and	O
chronic	O
changes	O
in	O
the	O
lung	O
parenchyma	O
,	O
the	O
tissue	O
of	O
the	O
lungs	O
.	O

On	O
19	O
April	O
it	O
was	O
reported	O
that	O
the	O
country	O
had	O
its	O
lowest	O
deaths	O
at	O
433	O
in	O
seven	O
days	O
,	O
some	O
businesses	O
after	O
six	O
weeks	O
of	O
lockdown	O
are	O
asking	O
for	O
a	O
loosening	O
of	O
restrictions	O
.	O

The	O
war	O
,	O
however	O
,	O
had	O
initially	O
been	O
expected	O
to	O
end	O
quickly	O
but	O
lasted	O
for	O
four	O
years	O
by	O
the	O
time	O
the	O
pandemic	O
struck	O
.	O

Two	O
days	O
ago	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
reported	O
that	O
the	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
has	O
sickened	O
188	O
people	O
and	O
killed	O
118	O
in	O
the	O
northeastern	O
region	O
of	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
.	O
Lillibridge	S-Person
noted	O
that	O
Ebola	S-Disease
continues	O
to	O
spread	O
in	O
what	O
is	O
considered	O
a	O
conflict	O
zone	O
,	O
making	O
it	O
nearly	O
impossible	O
for	O
the	O
to	O
sufficiently	O
access	O
the	O
stricken	O
population	O
there	O
.	O

Late	O
on	O
July	O
7	O
,	O
the	O
vials	O
were	O
transported	O
safely	O
and	O
securely	O
with	O
the	O
assistance	O
of	O
federal	O
and	O
local	O
law	O
enforcement	O
agencies	O
to	O
CDC	S-Organization
high-containment	O
facility	O
in	O
Atlanta	S-Location
.	O
Overnight	O
PCR	B-Technology
testing	E-Technology
done	O
by	O
CDC	S-Organization
in	O
the	O
BSL-4	S-Platform
lab	O
confirmed	O
the	O
presence	O
of	O
variola	B-Pathogen
virus	E-Pathogen
DNA	O
.	O

The	O
De­fense	B-Organization
Threat	I-Organization
Re­duc­tion	I-Organization
Agency	E-Organization
is	O
chip­ping	O
in	O
$1.	O
25	O
mil­lion	O
to	O
fund	O
non­clin­i­cal	O
biode­fense	O
as­pects	O
of	O
the	O
col­lab­o­ra­tion	O
,	O
says	O
,	O
with	O
an	O
ad­di­tion­al	O
$8.	O
75	O
mil­lion	O
tied	O
to	O
mile­stones	O
down	O
the	O
road	O
.	O

You've	O
likely	O
already	O
tried	O
a	O
common	O
nootropic	O
-	O
caffeine	O
.	O

Dr	O
.	O

Dr	O
.	O

MRI	S-Technology
requires	O
a	O
magnetic	O
field	O
that	O
is	O
both	O
strong	O
and	O
uniform	O
to	O
a	O
few	O
parts	O
per	O
million	O
across	O
the	O
scan	O
volume	O
.	O

So	O
that	O
leads	O
to	O
some	O
early	O
hypotheses	O
of	O
what	O
might	O
have	O
happened	O
.	O

The	O
British	B-Organization
military	E-Organization
likely	O
employed	O
such	O
deliberate	O
infection	O
to	O
spread	O
smallpox	S-Pathogen
among	O
forces	O
of	O
the	O
.	O

Phages	O
can	O
be	O
bioengineered	O
to	O
target	O
multidrug-resistant	O
bacterial	O
infections	O
,	O
and	O
their	O
use	O
involves	O
the	O
added	O
benefit	O
of	O
preventing	O
the	O
elimination	O
of	O
beneficial	O
bacteria	O
in	O
the	O
human	O
body	O
.	O

No	O
geographic	O
or	O
chronologic	O
indication	O
exists	O
to	O
suggest	O
that	O
one	O
of	O
these	O
variants	O
was	O
the	O
precursor	O
of	O
the	O
other	O
,	O
nor	O
are	O
there	O
consistent	O
differences	O
between	O
the	O
case	O
histories	O
or	O
histopathologic	O
features	O
of	O
the	O
5	O
patients	O
infected	O
with	O
them	O
.	O

SysMO-SEEK	S-Platform
was	O
developed	O
to	O
be	O
integrated	O
with	O
other	O
data	O
management	O
systems	O
via	O
a	O
software	O
architecture	O
using	O
web	O
interfaces	O
for	O
the	O
adaptation	O
of	O
external	O
systems	O
.	O

IRF	S-Organization
Staff	O
may	O
be	O
required	O
at	O
times	O
to	O
deploy	O
to	O
infectious	O
disease	O
outbreak	O
sites	O
in	O
support	O
of	O
clinical	O
protocols	O
around	O
the	O
world	O
.	O

Symptoms	O
are	O
high	B-Phenotype
fevers	E-Phenotype
and	O
purple	B-Phenotype
skin	I-Phenotype
patches	E-Phenotype
(	O
purpura	S-Phenotype
due	O
to	O
disseminated	B-Disease
intravascular	I-Disease
coagulation	E-Disease
)	O
.	O

The	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	E-Incident
(	O
EVD	S-Disease
)	O
in	O
West	B-Location
Africa	E-Location
between	O
2014	O
and	O
2015	O
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
,	O
and	O
the	O
countries	O
most	O
strongly	O
affected	O
were	O
Sierra	B-Location
Leone	E-Location
,	O
Guinea	S-Location
,	O
and	O
.	O

These	O
CRISPR	S-Technology
cellular	O
models	O
,	O
with	O
isogenic	O
controls	O
,	O
provide	O
a	O
new	O
way	O
to	O
study	O
human	O
disease	O
and	O
test	O
drugs	O
.	O

The	O
outbreak	O
is	O
in	O
the	O
northwestern	O
town	O
of	O
Bikoro	S-Location

The	O
moratorium	O
will	O
remain	O
in	O
place	O
pending	O
review	O
by	O
an	O
advisory	O
committee	O
.	O

The	O
Life	B-Organization
Sciences	I-Organization
Division	I-Organization
(LSD)	I-Organization
at	I-Organization
Dugway	I-Organization
Proving	I-Organization
Ground	E-Organization
is	O
tasked	O
with	O
the	O
production	O
of	O
bio-agents	O
.	O

In	O
January	O
2015	O
,	O
the	O
MSF	S-Person
field	O
coordinator	O
reported	O
that	O
Liberia	S-Location
was	O
down	O
to	O
only	O
5 confirmed	O
cases	O
.	O

Some	O
believe	O
that	O
after	O
the	O
collapse	O
of	O
the	O
Soviet	B-Organization
Union	E-Organization
,	O
cultures	O
of	O
smallpox	S-Pathogen
have	O
become	O
available	O
in	O
other	O
countries	O
.	O

Birmingham	S-Location
was	O
declared	O
officially	O
free	O
of	O
smallpox	S-Disease
on	O
16	O
October	O
1978	O
.	O

The	O
Experimental	B-Organization
Therapeutics	I-Organization
(ET)	I-Organization
Branch	I-Organization
of	I-Organization
the	I-Organization
Walter	I-Organization
Reed	I-Organization
Army	I-Organization
Institute	I-Organization
of	I-Organization
Research	E-Organization
(	O
WRAIR	S-Organization
)	O
focuses	O
on	O
the	O
development	O
of	O
new	O
drugs	O
to	O
prevent	O
and	O
treat	O
malaria	S-Disease
,	O
leishmaniosis	S-Disease
,	O
,	O
and	O
other	O
infectious	O
disease	O
threats	O
to	O
US	O
Service	O
members	O
.	O

If	O
a	O
patient	O
is	O
alert	O
and	O
is	O
not	O
vomiting	S-Phenotype
oral	B-Technology
rehydration	I-Technology
therapy	E-Technology
may	O
be	O
instituted	O
,	O
but	O
patients	O
who	O
are	O
vomiting	S-Phenotype
or	O
are	O
delirious	S-Phenotype
must	O
be	O
hydrated	O
with	O
.	O

Several	O
Pacific	S-Location
island	O
territories	O
were	O
hit	O
particularly	O
hard	O
.	O

The	O
CDC	S-Organization
lab	O
is	O
one	O
of	O
only	O
eight	O
U.S.	S-Location
labs	O
with	O
the	O
security	O
and	O
safety	O
features	O
necessary	O
to	O
work	O
with	O
the	O
highest-threat	O
germs	O
,	O
said	O
James	B-Person
Le	I-Person
Duc	E-Person
,	O
director	O
of	O
one	O
of	O
them	O
,	O
the	O
.	O
Five	O
of	O
the	O
eight	O
are	O
run	O
by	O
the	O
federal	O
government	O
.	O

One	O
of	O
the	O
few	O
regions	O
of	O
the	O
world	O
seemingly	O
less	O
affected	O
by	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
was	O
China	S-Location
,	O
where	O
several	O
studies	O
have	O
documented	O
a	O
comparatively	O
mild	O
flu	S-Disease
season	O
in	O
1918.	O
(Although	O
this	O
is	O
disputed	O
due	O
to	O
lack	O
of	O
data	O
during	O
the	O
Warlord	O
Period	O
,	O
see	O
Around	O
the	O
globe)	O
.	O

Iraqi	S-Organization
scientist	O
Nassir	B-Person
al-Hindawi	E-Person
was	O
described	O
by	O
United	B-Organization
Nations	E-Organization
inspectors	O
as	O
the	O
"	O
father	O
of	O
Iraq's	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
"	O
.	O
Two	O
of	O
the	O
leading	O
researchers	O
in	O
the	O
program	O
studied	O
in	O
Britain	S-Location
.	O
Rihab	B-Person
al-Taha	E-Person
(	O
"	O
Dr	O
.	O

Saddam	B-Person
Hussein	E-Person
(1937–2006)	O
initiated	O
an	O
extensive	O
biological	O
weapons	O
(BW)	O
program	O
in	O
Iraq	S-Location
in	O
the	O
early	O
1980s	O
,	O
in	O
violation	O
of	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
(	O
BWC	S-Document
)	O
of	O
1972	O
.	O

But	O
terror	O
experts	O
say	O
impoverished	O
Russian	O
scientists	O
may	O
have	O
sold	O
the	O
virus	O
to	O
foreigners	O
.	O

The	O
humanitarian	O
crisis	O
and	O
deterioration	O
of	O
the	O
security	O
situation	O
is	O
expected	O
to	O
affect	O
any	O
response	O
to	O
the	O
outbreak	O
.	O

Since	O
biohackers	O
are	O
often	O
interested	O
in	O
quantifying	O
every	O
aspect	O
of	O
themselves	O
,	O
they	O
may	O
buy	O
wearable	O
devices	O
to	O
,	O
say	O
,	O
track	O
their	O
sleep	O
patterns.	O
(For	O
that	O
purpose	O
,	O
Dorsey	S-Person
swears	O
by	O
the	O
.	O
)	O
The	O
more	O
data	O
you	O
have	O
on	O
your	O
body's	O
mechanical	O
functions	O
,	O
the	O
more	O
you	O
can	O
optimize	O
the	O
machine	O
that	O
is	O
you	O
-	O
or	O
so	O
the	O
thinking	O
goes	O
.	O

The	O
availability	O
of	O
medical	O
resources	O
and	O
the	O
socioeconomics	O
of	O
a	O
region	O
may	O
also	O
affect	O
mortality	O
.	O

As	O
of	O
2004	O
,	O
several	O
European	O
countries	O
established	O
a	O
decline	O
of	O
antimicrobial	O
resistance	O
in	O
humans	O
through	O
limiting	O
the	O
use	O
of	O
antimicrobials	O
in	O
agriculture	O
and	O
food	O
industries	O
without	O
jeopardizing	O
animal	O
health	O
or	O
economic	O
cost	O
.	O

Children	O
were	O
hit	O
the	O
hardest	O
because	O
many	O
diseases	O
,	O
such	O
as	O
typhus	S-Disease
and	O
,	O
target	O
the	O
immune	O
system	O
,	O
leaving	O
young	O
children	O
without	O
a	O
fighting	O
chance	O
.	O

South	O
Korean	O
society	O
was	O
initially	O
polarised	O
on	O
President	O
Moon	B-Person
Jae-in	E-Person
response	O
to	O
the	O
crisis	O
,	O
many	O
signing	O
petitions	O
either	O
praising	O
it	O
or	O
calling	O
for	O
impeachment	O
.	O

On	O
26	O
January	O
,	O
the	O
government	O
instituted	O
further	O
measures	O
to	O
contain	O
the	O
COVID-19	B-Incident
outbreak	E-Incident
including	O
issuing	O
health	O
declarations	O
for	O
travellers	O
and	O
extending	O
the	O
Spring	O
Festival	O
holiday	O
.	O

The	O
Defense	B-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
(	O
DARPA	S-Organization
)	O
launched	O
the	O
Pandemic	B-Scientific_research_project
Prevention	I-Scientific_research_project
Platform	E-Scientific_research_project
()	O
program	O
in	O
2017	O
,	O
with	O
the	O
eventual	O
goal	O
of	O
halting	O
the	O
spread	O
of	O
any	O
infectious	O
disease	O
outbreak	O
before	O
it	O
can	O
escalate	O
into	O
a	O
pandemic	O
.	O

On	O
the	O
phone?	O

The	O
company	O
has	O
only	O
two	O
employees	O
and	O
no	O
previous	O
record	O
on	O
bio-research	O
.	O

In	O
recent	O
years	O
,	O
such	O
professionals	O
have	O
responded	O
to	O
the	O
Sept.	B-Incident
11,	I-Incident
2001	I-Incident
terror	I-Incident
attacks	E-Incident
the	O
anthrax	B-Incident
attacks	E-Incident
,	O
the	O
2014-2015	O
Ebola	B-Incident
outbreak	E-Incident
,	O
and	O
the	O
spread	O
of	O
the	O
Zika	B-Pathogen
virus	E-Pathogen
in	O
,	O
among	O
other	O
public	O
health	O
emergencies	O
.	O

Atlanta	O
,	O
GA	O
30333	O
,	O
USA	O
"	O
Compare	O
this	O
to	O
the	O
CDP	O
map:	O
"	O
2010	O
CENSUS	O
-	O
CENSUS	O
BLOCK	O
MAP:	O
Druid	O
Hills	O
CDP	O
,	O
GA.	O
"	O
.	O
Retrieved	O
on	O
June	O
1	O
,	O
2017	O
.	O

Some	O
of	O
these	O
products	O
,	O
which	O
mainly	O
consist	O
of	O
injectable	O
antibiotics	O
,	O
can	O
still	O
be	O
bought	O
over	O
the	O
counter	O
,	O
without	O
a	O
veterinary	O
prescription	O
.	O

The	O
disease	O
was	O
also	O
spread	O
to	O
Liberia	S-Location
by	O
a	O
woman	O
who	O
went	O
there	O
after	O
her	O
husband	O
had	O
died	O
of	O
.	O

The	O
United	B-Location
States	E-Location
which	O
has	O
been	O
instrumental	O
in	O
launching	O
the	O
GHSA	S-International_exchange_and_cooperation
and	O
in	O
helping	O
to	O
build	O
the	O
capacity	O
of	O
countries	O
to	O
prevent	O
,	O
detect	O
and	O
respond	O
to	O
emergent	O
health	O
threats	O
,	O
now	O
faces	O
a	O
major	O
funding	O
challenge	O
,	O
she	O
said	O
,	O
pointing	O
to	O
historical	O
funding	O
data	O
dating	O
back	O
to	O
2006	O
showing	O
that	O
,	O
on	O
average	O
,	O
the	O
nation	O
spent	O
about	O
$400	O
million	O
annually	O
on	O
global	O
health	O
security	O
activities	O
.	O

The	O
outbreak	O
was	O
first	O
identified	O
in	O
Wuhan	S-Location
,	O
China	S-Location
,	O
in	O
December	O
2019	O
.	O

On	O
19	O
May	O
,	O
it	O
was	O
reported	O
that	O
the	O
country	O
had	O
in	O
the	O
week	O
of	O
12–19	O
May	O
the	O
highest	O
per	O
capita	O
deaths	O
in	O
,	O
6.	O
25	O
deaths	O
per	O
million	O
per	O
day	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

And	O
those	O
funds	O
would	O
be	O
deployed	O
rapidly	O
,	O
he	O
said	O
,	O
and	O
accountability	O
would	O
be	O
built	O
in	O
.	O

However	O
,	O
overgrowth	O
of	O
Candida	O
can	O
lead	O
to	O
.	O
Some	O
Candida	O
strains	O
are	O
becoming	O
resistant	O
to	O
first-line	O
and	O
second-line	O
antifungal	O
agents	O
such	O
as	O
azoles	O
and	O
echinocandins	O
.	O

The	O
majority	O
of	O
people	O
who	O
catch	O
the	O
infection	O
recover	O
,	O
but	O
many	O
are	O
left	O
with	O
large	O
scars	O
from	O
the	O
rash	S-Disease
There	O
are	O
those	O
who	O
become	O
blind	O
from	O
the	O
infection	O
.	O

A	O
disclaimer	O
was	O
introduced	O
at	O
this	O
point	O
stating	O
that	O
all	O
data	O
will	O
be	O
confidential	O
and	O
anonymous	O
.	O

As	O
of	O
11	O
April	O
2020	O
,	O
access	O
in	O
Canada	S-Location
was	O
only	O
to	O
those	O
who	O
will	O
be	O
involved	O
in	O
a	O
clinical	O
trial	O
.	O

Some	O
have	O
suggested	O
that	O
the	O
epidemic	O
originated	O
in	O
the	O
United	B-Location
States	E-Location
Historian	O
Alfred	B-Person
W.	I-Person
Crosby	E-Person
stated	O
in	O
2003	O
that	O
the	O
flu	S-Disease
originated	O
in	O
Kansas	S-Location
,	O
and	O
popular	O
author	O
John	B-Person
M.	I-Person
Barry	E-Person
described	O
a	O
January	O
1918	O
outbreak	O
in	O
Haskell	B-Location
County	E-Location
,	O
,	O
as	O
the	O
point	O
of	O
origin	O
in	O
his	O
2004	O
article	O
.	O

Spain	S-Location
was	O
not	O
involved	O
in	O
the	O
war	O
,	O
having	O
remained	O
neutral	O
,	O
and	O
had	O
not	O
imposed	O
wartime	O
censorship	O
.	O

For	O
the	O
moment	O
,	O
however	O
,	O
this	O
stand-down	O
remains	O
the	O
sum	O
total	O
of	O
government	O
actions	O
.	O

Goble	S-Person
et	O
al.	O
provide	O
a	O
description	O
of	O
the	O
different	O
levels	O
of	O
integration	O
and	O
locate	O
mashups	O
at	O
the	O
lightweight	O
integration	O
extreme	O
.	O

Redd	S-Person
testified	O
in	O
place	O
of	O
CDC	S-Organization
Director	O
Dr.	O
,	O
who	O
is	O
presently	O
embroiled	O
in	O
financial	O
conflicts	O
of	O
interest	O
.	O

The	O
provides	O
quantitative	O
,	O
real-time	O
,	O
thermal	O
images	O
of	O
the	O
treated	O
area	O
.	O

And	O
Americans	O
should	O
know	O
that	O
we're	O
implementing	O
the	O
highest	O
levels	O
of	O
safety	O
and	O
security	O
in	O
our	O
laboratories	O
and	O
throughout	O
our	O
work	O
.	O

Sanitation	O
and	O
water	O
for	O
all	O
by	O
2030	O
is	O
Goal	O
Number	O
6	O
of	O
the	O
Sustainable	O
Development	O
Goals	O
.	O

Both	O
issues	O
are	O
a	O
problem	O
for	O
using	O
the	O
technology	O
in	O
medicine	O
.	O

We've	O
got	O
a	O
lot	O
of	O
people	O
on	O
the	O
phone	O
.	O

Holy	O
Week	O
observances	O
in	O
Rome	S-Location
which	O
occur	O
during	O
the	O
last	O
week	O
of	O
the	O
Christian	O
penitential	O
season	O
of	O
Lent	O
,	O
were	O
cancelled	O
.	O

Additionally	O
,	O
they	O
said	O
they	O
need	O
to	O
mitigate	O
risks	O
of	O
misuse	O
associated	O
with	O
enabling	O
technologies	O
and	O
services	O
,	O
such	O
as	O
and	O
cloud-based	O
laboratories	O
.	O

The	O
USA	S-Organization
Georgia	S-Organization
agreement	O
accords	O
diplomatic	O
status	O
to	O
the	O
US	S-Location
military	O
and	O
civilian	O
personnel	O
(including	O
diplomatic	O
vehicles)	O
,	O
working	O
on	O
the	O
Pentagon	B-Scientific_research_project
program	E-Scientific_research_project
in	O
.	O

This	O
followed	O
reports	O
that	O
NHS	B-Organization
Nightingale	E-Organization
in	O
London	S-Location
"	O
treated	O
51	O
patients	O
"	O
within	O
the	O
first	O
three	O
weeks	O
of	O
opening	O
.	O

On	O
30	O
July	O
,	O
a	O
second	O
case	O
of	O
EVD	S-Disease
was	O
confirmed	O
in	O
the	O
city	O
of	O
Goma	S-Location
,	O
apparently	O
not	O
linked	O
to	O
the	O
first	O
case	O
,	O
and	O
declared	O
dead	O
the	O
following	O
day	O
.	O

Others	O
were	O
exposed	O
to	O
an	O
aerosol	O
of	O
anthrax	S-Pathogen
sprayed	O
into	O
a	O
chamber	O
while	O
doctors	O
watched	O
behind	O
a	O
glass	O
screen	O
.	O

The	O
employee	O
was	O
retrained	O
on	O
proper	O
procedures	O
for	O
removing	O
protective	O
equipment	O
and	O
exiting	O
animal	O
containment	O
rooms	O
,	O
records	O
say	O
.	O

Other	O
aspects	O
included	O
bioterrorism	O
and	O
means	O
to	O
combat	O
it	O
,	O
as	O
well	O
as	O
bioethics	O
and	O
dual	O
use	O
research	O
of	O
concern	O
and	O
other	O
ethical	O
dilemmas	O
.	O

Stephen	B-Person
C.	I-Person
Redd	E-Person
,	O
director	O
of	O
the	O
.	O

In	O
the	O
world	O
of	O
infectious	O
diseases	O
,	O
being	O
busy	O
is	O
not	O
good	O
.	O

Vladimir	B-Person
Pasechnik	E-Person
defected	O
in	O
1989	O
,	O
and	O
Dr	O
.	O

One	O
way	O
of	O
looking	O
at	O
the	O
evolutionary	O
distance	O
of	O
genes	O
is	O
to	O
compare	O
ratios	O
of	O
synonymous	O
to	O
nonsynonymous	O
nucleotide	O
substitutions	O
.	O

Anthrax	S-Pathogen
has	O
been	O
used	O
as	O
a	O
weapon	O
before	O
.	O

Epub	O
2003	O
Dec	O
2.	O
)	O
,	O
and	O
including	O
the	O
most	O
recent	O
research	O
and	O
publication	O
on	O
creating	B-Technology
the	I-Technology
first	I-Technology
self-replicating	I-Technology
synthetic	I-Technology
bacterial	I-Technology
cell	E-Technology
,	O
the	O
work	O
has	O
been	O
reviewed	O
by	O
White	B-Organization
House	I-Organization
offices	E-Organization
including	O
the	O
Office	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
and	O
Office	B-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	E-Organization
,	O
the	O
National	B-Organization
Science	I-Organization
Advisory	I-Organization
Board	I-Organization
for	I-Organization
Biosecurity	E-Organization
(	O
NSABB	S-Organization
)	O
,	O
the	O
Department	B-Organization
of	I-Organization
Energy	E-Organization
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
,	O
and	O
others	O
.	O

Search	O
,	O
Compare	O
&amp	O
;	O
Book	O
a	O
Flight	O
today	O
w	O
ith	B-Platform
Airfarewatc	E-Platform
and	O
Save	O
Big!	O

In	O
early	O
March	O
,	O
the	O
Indian	B-Organization
government	E-Organization
began	O
evacuating	O
its	O
citizens	O
from	O
Iran	S-Location
.	O
On	O
20	O
March	O
,	O
the	O
United	B-Location
States	E-Location
began	O
to	O
partially	O
withdraw	O
its	O
troops	O
from	O
due	O
to	O
the	O
pandemic	O
.	O

"	O
You	O
can	O
develop	O
solutions	O
through	O
partnerships	O
.	O

The	O
relative	O
safety	O
that	O
can	O
be	O
assumed	O
today	O
will	O
then	O
be	O
gone	O
.	O

ReGenesis	O
episode	O
"	O
Let	O
it	O
burn	O
"	O
(2007)	O
.	O

It	O
was	O
responsible	O
for	O
some	O
of	O
the	O
most	O
notorious	O
war	O
crimes	O
carried	O
out	O
by	O
Imperial	B-Organization
Japan	E-Organization
.	O
Unit	B-Organization
731	E-Organization
was	O
based	O
at	O
the	O
Pingfang	B-Location
district	I-Location
of	I-Location
Harbin	E-Location
,	O
the	O
largest	O
gas	O
chamber	O
in	O
the	O
Japanese	O
puppet	O
state	O
of	O
Manchukuo	S-Location
(now	O
Northeast	B-Location
China	E-Location
)	O
,	O
and	O
had	O
active	O
branch	O
offices	O
throughout	O
China	S-Location
and	O
.	O

"	O
Over	O
the	O
last	O
summer	O
,	O
the	O
first	O
experiment	O
was	O
conducted	O
to	O
edit	O
a	O
human	O
embryo	O
,	O
and	O
this	O
opened	O
a	O
can	O
of	O
worms,	O
"	O
said	O
Jorgensen	S-Person
She	O
explained	O
that	O
people	O
started	O
questioning	O
how	O
this	O
technology	O
should	O
be	O
regulated	O
,	O
who	O
should	O
get	O
access	O
to	O
it	O
and	O
a	O
host	O
of	O
other	O
concerns	O
.	O

Each	O
year	O
in	O
the	O
United	B-Location
States	E-Location
at	O
least	O
2.	O
8 million	O
people	O
become	O
infected	O
with	O
bacteria	O
that	O
are	O
resistant	O
to	O
antibiotics	O
and	O
at	O
least	O
35,000	O
people	O
die	O
as	O
a	O
result	O
.	O

In	O
late	O
March	O
2020	O
,	O
the	O
WHO	S-Organization
and	O
other	O
health	O
bodies	O
began	O
to	O
replace	O
the	O
use	O
of	O
the	O
term	O
"	O
social	O
distancing	O
"	O
with	O
"	O
physical	O
distancing"	O
,	O
to	O
clarify	O
that	O
the	O
aim	O
is	O
to	O
reduce	O
physical	O
contact	O
while	O
maintaining	O
social	O
connections	O
,	O
either	O
virtually	O
or	O
at	O
a	O
distance	O
.	O

It	O
included	O
questions	O
about	O
technically	O
skilled	O
human	O
resources	O
in	O
various	O
aspects	O
of	O
biosafety	O
management	O
systems	O
,	O
availability	O
of	O
sustainable	O
training	O
programs	O
,	O
and	O
challenges	O
such	O
as	O
lack	O
of	O
human	O
resources	O
,	O
monetary	O
funds	O
,	O
specific	O
bio	O
risk	O
management	O
skills	O
,	O
etc	O
.	O

Benedetto	S-Person
Richard	S-Person
.	O
"	O
Secret	B-Organization
Service	E-Organization
investigated	O
ricin	S-Pathogen
quietly"	O
,	O
USA	O
Today	O
,	O
February	O
4	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

But	O
the	O
project's	O
success	O
could	O
signal	O
the	O
impact	O
of	O
synthetic	O
DNA	O
on	O
the	O
future	O
of	O
biotechnology	O
.	O

On	O
27	O
September	O
,	O
the	O
CDC	S-Organization
and	O
U.S.	B-Organization
State	I-Organization
Department	E-Organization
alerted	O
potential	O
travellers	O
to	O
the	O
possibility	O
of	O
unreported	O
EVD	S-Disease
cases	O
within	O
Tanzania	S-Location
.	O
On	O
28	O
September	O
,	O
the	O
United	B-Location
Kingdom	E-Location
began	O
indicating	O
to	O
potential	O
travelers	O
to	O
Tanzania	S-Location
,	O
the	O
undiagnosed	O
death	O
of	O
an	O
individual	O
(and	O
referencing	O
the	O
,	O
21	O
September	O
statement)	O
.	O

As	O
this	O
type	O
of	O
hardware	O
and	O
software	O
is	O
deployed	O
throughout	O
DoD	O
,	O
I	O
believe	O
we	O
will	O
see	O
improved	O
access	O
to	O
healthcare	O
specialists	O
,	O
improved	O
patient	O
outcomes	O
,	O
improved	O
patient	O
and	O
provider	O
education	O
in	O
outlying	O
clinics	O
,	O
and	O
improved	O
patient	O
access	O
to	O
their	O
primary	O
care	O
manager	O
(PCM)	O
.	O

Researchers	O
at	O
the	O
Sandia	B-Organization
National	I-Organization
Laboratories	E-Organization
(	O
SNL	S-Organization
)	O
,	O
the	O
University	B-Organization
of	I-Organization
New	I-Organization
Mexico	E-Organization
(	O
UNM	S-Organization
)	O
and	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
are	O
working	O
to	O
improve	O
the	O
U.S.	O
biosurveillance	O
system	O
that	O
warns	O
authorities	O
of	O
disease	O
outbreaks	O
by	O
mimicking	O
the	O
human	O
immune	O
system	O
.	O

Details	O
of	O
the	O
BW	O
program-along	O
with	O
a	O
chemical	O
weapons	O
program-surfaced	O
only	O
in	O
the	O
wake	O
of	O
the	O
Gulf	O
War	O
(1990–91)	O
following	O
investigations	O
conducted	O
by	O
the	O
United	B-Organization
Nations	I-Organization
Special	I-Organization
Commission	E-Organization
(	O
UNSCOM	S-Organization
)	O
which	O
had	O
been	O
charged	O
with	O
the	O
post-war	O
disarmament	O
of	O
Saddam	S-Person
's	O
Iraq	S-Location
.	O
By	O
the	O
end	O
of	O
the	O
war	O
,	O
program	O
scientists	O
had	O
investigated	O
the	O
BW	O
potential	O
of	O
five	O
bacterial	O
strains	O
,	O
one	O
fungal	O
strain	O
,	O
five	O
types	O
of	O
virus	O
,	O
and	O
four	O
toxins	O
.	O

The	O
CDC	S-Organization
offers	O
grants	O
that	O
help	O
many	O
organizations	O
each	O
year	O
advance	O
health	O
,	O
safety	O
and	O
awareness	O
at	O
the	O
community	O
level	O
throughout	O
the	O
United	B-Location
States	E-Location
.	O
The	O
awards	O
over	O
85	O
percent	O
of	O
its	O
annual	O
budget	O
through	O
these	O
grants	O
.	O

In	O
total	O
,	O
the	O
plague	S-Disease
may	O
have	O
reduced	O
the	O
world	O
population	O
from	O
an	O
estimated	O
475 million	O
to	O
350–375	O
million	O
in	O
the	O
14th	O
century	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture's	I-Organization
National	I-Organization
Animal	I-Organization
Disease	I-Organization
Center	E-Organization
in	O
Ames	S-Location
,	O
Iowa	S-Location
.	O
In	O
separate	O
incidents	O
last	O
summer	O
,	O
workers	O
at	O
the	O
USDA's	B-Organization
National	I-Organization
Animal	I-Organization
Disease	I-Organization
Center	E-Organization
in	O
Ames	S-Location
,	O
Iowa	S-Location
,	O
were	O
potentially	O
exposed	O
to	O
,	O
a	O
dangerous	O
bacteria	O
,	O
because	O
they	O
didn't	O
follow	O
basic	O
safety	O
procedures	O
.	O

The	O
Indonesian	B-Organization
government	E-Organization
also	O
halted	O
the	O
importation	O
of	O
pigs	O
and	O
initiated	O
the	O
examination	O
of	O
pigs	O
in	O
Indonesia	S-Location
.	O
The	O
Egyptian	B-Organization
government	E-Organization
ordered	O
the	O
slaughter	O
of	O
all	O
pigs	O
in	O
on	O
29	O
April	O
.	O

The	O
agreements	O
were	O
structured	O
so	O
that	O
the	O
licensees	O
can	O
set	O
their	O
own	O
prices	O
and	O
will	O
not	O
have	O
to	O
pay	O
royalties	O
to	O
Gilead	S-Organization
until	O
the	O
WHO	S-Organization
declares	O
an	O
end	O
to	O
the	O
COVID-19	S-Disease
emergency	O
or	O
another	O
medicine	O
or	O
vaccine	O
is	O
approved	O
for	O
,	O
whichever	O
comes	O
first	O
.	O

Metabiota	S-Organization
worked	O
on	O
a	O
Pentagon	S-Organization
's	O
project	O
at	O
the	O
,	O
where	O
three	O
US	O
biolabs	O
are	O
situated	O
.	O

On	O
16	O
November	O
2002	O
,	O
an	O
outbreak	B-Incident
of	I-Incident
severe	I-Incident
acute	I-Incident
respiratory	I-Incident
syndrome	E-Incident
(	O
SARS	S-Disease
)	O
began	O
in	O
China	S-Location
's	O
Guangdong	B-Location
province	E-Location
,	O
bordering	O
Hong	B-Location
Kong	E-Location
.	O
The	O
first	O
case	O
of	O
infection	O
was	O
traced	O
to	O
Foshan	S-Location
.	O
This	O
first	O
outbreak	O
affected	O
people	O
in	O
the	O
food	O
industry	O
,	O
such	O
as	O
farmers	O
,	O
market	O
vendors	O
,	O
and	O
chefs	O
.	O

In	O
May	O
2015	O
,	O
Dr	O
Margaret	B-Person
Chan	E-Person
indicated	O
,	O
"	O
demands	O
on	O
WHO	S-Organization
were	O
more	O
than	O
ten	O
times	O
greater	O
than	O
ever	O
experienced	O
in	O
the	O
almost	O
70-year	O
history	O
of	O
this	O
Organization	O
"	O
Bruce-Cunning	S-Person
,	O
Nick	S-Person
.	O
(18	O
May	O
2015)	O
.	O

The	O
war	O
also	O
gave	O
science	O
greater	O
importance	O
as	O
governments	O
relied	O
on	O
scientists	O
,	O
now	O
armed	O
with	O
the	O
new	O
germ	O
theory	O
and	O
the	O
development	O
of	O
antiseptic	O
surgery	O
,	O
to	O
design	O
vaccines	O
and	O
reduce	O
mortalities	O
of	O
disease	O
and	O
battle	O
wounds	O
.	O

On	O
26–27	O
April	O
,	O
Chinese	B-Organization
authorities	E-Organization
closed	O
down	O
theatres	O
,	O
discos	O
,	O
and	O
other	O
entertainment	O
venues	O
in	O
Beijing	S-Location
as	O
the	O
death	O
toll	O
in	O
Beijing	S-Location
continued	O
to	O
rise	O
,	O
threatening	O
to	O
become	O
the	O
worst-hit	O
area	O
of	O
the	O
country	O
,	O
eclipsing	O
the	O
Guangdong	S-Location
.	O
Authorities	O
were	O
bolstered	O
by	O
the	O
fact	O
that	O
the	O
infection	O
rate	O
seemed	O
to	O
have	O
declined	O
,	O
with	O
the	O
only	O
exporting	O
three	O
new	O
infections	O
over	O
the	O
weekend	O
.	O

The	O
clinical	O
signs	O
and	O
symptoms	O
are	O
mainly	O
fever	S-Phenotype
,	O
with	O
a	O
few	O
patients	O
having	O
difficulty	B-Phenotype
in	I-Phenotype
breathing	E-Phenotype
,	O
and	O
chest	O
radiographs	O
showing	O
.	O

The	O
facility	O
itself	O
is	O
generally	O
a	O
separate	O
building	O
or	O
completely	O
isolated	O
zone	O
with	O
complex	O
,	O
specialized	O
ventilation	O
requirements	O
and	O
waste	O
management	O
systems	O
to	O
prevent	O
release	O
of	O
viable	O
agents	O
to	O
the	O
environment	O
.	O

General	O
Burgasov	S-Person
said	O
the	O
crew	O
member	O
on	O
the	O
research	O
ship	O
picked	O
up	O
the	O
virus	O
when	O
it	O
passed	O
within	O
15	O
kilometers	O
,	O
or	O
about	O
9	O
miles	O
,	O
of	O
an	O
off-limits	O
isle	O
.	O

Agencies	O
tasked	O
with	O
biosecurity	O
get	O
a	O
decrease	O
in	O
funding	O
under	O
the	O
Administration's	O
budget	O
proposal	O
.	O

She	O
said	O
H.R.	B-Document
6378	E-Document
reflects	O
extensive	O
feedback	O
from	O
stakeholders	O
across	O
the	O
full	O
range	O
of	O
medical	O
and	O
public	O
health	O
preparedness	O
and	O
response	O
,	O
who	O
offered	O
suggestions	O
on	O
how	O
the	O
nation	O
might	O
best	O
address	O
threats	O
more	O
cohesively	O
.	O

This	O
special	O
technique	O
is	O
called	O
that	O
produces	O
a	O
sampling	O
of	O
the	O
lung	O
,	O
and	O
not	O
continuous	O
images	O
.	O

According	O
to	O
Biraben	S-Person
,	O
the	O
plague	S-Disease
was	O
present	O
somewhere	O
in	O
Europe	S-Location
in	O
every	O
year	O
between	O
1346	O
and	O
1671.	O
(Note	O
that	O
some	O
researchers	O
have	O
cautions	O
about	O
the	O
uncritical	O
use	O
of	O
Biraben	S-Person
's	O
data.	O
)	O
The	O
second	O
pandemic	O
was	O
particularly	O
widespread	O
in	O
the	O
following	O
years:	O
1360–1363	O
;	O
1374	O
;	O
1400	O
;	O
1438–1439	O
;	O
1456–1457	O
;	O
1464–1466	O
;	O
1481–1485	O
;	O
1500–1503	O
;	O
1518–1531	O
;	O
1544–1548	O
;	O
1563–1566	O
;	O
1573–1588	O
;	O
1596–1599	O
;	O
1602–1611	O
;	O
1623–1640	O
;	O
1644–1654	O
;	O
and	O
1664–1667	O
.	O

Infusion‐related	O
reactions	O
have	O
been	O
seen	O
during	O
a	O
remdesivir	S-Drug
infusion	O
or	O
around	O
the	O
time	O
remdesivir	S-Drug
was	O
given	O
.	O

The	O
aim	O
of	O
the	O
network	O
is	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
to	O
improve	O
Sweden	S-Location
's	O
biopreparedness	O
,	O
in	O
line	O
with	O
recommendations	O
from	O
the	O
EU	S-Location
and	O
WHO	S-Organization
.	O
Since	O
forming	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
quality	O
assurance	O
protocols	O
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

This	O
progress	O
is	O
continuing	O
at	O
a	O
rapid	O
pace	O
.	O

The	O
team	O
realized	O
that	O
a	O
campaign	O
like	O
this	O
would	O
most	O
likely	O
reach	O
a	O
different	O
audience	O
from	O
the	O
one	O
that	O
normally	O
pays	O
attention	O
to	O
hurricane-preparedness	O
warnings	O
and	O
went	O
to	O
work	O
on	O
the	O
zombie	O
campaign	O
,	O
launching	O
it	O
right	O
before	O
hurricane	O
season	O
began.	O
"	O
The	O
whole	O
idea	O
was	O
,	O
if	O
you're	O
prepared	O
for	O
a	O
zombie	O
apocalypse	O
,	O
you're	O
prepared	O
for	O
pretty	O
much	O
anything,	O
"	O
said	O
.	O

115	O
Botulism	S-Disease
cases	O
,	O
with	O
12	O
deaths	O
,	O
were	O
reported	O
in	O
in	O
2016	O
.	O

Most	O
common	O
are	O
multiplanar	B-Technology
reconstructions	E-Technology
(	O
MPR	S-Technology
)	O
and	O
volume	O
rendering	O
.	O

Alibekov	S-Person
says	O
if	O
the	O
wind	O
had	O
been	O
in	O
the	O
opposite	O
direction	O
that	O
day--toward	O
the	O
city	O
of	O
--the	O
death	O
rate	O
could	O
have	O
been	O
in	O
the	O
hundreds	O
of	O
thousands	O
.	O

On	O
27	O
July	O
,	O
President	B-Person
Ellen	I-Person
Johnson	I-Person
Sirleaf	E-Person
announced	O
that	O
would	O
close	O
its	O
borders	O
,	O
with	O
the	O
exception	O
of	O
a	O
few	O
crossing	O
points	O
such	O
as	O
the	O
airport	O
,	O
where	O
screening	O
centres	O
would	O
be	O
established	O
.	O

During	O
the	O
First	O
Sacred	O
War	O
in	O
Greece	S-Location
in	O
about	O
590	O
BC	O
,	O
Athens	S-Location
and	O
the	O
Amphictionic	B-Organization
League	E-Organization
poisoned	O
the	O
water	O
supply	O
of	O
the	O
besieged	O
town	O
of	O
Kirrha	S-Location
(near	O
Delphi	S-Location
)	O
with	O
the	O
toxic	O
plant	O
hellebore	O
.	O

As	O
a	O
key	O
protection	O
against	O
the	O
world's	O
most	O
deadly	O
pathogens	O
,	O
including	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
scientists	O
in	O
the	O
BSL-4	S-Platform
labs	O
at	O
the	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
at	O
Fort	B-Location
Detrick	E-Location
in	O
Maryland	S-Location
wear	O
pressurized	O
,	O
full-body	O
spacesuit-like	O
gear	O
and	O
breathe	O
purified	O
air	O
.	O

The	O
original	O
end-to-end	O
manufacturing	O
process	O
required	O
9	O
to	O
12	O
months	O
to	O
go	O
from	O
raw	O
materials	O
at	O
contract	O
manufacturers	O
to	O
finished	O
product	O
,	O
but	O
after	O
restarting	O
production	O
in	O
January	O
,	O
was	O
able	O
to	O
find	O
ways	O
to	O
reduce	O
the	O
production	O
time	O
to	O
six	O
months	O
.	O

German	O
soldiers	O
became	O
ill	O
with	O
the	O
rare	O
pulmonary	S-Phenotype
form	O
of	O
tularemia	S-Disease
,	O
which	O
may	O
indicate	O
the	O
use	O
of	O
an	O
aerosol	O
biological	O
weapon	O
(the	O
ordinary	O
transmission	O
pathway	O
is	O
through	O
ticks	O
and	O
rodents)	O
.	O

This	O
is	O
the	O
same	O
strain	O
that	O
was	O
involved	O
in	O
the	O
early	O
2018	O
outbreak	O
in	O
western	O
.	O

About	O
keeping	O
over	O
environment	O
free	O
and	O
not	O
attractive	O
to	O
rats	O
.	O

In	O
2003	O
the	O
Swedish	B-Organization
National	I-Organization
Board	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Welfare	E-Organization
started	O
an	O
exercise	O
to	O
map	O
microbiology	O
laboratories	O
and	O
regional	O
clinical	O
laboratories	O
across	O
,	O
looking	O
at	O
their	O
capacity	O
and	O
levels	O
of	O
coordination	O
from	O
the	O
perspective	O
of	O
biopreparedness	O
.	O

Authorities	O
believe	O
the	O
current	O
infestation	O
began	O
in	O
Whittier	S-Location
where	O
a	O
Medfly	O
was	O
first	O
trapped	O
on	O
Sept.26	O
.	O

In	O
one	O
statement	O
,	O
IDSA	S-Organization
expressed	O
its	O
support	O
for	O
recommendations	O
on	O
the	O
global	O
strategy	O
and	O
plan	O
of	O
action	O
on	O
public	O
health	O
,	O
innovation	O
and	O
intellectual	O
property	O
from	O
an	O
expert	O
review	O
panel	O
at	O
the	O
assembly	O
.	O

By	O
3	O
August	O
,	O
the	O
virus	O
had	O
developed	O
in	O
multiple	O
locations	O
;	O
cases	O
were	O
reported	O
in	O
five	O
health	O
zones –	O
Beni	S-Location
Butembo	S-Location
,	O
Oicha	S-Location
,	O
Musienene	S-Location
and	O
Mabalako	S-Location
–	O
in	O
North	B-Location
Kivu	E-Location
province	O
and	O
additionally	O
,	O
Mandima	S-Location
and	O
Mambasa	S-Location
in	O
Ituri	B-Location
Province	E-Location
.	O
However	O
,	O
one	O
month	O
later	O
there	O
had	O
been	O
confirmed	O
cases	O
only	O
in	O
the	O
Mabalako	S-Location
,	O
Mandima	S-Location
,	O
Beni	S-Location
and	O
Oicha	S-Location
health	O
zones	O
.	O

WHO	S-Organization
.	O
Decade	O
of	O
Action	O
for	O
Road	O
Safety	O
2011–2020	O
It	O
has	O
also	O
worked	O
on	O
global	O
initiatives	O
in	O
surgery	O
,	O
including	O
emergency	O
and	O
essential	O
surgical	O
care	O
,	O
trauma	O
care	O
,	O
and	O
safe	O
surgery	O
.	O

The	O
U.S.	B-Document
National	I-Document
Institutes	I-Document
of	I-Document
Health	I-Document
guidelines	E-Document
do	O
not	O
recommend	O
any	O
medication	O
for	O
prevention	O
of	O
COVID‑19	S-Disease
,	O
before	O
or	O
after	O
exposure	O
to	O
the	O
,	O
outside	O
the	O
setting	O
of	O
a	O
clinical	O
trial	O
.	O

Balanced	O
steady-state	O
free	O
precession	O
(bSSFP)	O
imaging	O
has	O
a	O
better	O
image	O
contrast	O
between	O
the	O
blood	O
pool	O
and	O
myocardium	O
than	O
the	O
FLASH	B-Technology
MRI	E-Technology
,	O
yet	O
it	O
will	O
produce	O
severe	O
banding	O
artifact	O
when	O
the	O
B0	O
inhomogeneity	O
is	O
strong	O
.	O

The	O
group	O
agreed	O
to	O
initiate	O
an	O
international	O
forum	O
to	O
address	O
such	O
concerns	O
and	O
harmonize	O
regulations	O
across	O
countries	O
.	O

Following	O
its	O
approval	O
of	O
the	O
bill	O
yesterday	O
,	O
the	O
House	S-Organization
sent	O
H.R.	B-Document
6378	E-Document
to	O
the	O
for	O
review	O
.	O

It	O
is	O
"	O
well	O
suited	O
for	O
use	O
against	O
a	O
wide	O
range	O
of	O
biological	O
threats	O
and	O
amenable	O
to	O
rapid	O
,	O
large-scale	O
production,	O
"	O
said	O
Rahul	B-Person
Basu	E-Person
scientist	O
at	O
and	O
lead	O
author	O
on	O
the	O
study	O
.	O

As	O
part	O
of	O
a	O
plea	O
bargain	O
arrangement	O
,	O
he	O
pleaded	O
guilty	O
to	O
two	O
counts	O
of	O
making	O
false	O
statements	O
to	O
immigration	O
officials	O
.	O

2011,The	O
Lugar	B-Organization
Center	E-Organization
Andrew	B-Person
C.	I-Person
Weber	E-Person
(on	O
the	O
right)	O
–	O
US	S-Location
Assistant	O
Secretary	O
of	O
Defense	O
(2009-2014)	O
,	O
US	B-Organization
DoD	E-Organization
Deputy	O
Coordinator	O
for	O
Ebola	S-Disease
Response	O
(2014-2015)	O
,	O
is	O
currently	O
a	O
Metabiota	S-Organization
(	O
the	O
contractor)	O
employee	O
.	O

The	O
annual	O
toll	O
from	O
seasonal	B-Disease
influenza	E-Disease
in	O
the	O
US	S-Location
between	O
1979	O
and	O
2001	O
is	O
estimated	O
at	O
41,400	O
deaths	O
on	O
average	O
.	O

A	O
study	O
on	O
's	O
success	O
story	O
stated	O
that	O
,	O
in	O
this	O
case	O
,	O
a	O
prompt	O
response	O
by	O
the	O
government	O
and	O
proactive	O
public	O
health	O
measures	O
had	O
resulted	O
in	O
the	O
quick	O
control	O
of	O
the	O
outbreak	O
.	O

It	O
had	O
been	O
written	O
to	O
provide	O
advice	O
for	O
faith	O
leaders	O
,	O
places	O
of	O
business	O
and	O
other	O
public	O
places	O
,	O
educators	O
,	O
and	O
state	O
and	O
local	O
officials	O
as	O
they	O
began	O
to	O
reopen	O
.	O

Of	O
the	O
62	O
completed	O
projects	O
,	O
39	O
were	O
done	O
according	O
to	O
original	O
time	O
frames	O
and	O
budgeted	O
costs	O
,	O
with	O
extensions	O
given	O
for	O
23	O
.	O

Want	O
to	O
participate?	O
Take	O
a	O
moment	O
to	O
buy	O
yourself	O
a	O
lab	O
on	O
eBay	S-Platform
.	O
"	O
He	O
then	O
set	O
up	O
a	O
garage	O
lab	O
the	O
same	O
year	O
,	O
working	O
on	O
a	O
project	O
he	O
had	O
previously	O
worked	O
at	O
the	O
Molecular	B-Organization
Sciences	I-Organization
Institute	E-Organization
in	O
Berkeley	S-Location
,	O
.	O

This	O
design	O
necessitates	O
the	O
use	O
of	O
a	O
variety	O
of	O
experimental	O
methods	O
.	O

Until	O
recently	O
in	O
the	O
United	B-Location
States	E-Location
most	O
biological	O
defense	O
strategies	O
have	O
been	O
geared	O
to	O
protecting	O
soldiers	O
on	O
the	O
battlefield	O
rather	O
than	O
ordinary	O
people	O
in	O
cities	O
.	O

In	O
the	O
coming	O
decades	O
,	O
scientists	O
will	O
use	O
the	O
tools	O
of	O
biotechnology	O
to	O
manipulate	O
cells	O
with	O
increasing	O
control	O
,	O
from	O
precision	B-Technology
editing	I-Technology
of	I-Technology
DNA	E-Technology
to	O
.	O
These	O
cells	O
could	O
go	O
on	O
to	O
become	O
bomb-sniffing	O
plants	O
,	O
miracle	O
cancer	O
drugs	O
,	O
or	O
'de-extincted'	O
wooly	O
mammoths	O
.	O

As	O
an	O
adenosine	O
nucleoside	O
triphosphate	O
analog	O
,	O
the	O
active	O
metabolite	O
of	O
remdesivir	S-Drug
interferes	O
with	O
the	O
action	O
of	O
viral	O
RNA-dependent	O
RNA	O
polymerase	O
and	O
evades	O
proofreading	O
by	O
viral	O
exoribonuclease	O
(ExoN)	O
,	O
causing	O
a	O
decrease	O
in	O
viral	O
RNA	O
production	O
.	O

Studies	O
have	O
found	O
that	O
bacteria	O
that	O
evolve	O
antibiotic	O
resistance	O
towards	O
one	O
group	O
of	O
antibiotic	O
may	O
become	O
more	O
sensitive	O
to	O
others	O
.	O

The	O
symptoms	O
of	O
bubonic	B-Disease
plague	E-Disease
are	O
first	O
attested	O
in	O
a	O
fragment	O
of	O
Rufus	O
of	O
Ephesus	O
preserved	O
by	O
Oribasius	S-Person
;	O
these	O
ancient	O
medical	O
authorities	O
suggest	O
bubonic	B-Disease
plague	E-Disease
had	O
appeared	O
in	O
the	O
Roman	B-Location
Empire	E-Location
before	O
the	O
reign	O
of	O
Trajan	S-Person
,	O
six	O
centuries	O
before	O
arriving	O
at	O
Pelusium	S-Location
in	O
the	O
reign	O
of	O
Justinian	B-Person
I	E-Person
.	O
In	O
2013	O
,	O
researchers	O
confirmed	O
earlier	O
speculation	O
that	O
the	O
cause	O
of	O
the	O
Plague	B-Incident
of	I-Incident
Justinian	E-Incident
(541–542	O
AD	O
,	O
with	O
recurrences	O
until	O
750)	O
was	O
.	O
This	O
is	O
known	O
as	O
the	O
First	O
plague	O
pandemic	O
.	O

Details	O
of	O
the	O
photodiodes	O
were	O
also	O
published	O
in	O
the	O
February	O
14	O
,	O
2008	O
issue	O
of	O
the	O
journal	O
Electronics	O
Letters	O
and	O
the	O
November	O
2007	O
issue	O
of	O
the	O
journal	O
IEEE	O
Photonics	O
Technology	O
Letters.	O
,	O
Retrieved	O
on	O
June	O
25	O
,	O
2008	O
.	O

The	O
next	O
Working	O
Group	O
report	O
is	O
due	O
to	O
Congress	S-Organization
and	O
the	O
Secretary	O
by	O
December	O
2020	O
.	O

Each	O
specimen	O
was	O
tested	O
in	O
duplicate	O
.	O

An	O
act	O
of	O
the	O
United	O
States	O
Congress	O
appended	O
the	O
words	O
"	O
and	O
Prevention	O
"	O
to	O
the	O
name	O
effective	O
October	O
27	O
,	O
1992	O
.	O

Each	O
project	O
has	O
a	O
budget	O
that	O
pays	O
for	O
salaries	O
(typically	O
10%	O
of	O
full	O
time	O
for	O
each	O
person	O
involved)	O
,	O
consumables	O
,	O
equipment	O
,	O
and	O
travel	O
.	O

Unit	B-Organization
731	E-Organization
Laboratory	O
of	O
the	O
Devil	O
(1992)	O
,	O
China	S-Location
,	O
directed	O
by	O
.	O

In	O
cases	O
of	O
influenza	O
outbreaks	O
,	O
WHO	S-Organization
and	O
associated	O
agencies	O
have	O
moved	O
rapidly	O
to	O
isolate	O
and	O
eliminate	O
new	O
outbreaks	O
of	O
infection	O
.	O

Some	O
resistance	O
occurs	O
without	O
human	O
action	O
,	O
as	O
bacteria	O
can	O
produce	O
and	O
use	O
antibiotics	O
against	O
other	O
bacteria	O
,	O
leading	O
to	O
a	O
low-level	O
of	O
natural	O
selection	O
for	O
resistance	O
to	O
antibiotics	O
.	O

John	S-Person
of	O
Fordun's	O
Scotichronicon	O
("there	O
was	O
a	O
great	O
pestilence	O
and	O
mortality	O
of	O
men")	O
Subsequent	O
to	O
the	O
pandemic	O
"	O
the	O
furste	O
moreyn	O
"	O
(first	O
murrain)	O
or	O
"	O
first	O
pestilence	O
"	O
was	O
applied	O
,	O
to	O
distinguish	O
the	O
mid-14th	O
century	O
phenomenon	O
from	O
other	O
infectious	O
diseases	O
and	O
epidemics	O
of	O
plague	O
.	O

On	O
22	O
April	O
it	O
was	O
reported	O
that	O
two	O
Californians	O
had	O
died	O
from	O
the	O
virus	O
(not	O
,	O
as	O
previously	O
thought	O
,	O
influenza)	O
on	O
6and	O
17	O
February	O
,	O
three	O
weeks	O
before	O
the	O
first	O
official	O
COVID-19	S-Disease
death	O
in	O
the	O
U.S.	S-Location
had	O
been	O
acknowledged	O
.	O

A	O
search	O
of	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
()	O
laboratories	O
for	O
forgotten	O
infectious	O
agents	O
has	O
turned	O
up	O
a	O
handful	O
of	O
dangerous	O
bacteria	O
and	O
toxins	O
in	O
labs	O
not	O
approved	O
to	O
handle	O
them	O
,	O
according	O
toThe	O
Washington	O
Post	O
,	O
which	O
broke	O
the	O
story	O
late	O
Friday	O
.	O

In	O
December	O
,	O
Dr	O
.	O

The	O
fermentation	O
laboratories	O
at	O
the	O
Life	B-Organization
Sciences	I-Organization
Test	I-Organization
Facility	E-Organization
grow	O
bacteria	O
in	O
fermentors	O
ranging	O
from	O
a	O
small	O
2	O
L	O
to	O
a	O
large	O
1500	O
L	O
system	O
.	O

William	O
Trent	O
,	O
the	O
militia	O
commander	O
,	O
sent	O
a	O
bill	O
to	O
the	O
British	O
Army	O
indicating	O
that	O
the	O
purpose	O
of	O
giving	O
the	O
blankets	O
was	O
"	O
to	O
Convey	O
the	O
Smallpox	O
to	O
the	O
Indians.	O
"	O
The	O
invoice's	O
approval	O
confirms	O
that	O
the	O
British	O
command	O
endorsed	O
Ecuyer	O
actions.Calloway	O
,	O
Scratch	O
of	O
a	O
Penn	O
,	O
73	O
.	O

Some	O
non-U.S.	O
airlines	O
,	O
mostly	O
Asian	O
,	O
including	O
Singapore	B-Organization
Airlines	E-Organization
,	O
China	B-Organization
Eastern	I-Organization
Airlines	E-Organization
,	O
China	B-Organization
Southern	I-Organization
Airlines	E-Organization
,	O
Cathay	B-Organization
Pacific	E-Organization
and	O
Aeromexico	S-Organization
,	O
took	O
measures	O
such	O
as	O
stepping	O
up	O
cabin	O
cleaning	O
,	O
installing	O
state-of-the-art	O
air	O
filters	O
and	O
allowing	O
in-flight	O
staff	O
to	O
wear	O
.	O

Results	O
showed	O
that	O
28.	O
4%	O
of	O
the	O
laboratory	O
technicians	O
from	O
Punjab	S-Location
35.	O
7%	O
from	O
Sindh	S-Location
,	O
32%	O
from	O
Balochistan	S-Location
and	O
38.	O
4%	O
from	O
Khyber	B-Location
Pakhtoon	I-Location
Khawa	E-Location
(	O
KPK	S-Location
)	O
did	O
not	O
use	O
any	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
.	O
Almost	O
46%	O
of	O
the	O
respondents	O
(34.	O
2%	O
from	O
Punjab	S-Location
,	O
61.	O
9%	O
from	O
Sindh	S-Location
,	O
25.	O
2%	O
from	O
Balochistan	S-Location
and	O
85%	O
from	O
)	O
said	O
they	O
reused	O
syringes	O
either	O
occasionally	O
or	O
regularly	O
.	O

The	O
earlier	O
you	O
know	O
you'll	O
be	O
sick	O
,	O
the	O
faster	O
you	O
can	O
begin	O
to	O
respond	O
,	O
and	O
perhaps	O
avoid	O
the	O
worst	O
of	O
the	O
illness	O
completely,	O
"	O
said	O
Albert	B-Person
Swiston	E-Person
a	O
principal	O
researcher	O
on	O
the	O
.	O
"	O
Earlier	O
detection	O
of	O
epidemics	O
on	O
the	O
per-person	O
scale	O
also	O
offers	O
an	O
entirely	O
new	O
method	O
for	O
public	O
health	O
surveillance	O
and	O
countermeasures,	O
"	O
he	O
added	O
.	O

Physical	O
distancing	O
measures	O
are	O
also	O
recommended	O
to	O
prevent	O
transmission	O
.	O

A	O
second	O
case	O
,	O
from	O
nearby	O
Imperial	B-Location
County	E-Location
,	O
California	S-Location
,	O
was	O
confirmed	O
on	O
17	O
April	O
.	O

How	O
Well	O
Is	O
Environmental	O
Biosafety	O
Research	O
Supporting	O
the	O
Scientific	O
Debate	O
on	O
the	O
Biosafety	O
of	O
Genetically	B-Technology
Modified	I-Technology
Organisms	E-Technology
()?	O

Certain	O
characteristics	O
of	O
the	O
1989	O
medfly	O
infestation	O
led	O
investigators	O
to	O
the	O
conclusion	O
that	O
someone	O
was	O
responsible	O
for	O
deliberately	O
releasing	O
medflies	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
for	O
more	O
information	O
.	O

Biting	O
flies	O
,	O
which	O
live	O
in	O
drains	O
,	O
are	O
also	O
listed	O
in	O
the	O
document	O
.	O

One	O
of	O
the	O
many	O
different	O
strategies	O
developed	O
since	O
the	O
early	O
2000s	O
is	O
based	O
on	O
radial	B-Technology
FLASH	I-Technology
MRI	E-Technology
,	O
and	O
iterative	O
reconstruction	O
.	O

Although	O
a	O
causal	O
link	O
has	O
not	O
been	O
definitively	O
established	O
,	O
current	O
guidelines	O
in	O
the	O
United	B-Location
States	E-Location
are	O
that	O
dialysis	O
patients	O
should	O
only	O
receive	O
gadolinium	O
agents	O
where	O
essential	O
and	O
that	O
should	O
be	O
performed	O
as	O
soon	O
as	O
possible	O
after	O
the	O
scan	O
to	O
remove	O
the	O
agent	O
from	O
the	O
body	O
promptly	O
.	O

Microbiol	O
.	O

Eshoo	S-Person
who	O
co-authored	O
the	O
proposal	O
with	O
Rep	O
.	O

Jacobs	B-Organization
Engineering	I-Organization
Group	E-Organization
has	O
secured	O
a	O
deal	O
to	O
build	O
a	O
facility	O
for	O
pharmaceutical	O
company	O
to	O
manufacture	O
gene	O
therapy	O
products	O
.	O

It	O
is	O
experimenting	O
on	O
the	O
cheap	O
,	O
usually	O
without	O
the	O
benefit	O
of	O
a	O
fancy	O
university	O
laboratory	O
,	O
and	O
it	O
often	O
involves	O
DNA	O
and	O
genes	O
.	O

There	O
was	O
consensus	O
among	O
US	S-Location
researchers	O
in	O
the	O
postwar	O
period	O
that	O
the	O
human	O
experimentation	O
data	O
gained	O
was	O
of	O
little	O
value	O
to	O
the	O
development	O
of	O
American	O
biological	O
weapons	O
and	O
medicine	O
.	O

The	O
three	O
most	O
affected	O
countries-	O
Guinea	S-Location
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
-are	O
among	O
the	O
poorest	O
in	O
the	O
world	O
,	O
with	O
extremely	O
low	O
levels	O
of	O
literacy	O
,	O
few	O
hospitals	O
or	O
doctors	O
,	O
low-quality	O
physical	O
infrastructure	O
,	O
and	O
weakly	O
functioning	O
government	O
institutions	O
.	O

China	S-Location
maintained	O
its	O
automatic	O
qualification	O
and	O
later	O
hosted	O
the	O
Women's	B-Activity
World	I-Activity
Cup	E-Activity
four	O
years	O
later	O
.	O

Patrick	B-Person
Leahy	E-Person
,	O
among	O
others	O
.	O

The	O
letters	O
claimed	O
that	O
officials	O
would	O
have	O
noticed	O
an	O
uptick	O
in	O
medfly	O
numbers	O
around	O
March	O
1989	O
.	O

CDC	S-Organization
analyses	O
demonstrate	O
that	O
the	O
number	O
of	O
U.S.	S-Location
jobs	O
at	O
risk	O
rapidly	O
goes	O
up	O
as	O
an	O
outbreak	O
spreads	O
from	O
a	O
single	O
country	O
to	O
multiple	O
countries	O
.	O

However	O
,	O
new	O
strains	O
that	O
escape	O
immunity	O
induced	O
by	O
vaccines	O
may	O
evolve	O
;	O
for	O
example	O
,	O
an	O
updated	O
influenza	S-Disease
vaccine	O
is	O
needed	O
each	O
year	O
.	O

An	O
estimated	O
500,000	O
laboratory	O
workers	O
in	O
the	O
United	B-Location
States	E-Location
are	O
at	O
risk	O
of	O
exposure	O
to	O
infectious	O
agents	O
that	O
cause	O
disease	O
ranging	O
from	O
inapparent	O
to	O
life-threatening	O
infections	O
,	O
but	O
the	O
precise	O
risk	O
to	O
a	O
given	O
worker	O
unknown	O
.	O

Students	O
compare	O
their	O
findings	O
to	O
those	O
reported	O
by	O
Chou	S-Person
and	O
and	O
use	O
the	O
results	O
to	O
determine	O
the	O
strain	O
they	O
used	O
in	O
the	O
lab	O
.	O

+Minor	O
Ebola	B-Incident
virus	I-Incident
outbreaks	E-Incident
by	O
country	O
and	O
by	O
date	O
–	O
30	O
July	O
2014	O
to	O
most	O
recent	O
WHO	S-Organization
/	O
Gov	O
update	O
30	O
August	O
2015Date	O
Aggregate	O
Total	O
Nigeria	S-Location
Senegal	S-Location
United	B-Location
States	E-Location
Spain	S-Location
Mali	S-Location
United	B-Location
Kingdom	E-Location
Refs	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
Cases	O
Deaths	O
30	O
August	O
2015	O
36	O
15	O
20	O
8	O
1	O
0	O
4	O
1	O
1	O
0	O
8	O
6	O
1	O
0	O
1	O
0	O
29	O
December	O
2014	O
35	O
15	O
20	O
8	O
1	O
0	O
4	O
1	O
1	O
0	O
8	O
6	O
1	O
0	O
–	O
–	O
14	O
December	O
2014	O
32	O
15	O
20	O
8	O
1	O
0	O
4	O
1	O
1	O
0	O
6	O
6	O
–	O
–	O
–	O
–	O
2	O
November	O
2014	O
27	O
10	O
20	O
8	O
1	O
0	O
4	O
1	O
1	O
0	O
1	O
1	O
–	O
–	O
–	O
–	O
12	O
October	O
2014	O
23	O
8	O
20	O
8	O
1	O
0	O
1	O
0	O
1	O
0-	O
–	O
28	O
September	O
2014	O
22	O
8	O
20	O
8	O
1	O
0	O
1	O
0-	O
–	O
-	O

That	O
does	O
not	O
mean	O
that	O
everyone	O
over	O
52	O
is	O
immune	O
,	O
since	O
Americans	O
and	O
Mexicans	O
older	O
than	O
that	O
have	O
died	O
of	O
the	O
new	O
flu"	O
.	O

This	O
is	O
also	O
the	O
first	O
reported	O
case	O
in	O
.	O

CDC	S-Organization
reported	O
on	O
its	O
response	O
to	O
the	O
Animal	B-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Service	E-Organization
's	O
(	O
APHIS	S-Organization
)	O
Agricultural	B-Activity
Select	I-Activity
Agent	I-Activity
Program	E-Activity
's	O
(	O
ASAP	S-Activity
)	O
,	O
part	O
of	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
,	O
summary	O
of	O
findings	O
on	O
the	O
anthrax	S-Pathogen
incident	O
.	O

American	O
soldiers	O
in	O
Kuwait	B-Location
City	E-Location
receive	O
in	O
March	O
1998	O
.	O

And	O
that's	O
going	O
to	O
require	O
careful	O
review	O
of	O
what	O
actually	O
happened	O
and	O
a	O
careful	O
consideration	O
for	O
what	O
will	O
be	O
effective	O
at	O
improving	O
laboratory	O
safety	O
around	O
the	O
country	O
and	O
around	O
the	O
world	O
.	O

In	O
his	O
fingers	O
,	O
he	O
has	O
magnets	O
and	O
two	O
near-field	O
communication	O
(NFC)	O
chips	O
that	O
can	O
be	O
programmed	O
to	O
link	O
to	O
websites	O
or	O
open	O
car	O
doors	O
,	O
among	O
other	O
tasks	O
.	O

What	O
can	O
synthetic	B-Technology
biology	E-Technology
do	O
for	O
us?	O
How	O
can	O
moving	O
genes	O
around	O
cells	O
,	O
creating	O
biological	O
circuits	O
,	O
and	O
writing	O
new	O
genetic	O
programs	O
change	O
the	O
world?	O
Many	O
of	O
the	O
major	O
global	O
problems	O
,	O
such	O
as	O
famine	O
,	O
disease	O
and	O
energy	O
shortages	O
,	O
have	O
potential	O
solutions	O
in	O
the	O
world	O
of	O
engineered	O
cells4	O
.	O

Following	O
a	O
joint	O
workshop	O
,	O
the	O
Nordic	B-Platform
Biopreparedness	I-Platform
Forum	E-Platform
was	O
formed	O
in	O
2015	O
and	O
is	O
now	O
governed	O
by	O
a	O
committee	O
made	O
up	O
of	O
representatives	O
from	O
each	O
country	O
.	O

All	O
authors	O
reviewed	O
the	O
final	O
manuscript	O
.	O

Biosurveillance	O
is	O
the	O
science	O
of	O
real-time	O
disease	O
outbreak	O
detection	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Good	O
morning	O
,	O
everyone	O
.	O

The	O
symptoms	O
ranged	O
from	O
mild	O
(e.g.	O
hair	B-Phenotype
loss	E-Phenotype
)	O
to	O
more	O
severe	O
complications	O
requiring	O
re-hospitalisation	O
or	O
treatment	O
.	O

They	O
assessed	O
the	O
presence	O
of	O
DNA/RNA	O
with	O
polymerase	B-Technology
chain	I-Technology
reaction	E-Technology
(	O
PCR	S-Technology
)	O
techniques	O
for	O
Y.	B-Pathogen
pestis	E-Pathogen
from	O
the	O
tooth	O
sockets	O
in	O
human	O
skeletons	O
from	O
mass	O
graves	O
in	O
northern	O
,	O
central	O
and	O
southern	O
Europe	O
that	O
were	O
associated	O
archaeologically	O
with	O
the	O
Black	O
Death	O
and	O
subsequent	O
resurgences	O
.	O

The	O
aggressive	O
support	O
of	O
the	O
Bill	B-Organization
&amp;	I-Organization
Melinda	I-Organization
Gates	I-Organization
Founda	E-Organization
for	O
intermittent	O
preventive	O
therapy	O
of	B-Disease
mal	E-Disease
aria	O
triggered	O
a	O
memo	O
from	O
the	O
for	O
mer	S-Organization
WHO	B-Disease
mal	E-Disease
aria	O
chochi	O
.	O

While	O
the	O
full	O
impact	O
of	O
CRISPR	S-Technology
will	O
likely	O
be	O
felt	O
in	O
another	O
five	O
to	O
ten	O
years	O
,	O
the	O
technology	O
has	O
already	O
shown	O
promise	O
in	O
gene	O
therapy	O
,	O
understanding	O
complex	O
disease	O
and	O
advanced	O
drug	O
development	O
,	O
added	O
.	O

The	O
severity	O
of	O
COVID‑19	S-Disease
varies	O
.	O

The	O
research	O
team	O
began	O
creating	O
algorithms	O
that	O
mimic	O
these	O
T-cells	O
and	O
look	O
at	O
multiple	O
variables	O
at	O
once	O
,	O
such	O
as	O
the	O
number	O
of	O
clinic	O
visits	O
,	O
the	O
day	O
of	O
the	O
year	O
and	O
intake	O
temperature	O
.	O

They	O
were	O
then	O
treated	O
with	O
antibiotics	S-Drug
The	O
goal	O
of	O
the	O
experiment	O
,	O
unknown	O
to	O
the	O
volunteers	O
,	O
was	O
to	O
standardize	O
bomb-fill	O
for	O
attacks	O
on	O
civilian	O
populations	O
.	O

First	O
,	O
researchers	O
aim	O
to	O
build	O
a	O
whole	O
virus	O
vaccine	O
.	O

These	O
incidents	O
are	O
believed	O
to	O
be	O
due	O
to	O
human	O
error	O
.	O

A	O
One	O
Health	B-International_exchange_and_cooperation
approach	E-International_exchange_and_cooperation
to	O
antimicrobial	O
resistance	O
surveillance	O
,	O
infection	O
prevention	O
,	O
and	O
antimicrobial	O
stewardship	O
could	O
limit	O
the	O
spread	O
and	O
potential	O
global	O
dominance	O
of	O
CRE	O
.	O

Implants	O
,	O
for	O
them	O
,	O
are	O
a	O
starter	O
experiment	O
.	O

Another	O
study	O
showed	O
that	O
the	O
economic	O
effect	O
of	O
the	O
Ebola	B-Incident
outbreak	E-Incident
would	O
be	O
felt	O
for	O
years	O
due	O
to	O
preexisting	O
social	O
vulnerability	O
.	O

On	O
11	O
May	O
2014	O
,	O
two	O
people	O
in	O
Medan	S-Location
were	O
suspected	O
infected	O
by	O
MERS-Cov	S-Pathogen
()	O
.	O

Readers	O
are	O
strongly	O
urged	O
to	O
review	O
this	O
publication	O
prior	O
to	O
initiating	O
any	O
experiment	O
outlined	O
in	O
this	O
manual	O
.	O

The	O
overall	O
cylinders	O
are	O
generally	O
approximately	O
80 nm	O
in	O
diameter	O
,	O
and	O
have	O
a	O
virally	O
encoded	O
glycoprotein	O
(GP)	O
projecting	O
as	O
7–10 nm	O
long	O
spikes	O
from	O
its	O
lipid	O
bilayer	O
surface	O
.	O

On	O
1	O
January	O
2020	O
,	O
WHO	S-Organization
requested	O
further	O
information	O
from	O
national	O
authorities	O
to	O
assess	O
the	O
risk	O
.	O

The	O
first	O
pandemic	O
influenza	S-Disease
wave	O
appeared	O
in	O
the	O
spring	O
of	O
1918	O
,	O
followed	O
in	O
rapid	O
succession	O
by	O
much	O
more	O
fatal	O
second	O
and	O
third	O
waves	O
in	O
the	O
fall	O
and	O
winter	O
of	O
1918–1919	O
,	O
respectively	O
(Figure	O
1)	O
.	O

Stericycle	S-Organization
and	O
Daniels	O
Health	O
are	O
two	O
national	O
leaders	O
in	O
medical	O
waste	O
and	O
pharmaceutical	O
disposal	O
in	O
.	O

Moreover	O
,	O
by	O
providing	O
information	O
and	O
education	O
to	O
public	O
leaders	O
,	O
emergency	O
medical	O
services	O
and	O
all	O
employees	O
of	O
the	O
DHS	S-Organization
,	O
suggests	O
it	O
can	O
significantly	O
decrease	O
the	O
impact	O
of	O
bioterrorism	O
.	O

In	O
the	O
U.S.	S-Location
and	O
other	O
countries	O
around	O
the	O
world	O
,	O
pharmacies	O
are	O
not	O
permitted	O
to	O
sell	O
antibiotics	O
to	O
people	O
who	O
are	O
unable	O
to	O
produce	O
a	O
prescription	O
.	O

Post	B-Incident
9/11	I-Incident
and	I-Incident
anthrax	I-Incident
in	I-Incident
the	I-Incident
mail	I-Incident
bioterrorism	I-Incident
in	I-Incident
2001	E-Incident
the	O
focus	O
on	O
biosafety	O
initiatives	O
in	O
the	O
BMENA	S-Location
region	O
broadened	O
to	O
include	O
other	O
sciences	O
,	O
mainly	O
biomedical	O
sciences	O
and	O
to	O
some	O
extent	O
veterinary	O
sciences	O
,	O
bioengineering	O
,	O
chemical/nuclear	O
sciences	O
,	O
and	O
agricultural	O
sciences	O
,	O
especially	O
in	O
countries	O
with	O
the	O
backdrop	O
of	O
dynamic	O
or	O
unstable	O
geopolitical	O
circumstances	O
.	O

Standard	O
microbiological	O
practices	O
should	O
be	O
followed	O
when	O
working	O
with	O
these	O
organisms	O
.	O

More	O
than	O
2.	O
8	O
million	O
antibiotic-resistant	O
infections	O
occur	O
in	O
the	O
United	B-Location
States	E-Location
each	O
year	O
,	O
and	O
more	O
than	O
35,000	O
people	O
die	O
as	O
a	O
result	O
.	O

It	O
will	O
take	O
a	O
number	O
of	O
years	O
to	O
build	O
the	O
new	O
facility	O
and	O
have	O
it	O
certified	O
for	O
select-agent	O
research	O
.	O

In	O
addition	O
to	O
these	O
annual	O
epidemics	O
,	O
Influenza	B-Pathogen
A	I-Pathogen
virus	E-Pathogen
strains	O
caused	O
three	O
global	O
pandemics	O
during	O
the	O
20th	O
century:	O
the	O
Spanish	B-Disease
flu	E-Disease
in	O
1918	O
,	O
Asian	B-Disease
flu	E-Disease
in	O
1957	O
,	O
and	O
Hong	B-Disease
Kong	I-Disease
flu	E-Disease
in	O
1968–69	O
.	O

Biosecurity	O
has	O
also	O
been	O
raised	O
to	O
a	O
place	O
of	O
prominence	O
in	O
security	O
discussions	O
throughout	O
much	O
of	O
the	O
rest	O
of	O
the	O
globe	O
,	O
largely	O
through	O
the	O
mechanisms	O
of	O
the	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
and	O
related	O
groups	O
,	O
but	O
also	O
through	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
and	O
the	O
implementation	O
of	O
the	O
,	O
which	O
is	O
scheduled	O
for	O
2012	O
.	O

On	O
March	O
26-28	O
,	O
the	O
United	B-Location
States	E-Location
will	O
participate	O
in	O
the	O
next	O
GHSA	S-International_exchange_and_cooperation
high-level	O
meeting	O
being	O
held	O
in	O
Tbilisi	S-Location
,	O
Georgia	S-Location
on	O
biosurveillance	O
of	O
infectious	O
disease	O
threats	O
,	O
which	O
include	O
such	O
modern-day	O
examples	O
as	O
HIV	S-Pathogen
/	O
AIDS	S-Disease
,	O
severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
SARS	S-Disease
)	O
,	O
H1N1	B-Disease
influenza	E-Disease
,	O
-	O
any	O
emerging	O
or	O
reemerging	O
disease	O
that	O
threatens	O
human	O
health	O
and	O
global	O
economic	O
stability	O
.	O

Real-time	B-Technology
MRI	E-Technology
videos:	O
.	O

He	O
was	O
treated	O
for	O
respiratory	O
disease	O
and	O
,	O
like	O
the	O
first	O
patient	O
in	O
Saudi	B-Location
Arabia	E-Location
,	O
died	O
of	O
in	O
October	O
2012	O
.	O

Rabobank	S-Organization
Mr	O
calls	O
their	O
current	O
trade	O
tensions	O
an	O
"	O
unwelcome	O
complication"	O
,	O
but	O
predicts	O
the	O
pork	O
shortage	O
could	O
lead	O
to	O
an	O
accelerated	O
deal	O
between	O
the	O
two	O
sides	O
.	O

These	O
and	O
other	O
labs	O
study	O
viruses	O
or	O
toxins	O
to	O
better	O
understand	O
the	O
threats	O
they	O
pose	O
and	O
to	O
try	O
to	O
find	O
cures	O
,	O
but	O
their	O
work	O
could	O
set	O
off	O
a	O
public	O
health	O
emergency	O
if	O
a	O
deadly	O
material	O
is	O
released	O
or	O
mishandled	O
as	O
a	O
result	O
of	O
human	O
error	O
.	O

With	O
the	O
current	O
outbreak	O
,	O
it	O
was	O
initially	O
thought	O
that	O
a	O
new	O
species	O
native	O
to	O
Guinea	S-Location
might	O
be	O
the	O
cause	O
,	O
rather	O
than	O
being	O
imported	O
from	O
Middle	B-Location
to	I-Location
Western	I-Location
Africa	E-Location
.	O
However	O
,	O
further	O
studies	O
have	O
shown	O
that	O
the	O
outbreak	O
was	O
likely	O
caused	O
by	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
lineage	O
that	O
spread	O
from	O
Middle	B-Location
Africa	E-Location
via	O
an	O
animal	O
host	O
within	O
the	O
last	O
decade	O
,	O
with	O
the	O
first	O
viral	O
transfer	O
to	O
humans	O
in	O
.	O

A	O
new	O
DARPA	S-Organization
program	O
called	O
Preventing	B-Scientific_research_project
Emerging	I-Scientific_research_project
Pathogenic	I-Scientific_research_project
Threats	E-Scientific_research_project
,	O
or	O
PREEMPT	S-Scientific_research_project
,	O
seeks	O
to	O
support	O
military	O
readiness	O
by	O
going	O
after	O
new	O
viral	O
infectious	O
diseases	O
at	O
the	O
source	O
,	O
animal	O
reservoirs-the	O
species	O
in	O
which	O
a	O
pathogen	O
lives	O
,	O
multiplies	O
,	O
and	O
potentially	O
evolves	O
into	O
a	O
strain	O
that	O
can	O
threaten	O
humans.	O
aims	O
to	O
advance	O
understanding	O
of	O
viruses	O
and	O
their	O
interaction	O
with	O
animals	O
,	O
insects	O
,	O
and	O
humans	O
,	O
and	O
deliver	O
new	O
,	O
proactive	O
interventions	O
to	O
reduce	O
the	O
risk	O
from	O
emerging	O
and	O
reemerging	O
pathogens	O
.	O

By	O
3	O
August	O
,	O
the	O
virus	O
had	O
developed	O
in	O
multiple	O
locations	O
;	O
cases	O
were	O
reported	O
in	O
five	O
health	O
zones –	O
Beni	S-Location
Butembo	S-Location
,	O
Oicha	S-Location
,	O
Musienene	S-Location
and	O
Mabalako	S-Location
–	O
in	O
North	B-Location
Kivu	E-Location
province	O
and	O
additionally	O
,	O
Mandima	S-Location
and	O
Mambasa	S-Location
in	O
Ituri	B-Location
Province	E-Location
.	O
However	O
,	O
one	O
month	O
later	O
there	O
had	O
been	O
confirmed	O
cases	O
only	O
in	O
the	O
Mabalako	S-Location
,	O
Mandima	S-Location
,	O
Beni	S-Location
and	O
Oicha	S-Location
health	O
zones	O
.	O

And	O
while	O
leadership	O
on	O
the	O
issue	O
is	O
needed	O
,	O
he	O
thinks	O
the	O
solution	O
is	O
organization	O
rather	O
than	O
whomever	O
mans	O
it	O
.	O

Today's	O
action	O
reflects	O
the	O
FDA	S-Organization
's	O
commitment	O
to	O
ensuring	O
that	O
the	O
is	O
prepared	O
for	O
any	O
public	O
health	O
emergency	O
with	O
timely	O
,	O
safe	O
and	O
effective	O
medical	O
products.	O
"	O

Pat	B-Person
Mooney	E-Person
executive	O
director	O
of	O
ETC	B-International_exchange_and_cooperation
Group	E-International_exchange_and_cooperation
,	O
is	O
a	O
critic	O
of	O
biohacking	O
who	O
argues	O
that-using	O
a	O
laptop	O
computer	O
,	O
published	O
gene	O
sequence	O
information	O
,	O
and	O
mail-order	O
synthetic	O
DNA-just	O
about	O
anyone	O
has	O
the	O
potential	O
to	O
construct	O
genes	O
or	O
entire	O
genomes	O
from	O
scratch	O
(including	O
those	O
of	O
the	O
lethal	O
pathogens)	O
in	O
the	O
near-future	O
.	O

A	O
5	O
September	O
memo	O
from	O
NIH	S-Organization
Director	O
Francis	B-Person
Collins	E-Person
to	O
staff	O
(see	O
below)	O
says	O
that	O
the	O
bacteria	O
samples	O
were	O
all	O
stored	O
at	O
NIH's	B-Organization
Clinical	I-Organization
Center	E-Organization
.	O
The	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
samples	O
were	O
an	O
isolate	O
from	O
a	O
patient	O
;	O
the	O
others	O
were	O
testing	O
samples	O
.	O

Retrieved	O
22	O
January	O
2020	O
On	O
11	O
April	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
issued	O
a	O
global	O
health	O
alert	O
for	O
as	O
it	O
became	O
clear	O
the	O
disease	O
was	O
being	O
spread	O
by	O
global	O
air	O
travel	O
.	O

Under	O
,	O
194	O
countries	O
agreed	O
to	O
develop	O
national	O
AMR	O
action	O
plans	O
by	O
2017	O
.	O

Neither	O
bacteria	O
was	O
weaponized	O
.	O

The	O
Occupational	B-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Administration	E-Organization
()	O
regulations	O
in	O
29	O
CFR	O
parts	O
1910.1200	O
and	O
1910.1450	O
.	O

The	O
further	O
advised	O
that	O
persons	O
in	O
the	O
workplace	O
should	O
stay	O
home	O
sick	O
for	O
seven	O
days	O
after	O
getting	O
the	O
flu	O
,	O
or	O
24	O
hours	O
after	O
symptoms	O
end	O
,	O
whichever	O
is	O
longer	O
.	O

Intein-inducible	O
split-Cas9	O
allows	O
dimerization	O
of	O
Cas9	O
fragments	O
and	O
rapamycin-inducible	O
split-Cas9	O
system	O
developed	O
by	O
fusing	O
two	O
constructs	O
of	O
split-Cas9	O
with	O
FRB	O
and	O
FKBP	O
fragments	O
.	O

The	O
CDC	S-Organization
runs	O
a	O
program	O
that	O
protects	O
the	O
public	O
from	O
rare	O
and	O
dangerous	O
substances	O
such	O
as	O
anthrax	S-Pathogen
and	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
The	O
program	O
,	O
called	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
,	O
calls	O
for	O
inspections	O
of	O
labs	O
in	O
the	O
U.S.	S-Location
that	O
work	O
with	O
dangerous	O
pathogens..	O
"	O
CDC's	O
Select	O
Agents	O
Program	O
protects	O
against	O
bioterror	O
threats	O
"	O
,	O
BioPrepWatch	O
,	O
February	O
10	O
,	O
2014	O
;	O
accessed	O
October	O
17	O
,	O
2014	O
.	O

Hargan	S-Person
said	O
the	O
is	O
committed	O
to	O
collaborating	O
across	O
borders	O
to	O
strengthen	O
the	O
capacities	O
to	O
prevent	O
outbreaks	O
and	O
other	O
public	O
health	O
emergencies	O
.	O

For	O
details	O
of	O
the	O
event	O
,	O
including	O
registration	O
requirements	O
,	O
visit:	O

Three	O
out	O
of	O
10	O
people	O
with	O
died	O
.	O

In	O
this	O
way	O
,	O
students	O
also	O
learn	O
about	O
the	O
importance	O
of	O
comparing	O
their	O
results	O
to	O
scientifically	O
published	O
data	O
.	O

Potential	O
hazards	O
include	O
drought	O
,	O
flooding	O
and	O
"	O
intentional	O
attack	O
by	O
an	O
adversary,	O
"	O
he	O
noted	O
.	O

Emboldened	O
by	O
these	O
discoveries	O
,	O
Stalin	S-Person
put	O
KGB	S-Organization
chief	O
in	O
charge	O
of	O
a	O
new	O
BW	O
program	O
.	O

When	O
the	O
United	O
States	O
entered	O
the	O
war	O
,	O
mounting	O
British	O
pressure	O
for	O
the	O
creation	O
of	O
a	O
similar	O
research	O
program	O
for	O
an	O
Allied	O
pooling	O
of	O
resources	O
led	O
to	O
the	O
creation	O
of	O
a	O
large	O
industrial	O
complex	O
at	O
Fort	B-Location
Detrick	E-Location
Maryland	S-Location
in	O
1942	O
under	O
the	O
direction	O
of	O
George	O
W	O
.	O

Emergency	B-Organization
Response	I-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Database	E-Organization
.	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Occupational	I-Organization
Safety	I-Organization
and	I-Organization
Health	E-Organization
.	O
Accessed	O
April	O
20	O
,	O
2009	O
.	O

Testing	O
was	O
marred	O
by	O
defective	O
test	O
kits	O
produced	O
by	O
the	O
government	O
in	O
February	O
,	O
a	O
lack	O
of	O
federal	O
approval	O
for	O
non-government	O
test	O
kits	O
,	O
and	O
restrictive	O
criteria	O
for	O
people	O
to	O
qualify	O
for	O
a	O
test	O
.	O

Chikwe	B-Person
Ihekweazu	E-Person
is	O
the	O
CEO	O
of	O
the	O
.	O

The	O
experimental	O
Flettner	O
rotor	O
bomblet	O
was	O
also	O
developed	O
during	O
this	O
time	O
period	O
.	O

And	O
at	O
that	O
point	O
,	O
you	O
have	O
to	O
exit	O
for	O
your	O
own	O
safety ..	O
.	O

Although	O
Britain	O
never	O
offensively	O
used	O
the	O
biological	O
weapons	O
it	O
developed	O
,	O
its	O
program	O
was	O
the	O
first	O
to	O
successfully	O
weaponize	O
a	O
variety	O
of	O
deadly	O
pathogens	O
and	O
bring	O
them	O
into	O
industrial	O
production	O
.	O

From	O
August	O
through	O
December	O
2014	O
,	O
a	O
total	O
of	O
10	O
patients	O
with	O
Ebola	S-Disease
were	O
treated	O
in	O
US	O
hospitals	O
;	O
of	O
these	O
patients	O
,	O
8	O
survived	O
.	O

In	O
2015	O
,	O
a	O
team	O
eliminated	O
62	O
copies	O
of	O
a	O
particular	O
retroviral	O
DNA	O
sequence	O
from	O
the	O
pig	O
genome	O
in	O
a	O
kidney	O
epithelial	O
cell	O
.	O

Some	O
scientists	O
reasoned	O
that	O
such	O
knowledge	O
would	O
help	O
them	O
prepare	O
a	O
defense	O
against	O
a	O
more	O
deadly	O
form	O
of	O
the	O
fungus	O
.	O

The	O
recommended	O
gear	O
is	O
a	O
PPE	B-Equipment
gown	E-Equipment
,	O
respirator	B-Equipment
or	I-Equipment
facemask	E-Equipment
,	O
eye	B-Equipment
protection	E-Equipment
,	O
and	O
.	O

Additionally	O
,	O
HHS	S-Organization
Secretary	O
Alex	B-Person
Azar	E-Person
delivered	O
a	O
video	O
message	O
to	O
the	O
delegation	O
at	O
the	O
,	O
praising	O
the	O
organization	O
for	O
what	O
its	O
achieved	O
so	O
far	O
and	O
focusing	O
on	O
the	O
work	O
that	O
remains	O
.	O

The	O
lab	O
investigates	O
deadly	O
and	O
exotic	O
germs	O
like	O
Ebola	S-Disease
,	O
and	O
dangerous	O
new	O
forms	O
of	O
flu	O
.	O

Sharp	B-Equipment
disposable	I-Equipment
containers	E-Equipment
were	O
found	O
in	O
84	O
(44.2%)	O
.	O

On	O
17	O
April	O
,	O
the	O
UAE	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
reported	O
another	O
fatality	O
and	O
four	O
additional	O
cases	O
,	O
including	O
the	O
Filipino	O
medical	O
worker	O
who	O
travelled	O
to	O
the	O
on	O
16	O
April	O
.	O

However	O
,	O
federal	O
agencies	O
have	O
worked	O
for	O
years	O
with	O
health	O
departments	O
across	O
the	O
country	O
to	O
plan	O
and	O
prepare	O
for	O
an	O
anthrax	S-Pathogen
attack	O
.	O

As	O
a	O
world	O
leader	O
,	O
the	O
United	B-Location
States	E-Location
should	O
also	O
encourage	O
other	O
nations	O
to	O
adopt	O
sound	O
biosecurity	O
governance	O
systems	O
.	O

The	O
infected	O
boy	O
died	O
on	O
24	O
November	O
,	O
and	O
on	O
3	O
December	O
2	O
remaining	O
cases	O
were	O
released	O
after	O
recovering	O
from	O
the	O
disease	O
.	O

Under	O
the	O
announced	O
contract	O
,	O
Emergent	B-Organization
BioSolutions	E-Organization
will	O
conduct	O
manufacturing	O
runs	O
,	O
collect	O
plasma	O
needed	O
for	O
future	O
manufacturing	O
,	O
and	O
engage	O
in	O
other	O
activities	O
and	O
requirements	O
to	O
retain	O
FDA	S-Organization
licensing	O
of	O
VIGIV	S-Vaccine
.	O
VIGIV	S-Vaccine
has	O
been	O
licensed	O
by	O
the	O
FDA	S-Organization
since	O
2005	O
and	O
by	O
since	O
2007	O
.	O

But	O
it's	O
going	O
to	O
take	O
a	O
detailed	O
investigation	O
.	O

ST1284	O
is	O
a	O
double-locus	O
variant	O
of	O
ST167	O
,	O
which	O
suggests	O
possible	O
distant	O
relatedness	O
of	O
these	O
isolates	O
;	O
ST410	O
does	O
not	O
share	O
any	O
multilocus	O
sequence	O
type	O
alleles	O
with	O
ST167	O
(5)	O
.	O

On	O
26	O
January	O
WHO	S-Organization
Director-General	O
,	O
Dr Margaret	B-Person
Chan	E-Person
officially	O
confirmed	O
that	O
the	O
outbreak	O
was	O
not	O
yet	O
over	O
;	O
that	O
same	O
day	O
,	O
it	O
was	O
also	O
reported	O
that	O
Ebola	S-Disease
restrictions	O
had	O
halted	O
market	O
activity	O
in	O
Kambia	B-Location
District	E-Location
amid	O
protests	O
.	O

A	O
WHO	S-Organization
2013	O
study	O
estimated	O
that	O
the	O
2009	O
global	O
pandemic	O
respiratory	O
mortality	O
was	O
~10-fold	O
higher	O
than	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
's	O
laboratory-confirmed	O
mortality	O
count	O
(18.631)	O
.	O

It	O
also	O
called	O
for	O
the	O
inclusion	O
of	O
child-specific	O
targets	O
and	O
targets	O
addressing	O
antimicrobial	O
resistance	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	S-Organization
DHHS	O
,	O
DoT	O
,	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Another	O
author	O
of	O
the	O
report	O
is	O
Jonathan	B-Person
B.	I-Person
Tucker	E-Person
a	O
Monterey	S-Location
official	O
and	O
author	O
of	O
"	O
Scourge,"	O
a	O
book	O
on	O
the	O
threat	O
.	O

Less	O
common	O
symptoms	O
include	O
sneezing	S-Phenotype
runny	B-Phenotype
nose	E-Phenotype
,	O
sore	B-Phenotype
throat	E-Phenotype
,	O
and	O
skin	B-Phenotype
lesions	E-Phenotype
.	O
Some	O
cases	O
in	O
China	O
initially	O
presented	O
with	O
only	O
chest	B-Phenotype
tightness	E-Phenotype
and	O
.	O

Are	O
you	O
shutting	O
down	O
shipments	O
out	O
of	O
any	O
non-CDC	O
BSL-3	S-Platform
or	O
laboratories	O
or	O
are	O
you	O
asking	O
any	O
other	O
federal	O
agencies	O
or	O
university	O
labs	O
to	O
shut	O
down	O
those	O
kinds	O
of	O
shipments?	O

The	O
influenza	O
virus	O
has	O
caused	O
several	O
pandemic	O
threats	O
over	O
the	O
past	O
century	O
,	O
including	O
the	O
pseudo-pandemic	S-Incident
of	O
1947	O
(thought	O
of	O
as	O
mild	O
because	O
although	O
globally	O
distributed	O
,	O
it	O
caused	O
relatively	O
few	O
deaths)	O
,	O
the	O
1976	O
swine	B-Incident
flu	I-Incident
outbreak	E-Incident
and	O
the	O
1977	B-Disease
Russian	I-Disease
flu	E-Disease
,	O
all	O
caused	O
by	O
the	O
H1N1	S-Pathogen
subtype	O
.	O

Operation	B-Scientific_research_project
Whitecoat	E-Scientific_research_project
was	O
a	O
bio-defense	O
medical	O
research	O
program	O
carried	O
out	O
by	O
the	O
US	B-Organization
Army	E-Organization
at	O
Fort	B-Location
Detrick	E-Location
,	O
between	O
1954	O
and	O
1973	O
.	O

After	O
three	O
months	O
with	O
no	O
new	O
reports	O
of	O
cases	O
,	O
on	O
29	O
June	O
Liberia	S-Location
reported	O
that	O
the	O
body	O
of	O
a	O
17-year-old	O
boy	O
,	O
who	O
had	O
been	O
treated	O
for	O
malaria	S-Disease
,	O
tested	O
positive	O
for	O
Ebola	S-Disease
.	O
The	O
WHO	S-Organization
said	O
the	O
boy	O
had	O
been	O
in	O
close	O
contact	O
with	O
at	O
least	O
200	O
people	O
,	O
who	O
they	O
were	O
following	O
up	O
,	O
and	O
that	O
"	O
the	O
case	O
reportedly	O
had	O
no	O
recent	O
history	O
of	O
travel	O
,	O
contact	O
with	O
visitors	O
from	O
affected	O
areas	O
,	O
or	O
funeral	O
attendance.	O
"	O
A	O
second	O
case	O
was	O
confirmed	O
on	O
1	O
July	O
.	O

On	O
26–27	O
April	O
,	O
Chinese	B-Organization
authorities	E-Organization
closed	O
down	O
theatres	O
,	O
discos	O
,	O
and	O
other	O
entertainment	O
venues	O
in	O
Beijing	S-Location
as	O
the	O
death	O
toll	O
in	O
Beijing	S-Location
continued	O
to	O
rise	O
,	O
threatening	O
to	O
become	O
the	O
worst-hit	O
area	O
of	O
the	O
country	O
,	O
eclipsing	O
the	O
Guangdong	S-Location
.	O
Authorities	O
were	O
bolstered	O
by	O
the	O
fact	O
that	O
the	O
infection	O
rate	O
seemed	O
to	O
have	O
declined	O
,	O
with	O
the	O
only	O
exporting	O
three	O
new	O
infections	O
over	O
the	O
weekend	O
.	O

In	O
a	O
nutshell	O
,	O
the	O
greatest	O
funding	O
amount	O
has	O
gone	O
toward	O
food	B-Scientific_research_project
security	I-Scientific_research_project
projects	E-Scientific_research_project
crisis	O
mitigation	O
,	O
and	O
non-Ebola	O
emergency	O
health	O
services	O
.	O

The	O
says	O
that	O
meeting	O
this	O
goal	O
will	O
require	O
a	O
30-fold	O
increase	O
in	O
biofuel	O
production	O
capacity	O
by	O
2030	O
.	O

Pixel	O
is	O
a	O
two	O
dimensional	O
unit	O
based	O
on	O
the	O
matrix	O
size	O
and	O
the	O
field	O
of	O
view	O
.	O

Bacteria	O
were	O
the	O
perfect	O
choice	O
because	O
they	O
are	O
prokaryotic	O
cells	O
.	O

One	O
of	O
the	O
big	O
arguments	O
made	O
for	O
-	O
in	O
defense	O
of	O
gain	O
of	O
function	O
work	O
on	O
flu	O
was	O
that	O
this	O
work	O
is	O
done	O
very	O
safely	O
and	O
that	O
labs	O
know	O
how	O
to	O
do	O
this	O
very	O
safely	O
.	O

MappBio	S-Organization
is	O
also	O
separately	O
developing	O
ZMappTM	S-Drug
,	O
a	O
cocktail	O
of	O
mouse-human	O
chimeric	O
monoclonal	O
antibodies	O
for	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
a	O
different	O
therapy	O
than	O
.	O

Concerns	O
about	O
possible	O
dual	O
use	O
led	O
DARPA	S-Organization
to	O
structure	O
the	O
Insect	B-Scientific_research_project
Allies	E-Scientific_research_project
Program	O
as	O
"	O
a	O
transparent	O
,	O
university-led	O
,	O
fundamental	O
research	O
effort	O
that	O
benefits	O
from	O
the	O
active	O
participation	O
of	O
regulators	O
and	O
ethicists,	O
"	O
wrote	O
in	O
an	O
email.	O
"	O
We	O
also	O
have	O
numerous	O
,	O
layered	O
safeguards	O
in	O
place	O
to	O
maintain	O
biosecurity	O
and	O
ensure	O
the	O
systems	O
we're	O
developing	O
function	O
only	O
as	O
intended.	O
"	O
Safeguards	O
include	O
conducting	O
all	O
of	O
the	O
work	O
for	O
the	O
program	O
inside	O
contained	O
,	O
biosecure	O
facilities	O
.	O

The	O
Soviet	B-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
began	O
in	O
the	O
1920s	O
at	O
the	O
Leningrad	B-Organization
Military	I-Organization
Academy	E-Organization
under	O
the	O
control	O
of	O
the	O
state	O
security	O
apparatus	O
,	O
known	O
as	O
the	O
GPU	S-Organization
.	O
This	O
occurred	O
despite	O
the	O
fact	O
that	O
the	O
USSR	S-Location
was	O
a	O
signatory	O
to	O
the	O
1925	O
Geneva	B-Document
Convention	E-Document
,	O
which	O
banned	O
both	O
chemical	O
and	O
biological	O
weapons	O
.	O

It	O
does	O
so	O
by	O
neutralizing	O
a	O
special	O
iron	B-Drug
complexing	I-Drug
agent	E-Drug
produced	O
by	O
the	O
bacterium	O
.	O

Evidence	O
strongly	O
implicates	O
bats	O
as	O
the	O
reservoir	O
hosts	O
for	O
ebolaviruses	S-Pathogen
(however	O
,	O
despite	O
considerable	O
research	O
,	O
infectious	O
have	O
never	O
been	O
recovered	O
from	O
bats)	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
USDA	O
,	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

The	O
WHO	S-Organization
states	O
that	O
its	O
objective	O
"	O
is	O
the	O
attainment	O
by	O
all	O
people	O
of	O
the	O
highest	O
possible	O
level	O
of	O
health"	O
.	O

This	O
occurs	O
more	O
commonly	O
when	O
a	O
thin	O
slice	O
thickness	O
is	O
used	O
.	O

Analysis	O
of	O
the	O
genetic	O
divergence	O
of	O
the	O
virus	O
in	O
samples	O
from	O
different	O
cases	O
indicated	O
that	O
the	O
virus	O
jumped	O
to	O
humans	O
in	O
2008	O
,	O
probably	O
after	O
June	O
,	O
and	O
not	O
later	O
than	O
the	O
end	O
of	O
November	O
,	O
likely	O
around	O
September	O
2008	O
.	O

This	O
means	O
that	O
the	O
cut	O
DNA	O
could	O
be	O
joined	O
back	O
together	O
with	O
any	O
other	O
piece	O
of	O
DNA	O
that	O
had	O
the	O
same	O
sticky	O
end	O
.	O

Dr	O
.	O

For	O
instance	O
,	O
it	O
took	O
researchers	O
just	O
3	O
years	O
to	O
make	O
from	O
scratch	O
in	O
2006	O
,	O
and	O
today	O
the	O
same	O
could	O
be	O
accomplished	O
in	O
a	O
matter	O
of	O
weeks	O
.	O

In	O
February	O
2019	O
,	O
it	O
was	O
reported	O
that	O
attacks	O
at	O
treatment	O
centers	O
had	O
been	O
carried	O
out	O
in	O
Butembo	S-Location
and	O
Katwa	S-Location
.	O
The	O
motives	O
behind	O
the	O
attacks	O
were	O
unclear	O
.	O

Late	O
on	O
July	O
7	O
,	O
the	O
vials	O
were	O
transported	O
safely	O
and	O
securely	O
with	O
the	O
assistance	O
of	O
federal	O
and	O
local	O
law	O
enforcement	O
agencies	O
to	O
CDC	S-Organization
high-containment	O
facility	O
in	O
Atlanta	S-Location
.	O
Overnight	O
PCR	B-Technology
testing	E-Technology
done	O
by	O
CDC	S-Organization
in	O
the	O
BSL-4	S-Platform
lab	O
confirmed	O
the	O
presence	O
of	O
variola	B-Pathogen
virus	E-Pathogen
DNA	O
.	O

By	O
2	O
March	O
there	O
were	O
80	O
confirmed	O
cases	O
,	O
with	O
half	O
of	O
the	O
cases	O
in	O
California	S-Location
Florida	S-Location
and	O
New	B-Location
York	E-Location
had	O
declared	O
their	O
first	O
two	O
cases	O
and	O
the	O
state	O
of	O
Washington	S-Location
reported	O
many	O
suspected	O
cases	O
and	O
the	O
first	O
death	O
.	O

Remdesivir	S-Drug
is	O
a	O
broad-spectrum	O
antiviral	O
medication	O
developed	O
by	O
the	O
biopharmaceutical	O
company	O
Gilead	B-Organization
Sciences	E-Organization
.	O
As	O
of	O
2020	O
,	O
remdesivir	S-Drug
is	O
being	O
tested	O
as	O
a	O
specific	O
treatment	O
for	O
COVID-19	S-Pathogen
,	O
and	O
has	O
been	O
authorized	O
for	O
emergency	O
use	O
in	O
the	O
U.S.	S-Location
and	O
approved	O
for	O
use	O
in	O
for	O
people	O
with	O
severe	O
symptoms	O
.	O

The	O
Kivu	S-Location
outbreak	O
includes	O
Ituri	B-Organization
Province	E-Organization
,	O
after	O
the	O
first	O
case	O
was	O
confirmed	O
on	O
13	O
August	O
,	O
and	O
in	O
June	O
2019	O
,	O
the	O
virus	O
reached	O
Uganda	S-Location
,	O
having	O
infected	O
a	O
5-year-old	O
Congolese	O
boy	O
who	O
entered	O
Uganda	S-Location
with	O
his	O
family	O
,	O
but	O
was	O
contained	O
.	O

Human-adapted	O
influenza	B-Pathogen
viruses	E-Pathogen
are	O
thought	O
to	O
preferentially	O
bind	O
receptors	O
with	O
α	O
(2–6)	O
linkages	O
.	O

Government	O
officials	O
last	O
week	O
approached	O
Congress	S-Organization
about	O
a	O
plan	O
to	O
fund	O
the	O
project	O
with	O
discretionary	O
funds	O
.	O

On	O
10	O
December	O
2013	O
,	O
a	O
new	O
WHO	S-Organization
database	O
,	O
known	O
as	O
MiNDbank	S-Platform
,	O
went	O
online	O
.	O

Overall	O
,	O
nearly	O
half	O
of	O
the	O
influenza-related	O
deaths	O
in	O
tmic	O
were	O
in	O
young	O
adults	O
20–40	O
years	O
of	O
age	O
,	O
a	O
phenomenon	O
unique	O
to	O
that	O
pandemic	O
year	O
.	O

Eighty	O
percent	O
held	O
bachelor's	O
degrees	O
or	O
higher	O
;	O
almost	O
half	O
had	O
advanced	O
degrees	O
(a	O
master's	O
degree	O
or	O
a	O
doctorate	O
such	O
as	O
a	O
PhD	O
,	O
D.O.	O
,	O
or	O
M.D.)	O
.	O

MRI	S-Technology
also	O
is	O
used	O
in	O
stereotactic	O
surgery	O
and	O
radiosurgery	O
for	O
treatment	O
of	O
intracranial	B-Disease
tumors	E-Disease
,	O
arteriovenous	B-Disease
malformations	E-Disease
,	O
and	O
other	O
surgically	O
treatable	O
conditions	O
using	O
a	O
device	O
known	O
as	O
the	O
.	O

The	O
Task	B-Organization
Force	I-Organization
for	I-Organization
Combating	I-Organization
Antibiotic-Resistant	I-Organization
Bacteria	E-Organization
developed	O
The	O
National	B-Document
Action	I-Document
Plan	I-Document
for	I-Document
Combating	I-Document
Antibiotic-Resistant	I-Document
Bacteria	E-Document
with	O
the	O
intent	O
of	O
providing	O
a	O
roadmap	O
to	O
guide	O
the	O
in	O
the	O
antibiotic	O
resistance	O
challenge	O
and	O
with	O
hopes	O
of	O
saving	O
many	O
lives	O
.	O

Since	O
the	O
medical	O
practitioners	O
were	O
away	O
with	O
the	O
troops	O
,	O
only	O
the	O
medical	O
students	O
were	O
left	O
to	O
care	O
for	O
the	O
sick	O
.	O

It	O
is	O
transmitted	O
easily	O
through	O
the	O
atmosphere	O
and	O
has	O
a	O
high	O
mortality	O
rate	O
(20–40%)	O
.	O

The	O
final	O
step	O
in	O
the	O
biocontainment	O
process	O
is	O
the	O
assumption	O
of	O
Principal	O
Investigator	O
role	O
with	O
full	O
responsibility	O
for	O
the	O
structure	O
of	O
the	O
site-specific	O
biosafety	O
program	O
plan	O
by	O
core	O
facility	O
leadership	O
.	O

HIV	S-Pathogen
and	O
are	O
such	O
viruses	O
.	O

The	O
virus	O
soon	O
spread	O
to	O
nearby	O
hospitals	O
.	O

Two-dimensional	B-Technology
CT	I-Technology
images	E-Technology
are	O
conventionally	O
rendered	O
so	O
that	O
the	O
view	O
is	O
as	O
though	O
looking	O
up	O
at	O
it	O
from	O
the	O
patient's	O
feet.	O
.	O

For	O
repressing	O
genes	O
Cas9	O
can	O
be	O
fused	O
to	O
KRAB	O
effector	O
domain	O
that	O
makes	O
complex	O
with	O
gRNA	O
,	O
whereas	O
utilizes	O
dCas9	O
fused	O
to	O
different	O
transcriptional	O
activation	O
domains	O
,	O
which	O
are	O
further	O
directed	O
by	O
gRNA	O
to	O
promoter	O
regions	O
to	O
upregulate	O
expression	O
.	O

Pixel	O
values	O
of	O
0	O
and	O
lower	O
,	O
are	O
displayed	O
as	O
black	O
;	O
values	O
of	O
80	O
and	O
higher	O
are	O
displayed	O
as	O
white	O
;	O
values	O
within	O
the	O
window	O
are	O
displayed	O
as	O
a	O
grey	O
intensity	O
proportional	O
to	O
position	O
within	O
the	O
window	O
.	O

Financial	O
cutbacks	O
have	O
limited	O
the	O
tracking	O
of	O
disease	O
outbreaks	O
.	O

The	O
Kivu	S-Location
outbreak	O
includes	O
Ituri	B-Organization
Province	E-Organization
,	O
after	O
the	O
first	O
case	O
was	O
confirmed	O
on	O
13	O
August	O
,	O
and	O
in	O
June	O
2019	O
,	O
the	O
virus	O
reached	O
Uganda	S-Location
,	O
having	O
infected	O
a	O
5-year-old	O
Congolese	O
boy	O
who	O
entered	O
Uganda	S-Location
with	O
his	O
family	O
,	O
but	O
was	O
contained	O
.	O

By	O
simple	O
changing	O
sequence	O
of	O
gRNA	O
,	O
Cas9-endonuclease	O
can	O
be	O
delivered	O
to	O
a	O
gene	O
of	O
interest	O
and	O
induce	O
DSBs	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here:	O

Oregon	O
Democratic	O
Congressman	O
James	B-Person
H.	I-Person
Weaver	E-Person
continued	O
to	O
investigate	O
because	O
he	O
believed	O
that	O
the	O
officials'	O
conclusion	O
did	O
not	O
adequately	O
explain	O
the	O
facts	O
.	O

On	O
30	O
January	O
,	O
the	O
WHO	S-Organization
declared	O
the	O
outbreak	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
(PHEIC)	O
,	O
warning	O
that	O
"	O
all	O
countries	O
should	O
be	O
prepared	O
for	O
containment	O
,	O
including	O
active	O
surveillance	O
,	O
early	O
detection	O
,	O
isolation	O
and	O
case	O
management	O
,	O
contact	O
tracing	O
and	O
prevention	O
of	O
onward	O
spread	O
"	O
of	O
the	O
virus	O
,	O
following	O
an	O
increase	O
in	O
cases	O
outside	O
China	S-Location
.	O
This	O
was	O
the	O
sixth-ever	O
PHEIC	O
since	O
the	O
measure	O
was	O
first	O
invoked	O
during	O
the	O
2009	B-Incident
swine	I-Incident
flu	I-Incident
pandemic	E-Incident
.	O
WHO	S-Organization
Director-General	O
Tedros	B-Person
Adhanom	E-Person
said	O
the	O
PHEIC	O
was	O
due	O
to	O
"	O
the	O
risk	O
of	O
global	O
spread	O
,	O
especially	O
to	O
low-	O
and	O
middle-income	O
countries	O
without	O
robust	O
health	O
systems	O
"	O
but	O
that	O
the	O
did	O
not	O
"	O
recommend	O
limiting	O
trade	O
and	O
movement"	O
.	O

The	O
Black	B-Disease
Death	E-Disease
most	O
likely	O
originated	O
in	O
Central	B-Location
Asia	E-Location
or	O
East	B-Location
Asia	E-Location
,	O
from	O
where	O
it	O
travelled	O
along	O
the	O
Silk	B-Location
Road	E-Location
,	O
reaching	O
Crimea	S-Location
by	O
1347	O
.	O

The	O
system	O
not	O
only	O
monitors	O
infected	O
persons	O
,	O
but	O
attempts	O
to	O
discern	O
the	O
origin	O
of	O
the	O
outbreak	O
.	O

For	O
instance	O
,	O
James	B-Person
Carey	E-Person
a	O
member	O
of	O
the	O
science	O
panel	O
,	O
said	O
the	O
small	O
number	O
of	O
larvae	O
detected	O
does	O
not	O
necessarily	O
mean	O
that	O
the	O
fly	O
is	O
being	O
spread	O
unnaturally	O
,	O
rather	O
than	O
by	O
breeding	O
and	O
moving	O
.	O

The	O
use	O
of	O
protective	O
clothing	O
such	O
as	O
buttoned	O
labcoats	O
or	O
back‐closing	O
gowns	O
and	O
gloves	O
are	O
commonplace	O
in	O
today's	O
research	O
laboratory	O
.	O

Control	O
measures	O
in	O
human	O
healthcare	O
settings	O
include	O
strict	O
hand	O
hygiene	O
,	O
use	O
of	O
personal	O
protective	O
equipment	O
,	O
and	O
environmental	O
decontamination	O
(10)	O
.	O

At	O
least	O
since	B-Incident
2001	I-Incident
and	I-Incident
the	I-Incident
Amerithrax	I-Incident
anthrax	I-Incident
letters	E-Incident
the	O
USA	S-Location
has	O
had	O
a	O
significant	O
focus	O
on	O
biosecurity	O
and	O
the	O
related	O
subject	O
of	O
biosafety	O
.	O

It	O
was	O
introduced	O
into	O
Norway	S-Location
in	O
1349	O
when	O
a	O
ship	O
landed	O
at	O
Askøy	S-Location
,	O
then	O
spread	O
to	O
Bjørgvin	S-Location
(modern	O
Bergen	S-Location
)	O
and	O
Iceland	S-Location
.	O
Finally	O
,	O
it	O
spread	O
to	O
northwestern	O
Russia	S-Location
in	O
1351	O
.	O

It	O
occupies	O
a	O
surface	O
area	O
of	O
1813	O
metres	O
square	O
.	O

The	O
same	O
year	O
NATO	S-Organization
started	O
human	O
based	O
anthrax	B-Vaccine
vaccine	E-Vaccine
tests	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
in	O
.	O

Since	O
then	O
,	O
scientists	O
have	O
made	O
bigger	O
and	O
bigger	O
genomes	O
,	O
and	O
recently	O
,	O
the	O
launched	O
with	O
the	O
intention	O
of	O
tackling	O
perhaps	O
the	O
ultimate	O
goal:	O
chemically	O
fabricating	O
an	O
entire	O
human	O
genome	O
.	O

At	O
the	O
core	O
of	O
our	O
efforts	O
was	O
a	O
massive	O
coordination	O
campaign	O
.	O

The	O
pressure	O
in	O
the	O
BSL-3	S-Platform
laboratory	O
is	O
recorded	O
by	O
checking	O
the	O
pressure	O
gauge	O
in	O
the	O
lab	O
every	O
day	O
,	O
and	O
it	O
was	O
also	O
real-time	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

The	O
American	O
peoples	O
got	O
by	O
far	O
the	O
worse	O
end	O
of	O
the	O
exchange	O
,	O
through	O
diseases	O
such	O
as	O
measles	S-Disease
,	O
influenza	S-Disease
and	O
,	O
especially	O
,	O
.	O

It	O
was	O
confirmed	O
that	O
the	O
virus	O
spread	O
via	O
droplets	O
,	O
but	O
this	O
later	O
outbreak	O
made	O
officials	O
question	O
the	O
possibility	O
that	O
the	O
virus	O
could	O
be	O
spread	O
through	O
the	O
air	O
.	O

openBIS	S-Platform
is	O
successfully	O
employed	O
in	O
the	O
large-scale	O
systems	O
biologic	O
project	O
SystemsX	S-Scientific_research_project
(250	O
research	O
groups	O
in	O
62	O
approved	O
projects)	O
and	O
several	O
EU	S-Location
projects.	O
can	O
be	O
installed	O
with	O
some	O
IT	O
expertise	O
.	O

It	O
doesn't	O
matter	O
if	O
it	O
was	O
a	O
statistical	O
fluke	O
or	O
not.	O
"	O
As	O
a	O
precaution	O
during	O
the	O
decontamination	O
and	O
university's	O
inquiry	O
,	O
Schneewind	S-Person
is	O
moving	O
work	O
on	O
B.	O
cereus	O
and	O
some	O
other	O
BSL-2	S-Platform
pathogens	O
that	O
his	O
team	O
had	O
been	O
studying	O
using	O
BSL-3	S-Platform
practices	O
from	O
the	O
Cummings	O
building	O
to	O
the	O
off-campus	O
Ricketts	S-Person
facility	O
.	O

If	O
such	O
an	O
emergency	O
were	O
to	O
occur	O
in	O
the	O
United	B-Location
States	E-Location
,	O
and	O
other	O
federal	O
agencies	O
would	O
work	O
closely	O
with	O
local	O
and	O
state	O
partners	O
to	O
coordinate	O
a	O
response	O
.	O

As	O
a	O
result	O
of	O
the	O
attack	O
,	O
751	O
people	O
contracted	O
salmonellosis	S-Pathogen
45 of	O
whom	O
were	O
hospitalized	O
,	O
but	O
none	O
died	O
.	O

"	O
Essentially,	O
what	O
the	O
government	O
will	O
request	O
is	O
a	O
short	O
term	O
on	O
the	O
order	O
of	O
24	O
hours	O
suspension	O
of	O
research	O
involving	O
high-consequence	O
pathogens	O
in	O
order	O
to	O
allow	O
institutional	O
lab	O
personnel	O
to	O
take	O
stock	O
of	O
what	O
pathogens	O
they	O
have	O
stored	O
in	O
freezers	O
,	O
cold	O
rooms	O
,	O
etc.	O
,	O
"	O
reads	O
a	O
memo	O
distributed	O
to	O
universities	O
today	O
and	O
signed	O
by	O
Carol	B-Person
Blum	E-Person
of	O
the	O
Council	B-Organization
on	I-Organization
Governmental	I-Organization
Relations	E-Organization
(	O
COGR	S-Organization
)	O
in	O
,	O
D.C	O
.	O

Multidrug	O
resistance	O
in	O
fungi	O
is	O
increasing	O
because	O
of	O
the	O
widespread	O
use	O
of	O
antifungal	O
drugs	O
to	O
treat	O
infections	O
in	O
immunocompromised	O
individuals	O
.	O

WHO	S-Organization
stated	O
that	O
the	O
rVSV-ZEBOV-GP	B-Vaccine
vaccine	E-Vaccine
had	O
been	O
97.	O
5%	O
effective	O
at	O
stopping	O
Ebola	S-Pathogen
transmission	O
,	O
relative	O
to	O
no	O
vaccination	O
.	O

The	O
event	O
,	O
held	O
in	O
Libreville	S-Location
Gabon	S-Location
,	O
was	O
the	O
second	O
in	O
a	O
series	O
of	O
workshops	O
to	O
advance	O
Africa	B-Organization
CDC	E-Organization
's	O
Initiative	O
to	O
Strengthen	O
Biosecurity	O
and	O
Biosafety	O
,	O
launched	O
during	O
the	O
Nuclear	B-Activity
Threat	I-Activity
Initiative's	I-Activity
NTI	I-Activity
Global	I-Activity
Biosecurity	I-Activity
Dialogue	I-Activity
at	I-Activity
the	I-Activity
African	I-Activity
Union	E-Activity
in	O
Addis	B-Location
Ababa	E-Location
,	O
.	O

Teams	O
will	O
demonstrate	O
the	O
ability	O
to	O
rapidly	O
discover	O
and	O
optimize	O
antibodies	O
so	O
that	O
they	O
are	O
most	O
effective	O
against	O
an	O
infectious	O
agent	O
.	O

MERS	S-Disease
first	O
reported	O
in	O
Saudi	B-Location
Arabia	E-Location
in	O
2012	O
,	O
kills	O
about	O
30%	O
of	O
the	O
people	O
who	O
contract	O
it	O
,	O
according	O
to	O
the	O
.	O

This	O
death	O
toll	O
outstripped	O
that	O
of	O
the	O
first	O
world	O
war	O
.	O

On	O
15	O
May	O
it	O
was	O
reported	O
that	O
about	O
two	O
thousand	O
businesses	O
were	O
told	O
to	O
close	O
again	O
when	O
a	O
cluster	O
of	O
a	O
hundred	O
infected	O
individuals	O
was	O
discovered	O
;	O
contact	O
tracing	O
is	O
being	O
done	O
on	O
11,000	O
people	O
.	O

Laboratory	O
staff	O
is	O
at	O
high	O
risk	O
of	O
acquiring	O
infectious	O
diseases	O
including	O
vaccine	O
preventable	O
diseases	O
.	O

Without	O
international	O
cooperation	O
,	O
every	O
country's	O
efforts	O
to	O
fight	O
AMR	O
have	O
limited	O
effectiveness	O
.	O

Engineered	O
systems	O
can	O
also	O
help	O
with	O
carefully	O
timed	O
drug	O
delivery	O
.	O

Workers	O
wear	O
protective	O
gear	O
and	O
there's	O
a	O
web	O
of	O
computerized	O
systems	O
that	O
monitor	O
workers	O
,	O
lock	O
doors	O
,	O
and	O
ensure	O
that	O
dangerous	O
germs	O
don't	O
escape	O
.	O

They	O
used	O
a	O
process	O
that	O
they	O
thought	O
would	O
kill	O
the	O
anthrax	S-Pathogen
bacteria	O
,	O
and	O
it	O
may	O
not	O
have	O
.	O

The	O
study	O
involved	O
scientists	O
placing	O
identical	O
oral	O
swab	O
samples	O
from	O
guinea	O
pigs	O
into	O
two	O
sets	O
of	O
tubes-one	O
set	O
of	O
tubes	O
for	O
live	O
virus	O
studies	O
and	O
one	O
set	O
of	O
tubes	O
for	O
studies	O
with	O
inactivated	O
material	O
.	O

When	O
the	O
application	O
of	O
administrative	O
and	O
engineering	O
controls	O
and	O
work	O
practices	O
is	O
not	O
sufficient	O
to	O
protect	O
against	O
exposure	O
,	O
PPE	S-Equipment
is	O
used	O
to	O
provide	O
an	O
additional	O
and/or	O
redundant	O
layer	O
of	O
protection	O
.	O

This	O
is	O
the	O
preeminent	O
infectious	O
disease	O
sleuthing	O
agency	O
.	O

To	O
address	O
famine	O
in	O
developing	O
countries	O
,	O
genetic	O
engineers	O
can	O
make	O
inexpensive	O
food	O
crops	O
,	O
such	O
as	O
rice	O
or	O
corn	O
,	O
that	O
contain	O
extra	O
nutrients	O
.	O

The	O
experimental	O
Flettner	O
rotor	O
bomblet	O
was	O
also	O
developed	O
during	O
this	O
time	O
period	O
.	O

Smallpox	S-Pathogen
emerged	O
thousands	O
of	O
years	O
ago	O
,	O
plaguing	O
populations	O
around	O
the	O
world	O
with	O
severe	O
illness	O
and	O
death	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
reports	O
.	O

In	O
light	O
of	O
the	O
likely	O
multiple	O
calls	O
for	O
a	O
stand-down	O
,	O
we	O
encourage	O
institutions	O
to	O
coordinate	O
the	O
activity	O
on	O
campus	O
to	O
avoid	O
miscommunications.	O
*Does	O
this	O
only	O
apply	O
to	O
Select	O
Agents*?	O
No	O
,	O
because	O
all	O
institutions	O
using	O
Select	O
Agents	O
and	O
Toxins	O
should	O
already	O
be	O
keeping	O
track	O
of	O
those	O
pathogens	O
.	O

For	O
biodefense	O
categorization	O
,	O
group	O
1	O
represents	O
the	O
highest	O
threat	O
,	O
unlike	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
laboratory	O
biosafety	O
category	O
lists	O
,	O
for	O
which	O
group	O
4	O
is	O
defined	O
as	O
the	O
highest	O
threat	O
.	O

The	O
cases	O
raise	O
the	O
WHO	S-Organization
's	O
count	O
to	O
94	O
cases	O
and	O
46	O
deaths.	O
"	O

In	O
December	O
2015	O
,	O
an	B-Activity
International	I-Activity
Summit	I-Activity
on	I-Activity
Human	I-Activity
Gene	I-Activity
Editing	E-Activity
took	O
place	O
in	O
Washington	S-Location
under	O
the	O
guidance	O
of	O
David	B-Person
Baltimore	E-Person
.	O
Members	O
of	O
national	O
scientific	O
academies	O
of	O
the	O
US	S-Location
,	O
UK	S-Location
,	O
and	O
discussed	O
the	O
ethics	O
of	O
germline	O
modification	O
.	O

1958:	O
Viktor	B-Person
Zhdanov	E-Person
Deputy	O
Minister	O
of	O
Health	O
for	O
the	O
USSR	S-Location
,	O
called	O
on	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
to	O
undertake	O
a	O
global	O
initiative	O
to	O
eradicate	O
smallpox	S-Disease
,	O
resulting	O
in	O
Resolution	B-Document
WHA11.54	E-Document
.	O
At	O
this	O
point	O
,	O
2	O
million	O
people	O
were	O
dying	O
from	O
every	O
year	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
has	O
caused	O
the	O
majority	O
of	O
human	O
deaths	O
from	O
EVD	S-Disease
,	O
and	O
was	O
the	O
cause	O
of	O
the	O
,	O
which	O
resulted	O
in	O
at	O
least	O
suspected	O
cases	O
and	O
confirmed	O
deaths	O
.	O

The	O
White	B-Organization
House	E-Organization
refused	O
to	O
use	O
the	O
report.	O
said	O
he	O
felt	O
the	O
guidelines	O
were	O
too	O
restrictive	O
,	O
commenting	O
"	O
I	O
see	O
the	O
new	O
normal	O
being	O
what	O
it	O
was	O
three	O
months	O
ago	O
.	O

MRI	S-Technology
has	O
a	O
wide	O
range	O
of	O
applications	O
in	O
medical	O
diagnosis	O
and	O
more	O
than	O
25,000	O
scanners	O
are	O
estimated	O
to	O
be	O
in	O
use	O
worldwide.	O
affects	O
diagnosis	O
and	O
treatment	O
in	O
many	O
specialties	O
although	O
the	O
effect	O
on	O
improved	O
health	O
outcomes	O
is	O
disputed	O
in	O
certain	O
cases	O
.	O

Although	O
the	O
Federal	B-Organization
Government	E-Organization
&amp	O
;	O
DOT	O
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

So	O
as	O
I've	O
said	O
,	O
I've	O
taken	O
a	O
series	O
of	O
steps	O
in	O
response	O
to	O
these	O
incidents	O
.	O

It	O
has	O
persisted	O
over	O
the	O
years	O
,	O
as	O
Dr	O
.	O

Aegypti	O
mosquitoes	O
were	O
produced	O
,	O
1/3	O
were	O
placed	O
in	O
munitions	O
and	O
dropped	O
from	O
aircraft	O
,	O
or	O
dispersed	O
on	O
the	O
ground	O
.	O

But	O
,	O
there's	O
no	O
single	O
problem	O
,	O
and	O
there's	O
no	O
single	O
solution	O
.	O

Books	O
have	O
been	O
written	O
.	O

Liviu	B-Person
Babitz	E-Person
wants	O
to	O
create	O
new	O
human	O
senses	O
.	O

Roughly	O
20–50	O
students	O
participate	O
in	O
the	O
laboratory	O
class	O
simultaneously	O
.	O

All	O
data	O
management	O
systems	O
reviewed	O
here	O
have	O
particular	O
strengths	O
coming	O
from	O
the	O
dedicated	O
contexts	O
;	O
they	O
have	O
been	O
developed	O
in	O
DIPSBC	S-Platform
the	O
flexibility	O
to	O
easily	O
add	O
new	O
data	O
types	O
and	O
the	O
large	O
collection	O
of	O
integrated	O
types	O
;	O
ISA-Tab	O
,	O
the	O
direct	O
connection	O
to	O
the	O
EBI	O
ArrayExpress	O
repository	O
and	O
the	O
good	O
metadata	O
annotation	O
facilities	O
proved	O
in	O
many	O
projects	O
;	O
XperimentR	S-Platform
,	O
the	O
good	O
microscopy	O
,	O
metabolomics	O
,	O
microarray	O
and	O
annotation	O
facilities	O
;	O
Gaggle	S-Platform
,	O
the	O
good	O
extensibility	O
and	O
the	O
collection	O
of	O
interesting	O
extensions	O
already	O
existing	O
;	O
openBIS	S-Platform
and	O
,	O
the	O
next-generation	O
sequencing	O
integration	O
;	O
BASE	O
,	O
the	O
good	O
microarray	O
management	O
and	O
extension	O
system	O
proved	O
in	O
many	O
projects	O
and	O
LabKey	O
,	O
the	O
specimen	O
management	O
and	O
semantic	O
web	O
features	O
.	O

A	O
2018	O
New	B-Organization
York	I-Organization
Times	E-Organization
piece	O
covered	O
grinders	O
who	O
inserted	O
RFID	O
chips	O
in	O
their	O
bodies	O
to	O
access	O
secure	O
areas	O
in	O
hospitals	O
or	O
put	O
sound-enhancing	O
magnets	O
in	O
their	O
ears	O
to	O
have	O
"	O
built-in"	O
headphones	O
.	O

The	O
public	O
disclosure	O
of	O
the	O
second	O
ricin	O
letter	O
from	O
Fallen	B-Person
Angel	E-Person
coincided	O
with	O
the	O
discovery	O
of	O
in	O
the	O
mail	O
room	O
of	O
a	O
senate	O
office	O
building	O
.	O

It	O
was	O
first	O
identified	O
in	O
December	O
2019	O
in	O
Wuhan	S-Location
,	O
and	O
has	O
since	O
spread	O
globally	O
,	O
resulting	O
in	O
an	O
ongoing	O
pandemic	O
.	O

People	O
are	O
managed	O
with	O
supportive	O
care	O
,	O
which	O
may	O
include	O
fluid	O
therapy	O
,	O
oxygen	O
support	O
,	O
and	O
supporting	O
other	O
affected	O
vital	O
organs	O
.	O

In	O
some	O
areas	O
,	O
the	O
was	O
not	O
reported	O
on	O
,	O
the	O
only	O
mention	O
being	O
that	O
of	O
advertisements	O
for	O
medicines	O
claiming	O
to	O
cure	O
it	O
.	O

This	O
home	O
biohacking	O
can	O
of	O
course	O
go	O
very	O
badly	O
wrong	O
-	O
Rich	S-Person
pulls	O
up	O
his	O
trouser	O
legs	O
to	O
reveal	O
a	O
selection	O
of	O
scars	O
from	O
implanted	O
shin	O
guards	O
that	O
got	O
so	O
swollen	O
they	O
had	O
to	O
be	O
removed	O
,	O
which	O
he	O
did	O
with	O
pliers	O
and	O
no	O
.	O

FDA	S-Organization
said	O
Friday	O
it	O
signed	O
a	O
memorandum	O
of	O
understanding	O
with	O
the	O
DoD's	B-Organization
Office	I-Organization
of	I-Organization
Health	I-Organization
Affairs	E-Organization
to	O
commence	O
with	O
the	O
program's	O
implementation	O
,	O
as	O
provided	O
for	O
under	O
that	O
was	O
passed	O
in	O
2017	O
.	O

Researchers	O
who	O
want	O
to	O
fight	O
aging	O
generally	O
adopt	O
two	O
different	O
approaches	O
.	O

After	O
completion	O
of	O
this	O
testing	O
,	O
the	O
samples	O
will	O
be	O
destroyed	O
.	O

Wikipedia	S-Platform
is	O
already	O
the	O
world's	O
'Dr	O
Google	S-Platform
'	O
-	O
it's	O
time	O
for	O
doctors	O
and	O
researchers	O
to	O
make	O
it	O
better	O
Huffington	B-Organization
Post	E-Organization
.	O
.Oct.18	O
,	O
2016	O
.	O

For	O
her	O
part	O
,	O
Madam	B-Person
Monica	I-Person
Dea	E-Person
Representing	O
the	O
stated	O
that	O
eliminating	O
the	O
disease	O
depends	O
on	O
the	O
implementation	O
of	O
specific	O
local	O
strategies	O
,	O
the	O
participation	O
of	O
the	O
population	O
in	O
general	O
and	O
technical	O
cooperation	O
among	O
partners	O
.	O

The	O
president	O
of	O
Estonia	S-Location
,	O
Kersti	B-Person
Kaljulaid	E-Person
,	O
made	O
a	O
global	O
call	O
for	O
creative	O
solutions	O
against	O
.	O

Besides	O
working	O
on	O
the	O
joint	O
projects	O
,	O
all	O
members	O
of	O
the	O
network	O
meet	O
approximately	O
3	O
times	O
a	O
year	O
for	O
a	O
shared	O
workshop	O
,	O
including	O
progress	O
reports	O
and	O
seminars	O
.	O

On	O
28	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
released	O
its	O
first	O
estimate	O
of	O
the	O
possible	O
total	O
cases	O
from	O
the	O
outbreak	O
as	O
part	O
of	O
its	O
road	O
map	O
for	O
stopping	O
the	O
transmission	O
of	O
the	O
virus	O
.	O

She	O
soon	O
fell	O
seriously	O
ill	O
,	O
and	O
was	O
tended	O
to	O
by	O
her	O
younger	O
sister	O
.	O

Local	O
people	O
complain	O
of	O
being	O
bitten	O
by	O
these	O
newly	O
appeared	O
flies	O
while	O
naked	O
in	O
their	O
bathrooms	O
.	O

A	O
$12	O
million	O
disposal	O
plan	O
was	O
undertaken	O
at	O
Pine	B-Location
Bluff	I-Location
Arsenal	E-Location
Mangold	S-Person
,	O
Tom	S-Person
.	O
Plague	O
Wars:	O
The	O
Terrifying	O
Reality	O
of	O
Biological	O
Warfare	O
,	O
(Google	O
Books)	O
,	O
Macmillan	O
,	O
1999	O
,	O
pp.	O
54–57	O
,	O
().	O
where	O
all	O
U.S.	O
anti-personnel	O
biological	O
agents	O
were	O
stored	O
.	O

Due	O
to	O
the	O
pandemic	O
in	O
Europe	S-Location
,	O
many	O
countries	O
in	O
the	O
have	O
restricted	O
free	O
movement	O
and	O
set	O
up	O
border	O
controls	O
.	O

The	O
key	O
elements	O
of	O
this	O
system	O
are	O
administrative	O
procedure	O
,	O
risk	O
assessment	O
,	O
enforcement	O
,	O
and	O
public	O
participation	O
and	O
information	O
.	O

It	O
is	O
recognised	O
that	O
an	O
epidemiological	O
account	O
of	O
the	O
plague	S-Disease
is	O
as	O
important	O
as	O
an	O
identification	O
of	O
symptoms	O
,	O
but	O
researchers	O
are	O
hampered	O
by	O
the	O
lack	O
of	O
reliable	O
statistics	O
from	O
this	O
period	O
.	O

Each	O
specimen	O
was	O
tested	O
in	O
duplicate	O
.	O

Plus:	O
new	O
efforts	O
to	O
come	O
up	O
with	O
a	O
code	O
of	O
conduct	O
for	O
biohackers	O
,	O
from	O
legislation	O
to	O
self-regulation	O
.	O

In	O
response	O
,	O
in	O
February	O
2011	O
the	O
Ministry	B-Organization
of	I-Organization
Health	E-Organization
began	O
to	O
excavate	O
the	O
site.Associated	O
Press	O
,	O
"	O
Work	O
starts	O
at	O
Shinjuku	S-Location
site"	O
,	O
Japan	O
Times	O
,	O
22	O
February	O
2011	O
,	O
p.	O
1	O
.	O

LabKey	S-Platform
and	O
.	O
Semantic	O
web	O
uses	O
knowledge	O
representation	O
to	O
achieve	O
an	O
improved	O
exploitation	O
of	O
web	O
resources	O
.	O

During	O
the	O
initial	B-Incident
outbreak	I-Incident
in	I-Incident
Wuhan,	I-Incident
China	E-Incident
the	O
virus	O
and	O
disease	O
were	O
commonly	O
referred	O
to	O
as	O
"	O
coronavirus	S-Pathogen
"	O
and	O
"	O
Wuhan	B-Pathogen
coronavirus	E-Pathogen
"	O
,	O
with	O
the	O
disease	O
sometimes	O
called	O
"	O
Wuhan	B-Disease
pneumonia	E-Disease
"	O
.	O
In	O
the	O
past	O
,	O
many	O
diseases	O
have	O
been	O
named	O
after	O
geographical	O
locations	O
,	O
such	O
as	O
the	O
Spanish	B-Disease
flu	E-Disease
,	O
Middle	B-Disease
East	I-Disease
Respiratory	I-Disease
Syndrome	E-Disease
,	O
and	O
.	O

Waste	O
from	O
the	O
lab	O
was	O
sterilised	O
directly	O
in	O
the	O
autoclave	O
in	O
the	O
decontamination	O
room	O
.	O

On	O
10	O
December	O
,	O
a	O
researcher	O
in	O
a	O
SARS	S-Disease
lab	O
in	O
Taiwan	S-Location
was	O
found	O
infected	O
with	O
SARS	S-Disease
after	O
returning	O
from	O
Singapore	S-Location
attending	O
a	O
medical	O
conference	O
;	O
74	O
people	O
in	O
were	O
quarantined	O
but	O
none	O
of	O
them	O
were	O
infected	O
.	O

The	O
major	O
UK	S-Location
troop	O
staging	O
and	O
hospital	O
camp	O
in	O
Étaples	S-Location
in	O
France	S-Location
has	O
been	O
theorized	O
by	O
virologist	O
John	B-Person
Oxford	E-Person
as	O
being	O
at	O
the	O
center	O
of	O
the	O
Spanish	B-Disease
flu	E-Disease
.	O
His	O
study	O
found	O
that	O
in	O
late	O
1916	O
the	O
Étaples	S-Location
camp	O
was	O
hit	O
by	O
the	O
onset	O
of	O
a	O
new	O
disease	O
with	O
high	O
mortality	O
that	O
caused	O
symptoms	O
similar	O
to	O
the	O
flu	S-Disease
.	O
According	O
to	O
Oxford	S-Person
,	O
a	O
similar	O
outbreak	O
occurred	O
in	O
March	O
1917	O
at	O
army	O
barracks	O
in	O
Aldershot	S-Location
,	O
and	O
military	O
pathologists	O
later	O
recognized	O
these	O
early	O
outbreaks	O
as	O
the	O
same	O
disease	O
as	O
the	O
1918	B-Disease
flu	E-Disease
.	O
The	O
overcrowded	O
camp	O
and	O
hospital was	O
an	O
ideal	O
environment	O
for	O
the	O
spread	O
of	O
a	O
respiratory	O
virus	O
.	O

On	O
April	O
23	O
,	O
agents	O
in	O
hazardous	O
materials	O
suits	O
searched	O
the	O
home	O
of	O
a	O
Tupelo	S-Location
Mississippi	S-Location
man	O
in	O
connection	O
with	O
the	O
ricin	S-Pathogen
investigation	O
.	O

Having	O
a	O
rotating	O
presidency	O
has	O
fostered	O
trust	O
and	O
commitment	O
from	O
all	O
agencies	O
involved	O
.	O

For	O
each	O
biosafety	O
level	O
,	O
there	O
are	O
specific	O
supervisory	O
qualifications	O
as	O
assurance	O
that	O
laboratory	O
workers	O
are	O
provided	O
appropriate	O
role	O
models	O
and	O
knowledgeable	O
mentors	O
.	O

On	O
26	O
April	O
,	O
Wu	B-Person
Yi	E-Person
was	O
named	O
Zhang	B-Person
Wenkang	E-Person
's	O
replacement	O
as	O
PRC	S-Organization
health	O
minister	O
.	O

This	O
case	O
triggered	O
the	O
decision	O
by	O
the	O
to	O
again	O
reconvene	O
an	O
emergency	O
committee	O
,	O
at	O
which	O
the	O
situation	O
was	O
officially	O
announced	O
as	O
a	O
PHEIC	O
on	O
17	O
July	O
2019	O
.	O

An	O
increasing	O
number	O
of	O
vaccines	O
and	O
drugs	O
are	O
the	O
direct	O
products	O
of	O
rDNA	O
.	O

1947:	O
The	O
WHO	S-Organization
established	O
an	O
epidemiological	B-Platform
information	I-Platform
service	E-Platform
via	O
telex	O
,	O
and	O
by	O
1950	O
a	O
mass	O
tuberculosis	S-Disease
inoculation	O
drive	O
using	O
the	O
was	O
under	O
way	O
.	O

Aum	O
Shinrikyo	O
ordered	O
C.	B-Pathogen
botulinum	E-Pathogen
from	O
a	O
pharmaceutical	O
company	O
and	O
attempted	O
to	O
acquire	O
from	O
under	O
guise	O
of	O
a	O
"	O
humanitarian	O
mission	O
"	O

On	O
September	O
9	O
,	O
2009	O
,	O
Ethiopia	S-Organization
enacted	O
a	O
highly	O
restrictive	O
biosafety	B-Document
law	I-Document
firmly	I-Document
based	I-Document
on	I-Document
precautionary	I-Document
principles	E-Document
as	O
a	O
foundation	O
for	O
its	O
GMO	B-Platform
regulation	I-Platform
system	E-Platform
.	O
Its	O
drafting	O
process	O
,	O
led	O
by	O
the	O
country's	O
Environmental	B-Organization
Protection	I-Organization
Authority	E-Organization
,	O
was	O
judged	O
as	O
biased	O
,	O
focusing	O
only	O
on	O
protecting	O
the	O
environment	O
from	O
perceived	O
risks	O
,	O
giving	O
little	O
attention	O
to	O
potential	O
benefits	O
of	O
GMOs	S-Technology
.	O
Many	O
of	O
its	O
provisions	O
are	O
very	O
stringent	O
,	O
exceeding	O
those	O
of	O
,	O
while	O
others	O
cannot	O
be	O
fulfilled	O
by	O
applicants	O
,	O
collectively	O
rendering	O
the	O
emerged	O
biosafety	O
system	O
unworkable	O
.	O

That	O
study	O
was	O
subsequently	O
criticised	O
as	O
underpowered	O
.	O

The	O
delay	O
in	O
vaccine	O
administration	O
demonstrated	O
the	O
shortcomings	O
of	O
the	O
world's	O
capacity	O
for	O
vaccine-production	O
,	O
as	O
well	O
as	O
problems	O
with	O
international	O
distribution	O
.	O

Germany	S-Location
and	O
its	O
allies	O
infected	O
French	S-Location
cavalry	O
horses	O
and	O
many	O
of	O
Russia	S-Location
's	O
mules	O
and	O
horses	O
on	O
the	O
.	O
These	O
actions	O
hindered	O
artillery	O
and	O
troop	O
movements	O
,	O
as	O
well	O
as	O
supply	O
convoys	O
.	O

One	O
major	O
example	O
of	O
a	O
place	O
that	O
faces	O
these	O
challenges	O
is	O
India	S-Location
where	O
in	O
the	O
state	O
of	O
73%	O
of	O
the	O
population	O
resorted	O
to	O
treating	O
their	O
minor	O
health	O
issues	O
and	O
chronic	O
illnesses	O
through	O
self-medication	O
.	O

One	O
explanation	O
for	O
the	O
rapid	O
decline	O
in	O
the	O
lethality	O
of	O
the	O
disease	O
is	O
that	O
doctors	O
became	O
more	O
effective	O
in	O
prevention	O
and	O
treatment	O
of	O
the	O
pneumonia	S-Disease
that	O
developed	O
after	O
the	O
victims	O
had	O
contracted	O
the	O
virus	O
.	O

Other	O
candidates	O
in	O
trials	O
include	O
vasodilators	S-Drug
corticosteroids	S-Drug
,	O
immune	B-Drug
therapies	E-Drug
,	O
lipoic	B-Drug
acid	E-Drug
,	O
bevacizumab	S-Drug
,	O
and	O
.	O

Functional	O
imaging	O
of	O
the	O
pancreas	O
is	O
performed	O
following	O
administration	O
of	O
secretin	S-Drug
.	O
MR	B-Technology
enterography	E-Technology
provides	O
non-invasive	O
assessment	O
of	O
inflammatory	B-Disease
bowel	I-Disease
disease	E-Disease
and	O
small	B-Disease
bowel	I-Disease
tumors	E-Disease
.	O
MR-colonography	S-Technology
may	O
play	O
a	O
role	O
in	O
the	O
detection	O
of	O
large	O
polyps	O
in	O
patients	O
at	O
increased	O
risk	O
of	O
.	O

CDC	S-Organization
continues	O
to	O
investigate	O
an	O
incident	O
in	O
which	O
staff	O
in	O
three	O
of	O
its	O
laboratories	O
may	O
have	O
been	O
potentially	O
exposed	O
to	O
live	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
(	O
anthrax	S-Pathogen
)	O
bacteria	O
after	O
established	O
lab	O
safety	O
practices	O
were	O
not	O
followed	O
.	O

Of	O
the	O
six	O
,	O
two	O
died	O
.	O

In	O
2019	O
,	O
he	O
was	O
,	O
for	O
a	O
time	O
,	O
under	O
investigation	O
by	O
California's	B-Organization
Department	I-Organization
of	I-Organization
Consumer	I-Organization
Affairs	E-Organization
accused	O
of	O
practicing	O
medicine	O
without	O
a	O
license	O
.	O

Silencing	O
its	O
effect	O
with	O
siRNA	O
prevented	O
infection	O
of	O
Vero	O
cells	O
.	O

Government	O
officials	O
last	O
week	O
approached	O
Congress	S-Organization
about	O
a	O
plan	O
to	O
fund	O
the	O
project	O
with	O
discretionary	O
funds	O
.	O

The	O
procedure	O
used	O
in	O
the	O
lab	O
may	O
not	O
have	O
fully	O
inactivated	O
the	O
samples	O
.	O

In	O
fact	O
,	O
germs	O
will	O
always	O
look	O
for	O
ways	O
to	O
survive	O
and	O
resist	O
new	O
drugs	O
.	O

Focal	O
or	O
diffuse	O
disorders	O
of	O
the	O
liver	O
may	O
be	O
evaluated	O
using	O
diffusion-weighted	O
,	O
opposed-phase	O
imaging	O
and	O
dynamic	O
contrast	O
enhancement	O
sequences	O
.	O

Gilliam	S-Person
said	O
that	O
Olaf	B-Person
Schneewind	E-Person
's	O
group	O
was	O
studying	O
B.	B-Pathogen
cereus	E-Pathogen
in	O
a	O
BSL-2	S-Platform
facility	O
using	O
BSL-3	S-Platform
practices	O
,	O
such	O
as	O
a	O
biosafety	B-Equipment
cabinet	E-Equipment
,	O
as	O
a	O
precaution	O
.	O

Work	O
with	O
or	O
potential	O
exposure	O
to	O
biological	O
materials	O
in	O
the	O
course	O
of	O
performing	O
research	O
or	O
other	O
work	O
activities	O
at	O
Lawrence	B-Organization
Berkeley	I-Organization
National	I-Organization
Laboratory	E-Organization
(	O
LBNL	S-Organization
)	O
must	O
be	O
conducted	O
in	O
a	O
safe	O
,	O
ethical	O
,	O
environmentally	O
sound	O
,	O
and	O
compliant	O
manner	O
.	O

Axial	O
images	O
through	O
the	O
spine	O
will	O
only	O
show	O
one	O
vertebral	O
body	O
at	O
a	O
time	O
and	O
cannot	O
reliably	O
show	O
the	O
intervertebral	O
discs	O
.	O

Lab	O
officials	O
say	O
the	O
researcher	O
was	O
closely	O
monitored	O
and	O
did	O
not	O
get	O
sick	O
or	O
show	O
symptoms	O
of	O
an	O
influenza	B-Disease
infection	E-Disease

Genetic	O
analysis	O
has	O
revealed	O
that	O
the	O
coronavirus	S-Pathogen
genetically	O
clusters	O
with	O
the	O
genus	B-Pathogen
Betacoronavirus	E-Pathogen
,	O
in	O
subgenus	O
Sarbecovirus	O
(lineage	O
B)	O
together	O
with	O
two	O
bat-derived	O
strains	O
.	O

United	B-Organization
States.Cong.House	E-Organization
.	O
Committee	B-Organization
on	I-Organization
Homeland	I-Organization
Security	E-Organization
.	O
Ensuring	O
Effective	O
Preparedness	O
Responses	O
and	O
Recovery	O
for	O
Events	O
Impacting	O
Health	O
Security	O
Hearing	O
before	O
the	O
Subcommittee	O
on	O
Emergency	O
Preparedness	O
,	O
Response	O
and	O
Communications	O
of	O
the	O
Committee	O
on	O
Homeland	O
Security	O
,	O
House	O
of	O
Representatives	O
,	O
One	O
Hundred	O
Twelfth	O
Congress	O
,	O
First	O
Session	O
,	O
March	O
17	O
,	O
2011.	O
112th	O
Cong.	O
,	O
1st	O
sess.HR	O
397.	O
:	O
U.S.G.P.O.	O
,	O
2012	O
.	O

In	O
2013	O
Warren	S-Person
reviewed	O
the	O
issue	O
and	O
argued	O
that	O
smallpox	S-Pathogen
did	O
not	O
spread	O
across	O
Australia	S-Location
before	O
1824	O
and	O
showed	O
that	O
there	O
was	O
no	O
smallpox	S-Pathogen
at	O
Macassar	S-Location
that	O
could	O
have	O
caused	O
the	O
outbreak	O
at	O
Sydney	S-Location
.	O
Warren	S-Person
,	O
however	O
,	O
did	O
not	O
address	O
the	O
issue	O
of	O
persons	O
who	O
joined	O
the	O
Macassan	O
fleet	O
from	O
other	O
islands	O
and	O
from	O
parts	O
of	O
Sulawesi	S-Location
other	O
than	O
the	O
port	O
of	O
Macassar	S-Location
.	O
Warren	O
concluded	O
that	O
the	O
British	O
were	O
"	O
the	O
most	O
likely	O
candidates	O
to	O
have	O
released	O
smallpox	O
"	O
near	O
Sydney	O
Cove	O
in	O
1789	O
.	O

The	O
agency's	O
response	O
to	O
the	O
2001	B-Incident
anthrax	I-Incident
attacks	E-Incident
was	O
also	O
criticized	O
for	O
ineffective	O
communication	O
with	O
other	O
public	O
health	O
agencies	O
and	O
with	O
the	O
public	O
.	O

But	O
rewriting	O
the	O
blueprints	O
of	O
life	O
carries	O
an	O
enormous	O
risk	O
.	O

After	O
selection	O
genomic	O
DNA	O
is	O
collected	O
and	O
sequenced	O
by	O
NGS	O
.	O

The	O
ill	O
crew	O
member	O
returned	O
to	O
her	O
home	O
,	O
and	O
she	O
developed	O
a	O
cough	S-Phenotype
and	O
temperature	B-Phenotype
exceeding	I-Phenotype
38.	I-Phenotype
9 °C	I-Phenotype
(102 °F)	E-Phenotype
.	O
Her	O
physician	O
prescribed	O
antibiotics	S-Drug
and	O
aspirin	S-Drug
.	O
Although	O
she	O
was	O
previously	O
vaccinated	O
for	O
smallpox	S-Pathogen
,	O
a	O
rash	S-Phenotype
subsequently	O
appeared	O
on	O
her	O
back	O
,	O
face	O
,	O
and	O
scalp	O
;	O
her	O
fever	S-Phenotype
subsided	O
;	O
and	O
she	O
recovered	O
by	O
15	O
August	O
.	O

Preceding	O
its	O
founding	O
,	O
organizations	O
with	O
global	O
influence	O
in	O
malaria	S-Disease
control	O
were	O
the	O
and	O
the	O
Rockefeller	O
Foundation	O
.	O

Many	O
important	O
crops	O
have	O
been	O
genetically	O
modified	O
to	O
produce	O
higher	O
yields	O
,	O
withstand	O
environmental	O
stress	O
,	O
or	O
grow	O
without	O
pesticides	O
.	O

Antiviral	O
medications	O
are	O
under	O
investigation	O
for	O
COVID-19	S-Disease
as	O
well	O
as	O
medications	O
targeting	O
the	O
immune	O
response	O
.	O

Michael	B-Person
J.	I-Person
Reilly	E-Person
,	O
director	O
of	O
the	O
.	O

Spread	O
of	O
NDM-5–positive	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
has	O
occurred	O
globally	O
and	O
included	O
reports	O
of	O
ST167	O
in	O
persons	O
in	O
Europe	S-Location
and	O
(8,9)	O
.	O

Earlier	O
experience	O
pinpoints	O
mutual	O
trust	O
between	O
partners	O
as	O
a	O
cornerstone	O
for	O
a	O
successful	O
network	O
.	O

The	O
other	O
approach	O
is	O
more	O
dramatic:	O
genetic	O
engineering	O
.	O

The	O
initial	O
infection	O
is	O
believed	O
to	O
occur	O
after	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
is	O
transmitted	O
to	O
a	O
human	O
by	O
contact	O
with	O
an	O
infected	O
animal's	O
body	O
fluids	O
.	O

Many	O
hospitals	O
had	O
to	O
shut	O
down	O
,	O
leaving	O
people	O
with	O
other	O
medical	O
needs	O
without	O
care	O
.	O

Researchers	O
thus	O
can	O
control	O
if	O
they	O
want	O
to	O
keep	O
their	O
data	O
private	O
or	O
with	O
whom	O
they	O
want	O
to	O
share	O
it	O
.	O

Complications	O
may	O
include	O
pneumonia	S-Disease
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
,	O
multi-organ	B-Disease
failure	E-Disease
,	O
,	O
and	O
death	O
.	O

The	O
greatest	O
concentration	O
of	O
medflies	O
were	O
found	O
in	O
Orange	B-Location
County	E-Location
and	O
within	O
a	O
triangle	O
linking	O
the	O
eastern	O
edge	O
of	O
the	O
Los	B-Location
Angeles	I-Location
Basin	E-Location
with	O
San	B-Location
Bernardino	E-Location
and	O
.	O

This	O
is	O
the	O
preeminent	O
infectious	O
disease	O
sleuthing	O
agency	O
.	O

During	O
the	O
June	O
6	O
hearing	O
examining	O
PAHPA	S-Document
U.S.Rep	O
.	O

Incidents	O
of	O
Food	O
Bioterrorism	O
.	O

They	O
agreed	O
to	O
support	O
basic	O
and	O
clinical	O
research	O
under	O
certain	O
legal	O
and	O
ethical	O
guidelines	O
.	O

the	O
patent	O
situation	O
in	O
Europe	S-Location
was	O
complex	O
,	O
with	O
MilliporeSigma	S-Organization
,	O
ToolGen	S-Organization
,	O
Vilnius	B-Organization
University	E-Organization
,	O
and	O
Harvard	S-Organization
contending	O
for	O
claims	O
,	O
along	O
with	O
.	O

HindII	O
was	O
the	O
first	O
restriction	O
enzyme	O
,	O
an	O
enzyme	O
that	O
cuts	O
DNA	O
at	O
a	O
specific	O
sequence	O
.	O

The	O
CDC	S-Organization
also	O
works	O
on	O
non-communicable	O
diseases	O
,	O
including	O
chronic	O
diseases	O
caused	O
by	O
obesity	S-Disease
,	O
physical	B-Disease
inactivity	E-Disease
and	O
.	O

The	O
first	O
is	O
the	O
moratorium	O
on	O
biological	O
material	O
leaving	O
BSL-3	O
and	O
BSL-4	S-Platform
laboratories	O
,	O
and	O
we	O
will	O
assess	O
laboratory	O
by	O
laboratory	O
before	O
reopening	O
.	O

It's	O
nearly	O
impossible	O
to	O
imagine	O
modern	O
biotechnology	O
without	O
DNA	B-Technology
sequencing	E-Technology
Since	O
virtually	O
all	O
of	O
biology	O
centers	O
around	O
the	O
instructions	O
contained	O
in	O
DNA	O
,	O
biotechnologists	O
who	O
hope	O
to	O
modify	O
the	O
properties	O
of	O
cells	O
,	O
plants	O
,	O
and	O
animals	O
must	O
speak	O
the	O
same	O
molecular	O
language	O
.	O

So	O
,	O
they	O
reasoned	O
that	O
importing	O
a	O
natural	O
predator	O
,	O
the	O
cane	O
toad	O
,	O
could	O
be	O
a	O
natural	O
form	O
of	O
pest	O
control	O
.	O

CARITAS	B-Organization
DRC	E-Organization
CARE	B-Organization
International	E-Organization
,	O
Cooperazione	B-Organization
Internationale	E-Organization
(	O
COOPE	S-Organization
)	O
,	O
Catholic	B-Organization
Organization	I-Organization
for	I-Organization
Relief	I-Organization
and	I-Organization
Development	I-Organization
Aid	E-Organization
(	O
CORDAID/PAP-DRC	S-Organization
)	O
,	O
International	B-Organization
Rescue	I-Organization
Committee	E-Organization
(	O
IRC	S-Organization
)	O
,	O
Médecins	B-Organization
Sans	I-Organization
Frontières	E-Organization
(	O
MSF	S-Organization
)	O
,	O
Oxfam	S-Organization
,	O
International	B-Organization
Federation	I-Organization
of	I-Organization
Red	I-Organization
Cross	I-Organization
and	I-Organization
Red	I-Organization
Crescent	I-Organization
Societies	E-Organization
(	O
IFRC	S-Organization
)	O
,	O
International	B-Organization
Committee	I-Organization
of	I-Organization
the	I-Organization
Red	I-Organization
Cross	E-Organization
(	O
ICRC	S-Organization
)	O
,	O
and	O
.	O

These	O
first	O
epidemics	O
at	O
training	O
camps	O
were	O
a	O
sign	O
of	O
what	O
was	O
coming	O
in	O
greater	O
magnitude	O
in	O
the	O
fall	O
and	O
winter	O
of	O
1918	O
to	O
the	O
entire	O
world	O
.	O

In	O
the	O
1990s	O
,	O
the	O
President	O
of	O
the	O
Russian	B-Organization
Federation	E-Organization
Boris	B-Person
Yeltsin	E-Person
,	O
admitted	O
to	O
an	O
offensive	O
bio-weapons	O
program	O
as	O
well	O
as	O
to	O
the	O
true	O
nature	O
of	O
the	O
Sverdlovsk	B-Incident
biological	I-Incident
weapons	I-Incident
accident	I-Incident
of	I-Incident
1979	E-Incident
,	O
which	O
had	O
resulted	O
in	O
the	O
deaths	O
of	O
at	O
least	O
64	O
people	O
.	O

Antimicrobial	B-Technology
susceptibility	I-Technology
testing	E-Technology
()	O
can	O
help	O
practitioners	O
avoid	O
prescribing	O
unnecessary	O
antibiotics	O
in	O
the	O
style	O
of	O
precision	O
medicine	O
,	O
and	O
help	O
them	O
prescribe	O
effective	O
antibiotics	O
,	O
but	O
with	O
the	O
traditional	O
approach	O
it	O
could	O
take	O
12	O
to	O
48	O
hours	O
.	O

It	O
works	O
closely	O
with	O
many	O
international	O
organizations	O
such	O
as	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
as	O
well	O
as	O
ministries	O
of	O
health	O
and	O
other	O
groups	O
on	O
the	O
front	O
lines	O
of	O
outbreaks	O
.	O

The	O
plague	S-Disease
repeatedly	O
returned	O
to	O
haunt	O
Europe	S-Location
and	O
the	O
Mediterranean	S-Location
throughout	O
the	O
14th	O
to	O
17th	O
centuries	O
.	O

In	O
the	O
first	O
,	O
during	O
a	O
parley	O
at	O
Fort	B-Location
Pitt	E-Location
on	O
June	O
24	O
,	O
1763	O
,	O
Captain	O
Simeon	B-Person
Ecuyer	E-Person
gave	O
representatives	O
of	O
the	O
besieging	O
Delawares	O
two	O
blankets	O
and	O
a	O
handkerchief	O
enclosed	O
in	O
small	O
metal	O
boxes	O
that	O
had	O
been	O
exposed	O
to	O
,	O
hoping	O
to	O
spread	O
the	O
disease	O
to	O
the	O
Natives	O
in	O
order	O
to	O
end	O
the	O
siege.Anderson	O
,	O
Crucible	O
of	O
War	O
,	O
541–42	O
;	O
Jennings	O
,	O
Empire	O
of	O
Fortune	O
,	O
447n26	O
.	O

By	O
14	O
November	O
2009	O
,	O
the	O
virus	O
had	O
infected	O
one	O
in	O
six	O
Americans	O
with	O
200,000	O
hospitalisations	O
and	O
10,000	O
deaths-as	O
many	O
hospitalizations	O
and	O
fewer	O
deaths	O
than	O
in	O
an	O
average	O
flu	O
season	O
overall	O
,	O
but	O
with	O
much	O
higher	O
risk	O
for	O
those	O
under	O
50	O
.	O

"	O
Some	O
of	O
these	O
bacteria	O
are	O
carried	O
by	O
patients	O
into	O
the	O
hospital	O
,	O
while	O
others	O
are	O
acquired	O
,	O
in	O
part	O
due	O
to	O
otherwise	O
lifesaving	O
interventions	O
,	O
including	O
antibiotic	O
treatments	O
and	O
[other	O
interventions	O
involving]	O
medical	O
devices	O
like	O
intravenous	O
catheters	O
and	O
mechanical	O
ventilators,	O
"	O
Dr	O
.	O

This	O
is	O
called	O
the	O
incubation	O
period	O
.	O

It	O
spreads	O
between	O
people	O
very	O
efficiently	O
and	O
sustainably-easier	O
than	O
influenza	S-Disease
but	O
not	O
as	O
easily	O
as	O
measles	S-Disease
.	O
This	O
occurs	O
mainly	O
when	O
people	O
are	O
in	O
close	O
contact	O
(two	O
metres	O
or	O
six	O
feet)	O
via	O
small	O
droplets	O
produced	O
during	O
coughing	O
,	O
sneezing	O
,	O
or	O
talking	O
.	O

On	O
10	O
August	O
2010	O
,	O
the	O
Director-General	O
of	O
the	O
WHO	S-Organization
Margaret	B-Person
Chan	E-Person
,	O
announced	O
the	O
end	O
of	O
the	O
H1N1	B-Incident
pandemic	E-Incident
and	O
announced	O
that	O
the	O
H1N1	B-Incident
influenza	I-Incident
event	E-Incident
had	O
moved	O
into	O
the	O
post-pandemic	O
period	O
.	O

Hearing	O
before	O
the	O
Subcommittee	O
on	O
Emergency	O
Preparedness	O
,	O
Response	O
and	O
Communications	O
of	O
the	O
Committee	O
on	O
Homeland	O
Security	O
,	O
House	B-Organization
of	I-Organization
Representatives	E-Organization
,	O
One	O
Hundred	O
Twelfth	O
Congress	O
,	O
First	O
Session	O
,	O
April	O
13	O
,	O
2011	O
and	O
May	O
12	O
,	O
2011.	O
112	O
Cong.	O
,	O
1st	O
sess	O
.	O

SPR994	S-Drug
is	O
Spero	S-Organization
's	O
in­ves­ti­ga­tion­al	O
oral	O
for­mu­la­tion	O
of	O
tebipen­em	S-Drug
,	O
a	O
car­bapen­em-class	O
an­tibi­ot­ic	O
mar­ket­ed	O
by	O
Mei­ji	B-Organization
Sei­ka	I-Organization
Phar­ma	E-Organization
in	O
Japan	S-Location
as	O
Orapen­em	S-Drug
since	O
2009	O
for	O
com­mon	O
pe­di­atric	O
in­fec­tions	O
.	O

The	O
idea	O
behind	O
is	O
to	O
help	O
researchers	O
and	O
clinicians	O
understand	O
which	O
strains	O
of	O
bacteria	O
are	O
spreading	O
through	O
the	O
healthcare	O
system	O
and	O
where	O
they	O
are	O
spreading	O
,	O
to	O
identify	O
which	O
strains	O
are	O
drug-resistant	O
or	O
virulent	O
,	O
and	O
to	O
find	O
the	O
genetic	O
markers	O
that	O
give	O
them	O
away	O
.	O

The	O
Ukrainian	B-Organization
government	E-Organization
did	O
not	O
report	O
on	O
the	O
dead	O
Ukrainian	O
soldiers	O
in	O
Kharkiv	S-Location
.	O
As	O
of	O
March	O
2016	O
364	O
deaths	O
have	O
been	O
reported	O
across	O
Ukraine	S-Organization
(81.	O
3	O
%	O
caused	O
by	O
–	O
the	O
same	O
strain	O
which	O
caused	O
the	O
world	O
pandemic	O
in	O
2009)	O
.	O

TIM-1	O
was	O
shown	O
to	O
bind	O
to	O
the	O
receptor	O
binding	O
domain	O
of	O
the	O
EBOV	S-Pathogen
glycoprotein	O
,	O
to	O
increase	O
the	O
receptivity	O
of	O
Vero	O
cells	O
.	O

At	O
Google	O
Books	O
.	O

The	O
symptoms	O
of	O
H1N1	B-Disease
flu	E-Disease
are	O
similar	O
to	O
those	O
of	O
other	O
influenzas	O
,	O
and	O
may	O
include	O
fever	S-Phenotype
,	O
cough	S-Phenotype
(typically	O
a	O
"	O
dry	B-Phenotype
cough	E-Phenotype
"	O
),	O
headache	S-Phenotype
,	O
muscle	B-Phenotype
or	I-Phenotype
joint	I-Phenotype
pain	E-Phenotype
,	O
sore	B-Phenotype
throat	E-Phenotype
,	O
chills	S-Phenotype
,	O
fatigue	S-Phenotype
,	O
and	O
runny	B-Phenotype
nose	E-Phenotype
.	O
Diarrhea	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
and	O
neurological	O
problems	O
have	O
also	O
been	O
reported	O
in	O
some	O
cases	O
.	O

openBIS	S-Platform
is	O
an	O
open-source	O
distributed	O
data	O
management	O
system	O
for	O
biologic	O
information	O
developed	O
at	O
the	O
ETH	B-Organization
Zürich	E-Organization
.	O
The	O
central	O
components	O
of	O
openBIS	O
are	O
an	O
application	O
server	O
and	O
a	O
data	O
store	O
server	O
.	O

This	O
also	O
resulted	O
in	O
a	O
33–43	O
percent	O
drop	O
in	O
foot	O
traffic	O
to	O
shopping	O
centres	O
in	O
March	O
compared	O
to	O
February	O
.	O

Yuri	B-Person
OvchinnikovBirstein	E-Person
Vadim	B-Person
J	E-Person
.	O
(2004)	O
,	O
The	O
Perversion	O
Of	O
Knowledge:	O
The	O
True	O
Story	O
of	O
Science	O
,	O
Westview	O
Press	O
.	O

The	O
experimentation	O
on	O
superhumans	O
by	O
the	O
Japanese	O
and	O
Americans	O
is	O
a	O
parallel	O
to	O
Unit	B-Organization
731	E-Organization

However	O
,	O
during	O
the	O
1785	O
siege	O
of	O
,	O
Tunisian	O
forces	O
flung	O
diseased	O
clothing	O
into	O
the	O
city	O
.	O

WHO	S-Organization
does	O
not	O
recommend	O
any	O
specific	O
measures	O
for	O
travellers	O
.	O

In	O
1936	O
,	O
Emperor	O
Hirohito	S-Person
authorized	O
by	O
decree	O
the	O
expansion	O
of	O
this	O
unit	O
and	O
its	O
integration	O
into	O
the	O
Kwantung	B-Organization
Army	E-Organization
as	O
the	O
Epidemic	B-Organization
Prevention	I-Organization
Department	E-Organization
.	O
Daniel	B-Person
Barenblat	E-Person
,	O
A	O
plague	O
upon	O
humanity	O
,	O
2004	O
,	O
p.37	O
.	O

For	O
the	O
moment	O
,	O
however	O
,	O
this	O
stand-down	O
remains	O
the	O
sum	O
total	O
of	O
government	O
actions	O
.	O

Brucella	S-Pathogen
transmitted	O
by	O
contact	O
with	O
infected	O
livestock	O
including	O
cattle	O
and	O
sheep	O
or	O
by	O
eating	O
unpasteurized	O
dairy	O
products	O
,	O
can	O
cause	O
brucellosis	S-Disease
,	O
also	O
known	O
as	O
the	O
Mediterranean	B-Disease
fever	E-Disease
.	O
It	O
is	O
characterized	O
by	O
fever	S-Phenotype
,	O
malaise	S-Phenotype
and	O
.	O
The	O
risk	O
of	O
human-to-human	O
transmission	O
is	O
said	O
to	O
be	O
minimal	O
.	O

In	O
the	O
suburbs	O
of	O
,	O
an	O
illness	O
similar	O
to	O
"	O
red	O
mold	O
disease	O
"	O
was	O
described	O
in	O
an	O
outbreak	O
of	O
a	O
food	O
borne	O
disease	O
,	O
as	O
a	O
result	O
of	O
the	O
consumption	O
of	O
Fusarium-	O
infected	O
rice	O
.	O

Resources	O
and	O
medical	O
facilities	O
are	O
part	O
of	O
the	O
problem	O
.	O

A	O
dose	O
of	O
40	O
mg/kg	O
for	O
14	O
days	O
was	O
found	O
to	O
be	O
similarly	O
efficacious	O
in	O
the	O
rabbitpox/rabbit	O
model	O
.	O

Risks:	O
The	O
inventors	O
of	O
rDNA	S-Technology
themselves	O
warned	O
the	O
public	O
and	O
their	O
colleagues	O
about	O
the	O
dangers	O
of	O
this	O
technology	O
.	O

Recently	O
,	O
the	O
US	B-Organization
Center	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
tracked	O
multistate	B-Incident
Salmonella	I-Incident
Heidelberg	I-Incident
infections	E-Incident
associated	O
with	O
contaminated	O
ground	O
turkey	O
that	O
sickened	O
more	O
than	O
130	O
people	O
in	O
32	O
different	O
states	O
.	O

The	O
exercises	O
,	O
ring	O
trials	O
,	O
and	O
audits	O
carried	O
out	O
at	O
the	O
network	O
members'	O
various	O
laboratories	O
have	O
shed	O
light	O
on	O
some	O
areas	O
of	O
inconsistency	O
regarding	O
how	O
practices	O
are	O
handled	O
and	O
how	O
Swedish	S-Location
biopreparedness	O
could	O
be	O
improved	O
.	O

Chan	S-Person
said	O
she	O
would	O
recommend	O
that	O
vaccine	O
manufacturers	O
proceed	O
with	O
mass	O
production	O
of	O
an	O
inoculation	O
against	O
the	O
new	O
strain	O
as	O
soon	O
as	O
they	O
finish	O
production	O
of	O
seasonal	O
vaccine	O
,	O
which	O
she	O
estimated	O
would	O
be	O
complete	O
in	O
about	O
two	O
weeks	O
.	O

The	O
most	O
frequent	O
areas	O
of	O
interest	O
were	O
biorisk	O
management	O
in	O
biomedical	O
and	O
biotechnology	O
laboratories	O
13%	O
(n = 239)	O
,	O
followed	O
by	O
living	B-Technology
modified	I-Technology
organisms	E-Technology
()	O
9.17%	O
(n = 168)	O
.	O

Rather	O
,	O
that	O
is	O
the	O
capripneumoniae	O
subspecies	O
of	O
Mycoplasma	O
capricolum	O
.	O

They	O
infect	O
the	O
cells	O
with	O
different	O
titrations	O
of	O
HSV‐1	S-Pathogen
virus	O
in	O
a	O
biological	O
hood	O
under	O
the	O
same	O
conditions	O
described	O
in	O
the	O
second	O
lab	O
settings	O
(lab3	O
,	O
Table	O
1)	O
.	O

So	O
we	O
do	O
not	O
think	O
there	O
was	O
a	O
human	O
exposure	O
there	O
.	O

Some	O
12-17 million	O
people	O
died	O
in	O
India	S-Location
about	O
5%	O
of	O
the	O
population	O
.	O

The	O
most	O
common	O
adverse	O
effects	O
in	O
studies	O
of	O
remdesivir	S-Drug
for	O
include	O
respiratory	O
failure	O
and	O
organ	O
impairment	O
,	O
including	O
low	O
albumin	O
,	O
low	O
potassium	O
,	O
low	O
count	O
of	O
red	O
blood	O
cells	O
,	O
low	O
count	O
of	O
platelets	O
that	O
help	O
with	O
clotting	O
,	O
and	O
yellow	O
discoloration	O
of	O
the	O
skin	O
.	O

In	O
August	O
they	O
published	O
a	O
road	O
map	O
to	O
guide	O
and	O
coordinate	O
the	O
international	O
response	O
to	O
the	O
outbreak	O
,	O
aiming	O
to	O
stop	O
ongoing	O
Ebola	S-Disease
transmission	O
worldwide	O
within	O
6–9	O
months	O
,	O
and	O
formally	O
designated	O
the	O
outbreak	O
as	O
a	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
.	O
This	O
is	O
a	O
legal	O
designation	O
used	O
only	O
twice	O
before	O
(for	O
the	O
2009	O
H1N1	S-Disease
(	O
swine	B-Disease
flu	E-Disease
)	O
pandemic	O
and	O
the	O
2014	O
resurgence	O
of	O
)	O
that	O
invokes	O
legal	O
measures	O
on	O
disease	O
prevention	O
,	O
surveillance	O
,	O
control	O
,	O
and	O
response	O
,	O
by	O
194	O
signatory	O
countries	O
.	O

In	O
March	O
,	O
after	O
two	O
weeks	O
of	O
not	O
reporting	O
any	O
new	O
cases	O
,	O
3 new	O
cases	O
were	O
confirmed	O
.	O

In	O
Liberia	S-Location
the	O
disease	O
was	O
reported	O
in	O
four	O
counties	O
by	O
mid-April	O
2014	O
and	O
cases	O
in	O
Liberia	S-Location
's	O
capital	O
Monrovia	S-Location
were	O
reported	O
in	O
mid-June	O
.	O

Senate	B-Organization
HELP	I-Organization
Committee	E-Organization
Ranking	O
Member	O
Sen.	O
(D-WA)	O
said	O
that	O
it's	O
important	O
for	O
the	O
nation	O
to	O
be	O
cognizant	O
of	O
both	O
local	O
level	O
pandemics	O
and	O
those	O
occurring	O
on	O
a	O
global	O
scale.	O
"	O
Diseases	O
are	O
not	O
stopped	O
by	O
borders	O
,	O
walls	O
or	O
by	O
bans,	O
"	O
she	O
said	O
.	O

BSL‐3	S-Platform
is	O
suitable	O
for	O
work	O
with	O
infectious	O
agents	O
,	O
which	O
may	O
cause	O
serious	O
or	O
potentially	O
lethal	O
diseases	O
as	O
a	O
result	O
of	O
exposure	O
by	O
the	O
inhalation	O
route	O
.	O

This	O
group	O
formulated	O
a	O
set	O
of	O
minimum	O
standards	O
for	O
laboratory	O
safety	O
compiled	O
in	O
a	O
.	O
This	O
Manual	O
has	O
been	O
revised	O
periodicaly	O
,	O
the	O
last	O
version	O
having	O
been	O
published	O
in	O
2003	O
.	O

This	O
generally	O
proved	O
to	O
be	O
ineffective	O
.	O

A	O
full	O
discussion	O
of	O
the	O
large	O
variety	O
of	O
countries'	O
data	O
sharing	O
policies	O
and	O
infrastructures	O
would	O
go	O
beyond	O
the	O
scope	O
of	O
this	O
review	O
.	O

The	O
study	O
found	O
that	O
laboratory	O
staff	O
did	O
not	O
wear	O
lab-coat	O
and	O
gloves	O
in	O
all	O
laboratory	O
procedures	O
as	O
the	O
percentage	O
was	O
very	O
low	O
.	O

The	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
is	O
developing	O
a	O
strategic	O
framework	O
to	O
advance	O
tuberculosis	S-Disease
()	O
research	O
and	O
development	O
for	O
the	O
next	O
five	O
years	O
and	O
beyond	O
.	O

Some	O
specialized	O
MRI	S-Technology
systems	O
allow	O
imaging	O
concurrent	O
with	O
the	O
surgical	O
procedure	O
.	O

The	O
Fiscal	B-Document
Year	I-Document
2019	I-Document
President's	I-Document
Budget	E-Document
proposes	O
additional	O
resources	O
for	O
,	O
and	O
emphasizes	O
the	O
importance	O
of	O
strengthening	O
countries'	O
ability	O
to	O
prevent	O
,	O
detect	O
,	O
and	O
respond	O
to	O
infectious	O
disease	O
threats	O
.	O

In	O
addition	O
,	O
the	O
involved	O
BSL-4	S-Platform
lab	O
has	O
suspended	O
transfers	O
out	O
of	O
the	O
lab	O
until	O
a	O
full	O
review	O
of	O
the	O
incident	O
is	O
completed	O
and	O
appropriate	O
improvements	O
are	O
initiated	O
.	O

This	O
has	O
led	O
to	O
speculation	O
that	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
originated	O
in	O
China	S-Location
,	O
as	O
the	O
lower	O
rates	O
of	O
flu	S-Disease
mortality	O
may	O
be	O
explained	O
by	O
the	O
Chinese	O
population's	O
previously	O
acquired	O
immunity	O
to	O
the	O
.	O

Using	O
stored	O
laboratory	O
samples	O
for	O
all	O
six	O
,	O
it	O
was	O
found	O
that	O
samples	O
from	O
the	O
two	O
patients	O
who	O
had	O
died	O
tested	O
positive	O
for	O
.	O

The	O
emergence	O
of	O
human	B-Pathogen
immunodeficiency	I-Pathogen
virus	E-Pathogen
and	O
hantavirus	S-Pathogen
,	O
the	O
continuing	O
problem	O
of	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
,	O
and	O
the	O
reemergence	O
of	O
have	O
renewed	O
interest	O
in	O
biosafety	O
for	O
the	O
employees	O
of	O
laboratories	O
and	O
health	O
care	O
facilities	O
.	O

In	O
late	O
October	O
2014	O
,	O
a	O
publication	O
reported	O
a	O
study	O
of	O
the	O
response	O
to	O
a	O
mouse-adapted	O
strain	O
of	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
presented	O
by	O
a	O
genetically	O
diverse	O
population	O
of	O
mice	O
that	O
was	O
bred	O
to	O
have	O
a	O
range	O
of	O
responses	O
to	O
the	O
virus	O
that	O
includes	O
fatality	O
from	O
.	O

Death	O
occurs	O
in	O
about	O
two	O
to	O
30	O
people	O
per	O
1,000,000	O
administrations	O
,	O
with	O
newer	O
agents	O
being	O
safer	O
.	O

And	O
yesterday	O
we	O
learned	O
that	O
two	O
of	O
the	O
six	O
vials	O
showed	O
evidence	O
of	O
growth	O
.	O

Once	O
subjected	O
to	O
steam	O
sterilization	O
,	O
where	O
it	O
is	O
super-heated	O
to	O
about	O
250	O
degrees	O
Fahrenheit	O
for	O
20	O
minutes	O
,	O
the	O
liquid	O
can	O
then	O
be	O
treated	O
as	O
normal	O
wastewater	O
.	O

Laboratory	O
procedures	O
must	O
be	O
documented	O
and	O
recordkeeping	O
must	O
be	O
implemented	O
so	O
that	O
processes	O
used	O
during	O
research	O
are	O
clearly	O
outlined	O
.	O

On	O
27	O
September	O
a	O
new	O
42-day	O
countdown	O
began	O
to	O
declare	O
the	O
country	O
Ebola	S-Disease
-free	O
,	O
which	O
eventually	O
occurred	O
on	O
7	O
November	O
2015	O
;	O
thereafter	O
,	O
the	O
country	O
increased	O
its	O
vigilance	O
on	O
the	O
border	O
.	O

How	O
can	O
the	O
Department	O
of	O
Defense-whose	O
forces	O
,	O
deployed	O
around	O
the	O
world	O
,	O
constantly	O
come	O
into	O
contact	O
with	O
new	O
bacteria-discriminate	O
between	O
harmless	O
and	O
virulent	O
strains	O
to	O
prevent	O
a	O
disease	O
outbreak	O
that	O
threatens	O
military	O
readiness?	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
a	O
new	O
program	O
from	O
DARPA	S-Organization
's	O
,	O
proposes	O
to	O
develop	O
a	O
platform	O
technology	O
that	O
rapidly	O
screens	O
unfamiliar	O
bacteria	O
to	O
establish	O
their	O
pathogenicity	O
and	O
even	O
discover	O
unknown	O
pathogenic	O
traits	O
,	O
necessary	O
first	O
steps	O
for	O
designing	O
effective	O
biosurveillance	O
and	O
countermeasures	O
.	O

Warren	O
also	O
uses	O
native	O
oral	O
tradition	O
and	O
the	O
archaeology	O
of	O
native	O
graves	O
to	O
analyse	O
the	O
cause	O
and	O
effect	O
of	O
the	O
spread	O
of	O
in	O
1789	O
.	O

He	O
said	O
that	O
twin	O
girls	O
,	O
Lulu	S-Person
and	O
Nana	S-Person
,	O
had	O
been	O
born	O
a	O
few	O
weeks	O
earlier	O
.	O

The	O
fire	O
broke	O
out	O
when	O
a	O
gas	O
cylinder	O
exploded	O
on	O
the	O
fifth	O
floor	O
of	O
the	O
six-story	O
laboratory	O
building	O
in	O
the	O
city	O
of	O
Koltsovo	S-Location
The	O
blast	O
caused	O
windows	O
to	O
smash	O
but	O
there	O
was	O
no	O
structural	O
damage	O
to	O
the	O
building	O
,	O
reported	O
.	O

Scott	B-Person
Lillibridge	E-Person
didn't	O
realize	O
then	O
what	O
would	O
emerge	O
as	O
the	O
almost	O
surreal	O
scope	O
of	O
biothreats	O
now	O
challenging	O
the	O
.	O

One	O
of	O
Ishii	S-Person
main	O
supporters	O
inside	O
the	O
army	O
was	O
Colonel	O
Chikahiko	B-Person
Koizumi	E-Person
,	O
who	O
later	O
became	O
Japan's	O
Health	O
Minister	O
from	O
1941	O
to	O
1945	O
.	O

In	O
one	O
study	O
,	O
mice	O
with	O
one	O
copy	O
of	O
the	O
NPC1	O
gene	O
removed	O
showed	O
an	O
80	O
percent	O
survival	O
rate	O
fifteen	O
days	O
after	O
exposure	O
to	O
mouse-adapted	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
while	O
only	O
10	O
percent	O
of	O
unmodified	O
mice	O
survived	O
this	O
long	O
.	O

Since	O
the	O
discovery	O
of	O
antibiotics	O
,	O
research	O
and	O
development	O
(R&amp;D)	O
efforts	O
have	O
provided	O
new	O
drugs	O
in	O
time	O
to	O
treat	O
bacteria	O
that	O
became	O
resistant	O
to	O
older	O
antibiotics	O
,	O
but	O
in	O
the	O
2000s	O
there	O
has	O
been	O
concern	O
that	O
development	O
has	O
slowed	O
enough	O
that	O
seriously	O
ill	O
people	O
may	O
run	O
out	O
of	O
treatment	O
options	O
.	O

Local	O
people	O
complain	O
of	O
being	O
bitten	O
by	O
these	O
newly	O
appeared	O
flies	O
while	O
naked	O
in	O
their	O
bathrooms	O
.	O

The	O
$100	O
million	O
program	O
Blue	B-Scientific_research_project
Angel	E-Scientific_research_project
was	O
launched	O
as	O
a	O
response	O
to	O
the	O
H1N1	B-Incident
pandemic	E-Incident
in	O
2009	O
.	O

Their	O
feedback	O
also	O
ensures	O
that	O
in	O
the	O
future	O
,	O
"	O
we	O
have	O
clear	O
procedures	O
,	O
resources	O
,	O
and	O
support	O
in	O
place	O
to	O
keep	O
Americans	O
safe,	O
"	O
said	O
.	O

According	O
to	O
CEBM	S-Organization
random	O
antibody	O
testing	O
in	O
suggested	O
an	O
IFR	O
of	O
0.37%	O
(0.12%	O
to	O
0.	O
87%)	O
there	O
,	O
but	O
there	O
have	O
been	O
concerns	O
about	O
false	O
positives	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	O
,	O
DHHS	S-Organization
DoT	O
,	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

The	O
companies	O
are	O
producing	O
pilot	O
lots	O
.	O

The	O
mayor	O
of	O
Rajneeshpuram	S-Location
David	B-Person
Berry	I-Person
Knapp	E-Person
(known	O
as	O
Swami	B-Person
Krishna	I-Person
Deva	E-Person
or	O
KD	S-Person
)	O
,	O
turned	O
state's	O
evidence	O
and	O
gave	O
an	O
account	O
of	O
his	O
knowledge	O
of	O
the	O
Salmonella	B-Incident
attack	E-Incident
to	O
the	O
FBI	S-Organization
.	O
He	O
claimed	O
that	O
Sheela	S-Person
said	O
"	O
she	O
had	O
talked	O
with	O
[Rajneesh]	O
about	O
the	O
plot	O
to	O
decrease	O
voter	O
turnout	O
in	O
The	O
Dalles	S-Location
by	O
making	O
people	O
sick	O
.	O

Previous	O
experiences	O
of	O
laboratory	O
networks	O
have	O
reported	O
on	O
the	O
importance	O
of	O
quality	O
assurance	O
management	O
programs	O
,	O
including	O
reference	O
material	O
and	O
well-designed	O
validation	O
parameters	O
as	O
a	O
basis	O
for	O
inter-agency	O
cooperation	O
.	O

Study	O
setting:	O
The	O
study	O
was	O
conducted	O
in	O
Khartoum	S-Location
state	O
diagnostic	O
laboratories	O
.	O

Chan	S-Person
said	O
she	O
would	O
recommend	O
that	O
vaccine	O
manufacturers	O
proceed	O
with	O
mass	O
production	O
of	O
an	O
inoculation	O
against	O
the	O
new	O
strain	O
as	O
soon	O
as	O
they	O
finish	O
production	O
of	O
seasonal	O
vaccine	O
,	O
which	O
she	O
estimated	O
would	O
be	O
complete	O
in	O
about	O
two	O
weeks	O
.	O

In	O
the	O
article	O
,	O
they	O
noted	O
that	O
the	O
same	O
aerosol	O
technology	O
used	O
to	O
develop	O
inhaled	B-Technology
insulin	I-Technology
for	I-Technology
the	I-Technology
treatment	I-Technology
of	I-Technology
diabetes	E-Technology
could	O
also	O
be	O
used	O
to	O
push	O
anthrax	S-Pathogen
or	O
other	O
large	O
molecules	O
past	O
the	O
lung's	O
immune	O
system	O
and	O
deep	O
into	O
the	O
airways	O
where	O
they	O
can	O
cause	O
disease	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(CDC)	O
is	O
the	O
leading	O
national	O
public	O
health	O
institute	O
of	O
the	O
.	O

They	O
obtained	O
search	O
warrants	O
and	O
subpoenas	O
;	O
50	O
investigators	O
entered	O
the	O
Ranch	O
on	O
October	O
2	O
,	O
1985	O
.	O

Two	O
British-trained	O
scientists	O
have	O
been	O
identified	O
as	O
leading	O
figures	O
in	O
the	O
programme.	O
…	O
According	O
to	O
Israeli	O
military	O
intelligence	O
sources	O
,	O
10	O
Iranian	O
prisoners	O
of	O
war	O
were	O
taken	O
to	O
a	O
location	O
near	O
Iraq	S-Location
's	O
border	O
with	O
Saudi	B-Location
Arabia	E-Location
.	O
They	O
were	O
lashed	O
to	O
posts	O
and	O
left	O
helpless	O
as	O
an	O
anthrax	S-Pathogen
bomb	O
was	O
exploded	O
by	O
remote	O
control	O
15	O
yards	O
away	O
.	O

When	O
Venter	S-Person
and	O
his	O
colleagues	O
announced	O
the	O
construction	O
of	O
cells	O
with	O
entirely	O
synthetic	O
genomes	O
in	O
2010	O
,	O
public	O
figures	O
including	O
President	O
Barack	B-Person
Obama	E-Person
and	O
commented	O
on	O
the	O
breakthrough	O
,	O
discussing	O
the	O
potential	O
benefits	O
to	O
society	O
as	O
well	O
as	O
the	O
risks	O
to	O
keep	O
in	O
mind	O
.	O

Mona	B-Person
Siddiqui	E-Person
,	O
a	O
small	O
team	O
of	O
HHS	S-Organization
staff	O
interviewed	O
agency	O
leadership	O
and	O
staff	O
from	O
eleven	O
HHS	S-Organization
agencies	O
,	O
including	O
at	O
the	O
NIH	S-Organization
,	O
CDC	S-Organization
,	O
FDA	S-Organization
,	O
CMS	S-Organization
,	O
and	O
,	O
about	O
the	O
challenges	O
and	O
opportunities	O
in	O
sharing	O
data	O
between	O
agencies	O
.	O

"	O
[The]	O
CDC	S-Organization
released	O
the	O
first	O
antibiotic	O
resistance	O
threat	O
report	O
in	O
2013	O
,	O
so	O
this	O
[situation]	O
is	O
not	O
new,	O
"	O
Dr.	O
told	O
us	O
.	O

Those	O
wishing	O
to	O
enter	O
China	S-Location
must	O
to	O
apply	O
for	O
visas	O
in	O
Chinese	O
embassies	O
or	O
consulates	O
.	O

USAID	S-Organization
allocated	O
the	O
$411.	O
6	O
in	O
Ebola	S-Pathogen
recovery	O
money	O
to	O
three	O
accounting	O
umbrellas	O
,	O
including	O
$247.	O
6	O
million	O
for	O
shoring	O
up	O
health	O
systems	O
,	O
addressing	O
government	O
and	O
economic	O
crises	O
,	O
and	O
helping	O
Ebola	B-Person
survivors	E-Person
.	O
The	O
agency	O
obligated	O
$118.	O
5	O
million	O
for	O
food	B-Scientific_research_project
security	I-Scientific_research_project
projects	E-Scientific_research_project
and	O
agricultural	O
market	O
support	O
,	O
as	O
well	O
as	O
$45.	O
5	O
million	O
for	O
global	B-Scientific_research_project
health	I-Scientific_research_project
programs	E-Scientific_research_project
,	O
which	O
also	O
includes	O
assistance	O
for	O
Ebola	B-Person
survivors	E-Person
as	O
well	O
as	O
.	O

In	O
addition	O
,	O
in	O
2004	O
the	O
Swedish	B-Organization
Laboratory	I-Organization
for	I-Organization
Food	I-Organization
Safety	I-Organization
and	I-Organization
Biopreparedness	E-Organization
was	O
established	O
.	O

Labels	O
like	O
"	O
H1N1	B-Disease
flu	E-Disease
"	O
Swine	B-Disease
flu	E-Disease
"	O
,	O
"	O
Mexican	B-Disease
flu	E-Disease
"	O
,	O
and	O
variations	O
thereof	O
were	O
typical	O
.	O

These	O
numbers	O
vary	O
by	O
region	O
and	O
over	O
time	O
,	O
influenced	O
by	O
testing	O
volume	O
,	O
healthcare	O
system	O
quality	O
,	O
treatment	O
options	O
,	O
effectiveness	O
and	O
rapidity	O
of	O
government	O
response	O
,	O
Ward	S-Person
Dan	S-Person
(2020)	O
"	O
Actions	O
Speak	O
Louder	O
Than	O
Age:	O
Explaining	O
Wide	O
Variations	O
in	O
COVID-19	S-Disease
Deaths.	O
"	O
doi:	O
10.13140/RG.2.2.33339.03363	O
Technical	O
Report	O
.	O

Many	O
studies	O
emphasize	O
the	O
importance	O
of	O
combining	O
laboratory	O
courses	O
with	O
theoretical	O
courses	O
to	O
attain	O
deeper	O
student	O
understanding	O
and	O
higher	O
student	O
satisfaction	O
14	O
,	O
15	O
.	O

Three	O
veterans	O
of	O
Unit	O
731	O
testified	O
in	O
a	O
1989	O
interview	O
to	O
the	O
Asahi	O
Shimbun	O
that	O
they	O
contaminated	O
the	O
Horustein	B-Location
river	E-Location
with	O
typhoid	S-Disease
near	O
the	O
Soviet	O
troops	O
during	O
the	O
Battle	O
of	O
Khalkhin	O
Gol	O
.	O

The	O
Ministry	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Medical	I-Organization
Education	I-Organization
of	I-Organization
Iran	E-Organization
reported	O
that	O
two	O
women	O
had	O
been	O
diagnosed	O
with	O
MERS	S-Disease
and	O
on	O
29	O
May	O
2014	O
one	O
of	O
the	O
women	O
died	O
of	O
the	O
disease	O
in	O
the	O
city	O
of	O
Kerman	S-Location
.	O
According	O
to	O
Dr	O
.	O

During	O
biological	O
bomb	O
experiments	O
,	O
researchers	O
dressed	O
in	O
protective	B-Equipment
suits	E-Equipment
would	O
examine	O
the	O
dying	O
victims	O
.	O

The	O
term	O
biohacker	O
is	O
now	O
ubiquitous	O
.	O

The	O
pneumonia	S-Disease
caused	O
by	O
flu	O
can	O
be	O
either	O
direct	O
viral	B-Disease
pneumonia	E-Disease
or	O
a	O
secondary	O
bacterial	B-Disease
pneumonia	E-Disease
.	O
A	O
November	O
2009	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
article	O
recommended	O
that	O
flu	O
patients	O
whose	O
chest	O
X-ray	O
indicates	O
pneumonia	S-Disease
receive	O
both	O
antivirals	O
and	O
antibiotics	O
.	O

Their	O
analysis	O
is	O
outlined	O
in	O
an	O
article	O
published	O
in	O
the	O
January	O
2003	O
edition	O
of	O
the	O
journal	O
Biosecurity	O
and	O
Bioterrorism	O
.	O

SIGMA+	S-Scientific_research_project
aims	O
to	O
achieve	O
sensitivity	O
enhancement	O
over	O
the	O
current	O
for	O
interdicting	O
radiological	O
and	O
nuclear	O
threats	O
.	O

The	O
organization	O
was	O
renamed	O
the	O
Center	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
(	O
CDC	S-Organization
)	O
on	O
June	O
24	O
,	O
1970	O
,	O
and	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
effective	O
October	O
14	O
,	O
1980	O
.	O

However	O
,	O
the	O
did	O
further	O
indicate	O
that	O
individuals	O
travelling	O
to	O
the	O
country	O
should	O
take	O
precaution	O
with	O
sick	O
people	O
and	O
body	O
fluids	O
.	O

Influenza	B-Pathogen
A	I-Pathogen
viruses	E-Pathogen
(	O
IAVs	S-Pathogen
)	O
,	O
particularly	O
the	O
highly	O
pathogenic	O
avian	O
influenza	B-Pathogen
H5N1	E-Pathogen
,	O
have	O
posed	O
a	O
substantial	O
threat	O
to	O
public	O
health	O
worldwide	O
.	O

Although	O
some	O
mice	O
have	O
also	O
tested	O
positive	O
to	O
the	O
infection	O
,	O
an	O
investigation	O
has	O
yet	O
to	O
announce	O
the	O
strain	O
of	O
Brucella	S-Pathogen
in	O
the	O
infected	O
people	O
,	O
or	O
the	O
source	O
of	O
the	O
outbreak	O
.	O

In	O
2016	O
,	O
the	O
United	B-Organization
States	I-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
approved	O
a	O
clinical	O
trial	O
in	O
which	O
CRISPR	S-Technology
would	O
be	O
used	O
to	O
alter	O
T	O
cells	O
extracted	O
from	O
people	O
with	O
different	O
kinds	O
of	O
and	O
then	O
administer	O
those	O
engineered	O
T	O
cells	O
back	O
to	O
the	O
same	O
people	O
.	O

But	O
there	O
might	O
be	O
other	O
ways	O
.	O

CDC	S-Organization
working	O
in	O
partnership	O
with	O
myriad	O
groups	O
,	O
including	O
ministries	O
of	O
health	O
,	O
civil	O
societies	O
,	O
academic	O
institutions	O
and	O
other	O
partners	O
,	O
is	O
on	O
the	O
ground	O
in	O
more	O
than	O
60	O
countries	O
,	O
said	O
Schuchat	S-Person
,	O
who	O
highlighted	O
a	O
recent	O
success	O
related	O
to	O
U.S.	S-Location
investments	O
in	O
.	O
The	O
report	O
summarizes	O
others	O
.	O

The	O
goal	O
of	O
the	O
Observatory	S-Scientific_research_project
-	O
to	O
be	O
an	O
independent	O
entity	O
that	O
gathers	O
information	O
as	O
the	O
public	O
health	O
emergency	O
occurs	O
-	O
is	O
rooted	O
in	O
the	O
reality	O
that	O
knowledge	O
is	O
sometimes	O
forgotten	O
when	O
experts	O
are	O
finally	O
able	O
to	O
complete	O
reports	O
after	O
the	O
outbreak	O
has	O
subsided	O
,	O
Nuzzo	S-Person
said	O
during	O
a	O
Wednesday	O
afternoon	O
webinar	O
also	O
hosted	O
by	O
the	O
.	O

When	O
BSL‐3	S-Platform
	S-Platform
are	O
appropriate	O
to	O
the	O
organism	O
under	O
investigation	O
,	O
the	O
following	O
note	O
is	O
included	O
in	O
the	O
unit	O
introduction	O
.	O

Hydrogen	O
has	O
the	O
most	O
frequently	O
imaged	O
nucleus	O
in	O
MRI	S-Technology
because	O
it	O
is	O
present	O
in	O
biological	O
tissues	O
in	O
great	O
abundance	O
,	O
and	O
because	O
its	O
high	O
gyromagnetic	O
ratio	O
gives	O
a	O
strong	O
signal	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
reporting	O
today	O
that	O
a	O
small	O
amount	O
of	O
material	O
from	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
experiment	O
that	O
was	O
securely	O
transported	O
from	O
a	O
Select‐Agent‐approved	O
BSL‐4	S-Platform
lab	O
to	O
a	O
Select‐Agent‐approved	O
BSL‐2	S-Platform
lab	O
may	O
have	O
contained	O
live	O
virus	O
.	O

The	O
program	O
offers	O
an	O
integrated	O
,	O
layered	O
defense	O
through	O
engineering	O
and	O
integrating	O
material	O
solutions	O
for	O
warfighters	O
.	O

Zayner	S-Person
the	O
biohacker	O
who	O
once	O
injected	O
himself	O
with	O
CRISPR	S-Technology
DNA	O
,	O
has	O
also	O
had	O
health	O
problems	O
for	O
years	O
,	O
and	O
some	O
of	O
his	O
biohacking	O
pursuits	O
have	O
been	O
explicit	O
attempts	O
to	O
cure	O
himself	O
.	O

In	O
this	O
group	O
,	O
one	O
in	O
every	O
1,800	O
CT	B-Technology
scans	E-Technology
was	O
followed	O
by	O
an	O
excess	O
cancer	O
.	O

COVID‑19	S-Disease
is	O
a	O
new	O
disease	O
,	O
and	O
many	O
of	O
the	O
details	O
of	O
its	O
spread	O
are	O
still	O
under	O
investigation	O
.	O

However	O
,	O
it	O
has	O
developed	O
and	O
implemented	O
an	O
efficient	O
national	O
biosafety	O
system	O
.	O

Experience	O
indicates	O
Ebola	S-Disease
was	O
not	O
a	O
singular	O
isolated	O
incident	O
,	O
but	O
rather	O
one	O
of	O
a	O
consistent	O
pattern	O
of	O
emerging	O
disease	O
outbreaks	O
that	O
cost	O
dearly	O
in	O
lives	O
and	O
economic	O
loss	O
,	O
such	O
as	O
SARS	S-Disease
,	O
influenza	O
pandemics	O
and	O
.	O

We	O
believe	O
that	O
the	O
ability	O
to	O
"	O
write	O
the	O
genetic	O
code	O
"	O
as	O
we	O
describe	O
synthetic	B-Technology
genomics	I-Technology
research	E-Technology
will	O
enable	O
a	O
better	O
understanding	O
of	O
the	O
fundamentals	O
of	O
living	O
cells	O
.	O

We	O
are	O
essentially	O
the	O
reference	O
laboratory	O
for	O
the	O
world	O
.	O

There	O
are	O
two	O
plasmid	O
systems	O
in	O
CRISPR	S-Technology
libraries	O
.	O

Bio-agents	O
tested	O
there	O
included	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
Coxiella	B-Pathogen
burnetii	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Brucella	B-Pathogen
suis	E-Pathogen
,	O
Rickettsia	B-Pathogen
prowazekii	E-Pathogen
,	O
Variola	B-Pathogen
major	E-Pathogen
(	O
smallpox	S-Pathogen
)	O
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
and	O
Venezuelan	B-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
virus	E-Pathogen
.	O
Bozheyeva	S-Person
,	O
G.	S-Person
,	O
Y.	B-Person
Kunakbayev	E-Person
and	O
D.	B-Person
Yeleukenov	E-Person
(1999)	O
,	O
Former	B-Platform
Soviet	I-Platform
Biological	I-Platform
Weapons	I-Platform
Facilities	E-Platform
in	O
Kazakhstan	S-Location
:	O
Past	O
,	O
Present	O
and	O
Future	O
;	O
Monterey	S-Location
,	O
Calif	S-Location
:	O
Monterey	B-Organization
Institute	I-Organization
of	I-Organization
International	I-Organization
Studies	E-Organization
,	O
Center	B-Organization
for	I-Organization
Nonproliferation	I-Organization
Studies	E-Organization
;	O
Occasional	O
Paper	O
1.	O
(By	O
1960	O
,	O
the	O
Soviet	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
also	O
included	O
numerous	O
other	O
research	O
and	O
operational	O
facilities	O
throughout	O
the	O
country.	O
)	O
Aralsk-7	S-Platform
had	O
a	O
history	O
of	O
association	O
with	O
mass	O
deaths	O
of	O
fish	O
,	O
various	O
regional	O
plague	O
outbreaks	O
,	O
a	O
saiga	O
antelope	O
die-off	O
,	O
and	O
individual	O
cases	O
of	O
infectious	O
disease	O
among	O
visitors	O
to	O
Vozrozhdeniya	B-Location
Island	E-Location
.	O
,	O
Op.cit	O
.	O

Led	O
by	O
HHS	S-Organization
Chief	O
Data	O
Officer	O
Dr	O
.	O

Although	O
rare	O
,	O
smallpox	B-Disease
vaccination	I-Disease
complications	E-Disease
can	O
include	O
progressive	O
vaccinia	S-Disease
,	O
postvaccinal	B-Disease
central	I-Disease
nervous	I-Disease
system	I-Disease
disease	E-Disease
,	O
and	O
.	O

The	O
Department	O
of	O
Veterans	O
Affairs	O
denies	O
almost	O
all	O
claims	O
for	O
care	O
and	O
compensation	O
made	O
by	O
veterans	O
who	O
believe	O
they	O
got	O
sick	O
as	O
a	O
result	O
of	O
the	O
tests	O
.	O

If	O
left	O
untreated	O
,	O
the	O
infection	O
can	O
travel	O
to	O
the	O
heart	O
or	O
brain	O
and	O
,	O
in	O
rare	O
cases	O
,	O
be	O
fatal	O
.	O

Frederick	B-Person
Sparling	E-Person
MD	O
,	O
is	O
Professor	O
of	O
Medicine	O
in	O
the	O
School	O
of	O
Medicine	O
at	O
the	O
University	O
of	O
North	O
Carolina	O
,	O
Chapel	O
Hill	O
.	O

As	O
a	O
result	O
of	O
lapses	B-Incident
in	I-Incident
biosafety	I-Incident
practices	I-Incident
that	I-Incident
were	I-Incident
discovered/came	I-Incident
to	I-Incident
light	I-Incident
in	I-Incident
the	I-Incident
summer	I-Incident
of	I-Incident
2014	E-Incident
,	O
Assistant	O
to	O
the	O
President	O
for	O
Homeland	O
Security	O
and	O
Counterterrorism	O
Lisa	B-Person
Monaco	E-Person
and	O
Assistant	O
to	O
the	O
President	O
for	O
Science	O
and	O
Technology	O
John	B-Person
Holdren	E-Person
issued	O
on	O
August	O
18	O
,	O
2014	O
a	O
memorandum	O
,	O
entitled	O
,	O
"	O
Enhancing	B-Document
Biosafety	I-Document
and	I-Document
Biosecurity	I-Document
in	I-Document
the	I-Document
United	I-Document
States	E-Document
,	O
"	O
which	O
urged	O
all	O
Government	O
departments	O
and	O
agencies	O
that	O
work	O
with	O
infectious	O
agents	O
to	O
take	O
immediate	O
and	O
long-term	O
steps	O
to	O
enhance	O
safety	O
and	O
security	O
of	O
research	O
to	O
minimize	O
the	O
potential	O
for	O
future	O
incidents	O
.	O

The	O
isolates	O
from	O
Finland	S-Location
were	O
also	O
ST167	O
;	O
the	O
isolates	O
from	O
South	B-Location
Korea	E-Location
and	O
Algeria	S-Location
were	O
obtained	O
from	O
canine	O
feces	O
and	O
identified	O
as	O
ST410	O
and	O
ST1284	O
.	O

First	O
there	O
is	O
OHA	S-Organization
's	O
BioWatch	B-Scientific_research_project
program	E-Scientific_research_project
in	O
which	O
collection	O
devices	O
are	O
disseminated	O
to	O
thirty	O
high	O
risk	O
areas	O
throughout	O
the	O
country	O
to	O
detect	O
the	O
presence	O
of	O
aerosolized	O
biological	O
agents	O
before	O
symptoms	O
present	O
in	O
patients	O
.	O

Despite	O
its	O
name	O
,	O
historical	O
and	O
epidemiological	O
data	O
cannot	O
identify	O
the	O
geographic	O
origin	O
of	O
the	O
Spanish	B-Incident
flu	E-Incident

He	O
left	O
a	O
written	O
notice	O
,	O
but	O
his	O
supervisor	O
did	O
not	O
write	O
this	O
down	O
in	O
the	O
logbook	O
as	O
he	O
was	O
supposed	O
to	O
do	O
.	O

With	O
only	O
50	O
physicians	O
in	O
the	O
entire	O
country-one	O
for	O
every	O
70,000 citizens-	O
Liberia	S-Location
was	O
already	O
in	O
a	O
healthcare	O
crisis	O
.	O

In	O
February	O
2018	O
,	O
three	O
isolates	O
of	O
NDM-5–positive	B-Pathogen
E.	I-Pathogen
coli	I-Pathogen
(ST43)	E-Pathogen
were	O
isolated	O
from	O
2	O
patients	O
in	O
a	O
skilled	O
nursing	O
facility	O
in	O
New	B-Location
York	E-Location
,	O
New	B-Location
York	E-Location
(7)	O
.	O

Early	O
research	O
in	O
animal	O
models	O
suggest	O
that	O
therapies	O
based	O
on	O
CRISPR	S-Technology
technology	O
have	O
potential	O
to	O
treat	O
a	O
wide	O
range	O
of	O
diseases	O
,	O
including	O
cancer	S-Disease
,	O
beta-thalassemia	S-Disease
,	O
sickle	B-Disease
cell	I-Disease
disease	E-Disease
,	O
hemophilia	S-Disease
,	O
cystic	B-Disease
fibrosis	E-Disease
,	O
Duchenne's	B-Disease
muscular	I-Disease
dystrophy	E-Disease
,	O
Huntington's	B-Disease
disease	E-Disease
,	O
and	O
heart	B-Disease
disease	E-Disease
.	O
may	O
also	O
have	O
applications	O
in	O
tissue	O
engineering	O
and	O
regenerative	O
medicine	O
,	O
such	O
as	O
by	O
creating	O
human	O
blood	O
vessels	O
that	O
lack	O
expression	O
of	O
MHC	O
class	O
II	O
proteins	O
,	O
which	O
often	O
cause	O
transplant	O
rejection	O
.	O

Homer,	B-Person
Odyssey	E-Person
,	O
XII	O
,	O
92	O
.	O

X-ray	B-Technology
CT	E-Technology
is	O
used	O
in	O
geological	O
studies	O
to	O
quickly	O
reveal	O
materials	O
inside	O
a	O
drill	O
core	O
.	O

They	O
had	O
no	O
charges	O
filed	O
against	O
them	O
.	O

In	O
general	O
,	O
the	O
Biological	O
Agent	O
Laboratory	O
Biosafety	O
Category	O
Lists	O
focus	O
mainly	O
on	O
the	O
disease	O
severity	O
,	O
the	O
ability	O
of	O
the	O
agent	O
to	O
spread	O
through	O
the	O
population	O
and	O
whether	O
effective	O
prevention	O
and	O
treatment	O
measures	O
are	O
available	O
.	O

This	O
list	O
is	O
subject	O
to	O
annual	O
reviewing	O
by	O
a	O
special	O
committee	O
of	O
the	O
.	O

Early	O
on	O
23	O
April	O
2014	O
,	O
11	O
new	O
cases	O
including	O
a	O
first	O
case	O
for	O
Mecca	S-Location
were	O
reported	O
by	O
the	O
.	O
An	O
additional	O
13	O
cases	O
were	O
reported	O
on	O
the	O
same	O
day	O
.	O

Being	O
non-invasive	O
and	O
non-damaging	O
,	O
MRI	S-Technology
can	O
be	O
used	O
to	O
study	O
the	O
anatomy	O
of	O
plants	O
,	O
their	O
water	O
transportation	O
processes	O
and	O
water	O
balance	O
.	O

But	O
BZ	O
caused	O
very	O
different	O
effects	O
in	O
different	O
individuals	O
and	O
was	O
considered	O
to	O
be	O
unreliable	O
,	O
leading	O
to	O
its	O
banishment	O
from	O
the	O
chemical	O
arsenal	O
in	O
the	O
late	O
1960s	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
strain	O
is	O
the	O
most	O
lethal	O
of	O
the	O
six	O
known	O
strains	O
(including	O
the	O
newly	O
discovered	O
Bombali	S-Location
strain)	O
;	O
it	O
is	O
fatal	O
in	O
up	O
to	O
90%	O
of	O
cases	O
.	O

Schneewind	S-Person
did	O
not	O
respond	O
to	O
an	O
e-mail	O
this	O
morning	O
seeking	O
comment	O
.	O

When	O
EthR	O
is	O
turned	O
on	O
,	O
antibiotics	S-Drug
can't	O
kill	O
the	O
tuberculosis	B-Pathogen
mycobacteria	E-Pathogen
.	O
Synthetic	O
biologist	O
Martin	B-Person
Fussenegger	E-Person
of	O
the	O
Swiss	B-Organization
Federal	I-Organization
Institute	I-Organization
of	I-Organization
Technology	E-Organization
in	O
set	O
up	O
a	O
system	O
that	O
makes	O
cells	O
light	O
up	O
under	O
the	O
microscope	O
when	O
EthR	O
is	O
turned	O
off	O
.	O

OPERATOR:	O
On	O
the	O
phone	O
lines	O
if	O
you'd	O
like	O
to	O
ask	O
a	O
question	O
,	O
just	O
press	O
star-1	O
at	O
this	O
time	O
.	O

That	O
should	O
have	O
happened	O
,	O
and	O
it	O
didn't	O
.	O

The	O
WHO	S-Organization
also	O
helped	O
contain	O
the	O
last	O
European	O
outbreak	O
in	O
Yugoslavia	S-Location
in	O
1972	O
.	O

Zombie-themed	O
educational	O
materials	O
for	O
teachers	O
are	O
available	O
on	O
the	O
site	O
.	O

At	O
BSL‐3	S-Platform
more	O
emphasis	O
is	O
placed	O
on	O
primary	O
and	O
secondary	O
barriers	O
to	O
protect	O
personnel	O
in	O
contiguous	O
areas	O
,	O
the	O
community	O
,	O
and	O
the	O
environment	O
from	O
exposure	O
to	O
potentially	O
infectious	O
aerosols	O
(see	O
Table	O
1)	O
.	O

The	O
cruise	O
line	O
industry	O
was	O
hard	O
hit	O
,	O
and	O
several	O
train	O
stations	O
and	O
ferry	O
ports	O
have	O
also	O
been	O
closed	O
.	O

In	O
addition	O
to	O
the	O
CDC	S-Organization
has	O
some	O
of	O
the	O
most	O
accessible	O
information	O
on	O
ecological	O
impacts	O
of	O
biohazards	O
,	O
how	O
to	O
handle	O
spills	O
,	O
reporting	O
guidelines	O
and	O
proper	O
disposal	O
of	O
agents	O
dangerous	O
to	O
the	O
environment	O
.	O

"	O
The	O
way	O
that	O
people	O
think	O
about	O
[nuclear	O
weapons]	O
is	O
on	O
a	O
much	O
,	O
much	O
grander	O
scale	O
than	O
biological	O
weapons	O
,	O
and	O
I	O
think	O
that's	O
a	O
misperception,	O
"	O
said	O
Dr	O
.	O

As	O
the	O
battle	O
against	O
the	O
Mediterranean	B-Incident
fruit	I-Incident
fly	E-Incident
enters	O
a	O
new	O
year	O
and	O
aerial	O
pesticide	O
spraying	O
covers	O
still	O
more	O
neighborhoods	O
in	O
,	O
state	O
and	O
federal	O
officials	O
remain	O
baffled	O
by	O
several	O
aspects	O
of	O
a	O
stubborn	O
infestation	O
.	O

Kirby	S-Person
,	O
.	O
"	O
The	O
CB	O
Battlefield	O
Legacy:	O
Understanding	O
the	O
Potential	O
Problem	O
of	O
Clustered	O
CB	O
Weapons	O
"	O
,	O
Army	O
Chemical	O
Review	O
,	O
pp.	O
25–29	O
,	O
July–December	O
2006	O
.	O

The	O
ensuing	O
Black	B-Disease
Death	E-Disease
may	O
have	O
killed	O
up	O
to	O
25	O
million	O
total	O
,	O
including	O
China	S-Location
and	O
roughly	O
a	O
third	O
of	O
the	O
population	O
of	O
and	O
in	O
the	O
next	O
decades	O
,	O
changing	O
the	O
course	O
of	O
Asian	O
and	O
European	O
history	O
.	O

Of	O
course	O
,	O
work	O
like	O
this	O
is	O
not	O
free	O
,	O
so	O
it	O
was	O
also	O
important	O
to	O
pool	O
resources	O
with	O
the	O
international	O
community	O
.	O

HSV	O
17+/pR20.5/5	O
contains	O
the	O
β‐galactosidase	O
(β‐Gal)	O
gene	O
,	O
which	O
is	O
under	O
the	O
control	O
of	O
the	O
Rous	B-Pathogen
sarcoma	I-Pathogen
virus	E-Pathogen
(	O
RSV	S-Pathogen
)	O
promoter	O
,	O
and	O
the	O
green	O
fluorescent	O
protein	O
(GFP)	O
gene	O
,	O
which	O
is	O
under	O
the	O
control	O
of	O
the	O
cytomegalovirus	S-Pathogen
(	O
hCMV	S-Pathogen
)	O
promoter	O
.	O

Web	O
.	O

Iran	S-Location
reported	O
its	O
first	O
confirmed	O
cases	O
of	O
SARS‑CoV‑2	S-Pathogen
infections	O
on	O
19	O
February	O
in	O
Qom	S-Location
,	O
where	O
,	O
according	O
to	O
the	O
Ministry	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Medical	I-Organization
Education	E-Organization
,	O
two	O
people	O
died	O
on	O
that	O
day	O
.	O

These	O
are	O
binary	O
biological	O
weapons	O
(a	O
lethal	O
combination	O
of	O
two	O
viruses)	O
,	O
host	O
swapping	O
diseases	O
(animal	O
viruses	O
that	O
"	O
jump"	O
to	O
humans	O
,	O
like	O
the	O
)	O
,	O
stealth	O
viruses	O
,	O
and	O
designer	O
diseases	O
.	O

New	B-Location
England	E-Location
--	O
particularly	O
Massachusetts	S-Location
--	O
and	O
the	O
New	B-Location
York	E-Location
and	O
New	B-Location
Jersey	E-Location
areas	O
have	O
been	O
hit	O
the	O
hardest	O
,	O
Schuchat	S-Person
said	O
Thursday	O
at	O
a	O
news	O
conference	O
.	O

The	O
strain	B-Pathogen
of	I-Pathogen
anthrax	E-Pathogen
produced	O
in	O
the	O
on	O
the	O
southern	O
edge	O
of	O
Sverdlovsk	S-Location
was	O
the	O
most	O
powerful	O
in	O
the	O
Soviet	S-Organization
arsenal	O
(	O
"	O
Anthrax	B-Pathogen
836	E-Pathogen
"	O
).	O
It	O
had	O
been	O
isolated	O
as	O
a	O
result	O
of	O
another	O
anthrax	S-Pathogen
leak	O
accident	O
that	O
happened	O
in	O
1953	O
in	O
the	O
city	O
of	O
Kirov	S-Location
.	O
A	O
leak	O
from	O
a	O
bacteriological	O
facility	O
contaminated	O
the	O
city	O
sewer	O
system	O
.	O

Zaki	S-Person
and	O
co-authors	O
from	O
the	O
Erasmus	B-Organization
Medical	I-Organization
Center	E-Organization
published	O
more	O
details	O
,	O
including	O
a	O
scientific	O
name	O
,	O
Human	B-Organization
Coronavirus-Erasmus	I-Organization
Medical	I-Organization
Center	E-Organization
(	O
HCoV-EMC	S-Organization
)	O
,	O
which	O
was	O
then	O
used	O
in	O
scientific	O
literature	O
.	O

The	O
hospital	O
treated	O
thousands	O
of	O
victims	O
of	O
poison	O
gas	O
attacks	O
,	O
and	O
other	O
casualties	O
of	O
war	O
,	O
and	O
100,000 soldiers	O
passed	O
through	O
the	O
camp	O
every	O
day	O
.	O

In	O
December	O
,	O
CDC	S-Organization
reported	O
that	O
a	O
small	O
amount	O
of	O
material	O
from	O
an	O
experiment	O
that	O
was	O
part	O
of	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
study	O
was	O
securely	O
transported	O
from	O
a	O
select‐agent‐approved	O
BSL‐4	S-Platform
lab	O
to	O
a	O
select‐agent‐approved	O
BSL‐2	S-Platform
lab	O
and	O
may	O
have	O
contained	O
live	O
virus	O
.	O

The	O
says	O
it	O
is	O
also	O
investigating	O
the	O
outbreak	O
.	O

It's	O
nearly	O
impossible	O
to	O
imagine	O
modern	O
biotechnology	O
without	O
DNA	B-Technology
sequencing	E-Technology
Since	O
virtually	O
all	O
of	O
biology	O
centers	O
around	O
the	O
instructions	O
contained	O
in	O
DNA	O
,	O
biotechnologists	O
who	O
hope	O
to	O
modify	O
the	O
properties	O
of	O
cells	O
,	O
plants	O
,	O
and	O
animals	O
must	O
speak	O
the	O
same	O
molecular	O
language	O
.	O

Croddy	S-Person
,	O
Eric	B-Person
C.	E-Person
and	O
Hart,	B-Person
C.	E-Person
Perez-Armendariz	B-Person
J.	E-Person
,	O
Chemical	O
and	O
Biological	O
Warfare	O
,	O
(Google	O
Books)	O
,	O
Springer	O
,	O
2002	O
,	O
pp.	O
30–31	O
,	O
()	O
.	O

HHSO100201700023C	O
.	O

Chinese	O
racism	O
and	O
xenophobia	O
was	O
criticised	O
by	O
foreign	O
governments	O
and	O
diplomatic	O
corps	O
,	O
and	O
China	S-Location
apologised	O
for	O
discriminatory	O
practices	O
such	O
as	O
restaurants	O
excluding	O
black	O
customers	O
,	O
although	O
these	O
and	O
other	O
accusations	O
of	O
harassment	O
,	O
discrimination	O
and	O
eviction	O
of	O
black	O
people	O
in	O
continued	O
.	O

Antiviral	O
drugs	O
typically	O
target	O
key	O
components	O
of	O
viral	O
reproduction	O
;	O
for	O
example	O
,	O
oseltamivir	S-Drug
targets	O
influenza	O
neuraminidase	O
,	O
while	O
guanosine	O
analogs	O
inhibit	O
viral	O
DNA	O
polymerase	O
.	O

Optimal	O
mitigation	O
policies	O
might	O
reduce	O
peak	O
healthcare	O
demand	O
by	O
two-thirds	O
and	O
deaths	O
by	O
half	O
,	O
but	O
still	O
result	O
in	O
hundreds	O
of	O
thousands	O
of	O
deaths	O
and	O
overwhelmed	O
health	O
systems	O
.	O

Increases	O
in	O
levels	O
of	O
liver	O
enzymes	O
,	O
seen	O
in	O
abnormal	O
liver	O
blood	O
tests	O
.	O

This	O
was	O
largely	O
due	O
to	O
the	O
early	O
quarantine	O
efforts	O
of	O
Dr	O
.	O

However	O
,	O
it	O
should	O
be	O
noted	O
that	O
this	O
method	O
is	O
complex	O
,	O
and	O
probably	O
only	O
a	O
few	O
highly	O
trained	O
experts	O
would	O
be	O
able	O
to	O
master	O
this	O
technique	O
,	O
at	O
least	O
for	O
the	O
time	O
being	O
.	O

If	O
these	O
creations	O
somehow	O
get	O
to	O
the	O
hands	O
of	O
terrorists	O
,	O
it	O
could	O
prove	O
to	O
be	O
extremely	O
dangerous	O
worldwide	O
.	O

On	O
30	O
January	O
2020	O
,	O
the	O
WHO	S-Organization
declared	O
the	O
was	O
a	O
Public	O
Health	O
Emergency	O
of	O
International	O
Concern	O
(PHEIC)	O
.	O

These	O
fungi	O
provide	O
a	O
quintessential	O
example	O
of	O
the	O
hostile	O
use	O
of	O
biological	O
agents	O
.	O

The	O
polio	B-Pathogen
virus	E-Pathogen
itself	O
is	O
not	O
an	O
effective	O
biological	O
weapon	O
,	O
but	O
the	O
experiment	O
shows	O
the	O
tremendous	O
potential	O
of	O
genetic	B-Technology
engineering	E-Technology
and	O
also	O
highlights	O
its	O
problems	O
,	O
particularly	O
when	O
applied	O
to	O
smallpox	S-Pathogen
.	O
The	O
current	O
risk	O
assessments	O
with	O
regard	O
to	O
this	O
virus	O
rate	O
the	O
likelihood	O
of	O
an	O
attack	O
as	O
being	O
rather	O
low	O
,	O
because	O
it	O
is	O
highly	O
unlikely-although	O
not	O
completely	O
impossible-that	O
countries	O
other	O
than	O
Russia	S-Location
and	O
the	O
USA	S-Location
have	O
access	O
to	O
it	O
.	O

Treatment	O
centres	O
were	O
overflowing	O
with	O
patients	O
while	O
others	O
waited	O
to	O
be	O
admitted	O
;	O
dead	O
patients	O
were	O
so	O
numerous	O
that	O
it	O
was	O
difficult	O
to	O
arrange	O
for	O
safe	O
burials	O
.	O

He	O
takes	O
supplements	O
,	O
applies	O
electricity	O
to	O
his	O
brain	O
and	O
his	O
muscles	O
,	O
to	O
improve	O
his	O
body	O
and	O
his	O
mind	O
.	O

Production	O
of	O
cluster	O
bomb	O
submunitions	O
began	O
to	O
shift	O
from	O
cylindrical	O
to	O
spherical	O
bomblets	O
,	O
which	O
had	O
a	O
larger	O
coverage	O
area	O
.	O

BBC	S-Organization
quoted	O
Rory	B-Person
O'Connor	E-Person
in	O
saying	O
,	O
"	O
Increased	O
social	O
isolation	O
,	O
loneliness	O
,	O
health	O
anxiety	O
,	O
stress	O
,	O
and	O
an	O
economic	O
downturn	O
are	O
a	O
perfect	O
storm	O
to	O
harm	O
people's	O
mental	O
health	O
and	O
wellbeing.	O
"	O
Coronavirus	S-Pathogen
:	O
'Profound'	O
mental	O
health	O
impact	O
prompts	O
calls	O
for	O
urgent	O
research	O
,	O
BBC	O
,	O
Philippa	B-Person
Roxby	E-Person
,	O
April	O
16	O
,	O
2020.Multidisciplinary	O
research	O
priorities	O
for	O
the	O
COVID‑19	B-Incident
pandemic	E-Incident
:	O
a	O
call	O
for	O
action	O
for	O
mental	O
health	O
science	O
,	O
The	O
Lancet	O
,	O
Emily	O
Holmes	O
,	O
Rory	O
O'Connor	O
,	O
,	O
et	O
al.	O
,	O
April	O
15	O
,	O
2020	O
,	O
page	O
1:	O
"	O
A	O
fragmented	O
research	O
response	O
,	O
characterised	O
by	O
small-scale	O
and	O
localised	O
initiatives	O
,	O
will	O
not	O
yield	O
the	O
clear	O
insights	O
necessary	O
to	O
guide	O
policymakers	O
or	O
the	O
public.	O
"	O

Herman,	B-Person
G.T.	E-Person
,	O
Fundamentals	O
of	O
computerized	B-Technology
tomography	E-Technology
:	O
Image	O
reconstruction	O
from	O
projection	O
,	O
2nd	O
edition	O
,	O
Springer	O
,	O
2009	O
Medical	O
imaging	O
is	O
the	O
most	O
common	O
application	O
of	O
X-ray	B-Technology
CT	E-Technology
.	O
Its	O
cross-sectional	O
images	O
are	O
used	O
for	O
diagnostic	O
and	O
therapeutic	O
purposes	O
in	O
various	O
medical	O
disciplines	O
.	O

Here	O
are	O
a	O
few	O
examples	O
of	O
how	O
things	O
can	O
go	O
wrong	O
.	O

But	O
Frieden	S-Person
said	O
overall	O
the	O
facility	O
has	O
performed	O
well	O
and	O
the	O
incidents	O
were	O
not	O
the	O
reason	O
for	O
the	O
replacement	O
plans	O
.	O

The	O
pandemic	O
virus	O
is	O
a	O
type	O
of	O
swine	B-Disease
influenza	E-Disease
derived	O
originally	O
from	O
a	O
strain	O
which	O
lived	O
in	O
pigs	O
,	O
and	O
this	O
origin	O
gave	O
rise	O
to	O
the	O
common	O
name	O
of	O
"	O
swine	B-Disease
flu	E-Disease
"	O
.	O
This	O
term	O
is	O
widely	O
used	O
by	O
mass	O
media	O
,	O
though	O
the	O
Paris	S-Location
-based	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
as	O
well	O
as	O
industry	O
groups	O
such	O
as	O
the	O
U.S.	B-Organization
National	I-Organization
Pork	I-Organization
Board	E-Organization
,	O
the	O
American	B-Organization
Meat	I-Organization
Institute	E-Organization
,	O
and	O
the	O
Canadian	B-Organization
Pork	I-Organization
Council	E-Organization
objected	O
to	O
widespread	O
media	O
use	O
of	O
the	O
name	O
"	O
swine	B-Disease
flu	E-Disease
"	O
and	O
suggested	O
it	O
should	O
be	O
called	O
"	O
North	B-Disease
American	I-Disease
flu	E-Disease
"	O
instead	O
,	O
while	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
switched	O
its	O
designation	O
from	O
"	O
swine	B-Disease
influenza	E-Disease
"	O
to	O
"	O
influenza	B-Disease
A	I-Disease
(H1N1)	E-Disease
"	O
in	O
late	O
April	O
2009	O
.	O

The	O
food	O
you	O
eat	O
and	O
the	O
pets	O
you	O
love?	O
You	O
can	O
thank	O
our	O
distant	O
ancestors	O
for	O
kickstarting	O
the	O
agricultural	O
revolution	O
,	O
using	O
artificial	O
selection	O
for	O
crops	O
,	O
livestock	O
,	O
and	O
other	O
domesticated	O
animals	O
.	O

So	O
far	O
,	O
the	O
focus	O
has	O
been	O
on	O
real-time	B-Equipment
PCR	E-Equipment
analyses	O
and	O
cultivation	O
methods	O
of	O
the	O
high-consequence	O
pathogens	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Brucella	B-Pathogen
spp.	E-Pathogen
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
,	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
and	O
.	O

While	O
biocontainment	O
,	O
as	O
defined	O
in	O
the	O
Biosafety	O
in	O
Microbiological	O
and	O
Biomedical	O
Laboratories	O
and	O
Primary	B-Document
Containment	I-Document
for	I-Document
Biohazards:	I-Document
Selection,	I-Document
Installation	I-Document
and	I-Document
Use	I-Document
of	I-Document
Biosafety	I-Document
Cabinets	E-Document
manuals	O
available	O
at	O
the	O
website	O
much	O
of	O
the	O
design	O
,	O
implementation	O
and	O
monitoring	O
of	O
protocols	O
are	O
left	O
up	O
to	O
state	O
and	O
local	O
authorities	O
.	O

To	O
see	O
a	O
wrong	O
and	O
not	O
expose	O
it	O
,	O
is	O
to	O
become	O
a	O
silent	O
partner	O
to	O
its	O
continuance.	O
"	O
and	O
"	O
I	O
am	O
KC	O
and	O
I	O
approve	O
this	O
message.	O
"	O

Cardiovascular	B-Disease
complications	E-Disease
may	O
include	O
heart	B-Phenotype
failure	E-Phenotype
,	O
arrhythmias	S-Phenotype
,	O
heart	B-Phenotype
inflammation	E-Phenotype
,	O
and	O
.	O

NIH	B-Document
Guidelines	I-Document
for	I-Document
Research	I-Document
Involving	I-Document
Recombinant	I-Document
DNA	I-Document
Molecules	E-Document

DONALD	B-Person
MCNEIL	E-Person
Thank	O
you	O
.	O

Hand	O
washing	O
is	O
recommended	O
to	O
prevent	O
the	O
spread	O
of	O
the	O
disease	O
.	O

Government	O
officials	O
say	O
the	O
spray	O
poses	O
no	O
threat	O
to	O
human	O
health	O
because	O
the	O
pesticide	O
is	O
applied	O
in	O
extremely	O
low	O
doses	O
.	O

But	O
if	O
you	O
work	O
with	O
that	O
organism	O
day	O
in	O
and	O
day	O
out	O
for	O
days	O
,	O
weeks	O
,	O
months	O
and	O
years	O
,	O
you	O
can	O
get	O
a	O
little	O
careless	O
.	O

Common	O
symptoms	O
include	O
fever	S-Phenotype
cough	S-Phenotype
,	O
fatigue	S-Phenotype
,	O
shortness	B-Phenotype
of	I-Phenotype
breath	E-Phenotype
,	O
and	O
loss	B-Phenotype
of	I-Phenotype
sense	I-Phenotype
of	I-Phenotype
smell	E-Phenotype
.	O
Complications	O
may	O
include	O
pneumonia	S-Disease
and	O
.	O
The	O
time	O
from	O
exposure	O
to	O
onset	O
of	O
symptoms	O
is	O
typically	O
around	O
five	O
days	O
but	O
may	O
range	O
from	O
two	O
to	O
fourteen	O
days	O
.	O

At	O
HHS	S-Organization
there	O
already	O
is	O
such	O
a	O
fund	O
,	O
according	O
to	O
Kadlec	S-Person
,	O
who	O
said	O
it	O
currently	O
has	O
$57,000	O
in	O
it	O
.	O

The	O
armies	O
,	O
composed	O
of	O
the	O
most	O
rapidly	O
moving	O
travelers	O
who	O
had	O
ever	O
moved	O
between	O
the	O
steppes	O
of	O
East	B-Location
Asia	E-Location
(where	O
bubonic	B-Pathogen
plague	E-Pathogen
was	O
and	O
remains	O
endemic	O
among	O
small	O
rodents)	O
,	O
managed	O
to	O
keep	O
the	O
chain	O
of	O
infection	O
without	O
a	O
break	O
until	O
they	O
reached	O
,	O
and	O
infected	O
,	O
peoples	O
and	O
rodents	O
who	O
had	O
never	O
encountered	O
it	O
.	O

In	O
November	O
11	O
of	O
1918	O
the	O
end	O
of	O
the	O
war	O
enabled	O
a	O
resurgence	O
.	O

As	O
a	O
result	O
of	O
these	O
two	O
incidents	O
,	O
CDC	S-Organization
is	O
issuing	O
,	O
effective	O
immediately	O
,	O
a	O
moratorium	O
on	O
the	O
movement	O
(i.e.	O
,	O
transfer	O
inside	O
or	O
outside	O
the	O
agency)	O
of	O
biological	O
materials	O
(i.e.	O
,	O
infectious	B-Pathogen
agents	E-Pathogen
,	O
active	O
or	O
inactivated	O
specimens)	O
from	O
BSL3	S-Platform
or	O
facilities	O
.	O

Characterization	O
of	O
the	O
Reconstructed	O
1918	O
Spanish	O
Influenza	O
Pandemic	O
Virus	O
.	O

Their	O
work	O
has	O
brought	O
us	O
the	O
powerful	O
cellular	O
tools	O
at	O
biotechnologists'	O
disposal	O
today	O
.	O

Researchers	O
who	O
want	O
to	O
fight	O
aging	O
generally	O
adopt	O
two	O
different	O
approaches	O
.	O

The	O
outbreak	O
was	O
labeled	O
the	O
"	O
most	O
alarming	O
event	O
"	O
of	O
1971	O
by	O
the	O
United	B-Organization
Nations	I-Organization
Food	I-Organization
and	I-Organization
Agricultural	I-Organization
Organization	E-Organization
.	O
Six	O
years	O
after	O
the	O
event	O
,	O
the	O
newspaper	O
Newsday	O
,	O
citing	O
untraceable	O
sources	O
,	O
claimed	O
that	O
anti-Castro	O
saboteurs	O
,	O
with	O
at	O
least	O
the	O
tacit	O
backing	O
of	O
U.S.	B-Organization
Central	I-Organization
Intelligence	I-Organization
Agency	E-Organization
officials	O
,	O
introduced	O
African	B-Pathogen
swine	I-Pathogen
fever	I-Pathogen
virus	E-Pathogen
into	O
Cuba	S-Location
six	O
weeks	O
before	O
the	O
outbreak	O
in	O
1971	O
,	O
to	O
destabilize	O
the	O
Cuban	O
economy	O
and	O
encourage	O
domestic	O
opposition	O
to	O
Fidel	B-Person
Castro	E-Person
.	O
The	O
virus	O
was	O
allegedly	O
delivered	O
to	O
the	O
operatives	O
from	O
an	O
army	O
base	O
in	O
the	O
Panama	B-Location
Canal	I-Location
Zone	E-Location
by	O
an	O
unnamed	O
intelligence	O
source	O
.	O

Held	O
every	O
November	O
since	O
2015	O
with	O
the	O
theme	O
"	O
Antibiotics:	B-Activity
Handle	I-Activity
with	I-Activity
care	E-Activity
the	O
global	O
,	O
multi-year	O
campaign	O
has	O
increasing	O
volume	O
of	O
activities	O
during	O
the	O
week	O
of	O
the	O
campaign	O
.	O

It	O
is	O
simply	O
not	O
acceptable	O
that	O
so	O
many	O
people	O
die	O
of	O
this	O
disease	O
.	O

Today	O
,	O
the	O
protection	O
issue	O
is	O
back	O
on	O
the	O
public	O
agenda	O
as	O
fears	O
of	O
germ	O
terrorism	O
have	O
grown	O
.	O

It	O
takes	O
place	O
in	O
small	O
labs	O
-	O
mostly	O
non-university	O
-	O
where	O
all	O
sorts	O
of	O
people	O
get	O
together	O
to	O
explore	O
biology	O
.	O

But	O
it	O
is	O
not	O
the	O
possibility	O
of	O
misuse	O
that	O
concerns	O
me	O
here.	O
's	O
research	O
provides	O
a	O
clear	O
example	O
of	O
well-intentioned	O
scientists	O
enhancing	O
the	O
destructive	O
capabilities	O
of	O
pathogens	O
known	O
to	O
threaten	O
global	O
catastrophe	O
.	O

In	O
his	O
opinion	O
,	O
lawmakers	O
would	O
be	O
"	O
trading	O
some	O
debatable	O
improvements	O
in	O
procurement	O
efficiency	O
on	O
the	O
front	O
end	O
for	O
the	O
ability	O
to	O
more	O
effectively	O
reach	O
communities	O
and	O
individuals	O
with	O
the	O
materials	O
they	O
need	O
in	O
case	O
of	O
a	O
public	O
health	O
emergency,	O
"	O
said	O
Pallone	S-Person

However	O
,	O
several	O
cases	O
were	O
reported	O
until	O
May	O
2004	O
.	O

(	O
CNN	S-Organization
--	O
The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
raised	O
the	O
swine	O
flu	S-Disease
alert	O
Thursday	O
to	O
its	O
highest	O
level	O
,	O
saying	O
the	O
has	O
spread	O
to	O
enough	O
countries	O
to	O
be	O
considered	O
a	O
global	O
pandemic	O
.	O

To	O
evaluate	O
's	O
performance	O
with	O
data	O
from	O
noninvasive	O
devices	O
,	O
which	O
would	O
be	O
practical	O
for	O
clinicians	O
and	O
public	O
health	O
workers	O
to	O
use	O
,	O
the	O
researchers	O
conducted	O
a	O
computer	O
simulation	O
using	O
a	O
dataset	O
that	O
included	O
only	O
ECG-derived	O
features	O
,	O
such	O
as	O
the	O
time	O
intervals	O
between	O
certain	O
peaks	O
of	O
the	O
ECG	O
waveform	O
.	O

They	O
included:	O
smallpox	S-Pathogen
,	O
EEE	S-Pathogen
and	O
WEE	S-Pathogen
,	O
AHF	S-Pathogen
,	O
Hantavirus	S-Pathogen
,	O
BHF	S-Pathogen
,	O
Lassa	B-Pathogen
fever	E-Pathogen
,	O
Coronavirus	S-Pathogen
,The	O
United	B-Location
States	E-Location
is	O
known	O
to	O
have	O
researched	O
both	O
B.	B-Pathogen
mallei	E-Pathogen
(the	O
causal	O
agent	O
of	O
glanders	S-Disease
)	O
and	O
B.	B-Pathogen
pseudomallei	E-Pathogen
(the	O
causal	O
agent	O
of	O
)	O
from	O
1943–1944	O
.	O

New	O
proactive	O
interventions	O
will	O
center	O
on	O
methods	O
for	O
disarming	O
a	O
virus	O
before	O
it	O
can	O
make	O
a	O
jump	O
across	O
species	O
.	O

Sheela	S-Person
and	O
Puja	S-Person
were	O
arrested	O
in	O
West	B-Location
Germany	E-Location
on	O
October	O
28	O
,	O
1985	O
.	O

Spinning	B-Technology
tube	E-Technology
commonly	O
called	O
spiral	B-Technology
CT	E-Technology
,	O
or	O
helical	B-Equipment
CT	E-Equipment
is	O
an	O
imaging	O
technique	O
in	O
which	O
an	O
entire	O
X-ray	O
tube	O
is	O
spun	O
around	O
the	O
central	O
axis	O
of	O
the	O
area	O
being	O
scanned	O
.	O

A	O
2007	O
report	O
warns	O
that	O
the	O
danger	O
of	O
this	O
development	O
is	O
not	O
just	O
bio-terror	O
,	O
but	O
"	O
bio-error".	O

Only	O
10	O
countries	O
reported	O
having	O
regulations	O
that	O
could	O
limit	O
the	O
discharge	O
of	O
antimicrobial	O
residues	O
into	O
the	O
environment	O
.	O

Her	O
current	O
report	O
provides	O
an	O
overview	O
of	O
's	O
vigour	O
in	O
the	O
development	O
of	O
biological	O
weapons	O
.	O

In	O
the	O
following	O
paragraphs	O
,	O
we	O
document	O
three	O
real	O
examples	O
of	O
biological	O
and	O
chemical	O
weapons	O
development	O
that	O
are	O
now	O
being	O
pursued	O
by	O
democracies	O
in	O
the	O
Western	O
world	O
.	O

XperimentR	S-Platform
developed	O
at	O
the	O
Imperial	B-Organization
College	E-Organization
in	O
London	S-Location
-is	O
not	O
distributed	O
as	O
software	O
but	O
instead	O
provides	O
all	O
its	O
features	O
via	O
the	O
web	O
with	O
the	O
intention	O
to	O
free	O
the	O
user	O
from	O
installation	O
tasks	O
.	O

This	O
unit	O
,	O
in	O
conjunction	O
with	O
local	O
and	O
national	O
guidelines	O
and	O
regulations	O
(see	O
appendix	O
1b)	O
,	O
provides	O
the	O
basic	O
biosafety	O
information	O
needed	O
to	O
perform	O
the	O
procedures	O
detailed	O
in	O
this	O
manual	O
.	O

Also	O
,	O
in	O
1918	O
those	O
5	O
to	O
14	O
years	O
of	O
age	O
accounted	O
for	O
a	O
disproportionate	O
number	O
of	B-Disease
influe	E-Disease
nza	O
cases	O
,	O
but	O
had	O
a	O
much	O
lower	O
death	O
rate	O
fr	O
om	B-Disease
influe	E-Disease
nza	O
ania	O
than	O
other	O
age	O
groups	O
.	O

Los	B-Organization
Angeles	I-Organization
Police	I-Organization
Department	E-Organization
Detective	O
,	O
who	O
with	O
his	O
partner	O
is	O
conducting	O
the	O
investigation	O
,	O
said	O
it	O
is	O
in	O
its	O
"	O
embryo	O
stage	O
"	O
and	O
that	O
tests	O
will	O
be	O
conducted	O
on	O
the	O
letter's	O
stationery	O
and	O
envelope	O
.	O

Infection	O
appears	O
to	O
set	O
off	O
a	O
chain	O
of	O
vasoconstrictive	O
responses	O
within	O
the	O
body	O
,	O
constriction	O
of	O
blood	O
vessels	O
within	O
the	O
pulmonary	O
circulation	O
has	O
also	O
been	O
posited	O
as	O
a	O
mechanism	O
in	O
which	O
oxygenation	O
decreases	O
alongside	O
the	O
presentation	O
of	O
viral	B-Disease
pneumonia	E-Disease

Although	O
deadly	O
,	O
is	O
notoriously	O
unstable	O
when	O
removed	O
from	O
a	O
human	O
or	O
animal	O
host	O
,	O
making	O
weaponization	O
of	O
the	O
virus	O
unlikely	O
,	O
two	O
experts	O
told	O
Live	O
Science	O
.	O

Igor	B-Person
DomaradskijDomaradskij,	I-Person
Igor	I-Person
V.	E-Person
and	O
(2003)	O
,	O
Biowarrior:	O
Inside	O
the	O
Soviet/Russian	O
Biological	O
War	O
Machine	O
;	O
Prometheus	O
Books	O
.	O

The	O
seat	O
of	O
the	O
organization	O
is	O
in	O
Geneva	S-Location
Switzerland	S-Location
.	O
It	O
was	O
designed	O
by	O
Swiss	O
architect	O
and	O
inaugurated	O
in	O
1966	O
.	O

The	O
Evangelista	B-Organization
Medical	I-Organization
Hospital	E-Organization
in	O
San	B-Location
Pedro	E-Location
,	O
Laguna	S-Location
,	O
the	O
facility	O
where	O
the	O
patient	O
was	O
first	O
admitted	O
,	O
was	O
temporarily	O
closed	O
by	O
DOH	S-Organization
for	O
fourteen	O
days	O
.	O

Reduce	O
the	O
number	O
of	O
people	O
who	O
have	O
access	O
to	O
those	O
laboratories	O
to	O
the	O
absolute	O
minimum	O
necessary	O
.	O

This	O
is	O
indeed	O
true	O
in	O
that	O
biological	O
weapons	O
can	O
be	O
used	O
without	O
genetic	O
engineering-or	O
,	O
for	O
that	O
matter	O
,	O
without	O
any	O
scientific	O
knowledge-as	O
has	O
been	O
shown	O
by	O
their	O
effective	O
use	O
in	O
past	O
centuries	O
.	O

The	O
CDC	S-Organization
is	O
also	O
a	O
lead	O
implementer	O
of	O
key	O
U.S.	S-Location
global	O
health	O
initiatives	O
such	O
as	O
the	O
President's	B-Activity
Emergency	I-Activity
Plan	I-Activity
for	I-Activity
AIDS	I-Activity
Relief	E-Activity
(	O
PEPFAR	S-Activity
)	O
and	O
.	O

The	O
CDC	S-Organization
recommends	O
that	O
if	O
a	O
case	O
is	O
suspected	O
or	O
confirmed	O
at	O
a	O
facility	O
such	O
as	O
an	O
office	O
or	O
day	O
care	O
,	O
all	O
areas	O
such	O
as	O
offices	O
,	O
bathrooms	O
,	O
common	O
areas	O
,	O
shared	O
electronic	O
equipment	O
like	O
tablets	O
,	O
touch	O
screens	O
,	O
keyboards	O
,	O
remote	O
controls	O
,	O
and	O
ATM	O
machines	O
used	O
by	O
the	O
ill	O
persons	O
should	O
be	O
disinfected	O
.	O

Inspectors	O
from	O
the	O
WHO	S-Organization
had	O
told	O
Bedson	S-Person
that	O
the	O
physical	O
facilities	O
at	O
the	O
laboratory	O
did	O
not	O
meet	O
WHO	S-Organization
standards	O
,	O
but	O
had	O
nonetheless	O
only	O
recommended	O
a	O
few	O
changes	O
in	O
laboratory	O
procedures	O
.	O

The	O
joint	O
projects	O
and	O
regular	O
meetings	O
have	O
generally	O
created	O
a	O
positive	O
and	O
understanding	O
attitude	O
among	O
the	O
network	O
agencies	O
.	O

Their	O
efforts	O
were	O
complicated	O
by	O
the	O
fact	O
that	O
less	O
than	O
50%	O
of	O
the	O
schools	O
in	O
these	O
three	O
countries	O
had	O
access	O
to	O
running	O
water	O
.	O

Phage	B-Technology
therapy	E-Technology
is	O
the	O
therapeutic	O
use	O
of	O
bacteriophages	O
to	O
treat	O
pathogenic	O
bacterial	O
infections.	O
has	O
many	O
potential	O
applications	O
in	O
human	O
medicine	O
as	O
well	O
as	O
dentistry	O
,	O
veterinary	O
science	O
,	O
and	O
agriculture	O
.	O

Users	O
may	O
submit	O
data	O
from	O
antibiograms	O
for	O
individual	O
hospitals	O
or	O
laboratories	O
.	O

Currently	O
,	O
40%	O
of	O
the	O
medically	O
important	O
antibiotics	O
approved	O
for	O
use	O
in	O
food-animals	O
have	O
at	O
least	O
one	O
indication	O
without	O
a	O
defined	O
duration	O
of	O
use	O
,	O
which	O
means	O
farmers	O
can	O
continuously	O
use	O
them	O
at	O
sub-therapeutic	O
doses	O
.	O

But	O
mathematical	O
modelling	O
showed	O
an	O
estimated	O
Americans	O
had	O
the	O
2009	B-Disease
pandemic	I-Disease
flu	E-Disease
at	O
the	O
time	O
,	O
according	O
to	O
Lyn	B-Person
Finelli	E-Person
,	O
a	O
flu	O
surveillance	O
official	O
with	O
the	O
.	O

Retesting	O
of	O
prior	O
samples	O
found	O
a	O
person	O
in	O
France	S-Location
who	O
had	O
the	O
virus	O
on	O
27	O
December	O
2019	O
and	O
a	O
person	O
in	O
who	O
died	O
from	O
the	O
disease	O
on	O
6February	O
2020	O
.	O

Then	O
there	O
is	O
the	O
danger	O
that	O
the	O
ignorant	O
man	O
may	O
easily	O
under-dose	O
himself	O
and	O
by	O
exposing	O
his	O
microbes	O
to	O
nonlethal	O
quantities	O
of	O
the	O
drug	O
make	O
them	O
resistant.	O
"	O
Amábile-Cuevas	O
CF	O
,	O
editor	O
.	O

Some	O
question	O
whether	O
altering	O
human	O
genes	O
means	O
"	O
playing	O
God,	O
"	O
and	O
if	O
so	O
,	O
whether	O
we	O
should	O
do	O
that	O
at	O
all	O
.	O

Due	O
to	O
the	O
violence	O
,	O
international	O
aid	O
organizations	O
had	O
to	O
stop	O
their	O
work	O
in	O
the	O
two	O
communities	O
.	O

For	O
nearly	O
15	O
years	O
researchers	O
at	O
the	O
JCVI	S-Organization
have	O
been	O
working	O
on	O
various	O
aspects	O
of	O
the	O
synthetic	B-Technology
genomics	I-Technology
research	E-Technology
and	O
the	O
quest	O
to	O
create	O
the	O
first	O
synthetic	O
cell	O
.	O

The	O
toxin	O
inhibits	O
the	O
formation	O
of	O
proteins	O
within	O
cells	O
of	O
exposed	O
individuals	O
.	O

The	O
is	O
a	O
national	O
agency	O
with	O
the	O
mission	O
to	O
improve	O
the	O
management	O
of	O
crises	O
in	O
society	O
.	O

Leptospira	B-Pathogen
bacteria	E-Pathogen
cause	O
leptospirosis	S-Disease
,	O
a	O
disease	O
of	O
humans	O
and	O
animals	O
that	O
if	O
untreated	O
can	O
result	O
in	O
kidney	B-Phenotype
damage	E-Phenotype
,	O
meningitis	S-Phenotype
,	O
liver	B-Phenotype
failure	E-Phenotype
,	O
respiratory	B-Phenotype
problems	E-Phenotype
and	O
sometimes	O
death	S-Phenotype
,	O
according	O
to	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
.	O
In	O
nature	O
,	O
people	O
get	O
generally	O
through	O
contact	O
with	O
soil	O
or	O
water	O
that	O
has	O
been	O
contaminated	O
by	O
urine	O
or	O
body	O
fluids	O
from	O
infected	O
animals	O
.	O

Work	O
will	O
begin	O
on	O
a	O
limited	O
scale	O
.	O

Herbig	O
,	O
1832)	O
,	O
page	O
3	O
.	O

As	O
early	O
as	O
December	O
1989	O
the	O
group's	O
claim	O
was	O
taken	O
seriously	O
.	O

"	O
You're	O
talking	O
about	O
the	O
use	O
of	O
antibiotics	O
in	O
the	O
absence	O
of	O
disease,	O
"	O
Kar	S-Person
said.	O
"	O
I	O
think	O
there's	O
very	O
little	O
justification	O
for	O
calling	O
that	O
therapeutic	O
,	O
and	O
there's	O
a	O
lot	O
of	O
overlap	O
between	O
growth	O
promotion	O
and	O
disease	O
prevention	O
in	O
that	O
context.	O
"	O

The	O
convention	O
bound	O
its	O
signatories	O
to	O
a	O
far	O
more	O
stringent	O
set	O
of	O
regulations	O
than	O
had	O
been	O
envisioned	O
by	O
the	O
1925	O
.	O
By	O
1996	O
,	O
137	O
countries	O
had	O
signed	O
the	O
treaty	O
;	O
however	O
it	O
is	O
believed	O
that	O
since	O
the	O
signing	O
of	O
the	O
Convention	O
the	O
number	O
of	O
countries	O
capable	O
of	O
producing	O
such	O
weapons	O
has	O
increased	O
.	O

We	O
have	O
wonderful	O
laboratory	O
scientists	O
in	O
that	O
laboratory	O
and	O
throughout	O
.	O
So	O
to	O
me	O
,	O
the	O
fact	O
that	O
something	O
like	O
this	O
could	O
happen	O
in	O
such	O
a	O
superb	O
laboratory	O
is	O
unsettling	O
because	O
it	O
tells	O
me	O
that	O
we	O
need	O
to	O
look	O
at	O
our	O
culture	O
of	O
safety	O
throughout	O
all	O
of	O
our	O
laboratories	O
.	O

In	O
a	O
statement	O
today	O
,	O
Trump	S-Person
said	O
that	O
implementing	O
the	O
steps	O
would	O
promote	O
a	O
more	O
efficient	O
,	O
coordinated	O
,	O
and	O
accountable	O
biodefense	O
enterprise.	O
"	O
Taken	O
together	O
,	O
they	O
represent	O
a	O
new	O
direction	O
in	O
the	O
Nation's	O
defense	O
against	O
biological	O
threats,	O
"	O
he	O
said	O
.	O

Escherichia	B-Pathogen
coli	E-Pathogen
lysogenic	O
strain	O
bearing	O
bacteriophages	O
λ	O
cI857	O
,	O
carrying	O
a	O
temperature‐sensitive	O
repressor	O
mutation	O
6	O
and	O
host	O
strain	O
ER1647	O
(Novagen	O
corp)	O
were	O
grown	O
in	O
Liquid	O
Broth	O
(LB)	O
medium	O
contained	O
1%	O
Trypton	O
(Bactlab	O
‐	O
Becton	O
Dickinson)	O
,	O
0.	O
5%	O
NaCl	O
,	O
and	O
0.	O
5%	O
yeast	O
extract	O
(Bactlab	O
‐	O
Becton	O
Dickinson)	O
.	O

In	O
fact	O
,	O
the	O
CDC	S-Organization
mission	O
was	O
set	O
under	O
PAHPRA	S-Document
,	O
said	O
,	O
and	O
includes	O
laboratory	O
testing	O
,	O
surveillance	O
(for	O
disease	O
detection)	O
,	O
epidemiology	O
,	O
guidance	O
to	O
healthcare	O
providers	O
,	O
incident	O
management	O
,	O
logistics	O
,	O
emergency	O
risk	O
communication	O
,	O
disease	O
control	O
programs	O
,	O
distribution	O
of	O
medical	O
countermeasures	O
,	O
responder	O
health	O
and	O
well-being	O
,	O
and	O
human	O
and	O
animal	O
medicine	O
.	O

Robert	B-Person
Kadlec	E-Person
who	O
serves	O
as	O
Assistant	B-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
,	O
testified	O
that	O
the	O
control	O
shift	O
is	O
already	O
under	O
way	O
and	O
extensive	O
work	O
has	O
been	O
ongoing	O
between	O
his	O
office	O
and	O
the	O
CDC	S-Organization
.	O
For	O
instance	O
,	O
working	O
groups	O
have	O
been	O
established	O
to	O
deal	O
with	O
topics	O
such	O
as	O
contracts	O
and	O
how	O
they'll	O
be	O
administered	O
,	O
and	O
regarding	O
replenishment	O
of	O
the	O
stockpile	O
,	O
he	O
testified	O
.	O

MRI	S-Technology
does	O
not	O
involve	O
X-rays	O
or	O
the	O
use	O
of	O
ionizing	O
radiation	O
,	O
which	O
distinguishes	O
it	O
from	O
CT	S-Technology
and	O
PET	B-Technology
scans	E-Technology
.	O
MRI	S-Technology
	S-Technology
is	O
a	O
medical	O
application	O
of	O
nuclear	B-Technology
magnetic	I-Technology
resonance	E-Technology
(	O
NMR	S-Technology
)	O
.	O

Susan	B-Person
Brooks	E-Person
(R-IN)	O
and	O
Rep	O
.	O

Test	O
subjects	O
were	O
gathered	O
from	O
the	O
surrounding	O
population	O
and	O
were	O
sometimes	O
referred	O
to	O
euphemistically	O
as	O
,	O
used	O
in	O
such	O
contexts	O
as	O
"	O
How	O
many	O
logs	O
fell?"	O
.	O

Berns	S-Person
is	O
a	O
current	O
member	O
of	O
the	O
National	B-Organization
Science	I-Organization
Advisory	I-Organization
Board	I-Organization
for	I-Organization
Biosecurity	E-Organization
,	O
and	O
a	O
past	O
member	O
of	O
the	O
Board	B-Organization
of	I-Organization
Scientific	I-Organization
Counselors	E-Organization
,	O
NIAID	S-Organization
.	O
He	O
is	O
a	O
past	O
President	O
of	O
the	O
.	O

The	O
State	B-Organization
Department	E-Organization
closely	O
with	O
U.S.	S-Location
and	O
West	B-Location
African	E-Location
diplomats	O
on	O
the	O
ground	O
,	O
and	O
our	O
counterparts	O
throughout	O
the	O
government	O
to	O
bring	O
the	O
full	O
range	O
of	O
U.S.	S-Location
resources	O
to	O
bear	O
.	O

We	O
will	O
hear	O
from	O
CDC	S-Organization
Director	O
Tom	B-Person
Frieden	E-Person
.	O
There	O
will	O
be	O
time	O
for	O
Q&amp;A	O
following	O
his	O
opening	O
remarks	O
.	O

In	O
the	O
US	S-Location
,	O
it	O
can	O
take	O
10	O
years	O
for	O
a	O
new	O
drug	O
to	O
be	O
developed	O
and	O
approved	O
;	O
for	O
people	O
with	O
serious	O
health	O
conditions	O
,	O
that	O
wait	O
time	O
can	O
feel	O
cruelly	O
long.	O
claims	O
that's	O
part	O
of	O
why	O
he	O
wants	O
to	O
democratize	O
science	O
and	O
empower	O
people	O
to	O
experiment	O
on	O
themselves	O
.	O

The	O
reverse	O
process	O
has	O
become	O
much	O
easier	O
,	O
too:	O
online	O
DNA	O
synthesis	O
services	O
allow	O
anyone	O
to	O
upload	O
a	O
DNA	O
sequence	O
of	O
their	O
choice	O
then	O
have	O
it	O
constructed	O
and	O
shipped	O
to	O
their	O
address	O
.	O

So	O
far	O
,	O
the	O
focus	O
has	O
been	O
on	O
real-time	B-Equipment
PCR	E-Equipment
analyses	O
and	O
cultivation	O
methods	O
of	O
the	O
high-consequence	O
pathogens	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Brucella	B-Pathogen
spp.	E-Pathogen
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
,	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
and	O
.	O

Trypanosomes	S-Pathogen
are	O
parasitic	O
protozoa	O
that	O
cause	O
African	B-Disease
trypanosomiasis	E-Disease
and	O
Chagas	B-Disease
disease	E-Disease
(	O
American	B-Disease
trypanosomiasis	E-Disease
)	O
.	O

Such	O
species	O
of	O
mosquitoes	O
and	O
fleas	O
(studied	O
in	O
the	O
past	O
under	O
the	O
US	S-Location
Entomological	O
Warfare	O
Program)	O
have	O
also	O
been	O
collected	O
in	O
Georgia	S-Location
and	O
tested	O
at	O
The	O
.	O

People	O
do	O
not	O
think	O
to	O
wash	O
their	O
hands	O
when	O
they	O
do	O
not	O
have	O
enough	O
water	O
to	O
drink.	O
"	O
One	O
study	O
showed	O
that	O
once	O
people	O
had	O
heard	O
of	O
the	O
,	O
hand	O
washing	O
with	O
soap	O
and	O
water	O
improved	O
,	O
though	O
socio-demographic	O
factors	O
influenced	O
hygiene	O
.	O

The	O
authors	O
concluded	O
that	O
this	O
new	O
research	O
,	O
together	O
with	O
prior	O
analyses	O
from	O
the	O
south	O
of	O
France	S-Location
and	O
Germany	S-Location
,	O
"	O
ends	O
the	O
debate	O
about	O
the	O
cause	O
of	O
the	O
Black	B-Disease
Death	E-Disease
,	O
and	O
unambiguously	O
demonstrates	O
that	O
Y.	B-Pathogen
pestis	E-Pathogen
was	O
the	O
causative	O
agent	O
of	O
the	O
epidemic	O
plague	S-Disease
that	O
devastated	O
Europe	S-Location
during	O
the	O
Middle	O
Ages"	O
.	O

Details	O
of	O
the	O
BW	O
program-along	O
with	O
a	O
chemical	O
weapons	O
program-surfaced	O
only	O
in	O
the	O
wake	O
of	O
the	O
Gulf	O
War	O
(1990–91)	O
following	O
investigations	O
conducted	O
by	O
the	O
United	B-Organization
Nations	I-Organization
Special	I-Organization
Commission	E-Organization
(	O
UNSCOM	S-Organization
)	O
which	O
had	O
been	O
charged	O
with	O
the	O
post-war	O
disarmament	O
of	O
Saddam	S-Person
's	O
Iraq	S-Location
.	O
By	O
the	O
end	O
of	O
the	O
war	O
,	O
program	O
scientists	O
had	O
investigated	O
the	O
BW	O
potential	O
of	O
five	O
bacterial	O
strains	O
,	O
one	O
fungal	O
strain	O
,	O
five	O
types	O
of	O
virus	O
,	O
and	O
four	O
toxins	O
.	O

I	O
wanted	O
to	O
know	O
,	O
what	O
is	O
the	O
training	O
for	O
people	O
when	O
a	O
new	O
protocol	O
is	O
introduced?	O
How	O
are	O
staff	O
kind	O
of	O
made	O
aware	O
of	O
the	O
new	O
protocols	O
and	O
what	O
they	O
should	O
be	O
doing?	O

They	O
can	O
also	O
be	O
engineered	O
with	O
so	O
called	O
"	O
suicide	O
genes	O
"	O
that	O
kick	O
in	O
to	O
prevent	O
the	O
organism	O
from	O
living	O
outside	O
of	O
the	O
lab	O
or	O
environment	O
in	O
which	O
they	O
were	O
grown	O
.	O

Collaboration	O
agreements	O
were	O
signed	O
by	O
the	O
4	O
agencies	O
in	O
2008	O
and	O
renewed	O
in	O
2014	O
.	O

She	O
was	O
wearing	O
the	O
normal	O
protective	B-Equipment
clothing	E-Equipment
including	O
rubber	B-Equipment
gloves	E-Equipment
,	O
and	O
got	O
immediate	O
medical	O
attention	O
,	O
but	O
the	O
dose	O
still	O
killed	O
her	O
two	O
weeks	O
later	O
.	O

The	O
organization	O
tries	O
to	O
counter	O
this	O
with	O
their	O
blog	O
Outbreak	O
Thursday	O
,	O
published	O
on	O
the	O
's	O
website	O
.	O

Since	O
its	O
formation	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
QA	O
protocols	O
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

On	O
22	O
March	O
2020	O
,	O
Germany	S-Organization
banned	O
public	O
gatherings	O
of	O
more	O
than	O
two	O
people	O
.	O

Daniel	S-Person
said	O
he	O
thinks	O
the	O
fact	O
that	O
the	O
is	O
moving	O
from	O
acknowledging	O
the	O
reimbursement	O
problem	O
to	O
actively	O
proposing	O
ideas	O
to	O
solve	O
it	O
sends	O
an	O
important	O
message	O
to	O
pharmaceutical	O
companies.	O
"	O
I	O
think	O
it	O
speaks	O
volumes	O
,	O
and	O
shows	O
that	O
it's	O
reached	O
a	O
fever	O
pitch	O
to	O
actually	O
start	O
getting	O
some	O
action.	O
"	O

The	O
main	O
planners	O
of	O
the	O
attack	O
included	O
Sheela	B-Person
Silverman	E-Person
(	O
Ma	B-Person
Anand	I-Person
Sheela	E-Person
)	O
,	O
Rajneesh	S-Person
's	O
chief	O
lieutenant	O
,	O
and	O
Diane	B-Person
Yvonne	I-Person
Onang	E-Person
(	O
Ma	B-Person
Anand	I-Person
Puja	E-Person
)	O
,	O
a	O
nurse	O
practitioner	O
and	O
secretary-treasurer	O
of	O
the	O
Rajneesh	B-Organization
Medical	I-Organization
Corporation	E-Organization
.	O
They	O
purchased	O
Salmonella	B-Pathogen
bacteria	E-Pathogen
from	O
a	O
medical	O
supply	O
company	O
in	O
Seattle	S-Location
,	O
Washington	S-Location
,	O
and	O
staff	O
cultured	O
it	O
in	O
labs	O
within	O
the	O
commune	O
.	O

In	O
Colombia	O
,	O
the	O
biggest	O
areas	O
of	O
coca	O
and	O
opium	O
poppy	O
cultivation	O
are	O
in	O
combat	O
zones	O
,	O
and	O
the	O
'War	O
on	O
Drugs'	O
is	O
part	O
of	O
the	O
country's	O
continuing	O
armed	O
conflict	O
.	O

Officials	O
said	O
the	O
national	B-Scientific_research_project
Viral	I-Scientific_research_project
Hemorrhagic	I-Scientific_research_project
Fever	I-Scientific_research_project
(VHF)	E-Scientific_research_project
program	O
is	O
a	O
collaboration	O
between	O
CDC	S-Organization
,	O
the	O
Uganda	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
(	O
MOH	S-Organization
)	O
and	O
the	O
Uganda	B-Organization
Virus	I-Organization
Research	I-Organization
Institute	E-Organization
()	O
.	O

And	O
the	O
Dutch	S-Location
government	O
claimed	O
that	O
the	O
research	O
broke	O
EU	S-Location
law	O
on	O
exporting	O
information	O
useful	O
for	O
bioweapons	O
.	O

When	O
DNA	O
is	O
heated	O
up	O
,	O
however	O
,	O
the	O
strands	O
come	O
apart	O
.	O

One	O
theory	O
speculated	O
that	O
the	O
virus	O
was	O
spread	O
by	O
airborne	O
transmission	O
,	O
through	O
dried	O
up	O
U-shaped	O
P-traps	O
in	O
the	O
drainage	O
system	O
which	O
a	O
maritime	O
breeze	O
blew	O
into	O
the	O
estate's	O
balconies	O
and	O
stairwell	O
ventilation	O
.	O

In	O
September	O
2014	O
,	O
it	O
was	O
estimated	O
that	O
the	O
affected	O
countries'	O
capacity	O
for	O
treating	O
Ebola	O
patients	O
was	O
insufficient	O
by	O
the	O
equivalent	O
of	O
2,122	O
beds	O
;	O
however	O
,	O
by	O
December	O
2014	O
there	O
were	O
enough	O
beds	O
to	O
treat	O
and	O
isolate	O
all	O
reported	O
cases	O
,	O
although	O
the	O
uneven	O
distribution	O
of	O
cases	O
was	O
resulting	O
in	O
serious	O
shortfalls	O
in	O
some	O
areas	O
.	O

The	O
key	O
to	O
sleep	O
is	O
to	O
save	O
the	O
last	O
hour	O
of	O
the	O
day	O
for	O
non-work-related	O
things	O
that	O
let	O
your	O
brain	O
cool	O
down	O
.	O

In	O
the	O
late	O
1980s	O
and	O
1990s	O
,	O
many	O
of	O
these	O
scientists	O
became	O
free	O
agents-with	O
dangerous	O
knowledge	O
for	O
sale	O
.	O

These	O
laboratories	O
included	O
51	O
(27%)	O
labs	O
from	O
government	O
,	O
75	O
(39%)	O
from	O
private	O
sectors	O
and	O
64	O
(34%)	O
labs	O
belong	O
to	O
organization	O
providing	O
health	O
care	O
services	O
.	O

More	O
people	O
died	O
of	O
influenza	O
in	O
a	O
single	O
year	O
than	O
in	O
four-years	O
of	O
the	O
Black	B-Incident
Death	I-Incident
Bubonic	I-Incident
Plague	E-Incident
from	O
1347	O
to	O
1351	O
.	O

The	O
UK	S-Location
DfID	O
minister	O
,	O
Rory	B-Person
Stewart	E-Person
,	O
visited	O
the	O
area	O
in	O
July	O
2019	O
,	O
and	O
called	O
for	O
other	O
western	O
countries	O
,	O
including	O
Canada	S-Location
,	O
France	S-Location
and	O
Germany	S-Location
,	O
to	O
donate	O
more	O
financial	O
aid	O
.	O

One	O
way	O
to	O
measure	O
the	O
outbreak	O
is	O
the	O
basic	O
reproduction	O
number	O
,	O
R0	O
,	O
a	O
statistical	O
measure	O
of	O
the	O
average	O
number	O
of	O
people	O
expected	O
to	O
be	O
infected	O
by	O
one	O
person	O
who	O
has	O
a	O
disease	O
.	O

This	O
request	O
is	O
deliberately	O
more	O
about	O
best	O
practices	O
in	O
lab	O
management	O
than	O
it	O
is	O
about	O
imposing	O
new	O
regulations	O
on	O
the	O
community	O
.	O

The	O
Chinese	B-Organization
government	E-Organization
said	O
product	O
instructions	O
might	O
not	O
have	O
been	O
followed	O
,	O
and	O
that	O
some	O
products	O
were	O
not	O
purchased	O
directly	O
from	O
certified	O
companies	O
.	O

That	O
could	O
mean	O
figuring	O
out	O
how	O
the	O
DNA	O
in	O
plants	O
affects	O
their	O
growth	O
,	O
or	O
how	O
to	O
manipulate	O
genes	O
from	O
another	O
source	O
to	O
make	O
a	O
plant	O
glow	O
in	O
the	O
dark	O
.	O

Over	O
time	O
,	O
studies	O
have	O
suggested	O
that	O
the	O
virus	O
can	O
persist	O
in	O
seminal	O
fluid	O
,	O
with	O
a	O
study	O
released	O
in	O
September	O
2016	O
suggesting	O
that	O
the	O
virus	O
may	O
survive	O
more	O
than	O
530 days	O
after	O
infection	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
attributes	O
human	O
error	O
and	O
poor	O
technique	O
as	O
the	O
primary	O
cause	O
of	O
.	O

Known	O
as	O
a	O
'	O
gene	B-Technology
drive	E-Technology
,'	O
the	O
technology	O
is	O
designed	O
to	O
spread	O
a	O
gene	O
quickly	O
through	O
a	O
population	O
by	O
sexual	O
reproduction	O
.	O

Next	O
question	O
on	O
the	O
phone	O
.	O

The	O
labeling	O
of	O
GM	S-Technology
crops	O
and	O
their	O
products	O
are	O
mandatory	O
if	O
the	O
genetically	B-Technology
modified	I-Technology
organism	E-Technology
(	O
GMO	S-Technology
)	O
content	O
exceeds	O
the	O
levels	O
of	O
a	O
recommended	O
threshold	O
.	O

The	O
Rockefeller	B-Organization
Foundation	E-Organization
greatly	O
supported	O
control	O
,	O
sought	O
to	O
have	O
the	O
governments	O
take	O
over	O
some	O
of	O
its	O
efforts	O
,	O
and	O
collaborated	O
with	O
the	O
agency	O
.	O

The	O
Roman	O
commander	O
Manius	O
Aquillius	O
poisoned	O
the	O
wells	O
of	O
besieged	O
enemy	O
cities	O
in	O
about	O
130	O
BC	O
.	O

On	O
the	O
other	O
hand	O
,	O
positive	O
selection	O
gives	O
a	O
collection	O
of	O
growth-advantage	O
acquired	O
populations	O
by	O
random	O
mutagenesis	O
.	O

A	O
study	O
on	O
's	O
success	O
story	O
stated	O
that	O
,	O
in	O
this	O
case	O
,	O
a	O
prompt	O
response	O
by	O
the	O
government	O
and	O
proactive	O
public	O
health	O
measures	O
had	O
resulted	O
in	O
the	O
quick	O
control	O
of	O
the	O
outbreak	O
.	O

MIMAS	S-Platform
	S-Platform
is	O
implemented	O
in	O
Perl	O
as	O
a	O
web	O
application	O
for	O
the	O
Apache	O
server	O
and	O
is	O
portable	O
between	O
MySQL	O
and	O
Oracle	O
databases	O
.	O

Some	O
Atlanta	S-Location
staff	O
were	O
being	O
monitored	O
and	O
provided	O
or	O
prescribed	O
antibiotics	S-Drug
because	O
they	O
may	O
have	O
been	O
unintentionally	O
exposed	O
to	O
live	O
anthrax	S-Pathogen
bacteria	O
after	O
established	O
safety	O
practices	O
were	O
not	O
followed	O
during	O
a	O
laboratory	O
procedure	O
(	O
)	O
This	O
broad	O
action	O
was	O
taken	O
out	O
of	O
an	O
abundance	O
of	O
caution	O
,	O
and	O
the	O
agency	O
began	O
immediate	O
work	O
to	O
better	O
determine	O
employees'	O
potential	O
risk	O
by	O
administering	O
a	O
detailed	O
epidemiologic	O
questionnaire	O
to	O
those	O
believed	O
to	O
be	O
affected	O
to	O
learn	O
more	O
about	O
their	O
whereabouts	O
and	O
their	O
specific	O
work	O
during	O
the	O
time	O
of	O
potential	O
exposure	O
–	O
June	O
6	O
to	O
June	O
13	O
.	O

The	O
professional	O
laboratory	O
staff	O
is	O
also	O
well	O
trained	O
in	O
tissue	O
culture	O
techniques	O
and	O
provides	O
the	O
general	O
year‐round	O
support	O
for	O
maintenance	O
of	O
cell	O
lines	O
and	O
tissue	O
culture	O
rooms	O
.	O

I	O
know	O
its	O
frustrating	O
for	O
all	O
of	O
us	O
.	O

On	O
30	O
September	O
2014	O
,	O
the	O
CDC	S-Organization
declared	O
its	O
first	O
case	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
It	O
disclosed	O
that	O
Thomas	B-Person
Eric	I-Person
Duncan	E-Person
became	O
infected	O
in	O
Liberia	S-Location
and	O
travelled	O
to	O
Dallas	S-Location
,	O
Texas	O
on	O
20	O
September	O
.	O

The	O
principal	O
investigator	O
at	O
the	O
Naval	B-Organization
Research	I-Organization
Laboratory	E-Organization
,	O
James	B-Person
Campbell	E-Person
,	O
described	O
possible	O
applications	O
of	O
this	O
technology	O
in	O
his	O
presentation	O
at	O
.	O
Among	O
them	O
were	O
"	O
microbial	O
derived	O
or	O
based	O
esterases	O
[that]	O
might	O
be	O
used	O
to	O
strip	O
signature-control	O
coatings	O
from	O
aircraft	O
,	O
thus	O
facilitating	O
detection	O
and	O
destruction	O
of	O
the	O
aircraft	O
"	O
(www.dtic.mil/ndia/NLD3/camp.pdf)	O
.	O

The	O
updates	O
allow	O
clinicians	O
to	O
quickly	O
and	O
cheaply	O
diagnose	O
patient	O
samples	O
and	O
track	O
epidemic	O
spread	O
directly	O
in	O
bodily	O
fluids	O
,	O
eliminating	O
the	O
need	O
for	O
excessive	O
lab	O
equipment	O
and	O
allow	O
more	O
rapid	O
efforts	O
to	O
be	O
conducted	O
in	O
the	O
field	O
.	O

UK	S-Location
was	O
the	O
first	O
country	O
in	O
Europe	S-Location
to	O
propose	O
a	O
classification	O
.	O

All	O
the	O
cases	O
were	O
reported	O
to	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
(	O
ECDC	S-Organization
)	O
.	O

Next	O
question	O
comes	O
from	O
Mike	B-Person
Stobbe	E-Person
with	O
the	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

And	O
it	O
is	O
very	O
difficult	O
to	O
tease	O
out	O
how	O
much	O
of	O
this	O
should	O
be	O
attributed	O
to	O
war	O
and	O
occupation	O
,	O
rather	O
than	O
disease	O
.	O

It	O
is	O
suspected	O
that	O
the	O
children	O
of	O
female	O
prisoners	O
were	O
killed	O
after	O
birth	O
or	O
aborted	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
identify	O
and	O
assess	O
the	O
impact	O
of	O
capacity-building	O
biosafety	O
initiatives	O
and	O
programs	O
that	O
have	O
taken	O
place	O
in	O
the	O
broader	B-Location
Middle	I-Location
East	I-Location
and	I-Location
North	I-Location
Africa	E-Location
()	O
region	O
between	O
2001	O
and	O
2013	O
,	O
to	O
highlight	O
gaps	O
that	O
require	O
further	O
development	O
,	O
and	O
to	O
suggest	O
sustainable	O
ways	O
to	O
build	O
cooperative	O
regional	O
biosafety	O
opportunities	O
.	O

As	O
they	O
fled	O
the	O
besieged	O
cities	O
these	O
civilians	O
,	O
the	O
British	O
hoped	O
,	O
would	O
carry	O
to	O
rebel	O
troops	O
.	O

Another	O
oddity	O
was	O
that	O
the	O
outbreak	O
was	O
widespread	O
in	O
the	O
summer	O
and	O
autumn	O
(in	O
the	O
Northern	O
Hemisphere)	O
;	O
influenza	S-Disease
is	O
usually	O
worse	O
in	O
winter	O
.	O

Some	O
non-U.S.	O
airlines	O
,	O
mostly	O
Asian	O
,	O
including	O
Singapore	B-Organization
Airlines	E-Organization
,	O
China	B-Organization
Eastern	I-Organization
Airlines	E-Organization
,	O
China	B-Organization
Southern	I-Organization
Airlines	E-Organization
,	O
Cathay	B-Organization
Pacific	E-Organization
and	O
Aeromexico	S-Organization
,	O
took	O
measures	O
such	O
as	O
stepping	O
up	O
cabin	O
cleaning	O
,	O
installing	O
state-of-the-art	O
air	O
filters	O
and	O
allowing	O
in-flight	O
staff	O
to	O
wear	O
.	O

It	O
was	O
addressed	O
to	O
top	O
officials	O
at	O
16	O
federal	O
agencies	O
,	O
including	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
which	O
this	O
past	O
July	O
was	O
criticized	O
for	O
repeated	O
mishandling	O
of	O
anthrax	S-Pathogen
at	O
a	O
U.S.	B-Organization
Army	I-Organization
laboratory	E-Organization
in	O
.	O

The	O
current	O
Director-General	O
is	O
Tedros	B-Person
Adhanom	E-Person
,	O
former	O
Health	O
Minister	O
and	O
Foreign	O
Minister	O
of	O
,	O
who	O
began	O
his	O
five-year	O
term	O
on	O
1	O
July	O
2017	O
.	O

Improvements	O
to	O
increase	O
MR	O
sensitivity	O
include	O
increasing	O
magnetic	O
field	O
strength	O
and	O
hyperpolarization	O
via	O
optical	O
pumping	O
or	O
dynamic	O
nuclear	O
polarization	O
.	O

For	O
the	O
mere	O
diagnosis	O
of	O
influenza	S-Disease
and	O
not	O
pandemic	B-Disease
H1N1	I-Disease
flu	E-Disease
specifically	O
,	O
more	O
widely	O
available	O
tests	O
include	O
rapid	B-Technology
influenza	I-Technology
diagnostic	I-Technology
tests	E-Technology
(	O
RIDT	S-Technology
)	O
,	O
which	O
yield	O
results	O
in	O
about	O
30	O
minutes	O
,	O
and	O
direct	O
and	O
indirect	O
immunofluorescence	O
assays	O
(	O
DFA	S-Technology
and	O
)	O
,	O
which	O
take	O
2–4	O
hours	O
.	O

Subsequent	O
outbreaks	O
,	O
though	O
severe	O
,	O
marked	O
the	O
retreat	O
from	O
most	O
of	O
Europe	S-Location
(18th century)	O
and	O
northern	B-Location
Africa	E-Location
(19th century)	O
.	O

In	O
2014	O
,	O
incidents	B-Incident
with	I-Incident
Anthrax	I-Incident
and	I-Incident
Ebola	I-Incident
pathogens	I-Incident
in	I-Incident
CDC	I-Incident
laboratories	E-Incident
()	O
,	O
prompted	O
the	O
director	O
Tom	O
Frieden	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

The	O
12	O
May	O
2019	O
issue	O
of	O
WHO	B-Document
Weekly	I-Document
Bulletin	I-Document
on	I-Document
Outbreaks	I-Document
and	I-Document
Other	I-Document
Emergencies	E-Document
indicates	O
that	O
"	O
continued	O
increase	O
in	O
the	O
number	O
of	O
new	O
EVD	S-Disease
cases	O
in	O
the	O
is	O
worrying...no	O
end	O
in	O
sight	O
to	O
the	O
difficult	O
security	O
situation"	O
.	O

In	O
Liberia	S-Location
,	O
a	O
mob	O
attacked	O
an	O
Ebola	S-Disease
isolation	O
centre	O
,	O
stealing	O
equipment	O
and	O
"	O
freeing"	O
patients	O
while	O
shouting	O
"	O
There's	O
no	O
Ebola	S-Disease
.	O
"	O
Red	B-Organization
Cross	E-Organization
staff	O
were	O
forced	O
to	O
suspend	O
operations	O
in	O
southeast	O
Guinea	S-Location
after	O
they	O
were	O
threatened	O
by	O
a	O
group	O
of	O
men	O
armed	O
with	O
knives	O
.	O

Plans	O
to	O
limit	O
travel	O
between	O
cities	O
were	O
announced	O
in	O
March	O
,	O
although	O
heavy	O
traffic	O
between	O
cities	O
ahead	O
of	O
the	O
Persian	O
New	O
Year	O
Nowruz	O
continued	O
.	O

Metabiota	B-Organization
Inc.	E-Organization
had	O
been	O
contracted	O
by	O
the	O
Pentagon	S-Organization
to	O
perform	O
work	O
for	O
DTRA	S-Scientific_research_project
before	O
and	O
during	O
the	O
Ebola	B-Incident
crisis	E-Incident
in	O
West	B-Location
Africa	E-Location
and	O
was	O
awarded	O
$3.	O
1	O
million	O
(2012-2015)	O
for	O
work	O
in	O
Sierra	B-Location
Leone	E-Location
–	O
one	O
of	O
the	O
countries	O
at	O
the	O
epicenter	O
of	O
the	O
.	O

The	O
protective	O
group	O
,	O
benzyl	O
,	O
was	O
then	O
removed	O
with	O
boron	O
trichloride	O
in	O
dichloromethane	O
at	O
.	O
The	O
excess	O
of	O
boron	O
trichloride	O
was	O
quenched	O
in	O
a	O
mixture	O
of	O
potassium	O
carbonate	O
and	O
methanol	O
.	O

The	O
laboratory	O
technician	O
who	O
worked	O
directly	O
with	O
the	O
specimens	O
in	O
the	O
BSL-2	S-Platform
laboratory	O
completed	O
21	O
days	O
of	O
direct	O
active	O
monitoring	O
and	O
reported	O
no	O
illness	O
consistent	O
with	O
Ebola	S-Disease
.	O
The	O
agency	O
performed	O
additional	O
laboratory	O
studies	O
on	O
swabs	O
taken	O
the	O
workdays	O
before	O
and	O
after	O
the	O
incident	O
which	O
found	O
it	O
was	O
unlikely	O
that	O
the	O
specimens	O
transferred	O
to	O
the	O
BSL-2	S-Platform
laboratory	O
contained	O
live	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
Although	O
the	O
studies	O
determined	O
there	O
was	O
no	O
safety	O
risk	O
to	O
CDC	S-Organization
staff	O
or	O
the	O
public	O
,	O
CDC	S-Organization
will	O
ensure	O
continuous	O
improvements	O
occur	O
to	O
protect	O
the	O
safety	O
of	O
staff	O
and	O
the	O
broader	O
community	O
.	O

The	O
relies	O
on	O
3	O
fundamental	O
principles:	O
(1)	O
crises	O
should	O
be	O
managed	O
by	O
the	O
same	O
authorities	O
that	O
manage	O
the	O
relevant	O
activities	O
in	O
normal	O
times	O
;	O
(2)	O
crises	O
should	O
be	O
managed	O
primarily	O
at	O
the	O
local	O
level	O
;	O
and	O
(3)	O
crises	O
should	O
be	O
handled	O
using	O
normal	O
practices	O
.	O

Frieden	S-Person
described	O
the	O
moratorium	O
and	O
other	O
steps	O
CDC	S-Organization
is	O
taking	O
to	O
create	O
a	O
strong	O
culture	O
of	O
safety	O
in	O
the	O
agency's	O
laboratories	O
in	O
a	O
report	O
released	O
July	O
11	O
,	O
2014	O
,	O
and	O
during	O
testimony	O
July	O
16	O
,	O
2014	O
,	O
before	O
the	O
on	O
Oversight	O
and	O
Investigations	O
.	O

On	O
30	O
September	O
2014	O
,	O
the	O
CDC	S-Organization
declared	O
its	O
first	O
case	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
It	O
disclosed	O
that	O
Thomas	B-Person
Eric	I-Person
Duncan	E-Person
became	O
infected	O
in	O
Liberia	S-Location
and	O
travelled	O
to	O
Dallas	S-Location
,	O
Texas	O
on	O
20	O
September	O
.	O

Tian	B-Person
D	E-Person
Zheng	O
T	O
.	O

The	O
final	O
step	O
in	O
the	O
biocontainment	O
process	O
is	O
the	O
assumption	O
of	O
Principal	O
Investigator	O
role	O
with	O
full	O
responsibility	O
for	O
the	O
structure	O
of	O
the	O
site-specific	O
biosafety	O
program	O
plan	O
by	O
core	O
facility	O
leadership	O
.	O

For	O
natural	O
pandemics	O
,	O
SIGMA+	S-Scientific_research_project
sensing	O
methods	O
could	O
yield	O
awareness	O
of	O
major	O
outbreaks	O
weeks	O
sooner	O
than	O
currently	O
is	O
possible	O
.	O

Drug	O
resistance	O
has	O
"	O
become	O
a	O
major	O
concern"	O
.	O

China	O
requested	O
DNA	O
samples	O
from	O
any	O
human	O
remains	O
discovered	O
at	O
the	O
site	O
.	O

In	O
August	O
2018	O
a	O
UN	S-Organization
agency	O
indicated	O
that	O
steps	O
were	O
being	O
taken	O
to	O
ensure	O
that	O
those	O
leaving	O
the	O
DRC	S-Location
into	O
Uganda	S-Location
were	O
not	O
infected	O
with	O
Ebola	S-Pathogen
,	O
which	O
was	O
being	O
done	O
via	O
active	O
screening	O
.	O

PREEMPT	S-Scientific_research_project
will	O
have	O
two	O
technical	O
thrusts:	O
development	O
of	O
multiscale	O
models	O
and	O
test	O
beds	O
to	O
quantify	O
the	O
imminent	O
emergence	O
and	O
reemergence	O
of	O
human	O
pathogens	O
;	O
and	O
development	O
of	O
new	O
,	O
scalable	O
approaches	O
to	O
preventing	O
pathogen	O
spillover	O
and	O
transmission	O
from	O
animals	O
and	O
vectors	O
into	O
humans	O
.	O

It	O
looks	O
as	O
if	O
it	O
was	O
lost	O
in	O
the	O
wake	O
of	O
the	O
first	O
world	O
war	O
,	O
which	O
,	O
despite	O
a	O
smaller	O
death	O
toll	O
,	O
seems	O
to	O
have	O
had	O
a	O
much	O
larger	O
effect	O
on	O
the	O
course	O
of	O
history	O
.	O

But	O
there's	O
more	O
that	O
we're	O
doing	O
around	O
the	O
world	O
.	O

Despite	O
the	O
lack	O
of	O
review	O
,	O
the	O
biological	O
warfare	O
program	O
had	O
increased	O
in	O
cost	O
and	O
size	O
since	O
1961	O
;	O
when	O
Nixon	O
ended	O
the	O
program	O
the	O
budget	O
was	O
$300	O
million	O
annually	O
.	O

The	O
symptoms	O
reported	O
among	O
the	O
patients	O
are	O
common	O
to	O
several	O
respiratory	O
diseases	O
,	O
and	O
pneumonia	S-Disease
is	O
common	O
in	O
the	O
winter	O
season	O
;	O
however	O
,	O
the	O
occurrence	O
of	O
44	O
cases	O
of	O
requiring	O
hospitalization	O
clustered	O
in	O
space	O
and	O
time	O
should	O
be	O
handled	O
prudently	O
.	O

Matthew	B-Person
Hepburn	E-Person
,	O
M.D.	O
,	O
the	O
program	O
manager	O
for	O
,	O
announced	O
that	O
all	O
performer	O
institutions	O
are	O
now	O
on	O
contract	O
and	O
moving	O
forward	O
with	O
the	O
program's	O
goals	O
.	O

Industrial	B-Technology
CT	I-Technology
scanning	E-Technology
(	O
industrial	B-Technology
computed	I-Technology
tomography	E-Technology
)	O
is	O
a	O
process	O
which	O
utilizes	O
X-ray	O
equipment	O
to	O
produce	O
3D	O
representations	O
of	O
components	O
both	O
externally	O
and	O
internally	O
.	O

However	O
,	O
in	O
tallying	O
up	O
the	O
projects	O
and	O
their	O
scope	O
,	O
the	O
GAO	S-Organization
found	O
that	O
USAID	S-Organization
needs	O
to	O
do	O
more	O
to	O
ensure	O
a	O
complete	O
inventory	O
of	O
all	O
of	O
its	O
recovery	O
projects	O
.	O

On	O
25	O
January	O
2018	O
,	O
Brazilian	B-Organization
health	E-Organization
authorities	O
began	O
a	O
vaccination	O
campaign	O
(fractional	O
and	O
standard	O
doses)	O
targeting	O
69	O
municipalities	O
within	O
Rio	B-Location
de	I-Location
Janeiro	E-Location
(10	O
million	O
persons	O
in	O
15	O
municipalities)	O
and	O
(10.	O
3	O
million	O
in	O
54	O
municipalities)	O
states	O
.	O

The	O
ADLSS	O
works	O
in	O
partnership	O
with	O
's	O
world-class	O
laboratories	O
to	O
realize	O
this	O
vision	O
.	O

The	O
following	O
tables	O
of	O
outbreaks	O
are	O
based	O
upon	O
information	O
provided	O
by	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
which	O
excludes	O
all	O
laboratory	O
personnel	O
cases	O
,	O
cases	O
(since	O
they	O
are	O
all	O
asymptomatic)	O
,	O
or	O
suspected	O
cases	O
.	O

Renewed	O
religious	O
fervour	O
and	O
fanaticism	O
bloomed	O
in	O
the	O
wake	O
of	O
the	O
Black	B-Disease
Death	E-Disease
Some	O
Europeans	O
targeted	O
"	O
various	O
groups	O
such	O
as	O
Jews	O
,	O
friars	O
,	O
foreigners	O
,	O
beggars	O
,	O
pilgrims"	O
,	O
lepers	O
,	O
and	O
Romani	O
,	O
blaming	O
them	O
for	O
the	O
crisis	O
.	O

Good	O
afternoon	O
,	O
Dr	O
.	O

The	O
poisoning	O
of	O
Sergei	B-Person
Skripal	E-Person
and	O
his	O
daughter	O
by	O
GRU	S-Organization
agents	O
in	O
Britain	S-Location
last	O
year	O
with	O
the	O
deadly	O
nerve	O
agent	O
Novichok	S-Drug
shows	O
that	O
Russia	S-Location
continues	O
to	O
develop	O
these	O
banned	O
pathogens	O
,	O
and	O
is	O
prepared	O
to	O
release	O
then	O
on	O
civilian	O
populations	O
.	O

Viral	O
infectious	O
diseases	O
often	O
arise	O
in	O
animals	O
.	O

For	O
another	O
form	O
of	O
growing	O
,	O
what	O
are	O
called	O
spores	O
,	O
which	O
are	O
quite	O
resistant	O
to	O
being	O
killed	O
,	O
there	O
is	O
the	O
possibility	O
,	O
although	O
unlikely	O
,	O
that	O
some	O
got	O
out	O
.	O

The	O
Division	B-Organization
of	I-Organization
Research,	I-Organization
Innovation	I-Organization
and	I-Organization
Ventures	E-Organization
,	O
or	O
DRIVe	S-Organization
,	O
aims	O
to	O
bring	O
the	O
medical	O
and	O
scientific	O
communities	O
together	O
with	O
government	O
and	O
venture	O
capital	O
to	O
establish	O
innovation	O
in	O
health	O
security	O
,	O
such	O
as	O
making	O
advancements	O
in	O
the	O
treatment	O
of	O
,	O
which	O
affects	O
1.	O
5	O
million	O
people	O
annually	O
.	O

In	O
late	O
2004	O
the	O
amount	O
of	O
the	O
reward	O
was	O
increased	O
to	O
$120,000.Staff.	O
"	O
Reward	O
in	O
ricin	O
inquiry	O
increased"	O
,	O
The	O
Washington	S-Location
Times	O
,	O
December	O
23	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

The	O
documents	O
are	O
comprised	O
of	O
four	O
layers	O
,	O
including	O
the	O
management	O
manual	O
(30	O
files	O
,	O
describe	O
the	O
quality	O
management	O
system	O
documentation)	O
,	O
program	O
documents	O
(50	O
files	O
,	O
describe	O
the	O
function	O
of	O
quality	O
requirement	O
allocation)	O
,	O
standard	O
operation	O
procedures	O
(SOP)	O
(20	O
files	O
,	O
describe	O
the	O
operation	O
procedures	O
,	O
inspection	O
standard	O
,	O
etc.	O
)	O
,	O
and	O
working	O
manual	O
(29	O
files	O
,	O
describe	O
the	O
records	O
of	O
operation	O
results)	O
.	O

Mayor	O
,	O
(2003)	O
,	O
Greek	O
Fire	O
,	O
Poison	O
Arrows	O
,	O
and	O
Scorpion	O
Bombs:	O
Biological	O
and	O
Chemical	O
Warfare	O
in	O
the	O
Ancient	O
World	O
,	O
The	O
Overlook	O
Press	O
,	O
Peter	O
Mayer	O
Publishers	O
,	O
Inc.	O
,	O
,	O
pp	O
100–101	O
During	O
the	O
4th	O
century	O
BC	O
Scythian	O
archers	O
tipped	O
their	O
arrow	O
tips	O
with	O
snake	O
venom	O
,	O
human	O
blood	O
,	O
and	O
animal	O
feces	O
to	O
cause	O
wounds	O
to	O
become	O
infected	O
.	O

Spain	S-Location
was	O
not	O
involved	O
in	O
the	O
war	O
,	O
having	O
remained	O
neutral	O
,	O
and	O
had	O
not	O
imposed	O
wartime	O
censorship	O
.	O

And	O
the	O
fact	O
that	O
they	O
had	O
to	O
deal	O
with	O
uncertainty	O
,	O
stress	O
,	O
potential	O
risk	O
and	O
to	O
take	O
preventive	O
medicines	O
that	O
can	O
have	O
adverse	O
events	O
as	O
a	O
result	O
of	O
this	O
incident	O
is	O
something	O
that	O
I	O
feel	O
terrible	O
about	O
,	O
and	O
I	O
wish	O
had	O
not	O
happened	O
.	O

Although	O
the	O
Assyrians	O
knew	O
of	O
ergot	S-Pathogen
,	O
a	O
parasitic	O
fungus	O
of	O
rye	O
which	O
produces	O
when	O
ingested	O
,	O
there	O
is	O
no	O
evidence	O
that	O
they	O
poisoned	O
enemy	O
wells	O
with	O
the	O
fungus	O
,	O
as	O
has	O
been	O
claimed	O
.	O

Antonina	B-Person
Presnyakova	E-Person
was	O
an	O
experienced	O
researcher	O
,	O
who	O
was	O
doing	O
tests	O
on	O
guinea	O
pigs	O
at	O
the	O
time	O
,	O
daily	O
reported	O
.	O

In	O
Bioterrorism:	O
A	O
Threat	O
to	O
National	O
Security	O
or	O
Public	O
Health	O
Defining	O
Issue	O
,	O
University	B-Organization
of	I-Organization
Wisconsin	E-Organization
–	O
Madison	B-Organization
and	I-Organization
the	I-Organization
Wisconsin	I-Organization
State	I-Organization
Laboratory	I-Organization
of	I-Organization
Hygiene	E-Organization
,	O
MM&amp;I	O
554	O
,	O
September	O
30	O
,	O
2008	O
It	O
was	O
also	O
the	O
single	O
largest	O
bioterrorism	O
attacksoil	O
.	O

But	O
far	O
from	O
resigning	O
to	O
her	O
fate	O
,	O
Sonia	S-Person
and	O
her	O
husband	O
Eric	S-Person
decided	O
to	O
fight	O
back	O
,	O
and	O
today	O
they	O
are	O
graduate	O
students	O
at	O
Harvard	S-Organization
,	O
racing	O
to	O
find	O
a	O
cure	O
.	O

On	O
6	O
July	O
2015	O
,	O
DOH	S-Organization
confirmed	O
the	O
second	O
detected	O
case	O
of	O
MERS-CoV	S-Pathogen
in	O
the	O
country	O
.	O

Medical	O
authorities	O
will	O
not	O
choose	O
which	O
of	O
four	O
experimental	O
treatments	O
will	O
be	O
given	O
to	O
an	O
individual	O
;	O
instead	O
it	O
will	O
be	O
randomized	O
.	O

Prime	O
Minister	O
Philemon	B-Person
Yang	E-Person
on	O
December	O
3	O
,	O
2018	O
chaired	O
the	O
inauguration	O
ceremony	O
of	O
Cameroon	B-Organization
Public	I-Organization
Health	I-Organization
Emergency	I-Organization
Operations	I-Organization
Centre	E-Organization
located	O
at	O
Messa	S-Location
,	O
.	O

Maintain	O
a	O
somewhat	O
regular	O
sleep	O
schedule	O
,	O
and	O
keep	O
your	O
bedroom	O
dark-or	O
wear	O
an	O
eye	O
mask	O
and	O
bring	O
the	O
darkness	O
wherever	O
you	O
go	O
.	O

On	O
2	O
November	O
,	O
it	O
was	O
reported	O
that	O
the	O
Ugandan	O
government	O
would	O
start	O
vaccination	O
of	O
health	O
workers	O
along	O
the	O
border	O
with	O
the	O
DRC	S-Location
as	O
a	O
proactive	O
measure	O
against	O
the	O
virus	O
.	O

The	O
1950s	O
to	O
1970s	O
represented	O
the	O
golden	O
age	O
of	O
antibiotic	O
discovery	O
,	O
where	O
countless	O
new	O
classes	O
of	O
antibiotics	O
were	O
discovered	O
to	O
treat	O
previously	O
incurable	O
diseases	O
such	O
as	O
tuberculosis	S-Disease
and	O
.	O
However	O
,	O
since	O
that	O
time	O
the	O
discovery	O
of	O
new	O
classes	O
of	O
antibiotics	O
has	O
been	O
almost	O
nonexistent	O
,	O
and	O
represents	O
a	O
situation	O
that	O
is	O
especially	O
problematic	O
considering	O
the	O
resiliency	O
of	O
bacteria	O
shown	O
over	O
time	O
and	O
the	O
continued	O
misuse	O
and	O
overuse	O
of	O
antibiotics	O
in	O
treatment	O
.	O

A	O
significant	O
part	O
of	O
the	O
actual	O
EVD	S-Disease
infection	O
is	O
based	O
on	O
immune	O
suppression	O
.	O

The	O
review	O
began	O
immediately	O
to	O
assess	O
the	O
health	O
risk	O
,	O
and	O
those	O
workers	O
handling	O
the	O
plates	O
were	O
immediately	O
notified	O
.	O

The	O
CDC	S-Organization
had	O
requested	O
that	O
the	O
Atlanta	O
city	O
government	O
annex	O
the	O
area	O
.	O

With	O
the	O
goal	O
of	O
establishing	O
a	O
DOI	O
infrastructure	O
for	O
data	O
in	O
2009	O
,	O
the	O
international	O
'	O
DataCite	S-Organization
'	O
organization	O
was	O
founded	O
.	O

Shigeo	B-Person
Ozeki	E-Person
"	O
civilian	O
employee	O
"	O

The	O
incident	O
also	O
raises	O
the	O
possibility	O
that	O
the	O
Soviet	S-Organization
virus	O
was	O
unusually	O
potent	O
and	O
thus	O
able	O
to	O
overcome	O
at	O
least	O
partially	O
the	O
protective	O
effects	O
of	O
vaccination	O
.	O

But	O
civilians	O
and	O
lawmakers	O
are	O
raising	O
concerns	O
about	O
a	O
mosquito	O
control	O
strategy	O
that	O
would	O
genetically	O
alter	O
and	O
destroy	O
disease-carrying	O
species	O
of	O
mosquitoes	O
.	O

Nevertheless	O
,	O
biological	O
hazards	O
differ	O
from	O
all	O
other	O
kinds	O
of	O
safety	O
hazards	O
in	O
one	O
major	O
significant	O
way:	O
biological	O
agents	O
can	O
grow	O
and	O
multiply	O
in	O
the	O
host	O
organism	O
.	O

This	O
included	O
new	O
production	O
plants	O
for	O
anthrax	S-Pathogen
brucellosis	S-Pathogen
,	O
and	O
anti-crop	O
agents	O
,	O
as	O
well	O
as	O
the	O
development	O
of	O
the	O
cluster	O
bomb.The	O
U.S.	S-Location
public	O
was	O
also	O
unaware	O
of	O
ongoing	O
studies	O
,	O
particularly	O
the	O
environmental	O
and	O
open-air	O
experiments	O
that	O
were	O
taking	O
place	O
.	O

With	O
the	O
onset	O
of	O
hostilities	O
,	O
the	O
Ministry	B-Organization
of	I-Organization
Supply	E-Organization
finally	O
established	O
a	O
biological	O
weapons	O
programme	O
at	O
Porton	O
Down	O
,	O
headed	O
by	O
the	O
microbiologist	O
Paul	B-Person
Fildes	E-Person
.	O
The	O
research	O
was	O
championed	O
by	O
Winston	B-Person
Churchill	E-Person
and	O
soon	O
tularemia	S-Pathogen
,	O
anthrax	S-Pathogen
,	O
brucellosis	S-Pathogen
,	O
and	O
botulism	B-Pathogen
toxins	E-Pathogen
had	O
been	O
effectively	O
weaponized	O
.	O

37	O
people	O
have	O
been	O
hospitalized	O
for	O
Hepatitis	B-Disease
A	E-Disease
in	O
the	O
Ukrainian	O
city	O
of	O
Mykolaiv	S-Location
as	O
of	O
January	O
2018	O
.	O

Partial	O
volume	O
effect	O
This	O
appears	O
as	O
"	O
blurring"	O
of	O
edges	O
.	O

On	O
13	O
March	O
2020	O
,	O
an	O
unverified	O
report	O
from	O
the	O
South	B-Organization
China	I-Organization
Morning	I-Organization
Post	E-Organization
suggested	O
a	O
case	O
traced	O
back	O
to	O
17	O
November	O
2019	O
(a	O
55-year-old	O
from	O
)	O
may	O
have	O
been	O
the	O
first	O
person	O
infected	O
.	O

Historian	O
Nancy	B-Person
Bristow	E-Person
has	O
argued	O
that	O
the	O
pandemic	O
,	O
when	O
combined	O
with	O
the	O
increasing	O
number	O
of	O
women	O
attending	O
college	O
,	O
contributed	O
to	O
the	O
success	O
of	O
women	O
in	O
the	O
field	O
of	O
nursing	O
.	O

Before	O
they	O
arrived	O
they	O
had	O
been	O
provided	O
by	O
the	O
authorities	O
with	O
a	O
list	O
of	O
68	O
known	O
incident	O
victims	O
in	O
.	O
By	O
visiting	O
and	O
questioning	O
in	O
their	O
homes	O
surviving	O
relatives	O
of	O
those	O
who	O
had	O
died	O
,	O
the	O
investigating	O
researchers	O
ascertained	O
both	O
where	O
the	O
victims	O
had	O
been	O
living	O
and	O
where	O
they	O
had	O
been	O
during	O
daylight	O
hours	O
at	O
the	O
time	O
during	O
which	O
hospital	O
admission	O
records	O
indicated	O
a	O
possible	O
release	O
into	O
the	O
atmosphere	O
of	O
anthrax	O
dust	O
.	O

People	O
who	O
have	O
developed	O
pneumonia	S-Disease
should	O
be	O
given	O
both	O
antivirals	O
and	O
antibiotics	O
,	O
as	O
in	O
many	O
severe	O
cases	O
of	O
H1N1-caused	O
illness	O
,	O
bacterial	B-Disease
infection	E-Disease
develops	O
.	O

Did	O
we	O
have	O
a	O
question	O
in	O
the	O
room?	O

First	O
,	O
has	O
a	O
sensitivity	O
of	O
around	O
10−3	O
mol/L	O
to	O
10−5	O
mol/L	O
,	O
which	O
,	O
compared	O
to	O
other	O
types	O
of	O
imaging	O
,	O
can	O
be	O
very	O
limiting	O
.	O

On	O
April	O
27	O
,	O
the	O
man	O
,	O
identified	O
as	O
James	B-Person
Everett	I-Person
Dutschke	E-Person
,	O
was	O
arrested	O
in	O
connection	O
with	O
the	O
case	O
.	O

So	O
all	O
materials	O
either	O
should	O
have	O
been	O
here	O
in	O
our	O
laboratory	O
where	O
they're	O
secured	O
or	O
in	O
Russia	S-Location
or	O
destroyed	O
.	O

Researchers	O
can	O
engineer	O
cells	O
to	O
light	O
up	O
when	O
a	O
particular	O
gene	O
is	O
turned	O
on	O
or	O
off	O
.	O

Yuval	B-Person
Levin	E-Person
,	O
after	O
contacting	O
HHS	S-Organization
officials	O
,	O
wrote	O
in	O
that	O
the	O
Post	O
story	O
was	O
not	O
accurate	O
.	O

General	O
Shirō	B-Person
Ishii	E-Person
medal	O
from	O
simulated	O
drowning	O
when	O
applied	O
to	O
a	O
victim's	O
skin	O
.	O

Of	O
the	O
eight	O
Millennium	O
Development	O
Goals	O
,	O
three	O
–	O
reducing	O
child	O
mortality	O
by	O
two-thirds	O
,	O
to	O
reduce	O
maternal	O
deaths	O
by	O
three-quarters	O
,	O
and	O
to	O
halt	O
and	O
begin	O
to	O
reduce	O
the	O
spread	O
of	O
HIV/AIDS	S-Disease
–	O
relate	O
directly	O
to	O
's	O
scope	O
;	O
the	O
other	O
five	O
inter-relate	O
and	O
affect	O
world	O
health	O
.	O

A	O
New	O
Gene	O
Editing	O
Tool	O
Could	O
Make	O
CRISPR	S-Technology
More	O
Precise.	O
,	O
The	O
Smithsonian	O
Magazine.	O
21	O
October	O
2019	O
.	O

The	O
open-air	O
test	O
of	O
a	O
Soviet	O
smallpox	O
weapon	O
in	O
1971	O
caused	O
a	B-Incident
small	I-Incident
outbreak	I-Incident
of	I-Incident
the	I-Incident
disease	I-Incident
in	I-Incident
a	I-Incident
port	I-Incident
on	I-Incident
the	I-Incident
Aral	I-Incident
Sea	E-Incident
,	O
in	O
what	O
is	O
now	O
,	O
even	O
among	O
people	O
who	O
had	O
been	O
vaccinated	O
.	O

According	O
to	O
the	O
Israeli	O
government	O
,	O
the	O
measure	O
was	O
taken	O
to	O
enforce	O
quarantine	O
and	O
protect	O
those	O
who	O
may	O
come	O
into	O
contact	O
with	O
infected	O
citizens	O
.	O

Semantic	O
web	O
concepts	O
are	O
Resource	O
Description	O
Framework	O
(RDF)	O
for	O
simple	O
descriptions	O
of	O
resources	O
and	O
relationships	O
between	O
them	O
and	O
Web	O
ontology	O
language	O
for	O
a	O
language	O
about	O
ontologies	O
(see	O
'Level	O
of	O
Integration'	O
section)	O
.	O

Common	B-Organization
CDC	E-Organization
job	O
titles	O
include	O
engineer	O
,	O
entomologist	O
,	O
epidemiologist	O
,	O
biologist	O
,	O
physician	O
,	O
veterinarian	O
,	O
behavioral	O
scientist	O
,	O
nurse	O
,	O
medical	O
technologist	O
,	O
economist	O
,	O
public	O
health	O
advisor	O
,	O
health	O
communicator	O
,	O
toxicologist	O
,	O
chemist	O
,	O
computer	O
scientist	O
,	O
and	O
statistician	O
.	O

However	O
,	O
all	O
systems	O
are	O
scalable	O
and	O
no	O
great	O
obstacles	O
can	O
be	O
expected	O
getting	O
them	O
on	O
the	O
cloud	O
.	O

Scientists	O
tested	O
biological	O
pathogens	O
,	O
including	O
Bacillus	B-Pathogen
globigii	E-Pathogen
which	O
were	O
thought	O
to	O
be	O
harmless	O
,	O
at	O
public	O
places	O
such	O
as	O
subways	O
.	O

A	O
medical	O
school	O
and	O
research	O
facility	O
belonging	O
to	O
Unit	B-Organization
731	E-Organization
operated	O
in	O
the	O
Shinjuku	B-Location
District	I-Location
of	I-Location
Tokyo	E-Location
during	O
World	O
War	O
II	O
.	O

South	O
Korean	O
society	O
was	O
initially	O
polarised	O
on	O
President	O
Moon	B-Person
Jae-in	E-Person
response	O
to	O
the	O
crisis	O
,	O
many	O
signing	O
petitions	O
either	O
praising	O
it	O
or	O
calling	O
for	O
impeachment	O
.	O

The	O
head	O
of	O
the	O
Koltsovo	S-Location
science	O
city	O
,	O
where	O
Vector	S-Organization
is	O
located	O
,	O
told	O
Russian	O
state	O
news	O
agency	O
that	O
there	O
was	O
no	O
biological	O
threat	O
.	O

When	O
you	O
hear	O
about	O
people	O
genetically	O
engineering	O
themselves	O
or	O
trying	O
young	O
blood	O
transfusions	O
in	O
an	O
effort	O
to	O
ward	O
off	O
death	O
,	O
it's	O
easy	O
to	O
feel	O
a	O
sense	O
of	O
vertigo	S-Phenotype
about	O
what	O
we're	O
coming	O
to	O
as	O
a	O
species	O
.	O

The	O
countries	O
most	O
strongly	O
affected	O
were	O
Guinea	S-Location
,	O
Liberia	S-Location
,	O
and	O
Sierra	B-Location
Leone	E-Location
,	O
accounting	O
for	O
99	O
%	O
of	O
EVD	S-Disease
cases	O
worldwide	O
.	O

Upon	O
activation	O
,	O
samples	O
may	O
be	O
shipped	O
to	O
the	O
assisting	O
agencies	O
that	O
will	O
assist	O
with	O
the	O
diagnostics	O
.	O

The	O
WHO	S-Organization
has	O
played	O
a	O
leading	O
role	O
in	O
several	O
public	O
health	O
achievements	O
,	O
most	O
notably	O
the	O
eradication	O
of	O
smallpox	S-Disease
,	O
the	O
near-eradication	O
of	O
polio	S-Disease
,	O
and	O
the	O
development	O
of	O
an	O
Ebola	B-Vaccine
vaccine	E-Vaccine
.	O
Its	O
current	O
priorities	O
include	O
communicable	O
diseases	O
,	O
particularly	O
HIV/AIDS	S-Disease
,	O
Ebola	S-Disease
,	O
malaria	S-Disease
and	O
tuberculosis	S-Disease
;	O
non-communicable	O
diseases	O
such	O
as	O
heart	B-Disease
disease	E-Disease
and	O
;	O
healthy	O
diet	O
,	O
nutrition	O
,	O
and	O
food	O
security	O
;	O
occupational	O
health	O
;	O
and	O
substance	O
abuse	O
.	O

In	O
March	O
2014	O
,	O
the	O
Senegal	B-Organization
Ministry	I-Organization
of	I-Organization
Interior	E-Organization
closed	O
its	O
southern	O
border	O
with	O
Guinea	S-Location
,	O
but	O
on	O
29	O
August	O
,	O
the	O
health	O
minister	O
announced	O
the	O
country's	O
first	O
case	O
–	O
a	O
university	O
student	O
from	O
Guinea	S-Location
who	O
was	O
being	O
treated	O
in	O
a	O
Dakar	B-Organization
hospital	E-Organization
.	O
The	O
patient	O
was	O
a	O
native	O
of	O
Guinea	S-Location
who	O
had	O
travelled	O
to	O
Dakar	S-Location
,	O
arriving	O
on	O
20	O
August	O
.	O

Further	O
,	O
overall	O
future	O
prospects	O
are	O
also	O
highlighted	O
.	O

Speaking	O
at	O
the	O
World	B-Organization
Bank	E-Organization
and	O
the	O
International	B-Organization
Monetary	I-Organization
Fund	E-Organization
(	O
IMF	S-Organization
)	O
,	O
said	O
the	O
amount	O
was	O
needed	O
because	O
"	O
[o]ur	O
health	O
systems	O
collapsed	O
,	O
investors	O
left	O
our	O
countries	O
,	O
revenues	O
declined	O
and	O
spending	O
increased	O
.	O
"	O

This	O
home	O
biohacking	O
can	O
of	O
course	O
go	O
very	O
badly	O
wrong	O
-	O
Rich	S-Person
pulls	O
up	O
his	O
trouser	O
legs	O
to	O
reveal	O
a	O
selection	O
of	O
scars	O
from	O
implanted	O
shin	O
guards	O
that	O
got	O
so	O
swollen	O
they	O
had	O
to	O
be	O
removed	O
,	O
which	O
he	O
did	O
with	O
pliers	O
and	O
no	O
.	O

This	O
popular	O
,	O
although	O
controversial	O
,	O
type	O
of	O
biohacking	O
is	O
founded	O
on	O
the	O
idea	O
that	O
your	O
body's	O
total	O
genetic	O
expression	O
can	O
be	O
mapped	O
out	O
and	O
optimized	O
by	O
testing	O
how	O
different	O
nutrients	O
affect	O
your	O
health	O
Trusted	B-Platform
Source	E-Platform
over	O
time	O
.	O

Their	O
recommendations	O
were	O
published	O
in	O
the	O
November	O
issue	O
of	O
The	O
Lancet	S-Organization
According	O
to	O
the	O
panel	O
,	O
the	O
epidemic	O
had	O
exposed	O
problems	O
in	O
the	O
national	O
(and	O
international)	O
institutions	O
responsible	O
for	O
protecting	O
the	O
public	O
from	O
the	O
human	O
consequences	O
of	O
infectious	O
disease	O
outbreaks	O
such	O
as	O
the	O
Ebola	B-Disease
epidemic	E-Disease
.	O
The	O
panel	O
was	O
highly	O
critical	O
of	O
the	O
WHO	S-Organization
's	O
management	O
of	O
the	O
Ebola	B-Incident
crisis	E-Incident
noting	O
that	O
it	O
took	O
them	O
months	O
to	O
respond	O
and	O
when	O
they	O
did	O
they	O
were	O
slow	O
to	O
act	O
,	O
poorly	O
co-ordinated	O
and	O
inadequately	O
informed	O
.	O

Therefore	O
,	O
only	O
a	O
minority	O
of	O
the	O
infected	O
persons	O
will	O
die	O
from	O
an	O
anthrax	S-Pathogen
attack	O
in	O
most	O
instances	O
,	O
as	O
has	O
been	O
shown	O
by	O
.	O

The	O
lab	O
technician	O
of	O
this	O
ship	O
took	O
samples	O
of	O
plankton	O
twice	O
a	O
day	O
from	O
the	O
top	O
deck	O
.	O

In	O
November	O
2018	O
,	O
a	O
paper	O
by	O
the	O
U.S.	B-Organization
Center	I-Organization
for	I-Organization
Strategic	I-Organization
and	I-Organization
International	I-Organization
Studies	E-Organization
on	O
the	O
violence	O
and	O
the	O
EVD	B-Incident
outbreak	E-Incident
indicated	O
the	O
situation	O
might	O
worsen	O
depending	O
on	O
the	O
result	O
and	O
response	O
of	O
presidential	O
elections	O
in	O
the	O
country	O
in	O
2018	O
.	O

PREEMPT	S-Scientific_research_project
will	O
seek	O
to	O
identify	O
these	O
opportunities	O
for	O
intervention	O
by	O
modeling	O
the	O
factors	O
that	O
enable	O
species	O
jump	O
.	O

The	O
organization	O
has	O
previously	O
instigated	O
the	O
in	O
2003	O
.	O

Quick	O
bipartisan	O
action	O
is	O
the	O
best	O
response	O
,	O
Murray	S-Person
said	O
,	O
adding	O
that	O
hiring	O
freezes	O
and	O
funding	O
cuts	O
stand	O
to	O
leave	O
less	O
prepared	O
.	O

The	O
incident	O
caused	O
ten	O
individuals	O
to	O
contract	O
smallpox	S-Pathogen
and	O
three	O
unvaccinated	O
individuals	O
(a	O
woman	O
and	O
two	O
children)	O
died	O
from	O
the	O
haemorrhagic	S-Phenotype
form	O
of	O
the	O
disease	O
.	O

She	O
was	O
stated	O
to	O
be	O
in	O
stable	O
condition	O
,	O
and	O
investigators	O
from	O
the	O
are	O
investigating	O
whom	O
she	O
came	O
in	O
contact	O
with	O
.	O

Yet	O
the	O
systemic	O
safety	O
problems	O
identified	O
at	O
the	O
CDC	S-Organization
's	O
prestigious	O
labs	O
have	O
raised	O
questions	O
about	O
what's	O
happening	O
elsewhere.	O
"	O
It's	O
a	O
matter	O
of	O
some	O
concern,	O
"	O
said	O
Berns	S-Person
,	O
a	O
distinguished	O
professor	O
emeritus	O
of	O
molecular	O
genetics	O
and	O
microbiology	O
at	O
the	O
.	O

Adornato	S-Person
is	O
aiming	O
to	O
demonstrate	O
the	O
approach	O
and	O
its	O
advantages	O
in	O
realistic	O
environments	O
to	O
convey	O
military	O
utility	O
.	O

There	O
is	O
no	O
COVID-19	B-Vaccine
vaccine	E-Vaccine
though	O
many	O
organisations	O
are	O
working	O
to	O
develop	O
one	O
.	O

In	O
Ghana	S-Location
the	O
influenza	S-Disease
epidemic	O
killed	O
at	O
least	O
100,000 people	O
.	O

In	O
a	O
press	O
release	O
on	O
19	O
April	O
,	O
DOH	S-Organization
announced	O
that	O
the	O
OFW	O
who	O
UAE	S-Location
doctors	O
found	O
positive	O
for	O
M	O
ERS-CoV	S-Pathogen
was	O
found	O
negative	O
for	O
the	O
virus	O
in	O
an	O
subsequent	O
test	O
by	O
Research	B-Organization
Institute	I-Organization
for	I-Organization
Tropical	I-Organization
Medicine	E-Organization
()	O
.	O

As	O
a	O
refresher	O
,	O
that's	O
when	O
an	O
older	O
person	O
pays	O
for	O
a	O
young	O
person's	O
blood	O
and	O
has	O
it	O
pumped	O
into	O
their	O
veins	O
in	O
the	O
hope	O
that	O
it'll	O
fight	O
aging	O
.	O

These	O
concerns	O
were	O
more	O
pronounced	O
in	O
the	O
agriculture	O
field	O
with	O
development	O
of	O
Bt.	O
cotton	O
(	O
GMOs	S-Technology
and	O
its	O
impacts	O
on	O
natural	O
plants	O
and	O
the	O
environment	O
.	O

The	O
floR	O
gene	O
was	O
detected	O
in	O
all	O
isolates	O
except	O
27025–1-18	O
.	O

WHO	S-Organization
a	O
sector	O
of	O
the	O
United	B-Organization
Nations	E-Organization
,	O
partners	O
with	O
UNAIDS	S-Organization
to	O
contribute	O
to	O
the	O
development	O
of	O
responses	O
in	O
different	O
areas	O
of	O
the	O
world	O
.	O

X-ray	B-Technology
tomography	E-Technology
,	O
a	O
predecessor	O
of	O
,	O
is	O
one	O
form	O
of	O
radiography	O
,	O
along	O
with	O
many	O
other	O
forms	O
of	O
tomographic	O
and	O
non-tomographic	O
radiography	O
.	O

I	O
call	O
this	O
the	O
Amazing	O
Hour	O
,	O
but	O
you	O
can	O
call	O
it	O
whatever	O
you	O
like	O
.	O

In	O
total	O
,	O
the	O
plague	S-Disease
may	O
have	O
reduced	O
the	O
world	O
population	O
from	O
an	O
estimated	O
475 million	O
to	O
350–375	O
million	O
in	O
the	O
14th	O
century	O
.	O

Three	O
of	O
the	O
agencies-the	O
National	B-Organization
Veterinary	I-Organization
Institute	E-Organization
the	O
National	B-Organization
Food	I-Organization
Agency	E-Organization
,	O
and	O
the	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Sweden	E-Organization
-have	O
designated	O
responsibility	O
for	O
expertise	O
and	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
(risk	O
class	O
3	O
microorganisms)	O
within	O
their	O
sectors	O
.	O

As	O
of	O
June	O
2007	O
,	O
the	O
BBD	S-Platform
contained	O
6694	O
records	O
pertaining	O
to	O
scientific	O
publications	O
(full	O
references	O
and	O
abstracts)	O
,	O
and	O
appearing	O
in	O
international	O
and	O
national	O
scientific	O
periodicals	O
and	O
books	O
.	O

The	O
anthrax	S-Pathogen
pathogen	O
can	O
survive	O
in	O
the	O
soil	O
for	O
decades	O
in	O
the	O
form	O
of	O
spores	O
.	O

A	O
typical	O
is	O
done	O
without	O
the	O
use	O
of	O
radiocontrast	O
,	O
but	O
it	O
can	O
possibly	O
be	O
done	O
from	O
contrast-enhanced	O
images	O
as	O
well	O
.	O

However	O
,	O
evaluating	O
the	O
sensing	O
capabilities	O
of	O
sea	O
life	O
is	O
only	O
one	O
of	O
the	O
challenges	O
for	O
PALS	B-Person
researchers	E-Person
Performer	O
teams	O
supporting	O
will	O
also	O
have	O
to	O
develop	O
hardware	O
,	O
software	O
,	O
and	O
algorithms	O
to	O
translate	O
organism	O
behavior	O
into	O
actionable	O
information	O
and	O
then	O
communicate	O
it	O
to	O
end	O
users	O
.	O

Severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus	I-Pathogen
2	E-Pathogen
(	O
SARS‑CoV‑2	S-Pathogen
)	O
is	O
a	O
novel	O
virus	O
,	O
first	O
isolated	O
from	O
three	O
people	O
with	O
pneumonia	S-Disease
connected	O
to	O
the	O
cluster	O
of	O
acute	B-Disease
respiratory	I-Disease
illness	E-Disease
cases	O
in	O
Wuhan	S-Location
.	O
All	O
features	O
of	O
the	O
novel	O
virus	O
occur	O
in	O
related	O
coronaviruses	O
in	O
nature	O
.	O

And	O
there's	O
the	O
prospect	O
of	O
genetically	O
engineered	O
viruses	O
,	O
which	O
warned	O
about	O
at	O
an	O
international	O
security	O
conference	O
last	O
year	O
.	O

This	O
system	O
was	O
shown	O
to	O
be	O
a	O
strong	O
selective	O
pressure	O
for	O
the	O
acquisition	O
of	O
antibiotic	O
resistance	O
and	O
virulence	O
factor	O
in	O
bacterial	O
pathogens	O
.	O

It	O
had	O
been	O
written	O
to	O
provide	O
advice	O
for	O
faith	O
leaders	O
,	O
places	O
of	O
business	O
and	O
other	O
public	O
places	O
,	O
educators	O
,	O
and	O
state	O
and	O
local	O
officials	O
as	O
they	O
began	O
to	O
reopen	O
.	O

Language	O
barriers	O
and	O
the	O
appearance	O
of	O
medical	O
teams	O
in	O
protective	B-Equipment
suits	E-Equipment
sometimes	O
increased	O
fears	O
of	O
the	O
virus	O
.	O

As	O
a	O
COVID-19	S-Disease
vaccine	O
is	O
not	O
expected	O
until	O
2021	O
at	O
the	O
earliest	O
,	O
a	O
key	O
part	O
of	O
managing	O
is	O
trying	O
to	O
decrease	O
and	O
delay	O
the	O
epidemic	O
peak	O
,	O
known	O
as	O
"	O
flattening	O
the	O
curve"	O
.	O

Once	O
pooled	O
library	O
is	O
prepared	O
it	O
is	O
necessary	O
to	O
carry	O
out	O
a	O
deep	O
sequencing	O
(NGS	O
,	O
next	O
generation	O
sequencing)	O
of	O
PCR	S-Technology
plasmid	O
DNA	O
in	O
order	O
to	O
reveal	O
abundance	O
of	O
sgRNAs	O
.	O

NANCY	B-Person
SNYDERMAN	E-Person
Dr.	O
,	O
you	O
just	O
alluded	O
to	O
sloppiness	O
.	O

There	O
was	O
consensus	O
among	O
US	S-Location
researchers	O
in	O
the	O
postwar	O
period	O
that	O
the	O
human	O
experimentation	O
data	O
gained	O
was	O
of	O
little	O
value	O
to	O
the	O
development	O
of	O
American	O
biological	O
weapons	O
and	O
medicine	O
.	O

In	O
industrialised	O
countries	O
,	O
severe	O
illness	O
and	O
deaths	O
occur	O
mainly	O
in	O
the	O
high-risk	O
populations	O
of	O
infants	O
,	O
the	O
elderly	O
and	O
chronically	O
ill	O
patients	O
,	O
although	O
the	O
H1N1	B-Incident
flu	I-Incident
outbreak	E-Incident
(like	O
the	O
)	O
differs	O
in	O
its	O
tendency	O
to	O
affect	O
younger	O
,	O
healthier	O
people	O
.	O

More	O
than	O
ten	O
countries	O
had	O
traced	O
their	O
cases	O
back	O
to	O
Iran	S-Location
by	O
28	O
February	O
,	O
indicating	O
the	O
outbreak	O
may	O
have	O
been	O
more	O
severe	O
than	O
the	O
388	O
cases	O
reported	O
by	O
the	O
Iranian	B-Organization
government	E-Organization
by	O
that	O
date	O
.	O

On	O
23	O
June	O
,	O
Hong	B-Location
Kong	E-Location
was	O
removed	O
from	O
WHO's	B-Document
list	I-Document
of	I-Document
'Affected	I-Document
Areas'	E-Document
,	O
while	O
Toronto	S-Location
,	O
Beijing	S-Location
,	O
and	O
Taiwan	S-Location
remained	O
.	O

In	O
June	O
2014	O
,	O
another	O
employee	O
in	O
a	O
different	O
BSL-3	S-Platform
lab	O
experienced	O
reduced	O
airflow	O
through	O
a	O
respirator	S-Equipment
while	O
taking	O
samples	O
from	O
ducks	O
involved	O
in	O
an	O
H5N1	B-Disease
avian	I-Disease
influenza	E-Disease
experiment	O
.	O

Tom	B-Person
Ridge	E-Person
co-chair	O
of	O
the	O
panel	O
and	O
the	O
first	O
secretary	O
of	O
the	O
,	O
echoed	O
those	O
sentiments	O
.	O

The	O
two	O
youngest	O
children	O
and	O
the	O
23-year-old	O
subsequently	O
developed	O
the	O
haemorrhagic	B-Disease
form	I-Disease
of	I-Disease
smallpox	E-Disease
and	O
died	O
.	O

Students	O
infect	O
the	O
cells	O
with	O
an	O
MulV	S-Pathogen
vector	O
expressing	O
the	O
β‐gal	O
gene	O
.	O

The	O
WHO	S-Organization
has	O
published	O
several	O
testing	O
protocols	O
for	O
the	O
disease	O
.	O

The	O
aim	O
of	O
the	O
network	O
is	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
to	O
improve	O
Sweden	S-Location
's	O
biopreparedness	O
,	O
in	O
line	O
with	O
recommendations	O
from	O
the	O
EU	S-Location
and	O
WHO	S-Organization
.	O
Since	O
forming	O
in	O
2007	O
,	O
the	O
FBD	S-Platform
network	O
has	O
contributed	O
to	O
the	O
harmonization	O
of	O
diagnostic	O
methods	O
,	O
equipment	O
,	O
quality	O
assurance	O
protocols	O
,	O
and	O
biosafety	O
practices	O
among	O
the	O
national	O
laboratories	O
.	O

In	O
January	O
2020	O
,	O
Gilead	S-Organization
began	O
laboratory	O
testing	O
of	O
remdesivir	S-Drug
against	O
SARS-CoV-2	S-Pathogen
,	O
stating	O
that	O
remdesivir	S-Drug
had	O
been	O
shown	O
to	O
be	O
active	O
against	O
severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
SARS	S-Disease
)	O
and	O
Middle	B-Disease
East	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
MERS	S-Disease
)	O
in	O
animal	O
models	O
.	O

The	O
size	O
and	O
scope	O
of	O
the	O
organization	O
also	O
needs	O
&quot;to	O
be	O
more	O
like	O
the	O
Manh	S-Location
Project	O
rather	O
than	O
a	O
small	O
program	O
in	O
a	O
discreet	O
agency	O
or	O
department	O
;	O
it	O
should	O
be	O
over-arching,&quot	O
;	O
he	O
said	O
.	O

In	O
,	O
nearly	O
12,000	O
perished	O
.	O

Together	O
,	O
they	O
will	O
gather	O
veterinary	O
and	O
medical	O
experts	O
to	O
address	O
a	O
problem	O
that	O
leads	O
to	O
at	O
least	O
2	O
million	O
people	O
sickened	O
annually	O
-	O
and	O
23,000	O
dead	O
of	O
infection	O
.	O

It	O
was	O
divided	O
at	O
the	O
same	O
time	O
into	O
the	O
"	O
Ishii	B-Organization
Unit	E-Organization
"	O
and	O
"	O
Wakamatsu	B-Organization
Unit	E-Organization
"	O
with	O
a	O
base	O
in	O
Hsinking	S-Location
.	O
From	O
August	O
1940	O
,	O
the	O
units	O
were	O
known	O
collectively	O
as	O
the	O
"	O
Epidemic	B-Organization
Prevention	I-Organization
and	I-Organization
Water	I-Organization
Purification	I-Organization
Department	I-Organization
of	I-Organization
the	I-Organization
Kwantung	I-Organization
Army	E-Organization
(	O
関東軍防疫給水部本部	S-Organization
)	O
"	O
Yuki	B-Person
Tanaka	E-Person
,	O
Hidden	O
Horrors	O
,	O
1996	O
,	O
p.136	O
or	O
"	O
"	O
(満州第731部隊)	O
for	O
short	O
.	O

The	O
report	O
cited	O
increased	O
globalization	O
,	O
rapid	O
international	O
air	O
travel	O
,	O
and	O
urbanization	O
as	O
increased	O
reasons	O
for	O
concern	O
.	O

Marines	S-Organization
and	O
sailors	O
with	O
the	O
Chemical	B-Organization
Biological	I-Organization
Incident	I-Organization
Response	I-Organization
Force	E-Organization
(	O
CBRIF	S-Organization
)	O
participated	O
in	O
Exercise	B-Activity
Chicago	I-Activity
Response	E-Activity
in	O
Chicago	S-Location
,	O
,	O
trading	O
tactics	O
,	O
techniques	O
,	O
and	O
procedures	O
that	O
could	O
potentially	O
save	O
lives	O
.	O

South	O
Korean	O
society	O
was	O
initially	O
polarised	O
on	O
President	O
Moon	B-Person
Jae-in	E-Person
's	O
response	O
to	O
the	O
crisis	O
;	O
many	O
Koreans	O
signed	O
petitions	O
either	O
calling	O
for	O
's	O
impeachment	O
or	O
praising	O
his	O
response	O
.	O

Tourism	O
was	O
directly	O
impacted	O
in	O
the	O
affected	O
countries	O
.	O

Use	O
of	O
CT	S-Equipment
has	O
increased	O
dramatically	O
over	O
the	O
last	O
two	O
decades	O
.	O

A	O
2015	O
interview-based	O
evaluation	O
of	O
the	O
network	O
,	O
carried	O
out	O
by	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
concluded	O
that	O
the	O
4	O
partners	O
see	O
their	O
work	O
in	O
FBD	S-Platform
as	O
having	O
been	O
democratic	O
,	O
transparent	O
,	O
and	O
equal	O
.	O

The	O
area	O
in	O
question	O
,	O
North	B-Location
Kivu	E-Location
is	O
in	O
the	O
middle	O
of	O
the	O
Kivu	B-Location
Conflict	E-Location
,	O
a	O
military	O
conflict	O
with	O
thousands	O
of	O
displaced	O
refugees	O
.	O

Why	O
did	O
it	O
take	O
so	O
long	O
for	O
the	O
second	O
incident	O
that	O
you've	O
described	O
to	O
be	O
revealed?	O
And	O
how	O
many	O
lab	O
folks	O
at	O
CDC	S-Organization
employees	O
are	O
being	O
tested	O
or	O
are	O
concerned	O
about	O
possible	O
exposure	O
to	O
this	O
mixed	O
with	O
a	O
more	O
easily	O
transmissible	O
flu	O
,	O
I	O
presume?	O

The	O
threat	O
has	O
actually	O
gotten	O
worse	O
since	O
2001.	O
"	O

In	O
October	O
2014	O
,	O
a	O
nursing	O
assistant	O
,	O
Teresa	B-Person
Romero	E-Person
who	O
had	O
cared	O
for	O
these	O
patients	O
became	O
unwell	O
and	O
on	O
6	O
October	O
tested	O
positive	O
for	O
Ebola	S-Disease
,	O
making	O
this	O
the	O
first	O
confirmed	O
case	O
of	O
Ebola	S-Disease
transmission	O
outside	O
of	O
Africa	S-Location
.	O
On	O
19	O
October	O
,	O
it	O
was	O
reported	O
that	O
Romero	S-Person
had	O
recovered	O
,	O
and	O
on	O
2	O
December	O
the	O
WHO	S-Organization
declared	O
Spain	S-Location
Ebola	S-Disease
-free	O
following	O
the	O
passage	O
of	O
42	O
days	O
since	O
was	O
found	O
to	O
be	O
cured	O
.	O

Anthrax	S-Pathogen
also	O
could	O
be	O
released	O
into	O
the	O
air	O
from	O
a	O
truck	O
,	O
building	O
,	O
or	O
plane	O
.	O

This	O
limited	O
capacity	O
is	O
a	O
significant	O
driver	O
behind	O
calls	O
to	O
flatten	O
the	O
curve	O
.	O

Gloved	O
hands	O
sorting	O
through	O
mail	O
during	O
2001	B-Incident
anthrax	I-Incident
scare	E-Incident
anthrax	S-Pathogen
attack	O
could	O
take	O
many	O
forms	O
.	O

Efforts	O
include	O
decontamination	B-Technology
technologies	E-Technology
to	O
restore	O
facilities	O
without	O
causing	O
additional	O
environmental	O
concerns	O
.	O

The	O
moratorium	O
will	O
remain	O
in	O
place	O
pending	O
review	O
by	O
an	O
advisory	O
committee	O
.	O

In	O
2001	O
,	O
Britain	S-Location
was	O
struck	O
by	O
a	O
devastating	O
outbreak	O
of	O
foot-and-mouth	B-Disease
disease	E-Disease
in	O
livestock	O
.	O

In	O
2005	O
,	O
Jay	B-Person
Keasling	E-Person
at	O
the	O
Lawrence	B-Organization
Berkeley	I-Organization
National	I-Organization
Laboratory	E-Organization
in	O
California	S-Location
put	O
a	O
group	O
of	O
genes	O
into	O
yeast	O
to	O
produce	O
a	O
precursor	O
to	O
a	O
drug	O
that	O
treats	O
malaria2	S-Disease
.	O
The	O
drug	O
,	O
artemisinin	S-Drug
,	O
is	O
the	O
most	O
effective	O
antimalarial	O
medication	O
available	O
,	O
but	O
it	O
could	O
previously	O
only	O
be	O
harvested	O
from	O
a	O
herb	O
called	O
Artemisia	O
annua	O
.	O

From	O
there	O
,	O
it	O
was	O
most	O
likely	O
carried	O
by	O
fleas	O
living	O
on	O
the	O
black	O
rats	O
that	O
travelled	O
on	O
Genoese	S-Location
merchant	O
ships	O
,	O
spreading	O
throughout	O
the	O
Mediterranean	B-Location
Basin	E-Location
and	O
reaching	O
Africa	S-Location
,	O
Western	B-Location
Asia	E-Location
,	O
and	O
the	O
rest	O
of	O
Europe	S-Location
via	O
Constantinople	S-Location
,	O
Sicily	S-Location
,	O
and	O
the	O
Italian	B-Location
Peninsula	E-Location
.	O
Current	O
evidence	O
indicates	O
that	O
once	O
it	O
came	O
onshore	O
,	O
the	O
Black	B-Disease
Death	E-Disease
was	O
in	O
large	O
part	O
spread	O
by	O
human	O
fleas	O
–	O
which	O
cause	O
pneumonic	B-Disease
plague	E-Disease
–	O
and	O
the	O
person-to-person	O
contact	O
via	O
aerosols	O
which	O
pneumonic	B-Disease
plague	E-Disease
enables	O
,	O
thus	O
explaining	O
the	O
very	O
fast	O
inland	O
spread	O
of	O
the	O
epidemic	O
,	O
which	O
was	O
faster	O
than	O
would	O
be	O
expected	O
if	O
the	O
primary	O
vector	O
was	O
rat	O
fleas	O
causing	O
.	O

As	O
the	O
Swedish	S-Location
national	O
BSL-3	S-Platform
laboratories	O
are	O
each	O
governed	O
by	O
their	O
own	O
QA	B-Platform
systems	E-Platform
and	O
diagnostic	O
methods	O
,	O
it	O
has	O
been	O
important	O
to	O
define	O
how	O
the	O
FBD	S-Platform
activities	O
relate	O
to	O
existing	O
ways	O
of	O
doing	O
things	O
.	O

Officials	O
specified	O
the	O
platform	O
must	O
include	O
a	O
handful	O
of	O
basic	O
analytics	O
tools	O
that	O
can	O
signal	O
unusual	O
incidents	O
and	O
inform	O
the	O
agency's	O
broader	O
decisions	O
.	O

Another	O
powerful	O
tool	O
developed	O
within	O
New	B-Location
York	I-Location
City	E-Location
for	O
use	O
in	O
countering	O
bioterrorism	O
is	O
the	O
development	O
of	O
the	O
New	B-Platform
York	I-Platform
City	I-Platform
Syndromic	I-Platform
Surveillance	I-Platform
System	E-Platform
.	O
This	O
system	O
is	O
essentially	O
a	O
way	O
of	O
tracking	O
disease	O
progression	O
throughout	O
New	B-Location
York	I-Location
City	E-Location
,	O
and	O
was	O
developed	O
by	O
the	O
New	B-Organization
York	I-Organization
City	I-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Mental	I-Organization
Hygiene	E-Organization
(	O
NYC	B-Organization
DOHMH	E-Organization
)	O
in	O
the	O
wake	O
of	O
the	O
9/11	O
attacks	O
.	O

Pregnant	O
women	O
may	O
be	O
at	O
higher	O
risk	O
for	O
severe	O
infection	O
with	O
COVID‑19	S-Disease
based	O
on	O
data	O
from	O
other	O
similar	O
viruses	O
,	O
like	O
Severe	B-Disease
acute	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
SARS	S-Disease
)	O
and	O
Middle	B-Disease
East	I-Disease
respiratory	I-Disease
syndrome	E-Disease
(	O
MERS	S-Disease
)	O
,	O
but	O
data	O
for	O
COVID‑19	S-Disease
is	O
lacking	O
.	O

Such	O
laboratories	O
,	O
known	O
as	O
Category	O
4	O
or	O
Biosafety	O
level	O
4	O
Labs	O
,	O
are	O
not	O
easy	O
to	O
come	O
by	O
,	O
he	O
said	O
.	O

Unlike	O
most	O
strains	O
of	O
influenza	O
,	O
the	O
Pandemic	B-Pathogen
H1N1/09	I-Pathogen
virus	E-Pathogen
does	O
not	O
disproportionately	O
infect	O
adults	O
older	O
than	O
60 years	O
;	O
this	O
was	O
an	O
unusual	O
and	O
characteristic	O
feature	O
of	O
the	O
H1N1	B-Incident
pandemic	E-Incident
.	O
Even	O
in	O
the	O
case	O
of	O
previously	O
healthy	O
people	O
,	O
a	O
small	O
percentage	O
develop	O
pneumonia	S-Disease
or	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
.	O

Political	O
analysts	O
anticipated	O
it	O
may	O
negatively	O
affect	O
Donald	B-Person
Trump	E-Person
's	O
chances	O
of	O
re-election	O
in	O
the	O
2020	B-Activity
presidential	I-Activity
election	E-Activity
.	O
Beginning	O
in	O
mid-April	O
2020	O
,	O
there	O
were	O
protests	O
in	O
several	O
U.S.	B-Location
states	E-Location
against	O
government-imposed	O
business	O
closures	O
and	O
restricted	O
personal	O
movement	O
and	O
association.	O
"	O
Coronavirus	S-Pathogen
:	O
Anti-Lockdown	O
Protests	O
Grow	O
Across	O
US	S-Location
"	O
.	O
.	O
17	O
April	O
2020	O
.	O

This	O
image	O
weighting	O
is	O
useful	O
for	O
assessing	O
the	O
cerebral	O
cortex	O
,	O
identifying	O
fatty	O
tissue	O
,	O
characterizing	O
focal	B-Disease
liver	I-Disease
lesions	E-Disease
and	O
in	O
general	O
obtaining	O
morphological	O
information	O
,	O
as	O
well	O
as	O
for	O
post-contrast	O
imaging	O
.	O

Prior	O
to	O
the	O
publication	O
of	O
Warren's	O
article	O
(2013)	O
,	O
a	O
professor	O
of	O
physiology	O
John	B-Person
Carmody	E-Person
argued	O
that	O
the	O
epidemic	O
was	O
an	O
outbreak	O
of	O
chickenpox	S-Disease
which	O
took	O
a	O
drastic	O
toll	O
on	O
an	O
Aboriginal	O
population	O
without	O
immunological	O
resistance	O
.	O

However	O
,	O
some	O
inconsistencies	O
were	O
identified	O
.	O

Moreover	O
,	O
secondary	B-Disease
infections	E-Disease
in	O
non-laboratory	O
workers	O
can	O
occur	O
,	O
depending	O
on	O
the	O
communicability	O
of	O
the	O
infectious	O
agent	O
.	O

The	O
tubes	O
were	O
identical	O
in	O
brand	O
and	O
size	O
and	O
only	O
differentiated	O
by	O
color	O
caps	O
and	O
labels	O
.	O

The	O
fire	O
broke	O
out	O
when	O
a	O
gas	O
cylinder	O
exploded	O
on	O
the	O
fifth	O
floor	O
of	O
the	O
six-story	O
laboratory	O
building	O
in	O
the	O
city	O
of	O
Koltsovo	S-Location
The	O
blast	O
caused	O
windows	O
to	O
smash	O
but	O
there	O
was	O
no	O
structural	O
damage	O
to	O
the	O
building	O
,	O
reported	O
.	O

The	O
average	O
research	O
award	O
was	O
$485,985	O
(total	O
costs)	O
for	O
approximately	O
36	O
months	O
.	O

Hospital	O
workers	O
,	O
who	O
worked	O
closely	O
with	O
the	O
highly	O
contagious	O
body	O
fluids	O
of	O
the	O
victims	O
,	O
were	O
especially	O
vulnerable	O
to	O
contracting	O
the	O
virus	O
;	O
in	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
ten	O
per	O
cent	O
of	O
the	O
dead	O
had	O
been	O
healthcare	O
workers	O
.	O

Later	O
in	O
2011	O
,	O
Bos	S-Person
et	O
al.	O
reported	O
in	O
Nature	S-Organization
the	O
first	O
draft	O
genome	O
of	O
Y.	B-Pathogen
pestis	E-Pathogen
from	O
plague	S-Disease
victims	O
from	O
the	O
same	O
East	B-Location
Smithfield	E-Location
cemetery	O
and	O
indicated	O
that	O
the	O
strain	O
that	O
caused	O
the	O
Black	B-Disease
Death	E-Disease
is	O
ancestral	O
to	O
most	O
modern	O
strains	O
of	O
.	O

There	O
are	O
no	O
vaccines	O
to	O
prevent	O
these	O
infections	O
so	O
drugs	O
such	O
as	O
pentamidine	S-Drug
and	O
suramin	S-Drug
,	O
benznidazole	S-Drug
and	O
are	O
used	O
to	O
treat	O
infections	O
.	O

Biohacking	O
entered	O
the	O
San	B-Location
Francisco	E-Location
programmer	O
and	O
maker	O
communities	O
as	O
early	O
as	O
2005	O
,	O
through	O
simple	O
demonstrations	O
of	O
basic	O
experiments	O
.	O

Teaching	O
practical	O
virology	O
in	O
a	O
student	O
laboratory	O
setup	O
presents	O
safety	O
challenges	O
,	O
however	O
.	O

By	O
1960	O
,	O
numerous	O
BW	O
research	O
facilities	O
existed	O
throughout	O
the	O
Soviet	B-Location
Union	E-Location
Although	O
the	O
USSR	S-Organization
also	O
signed	O
the	O
1972	B-Document
Biological	I-Document
Weapons	I-Document
Convention	E-Document
(	O
BWC	S-Document
)	O
,	O
the	O
Soviets	O
subsequently	O
augmented	O
their	O
biowarfare	O
programs	O
.	O

Silencing	O
its	O
effect	O
with	O
siRNA	O
prevented	O
infection	O
of	O
Vero	O
cells	O
.	O

In	O
2015	O
,	O
a	O
team	O
eliminated	O
62	O
copies	O
of	O
a	O
particular	O
retroviral	O
DNA	O
sequence	O
from	O
the	O
pig	O
genome	O
in	O
a	O
kidney	O
epithelial	O
cell	O
.	O

They	O
are:	O
J.	B-Person
Craig	I-Person
Venter	E-Person
,	O
Hamilton	B-Person
Smith	E-Person
,	O
Clyde	B-Person
Hutchison	E-Person
,	O
John	B-Person
Glass	E-Person
,	O
Dan	B-Person
Gibson	E-Person
,	O
Carole	B-Person
Lartigue	E-Person
,	O
Gwyn	B-Person
Benders	E-Person
,	O
Vladimir	B-Person
N.	I-Person
Noskov	E-Person
,	O
Ray-Yuan	B-Person
Chuang	E-Person
,	O
Mikkel	B-Person
A.	I-Person
Algire	E-Person
,	O
Michael	B-Person
G.	I-Person
Montague	E-Person
,	O
Li	B-Person
Ma	E-Person
,	O
Monzia	B-Person
M.	I-Person
Moodie	E-Person
,	O
Chuck	B-Person
Merryman	E-Person
,	O
Sanjay	B-Person
Vashee	E-Person
,	O
Radha	B-Person
Krishnakumar	E-Person
,	O
Nacyra	B-Person
Assad-Garcia	E-Person
,	O
Cynthia	B-Person
Andrews-Pfannkoch	E-Person
,	O
Evgeniya	B-Person
A.	I-Person
Denisova	E-Person
,	O
Lei	B-Person
Young	E-Person
,	O
Zhi-Qing	B-Person
Qi	E-Person
,	O
Thomas	B-Person
H.	I-Person
Segall-Shapiro	E-Person
,	O
Christopher	B-Person
H.	I-Person
Calvey	E-Person
,	O
and	O
.	O

A	O
rats'	O
nest	O
made	O
of	O
shredded	O
biohazard	B-Equipment
bags	E-Equipment
and	O
containing	O
lab	O
supplies	O
was	O
discovered	O
in	O
a	O
secure	O
,	O
fenced-off	O
medical	O
waste	O
accumulation	O
area	O
at	O
the	O
in	O
March	O
2014	O
,	O
the	O
university's	O
biosafety	O
committee	O
minutes	O
and	O
incident	O
report	O
show	O
.	O

The	O
administration's	O
new	O
strategy	O
rightly	O
recognizes	O
biotechnology	O
benefits	O
while	O
calling	O
out	O
the	O
need	O
to	O
strengthen	O
biosafety	O
and	O
biosecurity	O
in	O
the	O
life	O
sciences	O
,	O
including	O
a	O
call	O
to	O
promote	O
global	O
oversight	O
of	O
high-consequence	O
research	O
,	O
such	O
as	O
that	O
involving	O
pandemic	O
pathogens	O
,	O
Inglesby	S-Person
said	O
.	O

The	O
PRESAGED	S-Technology
team	O
compared	O
the	O
performance	O
of	O
the	O
PRESAGED	S-Technology
algorithm	O
when	O
all	O
available	O
physiological	O
features	O
were	O
analyzed	O
against	O
the	O
algorithm's	O
performance	O
when	O
features	O
derived	O
only	O
from	O
the	O
ECG	O
waveform	O
were	O
considered	O
.	O

Did	O
some	O
critical	O
viral	O
genetic	O
event	O
produce	O
a	O
1918	B-Pathogen
virus	E-Pathogen
of	O
remarkable	O
pathogenicity	O
and	O
then	O
other	O
critical	O
genetic	O
event	O
occur	O
soon	O
after	O
the	O
1918	B-Incident
pandemic	E-Incident
to	O
produce	O
an	O
attenuated	O
?	O

As	O
of	O
,	O
more	O
than	O
cases	O
of	O
have	O
been	O
reported	O
in	O
more	O
than	O
countries	O
and	O
territories	O
,	O
resulting	O
in	O
more	O
than	O
deaths	O
;	O
more	O
than	O
people	O
have	O
recovered	O
.	O

In	O
2016	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
American	S-Organization
scientists	O
carried	O
out	O
research	O
on	O
the	O
"	O
Genome	B-Scientific_research_project
Sequence	I-Scientific_research_project
of	I-Scientific_research_project
the	I-Scientific_research_project
Soviet/Russian	I-Scientific_research_project
Vaccine	I-Scientific_research_project
Strain	I-Scientific_research_project
55-VNIIVViM	E-Scientific_research_project
"	O
,	O
which	O
was	O
funded	O
by	O
the	O
U.S.	B-Organization
Defense	I-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
's	O
(	O
DTRA	S-Organization
)	O
Cooperative	O
Biological	O
Engagement	O
Program	O
in	O
Tbilisi	S-Location
,	O
and	O
administered	O
by	O
Metabiota	S-Organization
(the	O
US	S-Location
contractor	O
under	O
the	O
Pentagon	B-Scientific_research_project
program	E-Scientific_research_project
in	O
)	O
.	O

Ventilators	B-Equipment
capable	I-Equipment
of	I-Equipment
pressure	I-Equipment
control	I-Equipment
modes	I-Equipment
and	I-Equipment
high	I-Equipment
PEEP	E-Equipment
are	O
needed	O
to	O
maximise	O
oxygen	O
delivery	O
while	O
minimising	O
the	O
risk	O
of	O
ventilator-associated	B-Phenotype
lung	I-Phenotype
injury	I-Phenotype
and	I-Phenotype
pneumothorax	E-Phenotype
.	O
High	B-Technology
PEEP	E-Technology
may	O
not	O
be	O
available	O
on	O
.	O

Through	O
excretion	O
,	O
the	O
virus	O
spread	O
through	O
drainage	O
.	O

On	O
4	O
September	O
,	O
Butembo	S-Location
a	O
city	O
with	O
almost	O
one	O
million	O
people	O
and	O
an	O
international	O
airport	O
,	O
logged	O
its	O
first	O
fatality	O
in	O
the	O
Ebola	B-Incident
outbreak	E-Incident
.	O
The	O
city	O
of	O
Butembo	S-Location
,	O
in	O
the	O
DRC	S-Location
,	O
has	O
trade	O
links	O
to	O
,	O
which	O
it	O
borders	O
.	O

Therefore	O
,	O
traceability	O
of	O
the	O
transgene	O
and	O
its	O
protein	O
expression	O
in	O
crops	O
is	O
an	O
important	O
issue	O
that	O
needs	O
to	O
be	O
addressed	O
on	O
a	O
priority	O
basis	O
.	O

The	O
instructors	O
are	O
all	O
graduate	O
students	O
,	O
experienced	O
with	O
cell	O
culture	O
techniques	O
and	O
handling	O
of	O
viruses	O
.	O

It's	O
method	O
of	O
transmission	O
makes	O
Ebola	S-Pathogen
less	O
contagious	O
than	O
airborne	O
viruses	O
,	O
and	O
therefore	O
easier	O
to	O
contain	O
,	O
provided	O
that	O
strict	O
protocols	O
for	O
containment	O
are	O
followed	O
,	O
de	B-Person
Bretton-Gordon	E-Person
said	O
.	O

On	O
19	O
April	O
it	O
was	O
reported	O
that	O
the	O
country	O
had	O
its	O
lowest	O
deaths	O
at	O
433	O
in	O
seven	O
days	O
,	O
some	O
businesses	O
after	O
six	O
weeks	O
of	O
lockdown	O
are	O
asking	O
for	O
a	O
loosening	O
of	O
restrictions	O
.	O

To	O
assure	O
effective	O
work	O
,	O
a	O
set	O
of	O
network	O
tools	O
was	O
developed	O
.	O

Existing	O
regulations	O
are	O
not	O
specific	O
to	O
this	O
field	O
,	O
so	O
that	O
the	O
possibility	O
of	O
pathological	O
organisms	O
being	O
created	O
and	O
released	O
unintentionally	O
or	O
intentionally	O
by	O
biohackers	O
has	O
become	O
a	O
matter	O
of	O
concern	O
,	O
for	O
example	O
,	O
in	O
the	O
spirit	O
of	O
the	O
re-creation	O
of	O
the	O
1917	O
flu	B-Pathogen
virus	E-Pathogen
by	O
Armed	B-Organization
Forces	I-Organization
Institute	I-Organization
of	I-Organization
Pathology	E-Organization
researchers	O
in	O
2005	O
.	O

The	O
Open	O
Biological	O
and	O
Biomedical	O
Ontologies	O
foundry	O
provides	O
a	O
suite	O
of	O
open-source	O
ontologies	O
in	O
the	O
biomedical	O
area	O
.	O

Anthrax	S-Person
"	O
,	O
"	O
Chemical	B-Person
Sally	E-Person
"	O
),	O
who	O
was	O
trained	O
at	O
the	O
University	B-Organization
of	I-Organization
Missouri	E-Organization
-	O
helped	O
to	O
rebuild	O
Iraq's	B-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
in	O
the	O
mid-1990s	O
after	O
the	O
Gulf	O
War	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
is	O
a	O
member	O
of	O
the	O
.	O

DIY	O
biology	O
is	O
primarily	O
undertaken	O
by	O
individuals	O
with	O
extensive	O
research	O
training	O
from	O
academia	O
or	O
corporations	O
,	O
who	O
then	O
mentor	O
and	O
oversee	O
other	O
DIY	O
biologists	O
with	O
little	O
or	O
no	O
formal	O
training	O
.	O

Some	O
experts	O
note	O
that	O
CT	S-Technology
scans	O
are	O
known	O
to	O
be	O
"	O
overused,"	O
and	O
"	O
there	O
is	O
distressingly	O
little	O
evidence	O
of	O
better	O
health	O
outcomes	O
associated	O
with	O
the	O
current	O
high	O
rate	O
of	O
scans.	O
"	O

Throughout	O
its	O
history	O
,	O
the	O
U.S.	B-Scientific_research_project
bioweapons	I-Scientific_research_project
program	E-Scientific_research_project
was	O
secret	O
.	O

Laboratory	O
procedures	O
must	O
be	O
documented	O
and	O
recordkeeping	O
must	O
be	O
implemented	O
so	O
that	O
processes	O
used	O
during	O
research	O
are	O
clearly	O
outlined	O
.	O

The	O
relies	O
on	O
3	O
fundamental	O
principles:	O
(1)	O
crises	O
should	O
be	O
managed	O
by	O
the	O
same	O
authorities	O
that	O
manage	O
the	O
relevant	O
activities	O
in	O
normal	O
times	O
;	O
(2)	O
crises	O
should	O
be	O
managed	O
primarily	O
at	O
the	O
local	O
level	O
;	O
and	O
(3)	O
crises	O
should	O
be	O
handled	O
using	O
normal	O
practices	O
.	O

The	O
reviewed	O
systems	O
proved	O
useful	O
for	O
systems	O
biology	O
projects	O
at	O
least	O
in	O
dedicated	O
environments	O
,	O
SysMO-SEEK	S-Platform
out-of-the-box	O
provides	O
most	O
useful	O
features	O
for	O
large-scale	O
systems	O
biology	O
projects	O
.	O

Understanding	O
the	O
long-term	O
consequences	O
of	O
altering	O
genes	O
or	O
experimenting	O
in	O
other	O
ways	O
on	O
humans	O
can	O
be	O
difficult	O
without	O
traditional	O
,	O
controlled	O
experimentation	O
.	O

But	O
in	O
Boston	S-Location
,	O
and	O
perhaps	O
also	O
Quebec	S-Location
,	O
the	O
British	O
may	O
have	O
forced	O
smallpox	S-Pathogen
on	O
civilians	O
.	O

It	O
is	O
known	O
that	O
Vozrozhdeniye	B-Location
Island	E-Location
,	O
located	O
in	O
the	O
Aral	B-Location
Sea	E-Location
,	O
was	O
used	O
as	O
a	O
testing	O
site	O
.	O

Most	O
transmissions	O
occur	O
soon	O
before	O
or	O
after	O
the	O
onset	O
of	O
symptoms	O
.	O

There	O
are	O
many	O
species	O
and	O
subspecies	O
of	O
Mycoplasmas	O
,	O
many	O
with	O
similar	O
sounding	O
names	O
.	O

They	O
could	O
do	O
this	O
by	O
finding	O
genes	O
in	O
other	O
organisms	O
that	O
efficiently	O
produce	O
vitamin	B-Drug
D	E-Drug
,	O
for	O
example	O
,	O
and	O
then	O
add	O
those	O
genes	O
to	O
the	O
food's	O
own	O
genome	O
.	O

Results	O
are	O
generally	O
available	O
within	O
a	O
few	O
hours	O
to	O
two	O
days	O
.	O

Four	O
days	O
later	O
,	O
on	O
26	O
December	O
,	O
the	O
DRC	S-Location
government	O
reversed	O
itself	O
to	O
indicate	O
those	O
Ebola	S-Disease
-stricken	O
areas	O
,	O
such	O
as	O
Beni	S-Location
,	O
would	O
not	O
vote	O
for	O
several	O
months	O
;	O
as	O
a	O
consequence	O
election	O
protesters	O
ransacked	O
an	O
Ebola	S-Disease
assessment	O
center	O
in	O
Beni	S-Location
just	O
24	O
hours	O
later	O
.	O

PhaseIII	B-Activity
clinical	I-Activity
trials	E-Activity
are	O
underway	O
in	O
the	O
U.S.	S-Location
,	O
China	S-Location
,	O
and	O
.	O

Furthermore	O
,	O
humans	O
may	O
also	O
become	O
infected	O
with	O
the	O
illness	O
if	O
the	O
meat	O
of	O
infected	O
animals	O
is	O
not	O
sufficiently	O
heated	O
.	O

Similar	O
increases	O
have	O
been	O
seen	O
in	O
Europe	O
and	O
Asia	O
.	O

Inger	B-Person
Damon,	E-Person
head	O
of	O
the	O
division	O
of	O
high	O
consequence	O
pathogens	O
and	O
pathology	O
.	O

The	O
Post	O
also	O
reported	O
that	O
in	O
July	O
,	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
found	O
samples	O
of	O
staphylococcal	B-Pathogen
enterotoxin	E-Pathogen
,	O
which	O
can	O
cause	O
food	O
poisoning	O
,	O
in	O
an	O
unapproved	O
lab	O
.	O

HindII	O
was	O
the	O
first	O
restriction	O
enzyme	O
,	O
an	O
enzyme	O
that	O
cuts	O
DNA	O
at	O
a	O
specific	O
sequence	O
.	O

A	O
previous	O
ricin	B-Incident
scare	E-Incident
hit	O
the	O
Capitol	S-Location
in	O
2004	O
,	O
when	O
tests	O
identified	O
a	O
letter	O
in	O
a	O
Senate	S-Organization
mailroom	O
that	O
served	O
then-Majority	O
Leader	O
Bill	O
Frist's	O
office	O
.	O

In	O
recent	O
years	O
,	O
the	O
emergence	O
or	O
re-emergence	O
of	O
critical	O
issues	O
in	O
infectious	O
disease	O
and	O
public	O
health	O
has	O
presented	O
new	O
challenges	O
and	O
opportunities	O
for	O
laboratory	O
animal	O
care	O
professionals	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
has	O
a	O
vested	O
interest	O
in	O
outmaneuvering	O
infectious	O
disease	O
.	O

A	O
US	B-Organization
Army	E-Organization
report	O
in	O
1981	O
compared	O
two	O
scenarios	O
–	O
16	O
simultaneous	O
attacks	O
on	O
a	O
city	O
by	O
mosquitoes	O
,	O
infected	O
with	O
Yellow	B-Disease
Fever	E-Disease
,	O
and	O
aerosol	O
attack	O
,	O
and	O
assesses	O
their	O
effectiveness	O
in	O
cost	O
and	O
casualties	O
.	O

Central	O
authorities	O
confirmed	O
the	O
devastating	O
illness	O
in	O
a	O
pig	O
on	O
Friday	O
in	O
a	O
community	O
in	O
Shenyang	S-Location
Shenbei	B-Location
New	I-Location
Area	E-Location
,	O
before	O
killing	O
all	O
the	O
pigs	O
there	O
that	O
were	O
thought	O
to	O
be	O
affected	O
and	O
launching	O
tests	O
on	O
others	O
in	O
the	O
area	O
that	O
might	O
be	O
threatened	O
,	O
reported	O
.	O

On	O
5	O
September	O
1978	O
,	O
Parker's	B-Person
71-year-old	I-Person
father	E-Person
Frederick	B-Person
Witcomb	E-Person
,	O
of	O
Myrtle	B-Location
Avenue	E-Location
,	O
Kings	B-Location
Heath	E-Location
,	O
died	O
while	O
in	O
quarantine	O
at	O
Catherine-de-Barnes	B-Location
Hospital	E-Location
.	O
He	O
appeared	O
to	O
have	O
died	O
following	O
a	O
cardiac	B-Disease
arrest	E-Disease
when	O
visiting	O
his	O
daughter	O
.	O

Ban	S-Person
included	O
an	O
account	O
of	O
his	O
trip	O
to	O
Nanking	S-Location
in	O
1941	O
to	O
participate	O
in	O
the	O
testing	O
of	O
poisons	O
on	O
Chinese	O
prisoners	O
.	O

Emerging	O
Viruses	O
and	O
Genome	B-Technology
Editing	E-Technology
for	O
the	O
Pentagon	S-Organization
,	O
and	O
Synthetic	O
Viruses	O
for	O
the	O
.	O

On	O
17	O
March	O
,	O
an	O
international	O
network	O
of	O
11	O
laboratories	O
was	O
established	O
to	O
determine	O
the	O
cause	O
of	O
SARS	S-Disease
and	O
develop	O
potential	O
treatments	O
.	O

The	O
EIS	B-International_exchange_and_cooperation
program	E-International_exchange_and_cooperation
is	O
a	O
model	O
for	O
the	O
.	O

After	O
the	O
lethal	O
second	O
wave	O
struck	O
in	O
late	O
1918	O
,	O
new	O
cases	O
dropped	O
abruptly –	O
almost	O
to	O
nothing	O
after	O
the	O
peak	O
in	O
the	O
second	O
wave	O
.	O

An	O
increased	O
international	O
donor	O
interest	O
was	O
noted	O
in	O
the	O
BMENA	S-Location
region	O
for	O
biosafety	O
and	O
biosecurity	O
initiatives	O
post	O
2000	O
;	O
80%	O
of	O
the	O
initiatives	O
reviewed	O
were	O
funded	O
by	O
international	O
donor/scientific	O
agencies	O
such	O
as	O
the	O
United	B-Organization
Nations	I-Organization
WHO	I-Organization
and	I-Organization
the	I-Organization
Environment	I-Organization
Programme	E-Organization
(	O
UNEP	S-Organization
)	O
,	O
the	O
International	B-Organization
Council	I-Organization
for	I-Organization
Life	I-Organization
Scientists	E-Organization
(	O
ICLS	S-Organization
)	O
,	O
and	O
CRDF	B-Organization
Global	E-Organization
.	O
United	B-Location
States	E-Location
sponsored/funded	O
biosafety	O
activities	O
organized	O
in	O
2001–2013	O
in	O
the	O
BMENA	S-Location
region	O
included	O
the	O
Department	B-Organization
of	I-Organization
State	I-Organization
Cooperative	I-Organization
Biosafety	I-Organization
Engagement	I-Organization
Program	E-Organization
(	O
CBEP	S-Organization
)	O
and	O
the	O
American	B-Organization
Association	I-Organization
for	I-Organization
the	I-Organization
Advancement	I-Organization
of	I-Organization
Science-Center	I-Organization
for	I-Organization
Science,	I-Organization
Technology,	I-Organization
and	I-Organization
Security	I-Organization
Policy	E-Organization
()	O
.	O

A	O
lab	O
worker	O
at	O
the	O
University	B-Organization
of	I-Organization
Pittsburgh	E-Organization
became	O
infected	O
with	O
Zika	B-Pathogen
virus	E-Pathogen
last	O
month	O
(May	O
23)	O
after	O
accidentally	O
sticking	O
herself	O
with	O
a	O
needle	O
.	O

WHO	S-Organization
Leader	O
Outlines	O
Changes	O
in	O
Response	O
to	O
Ebola	B-Disease
Epidemic	E-Disease
.	O
.	O
and	O
on	O
23	O
March	O
,	O
she	O
stated	O
that	O
"	O
the	O
world	O
remains	O
woefully	O
ill-prepared	O
to	O
respond	O
to	O
outbreaks	O
that	O
are	O
both	O
severe	O
and	O
sustained.	O
"	O

One	O
possible	O
explanation	O
is	O
that	O
these	O
unusual	O
gene	O
segments	O
were	O
acquired	O
from	O
a	O
reservoir	O
of	O
influenza	B-Pathogen
virus	E-Pathogen
that	O
has	O
not	O
yet	O
been	O
identified	O
or	O
sampled	O
.	O

As	O
in	O
other	O
fields	O
,	O
many	O
programming	O
languages	O
can	O
be	O
used	O
in	O
D	O
but	O
most	O
of	O
the	O
languages	O
that	O
are	O
used	O
are	O
those	O
with	O
large	O
bioinformatics	O
libraries	O
.	O

Maintain	O
a	O
somewhat	O
regular	O
sleep	O
schedule	O
,	O
and	O
keep	O
your	O
bedroom	O
dark-or	O
wear	O
an	O
eye	O
mask	O
and	O
bring	O
the	O
darkness	O
wherever	O
you	O
go	O
.	O

For	O
biodefense	O
categorization	O
,	O
the	O
US	B-Organization
CDC	E-Organization
and	O
Russia	S-Location
divided	O
biological	O
agents	O
into	O
three	O
groups	O
,	O
with	O
the	O
EU	S-Location
defining	O
two	O
groups	O
.	O

ASF	S-Disease
occurs	O
among	O
pigs	O
and	O
wild	O
boars	O
.	O

If	O
you	O
cut	O
two	O
pieces	O
of	O
DNA	O
with	O
the	O
same	O
restriction	O
enzyme	O
,	O
you	O
can	O
paste	O
them	O
together	O
.	O

The	O
BEST	S-Scientific_research_project
initiative	O
also	O
includes	O
the	O
development	O
of	O
semi-autonomous	O
methods	O
to	O
facilitate	O
reviews	O
of	O
medical	O
charts	O
.	O

But	O
Kar	S-Person
noted	O
that	O
the	O
document	O
does	O
not	O
address	O
the	O
issue	O
of	O
using	O
medically	O
important	O
antibiotics	O
for	O
disease	O
prevention	O
in	O
herds	O
and	O
flocks	O
,	O
which	O
many	O
experts	O
believe	O
is	O
driving	O
resistance	O
,	O
nor	O
does	O
it	O
include	O
targets	O
for	O
reducing	O
antibiotic	O
use	O
on	O
farms	O
.	O

The	O
university	O
said	O
that	O
's	O
public	O
health	O
department	O
has	O
visited	O
the	O
campus	O
and	O
reviewed	O
the	O
lab's	O
safety	O
procedures	O
.	O

Health	O
agencies	O
,	O
for	O
instance	O
,	O
would	O
be	O
able	O
to	O
respond	O
immediately	O
to	O
emergencies	O
rather	O
than	O
being	O
required	O
first	O
to	O
ask	O
for	O
federal	O
funding	O
.	O

Dispose	O
of	O
according	O
to	O
institutional	O
procedure	O
.	O

These	O
range	O
from	O
disposable	B-Equipment
gloves	E-Equipment
and	O
other	O
personnel	B-Equipment
protective	I-Equipment
equipment	E-Equipment
to	O
complex	O
or	O
other	O
containment	O
devices	O
.	O

1974:	O
The	O
Expanded	O
Programme	O
on	O
Immunization	O
and	O
the	O
control	O
programme	O
of	O
onchocerciasis	S-Disease
was	O
started	O
,	O
an	O
important	O
partnership	O
between	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	E-Organization
(	O
FAO	S-Organization
)	O
,	O
the	O
United	B-Organization
Nations	I-Organization
Development	I-Organization
Programme	E-Organization
(	O
UNDP	S-Organization
)	O
,	O
and	O
the	O
.	O

The	O
number	O
of	O
waste	O
and	O
sharp	O
disposable	O
containers	O
and	O
was	O
not	O
significant	O
when	O
compared	O
to	O
the	O
ideal	O
number	O
that	O
should	O
be	O
provided	O
for	O
laboratories	O
.	O

International	O
research	O
on	O
vaccines	O
and	O
medicines	O
in	O
COVID‑19	S-Disease
is	O
underway	O
by	O
government	O
organisations	O
,	O
academic	O
groups	O
,	O
and	O
industry	O
researchers	O
.	O

Select	O
Agent	O
Registration	O
,	O
American	B-Organization
Society	I-Organization
of	I-Organization
Clinical	I-Organization
Pathologist	E-Organization
())	O
as	O
determined	O
by	O
each	O
local	O
Laboratory	O
Director	O
.	O

DHS	B-Organization
S&a	E-Organization
issued	O
the	O
$300,000	O
Hidden	O
Signals	O
Challenge	O
in	O
collaboration	O
with	O
the	O
Office	B-Organization
of	I-Organization
Health	I-Organization
Affairs	I-Organization
National	I-Organization
Biosurveillance	I-Organization
Integration	I-Organization
Cen	E-Organization
tNBIC)	O
.	O

The	O
prototype	O
has	O
a	O
small	O
,	O
battery-powered	O
cooling	O
pack	O
on	O
the	O
worker's	O
belt.	O
"	O
You'll	O
have	O
air	O
blowing	O
out	O
that	O
is	O
room	O
temperature	O
but	O
it's	O
0%	O
humidity ...	O
the	O
Ebola	S-Disease
worker	O
is	O
going	O
to	O
feel	O
cold	O
and	O
will	O
be	O
able	O
to	O
function	O
inside	O
the	O
suit	O
without	O
having	O
to	O
change	O
the	O
suit	O
so	O
frequently"	O
,	O
said	O
one	O
source	O
.	O

The	O
lab	O
work	O
station	O
design	O
allows	O
for	O
personal	O
supervision	O
of	O
students	O
work	O
by	O
a	O
biological	O
hood	O
even	O
though	O
there	O
are	O
only	O
4	O
hoods	O
and	O
an	O
average	O
of	O
35	O
students	O
per	O
class	O
.	O

The	O
causal	O
agent	O
has	O
not	O
yet	O
been	O
identified	O
or	O
confirmed	O
.	O

Inglesby	S-Person
has	O
delivered	O
testimony	O
on	O
public	O
health	O
preparedness	O
and	O
biosecurity	O
.	O

The	O
M33's	O
sub-munition	O
,	O
the	O
pipe-bomb-like	O
cylindrical	O
M114	O
bomb	O
,	O
was	O
also	O
completed	O
and	O
battle-ready	O
by	O
1952	O
.	O

Category:Medical	O
and	O
health	O
organizations	O
based	O
in	O
Washington,	B-Location
D.C	E-Location

Students	O
also	O
use	O
a	O
recombinant	O
replicative	O
HSV‐1	S-Pathogen
virus	O
(	O
Herpes	B-Pathogen
Simplex	I-Pathogen
Virus	I-Pathogen
type	I-Pathogen
1	E-Pathogen
)	O
8	O
.	O

The	O
new	O
report	O
from	O
the	O
CDC	S-Organization
lists	O
antibiotic	B-Pathogen
resistant	I-Pathogen
Acinetobacter	E-Pathogen
,	O
C.	B-Pathogen
difficile	E-Pathogen
,	O
and	O
as	O
some	O
of	O
the	O
most	O
urgent	O
threats	O
to	O
health	O
,	O
according	O
to	O
recent	O
data	O
.	O

Annualized	O
production	O
capacity	O
for	O
weaponized	O
smallpox	S-Pathogen
,	O
rabies	S-Pathogen
,	O
and	O
typhus	S-Pathogen
,	O
for	O
example	O
,	O
was	O
90	O
to	O
100	O
tons.B	O
.	O

An	O
inflexion	O
point	O
in	O
the	O
race	O
to	O
establish	O
efficient	O
gene	O
therapy	O
approaches	O
with	O
real	O
therapeutic	O
potential	O
for	O
genetic	B-Disease
disorders	E-Disease
was	O
published	O
in	O
October	O
in	O
Science	O
.	O

That	O
was	O
a	O
central	O
recommendation	O
of	O
an	O
October	O
2017	O
WHO	S-Organization
report	O
on	O
antimicrobial	O
use	O
in	O
food-producing	O
animals	O
.	O

This	O
strategy	O
was	O
tried	O
for	O
SARS	S-Disease
with	O
inconclusive	O
results	O
.	O

Chinese	O
aid	O
was	O
well-received	O
in	O
parts	O
of	O
Latin	B-Location
America	E-Location
and	O
Africa	S-Location
.	O
On	O
2April	O
,	O
the	O
launched	O
emergency	O
support	O
operations	O
for	O
developing	O
countries	O
.	O

Each	O
class	O
includes	O
17–25	O
pairs	O
of	O
students	O
.	O

That	O
question	O
did	O
not	O
begin	O
to	O
be	O
resolved	O
until	O
the	O
1930s	O
,	O
when	O
closely	O
related	O
influenza	S-Disease
viruses	O
(now	O
known	O
to	O
be	O
H1N1	B-Pathogen
viruses	E-Pathogen
)	O
were	O
isolated	O
,	O
first	O
from	O
pigs	O
and	O
shortly	O
thereafter	O
from	O
humans	O
.	O

The	O
Soviet	B-Organization
government	E-Organization
claimed	O
the	O
deaths	O
were	O
caused	O
by	O
intestinal	O
anthrax	S-Pathogen
from	O
tainted	O
meat	O
,	O
a	O
story	O
some	O
influential	O
American	O
scientists	O
found	O
believable	O
.	O

Many	O
online	O
tools	O
are	O
available	O
to	O
aid	O
in	O
designing	O
effective	O
sgRNA	B-Technology
sequences	E-Technology

The	O
international	B-Document
Cartagena	I-Document
Protocol	I-Document
on	I-Document
Biosafety	E-Document
deals	O
primarily	O
with	O
but	O
many	O
advocacy	O
groups	O
seek	O
to	O
expand	O
it	O
to	O
include	O
post-genetic	O
threats:	O
new	O
molecules	O
,	O
artificial	O
life	O
forms	O
,	O
and	O
even	O
robots	O
which	O
may	O
compete	O
directly	O
in	O
the	O
natural	O
food	O
chain	O
.	O

She	O
also	O
noted	O
that	O
Rabies	S-Disease
is	O
one	O
of	O
the	O
top	O
five	O
priority	O
zoonotic	O
diseases	O
in	O
that	O
affect	O
both	O
animals	O
and	O
human	O
and	O
spread	O
to	O
people	O
mainly	O
through	O
the	O
bite	O
of	O
rabies-infected	O
dogs	O
.	O

We	O
identified	O
antimicrobial	O
resistance	O
genes	O
by	O
using	O
the	O
National	B-Equipment
Center	I-Equipment
for	I-Equipment
Biotechnology	I-Equipment
Information	I-Equipment
Pathogen	I-Equipment
Detection	I-Equipment
Isolates	I-Equipment
Browser	E-Equipment
,	O
which	O
uses	O
Link)	O
.	O

By	O
mid-May	O
reports	O
of	O
new	O
cases	O
began	O
to	O
level	O
off	O
and	O
most	O
states	O
began	O
to	O
open	O
restaurants	O
and	O
other	O
places	O
of	O
business	O
,	O
placing	O
limits	O
to	O
the	O
numbers	O
of	O
people	O
allowed	O
in	O
the	O
establishment	O
at	O
the	O
same	O
time	O
.	O

Peter	B-Person
Piot	E-Person
,	O
co-discoverer	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
called	O
the	O
WHO	B-Organization
regional	I-Organization
office	I-Organization
in	I-Organization
Africa	E-Organization
"	O
really	O
not	O
competent.	O
"	O
In	O
April	O
2015	O
,	O
the	O
admitted	O
very	O
serious	O
failings	O
in	O
handling	O
the	O
crisis	O
and	O
indicated	O
reforms	O
for	O
any	O
future	O
crises	O
;	O
"	O
we	O
did	O
not	O
work	O
effectively	O
in	O
coordination	O
with	O
other	O
partners	O
,	O
there	O
were	O
shortcomings	O
in	O
risk	O
communications	O
and	O
there	O
was	O
confusion	O
of	O
roles	O
and	O
responsibilities"	O
.	O

Some	O
of	O
their	O
techniques	O
for	O
achieving	O
that	O
are	O
things	O
people	O
have	O
been	O
doing	O
for	O
centuries	O
,	O
like	O
Vipassana	O
meditation	O
and	O
intermittent	O
fasting	O
.	O

The	O
Center	B-Organization
for	I-Organization
Civilian	I-Organization
Biodefense	I-Organization
Strategies	E-Organization
recommends	O
governments	O
and	O
the	O
scientific	O
community	O
take	O
steps	O
to	O
ensure	O
security	O
without	O
hampering	O
legitimate	O
research	O
or	O
the	O
flow	O
of	O
information	O
.	O

For	O
example	O
,	O
BD21	S-Document
will	O
continuously	O
scan	O
the	O
environment	O
for	O
anomalies	O
,	O
or	O
indicators	O
,	O
that	O
he	O
said	O
may	O
or	O
may	O
not	O
point	O
to	O
the	O
presence	O
of	O
a	O
biological	O
agent	O
.	O

New	O
trends	O
illustrate	O
a	O
greater	O
appreciation	O
of	O
a	O
strong	O
need	O
for	O
a	O
cooperative	O
partnership	O
.	O

Leyva	S-Person
,	O
.	O

MRA	S-Technology
is	O
often	O
used	O
to	O
evaluate	O
the	O
arteries	O
of	O
the	O
neck	O
and	O
brain	O
,	O
the	O
thoracic	O
and	O
abdominal	O
aorta	O
,	O
the	O
renal	O
arteries	O
,	O
and	O
the	O
legs	O
(called	O
a	O
"	O
run-off").	O
A	O
variety	O
of	O
techniques	O
can	O
be	O
used	O
to	O
generate	O
the	O
pictures	O
,	O
such	O
as	O
administration	O
of	O
a	O
paramagnetic	O
contrast	O
agent	O
(gadolinium)	O
or	O
using	O
a	O
technique	O
known	O
as	O
"	O
flow-related	B-Technology
enhancement	E-Technology
"	O
(e.g.	O
,	O
2D	O
and	O
3D	O
time-of-flight	O
sequences)	O
,	O
where	O
most	O
of	O
the	O
signal	O
on	O
an	O
image	O
is	O
due	O
to	O
blood	O
that	O
recently	O
moved	O
into	O
that	O
plane	O
(see	O
also	O
)	O
.	O

An	O
estimate	O
of	O
the	O
case	O
fatality	O
rate	O
for	O
the	O
modern	O
bubonic	B-Disease
plague	E-Disease
following	O
the	O
introduction	O
of	O
antibiotics	O
,	O
is	O
11%	O
,	O
although	O
it	O
may	O
be	O
higher	O
in	O
underdeveloped	O
regions	O
.	O

While	O
that's	O
good	O
stewardship	O
,	O
it	O
means	O
that	O
the	O
company	O
that	O
developed	O
the	O
antibiotic	O
doesn't	O
make	O
much	O
money	O
early	O
in	O
the	O
drug's	O
patent	O
life	O
.	O

In	O
a	O
September	O
2016	O
interview	O
conducted	O
by	O
Homeland	O
Preparedness	O
News	O
,	O
Daniel	B-Person
Gerstein	E-Person
a	O
senior	O
policy	O
researcher	O
for	O
the	O
RAND	B-Organization
Corporation	E-Organization
,	O
stresses	O
the	O
importance	O
in	O
preparing	O
for	O
potential	O
bioterrorist	O
attacks	O
on	O
the	O
nation	O
.	O

This	O
could	O
be	O
a	O
whole	O
new	O
source	O
of	O
energy	O
.	O

These	O
statistics	O
are	O
not	O
timebound	O
and	O
follow	O
a	O
specific	O
population	O
from	O
infection	O
through	O
case	O
resolution	O
.	O

New	O
information	O
about	O
an	O
apparent	O
accident	O
in	O
the	O
former	B-Scientific_research_project
Soviet	I-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
testing	I-Scientific_research_project
program	E-Scientific_research_project
three	O
decades	O
ago	O
has	O
raised	O
some	O
troubling	O
questions	O
about	O
our	O
own	O
nation's	O
ability	O
to	O
protect	O
its	O
citizens	O
against	O
a	O
potential	O
terrorist	O
attack	O
.	O

The	O
network	O
project	O
has	O
been	O
funded	O
by	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
for	O
4	O
consecutive	O
periods	O
and	O
has	O
now	O
been	O
running	O
since	O
2007	O
.	O

These	O
results	O
suggest	O
that	O
the	O
conservative	O
NHP	O
model	O
would	O
be	O
an	O
appropriate	O
model	O
for	O
estimation	O
of	O
human	O
drug	O
exposure.A	O
total	O
of	O
851	O
human	O
volunteers	O
were	O
screened	O
for	O
the	O
safety	O
trial	O
.	O

As	O
the	O
Swedish	S-Location
national	O
BSL-3	S-Platform
laboratories	O
work	O
under	O
different	O
ministries	O
,	O
there	O
is	O
no	O
central	O
command	O
structure	O
to	O
which	O
all	O
laboratories	O
are	O
connected	O
,	O
in	O
contrast	O
to	O
,	O
for	O
example	O
,	O
the	O
,	O
which	O
is	O
overseen	O
by	O
a	O
program	O
leader	O
.	O

For	O
purposes	O
of	O
comparison	O
,	O
the	O
world	O
average	O
dose	O
rate	O
from	O
naturally	O
occurring	O
sources	O
of	O
background	O
radiation	O
is	O
2.	O
4 mSv	O
per	O
year	O
,	O
equal	O
for	O
practical	O
purposes	O
in	O
this	O
application	O
to	O
2.	O
4 mGy	O
per	O
year	O
.	O

LabKey	S-Platform
server	O
is	O
an	O
open-source	O
data	O
management	O
system	O
developed	O
by	O
LabKey	S-Platform
Software	O
with	O
the	O
focus	O
on	O
specimen	O
management	O
.	O

In	O
Hong	B-Location
Kong	E-Location
,	O
an	O
entire	O
hotel	O
was	O
quarantined	O
with	O
240	O
guests	O
;	O
Australia	S-Organization
ordered	O
a	O
cruise	O
ship	O
with	O
2,000	O
passengers	O
to	O
stay	O
at	O
sea	O
because	O
of	O
a	O
swine	B-Disease
flu	E-Disease
threat	O
.	O

Transmission	O
can	O
be	O
direct	O
from	O
animal	O
to	O
human	O
,	O
from	O
animal	O
to	O
"	O
bridge"	O
animal	O
to	O
human	O
,	O
or	O
animal	O
to	O
vector	O
to	O
human	O
.	O

Using	O
helium	O
or	O
xenon	O
has	O
the	O
advantage	O
of	O
reduced	O
background	O
noise	O
,	O
and	O
therefore	O
increased	O
contrast	O
for	O
the	O
image	O
itself	O
,	O
because	O
these	O
elements	O
are	O
not	O
normally	O
present	O
in	O
biological	O
tissues	O
.	O

The	O
WHA	S-Organization
composed	O
of	O
representatives	O
from	O
all	O
194	O
member	O
states	O
,	O
serves	O
as	O
the	O
agency's	O
supreme	O
decision-making	O
body	O
.	O

On	O
15	O
February	O
,	O
the	O
U.S.	S-Location
announced	O
it	O
would	O
evacuate	O
Americans	O
aboard	O
the	O
cruise	O
ship	O
Diamond	O
Princess	O
,	O
and	O
on	O
21	O
February	O
,	O
Canada	S-Location
evacuated	O
129	O
Canadian	O
passengers	O
from	O
the	O
ship	O
.	O

Martin	S-Person
,	O
Op.cit	O
.	O

In	O
recent	O
years	O
,	O
there	O
are	O
various	O
DIY	O
ways	O
to	O
live	O
healthy	O
and	O
many	O
of	O
them	O
also	O
focuses	O
on	O
different	O
simple	O
ways	O
to	O
biohack	O
mind	O
,	O
body	O
,	O
metabolism	O
and	O
sleep	O
.	O

Because	O
the	O
1918	O
gene	O
segments	O
have	O
more	O
synonymous	O
changes	O
from	O
known	O
sequences	O
of	O
wild	B-Pathogen
bird	I-Pathogen
strains	E-Pathogen
than	O
expected	O
,	O
they	O
are	O
unlikely	O
to	O
have	O
emerged	O
directly	O
from	O
an	O
avian	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
similar	O
to	O
those	O
that	O
have	O
been	O
sequenced	O
so	O
far	O
.	O

But	O
the	O
denied	O
any	O
activities	O
relating	O
to	O
biological	O
weapons	O
and	O
at	O
numerous	O
international	O
conferences	O
tried	O
to	O
prove	O
their	O
contaminated	O
meat	O
story	O
.	O

"	O
Creating	O
new	O
demands	O
for	O
plant	O
materials	O
will	O
never	O
solve	O
the	O
problem	O
of	O
climate	O
change	O
"	O
stated	O
Rachel	B-Person
Smolker	E-Person
from	O
.	O
"	O
Incredibly,	O
some	O
are	O
now	O
advocating	O
that	O
we	O
burn	O
massive	O
quantities	O
of	O
plant	O
material	O
to	O
make	O
charcoal	O
(aka	O
biochar)	O
and	O
bury	O
it	O
in	O
soils	O
.	O

The	O
office	B-Organization
of	I-Organization
the	I-Organization
assistant	I-Organization
secretary	I-Organization
for	I-Organization
preparedness	I-Organization
and	I-Organization
response	E-Organization
(	O
ASPR	S-Organization
)	O
oversees	O
the	O
process	O
by	O
which	O
the	O
government	O
awards	O
contracts	O
to	O
private	O
biotechnology	O
companies	O
that	O
develop	O
and	O
manufacture	O
medicines	O
such	O
as	O
anthrax	B-Vaccine
vaccine	E-Vaccine
.	O
The	O
CDC	S-Organization
then	O
is	O
responsible	O
for	O
buying	O
and	O
replenishing	O
the	O
materials	O
.	O

Lokela	S-Person
died	O
shortly	O
afterwards	O
on	O
8	O
September	O
.	O

Confirmed	O
diagnosis	O
of	O
pandemic	B-Disease
H1N1	I-Disease
flu	E-Disease
requires	O
testing	O
of	O
a	O
nasopharyngeal	O
,	O
nasal	O
,	O
or	O
oropharyngeal	O
tissue	O
swab	O
from	O
the	O
patient	O
.	O

As	O
of	O
August	O
2019	O
,	O
Merck	B-Organization
&amp	E-Organization
Co	O
,	O
the	O
producers	O
of	O
the	O
vaccine	O
in	O
use	O
,	O
reported	O
a	O
stockpile	O
sufficient	O
for	O
500,000	O
individuals	O
,	O
with	O
more	O
in	O
production	O
.	O

And	O
those	O
experiments	O
which	O
we	O
did	O
and	O
a	O
partner	O
laboratory	O
,	O
the	O
Michigan	B-Organization
Department	I-Organization
of	I-Organization
Community	I-Organization
Health	E-Organization
did	O
,	O
suggested	O
that	O
for	O
one	O
form	O
of	O
anthrax	S-Pathogen
,	O
the	O
form	O
that	O
grows	O
,	O
this	O
procedure	O
certainly	O
killed	O
all	O
of	O
the	O
organisms	O
.	O

Study	O
subject:	O
Diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
state	O
represented	O
as	O
study	O
subject	O
which	O
included	O
laboratories	O
belonged	O
to	O
government	O
,	O
private	O
institutions	O
and	O
organization	O
providing	O
health	O
services	O
.	O

The	O
lecture	O
,	O
given	O
twice	O
during	O
the	O
second	O
lab	O
period	O
,	O
provides	O
theoretical	O
background	O
on	O
methods	O
for	O
counting	O
cells	O
,	O
transfection	O
,	O
and	O
infection	O
approaches	O
,	O
and	O
practical	O
guidelines	O
for	O
selecting	O
the	O
right	O
method	O
or	O
approach	O
under	O
different	O
circumstances	O
.	O

In	O
remarks	O
,	O
both	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
and	O
the	O
United	B-Organization
States	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
assured	O
the	O
Government	B-Organization
of	I-Organization
Liberia	E-Organization
of	O
their	O
commitment	O
in	O
supporting	O
the	O
"	O
One	O
Health	O
"	O
Approach	O
geared	O
towards	O
preventing	O
rabies	S-Disease
in	O
.	O

So	O
what	O
was	O
that	O
,	O
please?	O
It	O
clearly	O
wasn't	O
seasonal	O
flu	O
.	O

The	O
1979	O
Nobel	O
Prize	O
in	O
Physiology	O
or	O
Medicine	O
was	O
awarded	O
jointly	O
to	O
South	O
African	O
American	O
physicist	O
Allan	B-Person
M.	I-Person
Cormack	E-Person
and	O
British	O
electrical	O
engineer	O
Godfrey	B-Person
N.	I-Person
Hounsfield	E-Person
"	O
for	O
the	O
development	O
of	O
.	O
"	O

The	O
Cas9	O
/gRNAs	O
delivery	O
systems	O
infectivity	O
,	O
chromatin	O
state	O
and	O
self-renewal	O
rate	O
of	O
the	O
targeted	O
cells	O
are	O
key	O
for	O
the	O
success	O
of	O
the	O
technique	O
.	O

They	O
are	O
designed	O
to	O
protect	O
from	O
airborne	O
particles	O
like	O
dust	O
but	O
effectiveness	O
against	O
a	O
specific	O
biological	O
agent	O
is	O
not	O
guaranteed	O
for	O
off-label	O
uses	O
.	O

But	O
in	O
1977	O
,	O
human	O
H1N1	B-Pathogen
viruses	E-Pathogen
suddenly	O
"	O
reemerged"	O
from	O
a	O
laboratory	O
freezer	O
.	O

The	O
International	B-Document
Regulations	I-Document
and	I-Document
the	I-Document
Codex	I-Document
guidelines	E-Document
regulate	O
the	O
biosafety	O
requirements	O
of	O
the	O
GM	S-Technology
crops	O
.	O

Thousands	O
of	O
men	O
,	O
women	O
,	O
children	O
and	O
infants	O
interned	O
at	O
prisoner	O
of	O
war	O
camps	O
were	O
subjected	O
to	O
vivisection	O
,	O
often	O
without	O
anesthesia	O
and	O
usually	O
ending	O
with	O
the	O
death	O
of	O
the	O
victim	O
.	O

Senator	O
Ayala's	O
proposal	O
became	O
law	O
June	O
22	O
,	O
1990	O
,	O
and	O
added	O
Section	O
6306	O
to	O
the	O
.	O

It	O
also	O
stood	O
by	O
its	O
recommendation	O
based	O
upon	O
its	O
own	O
analysis	O
of	O
scientific	O
studies	O
.	O

The	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
(	O
DTRA	S-Organization
)	O
has	O
outsourced	O
much	O
of	O
the	O
work	O
under	O
the	O
military	O
program	O
to	O
private	O
companies	O
,	O
which	O
are	O
not	O
held	O
accountable	O
to	O
Congress	S-Organization
,	O
and	O
which	O
can	O
operate	O
more	O
freely	O
and	O
move	O
around	O
the	O
rule	O
of	O
law	O
.	O

The	O
lungs	O
are	O
the	O
organs	O
most	O
affected	O
by	O
COVID‑19	S-Disease
because	O
the	O
virus	O
accesses	O
host	O
cells	O
via	O
the	O
enzyme	O
angiotensin-converting	O
enzyme	O
2	O
(ACE2)	O
,	O
which	O
is	O
most	O
abundant	O
in	O
type	O
II	O
alveolar	O
cells	O
of	O
the	O
lungs	O
.	O

CDC	S-Organization
guiding	O
principles	O
for	O
laboratory	O
work	O
are	O
to	O
ensure	O
the	O
safety	O
of	O
all	O
staff	O
and	O
the	O
community	O
and	O
be	O
as	O
transparent	O
as	O
possible	O
about	O
our	O
work	O
as	O
we	O
conduct	O
high-quality	O
scientific	O
research	O
to	O
protect	O
people	O
in	O
this	O
country	O
and	O
around	O
the	O
world	O
.	O

PPE	S-Equipment
removal	O
in	O
the	O
region	O
and	O
the	O
2nd	O
changing	O
room	O
should	O
be	O
carefully	O
monitored	O
by	O
a	O
working	O
partner	O
or	O
by	O
the	O
staffs	O
in	O
the	O
central	O
control	O
room	O
through	O
the	O
emergency	O
window	O
(Fig.1)	O
.	O

A	O
number	O
of	O
laboratories	O
and	O
companies	O
have	O
developed	O
serological	B-Technology
tests	E-Technology
which	O
detect	O
antibodies	O
produced	O
by	O
the	O
body	O
in	O
response	O
to	O
infection	O
.	O

This	O
makes	O
it	O
imperative	O
that	O
the	O
Bush	B-Organization
administration	E-Organization
press	O
Russia	S-Location
for	O
full	O
details	O
on	O
what	O
was	O
tested	O
and	O
how	O
it	O
was	O
disseminated	O
.	O

The	O
CDC	S-Organization
further	O
indicated	O
that	O
healthcare	O
workers	O
in	O
were	O
less	O
likely	O
to	O
report	O
contact	O
with	O
an	O
infected	O
individual	O
than	O
non-healthcare	O
workers	O
.	O

Computed	B-Technology
tomography	E-Technology
operates	O
by	O
using	O
an	O
X-ray	B-Equipment
generator	E-Equipment
that	O
rotates	O
around	O
the	O
object	O
;	O
X-ray	O
detectors	O
are	O
positioned	O
on	O
the	O
opposite	O
side	O
of	O
the	O
circle	O
from	O
the	O
X-ray	O
source	O
.	O

A	O
fourth	O
Ebola	S-Pathogen
Treatment	O
Center	O
(after	O
those	O
in	O
Mangina	S-Location
,	O
Beni	S-Location
and	O
Butembo	S-Location
)	O
was	O
inaugurated	O
in	O
September	O
in	O
Makeke	S-Location
in	O
the	O
Mandima	B-Location
Health	I-Location
Zone	I-Location
of	I-Location
Ituri	I-Location
Province	E-Location
.	O
Makeke	S-Location
is	O
less	O
than	O
five	O
kilometers	O
from	O
Mangina	S-Location
along	O
a	O
well-traveled	O
local	O
road	O
;	O
the	O
site	O
had	O
been	O
proposed	O
in	O
August	O
when	O
it	O
appeared	O
that	O
a	O
second	O
Ebola	S-Pathogen
Treatment	O
Center	O
would	O
be	O
needed	O
in	O
the	O
area	O
,	O
and	O
space	O
was	O
insufficient	O
in	O
Mangina	S-Location
itself	O
to	O
accommodate	O
one	O
.	O

Even	O
though	O
organisms	O
routinely	O
manipulated	O
at	O
Biosafety	B-Platform
Level	I-Platform
2	E-Platform
are	O
not	O
known	O
to	O
be	O
transmissible	O
by	O
the	O
aerosol	O
route	O
,	O
procedures	O
with	O
aerosol	O
or	O
high	O
splash	O
potential	O
that	O
may	O
increase	O
the	O
risk	O
of	O
such	O
personnel	O
exposure	O
must	O
be	O
conducted	O
in	O
primary	O
containment	O
equipment	O
,	O
or	O
in	O
devices	O
such	O
as	O
a	O
biological	B-Equipment
safety	I-Equipment
cabinet	E-Equipment
(	O
BSC	S-Equipment
)	O
or	O
safety	B-Equipment
centrifuge	I-Equipment
cups	E-Equipment
.	O
Personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
should	O
be	O
used	O
as	O
appropriate	O
,	O
such	O
as	O
,	O
face	O
protection	O
,	O
gowns	O
,	O
and	O
gloves	O
.	O

And	O
third	O
,	O
we	O
had	O
the	O
discovery	O
of	O
vials	O
labeled	O
as	O
smallpox	S-Disease
in	O
a	O
storage	O
room	O
on	O
the	O
NIH	S-Organization
campus	O
and	O
CDC	S-Organization
's	O
work	O
to	O
secure	O
and	O
to	O
characterize	O
these	O
materials	O
.	O

This	O
outbreak	O
started	O
just	O
days	O
after	O
the	O
end	O
of	O
the	O
outbreak	O
in	O
.	O

The	O
FAO	S-Organization
warned	O
that	O
the	O
outbreak	O
could	O
endanger	O
harvests	O
and	O
food	O
security	O
in	O
Western	B-Location
Africa	E-Location
,	O
and	O
that	O
with	O
all	O
the	O
quarantines	O
and	O
movement	O
limitations	O
placed	O
on	O
them	O
,	O
more	O
than	O
1	O
million	O
people	O
could	O
be	O
food	O
insecure	O
by	O
March	O
2015	O
.	O

Then	O
,	O
around	O
the	O
1960s	O
,	O
most	O
likely	O
due	O
to	O
climate	O
change	O
or	O
human	O
activities	O
,	O
the	O
genetic	O
diversity	O
of	O
the	O
virus	O
dropped	O
rapidly	O
and	O
most	O
lineages	O
became	O
extinct	O
.	O

Early	O
research	O
in	O
animal	O
models	O
suggest	O
that	O
therapies	O
based	O
on	O
CRISPR	S-Technology
technology	O
have	O
potential	O
to	O
treat	O
a	O
wide	O
range	O
of	O
diseases	O
,	O
including	O
cancer	S-Disease
,	O
beta-thalassemia	S-Disease
,	O
sickle	B-Disease
cell	I-Disease
disease	E-Disease
,	O
hemophilia	S-Disease
,	O
cystic	B-Disease
fibrosis	E-Disease
,	O
Duchenne's	B-Disease
muscular	I-Disease
dystrophy	E-Disease
,	O
Huntington's	B-Disease
disease	E-Disease
,	O
and	O
heart	B-Disease
disease	E-Disease
.	O
may	O
also	O
have	O
applications	O
in	O
tissue	O
engineering	O
and	O
regenerative	O
medicine	O
,	O
such	O
as	O
by	O
creating	O
human	O
blood	O
vessels	O
that	O
lack	O
expression	O
of	O
MHC	O
class	O
II	O
proteins	O
,	O
which	O
often	O
cause	O
transplant	O
rejection	O
.	O

Image	O
caption:	O
The	O
Persistent	B-Scientific_research_project
Aquatic	I-Scientific_research_project
Living	I-Scientific_research_project
Sensors	E-Scientific_research_project
(	O
PALS	S-Scientific_research_project
)	O
program	O
envisions	O
using	O
the	O
natural	O
sensing	O
capabilities	O
of	O
marine	O
organisms	O
to	O
detect	O
the	O
presence	O
of	O
underwater	O
vehicles	O
in	O
strategic	O
waters	O
such	O
as	O
straits	O
and	O
littoral	O
regions.	O
technology	O
would	O
register	O
organisms'	O
responses	O
to	O
target	O
stimuli	O
,	O
process	O
and	O
distill	O
that	O
information	O
,	O
and	O
relay	O
it	O
to	O
remote	O
end	O
users	O
.	O

Established	O
in	O
2003	O
,	O
the	O
mission	O
of	O
the	O
BioWatch	S-Document
program	O
is	O
to	O
provide	O
and	O
maintain	O
a	O
continuous	O
bio-terrorism	O
air	O
monitoring	O
system	O
in	O
large	O
metropolitan	O
areas	O
and	O
coordinate	O
with	O
state	O
and	O
local	O
public	O
health	O
communities	O
to	O
prepare	O
for	O
and	O
respond	O
to	O
a	O
bioterrorist	O
event	O
.	O

A	O
full	O
program	O
description	O
will	O
be	O
made	O
available	O
in	O
a	O
forthcoming	O
Broad	O
Agency	O
Announcement	O
.	O

An	O
accidental	O
release	O
of	O
an	O
infectious	O
disease	O
capable	O
of	O
devastating	O
agriculture	O
could	O
be	O
better	O
controlled	O
in	O
much-more	O
isolated	O
Plum	B-Location
Island	E-Location
than	O
in	O
the	O
college	O
town	O
of	O
Manhattan.	B-Location
Kansas	I-Location
State	E-Location
is	O
free	O
to	O
brag	O
that	O
it	O
is	O
the	O
"	O
''	O
for	O
biodefense	O
all	O
it	O
wants	O
,	O
but	O
it's	O
too	O
risky	O
to	O
move	O
the	O
federal	O
center	O
there	O
.	O

Most	O
cases	O
of	O
COVID‑19	S-Disease
are	O
not	O
severe	O
enough	O
to	O
require	O
mechanical	O
ventilation	O
or	O
alternatives	O
,	O
but	O
a	O
percentage	O
of	O
cases	O
are	O
.	O

Retrieved	O
November	O
17	O
,	O
2008	O
.	O

Then	O
,	O
in	O
2007	O
,	O
there	O
was	O
another	O
outbreak	O
,	O
which	O
was	O
traced	O
to	O
a	O
lab	O
working	O
on	O
the	O
disease	O
.	O

Lab	O
mice	O
infected	O
with	O
deadly	O
viruses	O
have	O
escaped	O
,	O
and	O
wild	O
rodents	O
have	O
been	O
found	O
making	O
nests	O
with	O
research	O
waste	O
.	O

The	O
facility	O
was	O
set	O
up	O
in	O
1974	O
as	O
a	O
closed	O
institute	O
researching	O
vaccines	O
and	O
"	O
defences	O
against	O
bacteriological	O
and	O
biological	O
weapons"	O
,	O
Russian	B-Organization
Interfax	I-Organization
news	I-Organization
agency	E-Organization
reports	O
.	O

Data	O
centers	O
are	O
the	O
basis	O
of	O
this	O
infrastructure	O
,	O
but	O
networks	O
of	O
institutional	O
repositories	O
gain	O
importance	O
.	O

As	O
the	O
Swedish	O
national	O
BSL-3	S-Platform
laboratories	O
work	O
under	O
different	O
ministries	O
,	O
there	O
is	O
no	O
central	O
command	O
structure	O
to	O
which	O
all	O
laboratories	O
are	O
connected	O
,	O
in	O
contrast	O
to	O
,	O
for	O
example	O
,	O
the	O
,	O
which	O
is	O
overseen	O
by	O
a	O
program	O
leader	O
.	O

In	O
late	O
March	O
2020	O
,	O
the	O
WHO	S-Organization
and	O
other	O
health	O
bodies	O
began	O
to	O
replace	O
the	O
use	O
of	O
the	O
term	O
"	O
social	O
distancing	O
"	O
with	O
"	O
physical	O
distancing"	O
,	O
to	O
clarify	O
that	O
the	O
aim	O
is	O
to	O
reduce	O
physical	O
contact	O
while	O
maintaining	O
social	O
connections	O
,	O
either	O
virtually	O
or	O
at	O
a	O
distance	O
.	O

This	O
was	O
estimated	O
as	O
ranging	O
from	O
5	O
million	O
in	O
Brazil	S-Location
to	O
up	O
to	O
590 million	O
in	O
by	O
the	O
year	O
2030	O
.	O

For	O
this	O
purpose	O
,	O
a	O
prison	O
was	O
constructed	O
to	O
contain	O
around	O
three	O
to	O
four	O
hundred	O
people	O
.	O

The	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
outbreak	O
in	O
Zaire	S-Location
(	O
Yambuku	S-Location
)	O
started	O
in	O
late	O
1976	O
,	O
and	O
was	O
the	O
second	O
outbreak	O
ever	O
after	O
the	O
earlier	O
one	O
in	O
Sudan	S-Location
the	O
same	O
year	O
.	O

The	O
method	O
has	O
its	O
roots	O
in	O
PCR	S-Equipment
but	O
integrates	O
many	O
technologies	O
.	O

This	O
gender	O
disparity	O
is	O
thought	O
to	O
be	O
because	O
most	O
women	O
in	O
Saudi	B-Location
Arabia	E-Location
wear	O
veils	O
that	O
cover	O
the	O
mouth	O
and	O
nose	O
,	O
decreasing	O
their	O
chances	O
of	O
being	O
exposed	O
to	O
the	O
virus	O
.	O

Bats	O
drop	O
partially	O
eaten	O
fruit	O
and	O
pulp	O
,	O
then	O
land	O
mammals	O
such	O
as	O
gorillas	O
and	O
duikers	O
feed	O
on	O
this	O
fallen	O
fruit	O
.	O

At	O
the	O
same	O
time	O
,	O
it	O
will	O
strengthen	O
the	O
results-based	O
planning	O
(collection	O
,	O
data	O
management,)	O
;	O
strengthen	O
resource	O
mobilization	O
and	O
financial	O
sustainability	O
of	O
the	O
national	O
action	O
plan	O
to	O
overcome	B-Incident
transmitted	I-Incident
rabies	E-Incident
advocate	O
for	O
the	O
national	O
ownership	O
of	O
the	O
and	O
improve	O
monitoring	O
,	O
evaluation	O
,	O
surveillance	O
and	O
research	O
on	O
rabies	O
prevention	O
as	O
well	O
as	O
control	O
and	O
eradication	O
.	O

"	O
We	O
hope	O
we	O
can	O
upgrade	O
to	O
better	O
technology	O
not	O
only	O
to	O
train	O
our	O
students	O
but	O
all	O
people	O
that	O
come	O
here	O
for	O
medical	O
education	O
simulation	O
training,	O
"	O
Reilly	S-Person
said	O
.	O

There	O
are	O
various	O
theories	O
of	O
why	O
the	O
Spanish	B-Disease
flu	E-Disease
was	O
"	O
forgotten".	O
The	O
rapid	O
pace	O
of	O
the	O
pandemic	O
,	O
which	O
,	O
for	O
example	O
,	O
killed	O
most	O
of	O
its	O
victims	O
in	O
the	O
United	B-Location
States	E-Location
within	O
less	O
than	O
nine	O
months	O
,	O
resulted	O
in	O
limited	O
media	O
coverage	O
.	O

Rep	O
.	O

The	O
aim	O
of	O
FBD	S-Platform
was	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
laboratories	O
through	O
harmonization	O
.	O

However	O
,	O
such	O
factors	O
cannot	O
explain	O
the	O
3	O
pandemic	O
waves	O
of	O
1918–1919	O
,	O
which	O
occurred	O
in	O
the	O
spring-summer	O
,	O
summer-fall	O
,	O
and	O
winter	O
(of	O
the	O
Northern	O
Hemisphere)	O
,	O
respectively	O
.	O

New	O
'prime'	O
genome	O
editor	O
could	O
surpass	O
CRISPR	S-Technology
.	O
,	O
Science.	O
21	O
October	O
2019	O
.	O

The	O
request	O
,	O
which	O
will	O
come	O
from	O
the	O
White	B-Organization
House's	I-Organization
Office	I-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	I-Organization
and	I-Organization
National	I-Organization
Security	I-Organization
Council	E-Organization
will	O
not	O
use	O
the	O
word	O
"	O
suspend,"	O
the	O
source	O
says	O
.	O

Once	O
polio	S-Disease
is	O
eradicated	O
,	O
and	O
I	O
am	O
confident	O
it	O
will	O
be	O
,	O
we'll	O
need	O
to	O
do	O
something	O
very	O
similar	O
with	O
the	O
virus	O
.	O

Iran	S-Location
President	O
Hassan	B-Person
Rouhani	E-Person
wrote	O
a	O
public	O
letter	O
to	O
world	O
leaders	O
asking	O
for	O
help	O
on	O
14	O
March	O
2020	O
,	O
saying	O
they	O
were	O
struggling	O
to	O
fight	O
the	O
outbreak	O
due	O
to	O
a	O
lack	O
of	O
access	O
to	O
international	O
markets	O
from	O
the	O
United	B-Location
States	E-Location
sanctions	O
against	O
Iran	S-Location
.	O
Saudi	B-Organization
Arabia	E-Organization
,	O
which	O
launched	O
a	O
military	O
intervention	O
in	O
in	O
March	O
2015	O
,	O
declared	O
a	O
ceasefire	O
.	O

This	O
type	O
of	O
attack	O
would	O
mean	O
the	O
anthrax	B-Pathogen
spores	E-Pathogen
could	O
easily	O
be	O
blown	O
around	O
by	O
the	O
wind	O
or	O
carried	O
on	O
people's	O
clothes	O
,	O
shoes	O
,	O
and	O
other	O
objects	O
.	O

The	O
calculations	O
were	O
not	O
allowed	O
to	O
factor	O
in	O
such	O
delays	O
as	O
food	O
and	O
fuel	O
stops	O
and	O
other	O
time	O
spent	O
waiting	O
at	O
,	O
for	O
instance	O
,	O
a	O
factory	O
for	O
a	O
load	O
.	O

The	O
retail	O
sector	O
has	O
been	O
impacted	O
globally	O
,	O
with	O
reductions	O
in	O
store	O
hours	O
or	O
temporary	O
closures	O
.	O

The	O
New	B-Organization
York	I-Organization
Times	E-Organization
.	O
and	O
on	O
3	O
September	O
2015	O
,	O
Liberia	S-Location
was	O
declared	O
-free	O
again	O
.	O

The	O
last	O
topic	O
covered	O
during	O
the	O
third	O
and	O
fourth	O
labs	O
is	O
quantification	O
of	O
the	O
HSV‐1	S-Pathogen
virus	O
using	O
an	O
immunocytological	O
method	O
and	O
the	O
enzyme‐linked	B-Equipment
immunosorbent	I-Equipment
assay	E-Equipment
(	O
ELISA	S-Equipment
)	O
detection	O
technique	O
13	O
.	O

But	O
the	O
project's	O
success	O
could	O
signal	O
the	O
impact	O
of	O
synthetic	O
DNA	O
on	O
the	O
future	O
of	O
biotechnology	O
.	O

West	B-Location
Africa	E-Location
is	O
now	O
also	O
home	O
to	O
large	O
collections	O
of	O
samples	O
,	O
and	O
we	O
are	O
putting	O
a	O
high	O
priority	O
on	O
ensuring	O
these	O
collections	O
will	O
not	O
be	O
exploited	O
for	O
malicious	O
purposes	O
.	O

Bloomberg	S-Organization
In	O
March	O
2010	O
,	O
the	O
Council	B-Organization
of	I-Organization
Europe	E-Organization
launched	O
an	O
enquiry	O
into	O
"	O
the	O
influence	O
of	O
the	O
pharmaceutical	O
companies	O
on	O
the	O
global	O
campaign"	O
,	O
and	O
a	O
preliminary	O
report	O
is	O
in	O
preparation	O
.	O

In	O
the	O
UK	S-Location
,	O
the	O
NHS	S-Organization
recommended	O
vaccine	O
priority	O
go	O
to	O
people	O
over	O
six	O
months	O
old	O
who	O
were	O
clinically	O
at	O
risk	O
for	O
,	O
pregnant	O
women	O
and	O
households	O
of	O
people	O
with	O
compromised	O
immunity	O
.	O

The	O
introduction	O
of	O
Bacillus	B-Pathogen
thuringiensis	E-Pathogen
(	O
Bt	S-Pathogen
)	O
genes	O
into	O
the	O
plants	O
has	O
raised	O
issues	O
related	O
to	O
its	O
risk	O
assessment	O
and	O
biosafety	O
.	O

In	O
the	O
1980s	O
and	O
1990s	O
,	O
many	O
of	O
these	O
agents	O
were	O
genetically	O
altered	O
to	O
resist	O
heat	O
,	O
cold	O
,	O
and	O
antibiotics	O
.	O

Inhaled	O
hyperpolarized	O
3He	O
can	O
be	O
used	O
to	O
image	O
the	O
distribution	O
of	O
air	O
spaces	O
within	O
the	O
lungs	O
.	O

Large	O
filters	O
over	O
the	O
exhaust	O
pipes	O
were	O
the	O
only	O
barriers	O
between	O
the	O
anthrax	S-Pathogen
dust	O
and	O
the	O
outside	O
environment	O
.	O

A	O
United	B-Location
Kingdom	E-Location
investigation	O
of	O
risk	O
factors	O
for	O
hospitalisation	O
and	O
poor	O
outcome	O
with	O
pandemic	O
A/H1N1	B-Disease
influenza	E-Disease
looked	O
at	O
631	O
patients	O
from	O
55	O
hospitals	O
admitted	O
with	O
confirmed	O
infection	O
from	O
May	O
through	O
September	O
2009.	O
13%	O
were	O
admitted	O
to	O
a	O
high	O
dependency	O
or	O
intensive	O
care	O
unit	O
and	O
5%	O
died	O
;	O
36%	O
were	O
aged	O
&lt;16	O
years	O
and	O
5%	O
were	O
aged	O
≥65	O
years	O
.	O

A	O
second	O
evaluation	O
parameter	O
is	O
the	O
students'	O
laboratory	O
reports	O
.	O

The	O
earliest	O
documented	O
incident	O
of	O
the	O
intention	O
to	O
use	O
biological	O
weapons	O
is	O
possibly	O
recorded	O
in	O
Hittite	O
texts	O
of	O
1500–1200	O
BC	O
,	O
in	O
which	O
victims	O
of	O
tularemia	S-Pathogen
were	O
driven	O
into	O
enemy	O
lands	O
,	O
causing	O
an	O
epidemic	O
.	O

The	O
agency's	O
National	B-Organization
Biosurveillance	I-Organization
Integration	I-Organization
Center	E-Organization
on	O
Thursday	O
began	O
looking	O
for	O
groups	O
to	O
provide	O
nationwide	O
information	O
on	O
medical	O
interventions	O
,	O
food	O
safety	O
,	O
wildlife	O
health	O
,	O
travel	O
itineraries	O
and	O
other	O
health-related	O
topics	O
.	O

Switching	O
to	O
Keasling	S-Person
's	O
method	O
for	O
production	O
is	O
likely	O
to	O
shave	O
30–60%	O
off	O
the	O
cost	O
of	O
the	O
drug	O
,	O
making	O
it	O
more	O
affordable	O
in	O
the	O
developing	O
countries	O
that	O
need	O
it	O
.	O

In	O
August	O
2015	O
,	O
after	O
substantial	O
progress	O
in	O
reducing	O
the	O
scale	O
of	O
the	O
epidemic	O
,	O
the	O
WHO	S-Organization
held	O
a	O
meeting	O
to	O
work	O
out	O
a	O
"	O
Comprehensive	O
care	O
plan	O
for	O
Ebola	O
survivors	O
"	O
and	O
identify	O
research	O
needed	O
to	O
optimise	O
clinical	O
care	O
and	O
social	O
well-being	O
.	O

So	O
that	O
kind	O
of	O
delay	O
is	O
very	O
troubling	O
.	O

The	O
study	O
was	O
commissioned	O
by	O
the	O
US	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)	O
,	O
funded	O
by	O
the	O
Defense	B-Organization
Health	I-Organization
Agency	E-Organization
's	O
Defense	B-Scientific_research_project
Health	I-Scientific_research_project
Program	E-Scientific_research_project
and	O
performed	O
at	O
the	O
Department	B-Organization
of	I-Organization
Enteric	I-Organization
Diseases	E-Organization
(	O
DED	S-Organization
)	O
,	O
Armed	B-Organization
Forces	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Medical	I-Organization
Sciences	E-Organization
(	O
AFRIMS	S-Organization
)	O
,	O
an	O
overseas	O
laboratory	O
of	O
the	O
Walter	B-Organization
Reed	I-Organization
Army	I-Organization
Institute	I-Organization
of	I-Organization
Research	E-Organization
(	O
WRAIR	S-Organization
)	O
,	O
located	O
in	O
Bangkok	S-Location
,	O
Thailand	S-Location
.	O
The	O
primary	O
goal	O
of	O
this	O
program	O
was	O
to	O
investigate	O
Travelan®	S-Drug
immunological	O
reactivity	O
with	O
pathogenic	O
bacteria	O
including	O
Campylobacter	S-Pathogen
,	O
Enterotoxigenic	B-Pathogen
Escherichia	I-Pathogen
coli	E-Pathogen
(	O
ETEC	S-Pathogen
)	O
and	O
Shigella	S-Pathogen
.	O
The	O
tested	O
bacterial	O
isolates	O
originated	O
from	O
the	O
AFRIMS	S-Organization
's	O
.	O

In	O
the	O
words	O
of	O
one	O
researcher:	O
"	O
Finally,	O
plague	S-Disease
is	O
.	O
"	O

And	O
recombinant	O
viruses	O
,	O
useful	O
for	O
introducing	O
genes	O
into	O
cells	O
in	O
a	O
petri	O
dish	O
,	O
might	O
instead	O
infect	O
the	O
human	O
researchers	O
.	O

South	B-Location
Korea	E-Location
introduced	O
mass	O
screening	O
and	O
localised	O
quarantines	O
,	O
and	O
issued	O
alerts	O
on	O
the	O
movements	O
of	O
infected	O
individuals	O
.	O

In	O
this	O
manual	O
,	O
when	O
conditions	O
are	O
appropriate	O
to	O
the	O
experiments	O
described	O
,	O
the	O
following	O
note	O
will	O
appear	O
in	O
the	O
unit	O
introduction	O
.	O

In	O
addition	O
,	O
they	O
agreed	O
to	O
nominate	O
representatives	O
of	O
the	O
region	O
to	O
participate	O
in	O
the	O
.	O

Michael	B-Person
Burgess	E-Person
(R-TX)	O
,	O
chairman	O
of	O
the	O
House	B-Organization
Energy	I-Organization
and	I-Organization
Commerce	I-Organization
Health	I-Organization
Subcommittee	E-Organization
,	O
noted	O
that	O
the	O
creation	O
of	O
the	O
Assistant	B-Organization
Secretary	I-Organization
of	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
within	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
(	O
HHS	S-Organization
)	O
under	O
the	O
original	O
law	O
has	O
allowed	O
to	O
make	O
"	O
monumental	O
strides	O
"	O
in	O
preparedness	O
,	O
coordination	O
and	O
response	O
.	O

Amongst	O
them	O
to	O
characterize	O
classical	O
,	O
emerging	O
and	O
genetically	O
engineered	O
pathogens	O
for	O
their	O
BTA	O
(biological	O
threat	O
agent)	O
potential	O
;	O
assess	O
the	O
nature	O
of	O
nontraditional	O
,	O
novel	O
and	O
non-endemic	O
induction	O
of	O
disease	O
from	O
potential	O
BTA	O
and	O
to	O
expand	O
aerosol-challenge	O
testing	O
capacity	O
for	O
non-human	O
primates	O
.	O

The	O
third	O
example	O
is	O
not	O
about	O
biological	O
weapons	O
but	O
new	O
types	O
of	O
chemical	O
,	O
or	O
rather	O
biochemical	O
,	O
weapons	O
.	O

The	O
toggle	O
switch	O
and	O
other	O
early	O
examples	O
of	O
engineered	O
circuits	O
showed	O
that	O
the	O
cut-and-paste	B-Technology
genetic	I-Technology
technology	E-Technology
that	O
had	O
been	O
around	O
for	O
almost	O
three	O
decades	O
could	O
be	O
used	O
to	O
give	O
cells	O
functions	O
that	O
hadn't	O
previously	O
existed	O
in	O
any	O
cell	O
.	O

George	B-Person
Church	E-Person
of	O
has	O
proposed	O
using	O
DNA	O
synthesis	O
technology	O
to	O
'de-extinct'	O
the	O
passenger	O
pigeon	O
,	O
wooly	O
mammoth	O
,	O
or	O
even	O
Neanderthals	O
.	O

Future	O
initiatives	O
fostering	O
private–public	O
partnership	O
are	O
strongly	O
recommended	O
for	O
successful	O
and	O
sustainable	O
outcomes	O
.	O

In	O
December	O
2012	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
reported	O
314	O
samples	O
of	O
the	O
2009	O
pandemic	O
H1N1	B-Disease
flu	E-Disease
tested	O
worldwide	O
have	O
shown	O
resistance	O
to	O
oseltamivir	S-Drug
(	O
Tamiflu	S-Drug
)	O
.	O

In	O
February	O
2020	O
,	O
China	S-Location
launched	O
a	O
mobile	O
app	O
to	O
deal	O
with	O
the	O
disease	O
outbreak	O
.	O

RODS	O
,	O
and	O
other	O
systems	O
like	O
it	O
,	O
collect	O
data	O
from	O
sources	O
including	O
clinic	O
data	O
,	O
laboratory	O
data	O
,	O
and	O
data	O
from	O
over-the-counter	O
drug	O
sales	O
.	O

One	O
group	O
of	O
researchers	O
recovered	O
the	O
virus	O
from	O
the	O
bodies	O
of	O
frozen	O
victims	O
and	O
transfected	O
animals	O
with	O
it	O
.	O

The	O
combination	O
of	O
atovaquone	S-Drug
proguanil	S-Drug
(	O
Malarone®	S-Drug
)	O
and	O
doxycycline	S-Drug
are	O
the	O
only	O
-approved	O
prophylactic	O
drugs	O
for	O
malaria	O
prevention	O
.	O

Nikki	B-Person
Shindo	E-Person
of	O
the	O
WHO	S-Organization
has	O
expressed	O
regret	O
at	O
reports	O
of	O
treatment	O
being	O
delayed	O
by	O
waiting	O
for	O
test	O
results	O
and	O
suggests	O
,	O
"	O
[D]octors	O
should	O
not	O
wait	O
for	O
the	O
laboratory	O
confirmation	O
but	O
make	O
diagnosis	O
based	O
on	O
clinical	O
and	O
epidemiological	O
backgrounds	O
and	O
start	O
treatment	O
early.	O
"	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	O
established	O
an	O
External	B-Organization
Laboratory	I-Organization
Safety	I-Organization
Workgroup	E-Organization
()	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
Federal	O
Select	O
Agent	O
Program	O
.	O

Antiviral	O
drugs	O
typically	O
target	O
key	O
components	O
of	O
viral	O
reproduction	O
;	O
for	O
example	O
,	O
oseltamivir	S-Drug
targets	O
influenza	O
neuraminidase	O
,	O
while	O
guanosine	O
analogs	O
inhibit	O
viral	O
DNA	O
polymerase	O
.	O

Sign	O
up	O
for	O
the	O
Future	B-Platform
Perfect	E-Platform
newsletter	O
.	O

All	O
major	O
sporting	O
events	O
were	O
to	O
be	O
held	O
behind	O
closed	O
doors	O
until	O
April	O
,	O
but	O
on	O
9March	O
all	O
sport	O
was	O
suspended	O
completely	O
for	O
at	O
least	O
one	O
month	O
.	O

MIMAS	S-Platform
is	O
used	O
in	O
about	O
50	O
academic	O
laboratories	O
in	O
Switzerland	S-Location
and	O
France	S-Location
.	O
Upload	O
of	O
data	O
in	O
MAGE-TAB	O
format	O
to	O
European	B-Platform
Bioinformatics	I-Platform
Institute's	I-Platform
(EBI)	I-Platform
ArrayExpress	I-Platform
repository	E-Platform
is	O
alleviated	O
with	O
a	O
one-step	O
upload	O
procedure	O
.	O

On	O
14	O
March	O
,	O
South	B-Organization
Africa	E-Organization
repatriated	O
112	O
South	O
Africans	O
who	O
tested	O
negative	O
for	O
the	O
virus	O
from	O
Wuhan	S-Location
,	O
while	O
four	O
who	O
showed	O
symptoms	O
were	O
left	O
behind	O
to	O
mitigate	O
risk	O
.	O

And	O
I	O
will	O
say	O
that	O
we	O
have	O
a	O
lot	O
to	O
cover	O
.	O

Biosurveillance	O
is	O
the	O
science	O
of	O
real-time	O
disease	O
outbreak	O
detection	O
.	O

Much	O
of	O
the	O
military	O
projects	O
on	O
synthetic	O
biology	O
are	O
classified	O
,	O
among	O
them	O
are	O
a	O
number	O
of	O
classified	O
studies	O
by	O
the	O
secretive	O
JASON	S-Organization
group	O
of	O
US	B-Organization
military	E-Organization
advisors	O
–	O
e.g	O
.	O

By	O
the	O
time	O
it	O
passed	O
to	O
the	O
final	O
ferret	O
,	O
his	O
strain	O
of	O
had	O
become	O
directly	O
transmissible	O
between	O
mammals	O
.	O

Antibiotics	O
are	O
fed	O
to	O
livestock	O
to	O
act	O
as	O
growth	O
supplements	O
,	O
and	O
a	O
preventative	O
measure	O
to	O
decrease	O
the	O
likelihood	O
of	O
infections	O
.	O

Forty‐eight	O
hours	O
postinfection	O
,	O
the	O
lab	O
technicians	O
fix	O
the	O
cells	O
with	O
formaldehyde	O
(in	O
a	O
chemical	O
hood)	O
and	O
wash	O
the	O
cells	O
to	O
prepare	O
them	O
for	O
immunocytology	O
.	O

And	O
lately	O
,	O
we've	O
been	O
very	O
busy	O
.	O

Jan	B-Person
Schakowsky	E-Person
(D-IL)	O
during	O
the	O
hearing	O
announced	O
that	O
she	O
had	O
introduced	O
the	O
Securing	B-Document
Experts	I-Document
to	I-Document
Control,	I-Document
Understand,	I-Document
and	I-Document
Respond	I-Document
to	I-Document
Emergencies	I-Document
(SECURE)	I-Document
Act	E-Document
,	O
H.R.	B-Document
5998	E-Document
,	O
which	O
she	O
hopes	O
to	O
get	O
included	O
in	O
the	O
reauthorization	O
.	O

In	O
September	O
,	O
in	O
the	O
town	O
of	O
Womey	S-Location
in	O
,	O
suspicious	O
inhabitants	O
wielding	O
machetes	O
murdered	O
at	O
least	O
eight	O
aid	O
workers	O
and	O
dumped	O
their	O
bodies	O
in	O
a	O
latrine	O
.	O

In	O
the	O
1960s	O
,	O
the	O
U.S.	S-Location
changed	O
its	O
main	O
approach	O
from	O
biological	O
agents	O
aimed	O
to	O
kill	O
to	O
those	O
that	O
would	O
incapacitate	O
.	O

According	O
to	O
the	O
California	B-Organization
Department	I-Organization
of	I-Organization
Food	I-Organization
and	I-Organization
Agriculture	E-Organization
,	O
"	O
California	S-Location
agriculture	O
is	O
nearly	O
a	O
$36.6	O
billion	O
dollar	O
industry	O
that	O
generates	O
$100	O
billion	O
in	O
related	O
economic	O
activity.	O
"	O
The	O
state's	O
agricultural	O
sales	O
first	O
exceeded	O
$30	O
billion	O
in	O
2004	O
,	O
Since	O
1975	O
,	O
California	S-Location
had	O
seen	O
small	O
annual	O
infestations	O
of	O
the	O
medfly	O
,	O
typically	O
ascribing	O
their	O
appearance	O
to	O
the	O
casual	O
shipping	O
of	O
fruit	O
,	O
and	O
visits	O
,	O
between	O
relatives	O
and	O
friends	O
in	O
California	S-Location
and	O
.	O

Garrett	O
,	O
Laurie	O
.	O

For	O
laboratory	O
biosafety	O
assessment	O
,	O
the	O
main	O
consideration	O
is	O
the	O
ability	O
of	O
biological	O
agents	O
to	O
cause	O
disease	O
and	O
the	O
risk	O
of	O
exposure	O
in	O
laboratory	O
accidents	O
.	O

labs	O
(e.g.	O
,	O
culture	B-Equipment
dishes	E-Equipment
serological	B-Equipment
pipettes	E-Equipment
,	O
etc.).	O
"	O
Investigators	O
noted	O
that	O
some	O
smaller	O
items	O
were	O
found	O
,	O
including	O
pipette	B-Equipment
tips	E-Equipment
,	O
gloves	S-Equipment
and	O
plastic	B-Equipment
tubes	E-Equipment
,	O
but	O
speculated	O
that	O
the	O
lab	O
supplies	O
likely	O
came	O
from	O
a	O
nearby	O
dumpster	O
used	O
for	O
non-hazardous	O
lab	O
waste	O
.	O

North	B-Location
America	E-Location
and	O
retailers	O
saw	O
a	O
50–60	O
percent	O
drop	O
.	O

Therefore	O
,	O
governments	O
,	O
funding	O
agencies	O
and	O
the	O
Organization	B-Organization
for	I-Organization
Economic	I-Organization
Cooperation	I-Organization
and	I-Organization
Development	E-Organization
OECD	S-Organization
)	O
commissioned	O
studies	O
concerning	O
the	O
best	O
practice	O
to	O
handle	O
publicly	O
funded	O
research	O
data	O
.	O

The	O
NIAID	B-Platform
TB	I-Platform
Strategic	I-Platform
Framework	E-Platform
aims	O
to	O
progress	O
areas	O
of	O
research	O
opportunity	O
vital	O
to	O
advancing	O
understanding	O
,	O
prevention	O
,	O
and	O
treatment	O
of	O
TB	S-Disease
,	O
and	O
highlights	O
research	O
gaps	O
critical	O
to	O
achieving	O
the	O
aspirational	O
goal	O
of	O
ending	O
.	O

According	O
to	O
the	O
local	O
Veterinary	O
Department	O
report	O
,	O
only	O
one	O
tick	O
from	O
all	O
of	O
the	O
collected	O
species	O
from	O
the	O
infected	O
villages	O
tested	O
positive	O
for	O
the	O
disease	O
.	O

The	O
filters	O
that	O
kept	O
the	O
anthrax	S-Pathogen
dust	O
from	O
leaking	O
into	O
the	O
environment	O
had	O
to	O
be	O
cleaned	O
with	O
the	O
drying	O
machines	O
turned	O
off	O
.	O

Many	O
agents	O
not	O
ordinarily	O
associated	O
with	O
disease	O
processes	O
in	O
humans	O
are	O
,	O
however	O
,	O
opportunistic	O
pathogens	O
and	O
may	O
cause	O
infection	O
in	O
the	O
young	O
,	O
the	O
aged	O
,	O
and	O
immunodeficient	O
or	O
immunosuppressed	O
individuals	O
.	O

They	O
should	O
have	O
been	O
destroyed	O
decades	O
ago	O
,	O
and	O
once	O
we	O
complete	O
the	O
work	O
here	O
,	O
we	O
will	O
destroy	O
them	O
.	O

The	O
epidemic	O
caused	O
significant	O
mortality	O
,	O
with	O
reported	O
CFRs	O
of	O
up	O
to	O
70%	O
.	O

The	O
re-emergence	B-Incident
of	I-Incident
bioterrorism	E-Incident
as	O
a	O
threat	O
activity	O
of	O
individuals	O
or	O
small	O
groups	O
has	O
caused	O
a	O
heightened	O
awareness	O
of	O
biosecurity	O
and	O
improved	O
biosafety	O
.	O

Good	O
preparedness	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
PPE	S-Equipment
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
laboratory	O
sectioning	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

For	O
example	O
,	O
to	O
control	O
mosquitoes	O
,	O
scientists	O
could	O
release	O
males	O
into	O
the	O
wild	O
that	O
have	O
been	O
modified	O
to	O
produce	O
only	O
sterile	O
offspring	O
.	O

The	O
Japanese	O
government	O
severely	O
restricted	O
sea	O
travel	O
to	O
and	O
from	O
the	O
home	O
islands	O
when	O
the	O
pandemic	O
struck	O
.	O

The	O
network	O
project	O
has	O
been	O
funded	O
by	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
for	O
4	O
consecutive	O
periods	O
and	O
has	O
now	O
been	O
running	O
since	O
2007	O
.	O

Wikipedia	S-Platform
Emerges	O
as	O
Trusted	O
Internet	O
Source	O
for	O
Ebola	S-Disease
Information	O
By	O
.Oct.26.2014	O
.	O

Experts	O
discussed	O
surveillance	O
and	O
outbreak	O
response	O
measures	O
,	O
as	O
well	O
as	O
the	O
new	O
dangers	O
such	O
containment	O
efforts	O
face	O
,	O
such	O
as	O
antimicrobial	O
resistance	O
.	O

Since	O
that	O
time	O
,	O
there	O
have	O
been	O
many	O
reports	O
of	O
laboratory‐acquired	O
infection	O
,	O
with	O
many	O
more	O
cases	O
probably	O
having	O
gone	O
unreported	O
.	O

The	O
ring	O
trials	O
include	O
both	O
live	O
and	O
inactivated	O
samples	O
that	O
are	O
prepared	O
by	O
one	O
arranging	O
laboratory	O
and	O
sent	O
to	O
the	O
other	O
participating	O
agencies	O
.	O

They	O
found	O
humidity	O
to	O
be	O
linked	O
with	O
more	O
severe	O
epidemics	O
as	O
it	O
"	O
fosters	O
the	O
dissemination	O
of	O
the	O
bacteria,	O
"	O
(	O
Committee	B-Organization
on	I-Organization
Atmosphere	I-Organization
and	I-Organization
Man	E-Organization
1923)	O
.	O

These	O
guidelines	O
also	O
include	O
an	O
appendix	O
listing	O
the	O
biological	O
agents	O
known	O
to	O
infect	O
humans	O
as	O
well	O
as	O
selected	O
animal	O
agents	O
that	O
may	O
pose	O
theoretical	O
risks	O
if	O
inoculated	O
into	O
humans	O
.	O

A	O
team	O
of	O
reporters	O
who	O
work	O
for	O
the	O
USA	B-Organization
TODAY	I-Organization
Network	I-Organization
of	I-Organization
Gannett	I-Organization
newspapers	E-Organization
and	O
TV	O
stations	O
identified	O
more	O
than	O
200	O
of	O
these	O
high-containment	O
lab	O
facilities	O
in	O
all	O
50	O
states	O
and	O
the	O
District	B-Location
of	I-Location
Columbia	E-Location
operated	O
by	O
government	O
agencies	O
,	O
universities	O
and	O
private	O
companies	O
.	O

On	O
31	O
October	O
2013	O
,	O
the	O
WHO	S-Organization
announced	O
that	O
three	O
patients	O
in	O
Saudi	B-Location
Arabia	E-Location
died	O
of	O
.	O
The	O
patients	O
were	O
one	O
woman	O
and	O
two	O
men	O
and	O
"	O
all	O
had	O
underlying	O
medical	O
conditions	O
but	O
all	O
reported	O
having	O
had	O
no	O
contact	O
with	O
animals	O
before	O
falling	O
ill"	O
.	O

More	O
than	O
people	O
have	O
recovered	O
.	O

Several	O
mobile	O
apps	O
have	O
been	O
implemented	O
or	O
proposed	O
for	O
voluntary	O
use	O
,	O
and	O
as	O
of	O
7April	O
2020	O
more	O
than	O
a	O
dozen	O
expert	O
groups	O
were	O
working	O
on	O
privacy-friendly	O
solutions	O
such	O
as	O
using	O
Bluetooth	O
to	O
log	O
a	O
user's	O
proximity	O
to	O
other	O
cellphones	O
.	O

Full	O
details	O
will	O
be	O
made	O
available	O
in	O
a	O
forthcoming	O
Broad	B-Organization
Agency	I-Organization
Announcement	E-Organization

The	O
National	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
of	I-Organization
Papua	I-Organization
New	I-Organization
Guinea	E-Organization
(	O
NDOH	S-Organization
)	O
and	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
yesterday	O
announced	O
a	O
case	O
of	O
polio	S-Disease
in	O
a	O
3-year	O
old	O
boy	O
from	O
Mulitaka	S-Location
,	O
Laigam	B-Location
District	E-Location
in	O
.	O

It	O
is	O
96%	O
identical	O
at	O
the	O
whole	O
genome	O
level	O
to	O
other	O
bat	O
coronavirus	O
samples	O
(	O
BatCov	B-Pathogen
RaTG13	E-Pathogen
)	O
.	O

This	O
work	O
is	O
of	O
relevance	O
for	O
similar	O
projects	O
such	O
as	O
.	O

Smart	S-Person
,	O
Jeffery	B-Person
K.	E-Person
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
19	O
-	O
The	O
U.S	O
.	O

The	O
DoD	B-Organization
Defense	I-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
(	O
DTRA	S-Organization
)	O
has	O
funded	O
11	O
bio-laboratories	O
in	O
the	O
former	O
Soviet	O
Union	O
Country	O
Ukraine	S-Location
,	O
bordering	O
on	O
.	O

This	O
article	O
examines	O
the	O
status	O
of	O
biosafety	O
regulation	O
across	O
,	O
pertinent	O
challenges	O
and	O
the	O
extent	O
to	O
which	O
regulation	O
fosters	O
or	O
constrains	O
the	O
development	O
of	O
agricultural	O
biotechnology	O
.	O

BSL‐2	S-Platform
practices	O
,	O
equipment	O
,	O
and	O
facility	O
design	O
and	O
construction	O
are	O
applicable	O
to	O
clinical	O
,	O
diagnostic	O
,	O
teaching	O
,	O
and	O
other	O
laboratories	O
in	O
which	O
work	O
is	O
done	O
with	O
the	O
broad	O
spectrum	O
of	O
indigenous	O
moderate‐risk	O
agents	O
that	O
are	O
present	O
in	O
the	O
community	O
and	O
associated	O
with	O
human	O
disease	O
of	O
varying	O
severity	O
.	O

Joseph	B-Person
Lieberman	E-Person
of	O
the	O
experts	O
.	O

On	O
8	O
October	O
,	O
she	O
was	O
readmitted	O
for	O
complications	O
caused	O
by	O
the	O
virus	O
and	O
was	O
in	O
"	O
serious"	O
condition	O
,	O
according	O
to	O
a	O
hospital	O
report	O
.	O

Availability	O
of	O
effective	O
preventive	O
measures	O
.	O

Olinger	S-Person
has	O
served	O
on	O
the	O
Scientific	B-Organization
Advisory	I-Organization
Board	E-Organization
for	O
NIH's	B-Activity
National	I-Activity
Biosafety	I-Activity
and	I-Activity
Biocontainment	I-Activity
Training	I-Activity
Program	E-Activity
(	O
NBBTP	S-Activity
)	O
and	O
has	O
served	O
as	O
Councilor	O
of	O
the	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
.	O
She	O
is	O
one	O
of	O
the	O
only	O
a	O
few	O
individuals	O
who	O
has	O
implemented	O
a	O
biorisk	B-Platform
laboratory	I-Platform
management	I-Platform
system	E-Platform
in	O
.	O

The	O
writer	O
of	O
the	O
letter	O
,	O
and	O
any	O
members	O
of	O
the	O
alleged	O
group	O
,	O
were	O
never	O
identified	O
.	O

He	O
was	O
isolated	O
in	O
an	O
intensive	O
care	O
unit	O
.	O

Dense	O
minerals	O
such	O
as	O
pyrite	O
and	O
barite	O
appear	O
brighter	O
and	O
less	O
dense	O
components	O
such	O
as	O
clay	O
appear	O
dull	O
in	O
.	O

The	O
virus	O
soon	O
spread	O
to	O
nearby	O
hospitals	O
.	O

This	O
crew	O
member	O
became	O
ill	O
on	O
6	O
August	O
with	O
fever	S-Phenotype
,	O
headache	S-Phenotype
,	O
and	O
myalgia	S-Phenotype
.	O
The	O
ship	O
then	O
landed	O
in	O
the	O
port	O
city	O
of	O
Aral	O
on	O
11	O
August	O
.	O

In	O
Brazil	S-Location
300,000	O
died	O
,	O
including	O
president	O
Rodrigues	B-Person
Alves	E-Person
.	O
In	O
Britain	S-Location
,	O
as	O
many	O
as	O
250,000	O
died	O
;	O
in	O
,	O
more	O
than	O
400,000	O
.	O

This	O
manual	O
suggests	O
the	O
criteria	O
for	O
classification	O
of	O
biological	O
agents	O
based	O
on	O
laboratory	O
biosafety	O
,	O
but	O
does	O
not	O
identify	O
the	O
specific	O
category	O
for	O
each	O
biological	O
agent	O
.	O

The	O
US	S-Location
believed	O
that	O
the	O
Soviet	B-Organization
Union	E-Organization
was	O
violating	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
signed	O
in	O
1972	O
and	O
made	O
their	O
suspicions	O
public	O
.	O

Carbapenem-resistant	B-Pathogen
Enterobacteriaceae	E-Pathogen
(	O
CRE	S-Pathogen
)	O
have	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
human	O
healthcare-associated	O
infections	O
and	O
are	O
a	O
major	O
clinical	O
and	O
public	O
health	O
problem	O
(1)	O
.	O

The	O
small	O
provided	O
helicopters	O
to	O
allow	O
the	O
outbreak	O
team	O
to	O
visit	O
550	O
villages	O
in	O
the	O
area	O
.	O

The	O
principles	O
and	O
practices	O
of	O
biosurveillance	O
,	O
a	O
new	O
interdisciplinary	O
science	O
,	O
were	O
defined	O
and	O
described	O
in	O
the	O
Handbook	O
of	O
Biosurveillance	O
,	O
edited	O
by	O
Michael	B-Person
Wagner	E-Person
Andrew	B-Person
Moore	E-Person
and	O
,	O
and	O
published	O
in	O
2006	O
.	O

She	O
based	O
this	O
on	O
the	O
reported	O
symptoms	O
in	O
those	O
dying	O
from	O
the	O
flu	S-Disease
,	O
as	O
reported	O
in	O
the	O
post	O
mortem	O
reports	O
still	O
available	O
,	O
and	O
also	O
the	O
timing	O
of	O
the	O
big	O
"	O
death	O
spike	O
"	O
in	O
October	O
1918	O
.	O

On	O
6	O
November	O
2018	O
,	O
the	O
CDC	S-Organization
indicated	O
that	O
the	O
current	O
outbreak	O
in	O
the	O
east	O
region	O
of	O
the	O
DRC	S-Location
may	O
not	O
be	O
containable	O
due	O
to	O
several	O
factors	O
.	O

Tocilizumab	S-Drug
has	O
been	O
included	O
in	O
treatment	O
guidelines	O
by	O
China's	B-Organization
National	I-Organization
Health	I-Organization
Commission	E-Organization
after	O
a	O
small	O
study	O
was	O
completed	O
.	O

Empty	O
had	O
previously	O
been	O
stored	O
in	O
the	O
area	O
,	O
and	O
investigators	O
said	O
they	O
suspected	O
the	O
rats	O
used	O
the	O
clean	O
bags	O
-	O
rather	O
than	O
contaminated	O
bags	O
-	O
to	O
make	O
their	O
nest	O
.	O

Therefore	O
,	O
many	O
synthesis	O
companies	O
make	O
voluntary	O
efforts	O
to	O
manage	O
this	O
risk	O
,	O
screening	O
their	O
orders	O
for	O
dangerous	O
sequences	O
.	O

This	O
increased	O
severity	O
has	O
been	O
attributed	O
to	O
the	O
circumstances	O
of	O
the	O
First	B-Incident
World	I-Incident
War	E-Incident
In	O
civilian	O
life	O
,	O
natural	O
selection	O
favors	O
a	O
mild	O
strain	O
.	O

In	O
about	O
AD	O
198	O
,	O
the	O
Parthian	O
city	O
of	O
Hatra	S-Location
(near	O
Mosul	S-Location
,	O
Iraq	S-Location
)	O
repulsed	O
the	O
Roman	O
army	O
led	O
by	O
Septimius	B-Person
Severus	E-Person
by	O
hurling	O
clay	O
pots	O
filled	O
with	O
live	O
scorpions	O
at	O
them	O
.	O

These	O
biting	O
insects	O
live	O
indoors	O
,	O
in	O
bathrooms	O
,	O
all	O
year	O
long	O
,	O
which	O
was	O
not	O
the	O
typical	O
behaviour	O
of	O
these	O
species	O
in	O
Georgia	S-Location
previously	O
(normally	O
the	O
Phlebotomine	O
fly	O
season	O
in	O
is	O
exceptionally	O
short	O
–	O
from	O
June	O
to	O
September)	O
.	O

Despite	O
being	O
informally	O
called	O
"	O
swine	B-Disease
flu	E-Disease
the	O
H1N1	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
cannot	O
be	O
spread	O
by	O
eating	O
pork	O
products	O
;	O
similar	O
to	O
other	O
influenza	O
viruses	O
,	O
it	O
is	O
typically	O
contracted	O
by	O
person	O
to	O
person	O
transmission	O
through	O
respiratory	O
droplets	O
.	O

Do	O
you	O
mind	O
clarifying	O
why	O
and	O
also	O
addressing	O
-	O
did	O
the	O
sample	O
end	O
up	O
mutating	O
or	O
changing	O
as	O
a	O
result	O
of	O
-	O
is	O
there	O
some	O
ongoing	O
concern	O
regarding	O
the	O
results	O
of	O
that	O
cross-contamination?	O

The	O
United	B-Location
States	E-Location
refused	O
to	O
acknowledge	O
the	O
trials	O
,	O
branding	O
them	O
communist	O
propaganda	O
.	O

EBOV	S-Pathogen
carries	O
a	O
negative-sense	O
RNA	O
genome	O
in	O
virions	O
that	O
are	O
cylindrical/tubular	O
,	O
and	O
contain	O
viral	O
envelope	O
,	O
matrix	O
,	O
and	O
nucleocapsid	O
components	O
.	O

The	O
threat	O
has	O
actually	O
gotten	O
worse	O
since	O
2001.	O
"	O

NTI	S-Organization
works	O
to	O
prevent	O
catastrophic	O
attacks	O
with	O
weapons	O
of	O
mass	O
destruction	O
and	O
disruption	O
(WMDD)	O
,	O
including	O
nuclear	O
,	O
biological	O
,	O
radiological	O
,	O
chemical	O
,	O
and	O
cyber	O
.	O

The	O
facility	O
itself	O
is	O
generally	O
a	O
separate	O
building	O
or	O
completely	O
isolated	O
zone	O
with	O
complex	O
,	O
specialized	O
ventilation	O
requirements	O
and	O
waste	O
management	O
systems	O
to	O
prevent	O
release	O
of	O
viable	O
agents	O
to	O
the	O
environment	O
.	O

The	O
team	O
is	O
piloting	O
a	O
working	O
prototype	O
with	O
New	B-Organization
York	I-Organization
City's	I-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Mental	I-Organization
Hygiene	E-Organization
and	O
other	O
city	O
agencies	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
is	O
a	O
member	O
of	O
the	O
.	O

In	O
cases	O
of	O
pneumonic	O
and	O
particularly	O
,	O
the	O
progress	O
of	O
the	O
disease	O
is	O
so	O
rapid	O
that	O
there	O
would	O
often	O
be	O
no	O
time	O
for	O
the	O
development	O
of	O
the	O
enlarged	O
lymph	O
nodes	O
that	O
were	O
noted	O
as	O
buboes	O
.	O

During	O
the	O
early	O
stages	O
of	O
the	O
outbreak	O
,	O
the	O
number	O
of	O
cases	O
doubled	O
approximately	O
every	O
seven	O
and	O
a	O
half	O
days	O
.	O

Scott	B-Person
Lillibridge	E-Person
didn't	O
realize	O
then	O
what	O
would	O
emerge	O
as	O
the	O
almost	O
surreal	O
scope	O
of	O
biothreats	O
now	O
challenging	O
.	O

Remdesivir	S-Drug
was	O
rapidly	O
pushed	O
through	O
clinical	O
trials	O
due	O
to	O
the	O
West	B-Incident
African	I-Incident
Ebola	I-Incident
virus	I-Incident
epidemic	I-Incident
of	I-Incident
2013–2016	E-Incident
,	O
eventually	O
being	O
used	O
in	O
people	O
with	O
the	O
disease	O
.	O

In	O
February	O
2003	O
,	O
Hong	B-Location
Kong	E-Location
SARS	S-Disease
index	O
patient	O
was	O
Liu	B-Person
Jianlun	E-Person
,	O
who	O
had	O
come	O
to	O
attend	O
a	O
family	O
wedding	O
gathering	O
;	O
Liu	S-Person
was	O
on	O
the	O
staff	O
at	O
Sun	B-Organization
Yat-Sen	I-Organization
Memorial	I-Organization
Hospital	E-Organization
in	O
and	O
had	O
treated	O
SARS	O
patients	O
.	O

This	O
requires	O
the	O
use	O
of	O
specific	O
precautions	O
with	O
all	O
clinical	O
specimens	O
of	O
blood	O
or	O
other	O
potentially	O
infectious	O
material	O
(	O
Universal	B-Document
or	I-Document
Standard	I-Document
Precautions	E-Document
;	O
MMWR	S-Organization
,	O
1988)	O
.	O

Identifying	O
ways	O
to	O
provide	O
stronger	O
safeguards	O
for	O
laboratories	O
across	O
the	O
United	B-Location
States	E-Location

Security	O
for	O
highly	O
dangerous	O
pathogens	O
has	O
been	O
deeply	O
flawed	O
,	O
and	O
remains	O
insufficient	O
.	O

With	O
a	O
budget	O
at	O
the	O
time	O
of	O
about	O
$1million	O
,	O
59	O
percent	O
of	O
its	O
personnel	O
were	O
engaged	O
in	O
mosquito	O
abatement	O
and	O
habitat	O
control	O
with	O
the	O
objective	O
of	O
control	O
and	O
eradication	O
of	O
malaria	S-Disease
in	O
the	O
(see	O
National	O
Malaria	O
Eradication	O
Program)	O
.	O

What	O
are	O
the	O
next	O
steps	O
for	O
this	O
research	O
at	O
JCVI	S-Organization

The	O
13th-century	O
Mongol	S-Organization
conquest	O
of	O
China	S-Location
caused	O
a	O
decline	O
in	O
farming	O
and	O
trading	O
.	O

Lokela	S-Person
was	O
initially	O
diagnosed	O
with	O
malaria	S-Disease
at	O
the	O
Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
and	O
given	O
quinine	S-Drug
.	O
However	O
,	O
Lokela	S-Person
returned	O
to	O
the	O
mission	O
hospital	O
on	O
1	O
September	O
with	O
a	O
high	B-Phenotype
fever	E-Phenotype
.	O
Rest	O
was	O
recommended	O
,	O
and	O
he	O
returned	O
home	O
to	O
his	O
village	O
of	O
Yalikonde	S-Location
,	O
about	O
one kilometer	O
from	O
the	O
mission	O
complex	O
.	O

SAN	B-Location
DIEGO	E-Location
Sept.	O
28	O
,	O
2018	O
/PRNewswire/	O
--	O
Mapp	B-Organization
Biopharmaceutical,	I-Organization
Inc	E-Organization
.	O
(	O
MappBio	S-Organization
)	O
,	O
announced	O
today	O
that	O
it	O
has	O
been	O
awarded	O
a	O
contract	O
(HHSO100201800024C)	O
of	O
$14.	O
8	O
million	O
with	O
options	O
for	O
an	O
additional	O
$32.	O
0	O
million	O
by	O
the	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
,	O
part	O
of	O
the	O
Office	B-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	I-Organization
at	I-Organization
the	I-Organization
U.S.	I-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
,	O
to	O
advance	O
through	O
a	O
Phase	O
1	O
clinical	O
trial	O
.	O

In	O
2001	O
,	O
powdered	O
anthrax	B-Pathogen
spores	E-Pathogen
were	O
deliberately	O
put	O
into	O
letters	O
that	O
were	O
mailed	O
through	O
the	O
U.S.	O
postal	O
system	O
.	O

People	O
who	O
have	O
developed	O
pneumonia	S-Disease
should	O
be	O
given	O
both	O
antivirals	O
and	O
antibiotics	O
,	O
as	O
in	O
many	O
severe	O
cases	O
of	O
H1N1-caused	O
illness	O
,	O
bacterial	B-Disease
infection	E-Disease
develops	O
.	O

In	O
envisioning	O
a	O
smallpox	S-Pathogen
attack	O
,	O
terrorism	O
experts	O
consider	O
person-to-person	O
contact	O
a	O
main	O
threat	O
.	O

The	O
Eighteen	B-Organization
Nation	I-Organization
Disarmament	I-Organization
Committee	E-Organization
was	O
discussing	O
a	O
British	O
draft	O
of	O
a	O
biological	O
weapons	O
treaty	O
which	O
the	O
United	B-Organization
Nations	I-Organization
General	I-Organization
Assembly	E-Organization
approved	O
in	O
1968	O
and	O
that	O
NATO	S-Organization
supported	O
.	O

The	O
ring	O
trials	O
include	O
both	O
live	O
and	O
inactivated	O
samples	O
that	O
are	O
prepared	O
by	O
one	O
arranging	O
laboratory	O
and	O
sent	O
to	O
the	O
other	O
participating	O
agencies	O
.	O

My	O
question	O
is	O
what	O
were	O
the	O
security	O
protocols	O
that	O
were	O
put	O
in	O
place	O
following	O
that?	O
And	O
were	O
those	O
protocols	O
followed?	O
You'd	O
think	O
if	O
you	O
had	O
a	O
similar	O
incident	O
in	O
2006	O
,	O
you	O
wouldn't	O
be	O
in	O
the	O
position	O
that	O
you	O
find	O
yourself	O
in	O
today	O
.	O

Among	O
them	O
,	O
44	O
were	O
positive	O
for	O
,	O
and	O
the	O
positive	O
rates	O
were	O
11.71	O
%	O
in	O
blood	O
samples	O
(41/350)	O
and	O
0.53	O
%	O
(3/563)	O
in	O
throat	O
swab	O
samples	O
.	O

MIMAS	S-Platform
is	O
an	O
open-source	O
data	O
management	O
system	O
for	O
multi-omics	O
.	O

The	O
-	O
the	O
flu	B-Pathogen
strain	E-Pathogen
that	O
your	O
lab	O
thought	O
it	O
was	O
sending	O
isn't	O
identified	O
,	O
but	O
it	O
was	O
going	O
to	O
a	O
bsl-3	S-Platform
lab	O
.	O

The	O
CDC	B-Organization
Foundation	E-Organization
operates	O
independently	O
from	O
CDC	S-Organization
as	O
a	O
private	O
,	O
nonprofit	O
501(c)(3)	O
organization	O
incorporated	O
in	O
the	O
State	O
of	O
Georgia	S-Location
.	O
The	O
creation	O
of	O
the	O
Foundation	O
was	O
authorized	O
by	O
section	B-Document
399F	I-Document
of	I-Document
the	I-Document
Public	I-Document
Health	I-Document
Service	I-Document
Act	E-Document
to	O
support	O
the	O
mission	O
of	O
in	O
partnership	O
with	O
the	O
private	O
sector	O
,	O
including	O
organizations	O
,	O
foundations	O
,	O
businesses	O
,	O
educational	O
groups	O
,	O
and	O
individuals	O
.	O

Most	O
of	O
those	O
who	O
die	O
of	O
COVID‑19	S-Disease
have	O
pre-existing	O
(underlying)	O
conditions	O
,	O
including	O
hypertension	S-Disease
,	O
diabetes	B-Disease
mellitus	E-Disease
,	O
and	O
cardiovascular	B-Disease
disease	E-Disease
.	O
The	O
Istituto	B-Organization
Superiore	I-Organization
di	I-Organization
Sanità	E-Organization
reported	O
that	O
out	O
of	O
8.	O
8%	O
of	O
deaths	O
where	O
medical	O
charts	O
were	O
available	O
,	O
97%	O
of	O
people	O
had	O
at	O
least	O
one	O
comorbidity	O
with	O
the	O
average	O
person	O
having	O
2.7	O
diseases	O
.	O

The	O
virology	O
results	O
and	O
epidemiological	O
findings	O
indicated	O
no	O
connection	O
to	O
the	O
epidemic	O
in	O
.	O

In	O
addition	O
,	O
the	O
names	O
of	O
biological	O
agents	O
are	O
occasionally	O
inconsistent	O
.	O

Seventy	O
percent	O
of	O
the	O
total	O
initiatives	O
recorded	O
fell	O
in	O
the	O
category	O
of	O
general	O
biosafety	O
awareness	O
sessions	O
,	O
which	O
is	O
an	O
encouraging	O
finding	O
.	O

It	O
is	O
96%	O
identical	O
at	O
the	O
whole	O
genome	O
level	O
to	O
other	O
bat	O
coronavirus	O
samples	O
(	O
BatCov	B-Pathogen
RaTG13	E-Pathogen
)	O
.	O

Viral	O
agents:	O
[[	O
Smallpox	S-Pathogen
,	O
etc	O
.	O

In	O
August	O
2018	O
,	O
the	O
Mangina	B-Organization
Ebola	I-Organization
Treatment	I-Organization
Center	E-Organization
was	O
reported	O
to	O
be	O
operational	O
.	O

You	O
said	O
Lassa	S-Pathogen
is	O
a	O
deadly	O
virus	O
,	O
like	O
.	O
What	O
else	O
do	O
we	O
need	O
to	O
know	O
about	O
the	O
disease?	O

The	O
first	O
person	O
reported	O
infected	O
in	O
Sierra	B-Location
Leone	E-Location
according	O
to	O
media	O
reports	O
,	O
was	O
a	O
tribal	O
healer	O
who	O
had	O
been	O
treating	O
Ebola	S-Disease
patients	O
from	O
across	O
the	O
nearby	O
border	O
with	O
Guinea	S-Location
and	O
who	O
died	O
on	O
26	O
May	O
2014	O
;	O
according	O
to	O
tribal	O
tradition	O
,	O
her	O
body	O
was	O
washed	O
for	O
burial	O
,	O
and	O
this	O
appears	O
to	O
have	O
led	O
to	O
infections	O
in	O
women	O
from	O
neighbouring	O
towns	O
.	O

During	O
the	O
closing	O
stages	O
of	O
the	O
Rhodesian	O
Bush	O
War	O
,	O
the	O
Rhodesian	O
government	O
resorted	O
to	O
use	O
chemical	O
and	O
biological	O
warfare	O
agents	O
.	O

However	O
,	O
increased	O
dosage	O
raises	O
the	O
adverse	O
side	O
effects	O
,	O
including	O
the	O
risk	O
of	O
radiation-induced	O
cancer	O
–	O
a	O
four-phase	O
abdominal	O
CT	S-Technology
gives	O
the	O
same	O
radiation	O
dose	O
as	O
300	O
chest	O
X-rays	O
(See	O
the	O
Scan	O
dose	O
section)	O
.	O

Here	O
at	O
CDC	S-Organization
or	O
in	O
Russia	S-Location
where	O
there's	O
a	O
WHO	S-Organization
.	O
,	O
world	B-Organization
health	I-Organization
organization	E-Organization
,	O
authorized	O
laboratory	O
.	O

A	O
researcher	O
can	O
test	O
the	O
many	O
created	O
strands	O
to	O
find	O
the	O
ones	O
that	O
have	O
a	O
particular	O
function	O
.	O

Laboratory	O
acquired	O
infections	O
are	O
a	O
common	O
problem	O
all	O
over	O
the	O
world	O
and	O
many	O
cases	O
have	O
been	O
reported	O
.	O

The	O
lungs	O
of	O
animals	O
infected	O
with	O
the	O
1918	O
HA/NA	O
construct	O
showed	O
bronchial	O
and	O
alveolar	O
epithelial	O
necrosis	O
and	O
a	O
marked	O
inflammatory	O
infiltrate	O
,	O
which	O
suggests	O
that	O
the	O
1918	O
HA	O
(and	O
possibly	O
the	O
NA)	O
contain	O
virulence	O
factors	O
for	O
mice	O
.	O

It	O
had	O
gone	O
from	O
one	O
culture	O
plate	O
to	O
another	O
.	O

Even	O
if	O
there	O
are	O
sharing	O
policies	O
installed	O
,	O
the	O
practices	O
to	O
control	O
data	O
availability	O
vary	O
as	O
the	O
US	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
reports	O
for	O
the	O
field	O
of	O
climate	O
research	O
.	O

As	O
a	O
result	O
,	O
foreign	O
technology	O
owners	O
that	O
provide	O
highly	O
demanded	O
technologies	O
like	O
Bt	O
cotton	O
declined	O
to	O
work	O
with	O
Ethiopia	S-Organization
There	O
is	O
a	O
fear	O
that	O
the	O
emerged	O
biosafety	O
system	O
might	O
also	O
continue	O
to	O
suppress	O
domestic	O
genetic	O
engineering	O
research	O
and	O
development	O
.	O

The	O
devastating	O
impact	O
of	O
this	O
loss	O
is	O
still	O
being	O
felt	O
years	O
after	O
the	O
outbreak	O
ended	O
,	O
said	O
.	O

Some	O
of	O
the	O
allies	O
thought	O
of	O
the	O
epidemic	O
as	O
a	O
biological	O
warfare	O
tool	O
of	O
the	O
Germans	O
.	O

Distancing	O
guidelines	O
also	O
include	O
that	O
people	O
stay	O
at	O
least	O
apart	O
.	O

Seneca,	B-Person
Oedipus	E-Person
,	O
164–170	O
.	O

By	O
contrast	O
,	O
it	O
must	O
not	O
be	O
underestimated	O
that	O
hardly	O
any	O
natural	O
pathogens	O
are	O
really	O
well	O
suited	O
to	O
being	O
biowarfare	O
agents	O
from	O
a	O
military	O
point	O
of	O
view	O
.	O

"	O
Recent	O
analysis	O
has	O
suggested	O
we	O
could	O
expect	O
African	B-Disease
swine	I-Disease
fever	E-Disease
to	O
emerge	O
in	O
the	O
wild	O
boar	O
population	O
over	O
the	O
next	O
four	O
years,	O
"	O
she	O
says	O
.	O

Brooks	S-Person
office	O
.	O

The	O
White	B-Organization
House	E-Organization
has	O
been	O
criticised	O
for	O
downplaying	O
the	O
threat	O
and	O
controlling	O
the	O
messaging	O
by	O
directing	O
health	O
officials	O
and	O
scientists	O
to	O
coordinate	O
public	O
statements	O
and	O
publications	O
related	O
to	O
the	O
virus	O
with	O
the	O
office	O
of	O
Vice-President	O
Mike	B-Person
Pence	E-Person
.	O
On	O
14	O
April	O
,	O
President	O
Trump	S-Person
halted	O
funding	O
to	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
saying	O
they	O
had	O
mismanaged	O
the	O
pandemic	O
.	O

In	O
Oregon	S-Location
in	O
1984	O
,	O
followers	O
of	O
the	O
Bhagwan	B-Person
Shree	I-Person
Rajneesh	E-Person
attempted	O
to	O
control	O
a	O
local	O
election	O
by	O
incapacitating	O
the	O
local	O
population	O
.	O

When	O
BSL‐2	S-Platform
conditions	O
are	O
appropriate	O
to	O
the	O
organism	O
under	O
investigation	O
,	O
the	O
following	O
note	O
is	O
included	O
in	O
the	O
unit	O
introduction	O
.	O

Recent	O
studies	O
suggest	O
a	O
correlation	O
between	O
the	O
interfering	O
of	O
the	O
locus	O
and	O
acquisition	O
of	O
antibiotic	O
resistance	O
.	O

Scott	B-Person
Lillibridge	E-Person
didn't	O
realize	O
then	O
what	O
would	O
emerge	O
as	O
the	O
almost	O
surreal	O
scope	O
of	O
biothreats	O
now	O
challenging	O
the	O
.	O

During	O
the	O
period	O
of	O
closure	O
UNICEF	S-Organization
and	O
its	O
partners	O
established	O
strict	O
hygiene	O
protocols	O
to	O
be	O
used	O
when	O
the	O
schools	O
were	O
reopened	O
in	O
January	O
2015	O
.	O

At	O
the	O
beginning	O
of	O
other	O
"	O
off	O
season	O
"	O
influenza	O
pandemics	O
,	O
successive	O
distinct	O
waves	O
within	O
a	O
year	O
have	O
not	O
been	O
reported	O
.	O

Zika	S-Pathogen
can	O
cause	O
congenital	B-Disease
Zika	I-Disease
syndrome	E-Disease
(	O
CZS	S-Disease
)	O
,	O
including	O
microcephaly	S-Disease
and	O
other	O
congenital	B-Disease
brain	I-Disease
abnormalities	E-Disease
,	O
in	O
infants	O
born	O
to	O
mothers	O
infected	O
during	O
pregnancy	O
.	O

The	O
CDC	S-Organization
coordinates	O
the	O
.	O
It	O
collects	O
anonymized	O
data	O
from	O
emergency	O
departments	O
around	O
the	O
nation	O
,	O
analyzes	O
public	O
health	O
indicators	O
and	O
uses	O
statistical	O
analyses	O
to	O
look	O
for	O
anomalies	O
,	O
such	O
as	O
a	O
sudden	O
increase	O
in	O
ER	O
visits	O
,	O
that	O
could	O
indicate	O
an	O
outbreak	O
.	O

No	O
post-mortem	O
was	O
carried	O
out	O
on	O
his	O
body	O
because	O
of	O
the	O
risk	O
of	O
.	O

This	O
included	O
new	O
production	O
plants	O
for	O
anthrax	S-Pathogen
brucellosis	S-Pathogen
,	O
and	O
anti-crop	O
agents	O
,	O
as	O
well	O
as	O
the	O
development	O
of	O
the	O
cluster	O
bomb.The	O
U.S.	S-Location
public	O
was	O
also	O
unaware	O
of	O
ongoing	O
studies	O
,	O
particularly	O
the	O
environmental	O
and	O
open-air	O
experiments	O
that	O
were	O
taking	O
place	O
.	O

On	O
July	O
1	O
,	O
2014	O
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
notified	O
the	O
appropriate	O
regulatory	O
agency	O
,	O
the	O
Division	B-Organization
of	I-Organization
Select	I-Organization
Agents	I-Organization
and	I-Organization
Toxins	E-Organization
(	O
DSAT	S-Organization
)	O
of	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
,	O
that	O
employees	O
discovered	O
vials	O
labeled	O
"	O
variola	S-Disease
,	O
"	O
commonly	O
known	O
as	O
smallpox	S-Disease
,	O
in	O
an	O
unused	O
portion	O
of	O
a	O
storage	O
room	O
in	O
a	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
laboratory	O
located	O
on	O
the	O
.	O

DARPA	S-Organization
Project	O
seeks	O
to	O
create	O
a	O
biological	O
platform	O
inside	O
the	O
human	O
body	O
,	O
using	O
it	O
to	O
deliver	O
new	O
genetic	O
information	O
,	O
and	O
thus	O
altering	O
humans	O
at	O
the	O
DNA	O
level	O
.	O

Magnetic	B-Technology
resonance	I-Technology
spectroscopy	E-Technology
(	O
MRS	S-Technology
)	O
is	O
used	O
to	O
measure	O
the	O
levels	O
of	O
different	O
metabolites	O
in	O
body	O
tissues	O
,	O
which	O
can	O
be	O
achieved	O
through	O
a	O
variety	O
of	O
single	O
voxel	O
or	O
imaging-based	O
techniques	O
.	O

Eastern	B-Pathogen
and	I-Pathogen
Western	I-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
viruses	E-Pathogen
were	O
included	O
in	O
risk	O
group	O
1	O
of	O
the	O
China	S-Location
biosafety	O
categorization	O
,	O
but	O
were	O
included	O
in	O
risk	O
groups	O
2	O
and	O
3	O
according	O
to	O
NIH	S-Organization
and	O
categorization	O
,	O
respectively	O
.	O

These	O
then	O
self-assemble	O
into	O
viral	O
macromolecular	O
structures	O
in	O
the	O
host	O
cell	O
.	O

Built-in	O
tools	O
allow	O
converting	O
data	O
between	O
multiple	O
formats	O
.	O

As	O
events	O
later	O
showed	O
,	O
Weaver	O
had	O
presented	O
a	O
well-reasoned	O
,	O
if	O
only	O
circumstantial	O
,	O
case	O
;	O
these	O
circumstantial	O
elements	O
were	O
confirmed	O
by	O
evidence	O
found	O
after	O
investigators	O
gained	O
access	O
to	O
several	O
months	O
later	O
.	O

In	O
1999	O
,	O
the	O
University	B-Organization
of	I-Organization
Pittsburgh's	I-Organization
Center	I-Organization
for	I-Organization
Biomedical	I-Organization
Informatics	E-Organization
deployed	O
the	O
first	O
automated	O
bioterrorism	B-Platform
detection	I-Platform
system	E-Platform
,	O
called	O
RODS	S-Platform
(	O
Real-Time	B-Platform
Outbreak	I-Platform
Disease	I-Platform
Surveillance	E-Platform
)	O
.	O

The	O
US	O
has	O
an	O
elaborate	O
,	O
interdepartmental	O
regulatory	O
system	O
to	O
evaluate	O
new	O
genetically	O
modified	O
foods	O
and	O
crops	O
.	O

Howitt	S-Person
,	O
Arnold	B-Person
M.	E-Person
and	O
Pangi	S-Person
,	O
Countering	O
Terrorism:	O
Dimensions	O
of	O
Preparedness	O
,	O
(Google	O
Books	O
link)	O
,	O
MIT	O
Press	O
,	O
2003	O
,	O
pp.	O
202-03	O
,	O
()	O
.	O

The	O
sequence	O
is	O
not	O
part	O
of	O
the	O
Cas9	O
protein	O
and	O
as	O
a	O
result	O
is	O
customizable	O
and	O
can	O
be	O
independently	O
synthesized	O
.	O

The	O
UN	S-Organization
High	O
Commissioner	O
for	O
Human	O
Rights	O
has	O
demanded	O
economic	O
sanctions	O
to	O
be	O
eased	O
for	O
nations	O
most	O
affected	O
by	O
the	O
pandemic	O
,	O
including	O
Iran	S-Location
.	O
On	O
20	O
April	O
it	O
was	O
reported	O
that	O
Iran	S-Location
had	O
reopened	O
shopping	O
malls	O
and	O
other	O
shopping	O
areas	O
across	O
the	O
country	O
,	O
though	O
there	O
is	O
fear	O
of	O
a	O
second	O
wave	O
of	O
infection	O
due	O
to	O
this	O
move	O
.	O

Thus	O
,	O
during	O
a	O
crisis	O
,	O
each	O
sector	O
is	O
responsible	O
only	O
for	O
its	O
own	O
area	O
of	O
expertise	O
,	O
and	O
most	O
crises	O
are	O
managed	O
by	O
the	O
municipalities	O
responsible	O
at	O
a	O
local	O
level	O
.	O

The	O
increased	O
use	O
of	O
CT	S-Equipment
scans	O
has	O
been	O
the	O
greatest	O
in	O
two	O
fields:	O
screening	O
of	O
adults	O
(screening	O
CT	S-Equipment
of	O
the	O
lung	O
in	O
smokers	O
,	O
virtual	O
colonoscopy	O
,	O
CT	S-Equipment
cardiac	O
screening	O
,	O
and	O
whole-body	O
CT	S-Equipment
in	O
asymptomatic	O
patients)	O
and	O
CT	S-Equipment
imaging	O
of	O
children	O
.	O

It	O
is	O
great	O
to	O
be	O
down	O
here	O
in	O
Charlottesville	S-Location
It's	O
also	O
great	O
to	O
see	O
so	O
many	O
young	O
people	O
here	O
at	O
the	O
start	O
of	O
a	O
three	O
day	O
weekend	O
ready	O
to	O
talk	O
about	O
germs	O
and	O
bugs	O
.	O

In	O
addition	O
,	O
the	O
Swedish	B-Organization
Defence	I-Organization
Research	I-Organization
Agency	E-Organization
is	O
the	O
national	O
authority	O
for	O
research	O
and	O
expertise	O
in	O
defense	O
and	O
security	O
(Table	O
1	O
,	O
Figure	O
2)	O
.	O

As	O
the	O
epidemic	O
progressed	O
,	O
a	O
small	O
outbreak	O
occurred	O
in	O
Nigeria	S-Location
that	O
resulted	O
in	O
20	O
cases	O
and	O
another	O
in	O
Mali	S-Location
with	O
7 cases	O
.	O

Image	O
Caption:	O
DARPA	S-Organization
SIGMA+	S-Scientific_research_project
program	O
seeks	O
to	O
develop	O
highly	O
sensitive	O
detectors	O
and	O
advanced	O
intelligence	O
analytics	O
to	O
detect	O
minute	O
traces	O
of	O
materials	O
used	O
for	O
chemical	O
,	O
biological	O
,	O
radiological	O
,	O
nuclear	O
,	O
and	O
high-yield	O
explosive	O
(CBRNE)	O
weapons	O
.	O

This	O
will	O
be	O
an	O
important	O
opportunity	O
to	O
uphold	O
and	O
widen	O
the	O
contacts	O
between	O
people	O
in	O
this	O
field	O
,	O
to	O
share	O
knowledge	O
and	O
experience	O
from	O
outbreaks	O
,	O
and	O
to	O
discuss	O
how	O
to	O
improve	O
current	O
methods	O
and	O
strategies	O
for	O
quality	O
assurance	O
.	O

Trump	S-Person
said	O
biological	O
threats	O
come	O
from	O
many	O
sources	O
and	O
know	O
no	O
borders.	O
"	O
They	O
have	O
great	O
potential	O
to	O
disrupt	O
the	O
economy	O
,	O
exact	O
a	O
toll	O
on	O
human	O
life	O
,	O
and	O
tear	O
at	O
the	O
very	O
fabric	O
of	O
society,	O
"	O
he	O
said.	O
"	O
My	O
Administration	O
will	O
take	O
steps	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
risks	O
posed	O
by	O
biological	O
threats	O
and	O
to	O
respond	O
to	O
them	O
effectively	O
and	O
efficiently.	O
"	O

In	O
Bioterrorism:	O
A	O
Threat	O
to	O
National	O
Security	O
or	O
Public	O
Health	O
Defining	O
Issue	O
,	O
University	B-Organization
of	I-Organization
Wisconsin	E-Organization
–	O
Madison	B-Organization
and	I-Organization
the	I-Organization
Wisconsin	I-Organization
State	I-Organization
Laboratory	I-Organization
of	I-Organization
Hygiene	E-Organization
,	O
MM&amp;I	O
554	O
,	O
September	O
30	O
,	O
2008	O
It	O
was	O
also	O
the	O
single	O
largest	O
bioterrorism	O
attacksoil	O
.	O

The	O
economic	O
impact	O
was	O
becoming	O
dramatic	O
as	O
shops	O
,	O
restaurants	O
,	O
markets	O
,	O
bars	O
,	O
universities	O
,	O
schools	O
,	O
and	O
many	O
other	O
businesses	O
had	O
closed	O
,	O
while	O
some	O
government	O
ministries	O
and	O
large	O
state	O
banks	O
were	O
working	O
with	O
minimal	O
staff	O
levels	O
.	O

Outside	O
this	O
,	O
its	O
use	O
in	O
zoology	O
is	O
limited	O
due	O
to	O
the	O
high	O
cost	O
;	O
but	O
it	O
can	O
be	O
used	O
on	O
many	O
species	O
.	O

For	O
regulations	O
and	O
guidelines	O
applicable	O
outside	O
of	O
the	O
U.S	S-Location
,	O
please	O
refer	O
to	O
appendix	O
mca01b	O
and	O
Internet	O
Resources	O
.	O

In	O
addition	O
,	O
it	O
will	O
cover	O
studies	O
involving	O
any	O
kind	O
of	O
pathogen	O
,	O
not	O
just	O
the	O
most	O
dangerous	O
agents	O
.	O

However	O
this	O
work	O
carries	O
risks	O
.	O

Online	O
,	O
numerous	O
-themed	O
Internet	O
memes	O
have	O
spread	O
as	O
many	O
turn	O
to	O
humour	O
and	O
distraction	O
amid	O
uncertainty	O
.	O

A	O
biohazard	B-Equipment
container	E-Equipment
is	O
used	O
for	O
the	O
temporary	O
disposal	O
of	O
needles	O
and	O
other	O
sharp	O
objects	O
.	O

I	O
think	O
one	O
of	O
the	O
biggest	O
lessons	O
learned	O
from	O
the	O
first	O
year	O
of	O
the	O
Global	O
Health	O
Security	O
Agenda	O
is	O
that	O
resolve	O
makes	O
all	O
the	O
difference	O
.	O

By	O
tinkering	O
with	O
your	O
genome	O
,	O
you	O
could	O
unintentionally	O
cause	O
a	O
mutation	O
that	O
increases	O
your	O
risk	O
of	O
developing	O
,	O
she	O
said	O
.	O

Cas9	S-Technology
was	O
used	O
to	O
carry	O
synthetic	O
transcription	O
factors	O
that	O
activated	O
specific	O
human	O
genes	O
.	O

The	O
scientists	O
behind	O
the	O
technology	O
called	O
believe	O
it	O
may	O
be	O
the	O
key	O
to	O
safely	O
editing	O
DNA	O
for	O
curing	O
genetic	O
disease	O
.	O

Computed	B-Technology
tomography	I-Technology
angiography	E-Technology
(	O
CTA	S-Technology
)	O
is	O
contrast	O
CT	S-Equipment
to	O
visualize	O
the	O
arteries	O
and	O
veins	O
throughout	O
the	O
body	O
.	O

The	O
ECDC	S-Organization
and	O
the	O
European	B-Organization
regional	I-Organization
office	I-Organization
of	I-Organization
the	I-Organization
WHO	E-Organization
have	O
issued	O
guidelines	O
for	O
hospitals	O
and	O
primary	O
healthcare	O
services	O
for	O
shifting	O
of	O
resources	O
at	O
multiple	O
levels	O
,	O
including	O
focusing	O
laboratory	O
services	O
towards	O
COVID-19	S-Disease
testing	O
,	O
cancelling	O
elective	O
procedures	O
whenever	O
possible	O
,	O
separating	O
and	O
isolating	O
positive	O
patients	O
,	O
and	O
increasing	O
intensive	O
care	O
capabilities	O
by	O
training	O
personnel	O
and	O
increasing	O
the	O
number	O
of	O
available	O
ventilators	O
and	O
beds	O
.	O

Therefore	O
,	O
traceability	O
of	O
the	O
transgene	O
and	O
its	O
protein	O
expression	O
in	O
crops	O
is	O
an	O
important	O
issue	O
that	O
needs	O
to	O
be	O
addressed	O
on	O
a	O
priority	O
basis	O
.	O

Despite	O
clinical	O
and	O
epidemiologic	O
similarities	O
to	O
influenza	S-Disease
pandemics	O
of	O
1889	O
,	O
1847	O
,	O
and	O
even	O
earlier	O
,	O
many	O
questioned	O
whether	O
such	O
an	O
explosively	O
fatal	O
disease	O
could	O
be	O
influenza	S-Disease
at	O
all	O
.	O

Shopping	O
mall	O
operators	O
around	O
the	O
world	O
imposed	O
additional	O
measures	O
,	O
such	O
as	O
increased	O
sanitation	O
,	O
installation	O
of	O
thermal	O
scanners	O
to	O
check	O
the	O
temperature	O
of	O
shoppers	O
,	O
and	O
cancellation	O
of	O
events	O
.	O

In	O
October	O
2015	O
,	O
the	O
recorded	O
its	O
first	O
week	O
without	O
any	O
new	O
cases	O
,	O
and	O
while	O
the	O
large-scale	O
epidemic	O
appeared	O
to	O
have	O
ended	O
by	O
late	O
2015	O
,	O
sporadic	O
new	O
cases	O
continued	O
to	O
be	O
reported	O
.	O

On	O
8	O
August	O
2014	O
,	O
WHO	S-Organization
declared	O
that	O
the	O
spread	O
of	O
Ebola	S-Disease
was	O
a	O
public	O
health	O
emergency	O
;	O
an	O
outbreak	O
which	O
was	O
believed	O
to	O
have	O
started	O
in	O
Guinea	S-Location
had	O
spread	O
to	O
other	O
nearby	O
countries	O
such	O
as	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
situation	O
in	O
was	O
considered	O
very	O
serious	O
.	O

Former	O
members	O
of	O
Unit	B-Organization
731	E-Organization
secretly	O
continue	O
their	O
experiments	O
on	O
humans	O
under	O
control	O
of	O
a	O
covert	O
agency	O
.	O

Despite	O
being	O
informally	O
called	O
"	O
swine	B-Disease
flu	E-Disease
the	O
H1N1	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
cannot	O
be	O
spread	O
by	O
eating	O
pork	O
products	O
;	O
similar	O
to	O
other	O
influenza	O
viruses	O
,	O
it	O
is	O
typically	O
contracted	O
by	O
person	O
to	O
person	O
transmission	O
through	O
respiratory	O
droplets	O
.	O

Prisoners	O
were	O
injected	O
with	O
diseases	O
,	O
disguised	O
as	O
vaccinations	O
,	O
to	O
study	O
their	O
effects	O
.	O

Cells	O
were	O
washed	O
with	O
1×	O
PBS	O
0.	O
02%	O
Tween	O
20	O
and	O
treated	O
with	O
50 μl	O
polyclonal	O
Rabbit	O
anti	O
glycoproteins	O
(Biotest)	O
diluted	O
1:100	O
with	O
blocking	O
solution	O
for	O
1	O
hr	O
at	O
room	O
temperature	O
.	O

Anecdotal	O
data	O
does	O
not	O
replace	O
large-scale	O
data	O
analysis	O
,	O
although	O
Nuzzo	S-Person
said	O
enough	O
of	O
these	O
reports	O
over	O
time	O
could	O
make	O
their	O
way	O
into	O
bigger	O
epidemiological	O
studies	O
.	O

The	O
network	O
has	O
,	O
so	O
far	O
,	O
involved	O
around	O
80	O
people	O
in	O
total	O
,	O
with	O
roughly	O
30	O
participants	O
each	O
year	O
.	O

On	O
15	O
March	O
,	O
the	O
Iranian	B-Organization
government	E-Organization
reported	O
a	O
hundred	O
deaths	O
in	O
a	O
single	O
day	O
,	O
the	O
most	O
recorded	O
in	O
the	O
country	O
since	O
the	O
outbreak	O
began	O
.	O

Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(commonly	O
known	O
as	O
"	O
Ebola	S-Disease
"	O
)	O
was	O
first	O
described	O
in	O
1976	O
in	O
two	O
simultaneous	O
outbreaks	O
in	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
and	O
what	O
is	O
now	O
South	B-Location
Sudan	E-Location
.	O
The	O
2013–2016	O
outbreak	O
,	O
caused	O
by	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
was	O
the	O
first	O
anywhere	O
in	O
the	O
world	O
to	O
reach	O
epidemic	O
proportions	O
.	O

Influenza	B-Pathogen
virus	E-Pathogen
gene	O
sequences	O
from	O
a	O
number	O
of	O
fixed	O
specimens	O
of	O
wild	O
birds	O
collected	O
circa	O
1918	O
show	O
little	O
difference	O
from	O
avian	B-Pathogen
viruses	E-Pathogen
isolated	O
today	O
,	O
indicating	O
that	O
likely	O
undergo	O
little	O
antigenic	O
change	O
in	O
their	O
natural	O
hosts	O
even	O
over	O
long	O
periods	O
(,)	O
.	O

By	O
the	O
end	O
of	O
the	O
program	O
,	O
seeks	O
to	O
demonstrate	O
in	O
controlled	O
laboratory	O
conditions	O
the	O
suppression	O
of	O
viral	O
jump	O
to	O
a	O
new	O
species	O
.	O

But	O
,	O
many	O
other	O
types	O
of	O
CT	S-Technology
exist	O
,	O
such	O
as	O
positron	B-Technology
emission	I-Technology
tomography	E-Technology
(	O
PET	S-Technology
)	O
and	O
single-photon	B-Technology
emission	I-Technology
computed	I-Technology
tomography	E-Technology
(	O
SPECT	S-Technology
)	O
.	O

Modern	O
biomedical	O
research	O
,	O
many	O
best-selling	O
drugs	O
,	O
most	O
of	O
the	O
clothes	O
you	O
wear	O
,	O
and	O
many	O
of	O
the	O
foods	O
you	O
eat	O
rely	O
on	O
rDNA	O
biotechnology	O
.	O

Retrieved	O
November	O
17	O
,	O
2008	O
.	O

Evidence	O
linking	O
these	O
incidents	O
to	O
biological	O
warfare	O
has	O
not	O
been	O
confirmed	O
.	O

The	O
ongoing	O
COVID-19	B-Incident
pandemic	E-Incident
is	O
caused	O
by	O
SARS-CoV-2	S-Pathogen
,	O
a	O
strain	O
of	O
coronavirus	O
related	O
to	O
the	O
one	O
which	O
causes	O
.	O

The	O
field	O
revolved	O
around	O
cutting	O
and	O
pasting	O
DNA	O
-	O
like	O
the	O
gene	O
for	O
insulin	O
-	O
from	O
one	O
organism	O
to	O
another	O
.	O

For	O
example	O
,	O
two	O
studies	O
done	O
on	O
previous	O
outbreaks	O
showed	O
that	O
71%	O
of	O
seropositive	O
individuals	O
did	O
not	O
have	O
the	O
clinical	O
disease	O
in	O
one	O
outbreak	O
and	O
another	O
study	O
reported	O
that	O
46%	O
of	O
asymptomatic	O
close	O
contacts	O
of	O
patients	O
with	O
Ebola	S-Disease
were	O
seropositive	O
.	O

Advancements	O
in	O
biotechnology	O
have	O
also	O
significantly	O
impacted	O
healthcare	O
,	O
particularly	O
in	O
preventative	O
medicine	O
,	O
according	O
to	O
the	O
third	O
speaker	O
,	O
Craig	B-Person
Venter	E-Person
Co-Founder	O
,	O
Chairman	O
and	O
Chief	O
Executive	O
Officer	O
of	O
Human	B-Organization
Longevity	E-Organization
,	O
Inc.	O
()	O
,	O
a	O
genomics-based	O
health	O
intelligence	O
company	O
focused	O
on	O
understanding	O
how	O
to	O
prolong	O
healthy	O
human	O
life	O
.	O

The	O
budget	O
for	O
fiscal	O
year	O
1966	O
was	O
$38	O
million	O
.	O

On	O
27	O
January	O
,	O
the	O
assessed	O
the	O
risk	O
of	O
the	O
outbreak	O
to	O
be	O
"	O
high	O
at	O
the	O
global	O
level"	O
.	O

He	O
was	O
treated	O
for	O
kidney	O
failure	O
but	O
was	O
not	O
tested	O
for	O
Ebola	S-Disease
;	O
he	O
died	O
on	O
27	O
October	O
and	O
his	O
body	O
returned	O
to	O
Guinea	S-Location
for	O
burial	O
.	O

They	O
are	O
designed	O
to	O
protect	O
from	O
airborne	O
particles	O
like	O
dust	O
but	O
effectiveness	O
against	O
a	O
specific	O
biological	O
agent	O
is	O
not	O
guaranteed	O
for	O
off-label	O
uses	O
.	O

In	O
October	O
1963	O
,	O
William	B-Person
Henry	I-Person
Oldendorf	E-Person
received	O
a	O
U.S.	O
patent	O
for	O
a	O
"	O
radiant	B-Document
energy	I-Document
apparatus	I-Document
for	I-Document
investigating	I-Document
selected	I-Document
areas	I-Document
of	I-Document
interior	I-Document
objects	I-Document
obscured	I-Document
by	I-Document
dense	I-Document
material	E-Document
"	O
.	O
The	O
first	O
commercially	O
viable	O
CT	B-Equipment
scanner	E-Equipment
was	O
invented	O
by	O
in	O
1972	O
.	O

Based	O
on	O
the	O
risk	O
assessment	O
for	O
EBOV	S-Pathogen
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
was	O
sectioned	O
into	O
a	O
green	O
zone	O
,	O
which	O
had	O
no	O
risk	O
of	O
contamination	O
[including	O
the	O
central	O
control	O
room	O
,	O
offices	O
,	O
lobby	O
(where	O
the	O
laboratory	O
staffs	O
getting	O
into	O
the	O
BSL-3	S-Platform
lab)	O
,	O
electricity	O
distribution	O
room	O
,	O
and	O
air	O
conditioning	O
engine	O
unit]	O
;	O
a	O
yellow	O
zone	O
,	O
which	O
had	O
the	O
potential	O
for	O
contamination	O
with	O
EBOV	S-Pathogen
nucleic	O
acids	O
(including	O
the	O
BSL-2	S-Platform
lab	O
,	O
the	O
PCR	S-Equipment
preparation	O
room	O
,	O
the	O
storage	O
room	O
,	O
the	O
corridor	O
,	O
the	O
1st	O
changing	O
room	O
,	O
the	O
shower	O
room	O
,	O
and	O
the	O
decontamination	O
room)	O
;	O
a	O
brown	O
zone	O
,	O
which	O
has	O
the	O
potential	O
for	O
contamination	O
with	O
EBOV	S-Pathogen
nucleic	O
acids	O
and	O
an	O
extremely	O
low	O
risk	O
of	O
contamination	O
with	O
live	O
EBOV	S-Pathogen
(2nd	O
changing	O
room)	O
;	O
and	O
a	O
red	O
zone	O
,	O
which	O
has	O
the	O
potential	O
for	O
contamination	O
with	O
live	O
EBOV	S-Pathogen
(	O
lab)	O
(Fig.1)	O
.	O

My	O
understanding	O
is	O
that	O
NIH	S-Organization
will	O
scour	O
their	O
entire	O
campus	O
to	O
see	O
if	O
there	O
are	O
any	O
other	O
stray	O
materials	O
that	O
shouldn't	O
be	O
present	O
,	O
and	O
CDC	S-Organization
,	O
which	O
has	O
a	O
regulatory	O
function	O
in	O
this	O
area	O
,	O
will	O
monitor	O
their	O
progress	O
and	O
completion	O
in	O
doing	O
this	O
.	O

On	O
18	O
April	O
it	O
was	O
reported	O
that	O
schools	O
in	O
France	S-Location
had	O
to	O
close	O
again	O
after	O
reopening	O
,	O
due	O
to	O
case	O
flare-ups	O
.	O

The	O
public	O
health	O
departments	O
distributed	O
gauze	B-Equipment
masks	E-Equipment
to	O
be	O
worn	O
in	O
public	O
.	O

Because	O
of	O
Schully's	O
findings	O
,	O
the	O
U.S.	B-Organization
Indo-Pacific	I-Organization
Command	E-Organization
(	O
PACOM	S-Organization
)	O
has	O
requested	O
that	O
the	O
same	O
forces	O
serving	O
in	O
Darwin	S-Location
be	O
screened	O
for	O
the	O
mosquito-borne	O
Ross	B-Pathogen
River	I-Pathogen
Virus	E-Pathogen
,	O
and	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center	I-Organization
Asia	E-Organization
is	O
using	O
the	O
study	O
to	O
provide	O
additional	O
surveillance	O
of	O
diseases	O
endemic	O
to	O
and	O
the	O
risks	O
they	O
present	O
to	O
the	O
servicemembers	O
.	O

Four	O
of	O
the	O
five	O
variants	O
have	O
caused	O
the	O
disease	O
in	O
humans	O
as	O
well	O
as	O
other	O
animals	O
;	O
RESTV	S-Pathogen
has	O
caused	O
clinical	O
symptoms	O
only	O
in	O
non-human	O
primates.	O
has	O
caused	O
subclinical	O
infections	O
in	O
humans	O
,	O
producing	O
an	O
antibody	O
response	O
but	O
no	O
visual	O
symptoms	O
or	O
disease	O
state	O
manifestations	O
.	O

The	O
New	B-Organization
York	I-Organization
Times	E-Organization
said	O
that	O
,	O
as	O
of	O
May	O
2020	O
,	O
the	O
outbreak	O
had	O
been	O
far	O
deadlier	O
there	O
but	O
the	O
economic	O
impact	O
had	O
been	O
reduced	O
as	O
Swedes	O
have	O
continued	O
to	O
go	O
to	O
work	O
,	O
restaurants	O
,	O
and	O
shopping	O
.	O

We	O
do	O
not	O
know	O
if	O
or	O
when	O
another	O
anthrax	S-Pathogen
attack	O
might	O
occur	O
.	O

The	O
boy	O
had	O
an	O
onset	O
of	O
symptoms	O
on	O
June	O
30	O
,	O
and	O
onset	O
of	O
paralysis	S-Disease
on	O
July	O
2	O
.	O

237	O
cases	O
of	O
Crimean-Congo	B-Disease
Hemorrhagic	I-Disease
Fever	E-Disease
(	O
CCHF	S-Disease
)	O
have	O
also	O
been	O
reported	O
across	O
Afghanistan	S-Location
,	O
41	O
of	O
which	O
were	O
fatal	O
as	O
of	O
December	O
2017	O
.	O

The	O
fact	O
that	O
most	O
of	O
those	O
who	O
recovered	O
from	O
first-wave	O
infections	O
had	O
become	O
immune	O
showed	O
that	O
it	O
must	O
have	O
been	O
the	O
same	O
strain	O
of	O
flu	S-Disease
This	O
was	O
most	O
dramatically	O
illustrated	O
in	O
,	O
which	O
escaped	O
with	O
a	O
combined	O
mortality	O
rate	O
of	O
just	O
0.29%	O
(0.	O
02%	O
in	O
the	O
first	O
wave	O
and	O
0.	O
27%	O
in	O
the	O
second	O
wave)	O
because	O
of	O
exposure	O
to	O
the	O
less-lethal	O
first	O
wave	O
.	O

The	O
act	O
regulates	O
any	O
genetically	O
modified	O
organism	O
that	O
utilizes	O
the	O
genome	O
of	O
a	O
predefined	O
"	O
plant	O
pest	O
"	O
or	O
any	O
plant	O
not	O
previously	O
categorized	O
.	O

The	O
same	O
approach	O
should	O
be	O
applied	O
to	O
antibiotic	O
resistance	O
;	O
a	O
new	O
generation	O
of	O
physician/scientists	O
with	O
modern	O
approaches	O
to	O
diagnostic/predictive	O
medicine	O
needs	O
to	O
be	O
trained	O
.	O

Raymond	B-Person
A.	I-Person
Zilinskas	E-Person
one	O
of	O
the	O
report's	O
authors	O
,	O
said	O
in	O
an	O
interview	O
that	O
American	O
officials	O
should	O
try	O
to	O
obtain	O
the	O
strain	O
from	O
the	O
Russians	O
in	O
order	O
to	O
test	O
the	O
American	O
vaccine's	O
effectiveness	O
.	O

1998:	O
WHO	S-Organization
Director-General	O
highlighted	O
gains	O
in	O
child	O
survival	O
,	O
reduced	O
infant	O
mortality	O
,	O
increased	O
life	O
expectancy	O
and	O
reduced	O
rates	O
of	O
"	O
scourges"	O
such	O
as	O
smallpox	S-Disease
and	O
polio	S-Disease
on	O
the	O
fiftieth	O
anniversary	O
of	O
's	O
founding	O
.	O

Additionally	O
,	O
she	O
serves	O
as	O
the	O
Director-of-Record	O
for	O
the	O
Wadsworth	B-Organization
Center's	I-Organization
clinical	I-Organization
laboratory	E-Organization
.	O
Among	O
her	O
professional	O
activities	O
,	O
Dr	O
.	O

Speaking	O
on	O
27	O
January	O
2015	O
,	O
Guinea's	O
Grand	O
Imam	O
,	O
the	O
country's	O
highest	O
cleric	O
,	O
gave	O
a	O
very	O
strong	O
message	O
saying	O
,	O
"	O
There	O
is	O
nothing	O
in	O
the	O
Koran	O
that	O
says	O
you	O
must	O
wash	O
,	O
kiss	O
or	O
hold	O
your	O
dead	O
loved	O
ones,	O
"	O
and	O
he	O
called	O
on	O
citizens	O
to	O
do	O
more	O
to	O
stop	O
the	O
virus	O
by	O
practising	O
safer	O
burying	O
rituals	O
that	O
do	O
not	O
compromise	O
tradition	O
.	O

Kadlec	S-Person
likened	O
's	O
financial	O
resources	O
on	O
hand	O
to	O
operating	O
with	O
half	O
an	O
aircraft	O
carrier	O
to	O
complete	O
its	O
mission	O
of	O
protecting	O
the	O
nation's	O
more	O
than	O
320	O
million	O
people	O
.	O

Title	B-Document
42	I-Document
of	I-Document
the	I-Document
Code	I-Document
of	I-Document
Federal	I-Document
Regulations	E-Document
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
citation	O
42	O
CFR	O
73	O
to	O
42	O
CFR	O
73.21	O
by	O
accessing	O
the	O
US	O
Code	O
of	O
Federal	O
Regulations	O
()	O
website	O
.	O

The	O
information	O
gathered	O
in	O
this	O
portal	O
is	O
used	O
by	O
the	O
countries	O
to	O
set	O
priorities	O
for	O
future	O
strategies	O
or	O
plans	O
,	O
implement	O
,	O
monitor	O
,	O
and	O
evaluate	O
it	O
.	O

The	O
great	O
majority	O
of	O
deaths	O
in	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
were	O
the	O
result	O
of	O
secondary	O
bacterial	B-Disease
pneumonia	E-Disease
.	O
The	O
influenza	O
virus	O
damaged	O
the	O
lining	O
of	O
the	O
bronchial	O
tubes	O
and	O
lungs	O
of	O
victims	O
,	O
allowing	O
common	O
bacteria	O
from	O
the	O
nose	O
and	O
throat	O
to	O
infect	O
their	O
lungs	O
.	O

The	O
1981	B-Incident
infestation	E-Incident
turned	O
into	O
a	O
political	O
crisis	O
and	O
led	O
to	O
the	O
beginning	O
of	O
the	O
state's	O
aerial	O
spraying	O
program	O
in	O
July	O
of	O
that	O
year	O
.	O

The	O
DIYbio	B-Activity
movement	E-Activity
seeks	O
to	O
revise	O
the	O
notion	O
that	O
one	O
must	O
be	O
an	O
academic	O
with	O
an	O
advanced	O
degree	O
to	O
make	O
any	O
significant	O
contribution	O
to	O
the	O
biology	O
community	O
.	O

One	O
of	O
the	O
solutions	O
is	O
to	O
promote	O
global	B-Platform
research	I-Platform
coordination	I-Platform
networks	E-Platform
that	O
share	O
functional	O
,	O
technical	O
,	O
and	O
policy	O
norms	O
and	O
enhance	O
transparency	O
among	O
researchers	O
to	O
promote	O
collaborative	O
global	O
biodefense	O
.	O

As	O
of	O
April	O
2014	O
,	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
reported	O
a	O
total	O
of	O
4	O
cases	O
in	O
,	O
3	O
of	O
which	O
were	O
fatalities	O
.	O

But	O
in	O
1918	O
,	O
cases	O
in	O
the	O
5-	O
to	O
15-year-old	O
group	O
jumped	O
to	O
25%	O
of	B-Disease
influe	E-Disease
nza	O
cases	O
(compatible	O
with	O
exposure	O
to	O
an	O
antigenically	O
novel	O
virus	O
strain)	O
,	O
while	O
the	O
&gt;65	O
age	O
group	O
only	O
accounted	O
for	O
0.	O
6%	O
o	O
f	B-Disease
the	I-Disease
inf	E-Disease
luenza	O
cases	O
,	O
findings	O
consistent	O
with	O
previously	O
acquired	O
protective	O
immunity	O
caused	O
by	O
an	O
identical	O
or	O
closely	O
related	O
viral	O
protein	O
to	O
which	O
older	O
persons	O
had	O
once	O
been	O
exposed	O
.	O

Old	O
tests	O
took	O
weeks	O
to	O
yield	O
results	O
;	O
the	O
new	O
test	O
takes	O
only	O
two	O
days	O
.	O

On	O
19	O
March	O
,	O
Italy	S-Organization
overtook	O
China	S-Location
as	O
the	O
country	O
with	O
the	O
most	O
coronavirus-related	O
deaths	O
in	O
the	O
world	O
after	O
reporting	O
3,405	O
fatalities	O
from	O
the	O
pandemic	O
.	O

X-ray	B-Technology
CT	E-Technology
is	O
used	O
in	O
geological	O
studies	O
to	O
quickly	O
reveal	O
materials	O
inside	O
a	O
drill	O
core	O
.	O

CDC	S-Organization
has	O
established	O
a	O
‐wide	O
single	O
point	O
of	O
accountability	O
for	O
laboratory	O
science	O
and	O
safety	O
and	O
this	O
will	O
aid	O
in	O
ensuring	O
accountability	O
in	O
this	O
situation	O
.	O

The	O
coordinated	O
monitoring	O
of	O
the	O
national	O
use	O
of	O
antimicrobials	O
and	O
antimicrobial	O
resistance	O
is	O
necessary	O
to	O
understand	O
the	O
extent	O
,	O
distribution	O
and	O
impact	O
of	O
resistant	O
organisms	O
and	O
antibacterial	O
use	O
,	O
and	O
identification	O
of	O
drug	O
resistance	O
and	O
emerging	O
trends	O
,	O
and	O
determine	O
the	O
relationship	O
between	O
use	O
and	O
drug	O
resistance	O
.	O

President	O
Trump	S-Person
expressed	O
surprise	O
and	O
disapproval	O
at	O
's	O
statements	O
saying	O
,	O
"	O
To	O
me	O
it's	O
not	O
an	O
acceptable	O
answer	O
,	O
especially	O
when	O
it	O
comes	O
to	O
schools.	O
"	O

The	O
ability	O
to	O
develop	O
vaccines	O
such	O
as	O
Imvamune	S-Vaccine
is	O
dependent	O
on	O
the	O
guarantees	O
of	O
multi-year	O
funding	O
from	O
the	O
U.S.	B-Organization
government	E-Organization
to	O
pharmaceutical	O
companies	O
.	O

The	O
head	O
of	O
the	O
NIAID	S-Organization
Anthony	B-Person
Fauci	E-Person
,	O
warned	O
that	O
if	O
caution	O
was	O
not	O
used	O
the	O
rate	O
of	O
infections	O
could	O
rebound	O
and	O
he	O
was	O
particularly	O
concerned	O
about	O
opening	O
the	O
schools	O
in	O
the	O
fall	O
.	O

Bradley	B-Person
A.	I-Person
Thayer	E-Person
,	O
Lianchao	B-Person
Han	E-Person
,	O
China	S-Location
and	O
the	O
's	O
chief:	O
Hold	O
them	O
both	O
accountable	O
for	O
pandemic	O
,	O
The	O
Hill	O
,	O
17	O
March	O
2020	O
.	O

Asprey	S-Person
glorifies	O
coconut	O
oil	O
and	O
demonizes	O
olive	O
oil	O
,	O
ignoring	O
the	O
wealth	O
of	O
randomized	O
trials	O
(the	O
highest	O
quality	O
of	O
evidence)	O
that	O
have	O
demonstrated	O
olive	O
oil	O
is	O
beneficial	O
for	O
health	O
.	O

Image	O
Caption:	O
DARPA	S-Organization
SIGMA+	S-Scientific_research_project
program	O
seeks	O
to	O
develop	O
highly	O
sensitive	O
detectors	O
and	O
advanced	O
intelligence	O
analytics	O
to	O
detect	O
minute	O
traces	O
of	O
materials	O
used	O
for	O
chemical	O
,	O
biological	O
,	O
radiological	O
,	O
nuclear	O
,	O
and	O
high-yield	O
explosive	O
(CBRNE)	O
weapons	O
.	O

One	O
summary	O
of	O
available	O
studies	O
estimated	O
the	O
number	O
of	O
those	O
infected	O
who	O
are	O
asymptomatic	O
to	O
be	O
40%	O
.	O

New	B-Location
England	E-Location
--	O
particularly	O
Massachusetts	S-Location
--	O
and	O
the	O
New	B-Location
York	E-Location
and	O
New	B-Location
Jersey	E-Location
areas	O
have	O
been	O
hit	O
the	O
hardest	O
,	O
Schuchat	S-Person
said	O
Thursday	O
at	O
a	O
news	O
conference	O
.	O

Reports	O
by	O
the	O
Outbreak	B-Scientific_research_project
Observatory	E-Scientific_research_project
can	O
be	O
found	O
at	O
outbreakobservatory.org	O
.	O

Surfaces	O
are	O
easily	O
decontaminated	O
with	O
household	O
disinfectants	O
which	O
kill	O
the	O
virus	O
outside	O
the	O
human	O
body	O
or	O
on	O
the	O
hands	O
.	O

One	O
type	O
of	O
simulator	O
,	O
which	O
said	O
costs	O
from	O
$75,000	O
to	O
$90,000	O
,	O
can	O
replicate	O
basic	O
human	O
actions	O
such	O
as	O
breathing	O
and	O
blinking	O
and	O
is	O
operated	O
through	O
Wi-Fi	O
to	O
display	O
symptoms	O
and	O
injuries	O
.	O

Understanding	O
how	O
viruses	O
evolve	O
within	O
a	O
species	O
will	O
be	O
a	O
core	O
area	O
of	O
research	O
.	O

Representatives	O
attend	O
from	O
each	O
member	O
or	O
associative	O
member	O
in	O
each	O
region	O
,	O
including	O
those	O
states	O
that	O
are	O
not	O
full	O
members	O
.	O

Biodefense:	O
Worldwide	O
Threats	O
and	O
Countermeasure	O
Efforts	O
for	O
the	O
Department	O
of	O
Defense	O
:	O
Hearing	O
Before	O
the	O
Subcommittee	O
on	O
Intelligence	O
,	O
Emerging	O
Threats	O
and	O
Capabilities	O
of	O
the	O
Committee	O
on	O
Armed	O
Services	O
,	O
,	O
One	O
Hundred	O
Thirteenth	O
Congress	O
,	O
First	O
Session	O
,	O
Hearing	O
Held	O
October	O
11	O
,	O
2013.	O
p.	O
34	O
.	O

On	O
18 January	O
2007	O
,	O
Kobasa	S-Person
et	O
al.	O
(2007)	O
reported	O
that	O
monkeys	O
(Macaca	O
fascicularis)	O
infected	O
with	O
the	O
recreated	O
flu	O
strain	O
exhibited	O
classic	O
symptoms	O
of	O
the	O
1918	B-Incident
pandemic	E-Incident
,	O
and	O
died	O
from	O
cytokine	B-Disease
storms	E-Disease
 –	O
an	O
overreaction	O
of	O
the	O
immune	O
system	O
.	O

Although	O
toxicity	O
and	O
allergenicity	O
are	O
included	O
in	O
the	O
definition	O
of	O
biological	O
agents	O
,	O
the	O
four	O
risk	O
groups	O
are	O
based	O
on	O
the	O
level	O
of	O
risk	O
of	O
infection	O
.	O

Researchers	O
can	O
use	O
the	O
method	O
to	O
make	O
random	O
versions	O
of	O
bacteria	O
and	O
test	O
them	O
for	O
their	O
ability	O
to	O
make	O
biofuels	O
,	O
for	O
example	O
,	O
or	O
to	O
digest	O
oil	O
from	O
an	O
oil	O
spill	O
.	O

Only	O
a	O
few	O
countries	O
have	O
this	O
disease	O
,	O
just	O
a	O
small	O
cluster	O
in	O
West	B-Location
Africa	E-Location
mostly	O
in	O
Sierra	B-Location
Leone	E-Location
but	O
also	O
Liberia	S-Location
and	O
Guinea	S-Location
.	O
And	O
also	O
a	O
significant	O
number	O
in	O
.	O
Because	O
of	O
the	O
limited	O
geographical	O
spread	O
,	O
we	O
don't	O
think	O
this	O
disease	O
gets	O
the	O
attention	O
it	O
deserves	O
,	O
for	O
the	O
mortality	O
that	O
it	O
causes	O
.	O

However	O
,	O
emergency	O
supplemental	O
funding	O
has	O
been	O
depleted	O
,	O
he	O
added	O
,	O
and	O
the	O
H7N9	B-Pathogen
influenza	I-Pathogen
virus	E-Pathogen
is	O
currently	O
circulating	O
in	O
China	S-Location
.	O
"	O
We	O
are	O
concerned	O
with	O
the	O
ominous	O
trends	O
that	O
we	O
are	O
seeing,	O
"	O
said	O
.	O

XperimentR	S-Platform
developed	O
at	O
the	O
Imperial	B-Organization
College	E-Organization
in	O
London	S-Location
-is	O
not	O
distributed	O
as	O
software	O
but	O
instead	O
provides	O
all	O
its	O
features	O
via	O
the	O
web	O
with	O
the	O
intention	O
to	O
free	O
the	O
user	O
from	O
installation	O
tasks	O
.	O

On	O
14	O
April	O
2014	O
,	O
one	O
Filipino	O
paramedic	O
died	O
in	O
the	O
United	B-Location
Arab	I-Location
Emirates	E-Location
with	O
six	O
other	O
reported	O
to	O
be	O
infected	O
with	O
the	O
virus	O
.	O

Although	O
the	O
facility	O
will	O
ultimately	O
be	O
finished	O
in	O
Kansas	S-Location
the	O
U.S.	S-Location
livestock	O
industry	O
should	O
continue	O
to	O
cast	O
a	O
watchful	O
eye	O
on	O
its	O
operation	O
.	O

That's	O
a	O
different	O
form	O
of	O
.	O
But	O
this	O
one	O
has	O
been	O
around	O
for	O
about	O
a	O
decade	O
,	O
and	O
it's	O
one	O
of	O
the	O
ones	O
that	O
does	O
concern	O
us	O
because	O
it	O
can	O
be	O
quite	O
deadly	O
both	O
for	O
poultry	O
and	O
for	O
people	O
.	O

The	O
organization	O
develops	O
and	O
promotes	O
the	O
use	O
of	O
evidence-based	O
tools	O
,	O
norms	O
and	O
standards	O
to	O
support	O
member	O
states	O
to	O
inform	O
health	O
policy	O
options	O
.	O

When	O
the	O
war	O
ended	O
,	O
the	O
US	B-Organization
Army	E-Organization
quietly	O
enlisted	O
certain	O
members	O
of	O
Noborito	S-Organization
in	O
its	O
efforts	O
against	O
the	O
communist	O
camp	O
in	O
the	O
early	O
years	O
of	O
the	O
Cold	O
War	O
.	O

Transmission	O
of	O
the	O
ebolaviruses	S-Pathogen
between	O
natural	O
reservoirs	O
and	O
humans	O
is	O
rare	O
,	O
and	O
outbreaks	O
of	O
are	O
often	O
traceable	O
to	O
a	O
single	O
case	O
where	O
an	O
individual	O
has	O
handled	O
the	O
carcass	O
of	O
a	O
gorilla	O
,	O
chimpanzee	O
,	O
bats	O
,	O
or	O
duiker	O
.	O

As	O
the	O
toxic	O
threat	O
constantly	O
evolves	O
,	O
warfighters	O
rely	O
on	O
PPE	S-Equipment
that	O
can	O
adapt	O
at	O
the	O
speed	O
of	O
relevancy	O
from	O
hostile	O
enemies	O
to	O
viruses	O
and	O
volatile	O
chemicals	O
.	O

Using	O
smallpox	S-Pathogen
as	O
a	O
weapon	O
was	O
not	O
unprecedented	O
for	O
the	O
British	B-Organization
military	E-Organization
;	O
Native	O
Americans	O
were	O
the	O
targets	O
of	O
attack	O
earlier	O
in	O
the	O
century	O
.	O

Dissemination	O
of	O
scientific	O
data	O
and	O
knowledge	O
catalyzes	O
worldwide	O
scientific	O
progress	O
.	O

Antibiotic-resistant	O
strains	O
of	O
bacteria	O
help	O
scientists	O
determine	O
which	O
antibiotic	O
therapies	O
will	O
be	O
most	O
effective	O
in	O
treating	O
an	O
illness	O
,	O
but	O
former	O
Soviet	O
bioweapons	O
builders	O
are	O
suspected	O
using	O
this	O
technology	O
to	O
develop	O
antibiotic-resistant	O
forms	O
of	O
plague	S-Disease
,	O
anthrax	S-Disease
,	O
and	O
tularemia	S-Disease
.	O
Last	O
year	O
,	O
Australian	O
researchers	O
inadvertently	O
created	O
a	O
lethal	O
form	O
of	O
mousepox	S-Disease
by	O
adding	O
a	O
single	O
gene	O
to	O
the	O
virus	O
,	O
and	O
this	O
year	O
scientists	O
in	O
were	O
able	O
to	O
create	O
polio	O
virus	O
from	O
scratch	O
by	O
assembling	O
pieces	O
of	O
DNA	O
.	O

"	O
Ebola	S-Pathogen
Ground	O
Zero	O
My	O
Journey	O
Back	O
"	O
Financial	O
Times	O
3	O
May	O
2014	O
Lokela	S-Person
had	O
toured	O
with	O
a	O
Yambuku	O
mission	O
in	O
August	O
1976	O
near	O
the	O
Central	B-Location
African	I-Location
Republic	E-Location
border	O
and	O
along	O
the	O
Ebola	O
River-the	O
namesake	O
of	O
and	O
the	O
origin	O
of	O
the	O
outbreak	O
.	O

For	O
more	O
detailed	O
discussion	O
of	O
the	O
chickenpox	S-Disease
theory	O
,	O
as	O
developed	O
by	O
Drs	O
Carmody	S-Person
and	O
G	B-Person
E	I-Person
Ford	E-Person
,	O
and	O
by	O
the	O
archaeologist	O
,	O
see	O
Wikipedia's	O
article	O
on	O
The	O
History	O
Wars	O
.	O

Global	B-Organization
Biodefense	E-Organization
is	O
an	O
official	O
media	O
partner	O
of	O
the	O
Biodefense	O
World	O
Summit	O
.	O

It	O
also	O
reviews	O
reports	O
of	O
the	O
Executive	O
Board	O
and	O
decides	O
whether	O
there	O
are	O
areas	O
of	O
work	O
requiring	O
further	O
examination	O
.	O

Plenty	O
of	O
age-old	O
techniques	O
-	O
meditation	O
,	O
fasting	O
-	O
can	O
be	O
considered	O
a	O
basic	O
type	O
of	O
biohacking	O
.	O

Further	O
investigation	O
,	O
review	O
,	O
and	O
action	O
is	O
underway	O
.	O

The	O
CIA	S-Organization
maintained	O
its	O
collection	O
of	O
biologicals	O
well	O
into	O
1975	O
when	O
it	O
became	O
the	O
subject	O
of	O
the	O
.	O

Lokela	S-Person
died	O
shortly	O
afterwards	O
on	O
8	O
September	O
.	O

Other	O
suspected	O
Japanese	O
war	O
criminals	O
who	O
were	O
never	O
indicted	O
include	O
three	O
postwar	O
prime	O
ministers:	O
Hatoyama	B-Person
Ichirō	E-Person
(1954–1956)	O
,	O
Ikeda	B-Person
Hayato	E-Person
(1960–1964)	O
,	O
and	O
(1957)	O
.	O

There	O
were	O
so	O
many	O
dead	O
that	O
mass	O
graves	O
needed	O
to	O
be	O
dug	O
and	O
,	O
even	O
then	O
,	O
cemeteries	O
ran	O
out	O
of	O
room	O
for	O
the	O
bodies	O
.	O

Recent	O
findings	O
show	O
no	O
necessity	O
of	O
large	O
populations	O
of	O
bacteria	O
for	O
the	O
appearance	O
of	O
antibiotic	O
resistance	O
.	O

These	O
are	O
binary	O
biological	O
weapons	O
(a	O
lethal	O
combination	O
of	O
two	O
viruses)	O
,	O
host	O
swapping	O
diseases	O
(animal	O
viruses	O
that	O
"	O
jump"	O
to	O
humans	O
,	O
like	O
the	O
)	O
,	O
stealth	O
viruses	O
,	O
and	O
designer	O
diseases	O
.	O

It	O
has	O
also	O
been	O
argued	O
that	O
the	O
Black	B-Disease
Death	E-Disease
prompted	O
a	O
new	O
wave	O
of	O
piety	O
,	O
manifested	O
in	O
the	O
sponsorship	O
of	O
religious	O
works	O
of	O
art	O
.	O

Although	O
the	O
Federal	B-Organization
Government	E-Organization
&amp	O
;	O
DOT	O
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

Based	O
on	O
the	O
review	O
to	O
date	O
,	O
CDC	S-Organization
believes	O
that	O
other	O
CDC	S-Organization
staff	O
,	O
family	O
members	O
,	O
and	O
the	O
general	O
public	O
are	O
not	O
at	O
risk	O
of	O
exposure	O
and	O
do	O
not	O
need	O
to	O
take	O
any	O
protective	O
action	O
.	O

Another	O
study	O
showed	O
that	O
the	O
economic	O
effect	O
of	O
the	O
Ebola	B-Incident
outbreak	E-Incident
would	O
be	O
felt	O
for	O
years	O
due	O
to	O
preexisting	O
social	O
vulnerability	O
.	O

In	O
2017	O
the	O
DTRA	S-Organization
funded	O
further	O
research	O
–	O
Ten	O
Genome	O
Sequences	O
of	O
Human	O
and	O
Livestock	O
Isolates	O
of	O
from	O
the	O
Country	O
of	O
Georgia	S-Location
,	O
which	O
was	O
performed	O
by	O
USAMRU-G	S-Organization
at	O
The	O
.	O

This	O
study	O
was	O
conducted	O
to	O
evaluate	O
the	O
biosafety	O
precautions	O
that	O
applied	O
by	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
state	O
,	O
2009	O
.	O

By	O
using	O
the	O
as	O
a	O
biological	O
weapon	O
,	O
the	O
story	O
goes	O
,	O
these	O
groups	O
could	O
wreak	O
havoc	O
around	O
the	O
globe	O
.	O

In	O
1947	O
,	O
the	O
CDC	S-Organization
made	O
a	O
token	O
payment	O
of	O
$10	O
to	O
Emory	B-Organization
University	I-Organization
for	I-Organization
of	I-Organization
land	I-Organization
on	I-Organization
Clifton	I-Organization
Road	I-Organization
in	I-Organization
DeKalb	I-Organization
County	E-Organization
,	O
still	O
the	O
home	O
of	O
headquarters	O
as	O
of	O
2019	O
.	O

In	O
February	O
2013	O
,	O
the	O
first	O
UK	S-Location
case	O
of	O
the	O
novel	O
coronavirus	O
was	O
confirmed	O
in	O
Manchester	S-Location
in	O
an	O
elderly	O
man	O
who	O
had	O
recently	O
visited	O
the	O
Middle	B-Location
East	E-Location
and	O
Pakistan	S-Location
;	O
it	O
was	O
the	O
10th	O
case	O
globally	O
.	O

Further	O
,	O
the	O
Africa	B-Organization
CDC	I-Organization
Central	I-Organization
Africa	I-Organization
Regional	I-Organization
Collaborating	I-Organization
Centre	E-Organization
pledged	O
to	O
fill	O
recognized	O
biosecurity	O
training	O
gaps	O
by	O
coordinating	O
a	O
regional	O
effort	O
,	O
through	O
partnerships	O
with	O
Africa	B-Organization
CDC's	I-Organization
Institute	I-Organization
for	I-Organization
Workforce	I-Organization
Development	E-Organization
,	O
Columbia	B-Organization
University	E-Organization
,	O
and	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Laboratories	E-Organization
.	O
The	O
idea	O
is	O
to	O
adapt	O
existing	O
biosecurity	O
and	O
biosafety	O
training	O
curricula	O
to	O
the	O
Central	O
African	O
Member	O
States	O
.	O

The	O
main	O
functions	O
of	O
WHO	S-Organization
country	O
offices	O
include	O
being	O
the	O
primary	O
adviser	O
of	O
that	O
country's	O
government	O
in	O
matters	O
of	O
health	O
and	O
pharmaceutical	O
policies	O
.	O

On	O
4	O
March	O
,	O
a	O
27-year-old	O
man	O
,	O
who	O
had	O
visited	O
a	O
guest	O
on	O
the	O
Metropole	S-Organization
9th	O
floor	O
11	O
days	O
earlier	O
,	O
was	O
admitted	O
to	O
Hong	B-Location
Kong	E-Location
's	O
.	O
At	O
least	O
99	O
hospital	O
workers	O
(including	O
17	O
medical	O
students)	O
were	O
infected	O
while	O
treating	O
him	O
.	O

With	O
many	O
of	O
the	O
mysteries	O
of	O
DNA	O
still	O
unsolved	O
,	O
some	O
scientists	O
believe	O
the	O
only	O
way	O
to	O
truly	O
understand	O
the	O
genome	O
is	O
to	O
make	O
one	O
from	O
its	O
basic	O
building	O
blocks	O
.	O

On	O
15	O
September	O
,	O
the	O
first	O
doctor	O
to	O
arrive	O
,	O
Mgoi	B-Person
Mushola	E-Person
,	O
prepared	O
a	O
report	O
in	O
which	O
he	O
noted	O
that	O
none	O
of	O
the	O
many	O
treatments	O
provided	O
met	O
with	O
success	O
.	O

Such	O
a	O
bioweapon	O
must	O
fulfil	O
a	O
variety	O
of	O
demands:	O
it	O
needs	O
to	O
be	O
produced	O
in	O
large	O
amounts	O
,	O
it	O
must	O
act	O
fast	O
,	O
it	O
must	O
be	O
environmentally	O
robust	O
,	O
and	O
the	O
disease	O
must	O
be	O
treatable	O
,	O
or	O
a	O
vaccine	O
must	O
be	O
available	O
,	O
to	O
allow	O
the	O
protection	O
of	O
one's	O
own	O
soldiers	O
.	O

In	O
a	O
study	O
of	O
early	O
cases	O
,	O
the	O
median	O
time	O
from	O
exhibiting	O
initial	O
symptoms	O
to	O
death	O
was	O
14	O
days	O
,	O
with	O
a	O
full	O
range	O
of	O
six	O
to	O
41	O
days	O
.	O

Waste	O
from	O
the	O
BSL-3	S-Platform
lab	O
was	O
carefully	O
wrapped	O
in	O
a	O
biohazard	O
bag	O
and	O
sterilised	O
twice	O
,	O
the	O
first	O
round	O
of	O
sterilisation	O
was	O
performed	O
in	O
an	O
autoclave	S-Equipment
in	O
BSL-3	S-Platform
laboratory	O
,	O
then	O
transferred	O
to	O
another	O
autoclave	S-Equipment
in	O
the	O
decontamination	O
room	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
for	O
a	O
second	O
round	O
of	O
sterilisation	O
.	O

The	O
employee	O
was	O
retrained	O
on	O
proper	O
procedures	O
for	O
removing	O
protective	O
equipment	O
and	O
exiting	O
animal	O
containment	O
rooms	O
,	O
records	O
say	O
.	O

One	O
recent	O
advancement	O
is	O
the	O
commercialization	O
of	O
a	O
new	O
form	O
of	O
Tyvex™	B-Equipment
armor	E-Equipment
which	O
protects	O
first	O
responders	O
and	O
patients	O
from	O
chemical	O
and	O
biological	O
contaminants	O
.	O

These	O
operations	O
were	O
part	O
of	O
the	O
US	S-Location
Entomological	O
Warfare	O
under	O
the	O
Program	O
for	O
Biological	O
Weapons	O
of	O
the	O
.	O

Leśne	O
morze)	O
(1960)	O
,	O
a	O
novel	O
by	O
a	O
Polish	O
writer	O
and	O
educator	O
Igor	B-Person
Newerly	E-Person
The	O
first	O
book	O
published	O
outside	O
which	O
refers	O
to	O
atrocities	O
committed	O
in	O
the	O
unit	O
.	O

Several	O
(25	O
January)	O
celebrations	O
were	O
also	O
cancelled	O
.	O

As	O
part	O
of	O
its	O
investigation	O
,	O
the	O
GAO	S-Organization
also	O
looked	O
at	O
the	O
way	O
USAID	S-Organization
evaluates	O
its	O
Ebola	B-Scientific_research_project
recovery	I-Scientific_research_project
activities	E-Scientific_research_project
,	O
part	O
of	O
which	O
involves	O
an	O
evaluation	O
plan	O
prepared	O
by	O
a	O
contractor	O
.	O

Between	O
2008	O
and	O
2014	O
,	O
the	O
United	B-Location
States	E-Location
invested	O
approximately	O
$820	O
million	O
in	O
synthetic	O
biology	O
research	O
,	O
Defense	S-Organization
being	O
a	O
major	O
contributor	O
.	O

"	O
I	O
am	O
proud	O
this	O
comprehensive	O
bill	O
ensures	O
our	O
healthcare	O
professionals	O
are	O
trained	O
to	O
respond	O
to	O
possible	O
pandemic	O
outbreaks	O
,	O
prioritizes	O
the	O
further	O
development	O
of	O
our	O
national	O
stockpile	O
of	O
vaccines	O
,	O
medical	O
equipment	O
,	O
and	O
diagnostics	O
,	O
and	O
establishes	O
new	O
advisory	O
groups	O
focused	O
on	O
protecting	O
vulnerable	O
populations,	O
"	O
Rep	O
.	O

When	O
smallpox	S-Pathogen
was	O
eradicated	O
,	O
there	O
was	O
a	O
global	O
agreement	O
to	O
identify	O
any	O
existing	O
sample	O
and	O
to	O
either	O
destroy	O
it	O
or	O
send	O
it	O
to	O
one	O
of	O
two	O
laboratories	O
.	O

The	O
other	O
close	O
contacts	O
,	O
which	O
included	O
two	O
biomedical	O
scientists	O
from	O
the	O
Regional	B-Organization
Virus	I-Organization
Laboratory	E-Organization
,	O
were	O
released	O
from	O
quarantine	O
in	O
on	O
10	O
October	O
1978	O
.	O

The	O
FBI	S-Organization
became	O
involved	O
in	O
the	O
investigation	O
and	O
the	O
letters	O
were	O
turned	O
over	O
to	O
the	O
Los	B-Organization
Angeles	I-Organization
Police	I-Organization
Department's	I-Organization
Criminal	I-Organization
Conspiracy	I-Organization
Section	E-Organization
.	O
During	O
the	O
course	O
of	O
the	O
investigation	O
,	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
attempted	O
to	O
contact	O
The	O
Breeders	O
through	O
a	O
classified	O
ad	O
placed	O
in	O
the	O
Los	B-Location
Angeles	E-Location
Times	O
.	O

It	O
is	O
not	O
clear	O
whether	O
the	O
traditional	O
healer	O
was	O
infected	O
with	O
both	O
variants	O
,	O
or	O
if	O
perhaps	O
one	O
of	O
the	O
women	O
attending	O
the	O
funeral	O
was	O
independently	O
infected	O
.	O

The	O
FDA	S-Organization
first	O
determined	O
in	O
1977	O
that	O
there	O
is	O
evidence	O
of	O
emergence	O
of	O
antibiotic-resistant	O
bacterial	O
strains	O
in	O
livestock	O
.	O

Insulin	S-Drug
doesn't	O
cost	O
much	O
to	O
produce	O
,	O
but	O
as	O
a	O
society	O
we've	O
allowed	O
companies	O
to	O
jack	O
up	O
the	O
price	O
so	O
high	O
that	O
many	O
people	O
with	O
are	O
now	O
skipping	O
lifesaving	O
doses	O
.	O

The	O
Persistent	B-Scientific_research_project
Aquatic	I-Scientific_research_project
Living	I-Scientific_research_project
Sensors	E-Scientific_research_project
(	O
PALS	S-Scientific_research_project
)	O
program	O
,	O
led	O
by	O
program	O
manager	O
Lori	B-Person
Adornato	E-Person
,	O
will	O
study	O
natural	O
and	O
modified	O
organisms	O
to	O
determine	O
which	O
ones	O
could	O
best	O
support	O
sensor	O
systems	O
that	O
detect	O
the	O
movement	O
of	O
manned	O
and	O
unmanned	O
underwater	O
vehicles.	O
will	O
investigate	O
marine	O
organisms'	O
responses	O
to	O
the	O
presence	O
of	O
such	O
vehicles	O
,	O
and	O
characterize	O
the	O
resulting	O
signals	O
or	O
behaviors	O
so	O
they	O
can	O
be	O
captured	O
,	O
interpreted	O
,	O
and	O
relayed	O
by	O
a	O
network	O
of	O
hardware	O
devices	O
.	O

CRISPR-Cas9	S-Technology
offers	O
a	O
high	O
degree	O
of	O
fidelity	O
and	O
relatively	O
simple	O
construction	O
.	O

"	O
For	O
a	O
company	O
like	O
Bavarian	B-Organization
Nordic	E-Organization
[vaccine	O
development]	O
would	O
have	O
been	O
impossible	O
without	O
this	O
long-term	O
commitment,	O
"	O
he	O
said	O
,	O
adding	O
that	O
it	O
takes	O
about	O
a	O
$1	O
billion	O
to	O
develop	O
a	O
drug	O
to	O
approval	O
.	O

So	O
as	O
I've	O
said	O
,	O
I've	O
taken	O
a	O
series	O
of	O
steps	O
in	O
response	O
to	O
these	O
incidents	O
.	O

Conversely	O
,	O
CRISPR-mediated	B-Technology
activation	E-Technology
()	O
promotes	O
gene	O
transcription	O
.	O

Ministries	B-Organization
in	I-Organization
Tokyo	E-Organization
ordered	O
the	O
destruction	O
of	O
all	O
incriminating	O
materials	O
,	O
including	O
those	O
in	O
Pingfan	S-Location
.	O
Potential	O
witnesses	O
,	O
such	O
as	O
the	O
300	O
remaining	O
prisoners	O
were	O
either	O
gassed	O
or	O
fed	O
poison	O
while	O
the	O
600	O
Chinese	O
and	O
Manchurian	O
laborers	O
were	O
shot.	O
ordered	O
every	O
member	O
of	O
the	O
group	O
to	O
disappear	O
and	O
"	O
take	O
the	O
secret	O
to	O
the	O
grave"	O
.	O

TOM	B-Person
FRIEDEN	E-Person
In	O
the	O
other	O
incidents	O
,	O
from	O
everything	O
I	O
understand	O
there	O
were	O
no	O
exposures	O
,	O
and	O
the	O
organisms	O
have	O
been	O
completely	O
contained	O
.	O

We	O
do	O
have	O
partners	O
who	O
rely	O
on	O
us	O
for	O
sending	O
out	O
things	O
like	O
proficiency	O
panels	O
.	O

A	O
CT	S-Equipment
scan	O
of	O
the	O
heart	O
is	O
performed	O
to	O
gain	O
knowledge	O
about	O
cardiac	O
or	O
coronary	O
anatomy	O
.	O

The	O
CRISPR	S-Person
edits	O
are	O
not	O
always	O
perfect	O
and	O
the	O
cuts	O
can	O
end	O
up	O
in	O
the	O
wrong	O
place	O
.	O

Some	O
countries	O
,	O
however	O
,	O
may	O
not	O
have	O
a	O
public	O
health	O
system	O
or	O
are	O
in	O
various	O
stages	O
of	O
developing	O
them	O
.	O

Beginning	O
in	O
1975	O
,	O
when	O
medflies	O
were	O
first	O
seen	O
in	O
the	O
area	O
,	O
California	S-Location
deployed	O
small	O
McPhail	S-Person
traps	O
to	O
attract	O
and	O
capture	O
the	O
medflies	O
to	O
help	O
measure	O
the	O
estimated	O
population	O
.	O

On	O
1	O
May	O
2020	O
,	O
the	O
U.S.	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
granted	O
Gilead	S-Organization
Emergency	B-Document
Use	I-Document
Authorization	E-Document
for	O
remdesivir	S-Drug
to	O
be	O
distributed	O
and	O
used	O
by	O
licensed	O
health	O
care	O
providers	O
to	O
treat	O
adults	O
and	O
children	O
hospitalized	O
with	O
severe	O
COVID‐19	S-Disease
.	O
Severe	O
COVID‐19	S-Disease
is	O
defined	O
as	O
patients	O
with	O
an	O
oxygen	O
saturation	O
(SpO2)	O
≤	O
94%	O
on	O
room	O
air	O
or	O
requiring	O
supplemental	O
oxygen	O
or	O
requiring	O
mechanical	O
ventilation	O
or	O
requiring	O
extracorporeal	B-Technology
membrane	I-Technology
oxygenation	E-Technology
(	O
ECMO	S-Technology
)	O
,	O
a	O
heart‐	O
lung	B-Equipment
bypass	I-Equipment
machine	E-Equipment
.	O
Distribution	O
of	O
remdesivir	S-Drug
under	O
the	O
EUA	O
will	O
be	O
controlled	O
by	O
the	O
U.S.	B-Organization
government	E-Organization
for	O
use	O
consistent	O
with	O
the	O
terms	O
and	O
conditions	O
of	O
the	O
EUA	O
.	O
Gilead	S-Organization
will	O
supply	O
remdesivir	S-Drug
to	O
authorized	O
distributors	O
,	O
or	O
directly	O
to	O
a	O
U.S.	B-Organization
government	E-Organization
agency	O
,	O
who	O
will	O
distribute	O
to	O
hospitals	O
and	O
other	O
healthcare	O
facilities	O
as	O
directed	O
by	O
the	O
,	O
in	O
collaboration	O
with	O
state	O
and	O
local	O
government	O
authorities	O
,	O
as	O
needed	O
.	O

The	O
RD	O
is	O
also	O
the	O
direct	O
supervising	O
authority-concomitantly	O
with	O
the	O
WHO	S-Organization
Director-General-of	O
all	O
the	O
heads	O
of	O
WHO	S-Organization
country	O
offices	O
,	O
known	O
as	O
Representatives	O
,	O
within	O
the	O
region	O
.	O

From	O
the	O
beginning	O
of	O
the	O
outbreak	O
,	O
there	O
existed	O
considerable	O
difficulty	O
in	O
getting	O
reliable	O
estimates-both	O
of	O
the	O
number	O
of	O
people	O
affected	O
and	O
of	O
its	O
geographical	O
extent	O
.	O

Other	O
than	O
Parker's	B-Person
mother	E-Person
,	O
no	O
further	O
cases	O
occurred	O
.	O

The	O
virus	O
was	O
isolated	O
in	O
contaminated	O
drinking	O
water	O
.	O

Early	O
reports	O
show	O
that	O
up	O
to	O
30%	O
of	O
hospitalized	O
patients	O
in	O
both	O
China	S-Location
and	O
New	B-Location
York	E-Location
have	O
experienced	O
some	O
injury	B-Phenotype
to	I-Phenotype
their	I-Phenotype
kidneys	E-Phenotype
,	O
including	O
some	O
persons	O
with	O
no	O
previous	O
kidney	O
problems	O
.	O

And	O
also	O
make	O
sure	O
that	O
in	O
the	O
work	O
that	O
we	O
do	O
,	O
we're	O
not	O
risking	O
others	O
.	O

Without	O
sufficient	O
staff	O
to	O
care	O
for	O
patients	O
,	O
needles	O
may	O
become	O
dislodged	O
or	O
pulled	O
out	O
by	O
a	O
delirious	O
patient	O
.	O

The	O
first	O
case	O
,	O
from	O
San	B-Location
Diego	I-Location
County	E-Location
,	O
California	S-Location
,	O
was	O
confirmed	O
from	O
clinical	O
specimens	O
(nasopharyngeal	O
swab)	O
examined	O
by	O
the	O
CDC	S-Organization
on	O
14	O
April	O
2009	O
.	O

The	O
authors	O
acknowledge	O
support	O
from	O
the	O
(	O
BMBF	S-Organization
)	O
,	O
which	O
is	O
a	O
partner	O
of	O
the	O
ERASysBio+	B-Scientific_research_project
initiative	E-Scientific_research_project
supported	O
under	O
the	O
in	O
FP7	O
.	O

Chinese	O
biological	O
material	O
has	O
been	O
collected	O
under	O
a	O
series	O
of	O
federal	O
projects	O
including	O
saliva	O
and	O
cancer	S-Disease
tissue	O
.	O

The	O
mosquitoes	O
survived	O
the	O
airdrop	O
and	O
actively	O
sought	O
out	O
human	O
blood	O
.	O

While	O
still	O
expensive	O
,	O
the	O
price	O
of	O
synthesis	O
has	O
fallen	O
by	O
a	O
factor	O
of	O
1,000	O
in	O
the	O
past	O
two	O
decades	O
,	O
and	O
continues	O
to	O
drop	O
.	O

Secondly	O
,	O
we've	O
been	O
supporting	O
all	O
the	O
states	O
in	O
Nigeria	S-Location
especially	O
those	O
affected	O
,	O
with	O
personal	O
protection	O
equipment	O
,	O
and	O
whatever	O
else	O
they	O
need	O
in	O
the	O
hospitals	O
to	O
care	O
for	O
these	O
patients	O
.	O

Downloaded	O
Oct.22	O
,	O
2017	O
.	O

This	O
system	O
,	O
which	O
was	O
never	O
very	O
satisfactory	O
,	O
was	O
superseded	O
in	O
1984	O
by	O
a	O
numerical	O
classification	O
(	O
Advisory	B-Organization
Committee	I-Organization
on	I-Organization
Dangerous	I-Organization
Pathogens	E-Organization
)	O
which	O
parallels	O
that	O
of	O
.	O

This	O
means	O
that	O
much	O
of	O
what	O
needs	O
to	O
be	O
done	O
to	O
fulfill	O
the	O
undertaking	O
of	O
Article	O
VII	O
is	O
also	O
necessary	O
for	O
disease	O
outbreaks	O
that	O
occur	O
naturally	O
.	O

Other	O
conclusions	O
were	O
that	O
the	O
Mukhabarat	S-Person
continued	O
to	O
investigate	O
toxins	O
as	O
tools	O
of	O
assassination	O
,	O
concealed	O
its	O
program	O
from	O
inspectors	O
after	O
the	O
1991	O
war	O
,	O
and	O
reportedly	O
conducted	O
lethal	O
human	O
experimentation	O
until	O
1994	O
.	O

Next	O
question	O
comes	O
from	O
Mike	B-Person
Stobbe	E-Person
with	O
the	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

These	O
2	O
national	O
initiatives	O
,	O
together	O
with	O
the	O
influence	O
of	O
other	O
international	O
and	O
EU	S-Location
activities	O
,	O
led	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
dealing	O
with	O
high-consequence	O
pathogens	O
to	O
establish	O
the	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
in	O
2007	O
(Table	O
1	O
,	O
Figure	O
2)	O
.	O

They	O
met	O
with	O
thousands	O
of	O
teachers	O
and	O
administrators	O
to	O
work	O
out	O
hygiene	O
guidelines	O
.	O

And	O
we'll	O
be	O
looking	O
at	O
what	O
the	O
implications	O
are	O
for	O
our	O
as	O
well	O
as	O
other	O
partners	O
.	O

Users	O
can	O
review	O
policies	O
,	O
laws	O
,	O
and	O
strategies	O
and	O
search	O
for	O
the	O
best	O
practices	O
and	O
success	O
stories	O
in	O
the	O
field	O
of	O
mental	O
health	O
.	O

And	O
this	O
fact	O
,	O
in	O
turn	O
,	O
means	O
that	O
the	O
work	O
of	O
the	O
BWC	S-Document
in	O
this	O
area	O
is	O
tied	O
closely	O
to	O
international	O
efforts	O
to	O
prepare	O
for	O
any	O
type	O
of	O
public	O
health	O
emergency	O
.	O

This	O
is	O
something	O
that	O
Dr	O
.	O

Robert	B-Person
Leggiadro	E-Person
a	O
physician	O
in	O
New	B-Location
York	E-Location
with	O
a	O
background	O
in	O
infectious	O
disease	O
and	O
bioterrorism	O
,	O
told	O
Live	O
Science	O
that	O
although	O
Ebola	S-Pathogen
is	O
listed	O
by	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
as	O
a	O
possible	O
bioterrorism	O
agent	O
,	O
that	O
doesn't	O
necessarily	O
mean	O
the	O
virus	O
could	O
be	O
used	O
in	O
a	O
bomb	O
.	O

But	O
what	O
has	O
led	O
to	O
this	O
problem	O
reaching	O
a	O
crisis	O
point?	O

Men	O
in	O
lab	O
Weapons	O
production	O
at	O
Fort	B-Location
Detrick	E-Location
Maryland	S-Location
,	O
the	O
's	O
base	O
for	O
biowarfare	O
research	O
.	O

In	O
1422	O
,	O
during	O
the	O
siege	O
of	O
Karlstein	B-Location
Castle	E-Location
in	O
,	O
Hussite	O
attackers	O
used	O
catapults	O
to	O
throw	O
dead	O
(but	O
not	O
plague-infected)	O
bodies	O
and	O
2000	O
carriage-loads	O
of	O
dung	O
over	O
the	O
walls	O
.	O

The	O
Western	B-Incident
African	I-Incident
Ebola	I-Incident
virus	I-Incident
epidemic	E-Incident
(2013–2016)	O
was	O
the	O
most	O
widespread	O
outbreak	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
in	O
history-causing	O
major	O
loss	O
of	O
life	O
and	O
socioeconomic	O
disruption	O
in	O
the	O
region	O
,	O
mainly	O
in	O
Guinea	S-Location
,	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
first	O
cases	O
were	O
recorded	O
in	O
Guinea	S-Location
in	O
December	O
2013	O
;	O
later	O
,	O
the	O
disease	O
spread	O
to	O
neighbouring	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
,	O
with	O
minor	O
outbreaks	O
occurring	O
elsewhere	O
.	O

It	O
is	O
not	O
clear	O
whether	O
this	O
is	O
because	O
young	O
people	O
are	O
less	O
likely	O
to	O
be	O
infected	O
,	O
or	O
less	O
likely	O
to	O
develop	O
serious	O
symptoms	O
and	O
seek	O
medical	O
attention	O
and	O
be	O
tested	O
.	O

In	O
food	O
or	O
drinks	O
,	O
nootropics	S-Drug
are	O
usually	O
safe	O
unless	O
consumed	O
at	O
high	O
levels	O
.	O

The	O
Iranian	B-Organization
Parliament	E-Organization
was	O
shut	O
down	O
,	O
with	O
23	O
of	O
its	O
290	O
members	O
reported	O
to	O
have	O
had	O
tested	O
positive	O
for	O
the	O
virus	O
on	O
3March	O
.	O

Synthetic	B-Technology
genomics	E-Technology
is	O
different	O
in	O
that	O
scientists	O
start	O
with	O
digital	O
information	O
in	O
the	O
computer	O
,	O
which	O
allows	O
for	O
the	O
design	O
of	O
entire	O
synthetic	O
chromosomes	O
to	O
replace	O
existing	O
chromosomes	O
in	O
cells	O
.	O

The	O
program	O
is	O
intended	O
to	O
ensure	O
the	O
safety	O
of	O
the	O
nation's	O
food	O
supply	O
,	O
according	O
to	O
its	O
benefactor	O
,	O
the	O
Defense	B-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
,	O
known	O
as	O
.	O

Maintaining	O
and	O
improving	O
the	O
diagnostics	O
for	O
those	O
rare	O
pathogens	O
that	O
require	O
analysis	O
by	O
BSL-3	B-Platform
and	I-Platform
-4	E-Platform
laboratories	O
is	O
resource-intensive	O
.	O

Small	O
populations	O
of	O
E.	B-Pathogen
coli	E-Pathogen
in	O
an	O
antibiotic	O
gradient	O
can	O
become	O
resistant	O
.	O

The	O
technology	O
may	O
reduce	O
,	O
from	O
days	O
to	O
hours	O
,	O
the	O
time	O
needed	O
to	O
diagnose	O
patients	O
with	O
bacterial	O
infections	O
and	O
determine	O
how	O
well	O
an	O
antibiotic	O
will	O
work	O
against	O
specific	O
infections	O
.	O

One	O
thing	O
has	O
been	O
educating	O
the	O
public	O
and	O
healthcare	O
workers	O
about	O
the	O
disease	O
and	O
how	O
to	O
prevent	O
it	O
.	O

Matheny	S-Person
noted	O
that	O
other	O
initiatives	O
will	O
work	O
to	O
optimize	O
encryption	O
;	O
build	O
superconducting	O
computers	O
for	O
hardware	O
security	O
;	O
and	O
support	O
the	O
use	O
of	O
proteins	O
to	O
identify	O
individuals	O
for	O
law	O
enforcement	O
purposes	O
.	O

The	O
ARMADA	S-Scientific_research_project
concept	O
builds	O
off	O
proof-of-principle	O
research	O
,	O
funded	O
by	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
,	O
in	O
which	O
Sokurenko	S-Person
and	O
colleagues	O
from	O
clinical	O
laboratories	O
in	O
four	O
US	S-Location
cities	O
are	O
analyzing	O
more	O
than	O
20,000	O
clinical	O
isolates	O
of	O
over	O
10	O
different	O
bacterial	O
species	O
.	O

Disaster	O
response	O
organizations	O
such	O
as	O
Direct	B-Organization
Relief	E-Organization
helped	O
by	O
providing	O
protective	O
items	O
to	O
clinical	O
workers	O
to	O
help	O
them	O
stay	O
healthy	O
throughout	O
flu	O
season	O
.	O

Early	O
studies	O
on	O
animals	O
,	O
especially	O
on	O
something	O
as	O
complex	O
as	O
nutrition	O
,	O
should	O
never	O
be	O
extrapolated	O
to	O
humans	O
.	O

On	O
a	O
more	O
hopeful	O
note	O
,	O
scientific	O
advances	O
may	O
allow	O
researchers	O
to	O
find	O
solutions	O
to	O
biotechnology	O
threats	O
as	O
quickly	O
as	O
they	O
arise	O
.	O

"	O
So	O
the	O
funding	O
is	O
ending	O
with	O
really	O
no	O
replenishment	O
in	O
sight	O
,	O
and	O
we're	O
already	O
learning	O
that	O
this	O
could	O
result	O
in	O
a	O
really	O
significant	O
scaling	O
back	O
of	O
U.S.	B-Organization
government	E-Organization
efforts,	O
"	O
said	O
.	O

According	O
to	O
WHO	S-Organization
,	O
health	O
care	O
workers	O
are	O
to	O
be	O
accompanied	O
by	O
military	O
personnel	O
for	O
protection	O
and	O
ring	O
vaccination	O
may	O
not	O
be	O
possible	O
.	O

The	O
ring	O
vaccination	O
strategy	O
was	O
effective	O
at	O
reducing	O
in	O
contacts	O
of	O
contacts	O
(tertiary	O
cases)	O
,	O
with	O
only	O
two	O
such	O
cases	O
being	O
reported	O
.	O

The	O
main	O
functions	O
of	O
the	O
Board	O
are	O
to	O
carry	O
out	O
the	O
decisions	O
and	O
policies	O
of	O
the	O
Assembly	O
,	O
to	O
advise	O
it	O
and	O
to	O
facilitate	O
its	O
work	O
.	O

It	O
has	O
also	O
been	O
argued	O
that	O
the	O
Black	B-Disease
Death	E-Disease
prompted	O
a	O
new	O
wave	O
of	O
piety	O
,	O
manifested	O
in	O
the	O
sponsorship	O
of	O
religious	O
works	O
of	O
art	O
.	O

I'm	O
Associate	O
Director	O
for	O
Communication	O
at	O
CDC	S-Organization
.	O
Welcome	O
to	O
our	O
guests	O
in	O
the	O
room	O
,	O
to	O
those	O
watching	O
on	O
IPTV	S-Platform
,	O
on	O
satellite	S-Platform
.	O
Today's	O
briefing	O
from	O
CDC	S-Organization
highlights	O
steps	O
to	O
improve	O
laboratory	O
safety	O
after	O
several	O
recent	O
laboratory	O
incidents	O
.	O

In	O
1971	O
the	O
first	B-Incident
serious	I-Incident
outbreak	I-Incident
of	I-Incident
African	I-Incident
Swine	I-Incident
Fever	E-Incident
in	O
the	O
Western	O
Hemisphere	O
occurred	O
in	O
Cuba	S-Location
.	O
The	O
Cuban	O
government	O
alleged	O
that	O
U.S.	S-Location
covert	O
biological	O
warfare	O
was	O
responsible	O
for	O
this	O
outbreak	O
,	O
which	O
led	O
to	O
the	O
preemptive	O
slaughter	O
of	O
500,000	O
pigs	O
.	O

So	O
every	O
time	O
we	O
collect	O
a	O
sample	O
,	O
we	O
have	O
to	O
fly	O
it	O
across	O
many	O
kilometers	O
to	O
the	O
three	O
labs	O
that	O
have	O
that	O
capacity	O
.	O

This	O
article	O
details	O
the	O
laboratory	O
design	O
,	O
management	O
,	O
and	O
student	O
evaluations	O
.	O

In	O
November	O
,	O
it	O
was	O
reported	O
that	O
the	O
EVD	S-Disease
outbreak	O
ran	O
across	O
two	O
provinces	O
(and	O
14	O
health	O
zones)	O
.	O

Once	O
pooled	O
library	O
is	O
prepared	O
it	O
is	O
necessary	O
to	O
carry	O
out	O
a	O
deep	O
sequencing	O
(NGS	O
,	O
next	O
generation	O
sequencing)	O
of	O
PCR	S-Technology
plasmid	O
DNA	O
in	O
order	O
to	O
reveal	O
abundance	O
of	O
sgRNAs	O
.	O

Each	O
pair	O
works	O
in	O
the	O
hood	O
in	O
a	O
successive	O
fashion	O
under	O
the	O
careful	O
supervision	O
of	O
the	O
instructor	O
.	O

The	O
Americans	O
believed	O
that	O
the	O
research	O
data	O
was	O
valuable	O
,	O
and	O
did	O
not	O
want	O
other	O
nations	O
,	O
particularly	O
the	O
Soviet	B-Organization
Union	E-Organization
,	O
to	O
acquire	O
data	O
on	O
biological	O
weapons.BBC	O
News	O
–	O
Unit	B-Organization
731	E-Organization
:	O
's	O
biological	O
force	O
.	O

It	O
also	O
was	O
home	O
to	O
a	O
piggery	O
,	O
and	O
poultry	O
was	O
regularly	O
brought	O
in	O
from	O
surrounding	O
villages	O
to	O
feed	O
the	O
camp.	O
and	O
his	O
team	O
postulated	O
that	O
a	O
precursor	O
virus	O
,	O
harbored	O
in	O
birds	O
,	O
mutated	O
and	O
then	O
migrated	O
to	O
pigs	O
kept	O
near	O
the	O
front	O
.	O

Usually	O
fatal	O
,	O
it	O
is	O
characterized	O
by	O
heavy	B-Phenotype
bleeding	E-Phenotype
and	O
normally	O
accounts	O
for	O
one	O
to	O
three	O
percent	O
of	O
cases	O
.	O

Sir	O
Robert	B-Person
Williams	E-Person
,	O
with	O
observers	O
from	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
The	O
.	O

Connor,	B-Person
Stephen	I-Person
Robert	E-Person
,	O
Gwyther,	B-Person
Elizabeth	E-Person
(February	O
2018)	O
[Epub	O
8	O
August	O
2017].	O
"	O
The	O
Worldwide	B-Organization
Hospice	I-Organization
Palliative	I-Organization
Care	I-Organization
Alliance	E-Organization
,	O
"	O
in	O
Journal	O
of	O
,	O
55	O
(2S):	O
S112-S116.	O
.	O
PubMed.gov	O
.	O

The	O
outbreak	B-Incident
of	I-Incident
Ebola	I-Incident
virus	I-Incident
disease	I-Incident
(EVD)	I-Incident
in	I-Incident
West	I-Incident
Africa	I-Incident
between	I-Incident
2014	I-Incident
and	I-Incident
2015	E-Incident
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
,	O
and	O
the	O
countries	O
most	O
strongly	O
affected	O
were	O
Sierra	B-Location
Leone	E-Location
,	O
Guinea	S-Location
,	O
and	O
.	O

The	O
US	B-Organization
National	I-Organization
Science	I-Organization
Advisory	I-Organization
Board	I-Organization
for	I-Organization
Biosecurity	E-Organization
ruled	O
that	O
his	O
paper	O
had	O
to	O
be	O
stripped	O
of	O
some	O
of	O
its	O
technical	O
details	O
before	O
publication	O
,	O
to	O
limit	O
the	O
ability	O
of	O
bad	O
actors	O
to	O
cause	O
a	O
pandemic	O
.	O

Murine	O
fibroblast	O
NIH3T3	O
and	O
Monkey	O
kidney	O
Vero	O
cells	O
were	O
cultured	O
in	O
Dulbecco's	O
Modified	O
Eagle's	O
Medium	O
(DMEM	O
,	O
Sigma	O
Aldrich	O
,	O
St	O
Louis	O
,	O
MO	O
,	O
USA)	O
supplemented	O
with	O
10%	O
fetal	O
calf	O
serum	O
(FCS	O
,	O
Sigma	O
Aldrich)	O
,	O
penicillin	S-Drug
(100 U/ml)	O
,	O
and	O
streptomycin	B-Pathogen
sulfate	E-Pathogen
(100 μg/ml)	O
at	O
37°C	O
in	O
5%	O
CO2	O
.	O

Acute	B-Phenotype
febrile	I-Phenotype
illness	E-Phenotype
is	O
a	O
common	O
reason	O
for	O
seeking	O
medical	O
care	O
worldwide	O
and	O
a	O
major	O
cause	O
of	O
morbidity	O
and	O
mortality	O
.	O

The	O
floR	O
gene	O
was	O
detected	O
in	O
all	O
isolates	O
except	O
27025–1-18	O
.	O

The	O
radiation	O
doses	O
received	O
from	O
CT	S-Technology
scans	O
is	O
variable	O
.	O

The	O
first	O
is	O
a	O
cholesterol	O
transporter	O
protein	O
,	O
the	O
host-encoded	O
Niemann–Pick	O
C1	O
(NPC1)	O
,	O
which	O
appears	O
to	O
be	O
essential	O
for	O
entry	O
of	O
Ebola	B-Pathogen
virions	E-Pathogen
into	O
the	O
host	O
cell	O
and	O
for	O
its	O
ultimate	O
replication	O
.	O

The	O
explains:	O
"	O
[I]nfluenza	O
is	O
infrequently	O
listed	O
on	O
death	O
certificates	O
of	O
people	O
who	O
die	O
from	O
flu-related	O
complications	O
"	O
and	O
hence	O
,	O
"	O
Only	O
counting	O
deaths	O
where	O
influenza	O
was	O
included	O
on	O
a	O
death	O
certificate	O
would	O
be	O
a	O
gross	O
underestimation	O
of	O
influenza's	O
true	O
impact.	O
"	O

In	O
China	S-Location
,	O
however	O
,	O
categorizations	O
are	O
in	O
reported	O
in	O
the	O
reverse	O
order	O
,	O
with	O
group	O
4	O
representing	O
the	O
least	O
risk	O
and	O
group	O
1	O
representing	O
the	O
highest	O
risk	O
.	O

Students	O
titrate	O
bacteriophage	O
Lambda	O
after	O
the	O
induction	O
of	O
a	O
lysogenic	O
E.	B-Pathogen
coli	E-Pathogen
harboring	O
a	O
temperature‐sensitive	O
(ts)	O
mutant	O
,	O
Lambda	O
prophage	O
.	O

Thank	O
you	O
very	O
much	O
,	O
Dr	O
.	O

Lab	O
officials	O
,	O
in	O
response	O
to	O
questions	O
from	O
USA	B-Organization
TODAY	E-Organization
said	O
the	O
worker's	O
risk	O
of	O
exposure	O
was	O
low	O
because	O
chickens	O
were	O
inside	O
HEPA-filtered	S-Equipment
"	O
animal	O
isolation	O
units	O
"	O
and	O
that	O
contain	O
the	O
virus	O
in	O
the	O
cage	O
,	O
rather	O
than	O
in	O
the	O
larger	O
room	O
.	O

When	O
sufficient	O
data	O
are	O
obtained	O
,	O
work	O
with	O
these	O
agents	O
may	O
continue	O
at	O
this	O
or	O
a	O
lower	O
level	O
.	O

On	O
12	O
May	O
2013	O
,	O
in	O
a	O
case	O
of	O
human	O
to	O
human	O
transmission	O
,	O
a	O
man	O
previously	O
hospitalized	O
in	O
the	O
same	O
room	O
as	O
the	O
first	O
patient	O
was	O
confirmed	O
by	O
French	B-Organization
Ministry	I-Organization
of	I-Organization
Social	I-Organization
Affairs	I-Organization
and	I-Organization
Health	E-Organization

Maintaining	O
and	O
improving	O
the	O
diagnostics	O
for	O
those	O
rare	O
pathogens	O
that	O
require	O
analysis	O
by	O
BSL-3	S-Platform
and	O
-4	O
laboratories	O
is	O
resource-intensive	O
.	O

In	O
multislice	B-Technology
computed	I-Technology
tomography	E-Technology
(	O
MSCT	S-Technology
)	O
or	O
multidetector	B-Technology
computed	I-Technology
tomography	E-Technology
(	O
MDCT	S-Technology
)	O
,	O
a	O
higher	O
number	O
of	O
tomographic	O
slices	O
allow	O
for	O
higher-resolution	O
imaging.	O
typically	O
generate	O
64-640	O
slices	O
per	O
scan	O
.	O

DNA	O
is	O
made	O
up	O
of	O
four	O
building	O
blocks	O
,	O
or	O
bases	O
,	O
and	O
DNA	O
sequencing	O
is	O
the	O
process	O
of	O
determining	O
the	O
order	O
of	O
those	O
bases	O
in	O
a	O
strand	O
of	O
DNA	O
.	O

The	O
study	O
concluded	O
that	O
the	O
epidemic	O
would	O
not	O
be	O
as	O
difficult	O
to	O
control	O
as	O
feared	O
,	O
if	O
rapid	O
,	O
vigorous	O
contact	O
tracing	O
and	O
quarantines	O
were	O
employed	O
.	O

On	O
18	O
May	O
,	O
after	O
no	O
new	O
infections	O
had	O
been	O
reported	O
in	O
a	O
three-week	O
period	O
,	O
WHO	S-Organization
announced	O
China	S-Location
as	O
free	O
of	O
further	O
cases	O
of	O
,	O
but	O
stated	O
that	O
"	O
biosafety	O
concerns	O
remain"	O
.	O

There	O
has	O
been	O
no	O
further	O
evidence	O
of	O
rodent	O
entry	O
into	O
the	O
barrels	O
,	O
the	O
university	O
said	O
.	O

And	O
some	O
of	O
the	O
sources	O
I've	O
talked	O
to	O
have	O
said	O
and	O
criticized	O
CDC	S-Organization
in	O
saying	O
that	O
there	O
is	O
-	O
there	O
has	O
been	O
this	O
reliance	O
-	O
almost	O
–	O
I	O
don't	O
want	O
to	O
say	O
arrogance	O
,	O
but	O
extreme	O
confidence	O
that	O
,	O
you	O
know	O
,	O
the	O
way	O
we	O
do	O
it	O
at	O
the	O
is	O
the	O
right	O
way	O
to	O
do	O
things	O
.	O

Tigers	O
and	O
lions	O
at	O
the	O
Bronx	B-Location
Zoo	I-Location
in	I-Location
New	I-Location
York	E-Location
United	B-Location
States	E-Location
,	O
tested	O
positive	O
for	O
the	O
virus	O
and	O
showed	O
symptoms	O
of	O
COVID‑19	S-Disease
,	O
including	O
a	O
dry	B-Phenotype
cough	E-Phenotype
and	O
.	O

On	O
27	O
March	O
,	O
Arthur	B-Person
K.C.	I-Person
Li	E-Person
head	O
of	O
the	O
Hong	O
Kong	O
Education	O
and	O
Manpower	O
Bureau	O
,	O
announced	O
cancellation	O
of	O
all	O
classes	O
in	O
educational	O
institutions	O
.	O

The	O
West	O
might	O
start	O
by	O
demanding	O
that	O
facilities	O
such	O
as	O
those	O
at	O
be	O
dismantled	O
and	O
inspected	O
before	O
any	O
deals	O
can	O
be	O
agreed	O
.	O

The	O
report	O
details	O
the	O
specifics	O
of	O
the	O
June	O
incident	O
.	O

Assuming	O
even	O
transient	O
postinfection	O
immunity	O
,	O
how	O
could	O
susceptible	O
persons	O
be	O
too	O
few	O
to	O
sustain	O
transmission	O
at	O
1	O
point	O
and	O
yet	O
enough	O
to	O
start	O
a	O
new	O
explosive	O
pandemic	O
wave	O
a	O
few	O
weeks	O
later?	O
Could	O
the	O
virus	O
have	O
mutated	O
profoundly	O
and	O
almost	O
simultaneously	O
around	O
the	O
world	O
,	O
in	O
the	O
short	O
periods	O
between	O
the	O
successive	O
waves?	O

On	O
5	O
May	O
2014	O
,	O
WHO	S-Organization
announced	O
that	O
the	O
spread	O
of	O
polio	S-Disease
was	O
a	O
world	O
health	O
emergency	O
–	O
outbreaks	O
of	O
the	O
disease	O
in	O
Asia	S-Location
,	O
Africa	S-Location
,	O
and	O
the	O
were	O
considered	O
"	O
extraordinary".	O

In	O
1971	O
,	O
such	O
testing	O
led	O
to	O
the	O
accidental	O
aerosol	O
release	O
of	O
smallpox	S-Pathogen
over	O
the	O
Aral	B-Location
Sea	E-Location
and	O
a	O
subsequent	O
epidemic	O
.	O

On	O
16 September	O
2008	O
,	O
the	O
body	O
of	O
British	O
politician	O
and	O
diplomat	O
Sir	B-Person
Mark	I-Person
Sykes	E-Person
was	O
exhumed	O
to	O
study	O
the	O
RNA	O
of	O
the	O
flu	S-Disease
virus	O
in	O
efforts	O
to	O
understand	O
the	O
genetic	O
structure	O
of	O
modern	O
H5N1	B-Disease
bird	I-Disease
flu	E-Disease
.	O
had	O
been	O
buried	O
in	O
1919	O
in	O
a	O
lead	O
coffin	O
which	O
scientists	O
hoped	O
had	O
helped	O
preserve	O
the	O
virus	O
.	O

"	O
A	O
pandemic	O
could	O
affect	O
half	O
a	O
billion	O
people	O
;	O
more	O
than	O
the	O
entire	O
population	O
of	O
the	O
United	B-Location
States	E-Location
And	O
that's	O
not	O
speculation	O
.	O

Later	O
that	O
day	O
,	O
Dutschke	S-Person
was	O
charged	O
with	O
attempted	O
use	O
of	O
a	O
biological	O
weapon	O
.	O

End	O
hosts	O
are	O
humans	O
and	O
great	O
apes	O
,	O
infected	O
through	O
bat	O
contact	O
or	O
through	O
other	O
end	O
hosts	O
.	O

A	O
WHO	S-Organization
2013	O
study	O
estimated	O
that	O
the	O
2009	O
global	O
pandemic	O
respiratory	O
mortality	O
was	O
~10-fold	O
higher	O
than	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
's	O
laboratory-confirmed	O
mortality	O
count	O
(18.631)	O
.	O

H.R.	B-Document
5998	E-Document
has	O
been	O
referred	O
to	O
the	O
for	O
consideration	O
.	O

While	O
African	B-Disease
swine	I-Disease
fever	E-Disease
can	O
live	O
on	O
for	O
weeks	O
or	O
months	O
in	O
uncooked	O
and	O
frozen	O
pork	O
,	O
it	O
is	O
not	O
harmful	O
to	O
humans	O
,	O
according	O
to	O
the	O
.	O

The	O
virus	O
has	O
also	O
been	O
associated	O
with	O
neurological	B-Disease
complications	E-Disease
,	O
including	O
Guillain-Barre	B-Disease
Syndrome	E-Disease
(	O
GBS	S-Disease
)	O
,	O
in	O
the	O
general	O
population	O
.	O

Biological	O
agents	O
were	O
divided	O
by	O
the	O
WHO	S-Organization
NIH	S-Organization
,	O
EU	S-Location
and	O
China	S-Location
into	O
four	O
laboratory	O
biosafety	O
categories	O
.	O

The	O
WHO	S-Organization
employs	O
8,500	O
people	O
in	O
147	O
countries	O
to	O
carry	O
out	O
its	O
principles	O
.	O

The	O
US	B-Organization
CDC	E-Organization
biological	O
agents	O
biodefense	O
evaluation	O
criteria	O
include:	O
(1)	O
can	O
be	O
easily	O
disseminated	O
or	O
transmitted	O
from	O
person	O
to	O
person	O
;	O
(2)	O
result	O
in	O
high	O
mortality	O
rates	O
and	O
have	O
the	O
potential	O
for	O
major	O
public	O
health	O
impacts	O
;	O
(3)	O
might	O
cause	O
public	O
panic	O
and	O
social	O
disruption	O
;	O
(4)	O
require	O
special	O
action	O
for	O
public	O
health	O
preparedness	O
[12]	O
.	O

CT	S-Technology
produces	O
data	O
that	O
can	O
be	O
manipulated	O
in	O
order	O
to	O
demonstrate	O
various	O
bodily	O
structures	O
based	O
on	O
their	O
ability	O
to	O
absorb	O
the	O
X-ray	O
beam	O
.	O

Medicago	S-Organization
being	O
awarded	O
$21	O
million	O
to	O
produce	O
10	O
,	O
000	O
million	O
doses	O
of	O
an	O
within	O
one	O
month	O
.	O

The	O
project	O
co-PIs	O
,	O
based	O
in	O
Pakistan	S-Location
and	O
the	O
U.S.	S-Location
,	O
worked	O
closely	O
with	O
two	O
Regional	O
Coordinators	O
in	O
North	B-Location
Africa	E-Location
(	O
Morocco	S-Location
and	O
Egypt	S-Location
)	O
to	O
recruit	O
a	O
project	O
coordinator	O
in	O
each	O
of	O
the	O
24	O
countries	O
participating	O
in	O
the	O
project	O
.	O

And	O
for	O
this	O
to	O
happen	O
and	O
put	O
our	O
workers	O
potentially	O
at	O
risk	O
is	O
totally	O
unacceptable	O
.	O

U.S.	B-Organization
airlines	E-Organization
had	O
made	O
no	O
major	O
changes	O
as	O
of	O
the	O
beginning	O
of	O
June	O
2009	O
,	O
but	O
continued	O
standing	O
practices	O
which	O
include	O
looking	O
for	O
passengers	O
with	O
symptoms	O
of	O
flu	O
,	O
measles	S-Disease
or	O
other	O
infections	O
,	O
and	O
relying	O
on	O
in-flight	O
air	O
filters	O
to	O
ensure	O
that	O
aircraft	O
were	O
sanitised	O
.	O

In	O
September	O
,	O
it	O
was	O
reported	O
that	O
2	O
peacekeepers	O
were	O
attacked	O
and	O
wounded	O
by	O
rebel	O
groups	O
in	O
Beni	S-Location
,	O
and	O
14	O
individuals	O
were	O
killed	O
in	O
a	O
military	O
attack	O
.	O

Current	O
information	O
indicates	O
the	O
discovery	O
of	O
a	O
clandestine	O
network	O
of	O
biological	O
laboratories	O
operated	O
by	O
the	O
Iraqi	B-Organization
Intelligence	I-Organization
Service	E-Organization
(	O
Mukhabarat	S-Organization
)	O
,	O
a	O
prison	O
laboratory	O
complex	O
possibly	O
used	O
for	O
human	O
experimentation	O
,	O
an	O
Iraqi	O
scientist's	O
private	O
culture	O
collection	O
with	O
a	O
strain	O
of	O
possible	O
BW	O
interest	O
,	O
and	O
new	O
research	O
activities	O
involving	O
Brucella	S-Pathogen
and	O
Crimean-Congo	B-Pathogen
hemorrhagic	I-Pathogen
fever	I-Pathogen
virus	E-Pathogen
.	O
,	O
Op.cit.	O
,	O
pg	O
8	O
.	O

But	O
it's	O
almost	O
impossible	O
to	O
make	O
any	O
sensible	O
projection	O
right	O
now	O
about	O
when	O
that	O
will	O
be.	O
"	O
The	O
Imperial	B-Scientific_research_project
College	I-Scientific_research_project
study	E-Scientific_research_project
led	O
by	O
Neil	B-Person
Ferguson	E-Person
stated	O
that	O
physical	O
distancing	O
and	O
other	O
measures	O
will	O
be	O
required	O
"	O
until	O
a	O
vaccine	O
becomes	O
available	O
(potentially	O
18	O
months	O
or	O
more)"	O
.	O

When	O
masks	O
are	O
not	O
available	O
,	O
the	O
CDC	S-Organization
recommends	O
using	O
or	O
,	O
as	O
a	O
last	O
resort	O
,	O
homemade	O
masks	O
.	O

X-ray	B-Technology
tomography	E-Technology
,	O
a	O
predecessor	O
of	O
,	O
is	O
one	O
form	O
of	O
radiography	O
,	O
along	O
with	O
many	O
other	O
forms	O
of	O
tomographic	O
and	O
non-tomographic	O
radiography	O
.	O

The	O
outbreak	O
then	O
spread	O
to	O
Sierra	B-Location
Leone	E-Location
and	O
progressed	O
rapidly	O
.	O

Escapes	O
occurred	O
in	O
a	O
variety	O
of	O
scenarios	O
,	O
including	O
mice	O
jumping	O
onto	O
researchers	O
and	O
running	O
under	O
freezers	S-Equipment
incident	O
records	O
show	O
.	O

Whole-genome	O
sequencing	O
was	O
performed	O
on	O
all	O
7	O
isolates	O
(24213-18	O
,	O
24920-18	O
,	O
27025-1-18	O
,	O
27025-2-18	O
,	O
27241-18	O
,	O
27609-18	O
,	O
and	O
27614-18)	O
by	O
using	O
the	O
Illumina	B-Platform
MiSeq	I-Platform
platform	E-Platform
Link)	O
.	O

Resistance	O
to	O
antivirals	O
is	O
thus	O
acquired	O
through	O
mutations	O
in	O
the	O
genes	O
that	O
encode	O
the	O
protein	O
targets	O
of	O
the	O
drugs	O
.	O

The	O
produced	O
anthrax	S-Pathogen
culture	O
had	O
to	O
be	O
dried	O
to	O
produce	O
a	O
fine	O
powder	O
for	O
use	O
as	O
an	O
aerosol	O
.	O

The	O
pandemic	O
has	O
caused	O
the	O
most	O
significant	O
disruption	O
to	O
the	O
worldwide	O
sporting	O
calendar	O
since	O
the	O
Second	B-Incident
World	I-Incident
War	E-Incident
Most	O
major	O
sporting	O
events	O
have	O
been	O
cancelled	O
or	O
postponed	O
,	O
including	O
the	O
2019–20	B-Activity
UEFA	I-Activity
Champions	I-Activity
League	E-Activity
,	O
2019–20	B-Activity
Premier	I-Activity
League	E-Activity
,	O
UEFA	B-Activity
Euro	I-Activity
2020,	I-Activity
2019–20	I-Activity
NBA	I-Activity
season	E-Activity
,	O
and	O
2019–20	B-Activity
NHL	I-Activity
season	E-Activity
.	O
The	O
outbreak	O
disrupted	O
plans	O
for	O
the	O
2020	B-Activity
Summer	I-Activity
Olympics	E-Activity
,	O
which	O
were	O
originally	O
scheduled	O
to	O
start	O
at	O
the	O
end	O
of	O
July	O
;	O
the	O
announced	O
on	O
24	O
March	O
that	O
they	O
will	O
be	O
"	O
rescheduled	O
to	O
a	O
date	O
beyond	O
2020	O
but	O
not	O
later	O
than	O
summer	O
2021"	O
.	O

WHO	S-Organization
	S-Organization
the	O
,	O
targeted	O
at	O
improving	O
health	O
policy	O
and	O
systems	O
.	O

A	O
retrospective	O
review	O
of	O
hospital	O
records	O
showed	O
that	O
,	O
during	O
July	O
11–August	O
3	O
,	O
2018	O
,	O
seven	O
carbapenem-resistant	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
were	O
isolated	O
from	O
6	O
animals	O
(Table)	O
.	O

This	O
can	O
be	O
partially	O
overcome	O
by	O
scanning	O
using	O
thinner	O
slices	O
,	O
or	O
an	O
isotropic	O
acquisition	O
on	O
a	O
.	O

The	O
use	O
of	O
the	O
CRISPR-Cas9-gRNA	O
complex	O
for	O
genome	B-Technology
editing	E-Technology
was	O
the	O
AAAS	S-Organization
's	O
choice	O
for	O
Breakthrough	O
of	O
the	O
Year	O
in	O
2015	O
.	O

It	O
will	O
take	O
four	O
years	O
to	O
construct	O
a	O
new	O
building	O
and	O
related	O
infrastructure	O
,	O
so	O
the	O
money	O
is	O
needed	O
now	O
,	O
CDC	S-Organization
officials	O
said	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	S-Organization
DHHS	O
,	O
DoT	O
,	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Part	O
of	O
the	O
college	O
questionnaire	O
allows	O
for	O
students	O
to	O
add	O
written	O
remarks	O
on	O
the	O
"	O
highlights"	O
and	O
"	O
lowlights"	O
of	O
the	O
course	O
they	O
are	O
evaluating	O
.	O

Ban	S-Person
included	O
an	O
account	O
of	O
his	O
trip	O
to	O
Nanking	S-Location
in	O
1941	O
to	O
participate	O
in	O
the	O
testing	O
of	O
poisons	O
on	O
Chinese	O
prisoners	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
is	O
the	O
leading	O
national	O
public	O
health	O
institute	O
of	O
the	O
United	O
States	O
.	O

U.S.	O
officials	O
alleged	O
that	O
a	O
third	O
scientist	O
-	O
Huda	B-Person
Salih	I-Person
Mahdi	I-Person
Ammash	E-Person
(	O
"	O
Mrs	O
.	O

Moreover	O
,	O
these	O
"	O
superbugs"	O
cause	O
35,000	O
deaths	O
per	O
year	O
in	O
the	O
country	O
.	O

ASF	S-Disease
can	O
cause	O
death	O
between	O
two	O
and	O
10	O
days	O
after	O
the	O
animals	O
have	O
contracted	O
it	O
and	O
mortality	O
rates	O
may	O
be	O
as	O
high	O
as	O
100	O
per	O
cent	O
,	O
according	O
to	O
the	O
.	O
Any	O
occurrence	O
of	O
the	O
disease	O
must	O
be	O
reported	O
to	O
the	O
organisation	O
.	O

United	B-Organization
States.	I-Organization
Congress.	I-Organization
House.	I-Organization
Committee	I-Organization
on	I-Organization
Armed	I-Organization
Services.	I-Organization
Subcommittee	I-Organization
on	I-Organization
Intelligence	E-Organization
,	O
Emerging	O
Threats	O
and	O
Capabilities.	O
(11	O
October	O
2013)	O
.	O

Unit	B-Organization
731	E-Organization
Laboratory	O
of	O
the	O
Devil	O
(1992)	O
,	O
China	S-Location
,	O
directed	O
by	O
.	O

Plague	S-Disease
was	O
reportedly	O
first	O
introduced	O
to	O
Europe	S-Location
via	O
Genoese	S-Location
traders	O
from	O
their	O
port	O
city	O
of	O
Kaffa	S-Location
in	O
the	O
Crimea	S-Location
in	O
1347	O
.	O

Here	O
,	O
the	O
sources	O
say	O
,	O
experiments	O
with	O
biological	O
and	O
chemical	O
agents	O
were	O
carried	O
out	O
first	O
on	O
dogs	O
and	O
cats	O
,	O
then	O
on	O
Iranian	O
prisoners	O
.	O

All	O
South	O
Korean	O
military	O
bases	O
were	O
quarantined	O
after	O
tests	O
showed	O
three	O
soldiers	O
had	O
the	O
virus	O
.	O

Ricin	S-Pathogen
is	O
a	O
highly	O
toxic	O
substance	O
derived	O
from	O
castor	O
beans	O
.	O

Signs	O
and	O
symptoms	O
of	O
infusion‐related	O
reactions	O
may	O
include:	O
low	B-Phenotype
blood	I-Phenotype
pressure	E-Phenotype
,	O
nausea	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
sweating	S-Phenotype
,	O
and	O
.	O

A	O
joint	O
effort	O
by	O
laboratory	O
personnel	O
from	O
across	O
the	O
different	O
sectors	O
would	O
increase	O
the	O
critical	O
mass	O
of	O
expertise	O
and	O
improve	O
's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

Despite	O
the	O
lack	O
of	O
review	O
,	O
the	O
biological	O
warfare	O
program	O
had	O
increased	O
in	O
cost	O
and	O
size	O
since	O
1961	O
;	O
when	O
ended	O
the	O
program	O
the	O
budget	O
was	O
$300	O
million	O
annually	O
.	O

About	O
200	O
soldiers	O
with	O
Rottweiler	O
dogs	O
still	O
patrol	O
the	O
complex	O
.	O

The	O
arenaviruses	S-Pathogen
have	O
a	O
somewhat	O
reduced	O
case-fatality	O
rate	O
compared	O
to	O
disease	O
caused	O
by	O
filoviruses	S-Pathogen
,	O
but	O
are	O
more	O
widely	O
distributed	O
,	O
chiefly	O
in	O
central	B-Location
Africa	E-Location
and	O
.	O

For	O
example	O
,	O
all	O
laboratory	O
manipulations	O
should	O
be	O
performed	O
in	O
a	O
BSC	S-Equipment
or	O
other	O
enclosed	O
equipment	O
,	O
such	O
as	O
a	O
.	O
Secondary	O
barriers	O
for	O
this	O
level	O
include	O
controlled	O
access	O
to	O
the	O
laboratory	O
and	O
ventilation	O
requirements	O
that	O
minimize	O
the	O
release	O
of	O
infectious	O
aerosols	O
from	O
the	O
laboratory	O
.	O

Some	O
biohackers	O
believe	O
that	O
by	O
leveraging	O
technology	O
,	O
they'll	O
be	O
able	O
to	O
live	O
longer	O
but	O
stay	O
younger	O
.	O

On	O
19	O
March	O
2020	O
,	O
Italy	S-Location
overtook	O
China	S-Location
as	O
the	O
country	O
with	O
the	O
most	O
deaths	O
.	O

In	O
Taiwan	O
,	O
administrators	O
and	O
staff	O
of	O
Taipei	B-Organization
Municipal	I-Organization
Hospital's	I-Organization
Hoping	I-Organization
branch	E-Organization
faced	O
disciplinary	O
action	O
from	O
the	O
Taipei	B-Organization
City	I-Organization
Government	E-Organization
.	O
The	O
Control	B-Organization
Yuan	E-Organization
also	O
launched	O
an	O
investigation	O
into	O
the	O
hospital's	O
closure	O
.	O

Whole-genome	O
sequencing	O
was	O
performed	O
on	O
all	O
7	O
isolates	O
(24213-18	O
,	O
24920-18	O
,	O
27025-1-18	O
,	O
27025-2-18	O
,	O
27241-18	O
,	O
27609-18	O
,	O
and	O
27614-18)	O
by	O
using	O
the	O
Illumina	B-Platform
MiSeq	I-Platform
platform	E-Platform
Link)	O
.	O

But	O
those	O
incidents	O
revealed	O
to	O
us	O
an	O
unacceptable	O
set	O
of	O
practices	O
at	O
CDC	S-Organization
.	O
As	O
a	O
result	O
of	O
that	O
,	O
we've	O
immediately	O
stopped	O
shipping	O
any	O
laboratory	O
samples	O
out	O
of	O
our	O
high	O
containment	O
laboratories	O
,	O
bsl-3	S-Platform
or	O
.	O
We've	O
established	O
a	O
single	O
point	O
of	O
accountability	O
,	O
and	O
we	O
will	O
look	O
at	O
every	O
aspect	O
of	O
laboratory	O
safety	O
with	O
a	O
laser	O
focus	O
.	O

Therefore	O
,	O
the	O
estimated	O
mortality	O
of	O
8,870	O
to	O
18,300	O
is	O
just	O
below	O
the	O
mid-range	O
of	O
estimates	O
.	O

As	O
an	O
adenosine	O
nucleoside	O
triphosphate	O
analog	O
,	O
the	O
active	O
metabolite	O
of	O
remdesivir	S-Drug
interferes	O
with	O
the	O
action	O
of	O
viral	O
RNA-dependent	O
RNA	O
polymerase	O
and	O
evades	O
proofreading	O
by	O
viral	O
exoribonuclease	O
(ExoN)	O
,	O
causing	O
a	O
decrease	O
in	O
viral	O
RNA	O
production	O
.	O

Those	O
who	O
may	O
already	O
have	O
the	O
infection	O
have	O
been	O
advised	O
to	O
wear	O
a	O
surgical	B-Equipment
mask	E-Equipment
in	O
public	O
.	O

Phages	O
can	O
be	O
bioengineered	O
to	O
target	O
multidrug-resistant	O
bacterial	O
infections	O
,	O
and	O
their	O
use	O
involves	O
the	O
added	O
benefit	O
of	O
preventing	O
the	O
elimination	O
of	O
beneficial	O
bacteria	O
in	O
the	O
human	O
body	O
.	O

In	O
December	O
2015	O
,	O
during	O
the	O
8th	O
meeting	O
of	O
WHO	S-Organization
"	O
IHR	B-Organization
Emergency	I-Organization
Committee	I-Organization
regarding	I-Organization
Ebola	E-Organization
"	O
,	O
it	O
spoke	O
out	O
against	O
further	O
travel	O
restrictions	O
saying:	O
"	O
The	O
Committee	O
remains	O
deeply	O
concerned	O
that	O
34	O
countries	O
still	O
enact	O
inappropriate	O
travel	O
and	O
transport	O
measures	O
and	O
highlights	O
the	O
need	O
to	O
immediately	O
terminate	O
any	O
such	O
measures	O
due	O
to	O
their	O
negative	O
impact	O
,	O
particularly	O
on	O
recovery	O
efforts.	O
"	O
In	O
December	O
2015	O
,	O
the	O
CDC	S-Organization
indicated	O
that	O
it	O
would	O
no	O
longer	O
make	O
the	O
recommendation	O
for	O
US	O
citizens	O
going	O
to	O
Sierra	B-Location
Leone	E-Location
to	O
be	O
extra	O
careful	O
.	O

On	O
28	O
April	O
,	O
WHO	S-Organization
declared	O
the	O
outbreak	B-Incident
in	I-Incident
Vietnam	E-Incident
to	O
be	O
over	O
as	O
no	O
new	O
cases	O
were	O
reported	O
for	O
20	O
days	O
.	O

According	O
to	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
policymakers	O
can	O
help	O
tackle	O
resistance	O
by	O
strengthening	O
resistance-tracking	O
and	O
laboratory	O
capacity	O
and	O
by	O
regulating	O
and	O
promoting	O
the	O
appropriate	O
use	O
of	O
medicines	O
.	O

The	O
sievert	O
unit	O
is	O
used	O
in	O
the	O
report	O
of	O
the	O
effective	O
dose	O
.	O

When	O
I	O
joined	O
CDC	S-Organization
as	O
director	O
in	O
2002	O
,	O
one	O
of	O
the	O
things	O
that	O
made	O
the	O
biggest	O
impression	O
on	O
me	O
was	O
how	O
wonderful	O
our	O
laboratories	O
are	O
.	O

On	O
8	O
December	O
2009	O
,	O
the	O
Cochrane	B-Organization
Collaboration	E-Organization
which	O
reviews	O
medical	O
evidence	O
,	O
announced	O
in	O
a	O
review	O
published	O
in	O
BMJ	S-Organization
that	O
it	O
had	O
reversed	O
its	O
previous	O
findings	O
that	O
the	O
antiviral	O
drugs	O
oseltamivir	S-Drug
(	O
Tamiflu	S-Drug
)	O
and	O
zanamivir	S-Drug
(	O
Relenza	S-Drug
)	O
can	O
ward	O
off	O
pneumonia	S-Disease
and	O
other	O
serious	O
conditions	O
linked	O
to	O
influenza	O
.	O

"	O
WHO	S-Organization
continues	O
to	O
recommend	O
no	O
restriction	O
on	O
travel	O
and	O
on	O
border	O
closures,	O
"	O
said	O
.	O

Michael	B-Person
Bell	E-Person
to	O
be	O
Director	O
of	O
Laboratory	O
Safety	O
and	O
serve	O
as	O
the	O
single	O
point	O
of	O
accountability	O
to	O
improve	O
all	O
laboratory	O
safety	O
protocols	O
and	O
practices	O
and	O
procedures	O
.	O

Although	O
SARS-COV-2	S-Disease
has	O
a	O
tropism	O
for	O
ACE2-expressing	O
epithelial	O
cells	O
of	O
the	O
respiratory	O
tract	O
,	O
patients	O
with	O
severe	O
COVID‑19	S-Disease
have	O
symptoms	O
of	O
systemic	B-Phenotype
hyperinflammation	E-Phenotype
.	O
Clinical	O
laboratory	O
findings	O
of	O
elevated	O
IL-2	O
,	O
IL-7	O
,	O
IL-6	O
,	O
granulocyte-macrophage	O
colony-stimulating	O
factor	O
(GM-CSF)	O
,	O
interferon-γ	O
inducible	O
protein	O
10	O
(IP-10)	O
,	O
monocyte	O
chemoattractant	O
protein1	O
(MCP-1)	O
,	O
macrophage	O
inflammatory	O
protein	O
1-α	O
(MIP-1α)	O
,	O
and	O
tumour	O
necrosis	O
factor-α	O
(TNF-α)	O
indicative	O
of	O
cytokine	B-Disease
release	I-Disease
syndrome	E-Disease
()	O
suggest	O
an	O
underlying	O
immunopathology	O
.	O

In	O
1918-19	O
this	O
deadly	O
influenza	O
pandemic	O
erupted	O
during	O
the	O
final	O
stages	O
of	O
World	B-Incident
War	I-Incident
I	E-Incident
Nations	O
were	O
already	O
attempting	O
to	O
deal	O
with	O
the	O
effects	O
and	O
costs	O
of	O
the	O
war	O
.	O

1941:	O
Soviet	S-Organization
bioweapons	O
facilities	O
are	O
transferred	O
to	O
the	O
city	O
of	O
.	O

The	O
CDC-UVRI	B-Scientific_research_project
Viral	I-Scientific_research_project
Hemorrhagic	I-Scientific_research_project
Fever	I-Scientific_research_project
Surveillance	I-Scientific_research_project
and	I-Scientific_research_project
Laboratory	I-Scientific_research_project
Program	E-Scientific_research_project
was	O
lauded	O
in	O
a	O
CDC	S-Organization
report	O
published	O
in	O
The	O
Lancet	O
Infectious	O
Diseases	O
.	O

To	O
explore	O
how	O
the	O
problem	O
of	O
antibiotic	O
resistance	O
might	O
best	O
be	O
addressed	O
,	O
a	O
group	O
of	O
thirty	O
scientists	O
from	O
academia	O
and	O
industry	O
gathered	O
at	O
the	O
Banbury	B-Location
Conference	I-Location
Centre	E-Location
in	O
Cold	B-Location
Spring	I-Location
Harbor	E-Location
,	O
,	O
May	O
16-18	O
,	O
2011	O
.	O

Maciej	B-Person
Boni	E-Person
of	O
Penn	B-Organization
State	I-Organization
University	E-Organization
said	O
,	O
"	O
Left	O
unchecked	O
,	O
infectious	O
outbreaks	O
typically	O
plateau	O
and	O
then	O
start	O
to	O
decline	O
when	O
the	O
disease	O
runs	O
out	O
of	O
available	O
hosts	O
.	O

The	O
study	O
concluded	O
that	O
the	O
standards	O
biosafety	O
precautions	O
adopted	O
by	O
the	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
state	O
was	O
very	O
low	O
.	O

It	O
is	O
not	O
clear	O
whether	O
the	O
$60	O
million	O
was	O
the	O
total	O
cost	O
,	O
or	O
only	O
represented	O
California	S-Location
's	O
half	O
of	O
a	O
possible	O
$120	O
million	O
cost	O
,	O
as	O
half	O
the	O
costs	O
were	O
borne	O
by	O
the	O
.	O

The	O
app	O
can	O
detect	O
'close	O
contact'	O
using	O
surveillance	O
data	O
and	O
therefore	O
a	O
potential	O
risk	O
of	O
infection	O
.	O

In	O
response	O
to	O
the	O
incident	O
,	O
the	O
lab's	O
workers	O
were	O
retrained	O
and	O
protocols	O
revised	O
.	O

During	O
the	O
height	O
of	O
the	O
crisis	O
,	O
Wikipedia	S-Platform
Ebola	S-Disease
page	O
received	O
2.	O
5	O
million	O
page	O
views	O
per	O
day	O
,	O
making	O
Wikipedia	S-Platform
one	O
of	O
the	O
world's	O
most	O
highly	O
used	O
sources	O
of	O
trusted	O
medical	O
information	O
regarding	O
the	O
disease	O
.	O

Conversely	O
,	O
deaths	O
of	O
people	O
who	O
had	O
underlying	O
conditions	O
may	O
lead	O
to	O
overcounting	O
.	O

Sixteen	O
directors	O
have	O
served	O
the	O
CDC	S-Organization
or	O
its	O
predecessor	O
agencies	O
.	O

You	O
just	O
talked	O
about	O
coming	O
down	O
the	O
amount	O
of	O
risky	O
work	O
.	O

"	O
We	O
have	O
more	O
information	O
about	O
how	O
the	O
vaccine	O
works	O
,	O
how	O
effective	O
is	O
it	O
is	O
...	O
if	O
there	O
was	O
an	O
event	O
that	O
required	O
a	O
massive	O
vaccination	O
of	O
thousands	O
or	O
even	O
hundreds	O
of	O
thousands	O
of	O
people,	O
"	O
Walke	S-Person
said	O
.	O

Due	O
to	O
the	O
pandemic	O
in	O
Europe	S-Location
,	O
many	O
countries	O
in	O
the	O
have	O
restricted	O
free	O
movement	O
and	O
set	O
up	O
border	O
controls	O
.	O

That	O
requires	O
putting	O
it	O
into	O
a	O
tissue	O
culture	O
and	O
seeing	O
if	O
it	O
grows	O
,	O
then	O
repeating	O
that	O
test	S-Equipment
to	O
see	O
if	O
the	O
number	O
of	O
organisms	O
is	O
increasing	O
.	O

The	O
Unit	B-Organization
731	E-Organization
complex	O
covered	O
and	O
consisted	O
of	O
more	O
than	O
150	O
buildings	O
.	O

Recombinant	O
DNA	O
and	O
biotechnology	O
tools	O
have	O
enabled	O
the	O
rapid	O
invention	O
of	O
new	O
vaccines	O
which	O
could	O
protect	O
against	O
new	O
outbreaks	O
,	O
natural	O
or	O
man-made	O
.	O

In	O
1347	O
,	O
death	O
came	O
to	O
Europe	S-Location
It	O
entered	O
through	O
the	O
Crimean	B-Location
town	E-Location
of	O
Caffa	S-Location
,	O
brought	O
by	O
the	O
besieging	O
Mongol	S-Location
army	O
.	O

Additionally	O
,	O
there	O
were	O
two	O
phase	O
III	O
studies	O
being	O
conducted	O
with	O
two	O
different	O
vaccines.	O
.	O

The	O
virus	O
then	O
spreads	O
person-to-person	O
,	O
especially	O
within	O
families	O
,	O
hospitals	O
and	O
during	O
some	O
mortuary	O
rituals	O
where	O
contact	O
among	O
individuals	O
becomes	O
more	O
likely	O
.	O

New	O
proactive	O
interventions	O
will	O
center	O
on	O
methods	O
for	O
disarming	O
a	O
virus	O
before	O
it	O
can	O
make	O
a	O
jump	O
across	O
species	O
.	O

Long-term	O
studies	O
need	O
to	O
be	O
done	O
to	O
study	O
the	O
stability	O
of	O
these	O
mutations	O
for	O
DMD	S-Disease
and	O
other	O
genetic	O
disorders	O
,	O
but	O
the	O
success	O
in	O
large	O
mammal	O
models	O
is	O
a	O
great	O
promise	O
.	O

Lower	O
field	O
strengths	O
can	O
be	O
achieved	O
with	O
permanent	O
magnets	O
,	O
which	O
are	O
often	O
used	O
in	O
"	O
open"	O
MRI	B-Equipment
scanners	E-Equipment
for	O
claustrophobic	S-Disease
patients	O
.	O

It	O
would	O
,	O
for	O
example	O
,	O
be	O
possible	O
to	O
start	O
with	O
a	O
closely	O
related	O
virus	O
,	O
such	O
as	O
monkeypox	S-Pathogen
or	O
mousepox	S-Pathogen
,	O
and	O
to	O
alter	O
specifically	O
those	O
bases	O
and	O
sequences	O
that	O
differ	O
from	O
human	O
smallpox	S-Pathogen
.	O
Some	O
months	O
ago	O
,	O
researchers	O
documented	O
for	O
the	O
first	O
time	O
that	O
the	O
sequence	O
of	O
a	O
pathogenicity-related	O
gene	O
from	O
the	O
vaccinia	B-Pathogen
virus	E-Pathogen
could	O
be	O
transformed	O
through	O
the	O
targeted	O
mutation	O
of	O
13	O
base	O
pairs	O
into	O
the	O
sequence	O
of	O
the	O
corresponding	O
smallpox	S-Pathogen
gene	O
(	O
et	O
al.	O
,	O
2002)	O
.	O

The	O
company	O
has	O
been	O
awarded	O
a	O
5-year	O
contract	O
for	O
field	O
tests	O
with	O
biological	O
simulants	O
at	O
.	O

The	O
bacteriophage	O
harbors	O
a	O
ts	O
mutation	O
in	O
the	O
gene	O
coding	O
for	O
the	O
Cl	O
repressor	O
(λc1857)	O
.	O

The	O
use	O
of	O
respirators	O
may	O
be	O
required	O
in	O
settings	O
where	O
airborne	O
transmission	O
is	O
possible.	O
(Note:	O
any	O
use	O
of	O
respiratory	O
protection	O
must	O
follow	O
an	O
institutional	B-Document
Respiratory	I-Document
Protection	I-Document
Program	E-Document
Institutional	O
industrial	O
hygienists	O
or	O
environmental	O
health	O
professionals	O
must	O
be	O
consulted	O
prior	O
to	O
using	O
a	O
respirator)	O
.	O

Ambulances	O
equipped	O
with	O
small	B-Equipment
bore	I-Equipment
multi-slice	I-Equipment
CT	I-Equipment
scanners	E-Equipment
respond	O
to	O
cases	O
involving	O
stroke	S-Disease
or	O
head	B-Disease
trauma	E-Disease
.	O
CT	B-Technology
scanning	I-Technology
of	I-Technology
the	I-Technology
head	E-Technology
is	O
also	O
used	O
in	O
CT-	B-Technology
stereotactic	I-Technology
surgery	E-Technology
and	O
radiosurgery	O
for	O
treatment	O
of	O
intracranial	O
tumors	O
,	O
arteriovenous	O
malformations	O
,	O
and	O
other	O
surgically	O
treatable	O
conditions	O
using	O
a	O
device	O
known	O
as	O
the	O
.	O

This	O
has	O
been	O
difficult	O
to	O
study	O
in	O
animal	O
models	O
that	O
respond	O
to	O
the	O
virus	O
with	O
hemorrhagic	B-Disease
fever	E-Disease
in	O
a	O
similar	O
manner	O
as	O
humans	O
,	O
because	O
typical	O
mouse	O
models	O
do	O
not	O
so	O
respond	O
,	O
and	O
the	O
required	O
large	O
numbers	O
of	O
appropriate	O
test	O
subjects	O
are	O
not	O
easily	O
available	O
.	O

While	O
ignited	O
by	O
World	O
War	O
II	O
,	O
bioweapons	O
programs	O
in	O
the	O
Soviet	B-Location
Union	E-Location
and	O
the	O
reached	O
new	O
heights	O
in	O
the	O
anxious	O
climate	O
of	O
the	O
Cold	O
War	O
.	O

For	O
example	O
,	O
in	O
2015	O
,	O
it	O
was	O
reported	O
that	O
Gambia	S-Location
's	O
tourism	O
had	O
fallen	O
below	O
50	O
per	O
cent	O
of	O
its	O
normal	O
business	O
during	O
the	O
same	O
period	O
the	O
prior	O
year	O
,	O
Elmina	B-Location
Bay	E-Location
in	O
Ghana	S-Location
had	O
an	O
80%	O
decrease	O
in	O
US	O
tourism	O
,	O
and	O
Kenya	S-Location
,	O
Zimbabwe	S-Location
,	O
Senegal	S-Location
,	O
Zambia	S-Location
,	O
and	O
also	O
reported	O
a	O
drop	O
.	O

On	O
14	O
September	O
2015	O
Sierra	B-Location
Leone	E-Location
National	B-Organization
Ebola	I-Organization
Response	I-Organization
Centre	E-Organization
confirmed	O
the	O
death	O
of	O
a	O
16-year-old	O
in	O
a	O
village	O
in	O
the	O
Bombali	B-Location
District	E-Location
.	O
It	O
is	O
suspected	O
that	O
she	O
contracted	O
the	O
disease	O
from	O
the	O
semen	O
of	O
an	O
Ebola	S-Disease
survivor	O
who	O
had	O
been	O
discharged	O
in	O
March	O
2015	O
.	O

They	O
reported	O
that	O
an	O
analysis	O
of	O
20	O
studies	O
showed	O
offered	O
mild	O
benefits	O
for	O
healthy	O
adults	O
if	O
taken	O
within	O
24	O
hours	O
of	O
onset	O
of	O
symptoms	O
,	O
but	O
found	O
no	O
clear	O
evidence	O
it	O
prevented	O
lower	O
respiratory	O
tract	O
infections	O
or	O
other	O
complications	O
of	O
influenza	O
.	O

Meantime	O
,	O
the	O
malathion	O
opposition	O
grows.	O
"	O
,	O
Los	B-Location
Angeles	E-Location
Times	O
,	O
December	O
8	O
,	O
1989	O
,	O
accessed	O
February	O
21	O
,	O
2012	O
.	O

Remdesivir	S-Drug
appears	O
to	O
be	O
the	O
most	O
promising	O
.	O

Laboratory	B-Incident
exposures	E-Incident
may	O
cause	O
serious	O
infection	O
,	O
but	O
effective	O
treatment	O
and	O
preventive	O
measures	O
are	O
available	O
and	O
the	O
risk	O
of	O
spread	O
of	O
infection	O
is	O
limited	O
.	O

After	O
months	O
of	O
claiming	O
the	O
situation	O
was	O
under	O
control	O
,	O
Beijing	S-Location
is	O
now	O
warning	O
that	O
pork	O
prices	O
in	O
could	O
rise	O
by	O
more	O
than	O
70%	O
in	O
the	O
second	O
half	O
of	O
this	O
year	O
.	O

At	O
the	O
end	O
of	O
each	O
project	O
,	O
a	O
report	O
is	O
printed	O
and	O
made	O
available	O
as	O
a	O
PDF	O
on	O
the	O
web	O
page	O
of	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
with	O
a	O
summary	O
in	O
English	O
.	O

The	O
operating	O
procedures	O
and	O
routes	O
for	O
EBOV	S-Pathogen
detection	O
were	O
carefully	O
draw	O
up	O
.	O

Two	O
instances	O
of	O
documents	O
discussing	O
the	O
use	O
of	O
biological	O
disease	O
by	O
the	O
British	O
against	O
North	O
American	O
Indians	O
during	O
Pontiac's	O
Rebellion	O
(1763–66)	O
have	O
been	O
examined	O
by	O
historians	O
,	O
but	O
the	O
actual	O
effectiveness	O
is	O
unknown	O
.	O

Harmonized	O
,	O
quality-assured	O
,	O
up-to-date	O
diagnostic	O
methods	O
have	O
been	O
a	O
key	O
factor	O
in	O
enabling	O
cooperation	O
in	O
the	O
network	O
.	O

As	O
of	O
17	O
May	O
,	O
according	O
to	O
a	O
New	B-Organization
York	I-Organization
Times	E-Organization
database	O
,	O
more	O
than	O
1,474,600	O
people	O
had	O
been	O
infected	O
and	O
at	O
least	O
88,600	O
had	O
died	O
in	O
the	O
United	B-Location
States	E-Location
.	O
The	O
Times	S-Organization
stated	O
that-previous	O
to	O
29	O
April-only	O
deaths	O
confirmed	O
through	O
testing	O
were	O
reported	O
,	O
but	O
new	O
criteria	O
include	O
probable	O
cases	O
and	O
deaths	O
.	O

On	O
24	O
September	O
,	O
it	O
was	O
reported	O
that	O
all	O
contact	O
tracing	O
and	O
vaccinations	O
would	O
stop	O
for	O
the	O
foreseeable	O
future	O
in	O
Beni	S-Location
due	O
to	O
an	O
attack	O
the	O
day	O
before	O
by	O
rebel	O
groups	O
that	O
left	O
several	O
individuals	O
dead	O
.	O

The	O
USA	S-Organization
Georgia	S-Organization
agreement	O
accords	O
diplomatic	O
status	O
to	O
the	O
US	S-Location
military	O
and	O
civilian	O
personnel	O
(including	O
diplomatic	O
vehicles)	O
,	O
working	O
on	O
the	O
Pentagon	B-Scientific_research_project
program	E-Scientific_research_project
in	O
.	O

In	O
November	O
2018	O
,	O
the	O
outbreak	O
became	O
the	O
biggest	O
Ebola	S-Disease
outbreak	O
in	O
the	O
DRC	S-Organization
's	O
history	O
,	O
and	O
by	O
November	O
,	O
it	O
had	O
become	O
the	O
second-largest	O
Ebola	S-Disease
outbreak	O
in	O
recorded	O
history	O
,	O
behind	O
only	O
the	O
2013–2016	B-Incident
Western	I-Incident
Africa	I-Incident
epidemic	E-Incident
.	O
On	O
3	O
May	O
2019	O
,	O
nine	O
months	O
into	O
the	O
outbreak	O
,	O
the	O
outbreak	O
death	O
toll	O
surpassed	O
1,000	O
.	O

The	O
country	O
office	O
consists	O
of	O
the	O
WR	O
,	O
and	O
several	O
health	O
and	O
other	O
experts	O
,	O
both	O
foreign	O
and	O
local	O
,	O
as	O
well	O
as	O
the	O
necessary	O
support	O
staff	O
.	O

The	O
bacterium	O
is	O
also	O
easily	O
transmitted	O
in	O
aerosols	O
.	O

The	O
circuit	O
is	O
arranged	O
so	O
that	O
the	O
genes	O
are	O
turned	O
on	O
and	O
off	O
in	O
sequence	O
,	O
which	O
is	O
useful	O
when	O
we	O
want	O
to	O
turn	O
a	O
gene	O
on	O
but	O
only	O
some	O
of	O
the	O
time	O
.	O

The	O
WHO	S-Organization
has	O
played	O
a	O
leading	O
role	O
in	O
several	O
public	O
health	O
achievements	O
,	O
most	O
notably	O
the	O
eradication	O
of	O
smallpox	S-Disease
,	O
the	O
near-eradication	O
of	O
polio	S-Disease
,	O
and	O
the	O
development	O
of	O
an	O
Ebola	B-Vaccine
vaccine	E-Vaccine
.	O
Its	O
current	O
priorities	O
include	O
communicable	O
diseases	O
,	O
particularly	O
HIV/AIDS	S-Disease
,	O
Ebola	S-Disease
,	O
malaria	S-Disease
and	O
tuberculosis	S-Disease
;	O
non-communicable	O
diseases	O
such	O
as	O
heart	B-Disease
disease	E-Disease
and	O
;	O
healthy	O
diet	O
,	O
nutrition	O
,	O
and	O
food	O
security	O
;	O
occupational	O
health	O
;	O
and	O
substance	O
abuse	O
.	O

SARS	S-Disease
broke	O
out	O
again	O
in	O
Beijing	S-Location
and	O
in	O
Anhui	B-Location
Province	E-Location
.	O
On	O
22	O
April	O
,	O
China	S-Location
announced	O
that	O
a	O
53-year-old	O
woman	O
had	O
died	O
on	O
19	O
April	O
,	O
its	O
first	O
SARS	S-Disease
death	O
since	O
June	O
.	O

Existing	O
regulations	O
weren't	O
built	O
to	O
make	O
sense	O
of	O
something	O
like	O
biohacking	O
,	O
which	O
in	O
some	O
cases	O
stretches	O
the	O
very	O
limits	O
of	O
what	O
it	O
means	O
to	O
be	O
a	O
human	O
being	O
.	O

Over	O
thousands	O
of	O
years	O
,	O
each	O
population	O
had	O
built	O
up	O
resistance	O
to	O
their	O
own	O
set	O
of	O
diseases	O
,	O
but	O
were	O
extremely	O
susceptible	O
to	O
the	O
others	O
.	O

In	O
light	O
of	O
this	O
concern	O
,	O
is	O
it	O
important	O
to	O
select	O
a	O
virus	O
that	O
poses	O
the	O
lowest	O
biosafety	O
risk	O
,	O
within	O
the	O
BSL2	S-Platform
guidelines	O
.	O

It	O
will	O
also	O
enable	O
us	O
to	O
direct	O
cells	O
and	O
organisms	O
to	O
perform	O
jobs	O
,	O
such	O
as	O
creating	O
clean	O
water	O
or	O
new	O
biofuels	O
that	O
natural	O
species	O
cannot	O
currently	O
do	O
to	O
the	O
needed	O
scale	O
and	O
efficiencies	O
.	O

Similarly	O
,	O
all	O
affected	O
countries	O
had	O
sufficient	O
and	O
widespread	O
capacity	O
to	O
bury	O
reported	O
deaths	O
;	O
however	O
,	O
because	O
not	O
all	O
deaths	O
were	O
reported	O
,	O
it	O
was	O
possible	O
that	O
the	O
reverse	O
could	O
have	O
been	O
the	O
case	O
in	O
some	O
areas	O
.	O

It	O
employs	O
and	O
an	O
iodine-based	O
contrast	O
agent	O
to	O
obtain	O
an	O
image	O
of	O
the	O
pulmonary	O
arteries	O
.	O

Medvedik	S-Person
dismissed	O
that	O
concern	O
,	O
arguing	O
that	O
a	O
lot	O
of	O
interventions	O
that	O
could	O
lengthen	O
our	O
lives	O
,	O
like	O
supplements	O
,	O
wouldn't	O
be	O
expensive	O
to	O
produce.	O
"	O
There's	O
no	O
reason	O
why	O
that	O
stuff	O
can't	O
be	O
dirt-cheap	O
.	O

Second	O
is	O
deeply	O
troubling	O
that	O
there	O
was	O
what	O
is	O
an	O
unacceptable	O
delay	O
in	O
providing	O
this	O
information	O
.	O

On	O
28	O
February	O
,	O
more	O
than	O
2,000	O
confirmed	O
cases	O
were	O
reported	O
,	O
rising	O
to	O
3,150	O
on	O
29	O
February	O
.	O

The	O
main	O
components	O
of	O
this	O
plasmid	O
are	O
displayed	O
in	O
the	O
image	O
and	O
listed	O
in	O
the	O
table	O
.	O

Our	O
primary	O
BWC	S-Document
objective	O
is	O
to	O
work	O
with	O
other	O
Parties	O
to	O
strengthen	O
the	O
Convention	O
as	O
an	O
instrument	O
for	O
combating	O
bioweapons	O
proliferation	O
and	O
terrorism	O
.	O

In	O
May	O
2014	O
,	O
the	O
WHO	S-Organization
said	O
it	O
was	O
monitoring	O
the	O
situation	O
as	O
global	O
cases	O
of	O
MERS	S-Disease
appeared	O
to	O
be	O
on	O
the	O
rise	O
,	O
but	O
said	O
the	O
situation	O
did	O
not	O
yet	O
constitute	O
a	O
health	O
emergency	O
.	O

If	O
a	O
potential	O
risk	O
is	O
detected	O
,	O
the	O
app	O
not	O
only	O
recommends	O
self-quarantine	O
,	O
it	O
also	O
alerts	O
local	O
health	O
officials	O
.	O

A	O
political	O
declaration	O
endorsed	O
by	O
Heads	O
of	O
State	O
at	O
the	O
United	B-Activity
Nations	I-Activity
General	I-Activity
Assembly	E-Activity
in	O
New	B-Location
York	E-Location
in	O
September	O
2016	O
signaled	O
the	O
world's	O
commitment	O
to	O
taking	O
a	O
broad	O
,	O
coordinated	O
approach	O
to	O
address	O
the	O
root	O
causes	O
of	O
antimicrobial	O
resistance	O
across	O
multiple	O
sectors	O
,	O
especially	O
human	O
health	O
,	O
animal	O
health	O
and	O
agriculture.	O
is	O
supporting	O
Member	O
States	O
to	O
develop	O
national	O
action	O
plans	O
on	O
antimicrobial	O
resistance	O
,	O
based	O
on	O
the	O
global	O
action	O
plan	O
.	O

LabKey	S-Platform
can	O
dynamically	O
access	O
external	O
resources	O
so	O
that	O
modifications	O
in	O
the	O
external	O
data	O
sets	O
are	O
immediately	O
visible	O
.	O

While	O
finalizing	O
this	O
report	O
,	O
CDC	S-Organization
leadership	O
was	O
made	O
aware	O
that	O
earlier	O
this	O
year	O
a	O
culture	O
of	O
non-pathogenic	O
avian	O
influenza	O
was	O
unintentionally	O
cross-contaminated	O
at	O
the	O
CDC	B-Organization
influenza	I-Organization
laboratory	E-Organization
with	O
the	O
highly	O
pathogenic	O
H5N1	B-Pathogen
strain	E-Pathogen
of	O
influenza	O
and	O
shipped	O
to	O
a	O
BSL-3	B-Organization
select-agent	I-Organization
laboratory	E-Organization
operated	O
by	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
.	O

IPRs	O
not	O
necessarily	O
have	O
to	O
be	O
in	O
conflict	O
with	O
open	O
access	O
to	O
data	O
.	O

But	O
perhaps	O
the	O
biggest	O
application	O
of	O
biotechnology	O
is	O
in	O
human	O
health	O
.	O

"	O
Working	O
on	O
this	O
project	O
,	O
we	O
envision	O
a	O
day	O
in	O
the	O
future	O
when	O
these	O
potentially	O
transformative	O
gene	O
therapies	O
become	O
available	O
to	O
treat	O
medical	O
conditions	O
to	O
help	O
people	O
enjoy	O
healthier	O
lives,	O
"	O
said	O
Ken	B-Person
Gilmartin	E-Person
senior	O
vice	O
president	O
and	O
general	O
manager	O
of	O
,	O
consumer	O
goods	O
and	O
manufacturing	O
business	O
.	O

The	O
WHO	S-Organization
works	O
to	O
improve	O
nutrition	O
,	O
food	O
safety	O
and	O
food	O
security	O
and	O
to	O
ensure	O
this	O
has	O
a	O
positive	O
effect	O
on	O
public	O
health	O
and	O
sustainable	O
development	O
.	O

Over-the-counter	O
pain	O
medications	O
such	O
as	O
acetaminophen	S-Drug
and	O
ibuprofen	S-Drug
do	O
not	O
kill	O
the	O
virus	O
;	O
however	O
,	O
they	O
may	O
be	O
useful	O
to	O
reduce	O
symptoms	O
.	O

The	O
smallpox	S-Pathogen
formulation-400	O
gr.	O
of	O
which	O
was	O
exploded	O
on	O
the	O
island-"got	O
her	O
"	O
and	O
she	O
became	O
infected	O
.	O

A	O
report	O
published	O
in	O
2016	O
in	O
the	O
Journal	B-Organization
of	I-Organization
the	I-Organization
Chinese	I-Organization
Medical	I-Organization
Association	E-Organization
found	O
no	O
evidence	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
was	O
imported	O
to	O
Europe	O
via	O
Chinese	O
and	O
Southeast	O
Asian	O
soldiers	O
and	O
workers	O
and	O
instead	O
found	O
evidence	O
of	O
its	O
circulation	O
in	O
Europe	O
before	O
the	O
pandemic	O
.	O

Of	O
131	O
planned	O
projects	O
,	O
the	O
GAO	S-Organization
found	O
that	O
USAID	S-Organization
has	O
completed	O
62	O
,	O
has	O
65	O
ongoing	O
,	O
and	O
has	O
yet	O
to	O
start	O
4	O
.	O

In	O
1997	O
,	O
European	B-Organization
Union	E-Organization
health	O
ministers	O
voted	O
to	O
ban	O
avoparcin	S-Drug
and	O
four	O
additional	O
antibiotics	O
used	O
to	O
promote	O
animal	O
growth	O
in	O
1999	O
.	O

The	O
entertainment	O
industry	O
has	O
also	O
been	O
affected	O
,	O
with	O
many	O
music	O
groups	O
suspending	O
or	O
cancelling	O
concert	O
tours	O
.	O

On	O
12	O
April	O
2019	O
,	O
the	O
WHO	B-Organization
Emergency	I-Organization
Committee	E-Organization
was	O
reconvened	O
by	O
the	O
WHO	S-Organization
Director-General	O
after	O
an	O
increase	O
in	O
the	O
rate	O
of	O
new	O
cases	O
,	O
and	O
determined	O
that	O
the	O
outbreak	O
still	O
failed	O
to	O
meet	O
the	O
criteria	O
for	O
a	O
.	O

Dissemination	O
of	O
scientific	O
data	O
and	O
knowledge	O
catalyzes	O
worldwide	O
scientific	O
progress	O
.	O

The	O
Iranian	O
government	O
has	O
been	O
heavily	O
affected	O
by	O
the	O
virus	O
,	O
with	O
about	O
two	O
dozen	O
parliament	O
members	O
and	O
fifteen	O
current	O
or	O
former	O
political	O
figures	O
infected	O
.	O

The	O
WHO	S-Organization
has	O
been	O
widely	O
criticised	O
for	O
its	O
delay	O
in	O
taking	O
action	O
to	O
address	O
the	O
epidemic	O
.	O

The	O
global	B-Document
norm	I-Document
against	I-Document
biological	I-Document
weapons	E-Document
laid	O
down	O
in	O
the	O
1925	B-International_exchange_and_cooperation
Geneva	I-International_exchange_and_cooperation
Convention	E-International_exchange_and_cooperation
and	O
the	O
1972	B-International_exchange_and_cooperation
Biological	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Toxin	I-International_exchange_and_cooperation
Weapons	I-International_exchange_and_cooperation
Convention	E-International_exchange_and_cooperation
,	O
clearly	O
contributed	O
to	O
the	O
fact	O
that	O
few	O
countries	O
have	O
been	O
engaged	O
in	O
research	O
into	O
offensive	O
biowarfare	O
during	O
recent	O
decades	O
.	O

The	O
work	O
in	O
biological	B-Equipment
(aseptic)	I-Equipment
hoods	E-Equipment
is	O
central	O
to	O
any	O
tissue	O
culture	O
work	O
and	O
is	O
continuously	O
used	O
in	O
2	O
out	O
of	O
the	O
5	O
laboratory	O
meetings	O
in	O
the	O
course	O
.	O

They	O
also	O
stockpiled	O
animal	O
manure	O
in	O
the	O
hope	O
of	O
spreading	O
illness	O
.	O

Projects	O
in	O
FBD	S-Platform
have	O
principally	O
been	O
funded	O
through	O
grants	O
from	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
,	O
2:4	B-Organization
Krisberedskap	E-Organization
.	O
The	O
Nordic	O
workshop	O
in	O
2016	O
was	O
funded	O
by	O
the	O
Nordic	B-Organization
Working	I-Organization
Group	I-Organization
for	I-Organization
Microbiology	I-Organization
and	I-Organization
Animal	I-Organization
Health	I-Organization
and	I-Organization
Welfare	E-Organization
(	O
NMDD	S-Organization
)	O
.	O

The	O
state	O
instead	O
opted	O
to	O
try	O
the	O
voluntary	O
introduction	O
of	O
millions	O
of	O
radiation-sterilized	O
medflies	O
to	O
interrupt	O
the	O
reproductive	O
cycle	O
and	O
control	O
the	O
population	O
.	O

The	O
United	B-Location
States	E-Location
declared	O
a	O
public	O
health	O
emergency	O
April	O
26	O
.	O

The	O
is	O
putting	O
a	O
stop	O
to	O
clinical	O
trials	O
on	O
the	O
transplants	O
for	O
now	O
.	O

Iran's	B-Organization
Health	I-Organization
Ministry	E-Organization
announced	O
the	O
cancellation	O
of	O
Friday	O
prayers	O
in	O
areas	O
affected	O
by	O
the	O
outbreak	O
and	O
shrines	O
were	O
later	O
closed	O
,	O
while	O
Saudi	B-Organization
Arabia	E-Organization
banned	O
the	O
entry	O
of	O
foreign	O
pilgrims	O
as	O
well	O
as	O
its	O
residents	O
to	O
holy	O
sites	O
in	O
Mecca	S-Location
and	O
.	O

The	O
move	O
is	O
designed	O
to	O
streamline	O
and	O
create	O
a	O
cohesive	O
leadership	O
structure	O
that	O
will	O
provide	O
swifter	O
responses	O
to	O
public	O
health	O
emergencies	O
.	O

The	O
US	B-Organization
Army	E-Organization
has	O
been	O
deployed	O
to	O
Vaziani	B-Organization
Military	I-Organization
Air	I-Organization
Base	E-Organization
,	O
17	O
km	O
away	O
from	O
the	O
Pentagon	B-Organization
bio-laboratory	E-Organization
at	O
The	O
.	O

NBIC	S-Organization
is	O
only	O
considering	O
platforms	O
that	O
include	O
national-level	O
information	O
and	O
meet	O
federal	O
regulations	O
for	O
data	O
privacy	O
and	O
confidentiality	O
,	O
according	O
to	O
the	O
.	O

These	O
include	O
photoactivatable	O
CRISPR	S-Technology
systems	O
developed	O
by	O
fusing	O
light-responsive	O
protein	O
partners	O
with	O
an	O
activator	O
domain	O
and	O
a	O
dCas9	O
for	O
gene	O
activation	O
,	O
or	O
by	O
fusing	O
similar	O
light-responsive	O
domains	O
with	O
two	O
constructs	O
of	O
split-Cas9	O
,	O
or	O
by	O
incorporating	O
caged	O
unnatural	B-Equipment
amino	I-Equipment
acids	E-Equipment
into	O
Cas9	O
,	O
or	O
by	O
modifying	O
the	O
guide	O
RNAs	O
with	O
.	O

In	O
support	O
of	O
the	O
principle	O
of	O
a	O
tobacco-free	O
work	O
environment	O
,	O
the	O
WHO	S-Organization
does	O
not	O
recruit	O
cigarette	O
smokers	O
.	O

It	O
killed	O
some	O
people	O
in	O
Eurasia	S-Location
The	O
mortality	O
rate	O
of	O
the	O
Black	B-Disease
Death	E-Disease
in	O
the	O
14th	O
century	O
was	O
far	O
greater	O
than	O
the	O
worst	O
20th-century	O
outbreaks	O
of	O
Y.	B-Disease
pestis	I-Disease
plague	E-Disease
,	O
which	O
occurred	O
in	O
and	O
killed	O
as	O
much	O
as	O
3%	O
of	O
the	O
population	O
of	O
certain	O
cities	O
.	O

All	O
documents	O
were	O
reviewed	O
and	O
issued	O
by	O
the	O
.	O

CDC	S-Organization
further	O
recommended	O
using	O
an	O
alcohol-based	O
hand	O
sanitiser	O
with	O
at	O
least	O
60	O
percent	O
alcohol	O
by	O
volume	O
when	O
soap	O
and	O
water	O
are	O
not	O
readily	O
available	O
.	O

These	O
include	O
avoiding	O
contact	O
with	O
infected	O
people	O
and	O
regular	O
hand	O
washing	O
using	O
soap	O
and	O
water	O
.	O

The	O
influenza	O
pandemic	O
circled	O
the	O
globe	O
.	O

DNA	O
samples	O
taken	O
from	O
the	O
man	O
,	O
who	O
eventually	O
died	O
of	O
the	O
virus	O
,	O
and	O
the	O
sick	O
animal	O
were	O
virtually	O
identical	O
providing	O
very	O
strong	O
evidence	O
the	O
man	O
had	O
got	O
the	O
virus	O
from	O
the	O
camel	O
.	O

On	O
15	O
May	O
it	O
was	O
reported	O
that	O
about	O
two	O
thousand	O
businesses	O
were	O
told	O
to	O
close	O
again	O
when	O
a	O
cluster	O
of	O
a	O
hundred	O
infected	O
individuals	O
was	O
discovered	O
;	O
contact	O
tracing	O
is	O
being	O
done	O
on	O
11,000	O
people	O
.	O

Calling	O
them	O
a	O
"	O
gang	O
of	O
fascists"	O
,	O
he	O
said	O
they	O
had	O
tried	O
to	O
poison	O
his	O
doctor	O
and	O
Rajneesh's	O
female	O
companion	O
,	O
as	O
well	O
as	O
the	O
Jefferson	O
County	O
district	O
attorney	O
and	O
the	O
water	O
system	O
in	O
The	O
Dalles	O
.	O

Each	O
specimen	O
was	O
tested	O
in	O
duplicate	O
.	O

Successfully	O
developing	O
scalable	O
,	O
long-range	O
chemical	O
sensors	O
would	O
help	O
enable	O
interdiction	O
of	O
improvised	O
chemical	O
and	O
explosive	O
threats	O
or	O
their	O
constituent	O
materials	O
before	O
an	O
attack	O
occurs	O
.	O

The	O
facility	O
is	O
designed	O
to	O
conduct	O
bioaerosol	O
studies	O
.	O

CHS	S-Organization
notes	O
that	O
the	O
Center	O
has	O
long	O
been	O
an	O
advocate	O
of	O
effective	O
global	O
health	O
security	O
policy	O
.	O

In	O
the	O
fifth	O
lab	O
restriction	O
enzyme	O
analysis	O
of	O
the	O
hCMV	S-Pathogen
DNA	O
is	O
conducted	O
based	O
on	O
a	O
paper	O
by	O
Chou	S-Person
and	O
Dennison	S-Person
9	O
.	O

The	O
design	O
of	O
the	O
facilities	O
made	O
them	O
hard	O
to	O
destroy	O
by	O
bombing	O
.	O

For	O
biodefense	O
categorization	O
,	O
group	O
1	O
represents	O
the	O
highest	O
threat	O
,	O
unlike	O
the	O
WHO	S-Organization
,	O
NIH	S-Organization
and	O
laboratory	O
biosafety	O
category	O
lists	O
,	O
for	O
which	O
group	O
4	O
is	O
defined	O
as	O
the	O
highest	O
threat	O
.	O

This	O
past	O
May	O
,	O
legislation	O
that	O
would	O
create	O
a	O
national	O
defense	O
strategy	O
was	O
introduced	O
in	O
the	O
Senate	S-Organization
,	O
coinciding	O
with	O
the	O
timing	O
of	O
ISIS-affiliated	O
terrorist	O
groups	O
get	O
closer	O
to	O
weaponizing	O
biological	O
agents	O
.	O

This	O
is	O
a	O
significant	O
issue	O
in	O
countries	O
like	O
India	S-Organization
and	O
,	O
which	O
are	O
major	O
hubs	O
of	O
antibiotic	O
production	O
.	O

Centuries	O
later	O
,	O
the	O
world	O
had	O
become	O
so	O
interconnected	O
that	O
a	O
truly	O
global	O
pandemic	O
was	O
possible	O
.	O

And	O
we	O
need	O
to	O
stop	O
,	O
reassess	O
,	O
fix	O
and	O
make	O
sure	O
that	O
we	O
do	O
everything	O
humanly	O
possible	O
to	O
make	O
sure	O
that	O
events	O
like	O
this	O
never	O
happen	O
in	O
the	O
future	O
.	O

The	O
survey	O
was	O
administered	O
to	O
the	O
life	O
scientists	O
identified	O
for	O
each	O
participating	O
country	O
using	O
the	O
commercially	O
available	O
MailChimp	O
software	O
program	O
within	O
the	O
SM	S-Platform
platform	O
,	O
an	O
internationally	O
recognized	O
leader	O
in	O
online	O
surveying	O
technology	O
.	O

Committee	B-Organization
on	I-Organization
Homeland	I-Organization
Security	E-Organization
Taking	O
Measure	O
of	O
Countermeasures	O
.	O

The	O
BioWatch	B-Organization
Program	I-Organization
Office	E-Organization
is	O
part	O
of	O
the	O
DHS	B-Organization
Office	I-Organization
of	I-Organization
Health	I-Organization
Affairs	E-Organization
()	O
in	O
Countering	O
Weapons	O
of	O
Mass	O
Destruction	O
(CWMD)	O
.	O

Briefly	O
,	O
samples	O
from	O
patients	O
suspected	O
to	O
have	O
EVD	S-Disease
were	O
transferred	O
into	O
the	O
BSL-3	S-Platform
lab	O
in	O
a	O
specimen	O
container	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
,	O
after	O
decontamination	O
of	O
the	O
outside	O
of	O
the	O
container	O
with	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
.	O

In	O
April	O
2012	O
,	O
six	O
hospital	O
workers	O
were	O
diagnosed	O
with	O
acute	B-Disease
respiratory	I-Disease
failure	E-Disease
of	O
unknown	O
origin	O
.	O

Both	O
Sheela	S-Person
and	O
Puja	S-Person
were	O
released	O
on	O
parole	O
early	O
for	O
good	O
behavior	O
,	O
after	O
serving	O
twenty-nine	O
months	O
of	O
their	O
sentences	O
in	O
a	O
minimum-security	O
federal	O
prison	O
.	O

BARDA	S-Organization
also	O
has	O
its	O
"	O
version"	O
of	O
DARPA	S-Organization
,	O
Ling	S-Person
said	O
.	O

A	O
major	O
1981	B-Incident
medfly	I-Incident
infestation	E-Incident
cost	O
California	S-Organization
$40	O
million	O
by	O
itself	O
.	O

Of	O
particular	O
concern	O
are	O
mishaps	O
occurring	O
at	O
institutions	O
working	O
with	O
the	O
world's	O
most	O
dangerous	O
pathogens	O
in	O
biosafety	O
level	O
3	O
and	O
4	O
labs	O
-	O
the	O
two	O
highest	O
levels	O
of	O
containment	O
that	O
have	O
proliferated	O
since	O
the	O
9/11	B-Incident
terror	I-Incident
attacks	E-Incident
in	O
2001	O
.	O

The	O
Yuancheng	B-Organization
Group	E-Organization
,	O
located	O
in	O
Wuhan	S-Location
,	O
China	S-Location
,	O
is	O
one	O
of	O
the	O
leading	O
suppliers	O
of	O
these	O
chemical	O
raw	O
materials	O
.	O

These	O
conditions	O
created	O
by	O
,	O
together	O
with	O
the	O
current	O
social	O
attitudes	O
and	O
ideas	O
,	O
led	O
to	O
the	O
relatively	O
calm	O
response	O
of	O
the	O
public	O
and	O
application	O
of	O
scientific	O
ideas	O
.	O

Zhang,	B-Person
Sarah	E-Person
,	O
"	O
An	O
Ancient	O
Case	O
of	O
the	O
Plague	S-Disease
Could	O
Rewrite	O
History	O
"	O
,	O
The	O
Atlantic	O
,	O
December	O
6	O
,	O
2018	O
This	O
Y.	B-Pathogen
pestis	E-Pathogen
may	O
have	O
been	O
different	O
to	O
more	O
modern	O
types	O
,	O
with	O
bubonic	B-Disease
plague	E-Disease
transmissible	O
by	O
fleas	O
first	O
known	O
from	O
Bronze	O
Age	O
remains	O
near	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
FDA	O
,	O
,	O
DHHS	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

There	O
are	O
currently	O
11	O
centers	O
of	O
excellence	O
in	O
New	B-Location
York	E-Location
state	O
focused	O
on	O
a	O
range	O
of	O
research	O
topics	O
,	O
but	O
this	O
will	O
be	O
the	O
first	O
in	O
the	O
Hudson	B-Location
Valley	E-Location
,	O
according	O
to	O
officials	O
.	O

The	O
database	O
allows	O
visitors	O
to	O
access	O
the	O
health	O
information	O
of	O
member	O
states	O
and	O
other	O
partners	O
.	O

You	O
can	O
accomplish	O
much	O
more	O
as	O
a	O
whole	O
than	O
by	O
working	O
alone,	O
"	O
said	O
Los	B-Organization
Alamos	I-Organization
National	I-Organization
Laboratory	E-Organization
scientist	O
and	O
partnership	O
coordinator	O
,	O
Ph.D	O
.	O

Labs	O
supporting	O
direct	O
patient	O
care	O
are	O
receiving	O
priority	O
review	O
.	O

Hence	O
,	O
the	O
title	O
of	O
Tuesday's	O
meeting	O
by	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
meeting	O
-	O
Fits	O
and	O
Starts:	O
Reactionary	O
Biodefense	O
,	O
he	O
said	O
.	O

It	O
only	O
takes	O
a	O
small	O
amount	O
of	O
to	O
infect	O
a	O
large	O
number	O
of	O
people	O
.	O

Olivet	B-Person
Buck	E-Person
was	O
the	O
Medical	O
Superintendent	O
at	O
Lumley	B-Organization
Government	I-Organization
Hospital	E-Organization
in	O
Freetown	S-Location
,	O
Sierra	B-Location
Leone	E-Location
.	O
It's	O
believed	O
that	O
she	O
contracted	O
the	O
virus	O
while	O
continuing	O
to	O
treat	O
patients	O
even	O
during	O
a	O
shortage	O
of	O
.	O
Her	O
loyalty	O
and	O
dedication	O
to	O
her	O
community	O
never	O
wavered	O
.	O

This	O
study	O
was	O
part	O
of	O
a	O
larger	O
project	O
titled	O
"	O
Scientific	B-International_exchange_and_cooperation
Engagement	I-International_exchange_and_cooperation
Defining	I-International_exchange_and_cooperation
Gaps	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Creating	I-International_exchange_and_cooperation
Opportunities	I-International_exchange_and_cooperation
for	I-International_exchange_and_cooperation
Cooperative	I-International_exchange_and_cooperation
Research	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Global	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
in	I-International_exchange_and_cooperation
the	I-International_exchange_and_cooperation
Broader	I-International_exchange_and_cooperation
Middle	I-International_exchange_and_cooperation
East	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
North	I-International_exchange_and_cooperation
Africa	I-International_exchange_and_cooperation
Region	E-International_exchange_and_cooperation
"	O
to	O
assess	O
the	O
overall	O
impact	O
of	O
global	O
biosecurity	O
capacity-building	O
initiatives	O
undertaken	O
in	O
recent	O
years	O
in	O
the	O
region	O
and	O
to	O
then	O
apply	O
the	O
knowledge	O
gained	O
from	O
this	O
assessment	O
to	O
suggest	O
sustainable	O
ways	O
to	O
build	O
cooperative	O
regional	O
biosafety	O
opportunities	O
.	O

Biosafety	B-Platform
level	I-Platform
4	E-Platform
labs	O
at	O
the	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	E-Organization
of	O
Infectious	O
Diseases	O
at	O
Fort	B-Location
Detrick	E-Location
in	O
Maryland	S-Location
wear	O
pressurized	O
,	O
full-body	O
spacesuit-like	O
gear	O
and	O
breathe	O
purified	O
air	O
.	O

"	O
We	O
need	O
more	O
of	O
these	O
boots-on-the-ground	O
disaster	O
detectives,	O
"	O
Schakowsky	S-Person
said	O
.	O

The	O
Ebola	B-Incident
virus	I-Incident
disease	I-Incident
(EVD)	I-Incident
outbreak	E-Incident
that	O
occurred	O
in	O
West	B-Location
Africa	E-Location
between	O
2014	O
and	O
2015	O
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
.	O

Biosecurity	O
is	O
an	O
issue	O
area	O
that	O
will	O
only	O
grow	O
in	O
importance	O
in	O
the	O
coming	O
years	O
,	O
so	O
it	O
is	O
encouraging	O
to	O
see	O
so	O
much	O
interest	O
.	O

Hence	O
,	O
is	O
classified	O
as	O
a	O
direct-acting	O
antiviral	O
agent	O
that	O
works	O
as	O
a	O
delayed	O
chain	O
terminator	O
.	O

NEW	B-Location
YORK	E-Location
(AP)	O
-	O
Thirteen	O
years	O
after	O
building	O
a	O
state-of-the-art	O
lab	O
for	O
the	O
world's	O
most	O
dangerous	O
germs	O
,	O
the	O
nation's	O
top	O
public	O
health	O
agency	O
is	O
asking	O
for	O
more	O
than	O
$400	O
million	O
to	O
build	O
a	O
new	O
one	O
.	O

On	O
23	O
March	O
2020	O
,	O
voluntarily	O
suspended	O
access	O
for	O
compassionate	O
use	O
(excepting	O
cases	O
of	O
critically	O
ill	O
children	O
and	O
pregnant	O
women)	O
,	O
for	O
reasons	O
related	O
to	O
supply	O
,	O
citing	O
the	O
need	O
to	O
continue	O
to	O
provide	O
the	O
agent	O
for	O
testing	O
in	O
clinical	O
trials	O
.	O

That	O
brings	O
me	O
to	O
the	O
second	O
incident	O
relating	O
to	O
influenza	O
.	O

Using	O
stored	O
laboratory	O
samples	O
for	O
all	O
six	O
,	O
it	O
was	O
found	O
that	O
samples	O
from	O
the	O
two	O
patients	O
who	O
had	O
died	O
tested	O
positive	O
for	O
.	O

Also	O
on	O
Thursday	O
,	O
Israel	S-Location
health	O
ministry	O
announced	O
that	O
the	O
number	O
of	O
people	O
diagnosed	O
with	O
there	O
was	O
68	O
.	O

The	O
peak	O
of	O
U.S.	S-Location
biological	O
weapons	O
delivery	O
system	O
development	O
came	O
during	O
the	O
1960s	O
.	O

When	O
Edward	B-Person
Jenner	E-Person
invented	O
vaccines	O
and	O
when	O
Alexander	B-Person
Fleming	E-Person
discovered	O
,	O
they	O
were	O
harnessing	O
the	O
power	O
of	O
biotechnology	O
.	O

More	O
than	O
100	O
countries	O
supported	O
this	O
motion	O
,	O
and	O
it	O
was	O
passed	O
unanimously	O
.	O

Modern	O
analysis	O
has	O
shown	O
the	O
virus	O
to	O
be	O
particularly	O
deadly	O
because	O
it	O
triggers	O
a	O
cytokine	B-Disease
storm	E-Disease
(	O
overreaction	B-Disease
of	I-Disease
the	I-Disease
body's	I-Disease
immune	I-Disease
system	E-Disease
)	O
,	O
which	O
ravages	O
the	O
stronger	O
immune	O
system	O
of	O
young	O
adults	O
.	O

On	O
24	O
April	O
2014	O
,	O
a	O
25-year-old	O
male	O
was	O
found	O
positive	O
for	O
the	O
coronavirus	S-Pathogen
He	O
had	O
history	O
of	O
exposure	O
to	O
camels	O
and	O
had	O
consumed	O
camel	O
milk	O
.	O

For	O
those	O
over	O
45	O
years	O
,	O
a	O
fatal	O
outcome	O
was	O
more	O
likely	O
in	O
the	O
epidemic	O
,	O
as	O
was	O
also	O
noted	O
in	O
preceding	O
outbreaks	O
.	O

This	O
manifests	O
itself	O
as	O
increased	O
breathing	B-Phenotype
difficulty	E-Phenotype
and	O
typically	O
occurs	O
three	O
to	O
six	O
days	O
after	O
initial	O
onset	O
of	O
flu	O
symptoms	O
.	O

Among	O
other	O
things	O
,	O
this	O
investigation	O
recommended	O
that	O
the	O
capacity	O
of	O
and	O
coordination	O
between	O
the	O
various	O
microbiology	O
laboratories	O
should	O
be	O
strengthened	O
,	O
in	O
order	O
to	O
ensure	O
a	O
diagnostic	O
service	O
that	O
is	O
sustainable	O
and	O
effective	O
in	O
the	O
event	O
of	O
any	O
crisis	O
generating	O
a	O
large	O
sample	O
load	O
.	O

"	O
The	O
Breeding	O
House	O
"	O
(1994)	O
,	O
Bruce	B-Person
Dickinson	E-Person
Segment	O
of	O
the	O
CD-single	O
Tears	O
of	O
the	O
Dragon	O
,	O
describing	O
the	O
atrocities	O
committed	O
by	O
and	O
the	O
immunity	O
granted	O
by	O
the	O
Americans	O
to	O
the	O
physicians	O
of	O
the	O
Unit	O
.	O

This	O
time	O
,	O
the	O
letter	O
was	O
addressed	O
to	O
The	O
White	B-Organization
House	E-Organization
and	O
it	O
was	O
discovered	O
at	O
a	O
White	B-Organization
House	I-Organization
mail-processing	I-Organization
facility	E-Organization
in	O
Washington	B-Location
D.C	E-Location
.	O
Hancock	S-Person
,	O
David	S-Person
.	O
"	O
Ricin	O
Letters	O
Still	O
a	O
Mystery"	O
,	O
CBS	O
News	O
,	O
February	O
5	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

An	O
outbreak	O
of	O
plague	O
followed	O
and	O
the	O
defending	O
forces	O
retreated	O
,	O
followed	O
by	O
the	O
conquest	O
of	O
the	O
city	O
by	O
the	O
Mongols	O
.	O

A	O
US	S-Location
medical	O
facility	O
in	O
Georgia	S-Location
may	O
have	O
been	O
involved	O
in	O
illegal	O
experiments	O
on	O
Georgian	B-Person
citizens	E-Person
,	O
Igor	B-Person
Giorgadze	E-Person
,	O
a	O
former	O
state	O
security	O
minister	O
turned-opposition	O
figure	O
,	O
claimed	O
.	O

A	O
public	O
notice	O
was	O
released	O
by	O
Wuhan	B-Organization
Municipal	I-Organization
Health	I-Organization
Commission	E-Organization
on	O
31	O
December	O
,	O
confirming	O
27	O
cases	O
and	O
suggesting	O
wearing	O
face	B-Equipment
masks	E-Equipment
.	O
The	O
WHO	S-Organization
was	O
informed	O
on	O
the	O
same	O
day	O
.	O

Among	O
those	O
who	O
develop	O
symptoms	O
,	O
approximately	O
one	O
in	O
five	O
may	O
become	O
more	O
seriously	O
ill	O
and	O
have	O
difficulty	B-Phenotype
breathing	E-Phenotype
Emergency	O
symptoms	O
include	O
difficulty	B-Phenotype
breathing	E-Phenotype
,	O
persistent	O
chest	B-Phenotype
pain	I-Phenotype
or	I-Phenotype
pressure	E-Phenotype
,	O
sudden	B-Phenotype
confusion	E-Phenotype
,	O
difficulty	B-Phenotype
waking	E-Phenotype
,	O
and	O
bluish	B-Phenotype
face	I-Phenotype
or	I-Phenotype
lips	E-Phenotype
;	O
immediate	O
medical	O
attention	O
is	O
advised	O
if	O
these	O
symptoms	O
are	O
present	O
.	O

In	O
Ireland	S-Location
the	O
accounted	O
for	O
10%	O
of	O
the	O
total	O
deaths	O
in	O
1918	O
.	O

His	O
reference	O
to	O
it	O
at	O
the	O
trial	O
is	O
believed	O
to	O
have	O
been	O
accidental	O
.	O

Sir	O
David	B-Person
Evans	E-Person
,	O
J.R.	B-Person
McDonald	E-Person
,	O
Dr	O
David	B-Person
Tyrrell	E-Person
and	O
Prof	O
.	O

Castro	S-Person
et	O
al.	O
and	O
Smedley	S-Person
et	O
al.	O
assess	O
several	O
approaches	O
for	O
integration	O
of	O
functional	O
genomics	O
data	O
.	O

And	O
biotechnology	O
may	O
be	O
a	O
crucial	O
ally	O
in	O
the	O
fight	O
against	O
climate	O
change	O
.	O

In	O
October	O
2017	O
the	O
deadliest	O
outbreak	O
of	O
the	O
plague	S-Disease
in	O
modern	O
times	O
hit	O
,	O
killing	O
170	O
people	O
and	O
infecting	O
thousands	O
.	O

It	O
can	O
identify	O
survival-essential	O
genes	O
,	O
which	O
can	O
be	O
further	O
serve	O
as	O
candidates	O
for	O
molecularly	O
targeted	O
drugs	O
.	O

The	O
operating	O
procedures	O
and	O
routes	O
for	O
EBOV	O
detection	O
were	O
carefully	O
draw	O
up	O
.	O

The	O
findings	O
are	O
mixed	O
.	O

Laboratory	O
personnel	O
in	O
the	O
United	B-Location
States	E-Location
working	O
with	O
human‐derived	O
materials	O
should	O
refer	O
to	O
the	O
U.S.	B-Document
Occupational	I-Document
Safety	I-Document
and	I-Document
Health	I-Document
Administration	I-Document
(OSHA)	I-Document
Bloodborne	I-Document
Pathogen	I-Document
Standard	E-Document
(	O
OSHA	S-Organization
,	O
1991)	O
,	O
available	O
online	O
at	O

In	O
1968	O
,	O
Hamilton	B-Person
Smith	E-Person
,	O
a	O
molecular	O
biologist	O
at	O
the	O
Johns	B-Organization
Hopkins	I-Organization
University	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
in	O
Baltimore	S-Location
,	O
made	O
a	O
chance	O
discovery	O
that	O
shaped	O
the	O
world	O
of	O
genetics	O
for	O
decades	O
to	O
come	O
.	O

Smallpox	S-Pathogen
was	O
eradicated	O
in	O
the	O
world	O
in	O
the	O
1970s	O
,	O
thanks	O
to	O
a	O
worldwide	O
vaccination	O
program	O
.	O

At	O
least	O
since	O
2001	O
and	O
the	O
Amerithrax	O
anthrax	S-Disease
letters	O
,	O
the	O
USA	S-Organization
has	O
had	O
a	O
significant	O
focus	O
on	O
biosecurity	O
and	O
the	O
related	O
subject	O
of	O
biosafety	O
.	O

Federal	O
investigators	O
reported	O
that	O
they	O
could	O
find	O
no	O
evidence	O
linking	O
him	O
to	O
the	O
letters	O
.	O

According	O
to	O
media	O
reports	O
,	O
the	O
concerned	O
market	O
in	O
was	O
closed	O
on	O
1	O
January	O
2020	O
for	O
environmental	O
sanitation	O
and	O
disinfection	O
.	O

He	O
believes	O
that	O
because	O
there	O
have	O
been	O
no	O
significant	O
instances	O
of	O
bioterrorism	O
since	O
the	O
,	O
the	O
government	O
has	O
allowed	O
itself	O
to	O
become	O
complacent	O
making	O
the	O
country	O
that	O
much	O
more	O
vulnerable	O
to	O
unsuspecting	O
attacks	O
,	O
thereby	O
further	O
endangering	O
the	O
lives	O
of	O
U.S.citizens	O
.	O

At	O
the	O
beginning	O
of	O
other	O
"	O
off	O
season	O
"	O
influenza	O
pandemics	O
,	O
successive	O
distinct	O
waves	O
within	O
a	O
year	O
have	O
not	O
been	O
reported	O
.	O

Though	O
"	O
a	O
large	O
number	O
of	O
babies	O
were	O
born	O
in	O
captivity"	O
,	O
there	O
have	O
been	O
no	O
accounts	O
of	O
any	O
survivors	O
of	O
,	O
children	O
included	O
.	O

In	O
comparison	O
,	O
the	O
&lt;65-year	O
age	O
group	O
accounted	O
for	O
36%	O
of	O
all	O
excess	O
influenza-related	O
deaths	O
in	O
t	O
he	B-Incident
1957	I-Incident
H2N2	I-Incident
pande	E-Incident
and	O
48%	O
in	O
tmic	O
.	O

Although	O
Moscow	S-Organization
has	O
never	O
acknowledged	O
either	O
the	O
outbreak	O
or	O
the	O
open-air	O
test	O
,	O
researchers	O
at	O
the	O
Monterey	B-Organization
Institute	I-Organization
of	I-Organization
International	I-Organization
Studies	E-Organization
,	O
with	O
the	O
help	O
of	O
Kazakh	S-Organization
officials	O
,	O
have	O
prepared	O
a	O
report	O
on	O
the	O
incident	O
.	O

Recommended	O
preventive	O
measures	O
include	O
hand	O
washing	O
,	O
covering	O
one's	O
mouth	O
when	O
coughing	S-Phenotype
maintaining	O
distance	O
from	O
other	O
people	O
,	O
wearing	O
a	O
in	O
public	O
settings	O
,	O
and	O
monitoring	O
and	O
self-isolation	O
for	O
people	O
who	O
suspect	O
they	O
are	O
infected	O
.	O

Steroids	S-Drug
such	O
as	O
methylprednisolone	S-Drug
,	O
are	O
not	O
recommended	O
unless	O
the	O
disease	O
is	O
complicated	O
by	O
.	O

The	O
vaccine	O
,	O
rVSV-ZEBOV	S-Vaccine
,	O
had	O
shown	O
high	O
efficacy	O
in	O
individuals	O
,	O
but	O
more	O
conclusive	O
evidence	O
was	O
needed	O
regarding	O
its	O
capacity	O
to	O
protect	O
populations	O
through	O
"	O
herd	O
immunity	O
"	O
.	O
The	O
vaccine	O
trial	O
employed	O
"	O
ring	B-Technology
vaccination	E-Technology
"	O
,	O
a	O
technique	O
that	O
was	O
also	O
used	O
in	O
the	O
1970s	O
to	O
eradicate	O
,	O
in	O
which	O
health	O
workers	O
control	O
an	O
outbreak	O
by	O
vaccinating	O
all	O
suspected	O
infected	O
individuals	O
within	O
the	O
surrounding	O
area	O
.	O

Phase	O
6	O
,	O
Chan	S-Person
said	O
,	O
is	O
meant	O
as	O
a	O
signal	O
to	O
countries	O
to	O
recalibrate	O
their	O
strategies	O
to	O
minimize	O
the	O
harm	O
from	O
swine	B-Disease
flu	E-Disease
.	O
In	O
countries	O
where	O
the	O
virus	O
and	O
the	O
response	O
to	O
it	O
are	O
already	O
widespread	O
,	O
it	O
is	O
not	O
likely	O
to	O
mean	O
significant	O
changes	O
,	O
but	O
urged	O
countries	O
that	O
have	O
not	O
seen	O
cases	O
,	O
or	O
seen	O
only	O
limited	O
cases	O
,	O
to	O
get	O
ready	O
.	O

In	O
the	O
fourth	O
lab	O
,	O
students	O
use	O
an	O
analytical	O
column	O
to	O
clean	O
their	O
PCR	S-Equipment
product	O
.	O

Some	O
of	O
these	O
recommendations	O
stem	O
from	O
a	O
time	O
before	O
we	O
had	O
an	O
,	O
he	O
added	O
.	O

Epidemiologic	O
data	O
on	O
rates	O
of	O
clinical	O
influenza	S-Disease
by	O
age	O
,	O
collected	O
between	O
1900	O
and	O
1918	O
,	O
provide	O
good	O
evidence	O
for	O
the	O
emergence	O
of	O
an	O
antigenically	O
novel	O
influenza	S-Disease
virus	O
in	O
1918	O
.	O

These	O
rule	O
changes	O
were	O
what	O
the	O
self-proclaimed	O
"	O
Fallen	B-Person
Angel	E-Person
took	O
aim	O
at	O
in	O
the	O
ricin	S-Pathogen
-laden	O
letters	O
.	O

History	O
has	O
shown	O
that	O
such	O
infections	O
occur	O
(documented	O
as	O
early	O
as	O
the	O
1890s)	O
and	O
that	O
laboratory	O
workers	O
are	O
clearly	O
at	O
higher	O
risk	O
for	O
infection	O
with	O
certain	O
agents	O
(i.e	O
.	O

It	O
is	O
great	O
to	O
be	O
down	O
here	O
in	O
Charlottesville	S-Location
It's	O
also	O
great	O
to	O
see	O
so	O
many	O
young	O
people	O
here	O
at	O
the	O
start	O
of	O
a	O
three	O
day	O
weekend	O
ready	O
to	O
talk	O
about	O
germs	O
and	O
bugs	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
a	O
pandemic	O
that	O
affected	O
all	O
of	O
Europe	S-Location
in	O
the	O
ways	O
described	O
,	O
not	O
only	O
.	O

Zaki	S-Person
and	O
co-authors	O
from	O
the	O
Erasmus	B-Organization
Medical	I-Organization
Center	E-Organization
published	O
more	O
details	O
,	O
including	O
a	O
scientific	O
name	O
,	O
Human	B-Organization
Coronavirus-Erasmus	I-Organization
Medical	I-Organization
Center	E-Organization
(	O
HCoV-EMC	S-Organization
)	O
,	O
which	O
was	O
then	O
used	O
in	O
scientific	O
literature	O
.	O

This	O
allows	O
the	O
physician	O
to	O
ensure	O
that	O
the	O
temperature	O
generated	O
during	O
each	O
cycle	O
of	O
ultrasound	O
energy	O
is	O
sufficient	O
to	O
cause	O
thermal	O
ablation	O
within	O
the	O
desired	O
tissue	O
and	O
if	O
not	O
,	O
to	O
adapt	O
the	O
parameters	O
to	O
ensure	O
effective	O
treatment	O
.	O

According	O
to	O
Afghanistan's	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
most	O
of	O
the	O
cases	O
have	O
been	O
registered	O
in	O
the	O
capital	O
Kabul	S-Location
where	O
71	O
cases	O
have	O
been	O
reported	O
with	O
13	O
fatalities	O
,	O
and	O
in	O
the	O
province	O
of	O
Herat	S-Location
near	O
the	O
border	O
with	O
(67	O
cases)	O
.	O

The	O
HPA	S-Organization
named	O
the	O
virus	O
the	O
.	O

The	O
disease	O
killed	O
in	O
many	O
parts	O
of	O
the	O
world	O
.	O

Their	O
target	O
was	O
livestock-the	O
horses	O
,	O
mules	O
,	O
sheep	O
,	O
and	O
cattle	O
being	O
shipped	O
from	O
neutral	O
countries	O
to	O
the	O
Allies	O
.	O

Botulinum	B-Pathogen
Toxin	E-Pathogen
was	O
tested	O
as	O
a	O
bio-weapon	O
by	O
the	O
US	B-Organization
Army	E-Organization
in	O
the	O
past	O
,	O
as	O
well	O
as	O
Anthrax	S-Disease
,	O
Brucella	S-Pathogen
and	O
Tularemia	S-Disease
.	O
Although	O
the	O
US	B-Scientific_research_project
bio-weapons	I-Scientific_research_project
program	E-Scientific_research_project
was	O
officially	O
terminated	O
in	O
1969	O
documents	O
show	O
that	O
the	O
military	O
experiments	O
have	O
never	O
ended	O
.	O

Oversight	O
of	O
biological	O
research	O
labs	O
is	O
fragmented	O
,	O
often	O
secretive	O
and	O
largely	O
self-policing	O
,	O
the	O
investigation	O
found	O
.	O

If	O
successful	O
,	O
they	O
planned	O
to	O
use	O
the	O
same	O
techniques	O
closer	O
to	O
Election	O
Day	O
.	O

In	O
February	O
2015	O
,	O
media	O
reported	O
that	O
Guinea	S-Location
recorded	O
a	O
rise	O
in	O
cases	O
for	O
the	O
second	O
week	O
in	O
a	O
row	O
,	O
health	O
authorities	O
stated	O
that	O
this	O
was	O
related	O
to	O
the	O
fact	O
that	O
they	O
"	O
were	O
only	O
now	O
gaining	O
access	O
to	O
faraway	O
villages"	O
,	O
where	O
violence	O
had	O
previously	O
prevented	O
them	O
from	O
entering	O
.	O

On	O
average	O
41,400	O
people	O
die	O
of	O
influenza-related	O
illnesses	O
each	O
year	O
in	O
the	O
United	B-Location
States	E-Location
based	O
on	O
data	O
collected	O
between	O
1979	O
and	O
2001	O
.	O

Sharpe	O
,	O
2005	O
;	O
.	O
The	O
CDC	O
director	O
concurrently	O
serves	O
as	O
the	O
Administrator	O
of	O
the	O
Agency	O
for	O
Toxic	O
Substances	O
and	O
Disease	O
Registry	O
.	O

On	O
28	O
January	O
2015	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
for	O
the	O
first	O
time	O
since	O
the	O
week	O
ending	O
29	O
June	O
2014	O
,	O
there	O
had	O
been	O
fewer	O
than	O
100	O
new	O
confirmed	O
cases	O
reported	O
in	O
a	O
week	O
in	O
the	O
three	O
most-affected	O
countries	O
.	O

Over	O
a	O
year	O
later	O
,	O
in	O
October	O
1979	O
,	O
the	O
university	O
authorities	O
fumigated	O
the	O
Medical	B-Organization
School	I-Organization
East	I-Organization
Wing	E-Organization
.	O
The	O
ward	O
at	O
Catherine-de-Barnes	B-Location
Hospital	E-Location
in	O
which	O
had	O
died	O
was	O
still	O
sealed	O
off	O
five	O
years	O
after	O
her	O
death	O
,	O
all	O
the	O
furniture	O
and	O
equipment	O
inside	O
left	O
untouched	O
.	O

Fearing	O
a	O
worst-case	O
scenario	O
,	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
(	O
HHS	S-Organization
)	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
the	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
(	O
DHS	S-Organization
)	O
developed	O
updated	O
guidance	O
and	O
a	O
video	O
for	O
employers	O
to	O
use	O
as	O
they	O
developed	O
plans	O
to	O
respond	O
to	O
the	O
.	O
The	O
guidance	O
suggested	O
that	O
employers	O
consider	O
and	O
communicate	O
their	O
objectives	O
,	O
such	O
as	O
reducing	O
transmission	O
among	O
staff	O
,	O
protecting	O
people	O
who	O
are	O
at	O
increased	O
risk	O
of	O
influenza-related	O
complications	O
from	O
becoming	O
infected	O
,	O
maintaining	O
business	O
operations	O
,	O
and	O
minimising	O
adverse	O
effects	O
on	O
other	O
entities	O
in	O
their	O
supply	O
chains	O
.	O

Basic	O
infrastructure	O
was	O
preserved	O
,	O
and	O
research	O
on	O
producing	O
dried	O
agent	O
was	O
conducted	O
under	O
the	O
guise	O
of	O
biopesticide	O
production	O
at	O
Al	B-Location
Hakum	E-Location
until	O
its	O
destruction	O
by	O
UNSCOM	S-Organization
inspectors	O
in	O
1996	O
.	O

The	O
second	O
is	O
that	O
we	O
will	O
-	O
I've	O
appointed	O
Dr	O
.	O

Another	O
protective	O
mechanism	O
found	O
among	O
bacterial	O
species	O
is	O
ribosomal	O
protection	O
proteins	O
.	O

A	O
spokesperson	O
for	O
the	O
UK-based	B-Organization
health	I-Organization
foundation	E-Organization
,	O
the	O
Wellcome	O
Trust	O
,	O
said	O
in	O
October	O
2014	O
that	O
"	O
the	O
additional	O
death	O
toll	O
from	O
malaria	S-Disease
and	O
other	O
diseases	O
[is]	O
likely	O
to	O
exceed	O
that	O
of	O
the	O
outbreak	O
itself"	O
.	O

Josiah	B-Person
Zayner	E-Person
is	O
a	O
biohacker	O
who's	O
famous	O
for	O
injecting	O
himself	O
with	O
the	O
gene-editing	O
tool	O
CRISPR	S-Technology
.	O
At	O
a	O
time	O
when	O
the	O
technology	O
exists	O
for	O
us	O
to	O
change	O
(or	O
hack)	O
our	O
own	O
DNA	O
,	O
what	O
are	O
the	O
ethics	O
of	O
experimenting	O
on	O
ourselves	O
,	O
and	O
others	O
,	O
at	O
home?	O
On	O
the	O
launch	O
episode	O
of	O
this	O
new	O
podcast	O
,	O
host	O
Arielle	B-Person
Duhaime-Ross	E-Person
talks	O
to	O
about	O
how	O
he's	O
thinking	O
about	O
human	O
experimentation	O
today	O
.	O

He	O
received	O
a	O
ten-year	O
suspended	O
sentence	O
and	O
a	O
fine	O
of	O
US$400,000	O
,	O
and	O
was	O
deported	O
and	O
barred	O
from	O
reentering	O
the	O
United	B-Location
States	E-Location
for	O
a	O
period	O
of	O
five	O
years	O
.	O

Safe	O
work	O
practices	O
and	O
the	O
use	O
of	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
must	O
be	O
included	O
in	O
the	O
procedures	O
.	O

Significant	O
advancements	O
in	O
the	O
field	O
of	O
biotechnology	O
in	O
the	O
late	O
1990s	O
and	O
early	O
2000s	O
raised	O
international	O
concerns	O
for	O
biosafety	O
related	O
to	O
biodiversity	O
,	O
particularly	O
pertaining	O
to	O
risk	O
assessment	O
and	O
risk	O
mitigation	O
regarding	O
the	O
impacts	O
of	O
new	O
research	O
products	O
.	O

Sex-based	O
immunological	O
differences	O
,	O
a	O
lower	O
prevalence	O
of	O
smoking	O
in	O
women	O
,	O
and	O
men	O
developing	O
co-morbid	O
conditions	O
such	O
as	O
hypertension	S-Disease
at	O
a	O
younger	O
age	O
than	O
women	O
could	O
have	O
contributed	O
to	O
the	O
higher	O
mortality	O
in	O
men	O
.	O

A	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
report	O
released	O
April	O
2014	O
stated	O
,	O
"	O
this	O
serious	O
threat	O
is	O
no	O
longer	O
a	O
prediction	O
for	O
the	O
future	O
,	O
it	O
is	O
happening	O
right	O
now	O
in	O
every	O
region	O
of	O
the	O
world	O
and	O
has	O
the	O
potential	O
to	O
affect	O
anyone	O
,	O
of	O
any	O
age	O
,	O
in	O
any	O
country	O
.	O

Bell	S-Person
that	O
will	O
report	O
to	O
me	O
to	O
accelerate	O
improvements	O
in	O
laboratory	O
safety	O
and	O
serve	O
as	O
the	O
transition	O
group	O
for	O
permanent	O
single	O
point	O
of	O
accountability	O
on	O
laboratory	O
safety	O
which	O
is	O
something	O
called	O
for	O
in	O
the	O
review	O
of	O
the	O
potential	O
exposure	O
to	O
anthrax	B-Incident
incident	E-Incident
.	O
The	O
culture	O
of	O
laboratory	O
safety	O
needs	O
to	O
improve	O
at	O
some	O
laboratories	O
.	O

MIAME	S-Equipment
for	O
microarrays	O
,	O
while	O
other	O
areas	O
as	O
novel	O
sequencing	O
techniques	O
require	O
further	O
elaboration.	O
is	O
complemented	O
by	O
many	O
other	O
standards	O
,	O
e.g.	O
protein	O
standards	O
initiative-molecular	O
interactions	O
(PSI-MI)	O
in	O
the	O
proteomics	O
area	O
,	O
mass	O
Spectrometry	O
Markup	O
Language	O
in	O
the	O
mass	O
spectrometry	O
area	O
,	O
BioPax	O
as	O
exchange	O
format	O
for	O
pathway	O
data	O
,	O
SBML	O
for	O
the	O
description	O
of	O
systems	O
biology	O
models	O
in	O
xml	O
and	O
similarly	O
CellML	O
with	O
the	O
ability	O
to	O
describe	O
arbitrary	O
mathematical	O
models	O
although	O
the	O
focus	O
is	O
biology	O
,	O
CabosML	O
for	O
the	O
description	O
of	O
carbohydrate	O
structures	O
.	O

Chinese	O
racism	O
and	O
xenophobia	O
was	O
criticised	O
by	O
foreign	O
governments	O
and	O
diplomatic	O
corps	O
,	O
and	O
China	S-Location
apologised	O
for	O
discriminatory	O
practices	O
such	O
as	O
restaurants	O
excluding	O
black	O
customers	O
,	O
although	O
these	O
and	O
other	O
accusations	O
of	O
harassment	O
,	O
discrimination	O
and	O
eviction	O
of	O
black	O
people	O
in	O
continued	O
.	O

The	O
CDC	S-Organization
has	O
launched	O
campaigns	O
targeting	O
the	O
transmission	O
of	O
influenza	O
,	O
including	O
the	O
,	O
and	O
launched	O
websites	O
to	O
educate	O
people	O
in	O
proper	O
hygiene	O
.	O

The	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
says	O
brucellosis	S-Pathogen
is	O
the	O
most	O
commonly	O
reported	O
bacterial	O
infection	O
acquired	O
in	O
scientific	O
laboratories	O
.	O

They	O
had	O
no	O
charges	O
filed	O
against	O
them	O
.	O

Tackling	O
antibiotic	O
resistance	O
is	O
a	O
high	O
priority	O
for	O
WHO	S-Organization
A	O
global	O
action	O
plan	O
on	O
antimicrobial	O
resistance	O
,	O
including	O
antibiotic	O
resistance	O
,	O
was	O
endorsed	O
at	O
the	O
in	O
May	O
2015	O
.	O

Redlener	S-Person
notes	O
that	O
the	O
United	B-Location
States	E-Location
is	O
better	O
prepared	O
for	O
a	O
biological	O
threat	O
now	O
than	O
it	O
was	O
20	O
years	O
ago.	O
"	O
We've	O
come	O
a	O
long	O
way	O
since	O
2001,	O
"	O
added	O
.	O

An	O
incidentally	O
found	O
nodule	S-Disease
in	O
the	O
absence	O
of	O
symptoms	O
(sometimes	O
referred	O
to	O
as	O
an	O
incidentaloma	S-Disease
)	O
may	O
raise	O
concerns	O
that	O
it	O
might	O
represent	O
a	O
tumor	O
,	O
either	O
benign	O
or	O
malignant	O
.	O

Contact	O
tracing	O
is	O
an	O
important	O
method	O
for	O
health	O
authorities	O
to	O
determine	O
the	O
source	O
of	O
an	O
infection	O
and	O
to	O
prevent	O
further	O
transmission	O
.	O

The	O
Mongol	O
Empire	O
established	O
commercial	O
and	O
political	O
connections	O
between	O
the	O
Eastern	O
and	O
Western	O
areas	O
of	O
the	O
world	O
,	O
through	O
the	O
most	O
mobile	O
army	O
ever	O
seen	O
.	O

The	O
plague	S-Disease
struck	O
various	O
regions	O
in	O
the	O
Middle	B-Location
East	E-Location
and	O
North	B-Location
Africa	E-Location
during	O
the	O
pandemic	O
,	O
leading	O
to	O
serious	O
depopulation	O
and	O
permanent	O
change	O
in	O
both	O
economic	O
and	O
social	O
structures	O
.	O

It	O
set	O
the	O
stage	O
for	O
combining	O
not	O
just	O
a	O
few	O
genes	O
,	O
but	O
entire	O
pathways	O
that	O
can	O
make	O
a	O
compound	O
,	O
or	O
a	O
whole	O
genome	O
that	O
can	O
let	O
a	O
cell	O
divide	O
,	O
grow	O
,	O
copy	O
itself	O
and	O
interact	O
with	O
other	O
organisms	O
.	O

Emphasis	O
is	O
placed	O
on	O
building	O
a	O
culture	O
of	O
risk	O
assessment-based	O
safety	O
through	O
competency	O
training	O
designed	O
to	O
enhance	O
understanding	O
and	O
recognition	O
of	O
potential	O
biological	O
hazards	O
as	O
well	O
as	O
methods	O
for	O
controlling	O
these	O
hazards	O
.	O

More	O
modern	O
terms	O
for	O
this	O
virus	O
include	O
the	O
"	O
1918	B-Incident
influenza	I-Incident
pandemic	E-Incident
,	O
"	O
the	O
"	O
,"	O
or	O
variations	O
of	O
these	O
.	O

•	O
Characterize	O
how	O
tick-borne	O
disease	O
affects	O
U.S.	S-Location
national	O
security	O
,	O
military	O
readiness	O
,	O
and	O
the	O
health	O
and	O
wellness	O
of	O
active	O
duty	O
service	O
members	O
,	O
veterans	O
and	O
their	O
families	O
.	O

But	O
there's	O
more	O
that	O
we're	O
doing	O
around	O
the	O
world	O
.	O

The	O
WRAIR	S-Organization
study	O
evaluates	O
the	O
VRC-MARADC087-00-VP	B-Vaccine
vaccine	E-Vaccine
,	O
developed	O
by	O
the	O
Vaccine	B-Organization
Research	I-Organization
Center	I-Organization
(VRC)	I-Organization
of	I-Organization
the	I-Organization
National	I-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	I-Organization
(NIAID),	I-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	I-Organization
(NIH)	E-Organization
.	O
The	O
recombinant	O
candidate	O
being	O
tested	O
is	O
aimed	O
at	O
stimulating	O
rapid	O
but	O
durable	O
immunity	O
.	O

In	O
it	O
accounts	O
for	O
15%	O
of	O
radiation	O
exposure	O
.	O

One	O
of	O
the	O
few	O
regions	O
of	O
the	O
world	O
seemingly	O
less	O
affected	O
by	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
was	O
China	S-Location
,	O
where	O
several	O
studies	O
have	O
documented	O
a	O
comparatively	O
mild	O
flu	S-Disease
season	O
in	O
1918.	O
(Although	O
this	O
is	O
disputed	O
due	O
to	O
lack	O
of	O
data	O
during	O
the	O
Warlord	O
Period	O
,	O
see	O
Around	O
the	O
globe)	O
.	O

That's	O
a	O
different	O
form	O
of	O
.	O
But	O
this	O
one	O
has	O
been	O
around	O
for	O
about	O
a	O
decade	O
,	O
and	O
it's	O
one	O
of	O
the	O
ones	O
that	O
does	O
concern	O
us	O
because	O
it	O
can	O
be	O
quite	O
deadly	O
both	O
for	O
poultry	O
and	O
for	O
people	O
.	O

But	O
scientists	O
at	O
the	O
military	O
base	O
on	O
Vozrozhdeniye	B-Location
Island	E-Location
routinely	O
exposed	O
animals	O
to	O
deadly	O
germs	O
and	O
measured	O
agent	O
dispersal	O
in	O
open	O
air	O
.	O

The	O
new	O
database	O
presents	O
a	O
great	O
deal	O
of	O
information	O
about	O
mental	O
health	O
,	O
substance	O
abuse	O
,	O
disability	O
,	O
human	O
rights	O
,	O
and	O
the	O
different	O
policies	O
,	O
strategies	O
,	O
laws	O
,	O
and	O
service	O
standards	O
being	O
implemented	O
in	O
different	O
countries	O
.	O

Another	O
of	O
the	O
thirteen	O
WHO	S-Organization
priority	O
areas	O
is	O
aimed	O
at	O
the	O
prevention	O
and	O
reduction	O
of	O
"	O
disease,	O
disability	O
and	O
premature	O
deaths	O
from	O
chronic	O
noncommunicable	O
diseases	O
,	O
mental	O
disorders	O
,	O
violence	O
and	O
injuries	O
,	O
and	O
visual	O
impairment"	O
.	O

Category	B-Pathogen
B	I-Pathogen
agents	E-Pathogen
are	O
moderately	O
easy	O
to	O
disseminate	O
and	O
have	O
low	O
mortality	O
rates	O
.	O

Another	O
laboratory-acquired	O
infection	O
may	O
have	O
occurred	O
in	O
a	O
University	B-Organization
of	I-Organization
Chicago	E-Organization
building	O
where	O
2	O
years	O
ago	O
a	O
researcher	O
contracted	O
and	O
later	O
died	O
.	O

The	O
committee	O
will	O
also	O
discuss	O
vaccines	O
for	O
human	B-Pathogen
papillomavirus	E-Pathogen
,	O
Japanese	B-Pathogen
encephalitis	E-Pathogen
and	O
.	O

It	O
became	O
the	O
National	B-Organization
Communicable	I-Organization
Disease	I-Organization
Center	E-Organization
(	O
NCDC	S-Organization
)	O
effective	O
July	O
1	O
,	O
1967	O
.	O

This	O
means	O
that	O
at	O
least	O
2	O
H1N1	S-Pathogen
receptor-binding	O
variants	O
cocirculated	O
in	O
1918:	O
1	O
with	O
high-affinity	O
binding	O
to	O
the	O
human	O
receptor	O
and	O
1	O
with	O
mixed-affinity	O
binding	O
to	O
both	O
avian	O
and	O
human	O
receptors	O
.	O

Evidence	O
linking	O
these	O
incidents	O
to	O
biological	O
warfare	O
has	O
not	O
been	O
confirmed	O
.	O

These	O
claims	O
are	O
controversial	O
as	O
it	O
is	O
argued	O
that	O
any	O
smallpox	B-Pathogen
virus	E-Pathogen
brought	O
to	O
New	B-Location
South	I-Location
Wales	E-Location
probably	O
would	O
have	O
been	O
sterilised	O
by	O
heat	O
and	O
humidity	O
encountered	O
during	O
the	O
voyage	O
of	O
the	O
First	B-Organization
Fleet	E-Organization
from	O
England	S-Location
and	O
incapable	O
of	O
biological	O
warfare	O
.	O

Redlener	S-Person
warned	O
that	O
"	O
we're	O
in	O
the	O
zone	O
of	O
the	O
unimaginable	O
things	O
that	O
have	O
to	O
do	O
with	O
preventing	O
and	O
preparing	O
for	O
the	O
most	O
horrible	O
threats.	O
"	O

To	O
meet	O
this	O
challenge	O
DARPA	S-Organization
today	O
announced	O
its	O
SIGMA+	S-Scientific_research_project
program	O
,	O
an	O
expansion	O
of	O
the	O
existing	O
program	O
,	O
which	O
detects	O
radiological	O
and	O
nuclear	O
materials	O
.	O

30	O
July	O
2014	O
3	O
1	O
3	O
1	O

Harmonized	O
,	O
quality-assured	O
,	O
up-to-date	O
diagnostic	O
methods	O
have	O
been	O
a	O
key	O
factor	O
in	O
enabling	O
cooperation	O
in	O
the	O
network	O
.	O

After	O
Kamel	S-Person
defection	O
,	O
it	O
became	O
known	O
that	O
in	O
December	O
1990	O
the	O
Iraqis	O
had	O
filled	O
100	O
R-400	O
bombs	O
with	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
50	O
with	O
anthrax	S-Pathogen
,	O
and	O
16	O
with	O
aflatoxin	S-Pathogen
.	O
In	O
addition	O
,	O
13	O
Al	O
Hussein	O
(SCUD)	O
warheads	O
were	O
filled	O
with	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
10	O
with	O
anthrax	S-Pathogen
,	O
and	O
2	O
with	O
.	O
These	O
weapons	O
were	O
deployed	O
in	O
January	O
1991	O
to	O
four	O
locations	O
for	O
use	O
against	O
Coalition	O
forces.Woods	O
,	O
Op.cit.	O
,	O
pg	O
8	O
.	O

Scientists	O
have	O
long	O
been	O
able	O
to	O
change	O
and/or	O
modify	O
single	O
genes	O
or	O
small	O
sets	O
of	O
genes	O
.	O

The	O
affected	O
area	O
has	O
about	O
one	O
million	O
uprooted	O
people	O
and	O
shares	O
borders	O
with	O
Rwanda	S-Location
and	O
,	O
with	O
cross	O
border	O
movement	O
because	O
of	O
trade	O
activities	O
.	O

In	O
debates	O
about	O
genetic	O
engineering	O
and	O
biological	O
weapons	O
it	O
is	O
often	O
stated	O
that	O
natural	O
pathogens	O
are	O
sufficiently	O
dangerous	O
and	O
deadly	O
,	O
and	O
that	O
genetic	B-Technology
engineering	E-Technology
is	O
not	O
necessary	O
to	O
turn	O
them	O
into	O
more	O
effective	O
biological	O
weapons	O
.	O

On	O
a	O
couple	O
of	O
occasions	O
,	O
samples	O
have	O
been	O
sent	O
between	O
the	O
agencies	O
,	O
for	O
example	O
,	O
when	O
there	O
have	O
been	O
problems	O
with	O
equipment	O
or	O
when	O
results	O
have	O
needed	O
to	O
be	O
confirmed	O
,	O
in	O
a	O
manner	O
that	O
would	O
not	O
have	O
been	O
possible	O
before	O
the	O
establishment	O
of	O
the	O
FBD	S-Platform
network.	O
.	O

This	O
review	O
introduces	O
the	O
classification	O
and	O
characterization	O
of	O
IAVs	S-Pathogen
,	O
pinpoints	O
historic	O
pandemics	O
and	O
epidemics	O
caused	O
by	O
IAVs	S-Pathogen
,	O
emphasizes	O
the	O
significance	O
and	O
necessity	O
of	O
biosafety	O
,	O
summarizes	O
currently	O
established	O
biosafety-related	O
protocols	O
for	O
research	O
,	O
and	O
provides	O
potential	O
strategies	O
to	O
improve	O
biosafety	O
protocols	O
for	O
dual-use	O
research	O
on	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
viruses	O
and	O
other	O
emerging	O
infectious	O
agents	O
.	O

On	O
11	O
December	O
,	O
it	O
was	O
reported	O
that	O
the	O
stock	O
of	O
vaccine	O
in	O
was	O
4,290	O
doses	O
.	O

Leitenberg	S-Person
,	O
Milton	S-Person
and	O
Raymond	B-Person
A.	I-Person
Zilinskas	E-Person
(2012)	O
,	O
The	O
Soviet	O
Biological	O
Weapons	O
Program:	O
A	O
History	O
;	O
Cambridge	S-Location
,	O
Massachusetts	S-Location
:	O
Press	O
,	O
p.11	O
.	O

In	O
July	O
2014	O
,	O
the	O
WHO	S-Organization
convened	O
an	O
emergency	O
meeting	O
of	O
health	O
ministers	O
from	O
eleven	O
countries	O
and	O
announced	O
collaboration	O
on	O
a	O
strategy	O
to	O
co-ordinate	O
technical	O
support	O
to	O
combat	O
the	O
epidemic	O
.	O

In	O
this	O
way	O
,	O
students	O
also	O
learn	O
about	O
the	O
importance	O
of	O
comparing	O
their	O
results	O
to	O
scientifically	O
published	O
data	O
.	O

The	O
next	O
RevCon	O
will	O
take	O
place	O
in	O
2016	O
.	O

Title	B-Document
42	I-Document
of	I-Document
the	I-Document
Code	I-Document
of	I-Document
Federal	I-Document
Regulations	E-Document
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
by	O
accessing	O
the	O
US	O
Code	O
of	O
Federal	O
Regulations	O
(CFR)	O
website	O
.	O

The	O
death	O
toll	O
was	O
at	O
least	O
105	O
,	O
but	O
no	O
one	O
knows	O
the	O
exact	O
number	O
,	O
because	O
all	O
hospital	O
records	O
and	O
other	O
evidence	O
were	O
destroyed	O
by	O
the	O
KGB	S-Organization
,	O
according	O
to	O
former	O
Biopreparat	S-Organization
deputy	O
director	O
.	O

It	O
cost	O
$42	O
million	O
to	O
construct	O
on	O
over	O
1100	O
acres	O
and	O
is	O
available	O
for	O
training	O
360	O
days	O
a	O
year	O
.	O

"	O
The	O
detection	O
of	O
the	O
case	O
is	O
a	O
result	O
of	O
our	O
enhanced	O
surveillance	O
system	O
put	O
in	O
place	O
in	O
all	O
provinces	O
in	O
response	O
to	O
the	O
confirmed	O
polio	S-Disease
cases	O
in	O
Morobe	B-Location
Province	E-Location
,	O
"	O
said	O
Pascoe	B-Person
Kase	E-Person
,	O
Secretary	O
of	O
the	O
.	O

Restriction	O
enzymes	O
changed	O
genetics	O
because	O
they	O
allow	O
scientists	O
to	O
cut	O
and	O
paste	O
pieces	O
of	O
DNA	O
,	O
although	O
it	O
took	O
two	O
more	O
scientists	O
to	O
realize	O
their	O
potential	O
.	O

Although	O
some	O
drugs	O
,	O
such	O
as	O
insulin	S-Drug
can	O
be	O
produced	O
in	O
bacteria	O
by	O
inserting	O
a	O
single	O
gene	O
,	O
others	O
require	O
a	O
whole	O
series	O
of	O
genes	O
.	O

Each	O
Action	O
Package	O
includes	O
a	O
five-year	O
target	O
,	O
indicators	O
to	O
measure	O
progress	O
,	O
and	O
lists	O
of	O
baseline	O
assessment	O
,	O
planning	O
,	O
monitoring	O
,	O
and	O
evaluation	O
activities	O
to	O
support	O
successful	O
implementation	O
.	O

A	O
joint	O
initiative	O
of	O
WHO	S-Organization
and	O
Drugs	B-Organization
for	I-Organization
Neglected	I-Organization
Diseases	I-Organization
initiative	E-Organization
(	O
DNDi	S-Organization
)	O
,	O
encourages	O
research	O
and	O
development	O
through	O
public-private	O
partnerships	O
.	O

To	O
overcome	O
the	O
inevitable	O
challenges	O
of	O
steering	O
cross-sector	O
collaboration	O
,	O
a	O
formal	O
agreement	O
between	O
directors	O
general	O
of	O
the	O
4	O
agencies	O
consolidates	O
the	O
FBD	S-Platform
network	O
.	O

Even	O
the	O
use	O
of	O
tear	O
gas	O
is	O
prohibited	O
because	O
of	O
the	O
enormous	O
danger	O
of	O
escalation	O
.	O

EBOV	S-Pathogen
carries	O
a	O
negative-sense	O
RNA	O
genome	O
in	O
virions	O
that	O
are	O
cylindrical/tubular	O
,	O
and	O
contain	O
viral	O
envelope	O
,	O
matrix	O
,	O
and	O
nucleocapsid	O
components	O
.	O

Cardiac	B-Technology
MRI	E-Technology
is	O
complementary	O
to	O
other	O
imaging	O
techniques	O
,	O
such	O
as	O
echocardiography	S-Technology
,	O
cardiac	B-Technology
CT	E-Technology
,	O
and	O
nuclear	O
medicine	O
.	O

Text	O
online	O
here	O
.	O

If	O
the	O
fever	S-Phenotype
is	O
mild	O
and	O
there	O
are	O
no	O
other	O
complications	O
,	O
medication	O
is	O
not	O
recommended	O
.	O

The	O
experiments	O
resulted	O
in	O
successfully	O
changing	O
only	O
some	O
of	O
the	O
intended	O
genes	O
,	O
and	O
had	O
off-target	O
effects	O
on	O
other	O
genes	O
.	O

In	O
the	O
Philippines	S-Location
lawmakers	O
granted	O
president	O
Rodrigo	B-Person
Duterte	E-Person
temporary	O
emergency	O
powers	O
during	O
the	O
pandemic	O
.	O

However	O
,	O
randomised	O
controlled	O
trials	O
are	O
considered	O
unethical	O
when	O
a	O
disease	O
is	O
frequently	O
fatal	O
,	O
as	O
is	O
the	O
case	O
with	O
Ebola	S-Disease
In	O
December	O
2015	O
,	O
a	O
study	O
was	O
released	O
that	O
found	O
that	O
the	O
viral	O
load	O
found	O
in	O
a	O
patient's	O
blood	O
in	O
the	O
week	O
after	O
the	O
onset	O
of	O
symptoms	O
is	O
a	O
strong	O
indication	O
of	O
the	O
patient's	O
likelihood	O
to	O
die	O
or	O
survive	O
the	O
disease	O
.	O

Once	O
a	O
new	O
method	O
has	O
been	O
implemented	O
,	O
it	O
is	O
still	O
a	O
challenge	O
for	O
each	O
agency	O
to	O
maintain	O
the	O
relevant	O
competence	O
over	O
time	O
for	O
those	O
methods	O
that	O
are	O
infrequently	O
used	O
,	O
especially	O
in	O
slimmed	O
down	O
organizations	O
.	O

A	O
study	O
asked	O
hospitalised	O
COVID‑19	S-Disease
patients	O
to	O
cough	O
into	O
a	O
sterile	B-Equipment
container	E-Equipment
,	O
thus	O
producing	O
a	O
saliva	O
sample	O
,	O
and	O
detected	O
the	O
virus	O
in	O
eleven	O
of	O
twelve	O
patients	O
using	O
.	O
This	O
technique	O
has	O
the	O
potential	O
of	O
being	O
quicker	O
than	O
a	O
swab	O
and	O
involving	O
less	O
risk	O
to	O
health	O
care	O
workers	O
(collection	O
at	O
home	O
or	O
in	O
the	O
car)	O
.	O

Students	O
receive	O
NIH3T3	O
cells	O
that	O
were	O
plated	O
a	O
day	O
earlier	O
and	O
perform	O
the	O
infection	O
themselves	O
.	O

On	O
the	O
human	O
side	O
,	O
the	O
agency	O
will	O
work	O
with	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
other	O
stakeholders	O
to	O
improve	O
the	O
collection	O
and	O
reporting	O
of	O
AMR	O
data	O
.	O

They	O
had	O
found	O
a	O
way	O
to	O
cut	O
and	O
paste	O
DNA	O
between	O
different	O
organisms	O
.	O

After	O
quenching	O
the	O
reaction	O
in	O
a	O
weakly	O
acidic	O
aqueous	O
solution	O
,	O
a	O
mixture	O
of	O
1:	O
1	O
anomers	O
was	O
obtained	O
.	O

Mosquitoes	O
are	O
carriers	O
of	O
disease	O
–	O
including	O
harmful	O
and	O
even	O
deadly	O
pathogens	O
like	O
Zika	S-Pathogen
malaria	S-Pathogen
,	O
and	O
dengue	S-Pathogen
–	O
and	O
they	O
seem	O
to	O
play	O
no	O
productive	O
role	O
in	O
the	O
ecosystem	O
.	O

OD	O
and	O
a	O
100 μl	O
sample	O
is	O
taken	O
every	O
20 min	O
for	O
75	O
min	O
.	O

DARPA	S-Organization
program	O
seeks	O
to	O
prevent	O
these	O
cross-species	O
jumps	O
by	O
predicting	O
viral	O
evolution	O
and	O
transmission	O
pathways	O
and	O
proactively	O
intervening	O
to	O
prevent	O
the	O
jump	O
to	O
humans	O
.	O

By	O
reformatting	O
the	O
volume	O
,	O
it	O
becomes	O
much	O
easier	O
to	O
visualise	O
the	O
position	O
of	O
one	O
vertebral	O
body	O
in	O
relation	O
to	O
the	O
others	O
.	O

All	O
manipulations	O
of	O
potentially	O
infectious	O
diagnostic	O
materials	O
,	O
isolates	O
,	O
and	O
naturally	O
or	O
experimentally	O
infected	O
animals	O
pose	O
a	O
high	O
risk	O
of	O
exposure	O
and	O
infection	O
to	O
laboratory	O
personnel	O
,	O
the	O
community	O
,	O
and	O
the	O
environment	O
.	O

A	O
high	O
incidence	B-Phenotype
of	I-Phenotype
thrombosis	E-Phenotype
(31%)	O
and	O
venous	B-Phenotype
thromboembolism	E-Phenotype
(25%)	O
have	O
been	O
found	O
in	O
ICU	O
patients	O
with	O
infections	O
and	O
may	O
be	O
related	O
to	O
poor	O
prognosis	O
.	O

When	O
someone	O
with	O
existing	O
respiratory	O
problems	O
is	O
infected	O
with	O
COVID-19	S-Pathogen
they	O
might	O
be	O
at	O
greater	O
risk	O
for	O
severe	O
symptoms	O
.	O

Frieden	S-Person
,	O
your	O
report	O
details	O
that	O
there	O
was	O
a	O
similar	O
incident	O
involving	O
the	O
bioterror	B-Organization
rapid	I-Organization
response	I-Organization
lab	E-Organization
and	O
in	O
2006	O
.	O

The	O
first	O
agent	O
that	O
was	O
a	O
candidate	O
for	O
development	O
was	O
foot	B-Pathogen
and	I-Pathogen
mouth	I-Pathogen
disease	E-Pathogen
(	O
FMD	S-Pathogen
)	O
.	O

There	O
were	O
multiple	O
other	O
problems	O
found	O
,	O
a	O
lack	O
of	O
standard	O
operating	O
procedures	O
,	O
a	O
lack	O
of	O
lab	O
–	O
adequate	O
laboratory	O
oversight	O
,	O
a	O
lack	O
of	O
an	O
approved	O
study	O
plan	O
,	O
use	O
of	O
unapproved	O
sterilization	O
techniques	O
for	O
anthrax	S-Pathogen
the	O
transfer	O
of	O
material	O
that	O
wasn't	O
confirmed	O
to	O
be	O
inactive	O
.	O

On	O
1	O
January	O
2020	O
,	O
WHO	S-Organization
requested	O
further	O
information	O
from	O
national	O
authorities	O
to	O
assess	O
the	O
risk	O
.	O

Iraq	S-Location
officially	O
acknowledged	O
that	O
it	O
had	O
worked	O
with	O
several	O
species	O
of	O
bacterial	O
pathogen	O
,	O
including	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Clostridium	B-Pathogen
botulinum	E-Pathogen
and	O
Clostridium	B-Pathogen
perfringens	E-Pathogen
(	O
gas	B-Pathogen
gangrene	E-Pathogen
)	O
and	O
several	O
viruses	O
(including	O
enterovirus	B-Pathogen
17	I-Pathogen
[human	I-Pathogen
conjunctivitis	E-Pathogen
]	O
,	O
rotavirus	S-Pathogen
and	O
camelpox	S-Pathogen
)	O
.	O

MRI	S-Technology
is	O
the	O
investigation	O
of	O
choice	O
in	O
the	O
preoperative	O
staging	O
of	O
rectal	B-Disease
and	I-Disease
prostate	I-Disease
cancer	E-Disease
and	O
has	O
a	O
role	O
in	O
the	O
diagnosis	O
,	O
staging	O
,	O
and	O
follow-up	O
of	O
other	O
,	O
as	O
well	O
as	O
for	O
determining	O
areas	O
of	O
tissue	O
for	O
sampling	O
in	O
biobanking	O
.	O

On	O
17	O
April	O
,	O
the	O
UAE	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
reported	O
another	O
fatality	O
and	O
four	O
additional	O
cases	O
,	O
including	O
the	O
Filipino	O
medical	O
worker	O
who	O
travelled	O
to	O
the	O
on	O
16	O
April	O
.	O

These	O
numbers	O
vary	O
by	O
region	O
and	O
over	O
time	O
,	O
influenced	O
by	O
testing	O
volume	O
,	O
healthcare	O
system	O
quality	O
,	O
treatment	O
options	O
,	O
effectiveness	O
and	O
rapidity	O
of	O
government	O
response	O
,	O
Ward	S-Person
Dan	S-Person
(2020)	O
"	O
Actions	O
Speak	O
Louder	O
Than	O
Age:	O
Explaining	O
Wide	O
Variations	O
in	O
COVID-19	S-Disease
Deaths.	O
"	O
doi:	O
10.13140/RG.2.2.33339.03363	O
Technical	O
Report	O
.	O

Researchers	O
supporting	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
must	O
adhere	O
to	O
all	O
applicable	O
guidelines	O
for	O
biosecurity.	O
has	O
structured	O
the	O
program	O
so	O
that	O
potential	O
discovery	O
of	O
new	O
pathogens	O
can	O
only	O
take	O
place	O
under	O
the	O
guidance	O
and	O
supervision	O
of	O
federal	O
agencies	O
tasked	O
with	O
preventing	O
the	O
spread	O
of	O
disease	O
.	O

The	O
Black	B-Disease
Death	E-Disease
also	O
known	O
as	O
the	O
Pestilence	B-Disease
and	I-Disease
the	I-Disease
Great	I-Disease
Mortality	E-Disease
,	O
was	O
the	O
most	O
fatal	O
pandemic	O
recorded	O
in	O
human	O
history	O
,	O
resulting	O
in	O
the	O
deaths	O
of	O
up	O
to	O
people	O
in	O
Eurasia	S-Location
and	O
North	B-Location
Africa	E-Location
,	O
peaking	O
in	O
Europe	S-Location
from	O
1347	O
to	O
1351	O
.	O

"	O
The	O
most	O
important	O
thing	O
from	O
my	O
point	O
of	O
view	O
is	O
that	O
this	O
particular	O
incident	O
is	O
unfortunate	O
,	O
but	O
it	O
compromised	O
absolutely	O
nothing,	O
"	O
Perlman	S-Person
said.	O
"	O
We	O
should	O
have	O
done	O
it	O
by	O
the	O
right	O
process	O
,	O
but	O
no	O
safety	O
was	O
compromised.	O
"	O

And	O
in-flu-enza	S-Disease

There's	O
a	O
reason	O
you	O
haven't	O
heard	O
about	O
Ebola	S-Disease
being	O
used	O
as	O
a	O
biological	O
weapon	O
in	O
the	O
past:	O
it	O
hasn't	O
been	O
.	O

Early	O
reports	O
show	O
that	O
one	O
of	O
CDC	S-Organization
biosafety	B-Platform
level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
was	O
preparing	O
anthrax	S-Pathogen
samples	O
to	O
be	O
sent	O
for	O
research	O
at	O
two	O
CDC	S-Organization
labs	O
with	O
lower	O
biosafety	O
levels	O
,	O
both	O
of	O
them	O
BSL-2	S-Platform
labs	O
.	O

The	O
latter	O
are	O
composed	O
of	O
key	O
genes	O
from	O
the	O
1918	B-Pathogen
virus	E-Pathogen
,	O
updated	O
by	O
subsequently	O
incorporated	O
avian	O
influenza	S-Disease
genes	O
that	O
code	O
for	O
novel	O
surface	O
proteins	O
,	O
making	O
the	O
indeed	O
the	O
"	O
mother"	O
of	O
all	O
pandemics	O
.	O

These	O
include	O
UNESCO	S-Organization
the	O
OECD	S-Organization
,	O
which	O
has	O
set	O
up	O
a	O
website	O
to	O
provide	O
an	O
active	O
resource	O
of	O
global	O
information	O
on	O
oversight	O
mechanisms	O
,	O
particularly	O
codes	O
of	O
conduct	O
for	O
the	O
biosciences	O
research	O
community	O
;	O
and	O
the	O
,	O
which	O
calls	O
on	O
the	O
scientific	O
and	O
medical	O
communities	O
and	O
industry	O
to	O
adopt	O
professional	O
and	O
industrial	O
codes	O
of	O
conduct	O
aimed	O
at	O
preventing	O
the	O
abuse	O
of	O
biological	O
agents	O
.	O

The	O
labeling	O
of	O
GM	S-Technology
crops	O
and	O
their	O
products	O
are	O
mandatory	O
if	O
the	O
genetically	B-Technology
modified	I-Technology
organism	E-Technology
(	O
GMO	S-Technology
)	O
content	O
exceeds	O
the	O
levels	O
of	O
a	O
recommended	O
threshold	O
.	O

Recently	O
,	O
I	O
assisted	O
an	O
ethical	O
round-table	O
about	O
CRISPR/Cas9	S-Technology
uses	O
in	O
human	O
therapies	O
and	O
the	O
expert	O
in	O
in	O
vitro	O
fertilisation	O
highlighted	O
two	O
interesting	O
points	O
of	O
why	O
will	O
ever	O
be	O
relevant	O
in	O
such	O
disorders:	O
1)	O
embryo	O
screening	O
and	O
selection	O
is	O
a	O
common	O
practice	O
before	O
in	O
vitro	O
fertilisation	O
,	O
2)	O
dominant	O
pathogenic	O
mutations	O
of	O
fertile	O
parents	O
tend	O
to	O
be	O
heterozygous	O
,	O
thus	O
healthy	O
embryos	O
can	O
be	O
easily	O
selected	O
,	O
3)	O
cases	O
where	O
healthy	O
embryos	O
cannot	O
be	O
selected	O
are	O
rare	O
and	O
yet	O
,	O
there	O
is	O
a	O
healthy	O
embryo	O
bank	O
that	O
is	O
often	O
used	O
.	O

Several	O
corporations	O
have	O
also	O
donated	O
money	O
or	O
medical	O
equipment	O
to	O
.	O

Aedes	O
Albopictus	O
is	O
a	O
vector	O
of	O
many	O
viral	O
pathogens	O
,	O
Yellow	B-Pathogen
fever	I-Pathogen
virus	E-Pathogen
Dengue	S-Pathogen
,	O
Chikungunya	S-Pathogen
and	O
.	O

This	O
report	O
aims	O
to	O
highlight	O
opportunities	O
for	O
improvement	O
so	O
that	O
HHS	S-Organization
can	O
become	O
a	O
more	O
data-driven	O
organization	O
.	O

Also	O
,	O
personnel	O
working	O
in	O
these	O
diagnostics	O
laboratories	O
did	O
not	O
receive	O
the	O
required	O
training	O
in	O
biosafety	O
.	O

Ebola	S-Pathogen
is	O
not	O
well	O
suited	O
to	O
any	O
of	O
these	O
processes	O
,	O
which	O
are	O
designed	O
to	O
ensure	O
that	O
the	O
biological	O
agent	O
survives	O
the	O
traumatic	O
experience	O
of	O
being	O
fired	O
from	O
a	O
rocket	O
,	O
dropped	O
from	O
an	O
aircraft	O
and	O
submitted	O
to	O
harsh	O
climatic	O
conditions	O
.	O

The	O
natural	O
reservoir	O
of	O
the	O
virus	O
is	O
thought	O
to	O
be	O
the	O
African	O
fruit	O
bat	O
,	O
which	O
is	O
used	O
in	O
many	O
parts	O
of	O
Africa	S-Location
as	O
bushmeat	O
.	O

Overall	O
reactions	O
occur	O
in	O
1	O
to	O
3%	O
with	O
nonionic	O
contrast	O
and	O
4	O
to	O
12%	O
of	O
people	O
with	O
ionic	O
contrast.	O
may	O
appear	O
within	O
a	O
week	O
to	O
3%	O
of	O
people	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

Early	O
estimates	O
of	O
harm	O
from	O
CT	S-Equipment
are	O
partly	O
based	O
on	O
similar	O
radiation	O
exposures	O
experienced	O
by	O
those	O
present	O
during	O
the	O
atomic	O
bomb	O
explosions	O
in	O
Japan	S-Location
after	O
the	O
Second	O
World	O
War	O
and	O
those	O
of	O
nuclear	O
industry	O
workers	O
.	O

It	O
is	O
hard	O
to	O
bend	O
these	O
criteria	O
,	O
no	O
matter	O
what	O
the	O
motive"	O
.	O

NANCY	B-Person
SNYDERMAN	E-Person
Thank	O
you	O
.	O

Researchers	O
presented	O
evidence	O
indicating	O
that	O
infected	O
people	O
that	O
lived	O
in	O
low	O
socioeconomic	O
areas	O
were	O
more	O
likely	O
to	O
transmit	O
the	O
virus	O
to	O
other	O
socioeconomic	O
status	O
(SES)	O
communities	O
,	O
in	O
contrast	O
to	O
individuals	O
in	O
higher	O
SES	O
areas	O
who	O
were	O
infected	O
as	O
well	O
.	O

Rapid	O
testing	O
,	O
possible	O
from	O
molecular	O
diagnostics	O
innovations	O
,	O
is	O
defined	O
as	O
"	O
being	O
feasible	O
within	O
an	O
8-h	O
working	O
shift"	O
.	O

This	O
map	O
shows	O
previous	O
EVD	S-Disease
outbreaks	O
in	O
the	O
area	O
of	O
central	O
Africa	S-Location
,	O
which	O
includes	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
.	O
This	O
outbreak	O
is	O
the	O
biggest	O
of	O
the	O
ten	O
recorded	O
outbreaks	O
that	O
have	O
occurred	O
in	O
the	O
.	O

"	O
Those	O
of	O
us	O
who	O
were	O
[in	O
Washington	B-Location
DC	E-Location
during	O
the	O
fall	O
of	O
2001	O
vividly	O
recall	O
the	O
chaos	O
that	O
a	O
few	O
small	O
envelopes	O
of	O
anthrax	S-Disease
caused	O
on	O
Capitol	B-Location
Hill	E-Location
,	O
"	O
Colorado	S-Location
Rep.	O
said	O
Friday	O
at	O
a	O
congressional	O
hearing	O
on	O
the	O
country's	O
preparedness	O
for	O
pandemics	O
and	O
biological	O
attacks.	O
"	O
Offices	O
were	O
closed	O
,	O
buildings	O
were	O
fumigated	O
,	O
some	O
congressional	O
business	O
was	O
suspended	O
,	O
and	O
thousands	O
of	O
staffers	O
and	O
other	O
personnel	O
lined	O
up	O
for	O
days	O
to	O
get	O
tested	O
for	O
exposure.	O
"	O
Far	O
worse	O
,	O
some	O
of	O
the	O
workers	O
at	O
our	O
postal	O
service	O
were	O
affected	O
and	O
died.	O
"	O

Over	O
time	O
,	O
as	O
the	O
virus	O
multiplies	O
and	O
mutates	O
,	O
variants	O
can	O
gain	O
the	O
ability	O
to	O
jump	O
between	O
species	O
.	O

The	O
mAbs	O
were	O
identified	O
from	O
a	O
survivor	O
of	O
the	O
2013-2016	B-Incident
Ebola	I-Incident
Virus	I-Incident
Disease	I-Incident
outbreak	E-Incident
via	O
a	O
collaboration	O
between	O
a	O
team	O
at	O
Adimab	B-Organization
LLC	E-Organization
(	O
Lebanon	S-Location
,	O
NH	S-Location
)	O
led	O
by	O
Dr	O
.	O

The	O
initial	O
problem	O
the	O
WHO	S-Organization
team	O
faced	O
was	O
inadequate	O
reporting	O
of	O
smallpox	S-Disease
	S-Disease
cases	O
.	O

As	O
shown	O
in	O
Fig.	O
1	O
,	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
mainly	O
consists	O
of	O
a	O
BSL-3	S-Platform
laboratory	O
with	O
negative	O
pressure	O
,	O
a	O
BSL-2	S-Platform
laboratory	O
,	O
a	O
PCR	S-Equipment
preparation	O
room	O
,	O
a	O
storage	O
room	O
and	O
two	O
sets	O
of	O
dressing	O
rooms	O
(including	O
two	O
1st	O
changing	O
rooms	O
,	O
two	O
shower	O
rooms	O
and	O
one	O
2nd	O
changing	O
room)	O
.	O

There	O
are	O
no	O
exact	O
figures	O
for	O
the	O
death	O
toll	O
;	O
the	O
rate	O
varied	O
widely	O
by	O
locality	O
.	O

For	O
biodefense	O
assessment	O
,	O
the	O
main	O
consideration	O
is	O
the	O
potential	O
for	O
biological	O
agent	O
weaponization	O
,	O
terrorism	O
and	O
the	O
harm	O
associated	O
with	O
deliberate	O
release	O
[1]	O
.	O

MR	B-Technology
imaging	E-Technology
provides	O
a	O
three-dimensional	O
view	O
of	O
the	O
target	O
tissue	O
,	O
allowing	O
for	O
the	O
precise	O
focusing	O
of	O
ultrasound	O
energy	O
.	O

Shortly	O
after	O
,	O
University	B-Organization
of	I-Organization
California	E-Organization
filed	O
an	O
appeal	O
of	O
this	O
ruling	O
.	O

A	O
2012	O
review	O
did	O
not	O
find	O
an	O
association	O
between	O
medical	O
radiation	O
and	O
cancer	O
risk	O
in	O
children	O
noting	O
however	O
the	O
existence	O
of	O
limitations	O
in	O
the	O
evidences	O
over	O
which	O
the	O
review	O
is	O
based	O
.	O

Looking	O
ahead	O
,	O
the	O
epidemic	O
could	O
decimate	O
around	O
200	O
million	O
pigs	O
in	O
China	S-Location
according	O
to	O
a	O
grim	O
report	O
by	O
.	O

Istvan	S-Person
also	O
noted	O
that	O
"	O
for	O
some	O
people	O
without	O
functioning	O
arms	O
,	O
chips	O
in	O
their	O
feet	O
are	O
the	O
simplest	O
way	O
to	O
open	O
doors	O
or	O
operate	O
some	O
household	O
items	O
modified	O
with	O
chip	O
readers.	O
"	O
Other	O
grinders	O
are	O
deeply	O
curious	O
about	O
blurring	O
the	O
line	O
between	O
human	O
and	O
machine	O
,	O
and	O
they	O
get	O
a	O
thrill	O
out	O
of	O
seeing	O
all	O
the	O
ways	O
we	O
can	O
augment	O
our	O
flesh-and-blood	O
bodies	O
using	O
tech	O
.	O

We're	O
doing	O
other	O
things	O
to	O
look	O
at	O
critical	O
control	O
points	O
.	O

"	O
I'm	O
happy	O
to	O
tell	O
you	O
…	O
that	O
we	O
intend	O
to	O
replace	O
BioWatch	S-Document
-	O
actually	O
we've	O
already	O
started	O
that	O
process,	O
"	O
said	O
McDonnell	S-Person
,	O
previously	O
the	O
director	O
of	O
the	O
federal	O
.	O

Critics	O
have	O
noted	O
that	O
for	O
those	O
who've	O
struggled	O
with	O
eating	O
disorders	O
,	O
it	O
could	O
be	O
dangerous	O
.	O

An	O
important	O
issue	O
within	O
radiology	O
today	O
is	O
how	O
to	O
reduce	O
the	O
radiation	O
dose	O
during	O
CT	S-Technology
examinations	O
without	O
compromising	O
the	O
image	O
quality	O
.	O

"	O
We	O
hope	O
we	O
can	O
upgrade	O
to	O
better	O
technology	O
not	O
only	O
to	O
train	O
our	O
students	O
but	O
all	O
people	O
that	O
come	O
here	O
for	O
medical	O
education	O
simulation	O
training,	O
"	O
Reilly	S-Person
said	O
.	O

Access	O
to	O
the	O
samples	O
would	O
be	O
limited	O
,	O
special	O
containers	O
are	O
used	O
and	O
the	O
storage	O
mechanism	O
is	O
different	O
from	O
other	O
laboratories	O
,	O
Kam	S-Person
said	O
.	O

Recently	O
,	O
MRI	S-Technology
has	O
been	O
demonstrated	O
also	O
at	O
ultra-low	O
fields	O
,	O
i.e.	O
,	O
in	O
the	O
microtesla-to-millitesla	O
range	O
,	O
where	O
sufficient	O
signal	O
quality	O
is	O
made	O
possible	O
by	O
prepolarization	O
(on	O
the	O
order	O
of	O
10–100	O
mT)	O
and	O
by	O
measuring	O
the	O
Larmor	O
precession	O
fields	O
at	O
about	O
100	O
microtesla	O
with	O
highly	O
sensitive	O
superconducting	B-Equipment
quantum	I-Equipment
interference	I-Equipment
devices	E-Equipment
()	O
.	O

Establish	O
a	O
'Special	O
Medical	O
Use	O
(SMU)'	O
pathway	O
for	O
FDA	S-Organization
to	O
approve	O
new	O
antimicrobial	O
agents	O
for	O
use	O
in	O
limited	O
patient	O
populations	O
,	O
shorten	O
the	O
approval	O
timeline	O
for	O
new	O
drug	O
so	O
patients	O
with	O
severe	O
infections	O
could	O
benefit	O
as	O
quickly	O
as	O
possible	O
.	O

Their	O
natural	O
habitats	O
,	O
though	O
,	O
are	O
the	O
Philippines	S-Location
,	O
not	O
Georgia	S-Location
or	O
.	O

From	O
the	O
onset	O
of	O
the	O
U.S.	O
biological	O
weapons	O
program	O
in	O
1943	O
through	O
the	O
end	O
of	O
World	O
War	O
II	O
the	O
United	O
States	O
spent	O
$400	O
million	O
on	O
biological	O
weapons	O
,	O
mostly	O
on	O
research	O
and	O
development	O
.	O

In	O
particular	O
,	O
Gruinard	B-Location
Island	E-Location
in	O
Scotland	S-Location
,	O
during	O
a	O
series	O
of	O
extensive	O
tests	O
,	O
was	O
contaminated	O
with	O
for	O
the	O
next	O
48	O
years	O
.	O

When	O
available	O
,	O
respirators	S-Equipment
(instead	O
of	O
face	O
masks)	O
are	O
preferred	O
.	O

He	O
himself	O
became	O
infected	O
and	O
died	O
on	O
29	O
March	O
.	O

Unlike	O
with	O
many	O
other	O
chain	O
terminators	O
,	O
this	O
is	O
not	O
mediated	O
by	O
preventing	O
addition	O
of	O
the	O
immediately	O
subsequent	O
nucleotide	O
,	O
but	O
is	O
instead	O
delayed	O
,	O
occurring	O
after	O
five	O
additional	O
bases	O
have	O
been	O
added	O
to	O
the	O
growing	O
RNA	O
chain	O
.	O

The	O
CDC/	O
NIH	S-Organization
	S-Organization
"	O
"	O

The	O
plague	S-Disease
did	O
not	O
appear	O
in	O
Douai	S-Location
in	O
Flanders	S-Location
until	O
the	O
turn	O
of	O
the	O
15th	O
century	O
,	O
and	O
the	O
impact	O
was	O
less	O
severe	O
on	O
the	O
populations	O
of	O
Hainaut	S-Location
,	O
Finland	S-Location
,	O
northern	O
Germany	S-Location
,	O
and	O
areas	O
of	O
Poland	S-Location
.	O
Monks	O
,	O
nuns	O
,	O
and	O
priests	O
were	O
especially	O
hard-hit	O
since	O
they	O
cared	O
for	O
victims	O
of	O
the	O
.	O

Electroporation	B-Technology
of	I-Technology
DNA,	I-Technology
RNA,	I-Technology
or	I-Technology
ribonucleocomplexes	E-Technology
is	O
a	O
common	O
technique	O
,	O
though	O
it	O
can	O
result	O
in	O
harmful	O
effects	O
on	O
the	O
target	O
cells	O
.	O

Other	O
forms	O
of	O
passive	O
antibody	O
therapy	O
,	O
for	O
example	O
,	O
using	O
manufactured	B-Technology
monoclonal	I-Technology
antibodies	E-Technology
are	O
in	O
development	O
.	O

Search	O
,	O
Compare	O
&amp	O
;	O
Book	O
a	O
Flight	O
today	O
w	O
ith	B-Platform
Airfarewatc	E-Platform
and	O
Save	O
Big!	O

On	O
24	O
August	O
,	O
the	O
DRC	S-Location
indicated	O
it	O
had	O
vaccinated	O
2,957	O
individuals	O
,	O
including	O
1,422	O
in	O
Mabalako	S-Location
against	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
By	O
late	O
October	O
,	O
more	O
than	O
20,000	O
individuals	O
had	O
been	O
vaccinated	O
.	O

While	O
the	O
majority	O
of	O
cases	O
result	O
in	O
mild	O
symptoms	O
,	O
some	O
progress	O
to	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
(	O
ARDS	S-Disease
)	O
likely	O
precipitated	O
by	O
a	O
cytokine	B-Phenotype
storm	E-Phenotype
,	O
multi-organ	B-Phenotype
failure	E-Phenotype
,	O
septic	B-Phenotype
shock	E-Phenotype
,	O
and	O
.	O

The	O
protective	B-Equipment
clothing	E-Equipment
sets	O
that	O
MSF	S-Organization
uses	O
cost	O
about	O
$75	O
apiece	O
.	O

Moreover	O
,	O
biosafety	B-Equipment
cabinet	E-Equipment
was	O
found	O
in	O
11	O
(5.	O
8%)	O
laboratories	O
,	O
autoclave	S-Equipment
in	O
28	O
(14.	O
7%)	O
and	O
incinerator	S-Equipment
in	O
only	O
two	O
(1.	O
1%)	O
laboratories	O
.	O

Although	O
PREEMPT	S-Scientific_research_project
is	O
a	O
fundamental	O
research	O
program	O
,	O
is	O
aware	O
of	O
biosafety	O
and	O
biosecurity	O
sensitivities	O
that	O
could	O
arise	O
.	O

The	O
standard	O
method	O
of	O
testing	O
is	O
real-time	B-Technology
reverse	I-Technology
transcription	I-Technology
polymerase	I-Technology
chain	I-Technology
reaction	E-Technology
(	O
rRT-PCR	S-Technology
)	O
.	O

On	O
April	O
2	O
,	O
1979	O
,	O
there	O
was	O
an	O
unusual	O
anthrax	S-Pathogen
outbreak	O
which	O
affected	O
94	O
people	O
and	O
killed	O
at	O
least	O
64	O
of	O
them	O
in	O
the	O
Soviet	O
city	O
of	O
Sverdlovsk	S-Location
(now	O
called	O
Ekaterinburg	S-Location
)	O
,	O
roughly	O
850	O
miles	O
east	O
of	O
.	O
The	O
first	O
victim	O
died	O
after	O
four	O
days	O
;	O
the	O
last	O
one	O
died	O
six	O
weeks	O
later	O
.	O

Rabies	S-Disease
is	O
transmitted	O
between	O
animals	O
and	O
humans	O
(a	O
zoonotic	O
disease)	O
,	O
usually	O
via	O
a	O
bite	O
wound	O
inflicted	O
by	O
an	O
infected	O
animal	O
,	O
although	O
licks	O
on	O
open	O
sores	O
and	O
scratches	O
may	O
also	O
pose	O
a	O
risk	O
to	O
developing	O
.	O

Enhancing	O
the	O
technological	O
capabilities	O
of	O
first	O
responders	O
is	O
accomplished	O
through	O
numerous	O
strategies	O
.	O

The	O
American	O
people	O
depend	O
on	O
CDC	S-Organization
to	O
work	O
24/7	O
to	O
protect	O
their	O
health	O
.	O

The	O
study	O
was	O
based	O
on	O
an	O
effectiveness	O
in	O
preventing	O
cases	O
,	O
hospitalizations	O
,	O
and	O
deaths	O
of	O
62%	O
for	O
all	O
subgroups	O
except	O
people	O
over	O
65	O
,	O
for	O
whom	O
the	O
effectiveness	O
was	O
estimated	O
at	O
43%	O
.	O

In	O
China	S-Location
thousands	O
of	O
people	O
have	O
already	O
died	O
;	O
large	O
outbreaks	O
have	O
begun	O
in	O
South	B-Location
Korea	E-Location
,	O
Iran	S-Location
and	O
;	O
and	O
the	O
rest	O
of	O
the	O
world	O
is	O
bracing	O
for	O
impact	O
.	O

More	O
recently	O
,	O
Alexandra	B-Person
Daisy	I-Person
Ginsberg	E-Person
has	O
used	O
old	O
floral	O
DNA	O
to	O
recreate	O
the	O
smell	O
of	O
flowers	O
driven	O
to	O
extinction	O
by	O
humans	O
,	O
enabling	O
us	O
to	O
catch	O
a	O
whiff	O
of	O
them	O
once	O
more	O
.	O

Therefore	O
,	O
the	O
development	O
of	O
more	O
effective	O
and	O
safer	O
prophylactic	O
and	O
therapeutic	O
measures	O
is	O
urgently	O
required	O
.	O

For	O
instance	O
,	O
we	O
have	O
only	O
three	O
laboratories	O
in	O
Nigeria	S-Location
at	O
the	O
moment	O
that	O
can	O
make	O
that	O
diagnosis	O
.	O

That	O
requires	O
putting	O
it	O
into	O
a	O
tissue	O
culture	O
and	O
seeing	O
if	O
it	O
grows	O
,	O
then	O
repeating	O
that	O
test	S-Equipment
to	O
see	O
if	O
the	O
number	O
of	O
organisms	O
is	O
increasing	O
.	O

However	O
,	O
ebolaviruses	S-Pathogen
have	O
not	O
been	O
isolated	O
in	O
bats	O
.	O

Despite	O
this	O
,	O
Dilyana	S-Person
continues	O
her	O
investigations	O
.	O

A	O
special	O
project	O
code-named	O
Maruta	S-Scientific_research_project
used	O
human	O
beings	O
for	O
experiments	O
.	O

Lentiviral	B-Pathogen
vectors	E-Pathogen
are	O
promising	O
tools	O
for	O
the	O
genetic	O
modification	O
of	O
cells	O
in	O
biomedical	O
research	O
and	O
gene	O
therapy	O
.	O

While	O
choosing	O
the	O
appropriate	O
virus	O
with	O
which	O
to	O
work	O
,	O
it	O
is	O
important	O
to	O
bear	O
in	O
mind	O
that	O
undergraduates	O
are	O
not	O
experienced	O
in	O
laboratory	O
work	O
.	O

The	O
IFRC	S-Organization
has	O
called	O
funerals	O
"	O
super-spreading	O
events	O
"	O
as	O
burial	O
traditions	O
include	O
kissing	O
and	O
generally	O
touching	O
bodies	O
.	O

Precautions	O
must	O
be	O
taken	O
to	O
minimise	O
the	O
risk	O
of	O
virus	O
transmission	O
,	O
especially	O
in	O
healthcare	O
settings	O
when	O
performing	O
procedures	O
that	O
can	O
generate	O
aerosols	O
,	O
such	O
as	O
intubation	O
or	O
hand	O
ventilation	O
.	O

Moreover	O
,	O
secondary	B-Disease
infections	E-Disease
in	O
non-laboratory	O
workers	O
can	O
occur	O
,	O
depending	O
on	O
the	O
communicability	O
of	O
the	O
infectious	O
agent	O
.	O

Incidents	O
of	O
Food	O
Bioterrorism	O
.	O

Parker	S-Person
was	O
born	O
in	O
March	O
1938	O
,	O
and	O
was	O
the	O
only	O
daughter	O
of	O
Frederick	S-Person
and	O
Hilda	B-Person
Witcomb	E-Person
(née	O
Linscott	S-Person
)	O
.	O

On	O
24	O
December	O
,	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
sent	O
a	O
bronchoalveolar	O
lavage	O
fluid	O
(BAL)	O
sample	O
from	O
an	O
unresolved	O
clinical	O
case	O
to	O
sequencing	O
company	O
Vision	B-Organization
Medicals	E-Organization
.	O
On	O
27	O
and	O
28	O
December	O
,	O
Vision	B-Organization
Medicals	E-Organization
informed	O
the	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
and	O
the	O
Chinese	B-Organization
CDC	E-Organization
of	O
the	O
results	O
of	O
the	O
test	O
,	O
showing	O
a	O
new	O
coronavirus	O
.	O

With	O
regard	O
to	O
Ebola	S-Disease
and	O
economic	O
activity	O
in	O
the	O
country	O
of	O
Liberia	S-Location
,	O
a	O
study	O
found	O
that	O
8%	O
of	O
automotive	O
firms	O
,	O
8%	O
of	O
construction	O
firms	O
,	O
15%	O
of	O
food	O
businesses	O
and	O
30%	O
of	O
restaurants	O
had	O
closed	O
due	O
to	O
the	O
Ebola	B-Incident
outbreak	E-Incident
.	O
Montserrado	B-Location
county	E-Location
experienced	O
up	O
to	O
20%	O
firm	O
closure	O
.	O

Without	O
international	O
cooperation	O
,	O
every	O
country's	O
efforts	O
to	O
fight	O
AMR	O
have	O
limited	O
effectiveness	O
.	O

The	O
City	B-Location
of	I-Location
Atlanta	E-Location
annexed	O
the	O
CDC	S-Organization
headquarters	O
effective	O
January	O
1	O
,	O
2018	O
,	O
a	O
part	O
of	O
the	O
city's	O
largest	O
annexation	O
within	O
a	O
period	O
of	O
65	O
years	O
;	O
the	O
Atlanta	B-Organization
City	I-Organization
Council	E-Organization
voted	O
to	O
do	O
so	O
the	O
prior	O
December	O
.	O

Contacts	O
have	O
now	O
been	O
established	O
with	O
national	O
agencies	O
of	O
the	O
other	O
Nordic	O
countries	O
,	O
with	O
an	O
aim	O
to	O
expanding	O
the	O
collaboration	O
,	O
broadening	O
the	O
network	O
,	O
finding	O
synergies	O
in	O
new	O
areas	O
,	O
strengthening	O
the	O
ability	O
to	O
share	O
resources	O
,	O
and	O
consolidating	O
long-term	O
financing	O
in	O
the	O
context	O
of	O
harmonized	O
European	S-Location
biopreparedness	O
.	O

The	O
WHO	S-Organization
recommends	O
the	O
use	O
of	O
2	O
pairs	O
of	O
gloves	O
,	O
with	O
the	O
outer	O
pair	O
worn	O
over	O
the	O
gown	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

In	O
2016	O
a	O
further	O
21	O
590	O
ticks	O
were	O
collected	O
and	O
studied	O
at	O
The	O
.	O

In	O
the	O
US	S-Location
an	O
anthrax	O
vaccine	O
,	O
Anthrax	B-Vaccine
Vaccine	I-Vaccine
Adsorbed	E-Vaccine
(	O
AVA	S-Vaccine
)	O
exists	O
and	O
requires	O
five	O
injections	O
for	O
stable	O
use	O
.	O

The	O
report	O
also	O
found	O
that	O
there	O
was	O
a	O
lack	O
of	O
standard	O
operating	O
procedures	O
to	O
document	O
when	O
biological	O
agents	O
are	O
properly	O
inactivated	O
in	O
laboratories	O
as	O
well	O
as	O
a	O
lack	O
of	O
adequate	O
laboratory	O
oversight	O
of	O
scientists	O
performing	O
work	O
in	O
these	O
labs	O
.	O

No	O
.	O

NAMRU-3	S-Organization
is	O
the	O
only	O
laboratory	O
in	O
Africa	S-Location
with	O
an	O
animal	O
facility	O
accredited	O
by	O
the	O
American	B-Organization
Association	I-Organization
of	I-Organization
Accreditation	I-Organization
of	I-Organization
Laboratory	I-Organization
Animal	I-Organization
Care	E-Organization
.	O
It	O
is	O
the	O
largest	O
DOD	S-Organization
overseas	O
laboratory	O
,	O
with	O
bio-safety	O
level	O
3	O
bio-containment	O
space	O
and	O
field	O
and	O
hospital	O
study	O
sites	O
located	O
throughout	O
Egypt	S-Location
.	O
A	O
malaria	S-Disease
field	O
site	O
is	O
located	O
in	O
the	O
upper	O
east	O
region	O
of	O
northern	O
.	O

Now	O
,	O
researchers	O
and	O
health	O
officials	O
know	O
that	O
this	O
superbug	O
,	O
which	O
was	O
found	O
to	O
be	O
100%	O
resistant	O
to	O
,	O
is	O
on	O
the	O
rise	O
,	O
and	O
may	O
be	O
able	O
to	O
do	O
something	O
to	O
stop	O
its	O
spread	O
.	O

In	O
2001	O
,	O
anti-communist	O
histor	O
ian	B-Person
Herbert	I-Person
Romers	E-Person
tein	O
suppor	O
ted	B-Person
Weathe	E-Person
rsby	O
and	B-Person
Leiten	E-Person
berg	O
,	O
criticiz	O
ing	B-Person
Endi	E-Person
cott's	O
research	O
for	O
using	O
evidence	O
provided	O
by	O
ment	O
.	O

By	O
contrast	O
,	O
the	O
DARPA	S-Organization
project	O
uses	O
"	O
horizontal	O
environmental	O
genetic	O
alteration	O
agents,	O
"	O
in	O
which	O
common	O
pests	O
are	O
the	O
agents	O
of	O
genetic	B-Technology
modification	E-Technology
.	O
The	O
insects	O
deliver	O
engineered	O
viruses	O
that	O
can	O
the	O
chromosomes	O
of	O
mature	O
plants	O
for	O
the	O
purpose	O
of	O
making	O
them	O
more	O
resistant	O
to	O
disease	O
and	O
drought	O
.	O

Initiatives	O
should	O
also	O
be	O
granted	O
guaranteed	O
purchase	O
agreements	O
,	O
something	O
the	O
federal	O
government	O
already	O
initiates	O
for	O
smallpox	S-Disease
therapeutics	O
,	O
said	O
.	O

Because	O
of	O
the	O
relatively	O
short	O
half-lives	O
of	O
the	O
drugs	O
,	O
successful	O
prevention	O
of	O
malaria	O
is	O
highly	O
dependent	O
on	O
compliance	O
with	O
a	O
daily	O
oral	O
dosing	O
regimen	O
.	O

Some	O
18	O
million	O
kilos	O
of	O
ground	O
turkey	O
product	O
have	O
been	O
recalled	O
to	O
date	O
.	O

The	O
milder	O
forms	O
of	O
illness	O
in	O
all	O
3	O
waves	O
were	O
identical	O
and	O
typical	O
of	O
influenza	S-Disease
seen	O
in	O
the	O
1889	O
pandemic	O
and	O
in	O
prior	O
interpandemic	O
years	O
.	O

In	O
late	O
June	O
2015	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
"	O
weekly	O
case	O
incidence	O
has	O
stalled	O
at	O
between	O
20	O
and	O
27	O
cases	O
since	O
the	O
end	O
of	O
May	O
,	O
whilst	O
cases	O
continue	O
to	O
arise	O
from	O
unknown	O
sources	O
of	O
infection	O
,	O
and	O
to	O
be	O
detected	O
only	O
after	O
post-mortem	O
testing	O
of	O
community	O
deaths"	O
.	O

PacBio	S-Organization
sequencing	O
of	O
isolate	O
24213-18	O
was	O
supported	O
by	O
the	O
as	O
part	O
of	O
routine	O
work	O
.	O

It	O
was	O
pushed	O
forward	O
by	O
a	O
small	O
group	O
,	O
mostly	O
healthy	O
,	O
wealthy-ish	O
men	O
,	O
certain	O
that	O
they	O
could	O
find	O
shortcuts	O
to	O
anything	O
,	O
including	O
themselves	O
.	O

The	O
FDA	S-Organization
	S-Organization
stated	O
on	O
1	O
May	O
2020	O
,	O
that	O
it	O
is	O
"	O
reasonable	O
to	O
believe	O
"	O
that	O
known	O
and	O
potential	O
benefits	O
of	O
remdesivir	S-Drug
outweigh	O
its	O
known	O
and	O
potential	O
risks	O
,	O
in	O
some	O
specific	O
populations	O
hospitalized	O
with	O
severe	O
COVID‑19	S-Disease
.	O
As	O
of	O
May	O
2020	O
,	O
there	O
was	O
no	O
good	O
evidence	O
that	O
remdesivir	S-Drug
reduced	O
mortality	O
in	O
people	O
with	O
.	O

The	O
protozoan	O
parasites	O
that	O
cause	O
the	O
diseases	O
malaria	S-Disease
trypanosomiasis	S-Disease
,	O
toxoplasmosis	S-Disease
,	O
cryptosporidiosis	S-Disease
and	O
are	O
important	O
human	O
pathogens	O
.	O

The	O
US	O
has	O
an	O
elaborate	O
,	O
interdepartmental	O
regulatory	O
system	O
to	O
evaluate	O
new	O
genetically	O
modified	O
foods	O
and	O
crops	O
.	O

Only	O
modest	O
performance	O
decreases	O
in	O
early-warning	O
time	O
and	O
probability	O
of	O
detection	O
were	O
seen	O
.	O

The	O
Pentagon	S-Organization
has	O
been	O
granted	O
access	O
to	O
certain	O
state	O
secrets	O
of	O
in	O
connection	O
with	O
the	O
projects	O
under	O
their	O
agreement	O
.	O

Biotechnology	O
can	O
range	O
from	O
using	O
bacterial	O
strains	O
for	O
brewing	O
beer	O
to	O
editing	O
genes	O
using	O
CRISPR	S-Technology

There	O
are	O
public	O
calls	O
for	O
global	O
collective	O
action	O
to	O
address	O
the	O
threat	O
that	O
include	O
proposals	O
for	O
international	O
treaties	O
on	O
antimicrobial	O
resistance	O
.	O

Kanatjan	B-Person
Alibekov	E-Person
,	O
former	O
first	O
deputy	O
chief	O
for	O
Biopreparat	S-Scientific_research_project
(the	O
civilian	O
part	O
of	O
the	O
Soviet	O
biological	O
weapons	O
program)	O
,	O
the	O
anthrax	S-Pathogen
airborne	O
leak	O
had	O
been	O
caused	O
by	O
workers	O
at	O
the	O
military	O
facility	O
who	O
forgot	O
to	O
replace	O
a	O
filter	S-Equipment
in	O
an	O
exhaust	O
system	O
.	O

•	O
Carey	B-Person
Schwartz	E-Person
a	O
program	O
manager	O
in	O
the	O
Information	B-Organization
Innovation	I-Organization
Office	E-Organization
,	O
will	O
focus	O
on	O
the	O
information	O
analytics	O
element	O
of	O
.	O

It	O
caused	O
significant	O
mortality	O
,	O
with	O
the	O
case	O
fatality	O
rate	O
reported	O
which	O
was	O
initially	O
considerable	O
,	O
while	O
the	O
rate	O
among	O
hospitalised	O
patients	O
was	O
57–59%	O
,	O
the	O
final	O
numbers	O
28,616	O
people	O
,	O
including	O
11,310	O
deaths	O
,	O
for	O
a	O
case-fatality	O
rate	O
of	O
40%	O
.	O

The	O
coordinated	O
monitoring	O
of	O
the	O
national	O
use	O
of	O
antimicrobials	O
and	O
antimicrobial	O
resistance	O
is	O
necessary	O
to	O
understand	O
the	O
extent	O
,	O
distribution	O
and	O
impact	O
of	O
resistant	O
organisms	O
and	O
antibacterial	O
use	O
,	O
and	O
identification	O
of	O
drug	O
resistance	O
and	O
emerging	O
trends	O
,	O
and	O
determine	O
the	O
relationship	O
between	O
use	O
and	O
drug	O
resistance	O
.	O

The	O
increasing	O
international	O
movement	O
of	O
people	O
,	O
animals	O
,	O
food	O
and	O
other	O
products	O
can	O
raise	O
the	O
potential	O
for	O
antimicrobial	O
resistance	O
to	O
spread	O
rapidly	O
around	O
the	O
world	O
.	O

This	O
phenomenon	O
can	O
be	O
used	O
to	O
select	O
against	O
resistant	O
bacteria	O
using	O
an	O
approach	O
termed	O
collateral	O
sensitivity	O
cycling	O
,	O
which	O
has	O
recently	O
been	O
found	O
to	O
be	O
relevant	O
in	O
developing	O
treatment	O
strategies	O
for	O
chronic	O
infections	O
caused	O
by	O
Pseudomonas	B-Pathogen
aeruginosa	E-Pathogen

NANCY	B-Person
SNYDERMAN	E-Person
And	O
on	O
a	O
secondary	O
note	O
very	O
quickly	O
,	O
the	O
whole	O
idea	O
of	O
keeping	O
smallpox	S-Pathogen
,	O
keeping	O
anthrax	S-Pathogen
cultures	O
,	O
would	O
you	O
talk	O
for	O
a	O
second	O
about	O
bioterrorism	O
and	O
why	O
certain	O
materials	O
are	O
kept	O
at	O
the	O
?	O

Colvin	S-Person
,	O
Marie	S-Person
and	O
Uzi	B-Person
Mahnaimi	E-Person
(1998)	O
,	O
"	O
Saddam	S-Person
Tested	O
on	O
Human	O
Guinea	O
Pigs"	O
,	O
London	O
Sunday	O
Times	O
(18	O
Jan	O
issue)	O
.	O

Mohammad	B-Person
Mehdi	I-Person
Gooya	E-Person
,	O
Chief	O
of	O
the	O
Center	B-Organization
for	I-Organization
Management	I-Organization
of	I-Organization
Contagious	I-Organization
Diseases	I-Organization
of	I-Organization
Iran	E-Organization
,	O
the	O
patient	O
had	O
been	O
diagnosed	O
with	O
and	O
her	O
immune	O
system	O
,	O
therefore	O
,	O
wasn't	O
strong	O
enough	O
to	O
fend	O
off	O
the	O
disease	O
.	O

The	O
anthrax	S-Pathogen
was	O
in	O
a	O
powder	O
form	O
and	O
it	O
was	O
delivered	O
by	O
the	O
mail	O
.	O

DNA	O
is	O
typically	O
composed	O
of	O
two	O
matching	O
strands	O
that	O
stick	O
together	O
like	O
Velcro	O
.	O

IARPA	S-Organization
will	O
also	O
carry	O
out	O
the	O
Ithildin	O
program	O
,	O
which	O
seeks	O
to	O
develop	O
a	O
mechanism	O
to	O
detect	O
the	O
presence	O
of	O
harmful	O
chemicals	O
at	O
minuscule	O
levels	O
.	O

Their	O
goal	O
was	O
to	O
win	O
two	O
of	O
three	O
seats	O
on	O
the	O
Wasco	B-Organization
County	I-Organization
Circuit	I-Organization
Court	E-Organization
,	O
as	O
well	O
as	O
the	O
sheriff's	O
office	O
.	O

The	O
pneumonia	S-Disease
caused	O
by	O
flu	O
can	O
be	O
either	O
direct	O
viral	B-Disease
pneumonia	E-Disease
or	O
a	O
secondary	O
bacterial	B-Disease
pneumonia	E-Disease
.	O
A	O
November	O
2009	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
article	O
recommended	O
that	O
flu	O
patients	O
whose	O
chest	O
X-ray	O
indicates	O
pneumonia	S-Disease
receive	O
both	O
antivirals	O
and	O
antibiotics	O
.	O

However	O
,	O
these	O
CDC	S-Organization
experiments	O
using	O
showed	O
that	O
a	O
very	O
small	O
number	O
of	O
spores	O
remained	O
viable	O
,	O
even	O
after	O
24	O
hours	O
of	O
treatment	O
with	O
the	O
extraction	O
chemicals	O
.	O

Comprised	O
of	O
experts	O
in	O
public	O
health	O
and	O
biosecurity	O
,	O
the	O
Observatory	S-Scientific_research_project
team	O
captures	O
and	O
publishes	O
stories	O
and	O
social	O
media	O
posts	O
much	O
like	O
a	O
journalist	O
would	O
from	O
the	O
experts	O
on	O
the	O
ground	O
tackling	O
evolving	O
public	O
health	O
challenges	O
in	O
the	O
United	B-Location
States	E-Location
and	O
abroad	O
.	O

MBP134	S-Drug
is	O
a	O
combination	O
of	O
two	O
human	O
monoclonal	O
antibodies	O
(mAbs)	O
being	O
developed	O
with	O
an	O
initial	O
indication	O
of	O
treatment	O
of	O
disease	B-Disease
caused	I-Disease
by	I-Disease
Sudan	I-Disease
virus	E-Disease
(	O
Sudan	B-Pathogen
ebolavirus	E-Pathogen
)	O
.	O

The	O
lab	O
was	O
not	O
one	O
of	O
the	O
two	O
labs	O
involved	O
in	O
recent	O
incidents	O
;	O
those	O
two	O
labs	O
remain	O
closed	O
.	O

The	O
at-risk	O
groups	O
include	O
pregnant	O
and	O
post	O
partum	O
women	O
,	O
children	O
under	O
two	O
years	O
old	O
,	O
and	O
people	O
with	O
underlying	O
conditions	O
such	O
as	O
respiratory	B-Disease
problems	E-Disease
.	O
People	O
who	O
are	O
not	O
in	O
an	O
at-risk	O
group	O
who	O
have	O
persistent	O
or	O
rapidly	O
worsening	O
symptoms	O
should	O
also	O
be	O
treated	O
with	O
antivirals	O
.	O

1941:	O
Soviet	S-Organization
bioweapons	O
facilities	O
are	O
transferred	O
to	O
the	O
city	O
of	O
.	O

Government	O
laboratories	O
were	O
more	O
likely	O
to	O
train	O
their	O
staff	O
when	O
compared	O
to	O
other	O
private	O
and	O
health	O
organization	O
laboratories	O
,	O
still	O
this	O
different	O
was	O
not	O
significant	O
(P=	O
0.145)	O
.	O

The	O
's	O
initial	O
estimates	O
of	O
the	O
R0	O
were	O
1.4-2.	O
5	O
(average	O
1.	O
95)	O
,	O
however	O
a	O
more	O
recent	O
review	O
found	O
the	O
basic	O
R0	O
(without	O
control	O
measures)	O
to	O
be	O
higher	O
at	O
3.	O
28	O
and	O
the	O
median	O
R0	O
to	O
be	O
2.79	O
.	O

This	O
has	O
led	O
to	O
speculation	O
that	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
originated	O
in	O
China	S-Location
,	O
as	O
the	O
lower	O
rates	O
of	O
flu	S-Disease
mortality	O
may	O
be	O
explained	O
by	O
the	O
Chinese	O
population's	O
previously	O
acquired	O
immunity	O
to	O
the	O
.	O

DONALD	B-Person
MCNEIL	E-Person
But	O
there's	O
no	O
effort	O
to	O
extend	O
it	O
even	O
by	O
request	O
to	O
other	O
agencies	O
or	O
to	O
any	O
private	O
labs	O
to	O
make	O
them	O
look	O
at	O
their	O
procedures	O
before	O
samples	O
are	O
shipped?	O
I	O
mean	O
,	O
this	O
obviously	O
is	O
related	O
to	O
the	O
gain	O
of	O
function	O
work	O
that's	O
going	O
on	O
around	O
the	O
country	O
.	O

According	O
to	O
the	O
WHO	S-Organization
director-general	O
Tedros	B-Person
Adhanom	E-Person
,	O
demand	O
for	O
personal	O
protection	O
equipment	O
has	O
risen	O
a	O
hundredfold	O
,	O
leading	O
to	O
prices	O
up	O
to	O
twenty	O
times	O
the	O
normal	O
price	O
and	O
also	O
delays	O
in	O
the	O
supply	O
of	O
medical	O
items	O
of	O
four	O
to	O
six	O
months	O
.	O

Although	O
people	O
born	O
pre-1970	O
will	O
have	O
been	O
vaccinated	O
for	O
smallpox	S-Pathogen
under	O
the	O
WHO	S-Organization
program	O
,	O
the	O
effectiveness	O
of	O
vaccination	O
is	O
limited	O
since	O
the	O
vaccine	O
provides	O
high	O
level	O
of	O
immunity	O
for	O
only	O
3	O
to	O
5	O
years	O
.	O

He	O
identified	O
a	O
funding	O
deficit	O
of	O
$100–300million	O
to	O
continue	O
responding	O
to	O
the	O
outbreak	O
until	O
December	O
,	O
for	O
example	O
to	O
pay	O
for	O
ring	O
vaccination	O
.	O

As	O
of	O
today	O
,	O
the	O
CDC	S-Organization
has	O
about	O
35	O
public	O
health	O
events	O
of	O
international	O
importance	O
under	O
surveillance	O
all	O
around	O
the	O
world	O
,	O
she	O
said	O
,	O
adding	O
that	O
the	O
public	O
health	O
system	O
is	O
dependent	O
upon	O
other	O
nations	O
being	O
able	O
to	O
effectively	O
operate	O
their	O
own	O
systems	O
.	O

IT	O
expertise	O
is	O
needed	O
to	O
install	O
,	O
a	O
demo	O
system	O
is	O
accessible	O
via	O
a	O
guest	O
login	O
.	O

It	O
also	O
contains	O
important	O
international	O
documents	O
and	O
information	O
.	O

Penicillin	S-Drug
the	O
first	O
commercialized	O
antibiotic	O
,	O
was	O
discovered	O
in	O
1928	O
by	O
.	O
Ever	O
since	O
,	O
there	O
has	O
been	O
discovery	O
and	O
acknowledgement	O
of	O
resistance	O
alongside	O
the	O
discovery	O
of	O
new	O
antibiotics	O
.	O

Each	O
project	O
has	O
a	O
budget	O
that	O
pays	O
for	O
salaries	O
(typically	O
10%	O
of	O
full	O
time	O
for	O
each	O
person	O
involved)	O
,	O
consumables	O
,	O
equipment	O
,	O
and	O
travel	O
.	O

The	O
request	O
,	O
which	O
is	O
currently	O
in	O
the	O
proposed	O
budget	O
for	O
fiscal	O
year	O
2018	O
,	O
is	O
for	O
$350	O
million	O
.	O

Additionally	O
on	O
the	O
same	O
date	O
the	O
FDA	S-Organization
set	O
a	O
target	O
action	O
date	O
for	O
14	O
March	O
2020	O
,	O
for	O
Merck	S-Organization
's	O
vaccine	O
;	O
should	O
it	O
be	O
approved	O
it	O
would	O
be	O
the	O
first	O
licensed	O
vaccine	O
.	O

In	O
contrast	O
,	O
a	O
2007	O
analysis	O
of	O
medical	O
journals	O
from	O
the	O
period	O
of	O
the	O
pandemic	O
found	O
that	O
the	O
viral	O
infection	O
was	O
no	O
more	O
aggressive	O
than	O
previous	O
strains	O
.	O

The	O
national	O
security	O
of	O
the	O
U.S.	S-Location
has	O
a	O
vested	O
interest	O
in	O
containing	O
the	O
virus	O
in	O
Africa	S-Location
,	O
but	O
the	O
U.S.	S-Location
lacks	O
a	O
coordinated	O
team	O
,	O
a	O
central	O
structure	O
to	O
meet	O
such	O
biodefense	O
goals,e	O
said	O
.	O

In	O
the	O
article	O
,	O
they	O
noted	O
four	O
respiratory	O
human	O
coronaviruses	O
(HCoV)	O
known	O
to	O
be	O
endemic:	O
229E	S-Pathogen
,	O
OC43	S-Pathogen
,	O
NL63	S-Pathogen
,	O
and	O
.	O

On	O
the	O
third	O
key	O
area	O
of	O
the	O
strategy	O
,	O
surveillance	O
,	O
Gottlieb	S-Person
said	O
the	O
agency	O
is	O
working	O
on	O
plans	O
to	O
expand	O
the	O
National	B-Platform
Antimicrobial	I-Platform
Resistance	I-Platform
Monitoring	I-Platform
System	E-Platform
(	O
NARMS	S-Platform
)-which	O
tracks	O
resistance	O
in	O
Salmonella	S-Pathogen
,	O
,	O
and	O
other	O
harmful	O
bacteria	O
transmitted	O
commonly	O
through	O
food-to	O
include	O
previously	O
underexplored	O
bacteria	O
and	O
other	O
pathogens	O
found	O
in	O
companion	O
animals	O
and	O
animal	O
feed	O
.	O

With	O
a	O
view	O
to	O
initiating	O
a	O
Nordic	O
network	O
for	O
cross-sector	O
collaboration	O
,	O
one	O
FBD	S-Platform
project	O
established	O
contact	O
with	O
the	O
corresponding	O
agencies	O
in	O
the	O
other	O
Nordic	O
countries	O
(	O
Denmark	S-Location
,	O
Finland	S-Location
,	O
Iceland	S-Location
,	O
and	O
Norway	S-Location
)	O
.	O

Carus	S-Person
writes	O
in	O
Toxic	O
Terror	O
that	O
,	O
"	O
There	O
is	O
no	O
way	O
to	O
know	O
to	O
what	O
extent	O
[Rajneesh]	O
participated	O
in	O
actual	O
decision-making	O
.	O

Recent	O
research	O
has	O
suggested	O
plague	S-Disease
first	O
infected	O
humans	O
in	O
Europe	S-Location
and	O
Asia	S-Location
in	O
the	O
Late	O
Neolithic-Early	O
Bronze	O
Age	O
.	O

Some	O
critical	O
issues	O
concerning	O
biosafety	O
are	O
lack	O
of	O
training	O
,	O
exceeding	O
workload	O
,	O
working	O
too	O
fast	O
,	O
deciding	O
not	O
to	O
follow	O
safe	O
practices	O
,	O
and	O
skepticism	O
about	O
biohazards	O
.	O

This	O
work	O
is	O
of	O
relevance	O
for	O
similar	O
projects	O
such	O
as	O
.	O

Language	O
barriers	O
and	O
the	O
appearance	O
of	O
medical	O
teams	O
in	O
protective	B-Equipment
suits	E-Equipment
sometimes	O
increased	O
fears	O
of	O
the	O
virus	O
.	O

The	O
CDC	S-Organization
has	O
recommended	O
cloth	O
face	O
coverings	O
in	O
public	O
settings	O
where	O
other	O
social	O
distancing	O
measures	O
are	O
difficult	O
to	O
maintain	O
,	O
in	O
part	O
to	O
limit	O
transmission	O
by	O
asymptomatic	O
individuals	O
.	O

These	O
techniques	O
depend	O
on	O
the	O
availability	O
of	O
web	O
services	O
,	O
which	O
are	O
rapidly	O
spreading	O
and	O
can	O
be	O
retrieved	O
from	O
collections	O
like	O
.	O

The	O
2009	B-Incident
pandemic	E-Incident
caused	O
US	O
hospitals	O
to	O
make	O
significant	O
preparations	O
in	O
terms	O
of	O
hospital	O
surge	O
capacities	O
,	O
especially	O
within	O
the	O
emergency	O
department	O
and	O
among	O
vulnerable	O
populations	O
.	O

Bell	S-Person
to	O
be	O
Director	O
of	O
Laboratory	O
Safety	O
and	O
serve	O
as	O
the	O
single	O
point	O
of	O
accountability	O
to	O
improve	O
all	O
laboratory	O
safety	O
protocols	O
and	O
practices	O
and	O
procedures	O
;	O
and	O
establishment	O
of	O
the	O
internal	O
working	O
group	O
headed	O
by	O
Dr.	O
.	O

Suddenly	O
I	O
was	O
informed	O
that	O
there	O
were	O
mysterious	O
cases	O
of	O
mortalities	O
in	O
Aralsk	S-Location
(	O
Aral	S-Location
)	O
.	O

People	O
with	O
the	O
motivation	O
to	O
wreak	O
global	O
destruction	O
are	O
mercifully	O
rare	O
.	O

These	O
programs	O
became	O
immense	O
and	O
were	O
conducted	O
at	O
52	O
clandestine	O
sites	O
employing	O
over	O
50,000	O
people	O
.	O

A	O
smallpox	S-Disease
outbreak	O
in	O
the	O
area	O
had	O
occurred	O
in	O
1966	O
,	O
when	O
Tony	B-Person
McLennan	E-Person
,	O
a	O
medical	O
photographer	O
working	O
at	O
the	O
medical	O
school	O
,	O
contracted	O
the	O
disease	O
.	O

The	O
confirmation	O
was	O
made	O
on	O
Friday	O
August	O
3	O
,	O
2018	O
,	O
by	O
the	O
Victorian	B-Organization
Infectious	I-Organization
Disease	I-Organization
Reference	I-Organization
Laboratory-a	I-Organization
WHO	I-Organization
collaborating	I-Organization
centre	E-Organization
in	O
.	O

CDC	S-Organization
will	O
also	O
report	O
this	O
event	O
to	O
its	O
which	O
provides	O
ongoing	O
advice	O
and	O
direction	O
for	O
laboratory	O
science	O
and	O
safety	O
.	O

Just	O
why	O
the	O
attacks	O
failed	O
is	O
not	O
known	O
,	O
but	O
some	O
experts	O
suspect	O
the	O
cult	O
did	O
not	O
sufficiently	O
refine	O
the	O
particle	O
size	O
of	O
its	O
agents	O
and	O
that	O
it	O
was	O
working	O
with	O
an	O
avirulent	O
strain	O
of	O
anthrax	S-Pathogen

Benefits:	O
Plummeting	O
costs	O
and	O
technical	O
advances	O
have	O
made	O
the	O
goal	O
of	O
total	O
genome	O
synthesis	O
seem	O
much	O
more	O
immediate	O
.	O

Ali	B-Person
Mohamed	I-Person
Zaki	E-Person
sent	O
a	O
virus	O
sample	O
from	O
the	O
first	O
confirmed	O
case	O
to	O
virologist	O
Ron	B-Person
Fouchier	E-Person
,	O
a	O
leading	O
coronavirus	O
researcher	O
at	O
the	O
Erasmus	B-Organization
Medical	I-Organization
Center	E-Organization
(	O
EMC	S-Organization
)	O
in	O
Rotterdam	S-Location
,	O
The	O
Netherlands	S-Location
.	O
The	O
second	O
laboratory-proven	O
case	O
was	O
in	O
London	S-Location
,	O
confirmed	O
by	O
the	O
UK	B-Organization
Health	I-Organization
Protection	I-Organization
Agency	E-Organization
(	O
HPA	S-Organization
)	O
.	O

The	O
report	O
,	O
among	O
other	O
items	O
,	O
recommended	O
the	O
research	O
and	O
development	O
of	O
an	O
offensive	O
biological	O
weapons	O
program	O
.	O

The	O
center	O
is	O
a	O
branch	O
of	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
that	O
fights	O
threats	O
like	O
anthrax	S-Pathogen
and	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
and	O
additionally	O
towards	O
research	O
on	O
.	O

The	O
program	O
was	O
aimed	O
at	O
rebuilding	O
WHO	S-Organization
capacity	O
for	O
direct	O
action	O
,	O
which	O
critics	O
said	O
had	O
been	O
lost	O
due	O
to	O
budget	O
cuts	O
in	O
the	O
previous	O
decade	O
that	O
had	O
left	O
the	O
organization	O
in	O
an	O
advisory	O
role	O
dependent	O
on	O
member	O
states	O
for	O
on-the-ground	O
activities	O
.	O

The	O
,	O
with	O
its	O
mass	O
movements	O
of	O
men	O
in	O
armies	O
and	O
aboard	O
ships	O
,	O
probably	O
aided	O
in	O
its	O
rapid	O
diffusion	O
and	O
attack	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
promotes	O
road	O
safety	O
as	O
a	O
means	O
to	O
reduce	O
traffic-related	O
injuries	O
.	O

As	O
a	O
biological	O
weapon	O
is	O
dangerous	O
because	O
of	O
the	O
highly	O
contagious	O
nature	O
of	O
both	O
the	O
infected	O
and	O
their	O
pox	O
.	O

Doctors	O
in	O
wrote	O
506	O
annual	O
antibiotic	O
scripts	O
for	O
every	O
1,000	O
people	O
,	O
with	O
353	O
being	O
medically	O
necessary	O
.	O

The	O
Fourth	B-Activity
Meeting	I-Activity
of	I-Activity
the	I-Activity
International	I-Activity
Health	I-Activity
Regulations	I-Activity
Emergency	I-Activity
Committee	I-Activity
concerning	I-Activity
MERS-CoV	E-Activity
was	O
held	O
on	O
4	O
December	O
2013	O
.	O

From	O
New	B-Location
Zealand	E-Location
,	O
the	O
flu	S-Disease
reached	O
Tonga	S-Location
(killing	O
8%	O
of	O
the	O
population)	O
,	O
Nauru	S-Location
(16%)	O
,	O
and	O
(5%	O
,	O
9,000 people)	O
.	O

As	O
the	O
number	O
of	O
susceptible	O
hosts	O
declines	O
,	O
so	O
does	O
the	O
effective	O
population	O
size	O
and	O
its	O
genetic	O
diversity	O
.	O

Viral	B-Disease
hemorrhagic	I-Disease
fevers	E-Disease
This	O
includes	O
hemorrhagic	B-Disease
fevers	E-Disease
caused	O
by	O
members	O
of	O
the	O
family	O
Filoviridae	S-Pathogen
(	O
Marburg	B-Pathogen
virus	E-Pathogen
and	O
Ebola	B-Pathogen
virus	E-Pathogen
)	O
,	O
and	O
by	O
the	O
family	O
Arenaviridae	S-Pathogen
(for	O
example	O
Lassa	B-Pathogen
virus	E-Pathogen
and	O
Machupo	B-Pathogen
virus	E-Pathogen
)	O
.	O

For	O
effective	O
military	O
use	O
it	O
was	O
dried	O
to	O
a	O
powder	O
that	O
could	O
be	O
dispersed	O
as	O
aerosols	O
.	O

For	O
healthcare	O
professionals	O
caring	O
for	O
people	O
with	O
COVID‑19	O
,	O
the	O
CDC	O
recommends	O
placing	O
the	O
person	O
in	O
an	O
Airborne	B-Equipment
Infection	I-Equipment
Isolation	I-Equipment
Room	E-Equipment
()	O
in	O
addition	O
to	O
using	O
standard	O
precautions	O
,	O
contact	O
precautions	O
,	O
and	O
airborne	O
precautions	O
.	O

Many	O
genes	O
in	O
the	O
body	O
are	O
not	O
on	O
at	O
the	O
same	O
levels	O
all	O
the	O
time	O
-	O
some	O
turn	O
off	O
when	O
you	O
sleep	O
,	O
or	O
after	O
you	O
eat	O
,	O
for	O
example	O
-	O
so	O
this	O
development	O
could	O
provide	O
a	O
way	O
to	O
deliver	O
compounds	O
in	O
natural	O
fluctuations	O
.	O

Plague	S-Disease
,	O
the	O
disease	O
caused	O
by	O
the	O
bacterium	O
Yersinia	S-Pathogen
pestis	O
,	O
was	O
the	O
cause	O
;	O
Y.	B-Pathogen
pestis	E-Pathogen
infection	O
most	O
commonly	O
results	O
in	O
bubonic	B-Disease
plague	E-Disease
,	O
but	O
can	O
cause	O
.	O

The	O
first	O
2	O
infected	O
cases	O
involved	O
a	O
postgraduate	O
student	O
and	O
a	O
researcher	O
at	O
the	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Viral	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(abbrev.	O
:	O
Institute	B-Organization
of	I-Organization
Virology	E-Organization
)	O
of	O
the	O
;	O
an	O
additional	O
7	O
cases	O
were	O
diagnosed	O
,	O
which	O
were	O
linked	O
with	O
close	O
personal	O
contact	O
with	O
the	O
student	O
,	O
the	O
lab	O
or	O
with	O
a	O
nurse	O
who	O
treated	O
the	O
student.	O
.	O

Furthermore	O
,	O
a	O
thorough	O
evaluation	O
of	O
a	O
DNA	O
extraction	O
robot	O
in	O
biosafety	B-Equipment
cabinets	E-Equipment
including	O
the	O
validation	O
of	O
the	O
extraction	O
process	O
using	O
a	O
broad	O
range	O
of	O
sample	O
types	O
(matrixes)	O
,	O
resulted	O
in	O
the	O
equipment's	O
being	O
implemented	O
at	O
all	O
4	O
agencies	O
.	O

Thanks	O
for	O
joining	O
us	O
today	O
.	O

It	O
is	O
a	O
United	B-Location
States	E-Location
federal	O
agency	O
,	O
under	O
the	O
,	O
and	O
is	O
headquartered	O
in	O
Atlanta	O
,	O
Georgia	O
.	O

The	O
number	O
of	O
war-related	O
deaths	O
of	O
young	O
adults	O
may	O
have	O
overshadowed	O
the	O
deaths	O
caused	O
by	O
.	O

Its	O
ability	O
to	O
modify	O
specific	O
DNA	O
sequences	O
makes	O
it	O
a	O
tool	O
with	O
potential	O
to	O
fix	O
disease-causing	O
mutations	O
.	O

This	O
was	O
the	O
first	O
report	O
of	O
that	O
particular	O
gene	O
in	O
E.	B-Pathogen
coli	E-Pathogen
from	O
pets	O
in	O
Philadelphia	S-Location
and	O
in	O
the	O
United	B-Location
States	E-Location
.	O
The	O
infection	O
has	O
previously	O
been	O
identified	O
in	O
animals	O
from	O
Europe	S-Location
and	O
.	O

The	O
E120	O
was	O
later	O
superseded	O
by	O
dry-type	O
agents	O
.	O

In	O
the	O
Dutch	B-Location
East	I-Location
Indies	E-Location
(now	O
Indonesia	S-Location
)	O
,	O
1.5 million	O
were	O
assumed	O
to	O
have	O
died	O
among	O
30 million	O
inhabitants.Historical	O
research	O
report	O
from	O
University	B-Organization
of	I-Organization
Indonesia	E-Organization
,	O
School	O
of	O
History	O
,	O
as	O
reported	O
in	O
Emmy	B-Person
Fitri	E-Person
.	O
Looking	O
Through	O
Indonesia	S-Location
's	O
History	O
For	O
Answers	O
to	O
Swine	O
Flu	O
.	O
The	O
Jakarta	S-Location
Globe.	O
28	O
October	O
2009	O
edition	O
.	O

Between	O
123,000	O
and	O
203,000	O
pandemic	O
respiratory	O
deaths	O
were	O
estimated	O
globally	O
for	O
the	O
last	O
nine	O
months	O
of	O
2009	O
.	O

Oregon	O
Attorney	O
General	O
Dave	B-Person
Frohnmayer	E-Person
established	O
a	O
task	O
force	O
among	O
the	O
Wasco	B-Organization
County	I-Organization
Sheriff's	I-Organization
office	E-Organization
,	O
the	O
Oregon	B-Organization
State	I-Organization
Police	E-Organization
,	O
the	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
(	O
FBI	S-Organization
)	O
,	O
the	O
Immigration	B-Organization
and	I-Organization
Naturalization	I-Organization
Service	E-Organization
(	O
INS	S-Organization
)	O
and	O
the	O
National	B-Organization
Guard	E-Organization
that	O
set	O
up	O
headquarters	O
on	O
the	O
Ranch	O
to	O
investigate	O
the	O
allegations	O
.	O

He	O
explained	O
that	O
HLI	S-Organization
has	O
new	O
and	O
advanced	O
techniques	O
for	O
early	O
detection	O
.	O

Previously	O
a	O
Chinese	O
study	O
published	O
in	O
the	O
Lancet	O
did	O
not	O
show	O
improvement	O
.	O

It	O
also	O
threatened	O
to	O
expand	O
its	O
medfly	O
infestation	O
into	O
the	O
San	B-Location
Joaquin	I-Location
Valley	E-Location
.	O
Fresno	S-Location
Bee	O
,	O
"	O
Medfly	O
threat	O
prompts	O
new	O
bill	O
Ayala	O
proposes	O
law	O
after	O
group	O
vows	O
to	O
unleash	O
flies"	O
,	O
(login	O
required)	O
,	O
Bee	O
,	O
January	O
18	O
,	O
1990	O
,	O
accessed	O
February	O
,	O
23	O
,	O
2012	O
.	O

For	O
instance	O
,	O
we	O
have	O
only	O
three	O
laboratories	O
in	O
Nigeria	S-Location
at	O
the	O
moment	O
that	O
can	O
make	O
that	O
diagnosis	O
.	O

In	O
early	O
July	O
2016	O
,	O
a	O
trial	O
for	O
males	O
with	O
detectable	O
RNA	O
in	O
semen	O
,	O
started	O
.	O

The	O
Antibiotic	B-Scientific_research_project
Resistance	I-Scientific_research_project
Monitoring,	I-Scientific_research_project
Analysis	I-Scientific_research_project
and	I-Scientific_research_project
Diagnostics	I-Scientific_research_project
Alliance	E-Scientific_research_project
(	O
ARMADA	S-Scientific_research_project
)	O
will	O
create	O
this	O
global	B-Platform
biobank	I-Platform
of	I-Platform
bacterial	I-Platform
strains	E-Platform
by	O
collecting	O
bacterial	O
isolates	O
from	O
hospitals	O
,	O
doctor's	O
offices	O
,	O
clinical	O
labs	O
,	O
and	O
veterinary	O
sources	O
and	O
then	O
analyzing	O
them	O
to	O
understand	O
their	O
resistance	O
profiles	O
,	O
their	O
genetic	O
identity	O
,	O
and	O
their	O
epidemiological	O
history	O
.	O

The	O
origins	O
of	O
the	O
deadly	O
flu	O
disease	O
were	O
unknown	O
but	O
widely	O
speculated	O
upon	O
.	O

Chromosomes	O
that	O
have	O
been	O
successfully	O
deleted	O
in	O
vivo	O
using	O
CRISPR	S-Technology
techniques	O
include	O
the	O
Y	O
chromosome	O
and	O
X	O
chromosome	O
of	O
adult	O
lab	O
mice	O
and	O
human	O
chromosomes	O
14	O
and	O
21	O
,	O
in	O
embryonic	O
stem	O
cell	O
lines	O
and	O
aneuploid	O
mice	O
respectively	O
.	O

The	O
four	O
Coordinating	O
Centers-established	O
under	O
the	O
G	O
.	O

"	O
CWMD,	O
including	O
biodefense	O
,	O
is	O
a	O
top	O
priority	O
of	O
this	O
administration	O
.	O

On	O
10	O
December	O
,	O
the	O
health	O
commission	O
for	O
the	O
province	O
of	O
Heilongjiang	S-Location
confirmed	O
that	O
13	O
students	O
at	O
the	O
Harbin	B-Organization
Veterinary	I-Organization
Research	I-Organization
Institute	E-Organization
,	O
around	O
2,600	O
kilometres	O
to	O
the	O
northeast	O
of	O
Lanzhou	S-Location
,	O
also	O
had	O
the	O
infection	O
.	O

Kanabrocki	S-Person
serves	O
as	O
Councilor	O
of	O
the	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
(	O
ABSA	S-Organization
)	O
and	O
is	O
a	O
member	O
of	O
the	O
Scientific	B-Organization
Advisory	I-Organization
Board	E-Organization
for	O
NIH's	B-Activity
National	I-Activity
Biosafety	I-Activity
and	I-Activity
Biocontainment	I-Activity
Training	I-Activity
Program	E-Activity
(	O
NBBTP	S-Activity
)	O
.	O

The	O
symptoms	O
ranged	O
from	O
mild	O
(e.g.	O
hair	B-Phenotype
loss	E-Phenotype
)	O
to	O
more	O
severe	O
complications	O
requiring	O
re-hospitalisation	O
or	O
treatment	O
.	O

The	O
economic	O
impact	O
was	O
becoming	O
dramatic	O
as	O
shops	O
,	O
restaurants	O
,	O
markets	O
,	O
bars	O
,	O
universities	O
,	O
schools	O
,	O
and	O
many	O
other	O
businesses	O
had	O
closed	O
,	O
while	O
some	O
government	O
ministries	O
and	O
large	O
state	O
banks	O
were	O
working	O
with	O
minimal	O
staff	O
levels	O
.	O

Leitenberg	S-Person
and	O
Zilinskas	S-Person
,	O
in	O
The	O
Soviet	B-Scientific_research_project
Biological	I-Scientific_research_project
Weapons	I-Scientific_research_project
Program	E-Scientific_research_project
:	O
A	O
History	O
(2012)	O
,	O
state	O
flatly	O
that	O
"	O
In	O
March	O
1992..	O
.	O

How	O
is	O
that	O
affecting	O
surveillance	O
in	O
over	O
the	O
summer?	O
I	O
know	O
that	O
it's	O
flu	O
season	O
in	O
different	O
parts	O
of	O
the	O
world	O
.	O

In	O
the	O
United	B-Location
States	E-Location
the	O
prisoner	O
population	O
is	O
aging	O
and	O
many	O
of	O
them	O
are	O
at	O
high	O
risk	O
for	O
poor	O
outcomes	O
from	O
due	O
to	O
high	O
rates	O
of	O
coexisting	O
heart	O
and	O
lung	O
disease	O
,	O
and	O
poor	O
access	O
to	O
high-quality	O
healthcare	O
.	O

Together	O
,	O
these	O
studies	O
suggest	O
NPC1	O
and	O
TIM-1	O
may	O
be	O
potential	O
therapeutic	O
targets	O
for	O
an	O
Ebola	O
anti-viral	O
drug	O
and	O
as	O
a	O
basis	O
for	O
a	O
rapid	O
field	O
diagnostic	O
assay	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
.	O

A	O
comparison	O
of	O
the	O
different	O
lists	O
of	O
animal	O
pathogens	O
issued	O
in	O
the	O
different	O
European	O
Member	O
States	O
was	O
made	O
by	O
the	O
European	B-Organization
Committee	I-Organization
for	I-Organization
Standardization	E-Organization
(	O
European	B-Organization
Committee	I-Organization
for	I-Organization
Standardization,Technical	I-Organization
Committee	E-Organization
233	O
-	O
Biotechnology	O
,	O
Working	O
group	O
1	O
.	O

On	O
30	O
December	O
,	O
a	O
test	O
report	O
addressed	O
to	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
,	O
from	O
company	O
CapitalBio	B-Organization
Medlab	E-Organization
,	O
stated	O
an	O
erroneous	O
positive	O
result	O
for	O
SARS	S-Disease
,	O
causing	O
a	O
group	O
of	O
doctors	O
at	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
to	O
alert	O
their	O
colleagues	O
and	O
relevant	O
hospital	O
authorities	O
of	O
the	O
result	O
.	O

All	O
charges	O
were	O
dropped	O
however	O
,	O
and	O
he	O
was	O
released	O
on	O
April	O
23	O
,	O
2013	O
.	O

Reports	O
by	O
the	O
Outbreak	B-Scientific_research_project
Observatory	E-Scientific_research_project
can	O
be	O
found	O
at	O
outbreakobservatory.org	O
.	O

Per	O
the	O
world	B-Organization
Health	I-Organization
Organization	E-Organization
the	O
current	O
outbreak	O
of	O
has	O
left	O
about	O
1,000	O
survivors	O
.	O

But	O
3	O
extensive	O
pandemic	O
waves	O
of	O
influenza	S-Disease
within	O
1	O
year	O
,	O
occurring	O
in	O
rapid	O
succession	O
,	O
with	O
only	O
the	O
briefest	O
of	O
quiescent	O
intervals	O
between	O
them	O
,	O
was	O
unprecedented	O
.	O

They're	O
popular	O
mainly	O
because	O
they're	O
easy	O
to	O
get	O
and	O
your	O
body	O
can	O
metabolize	O
them	O
in	O
a	O
few	O
hours	O
or	O
less	O
for	O
quick	O
results	O
.	O

A	O
disclaimer	O
was	O
introduced	O
at	O
this	O
point	O
stating	O
that	O
all	O
data	O
will	O
be	O
confidential	O
and	O
anonymous	O
.	O

Using	O
"	O
dead"	O
versions	O
of	O
Cas9	S-Technology
(	O
dCas9	S-Technology
)	O
eliminates	O
CRISPR	S-Technology
's	O
DNA-cutting	O
ability	O
,	O
while	O
preserving	O
its	O
ability	O
to	O
target	O
desirable	O
sequences	O
.	O

On	O
February	O
5	O
,	O
2002	O
,	O
George	B-Person
W.	I-Person
Bush	E-Person
visited	O
the	O
RODS	B-Organization
laboratory	E-Organization
and	O
used	O
it	O
as	O
a	O
model	O
for	O
a	O
$300	O
million	O
spending	O
proposal	O
to	O
equip	O
all	O
50	O
states	O
with	O
biosurveillance	O
systems	O
.	O

Constructing	O
the	O
Kansas	S-Location
center	O
has	O
also	O
proven	O
to	O
be	O
a	O
bit	O
of	O
a	O
boondoggle	O
.	O

Phages	O
destroy	O
bacterial	O
cell	O
walls	O
and	O
membrane	O
through	O
the	O
use	O
of	O
lytic	O
proteins	O
which	O
kill	O
bacteria	O
by	O
making	O
many	O
holes	O
from	O
the	O
inside	O
out	O
.	O

The	O
Director	O
of	O
CDC	S-Organization
is	O
a	O
Senior	O
Executive	O
Service	O
position	O
that	O
may	O
be	O
filled	O
either	O
by	O
a	O
career	O
employee	O
,	O
or	O
as	O
a	O
political	O
appointment	O
that	O
does	O
not	O
require	O
Senate	O
confirmation	O
,	O
with	O
the	O
latter	O
method	O
typically	O
being	O
used	O
.	O

Remdesivir	S-Drug
was	O
originally	O
created	O
and	O
developed	O
by	O
Gilead	B-Organization
Sciences	E-Organization
in	O
2009	O
,	O
as	O
part	O
of	O
the	O
company's	O
research	O
and	O
development	O
program	O
for	O
hepatitis	B-Disease
C	E-Disease
.	O
It	O
did	O
not	O
work	O
against	O
hepatitis	B-Disease
C	E-Disease
as	O
hoped	O
,	O
but	O
was	O
then	O
repurposed	O
and	O
studied	O
as	O
a	O
potential	O
treatment	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
and	O
Marburg	B-Disease
virus	I-Disease
infections	E-Disease
.	O
According	O
to	O
the	O
Czech	B-Organization
News	I-Organization
Agency	E-Organization
,	O
this	O
new	O
line	O
of	O
research	O
was	O
carried	O
out	O
under	O
the	O
direction	O
of	O
scientist	O
Tomáš	B-Person
Cihlář	E-Person
.	O
Czech	B-Organization
News	I-Organization
Agency	E-Organization
,	O
"	O
Did	O
Czech	S-Location
scientists	O
create	O
the	O
cure	O
for	O
coronavirus	S-Pathogen
?	O
"	O
,	O
Aktuálně.cz	S-Person
,	O
5	O
February	O
2020	O
.	O

The	O
generator	O
,	O
water	O
supplying	O
unit	O
and	O
incineration	O
units	O
are	O
located	O
outside	O
the	O
building	O
.	O

All	O
but	O
one	O
of	O
the	O
restaurants	O
affected	O
went	O
out	O
of	O
business	O
.	O

via	O
MapReduce	O
pipelines	O
.	O

Kanatjan	B-Person
Alibekov	E-Person
,	O
the	O
first	O
deputy	O
director	O
of	O
Biopreparat	S-Scientific_research_project
defected	O
in	O
1992	O
.	O

In	O
July	O
2014	O
,	O
for	O
instance	O
,	O
a	O
Liberian	S-Organization
businessman	O
flew	O
to	O
Lagos	S-Location
,	O
Nigeria	S-Location
.	O
He	O
became	O
sick	O
en	O
route	O
and	O
it	O
was	O
determined	O
he	O
had	O
brought	O
Ebola	S-Pathogen
to	O
Nigeria	S-Location
.	O
"	O
But	O
because	O
there	O
was	O
a	O
public	O
health	O
infrastructure	O
there	O
,	O
the	O
Nigerians	O
were	O
able	O
to	O
stop	O
the	O
Ebola	B-Incident
outbreak	E-Incident
after	O
19	O
cases,	O
"	O
said	O
.	O

Several	O
companies	O
formed	O
to	O
develop	O
related	O
drugs	O
and	O
research	O
tools	O
.	O

Next	O
question	O
on	O
the	O
phone	O
.	O

GCBRs	O
are	O
events	O
in	O
which	O
biological	O
agents	O
could	O
lead	O
to	O
a	O
sudden	O
,	O
extraordinary	O
,	O
widespread	O
disaster	O
beyond	O
the	O
collective	O
capability	O
of	O
national	O
and	O
international	O
governments	O
and	O
the	O
private	O
sector	O
to	O
control	O
.	O

How	O
many	O
researchers	O
were	O
involved	O
in	O
constructing	B-Incident
the	I-Incident
first	I-Incident
self-replicating,	I-Incident
synthetic	I-Incident
bacterial	I-Incident
cell	E-Incident

Preparation	O
of	O
bacteria	O
in	O
this	O
manner	O
is	O
routinely	O
done	O
within	O
the	O
CDC	S-Organization
campus	O
;	O
however	O
,	O
in	O
this	O
instance	O
,	O
the	O
lab	O
used	O
a	O
procedure	O
that	O
may	O
not	O
have	O
adequately	O
inactivated	O
the	O
samples	O
.	O

He	O
will	O
submit	O
a	O
report	O
to	O
CDC	S-Organization
Director	O
Dr	O
.	O

In	O
the	O
first	O
,	O
during	O
a	O
parley	O
at	O
Fort	B-Location
Pitt	E-Location
on	O
June	O
24	O
,	O
1763	O
,	O
Captain	O
Simeon	B-Person
Ecuyer	E-Person
gave	O
representatives	O
of	O
the	O
besieging	O
Delawares	O
two	O
blankets	O
and	O
a	O
handkerchief	O
enclosed	O
in	O
small	O
metal	O
boxes	O
that	O
had	O
been	O
exposed	O
to	O
,	O
hoping	O
to	O
spread	O
the	O
disease	O
to	O
the	O
Natives	O
in	O
order	O
to	O
end	O
the	O
siege.Anderson	O
,	O
Crucible	O
of	O
War	O
,	O
541–42	O
;	O
Jennings	O
,	O
Empire	O
of	O
Fortune	O
,	O
447n26	O
.	O

The	O
term	O
"	O
biohacking"	O
as	O
well	O
as	O
the	O
concept	O
of	O
do-it-yourself	B-Activity
biology	E-Activity
has	O
been	O
known	O
as	O
early	O
as	O
1988	O
.	O

Development	O
of	O
the	O
spherical	O
E120	O
bomblet	O
took	O
place	O
in	O
the	O
early	O
1960sCountermeasures	O
,	O
Chapter	O
6	O
–	O
An	O
Overview	O
of	O
Emerging	O
Missile	O
State	O
Countermeasures	O
,	O
p.	O
14	O
.	O

In	O
1995	O
,	O
a	O
scientific	O
team	O
identified	O
archival	O
influenza	S-Disease
autopsy	O
materials	O
collected	O
in	O
the	O
autumn	O
of	O
1918	O
and	O
began	O
the	O
slow	O
process	O
of	O
sequencing	O
small	O
viral	O
RNA	O
fragments	O
to	O
determine	O
the	O
genomic	O
structure	O
of	O
the	O
causative	O
influenza	S-Disease
virus	O
.	O

With	O
so	O
many	O
people	O
around	O
the	O
world	O
with	O
the	O
ability	O
to	O
self-medicate	O
using	O
antibiotics	O
,	O
and	O
a	O
vast	O
majority	O
unaware	O
of	O
what	O
antimicrobial	O
resistance	O
is	O
,	O
it	O
makes	O
the	O
increase	O
of	O
antimicrobial	O
resistance	O
much	O
more	O
likely	O
.	O

Lab	O
safety	O
consultant	O
Sean	B-Person
Kaufman	E-Person
of	O
Behavioral-Based	O
Improvement	O
Solutions	O
said	O
the	O
recommendations	O
offer	O
a	O
"	O
comprehensive	O
plan	O
"	O
for	O
reducing	O
risks	O
,	O
but	O
"	O
fall	O
extremely	O
short	O
"	O
in	O
providing	O
the	O
training	O
and	O
development	O
opportunities	O
required	O
to	O
change	O
the	O
culture	O
of	O
lab	O
safety	O
.	O

The	O
CDC/	O
NIH	S-Organization
	S-Organization
"	O
"	O

Once	O
subjected	O
to	O
steam	O
sterilization	O
,	O
where	O
it	O
is	O
super-heated	O
to	O
about	O
250	O
degrees	O
Fahrenheit	O
for	O
20	O
minutes	O
,	O
the	O
liquid	O
can	O
then	O
be	O
treated	O
as	O
normal	O
wastewater	O
.	O

In	O
1956	O
,	O
biologist	O
found	O
a	O
more	O
virulent	O
strain	O
in	O
rodents	O
captured	O
in	O
this	O
area	O
.	O

Authorities	O
worldwide	O
have	O
responded	O
by	O
implementing	O
travel	O
restrictions	O
,	O
lockdowns	O
,	O
workplace	O
hazard	O
controls	O
,	O
and	O
facility	O
closures	O
.	O

During	O
the	O
height	O
of	O
the	O
fear	O
of	O
a	O
pandemic	O
,	O
some	O
countries	O
initiated	O
or	O
threatened	O
to	O
initiate	O
quarantines	O
of	O
foreign	O
visitors	O
suspected	O
of	O
having	O
or	O
being	O
in	O
contact	O
with	O
others	O
who	O
may	O
have	O
been	O
infected	O
.	O

•	O
Adam	B-Person
Russell	E-Person
a	O
DSO	S-Organization
program	O
manager	O
,	O
will	O
lead	O
the	O
social	O
and	O
behavioral	O
modeling	O
aspects	O
of	O
.	O

Seen	O
through	O
the	O
eyes	O
of	O
Reeves	S-Person
and	O
his	O
co-authors	O
,	O
the	O
biological	O
,	O
economic	O
and	O
societal	O
implications	O
of	O
dispersing	O
horizontal	O
genetic	O
alteration	O
agents	O
into	O
ecosystems	O
are	O
"	O
profound,"	O
especially	O
in	O
light	O
of	O
the	O
insect	O
delivery	O
system	O
.	O

First	O
,	O
energy	O
from	O
an	O
oscillating	O
magnetic	O
field	O
is	O
temporarily	O
applied	O
to	O
the	O
patient	O
at	O
the	O
appropriate	O
resonance	O
frequency	O
.	O

Biohackers	O
want	O
to	O
make	O
their	O
bodies	O
and	O
brains	O
function	O
better	O
by	O
"	O
hacking"	O
their	O
biology	O
.	O

Landowners	O
were	O
also	O
pushed	O
to	O
substitute	O
monetary	O
rents	O
for	O
labour	O
services	O
in	O
an	O
effort	O
to	O
keep	O
tenants	O
.	O

Biohacking	O
comes	O
in	O
many	O
forms	O
.	O

Among	O
its	O
many	O
programs	O
,	O
duties	O
,	O
offices	O
and	O
responsibilities	O
both	O
in	O
the	O
U.S.	S-Location
and	O
internationally	O
,	O
the	O
CDC	S-Organization
also	O
operates	O
several	O
public	O
health	O
preparedness	O
programs	O
that	O
were	O
reauthorized	O
by	O
PAHPRA	S-Document
,	O
including	O
the	O
Cities	B-Scientific_research_project
Readiness	I-Scientific_research_project
Initiative	E-Scientific_research_project
,	O
the	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
(	O
SNS	S-Platform
)	O
and	O
biosurveillance	S-Scientific_research_project
,	O
explained	O
.	O

It	O
was	O
later	O
revealed	O
that	O
Gilead	S-Organization
had	O
been	O
providing	O
remdesivir	S-Drug
in	O
response	O
to	O
compassionate	O
use	O
requests	O
since	O
25	O
January	O
.	O

Ebright	S-Person
and	O
others	O
say	O
the	O
rapid	O
growth	O
in	O
the	O
number	O
of	O
federally	O
funded	O
biodefense	O
labs	O
following	O
the	O
2001	O
anthrax	S-Disease
attacks	O
has	O
only	O
increased	O
the	O
risks	O
of	O
an	O
accidental	O
or	O
deliberate	O
release	O
of	O
an	O
agent	O
.	O

According	O
to	O
the	O
Federation	B-Organization
of	I-Organization
American	I-Organization
Scientists	E-Organization
U.S.	S-Location
work	O
on	O
non-lethal	O
agents	O
exceeds	O
limitations	O
in	O
the	O
.	O

Two	O
American	O
health	O
workers	O
who	O
contracted	O
the	O
disease	O
and	O
later	O
recovered	O
said	O
that	O
to	O
the	O
best	O
of	O
their	O
knowledge	O
,	O
their	O
team	O
of	O
workers	O
had	O
been	O
following	O
"	O
to	O
the	O
letter	O
all	O
of	O
the	O
protocols	O
for	O
safety	O
that	O
were	O
developed	O
by	O
the	O
[	O
CDC	S-Organization
]	O
and	O
WHO	S-Organization
"	O
,	O
including	O
a	O
full	O
body	O
coverall	O
,	O
several	O
layers	O
of	O
gloves	O
,	O
and	O
face	O
protection	O
including	O
goggles	O
.	O

It	O
is	O
particularly	O
relevant	O
here	O
because	O
normal	O
two-dimensional	O
X-rays	O
do	O
not	O
show	O
such	O
defects	O
.	O

The	O
first	O
known	O
case	O
of	O
a	O
previously	O
unknown	O
coronavirus	O
was	O
identified	O
in	O
a	O
60-year-old	O
Saudi	B-Location
Arabian	E-Location
man	O
with	O
acute	O
pneumonia	S-Disease
,	O
who	O
died	O
of	O
kidney	B-Disease
failure	E-Disease
in	O
June	O
2012	O
.	O

The	O
strategy	O
was	O
developed	O
by	O
members	O
of	O
the	O
FDA	S-Organization
Center	B-Organization
for	I-Organization
Veterinary	I-Organization
Medicine	E-Organization
,	O
Center	B-Organization
for	I-Organization
Drug	I-Organization
Evaluation	I-Organization
and	I-Organization
Research	E-Organization
,	O
Center	B-Organization
for	I-Organization
Devices	I-Organization
and	I-Organization
Radiological	I-Organization
Health	E-Organization
,	O
Center	B-Organization
for	I-Organization
Biologics	I-Organization
Evaluation	I-Organization
and	I-Organization
Research	E-Organization
,	O
and	O
.	O

Researchers	O
hypothesize	O
that	O
the	O
mechanism	O
of	O
resistance	O
development	O
is	O
based	O
on	O
four	O
SNP	O
mutations	O
in	O
the	O
genome	O
of	O
produced	O
by	O
the	O
gradient	O
of	O
antibiotic	O
.	O

Bell	S-Person
and	O
his	O
working	O
group	O
will	O
look	O
at	O
is	O
exactly	O
that	O
.	O

During	O
the	O
initial	B-Incident
outbreak	I-Incident
in	I-Incident
Wuhan,	I-Incident
China	E-Incident
the	O
virus	O
and	O
disease	O
were	O
commonly	O
referred	O
to	O
as	O
"	O
coronavirus	S-Pathogen
"	O
and	O
"	O
Wuhan	B-Pathogen
coronavirus	E-Pathogen
"	O
,	O
with	O
the	O
disease	O
sometimes	O
called	O
"	O
Wuhan	B-Disease
pneumonia	E-Disease
"	O
.	O
In	O
the	O
past	O
,	O
many	O
diseases	O
have	O
been	O
named	O
after	O
geographical	O
locations	O
,	O
such	O
as	O
the	O
Spanish	B-Disease
flu	E-Disease
,	O
Middle	B-Disease
East	I-Disease
Respiratory	I-Disease
Syndrome	E-Disease
,	O
and	O
.	O

In	O
one	O
example	O
,	O
when	O
an	O
Italian	O
hospital	O
urgently	O
required	O
a	O
ventilator	B-Equipment
valve	E-Equipment
,	O
and	O
the	O
supplier	O
was	O
unable	O
to	O
deliver	O
in	O
the	O
timescale	O
required	O
,	O
a	O
local	O
startup	O
received	O
legal	O
threats	O
due	O
to	O
alleged	O
patent	O
infringement	O
after	O
reverse-engineering	O
and	O
printing	O
the	O
required	O
hundred	O
valves	O
overnight	O
.	O

The	O
funding	O
also	O
supports	O
drug	O
makers	O
in	O
the	O
research	O
and	O
development	O
of	O
medicines	O
,	O
medical	O
devices	O
and	O
vaccines	O
for	O
use	O
against	O
man-made	O
or	O
naturally	O
occurring	O
diseases	O
such	O
as	O
,	O
pandemic	O
flu	O
and	O
drug-resistant	O
bacteria	O
.	O

WHO	S-Organization
chief	O
Tedros	B-Person
Adhanom	I-Person
Ghebreyesus	E-Person
explained:	O
CO	O
for	O
corona	O
,	O
VI	O
for	O
virus	O
,	O
Dfor	O
disease	O
and	O
19	O
for	O
when	O
the	O
outbreak	O
was	O
first	O
identified	O
(31	O
December	O
2019)	O
.	O

Dr	O
.	O

A	O
decreased	B-Phenotype
sense	I-Phenotype
of	I-Phenotype
smell	E-Phenotype
or	O
disturbances	B-Phenotype
in	I-Phenotype
taste	E-Phenotype
may	O
occur	O
.	O

The	O
man's	O
son	O
,	O
whom	O
he	O
visited	O
in	O
the	O
hospital	O
in	O
Birmingham	S-Location
,	O
was	O
immuno-suppressed	O
because	O
of	O
a	O
,	O
and	O
contracted	O
the	O
virus	O
,	O
providing	O
the	O
first	O
clear	O
evidence	O
for	O
person-to-person	O
transmission	O
.	O

The	O
area	O
in	O
question	O
,	O
North	B-Location
Kivu	E-Location
is	O
in	O
the	O
middle	O
of	O
the	O
Kivu	B-Location
Conflict	E-Location
,	O
a	O
military	O
conflict	O
with	O
thousands	O
of	O
displaced	O
refugees	O
.	O

Forty	O
years	O
ago	O
,	O
on	O
April	O
2nd	O
,	O
1979	O
,	O
there	O
was	O
a	O
major	O
leak	O
of	O
deadly	O
anthrax	S-Pathogen
spores	O
from	O
the	O
Soviet	S-Organization
biological	O
warfare	O
facility	O
at	O
Military	B-Organization
Compound	I-Organization
19	E-Organization
on	O
the	O
edge	O
of	O
Sverdlovsk	S-Location
.	O
The	O
strain	O
of	O
the	O
pathogen	O
,	O
,	O
was	O
the	O
deadliest	O
.	O

On	O
5	O
April	O
,	O
the	O
Singapore	B-Organization
government	E-Organization
announced	O
that	O
school	O
closures	O
would	O
be	O
extended	O
.	O

Access	O
control	O
is	O
role-based	O
and	O
allows	O
users	O
to	O
keep	O
data	O
private	O
or	O
to	O
share	O
with	O
a	O
wider	O
community	O
.	O

We	O
have	O
to	O
increase	O
our	O
efforts	O
around	O
research	O
and	O
get	O
support	O
for	O
the	O
work	O
that	O
we've	O
been	O
doing	O
.	O

The	O
role	O
of	O
non-governmental	O
organisations	O
and	O
other	O
interested	O
observers	O
-	O
civil	O
society	O
-	O
has	O
long	O
been	O
neglected	O
by	O
governments	O
in	O
the	O
quest	O
for	O
a	O
world	O
secure	O
from	O
the	O
threat	O
of	O
biological	O
weapons	O
or	O
bioterrorism	O
.	O

As	O
part	O
of	O
one	O
of	O
the	O
FBD	S-Platform
projects	O
,	O
interagency	O
audits	O
were	O
performed	O
on	O
quality	O
assurance	O
of	O
diagnostic	O
methods	O
and	O
biosafety	O
at	O
the	O
BSL-3	S-Platform
laboratories	O
,	O
using	O
relevant	O
parts	O
of	O
the	O
ISO	B-Document
17025	E-Document
and	O
:	O
Laboratory	O
Biorisk	O
Management	O
.	O

Eitzen	S-Person
,	O
Edward	B-Person
M	E-Person
.	O
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare	O
:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	O
Air	O
Force	O
Base	O
,	O
accessed	O
November	O
12	O
,	O
2008	O
.	O

Around	O
the	O
time	O
Yeltsin	S-Person
admitted	O
the	O
military	O
facility	O
was	O
responsible	O
for	O
the	O
incident	O
,	O
Russia	S-Location
allowed	O
a	O
team	O
of	O
Western	O
scientists	O
to	O
go	O
to	O
Sverdlovsk	S-Location
to	O
investigate	O
the	O
outbreak	O
.	O

The	O
overall	O
cylinders	O
are	O
generally	O
approximately	O
80 nm	O
in	O
diameter	O
,	O
and	O
have	O
a	O
virally	O
encoded	O
glycoprotein	O
(GP)	O
projecting	O
as	O
7–10 nm	O
long	O
spikes	O
from	O
its	O
lipid	O
bilayer	O
surface	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
diverged	O
from	O
its	O
ancestors	O
between	O
1960–1976	O
.	O

For	O
large-scale	O
projects	O
,	O
more	O
professional	O
solutions	O
are	O
needed	O
.	O

The	O
book	O
Emerging	O
Infectious	O
Diseases:	O
Trends	O
and	O
Issues	O
cites	O
the	O
1984	B-Incident
Rajneeshee	I-Incident
bioterror	I-Incident
attack	E-Incident
along	O
with	O
the	O
Aum	O
Shinrikyo	O
group's	O
attempts	O
to	O
use	O
anthrax	S-Pathogen
and	O
other	O
agents	O
,	O
as	O
exceptions	O
to	O
the	O
belief	O
"	O
that	O
only	O
foreign-state	O
supported	O
groups	O
have	O
the	O
resources	O
to	O
execute	O
a	O
credible	O
bioterrorism	O
event"	O
.	O

WHO	S-Organization
Director-General	O
Margaret	B-Person
Chan	E-Person
appointed	O
29	O
flu	O
experts	O
from	O
outside	O
the	O
organization	O
to	O
conduct	O
a	O
review	O
of	O
WHO	S-Organization
's	O
handling	O
of	O
the	O
.	O
She	O
told	O
them	O
,	O
"	O
We	O
want	O
a	O
frank	O
,	O
critical	O
,	O
transparent	O
,	O
credible	O
and	O
independent	O
review	O
of	O
our	O
performance.	O
"	O

But	O
I	O
do	O
want	O
to	O
end	O
with	O
just	O
summarizing	O
what	O
we	O
found	O
.	O

On	O
multiple	O
occasions	O
Taiwanese	O
journalists	O
have	O
been	O
denied	O
access	O
to	O
report	O
on	O
the	O
assembly	O
.	O

She	O
believes	O
that	O
Germany	S-Organization
the	O
largest	O
pork	O
producer	O
and	O
exporter	O
in	O
,	O
has	O
the	O
most	O
to	O
lose	O
from	O
further	O
outbreaks	O
.	O

Another	O
example	O
is	O
archaeological	O
uses	O
such	O
as	O
imaging	O
the	O
contents	O
of	O
sarcophagi	O
or	O
ceramics	O
.	O

With	O
increasing	O
awareness	O
regarding	O
biorisk	O
management	O
worldwide	O
,	O
many	O
biosafety	O
laboratories	O
are	O
being	O
setup	O
in	O
India	S-Location
It	O
is	O
important	O
for	O
the	O
facility	O
users	O
,	O
project	O
managers	O
and	O
the	O
executing	O
agencies	O
to	O
understand	O
the	O
process	O
of	O
validation	O
and	O
certification	O
of	O
such	O
biosafety	O
laboratories	O
.	O

National	O
reactions	O
have	O
included	O
containment	O
measures	O
such	O
as	O
quarantines	O
and	O
curfews	O
(known	O
as	O
stay-at-home	O
orders	O
,	O
shelter-in-place	O
orders	O
,	O
or	O
lockdowns)	O
.	O

There	O
is	O
also	O
concern	O
that	O
persons	O
with	O
symptoms	O
of	O
stroke	S-Disease
and	O
are	O
delaying	O
seeking	O
help	O
.	O

Students	O
work	O
in	O
pairs	O
under	O
personal	O
supervision	O
and	O
use	O
biohazard	O
materials	O
in	O
biological	O
hoods	O
without	O
endangering	O
themselves	O
and	O
their	O
colleagues	O
.	O

In	O
terms	O
of	O
laboratory	O
culture	O
,	O
I	O
believe	O
it's	O
an	O
issue	O
that	O
requires	O
continuous	O
improvement	O
.	O

A	O
massive	O
network	O
of	O
stakeholders	O
is	O
involved	O
in	O
BioWatch	S-Document
from	O
across	O
public	O
health	O
,	O
emergency	O
management	O
,	O
law	O
enforcement	O
,	O
laboratory	O
,	O
scientific	O
,	O
and	O
environmental	O
health	O
organizations	O
who	O
collaborate	O
to	O
detect	O
and	O
prepare	O
a	O
coordinated	O
response	O
to	O
a	O
bioterrorism	O
attack	O
,	O
according	O
to	O
.	O

NOTE:	O
The	O
following	O
information	O
has	O
been	O
adapted	O
from	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories,	I-Document
5th	I-Document
Ed.	I-Document
(BMBL,	I-Document
5th	I-Document
Ed.	I-Document
)	E-Document
which	O
is	O
published	O
jointly	O
by	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
and	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
()	O
,	O
and	O
is	O
available	O
online	O
at	O
(see	O
Internet	O
Resources)	O
.	O

Good	O
evening	O
and	O
thank	O
you	O
for	O
the	O
kind	O
introduction	O
.	O

In	O
Japan	S-Location
23 million	O
people	O
were	O
affected	O
,	O
with	O
at	O
least	O
390,000 reported	O
deaths.	O
"	O
Spanish	B-Disease
Influenza	E-Disease
in	O
Japanese	O
Armed	O
Forces	O
,	O
1918–1920"	O
.	O

See	O
also	O

German	O
soldiers	O
became	O
ill	O
with	O
the	O
rare	O
pulmonary	S-Phenotype
form	O
of	O
tularemia	S-Disease
,	O
which	O
may	O
indicate	O
the	O
use	O
of	O
an	O
aerosol	O
biological	O
weapon	O
(the	O
ordinary	O
transmission	O
pathway	O
is	O
through	O
ticks	O
and	O
rodents)	O
.	O

At	O
the	O
same	O
time	O
,	O
Assistant	O
Agriculture	O
Minister	O
for	O
Extension	O
and	O
Research	O
Alvin	B-Person
Wesseh	E-Person
informed	O
participants	O
that	O
a	O
total	O
of	O
1,228	O
cases	O
of	O
human	O
exposure	O
of	O
rabies	S-Disease
from	O
animal	O
bites	O
were	O
reported	O
by	O
the	O
National	B-Organization
Public	I-Organization
Health	I-Organization
Institute	E-Organization
in	O
.	O

It	O
is	O
based	O
on	O
a	O
simplified	O
version	O
of	O
.	O
By	O
delivering	O
the	O
Cas9	O
nuclease	O
complexed	O
with	O
a	O
synthetic	O
guide	O
RNA	O
(gRNA)	O
into	O
a	O
cell	O
,	O
the	O
cell's	O
genome	O
can	O
be	O
cut	O
at	O
a	O
desired	O
location	O
,	O
allowing	O
existing	O
genes	O
to	O
be	O
removed	O
and/or	O
new	O
ones	O
added	O
in	O
vivo	O
.	O

Unit	B-Organization
731	E-Organization
and	O
the	O
other	O
Units	O
of	O
the	O
"	O
Epidemic	B-Organization
Prevention	I-Organization
and	I-Organization
Water	I-Organization
Purification	I-Organization
Department	E-Organization
"	O
were	O
biological	O
weapon	O
production	O
,	O
testing	O
,	O
deployment	O
and	O
storage	O
facilities	O
.	O

The	O
Black	B-Disease
Death	E-Disease
killed	O
about	O
40%	O
of	O
Egypt	S-Location
's	O
population	O
.	O

Table	O
1	O
provides	O
a	O
summary	O
of	O
recommended	O
biosafety	O
levels	O
for	O
infectious	O
agents	O
.	O

The	O
Ebola	S-Disease
Epidemic	O
underscores	O
the	O
significant	O
security	O
risks	O
that	O
infectious	O
disease	O
outbreaks	O
pose	O
.	O

The	O
outbreak	O
struck	O
Aralsk	S-Location
a	O
port	O
on	O
the	O
Aral	B-Location
sea	E-Location
in	O
what	O
was	O
then	O
the	O
Kazakh	B-Location
Republic	E-Location
.	O
The	O
report	O
says	O
a	O
ship	O
doing	O
ecological	O
research	O
sailed	O
too	O
close	O
to	O
a	O
military	O
test	O
that	O
sent	O
out	O
a	O
deadly	O
plume	O
of	O
germs	O
,	O
infecting	O
a	O
crew	O
member	O
who	O
carried	O
the	O
virus	O
back	O
to	O
the	O
city	O
.	O

DANNY	B-Person
AL-FARUQUE	E-Person
Thank	O
you	O
very	O
much	O
.	O

Francisella	B-Pathogen
tularensis	E-Pathogen
is	O
very	O
infectious	O
.	O

Tourism	O
was	O
directly	O
impacted	O
in	O
the	O
affected	O
countries	O
.	O

In	O
addition	O
to	O
the	O
United	B-Location
States	E-Location
contributing	O
countries	O
participating	O
in	O
Georgia	S-Organization
's	O
upcoming	O
Real-Time	B-Document
Surveillance	I-Document
Action	I-Document
Package	E-Document
-	O
which	O
will	O
include	O
two	O
technical	O
experts	O
from	O
each	O
country	O
;	O
one	O
from	O
the	O
human	O
and	O
one	O
from	O
the	O
animal	O
health	O
sectors	O
-	O
are:	O
Argentina	S-Organization
,	O
Azerbaijan	S-Organization
,	O
Bangladesh	S-Organization
,	O
Cote	B-Organization
d'Ivoire	E-Organization
,	O
Ethiopia	S-Organization
,	O
Finland	S-Organization
,	O
Ghana	S-Organization
,	O
Guinea-Bissau	S-Organization
,	O
Indonesia	S-Organization
,	O
Israel	S-Location
,	O
Italy	S-Organization
,	O
Kenya	S-Organization
,	O
Mexico	S-Organization
,	O
Mongolia	S-Organization
,	O
Norway	S-Organization
,	O
South	B-Organization
Africa	E-Organization
,	O
the	O
United	B-Location
Kingdom	E-Location
,	O
Yemen	S-Organization
,	O
and	O
.	O

Each	O
of	O
the	O
incidents	O
is	O
complicated	O
,	O
so	O
please	O
bear	O
with	O
me	O
because	O
I	O
want	O
to	O
be	O
sure	O
to	O
give	O
you	O
all	O
of	O
the	O
information	O
that	O
we're	O
aware	O
of	O
up	O
to	O
this	O
moment	O
.	O

On	O
24	O
May	O
,	O
the	O
number	O
of	O
newly	O
infected	O
patients	O
reached	O
zero	O
for	O
in	O
,	O
the	O
first	O
time	O
since	O
the	O
outbreak	O
in	O
the	O
territory	O
in	O
March	O
.	O

A	O
2015	O
interview-based	O
evaluation	O
of	O
the	O
network	O
,	O
carried	O
out	O
by	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
concluded	O
that	O
the	O
4	O
partners	O
see	O
their	O
work	O
in	O
FBD	S-Platform
as	O
having	O
been	O
democratic	O
,	O
transparent	O
,	O
and	O
equal	O
.	O

Other	O
conclusions	O
were	O
that	O
the	O
Mukhabarat	S-Person
continued	O
to	O
investigate	O
toxins	O
as	O
tools	O
of	O
assassination	O
,	O
concealed	O
its	O
program	O
from	O
inspectors	O
after	O
the	O
1991	O
war	O
,	O
and	O
reportedly	O
conducted	O
lethal	O
human	O
experimentation	O
until	O
1994	O
.	O

Influenza	O
surveillance	O
information	O
"	O
answers	O
the	O
questions	O
of	O
where	O
,	O
when	O
,	O
and	O
what	O
influenza	O
viruses	O
are	O
circulating	O
.	O

The	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
calculated	O
that	O
in	O
2015	O
there	O
were	O
671,689	O
infections	O
in	O
the	O
EU	S-Location
and	O
caused	O
by	O
antibiotic-resistant	O
bacteria	O
,	O
resulting	O
in	O
33,110	O
deaths	O
.	O

To	O
further	O
ensure	O
that	O
all	O
medically	O
important	O
antibiotics	O
used	O
in	O
livestock	O
and	O
poultry	O
are	O
being	O
used	O
appropriately	O
,	O
Gottlieb	S-Person
said	O
the	O
agency-through	O
the	O
-will	O
bring	O
the	O
remaining	O
5%	O
of	O
medically	O
important	O
antibiotics	O
under	O
veterinary	O
supervision	O
.	O

The	O
majority	O
(62–85%)	O
were	O
attributed	O
to	O
persons	O
under	O
65	O
years	O
of	O
age	O
.	O

Senior	O
US	S-Location
government	O
officials	O
including	O
those	O
at	O
the	O
were	O
briefed	O
and	O
allowed	O
to	O
review	O
our	O
study	O
prior	O
to	O
publication	O
.	O

Although	O
the	O
JASON	B-Document
Reports	E-Document
are	O
classified	O
,	O
another	O
US	B-Organization
Air	I-Organization
Force	E-Organization
study	O
titled	O
Biotechnology:	O
Genetically	B-Scientific_research_project
Engineered	I-Scientific_research_project
Pathogens	E-Scientific_research_project
,	O
sheds	O
some	O
light	O
on	O
what	O
the	O
secretive	O
JASON	B-Organization
group	E-Organization
has	O
researched	O
–	O
5	O
groups	O
of	O
genetically	O
engineered	O
pathogens	O
that	O
can	O
be	O
used	O
as	O
bio-weapons	O
.	O

In	O
2020	O
,	O
during	O
the	O
2019–20	B-Incident
coronavirus	I-Incident
pandemic	E-Incident
the	O
WHO	S-Organization
came	O
under	O
criticism	O
for	O
refusing	O
to	O
share	O
information	O
and	O
data	O
about	O
the	O
outbreak	O
with	O
public	O
health	O
officials	O
in	O
Taiwan	S-Location
.	O
Taiwan	S-Location
president	O
Tsai	B-Person
Ing-wen	E-Person
called	O
on	O
the	O
WHO	S-Organization
to	O
allow	O
Taiwanese	O
experts	O
to	O
participate	O
in	O
the	O
dialogue	O
and	O
for	O
the	O
WHO	S-Organization
to	O
share	O
data	O
on	O
the	O
virus	O
even	O
if	O
it	O
was	O
not	O
possible	O
admit	O
as	O
a	O
member	O
state	O
.	O

Contrast	B-Technology
CT	E-Technology
generally	O
the	O
initial	O
study	O
of	O
choice	O
for	O
neck	B-Disease
masses	E-Disease
in	O
adults	O
.	O

Davis	S-Person
argued	O
the	O
Spanish	B-Disease
flu	E-Disease
–	O
Don	B-Person
Juan	E-Person
connection	O
allowed	O
Spaniards	O
to	O
make	O
sense	O
of	O
their	O
epidemic	O
experience	O
by	O
interpreting	O
it	O
through	O
their	O
familiar	O
story	O
.	O

They	O
doubted	O
the	O
United	B-Location
States	E-Location
'	O
claimed	O
compliance	O
with	O
the	O
BWC	S-Document
,	O
which	O
further	O
motivated	O
their	O
program	O
.	O

Advantages	O
of	O
Biologics	O
as	O
Weapons	O
Bioterrorism:	O
A	O
Threat	O
to	O
National	O
Security	O
or	O
Public	O
Health	O
Defining	O
Issue?	O
MM&amp;I	O
554	B-Organization
University	I-Organization
of	I-Organization
Wisconsin–Mad	E-Organization
and	B-Organization
Wisconsin	I-Organization
State	I-Organization
Laboratory	I-Organization
of	I-Organization
Hyg	E-Organization
iene	O
,	O
September	O
30	O
,	O
2008	O
.	O

USAMRIID	S-Organization
stopped	O
its	O
work	O
in	O
its	O
biosafety	B-Platform
level	I-Platform
3	I-Platform
and	I-Platform
4	E-Platform
laboratories	O
in	O
July	O
after	O
receiving	O
a	O
July	O
15	O
cease	O
and	O
desist	O
letter	O
from	O
the	O
.	O
The	O
letter	O
ordered	O
that	O
the	O
laboratory	O
stop	O
most	O
of	O
its	O
operations	O
following	O
lapses	O
in	O
its	O
biosafety	O
protocol	O
,	O
according	O
to	O
previous	O
News-Post	O
reporting	O
.	O

Given	O
the	O
system	O
,	O
there	O
was	O
an	O
obvious	O
need	O
to	O
develop	O
means	O
for	O
cross-sectoral	O
cooperation	O
between	O
national	O
laboratories	O
in	O
order	O
to	O
improve	O
the	O
country's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

It	O
will	O
take	O
four	O
years	O
to	O
construct	O
a	O
new	O
building	O
and	O
related	O
infrastructure	O
,	O
so	O
the	O
money	O
is	O
needed	O
now	O
,	O
CDC	S-Organization
officials	O
said	O
.	O

The	O
second	O
wave	O
of	O
the	O
1918	B-Incident
pandemic	E-Incident
was	O
much	O
more	O
deadly	O
than	O
the	O
first	O
.	O

Denial	O
in	O
some	O
affected	O
countries	O
also	O
made	O
containment	O
efforts	O
difficult	O
.	O

Total	O
commitment	O
at	O
all	O
levels	O
of	O
the	O
population	O
is	O
the	O
only	O
solution	O
.	O

Historical	O
and	O
epidemiologic	O
data	O
are	O
inadequate	O
to	O
identify	O
the	O
geographic	O
origin	O
of	O
the	O
virus	O
,	O
and	O
recent	O
phylogenetic	O
analysis	O
of	O
the	O
1918	O
viral	O
genome	O
does	O
not	O
place	O
the	O
virus	O
in	O
any	O
geographic	O
context	O
.	O

Biosafety	O
level	O
refers	O
to	O
the	O
stringency	O
of	O
biocontainment	O
precautions	O
deemed	O
necessary	O
by	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
for	O
laboratory	O
work	O
with	O
infectious	O
materials	O
.	O

The	O
also	O
called	O
for	O
increased	O
patient	O
education	O
and	O
requiring	O
gadolinium	O
contrast	O
vendors	O
to	O
conduct	O
additional	O
animal	O
and	O
clinical	O
studies	O
to	O
assess	O
the	O
safety	O
of	O
these	O
agents	O
.	O

This	O
review	O
introduces	O
the	O
classification	O
and	O
characterization	O
of	O
IAVs	S-Pathogen
,	O
pinpoints	O
historic	O
pandemics	O
and	O
epidemics	O
caused	O
by	O
IAVs	S-Pathogen
,	O
emphasizes	O
the	O
significance	O
and	O
necessity	O
of	O
biosafety	O
,	O
summarizes	O
currently	O
established	O
biosafety-related	O
protocols	O
for	O
research	O
,	O
and	O
provides	O
potential	O
strategies	O
to	O
improve	O
biosafety	O
protocols	O
for	O
dual-use	O
research	O
on	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
viruses	O
and	O
other	O
emerging	O
infectious	O
agents	O
.	O

These	O
included	O
preventive	O
and	O
therapeutic	O
vaccines	O
for	O
HIV	S-Disease
(already	O
in	O
advanced	O
clinical	O
trials)	O
,	O
preventive	O
vaccines	O
for	O
Marburg	S-Disease
,	O
Sudan	S-Disease
and	O
Malaria	S-Disease
,	O
all	O
with	O
major	O
epidemic	O
potential	O
with	O
high	O
human	O
lethality	O
,	O
as	O
well	O
as	O
therapeutic	O
vaccines	O
for	O
chronic	B-Disease
hepatitis	I-Disease
B	I-Disease
infections	E-Disease
and	O
tumor-associated	O
antigen-based	O
.	O

In	O
some	O
areas	O
of	O
the	O
US	S-Location
,	O
the	O
nursing	O
shortage	O
was	O
so	O
acute	O
that	O
the	O
Red	B-Organization
Cross	E-Organization
had	O
to	O
ask	O
local	O
businesses	O
to	O
allow	O
workers	O
to	O
have	O
the	O
day	O
off	O
if	O
they	O
volunteer	O
in	O
the	O
hospitals	O
at	O
night	O
(	O
Deseret	B-Organization
News	E-Organization
)	O
.	O

The	O
cylinders	O
are	O
of	O
variable	O
length	O
,	O
typically	O
800 nm	O
,	O
but	O
sometimes	O
up	O
to	O
1000 nm	O
long	O
.	O

So	O
I'll	O
try	O
again	O
,	O
with	O
some	O
help	O
from	O
the	O
folks	O
I	O
talked	O
to	O
in	O
recent	O
weeks	O
.	O

It	O
has	O
been	O
stated	O
that	O
about	O
36,000	O
die	O
from	O
the	O
seasonal	B-Disease
flu	E-Disease
in	O
the	O
U.S.	S-Location
each	O
year	O
,	O
and	O
this	O
is	O
frequently	O
understood	O
as	O
an	O
indication	O
that	O
the	O
H1N1	S-Pathogen
strain	O
was	O
not	O
as	O
severe	O
as	O
seasonal	B-Disease
influenza	E-Disease
.	O
The	O
36,000	O
estimate	O
was	O
presented	O
in	O
a	O
2003	O
study	O
by	O
CDC	S-Organization
scientists	O
and	O
refers	O
to	O
a	O
period	O
from	O
1990–91	O
through	O
1998–99	O
.	O

While	O
there	O
are	O
project-by-project	O
successes	O
,	O
there	O
is	O
significant	O
opportunity	O
to	O
develop	O
a	O
framework	O
to	O
efficiently	O
scale	O
.	O

An	O
estimated	O
72 million	O
scans	O
were	O
performed	O
in	O
the	O
United	B-Location
States	E-Location
in	O
2007	O
and	O
more	O
than	O
80	O
million	O
a	O
year	O
in	O
2015	O
.	O

He	O
said	O
continued	O
development	O
of	O
a	O
system	O
to	O
harmonize	O
AMR	O
data	O
and	O
make	O
it	O
usable	O
across	O
institutions	O
()	O
should	O
"	O
unlock	O
the	O
ability	O
for	O
real-time	O
clinician	O
support	O
across	O
all	O
electronic	O
health	O
record	O
systems.	O
"	O

According	O
to	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
there	O
are	O
no	O
available	O
vaccines	O
nor	O
specific	O
antiviral	O
treatments	O
for	O
.	O

Without	O
fluid	O
replacement	O
,	O
such	O
an	O
extreme	O
loss	O
of	O
fluids	O
leads	O
to	O
dehydration	O
,	O
which	O
in	O
turn	O
may	O
lead	O
to	O
hypovolaemic	O
shock-a	O
condition	O
in	O
which	O
there	O
isn't	O
enough	O
blood	O
for	O
the	O
heart	O
to	O
pump	O
through	O
the	O
body	O
.	O

Some	O
commentators	O
have	O
expressed	O
concern	O
that	O
it	O
could	O
allow	O
governments	O
to	O
strengthen	O
their	O
grip	O
on	O
power	O
.	O

Thus	O
,	O
to	O
benefit	O
from	O
GMOs	S-Technology
,	O
has	O
to	O
revise	O
its	O
biosafety	O
system	O
,	O
primarily	O
by	O
making	O
changes	O
to	O
some	O
provisions	O
of	O
the	O
law	O
in	O
a	O
way	O
that	O
balances	O
its	O
diverse	O
interests	O
of	O
conserving	O
biodiversity	O
,	O
protecting	O
the	O
environment	O
and	O
enhancing	O
competition	O
in	O
agricultural	O
and	O
other	O
economic	O
sectors	O
.	O

During	O
a	O
protracted	O
siege	O
of	O
the	O
city	O
,	O
in	O
1345–1346	O
the	O
Mongol	B-Organization
Golden	I-Organization
Horde	E-Organization
army	O
of	O
Jani	B-Person
Beg	E-Person
,	O
whose	O
mainly	O
Tatar	O
troops	O
were	O
suffering	O
from	O
the	O
disease	O
,	O
catapulted	O
infected	O
corpses	O
over	O
the	O
city	O
walls	O
of	O
Kaffa	S-Location
to	O
infect	O
the	O
inhabitants	O
,	O
though	O
it	O
is	O
more	O
likely	O
that	O
infected	O
rats	O
travelled	O
across	O
the	O
siege	O
lines	O
to	O
spread	O
the	O
epidemic	O
to	O
the	O
inhabitants	O
.	O

On	O
25	O
February	O
,	O
the	O
WHO	S-Organization
declared	O
"	O
the	O
world	O
should	O
do	O
more	O
to	O
prepare	O
for	O
a	O
possible	O
coronavirus	B-Incident
pandemic	E-Incident
,	O
"	O
stating	O
that	O
while	O
it	O
was	O
too	O
early	O
to	O
call	O
it	O
a	O
pandemic	O
,	O
countries	O
should	O
be	O
"	O
in	O
a	O
phase	O
of	O
preparedness"	O
.	O

In	O
recent	O
years	O
,	O
there	O
are	O
various	O
DIY	O
ways	O
to	O
live	O
healthy	O
and	O
many	O
of	O
them	O
also	O
focuses	O
on	O
different	O
simple	O
ways	O
to	O
biohack	O
mind	O
,	O
body	O
,	O
metabolism	O
and	O
sleep	O
.	O

We've	O
looked	O
carefully	O
at	O
the	O
factors	O
that	O
led	O
to	O
that	O
mistake	O
.	O

ST1284	O
is	O
a	O
double-locus	O
variant	O
of	O
ST167	O
,	O
which	O
suggests	O
possible	O
distant	O
relatedness	O
of	O
these	O
isolates	O
;	O
ST410	O
does	O
not	O
share	O
any	O
multilocus	O
sequence	O
type	O
alleles	O
with	O
ST167	O
(5)	O
.	O

During	O
1347	O
,	O
the	O
disease	O
travelled	O
eastward	O
to	O
Gaza	S-Location
by	O
April	O
,	O
by	O
July	O
it	O
had	O
reached	O
Damascus	S-Location
,	O
and	O
in	O
October	O
plague	S-Disease
had	O
broken	O
out	O
in	O
Aleppo	S-Location
.	O
That	O
year	O
,	O
in	O
the	O
territory	O
of	O
modern	O
Lebanon	S-Location
,	O
Syria	S-Location
,	O
Israel	S-Location
,	O
and	O
Palestine	S-Location
,	O
the	O
cities	O
of	O
Ashkelon	S-Location
,	O
Acre	S-Location
,	O
Jerusalem	S-Location
,	O
Sidon	S-Location
,	O
and	O
Homs	S-Location
were	O
all	O
infected	O
.	O

Researchers	O
performed	O
invasive	O
surgery	O
on	O
prisoners	O
,	O
removing	O
organs	O
to	O
study	O
the	O
effects	O
of	O
disease	O
on	O
the	O
human	O
body	O
.	O

New	O
viruses	O
are	O
also	O
emerging	O
each	O
year	O
to	O
threaten	O
the	O
lives	O
of	O
both	O
humans	O
and	O
animals	O
.	O

That	O
appears	O
to	O
have	O
changed	O
with	O
the	O
recent	O
discovery	O
of	O
a	O
DNA	O
editing	O
system	O
called	O
CRISPR/Cas9	S-Technology
(A	O
note	O
on	O
terminology	O
–	O
CRISPR	S-Technology
is	O
a	O
bacterial	O
immune	O
system	O
,	O
while	O
Cas9	O
is	O
one	O
protein	O
component	O
of	O
that	O
system	O
,	O
but	O
both	O
terms	O
are	O
often	O
used	O
to	O
refer	O
to	O
the	O
protein.)	O
It	O
operates	O
in	O
cells	O
like	O
a	O
DNA	B-Technology
scissor	E-Technology
,	O
opening	O
slots	O
in	O
the	O
genome	O
where	O
scientists	O
can	O
insert	O
their	O
own	O
sequence	O
.	O

Venter	S-Person
and	O
his	O
teams	O
at	O
both	O
the	O
JCVI	S-Organization
and	O
at	O
SGI	S-Organization
,	O
have	O
,	O
as	O
the	O
leaders	O
of	O
this	O
field	O
been	O
driving	O
these	O
ethical	O
and	O
societal	O
implications	O
since	O
the	O
beginning	O
of	O
the	O
research	O
(for	O
nearly	O
15	O
years)	O
.	O

As	O
President	O
Trump	S-Person
has	O
said	O
,	O
"	O
We	O
cannot	O
have	O
prosperity	O
if	O
we	O
are	O
not	O
healthy.	O
"	O
The	O
report	O
details	O
how	O
GHSA	S-International_exchange_and_cooperation
support	O
enabled	O
countries	O
to	O
respond	O
to	O
and	O
contain	O
outbreaks	O
of	O
high-threat	O
diseases	O
,	O
including	O
dengue	B-Disease
fever	E-Disease
in	O
Burkina	B-Location
Faso	E-Location
and	O
the	O
Marburg	B-Pathogen
virus	E-Pathogen
in	O
.	O

I'll	O
give	O
you	O
the	O
facts	O
about	O
each	O
of	O
these	O
three	O
incidents	O
and	O
for	O
the	O
two	O
that	O
happened	O
here	O
at	O
,	O
what	O
we're	O
going	O
to	O
do	O
to	O
address	O
these	O
incidents	O
because	O
fundamentally	O
,	O
what	O
they	O
reveal	O
was	O
totally	O
unacceptable	O
behavior	O
.	O

"	O
Viruses	O
are	O
fragile	O
and	O
more	O
than	O
100	O
degrees	O
or	O
more	O
will	O
kill	O
them,	O
"	O
Kam	S-Person
said	O
.	O

Some	O
countries	O
,	O
however	O
,	O
may	O
not	O
have	O
a	O
public	O
health	O
system	O
or	O
are	O
in	O
various	O
stages	O
of	O
developing	O
them	O
.	O

Clinical	O
similarities	O
led	O
contemporary	O
observers	O
to	O
conclude	O
initially	O
that	O
they	O
were	O
observing	O
the	O
same	O
disease	O
in	O
the	O
successive	O
waves	O
.	O

Stocks	O
plunged	O
again	O
due	O
to	O
coronavirus	O
fears	O
,	O
the	O
largest	O
fall	O
being	O
on	O
16	O
March	O
.	O

The	O
presentation	O
will	O
provide	O
example	O
biohazard	O
protocol	O
reviews	O
and	O
accompanying	O
containment	O
measures	O
for	O
core	O
laboratories	O
at	O
Yale	B-Organization
University	E-Organization

The	O
schools	O
and	O
day	O
care	O
centers	O
were	O
told	O
to	O
close	O
for	O
14	O
days	O
as	O
investigators	O
tried	O
to	O
identify	O
the	O
source	O
of	O
the	O
infection	O
,	O
said	O
Tsang	S-Person
the	O
chief	O
executive	O
.	O

An	O
Australian	O
study	O
of	O
10.	O
9 million	O
people	O
reported	O
that	O
the	O
increased	O
incidence	O
of	O
cancer	S-Disease
after	O
CT	B-Incident
scan	I-Incident
exposure	I-Incident
in	I-Incident
this	I-Incident
cohort	E-Incident
was	O
mostly	O
due	O
to	O
irradiation	O
.	O

This	O
allows	O
the	O
ribosomes	O
to	O
continue	O
synthesizing	O
proteins	O
essential	O
to	O
the	O
cell	O
while	O
preventing	O
antibiotics	O
from	O
binding	O
to	O
the	O
ribosome	O
to	O
inhibit	O
protein	O
synthesis	O
.	O

The	O
1984	B-Incident
Rajneeshee	I-Incident
bioterror	I-Incident
attack	E-Incident
was	O
the	O
food	O
poisoning	O
of	O
751 individuals	O
in	O
The	O
Dalles	S-Location
,	O
Oregon	S-Location
,	O
through	O
the	O
deliberate	O
contamination	O
of	O
salad	O
bars	O
at	O
ten	O
local	O
restaurants	O
with	O
Salmonella	S-Pathogen
.	O
A	O
group	O
of	O
prominent	O
followers	O
of	O
Bhagwan	B-Person
Shree	I-Person
Rajneesh	E-Person
(later	O
known	O
as	O
Osho)	O
led	O
by	O
had	O
hoped	O
to	O
incapacitate	O
the	O
voting	O
population	O
of	O
the	O
city	O
so	O
that	O
their	O
own	O
candidates	O
would	O
win	O
the	O
1984	O
Wasco	O
County	O
elections	O
.	O

Support	O
of	O
upload	O
to	O
public	O
repositories	O
is	O
invaluable	O
to	O
alleviate	O
data	O
sharing	O
.	O

The	O
lab	O
is	O
and	O
has	O
been	O
certified	O
under	O
Clinical	B-Technology
Laboratory	I-Technology
Improvement	I-Technology
Amendments	E-Technology
(	O
CLIA	S-Technology
)	O
federal	O
standards	O
,	O
and	O
the	O
lab's	O
testing	O
results	O
and	O
quality-control	O
is	O
reviewed	O
in	O
real	O
time	O
by	O
a	O
CLIA	S-Technology
technical	O
supervisor	O
.	O

The	O
DTRA	S-Organization
contractor	O
on	O
this	O
project	O
–	O
Lovelace	B-Scientific_research_project
Biomedical	I-Scientific_research_project
and	I-Scientific_research_project
Environmental	I-Scientific_research_project
Research	I-Scientific_research_project
Institute	E-Scientific_research_project
(	O
LBERI	S-Scientific_research_project
)	O
,	O
operates	O
an	O
Animal	O
Bio-safety	O
3	O
Level	O
(ABSL-3)	O
laboratory	O
which	O
has	O
Select	O
Agent	O
status	O
.	O

People	O
at	O
higher	O
risk	O
of	O
serious	O
complications	O
include	O
people	O
over	O
65	O
,	O
children	O
younger	O
than	O
5	O
,	O
children	O
with	O
neurodevelopmental	O
conditions	O
,	O
pregnant	O
women	O
(especially	O
during	O
the	O
third	O
trimester)	O
,	O
and	O
people	O
of	O
any	O
age	O
with	O
underlying	O
medical	O
conditions	O
,	O
such	O
as	O
asthma	S-Disease
,	O
diabetes	S-Disease
,	O
obesity	S-Disease
,	O
heart	B-Disease
disease	E-Disease
,	O
or	O
a	O
weakened	O
immune	O
system	O
(e.g.	O
,	O
taking	O
immunosuppressive	O
medications	O
or	O
infected	O
with	O
HIV	S-Pathogen
)	O
.	O

Laws	O
relating	O
to	O
biosafety	O
are	O
not	O
easily	O
accessible	O
and	O
there	O
are	O
few	O
federal	O
regulations	O
that	O
are	O
readily	O
available	O
for	O
a	O
potential	O
trainee	O
to	O
reference	O
outside	O
of	O
the	O
publications	O
recommended	O
in	O
.	O

The	O
is	O
a	O
national	O
agency	O
with	O
the	O
mission	O
to	O
improve	O
the	O
management	O
of	O
crises	O
in	O
society	O
.	O

Y.	B-Pathogen
pestis	E-Pathogen
was	O
discovered	O
by	O
Alexandre	B-Person
Yersin	E-Person
,	O
a	O
pupil	O
of	O
Louis	B-Person
Pasteur	E-Person
,	O
during	O
an	O
epidemic	B-Incident
of	I-Incident
bubonic	I-Incident
plague	I-Incident
in	I-Incident
Hong	I-Incident
Kong	I-Incident
in	I-Incident
1894	E-Incident
;	O
Yersin	S-Person
also	O
proved	O
this	O
bacillus	S-Pathogen
was	O
present	O
in	O
rodents	O
and	O
suggested	O
the	O
rat	O
was	O
the	O
main	O
vehicle	O
of	O
transmission	O
.	O

By	O
26	O
March	O
,	O
the	O
United	B-Location
States	E-Location
had	O
overtaken	O
China	S-Location
and	O
Italy	S-Location
with	O
the	O
highest	O
number	O
of	O
confirmed	O
cases	O
in	O
the	O
world	O
.	O

Less	O
common	O
symptoms	O
include	O
fatigue	S-Phenotype
,	O
respiratory	B-Phenotype
sputum	I-Phenotype
production	E-Phenotype
(	O
phlegm	S-Phenotype
)	O
,	O
loss	B-Phenotype
of	I-Phenotype
the	I-Phenotype
sense	I-Phenotype
of	I-Phenotype
smell	E-Phenotype
,	O
loss	B-Phenotype
of	I-Phenotype
taste	E-Phenotype
,	O
shortness	B-Phenotype
of	I-Phenotype
breath	E-Phenotype
,	O
muscle	B-Phenotype
and	I-Phenotype
joint	I-Phenotype
pain	E-Phenotype
,	O
sore	B-Phenotype
throat	E-Phenotype
,	O
headache	S-Phenotype
,	O
chills	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
coughing	B-Phenotype
out	I-Phenotype
blood	E-Phenotype
,	O
diarrhea	S-Phenotype
,	O
and	O
.	O

"	O
We	O
can't	O
count	O
on	O
outracing	O
drug	O
resistance,	O
"	O
FDA	S-Organization
	S-Organization
,	O
MD	O
,	O
said	O
in	O
announcing	O
the	O
strategy.	O
"	O
But	O
we	O
can	O
use	O
stewardship	O
and	O
science	O
to	O
slow	O
its	O
pace	O
and	O
reduce	O
its	O
impact	O
on	O
human	O
and	O
animal	O
health.	O
"	O

Calculating	O
the	O
case	O
fatality	O
rate	O
(CFR)	O
accurately	O
is	O
difficult	O
in	O
an	O
ongoing	O
epidemic	O
due	O
to	O
differences	O
in	O
testing	O
policies	O
,	O
the	O
inclusion	O
of	O
probable	O
and	O
suspected	O
cases	O
,	O
and	O
the	O
inclusion	O
of	O
new	O
cases	O
that	O
have	O
not	O
run	O
their	O
course	O
.	O

Despite	O
its	O
name	O
,	O
historical	O
and	O
epidemiological	O
data	O
cannot	O
identify	O
the	O
geographic	O
origin	O
of	O
the	O
Spanish	B-Incident
flu	E-Incident

In	O
recent	O
years	O
,	O
the	O
emergence	O
or	O
re-emergence	O
of	O
critical	O
issues	O
in	O
infectious	O
disease	O
and	O
public	O
health	O
has	O
presented	O
new	O
challenges	O
and	O
opportunities	O
for	O
laboratory	O
animal	O
care	O
professionals	O
.	O

Some	O
doctors	O
prefer	O
staying	B-Technology
with	I-Technology
invasive	I-Technology
mechanical	I-Technology
ventilation	E-Technology
when	O
available	O
because	O
this	O
technique	O
limits	O
the	O
spread	O
of	O
aerosol	O
particles	O
compared	O
to	O
a	O
.	O

These	O
2	O
national	O
initiatives	O
,	O
together	O
with	O
the	O
influence	O
of	O
other	O
international	O
and	O
EU	S-Location
activities	O
,	O
led	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
dealing	O
with	O
high-consequence	O
pathogens	O
to	O
establish	O
the	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
in	O
2007	O
(Table	O
1	O
,	O
Figure	O
2)	O
.	O

Often	O
,	O
images	O
are	O
taken	O
both	O
with	O
and	O
without	O
radiocontrast	O
.	O

The	O
mechanism	O
by	O
which	O
Y.	B-Pathogen
pestis	E-Pathogen
is	O
usually	O
transmitted	O
was	O
established	O
in	O
1898	O
by	O
Paul-Louis	B-Person
Simond	E-Person
and	O
was	O
found	O
to	O
involve	O
the	O
bites	O
of	O
fleas	O
whose	O
midguts	O
had	O
become	O
obstructed	O
by	O
replicating	O
Y.	B-Pathogen
pestis	E-Pathogen
several	O
days	O
after	O
feeding	O
on	O
an	O
infected	O
host	O
.	O

Questions	O
can	O
be	O
directed	O
to	O
404-639-3286	O
,	O
or	O
they	O
can	O
be	O
e-mailed	O
to	O
media@cdc.gov.Thank	O
youeden?	O

A	O
doctored	O
photo	O
of	O
the	O
artist	O
holding	O
a	O
day-glow-green	O
tinted	O
rabbit	O
appears	O
on	O
his	O
website.	O
"	O
I	O
Love	O
My	O
Glow	O
Bunny	O
"	O
by	O
Christopher	B-Person
Dickey	E-Person
{copyright	O
2001	O
by	O
}	O
.	O

Still	O
experiencing	O
the	O
same	O
symptoms	O
,	O
on	O
26	O
August	O
he	O
was	O
referred	O
to	O
a	O
specialised	O
facility	O
for	O
infectious	O
diseases	O
,	O
and	O
subsequently	O
hospitalised	O
.	O

On	O
24	O
April	O
2014	O
,	O
a	O
25-year-old	O
male	O
was	O
found	O
positive	O
for	O
the	O
coronavirus	S-Pathogen
He	O
had	O
history	O
of	O
exposure	O
to	O
camels	O
and	O
had	O
consumed	O
camel	O
milk	O
.	O

The	O
WHA	S-Organization
composed	O
of	O
representatives	O
from	O
all	O
194	O
member	O
states	O
,	O
serves	O
as	O
the	O
agency's	O
supreme	O
decision-making	O
body	O
.	O

No	O
country	O
has	O
divulged	O
outdoor	O
tests	O
of	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
which	O
causes	O
and	O
usually	O
kills	O
one	O
in	O
three	O
unvaccinated	O
people	O
.	O

Besides	O
the	O
lack	O
of	O
health	O
care	O
workers	O
and	O
medical	O
supplies	O
,	O
there	O
was	O
a	O
shortage	O
of	O
coffins	O
,	O
morticians	O
and	O
gravediggers	O
()	O
.	O

A	O
review	O
found	O
that	O
early	O
quarantine	O
with	O
other	O
public	O
health	O
measures	O
are	O
effective	O
in	O
limiting	O
the	O
pandemic	O
,	O
but	O
the	O
best	O
manner	O
of	O
adopting	O
and	O
relaxing	O
policies	O
are	O
uncertain	O
,	O
as	O
local	O
conditions	O
vary	O
.	O

In	O
part	O
as	O
a	O
result	O
of	O
the	O
successes	O
of	O
the	O
Conferences	O
,	O
the	O
Pan-American	B-Organization
Sanitary	I-Organization
Bureau	E-Organization
(1902)	O
,	O
and	O
the	O
(1907)	O
were	O
soon	O
founded	O
.	O

It	O
cost	O
$42	O
million	O
to	O
construct	O
on	O
over	O
1100	O
acres	O
and	O
is	O
available	O
for	O
training	O
360	O
days	O
a	O
year	O
.	O

H.R.	B-Document
6378	E-Document
would	O
direct	O
federal	O
agencies	O
to	O
respond	O
to	O
new	O
and	O
emerging	O
threats	O
"	O
to	O
strengthen	O
our	O
nation's	O
existing	O
preparedness	O
and	O
response	O
programs,	O
"	O
Eshoo	S-Person
said	O
.	O

The	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
()	O
added	O
concerns	O
about	O
the	O
misuse	O
of	O
biological	O
research	O
to	O
its	O
code	O
of	O
ethics	O
in	O
April	O
2005	O
.	O

This	O
explains	O
why	O
only	O
a	O
minority	O
of	O
natural	O
pathogens	O
are	O
suitable	O
for	O
military	O
purposes	O
.	O

Deaths	O
have	O
occurred	O
.	O

Urgent	O
pleas	O
for	O
assistance	O
were	O
sent	O
out	O
on	O
12	O
September	O
.	O

This	O
term	O
originated	O
as	O
a	O
joke	O
on	O
the	O
part	O
of	O
the	O
staff	O
because	O
the	O
official	O
cover	O
story	O
for	O
the	O
facility	O
given	O
to	O
the	O
local	O
authorities	O
was	O
that	O
it	O
was	O
a	O
lumber	O
mill	O
.	O

So	O
much	O
you've	O
covered	O
,	O
I'll	O
ask	O
you	O
one	O
question	O
.	O

The	O
primary	O
delivery	O
tactic	O
involved	O
one	O
member	O
concealing	O
a	O
plastic	O
bag	O
containing	O
a	O
light-brown	O
liquid	O
with	O
the	O
Salmonella	B-Pathogen
bacteria	E-Pathogen
(referred	O
to	O
by	O
the	O
perpetrators	O
as	O
"	O
salsa"),	O
and	O
either	O
spreading	O
it	O
over	O
the	O
food	O
at	O
a	O
salad	O
bar	O
,	O
or	O
pouring	O
it	O
into	O
salad	O
dressing	O
.	O

In	O
August	O
1981	O
,	O
following	O
a	O
formal	O
claim	O
for	O
damages	O
made	O
by	O
the	O
trade	O
union	O
Association	B-Organization
of	I-Organization
Scientific,	I-Organization
Technical	I-Organization
and	I-Organization
Managerial	I-Organization
Staffs	E-Organization
in	O
1979	O
,	O
Parker	S-Person
's	O
husband	O
,	O
,	O
was	O
awarded	O
£25,000	O
in	O
compensation	O
.	O

Using	O
state	O
money	O
,	O
Reilly	S-Person
said	O
the	O
center	O
will	O
be	O
able	O
to	O
purchase	O
more	O
of	O
the	O
simulators	O
.	O

Wikipedia	S-Platform
is	O
already	O
the	O
world's	O
'Dr	O
Google	S-Platform
'	O
-	O
it's	O
time	O
for	O
doctors	O
and	O
researchers	O
to	O
make	O
it	O
better	O
Huffington	B-Organization
Post	E-Organization
.	O
Conversation	B-Organization
Global	I-Organization
Editorial	I-Organization
Group	E-Organization
.Oct.18	O
,	O
2016	O
.	O

In	O
addition	O
,	O
CDC	S-Organization
has	O
provided	O
to	O
APHIS	S-Organization
example	O
protocols	O
for	O
inactivation	O
of	O
anthrax	S-Pathogen
and	O
also	O
a	O
plan	O
outlining	O
required	O
refresher	O
training	O
of	O
laboratory	O
personnel	O
with	O
access	O
to	O
on	O
the	O
appropriate	O
use	O
of	O
the	O
inactivation	O
protocol	O
.	O

[There	O
was]	O
...	O
a	O
history	O
of	O
dozens	O
of	O
allegations	O
made	O
by	O
various	O
branches	O
of	O
the	O
Soviet	B-Organization
government	E-Organization
for	O
the	O
entire	O
post-World	O
War	O
II	O
period	O
charging	O
that	O
the	O
United	B-Location
States	E-Location
had	O
used	O
biological	O
weapons	O
.	O

This	O
has	O
led	O
some	O
historians	O
to	O
label	O
the	O
a	O
"	O
forgotten	O
pandemic"	O
.	O

This	O
would	O
include	O
agencies	O
such	O
as	O
HHS	S-Organization
's	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
()	O
,	O
which	O
supports	O
private-sector	O
development	O
of	O
new	O
drugs	O
and	O
vaccines	O
.	O

The	O
FBD	B-Document
QA	I-Document
manual	E-Document
has	O
gradually	O
been	O
revised	O
and	O
now	O
covers	O
network	O
organization	O
,	O
project	O
management	O
,	O
implementation	O
planning	O
,	O
communicating	O
project	O
results	O
,	O
recommendations	O
on	O
quality	O
assurance	O
of	O
diagnostics	O
at	O
BSL-3	S-Platform
laboratories	O
,	O
and	O
protocols	O
for	O
the	O
validation	O
of	O
diagnostic	O
PCR	S-Technology
methods	O
.	O

I	O
call	O
this	O
the	O
Amazing	O
Hour	O
,	O
but	O
you	O
can	O
call	O
it	O
whatever	O
you	O
like	O
.	O

USAMRIID	S-Organization
received	O
a	O
letter	O
from	O
the	O
CDC	S-Organization
and	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
,	O
the	O
two	O
agencies	O
that	O
oversee	O
the	O
FSAP	S-Scientific_research_project
,	O
partially	O
lifting	O
the	O
military	O
laboratory's	O
suspension	O
with	O
the	O
FSAP	S-Scientific_research_project
program	O
on	O
Nov.	O
20	O
,	O
said	O
Friday	O
.	O

USAMRIID	S-Organization
stopped	O
its	O
work	O
in	O
its	O
biosafety	B-Platform
level	I-Platform
3	I-Platform
and	I-Platform
4	E-Platform
laboratories	O
in	O
July	O
after	O
receiving	O
a	O
July	O
15	O
cease	O
and	O
desist	O
letter	O
from	O
the	O
.	O
The	O
letter	O
ordered	O
that	O
the	O
laboratory	O
stop	O
most	O
of	O
its	O
operations	O
following	O
lapses	O
in	O
its	O
biosafety	O
protocol	O
,	O
according	O
to	O
previous	O
News-Post	O
reporting	O
.	O

By	O
22	O
March	O
,	O
six	O
cases	O
in	O
Taiwan	S-Location
had	O
matched	O
the	O
definition	O
of	O
probable	O
.	O

The	O
office	O
tracks	O
outbreaks	O
of	O
disease	O
.	O

The	O
outbreak	O
was	O
contained	O
by	O
quarantining	O
hundreds	O
of	O
people	O
and	O
vaccinating	O
almost	O
50,000	O
residents	O
within	O
two	O
weeks	O
,	O
a	O
demonstration	O
that	O
public	O
health	O
responses	O
can	O
be	O
effective	O
.	O

In	O
a	O
summary	O
by	O
the	O
GAO	S-Organization
the	O
Secretary	B-Organization
of	I-Organization
the	I-Organization
Army	E-Organization
has	O
gone	O
so	O
far	O
as	O
to	O
implement	O
a	O
,	O
but	O
the	O
organization	O
has	O
not	O
created	O
the	O
strategy	O
and	O
execution	O
for	O
managing	O
the	O
initiative	O
.	O

&quot;This	O
is	O
a	O
large-scale	O
operation	O
so	O
five-	O
or	O
10-year	O
programs	O
are	O
going	O
to	O
be	O
need	O
ed,&quot;	B-Person
L	E-Person
said	O
.	O

In	O
support	O
of	O
the	O
principle	O
of	O
a	O
tobacco-free	O
work	O
environment	O
,	O
the	O
WHO	S-Organization
does	O
not	O
recruit	O
cigarette	O
smokers	O
.	O

Alteration	O
of	O
target-	O
or	O
binding	O
site:	O
for	O
example	O
,	O
alteration	O
of	O
PBP-the	O
binding	O
target	O
site	O
of	O
penicillins-in	O
MRSA	S-Pathogen
and	O
other	O
penicillin-resistant	O
bacteria	O
.	O

In	O
terms	O
of	O
medical	O
literature	O
that	O
are	O
reviews	O
,	O
few	O
articles	O
have	O
been	O
published	O
,	O
such	O
as	O
Shantha	S-Person
et	O
al.	O
which	O
discusses	O
management	O
of	O
panuveitis	S-Disease
and	O
iris	O
.	O

Homeland	O
Security	O
and	O
Terrorism:	O
Readings	O
and	O
Interpretations	O
,	O
(Google	O
Books)	O
,	O
McGraw-Hill	O
Professional	O
,	O
2006	O
,	O
p.	O
49	O
,	O
()	O
.	O

Lab	O
officials	O
say	O
the	O
researcher	O
was	O
closely	O
monitored	O
and	O
did	O
not	O
get	O
sick	O
or	O
show	O
symptoms	O
of	O
an	O
influenza	B-Disease
infection	E-Disease

He	O
explains	O
how	O
,	O
even	O
though	O
the	O
United	O
States	O
would	O
be	O
better	O
fending	O
off	O
bioterrorist	O
attacks	O
now	O
than	O
they	O
would	O
be	O
a	O
decade	O
ago	O
,	O
the	O
amount	O
of	O
money	O
available	O
to	O
fight	O
bioterrorism	O
over	O
the	O
last	O
three	O
years	O
has	O
begun	O
to	O
decrease	O
.	O

On	O
11	O
November	O
,	O
six	O
people	O
were	O
killed	O
in	O
an	O
attack	O
by	O
an	O
armed	O
rebel	O
group	O
in	O
Beni	S-Location
;	O
as	O
a	O
consequence	O
vaccinations	O
were	O
suspended	O
there	O
.	O

After	O
quenching	O
the	O
reaction	O
in	O
a	O
weakly	O
acidic	O
aqueous	O
solution	O
,	O
a	O
mixture	O
of	O
1:	O
1	O
anomers	O
was	O
obtained	O
.	O

They	O
have	O
highlighted	O
,	O
for	O
example	O
,	O
disparities	O
in	O
methods	O
,	O
diagnostic	B-Equipment
equipment	E-Equipment
,	O
QA	B-Platform
management	I-Platform
systems	E-Platform
,	O
the	O
transport	O
and	O
delivery	O
of	O
samples	O
,	O
and	O
inter-agency	O
communication	O
and	O
data	O
sharing	O
(Table	O
2)	O
.	O

"	O
Contrary	O
to	O
popular	O
myth	O
--	O
probably	O
from	O
the	O
film	O
'Outbreak'	O
--	O
Ebola	S-Pathogen
is	O
not	O
airborne	O
,	O
and	O
relies	O
on	O
transmission	O
through	O
the	O
consumption	O
of	O
contaminated	O
meat	O
and	O
direct	O
contact	O
with	O
infected	O
bodily	O
fluid,	O
"	O
said	O
.	O

The	O
$3.5	O
million	O
in	O
grants	O
is	O
available	O
through	O
NIFA	S-Organization
's	O
.	O

The	O
review	O
began	O
immediately	O
to	O
assess	O
the	O
health	O
risk	O
,	O
and	O
those	O
workers	O
handling	O
the	O
plates	O
were	O
immediately	O
notified	O
.	O

On	O
11	O
February	O
,	O
the	O
WHO	S-Organization
established	O
COVID-19	S-Disease
as	O
the	O
name	O
of	O
the	O
disease	O
,	O
and	O
UN	S-Organization
Secretary-General	O
António	B-Person
Guterres	E-Person
agreed	O
to	O
provide	O
the	O
"	O
power	O
of	O
the	O
entire	O
UN	S-Organization
system	O
in	O
the	O
response"	O
.	O

The	O
42-day	O
countdown	O
toward	O
Liberia	S-Location
being	O
declared	O
-free	O
,	O
for	O
the	O
third	O
time	O
,	O
started	O
on	O
4	O
December	O
2015	O
.	O

However	O
,	O
researchers	O
were	O
forbidden	O
from	O
implanting	O
the	O
embryos	O
and	O
the	O
embryos	O
were	O
to	O
be	O
destroyed	O
after	O
seven	O
days	O
.	O

This	O
type	O
had	O
a	O
major	O
advantage	O
since	O
sweep	O
speeds	O
can	O
be	O
much	O
faster	O
,	O
allowing	O
for	O
less	O
blurry	O
imaging	O
of	O
moving	O
structures	O
,	O
such	O
as	O
the	O
heart	O
and	O
arteries	O
.	O

Through	O
excretion	O
,	O
the	O
virus	O
spread	O
through	O
drainage	O
.	O

In	O
terms	O
of	O
monitoring	O
and	O
regulating	O
antimicrobial	O
consumption	O
,	O
the	O
report	O
found	O
68	O
nations	O
have	O
a	O
system	O
for	O
tracking	O
human	O
antibiotic	O
use	O
,	O
which	O
is	O
considered	O
critical	O
for	O
enabling	O
the	O
study	O
of	O
AMR	O
interventions	O
,	O
and	O
123	O
countries	O
have	O
policies	O
requiring	O
a	O
prescription	O
for	O
antibiotic	O
use	O
.	O

In	O
countries	O
without	O
biosafety	O
associations	O
,	O
members	O
of	O
other	O
scientifically	O
related	O
associations	O
were	O
invited	O
.	O

The	O
report	O
also	O
outlines	O
legal	O
,	O
technical	O
,	O
and	O
cultural	O
challenges	O
.	O

P3	S-Platform
performers	O
are	O
expected	O
to	O
demonstrate	O
safety	O
of	O
their	O
nucleic	O
acid	O
product	O
against	O
one	O
target	O
pathogen	O
in	O
a	O
phase	O
I	O
clinical	O
trial	O
.	O

On	O
17	O
March	O
2020	O
,	O
the	O
drug	O
was	O
provisionally	O
approved	O
for	O
use	O
for	O
COVID‑19	S-Disease
patients	O
in	O
a	O
serious	O
condition	O
as	O
a	O
result	O
of	O
the	O
outbreak	O
in	O
the	O
Czech	B-Location
Republic	E-Location
.	O
HTML	O
Version	O
On	O
20	O
March	O
2020	O
,	O
United	B-Location
States	E-Location
President	O
Donald	B-Person
Trump	E-Person
announced	O
that	O
remdesivir	S-Drug
was	O
available	O
for	O
"	O
compassionate	O
use	O
"	O
for	O
people	O
with	O
COVID‑19	S-Disease
;	O
FDA	S-Organization
Commissioner	O
Stephen	B-Person
Hahn	E-Person
confirmed	O
the	O
statement	O
at	O
the	O
same	O
press	O
conference	O
.	O

Most	O
genetic	O
alterations	O
that	O
people	O
know	O
about	O
today	O
are	O
through	O
engineering	O
of	O
crops	O
,	O
which	O
involves	O
adding	O
or	O
altering	O
less	O
than	O
10	O
genes	O
out	O
of	O
the	O
tens	O
of	O
thousands	O
that	O
are	O
contained	O
in	O
most	O
organisms	O
or	O
plants	O
.	O

All	O
animals	O
were	O
housed	O
in	O
the	O
intensive	O
care	O
unit	O
for	O
&gt;24	O
hours	O
(Appendix	O
Figure)	O
.	O

Functional	O
imaging	O
of	O
the	O
pancreas	O
is	O
performed	O
following	O
administration	O
of	O
secretin	S-Drug
.	O
MR	B-Technology
enterography	E-Technology
provides	O
non-invasive	O
assessment	O
of	O
inflammatory	B-Disease
bowel	I-Disease
disease	E-Disease
and	O
small	B-Disease
bowel	I-Disease
tumors	E-Disease
.	O
MR-colonography	S-Technology
may	O
play	O
a	O
role	O
in	O
the	O
detection	O
of	O
large	O
polyps	O
in	O
patients	O
at	O
increased	O
risk	O
of	O
.	O

However	O
,	O
HHS	S-Organization
did	O
not	O
explain	O
why	O
several	O
states	O
with	O
some	O
of	O
the	O
highest	O
caseloads	O
had	O
been	O
omitted	O
from	O
the	O
first	O
two	O
distribution	O
rounds	O
,	O
including	O
California	S-Location
,	O
Florida	S-Location
,	O
and	O
.	O

In	O
a	O
November	O
2017	O
JAMA	O
article	O
,	O
Center	O
authors	O
outlined	O
why	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)-a	O
formal	O
,	O
international	O
initiative	O
launched	O
in	O
2014	O
to	O
keep	O
the	O
world	O
safe	O
from	O
infectious	O
disease	O
threats-needed	O
additional	O
U.S.	S-Location
funding	O
to	O
ensure	O
its	O
long-term	O
sustainability	O
beyond	O
the	O
approaching	O
expiration	O
of	O
an	O
initial	O
$1	O
billion	O
U.S.	S-Location
investment	O
.	O

In	O
many	O
nations	O
,	O
a	O
third	O
wave	O
occurred	O
in	O
early	O
1919	O
.	O

Some	O
research	O
shows	O
that	O
ultraviolet	B-Equipment
avalanche	I-Equipment
photodiodes	E-Equipment
offer	O
the	O
high	O
gain	O
,	O
reliability	O
and	O
robustness	O
needed	O
to	O
detect	O
anthrax	S-Pathogen
and	O
other	O
bioterrorism	O
agents	O
in	O
the	O
air	O
.	O

One	O
theory	O
that	O
may	O
partially	O
explain	O
these	O
findings	O
is	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
had	O
an	O
intrinsically	O
high	O
virulence	O
,	O
tempered	O
only	O
in	O
those	O
patients	O
who	O
had	O
been	O
born	O
before	O
1889	O
,	O
e.g.	O
,	O
because	O
of	O
exposure	O
to	O
a	O
then-circulating	O
virus	O
capable	O
of	O
providing	O
partial	O
immunoprotection	O
against	O
the	O
strain	O
only	O
in	O
persons	O
old	O
enough	O
(&gt;35	O
years)	O
to	O
have	O
been	O
infected	O
during	O
that	O
prior	O
era	O
.	O

Other	O
aspects	O
included	O
bioterrorism	O
and	O
means	O
to	O
combat	O
it	O
,	O
as	O
well	O
as	O
bioethics	O
and	O
dual	O
use	O
resebiosafety	O
,	O
biosecurity	O
,	O
biocontainment	O
,	O
and	O
biorisk	O
management	O
in	O
biomedical	O
and	O
biotechnology	O
laboratories	O
.	O

He	O
pledged	O
to	O
commit	O
another	O
$150	O
million	O
to	O
the	O
to	O
achieve	O
the	O
goals	O
in	O
its	O
five-year	O
plan	O
.	O

They	O
said	O
"	O
scientists	O
should	O
avoid	O
even	O
attempting	O
,	O
in	O
lax	O
jurisdictions	O
,	O
germline	O
genome	O
modification	O
for	O
clinical	O
application	O
in	O
humans	O
"	O
until	O
the	O
full	O
implications	O
"	O
are	O
discussed	O
among	O
scientific	O
and	O
governmental	O
organizations"	O
.	O

In	O
China	S-Location
xenophobia	O
and	O
racism	O
against	O
non-Chinese	O
residents	O
has	O
been	O
inflamed	O
by	O
the	O
pandemic	O
,	O
with	O
foreigners	O
described	O
as	O
"	O
foreign	O
garbage	O
"	O
and	O
targeted	O
for	O
"	O
disposal".	O
Some	O
black	O
people	O
were	O
evicted	O
from	O
their	O
homes	O
by	O
police	O
and	O
told	O
to	O
leave	O
China	S-Location
within	O
24	O
hours	O
,	O
due	O
to	O
disinformation	O
that	O
they	O
and	O
other	O
foreigners	O
were	O
spreading	O
the	O
virus	O
.	O

Emsley	S-Person
,	O
.	O
Molecules	O
of	O
Murder:	O
Chemical	O
Molecules	O
and	O
Classic	O
Cases	O
,	O
(Google	O
Books)	O
,	O
Royal	O
Society	O
of	O
Chemistry	O
,	O
2008	O
,	O
pp.	O
9-12	O
,	O
()	O
.	O

Chavez	S-Person
,	O
Stephanie	S-Person
and	O
Simon	S-Person
,	O
Richard	S-Person
.	O
"	O
Months-Long	O
Spraying	O
of	O
Medfly	O
Is	O
Ordered	O
Infestation:	O
Officials	O
admit	O
underestimating	O
the	O
outbreak	O
.	O

Although	O
ARMADA	S-Scientific_research_project
is	O
just	O
getting	O
started	O
,	O
50	O
clinical	O
and	O
academic	O
institutions	O
have	O
agreed	O
to	O
join	O
the	O
effort	O
.	O

CRISPR	S-Technology
can	O
be	O
utilized	O
to	O
create	O
human	O
cellular	O
models	O
of	O
disease	O
.	O

Risk	O
assessments	O
help	O
us	O
ensure	O
the	O
hazards	O
will	O
not	O
happen	O
,	O
we	O
may	O
not	O
be	O
able	O
to	O
eliminate	O
all	O
the	O
hazards	O
,	O
however	O
,	O
the	O
probability	O
of	O
incidence	O
occurring	O
can	O
be	O
minimized	O
through	O
risk	O
assessment	O
.	O

Genome	B-Technology
editing	E-Technology
in	O
reproductive	O
cells	O
,	O
such	O
as	O
sperm	O
or	O
eggs	O
,	O
could	O
result	O
in	O
heritable	O
genetic	O
changes	O
,	O
meaning	O
dangerous	O
mutations	O
could	O
be	O
passed	O
down	O
to	O
future	O
generations	O
.	O

The	O
plan	O
submitted	O
by	O
the	O
TB	S-Disease
lab	O
to	O
the	O
internal	O
working	O
group	O
details	O
safety	O
procedures	O
for	O
each	O
step	O
of	O
the	O
TB	S-Disease
inactivation	O
process	O
.	O

The	O
primary	O
hazards	O
to	O
personnel	O
working	O
with	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
agents	O
are	O
respiratory	O
exposure	O
to	O
infectious	O
aerosols	O
,	O
mucous	O
membrane	O
or	O
broken	O
skin	O
exposure	O
to	O
infectious	O
droplets	O
,	O
and	O
autoinoculation	O
.	O

This	O
could	O
then	O
be	O
supplemented	O
by	O
a	O
review	O
of	O
experiments	O
involving	O
biological	O
agents	O
that	O
raise	O
concern	O
about	O
their	O
potential	O
for	O
misuse	O
.	O

Although	O
tularemia	S-Pathogen
is	O
treatable	O
by	O
antibiotics	S-Drug
,	O
treatment	O
does	O
not	O
shorten	O
the	O
course	O
of	O
the	O
disease	O
.	O

There	O
are	O
multiple	O
national	O
and	O
international	O
monitoring	O
programs	O
for	O
drug-resistant	O
threats	O
,	O
including	O
methicillin-resistant	B-Pathogen
Staphylococcus	I-Pathogen
aureus	E-Pathogen
(	O
MRSA	S-Pathogen
)	O
,	O
vancomycin-resistant	B-Pathogen
S.	I-Pathogen
aureus	E-Pathogen
(	O
VRSA	S-Pathogen
)	O
,	O
extended	O
spectrum	O
beta-lactamase	O
(ESBL)	O
,	O
vancomycin-resistant	B-Pathogen
Enterococcus	E-Pathogen
(	O
VRE	S-Pathogen
)	O
,	O
multidrug-resistant	B-Pathogen
A.	I-Pathogen
baumannii	E-Pathogen
()	O
.	O

The	O
application	O
of	O
CRISPR	S-Technology
with	O
therapeutic	O
purposes	O
have	O
been	O
explored	O
since	O
the	O
very	O
initial	O
moments	O
of	O
the	O
tool	O
description	O
.	O

Its	O
first	O
priorities	O
were	O
to	O
control	O
the	O
spread	O
of	O
malaria	S-Disease
,	O
tuberculosis	S-Disease
and	O
sexually	O
transmitted	O
infections	O
,	O
and	O
to	O
improve	O
maternal	O
and	O
child	O
health	O
,	O
nutrition	O
and	O
environmental	O
hygiene	O
.	O

At	O
least	O
twelve	O
sitting	O
or	O
former	O
Iranian	O
politicians	O
and	O
government	O
officials	O
had	O
died	O
from	O
the	O
disease	O
by	O
17	O
March	O
.	O

Prime	O
editingSearch-and-replace	O
genome	O
editing	O
without	O
double-strand	O
breaks	O
or	O
donor	O
DNA	O
.	O

In	O
early	O
and	O
mid-January	O
2020	O
,	O
the	O
virus	O
spread	O
to	O
other	O
Chinese	O
provinces	O
,	O
helped	O
by	O
the	O
Chinese	B-Activity
New	I-Activity
Year	I-Activity
migration	E-Activity
and	O
Wuhan	S-Location
being	O
a	O
transport	O
hub	O
and	O
major	O
rail	O
interchange	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
is	O
the	O
single	O
member	O
of	O
the	O
species	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
,	O
which	O
is	O
the	O
type	O
species	O
for	O
the	O
genus	O
Ebolavirus	S-Pathogen
,	O
family	O
Filoviridae	O
,	O
order	O
Mononegavirales	O
.	O

On	O
2	O
August	O
1991	O
,	O
representatives	O
of	O
the	O
Iraqi	O
government	O
announced	O
to	O
leaders	O
of	O
UNSCOM's	B-Organization
"	O
Team	I-Organization
7"	E-Organization
that	O
they	O
had	O
conducted	O
research	O
into	O
the	O
offensive	O
use	O
of	O
B.	B-Pathogen
anthracis	E-Pathogen
,	O
botulinum	B-Pathogen
toxins	E-Pathogen
,	O
and	O
Clostridium	B-Pathogen
perfringens	I-Pathogen
toxins	E-Pathogen
.	O
Woods	S-Person
,	O
Op.	O
cit.	O
,	O
pp	O
7-8	O
.	O

Iraq's	O
State	B-Location
Establishment	I-Location
for	I-Location
Pesticide	I-Location
Production	E-Location
(	O
SEPP	S-Location
)	O
also	O
ordered	O
culture	O
media	O
and	O
incubators	O
from	O
Germany	S-Organization
's	O
Water	O
Engineering	O
Trading	O
.	O

On	O
24	O
April	O
2014	O
,	O
a	O
25-year-old	O
male	O
was	O
found	O
positive	O
for	O
the	O
coronavirus	S-Pathogen
He	O
had	O
history	O
of	O
exposure	O
to	O
camels	O
and	O
had	O
consumed	O
camel	O
milk	O
.	O

In	O
2014	O
,	O
incidents	B-Incident
with	I-Incident
Anthrax	I-Incident
and	I-Incident
Ebola	I-Incident
pathogens	I-Incident
in	I-Incident
CDC	I-Incident
laboratories	E-Incident
()	O
,	O
prompted	O
the	O
CDC	O
director	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

In	O
March	O
2020	O
,	O
a	O
small	O
trial	O
of	O
remdesivir	S-Drug
in	O
rhesus	O
macaque	O
monkeys	O
with	O
COVID‑19	S-Disease
infections	O
found	O
that	O
it	O
prevents	O
disease	O
progression	O
.	O

As	O
a	O
consequence	O
,	O
the	O
high	O
level	O
of	O
misinterpretation	O
was	O
responsible	O
for	O
a	O
low	O
comprehensive	O
knowledge	O
about	O
the	O
virus	O
;	O
82%	O
of	O
individuals	O
believed	O
that	O
Ebola	S-Disease
was	O
the	O
result	O
of	O
a	O
virus	O
(36.2%	O
thought	O
that	O
a	O
higher	O
power	O
had	O
caused	O
it)	O
.	O

He	O
and	O
other	O
public	O
health	O
experts	O
also	O
question	O
whether	O
the	O
administration's	O
plan	O
will	O
politicize	O
decision-making	O
about	O
products	O
bought	O
for	O
the	O
stockpile	O
.	O

The	O
material	O
was	O
on	O
a	O
sealed	O
plate	O
but	O
should	O
not	O
have	O
been	O
moved	O
into	O
the	O
BSL‐2	S-Platform
laboratory	O
.	O

Some	O
authorities	O
have	O
criticized	O
this	O
decision	O
as	O
"	O
utterly	O
indefensible	O
"	O
from	O
an	O
ethical	O
perspective	O
.	O

They	O
included:	O
smallpox	S-Pathogen
,	O
EEE	S-Pathogen
and	O
WEE	S-Pathogen
,	O
AHF	S-Pathogen
,	O
Hantavirus	S-Pathogen
,	O
BHF	S-Pathogen
,	O
Lassa	B-Pathogen
fever	E-Pathogen
,	O
Coronavirus	S-Pathogen
,The	O
United	B-Location
States	E-Location
is	O
known	O
to	O
have	O
researched	O
both	O
B.	B-Pathogen
mallei	E-Pathogen
(the	O
causal	O
agent	O
of	O
glanders	S-Disease
)	O
and	O
B.	B-Pathogen
pseudomallei	E-Pathogen
(the	O
causal	O
agent	O
of	O
)	O
from	O
1943–1944	O
.	O

Shia	O
shrines	O
in	O
remained	O
open	O
to	O
pilgrims	O
until	O
16	O
March	O
.	O

Shooter	S-Organization
,	O
p.	O
72	O
Parker	S-Person
died	O
of	O
smallpox	S-Disease
at	O
Catherine-de-Barnes	S-Organization
	S-Organization
on	O
11	O
September	O
1978	O
.	O

On	O
12	O
January	O
,	O
the	O
journal	O
Nature	S-Organization
reported	O
that	O
the	O
virus	O
emergence	O
could	O
be	O
found	O
by	O
studying	O
how	O
bush-meat	O
hunters	O
interacted	O
with	O
the	O
ecosystem	O
.	O

House	O
.	O

With	O
many	O
of	O
the	O
mysteries	O
of	O
DNA	O
still	O
unsolved	O
,	O
some	O
scientists	O
believe	O
the	O
only	O
way	O
to	O
truly	O
understand	O
the	O
genome	O
is	O
to	O
make	O
one	O
from	O
its	O
basic	O
building	O
blocks	O
.	O

I'm	O
disappointed	O
by	O
what	O
happened	O
,	O
and	O
frankly	O
,	O
I'm	O
angry	O
about	O
it	O
.	O

The	O
June	O
incident	O
posed	O
a	O
low	O
risk	O
of	O
exposure	O
partly	O
because	O
it	O
occurred	O
on	O
the	O
ninth	O
day	O
of	O
the	O
experiment	O
,	O
when	O
there	O
had	O
historically	O
been	O
little	O
or	O
no	O
virus	O
left	O
in	O
the	O
ducks	O
,	O
the	O
lab	O
told	O
USA	B-Organization
TODAY	E-Organization
All	O
staff	O
using	O
facilities	O
were	O
retrained	O
on	O
proper	O
assembly	O
and	O
inspection	O
of	O
personal	O
protective	O
equipment	O
.	O

The	O
cross-sectoral	O
FBD	S-Platform
network	O
not	O
only	O
adopts	O
to	O
the	O
One	O
Health	O
concept	O
;	O
it	O
also	O
leads	O
to	O
improved	O
coordination	O
and	O
harmonization	O
between	O
laboratories	O
that	O
undoubtedly	O
will	O
save	O
resources	O
and	O
strengthen	O
national	O
biopreparedness	O
.	O

Several	O
thousand	O
of	O
Rajneesh	S-Person
followers	O
had	O
moved	O
onto	O
the	O
"	O
Big	O
Muddy	O
Ranch	O
"	O
in	O
rural	O
Wasco	B-Location
County	E-Location
in	O
1981	O
,	O
where	O
they	O
later	O
incorporated	O
as	O
a	O
city	O
called	O
Rajneeshpuram	S-Location
.	O
They	O
had	O
taken	O
political	O
control	O
of	O
the	O
small	O
nearby	O
town	O
of	O
Antelope	S-Location
,	O
Oregon	S-Location
(population	O
75)	O
,	O
the	O
name	O
of	O
which	O
they	O
changed	O
to	O
"	O
".	O
The	O
group	O
had	O
started	O
on	O
friendly	O
terms	O
with	O
the	O
local	O
population	O
,	O
but	O
relations	O
soon	O
degraded	O
because	O
of	O
land	O
use	O
conflicts	O
and	O
the	O
commune's	O
dramatic	O
expansion	O
.	O

Planning	O
to	O
deal	O
with	O
an	O
Article	O
VII	O
scenario	O
can	O
enhance	O
public	O
preparedness	O
,	O
but	O
must	O
also	O
be	O
done	O
with	O
the	O
experience	O
of	O
natural	O
disease	O
outbreaks	O
in	O
mind	O
.	O

The	O
National	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
of	I-Organization
Papua	I-Organization
New	I-Organization
Guinea	E-Organization
(	O
NDOH	S-Organization
)	O
and	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
yesterday	O
announced	O
a	O
case	O
of	O
polio	S-Disease
in	O
a	O
3-year	O
old	O
boy	O
from	O
Mulitaka	S-Location
,	O
Laigam	B-Location
District	E-Location
in	O
.	O

Techniques	O
involving	O
phase	O
accumulation	O
(known	O
as	O
phase	B-Technology
contrast	I-Technology
angiography	E-Technology
can	O
also	O
be	O
used	O
to	O
generate	O
flow	O
velocity	O
maps	O
easily	O
and	O
accurately	O
.	O

One	O
of	O
the	O
Pentagon	B-Organization
laboratories	E-Organization
is	O
located	O
in	O
Kharkiv	S-Location
,	O
where	O
in	O
January	O
2016	O
at	O
least	O
20	O
Ukrainian	O
soldiers	O
died	O
from	O
Flu-like	B-Pathogen
virus	E-Pathogen
in	O
just	O
two	O
days	O
with	O
200	O
more	O
being	O
hospitalized	O
.	O

Humphries	S-Person
,	O
of	O
the	O
Memorial	B-Organization
University	I-Organization
of	I-Organization
Newfoundland	E-Organization
in	O
St.	B-Location
John's	E-Location
,	O
based	O
his	O
conclusions	O
on	O
newly	O
unearthed	O
records	O
.	O

These	O
2	O
national	O
initiatives	O
,	O
together	O
with	O
the	O
influence	O
of	O
other	O
international	O
and	O
EU	S-Location
activities	O
,	O
led	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
dealing	O
with	O
high-consequence	O
pathogens	O
to	O
establish	O
the	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
in	O
2007	O
(Table	O
1	O
,	O
Figure	O
2)	O
.	O

Do	O
you	O
know	O
at	O
this	O
time	O
what	O
those	O
actions	O
will	O
be?	O
Are	O
there	O
specific	O
individuals	O
who	O
will	O
be	O
demoted	O
or	O
losing	O
their	O
jobs	O
over	O
this?	O
And	O
ultimately	O
,	O
who	O
is	O
responsible	O
for	O
the	O
safety	O
of	O
the	O
laboratories	O
at	O
?	O

Who	O
would	O
administer	O
it?	O
Who	O
would	O
pay	O
for	O
it?	O
Who	O
would	O
manufacture	O
it?	O
The	O
cost	O
of	O
complications	O
that	O
may	O
occur	O
.	O

Students	O
grow	O
the	O
bacteria	O
to	O
logarithmic	O
stage	O
,	O
switch	O
on	O
the	O
lytic	O
cycle	O
by	O
moving	O
the	O
bacteria	O
to	O
42°C	O
,	O
and	O
follow	O
bacterial	O
lysis	O
indirectly	O
by	O
recording	O
the	O
optical	O
density	O
of	O
the	O
medium	O
.	O

Student	O
safety	O
and	O
personal	O
mentoring	O
are	O
fundamental	O
to	O
any	O
teaching	O
laboratory	O
for	O
science	O
undergraduates	O
.	O

In	O
recent	O
years	O
,	O
such	O
professionals	O
have	O
responded	O
to	O
the	O
Sept.	B-Incident
11,	I-Incident
2001	I-Incident
terror	I-Incident
attacks	E-Incident
the	O
anthrax	B-Incident
attacks	E-Incident
,	O
the	O
2014-2015	O
Ebola	B-Incident
outbreak	E-Incident
,	O
and	O
the	O
spread	O
of	O
the	O
Zika	B-Pathogen
virus	E-Pathogen
in	O
,	O
among	O
other	O
public	O
health	O
emergencies	O
.	O

Vektor	S-Organization
has	O
one	O
of	O
the	O
world's	O
largest	O
collections	O
of	O
viruses	O
,	O
including	O
Ebola	S-Pathogen
,	O
according	O
to	O
Interfax	S-Organization
.	O
Reports	O
say	O
its	O
collection	O
includes	O
samples	O
of	O
smallpox	S-Pathogen
,	O
bird	B-Pathogen
flu	E-Pathogen
and	O
different	O
.	O

The	O
scientists	O
behind	O
the	O
technology	O
called	O
believe	O
it	O
may	O
be	O
the	O
key	O
to	O
safely	O
editing	O
DNA	O
for	O
curing	O
genetic	O
disease	O
.	O

Such	O
ongoing	O
global	O
health	O
security	O
collaboration	O
is	O
vital	O
,	O
CDC	S-Organization
Schuchat	S-Person
said	O
in	O
her	O
keynote	O
address	O
during	O
the	O
March	O
12	O
KFF	B-Activity
event	E-Activity
in	O
.	O

For	O
the	O
axial	O
skeleton	O
and	O
extremities	O
,	O
CT	S-Equipment
is	O
often	O
used	O
to	O
image	O
complex	O
fractures	S-Disease
,	O
especially	O
ones	O
around	O
joints	O
,	O
because	O
of	O
its	O
ability	O
to	O
reconstruct	O
the	O
area	O
of	O
interest	O
in	O
multiple	O
planes	O
.	O

The	O
International	B-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
(	O
ICTV	S-Organization
)	O
identifies	O
Ebola	B-Pathogen
virus	E-Pathogen
as	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
,	O
which	O
is	O
part	O
of	O
the	O
genus	O
Ebolavirus	S-Pathogen
,	O
family	O
Filoviridae	O
,	O
order	O
Mononegavirales	O
.	O

Regression	O
analyses	O
of	O
human	O
and	O
swine	O
influenza	O
sequences	O
obtained	O
from	O
1930	O
to	O
the	O
present	O
place	O
the	O
initial	O
circulation	O
of	O
the	O
1918	O
precursor	O
virus	O
in	O
humans	O
at	O
approximately	O
1915–1918	O
.	O

So	O
what	O
was	O
that	O
,	O
please?	O
It	O
clearly	O
wasn't	O
seasonal	O
flu	O
.	O

Individuals	O
who	O
receive	O
a	O
five-day	O
treatment	O
course	O
but	O
do	O
not	O
show	O
clinical	O
improvement	O
will	O
be	O
eligible	O
to	O
continue	O
receiving	O
remdesivir	S-Drug
	S-Drug
an	O
additional	O
five	O
days	O
.	O

Starko	S-Person
also	O
notes	O
that	O
many	O
early	O
deaths	O
showed	O
"	O
wet",	O
sometimes	O
hemorrhagic	B-Disease
lungs	E-Disease
,	O
whereas	O
late	O
deaths	O
showed	O
bacterial	B-Disease
pneumonia	E-Disease
.	O
She	O
suggests	O
that	O
the	O
wave	O
of	O
aspirin	S-Drug
poisonings	O
was	O
due	O
to	O
a	O
"	O
perfect	O
storm	O
"	O
of	O
events:	O
Bayer	S-Organization
's	O
patent	O
on	O
aspirin	S-Drug
expired	O
,	O
so	O
many	O
companies	O
rushed	O
in	O
to	O
make	O
a	O
profit	O
and	O
greatly	O
increased	O
the	O
supply	O
;	O
this	O
coincided	O
with	O
the	O
Spanish	B-Disease
flu	E-Disease
;	O
and	O
the	O
symptoms	O
of	O
poisoning	O
were	O
not	O
known	O
at	O
the	O
time	O
.	O

This	O
gender	O
disparity	O
is	O
thought	O
to	O
be	O
because	O
most	O
women	O
in	O
Saudi	B-Location
Arabia	E-Location
wear	O
veils	O
that	O
cover	O
the	O
mouth	O
and	O
nose	O
,	O
decreasing	O
their	O
chances	O
of	O
being	O
exposed	O
to	O
the	O
virus	O
.	O

Ban	B-Person
Shigeo	E-Person
a	O
technician	O
at	O
the	O
Japanese	B-Organization
Army's	I-Organization
9th	I-Organization
Technical	I-Organization
Research	I-Organization
Institute	E-Organization
,	O
left	O
an	O
account	O
of	O
the	O
activities	O
at	O
the	O
Institute	O
which	O
was	O
published	O
in	O
"	O
The	O
Truth	O
About	O
the	O
Army	O
Nororito	O
Institute"	O
.	O

As	O
part	O
of	O
an	O
ongoing	O
effort	O
to	O
be	O
prepared	O
,	O
the	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
will	O
review	O
on	O
Wednesday	O
its	O
recommendations	O
for	O
mass	O
vaccination	O
in	O
the	O
event	O
of	O
an	O
.	O

The	O
network	O
has	O
,	O
so	O
far	O
,	O
involved	O
around	O
80	O
people	O
in	O
total	O
,	O
with	O
roughly	O
30	O
participants	O
each	O
year	O
.	O

The	O
world's	O
vast	O
oceans	O
and	O
seas	O
offer	O
seemingly	O
endless	O
spaces	O
in	O
which	O
adversaries	O
of	O
the	O
United	B-Location
States	E-Location
can	O
maneuver	O
undetected.The	O
U.S.	B-Organization
military	E-Organization
deploys	O
networks	O
of	O
manned	O
and	O
unmanned	O
platforms	O
and	O
sensors	O
to	O
monitor	O
adversary	O
activity	O
,	O
but	O
the	O
scale	O
of	O
the	O
task	O
is	O
daunting	O
and	O
hardware	O
alone	O
cannot	O
meet	O
every	O
need	O
in	O
the	O
dynamic	O
marine	O
environment	O
.	O

The	O
CDC's	O
November	O
warning	O
mentioned	O
only	O
the	O
first	O
Fallen	O
Angel	O
letter	O
.	O

Dual	O
use	O
,	O
as	O
defined	O
by	O
,	O
describes	O
items	O
or	O
technologies	O
that	O
have	O
"	O
both	O
commercial	O
and	O
military	O
or	O
proliferation	O
applications.	O
"	O

According	O
to	O
a	O
2014	O
Russian	B-Organization
Research	I-Organization
Anti-Plaque	I-Organization
Institute	E-Organization
genetic	O
study	O
the	O
cholera	B-Pathogen
strain	E-Pathogen
isolated	O
in	O
Moscow	S-Location
was	O
similar	O
to	O
the	O
bacteria	O
which	O
caused	O
the	O
epidemic	O
in	O
neighboring	O
.	O

They	O
want	O
to	O
use	O
biohacking	O
to	O
save	O
the	O
environment	O
by	O
figuring	O
out	O
a	O
way	O
to	O
make	O
a	O
recyclable	O
plastic	O
or	O
a	O
biofuel	O
.	O

As	O
a	O
result	O
,	O
"	O
counties	O
have	O
access	O
to	O
a	O
new	O
technology	O
known	O
as	O
Mutualink	S-Technology
,	O
which	O
improves	O
interoperability	O
by	O
integrating	O
telephone	O
,	O
radio	O
,	O
video	O
,	O
and	O
file-sharing	O
into	O
one	O
application	O
to	O
allow	O
local	O
emergency	O
staff	O
to	O
share	O
real-time	O
information	O
with	O
the	O
state	O
and	O
other	O
counties.	O
"	O
The	O
State	B-Organization
Preparedness	I-Organization
Training	I-Organization
Center	E-Organization
in	O
Oriskany	S-Location
was	O
designed	O
by	O
the	O
State	O
Division	B-Organization
of	I-Organization
Homeland	I-Organization
Security,	I-Organization
and	I-Organization
Emergency	I-Organization
Services	E-Organization
(	O
DHSES	S-Organization
)	O
in	O
2006	O
.	O

Another	O
trend	O
noticeable	O
from	O
the	O
desktop	O
review	O
was	O
that	O
countries	O
with	O
actively	O
functional	O
NGOs	O
working	O
as	O
Biosafety	O
Associations	O
,	O
and/or	O
those	O
with	O
institutes	O
with	O
biosafety	O
missions	O
,	O
had	O
far	O
more	O
initiatives	O
on	O
general	O
awareness	O
of	O
biosafety-related	O
issues	O
than	O
those	O
without	O
such	O
associations	O
.	O

As	O
of	O
15	O
September	O
,	O
according	O
to	O
the	O
WHO	S-Organization
,	O
almost	O
a	O
quarter	O
of	O
a	O
million	O
individuals	O
have	O
been	O
vaccinated	O
in	O
this	O
current	O
outbreak	O
.	O

Some	O
countries	O
can	O
refer	O
to	O
the	O
biological	B-Document
agent	I-Document
list	I-Document
of	I-Document
US	I-Document
CDC	E-Document
but	O
this	O
is	O
not	O
a	O
universal	O
list	O
as	O
it	O
may	O
be	O
suitable	O
for	O
the	O
United	B-Location
States	E-Location
.	O
During	O
the	O
developments	O
of	O
,	O
developing	O
countries	O
should	O
evaluate	O
characteristics	O
of	O
each	O
biological	O
agent	O
and	O
threats	O
faced	O
,	O
existing	O
biodefense	O
capabilities	O
based	O
on	O
its	O
specific	O
regional	O
conditions	O
.	O

Daniel	B-Person
B.	I-Person
Neill	E-Person
and	O
Mallory	B-Person
Nobles	E-Person
of	O
Pittsburgh	S-Location
,	O
submitted	O
the	O
runner-up	O
solution	O
,	O
Pre-syndromic	O
Surveillance	O
,	O
and	O
will	O
receive	O
$50,000	O
.	O

Identifying	O
ways	O
to	O
provide	O
stronger	O
safeguards	O
for	O
laboratories	O
across	O
the	O
United	B-Location
States	E-Location

CDC	S-Organization
Director	O
Tom	B-Person
Frieden	E-Person
has	O
issued	O
a	O
moratorium	O
on	O
the	O
transfer	O
of	O
any	O
infectious	O
agents	O
(active	O
or	O
inactivated	O
specimens)	O
from	O
any	O
of	O
its	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
or	O
BSL-4	S-Platform
laboratories	O
to	O
any	O
other	O
facility	O
,	O
inside	O
or	O
outside	O
of	O
CDC	S-Organization
.	O
This	O
moratorium	O
will	O
remain	O
in	O
place	O
pending	O
review	O
by	O
a	O
.	O

Goldstein	S-Person
,	O
L.	O
,	O
Saddam	S-Person
's	O
Biological	O
Warfare	O
Card	O
,	O
Post	O
,	O
October	O
11	O
,	O
1996:A24	O
.	O

Frieden	S-Person
.	O
You	O
and	O
I	O
have	O
known	O
each	O
other	O
for	O
a	O
long	O
time	O
.	O

The	O
U.S.	B-Organization
Army	I-Organization
for	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
has	O
suspended	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
and	O
Biosafety	B-Platform
Level	I-Platform
4	E-Platform
()	O
operations	O
while	O
conducting	O
repairs	O
to	O
its	O
waste	O
treatment	O
plant	O
.	O

Over	O
the	O
last	O
two	O
years	O
she	O
has	O
published	O
a	O
series	O
of	O
revealed	O
reports	O
on	O
weapons	O
smuggling	O
.	O

On	O
4	O
March	O
,	O
the	O
Italian	B-Organization
government	E-Organization
ordered	O
the	O
full	O
closure	O
of	O
all	O
schools	O
and	O
universities	O
nationwide	O
as	O
Italy	S-Location
reached	O
a	O
hundred	O
deaths	O
.	O

A	O
condition	O
of	O
extreme	O
poverty	O
exists	O
in	O
many	O
of	O
the	O
areas	O
that	O
experienced	O
a	O
high	O
incidence	O
of	O
infections	O
.	O

The	O
CDC	S-Organization
defines	O
four	O
biosafety	O
levels	O
for	O
activities	O
involving	O
infectious	O
disease	O
work	O
with	O
experimental	O
animals	O
.	O

Planning	O
may	O
involve	O
the	O
development	O
of	O
biological	O
identification	O
systems	O
.	O

Most	O
recently	O
in	O
December	O
of	O
2008	O
,	O
JCVI	S-Organization
received	O
funding	O
from	O
the	O
Alfred	B-Organization
P.	I-Organization
Sloan	I-Organization
Foundation	E-Organization
to	O
examine	O
ethical	O
and	O
societal	O
concerns	O
that	O
are	O
associated	O
with	O
the	O
developing	O
science	O
of	O
.	O
The	O
ongoing	O
research	O
is	O
intended	O
to	O
inform	O
the	O
scientific	O
community	O
as	O
well	O
as	O
educate	O
our	O
policymakers	O
and	O
journalists	O
so	O
that	O
they	O
may	O
engage	O
in	O
informed	O
discussions	O
on	O
the	O
topic	O
.	O

In	O
the	O
wake	O
of	O
several	O
high-profile	O
laboratory	O
safety	O
incidents	O
involving	O
smallpox	S-Disease
anthrax	S-Disease
,	O
and	O
dangerous	O
flu	B-Disease
strains	E-Disease
,	O
the	O
will	O
ask	O
federally	O
funded	O
laboratories	O
to	O
inventory	O
pathogens	O
and	O
review	O
safety	O
practices	O
.	O

The	O
program	O
offers	O
an	O
integrated	O
,	O
layered	O
defense	O
through	O
engineering	O
and	O
integrating	O
material	O
solutions	O
for	O
warfighters	O
.	O

An	O
August	O
2014	O
study	O
found	O
that	O
nearly	O
two-thirds	O
of	O
Ebola	S-Disease
cases	O
in	O
were	O
believed	O
to	O
be	O
due	O
to	O
burial	O
practices	O
including	O
washing	O
of	O
the	O
body	O
of	O
one	O
who	O
had	O
died	O
.	O

About	O
a	O
decade	O
ago	O
,	O
the	O
USA	S-Location
also	O
increased	O
their	O
efforts	O
to	O
identify	O
microorganisms	O
that	O
kill	O
drug-producing	O
crops	O
;	O
by	O
the	O
late	O
1990s	O
,	O
this	O
research	O
focused	O
largely	O
on	O
two	O
fungi	O
.	O

Perhaps	O
more	O
importantly	O
,	O
CDC	S-Organization
is	O
able	O
to	O
help	O
countries	O
build	O
the	O
capacity	O
to	O
identify	O
and	O
stop	O
these	O
diseases	O
on	O
their	O
own	O
.	O

This	O
ancestor	O
virus	O
diverged	O
about	O
1913–1915	O
into	O
two	O
clades	O
(or	O
biological	O
groups)	O
,	O
which	O
gave	O
rise	O
to	O
the	O
classical	O
swine	O
and	O
human	O
H1N1	B-Disease
influenza	E-Disease
lineages	O
.	O

This	O
image	O
weighting	O
is	O
useful	O
for	O
assessing	O
the	O
cerebral	O
cortex	O
,	O
identifying	O
fatty	O
tissue	O
,	O
characterizing	O
focal	B-Disease
liver	I-Disease
lesions	E-Disease
and	O
in	O
general	O
obtaining	O
morphological	O
information	O
,	O
as	O
well	O
as	O
for	O
post-contrast	O
imaging	O
.	O

For	O
biodefense	O
categorization	O
,	O
the	O
US	B-Organization
CDC	E-Organization
and	O
Russia	S-Location
divided	O
biological	O
agents	O
into	O
three	O
groups	O
,	O
with	O
the	O
EU	S-Location
defining	O
two	O
groups	O
.	O

The	O
U.S.	B-Organization
Navy	E-Organization
is	O
awarding	O
funding	O
to	O
the	O
Noguchi	B-Organization
Memorial	I-Organization
Institute	I-Organization
for	I-Organization
Medical	I-Organization
Research	E-Organization
in	O
Ghana	S-Location
in	O
support	O
of	O
infectious	O
disease	O
research	O
in	O
.	O

To	O
do	O
this	O
,	O
we	O
have	O
used	O
a	O
unique	O
open	O
access	O
online	O
tool	O
,	O
the	O
Biosafety	B-Platform
Bibliographic	I-Platform
Database	E-Platform
(	O
BBD	S-Platform
)	O
that	O
has	O
been	O
provided	O
by	O
ICGEB	S-Organization
since	O
1990	O
.	O

The	O
clustered	B-Technology
regularly	I-Technology
interspaced	I-Technology
short	I-Technology
palindrome	I-Technology
repeats	E-Technology
(	O
CRISPR	S-Technology
)/Cas9	O
system	O
is	O
a	O
new	O
gene-editing	O
technology	O
that	O
can	O
induce	O
double-strand	O
breaks	O
(DSBs)	O
,	O
single-strand	O
nicks	O
,	O
or	O
anywhere	O
guide	O
ribonucleic	O
acids	O
(RNAs)	O
can	O
bind	O
with	O
the	O
protospacer	O
adjacent	O
motif	O
sequence	O
.	O

Looming	O
large	O
over	O
such	O
catastrophies	O
is	O
the	O
constant	O
development	O
and	O
worldwide	O
spread	O
of	O
antibiotic	O
genes	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	O
,	O
DHHS	S-Organization
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

These	O
US	O
bio-laboratories	O
are	O
funded	O
by	O
the	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
(	O
DTRA	S-Organization
)	O
under	O
a	O
$	O
2.1	O
billion	O
military	O
program–	O
Cooperative	B-Scientific_research_project
Biological	I-Scientific_research_project
Engagement	I-Scientific_research_project
Program	E-Scientific_research_project
(	O
CBEP	S-Scientific_research_project
)	O
,	O
and	O
are	O
located	O
in	O
former	O
Soviet	O
Union	O
countries	O
such	O
as	O
Georgia	S-Location
and	O
Ukraine	S-Location
,	O
the	O
Middle	B-Location
East	E-Location
,	O
South	B-Location
East	I-Location
Asia	E-Location
and	O
.	O

The	O
Board	O
must	O
approve	O
such	O
appointments	O
,	O
although	O
as	O
of	O
2004	O
,	O
it	O
had	O
never	O
over-ruled	O
the	O
preference	O
of	O
a	O
regional	O
committee	O
.	O

In	O
Japan	S-Location
257,363 deaths	O
were	O
attributed	O
to	O
by	O
July	O
1919	O
,	O
giving	O
an	O
estimated	O
0.	O
4%	O
mortality	O
rate	O
,	O
much	O
lower	O
than	O
nearly	O
all	O
other	O
Asian	O
countries	O
for	O
which	O
data	O
are	O
available	O
.	O

We	O
are	O
hoping	O
that	O
lessons	O
learned	O
from	O
the	O
response	O
to	O
the	O
Ebola	B-Incident
crisis	E-Incident
can	O
help	O
Parties	O
prepare	O
for	O
more	O
effective	O
coordination	O
in	O
the	O
event	O
of	O
future	O
disease	O
outbreaks	O
,	O
regardless	O
of	O
whether	O
such	O
outbreaks	O
are	O
naturally	O
occurring	O
,	O
the	O
result	O
of	O
accidents	O
,	O
or	O
caused	O
by	O
intentional	O
acts	O
.	O

In	O
order	O
to	O
determine	O
the	O
public's	O
knowledge	O
and	O
preconceived	O
notions	O
on	O
antibiotic	O
resistance	O
,	O
a	O
major	O
type	O
of	O
antimicrobial	O
resistance	O
,	O
a	O
screening	O
of	O
3537	O
articles	O
published	O
in	O
Europe	S-Location
Asia	S-Location
,	O
and	O
was	O
done	O
.	O

The	O
discovery	O
of	O
the	O
ricin	O
letter	O
at	O
the	O
White	O
House	O
facility	O
was	O
not	O
disclosed	O
to	O
the	O
public	O
until	O
early	O
February	O
2004	O
.	O

But	O
even	O
after	O
adjusting	O
age-specific	O
deaths	O
by	O
age-specific	O
clinical	O
attack	O
rates	O
(Figure	O
3	O
,	O
panel	O
B)	O
,	O
a	O
W-shaped	O
curve	O
with	O
a	O
case-fatality	O
peak	O
in	O
young	O
adults	O
remains	O
and	O
is	O
significantly	O
different	O
from	O
U-shaped	O
age-specific	O
case-fatality	O
curves	O
typically	O
seen	O
in	O
oth	O
er	B-Disease
influe	E-Disease
nza	O
years	O
,	O
e.g.	O
,	O
1928–1929	O
(Figure	O
3	O
,	O
panel	O
C)	O
.	O

The	O
primers	O
are	O
homologous	O
to	O
the	O
gB	O
glycoprotein	O
sequence	O
of	O
the	O
virus	O
9	O
.	O

With	O
such	O
a	O
large	O
population	O
decline	O
from	O
the	O
plague	S-Disease
wages	O
soared	O
in	O
response	O
to	O
a	O
labour	O
shortage	O
.	O

While	O
most	O
people's	O
genetic	O
blueprints	O
don't	O
contain	O
deadly	O
mysteries	O
,	O
our	O
health	O
is	O
increasingly	O
supported	O
by	O
the	O
medical	O
breakthroughs	O
that	O
DNA	B-Technology
sequencing	E-Technology
has	O
enabled	O
.	O

It's	O
very	O
important	O
that	O
people	O
understand	O
that	O
mistakes	O
are	O
human	O
.	O

In	O
China	S-Location
,	O
children	O
acquired	O
infections	O
mainly	O
through	O
close	O
contact	O
with	O
their	O
parents	O
or	O
other	O
family	O
members	O
who	O
lived	O
in	O
or	O
had	O
traveled	O
there	O
.	O

On	O
20	O
January	O
,	O
the	O
Chinese	B-Organization
National	I-Organization
Health	I-Organization
Commission	E-Organization
confirmed	O
human-to-human	O
transmission	O
of	O
the	O
virus	O
.	O

Crisis	O
management	O
in	O
Sweden	S-Location
is	O
based	O
on	O
the	O
premise	O
that	O
procedures	O
will	O
be	O
performed	O
as	O
normal	O
;	O
this	O
also	O
includes	O
sample	O
flow	O
upon	O
suspicion	O
of	O
high-consequence	O
pathogens	O
.	O

Reconciling	O
epidemiologically	O
the	O
steep	O
drop	O
in	O
cases	O
in	O
the	O
first	O
and	O
second	O
waves	O
with	O
the	O
sharp	O
rises	O
in	O
cases	O
of	O
the	O
second	O
and	O
third	O
waves	O
is	O
difficult	O
.	O

Zelicoff	S-Person
says	O
the	O
fact	O
that	O
the	O
Soviet	B-Organization
Union	E-Organization
never	O
reported	O
the	O
to	O
world	O
health	O
authorities	O
"	O
suggests	O
a	O
sinister	O
source.	O
"	O

Anthrax	S-Pathogen
cannot	O
be	O
spread	O
from	O
person	O
to	O
person	O
.	O

Biotechnology	B-Organization
and	I-Organization
Biological	I-Organization
Sciences	I-Organization
Research	I-Organization
Council	E-Organization
,	O
the	O
Wellcome	B-Organization
Trust	E-Organization
and	O
the	O
Sanger	B-Organization
Institute	E-Organization
-have	O
implemented	O
data	O
sharing	O
policies.	O
et	O
al.	O
suggest	O
to	O
agree	O
on	O
a	O
single	O
data	O
sharing	O
policy	O
consensus	O
template	O
emphasizing	O
public	O
and	O
timely	O
delivery	O
of	O
data	O
in	O
secure	O
public	O
databases	O
with	O
a	O
long-term	O
funding	O
horizon	O
.	O

Eitzen	S-Person
,	O
Edward	B-Person
M	E-Person
.	O
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare	O
:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	O
Air	O
Force	O
Base	O
,	O
accessed	O
November	O
12	O
,	O
2008	O
.	O

The	O
whole	O
system	O
is	O
controlled	O
by	O
one	O
or	O
more	O
computers	O
.	O

The	O
head	O
of	O
cardiology	O
at	O
the	O
University	B-Organization
of	I-Organization
Arizona	E-Organization
has	O
stated	O
,	O
"	O
My	O
worry	O
is	O
some	O
of	O
these	O
people	O
are	O
dying	O
at	O
home	O
because	O
they're	O
too	O
scared	O
to	O
go	O
to	O
the	O
hospital.	O
"	O
'Where	O
are	O
all	O
our	O
patients?	O
':	O
Covid	B-Disease
phobia	E-Disease
is	O
keeping	O
people	O
with	O
serious	O
heart	O
symptoms	O
away	O
from	O
ERs	O
,	O
Stat	O
News	O
,	O
Usha	O
Lee	O
McFarling	O
,	O
April	O
23	O
,	O
2020	O
.	O

Old	O
and	O
discarded	O
,	O
or	O
even	O
rejected	O
,	O
antibiotics	O
should	O
be	O
re-investigated	O
,	O
re-purposed	O
and	O
used	O
as	O
needed	O
.	O

Any	O
kind	O
of	O
biotechnological	O
or	O
biomedical	O
research	O
,	O
development	O
or	O
production	O
must	O
be	O
performed	O
in	O
an	O
internationally	O
transparent	O
and	O
controlled	O
manner	O
.	O

I	O
think	O
there's	O
some	O
major	O
systematic	O
issues	O
that	O
we	O
want	O
to	O
look	O
at.As	O
Dr.	O
mentioned	O
,	O
this	O
is	O
a	O
symptom	O
.	O

An	O
estimate	O
of	O
the	O
case	O
fatality	O
rate	O
for	O
the	O
modern	O
bubonic	B-Disease
plague	E-Disease
following	O
the	O
introduction	O
of	O
antibiotics	O
,	O
is	O
11%	O
,	O
although	O
it	O
may	O
be	O
higher	O
in	O
underdeveloped	O
regions	O
.	O

"	O
The	O
next	O
weapon	O
of	O
mass	O
destruction	O
may	O
not	O
be	O
a	O
bomb,	O
"	O
Lawrence	B-Person
O.	I-Person
Gostin	E-Person
the	O
director	O
of	O
the	O
,	O
told	O
The	O
New	O
York	O
Times''.	O
"	O
It	O
may	O
be	O
a	O
tiny	O
pathogen	O
that	O
you	O
can't	O
see	O
,	O
smell	O
or	O
taste	O
,	O
and	O
by	O
the	O
time	O
we	O
discover	O
it	O
,	O
it'll	O
be	O
too	O
late.	O
"	O

Cattle	O
infected	O
in	O
a	O
university's	O
vaccine	O
experiments	O
were	O
repeatedly	O
sent	O
to	O
slaughter	O
and	O
their	O
meat	O
sold	O
for	O
human	O
consumption	O
.	O

In	O
February	O
2020	O
,	O
Chinese	O
researchers	O
found	O
that	O
there	O
is	O
only	O
one	O
amino	O
acid	O
difference	O
in	O
the	O
binding	O
domain	O
of	O
the	O
S	O
protein	O
between	O
the	O
coronaviruses	S-Pathogen
from	O
pangolins	O
and	O
those	O
from	O
humans	O
;	O
however	O
,	O
whole-genome	O
comparison	O
to	O
date	O
found	O
that	O
at	O
most	O
92%	O
of	O
genetic	O
material	O
was	O
shared	O
between	O
pangolin	B-Pathogen
coronavirus	E-Pathogen
and	O
,	O
which	O
is	O
insufficient	O
to	O
prove	O
pangolins	O
to	O
be	O
the	O
intermediate	O
host	O
.	O

Mortality	B-Platform
Medical	I-Platform
Data	I-Platform
System	E-Platform

On	O
8	O
August	O
2014	O
,	O
a	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
was	O
declared	O
and	O
on	O
29	O
March	O
2016	O
,	O
the	O
WHO	S-Organization
terminated	O
the	O
Public	B-Incident
Health	I-Incident
Emergency	I-Incident
of	I-Incident
International	I-Incident
Concern	E-Incident
status	O
of	O
the	O
outbreak	O
.	O

Contrast	B-Technology
CT	E-Technology
generally	O
the	O
initial	O
study	O
of	O
choice	O
for	O
neck	B-Disease
masses	E-Disease
in	O
adults	O
.	O

CRISPR	S-Technology
had	O
been	O
studied	O
in	O
animal	O
models	O
and	O
cancer	S-Disease
cell	O
lines	O
,	O
to	O
learn	O
if	O
it	O
can	O
be	O
used	O
to	O
repair	O
or	O
thwart	O
mutated	O
genes	O
that	O
cause	O
.	O

Again	O
,	O
the	O
cause	O
was	O
likely	O
an	O
unauthorized	O
or	O
untested	O
procedure	O
to	O
inactivate	O
the	O
virus	O
.	O

"	O
We	O
need	O
more	O
of	O
these	O
boots-on-the-ground	O
disaster	O
detectives,	O
"	O
Schakowsky	S-Person
said	O
.	O

Although	O
the	O
memo	O
from	O
the	O
Office	B-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	E-Organization
()	O
uses	O
the	O
term	O
"	O
stand-down,"	O
it	O
says	O
explicitly	O
that	O
the	O
review	O
should	O
not	O
disrupt	O
ongoing	O
work	O
.	O

How	O
can	O
the	O
Department	O
of	O
Defense-whose	O
forces	O
,	O
deployed	O
around	O
the	O
world	O
,	O
constantly	O
come	O
into	O
contact	O
with	O
new	O
bacteria-discriminate	O
between	O
harmless	O
and	O
virulent	O
strains	O
to	O
prevent	O
a	O
disease	O
outbreak	O
that	O
threatens	O
military	O
readiness?	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
a	O
new	O
program	O
from	O
DARPA	S-Organization
's	O
,	O
proposes	O
to	O
develop	O
a	O
platform	O
technology	O
that	O
rapidly	O
screens	O
unfamiliar	O
bacteria	O
to	O
establish	O
their	O
pathogenicity	O
and	O
even	O
discover	O
unknown	O
pathogenic	O
traits	O
,	O
necessary	O
first	O
steps	O
for	O
designing	O
effective	O
biosurveillance	O
and	O
countermeasures	O
.	O

In	O
March	O
2015	O
,	O
the	O
CDC	S-Organization
interviewed	O
the	O
survivors	O
;	O
they	O
all	O
reported	O
having	O
had	O
at	O
least	O
one	O
adverse	O
symptom	O
during	O
their	O
recovery	O
period	O
.	O

However	O
,	O
specific	O
requirements	O
of	O
projects	O
restricted	O
to	O
dedicated	O
'omics'	O
might	O
be	O
adequately	O
met	O
by	O
systems	O
tailored	O
to	O
that	O
'omics'	O
data	O
,	O
e.g	O
.	O

A	O
significant	O
part	O
of	O
the	O
actual	O
EVD	S-Disease
infection	O
is	O
based	O
on	O
immune	O
suppression	O
.	O

The	O
first	O
round	O
of	O
fixed	O
laboratory	O
team	O
from	O
National	B-Organization
Institute	I-Organization
for	I-Organization
Viral	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
NIVDC	S-Organization
)	O
,	O
Chinese	B-Organization
Center	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
China	B-Organization
CDC	E-Organization
)	O
arrived	O
in	O
on	O
8	O
February	O
2015	O
.	O

In	O
particular	O
,	O
pathogenic	O
GM-CSF-secreting	O
T-cells	O
were	O
shown	O
to	O
correlate	O
with	O
the	O
recruitment	O
of	O
inflammatory	O
IL-6-secreting	O
monocytes	O
and	O
severe	O
lung	O
pathology	O
in	O
patients	O
.	O

Waste	O
from	O
the	O
BSL-3	S-Platform
lab	O
was	O
carefully	O
wrapped	O
in	O
a	O
biohazard	O
bag	O
and	O
sterilised	O
twice	O
,	O
the	O
first	O
round	O
of	O
sterilisation	O
was	O
performed	O
in	O
an	O
autoclave	S-Equipment
in	O
BSL-3	S-Platform
laboratory	O
,	O
then	O
transferred	O
to	O
another	O
autoclave	S-Equipment
in	O
the	O
decontamination	O
room	O
via	O
the	O
"	O
dirty"	O
transfer	O
window	O
for	O
a	O
second	O
round	O
of	O
sterilisation	O
.	O

In	O
addition	O
,	O
CDC	S-Organization
has	O
reported	O
the	O
incident	O
to	O
the	O
Federal	B-Activity
Select	I-Activity
Agent	I-Activity
Program	E-Activity
and	O
USDA's	B-Organization
Animal	I-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Service	E-Organization
(	O
APHIS	S-Organization
)	O
,	O
is	O
conducting	O
an	O
independent	O
investigation	O
.	O

1	O
.	O

Health	O
officials	O
in	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
have	O
reported	O
21	O
patients	O
showing	O
signs	O
of	O
hemorrhagic	B-Disease
fever	E-Disease
and	O
17	O
deaths	O
in	O
the	O
affected	O
area	O
before	O
an	O
was	O
confirmed	O
today	O
.	O

B.	B-Pathogen
anthracis	E-Pathogen
is	O
a	O
select	O
agent	O
.	O

Early	O
reports	O
show	O
that	O
one	O
of	O
CDC	S-Organization
biosafety	B-Platform
level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
was	O
preparing	O
anthrax	S-Pathogen
samples	O
to	O
be	O
sent	O
for	O
research	O
at	O
two	O
CDC	S-Organization
labs	O
with	O
lower	O
biosafety	O
levels	O
,	O
both	O
of	O
them	O
BSL-2	S-Platform
labs	O
.	O

On	O
20	O
January	O
2016	O
at	O
the	O
World	B-Activity
Economic	I-Activity
Forum	E-Activity
in	O
Davos	S-Location
,	O
,	O
more	O
than	O
"	O
80	O
pharmaceutical	O
and	O
diagnostic	O
companies	O
"	O
from	O
around	O
the	O
world	O
called	O
for	O
"	O
transformational	O
commercial	O
models	O
"	O
at	O
a	O
global	O
level	O
to	O
spur	O
research	O
and	O
development	O
on	O
antibiotics	O
and	O
on	O
the	O
"	O
enhanced	O
use	O
of	O
diagnostic	O
tests	O
that	O
can	O
rapidly	O
identify	O
the	O
infecting	O
organism"	O
.	O

Infected	O
food	O
supplies	O
and	O
clothing	O
were	O
dropped	O
by	O
airplane	O
into	O
areas	O
of	O
not	O
occupied	O
by	O
Japanese	O
forces	O
.	O

Pulmonary	B-Disease
complications	E-Disease
are	O
common	O
.	O

Jacobs	S-Organization
said	O
Thursday	O
it	O
will	O
also	O
design	O
and	O
qualify	O
the	O
multiproduct	O
factory	O
to	O
be	O
constructed	O
at	O
the	O
drugmaker's	O
Sanford	S-Location
,	O
,	O
production	O
site	O
.	O

Anna	B-Person
Eshoo	E-Person
(D-CA)	O
,	O
Greg	B-Person
Walden	E-Person
(R-OR)	O
,	O
and	O
Frank	B-Person
Pallone	E-Person
,	O
Jr.	O
(D-NJ)	O
,	O
was	O
among	O
38	O
bills	O
on	O
the	O
schedule	O
to	O
be	O
considered	O
on	O
Sept.25	O
.	O

So	O
just	O
to	O
give	O
a	O
little	O
bit	O
more	O
details	O
,	O
what	O
happened	O
was	O
that	O
the	O
process	O
to	O
inactivate	O
the	O
anthrax	S-Pathogen
spores	O
was	O
not	O
appropriate	O
.	O

Confronting	O
Gruesome	O
War	O
Atrocity	O
"	O
Vivisections	O
were	O
performed	O
on	O
prisoners	O
after	O
infecting	O
them	O
with	O
various	O
diseases	O
.	O

Attending	O
experts	O
use	O
the	O
occasion	O
to	O
address	O
the	O
emergence	O
,	O
spread	O
and	O
control	O
of	O
these	O
diseases	O
,	O
covering	O
a	O
host	O
of	O
health	O
threats	O
that	O
affect	O
both	O
and	O
its	O
colleagues	O
in	O
the	O
international	O
scene	O
.	O

Archived	O
from	O
the	O
original	O
on	O
17	O
April	O
2020	O
.	O

Backup	O
treatments	O
can	O
have	O
serious	O
side-effects	O
;	O
for	O
example	O
,	O
treatment	O
of	B-Disease
multi-drug-resistant	I-Disease
tubercul	E-Disease
can	O
ca	O
use	B-Disease
deaf	E-Disease
nesslity	O
.	O

Earlier	O
experience	O
pinpoints	O
mutual	O
trust	O
between	O
partners	O
as	O
a	O
cornerstone	O
for	O
a	O
successful	O
network	O
.	O

Ebola	B-Phenotype
symptoms	E-Phenotype
may	O
begin	O
as	O
early	O
as	O
two	O
days	O
or	O
as	O
long	O
as	O
21	O
days	O
after	O
one	O
is	O
exposed	O
to	O
the	O
virus	O
.	O

Health	O
officials	O
worldwide	O
were	O
also	O
concerned	O
because	O
the	O
virus	O
was	O
new	O
and	O
could	O
easily	O
mutate	O
and	O
become	O
more	O
virulent	O
,	O
even	O
though	O
most	O
flu	O
symptoms	O
were	O
mild	O
and	O
lasted	O
only	O
a	O
few	O
days	O
without	O
treatment	O
.	O

This	O
manifests	O
itself	O
as	O
increased	O
breathing	B-Phenotype
difficulty	E-Phenotype
and	O
typically	O
occurs	O
three	O
to	O
six	O
days	O
after	O
initial	O
onset	O
of	O
flu	O
symptoms	O
.	O

Students	O
assess	O
the	O
course	O
instructor	O
,	O
the	O
course	O
design	O
and	O
structure	O
,	O
and	O
the	O
educational	O
contribution	O
of	O
the	O
course	O
in	O
their	O
opinion	O
.	O

CR	O
12250	O
,	O
1996)	O
,	O
and	O
the	O
.	O

The	O
fermentors	O
are	O
tailored	O
specifically	O
to	O
the	O
requirements	O
of	O
the	O
microorganism	O
that	O
is	O
being	O
engineered	O
–	O
pH	O
,	O
temperature	O
,	O
light	O
,	O
pressure	O
,	O
and	O
nutrient	O
concentrations	O
that	O
give	O
the	O
microorganism	O
optimal	O
growth	O
rates	O
.	O

Ricin	S-Pathogen
:	O
Biotoxin	O
.	O

Māori	O
were	O
8	O
to	O
10	O
times	O
as	O
likely	O
to	O
die	O
as	O
other	O
New	O
Zealanders	O
(Pakeha)	O
because	O
of	O
their	O
more	O
crowded	O
living	O
conditions	O
.	O

After	O
selection	O
genomic	O
DNA	O
is	O
collected	O
and	O
sequenced	O
by	O
NGS	O
.	O

You	O
just	O
talked	O
about	O
coming	O
down	O
the	O
amount	O
of	O
risky	O
work	O
.	O

In	O
comparison	O
,	O
billions	O
of	O
dollars	O
have	O
been	O
spent	O
by	O
developed	O
countries	O
on	O
the	O
2013–2016	B-Incident
Ebola	I-Incident
epidemic	E-Incident
and	O
.	O

If	O
some	O
animals	O
can	O
already	O
sense	O
direction	O
,	O
why	O
shouldn't	O
we?	O

i	O
Select	O
agents	O
are	O
biological	O
agents	O
and	O
toxins	O
that	O
HHS	S-Organization
and	O
have	O
determined	O
have	O
the	O
potential	O
to	O
pose	O
a	O
severe	O
threat	O
to	O
public	O
health	O
and/or	O
animal	O
health	O
,	O
or	O
to	O
plant	O
health	O
;	O
or	O
to	O
agricultural	O
animal	O
or	O
plant	O
products	O
.	O

For	O
evaluation	O
of	O
chronic	O
interstitial	O
processes	O
such	O
as	O
emphysema	S-Disease
,	O
and	O
fibrosis	S-Disease
,	O
thin	O
sections	O
with	O
high	O
spatial	O
frequency	O
reconstructions	O
are	O
used	O
;	O
often	O
scans	O
are	O
performed	O
both	O
on	O
inspiration	O
and	O
expiration	O
.	O

Gottlieb	S-Person
added	O
that	O
the	O
is	O
also	O
committed	O
to	O
developing	O
vaccines	O
to	O
prevent	O
infections	O
by	O
resistant	O
microbes	O
,	O
along	O
with	O
non-traditional	O
products	O
like	O
bacteriophages	O
,	O
live	O
biotherapeutic	O
products	O
(probiotics)	O
,	O
and	O
fecal	O
microbiota	O
transplantation	O
.	O

Initially	O
,	O
the	O
letter	O
was	O
dismissed	O
as	O
"	O
some	O
crank	O
trying	O
to	O
get	O
a	O
lot	O
of	O
publicity",Published	O
on	O
December	O
2	O
,	O
1989	O
,	O
Daily	O
News	O
of	O
Los	B-Location
Angeles	E-Location
(CA)	O
GROUP	O
CLAIMS	O
RESPONSIBILITY	O
FOR	O
MEDFLY	O
WOES	O
but	O
there	O
was	O
evidence	O
the	O
group	O
played	O
a	O
role	O
in	O
the	O
infestation	O
.	O

It	O
has	O
done	O
this	O
mainly	O
through	O
carrying	O
out	O
joint	O
projects	O
,	O
which	O
have	O
included	O
activities	O
such	O
as	O
ring	O
trials	O
(analysis	O
of	O
spiked	O
samples	O
for	O
detection	O
of	O
high-consequence	O
pathogens)	O
,	O
exercises	O
,	O
and	O
audits	O
.	O

The	O
mechanism	O
by	O
which	O
Y.	B-Pathogen
pestis	E-Pathogen
is	O
usually	O
transmitted	O
was	O
established	O
in	O
1898	O
by	O
Paul-Louis	B-Person
Simond	E-Person
and	O
was	O
found	O
to	O
involve	O
the	O
bites	O
of	O
fleas	O
whose	O
midguts	O
had	O
become	O
obstructed	O
by	O
replicating	O
Y.	B-Pathogen
pestis	E-Pathogen
several	O
days	O
after	O
feeding	O
on	O
an	O
infected	O
host	O
.	O

The	O
economic	O
and	O
human	O
cost	O
of	O
antibiotic	O
resistance	O
is	O
already	O
enormous	O
.	O

During	O
the	O
Chinese	B-Activity
New	I-Activity
Year	I-Activity
travel	E-Activity
period	O
,	O
authorities	O
instigated	O
a	O
City	B-Activity
of	I-Activity
Wuhan	I-Activity
lockdown	E-Activity
.	O
On	O
10	O
February	O
the	O
Chinese	B-Organization
government	E-Organization
launched	O
a	O
radical	O
campaign	O
described	O
by	O
paramount	O
leader	O
and	O
Chinese	B-Organization
Communist	I-Organization
Party	E-Organization
general	B-Person
secretary	I-Person
Xi	E-Person
as	O
a	O
"	O
people's	O
war	O
"	O
to	O
contain	O
the	O
viral	O
spread	O
.	O

A	O
corporate	O
mailroom	O
employee	O
in	O
New	B-Location
York	E-Location
City	O
uses	O
gloves	O
while	O
sifting	O
through	O
letters	O
in	O
October	O
2001	O
.	O

In	O
2011	O
,	O
these	O
results	O
were	O
further	O
confirmed	O
with	O
genetic	O
evidence	O
derived	O
from	O
Black	B-Disease
Death	E-Disease
victims	O
in	O
the	O
East	B-Location
Smithfield	E-Location
burial	O
site	O
in	O
.	O
Schuenemann	O
et	O
al	O
.	O

Many	O
informal	O
horizontal	O
links	O
have	O
been	O
created	O
,	O
and	O
this	O
has	O
expanded	O
the	O
communication	O
between	O
agencies	O
at	O
all	O
levels	O
.	O

We	O
have	O
to	O
keep	O
driving	O
home	O
those	O
messages	O
about	O
prevention	O
.	O

Conflicting	O
official	O
accounts	O
regarding	O
the	O
incident	O
heightened	O
concerns	O
of	O
a	O
potential	O
cover-up	O
.	O

Bodily	O
fluids:	O
The	O
most	O
common	O
way	O
of	O
transmitting	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
humans	O
is	O
through	O
the	O
contact	O
with	O
infected	O
bodily	O
fluids	O
.	O

For	O
example	O
,	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Variola	B-Pathogen
major	E-Pathogen
and	O
Marburg	B-Pathogen
virus	E-Pathogen
were	O
all	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
.	O

Leśne	O
morze)	O
(1960)	O
,	O
a	O
novel	O
by	O
a	O
Polish	O
writer	O
and	O
educator	O
Igor	B-Person
Newerly	E-Person
The	O
first	O
book	O
published	O
outside	O
which	O
refers	O
to	O
atrocities	O
committed	O
in	O
the	O
unit	O
.	O

Balanced	O
steady-state	O
free	O
precession	O
(bSSFP)	O
imaging	O
has	O
a	O
better	O
image	O
contrast	O
between	O
the	O
blood	O
pool	O
and	O
myocardium	O
than	O
the	O
FLASH	B-Technology
MRI	E-Technology
,	O
yet	O
it	O
will	O
produce	O
severe	O
banding	O
artifact	O
when	O
the	O
B0	O
inhomogeneity	O
is	O
strong	O
.	O

Yet	O
there	O
is	O
no	O
publicly	O
available	O
list	O
of	O
these	O
labs	O
,	O
and	O
the	O
scope	O
of	O
their	O
research	O
and	O
safety	O
records	O
are	O
largely	O
unknown	O
to	O
most	O
state	O
health	O
departments	O
charged	O
with	O
responding	O
to	O
disease	O
outbreaks	O
.	O

On	O
17	O
March	O
,	O
an	O
international	O
network	O
of	O
11	O
laboratories	O
was	O
established	O
to	O
determine	O
the	O
cause	O
of	O
SARS	S-Disease
and	O
develop	O
potential	O
treatments	O
.	O

Although	O
COVID‑19	S-Disease
is	O
not	O
a	O
sexually	O
transmitted	O
infection	O
,	O
kissing	O
,	O
intimate	O
contact	O
,	O
and	O
faecal-oral	O
routes	O
are	O
suspected	O
to	O
transmit	O
the	O
virus	O
.	O

Black	B-Disease
Death	E-Disease
,	O
Jewishencyclopedia.com	O
In	O
the	O
Strasbourg	S-Location
massacre	O
of	O
February	O
1349	O
,	O
about	O
2,000	O
Jews	O
were	O
murdered	O
.	O

During	O
that	O
time	O
,	O
dust	O
leaked	O
from	O
the	O
plant	O
and	O
was	O
carried	O
by	O
the	O
wind	O
.	O

A	O
demo	O
system	O
is	O
online	O
and	O
an	O
installation	O
guide	O
and	O
comprehensive	O
documentations	O
are	O
available	O
.	O

However	O
,	O
only	O
about	O
one-tenth	O
of	O
those	O
cases	O
are	O
reported	O
to	O
local	O
and	O
state	O
health	O
departments	O
and	O
the	O
CDC	S-Organization
.	O
Many	O
patients	O
and	O
advocates	O
submitted	O
comments	O
to	O
the	O
Working	B-Organization
Group	E-Organization
,	O
describing	O
debilitating	O
symptoms	O
from	O
tick-borne	O
diseases	O
that	O
require	O
prolonged	O
treatment	O
often	O
resulting	O
in	O
large	O
medical	O
bills	O
that	O
are	O
not	O
reimbursed	O
by	O
medical	O
insurers	O
.	O

Half	O
of	O
Paris	S-Organization
'	O
population	O
of	O
100,000	O
people	O
died	O
.	O

The	O
groups	O
also	O
urged	O
WHO	S-Organization
to	O
accelerate	O
efforts	O
towards	O
improving	O
various	O
core	O
health	O
emergency	O
capacities	O
,	O
including	O
health	O
systems	O
and	O
workforces	O
,	O
and	O
called	O
on	O
international	O
donors	O
to	O
work	O
with	O
to	O
expedite	O
the	O
implementation	O
of	O
national	O
action	O
plans	O
against	O
outbreaks	O
.	O

Data	O
federation	O
of	O
distributed	O
international	O
repositories-a	O
reasonable	O
complementary	O
approach	O
to	O
central	O
national	O
repositories-is	O
not	O
easy	O
to	O
implement	O
because	O
it	O
has	O
to	O
deal	O
with	O
different	O
data	O
formats	O
,	O
different	O
languages	O
in	O
essential	O
documents	O
and	O
jurisdictional	O
hurdles	O
like	O
license	O
agreements	O
.	O

Based	O
on	O
statistics	O
,	O
the	O
global	O
death-to-case	O
ratio	O
is	O
(	O
deaths	O
for	O
cases)	O
as	O
of	O
.	O
The	O
number	O
varies	O
by	O
region	O
.	O

Several	O
measures	O
are	O
used	O
to	O
quantify	O
mortality	O
.	O

IARPA	S-Organization
Director	O
Jason	B-Person
Matheny	E-Person
told	O
in	O
an	O
interview	O
that	O
advances	O
in	O
biotechnology	O
present	O
growth	O
opportunities	O
for	O
medicine	O
,	O
agriculture	O
,	O
energy	O
and	O
materials	O
,	O
but	O
could	O
also	O
lead	O
to	O
the	O
creation	O
of	O
weapons	O
of	O
mass	O
destruction	O
.	O

The	O
human	O
immune	O
system	O
prevents	O
this	O
via	O
a	O
protein	O
that	O
circulates	O
in	O
the	O
blood	O
called	O
siderocalin	O
.	O

World	O
Health	O
Organization	O
{www.who.int)	O
.	O

If	O
they	O
had	O
used	O
that	O
particular	O
procedure	O
for	O
this	O
type	O
of	O
specimen	O
,	O
then	O
it	O
would	O
not	O
have	O
happened	O
.	O

Treatment	O
was	O
conducted	O
by	O
four	O
Belgian	O
nuns	O
,	O
a	O
priest	O
,	O
one	O
female	O
nurse	O
from	O
Zaire	S-Location
,	O
and	O
seven	O
male	O
Zaireians	O
.	O

These	O
people	O
may	O
be	O
the	O
people	O
who	O
can	O
spread	O
the	O
virus	O
better	O
,	O
but	O
we	O
still	O
don't	O
know	O
that	O
yet	O
.	O

Dr	O
.	O

If	O
anthrax	B-Pathogen
spores	E-Pathogen
were	O
released	O
into	O
the	O
air	O
,	O
people	O
could	O
breathe	O
them	O
in	O
and	O
get	O
sick	O
with	O
anthrax	S-Pathogen
.	O
Inhalation	O
anthrax	S-Pathogen
is	O
the	O
most	O
serious	O
form	O
and	O
can	O
kill	O
quickly	O
if	O
not	O
treated	O
immediately	O
.	O

Last	O
February	O
,	O
countries	O
were	O
called	O
upon	O
to	O
make	O
new	O
,	O
concrete	O
commitments	O
to	O
advance	O
national	O
,	O
regional	O
or	O
global	O
capacity	O
to	O
prevent	O
,	O
detect	O
,	O
and	O
rapidly	O
respond	O
to	O
biological	O
threats	O
.	O

Primary	O
treatment	O
is	O
symptomatic	O
and	O
supportive	O
therapy	O
.	O

Further	O
concerns	O
regarding	O
Taiwan	S-Location
's	O
non-member	O
status	O
in	O
the	O
WHO	S-Organization
has	O
been	O
on	O
the	O
effect	O
this	O
has	O
on	O
increasing	O
Taiwan	S-Location
's	O
vulnerability	O
in	O
the	O
case	O
of	O
an	O
outbreak	O
in	O
the	O
country	O
without	O
proper	O
channels	O
to	O
the	O
WHO	S-Organization
.	O
In	O
response	O
,	O
the	O
has	O
said	O
that	O
they	O
"	O
have	O
Taiwanese	O
experts	O
involved	O
in	O
all	O
of	O
our	O
consultations	O
...	O
so	O
they're	O
fully	O
engaged	O
and	O
fully	O
aware	O
of	O
all	O
of	O
the	O
developments	O
in	O
the	O
expert	O
networks.	O
"	O

I	O
don't	O
think	O
it	O
would	O
be	O
practical,	O
"	O
Redlener	S-Person
said	O
.	O

Together	O
with	O
openBIS	S-Platform
MIMAS	S-Platform
is	O
pioneer	O
in	O
integrating	O
next-generation	O
sequencing	O
techniques	O
.	O

In	O
recent	O
years	O
,	O
the	O
emergence	O
or	O
re-emergence	O
of	O
critical	O
issues	O
in	O
infectious	O
disease	O
and	O
public	O
health	O
has	O
presented	O
new	O
challenges	O
and	O
opportunities	O
for	O
laboratory	O
animal	O
care	O
professionals	O
.	O

In	O
a	O
naval	O
battle	O
against	O
King	O
Eumenes	S-Person
of	O
Pergamon	O
in	O
184	O
BC	O
,	O
Hannibal	S-Person
of	O
Carthage	O
had	O
clay	O
pots	O
filled	O
with	O
venomous	O
snakes	O
and	O
instructed	O
his	O
sailors	O
to	O
throw	O
them	O
onto	O
the	O
decks	O
of	O
enemy	O
ships	O
.	O

The	O
Occupational	B-Organization
Safety	I-Organization
and	I-Organization
Health	I-Organization
Administration	E-Organization
()	O
regulations	O
in	O
29	O
CFR	O
parts	O
1910.1200	O
and	O
1910.1450	O
.	O

In	O
Philadelphia	S-Location
for	O
example	O
,	O
4,597 people	O
died	O
in	O
the	O
week	O
ending	O
16 October	O
,	O
but	O
by	O
11 November	O
,	O
influenza	S-Disease
had	O
almost	O
disappeared	O
from	O
the	O
city	O
.	O

Such	O
ongoing	O
global	O
health	O
security	O
collaboration	O
is	O
vital	O
,	O
CDC	S-Organization
Schuchat	S-Person
said	O
in	O
her	O
keynote	O
address	O
during	O
the	O
March	O
12	O
KFF	B-Activity
event	E-Activity
in	O
.	O

The	O
principal	O
investigator	O
at	O
the	O
Naval	B-Organization
Research	I-Organization
Laboratory	E-Organization
,	O
James	B-Person
Campbell	E-Person
,	O
described	O
possible	O
applications	O
of	O
this	O
technology	O
in	O
his	O
presentation	O
at	O
.	O
Among	O
them	O
were	O
"	O
microbial	O
derived	O
or	O
based	O
esterases	O
[that]	O
might	O
be	O
used	O
to	O
strip	O
signature-control	O
coatings	O
from	O
aircraft	O
,	O
thus	O
facilitating	O
detection	O
and	O
destruction	O
of	O
the	O
aircraft	O
"	O
(www.dtic.mil/ndia/NLD3/camp.pdf)	O
.	O

Iran	S-Location
became	O
a	O
centre	O
of	O
the	O
spread	O
of	O
the	O
virus	O
after	O
China	S-Location
during	O
February	O
.	O

An	O
omnibus	O
spending	O
bill	O
passed	O
by	O
Congress	S-Organization
earlier	O
this	O
year	O
included	O
3	O
years	O
of	O
"	O
bridge"	O
funding	O
for	O
GHSA	S-International_exchange_and_cooperation
work	O
at	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
;	O
the	O
bill	O
also	O
directed	O
the	O
White	B-Organization
House	E-Organization
to	O
create	O
a	O
.	O

Multinuclear	B-Technology
imaging	E-Technology
is	O
primarily	O
a	O
research	O
technique	O
at	O
present	O
.	O

It	O
made	O
CRISPR/Cas9	B-Technology
system	E-Technology
even	O
more	O
interesting	O
in	O
gene	O
editing	O
.	O

For	O
non-genetic	O
disorders	O
such	O
as	O
cancer	S-Disease
are	O
very	O
promising	O
since	O
it	O
can	O
be	O
used	O
as	O
a	O
selective-labelling	O
of	O
tumoral	O
cells	O
in	O
combination	O
with	O
targeted	O
therapies	O
.	O

Microorganisms	O
do	O
not	O
develop	O
resistance	O
to	O
vaccines	O
because	O
a	O
vaccine	O
enhances	O
the	O
body's	O
immune	O
system	O
,	O
whereas	O
an	O
antibiotic	O
operates	O
separately	O
from	O
the	O
body's	O
normal	O
defenses	O
.	O

Within	O
the	O
European	B-Organization
Union	E-Organization
(	O
EU	S-Location
)	O
,	O
the	O
European	B-Organization
Commission	E-Organization
has	O
launched	O
a	O
green	O
paper	O
on	O
biopreparedness	O
,	O
an	O
EU	B-Document
CBRN	I-Document
action	I-Document
plan	E-Document
,	O
and	O
EU	B-Document
legislation	E-Document
concerning	O
serious	O
cross-border	O
threats	O
to	O
health	O
.	O

Transmission	O
can	O
be	O
direct	O
from	O
animal	O
to	O
human	O
,	O
from	O
animal	O
to	O
"	O
bridge"	O
animal	O
to	O
human	O
,	O
or	O
animal	O
to	O
vector	O
to	O
human	O
.	O

Similarly	O
,	O
the	O
intermittent	O
fasting	O
that	O
Dorsey	S-Person
endorses	O
may	O
yield	O
health	O
benefits	O
for	O
some	O
,	O
but	O
scientists	O
still	O
have	O
plenty	O
of	O
questions	O
about	O
it	O
.	O

The	O
bottom	O
line	O
,	O
however	O
,	O
is	O
that	O
decisions	O
to	O
raise	O
the	O
level	O
of	O
pandemic	O
alert	O
were	O
based	O
on	O
clearly	O
defined	O
virological	O
and	O
epidemiological	O
criteria	O
.	O

Just	O
like	O
any	O
cell	O
in	O
the	O
body	O
,	O
bacteria	O
require	O
the	O
essential	O
trace	O
element	O
iron	S-Drug
However	O
,	O
in	O
body	O
fluids	O
,	O
iron	S-Drug
is	O
tightly	O
bound	O
to	O
proteins	O
and	O
,	O
therefore	O
,	O
not	O
easily	O
available	O
.	O

The	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
of	O
the	O
United	B-Location
Stated	E-Location
(	O
US	S-Location
)	O
released	O
"	O
"	O
[5]	O
,	O
which	O
divided	O
biological	O
agents	O
into	O
four	O
groups	O
,	O
and	O
published	O
the	O
category	O
lists	O
for	O
each	O
biological	O
agent	O
.	O

In	O
2016	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
drafted	O
a	O
global	O
health	O
sector	O
strategy	O
on	O
HIV	S-Pathogen
.	O
In	O
the	O
draft	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
outlines	O
its	O
commitment	O
to	O
ending	O
the	O
AIDS	S-Disease
epidemic	O
by	O
the	O
year	O
2030	O
with	O
interim	O
targets	O
for	O
the	O
year	O
2020	O
.	O

Adrianna	B-Person
Rodriguez	E-Person
,	O
These	O
countries	O
have	O
no	O
reports	O
of	O
coronavirus	O
cases	O
.	O

A	O
specialized	O
growing	O
subset	O
of	O
interventional	B-Technology
MRI	E-Technology
is	O
intraoperative	B-Technology
MRI	E-Technology
,	O
in	O
which	O
an	O
MRI	S-Technology
is	O
used	O
in	O
surgery	O
.	O

These	O
precisely	O
placed	O
modifications	O
may	O
then	O
be	O
used	O
to	O
regulate	O
the	O
effects	O
on	O
gene	O
expressions	O
and	O
DNA	O
dynamics	O
after	O
the	O
inhibition	O
of	O
certain	O
genome	O
sequences	O
within	O
DNA	O
.	O

However	O
,	O
some	O
virus	O
samples	O
are	O
still	O
available	O
in	O
Russian	O
and	O
American	O
laboratories	O
.	O

And	O
even	O
when	O
research	O
facilities	O
commit	O
the	O
most	O
egregious	O
safety	O
or	O
security	O
breaches	O
-	O
as	O
more	O
than	O
100	O
labs	O
have	O
-	O
federal	B-Organization
regulators	E-Organization
keep	O
their	O
names	O
secret	O
.	O

In	O
a	O
recent	O
study	O
published	O
in	O
Clinical	O
Infectious	O
Diseases	O
,	O
they	O
reported	O
that	O
barcode	O
analysis	O
of	O
more	O
than	O
6,000	O
Escherichia	B-Pathogen
coli	E-Pathogen
isolates	O
from	O
bloodstream	O
and	O
urinary	O
tract	O
infections	O
revealed	O
the	O
rise	O
of	O
a	O
new	O
multidrug-resistant	B-Pathogen
E	I-Pathogen
coli	I-Pathogen
clonal	I-Pathogen
group	E-Pathogen
,	O
,	O
that	O
has	O
seen	O
a	O
dramatic	O
increase	O
in	O
prevalence	O
in	O
recent	O
years	O
.	O

On	O
September	O
9	O
,	O
2009	O
,	O
Ethiopia	S-Location
enacted	O
a	O
highly	O
restrictive	O
biosafety	O
law	O
firmly	O
based	O
on	O
precautionary	O
principles	O
as	O
a	O
foundation	O
for	O
its	O
GMO	S-Technology
regulation	O
system	O
.	O

We	O
have	O
laboratories	O
here	O
at	O
the	O
Atlanta	S-Location
campus	O
at	O
Roybal	O
,	O
we	O
have	O
one	O
BSL-3	S-Platform
laboratory	O
over	O
at	O
the	O
Chamblee	B-Location
campus	E-Location
,	O
we	O
have	O
BSL-3	S-Platform
laboratories	O
out	O
in	O
Fort	B-Location
Collins	E-Location
,	O
Colorado	S-Location
,	O
our	O
vector-born	O
program	O
.	O

Venter	S-Person
team	O
and	O
other	O
scientists	O
around	O
the	O
world	O
are	O
trying	O
to	O
engineer	O
photosynthetic	O
bacteria	O
that	O
use	O
light	O
and	O
water	O
to	O
create	O
hydrogen	O
gas	O
.	O

And	O
they	O
tell	O
us	O
that	O
we	O
they'd	O
to	O
make	O
significant	O
improvements	O
to	O
ensure	O
that	O
our	O
lab	O
workers	O
remain	O
safe	O
.	O

The	O
report	O
also	O
gives	O
an	O
example	O
for	O
withholding	O
of	O
grant	O
payments	O
because	O
of	O
reluctance	O
to	O
share	O
data	O
with	O
other	O
researchers	O
.	O

As	O
of	O
mid-May	O
2020	O
,	O
the	O
effective	O
R	O
is	O
close	O
to	O
or	O
below	O
1.	O
0	O
in	O
many	O
countries	O
,	O
meaning	O
the	O
spread	O
of	O
the	O
disease	O
in	O
these	O
areas	O
is	O
stable	O
or	O
decreasing	O
.	O

Three	O
million	O
people	O
in	O
the	O
UK	S-Location
used	O
an	O
app	O
developed	O
by	O
King's	B-Organization
College	I-Organization
London	E-Organization
and	O
Zoe	S-Person
to	O
track	O
people	O
with	O
COVID‑19	S-Pathogen
symptoms	O
.	O

Created	O
the	O
position	O
of	O
the	O
Associate	O
Director	O
for	O
Laboratory	O
Science	O
and	O
Safety	O
(ADLSS)-a	O
senior	O
official	O
who	O
serves	O
as	O
the	O
single	O
point	O
of	O
accountability	O
for	O
laboratory	O
safety	O
and	O
science	O
at	O
CDC	S-Organization

Here	O
at	O
CDC	S-Organization
or	O
in	O
Russia	S-Location
where	O
there's	O
a	O
WHO	S-Organization
.	O
,	O
world	B-Organization
health	I-Organization
organization	E-Organization
,	O
authorized	O
laboratory	O
.	O

The	O
algorithm	O
robustly	O
predicts	O
the	O
probability	O
of	O
pathogen	O
exposure	O
,	O
without	O
regard	O
to	O
the	O
particular	O
pathogen	O
,	O
the	O
exposure	O
route	O
,	O
or	O
pathogen	O
dose	O
.	O

Those	O
limbs	O
that	O
were	O
removed	O
were	O
sometimes	O
re-attached	O
to	O
the	O
opposite	O
sides	O
of	O
the	O
body	O
.	O

Although	O
,	O
historically	O
,	O
the	O
images	O
generated	O
were	O
in	O
the	O
axial	O
or	O
transverse	O
plane	O
,	O
perpendicular	O
to	O
the	O
long	O
axis	O
of	O
the	O
body	O
,	O
modern	O
scanners	O
allow	O
this	O
volume	O
of	O
data	O
to	O
be	O
reformatted	O
in	O
various	O
planes	O
or	O
even	O
as	O
volumetric	O
(3D)	O
representations	O
of	O
structures	O
.	O

On	O
20	O
April	O
2014	O
,	O
Greece	S-Organization
reported	O
its	O
first	O
MERS-CoV	S-Pathogen
case	O
.	O

Both	O
nations	O
explored	O
the	O
use	O
of	O
hundreds	O
of	O
different	O
bacteria	O
,	O
viruses	O
,	O
and	O
biological	O
toxins	O
.	O

The	O
Demon	O
in	O
the	O
Freezer	O
,	O
Ballantine	O
Books	O
,	O
.	O
.	O

In	O
the	O
meantime	O
,	O
Reeves	S-Person
and	O
his	O
co-authors	O
remain	O
concerned	O
.	O

Military	O
service	O
members	O
are	O
called	O
upon	O
to	O
operate	O
virtually	O
anywhere	O
in	O
the	O
world	O
,	O
often	O
on	O
short	O
notice	O
,	O
and	O
the	O
locations	O
to	O
which	O
they	O
deploy	O
frequently	O
lack	O
the	O
robust	O
public	O
health	O
infrastructure	O
to	O
identify	O
and	O
contain	O
the	O
spread	O
of	O
new	O
viral	O
infectious	O
diseases	O
.	O

The	O
development	O
of	O
laboratory	O
biosafety	O
and	O
biodefense	O
capabilities	O
require	O
shared	O
experience	O
to	O
face	O
the	O
pressing	O
questions	O
of	O
modern-day	O
threat	O
.	O

Healthcare-associated	O
spread	O
of	O
this	O
E.	B-Pathogen
coli	E-Pathogen
strain	O
in	O
the	O
veterinary	O
intensive	O
care	O
unit	O
emphasizes	O
the	O
need	O
to	O
rapidly	O
identify	O
and	O
characterize	O
carbapenem-resistant	O
isolates	O
from	O
animals	O
.	O

The	O
organization	O
has	O
previously	O
instigated	O
the	O
in	O
2003	O
.	O

For	O
more	O
information	O
,	O
refer	O
to	O
the	O
Section	B-Document
V	I-Document
of	I-Document
the	I-Document
BMBL,	I-Document
5th	I-Document
Ed.	E-Document
available	O
online	O
at	O

As	O
was	O
true	O
for	O
the	O
,	O
the	O
second	O
1891	O
recurrence	O
produced	O
of	O
the	O
most	O
deaths	O
.	O

By	O
the	O
use	O
of	O
high-throughput	O
methods	O
in	O
many	O
research	O
areas	O
from	O
physics	O
to	O
systems	O
biology	O
,	O
large	O
data	O
collections	O
are	O
increasingly	O
important	O
as	O
raw	O
material	O
for	O
research	O
.	O

Contaminated	O
droplets	O
exhaled	O
by	O
infected	O
people	O
are	O
then	O
inhaled	O
into	O
the	O
lungs	O
,	O
or	O
settle	O
on	O
other	O
people's	O
faces	O
to	O
cause	O
new	O
infection	O
.	O

Outbreaks	O
of	O
anthrax	S-Pathogen
and	O
glanders	S-Pathogen
are	O
traced	O
to	O
World	O
War	O
II	O
.	O

"	O
If	O
it	O
can	O
be	O
put	O
under	O
control	O
,	O
it	O
should	O
not	O
be	O
a	O
problem	O
…	O
but	O
we	O
have	O
to	O
watch	O
the	O
developments	O
very	O
carefully,	O
"	O
said	O
Yao	B-Person
Guiling	E-Person
an	O
analyst	O
with	O
consultancy	O
.	O

Anti-herpesvirus	B-Technology
CRISPRs	E-Technology
have	O
promising	O
applications	O
such	O
as	O
removing	O
cancer-causing	O
from	O
tumor	O
cells	O
,	O
helping	O
rid	O
donated	O
organs	O
for	O
immunocompromised	O
patients	O
of	O
viral	O
invaders	O
,	O
or	O
preventing	O
cold	O
sore	O
outbreaks	O
and	O
recurrent	O
eye	O
infections	O
by	O
blocking	O
HSV-1	O
reactivation.	O
,	O
these	O
were	O
awaiting	O
testing	O
.	O

Sheela	S-Person
and	O
Puja	S-Person
were	O
arrested	O
in	O
West	B-Location
Germany	E-Location
on	O
October	O
28	O
,	O
1985	O
.	O

Finally	O
,	O
DNA	B-Technology
testing	E-Technology
the	O
door	O
to	O
sticky	O
ethical	O
questions	O
,	O
such	O
as	O
whether	O
to	O
carry	O
to	O
term	O
a	O
pregnancy	O
after	O
the	O
fetus	O
is	O
found	O
to	O
have	O
a	O
genetic	O
mutation	O
.	O

Debra	B-Person
Hunt	E-Person
DrPH	O
,	O
CBSP†	O
,	O
is	O
the	O
Director	O
of	O
Biological	O
Safety	O
within	O
the	O
Occupational	B-Organization
and	I-Organization
Environmental	I-Organization
Safety	I-Organization
Office	E-Organization
at	O
Duke	B-Organization
University	E-Organization
,	O
with	O
responsibilities	O
in	O
the	O
University	O
,	O
the	O
Medical	O
Center	O
,	O
and	O
Duke	B-Platform
Health	I-Platform
System	E-Platform
.	O
She	O
is	O
also	O
an	O
Assistant	O
Professor	O
in	O
the	O
university's	O
Department	B-Organization
of	I-Organization
Community	I-Organization
and	I-Organization
Family	I-Organization
Medicine	E-Organization
,	O
Division	B-Organization
of	I-Organization
Occupational	I-Organization
Medicine	E-Organization
.	O
She	O
serves	O
on	O
the	O
Duke	B-Organization
University	I-Organization
Institutional	I-Organization
Biosafety	I-Organization
Committee	E-Organization
,	O
the	O
Duke	B-Organization
University	I-Organization
Safety	I-Organization
Committee	E-Organization
,	O
and	O
is	O
the	O
designated	O
"	O
Responsible	O
Official	O
"	O
for	O
Duke	B-Scientific_research_project
University's	I-Scientific_research_project
Select	I-Scientific_research_project
Agent	I-Scientific_research_project
Program	E-Scientific_research_project
.	O
She	O
is	O
a	O
Certified	O
Biological	O
Safety	O
Professional	O
(CBSP)	O
and	O
a	O
Past-President	O
of	O
the	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
.	O

From	O
January	O
1962	O
,	O
Rocky	B-Location
Mountain	I-Location
Arsenal	E-Location
"	O
grew,	O
purified	O
and	O
biodemilitarized	O
"	O
plant	O
pathogen	O
Wheat	B-Pathogen
Stem	I-Pathogen
Rust	E-Pathogen
(	O
Agent	B-Pathogen
TX	E-Pathogen
)	O
,	O
Puccinia	B-Pathogen
graminis	E-Pathogen
,	O
var.	O
tritici	O
,	O
for	O
the	O
Air	B-Organization
Force	E-Organization
biological	O
anti-crop	O
program	O
.	O

Annualized	O
production	O
capacity	O
for	O
weaponized	O
smallpox	S-Pathogen
for	O
example	O
,	O
was	O
90	O
to	O
100	O
tons	O
.	O

During	O
the	O
outbreak	O
Canadian	O
Prime	O
Minister	O
Justin	B-Person
Trudeau	E-Person
voiced	O
his	O
support	O
for	O
Taiwan	S-Location
's	O
participation	O
in	O
WHO	S-Organization
,	O
as	O
did	O
Japanese	O
Prime	O
Minister	O
Shinzo	B-Person
Abe	E-Person
.	O
In	O
January	O
2020	O
the	O
European	B-Organization
Union	E-Organization
,	O
a	O
WHO	S-Organization
observer	O
,	O
backed	O
Taiwan	S-Location
's	O
participation	O
in	O
meetings	O
related	O
to	O
the	O
coronavirus	O
pandemic	O
as	O
well	O
as	O
their	O
general	O
participation	O
.	O

The	O
U.S.	B-Organization
Attorney's	I-Organization
office	E-Organization
handled	O
the	O
prosecution	O
of	O
the	O
poisoning	O
cases	O
related	O
to	O
the	O
10	O
restaurants	O
,	O
and	O
the	O
Oregon	B-Organization
Attorney	I-Organization
General's	I-Organization
office	E-Organization
prosecuted	O
the	O
poisoning	O
cases	O
of	O
Commissioner	O
Matthews	S-Person
and	O
Judge	O
.	O

AMR	O
is	O
a	O
global	O
concern	O
,	O
which	O
requires	O
every	O
country	O
to	O
have	O
an	O
action	O
against	O
it	O
.	O

In	O
the	O
event	O
of	O
a	O
crisis	O
,	O
network	O
activation	O
relies	O
on	O
a	O
request	O
of	O
assistance	O
from	O
any	O
of	O
the	O
network	O
agencies	O
.	O

Consequently	O
,	O
between	O
May	O
2014	O
and	O
April	O
2015	O
,	O
the	O
deaths	O
of	O
women	O
during	O
or	O
just	O
after	O
childbirth	O
rose	O
by	O
almost	O
a	O
third	O
and	O
those	O
of	O
newborns	O
by	O
a	O
quarter	O
,	O
compared	O
to	O
the	O
previous	O
year	O
.	O

It	O
had	O
around	O
4,500	O
containers	O
to	O
be	O
used	O
to	O
raise	O
fleas	O
,	O
six	O
cauldrons	O
to	O
produce	O
various	O
chemicals	O
,	O
and	O
around	O
1,800	O
containers	O
to	O
produce	O
biological	O
agents	O
.	O

When	O
discovered	O
early	O
,	O
anthrax	S-Disease
can	O
be	O
cured	O
by	O
administering	O
antibiotics	O
(such	O
as	O
)	O
.	O

Nootropics	S-Drug
are	O
substances	O
in	O
natural	O
,	O
supplement	O
,	O
or	O
food	O
and	O
beverage	O
form	O
used	O
to	O
increase	O
cognitive	O
function	O
.	O

On	O
23	O
March	O
,	O
it	O
was	O
reported	O
that	O
South	B-Location
Korea	E-Location
had	O
the	O
lowest	O
one-day	O
case	O
total	O
in	O
four	O
weeks	O
.	O

Researchers	O
on	O
the	O
program	O
will	O
be	O
required	O
to	O
conduct	O
field	O
surveillance	O
of	O
animal	O
and	O
insect	O
species	O
in	O
high-risk	O
areas	O
around	O
the	O
world	O
;	O
generate	O
data	O
in	O
lab	O
testing	O
and	O
sequence	O
viruses	O
as	O
they	O
evolve	O
;	O
analyze	O
the	O
jump	O
risk	O
by	O
weighing	O
factors	O
such	O
as	O
past	O
known	O
jump	O
events	O
,	O
ecology	O
,	O
seasonal	O
variants	O
,	O
and	O
geospatial	O
data	O
;	O
and	O
,	O
finally	O
,	O
validate	O
models	O
using	O
simulated	O
natural	O
environments	O
.	O

For	O
example	O
,	O
researchers	O
were	O
able	O
to	O
track	O
the	O
2014	B-Incident
Ebola	I-Incident
epidemic	E-Incident
in	O
real	O
time	O
using	O
DNA	B-Technology
sequencing	E-Technology
.	O
And	O
pharmaceutical	O
companies	O
are	O
designing	O
new	O
anti-cancer	O
drugs	O
targeted	O
to	O
people	O
with	O
a	O
specific	O
DNA	O
mutation	O
.	O

The	O
Lanzhou	B-Organization
Veterinary	I-Organization
Research	I-Organization
Institute	E-Organization
in	O
central	O
China	S-Location
confirmed	O
on	O
7	O
December	O
that	O
96	O
staff	O
and	O
students	O
have	O
tested	O
positive	O
for	O
the	O
infection	O
.	O

This	O
is	O
an	O
extremely	O
important	O
question	O
for	O
this	O
research	O
and	O
as	O
such	O
has	O
been	O
a	O
big	O
focus	O
for	O
the	O
researchers	O
at	O
JCVI	S-Organization
as	O
well	O
as	O
the	O
company	O
Synthetic	B-Technology
Genomics	E-Technology
Inc	O
.	O

The	O
U.S.	B-Organization
military	E-Organization
for	O
decades	O
remained	O
silent	O
about	O
"	O
Project	B-Scientific_research_project
112	E-Scientific_research_project
"	O
and	O
its	O
victims	O
,	O
a	O
slew	O
of	O
tests	O
overseen	O
by	O
the	O
Army's	B-Organization
Deseret	I-Organization
Test	I-Organization
Center	E-Organization
in	O
Salt	B-Location
Lake	I-Location
City	E-Location
.	O
Project	B-Scientific_research_project
112	E-Scientific_research_project
starting	O
in	O
the	O
1960s	O
tested	O
chemical	O
and	O
biological	O
agents	O
,	O
including	O
VX	S-Pathogen
,	O
sarin	S-Pathogen
and	O
E.	B-Pathogen
coli	E-Pathogen
,	O
on	O
military	O
personnel	O
who	O
did	O
not	O
know	O
they	O
were	O
being	O
tested	O
.	O

In	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
Congo	E-Location
for	O
instance	O
,	O
the	O
UN	S-Organization
is	O
supervising	O
the	O
overall	O
response	O
to	O
the	O
Ebola	S-Disease
crisis	O
,	O
the	O
first	O
time	O
said	O
he's	O
seen	O
it	O
become	O
operational.U.S.	O
investment	O
in	O
such	O
responses	O
would	O
benefit	O
the	O
nation	O
,	O
he	O
said	O
.	O

These	O
operations	O
were	O
part	O
of	O
the	O
US	S-Location
Entomological	O
Warfare	O
under	O
the	O
Program	O
for	O
Biological	O
Weapons	O
of	O
the	O
.	O

Our	O
commitment	O
to	O
delivering	O
unmatched	O
performance	O
,	O
security	O
and	O
scalability	O
extends	O
beyond	O
our	O
government	O
clients	O
to	O
those	O
in	O
the	O
commercial	O
enterprise	O
space	O
,	O
giving	O
physician	O
groups	O
and	O
non-government	O
hospitals	O
an	O
added	O
measure	O
of	O
reassurance.	O
"	O
According	O
to	O
the	O
KPMG	O
survey	O
,	O
12	O
percent	O
of	O
survey	O
respondents	O
are	O
concerned	O
with	O
regulatory	O
compliance	O
and	O
risk/liability	O
.	O

In	O
October	O
2014	O
,	O
a	O
World	B-Organization
Bank	E-Organization
report	O
estimated	O
overall	O
economic	O
impacts	O
of	O
between	O
$3.8	O
billion	O
and	O
$32.6	O
billion	O
,	O
depending	O
on	O
the	O
extent	O
of	O
the	O
outbreak	O
and	O
speed	O
of	O
containment	O
.	O

,	O
patent	O
rights	O
to	O
CRISPR	S-Technology
were	O
contested	O
.	O

Goble	S-Person
et	O
al.	O
provide	O
a	O
description	O
of	O
the	O
different	O
levels	O
of	O
integration	O
and	O
locate	O
mashups	O
at	O
the	O
lightweight	O
integration	O
extreme	O
.	O

However	O
,	O
this	O
technique	O
is	O
susceptible	O
to	O
noise	O
and	O
other	O
factors	O
which	O
can	O
affect	O
the	O
linearity	O
of	O
the	O
voltage	O
to	O
x-ray	O
intensity	O
relationship	O
.	O

Due	O
to	O
overlap	O
with	O
other	O
infections	O
such	O
as	O
adenovirus	O
,	O
imaging	O
without	O
confirmation	O
by	O
rRT-PCR	S-Technology
is	O
of	O
limited	O
specificity	O
in	O
identifying	O
COVID-19	S-Disease
.	O
A	O
large	O
study	O
in	O
China	S-Location
compared	O
chest	B-Equipment
CT	E-Equipment
results	O
to	O
and	O
demonstrated	O
that	O
though	O
imaging	O
is	O
less	O
specific	O
for	O
the	O
infection	O
,	O
it	O
is	O
faster	O
and	O
more	O
sensitive	O
.	O

The	O
report	O
also	O
recommended	O
that	O
the	O
USAID	B-Person
administrator	E-Person
ensure	O
that	O
a	O
complete	O
and	O
accurate	O
inventory	O
of	O
is	O
compiled	O
for	O
ongoing	O
evaluations	O
.	O

It	O
was	O
not	O
even	O
the	O
only	O
great	O
bubonic	B-Disease
plague	E-Disease
.	O
In	O
AD541	O
struck	O
the	O
Byzantine	O
empire	O
.	O

An	O
attack	O
on	O
Changda	S-Location
in	O
1941	O
reportedly	O
led	O
to	O
approximately	O
10,000	O
biological	O
casualties	O
and	O
1700	O
deaths	O
among	O
ill-prepared	O
Japanese	O
troops	O
,	O
with	O
most	O
cases	O
due	O
to	O
cholera	S-Pathogen
.	O
Japanese	O
researchers	O
performed	O
tests	O
on	O
prisoners	O
with	O
bubonic	B-Disease
plague	E-Disease
,	O
cholera	S-Disease
,	O
smallpox	S-Disease
,	O
botulism	S-Disease
,	O
as	O
well	O
as	O
other	O
diseases	O
.	O

Gilead	B-Organization
Sciences	E-Organization
subsequently	O
discovered	O
that	O
remdesivir	S-Drug
had	O
antiviral	O
activity	O
in	O
vitro	O
against	O
multiple	O
filoviruses	S-Pathogen
,	O
pneumoviruses	S-Pathogen
,	O
paramyxoviruses	S-Pathogen
,	O
and	O
.	O

The	O
contrast	O
provided	O
between	O
grey	O
and	O
white	O
matter	O
makes	O
MRI	S-Technology
the	O
best	O
choice	O
for	O
many	O
conditions	O
of	O
the	O
central	O
nervous	O
system	O
,	O
including	O
demyelinating	B-Disease
diseases	E-Disease
,	O
dementia	S-Disease
,	O
cerebrovascular	B-Disease
disease	E-Disease
,	O
infectious	B-Disease
diseases	E-Disease
,	O
Alzheimer's	B-Disease
disease	E-Disease
and	O
epilepsy	S-Disease
.	O
Since	O
many	O
images	O
are	O
taken	O
milliseconds	O
apart	O
,	O
it	O
shows	O
how	O
the	O
brain	O
responds	O
to	O
different	O
stimuli	O
,	O
enabling	O
researchers	O
to	O
study	O
both	O
the	O
functional	O
and	O
structural	O
brain	O
abnormalities	O
in	O
psychological	O
disorders	O
.	O

Each	O
year	O
,	O
the	O
organization	O
marks	O
World	O
Health	O
Day	O
and	O
other	O
observances	O
focusing	O
on	O
a	O
specific	O
health	O
promotion	O
topic	O
.	O

From	O
left	O
,	O
Ken	B-Person
Bayles	E-Person
Ph.D.	O
,	O
of	O
UNMC	S-Organization
;	O
Mark	B-Person
Riley	E-Person
,	O
Ph.D.	O
,	O
of	O
the	O
University	B-Organization
of	I-Organization
Nebraska-Lincoln	E-Organization
;	O
and	O
Harshini	B-Person
Mukundan	E-Person
,	O
Ph.D.	O
,	O
of	O
.	O

As	O
these	O
notifications	O
occurred	O
,	O
doctors	O
in	O
Wuhan	S-Location
were	O
warned	O
by	O
police	O
for	O
"	O
spreading	O
rumours	O
"	O
about	O
the	O
outbreak	O
.	O

It	O
was	O
later	O
revealed	O
that	O
Gilead	S-Organization
had	O
been	O
providing	O
remdesivir	S-Drug
in	O
response	O
to	O
compassionate	O
use	O
requests	O
since	O
25	O
January	O
.	O

Mouth	O
pipetting	O
was	O
reported	O
by	O
28.	O
3%	O
technicians	O
.	O

One	O
example	O
occurred	O
in	O
2009	O
during	O
the	O
first	O
herd	O
in	O
27	O
years	O
.	O

"	O
Would	O
I	O
be	O
surprised	O
if	O
we	O
had	O
a	O
release	O
now?	O
I'd	O
be	O
shocked	O
and	O
horrified	O
but	O
not	O
surprised,	O
"	O
he	O
said	O
,	O
adding	O
that	O
if	O
anthrax	S-Pathogen
were	O
released	O
on	O
the	O
subway	O
in	O
City	O
,	O
for	O
example	O
,	O
it	O
would	O
spread	O
like	O
wildfire	O
.	O

The	O
phage	O
is	O
lysogenic	O
at	O
30°C	O
,	O
but	O
turns	O
lytic	O
at	O
42°C	O
due	O
to	O
inactivation	O
of	O
the	O
ts	O
repressor	O
.	O

The	O
work	O
in	O
biological	B-Equipment
(aseptic)	I-Equipment
hoods	E-Equipment
is	O
central	O
to	O
any	O
tissue	O
culture	O
work	O
and	O
is	O
continuously	O
used	O
in	O
2	O
out	O
of	O
the	O
5	O
laboratory	O
meetings	O
in	O
the	O
course	O
.	O

And	O
so	O
we'll	O
be	O
looking	O
at	O
ways	O
to	O
have	O
redundant	O
systems	O
to	O
affect	O
and	O
improve	O
this	O
through	O
our	O
work	O
.	O

By	O
the	O
time	O
of	O
the	O
Gulf	O
War	O
cease-fire	O
in	O
1991	O
,	O
however	O
,	O
Iraq	S-Location
had	O
weaponized	O
anthrax	S-Pathogen
,	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
and	O
aflatoxin	S-Pathogen
and	O
had	O
several	O
other	O
lethal	O
agents	O
in	O
development	O
.	O

Thus	O
,	O
the	O
potentially	O
infectious	O
samples	O
were	O
moved	O
and	O
used	O
for	O
experimentation	O
by	O
researchers	O
in	O
these	O
lower	O
biosafety	O
level	O
laboratories	O
,	O
who	O
believing	O
the	O
samples	O
were	O
inactivated	O
,	O
were	O
not	O
wearing	O
adequate	O
while	O
handling	O
the	O
material	O
.	O

Biosafety	O
Perspective	O
of	O
Clinical	O
Laboratory	O
Workers:	O
A	O
Profile	O
of	O
Pakistan	S-Location
Biosafety	O
during	O
lab	O
work	O
is	O
an	O
important	O
concern	O
in	O
developing	O
countries	O
.	O

This	O
includes	O
passive	O
immunization	O
and	O
postexposure	O
vaccination	O
,	O
antibiotics	S-Drug
and	O
,	O
taking	O
into	O
consideration	O
the	O
possibility	O
of	O
emergence	O
of	O
resistant	O
strains	O
.	O

In	O
addition	O
,	O
these	O
bodies	O
synergize	O
and	O
harmonize	O
the	O
ethical	O
issues	O
related	O
to	O
the	O
release	O
and	O
use	O
of	O
GM	S-Technology
products	O
.	O

The	O
number	O
of	O
extra	O
hospital	O
days	O
was	O
2.5	O
million	O
.	O

That's	O
when	O
they	O
were	O
created	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
FDA	O
,	O
USDA	O
,	O
DHHS	O
,	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Currently	O
,	O
the	O
best-possible	O
tests	O
to	O
indicate	O
pathogen	O
exposure	O
are	O
invasive	O
,	O
labor-intensive	O
,	O
serially-sampled	O
blood-based	O
assays	O
,	O
which	O
may	O
give	O
only	O
6	O
to	O
12	O
hours	O
of	O
warning	O
.	O

In	O
May	O
2013	O
,	O
the	O
Coronavirus	B-Organization
Study	I-Organization
Group	I-Organization
of	I-Organization
the	I-Organization
International	I-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
adopted	O
the	O
official	O
designation	O
,	O
the	O
Middle	B-Pathogen
East	I-Pathogen
Respiratory	I-Pathogen
Syndrome	I-Pathogen
Coronavirus	E-Pathogen
(	O
MERS-CoV	S-Pathogen
).	O
which	O
was	O
adopted	O
by	O
the	O
to	O
"	O
provide	O
uniformity	O
and	O
facilitate	O
communication	O
about	O
the	O
disease	O
"	O

Most	O
pesticides	O
protect	O
crops	O
against	O
insects	O
and	O
plants	O
,	O
but	O
in	O
some	O
cases	O
antimicrobial	O
pesticides	O
are	O
used	O
to	O
protect	O
against	O
various	O
microorganisms	O
such	O
as	O
bacteria	O
,	O
viruses	O
,	O
fungi	O
,	O
algae	O
,	O
and	O
protozoa	O
.	O

Anthrax	S-Pathogen
letter	O
When	O
these	O
letters	O
were	O
opened	O
,	O
the	O
fine-grained	O
within	O
them	O
misted	O
into	O
the	O
air	O
.	O

By	O
the	O
1380s	O
in	O
Europe	S-Location
,	O
it	O
predominantly	O
affected	O
children	O
.	O

The	O
directive	O
,	O
a	O
memo	O
sent	O
to	O
federal	O
agencies	O
on	O
19	O
August	O
but	O
only	O
posted	O
online	O
today	O
,	O
allays	O
fears	O
in	O
the	O
academic	O
community	O
that	O
nongovernment	O
microbiologists	O
might	O
be	O
ordered	O
to	O
stop	O
work	O
for	O
24	O
hours	O
and	O
conduct	O
an	O
inventory	O
.	O

On	O
6	O
April	O
,	O
a	O
SARS	S-Disease
case	O
was	O
found	O
in	O
Manila	S-Location
,	O
a	O
person	O
who	O
had	O
returned	O
from	O
.	O

PRESAGED	S-Technology
is	O
the	O
first	O
system	O
capable	O
of	O
giving	O
early	O
warning	O
of	O
incipient	O
disease	O
symptoms	O
(e.g.	O
,	O
fever)	O
.	O

At	O
the	O
end	O
of	O
the	O
summer	O
,	O
HHS	S-Organization
will	O
decide	O
whether	O
to	O
go	O
into	O
production	O
.	O

And	O
so	O
they	O
call	O
for	O
more	O
transparency	O
from	O
DARPA	S-Organization
in	O
addition	O
to	O
more	O
opportunities	O
for	O
public	O
discussion	O
of	O
this	O
new	O
strategy	O
.	O

Metabiota	S-Organization
worked	O
on	O
a	O
Pentagon	S-Organization
's	O
project	O
at	O
the	O
,	O
where	O
three	O
US	O
biolabs	O
are	O
situated	O
.	O

This	O
chromosome	O
will	O
deliver	O
new	O
genes	O
that	O
will	O
be	O
used	O
for	O
engineering	O
the	O
human	O
body.	O
been	O
awarded	O
two	O
contracts	O
under	O
the	O
program	O
totaling	O
$1.	O
1	O
million	O
(2015-2016	O
–	O
$	O
100,600	O
for	O
the	O
first	O
phase	O
of	O
the	O
research	O
;	O
2015-2017	O
–	O
$	O
999,300	O
for	O
work	O
which	O
is	O
not	O
specified	O
in	O
the	O
federal	O
contracts	O
registry	O
.	O

Ron	B-Person
Atlas	E-Person
a	O
past	O
president	O
of	O
ASM	S-Organization
,	O
said	O
in	O
a	O
statement:	O
"	O
The	O
community	O
wants	O
to	O
act	O
responsibly	O
and	O
looks	O
forward	O
to	O
the	O
public	O
release	O
of	O
the	O
[OSTP]	B-Document
memo	E-Document
to	O
clear	O
up	O
any	O
uncertainties	O
.	O

Together	O
,	O
these	O
studies	O
suggest	O
NPC1	O
and	O
TIM-1	O
may	O
be	O
potential	O
therapeutic	O
targets	O
for	O
an	O
Ebola	O
anti-viral	O
drug	O
and	O
as	O
a	O
basis	O
for	O
a	O
rapid	O
field	O
diagnostic	O
assay	O
.	O

While	O
detractors	O
argue	O
that	O
do-it-yourself	O
biologists	O
need	O
some	O
sort	O
of	O
supervision	O
,	O
enthusiasts	O
argue	O
that	O
uniform	O
supervision	O
is	O
impossible	O
and	O
the	O
best	O
way	O
to	O
prevent	O
accidents	O
or	O
malevolence	O
is	O
to	O
encourage	O
a	O
culture	O
of	O
transparency	O
,	O
where	O
,	O
in	O
essence	O
,	O
do-it-yourself	O
biologists	O
would	O
be	O
peer	O
reviewed	O
by	O
other	O
biohackers	O
.	O

Propaganda	O
campaigns	O
and	O
war	O
restrictions	O
and	O
rations	O
had	O
been	O
implemented	O
by	O
governments	O
.	O

The	O
encouraged	O
businesses	O
and	O
factories	O
to	O
re-open	O
on	O
30	O
March	O
,	O
and	O
provided	O
monetary	O
stimulus	O
packages	O
for	O
firms	O
.	O

The	O
study	O
concluded	O
that	O
the	O
standards	O
biosafety	O
precautions	O
adopted	O
by	O
the	O
diagnostic	O
laboratories	O
in	O
Khartoum	S-Location
state	O
was	O
very	O
low	O
.	O

U.S.	O
biological	O
weapons	O
stocks	O
were	O
destroyed	O
over	O
the	O
next	O
few	O
years	O
.	O

But	O
the	O
maintains	O
that	O
disease	O
prevention	O
is	O
an	O
element	O
of	O
judicious	O
use	O
.	O

Other	O
African	O
countries	O
that	O
were	O
not	O
directly	O
affected	O
by	O
the	O
virus	O
also	O
reported	O
adverse	O
effects	O
on	O
tourism	O
.	O

A	O
Proposers	O
Day	O
is	O
scheduled	O
for	O
March	O
7	O
,	O
2018	O
in	O
Arlington	S-Location
.	O
Details	O
and	O
registration	O
instructions	O
are	O
available	O
here:	O
https://go.usa.gov/xnFub	O
.	O

In	O
December	O
2016	O
,	O
the	O
WHO	S-Organization
announced	O
that	O
a	O
two-year	O
trial	O
of	O
the	O
rVSV-ZEBOV	B-Vaccine
vaccine	E-Vaccine
appeared	O
to	O
offer	O
protection	O
from	O
the	O
variant	O
of	O
EBOV	S-Pathogen
responsible	O
for	O
the	O
Western	B-Incident
Africa	I-Incident
outbreak	E-Incident
.	O
The	O
vaccine	O
is	O
considered	O
to	O
be	O
effective	O
and	O
is	O
the	O
only	O
prophylactic	O
which	O
offers	O
protection	O
;	O
hence	O
,	O
300,000	O
doses	O
have	O
been	O
stockpiled.	O
received	O
regulatory	O
approval	O
in	O
2019	O
.	O

On	O
21	O
February	O
2013	O
,	O
WHO	S-Organization
stated	O
that	O
there	O
had	O
been	O
13	O
laboratory-confirmed	O
cases	O
,	O
6	O
cases	O
(4	O
fatal)	O
from	O
Saudi	O
Arabia	O
,	O
2	O
cases	O
(both	O
fatal)	O
from	O
Jordan	S-Location
,	O
2	O
cases	O
from	O
Qatar	S-Location
,	O
and	O
3	O
from	O
.	O

To	O
integrate	O
applications	O
,	O
the	O
Gaggle	S-Platform
boss	O
relays	O
messages	O
of	O
these	O
basic	O
data	O
types	O
between	O
'geese'	O
(software	O
adapted	O
to	O
Gaggle	S-Platform
)	O
.	O

To	O
address	O
this	O
problem	O
,	O
Gottlieb	S-Person
suggested	O
the	O
development	O
of	O
a	O
new	O
reimbursement	O
model	O
that	O
would	O
combine	O
milestone	O
payments	O
and	O
subscription	O
fees	O
for	O
new	O
FDA	S-Organization
-approved	O
antibiotics	O
that	O
have	O
high	O
clinical	O
and	O
social	O
value-such	O
as	O
drugs	O
that	O
treat	O
multidrug-resistant	O
organisms	O
.	O

The	O
Spanish	B-Disease
flu	E-Disease
began	O
with	O
a	O
wave	O
of	O
mild	O
cases	O
in	O
the	O
spring	O
,	O
followed	O
by	O
more	O
deadly	O
waves	O
in	O
the	O
autumn	O
,	O
eventually	O
killing	O
hundreds	O
of	O
thousands	O
in	O
the	O
United	B-Location
States	E-Location
and	O
50–100	O
million	O
worldwide	O
.	O

On	O
23	O
February	O
,	O
an	O
elderly	O
woman	O
named	O
Kwan	B-Person
Sui-Chu	E-Person
who	O
had	O
also	O
been	O
a	O
Metropole	B-Organization
Hotel	E-Organization
guest	O
,	O
returned	O
to	O
Toronto	S-Location
,	O
Canada	S-Location
,	O
from	O
Hong	B-Location
Kong	E-Location
.	O
She	O
died	O
at	O
home	O
on	O
5	O
March	O
,	O
after	O
infecting	O
her	O
son	O
Tse	B-Person
Chi	I-Person
Kwai	E-Person
,	O
who	O
subsequently	O
spread	O
the	O
disease	O
to	O
and	O
died	O
on	O
13	O
March	O
.	O

On	O
17	O
March	O
2016	O
,	O
the	O
government	B-Organization
of	I-Organization
Guinea	E-Organization
reported	O
,	O
per	O
the	O
media	O
,	O
that	O
2	O
people	O
had	O
again	O
tested	O
positive	O
for	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
Korokpara	S-Location
,	O
it	O
was	O
also	O
reported	O
that	O
they	O
were	O
from	O
the	O
village	O
where	O
members	O
of	O
one	O
family	O
had	O
recently	O
died	O
from	O
vomiting	S-Phenotype
(and	O
diarrhea	S-Phenotype
)	O
.	O

They	O
are	O
likely	O
to	O
have	O
milder	O
symptoms	O
and	O
a	O
lower	O
chance	O
of	O
severe	O
disease	O
than	O
adults	O
;	O
in	O
those	O
younger	O
than	O
50	O
years	O
the	O
risk	O
of	O
death	O
is	O
less	O
than	O
0.	O
5%	O
,	O
while	O
in	O
those	O
older	O
than	O
70	O
it	O
is	O
more	O
than	O
8%	O
.	O

This	O
was	O
in	O
reference	O
to	O
the	O
lab	O
synthesis	O
of	O
horsepox	S-Pathogen
in	O
2017	O
by	O
researchers	O
at	O
the	O
University	B-Organization
of	I-Organization
Alberta	E-Organization
.	O
The	O
researchers	O
recreated	O
horsepox	S-Pathogen
,	O
an	O
extinct	O
cousin	O
of	O
the	O
,	O
in	O
order	O
to	O
research	O
new	O
ways	O
to	O
treat	O
cancer	O
.	O

Recently	O
published	O
sequence	O
and	O
phylogenetic	O
analyses	O
suggest	O
that	O
the	O
genes	O
encoding	O
the	O
HA	O
and	O
neuraminidase	O
(NA)	O
surface	O
proteins	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
were	O
derived	O
from	O
an	O
avianlike	O
virus	O
shortly	O
before	O
the	O
start	O
of	O
the	O
pandemic	O
and	O
that	O
the	O
precursor	O
virus	O
had	O
not	O
circulated	O
widely	O
in	O
humans	O
or	O
swine	O
in	O
the	O
few	O
decades	O
before	O
(,,)	O
.	O

British	O
Gen	O
.	O

The	O
cross-sectoral	O
FBD	S-Platform
network	O
not	O
only	O
adopts	O
to	O
the	O
One	O
Health	O
concept	O
;	O
it	O
also	O
leads	O
to	O
improved	O
coordination	O
and	O
harmonization	O
between	O
laboratories	O
that	O
undoubtedly	O
will	O
save	O
resources	O
and	O
strengthen	O
national	O
biopreparedness	O
.	O

Each	O
review	O
resulted	O
in	O
a	O
report	O
of	O
findings	O
and	O
recommendations	O
.	O

This	O
is	O
doubly	O
so	O
in	O
a	O
world	O
that	O
is	O
confronting	O
naturally	O
occurring	O
epidemics	O
like	O
Ebola	S-Disease
,	O
while	O
guarding	O
against	O
the	O
possibility	O
of	O
bioterror	O
.	O

While	O
biocontainment	O
,	O
as	O
defined	O
in	O
the	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories	E-Document
and	O
Primary	O
Containment	O
for	O
Biohazards:	O
Selection	O
,	O
Installation	O
and	O
Use	O
of	O
Biosafety	O
Cabinets	O
manuals	O
available	O
at	O
the	O
website	O
much	O
of	O
the	O
design	O
,	O
implementation	O
and	O
monitoring	O
of	O
protocols	O
are	O
left	O
up	O
to	O
state	O
and	O
local	O
authorities	O
.	O

In	O
the	O
fall	O
of	O
2001	O
,	O
these	O
warnings	O
took	O
on	O
a	O
new	O
urgency	O
.	O

The	O
university	O
suspended	O
Perlman	S-Person
's	O
work	O
while	O
he	O
gained	O
permission	O
to	O
do	O
the	O
research	O
and	O
reported	O
the	O
non-compliance	O
to	O
the	O
.	O

To	O
make	O
achievements	O
towards	O
these	O
targets	O
,	O
the	O
draft	O
lists	O
actions	O
that	O
countries	O
and	O
the	O
WHO	S-Organization
can	O
take	O
,	O
such	O
as	O
a	O
commitment	O
to	O
universal	O
health	O
coverage	O
,	O
medical	O
accessibility	O
,	O
prevention	O
and	O
eradication	O
of	O
disease	O
,	O
and	O
efforts	O
to	O
educate	O
the	O
public	O
.	O

This	O
knowledge	O
should	O
be	O
initiated	O
in	O
schools	O
.	O

Retrieved	O
17	O
April	O
2020	O
.	O

Indeed	O
,	O
many	O
research	O
projects	O
in	O
basic	O
science	O
show-sometimes	O
unwillingly	O
and	O
unwittingly-how	O
to	O
overcome	O
current	O
scientific	O
and	O
technological	O
limits	O
in	O
the	O
military	O
use	O
of	O
pathogenic	O
agents	O
.	O

A	O
reduction	O
of	O
the	O
diarrhea	S-Phenotype
disease	O
burden	O
through	O
improved	O
infrastructure	O
would	O
result	O
in	O
large	O
decreases	O
in	O
the	O
number	O
of	O
diarrhea	S-Phenotype
cases	O
treated	O
with	O
antibiotics	O
.	O

The	O
risk	O
for	O
someone	O
who	O
is	O
40	O
years	O
old	O
is	O
half	O
that	O
of	O
someone	O
who	O
is	O
20	O
years	O
old	O
with	O
substantially	O
less	O
risk	O
in	O
the	O
elderly	O
.	O

When	O
you	O
consider	O
the	O
viral	O
infectious	O
diseases	O
that	O
emerged	O
and	O
reemerged	O
around	O
the	O
world	O
in	O
2017	O
alone	O
,	O
what	O
many	O
of	O
them	O
have	O
in	O
common	O
is	O
that	O
they	O
originated	O
in	O
animals	O
and	O
spilled	O
over	O
into	O
humans	O
after	O
a	O
series	O
of	O
mutations	O
that	O
enable	O
the	O
pathogens	O
to	O
jump	O
species	O
.	O

Two	O
cases	O
stemmed	O
from	O
Duncan	S-Location
,	O
when	O
two	O
nurses	O
that	O
had	O
treated	O
him	O
tested	O
positive	O
for	O
the	O
virus	O
on	O
10	O
and	O
14	O
October	O
and	O
ended	O
when	O
they	O
were	O
declared	O
-free	O
on	O
24	O
and	O
22	O
October	O
,	O
respectively	O
.	O

This	O
technology	O
thus	O
represents	O
a	O
novel	O
form	O
of	O
antimicrobial	O
therapy	O
and	O
a	O
strategy	O
by	O
which	O
to	O
manipulate	O
bacterial	O
populations	O
.	O

On	O
20	O
January	O
,	O
the	O
WHO	S-Organization
said	O
it	O
was	O
"	O
now	O
very	O
clear	O
"	O
human-to-human	O
transmission	O
of	O
the	O
coronavirus	O
had	O
occurred	O
,	O
given	O
that	O
healthcare	O
workers	O
had	O
been	O
infected	O
.	O

When	O
sufficient	O
data	O
are	O
obtained	O
,	O
work	O
with	O
these	O
agents	O
may	O
continue	O
at	O
this	O
or	O
a	O
lower	O
level	O
.	O

The	O
head	O
of	O
the	O
organization	O
is	O
the	O
Director-General	O
,	O
elected	O
by	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
The	O
term	O
lasts	O
for	O
5	O
years	O
,	O
and	O
Directors-General	O
are	O
typically	O
appointed	O
in	O
May	O
,	O
when	O
the	O
Assembly	O
meets	O
.	O

On	O
4	O
August	O
,	O
the	O
WHO	S-Organization
indicated	O
that	O
the	O
current	O
situation	O
in	O
the	O
,	O
due	O
to	O
several	O
factors	O
,	O
warranted	O
a	O
"	O
high	O
risk	O
assessment	O
"	O
at	O
the	O
national	O
and	O
regional	O
level	O
for	O
public	O
health	O
.	O

In	O
December	O
2016	O
,	O
the	O
results	O
of	O
the	O
two-year	O
Guinea	S-Location
trial	O
were	O
published	O
announcing	O
that	O
rVSV-ZEBOV	S-Vaccine
had	O
been	O
found	O
to	O
protect	O
people	O
who	O
had	O
been	O
exposed	O
to	O
cases	O
of	O
.	O

Ebola	B-Phenotype
symptoms	E-Phenotype
may	O
begin	O
as	O
early	O
as	O
two	O
days	O
or	O
as	O
long	O
as	O
21	O
days	O
after	O
one	O
is	O
exposed	O
to	O
the	O
virus	O
.	O

If	O
you	O
cut	O
two	O
pieces	O
of	O
DNA	O
with	O
the	O
same	O
restriction	O
enzyme	O
,	O
you	O
can	O
paste	O
them	O
together	O
.	O

At	O
the	O
same	O
time	O
,	O
a	O
strong	O
anti-foreigner	O
sentiment	O
quickly	O
took	O
hold	O
,	O
and	O
foreigners	O
experienced	O
harassment	O
by	O
the	O
general	O
public	O
and	O
forced	O
evictions	O
from	O
apartments	O
and	O
hotels	O
.	O

If	O
I	O
could	O
start	O
,	O
doctor	O
,	O
you	O
said	O
that	O
the	O
was	O
the	O
most	O
distressing	O
.	O

SysMO-SEEK	S-Platform
supports	O
upload	O
to	O
repositories	O
like	O
JWS-Online	O
,	O
Array-Express	O
,	O
NCBI	S-Organization
GEO	O
.	O

A	O
strategy	O
and	O
implementation	O
plan	O
would	O
help	O
the	O
CWMD	B-Organization
Office	E-Organization
mitigate	O
the	O
risk	O
of	O
fragmentation	O
among	O
DHS	S-Organization
programs	O
and	O
activities	O
as	O
well	O
as	O
leverage	O
resources	O
and	O
capabilities	O
and	O
provide	O
a	O
roadmap	O
for	O
addressing	O
any	O
gaps.	O
agreed	O
with	O
the	O
recommendations	O
and	O
will	O
address	O
them	O
.	O

PREEMPT	S-Scientific_research_project
will	O
seek	O
to	O
identify	O
these	O
opportunities	O
for	O
intervention	O
by	O
modeling	O
the	O
factors	O
that	O
enable	O
species	O
jump	O
.	O

DARPA	S-Organization
Pandemic	B-Platform
Protection	I-Platform
Platform	E-Platform
will	O
be	O
used	O
to	O
develop	O
protective	O
antibody	O
treatments	O
that	O
can	O
be	O
rapidly	O
dispersed	O
to	O
healthcare	O
providers	O
around	O
the	O
world	O
within	O
60	O
days	O
of	O
an	O
outbreak–an	O
ambitious	O
break	O
from	O
the	O
months	O
countermeasures	O
currently	O
take	O
to	O
create	O
and	O
distribute	O
.	O

The	O
aim	O
of	O
the	O
week	O
is	O
to	O
increase	O
global	O
awareness	O
of	O
antibiotic	O
resistance	O
.	O

So	O
far	O
,	O
researchers	O
have	O
cited	O
green	B-Drug
tea	E-Drug
cranberries	S-Drug
,	O
Persian	B-Drug
shallots	E-Drug
,	O
and	O
as	O
potential	O
sources	O
of	O
effective	O
alternatives	O
to	O
antibiotics	O
.	O

Upon	O
activation	O
,	O
samples	O
may	O
be	O
shipped	O
to	O
the	O
assisting	O
agencies	O
that	O
will	O
assist	O
with	O
the	O
diagnostics	O
.	O

In	O
August	O
1949	O
a	O
U.S.	B-Organization
Army	I-Organization
Special	I-Organization
Operations	I-Organization
Division	E-Organization
operating	O
out	O
of	O
Fort	B-Location
Detrick	E-Location
in	O
Maryland	S-Location
,	O
set	O
up	O
its	O
first	O
test	O
at	O
The	O
Pentagon	S-Organization
in	O
Washington	S-Location
,	O
D.C.	S-Location
Operatives	O
sprayed	O
harmless	O
bacteria	O
into	O
the	O
building's	O
air	O
conditioning	O
system	O
and	O
observed	O
as	O
the	O
microbes	O
spread	O
throughout	O
the	O
.	O

In	O
Europe	S-Location
,	O
WHO	S-Organization
Representatives	O
also	O
serve	O
as	O
Head	O
of	O
Country	O
Office	O
,	O
and	O
are	O
nationals	O
with	O
the	O
exception	O
of	O
Serbia	S-Location
;	O
there	O
are	O
also	O
Heads	O
of	O
Country	O
Office	O
in	O
Albania	S-Location
,	O
the	O
Russian	B-Location
Federation	E-Location
,	O
Tajikistan	S-Location
,	O
Turkey	S-Location
,	O
and	O
Uzbekistan	S-Location
.	O
The	O
WR	O
is	O
member	O
of	O
the	O
UN	S-Organization
system	O
country	O
team	O
which	O
is	O
coordinated	O
by	O
the	O
System	O
Resident	O
Coordinator	O
.	O

The	O
letter	O
was	O
postmarked	O
on	O
October	O
17	O
in	O
Chattanooga	S-Location
Tennessee	S-Location
.	O
Though	O
addressed	O
to	O
the	O
White	B-Organization
House	E-Organization
,	O
the	O
threatening	O
language	O
contained	O
in	O
the	O
letter	O
was	O
again	O
directed	O
at	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Transportation	E-Organization
and	O
written	O
by	O
an	O
individual	O
calling	O
him/herself	O
"	O
Fallen	B-Person
Angel	E-Person
"	O
,	O
as	O
with	O
previous	O
letter	O
.	O

As	O
to	O
how	O
you	O
feel	O
about	O
this	O
happening	O
at	O
this	O
place	O
.	O

On	O
11	O
February	O
2015	O
,	O
a	O
32-year-old	O
Filipino	O
nurse	O
from	O
Saudi	B-Location
Arabia	E-Location
who	O
was	O
also	O
1	O
month	O
pregnant	O
,	O
was	O
the	O
country's	O
first	O
MERS-CoV	S-Pathogen
case	O
,	O
DOH	S-Organization
confirmed	O
after	O
the	O
test	O
for	O
the	O
virus	O
turned	O
out	O
to	O
be	O
positive	O
.	O

Tularemia	S-Pathogen
was	O
allegedly	O
used	O
against	O
German	O
troops	O
in	O
1942	O
near	O
Stalingrad	S-Location
.	O
Around	O
10,000	O
cases	O
of	O
tularemia	S-Disease
had	O
been	O
reported	O
in	O
the	O
Soviet	B-Location
Union	E-Location
between	O
1941	O
and	O
1943	O
.	O

The	O
technique	O
is	O
also	O
used	O
,	O
for	O
example	O
,	O
to	O
measure	O
the	O
ratio	O
between	O
water	O
and	O
fat	O
in	O
foods	O
,	O
monitoring	O
of	O
flow	O
of	O
corrosive	O
fluids	O
in	O
pipes	O
,	O
or	O
to	O
study	O
molecular	O
structures	O
such	O
as	O
catalysts	O
.	O

Over	O
thousands	O
of	O
years	O
,	O
each	O
population	O
had	O
built	O
up	O
resistance	O
to	O
their	O
own	O
set	O
of	O
diseases	O
,	O
but	O
were	O
extremely	O
susceptible	O
to	O
the	O
others	O
.	O

The	O
request	O
,	O
which	O
will	O
come	O
from	O
the	O
White	B-Organization
House's	I-Organization
Office	I-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	I-Organization
and	I-Organization
National	I-Organization
Security	I-Organization
Council	E-Organization
will	O
not	O
use	O
the	O
word	O
"	O
suspend,"	O
the	O
source	O
says	O
.	O

Sure	O
,	O
the	O
hero	O
has	O
done	O
what	O
he	O
set	O
out	O
to	O
do	O
and	O
solved	O
whatever	O
crisis	O
he	O
faced	O
,	O
but	O
in	O
real	O
life	O
that	O
would	O
only	O
be	O
a	O
small	O
part	O
of	O
the	O
story	O
,	O
said	O
Amler	S-Person
After	O
all	O
,	O
plenty	O
of	O
people	O
may	O
have	O
been	O
harmed	O
before	O
our	O
hero	O
finally	O
resolved	O
or	O
prevented	O
the	O
calamity	O
.	O

On	O
8	O
December	O
2009	O
,	O
the	O
Cochrane	B-Organization
Collaboration	E-Organization
which	O
reviews	O
medical	O
evidence	O
,	O
announced	O
in	O
a	O
review	O
published	O
in	O
BMJ	S-Organization
that	O
it	O
had	O
reversed	O
its	O
previous	O
findings	O
that	O
the	O
antiviral	O
drugs	O
oseltamivir	S-Drug
(	O
Tamiflu	S-Drug
)	O
and	O
zanamivir	S-Drug
(	O
Relenza	S-Drug
)	O
can	O
ward	O
off	O
pneumonia	S-Disease
and	O
other	O
serious	O
conditions	O
linked	O
to	O
influenza	O
.	O

The	O
CDC	S-Organization
goal	O
is	O
to	O
have	O
the	O
new	O
facility	O
built	O
in	O
time	O
to	O
ensure	O
the	O
transition	O
from	O
the	O
current	O
labs	O
to	O
the	O
new	O
ones	O
is	O
seamless	O
,	O
said	O
.	O

The	O
13	O
students	O
were	O
among	O
49	O
students	O
who	O
had	O
previously	O
worked	O
as	O
interns	O
at	O
the	O
Lanzhou	S-Location
institute	O
.	O

He	O
had	O
inadvertently	O
produced	O
the	O
first	O
description	O
of	O
.	O

Retrieved	O
January	O
7	O
,	O
2009	O
.	O

Skeels	S-Person
described	O
the	O
scene	O
at	O
the	O
Rajneesh	O
laboratory	O
as	O
"	O
a	O
bacteriological	O
freezer-dryer	O
for	O
large-scale	O
production	O
"	O
of	O
microbes	O
.	O

The	O
second	O
is	O
that	O
we	O
will	O
-	O
I've	O
appointed	O
Dr	O
.	O

But	O
fecal	O
transplants	O
are	O
still	O
experimental	O
and	O
not	O
approved	O
by	O
the	O
FDA	S-Organization
The	O
FDA	S-Organization
recently	O
reported	O
that	O
two	O
people	O
had	O
contracted	O
serious	O
infections	O
from	O
fecal	O
transplants	O
that	O
contained	O
drug-resistant	O
bacteria	O
.	O

The	O
extremes	O
poles	O
are	O
simple	O
hyperlinks	O
connecting	O
resources	O
versus	O
full	O
integration	O
in	O
a	O
data	O
warehouse	O
structure	O
.	O

This	O
is	O
a	O
common	O
occurrence	O
with	O
viruses:	O
there	O
is	O
a	O
tendency	O
for	O
pathogenic	O
viruses	O
to	O
become	O
less	O
lethal	O
with	O
time	O
,	O
as	O
the	O
hosts	O
of	O
more	O
dangerous	O
strains	O
tend	O
to	O
die	O
out	O
(see	O
also	O
"	O
Deadly	O
Second	O
Wave"	O
,	O
above)	O
.	O

The	O
three-day	O
conference	O
includes	O
panel	O
sessions	O
,	O
presentations	O
,	O
and	O
scientific	O
and	O
public	O
health	O
exhibitors	O
.	O

Like	O
RNAi	S-Technology
,	O
CRISPR	B-Technology
interference	E-Technology
(	O
CRISPRi	S-Technology
)	O
turns	O
off	O
genes	O
in	O
a	O
reversible	O
fashion	O
by	O
targeting	O
,	O
but	O
not	O
cutting	O
a	O
site	O
.	O

At	O
the	O
end	O
of	O
each	O
project	O
,	O
a	O
report	O
is	O
printed	O
and	O
made	O
available	O
as	O
a	O
PDF	O
on	O
the	O
web	O
page	O
of	O
the	O
Swedish	B-Organization
Civil	I-Organization
Contingencies	I-Organization
Agency	E-Organization
with	O
a	O
summary	O
in	O
English	O
.	O

All	O
materials	O
that	O
came	O
into	O
contact	O
with	O
clinical	O
samples	O
were	O
immediately	O
soaked	O
in	O
a	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
for	O
at	O
least	O
10	O
min	O
.	O

Tina	B-Person
Smith	E-Person
(D-MN)	O
mentioned	O
three	O
significant	O
outbreaks	O
that	O
have	O
occurred	O
in	O
her	O
home	O
state	O
recently	O
and	O
financial	O
resources	O
couldn't	O
cover	O
the	O
expenses	O
.	O

In	O
Europe	S-Location
disease	O
surveillance	O
is	O
beginning	O
to	O
be	O
organized	O
on	O
the	O
continent-wide	O
scale	O
needed	O
to	O
track	O
a	O
biological	O
emergency	O
.	O

He	O
had	O
procured	O
a	O
friend's	O
poop	O
and	O
planned	O
to	O
inoculate	O
himself	O
using	O
the	O
microbes	O
in	O
it	O
.	O

Amesh	B-Person
Adalja	E-Person
a	O
senior	O
scholar	O
at	O
the	O
.	O
"	O
If	O
you	O
use	O
a	O
contagious	O
infectious	O
disease	O
,	O
you	O
really	O
could	O
create	O
havoc	O
on	O
a	O
different	O
scale.	O
"	O

Production	O
ceased	O
in	O
early	O
2006	O
.	O

Our	O
scientists	O
again	O
repeated	O
the	O
PCR	B-Technology
testing	E-Technology
and	O
determined	O
that	O
the	O
growth	O
is	O
indeed	O
smallpox	B-Pathogen
virus	E-Pathogen
.	O
This	O
is	O
growing	O
in	O
our	O
approved	O
smallpox	B-Organization
containment	I-Organization
laboratory	E-Organization
,	O
a	O
BSL-4	S-Platform
facility	O
.	O

The	O
discovery	O
of	O
penicillin	S-Drug
in	O
1928	O
and	O
other	O
antibiotics	O
in	O
the	O
20th	O
century	O
proved	O
to	O
be	O
a	O
significant	O
medical	O
achievement	O
,	O
saving	O
millions	O
of	O
lives	O
and	O
significantly	O
reducing	O
the	O
burden	O
of	O
infectious	O
diseases	O
.	O

HDR	S-Technology
employs	O
the	O
use	O
of	O
similar	O
DNA	O
sequences	O
to	O
drive	O
the	O
repair	O
of	O
the	O
break	O
via	O
the	O
incorporation	O
of	O
exogenous	O
DNA	O
to	O
function	O
as	O
the	O
repair	O
template	O
.	O

Mechanical	B-Technology
ventilation	E-Technology
had	O
been	O
performed	O
in	O
79%	O
of	O
critically	O
ill	O
people	O
in	O
hospital	O
including	O
62%	O
who	O
previously	O
received	O
other	O
treatment	O
.	O

For	O
example	O
,	O
nearly	O
all	O
insulin	O
used	O
in	O
treating	O
today	O
is	O
produced	O
recombinantly	O
.	O

Strains	O
of	O
dual-use	O
biological	O
material	O
from	O
France	O
also	O
helped	O
advance	O
Iraq's	B-Scientific_research_project
biological	I-Scientific_research_project
warfare	I-Scientific_research_project
program	E-Scientific_research_project
.	O
From	O
the	O
United	B-Location
States	E-Location
,	O
the	O
non-profit	O
American	B-Organization
Type	I-Organization
Culture	I-Organization
Collection	E-Organization
and	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
sold	O
or	O
sent	O
biological	O
samples	O
to	O
Iraq	S-Location
up	O
until	O
1989	O
,	O
which	O
Iraq	S-Location
claimed	O
to	O
need	O
for	O
medical	O
research	O
.	O

A	O
major	O
nuclear	O
accident	O
happened	O
in	O
this	O
region	O
in	O
1957	O
,	O
when	O
a	O
nuclear	O
waste	O
facility	O
exploded	O
(known	O
as	O
the	O
Kyshtym	B-Incident
disaster	E-Incident
)	O
,	O
resulting	O
in	O
the	O
spread	O
of	O
radioactive	O
dust	O
over	O
a	O
thousand	O
square	O
kilometers	O
.	O

UCLA	S-Organization
said	O
it	O
found	O
no	O
direct	O
evidence	O
that	O
either	O
of	O
the	O
rat	O
incidents	O
involved	O
an	O
actual	O
loss	O
of	O
containment	O
of	O
biohazardous	O
materials	O
.	O

This	O
took	O
place	O
in	O
August	O
1946	O
and	O
was	O
instigated	O
by	O
David	B-Person
Sutton	E-Person
,	O
assistant	O
to	O
the	O
Chinese	O
prosecutor	O
.	O

Influenza	B-Pathogen
virus	I-Pathogen
strains	E-Pathogen
adapted	O
to	O
birds	O
preferentially	O
bind	O
sialic	O
acid	O
receptors	O
with	O
α	O
(2–3)	O
linked	O
sugars	O
(–)	O
.	O

U.S.	O
officials	O
observed	O
that	O
six	O
years	O
of	O
concern	O
about	O
H5N1	B-Disease
avian	I-Disease
flu	E-Disease
did	O
much	O
to	O
prepare	O
for	O
the	O
current	O
H1N1	B-Incident
outbreak	E-Incident
,	O
noting	O
that	O
after	O
H5N1	S-Pathogen
emerged	O
in	O
Asia	S-Location
,	O
ultimately	O
killing	O
about	O
60%	O
of	O
the	O
few	O
hundred	O
people	O
infected	O
over	O
the	O
years	O
,	O
many	O
countries	O
took	O
steps	O
to	O
try	O
to	O
prevent	O
any	O
similar	O
crisis	O
from	O
spreading	O
further	O
.	O

When	O
categorized	O
into	O
types	O
,	O
most	O
of	O
the	O
initiatives	O
were	O
found	O
to	O
be	O
in	O
the	O
category	O
of	O
general	O
awareness	O
and	O
information	O
exchange	O
workshops	O
at	O
country	O
level	O
70.	O
68%	O
(n = 1295)	O
.	O

The	O
most	O
common	O
mechanism	O
of	O
resistance	O
is	O
production	O
of	O
carbapenemases	O
,	O
which	O
hydrolyze	O
and	O
many	O
other	O
β-lactams	O
.	O

Remdesivir	S-Drug
was	O
originally	O
developed	O
to	O
treat	O
hepatitis	B-Disease
C	E-Disease
and	O
was	O
then	O
tested	O
against	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
and	O
,	O
but	O
was	O
ineffective	O
for	O
all	O
of	O
these	O
viral	O
infections	O
.	O

The	O
severity	O
of	O
the	O
disease	O
in	O
humans	O
varies	O
widely	O
,	O
from	O
rapid	O
fatality	O
to	O
mild	O
illness	O
or	O
even	O
asymptomatic	O
response	O
.	O

A	O
variety	O
of	O
techniques	O
are	O
used	O
,	O
depending	O
on	O
the	O
suspected	O
abnormality	O
.	O

The	O
toxin	O
inhibits	O
the	O
formation	O
of	O
proteins	O
within	O
cells	O
of	O
exposed	O
individuals	O
.	O

The	O
Ebola	B-Disease
epidemic	E-Disease
caused	O
an	O
increasing	O
demand	O
for	O
protective	B-Equipment
clothing	E-Equipment
.	O
A	O
full	O
set	O
of	O
protective	B-Equipment
clothing	E-Equipment
includes	O
a	O
suit	O
,	O
goggles	O
,	O
a	O
mask	O
,	O
socks	O
and	O
boots	O
,	O
and	O
an	O
apron	O
.	O

New	O
research	O
covered	O
on	O
MNT	S-Organization
has	O
found	O
that	O
antibiotic	O
resistance	O
is	O
now	O
on	O
the	O
rise	O
in	O
farm	O
animals	O
,	O
too	O
-	O
and	O
the	O
rates	O
are	O
increasing	O
fast	O
.	O

The	O
effort	O
involves	O
combining	O
real-time	O
surveillance	O
with	O
laboratory	O
testing	O
and	O
emergency	O
response	O
to	O
significantly	O
decrease	O
both	O
intensity	O
and	O
length	O
of	O
VHF	S-Disease
outbreaks	O
in	O
the	O
country	O
,	O
potentially	O
saving	O
hundreds	O
or	O
thousands	O
of	O
lives	O
.	O

The	O
American	B-Organization
Medical	I-Organization
Association	E-Organization
the	O
American	B-Organization
Psychological	I-Organization
Association	E-Organization
and	O
the	O
American	B-Organization
Academy	I-Organization
of	I-Organization
Pediatrics	E-Organization
sent	O
a	O
letter	O
to	O
the	O
leaders	O
of	O
the	O
Senate	B-Organization
Appropriations	I-Organization
Committee	E-Organization
in	O
2013	O
asking	O
them	O
"	O
to	O
support	O
at	O
least	O
$10million	O
within	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
in	O
FY	O
2014	O
along	O
with	O
sufficient	O
new	O
funding	O
at	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
to	O
support	O
research	O
into	O
the	O
causes	O
and	O
prevention	O
of	O
gun	O
violence	O
.	O

I'm	O
just	O
-	O
it's	O
said	O
that	O
the	O
lab	O
was	O
closed	O
for	O
now	O
until	O
the	O
investigation	O
is	O
complete	O
.	O

In	O
1992	O
,	O
Mark	B-Person
L.	I-Person
Rosenberg	E-Person
and	O
five	B-Person
CDC	I-Person
colleagues	E-Person
founded	O
the	O
CDC's	B-Organization
National	I-Organization
Center	I-Organization
for	I-Organization
Injury	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
,	O
with	O
an	O
annual	O
budget	O
of	O
c.	O
$260,000	O
that	O
focused	O
on	O
"	O
identifying	O
the	O
root	O
causes	O
of	O
firearm	O
deaths	O
and	O
the	O
best	O
methods	O
to	O
prevent	O
them"	O
.	O

The	O
pressure	O
in	O
the	O
BSL-3	S-Platform
laboratory	O
is	O
recorded	O
by	O
checking	O
the	O
pressure	O
gauge	O
in	O
the	O
lab	O
every	O
day	O
,	O
and	O
it	O
was	O
also	O
real-time	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

When	O
Nixon	S-Person
ended	O
the	O
U.S.	O
bio-weapons	O
program	O
it	O
represented	O
the	O
first	O
review	O
of	O
the	O
U.S.	O
biological	O
warfare	O
program	O
since	O
1954	O
.	O

A	O
nonsynonymous	O
substitution	O
is	O
a	O
nucleotide	O
change	O
in	O
a	O
codon	O
that	O
results	O
in	O
an	O
amino	O
acid	O
replacement	O
.	O

Biotechnologists	O
do	O
this	O
by	O
found	O
in	O
nature	O
,	O
and	O
then	O
manipulating	O
it	O
in	O
a	O
test	O
tube	O
–	O
or	O
,	O
more	O
recently	O
,	O
inside	O
of	O
living	O
cells	O
.	O

Additional	O
testing	O
of	O
the	O
is	O
under	O
way	O
to	O
determine	O
if	O
the	O
material	O
in	O
the	O
vials	O
is	O
viable	O
(i.e.	O
,	O
can	O
grow	O
in	O
tissue	O
culture)	O
.	O

Prisoners	O
were	O
also	O
repeatedly	O
subject	O
to	O
rape	O
by	O
guards	O
.	O

Henderson	S-Person
said	O
in	O
an	O
interview	O
.	O

On	O
February	O
28	O
,	O
1985	O
,	O
Weaver	S-Person
gave	O
a	O
speech	O
at	O
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
in	O
which	O
he	O
accused	O
the	O
Rajneeshees	O
of	O
contaminating	O
salad	O
bar	O
ingredients	O
in	O
eight	O
restaurants	O
.	O

Yukihiro	B-Person
Nishiyama	E-Person
,	O
professor	O
of	O
virology	O
at	O
Nagoya	B-Organization
University's	I-Organization
School	I-Organization
of	I-Organization
Medicine	E-Organization
,	O
commented	O
that	O
the	O
are	O
"	O
better	O
than	O
nothing	O
,	O
but	O
it's	O
hard	O
to	O
completely	O
block	O
out	O
an	O
airborne	O
virus	O
since	O
it	O
can	O
easily	O
slip	O
through	O
the	O
gaps"	O
.	O

Signs	O
and	O
symptoms	O
of	O
infusion‐related	O
reactions	O
may	O
include:	O
low	B-Phenotype
blood	I-Phenotype
pressure	E-Phenotype
,	O
nausea	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
sweating	S-Phenotype
,	O
and	O
.	O

Some	O
countries	O
(like	O
Belgium	S-Location
)	O
include	O
deaths	O
from	O
suspected	O
cases	O
of	O
,	O
regardless	O
of	O
whether	O
the	O
person	O
was	O
tested	O
,	O
resulting	O
in	O
higher	O
numbers	O
compared	O
to	O
countries	O
that	O
include	O
only	O
test-confirmed	O
cases	O
.	O

Overuse	O
of	O
antibiotics	O
has	O
become	O
the	O
primary	O
cause	O
of	O
rising	O
levels	O
of	O
antibiotic	O
resistance	O
.	O

And	O
they	O
therefore	O
did	O
tests	O
and	O
identified	O
on	O
May	O
23rd	O
or	O
thereabouts	O
that	O
it	O
was	O
contaminated	O
with	O
.	O

On	O
13	O
March	O
,	O
Prime	O
Minister	O
Édouard	B-Person
Philippe	E-Person
ordered	O
the	O
closure	O
of	O
all	O
non-essential	O
public	O
places	O
,	O
and	O
on	O
16	O
March	O
,	O
French	O
President	O
Emmanuel	B-Person
Macron	E-Person
announced	O
mandatory	O
home	O
confinement	O
,	O
a	O
policy	O
which	O
was	O
extended	O
at	O
least	O
until	O
11	O
May.	O
,	O
France	S-Location
has	O
reported	O
more	O
than	O
120,804	O
confirmed	O
cases	O
,	O
21,856	O
deaths	O
,	O
and	O
42,088	O
recoveries	O
,	O
ranking	O
fourth	O
in	O
number	O
of	O
confirmed	O
cases	O
.	O

This	O
means	O
that	O
at	O
least	O
2	O
H1N1	S-Pathogen
receptor-binding	O
variants	O
cocirculated	O
in	O
1918:	O
1	O
with	O
high-affinity	O
binding	O
to	O
the	O
human	O
receptor	O
and	O
1	O
with	O
mixed-affinity	O
binding	O
to	O
both	O
avian	O
and	O
human	O
receptors	O
.	O

The	O
concerns	O
aroused	O
by	O
recent	O
developments	O
in	O
genetic	B-Technology
engineering	E-Technology
and	O
by	O
the	O
epidemics	O
of	O
acquired	B-Disease
immunodifiency	I-Disease
syndrome	E-Disease
()	O
have	O
influenced	O
those	O
involved	O
in	O
biological	O
and	O
biomedical	O
research	O
by	O
increasing	O
their	O
awareness	O
of	O
the	O
safety	O
aspects	O
of	O
their	O
work	O
.	O

The	O
prisoners	O
were	O
secured	O
to	O
a	O
bed	O
in	O
a	O
purpose-built	O
chamber	O
,	O
into	O
which	O
lethal	O
agents	O
,	O
including	O
anthrax	S-Pathogen
were	O
sprayed	O
from	O
a	O
high-velocity	O
device	O
mounted	O
in	O
the	O
ceiling	O
.	O

CDC	S-Organization
is	O
currently	O
installing	O
camera	O
systems	O
in	O
the	O
BSL-4	S-Platform
laboratory	O
and	O
providing	O
clear	O
instructions	O
on	O
the	O
intended	O
use	O
of	O
the	O
MTC	S-Organization
form	O
prior	O
to	O
resuming	O
full	O
operations	O
.	O

The	O
samples	O
were	O
transferred	O
to	O
the	O
BSL-2	S-Platform
labs	O
on	O
June	O
6	O
.	O

Those	O
three	O
independent	O
pairing	O
events	O
each	O
provide	O
an	O
opportunity	O
to	O
prevent	O
off-target	O
sequences	O
,	O
which	O
significantly	O
increases	O
targeting	O
flexibility	O
and	O
editing	O
precision	O
.	O

Led	O
by	O
HHS	S-Organization
Chief	O
Data	O
Officer	O
Dr	O
.	O

Staff	O
who	O
may	O
have	O
been	O
potentially	O
exposed	O
to	O
aerosols	O
in	O
affected	O
laboratory	O
space	O
.	O

Just	O
15	O
years	O
later	O
,	O
a	O
genome	O
can	O
be	O
sequenced	O
for	O
under	O
$1,000	O
,	O
and	O
within	O
a	O
single	O
hour	O
.	O

As	O
the	O
Soviet	B-Organization
Union	E-Organization
program	O
began	O
to	O
crumble	O
in	O
the	O
1990s	O
,	O
and	O
scientists'	O
salaries	O
dwindled	O
,	O
some	O
bioweapons	O
experts	O
may	O
have	O
been	O
lured	O
to	O
Iraq	S-Location
.	O
launched	O
its	O
own	O
bioweapons	O
program	O
around	O
1985	O
but	O
initially	O
lacked	O
the	O
expertise	O
to	O
develop	O
sophisticated	O
arms	O
.	O

The	O
course	O
provides	O
students	O
with	O
working	O
tools	O
that	O
are	O
valuable	O
after	O
graduation	O
.	O

Inglesby	S-Person
is	O
Chair	O
of	O
the	O
Board	B-Organization
of	I-Organization
Scientific	I-Organization
Counselors	E-Organization
,	O
Office	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
,	O
CDC	S-Organization
,	O
and	O
he	O
is	O
Co-chair	O
of	O
the	O
National	O
Health	O
Security	O
Preparedness	O
Index	O
initiative	O
.	O

Bioterrorism	O
is	O
the	O
deliberate	O
release	O
of	O
viruses	O
,	O
bacteria	O
,	O
toxins	O
or	O
other	O
harmful	O
agents	O
to	O
cause	O
illness	O
or	O
death	O
in	O
people	O
,	O
animals	O
,	O
or	O
plants	O
.	O

June	O
prices	O
were	O
down	O
but	O
in	O
the	O
positive	O
range	O
,	O
with	O
a	O
barrel	O
of	O
West	O
Texas	O
trading	O
above	O
$20	O
.	O

Remdesivir	S-Drug
can	O
be	O
synthesized	O
in	O
multiple	O
steps	O
from	O
ribose	O
derivatives	O
.	O

"	O
Biosecurity:	B-Document
Responsible	I-Document
Stewardship	I-Document
of	I-Document
Bioscience	I-Document
in	I-Document
an	I-Document
Age	I-Document
of	I-Document
Catastrophic	I-Document
Terrorism	E-Document
was	O
written	O
by	O
Gigi	B-Person
Kwik	E-Person
,	O
Joe	B-Person
Fitzgerald	E-Person
,	O
Tom	B-Person
Inglesby	E-Person
,	O
and	O
Tara	B-Person
O'Toole	E-Person
and	O
funded	O
by	O
the	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
awarded	O
a	O
12-month	O
,	O
$26	O
million	O
contract	O
to	O
Emergent	B-Organization
BioSolutions	E-Organization
on	O
Wednesday	O
for	O
the	O
continued	O
supply	O
of	O
Vaccinia	B-Vaccine
Immune	I-Vaccine
Globulin	I-Vaccine
Intravenous	E-Vaccine
(	O
VIGIV	S-Vaccine
)	O
to	O
the	O
U.S.	B-Organization
Strategic	I-Organization
National	I-Organization
Stockpile	E-Organization
()	O
.	O

The	O
World	B-Organization
Bank	E-Organization
was	O
criticised	O
when	O
its	O
Pandemic	O
Emergency	O
Financing	O
Facility	O
,	O
a	O
fund	O
backed	O
by	O
private	O
finance	O
intended	O
to	O
support	O
countries	O
affected	O
by	O
pandemic	O
diseases	O
,	O
had	O
only	O
paid	O
out	O
$31 million	O
of	O
a	O
potential	O
total	O
of	O
$425 million	O
by	O
August	O
2019	O
,	O
while	O
generating	O
substantial	O
returns	O
for	O
investors	O
.	O

As	O
an	O
example	O
,	O
in	O
1910	O
,	O
Dr	O
.	O

Tensions	O
between	O
the	O
two	O
countries	O
,	O
coupled	O
with	O
confirmed	O
research	O
into	O
entomological	O
warfare	O
during	O
the	O
1950s	O
,	O
made	O
these	O
charges	O
seem	O
not	O
implausible	O
to	O
some	O
people	O
.	O

I	O
can	O
later	O
go	O
into	O
some	O
details	O
about	O
this	O
,	O
but	O
as	O
I	O
think	O
about	O
it	O
,	O
what	O
we	O
learned	O
made	O
us	O
more	O
reassured	O
about	O
the	O
likelihood	O
that	O
people	O
were	O
actually	O
exposed	O
,	O
which	O
now	O
looks	O
very	O
,	O
very	O
unlikely	O
.	O

Use	O
of	O
CT	S-Technology
has	O
increased	O
dramatically	O
over	O
the	O
last	O
two	O
decades	O
in	O
many	O
countries	O
.	O

Several	O
internationally	O
recognised	O
experts	O
produced	O
evidence	O
during	O
the	O
prosecution	O
to	O
show	O
that	O
it	O
was	O
unlikely	O
that	O
Parker	S-Person
was	O
infected	O
by	O
airborne	O
transmission	O
in	O
this	O
way	O
.	O

"	O
Biological	O
weapons	O
pose	O
a	O
strategic	O
threat	O
mirrored	O
by	O
no	O
other	O
form	O
of	O
attack	O
other	O
than	O
nuclear	O
weapons	O
.	O

To	O
begin	O
with	O
,	O
the	O
same	O
technology	O
being	O
used	O
to	O
extend	O
our	O
lives	O
could	O
instead	O
be	O
used	O
to	O
end	O
them	O
.	O

Cutting-edge	O
tools	O
like	O
CRISPR/Cas9	S-Technology
and	O
DNA	O
synthesis	O
raise	O
important	O
ethical	O
questions	O
that	O
are	O
increasingly	O
urgent	O
to	O
answer	O
.	O

William	B-Person
Close	E-Person
1995	O
Ebola	S-Pathogen
:	O
A	O
Documentary	O
Novel	O
of	O
Its	O
First	O
Explosion	O
and	O
2002	O
Ebola	S-Pathogen
:	O
Through	O
the	O
Eyes	O
of	O
the	O
People	O
focused	O
on	O
individuals'	O
reactions	O
to	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
in	O
.	O
At	O
Google	O
Books	O
.	O

This	O
paper	O
will	O
not	O
be	O
able	O
to	O
explore	O
all	O
of	O
these	O
new	O
topics	O
but	O
will	O
instead	O
attempt	O
to	O
present	O
an	O
overview	O
of	O
some	O
of	O
the	O
issues	O
at	O
play	O
today	O
in	O
the	O
biosecurity	O
dialogue	O
.	O

By	O
the	O
1380s	O
in	O
Europe	S-Location
,	O
it	O
predominantly	O
affected	O
children	O
.	O

CDC	S-Organization
is	O
committed	O
to	O
ensuring	O
that	O
people	O
feel	O
safe	O
and	O
are	O
safe	O
in	O
the	O
workplace	O
and	O
the	O
community	O
as	O
employees	O
conduct	O
life-saving	O
laboratory	O
work	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
has	O
proposed	O
a	O
goal	O
of	O
"	O
10	O
new	O
antibiotics	O
for	O
2020	O
"	O
(Ref)	O
.	O

On	O
regulatory	O
science	O
,	O
Gottlieb	S-Person
said	O
the	O
will	O
be	O
working	O
with	O
partners	O
to	O
streamline	O
clinical	O
trials	O
and	O
to	O
identify	O
areas	O
in	O
which	O
regulatory	O
science	O
can	O
support	O
new	O
antibiotic	O
development	O
.	O

If	O
Cas9	O
can	O
somehow	O
be	O
inserted	O
into	O
a	O
patient's	O
cells	O
,	O
it	O
could	O
fix	O
the	O
mutations	O
that	O
cause	O
such	O
diseases	O
,	O
offering	O
a	O
permanent	O
cure	O
.	O

NIH	S-Organization
notice	O
comes	O
in	O
the	O
wake	O
of	O
a	O
Monday	O
statement	O
from	O
the	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
()	O
,	O
which	O
represents	O
many	O
researchers	O
working	O
with	O
dangerous	O
pathogens	O
,	O
which	O
called	O
on	O
its	O
members	O
to	O
conduct	O
a	O
similar	O
inventory	O
.	O

JOHN	B-Person
ROBERTS	E-Person
Yes	O
,	O
Dr	O
.	O

The	O
big	O
question	O
about	O
biohacking	O
is	O
,	O
what	O
is	O
it?	O
That's	O
a	O
question	O
my	O
editors	O
and	O
my	O
friends	O
all	O
asked	O
me	O
as	O
I	O
prepared	O
a	O
story	O
for	O
the	O
PBS	B-Organization
NewsHour	E-Organization
on	O
this	O
new	O
biology	O
term	O
.	O

"	O
I	O
wouldn't	O
be	O
sitting	O
here	O
testifying	O
today	O
without	O
it,	O
"	O
Redd	S-Person
said	O
.	O

In	O
certain	O
circumstances	O
,	O
shoe	O
or	O
hair	O
covers	O
may	O
be	O
required	O
.	O

Immediately	O
following	O
the	O
incident	O
in	O
Frist's	O
office	O
,	O
both	O
the	O
FBI	S-Organization
and	O
the	O
United	B-Organization
States	I-Organization
Capitol	I-Organization
Police	E-Organization
were	O
tasked	O
to	O
the	O
investigation	O
;	O
like	O
in	O
the	O
Fallen	B-Activity
Angel	I-Activity
investigation	E-Activity
,	O
the	O
FBI	S-Organization
was	O
the	O
lead	O
agency	O
.	O

Staff	O
entering	O
the	O
yellow	O
zone	O
must	O
wear	O
at	O
least	O
disposable	B-Equipment
protective	I-Equipment
clothing	E-Equipment
a	O
disposable	B-Equipment
medical	I-Equipment
protective	I-Equipment
mask	E-Equipment
,	O
a	O
disposable	B-Equipment
hat	E-Equipment
,	O
long-sleeved	B-Equipment
medical	I-Equipment
rubber	I-Equipment
gloves	I-Equipment
and	I-Equipment
overshoes	E-Equipment
.	O
Staff	O
entering	O
the	O
BSL-3	S-Platform
lab	O
must	O
wear	O
a	O
l	O
ong-sleeved	B-Equipment
inner	I-Equipment
gown	E-Equipment
,	O
a	O
disposable	B-Equipment
hat	E-Equipment
,	O
lab	B-Equipment
stockings	E-Equipment
,	O
an	O
N95	B-Equipment
mask	E-Equipment
,	O
inner-layer	B-Equipment
gloves	E-Equipment
,	O
medical	B-Equipment
protective	I-Equipment
clothing	E-Equipment
,	O
long-sleeved	B-Equipment
medical	I-Equipment
outer	I-Equipment
gloves	E-Equipment
and	O
lab	B-Equipment
shoes	E-Equipment
in	O
the	O
1st	O
changing	O
room	O
,	O
and	O
overshoes	S-Equipment
and	O
long	B-Equipment
waterproof	I-Equipment
boots	E-Equipment
covers	O
in	O
the	O
shower	O
room	O
,	O
a	O
positive-pressure	B-Equipment
breathing	I-Equipment
protection	I-Equipment
devic	E-Equipment
e	O
and	O
disposable	B-Equipment
waterproof	I-Equipment
clothing	E-Equipment
in	O
the	O
2nd	O
changing	O
room	O
.	O

A	O
total	O
restriction	O
on	O
both	O
human-approved	O
compounds	O
and	O
their	O
structural	O
derivatives	O
as	O
routine	O
feedstocks	O
in	O
animal	O
feed	O
,	O
agriculture	O
,	O
or	O
fisheries	O
must	O
be	O
enforced	O
.	O

Each	O
lab	O
is	O
expected	O
to	O
establish	O
redundant	O
controls	O
,	O
similar	O
to	O
the	O
two-key	O
system	O
used	O
in	O
other	O
contexts	O
for	O
critical	O
control	O
points	O
.	O

Kadlec	S-Person
stresses	O
that	O
the	O
impending	O
change	O
has	O
nothing	O
to	O
do	O
with	O
's	O
performance.	O
"	O
The	O
question	O
here	O
is	O
whether	O
we	O
can	O
get	O
better	O
efficiencies,	O
"	O
he	O
said	O
in	O
an	O
interview	O
.	O

On	O
April	O
17	O
,	O
2013	O
,	O
FBI	S-Organization
agents	O
detained	O
a	O
Corinth	S-Location
,	O
Mississippi	S-Location
,	O
man	O
on	O
suspicion	O
of	O
mailing	O
the	O
ricin	S-Pathogen
-laced	O
letters	O
.	O

Pixels	O
in	O
an	O
image	O
obtained	O
by	O
CT	B-Technology
scanning	E-Technology
are	O
displayed	O
in	O
terms	O
of	O
relative	O
radiodensity	O
.	O

Sam	B-Person
Nunn	E-Person
and	O
philanthropist	O
who	O
continue	O
to	O
serve	O
as	O
co-chairs	O
.	O

Bats	O
have	O
been	O
blamed	O
for	O
the	O
deadly	O
Ebola	B-Incident
outbreak	E-Incident
in	O
(2014-2016)	O
.	O

Because	O
of	O
its	O
high	O
mortality	O
rate	O
(up	O
to	O
83	O
to	O
90	O
percent)	O
,	O
EBOV	S-Pathogen
is	O
also	O
listed	O
as	O
a	O
select	O
agent	O
,	O
World	B-Organization
Health	I-Organization
Organization	I-Organization
Risk	I-Organization
Group	E-Organization
4	O
Pathogen	O
(requiring	O
Biosafety	O
Level	O
4-equivalent	O
containment)	O
,	O
a	O
US	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
/	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	E-Organization
and	O
Infectious	O
Diseases	O
Category	O
A	O
Priority	O
Pathogen	O
,	O
US	B-Organization
CDC	E-Organization
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
and	O
Prevention	O
Category	O
A	O
Bioterrorism	O
Agent	O
,	O
and	O
a	O
Biological	O
Agent	O
for	O
Export	O
Control	O
by	O
the	O
.	O

Basic	O
infrastructure	O
was	O
preserved	O
,	O
and	O
research	O
on	O
producing	O
dried	O
agent	O
was	O
conducted	O
under	O
the	O
guise	O
of	O
biopesticide	O
production	O
at	O
Al	B-Location
Hakum	E-Location
until	O
its	O
destruction	O
by	O
UNSCOM	S-Organization
inspectors	O
in	O
1996	O
.	O

What's	O
preferable	O
,	O
he	O
said	O
,	O
would	O
be	O
a	O
fund	O
containing	O
roughly	O
$2.	O
5	O
billion	O
to	O
$3.	O
5	O
billion	O
,	O
based	O
on	O
the	O
costs	O
associated	O
with	O
fighting	O
previous	O
pandemics	O
,	O
and	O
the	O
fund	O
would	O
be	O
managed	O
by	O
the	O
HHS	S-Organization
Secretary	O
,	O
who	O
would	O
distribute	O
funds	O
across	O
or	O
to	O
states	O
.	O

The	O
overall	O
design	O
of	O
the	O
lab	O
is	O
shown	O
in	O
Table	O
1	O
.	O

TOM	B-Person
FRIEDEN	E-Person
So	O
there	O
are	O
multiple	O
forms	O
of	O
avian	B-Disease
flu	E-Disease
,	O
and	O
this	O
is	O
one	O
of	O
them	O
.	O

The	O
Experimental	B-Organization
Therapeutics	I-Organization
(ET)	I-Organization
Branch	I-Organization
of	I-Organization
the	I-Organization
Walter	I-Organization
Reed	I-Organization
Army	I-Organization
Institute	I-Organization
of	I-Organization
Research	E-Organization
(	O
WRAIR	S-Organization
)	O
focuses	O
on	O
the	O
development	O
of	O
new	O
drugs	O
to	O
prevent	O
and	O
treat	O
malaria	S-Disease
,	O
leishmaniosis	S-Disease
,	O
,	O
and	O
other	O
infectious	O
disease	O
threats	O
to	O
US	O
Service	O
members	O
.	O

Even	O
where	O
hospital	O
beds	O
were	O
available	O
,	O
it	O
was	O
debated	O
whether	O
conventional	O
hospitals	O
are	O
the	O
best	O
place	O
to	O
care	O
for	O
Ebola	S-Disease
patients	O
,	O
as	O
the	O
risk	O
of	O
spreading	O
the	O
infection	O
is	O
high	O
.	O

A	O
study	O
of	O
the	O
first	O
41	O
cases	O
of	O
confirmed	O
COVID‑19	S-Disease
,	O
published	O
in	O
January	O
2020	O
in	O
The	O
Lancet	S-Location
,	O
revealed	O
the	O
earliest	O
date	O
of	O
onset	O
of	O
symptoms	O
as	O
1December	O
2019	O
.	O

The	O
also	O
serves	O
as	O
a	O
forum	O
for	O
summits	O
and	O
discussions	O
on	O
health	O
issues	O
.	O

The	O
animals	O
suffered	O
rapidly	O
progressive	B-Disease
respiratory	I-Disease
failure	E-Disease
and	O
death	O
through	O
a	O
.	O
The	O
strong	O
immune	O
reactions	O
of	O
young	O
adults	O
were	O
postulated	O
to	O
have	O
ravaged	O
the	O
body	O
,	O
whereas	O
the	O
weaker	O
immune	O
reactions	O
of	O
children	O
and	O
middle-aged	O
adults	O
resulted	O
in	O
fewer	O
deaths	O
among	O
those	O
groups	O
.	O

The	O
assignment	O
of	O
Personal	B-Equipment
Protective	I-Equipment
Equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
is	O
considered	O
to	O
be	O
the	O
"	O
last	O
resort	O
"	O
for	O
preventing	O
and	O
protecting	O
against	O
hazard	O
exposures	O
.	O

But	O
those	O
incidents	O
revealed	O
to	O
us	O
an	O
unacceptable	O
set	O
of	O
practices	O
at	O
CDC	S-Organization
.	O
As	O
a	O
result	O
of	O
that	O
,	O
we've	O
immediately	O
stopped	O
shipping	O
any	O
laboratory	O
samples	O
out	O
of	O
our	O
high	O
containment	O
laboratories	O
,	O
bsl-3	S-Platform
or	O
.	O
We've	O
established	O
a	O
single	O
point	O
of	O
accountability	O
,	O
and	O
we	O
will	O
look	O
at	O
every	O
aspect	O
of	O
laboratory	O
safety	O
with	O
a	O
laser	O
focus	O
.	O

Anna	B-Person
Eshoo	E-Person
(D-CA)	O
,	O
Greg	B-Person
Walden	E-Person
(R-OR)	O
,	O
and	O
Frank	B-Person
Pallone	E-Person
,	O
Jr.	O
(D-NJ)	O
,	O
was	O
among	O
38	O
bills	O
on	O
the	O
schedule	O
to	O
be	O
considered	O
on	O
Sept.25	O
.	O

BETSY	B-Person
MCKAY	E-Person
Thank	O
you.Dr	O
.	O

TOM	B-Person
FRIEDEN	E-Person
At	O
this	O
point	O
everything	O
we've	O
looked	O
at	O
strongly	O
suggests	O
that	O
there	O
was	O
no	O
exposure	O
of	O
anyone	O
to	O
influenza	O
in	O
the	O
second	O
incident	O
that	O
I	O
described	O
.	O

Outbreaks	O
have	O
occurred	O
in	O
prisons	O
due	O
to	O
crowding	O
and	O
an	O
inability	O
to	O
enforce	O
adequate	O
social	O
distancing	O
.	O

Associated	O
images	O
posted	O
on	O
and	O
video	O
posted	O
at	O
may	O
be	O
reused	O
according	O
to	O
the	O
terms	O
of	O
the	O
DARPA	S-Organization
User	O
Agreement	O
,	O
available	O
here	O
:	O

Of	O
131	O
planned	O
projects	O
,	O
the	O
GAO	S-Organization
found	O
that	O
USAID	S-Organization
has	O
completed	O
62	O
,	O
has	O
65	O
ongoing	O
,	O
and	O
has	O
yet	O
to	O
start	O
4	O
.	O

The	O
United	B-Location
States	E-Location
has	O
launched	O
"	O
Project	B-Scientific_research_project
Bioshield	E-Scientific_research_project
"	O
and	O
other	O
project	O
to	O
strengthen	O
their	O
biological	O
defense	O
capability	O
[16]	O
,	O
which	O
is	O
mainly	O
based	O
on	O
the	O
CDC	B-Document
biological	I-Document
agent	I-Document
list	E-Document
.	O
The	O
and	O
countries	O
in	O
other	O
regions	O
also	O
attach	O
great	O
importance	O
to	O
the	O
development	O
of	O
biological	O
defense	O
capabilities	O
,	O
based	O
on	O
their	O
respective	O
biological	O
agent	O
lists	O
.	O

U.S.	B-Organization
airlines	E-Organization
had	O
made	O
no	O
major	O
changes	O
as	O
of	O
the	O
beginning	O
of	O
June	O
2009	O
,	O
but	O
continued	O
standing	O
practices	O
which	O
include	O
looking	O
for	O
passengers	O
with	O
symptoms	O
of	O
flu	O
,	O
measles	S-Disease
or	O
other	O
infections	O
,	O
and	O
relying	O
on	O
in-flight	O
air	O
filters	O
to	O
ensure	O
that	O
aircraft	O
were	O
sanitised	O
.	O

In	O
1972	O
,	O
Herbert	B-Person
Boyer	E-Person
and	O
Stanley	B-Person
Cohen	E-Person
met	O
at	O
a	O
conference	O
about	O
plasmids	O
,	O
small	O
circles	O
of	O
DNA	O
that	O
can	O
move	O
between	O
cells	O
.	O

And	O
if	O
you	O
remember	O
nothing	O
else	O
from	O
what	O
I	O
say	O
this	O
morning	O
,	O
I	O
want	O
you	O
to	O
remember	O
three	O
things	O
.	O

But	O
I	O
think	O
absolutely	O
,	O
we're	O
going	O
to	O
look	O
at	O
this	O
experience	O
and	O
these	O
two	O
incidents	O
or	O
three	O
incidents	O
in	O
particular	O
and	O
more	O
broadly	O
at	O
a	O
culture	O
of	O
lab	O
safety	O
to	O
see	O
what	O
we	O
can	O
do	O
to	O
ensure	O
that	O
work	O
that's	O
done	O
with	O
either	O
select	O
agents	O
or	O
other	O
dangerous	O
microbes	O
is	O
done	O
safely	O
.	O

In	O
2006	O
a	O
ban	O
on	O
the	O
use	O
of	O
antibiotics	O
in	O
European	O
feed	O
,	O
with	O
the	O
exception	O
of	O
two	O
antibiotics	O
in	O
poultry	O
feeds	O
,	O
became	O
effective	O
.	O

The	O
at-risk	O
groups	O
include	O
pregnant	O
and	O
post	O
partum	O
women	O
,	O
children	O
under	O
two	O
years	O
old	O
,	O
and	O
people	O
with	O
underlying	O
conditions	O
such	O
as	O
respiratory	B-Disease
problems	E-Disease
.	O
People	O
who	O
are	O
not	O
in	O
an	O
at-risk	O
group	O
who	O
have	O
persistent	O
or	O
rapidly	O
worsening	O
symptoms	O
should	O
also	O
be	O
treated	O
with	O
antivirals	O
.	O

The	O
WHO	S-Organization
along	O
with	O
the	O
World	B-Organization
Bank	E-Organization
constitute	O
the	O
core	O
team	O
responsible	O
for	O
administering	O
the	O
International	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Partnership	E-International_exchange_and_cooperation
(	O
IHP+	S-International_exchange_and_cooperation
)	O
.	O

Andrew	B-Person
V.	I-Person
Anzalone	E-Person
Peyton	B-Person
B.	I-Person
Randolph	E-Person
,	O
Jessie	B-Person
R.	I-Person
Davis	E-Person
,	O
Alexander	B-Person
A.	I-Person
Sousa	E-Person
,	O
Luke	B-Person
W.	I-Person
Koblan	E-Person
,	O
Jonathan	B-Person
M.	I-Person
Levy	E-Person
,	O
Peter	B-Person
J.	I-Person
Chen	E-Person
,	O
Christopher	B-Person
Wilson	E-Person
,	O
Gregory	B-Person
A.	I-Person
Newby	E-Person
,	O
Aditya	B-Person
Raguram	E-Person
,	O
and	O
David	B-Person
R.Liu	E-Person
.	O
Nature(October	O
2019)	O
(or	O
base	O
editing)	O
is	O
a	O
CRISPR	S-Technology
refinement	O
to	O
accurately	O
insert	O
or	O
delete	O
sections	O
of	O
DNA	O
.	O

Also	O
Davis	S-Person
,	O
Jack	S-Person
,	O
in	O
''Aborigines	O
of	O
the	O
West:	O
Their	O
Past	O
and	O
Their	O
Present''	O
ed	O
.	O

As	O
many	O
as	O
18	O
labs	O
in	O
nine	O
states	O
received	O
the	O
samples	O
,	O
the	O
said	O
Thursday	O
.	O

Good	O
accessibility	O
of	O
publicly	O
funded	O
research	O
data	O
is	O
essential	O
to	O
secure	O
an	O
open	O
scientific	O
system	O
and	O
eventually	O
becomes	O
mandatory	O
[	O
Wellcome	B-Organization
Trust	E-Organization
will	O
Penalise	O
Scientists	O
Who	O
Don't	O
Embrace	O
Open	O
Access	O
.	O

EBOV	S-Pathogen
RNA	O
in	O
semen	O
is	O
not	O
the	O
same	O
situation	O
as	O
perseverance	O
of	O
in	O
semen	O
,	O
however	O
the	O
"	O
clinical	O
significance	O
of	O
low	O
levels	O
of	O
virus	O
RNA	O
in	O
convalescent	O
"	O
individuals	O
who	O
are	O
healthy	O
is	O
unknown	O
.	O

In	O
addition	O
,	O
will	O
review	O
the	O
safety	O
protocol	O
again	O
with	O
all	O
employees	O
who	O
work	O
in	O
this	O
area	O
.	O

Cases	O
continued	O
to	O
gradually	O
dwindle	O
and	O
on	O
7	O
October	O
2015	O
,	O
all	O
three	O
of	O
the	O
most	O
seriously	O
affected	O
countries	O
,	O
per	O
media	O
reports	O
,	O
recorded	O
their	O
first	O
joint	O
week	O
without	O
any	O
new	O
cases	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
(	O
IDSA	S-Organization
)	O
presented	O
and	O
joined	O
statements	O
reflecting	O
various	O
aspects	O
of	O
its	O
priorities	O
at	O
the	O
71st	B-International_exchange_and_cooperation
World	I-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Assembly	E-International_exchange_and_cooperation
in	O
last	O
week	O
.	O

The	O
growing	O
threat	O
of	O
biological	O
weapons	O
,	O
American	O
Scientist	O
,	O
89:1	O
.	O

Retrieved	O
August	O
9	O
,	O
2006	O
.	O

Postwar	O
reports	O
have	O
generally	O
regarded	O
the	O
data	O
as	O
"	O
crude	O
and	O
ineffective"	O
,	O
with	O
one	O
expert	O
even	O
deeming	O
it	O
"	O
amateurish".	O
Harris	S-Person
speculates	O
that	O
the	O
reason	O
scientists	O
generally	O
wanted	O
to	O
acquire	O
it	O
was	O
due	O
to	O
the	O
concept	O
of	O
forbidden	O
fruit	O
,	O
believing	O
that	O
lawful	O
and	O
ethical	O
prohibitions	O
could	O
affect	O
the	O
outcomes	O
of	O
their	O
research	O
.	O

The	O
national	O
security	O
of	O
the	O
U.S.	S-Location
has	O
a	O
vested	O
interest	O
in	O
containing	O
the	O
virus	O
in	O
Africa	S-Location
,	O
but	O
the	O
U.S.	S-Location
lacks	O
a	O
coordinated	O
team	O
,	O
a	O
central	O
structure	O
to	O
meet	O
such	O
biodefense	O
goals	O
,	O
said	O
.	O

In	O
spite	O
of	O
the	O
end	O
of	O
civil	O
violence	O
since	O
2003	O
and	O
inflows	O
from	O
international	O
donors	O
,	O
the	O
reconstruction	O
of	O
Liberia	S-Location
had	O
been	O
very	O
slow	O
and	O
non-productive-water	O
delivery	O
systems	O
,	O
sanitation	O
facilities	O
and	O
centralised	O
electricity	O
were	O
practically	O
non-existent	O
,	O
even	O
in	O
.	O

Establish	O
a	O
'Special	O
Medical	O
Use	O
(SMU)'	O
pathway	O
for	O
FDA	S-Organization
to	O
approve	O
new	O
antimicrobial	O
agents	O
for	O
use	O
in	O
limited	O
patient	O
populations	O
,	O
shorten	O
the	O
approval	O
timeline	O
for	O
new	O
drug	O
so	O
patients	O
with	O
severe	O
infections	O
could	O
benefit	O
as	O
quickly	O
as	O
possible	O
.	O

This	O
image	O
weighting	O
is	O
useful	O
for	O
detecting	O
edema	S-Phenotype
and	O
inflammation	S-Phenotype
,	O
revealing	O
,	O
and	O
assessing	O
zonal	O
anatomy	O
in	O
the	O
prostate	O
and	O
uterus	O
.	O

The	O
letter	O
contained	O
a	O
small	O
vial	O
of	O
a	O
white	O
powdery	O
substance	O
that	O
was	O
initially	O
tested	O
negative	O
for	O
ricin	S-Pathogen
.	O
After	O
subsequent	O
testing	O
at	O
the	O
mail	O
facility	O
resulted	O
in	O
positives	O
for	O
ricin	S-Pathogen
contamination	O
on	O
mail	O
equipment	O
,	O
the	O
U.S.	B-Organization
Secret	I-Organization
Service	E-Organization
ordered	O
a	O
retest	O
that	O
showed	O
by	O
November	O
10	O
the	O
letter	O
was	O
"	O
probable	O
for	O
ricin"	O
.	O

The	O
idea	O
behind	O
is	O
to	O
help	O
researchers	O
and	O
clinicians	O
understand	O
which	O
strains	O
of	O
bacteria	O
are	O
spreading	O
through	O
the	O
healthcare	O
system	O
and	O
where	O
they	O
are	O
spreading	O
,	O
to	O
identify	O
which	O
strains	O
are	O
drug-resistant	O
or	O
virulent	O
,	O
and	O
to	O
find	O
the	O
genetic	O
markers	O
that	O
give	O
them	O
away	O
.	O

The	O
declared	O
the	O
outbreak	O
over	O
on	O
21	O
November	O
2014	O
,	O
after	O
a	O
total	O
of	O
66	O
cases	O
and	O
49	O
deaths	O
.	O

These	O
initiatives	O
were	O
primarily	O
focused	O
on	O
raising	O
awareness	O
about	O
biosafety	O
and	O
biosecurity	O
.	O

The	O
origin	O
of	O
the	O
"	O
Spanish	B-Incident
flu	E-Incident
name	O
stems	O
from	O
the	O
pandemic's	O
spread	O
to	O
Spain	S-Location
from	O
France	S-Location
in	O
November	O
1918	O
.	O

The	O
way	O
that	O
this	O
research	O
will	O
impact	O
human	O
lives	O
is	O
through	O
the	O
numerous	O
applications	O
such	O
as	O
new	O
vaccines	O
,	O
pharmaceuticals	O
,	O
biofuels	O
,	O
etc	O
.	O

As	O
a	O
note	O
,	O
the	O
use	O
of	O
biological	O
weapons	O
was	O
banned	O
by	O
the	O
1925	O
.	O
My	O
team	O
at	O
State	O
has	O
led	O
outreach	O
to	O
expand	O
the	O
convention's	O
membership	O
,	O
and	O
today	O
there	O
are	O
172	O
States	O
Parties	O
.	O

More	O
recent	O
analyses	O
of	O
the	O
other	O
gene	O
segments	O
of	O
the	O
virus	O
also	O
support	O
this	O
conclusion	O
.	O

Despite	O
the	O
Pentagon	S-Organization
's	O
claims	O
that	O
its	O
program	O
is	O
only	O
defensive	O
,	O
there	O
are	O
facts	O
to	O
the	O
contrary	O
.	O

That	O
,	O
Dr.	O
said	O
,	O
strengthened	O
the	O
idea	O
that	O
she	O
picked	O
up	O
the	O
virus	O
from	O
the	O
wind	O
rather	O
than	O
from	O
a	O
port	O
of	O
call	O
.	O

There	O
has	O
been	O
a	O
great	O
deal	O
of	O
COVID-19	S-Pathogen
research	O
,	O
involving	O
accelerated	O
research	O
processes	O
and	O
publishing	O
shortcuts	O
to	O
meet	O
the	O
global	O
demand	O
.	O

Another	O
example	O
is	O
archaeological	O
uses	O
such	O
as	O
imaging	O
the	O
contents	O
of	O
sarcophagi	O
or	O
ceramics	O
.	O

Work	O
must	O
be	O
conducted	O
in	O
accordance	O
with	O
established	O
biosafety	O
standards	O
,	O
the	O
principles	O
and	O
functions	O
of	O
Integrated	B-Document
Safety	I-Document
Management	E-Document
(	O
ISM	S-Document
)	O
,	O
this	O
Biosafety	O
Manual	O
,	O
Chapter	O
26	O
(Biosafety)	O
of	O
the	O
Health	B-Document
and	I-Document
Safety	I-Document
Manual	E-Document
(PUB-3000)	O
,	O
and	O
applicable	O
standards	O
and	O
policies	O
.	O

The	O
whole	O
world	O
can	O
judge	O
.	O

Multiple	O
groups	O
added	O
various	O
regulatory	O
factors	O
to	O
dCas9s	S-Technology
,	O
enabling	O
them	O
to	O
turn	O
almost	O
any	O
gene	O
on	O
or	O
off	O
or	O
adjust	O
its	O
level	O
of	O
activity	O
.	O

On	O
14	O
June	O
it	O
was	O
reported	O
that	O
there	O
were	O
112	O
contacts	O
since	O
EVD	S-Disease
was	O
first	O
detected	O
in	O
Uganda	S-Location
.	O
Ring	O
vaccination	O
of	O
Ugandan	O
contacts	O
was	O
scheduled	O
to	O
start	O
on	O
15	O
June	O
.	O

The	O
Sierra	B-Organization
Leone-China	I-Organization
Friendship	I-Organization
Biological	I-Organization
Safety	I-Organization
Laboratory	E-Organization
(	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
)	O
,	O
a	O
fixed	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
laboratory	O
in	O
the	O
capital	O
city	O
of	O
Sierra	B-Location
Leone	E-Location
,	O
was	O
established	O
by	O
the	O
Chinese	O
government	O
and	O
has	O
been	O
active	O
in	O
EBOV	S-Pathogen
detection	O
since	O
11	O
March	O
2015	O
.	O

This	O
knowledge	O
should	O
be	O
initiated	O
in	O
schools	O
.	O

Despite	O
the	O
claims	O
of	O
the	O
local	O
authorities	O
that	O
the	O
virus	O
was	O
transmitted	O
to	O
humans	O
from	O
animals	O
,	O
all	O
animal	O
blood	O
samples	O
were	O
negative	O
too	O
.	O

The	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
(	O
WHA	S-Organization
)	O
is	O
the	O
legislative	O
and	O
supreme	O
body	O
of	O
WHO	S-Organization
.	O
Based	O
in	O
Geneva	S-Location
,	O
it	O
typically	O
meets	O
yearly	O
in	O
May	O
.	O

Six	O
million	O
animals	O
were	O
killed	O
in	O
an	O
attempt	O
to	O
halt	O
its	O
spread	O
,	O
and	O
the	O
economic	O
damages	O
totalled	O
£8bn	O
.	O

Despite	O
the	O
claims	O
of	O
some	O
agents	O
,	O
their	O
overall	O
impact	O
on	O
the	O
war	O
was	O
negligible	O
.	O

MIRIAM	B-Person
FALCO	E-Person
Hi	O
,	O
Dr.Frieden	S-Person
.	O
Thank	O
you	O
for	O
taking	O
these	O
questions	O
.	O

Another	O
concern	O
is	O
that	O
doctors	O
may	O
become	O
reluctant	O
to	O
perform	O
routine	O
surgeries	O
because	O
of	O
the	O
increased	O
risk	O
of	O
harmful	O
infection	O
.	O

Hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
,	O
HIV	S-Pathogen
,	O
the	O
Salmonella	B-Pathogen
e	E-Pathogen
,	O
and	O
are	O
representative	O
of	O
microorganisms	O
assigned	O
to	O
this	O
containment	O
level	O
.	O

COVID-19	S-Disease
was	O
confirmed	O
to	O
have	O
spread	O
to	O
South	B-Location
Korea	E-Location
on	O
20	O
January	O
2020	O
from	O
China	S-Location
.	O
The	O
nation's	O
health	O
agency	O
reported	O
a	O
significant	O
increase	O
in	O
confirmed	O
cases	O
on	O
20	O
February	O
,	O
largely	O
attributed	O
to	O
a	O
gathering	O
in	O
Daegu	S-Location
of	O
the	O
Shincheonji	B-Organization
Church	I-Organization
of	I-Organization
Jesus	E-Organization
.	O
Shincheonji	O
devotees	O
visiting	O
Daegu	S-Location
from	O
were	O
suspected	O
to	O
be	O
the	O
origin	O
of	O
the	O
outbreak.	O
,	O
among	O
9,336	O
followers	O
of	O
the	O
church	O
,	O
1,261	O
or	O
about	O
13	O
percent	O
reported	O
symptoms	O
.	O

The	O
findings	O
are	O
mixed	O
.	O

Some	O
speculate	O
the	O
soldiers'	O
immune	O
systems	O
were	O
weakened	O
by	O
malnourishment	O
,	O
as	O
well	O
as	O
the	O
stresses	O
of	O
combat	O
and	O
chemical	O
attacks	O
,	O
increasing	O
their	O
susceptibility	O
.	O

Specifically	O
,	O
the	O
proposal	O
would	O
reauthorize	O
funds	O
to	O
improve	O
bioterrorism	O
and	O
other	O
public	O
health	O
emergency	O
preparedness	O
and	O
response	O
activities	O
,	O
such	O
as	O
those	O
operated	O
by	O
the	O
Hospital	B-Scientific_research_project
Preparedness	I-Scientific_research_project
Program	E-Scientific_research_project
the	O
Public	B-Document
Health	I-Document
Emergency	I-Document
Preparedness	I-Document
Cooperative	I-Document
Agreement	E-Document
,	O
Project	B-Document
BioShield	E-Document
,	O
and	O
for	O
the	O
advanced	O
research	O
and	O
development	O
of	O
medical	O
countermeasures	O
.	O

Outbreaks	O
swept	O
through	O
North	B-Location
America	E-Location
Europe	S-Location
,	O
Asia	S-Location
,	O
Africa	S-Location
,	O
Brazil	S-Location
and	O
the	O
South	B-Location
Pacific	E-Location
(	O
Taubenberger	S-Location
)	O
.	O

There	O
are	O
about	O
70	O
armed	O
military	O
groups	O
,	O
among	O
them	O
the	O
Alliance	B-Organization
of	I-Organization
Patriots	E-Organization
for	O
a	O
Free	B-Location
and	I-Location
Sovereign	I-Location
Congo	E-Location
and	O
the	O
Mai-Mayi	B-Location
Nduma	E-Location
défense	O
du	O
Congo-Rénové	S-Organization
,	O
in	O
North	B-Location
Kivu	E-Location
.	O
The	O
armed	O
fighting	O
has	O
displaced	O
thousands	O
of	O
individuals	O
.	O

Paris	S-Organization
has	O
seen	O
riots	O
break	O
out	O
over	O
police	O
treatment	O
of	O
ethnic	O
minorities	O
during	O
the	O
coronavirus	O
lockdown	O
.	O

Yes	O
,	O
you	O
read	O
that	O
right:	O
The	O
cheese	O
was	O
created	O
with	O
bacteria	O
harvested	O
from	O
the	O
armpits	O
,	O
toes	O
,	O
bellybuttons	O
,	O
and	O
nostrils	O
of	O
famous	O
people	O
.	O

On	O
26	O
April	O
2009	O
,	O
the	O
announced	O
that	O
visitors	O
returning	O
from	O
flu-affected	O
areas	O
who	O
experienced	O
flu-like	O
symptoms	O
within	O
two	O
weeks	O
would	O
be	O
quarantined	O
.	O

Lillibridge	S-Person
who	O
experienced	O
firsthand	O
the	O
anthrax	B-Incident
events	I-Incident
of	I-Incident
2001	E-Incident
,	O
addressed	O
these	O
and	O
other	O
future	O
biological	O
challenges	O
during	O
one	O
of	O
several	O
panels	O
held	O
during	O
Tuesday's	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
meeting	O
to	O
review	O
the	O
state	O
of	O
biodefense	O
.	O

This	O
could	O
then	O
be	O
supplemented	O
by	O
a	O
review	O
of	O
experiments	O
involving	O
biological	O
agents	O
that	O
raise	O
concern	O
about	O
their	O
potential	O
for	O
misuse	O
.	O

Oregon	O
Attorney	O
General	O
Dave	B-Person
Frohnmayer	E-Person
commented	O
on	O
the	O
poisoning	O
incident	O
and	O
other	O
acts	O
perpetrated	O
by	O
the	O
group	O
,	O
stating:	O
"	O
The	O
Rajneeshees	O
committed	O
the	O
most	O
significant	O
crimes	O
of	O
their	O
kind	O
in	O
the	O
history	O
of	O
the	O
United	O
States	O
..	O
.	O

The	O
need	O
for	O
animal	O
work	O
involving	O
high-risk	O
or	O
high-consequence	O
pathogens	O
and	O
for	O
arthropod-borne	O
diseases	O
has	O
stimulated	O
renewed	O
interest	O
in	O
animal	O
biosafety	O
matters	O
,	O
particularly	O
for	O
work	O
in	O
containment	O
.	O

The	O
Occupational	O
Safety	O
and	O
Health	O
Administration	O
(	O
OSHA	S-Organization
regulations	O
in	O
.	O

Prisoners	O
had	O
limbs	O
amputated	O
in	O
order	O
to	O
study	O
blood	O
loss	O
.	O

Make	O
sure	O
we	O
wear	O
gloves	O
all	O
the	O
time	O
when	O
we're	O
managing	O
patients	O
and	O
using	O
tests	O
for	O
.	O

In	O
November	O
2018	O
,	O
a	O
paper	O
by	O
the	O
U.S.	B-Organization
Center	I-Organization
for	I-Organization
Strategic	I-Organization
and	I-Organization
International	I-Organization
Studies	E-Organization
on	O
the	O
violence	O
and	O
the	O
EVD	B-Incident
outbreak	E-Incident
indicated	O
the	O
situation	O
might	O
worsen	O
depending	O
on	O
the	O
result	O
and	O
response	O
of	O
presidential	O
elections	O
in	O
the	O
country	O
in	O
2018	O
.	O

Former	O
Senate	O
Majority	O
Leader	O
Tom	B-Person
Daschle	E-Person
and	O
member	O
of	O
the	O
panel	O
,	O
asked	O
the	O
experts	O
to	O
"	O
drill	O
down	O
on	O
the	O
whole	O
notion	O
of	O
a	O
public-private	O
partnership,	O
"	O
seeking	O
clarification	O
on	O
how	O
the	O
private	O
entities	O
they	O
represent	O
navigate	O
the	O
seemingly	O
endless	O
number	O
of	O
contacts	O
with	O
governments	O
and	O
companies	O
around	O
the	O
world	O
during	O
an	O
emergency	O
.	O

In	O
addition	O
,	O
the	O
names	O
of	O
biological	O
agents	O
are	O
occasionally	O
inconsistent	O
.	O

On	O
1May	O
antibody	B-Technology
testing	E-Technology
in	O
suggested	O
an	O
IFR	O
of	O
0.86%	O
.	O

Taiwan	S-Location
notified	O
the	O
WHO	S-Organization
of	O
a	O
new	O
virus	O
on	O
31	O
December	O
2019	O
.	O

Only	O
the	O
CDC	S-Organization
and	O
the	O
Russian	B-Organization
State	I-Organization
Centre	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	E-Organization
in	O
the	O
Russian	B-Location
Federation	E-Location
are	O
approved	O
to	O
have	O
the	O
for	O
research	O
.	O

A	O
synonymous	O
substitution	O
represents	O
a	O
silent	O
change	O
,	O
a	O
nucleotide	O
change	O
in	O
a	O
codon	O
that	O
does	O
not	O
result	O
in	O
an	O
amino	O
acid	O
replacement	O
.	O

"	O
The	O
fact	O
that	O
it	O
is	O
published	O
along	O
with	O
a	O
Presidential	B-Document
Memorandum	E-Document
adds	O
power	O
to	O
it	O
all	O
,	O
including	O
the	O
direction	O
that	O
budgets	O
will	O
need	O
to	O
respond	O
to	O
this	O
strategy,	O
"	O
he	O
said	O
.	O

A	O
person's	O
age	O
plays	O
a	O
significant	O
role	O
in	O
the	O
subsequent	O
risk	O
of	O
cancer	S-Disease
Estimated	O
lifetime	O
cancer	S-Disease
mortality	O
risks	O
from	O
an	O
abdominal	O
of	O
a	O
one-year-old	O
is	O
0.	O
1%	O
or	O
1:1000	O
scans	O
.	O

The	O
ability	O
to	O
develop	O
vaccines	O
such	O
as	O
Imvamune	S-Vaccine
is	O
dependent	O
on	O
the	O
guarantees	O
of	O
multi-year	O
funding	O
from	O
the	O
U.S.	B-Organization
government	E-Organization
to	O
pharmaceutical	O
companies	O
.	O

Former	O
U.S	O
.	O

In	O
some	O
countries	O
and	O
over	O
the	O
Internet	O
,	O
antibiotics	O
can	O
be	O
purchased	O
without	O
a	O
doctor's	O
prescription	O
.	O

In	O
response	O
,	O
the	O
organizers	O
of	O
insist	O
that	O
they	O
welcome	O
a	O
vigorous	O
ethical	O
debate	O
,	O
and	O
have	O
no	O
intention	O
of	O
turning	O
synthetic	O
cells	O
into	O
living	O
humans	O
.	O

Since	O
its	O
introduction	O
in	O
the	O
1970s	O
,	O
CT	S-Equipment
has	O
become	O
an	O
important	O
tool	O
in	O
medical	O
imaging	O
to	O
supplement	O
X-rays	O
and	O
medical	O
ultrasonography	O
.	O

The	O
centre	O
is	O
a	O
two-storey	O
building	O
with	O
a	O
maximum	O
capacity	O
of	O
116	O
people	O
at	O
a	O
time	O
.	O

Those	O
who	O
may	O
already	O
have	O
the	O
infection	O
have	O
been	O
advised	O
to	O
wear	O
a	O
surgical	B-Equipment
mask	E-Equipment
in	O
public	O
.	O

UCLA	S-Organization
said	O
it	O
found	O
no	O
direct	O
evidence	O
that	O
either	O
of	O
the	O
rat	O
incidents	O
involved	O
an	O
actual	O
loss	O
of	O
containment	O
of	O
biohazardous	O
materials	O
.	O

Is	O
there	O
any	O
common	O
denominator	O
as	O
you	O
look	O
at	O
this	O
early	O
as	O
to	O
whether	O
your	O
protocols	O
for	O
safety	O
are	O
antiquated	O
or	O
whether	O
these	O
are	O
junior	O
lab	O
people	O
who	O
have	O
-	O
don't	O
have	O
experience	O
,	O
or	O
to	O
the	O
contrary	O
,	O
senior	O
people	O
who	O
have	O
just	O
become	O
lax	O
after	O
years	O
and	O
years	O
of	O
being	O
in	O
a	O
lab?	O

More	O
importantly	O
,	O
the	O
company	O
can	O
predict	O
diseases	O
through	O
genome	B-Technology
reading	E-Technology
and	O
advanced	O
detection	O
algorithms.	O
"	O
The	O
new	O
preventive	O
medicine	O
paradigm	O
is	O
turning	O
healthcare	O
on	O
its	O
head,	O
"	O
added	O
.	O

On	O
23	O
August	O
,	O
he	O
sought	O
medical	O
care	O
for	O
symptoms	O
including	O
diarrhoea	S-Phenotype
,	O
and	O
vomiting	S-Phenotype
plus	O
signs	B-Phenotype
of	I-Phenotype
fever	E-Phenotype
.	O
He	O
received	O
treatment	O
for	O
but	O
did	O
not	O
improve	O
and	O
left	O
the	O
facility	O
.	O

On	O
5February	O
,	O
the	O
Chinese	O
foreign	O
ministry	O
said	O
21	O
countries	O
(including	O
Belarus	S-Organization
,	O
Pakistan	S-Organization
,	O
Trinidad	S-Organization
and	O
Tobago	S-Organization
,	O
Egypt	S-Organization
,	O
and	O
Iran	S-Location
)	O
had	O
sent	O
aid	O
to	O
China	S-Location
,	O
and	O
Bill	S-Person
and	O
Melinda	B-Person
Gates	E-Person
announced	O
a	O
$100 million	O
donation	O
to	O
the	O
WHO	S-Organization
to	O
fund	O
vaccine	O
research	O
and	O
treatment	O
efforts	O
and	O
protect	O
"	O
at-risk	O
populations	O
in	O
Africa	S-Location
and	O
South	B-Location
Asia	E-Location
"	O
.	O
Interaksyon	S-Person
said	O
the	O
Chinese	B-Organization
government	E-Organization
had	O
donated	O
200,000	O
masks	O
to	O
the	O
Philippines	S-Organization
on	O
6February	O
after	O
Philippine	O
senator	O
Richard	B-Person
Gordon	E-Person
shipped	O
3.16 million	O
masks	O
to	O
Wuhan	S-Location
.	O
On	O
19	O
February	O
,	O
the	O
Singapore	B-Organization
Red	I-Organization
Cross	E-Organization
announced	O
it	O
would	O
send	O
$2.26 million	O
worth	O
of	O
aid	O
to	O
.	O

On	O
19	O
March	O
2020	O
,	O
Italy	S-Location
overtook	O
China	S-Location
as	O
the	O
country	O
with	O
the	O
most	O
deaths	O
.	O

Ban	B-Person
Shigeo	E-Person
a	O
technician	O
at	O
the	O
Japanese	B-Organization
Army's	I-Organization
9th	I-Organization
Technical	I-Organization
Research	I-Organization
Institute	E-Organization
,	O
left	O
an	O
account	O
of	O
the	O
activities	O
at	O
the	O
Institute	O
which	O
was	O
published	O
in	O
"	O
The	O
Truth	O
About	O
the	O
Army	O
Nororito	O
Institute"	O
.	O

Several	O
have	O
been	O
evaluated	O
by	O
Public	B-Organization
Health	I-Organization
England	E-Organization
and	O
approved	O
for	O
use	O
in	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

The	O
1347	O
pandemic	O
plague	S-Disease
was	O
not	O
referred	O
to	O
specifically	O
as	O
"	O
black"	O
in	O
the	O
14th	O
or	O
15th	O
centuries	O
in	O
any	O
European	O
language	O
,	O
though	O
the	O
expression	O
"	O
"	O
had	O
occasionally	O
been	O
applied	O
to	O
fatal	O
disease	O
beforehand	O
.	O

Laura	B-Person
Walker	E-Person
,	O
a	O
MappBio	B-Organization
team	E-Organization
led	O
by	O
Dr	O
.	O

The	O
WHO	S-Organization
operates	O
"	O
Goodwill	O
Ambassadors"	O
;	O
members	O
of	O
the	O
arts	O
,	O
sports	O
,	O
or	O
other	O
fields	O
of	O
public	O
life	O
aimed	O
at	O
drawing	O
attention	O
to	O
WHO	S-Organization
's	O
initiatives	O
and	O
projects	O
.	O

Unprocessed	O
TX	O
was	O
also	O
transported	O
from	O
Beale	O
AFB	O
for	O
purification	O
,	O
storage	O
,	O
and	O
disposal	O
.	O

"	O
to	O
develop	O
and	O
sustain	O
WHO	S-Organization
as	O
a	O
flexible	O
,	O
learning	O
organization	O
,	O
enabling	O
it	O
to	O
carry	O
out	O
its	O
mandate	O
more	O
efficiently	O
and	O
effectively"	O
.	O

The	O
etiological	O
agents	O
have	O
been	O
extensively	O
cultured	O
and	O
studied	O
since	O
the	O
end	O
of	O
the	O
last	O
century	O
(isolation	O
of	O
pure	O
cultures)	O
.	O

For	O
example	O
,	O
getting	O
a	O
blood	O
test	O
before	O
and	O
after	O
taking	O
vitamin	B-Drug
B12	E-Drug
supplements	O
for	O
greater	O
cognitive	O
function	O
can	O
show	O
you	O
whether	O
the	O
supplements	O
have	O
affected	O
your	O
levels	O
.	O

A	O
single	O
gram	O
of	O
crystalline	O
toxin	O
,	O
evenly	O
dispersed	O
and	O
inhaled	O
can	O
kill	O
more	O
than	O
one	O
million	O
people	O
.	O

Together	O
with	O
a	O
decreased	O
willingness	O
to	O
travel	O
,	O
this	O
had	O
a	O
negative	O
economic	O
and	O
social	O
impact	O
on	O
the	O
travel	O
sector	O
.	O

MERS	B-Disease
coronavirus	E-Disease
.	O
Ebola	S-Disease
.	O
Hepatitis	B-Disease
E	E-Disease
.	O
Yellow	B-Disease
Fever	E-Disease
.	O
Lassa	S-Disease
.	O
.	O

Frieden	S-Person
.	O
I	O
have	O
three	O
quick	O
questions	O
.	O

Genetic	B-Technology
Engineers	E-Technology
are	O
a	O
subculture	O
of	O
biohackers	O
as	O
one	O
of	O
the	O
most	O
accessible	O
forms	O
of	O
biohacking	O
is	O
through	O
engineering	O
microorganisms	O
or	O
plants	O
.	O

On	O
20	O
January	O
2016	O
at	O
the	O
World	B-Activity
Economic	I-Activity
Forum	E-Activity
in	O
Davos	S-Location
,	O
,	O
more	O
than	O
"	O
80	O
pharmaceutical	O
and	O
diagnostic	O
companies	O
"	O
from	O
around	O
the	O
world	O
called	O
for	O
"	O
transformational	O
commercial	O
models	O
"	O
at	O
a	O
global	O
level	O
to	O
spur	O
research	O
and	O
development	O
on	O
antibiotics	O
and	O
on	O
the	O
"	O
enhanced	O
use	O
of	O
diagnostic	O
tests	O
that	O
can	O
rapidly	O
identify	O
the	O
infecting	O
organism"	O
.	O

In	O
2014	O
,	O
incidents	B-Incident
with	I-Incident
Anthrax	I-Incident
and	I-Incident
Ebola	I-Incident
pathogens	I-Incident
in	I-Incident
CDC	I-Incident
laboratories	E-Incident
()	O
,	O
prompted	O
the	O
CDC	O
director	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

However	O
,	O
in	O
2015	O
the	O
United	B-Location
States	E-Location
had	O
a	O
significant	O
funding	O
spike	O
from	O
$433	O
million	O
allocated	O
to	O
$1.34	O
billion	O
with	O
supplemental	O
funds	O
to	O
fight	O
the	O
Ebola	B-Incident
outbreak	E-Incident
and	O
pay	O
for	O
costs	O
associated	O
with	O
related	O
GHSA	S-International_exchange_and_cooperation
efforts	O
,	O
according	O
to	O
Kates	S-Person
.	O
In	O
2016	O
,	O
there	O
was	O
another	O
small	O
jump	O
in	O
global	O
health	O
security	O
spending	O
to	O
$552	O
million	O
from	O
$407	O
million	O
allocated	O
due	O
to	O
the	O
Zika	B-Pathogen
virus	E-Pathogen
and	O
related	O
efforts	O
.	O

As	O
of	O
17	O
May	O
,	O
the	O
U.S.	S-Location
,	O
which	O
accounts	O
for	O
about	O
4.	O
25%	O
of	O
the	O
world's	O
population	O
,	O
had	O
about	O
29%	O
of	O
the	O
confirmed	O
deaths	O
.	O

Importantly	O
toward	O
such	O
goals	O
,	O
H.R.	B-Document
6378	E-Document
would	O
codify	O
the	O
duties	O
of	O
ASPR	S-Organization
,	O
putting	O
the	O
office	O
in	O
the	O
lead	O
of	O
these	O
national	O
efforts	O
,	O
but	O
would	O
maintain	O
the	O
role	O
of	O
the	O
in	O
emergency	O
and	O
response	O
activities	O
.	O

Some	O
countries	O
and	O
organizations	O
have	O
compiled	O
a	O
biological	B-Document
agent	I-Document
category	I-Document
list	E-Document
according	O
to	O
evaluations	O
of	O
the	O
risk	O
of	O
biological	O
agents	O
based	O
on	O
laboratory	O
biosafety	O
.	O

When	O
the	O
contaminated	O
droplets	O
fall	O
to	O
floors	O
or	O
surfaces	O
they	O
can	O
,	O
though	O
less	O
commonly	O
,	O
remain	O
infectious	O
if	O
people	O
touch	O
contaminated	O
surfaces	O
and	O
then	O
their	O
eyes	O
,	O
nose	O
or	O
mouth	O
with	O
unwashed	O
hands	O
.	O

The	O
British	O
routinely	O
inoculated	O
their	O
own	O
troops	O
,	O
exposing	O
soldiers	O
to	O
the	O
material	O
from	O
smallpox	S-Pathogen
pustules	O
to	O
induce	O
a	O
mild	O
case	O
of	O
disease	O
and	O
,	O
once	O
they	O
recovered	O
,	O
life-long	O
immunity	O
.	O

That's	O
what	O
redundant	O
systems	O
are	O
about	O
.	O

Azar	S-Person
has	O
asked	O
to	O
lead	O
the	O
day-to-day	O
coordination	O
team	O
that	O
supports	O
the	O
steering	O
committee	O
.	O

Airline	O
schedules	O
were	O
also	O
changed	O
.	O

In	O
addition	O
to	O
the	O
use	O
of	O
bursting	O
bomblets	O
for	O
creating	O
biological	O
aerosols	O
,	O
the	O
Chemical	B-Organization
Corps	E-Organization
started	O
investigating	O
aerosol-generating	O
bomblets	O
in	O
the	O
1950s	O
.	O

On	O
1	O
August	O
,	O
just	O
after	O
the	O
Ebola	S-Disease
epidemic	O
had	O
been	O
declared	O
,	O
Doctors	O
Without	O
Borders/	O
Médecins	B-Organization
Sans	I-Organization
Frontières	E-Organization
(	O
MSF	S-Organization
)	O
arrived	O
in	O
Mangina	S-Location
,	O
the	O
point	O
of	O
origin	O
of	O
the	O
outbreak	O
,	O
to	O
mount	O
a	O
response	O
against	O
the	O
outbreak	O
.	O

The	O
U.S.	B-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
on	O
Tuesday	O
advanced	O
bipartisan	O
legislation	O
sponsored	O
by	O
U.S.	S-Location
Rep	O
.	O

In	O
active	O
military	O
campaigns	O
,	O
several	O
hundred	O
thousand	O
people-mostly	O
Chinese	O
civilians-fell	O
victim	O
.	O

In	O
March	O
2015	O
,	O
the	O
United	B-Organization
Nations	I-Organization
Development	I-Organization
Group	E-Organization
reported	O
that	O
due	O
to	O
a	O
decrease	O
in	O
trade	O
,	O
closing	O
of	O
borders	O
,	O
flight	O
cancellations	O
,	O
and	O
drop	O
in	O
foreign	O
investment	O
and	O
tourism	O
activity	O
fuelled	O
by	O
stigma	O
,	O
the	O
epidemic	O
resulted	O
in	O
vast	O
economic	O
consequences	O
both	O
in	O
the	O
affected	O
areas	O
and	O
throughout	O
Africa	S-Location
.	O
A	O
September	O
2014	O
report	O
in	O
the	O
Financial	B-Organization
Times	E-Organization
suggested	O
that	O
the	O
economic	O
impact	O
of	O
the	O
could	O
kill	O
more	O
people	O
than	O
the	O
disease	O
itself	O
.	O

The	O
agency	O
awarded	O
a	O
contract	O
several	O
weeks	O
ago	O
to	O
five	O
manufacturers	O
to	O
develop	O
an	O
H1N1	S-Pathogen
antigen	O
.	O

Osman	B-Person
Dar	E-Person
,	O
director	O
of	O
the	O
One	O
Health	O
Project	O
at	O
the	O
Chatham	B-Organization
House	I-Organization
Centre	I-Organization
on	I-Organization
Global	I-Organization
Health	I-Organization
Security	E-Organization
defended	O
the	O
WHO	S-Organization
's	O
conduct	O
,	O
stating	O
that	O
the	O
same	O
pressure	O
was	O
one	O
"	O
that	O
organisations	O
have	O
always	O
had	O
from	O
the	O
advanced	O
economies.	O
"	O

In	O
2008	O
,	O
a	O
new	O
contrast	O
agent	O
named	O
gadoxetate	O
,	O
brand	O
name	O
Eovist	O
(	O
US	S-Location
)	O
or	O
Primovist	O
()	O
,	O
was	O
approved	O
for	O
diagnostic	O
use:	O
This	O
has	O
the	O
theoretical	O
benefit	O
of	O
a	O
dual	O
excretion	O
path	O
.	O

The	O
United	B-Location
States	E-Location
initiated	O
its	O
weaponization	O
efforts	O
with	O
disease	O
vectors	O
in	O
1953	O
,	O
focused	O
on	O
Plague-fleas	S-Pathogen
,	O
EEE-mosquitoes	S-Pathogen
,	O
and	O
yellow	B-Pathogen
fever	E-Pathogen
–	O
mosquitoes	O
(OJ-AP)	O
.	O

Pat	B-Person
Finley	E-Person
another	O
SNL	S-Organization
computer	O
scientist	O
on	O
the	O
project	O
,	O
says	O
this	O
could	O
be	O
especially	O
useful	O
for	O
detecting	O
outbreaks	O
of	O
regional	O
diseases	O
like	O
Lyme	B-Disease
disease	E-Disease
,	O
plague	S-Disease
,	O
and	O
.	O
They	O
could	O
also	O
more	O
efficiently	O
bypass	O
physical	O
and	O
power	O
consumption	O
limits	O
that	O
computers	O
face	O
.	O

Because	O
the	O
H1N1	B-Vaccine
vaccine	E-Vaccine
was	O
initially	O
in	O
short	O
supply	O
and	O
in	O
the	O
U.S.	S-Location
,	O
the	O
CDC	S-Organization
recommended	O
that	O
initial	O
doses	O
should	O
go	O
to	O
priority	O
groups	O
such	O
as	O
pregnant	O
women	O
,	O
people	O
who	O
live	O
with	O
or	O
care	O
for	O
babies	O
under	O
six	O
months	O
old	O
,	O
children	O
six	O
months	O
to	O
four	O
years	O
old	O
and	O
health-care	O
workers	O
.	O

Taiwan	S-Location
increased	O
production	O
and	O
penalised	O
hoarding	O
of	O
medical	O
supplies	O
.	O

The	O
outbreak	O
was	O
confirmed	O
to	O
have	O
spread	O
to	O
Italy	S-Location
on	O
31	O
January	O
,	O
when	O
two	O
Chinese	O
tourists	O
tested	O
positive	O
for	O
SARS‑CoV‑2	S-Disease
in	O
Rome	S-Location
.	O
Cases	O
began	O
to	O
rise	O
sharply	O
,	O
which	O
prompted	O
the	O
Italian	B-Organization
government	E-Organization
to	O
suspend	O
all	O
flights	O
to	O
and	O
from	O
China	S-Location
and	O
declare	O
a	O
state	O
of	O
emergency	O
.	O

After	O
the	O
Soviet	B-Organization
Union	E-Organization
ceased	O
to	O
exist	O
,	O
the	O
island	O
became	O
joint	O
territory	O
of	O
Kazakhstan	S-Location
and	O
.	O

JCVI	S-Organization
is	O
a	O
not-for-profit	O
,	O
genomic-focused	O
basic	O
research	O
organization	O
.	O

Any	O
improperly	O
performed	O
operations	O
,	O
from	O
the	O
acceptance	O
of	O
specimens	O
to	O
PCR	S-Equipment
preparation	O
,	O
will	O
result	O
in	O
the	O
possibility	O
of	O
EVD	S-Disease
laboratory	O
infection	O
or	O
environmental	O
contamination	O
with	O
EBOV	S-Pathogen
RNA	O
,	O
making	O
test	O
results	O
unreliable	O
.	O

If	O
you're	O
thoroughly	O
grossed	O
out	O
by	O
this	O
,	O
don't	O
worry:	O
The	O
food	O
won't	O
actually	O
be	O
eaten	O
-	O
this	O
"	O
bioart"	O
project	O
is	O
meant	O
more	O
as	O
a	O
thought	O
experiment	O
than	O
as	O
dinner	O
.	O

While	O
a	O
bad	O
haircut	O
might	O
be	O
embarrassing	O
,	O
the	O
wrong	O
cut	O
by	O
could	O
be	O
much	O
more	O
serious	O
,	O
making	O
you	O
sicker	O
instead	O
of	O
healthier	O
.	O

Different	O
types	O
of	O
safe	O
and	O
appropriate	O
personnel	B-Equipment
protection	I-Equipment
equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
are	O
used	O
in	O
different	O
zones	O
of	O
the	O
laboratory	O
,	O
and	O
it	O
fully	O
meets	O
the	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
laboratory	O
standards	O
of	O
the	O
.	O

Particularly	O
in	O
Europe	S-Location
,	O
where	O
the	O
war's	O
toll	O
was	O
high	O
,	O
the	O
may	O
not	O
have	O
had	O
a	O
tremendous	O
psychological	O
impact	O
or	O
may	O
have	O
seemed	O
an	O
extension	O
of	O
the	O
war's	O
tragedies	O
.	O

Other	O
aspects	O
included	O
bioterrorism	O
and	O
means	O
to	O
combat	O
it	O
,	O
as	O
well	O
as	O
bioethics	O
and	O
dual	O
use	O
resebiosafety	O
,	O
biosecurity	O
,	O
biocontainment	O
,	O
and	O
biorisk	O
management	O
in	O
biomedical	O
and	O
biotechnology	O
laboratories	O
.	O

On	O
8	O
September	O
,	O
Singapore	S-Location
announced	O
that	O
a	O
post-doctoral	O
worker	O
in	O
a	O
SARS	S-Disease
research	O
lab	O
in	O
the	O
National	B-Organization
University	I-Organization
of	I-Organization
Singapore	E-Organization
had	O
contracted	O
the	O
disease	O
while	O
working	O
on	O
the	O
but	O
recovered	O
shortly	O
thereafter	O
.	O

"	O
You	O
wouldn't	O
have	O
to	O
create	O
new	O
legislation	O
at	O
all,	O
"	O
said	O
Geoffrey	B-Person
Ling	E-Person
chief	O
executive	O
officer	O
of	O
,	O
a	O
firm	O
specializing	O
in	O
technology	O
development	O
for	O
health	O
care	O
,	O
emphasizing	O
that	O
extending	O
funding	O
would	O
do	O
little	O
to	O
disrupt	O
policies	O
already	O
in	O
place	O
.	O

During	O
World	O
War	O
II	O
,	O
Joseph	B-Person
Stalin	E-Person
was	O
forced	O
to	O
move	O
his	O
biological	O
warfare	O
(BW)	O
operations	O
out	O
of	O
the	O
path	O
of	O
advancing	O
German	B-Organization
forces	E-Organization
and	O
may	O
have	O
used	O
tularemia	S-Pathogen
against	O
German	O
troops	O
in	O
1942	O
near	O
.	O

Another	O
good	O
development	O
is	O
that	O
the	O
plan	O
spells	O
the	O
day-to-day	O
coordination	O
and	O
execution	O
by	O
the	O
HHS	S-Organization
secretary	O
,	O
which	O
builds	O
in	O
top-level	O
accountability	O
and	O
clearly	O
assigned	O
responsibility	O
,	O
according	O
to	O
.	O

At	O
the	O
same	O
time	O
,	O
in	O
parallel	O
with	O
the	O
design	O
and	O
build	O
phase	O
,	O
Saward	S-Person
said	O
is	O
in	O
discussions	O
with	O
potential	O
partners	O
on	O
this	O
initiative	O
.	O

Supplies	O
depended	O
on	O
crops	O
of	O
the	O
plant	O
.	O

In	O
separate	O
incidents	O
last	O
summer	O
,	O
workers	O
at	O
the	O
USDA	S-Organization
National	B-Organization
Animal	I-Organization
Disease	I-Organization
Center	E-Organization
in	O
Ames	S-Location
,	O
Iowa	S-Location
,	O
were	O
potentially	O
exposed	O
to	O
leptospira	S-Pathogen
,	O
a	O
dangerous	O
bacteria	O
,	O
because	O
they	O
didn't	O
follow	O
basic	O
safety	O
procedures	O
,	O
according	O
to	O
a	O
list	O
of	O
incident	O
summaries	O
obtained	O
under	O
the	O
federal	O
.	O

Carter's	O
book	O
Charisma	O
and	O
Control	O
in	O
Rajneeshpuram	O
,	O
"	O
many	O
treated	O
his	O
concern	O
"	O
as	O
paranoid	O
or	O
as	O
an	O
example	O
of	O
"	O
Rajneeshee	O
bashing"	O
.	O

WHO	S-Organization
also	O
aims	O
to	O
improve	O
access	O
to	O
health	O
research	O
and	O
literature	O
in	O
developing	O
countries	O
such	O
as	O
through	O
the	O
.	O

The	O
development	O
of	O
laboratory	O
biosafety	O
and	O
biodefense	O
capabilities	O
require	O
shared	O
experience	O
to	O
face	O
the	O
pressing	O
questions	O
of	O
modern-day	O
threat	O
.	O

The	O
UNSCOM	S-Organization
team	O
found	O
that	O
's	O
stockpile	O
included	O
Scud	O
missiles	O
loaded	O
to	O
deliver	O
disease	O
.	O

The	O
US	B-Organization
Army	E-Organization
report	O
lists	O
numerous	O
dissemination	O
techniques	O
including	O
by	O
.	O

The	O
2010–2011	B-Vaccine
vaccine	E-Vaccine
will	O
protect	O
against	O
the	O
and	O
two	O
other	O
flu	O
viruses	O
.	O

When	O
Nixon	S-Person
ended	O
the	O
U.S.	O
bio-weapons	O
program	O
it	O
represented	O
the	O
first	O
review	O
of	O
the	O
U.S.	O
biological	O
warfare	O
program	O
since	O
1954	O
.	O

Several	O
defectors	O
(see	O
Khidir	B-Person
Hamza	E-Person
have	O
claimed	O
that	O
these	O
weapons	O
were	O
intended	O
only	O
as	O
"	O
weapons	O
of	O
last	O
resort	O
"	O
in	O
case	O
the	O
Coalition	O
stormed	O
the	O
gates	O
of	O
Baghdad	S-Location
.	O
Since	O
this	O
never	O
happened	O
,	O
found	O
their	O
use	O
unnecessary	O
.	O

The	O
statement	O
also	O
expressed	O
support	O
for	O
efforts	O
to	O
establish	O
a	O
political	O
declaration	O
based	O
on	O
human	O
rights	O
,	O
equity	O
,	O
and	O
medical	O
science	O
that	O
sets	O
targets	O
related	O
to	O
ending	O
TB	S-Disease
The	O
statement	O
urged	O
the	O
inclusion	O
of	O
targets	O
for	O
finding	O
a	O
missing	O
4	O
million	O
cases	O
,	O
improving	O
treatment	O
and	O
prevention	O
and	O
increasing	O
investments	O
in	O
research	O
and	O
development	O
for	O
diagnostic	O
,	O
preventive	O
and	O
treatment	O
tools	O
.	O

Antivirals	O
are	O
most	O
useful	O
if	O
given	O
within	O
48	O
hours	O
of	O
the	O
start	O
of	O
symptoms	O
and	O
may	O
improve	O
outcomes	O
in	O
hospitalised	O
patients	O
.	O

Without	O
such	O
drift	O
,	O
circulating	O
human	O
influenza	S-Disease
viruses	O
would	O
presumably	O
disappear	O
once	O
herd	O
immunity	O
had	O
reached	O
a	O
critical	O
threshold	O
at	O
which	O
further	O
virus	O
spread	O
was	O
sufficiently	O
limited	O
.	O

The	O
New	B-Organization
York	I-Organization
Times	E-Organization
said	O
that	O
,	O
as	O
of	O
May	O
2020	O
,	O
the	O
outbreak	O
had	O
been	O
far	O
deadlier	O
there	O
but	O
the	O
economic	O
impact	O
had	O
been	O
reduced	O
as	O
Swedes	O
have	O
continued	O
to	O
go	O
to	O
work	O
,	O
restaurants	O
,	O
and	O
shopping	O
.	O

This	O
allowed	O
the	O
public	O
health	O
departments	O
to	O
easily	O
step	O
in	O
and	O
implement	O
their	O
restrictive	O
measures	O
.	O

Results:	O
A	O
total	O
of	O
1,647	O
(92.	O
4%)	O
males	O
and	O
135	O
(7.	O
6%)	O
females	O
participated	O
in	O
the	O
study	O
,	O
with	O
over	O
half	O
(59.	O
7%)	O
having	O
more	O
than	O
five	O
years	O
of	O
work	O
experience	O
.	O

The	O
next	O
3 cases	O
were	O
related	O
to	O
the	O
imam	O
as	O
well:	O
a	O
man	O
who	O
had	O
visited	O
the	O
imam	O
while	O
he	O
was	O
in	O
hospital	O
,	O
his	O
wife	O
and	O
his	O
son	O
.	O

Largely	O
because	O
of	O
its	O
sunny	O
Mediterranean	O
climate	O
and	O
widespread	O
irrigation	O
,	O
California	S-Location
is	O
the	O
world's	O
fifth	O
largest	O
supplier	O
of	O
food	O
and	O
agriculture	O
commodities	O
.	O

Ensure	O
CDC	S-Organization
scientists	O
have	O
a	O
full	O
understanding	O
of	O
previously	O
recommended	O
laboratory	O
safety	O
improvements	O
,	O
including	O
required	O
use	O
of	O
the	O
form	O
,	O
and	O
that	O
they	O
implement	O
them	O
.	O

To	O
study	O
the	O
effects	O
of	O
untreated	O
venereal	O
diseases	O
,	O
male	O
and	O
female	O
prisoners	O
were	O
deliberately	O
infected	O
with	O
syphilis	S-Pathogen
and	O
,	O
then	O
studied	O
.	O

After	O
the	O
outbreak	O
entered	O
its	O
global	O
phase	O
in	O
March	O
,	O
Chinese	B-Organization
authorities	E-Organization
took	O
strict	O
measures	O
to	O
prevent	O
the	O
virus	O
re-entering	O
China	S-Location
from	O
other	O
countries	O
.	O

The	O
first	O
cases	O
of	O
atypical	B-Disease
pneumonia	E-Disease
in	O
Taiwan	S-Location
were	O
identified	O
in	O
a	O
Guangdong-based	O
businessman	O
and	O
his	O
wife	O
on	O
14	O
March	O
and	O
confirmed	O
on	O
17	O
March	O
.	O

The	O
investigation	O
identified	O
the	O
bacteria	O
as	O
and	O
initially	O
concluded	O
that	O
the	O
outbreak	O
had	O
been	O
due	O
to	O
food	O
handlers'	O
poor	O
personal	O
hygiene	O
.	O

My	O
understanding	O
is	O
that	O
the	O
staff	O
were	O
not	O
the	O
same	O
staff	O
at	O
that	O
time	O
.	O

There's	O
a	O
reason	O
you	O
haven't	O
heard	O
about	O
Ebola	S-Disease
being	O
used	O
as	O
a	O
biological	O
weapon	O
in	O
the	O
past:	O
it	O
hasn't	O
been	O
.	O

The	O
basic	O
reproduction	O
number	O
(the	O
average	O
number	O
of	O
other	O
individuals	O
whom	O
each	O
infected	O
individual	O
will	O
infect	O
,	O
in	O
a	O
population	O
which	O
has	O
no	O
immunity	O
to	O
the	O
disease)	O
for	O
the	O
2009	B-Pathogen
novel	I-Pathogen
H1N1	E-Pathogen
is	O
estimated	O
to	O
be	O
1.75	O
.	O

One	O
even	O
could	O
think	O
that	O
binding	O
small	O
chemical	O
compounds	O
or	O
peptides	O
to	O
the	O
Cas9	O
that	O
be	O
used	O
as	O
an	O
direct	O
or	O
indirect	O
apoptotic	O
signal	O
.	O

The	O
capital	O
city	O
suffered	O
construction	O
and	O
restaurant	O
unemployment	O
the	O
most	O
,	O
while	O
outside	O
the	O
capital	O
,	O
the	O
food	O
and	O
beverage	O
sectors	O
suffered	O
economically	O
.	O

Carbapenems	S-Drug
are	O
critically	O
useful	O
antimicrobial	O
drugs	O
that	O
are	O
reserved	O
for	O
treatment	O
of	O
infections	O
caused	O
by	O
multidrug-resistant	O
,	O
gram-negative	O
bacteria	O
(1)	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	O
,	O
USDA	O
,	O
DHHS	O
,	O
DoT	S-Organization
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Will	O
biohacking	O
undergo	O
the	O
same	O
progression?	O
Or	O
is	O
it	O
really	O
altering	O
human	O
nature	O
in	O
a	O
more	O
fundamental	O
way	O
,	O
a	O
way	O
that	O
should	O
concern	O
us?	O

"	O
The	O
SECURE	B-Document
Act	E-Document
addresses	O
the	O
need	O
for	O
a	O
public	O
health	O
workforce	O
that	O
is	O
trained	O
,	O
ready	O
and	O
sufficient	O
to	O
respond	O
to	O
large-scale	O
infectious	O
disease	O
outbreaks	O
,	O
and	O
other	O
threats	O
to	O
our	O
health	O
security,	O
"	O
the	O
society	O
said	O
in	O
a	O
June	O
5	O
statement	O
.	O

In	O
response	O
to	O
the	O
threat	O
,	O
California	O
State	O
Senator	O
Ruben	B-Person
S.	I-Person
Ayala	E-Person
introduced	O
the	O
bill	O
SB1754	S-Document
in	O
the	O
Senate	B-Organization
Agriculture	I-Organization
and	I-Organization
Water	I-Organization
Resources	I-Organization
Committee	E-Organization
to	O
make	O
it	O
a	O
felony	O
for	O
any	O
person	O
to	O
import	O
Mediterranean	S-Location
fruit	O
flies	O
into	O
the	O
state,"Panel	O
OKS	O
Bill	O
Making	O
Medfly	O
Import	O
Felony"	O
,	O
(login	O
required)	O
,	O
Fresno	S-Location
Bee	O
,	O
March	O
7	O
,	O
1990	O
,	O
accessed	O
February	O
23	O
,	O
2012.	O
rather	O
than	O
the	O
misdemeanor	O
it	O
already	O
was	O
.	O

While	O
biocontainment	O
,	O
as	O
defined	O
in	O
the	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories	E-Document
and	O
manuals	O
available	O
at	O
the	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
website	O
much	O
of	O
the	O
design	O
,	O
implementation	O
and	O
monitoring	O
of	O
protocols	O
are	O
left	O
up	O
to	O
state	O
and	O
local	O
authorities	O
.	O

But	O
anthrax	S-Pathogen
which	O
is	O
not	O
contagious	O
,	O
may	O
be	O
only	O
the	O
tip	O
of	O
the	O
iceberg	O
.	O

GlobalMed	S-Organization
ATO	O
certification	O
was	O
granted	O
on	O
November	O
18	O
,	O
2017	O
.	O

Whether	O
it's	O
MERS	S-Disease
in	O
Saudi	B-Location
Arabia	E-Location
where	O
we're	O
helping	O
to	O
contain	O
the	O
outbreak	O
,	O
or	O
Ebola	S-Disease
in	O
West	B-Location
Africa	E-Location
where	O
we	O
have	O
teams	O
helping	O
to	O
stop	O
the	O
outbreak	O
there	O
or	O
the	O
emergence	O
of	O
a	O
new	O
mosquito-caused	O
disease	O
,	O
a	O
mosquito-carried	O
disease	O
,	O
Chikungunya	S-Disease
,	O
in	O
the	O
hemisphere	O
,	O
we're	O
helping	O
countries	O
to	O
respond.	O
is	O
active	O
all	O
over	O
the	O
world	O
.	O

The	O
joint	O
projects	O
and	O
regular	O
meetings	O
have	O
generally	O
created	O
a	O
positive	O
and	O
understanding	O
attitude	O
among	O
the	O
network	O
agencies	O
.	O

"	O
Sprayed	O
treatments	O
are	O
impractical	O
for	O
introducing	O
genetic	B-Technology
modifications	E-Technology
on	O
a	O
large	O
scale	O
and	O
potentially	O
infeasible,	O
"	O
wrote.	O
"	O
Meanwhile,	O
traditional	O
selective	O
breeding	O
methods	O
for	O
introducing	O
protective	O
traits	O
into	O
plants	O
require	O
years	O
to	O
propagate	O
,	O
nowhere	O
near	O
the	O
speed	O
required	O
to	O
prevent	O
a	O
fast-moving	O
threat	O
from	O
developing	O
into	O
a	O
crisis.	O
"	O

Butlin	S-Person
,	O
,	O
Our	O
Original	O
Aggression:	O
Aboriginal	O
Populations	O
of	O
Southeastern	O
Australia	O
1788–1850	O
(1983)	O
,	O
Allen	O
&amp	O
;	O
Unwin	O
,	O
Syd	O
.	O

On	O
April	O
2	O
,	O
1979	O
,	O
there	O
was	O
an	O
unusual	O
anthrax	S-Pathogen
outbreak	O
which	O
affected	O
94	O
people	O
and	O
killed	O
at	O
least	O
64	O
of	O
them	O
in	O
the	O
Soviet	O
city	O
of	O
Sverdlovsk	S-Location
(now	O
called	O
Ekaterinburg	S-Location
)	O
,	O
roughly	O
850	O
miles	O
east	O
of	O
.	O
The	O
first	O
victim	O
died	O
after	O
four	O
days	O
;	O
the	O
last	O
one	O
died	O
six	O
weeks	O
later	O
.	O

This	O
sgRNA	O
can	O
be	O
included	O
alongside	O
the	O
gene	O
that	O
codes	O
for	O
the	O
Cas9	O
protein	O
and	O
made	O
into	O
a	O
plasmid	O
in	O
order	O
to	O
be	O
transfected	O
into	O
cells	O
.	O

Plague	O
remained	O
a	O
major	O
event	O
in	O
Ottoman	B-Location
society	E-Location
until	O
the	O
second	O
quarter	O
of	O
the	O
19th	O
century	O
.	O

In	O
guided	O
therapy	O
,	O
high-intensity	B-Technology
focused	I-Technology
ultrasound	E-Technology
(	O
HIFU	S-Technology
)	O
beams	O
are	O
focused	O
on	O
a	O
tissue	O
,	O
that	O
are	O
controlled	O
using	O
MR	B-Technology
thermal	I-Technology
imaging	E-Technology
.	O
Due	O
to	O
the	O
high	O
energy	O
at	O
the	O
focus	O
,	O
the	O
temperature	O
rises	O
to	O
above	O
65	O
°C	O
(150 °F)	O
which	O
completely	O
destroys	O
the	O
tissue	O
.	O

President	O
Hassan	B-Person
Rouhani	E-Person
said	O
on	O
26	O
February	O
there	O
were	O
no	O
plans	O
to	O
quarantine	O
areas	O
affected	O
by	O
the	O
outbreak	O
,	O
and	O
only	O
individuals	O
would	O
be	O
quarantined	O
.	O

This	O
will	O
be	O
difficult	O
,	O
given	O
that	O
industry's	O
search	O
for	O
novel	O
chemical	O
agents	O
acting	O
on	O
new	O
biological	O
targets	O
has	O
become	O
non-productive	O
.	O

And	O
they	O
tell	O
us	O
that	O
we	O
they'd	O
to	O
make	O
significant	O
improvements	O
to	O
ensure	O
that	O
our	O
lab	O
workers	O
remain	O
safe	O
.	O

Researchers	O
on	O
the	O
program	O
will	O
be	O
required	O
to	O
conduct	O
field	O
surveillance	O
of	O
animal	O
and	O
insect	O
species	O
in	O
high-risk	O
areas	O
around	O
the	O
world	O
;	O
generate	O
data	O
in	O
lab	O
testing	O
and	O
sequence	O
viruses	O
as	O
they	O
evolve	O
;	O
analyze	O
the	O
jump	O
risk	O
by	O
weighing	O
factors	O
such	O
as	O
past	O
known	O
jump	O
events	O
,	O
ecology	O
,	O
seasonal	O
variants	O
,	O
and	O
geospatial	O
data	O
;	O
and	O
,	O
finally	O
,	O
validate	O
models	O
using	O
simulated	O
natural	O
environments	O
.	O

In	O
January	O
2020	O
,	O
Gilead	S-Organization
began	O
working	O
on	O
restarting	O
remdesivir	S-Drug
production	O
in	O
glass-lined	O
steel	O
chemical	O
reactors	O
at	O
its	O
manufacturing	O
plant	O
in	O
Edmonton	S-Location
,	O
Alberta	S-Location
.	O
On	O
2	O
February	O
2020	O
,	O
the	O
company	O
flew	O
its	O
entire	O
stock	O
of	O
remdesivir	S-Drug
,	O
100	O
kilograms	O
in	O
powder	O
form	O
(left	O
over	O
from	O
Ebola	S-Pathogen
research)	O
,	O
to	O
its	O
filling	O
plant	O
in	O
La	B-Location
Verne	E-Location
,	O
California	S-Location
to	O
start	O
filling	O
vials	O
.	O

The	O
radiation	O
doses	O
received	O
from	O
CT	S-Technology
scans	O
is	O
variable	O
.	O

Martin	S-Person
,	O
Op.cit	O
.	O

The	O
BSL-3	S-Platform
laboratory	O
is	O
connected	O
to	O
the	O
other	O
labs	O
through	O
two	O
transfer	O
windows	O
(a	O
"	O
clean"	O
transfer	O
window	O
and	O
a	O
"	O
dirty"	O
transfer	O
window)	O
.	O

Their	O
results	O
showed	O
that	O
on	O
the	O
day	O
of	O
the	O
incident	O
all	O
the	O
victims	O
were	O
clustered	O
along	O
a	O
straight	O
line	O
downwind	O
from	O
the	O
military	O
facility	O
.	O

Therefore	O
,	O
appropriate	O
PPE	S-Equipment
and	O
good	O
practices	O
are	O
essential	O
for	O
protecting	O
medical	O
and	O
laboratory	O
staff	O
dealing	O
with	O
EVD	S-Disease
.	O
We	O
believe	O
that	O
adequate	O
preparation	O
,	O
comprehensive	O
risk	O
assessment	O
and	O
operation	O
documents	O
,	O
appropriate	O
,	O
effective	O
monitoring	O
and	O
intensive	O
training	O
,	O
together	O
with	O
well-designed	O
and	O
reasonable	O
sectioning	O
of	O
the	O
biosafety	O
laboratory	O
,	O
are	O
essential	O
for	O
guaranteeing	O
biosafety	O
.	O

As	O
Chavie	B-Person
Lieber	E-Person
noted	O
for	O
Vox	S-Platform
,	O
although	O
some	O
limited	O
studies	O
suggest	O
that	O
these	O
transfusions	O
might	O
fend	O
off	O
diseases	O
like	O
Alzheimer's	S-Disease
,	O
Parkinson's	S-Disease
,	O
heart	B-Disease
disease	E-Disease
,	O
and	O
,	O
these	O
claims	O
haven't	O
been	O
proven	O
.	O

That's	O
about	O
30%	O
of	O
all	O
antibiotics	O
prescribed	O
in	O
these	O
settings	O
.	O

The	O
targeted	O
site	O
is	O
methylated	O
,	O
epigenetically	O
modifying	O
the	O
gene	O
.	O

It	O
also	O
operates	O
several	O
liaison	O
offices	O
,	O
including	O
those	O
with	O
the	O
European	B-Organization
Union	E-Organization
,	O
United	B-Organization
Nations	E-Organization
and	O
a	O
single	O
office	O
covering	O
the	O
World	B-Organization
Bank	E-Organization
and	O
International	B-Organization
Monetary	I-Organization
Fund	E-Organization
.	O
It	O
also	O
operates	O
the	O
International	B-Organization
Agency	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Cancer	E-Organization
in	O
Lyon	S-Location
,	O
France	S-Location
,	O
and	O
the	O
WHO	B-Organization
Centre	I-Organization
for	I-Organization
Health	I-Organization
Development	E-Organization
in	O
Kobe	S-Location
,	O
Japan	S-Location
.	O
Additional	O
offices	O
include	O
those	O
in	O
Pristina	S-Location
;	O
the	O
West	B-Location
Bank	E-Location
and	O
Gaza	S-Location
;	O
the	O
US-Mexico	B-Organization
Border	I-Organization
Field	I-Organization
Office	E-Organization
in	O
El	B-Location
Paso	E-Location
;	O
the	O
Office	B-Organization
of	I-Organization
the	I-Organization
Caribbean	I-Organization
Program	I-Organization
Coordination	E-Organization
in	O
Barbados	S-Location
;	O
and	O
the	O
Northern	B-Organization
Micronesia	I-Organization
office	E-Organization
.	O
There	O
will	O
generally	O
be	O
one	O
country	O
office	O
in	O
the	O
capital	O
,	O
occasionally	O
accompanied	O
by	O
satellite-offices	O
in	O
the	O
provinces	O
or	O
sub-regions	O
of	O
the	O
country	O
in	O
question	O
.	O

Since	O
,	O
the	O
cost	O
of	O
DNA	O
sequencing	O
has	O
dropped	O
dramatically	O
,	O
making	O
it	O
a	O
simple	O
and	O
widespread	O
research	O
tool	O
.	O

The	O
program	O
calls	O
for	O
the	O
development	O
of	O
highly	O
sensitive	O
detectors	O
and	O
advanced	O
intelligence	O
analytics	O
to	O
detect	O
minute	O
traces	O
of	O
various	O
substances	O
related	O
to	O
WMD	O
threats	O
.	O

Those	O
same	O
skills	O
are	O
helping	O
us	O
to	O
reduce	O
the	O
likelihood	O
that	O
aspiring	O
bioterrorists	O
get	O
their	O
hands	O
on	O
samples	O
.	O

This	O
vector	O
does	O
not	O
contain	O
any	O
viral	O
structural	O
protein	O
genes	O
.	O

In	O
the	O
UK	S-Location
,	O
the	O
NHS	S-Organization
recommended	O
vaccine	O
priority	O
go	O
to	O
people	O
over	O
six	O
months	O
old	O
who	O
were	O
clinically	O
at	O
risk	O
for	O
,	O
pregnant	O
women	O
and	O
households	O
of	O
people	O
with	O
compromised	O
immunity	O
.	O

The	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Unit	I-Organization
Two	E-Organization
(	O
NAMRU-2	S-Organization
)	O
headquartered	O
in	O
Singapore	S-Location
with	O
its	O
main	O
laboratory	O
in	O
Phnom	B-Location
Penh,	I-Location
Cambodia	E-Location
,	O
is	O
at	O
the	O
forefront	O
of	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)'s	O
disease	O
surveillance	O
and	O
response	O
efforts	O
in	O
the	O
.	O

On	O
28	O
August	O
,	O
a	O
second	O
man	O
presented	O
symptoms	O
,	O
claiming	O
he	O
was	O
from	O
the	O
nearby	O
village	O
of	O
Yandongi	S-Location
.	O
He	O
left	O
the	O
hospital	O
on	O
30	O
August	O
,	O
as	O
no	O
clear	O
cause	O
could	O
be	O
identified	O
from	O
his	O
symptoms	O
,	O
and	O
was	O
not	O
seen	O
again	O
.	O

"	O
All	O
hospitals	O
,	O
both	O
human	O
and	O
veterinary	O
,	O
periodically	O
manage	O
the	O
presence	O
of	O
drug-resistant	O
bacteria,	O
"	O
Michael	B-Person
Mison	E-Person
's	O
chief	O
medical	O
officer	O
,	O
said	O
in	O
a	O
news	O
release.	O
"	O
Since	O
it	O
is	O
not	O
possible	O
to	O
completely	O
eliminate	O
the	O
risk	O
,	O
we	O
continually	O
monitor	O
our	O
infection	O
control	O
procedures	O
and	O
isolation	O
protocols.	O
"	O

The	O
agency	O
will	O
work	O
with	O
external	O
bioethics	O
advisors	O
to	O
ensure	O
efforts	O
funded	O
by	O
the	O
program	O
adhere	O
to	O
regulations	O
and	O
ethical	O
best	O
practices	O
.	O

In	O
December	O
1989	O
,	O
a	O
two-page	O
letter	O
addressing	O
Los	B-Location
Angeles	E-Location
Mayor	O
Tom	B-Person
Bradley	E-Person
was	O
sent	O
to	O
the	O
Los	B-Location
Angeles	E-Location
Times	O
and	O
Fresno	O
Bee	O
ostensibly	O
from	O
an	O
"	O
ecoterrorist	O
organization	O
"	O
calling	O
itself	O
"	O
The	O
Breeders".	O
"	O
Medfly	O
letter	O
puts	O
blame	O
on	O
mystery	O
group	O
,	O
San	B-Location
Jose	E-Location
Mercury	O
News	O
,	O
December	O
5	O
,	O
1989	O
.	O

One	O
major	O
example	O
of	O
a	O
place	O
that	O
faces	O
these	O
challenges	O
is	O
India	S-Location
where	O
in	O
the	O
state	O
of	O
73%	O
of	O
the	O
population	O
resorted	O
to	O
treating	O
their	O
minor	O
health	O
issues	O
and	O
chronic	O
illnesses	O
through	O
self-medication	O
.	O

What	O
happens	O
when	O
the	O
circle	O
of	O
people	O
able	O
to	O
create	O
a	O
global	O
pandemic	O
becomes	O
wide	O
enough	O
to	O
include	O
members	O
of	O
such	O
a	O
group?	O
Or	O
members	O
of	O
a	O
terrorist	O
organisation	O
or	O
rogue	O
state	O
that	O
could	O
try	O
to	O
build	O
an	O
omnicidal	O
weapon	O
for	O
the	O
purposes	O
of	O
extortion	O
or	O
deterrence?	O

However	O
,	O
it	O
wasn't	O
until	O
June	O
13	O
that	O
laboratory	O
staff	O
discovered	O
that	O
the	O
anthrax	S-Pathogen
may	O
not	O
have	O
been	O
successfully	O
inactivated	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
which	O
has	O
worked	O
to	O
inform	O
policy	O
makers	O
of	O
the	O
critical	O
need	O
to	O
build	O
up	O
the	O
network	O
of	O
physicians	O
equipped	O
to	O
detect	O
,	O
prevent	O
and	O
respond	O
to	O
disease	O
outbreaks	O
,	O
and	O
which	O
helped	O
develop	O
H.R.	B-Document
5998	E-Document
,	O
also	O
wants	O
it	O
included	O
in	O
the	O
reauthorization	O
.	O

As	O
little	O
as	O
500	O
micrograms	O
--	O
an	O
amount	O
the	O
size	O
of	O
the	O
head	O
of	O
a	O
pin	O
--	O
can	O
kill	O
an	O
adult	O
.	O

TIM1	O
is	O
expressed	O
in	O
tissues	O
known	O
to	O
be	O
seriously	O
impacted	O
by	O
EBOV	S-Pathogen
lysis	O
(trachea	O
,	O
cornea	O
,	O
and	O
conjunctiva)	O
.	O

The	O
use	O
of	O
location	O
data	O
from	O
mobile	O
phones	O
by	O
governments	O
for	O
this	O
purpose	O
has	O
prompted	O
privacy	O
concerns	O
,	O
with	O
Amnesty	B-Organization
International	E-Organization
and	O
more	O
than	O
a	O
hundred	O
other	O
organisations	O
issuing	O
a	O
statement	O
calling	O
for	O
limits	O
on	O
this	O
kind	O
of	O
surveillance	O
.	O

Tularemia	S-Pathogen
was	O
allegedly	O
used	O
against	O
German	O
troops	O
in	O
1942	O
near	O
Stalingrad	S-Location
.	O
Around	O
10,000	O
cases	O
of	O
tularemia	S-Disease
had	O
been	O
reported	O
in	O
the	O
Soviet	B-Location
Union	E-Location
between	O
1941	O
and	O
1943	O
.	O

These	O
supposedly	O
'	O
non-lethal'	B-Equipment
chemical	I-Equipment
weapons	E-Equipment
had	O
been	O
developed	O
as	O
early	O
as	O
the	O
1950s	O
,	O
particularly	O
a	O
substance	O
called	O
'BZ'	O
,	O
known	O
in	O
the	O
US	O
army	O
as	O
'sleeping	O
gas'	O
.	O

The	O
Soviet	B-Location
Union	E-Location
investigated	O
the	O
use	O
of	O
filoviruses	O
for	O
biological	O
warfare	O
,	O
and	O
the	O
Aum	O
Shinrikyo	O
group	O
unsuccessfully	O
attempted	O
to	O
obtain	O
cultures	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
Death	O
from	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
is	O
commonly	O
due	O
to	O
multiple	O
organ	B-Phenotype
failure	E-Phenotype
and	O
hypovolemic	B-Phenotype
shock	E-Phenotype
.	O
Marburg	B-Pathogen
virus	E-Pathogen
was	O
first	O
discovered	O
in	O
Marburg	S-Location
,	O
Germany	S-Location
.	O
No	O
treatments	O
currently	O
exist	O
aside	O
from	O
supportive	O
care	O
.	O

LENA	B-Person
SUN	E-Person
Do	O
you	O
know	O
whether	O
these	O
-	O
in	O
the	O
previous	O
incidents	O
when	O
those	O
-	O
aside	O
from	O
the	O
flu	O
one	O
,	O
the	O
other	O
three	O
incidents	O
,	O
what	O
happened	O
to	O
those	O
organisms	O
and	O
whether	O
there	O
were	O
any	O
exposures?	O

For	O
repressing	O
genes	O
Cas9	O
can	O
be	O
fused	O
to	O
KRAB	O
effector	O
domain	O
that	O
makes	O
complex	O
with	O
gRNA	O
,	O
whereas	O
utilizes	O
dCas9	O
fused	O
to	O
different	O
transcriptional	O
activation	O
domains	O
,	O
which	O
are	O
further	O
directed	O
by	O
gRNA	O
to	O
promoter	O
regions	O
to	O
upregulate	O
expression	O
.	O

Our	O
society	O
relies	O
on	O
energy	O
to	O
do	O
almost	O
everything	O
,	O
from	O
lighting	O
and	O
heating	O
our	O
homes	O
and	O
workplaces	O
to	O
driving	O
around	O
and	O
even	O
growing	O
food.	O
's	O
method	O
of	O
creating	O
many	O
different	O
versions	O
of	O
genes	O
at	O
once	O
allows	O
genetic	O
engineers	O
to	O
find	O
changes	O
to	O
genes	O
that	O
lead	O
to	O
cheaper	O
,	O
more	O
efficient	O
energy	O
production	O
.	O

Twentieth-century	O
advances	O
in	O
microbiology	O
enabled	O
the	O
first	O
pure-culture	O
biological	O
agents	O
to	O
be	O
developed	O
by	O
World	O
War	O
II	O
.	O

"	O
A	O
threatening	O
letter	O
is	O
something	O
we	O
take	O
seriously,	O
"	O
Booth	S-Person
said	O
.	O

Following	O
a	O
joint	O
workshop	O
,	O
the	O
Nordic	B-Platform
Biopreparedness	I-Platform
Forum	E-Platform
was	O
formed	O
in	O
2015	O
and	O
is	O
now	O
governed	O
by	O
a	O
committee	O
made	O
up	O
of	O
representatives	O
from	O
each	O
country	O
.	O

Smith	S-Person
was	O
studying	O
a	O
bacterium	O
,	O
Haemophilus	B-Pathogen
influenzae	E-Pathogen
,	O
and	O
the	O
small	O
viral	O
particles	O
called	O
phages	S-Pathogen
that	O
infect	O
bacterial	O
cells	O
.	O

Supporters	O
say	O
the	O
Kansas	S-Location
facility	O
is	O
a	O
logical	O
fit	O
with	O
the	O
university's	O
,	O
where	O
veterinary	O
,	O
agricultural	O
and	O
biosecurity	O
research	O
is	O
conducted	O
.	O

Felipe	B-Person
Francisco	I-Person
Tuon	E-Person
coordinator	O
of	O
the	O
Laboratory	B-Organization
of	I-Organization
Emerging	I-Organization
Infectious	I-Organization
Diseases	E-Organization
at	O
the	O
Pontifical	B-Organization
Catholic	I-Organization
University	I-Organization
of	I-Organization
Paraná	E-Organization
in	O
Curitiba	S-Location
,	O
,	O
says	O
that	O
outbreaks	O
in	O
laboratories	O
are	O
usually	O
found	O
to	O
be	O
linked	O
to	O
insufficient	O
safety	O
precautions	O
.	O

Preventive	O
measures	O
to	O
reduce	O
the	O
chances	O
of	O
infection	O
include	O
staying	O
at	O
home	O
,	O
avoiding	O
crowded	O
places	O
,	O
keeping	O
distance	O
from	O
others	O
,	O
washing	O
hands	O
with	O
soap	O
and	O
water	O
often	O
and	O
for	O
at	O
least	O
20	O
seconds	O
,	O
practising	O
good	O
respiratory	O
hygiene	O
,	O
and	O
avoiding	O
touching	O
the	O
eyes	O
,	O
nose	O
,	O
or	O
mouth	O
with	O
unwashed	O
hands.The	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
recommends	O
covering	O
the	O
mouth	O
and	O
nose	O
with	O
a	O
tissue	O
when	O
coughing	O
or	O
sneezing	O
and	O
recommends	O
using	O
the	O
inside	O
of	O
the	O
elbow	O
if	O
no	O
tissue	O
is	O
available	O
.	O

Next	O
question	O
comes	O
from	O
Lena	B-Person
Sun	E-Person
with	O
the	O
.	O
Go	O
ahead	O
with	O
your	O
question	O
.	O

During	O
this	O
period	O
,	O
State	O
and	O
Defense	O
developed	O
substantial	O
expertise	O
in	O
training	O
scientific	O
and	O
laboratory	O
personnel	O
in	O
biosafety	O
and	O
biosecurity	O
best	O
practices	O
,	O
securing	O
collections	O
of	O
pathogens	O
such	O
as	O
Ebola	S-Pathogen
and	O
anthrax	S-Pathogen
,	O
and	O
improving	O
disease	O
detection	O
systems	O
.	O

And	O
if	O
there's	O
a	O
failure	O
,	O
we	O
lose	O
an	O
essential	O
line	O
of	O
defense	O
"	O
against	O
disease	O
threats	O
,	O
said	O
the	O
CDC	S-Organization
former	O
director	O
,	O
Dr.	O
.	O

Two	O
additional	O
confirmed	O
cases	O
of	O
SARS	S-Disease
and	O
three	O
additional	O
suspected	O
cases	O
were	O
reported	O
in	O
Beijing	S-Location
on	O
1	O
May	O
,	O
all	O
related	O
to	O
a	O
single	O
research	O
lab	O
,	O
the	O
Diarrhea	B-Organization
Virus	I-Organization
Laboratory	E-Organization
in	O
the	O
CDC	S-Organization
's	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Virology	E-Organization
in	O
Beijing	S-Location
.	O
"	O
The	O
cases	O
had	O
been	O
linked	O
to	O
experiments	O
using	O
live	O
and	O
inactive	O
SARS	B-Pathogen
coronavirus	E-Pathogen
in	O
the	O
CDC's	B-Organization
virology	I-Organization
and	I-Organization
diarrhea	I-Organization
institutes	E-Organization
where	O
interdisciplinary	O
research	O
on	O
the	O
SARS	B-Pathogen
virus	E-Pathogen
was	O
conducted.	O
"	O
The	O
total	O
number	O
of	O
cases	O
was	O
six	O
,	O
with	O
four	O
in	O
Beijing	S-Location
and	O
two	O
in	O
.	O

Sara	B-Person
Roszak	E-Person
senior	O
director	O
of	O
research	O
programs	O
of	O
the	O
National	B-Organization
Association	I-Organization
of	I-Organization
Chain	I-Organization
Drug	I-Organization
Stores	E-Organization
,	O
gave	O
the	O
example	O
of	O
the	O
.	O
When	O
the	O
outbreak	O
occurred	O
,	O
she	O
said	O
her	O
organization	O
was	O
able	O
to	O
pull	O
together	O
a	O
network	O
of	O
pharmacies	O
to	O
initiate	O
a	O
nationwide	O
vaccination	O
campaign	O
"	O
on	O
a	O
drop	O
of	O
a	O
dime	O
"	O
primarily	O
because	O
there	O
were	O
existing	O
relationships	O
within	O
this	O
pharmacy	O
system	O
.	O

Knock-out	O
mutations	O
caused	O
by	O
CRISPR-Cas9	S-Technology
result	O
in	O
the	O
repair	O
of	O
the	O
double-stranded	O
break	O
by	O
means	O
of	O
non-homologous	B-Technology
end	I-Technology
joining	E-Technology
()	O
.	O

History	O
has	O
shown	O
that	O
such	O
infections	O
occur	O
(documented	O
as	O
early	O
as	O
the	O
1890s)	O
and	O
that	O
laboratory	O
workers	O
are	O
clearly	O
at	O
higher	O
risk	O
for	O
infection	O
with	O
certain	O
agents	O
(i.e	O
.	O

Dr	O
.	O

About	O
a	O
month	O
after	O
the	O
Agenda's	O
launch	O
,	O
in	O
March	O
2014	O
,	O
Guinea	S-Location
first	O
reported	O
confirmed	O
Ebola	S-Disease
cases	O
.	O

The	O
first	O
meeting	O
of	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
finished	O
on	O
24	O
July	O
1948	O
,	O
having	O
secured	O
a	O
budget	O
of	O
(then	O
)	O
for	O
the	O
1949	O
year	O
.	O

Extracellular	O
contrast	O
agents	O
are	O
used	O
widely	O
in	O
liver	B-Technology
MRI	E-Technology
,	O
and	O
newer	O
hepatobiliary	O
contrast	O
agents	O
also	O
provide	O
the	O
opportunity	O
to	O
perform	O
functional	O
biliary	O
imaging	O
.	O

The	O
Tick-Borne	B-Organization
Disease	I-Organization
Working	I-Organization
Group	E-Organization
a	O
federal	O
advisory	O
committee	O
established	O
by	O
Congress	S-Organization
in	O
the	O
,	O
issued	O
its	O
first	O
report	O
today	O
.	O

Stericycle	O
and	O
Daniels	B-Organization
Health	E-Organization
are	O
two	O
national	O
leaders	O
in	O
medical	O
waste	O
and	O
pharmaceutical	O
disposal	O
in	O
.	O

Now	O
a	O
team	O
of	O
experts	O
at	O
the	O
Monterey	B-Organization
Institute	I-Organization
of	I-Organization
International	I-Organization
Studies	E-Organization
drawing	O
on	O
formerly	O
secret	O
Soviet	S-Organization
	S-Organization
documents	O
and	O
interviews	O
with	O
survivors	O
,	O
has	O
written	O
a	O
report	O
on	O
the	O
.	O

A	O
Broad	O
Agency	O
Announcement	O
(BAA)	O
solicitation	O
for	O
the	O
first	O
phase	O
of	O
the	O
program	O
is	O
expected	O
to	O
be	O
available	O
in	O
March	O
on	O
FedBizOpps	O
here:	O
http://go.usa.gov/3W53j	O
.	O

A	O
cross-sectional	O
online	O
survey	O
was	O
conducted	O
throughout	O
the	O
region	O
.	O

In	O
2013	O
,	O
the	O
AIR	B-Organization
Worldwide	I-Organization
Research	I-Organization
and	I-Organization
Modeling	I-Organization
Group	E-Organization
"	O
characterized	O
the	O
historic	O
1918	O
pandemic	O
and	O
estimated	O
the	O
effects	O
of	O
a	O
similar	O
pandemic	O
occurring	O
today	O
using	O
the	O
AIR	O
Pandemic	O
Flu	O
Model"	O
.	O

The	O
first	O
is	O
the	O
moratorium	O
on	O
biological	O
material	O
leaving	O
BSL-3	O
and	O
BSL-4	S-Platform
laboratories	O
,	O
and	O
we	O
will	O
assess	O
laboratory	O
by	O
laboratory	O
before	O
reopening	O
.	O

For	O
example	O
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
was	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
biodefense	O
categorization	O
of	O
the	O
EU	S-Location
and	O
Russia	S-Location
,	O
while	O
the	O
US	B-Organization
CDC	E-Organization
listed	O
this	O
agent	O
in	O
the	O
second	O
highest	O
category	O
.	O

The	O
CDC	S-Organization
also	O
operates	O
the	O
Public	B-Document
Health	I-Document
Associate	I-Document
Program	E-Document
(	O
PHAP	S-Document
)	O
,	O
a	O
two-year	O
paid	O
fellowship	O
for	O
recent	O
college	O
graduates	O
to	O
work	O
in	O
public	O
health	O
agencies	O
all	O
over	O
the	O
United	B-Location
States	E-Location
.	O
was	O
founded	O
in	O
2007	O
and	O
currently	O
has	O
159	O
associates	O
in	O
34	O
states	O
.	O

Public	B-Organization
Health	I-Organization
England	E-Organization
reported	O
that	O
the	O
total	O
number	O
of	O
antibiotic	O
resistant	O
infections	O
in	O
rose	O
by	O
9%	O
from	O
55,812	O
in	O
2017	O
to	O
60,788	O
in	O
2018	O
,	O
but	O
antibiotic	O
consumption	O
had	O
fallen	O
by	O
9%	O
from	O
20.0	O
to	O
18.	O
2	O
defined	O
daily	O
doses	O
per	O
1,000	O
inhabitants	O
per	O
day	O
between	O
2014	O
and	O
2018	O
.	O

What	O
is	O
the	O
relationship	O
between	O
JCVI	S-Organization
and	O
the	O
company	O
Synthetic	O
Genomics	O
Inc	O
and	O
in	O
particular	O
how	O
it	O
relates	O
to	O
the	O
research	O
to	O
?	O

Bacterial	O
agents:	O
Anthrax	S-Pathogen
Brucella	S-Pathogen
,	O
,	O
etc	O
.	O

2001:	O
The	O
measles	S-Disease
initiative	O
was	O
formed	O
,	O
and	O
credited	O
with	O
reducing	O
global	O
deaths	O
from	O
the	O
disease	O
by	O
68%	O
by	O
2007	O
.	O

One	O
day	O
later	O
the	O
figure	O
had	O
increased	O
to	O
407	O
.	O

Disaster	O
response	O
organizations	O
such	O
as	O
Direct	B-Organization
Relief	E-Organization
helped	O
by	O
providing	O
protective	O
items	O
to	O
clinical	O
workers	O
to	O
help	O
them	O
stay	O
healthy	O
throughout	O
flu	O
season	O
.	O

"	O
That	O
said	O
,	O
we	O
do	O
accept	O
and	O
agree	O
with	O
concerns	O
about	O
potential	O
dual	O
use	O
of	O
technology	O
,	O
an	O
issue	O
that	O
comes	O
up	O
with	O
virtually	O
every	O
new	O
powerful	O
technology,	O
"	O
Adams	S-Person
said	O
.	O

Based	O
on	O
the	O
circulation	O
measurements	O
,	O
thousands	O
of	O
people	O
would	O
have	O
been	O
killed	O
if	O
a	O
dangerous	O
microbe	O
was	O
released	O
in	O
the	O
same	O
manner	O
.	O

BASE	S-Platform
was	O
developed	O
at	O
the	O
Lund	B-Organization
University	E-Organization
for	O
microarray	O
data	O
management	O
.	O

Methodology:	O
A	O
total	O
of	O
1,782	O
laboratory	O
technicians	O
were	O
interviewed	O
from	O
major	O
public	O
sector	O
hospitals	O
and	O
a	O
few	O
private	O
hospital	O
laboratories	O
throughout	O
Pakistan	S-Location

In	O
Britain	S-Location
the	O
1950s	O
saw	O
the	O
weaponization	O
of	O
plague	S-Pathogen
,	O
brucellosis	S-Pathogen
,	O
tularemia	S-Pathogen
and	O
later	O
equine	B-Pathogen
encephalomyelitis	E-Pathogen
and	O
vaccinia	B-Pathogen
viruses	E-Pathogen
.	O
Trial	O
tests	O
at	O
sea	O
were	O
carried	O
out	O
including	O
Operation	O
Cauldron	O
off	O
in	O
1952	O
.	O

Experiments	O
can	O
be	O
described	O
via	O
general	O
templates	O
for	O
assays	O
or	O
via	O
specialized	O
types	O
which	O
are	O
provided	O
for	O
many	O
objects	O
including	O
neutralizing	O
antibody	O
or	O
microarrays	O
.	O

Stating	O
that	O
"	O
the	O
Ebola	B-Incident
outbreak	E-Incident
has	O
decimated	O
families	O
,	O
health	O
systems	O
,	O
economies	O
,	O
and	O
social	O
structures"	O
,	O
the	O
WHO	S-Organization
called	O
the	O
aftermath	O
of	O
the	O
epidemic	O
"	O
an	O
emergency	O
within	O
an	O
emergency.	O
"	O
Of	O
special	O
concern	O
is	O
recent	O
research	O
that	O
shows	O
some	O
Ebola	S-Disease
survivors	O
experience	O
a	O
so-called	O
"	O
",	O
with	O
symptoms	O
so	O
severe	O
that	O
survivors	O
may	O
require	O
medical	O
care	O
for	O
months	O
and	O
even	O
years	O
.	O

General	O
Shirō	B-Person
Ishii	E-Person
medal	O
from	O
simulated	O
drowning	O
when	O
applied	O
to	O
a	O
victim's	O
skin	O
.	O

On	O
9	O
May	O
2020	O
,	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
(	O
HHS	S-Organization
)	O
explained	O
in	O
a	O
statement	O
that	O
it	O
would	O
be	O
distributing	O
remdesivir	S-Drug
vials	O
to	O
state	O
health	O
departments	O
,	O
then	O
would	O
allow	O
each	O
department	O
to	O
redistribute	O
vials	O
to	O
hospitals	O
in	O
their	O
respective	O
states	O
based	O
upon	O
each	O
department's	O
insight	O
into	O
"	O
community-level	O
needs.	O
"	O
HHS	S-Organization
also	O
clarified	O
that	O
only	O
607,000	O
vials	O
of	O
Gilead	S-Organization
's	O
promised	O
donation	O
of	O
1.5	O
million	O
vials	O
would	O
be	O
going	O
to	O
American	O
patients	O
.	O

A	O
major	O
Russian	O
research	O
centre	O
studying	O
lethal	O
viruses	O
including	O
Ebola	S-Pathogen
and	O
says	O
there	O
was	O
no	O
biological	O
contamination	O
from	O
an	O
explosion	O
and	O
fire	O
in	O
one	O
of	O
its	O
buildings	O
.	O

The	O
WHO	S-Organization
congratulated	O
Liberia	S-Location
saying	O
,	O
"	O
reaching	O
this	O
milestone	O
is	O
a	O
testament	O
to	O
the	O
strong	O
leadership	O
and	O
coordination	O
of	O
Liberian	B-Person
President	I-Person
Ellen	I-Person
Johnson	I-Person
Sirleaf	E-Person
and	O
the	O
,	O
the	O
determination	O
and	O
vigilance	O
of	O
Liberian	O
communities	O
,	O
the	O
extensive	O
support	O
of	O
global	O
partners	O
,	O
and	O
the	O
tireless	O
and	O
heroic	O
work	O
of	O
local	O
and	O
international	O
health	O
teams.	O
"	O

The	O
company	O
paid	O
$	O
250	O
000	O
for	O
lobbying	O
the	O
then	O
Senator	O
Jeff	B-Person
Sessions	E-Person
in	O
2008-2009	O
(currently	O
the	O
US	S-Location
Attorney	O
General	O
appointed	O
by	O
)	O
,	O
when	O
the	O
institute	O
was	O
awarded	O
a	O
number	O
of	O
federal	O
contracts	O
.	O

Hepatobiliary	B-Technology
MR	E-Technology
is	O
used	O
to	O
detect	O
and	O
characterize	O
lesions	O
of	O
the	O
liver	O
,	O
pancreas	O
,	O
and	O
bile	O
ducts	O
.	O

Only	O
RNA–positive	O
human	O
samples	O
from	O
before	O
1918	O
,	O
and	O
from	O
all	O
3	O
waves	O
,	O
can	O
answer	O
this	O
question	O
.	O

The	O
inactivated	O
samples	O
were	O
transferred	O
to	O
the	O
RNA	O
extraction	O
bench	O
for	O
either	O
manual	O
or	O
automatic	O
RNA	O
extraction	O
.	O

This	O
blockage	O
starves	O
the	O
fleas	O
and	O
drives	O
them	O
to	O
aggressive	O
feeding	O
behaviour	O
and	O
attempts	O
to	O
clear	O
the	O
blockage	O
by	O
regurgitation	O
,	O
resulting	O
in	O
thousands	O
of	O
plague	B-Pathogen
bacteria	E-Pathogen
being	O
flushed	O
into	O
the	O
feeding	O
site	O
,	O
infecting	O
the	O
host	O
.	O

In	O
2011	O
Ukraine	S-Location
was	O
hit	O
by	O
a	O
cholera	B-Incident
outbreak	E-Incident
.	O
33	O
patients	O
were	O
reportedly	O
hospitalized	O
for	O
severe	O
diarrhea	S-Disease
.	O
A	O
second	O
outbreak	O
struck	O
the	O
country	O
in	O
2014	O
when	O
more	O
than	O
800	O
people	O
all	O
across	O
Ukraine	S-Location
were	O
reported	O
to	O
have	O
contracted	O
the	O
disease	O
.	O

On	O
8	O
September	O
,	O
Singapore	S-Location
announced	O
that	O
a	O
post-doctoral	O
worker	O
in	O
a	O
SARS	S-Disease
research	O
lab	O
in	O
the	O
National	B-Organization
University	I-Organization
of	I-Organization
Singapore	E-Organization
had	O
contracted	O
the	O
disease	O
while	O
working	O
on	O
the	O
but	O
recovered	O
shortly	O
thereafter	O
.	O

Risk	O
assessment	O
guidelines	O
include	O
the	O
pathogenicity	O
of	O
the	O
infectious	O
agent	O
,	O
the	O
method	O
of	O
transmission	O
,	O
worker-related	O
risk	O
factors	O
,	O
the	O
source	O
and	O
route	O
of	O
infection	O
,	O
and	O
the	O
design	O
of	O
the	O
laboratory	O
facility	O
.	O

This	O
practice	O
has	O
been	O
ongoing	O
since	O
the	O
1950s	O
,	O
despite	O
efforts	O
to	O
prevent	O
such	O
non-prescription	O
use	O
by	O
regulatory	O
authorities	O
,	O
such	O
as	O
the	O
UN	S-Organization
and	O
.	O
Is	O
there	O
convincing	O
evidence	O
that	O
these	O
supplements	O
are	O
of	O
use	O
when	O
good	O
animal	O
husbandry	O
is	O
common	O
practice?	O
Appropriate	O
treatment	O
for	O
sick	O
animals	O
must	O
,	O
of	O
course	O
,	O
be	O
maintained	O
.	O

BASE	S-Platform
,	O
DIPSBC	S-Platform
,	O
Gaggle	S-Platform
and	O
MIMAS	S-Platform
have	O
implemented	O
functionality	O
concerning	O
upload	O
to	O
NCBI	S-Organization
GEO	O
or	O
Array-Express	O
.	O

Lauterbur	S-Person
called	O
his	O
imaging	O
method	O
zeugmatography	S-Technology
,	O
a	O
term	O
which	O
was	O
later	O
replaced	O
by	O
(N)MR	B-Technology
imaging	E-Technology
.	O
In	O
the	O
late	O
1970s	O
,	O
physicists	O
Peter	B-Person
Mansfield	E-Person
and	O
Paul	B-Person
Lauterbur	E-Person
,	O
developed	O
MRI	S-Technology
-related	O
techniques	O
,	O
like	O
the	O
echo-planar	B-Technology
imaging	E-Technology
()	O
technique	O
.	O

Meeting	O
this	O
goal	O
–	O
and	O
within	O
a	O
10	O
year	O
timeline	O
–	O
will	O
require	O
new	O
technology	O
and	O
an	O
explosion	O
in	O
manufacturing	O
capacity	O
.	O

The	O
National	B-Organization
Center	I-Organization
for	I-Organization
Emerging	I-Organization
and	I-Organization
Zoonotic	I-Organization
Infectious	I-Organization
Diseases	E-Organization
would	O
be	O
cut	O
by	O
$65	O
million	O
,	O
or	O
11	O
percent	O
.	O

The	O
flu	S-Disease
has	O
been	O
linked	O
to	O
the	O
in	O
the	O
1920s	O
.	O

Anthrax	S-Disease
is	O
caused	O
by	O
a	O
bacterium	O
--	O
--	O
that	O
can	O
persist	O
in	O
soil	O
,	O
water	O
and	O
,	O
most	O
infamously	O
,	O
long	O
journeys	O
through	O
the	O
mail	O
system	O
.	O

Skeels	S-Person
found	O
glass	O
vials	O
containing	O
Salmonella	O
"	O
bactrol	O
disks	O
"	O
in	O
the	O
laboratory	O
of	O
a	O
Rajneeshpuram	O
medical	O
clinic	O
.	O

Although	O
the	O
number	O
of	O
Biosafety	B-Equipment
cabinets	E-Equipment
was	O
very	O
low	O
11	O
(5.	O
8%)	O
when	O
compared	O
with	O
study	O
conducted	O
in	O
Japan	S-Location
,	O
where	O
70%	O
of	O
surveyed	O
laboratories	O
had	O
biosafety	B-Equipment
cabinet	E-Equipment
.	O
Although	O
the	O
biosafety	B-Equipment
cabinet	E-Equipment
number	O
was	O
low	O
,	O
it	O
found	O
only	O
in	O
the	O
government	O
and	O
private	O
laboratories	O
,	O
no	O
one	O
was	O
reported	O
in	O
laboratories	O
belong	O
to	O
organization	O
provide	O
health	O
services	O
.	O

The	O
main	O
problem	O
is	O
that	O
doctors	O
are	O
willing	O
to	O
prescribe	O
antibiotics	O
to	O
ill-informed	O
individuals	O
who	O
believe	O
that	O
antibiotics	O
can	O
cure	O
nearly	O
all	O
illnesses	O
,	O
including	O
viral	O
infections	O
like	O
the	O
common	B-Disease
cold	E-Disease
In	O
an	O
analysis	O
of	O
drug	O
prescriptions	O
,	O
36%	O
of	O
individuals	O
with	O
a	O
cold	O
or	O
an	O
(both	O
viral	O
in	O
origin)	O
were	O
given	O
prescriptions	O
for	O
antibiotics	O
.	O

The	O
outbreak	O
was	O
labeled	O
the	O
"	O
most	O
alarming	O
event	O
"	O
of	O
1971	O
by	O
the	O
United	B-Organization
Nations	I-Organization
Food	I-Organization
and	I-Organization
Agricultural	I-Organization
Organization	E-Organization
.	O
Six	O
years	O
after	O
the	O
event	O
,	O
the	O
newspaper	O
Newsday	O
,	O
citing	O
untraceable	O
sources	O
,	O
claimed	O
that	O
anti-Castro	O
saboteurs	O
,	O
with	O
at	O
least	O
the	O
tacit	O
backing	O
of	O
U.S.	B-Organization
Central	I-Organization
Intelligence	I-Organization
Agency	E-Organization
officials	O
,	O
introduced	O
African	B-Pathogen
swine	I-Pathogen
fever	I-Pathogen
virus	E-Pathogen
into	O
Cuba	S-Location
six	O
weeks	O
before	O
the	O
outbreak	O
in	O
1971	O
,	O
to	O
destabilize	O
the	O
Cuban	O
economy	O
and	O
encourage	O
domestic	O
opposition	O
to	O
Fidel	B-Person
Castro	E-Person
.	O
The	O
virus	O
was	O
allegedly	O
delivered	O
to	O
the	O
operatives	O
from	O
an	O
army	O
base	O
in	O
the	O
Panama	B-Location
Canal	I-Location
Zone	E-Location
by	O
an	O
unnamed	O
intelligence	O
source	O
.	O

Price	O
increases	O
and	O
shortages	O
in	O
these	O
illegal	O
drugs	O
have	O
been	O
noticed	O
on	O
the	O
street	O
of	O
the	O
UK	S-Location
.	O
U.S.	S-Location
law	O
enforcement	O
also	O
told	O
the	O
Mexican	O
drug	O
cartels	O
were	O
having	O
difficulty	O
in	O
obtaining	O
precursors	O
.	O

Three	O
vaccination	O
strategies	O
are	O
being	O
investigated	O
.	O

Both	O
Sheela	S-Person
and	O
Puja	S-Person
were	O
released	O
on	O
parole	O
early	O
for	O
good	O
behavior	O
,	O
after	O
serving	O
twenty-nine	O
months	O
of	O
their	O
sentences	O
in	O
a	O
minimum-security	O
federal	O
prison	O
.	O

All	O
materials	O
that	O
came	O
into	O
contact	O
with	O
clinical	O
samples	O
were	O
immediately	O
soaked	O
in	O
a	O
0.	O
5	O
%	O
chlorine-containing	O
disinfectant	O
for	O
at	O
least	O
10	O
min	O
.	O

Risk	O
Group	O
2	O
:	O
(moderate	O
individual	O
risk	O
,	O
low	O
community	O
risk)	O
A	O
pathogen	O
that	O
can	O
cause	O
human	O
or	O
animal	O
disease	O
but	O
is	O
unlikely	O
to	O
be	O
a	O
serious	O
hazard	O
to	O
laboratory	O
workers	O
,	O
the	O
community	O
,	O
livestock	O
or	O
the	O
environment	O
.	O

She	O
was	O
hospitalized	O
on	O
27	O
August	O
;	O
after	O
receiving	O
surgery	O
and	O
antibiotics	S-Drug
,	O
she	O
was	O
released	O
.	O

It	O
also	O
wants	O
to	O
promote	O
the	O
correct	O
usage	O
of	O
antibiotics	O
across	O
all	O
fields	O
in	O
order	O
to	O
prevent	O
further	O
instances	O
of	O
antibiotic	O
resistance	O
.	O

The	O
lists	O
can	O
be	O
accessed	O
on	O
the	O
OIE	S-Organization
website	O
.	O

Ocular	O
problems	O
could	O
threaten	O
sight	O
in	O
survivors	O
,	O
thus	O
the	O
need	O
for	O
prompt	O
treatment	O
.	O

CDC	S-Organization
estimates	O
there	O
are	O
1.	O
2	O
million	O
cases	O
of	O
Salmonella	B-Disease
infection	E-Disease
each	O
year	O
in	O
the	O
United	B-Location
States	E-Location
.	O
Salmonella	B-Disease
infections	E-Disease
are	O
usually	O
acquired	O
by	O
eating	O
contaminated	O
food	O
.	O

The	O
call	O
was	O
repeated	O
in	O
April	O
2015	O
when	O
the	O
most-affected	O
Western	O
African	O
countries	O
asked	O
for	O
an	O
$8	O
billion	O
"	O
Marshall	B-Activity
Plan	E-Activity
"	O
to	O
rebuild	O
their	O
economies	O
.	O

"	O
I	O
think	O
a	O
vaccination	O
program	O
would	O
be	O
a	O
nightmare	O
.	O

Unit	B-Organization
Tōgō	E-Organization
was	O
implemented	O
in	O
the	O
Zhongma	B-Location
Fortress	E-Location
,	O
a	O
prison/experimentation	O
camp	O
in	O
Beiyinhe	S-Location
,	O
a	O
village	O
south	O
of	O
Harbin	S-Location
on	O
the	O
South	B-Location
Manchuria	I-Location
Railway	E-Location
.	O
In	O
autumn	O
1934	O
,	O
a	O
jailbreak	O
which	O
jeopardized	O
the	O
facility's	O
secrecy	O
along	O
with	O
a	O
later	O
explosion	O
(believed	O
to	O
be	O
sabotage)	O
in	O
1935	O
led	O
Ishii	S-Person
to	O
shut	O
down	O
Zhongma	B-Location
Fortress	E-Location
.	O
He	O
received	O
the	O
authorization	O
to	O
move	O
to	O
Pingfang	S-Location
,	O
approximately	O
south	O
of	O
,	O
to	O
set	O
up	O
a	O
new	O
and	O
much	O
larger	O
facility	O
.	O

In	O
addition	O
,	O
reporting	O
system	O
for	O
laboratory	O
accidents	O
and	O
clean-up	O
of	O
spills	O
was	O
not	O
completely	O
carried	O
out	O
.	O

In	O
cases	O
of	O
influenza	S-Disease
outbreaks	O
,	O
and	O
associated	O
agencies	O
have	O
moved	O
rapidly	O
to	O
isolate	O
and	O
eliminate	O
new	O
outbreaks	O
of	O
infection	O
.	O

Antimicrobial	O
resistance	O
is	O
increasing	O
globally	O
because	O
of	O
greater	O
access	O
to	O
antibiotic	O
drugs	O
in	O
developing	O
countries	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	O
established	O
an	O
External	B-Organization
Laboratory	I-Organization
Safety	I-Organization
Workgroup	E-Organization
(ELSW)	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
.	O

On	O
11	O
November	O
,	O
six	O
people	O
were	O
killed	O
in	O
an	O
attack	O
by	O
an	O
armed	O
rebel	O
group	O
in	O
Beni	S-Location
;	O
as	O
a	O
consequence	O
vaccinations	O
were	O
suspended	O
there	O
.	O

My	O
feeling	O
is	O
that	O
there	O
is	O
a	O
clear	O
unmatched	O
in	O
what	O
basic	O
science	O
is	O
exploring	O
and	O
the	O
urgencies	O
of	O
the	O
society	O
.	O

We	O
identified	O
antimicrobial	O
resistance	O
genes	O
by	O
using	O
the	O
National	B-Equipment
Center	I-Equipment
for	I-Equipment
Biotechnology	I-Equipment
Information	I-Equipment
Pathogen	I-Equipment
Detection	I-Equipment
Isolates	I-Equipment
Browser	E-Equipment
,	O
which	O
uses	O
Link)	O
.	O

Some	O
doctors	O
prefer	O
staying	B-Technology
with	I-Technology
invasive	I-Technology
mechanical	I-Technology
ventilation	E-Technology
when	O
available	O
because	O
this	O
technique	O
limits	O
the	O
spread	O
of	O
aerosol	O
particles	O
compared	O
to	O
a	O
.	O

Daniel	S-Person
said	O
he	O
thinks	O
the	O
fact	O
that	O
the	O
is	O
moving	O
from	O
acknowledging	O
the	O
reimbursement	O
problem	O
to	O
actively	O
proposing	O
ideas	O
to	O
solve	O
it	O
sends	O
an	O
important	O
message	O
to	O
pharmaceutical	O
companies.	O
"	O
I	O
think	O
it	O
speaks	O
volumes	O
,	O
and	O
shows	O
that	O
it's	O
reached	O
a	O
fever	O
pitch	O
to	O
actually	O
start	O
getting	O
some	O
action.	O
"	O

On	O
21	O
April	O
2014	O
,	O
the	O
Health	B-Organization
Ministry	I-Organization
of	I-Organization
UAE	E-Organization
reported	O
an	O
additional	O
9	O
cases	O
.	O

Cairo	S-Location
population	O
,	O
partly	O
owing	O
to	O
the	O
numerous	O
plague	S-Disease
epidemics	O
,	O
was	O
in	O
the	O
early	O
18th	O
century	O
half	O
of	O
what	O
it	O
was	O
in	O
1347	O
.	O

He	O
sees	O
this	O
as	O
the	O
first	O
step	O
in	O
an	O
entirely	O
in-built	O
navigation	O
system	O
and	O
hopes	O
to	O
end	O
what	O
he	O
calls	O
"	O
generation	O
screen"	O
.	O

These	O
individuals	O
are	O
being	O
advised	O
that	O
they	O
can	O
discontinue	O
antibiotics	S-Drug

For	O
example	O
,	O
BD21	S-Document
will	O
continuously	O
scan	O
the	O
environment	O
for	O
anomalies	O
,	O
or	O
indicators	O
,	O
that	O
he	O
said	O
may	O
or	O
may	O
not	O
point	O
to	O
the	O
presence	O
of	O
a	O
biological	O
agent	O
.	O

A	O
five-year	O
partnership	O
agreement	O
has	O
been	O
reached	O
between	O
the	O
U.S.	B-Organization
Defense	I-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
(	O
DARPA	S-Organization
)	O
and	O
the	O
Vanderbilt	B-Organization
University	I-Organization
Medical	I-Organization
Center	E-Organization
()	O
,	O
representing	O
a	O
$28	O
million	O
investment	O
in	O
the	O
fight	O
against	O
viral	O
outbreaks	O
.	O

In	O
some	O
viruses	O
such	O
as	O
the	O
respiratory	B-Pathogen
syncytial	I-Pathogen
virus	E-Pathogen
it	O
causes	O
the	O
RNA-dependent	O
RNA	O
polymerases	O
to	O
pause	O
,	O
but	O
its	O
predominant	O
effect	O
(as	O
in	O
Ebola	S-Disease
)	O
is	O
to	O
induce	O
an	O
irreversible	O
chain	O
termination	O
.	O

The	O
H1N1	B-Pathogen
virus	E-Pathogen
has	O
been	O
transmitted	O
to	O
animals	O
,	O
including	O
swine	O
,	O
turkeys	O
,	O
ferrets	O
,	O
household	O
cats	O
,	O
at	O
least	O
one	O
dog	O
,	O
and	O
a	O
cheetah	O
.	O

Andrew	B-Person
V.	I-Person
Anzalone	E-Person
,	O
Peyton	B-Person
B.	I-Person
Randolph	E-Person
,	O
Jessie	B-Person
R.	I-Person
Davis	E-Person
,	O
Alexander	B-Person
A.	I-Person
Sousa	E-Person
,	O
Luke	B-Person
W.	I-Person
Koblan	E-Person
,	O
Jonathan	B-Person
M.	I-Person
Levy	E-Person
,	O
Peter	B-Person
J.	I-Person
Chen	E-Person
,	O
Christopher	B-Person
Wilson	E-Person
,	O
Gregory	B-Person
A.	E-Person
Newby,	S-Technology
Aditya	B-Person
Raguram	E-Person
,	O
and	O
David	B-Person
R.Liu	E-Person
.	O
Nature(October	O
2019)	O
(or	O
base	O
editing)	O
is	O
a	O
CRISPR	S-Technology
refinement	O
to	O
accurately	O
insert	O
or	O
delete	O
sections	O
of	O
DNA	O
.	O

In	O
a	O
final	O
point	O
,	O
George	B-Person
Poste	E-Person
accomplished	O
scientist	O
and	O
ex	O
officio	O
of	O
the	O
panel	O
,	O
questioned	O
whether	O
was	O
prepared	O
to	O
provide	O
enough	O
generic	O
medications	O
during	O
a	O
national	O
emergency	O
when	O
85	O
percent	O
of	O
these	O
drugs	O
are	O
manufactured	O
overseas	O
.	O

It	O
can	O
identify	O
survival-essential	O
genes	O
,	O
which	O
can	O
be	O
further	O
serve	O
as	O
candidates	O
for	O
molecularly	O
targeted	O
drugs	O
.	O

The	O
lack	O
of	O
harmful	O
effects	O
on	O
the	O
patient	O
and	O
the	O
operator	O
make	O
MRI	S-Technology
well-suited	O
for	O
interventional	O
radiology	O
,	O
where	O
the	O
images	O
produced	O
by	O
an	O
guide	O
minimally	O
invasive	O
procedures	O
.	O

Flu	O
viruses	O
are	O
spread	O
mainly	O
from	O
person	O
to	O
person	O
through	O
coughing	S-Phenotype
or	O
by	O
people	O
with	O
influenza	O
.	O

Hunt	S-Person
has	O
served	O
on	O
the	O
Planetary	B-Organization
Protection	I-Organization
Advisory	I-Organization
Committee	E-Organization
for	O
NASA	S-Organization
.	O
She	O
serves	O
on	O
the	O
Scientific	B-Organization
Advisory	I-Organization
Board	E-Organization
for	O
NIH's	B-Activity
National	I-Activity
Biosafety	I-Activity
and	I-Activity
Biocontainment	I-Activity
Training	I-Activity
Program	E-Activity
()	O
,	O
and	O
is	O
currently	O
Chairman	O
.	O

Cas9	O
derived	O
from	O
the	O
bacterial	O
species	O
Streptococcus	O
pyogenes	O
has	O
facilitated	O
targeted	B-Technology
genomic	I-Technology
modification	I-Technology
in	I-Technology
eukaryotic	I-Technology
cells	E-Technology
by	O
allowing	O
for	O
a	O
reliable	O
method	O
of	O
creating	O
a	O
targeted	O
break	O
at	O
a	O
specific	O
location	O
as	O
designated	O
by	O
the	O
crRNA	O
and	O
tracrRNA	O
guide	O
strands	O
.	O

The	O
N95	B-Equipment
mask	E-Equipment
disposable	O
hat	O
,	O
overshoes	O
and	O
inner-layer	O
gloves	O
should	O
be	O
removed	O
in	O
the	O
shower	O
room	O
.	O

That	O
was	O
the	O
case	O
for	O
Asprey	S-Person
Now	O
in	O
his	O
40s	O
,	O
he	O
got	O
into	O
biohacking	O
because	O
he	O
was	O
unwell	O
.	O

The	O
most	O
frequently	O
linked	O
is	O
gadodiamide	O
,	O
but	O
other	O
agents	O
have	O
been	O
linked	O
too	O
.	O

The	O
Communicable	O
Disease	O
Center	O
was	O
founded	O
July	O
1	O
,	O
1946	O
,	O
as	O
the	O
successor	O
to	O
the	O
World	B-Document
War	I-Document
II	I-Document
Malaria	I-Document
Control	I-Document
in	I-Document
War	I-Document
Areas	I-Document
program	E-Document
of	O
.	O

This	O
testing	O
confirmed	O
and	O
identified	O
a	O
circular	O
IncFII	O
plasmid	O
of	O
139,547	O
bp	O
,	O
which	O
contained	O
the	O
blaNDM-5	O
gene	O
and	O
additional	O
resistance	O
genes:	O
tet(A)	O
,	O
aac(6′)-Ib-cr	O
,	O
aadA5	O
,	O
aadA2	O
,	O
blaOXA-1	O
,	O
blaCTX-M-15	O
,	O
catB3	O
,	O
dfrA17	O
,	O
dfrA12	O
,	O
sul1	O
(2	O
copies)	O
,	O
and	O
mph(A)	O
(3)	O
.	O

The	O
views	O
expressed	O
here	O
are	O
those	O
of	O
the	O
authors	O
and	O
do	O
not	O
necessarily	O
represent	O
the	O
position	O
of	O
the	O
.	O

But	O
this	O
theory	O
would	O
present	O
an	O
additional	O
paradox:	O
an	O
obscure	O
precursor	O
virus	O
that	O
left	O
no	O
detectable	O
trace	O
today	O
would	O
have	O
had	O
to	O
have	O
appeared	O
and	O
disappeared	O
before	O
1889	O
and	O
then	O
reappeared	O
more	O
than	O
3	O
decades	O
later	O
.	O

When	O
the	O
application	O
of	O
administrative	O
and	O
engineering	O
controls	O
and	O
work	O
practices	O
is	O
not	O
sufficient	O
to	O
protect	O
against	O
exposure	O
,	O
PPE	S-Equipment
is	O
used	O
to	O
provide	O
an	O
additional	O
and/or	O
redundant	O
layer	O
of	O
protection	O
.	O

The	O
expenditure	O
associated	O
with	O
these	O
infections	O
in	O
terms	O
of	O
extra	O
hospital	O
costs	O
and	O
productivity	O
losses	O
exceeded	O
€1.	O
5	O
billion	O
each	O
year	O
(Ref)	O
.	O

By	O
5	O
September	O
,	O
Lokela	S-Person
was	O
in	O
a	O
critical	O
condition	O
with	O
profuse	O
bleeding	O
from	O
all	O
orifices	O
,	O
vomiting	S-Phenotype
,	O
acute	O
diarrhea	S-Phenotype
,	O
chest	B-Phenotype
pains	E-Phenotype
,	O
headache	S-Phenotype
,	O
fever	S-Phenotype
and	O
in	O
an	O
agitated	S-Phenotype
and	O
confused	S-Phenotype
state	O
.	O

&quot;We	O
have	O
a	O
tendency	O
in	O
this	O
country	O
to	O
react	O
to	O
things	O
after	O
they	O
occur,&quot	O
;	O
said	O
Blue	O
Ribbon	O
panel	O
co	O
-chairman	S-Person
Tom	O
Ridge	O
,	O
former	O
gonnsylvania	O
.	O

The	O
COVID‑19	B-Organization
Clinical	I-Organization
Research	I-Organization
Coalition	E-Organization
has	O
goals	O
to	O
1)	O
facilitate	O
rapid	O
reviews	O
of	O
clinical	O
trial	O
proposals	O
by	O
ethics	O
committees	O
and	O
national	O
regulatory	O
agencies	O
,	O
2)	O
fast-track	O
approvals	O
for	O
the	O
candidate	O
therapeutic	O
compounds	O
,	O
3)	O
ensure	O
standardised	O
and	O
rapid	O
analysis	O
of	O
emerging	O
efficacy	O
and	O
safety	O
data	O
and	O
4)	O
facilitate	O
sharing	O
of	O
clinical	O
trial	O
outcomes	O
before	O
publication	O
.	O

Several	O
compounds	O
which	O
were	O
previously	O
approved	O
for	O
treatment	O
of	O
other	O
viral	O
diseases	O
are	O
being	O
investigated	O
for	O
use	O
in	O
treating	O
.	O

Besides	O
,	O
implementation	O
of	O
biosafety	O
precautions	O
,	O
it	O
is	O
essential	O
to	O
provide	O
immunity	O
from	O
vaccine	O
preventable	O
diseases	O
such	O
as	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
,	O
tuberculosis	S-Disease
,	O
influenza	S-Disease
,	O
and	O
poliomyelitis	S-Disease
.	O
Provision	O
of	O
vaccines	O
for	O
these	O
diseases	O
was	O
investigated	O
,	O
but	O
the	O
percentage	O
of	O
vaccination	O
programme	O
was	O
very	O
low	O
for	O
example	O
only	O
19	O
(10)	O
of	O
these	O
labs	O
had	O
a	O
policy	O
for	O
vaccination	O
.	O

He	O
was	O
never	O
prosecuted	O
for	O
crimes	O
related	O
to	O
.	O

It	O
took	O
13	O
years	O
and	O
$500m	O
to	O
produce	O
the	O
full	O
DNA	O
sequence	O
of	O
the	O
human	O
genome	O
.	O

The	O
Edmonton	S-Location
plant	O
finished	O
its	O
first	O
new	O
batch	O
of	O
remdesivir	S-Drug
in	O
April	O
2020	O
.	O

When	O
the	O
official	O
memo	O
is	O
released	O
,	O
or	O
if	O
we	O
or	O
AAU	S-Organization
receive	O
any	O
additional	O
information	O
,	O
we	O
will	O
keep	O
the	O
membership	O
informed	O
.	O

The	O
disease	O
was	O
first	O
characterized	O
in	O
Crimea	S-Location
in	O
1944	O
and	O
given	O
the	O
name	O
Crimean	B-Disease
hemorrhagic	I-Disease
fever	E-Disease
.	O
It	O
was	O
then	O
later	O
recognized	O
in	O
1969	O
as	O
the	O
cause	O
of	O
illness	O
in	O
Congo	S-Location
,	O
thus	O
resulting	O
in	O
the	O
current	O
name	O
of	O
the	O
disease	O
.	O

Streamlined	O
,	O
centralized	O
,	O
and	O
educated	O
CDC	S-Organization
staff	O
on	O
laboratory	O
safety	O
event	O
reporting	O
for	O
improved	O
monitoring	O
of	O
events	O
and	O
patterns	O
of	O
events	O
.	O

Inactivation	O
,	O
for	O
example	O
,	O
is	O
a	O
critical	O
control	O
point	O
within	O
laboratory	O
safety	O
.	O

If	O
they	O
had	O
used	O
that	O
particular	O
procedure	O
for	O
this	O
type	O
of	O
specimen	O
,	O
then	O
it	O
would	O
not	O
have	O
happened	O
.	O

Over	O
the	O
course	O
of	O
the	O
study	O
,	O
the	O
group	O
explored	O
the	O
risks	O
and	O
benefits	O
of	O
the	O
emerging	O
technology	O
,	O
as	O
well	O
as	O
possible	O
safeguards	O
to	O
prevent	O
abuse	O
,	O
such	O
as	O
bioterrorism	O
.	O

Although	O
the	O
WHO	S-Organization
does	O
not	O
advise	O
caring	O
for	O
Ebola	S-Disease
patients	O
at	O
home	O
,	O
in	O
some	O
cases	O
it	O
became	O
a	O
necessity	O
when	O
no	O
hospital	O
treatment	O
beds	O
were	O
available	O
.	O

Generally	O
,	O
CDC	S-Organization
"	O
Offices"	O
are	O
subdivided	O
into	O
Centers	O
,	O
which	O
in	O
turn	O
are	O
composed	O
of	O
Divisions	O
and	O
Branches	O
.	O

Worst	O
affected	O
was	O
Western	B-Location
Samoa	E-Location
formerly	O
German	O
Samoa	S-Location
,	O
which	O
had	O
been	O
occupied	O
by	O
New	B-Location
Zealand	E-Location
in	O
1914.	O
90%	O
of	O
the	O
population	O
was	O
infected	O
;	O
30%	O
of	O
adult	O
men	O
,	O
22%	O
of	O
adult	O
women	O
,	O
and	O
10%	O
of	O
children	O
died	O
.	O

At	O
the	O
same	O
time	O
,	O
medical	O
school	O
debt	O
remains	O
one	O
of	O
the	O
most	O
consistent	O
barriers	O
to	O
choosing	O
EIS	S-Scientific_research_project
service	O
over	O
more	O
highly	O
paid	O
career	O
options	O
,	O
she	O
said	O
.	O

"	O
The	O
fact	O
that	O
it	O
is	O
published	O
along	O
with	O
a	O
Presidential	B-Document
Memorandum	E-Document
adds	O
power	O
to	O
it	O
all	O
,	O
including	O
the	O
direction	O
that	O
budgets	O
will	O
need	O
to	O
respond	O
to	O
this	O
strategy,	O
"	O
he	O
said	O
.	O

The	O
studies	O
of	O
chloroquine	S-Drug
and	O
hydroxychloroquine	S-Drug
with	O
or	O
without	O
have	O
major	O
limitations	O
that	O
have	O
prevented	O
the	O
medical	O
community	O
from	O
embracing	O
these	O
therapies	O
without	O
further	O
study	O
.	O

The	O
CDC	S-Organization
warned	O
that	O
the	O
indiscriminate	O
use	O
of	O
antiviral	O
medications	O
to	O
prevent	O
and	O
treat	O
could	O
ease	O
the	O
way	O
for	O
drug-resistant	O
strains	O
to	O
emerge	O
,	O
which	O
would	O
make	O
the	O
fight	O
against	O
the	O
pandemic	O
that	O
much	O
harder	O
.	O

This	O
superinfection	O
killed	O
most	O
of	O
the	O
victims	O
,	O
typically	O
after	O
a	O
somewhat	O
prolonged	O
death	O
bed	O
.	O

The	O
federal	B-Organization
government	E-Organization
does	O
set	O
some	O
standards	O
and	O
recommendations	O
for	O
States	O
to	O
meet	O
their	O
standards	O
,	O
most	O
of	O
which	O
fall	O
under	O
.	O
but	O
currently	O
,	O
there	O
is	O
no	O
single	O
federal	O
regulating	O
agency	O
directly	O
responsible	O
for	O
ensuring	O
the	O
safety	O
of	O
biohazardous	O
handling	O
,	O
storage	O
,	O
identification	O
,	O
clean-up	O
and	O
disposal	O
.	O

Grafton	O
Books	O
,	O
p.44	O
.	O

A	O
U.S.	S-Location
facility	O
at	O
Fort	B-Location
Terry	E-Location
focused	O
primarily	O
on	O
anti-animal	O
biological	O
agents	O
.	O

Susan	B-Person
Brooks	E-Person
(R-IN)	O
to	O
bolster	O
's	O
preparedness	O
and	O
response	O
to	O
public	O
health	O
emergencies	O
,	O
including	O
biological	O
threats	O
like	O
emerging	O
infectious	O
diseases	O
,	O
as	O
well	O
as	O
chemical	O
,	O
bio	O
or	O
nuclear	O
terrorist	O
attacks	O
.	O

Sergei	B-Person
Netyosov	E-Person
in	O
the	O
mid-1990s	O
,	O
according	O
to	O
Kenneth	B-Person
Alibek	E-Person
.	O
(aka	O
)	O
.	O

Following	O
an	O
admission	O
by	O
President	O
Boris	B-Person
Yeltsin	E-Person
that	O
"	O
our	O
military	O
development	O
was	O
the	O
cause,	O
"	O
Sverdlovsk	S-Location
's	O
Communist	B-Organization
Party	E-Organization
chief	O
in	O
1979	O
,	O
of	O
the	O
true	O
nature	O
of	O
the	O
anthrax	S-Pathogen
outbreak	O
,	O
Wall	B-Organization
Street	I-Organization
Journal	E-Organization
reporter	O
Peter	B-Person
Gumbel	E-Person
traveled	O
to	O
Sverdlovsk	S-Location
where	O
he	O
interviewed	O
families	O
affected	O
by	O
the	O
outbreak	O
,	O
hospital	O
workers	O
,	O
and	O
various	O
officials	O
,	O
confirming	O
Yeltsin	S-Person
's	O
comments	O
.	O

Many	O
large	O
theatres	O
such	O
as	O
those	O
on	O
Broadway	S-Organization
also	O
suspended	O
all	O
performances	O
.	O

A	O
biological	O
weapon	O
is	O
useful	O
to	O
terrorists	O
mainly	O
as	O
a	O
method	O
of	O
creating	O
mass	O
panic	O
and	O
disruption	O
to	O
a	O
state	O
or	O
a	O
country	O
.	O

All	O
died	O
painfully	O
from	O
internal	O
haemorrhaging	O
.	O

The	O
1979	O
Nobel	O
Prize	O
in	O
Physiology	O
or	O
Medicine	O
was	O
awarded	O
jointly	O
to	O
South	O
African	O
American	O
physicist	O
Allan	B-Person
M.	I-Person
Cormack	E-Person
and	O
British	O
electrical	O
engineer	O
Godfrey	B-Person
N.	I-Person
Hounsfield	E-Person
"	O
for	O
the	O
development	O
of	O
.	O
"	O

WHO	S-Organization
advises	O
against	O
the	O
application	O
of	O
any	O
travel	O
or	O
trade	O
restrictions	O
on	O
based	O
on	O
the	O
current	O
information	O
available	O
on	O
this	O
event	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
promotes	O
road	O
safety	O
as	O
a	O
means	O
to	O
reduce	O
traffic-related	O
injuries	O
.	O

"	O
The	O
New	O
Eternity	O
"	O
(2018)	O
,	O
from	O
the	O
Silent	O
Planet	O
album	O
When	O
the	O
End	O
Began	O
refers	O
to	O
Unit	B-Organization
731	E-Organization
human	O
experimentation	O
and	O
other	O
crimes	O
against	O
humanity	O
.	O

The	O
national	O
security	O
of	O
the	O
U.S.	S-Location
has	O
a	O
vested	O
interest	O
in	O
containing	O
the	O
virus	O
in	O
Africa	S-Location
,	O
but	O
the	O
U.S.	S-Location
lacks	O
a	O
coordinated	O
team	O
,	O
a	O
central	O
structure	O
to	O
meet	O
such	O
biodefense	O
goals	O
,	O
said	O
.	O

Sanders	S-Person
was	O
a	O
highly	O
regarded	O
microbiologist	O
and	O
a	O
member	O
of	O
America's	B-Organization
military	I-Organization
center	I-Organization
for	I-Organization
biological	I-Organization
weapons	E-Organization
.	O
Sanders	S-Person
'	O
duty	O
was	O
to	O
investigate	O
Japanese	O
biological	O
warfare	O
activity	O
.	O

Regardless	O
,	O
on	O
June	O
8	O
,	O
1943	O
President	O
Roosevelt	S-Person
affirmed	O
a	O
no-first-use	O
policy	O
for	O
the	O
United	B-Location
States	E-Location
concerning	O
biological	O
weapons	O
.	O

"	O
In	O
the	O
United	B-Location
States	E-Location
we	O
rely	O
on	O
a	O
trained	O
public	O
health	O
staff	O
,	O
a	O
national	O
laboratory	O
response	O
effort	O
,	O
on	O
emergency	O
operations	O
centers	O
to	O
detect	O
and	O
prevent	O
,	O
on	O
effective	O
disease	O
surveillance	O
programs	O
,	O
and	O
more	O
than	O
anything	O
we	O
rely	O
on	O
speed,	O
"	O
said	O
.	O

Biotechnology	O
is	O
a	O
broad	O
term	O
referring	O
to	O
the	O
study	O
of	O
biological	O
processes	O
to	O
inform	O
technological	O
advancement	O
.	O

One	O
such	O
carbapenemase	O
is	O
New	O
Delhi	O
metallo-beta-lactamase	O
1	O
(NDM-1)	O
,	O
an	O
enzyme	O
that	O
makes	O
bacteria	O
resistant	O
to	O
a	O
broad	O
range	O
of	O
beta-lactam	O
antibiotics	O
.	O

Skilled	O
lab	O
scientists	O
in	O
the	O
response	O
are	O
valued	O
contributors	O
to	O
ending	O
this	O
epidemic	O
.	O

Adding	O
to	O
concerns	O
,	O
DIY	O
scientists	O
are	O
increasingly	O
taking	O
biotech	O
tools	O
outside	O
of	O
the	O
lab	O
.	O

Magnetic	B-Technology
resonance	I-Technology
venography	E-Technology
()	O
is	O
a	O
similar	O
procedure	O
that	O
is	O
used	O
to	O
image	O
veins	O
.	O

Gooya	S-Person
the	O
infection	O
of	O
1	O
out	O
of	O
the	O
3	O
suspected	O
patients	O
was	O
confirmed	O
and	O
more	O
tests	O
were	O
under	O
way	O
to	O
determine	O
the	O
situation	O
of	O
the	O
other	O
two	O
patients	O
.	O

Generally	O
,	O
a	O
viral	O
gene	O
subjected	O
to	O
immunologic	O
drift	O
pressure	O
or	O
adapting	O
to	O
a	O
new	O
host	O
exhibits	O
a	O
greater	O
percentage	O
of	O
nonsynonymous	O
mutations	O
,	O
while	O
a	O
virus	O
under	O
little	O
selective	O
pressure	O
accumulates	O
mainly	O
synonymous	O
changes	O
.	O

Given	O
substantial	O
vaccination	O
coverage	O
gaps	O
across	O
the	O
country	O
,	O
the	O
risk	O
of	O
further	O
spread	O
of	O
polio	S-Disease
within	O
the	O
country	O
continues	O
to	O
be	O
classified	O
as	O
high	O
,	O
particularly	O
with	O
confirmation	O
of	O
spread	O
of	O
the	O
virus	O
to	O
.	O

Littlewood	S-Person
,	O
.	O
The	O
Biological	O
Weapons	O
Convention:	O
A	O
Failed	O
Revolution	O
,	O
(Google	O
Books)	O
,	O
Ashgate	O
Publishing	O
,	O
Ltd.	O
,	O
2005	O
,	O
p.	O
9	O
,	O
()	O
.	O

On	O
the	O
phone?	O

Side	O
effects	O
may	O
include	O
liver	O
inflammation	O
and	O
an	O
infusion-related	O
reaction	O
with	O
nausea	S-Phenotype
low	B-Phenotype
blood	I-Phenotype
pressure	E-Phenotype
,	O
and	O
sweating	S-Phenotype
.	O
It	O
is	O
a	O
pro-drug	O
that	O
is	O
converted	O
in	O
the	O
body	O
into	O
,	O
a	O
ribonucleotide	O
analog	O
.	O

These	O
findings	O
are	O
unexpected	O
because	O
the	O
viruses	O
with	O
the	O
1918	O
genes	O
had	O
not	O
been	O
adapted	O
to	O
mice	O
;	O
control	O
experiments	O
in	O
which	O
mice	O
were	O
infected	O
with	O
modern	O
human	O
viruses	O
showed	O
little	O
disease	O
and	O
limited	O
viral	O
replication	O
.	O

The	O
cause	O
of	O
the	O
outbreak	O
was	O
denied	O
for	O
years	O
by	O
the	O
Soviet	O
authorities	O
,	O
which	O
blamed	O
the	O
deaths	O
on	O
consumption	O
of	O
tainted	O
meat	O
from	O
the	O
area	O
,	O
and	O
subcutaneous	O
exposure	O
due	O
to	O
butchers	O
handling	O
the	O
tainted	O
meat	O
.	O

NOTE:	O
The	O
following	O
information	O
has	O
been	O
adapted	O
from	O
Biosafety	B-Document
in	I-Document
Microbiological	I-Document
and	I-Document
Biomedical	I-Document
Laboratories,	I-Document
5th	I-Document
Ed.	I-Document
(BMBL,	I-Document
5th	I-Document
Ed.	I-Document
)	E-Document
which	O
is	O
published	O
jointly	O
by	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
and	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
()	O
,	O
and	O
is	O
available	O
online	O
at	O
(see	O
Internet	O
Resources)	O
.	O

By	O
November	O
2014	O
,	O
the	O
rate	O
of	O
new	O
infections	O
in	O
Liberia	S-Location
appeared	O
to	O
be	O
declining	O
and	O
the	O
state	O
of	O
emergency	O
was	O
lifted	O
.	O

It	O
was	O
introduced	O
into	O
Norway	S-Location
in	O
1349	O
when	O
a	O
ship	O
landed	O
at	O
Askøy	S-Location
,	O
then	O
spread	O
to	O
Bjørgvin	S-Location
(modern	O
Bergen	S-Location
)	O
and	O
Iceland	S-Location
.	O
Finally	O
,	O
it	O
spread	O
to	O
northwestern	O
Russia	S-Location
in	O
1351	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

According	O
to	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
there	O
are	O
no	O
available	O
vaccines	O
nor	O
specific	O
antiviral	O
treatments	O
for	O
.	O

Proactive	O
vaccination	O
has	O
also	O
been	O
carried	O
out	O
in	O
,	O
with	O
1,471	O
health	O
workers	O
vaccinated	O
by	O
7	O
May	O
2019	O
.	O

This	O
list	O
of	O
national	O
public	O
health	O
agencies	O
includes	O
national	O
level	O
organizations	O
responsible	O
for	O
public	O
health	O
,	O
infectious	O
disease	O
control	O
,	O
and	O
epidemiology	O
.	O

The	O
agreement	O
specifically	O
points	O
to	O
chikungunya	S-Disease
Ebola	S-Disease
,	O
Zika	S-Disease
,	O
and	O
the	O
virus	O
as	O
examples	O
of	O
what	O
they	O
are	O
fighting	O
.	O

In	O
2005	O
,	O
the	O
Iraq	B-Organization
Survey	I-Organization
Group	E-Organization
-	O
an	O
international	O
group	O
composed	O
of	O
civilian	O
and	O
military	O
experts	O
-	O
concluded	O
that	O
the	O
Iraqi	B-Scientific_research_project
military	I-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
had	O
been	O
abandoned	O
during	O
1995	O
and	O
1996	O
because	O
of	O
fear	O
that	O
discovery	O
of	O
continued	O
activity	O
would	O
result	O
in	O
severe	O
political	O
repercussions	O
including	O
the	O
extension	O
of	O
UN	S-Organization
sanctions	O
.	O

These	O
countries	O
hosted	O
biosafety	O
programs	O
,	O
reflecting	O
the	O
heightened	O
concern	O
in	O
the	O
region	O
.	O

Anne	B-Person
Schuchat	E-Person
,	O
the	O
CDC	S-Organization
's	O
principal	O
deputy	O
director	O
,	O
said	O
in	O
prepared	O
testimony	O
for	O
Friday's	O
,	O
where	O
policymakers	O
sought	O
to	O
renew	O
funding	O
for	O
biopreparedness	O
legislation	O
.	O

This	O
occurred	O
shortly	O
after	O
the	O
Surgeon	O
General	O
of	O
the	O
U.S.	B-Organization
Army	E-Organization
and	O
the	O
Journal	O
of	O
the	O
American	O
Medical	O
Association	O
both	O
recommended	O
very	O
large	O
doses	O
of	O
8	O
to	O
31 grams	O
of	O
aspirin	O
per	O
day	O
as	O
part	O
of	O
treatment	O
.	O

Some	O
people	O
mistakenly	O
believe	O
that	O
taking	O
any	O
kind	O
of	O
antibiotics	O
acts	O
as	O
a	O
sort	O
of	O
panacea	O
,	O
and	O
they	O
use	O
these	O
drugs	O
to	O
treat	O
illnesses	O
such	O
as	O
influenza	S-Disease
However	O
,	O
antibiotics	O
can	O
only	O
target	O
and	O
kill	O
bacteria	O
and	O
thus	O
only	O
treat	O
bacterial	O
infections	O
.	O

In	O
March	O
,	O
and	O
again	O
in	O
April	O
,	O
there	O
were	O
reports	O
that	O
Iran	S-Location
was	O
under-reporting	O
cases	O
and	O
deaths	O
.	O

Laboratory	O
wastewater	O
on	O
Fort	B-Location
Detrick	E-Location
is	O
chemically	O
disinfected	O
at	O
the	O
source	O
,	O
then	O
routed	O
to	O
the	O
,	O
where	O
it	O
is	O
held	O
in	O
these	O
storage	O
tanks	O
prior	O
to	O
entering	O
the	O
steam	O
sterilization	O
process	O
.	O

This	O
initiative	O
is	O
organized	O
by	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
(	O
FAO	S-Organization
)	O
through	O
its	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)	O
Program	O
with	O
funding	O
from	O
United	B-Organization
States	I-Organization
Agency	I-Organization
for	I-Organization
International	I-Organization
Development	E-Organization
(	O
USAID	S-Organization
)	O
in	O
partnership	O
with	O
the	O
and	O
other	O
stakeholders	O
.	O

Some	O
have	O
suggested	O
that	O
the	O
epidemic	O
originated	O
in	O
the	O
United	B-Location
States	E-Location
Historian	O
Alfred	B-Person
W.	I-Person
Crosby	E-Person
stated	O
in	O
2003	O
that	O
the	O
flu	S-Disease
originated	O
in	O
Kansas	S-Location
,	O
and	O
popular	O
author	O
John	B-Person
M.	I-Person
Barry	E-Person
described	O
a	O
January	O
1918	O
outbreak	O
in	O
Haskell	B-Location
County	E-Location
,	O
,	O
as	O
the	O
point	O
of	O
origin	O
in	O
his	O
2004	O
article	O
.	O

Greece	S-Location
France	S-Location
and	O
have	O
high	O
prescribing	O
rates	O
of	O
more	O
than	O
28	O
DDD	O
.	O

Annotations	O
ensure	O
compliance	O
of	O
data	O
descriptions	O
to	O
ontologies	O
.	O

Training	O
and	O
accreditation	O
programs	O
could	O
increase	O
awareness	O
and	O
stimulate	O
better	O
communication	O
between	O
the	O
scientific	O
and	O
national	O
security	O
communities	O
.	O

Brooks	S-Person
said	O
following	O
the	O
Sept.	O
25	O
voice	O
vote	O
approving	O
the	O
bill	O
.	O

Instead	O
,	O
the	O
government	O
is	O
seeking	O
voluntary	O
compliance	O
in	O
a	O
timely	O
manner	O
consistent	O
with	O
the	O
proper	O
management	O
of	O
pathogens	O
.	O

The	O
laboratory	O
course	O
in	O
virology	O
allows	O
a	O
relatively	O
large	O
group	O
of	O
students	O
to	O
conduct	O
experiments	O
using	O
a	O
variety	O
of	O
methods	O
in	O
virology	O
including	O
infection	O
and	O
counting	O
methods	O
and	O
molecular	O
biology	O
techniques	O
.	O

The	O
virus	O
uses	O
a	O
special	O
surface	O
glycoprotein	O
called	O
a	O
"	O
spike"	O
(peplomer)	O
to	O
connect	O
to	O
ACE2	O
and	O
enter	O
the	O
host	O
cell	O
.	O

Of	O
the	O
55,225	O
total	O
people	O
surveyed	O
,	O
70%	O
had	O
heard	O
of	O
antibiotic	O
resistance	O
previously	O
,	O
but	O
88%	O
of	O
those	O
people	O
thought	O
it	O
referred	O
to	O
some	O
type	O
of	O
physical	O
change	O
in	O
the	O
body	O
.	O

The	O
existing	O
facility	O
contains	O
a	O
number	O
of	O
BSL4	S-Platform
labs	O
and	O
labs	O
that	O
are	O
one	O
step	O
down	O
the	O
biosafety	O
and	O
biosecurity	O
ladder	O
,	O
BSL	B-Platform
3	E-Platform
enhanced	O
.	O

Cong	O
.	O

An	O
observational	O
study	O
,	O
done	O
roughly	O
29	O
months	O
after	O
the	O
2007	O
Bundibugyo	B-Incident
outbreak	E-Incident
in	O
Uganda	S-Location
,	O
found	O
that	O
long-term	O
sequelae	O
(i.e.	O
consequences)	O
persisted	O
among	O
survivors	O
.	O

Isolates	O
were	O
obtained	O
from	O
5	O
dogs	O
and	O
1	O
cat	O
;	O
all	O
were	O
from	O
respiratory	O
tract	O
specimens	O
,	O
except	O
for	O
2	O
isolates	O
from	O
the	O
urine	O
of	O
1	O
dog	O
.	O

Treatment	O
is	O
given	O
by	O
injection	O
into	O
a	O
vein	O
.	O

Masks	S-Equipment
were	O
not	O
generally	O
provided	O
by	O
airlines	O
and	O
the	O
CDC	S-Organization
did	O
not	O
recommend	O
that	O
airline	O
crews	O
wear	O
them	O
.	O

Structural	O
factors	O
that	O
prevent	O
African	O
Americans	O
from	O
practicing	O
social	O
distancing	O
include	O
their	O
concentration	O
in	O
crowded	O
substandard	O
housing	O
and	O
in	O
"	O
essential"	O
occupations	O
such	O
as	O
public	O
transit	O
and	O
health	O
care	O
.	O

There's	O
just	O
one	O
problem	O
-	O
President	O
's	O
trade	O
war	O
.	O

Twice	O
a	O
week	O
,	O
you'll	O
get	O
a	O
roundup	O
of	O
ideas	O
and	O
solutions	O
for	O
tackling	O
our	O
biggest	O
challenges:	O
improving	O
public	O
health	O
,	O
decreasing	O
human	O
and	O
animal	O
suffering	O
,	O
easing	O
catastrophic	O
risks	O
,	O
and	O
-	O
to	O
put	O
it	O
simply	O
-	O
getting	O
better	O
at	O
doing	O
good	O
.	O

Blood	O
tests	O
can	O
tell	O
you	O
if	O
a	O
new	O
food	O
you're	O
eating	O
is	O
affecting	O
your	O
vitamin	O
levels	O
or	O
helping	O
you	O
to	O
achieve	O
a	O
specific	O
biological	O
process	O
.	O

The	O
threat	O
of	O
biological	O
agents	O
not	O
only	O
includes	O
naturally	O
occurring	O
and	O
emerging	O
infectious	O
diseases	O
[9]	O
,	O
but	O
also	O
biological	O
weapons	O
and	O
bioterrorism	O
[10]	O
.	O

Pharmaceutical	O
companies	O
should	O
provide	O
their	O
stocks	O
for	O
this	O
purpose	O
(retaining	O
rights	O
to	O
other	O
applications)	O
.	O

Great	O
care	O
was	O
taken	O
to	O
develop	O
a	O
sampling	O
process	O
that	O
would	O
protect	O
the	O
confidentiality	O
of	O
survey	O
participants	O
and	O
their	O
responses	O
.	O

This	O
outbreak	O
started	O
just	O
days	O
after	O
the	O
end	O
of	O
the	O
outbreak	O
in	O
.	O

Those	O
same	O
skills	O
are	O
helping	O
us	O
to	O
reduce	O
the	O
likelihood	O
that	O
aspiring	O
bioterrorists	O
get	O
their	O
hands	O
on	O
samples	O
.	O

We	O
continue	O
our	O
push	O
for	O
universal	O
adherence	O
to	O
the	O
,	O
in	O
order	O
to	O
globalize	O
its	O
ban	O
on	O
these	O
weapons	O
.	O

Chinese	O
people	O
and	O
other	O
Asians	O
in	O
the	O
United	B-Location
Kingdom	E-Location
and	O
United	B-Location
States	E-Location
have	O
reported	O
increasing	O
levels	O
of	O
racist	O
abuse	O
and	O
assaults	O
.	O

The	O
CDC	S-Organization
is	O
asking	O
Congress	S-Organization
for	O
$350	O
million	O
for	O
the	O
lab	O
and	O
more	O
than	O
$50	O
million	O
for	O
related	O
work	O
.	O

Brooks	S-Person
office	O
.	O

As	O
tensions	O
increased	O
,	O
Sir	O
Frederick	B-Person
Banting	E-Person
began	O
lobbying	O
the	O
British	O
government	O
to	O
establish	O
a	O
research	O
program	O
into	O
the	O
research	O
and	O
development	O
of	O
biological	O
weapons	O
to	O
effectively	O
deter	O
the	O
Germans	O
from	O
launching	O
a	O
biological	O
attack.	O
proposed	O
a	O
number	O
of	O
innovative	O
schemes	O
for	O
the	O
dissemination	O
of	O
pathogens	O
,	O
including	O
aerial-spray	O
attacks	O
and	O
germs	O
distributed	O
through	O
the	O
mail	O
system	O
.	O

Anna	B-Person
Eshoo	E-Person
(D-CA)	O
entitled	O
the	O
.	O

The	O
trial	O
attack	O
was	O
successful	O
;	O
it	O
triggered	O
more	O
than	O
750	O
cases	O
of	O
food	B-Disease
poisoning	E-Disease
45	O
of	O
which	O
required	O
hospitalization	O
.	O

NTI	S-Organization
works	O
to	O
prevent	O
catastrophic	O
attacks	O
with	O
weapons	O
of	O
mass	O
destruction	O
and	O
disruption	O
(WMDD)	O
,	O
including	O
nuclear	O
,	O
biological	O
,	O
radiological	O
,	O
chemical	O
,	O
and	O
cyber	O
.	O

Marcel	B-Person
Kuntz	E-Person
,	O
a	O
French	O
director	O
of	O
research	O
at	O
the 	O
,	O
criticized	O
the	O
agency	O
for	O
its	O
classification	O
of	O
potentially	O
carcinogenic	O
substances	O
.	O

Since	O
the	O
discovery	O
of	O
the	O
viruses	O
in	O
1976	O
,	O
when	O
outbreaks	O
occurred	O
in	O
South	B-Location
Sudan	E-Location
(then	O
Sudan	S-Location
)	O
and	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
(then	O
Zaire	S-Location
)	O
,	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
had	O
been	O
confined	O
to	O
areas	O
in	O
Middle	B-Location
Africa	E-Location
,	O
where	O
it	O
is	O
native	O
.	O

Samples	O
were	O
incubated	O
at	O
room	O
temperature	O
for	O
10	O
min	O
and	O
mixed	O
with	O
LB	O
soft	O
agar	O
(0.	O
6%	O
,	O
Novamed	O
corp.	O
)	O
at	O
56°C	O
,	O
and	O
plated	O
on	O
LB	O
plates	O
(Novamed	O
corp)	O
,	O
for	O
overnight	O
incubation	O
at	O
37°C	O
.	O

Experts	O
discussed	O
advancements	O
in	O
genome	B-Technology
editing	E-Technology
and	O
biotechnology	O
,	O
along	O
with	O
their	O
implications	O
on	O
society	O
and	O
healthcare	O
in	O
a	O
series	O
of	O
sessions	O
themed	O
The	O
Future	O
of	O
Health	O
on	O
day	O
one	O
of	O
the	O
sixth	B-Activity
World	I-Activity
Government	I-Activity
Summit	E-Activity
(	O
WGS	B-Activity
2018	E-Activity
)	O
in	O
.	O

Medical	O
,	O
industrial	O
,	O
and	O
basic	O
research	O
relies	O
heavily	O
on	O
the	O
use	O
of	O
viruses	O
and	O
vectors	O
.	O

Within	O
the	O
division	O
are	O
two	O
programs:	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
(	O
FSAP	S-Document
)	O
and	O
the	O
Import	B-Document
Permit	I-Document
Program	E-Document
.	O
The	O
FSAP	S-Document
is	O
run	O
jointly	O
with	O
an	O
office	O
within	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
,	O
regulating	O
agents	O
that	O
can	O
cause	O
disease	O
in	O
humans	O
,	O
animals	O
,	O
and	O
plants.	O
regulates	O
the	O
importation	O
of	O
"	O
infectious	O
biological	O
materials.	O
"	O

Until	O
the	O
outbreak	O
in	O
North	B-Location
Kivu	E-Location
in	O
2018	O
,	O
no	O
outbreak	O
had	O
surpassed	O
320	O
total	O
cases	O
in	O
the	O
.	O
By	O
24	O
February	O
2019	O
,	O
the	O
outbreak	O
had	O
surpassed	O
1,000	O
total	O
cases	O
(1,048)	O
,	O
and	O
by	O
the	O
same	O
time	O
in	O
2020	O
it	O
had	O
surpassed	O
3,000	O
.	O

This	O
is	O
often	O
carried	O
out	O
by	O
granting	O
temporary	O
project	O
funding	O
to	O
stakeholders	O
who	O
are	O
involved	O
in	O
handling	O
crises	O
at	O
the	O
national	O
and	O
local	O
or	O
regional	O
levels	O
.	O

At	O
present	O
,	O
ICTV	S-Organization
does	O
not	O
officially	O
recognize	O
"	O
Ebola	B-Pathogen
virus	E-Pathogen
"	O
as	O
a	O
taxonomic	O
rank	O
,	O
but	O
rather	O
continues	O
to	O
use	O
and	O
recommend	O
only	O
the	O
species	O
designation	O
.	O

Reilly	S-Person
said	O
the	O
college	O
hopes	O
to	O
ramp	O
up	O
its	O
emergency	O
response	O
programming	O
by	O
August	O
.	O

In	O
,	O
it	O
is	O
consent	O
'that	O
all	O
funded	O
research	O
be	O
made	O
openly	O
available	O
for	O
future	O
use	O
and	O
ensure	O
this	O
is	O
a	O
condition	O
attached	O
to	O
future	O
funding	O
decisions'	O
at	O
the	O
latest	O
2016	O
.	O

Hydrogen	O
atoms	O
are	O
naturally	O
abundant	O
in	O
humans	O
and	O
other	O
biological	O
organisms	O
,	O
particularly	O
in	O
water	O
and	O
fat	O
.	O

Their	O
first	O
report	O
which	O
was	O
published	O
in	O
the	O
New	O
England	O
Journal	O
of	O
Medicine	O
in	O
1993	O
,	O
entitled	O
"	O
Gun	B-Document
Ownership	I-Document
as	I-Document
a	I-Document
Risk	I-Document
Factor	I-Document
for	I-Document
Homicide	I-Document
in	I-Document
the	I-Document
Home	E-Document
"	O
reported	O
that	O
the	O
"	O
mere	O
presence	O
of	O
a	O
gun	O
in	O
a	O
home	O
increased	O
the	O
risk	O
of	O
a	O
firearm-related	O
death	O
by	O
2.7	O
percent	O
,	O
and	O
suicide	O
fivefold-a	O
"	O
huge"	O
increase.	O
"	O
In	O
response	O
,	O
the	O
NRA	S-Organization
launched	O
a	O
"	O
campaign	B-Activity
to	I-Activity
shut	I-Activity
down	I-Activity
the	I-Activity
Injury	I-Activity
Center	E-Activity
.	O
"	O
Doctors	O
for	O
Responsible	B-Organization
Gun	I-Organization
Ownership	I-Organization
and	I-Organization
Doctors	E-Organization
for	O
joined	O
the	O
pro-gun	O
effort	O
and	O
by	O
1995	O
,	O
politicians	O
also	O
supported	O
the	O
pro-gun	O
initiative	O
.	O

Spread	O
of	O
the	O
H1N1	B-Pathogen
virus	E-Pathogen
is	O
thought	O
to	O
occur	O
in	O
the	O
same	O
way	O
that	O
seasonal	B-Disease
flu	E-Disease
spreads	O
.	O

The	O
outcome	O
of	O
the	O
infection	O
is	O
dependent	O
on	O
the	O
properties	O
of	O
the	O
pathogen	O
(virulence	O
,	O
invasiveness	O
,	O
toxic	O
or	O
allergenic	S-Disease
effects)	O
but	O
also	O
upon	O
the	O
host	O
immunity	O
status	O
.	O

Estimates	O
of	O
the	O
mortality	O
from	O
the	O
condition	O
vary	O
because	O
of	O
those	O
regional	O
differences	O
,	O
but	O
also	O
because	O
of	O
methodological	O
difficulties	O
.	O

This	O
interview	O
was	O
conducted	O
by	O
Zipporah	B-Person
Nyambura	E-Person
It	O
has	O
been	O
edited	O
for	O
clarity	O
.	O

Preceding	O
its	O
founding	O
,	O
organizations	O
with	O
global	O
influence	O
in	O
malaria	O
control	O
were	O
the	O
Malaria	B-Organization
Commission	I-Organization
of	I-Organization
the	I-Organization
League	I-Organization
of	I-Organization
Nations	E-Organization
and	O
the	O
.	O

External	O
test	O
panels	O
for	O
such	O
pathogens	O
are	O
generally	O
not	O
commercially	O
available	O
,	O
but	O
capability	O
testing	O
has	O
been	O
made	O
possible	O
in	O
the	O
FBD	S-Platform
network	O
projects	O
through	O
in-house	O
ring	O
trials	O
that	O
are	O
performed	O
annually	O
in	O
the	O
network	O
.	O

We	O
do	O
not	O
yet	O
know	O
whether	O
the	O
final	O
toll	O
will	O
be	O
measured	O
in	O
thousands	O
or	O
hundreds	O
of	O
thousands	O
.	O

Over	O
a	O
year	O
later	O
,	O
in	O
October	O
1979	O
,	O
the	O
university	O
authorities	O
fumigated	O
the	O
Medical	B-Organization
School	I-Organization
East	I-Organization
Wing	E-Organization
.	O
The	O
ward	O
at	O
Catherine-de-Barnes	B-Location
Hospital	E-Location
in	O
which	O
had	O
died	O
was	O
still	O
sealed	O
off	O
five	O
years	O
after	O
her	O
death	O
,	O
all	O
the	O
furniture	O
and	O
equipment	O
inside	O
left	O
untouched	O
.	O

The	O
US	B-Organization
National	I-Organization
Cancer	I-Organization
Institute	E-Organization
has	O
been	O
collecting	O
biological	O
material	O
from	O
patients	O
of	O
the	O
Chinese	B-Organization
Cancer	I-Organization
Hospital	E-Organization
in	O
.	O

Each	O
virion	O
contains	O
one	O
molecule	O
of	O
linear	O
,	O
single-stranded	O
,	O
negative-sense	O
RNA	O
,	O
18,959	O
to	O
18,961	O
nucleotides	O
in	O
length	O
.	O

The	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
(	O
DHS	S-Organization
)	O
is	O
seeking	O
laboratory	O
staffing	O
support	O
services	O
for	O
its	O
BioWatch	B-Platform
Laboratory	I-Platform
Response	I-Platform
Network	E-Platform
(	O
LRN	S-Platform
)	O
laboratories	O
throughout	O
.	O

The	O
technology	O
to	O
do	O
this	O
quickly	O
has	O
been	O
around	O
since	O
1985	O
,	O
when	O
chemist	O
Kary	B-Person
Mullis	E-Person
developed	O
a	O
procedure	O
called	O
the	O
polymerase	B-Technology
chain	I-Technology
reaction	E-Technology
(	O
PCR	S-Technology
).	O
is	O
essentially	O
a	O
cycle	O
of	O
heating	O
and	O
cooling	O
that	O
forces	O
certain	O
proteins	O
to	O
copy	O
DNA	O
.	O

Questions	O
were	O
raised	O
about	O
detrimental	O
health	O
effects	O
after	O
experiments	O
in	O
San	B-Location
Francisco	E-Location
California	S-Location
,	O
were	O
followed	O
by	O
a	O
spike	O
in	O
hospital	O
visits	O
;	O
however	O
,	O
in	O
1977	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
determined	O
that	O
there	O
was	O
no	O
association	O
between	O
the	O
testing	O
and	O
the	O
occurrence	O
of	O
pneumonia	S-Disease
or	O
influenza	S-Disease
.	O
The	O
San	B-Location
Francisco	E-Location
test	O
involved	O
a	O
U.S.	B-Organization
Navy	E-Organization
ship	O
that	O
sprayed	O
Serratia	B-Pathogen
marcescens	E-Pathogen
from	O
the	O
bay	O
;	O
it	O
traveled	O
more	O
than	O
30	O
miles	O
.	O

In	O
spring	O
1920	O
a	O
very	O
minor	O
fourth	O
wave	O
occurred	O
in	O
isolated	O
areas	O
including	O
New	B-Location
York	I-Location
City	E-Location
the	O
United	B-Location
Kingdom	E-Location
,	O
Austria	S-Location
,	O
Scandinavia	S-Location
,	O
and	O
some	O
.	O
Mortality	O
rates	O
were	O
very	O
low	O
.	O

In	O
early	O
July	O
2016	O
,	O
a	O
trial	O
for	O
males	O
with	O
detectable	O
RNA	O
in	O
semen	O
,	O
started	O
.	O

The	O
Hong	B-Organization
Kong	I-Organization
Hospital	I-Organization
Authority	E-Organization
found	O
a	O
drop	O
of	O
20%	O
to	O
30%	O
in	O
lung	O
capacity	O
in	O
some	O
people	O
who	O
recovered	O
from	O
the	O
disease	O
,	O
and	O
lung	O
scans	O
suggested	O
.	O
This	O
may	O
also	O
lead	O
to	O
post-intensive	O
care	O
syndrome	O
following	O
recovery	O
.	O

For	O
the	O
rest	O
of	O
the	O
population	O
,	O
the	O
second	O
wave	O
was	O
far	O
more	O
deadly	O
;	O
the	O
most	O
vulnerable	O
people	O
were	O
those	O
like	O
the	O
soldiers	O
in	O
the	O
trenches	O
–	O
adults	O
who	O
were	O
young	O
and	O
fit	O
.	O

Types	O
of	O
cells	O
that	O
are	O
more	O
difficult	O
to	O
transfect	O
(e.g.	O
stem	O
cells	O
,	O
neurons	O
,	O
and	O
hematopoietic	O
cells)	O
require	O
more	O
efficient	O
delivery	O
systems	O
,	O
such	O
as	O
those	O
based	O
on	O
lentivirus	O
(LVs)	O
,	O
adenovirus	O
(AdV)	O
,	O
and	O
adeno-associated	O
virus	O
(AAV)	O
.	O

Subsequent	O
flare-ups	O
occurred	O
;	O
the	O
last	O
was	O
declared	O
over	O
on	O
9	O
June	O
2016	O
,	O
42	O
days	O
after	O
the	O
last	O
case	O
tested	O
negative	O
on	O
28	O
April	O
2016	O
in	O
.	O

SARS‑CoV‑2	S-Pathogen
is	O
closely	O
related	O
to	O
SARS‑CoV	S-Pathogen
,	O
and	O
is	O
thought	O
to	O
have	O
a	O
zoonotic	O
origin.	O
genetically	O
clusters	O
with	O
the	O
genus	O
Betacoronavirus	O
,	O
and	O
is	O
96	O
percent	O
identical	O
at	O
the	O
whole	O
genome	O
level	O
to	O
other	O
bat	O
coronavirus	O
samples	O
and	O
92	O
percent	O
identical	O
to	O
pangolin	O
coronavirus	O
.	O

In	O
August	O
2002	O
,	O
the	O
Tokyo	S-Location
district	O
court	O
ruled	O
for	O
the	O
first	O
time	O
that	O
Japan	S-Location
had	O
engaged	O
in	O
biological	O
warfare	O
.	O

If	O
officials	O
decide	O
to	O
produce	O
a	O
vaccine	O
,	O
the	O
first	O
doses	O
would	O
be	O
ready	O
early	O
in	O
the	O
fall	O
.	O

Biological	O
agents	O
can	O
be	O
spread	O
through	O
the	O
air	O
,	O
water	O
,	O
or	O
in	O
food	O
.	O

The	O
implementation	O
of	O
these	O
guidelines	O
and	O
technologies	O
will	O
promote	O
state-of-the-art	O
research	O
while	O
minimizing	O
risk	O
to	O
laboratory	O
animals	O
,	O
researchers	O
,	O
and	O
the	O
environment	O
.	O

"	O
A	O
joint	O
Health	B-Organization
Department	E-Organization
and	O
WHO	S-Organization
team	O
is	O
currently	O
in	O
the	O
field	O
to	O
conduct	O
an	O
epidemiological	O
investigation	O
.	O

Next	O
question	O
comes	O
from	O
Lisa	B-Person
Schnirring	E-Person
from	O
.	O
Go	O
ahead	O
with	O
your	O
question	O
.	O

The	O
memo	O
is	O
a	O
response	O
to	O
"	O
three	O
recent	O
U.S.	S-Location
biosafety	O
and	O
biosecurity	O
incidents	O
"	O
that	O
have	O
been	O
widely	O
publicized:	O
the	O
mistaken	O
shipment	O
of	O
live	O
anthrax	S-Disease
samples	O
by	O
a	O
biodefense	O
lab	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
in	O
Atlanta	S-Location
;	O
the	O
discovery	O
of	O
60-year-old	O
vials	O
of	O
smallpox	S-Disease
on	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
campus	O
in	O
suburban	O
Maryland	S-Location
;	O
and	O
the	O
accidental	O
contamination	O
at	O
CDC	S-Organization
of	O
benign	O
poultry	O
flu	O
samples	O
with	O
the	O
deadly	O
H5N1	B-Disease
bird	I-Disease
flu	E-Disease
.	O
CDC	S-Organization
has	O
already	O
announced	O
sweeping	O
changes	O
to	O
improve	O
safety	O
,	O
and	O
the	O
OSTP	B-Document
memo	E-Document
aims	O
to	O
"	O
maximize	O
the	O
positive	O
effect	O
of	O
lessons	O
learned	O
"	O
across	O
the	O
.	O

As	O
a	O
result	O
,	O
foreign	O
technology	O
owners	O
that	O
provide	O
highly	O
demanded	O
technologies	O
like	O
Bt	O
cotton	O
declined	O
to	O
work	O
with	O
Ethiopia	S-Location
There	O
is	O
a	O
fear	O
that	O
the	O
emerged	O
biosafety	O
system	O
might	O
also	O
continue	O
to	O
suppress	O
domestic	O
genetic	O
engineering	O
research	O
and	O
development	O
.	O

Standards	O
precautions	O
such	O
as	O
gloves	O
wearing	O
,	O
hands	O
washing	O
,	O
safety	O
glasses	O
and	O
face	O
shield	O
is	O
highly	O
recommend	O
in	O
diagnostic	O
laboratories	O
.	O

Export	O
controls	O
on	O
biological	O
agents	O
are	O
not	O
applied	O
uniformly	O
providing	O
terrorists	O
a	O
route	O
for	O
acquisition	O
.	O

DARPA	S-Organization
new	O
program	O
aims	O
to	O
develop	O
a	O
platform	O
technology	O
that	O
rapidly	O
screens	O
unfamiliar	O
bacteria	O
to	O
establish	O
their	O
pathogenicity	O
and	O
even	O
discover	O
unknown	O
pathogenic	O
traits	O
,	O
necessary	O
first	O
steps	O
for	O
designing	O
effective	O
biosurveillance	O
and	O
countermeasures	O
.	O

The	O
White	B-Organization
House	E-Organization
refused	O
to	O
use	O
the	O
report.	O
said	O
he	O
felt	O
the	O
guidelines	O
were	O
too	O
restrictive	O
,	O
commenting	O
"	O
I	O
see	O
the	O
new	O
normal	O
being	O
what	O
it	O
was	O
three	O
months	O
ago	O
.	O

With	O
the	O
stated	O
figures	O
given	O
,	O
she	O
noted	O
that	O
rabies	S-Disease
is	O
a	O
100%	O
preventable	O
disease	O
.	O

However	O
,	O
a	O
first	O
wave	O
of	O
influenza	O
appeared	O
early	O
in	O
the	O
spring	O
of	O
1918	O
in	O
Kansas	S-Location
and	O
in	O
military	O
camps	O
throughout	O
the	O
US	S-Location
.	O
Few	O
noticed	O
the	O
epidemic	O
in	O
the	O
midst	O
of	O
the	O
war.	O
had	O
just	O
given	O
his	O
14	O
point	O
address	O
.	O

In	O
fact	O
,	O
he	O
says	O
the	O
first	O
person	O
who	O
will	O
live	O
to	O
1,000	O
has	O
already	O
been	O
born	O
.	O

Members	O
of	O
the	O
Blue	B-Organization
Ribbon	I-Organization
Study	I-Organization
Panel	I-Organization
on	I-Organization
Biodefense	E-Organization
agreed	O
with	O
that	O
assessment	O
.	O

,	O
the	O
WHO	S-Organization
has	O
194	O
member	O
states:	O
all	O
of	O
the	O
member	O
states	O
of	O
the	O
United	B-Organization
Nations	E-Organization
except	O
for	O
Liechtenstein	S-Organization
,	O
plus	O
the	O
Cook	B-Organization
Islands	E-Organization
and	O
Niue	S-Organization
.	O
(A	O
state	O
becomes	O
a	O
full	O
member	O
of	O
WHO	S-Organization
by	O
ratifying	O
the	O
treaty	O
known	O
as	O
the	O
Constitution	B-Document
of	I-Document
the	I-Document
World	I-Document
Health	I-Document
Organization	E-Document
.)	O
,	O
it	O
also	O
had	O
two	O
associate	O
members	O
,	O
Puerto	B-Organization
Rico	E-Organization
and	O
Tokelau	S-Organization
.	O
Several	O
other	O
countries	O
have	O
been	O
granted	O
observer	O
status	O
.	O

A	O
physician	O
working	O
in	O
Sierra	B-Location
Leone	E-Location
has	O
said:	O
"	O
After	O
about	O
30	O
or	O
40	O
minutes	O
,	O
your	O
goggles	O
have	O
fogged	O
up	O
;	O
your	O
socks	O
are	O
completely	O
drenched	O
in	O
sweat	O
.	O

The	O
NIAID	S-Organization
strategic	O
framework	O
is	O
also	O
aligned	O
with	O
NIAID	S-Organization
's	O
ongoing	O
efforts	O
to	O
intensify	O
TB	S-Disease
research	O
and	O
innovation	O
in	O
support	O
of	O
the	O
U.S.	B-Document
Government	I-Document
Global	I-Document
Tuberculosis	I-Document
Strategy	E-Document
and	O
the	O
National	B-Document
Action	I-Document
Plan	I-Document
for	I-Document
Combating	I-Document
Multidrug-Resistant	I-Document
Tuberculosis	E-Document
,	O
which	O
share	O
and	O
complement	O
the	O
WHO	S-Organization
commitment	O
to	O
reduce	O
TB	S-Disease
deaths	O
by	O
95%	O
and	O
reduce	O
TB	S-Disease
incidence	O
by	O
90%	O
by	O
2035	O
through	O
advancing	O
research	O
and	O
innovation	O
.	O

And	O
,	O
of	O
course	O
,	O
modern	O
civilization	O
would	O
hardly	O
be	O
imaginable	O
without	O
the	O
fermentation	O
processes	O
that	O
gave	O
us	O
beer	O
,	O
wine	O
,	O
and	O
cheese!	O

There	O
was	O
still	O
a	O
belief	O
by	O
some	O
in	O
surrounding	O
areas	O
that	O
the	O
epidemic	O
was	O
a	O
hoax	O
.	O

Members	O
of	O
the	O
U.S.	B-Organization
House	I-Organization
Energy	I-Organization
and	I-Organization
Commerce	I-Organization
Subcommittee	I-Organization
on	I-Organization
Health	E-Organization
on	O
Wednesday	O
considered	O
proposed	O
updates	O
to	O
the	O
nation's	O
law	O
on	O
preparing	O
for	O
and	O
responding	O
to	O
national	O
and	O
global	O
public	O
health	O
emergencies	O
resulting	O
from	O
any	O
chemical	O
,	O
biological	O
,	O
radiological	O
,	O
or	O
nuclear	O
(CBRN)	O
agent	O
,	O
toxin	O
,	O
disaster	O
,	O
threat	O
or	O
attack	O
-	O
be	O
it	O
naturally	O
occurring	O
,	O
unintentional	O
or	O
deliberate	O
.	O

The	O
general	O
public	O
must	O
be	O
made	O
aware	O
of	O
the	O
facts	O
concerning	O
the	O
critical	O
roles	O
that	O
bacteria	O
play	O
in	O
their	O
lives	O
and	O
well-being	O
,	O
the	O
precious	O
nature	O
of	O
antibiotics	O
and	O
the	O
concomitant	O
importance	O
of	O
using	O
them	O
prudently	O
.	O

The	O
U.S.	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
has	O
recently	O
released	O
its	O
findings	O
regarding	O
how	O
effective	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
has	O
been	O
with	O
addressing	O
the	O
lapses	O
made	O
at	O
the	O
laboratory	O
at	O
Dugway	B-Location
Proving	I-Location
Ground	E-Location
,	O
Utah	S-Location
,	O
and	O
whether	O
systemic	O
oversight	O
changes	O
regarding	O
biosecurity	O
have	O
since	O
been	O
implemented	O
across	O
facilities	O
.	O

Every	O
center	O
director	O
,	O
every	O
division	O
director	O
,	O
every	O
branch	O
director	O
,	O
every	O
lab	O
director	O
,	O
every	O
lab	O
worker	O
,	O
and	O
myself	O
.	O

Both	O
al-Taha	S-Person
and	O
Ammash	S-Person
were	O
captured	O
by	O
U.S.	B-Organization
forces	E-Organization
after	O
the	O
2003	O
invasion	O
of	O
,	O
but	O
both	O
were	O
released	O
in	O
2005	O
after	O
they	O
were	O
among	O
those	O
an	O
American-Iraqi	O
board	O
found	O
to	O
be	O
no	O
longer	O
security	O
threats	O
.	O

This	O
will	O
be	O
difficult	O
,	O
given	O
that	O
industry's	O
search	O
for	O
novel	O
chemical	O
agents	O
acting	O
on	O
new	O
biological	O
targets	O
has	O
become	O
non-productive	O
.	O

On	O
27	O
May	O
,	O
the	O
Taichung	B-Organization
City	I-Organization
Government	E-Organization
,	O
led	O
by	O
mayor	O
Jason	B-Person
Hu	E-Person
,	O
established	O
a	O
command	O
center	O
in	O
central	O
Taiwan	S-Location
to	O
handle	O
SARS	S-Disease
.	O
The	O
Department	B-Organization
of	I-Organization
Health	E-Organization
worked	O
with	O
several	O
hospitals	O
in	O
Taiwan	S-Location
to	O
expand	O
medical	O
facilities	O
and	O
treatment	O
for	O
patients	O
.	O

By	O
the	O
time	O
World	O
War	O
I	O
began	O
,	O
attempts	O
to	O
use	O
anthrax	S-Pathogen
were	O
directed	O
at	O
animal	O
populations	O
.	O

Although	O
there	O
has	O
been	O
one	O
short	O
publication	O
comparing	O
the	O
data	O
management	O
system	O
MIMAS	S-Platform
to	O
other	O
systems	O
,	O
this	O
is	O
the	O
first	O
comprehensive	O
review	O
of	O
data	O
management	O
systems	O
successfully	O
employed	O
in	O
large-scale	O
biology	O
projects	O
which	O
are	O
surveyed	O
in	O
an	O
environment	O
of	O
multi-national	O
data	O
sharing	O
strategies	O
.	O

The	O
consequences	O
could	O
be	O
devastating	O
if	O
accidents	O
were	O
to	O
occur	O
with	O
lab-created	O
strains	O
of	O
deadly	O
influenza	O
viruses	O
that	O
are	O
purposely	O
engineered	O
to	O
be	O
easier	O
to	O
spread	O
than	O
what's	O
found	O
in	O
nature	O
,	O
said	O
David	B-Person
Relman	E-Person
a	O
microbiology	O
professor	O
at	O
Stanford	B-Organization
University	E-Organization
who	O
is	O
a	O
federal	O
adviser	O
on	O
lab	O
safety	O
and	O
a	O
past	O
president	O
of	O
the	O
.	O

Walsh	S-Person
warned	O
that	O
terrorists	O
could	O
"	O
harness	O
the	O
virus	O
as	O
a	O
powder,	O
"	O
load	O
it	O
into	O
a	O
bomb	O
,	O
and	O
then	O
explode	O
the	O
bomb	O
in	O
a	O
highly	O
populated	O
area	O
,	O
CBS	O
Atlanta	O
reports	O
.	O

In	O
May	O
2004	O
a	O
scientist	O
working	O
in	O
a	O
Vektor	S-Organization
lab	O
at	O
Koltsovo	S-Location
died	O
after	O
accidentally	O
jabbing	O
her	O
left	O
hand	O
with	O
a	O
syringe	O
containing	O
.	O

Pharmaceutical	O
companies	O
should	O
provide	O
their	O
stocks	O
for	O
this	O
purpose	O
(retaining	O
rights	O
to	O
other	O
applications)	O
.	O

The	O
diseases	O
they	O
cultivated	O
as	O
weapons	O
were	O
glanders	S-Pathogen
and	O
,	O
both	O
known	O
to	O
ravage	O
populations	O
of	O
grazing	O
animals	O
in	O
natural	O
epidemics	O
.	O

It	O
attempted	O
to	O
weaponise	O
,	O
but	O
did	O
not	O
succeed	O
.	O

We	O
are	O
anticipating	O
a	O
scenario	O
of	O
continued	O
intense	O
transmission"	O
.	O

Others	O
were	O
exposed	O
to	O
an	O
aerosol	O
of	O
anthrax	S-Pathogen
sprayed	O
into	O
a	O
chamber	O
while	O
doctors	O
watched	O
behind	O
a	O
glass	O
screen	O
.	O

The	O
challenge	O
of	O
transporting	O
and	O
delivering	O
samples	O
containing	O
class	O
3	O
microorganisms	O
is	O
well	O
described	O
by	O
Mèrens	S-Person
et	O
al	O
.	O

Using	O
data	O
acquired	O
from	O
non-human	O
primates	O
at	O
USAMRIID	S-Organization
and	O
NIH-IRF	S-Organization
,	O
the	O
researchers	O
developed	O
and	O
tested	O
PRESAGED	S-Technology
for	O
several	O
exposure	O
methods	O
(intramuscular	O
,	O
aerosol	O
,	O
or	O
intratracheal	O
routes)	O
to	O
one	O
of	O
several	O
viral	O
hemorrhagic	B-Disease
fevers	E-Disease
,	O
including	O
,	O
or	O
the	O
bacterial	O
pathogen	O
,	O
Y.pestis	O
.	O

MRI	S-Technology
uses	O
powerful	O
magnets	O
and	O
can	O
therefore	O
cause	O
magnetic	O
materials	O
to	O
move	O
at	O
great	O
speeds	O
posing	O
a	O
projectile	O
risk	O
.	O

XperimentR	S-Platform
lets	O
users	O
describe	O
experimental	O
metadata	O
via	O
a	O
graphical	O
representation	O
based	O
on	O
the	O
ISA-Tab	O
structure	O
.	O

The	O
says	O
it	O
is	O
also	O
investigating	O
the	O
outbreak	O
.	O

The	O
outbreak	O
has	O
been	O
blamed	O
for	O
several	O
instances	O
of	O
supply	O
shortages	O
,	O
stemming	O
from	O
globally	O
increased	O
usage	O
of	O
equipment	O
to	O
fight	O
outbreaks	O
,	O
panic	O
buying	O
(which	O
in	O
several	O
places	O
led	O
to	O
shelves	O
being	O
cleared	O
of	O
grocery	O
essentials	O
such	O
as	O
food	O
,	O
toilet	O
paper	O
,	O
and	O
bottled	O
water)	O
,	O
and	O
disruption	O
to	O
factory	O
and	O
logistic	O
operations	O
.	O

Old	O
and	O
discarded	O
,	O
or	O
even	O
rejected	O
,	O
antibiotics	O
should	O
be	O
re-investigated	O
,	O
re-purposed	O
and	O
used	O
as	O
needed	O
.	O

CAUTION:	O
&lt;organism	O
name&gt	O
;	O
is	B-Platform
a	I-Platform
Biosafety	I-Platform
L	E-Platform
pathogen	O
.	O

It	O
also	O
was	O
home	O
to	O
a	O
piggery	O
,	O
and	O
poultry	O
was	O
regularly	O
brought	O
in	O
from	O
surrounding	O
villages	O
to	O
feed	O
the	O
camp.	O
and	O
his	O
team	O
postulated	O
that	O
a	O
precursor	O
virus	O
,	O
harbored	O
in	O
birds	O
,	O
mutated	O
and	O
then	O
migrated	O
to	O
pigs	O
kept	O
near	O
the	O
front	O
.	O

"	O
We	O
are	O
pleased	O
to	O
continue	O
and	O
expand	O
our	O
productive	O
relationship	O
with	O
BARDA	S-Organization
which	O
represents	O
a	O
good	O
example	O
of	O
a	O
public-private	O
partnership	O
that	O
advances	O
much	O
needed	O
therapeutics	O
for	O
infected	O
individuals	O
and	O
the	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
,	O
"	O
said	O
Dr.	O
,	O
Chief	O
Executive	O
Officer	O
.	O

Modern	O
treatment	O
methods	O
include	O
insecticides	O
,	O
the	O
use	O
of	O
antibiotics	O
,	O
and	O
a	O
plague	B-Vaccine
vaccine	E-Vaccine
It	O
is	O
feared	O
that	O
the	O
plague	S-Disease
bacterium	O
could	O
develop	O
drug	O
resistance	O
and	O
again	O
become	O
a	O
major	O
health	O
threat	O
.	O

"	O
I	O
believe	O
the	O
first	O
equipment	O
for	O
the	O
system	O
will	O
be	O
in	O
the	O
field	O
next	O
month,	O
"	O
he	O
added	O
,	O
noting	O
that	O
contracts	O
for	O
BD21	S-Document
are	O
being	O
handled	O
by	O
the	O
CWMD	O
Consortium	O
at	O
Aberdeen	O
Proving	O
Grounds	O
with	O
the	O
.	O

LENA	B-Person
SUN	E-Person
Hi	O
,	O
Dr	O
.	O

Start-up	O
companies	O
could	O
use	O
this	O
opportunity	O
to	O
generate	O
effective	O
,	O
new	O
,	O
antibiotic	O
combinations	O
.	O

On	O
20	O
April	O
,	O
Beijing	S-Organization
mayor	O
Meng	B-Person
Xuenong	E-Person
and	O
the	O
health	O
minister	O
of	O
the	O
PRC	S-Organization
Zhang	B-Person
Wenkang	E-Person
were	O
replaced	O
respectively	O
by	O
Wang	B-Person
Qishan	E-Person
from	O
Hainan	S-Location
and	O
the	O
former	O
deputy	O
health	O
minister	O
Gao	B-Person
Qiang	E-Person
.	O
They	O
were	O
the	O
first	O
two	O
high-rank	O
officials	O
in	O
the	O
PRC	S-Organization
to	O
be	O
dismissed	O
because	O
of	O
the	O
fallout	O
of	O
the	O
epidemic	O
.	O

Bodily	O
fluids:	O
The	O
most	O
common	O
way	O
of	O
transmitting	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
humans	O
is	O
through	O
the	O
contact	O
with	O
infected	O
bodily	O
fluids	O
.	O

1966:	O
The	O
WHO	S-Organization
moved	O
its	O
headquarters	O
from	O
the	O
Ariana	B-Location
wing	I-Location
at	I-Location
the	I-Location
Palace	I-Location
of	I-Location
Nations	E-Location
to	O
a	O
newly	O
constructed	O
HQ	O
elsewhere	O
in	O
.	O

So	O
far	O
,	O
researchers	O
have	O
cited	O
green	B-Drug
tea	E-Drug
cranberries	S-Drug
,	O
Persian	B-Drug
shallots	E-Drug
,	O
and	O
as	O
potential	O
sources	O
of	O
effective	O
alternatives	O
to	O
antibiotics	O
.	O

Infections	O
by	O
fungi	O
are	O
a	O
cause	O
of	O
high	O
morbidity	O
and	O
mortality	O
in	O
immunocompromised	O
persons	O
,	O
such	O
as	O
those	O
with	O
HIV/AIDS	S-Disease
tuberculosis	S-Disease
or	O
receiving	O
chemotherapy	O
.	O

Study	O
co-author	O
Pamela	B-Person
Yeh	E-Person
Ph.D.	O
,	O
argues	O
that	O
combinations	O
of	O
multiple	O
antibiotics	O
"	O
will	O
work	O
much	O
better	O
"	O
than	O
current	O
strategies	O
,	O
when	O
it	O
comes	O
to	O
fighting	O
superbugs	O
.	O

Altering	O
of	O
gametocytes	O
and	O
embryos	O
to	O
generate	O
heritable	O
changes	O
in	O
humans	O
was	O
defined	O
to	O
be	O
irresponsible	O
.	O

The	O
general	O
public	O
must	O
be	O
made	O
aware	O
of	O
the	O
facts	O
concerning	O
the	O
critical	O
roles	O
that	O
bacteria	O
play	O
in	O
their	O
lives	O
and	O
well-being	O
,	O
the	O
precious	O
nature	O
of	O
antibiotics	O
and	O
the	O
concomitant	O
importance	O
of	O
using	O
them	O
prudently	O
.	O

This	O
explains	O
why	O
only	O
a	O
minority	O
of	O
natural	O
pathogens	O
are	O
suitable	O
for	O
military	O
purposes	O
.	O

Moscow	S-Organization
has	O
never	O
acknowledged	O
the	O
outbreak	O
or	O
that	O
it	O
ever	O
tested	O
smallpox	S-Pathogen
in	O
the	O
open	O
air	O
.	O

1953:	O
The	O
fifteenth	O
directorate	O
of	O
the	O
Red	B-Organization
Army	E-Organization
takes	O
responsibility	O
for	O
the	O
program	O
.	O

Most	O
of	O
the	O
biological	O
agents	O
in	O
the	O
biodefense	O
category	O
lists	O
of	O
the	O
US	B-Organization
CDC	E-Organization
EU	S-Location
and	O
Russia	S-Location
were	O
found	O
to	O
be	O
consistent	O
.	O

We're	O
very	O
concerned	O
about	O
the	O
health	O
and	O
well-being	O
of	O
our	O
own	O
staff	O
.	O

This	O
left-right	O
interchange	O
corresponds	O
to	O
the	O
view	O
that	O
physicians	O
generally	O
have	O
in	O
reality	O
when	O
positioned	O
in	O
front	O
of	O
patients	O
.	O

At	O
a	O
rough	O
estimate	O
,	O
as	O
many	O
as	O
10%	O
of	O
the	O
world's	O
people	O
may	O
have	O
been	O
killed	O
.	O

The	O
plants	O
turn	O
white	O
,	O
a	O
clear	O
signal	O
of	O
danger	O
.	O

They	O
were	O
charged	O
with	O
attempting	O
to	O
murder	O
Rajneesh's	O
personal	O
physician	O
,	O
first-degree	O
assault	O
for	O
poisoning	O
Judge	O
William	B-Person
Hulse	E-Person
,	O
second-degree	O
assault	O
for	O
poisoning	O
The	O
Dalles	O
Commissioner	O
Raymond	B-Person
Matthews	E-Person
,	O
and	O
product	O
tampering	O
for	O
the	O
poisonings	O
in	O
The	O
Dalles	S-Location
,	O
as	O
well	O
as	O
wiretapping	O
and	O
immigration	O
offenses	O
.	O

However	O
,	O
there	O
was	O
a	O
very	O
precise	O
indication	O
from	O
their	O
reported	O
locations	O
during	O
working	O
hours	O
,	O
that	O
all	O
of	O
the	O
victims	O
had	O
been	O
directly	O
downwind	O
at	O
the	O
time	O
of	O
the	O
release	O
of	O
the	O
spores	O
via	O
aerosol	O
.	O

Some	O
studies	O
have	O
shown	O
that	O
publications	O
indicating	O
an	O
increased	O
risk	O
of	O
cancer	S-Disease
from	O
typical	O
doses	O
of	O
body	O
scans	O
are	O
plagued	O
with	O
serious	O
methodological	O
limitations	O
and	O
several	O
highly	O
improbable	O
results	O
,	O
concluding	O
that	O
no	O
evidence	O
indicates	O
such	O
low	O
doses	O
cause	O
any	O
long-term	O
harm	O
.	O

Technical	O
Report.	O
.	O

See	O
also	O
pp.407–22	O
.	O

When	O
available	O
,	O
respirators	S-Equipment
(instead	O
of	O
face	O
masks)	O
are	O
preferred	O
.	O

A	O
2009	O
review	O
by	O
the	O
U.S.	B-Organization
National	I-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
concluded	O
that	O
the	O
has	O
a	O
safety	O
profile	O
similar	O
to	O
that	O
of	O
seasonal	O
vaccine	O
.	O

The	O
United	B-Location
States	E-Location
seriously	O
researched	O
the	O
potential	O
of	O
entomological	O
warfare	O
(EW)	O
during	O
the	O
Cold	O
War	O
.	O

SGI	S-Organization
believes	O
that	O
intellectual	O
property	O
is	O
important	O
in	O
the	O
synthetic	O
genomics/biology	O
space	O
as	O
it	O
is	O
one	O
of	O
the	O
best	O
means	O
to	O
ensure	O
that	O
this	O
important	O
area	O
of	O
basic	O
science	O
research	O
will	O
be	O
translated	O
into	O
key	O
commercial	O
products	O
and	O
services	O
for	O
the	O
benefit	O
of	O
society	O
.	O

Non-pathogenic	O
micro-organisms	O
have	O
also	O
been	O
used	O
as	O
inoculum	O
to	O
protect	O
from	O
diseases	O
(	O
biocontrol	B-Technology
and	I-Technology
biofertilizers	I-Technology
in	I-Technology
agriculture	E-Technology
probiotics)	O
,	O
to	O
restore	O
contaminated	O
sites	O
()	O
or	O
for	O
fermentation	O
in	O
food	O
processes	O
.	O

Spread	O
of	O
the	O
H1N1	B-Pathogen
virus	E-Pathogen
is	O
thought	O
to	O
occur	O
in	O
the	O
same	O
way	O
that	O
seasonal	B-Disease
flu	E-Disease
spreads	O
.	O

Complete	O
management	O
and	O
program	O
documents	O
were	O
created	O
for	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
,	O
and	O
it	O
was	O
divided	O
into	O
four	O
zones	O
(the	O
green	O
,	O
yellow	O
,	O
brown	O
,	O
and	O
red	O
zones)	O
based	O
on	O
the	O
risk	O
assessment	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	S-Organization
established	O
an	O
External	O
Laboratory	O
Safety	O
Workgroup	O
(ELSW)	O
,	O
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
.	O

China	S-Location
is	O
,	O
however	O
,	O
trying	O
to	O
boost	O
pork	O
imports	O
from	O
another	O
big	O
producer	O
-	O
the	O
US	S-Location
-	O
to	O
make	O
up	O
for	O
its	O
lost	O
domestic	O
supply	O
.	O

Rep	O
.	O

This	O
is	O
especially	O
apparent	O
when	O
one	O
examines	O
the	O
differences	O
at	O
4-fold	O
degenerate	O
codons	O
,	O
the	O
subset	O
of	O
synonymous	O
changes	O
in	O
which	O
,	O
at	O
the	O
third	O
codon	O
position	O
,	O
any	O
of	O
the	O
4	O
possible	O
nucleotides	O
can	O
be	O
substituted	O
without	O
changing	O
the	O
resulting	O
amino	O
acid	O
.	O

A	O
representative	O
evaluation	O
is	O
presented	O
in	O
Fig.3	O
.	O

17–22.Anthrax	O
Sabotage	O
in	O
Finland	S-Location
In	O
1993	O
,	O
the	O
Aum	O
Shinrikyo	O
used	O
anthrax	S-Pathogen
in	O
an	O
unsuccessful	O
attempt	O
in	O
Tokyo	S-Location
with	O
zero	O
fatalities	O
.	O

It	O
will	O
be	O
chaired	O
by	O
former	O
commissioner	O
of	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
Margaret	B-Person
Hamburg	E-Person
.	O
Hamburg	S-Person
is	O
an	O
NTI	S-Organization
board	O
member	O
who	O
now	O
serves	O
as	O
foreign	O
secretary	O
of	O
the	O
.	O

Components	O
of	O
this	O
manuscript	O
may	O
be	O
found	O
as	O
part	O
of	O
the	O
final	O
report	O
that	O
was	O
submitted	O
to	O
the	O
funding	O
agency	O
at	O
the	O
end	O
of	O
the	O
project	O
.	O

Frieden	S-Person
.	O
H5N1	S-Disease
,	O
is	O
this	O
the	O
same	O
H5N1	S-Disease
that	O
was	O
commonly	O
referred	O
to	O
as	O
bird	B-Disease
flu	E-Disease
or	O
?	O

The	O
De­fense	B-Organization
Threat	I-Organization
Re­duc­tion	I-Organization
Agency	E-Organization
is	O
chip­ping	O
in	O
$1.	O
25	O
mil­lion	O
to	O
fund	O
non­clin­i­cal	O
biode­fense	O
as­pects	O
of	O
the	O
col­lab­o­ra­tion	O
,	O
says	O
,	O
with	O
an	O
ad­di­tion­al	O
$8.	O
75	O
mil­lion	O
tied	O
to	O
mile­stones	O
down	O
the	O
road	O
.	O

This	O
was	O
reiterated	O
shortly	O
thereafter	O
by	O
John	B-Person
Bolton	E-Person
the	O
then	O
Under	B-Organization
Secretary	I-Organization
of	I-Organization
State	I-Organization
for	I-Organization
Arms	I-Organization
Control	I-Organization
and	I-Organization
International	I-Organization
Security	E-Organization
,	O
at	O
,	O
who	O
said	O
,	O
a	O
professional	O
code	O
of	O
conduct	O
for	O
scientists	O
working	O
with	O
pathogenic	O
microorganisms	O
[is	O
critical	O
and	O
timely]	O
.	O

The	O
vaccine	O
has	O
not	O
yet	O
had	O
regulatory	O
approval	O
,	O
but	O
it	O
is	O
considered	O
to	O
be	O
so	O
effective	O
that	O
300,000	O
doses	O
have	O
already	O
been	O
stockpiled	O
.	O

(1995)	O
.	O

Heritable	O
modifications	O
could	O
have	O
unintended	O
and	O
far-reaching	O
consequences	O
for	O
human	O
evolution	O
,	O
genetically	O
(e.g.	O
gene-environment	O
interactions)	O
and	O
culturally	O
(e.g.	O
social	O
Darwinism)	O
.	O

Outbreaks	O
of	O
the	O
recurred	O
at	O
various	O
locations	O
around	O
the	O
world	O
until	O
the	O
early	O
19th	O
century	O
.	O

The	O
report	O
also	O
gives	O
an	O
example	O
for	O
withholding	O
of	O
grant	O
payments	O
because	O
of	O
reluctance	O
to	O
share	O
data	O
with	O
other	O
researchers	O
.	O

After	O
WWII	O
,	O
the	O
Office	B-Organization
of	I-Organization
Special	I-Organization
Investigations	E-Organization
created	O
a	O
watchlist	O
of	O
suspected	O
Axis	O
collaborators	O
and	O
persecutors	O
that	O
are	O
banned	O
from	O
entering	O
the	O
United	B-Location
States	E-Location
.	O
While	O
they	O
have	O
added	O
over	O
60,000	O
names	O
to	O
the	O
watchlist	O
,	O
they	O
have	O
only	O
been	O
able	O
to	O
identify	O
under	O
100	O
Japanese	O
participants	O
.	O

Only	O
the	O
CDC	S-Organization
and	O
the	O
Russian	B-Organization
State	I-Organization
Centre	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	E-Organization
in	O
the	O
Russian	B-Location
Federation	E-Location
are	O
approved	O
to	O
have	O
the	O
for	O
research	O
.	O

In	O
the	O
United	B-Location
States	E-Location
,	O
isolated	O
outbreaks	O
occurred	O
in	O
some	O
cities	O
including	O
Los	B-Location
Angeles	E-Location
,	O
New	B-Location
York	I-Location
City	E-Location
,	O
Memphis	S-Location
,	O
Nashville	S-Location
,	O
San	B-Location
Francisco	E-Location
and	O
.	O
Overall	O
American	O
mortality	O
rates	O
were	O
in	O
the	O
tens	O
of	O
thousands	O
during	O
the	O
first	O
six	O
months	O
of	O
1919	O
.	O

The	O
much	O
more	O
apparent	O
horrors	O
of	O
chemical	O
warfare	O
led	O
,	O
in	O
1925	O
,	O
to	O
the	O
Geneva	B-Document
Protocol	E-Document
It	O
prohibits	O
the	O
use	O
of	O
chemical	O
and	O
biological	O
agents	O
,	O
but	O
not	O
research	O
and	O
development	O
of	O
these	O
agents	O
.	O

Luke	B-Person
Robert	I-Person
Mason	E-Person
director	O
of	O
the	O
,	O
says	O
there	O
is	O
a	O
great	O
deal	O
of	O
excitement	O
around	O
biohacking	O
but	O
"	O
we	O
are	O
a	O
long	O
way	O
from	O
radically	O
altering	O
the	O
human	O
body	O
in	O
the	O
sorts	O
of	O
ways	O
they	O
evangelise"	O
.	O

The	O
center	O
is	O
responsible	O
for	O
collecting	O
and	O
analyzing	O
biological	O
data	O
from	O
across	O
the	O
country	O
and	O
alerting	O
relevant	O
groups	O
when	O
incidents	O
have	O
the	O
potential	O
for	O
widespread	O
damage	O
.	O

Self-isolation	O
at	O
home	O
has	O
been	O
recommended	O
for	O
those	O
diagnosed	O
with	O
COVID-19	S-Disease
and	O
those	O
who	O
suspect	O
they	O
have	O
been	O
infected	O
.	O

Students	O
from	O
SUNY	B-Organization
Albany's	I-Organization
College	I-Organization
of	I-Organization
Emergency	I-Organization
Preparedness	E-Organization
,	O
Homeland	B-Organization
Security	I-Organization
and	I-Organization
Cybersecurity	E-Organization
,	O
were	O
able	O
to	O
participate	O
in	O
this	O
year's	O
exercise	O
and	O
learn	O
how	O
"	O
supports	O
law	O
enforcement	O
specialty	O
teams.	O
"	O

And	O
newer	O
research	O
,	O
worryingly	O
,	O
has	O
found	O
that	O
C.	B-Pathogen
difficile	E-Pathogen
to	O
be	O
resilient	O
in	O
the	O
face	O
of	O
all	O
hospital	O
disinfectants	O
.	O

The	O
aim	O
of	O
the	O
week	O
is	O
to	O
increase	O
global	O
awareness	O
of	O
antibiotic	O
resistance	O
.	O

Bill	B-Person
Gates	E-Person
said	O
in	O
a	O
February	O
18	O
,	O
2017	O
Business	O
Insider	O
op-ed	O
(published	O
near	O
the	O
time	O
of	O
his	O
Munich	O
Security	O
Conference	O
speech)	O
that	O
it	O
is	O
possible	O
for	O
an	O
airborne	O
pathogen	O
to	O
kill	O
at	O
least	O
30	O
million	O
people	O
over	O
the	O
course	O
of	O
a	O
year	O
.	O

The	O
outbreak	O
prompted	O
calls	O
for	O
the	O
United	B-Location
States	E-Location
to	O
adopt	O
social	O
policies	O
common	O
in	O
other	O
wealthy	O
countries	O
,	O
including	O
universal	O
health	O
care	O
,	O
universal	O
child	O
care	O
,	O
paid	O
sick	O
leave	O
,	O
and	O
higher	O
levels	O
of	O
funding	O
for	O
public	O
health	O
.	O

"	O
There's	O
no	O
specific	O
date	O
on	O
the	O
calendar,	O
"	O
Hall	S-Person
said	O
.	O

An	O
analysis	O
of	O
the	O
early	O
phase	O
of	O
the	O
outbreak	O
up	O
to	O
23	O
January	O
estimated	O
86	O
percent	O
of	O
infections	O
had	O
not	O
been	O
detected	O
,	O
and	O
that	O
these	O
undocumented	O
infections	O
were	O
the	O
source	O
for	O
79	O
percent	O
of	O
documented	O
cases	O
.	O

At	O
the	O
present	O
time	O
more	O
than	O
50%	O
of	O
the	O
antibiotics	O
produced	O
are	O
employed	O
as	O
animal	O
feeds	O
to	O
promote	O
growth	O
.	O

Others	O
adopted	O
preventive	O
measures	O
and	O
treatments	O
for	O
the	O
used	O
by	O
Europeans	O
.	O

Other	O
countries	O
that	O
border	O
the	O
DRC	S-Location
are	O
South	B-Location
Sudan	E-Location
,	O
Rwanda	S-Location
and	O
Burundi	S-Location
,	O
as	O
well	O
as	O
Angola	S-Location
,	O
Zambia	S-Location
,	O
Tanzania	S-Location
,	O
,	O
which	O
are	O
considered	O
to	O
have	O
a	O
lower	O
risk	O
of	O
transmission	O
.	O

The	O
historian	O
George	B-Person
Hussman	E-Person
claimed	O
that	O
the	O
plague	S-Disease
had	O
not	O
occurred	O
in	O
East	B-Location
Africa	E-Location
until	O
the	O
1900s	O
.	O

The	O
strain	O
used	O
in	O
the	O
2001	B-Incident
anthrax	I-Incident
attack	E-Incident
was	O
identical	O
to	O
the	O
strain	O
used	O
by	O
the	O
.	O

Deployed	O
hardware	O
systems	O
operating	O
at	O
a	O
standoff	O
distance	O
of	O
up	O
to	O
500	O
meters	O
must	O
collect	O
signals	O
of	O
interest	O
from	O
relevant	O
species	O
,	O
process	O
and	O
distill	O
them	O
,	O
and	O
then	O
relay	O
them	O
to	O
remote	O
end	O
users	O
.	O

Our	O
study	O
findings	O
suggest	O
that	O
to	O
date	O
,	O
efforts	O
have	O
largely	O
been	O
focused	O
on	O
raising	O
general	O
awareness	O
among	O
the	O
broad	O
scientific	O
community	O
.	O

The	O
purpose	O
of	O
the	O
Biosafety	O
Program	O
is	O
to	O
protect	O
workers	O
,	O
the	O
public	O
,	O
agriculture	O
,	O
and	O
the	O
environment	O
from	O
exposure	O
to	O
biological	O
agents	O
or	O
materials	O
that	O
may	O
cause	O
disease	O
or	O
other	O
detrimental	O
effects	O
in	O
humans	O
,	O
animals	O
,	O
or	O
plants	O
.	O

One	O
of	O
those	O
incidents	O
was	O
in	O
2006	O
from	O
the	O
same	O
laboratory	O
that	O
was	O
involved	O
in	O
the	O
work	O
that	O
we	O
described	O
now	O
.	O

He	O
said	O
continued	O
development	O
of	O
a	O
system	O
to	O
harmonize	O
AMR	O
data	O
and	O
make	O
it	O
usable	O
across	O
institutions	O
()	O
should	O
"	O
unlock	O
the	O
ability	O
for	O
real-time	O
clinician	O
support	O
across	O
all	O
electronic	O
health	O
record	O
systems.	O
"	O

Under	O
Joseph	B-Person
Walter	I-Person
Mountin	E-Person
the	O
continued	O
to	O
advocate	O
for	O
public	O
health	O
issues	O
and	O
pushed	O
to	O
extend	O
its	O
responsibilities	O
to	O
many	O
other	O
communicable	O
diseases	O
.	O

All	O
the	O
cases	O
were	O
reported	O
to	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
(	O
ECDC	S-Organization
)	O
.	O

Los	B-Organization
Angeles	I-Organization
Police	E-Organization
Cmdr	O
.	O

First	O
,	O
the	O
students	O
,	O
working	O
in	O
pairs	O
,	O
learn	O
to	O
observe	O
animal	O
cells	O
in	O
culture	O
by	O
inverted	O
microscope	O
under	O
BSL2	S-Platform
conditions	O
in	O
biological	O
hoods	O
.	O

The	O
high	O
procurement	O
and	O
maintenance	O
costs	O
of	O
MRI	S-Technology
with	O
extremely	O
high	O
field	O
strengths	O
inhibit	O
their	O
popularity	O
.	O

Under	O
the	O
program	O
,	O
P3	S-Platform
performer	O
teams	O
are	O
developing	O
technologies	O
for	O
an	O
end-to-end	O
pandemic	O
response	O
platform	O
that	O
includes	O
the	O
ability	O
to	O
study	O
viruses	O
for	O
downstream	O
antibody	O
discovery	O
and	O
final	O
evaluation	O
and	O
testing	O
of	O
candidate	O
therapeutic	O
products	O
.	O

The	O
White	B-Organization
House	E-Organization
is	O
asking	O
federally	O
funded	O
labs	O
studying	O
infectious	O
agents	O
to	O
take	O
"	O
immediate	O
action	O
"	O
to	O
inventory	O
samples	O
and	O
review	O
safety	O
and	O
security	O
procedures	O
in	O
the	O
wake	O
of	O
several	O
high-profile	O
accidents	O
earlier	O
this	O
year	O
.	O

Many	O
countries	O
,	O
early	O
on	O
,	O
had	O
official	O
policies	O
to	O
not	O
test	O
those	O
with	O
only	O
mild	O
symptoms	O
.	O

The	O
advantage	O
of	O
pooled	O
libraries	O
is	O
that	O
more	O
genes	O
can	O
be	O
targeted	O
at	O
once	O
.	O

The	O
Western	B-Incident
African	I-Incident
Ebola	I-Incident
virus	I-Incident
epidemic	E-Incident
(2013–2016)	O
was	O
the	O
most	O
widespread	O
outbreak	O
of	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
in	O
history-causing	O
major	O
loss	O
of	O
life	O
and	O
socioeconomic	O
disruption	O
in	O
the	O
region	O
,	O
mainly	O
in	O
Guinea	S-Location
,	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
first	O
cases	O
were	O
recorded	O
in	O
Guinea	S-Location
in	O
December	O
2013	O
;	O
later	O
,	O
the	O
disease	O
spread	O
to	O
neighbouring	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
,	O
with	O
minor	O
outbreaks	O
occurring	O
elsewhere	O
.	O

External	O
test	O
panels	O
for	O
such	O
pathogens	O
are	O
generally	O
not	O
commercially	O
available	O
,	O
but	O
capability	O
testing	O
has	O
been	O
made	O
possible	O
in	O
the	O
FBD	S-Platform
network	O
projects	O
through	O
in-house	O
ring	O
trials	O
that	O
are	O
performed	O
annually	O
in	O
the	O
network	O
.	O

Since	O
then	O
some	O
scholars	O
have	O
argued	O
that	O
the	O
British	O
committed	O
biological	O
warfare	O
in	O
1789	O
near	O
their	O
new	O
convict	O
settlement	O
at	O
.	O

Anthrax	S-Disease
Anthrax	S-Disease
is	O
a	O
non-contagious	O
disease	O
caused	O
by	O
the	O
spore-forming	O
bacterium	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
.	O
The	O
ability	O
of	O
Anthrax	S-Disease
to	O
produce	O
within	O
small	O
spores	O
,	O
or	O
bacilli	O
bacterium	O
,	O
makes	O
it	O
readily	O
permeable	O
to	O
porous	O
skin	O
and	O
can	O
cause	O
abrupt	O
symptoms	O
within	O
24	O
hours	O
of	O
exposure	O
.	O

Some	O
people	O
spend	O
hundreds	O
of	O
thousands	O
of	O
dollars	O
on	O
these	O
treatments	O
.	O

The	O
pandemic	O
has	O
caused	O
global	O
social	O
and	O
economic	O
disruption	O
,	O
including	O
the	O
largest	O
global	O
recession	O
since	O
the	O
Great	B-Incident
Depression	E-Incident
It	O
has	O
led	O
to	O
the	O
postponement	O
or	O
cancellation	O
of	O
sporting	O
,	O
religious	O
,	O
political	O
,	O
and	O
cultural	O
events	O
,	O
widespread	O
supply	O
shortages	O
exacerbated	O
by	O
panic	O
buying	O
,	O
and	O
decreased	O
emissions	O
of	O
pollutants	O
and	O
greenhouse	O
gases	O
.	O

Public	B-Document
Health	I-Document
Agency	I-Document
of	I-Document
Canada,	I-Document
Laboratory	I-Document
Biosafety	I-Document
Guidelines	E-Document
3rd	O
edition	O
,	O
2004	O
.	O

However	O
,	O
they	O
concluded	O
,	O
Hussein	S-Person
had	O
perpetuated	O
ambiguity	O
regarding	O
a	O
possible	O
program	O
as	O
a	O
strategic	O
deterrent	O
against	O
Iran	S-Location
.	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
State	E-Organization
(2005)	O
,	O
[https://2009-2017.state.gov/documents/organization/52113.pdf	O
Adherence	B-Document
To	I-Document
and	I-Document
Compliance	I-Document
With	I-Document
Arms	I-Document
Control	E-Document
,	O
Nonproliferation	O
and	O
Disarmament	O
Agreements	O
and	O
Commitments]	O
,	O
Washington,	B-Location
DC	E-Location
.	O
Accessed	O
November	O
18	O
,	O
2008	O
.	O

Members	O
of	O
the	O
Monterey	O
team	O
said	O
the	O
blowing	O
of	O
germs	O
in	O
the	O
wind	O
suggested	O
that	O
a	O
contemporary	O
threat	O
could	O
be	O
harder	O
to	O
combat	O
and	O
contain	O
.	O

Sanitation	O
and	O
water	O
for	O
all	O
by	O
2030	O
is	O
Goal	O
Number	O
6	O
of	O
the	O
Sustainable	O
Development	O
Goals	O
.	O

A	O
project	O
of	O
the	O
nonprofit	O
Hopewell	B-Organization
Fund	E-Organization
ARMADA	S-Scientific_research_project
will	O
use	O
the	O
technology	O
and	O
expertise	O
of	O
ID	B-Organization
Genomics	E-Organization
,	O
a	O
Seattle	S-Location
-based	O
diagnostics	O
company	O
,	O
to	O
build	O
the	O
database	O
and	O
characterize	O
the	O
bacterial	O
strains	O
through	O
their	O
genetic	O
fingerprints.	O
has	O
developed	O
a	O
diagnostic	O
technology	O
that	O
,	O
instead	O
of	O
analyzing	O
the	O
entire	O
genome	O
of	O
a	O
pathogen	O
,	O
looks	O
for	O
certain	O
"	O
barcode"	O
genes	O
that	O
can	O
be	O
used	O
to	O
identify	O
the	O
genetic	O
fingerprint	O
of	O
a	O
bacterial	O
strain	O
.	O

Critics	O
have	O
lambasted	O
the	O
Trump	S-Person
administration	O
for	O
proposing	O
budget	O
cuts	O
to	O
public	O
health	O
programs	O
,	O
including	O
the	O
.	O

BioMart	O
is	O
an	O
example	O
of	O
a	O
data	O
warehouse	O
system	O
.	O

This	O
in	O
turn	O
would	O
have	O
a	O
knock-on	O
impact	O
on	O
China	S-Location
economy	O
,	O
given	O
that	O
pork	O
prices	O
are	O
an	O
important	O
contributor	O
to	O
its	O
inflation	O
levels	O
.	O

Will	O
today's	O
income	O
inequality	O
,	O
combined	O
with	O
biotechnology	O
tools	O
and	O
talk	O
of	O
'designer	O
babies'	O
,	O
lead	O
to	O
tomorrow's	O
permanent	O
underclass	O
of	O
people	O
who	O
couldn't	O
afford	O
genetic	O
enhancement?	O

On	O
4	O
June	O
2014	O
,	O
a	O
study	O
published	O
in	O
The	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
indicated	O
that	O
camel	O
to	O
human	O
transmission	O
of	O
the	O
virus	O
was	O
possible	O
.	O

Suspension	O
of	O
work	O
activities	O
and	O
sports	O
events	O
has	O
already	O
been	O
ordered	O
in	O
those	O
areas.	O
"	O

These	O
are	O
only	O
the	O
tip	O
of	O
the	O
iceberg	O
in	O
terms	O
of	O
the	O
vast	O
reservoir	O
of	O
bioactive	O
compounds	O
available	O
in	O
nature	O
.	O

A	O
sharper	O
perspective	O
emerges	O
when	O
1918	O
age-specific	O
influenza	S-Disease
morbidity	O
rates	O
are	O
used	O
to	O
adjust	O
the	O
W-shaped	O
mortality	O
curve	O
(Figure	O
3	O
,	O
panels	O
,	O
A	O
,	O
B	O
,	O
and	O
C)	O
.	O

Very	O
often	O
,	O
as	O
biomedical	O
geneticists	O
we	O
found	O
ourselves	O
talking	O
about	O
the	O
potentials	O
and	O
drawbacks	O
of	O
both	O
at	O
scientific	O
and	O
layman	O
level	O
.	O

The	O
office	O
experiments	O
with	O
technologies	O
in	O
real	O
time	O
to	O
address	O
both	O
urgent	O
and	O
emerging	O
threats	O
and	O
reports	O
to	O
a	O
board	O
of	O
directors	O
led	O
by	O
the	O
U.S	O
.	O

PAHPRA	S-Organization
recognized	O
the	O
importance	O
of	O
the	O
Animal	B-Document
Rule	E-Document
and	O
in	O
2015	O
,	O
Gottlieb	S-Person
said	O
the	O
FDA	S-Organization
finalized	O
guidance	O
for	O
product	O
development	O
under	O
the	O
rule	O
,	O
providing	O
scientific	O
and	O
regulatory	O
expectations	O
for	O
animal	O
data	O
intended	O
to	O
support	O
medical	O
countermeasure	O
approval	O
.	O

Woodruff	S-Person
had	O
a	O
long-time	O
interest	O
in	O
malaria	O
control	O
,	O
which	O
had	O
been	O
a	O
problem	O
in	O
areas	O
where	O
he	O
went	O
hunting	O
.	O

Under	O
the	O
terms	O
of	O
the	O
new	O
agreement	O
,	O
and	O
his	O
colleagues	O
will	O
create	O
a	O
pipeline	O
for	O
rapid	O
discovery	O
of	O
pathogens	O
,	O
protective	O
antigens	O
and	O
development	O
of	O
antibody	O
therapeutics	O
.	O

Photon	B-Equipment
counting	I-Equipment
detectors	E-Equipment
(	O
PCDs	S-Equipment
)	O
are	O
still	O
affected	O
by	O
noise	O
but	O
it	O
does	O
not	O
change	O
the	O
measured	O
counts	O
of	O
photons	O
.	O

The	O
Human	B-Scientific_research_project
Genome	I-Scientific_research_project
Project	E-Scientific_research_project
was	O
the	O
largest	O
ever	O
scientific	O
collaboration	O
in	O
biology	O
.	O

But	O
perhaps	O
the	O
biggest	O
application	O
of	O
biotechnology	O
is	O
in	O
human	O
health	O
.	O

On	O
22	O
February	O
,	O
the	O
Council	O
of	O
Ministers	O
announced	O
a	O
new	O
decree-law	O
to	O
contain	O
the	O
outbreak	O
,	O
including	O
quarantining	O
more	O
than	O
50,000	O
people	O
from	O
eleven	O
different	O
municipalities	O
in	O
northern	O
Italy	S-Location
Prime	O
Minister	O
said	O
,	O
"	O
In	O
the	O
outbreak	O
areas	O
,	O
entry	O
and	O
exit	O
will	O
not	O
be	O
provided	O
.	O

Each	O
year	O
in	O
the	O
U.S.	S-Location
,	O
at	O
least	O
2.	O
8	O
million	O
people	O
are	O
infected	O
with	O
antibiotic-resistant	O
bacteria	O
or	O
fungi	O
,	O
and	O
more	O
than	O
35,000	O
people	O
die	O
as	O
a	O
result	O
.	O

Furthermore	O
,	O
certain	O
conditions	O
can	O
require	O
children	O
to	O
be	O
exposed	O
to	O
multiple	O
CT	B-Technology
scans	E-Technology
.	O
Studies	O
support	O
informing	O
parents	O
of	O
the	O
risks	O
of	O
pediatric	O
.	O

This	O
vector	O
does	O
not	O
contain	O
any	O
viral	O
structural	O
protein	O
genes	O
.	O

A	O
person	O
or	O
group	O
calling	O
itself	O
"	O
The	O
Breeders	O
"	O
took	O
responsibility	O
for	O
the	O
bioterrorist	O
attack	O
,	O
as	O
financial	O
retaliation	O
for	O
the	O
environmental	O
damage	O
caused	O
by	O
the	O
state's	O
Malathion	O
aerial	O
spraying	O
;	O
the	O
group's	O
members	O
were	O
never	O
identified	O
.	O

The	O
's	O
stated	O
objective	O
is	O
to	O
engineer	O
GM	O
organisms	O
so	O
that	O
they	O
can	O
resist	O
certain	O
temperatures	O
,	O
change	O
their	O
habitat	O
and	O
food	O
sources	O
.	O

These	O
prescriptions	O
accomplished	O
nothing	O
other	O
than	O
increasing	O
the	O
risk	O
of	O
further	O
evolution	O
of	O
antibiotic	O
resistant	O
bacteria	O
.	O

Also	O
,	O
personnel	O
working	O
in	O
these	O
diagnostics	O
laboratories	O
did	O
not	O
receive	O
the	O
required	O
training	O
in	O
biosafety	O
.	O

Chikwe	B-Person
Ihekweazu	E-Person
Lassa	B-Disease
fever	E-Disease
has	O
been	O
endemic	O
in	O
our	O
country	O
for	O
many	O
years	O
.	O

U.S.	S-Location
president	O
Donald	B-Person
Trump	E-Person
has	O
been	O
criticised	O
for	O
referring	O
to	O
the	O
as	O
the	O
"	O
Chinese	O
Virus"	O
,	O
which	O
critics	O
say	O
is	O
racist	O
and	O
anti-Chinese	O
.	O

Parts	O
of	O
organs	O
,	O
such	O
as	O
the	O
brain	O
,	O
lungs	O
,	O
and	O
liver	O
,	O
were	O
removed	O
from	O
some	O
prisoners	O
.	O

The	O
facility	O
is	O
overseen	O
by	O
the	O
Army	S-Organization
Test	O
and	O
.	O

In	O
New	B-Location
York	I-Location
City	E-Location
,	O
deaths	O
have	O
been	O
four	O
times	O
higher	O
than	O
average	O
,	O
in	O
twice	O
as	O
high	O
,	O
and	O
in	O
many	O
European	O
countries	O
,	O
deaths	O
have	O
been	O
on	O
average	O
20	O
to	O
30	O
percent	O
higher	O
than	O
normal	O
.	O

One	O
dispersion	O
test	O
involved	O
laboratory	O
personnel	O
disguised	O
as	O
passengers	O
spraying	O
harmless	O
bacteria	O
in	O
.	O

An	O
Epidemic	B-Organization
Intelligence	I-Organization
Service	E-Organization
(	O
EIS	S-Organization
)	O
was	O
established	O
in	O
1951	O
,	O
originally	O
due	O
to	O
biological	B-Incident
warfare	I-Incident
concerns	I-Incident
arising	I-Incident
from	I-Incident
the	I-Incident
Korean	I-Incident
War	E-Incident
;	O
it	O
evolved	O
into	O
two-year	O
postgraduate	O
training	O
program	O
in	O
epidemiology	O
,	O
and	O
a	O
prototype	O
for	O
Field	B-Scientific_research_project
Epidemiology	I-Scientific_research_project
Training	I-Scientific_research_project
Programs	E-Scientific_research_project
()	O
,	O
now	O
found	O
in	O
numerous	O
countries	O
,	O
reflecting	O
CDC's	O
influence	O
in	O
promoting	O
this	O
model	O
internationally	O
.	O

And	O
what	O
about	O
ways	O
that	O
biotechnology	O
may	O
contribute	O
to	O
inequality	O
in	O
society?	O
Early	O
work	O
in	O
gene	B-Technology
surgery	E-Technology
will	O
no	O
doubt	O
be	O
expensive	O
–	O
for	O
example	O
,	O
Novartis	O
plans	O
to	O
charge	O
$475,000	O
for	O
a	O
one-time	O
treatment	O
of	O
their	O
recently	O
approved	O
cancer	O
therapy	O
,	O
a	O
drug	O
which	O
,	O
in	O
trials	O
,	O
has	O
rescued	O
patients	O
facing	O
certain	O
death	O
.	O

They	O
were	O
then	O
treated	O
with	O
antibiotics	S-Drug
The	O
goal	O
of	O
the	O
experiment	O
,	O
unknown	O
to	O
the	O
volunteers	O
,	O
was	O
to	O
standardize	O
bomb-fill	O
for	O
attacks	O
on	O
civilian	O
populations	O
.	O

Other	O
widely	O
used	O
nootropics	S-Drug
include	O
piracetam	S-Drug
.	O
is	O
a	O
medication	O
used	O
for	O
improving	O
cognitive	O
function	O
.	O

All	O
the	O
cases	O
were	O
reported	O
to	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
(	O
ECDC	S-Organization
)	O
.	O

The	O
index	O
case	O
is	O
believed	O
to	O
have	O
been	O
the	O
death	O
and	O
unsafe	O
burial	O
of	O
a	O
65-year-old	O
woman	O
on	O
25	O
July	O
in	O
the	O
town	O
of	O
Mangina	S-Location
soon	O
afterwards	O
seven	O
members	O
of	O
her	O
immediate	O
family	O
died	O
.	O

From	O
26	O
April	O
2009	O
,	O
to	O
13	O
February	O
2010	O
,	O
the	O
CDC	S-Organization
had	O
received	O
reports	O
of	O
the	O
deaths	O
of	O
277	O
children	O
with	O
laboratory-confirmed	O
2009	B-Disease
influenza	I-Disease
A	I-Disease
(H1N1)	E-Disease
within	O
.	O

A	O
subsequent	O
investigation	O
found	O
that	O
a	O
technician	O
had	O
removed	O
a	O
filter	S-Equipment
,	O
leaving	O
a	O
note	O
to	O
that	O
effect	O
.	O

The	O
reported	O
link	O
to	O
a	O
wholesale	O
fish	O
and	O
live	O
animal	O
market	O
could	O
indicate	O
an	O
exposure	O
link	O
to	O
animals	O
.	O

Although	O
the	O
Federal	O
Government	O
,	O
EPA	S-Organization
	S-Organization
provide	O
some	O
oversight	O
of	O
regulated	O
medical	O
waste	O
storage	O
,	O
transportation	O
,	O
and	O
disposal	O
the	O
majority	O
of	O
biohazard	O
medical	O
waste	O
is	O
regulated	O
at	O
the	O
state	O
level	O
.	O

Eighth	O
,	O
our	O
response	O
to	O
future	O
incidents	O
will	O
be	O
improved	O
by	O
rapidly	O
using	O
incident	O
management	O
systems	O
such	O
as	O
the	O
one	O
that	O
we	O
use	O
for	O
external	O
events	O
.	O

The	O
second	O
candidate	O
is	O
TIM-1	O
(a.k.a.HAVCR1)	O
.	O

Researchers	O
have	O
found	O
the	O
results	O
"	O
quite	O
encouraging	O
[but]	O
there	O
is	O
still	O
a	O
lot	O
more	O
work	O
to	O
be	O
done	O
on	O
vaccines	O
for	O
Ebola	S-Disease
.	O
"	O
Not	O
yet	O
known	O
is	O
the	O
length	O
of	O
time	O
that	O
a	O
vaccination	O
will	O
be	O
effective	O
and	O
whether	O
it	O
will	O
prove	O
effective	O
for	O
the	O
Sudan	B-Pathogen
virus	E-Pathogen
rather	O
than	O
only	O
EBOV	S-Pathogen
,	O
which	O
is	O
responsible	O
for	O
the	O
.	O

Betrayal	O
of	O
Trust:	O
The	O
Collapse	O
of	O
Global	O
Public	O
Health	O
,	O
(Google	O
Books)	O
,	O
Oxford	O
University	O
Press	O
,	O
2003	O
,	O
p.	O
340-41	O
,	O
()	O
.	O

If	O
oseltamivir	S-Drug
(	O
Tamiflu	S-Drug
)	O
is	O
unavailable	O
or	O
cannot	O
be	O
used	O
,	O
zanamivir	S-Drug
()	O
is	O
recommended	O
as	O
a	O
substitute	O
.	O

CRISPR-Cas	B-Technology
systems	E-Technology
can	O
also	O
be	O
employed	O
for	O
editing	O
of	O
micro-RNA	O
and	O
long-noncoding	O
RNA	O
genes	O
in	O
plants	O
.	O

Efforts	O
include	O
decontamination	B-Technology
technologies	E-Technology
to	O
restore	O
facilities	O
without	O
causing	O
additional	O
environmental	O
concerns	O
.	O

The	O
US	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
()	O
today	O
announced	O
a	O
multipronged	O
strategy	O
to	O
address	O
antimicrobial	O
resistance	O
(AMR)	O
that	O
emphasizes	O
new	O
measures	O
to	O
spur	O
development	O
of	O
antibiotics	O
and	O
alternative	O
therapies	O
,	O
promote	O
antibiotic	O
stewardship	O
in	O
animal	O
health	O
,	O
advance	O
antibiotic	O
resistance	O
surveillance	O
,	O
and	O
enhance	O
regulatory	O
science	O
.	O

This	O
type	O
of	O
attack	O
would	O
mean	O
the	O
anthrax	B-Pathogen
spores	E-Pathogen
could	O
easily	O
be	O
blown	O
around	O
by	O
the	O
wind	O
or	O
carried	O
on	O
people's	O
clothes	O
,	O
shoes	O
,	O
and	O
other	O
objects	O
.	O

As	O
the	O
epidemic	O
drew	O
to	O
a	O
close	O
in	O
2015	O
,	O
a	O
report	O
from	O
Sierra	B-Location
Leone	E-Location
showed	O
that	O
the	O
fear	O
and	O
mistrust	O
of	O
hospitals	O
generated	O
by	O
the	O
epidemic	O
had	O
resulted	O
in	O
an	O
11%	O
decline	O
in	O
facility-based	O
births	O
,	O
and	O
that	O
those	O
receiving	O
care	O
before	O
or	O
after	O
birth	O
fell	O
by	O
about	O
a	O
fifth	O
.	O

That	O
means	O
they	O
wear	O
highly	B-Equipment
protective	I-Equipment
form	I-Equipment
of	I-Equipment
personal	I-Equipment
respiration	E-Equipment
,	O
and	O
we	O
have	O
a	O
high	O
degree	O
of	O
confidence	O
that	O
no	O
one	O
at	O
was	O
exposed	O
and	O
that	O
there	O
was	O
no	O
release	O
of	O
these	O
samples	O
.	O

By	O
26	O
March	O
,	O
the	O
United	B-Location
States	E-Location
had	O
overtaken	O
China	S-Location
and	O
Italy	S-Location
with	O
the	O
highest	O
number	O
of	O
confirmed	O
cases	O
in	O
the	O
world	O
.	O

On	O
April	O
15	O
,	O
2013	O
,	O
an	O
envelope	O
that	O
preliminarily	O
tested	O
positive	O
for	O
ricin	S-Pathogen
a	O
highly	O
toxic	O
protein	O
,	O
was	O
intercepted	O
at	O
the	O
US	B-Location
Capitol	E-Location
's	O
off-site	O
mail	O
facility	O
in	O
Washington,	B-Location
D.C	E-Location
.	O
According	O
to	O
reports	O
,	O
the	O
envelope	O
was	O
addressed	O
to	O
the	O
office	B-Location
of	I-Location
Mississippi	I-Location
Republican	I-Location
Senator	I-Location
Roger	I-Location
Wicker	E-Location
.	O
On	O
April	O
17	O
,	O
2013	O
,	O
an	O
envelope	O
addressed	O
to	O
President	O
of	O
the	O
United	O
States	O
Barack	B-Person
Obama	E-Person
preliminarily	O
tested	O
positive	O
for	O
.	O

At	O
NCDC	S-Organization
()	O
and	O
our	O
collaborating	O
labs	O
across	O
the	O
country	O
,	O
over	O
the	O
last	O
two	O
years	O
,	O
we	O
have	O
strengthened	O
our	O
surveillance	O
infrastructure	O
,	O
we	O
have	O
strengthened	O
our	O
laboratories	O
.	O

More	O
efficient	O
classical	O
biowarfare	O
agents	O
will	O
probably	O
have	O
only	O
a	O
marginal	O
role	O
,	O
even	O
if	O
the	O
genetically	O
engineered	O
'superbug'	O
is	O
still	O
routinely	O
featured	O
in	O
newspaper	O
reports	O
.	O

In	O
the	O
lab	O
,	O
students	O
encounter	O
a	O
variety	O
of	O
relevant	O
methods	O
including	O
ELISA	S-Equipment
,	O
,	O
quantification	O
using	O
reporter	O
gene	O
,	O
and	O
more	O
.	O

On	O
24	O
April	O
2014	O
,	O
a	O
25-year-old	O
male	O
was	O
found	O
positive	O
for	O
the	O
coronavirus	S-Pathogen
He	O
had	O
history	O
of	O
exposure	O
to	O
camels	O
and	O
had	O
consumed	O
camel	O
milk	O
.	O

The	O
42-day	O
countdown	O
toward	O
Liberia	S-Location
being	O
declared	O
-free	O
,	O
for	O
the	O
third	O
time	O
,	O
started	O
on	O
4	O
December	O
2015	O
.	O

The	O
Data	O
Store	O
server	O
handles	O
high-volume	O
data-e.g.	O
next-generation	O
sequencing	O
data-in	O
a	O
separate	O
database	O
and	O
collects	O
new	O
data	O
items	O
via	O
drop	O
boxes	O
(directories	O
monitored	O
for	O
incoming	O
data)	O
or	O
via	O
a	O
remote	O
Java	O
API	O
using	O
the	O
secure	O
HTTPS	O
protocol	O
.	O

On	O
24	O
December	O
,	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
sent	O
a	O
bronchoalveolar	O
lavage	O
fluid	O
(BAL)	O
sample	O
from	O
an	O
unresolved	O
clinical	O
case	O
to	O
sequencing	O
company	O
Vision	B-Organization
Medicals	E-Organization
.	O
On	O
27	O
and	O
28	O
December	O
,	O
Vision	B-Organization
Medicals	E-Organization
informed	O
the	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
and	O
the	O
Chinese	B-Organization
CDC	E-Organization
of	O
the	O
results	O
of	O
the	O
test	O
,	O
showing	O
a	O
new	O
coronavirus	O
.	O

"	O
Ebola	S-Pathogen
just	O
festered	O
there	O
…	O
and	O
was	O
very	O
,	O
very	O
difficult	O
to	O
stop,	O
"	O
said	O
.	O

The	O
general	O
population	O
remained	O
uninformed	O
of	O
any	O
breakthroughs	O
concerning	O
biological	O
warfare	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	O
,	O
FDA	S-Organization
USDA	O
,	O
DHHS	O
,	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Use	O
orange	O
or	O
red	O
biohazard	B-Equipment
bags	E-Equipment
(or	O
other	O
appropriate	O
color	O
in	O
accordance	O
with	O
local	O
regulations)	O
as	O
required	O
by	O
institutional	O
procedure	O
.	O

The	O
agency's	O
global	O
divisions	O
include	O
the	O
Division	B-Organization
of	I-Organization
Global	I-Organization
HIV	I-Organization
and	I-Organization
TB	E-Organization
(	O
DGHT	S-Organization
)	O
,	O
the	O
Division	B-Organization
of	I-Organization
Parasitic	I-Organization
Diseases	I-Organization
and	I-Organization
Malaria	E-Organization
(	O
DPDM	S-Organization
)	O
,	O
the	O
Division	B-Organization
of	I-Organization
Global	I-Organization
Health	I-Organization
Protection	E-Organization
(	O
DGHP	S-Organization
)	O
,	O
and	O
the	O
Global	B-Organization
Immunization	I-Organization
Division	E-Organization
()	O
.	O

The	O
Office	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
would	O
be	O
cut	O
by	O
$136	O
million	O
,	O
or	O
9.7	O
percent	O
.	O

While	O
this	O
crisis	O
has	O
been	O
primarily	O
humanitarian	O
in	O
nature	O
,	O
the	O
work	O
we	O
have	O
done	O
can	O
help	O
reinforce	O
nonproliferation	O
norms	O
around	O
the	O
world	O
.	O

Gerstein	S-Person
formerly	O
served	O
in	O
the	O
Science	B-Organization
and	I-Organization
Technology	I-Organization
Directorate	I-Organization
of	I-Organization
the	I-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
from	O
2011	O
to	O
2014	O
.	O

By	O
autumn	O
1347	O
,	O
the	O
plague	S-Disease
reached	O
Alexandria	S-Location
in	O
Egypt	S-Location
,	O
transmitted	O
by	O
sea	O
from	O
Constantinople	S-Location
;	O
according	O
to	O
a	O
contemporary	O
witness	O
,	O
from	O
a	O
single	O
merchant	O
ship	O
carrying	O
slaves	O
.	O

She	O
calls	O
this	O
her	O
cheap	O
biohack	O
version	O
of	O
cryotherapy	S-Technology
-	O
or	O
-	O
and	O
admits	O
the	O
"	O
cops	O
on	O
her	O
street	O
"	O
think	O
it	O
is	O
hilarious	O
.	O

The	O
Spanish	B-Incident
flu	E-Incident
also	O
known	O
as	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
,	O
was	O
an	O
unusually	O
deadly	O
influenza	O
pandemic	O
caused	O
by	O
the	O
H1N1	B-Pathogen
influenza	I-Pathogen
A	I-Pathogen
virus	E-Pathogen
.	O
Lasting	O
about	O
15	O
months	O
from	O
spring	O
1918	O
(northern	O
hemisphere)	O
to	O
early	O
summer	O
1919	O
,	O
it	O
infected	O
500 million	O
people –	O
about	O
a	O
third	O
of	O
the	O
world's	O
population	O
at	O
the	O
time.	O
1918	B-Incident
Pandemic	E-Incident
(	O
H1N1	B-Pathogen
virus	E-Pathogen
).	O
.	O
Retrieved	O
April	O
18	O
,	O
2020	O
.	O

No	O
further	O
cases	O
were	O
reported	O
,	O
and	O
on	O
17	O
October	O
2014	O
,	O
the	O
WHO	S-Organization
officially	O
declared	O
that	O
the	O
outbreak	O
in	O
had	O
ended	O
.	O

The	O
authors	O
went	O
on	O
to	O
state	O
that	O
social	O
vulnerability	O
has	O
multiple	O
factors	O
and	O
proposed	O
a	O
classification	O
based	O
on	O
multiple	O
variables	O
instead	O
of	O
single	O
indicators	O
such	O
as	O
food	O
insecurity	O
or	O
lack	O
of	O
hospitals	O
,	O
which	O
were	O
problems	O
faced	O
by	O
rural	O
Liberians	O
.	O

Norwegian	O
historian	O
Ole	B-Person
Benedictow	E-Person
suggests	O
it	O
could	O
have	O
been	O
as	O
much	O
as	O
60%	O
of	O
the	O
European	O
population	O
.	O

In	O
China	S-Location
where	O
social	O
conditions	O
sharply	O
contrast	O
with	O
those	O
of	O
the	O
West	S-Location
,	O
genetic	B-Disease
diseases	E-Disease
carry	O
a	O
heavy	O
stigma	O
.	O

A	O
project	O
of	O
the	O
nonprofit	O
Hopewell	B-Organization
Fund	E-Organization
ARMADA	S-Scientific_research_project
will	O
use	O
the	O
technology	O
and	O
expertise	O
of	O
ID	B-Organization
Genomics	E-Organization
,	O
a	O
Seattle	S-Location
-based	O
diagnostics	O
company	O
,	O
to	O
build	O
the	O
database	O
and	O
characterize	O
the	O
bacterial	O
strains	O
through	O
their	O
genetic	O
fingerprints.	O
has	O
developed	O
a	O
diagnostic	O
technology	O
that	O
,	O
instead	O
of	O
analyzing	O
the	O
entire	O
genome	O
of	O
a	O
pathogen	O
,	O
looks	O
for	O
certain	O
"	O
barcode"	O
genes	O
that	O
can	O
be	O
used	O
to	O
identify	O
the	O
genetic	O
fingerprint	O
of	O
a	O
bacterial	O
strain	O
.	O

A	O
report	O
on	O
the	O
Japanese	O
use	O
of	O
plague	S-Pathogen
-infested	O
fleas	O
on	O
Changde	S-Location
was	O
made	O
widely	O
available	O
the	O
following	O
year	O
,	O
but	O
was	O
not	O
addressed	O
by	O
the	O
Allied	B-Organization
Powers	E-Organization
until	O
issued	O
a	O
public	O
warning	O
in	O
1943	O
condemning	O
the	O
attacks	O
.	O

The	O
virus	O
was	O
less	O
lethal	O
than	O
previous	O
pandemic	O
strains	O
and	O
killed	O
about	O
0.01–0.03%	O
of	O
those	O
infected	O
;	O
the	O
1918	B-Disease
influenza	E-Disease
was	O
about	O
one	O
hundred	O
times	O
more	O
lethal	O
and	O
had	O
a	O
case	O
fatality	O
rate	O
of	O
2–3%	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Our	O
report	O
outlines	O
all	O
prior	O
incidents	O
that	O
we're	O
currently	O
aware	O
of	O
dangerous	O
pathogens	O
leaving	O
a	O
CDC	S-Organization
lab	O
when	O
they	O
shouldn't	O
have	O
left	O
a	O
CDC	S-Organization
laboratory	O
.	O

Even	O
though	O
it	O
is	O
amongst	O
the	O
possibilities	O
of	O
the	O
technique	O
and	O
certainly	O
one	O
of	O
the	O
most	O
notorious	O
applications	O
,	O
we	O
need	O
to	O
wonder	O
whether	O
there	O
is	O
a	O
real	O
need	O
to	O
put	O
too	O
many	O
eggs	O
in	O
this	O
basket	O
,	O
and	O
meanwhile	O
disregard	O
other	O
potential	O
uses	O
that	O
are	O
far	O
more	O
urgent	O
for	O
public	O
health	O
and	O
advancement	O
of	O
our	O
societies	O
in	O
general	O
.	O

By	O
plugging	O
into	O
that	O
stream	O
of	O
data	O
,	O
NBIC	S-Organization
could	O
"	O
improve	O
its	O
capability	O
for	O
biothreat	O
awareness	O
,	O
detection	O
,	O
and	O
information	O
sharing	O
to	O
respond	O
to	O
incidents	O
that	O
may	O
cascade	O
into	O
a	O
nationally	O
significant	O
event,	O
"	O
officials	O
wrote	O
in	O
a	O
request	O
for	O
information	O
.	O

At	O
the	O
same	O
time	O
,	O
numerous	O
trends	O
including	O
increased	O
interactions	O
between	O
human	O
,	O
animal	O
,	O
and	O
insect	O
populations	O
due	O
to	O
globalization	O
,	O
densification	O
of	O
livestock	O
production	O
,	O
and	O
rising	O
human	O
encroachment	O
into	O
animal	O
habitats	O
have	O
increased	O
the	O
threat	O
of	O
novel	O
pathogens	O
in	O
regions	O
where	O
troops	O
,	O
humanitarian	O
workers	O
,	O
and	O
peacekeepers	O
tend	O
to	O
deploy	O
.	O

The	O
radiation	O
used	O
in	O
CT	S-Technology
scans	O
can	O
damage	O
body	O
cells	O
,	O
including	O
DNA	O
molecules	O
,	O
which	O
can	O
lead	O
to	O
radiation-induced	O
cancer	O
.	O

Smallpox	S-Pathogen
has	O
actually	O
been	O
declared	O
as	O
eradicated	O
as	O
far	O
back	O
as	O
1980	O
,	O
but	O
the	O
disease	O
remains	O
a	O
threat	O
due	O
to	O
the	O
concerns	O
of	O
the	O
virus	O
being	O
used	O
as	O
a	O
biological	O
weapon	O
.	O

The	O
closed	O
city	O
of	O
Sverdlovsk	S-Location
had	O
been	O
a	O
major	O
production	O
center	O
of	O
the	O
Soviet	S-Organization
military-industrial	O
complex	O
since	O
World	B-Incident
War	I-Incident
II	E-Incident
.	O
It	O
produced	O
tanks	O
,	O
ballistic	O
missiles	O
,	O
rockets	O
and	O
other	O
armaments	O
.	O

This	O
new	O
funding	O
also	O
provides	O
an	O
important	O
bridge	O
to	O
the	O
extension	O
of	O
the	O
GHSA	S-International_exchange_and_cooperation
announced	O
by	O
the	O
administration	O
in	O
October	O
2017	O
in	O
Uganda	S-Location
.	O
The	O
second	O
phase	O
of	O
will	O
begin	O
in	O
2020	O
and	O
build	O
our	O
country's	O
protection	O
capacity	O
into	O
the	O
next	O
decade	O
.	O

The	O
Australasian	B-Organization
Society	I-Organization
of	I-Organization
Clinical	I-Organization
Immunology	I-Organization
and	I-Organization
Allergy	E-Organization
recommends	O
that	O
be	O
considered	O
an	O
off-label	O
treatment	O
option	O
for	O
those	O
with	O
COVID‑19-related	O
acute	O
respiratory	O
distress	O
syndrome	O
.	O

Between	O
1990	O
and	O
2010	O
,	O
WHO	S-Organization
help	O
has	O
contributed	O
to	O
a	O
40%	O
decline	O
in	O
the	O
number	O
of	O
deaths	O
from	O
tuberculosis	S-Disease
,	O
and	O
since	O
2005	O
,	O
over	O
46	O
million	O
people	O
have	O
been	O
treated	O
and	O
an	O
estimated	O
7 million	O
lives	O
saved	O
through	O
practices	O
advocated	O
by	O
WHO	S-Organization
.	O
These	O
include	O
engaging	O
national	O
governments	O
and	O
their	O
financing	O
,	O
early	O
diagnosis	O
,	O
standardising	O
treatment	O
,	O
monitoring	O
of	O
the	O
spread	O
and	O
effect	O
of	O
tuberculosis	S-Disease
and	O
stabilising	O
the	O
drug	O
supply	O
.	O

For	O
her	O
,	O
the	O
emphasis	O
is	O
on	O
democratizing	O
cutting-edge	O
science	O
while	O
keeping	O
it	O
safe	O
.	O

Multiple	O
crRNAs	O
and	O
the	O
tracrRNA	O
can	O
be	O
packaged	O
together	O
to	O
form	O
a	O
single-guide	O
RNA	O
(sgRNA)	O
.	O

Guillemin	S-Person
Biological	O
Weapons	O
,	O
pp.71–73	O
.	O

Preliminary	O
results	O
were	O
promising	O
;	O
it	O
was	O
used	O
in	O
the	O
emergency	O
setting	O
during	O
the	O
Kivu	S-Location
Ebola	B-Disease
epidemic	E-Disease
that	O
started	O
in	O
2018	O
,	O
along	O
with	O
further	O
clinical	O
trials	O
,	O
until	O
August	O
2019	O
,	O
when	O
Congolese	O
health	O
officials	O
announced	O
that	O
it	O
was	O
significantly	O
less	O
effective	O
than	O
monoclonal	O
antibody	O
treatments	O
such	O
as	O
mAb114	S-Drug
and	O
.	O
The	O
trials	O
,	O
however	O
,	O
established	O
its	O
safety	O
profile	O
.	O

Masks	O
may	O
benefit	O
people	O
in	O
close	O
contact	O
with	O
infected	O
persons	O
,	O
but	O
it	O
is	O
unknown	O
whether	O
they	O
prevent	O
H1N1	B-Disease
flu	E-Disease
infection	O
.	O

It	O
was	O
later	O
revealed	O
that	O
laboratory	O
and	O
field	O
testing	O
(some	O
of	O
the	O
latter	O
using	O
simulants	O
on	O
non-consenting	O
individuals)	O
had	O
been	O
common	O
.	O

These	O
events	O
should	O
never	O
happen	O
.	O

In	O
the	O
United	B-Location
States	E-Location
the	O
prisoner	O
population	O
is	O
aging	O
and	O
many	O
of	O
them	O
are	O
at	O
high	O
risk	O
for	O
poor	O
outcomes	O
from	O
due	O
to	O
high	O
rates	O
of	O
coexisting	O
heart	O
and	O
lung	O
disease	O
,	O
and	O
poor	O
access	O
to	O
high-quality	O
healthcare	O
.	O

The	O
use	O
of	O
steroids	S-Drug
may	O
worsen	O
outcomes	O
.	O

As	O
the	O
outbreak	O
unfolded	O
,	O
global	O
health	O
officials	O
also	O
warned	O
that	O
Ebola	S-Pathogen
survivors	O
would	O
face	O
long-term	O
health	O
and	O
socioeconomic	O
challenges	O
,	O
which	O
prompted	O
and	O
other	O
countries	O
to	O
retool	O
some	O
of	O
their	O
response	O
plans	O
.	O

Moreover	O
,	O
some	O
adaptive	O
mutations	O
can	O
propagate	O
not	O
only	O
through	O
inheritance	O
but	O
also	O
through	O
horizontal	O
gene	O
transfer	O
.	O

This	O
isn't	O
just	O
a	O
problem	O
in	O
the	O
United	B-Location
States	E-Location
but	O
a	O
global	O
emerging	O
threat	O
.	O

But	O
in	O
terms	O
of	O
smallpox	S-Pathogen
,	O
we're	O
confident	O
that	O
there	O
are	O
not	O
other	O
samples	O
anywhere	O
at	O
CDC	S-Organization
.	O
I	O
will	O
say	O
that	O
there	O
is	O
an	O
analogy	O
with	O
polio	S-Disease
because	O
we're	O
now	O
making	O
progress	O
toward	O
polio	S-Disease
eradication	O
.	O

Due	O
to	O
current	O
advances	O
in	O
genetics	O
and	O
biotechnology	O
these	O
bacteriophages	O
can	O
possibly	O
be	O
manufactured	O
to	O
treat	O
specific	O
infections	O
.	O

We	O
are	O
not	O
just	O
understanding	O
our	O
genome	O
,	O
we	O
are	O
editing	O
it	O
.	O

Announcing	O
a	O
review	O
of	O
the	O
WHO	S-Organization
's	O
actions	O
,	O
spokeswoman	O
Fadela	B-Person
Chaib	E-Person
stated:	O
"	O
Criticism	O
is	O
part	O
of	O
an	O
outbreak	O
cycle	O
.	O

WHO	S-Organization
Assistant	O
Director-General	O
for	O
Global	B-Organization
Health	I-Organization
Security	E-Organization
,	O
Keiji	B-Person
Fukuda	E-Person
,	O
said	O
on	O
3	O
September	O
2014	O
,	O
"	O
We	O
don't	O
have	O
enough	O
health	O
workers	O
,	O
doctors	O
,	O
nurses	O
,	O
drivers	O
,	O
and	O
contact	O
tracers	O
to	O
handle	O
the	O
increasing	O
number	O
of	O
cases.	O
"	O
There	O
was	O
a	O
massive	O
effort	O
to	O
train	O
volunteers	O
and	O
health	O
workers	O
,	O
sponsored	O
by	O
United	B-Organization
States	I-Organization
Agency	I-Organization
for	I-Organization
International	I-Organization
Development	E-Organization
(	O
USAID	S-Organization
)	O
.	O

As	O
evidence	O
of	O
a	O
weapons	O
link	O
,	O
the	O
Monterey	B-Document
report	E-Document
cites	O
an	O
interview	O
with	O
General	O
Pyotr	B-Person
Burgasov	E-Person
,	O
a	O
former	O
official	O
in	O
the	O
Soviet	B-Scientific_research_project
germ	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
.	O
News	O
,	O
a	O
Russian	O
publication	O
,	O
quoted	O
him	O
in	O
November	O
as	O
saying	O
the	O
outbreak	O
was	O
caused	O
by	O
field	O
testing	O
of	O
400	O
grams	O
,	O
or	O
a	O
little	O
less	O
than	O
a	O
pound	O
,	O
of	O
germs	O
.	O

Thus	O
,	O
the	O
can	O
be	O
regarded	O
as	O
complementary	O
to	O
each	O
agency's	O
existing	O
management	O
systems	O
.	O

There	O
were	O
ceramic	O
containers	O
that	O
had	O
some	O
similarity	O
to	O
Japanese	O
weapons	O
used	O
against	O
the	O
Chinese	O
in	O
World	O
War	O
II	O
,	O
developed	O
by	O
.	O

CRISPR	S-Technology
screening	O
helps	O
scientist	O
to	O
create	O
a	O
systematic	O
and	O
high-throughput	O
genetic	O
perturbation	O
within	O
live	O
model	O
organisms	O
.	O

On	O
25	O
August	O
,	O
ASM	S-Organization
asked	O
its	O
members	O
to	O
check	O
what's	O
in	O
their	O
freezers	O
.	O

On	O
29	O
April	O
,	O
WHO	S-Organization
reported	O
that	O
Liberia	S-Location
had	O
discharged	O
the	O
last	O
patient	O
and	O
had	O
begun	O
the	O
42-day	O
countdown	O
to	O
be	O
declared	O
Ebola	S-Disease
-free	O
once	O
more	O
.	O

ASM	O
members	O
are	O
now	O
obligated	O
to	O
discourage	O
any	O
use	O
of	O
microbiology	O
contrary	O
to	O
the	O
welfare	O
of	O
humankind	O
,	O
including	O
the	O
use	O
of	O
microbes	O
as	O
biological	O
weapons	O
and	O
will	O
call	O
to	O
the	O
attention	O
of	O
the	O
public	O
or	O
the	O
appropriate	O
authorities	O
misuses	O
of	O
microbiology	O
or	O
of	O
information	O
derived	O
from	O
microbiology	O
.	O

Definitive	O
confirmation	O
of	O
the	O
role	O
of	O
Y.	B-Pathogen
pestis	E-Pathogen
arrived	O
in	O
2010	O
with	O
a	O
publication	O
in	O
PLOS	B-Organization
Pathogens	I-Organization
by	I-Organization
Haensch	E-Organization
et	O
al	O
.	O

Facing	O
the	O
unprecedented	O
threats	O
of	O
climate	O
change	O
,	O
many	O
researchers	O
believe	O
rDNA	O
and	O
GMOs	O
will	O
be	O
crucial	O
in	O
humanity's	O
efforts	O
to	O
adapt	O
to	O
rapid	O
environmental	O
changes	O
.	O

This	O
was	O
intended	O
for	O
delivery	O
by	O
the	O
MGM-29	O
Sergeant	O
missile	O
warhead	O
and	O
could	O
produce	O
50%	O
infection	O
over	O
a	O
area.Countermeasures	O
,	O
Chapter	O
6	O
–	O
An	O
Overview	O
of	O
Emerging	O
Missile	O
State	O
Countermeasures	O
,	O
p.	O
14	O
,	O
accessed	O
November	O
12	O
,	O
2008	O
.	O

Boots	O
and	O
aprons	O
can	O
be	O
disinfected	O
and	O
reused	O
,	O
but	O
everything	O
else	O
must	O
be	O
destroyed	O
after	O
use	O
.	O

The	O
war	O
brought	O
the	O
virus	O
back	O
into	O
the	O
US	S-Location
for	O
the	O
second	O
wave	O
of	O
the	O
epidemic	O
.	O

Furthermore	O
,	O
following	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
"	O
Animal	O
Rule	O
"	O
interpreted	O
for	O
smallpox	S-Pathogen
therapeutics	O
by	O
an	O
expert	O
advisory	O
committee	O
,	O
the	O
investigators	O
on	O
the	O
study	O
found	O
that	O
the	O
minimum	O
dose	O
of	O
tecovirimat	S-Vaccine
needed	O
to	O
achieve	O
over	O
90%	O
survival	O
in	O
a	O
monkeypox/nonhuman	O
primate	O
(NHP)	O
model	O
was	O
10	O
mg/kg	O
for	O
14	O
days	O
.	O

The	O
participants	O
believe	O
that	O
if	O
the	O
appropriate	O
actions	O
are	O
taken	O
on	O
a	O
worldwide	O
scale	O
,	O
the	O
odds	O
can	O
be	O
changed	O
.	O

Werner	B-Person
Troesken	E-Person
,	O
The	O
Great	O
Lead	O
Water	O
Pipe	O
Disaster	O
(Cambridge	O
MA:	O
MIT	O
Press	O
,	O
2006)	O
,	O
205-7.	O
,	O
9780262201674	O
;	O
and	O
,	O
Lead	O
in	O
Drinking	O
Water:	O
Washington	O
,	O
DC	O
Issues	O
and	O
Broader	O
Regulatory	O
Implications	O
(Washington	O
DC:	O
Congressional	O
Research	O
Service	O
,	O
Library	O
of	O
Congress	O
,	O
2004)	O
.	O

"	O
Resources	O
are	O
critical	O
in	O
responding	O
to	O
emergencies,	O
"	O
said	O
Dr	O
.	O

The	O
panel	O
outlined	O
10	O
recommendations	O
for	O
the	O
prevention	O
and	O
handling	O
of	O
future	O
infectious	O
disease	O
outbreaks	O
.	O

The	O
safety	O
of	O
nootropics	S-Drug
is	O
controversial	O
.	O

Recommendations	O
in	O
the	O
report	O
,	O
issued	O
by	O
Lisa	B-Person
Monaco	E-Person
assistant	O
to	O
the	O
president	O
for	O
homeland	O
security	O
and	O
counterterrorism	O
,	O
and	O
,	O
assistant	O
to	O
the	O
president	O
for	O
science	O
and	O
technology	O
,	O
stressed	O
the	O
need	O
for	O
transparency	O
,	O
swift	O
reporting	O
of	O
incidents	O
,	O
accountability	O
to	O
the	O
public	O
and	O
strong	O
inventory	O
control	O
measures	O
.	O

This	O
was	O
followed	O
by	O
acute	B-Phenotype
fever	E-Phenotype
and	O
vomiting	B-Phenotype
of	I-Phenotype
blood	E-Phenotype
.	O
Most	O
victims	O
died	O
two	O
to	O
seven	O
days	O
after	O
initial	O
infection	O
.	O

Common	B-Organization
CDC	E-Organization
job	O
titles	O
include	O
engineer	O
,	O
entomologist	O
,	O
epidemiologist	O
,	O
biologist	O
,	O
physician	O
,	O
veterinarian	O
,	O
behavioral	O
scientist	O
,	O
nurse	O
,	O
medical	O
technologist	O
,	O
economist	O
,	O
public	O
health	O
advisor	O
,	O
health	O
communicator	O
,	O
toxicologist	O
,	O
chemist	O
,	O
computer	O
scientist	O
,	O
and	O
statistician	O
.	O

Amongst	O
the	O
secret	O
experiments	O
,	O
performed	O
by	O
Battelle	S-Organization
at	O
NBACC	S-Organization
,	O
are:	O
Assessment	O
of	O
powder	O
dissemination	O
technology	O
;	O
Assessment	O
of	O
hazard	O
posed	O
by	O
aerosolized	O
toxins	O
and	O
Assessment	O
of	O
virulence	O
of	O
B.	B-Pathogen
Pseudomallei	E-Pathogen
()	O
as	O
a	O
function	O
of	O
aerosol	O
particle	O
in	O
non-human	O
primates	O
.	O

On	O
26	O
July	O
,	O
it	O
was	O
reported	O
that	O
the	O
country	O
of	O
Saudi	B-Location
Arabia	E-Location
would	O
not	O
allow	O
visas	O
from	O
the	O
DRC	S-Location
after	O
the	O
WHO	S-Organization
declared	O
it	O
an	O
international	O
emergency	O
due	O
to	O
EVD	S-Disease
.	O
On	O
1	O
August	O
,	O
the	O
country	O
of	O
Rwanda	S-Location
closed	O
its	O
border	O
with	O
the	O
DRC	S-Location
,	O
due	O
to	O
multiple	O
cases	O
in	O
the	O
city	O
of	O
which	O
borders	O
the	O
country	O
in	O
the	O
upper	O
Northwestern	O
region	O
.	O

That	O
evening	O
,	O
the	O
issued	O
a	O
notice	O
to	O
various	O
medical	O
institutions	O
on	O
"	O
the	O
treatment	O
of	O
pneumonia	O
of	O
unknown	O
cause"	O
.	O

This	O
flu	O
killed	O
more	O
people	O
in	O
24 weeks	O
than	O
HIV/AIDS	S-Disease
killed	O
in	O
24	O
years	O
.	O

The	O
project	O
in	O
Afghanistan	S-Location
is	O
part	O
of	O
the	O
US	O
bio-defense	O
program	O
–	O
Cooperative	B-Scientific_research_project
Biological	I-Scientific_research_project
Engagement	I-Scientific_research_project
Program	E-Scientific_research_project
(	O
CBEP	S-Scientific_research_project
)	O
,	O
which	O
is	O
funded	O
by	O
the	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
(	O
DTRA	S-Organization
)	O
.	O

Germ	S-Person
"	O
),	O
educated	O
at	O
the	O
University	B-Organization
of	I-Organization
East	I-Organization
Anglia	E-Organization
,	O
was	O
head	O
of	O
Iraq's	B-Organization
military	I-Organization
research	I-Organization
and	I-Organization
development	I-Organization
institute	E-Organization
.	O
Another	O
scientist	O
received	O
a	O
doctorate	O
in	O
molecular	O
biology	O
from	O
the	O
University	B-Organization
of	I-Organization
Edinburgh	E-Organization
.Colvin	O
,	O
Op.	O
cit	O
.	O

On	O
9	O
April	O
,	O
James	B-Person
Earl	I-Person
Salisbury	E-Person
died	O
of	O
SARS	S-Disease
at	O
a	O
hospital	O
in	O
Hong	B-Location
Kong	E-Location
.	O
An	O
American	O
Mormon"Church	O
Member	O
Dies	O
of	O
SARS	S-Disease
"	O
,	O
11	O
April	O
2003	O
,	O
lds.org	O
.	O

As	O
of	O
,	O
more	O
than	O
cases	O
have	O
been	O
reported	O
across	O
countries	O
and	O
territories	O
,	O
resulting	O
in	O
more	O
than	O
deaths	O
.	O

In	O
the	O
past	O
seasons	O
,	O
for	O
example	O
,	O
the	O
outbreak	O
reached	O
a	O
population	O
of	O
8.	O
4	O
million	O
people	O
.	O

Production	O
of	O
cluster	O
bomb	O
submunitions	O
began	O
to	O
shift	O
from	O
cylindrical	O
to	O
spherical	O
bomblets	O
,	O
which	O
had	O
a	O
larger	O
coverage	O
area	O
.	O

The	O
JAMA	S-Organization
study	O
also	O
looked	O
at	O
-associated	O
deaths	O
over	O
a	O
23-year	O
period	O
,	O
from	O
1976–77	O
and	O
1998–99	O
with	O
estimates	O
of	O
respiratory	O
and	O
circulatory	O
influenza-associated	O
deaths	O
ranging	O
from	O
about	O
5,000	O
to	O
about	O
52,000	O
,	O
and	O
an	O
average	O
of	O
about	O
25,000	O
.	O

The	O
discovery	O
forced	O
16	O
employees	O
to	O
go	O
through	O
decontamination	O
procedures	O
,	O
but	O
no	O
one	O
reported	O
any	O
ill	O
effects	O
afterward	O
,	O
said	O
.	O

The	O
strong	O
link	O
between	O
increased	O
consumption	O
and	O
resistance	O
indicates	O
that	O
this	O
will	O
directly	O
mitigate	O
the	O
accelerating	O
spread	O
of	O
AMR	O
.	O

Each	O
of	O
the	O
bacteria	O
carried	O
a	O
set	O
of	O
genes	O
that	O
made	O
it	O
either	O
produce	O
black	O
pigment	O
or	O
not	O
.	O

The	O
subscription	O
fees	O
for	O
access	O
to	O
the	O
new	O
drugs	O
would	O
be	O
priced	O
at	O
such	O
a	O
level	O
to	O
create	O
a	O
sufficient	O
return	O
on	O
investment	O
,	O
explained.	O
"	O
This	O
should	O
have	O
the	O
effect	O
of	O
creating	O
a	O
natural	O
market	O
for	O
drugs	O
that	O
meet	O
certain	O
important	O
specifications,	O
"	O
he	O
said	O
.	O

They	O
are	O
accorded	O
diplomatic	O
immunity	O
under	O
the	O
2002	O
US	S-Location
-	O
Agreement	O
on	O
defense	O
cooperation	O
.	O

The	O
discussions	O
on	O
codes	O
can	O
be	O
traced	O
to	O
a	O
November	O
2001	O
White	B-Organization
House	E-Organization
statement	O
endorsing	O
a	O
solid	O
framework	O
for	O
bioscientists	O
in	O
the	O
form	O
of	O
a	O
code	O
of	O
ethical	O
conduct	O
that	O
would	O
have	O
universal	O
recognition	O
.	O

As	O
of	O
February	O
2016	O
is	O
in	O
use	O
at	O
three	O
sites	O
.	O

On	O
the	O
phone?	O

No	O
exhaustive	O
catalogue	O
of	O
GCBR	O
culprits	O
exists	O
,	O
leaving	O
the	O
health	O
security	O
community	O
to	O
rely	O
on	O
historical	O
examples	O
(e.g.	O
,	O
)	O
to	O
guide	O
their	O
preparedness	O
priorities	O
.	O

I'm	O
going	O
to	O
stop	O
there	O
.	O

With	O
such	O
a	O
treasure	O
trove	O
to	O
mine	O
and	O
the	O
active	O
involvement	O
and	O
wealth	O
of	O
experience	O
of	O
the	O
established	O
pharmaceutical	O
industry	O
(which	O
was	O
in	O
fact	O
founded	O
on	O
natural	O
product	O
development	O
in	O
the	O
1950s	O
–	O
70s)	O
the	O
target	O
would	O
be	O
attainable	O
.	O

According	O
to	O
the	O
authorities	O
,	O
some	O
patients	O
were	O
operating	O
dealers	O
or	O
vendors	O
in	O
the	O
Huanan	B-Location
Seafood	I-Location
market	E-Location
Based	O
on	O
the	O
preliminary	O
information	O
from	O
the	O
Chinese	O
investigation	O
team	O
,	O
no	O
evidence	O
of	O
significant	O
human-to-human	O
transmission	O
and	O
no	O
health	O
care	O
worker	O
infections	O
have	O
been	O
reported	O
.	O

Frieden	S-Person
.	O
I	O
have	O
three	O
quick	O
questions	O
.	O

Cong	O
.	O

CDC	S-Organization
today	O
released	O
the	O
findings	O
of	O
its	O
internal	O
investigation	O
into	O
the	O
and	O
the	O
subsequent	O
shipment	O
of	O
the	O
contaminated	O
culture	O
to	O
an	O
external	O
high-containment	O
laboratory	O
.	O

Something	O
that	O
may	O
take	O
up	O
to	O
two	O
weeks	O
.	O

On	O
8	O
November	O
2012	O
,	O
in	O
an	O
article	O
published	O
in	O
the	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
Dr	O
.	O

See	O
,	O
generally	O
,	O
Article	O
18	O
of	O
the	O
.	O

No	O
repeat	O
attacks	O
or	O
hoaxes	O
subsequently	O
occurred	O
,	O
and	O
a	O
detailed	O
account	O
of	O
the	O
incident	O
and	O
investigation	O
was	O
published	O
in	O
JAMA	S-Organization
in	O
1997	O
.	O

Boots	O
and	O
aprons	O
can	O
be	O
disinfected	O
and	O
reused	O
,	O
but	O
everything	O
else	O
must	O
be	O
destroyed	O
after	O
use	O
.	O

The	O
efficiency	O
of	O
Cas9-endonuclease	O
and	O
the	O
ease	O
by	O
which	O
genes	O
can	O
be	O
targeted	O
led	O
to	O
the	O
development	O
of	O
CRISPR-knockout	B-Platform
(KO)	I-Platform
libraries	E-Platform
both	O
for	O
mouse	O
and	O
human	O
cells	O
,	O
which	O
can	O
cover	O
either	O
specific	O
gene	O
sets	O
of	O
interest	O
or	O
the	O
whole-genome	O
.	O

In	O
MeSH	O
,	O
"	O
computed	B-Technology
axial	I-Technology
tomography	E-Technology
was	O
used	O
from	O
1977	O
to	O
1979	O
,	O
but	O
the	O
current	O
indexing	O
explicitly	O
includes	O
"	O
"	O
in	O
the	O
title	O
.	O

Nixon	S-Person
ended	O
the	O
debate	O
when	O
he	O
added	O
toxins	O
to	O
the	O
bio-weapons	O
ban	O
in	O
February	O
1970.The	O
U.S.	S-Location
also	O
ran	O
a	O
series	O
of	O
experiments	O
with	O
anthrax	S-Pathogen
,	O
code	O
named	O
Project	B-Scientific_research_project
Bacchus	E-Scientific_research_project
,	O
Project	B-Scientific_research_project
Clear	I-Scientific_research_project
Vision	E-Scientific_research_project
and	O
in	O
the	O
late	O
1990s	O
and	O
early	O
2000s	O
.	O

The	O
first	O
North	O
American	S-Location
plague	O
epidemic	O
was	O
the	O
,	O
followed	O
by	O
another	O
outbreak	O
in	O
1907–1908	O
.	O

DOIs	O
can	O
be	O
minted	O
via	O
DataCite's	O
MetadataStore	O
Application	O
interface	O
(API)	O
after	O
the	O
associated	O
data	O
center	O
,	O
institutional	O
repository	O
or	O
supplementary	O
data	O
archive	O
has	O
been	O
registered	O
with	O
the	O
MetadataStore	O
service	O
.	O

They	O
agreed	O
to	O
support	O
basic	O
and	O
clinical	O
research	O
under	O
certain	O
legal	O
and	O
ethical	O
guidelines	O
.	O

Zelicoff	S-Person
is	O
to	O
present	O
a	O
summary	O
of	O
the	O
report	O
today	O
in	O
Washington	S-Location
to	O
federal	O
officials	O
who	O
are	O
developing	O
guidelines	O
on	O
whether	O
should	O
be	O
offered	O
to	O
anyone	O
besides	O
the	O
few	O
researchers	O
who	O
now	O
work	O
with	O
the	O
virus	O
.	O

Werner	B-Person
Troesken	E-Person
,	O
The	O
Great	O
Lead	O
Water	O
Pipe	O
Disaster	O
(Cambridge	O
MA:	O
MIT	O
Press	O
,	O
2006)	O
,	O
205-7.	O
,	O
9780262201674	O
;	O
and	O
,	O
Lead	O
in	O
Drinking	O
Water:	O
Washington	O
,	O
DC	O
Issues	O
and	O
Broader	O
Regulatory	O
Implications	O
(Washington	O
DC:	O
Congressional	O
Research	O
Service	O
,	O
Library	O
of	O
Congress	O
,	O
2004)	O
.	O

A	O
monoclonal	O
antibody	O
against	O
the	O
IgV	O
domain	O
of	O
TIM-1	O
,	O
ARD5	O
,	O
blocked	O
binding	O
and	O
infection	O
.	O

Any	O
results	O
and	O
products	O
generated	O
in	O
a	O
project	O
are	O
jointly	O
owned	O
by	O
all	O
4	O
agencies	O
.	O

According	O
to	O
official	O
Chinese	O
sources	O
,	O
these	O
were	O
mostly	O
linked	O
to	O
the	O
,	O
which	O
also	O
sold	O
live	O
animals	O
.	O

"	O
To	O
give	O
you	O
some	O
context	O
,	O
the	O
decline	O
here	O
in	O
China	S-Location
is	O
now	O
almost	O
as	O
much	O
as	O
the	O
total	O
amount	O
of	O
pork	O
produced	O
in	O
the	O
EU	S-Location
as	O
a	O
whole,	O
"	O
says	O
Rabobank	S-Organization
global	O
strategist	O
.	O

Aspirin	S-Drug
and	O
other	O
salicylate	S-Drug
products	O
should	O
not	O
be	O
used	O
by	O
people	O
under	O
16	O
with	O
any	O
flu-type	O
symptoms	O
because	O
of	O
the	O
risk	O
of	O
developing	O
.	O

He	O
added	O
that	O
he	O
is	O
responding	O
to	O
queries	O
about	O
the	O
incident	O
so	O
that	O
can	O
focus	O
on	O
moving	O
four	O
researchers	O
and	O
their	O
projects	O
to	O
the	O
off-site	O
lab	O
.	O

During	O
the	O
1970s	O
,	O
WHO	S-Organization
had	O
dropped	O
its	O
commitment	O
to	O
a	O
global	O
malaria	O
eradication	O
campaign	O
as	O
too	O
ambitious	O
,	O
it	O
retained	O
a	O
strong	O
commitment	O
to	O
malaria	O
control	O
.	O

Environmental	O
risk	O
factors	O
,	O
such	O
as	O
air	O
,	O
water	O
and	O
soil	O
pollution	O
,	O
chemical	O
exposures	O
,	O
climate	O
change	O
,	O
and	O
ultraviolet	O
radiation	O
,	O
contribute	O
to	O
more	O
than	O
100	O
diseases	O
and	O
injuries	O
.	O

US	B-Organization
Army	E-Organization
documents	O
and	O
photos	O
show	O
that	O
the	O
has	O
developed	O
various	O
dissemination	O
methods	O
for	O
bioterrorism	O
attacks	O
including	O
by	O
explosives	O
.	O

22	O
states	O
have	O
approved	O
Occupational	B-Document
Safety	I-Document
plans	E-Document
by	O
that	O
are	O
audited	O
annually	O
for	O
effectiveness	O
.	O

The	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
is	O
developing	O
materials	O
to	O
provide	O
'second	O
skin'	O
protection	O
from	O
exposure	O
to	O
chemical	O
and	O
biological	O
agents	O
with	O
the	O
breathability	O
and	O
comfort	O
of	O
warfighters'	O
own	O
skin	O
.	O

In	O
supplement	O
form	O
,	O
nootropics	S-Drug
aren't	O
regulated	O
by	O
the	O
.	O

The	O
most	O
frequently	O
reported	O
symptoms	O
were	O
lethargy	S-Phenotype
or	O
fatigue	S-Phenotype
,	O
joint	B-Phenotype
pain	E-Phenotype
,	O
and	O
hair	B-Phenotype
loss	E-Phenotype
.	O
Sixty-three	O
per	O
cent	O
reported	O
having	O
eye	O
problems	O
including	O
two	O
who	O
were	O
diagnosed	O
with	O
,	O
75%	O
reported	O
psychological	O
or	O
cognitive	O
symptoms	O
,	O
and	O
38%	O
reported	O
neural	O
difficulties	O
.	O

The	O
ad	O
stated:	O
"	O
Breeders	O
if	O
you're	O
for	O
real	O
send	O
one	O
of	O
your	O
little	O
friends	O
.	O

This	O
report	O
focuses	O
specifically	O
on	O
data	O
assets	O
identified	O
by	O
the	O
agencies	O
as	O
having	O
high	O
value	O
and	O
that	O
are	O
restricted	O
or	O
nonpublic	O
.	O

At	O
Karlstein	S-Location
in	O
,	O
attacking	O
forces	O
launched	O
the	O
decaying	O
cadavers	O
of	O
men	O
killed	O
in	O
battle	O
over	O
the	O
castle	O
walls	O
.	O

Scientists	O
were	O
puzzled	O
and	O
said	O
that	O
the	O
sudden	O
appearance	O
of	O
the	O
insects	O
"	O
defies	O
logic"	O
,	O
and	O
some	O
speculated	O
"	O
biological	O
terrorists	O
"	O
were	O
responsible	O
.	O

In	O
2016	O
,	O
the	O
agency	O
objected	O
to	O
Zayner	S-Person
selling	O
kits	O
to	O
brew	O
glow-in-the-dark	O
beer	O
.	O

A	O
field	O
scientific	O
research	O
laboratory	O
to	O
conduct	O
biological	O
experiments	O
was	O
expanded	O
,	O
and	O
the	O
town	B-Location
of	I-Location
Kantubek	E-Location
was	O
constructed	O
to	O
house	O
employees	O
and	O
scientists.	O
,	O
A.P	O
.	O

With	O
the	O
support	O
of	O
international	O
organizations	O
that	O
focus	O
on	O
biosafety	O
and	O
biosecurity	O
,	O
a	O
number	O
of	O
biosafety	O
initiatives	O
took	O
place	O
after	O
2000	O
in	O
the	O
scientific	O
community	O
of	O
the	O
region	O
.	O

DNA	O
taken	O
from	O
25	O
skeletons	O
from	O
14th	O
century	O
London	S-Location
have	O
shown	O
the	O
plague	S-Disease
is	O
a	O
strain	O
of	O
Y.	B-Pathogen
pestis	E-Pathogen
almost	O
identical	O
to	O
that	O
which	O
hit	O
in	O
2013	O
.	O

A	O
2007	O
report	O
warns	O
that	O
the	O
danger	O
of	O
this	O
development	O
is	O
not	O
just	O
bio-terror	O
,	O
but	O
"	O
bio-error".	O

Fort	B-Organization
Detrick	E-Organization
officials	O
stated	O
they	O
have	O
notified	O
appropriate	O
local	O
,	O
state	O
and	O
federal	O
officials	O
of	O
the	O
situation	O
and	O
will	O
continue	O
to	O
work	O
with	O
regulatory	O
agencies	O
,	O
including	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
and	O
the	O
,	O
to	O
ensure	O
compliance	O
and	O
determine	O
the	O
necessary	O
next	O
steps	O
.	O

The	O
1925	B-Document
Geneva	I-Document
Protocol	E-Document
ratified	O
by	O
most	O
major	O
powers	O
in	O
the	O
1920s	O
and	O
30s	O
,	O
had	O
still	O
not	O
been	O
ratified	O
by	O
the	O
United	B-Location
States	E-Location
at	O
the	O
dawn	O
of	O
World	O
War	O
II	O
.	O

There	O
is	O
no	O
known	O
vaccine	O
or	O
specific	O
antiviral	O
treatment	O
.	O

Retrieved	O
March	O
4	O
,	O
2011	O
.	O

The	O
report	O
,	O
"	O
The	O
Characteristics	B-Document
of	I-Document
Pandemic	I-Document
Pathogens	E-Document
establishes	O
a	O
framework	O
for	O
identifying	O
naturally	O
occurring	O
microorganisms	O
that	O
pose	O
a	O
global	O
catastrophic	O
biological	O
risk	O
(GCBR)	O
and	O
makes	O
broad	O
recommendations	O
for	O
improving	O
GCBR	O
preparedness	O
efforts	O
.	O

Only	O
rarely	O
do	O
pregnant	O
women	O
survive-a	O
midwife	O
who	O
worked	O
with	O
MSF	S-Organization
in	O
a	O
Sierra	B-Organization
Leone	I-Organization
treatment	I-Organization
centre	E-Organization
stated	O
that	O
she	O
knew	O
of	O
"	O
no	O
reported	O
cases	O
of	O
pregnant	O
mothers	O
and	O
unborn	O
babies	O
surviving	O
Ebola	S-Disease
in	O
Sierra	B-Location
Leone	E-Location
.	O
"	O
In	O
September	O
2015	O
,	O
the	O
WHO	S-Organization
issued	O
pregnancy	O
guidance	O
information	O
entitled	O
,	O
"	O
."	O

Very	O
few	O
initiatives	O
were	O
identified	O
using	O
key	O
words	O
"	O
student	O
exchange	O
program	O
,	O
regional	O
training	O
centers	O
,	O
and	O
disease	O
surveillance	O
"	O
against	O
collective	O
term	O
BMENA	S-Location
representing	O
the	O
region	O
.	O

And	O
in	O
a	O
final	O
riddle	O
,	O
many	O
of	O
the	O
Medflies	O
have	O
been	O
trapped	O
just	O
outside	O
previous	O
spray	O
zones	O
,	O
forcing	O
steady	O
expansion	O
of	O
the	O
area	O
undergoing	O
malathion	S-Drug
treatments	O
.	O

Post	B-Incident
9/11	I-Incident
and	I-Incident
anthrax	I-Incident
in	I-Incident
the	I-Incident
mail	I-Incident
bioterrorism	I-Incident
in	I-Incident
2001	E-Incident
the	O
focus	O
on	O
biosafety	O
initiatives	O
in	O
the	O
BMENA	S-Location
region	O
broadened	O
to	O
include	O
other	O
sciences	O
,	O
mainly	O
biomedical	O
sciences	O
and	O
to	O
some	O
extent	O
veterinary	O
sciences	O
,	O
bioengineering	O
,	O
chemical/nuclear	O
sciences	O
,	O
and	O
agricultural	O
sciences	O
,	O
especially	O
in	O
countries	O
with	O
the	O
backdrop	O
of	O
dynamic	O
or	O
unstable	O
geopolitical	O
circumstances	O
.	O

Since	O
the	O
program's	O
inception	O
,	O
officials	O
said	O
,	O
scientists	O
at	O
the	O
laboratory	O
have	O
tested	O
more	O
than	O
11,000	O
human	O
blood	O
samples	O
and	O
have	O
confirmed	O
16	O
outbreaks	O
,	O
including	O
Ebola	S-Pathogen
Marburg	B-Disease
hemorrhagic	I-Disease
fever	E-Disease
,	O
Rift	B-Disease
Valley	I-Disease
Fever	E-Disease
,	O
and	O
.	O

In	O
April	O
2020	O
,	O
the	O
European	B-Organization
Medicines	I-Organization
Agency	E-Organization
(	O
EMA	S-Organization
)	O
started	O
a	O
'rolling	O
review'	O
of	O
data	O
on	O
the	O
use	O
of	O
remdesivir	S-Drug
in	O
.	O

The	O
report	O
by	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
,	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
(	O
FAO	S-Organization
)	O
,	O
and	O
the	O
World	B-Organization
Organization	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
(	O
OIE	S-Organization
)	O
evaluates	O
countries'	O
responses	O
to	O
a	O
self-assessment	O
survey	O
on	O
their	O
efforts	O
to	O
address	O
AMR	O
in	O
humans	O
,	O
animals	O
,	O
and	O
the	O
environment	O
.	O

These	O
are	O
all	O
types	O
of	O
biohacking	O
,	O
a	O
broad	O
term	O
for	O
a	O
lifestyle	O
that's	O
growing	O
increasingly	O
popular	O
,	O
and	O
not	O
just	O
in	O
Silicon	B-Location
Valley	E-Location
where	O
it	O
really	O
took	O
off	O
.	O

Study	O
co-author	O
Pamela	B-Person
Yeh	E-Person
Ph.D.	O
,	O
argues	O
that	O
combinations	O
of	O
multiple	O
antibiotics	O
"	O
will	O
work	O
much	O
better	O
"	O
than	O
current	O
strategies	O
,	O
when	O
it	O
comes	O
to	O
fighting	O
superbugs	O
.	O

Retrieved	O
21	O
September	O
2019	O
.	O

The	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
is	O
a	O
network	O
that	O
fosters	O
collaboration	O
among	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
the	O
laboratory	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
,	O
covering	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
public	O
health	O
and	O
biodefense	O
,	O
and	O
security	O
.	O

During	O
the	O
Middle	O
Ages	O
,	O
victims	O
of	O
the	O
bubonic	B-Disease
plague	E-Disease
were	O
used	O
for	O
biological	O
attacks	O
,	O
often	O
by	O
flinging	O
fomites	O
such	O
as	O
infected	O
corpses	O
and	O
excrement	O
over	O
castle	O
walls	O
using	O
catapults	O
.	O

The	O
great	O
majority	O
of	O
micro-organisms	O
are	O
harmless	O
and	O
many	O
are	O
beneficial	O
.	O

And	O
for	O
me	O
personally	O
,	O
this	O
is	O
the	O
most	O
distressing	O
of	O
the	O
three	O
incidents	O
for	O
two	O
reasons	O
.	O

This	O
involved	O
organization	O
and	O
hosting	O
of	O
national	O
and	O
international	O
conferences	O
,	O
seminars	O
,	O
and	O
training	O
workshops	O
on	O
general	O
awareness	O
aspects	O
of	O
biosafety	O
and	O
biosecurity	O
(Table	O
1)	O
.	O

By	O
negative	O
selection	O
dead	O
or	O
slow	O
growing	O
cells	O
are	O
efficiently	O
detected	O
.	O

The	O
data	O
,	O
gathered	O
during	O
three	O
weeks	O
of	O
contact	O
tracing	O
in	O
August	O
,	O
showed	O
that	O
the	O
third	O
person	O
in	O
any	O
transmission	O
chain	O
often	O
knew	O
both	O
the	O
first	O
and	O
second	O
person	O
.	O

Cell	O
culture	O
techniques	O
,	O
animal	O
virus	O
infection	O
,	O
quantification	O
,	O
and	O
identification	O
are	O
taught	O
at	O
a	O
biosafety	B-Platform
level	I-Platform
2	E-Platform
for	O
a	O
diverse	O
group	O
of	O
undergraduates	O
ranging	O
from	O
20	O
to	O
50	O
students	O
per	O
group.	O
©	O
2017	O
by	O
The	O
,	O
45(6):537–543	O
,	O
2017	O
.	O

In	O
addition	O
to	O
being	O
a	O
source	O
of	O
information	O
in	O
and	O
of	O
itself	O
,	O
it	O
is	O
also	O
host	O
to	O
the	O
International	B-Organization
Biosafety	I-Organization
Working	I-Organization
Group	E-Organization
()	O
,	O
a	O
compendium	O
of	O
international	O
regulations	O
and	O
guidelines	O
with	O
descriptions	O
and	O
URLs.	O
(Access	O
by	O
clicking	O
International	O
Biosafety	O
from	O
the	O
menu	O
bar	O
on	O
the	O
top	O
of	O
the	O
screen	O
.	O

The	O
pilot	O
survey	O
was	O
released	O
on	O
June	O
5	O
,	O
2013:	O
50	O
requests	O
to	O
participate	O
were	O
sent	O
out	O
,	O
with	O
25	O
participants	O
opening	O
the	O
request	O
,	O
and	O
23	O
agreeing	O
to	O
participate	O
.	O

Discrimination	O
against	O
Muslims	O
in	O
India	S-Location
escalated	O
after	O
public	O
health	O
authorities	O
identified	O
an	O
Islamic	O
missionary	O
group's	O
gathering	O
in	O
New	B-Location
Delhi	E-Location
in	O
early	O
March	O
2020	O
as	O
a	O
source	O
of	O
spread	O
.	O

The	O
tubes	O
were	O
identical	O
in	O
brand	O
and	O
size	O
and	O
only	O
differentiated	O
by	O
color	O
caps	O
and	O
labels	O
.	O

Each	O
Action	O
Package	O
includes	O
a	O
five-year	O
target	O
,	O
indicators	O
to	O
measure	O
progress	O
,	O
and	O
lists	O
of	O
baseline	O
assessment	O
,	O
planning	O
,	O
monitoring	O
,	O
and	O
evaluation	O
activities	O
to	O
support	O
successful	O
implementation	O
.	O

It	O
was	O
not	O
appropriate	O
.	O

Instead	O
,	O
malnourishment	O
,	O
overcrowded	O
medical	O
camps	O
and	O
hospitals	O
,	O
and	O
poor	O
hygiene	O
,	O
all	O
exacerbated	O
by	O
the	O
recent	O
war	O
,	O
promoted	O
bacterial	O
superinfection	O
.	O

Since	O
the	O
discovery	O
of	O
the	O
viruses	O
in	O
1976	O
,	O
when	O
outbreaks	O
occurred	O
in	O
South	B-Location
Sudan	E-Location
(then	O
Sudan	S-Location
)	O
and	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
(then	O
Zaire	S-Location
)	O
,	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
had	O
been	O
confined	O
to	O
areas	O
in	O
Middle	B-Location
Africa	E-Location
,	O
where	O
it	O
is	O
native	O
.	O

First	O
,	O
has	O
a	O
sensitivity	O
of	O
around	O
10−3	O
mol/L	O
to	O
10−5	O
mol/L	O
,	O
which	O
,	O
compared	O
to	O
other	O
types	O
of	O
imaging	O
,	O
can	O
be	O
very	O
limiting	O
.	O

That	O
was	O
before	O
smallpox	S-Pathogen
eradication	O
.	O

These	O
inappropriate	O
uses	O
of	O
antimicrobial	O
agents	O
promote	O
the	O
development	O
of	O
antimicrobial	O
resistance	O
by	O
supporting	O
the	O
bacteria	O
in	O
developing	O
genetic	O
alterations	O
that	O
lead	O
to	O
resistance	O
.	O

The	O
partnership	O
was	O
made	O
possible	O
through	O
a	O
meeting	O
of	O
the	O
two	O
institutions	O
arranged	O
by	O
the	O
National	B-Organization
Strategic	I-Organization
Research	I-Organization
Institute	E-Organization
(	O
NSRI	S-Organization
)	O
,	O
which	O
is	O
headquartered	O
on	O
the	O
UNMC	S-Organization
campus	O
in	O
Omaha	S-Location
.	O
The	O
NSRI	S-Organization
is	O
one	O
of	O
only	O
13	O
University	B-Organization
Affiliated	I-Organization
Research	I-Organization
Centers	E-Organization
(	O
UARC	S-Organization
)	O
in	O
the	O
country	O
,	O
and	O
the	O
only	O
with	O
a	O
primary	O
mission	O
responsibility	O
to	O
deliver	O
research	O
solutions	O
across	O
the	O
Combating	O
Weapons	O
of	O
Mass	O
Destruction	O
(chemical	O
,	O
biological	O
,	O
radiological	O
and	O
nuclear)	O
portfolio	O
.	O

Improvements	O
to	O
increase	O
MR	O
sensitivity	O
include	O
increasing	O
magnetic	O
field	O
strength	O
and	O
hyperpolarization	O
via	O
optical	O
pumping	O
or	O
dynamic	O
nuclear	O
polarization	O
.	O

Eastern	B-Pathogen
and	I-Pathogen
Western	I-Pathogen
equine	I-Pathogen
encephalitis	I-Pathogen
viruses	E-Pathogen
were	O
included	O
in	O
risk	O
group	O
1	O
of	O
the	O
China	S-Location
biosafety	O
categorization	O
,	O
but	O
were	O
included	O
in	O
risk	O
groups	O
2	O
and	O
3	O
according	O
to	O
NIH	S-Organization
and	O
categorization	O
,	O
respectively	O
.	O

The	O
system	O
works	O
by	O
tracking	O
the	O
symptoms	O
of	O
those	O
taken	O
into	O
the	O
emergency	O
department-based	O
on	O
the	O
location	O
of	O
the	O
hospital	O
to	O
which	O
they	O
are	O
taken	O
and	O
their	O
home	O
address-and	O
assessing	O
any	O
patterns	O
in	O
symptoms	O
.	O

Evidence	O
presented	O
by	O
several	O
internationally	O
recognised	O
experts	O
,	O
including	O
Kevin	B-Person
McCarthy	E-Person
Allan	B-Person
Watt	I-Person
Downie	E-Person
and	O
Keith	B-Person
R.	I-Person
Dumbell,	E-Person
showed	O
that	O
airborne	O
transmission	O
from	O
the	O
laboratory	O
to	O
the	O
telephone	O
room	O
where	O
Parker	S-Person
was	O
supposedly	O
infected	O
was	O
highly	O
improbable	O
.	O

As	O
of	O
17	O
May	O
,	O
according	O
to	O
a	O
New	B-Organization
York	I-Organization
Times	E-Organization
database	O
,	O
more	O
than	O
1,474,600	O
people	O
had	O
been	O
infected	O
and	O
at	O
least	O
88,600	O
had	O
died	O
in	O
the	O
United	B-Location
States	E-Location
.	O
The	O
Times	S-Organization
stated	O
that-previous	O
to	O
29	O
April-only	O
deaths	O
confirmed	O
through	O
testing	O
were	O
reported	O
,	O
but	O
new	O
criteria	O
include	O
probable	O
cases	O
and	O
deaths	O
.	O

The	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
()	O
is	O
a	O
network	O
that	O
fosters	O
collaboration	O
among	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
the	O
laboratory	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
,	O
covering	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
public	O
health	O
and	O
biodefense	O
,	O
and	O
security	O
.	O

A	O
dose	O
of	O
40	O
mg/kg	O
for	O
14	O
days	O
was	O
found	O
to	O
be	O
similarly	O
efficacious	O
in	O
the	O
rabbitpox/rabbit	O
model	O
.	O

Although	O
the	O
cell	O
had	O
all	O
its	O
original	O
parts	O
-	O
its	O
cell	O
membrane	O
and	O
all	O
its	O
organelles	O
-	O
all	O
the	O
DNA	O
was	O
replaced	O
.	O

We	O
do	O
have	O
the	O
ability	O
to	O
answer	O
your	O
questions	O
going	O
forward	O
.	O

Because	O
the	O
H1N1	B-Vaccine
vaccine	E-Vaccine
was	O
initially	O
in	O
short	O
supply	O
and	O
in	O
the	O
U.S.	S-Location
,	O
the	O
CDC	S-Organization
recommended	O
that	O
initial	O
doses	O
should	O
go	O
to	O
priority	O
groups	O
such	O
as	O
pregnant	O
women	O
,	O
people	O
who	O
live	O
with	O
or	O
care	O
for	O
babies	O
under	O
six	O
months	O
old	O
,	O
children	O
six	O
months	O
to	O
four	O
years	O
old	O
and	O
health-care	O
workers	O
.	O

In	O
May	O
2020	O
,	O
a	O
number	O
of	O
companies	O
in	O
India	S-Location
and	O
have	O
been	O
given	O
the	O
right	O
to	O
make	O
the	O
medication	O
.	O

If	O
a	O
terrorist	O
organization	O
were	O
able	O
to	O
obtain	O
a	O
host	O
,	O
gain	O
access	O
to	O
a	O
Category	O
4	O
Lab	O
and	O
isolate	O
the	O
virus	O
,	O
they	O
still	O
would	O
have	O
a	O
lot	O
of	O
work	O
to	O
do	O
before	O
they	O
could	O
use	O
Ebola	S-Disease
as	O
a	O
biological	O
weapon	O
.	O

The	O
first	O
wave	O
had	O
resembled	O
typical	O
flu	S-Disease
epidemics	O
;	O
those	O
most	O
at	O
risk	O
were	O
the	O
sick	O
and	O
elderly	O
,	O
while	O
younger	O
,	O
healthier	O
people	O
recovered	O
easily	O
.	O

The	O
ISA	O
software	O
suite	O
has	O
been	O
employed	O
in	O
several	O
projects	O
and	O
integrated	O
into	O
other	O
data	O
management	O
systems	O
,	O
e.g.	O
the	O
Harvard	B-Platform
stem	I-Platform
cell	I-Platform
discovery	I-Platform
engine	E-Platform
Installation	O
of	O
the	O
Java	O
applications	O
of	O
the	O
software	O
suite	O
is	O
simple	O
.	O

Because	O
our	O
scientists	O
and	O
our	O
laboratories	O
are	O
national	O
treasures	O
,	O
all	O
of	O
us	O
at	O
share	O
a	O
responsibility	O
to	O
make	O
sure	O
that	O
we	O
do	O
everything	O
possible	O
to	O
make	O
sure	O
our	O
staff	O
are	O
safe	O
when	O
they	O
do	O
their	O
work	O
.	O

In	O
Germany	S-Location
,	O
an	O
epidemic	O
of	O
infections	O
due	O
to	O
contaminated	O
vegetables	O
affected	O
up	O
to	O
5000	O
people	O
with	O
more	O
than	O
50	O
deaths	O
.	O

The	O
whole	O
system	O
is	O
controlled	O
by	O
one	O
or	O
more	O
computers	O
.	O

How	O
to	O
help	O
those	O
medical	O
responders	O
deal	O
with	O
a	O
rush	O
of	O
victims	O
in	O
a	O
stressful	O
setting	O
following	O
a	O
terror	O
attack	O
or	O
natural	O
disaster	O
will	O
be	O
part	O
of	O
the	O
focus	O
for	O
the	O
Valhalla	B-Organization
center	E-Organization
which	O
the	O
college	O
officially	O
opened	O
on	O
June	O
8	O
.	O

In	O
July	O
2014	O
,	O
leading	O
Ebola	S-Disease
doctor	O
Sheik	B-Person
Umar	I-Person
Khan	E-Person
from	O
Sierra	B-Location
Leone	E-Location
also	O
died	O
in	O
the	O
outbreak	O
.	O

The	O
ability	O
of	O
Cas9	O
to	O
be	O
introduced	O
in	O
vivo	O
allows	O
for	O
the	O
creation	O
of	O
more	O
accurate	O
models	O
of	O
gene	O
function	O
and	O
mutation	O
effects	O
,	O
all	O
while	O
avoiding	O
the	O
off-target	O
mutations	O
typically	O
observed	O
with	O
older	O
methods	O
of	O
.	O

In	O
December	O
,	O
CDC	S-Organization
reported	O
that	O
a	O
small	O
amount	O
of	O
material	O
from	O
an	O
experiment	O
that	O
was	O
part	O
of	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
study	O
was	O
securely	O
transported	O
from	O
a	O
select‐agent‐approved	O
BSL‐4	S-Platform
lab	O
to	O
a	O
select‐agent‐approved	O
BSL‐2	S-Platform
lab	O
and	O
may	O
have	O
contained	O
live	O
virus	O
.	O

Since	O
January	O
2015	O
,	O
the	O
affected	O
province	O
and	O
general	O
area	O
have	O
been	O
experiencing	O
a	O
military	O
conflict	O
,	O
which	O
is	O
hindering	O
treatment	O
and	O
prevention	O
efforts	O
.	O

Trump	S-Person
said	O
biological	O
threats	O
come	O
from	O
many	O
sources	O
and	O
know	O
no	O
borders.	O
"	O
They	O
have	O
great	O
potential	O
to	O
disrupt	O
the	O
economy	O
,	O
exact	O
a	O
toll	O
on	O
human	O
life	O
,	O
and	O
tear	O
at	O
the	O
very	O
fabric	O
of	O
society,	O
"	O
he	O
said.	O
"	O
My	O
Administration	O
will	O
take	O
steps	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
risks	O
posed	O
by	O
biological	O
threats	O
and	O
to	O
respond	O
to	O
them	O
effectively	O
and	O
efficiently.	O
"	O

"	O
What	O
the	O
CDC	S-Organization
incidents	O
showed	O
us	O
...	O
is	O
that	O
the	O
very	O
best	O
labs	O
are	O
not	O
perfectly	O
safe,	O
"	O
says	O
Marc	B-Person
Lipsitch	E-Person
,	O
a	O
professor	O
of	O
epidemiology.	O
"	O
If	O
it	O
can	O
happen	O
there	O
,	O
it	O
certainly	O
can	O
happen	O
anywhere.	O
"	O

Citizens	O
in	O
countries	O
including	O
Malaysia	S-Organization
,	O
New	B-Organization
Zealand	E-Organization
,	O
Singapore	S-Organization
,	O
Japan	S-Location
,	O
Vietnam	S-Organization
,	O
and	O
South	B-Location
Korea	E-Location
lobbied	O
to	O
ban	O
Chinese	O
people	O
from	O
entering	O
their	O
countries	O
.	O

China	S-Location
has	O
reported	O
its	O
first	O
case	O
of	O
African	B-Disease
swine	I-Disease
fever	E-Disease
(	O
ASF	S-Disease
)	O
,	O
a	O
highly	O
contagious	O
disease	O
of	O
pigs	O
,	O
in	O
the	O
northeastern	O
city	O
of	O
Shenyang	S-Location
and	O
culled	O
more	O
than	O
900	O
hogs	O
to	O
prevent	O
the	O
epidemic	O
from	O
spreading	O
,	O
local	O
media	O
reported	O
.	O

The	O
humanitarian	B-Organization
aid	I-Organization
organisation	I-Organization
Direct	I-Organization
Relief	E-Organization
sent	O
200,000	O
face	O
masks	O
and	O
other	O
personal	O
protective	O
equipment	O
to	O
the	O
Wuhan	B-Organization
Union	I-Organization
Hospital	E-Organization
the	O
same	O
day	O
.	O

On	O
20	O
April	O
it	O
was	O
reported	O
that	O
Brazil	S-Organization
had	O
a	O
record	O
1,179	O
deaths	O
in	O
a	O
single	O
day	O
,	O
for	O
a	O
total	O
of	O
almost	O
18,000	O
fatalities	O
.	O

And	O
in	O
case	O
of	O
backup	O
,	O
we're	O
authorized	O
to	O
work	O
in	O
one	O
of	O
our	O
laboratories	O
that	O
we	O
don't	O
have	O
contained	O
specimens	O
there	O
,	O
but	O
that's	O
a	O
backup	O
redundant	O
facility	O
.	O

A	O
new	O
highly	O
virulent	O
variant	O
of	O
the	O
cholera	S-Disease
agent	O
with	O
a	O
high	O
genetic	O
similarity	O
to	O
the	O
strains	O
reported	O
in	O
Ukraine	S-Location
,	O
hit	O
Moscow	S-Location
in	O
2014	O
.	O

This	O
study	O
was	O
investigating	O
the	O
compliance	O
of	O
diagnostics	O
laboratory	O
to	O
standard	O
biosafety	O
precautions	O
.	O

Dave	B-Person
Asprey	E-Person
a	O
biohacker	O
who	O
created	O
the	O
supplement	O
company	O
,	O
told	O
me	O
that	O
for	O
him	O
,	O
biohacking	O
is	O
"	O
the	O
art	O
and	O
science	O
of	O
changing	O
the	O
environment	O
around	O
you	O
and	O
inside	O
you	O
so	O
that	O
you	O
have	O
full	O
control	O
over	O
your	O
own	O
biology.	O
"	O
He's	O
very	O
game	O
to	O
experiment	O
on	O
his	O
body:	O
He	O
has	O
stem	O
cells	O
injected	O
into	O
his	O
joints	O
,	O
takes	O
dozens	O
of	O
supplements	O
daily	O
,	O
bathes	O
in	O
infrared	O
light	O
,	O
and	O
much	O
more	O
.	O

The	O
density	O
of	O
ACE2	O
in	O
each	O
tissue	O
correlates	O
with	O
the	O
severity	O
of	O
the	O
disease	O
in	O
that	O
tissue	O
and	O
some	O
have	O
suggested	O
decreasing	O
ACE2	O
activity	O
might	O
be	O
protective	O
,	O
though	O
another	O
view	O
is	O
that	O
increasing	O
ACE2	O
using	O
could	O
be	O
protective	O
.	O

In	O
retrospect	O
,	O
even	O
the	O
rapid	O
progressions	O
from	O
uncomplicated	O
influenza	S-Disease
infections	O
to	O
fatal	O
,	O
a	O
hallmark	O
of	O
the	O
1918–1919	O
fall	O
and	O
winter	O
waves	O
,	O
had	O
been	O
noted	O
in	O
the	O
relatively	O
few	O
severe	O
spring	O
wave	O
cases	O
.	O

A	O
cross-sectional	O
descriptive	O
study	O
was	O
designed	O
consisting	O
of	O
two	O
steps:	O
(1)	O
a	O
desktop	O
review/literature	O
search	O
for	O
all	O
biosafety-	O
and	O
biosecurity-related	O
initiatives	O
that	O
were	O
reported	O
from	O
the	O
BMENA	S-Location
region	O
between	O
2001	O
and	O
2013	O
using	O
commercial	O
search	O
engines	O
and	O
(2)	O
building	O
a	O
survey	O
instrument	O
in	O
the	O
commercially	O
available	O
SurveyMonkey	S-Platform
()	O
platform	O
and	O
administering	O
it	O
independently	O
to	O
scientists	O
in	O
the	O
study	O
countries	O
.	O

Speaking	O
on	O
27	O
January	O
2015	O
,	O
Guinea's	O
Grand	O
Imam	O
,	O
the	O
country's	O
highest	O
cleric	O
,	O
gave	O
a	O
very	O
strong	O
message	O
saying	O
,	O
"	O
There	O
is	O
nothing	O
in	O
the	O
Koran	O
that	O
says	O
you	O
must	O
wash	O
,	O
kiss	O
or	O
hold	O
your	O
dead	O
loved	O
ones,	O
"	O
and	O
he	O
called	O
on	O
citizens	O
to	O
do	O
more	O
to	O
stop	O
the	O
virus	O
by	O
practising	O
safer	O
burying	O
rituals	O
that	O
do	O
not	O
compromise	O
tradition	O
.	O

Thus	O
,	O
these	O
early	O
cases	O
were	O
diagnosed	O
as	O
other	O
conditions	O
more	O
common	O
to	O
the	O
area	O
and	O
the	O
disease	O
had	O
several	O
months	O
to	O
spread	O
before	O
it	O
became	O
recognised	O
as	O
.	O

But	O
,	O
we	O
are	O
doing	O
everything	O
possible	O
to	O
avert	O
even	O
more	O
cases	O
.	O

However	O
,	O
these	O
CDC	S-Organization
experiments	O
using	O
showed	O
that	O
a	O
very	O
small	O
number	O
of	O
spores	O
remained	O
viable	O
,	O
even	O
after	O
24	O
hours	O
of	O
treatment	O
with	O
the	O
extraction	O
chemicals	O
.	O

It	O
attracted	O
several	O
thousand	O
members	O
,	O
including	O
people	O
with	O
advanced	O
skills	O
in	O
chemistry	O
and	O
biology	O
.	O

Due	O
to	O
the	O
outcry	O
,	O
the	O
following	O
day	O
the	O
appointment	O
was	O
revoked	O
.	O

Equipment	O
failures	O
of	O
air-purifying	O
respirators	S-Equipment
potentially	O
exposed	O
workers	O
to	O
the	O
deadly	O
H5N1	B-Pathogen
strain	E-Pathogen
of	O
avian	B-Disease
influenza	E-Disease
during	O
separate	O
incidents	O
in	O
June	O
and	O
September	O
2014	O
at	O
the	O
USDA	S-Organization
's	O
Southeast	B-Organization
Poultry	I-Organization
Research	I-Organization
Laboratory	E-Organization
in	O
Athens	S-Location
,	O
Ga.	S-Location
,	O
records	O
obtained	O
under	O
the	O
show	O
.	O

One	O
of	O
those	O
DHS	S-Organization
partners	O
,	O
for	O
instance	O
,	O
is	O
the	O
,	O
which	O
has	O
been	O
realigned	O
to	O
focus	O
on	O
top	O
modernization	O
priorities	O
such	O
as	O
building	O
stronger	O
tactical	O
cyber	O
teams	O
.	O

The	O
general	O
population	O
remained	O
uninformed	O
of	O
any	O
breakthroughs	O
concerning	O
biological	O
warfare	O
.	O

Emergency	O
use	O
authorisation	O
for	O
remdesivir	S-Drug
was	O
granted	O
in	O
the	O
U.S.	S-Location
on	O
1May	O
,	O
for	O
people	O
hospitalised	O
with	O
severe	O
COVID-19	S-Disease
.	O
The	O
interim	O
authorisation	O
was	O
granted	O
considering	O
the	O
lack	O
of	O
other	O
specific	O
treatments	O
,	O
and	O
that	O
its	O
potential	O
benefits	O
appear	O
to	O
outweigh	O
the	O
potential	O
risks	O
.	O

Within	O
two	O
weeks	O
of	O
the	O
incident	O
,	O
investigators	O
were	O
questioning	O
the	O
validity	O
of	O
the	O
positive	O
ricin	O
tests	O
at	O
the	O
Senate	O
building	O
.	O

Chestnov,	B-Person
Oleg	E-Person
(January	O
2014).	O
"	O
Forward",	O
in	O
Connor,	B-Person
Stephen	E-Person
and	O
Sepulveda	B-Person
Bermedo	E-Person
,	O
Maria	B-Person
Cecilia	E-Person
(editors)	O
,	O
Global	B-Document
Atlas	I-Document
of	I-Document
Palliative	I-Document
Care	I-Document
at	I-Document
the	I-Document
End	I-Document
of	I-Document
Life	E-Document
,	O
Worldwide	B-Organization
Palliative	I-Organization
Care	I-Organization
Alliance	I-Organization
and	I-Organization
World	I-Organization
Health	I-Organization
Organization	E-Organization
,	O
p.	O
3	O
.	O

Several	O
of	O
the	O
early	O
cases	O
had	O
visited	O
Huanan	B-Organization
Seafood	I-Organization
Wholesale	I-Organization
Market	E-Organization
and	O
so	O
the	O
virus	O
is	O
thought	O
to	O
have	O
a	O
zoonotic	O
origin	O
.	O

In	O
April	O
2014	O
,	O
Nigeria	S-Location
reported	O
that	O
75%	O
of	O
hotel	O
business	O
had	O
been	O
lost	O
due	O
to	O
fears	O
of	O
the	O
outbreak	O
;	O
the	O
limited	O
Ebola	B-Incident
outbreak	E-Incident
had	O
cost	O
that	O
country	O
₦8	O
billion	O
.	O

While	O
the	O
WHO	S-Organization
and	O
some	O
world	O
leaders	O
have	O
praised	O
the	O
Chinese	O
government's	O
transparency	O
in	O
comparison	O
to	O
the	O
2003	B-Incident
SARS	I-Incident
outbreak	E-Incident
,	O
others	O
including	O
John	B-Person
Mackenzie	E-Person
of	O
the	O
WHO	S-Organization
's	O
emergency	O
committee	O
and	O
Anne	B-Person
Schuchat	E-Person
of	O
the	O
US'	B-Organization
CDC	E-Organization
have	O
shown	O
skepticism	O
,	O
suggesting	O
that	O
's	O
official	O
tally	O
of	O
cases	O
and	O
deaths	O
may	O
be	O
an	O
underestimation	O
.	O

The	O
stockpile	O
program	O
was	O
created	O
in	O
1999	O
under	O
President	O
Bill	B-Person
Clinton	E-Person
to	O
respond	O
to	O
terrorist	O
events	O
,	O
including	O
the	O
first	O
World	B-Incident
Trade	I-Incident
Center	I-Incident
bombing	E-Incident
,	O
the	O
sarin	B-Incident
gas	I-Incident
attack	I-Incident
on	I-Incident
the	I-Incident
Tokyo	I-Incident
subway	E-Incident
and	O
the	O
.	O
The	O
original	O
goal	O
was	O
to	O
be	O
ready	O
for	O
chemical	O
,	O
biological	O
,	O
radiological	O
and	O
nuclear	O
threats	O
.	O

It	O
has	O
been	O
alleged	O
that	O
the	O
WHO	S-Organization
was	O
aware	O
of	O
a	O
Dr	O
.	O

The	O
questions	O
are	O
based	O
on	O
the	O
objectives	O
of	O
the	O
Global	B-Document
Action	I-Document
Plan	I-Document
on	I-Document
AMR	E-Document
(	O
GAP	S-Document
)	O
,	O
which	O
was	O
established	O
in	O
2015	O
by	O
the	O
three	O
organizations	O
.	O

On	O
29	O
December	O
,	O
an	O
American	O
physician	O
who	O
was	O
exposed	O
to	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
(and	O
who	O
was	O
non-symptomatic)	O
was	O
evacuated	O
,	O
and	O
taken	O
to	O
the	O
.	O
On	O
12	O
January	O
,	O
the	O
individual	O
was	O
released	O
after	O
21	O
days	O
without	O
symptoms	O
.	O

Continuing	O
international	O
donor	O
interest	O
providing	O
opportunities	O
for	O
future	O
assistance	O
in	O
the	O
development	O
of	O
technical	O
expertise	O
can	O
lead	O
to	O
development	O
of	O
local	O
guidelines	O
related	O
to	O
issues	O
unique	O
to	O
the	O
region	O
.	O

The	O
situation	O
is	O
dire	O
indeed:	O
According	O
to	O
the	O
newest	O
data	O
,	O
more	O
than	O
2.	O
8	O
million	O
people	O
in	O
the	O
United	B-Location
States	E-Location
experience	O
an	O
infection	O
from	O
antibiotic	O
resistant	O
bacteria	O
each	O
year	O
.	O

Influenza	O
surveillance	O
information	O
on	O
the	O
2009	B-Incident
H1N1	I-Incident
flu	I-Incident
pandemic	E-Incident
is	O
available	O
,	O
but	O
almost	O
no	O
studies	O
attempted	O
to	O
estimate	O
the	O
total	O
number	O
of	O
deaths	O
attributable	O
to	O
H1N1	B-Disease
flu	E-Disease
.	O
Two	O
studies	O
were	O
carried	O
out	O
by	O
the	O
CDC	S-Organization
;	O
the	O
later	O
of	O
them	O
estimated	O
that	O
between	O
7,070	O
and	O
13,930	O
deaths	O
were	O
attributable	O
to	O
H1N1	B-Disease
flu	E-Disease
from	O
April	O
to	O
14	O
November	O
2009	O
.	O

To	O
directly	O
and	O
efficiently	O
test	O
for	O
pathogenicity	O
,	O
Friend	B-Scientific_research_project
or	I-Scientific_research_project
Foe	E-Scientific_research_project
aims	O
to	O
build	O
a	O
portable	O
platform	O
that	O
screens	O
many	O
unfamiliar	O
strains	O
of	O
bacteria	O
at	O
once	O
to	O
reveal	O
their	O
phenotypes	O
.	O

Taipei	B-Organization
City	I-Organization
Bureau	I-Organization
of	I-Organization
Health	E-Organization
director	O
Chiu	B-Person
Shu-ti	E-Person
resigned	O
from	O
Ma	B-Person
Ying-jeou	E-Person
's	O
mayoral	O
administration	O
on	O
25	O
May	O
.	O

From	O
Italy	S-Location
the	O
disease	O
spread	O
northwest	O
across	O
Europe	S-Location
,	O
striking	O
France	S-Location
,	O
Spain	S-Location
(which	O
was	O
hit	O
due	O
to	O
the	O
heat	O
–	O
the	O
epidemic	O
raged	O
in	O
the	O
early	O
weeks	O
of	O
July)	O
,	O
Portugal	S-Location
and	O
England	S-Location
by	O
June	O
1348	O
,	O
then	O
spread	O
east	O
and	O
north	O
through	O
Germany	S-Location
,	O
Scotland	S-Location
and	O
Scandinavia	S-Location
from	O
1348	O
to	O
1350	O
.	O

Already	O
,	O
the	O
team	O
has	O
shown	O
SHERLOCK	S-Platform
sensitivity	O
to	O
mutations	O
that	O
occur	O
in	O
something	O
as	O
small	O
as	O
a	O
single	O
nucleotide	O
and	O
designed	O
assays	O
that	O
could	O
identify	O
Zika	B-Pathogen
virus	I-Pathogen
mutations	E-Pathogen
associated	O
with	O
microcephaly	S-Disease
.	O
Broad	S-Organization
hopes	O
to	O
make	O
the	O
diagnostic	O
platform	O
easily	O
accessible	O
in	O
the	O
developing	O
world	O
.	O

Levin	S-Person
then	O
ran	O
the	O
T-cell	O
algorithms	O
against	O
CDC	S-Organization
and	O
data	O
,	O
mimicking	O
the	O
T-cell	O
negative	O
selection	O
process	O
.	O

One	O
of	O
the	O
more	O
controversial	O
experiments	O
was	O
conducted	O
in	O
1951	O
,	O
when	O
a	O
disproportionate	O
number	O
of	O
African	O
Americans	O
were	O
exposed	O
to	O
the	O
fungus	O
Aspergillus	B-Pathogen
fumigatus	E-Pathogen
,	O
to	O
see	O
if	O
they	O
were	O
more	O
susceptible	O
to	O
infection	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
outbreaks	O
tend	O
to	O
occur	O
when	O
temperatures	O
are	O
lower	O
and	O
humidity	O
is	O
higher	O
than	O
usual	O
for	O
Africa	S-Location
.	O
Even	O
after	O
a	O
person	O
recovers	O
from	O
the	O
acute	O
phase	O
of	O
the	O
disease	O
,	O
survives	O
for	O
months	O
in	O
certain	O
organs	O
such	O
as	O
the	O
eyes	O
and	O
testes	O
.	O

Confounding	O
definite	O
assignment	O
of	O
a	O
geographic	O
point	O
of	O
origin	O
,	O
the	O
1918	B-Incident
pandemic	E-Incident
spread	O
more	O
or	O
less	O
simultaneously	O
in	O
3	O
distinct	O
waves	O
during	O
an	O
≈12-month	O
period	O
in	O
1918–1919	O
,	O
in	O
Europe	S-Location
,	O
Asia	S-Location
,	O
and	O
North	B-Location
America	E-Location
(the	O
first	O
wave	O
was	O
best	O
described	O
in	O
in	O
March	O
1918)	O
.	O

One	O
case	O
occurred	O
in	O
Egypt	S-Location

This	O
experiment	O
requires	O
Animal	O
Biosafety	O
Level	O
x	O
(ABSL‐x)	O
conditions	O
.	O

Anthrax	S-Pathogen
has	O
been	O
used	O
as	O
a	O
weapon	O
around	O
the	O
world	O
for	O
nearly	O
a	O
century	O
.	O

Tian	O
D	O
,	O
Zheng	B-Person
T	E-Person
Comparison	O
and	O
Analysis	O
of	O
Biological	O
Agent	O
Category	O
Lists	O
Based	O
On	O
Biosafety	O
and	O
Biodefense.PLoS	O
One.2014;9(6).	O
.	O

Global	O
surveillance	O
of	O
potential	O
epidemics	O
and	O
preparation	O
has	O
improved	O
since	O
and	O
because	O
of	O
the	O
SARS	S-Disease
epidemic	O
,	O
and	O
MERS	S-Disease
is	O
being	O
closely	O
monitored.As	O
noted	O
in	O
the	O
article	O
published	O
in	O
The	O
Economist	S-Organization
on	O
20	O
April	O
2013	O
,	O
ProMED	S-Platform
is	O
an	O
online	O
reporting	O
programme	O
at	O
the	O
International	B-Organization
Society	I-Organization
for	I-Organization
Infectious	I-Organization
Diseases	E-Organization
,	O
part	O
of	O
improved	O
surveillance	O
systems	O
that	O
"	O
use	O
a	O
range	O
of	O
sources	O
to	O
provide	O
quick	O
information	O
on	O
emerging	O
threats	O
"	O
that	O
were	O
not	O
available	O
at	O
the	O
time	O
of	O
the	O
SARS	B-Incident
outbreak	E-Incident
(in	O
2003)	O
,	O
H5N1	B-Disease
bird	I-Disease
flu	E-Disease
(in	O
2005)	O
and	O
(in	O
2009)	O
.	O

The	O
lab	O
adjoined	O
an	O
insectary	O
where	O
genetically	O
modified	O
mosquitoes	O
were	O
being	O
used	O
in	O
a	O
dengue	B-Pathogen
virus	E-Pathogen
experiment	O
,	O
according	O
to	O
an	O
incident	O
report	O
the	O
university	O
filed	O
with	O
the	O
.	O

Conclusion:	O
Laboratory	O
technicians	O
in	O
Pakistan	S-Location
lack	O
awareness	O
of	O
good	O
laboratory	O
practices	O
and	O
biosafety	O
measures	O
,	O
and	O
also	O
face	O
a	O
lack	O
of	O
resources	O
.	O

Finnish	B-Organization
Institute	I-Organization
for	I-Organization
Health	I-Organization
and	I-Organization
Welfare	E-Organization
(	O
THL	S-Organization
;	O
)What	O
is	O
?	O

However	O
,	O
for	O
more	O
specific	O
types	O
of	O
imaging	O
,	O
exogenous	O
contrast	O
agents	O
may	O
be	O
given	O
intravenously	O
,	O
orally	O
,	O
or	O
intra-articularly	O
.	O

On	O
28	O
October	O
,	O
an	O
additional	O
3	O
cases	O
were	O
reported	O
in	O
the	O
Forécariah	B-Location
Prefecture	E-Location
by	O
the	O
WHO	S-Organization
.	O
On	O
6	O
November	O
,	O
a	O
media	O
report	O
indicated	O
Tana	B-Location
village	E-Location
to	O
be	O
the	O
last	O
known	O
place	O
with	O
Ebola	S-Disease
in	O
the	O
country	O
,	O
and	O
on	O
11	O
November	O
,	O
WHO	S-Organization
indicated	O
that	O
no	O
Ebola	S-Disease
cases	O
were	O
reported	O
in	O
;	O
this	O
was	O
the	O
first	O
time	O
since	O
the	O
epidemic	O
began	O
,	O
that	O
no	O
cases	O
had	O
been	O
reported	O
in	O
any	O
country	O
.	O

One	O
day	O
,	O
Smith	S-Person
infected	O
the	O
bacteria	O
with	O
a	O
phage	S-Pathogen
called	O
P22	S-Pathogen
.	O
The	O
phage	O
DNA	O
was	O
quickly	O
cut	O
up.	O
was	O
able	O
to	O
isolate	O
the	O
enzyme	O
responsible	O
for	O
the	O
cutting	O
and	O
eventually	O
showed	O
that	O
the	O
enzyme	O
,	O
now	O
known	O
as	O
HindII	O
,	O
always	O
cuts	O
DNA	O
at	O
a	O
particular	O
sequence	O
of	O
nucleotides	O
.	O

Mukundan	S-Person
called	O
the	O
partnership	O
"	O
a	O
technology	O
exchange,	O
"	O
noting	O
that	O
seven	O
Los	B-Organization
Alamos	E-Organization
researchers	O
attended	O
a	O
mini-symposium	O
in	O
Omaha	S-Location
,	O
and	O
that	O
the	O
collaboration	O
also	O
would	O
feature	O
a	O
variety	O
of	O
opportunities	O
for	O
Nebraska	S-Location
students	O
to	O
participate	O
in	O
internships	O
at	O
.	O

So	O
the	O
NIH	S-Organization
and	O
FDA	S-Organization
are	O
both	O
scouring	O
their	O
campuses	O
to	O
see	O
if	O
there	O
are	O
other	O
examples	O
.	O

Masateru	B-Person
Saito	E-Person
"	O
civilian	O
employee	O
"	O

In	O
May	O
2015	O
,	O
Dr	O
Margaret	B-Person
Chan	E-Person
indicated	O
,	O
"	O
demands	O
on	O
WHO	S-Organization
were	O
more	O
than	O
ten	O
times	O
greater	O
than	O
ever	O
experienced	O
in	O
the	O
almost	O
70-year	O
history	O
of	O
this	O
Organization	O
"	O
Bruce-Cunning	S-Person
,	O
Nick	S-Person
.	O
(18	O
May	O
2015)	O
.	O

Kayvon	B-Person
Modjarrad	E-Person
,	O
the	O
director	O
of	O
the	O
.	O

Title	B-Document
42	I-Document
of	I-Document
the	I-Document
Code	I-Document
of	I-Document
Federal	I-Document
Regulations	E-Document
addresses	O
laws	O
concerning	O
Public	O
Health	O
issues	O
including	O
biosafety	O
which	O
can	O
be	O
found	O
under	O
the	O
citation	O
42	O
CFR	O
73	O
to	O
42	O
CFR	O
73.21	O
by	O
accessing	O
the	O
(CFR)	O
website	O
.	O

Birmingham	S-Location
was	O
declared	O
officially	O
free	O
of	O
smallpox	S-Disease
on	O
16	O
October	O
1978	O
.	O

As	O
of	O
2008	O
,	O
no	O
direct	O
connection	O
has	O
yet	O
been	O
found	O
between	O
the	O
First	O
case	O
and	O
the	O
Fallen	B-Incident
Angel	I-Incident
case	E-Incident
and	O
no	O
explanation	O
found	O
for	O
the	O
origin	O
of	O
the	O
ricin	S-Pathogen
in	O
Frist's	B-Location
office	E-Location
.	O
Ryan	S-Person
,	O
Jeffrey	B-Person
R	E-Person
.	O
and	O
Glarum	S-Person
,	O
.	O
Biosecurity	O
and	O
Bioterrorism:	O
Containing	O
and	O
Preventing	O
Biological	O
Threats	O
,	O
(Google	O
Books)	O
,	O
Butterworth-Heinemann	O
,	O
2008	O
,	O
p.	O
148	O
,	O
()	O
.	O

The	O
text	O
of	O
the	O
letter	O
stated:	O
Department	B-Organization
of	I-Organization
transportation	E-Organization
If	O
you	O
change	O
the	O
hours	O
of	O
service	O
onJanuary	O
4	O
,	O
2004	O
I	O
will	O
turn	O
D.C	S-Location
into	O
a	O
ghost	O
townThe	O
powder	O
on	O
the	O
letter	O
is	O
RICINhave	O
a	O
nice	O
dayFallen	O
Angel	O
The	O
Secret	B-Organization
Service	E-Organization
did	O
not	O
alert	O
the	O
White	B-Organization
House	E-Organization
,	O
the	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
(	O
FBI	S-Organization
)	O
,	O
and	O
other	O
key	O
agencies	O
,	O
including	O
the	O
,	O
of	O
the	O
discovery	O
and	O
positive	O
tests	O
until	O
November	O
12	O
.	O

Moreover	O
,	O
the	O
nucleus	O
of	O
any	O
atom	O
that	O
has	O
a	O
net	O
nuclear	O
spin	O
and	O
that	O
is	O
bonded	O
to	O
a	O
hydrogen	O
atom	O
could	O
potentially	O
be	O
imaged	O
via	O
heteronuclear	O
magnetization	O
transfer	O
MRI	S-Technology
that	O
would	O
image	O
the	O
high-gyromagnetic-ratio	O
hydrogen	O
nucleus	O
instead	O
of	O
the	O
low-gyromagnetic-ratio	O
nucleus	O
that	O
is	O
bonded	O
to	O
the	O
hydrogen	O
atom	O
.	O

The	O
institution	O
has	O
to	O
crawl	O
before	O
it	O
can	O
run	O
,	O
he	O
said	O
.	O

Even	O
though	O
it	O
is	O
amongst	O
the	O
possibilities	O
of	O
the	O
technique	O
and	O
certainly	O
one	O
of	O
the	O
most	O
notorious	O
applications	O
,	O
we	O
need	O
to	O
wonder	O
whether	O
there	O
is	O
a	O
real	O
need	O
to	O
put	O
too	O
many	O
eggs	O
in	O
this	O
basket	O
,	O
and	O
meanwhile	O
disregard	O
other	O
potential	O
uses	O
that	O
are	O
far	O
more	O
urgent	O
for	O
public	O
health	O
and	O
advancement	O
of	O
our	O
societies	O
in	O
general	O
.	O

It	O
will	O
ask	O
for	O
an	O
inventory	O
and	O
scrutiny	O
of	O
safety	O
practices	O
.	O

Fifth	O
,	O
I've	O
ordered	O
an	O
investigation	O
to	O
determine	O
the	O
root	O
causes	O
that	O
led	O
to	O
contamination	B-Incident
of	I-Incident
H5N1	I-Incident
in	I-Incident
the	I-Incident
influenza	I-Incident
laboratory	E-Incident
.	O
Sixth	O
,	O
I've	O
reported	O
the	O
incident	O
through	O
the	O
proper	O
channels	O
-	O
or	O
CDC	S-Organization
has	O
reported	O
the	O
incident	O
through	O
the	O
proper	O
channels	O
to	O
the	O
select	O
agent	O
oversight	O
body	O
,	O
the	O
agriculture	B-Organization
department	E-Organization
's	O
inspection	O
service	O
which	O
is	O
known	O
as	O
.	O

Poor	O
record	O
keeping	O
,	O
improper	O
disposal	O
,	O
and	O
mishandling	O
biohazardous	O
materials	O
result	O
in	O
increased	O
risks	O
of	O
biochemical	B-Incident
contamination	E-Incident
for	O
both	O
the	O
public	O
and	O
environment	O
.	O

On	O
31	O
May	O
,	O
Singapore	S-Location
was	O
removed	O
from	O
.	O

Vice	O
President	O
Pence	S-Person
maintained	O
that	O
the	O
threat	O
of	O
the	O
virus	O
spreading	O
throughout	O
was	O
small	O
.	O

Based	O
on	O
what	O
is	O
currently	O
known	O
,	O
CDC	S-Organization
believes	O
that	O
other	O
CDC	S-Organization
staff	O
,	O
family	O
members	O
,	O
and	O
the	O
general	O
public	O
are	O
not	O
at	O
risk	O
.	O

The	O
average	O
radiation	O
dose	O
from	O
medical	O
sources	O
is	O
≈0.	O
6 mSv	O
per	O
person	O
globally	O
as	O
of	O
2007	O
.	O

The	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
on	O
28	O
November	O
,	O
per	O
media	O
reports	O
on	O
29	O
December	O
2015	O
,	O
upon	O
expiration	O
of	O
the	O
42-day	O
waiting	O
period	O
,	O
the	O
WHO	S-Organization
declared	O
Guinea	S-Location
-free	O
.	O

The	O
BBC	S-Organization
programme	O
meets	O
the	O
people	O
who	O
are	O
inserting	O
technology	O
under	O
their	O
skin	O
,	O
adopting	O
extreme	O
diets	O
and	O
trying	O
to	O
change	O
their	O
DNA	O
.	O

Operation	B-Activity
May	I-Activity
Day	E-Activity
Aedes	O
Aegypti	O
mosquitoes	O
were	O
dispersed	O
through	O
ground	O
based	O
methods	O
in	O
Georgia	S-Location
,	O
USA	S-Location
,	O
during	O
a	O
operation	O
codenamed	O
May	O
Day	O
.	O

In	O
1997	O
,	O
David	O
Day	O
claimed	O
there	O
"	O
remains	O
considerable	O
circumstantial	O
evidence	O
to	O
suggest	O
that	O
officers	O
other	O
than	O
Phillip	S-Person
or	O
perhaps	O
convicts	O
or	O
soldiers	O
…	O
deliberately	O
spread	O
smallpox	S-Pathogen
among	O
aborigines	O
"	O
Day	S-Person
,	O
David	S-Person
,	O
Claiming	O
a	O
Continent:	O
a	O
new	O
history	O
of	O
Australia	S-Location
(1996)	O
,	O
Angus	O
&amp	O
;	O
Roberts	O
on,	B-Location
Sy	E-Location
dney	O
,	O
p63f.	O
and	O
in	O
2000	O
Dr	O
John	B-Person
Lam	E-Person
bert	O
argued	O
that	O
"	O
strong	O
circumstantial	O
evidence	O
suggests	O
the	O
smallpox	B-Incident
epidemic	I-Incident
which	I-Incident
ravaged	I-Incident
Aborigines	I-Incident
in	E-Incident
1789	O
,	O
may	O
have	O
resulted	O
from	O
deliberate	O
infectio	O
n".	B-Person
Lam	E-Person
be	O
JT.	O
,	O
''Brokers	O
of	O
Cultural	O
Change''	O
(2000)	O
,	O
,	O
p245	O
.	O

The	O
infected	O
boy	O
died	O
on	O
24	O
November	O
,	O
and	O
on	O
3	O
December	O
2	O
remaining	O
cases	O
were	O
released	O
after	O
recovering	O
from	O
the	O
disease	O
.	O

For	O
tireless	O
acts	O
of	O
courage	O
and	O
mercy	O
,	O
for	O
buying	O
the	O
world	O
time	O
to	O
boost	O
its	O
defences	O
,	O
for	O
risking	O
,	O
for	O
persisting	O
,	O
for	O
sacrificing	O
and	O
saving	O
,	O
the	O
Ebola	S-Disease
fighters	O
are	O
Time	S-Organization
's	O
2014	O
Person	O
of	O
the	O
Year.	O
"	O
According	O
to	O
an	O
October	O
2015	O
report	O
by	O
the	O
CDC	S-Organization
,	O
Guinean	O
healthcare	O
workers	O
had	O
42.2	O
times	O
higher	O
Ebola	S-Disease
infection	O
rates	O
than	O
non-healthcare	O
workers	O
,	O
and	O
male	O
healthcare	O
workers	O
were	O
more	O
affected	O
than	O
their	O
female	O
counterparts	O
.	O

The	O
death	O
toll	O
in	O
India	S-Location
's	O
British-ruled	O
districts	O
was	O
13.88 million	O
.	O

During	O
the	O
epidemic	O
some	O
patients	O
received	O
experimental	O
blood	O
transfusions	O
from	O
Ebola	S-Disease
survivors	O
,	O
but	O
a	O
later	O
study	O
found	O
that	O
the	O
treatment	O
did	O
not	O
provide	O
significant	O
benefit	O
.	O

It	O
only	O
takes	O
a	O
small	O
amount	O
of	O
to	O
infect	O
a	O
large	O
number	O
of	O
people	O
.	O

We	O
have	O
to	O
keep	O
driving	O
home	O
those	O
messages	O
about	O
prevention	O
.	O

Weapons	O
of	O
this	O
type	O
were	O
in	O
advanced	O
development	O
by	O
the	O
time	O
the	O
program	O
ended	O
.	O

On	O
June	O
3	O
,	O
2013	O
,	O
Dutschke	S-Person
was	O
indicted	O
by	O
a	O
federal	O
grand	O
jury	O
on	O
five	O
counts	O
.	O

Ring	O
artefacts	O
can	O
largely	O
be	O
reduced	O
by	O
intensity	O
normalization	O
,	O
also	O
referred	O
to	O
as	O
flat	O
field	O
correction	O
.	O

The	O
development	O
and	O
implementation	O
of	O
an	O
effective	O
national	O
biosafety	O
system	O
is	O
important	O
for	O
several	O
key	O
reasons:	O
to	O
ensure	O
safe	O
access	O
to	O
products	O
of	O
modern	O
biotechnology	O
,	O
to	O
build	O
public	O
confidence	O
,	O
to	O
encourage	O
the	O
growth	O
of	O
domestic	O
modern	O
biotechnology	O
,	O
and	O
to	O
comply	O
with	O
international	O
standards	O
and	O
agreements	O
.	O

Shortening	O
of	O
the	O
scanning	O
time	O
to	O
around	O
1	O
second	O
,	O
eliminating	O
the	O
strict	O
need	O
for	O
the	O
subject	O
to	O
remain	O
still	O
or	O
be	O
sedated	O
,	O
is	O
one	O
of	O
the	O
main	O
reasons	O
for	O
the	O
large	O
increase	O
in	O
the	O
pediatric	O
population	O
(especially	O
for	O
the	O
diagnosis	O
of	O
appendicitis)	O
.	O

The	O
vaccines	O
are	O
suitable	O
for	O
repeated	O
use	O
,	O
stable	O
at	O
refrigerator	O
temperatures	O
or	O
lyophilized	O
for	O
non-cold	O
chain	O
needle-free	O
application	O
,	O
and	O
amenable	O
to	O
rapid	O
and	O
affordable	O
scale-up	O
for	O
use	O
in	O
both	O
epidemic	O
response	O
and	O
routine	O
vaccination	O
,	O
according	O
to	O
Basu	S-Person

Other	O
delivery	O
systems	O
researched	O
and	O
at	O
least	O
partially	O
developed	O
during	O
the	O
1950s	O
included	O
the	O
E77	O
balloon	O
bomb	O
and	O
the	O
E86	O
cluster	O
bomb	O
.	O

In	O
Brazil	S-Location
the	O
yellow	B-Incident
fever	I-Incident
outbreak	E-Incident
continues	O
to	O
roll	O
on	O
with	O
some	O
numbers	O
not	O
seen	O
in	O
decades	O
.	O

Some	O
Chinese	O
students	O
at	O
American	O
universities	O
sent	O
aid	O
,	O
including	O
50,000	O
N95	B-Equipment
masks	E-Equipment
on	O
30	O
January	O
.	O

The	O
term	O
"	O
computed	B-Technology
tomography	E-Technology
(	O
CT	S-Technology
)	O
is	O
often	O
used	O
to	O
refer	O
to	O
X-ray	B-Technology
CT	E-Technology
because	O
it	O
is	O
the	O
most	O
commonly	O
known	O
form	O
.	O

The	O
should	O
prove	O
to	O
be	O
a	O
useful	O
starting	O
point	O
for	O
diverse	O
bibliometric	O
studies	O
of	O
publications	O
in	O
this	O
area	O
.	O

"	O
The	O
chance	O
of	O
the	O
Zaire	B-Incident
strain	I-Incident
of	I-Incident
Ebola	E-Incident
being	O
made	O
into	O
a	O
biological	O
weapon	O
is	O
less	O
than	O
nil,	O
"	O
de	B-Person
Bretton-Gordon	E-Person
said	O
,	O
referring	O
to	O
the	O
strain	O
of	O
Ebola	S-Pathogen
that	O
is	O
causing	O
the	O
current	O
outbreak	O
in	O
.	O
"	O
It's	O
just	O
not	O
going	O
to	O
happen.	O
"	O

On	O
17	O
February	O
2015	O
,	O
all	O
those	O
who	O
had	O
exposure	O
or	O
had	O
contact	O
with	O
the	O
said	O
nurse	O
were	O
tested	O
negative	O
for	O
the	O
virus	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
works	O
to	O
provide	O
the	O
needed	O
health	O
and	O
well-being	O
evidence	O
through	O
a	O
variety	O
of	O
data	O
collection	O
platforms	O
,	O
including	O
the	O
World	B-Platform
Health	I-Platform
Survey	E-Platform
covering	O
almost	O
400,000	O
respondents	O
from	O
70	O
countries	O
,	O
and	O
the	O
Study	B-Platform
on	I-Platform
Global	I-Platform
Aging	I-Platform
and	I-Platform
Adult	I-Platform
Health	E-Platform
(	O
SAGE	S-Platform
)	O
covering	O
over	O
50,000	O
persons	O
over	O
50	O
years	O
old	O
in	O
23	O
countries	O
.	O

These	O
mutations	O
make	O
the	O
viruses	O
less	O
effective	O
in	O
nature	O
,	O
and	O
the	O
researchers	O
believe	O
they	O
will	O
likely	O
not	O
persist	O
where	O
the	O
drug	O
is	O
not	O
being	O
used	O
.	O

In	O
August	O
2018	O
,	O
the	O
Mangina	B-Organization
Ebola	I-Organization
Treatment	I-Organization
Center	E-Organization
was	O
reported	O
to	O
be	O
operational	O
.	O

Based	O
on	O
the	O
risk	O
assessment	O
for	O
EBOV	S-Pathogen
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
was	O
sectioned	O
into	O
a	O
green	O
zone	O
,	O
which	O
had	O
no	O
risk	O
of	O
contamination	O
[including	O
the	O
central	O
control	O
room	O
,	O
offices	O
,	O
lobby	O
(where	O
the	O
laboratory	O
staffs	O
getting	O
into	O
the	O
BSL-3	S-Platform
lab)	O
,	O
electricity	O
distribution	O
room	O
,	O
and	O
air	O
conditioning	O
engine	O
unit]	O
;	O
a	O
yellow	O
zone	O
,	O
which	O
had	O
the	O
potential	O
for	O
contamination	O
with	O
EBOV	S-Pathogen
nucleic	O
acids	O
(including	O
the	O
BSL-2	S-Platform
lab	O
,	O
the	O
PCR	S-Equipment
preparation	O
room	O
,	O
the	O
storage	O
room	O
,	O
the	O
corridor	O
,	O
the	O
1st	O
changing	O
room	O
,	O
the	O
shower	O
room	O
,	O
and	O
the	O
decontamination	O
room)	O
;	O
a	O
brown	O
zone	O
,	O
which	O
has	O
the	O
potential	O
for	O
contamination	O
with	O
EBOV	S-Pathogen
nucleic	O
acids	O
and	O
an	O
extremely	O
low	O
risk	O
of	O
contamination	O
with	O
live	O
EBOV	S-Pathogen
(2nd	O
changing	O
room)	O
;	O
and	O
a	O
red	O
zone	O
,	O
which	O
has	O
the	O
potential	O
for	O
contamination	O
with	O
live	O
EBOV	S-Pathogen
(	O
lab)	O
(Fig.1)	O
.	O

Experience	O
shows	O
that	O
organizing	O
and	O
coordinating	O
networks	O
can	O
be	O
challenging	O
in	O
those	O
countries	O
where	O
there	O
is	O
limited	O
cooperation	O
between	O
different	O
sectors-for	O
example	O
,	O
where	O
each	O
sector	O
relates	O
to	O
different	O
ministries	O
or	O
is	O
governed	O
by	O
separate	O
legal	O
frameworks	O
.	O

The	O
Manual	O
includes	O
the	O
definition	O
of	O
four	O
risk	O
groups	O
based	O
on	O
the	O
relative	O
hazard	O
of	O
infective	O
micro-organisms	O
to	O
the	O
laboratory	O
workers	O
,	O
the	O
community	O
,	O
the	O
livestock	O
and	O
the	O
environment	O
.	O

Why	O
did	O
it	O
take	O
so	O
long	O
for	O
the	O
second	O
incident	O
that	O
you've	O
described	O
to	O
be	O
revealed?	O
And	O
how	O
many	O
lab	O
folks	O
at	O
CDC	S-Organization
employees	O
are	O
being	O
tested	O
or	O
are	O
concerned	O
about	O
possible	O
exposure	O
to	O
this	O
mixed	O
with	O
a	O
more	O
easily	O
transmissible	O
flu	O
,	O
I	O
presume?	O

This	O
study	O
involved	O
a	O
total	O
of	O
272	O
patients	O
,	O
which	O
represents	O
approximately	O
25%	O
of	O
US	O
hospitalized	O
patients	O
with	O
lab-confirmed	O
H1N1	S-Pathogen
whose	O
cases	O
were	O
reported	O
to	O
the	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
from	O
1May	O
to	O
9June	O
2009	O
.	O

For	O
example	O
,	O
the	O
1918	O
nucleoprotein	O
(NP)	O
gene	O
sequence	O
is	O
similar	O
to	O
that	O
of	O
viruses	O
found	O
in	O
wild	O
birds	O
at	O
the	O
amino	O
acid	O
level	O
but	O
very	O
divergent	O
at	O
the	O
nucleotide	O
level	O
,	O
which	O
suggests	O
considerable	O
evolutionary	O
distance	O
between	O
the	O
sources	O
of	O
the	O
1918	O
NP	O
and	O
of	O
currently	O
sequenced	O
NP	O
genes	O
in	O
wild	B-Pathogen
bird	I-Pathogen
strains	E-Pathogen
(,)	O
.	O

29	O
cases	O
of	O
Hepatitis	B-Disease
A	E-Disease
were	O
reported	O
in	O
Kharkiv	S-Location
in	O
November	O
2017	O
.	O

Thomas	B-Person
Inglesby	E-Person
MD	O
,	O
is	O
Chief	O
Executive	O
Officer	O
and	O
Director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
,	O
University	B-Organization
of	I-Organization
Pittsburgh	I-Organization
Medical	I-Organization
Center	E-Organization
.	O
His	O
work	O
is	O
internationally	O
recognized	O
in	O
the	O
fields	O
of	O
public	O
health	O
preparedness	O
,	O
pandemic	O
flu	O
and	O
epidemic	O
planning	O
,	O
and	O
biosecurity.Dr	O
.	O

"	O
Yes,	O
that's	O
my	O
understanding,	O
"	O
Kadlec	S-Person
said	O
.	O

It	O
is	O
anticipated	O
that	O
given	O
how	O
little	O
is	O
known	O
about	O
human	O
biology	O
that	O
no	O
applications	O
of	O
this	O
work	O
will	O
or	O
should	O
be	O
attempted	O
in	O
humans	O
.	O

The	O
incident	O
was	O
reported	O
to	O
military	O
command	O
,	O
but	O
local	O
and	O
city	O
officials	O
were	O
not	O
immediately	O
informed	O
.	O

A	O
person's	O
age	O
plays	O
a	O
significant	O
role	O
in	O
the	O
subsequent	O
risk	O
of	O
cancer	S-Disease
Estimated	O
lifetime	O
cancer	S-Disease
mortality	O
risks	O
from	O
an	O
abdominal	O
of	O
a	O
one-year-old	O
is	O
0.	O
1%	O
or	O
1:1000	O
scans	O
.	O

Josiah	B-Person
Zayner	E-Person
is	O
a	O
biohacker	O
who's	O
famous	O
for	O
injecting	O
himself	O
with	O
the	O
gene-editing	O
tool	O
CRISPR	S-Technology
.	O
At	O
a	O
time	O
when	O
the	O
technology	O
exists	O
for	O
us	O
to	O
change	O
(or	O
hack)	O
our	O
own	O
DNA	O
,	O
what	O
are	O
the	O
ethics	O
of	O
experimenting	O
on	O
ourselves	O
,	O
and	O
others	O
,	O
at	O
home?	O
On	O
the	O
launch	O
episode	O
of	O
this	O
new	O
podcast	O
,	O
host	O
Arielle	B-Person
Duhaime-Ross	E-Person
talks	O
to	O
about	O
how	O
he's	O
thinking	O
about	O
human	O
experimentation	O
today	O
.	O

However	O
,	O
genetic	O
modification	O
with	O
viral	O
vectors	O
in	O
general	O
and	O
stable	O
integration	O
of	O
the	O
therapeutic	O
gene	O
into	O
the	O
host	O
cell	O
genome	O
bear	O
concerns	O
with	O
respect	O
to	O
different	O
levels	O
of	O
personal	O
or	O
environmental	O
safety	O
.	O

Geneva	S-Location
:	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
;	O
2003	O
(	O
WHO	B-Document
Technical	I-Document
Report	E-Document
Series	O
916).	O
which	O
recommended	O
that	O
free	O
sugars	O
should	O
form	O
no	O
more	O
than	O
10%	O
of	O
a	O
healthy	O
diet	O
.	O

In	O
contrast	O
to	O
the	O
genetic	O
makeup	O
of	O
the	O
1918	B-Pathogen
pandemic	I-Pathogen
virus	E-Pathogen
the	O
novel	O
gene	O
segments	O
of	O
the	O
reassorted	O
1957	B-Pathogen
and	I-Pathogen
1968	I-Pathogen
pandemic	I-Pathogen
viruses	E-Pathogen
all	O
originated	O
in	O
Eurasian	B-Pathogen
avian	I-Pathogen
viruses	E-Pathogen
;	O
both	O
human	O
viruses	O
arose	O
by	O
the	O
same	O
mechanism-reassortment	O
of	O
a	O
Eurasian	B-Pathogen
wild	I-Pathogen
waterfowl	I-Pathogen
strain	E-Pathogen
with	O
the	O
previously	O
circulating	O
human	O
H1N1	B-Pathogen
strain	E-Pathogen
.	O
Proving	O
the	O
hypothesis	O
that	O
the	O
virus	O
responsible	O
for	O
the	O
1918	B-Incident
pandemic	E-Incident
had	O
a	O
markedly	O
different	O
origin	O
requires	O
samples	O
of	O
human	O
influenza	B-Pathogen
strains	E-Pathogen
circulating	O
before	O
1918	O
and	O
samples	O
of	O
in	O
the	O
wild	O
that	O
more	O
closely	O
resemble	O
the	O
1918	O
sequences	O
.	O

The	O
British	O
routinely	O
inoculated	O
their	O
own	O
troops	O
,	O
exposing	O
soldiers	O
to	O
the	O
material	O
from	O
smallpox	S-Pathogen
pustules	O
to	O
induce	O
a	O
mild	O
case	O
of	O
disease	O
and	O
,	O
once	O
they	O
recovered	O
,	O
life-long	O
immunity	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We	O
have	O
done	O
that	O
.	O

How	O
Well	O
Is	O
Environmental	O
Biosafety	O
Research	O
Supporting	O
the	O
Scientific	O
Debate	O
on	O
the	O
Biosafety	O
of	O
Genetically	B-Technology
Modified	I-Technology
Organisms	E-Technology
()?	O

This	O
is	O
done	O
by	O
,	O
for	O
example	O
,	O
ensuring	O
that	O
these	O
organisms	O
have	O
built	O
in	O
dependencies	O
for	O
certain	O
nutrients	O
without	O
which	O
they	O
cannot	O
survive	O
.	O

The	O
causal	O
agent	O
has	O
not	O
yet	O
been	O
identified	O
or	O
confirmed	O
.	O

Between	O
123,000	O
and	O
203,000	O
pandemic	O
respiratory	O
deaths	O
were	O
estimated	O
globally	O
for	O
the	O
last	O
nine	O
months	O
of	O
2009	O
.	O

Kevin	B-Person
Schully	E-Person
contractor	O
and	O
chief	O
science	O
officer	O
with	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center's	I-Organization
(NMRC)	I-Organization
Austere	I-Organization
environments	I-Organization
Consortium	I-Organization
for	I-Organization
Enhanced	I-Organization
Sepsis	I-Organization
Outcomes	I-Organization
Department	E-Organization
(	O
ACESO	S-Organization
)	O
recently	O
returned	O
stateside	O
after	O
screening	O
Sailors	O
and	O
Marines	O
deployed	O
to	O
Darwin	S-Location
,	O
Australia	S-Location
,	O
who	O
are	O
at	O
risk	O
of	O
developing	O
.	O

Let	O
me	O
get	O
you	O
to	O
expand	O
on	O
that	O
if	O
I	O
could	O
.	O

She	O
calls	O
this	O
her	O
cheap	O
biohack	O
version	O
of	O
cryotherapy	S-Technology
-	O
or	O
-	O
and	O
admits	O
the	O
"	O
cops	O
on	O
her	O
street	O
"	O
think	O
it	O
is	O
hilarious	O
.	O

Brooks	S-Person
said	O
she	O
hopes	O
is	O
ready	O
for	O
introduction	O
later	O
this	O
month	O
,	O
would	O
be	O
the	O
House	S-Organization
version	O
to	O
reauthorize	O
PAHPA	S-Document
.The	O
U.S.	B-Organization
Senate	I-Organization
Health,	I-Organization
Education,	I-Organization
Labor,	I-Organization
and	I-Organization
Pensions	I-Organization
(HELP)	I-Organization
Committee	E-Organization
on	O
May	O
23	O
approved	O
22-1	O
its	O
version	O
,	O
the	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
and	I-Document
Advancing	I-Document
Innovation	I-Document
Act	E-Document
of	O
2018	O
,	O
S.	B-Document
2852	E-Document
,	O
which	O
U.S.Sen	O
.	O

Experimental	O
vaccines	O
from	O
any	O
of	O
these	O
strategies	O
would	O
have	O
to	O
be	O
tested	O
for	O
safety	O
and	O
efficacy	O
.	O

As	O
of	O
2012	O
,	O
the	O
WHO	S-Organization
was	O
to	O
report	O
as	O
to	O
whether	O
RTS,S/AS01	S-Vaccine
,	O
were	O
a	O
viable	O
malaria	O
vaccine	O
.	O

The	O
mid-level	O
in	O
this	O
range	O
is	O
about	O
274,000	O
2009	O
-related	O
hospitalizations	O
.	O

A	O
FedBizOpps	O
notice	O
posted	O
Monday	O
says	O
IBM	S-Organization
(NYSE:	O
IBM	S-Organization
)	O
,	O
Acumen	S-Organization
,	O
Dovel	B-Organization
Technologies	E-Organization
and	O
IQVIA	B-Organization
Government	I-Organization
Solutions	E-Organization
will	O
perform	O
work	O
at	O
their	O
respective	O
facilities	O
in	O
support	O
of	O
CBER	S-Organization
's	O
.	O

The	O
United	B-Location
States	E-Location
is	O
part	O
of	O
the	O
international	O
plan	O
to	O
prevent	O
the	O
naturally	O
occurring	O
,	O
accidental	O
or	O
deliberate	O
spread	O
of	O
infectious	O
diseases	O
,	O
but	O
remains	O
among	O
many	O
countries	O
hampered	O
by	O
the	O
inadequate	O
or	O
underprepared	O
systems	O
around	O
the	O
world	O
that	O
can't	O
effectively	O
deal	O
with	O
rapidly	O
emerging	O
unexpected	O
threats	O
.	O

Medvedik	S-Person
calls	O
that	O
the	O
"	O
low-hanging	O
fruit.	O
"	O
He	O
spoke	O
excitedly	O
about	O
the	O
possibility	O
of	O
creating	O
a	O
supplement	O
from	O
a	O
plant	O
compound	O
called	O
fisetin	O
,	O
noting	O
that	O
a	O
recent	O
(small)	O
trial	O
suggests	O
high	O
concentrations	O
of	O
fisetin	O
can	O
clear	O
out	O
senescent	O
cells	O
in	O
humans	O
-	O
cells	O
that	O
have	O
stopped	O
dividing	O
and	O
that	O
contribute	O
to	O
aging	O
.	O

Lane	B-Person
Stephenson	E-Person
the	O
university's	O
director	O
of	O
news	O
and	O
information	O
services	O
,	O
declined	O
to	O
answer	O
questions	O
about	O
the	O
lab	O
incidents	O
.	O

The	O
first	O
ever	O
uses	O
of	O
Crispr	S-Technology
and	O
were	O
the	O
biotechnology	O
achievements	O
of	O
the	O
decade	O
.	O

In	O
the	O
wake	O
of	O
several	O
high-profile	O
laboratory	O
safety	O
incidents	O
involving	O
smallpox	S-Disease
anthrax	S-Disease
,	O
and	O
dangerous	O
flu	B-Disease
strains	E-Disease
,	O
the	O
will	O
ask	O
federally	O
funded	O
laboratories	O
to	O
inventory	O
pathogens	O
and	O
review	O
safety	O
practices	O
.	O

Injectable	O
solutions	O
containing	O
13C	O
or	O
stabilized	O
bubbles	O
of	O
hyperpolarized	O
129Xe	O
have	O
been	O
studied	O
as	O
contrast	O
agents	O
for	O
angiography	O
and	O
perfusion	O
imaging.	O
31P	O
can	O
potentially	O
provide	O
information	O
on	O
bone	O
density	O
and	O
structure	O
,	O
as	O
well	O
as	O
functional	O
imaging	O
of	O
the	O
brain	O
.	O

Anthrax	B-Pathogen
spores	E-Pathogen
are	O
easily	O
found	O
in	O
nature	O
,	O
can	O
be	O
produced	O
in	O
a	O
lab	O
,	O
and	O
can	O
last	O
for	O
a	O
long	O
time	O
in	O
the	O
environment	O
.	O

In	O
addition	O
,	O
the	O
lab	O
contains	O
a	O
central	O
control	O
room	O
and	O
offices	O
on	O
the	O
left	O
side	O
,	O
and	O
a	O
decontamination	O
room	O
,	O
an	O
electricity	O
distribution	O
room	O
,	O
and	O
an	O
air	O
conditioning	O
engine	O
unit	O
on	O
the	O
right	O
side	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

The	O
American	B-Organization
Society	I-Organization
for	I-Organization
Microbiology	E-Organization
(	O
ASM	S-Organization
)	O
is	O
"	O
supportive	O
of	O
efforts	O
to	O
ensure	O
"	O
biosafety	O
,	O
the	O
group	O
said	O
in	O
a	O
comment	O
to	O
ScienceInsider	O
.	O

The	O
Ebola	S-Disease
Epidemic	O
underscores	O
the	O
significant	O
security	O
risks	O
that	O
infectious	O
disease	O
outbreaks	O
pose	O
.	O

Next	O
to	O
a	O
cupboard	O
that	O
resembles	O
a	O
chemist's	O
shop	O
,	O
she	O
also	O
has	O
a	O
Power	B-Equipment
Plate	E-Equipment
which	O
vibrates	O
from	O
30	O
to	O
50	O
times	O
a	O
second	O
to	O
make	O
her	O
exercise	O
more	O
effective	O
.	O

In	O
natural	O
evolutionary	O
competition	O
there	O
is	O
no	O
guarantee	O
that	O
we	O
will	O
find	O
ourselves	O
the	O
survivors.	O
"	O
(Ref)	O
.	O

On	O
April	O
15	O
,	O
2013	O
,	O
an	O
envelope	O
that	O
preliminarily	O
tested	O
positive	O
for	O
ricin	S-Pathogen
a	O
highly	O
toxic	O
protein	O
,	O
was	O
intercepted	O
at	O
the	O
US	B-Location
Capitol	E-Location
's	O
off-site	O
mail	O
facility	O
in	O
Washington,	B-Location
D.C	E-Location
.	O
According	O
to	O
reports	O
,	O
the	O
envelope	O
was	O
addressed	O
to	O
the	O
office	B-Location
of	I-Location
Mississippi	I-Location
Republican	I-Location
Senator	I-Location
Roger	I-Location
Wicker	E-Location
.	O
On	O
April	O
17	O
,	O
2013	O
,	O
an	O
envelope	O
addressed	O
to	O
President	O
of	O
the	O
United	O
States	O
Barack	B-Person
Obama	E-Person
preliminarily	O
tested	O
positive	O
for	O
.	O

These	O
events	O
should	O
never	O
have	O
happened	O
.	O

Crisis	O
management	O
in	O
Sweden	S-Location
is	O
based	O
on	O
the	O
premise	O
that	O
procedures	O
will	O
be	O
performed	O
as	O
normal	O
;	O
this	O
also	O
includes	O
sample	O
flow	O
upon	O
suspicion	O
of	O
high-consequence	O
pathogens	O
.	O

Instead	O
of	O
budgets	O
that	O
are	O
renewed	O
annually	O
,	O
agencies	O
should	O
be	O
given	O
at	O
least	O
four	O
years	O
of	O
funding	O
for	O
biosurveillance	O
projects	O
.	O

While	O
the	O
M.	B-Pathogen
mycoides	I-Pathogen
mycoides	E-Pathogen
and	O
M.	B-Pathogen
capricolum	I-Pathogen
capripneumoniae	I-Pathogen
subspecies	E-Pathogen
are	O
endemic	O
in	O
Africa	S-Location
and	O
a	O
huge	O
burden	O
for	O
cattle	O
and	O
goat	O
populations	O
there	O
,	O
the	O
organisms	O
are	O
not	O
present	O
in	O
the	O
.	O

Perhaps	O
the	O
best	O
example	O
is	O
the	O
Aum	O
Shinrikyo	O
cult	O
in	O
Japan	S-Location
active	O
between	O
1984	O
and	O
1995	O
,	O
which	O
sought	O
to	O
bring	O
about	O
the	O
destruction	O
of	O
humanity	O
.	O

Thus	O
,	O
the	O
can	O
be	O
regarded	O
as	O
complementary	O
to	O
each	O
agency's	O
existing	O
management	O
systems	O
.	O

Please	O
note:	O
the	O
following	O
Q&amp;A	O
is	O
not	O
an	O
official	O
communications	O
from	O
the	O
government	O
but	O
based	O
on	O
notes	O
from	O
the	O
discussion	O
w	O
AAU	O
staff.	O
*What	O
is	O
the	O
stand-down*?	O
Essentially	O
,	O
what	O
the	O
government	O
will	O
request	O
is	O
a	O
short	O
term	O
on	O
the	O
order	O
of	O
24	O
hours	O
suspension	O
of	O
research	O
involving	O
high-consequence	O
pathogens	O
in	O
order	O
to	O
allow	O
institutional	O
lab	O
personnel	O
to	O
take	O
stock	O
of	O
what	O
pathogens	O
they	O
have	O
stored	O
in	O
freezers	O
,	O
cold	O
rooms	O
,	O
etc	O
.	O

On	O
the	O
skin	O
,	O
the	O
bacteria	O
can	O
cause	O
blisters	S-Disease
and	O
ulcers	S-Disease
with	O
a	O
black	O
center	O
.	O

The	O
duration	O
of	O
the	O
pandemic	O
and	O
the	O
war	O
could	O
have	O
also	O
played	O
a	O
role	O
.	O

Second	O
,	O
because	O
of	O
the	O
inherent	O
high-contrast	O
resolution	O
of	O
CT	S-Technology
,	O
differences	O
between	O
tissues	O
that	O
differ	O
in	O
physical	O
density	O
by	O
less	O
than	O
1%	O
can	O
be	O
distinguished	O
.	O

For	O
the	O
Zika	B-Vaccine
vaccine	E-Vaccine
a	O
single	O
inoculation	O
of	O
MVA-Zika	B-Vaccine
vaccine	E-Vaccine
in	O
normal	O
mice	O
provided	O
100	O
percent	O
protection	O
against	O
a	O
lethal	O
challenge	O
dose	O
of	O
a	O
neurovirulent	O
delivered	O
directly	O
into	O
the	O
brain	O
.	O

Nolin	S-Person
,	O
Robert	S-Person
.	O
"	O
Medflies	O
found	O
in	O
"	O
,	O
Sun-Sentinel	O
,	O
June	O
15	O
,	O
2010	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
the	O
second	O
disaster	O
affecting	O
Europe	S-Location
during	O
the	O
Late	O
Middle	O
Ages	O
(the	O
first	O
one	O
being	O
the	O
Great	O
Famine)	O
and	O
is	O
estimated	O
to	O
have	O
killed	O
30%	O
to	O
60%	O
of	O
Europe	S-Location
's	O
population	O
.	O

His	O
testimony	O
tied	O
the	O
Noborito	B-Organization
Institute	E-Organization
to	O
the	O
infamous	O
,	O
which	O
participated	O
in	O
biomedical	O
research	O
.	O

Most	O
clinical	O
magnets	O
are	O
superconducting	O
magnets	O
,	O
which	O
require	O
liquid	O
helium	O
.	O

We	O
have	O
such	O
great	O
scientists	O
.	O

They	O
contaminated	O
the	O
produce	O
at	O
the	O
salad	O
bars	O
as	O
a	O
"	O
trial	O
run"	O
.	O

The	O
American	O
people	O
depend	O
on	O
us	O
24/7	O
to	O
protect	O
them	O
.	O

Another	O
recent	O
study	O
,	O
from	O
the	O
University	B-Organization
of	I-Organization
California	E-Organization
,	O
suggests	O
that	O
instead	O
of	O
using	O
combinations	O
of	O
one	O
or	O
two	O
antibiotics	O
,	O
as	O
doctors	O
typically	O
do	O
,	O
healthcare	O
professionals	O
may	O
want	O
to	O
use	O
combinations	O
of	O
four	O
or	O
even	O
five	O
such	O
drugs	O
.	O

The	O
review	O
of	O
experiments	O
would	O
be	O
added	O
on	O
to	O
the	O
already	O
established	O
NIH	S-Organization
system	O
for	O
reviewing	O
recombinant	O
DNA	O
experiments	O
through	O
local	O
institutional	O
biosafety	O
committees	O
.	O

A	O
number	O
of	O
provincial-level	O
administrators	O
of	O
the	O
Communist	B-Organization
Party	I-Organization
of	I-Organization
China	E-Organization
were	O
dismissed	O
over	O
their	O
handling	O
of	O
the	O
quarantine	O
efforts	O
in	O
central	O
China	S-Location
,	O
a	O
sign	O
of	O
discontent	O
with	O
their	O
response	O
to	O
the	O
outbreak	O
.	O

Representatives	O
attend	O
from	O
each	O
member	O
or	O
associative	O
member	O
in	O
each	O
region	O
,	O
including	O
those	O
states	O
that	O
are	O
not	O
full	O
members	O
.	O

Since	O
the	O
insertion	O
of	O
a	O
gene	O
into	O
the	O
host	O
genome	O
may	O
even	O
cause	O
copy	O
number	O
variation	O
,	O
this	O
may	O
be	O
uncovered	O
using	O
real	O
time	O
PCR	S-Equipment
Besides	O
,	O
assessing	O
the	O
exact	O
number	O
of	O
mRNA	O
transcripts	O
of	O
a	O
gene	O
,	O
correlation	O
between	O
the	O
template	O
activity	O
and	O
expressed	O
protein	O
may	O
be	O
established	O
.	O

Call	O
John	S-Person
at	O
.	O
"	O

Zachary	B-Person
Bornholdt	E-Person
,	O
and	O
a	O
group	O
of	O
academic	O
and	O
government	O
partners	O
that	O
included	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
NIAID	S-Organization
)	O
supported	O
Centers	O
of	O
Excellence	O
for	O
Translational	O
Research	O
at	O
four	O
institutions:	O
Albert	B-Organization
Einstein	I-Organization
College	I-Organization
of	I-Organization
Medicine	E-Organization
(	O
Einstein	S-Person
)	O
,	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Canada	E-Organization
,	O
the	O
University	B-Organization
of	I-Organization
Texas	I-Organization
Medical	I-Organization
Branch	I-Organization
at	I-Organization
Galveston	E-Organization
,	O
and	O
the	O
United	B-Organization
States	I-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
.	O

Operation	B-Activity
Big	I-Activity
Itch	E-Activity
Field	O
tests	O
were	O
performed	O
to	O
determine	O
coverage	O
patterns	O
and	O
survivability	O
of	O
the	O
tropical	O
rat	O
flea	O
for	O
use	O
as	O
a	O
disease	O
vector	O
in	O
biological	O
warfare	O
.	O

While	O
there	O
is	O
some	O
variation	O
,	O
most	O
people	O
(99%)	O
received	O
less	O
than	O
7 mSv	O
per	O
year	O
as	O
background	O
radiation	O
.	O

The	O
generator	O
,	O
water	O
supplying	O
unit	O
and	O
incineration	O
units	O
are	O
located	O
outside	O
the	O
building	O
.	O

When	O
plans	O
were	O
announced	O
to	O
build	O
the	O
facility	O
in	O
Kansas	S-Location
a	O
state	O
within	O
the	O
bread	O
basket	O
of	O
grain	O
and	O
livestock	O
production	O
,	O
critics	O
pounced	O
.	O

Spero	S-Organization
plans	O
to	O
start	O
a	O
Phase	O
III	O
tri­al	O
of	O
SPR994	S-Drug
for	O
the	O
treat­ment	O
of	O
around	O
year-end	O
2018	O
.	O

In	O
fact	O
,	O
current	O
H1N1	S-Pathogen
death	O
rates	O
are	O
even	O
lower	O
than	O
those	O
for	O
H3N2	S-Pathogen
lineage	O
strains	O
(prevalent	O
from	O
1968	O
until	O
the	O
present)	O
.	O

During	O
the	O
mid-2010s	O
,	O
the	O
Mintz	O
Levin	O
law	O
firm	O
prosecuted	O
various	O
patent	O
applications	O
for	O
remdesivir	S-Drug
on	O
behalf	O
of	O
Gilead	B-Organization
Sciences	E-Organization
before	O
the	O
United	B-Organization
States	I-Organization
Patent	I-Organization
and	I-Organization
Trademark	I-Organization
Office	E-Organization
(	O
USPTO	S-Organization
)	O
.	O

"	O
We	O
don't	O
know	O
when	O
they	O
were	O
vaccinated	O
or	O
whether	O
they	O
were	O
successfully	O
vaccinated,	O
"	O
Dr	O
.	O

Evidence	O
is	O
not	O
available	O
yet	O
beyond	O
82	O
days.	O
"	O
In	O
April	O
2015	O
,	O
following	O
a	O
report	O
that	O
the	O
RNA	O
virus	O
had	O
been	O
detected	O
in	O
a	O
semen	O
sample	O
six	O
months	O
after	O
a	O
man's	O
recovery	O
,	O
the	O
WHO	S-Organization
issued	O
a	O
statement:	O
"	O
For	O
greater	O
security	O
and	O
prevention	O
of	O
other	O
sexually	O
transmitted	O
infections	O
,	O
survivors	O
should	O
consider	O
correct	O
and	O
consistent	O
use	O
of	O
condoms	O
for	O
all	O
sexual	O
acts	O
beyond	O
three	O
months	O
until	O
more	O
information	O
is	O
available.	O
"	O

According	O
to	O
WHO	S-Organization
reports	O
,	O
25,926	O
contacts	O
from	O
Guinea	S-Location
,	O
35,183	O
from	O
Liberia	S-Location
and	O
104,454	O
from	O
were	O
listed	O
and	O
traced	O
as	O
of	O
23	O
November	O
2014	O
.	O

Some	O
scientists	O
reasoned	O
that	O
such	O
knowledge	O
would	O
help	O
them	O
prepare	O
a	O
defense	O
against	O
a	O
more	O
deadly	O
form	O
of	O
the	O
fungus	O
.	O

In	O
September	O
2014	O
,	O
the	O
WHO	S-Organization
had	O
reported:	O
"	O
No	O
formal	O
evidence	O
exists	O
of	O
sexual	O
transmission	O
,	O
but	O
sexual	O
transmission	O
from	O
convalescent	O
patients	O
cannot	O
be	O
ruled	O
out	O
.	O

Note	O
1:This	O
table	O
contains	O
countries	O
that	O
had	O
limited	O
local	O
cases.Note	O
2:Date	O
is	O
the	O
"	O
as	O
of	O
"	O
date	O
from	O
the	O
reference	O
.	O
A	O
single	O
source	O
may	O
report	O
statistics	O
for	O
multiple	O
"	O
as	O
of	O
"	O
dates	O
.	O

These	O
arms	O
control	O
talks	O
would	O
eventually	O
lead	O
to	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
,	O
the	O
international	O
treaty	O
outlawing	O
biological	O
warfare	O
.	O

The	O
work	O
of	O
safety	O
is	O
never	O
complete	O
.	O

Antibiotic	O
resistance-when	O
bacteria	O
change	O
so	O
antibiotics	O
no	O
longer	O
work	O
in	O
people	O
who	O
need	O
them	O
to	O
treat	O
infections-is	O
now	O
a	O
major	O
threat	O
to	O
public	O
health.	O
"	O
"	O
WHO's	B-Document
first	I-Document
global	I-Document
report	I-Document
on	I-Document
antibiotic	I-Document
resistance	E-Document
reveals	O
serious	O
,	O
worldwide	O
threat	O
to	O
public	O
health	O
"	O
Retrieved	O
2	O
May	O
2014	O
In	O
2018	O
,	O
WHO	S-Organization
considered	O
antibiotic	O
resistance	O
to	O
be	O
one	O
of	O
the	O
biggest	O
threats	O
to	O
global	O
health	O
,	O
food	O
security	O
and	O
development	O
.	O

In	O
Europe	S-Location
,	O
WHO	S-Organization
Representatives	O
also	O
serve	O
as	O
Head	O
of	O
Country	O
Office	O
,	O
and	O
are	O
nationals	O
with	O
the	O
exception	O
of	O
Serbia	S-Location
;	O
there	O
are	O
also	O
Heads	O
of	O
Country	O
Office	O
in	O
Albania	S-Location
,	O
the	O
Russian	B-Location
Federation	E-Location
,	O
Tajikistan	S-Location
,	O
Turkey	S-Location
,	O
and	O
Uzbekistan	S-Location
.	O
The	O
WR	O
is	O
member	O
of	O
the	O
UN	S-Organization
system	O
country	O
team	O
which	O
is	O
coordinated	O
by	O
the	O
System	O
Resident	O
Coordinator	O
.	O

Pixels	O
in	O
an	O
image	O
obtained	O
by	O
CT	B-Technology
scanning	E-Technology
are	O
displayed	O
in	O
terms	O
of	O
relative	O
radiodensity	O
.	O

There	O
is	O
no	O
evidence	O
that	O
any	O
of	O
the	O
vials	O
labeled	O
variola	S-Disease
has	O
been	O
breached	O
,	O
and	O
onsite	O
biosafety	O
personnel	O
have	O
not	O
identified	O
any	O
infectious	O
exposure	O
risk	O
to	O
lab	O
workers	O
or	O
the	O
public	O
.	O

Most	O
prominent	O
among	O
medical	O
organizations	O
supporting	O
codes	O
of	O
conduct	O
have	O
been	O
the	O
World	B-Organization
Medical	I-Organization
Association	E-Organization
the	O
American	B-Organization
Medical	I-Organization
Association	E-Organization
,	O
and	O
the	O
British	B-Organization
Medical	I-Organization
Association	E-Organization
.	O
The	O
has	O
drawn	O
up	O
a	O
set	O
of	O
guidelines	O
to	O
prevent	O
the	O
malevolent	O
use	O
of	O
biomedical	O
research	O
,	O
in	O
which	O
physician	O
researchers	O
are	O
asked	O
to	O
assess	O
foreseeable	O
ramifications	O
before	O
they	O
participate	O
in	O
research	O
to	O
balance	O
the	O
promise	O
of	O
benefit	O
from	O
biomedical	O
innovation	O
against	O
potential	O
harms	O
from	O
corrupt	O
application	O
of	O
the	O
findings	O
.	O

Other	O
suspected	O
Japanese	O
war	O
criminals	O
who	O
were	O
never	O
indicted	O
include	O
three	O
postwar	O
prime	O
ministers:	O
Hatoyama	B-Person
Ichirō	E-Person
(1954–1956)	O
,	O
Ikeda	B-Person
Hayato	E-Person
(1960–1964)	O
,	O
and	O
(1957)	O
.	O

The	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
Biosafety	O
Guidelines	O
Web	O
site	O
.	O

Soviet	S-Organization
"	O
Superbugs"	O

On	O
14	O
July	O
2019	O
,	O
the	O
first	O
case	O
of	O
EVD	S-Disease
was	O
confirmed	O
in	O
the	O
capital	O
of	O
North	B-Location
Kivu	E-Location
,	O
Goma	S-Location
,	O
a	O
city	O
with	O
an	O
international	O
airport	O
and	O
a	O
highly	O
mobile	O
population	O
of	O
2million	O
people	O
,	O
which	O
is	O
right	O
at	O
the	O
DRC	S-Location
's	O
eastern	O
border	O
with	O
Rwanda	S-Location
.	O
This	O
case	O
was	O
a	O
man	O
who	O
passed	O
through	O
three	O
health	O
checkpoints	O
,	O
with	O
different	O
names	O
on	O
traveller	O
lists	O
.	O

Biopreparat	S-Organization
pursued	O
offensive	O
research	O
,	O
development	O
,	O
and	O
production	O
of	O
biological	O
agents	O
under	O
the	O
guise	O
of	O
legitimate	O
civil	O
biotechnology	O
research	O
.	O

A	O
highly	O
suspicious	O
Hepatitis	B-Disease
A	E-Disease
infection	O
spread	O
rapidly	O
in	O
just	O
few	O
months	O
across	O
South	B-Location
East	I-Location
Ukraine	E-Location
where	O
most	O
of	O
the	O
biolabs	O
are	O
located	O
.	O

Anthrax	S-Pathogen
is	O
one	O
of	O
the	O
few	O
biological	O
agents	O
that	O
federal	O
employees	O
have	O
been	O
vaccinated	O
for	O
.	O

As	O
a	O
result	O
Tbilisi	S-Organization
has	O
been	O
infested	O
with	O
biting	O
flies	O
since	O
2015	O
.	O

"	O
If	O
we	O
are	O
able	O
to	O
predict	O
how	O
viruses	O
might	O
mutate	O
and	O
spread	O
,	O
and	O
take	O
steps	O
to	O
prevent	O
those	O
mutations	O
from	O
impacting	O
humans	O
,	O
then	O
we'll	O
vastly	O
diminish	O
the	O
possibility	O
of	O
future	O
viral	O
pandemics,	O
"	O
said	O
Gimlett	S-Person

A	O
total	O
of	O
countries	O
and	O
territories	O
have	O
had	O
at	O
least	O
one	O
case	O
of	O
COVID-19	S-Disease
so	O
far	O
.	O

These	O
include	O
actions	O
identified	O
by	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture's	I-Organization
Animal	I-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Services	E-Organization
and	O
CDC's	B-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Associate	I-Organization
Director	I-Organization
for	I-Organization
Science	E-Organization
following	O
investigations	O
conducted	O
in	O
response	O
to	O
the	O
June	B-Incident
2014	I-Incident
transfer	I-Incident
of	I-Incident
potentially	I-Incident
viable	I-Incident
Bacillus	I-Incident
anthracis	I-Incident
from	I-Incident
a	I-Incident
CDC	I-Incident
BSL-3	I-Incident
facility	I-Incident
to	I-Incident
CDC	I-Incident
BSL-2	I-Incident
facilities	E-Incident
;	O
actions	O
identified	O
in	O
follow	O
up	O
to	O
an	O
inadvertent	O
shipment	O
of	O
an	O
H5N1	S-Pathogen
influenza-containing	O
laboratory	O
specimen	O
to	O
an	O
external	O
laboratory	O
;	O
and	O
other	O
necessary	O
actions	O
identified	O
through	O
ongoing	O
procedural	O
reviews	O
.	O

Inglesby	S-Person
said	O
he's	O
hopeful	O
that	O
federal	O
officials	O
follow	O
up	O
with	O
more	O
details	O
on	O
how	O
they	O
will	O
implement	O
the	O
new	O
strategy	O
,	O
and	O
he	O
hopes	O
,	O
a	O
planning	O
document	O
spelling	O
it	O
out	O
will	O
follow	O
.	O

At	O
this	O
point	O
,	O
most	O
respondents	O
stopped	O
participating	O
.	O

In	O
,	O
antibiotic-resistant	O
infections	O
are	O
responsible	O
for	O
$20	O
billion	O
per	O
year	O
in	O
excess	O
health	O
care	O
costs	O
,	O
$35	O
billion	O
per	O
year	O
in	O
societal	O
costs	O
and	O
8	O
million	O
additional	O
hospital	O
days	O
each	O
year	O
(REF)	O
.	O

Apart	O
from	O
Russians	O
,	O
the	O
US	S-Location
has	O
been	O
collecting	O
biological	O
material	O
from	O
both	O
healthy	O
and	O
cancer	S-Disease
patients	O
in	O
China	S-Location
.	O
The	O
National	B-Organization
Cancer	I-Organization
Institute	E-Organization
has	O
collected	O
biological	O
samples	O
from	O
300	O
subjects	O
from	O
Linxian	S-Location
,	O
Zhengzhou	S-Location
,	O
and	O
Chengdu	S-Location
in	O
China	S-Location
.	O
While	O
another	O
federal	O
project	O
,	O
titled	O
,	O
includes	O
analysis	O
of	O
349	O
serum	O
samples	O
which	O
have	O
been	O
collected	O
from	O
Chinese	O
patients	O
.	O

Badie	S-Person
,	O
Rick	S-Person
.	O
"	O
Medfly	O
Scare	O
Yet	O
Another	O
Challenge	O
For	O
Citrus	O
Industry	O
,	O
Very	O
Much	O
Alive	O
In	O
Lake"	O
,	O
Orlando	B-Person
Sentinel	E-Person
,	O
July	O
13	O
,	O
1997	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

This	O
gives	O
a	O
temporal	O
resolution	O
of	O
20–30	O
ms	O
for	O
images	O
with	O
an	O
in-plane	O
resolution	O
of	O
1.5–2.0 mm	O
.	O

We're	O
doing	O
other	O
things	O
to	O
look	O
at	O
critical	O
control	O
points	O
.	O

Electron	B-Technology
beam	I-Technology
tomography	E-Technology
(	O
EBT	S-Technology
)	O
is	O
a	O
specific	O
form	O
of	O
CT	S-Equipment
in	O
which	O
a	O
large	O
enough	O
X-ray	B-Equipment
tube	E-Equipment
is	O
constructed	O
so	O
that	O
only	O
the	O
path	O
of	O
the	O
electrons	O
,	O
travelling	O
between	O
the	O
cathode	O
and	O
anode	O
of	O
the	O
X-ray	O
tube	O
,	O
are	O
spun	O
using	O
deflection	O
coils	O
.	O

Cas9	S-Technology
can	O
specifically	O
deplete	O
the	O
undesired	O
sequences	O
with	O
double	O
strand	O
breakage	O
with	O
up	O
to	O
99%	O
efficiency	O
and	O
without	O
significant	O
off-target	O
effects	O
as	O
seen	O
with	O
restriction	O
enzymes	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
has	O
proposed	O
a	O
goal	O
of	O
"	O
10	O
new	O
antibiotics	O
for	O
2020	O
"	O
(Ref)	O
.	O

Daniel	O
Barenblatt	O
,	O
A	O
Plague	O
upon	O
Humanity	O
,	O
2004	O
,	O
p.32	O
.	O

Due	O
to	O
capacity	O
limitations	O
in	O
the	O
standard	O
supply	O
chains	O
,	O
some	O
manufacturers	O
are	O
3D	O
printing	O
healthcare	O
material	O
such	O
as	O
nasal	B-Equipment
swabs	E-Equipment
and	O
ventilator	S-Equipment
parts	O
.	O

On	O
January	O
4	O
,	O
2004	O
the	O
FBI	S-Organization
along	O
with	O
the	O
USPIS	S-Organization
and	O
the	O
DOT	S-Organization
,	O
offered	O
a	O
$100,000	O
reward	O
in	O
connection	O
with	O
the	O
October	O
2003	O
case	O
from	O
Greenville	S-Location
,	O
South	B-Location
Carolina	E-Location
.	O
"	O
$100,000	O
Reward	O
"	O
,	O
(Press	O
release)	O
,	O
Federal	B-Organization
Bureau	I-Organization
of	I-Organization
Investigation	E-Organization
,	O
January	O
4	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

He	O
said	O
that	O
twin	O
girls	O
,	O
Lulu	S-Person
and	O
Nana	S-Person
,	O
had	O
been	O
born	O
a	O
few	O
weeks	O
earlier	O
.	O

Summaries	O
of	O
the	O
pandemic	O
.	O

They	O
note	O
that	O
as	O
caregivers	O
of	O
the	O
sick	O
,	O
pregnant	O
and	O
lactating	O
women	O
are	O
more	O
likely	O
to	O
contract	O
Ebola	S-Pathogen
.	O
They	O
also	O
note	O
that	O
since	O
it	O
is	O
known	O
that	O
almost	O
100%	O
of	O
pregnant	O
women	O
who	O
contract	O
will	O
die	O
,	O
a	O
safety	O
concern	O
should	O
not	O
be	O
a	O
deciding	O
factor	O
.	O

In	O
all	O
,	O
318	O
cases	O
of	O
Ebola	S-Pathogen
were	O
identified	O
in	O
Zaire	S-Location
,	O
and	O
280	O
resulted	O
in	O
death	O
.	O

Risk	O
assessments	O
help	O
us	O
ensure	O
the	O
hazards	O
will	O
not	O
happen	O
,	O
we	O
may	O
not	O
be	O
able	O
to	O
eliminate	O
all	O
the	O
hazards	O
,	O
however	O
,	O
the	O
probability	O
of	O
incidence	O
occurring	O
can	O
be	O
minimized	O
through	O
risk	O
assessment	O
.	O

Meanwhile	O
,	O
the	O
UK's	B-Platform
National	I-Platform
Health	I-Platform
Service	E-Platform
website	O
states	O
that:	O
"	O
Many	O
global	O
outbreaks	O
of	O
infectious	O
illnesses	O
(pandemics)	O
that	O
have	O
occurred	O
in	O
recent	O
history	O
are	O
thought	O
to	O
have	O
been	O
caused	O
by	O
viruses	O
previously	O
only	O
found	O
in	O
animals	O
.	O

Users	O
could	O
then	O
receive	O
a	O
message	O
if	O
they've	O
been	O
in	O
close	O
contact	O
with	O
someone	O
who	O
has	O
subsequently	O
tested	O
positive	O
for	O
COVID-19	S-Disease

For	O
example	O
,	O
a	O
team	O
of	O
researchers	O
from	O
the	O
University	B-Organization
of	I-Organization
Sheffield	E-Organization
and	O
the	O
Rutherford	B-Organization
Appleton	I-Organization
Laboratory	E-Organization
,	O
in	O
Didcot	S-Location
-	O
both	O
in	O
the	O
United	B-Location
Kingdom	E-Location
-	O
started	O
developing	O
a	O
new	O
compound	O
earlier	O
this	O
year	O
that	O
they	O
hope	O
will	O
be	O
able	O
to	O
effectively	O
target	O
bacteria	O
,	O
particularly	O
strains	O
of	O
,	O
that	O
are	O
resistant	O
to	O
multiple	O
drugs	O
.	O

It	O
happened	O
a	O
hundred	O
years	O
ago,	O
"	O
Murray	S-Person
said	O
,	O
referring	O
to	O
the	O
1918	B-Incident
influenza	I-Incident
epidemic	E-Incident
that	O
eventually	O
caused	O
more	O
deaths	O
than	O
in	O
.	O

These	O
systems	O
allow	O
conditional	O
control	O
of	O
activity	O
for	O
improved	O
precision	O
,	O
efficiency	O
,	O
and	O
spatiotemporal	O
control	O
.	O

Depending	O
on	O
the	O
disease	O
outbreak	O
scenario	O
explored	O
,	O
the	O
number	O
of	O
U.S.	S-Location
jobs	O
at	O
risk	O
jumps	O
from	O
about	O
1,400	O
to	O
more	O
than	O
1.3	O
million	O
.	O

Broad	B-Organization
Institute	I-Organization
of	I-Organization
MIT	E-Organization
and	O
Harvard	S-Organization
researchers	O
have	O
created	O
a	O
new	O
tool	O
that	O
better	O
prepares	O
the	O
CRISPR	S-Technology
-based	O
diagnostic	O
tool	O
,	O
,	O
for	O
rapid	O
response	O
to	O
viral	O
outbreaks	O
.	O

She	O
was	O
the	O
last	O
recorded	O
person	O
to	O
die	O
from	O
.	O

Health	O
care	O
providers	O
taking	O
care	O
of	O
someone	O
who	O
may	O
be	O
infected	O
are	O
recommended	O
to	O
use	O
standard	O
precautions	O
,	O
contact	O
precautions	O
,	O
and	O
eye	O
protection	O
.	O

This	O
initiative	O
is	O
organized	O
by	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organization	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
(	O
FAO	S-Organization
)	O
through	O
its	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)	O
Program	O
with	O
funding	O
from	O
United	B-Organization
States	I-Organization
Agency	I-Organization
for	I-Organization
International	I-Organization
Development	E-Organization
(	O
USAID	S-Organization
)	O
in	O
partnership	O
with	O
the	O
and	O
other	O
stakeholders	O
.	O

Viral	O
neutralisation	O
is	O
the	O
anticipated	O
mechanism	O
of	O
action	O
by	O
which	O
passive	O
antibody	O
therapy	O
can	O
mediate	O
defence	O
against	O
.	O

SABRIYA	B-Person
RICE	E-Person
Yeah	O
,	O
good	O
morning	O
.	O

"	O
You	O
can	O
develop	O
solutions	O
through	O
partnerships	O
.	O

Transmission	O
can	O
be	O
direct	O
from	O
animal	O
to	O
human	O
,	O
from	O
animal	O
to	O
"	O
bridge"	O
animal	O
to	O
human	O
,	O
or	O
animal	O
to	O
vector	O
to	O
human	O
.	O

Earlier	O
studies	O
found	O
antiviral	O
activity	O
against	O
several	O
RNA	O
viruses	O
including	O
SARS	B-Pathogen
coronavirus	E-Pathogen
and	O
MERS	B-Pathogen
coronavirus	E-Pathogen
,	O
but	O
it	O
is	O
not	O
approved	O
for	O
any	O
indication	O
.	O

The	O
goal	O
of	O
PPE	S-Equipment
is	O
two‐fold:	O
(1)	O
PPE	S-Equipment
provides	O
a	O
barrier	O
to	O
possible	O
routes	O
of	O
entry	O
on	O
a	O
worker's	O
body	O
and	O
(2)	O
protects	O
street	O
clothing	O
and	O
shoes	O
so	O
that	O
laboratory	O
contaminants	O
are	O
not	O
inadvertently	O
taken	O
from	O
the	O
laboratory	O
into	O
a	O
nonresearch	O
area	O
,	O
such	O
as	O
a	O
worker's	O
home	O
.	O

D.	B-Person
A.	I-Person
Henderson	E-Person
a	O
top	O
bioterrorism	O
adviser	O
to	O
the	O
secretary	O
of	O
heath	O
and	O
human	O
services	O
,	O
said	O
he	O
was	O
skeptical	O
of	O
the	O
Monterey	S-Location
report's	O
conclusions	O
and	O
expressed	O
confidence	O
in	O
the	O
American	O
vaccine	O
.	O

In	O
the	O
other	O
two	O
stations	O
,	O
students	O
either	O
count	O
the	O
number	O
of	O
foci	O
formed	O
in	O
lab1	O
(Table	O
1)	O
or	O
start	O
a	O
virus	O
identification	O
procedure	O
with	O
a	O
PCR	O
of	O
a	O
DNA	O
extracted	O
from	O
cells	O
infected	O
with	O
the	O
human	B-Pathogen
cytomegalovirus	E-Pathogen
()	O
.	O

Several	O
agencies	O
,	O
including	O
the	O
,	O
appear	O
to	O
have	O
already	O
begun	O
the	O
process	O
.	O

To	O
uncover	O
chemical	O
and	O
explosives	O
threats	O
,	O
SIGMA+	S-Scientific_research_project
seeks	O
unprecedented	O
long-range	O
detection	O
of	O
hundreds	O
of	O
chemicals	O
at	O
trace	O
levels	O
to	O
help	O
authorities	O
identify	O
bomb-making	O
safe	O
houses	O
in	O
large	O
urban	O
areas	O
,	O
for	O
example	O
.	O

And	O
yes	O
,	O
in	O
fact	O
,	O
there	O
was	O
.	O

The	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
and	I-Document
Advancing	I-Document
Innovation	I-Document
Act	E-Document
of	O
2018	O
,	O
H.R.	B-Document
6378	E-Document
,	O
introduced	O
by	O
Brooks	S-Person
on	O
July	O
16	O
with	O
original	O
cosponsors	O
U.S.	S-Location
Reps	O
.	O

Some	O
scientists	O
chose	O
to	O
share	O
their	O
results	O
quickly	O
on	O
preprint	O
servers	O
such	O
as	O
bioRxiv	S-Platform

The	O
excited	O
atoms	O
emit	O
a	O
radio	O
frequency	O
(RF)	O
signal	O
,	O
which	O
is	O
measured	O
by	O
a	O
receiving	O
coil	O
.	O

In	O
addition	O
,	O
a	O
bilateral	O
collaboration	O
between	O
Sweden	S-Location
and	O
has	O
resulted	O
in	O
joint	O
ring	O
trials	O
for	O
analysis	O
of	O
spiked	O
samples	O
for	O
detecting	O
high-consequence	O
bacteria	O
.	O

The	O
biological	O
and	O
chemical	O
weapons	O
developed	O
during	O
that	O
period	O
were	O
tested	O
at	O
the	O
Dugway	B-Location
Proving	I-Location
Grounds	I-Location
in	I-Location
Utah	E-Location
.	O
Soon	O
there	O
were	O
facilities	O
for	O
the	O
mass	O
production	O
of	O
anthrax	B-Pathogen
spores	E-Pathogen
,	O
brucellosis	S-Pathogen
,	O
and	O
,	O
although	O
the	O
war	O
was	O
over	O
before	O
these	O
weapons	O
could	O
be	O
of	O
much	O
operational	O
use	O
.	O

Inactive	O
dCas9	O
protein	O
modulate	O
gene	O
expression	O
by	O
targeting	O
dCas9-repressors	O
or	O
activators	O
toward	O
promoter	O
or	O
transcriptional	O
start	O
sites	O
of	O
target	O
genes	O
.	O

Previous	O
outbreaks	O
had	O
been	O
brought	O
under	O
control	O
in	O
a	O
much	O
shorter	O
period	O
of	O
time	O
.	O

Minnesota	S-Organization
eventually	O
established	O
an	O
emergency	O
response	O
account	O
to	O
quickly	O
deal	O
with	O
such	O
problems	O
,	O
said	O
Sen.	O
,	O
who	O
asked	O
if	O
such	O
a	O
fund	O
would	O
help	O
federal	O
agencies	O
better	O
respond	O
and	O
support	O
the	O
nation	O
.	O

For	O
example	O
,	O
in	O
2015	O
,	O
it	O
was	O
reported	O
that	O
Gambia	S-Location
's	O
tourism	O
had	O
fallen	O
below	O
50	O
per	O
cent	O
of	O
its	O
normal	O
business	O
during	O
the	O
same	O
period	O
the	O
prior	O
year	O
,	O
Elmina	B-Location
Bay	E-Location
in	O
Ghana	S-Location
had	O
an	O
80%	O
decrease	O
in	O
US	O
tourism	O
,	O
and	O
Kenya	S-Location
,	O
Zimbabwe	S-Location
,	O
Senegal	S-Location
,	O
Zambia	S-Location
,	O
and	O
also	O
reported	O
a	O
drop	O
.	O

Despite	O
this	O
,	O
had	O
a	O
slow	O
start	O
in	O
testing	O
,	O
which	O
obscured	O
the	O
extent	O
of	O
the	O
outbreak	O
.	O

Oxford	O
University	O
Press	O
,	O
2011	O
.	O

And	O
none	O
of	O
the	O
steps	O
are	O
mandatory	O
for	O
extramural	O
labs	O
with	O
federal	O
funding	O
.	O

But	O
he's	O
also	O
motivated	O
in	O
large	O
part	O
by	O
frustration	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
,	O
USDA	O
,	O
DHHS	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

Anatomical	O
imaging	O
of	O
the	O
bile	O
ducts	O
is	O
achieved	O
by	O
using	O
a	O
heavily	O
T2-weighted	O
sequence	O
in	O
magnetic	B-Technology
resonance	I-Technology
cholangiopancreatography	E-Technology
(	O
MRCP	S-Technology
)	O
.	O

Get	O
the	O
Coronavirus	B-Organization
Watch	E-Organization
newsletter	O
in	O
your	O
inbox	O
.	O

While	O
the	O
hazards	O
of	O
ionizing	O
radiation	O
are	O
now	O
well	O
controlled	O
in	O
most	O
medical	O
contexts	O
,	O
an	O
MRI	S-Technology
may	O
still	O
be	O
seen	O
as	O
a	O
better	O
choice	O
than	O
a	O
CT	B-Technology
scan	E-Technology
.	O
MRI	S-Technology
is	O
widely	O
used	O
in	O
hospitals	O
and	O
clinics	O
for	O
medical	O
diagnosis	O
and	O
staging	O
and	O
follow-up	O
of	O
disease	O
without	O
exposing	O
the	O
body	O
to	O
radiation	O
.	O

The	O
balcony	O
was	O
completely	O
closed	O
and	O
guarded	O
by	O
the	O
police	O
.	O

This	O
result	O
is	O
not	O
unexpected	O
as	O
bacterial	O
spores	O
are	O
typically	O
much	O
more	O
resistant	O
to	O
chemical	O
inactivation	O
than	O
bacterial	O
cells	O
.	O

Beam	O
hardening	O
This	O
can	O
give	O
a	O
"	O
cupped	O
appearance	O
"	O
when	O
grayscale	O
is	O
visualized	O
as	O
height	O
.	O

Beyond	O
voluntariness-making	O
data	O
management	O
and	O
sharing	O
a	O
condition	O
of	O
funding	O
,	O
using	O
data	O
management	O
plans	O
and	O
controlling	O
these-are	O
efficient	O
mechanisms	O
to	O
get	O
publicly	O
funded	O
data	O
shared	O
and	O
are	O
on	O
the	O
road	O
map	O
in	O
some	O
countries	O
.	O

The	O
response	O
to	O
the	O
epidemic	O
then	O
moved	O
to	O
a	O
second	O
phase	O
,	O
as	O
the	O
focus	O
shifted	O
from	O
slowing	O
transmission	O
to	O
ending	O
the	O
epidemic	O
.	O

Although	O
,	O
historically	O
,	O
the	O
images	O
generated	O
were	O
in	O
the	O
axial	O
or	O
transverse	O
plane	O
,	O
perpendicular	O
to	O
the	O
long	O
axis	O
of	O
the	O
body	O
,	O
modern	O
scanners	O
allow	O
this	O
volume	O
of	O
data	O
to	O
be	O
reformatted	O
in	O
various	O
planes	O
or	O
even	O
as	O
volumetric	O
(3D)	O
representations	O
of	O
structures	O
.	O

The	O
causal	O
agent	O
has	O
not	O
yet	O
been	O
identified	O
or	O
confirmed	O
.	O

After	O
the	O
Defense	B-Organization
Department	E-Organization
finally	O
acknowledged	O
conducting	O
the	O
tests	O
on	O
unwitting	O
human	O
subjects	O
,	O
it	O
agreed	O
to	O
help	O
the	O
Veterans'	B-Organization
Affairs	I-Organization
Department	E-Organization
track	O
down	O
those	O
who	O
were	O
exposed	O
,	O
but	O
a	O
report	O
in	O
2008	O
scolded	O
the	O
military	O
for	O
ceasing	O
the	O
effort	O
.	O

CDC	S-Organization
is	O
committed	O
to	O
continuous	O
improvement	O
in	O
its	O
laboratories	O
and	O
ensuring	O
its	O
laboratories	O
are	O
a	O
model	O
of	O
excellence	O
and	O
safety	O
.	O

A	O
number	O
of	O
parallel	O
projects	O
,	O
in	O
which	O
all	O
agencies	O
are	O
represented	O
by	O
at	O
least	O
1	O
person	O
,	O
catalyzes	O
cooperation	O
.	O

By	O
1	O
July	O
2015	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
a	O
total	O
of	O
874	O
health	O
workers	O
had	O
been	O
infected	O
,	O
of	O
which	O
509	O
had	O
died	O
.	O

The	O
purpose	O
of	O
the	O
Biosafety	O
Program	O
is	O
to	O
protect	O
workers	O
,	O
the	O
public	O
,	O
agriculture	O
,	O
and	O
the	O
environment	O
from	O
exposure	O
to	O
biological	O
agents	O
or	O
materials	O
that	O
may	O
cause	O
disease	O
or	O
other	O
detrimental	O
effects	O
in	O
humans	O
,	O
animals	O
,	O
or	O
plants	O
.	O

The	O
Communicable	B-Organization
Disease	I-Organization
Center	E-Organization
was	O
founded	O
July	O
1	O
,	O
1946	O
,	O
as	O
the	O
successor	O
to	O
the	O
of	O
the	O
Office	O
of	O
National	O
Defense	O
Malaria	O
Control	O
Activities	O
.	O

LISA	B-Person
SCHNIRRING	E-Person
Hi	O
.	O

2)	O
and	O
the	O
USSR	S-Location
Even	O
Iraq	S-Location
,	O
after	O
several	O
years	O
of	O
an	O
active	O
biowarfare	O
programme	O
,	O
had	O
developed	O
only	O
rudimentary	O
methods	O
of	O
delivery	O
.	O

The	O
fungi	B-Pathogen
candida	E-Pathogen
,	O
Cryptococcus	B-Pathogen
neoformans	E-Pathogen
and	O
cause	O
most	O
of	O
these	O
infections	O
and	O
antifungal	O
resistance	O
occurs	O
in	O
all	O
of	O
them	O
.	O

Application	O
of	O
these	O
principles	O
to	O
animals	O
retained	O
in	O
outdoor	O
environments	O
has	O
been	O
a	O
consequence	O
of	O
disease	O
eradication	O
programs	O
.	O

Henderson	S-Person
suggested	O
that	O
a	O
natural	O
outbreak	O
might	O
have	O
carried	O
the	O
virus	O
to	O
Aralsk	S-Location
from	O
Afghanistan	S-Location
,	O
where	O
in	O
1971	O
was	O
still	O
endemic	O
.	O

They	O
are	O
well	O
established	O
in	O
many	O
areas	O
,	O
e.g	O
.	O

The	O
main	O
area	O
where	O
training	O
and	O
simulation	O
will	O
be	O
staged	O
is	O
still	O
undergoing	O
renovations	O
.	O

The	O
American	B-Organization
Biological	I-Organization
Safety	I-Organization
Association	E-Organization
()	O
has	O
a	O
list	O
of	O
such	O
agencies	O
and	O
links	O
to	O
their	O
websites	O
,	O
along	O
with	O
links	O
to	O
publications	O
and	O
guidance	O
documents	O
to	O
assist	O
in	O
risk	O
assessment	O
,	O
lab	O
design	O
and	O
adherence	O
to	O
laboratory	O
exposure	O
control	O
plans	O
.	O

As	O
of	O
mid-May	O
2020	O
,	O
the	O
effective	O
R	O
is	O
close	O
to	O
or	O
below	O
1.	O
0	O
in	O
many	O
countries	O
,	O
meaning	O
the	O
spread	O
of	O
the	O
disease	O
in	O
these	O
areas	O
is	O
stable	O
or	O
decreasing	O
.	O

As	O
part	O
of	O
US	S-Location
funding	O
for	O
Ebola	S-Pathogen
response	O
,	O
Congress	S-Organization
in	O
2014	O
passed	O
an	O
appropriations	O
act	O
allocating	O
about	O
$2.	O
5	O
billion	O
to	O
USAID	S-Organization
and	O
the	O
State	B-Organization
Department	E-Organization
to	O
help	O
countries	O
affected	O
by	O
the	O
outbreak	O
,	O
most	O
of	O
it	O
for	O
USAID	S-Organization
efforts	O
.	O

However	O
,	O
microbiologists	O
recognize	O
that	O
pathogenicity	O
represents	O
a	O
form	O
of	O
versatility	O
and	O
specialization	O
that	O
enables	O
certain	O
micro-organisms	O
to	O
replicate	O
within	O
a	O
specific	O
host	O
(infectivity)	O
and	O
damage	O
host	O
cells	O
.	O

5	O
.	O

Last	O
year	O
,	O
the	O
US	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
announced	O
its	O
approval	O
of	O
the	O
first	O
drug	O
to	O
treat	O
.	O
The	O
contagious	O
disease	O
was	O
eradicated	O
in	O
1980	O
thanks	O
to	O
vaccination	O
efforts	O
,	O
but	O
there	O
are	O
concerns	O
that	O
it	O
could	O
be	O
used	O
in	O
a	O
bioterror	O
attack	O
.	O

Time:	O
H1N1	S-Disease
Is	O
this	O
a	O
pandemic	O
or	O
isn't	O
it?	O

We	O
describe	O
a	O
unique	O
cluster	O
of	O
blaNDM-5–producing	O
E.	O
coli	O
in	O
a	O
veterinary	O
hospital	O
.	O

Delivery	O
of	O
Cas9	O
,	O
sgRNA	O
,	O
and	O
associated	O
complexes	O
into	O
cells	O
can	O
occur	O
via	O
viral	O
and	O
non-viral	O
systems	O
.	O

On	O
4	O
March	O
,	O
a	O
27-year-old	O
man	O
,	O
who	O
had	O
visited	O
a	O
guest	O
on	O
the	O
Metropole	S-Organization
9th	O
floor	O
11	O
days	O
earlier	O
,	O
was	O
admitted	O
to	O
Hong	B-Location
Kong	E-Location
's	O
.	O
At	O
least	O
99	O
hospital	O
workers	O
(including	O
17	O
medical	O
students)	O
were	O
infected	O
while	O
treating	O
him	O
.	O

She	O
was	O
married	O
to	O
Joseph	B-Person
Parker	E-Person
,	O
a	O
Post	B-Organization
Office	E-Organization
engineer	O
,	O
and	O
lived	O
in	O
Burford	B-Location
Park	I-Location
Road	E-Location
,	O
Kings	B-Location
Norton	E-Location
,	O
Birmingham	S-Location
,	O
UK	S-Location
.	O
After	O
several	O
years	O
as	O
a	O
police	O
photographer	O
she	O
joined	O
the	O
University	B-Organization
of	I-Organization
Birmingham	I-Organization
Medical	I-Organization
School	E-Organization
,	O
where	O
she	O
was	O
employed	O
as	O
a	O
medical	O
photographer	O
in	O
the	O
Anatomy	B-Organization
Department	E-Organization
.	O
Parker	S-Person
often	O
worked	O
in	O
a	O
darkroom	O
above	O
the	O
laboratory	O
where	O
research	O
on	O
was	O
being	O
conducted	O
.	O

In	O
April	O
2014	O
,	O
Nigeria	S-Location
reported	O
that	O
75%	O
of	O
hotel	O
business	O
had	O
been	O
lost	O
due	O
to	O
fears	O
of	O
the	O
outbreak	O
;	O
the	O
limited	O
Ebola	B-Incident
outbreak	E-Incident
had	O
cost	O
that	O
country	O
₦8	O
billion	O
.	O

The	O
End	O
of	O
Europe	S-Location
's	O
Middle	O
Ages:	O
The	O
Black	B-Organization
Death	I-Organization
University	I-Organization
of	I-Organization
Calgary	E-Organization
website.	O
(Retrieved	O
on	O
April	O
5	O
,	O
2007)	O
However	O
,	O
this	O
does	O
not	O
fully	O
explain	O
why	O
the	O
Renaissance	O
occurred	O
specifically	O
in	O
Italy	S-Location
in	O
the	O
14th	O
century	O
.	O

How	O
serious	O
is	O
the	O
North	B-Location
Korean	E-Location
threat?	O

The	O
Pentagon	S-Organization
has	O
invested	O
at	O
least	O
$65	O
million	O
in	O
gene	B-Technology
editing	E-Technology
.	O
The	O
US	B-Organization
Defense	I-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Agency	E-Organization
(	O
DARPA	S-Organization
)	O
has	O
awarded	O
7	O
research	O
teams	O
to	O
develop	O
tools	O
for	O
genome	O
engineering	O
in	O
insects	O
,	O
rodents	O
and	O
bacteria	O
under	O
DARPA's	B-Scientific_research_project
Safe	I-Scientific_research_project
Gene	I-Scientific_research_project
program	E-Scientific_research_project
,	O
using	O
a	O
novel	O
technology	O
.	O

On	O
31	O
May	O
2013	O
,	O
the	O
Italian	O
health	O
ministry	O
announced	O
its	O
first	O
case	O
of	O
MERS-CoV	S-Pathogen
in	O
a	O
45-year-old	O
man	O
who	O
had	O
traveled	O
to	O
Jordan	S-Location
.	O
The	O
patient	O
was	O
being	O
treated	O
in	O
a	O
hospital	O
in	O
and	O
his	O
condition	O
was	O
reported	O
as	O
not	O
life-threatening	O
.	O

A	O
production	O
line	O
to	O
manufacture	O
smallpox	S-Pathogen
on	O
an	O
industrial	O
scale	O
was	O
launched	O
in	O
the	O
Vector	B-Organization
Institute	E-Organization
in	O
1990	O
.	O

The	O
investigation	O
also	O
revealed	O
experimentation	O
at	O
Rajneeshpuram	S-Location
with	O
poisons	O
,	O
chemicals	O
and	O
bacteria	O
which	O
had	O
been	O
carried	O
out	O
during	O
1984	O
and	O
1985	O
.	O

For	O
45	O
minutes	O
each	O
morning	O
,	O
the	O
veteran	O
hockey	O
player	O
Duncan	B-Person
Keith	E-Person
ritually	O
goes	O
upstairs	O
to	O
what	O
he	O
calls	O
his	O
"	O
lab,"	O
where	O
he	O
has	O
"	O
a	O
bunch	O
of	O
little	O
things	O
that	O
I	O
do	O
to	O
stay	O
healthy.	O
"	O
This	O
,	O
according	O
to	O
an	O
interview	O
this	O
week	O
in	O
The	O
New	B-Organization
York	I-Organization
Times	E-Organization
,	O
includes	O
dousing	O
himself	O
with	O
infrared	O
light	O
,	O
lying	O
for	O
eight	O
minutes	O
on	O
a	O
mat	O
that	O
"	O
has	O
electromagnetic	O
currents,	O
"	O
and	O
taking	O
supplement	O
pills	O
such	O
as	O
glutathione	S-Drug
and	O
vitamin	B-Drug
C	E-Drug
,	O
and	O
liquid	O
herbs	O
such	O
as	O
.	O

A	O
number	O
of	O
problems	O
have	O
been	O
reported	O
over	O
the	O
years	O
in	O
the	O
building	O
,	O
including	O
a	O
2009	O
decontamination	O
shower	O
failure	O
and	O
a	O
2015	O
fire	O
in	O
a	O
lower-level	O
lab	O
.	O

In	O
some	O
viruses	O
such	O
as	O
the	O
respiratory	B-Pathogen
syncytial	I-Pathogen
virus	E-Pathogen
it	O
causes	O
the	O
RNA-dependent	O
RNA	O
polymerases	O
to	O
pause	O
,	O
but	O
its	O
predominant	O
effect	O
(as	O
in	O
Ebola	S-Disease
)	O
is	O
to	O
induce	O
an	O
irreversible	O
chain	O
termination	O
.	O

As	O
per	O
the	O
IRB	O
protocol	O
,	O
respondents	O
were	O
required	O
to	O
agree	O
to	O
take	O
the	O
survey	O
once	O
they	O
understood	O
any	O
potential	O
harm	O
by	O
participating	O
before	O
they	O
could	O
proceed	O
to	O
the	O
questions	O
within	O
.	O

There	O
are	O
mixed	O
results	O
as	O
of	O
3	O
April	O
2020	O
as	O
to	O
the	O
effectiveness	O
of	O
hydroxychloroquine	S-Drug
as	O
a	O
treatment	O
for	O
COVID‑19	S-Disease
,	O
with	O
some	O
studies	O
showing	O
little	O
or	O
no	O
improvement	O
.	O

The	O
WHO	S-Organization
system	O
supports	O
a	O
standardized	O
approach	O
to	O
the	O
collection	O
,	O
analysis	O
and	O
sharing	O
of	O
data	O
related	O
to	O
antimicrobial	O
resistance	O
at	O
a	O
global	O
level	O
to	O
inform	O
decision-making	O
,	O
drive	O
local	O
,	O
national	O
and	O
regional	O
action	O
.	O

In	O
a	O
statement	O
today	O
,	O
Trump	S-Person
said	O
that	O
implementing	O
the	O
steps	O
would	O
promote	O
a	O
more	O
efficient	O
,	O
coordinated	O
,	O
and	O
accountable	O
biodefense	O
enterprise.	O
"	O
Taken	O
together	O
,	O
they	O
represent	O
a	O
new	O
direction	O
in	O
the	O
Nation's	O
defense	O
against	O
biological	O
threats,	O
"	O
he	O
said	O
.	O

Biohacking	O
can	O
be	O
described	O
as	O
citizen	O
or	O
do-it-yourself	B-Activity
biology	E-Activity
For	O
many	O
"	O
biohackers,"	O
this	O
consists	O
of	O
making	O
small	O
,	O
incremental	O
diet	O
or	O
lifestyle	O
changes	O
to	O
make	O
small	O
improvements	O
in	O
your	O
health	O
and	O
well-being	O
.	O

As	O
in	O
the	O
other	O
examples	O
,	O
the	O
revolution	O
in	O
biomedicine	O
created	O
new	O
desires	O
in	O
the	O
East	O
and	O
the	O
West	O
,	O
and	O
there	O
are	O
already	O
new	O
weapons	O
under	O
development	O
that	O
violate	O
international	O
treaties	O
.	O

Depending	O
on	O
the	O
severity	O
,	O
oxygen	O
therapy	O
,	O
intravenous	O
fluids	O
,	O
and	O
breathing	O
support	O
may	O
be	O
required	O
.	O

They	O
knew	O
the	O
effort	O
we	O
were	O
starting	O
was	O
too	O
important	O
to	O
delay	O
.	O

The	O
episode	O
,	O
the	O
researchers	O
say	O
,	O
raises	O
questions	O
about	O
whether	O
new	O
vaccines	O
or	O
drugs	O
might	O
be	O
needed	O
if	O
this	O
strain	O
were	O
used	O
in	O
an	O
attack	O
.	O

A	O
study	O
published	O
in	O
May	O
2015	O
discussed	O
the	O
case	O
of	O
Ian	B-Person
Crozier	E-Person
a	O
Zimbabwe	S-Location
-born	O
physician	O
and	O
American	O
citizen	O
who	O
became	O
infected	O
with	O
Ebola	S-Disease
while	O
he	O
was	O
working	O
at	O
an	O
Ebola	S-Disease
treatment	O
centre	O
in	O
Sierra	B-Location
Leone	E-Location
.	O
He	O
was	O
transported	O
to	O
the	O
US	S-Location
and	O
successfully	O
treated	O
at	O
Emory	B-Organization
University	I-Organization
Hospital	E-Organization
.	O
However	O
,	O
after	O
discharge	O
Crozier	S-Person
began	O
to	O
experience	O
symptoms	O
including	O
low	B-Phenotype
back	I-Phenotype
pain	E-Phenotype
,	O
bilateral	B-Phenotype
enthesitis	I-Phenotype
of	I-Phenotype
the	I-Phenotype
Achilles	I-Phenotype
tendon	E-Phenotype
,	O
paresthesias	S-Phenotype
involving	O
his	O
lower	O
legs	O
,	O
and	O
eye	B-Phenotype
pain	E-Phenotype
,	O
which	O
was	O
diagnosed	O
as	O
uveitis	S-Disease
.	O
His	O
eye	O
condition	O
worsened	O
and	O
a	O
specimen	O
of	O
aqueous	O
humor	O
obtained	O
from	O
his	O
eye	O
tested	O
positive	O
for	O
Ebola	S-Disease
.	O
The	O
authors	O
of	O
the	O
study	O
concluded	O
that	O
"	O
further	O
studies	O
to	O
investigate	O
the	O
mechanisms	O
responsible	O
for	O
the	O
ocular	O
persistence	O
of	O
and	O
the	O
possible	O
presence	O
of	O
the	O
virus	O
in	O
other	O
immune-privileged	O
sites	O
(e.g.	O
,	O
in	O
the	O
central	O
nervous	O
system	O
,	O
gonads	O
,	O
and	O
articular	O
cartilage)	O
are	O
warranted.	O
"	O

The	O
GAO	S-Organization
report	O
also	O
found	O
that	O
the	O
DoD	S-Organization
made	O
no	O
effort	O
to	O
inform	O
civilians	O
of	O
exposure	O
,	O
and	O
that	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Veterans	I-Organization
Affairs	E-Organization
(	O
VA	S-Organization
)	O
is	O
failing	O
to	O
use	O
available	O
resources	O
to	O
inform	O
veterans	O
of	O
possible	O
exposure	O
or	O
to	O
determine	O
if	O
they	O
were	O
deceased	O
.	O

In	O
1995	O
,	O
the	O
apocalyptic	O
religious	O
sect	O
Aum	O
Shinrikyo	O
released	O
sarin	S-Pathogen
gas	O
in	O
a	O
Tokyo	S-Location
subway	O
,	O
killing	O
12	O
commuters	O
and	O
injuring	O
thousands	O
.	O

The	O
Iraqis	O
claimed	O
to	O
have	O
destroyed	O
their	O
biological	O
arsenal	O
immediately	O
after	O
the	O
1991	O
war	O
,	O
but	O
they	O
did	O
not	O
provide	O
confirmatory	O
evidence	O
.	O

Nigeria	S-Location
was	O
the	O
first	O
country	O
in	O
western	O
to	O
successfully	O
curtail	O
the	O
virus	O
,	O
and	O
its	O
procedures	O
have	O
served	O
as	O
a	O
model	O
for	O
other	O
countries	O
to	O
follow	O
.	O

Let	O
me	O
get	O
you	O
to	O
expand	O
on	O
that	O
if	O
I	O
could	O
.	O

According	O
to	O
historian	O
Geoffrey	B-Person
Parker	E-Person
"	O
France	S-Location
alone	O
lost	O
almost	O
a	O
million	O
people	O
to	O
the	O
plague	S-Disease
in	O
the	O
epidemic	O
of	O
1628–31.	O
"	O
In	O
the	O
first	O
half	O
of	O
the	O
17th	O
century	O
,	O
a	O
plague	S-Disease
claimed	O
some	O
1.7	O
million	O
victims	O
in	O
Italy	S-Location
.	O
Karl	B-Person
Julius	I-Person
Beloch	E-Person
,	O
Bevölkerungsgeschichte	O
Italiens	O
,	O
volume	O
3	O
,	O
pp.	O
359–360	O
.	O

He	O
had	O
a	O
mild	O
form	O
of	O
the	O
disease	O
,	O
which	O
was	O
not	O
diagnosed	O
for	O
eight	O
weeks	O
.	O

"	O
The	O
virus	O
is	O
not	O
stoppable,	O
"	O
she	O
said.	O
"	O
I	O
would	O
advise	O
them	O
to	O
maintain	O
vigilance	O
,	O
enhance	O
surveillance	O
and	O
be	O
prepared	O
for	O
the	O
arrival	O
of	O
the	O
novel	B-Pathogen
H1N1	E-Pathogen
in	O
their	O
country.	O
"	O

However	O
,	O
several	O
cases	O
were	O
reported	O
until	O
May	O
2004	O
.	O

The	O
,	O
however	O
,	O
is	O
not	O
a	O
state	O
party	O
to	O
the	O
international	O
treaty	O
,	O
and	O
cannot	O
be	O
held	O
accountable	O
for	O
its	O
war	O
crimes	O
.	O

Evidence	O
suggests	O
that	O
diseases	O
are	O
crossing	O
over	O
into	O
human	O
populations	O
from	O
animals	O
at	O
an	O
increasing	O
rate	O
.	O

Biohacking	O
is	O
a	O
concept	O
that	O
gained	O
currency	O
in	O
popular	O
culture	O
over	O
the	O
past	O
decade	O
,	O
initially	O
as	O
an	O
apparently	O
earnest	O
approach	O
to	O
applying	O
the	O
tech-hacker	O
ethos	O
to	O
biology	O
.	O

Some	O
have	O
suggested	O
that	O
the	O
epidemic	O
originated	O
in	O
the	O
United	B-Location
States	E-Location
Historian	O
Alfred	B-Person
W.	I-Person
Crosby	E-Person
stated	O
in	O
2003	O
that	O
the	O
flu	S-Disease
originated	O
in	O
Kansas	S-Location
,	O
and	O
popular	O
author	O
John	B-Person
M.	I-Person
Barry	E-Person
described	O
a	O
January	O
1918	O
outbreak	O
in	O
Haskell	B-Location
County	E-Location
,	O
,	O
as	O
the	O
point	O
of	O
origin	O
in	O
his	O
2004	O
article	O
.	O

But	O
molecular	O
biologist	O
Richard	B-Person
Ebright	E-Person
of	O
Rutgers	B-Organization
University	E-Organization
in	O
Piscataway	S-Location
,	O
New	B-Location
Jersey	E-Location
,	O
calls	O
the	O
memo	O
"	O
very	O
thin	O
gruel.	O
"	O
A	O
longtime	O
critic	O
of	O
biodefense	O
labs	O
,	O
Ebright	S-Person
notes	O
that	O
most	O
select	O
agent	O
work	O
takes	O
place	O
at	O
academic	O
or	O
other	O
nonfederal	O
labs	O
.	O

Beginning	O
in	O
2003	O
with	O
the	O
publication	O
of	O
the	O
research	O
at	O
JCVI	S-Organization
in	O
creating	B-Technology
the	I-Technology
synthetic	I-Technology
phiX174	E-Technology
(	O
"	O
Generating	B-Document
a	I-Document
synthetic	I-Document
genome	I-Document
by	I-Document
whole	I-Document
genome	I-Document
assembly:	I-Document
phiX174	I-Document
bacteriophage	I-Document
from	I-Document
synthetic	I-Document
oligonucleotides	E-Document
.	O
"	O
Smith	S-Person
et	O
al	O
,	O
PNAS	O
2003	O
Dec	O
23;100(26):15440-5	O
.	O

This	O
test	O
uses	O
real-time	O
which	O
detects	O
presence	O
of	O
viral	O
RNA	O
fragments	O
.	O

O'Brien	S-Person
,	O
Neil	S-Person
.	O
An	O
American	O
Editor	O
in	O
Early	O
Revolutionary	O
China	S-Location
:	O
John	B-Person
William	I-Person
Powell	E-Person
and	O
the	O
China	O
Weekly/monthly	O
Review	O
,	O
(Google	O
Books)	O
,	O
Routledge	O
,	O
2003	O
,	O
pp.	O
217–19	O
,	O
()	O
.	O

•	O
Anne	B-Person
Fischer	E-Person
is	O
a	O
program	O
manager	O
in	O
DSO	S-Organization
.	O
For	O
,	O
she	O
is	O
leading	O
the	O
chemical	O
sensor	O
network	O
development	O
and	O
integration	O
.	O

She	O
also	O
stated	O
that	O
they	O
were	O
"	O
marginalizing	O
the	O
affected	O
population	O
and	O
potentially	O
worsening	O
the	O
crisis"	O
.	O

Based	O
on	O
the	O
records	O
in	O
the	O
BBD	S-Platform
,	O
biosafety	O
research	O
activity	O
over	O
the	O
past	O
16-17	O
years	O
can	O
be	O
summarized	O
by	O
analyzing	O
basic	O
statistics	O
.	O

The	O
facility	O
is	O
designed	O
to	O
conduct	O
bioaerosol	O
studies	O
.	O

In	O
New	B-Location
Zealand	E-Location
8,573 deaths	O
were	O
attributed	O
to	O
,	O
resulting	O
in	O
a	O
total	O
population	O
fatality	O
rate	O
of	O
0.7%	O
.	O

The	O
program	O
aims	O
to	O
provide	O
immediate	O
,	O
continuous	O
monitoring	O
of	O
pathogen	O
background	O
levels	O
and	O
spikes	O
,	O
which	O
could	O
indicate	O
malicious	O
release	O
of	O
a	O
biological	O
agent	O
.	O

Documents	O
prove	O
that	O
the	O
US	B-Organization
Army	E-Organization
produces	O
,	O
possesses	O
and	O
tests	O
aerosols	O
of	O
the	O
most	O
lethal	O
toxin	O
in	O
the	O
world	O
–	O
Botulinum	B-Pathogen
Neurotoxin	E-Pathogen
.	O
In	O
2014	O
the	O
Department	O
of	O
the	O
Army	S-Organization
purchased	O
100	O
mg	O
of	O
Botulinum	B-Pathogen
Toxin	E-Pathogen
from	O
Metabiologics	S-Organization
for	O
tests	O
at	O
.	O

Laboratory	O
wastewater	O
on	O
Fort	B-Location
Detrick	E-Location
is	O
chemically	O
disinfected	O
at	O
the	O
source	O
,	O
then	O
routed	O
to	O
the	O
,	O
where	O
it	O
is	O
held	O
in	O
these	O
storage	O
tanks	O
prior	O
to	O
entering	O
the	O
steam	O
sterilization	O
process	O
.	O

Significant	O
increases	O
in	O
public	O
education	O
about	O
bacteria	O
and	O
antibiotic	O
resistance	O
are	O
vitally	O
important	O
.	O

Milton	B-Person
Leitenberg	E-Person
noted	O
in	O
the	O
2005	O
work	O
Assessing	B-Scientific_research_project
the	I-Scientific_research_project
Biological	I-Scientific_research_project
Weapons	I-Scientific_research_project
and	I-Scientific_research_project
Bioterrorism	I-Scientific_research_project
Threat	E-Scientific_research_project
,	O
"	O
there	O
is	O
apparently	O
no	O
other	O
'terrorist'	O
group	O
that	O
is	O
known	O
to	O
have	O
successfully	O
cultured	O
any	O
pathogen.	O
"	O
Federal	O
and	O
state	O
investigators	O
requested	O
that	O
details	O
of	O
the	O
incident	O
not	O
be	O
published	O
in	O
the	O
Journal	B-Organization
of	I-Organization
the	I-Organization
American	I-Organization
Medical	I-Organization
Association	E-Organization
(	O
JAMA	S-Organization
)	O
for	O
12	O
years	O
,	O
for	O
they	O
feared	O
a	O
description	O
of	O
the	O
events	O
could	O
spark	O
copycat	O
crimes	O
,	O
and	O
JAMA	S-Organization
complied	O
.	O

In	O
early	O
February	O
2020	O
,	O
Organization	B-Organization
of	I-Organization
the	I-Organization
Petroleum	I-Organization
Exporting	I-Organization
Countries	E-Organization
(	O
OPEC	S-Organization
)	O
"	O
scrambled"	O
after	O
a	O
steep	O
decline	O
in	O
oil	O
prices	O
due	O
to	O
lower	O
demand	O
from	O
China	S-Location
.	O
On	O
Monday	O
,	O
20	O
April	O
,	O
the	O
price	O
of	O
West	B-Organization
Texas	I-Organization
Intermediate	E-Organization
(	O
WTI	S-Organization
)	O
went	O
negative	O
and	O
fell	O
to	O
a	O
record	O
low	O
(minus	O
$37.63	O
a	O
barrel)	O
due	O
to	O
traders'	O
offloading	O
holdings	O
so	O
as	O
not	O
to	O
take	O
delivery	O
and	O
incur	O
storage	O
costs	O
.	O

When	O
someone	O
with	O
existing	O
respiratory	O
problems	O
is	O
infected	O
with	O
COVID-19	S-Pathogen
they	O
might	O
be	O
at	O
greater	O
risk	O
for	O
severe	O
symptoms	O
.	O

Practically	O
,	O
preparation	O
of	O
a	O
national	O
biotechnology	O
strategic	O
plan	O
in	O
the	O
country	O
coincided	O
with	O
development	O
of	O
a	O
national	O
biosafety	O
framework	O
that	O
was	O
the	O
basis	O
for	O
the	O
drafted	O
biosafety	O
law	O
.	O

As	O
the	O
epidemic	O
progressed	O
,	O
one	O
virus	O
lineage	O
disappeared	O
from	O
patient	O
samples	O
,	O
while	O
a	O
third	O
one	O
appeared	O
.	O

Updated	O
October	O
29	O
,	O
2019	O
,	O
to	O
edit	O
the	O
program	O
manager	O
for	O
the	O
Biological	B-Organization
Technologies	I-Organization
Office	E-Organization

As	O
primates	O
in	O
the	O
area	O
were	O
not	O
found	O
to	O
be	O
infected	O
and	O
fruit	O
bats	O
do	O
not	O
live	O
near	O
the	O
location	O
of	O
the	O
initial	O
zoonotic	O
transmission	O
event	O
in	O
Meliandou	S-Location
,	O
it	O
is	O
suspected	O
that	O
the	O
index	O
case	O
occurred	O
after	O
a	O
child	O
had	O
contact	O
with	O
an	O
insectivorous	O
bat	O
from	O
a	O
colony	O
of	O
Angolan	O
free-tailed	O
bats	O
near	O
the	O
village	O
.	O

So	O
when	O
something	O
like	O
this	O
happens	O
here	O
,	O
I'm	O
deeply	O
concerned	O
about	O
it	O
.	O

"	O
Assuming	O
a	O
terrorist	O
organization	O
manages	O
to	O
capture	O
a	O
suitable	O
Ebola	S-Pathogen
host	O
,	O
extract	O
the	O
virus	O
,	O
weaponize	O
the	O
virus	O
,	O
transport	O
the	O
virus	O
to	O
a	O
populated	O
city	O
and	O
deliver	O
the	O
virus	O
,	O
it	O
is	O
entirely	O
likely	O
that	O
the	O
sub-optimal	O
climatic	O
conditions	O
of	O
a	O
Western	O
city	O
will	O
kill	O
it	O
off	O
relatively	O
quickly,	O
"	O
said	O
.	O

However	O
,	O
it	O
is	O
often	O
pointed	O
out	O
that	O
Dis	O
at	O
too	O
early	O
a	O
stage	O
to	O
consider	O
such	O
advanced	O
projects	O
feasible	O
,	O
as	O
few	O
successful	O
transformative	O
genetics	O
projects	O
have	O
been	O
undertaken	O
yet	O
.	O

He	O
also	O
said	O
the	O
U.S.	S-Location
would	O
not	O
participate	O
in	O
a	O
global	O
effort	O
with	O
the	O
WHO	S-Organization
to	O
develop	O
a	O
vaccine	O
and	O
drugs	O
to	O
combat	O
the	O
virus	O
.	O

Bacteria	O
with	O
C2c2	O
make	O
molecules	O
that	O
can	O
dismember	O
RNA	O
,	O
destroying	O
the	O
virus	O
.	O

CDC	S-Organization
continues	O
to	O
respond	O
to	O
this	O
incident	O
.	O

Preceding	O
its	O
founding	O
,	O
organizations	O
with	O
global	O
influence	O
in	O
malaria	S-Disease
control	O
were	O
the	O
Malaria	O
Commission	O
of	O
the	O
League	O
of	O
Nations	O
and	O
the	O
.	O

In	O
her	O
lab	O
,	O
where	O
B.	B-Pathogen
cereus	E-Pathogen
was	O
studied	O
in	O
conditions	O
(on	O
the	O
lower	O
end	O
of	O
four	O
biosafety	O
levels)	O
,	O
the	O
university	O
suspended	O
research	O
to	O
decontaminate	O
the	O
area	O
as	O
a	O
precautionary	O
measure	O
(it	O
was	O
expected	O
to	O
open	O
later	O
this	O
week)	O
.	O

The	O
report	O
indicated	O
that	O
27%	O
of	O
Ebola	S-Disease
infections	O
among	O
healthcare	O
workers	O
in	O
occurred	O
among	O
doctors	O
.	O

One	O
of	O
the	O
few	O
regions	O
of	O
the	O
world	O
seemingly	O
less	O
affected	O
by	O
the	O
1918	B-Incident
flu	I-Incident
pandemic	E-Incident
was	O
China	S-Location
,	O
where	O
several	O
studies	O
have	O
documented	O
a	O
comparatively	O
mild	O
flu	S-Disease
season	O
in	O
1918.	O
(Although	O
this	O
is	O
disputed	O
due	O
to	O
lack	O
of	O
data	O
during	O
the	O
Warlord	O
Period	O
,	O
see	O
Around	O
the	O
globe)	O
.	O

This	O
EU	B-Document
legislation	E-Document
complements	O
the	O
World	B-Document
Health	I-Document
Organization's	I-Document
(WHO)	I-Document
International	I-Document
Health	I-Document
Regulations	I-Document
(IHR)	I-Document
agreement	I-Document
on	I-Document
cross-border	I-Document
cooperation	E-Document
to	O
combat	O
certain	O
contagious	O
human	O
diseases	O
.	O

For	O
those	O
of	O
you	O
who	O
may	O
have	O
started	O
out	O
wondering	O
why	O
the	O
Under	O
Secretary	O
of	O
State	O
for	O
Arms	O
Control	O
and	O
International	O
Security	O
was	O
talking	O
about	O
Ebola	S-Disease
I	O
assume	O
it	O
is	O
clear	O
now	O
.	O

When	O
the	O
study	O
animals	O
died	O
with	O
symptoms	O
of	O
anthrax	S-Disease
it	O
was	O
found	O
that	O
the	O
inactivation	O
procedure	O
had	O
not	O
been	O
validated	O
in	O
the	O
laboratory	O
in	O
Maryland	S-Location
and	O
that	O
viable	O
B.	B-Pathogen
anthracis	E-Pathogen
was	O
received	O
by	O
an	O
unsuspecting	O
laboratory	O
.	O

Federal	O
officials	O
may	O
have	O
a	O
vaccine	O
and	O
decide	O
not	O
to	O
use	O
it	O
,	O
he	O
said	O
.	O

Some	O
of	O
the	O
research	O
he	O
cites	O
was	O
done	O
on	O
very	O
specific	O
sub-populations	O
,	O
such	O
as	O
diabetics	O
,	O
or	O
on	O
very	O
small	O
groups	O
of	O
people	O
.	O

Furthermore	O
,	O
RNA	O
had	O
been	O
found	O
up	O
to	O
284	O
days	O
post-onset	O
of	O
viral	O
symptoms	O
.	O

Some	O
historians	O
believe	O
the	O
innumerable	O
deaths	O
brought	O
on	O
by	O
the	O
plague	S-Disease
cooled	O
the	O
climate	O
by	O
freeing	O
up	O
land	O
and	O
triggering	O
reforestation	O
.	O

According	O
to	O
FRONTLINE	S-Organization
interview	O
with	O
Dr	O
.	O

"	O
Only	O
a	O
full	O
analysis	O
performed	O
at	O
an	O
accredited	O
laboratory	O
can	O
determine	O
the	O
presence	O
of	O
a	O
biological	O
agent	O
such	O
as	O
ricin	S-Pathogen
according	O
to	O
the	O
bureau.	O
"	O
Those	O
tests	O
are	O
in	O
the	O
process	O
of	O
being	O
conducted	O
and	O
generally	O
take	O
from	O
24	O
to	O
48	O
hours.	O
"	O

"	O
Having	O
a	O
lab	O
being	O
replaced	O
after	O
about	O
12	O
years	O
seems	O
unusual,	O
"	O
said	O
Stephen	B-Person
Higgs	E-Person
director	O
of	O
the	O
Biosecurity	B-Organization
Research	I-Organization
Institute	E-Organization
at	O
.	O

Experiments	O
to	O
map	O
further	O
the	O
genetic	O
basis	O
of	O
virulence	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
in	O
various	O
animal	O
models	O
are	O
planned	O
.	O

On	O
29	O
March	O
it	O
was	O
reported	O
that	O
beginning	O
1April	O
all	O
new	O
overseas	O
arrivals	O
will	O
be	O
quarantined	O
for	O
two	O
weeks	O
.	O

Several	O
methods	O
that	O
can	O
reduce	O
the	O
exposure	O
to	O
ionizing	O
radiation	O
during	O
a	O
CT	O
scan	O
exist	O
.	O

Both	O
organizations	O
were	O
founded	O
by	O
and	O
are	O
headed	O
by	O
Dr	O
.	O

The	O
programme	O
was	O
cancelled	O
in	O
1956	O
,	O
when	O
the	O
British	O
government	O
unilaterally	O
renounced	O
the	O
use	O
of	O
biological	O
and	O
chemical	O
weapons	O
.	O

Aside	O
from	O
being	O
a	O
meal	O
staple	O
,	O
the	O
pig	O
is	O
historically	O
and	O
culturally	O
one	O
of	O
China	S-Location
favourite	O
animals	O
.	O

These	O
children	O
and	O
the	O
23-year-old	O
were	O
previously	O
unvaccinated	O
.	O

There	O
are	O
still	O
'Missing	O
Pieces.'	O
Maybe	O
I	O
have	O
your	O
attention	O
now	O
even	O
if	O
that	O
means	O
someone	O
must	O
die	O
.	O

Although	O
the	O
laboratory	O
generation	O
of	O
the	O
mutant	O
influenza	B-Pathogen
virus	I-Pathogen
H5N1	E-Pathogen
with	O
airborne	O
transmissibility	O
among	O
mammals	O
,	O
which	O
has	O
been	O
considered	O
as	O
a	O
dual-use	O
research	O
,	O
may	O
benefit	O
the	O
development	O
of	O
effective	O
vaccines	O
and	O
therapeutics	O
against	O
the	O
emerging	O
infectious	O
agents	O
,	O
it	O
may	O
also	O
pose	O
threats	O
to	O
national	O
biosecurity	O
,	O
laboratory	O
biosafety	O
,	O
and/or	O
public	O
health	O
.	O

Of	O
particular	O
interest	O
is	O
the	O
lower	O
incidence	O
of	O
nephrotoxicity	S-Disease
,	O
compared	O
with	O
iodinated	O
agents	O
,	O
when	O
given	O
at	O
usual	O
doses-this	O
has	O
made	O
contrast-enhanced	B-Technology
MRI	I-Technology
scanning	E-Technology
an	O
option	O
for	O
patients	O
with	O
renal	B-Disease
impairment	E-Disease
,	O
who	O
would	O
otherwise	O
not	O
be	O
able	O
to	O
undergo	O
contrast-enhanced	O
.	O

National	O
reactions	O
have	O
included	O
containment	O
measures	O
such	O
as	O
quarantines	O
and	O
curfews	O
(known	O
as	O
stay-at-home	O
orders	O
,	O
shelter-in-place	O
orders	O
,	O
or	O
lockdowns)	O
.	O

Designer	O
diseases	O
can	O
be	O
engineered	O
to	O
target	O
a	O
certain	O
ethnic	O
group	O
,	O
meaning	O
that	O
they	O
can	O
be	O
used	O
as	O
ethnic	O
bio-weapons	O
.	O

On	O
6	O
August	O
2014	O
,	O
the	O
Nigerian	O
health	O
minister	O
told	O
reporters	O
that	O
one	O
of	O
the	O
nurses	O
that	O
attended	O
to	O
the	O
Liberian	O
had	O
died	O
from	O
the	O
disease.	O
5	O
newly	O
confirmed	O
cases	O
were	O
being	O
treated	O
at	O
an	O
isolation	O
ward	O
.	O

By	O
simple	O
changing	O
sequence	O
of	O
gRNA	O
,	O
Cas9-endonuclease	O
can	O
be	O
delivered	O
to	O
a	O
gene	O
of	O
interest	O
and	O
induce	O
DSBs	O
.	O

It	O
oversees	O
the	O
implementation	O
of	O
the	O
International	B-Document
Health	I-Document
Regulations	E-Document
and	O
publishes	O
a	O
series	O
of	O
medical	O
classifications	O
;	O
of	O
these	O
,	O
three	O
are	O
over-reaching	O
"	O
reference	O
classifications":	O
the	O
International	B-Document
Statistical	I-Document
Classification	I-Document
of	I-Document
Diseases	E-Document
(	O
ICD	S-Document
)	O
,	O
the	O
International	B-Document
Classification	I-Document
of	I-Document
Functioning,	I-Document
Disability	I-Document
and	I-Document
Health	E-Document
(	O
ICF	S-Document
)	O
and	O
the	O
International	B-Document
Classification	I-Document
of	I-Document
Health	I-Document
Interventions	E-Document
(	O
ICHI	S-Document
)	O
.	O

The	O
Ukrainian	B-Organization
government	E-Organization
stopped	O
supplying	O
antitoxin	O
in	O
2014	O
and	O
no	O
in	O
stock	O
were	O
available	O
during	O
the	O
2016-2017	O
outbreak	O
.	O

But	O
BZ	O
caused	O
very	O
different	O
effects	O
in	O
different	O
individuals	O
and	O
was	O
considered	O
to	O
be	O
unreliable	O
,	O
leading	O
to	O
its	O
banishment	O
from	O
the	O
chemical	O
arsenal	O
in	O
the	O
late	O
1960s	O
.	O

Sheela's	O
Green	O
Card	O
was	O
revoked	O
;	O
she	O
moved	O
to	O
.	O

Colvin	S-Person
,	O
Marie	S-Person
and	O
Uzi	B-Person
Mahnaimi	E-Person
(1998)	O
,	O
"	O
Saddam	S-Person
Tested	O
on	O
Human	O
Guinea	O
Pigs"	O
,	O
London	O
Sunday	O
Times	O
(18	O
Jan	O
issue)	O
.	O

A	O
number	O
of	O
parallel	O
projects	O
,	O
in	O
which	O
all	O
agencies	O
are	O
represented	O
by	O
at	O
least	O
1	O
person	O
,	O
catalyzes	O
cooperation	O
.	O

According	O
to	O
the	O
WHO	S-Organization
,	O
tests	O
indicated	O
that	O
the	O
flare-up	O
was	O
likely	O
due	O
to	O
contact	O
with	O
a	O
prior	O
Ebola	S-Disease
survivor's	O
infected	O
body	O
fluids	O
.	O

On	O
20	O
March	O
,	O
the	O
government	O
announced	O
that	O
all	O
leisure	O
establishments	O
such	O
as	O
pubs	O
and	O
gyms	O
were	O
to	O
close	O
as	O
soon	O
as	O
possible	O
,	O
and	O
promised	O
to	O
pay	O
up	O
to	O
80	O
percent	O
of	O
workers'	O
wages	O
to	O
a	O
limit	O
of	O
£2,500	O
per	O
month	O
to	O
prevent	O
unemployment	O
during	O
the	O
crisis	O
.	O

The	O
disease	O
may	O
have	O
travelled	O
along	O
the	O
Silk	O
Road	O
with	O
Mongol	S-Organization
armies	O
and	O
traders	O
,	O
or	O
it	O
could	O
have	O
arrived	O
via	O
ship	O
.	O

Chan	S-Person
indicated	O
that	O
a	O
major	O
factor	O
in	O
the	O
decision	O
was	O
surveillance	O
from	O
countries	O
in	O
the	O
Southern	O
Hemisphere	O
,	O
where	O
flu	S-Disease
season	O
is	O
under	O
way	O
.	O

On	O
2	O
August	O
,	O
Oxfam	S-Organization
indicated	O
it	O
would	O
be	O
taking	O
part	O
in	O
the	O
response	O
to	O
this	O
latest	O
outbreak	O
in	O
the	O
.	O

The	O
metadata	O
model	O
is	O
often	O
related	O
to	O
the	O
standard	O
formats	O
used	O
.	O

This	O
much	O
coveted	O
certification	O
enables	O
GlobalMed	S-Organization
to	O
put	O
their	O
virtual	O
health	O
applications	O
,	O
hardware	O
and	O
software	O
directly	O
on	O
the	O
DoD	S-Organization
network	O
,	O
making	O
their	O
solutions	O
available	O
to	O
the	O
DOD's	B-Platform
integrated	I-Platform
healthcare	I-Platform
system	E-Platform
known	O
as	O
the	O
.	O
In	O
addition	O
to	O
providing	O
medical	O
care	O
in	O
combat	O
situations	O
and	O
at	O
bases	O
overseas	O
(as	O
well	O
as	O
on	O
ships)	O
,	O
the	O
system	O
has	O
57	O
hospitals	O
and	O
400	O
clinics	O
.	O

ASF	S-Disease
occurs	O
among	O
pigs	O
and	O
wild	O
boars	O
.	O

Updated	O
on	O
13	O
September:	O
Today	O
ScienceInsider	O
discussed	O
the	O
incident	O
with	O
Conrad	B-Person
Gilliam	E-Person
University	B-Organization
of	I-Organization
Chicago	E-Organization
dean	O
for	O
research	O
and	O
graduate	O
education	O
in	O
the	O
biological	O
sciences	O
division	O
.	O

The	O
use	O
of	O
the	O
term	O
"	O
social	O
distancing	O
"	O
had	O
led	O
to	O
implications	O
that	O
people	O
should	O
engage	O
in	O
complete	O
social	O
isolation	O
,	O
rather	O
than	O
encouraging	O
them	O
to	O
stay	O
in	O
contact	O
through	O
alternative	O
means	O
.	O

Whether	O
it's	O
MERS	S-Disease
in	O
Saudi	B-Location
Arabia	E-Location
where	O
we're	O
helping	O
to	O
contain	O
the	O
outbreak	O
,	O
or	O
Ebola	S-Disease
in	O
West	B-Location
Africa	E-Location
where	O
we	O
have	O
teams	O
helping	O
to	O
stop	O
the	O
outbreak	O
there	O
or	O
the	O
emergence	O
of	O
a	O
new	O
mosquito-caused	O
disease	O
,	O
a	O
mosquito-carried	O
disease	O
,	O
Chikungunya	S-Disease
,	O
in	O
the	O
hemisphere	O
,	O
we're	O
helping	O
countries	O
to	O
respond.	O
is	O
active	O
all	O
over	O
the	O
world	O
.	O

That	O
same	O
day	O
,	O
Chinese	B-Organization
Communist	I-Organization
Party	E-Organization
general	O
secretary	O
Xi	B-Person
Jinping	E-Person
and	O
State	B-Organization
Council	E-Organization
premier	O
Li	B-Person
Keqiang	E-Person
issued	O
their	O
first	O
public	O
comments	O
about	O
the	O
virus	O
,	O
telling	O
people	O
in	O
infected	O
areas	O
to	O
practice	O
social	O
distancing	O
and	O
avoid	O
travel	O
.	O

If	O
you've	O
watched	O
HBO	S-Organization
,	O
then	O
you're	O
already	O
familiar	O
with	O
young	O
blood	O
transfusions	O
.	O

And	O
so	O
we	O
have	O
to	O
do	O
this	O
research	O
.	O

The	O
BWC	S-Document
for	O
those	O
of	O
you	O
who	O
don't	O
know	O
,	O
is	O
a	O
legally	O
binding	O
treaty	O
that	O
bans	O
the	O
development	O
,	O
stockpiling	O
,	O
acquisition	O
,	O
retention	O
,	O
and	O
production	O
of	O
biological	O
agents	O
and	O
toxins	O
in	O
types	O
and	O
in	O
quantities	O
that	O
have	O
no	O
justification	O
for	O
protective	O
or	O
peaceful	O
purposes	O
.	O

While	O
most	O
systems	O
access	O
external	O
resources	O
via	O
web	O
services	O
or	O
URLs	O
,	O
the	O
BRM	S-Platform
uses	O
data	O
warehousing	O
to	O
integrate	O
them	O
.	O

CRISPR	S-Technology
was	O
named	O
as	O
one	O
of	O
MIT	O
Technology	O
Reviews	O
10	O
breakthrough	O
technologies	O
in	O
2014	O
and	O
2016	O
.	O

It	O
is	O
pulling	O
together	O
scientists	O
with	O
different	O
capabilities	O
to	O
solve	O
problems	O
.	O

A	O
comparison	O
of	O
the	O
different	O
existing	O
lists	O
of	O
human	O
pathogens	O
has	O
been	O
made	O
by	O
the	O
European	B-Organization
Federation	I-Organization
of	I-Organization
Biotechnology	E-Organization
(Frommer	O
W.	O
,	O
The	O
WP	O
Safety	O
in	O
Biotechnology	O
of	O
the	O
European	O
Federation	O
Biotechnology	O
,	O
Safe	O
Biotechnology	O
-	O
3	O
.	O

An	O
unfortunate	O
example	O
is	O
the	O
likelihood	O
that	O
materials	O
derived	O
from	O
Old	O
World	O
nonhuman	O
primates	O
such	O
as	O
the	O
macaque	O
may	O
contain	O
cercopithecine	B-Pathogen
herpesvirus	E-Pathogen
(	O
CHV‐1	S-Pathogen
)	O
,	O
also	O
called	O
herpes	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
or	O
B‐virus	S-Pathogen
.	O
This	O
virus	O
causes	O
simple	O
cold	B-Phenotype
sores	E-Phenotype
in	O
macaques	O
but	O
can	O
be	O
fatal	O
to	O
humans	O
(	O
Holmes	S-Person
et	O
al.	O
,	O
1995)	O
.	O

Van	O
der	O
Kloot	O
2004	O
,	O
p.152	O
.	O

In	O
September	O
2015	O
,	O
a	O
new	O
chip-based	O
testing	O
method	O
that	O
can	O
detect	O
accurately	O
was	O
reported	O
.	O

On	O
2	O
August	O
,	O
Oxfam	S-Organization
indicated	O
it	O
would	O
be	O
taking	O
part	O
in	O
the	O
response	O
to	O
this	O
latest	O
outbreak	O
in	O
the	O
.	O

All	O
influenza	S-Disease
A	O
pandemics	O
since	O
that	O
time	O
,	O
and	O
indeed	O
almost	O
all	O
cases	O
of	O
influenza	O
A	O
worldwide	O
(excepting	O
human	O
infections	O
from	O
avian	O
viruses	O
such	O
as	O
H5N1	S-Pathogen
and	O
H7N7	S-Pathogen
)	O
,	O
have	O
been	O
caused	O
by	O
descendants	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
,	O
including	O
"	O
drifted"	O
H1N1	S-Pathogen
viruses	O
and	O
reassorted	O
H2N2	S-Pathogen
and	O
H3N2	S-Pathogen
viruses	O
.	O

Apart	O
from	O
knock-out	O
there	O
are	O
also	O
knock-down	O
(	O
CRISPRi	S-Technology
and	O
activation	O
(	O
CRISPRa	S-Technology
)	O
libraries	O
,	O
which	O
using	O
the	O
ability	O
of	O
proteolytically	O
deactivated	O
Cas9-fusion	O
proteins	O
(dCas9)	O
to	O
bind	O
target	O
DNA	O
,	O
which	O
means	O
that	O
gene	O
of	O
interest	O
is	O
not	O
cut	O
but	O
is	O
over-expressed	O
or	O
repressed	O
.	O

After	O
the	O
September	O
identification	O
of	O
a	O
novel	O
CoV	B-Pathogen
strain	E-Pathogen
,	O
a	O
retroactive	O
analysis	O
of	O
the	O
hospital	O
workers	O
was	O
performed	O
.	O

Conflicting	O
usability	O
requirements	O
of	O
two	O
groups	O
-	O
metadata	O
creators	O
and	O
metadata	O
users	O
-	O
are	O
identified	O
along	O
with	O
associated	O
limitations	O
of	O
current	O
metadata	O
standards	O
.	O

In	O
principle	O
,	O
rather	O
than	O
transporting	O
samples	O
to	O
a	O
different	O
laboratory	O
in	O
the	O
network	O
,	O
an	O
alternative	O
would	O
be	O
to	O
exchange	O
staff	O
,	O
as	O
the	O
network	O
members'	O
staff	O
are	O
now	O
familiar	O
with	O
the	O
methods	O
and	O
practices	O
used	O
in	O
the	O
other	O
laboratories	O
.	O

Patients	O
sometimes	O
take	O
antibiotics	O
unnecessarily	O
,	O
to	O
treat	O
viral	O
illnesses	O
like	O
the	O
common	B-Disease
cold	E-Disease

That	O
is	O
a	O
violation	O
of	O
the	O
law.	O
"	O
The	O
"	O
Breeders"	O
also	O
could	O
be	O
guilty	O
of	O
other	O
crimes	O
,	O
including	O
extortion	O
,	O
he	O
said	O
.	O

Thank	O
you	O
very	O
much	O
,	O
Dr	O
.	O

All	O
of	O
these	O
findings	O
beg	O
the	O
question:	O
where	O
did	O
the	O
come	O
from?	O

Moving	O
it	O
to	O
is	O
unwise	O
.	O

Policy	O
regulations	O
for	O
the	O
CRISPR-Cas9	B-Technology
system	E-Technology
vary	O
around	O
the	O
globe	O
.	O

For	O
example	O
,	O
Inglesby	S-Person
notes	O
that	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
,	O
and	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
are	O
where	O
the	O
main	O
HHS	S-Organization
capabilities	O
reside	O
,	O
but	O
other	O
agencies-including	O
the	O
,	O
and	O
the	O
intelligence	O
community-also	O
play	O
key	O
roles	O
.	O

The	O
following	O
month	O
,	O
the	O
5	O
April	O
WHO	S-Organization
report	O
again	O
disclosed	O
a	O
downward	O
trend	O
and	O
the	O
WHO	S-Organization
weekly	O
update	O
for	O
29	O
July	O
reported	O
a	O
total	O
of	O
only	O
3	O
new	O
cases	O
,	O
the	O
lowest	O
in	O
more	O
than	O
a	O
year	O
.	O

The	O
eluted	O
PCR	S-Equipment
product	O
is	O
visualized	O
by	O
agarose	O
gel	O
electrophoresis	O
.	O

On	O
14	O
July	O
,	O
an	O
individual	O
entered	O
the	O
country	O
of	O
Uganda	S-Location
from	O
DRC	S-Location
while	O
symptomatic	O
for	O
EVD	S-Disease
;	O
there	O
is	O
an	O
ongoing	O
search	O
for	O
contacts	O
in	O
Mpondwe	S-Location
.	O
On	O
24	O
July	O
,	O
Uganda	S-Location
marked	O
the	O
needed	O
42	O
day	O
period	O
without	O
any	O
EVD	S-Disease
cases	O
to	O
be	O
declared	O
Ebola-free	O
.	O

Objective:	O
The	O
aim	O
of	O
this	O
paper	O
is	O
to	O
describe	O
the	O
approach	O
we	O
used	O
during	O
the	O
HANDOVER	S-International_exchange_and_cooperation
Project	O
to	O
develop	O
a	O
multicentre	O
,	O
multinational	O
research	O
project	O
for	O
studying	O
transitions	O
of	O
patient	O
care	O
while	O
creating	O
a	O
community	O
of	O
practice	O
for	O
the	O
researchers	O
.	O

Students	O
grow	O
the	O
bacteria	O
to	O
logarithmic	O
stage	O
,	O
switch	O
on	O
the	O
lytic	O
cycle	O
by	O
moving	O
the	O
bacteria	O
to	O
42°C	O
,	O
and	O
follow	O
bacterial	O
lysis	O
indirectly	O
by	O
recording	O
the	O
optical	O
density	O
of	O
the	O
medium	O
.	O

Initial	O
estimates	O
of	O
the	O
basic	O
reproduction	O
number	O
(R0)	O
for	O
COVID-19	S-Disease
in	O
January	O
were	O
between	O
1.4	O
and	O
2.	O
5	O
,	O
but	O
a	O
subsequent	O
analysis	O
has	O
concluded	O
that	O
it	O
may	O
be	O
about	O
5.	O
7	O
(with	O
a	O
95	O
percent	O
confidence	O
interval	O
of	O
3.8	O
to	O
8.9)	O
.	O

However	O
,	O
on	O
23	O
February	O
,	O
Ms.	B-Person
Cafferkey	E-Person
was	O
admitted	O
for	O
a	O
third	O
time	O
,	O
"	O
under	O
routine	O
monitoring	O
by	O
the	O
 ...	O
for	O
further	O
investigations"	O
,	O
according	O
to	O
a	O
spokesperson	O
.	O

Records	O
obtained	O
by	O
the	O
USA	B-Organization
TODAY	I-Organization
Network	E-Organization
show	O
hundreds	O
of	O
incidents	O
have	O
occurred	O
in	O
labs	O
across	O
the	O
country	O
in	O
recent	O
years	O
.	O

It	O
describes	O
about	O
50	O
steps	O
with	O
timelines	O
,	O
ranging	O
from	O
beefed-up	O
biosafety	O
training	O
to	O
plans	O
for	O
an	O
outside	O
review	O
of	O
local	O
labs'	O
protocols	O
for	O
inactivating	O
select	O
agents	O
.	O

"	O
As	O
the	O
White	O
House	O
Medical	O
Unit	O
Telemedicine	O
Program	O
Manager	O
,	O
I	O
am	O
excited	O
to	O
see	O
that	O
GlobalMed	S-Organization
ATO	O
was	O
approved,	O
"	O
said	O
James	B-Person
J.	I-Person
Jones	E-Person
,	O
PhD	O
,	O
PA-CLTC	O
,	O
SP	O
,	O
USA	O
,	O
Director	O
,	O
Medical	O
Evaluation	O
&amp	O
;	O
Treatment	O
Unit	O
and	O
PA/Physician	O
to	O
the	O
President.	O
"	O
This	O
is	O
a	O
key	O
milestone	O
in	O
the	O
Defense	B-Organization
Health	I-Organization
Ag	E-Organization
en	O
cy	S-Organization
	S-Organization
(DHA)	O
and	O
military	O
medicine's	O
goal	O
of	O
developing	O
a	O
robust	O
virtual	O
healthcare	O
solution	O
throughout	O
the	O
entire	O
military	O
enterprise	O
.	O

WHO	S-Organization
claimed	O
they	O
could	O
only	O
evacuate	O
medical	O
professionals	O
they	O
had	O
deployed	O
to	O
the	O
region	O
,	O
not	O
locals	O
.	O

The	O
droplets	O
are	O
relatively	O
heavy	O
,	O
usually	O
fall	O
to	O
surfaces	O
,	O
and	O
do	O
not	O
travel	O
far	O
through	O
the	O
air	O
.	O

CDC	S-Organization
has	O
notified	O
WHO	S-Organization
about	O
the	O
discovery	O
,	O
and	O
WHO	S-Organization
has	O
been	O
invited	O
to	O
participate	O
in	O
the	O
investigation	O
.	O

The	O
country's	O
best	O
labs	O
have	O
robust	O
safety	O
programs	O
,	O
said	O
Kenneth	B-Person
Berns	E-Person
co-chair	O
of	O
a	O
panel	B-Organization
of	I-Organization
outside	I-Organization
lab	I-Organization
safety	I-Organization
advisers	E-Organization
currently	O
examining	O
biosafety	O
at	O
CDC	S-Organization
and	O
other	O
federal	O
labs	O
.	O

Common	O
examples	O
in	O
bioinformatics	O
are	O
the	O
formal	O
characterization	O
of	O
genes	O
in	O
the	O
Gene	O
Ontology	O
and	O
of	O
gene	O
expression	O
experiments	O
in	O
Microarray	B-Organization
Genomics	I-Organization
Data	I-Organization
Society	E-Organization
()	O
ontologies	O
.	O

With	O
current	O
labs	O
,	O
an	O
escape	O
of	O
a	O
pandemic	O
pathogen	O
is	O
only	O
a	O
matter	O
of	O
time	O
.	O

Third	O
and	O
forth	O
year	O
classes	O
were	O
closed	O
and	O
the	O
students	O
assigned	O
jobs	O
as	O
interns	O
or	O
nurses	O
(	O
Starr	S-Organization
One	O
article	O
noted	O
that	O
"	O
depletion	O
has	O
been	O
carried	O
to	O
such	O
an	O
extent	O
that	O
the	O
practitioners	O
are	O
brought	O
very	O
near	O
the	O
breaking	O
point,	O
"	O
(	O
BMJ	S-Organization
,	O
11/2/1918)	O
.	O

The	O
members	O
of	O
the	O
species	O
are	O
called	O
Zaire	B-Pathogen
ebolaviruses	E-Pathogen
.	O
The	O
natural	O
reservoir	O
of	O
is	O
believed	O
to	O
be	O
bats	O
,	O
particularly	O
fruit	O
bats	O
,	O
and	O
it	O
is	O
primarily	O
transmitted	O
between	O
humans	O
and	O
from	O
animals	O
to	O
humans	O
through	O
body	O
fluids	O
.	O

Critics	O
contend	O
that	O
this	O
contributes	O
to	O
the	O
development	O
of	O
antibiotic	O
resistance	O
and	O
have	O
called	O
on	O
the	O
FDA	S-Organization
to	O
address	O
the	O
loophole	O
.	O

In	O
a	O
report	O
released	O
on	O
23	O
September	O
2014	O
,	O
the	O
CDC	S-Organization
analysed	O
the	O
impact	O
of	O
under-reporting	O
,	O
which	O
required	O
correction	O
of	O
case	O
numbers	O
by	O
a	O
factor	O
of	O
up	O
to	O
2.5	O
.	O

He	O
contacted	O
physicians	O
at	O
the	O
CDC	S-Organization
and	O
other	O
agencies	O
and	O
urged	O
them	O
to	O
investigate	O
Rajneeshpuram	S-Location
.	O
According	O
to	O
Lewis	O
F	O
.	O

We	O
expect	O
and	O
indeed	O
welcome	O
criticism	O
and	O
the	O
chance	O
to	O
discuss	O
it"	O
.	O

In	O
2016	O
another	O
21	O
590	O
ticks	O
were	O
collected	O
for	O
DNA	O
database	O
for	O
future	O
studies	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
under	O
the	O
Pentagon	B-Scientific_research_project
project	E-Scientific_research_project
"	O
".	O

Per	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
as	O
of	O
April	O
2020	O
,	O
there	O
is	O
no	O
specific	O
treatment	O
for	O
COVID‑19	O
.	O

The	O
expenditure	O
associated	O
with	O
these	O
infections	O
in	O
terms	O
of	O
extra	O
hospital	O
costs	O
and	O
productivity	O
losses	O
exceeded	O
€1.	O
5	O
billion	O
each	O
year	O
(Ref)	O
.	O

The	O
government	O
of	O
Uganda	S-Location
opened	O
two	O
Ebola	S-Pathogen
treatment	O
centers	O
at	O
the	O
border	O
with	O
the	O
DRC	S-Location
,	O
though	O
there	O
had	O
not	O
yet	O
been	O
any	O
confirmed	O
cases	O
in	O
the	O
country	O
of	O
.	O
By	O
13	O
June	O
2019	O
,	O
nine	O
treatment	O
units	O
were	O
in	O
place	O
near	O
the	O
affected	O
border	O
.	O

During	O
those	O
years	O
,	O
the	O
number	O
of	O
estimated	O
deaths	O
ranged	O
from	O
17,000	O
to	O
52,000	O
,	O
with	O
an	O
average	O
of	O
about	O
36,000	O
.	O

At	O
the	O
time	O
of	O
the	O
Korean	O
War	O
the	O
United	B-Location
States	E-Location
had	O
only	O
weaponized	O
one	O
agent	O
,	O
brucellosis	S-Pathogen
(	O
"	O
Agent	B-Pathogen
US	E-Pathogen
"	O
),	O
which	O
is	O
caused	O
by	O
Brucella	B-Pathogen
suis	E-Pathogen
.	O
The	O
original	O
weaponized	O
form	O
used	O
the	O
M114	O
bursting	O
bomblet	O
in	O
M33	O
cluster	O
bombs	O
.	O

On	O
11	O
May	O
2014	O
,	O
two	O
people	O
in	O
Medan	S-Location
were	O
suspected	O
infected	O
by	O
MERS-Cov	S-Pathogen
()	O
.	O

Two	O
of	O
the	O
Saudi	B-Location
Arabia	E-Location
cases	O
were	O
from	O
the	O
same	O
family	O
and	O
from	O
that	O
family	O
at	O
least	O
one	O
additional	O
person	O
presented	O
similar	O
symptoms	O
but	O
tested	O
negative	O
for	O
the	O
novel	O
coronavirus	O
.	O

Whether	O
the	O
viruses	O
were	O
equally	O
transmissible	O
in	O
1918	O
,	O
whether	O
they	O
had	O
identical	O
patterns	O
of	O
replication	O
in	O
the	O
respiratory	O
tree	O
,	O
and	O
whether	O
one	O
or	O
both	O
also	O
circulated	O
in	O
the	O
first	O
and	O
third	O
pandemic	O
waves	O
,	O
are	O
unknown	O
.	O

1946:	O
A	O
biological	O
weapons	O
facility	O
was	O
established	O
in	O
Sverdlovsk	S-Location

When	O
compared	O
to	O
the	O
control	O
,	O
researchers	O
found	O
that	O
the	O
antibodies	O
within	O
Immuron's	O
Travelan®	S-Drug
product	O
were	O
reactive	O
to	O
all	O
180	O
clinical	O
isolates	O
from	O
these	O
infected	O
individuals	O
.	O

The	O
lab	O
work	O
station	O
design	O
allows	O
for	O
personal	O
supervision	O
of	O
students	O
work	O
by	O
a	O
biological	O
hood	O
even	O
though	O
there	O
are	O
only	O
4	O
hoods	O
and	O
an	O
average	O
of	O
35	O
students	O
per	O
class	O
.	O

ASF	O
,	O
which	O
poses	O
no	O
threat	O
to	O
humans	O
,	O
is	O
often	O
prevalent	O
in	O
countries	O
in	O
Sub-Saharan	B-Location
Africa	E-Location
Outbreaks	O
have	O
also	O
occurred	O
in	O
.	O

But	O
some	O
of	O
the	O
memo	O
is	O
incorrect	O
,	O
the	O
source	O
says	O
.	O

In	O
1992	O
,	O
Mark	B-Person
L.	I-Person
Rosenberg	E-Person
and	O
five	B-Person
CDC	I-Person
colleagues	E-Person
founded	O
the	O
CDC's	B-Organization
National	I-Organization
Center	I-Organization
for	I-Organization
Injury	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
,	O
with	O
an	O
annual	O
budget	O
of	O
c.	O
$260,000	O
that	O
focused	O
on	O
"	O
identifying	O
the	O
root	O
causes	O
of	O
firearm	O
deaths	O
and	O
the	O
best	O
methods	O
to	O
prevent	O
them"	O
.	O

From	O
here	O
the	O
logical	O
progression	O
is	O
into	O
the	O
realm	O
of	O
's	O
specific	O
strategies	O
to	O
prevent	O
bioterrorism	O
.	O

The	O
air	O
flow	O
in	O
laboratory	O
is	O
also	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

According	O
to	O
the	O
incident	O
document	O
,	O
there	O
was	O
"	O
no	O
injury	O
"	O
associated	O
with	O
the	O
incident	O
,	O
and	O
the	O
employee	O
was	O
retrained	O
on	O
proper	O
lab	O
procedures	O
.	O

In	O
early	O
March	O
,	O
the	O
Indian	B-Organization
government	E-Organization
began	O
evacuating	O
its	O
citizens	O
from	O
Iran	S-Location
.	O
On	O
20	O
March	O
,	O
the	O
United	B-Location
States	E-Location
began	O
to	O
partially	O
withdraw	O
its	O
troops	O
from	O
due	O
to	O
the	O
pandemic	O
.	O

The	O
focus	O
of	O
these	O
initiatives	O
was	O
found	O
to	O
be	O
general	O
awareness	O
in	O
the	O
field	O
of	O
biotechnology	O
and	O
biomedical	O
laboratories	O
with	O
particular	O
interest	O
in	O
risk	O
assessment	O
and	O
mitigation	O
13%	O
(n = 239)	O
,	O
followed	O
by	O
awareness	O
of	O
genetically	B-Technology
modified	I-Technology
organisms	E-Technology
()	O
9.17%	O
(n = 168)	O
.	O

A	O
total	O
number	O
of	O
190	O
laboratories	O
(labs)	O
were	O
surveyed	O
about	O
their	O
compliance	O
with	O
standard	O
biosafety	O
precautions	O
.	O

The	O
PRE-Symptomatic	B-Technology
AGent	I-Technology
Exposure	I-Technology
Detection	E-Technology
()	O
algorithm	O
uses	O
real-time	O
physiological	O
data	O
,	O
such	O
as	O
heart	O
electrical	O
activity	O
(electrocardiography	O
,	O
ECG)	O
,	O
breathing	O
rate	O
,	O
and	O
temperature	O
,	O
to	O
calculate	O
the	O
probability	O
that	O
a	O
person	O
has	O
been	O
exposed	O
to	O
a	O
virus	O
or	O
bacteria	O
.	O

About	O
a	O
third	O
of	O
antibiotic	O
prescriptions	O
written	O
in	O
outpatient	O
settings	O
in	O
the	O
United	B-Location
States	E-Location
were	O
not	O
appropriate	O
in	O
2010	O
and	O
2011	O
.	O

There	O
was	O
a	O
lack	O
of	O
awareness	O
and	O
understanding	O
about	O
reporting	O
requirements	O
for	O
Select	O
Agents	O
,	O
such	O
as	O
H5N1	S-Pathogen
which	O
contributed	O
to	O
the	O
delay	O
in	O
reporting	O
this	O
incident	O
.	O

Three	O
types	O
of	O
traps	O
are	O
being	O
used	O
to	O
lure	O
Medflies--the	O
Jackson,	B-Equipment
Steiner	I-Equipment
and	I-Equipment
McPhail	I-Equipment
traps	E-Equipment
Almost	O
all	O
of	O
the	O
flies	O
are	O
females	O
,	O
and	O
are	O
showing	O
up	O
in	O
the	O
McPhail	B-Equipment
traps	E-Equipment
.	O
It	O
would	O
be	O
expected	O
that	O
males	O
would	O
be	O
caught	O
in	O
the	O
,	O
which	O
contains	O
a	O
sex	O
lure	O
that	O
has	O
proven	O
effective	O
in	O
past	O
Medfly	O
invasions	O
.	O

After	O
cases	O
in	O
China	S-Location
stabilised	O
,	O
the	O
country	O
began	O
sending	O
aid	O
to	O
other	O
nations	O
.	O

And	O
so	O
I	O
wonder	O
if	O
you	O
could	O
talk	O
about	O
whether	O
you	O
think	O
procedures	O
for	O
regular	O
inspections	O
of	O
labs	O
that	O
work	O
with	O
select	O
agents	O
need	O
to	O
be	O
toughened	O
since	O
has	O
played	O
a	O
role	O
itself	O
in	O
these	O
inspections	O
.	O

Third	O
,	O
the	O
general	O
issue	O
of	O
inactivation	O
,	O
how	O
do	O
you	O
kill	O
bacteria	O
or	O
viruses	O
before	O
you	O
transfer	O
them	O
out	O
,	O
that	O
procedure	O
will	O
be	O
looked	O
at	O
every	O
laboratory	O
that	O
works	O
on	O
not	O
just	O
select	O
agents	O
but	O
any	O
dangerous	O
pathogen	O
at	O
CDC	S-Organization
and	O
if	O
needed	O
,	O
we	O
will	O
improve	O
it	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
the	O
second	O
plague	S-Disease
pandemic	O
recorded	O
,	O
after	O
the	O
Plague	B-Disease
of	I-Disease
Justinian	E-Disease
(542–546)	O
.	O

Another	O
study	O
showed	O
that	O
,	O
in	O
Guinea	S-Location
a	O
satisfactory	O
knowledge	O
had	O
not	O
altered	O
the	O
level	O
of	O
comprehensive	O
knowledge	O
about	O
the	O
virus	O
.	O

Eitzen	S-Person
Edward	B-Person
M	E-Person
.	O
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	O
Air	O
Force	O
Base	O
.	O

But	O
in	O
terms	O
of	O
smallpox	S-Pathogen
,	O
we're	O
confident	O
that	O
there	O
are	O
not	O
other	O
samples	O
anywhere	O
at	O
CDC	S-Organization
.	O
I	O
will	O
say	O
that	O
there	O
is	O
an	O
analogy	O
with	O
polio	S-Disease
because	O
we're	O
now	O
making	O
progress	O
toward	O
polio	S-Disease
eradication	O
.	O

Because	O
of	O
the	O
Lead	B-Incident
contamination	I-Incident
in	I-Incident
Washington,	I-Incident
D.C.	I-Incident
drinking	I-Incident
water	E-Incident
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
conducted	O
an	O
investigation	O
,	O
that	O
uncovered	O
that	O
the	O
CDC	S-Organization
had	O
made	O
claims	O
in	O
a	O
report	O
that	O
had	O
indicated	O
there	O
was	O
no	O
risk	O
from	O
high	O
lead	O
levels	O
-	O
although	O
it	O
is	O
the	O
opposite	O
.	O

It	O
opened	O
in	O
2005	O
and	O
cost	O
$214	O
million	O
,	O
although	O
the	O
lab	O
area	O
that	O
handles	O
the	O
most	O
fearsome	O
bugs	O
didn't	O
begin	O
work	O
until	O
2009	O
.	O

Germany	S-Location
)	O
is	O
to	O
make	O
data	O
sharing	O
mandatory	O
in	O
order	O
to	O
receive	O
(full)	O
funding	O
.	O

Residents	O
of	O
The	O
Dalles	S-Location
commented	O
that	O
they	O
have	O
an	O
understanding	O
of	O
how	O
bioterrorism	O
can	O
occur	O
in	O
the	O
United	B-Location
States	E-Location
.	O
The	O
incident	O
had	O
spread	O
fear	O
in	O
the	O
community	O
,	O
and	O
drained	O
the	O
local	O
economy	O
.	O

In	O
1932	O
,	O
Surgeon	O
General	O
Shirō	B-Person
Ishii	E-Person
(	O
石井四郎	S-Person
Ishii	B-Person
Shirō	E-Person
)	O
,	O
chief	O
medical	O
officer	O
of	O
the	O
Japanese	B-Organization
Army	E-Organization
and	O
protégé	O
of	O
Army	O
Minister	O
Sadao	B-Person
Araki	E-Person
was	O
placed	O
in	O
a	O
command	O
of	O
the	O
Army	B-Organization
Epidemic	I-Organization
Prevention	I-Organization
Research	I-Organization
Laboratory	E-Organization
(	O
AEPRL	S-Organization
)	O
.	O
Ishii	S-Person
organized	O
a	O
secret	O
research	O
group	O
,	O
the	O
"	O
Tōgō	B-Organization
Unit	E-Organization
"	O
,	O
for	O
various	O
chemical	O
and	O
biological	O
experimentation	O
in	O
Manchuria	S-Location
.	O
had	O
proposed	O
the	O
creation	O
of	O
a	O
Japanese	O
biological	O
and	O
chemical	O
research	O
unit	O
in	O
1930	O
,	O
after	O
a	O
two-year	O
study	O
trip	O
abroad	O
,	O
on	O
the	O
grounds	O
that	O
Western	O
powers	O
were	O
developing	O
their	O
own	O
programs	O
.	O

They	O
reported	O
that	O
an	O
analysis	O
of	O
20	O
studies	O
showed	O
offered	O
mild	O
benefits	O
for	O
healthy	O
adults	O
if	O
taken	O
within	O
24	O
hours	O
of	O
onset	O
of	O
symptoms	O
,	O
but	O
found	O
no	O
clear	O
evidence	O
it	O
prevented	O
lower	O
respiratory	O
tract	O
infections	O
or	O
other	O
complications	O
of	O
influenza	O
.	O

The	O
economic	O
and	O
human	O
cost	O
of	O
antibiotic	O
resistance	O
is	O
already	O
enormous	O
.	O

Bilateral	O
multilobar	O
ground-glass	O
opacities	O
with	O
a	O
peripheral	O
,	O
asymmetric	O
,	O
and	O
posterior	O
distribution	O
are	O
common	O
in	O
early	O
infection	O
.	O

Like	O
some	O
other	O
biohackers	O
with	O
an	O
anti-establishment	O
streak	O
,	O
he's	O
irritated	O
by	O
federal	O
officials'	O
purported	O
sluggishness	O
in	O
greenlighting	O
all	O
sorts	O
of	O
medical	O
treatments	O
.	O

These	O
supposedly	O
'	O
non-lethal'	B-Equipment
chemical	I-Equipment
weapons	E-Equipment
had	O
been	O
developed	O
as	O
early	O
as	O
the	O
1950s	O
,	O
particularly	O
a	O
substance	O
called	O
'BZ'	O
,	O
known	O
in	O
the	O
US	O
army	O
as	O
'sleeping	O
gas'	O
.	O

The	O
biohacking	O
community	O
also	O
offers	O
just	O
that:	O
community	O
.	O

In	O
February	O
,	O
one	O
research	O
group	O
estimated	O
the	O
IFR	O
at	O
0.	O
94%	O
,	O
with	O
a	O
confidence	O
interval	O
between	O
0.	O
37	O
percent	O
to	O
2.9	O
percent	O
.	O

Yet	O
the	O
defense	O
held	O
fast	O
,	O
and	O
the	O
siege	O
was	O
abandoned	O
after	O
five	O
months	O
.	O

Some	O
of	O
the	O
most	O
important	O
are	O
the	O
virulence	O
,	O
pathogenicity	O
,	O
biological	O
stability	O
,	O
route	O
of	O
spread	O
,	O
and	O
communicability	O
of	O
the	O
agent	O
;	O
the	O
nature	O
or	O
function	O
of	O
the	O
laboratory	O
;	O
the	O
procedures	O
and	O
manipulations	O
involving	O
the	O
agent	O
;	O
the	O
endemicity	O
of	O
the	O
agent	O
;	O
and	O
the	O
availability	O
of	O
effective	O
vaccines	O
or	O
therapeutic	O
measures	O
.	O

Therefore	O
,	O
it	O
is	O
important	O
that	O
bioscience	O
undergraduates	O
learn	O
the	O
practicalities	O
of	O
handling	O
viruses	O
.	O

Common	O
interests	O
among	O
the	O
agencies	O
define	O
the	O
scope	O
of	O
the	O
projects	O
.	O

The	O
phage	O
is	O
lysogenic	O
at	O
30°C	O
,	O
but	O
turns	O
lytic	O
at	O
42°C	O
due	O
to	O
inactivation	O
of	O
the	O
ts	O
repressor	O
.	O

On	O
29	O
September	O
,	O
the	O
leaders	O
of	O
both	O
Sierra	B-Location
Leone	E-Location
and	O
Liberia	S-Location
indicated	O
at	O
the	O
UN	B-Activity
General	I-Activity
Assembly	E-Activity
the	O
launch	O
of	O
a	O
"	O
Post-Ebola	B-Document
Economic	I-Document
Stabilization	I-Document
and	I-Document
Recovery	I-Document
Plan	E-Document
"	O
.	O
On	O
24	O
November	O
,	O
it	O
was	O
reported	O
that	O
due	O
to	O
the	O
decrease	O
in	O
commodity	O
prices	O
and	O
the	O
Western	B-Disease
African	I-Disease
Ebola	I-Disease
epidemic	E-Disease
,	O
's	O
investment	O
in	O
the	O
continent	O
had	O
declined	O
43%	O
in	O
the	O
first	O
6 months	O
of	O
2015	O
.	O

This	O
was	O
estimated	O
as	O
ranging	O
from	O
5	O
million	O
in	O
Brazil	S-Location
to	O
up	O
to	O
590 million	O
in	O
by	O
the	O
year	O
2030	O
.	O

The	O
Rajneeshees'	O
scheme	O
was	O
to	O
sicken	O
local	O
citizens	O
and	O
thus	O
prevent	O
them	O
from	O
voting	O
in	O
an	O
upcoming	O
election	O
.	O

With	O
modern	B-Equipment
dual-energy	I-Equipment
CT	I-Equipment
scanners	E-Equipment
,	O
new	O
areas	O
of	O
use	O
have	O
been	O
established	O
,	O
such	O
as	O
aiding	O
in	O
the	O
diagnosis	O
of	O
.	O

Influenza	B-Disease
virus	I-Disease
infection	E-Disease
requires	O
binding	O
of	O
the	O
HA	O
protein	O
to	O
sialic	O
acid	O
receptors	O
on	O
host	O
cell	O
surface	O
.	O

A	O
straightforward	O
approach	O
which	O
is	O
already	O
exercised	O
in	O
UK	S-Location
,	O
Canada	S-Location
and	O
USA	S-Location
(and	O
recommended	O
to	O
funding	O
partners	O
in	O
other	O
countries	O
,	O
e.g	O
.	O

While	O
the	O
risks	O
of	O
biotechnology	O
have	O
been	O
fretted	O
over	O
for	O
decades	O
,	O
the	O
increasing	O
pace	O
of	O
progress	O
–	O
from	O
low	O
cost	O
DNA	B-Technology
sequencing	E-Technology
to	O
rapid	O
gene	B-Technology
synthesis	E-Technology
to	O
precision	O
–	O
suggests	O
biotechnology	O
is	O
entering	O
a	O
new	O
realm	O
of	O
maturity	O
regarding	O
both	O
beneficial	O
applications	O
and	O
more	O
worrisome	O
risks	O
.	O

Your	O
organization	O
already	O
has	O
before	O
it	O
a	O
request	O
from	O
The	O
Surgeon	O
General	O
for	O
the	O
appointment	O
of	O
a	O
committee	O
by	O
the	O
Division	B-Organization
of	I-Organization
Medical	I-Organization
Sciences	I-Organization
of	I-Organization
the	I-Organization
National	I-Organization
Research	I-Organization
Council	E-Organization
to	O
examine	O
one	O
phase	O
of	O
the	O
matter	O
.	O

More	O
recently	O
,	O
Alexandra	B-Person
Daisy	I-Person
Ginsberg	E-Person
has	O
used	O
old	O
floral	O
DNA	O
to	O
recreate	O
the	O
smell	O
of	O
flowers	O
driven	O
to	O
extinction	O
by	O
humans	O
,	O
enabling	O
us	O
to	O
catch	O
a	O
whiff	O
of	O
them	O
once	O
more	O
.	O

All	O
GHSA	S-International_exchange_and_cooperation
member	O
countries	O
participate	O
in	O
one	O
or	O
more	O
Action	O
Packages	O
and	O
may	O
choose	O
to	O
fulfill	O
commitments	O
by	O
building	O
capacity	O
at	O
a	O
national	O
,	O
regional	O
and/or	O
global	O
level	O
,	O
according	O
to	O
.	O

PCDs	S-Equipment
have	O
only	O
recently	O
become	O
feasible	O
in	O
CT	B-Equipment
scanners	E-Equipment
due	O
to	O
improvements	O
in	O
detector	O
technologies	O
that	O
can	O
cope	O
with	O
the	O
volume	O
and	O
rate	O
of	O
data	O
required	O
.	O

MRI	B-Technology
scans	E-Technology
are	O
capable	O
of	O
producing	O
a	O
variety	O
of	O
chemical	O
and	O
physical	O
data	O
,	O
in	O
addition	O
to	O
detailed	O
spatial	O
images	O
.	O

Now	O
that	O
a	O
cell	O
can	O
be	O
synthesized	O
from	O
a	O
in	O
a	O
simple	O
near-minimal	O
bacterial	O
cell	O
,	O
it	O
becomes	O
possible	O
for	O
the	O
team	O
to	O
test	O
for	O
the	O
functionality	O
of	O
a	O
genome	O
.	O

In	O
February	O
2015	O
,	O
a	O
Sierra	B-Location
Leone	E-Location
physician	O
said	O
about	O
half	O
of	O
the	O
recovered	O
patients	O
she	O
saw	O
reported	O
declining	O
health	O
and	O
that	O
she	O
had	O
seen	O
survivors	O
go	O
blind	S-Phenotype
.	O
In	O
May	O
2015	O
,	O
a	O
senior	O
consultant	O
to	O
the	O
WHO	S-Organization
said	O
that	O
the	O
reports	O
of	O
eye	O
problems	O
were	O
especially	O
worrying	O
because	O
"	O
there	O
are	O
hardly	O
any	O
ophthalmologists	O
in	O
Western	B-Location
Africa	E-Location
,	O
and	O
only	O
they	O
have	O
the	O
skills	O
and	O
equipment	O
to	O
diagnose	O
conditions	O
like	O
that	O
affect	O
the	O
inner	O
chambers	O
of	O
the	O
eye.	O
"	O

TOM	B-Person
FRIEDEN	E-Person
Next	O
question	O
on	O
the	O
phone?	O

By	O
designing	O
2	O
or	O
3	O
experiments	O
that	O
intertwine	O
with	O
each	O
other	O
during	O
different	O
periods	O
of	O
the	O
lab	O
,	O
a	O
potential	O
bottle‐neck	O
problem	O
is	O
avoided	O
,	O
while	O
still	O
allowing	O
students	O
to	O
learn	O
invaluable	O
techniques	O
by	O
performing	O
the	O
experiments	O
themselves	O
in	O
an	O
individual	O
,	O
supervised	O
way	O
.	O

The	O
crRNA	O
is	O
uniquely	O
designed	O
for	O
each	O
application	O
,	O
as	O
this	O
is	O
the	O
sequence	O
that	O
Cas9	O
uses	O
to	O
identify	O
and	O
directly	O
bind	O
to	O
specific	O
sequences	O
within	O
the	O
host	O
cell's	O
DNA	O
.	O

Ebola's	O
toll	O
on	O
the	O
social	O
and	O
economic	O
fabric	O
of	O
is	O
undermining	O
political	O
stability	O
and	O
the	O
progress	O
that	O
this	O
region	O
has	O
made	O
after	O
decades	O
of	O
civil	O
war	O
.	O

Many	O
biological	O
agents	O
have	O
no	O
effective	O
preventive	O
or	O
treatment	O
measures	O
,	O
and	O
even	O
usable	O
vaccines	O
and	O
drugs	O
often	O
have	O
serious	O
side	O
effects	O
.	O

Lepers	O
,	O
and	O
others	O
with	O
skin	O
diseases	O
such	O
as	O
acne	S-Disease
or	O
psoriasis	S-Disease
,	O
were	O
killed	O
throughout	O
.	O

But	O
as	O
McDonnell	S-Person
pointed	O
out	O
last	O
week	O
,	O
a	O
new	O
plan	O
focused	O
on	O
big	O
data	O
and	O
distributed	O
sensors	O
is	O
needed	O
to	O
replace	O
a	O
slow	O
,	O
outmoded	O
program	O
that	O
he	O
called	O
unacceptable	O
.	O

These	O
initiatives	O
were	O
primarily	O
focused	O
on	O
raising	O
awareness	O
about	O
biosafety	O
and	O
biosecurity	O
.	O

As	O
a	O
founding	O
director	O
of	O
the	O
nation's	O
first	O
bioterrorism	O
preparedness	O
program	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
in	O
1999	O
,	O
Dr	O
.	O

Ling	S-Person
discussed	O
his	O
experience	O
at	O
DARPA	S-Organization
as	O
a	O
model	O
for	O
what	O
the	O
federal	O
government	O
should	O
do	O
to	O
enhance	O
numerous	O
agencies'	O
abilities	O
in	O
biosurveillance	O
.	O

Government	O
actions	O
in	O
the	O
early	O
stages	O
of	O
the	O
virus'	O
arrival	O
in	O
the	O
country	O
in	O
September	O
1918	O
are	O
believed	O
to	O
have	O
unintentionally	O
accelerated	O
its	O
spread	O
throughout	O
the	O
country	O
.	O

Notably	O
,	O
they	O
represent	O
a	O
risk	O
to	O
22	O
crops	O
in	O
,	O
including	O
apples	O
,	O
apricots	O
,	O
avocados	O
,	O
bell	O
peppers	O
,	O
cherries	O
,	O
dates	O
,	O
figs	O
,	O
grapes	O
,	O
grapefruits	O
,	O
kiwis	O
,	O
limes	O
,	O
mandarin	O
oranges	O
,	O
nectarines	O
,	O
olives	O
,	O
oranges	O
,	O
peaches	O
,	O
pears	O
,	O
persimmons	O
,	O
plums	O
,	O
prunes	O
and	O
tomatoes	O
.	O

The	O
blast	O
occurred	O
Monday	O
during	O
repair	O
work	O
of	O
a	O
sanitary	O
inspection	O
room	O
at	O
the	O
Russian	B-Organization
State	I-Organization
Centre	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	E-Organization
known	O
as	O
Vector	S-Organization
,	O
near	O
the	O
Russian	O
city	O
of	O
Novosibirsk	S-Location
in	O
,	O
the	O
center	O
said	O
in	O
a	O
statement	O
.	O

Germ	S-Person
"	O
),	O
educated	O
at	O
the	O
University	B-Organization
of	I-Organization
East	I-Organization
Anglia	E-Organization
,	O
was	O
head	O
of	O
Iraq's	B-Organization
military	I-Organization
research	I-Organization
and	I-Organization
development	I-Organization
institute	E-Organization
.	O
Another	O
scientist	O
received	O
a	O
doctorate	O
in	O
molecular	O
biology	O
from	O
the	O
University	B-Organization
of	I-Organization
Edinburgh	E-Organization
.Colvin	O
,	O
Op.	O
cit	O
.	O

Touch	O
his	O
chest	O
and	O
you	O
feel	O
his	O
first	O
effort	O
,	O
a	O
vibration	O
every	O
time	O
he	O
faces	O
north	O
.	O

Biosafety	B-Platform
Level	I-Platform
2	E-Platform
(	O
BLS2	S-Platform
):	O
All	O
work	O
involving	O
infection	O
with	O
MulV	S-Pathogen
requires	O
students	O
to	O
comply	O
with	O
following	O
guidelines:	O
listen	O
to	O
a	O
safety	O
lecture	O
;	O
wear	O
protective	O
clothes	O
,	O
gloves	O
,	O
and	O
glasses	O
;	O
pour	O
liquid	O
waste	O
into	O
bleach	O
containers	O
;	O
autoclave	O
any	O
liquid	O
and	O
solid	O
waste	O
;	O
use	O
virus‐containing	O
tubes	O
only	O
within	O
biological	O
hoods	O
;	O
and	O
centrifuge	O
the	O
virus	O
in	O
special	O
.	O

When	O
the	O
proper	O
protocol	O
is	O
followed	O
,	O
Ebola	S-Pathogen
is	O
considerably	O
less	O
contagious	O
than	O
common	O
viruses	O
,	O
such	O
as	O
measles	S-Pathogen
or	O
the	O
,	O
he	O
said	O
.	O

Garrett	O
,	O
Laurie	O
.	O

"	O
Our	O
aim	O
is	O
to	O
develop	O
rapid	O
and	O
reliable	O
diagnostic	O
methods	O
,	O
as	O
well	O
as	O
to	O
find	O
ways	O
to	O
reduce	O
the	O
risk	O
of	O
melioidosis	S-Pathogen
in	O
deployed	O
service	O
members,	O
"	O
said	O
.	O

By	O
May	O
2013	O
,	O
10	O
of	O
the	O
22	O
people	O
who	O
died	O
and	O
22	O
of	O
44	O
cases	O
reported	O
were	O
in	O
Saudi	B-Location
Arabia	E-Location
and	O
over	O
80%	O
were	O
male	O
.	O

As	O
early	O
as	O
December	O
1989	O
the	O
group's	O
claim	O
was	O
taken	O
seriously	O
.	O

A	O
proof-of-principle	O
that	O
mutations	O
in	O
the	O
dystrophin	O
gene	O
,	O
leading	O
cause	O
of	O
the	O
lethal	O
Duchenne	B-Disease
Muscular	I-Disease
Dystrophy	I-Disease
syndrome	E-Disease
,	O
were	O
corrected	O
in	O
the	O
muscle	O
in	O
mice	O
,	O
human	O
cells	O
in	O
vitro	O
and	O
more	O
relevant	O
,	O
in	O
dogs	O
.	O

Experience	O
shows	O
that	O
organizing	O
and	O
coordinating	O
networks	O
can	O
be	O
challenging	O
in	O
those	O
countries	O
where	O
there	O
is	O
limited	O
cooperation	O
between	O
different	O
sectors-for	O
example	O
,	O
where	O
each	O
sector	O
relates	O
to	O
different	O
ministries	O
or	O
is	O
governed	O
by	O
separate	O
legal	O
frameworks	O
.	O

The	O
,	O
however	O
,	O
is	O
not	O
a	O
state	O
party	O
to	O
the	O
international	O
treaty	O
,	O
and	O
cannot	O
be	O
held	O
accountable	O
for	O
its	O
war	O
crimes	O
.	O

The	O
BSL-3	S-Platform
laboratory	O
is	O
connected	O
to	O
the	O
other	O
labs	O
through	O
two	O
transfer	O
windows	O
(a	O
"	O
clean"	O
transfer	O
window	O
and	O
a	O
"	O
dirty"	O
transfer	O
window)	O
.	O

Zika	S-Pathogen
can	O
cause	O
congenital	B-Disease
Zika	I-Disease
syndrome	E-Disease
(	O
CZS	S-Disease
)	O
,	O
including	O
microcephaly	S-Disease
and	O
other	O
congenital	B-Disease
brain	I-Disease
abnormalities	E-Disease
,	O
in	O
infants	O
born	O
to	O
mothers	O
infected	O
during	O
pregnancy	O
.	O

Skeleton	O
crews	O
of	O
Ishii	S-Person
Japanese	O
troops	O
blew	O
up	O
the	O
compound	O
in	O
the	O
final	O
days	O
of	O
the	O
war	O
to	O
destroy	O
evidence	O
of	O
their	O
activities	O
,	O
but	O
many	O
were	O
sturdy	O
enough	O
to	O
remain	O
somewhat	O
intact	O
.	O

American	O
researchers	O
have	O
developed	O
a	O
platform	O
that	O
can	O
deliver	O
single-dose	O
vaccines	O
,	O
which	O
fully	O
protect	O
against	O
emerging	O
infectious	O
diseases	O
such	O
as	O
Zika	S-Disease
Ebola	S-Disease
and	O
.	O

It	O
is	O
clear	O
that	O
genetic	O
engineering	O
offers	O
new	O
ways	O
of	O
interacting	O
with	O
our	O
environment	O
,	O
including	O
some	O
we	O
can	O
barely	O
imagine	O
.	O

Prior	O
to	O
every	O
CT	S-Equipment
examination	O
,	O
evaluate	O
the	O
appropriateness	O
of	O
the	O
exam	O
whether	O
it	O
is	O
motivated	O
or	O
if	O
another	O
type	O
of	O
examination	O
is	O
more	O
suitable	O
.	O

In	O
addition	O
to	O
showing	O
high	O
efficacy	O
among	O
those	O
vaccinated	O
,	O
the	O
trial	O
also	O
showed	O
that	O
unvaccinated	O
people	O
were	O
indirectly	O
protected	O
from	O
Ebola	B-Pathogen
virus	E-Pathogen
through	O
the	O
ring	O
vaccination	O
approach	O
,	O
termed	O
"	O
herd	O
immunity"	O
.	O

In	O
addition	O
to	O
the	O
epidemiologic	O
survey	O
,	O
CDC	S-Organization
conducted	O
environmental	O
sampling	O
of	O
surfaces	O
in	O
the	O
affected	O
areas	O
and	O
also	O
performed	O
additional	O
studies	O
to	O
learn	O
if	O
the	O
bacterial	O
samples	O
might	O
have	O
been	O
inactivated	O
when	O
they	O
were	O
taken	O
out	O
of	O
the	O
BSL	B-Platform
3	E-Platform
laboratory	O
.	O

And	O
even	O
when	O
research	O
facilities	O
commit	O
the	O
most	O
egregious	O
safety	O
or	O
security	O
breaches	O
-	O
as	O
more	O
than	O
100	O
labs	O
have	O
-	O
federal	B-Organization
regulators	E-Organization
keep	O
their	O
names	O
secret	O
.	O

The	O
serious	O
outbreaks	O
of	O
bacterial	O
infection	O
that	O
are	O
increasingly	O
being	O
reported	O
are	O
costly	O
in	O
many	O
respects	O
.	O

With	O
one-quarter	O
of	O
the	O
US	S-Location
and	O
one-fifth	O
of	O
the	O
world	O
infected	O
with	O
the	O
influenza	O
,	O
it	O
was	O
impossible	O
to	O
escape	O
from	O
the	O
illness	O
.	O

manifesting	O
,	O
in	O
slower	O
growth	O
rate	O
.	O

Cas9	O
uses	O
cell-specific	O
promoters	O
allowing	O
a	O
controlled	O
use	O
of	O
the	O
Cas9	O
.	O

As	O
for	O
the	O
recent	O
Zika	B-Incident
virus	I-Incident
outbreak	I-Incident
in	I-Incident
the	I-Incident
United	I-Incident
States	E-Incident
greater	O
on-the-ground	O
reporting	O
of	O
the	O
response	O
,	O
even	O
during	O
periods	O
where	O
case	O
reports	O
were	O
fewer	O
,	O
could	O
have	O
swayed	O
lawmakers	O
to	O
fund	O
outbreak	O
efforts	O
more	O
consistently	O
,	O
said	O
.	O

The	O
director	O
serves	O
at	O
the	O
pleasure	O
of	O
the	O
President	O
and	O
may	O
be	O
fired	O
at	O
any	O
time	O
.	O

Hannoun	S-Person
considered	O
several	O
alternative	O
hypotheses	O
of	O
origin	O
,	O
such	O
as	O
Spain	S-Location
,	O
Kansas	S-Location
,	O
and	O
,	O
as	O
being	O
possible	O
,	O
but	O
not	O
likely	O
.	O

Local	O
emergency	O
departments	O
were	O
notified	O
to	O
see	O
if	O
any	O
cases	O
of	O
brucellosis	S-Disease
had	O
been	O
reported	O
,	O
but	O
none	O
was	O
.	O

The	O
Board	O
must	O
approve	O
such	O
appointments	O
,	O
although	O
as	O
of	O
2004	O
,	O
it	O
had	O
never	O
over-ruled	O
the	O
preference	O
of	O
a	O
regional	O
committee	O
.	O

Fleeing	O
residents	O
carried	O
the	O
disease	O
to	O
Italy	S-Location
,	O
furthering	O
the	O
second	O
major	O
epidemic	O
of	O
"	O
Black	B-Incident
Death	E-Incident
"	O
in	O
.	O

So	O
they're	O
really	O
events	O
that	O
serve	O
as	O
a	O
warning	O
that	O
the	O
protocols	O
are	O
not	O
what	O
they	O
need	O
to	O
be	O
to	O
ensure	O
that	O
our	O
laboratories	O
operate	O
safely	O
.	O

It's	O
all	O
part	O
of	O
his	O
quest	O
to	O
live	O
until	O
at	O
least	O
age	O
180	O
.	O

Nearly	O
50,000	O
residents	O
of	O
Aralsk	S-Location
were	O
vaccinated	O
in	O
less	O
than	O
two	O
weeks	O
,	O
and	O
hundreds	O
were	O
placed	O
in	O
isolation	O
in	O
a	O
makeshift	O
facility	O
on	O
the	O
edge	O
of	O
town	O
where	O
they	O
could	O
receive	O
no	O
visitors	O
.	O

Fantastical	O
applications	O
of	O
DNA	O
synthesis	O
include	O
human	O
cells	O
that	O
are	O
immune	O
to	O
all	O
viruses	O
or	O
DNA-based	O
data	O
storage.Prof	O
.	O

Joseph	B-Person
Cirincione	E-Person
,	O
et	O
al	O
.	O

Given	O
the	O
volume	O
of	O
care	O
provided	O
in	O
primary	O
care	O
(General	O
Practice)	O
,	O
recent	O
strategies	O
have	O
focused	O
on	O
reducing	O
unnecessary	O
antibiotic	O
prescribing	O
in	O
this	O
setting	O
.	O

The	O
clinical	O
signs	O
and	O
symptoms	O
are	O
mainly	O
,	O
with	O
a	O
few	O
patients	O
having	O
difficulty	O
in	O
breathing	O
,	O
and	O
chest	O
radiographs	O
showing	O
invasive	O
lesions	O
of	O
both	O
lungs	O
.	O

They	O
are	O
accorded	O
diplomatic	O
immunity	O
under	O
the	O
2002	O
US	S-Location
-	O
Agreement	O
on	O
defense	O
cooperation	O
.	O

The	O
Spanish	B-Disease
flu	E-Disease
infected	O
around	O
500	O
million	O
people	O
,	O
about	O
one-third	O
of	O
the	O
world's	O
population	O
.	O

Bioengineering	O
can	O
play	O
a	O
role	O
in	O
creating	O
successful	O
bacteriophages	O
.	O

Sugarcane	O
farmers	O
in	O
Australia	S-Location
in	O
the	O
1930's	O
had	O
a	O
problem:	O
cane	O
beetles	O
were	O
destroying	O
their	O
crop	O
.	O

Official	O
entities	O
adopted	O
terms	O
with	O
varying	O
consistency	O
over	O
the	O
course	O
of	O
the	O
pandemic	O
.	O

But	O
acknowledged	O
that	O
a	O
lot	O
of	O
work	O
remains	O
.	O

William	B-Person
Close	E-Person
1995	O
Ebola	S-Pathogen
:	O
A	O
Documentary	O
Novel	O
of	O
Its	O
First	O
Explosion	O
and	O
2002	O
Ebola	S-Pathogen
:	O
Through	O
the	O
Eyes	O
of	O
the	O
People	O
focused	O
on	O
individuals'	O
reactions	O
to	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
in	O
.	O
At	O
Google	O
Books	O
.	O

Do	O
not	O
wear	O
gloves	O
away	O
from	O
the	O
work	O
area	O
.	O

"	O
The	O
House	S-Organization
took	O
an	O
important	O
step	O
towards	O
keeping	O
our	O
families	O
safe	O
in	O
the	O
worst-case	O
scenarios	O
of	O
a	O
dangerous	O
disease	O
outbreak	O
or	O
bioterrorism	O
attack,	O
"	O
said	O
Rep	O
.	O

The	O
U.S.	S-Location
delegation	O
was	O
led	O
by	O
HHS	S-Organization
Deputy	O
Secretary	O
Eric	B-Person
Hargan	E-Person
,	O
who	O
reaffirmed	O
U.S.	S-Location
support	O
for	O
GHSA	S-International_exchange_and_cooperation
and	O
underscored	O
the	O
goal	O
to	O
prevent	O
,	O
detect	O
,	O
and	O
respond	O
to	O
infectious	O
diseases	O
.	O

The	O
joint	O
projects	O
and	O
regular	O
meetings	O
have	O
generally	O
created	O
a	O
positive	O
and	O
understanding	O
attitude	O
among	O
the	O
network	O
agencies	O
.	O

Some	O
of	O
the	O
research	O
he	O
cites	O
was	O
done	O
on	O
very	O
specific	O
sub-populations	O
,	O
such	O
as	O
diabetics	O
,	O
or	O
on	O
very	O
small	O
groups	O
of	O
people	O
.	O

In	O
2014	O
,	O
Public	B-Organization
Health	I-Organization
England	E-Organization
announced	O
the	O
results	O
of	O
an	O
examination	O
of	O
25	O
bodies	O
exhumed	O
in	O
the	O
Clerkenwell	S-Location
area	O
of	O
London	S-Location
,	O
as	O
well	O
as	O
of	O
wills	O
registered	O
in	O
during	O
the	O
period	O
,	O
which	O
supported	O
the	O
pneumonic	O
hypothesis	O
.	O

On	O
11	O
May	O
2020	O
,	O
the	O
Committee	B-Organization
for	I-Organization
Medicinal	I-Organization
Products	I-Organization
for	I-Organization
Human	I-Organization
Use	I-Organization
of	I-Organization
the	I-Organization
European	I-Organization
Medicines	I-Organization
Agency	E-Organization
(	O
EMA	S-Organization
)	O
recommended	O
expanding	O
the	O
compassionate	O
use	O
of	O
remdesivir	S-Drug
to	O
those	O
not	O
on	O
mechanical	O
ventilation	O
.	O

Most	O
infections	O
with	O
human	O
coronaviruses	O
are	O
mild	O
and	O
associated	O
with	O
common	B-Disease
colds	E-Disease
The	O
seven	O
coronaviruses	O
known	O
to	O
infect	O
humans	O
are	O
in	O
the	O
alpha	O
and	O
beta	O
genera	O
.	O

Additionally	O
,	O
a	O
designated	O
doffing	O
assistant	O
was	O
recommended	O
to	O
help	O
in	O
this	O
process	O
.	O

On	O
20	O
September	O
2019	O
it	O
was	O
reported	O
that	O
a	O
second	O
vaccine	O
by	O
Johnson	B-Organization
&amp;	I-Organization
Joh	E-Organization
would	O
be	O
introduced	O
in	O
the	O
curr	O
ent	S-Disease
EVD	O
epidemic	O
in	O
DRC	O
.	O

Per	O
the	O
Swedish	B-Document
Constitution	E-Document
,	O
the	O
Public	B-Organization
Health	I-Organization
Agency	I-Organization
of	I-Organization
Sweden	E-Organization
has	O
autonomy	O
that	O
prevents	O
political	O
interference	O
and	O
the	O
agency's	O
policy	O
favored	O
forgoing	O
a	O
lockdown	O
in	O
an	O
attempt	O
to	O
reach	O
herd	O
immunity	O
.	O

A	O
rats'	O
nest	O
made	O
of	O
shredded	O
biohazard	B-Equipment
bags	E-Equipment
and	O
containing	O
lab	O
supplies	O
was	O
discovered	O
in	O
a	O
secure	O
,	O
fenced-off	O
medical	O
waste	O
accumulation	O
area	O
at	O
the	O
in	O
March	O
2014	O
,	O
the	O
university's	O
biosafety	O
committee	O
minutes	O
and	O
incident	O
report	O
show	O
.	O

The	O
researchers	O
stated	O
that	O
CRISPR	S-Technology
is	O
not	O
ready	O
for	O
clinical	O
application	O
in	O
reproductive	O
medicine	O
.	O

Bodies	O
pilled	O
up	O
as	O
the	O
massive	O
deaths	O
of	O
the	O
epidemic	O
ensued	O
.	O

Aegypti	O
mosquitoes	O
were	O
produced	O
,	O
1/3	O
were	O
placed	O
in	O
munitions	O
and	O
dropped	O
from	O
aircraft	O
,	O
or	O
dispersed	O
on	O
the	O
ground	O
.	O

TOM	B-Person
FRIEDEN	E-Person
One	O
of	O
the	O
issues	O
,	O
which	O
Dr	O
.	O

The	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
was	O
signed	O
by	O
the	O
US	S-Location
,	O
UK	S-Organization
,	O
USSR	S-Organization
and	O
other	O
nations	O
,	O
as	O
a	O
ban	O
on	O
"	O
development,	O
production	O
and	O
stockpiling	O
of	O
microbes	O
or	O
their	O
poisonous	O
products	O
except	O
in	O
amounts	O
necessary	O
for	O
protective	O
and	O
peaceful	O
research	O
"	O
in	O
1972	O
.	O

MELBOURNE	S-Location
Australia	S-Location
,	O
Jan.	O
29	O
,	O
2018	O
(GLOBE	O
NEWSWIRE)	O
--	O
Immuron	B-Organization
Limited	E-Organization
(ASX:IMC)	O
(NASDAQ:IMRN)	O
,	O
an	O
Australian	O
microbiome	O
biopharmaceutical	O
company	O
focused	O
on	O
developing	O
and	O
commercializing	O
oral	O
immunotherapeutics	O
for	O
the	O
treatment	O
of	O
many	O
gut	O
mediated	O
diseases	O
,	O
today	O
highlighted	O
a	O
recent	O
study	O
on	O
the	O
immuno-reactivity	O
of	O
its	O
commercially	O
available	O
and	O
over-the-counter	O
gastrointestinal	O
and	O
digestive	O
health	O
supplement	O
Travelan®	S-Drug
to	O
infectious	O
bacterium	O
strains	O
from	O
.	O

In	O
comparison	O
,	O
billions	O
of	O
dollars	O
have	O
been	O
spent	O
by	O
developed	O
countries	O
on	O
the	O
2013–2016	B-Incident
Ebola	I-Incident
epidemic	E-Incident
and	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We're	O
confident	O
that	O
we'll	O
be	O
able	O
to	O
get	O
the	O
lab	O
reopened	O
in	O
time	O
to	O
do	O
the	O
essential	O
work	O
it	O
does	O
like	O
helping	O
to	O
prepare	O
the	O
influenza	O
vaccination	O
for	O
Americans	O
in	O
tracking	O
the	O
spread	O
of	O
flu	O
around	O
the	O
world	O
and	O
around	O
the	O
country	O
.	O

The	O
institute	O
then	O
tested	O
317	O
people	O
,	O
and	O
found	O
that	O
96	O
had	O
been	O
infected	O
.	O

You	O
could	O
it	O
call	O
citizen	O
or	O
do-it-your-self	O
biology	O
.	O

Other	O
employees	O
visited	O
the	O
CDC	S-Organization
clinic	O
and	O
were	O
determined	O
not	O
to	O
be	O
affected	O
by	O
the	O
incident	O
and	O
therefore	O
not	O
included	O
in	O
one	O
of	O
the	O
groups	O
.	O

Many	O
dioceses	O
have	O
recommended	O
older	O
Christians	O
stay	O
home	O
rather	O
than	O
attend	O
Mass	O
on	O
Sundays.	O
(Services	O
are	O
available	O
via	O
radio	O
,	O
online	O
live	O
streaming	O
and	O
television.	O
)	O
With	O
the	O
Roman	B-Organization
Catholic	I-Organization
Diocese	E-Organization
of	O
Rome	O
closing	O
its	O
churches	O
and	O
chapels	O
and	O
St.	B-Location
Peter's	I-Location
Square	E-Location
emptied	O
of	O
,	O
other	O
religious	O
bodies	O
also	O
cancelled	O
services	O
and	O
limited	O
public	O
gatherings	O
in	O
churches	O
,	O
mosques	O
,	O
synagogues	O
,	O
temples	O
and	O
gurdwaras	O
.	O

"	O
The	O
political	O
stakes	O
in	O
the	O
Medfly	B-Incident
infestation	E-Incident
California	S-Location
Journal	O
,	O
April	O
1981	O
,	O
pp.	O
137-39	O
.	O

He	O
added	O
that	O
under	O
certain	O
circumstances	O
,	O
an	O
explosion	O
could	O
spread	O
the	O
virus.	O
"	O
Part	O
of	O
the	O
wave	O
of	O
the	O
force	O
of	O
the	O
explosion	O
would	O
carry	O
it	O
away	O
from	O
the	O
site	O
when	O
it	O
was	O
first	O
stored,	O
"	O
he	O
said	O
.	O

Twice	O
a	O
week	O
,	O
you'll	O
get	O
a	O
roundup	O
of	O
ideas	O
and	O
solutions	O
for	O
tackling	O
our	O
biggest	O
challenges:	O
improving	O
public	O
health	O
,	O
decreasing	O
human	O
and	O
animal	O
suffering	O
,	O
easing	O
catastrophic	O
risks	O
,	O
and	O
-	O
to	O
put	O
it	O
simply	O
-	O
getting	O
better	O
at	O
doing	O
good	O
.	O

Many	O
of	O
the	O
studies	O
weren't	O
done	O
in	O
humans	O
but	O
in	O
rats	O
and	O
mice	O
.	O

The	O
fungi	B-Pathogen
candida	E-Pathogen
,	O
Cryptococcus	B-Pathogen
neoformans	E-Pathogen
and	O
cause	O
most	O
of	O
these	O
infections	O
and	O
antifungal	O
resistance	O
occurs	O
in	O
all	O
of	O
them	O
.	O

Capacity	O
building	O
was	O
defined	O
for	O
this	O
project	O
as	O
any	O
initiative	O
focused	O
on	O
technology	O
transfer	O
,	O
hands-on	O
training	O
,	O
and	O
assistance	O
in	O
development	O
of	O
national	O
framework	O
,	O
i.e.	O
,	O
development	O
of	O
national/institutional	O
biosafety	O
committees	O
or	O
sustainable	O
scientific	O
projects	O
with	O
common	O
regional	O
issues	O
and	O
long-term	O
measureable	O
outcome	O
,	O
such	O
as	O
infectious	O
disease	O
surveillance/laboratory	O
diagnosis	O
,	O
etc.	O
,	O
in	O
the	O
region	O
(Figure	O
3)	O
.	O

Currently	O
,	O
BioWatch	S-Document
provides	O
air-monitoring	O
,	O
analysis	O
,	O
notification	O
procedures	O
,	O
and	O
risk	O
assessment	O
to	O
more	O
than	O
30	O
metropolitan	O
jurisdictions	O
in	O
America	S-Location
toward	O
substantially	O
minimizing	O
the	O
catastrophic	O
impact	O
of	O
a	O
biological	O
attack	O
,	O
according	O
to	O
.	O

The	O
162	O
initiatives	O
in	O
Pakistan	S-Location
the	O
sixth	O
most	O
populous	O
country	O
in	O
the	O
world	O
with	O
an	O
estimated	O
population	O
of	O
184.	O
35	O
million	O
,	O
was	O
desperately	O
low	O
as	O
compared	O
to	O
109	O
initiatives	O
in	O
the	O
country	O
of	O
Morocco	S-Location
and	O
62	O
for	O
with	O
populations	O
of	O
32	O
and	O
2.	O
27	O
million	O
,	O
respectively	O
.	O

Intermediary	O
hosts	O
have	O
been	O
reported	O
to	O
be	O
"	O
various	O
species	O
of	O
fruit	O
bats ...	O
throughout	O
central	O
and	O
sub-Saharan	B-Location
Africa	E-Location
"	O
.	O
Evidence	O
of	O
infection	O
in	O
bats	O
has	O
been	O
detected	O
through	O
molecular	O
and	O
serologic	O
means	O
.	O

With	O
the	O
focus	O
on	O
high-consequence	O
pathogens	O
the	O
impact	O
,	O
nonetheless	O
,	O
should	O
be	O
focused	O
on	O
a	O
known	O
group	O
of	O
labs.	O
*Where	O
does	O
this	O
directive	O
come	O
from*?	O
The	O
directive	O
would	O
come	O
from	O
the	O
Office	B-Organization
of	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Policy	E-Organization
(	O
OSTP	S-Organization
)	O
,	O
through	O
the	O
research	O
agencies	O
,	O
via	O
a	O
memorandum	O
.	O

The	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
()	O
is	O
a	O
network	O
that	O
fosters	O
collaboration	O
among	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
the	O
laboratory	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
,	O
covering	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
public	O
health	O
and	O
biodefense	O
,	O
and	O
security	O
.	O

Here	O
,	O
we	O
can	O
only	O
name	O
the	O
standards	O
with	O
the	O
highest	O
relevance	O
to	O
systems	O
biology	O
data	O
management	O
and	O
refer	O
to	O
Brazma	S-Person
et	O
al.	O
for	O
a	O
more	O
detailed	O
discussion	O
of	O
standards	O
in	O
systems	O
biology	O
.	O

A	O
new	O
DARPA	S-Organization
program	O
called	O
Preventing	B-Scientific_research_project
Emerging	I-Scientific_research_project
Pathogenic	I-Scientific_research_project
Threats	E-Scientific_research_project
,	O
or	O
PREEMPT	S-Scientific_research_project
,	O
seeks	O
to	O
support	O
military	O
readiness	O
by	O
going	O
after	O
new	O
viral	O
infectious	O
diseases	O
at	O
the	O
source	O
,	O
animal	O
reservoirs-the	O
species	O
in	O
which	O
a	O
pathogen	O
lives	O
,	O
multiplies	O
,	O
and	O
potentially	O
evolves	O
into	O
a	O
strain	O
that	O
can	O
threaten	O
humans.	O
aims	O
to	O
advance	O
understanding	O
of	O
viruses	O
and	O
their	O
interaction	O
with	O
animals	O
,	O
insects	O
,	O
and	O
humans	O
,	O
and	O
deliver	O
new	O
,	O
proactive	O
interventions	O
to	O
reduce	O
the	O
risk	O
from	O
emerging	O
and	O
reemerging	O
pathogens	O
.	O

M.E	O
.	O

Some	O
of	O
the	O
properties	O
of	O
non-pathogenic	O
micro-organisms	O
have	O
for	O
instance	O
been	O
used	O
in	O
biotechnology	O
to	O
produce	O
metabolites	O
or	O
enzymes	O
.	O

He	O
pledged	O
to	O
commit	O
another	O
$150	O
million	O
to	O
the	O
to	O
achieve	O
the	O
goals	O
in	O
its	O
five-year	O
plan	O
.	O

As	O
DIYbio	S-Activity
experiments	O
became	O
the	O
focus	O
of	O
hackers	O
,	O
the	O
hobby	O
gained	O
additional	O
momentum	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
FDA	O
,	O
USDA	O
,	O
DHHS	O
,	O
DoT	O
,	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

CDC	S-Organization
employees	O
collected	O
the	O
money	O
to	O
make	O
the	O
purchase	O
.	O

Some	O
warn	O
that	O
such	O
databases	O
could	O
be	O
used	O
to	O
track	O
people	O
or	O
discriminate	O
on	O
the	O
basis	O
of	O
private	O
medical	O
records	O
–	O
a	O
dystopian	O
vision	O
of	O
the	O
future	O
familiar	O
to	O
anyone	O
who's	O
seen	O
the	O
movie	O
GATTACA	O
.	O

Now	O
,	O
the	O
institute	O
will	O
help	O
coordinate	O
and	O
implement	O
recommendations	O
for	O
universities	O
and	O
veterinary	O
medical	O
colleges	O
throughout	O
.	O

Toxic	O
trichothecenes	S-Pathogen
,	O
including	O
nivalenol	S-Pathogen
,	O
deoxynivalenol	S-Pathogen
,	O
and	O
monoace	B-Pathogen
tylnivalenol	E-Pathogen
(	O
fusarenon-	B-Pathogen
X	E-Pathogen
)	O
from	O
Fusarium	B-Pathogen
nivale	E-Pathogen
,	O
can	O
be	O
isolated	O
from	O
moldy	O
grains	O
.	O

Individuals	O
may	O
experience	O
distress	O
from	O
quarantine	O
,	O
travel	O
restrictions	O
,	O
side	O
effects	O
of	O
treatment	O
,	O
or	O
fear	O
of	O
the	O
infection	O
itself	O
.	O

For	O
example	O
,	O
at	O
1.5	O
teslas	O
,	O
a	O
typical	O
field	O
strength	O
for	O
clinical	O
MRI	O
,	O
the	O
difference	O
between	O
high	O
and	O
low	O
energy	O
states	O
is	O
approximately	O
9	O
molecules	O
per	O
2	O
million	O
.	O

OSTP	S-Organization
had	O
anticipated	O
issuing	O
the	O
memorandum	O
last	O
week	O
but	O
that	O
action	O
is	O
delayed	O
to	O
allow	O
for	O
additional	O
consultation	O
with	O
the	O
Federal	O
agencies.	O
anticipates	O
the	O
memo	O
will	O
be	O
released	O
soon	O
,	O
at	O
which	O
point	O
labs	O
and	O
institutions	O
may	O
be	O
contacted	O
by	O
multiple	O
agencies	O
about	O
the	O
stand-down	O
.	O

Using	O
the	O
technique	O
pioneered	O
by	O
Boyer	S-Person
and	O
Cohen	S-Person
,	O
scientists	O
at	O
the	O
pharmaceutical	B-Organization
company	I-Organization
Eli	I-Organization
Lilly	E-Organization
figured	O
out	O
how	O
to	O
insert	O
the	O
human	O
gene	O
for	O
producing	O
into	O
bacterial	O
cells	O
.	O

More	O
than	O
people	O
have	O
recovered	O
.	O

For	O
administrative	O
purposes	O
,	O
the	O
JASON	S-Organization
's	O
projects	O
are	O
run	O
by	O
the	O
MITRE	S-Organization
Corporation	O
,	O
which	O
has	O
contracts	O
with	O
the	O
Defense	B-Organization
Department	E-Organization
,	O
CIA	S-Organization
and	O
the	O
FBI	S-Organization
.	O
Since	O
2014	O
MITRE	S-Organization
has	O
been	O
awarded	O
some	O
$27.	O
4	O
million	O
in	O
contracts	O
with	O
the	O
.	O

But	O
even	O
if	O
there	O
were	O
clear	O
regulations	O
governing	O
all	O
biohacking	O
activities	O
,	O
there	O
would	O
be	O
no	O
straightforward	O
way	O
to	O
stop	O
people	O
from	O
pursuing	O
them	O
behind	O
closed	O
doors.	O
"	O
This	O
technology	O
is	O
available	O
and	O
implementable	O
anywhere	O
,	O
there's	O
no	O
physical	O
means	O
to	O
control	O
access	O
to	O
it	O
,	O
so	O
what	O
would	O
regulating	O
that	O
mean?	O
"	O
Carlson	S-Person
said	O
.	O

Wodarg	S-Person
said	O
the	O
WHO	S-Organization
's	O
"	O
false	B-Activity
pandemic"	I-Activity
flu	I-Activity
campaign	E-Activity
is	O
"	O
one	O
of	O
the	O
greatest	O
medicine	O
scandals	O
of	O
the	O
century"	O
.	O

The	O
experimental	O
Flettner	O
rotor	O
bomblet	O
was	O
also	O
developed	O
during	O
this	O
time	O
period	O
.	O

In	O
addition	O
,	O
a	O
bilateral	O
collaboration	O
between	O
Sweden	S-Organization
and	O
has	O
resulted	O
in	O
joint	O
ring	O
trials	O
for	O
analysis	O
of	O
spiked	O
samples	O
for	O
detecting	O
high-consequence	O
bacteria	O
.	O

Aug	O
.	O

The	O
treaty	O
bars	O
possession	O
of	O
deadly	O
biological	O
agents	O
except	O
for	O
defensive	O
research	O
.	O

Behavioral	B-Platform
Risk	I-Platform
Factor	I-Platform
Surveillance	I-Platform
System	E-Platform
()	O
,	O
the	O
world's	O
largest	O
,	O
ongoing	O
telephone	O
health-survey	O
system	O
.	O

Critics	O
criticised	O
the	O
G7	O
leaders	O
,	O
saying	O
they	O
were	O
not	O
committed	O
enough	O
in	O
the	O
fight	O
against	O
the	O
possibility	O
of	O
future	O
pandemics	O
.	O

The	O
contractors	O
will	O
provide	O
the	O
FDA	S-Organization
with	O
"	O
indirect	O
access	O
"	O
to	O
a	O
network	O
of	O
electronic	O
health	O
records	O
and	O
other	O
data	O
of	O
U.S.	S-Location
patients	O
through	O
a	O
distributed	O
data	O
framework	O
and	O
build	O
a	O
data	O
infrastructure	O
to	O
help	O
the	O
agency	O
run	O
observational	O
studies	O
and	O
queries	O
related	O
to	O
-regulated	O
biologics	O
,	O
according	O
to	O
the	O
solicitation	O
.	O

We	O
had	O
three	O
incidents	O
,	O
two	O
at	O
CDC	S-Organization
and	O
one	O
at	O
NIH	S-Organization
where	O
CDC	S-Organization
was	O
able	O
to	O
then	O
secure	O
that	O
material	O
.	O

In	O
2012	O
and	O
2013	O
,	O
CRISPR	S-Technology
was	O
a	O
runner-up	O
in	O
Science	O
Magazine's	O
Breakthrough	O
of	O
the	O
Year	O
award	O
.	O

The	O
group	O
threatened	O
to	O
spread	O
the	O
infestation	O
into	O
the	O
farm-rich	O
San	B-Location
Joaquin	I-Location
Valley	E-Location
if	O
aerial	O
spraying	O
is	O
not	O
stopped	O
in	O
the	O
area	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
for	O
more	O
information	O
.	O

SIGMA	S-Scientific_research_project
capabilities	O
are	O
currently	O
transitioning	O
to	O
operational	O
use	O
with	O
various	O
law	O
enforcement	O
and	O
counterterror	O
entities	O
.	O

The	O
key	O
elements	O
of	O
this	O
system	O
are	O
administrative	O
procedure	O
,	O
risk	O
assessment	O
,	O
enforcement	O
,	O
and	O
public	O
participation	O
and	O
information	O
.	O

Many	O
bioethical	O
concerns	O
have	O
been	O
raised	O
about	O
the	O
prospect	O
of	O
using	O
for	O
germline	O
editing	O
,	O
especially	O
in	O
human	O
embryos	O
.	O

By	O
this	O
time	O
the	O
rash	S-Disease
had	O
spread	O
and	O
covered	O
all	O
Parker	S-Person
's	O
body	O
,	O
including	O
the	O
palms	O
of	O
her	O
hands	O
and	O
soles	O
of	O
her	O
feet	O
,	O
and	O
it	O
was	O
confluent	O
on	O
her	O
face	O
.	O

Since	O
biohackers	O
are	O
often	O
interested	O
in	O
quantifying	O
every	O
aspect	O
of	O
themselves	O
,	O
they	O
may	O
buy	O
wearable	O
devices	O
to	O
,	O
say	O
,	O
track	O
their	O
sleep	O
patterns.	O
(For	O
that	O
purpose	O
,	O
Dorsey	S-Person
swears	O
by	O
the	O
.	O
)	O
The	O
more	O
data	O
you	O
have	O
on	O
your	O
body's	O
mechanical	O
functions	O
,	O
the	O
more	O
you	O
can	O
optimize	O
the	O
machine	O
that	O
is	O
you	O
-	O
or	O
so	O
the	O
thinking	O
goes	O
.	O

It	O
is	O
estimated	O
that	O
for	O
every	O
single	O
meal	O
a	O
person	O
consumes	O
,	O
0.	O
3 g	O
of	O
pesticides	O
is	O
used	O
,	O
as	O
90%	O
of	O
all	O
pesticide	O
use	O
is	O
used	O
on	O
agriculture	O
.	O

Baker	S-Person
,	O
Eric	S-Person
.	O
"	O
'Maggot	O
bombs'	O
and	O
malaria"	O
,	O
Casper	O
Star-Tribune	O
,	O
via	O
the	O
Laramie	O
Boomerang	O
,	O
February	O
27	O
,	O
2006	O
,	O
accessed	O
December	O
25	O
,	O
2008	O
.	O

The	O
most	O
frequently	O
reported	O
symptoms	O
were	O
lethargy	S-Phenotype
or	O
fatigue	S-Phenotype
,	O
joint	B-Phenotype
pain	E-Phenotype
,	O
and	O
hair	B-Phenotype
loss	E-Phenotype
.	O
Sixty-three	O
per	O
cent	O
reported	O
having	O
eye	O
problems	O
including	O
two	O
who	O
were	O
diagnosed	O
with	O
,	O
75%	O
reported	O
psychological	O
or	O
cognitive	O
symptoms	O
,	O
and	O
38%	O
reported	O
neural	O
difficulties	O
.	O

According	O
to	O
CH2M	B-Organization
Hill	E-Organization
the	O
US	O
Company	O
has	O
secured	O
biological	O
agents	O
and	O
employed	O
former	O
bio	O
warfare	O
scientists	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
.	O
These	O
are	O
scientists	O
who	O
are	O
working	O
for	O
another	O
American	O
company	O
involved	O
in	O
the	O
military	O
program	O
in	O
Georgia	S-Location
–	O
.	O

In	O
a	O
study	O
conducted	O
in	O
Maryland	S-Location
State	O
,	O
United	B-Location
States	I-Location
of	I-Location
America	E-Location
,	O
found	O
that	O
compliance	O
with	O
universal	O
precautions	O
in	O
health	O
care	O
facilities	O
was	O
reported	O
as	O
low	O
rate	O
for	O
certain	O
types	O
of	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
such	O
as	O
protective	B-Equipment
eye	I-Equipment
wear	E-Equipment
,	O
face	B-Equipment
mask	E-Equipment
and	O
.	O

NEW	B-Location
YORK	E-Location
(AP)	O
-	O
Thirteen	O
years	O
after	O
building	O
a	O
state-of-the-art	O
lab	O
for	O
the	O
world's	O
most	O
dangerous	O
germs	O
,	O
the	O
nation's	O
top	O
public	O
health	O
agency	O
is	O
asking	O
for	O
more	O
than	O
$400	O
million	O
to	O
build	O
a	O
new	O
one	O
.	O

As	O
DIYbio	S-Activity
experiments	O
became	O
the	O
focus	O
of	O
hackers	O
,	O
the	O
hobby	O
gained	O
additional	O
momentum	O
.	O

The	O
ability	O
of	O
to	O
bind	O
and	O
potentially	O
neutralise	O
these	O
bacteria	O
,	O
highlights	O
the	O
broad-spectrum	O
recognition	O
of	O
surface	O
antigens	O
on	O
potentially	O
debilitating	O
and	O
even	O
life-threatening	O
bacteria	O
.	O

The	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
is	O
a	O
network	O
that	O
fosters	O
collaboration	O
among	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
the	O
laboratory	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
,	O
covering	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
public	O
health	O
and	O
biodefense	O
,	O
and	O
security	O
.	O

In	O
addition	O
,	O
reporting	O
system	O
for	O
laboratory	O
accidents	O
and	O
clean-up	O
of	O
spills	O
was	O
not	O
completely	O
carried	O
out	O
.	O

And	O
while	O
leadership	O
on	O
the	O
issue	O
is	O
needed	O
,	O
he	O
thinks	O
the	O
solution	O
is	O
organization	O
rather	O
than	O
whomever	O
mans	O
it	O
.	O

There	O
is	O
no	O
specific	O
test	O
for	O
exposure	O
and	O
no	O
antidote	O
once	O
exposed	O
.	O

Several	O
Ebola	B-Vaccine
vaccine	E-Vaccine
candidates	O
had	O
been	O
developed	O
in	O
the	O
decade	O
prior	O
to	O
2014	O
and	O
had	O
been	O
shown	O
to	O
protect	O
nonhuman	O
primates	O
against	O
infection	O
,	O
but	O
none	O
had	O
yet	O
been	O
approved	O
for	O
clinical	O
use	O
in	O
humans	O
.	O

The	O
government	O
of	O
Uganda	S-Location
opened	O
two	O
Ebola	S-Pathogen
treatment	O
centers	O
at	O
the	O
border	O
with	O
the	O
DRC	S-Location
,	O
though	O
there	O
had	O
not	O
yet	O
been	O
any	O
confirmed	O
cases	O
in	O
the	O
country	O
of	O
.	O
By	O
13	O
June	O
2019	O
,	O
nine	O
treatment	O
units	O
were	O
in	O
place	O
near	O
the	O
affected	O
border	O
.	O

"	O
Our	O
bipartisan	O
work	O
has	O
resulted	O
in	O
strong	O
partnerships	O
with	O
our	O
states	O
and	O
local	O
counterparts	O
,	O
created	O
greater	O
certainty	O
and	O
accountability	O
to	O
bring	O
forward	O
medical	O
countermeasures	O
,	O
and	O
established	O
a	O
clear	O
strategy	O
with	O
which	O
we	O
can	O
combat	O
the	O
full	O
range	O
of	O
public	O
health	O
threats	O
we	O
face	O
today	O
and	O
those	O
we	O
may	O
encounter	O
in	O
the	O
future,	O
"	O
Burr	S-Person
said	O
during	O
his	O
opening	O
remarks	O
.	O

The	O
EU	S-Location
and	O
NIH	S-Organization
laboratory	O
biosafety	O
categorization	O
lists	O
the	O
Equine	B-Pathogen
Morbilli	I-Pathogen
Virus	E-Pathogen
,	O
while	O
the	O
same	O
virus	O
is	O
designated	O
as	O
Hendra	B-Pathogen
virus	E-Pathogen
in	O
the	O
.	O
These	O
inconsistencies	O
could	O
impede	O
international	O
communication	O
and	O
delay	O
situation	O
management	O
.	O

"	O
The	O
message	O
that	O
'earlier	O
is	O
better'	O
is	O
found	O
throughout	O
medicine	O
,	O
and	O
only	O
recently	O
have	O
small	O
,	O
wearable	O
medical	O
devices	O
enabled	O
the	O
persistent	O
surveillance	O
needed	O
for	O
detecting	O
pathogen	O
exposure	O
.	O

This	O
acknowledgement	O
was	O
also	O
extended	O
to	O
MSF	S-Organization
and	O
the	O
for	O
their	O
assistance	O
.	O

A	O
December	O
2009	O
study	O
found	O
that	O
the	O
transmissibility	O
of	O
the	O
in	O
households	O
is	O
lower	O
than	O
that	O
seen	O
in	O
past	O
pandemics	O
.	O

Petrobactin	S-Pathogen
is	O
a	O
peculiar	O
iron	O
carrier	O
produced	O
by	O
the	O
anthrax	S-Pathogen
pathogen	O
which	O
is	O
not	O
recognized	O
by	O
siderocalin	O
.	O

He	O
reports	O
that	O
since	O
January	O
there	O
have	O
been	O
42	O
attacks	O
on	O
health	O
facilities	O
and	O
85	O
health	O
workers	O
have	O
been	O
wounded	O
or	O
killed.	O
"	O
Every	O
time	O
we	O
have	O
managed	O
to	O
regain	O
control	O
over	O
the	O
virus	O
and	O
contain	O
its	O
spread	O
,	O
we	O
have	O
suffered	O
major	O
,	O
major	O
security	O
events	O
.	O

Additionally	O
,	O
the	O
bill	O
would	O
direct	O
the	O
HHS	B-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
to	O
convene	O
a	O
meeting	O
within	O
a	O
year	O
of	O
the	O
measure's	O
enactment	O
to	O
determine	O
"	O
how	O
genomic	O
engineering	O
can	O
be	O
used	O
both	O
in	O
countermeasures	O
and	O
in	O
national	O
security	O
threats,	O
"	O
she	O
said	O
.	O

While	O
the	O
last	O
naturally	O
occurring	O
smallpox	S-Pathogen
was	O
back	O
in	O
1977	O
,	O
says	O
that	O
it	O
has	O
been	O
used	O
historically	O
by	O
people	O
to	O
infect	O
their	O
enemies	O
.	O

This	O
classification	O
,	O
mainly	O
based	O
on	O
the	O
definitions	O
published	O
by	O
the	O
"	O
Association	B-Organization
Française	I-Organization
de	I-Organization
Normalisation	E-Organization
"	O
(	O
AFNOR	S-Organization
:	O
NF	B-Technology
X-42-075	I-Technology
Biotechnology	E-Technology
:	O
)	O
,	O
takes	O
into	O
account	O
the	O
importance	O
of	O
the	O
disease	O
,	O
its	O
communicability	O
and	O
the	O
maximal	O
risk	O
of	O
exposure	O
in	O
healthy	O
animals	O
.	O

And	O
the	O
advanced	O
genetic	O
tools	O
that	O
some	O
are	O
considering	O
for	O
mosquito	O
control	O
could	O
have	O
unforeseen	O
effects	O
,	O
possibly	O
leading	O
to	O
environmental	O
damage	O
.	O

The	O
origin	O
of	O
the	O
Spanish	B-Incident
flu	I-Incident
pandemic	E-Incident
and	O
the	O
relationship	O
between	O
the	O
near-simultaneous	O
outbreaks	O
in	O
humans	O
and	O
swine	O
,	O
have	O
been	O
controversial	O
.	O

The	O
aggressive	O
support	O
of	O
the	O
Bill	B-Organization
&amp;	I-Organization
Melinda	I-Organization
Gates	I-Organization
Founda	E-Organization
for	O
intermittent	O
preventive	O
therapy	O
of	B-Disease
mal	E-Disease
aria	O
triggered	O
a	O
memo	O
from	O
the	O
for	O
mer	S-Organization
WHO	B-Disease
mal	E-Disease
aria	O
chochi	O
.	O

That	O
was	O
the	O
case	O
for	O
Asprey	S-Person
Now	O
in	O
his	O
40s	O
,	O
he	O
got	O
into	O
biohacking	O
because	O
he	O
was	O
unwell	O
.	O

After	O
the	O
fall	O
of	O
the	O
Soviet	B-Organization
Union	E-Organization
the	O
Departments	O
of	O
State	O
,	O
Defense	O
,	O
and	O
Energy	O
implemented	O
the	O
Nunn-Lugar	B-Activity
Cooperative	I-Activity
Threat	I-Activity
Reduction	I-Activity
programs	E-Activity
to	O
reduce	O
risks	O
associated	O
with	O
dangerous	O
materials	O
,	O
equipment	O
,	O
and	O
expertise	O
from	O
the	O
Soviet	B-Organization
Union	E-Organization
's	O
nuclear	O
,	O
chemical	O
,	O
and	O
biological	O
weapons	O
programs	O
.	O

After	O
Nixon	S-Person
declared	O
an	O
end	O
to	O
the	O
U.S.	B-Scientific_research_project
bio-weapons	I-Scientific_research_project
program	E-Scientific_research_project
,	O
debate	O
in	O
the	O
Army	O
centered	O
around	O
whether	O
or	O
not	O
toxin	O
weapons	O
were	O
included	O
in	O
the	O
president's	O
declaration	O
.	O

It	O
launched	O
multiple	O
lethal	O
attacks	O
using	O
VX	O
gas	O
and	O
sarin	O
gas	O
,	O
killing	O
more	O
than	O
20	O
people	O
and	O
injuring	O
thousands	O
.	O

The	O
Basics	O
of	O
MRI	S-Technology
Underlying	O
physics	O
and	O
technical	O
aspects	O
.	O

These	O
lists	O
have	O
evolved	O
since	O
the	O
1920s	O
and	O
diseases	O
were	O
sometimes	O
added	O
,	O
sometimes	O
removed	O
.	O

Following	O
a	O
joint	O
workshop	O
,	O
the	O
Nordic	B-Platform
Biopreparedness	I-Platform
Forum	E-Platform
was	O
formed	O
in	O
2015	O
and	O
is	O
now	O
governed	O
by	O
a	O
committee	O
made	O
up	O
of	O
representatives	O
from	O
each	O
country	O
.	O

This	O
occurs	O
primarily	O
through	O
the	O
efforts	O
of	O
the	O
Office	B-Organization
of	I-Organization
Health	I-Organization
Affairs	E-Organization
(	O
OHA	S-Organization
)	O
,	O
a	O
part	O
of	O
the	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
(	O
DHS	S-Organization
)	O
,	O
whose	O
role	O
is	O
to	O
prepare	O
for	O
an	O
emergency	O
situation	O
that	O
impacts	O
the	O
health	O
of	O
the	O
American	O
populace	O
.	O

I	O
think	O
we	O
recognize	O
that	O
these	O
are	O
dangerous	O
agents	O
.	O

Digital	B-Technology
geometry	I-Technology
processing	E-Technology
is	O
used	O
to	O
further	O
generate	O
a	O
three-dimensional	O
volume	O
of	O
the	O
inside	O
of	O
the	O
object	O
from	O
a	O
small	O
series	O
of	O
two-dimensional	O
radiographic	O
images	O
taken	O
around	O
a	O
single	O
axis	O
of	O
rotation	O
.	O

The	O
spread	O
of	O
disease	O
was	O
significantly	O
more	O
rampant	O
in	O
areas	O
of	O
poverty	O
.	O

In	O
addition	O
to	O
the	O
outbreak	O
in	O
China	S-Location
there	O
are	O
also	O
now	O
reports	O
of	O
the	O
virus	O
in	O
Vietnam	S-Location
,	O
Laos	S-Location
,	O
Cambodia	S-Location
,	O
Thailand	S-Location
and	O
other	O
countries	O
in	O
.	O

Many	O
medical	O
advances	O
are	O
dependent	O
on	O
the	O
ability	O
to	O
fight	O
infections	O
using	O
antibiotics	O
,	O
including	O
joint	O
replacements	O
,	O
organ	B-Technology
transplants	E-Technology
cancer	O
therapy	O
,	O
and	O
treatment	O
of	O
chronic	O
diseases	O
like	O
diabetes	S-Disease
,	O
asthma	S-Disease
,	O
and	O
.	O

Although	O
most	O
symptoms	O
resolved	O
or	O
improved	O
over	O
time	O
,	O
only	O
one	O
survivor	O
reported	O
complete	O
resolution	O
of	O
all	O
symptoms	O
.	O

William	B-Person
Schaffner	E-Person
of	O
said	O
because	O
the	O
coronavirus	O
is	O
"	O
so	O
readily	O
transmissible"	O
,	O
it	O
"	O
might	O
turn	O
into	O
a	O
seasonal	O
disease	O
,	O
making	O
a	O
comeback	O
every	O
year"	O
.	O

Among	O
those	O
who	O
develop	O
symptoms	O
,	O
approximately	O
one	O
in	O
five	O
may	O
become	O
more	O
seriously	O
ill	O
and	O
have	O
difficulty	B-Phenotype
breathing	E-Phenotype
Emergency	O
symptoms	O
include	O
difficulty	B-Phenotype
breathing	E-Phenotype
,	O
persistent	O
chest	B-Phenotype
pain	I-Phenotype
or	I-Phenotype
pressure	E-Phenotype
,	O
sudden	B-Phenotype
confusion	E-Phenotype
,	O
difficulty	B-Phenotype
waking	E-Phenotype
,	O
and	O
bluish	B-Phenotype
face	I-Phenotype
or	I-Phenotype
lips	E-Phenotype
;	O
immediate	O
medical	O
attention	O
is	O
advised	O
if	O
these	O
symptoms	O
are	O
present	O
.	O

Given	O
that	O
those	O
outbreaks	O
of	O
infectious	O
disease	O
with	O
pandemic	O
potential	O
are	O
likely	O
to	O
continue	O
in	O
the	O
future	O
,	O
they	O
are	O
trying	O
to	O
evolve	O
how	O
antiviral	O
interventions	O
are	O
made	O
as	O
well	O
.	O

A	O
joint	O
effort	O
by	O
laboratory	O
personnel	O
from	O
across	O
the	O
different	O
sectors	O
would	O
increase	O
the	O
critical	O
mass	O
of	O
expertise	O
and	O
improve	O
's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

According	O
to	O
the	O
WHO	S-Organization
standard	O
,	O
the	O
NIH	S-Organization
and	O
EU	S-Location
list	O
should	O
not	O
include	O
Mycobacterium	B-Pathogen
tuberculosis	E-Pathogen
,	O
and	O
other	O
group	O
3	O
biological	O
agents	O
.	O

As	O
infected	O
rodents	O
infected	O
new	O
rodents	O
,	O
the	O
disease	O
spread	O
across	O
the	O
region	O
,	O
entering	O
also	O
from	O
southern	O
.	O

If	O
swallowed	O
,	O
it	O
may	O
cause	O
diarrhea	S-Disease
or	O
bloody	B-Disease
vomiting	E-Disease
.	O
If	O
inhaled	O
,	O
it	O
may	O
initially	O
look	O
like	O
a	O
bad	O
case	O
of	O
the	O
.	O

No	O
animals	O
received	O
a	O
carbapenem	O
drug	O
in	O
the	O
30-day	O
period	O
before	O
sample	O
submission	O
.	O

From	O
a	O
practical	O
perspective	O
,	O
pathogenicity	O
or	O
virulence	O
is	O
the	O
capacity	O
of	O
some	O
micro-organisms	O
to	O
cause	O
disease	O
.	O

17–22.Anthrax	O
Sabotage	O
in	O
Finland	S-Location
In	O
1993	O
,	O
the	O
Aum	O
Shinrikyo	O
used	O
anthrax	S-Pathogen
in	O
an	O
unsuccessful	O
attempt	O
in	O
Tokyo	S-Location
with	O
zero	O
fatalities	O
.	O

In	O
1969	O
,	O
the	O
U.S.	B-Organization
military	E-Organization
celebrated	O
the	O
success	O
of	O
a	O
massive	O
field	O
test	O
in	O
the	O
Pacific	S-Location
.	O
The	O
wargame-involving	O
a	O
fleet	O
of	O
ships	O
,	O
caged	O
animals	O
,	O
and	O
the	O
release	O
of	O
lethal	O
agents-provided	O
proof	O
of	O
the	O
impact	O
of	O
bioweapons	O
.	O

As	O
companies	O
ramp	O
up	O
financing	O
,	O
doubts	O
as	O
to	O
whether	O
CRISPR	S-Technology
can	O
be	O
quickly	O
monetized	O
were	O
raised	O
.	O

It's	O
a	O
potentially	O
fatal	O
disease	O
on	O
its	O
own	O
,	O
but	O
what	O
makes	O
smallpox	S-Pathogen
even	O
more	O
terrifying	O
is	O
the	O
prospect	O
of	O
it	O
being	O
used	O
as	O
a	O
bioweapon	O
.	O

Symptoms	O
usually	O
begin	O
with	O
a	O
sudden	O
influenza-like	O
illness	O
characterised	O
by	O
feeling	B-Phenotype
tired	E-Phenotype
,	O
and	O
pain	B-Phenotype
in	I-Phenotype
the	I-Phenotype
muscles	I-Phenotype
and	I-Phenotype
joints	E-Phenotype
.	O
Later	O
symptoms	O
may	O
include	O
headache	S-Phenotype
,	O
nausea	S-Phenotype
,	O
and	O
abdominal	B-Phenotype
pain	E-Phenotype
;	O
this	O
is	O
often	O
followed	O
by	O
severe	O
vomiting	S-Phenotype
and	O
diarrhoea	S-Phenotype
.	O
In	O
past	O
outbreaks	O
,	O
it	O
has	O
been	O
noted	O
that	O
some	O
patients	O
bleed	B-Phenotype
internally	I-Phenotype
and/or	I-Phenotype
externally	E-Phenotype
;	O
however	O
data	O
published	O
in	O
October	O
2014	O
showed	O
that	O
this	O
had	O
been	O
a	O
rare	O
symptom	O
in	O
the	O
Western	B-Incident
African	I-Incident
outbreak	E-Incident
.	O
Another	O
study	O
published	O
in	O
October	O
2014	O
suggested	O
that	O
a	O
person's	O
genetic	O
makeup	O
may	O
play	O
a	O
major	O
role	O
in	O
determining	O
how	O
an	O
infected	O
person's	O
body	O
reacts	O
to	O
the	O
disease	O
,	O
with	O
some	O
infected	O
people	O
experiencing	O
mild	O
or	O
no	O
symptoms	O
while	O
others	O
progress	O
to	O
a	O
very	O
severe	O
stage	O
that	O
includes	O
.	O

The	O
university	O
is	O
having	O
samples	O
sequenced	O
to	O
verify	O
that	O
the	O
strain	O
she	O
was	O
infected	O
with	O
was	O
acquired	O
in	O
the	O
lab	O
.	O

An	O
article	O
published	O
in	O
JAMA	S-Organization
in	O
September	O
2010	O
challenged	O
previous	O
reports	O
and	O
stated	O
that	O
children	O
infected	O
in	O
the	O
2009	O
flu	B-Disease
pandemic	E-Disease
were	O
no	O
more	O
likely	O
to	O
be	O
hospitalised	O
with	O
complications	O
or	O
get	O
pneumonia	S-Disease
than	O
those	O
who	O
catch	O
seasonal	B-Pathogen
strains	E-Pathogen
.	O
Researchers	O
found	O
that	O
about	O
1.	O
5%	O
of	O
children	O
with	O
the	O
H1N1	B-Pathogen
swine	I-Pathogen
flu	I-Pathogen
strain	E-Pathogen
were	O
hospitalised	O
within	O
30	O
days	O
,	O
compared	O
with	O
3.	O
7%	O
of	O
those	O
sick	O
with	O
a	O
seasonal	B-Pathogen
strain	I-Pathogen
of	I-Pathogen
H1N1	E-Pathogen
and	O
3.	O
1%	O
with	O
an	O
.	O

Political	O
pressure	O
from	O
China	S-Location
has	O
led	O
to	O
Taiwan	S-Location
being	O
barred	O
from	O
membership	O
of	O
the	O
WHO	S-Organization
and	O
other	O
UN-affiliated	O
organizations	O
,	O
and	O
in	O
2017	O
to	O
2020	O
the	O
WHO	S-Organization
refused	O
to	O
allow	O
Taiwanese	O
delegates	O
to	O
attend	O
the	O
annual	O
assembly	O
.	O

Ebola	S-Disease
patients'	O
healthcare	O
providers	O
,	O
as	O
well	O
as	O
family	O
and	O
friends	O
,	O
are	O
at	O
highest	O
risk	O
of	O
getting	O
infected	O
because	O
they	O
are	O
more	O
likely	O
to	O
come	O
in	O
direct	O
contact	O
with	O
their	O
blood	O
or	O
body	O
fluids	O
.	O

The	O
outer	O
viral	O
envelope	O
of	O
the	O
virion	O
is	O
derived	O
by	O
budding	O
from	O
domains	O
of	O
host	O
cell	O
membrane	O
into	O
which	O
the	O
GP	O
spikes	O
have	O
been	O
inserted	O
during	O
their	O
biosynthesis	O
.	O

Spores	O
of	O
weaponized	O
anthrax	S-Pathogen
were	O
accidentally	O
released	O
from	O
a	O
military	O
facility	O
near	O
the	O
city	O
of	O
Sverdlovsk	S-Location
in	O
1979	O
.	O

The	O
aim	O
of	O
FBD	S-Platform
was	O
to	O
strengthen	O
capabilities	O
and	O
capacities	O
for	O
diagnostics	O
at	O
the	O
national	O
laboratories	O
through	O
harmonization	O
.	O

Shigeo	B-Person
Ozeki	E-Person
"	O
civilian	O
employee	O
"	O

In	O
,	O
antibiotic-resistant	O
infections	O
are	O
responsible	O
for	O
$20	O
billion	O
per	O
year	O
in	O
excess	O
health	O
care	O
costs	O
,	O
$35	O
billion	O
per	O
year	O
in	O
societal	O
costs	O
and	O
8	O
million	O
additional	O
hospital	O
days	O
each	O
year	O
(REF)	O
.	O

I	O
just	O
wanted	O
to	O
ask	O
specifically	O
about	O
your	O
flu	O
lab	O
.	O

Southern	B-Organization
Research	I-Organization
Institute	E-Organization
one	O
of	O
the	O
US	S-Location
contractors	O
working	O
at	O
the	O
bio-laboratoriesin	O
Ukraine	S-Location
,	O
has	O
projects	O
on	O
Cholera	S-Disease
,	O
as	O
well	O
as	O
on	O
Influenza	S-Disease
and	O
Zika	S-Pathogen
–	O
all	O
pathogens	O
of	O
military	O
importance	O
to	O
the	O
.	O

Besides	O
gene	B-Technology
editing	E-Technology
in	O
insects	O
and	O
in	O
the	O
viruses	O
they	O
transmit	O
,	O
the	O
wants	O
to	O
engineer	O
humans	O
as	O
well	O
.	O

On	O
20	O
May	O
2013	O
,	O
the	O
novel	O
coronavirus	O
reached	O
Tunisia	S-Location
killing	O
one	O
man	O
and	O
infecting	O
two	O
of	O
his	O
relatives	O
.	O

Hospital	O
workers	O
,	O
who	O
worked	O
closely	O
with	O
the	O
highly	O
contagious	O
body	O
fluids	O
of	O
the	O
victims	O
,	O
were	O
especially	O
vulnerable	O
to	O
contracting	O
the	O
virus	O
;	O
in	O
August	O
2014	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
ten	O
per	O
cent	O
of	O
the	O
dead	O
had	O
been	O
healthcare	O
workers	O
.	O

An	O
inherent	O
challenge	O
of	O
biopreparedness	O
diagnostics	O
is	O
to	O
gather	O
expertise	O
covering	O
all	O
groups	O
of	O
high-consequence	O
pathogens	O
(ie	O
,	O
bacteria	O
,	O
viruses	O
,	O
RNA	O
viruses	O
,	O
and	O
toxins)	O
.	O

Control	O
of	O
these	O
infections	O
in	O
human	O
healthcare	O
settings	O
is	O
a	O
challenge	O
because	O
the	O
organisms	O
colonize	O
the	O
gastrointestinal	O
tract	O
and	O
can	O
go	O
undetected	O
(1)	O
.	O

On	O
7	O
May	O
2013	O
,	O
a	O
case	O
was	O
confirmed	O
in	O
Nord	B-Location
departement	I-Location
of	I-Location
France	E-Location
in	O
a	O
man	O
who	O
had	O
previously	O
traveled	O
to	O
Dubai	S-Location
,	O
.	O

•	O
Carey	B-Person
Schwartz	E-Person
a	O
program	O
manager	O
in	O
the	O
Information	B-Organization
Innovation	I-Organization
Office	E-Organization
,	O
will	O
focus	O
on	O
the	O
information	O
analytics	O
element	O
of	O
.	O

During	O
the	O
early	O
stages	O
of	O
the	O
outbreak	O
,	O
the	O
number	O
of	O
cases	O
doubled	O
approximately	O
every	O
seven	O
and	O
a	O
half	O
days	O
.	O

TOM	B-Person
FRIEDEN	E-Person
We	O
wish	O
we	O
didn't	O
have	O
to	O
do	O
research	O
like	O
this	O
.	O

The	O
material	O
was	O
on	O
a	O
sealed	O
plate	O
but	O
should	O
not	O
have	O
been	O
moved	O
into	O
the	O
BSL‐2	S-Platform
laboratory	O
.	O

Defecting	O
Soviet	O
bioweaponeers	O
such	O
as	O
Colonel	B-Person
Kanatjan	I-Person
Alibekov	E-Person
confirmed	O
that	O
the	O
program	O
had	O
been	O
massive	O
and	O
still	O
existed	O
.	O

In	O
some	O
places	O
affected	O
by	O
the	O
outbreak	O
,	O
care	O
may	O
have	O
been	O
provided	O
in	O
clinics	O
with	O
limited	O
resources	O
,	O
and	O
workers	O
could	O
be	O
in	O
these	O
areas	O
for	O
several	O
hours	O
with	O
a	O
number	O
of	O
Ebola	S-Disease
infected	O
patients	O
.	O

In	O
response	O
to	O
the	O
criticisms	O
,	O
Director-General	O
Tedros	S-Person
has	O
stated	O
that	O
China	S-Location
"	O
doesn't	O
need	O
to	O
be	O
asked	O
to	O
be	O
praised	O
.	O

However	O
,	O
there	O
have	O
been	O
credible	O
concerns	O
that	O
some	O
countries	O
used	O
it	O
to	O
create	O
bioweapons	O
.	O

PRESAGED	S-Technology
has	O
also	O
been	O
shown	O
to	O
provide	O
early	O
warning	O
on	O
exposure	O
to	O
entirely	O
novel	O
pathogens	O
(i.e.	O
,	O
pathogens	O
unavailable	O
for	O
algorithm	O
training)	O
,	O
suggesting	O
that	O
this	O
approach	O
will	O
be	O
robust	O
in	O
detecting	O
emergent	O
diseases	O
,	O
such	O
as	O
SARS	S-Disease
/	O
or	O
novel	O
flu	O
strains	O
,	O
well	O
before	O
new	O
training	O
data	O
are	O
available	O
.	O

I	O
will	O
personally	O
track	O
the	O
implementation	O
of	O
these	O
plans	O
.	O

The	O
Epidemic	B-Organization
Intelligence	I-Organization
Service	E-Organization
(	O
EIS	S-Organization
)	O
is	O
composed	O
of	O
"	O
boots-on-the-ground	O
disease	O
detectives	O
"	O
who	O
investigate	O
public	O
health	O
problems	O
domestically	O
and	O
globally	O
.	O

Guillemin	S-Person
Jeanne	S-Person
.	O
Biological	O
Weapons	O
,	O
pp.	O
122–27	O
.	O

The	O
curve	O
of	O
influenza	S-Disease
deaths	O
by	O
age	O
at	O
death	O
has	O
historically	O
,	O
for	O
at	O
least	O
150	O
years	O
,	O
been	O
U-shaped	O
(Figure	O
2)	O
,	O
exhibiting	O
mortality	O
peaks	O
in	O
the	O
very	O
young	O
and	O
the	O
very	O
old	O
,	O
with	O
a	O
comparatively	O
low	O
frequency	O
of	O
deaths	O
at	O
all	O
ages	O
in	O
between	O
.	O

In	O
August	O
2018	O
,	O
the	O
WHO	S-Organization
evaluated	O
the	O
benefits	O
and	O
risks	O
of	O
drug	O
treatment	O
for	O
EVD	S-Disease
:	O
Remdesivir	S-Drug
,	O
ZMapp	S-Drug
,	O
REGN3470-3471-3479	S-Drug
,	O
mAb114	S-Drug
and	O
favipiravir	S-Drug
.	O
The	O
drug	O
mAb114	S-Drug
(which	O
is	O
a	O
monoclonal	O
antibody)	O
is	O
being	O
used	O
for	O
the	O
first	O
time	O
to	O
treat	O
infected	O
individuals	O
during	O
this	O
outbreak	O
.	O

Non-white	O
and	O
pregnant	O
patients	O
were	O
over-represented.	O
45%	O
of	O
patients	O
had	O
at	O
least	O
one	O
underlying	O
condition	O
,	O
main	O
ly	B-Disease
ast	E-Disease
hma	O
,	O
and	O
13%	O
received	O
antiviral	O
drugs	O
before	O
admission	O
.	O

If	O
scientists	O
are	O
looking	O
for	O
a	O
drug	O
that	O
turns	O
on	O
a	O
disease-causing	O
gene	O
,	O
they	O
can	O
use	O
a	O
synthetic	O
system	O
to	O
quickly	O
look	O
through	O
massive	O
numbers	O
of	O
chemicals	O
for	O
the	O
right	O
drug	O
,	O
and	O
the	O
one	O
that	O
works	O
will	O
light	O
up	O
the	O
cell	O
.	O

Rabobank	S-Organization
Mr	O
calls	O
their	O
current	O
trade	O
tensions	O
an	O
"	O
unwelcome	O
complication"	O
,	O
but	O
predicts	O
the	O
pork	O
shortage	O
could	O
lead	O
to	O
an	O
accelerated	O
deal	O
between	O
the	O
two	O
sides	O
.	O

And	O
I'm	O
wondering	O
if	O
you're	O
rethinking	O
that	O
now	O
.	O

Emma	B-Person
Yasinski	E-Person
,	O
The	O
Scientist.	O
21	O
October	O
2019	O
.	O

Water	O
has	O
an	O
attenuation	O
of	O
0	O
Hounsfield	O
units	O
(HU)	O
,	O
while	O
air	O
is	O
−1,000 HU	O
,	O
cancellous	O
bone	O
is	O
typically	O
+400 HU	O
,	O
and	O
cranial	O
bone	O
can	O
reach	O
2,000 HU	O
or	O
more	O
(os	O
temporale)	O
and	O
can	O
cause	O
artifacts	O
.	O

1986:	O
The	O
WHO	S-Organization
began	O
its	O
global	O
programme	O
on	O
HIV/AIDS	S-Disease
.	O
Two	O
years	O
later	O
preventing	O
discrimination	O
against	O
sufferers	O
was	O
attended	O
to	O
and	O
in	O
1996	O
was	O
formed	O
.	O

The	O
re-emergence	O
of	O
bioterrorism	O
as	O
a	O
threat	O
activity	O
of	O
individuals	O
or	O
small	O
groups	O
has	O
caused	O
a	O
heightened	O
awareness	O
of	O
biosecurity	O
and	O
improved	O
biosafety	O
.	O

Cunningham	S-Person
recalled	O
that	O
a	O
similar	O
letter	O
,	O
which	O
apparently	O
was	O
a	O
hoax	O
,	O
was	O
written	O
toward	O
the	O
end	O
of	O
the	O
1980-81	B-Incident
Medfly	I-Incident
infestation	E-Incident
in	O
.	O

On	O
11	O
June	O
2019	O
,	O
the	O
WHO	S-Organization
confirmed	O
that	O
a	O
five-year-old	O
boy	O
in	O
Uganda	S-Location
died	O
after	O
being	O
diagnosed	O
with	O
.	O

Why	O
Saddam	B-Person
Hussein	E-Person
did	O
not	O
use	O
these	O
biological	O
weapons	O
in	O
1991	O
is	O
unclear	O
,	O
but	O
the	O
presumption	O
has	O
been	O
that	O
he	O
was	O
concerned	O
about	O
provoking	O
massive	O
retaliation	O
.	O

Ishii	S-Person
had	O
wanted	O
to	O
use	O
biological	O
weapons	O
in	O
the	O
War	O
since	O
May	O
1944	O
,	O
but	O
his	O
attempts	O
were	O
repeatedly	O
snubbed	O
.	O

Jeffery	B-Person
Amherst	E-Person
ordered	O
that	O
blankets	O
and	O
handkerchiefs	O
be	O
taken	O
from	O
smallpox	S-Pathogen
patients	O
in	O
the	O
fort's	O
infirmary	O
and	O
given	O
to	O
Indians	O
at	O
a	O
peace-making	O
parley	O
.	O

Procedures	O
used	O
in	O
two	O
of	O
the	O
three	O
involved	O
labs	O
also	O
may	O
have	O
aerosolized	O
the	O
anthrax	O
spores	O
(put	O
them	O
into	O
the	O
air)	O
.	O

Dr	O
.	O

And	O
this	O
is	O
part	O
of	O
the	O
work	O
that	O
we	O
do	O
in	O
public	O
health	O
to	O
maintain	O
safety	O
and	O
grow	O
with	O
the	O
science	O
so	O
that	O
we	O
can	O
assure	O
that	O
what	O
we	O
do	O
doesn't	O
harm	O
anybody	O
that's	O
doing	O
the	O
work	O
or	O
is	O
nearby	O
.	O

The	O
United	B-Location
States	E-Location
takes	O
biosafety	O
and	O
biosecurity	O
very	O
seriously	O
.	O

The	O
number	O
of	O
extra	O
hospital	O
days	O
was	O
2.5	O
million	O
.	O

Mukundan	S-Person
called	O
the	O
partnership	O
"	O
a	O
technology	O
exchange,	O
"	O
noting	O
that	O
seven	O
Los	B-Organization
Alamos	E-Organization
researchers	O
attended	O
a	O
mini-symposium	O
in	O
Omaha	S-Location
,	O
and	O
that	O
the	O
collaboration	O
also	O
would	O
feature	O
a	O
variety	O
of	O
opportunities	O
for	O
Nebraska	S-Location
students	O
to	O
participate	O
in	O
internships	O
at	O
.	O

Biological	O
agent	O
biodefense	O
categorization	O
is	O
not	O
as	O
common	O
as	O
laboratory	O
biosafety	O
categorization	O
,	O
mainly	O
having	O
been	O
defined	O
by	O
the	O
US	B-Organization
CDC	E-Organization
the	O
EU	S-Location
and	O
Russia	S-Location
.	O
Unlike	O
laboratory	O
biosafety	O
criteria	O
,	O
not	O
all	O
agents	O
are	O
divided	O
into	O
four	O
groups	O
.	O

When	O
the	O
two	O
scientists	O
began	O
sharing	O
their	O
work	O
,	O
they	O
realized	O
that	O
they	O
could	O
use	O
the	O
sticky	O
ends	O
to	O
put	O
new	O
pieces	O
of	O
DNA	O
into	O
the	O
plasmids	O
that	O
Cohen	S-Person
was	O
studying	O
.	O

Safe	O
burial	O
teams	O
formed	O
by	O
healthworkers	O
are	O
subject	O
to	O
suspicion	O
.	O

The	O
illness	O
is	O
characterized	O
with	O
a	O
high	O
temperature	B-Phenotype
of	I-Phenotype
about	I-Phenotype
39°C	E-Phenotype
hematemesis	S-Phenotype
,	O
diarrhea	B-Phenotype
with	I-Phenotype
blood	E-Phenotype
,	O
,	O
prostration	O
with	O
"	O
heavy"	O
articulations	O
,	O
and	O
rapid	O
evolution	O
death	O
after	O
a	O
mean	O
of	O
three	O
days	O
.	O

In	O
addition	O
to	O
the	O
agents	O
that	O
were	O
ready	O
to	O
be	O
used	O
,	O
the	O
U.S.	S-Location
program	O
conducted	O
research	O
into	O
the	O
weaponization	O
of	O
more	O
than	O
20	O
other	O
agents	O
.	O

Some	O
foreign	O
mining	O
companies	O
withdrew	O
all	O
non-essential	O
personnel	O
,	O
deferred	O
new	O
investment	O
,	O
and	O
cut	O
back	O
operations	O
.	O

A	O
pneumonia	S-Disease
cluster	O
of	O
unknown	O
cause	O
was	O
observed	O
on	O
26	O
December	O
and	O
treated	O
by	O
the	O
doctor	O
Zhang	B-Person
Jixian	E-Person
in	O
Hubei	B-Organization
Provincial	I-Organization
Hospital	E-Organization
,	O
who	O
informed	O
the	O
Wuhan	B-Organization
Jianghan	I-Organization
CDC	E-Organization
on	O
27	O
December	O
.	O

This	O
is	O
because	O
the	O
construction	O
of	O
the	O
centre	O
was	O
funded	O
by	O
the	O
Defence	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
which	O
is	O
an	O
agency	O
within	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
founded	O
in	O
October	O
1	O
,	O
1998	O
.	O

They	O
did	O
not	O
carry	O
out	O
the	O
second	O
part	O
of	O
the	O
plan	O
.	O

Our	O
scientists	O
go	O
anywhere	O
in	O
the	O
world	O
at	O
a	O
moment's	O
notice	O
to	O
stop	O
an	O
outbreak	O
.	O

The	O
most	O
important	O
development	O
with	O
an	O
international	O
impact	O
was	O
initiated	O
in	O
1979	O
by	O
the	O
World	B-Organization
Health	I-Organization
Organisation	E-Organization
(	O
WHO	S-Organization
)	O
,	O
which	O
set	O
up	O
a	O
Working	O
Group	O
within	O
a	O
special	O
programme	O
on	O
safety	O
measures	O
in	O
microbiology	O
.	O

Safety	O
precautions	O
for	O
handling	O
micro-organisms	O
of	O
different	O
risk	O
classes	O
Appl	O
.	O

Following	O
these	O
incidents	O
,	O
the	O
CDC	O
established	O
an	O
External	O
Laboratory	O
Safety	O
Workgroup	O
(	O
ELSW	S-Organization
and	O
suggestions	O
have	O
been	O
made	O
to	O
reform	O
effectiveness	O
of	O
the	O
.	O

1973:	O
A	O
"	O
civilian"	O
main	O
directorate	O
Biopreparat	S-Organization
was	O
founded	O
.	O

The	O
new	O
and	O
upcoming	O
GM	S-Technology
crops	O
carrying	O
multiple	O
stacked	O
traits	O
likely	O
to	O
be	O
commercialized	O
soon	O
warrant	O
sensitive	O
detection	O
methods	O
both	O
at	O
the	O
DNA	O
and	O
protein	O
levels	O
.	O

It	O
is	O
estimated	O
that	O
around	O
80%	O
of	O
the	O
Hong	B-Location
Kong	E-Location
cases	O
were	O
due	O
to	O
Liu	S-Person
.	O
Khan	S-Person
,	O
Ali	B-Person
S.	E-Person
&a	O
mp;	B-Person
Pat	E-Person
ri	O
ck,	B-Person
Wil	E-Person
liam.(2016).	O
"	O
The	O
Next	O
Pandemic	O
.	O
"	O
New	O
Yoairs	O
.	O

On	O
24	O
April	O
,	O
the	O
Hong	B-Organization
Kong	I-Organization
Government	E-Organization
announced	O
an	O
HK$11.8 billion	O
relief	O
package	O
designed	O
to	O
assist	O
's	O
battered	O
tourism	O
,	O
entertainment	O
,	O
retail	O
,	O
and	O
catering	O
sectors	O
,	O
consisting	O
of	O
a	O
waiver	O
of	O
tourism-	O
and	O
transport-related	O
license	O
fees	O
,	O
and	O
HK$1 billion	O
allocated	O
for	O
tourism	O
promotion	O
overseas	O
.	O

However	O
,	O
the	O
project	O
may	O
be	O
"	O
widely	O
perceived	O
as	O
an	O
effort	O
to	O
develop	O
biological	O
agents	O
for	O
hostile	O
purposes	O
and	O
their	O
means	O
of	O
delivery	O
,	O
which	O
--	O
if	O
true	O
--	O
would	O
constitute	O
a	O
breach	O
of	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
writes	O
Guy	B-Person
Reeves	E-Person
,	O
a	O
geneticist	O
at	O
the	O
,	O
and	O
his	O
co-authors	O
in	O
an	O
editorial	O
published	O
Thursday	O
in	O
the	O
journal	O
Science	O
.	O

•	O
Rohit	B-Person
Chitale	E-Person
is	O
a	O
program	O
manager	O
in	O
the	O
Biological	B-Organization
Technologies	I-Organization
Office	E-Organization
.	O
His	O
focus	O
in	O
is	O
biological-agent	O
detection	O
sensors	O
and	O
rapid-diagnostics	O
technologies	O
.	O

"	O
I	O
wouldn't	O
be	O
sitting	O
here	O
testifying	O
today	O
without	O
it,	O
"	O
Redd	S-Person
said	O
.	O

OPERATOR:	O
On	O
the	O
phone	O
lines	O
again	O
if	O
you'd	O
like	O
to	O
ask	O
a	O
question	O
,	O
just	O
press	O
star-1	O
.	O

There	O
are	O
a	O
number	O
of	O
reasons	O
for	O
this	O
including:	O
legal	O
concerns	O
,	O
financial	O
incentives	O
,	O
and	O
desire	O
by	O
the	O
public	O
.	O

A	O
number	O
of	O
Ebola	B-Organization
Treatment	I-Organization
Centres	E-Organization
were	O
set	O
up	O
in	O
the	O
area	O
,	O
supported	O
by	O
international	B-Organization
aid	I-Organization
organisations	E-Organization
and	O
staffed	O
by	O
a	O
combination	O
of	O
local	O
and	O
international	O
staff	O
.	O

With	O
a	O
view	O
to	O
initiating	O
a	O
Nordic	O
network	O
for	O
cross-sector	O
collaboration	O
,	O
one	O
FBD	S-Platform
project	O
established	O
contact	O
with	O
the	O
corresponding	O
agencies	O
in	O
the	O
other	O
Nordic	O
countries	O
(	O
Denmark	S-Location
,	O
Finland	S-Location
,	O
Iceland	S-Location
,	O
and	O
Norway	S-Location
)	O
.	O

Awards	O
totaling	O
$5,395,838	O
were	O
made	O
to	O
the	O
11	O
research	O
and	O
2	O
conference	O
proposals	O
that	O
were	O
highly	O
ranked	O
.	O

The	O
discussion	O
draft	O
also	O
would	O
fund	O
SNS	S-Platform
with	O
$610	O
million	O
a	O
year	O
"	O
in	O
order	O
to	O
keep	O
the	O
authorized	O
level	O
consistent	O
with	O
what	O
we've	O
currently	O
appropriated,	O
"	O
the	O
congresswoman	O
said	O
.	O

The	O
researcher	O
was	O
likely	O
exposed	O
through	O
an	O
open	O
wound	O
.	O

Other	O
solutions	O
,	O
such	O
as	O
benzalkonium	O
chloride	O
and	O
chlorhexidine	O
gluconate	O
,	O
are	O
less	O
effective	O
.	O

These	O
companies	O
do	O
not	O
currently	O
have	O
these	O
assurances	O
because	O
much	O
of	O
this	O
federal	O
research	O
funding	O
is	O
allocated	O
on	O
an	O
annual	O
basis	O
,	O
dissuading	O
companies	O
from	O
taking	O
risks	O
in	O
drug	O
development	O
,	O
said	O
.	O

OPERATOR:	O
Thank	O
you	O
.	O

Some	O
people	O
spend	O
hundreds	O
of	O
thousands	O
of	O
dollars	O
on	O
these	O
treatments	O
.	O

The	O
WHO	S-Organization
stated	O
that	O
he	O
died	O
in	O
a	O
treatment	O
centre	O
,	O
whereas	O
according	O
to	O
Reuters	S-Organization
he	O
died	O
en	O
route	O
to	O
a	O
treatment	O
centre	O
.	O

Claire	B-Person
McCaskill	E-Person
told	O
reporters	O
after	O
a	O
briefing	O
for	O
lawmakers	O
that	O
a	O
suspect	O
has	O
already	O
been	O
identified	O
in	O
the	O
incident	O
,	O
but	O
a	O
knowledgeable	O
source	O
said	O
no	O
one	O
was	O
in	O
custody	O
Tuesday	O
night	O
.	O

between	O
43 million	O
and	O
89 million	O
cases	O
of	O
2009	B-Disease
H1N1	E-Disease
occurred	O
between	O
April	O
2009	O
and	O
10	O
April	O
2010	O
.	O

Therefore	O
,	O
only	O
a	O
minority	O
of	O
the	O
infected	O
persons	O
will	O
die	O
from	O
an	O
anthrax	S-Pathogen
attack	O
in	O
most	O
instances	O
,	O
as	O
has	O
been	O
shown	O
by	O
.	O

Speaking	O
from	O
a	O
remote	O
region	O
,	O
an	O
MSF	S-Organization
worker	O
said	O
that	O
a	O
shortage	O
of	O
was	O
making	O
the	O
medical	O
management	O
of	O
the	O
disease	O
difficult	O
and	O
that	O
they	O
had	O
limited	O
capacity	O
to	O
safely	O
bury	O
bodies	O
.	O

Similarly	O
,	O
the	O
development	O
of	O
a	O
bioweapon	O
does	O
not	O
necessarily	O
require	O
genetic	B-Pathogen
engineering-smallpox	E-Pathogen
,	O
plague	S-Pathogen
and	O
are	O
deadly	O
enough	O
in	O
their	O
natural	O
states	O
.	O

The	O
company	O
was	O
also	O
a	O
prime	O
Pentagon	S-Organization
contractor	O
in	O
the	O
past	O
under	O
the	O
for	O
research	O
and	O
development	O
of	O
bio-agents	O
with	O
16	O
contracts	O
between	O
1951	O
and	O
1962	O
.	O

The	O
team	O
says	O
the	O
strain	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
appears	O
to	O
have	O
been	O
unusually	O
potent	O
and	O
even	O
sickened	O
seven	O
people	O
vaccinated	O
against	O
the	O
disease	O
.	O

Frieden	S-Person
halted	O
transfer	O
of	O
all	O
biological	O
materials	O
from	O
CDC	S-Organization
laboratories	O
in	O
response	O
to	O
incidents	O
in	O
which	O
CDC	S-Organization
employees	O
might	O
have	O
been	O
exposed	O
to	O
viable	O
anthrax	S-Pathogen
and	O
in	O
which	O
a	O
highly	O
pathogenic	O
influenza	O
virus	O
contaminated	O
a	O
low	O
pathogenic	O
influenza	O
virus	O
sample	O
sent	O
to	O
a	O
Department	B-Organization
of	I-Organization
Agriculture	I-Organization
high-containment	I-Organization
lab	E-Organization
.	O
While	O
there	O
appear	O
to	O
have	O
been	O
neither	O
human	O
exposures	O
nor	O
illness	O
as	O
a	O
result	O
of	O
these	O
incidents	O
,	O
immediately	O
undertook	O
a	O
series	O
of	O
remedial	O
actions	O
.	O

While	O
the	O
nation	O
has	O
become	O
better	O
prepared	O
over	O
the	O
last	O
century	O
in	O
some	O
respects	O
,	O
such	O
as	O
by	O
being	O
able	O
to	O
disperse	O
vaccines	O
to	O
states	O
from	O
the	O
Strategic	B-Platform
National	I-Platform
Stockpile	E-Platform
within	O
12	O
hours	O
and	O
in	O
speeding	O
federal	O
approvals	O
for	O
new	O
medical	O
countermeasures	O
to	O
combat	O
anthrax	S-Disease
,	O
for	O
example	O
,	O
"	O
our	O
track	O
record	O
is	O
far	O
from	O
perfect,	O
"	O
Sen.	O
said	O
.	O

On	O
16	O
March	O
2020	O
,	O
the	O
first	B-Incident
clinical	I-Incident
trial	I-Incident
of	I-Incident
a	I-Incident
vaccine	I-Incident
started	I-Incident
with	I-Incident
four	I-Incident
volunteers	E-Incident
in	O
Seattle	S-Location
,	O
Washington	S-Location
,	O
.	O
The	O
vaccine	O
contains	O
a	O
harmless	O
genetic	O
code	O
copied	O
from	O
the	O
virus	O
that	O
causes	O
the	O
disease	O
.	O

Data	O
are	O
integrated	O
using	O
semantic	O
web	O
methods	O
like	O
RDF	O
describing	O
the	O
connection	O
of	O
uniform	O
resource	O
identifiers	O
(URIs)	O
in	O
combination	O
with	O
SQL	O
functionality	O
.	O

On	O
July	O
1	O
,	O
2014	O
,	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
(	O
NIH	S-Organization
)	O
notified	O
the	O
appropriate	O
regulatory	O
agency	O
,	O
the	O
Division	B-Organization
of	I-Organization
Select	I-Organization
Agents	I-Organization
and	I-Organization
Toxins	E-Organization
(	O
DSAT	S-Organization
)	O
of	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
,	O
that	O
employees	O
discovered	O
vials	O
labeled	O
"	O
variola	S-Disease
,	O
"	O
commonly	O
known	O
as	O
smallpox	S-Disease
,	O
in	O
an	O
unused	O
portion	O
of	O
a	O
storage	O
room	O
in	O
a	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
laboratory	O
located	O
on	O
the	O
.	O

The	O
Pentagon	S-Organization
has	O
been	O
granted	O
access	O
to	O
certain	O
state	O
secrets	O
of	O
in	O
connection	O
with	O
the	O
projects	O
under	O
their	O
agreement	O
.	O

On	O
multiple	O
occasions	O
Taiwanese	O
journalists	O
have	O
been	O
denied	O
access	O
to	O
report	O
on	O
the	O
assembly	O
.	O

Another	O
patient	O
who	O
had	O
been	O
in	O
Guys	B-Organization
and	I-Organization
St	I-Organization
Thomas	I-Organization
hospital	E-Organization
in	O
the	O
UK	S-Location
since	O
September	O
2012	O
after	O
visiting	O
the	O
Middle	B-Location
East	E-Location
died	O
on	O
28	O
June	O
2013	O
.	O

In	O
light	O
of	O
this	O
incident	O
,	O
all	O
known	O
stocks	O
of	O
smallpox	S-Pathogen
were	O
destroyed	O
or	O
transferred	O
to	O
one	O
of	O
two	O
WHO	S-Organization
reference	O
laboratories	O
which	O
had	O
BSL-4	S-Platform
facilities:	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
in	O
the	O
United	B-Location
States	E-Location
and	O
the	O
State	B-Organization
Research	I-Organization
Center	I-Organization
of	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	I-Organization
VECTOR	E-Organization
in	O
Koltsovo	S-Location
,	O
.	O

1973:	O
A	O
"	O
civilian"	O
main	O
directorate	O
Biopreparat	S-Organization
was	O
founded	O
.	O

The	O
moratorium	O
will	O
remain	O
in	O
place	O
pending	O
lab-by-lab	O
review	O
of	O
policies	O
and	O
procedures	O
for	O
laboratory	O
safety	O
and	O
security	O
.	O

This	O
turned	O
the	O
bacteria	O
into	O
tiny	O
insulin	O
factories	O
.	O

The	O
DOI	O
minting	O
procedure	O
will	O
be	O
best	O
integrated	O
into	O
data	O
publishing	O
software	O
in	O
order	O
to	O
keep	O
references	O
to	O
data	O
up-to-date	O
and	O
thus	O
will	O
be	O
useful	O
functionality	O
for	O
systems	O
biology	O
data	O
management	O
.	O

Grafton	O
Books	O
,	O
p.44	O
.	O

Whole	O
communities	O
have	O
disappeared	O
but	O
many	O
of	O
them	O
are	O
not	O
in	O
the	O
statistics.	O
"	O
In	O
mid-November	O
the	O
WHO	S-Organization
reported	O
that	O
,	O
while	O
there	O
was	O
some	O
evidence	O
that	O
the	O
number	O
of	O
cases	O
were	O
no	O
longer	O
rising	O
in	O
Guinea	S-Location
and	O
Liberia	S-Location
,	O
steep	O
increases	O
persisted	O
in	O
.	O

Special	O
munitions	O
for	O
the	O
United	B-Organization
States	I-Organization
Special	I-Organization
Forces	E-Organization
and	O
the	O
CIA	S-Organization
and	O
the	O
Big	B-Organization
Five	I-Organization
Weapons	E-Organization
for	O
the	O
military	O
were	O
destroyed	O
in	O
accordance	O
with	O
Nixon's	O
executive	O
order	O
to	O
end	O
the	O
offensive	O
program	O
.	O

The	O
late	O
Joshua	B-Person
Lederberg	E-Person
observed	O
that	O
"	O
barring	O
geno-suicide	O
,	O
human	O
domination	O
is	O
challenged	O
only	O
by	O
pathogenic	O
microbes	O
,	O
for	O
which	O
we	O
are	O
the	O
prey	O
,	O
they	O
are	O
the	O
predators	O
.	O

Several	O
variants	O
of	O
CRISPR-Cas9	S-Technology
allow	O
gene	B-Technology
activation	E-Technology
or	O
genome	B-Technology
editing	E-Technology
with	O
an	O
external	O
trigger	O
such	O
as	O
light	O
or	O
small	O
molecules	O
.	O

Still	O
experiencing	O
the	O
same	O
symptoms	O
,	O
on	O
26	O
August	O
he	O
was	O
referred	O
to	O
a	O
specialised	O
facility	O
for	O
infectious	O
diseases	O
,	O
and	O
subsequently	O
hospitalised	O
.	O

It	O
is	O
particularly	O
relevant	O
here	O
because	O
normal	O
two-dimensional	O
X-rays	O
do	O
not	O
show	O
such	O
defects	O
.	O

Martin	S-Person
,	O
Op.cit	O
.	O

Identifying	O
training	O
and	O
oversight	O
needs	O
to	O
promote	O
and	O
sustain	O
a	O
culture	O
of	O
laboratory	O
safety	O
at	O
CDC	S-Organization

Once	O
a	O
new	O
method	O
has	O
been	O
implemented	O
,	O
it	O
is	O
still	O
a	O
challenge	O
for	O
each	O
agency	O
to	O
maintain	O
the	O
relevant	O
competence	O
over	O
time	O
for	O
those	O
methods	O
that	O
are	O
infrequently	O
used	O
,	O
especially	O
in	O
slimmed	O
down	O
organizations	O
.	O

If	O
the	O
lifetime	O
risk	O
of	O
developing	O
cancer	O
is	O
40%	O
then	O
the	O
absolute	O
risk	O
rises	O
to	O
40.	O
05%	O
after	O
a	O
.	O

Critics	O
contend	O
that	O
this	O
contributes	O
to	O
the	O
development	O
of	O
antibiotic	O
resistance	O
and	O
have	O
called	O
on	O
the	O
FDA	S-Organization
to	O
address	O
the	O
loophole	O
.	O

The	O
use	O
of	O
protective	O
clothing	O
such	O
as	O
buttoned	O
labcoats	O
or	O
back‐closing	O
gowns	O
and	O
gloves	O
are	O
commonplace	O
in	O
today's	O
research	O
laboratory	O
.	O

This	O
interaction	O
has	O
been	O
productive	O
and	O
useful	O
for	O
many	O
years	O
,	O
allowing	O
college	O
undergraduates	O
to	O
meet	O
graduate	O
students	O
from	O
advanced	O
research	O
programs	O
during	O
their	O
studies	O
.	O

The	O
alert	O
prompted	O
testing	O
for	O
Ebola	S-Disease
at	O
the	O
Dakar	B-Organization
laboratory	E-Organization
,	O
and	O
the	O
positive	O
result	O
launched	O
an	O
investigation	O
,	O
triggering	O
urgent	O
contact	O
tracing	O
.	O

The	O
incident	O
was	O
the	O
single	O
largest	O
bioterrorist	O
attack	O
in	O
United	O
States	O
history	O
.	O

Nicholas	B-Person
D.	I-Person
Kristof	E-Person
New	B-Location
York	E-Location
Times	O
,	O
March	O
17	O
,	O
1995.	O
"	O
Unmasking	O
Horror:	O
A	O
special	O
report	O
.	O

On	O
January	O
4	O
,	O
2004	O
new	O
federal	O
transportation	O
rules	O
took	O
effect	O
which	O
directly	O
affected	O
the	O
over-the-road	O
trucking	O
industry	O
in	O
the	O
United	O
States	O
.	O

Remdesivir	S-Drug
is	O
a	O
ProTide	O
(Prodrug	O
of	O
nucleoTide)	O
that	O
is	O
able	O
to	O
diffuse	O
into	O
cells	O
where	O
it	O
is	O
converted	O
to	O
GS-441524	O
mono-phosphate	O
via	O
the	O
actions	O
of	O
esterases	O
and	O
a	O
phosphoramidase	O
;	O
this	O
in	O
turn	O
is	O
further	O
phosphorylated	O
to	O
its	O
active	O
metabolite	O
triphosphate	O
by	O
nucleoside-phosphate	O
kinases	O
.	O

As	O
of	O
7May	O
,	O
in	O
New	B-Location
York	I-Location
City	E-Location
with	O
a	O
population	O
of	O
8.	O
4 million	O
,	O
14,162	O
have	O
died	O
from	O
COVID-19	S-Disease
(0.	O
17%	O
of	O
the	O
population)	O
.	O

Corina	S-Person
can	O
also	O
be	O
found	O
walking	O
the	O
freezing	O
cold	O
streets	O
of	O
Berlin	S-Location
with	O
bare	O
legs	O
.	O

When	O
BSL‐3	S-Platform
conditions	O
are	O
appropriate	O
due	O
to	O
the	O
use	O
of	O
human‐derived	O
materials	O
,	O
the	O
following	O
note	O
is	O
included	O
in	O
the	O
introduction	O
.	O

WHO	S-Organization
is	O
closely	O
monitoring	O
the	O
situation	O
and	O
is	O
in	O
close	O
contact	O
with	O
national	O
authorities	O
in	O
.	O

JASON	S-Organization
is	O
an	O
independent	O
scientific	O
advisory	O
group	O
that	O
provides	O
consulting	O
services	O
to	O
the	O
U.S.	B-Organization
government	E-Organization
on	O
matters	O
of	O
defense	O
science	O
and	O
technology	O
.	O

This	O
ancestor	O
virus	O
diverged	O
about	O
1913–1915	O
into	O
two	O
clades	O
(or	O
biological	O
groups)	O
,	O
which	O
gave	O
rise	O
to	O
the	O
classical	O
swine	O
and	O
human	O
H1N1	B-Disease
influenza	E-Disease
lineages	O
.	O

The	O
argument	O
for	O
the	O
Observatory	S-Scientific_research_project
is	O
that	O
anecdotal	O
information	O
gathered	O
from	O
outbreaks	O
as	O
they	O
occur	O
will	O
not	O
only	O
,	O
as	O
a	O
feedback	O
loop	O
,	O
improve	O
minute-to-minute	O
preparedness	O
,	O
but	O
it	O
could	O
shape	O
public	O
policy	O
and	O
public	O
perception	O
.	O

GlobalMed	S-Organization
ATO	O
certification	O
was	O
granted	O
on	O
November	O
18	O
,	O
2017	O
.	O

"	O
I'm	O
confident	O
that	O
efforts	O
we're	O
launching	O
today-and	O
the	O
ones	O
that	O
we'll	O
continue	O
in	O
the	O
months	O
and	O
years	O
to	O
come-will	O
help	O
us	O
achieve	O
our	O
goal	O
of	O
facilitating	O
stewardship	O
and	O
advancing	O
innovation	O
across	O
human	O
and	O
animal	O
health	O
,	O
within	O
our	O
borders	O
and	O
across	O
them,	O
"	O
Gottlieb	S-Person
said	O
.	O

On	O
9	O
June	O
,	O
the	O
flare-up	O
was	O
declared	O
over	O
,	O
and	O
the	O
country	O
Ebola	S-Disease
-free	O
,	O
due	O
to	O
the	O
passage	O
of	O
the	O
42-day	O
period	O
;	O
Liberia	S-Location
then	O
entered	O
a	O
90-day	O
period	O
of	O
heightened	O
surveillance	O
,	O
which	O
ended	O
on	O
7	O
September	O
2016	O
.	O

In	O
2016	O
,	O
sick	O
of	O
suffering	O
from	O
severe	O
stomach	B-Phenotype
pain	E-Phenotype
decided	O
to	O
give	O
himself	O
a	O
fecal	O
transplant	O
in	O
a	O
hotel	O
room	O
.	O

For	O
example	O
,	O
nearly	O
all	O
insulin	O
used	O
in	O
treating	O
today	O
is	O
produced	O
recombinantly	O
.	O

By	O
1351	O
,	O
60	O
major	O
and	O
150	O
smaller	O
Jewish	O
communities	O
had	O
been	O
destroyed.	O
"	O
Jewish	O
History	O
1340–1349	O
"	O
.	O
During	O
this	O
period	O
many	O
Jews	O
relocated	O
to	O
Poland	S-Location
,	O
where	O
they	O
received	O
a	O
warm	O
welcome	O
from	O
.	O

Disinfectants	O
or	O
bleach	O
are	O
not	O
a	O
treatment	O
for	O
COVID‑19	S-Disease
and	O
cause	O
health	O
problems	O
when	O
not	O
used	O
properly	O
,	O
such	O
as	O
when	O
used	O
inside	O
the	O
human	O
body	O
.	O

The	O
microscopic	O
spores	O
could	O
be	O
put	O
into	O
powders	O
,	O
sprays	O
,	O
food	O
,	O
and	O
water	O
.	O

In	O
a	O
press	O
release	O
from	O
USAMRIID	S-Organization
issued	O
Friday	O
,	O
said	O
that	O
the	O
institute	O
will	O
resume	O
work	O
in	O
a	O
"	O
stepwise"	O
fashion	O
.	O

There	O
is	O
also	O
possible	O
periarticular	B-Disease
tenosynovitis	E-Disease
affecting	O
the	O
shoulders	O
.	O

On	O
17	O
February	O
the	O
WHO	S-Organization
indicated	O
that	O
2,600	O
survivors	O
had	O
accessed	O
health	O
assessments	O
and	O
eye	O
examinations	O
.	O

We	O
also	O
completed	O
a	O
biosecurity	O
assessment	O
of	O
the	O
Malian	B-Organization
high	I-Organization
containment	I-Organization
laboratory	E-Organization
that	O
processes	O
Ebola	S-Pathogen
samples	O
,	O
and	O
will	O
soon	O
support	O
this	O
lab	O
in	O
bolstering	O
its	O
security	O
measures	O
.	O

Also	O
,	O
only	O
5	O
(2.	O
6%)	O
laboratories	O
had	O
waste	B-Equipment
container	I-Equipment
chemical	I-Equipment
materials	E-Equipment
and	O
4	O
(2.	O
1)	O
had	O
.	O

Travel	O
to	O
and	O
from	O
Aralsk	S-Location
was	O
stopped	O
,	O
and	O
many	O
homes	O
were	O
disinfected	O
,	O
along	O
with	O
18	O
metric	O
tons	O
of	O
household	O
goods	O
.	O

These	O
combinations	O
of	O
practices	O
,	O
safety	O
equipment	O
,	O
and	O
facilities	O
are	O
designated	O
Animal	O
Biosafety	O
Levels	O
1	O
,	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
and	O
provide	O
increasing	O
levels	O
of	O
protection	O
to	O
personnel	O
and	O
the	O
environment	O
.	O

On	O
28	O
February	O
,	O
Scope	B-Organization
Ratings	I-Organization
GmbH	E-Organization
affirmed	O
's	O
sovereign	O
credit	O
rating	O
but	O
maintained	O
a	O
Negative	O
Outlook	O
.	O

In	O
July	O
2014	O
,	O
the	O
WHO	S-Organization
convened	O
an	O
emergency	O
meeting	O
of	O
health	O
ministers	O
from	O
eleven	O
countries	O
and	O
announced	O
collaboration	O
on	O
a	O
strategy	O
to	O
co-ordinate	O
technical	O
support	O
to	O
combat	O
the	O
epidemic	O
.	O

Archaeologist	O
Barney	B-Person
Sloane	E-Person
has	O
argued	O
that	O
there	O
is	O
insufficient	O
evidence	O
of	O
the	O
extinction	O
of	O
numerous	O
rats	O
in	O
the	O
archaeological	O
record	O
of	O
the	O
medieval	O
waterfront	O
in	O
London	S-Location
and	O
that	O
the	O
plague	S-Disease
spread	O
too	O
quickly	O
to	O
support	O
the	O
thesis	O
that	O
Y.	B-Pathogen
pestis	E-Pathogen
was	O
spread	O
from	O
fleas	O
on	O
rats	O
;	O
he	O
argues	O
that	O
transmission	O
must	O
have	O
been	O
person	O
to	O
person	O
.	O

A	O
third	O
letter	O
mailed	O
to	O
a	O
Mississippi	S-Location
judge	O
,	O
Lee	B-Organization
County	I-Organization
Justice	I-Organization
Court	E-Organization
Judge	O
Sadie	B-Person
Holland	E-Person
,	O
that	O
was	O
received	O
and	O
opened	O
on	O
April	O
10	O
,	O
contained	O
similar	O
language	O
and	O
was	O
sent	O
for	O
testing	O
.	O

The	O
virus	O
has	O
been	O
found	O
in	O
American	O
hogs	O
,	O
and	O
Canadian	O
as	O
well	O
as	O
in	O
hogs	O
in	O
Northern	B-Location
Ireland	E-Location
,	O
Argentina	S-Location
,	O
and	O
Norway	S-Location
.	O
Leading	O
health	O
agencies	O
and	O
the	O
have	O
stressed	O
that	O
eating	O
properly	O
cooked	O
pork	O
or	O
other	O
food	O
products	O
derived	O
from	O
pigs	O
will	O
not	O
cause	O
flu	O
.	O

Most	O
influenza	S-Disease
outbreaks	O
disproportionately	O
kill	O
the	O
very	O
young	O
and	O
the	O
very	O
old	O
,	O
with	O
a	O
higher	O
survival	O
rate	O
for	O
those	O
in	O
between	O
,	O
but	O
the	O
Spanish	B-Incident
flu	I-Incident
pandemic	E-Incident
resulted	O
in	O
a	O
higher	O
than	O
expected	O
mortality	O
rate	O
for	O
young	O
adults	O
.	O

In	O
order	O
to	O
help	O
manage	O
panels	O
of	O
potential	O
survey	O
respondents	O
,	O
has	O
developed	O
a	O
dedicated	O
email	O
service	O
called	O
MailChimp	O
,	O
which	O
allows	O
for	O
targeted	O
delivery	O
of	O
survey	O
requests	O
for	O
participation	O
.	O

But	O
,	O
as	O
critics	O
pointed	O
out	O
,	O
the	O
technology	O
could	O
make	O
it	O
possible	O
to	O
produce	O
children	O
with	O
no	O
biological	O
parents	O
,	O
or	O
to	O
recreate	O
the	O
genome	O
of	O
another	O
human	O
,	O
like	O
making	O
cellular	O
replicas	O
of	O
Einstein.	O
"	O
To	O
create	O
a	O
human	O
genome	O
from	O
scratch	O
would	O
be	O
an	O
enormous	O
moral	O
gesture,	O
"	O
write	O
two	O
bioethicists	O
regarding	O
the	O
GP-Write	S-Activity
project	O
.	O

Whether	O
Asprey	S-Person
belongs	O
in	O
the	O
category	O
of	O
biohacker	O
,	O
is	O
unclear	O
.	O

Thus	O
,	O
one	O
major	O
reason	O
for	O
the	O
reluctance	O
to	O
share	O
data	O
before	O
publication	O
is	O
that	O
researchers	O
want	O
to	O
prevent	O
competitors	O
from	O
anticipating	O
publications	O
based	O
upon	O
their	O
data	O
.	O

The	O
second	O
wave	O
began	O
,	O
and	O
the	O
quickly	O
spread	O
around	O
the	O
world	O
again	O
.	O

The	O
group	O
is	O
currently	O
raising	O
money	O
to	O
establish	O
the	O
infrastructure	O
and	O
start	O
strain	O
analysis	O
,	O
and	O
is	O
seeking	O
additional	O
isolates	O
from	O
hospitals	O
,	O
clinical	O
labs	O
,	O
doctors	O
,	O
and	O
veterinarians	O
.	O

An	O
MRI	S-Technology
	S-Technology
is	O
a	O
particular	O
setting	O
of	O
radiofrequency	O
pulses	O
and	O
gradients	O
,	O
resulting	O
in	O
a	O
particular	O
image	O
appearance	O
.	O

The	O
E120	O
was	O
later	O
superseded	O
by	O
dry-type	O
agents	O
.	O

The	O
logo	O
of	O
the	O
features	O
the	O
Rod	O
of	O
Asclepius	O
as	O
a	O
symbol	O
for	O
healing	O
.	O

Small	O
outbreaks	O
occurred	O
in	O
Nigeria	S-Location
and	O
Mali	S-Location
,	O
and	O
secondary	O
infections	O
of	O
medical	O
workers	O
occurred	O
in	O
the	O
United	B-Location
States	E-Location
and	O
Spain	S-Location
.	O
In	O
addition	O
,	O
isolated	O
cases	O
were	O
recorded	O
in	O
Senegal	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
and	O
.	O

He	O
also	O
thinks	O
the	O
federal	O
government	O
hasn't	O
sufficiently	O
engaged	O
with	O
private	O
industry	O
on	O
biodefense	O
nor	O
invested	O
enough	O
resources	O
to	O
attract	O
the	O
industry's	O
best	O
and	O
brightest	O
to	O
work	O
for	O
Uncle	B-Person
Sam	E-Person
A	O
hybrid	O
of	O
academia	O
,	O
private	O
industry	O
and	O
other	O
key	O
stakeholders	O
should	O
be	O
involved	O
in	O
the	O
nation's	O
biodefense	O
preparedness	O
and	O
response	O
efforts	O
.	O

During	O
the	O
first	O
week	O
of	O
November	O
reports	O
told	O
of	O
a	O
worsening	O
situation	O
due	O
to	O
intense	O
transmission	O
in	O
Freetown	S-Location
According	O
to	O
the	O
Disaster	B-Organization
Emergency	I-Organization
Committee	E-Organization
,	O
food	O
shortages	O
resulting	O
from	O
aggressive	O
quarantines	O
were	O
making	O
the	O
situation	O
worse	O
,	O
and	O
on	O
4	O
November	O
media	O
reported	O
that	O
thousands	O
had	O
violated	O
quarantine	O
in	O
search	O
of	O
food	O
in	O
the	O
town	O
of	O
Kenema	S-Location
.	O
With	O
the	O
number	O
of	O
cases	O
continuing	O
to	O
increase	O
,	O
an	O
MSF	S-Organization
coordinator	O
described	O
the	O
situation	O
in	O
Sierra	B-Location
Leone	E-Location
as	O
"	O
catastrophic",	O
saying	O
,	O
"	O
there	O
are	O
several	O
villages	O
and	O
communities	O
that	O
have	O
been	O
basically	O
wiped	O
out ..	O
.	O

His	O
invention	O
is	O
highly	O
unusual	O
but	O
actually	O
seems	O
tame	O
in	O
comparison	O
with	O
Rich	B-Person
Lee	E-Person
a	O
40-year-old	O
cabinet-maker	O
from	O
St	B-Location
George	E-Location
,	O
in	O
the	O
US	S-Location
state	O
of	O
.	O

The	O
Shooter	B-Organization
Inquiry	E-Organization
found	O
that	O
Parker	S-Person
was	O
accidentally	O
exposed	O
to	O
a	O
strain	O
of	O
smallpox	B-Pathogen
virus	E-Pathogen
that	O
had	O
been	O
grown	O
in	O
a	O
research	O
laboratory	O
on	O
the	O
floor	O
below	O
her	O
workplace	O
at	O
the	O
University	B-Organization
of	I-Organization
Birmingham	I-Organization
Medical	I-Organization
School	E-Organization
.	O
Shooter	S-Organization
concluded	O
that	O
the	O
mode	O
of	O
transmission	O
was	O
most	O
likely	O
airborne	O
through	O
a	O
poorly	O
maintained	O
service	O
duct	O
between	O
the	O
two	O
floors	O
.	O

During	O
1347	O
,	O
the	O
disease	O
travelled	O
eastward	O
to	O
Gaza	S-Location
by	O
April	O
,	O
by	O
July	O
it	O
had	O
reached	O
Damascus	S-Location
,	O
and	O
in	O
October	O
plague	S-Disease
had	O
broken	O
out	O
in	O
Aleppo	S-Location
.	O
That	O
year	O
,	O
in	O
the	O
territory	O
of	O
modern	O
Lebanon	S-Location
,	O
Syria	S-Location
,	O
Israel	S-Location
,	O
and	O
Palestine	S-Location
,	O
the	O
cities	O
of	O
Ashkelon	S-Location
,	O
Acre	S-Location
,	O
Jerusalem	S-Location
,	O
Sidon	S-Location
,	O
and	O
Homs	S-Location
were	O
all	O
infected	O
.	O

Its	O
principles	O
apply	O
to	O
both	O
natural	O
and	O
man-made	O
epidemics	O
(bioterrorism)	O
.	O

"	O
The	O
reason	O
anthrax	S-Pathogen
has	O
been	O
the	O
biological	O
weapon	O
of	O
choice	O
is	O
not	O
for	O
its	O
mortality	O
rate	O
--	O
when	O
properly	O
weaponized	O
it	O
is	O
similar	O
to	O
Ebola	S-Pathogen
--	O
but	O
for	O
the	O
fact	O
that	O
it	O
is	O
exceptionally	O
hardy,	O
"	O
de	B-Person
Bretton-Gordon	E-Person
said.	O
"	O
can	O
and	O
will	O
survive	O
for	O
centuries	O
in	O
the	O
ground	O
,	O
enduring	O
frosts	O
,	O
extremes	O
of	O
temperature	O
,	O
wind	O
,	O
drought	O
and	O
rain	O
before	O
re-emerging.	O
"	O

Retroviruses	O
present	O
in	O
animal	O
genomes	O
could	O
harm	O
transplant	O
recipients	O
.	O

In	O
a	O
written	O
statement	O
,	O
the	O
lab	O
said	O
suits	O
are	O
replaced	O
regularly	O
.	O

Although	O
there	O
is	O
general	O
agreement	O
that	O
the	O
source	O
of	O
Parker	S-Person
's	O
infection	O
was	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
grown	O
at	O
the	O
Medical	O
School	O
laboratory	O
,	O
how	O
contracted	O
the	O
disease	O
remains	O
unknown	O
.	O

Numerous	O
factors	O
contribute	O
to	O
these	O
streaks:	O
undersampling	O
,	O
photon	O
starvation	O
,	O
motion	O
,	O
beam	O
hardening	O
,	O
and	O
Compton	O
scatter	O
.	O

Some	O
artists	O
have	O
explored	O
ways	O
to	O
continue	O
to	O
produce	O
and	O
share	O
work	O
over	O
the	O
internet	O
as	O
an	O
alternative	O
to	O
traditional	O
live	O
performance	O
,	O
such	O
as	O
live	O
streaming	O
concerts	O
or	O
creating	O
web-based	O
"	O
festivals"	O
for	O
artists	O
to	O
perform	O
,	O
distribute	O
,	O
and	O
publicise	O
their	O
work	O
.	O

In	O
May	O
2018	O
,	O
the	O
WHO	S-Organization
denied	O
access	O
to	O
its	O
annual	O
assembly	O
by	O
Taiwanese	O
media	O
reportedly	O
due	O
to	O
demands	O
from	O
China	S-Location
.	O
Later	O
in	O
May	O
172	O
members	O
of	O
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
wrote	O
to	O
the	O
Director	O
General	O
of	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
to	O
argue	O
for	O
Taiwan	S-Location
's	O
inclusion	O
as	O
an	O
observer	O
at	O
the	O
WHA	S-Organization
.	O
The	O
United	B-Location
States	E-Location
,	O
Japan	S-Location
,	O
Germany	S-Organization
,	O
and	O
Australia	S-Organization
all	O
support	O
Taiwan	S-Location
's	O
inclusion	O
in	O
.	O

As	O
the	O
DOI	O
infrastructure	O
for	O
data	O
is	O
just	O
in	O
the	O
process	O
of	O
being	O
established	O
,	O
none	O
of	O
the	O
systems	O
compared	O
here	O
have	O
special	O
support	O
for	O
data	O
DOIs	O
,	O
e.g.	O
using	O
DataCite	S-Organization
's	O
API	O
for	O
minting	O
DOIs	O
and	O
notifications	O
of	O
URL	O
changes	O
.	O

Wear	O
disposable	B-Equipment
gloves	E-Equipment
when	O
handling	O
viable	O
materials	O
.	O

Aside	O
from	O
electing	O
the	O
regional	O
director	O
,	O
the	O
regional	O
committee	O
is	O
also	O
in	O
charge	O
of	O
setting	O
the	O
guidelines	O
for	O
the	O
implementation	O
,	O
within	O
the	O
region	O
,	O
of	O
the	O
health	O
and	O
other	O
policies	O
adopted	O
by	O
the	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
.	O
The	O
regional	O
committee	O
also	O
serves	O
as	O
a	O
progress	O
review	O
board	O
for	O
the	O
actions	O
of	O
within	O
the	O
Region	O
.	O

While	O
modern	O
biotechnology	O
solutions	O
to	O
society's	O
problems	O
seem	O
much	O
more	O
sophisticated	O
than	O
airdropping	O
amphibians	O
into	O
Australia	S-Location
this	O
story	O
should	O
serve	O
as	O
a	O
cautionary	O
tale	O
.	O

As	O
researchers	O
Hoffman	S-Person
and	O
Rizvi	S-Person
report	O
"	O
As	O
of	O
July	O
4	O
,	O
2012	O
,	O
361	O
(32·7%)	O
of	O
1104	O
countries'	O
responses	O
were	O
misreported:	O
33	O
(3·0%)	O
were	O
clear	O
errors	O
(e.g.	O
,	O
database	O
indicated	O
"	O
yes"	O
when	O
report	O
indicated	O
"	O
no"),	O
270	O
(24·5%)	O
were	O
missing	O
despite	O
countries	O
having	O
submitted	O
responses	O
,	O
and	O
58	O
(5·3%)	O
were	O
,	O
in	O
our	O
opinion	O
,	O
misinterpreted	O
by	O
staff"	O
.	O

The	O
original	O
end-to-end	O
manufacturing	O
process	O
required	O
9	O
to	O
12	O
months	O
to	O
go	O
from	O
raw	O
materials	O
at	O
contract	O
manufacturers	O
to	O
finished	O
product	O
,	O
but	O
after	O
restarting	O
production	O
in	O
January	O
,	O
was	O
able	O
to	O
find	O
ways	O
to	O
reduce	O
the	O
production	O
time	O
to	O
six	O
months	O
.	O

Both	O
letters	O
,	O
which	O
were	O
mailed	O
from	O
Memphis	S-Location
,	O
included	O
the	O
phrases	O
"	O
No	O
one	O
wanted	O
to	O
listen	O
to	O
me	O
before	O
.	O

For	O
more	O
than	O
two	O
decades	O
,	O
bioterrorism	O
experts	O
warned	O
that	O
America	S-Organization
may	O
be	O
vulnerable	O
to	O
attack	O
with	O
biological	O
weapons	O
.	O

One	O
of	O
the	O
more	O
controversial	O
experiments	O
was	O
conducted	O
in	O
1951	O
,	O
when	O
a	O
disproportionate	O
number	O
of	O
African	O
Americans	O
were	O
exposed	O
to	O
the	O
fungus	O
Aspergillus	B-Pathogen
fumigatus	E-Pathogen
,	O
to	O
see	O
if	O
they	O
were	O
more	O
susceptible	O
to	O
infection	O
.	O

Even	O
though	O
it's	O
a	O
biotech	O
newcomer	O
,	O
much	O
of	O
the	O
scientific	O
community	O
has	O
already	O
caught	O
'-fever,'	O
and	O
biotech	O
companies	O
are	O
racing	O
to	O
turn	O
genome	O
editing	O
tools	O
into	O
the	O
next	O
blockbuster	O
pharmaceutical	O
.	O

When	O
associated	O
with	O
antibiotic	O
resistance	O
they	O
may	O
become	O
deadly	O
.	O

And	O
we	O
may	O
not	O
know	O
for	O
certain	O
exactly	O
what	O
happened	O
,	O
but	O
we'll	O
do	O
everything	O
we	O
can	O
to	O
find	O
out	O
.	O

The	O
memo	O
also	O
calls	O
for	O
a	O
federal	O
assessment	O
of	O
"	O
the	O
appropriate	O
number	O
of	O
high	O
containment	O
U.S	S-Organization
laboratories	O
required	O
"	O
to	O
handle	O
select	O
agents	O
.	O

The	O
MIBBI	S-Platform
recommendations	O
represent	O
community	O
standards	O
for	O
bioinformatics	O
data	O
in	O
form	O
of	O
checklists	O
specifying	O
the	O
minimal	O
information	O
needed	O
to	O
reproduce	O
experiments	O
.	O

The	O
level	O
of	O
preparedness	O
was	O
further	O
increased	O
and	O
sustained	O
with	O
the	O
advent	O
of	O
the	O
H5N1	B-Incident
bird	I-Incident
flu	I-Incident
outbreaks	E-Incident
because	O
of	O
's	O
high	O
fatality	O
rate	O
,	O
although	O
the	O
strains	O
currently	O
prevalent	O
have	O
limited	O
human-to-human	O
transmission	O
(anthroponotic)	O
capability	O
,	O
or	O
epidemicity	O
.	O

The	O
average	O
score	O
for	O
each	O
criterion	O
(BLACK)	O
is	O
compared	O
to	O
the	O
average	O
college	O
score	O
for	O
the	O
same	O
criterion	O
(WHITE)	O
.	O

The	O
WHO	S-Organization
regularly	O
publishes	O
a	O
World	B-Document
Health	I-Document
Report	E-Document
,	O
its	O
leading	O
publication	O
,	O
including	O
an	O
expert	O
assessment	O
of	O
a	O
specific	O
global	O
health	O
topic	O
.	O

In	O
the	O
Philippines	S-Location
lawmakers	O
granted	O
president	O
Rodrigo	B-Person
Duterte	E-Person
temporary	O
emergency	O
powers	O
during	O
the	O
pandemic	O
.	O

Understanding	O
how	O
viruses	O
evolve	O
within	O
a	O
species	O
will	O
be	O
a	O
core	O
area	O
of	O
research	O
.	O

As	O
they	O
came	O
together	O
,	O
they	O
brought	O
the	O
virus	O
with	O
them	O
and	O
to	O
those	O
they	O
contacted	O
.	O

The	O
12th–13th	O
century	O
French	O
physician	O
had	O
already	O
used	O
to	O
refer	O
to	O
a	O
"	O
pestilential	O
fever	O
"	O
()	O
in	O
his	O
work	O
On	O
the	O
Signs	O
and	O
Symptoms	O
of	O
Diseases	O
()	O
.	O

Established	O
a	O
high-level	O
working	O
group	O
,	O
reporting	O
to	O
the	O
CDC	S-Organization
Director	O
,	O
to	O
,	O
among	O
other	O
duties	O
,	O
accelerate	O
improvements	O
in	O
laboratory	O
safety	O
,	O
review	O
and	O
approve	O
,	O
on	O
a	O
laboratory-by-laboratory	O
basis	O
,	O
resumed	O
transfer	O
of	O
biological	O
materials	O
outside	O
of	O
BSL3	S-Platform
and	O
BSL4	S-Platform
laboratories	O
,	O
and	O
serve	O
as	O
the	O
transition	O
group	O
for	O
the	O
single	O
point	O
of	O
accountability	O
on	O
laboratory	O
safety	O
called	O
for	O
in	O
the	O
review	O
of	O
the	O
potential	O
exposure	O
to	O
incident	O
.	O

Why	O
the	O
Second	O
Wave	O
of	O
the	O
1918	B-Disease
Spanish	I-Disease
Flu	E-Disease
Was	O
So	O
Deadly	O
History.	O
com	O
-	O
Retrieved	O
8	O
May	O
2020	O
It	O
primarily	O
affected	O
Spain	S-Location
,	O
Serbia	S-Location
,	O
Mexico	S-Location
and	O
Great	B-Location
Britain	E-Location
,	O
resulting	O
in	O
hundreds	O
of	O
thousands	O
of	O
deaths	O
.	O

In	O
principle	O
,	O
could	O
be	O
used	O
to	O
detect	O
the	O
presence	O
or	O
absence	O
of	O
specific	O
chemical	O
bonds	O
.	O

A	O
step	O
toward	O
making	O
a	O
difference	O
,	O
said	O
Lillibridge	S-Person
would	O
be	O
to	O
consolidate	O
biodefense	O
budgets	O
across	O
all	O
federal	O
agencies	O
and	O
departments	O
,	O
which	O
he	O
thinks	O
would	O
resolve	O
90	O
percent	O
of	O
the	O
country's	O
coordination	O
issues.	O
"	O
You	O
can't	O
build	O
the	O
pizza	O
if	O
you	O
hand	O
out	O
the	O
slices,	O
"	O
he	O
said	O
,	O
referring	O
to	O
the	O
government's	O
disparate	O
biodefense	O
budgets	O
and	O
operations	O
.	O

The	O
table	O
reports	O
average	O
radiation	O
exposures	O
,	O
however	O
,	O
there	O
can	O
be	O
a	O
wide	O
variation	O
in	O
radiation	O
doses	O
between	O
similar	O
scan	O
types	O
,	O
where	O
the	O
highest	O
dose	O
could	O
be	O
as	O
much	O
as	O
22	O
times	O
higher	O
than	O
the	O
lowest	O
dose	O
.	O

A	O
third	O
project	O
,	O
also	O
including	O
sand	O
flies	O
collection	O
,	O
studied	O
the	O
characteristics	O
of	O
their	O
salivary	O
glands	O
.	O

In	O
February	O
2010	O
,	O
the	O
CDC	S-Organization
Advisory	B-Organization
Committee	I-Organization
on	I-Organization
Immunization	I-Organization
Practices	E-Organization
voted	O
for	O
"	O
universal"	B-Vaccine
flu	I-Vaccine
vaccination	E-Vaccine
in	O
the	O
U.S.	S-Location
to	O
include	O
all	O
people	O
over	O
six	O
months	O
of	O
age	O
.	O

But	O
now	O
he	O
knows	O
,	O
said	O
Lillibridge	S-Person
director	O
of	O
the	O
Center	B-Organization
for	I-Organization
Global	I-Organization
Health	I-Organization
and	I-Organization
Innovation	E-Organization
,	O
as	O
a	O
panelist	O
who	O
spoke	O
during	O
an	O
Oct.	O
9	O
panel	O
meeting	O
at	O
the	O
Hudson	B-Organization
Institute	E-Organization
in	O
Washington,	B-Location
D.C.	E-Location
,	O
held	O
by	O
the	O
.	O

Only	O
the	O
United	B-Location
States	E-Location
and	O
now	O
keep	O
publicly	O
declared	O
stocks	O
of	O
the	O
virus	O
.	O

Finley	S-Person
said	O
he	O
hopes	O
to	O
have	O
this	O
system	O
ready	O
by	O
October	O
to	O
be	O
combined	O
with	O
traditional	O
statistical	O
methods	O
at	O
the	O
national	O
scale	O
.	O

Nearly	O
all	O
express	O
couriers	O
follow	O
the	O
provisions	O
,	O
which	O
require	O
that	O
any	O
person	O
involved	O
in	O
transport	O
,	O
including	O
the	O
person	O
who	O
types	O
the	O
paperwork	O
to	O
accompany	O
the	O
shipment	O
or	O
who	O
signs	O
for	O
the	O
package	O
,	O
must	O
be	O
trained	O
in	O
the	O
proper	O
procedures	O
.	O

Here	O
,	O
Joint	B-Organization
Information	I-Organization
Systems	I-Organization
Committee	E-Organization
(	O
JISC	S-Organization
)	O
reports	O
provide	O
more	O
detail	O
.	O

According	O
to	O
media	O
reports	O
,	O
the	O
concerned	O
market	O
in	O
was	O
closed	O
on	O
1	O
January	O
2020	O
for	O
environmental	O
sanitation	O
and	O
disinfection	O
.	O

This	O
may	O
apply	O
to	O
clinical	O
,	O
diagnostic	O
,	O
teaching	O
,	O
research	O
,	O
or	O
production	O
facilities	O
in	O
which	O
work	O
is	O
done	O
with	O
indigenous	O
or	O
exotic	O
agents	O
with	O
potential	O
for	O
respiratory	O
transmission	O
,	O
and	O
which	O
may	O
cause	O
serious	O
and	O
potentially	O
lethal	O
infection	O
.	O

The	O
confirmed	O
this	O
demand	O
in	O
its	O
guidelines	O
arguing	O
that	O
open	O
access	O
to	O
data	O
enables	O
'testing	O
of	O
new	O
or	O
alternative	O
hypotheses	O
and	O
methods	O
of	O
analysis'	O
and	O
'exploration	O
of	O
topics	O
not	O
envisioned	O
by	O
the	O
initial	O
investigator'	O
.	O

A	O
team	O
led	O
by	O
professor	O
Arne	B-Person
Skerra	E-Person
at	O
the	O
Technical	B-Organization
University	I-Organization
of	I-Organization
Munich	E-Organization
(	O
TUM	S-Organization
)	O
has	O
developed	O
an	O
innovative	O
strategy	O
for	O
preventing	O
the	O
anthrax	S-Pathogen
bacterium	O
from	O
absorbing	O
iron	S-Drug
,	O
which	O
is	O
crucial	O
for	O
its	O
survival	O
.	O

The	O
Ebola	B-Incident
virus	I-Incident
disease	I-Incident
(EVD)	I-Incident
outbreak	I-Incident
that	I-Incident
occurred	I-Incident
in	I-Incident
West	I-Incident
Africa	I-Incident
between	I-Incident
2014	I-Incident
and	I-Incident
2015	E-Incident
was	O
the	O
largest	O
EDV	S-Disease
epidemic	O
since	O
the	O
identification	O
of	O
Ebola	B-Pathogen
virus	E-Pathogen
(	O
EBOV	S-Pathogen
)	O
in	O
1976	O
.	O

In	O
the	O
most	O
common	O
hoax	O
scenario	O
,	O
no	O
biological	O
agents	O
are	O
employed	O
.	O

Analysis	O
by	O
the	O
confirmed	O
that	O
the	O
bacteria	O
at	O
the	O
Rajneesh	O
laboratory	O
were	O
an	O
exact	O
match	O
to	O
those	O
that	O
sickened	O
individuals	O
who	O
had	O
eaten	O
at	O
local	O
restaurants	O
.	O

Under	O
another	O
military	O
program	O
–	O
Insect	B-Scientific_research_project
Allies	E-Scientific_research_project
GM	O
insects	O
are	O
engineered	O
to	O
transfer	O
modified	O
genes	O
to	O
plants.The	O
$10.	O
3	O
million	O
DARPA	S-Organization
project	O
includes	O
both	O
gene	B-Technology
editing	E-Technology
in	O
insects	O
and	O
in	O
the	O
viruses	O
that	O
they	O
transmit	O
.	O

It	O
is	O
also	O
worth	O
noting	O
that	O
,	O
while	O
an	O
individual	O
could	O
conceivably	O
do	O
harm	O
with	O
sufficient	O
skill	O
and	O
intent	O
,	O
there	O
exist	O
biology	O
labs	O
throughout	O
the	O
world	O
with	O
greater	O
access	O
to	O
the	O
technology	O
,	O
skill	O
and	O
funding	O
to	O
accomplish	O
a	O
bioweapons	O
project	O
.	O

Testing	O
of	O
the	O
dog's	O
remains	O
,	O
however	O
,	O
was	O
negative	O
for	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
Reuters	S-Organization
.	O
(7	O
July	O
2015).	O
"	O
Liberia	S-Location
:	O
Dog	O
Suspected	O
in	O
New	O
Ebola	S-Disease
Case	O
Tests	O
Negative	O
for	O
the	O
Virus".	O
.	O
By	O
9	O
July	O
3	O
more	O
cases	O
were	O
discovered	O
,	O
bringing	O
the	O
total	O
number	O
of	O
new	O
cases	O
to	O
5	O
,	O
all	O
from	O
the	O
same	O
area	O
.	O

Blood	O
tests	O
can	O
tell	O
you	O
if	O
a	O
new	O
food	O
you're	O
eating	O
is	O
affecting	O
your	O
vitamin	O
levels	O
or	O
helping	O
you	O
to	O
achieve	O
a	O
specific	O
biological	O
process	O
.	O

The	O
history	O
of	O
X-ray	B-Technology
computed	I-Technology
tomography	E-Technology
goes	O
back	O
to	O
at	O
least	O
1917	O
with	O
the	O
mathematical	O
theory	O
of	O
the	O
Radon	O
transform	O
.	O

The	O
influenza	O
laboratory	O
is	O
now	O
closed	O
and	O
will	O
not	O
reopen	O
until	O
adequate	O
procedures	O
are	O
put	O
in	O
place	O
.	O

Experience	O
shows	O
that	O
organizing	O
and	O
coordinating	O
networks	O
can	O
be	O
challenging	O
in	O
those	O
countries	O
where	O
there	O
is	O
limited	O
cooperation	O
between	O
different	O
sectors-for	O
example	O
,	O
where	O
each	O
sector	O
relates	O
to	O
different	O
ministries	O
or	O
is	O
governed	O
by	O
separate	O
legal	O
frameworks	O
.	O

Users	O
are	O
asked	O
to	O
enter	O
their	O
name	O
and	O
ID	O
number	O
.	O

In	O
recent	O
years	O
,	O
the	O
emergence	O
and	O
spread	O
of	O
β-lactamases	O
called	O
carbapenemases	O
has	O
become	O
a	O
major	O
health	O
crisis	O
.	O

U.S.	O
officials	O
alleged	O
that	O
a	O
third	O
scientist	O
-	O
Huda	B-Person
Salih	I-Person
Mahdi	I-Person
Ammash	E-Person
(	O
"	O
Mrs	O
.	O

In	O
April	O
2020	O
,	O
the	O
European	B-Organization
Medicines	I-Organization
Agency	E-Organization
(	O
EMA	S-Organization
)	O
provided	O
recommendations	O
on	O
compassionate	O
use	O
of	O
remdesivir	S-Drug
for	O
COVID‑19	S-Disease
in	O
the	O
.	O

However	O
,	O
bacteria	O
can	O
also	O
acquire	O
resistance	O
through	O
transformation	O
,	O
as	O
in	O
Streptococcus	B-Pathogen
pneumoniae	E-Pathogen
uptaking	O
of	O
naked	O
fragments	O
of	O
extracellular	O
DNA	O
that	O
contain	O
antibiotic	O
resistance	O
genes	O
to	O
streptomycin	S-Drug
,	O
through	O
transduction	O
,	O
as	O
in	O
the	O
bacteriophage-mediated	O
transfer	O
of	O
tetracycline	O
resistance	O
genes	O
between	O
strains	O
of	O
,	O
or	O
through	O
gene	O
transfer	O
agents	O
,	O
which	O
are	O
particles	O
produced	O
by	O
the	O
host	O
cell	O
that	O
resemble	O
bacteriophage	O
structures	O
and	O
are	O
capable	O
of	O
transferring	O
DNA	O
.	O

The	O
ET	B-Organization
branch	E-Organization
is	O
currently	O
attempting	O
to	O
develop	O
infused	O
implantable	O
matrices	O
that	O
have	O
sustained	O
release	O
.	O

We'll	O
be	O
continuing	O
to	O
have	O
new	O
technologies	O
.	O

NO	O
EXIT	O
The	O
variola	B-Pathogen
virus	E-Pathogen
that	O
causes	O
smallpox	S-Disease
(illustrated	O
,	O
DNA	O
in	O
red	O
and	O
surrounded	O
by	O
a	O
protein	O
coat	O
and	O
surface	O
tubules)	O
must	O
release	O
copies	O
of	O
itself	O
to	O
infect	O
other	O
cells	O
.	O

These	O
examples	O
of	O
synthetic	B-Technology
biology	E-Technology
rely	O
on	O
being	O
able	O
to	O
read	O
genes	O
,	O
that	O
is	O
,	O
knowing	O
the	O
link	O
between	O
their	O
sequence	O
and	O
their	O
function	O
.	O

Health	O
workers	O
also	O
have	O
to	O
deal	O
with	O
misinformation	O
spread	O
by	O
opposing	O
politicians	O
.	O

After	O
gaining	O
sponsorship	O
from	O
the	O
White	B-Organization
House	E-Organization
Medical	O
Unit	O
,	O
GlobalMed	S-Organization
was	O
awarded	O
the	O
DoD	S-Organization
ATO	O
following	O
a	O
stringent	O
process	O
known	O
as	O
a	O
Risk	O
Management	O
Framework	O
.	O

It	O
is	O
clear	O
that	O
genetic	O
engineering	O
offers	O
new	O
ways	O
of	O
interacting	O
with	O
our	O
environment	O
,	O
including	O
some	O
we	O
can	O
barely	O
imagine	O
.	O

In	O
February	O
,	O
one	O
research	O
group	O
estimated	O
the	O
IFR	O
at	O
0.	O
94%	O
,	O
with	O
a	O
confidence	O
interval	O
between	O
0.	O
37	O
percent	O
to	O
2.9	O
percent	O
.	O

Sponsored	O
by	O
the	O
Defense	B-Organization
Threat	I-Organization
Reduction	I-Organization
Agency	E-Organization
the	O
research	O
aims	O
to	O
provide	O
both	O
effective	O
individual	O
patient	O
care	O
resulting	O
from	O
early	O
treatment	O
and	O
faster	O
,	O
more	O
confident	O
implementation	O
of	O
public	O
health	O
measures	O
,	O
such	O
as	O
isolation	O
,	O
to	O
improve	O
overall	O
population	O
health	O
by	O
blunting	O
epidemics	O
.	O

The	O
CDC	S-Organization
publication	O
,	O
"	O
"	O

Tularemia	S-Pathogen
is	O
one	O
of	O
the	O
bio-weapons	O
that	O
the	O
developed	O
in	O
the	O
past	O
.	O

Governments	O
need	O
to	O
accept	O
and	O
embrace	O
some	O
of	O
these	O
new	O
trends	O
and	O
new	O
technologies	O
.	O

The	O
proper	O
use	O
of	O
infrastructure	O
for	O
water	O
,	O
sanitation	O
and	O
hygiene	O
(WASH)	O
can	O
result	O
in	O
a	O
47–72	O
percent	O
decrease	O
of	O
diarrhea	S-Phenotype
cases	O
treated	O
with	O
antibiotics	O
depending	O
on	O
the	O
type	O
of	O
intervention	O
and	O
its	O
effectiveness	O
.	O

The	O
first	O
to	O
be	O
operational	O
was	O
the	O
4000-bed	O
capacity	O
NHS	B-Organization
Nightingale	I-Organization
Hospital	I-Organization
London	E-Organization
,	O
constructed	O
within	O
the	O
ExCeL	B-Location
convention	I-Location
centre	E-Location
over	O
nine	O
days	O
.	O

The	O
BioTesting	B-Organization
Division	I-Organization
at	I-Organization
Dugway	I-Organization
Proving	I-Organization
Ground	E-Organization
is	O
working	O
to	O
regain	O
its	O
certification	O
as	O
a	O
covered	O
facility	O
under	O
the	O
Federal	B-Document
Select	I-Document
Agent	I-Document
Program	E-Document
to	O
possess	O
BSAT	O
in	O
.	O

Battelle	S-Organization
as	O
a	O
$59	O
million	O
subcontractor	O
at	O
Lugar	B-Organization
Center	E-Organization
has	O
extensive	O
experience	O
in	O
research	O
on	O
bio-agents	O
,	O
as	O
the	O
company	O
has	O
already	O
worked	O
on	O
the	O
US	O
Bio-weapons	O
Program	O
under	O
11	O
previous	O
contracts	O
with	O
the	O
(1952-1966)	O
.	O

But	O
Gentry	O
of	O
would	O
admit	O
him	O
to	O
the	O
club	O
.	O

It's	O
a	O
dangerous	O
practice	O
that	O
should	O
not	O
be	O
marketed	O
as	O
a	O
DIY	O
activity	O
.	O

The	O
Center	B-Organization
for	I-Organization
Disaster	I-Organization
Medicine	E-Organization
previously	O
has	O
conducted	O
this	O
type	O
of	O
first	O
responder	O
training	O
as	O
part	O
of	O
a	O
pilot	O
program	O
with	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense.	E-Organization
The	O
increased	O
state	O
funding	O
that	O
comes	O
with	O
being	O
declared	O
a	O
Center	B-Organization
of	I-Organization
Excellence	E-Organization
will	O
help	O
build	O
out	O
those	O
training	O
programs	O
,	O
which	O
use	O
military	O
strategies	O
to	O
guide	O
decisions	O
by	O
first	O
responders	O
in	O
dangerous	O
and	O
dynamic	O
environments	O
.	O

European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
()	O
.	O

This	O
resulted	O
in	O
international	O
criticism	O
,	O
which	O
seems	O
to	O
have	O
led	O
to	O
a	O
change	O
in	O
government	O
policy	O
in	O
early	O
April	O
.	O

Gaggle	S-Platform
is	O
now	O
employed	O
in	O
the	O
integration	O
of	O
databases	O
over	O
the	O
Internet	O
in	O
the	O
to	O
build	O
up	O
a	O
systems	O
biology	O
knowledgebase	O
.	O

In	O
terms	O
of	O
prognosis	O
,	O
aside	O
from	O
the	O
possible	O
effects	O
of	O
post-Ebola	B-Disease
syndrome	E-Disease
there	O
is	O
also	O
the	O
reality	O
of	O
survivors	O
returning	O
to	O
communities	O
where	O
they	O
might	O
be	O
shunned	O
due	O
to	O
the	O
fear	O
many	O
have	O
in	O
the	O
respective	O
areas	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
hence	O
psychosocial	O
assistance	O
is	O
needed	O
.	O

During	O
the	O
next	O
100	O
years	O
,	O
a	O
combination	O
of	O
invasion	O
and	O
disease	O
took	O
an	O
immense	O
toll	O
–	O
one	O
whose	O
scale	O
may	O
never	O
be	O
known	O
,	O
due	O
to	O
great	O
uncertainty	O
about	O
the	O
size	O
of	O
the	O
pre-existing	O
population	O
.	O

First	O
described	O
in	O
April	O
2009	O
,	O
the	O
virus	O
appeared	O
to	O
be	O
a	O
new	O
strain	O
of	O
H1N1	S-Pathogen
,	O
which	O
resulted	O
from	O
a	O
previous	O
triple	O
reassortment	O
of	O
bird	O
,	O
swine	O
,	O
and	O
human	B-Pathogen
flu	I-Pathogen
viruses	E-Pathogen
further	O
combined	O
with	O
a	O
Eurasian	B-Pathogen
pig	I-Pathogen
flu	I-Pathogen
virus	E-Pathogen
,	O
leading	O
to	O
the	O
term	O
"	O
".	O

The	O
culture	O
is	O
then	O
moved	O
to	O
42°C	O
.	O

In	O
preparation	O
for	O
the	O
hearing	O
,	O
health	O
subcommittee	O
members	O
reviewed	O
the	O
bipartisan	O
discussion	O
draft	O
authored	O
by	O
Rep	O
.	O

Any	O
heterogeneous	O
environment	O
with	O
respect	O
to	O
nutrient	O
and	O
antibiotic	O
gradients	O
may	O
facilitate	O
antibiotic	O
resistance	O
in	O
small	O
bacterial	O
populations	O
.	O

In	O
1997	O
,	O
"	O
Congress	S-Organization
redirected	O
all	O
of	O
the	O
money	O
previously	O
earmarked	O
for	O
gun	O
violence	O
research	O
to	O
the	O
study	O
of	O
traumatic	O
brain	O
injury.	O
"	O
David	B-Person
Satcher	E-Person
,	O
who	O
was	O
the	O
CDC	S-Organization
head	O
from	O
1993	O
to	O
1998	O
advocated	O
for	O
gun	O
violence	O
research	O
until	O
he	O
left	O
in	O
1998	O
.	O

For	O
example	O
,	O
too	O
much	O
coffee	O
can	O
cause	O
a	O
caffeine	O
overdose	O
.	O

The	O
pressure	O
in	O
the	O
BSL-3	S-Platform
laboratory	O
is	O
recorded	O
by	O
checking	O
the	O
pressure	O
gauge	O
in	O
the	O
lab	O
every	O
day	O
,	O
and	O
it	O
was	O
also	O
real-time	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

The	O
humanitarian	B-Organization
aid	I-Organization
organisation	I-Organization
Direct	I-Organization
Relief	E-Organization
sent	O
200,000	O
face	O
masks	O
and	O
other	O
personal	O
protective	O
equipment	O
to	O
the	O
Wuhan	B-Organization
Union	I-Organization
Hospital	E-Organization
the	O
same	O
day	O
.	O

Fearing	O
they	O
would	O
not	O
gain	O
enough	O
votes	O
,	O
some	O
Rajneeshpuram	O
officials	O
decided	O
to	O
incapacitate	O
voters	O
in	O
The	O
Dalles	S-Location
,	O
the	O
largest	O
population	O
center	O
in	O
Wasco	B-Location
County	E-Location
.	O
The	O
chosen	O
biological	O
agent	O
was	O
,	O
which	O
was	O
first	O
delivered	O
through	O
glasses	O
of	O
water	O
to	O
two	O
County	O
Commissioners	O
and	O
then	O
,	O
on	O
a	O
larger	O
scale	O
,	O
at	O
salad	O
bars	O
and	O
in	O
salad	O
dressing	O
.	O

Stores	O
could	O
not	O
hold	O
sales	O
,	O
funerals	O
were	O
limited	O
to	O
15	O
minutes	O
.	O

The	O
event	O
is	O
held	O
every	O
two	O
to	O
three	O
years	O
and	O
brings	O
out	O
more	O
than	O
1,500	O
public	O
health	O
professionals	O
from	O
around	O
the	O
world	O
for	O
the	O
International	B-Activity
Conference	I-Activity
on	I-Activity
Emerging	I-Activity
Infectious	I-Activity
Diseases	E-Activity
(	O
ICEID	S-Activity
)	O
.	O

It	O
is	O
commonly	O
used	O
to	O
investigate	O
acute	O
abdominal	O
pain	O
.	O

LANZHOU	S-Location
Dec.	O
26	O
(	O
Xinhua	S-Organization
)	O
--	O
Contaminated	O
factory	O
exhaust	O
was	O
blamed	O
for	O
the	O
181	O
human	O
cases	O
of	O
brucella	B-Disease
infection	E-Disease
in	O
a	O
veterinary	O
research	O
institute	O
in	O
Lanzhou	S-Location
,	O
northwest	O
China	S-Location
's	O
,	O
local	O
authorities	O
said	O
Thursday	O
.	O

Implementation	O
of	O
the	O
Generation-3	O
automated	O
detection	O
system	O
.	O

The	O
integration	O
of	O
resources	O
can	O
be	O
handled	O
in	O
manifold	O
ways	O
.	O

Asprey	S-Person
-	O
who	O
has	O
received	O
attention	O
online	O
and	O
at	O
conferences	O
-	O
says	O
he	O
has	O
used	O
biohacking	O
and	O
new	O
technical	O
measurement	O
tools	O
and	O
a	O
low-toxic	O
coffee	O
he	O
produces	O
(Bulletproof)	O
to	O
alter	O
his	O
cognition	O
,	O
his	O
weight	O
and	O
his	O
general	O
health	O
.	O

Approaches	O
based	O
on	O
voluntary	O
sharing	O
intend	O
to	O
reward	O
researchers	O
with	O
publication-like	O
citations	O
for	O
publishing	O
data	O
or	O
by	O
providing	O
attractive	O
data	O
management	O
systems	O
supporting	O
their	O
work	O
.	O

In	O
the	O
Odessa	S-Location
region	O
,	O
19	O
children	O
from	O
an	O
orphanage	O
were	O
hospitalized	O
for	O
in	O
June	O
2017	O
.	O

After	O
Iraqi	O
General	O
Hussein	B-Person
Kamel	I-Person
al-Majid	E-Person
defected	O
to	O
Jordan	S-Location
in	O
August	O
1995	O
,	O
the	O
Iraqi	O
government	O
further	O
disclosed	O
that	O
it	O
had	O
operated	O
a	O
robust	O
BW	O
program	O
at	O
six	O
major	O
sites	O
since	O
the	O
1980s	O
.	O

Online	O
,	O
numerous	O
-themed	O
Internet	O
memes	O
have	O
spread	O
as	O
many	O
turn	O
to	O
humour	O
and	O
distraction	O
amid	O
uncertainty	O
.	O

Collins	S-Person
describes	O
the	O
discoveries	O
as	O
"	O
a	O
small	O
number	O
of	O
instances	O
where	O
select	O
agents	O
were	O
improperly	O
stored.	O
"	O
Nobody	O
was	O
exposed	O
to	O
the	O
agents	O
and	O
toxins	O
,	O
which	O
were	O
in	O
sealed	O
containers	O
.	O

The	O
potential	O
role	O
of	O
the	O
other	O
1918	O
proteins	O
,	O
singularly	O
and	O
in	O
combination	O
,	O
is	O
also	O
unknown	O
.	O

It	O
gives	O
people	O
a	O
chance	O
to	O
explore	O
unconventional	O
ideas	O
in	O
a	O
non-hierarchical	O
setting	O
,	O
and	O
to	O
refashion	O
the	O
feeling	O
of	O
being	O
outside	O
the	O
norm	O
into	O
a	O
cool	O
identity	O
.	O

The	O
United	B-Location
States	E-Location
initiated	O
its	O
weaponization	O
efforts	O
with	O
disease	O
vectors	O
in	O
1953	O
,	O
focused	O
on	O
Plague-fleas	S-Pathogen
,	O
EEE-mosquitoes	S-Pathogen
,	O
and	O
yellow	B-Pathogen
fever	E-Pathogen
–	O
mosquitoes	O
(OJ-AP)	O
.	O

Laws	O
relating	O
to	O
biosafety	O
are	O
not	O
easily	O
accessible	O
and	O
there	O
are	O
few	O
federal	O
regulations	O
that	O
are	O
readily	O
available	O
for	O
a	O
potential	O
trainee	O
to	O
reference	O
outside	O
of	O
the	O
publications	O
recommended	O
in	O
42	O
CFR	O
73.12	O
.	O

This	O
is	O
especially	O
apparent	O
when	O
one	O
examines	O
the	O
differences	O
at	O
4-fold	O
degenerate	O
codons	O
,	O
the	O
subset	O
of	O
synonymous	O
changes	O
in	O
which	O
,	O
at	O
the	O
third	O
codon	O
position	O
,	O
any	O
of	O
the	O
4	O
possible	O
nucleotides	O
can	O
be	O
substituted	O
without	O
changing	O
the	O
resulting	O
amino	O
acid	O
.	O

This	O
material	O
may	O
not	O
be	O
published	O
,	O
broadcast	O
,	O
rewritten	O
or	O
redistributed	O
.	O

With	O
the	O
departure	O
of	O
fellows	O
and	O
students	O
,	O
pathogens	O
languish	O
forgotten	O
or	O
ignored	O
in	O
freezers	O
and	O
cold	O
rooms	O
.	O

Inglesby	S-Person
has	O
delivered	O
testimony	O
on	O
public	O
health	O
preparedness	O
and	O
biosecurity	O
.	O

The	O
disease	O
would	O
usually	O
only	O
affect	O
a	O
particular	O
area	O
for	O
a	O
month	O
before	O
leaving	O
.	O

On	O
28	O
May	O
2013	O
,	O
a	O
report	O
by	O
the	O
Associated	B-Organization
Press	E-Organization
said	O
a	O
French	O
patient	O
died	O
of	O
the	O
novel	O
coronavirus	O
related	O
to	O
.	O
Fifty	O
percent	O
of	O
those	O
infected	O
have	O
died	O
.	O

A	O
1999	O
empirical	O
analysis	O
in	O
the	O
journal	O
Emerging	O
Infectious	O
Diseases	O
published	O
by	O
the	O
described	O
six	O
motivational	O
factors	O
associated	O
with	O
bioterrorism	O
,	O
including:	O
charismatic	O
leadership	O
,	O
no	O
outside	O
constituency	O
,	O
apocalyptic	O
ideology	O
,	O
loner	O
or	O
splinter	O
group	O
,	O
sense	O
of	O
paranoia	O
and	O
grandiosity	O
,	O
and	O
defensive	O
aggression	O
.	O

The	O
impact	O
of	O
this	O
pandemic	O
was	O
not	O
limited	O
to	O
1918–1919	O
.	O

Most	O
systems	O
allow	O
granting	O
read/write	O
permissions	O
to	O
users	O
,	O
groups	O
and	O
the	O
general	O
public	O
.	O

As	O
a	O
key	O
protection	O
against	O
the	O
world's	O
most	O
deadly	O
pathogens	O
,	O
including	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
scientists	O
in	O
the	O
BSL-4	S-Platform
labs	O
at	O
the	O
U.S.	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infectious	I-Organization
Diseases	E-Organization
(	O
USAMRIID	S-Organization
)	O
at	O
Fort	B-Location
Detrick	E-Location
in	O
Maryland	S-Location
wear	O
pressurized	O
,	O
full-body	O
spacesuit-like	O
gear	O
and	O
breathe	O
purified	O
air	O
.	O

The	O
CDC	S-Organization
also	O
recommended	O
that	O
colleges	O
should	O
consider	O
suspending	O
fall	O
2009	O
classes	O
if	O
the	O
virus	O
began	O
to	O
cause	O
severe	O
illness	O
in	O
a	O
significantly	O
larger	O
share	O
of	O
students	O
than	O
the	O
previous	O
spring	O
.	O

Also	O
,	O
systems	O
like	O
ISA	O
software	O
suite	O
,	O
BASE	S-Platform
(e.g.	O
with	O
XperimentR	S-Platform
)	O
,	O
DIPSBC	S-Platform
or	O
Gaggle	S-Platform
(e.g.	O
with	O
)	O
have	O
been	O
integrated	O
with	O
other	O
data	O
management	O
solutions	O
.	O

In	O
May	O
2013	O
,	O
the	O
Coronavirus	B-Organization
Study	I-Organization
Group	I-Organization
of	I-Organization
the	I-Organization
International	I-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
adopted	O
the	O
official	O
designation	O
,	O
the	O
Middle	B-Pathogen
East	I-Pathogen
Respiratory	I-Pathogen
Syndrome	I-Pathogen
Coronavirus	E-Pathogen
(	O
MERS-CoV	S-Pathogen
).	O
which	O
was	O
adopted	O
by	O
the	O
to	O
"	O
provide	O
uniformity	O
and	O
facilitate	O
communication	O
about	O
the	O
disease	O
"	O

During	O
next	O
week's	O
PAHPA	S-Document
hearing	O
,	O
the	O
senators	O
will	O
hear	O
from	O
non-governmental	O
witnesses	O
,	O
Sen.	O
said	O
.	O

The	O
FBD	B-Document
QA	I-Document
manual	E-Document
has	O
gradually	O
been	O
revised	O
and	O
now	O
covers	O
network	O
organization	O
,	O
project	O
management	O
,	O
implementation	O
planning	O
,	O
communicating	O
project	O
results	O
,	O
recommendations	O
on	O
quality	O
assurance	O
of	O
diagnostics	O
at	O
BSL-3	S-Platform
laboratories	O
,	O
and	O
protocols	O
for	O
the	O
validation	O
of	O
diagnostic	O
PCR	S-Technology
methods	O
.	O

The	O
Guidelines	B-Document
for	I-Document
Biosafety	I-Document
Training	I-Document
Programs	I-Document
for	I-Document
Workers	I-Document
Assigned	I-Document
to	I-Document
BSL-3	I-Document
Research	I-Document
Laboratories	E-Document
were	O
developed	O
by	O
biosafety	O
professionals	O
who	O
oversee	O
training	O
programs	O
for	O
the	O
2	O
national	O
biocontainment	O
laboratories	O
(NBLs)	O
and	O
the	O
13	O
regional	O
biocontainment	O
laboratories	O
(RBLs)	O
that	O
participate	O
in	O
the	O
National	B-Platform
Institute	I-Platform
of	I-Platform
Allergy	I-Platform
and	I-Platform
Infectious	I-Platform
Diseases	I-Platform
(NIAID)	I-Platform
NBL/RBL	I-Platform
Network	E-Platform
.	O
These	O
guidelines	O
provide	O
a	O
general	O
training	O
framework	O
for	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
()	O
high-containment	O
laboratories	O
,	O
identify	O
key	O
training	O
concepts	O
,	O
and	O
outline	O
training	O
methodologies	O
designed	O
to	O
standardize	O
base	O
knowledge	O
,	O
understanding	O
,	O
and	O
technical	O
competence	O
of	O
laboratory	O
personnel	O
working	O
in	O
high-containment	O
laboratories	O
.	O

Another	O
13	O
cases	O
in	O
also	O
worked	O
in	O
the	O
institute	O
in	O
August	O
.	O

Without	O
fluid	O
replacement	O
,	O
such	O
an	O
extreme	O
loss	O
of	O
fluids	O
leads	O
to	O
dehydration	O
,	O
which	O
in	O
turn	O
may	O
lead	O
to	O
hypovolaemic	O
shock-a	O
condition	O
in	O
which	O
there	O
isn't	O
enough	O
blood	O
for	O
the	O
heart	O
to	O
pump	O
through	O
the	O
body	O
.	O

The	O
shortage	O
was	O
further	O
confounded	O
by	O
the	O
added	O
loss	O
of	O
physicians	O
to	O
the	O
epidemic	O
.	O

The	O
residents	O
of	O
the	O
building	O
were	O
later	O
transferred	O
to	O
the	O
quarantined	O
Lei	B-Organization
Yue	I-Organization
Mun	I-Organization
Holiday	I-Organization
Camp	E-Organization
and	O
on	O
1	O
April	O
because	O
the	O
building	O
was	O
deemed	O
a	O
health	O
hazard	O
.	O

All	O
of	O
those	O
allegations	O
were	O
denied	O
by	O
.	O

Kidney	O
organoids	O
with	O
mutations	O
in	O
a	O
gene	O
linked	O
to	O
FSGS	O
developed	O
junctional	O
defects	O
between	O
podocytes	O
,	O
the	O
filtering	O
cells	O
affected	O
in	O
that	O
disease	O
.	O

At	O
the	O
core	O
of	O
our	O
efforts	O
was	O
a	O
massive	O
coordination	O
campaign	O
.	O

In	O
cases	O
of	O
influenza	S-Disease
outbreaks	O
,	O
and	O
associated	O
agencies	O
have	O
moved	O
rapidly	O
to	O
isolate	O
and	O
eliminate	O
new	O
outbreaks	O
of	O
infection	O
.	O

While	O
theoretically	O
promising	O
,	O
antistaphylococcal	B-Vaccine
vaccines	E-Vaccine
have	O
shown	O
limited	O
efficacy	O
,	O
because	O
of	O
immunological	O
variation	O
between	O
Staphylococcus	O
species	O
,	O
and	O
the	O
limited	O
duration	O
of	O
effectiveness	O
of	O
the	O
antibodies	O
produced	O
.	O

According	O
to	O
Dr	O
.	O

Martin	S-Person
,	O
Op.cit	O
.	O

It	O
is	O
his	O
opinion	O
that	O
the	O
Los	B-Incident
Angeles	I-Incident
infestation	E-Incident
could	O
date	O
back	O
several	O
years	O
and	O
that	O
the	O
bug	O
has	O
become	O
established	O
in	O
the	O
region	O
.	O

This	O
is	O
quite	O
a	O
different	O
kind	O
of	O
warehouse	O
.	O

The	O
International	B-Organization
Committee	I-Organization
on	I-Organization
Taxonomy	I-Organization
of	I-Organization
Viruses	E-Organization
(	O
ICTV	S-Organization
)	O
identifies	O
Ebola	B-Pathogen
virus	E-Pathogen
as	O
species	B-Pathogen
Zaire	I-Pathogen
ebolavirus	E-Pathogen
,	O
which	O
is	O
part	O
of	O
the	O
genus	O
Ebolavirus	S-Pathogen
,	O
family	O
Filoviridae	O
,	O
order	O
Mononegavirales	O
.	O

The	O
president's	O
national	B-Document
security	I-Document
strategy	E-Document
includes	O
weapons	O
of	O
mass	O
destruction	O
and	O
specifically	O
calls	O
out	O
biodefense,	O
"	O
told	O
the	O
panel	O
members	O
.	O

Two	O
cases	O
stemmed	O
from	O
Duncan	S-Location
,	O
when	O
two	O
nurses	O
that	O
had	O
treated	O
him	O
tested	O
positive	O
for	O
the	O
virus	O
on	O
10	O
and	O
14	O
October	O
and	O
ended	O
when	O
they	O
were	O
declared	O
-free	O
on	O
24	O
and	O
22	O
October	O
,	O
respectively	O
.	O

By	O
contrast	O
,	O
it	O
must	O
not	O
be	O
underestimated	O
that	O
hardly	O
any	O
natural	O
pathogens	O
are	O
really	O
well	O
suited	O
to	O
being	O
biowarfare	O
agents	O
from	O
a	O
military	O
point	O
of	O
view	O
.	O

The	O
program	O
also	O
purified	O
biological	O
toxins	O
,	O
such	O
as	O
botulinum	B-Pathogen
toxin	E-Pathogen
,	O
ricin	S-Pathogen
and	O
aflatoxin	S-Pathogen
.	O
After	O
1995	O
,	O
it	O
was	O
learned	O
that	O
,	O
in	O
all	O
,	O
Iraq	S-Location
had	O
produced	O
19,000	O
liters	O
of	O
concentrated	O
botulinum	B-Pathogen
toxin	E-Pathogen
(nearly	O
10,000	O
liters	O
filled	O
into	O
munitions)	O
,	O
8,500	O
liters	O
of	O
concentrated	O
anthrax	S-Pathogen
(6,500	O
liters	O
filled	O
into	O
munitions)	O
and	O
2,200	O
liters	O
of	O
aflatoxin	S-Pathogen
(1,580	O
liters	O
filled	O
into	O
munitions).Woods	O
,	O
Op.cit.	O
,	O
pg	O
8	O
In	O
total	O
,	O
the	O
program	O
grew	O
a	O
half	O
million	O
liters	O
of	O
biological	O
agents.	O
,	O
Op.cit	O
.	O

Learning	O
from	O
other	O
responses	O
,	O
such	O
as	O
during	O
the	O
2000	O
outbreak	O
in	O
Uganda	S-Location
the	O
WHO	S-Organization
established	O
its	O
Global	B-Platform
Outbreak	I-Platform
Alert	I-Platform
and	I-Platform
Response	I-Platform
Network	E-Platform
,	O
and	O
other	O
public	O
health	O
measures	O
were	O
instituted	O
in	O
areas	O
at	O
high	O
risk	O
.	O

Ecological	B-Scientific_research_project
Niche-preference	I-Scientific_research_project
Engineering	E-Scientific_research_project
is	O
a	O
third	O
ongoing	O
military	O
program	O
for	O
genome	O
engineering	O
in	O
insects	O
.	O

The	O
Director-General	O
of	O
said:	O
"	O
Countries	O
affected	O
to	O
date	O
simply	O
do	O
not	O
have	O
the	O
capacity	O
to	O
manage	O
an	O
outbreak	O
of	O
this	O
size	O
and	O
complexity	O
on	O
their	O
own	O
.	O

Among	O
the	O
fatalities	O
was	O
Samuel	B-Person
Brisbane	E-Person
a	O
former	O
adviser	O
to	O
the	O
Liberian	B-Organization
Ministry	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Social	I-Organization
Welfare	E-Organization
,	O
described	O
as	O
"	O
one	O
of	O
Liberia	S-Location
's	O
most	O
high-profile	O
doctors"	O
.	O

Keasling	S-Person
took	O
the	O
set	O
of	O
genes	O
that	O
produce	O
the	O
artemisinin	S-Drug
precursor	O
in	O
the	O
plant	O
and	O
moved	O
the	O
pathway	O
-	O
along	O
with	O
other	O
required	O
genes	O
from	O
different	O
organisms	O
-	O
to	O
yeast	O
,	O
a	O
eukaryotic	O
single-celled	O
organism	O
that	O
is	O
easy	O
to	O
grow	O
in	O
the	O
lab	O
.	O

CDC	S-Organization
immediately	O
began	O
investigating	O
the	O
incident	O
to	O
assess	O
the	O
health	O
risk	O
to	O
staff	O
.	O

Kindergarten	O
students	O
,	O
some	O
wearing	O
masks	O
,	O
attend	O
school	O
in	O
a	O
residential	O
estate	O
in	O
Hong	B-Location
Kong	E-Location
on	O
Thursday	O
.	O

In	O
terms	O
of	O
medical	O
literature	O
that	O
are	O
reviews	O
,	O
few	O
articles	O
have	O
been	O
published	O
,	O
such	O
as	O
Shantha	S-Person
et	O
al.	O
which	O
discusses	O
management	O
of	O
panuveitis	S-Disease
and	O
iris	O
.	O

According	O
to	O
the	O
WHO	S-Organization
,	O
the	O
high	O
proportion	O
of	O
infected	O
medical	O
staff	O
could	O
be	O
explained	O
by	O
a	O
lack	O
of	O
adequate	O
manpower	O
to	O
manage	O
such	O
a	O
large	O
outbreak	O
,	O
shortages	O
of	O
or	O
improper	O
use	O
of	O
what	O
was	O
available	O
,	O
and	O
"	O
the	O
compassion	O
that	O
causes	O
medical	O
staff	O
to	O
work	O
in	O
isolation	O
wards	O
far	O
beyond	O
the	O
number	O
of	O
hours	O
recommended	O
as	O
safe"	O
.	O

The	O
pixel	O
itself	O
is	O
displayed	O
according	O
to	O
the	O
mean	O
attenuation	O
of	O
the	O
tissue(s)	O
that	O
it	O
corresponds	O
to	O
on	O
a	O
scale	O
from	O
+3,071	O
(most	O
attenuating)	O
to	O
−1,024	O
(least	O
attenuating)	O
on	O
the	O
Hounsfield	O
scale	O
.	O

Could	O
synthetic	O
biology	O
help	O
meet	O
those	O
needs?	O

Health	O
agencies	O
have	O
issued	O
detailed	O
instructions	O
for	O
proper	O
self-isolation	O
.	O

Initiatives	O
to	O
foster	O
open	O
accessibility	O
of	O
publicly	O
funded	O
research	O
data	O
are	O
now	O
put	O
into	O
practice	O
by	O
compilation	O
of	O
data	O
sharing	O
policies	O
and	O
mandatory	O
professional	O
data	O
management	O
strategies	O
in	O
application	O
calls	O
.	O

The	O
Grimnoire	O
Series	O
,	O
an	O
alternative-history	O
series	O
of	O
novels	O
by	O
Larry	B-Person
Correia	E-Person
has	O
conducting	O
brutal	O
magical	O
experiments	O
on	O
prisoners	O
of	O
the	O
Japanese	O
Imperium	O
.	O

These	O
outbreaks	O
probably	O
lessened	O
the	O
significance	O
of	O
the	O
influenza	S-Disease
pandemic	O
for	O
the	O
public	O
.	O

Operation	B-Scientific_research_project
Whitecoat	E-Scientific_research_project
was	O
a	O
bio-defense	O
medical	O
research	O
program	O
carried	O
out	O
by	O
the	O
US	B-Organization
Army	E-Organization
at	O
Fort	B-Location
Detrick	E-Location
,	O
between	O
1954	O
and	O
1973	O
.	O

Two	O
years	O
ago	O
,	O
a	O
researcher	O
who	O
worked	O
in	O
the	O
same	O
area	O
in	O
the	O
Cummings	B-Organization
Life	I-Organization
Science	I-Organization
Center	E-Organization
geneticist	O
Malcolm	B-Person
Casadaban	E-Person
,	O
a	O
co-principal	O
investigator	O
with	O
Schneewind	S-Person
,	O
died	O
after	O
becoming	O
infected	O
with	O
a	O
weakened	O
strain	O
of	O
the	O
Yersinia	B-Pathogen
pestis	I-Pathogen
bacterium	E-Pathogen
that	O
was	O
not	O
thought	O
to	O
infect	O
healthy	O
adults	O
.	O

Some	O
fatal	O
cases	O
did	O
continue	O
into	O
March	O
1919	O
,	O
killing	O
one	O
player	O
in	O
the	O
.	O

Bill	B-Person
Gates	E-Person
has	O
warned	O
that	O
bioterrorism	O
could	O
kill	O
more	O
people	O
than	O
nuclear	O
war	O
.	O

China	S-Location
also	O
converted	O
other	O
facilities	O
in	O
,	O
such	O
as	O
convention	O
centres	O
and	O
stadiums	O
,	O
into	O
temporary	O
hospitals	O
.	O

Gaseous	O
isotopes	O
such	O
as	O
3He	O
or	O
129Xe	O
must	O
be	O
hyperpolarized	O
and	O
then	O
inhaled	O
as	O
their	O
nuclear	O
density	O
is	O
too	O
low	O
to	O
yield	O
a	O
useful	O
signal	O
under	O
normal	O
conditions.	O
17O	O
and	O
19F	O
can	O
be	O
administered	O
in	O
sufficient	O
quantities	O
in	O
liquid	O
form	O
(e.g.	O
17O-water)	O
that	O
hyperpolarization	O
is	O
not	O
a	O
necessity	O
.	O

The	O
spike	O
in	O
the	O
number	O
of	O
cases	O
may	O
be	O
due	O
in	O
part	O
to	O
transport	O
links	O
between	O
Guayaquil	S-Location
,	O
a	O
large	O
key	O
port	O
,	O
and	O
Spain	S-Location
.	O
The	O
BBC	S-Organization
reports	O
that	O
so	O
many	O
have	O
died	O
in	O
Guayaquil	S-Location
that	O
residents	O
have	O
been	O
"	O
forced	O
to	O
store	O
bodies	O
in	O
their	O
homes	O
for	O
up	O
to	O
five	O
days	O
"	O
or	O
even	O
in	O
the	O
street	O
and	O
the	O
government	O
began	O
to	O
distribute	O
thousands	O
of	O
cardboard	O
coffins	O
to	O
residents	O
.	O

A	O
small	O
number	O
of	O
organisms	O
(10–50	O
or	O
so)	O
can	O
cause	O
disease	O
.	O

Physical	O
distancing	O
measures	O
are	O
also	O
recommended	O
to	O
prevent	O
transmission	O
.	O

Both	O
the	O
disease	O
and	O
virus	O
are	O
commonly	O
referred	O
to	O
as	O
"	O
coronavirus"	O
in	O
the	O
media	O
and	O
public	O
discourse	O
.	O

And	O
there	O
are	O
fears	O
the	O
disease	O
could	O
spread	O
to	O
pig	O
herds	O
in	O
Japan	S-Location
the	O
Korean	S-Location
peninsula	O
and	O
other	O
parts	O
of	O
Asia	S-Location
.	O
Cases	O
have	O
been	O
recorded	O
across	O
Europe	S-Location
,	O
Russia	S-Location
and	O
Sub-Saharan	B-Location
Africa	E-Location
,	O
but	O
it	O
has	O
never	O
occurred	O
in	O
East	B-Location
Asia	E-Location
until	O
now	O
,	O
according	O
to	O
the	O
.	O

And	O
there	O
are	O
fears	O
the	O
disease	O
could	O
spread	O
to	O
pig	O
herds	O
in	O
Japan	S-Location
the	O
Korean	S-Location
peninsula	O
and	O
other	O
parts	O
of	O
Asia	S-Location
.	O
Cases	O
have	O
been	O
recorded	O
across	O
Europe	S-Location
,	O
Russia	S-Location
and	O
Sub-Saharan	B-Location
Africa	E-Location
,	O
but	O
it	O
has	O
never	O
occurred	O
in	O
East	B-Location
Asia	E-Location
until	O
now	O
,	O
according	O
to	O
the	O
.	O

The	O
same	O
year	O
,	O
workers	O
at	O
the	O
Norfolk	B-Location
Supply	I-Location
Center	E-Location
in	O
Norfolk	S-Location
,	O
Virginia	S-Location
,	O
were	O
unknowingly	O
exposed	O
to	O
Aspergillus	B-Pathogen
fumigatus	I-Pathogen
spores	E-Pathogen
.	O
Another	O
case	O
of	O
human	O
research	O
was	O
the	O
biodefense	O
medical	O
research	O
program	O
,	O
.	O

In	O
crowded	O
cities	O
,	O
it	O
was	O
not	O
uncommon	O
for	O
as	O
much	O
as	O
50%	O
of	O
the	O
population	O
to	O
die	O
.	O

In	O
October	O
2014	O
,	O
a	O
nursing	O
assistant	O
,	O
Teresa	B-Person
Romero	E-Person
who	O
had	O
cared	O
for	O
these	O
patients	O
became	O
unwell	O
and	O
on	O
6	O
October	O
tested	O
positive	O
for	O
Ebola	S-Disease
,	O
making	O
this	O
the	O
first	O
confirmed	O
case	O
of	O
Ebola	S-Disease
transmission	O
outside	O
of	O
Africa	S-Location
.	O
On	O
19	O
October	O
,	O
it	O
was	O
reported	O
that	O
Romero	S-Person
had	O
recovered	O
,	O
and	O
on	O
2	O
December	O
the	O
WHO	S-Organization
declared	O
Spain	S-Location
Ebola	S-Disease
-free	O
following	O
the	O
passage	O
of	O
42	O
days	O
since	O
was	O
found	O
to	O
be	O
cured	O
.	O

In	O
1998	O
,	O
Canadian	O
researchers	O
and	O
historians	O
Stephen	B-Person
Endicott	E-Person
and	O
Edward	B-Person
Hagerman	E-Person
of	O
York	B-Organization
University	E-Organization
made	O
the	O
case	O
that	O
the	O
accusations	O
were	O
true	O
in	O
their	O
book	O
,	O
The	O
United	B-Location
States	E-Location
and	O
Biological	O
Warfare:	O
Secrets	O
from	O
the	O
Early	O
Cold	O
War	O
and	O
Korea	S-Location
.	O
Endicott	S-Person
,	O
Stephen	S-Person
,	O
and	O
Hagerman	S-Person
,	O
Edward	S-Person
.	O
The	O
United	B-Location
States	E-Location
and	O
Biological	O
Warfare:	O
Secrets	O
from	O
the	O
Early	O
Cold	O
War	O
and	O
Korea	S-Location
,	O
(Google	O
Books	O
,	O
relevant	O
excerpt)	O
,	O
Indiana	B-Organization
University	E-Organization
Press	O
,	O
1998	O
,	O
pp.	O
75–77	O
,	O
()	O
,	O
links	O
accessed	O
January	O
7	O
,	O
2009	O
.	O

Division	O
3:	O
Production	O
of	O
shells	O
containing	O
biological	O
agents	O
.	O

Matheny	S-Person
noted	O
that	O
other	O
initiatives	O
will	O
work	O
to	O
optimize	O
encryption	O
;	O
build	O
superconducting	O
computers	O
for	O
hardware	O
security	O
;	O
and	O
support	O
the	O
use	O
of	O
proteins	O
to	O
identify	O
individuals	O
for	O
law	O
enforcement	O
purposes	O
.	O

The	O
was	O
also	O
unsatisfied	O
with	O
the	O
operational	O
qualities	O
of	O
the	O
M114/US	O
bursting	O
bomblet	O
and	O
labeled	O
it	O
an	O
interim	O
item	O
until	O
the	O
Chemical	O
Corps	O
could	O
deliver	O
a	O
superior	O
weapon	O
.	O

Propaganda	O
campaigns	O
and	O
war	O
restrictions	O
and	O
rations	O
had	O
been	O
implemented	O
by	O
governments	O
.	O

While	O
it	O
has	O
been	O
thought	O
that	O
these	O
findings	O
suggest	O
the	O
partial	O
immunity	O
in	O
older	O
adults	O
may	O
be	O
due	O
to	O
previous	O
exposure	O
to	O
similar	O
seasonal	B-Pathogen
influenza	I-Pathogen
viruses	E-Pathogen
,	O
a	O
November	O
2009	O
study	O
of	O
a	O
rural	O
unvaccinated	O
population	O
in	O
China	S-Location
found	O
only	O
a	O
0.	O
3%	O
cross-reactive	O
antibody	O
reaction	O
to	O
the	O
H1N1	B-Pathogen
strain	E-Pathogen
,	O
suggesting	O
that	O
previous	O
vaccinations	B-Vaccine
for	I-Vaccine
seasonal	I-Vaccine
flu	E-Vaccine
and	O
not	O
exposure	O
may	O
have	O
resulted	O
in	O
the	O
immunity	O
found	O
in	O
the	O
older	O
population	O
.	O

In	O
Sweden	O
the	O
national	O
agencies	O
for	O
public	O
health	O
,	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
and	O
biodefense	O
and	O
security	O
each	O
has	O
its	O
own	O
biosafety	B-Platform
level-3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratories	O
,	O
to	O
which	O
samples	O
are	O
sent	O
for	O
analysis	O
from	O
around	O
the	O
country	O
(Figure	O
1	O
,	O
Table	O
1)	O
.	O

A	O
nitrile	O
intermediate	O
was	O
obtained	O
.	O

By	O
late	O
May	O
,	O
the	O
outbreak	O
had	O
spread	O
to	O
Conakry	S-Location
,	O
's	O
capital-a	O
city	O
of	O
about	O
two	O
million	O
people	O
.	O

The	O
work	O
caused	O
fierce	O
controversy	O
.	O

The	O
pixel	O
itself	O
is	O
displayed	O
according	O
to	O
the	O
mean	O
attenuation	O
of	O
the	O
tissue(s)	O
that	O
it	O
corresponds	O
to	O
on	O
a	O
scale	O
from	O
+3,071	O
(most	O
attenuating)	O
to	O
−1,024	O
(least	O
attenuating)	O
on	O
the	O
Hounsfield	O
scale	O
.	O

The	O
facility	O
,	O
containment	O
devices	O
,	O
administrative	O
controls	O
(discussed	O
below)	O
,	O
and	O
practices	O
and	O
procedures	O
that	O
constitute	O
BSL‐2	S-Platform
are	O
designed	O
to	O
maximize	O
safe	O
working	O
conditions	O
for	O
laboratorians	O
working	O
with	O
agents	O
of	O
moderate	O
risk	O
to	O
personnel	O
and	O
the	O
environment	O
.	O

Bell	S-Person
that	O
will	O
report	O
to	O
me	O
to	O
accelerate	O
improvements	O
in	O
laboratory	O
safety	O
and	O
serve	O
as	O
the	O
transition	O
group	O
for	O
permanent	O
single	O
point	O
of	O
accountability	O
on	O
laboratory	O
safety	O
which	O
is	O
something	O
called	O
for	O
in	O
the	O
review	O
of	O
the	O
potential	O
exposure	O
to	O
anthrax	B-Incident
incident	E-Incident
.	O
The	O
culture	O
of	O
laboratory	O
safety	O
needs	O
to	O
improve	O
at	O
some	O
laboratories	O
.	O

Around	O
1950	O
the	O
Chemical	B-Organization
Corps	E-Organization
also	O
initiated	O
a	O
program	O
to	O
weaponize	O
tularemia	S-Pathogen
(UL)	O
.	O

The	O
Post	O
also	O
reported	O
that	O
in	O
July	O
,	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
found	O
samples	O
of	O
staphylococcal	B-Pathogen
enterotoxin	E-Pathogen
,	O
which	O
can	O
cause	O
food	O
poisoning	O
,	O
in	O
an	O
unapproved	O
lab	O
.	O

Time:	O
H1N1	S-Disease
Is	O
this	O
a	O
pandemic	O
or	O
isn't	O
it?	O

Studies	O
have	O
found	O
that	O
this	O
method	O
reduces	O
the	O
rate	O
at	O
which	O
antibiotic	O
resistant	O
bacteria	O
emerge	O
in	O
vitro	O
relative	O
to	O
a	O
single	O
drug	O
for	O
the	O
entire	O
duration	O
.	O

The	O
Communicable	B-Organization
Disease	I-Organization
Center	E-Organization
was	O
founded	O
July	O
1	O
,	O
1946	O
,	O
as	O
the	O
successor	O
to	O
the	O
World	O
War	O
II	O
Malaria	O
Control	O
in	O
War	O
Areas	O
program	O
of	O
.	O

WHO	S-Organization
.	O
Decade	O
of	O
Action	O
for	O
Road	O
Safety	O
2011–2020	O
It	O
has	O
also	O
worked	O
on	O
global	O
initiatives	O
in	O
surgery	O
,	O
including	O
emergency	O
and	O
essential	O
surgical	O
care	O
,	O
trauma	O
care	O
,	O
and	O
safe	O
surgery	O
.	O

It's	O
a	O
question	O
of	O
time	O
,	O
hopefully	O
a	O
really	O
long	O
time	O
.	O

Despite	O
the	O
encroaching	O
funding	O
cliff	O
,	O
GHSA	S-International_exchange_and_cooperation
efforts	O
continue	O
and	O
the	O
U.S.	S-Location
will	O
participate	O
in	O
the	O
upcoming	O
meeting	O
in	O
Georgia	S-Location
,	O
which	O
is	O
the	O
lead	O
country	O
for	O
the	O
Real-Time	B-Document
Surveillance	I-Document
Action	I-Document
Package	E-Document
,	O
one	O
of	O
the	O
.	O

We	O
had	O
three	O
incidents	O
,	O
two	O
at	O
CDC	S-Organization
and	O
one	O
at	O
NIH	S-Organization
where	O
CDC	S-Organization
was	O
able	O
to	O
then	O
secure	O
that	O
material	O
.	O

Students	O
receive	O
Vero	O
cells	O
that	O
were	O
plated	O
in	O
96	O
well	O
plates	O
a	O
day	O
earlier	O
.	O

Additionally	O
,	O
individuals	O
travelling	O
to	O
the	O
country	O
should	O
avoid	O
contact	O
with	O
animals	O
.	O

Cooperation	O
can	O
benefit	O
each	O
other	O
,	O
including	O
further	O
discussions	O
into	O
the	O
making	O
or	O
revision	O
of	O
biological	B-Document
agent	I-Document
category	I-Document
lists	E-Document

As	O
these	O
coils	O
are	O
rapidly	O
switched	O
during	O
the	O
excitation	O
and	O
response	O
to	O
perform	O
a	O
moving	O
line	O
scan	O
,	O
they	O
create	O
the	O
characteristic	O
repetitive	O
noise	O
of	O
an	O
as	O
the	O
windings	O
move	O
slightly	O
due	O
to	O
magnetostriction	O
.	O

Researchers	O
often	O
used	O
broom	O
handles	O
to	O
corral	O
the	O
wayward	O
mice	O
that	O
had	O
previously	O
been	O
infected	O
with	O
a	O
variety	O
of	O
pathogens	O
.	O

Among	O
those	O
who	O
have	O
died	O
,	O
the	O
time	O
from	O
symptom	O
onset	O
to	O
death	O
has	O
ranged	O
from	O
two	O
to	O
eight	O
weeks	O
.	O

You	O
mentioned	O
that	O
the	O
delay	O
in	O
notification	O
was	O
one	O
of	O
your	O
concerns	O
.	O

Because	O
the	O
pathogen	O
only	O
spreads	O
in	O
the	O
body	O
when	O
it	O
receives	O
access	O
to	O
the	O
essential	O
element	O
,	O
this	O
is	O
expected	O
to	O
provide	O
an	O
effective	O
treatment	O
against	O
the	O
life-threatening	O
infection	O
.	O

We	O
don't	O
,	O
but	O
as	O
I	O
said	O
,	O
we	O
don't	O
have	O
many	O
tools	O
against	O
Lassa	S-Disease
We	O
don't	O
have	O
a	O
vaccine	O
;	O
there's	O
no	O
magic	O
bullet	O
.	O

Noise	O
This	O
appears	O
as	O
grain	O
on	O
the	O
image	O
and	O
is	O
caused	O
by	O
a	O
low	O
signal	O
to	O
noise	O
ratio	O
.	O

To	O
conclude	O
,	O
I	O
want	O
to	O
encourage	O
a	O
multidisciplinary	O
debate	O
in	O
which	O
real	O
needs	O
are	O
transmitted	O
into	O
academia	O
to	O
move	O
into	O
successful	O
approaches	O
for	O
the	O
current	O
needs	O
of	O
biomedicine	O
and	O
biotech	O
and	O
enhance	O
the	O
change	O
and	O
expansion	O
of	O
safe	O
gene	B-Technology
editing	I-Technology
methods	E-Technology
Solutions	O
would	O
probably	O
spin	O
on	O
the	O
increase	O
in	O
partnerships	O
between	O
industry	O
and	O
academia	O
that	O
work	O
towards	O
the	O
solution	O
of	O
problems	O
and	O
not	O
to	O
achieve	O
high-ranked	O
publications	O
to	O
warrant	O
lab	O
funding	O
.	O

Field	O
laboratories	O
were	O
established	O
to	O
confirm	O
cases	O
,	O
instead	O
of	O
shipping	O
samples	O
to	O
South	B-Location
Africa	E-Location
.	O
Additionally	O
,	O
outbreaks	O
are	O
also	O
closely	O
monitored	O
by	O
the	O
.	O

This	O
has	O
been	O
difficult	O
to	O
study	O
in	O
animal	O
models	O
that	O
respond	O
to	O
the	O
virus	O
with	O
hemorrhagic	B-Disease
fever	E-Disease
in	O
a	O
similar	O
manner	O
as	O
humans	O
,	O
because	O
typical	O
mouse	O
models	O
do	O
not	O
so	O
respond	O
,	O
and	O
the	O
required	O
large	O
numbers	O
of	O
appropriate	O
test	O
subjects	O
are	O
not	O
easily	O
available	O
.	O

This	O
moral	O
barrier	O
seems	O
to	O
be	O
lower	O
for	O
'non-lethal'	O
weapons	O
that	O
are	O
targeted	O
against	O
materials	O
or	O
drug-producing	O
plants	O
.	O

On	O
19	O
May	O
,	O
the	O
WHO	B-Activity
Annual	I-Activity
Meeting	E-Activity
was	O
held	O
in	O
Geneva	S-Location
.	O
Hong	B-Organization
Kong	E-Organization
pushed	O
for	O
the	O
to	O
be	O
lifted	O
.	O

President	O
Trump	S-Person
budget	O
request	O
of	O
$59	O
million	O
in	O
GHSA	S-International_exchange_and_cooperation
funding	O
for	O
fiscal	O
2019	O
demonstrates	O
the	O
administration's	O
commitment	O
to	O
global	O
health	O
security	O
.	O

MRI	S-Technology
is	O
the	O
investigative	O
tool	O
of	O
choice	O
for	O
neurological	B-Disease
cancers	E-Disease
over	O
CT	S-Technology
,	O
as	O
it	O
offers	O
better	O
visualization	O
of	O
the	O
posterior	O
cranial	O
fossa	O
,	O
containing	O
the	O
brainstem	O
and	O
the	O
cerebellum	O
.	O

Repurposed	O
antiviral	O
drugs	O
make	O
up	O
most	O
of	O
the	O
Chinese	O
research	O
,	O
with	O
nine	O
phase	O
III	O
trials	O
on	O
remdesivir	S-Drug
across	O
several	O
countries	O
due	O
to	O
report	O
by	O
the	O
end	O
of	O
April	O
.	O

One	O
theory	O
that	O
has	O
been	O
advanced	O
is	O
that	O
the	O
devastation	O
in	O
Florence	S-Location
caused	O
by	O
the	O
Black	B-Disease
Death	E-Disease
,	O
which	O
hit	O
Europe	S-Location
between	O
1348	O
and	O
1350	O
,	O
resulted	O
in	O
a	O
shift	O
in	O
the	O
world	O
view	O
of	O
people	O
in	O
14th-century	O
Italy	S-Location
and	O
led	O
to	O
the	O
Renaissance	O
.	O

By	O
2023	O
,	O
the	O
partnership	O
aims	O
to	O
develop	O
and	O
deliver	O
up	O
to	O
four	O
new	O
treatments	O
,	O
through	O
improvement	O
of	O
existing	O
antibiotics	O
and	O
acceleration	O
of	O
the	O
entry	O
of	O
new	O
antibiotic	O
drugs	O
.	O

Dr	O
.	O

All	O
laboratory	O
personnel	O
shall	O
meet	O
state/local	O
accreditation	O
requirements	O
(e.g	O
.	O

Thus	O
,	O
during	O
a	O
crisis	O
,	O
each	O
sector	O
is	O
responsible	O
only	O
for	O
its	O
own	O
area	O
of	O
expertise	O
,	O
and	O
most	O
crises	O
are	O
managed	O
by	O
the	O
municipalities	O
responsible	O
at	O
a	O
local	O
level	O
.	O

That	O
process	O
informed	O
the	O
team's	O
high-level	O
assessment	O
of	O
the	O
readiness	O
of	O
each	O
technology	O
(from	O
early	O
development	O
to	O
being	O
field-ready)	O
,	O
the	O
potential	O
impact	O
of	O
the	O
technology	O
on	O
GCBR	O
reduction	O
(from	O
low	O
to	O
high)	O
,	O
and	O
the	O
amount	O
of	O
financial	O
investment	O
that	O
would	O
be	O
needed	O
to	O
meaningfully	O
deploy	O
the	O
technology	O
(from	O
low	O
to	O
high)	O
.	O

In	O
October	O
,	O
2009	O
,	O
the	O
US	B-Organization
Food	I-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
(	O
FDA	S-Organization
)	O
initiated	O
an	O
investigation	O
of	O
brain	B-Technology
perfusion	I-Technology
CT	E-Technology
(	O
PCT	S-Technology
)	O
scans	O
,	O
based	O
on	O
radiation	O
burns	O
caused	O
by	O
incorrect	O
settings	O
at	O
one	O
particular	O
facility	O
for	O
this	O
particular	O
type	O
of	O
CT	B-Technology
scan	E-Technology
.	O
Over	O
256	O
patients	O
over	O
an	O
18-month	O
period	O
were	O
exposed	O
,	O
over	O
40%	O
lost	O
patches	O
of	O
hair	O
,	O
and	O
prompted	O
the	O
editorial	O
to	O
call	O
for	O
increased	O
CT	S-Technology
quality	O
assurance	O
programs	O
,	O
while	O
also	O
noting	O
that	O
"	O
while	O
unnecessary	O
radiation	O
exposure	O
should	O
be	O
avoided	O
,	O
a	O
medically	O
needed	O
obtained	O
with	O
appropriate	O
acquisition	O
parameter	O
has	O
benefits	O
that	O
outweigh	O
the	O
radiation	O
risks.	O
"	O
Similar	O
problems	O
have	O
been	O
reported	O
at	O
other	O
centers	O
.	O

Until	O
recently	O
in	O
the	O
United	B-Location
States	E-Location
most	O
biological	O
defense	O
strategies	O
have	O
been	O
geared	O
to	O
protecting	O
soldiers	O
on	O
the	O
battlefield	O
rather	O
than	O
ordinary	O
people	O
in	O
cities	O
.	O

The	O
epidemic's	O
profound	O
political	O
and	O
economic	O
consequences	O
also	O
threaten	O
political	O
stability	O
and	O
the	O
ability	O
of	O
governments	O
to	O
counter	O
violent	O
extremism	O
from	O
terrorist	O
groups	O
such	O
as	O
Al-Qaeda	O
in	O
the	O
Islamic	O
Maghreb	O
and	O
Boko	O
Haram	O
.	O

The	O
burden	O
varied	O
greatly	O
among	O
countries	O
.	O

The	O
challenge	O
of	O
transporting	O
and	O
delivering	O
samples	O
containing	O
class	O
3	O
microorganisms	O
is	O
well	O
described	O
by	O
et	O
al	O
.	O

"	O
This	O
is	O
a	O
large-scale	O
operation	O
so	O
five-	O
or	O
10-year	O
programs	O
are	O
going	O
to	O
be	O
needed,	O
"	O
Lillibridge	S-Person
said	O
.	O

After	O
the	O
fall	O
of	O
the	O
Soviet	B-Organization
Union	E-Organization
the	O
Departments	O
of	O
State	O
,	O
Defense	O
,	O
and	O
Energy	O
implemented	O
the	O
Nunn-Lugar	B-Activity
Cooperative	I-Activity
Threat	I-Activity
Reduction	I-Activity
programs	E-Activity
to	O
reduce	O
risks	O
associated	O
with	O
dangerous	O
materials	O
,	O
equipment	O
,	O
and	O
expertise	O
from	O
the	O
Soviet	B-Organization
Union	E-Organization
's	O
nuclear	O
,	O
chemical	O
,	O
and	O
biological	O
weapons	O
programs	O
.	O

The	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	I-Organization
(DHS)	I-Organization
Science	I-Organization
and	I-Organization
Technology	I-Organization
Directorate	E-Organization
(mp;T)	O
recently	O
announced	O
the	O
winner	O
of	O
a	O
biothreat	O
competition	O
,	O
which	O
called	O
for	O
the	O
design	O
of	O
an	O
early	O
warning	O
system	O
that	O
uses	O
existing	O
data	O
sources	O
to	O
reveal	O
emerging	O
biothreats	O
.	O

Application	O
of	O
these	O
principles	O
to	O
animals	O
retained	O
in	O
outdoor	O
environments	O
has	O
been	O
a	O
consequence	O
of	O
disease	O
eradication	O
programs	O
.	O

Using	O
contrast	O
material	O
can	O
also	O
help	O
to	O
obtain	O
functional	O
information	O
about	O
tissues	O
.	O

But	O
in	O
Quebec	S-Location
,	O
smallpox	S-Pathogen
swept	O
through	O
the	O
,	O
helping	O
to	O
prompt	O
a	O
retreat	O
.	O

The	O
repository	O
includes	O
nearly	O
2,000	O
caches	O
of	O
nerve	O
agent	O
antidotes	O
,	O
known	O
as	O
Chempacks	O
,	O
that	O
are	O
stored	O
and	O
maintained	O
separately	O
from	O
the	O
warehouses	O
at	O
more	O
than	O
1,300	O
locations	O
around	O
the	O
country	O
where	O
they	O
can	O
be	O
accessed	O
quickly	O
.	O

The	O
peak	O
of	O
U.S.	S-Location
biological	O
weapons	O
delivery	O
system	O
development	O
came	O
during	O
the	O
1960s	O
.	O

Lower	O
radiation	O
doses	O
are	O
often	O
used	O
in	O
many	O
areas	O
,	O
such	O
as	O
in	O
the	O
investigation	O
of	O
renal	B-Technology
colic	E-Technology
.	O
Side	O
effects	O
from	O
intravenous	O
contrast	O
used	O
in	O
some	O
types	O
of	O
studies	O
include	O
the	O
possibility	O
of	O
exacerbating	O
kidney	O
problems	O
in	O
the	O
setting	O
of	O
pre-existing	O
.	O

Infectious	O
disease	O
control	O
through	O
improved	O
water	O
,	O
sanitation	O
and	O
hygiene	O
(WASH)	O
infrastructure	O
needs	O
to	O
be	O
included	O
in	O
the	O
antimicrobial	O
resistance	O
(AMR)	O
agenda	O
.	O

Its	O
first	O
legislative	O
act	O
was	O
concerning	O
the	O
compilation	O
of	O
accurate	O
statistics	O
on	O
the	O
spread	O
and	O
morbidity	O
of	O
disease	O
.	O

Most	O
prominent	O
among	O
medical	O
organizations	O
supporting	O
codes	O
of	O
conduct	O
have	O
been	O
the	O
World	B-Organization
Medical	I-Organization
Association	E-Organization
the	O
American	B-Organization
Medical	I-Organization
Association	E-Organization
,	O
and	O
the	O
British	B-Organization
Medical	I-Organization
Association	E-Organization
.	O
The	O
has	O
drawn	O
up	O
a	O
set	O
of	O
guidelines	O
to	O
prevent	O
the	O
malevolent	O
use	O
of	O
biomedical	O
research	O
,	O
in	O
which	O
physician	O
researchers	O
are	O
asked	O
to	O
assess	O
foreseeable	O
ramifications	O
before	O
they	O
participate	O
in	O
research	O
to	O
balance	O
the	O
promise	O
of	O
benefit	O
from	O
biomedical	O
innovation	O
against	O
potential	O
harms	O
from	O
corrupt	O
application	O
of	O
the	O
findings	O
.	O

Chinese	O
scientists	O
were	O
able	O
to	O
isolate	O
a	O
strain	O
of	O
the	O
coronavirus	O
and	O
publish	O
the	O
genetic	O
sequence	O
so	O
laboratories	O
across	O
the	O
world	O
could	O
independently	O
develop	O
polymerase	B-Technology
chain	I-Technology
reaction	I-Technology
(PCR)	I-Technology
tests	E-Technology
to	O
detect	O
infection	O
by	O
the	O
virus.	O
,	O
(which	O
may	O
detect	O
active	O
infections	O
and	O
whether	O
a	O
person	O
had	O
been	O
infected	O
in	O
the	O
past)	O
were	O
in	O
development	O
,	O
but	O
not	O
yet	O
widely	O
used	O
.	O

With	O
the	O
current	O
outbreak	O
,	O
it	O
was	O
initially	O
thought	O
that	O
a	O
new	O
species	O
native	O
to	O
Guinea	S-Location
might	O
be	O
the	O
cause	O
,	O
rather	O
than	O
being	O
imported	O
from	O
Middle	B-Location
to	I-Location
Western	I-Location
Africa	E-Location
.	O
However	O
,	O
further	O
studies	O
have	O
shown	O
that	O
the	O
outbreak	O
was	O
likely	O
caused	O
by	O
an	O
Ebola	B-Pathogen
virus	E-Pathogen
lineage	O
that	O
spread	O
from	O
Middle	B-Location
Africa	E-Location
via	O
an	O
animal	O
host	O
within	O
the	O
last	O
decade	O
,	O
with	O
the	O
first	O
viral	O
transfer	O
to	O
humans	O
in	O
.	O

This	O
was	O
made	O
possible	O
by	O
the	O
rapidly	O
increasing	O
number	O
of	O
transistors	O
on	O
a	O
single	O
integrated	O
circuit	O
chip	O
.	O

The	O
CDC	S-Organization
held	O
its	O
first	O
briefing	O
on	O
SARS	S-Disease
and	O
said	O
that	O
14	O
suspected	O
SARS	S-Disease
cases	O
were	O
being	O
investigated	O
in	O
the	O
US.	S-Location
On	O
20	O
March	O
,	O
WHO	S-Organization
reported	O
that	O
several	O
hospitals	O
in	O
Vietnam	S-Location
and	O
Hong	B-Location
Kong	E-Location
were	O
operating	O
with	O
half	O
the	O
usual	O
staff	O
because	O
many	O
workers	O
stayed	O
home	O
out	O
of	O
fear	O
of	O
getting	O
infected.	O
raised	O
the	O
concern	O
that	O
substandard	O
care	O
of	O
the	O
infected	O
patients	O
might	O
contribute	O
to	O
the	O
spread	O
of	O
the	O
disease	O
.	O

In	O
Tahiti	S-Location
,	O
13%	O
of	O
the	O
population	O
died	O
during	O
one	O
month	O
.	O

In	O
a	O
New	O
York	O
Times	O
report	O
,	O
the	O
Gates	O
Foundation	O
predicted	O
that	O
a	O
modern	O
outbreak	O
similar	O
to	O
the	O
(which	O
killed	O
between	O
50	O
million	O
and	O
100	O
million	O
people)	O
could	O
end	O
up	O
killing	O
more	O
than	O
360	O
million	O
people	O
worldwide	O
,	O
even	O
considering	O
widespread	O
availability	O
of	O
vaccines	O
and	O
other	O
healthcare	O
tools	O
.	O

These	O
patients	O
will	O
need	O
medical	O
care	O
for	O
months	O
and	O
maybe	O
years.	O
"	O
A	O
physician	O
from	O
the	O
Kenema	B-Organization
hospital	E-Organization
in	O
reported	O
similar	O
health	O
difficulties	O
.	O

The	O
WHO	S-Organization
is	O
financed	O
by	O
contributions	O
from	O
member	O
states	O
and	O
outside	O
donors.	O
,	O
the	O
largest	O
annual	O
assessed	O
contributions	O
from	O
member	O
states	O
came	O
from	O
the	O
United	B-Location
States	E-Location
($110 million)	O
,	O
Japan	S-Location
($58 million)	O
,	O
Germany	S-Organization
($37 million)	O
,	O
United	B-Location
Kingdom	E-Location
($31 million)	O
and	O
($31 million)	O
.	O

Bacillus	B-Pathogen
anthracis	E-Pathogen
was	O
included	O
in	O
NIH	S-Organization
biosafety	O
category	O
risk	O
group	O
2	O
,	O
but	O
was	O
included	O
in	O
risk	O
group	O
3	O
according	O
to	O
the	O
EU	S-Location
categorization	O
.	O

In	O
a	O
specific	O
combat	O
situation	O
,	O
the	O
attacked	O
side	O
will	O
be	O
unable	O
to	O
identify	O
the	O
nature	O
of	O
the	O
chemical	O
used	O
and	O
might	O
feel	O
tempted	O
to	O
retaliate	O
in	O
kind	O
with	O
potentially	O
lethal	O
chemicals	O
.	O

Because	O
the	O
available	O
signal	O
is	O
used	O
to	O
encode	O
spatial	O
and	O
spectral	O
information	O
,	O
MRSI	S-Technology
requires	O
high	O
SNR	O
achievable	O
only	O
at	O
higher	O
field	O
strengths	O
(3	O
T	O
and	O
above)	O
.	O

Research	O
has	O
shown	O
that	O
viral	O
illnesses	O
like	O
Ebola	S-Disease
,	O
HIV	S-Disease
,	O
influenza	S-Disease
,	O
and	O
affect	O
men	O
and	O
women	O
differently	O
.	O

I	O
just	O
wanted	O
to	O
know	O
what	O
some	O
of	O
your	O
concerns	O
would	O
be	O
coming	O
into	O
this	O
position	O
.	O

Chikwe	B-Person
Ihekweazu	E-Person
is	O
the	O
CEO	O
of	O
the	O
.	O

Our	O
laboratories	O
are	O
core	O
to	O
our	O
ability	O
to	O
protect	O
Americans	O
.	O

The	O
Lugar	B-Organization
Center	E-Organization
is	O
the	O
Pentagon	B-Organization
bio	I-Organization
laboratory	E-Organization
in	O
Georgia	S-Location
.	O
It	O
is	O
located	O
just	O
17	O
km	O
away	O
from	O
the	O
US	B-Organization
Vaziani	I-Organization
military	I-Organization
airbase	E-Organization
in	O
the	O
capital	O
Tbilisi	S-Location
.	O
Tasked	O
with	O
the	O
military	O
program	O
are	O
biologists	O
from	O
the	O
US	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Unit-Georgia	E-Organization
(	O
USAMRU-G	S-Organization
)	O
along	O
with	O
private	O
contractors	O
.	O

The	O
virus	O
created	O
a	O
shortage	O
of	O
precursors	O
used	O
in	O
the	O
manufacturing	O
of	O
fentanyl	O
and	O
methamphetamine	O
.	O

The	O
researcher's	O
family	O
was	O
moved	O
to	O
a	O
hotel	O
and	O
later	O
an	O
apartment	O
during	O
the	O
quarantine	O
.	O

The	O
Koltsovo	B-Incident
incident	E-Incident
may	O
fuel	O
concern	O
about	O
the	O
safety	O
of	O
Russia	S-Location
's	O
many	O
secret	O
installations	O
.	O

Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
was	O
a	O
remote	O
Catholic	O
hospital	O
and	O
had	O
no	O
doctors	O
and	O
no	O
laboratory	O
facilities	O
to	O
aid	O
in	O
diagnosis	O
.	O

Trichothecenes	B-Pathogen
Mycotoxin	E-Pathogen
is	O
a	O
toxin	O
that	O
can	O
be	O
extracted	O
from	O
Wheat	B-Pathogen
Stem	I-Pathogen
Rust	E-Pathogen
and	O
Rice	B-Pathogen
Blast	E-Pathogen
and	O
can	O
kill	O
or	O
incapacitate	O
depending	O
on	O
the	O
concentration	O
used	O
.	O

As	O
a	O
positive	O
control	O
Vero	O
cells	O
were	O
infected	O
with	O
10−3	O
dilution	O
of	O
HSV	S-Pathogen
with	O
10 μM	O
of	O
(Sigma	O
Aldrich)	O
,	O
a	O
known	O
anti‐HSV	O
agent	O
.	O

In	O
1999	O
Rosenberg	S-Person
was	O
fired	O
.	O

On	O
6	O
March	O
,	O
the	O
Italian	B-Organization
College	I-Organization
of	I-Organization
Anaesthesia,	I-Organization
Analgesia,	I-Organization
Resuscitation	I-Organization
and	I-Organization
Intensive	I-Organization
Care	E-Organization
(	O
SIAARTI	S-Organization
)	O
published	O
medical	O
ethics	O
recommendations	O
regarding	O
triage	O
protocols	O
.	O

In	O
addition	O
,	O
many	O
countries	O
have	O
their	O
own	O
,	O
similar	O
provisions	O
for	O
ground	O
transport	O
.	O

In	O
Austria	S-Location
39%	O
fewer	O
persons	O
sought	O
help	O
for	O
cardiac	B-Disease
symptoms	E-Disease
in	O
the	O
month	O
of	O
March	O
.	O

Over	O
8,000	O
people	O
from	O
29	O
different	O
countries	O
and	O
territories	O
were	O
infected	O
,	O
and	O
at	O
least	O
774	O
died	O
worldwide	O
.	O

In	O
,	O
0.	O
57%	O
of	O
the	O
population	O
has	O
died	O
.	O

Post-war	O
inspections	O
by	O
UNSCOM	S-Organization
,	O
however	O
,	O
were	O
confounded	O
by	O
misinformation	O
and	O
obfuscation	O
.	O

Other	O
nations	O
,	O
notably	O
France	O
and	O
Japan	O
,	O
had	O
begun	O
their	O
own	O
biological-weapons	O
programs	O
.	O

A	O
2017	O
report	O
from	O
the	O
Brookings	B-Organization
Institute	E-Organization
cautions	O
that	O
biohacking	O
simultaneously	O
makes	O
science	O
available	O
to	O
everyone	O
while	O
also	O
introducing	O
countless	O
new	O
safety	O
concerns	O
.	O

"	O
I	O
want	O
to	O
make	O
clear	O
to	O
the	O
committee	O
that	O
this	O
is	O
a	O
reauthorization	O
of	O
a	O
national	O
security	O
bill,	O
"	O
Burr	S-Person
said	O
,	O
even	O
though	O
the	O
federal	O
agencies	O
that	O
oversee	O
public	O
health	O
are	O
funded	O
by	O
non-defense	O
monies	O
.	O

The	O
global	O
action	O
plan	O
aims	O
to	O
ensure	O
prevention	O
and	O
treatment	O
of	O
infectious	O
diseases	O
with	O
safe	O
and	O
effective	O
medicines	O
.	O

First	O
is	O
the	O
potential	O
exposure	O
to	O
anthrax	S-Pathogen
Today	O
,	O
we're	O
releasing	O
the	O
results	O
,	O
in	O
fact	O
,	O
our	O
full	O
internal	O
investigation	O
of	O
that	O
incident	O
as	O
well	O
as	O
the	O
steps	O
we're	O
taking	O
that	O
will	O
do	O
everything	O
humanly	O
possible	O
to	O
make	O
sure	O
that	O
nothing	O
like	O
that	O
happens	O
again	O
.	O

It	O
found	O
that	O
DHS	S-Organization
has	O
not	O
fully	O
integrated	O
and	O
coordinated	O
its	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

The	O
mistake	O
was	O
realized	O
shortly	O
after	O
,	O
but	O
by	O
then	O
some	O
anthrax	S-Pathogen
spores	O
were	O
released	O
.	O

It	O
will	O
drastically	O
improve	O
our	O
ability	O
to	O
help	O
pre-hospital	O
combat	O
medics	O
,	O
corpsmen	O
,	O
and	O
providers	O
in	O
austere	O
environments.	O
"	O

The	O
current	O
classification	O
uses	O
Risk	O
Groups	O
(Rgs)	O
instead	O
of	O
Risk	O
Classes	O
and	O
agents	O
are	O
classified	O
according	O
to	O
their	O
relative	O
pathogenicity	O
for	O
healthy	O
adult	O
humans	O
.	O

There	O
is	O
no	O
single	O
best	O
approach	O
in	O
the	O
development	O
and	O
implementation	O
of	O
a	O
national	O
biosafety	O
system	O
and	O
each	O
country	O
is	O
faced	O
with	O
unique	O
challenges	O
.	O

Thus	O
,	O
more	O
sophisticated	O
studies	O
are	O
required	O
at	O
individual	O
country	O
level	O
for	O
representative	O
situational	O
analysis	O
.	O

According	O
to	O
the	O
WHO	S-Organization
,	O
resistance	O
to	O
vaccination	O
in	O
the	O
was	O
ongoing	O
as	O
of	O
March	O
2019	O
.	O

If	O
some	O
worst-case	O
scenarios	O
are	O
to	O
be	O
believed	O
,	O
then	O
terrorist	O
groups	O
could	O
use	O
the	O
recent	O
outbreak	O
of	O
Ebola	S-Disease
in	O
Africa	S-Location
to	O
their	O
advantage	O
.	O

The	O
WHO	S-Organization
has	O
published	O
various	O
tools	O
for	O
measuring	O
and	O
monitoring	O
the	O
capacity	O
of	O
national	O
health	O
systems	O
and	O
health	O
workforces	O
.	O

Official	O
deaths	O
from	O
COVID-19	S-Disease
generally	O
refer	O
to	O
people	O
who	O
died	O
after	O
testing	O
positive	O
according	O
to	O
protocols	O
.	O

The	O
advantage	O
of	O
pooled	O
libraries	O
is	O
that	O
more	O
genes	O
can	O
be	O
targeted	O
at	O
once	O
.	O

These	O
countries	O
hosted	O
biosafety	O
programs	O
,	O
reflecting	O
the	O
heightened	O
concern	O
in	O
the	O
region	O
.	O

This	O
EU	B-Document
legislation	E-Document
complements	O
the	O
agreement	O
on	O
cross-border	O
cooperation	O
to	O
combat	O
certain	O
contagious	O
human	O
diseases	O
.	O

CRISPR-Cas9	S-Technology
often	O
employs	O
a	O
plasmid	O
to	O
transfect	O
the	O
target	O
cells	O
.	O

If	O
scientists	O
can	O
build	O
genes	O
from	O
scratch	O
,	O
they	O
can	O
create	O
organisms	O
with	O
new	O
traits	O
.	O

Aedes	O
Aegypti	O
Mosquitoes	O
have	O
been	O
distributed	O
only	O
in	O
Georgia	S-Location
Southern	B-Location
Russia	E-Location
and	O
Northern	B-Location
Turkey	E-Location
.	O
They	O
were	O
detected	O
for	O
the	O
first	O
time	O
in	O
2014	O
after	O
the	O
start	O
of	O
the	O
Pentagon	B-Scientific_research_project
program	E-Scientific_research_project
at	O
The	O
.	O

Other	O
investigators	O
are	O
thinking	O
further	O
outside	O
the	O
box	O
,	O
working	O
to	O
harness	O
the	O
potential	O
of	O
bacteriophages	O
,	O
or	O
bacteria-eating	O
viruses	O
.	O

The	O
person	O
was	O
a	O
54-year-old	O
man	O
who	O
had	O
traveled	O
to	O
Jeddah	S-Location
,	O
Saudi	B-Location
Arabia	E-Location
,	O
together	O
with	O
pilgrimage	O
group	O
composed	O
of	O
18	O
people	O
,	O
from	O
15–28	O
March	O
2014	O
.	O

In	O
areas	O
with	O
decreasing	O
malaria	S-Disease
incidence	O
,	O
many	O
febrile	O
patients	O
are	O
inappropriately	O
treated	O
for	O
malaria	S-Disease
,	O
and	O
in	O
the	O
absence	O
of	O
a	O
simple	O
diagnostic	O
test	O
to	O
identify	O
alternative	O
causes	O
of	O
fever	S-Phenotype
,	O
clinicians	O
presume	O
that	O
a	O
non-malarial	O
febrile	O
illness	O
is	O
most	O
likely	O
a	O
bacterial	O
infection	O
,	O
leading	O
to	O
inappropriate	O
use	O
of	O
antibiotics	O
.	O

How	O
we	O
train	O
staff	O
and	O
how	O
we	O
make	O
sure	O
that	O
new	O
staff	O
are	O
trained	O
,	O
that	O
people	O
learn	O
from	O
past	O
incidents	O
and	O
that	O
procedures	O
are	O
in	O
place	O
that	O
are	O
clear	O
,	O
understandable	O
,	O
easy	O
to	O
follow	O
and	O
that	O
training	O
is	O
then	O
assessed	O
and	O
repeated	O
as	O
necessary	O
.	O

An	O
estimated	O
date	O
for	O
its	O
appearance	O
in	O
mammalian	O
hosts	O
has	O
been	O
put	O
at	O
the	O
period	O
1882–1913	O
.	O

According	O
to	O
international	O
medical	O
geneticists	O
led	O
by	O
Mark	B-Person
Achtman	E-Person
that	O
analysed	O
the	O
global	O
sequence	O
variation	O
of	O
the	O
bacterium	O
,	O
all	O
three	O
of	O
the	O
great	O
waves	O
of	O
the	O
plague	S-Disease
had	O
their	O
bacterium	O
"	O
evolved	O
in	O
or	O
near	O
China	S-Location
"	O
.	O
The	O
analysis	O
also	O
found	O
that	O
"	O
sylvatic	O
cycles	O
of	O
disease	O
depend	O
on	O
transmission	O
by	O
flea	O
vectors	O
"	O
and	O
"	O
the	O
likely	O
origin	O
of	O
the	O
plague	S-Disease
in	O
has	O
nothing	O
to	O
do	O
with	O
its	O
people	O
or	O
crowded	O
cities"	O
.	O

ID	B-Organization
Genomics	E-Organization
is	O
currently	O
developing	O
its	O
barcode	O
technology	O
into	O
a	O
rapid	O
test	O
targeting	O
urinary	O
tract	O
infections	O
,	O
but	O
Sokurenko	S-Person
said	O
the	O
will	O
be	O
open	O
to	O
other	O
researchers	O
working	O
on	O
rapid	O
diagnostics	O
.	O

This	O
stage	O
introduces	O
working	O
techniques	O
with	O
viruses	O
while	O
teaching	O
students	O
the	O
principles	O
of	O
plaque	O
counting	O
.	O

They	O
continue	O
to	O
have	O
the	O
potential	O
to	O
be	O
used	O
as	O
weapons	O
against	O
individuals	O
.	O

A	O
jet	O
aircraft	O
released	O
material	O
over	O
Victoria	S-Location
Texas	S-Location
,	O
that	O
was	O
monitored	O
in	O
the	O
.	O

After	O
intensive	O
review	O
by	O
CDC	S-Organization
internal	O
Laboratory	B-Organization
Safety	I-Organization
Improvement	I-Organization
Working	I-Organization
Group	E-Organization
(internal	O
working	O
group)	O
,	O
CDC	S-Organization
Director	O
Tom	B-Person
Frieden	E-Person
,	O
M.D.	O
,	O
M.P.H.	O
,	O
has	O
lifted	O
the	O
moratorium	O
on	O
a	O
specific	O
type	O
of	O
material	O
transfer	O
for	O
the	O
CDC's	B-Organization
Clinical	I-Organization
Tuberculosis	I-Organization
Laboratory	E-Organization
.	O
The	O
moratorium	O
remains	O
in	O
place	O
for	O
other	O
high-containment	O
(	O
BSL-3	S-Platform
and	O
)	O
laboratories	O
.	O

In	O
April	O
2019	O
,	O
passive	O
surveillance	O
by	O
the	O
Veterinary	B-Platform
Laboratory	I-Platform
Information	I-Platform
and	I-Platform
Response	I-Platform
Network	I-Platform
of	I-Platform
the	I-Platform
US	I-Platform
Food	I-Platform
and	I-Platform
Drug	I-Platform
Administration	E-Platform
identified	O
the	O
blaNDM-5	O
gene	O
in	O
a	O
isolated	O
from	O
a	O
dog	O
in	O
July	O
2018	O
.	O

Presently	O
the	O
Pentagon	S-Organization
produces	O
and	O
tests	O
live	O
bio-	O
agents	O
at	O
the	O
same	O
military	O
facility	O
as	O
it	O
did	O
in	O
the	O
past	O
–	O
.	O

TOM	B-Person
FRIEDEN	E-Person
So	O
there	O
are	O
multiple	O
forms	O
of	O
avian	B-Disease
flu	E-Disease
,	O
and	O
this	O
is	O
one	O
of	O
them	O
.	O

As	O
the	O
disease	O
took	O
hold	O
,	O
Genoese	S-Organization
traders	O
fled	O
across	O
the	O
Black	B-Location
Sea	E-Location
to	O
Constantinople	S-Location
,	O
where	O
the	O
disease	O
first	O
arrived	O
in	O
Europe	S-Location
in	O
summer	O
1347	O
.	O

Merck.Covert	O
,	O
Norman	O
M.	O
(2000)	O
,	O
"	O
A	O
History	O
of	O
Fort	O
Detrick	O
,	O
Maryland"	O
,	O
4th	O
Edition:	O
2000	O
.	O

The	O
Kivu	S-Location
Ebola	S-Disease
epidemic	O
began	O
on	O
1	O
August	O
2018	O
,	O
when	O
it	O
was	O
confirmed	O
that	O
four	O
cases	O
had	O
tested	O
positive	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
(	O
EVD	S-Disease
)	O
in	O
the	O
eastern	O
region	O
of	O
Kivu	S-Location
in	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
(	O
DRC	S-Location
)	O
.	O

There	O
is	O
significant	O
room	O
for	O
improving	O
this	O
process	O
,	O
and	O
a	O
strong	O
case	O
for	O
making	O
screening	O
mandatory	O
.	O

People	O
can	O
transmit	O
the	O
virus	O
without	O
showing	O
symptoms	O
,	O
but	O
according	O
to	O
the	O
WHO	S-Organization
and	O
,	O
it	O
is	O
unknown	O
how	O
often	O
this	O
happens	O
.	O

Illness	O
rates	O
were	O
high	O
,	O
but	O
death	O
rates	O
in	O
most	O
locales	O
were	O
not	O
appreciably	O
above	O
normal	O
.	O

On	O
8	O
August	O
2014	O
,	O
WHO	S-Organization
declared	O
that	O
the	O
spread	O
of	O
Ebola	S-Disease
was	O
a	O
public	O
health	O
emergency	O
;	O
an	O
outbreak	O
which	O
was	O
believed	O
to	O
have	O
started	O
in	O
Guinea	S-Location
had	O
spread	O
to	O
other	O
nearby	O
countries	O
such	O
as	O
Liberia	S-Location
and	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
situation	O
in	O
was	O
considered	O
very	O
serious	O
.	O

Various	O
intergovernmental	O
organizations	O
have	O
also	O
supported	O
codes	O
of	O
conduct	O
.	O

During	O
the	O
Gulf	O
War	O
,	O
US	S-Location
and	O
other	O
intelligence	O
reports	O
had	O
suggested	O
that	O
Iraq	S-Location
was	O
operating	O
a	O
BW	O
program	O
.	O

The	O
DoD	S-Organization
selected	O
GlobalMed	S-Organization
for	O
its	O
that	O
seamlessly	O
and	O
securely	O
connects	O
healthcare	O
professionals	O
and	O
patients	O
,	O
regardless	O
of	O
location	O
.	O

And	O
the	O
fact	O
that	O
they	O
had	O
to	O
deal	O
with	O
uncertainty	O
,	O
stress	O
,	O
potential	O
risk	O
and	O
to	O
take	O
preventive	O
medicines	O
that	O
can	O
have	O
adverse	O
events	O
as	O
a	O
result	O
of	O
this	O
incident	O
is	O
something	O
that	O
I	O
feel	O
terrible	O
about	O
,	O
and	O
I	O
wish	O
had	O
not	O
happened	O
.	O

He	O
concluded	O
t	O
hat	B-Organization
the	I-Organization
Unite	E-Organization
d	O
States	O
did	O
,	O
in	O
fact	O
,	O
test	O
biological	O
weath	O
Korea	O
during	O
the	O
Korean	O
War	O
.	O

Each	O
region	O
has	O
a	O
regional	O
committee	O
,	O
which	O
generally	O
meets	O
once	O
a	O
year	O
,	O
normally	O
in	O
the	O
autumn	O
.	O

Ninth	O
,	O
as	O
I	O
mentioned	O
,	O
I'm	O
requiring	O
that	O
disciplinary	O
action	O
be	O
taken	O
as	O
appropriate	O
for	O
any	O
staff	O
member	O
who	O
knowingly	O
departed	O
from	O
lab	O
safety	O
protocols	O
or	O
who	O
knew	O
about	O
lab	O
safety	O
incidents	O
and	O
didn't	O
report	O
them	O
promptly	O
.	O

The	O
viral	O
genotypic	O
basis	O
of	O
this	O
pathogenicity	O
is	O
not	O
yet	O
mapped	O
.	O

So	O
all	O
materials	O
either	O
should	O
have	O
been	O
here	O
in	O
our	O
laboratory	O
where	O
they're	O
secured	O
or	O
in	O
Russia	S-Location
or	O
destroyed	O
.	O

The	O
disease	O
,	O
which	O
these	O
flies	O
carry	O
,	O
is	O
of	O
high	O
interest	O
to	O
the	O
Pentagon	S-Organization
In	O
2003	O
during	O
the	O
US	B-Incident
invasion	I-Incident
of	I-Incident
Iraq	E-Incident
American	O
soldiers	O
were	O
severely	O
bitten	O
by	O
sand	O
flies	O
and	O
contracted	O
Leishmoniasis	S-Disease
.	O
The	O
disease	O
is	O
native	O
to	O
Iraq	S-Location
and	O
Afghanistan	S-Location
and	O
if	O
left	O
untreated	O
the	O
acute	O
form	O
of	O
can	O
be	O
fatal	O
.	O

After	O
the	O
GHSA	S-International_exchange_and_cooperation
Ministerial	O
Meeting	O
,	O
Hargan	S-Person
traveled	O
to	O
Thailand	S-Location
to	O
visit	O
the	O
CDC	B-Organization
Bamrasnaradura	I-Organization
Infectious	I-Organization
Disease	I-Organization
Institute	I-Organization
laboratories	E-Organization
and	O
Bumrungrad	B-Organization
Hospital	E-Organization
.	O
He	O
also	O
met	O
with	O
his	O
Thai	S-Organization
counterparts	O
as	O
well	O
as	O
CDC	S-Organization
staff	O
in	O
the	O
country	O
to	O
address	O
global	O
health	O
security	O
concerns	O
such	O
as	O
influenza	S-Disease
,	O
malaria	S-Disease
,	O
dengue	S-Disease
,	O
and	O
tuberculosis	S-Disease
.	O
From	O
there	O
,	O
Hargan	S-Person
traveled	O
to	O
Laos	S-Location
to	O
meet	O
with	O
the	O
to	O
discuss	O
ways	O
to	O
combat	O
emerging	O
and	O
re-emerging	O
disease	O
threats	O
.	O

Tian	B-Person
D	E-Person
.	O
Comparison	O
and	O
Analysis	O
of	O
Biological	O
Agent	O
Category	O
Lists	O
Based	O
On	O
Biosafety	O
and	O
Biodefense.PLoS	O
One.2014;9(6).	O
.	O

Besides	O
,	O
the	O
generation	O
of	O
multiple	O
Cas9	O
modifications	O
to	O
improve	O
both	O
its	O
sensitivity	O
and	O
performance	O
avoiding	O
undesirable	O
off-target	O
effects	O
is	O
one	O
of	O
the	O
main	O
assets	O
of	O
the	O
incorporation	O
of	O
as	O
key	O
player	O
in	O
genome	O
editing	O
.	O

The	O
Guidelines	B-Document
for	I-Document
Biosafety	I-Document
Training	I-Document
Programs	I-Document
for	I-Document
Workers	I-Document
Assigned	I-Document
to	I-Document
BSL-3	I-Document
Research	I-Document
Laboratories	E-Document
were	O
developed	O
by	O
biosafety	O
professionals	O
who	O
oversee	O
training	O
programs	O
for	O
the	O
2	O
national	O
biocontainment	O
laboratories	O
(NBLs)	O
and	O
the	O
13	O
regional	O
biocontainment	O
laboratories	O
(RBLs)	O
that	O
participate	O
in	O
the	O
National	B-Platform
Institute	I-Platform
of	I-Platform
Allergy	I-Platform
and	I-Platform
Infectious	I-Platform
Diseases	I-Platform
(NIAID)	I-Platform
NBL/RBL	I-Platform
Network	E-Platform
.	O
These	O
guidelines	O
provide	O
a	O
general	O
training	O
framework	O
for	O
biosafety	B-Platform
level	I-Platform
3	E-Platform
()	O
high-containment	O
laboratories	O
,	O
identify	O
key	O
training	O
concepts	O
,	O
and	O
outline	O
training	O
methodologies	O
designed	O
to	O
standardize	O
base	O
knowledge	O
,	O
understanding	O
,	O
and	O
technical	O
competence	O
of	O
laboratory	O
personnel	O
working	O
in	O
high-containment	O
laboratories	O
.	O

The	O
pain	O
is	O
symmetrical	O
and	O
more	O
pronounced	O
in	O
the	O
morning	O
,	O
with	O
the	O
larger	O
joints	O
most	O
affected	O
.	O

A	O
covert	O
military	O
research	O
and	O
development	O
program	O
continued	O
for	O
another	O
four	O
years	O
,	O
with	O
the	O
intent	O
of	O
resuming	O
agent	O
production	O
and	O
weapons	O
manufacture	O
after	O
the	O
end	O
of	O
UN	S-Organization
sanctions	O
.	O

This	O
report	O
will	O
be	O
shared	O
with	O
US	S-Location
government	O
agencies	O
and	O
departments	O
that	O
oversee	O
global	O
health	O
security	O
programs	O
.	O

Several	O
(25	O
January)	O
celebrations	O
were	O
also	O
cancelled	O
.	O

None	O
has	O
yet	O
been	O
shown	O
to	O
be	O
clearly	O
effective	O
on	O
mortality	O
in	O
published	O
randomised	O
controlled	O
trials	O
.	O

Fonnie	O
was	O
also	O
a	O
co-author	O
of	O
a	O
study	O
that	O
analysed	O
the	O
genetics	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
;	O
five	O
others	O
contracted	O
and	O
died	O
while	O
working	O
on	O
the	O
same	O
study	O
.	O

As	O
of	O
April	O
2014	O
,	O
the	O
European	B-Organization
Centre	I-Organization
for	I-Organization
Disease	I-Organization
Prevention	I-Organization
and	I-Organization
Control	E-Organization
reported	O
a	O
total	O
of	O
4	O
cases	O
in	O
,	O
3	O
of	O
which	O
were	O
fatalities	O
.	O

On	O
1May	O
2020	O
,	O
the	O
United	B-Location
States	E-Location
gave	O
emergency	O
use	O
authorization	O
(not	O
full	O
approval)	O
for	O
remdesivir	S-Equipment
in	O
people	O
hospitalized	O
with	O
severe	O
after	O
a	O
study	O
suggested	O
it	O
reduced	O
the	O
duration	O
of	O
recovery	O
.	O

The	O
same	O
approach	O
should	O
be	O
applied	O
to	O
antibiotic	O
resistance	O
;	O
a	O
new	O
generation	O
of	O
physician/scientists	O
with	O
modern	O
approaches	O
to	O
diagnostic/predictive	O
medicine	O
needs	O
to	O
be	O
trained	O
.	O

As	O
shown	O
in	O
Fig.	O
1	O
,	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
mainly	O
consists	O
of	O
a	O
BSL-3	S-Platform
laboratory	O
with	O
negative	O
pressure	O
,	O
a	O
BSL-2	S-Platform
laboratory	O
,	O
a	O
PCR	S-Equipment
preparation	O
room	O
,	O
a	O
storage	O
room	O
and	O
two	O
sets	O
of	O
dressing	O
rooms	O
(including	O
two	O
1st	O
changing	O
rooms	O
,	O
two	O
shower	O
rooms	O
and	O
one	O
2nd	O
changing	O
room)	O
.	O

Reduce	O
the	O
number	O
of	O
dangerous	O
pathogens	O
we	O
work	O
with	O
in	O
those	O
laboratories	O
.	O

While	O
using	O
IV	O
treatment	O
for	O
as	O
many	O
patients	O
as	O
they	O
could	O
manage	O
,	O
they	O
argued	O
that	O
improperly	O
managed	O
IV	O
treatment	O
was	O
not	O
helpful	O
and	O
may	O
even	O
kill	O
a	O
patient	O
when	O
not	O
properly	O
managed	O
.	O

While	O
reference	O
will	O
be	O
made	O
to	O
EU	S-Location
regulations	O
,	O
the	O
underlying	O
principles	O
of	O
biosafety	O
and	O
risk	O
assessment	O
are	O
generic	O
to	O
most	O
countries	O
.	O

And	O
I'll	O
be	O
happy	O
to	O
answer	O
questions	O
.	O

The	O
organization	O
was	O
renamed	O
the	O
Center	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
(	O
CDC	S-Organization
)	O
on	O
June	O
24	O
,	O
1970	O
,	O
and	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
effective	O
October	O
14	O
,	O
1980	O
.	O

When	O
you	O
consider	O
the	O
viral	O
infectious	O
diseases	O
that	O
emerged	O
and	O
reemerged	O
around	O
the	O
world	O
in	O
2017	O
alone	O
,	O
what	O
many	O
of	O
them	O
have	O
in	O
common	O
is	O
that	O
they	O
originated	O
in	O
animals	O
and	O
spilled	O
over	O
into	O
humans	O
after	O
a	O
series	O
of	O
mutations	O
that	O
enable	O
the	O
pathogens	O
to	O
jump	O
species	O
.	O

MICHAEL	B-Person
BELL	E-Person
Thank	O
you	O
for	O
asking	O
that	O
.	O

On	O
12	O
August	O
2019	O
,	O
it	O
was	O
announced	O
that	O
two	O
clinical	O
trial	O
medications	O
were	O
found	O
to	O
improve	O
the	O
rate	O
of	O
survival	O
in	O
those	O
infected	O
by	O
EVD	S-Disease
They	O
are	O
REGN-EB3	S-Drug
,	O
a	O
cocktail	O
of	O
three	O
monoclonal	O
Ebola	S-Pathogen
antibodies	O
,	O
and	O
mAb114	S-Drug
.	O
These	O
two	O
will	O
be	O
further	O
used	O
in	O
therapy	O
;	O
when	O
used	O
shortly	O
after	O
infection	O
they	O
were	O
found	O
to	O
have	O
a	O
90%	O
survival	O
rate	O
.	O

The	O
second	O
session	O
hosted	O
renowned	O
science	O
journalist	O
Jennifer	B-Person
Kahn	E-Person
who	O
discussed	O
advancements	O
in	O
Clustered	B-Technology
Regularly	I-Technology
Interspaced	I-Technology
Short	I-Technology
Palindromic	I-Technology
Repeats	E-Technology
()	O
,	O
a	O
genome-editing	O
technology	O
that	O
enables	O
researchers	O
to	O
permanently	O
modify	O
genes	O
in	O
living	O
cells	O
and	O
potentially	O
correct	O
mutations	O
in	O
order	O
to	O
treat	O
genetic	O
causes	O
of	O
disease	O
.	O

Two	O
days	O
later	O
the	O
total	O
count	O
was	O
nearly	O
100	O
cases	O
.	O

"	O
Not	O
even	O
the	O
exposure	O
we	O
had	O
in	O
2001,	O
"	O
Adalja	S-Person
said.	O
"	O
We're	O
talking	O
about	O
the	O
Super	O
Bowl	O
or	O
something	O
like	O
that.	O
"	O

Real-time	B-Technology
MRI	E-Technology
refers	O
to	O
the	O
continuous	O
imaging	O
of	O
moving	O
objects	O
(such	O
as	O
the	O
heart)	O
in	O
real	O
time	O
.	O

The	O
risk	O
for	O
transmission	O
of	O
from	O
animals	O
to	O
persons	O
is	O
currently	O
poorly	O
understood	O
.	O

While	O
DNA	B-Technology
sequencing	E-Technology
alone	O
cannot	O
make	O
bioweapons	O
,	O
it's	O
hard	O
to	O
imagine	O
waging	O
biological	O
warfare	O
without	O
being	O
able	O
to	O
analyze	O
the	O
genes	O
of	O
infectious	O
or	O
deadly	O
cells	O
or	O
viruses	O
.	O

"	O
The	O
thing	O
about	O
Ebola	S-Pathogen
is	O
that	O
it's	O
not	O
easy	O
to	O
work	O
with,	O
"	O
said.	O
"	O
It	O
would	O
be	O
difficult	O
to	O
weaponize.	O
"	O

COVID-19	S-Disease
can	O
be	O
provisionally	O
diagnosed	O
on	O
the	O
basis	O
of	O
symptoms	O
and	O
confirmed	O
using	O
reverse	B-Technology
transcription	I-Technology
polymerase	I-Technology
chain	I-Technology
reaction	E-Technology
(	O
RT-PCR	S-Technology
)	O
testing	O
of	O
infected	O
secretions	O
or	O
of	O
the	O
chest	O
.	O

Analysis	O
by	O
age	O
in	O
China	S-Location
indicates	O
that	O
a	O
relatively	O
low	O
proportion	O
of	O
cases	O
occur	O
in	O
individuals	O
under	O
20	O
.	O

But	O
there's	O
going	O
to	O
be	O
time	O
to	O
answer	O
questions	O
.	O

One	O
exceptional	O
example	O
of	O
outstanding	O
community	O
spirit	O
are	O
the	O
human	B-Document
genome	I-Document
project's	I-Document
Bermuda	I-Document
principles	E-Document
with	O
the	O
requirement	O
to	O
upload	O
sequences	O
to	O
a	O
public	O
database	O
within	O
24	O
h	O
but	O
usually	O
the	O
willingness	O
to	O
share	O
systems	O
biology	O
data	O
is	O
not	O
that	O
high	O
(see	O
'Policies'	O
section).	O
et	O
al.	O
studied	O
reasons	O
why	O
researchers	O
do	O
not	O
want	O
to	O
share	O
and	O
give	O
a	O
detailed	O
description	O
that	O
emphasizes	O
lack	O
of	O
resources	O
and	O
lack	O
of	O
expertise	O
as	O
the	O
main	O
reasons	O
why	O
data	O
are	O
not	O
shared	O
easily	O
.	O

After	O
the	O
initial	B-Incident
outbreak	I-Incident
of	I-Incident
COVID‑19	E-Incident
conspiracy	O
theorists	O
spread	O
misinformation	O
and	O
disinformation	O
regarding	O
the	O
origin	O
,	O
scale	O
,	O
prevention	O
,	O
treatment	O
,	O
and	O
other	O
aspects	O
of	O
the	O
disease	O
,	O
which	O
rapidly	O
spread	O
online	O
.	O

According	O
to	O
the	O
2005	O
Agreement	O
between	O
the	O
US	B-Organization
DoD	E-Organization
and	O
the	O
Ministry	B-Organization
of	I-Organization
Health	I-Organization
of	I-Organization
Ukraine	E-Organization
the	O
Ukrainian	B-Organization
government	E-Organization
is	O
prohibited	O
from	O
public	O
disclosure	O
of	O
sensitive	O
information	O
about	O
the	O
US	S-Location
program	O
and	O
Ukraine	S-Organization
is	O
obliged	O
to	O
transfer	O
to	O
the	O
US	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)	O
dangerous	O
pathogens	O
for	O
biological	O
research	O
.	O

WHO	S-Organization
created	O
the	O
,	O
which	O
brings	O
together	O
other	O
networks	O
that	O
are	O
involved	O
in	O
policy	O
making	O
and	O
the	O
dissemination	O
of	O
guidelines	O
.	O

On	O
31	O
December	O
2019	O
,	O
the	O
WHO	B-Organization
China	I-Organization
Country	I-Organization
Office	E-Organization
was	O
informed	O
of	O
cases	O
of	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
(unknown	O
cause)	O
detected	O
in	O
Wuhan	B-Location
City	E-Location
,	O
Hubei	B-Location
Province	I-Location
of	I-Location
China	E-Location
.	O
As	O
of	O
3	O
January	O
2020	O
,	O
a	O
total	O
of	O
44	O
patients	O
with	O
pneumonia	S-Disease
of	O
unknown	O
etiology	O
have	O
been	O
reported	O
to	O
WHO	S-Organization
by	O
the	O
national	O
authorities	O
in	O
China	S-Location
.	O
Of	O
the	O
44	O
cases	O
reported	O
,	O
11	O
are	O
severely	O
ill	O
,	O
while	O
the	O
remaining	O
33	O
patients	O
are	O
in	O
stable	O
condition	O
.	O

You	O
need	O
a	O
manual	O
,	O
and	O
the	O
complexity	O
and	O
messiness	O
of	O
biology	O
means	O
we	O
are	O
a	O
long	O
way	O
from	O
having	O
a	O
manual	O
for	O
how	O
a	O
cell	O
works	O
.	O

The	O
DRC	B-Organization
Ministry	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
confirmed	O
that	O
the	O
new	O
Ebola	S-Pathogen
outbreak	O
is	O
caused	O
by	O
the	O
Zaire	B-Pathogen
ebolavirus	E-Pathogen
species	O
.	O

Hepatobiliary	B-Technology
MR	E-Technology
is	O
used	O
to	O
detect	O
and	O
characterize	O
lesions	O
of	O
the	O
liver	O
,	O
pancreas	O
,	O
and	O
bile	O
ducts	O
.	O

Southern	B-Organization
Research	I-Organization
Institute	E-Organization
was	O
also	O
a	O
subcontractor	O
on	O
a	O
Pentagon	S-Organization
program	O
for	O
anthrax	S-Disease
research	O
in	O
2001	O
.	O

The	O
U.S.	B-Organization
Attorney's	I-Organization
office	E-Organization
handled	O
the	O
prosecution	O
of	O
the	O
poisoning	O
cases	O
related	O
to	O
the	O
10	O
restaurants	O
,	O
and	O
the	O
Oregon	B-Organization
Attorney	I-Organization
General's	I-Organization
office	E-Organization
prosecuted	O
the	O
poisoning	O
cases	O
of	O
Commissioner	O
Matthews	S-Person
and	O
Judge	O
.	O

In	O
September	O
,	O
the	O
CDC	S-Organization
reported	O
that	O
some	O
hospitals	O
had	O
been	O
abandoned	O
,	O
while	O
those	O
still	O
functioning	O
lacked	O
basic	O
facilities	O
and	O
supplies	O
.	O

One	O
of	O
the	O
most	O
frequent	O
conversations	O
I	O
have	O
been	O
involved	O
in	O
is	O
about	O
correcting	O
life-threatening	O
disorders	O
in	O
human	O
embryos	O
.	O

One	O
early	O
medical	O
advance	O
as	O
a	O
result	O
of	O
the	O
Black	B-Disease
Death	E-Disease
was	O
the	O
establishment	O
of	O
the	O
idea	O
of	O
quarantine	O
in	O
the	O
city-state	O
of	O
Ragusa	S-Location
(modern	O
Dubrovnik	S-Location
,	O
)	O
in	O
1377	O
after	O
continuing	O
outbreaks	O
.	O

Precautions	O
described	O
in	O
this	O
unit	O
should	O
be	O
applied	O
to	O
the	O
routine	O
handling	O
of	O
viable	O
pathogenic	O
microorganisms	O
,	O
as	O
well	O
as	O
all	O
human‐derived	O
materials	O
,	O
because	O
they	O
may	O
harbor	O
dangerous	O
pathogens	O
such	O
as	O
human	B-Pathogen
immunodeficiency	I-Pathogen
virus	E-Pathogen
(	O
HIV	S-Pathogen
)	O
,	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
(	O
HBV	S-Pathogen
)	O
,	O
cytomegalovirus	S-Pathogen
(	O
CMV	S-Pathogen
)	O
,	O
Epstein‐Barr	B-Pathogen
virus	E-Pathogen
()	O
,	O
and	O
some	O
bacterial	O
pathogens	O
.	O

There	O
was	O
virtually	O
no	O
response	O
or	O
acknowledgment	O
to	O
the	O
epidemics	O
in	O
March	O
and	O
April	O
in	O
the	O
military	O
camps	O
.	O

The	O
Aral	B-Location
Sea	I-Location
island	I-Location
of	I-Location
Vozrozhdeniye	E-Location
housed	O
the	O
main	O
outdoor	O
testing	O
area	O
of	O
the	O
program	O
to	O
make	O
germ	O
weapons	O
.	O

Some	O
of	O
the	O
initial	O
fears	O
were	O
allayed	O
when	O
scientists	O
realized	O
that	O
genetic	O
modification	O
is	O
much	O
trickier	O
than	O
initially	O
thought	O
,	O
and	O
once	O
the	O
realistic	O
threats	O
were	O
identified	O
–	O
like	O
recombinant	O
viruses	O
or	O
the	O
handling	O
of	O
deadly	O
toxins	O
–	O
safety	O
and	O
regulatory	O
measures	O
were	O
put	O
in	O
place	O
.	O

For	O
instance	O
,	O
when	O
applied	O
to	O
human	O
pluripotent	O
stem	O
cells	O
,	O
CRISPR	S-Technology
has	O
been	O
used	O
to	O
introduce	O
targeted	O
mutations	O
in	O
genes	O
relevant	O
to	O
polycystic	B-Disease
kidney	I-Disease
disease	E-Disease
(	O
PKD	S-Disease
)	O
and	O
focal	B-Phenotype
segmental	I-Phenotype
glomerulosclerosis	E-Phenotype
(FSGS)	S-Phenotype
.	O
These	O
-modified	O
pluripotent	O
stem	O
cells	O
were	O
subsequently	O
grown	O
into	O
human	O
kidney	O
organoids	O
that	O
exhibited	O
disease-specific	O
phenotypes	O
.	O

The	O
note	O
was	O
not	O
seen	O
when	O
the	O
machines	O
were	O
later	O
switched	O
back	O
on	O
,	O
and	O
it	O
was	O
several	O
hours	O
before	O
the	O
mistake	O
was	O
spotted	O
.	O

The	O
US	B-Organization
Army	E-Organization
produces	O
and	O
tests	O
bio-agents	O
at	O
a	O
special	O
military	O
facility	O
located	O
at	O
Dugway	B-Organization
Proving	I-Organization
Ground	E-Organization
(	O
West	B-Organization
Desert	I-Organization
Test	I-Organization
Center	E-Organization
,	O
Utah	S-Location
)	O
,	O
as	O
proven	O
in	O
a	O
2012	O
US	B-Organization
Army	E-Organization
Report	O
.	O

A	O
study	O
published	O
in	O
December	O
2014	O
found	O
that	O
transmission	O
of	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
occurs	O
principally	O
within	O
families	O
,	O
in	O
hospitals	O
and	O
at	O
funerals	O
.	O

Yambuku	B-Organization
Mission	I-Organization
Hospital	E-Organization
was	O
closed	O
after	O
11	O
of	O
its	O
17	O
staff	O
members	O
died	O
.	O

On	O
15	O
September	O
2019	O
,	O
some	O
slowdown	O
of	O
EVD	S-Disease
cases	O
was	O
noted	O
by	O
the	O
WHO	S-Organization
in	O
DRC	S-Location
,	O
however	O
contact	O
tracing	O
continued	O
to	O
be	O
below	O
100%	O
,	O
then	O
at	O
89%	O
.	O

Although	O
Iraq	S-Location
had	O
loaded	O
anthrax	S-Pathogen
,	O
botulinum	S-Pathogen
,	O
and	O
aflatoxin	S-Pathogen
bio-agent	O
into	O
missiles	O
and	O
artillery	O
shells	O
in	O
preparing	O
for	O
the	O
war	O
,	O
and	O
although	O
these	O
munitions	O
were	O
deployed	O
to	O
four	O
locations	O
in	O
,	O
they	O
were	O
never	O
used	O
.	O

According	O
to	O
David	B-Person
Daigle	E-Person
the	O
Associate	O
Director	O
for	O
Communications,	B-Organization
Public	I-Organization
Health	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
,	O
the	O
idea	O
arose	O
when	O
his	O
team	O
was	O
discussing	O
their	O
upcoming	O
hurricane-information	O
campaign	O
and	O
Daigle	S-Person
mused	O
that	O
"	O
we	O
say	O
pretty	O
much	O
the	O
same	O
things	O
every	O
year	O
,	O
in	O
the	O
same	O
way	O
,	O
and	O
I	O
just	O
wonder	O
how	O
many	O
people	O
are	O
paying	O
attention.	O
"	O
A	O
social-media	O
employee	O
mentioned	O
that	O
the	O
subject	O
of	O
zombies	O
had	O
come	O
up	O
a	O
lot	O
on	O
Twitter	O
when	O
she	O
had	O
been	O
tweeting	O
about	O
the	O
Fukushima	B-Organization
Daiichi	I-Organization
nuclear	I-Organization
disaster	E-Organization
and	O
radiation	O
.	O

The	O
virus	O
was	O
kindly	O
provided	O
by	O
Dr	O
A.	B-Person
Panet	E-Person
()	O
.	O

Perlman	S-Person
told	O
The	O
in	O
2014	O
that	O
the	O
incident	O
was	O
a	O
miscommunication	O
.	O

We	O
do	O
unannounced	O
inspections	O
.	O

The	O
agencies	O
overseeing	O
this	O
permitting	O
process	O
vary	O
country	O
by	O
country	O
.	O

The	O
president's	O
national	B-Document
security	I-Document
strategy	E-Document
includes	O
weapons	O
of	O
mass	O
destruction	O
and	O
specifically	O
calls	O
out	O
biodefense,	O
"	O
told	O
the	O
panel	O
members	O
.	O

The	O
Campaign	B-Activity
for	I-Activity
Nuclear	I-Activity
Disarmament	E-Activity
's	O
general	O
secretary	O
Kate	B-Person
Hudson	E-Person
criticised	O
the	O
exercise	O
,	O
saying	O
"	O
it	O
jeopardises	O
the	O
lives	O
not	O
only	O
of	O
the	O
troops	O
from	O
the	O
and	O
the	O
many	O
European	O
countries	O
participating	O
but	O
the	O
inhabitants	O
of	O
the	O
countries	O
in	O
which	O
they	O
are	O
operating.	O
"	O

At	O
the	O
annual	B-Activity
meeting	I-Activity
of	I-Activity
the	I-Activity
world's	I-Activity
health	I-Activity
ministers	E-Activity
,	O
Dr	O
.	O

Over	O
time	O
,	O
studies	O
have	O
suggested	O
that	O
the	O
virus	O
can	O
persist	O
in	O
seminal	O
fluid	O
,	O
with	O
a	O
study	O
released	O
in	O
September	O
2016	O
suggesting	O
that	O
the	O
virus	O
may	O
survive	O
more	O
than	O
530 days	O
after	O
infection	O
.	O

The	O
Black	B-Disease
Death	E-Disease
was	O
a	O
pandemic	O
that	O
affected	O
all	O
of	O
Europe	S-Location
in	O
the	O
ways	O
described	O
,	O
not	O
only	O
.	O

CT	S-Equipment
of	O
the	O
thyroid	O
plays	O
an	O
important	O
role	O
in	O
the	O
evaluation	O
of	O
thyroid	B-Disease
cancer	E-Disease
.	O
Creative	O
Commons	O
Attribution	O
4.	O
0	O
International	O
License	O
Also	O
,	O
CT	B-Technology
scans	E-Technology
often	O
incidentally	O
find	O
,	O
and	O
thereby	O
practically	O
becomes	O
the	O
first	O
investigation	O
modality	O
.	O

It's	O
most	O
distressing	O
not	O
because	O
it's	O
most	O
dangerous	O
.	O

The	O
created	O
religious	O
,	O
social	O
,	O
and	O
economic	O
upheavals	O
,	O
with	O
profound	O
effects	O
on	O
the	O
course	O
of	O
European	O
history	O
.	O

Advanced	O
commercially	O
available	O
technologies-such	O
as	O
additive	O
manufacturing	O
(3-D	O
printing)	O
,	O
small-scale	O
chemical	O
reactors	O
for	O
pharmaceuticals	O
,	O
and	O
CRISPR	B-Technology
gene-manipulation	E-Technology
tools-have	O
opened	O
wide	O
access	O
to	O
scientific	O
exploration	O
and	O
discovery	O
.	O

A	O
country	O
that	O
shows	O
so	O
little	O
regard	O
for	O
international	O
agreements	O
and	O
conventions	O
should	O
be	O
treated	O
with	O
considerable	O
reserve	O
when	O
treaties	O
are	O
proposed	O
.	O

All	O
forms	O
involved	O
fever	S-Phenotype
,	O
exhaustion	S-Phenotype
and	O
an	O
intolerable	O
from	O
the	O
material	O
that	O
exuded	O
from	O
the	O
body	O
.	O

And	O
it's	O
a	O
totally	O
valid	O
question	O
.	O

As	O
such	O
,	O
potential	O
vendors	O
must	O
be	O
able	O
to	O
provide	O
both	O
real-time	O
and	O
historical	O
data	O
on	O
an	O
array	O
of	O
topics	O
that	O
potentially	O
factor	O
into	O
epidemics	O
,	O
bioattacks	O
and	O
other	O
incidents	O
.	O

Their	O
attempts	O
to	O
influence	O
the	O
election	O
included	O
the	O
"	O
Share-a-Home"	O
program	O
,	O
in	O
which	O
they	O
transported	O
thousands	O
of	O
homeless	O
people	O
to	O
Rajneeshpuram	S-Location
and	O
attempted	O
to	O
register	O
them	O
to	O
vote	O
to	O
inflate	O
the	O
constituency	O
of	O
voters	O
for	O
the	O
group's	O
candidates	O
.	O

On	O
23	O
February	O
,	O
an	O
elderly	O
woman	O
named	O
Kwan	B-Person
Sui-Chu	E-Person
who	O
had	O
also	O
been	O
a	O
Metropole	B-Organization
Hotel	E-Organization
guest	O
,	O
returned	O
to	O
Toronto	S-Location
,	O
Canada	S-Location
,	O
from	O
Hong	B-Location
Kong	E-Location
.	O
She	O
died	O
at	O
home	O
on	O
5	O
March	O
,	O
after	O
infecting	O
her	O
son	O
Tse	B-Person
Chi	I-Person
Kwai	E-Person
,	O
who	O
subsequently	O
spread	O
the	O
disease	O
to	O
and	O
died	O
on	O
13	O
March	O
.	O

The	O
exact	O
role	O
of	O
the	O
board	O
in	O
the	O
process	O
has	O
been	O
a	O
subject	O
of	O
debate	O
,	O
but	O
the	O
practical	O
effect	O
has	O
always	O
been	O
small	O
.	O

In	O
addition	O
,	O
CDC	S-Organization
is	O
conducting	O
an	O
internal	O
scientific	O
review	O
to	O
determine	O
why	O
established	O
procedures	O
were	O
not	O
used	O
by	O
the	O
lab	O
.	O

These	O
events	O
should	O
never	O
have	O
happened	O
.	O

To	O
this	O
purpose	O
,	O
adeno-associated	B-Pathogen
viruses	E-Pathogen
()	O
delivered	O
the	O
corrected	O
genomic	O
region	O
in	O
a	O
targeted	O
manner	O
,	O
correcting	O
this	O
way	O
the	O
mutations	O
in	O
the	O
dystrophin	O
gene	O
with	O
surprisingly	O
high	O
efficiency	O
.	O

She	O
soon	O
fell	O
seriously	O
ill	O
,	O
and	O
was	O
tended	O
to	O
by	O
her	O
younger	O
sister	O
.	O

Some	O
studies	O
estimated	O
that	O
the	O
actual	O
number	O
of	O
cases	O
including	O
asymptomatic	O
and	O
mild	O
cases	O
could	O
be	O
700	O
million	O
to	O
1.	O
4	O
billion	O
people-or	O
11	O
to	O
21	O
percent	O
of	O
the	O
global	O
population	O
of	O
6.	O
8	O
billion	O
at	O
the	O
time	O
.	O

1967:	O
The	O
WHO	S-Organization
intensified	O
the	O
global	O
smallpox	S-Disease
eradication	O
by	O
contributing	O
$2.	O
4 million	O
annually	O
to	O
the	O
effort	O
and	O
adopted	O
a	O
new	O
disease	O
surveillance	O
method	O
.	O

Newspapers	O
were	O
therefore	O
free	O
to	O
report	O
the	O
epidemic's	O
effects	O
,	O
such	O
as	O
the	O
grave	O
illness	O
of	O
King	B-Person
Alfonso	I-Person
XIII	E-Person
,	O
and	O
these	O
widely-spread	O
stories	O
created	O
a	O
false	O
impression	O
of	O
as	O
especially	O
hard	O
hit	O
.	O

When	O
cells	O
from	O
Niemann–Pick	O
Type	O
C	O
individuals	O
lacking	O
this	O
transporter	O
were	O
exposed	O
to	O
Ebola	B-Pathogen
virus	E-Pathogen
in	O
the	O
laboratory	O
,	O
the	O
cells	O
survived	O
and	O
appeared	O
impervious	O
to	O
the	O
virus	O
,	O
further	O
indicating	O
that	O
Ebola	S-Pathogen
relies	O
on	O
NPC1	O
to	O
enter	O
cells	O
;	O
mutations	O
in	O
the	O
NPC1	O
gene	O
in	O
humans	O
were	O
conjectured	O
as	O
a	O
possible	O
mode	O
to	O
make	O
some	O
individuals	O
resistant	O
to	O
this	O
deadly	O
viral	O
disease	O
.	O

A	O
full	O
discussion	O
of	O
the	O
large	O
variety	O
of	O
countries'	O
data	O
sharing	O
policies	O
and	O
infrastructures	O
would	O
go	O
beyond	O
the	O
scope	O
of	O
this	O
review	O
.	O

People	O
who	O
contracted	O
influenza	O
before	O
1957	O
appeared	O
to	O
have	O
some	O
immunity	O
to	O
H1N1	B-Disease
flu	E-Disease
According	O
to	O
Daniel	B-Person
Jernigan	E-Person
,	O
head	O
of	O
flu	O
epidemiology	O
for	O
the	O
U.S.	S-Location
"	O
Tests	O
on	O
blood	O
serum	O
from	O
older	O
people	O
showed	O
that	O
they	O
had	O
antibodies	O
that	O
attacked	O
the	O
new	O
virus ..	O
.	O

Comparison	O
and	O
Analysis	O
of	O
Biological	O
Agent	O
Category	O
Lists	O
Based	O
On	O
Biosafety	O
and	O
Biodefense.PLoS	O
One.2014;9(6).	O
.	O

A	O
joint	O
effort	O
by	O
laboratory	O
personnel	O
from	O
across	O
the	O
different	O
sectors	O
would	O
increase	O
the	O
critical	O
mass	O
of	O
expertise	O
and	O
improve	O
's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

In	O
2001	O
,	O
for	O
example	O
,	O
a	O
public	O
health	O
laboratory	O
worker	O
in	O
the	O
U.S.	S-Location
acquired	O
cutaneous	B-Disease
anthrax	E-Disease
due	O
to	O
an	O
unauthorized	O
switch	O
in	O
disinfectants	O
(MMWR	O
,	O
2002)	O
.	O

The	O
expenditure	O
associated	O
with	O
these	O
infections	O
in	O
terms	O
of	O
extra	O
hospital	O
costs	O
and	O
productivity	O
losses	O
exceeded	O
€1.	O
5	O
billion	O
each	O
year	O
(Ref)	O
.	O

In	O
March	O
2010	O
,	O
the	O
allegations	O
were	O
investigated	O
by	O
the	O
Al	O
Jazeera	O
English	O
news	O
program	O
People	O
&amp	O
;	O
Power	O
.	O

Countries	O
that	O
test	O
more	O
,	O
relative	O
to	O
the	O
number	O
of	O
deaths	O
,	O
have	O
a	O
younger	O
age	O
distribution	O
of	O
cases	O
,	O
relative	O
to	O
the	O
wider	O
population	O
.	O

Given	O
the	O
system	O
,	O
there	O
was	O
an	O
obvious	O
need	O
to	O
develop	O
means	O
for	O
cross-sectoral	O
cooperation	O
between	O
national	O
laboratories	O
in	O
order	O
to	O
improve	O
the	O
country's	O
biopreparedness	O
against	O
high-consequence	O
pathogens	O
.	O

See	O
unit	O
mc01a01	O
and	O
other	O
pertinent	O
resources	O
(appendix	O
mca01b)	O
for	O
more	O
information	O
.	O

Gupta	O
stated	O
that	O
the	O
cities	O
"	O
wouldn't	O
be	O
able	O
to	O
distribute	O
vaccines	O
as	O
well	O
"	O
and	O
"	O
wouldn't	O
be	O
able	O
to	O
track	O
viruses.	O
"	O
He	O
also	O
said	O
that	O
film	O
portrayals	O
of	O
global	O
pandemics	O
,	O
such	O
as	O
Contagion	O
,	O
were	O
actually	O
quite	O
possible	O
and	O
may	O
occur	O
in	O
the	O
United	O
States	O
under	O
the	O
right	O
conditions.John	O
King	O
,	O
USA	O
.	O

To	O
address	O
these	O
concerns	O
,	O
the	O
National	B-Organization
Health	I-Organization
Commission	I-Organization
of	I-Organization
China	E-Organization
published	O
a	O
on	O
27	O
January	O
2020	O
.	O

As	O
a	O
result	O
,	O
DHS	S-Organization
may	O
miss	O
an	O
opportunity	O
to	O
leverage	O
resources	O
and	O
share	O
information	O
that	O
could	O
lead	O
to	O
greater	O
effectiveness	O
addressing	O
chemical	O
threats	O
,	O
said	O
.	O

A	O
number	O
of	O
initiatives	O
were	O
taken	O
on	O
codes	O
in	O
between	O
the	O
2001	O
statement	O
and	O
the	O
2005	O
discussions	O
.	O

The	O
Intelligence	B-Organization
Advanced	I-Organization
Research	I-Organization
Projects	I-Organization
Activity	E-Organization
plans	O
to	O
launch	O
new	O
research	O
programs	O
in	O
2018	O
to	O
mitigate	O
threats	O
associated	O
with	O
biological	O
weapons	O
,	O
reported	O
Friday	O
.	O

MRI	S-Technology
does	O
have	O
several	O
disadvantages	O
though	O
.	O

In	O
a	O
series	O
of	O
in	O
vivo	O
experiments	O
,	O
recombinant	O
influenza	S-Disease
viruses	O
containing	O
between	O
1	O
and	O
5	O
gene	O
segments	O
of	O
the	O
have	O
been	O
produced	O
.	O

It	O
is	O
essential	O
that	O
antibiotic	O
discovery	O
and	O
production	O
be	O
maintained	O
on	O
a	O
scale	O
that	O
is	O
appropriate	O
to	O
our	O
increasing	O
requirements	O
.	O

Rebecca	B-Person
Moritz	E-Person
a	O
UW	B-Organization
lab	E-Organization
administrator	O
,	O
said	O
there	O
has	O
never	O
been	O
a	O
lab-acquired	O
infection	O
in	O
the	O
.	O

They	O
also	O
released	O
a	O
zombie-themed	O
graphic	O
novella	O
available	O
on	O
their	O
website	O
.	O

When	O
masks	O
are	O
not	O
available	O
,	O
the	O
CDC	S-Organization
recommends	O
using	O
or	O
,	O
as	O
a	O
last	O
resort	O
,	O
homemade	O
masks	O
.	O

Illness	O
rates	O
were	O
high	O
,	O
but	O
death	O
rates	O
in	O
most	O
locales	O
were	O
not	O
appreciably	O
above	O
normal	O
.	O

There	O
was	O
an	O
almost	O
20-fold	O
higher	O
mortality	O
in	O
some	O
countries	O
in	O
the	O
Americas	S-Location
than	O
in	O
.	O
The	O
model	O
attributed	O
148,000–249,000	O
respiratory	O
deaths	O
to	O
influenza	O
in	O
an	O
average	O
pre-pandemic	O
season	O
,	O
with	O
only	O
19%	O
in	O
persons	O
&lt;65	O
years	O
of	O
age	O
.	O

For	O
many	O
pharmaceutical	O
companies	O
,	O
this	O
makes	O
the	O
economics	O
of	O
antibiotic	O
development	O
unappealing	O
.	O

(	O
CNN	S-Organization
explosion	O
has	O
caused	O
a	O
fire	O
at	O
a	O
Russian	O
biological	O
research	O
facility	O
that's	O
one	O
of	O
only	O
two	O
centers	O
in	O
the	O
world	O
known	O
for	O
housing	O
samples	O
of	O
the	O
.	O

On	O
31	O
January	O
2020	O
,	O
Italy	S-Location
had	O
its	O
first	O
confirmed	O
cases	O
,	O
two	O
tourists	O
from	O
China	S-Location
.	O
As	O
of	O
13	O
March	O
2020	O
,	O
the	O
WHO	S-Organization
considered	O
Europe	S-Location
the	O
active	O
centre	O
of	O
the	O
pandemic	O
.	O

It	O
doesn't	O
matter	O
whether	O
this	O
is	O
from	O
insufficient	O
standards	O
,	O
inspections	O
,	O
operations	O
or	O
penalties	O
.	O

By	O
the	O
end	O
of	O
September	O
,	O
751 cases	O
of	O
acute	O
gastroenteritis	O
were	O
documented	O
;	O
lab	O
testing	O
determined	O
that	O
all	O
of	O
the	O
victims	O
were	O
infected	O
with	O
Salmonella	B-Pathogen
enterica	I-Pathogen
Typhimurium	E-Pathogen
.	O
Symptoms	O
included	O
diarrhea	S-Phenotype
,	O
fever	S-Phenotype
,	O
chills	S-Phenotype
,	O
nausea	S-Phenotype
,	O
vomiting	S-Phenotype
,	O
headaches	S-Phenotype
,	O
abdominal	B-Phenotype
pain	E-Phenotype
,	O
and	O
.	O
Victims	O
ranged	O
in	O
age	O
from	O
an	O
infant	O
,	O
born	O
two	O
days	O
after	O
his	O
mother's	O
infection	O
and	O
initially	O
given	O
a	O
five	O
percent	O
chance	O
of	O
survival	O
,	O
to	O
an	O
87-year-old	O
.	O

As	O
part	O
of	O
a	O
plea	O
bargain	O
arrangement	O
,	O
he	O
pleaded	O
guilty	O
to	O
two	O
counts	O
of	O
making	O
false	O
statements	O
to	O
immigration	O
officials	O
.	O

For	O
instance	O
,	O
James	B-Person
Carey	E-Person
a	O
member	O
of	O
the	O
science	O
panel	O
,	O
said	O
the	O
small	O
number	O
of	O
larvae	O
detected	O
does	O
not	O
necessarily	O
mean	O
that	O
the	O
fly	O
is	O
being	O
spread	O
unnaturally	O
,	O
rather	O
than	O
by	O
breeding	O
and	O
moving	O
.	O

The	O
bill	O
included	O
prison	O
sentences	O
ranging	O
from	O
16	O
months	O
to	O
three	O
years	O
,	O
and	O
fines	O
up	O
to	O
$10,000.	O
"	O
3	O
Pest	O
Bills	O
Pass	O
AG	O
Committee"	O
,	O
(login	O
required)	O
,	O
Fresno	S-Location
Bee	O
,	O
May	O
15	O
,	O
1990	O
,	O
accessed	O
February	O
23	O
,	O
2012	O
.	O

Part	O
of	O
that	O
innovation	O
investment	O
could	O
come	O
in	O
tandem	O
with	O
New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
BioInc@NYMC	B-Platform
life	I-Platform
sciences	I-Platform
incubator	E-Platform
,	O
which	O
occupies	O
a	O
portion	O
of	O
the	O
120,000-square-foot	O
building	O
at	O
7	O
Dana	O
Road	O
that	O
will	O
primarily	O
be	O
used	O
for	O
Center	B-Organization
of	I-Organization
Excellence	E-Organization
training.	O
explained	O
that	O
the	O
center's	O
research	O
on	O
strategies	O
to	O
combat	O
biological	O
and	O
chemical	O
threats	O
could	O
come	O
from	O
or	O
help	O
advance	O
products	O
from	O
companies	O
based	O
at	O
the	O
incubator	O
.	O

Phage	B-Technology
therapy	E-Technology
is	O
the	O
therapeutic	O
use	O
of	O
bacteriophages	O
to	O
treat	O
pathogenic	O
bacterial	O
infections.	O
has	O
many	O
potential	O
applications	O
in	O
human	O
medicine	O
as	O
well	O
as	O
dentistry	O
,	O
veterinary	O
science	O
,	O
and	O
agriculture	O
.	O

On	O
10	O
January	O
,	O
a	O
restaurant	O
worker	O
in	O
Guangdong	S-Location
was	O
confirmed	O
as	O
the	O
second	O
wild	O
source	O
SARS	S-Disease
since	O
the	O
outbreak	O
was	O
contained	O
.	O

The	O
possession	O
,	O
use	O
,	O
or	O
transfer	O
of	O
B.	B-Pathogen
anthracis	E-Pathogen
is	O
regulated	O
by	O
the	O
(DSAT)	O
,	O
located	O
in	O
.	O

To	O
do	O
this	O
,	O
we	O
have	O
used	O
a	O
unique	O
open	O
access	O
online	O
tool	O
,	O
the	O
Biosafety	B-Platform
Bibliographic	I-Platform
Database	E-Platform
(	O
BBD	S-Platform
)	O
that	O
has	O
been	O
provided	O
by	O
ICGEB	S-Organization
since	O
1990	O
.	O

Under	O
the	O
patronage	O
of	O
Sheikh	B-Person
Mohammed	I-Person
bin	I-Person
Rashid	I-Person
Al	I-Person
Maktoum	E-Person
vice	O
President	O
and	O
prime	O
minister	O
of	O
the	O
UAE	S-Organization
and	O
ruler	O
of	O
Dubai	S-Organization
,	O
the	O
World	B-Activity
Government	I-Activity
Summit	I-Activity
2018	E-Activity
runs	O
from	O
February	O
11	O
to	O
13	O
at	O
the	O
Madinat	B-Location
Jumeirah	E-Location
in	O
.	O
The	O
event	O
convenes	O
more	O
than	O
4,000	O
participants	O
from	O
140	O
countries	O
,	O
including	O
heads	O
of	O
state	O
and	O
governments	O
,	O
as	O
well	O
as	O
top-tier	O
representatives	O
of	O
16	O
international	O
organisations	O
.	O

Some	O
historians	O
believe	O
the	O
innumerable	O
deaths	O
brought	O
on	O
by	O
the	O
plague	S-Disease
cooled	O
the	O
climate	O
by	O
freeing	O
up	O
land	O
and	O
triggering	O
reforestation	O
.	O

Thanks	O
so	O
much	O
for	O
all	O
the	O
details	O
today	O
.	O

The	O
Saudi	B-Organization
government	E-Organization
asked	O
"	O
elderly	O
and	O
chronically	O
ill	O
Muslims	O
to	O
avoid	O
the	O
this	O
year	O
"	O
and	O
restricted	O
the	O
number	O
of	O
people	O
allowed	O
"	O
to	O
perform	O
the	O
pilgrimage"	O
.	O

Yet	O
,	O
leaking	O
into	O
the	O
groundwater	O
at	O
the	O
facility	O
.	O

Dr	O
.	O

In	O
2016	O
,	O
Margaret	B-Person
Chan	E-Person
,	O
Director-General	O
of	O
WHO	S-Organization
from	O
November	O
2006	O
to	O
June	O
2017	O
,	O
stayed	O
in	O
a	O
$1000-per-night	O
hotel	O
room	O
while	O
visiting	O
West	O
.	O

The	O
survey	O
questions	O
sought	O
to	O
collect	O
broad	O
observations	O
about	O
overall	O
capacity	O
needs	O
or	O
gaps	O
in	O
biorisk	O
management	O
systems	O
in	O
the	O
BMENA	S-Location
study	O
countries	O
.	O

In	O
addition	O
,	O
in	O
2004	O
the	O
Swedish	B-Organization
Laboratory	I-Organization
for	I-Organization
Food	I-Organization
Safety	I-Organization
and	I-Organization
Biopreparedness	E-Organization
was	O
established	O
.	O

Bacillus	B-Pathogen
anthracis	E-Pathogen
spores	O
can	O
become	O
"	O
activated"	O
once	O
in	O
the	O
body	O
,	O
where	O
bacteria	O
can	O
multiply	O
and	O
release	O
toxins	O
,	O
according	O
to	O
the	O
.	O

The	O
leaders	O
of	O
some	O
of	O
those	O
agencies	O
-	O
considered	O
among	O
the	O
nation's	O
heaviest	O
hitters	O
when	O
it	O
comes	O
to	O
U.S.	S-Location
preparedness	O
and	O
response	O
on	O
the	O
front	O
lines	O
-	O
testified	O
Wednesday	O
during	O
the	O
hearing	O
and	O
said	O
they	O
do	O
indeed	O
need	O
several	O
things	O
in	O
the	O
reauthorization	O
.	O

These	O
nonproliferation	O
norms	O
tie	O
directly	O
back	O
to	O
another	O
State	O
Department	O
responsibility	O
–	O
the	O
Biological	B-Document
Weapons	I-Document
Convention	E-Document
()	O
.	O

We	O
can't	O
rule	O
out	O
the	O
loss	O
of	O
more	O
than	O
90%	O
of	O
the	O
population	O
of	O
the	O
Americas	S-Location
during	O
that	O
century	O
,	O
though	O
the	O
number	O
could	O
also	O
be	O
much	O
lower	O
.	O

If	O
it	O
is	O
correct	O
,	O
Russia	S-Location
lost	O
roughly	O
0.4%	O
of	O
its	O
population	O
,	O
meaning	O
it	O
suffered	O
the	O
lowest	O
influenza	S-Disease
-related	O
mortality	O
in	O
Europe	S-Location
.	O
Another	O
study	O
considers	O
this	O
number	O
unlikely	O
,	O
given	O
that	O
the	O
country	O
was	O
in	O
the	O
grip	O
of	O
a	O
civil	O
war	O
,	O
and	O
the	O
infrastructure	O
of	O
daily	O
life	O
had	O
broken	O
down	O
;	O
the	O
study	O
suggests	O
that	O
's	O
death	O
toll	O
was	O
closer	O
to	O
2%	O
,	O
or	O
2.7	O
million	O
people	O
.	O

To	O
date	O
,	O
Gottlieb	S-Person
explained	O
,	O
inconsistencies	O
in	O
the	O
reporting	O
of	O
antibiotic	O
susceptibility	O
test	O
results	O
across	O
different	O
institutions	O
has	O
made	O
it	O
difficult	O
to	O
track	O
resistance	O
.	O

Nevertheless	O
,	O
biological	O
hazards	O
differ	O
from	O
all	O
other	O
kinds	O
of	O
safety	O
hazards	O
in	O
one	O
major	O
significant	O
way:	O
biological	O
agents	O
can	O
grow	O
and	O
multiply	O
in	O
the	O
host	O
organism	O
.	O

What	O
could	O
go	O
wrong?	O
Well	O
,	O
the	O
toads	O
became	O
a	O
major	O
nuisance	O
themselves	O
,	O
spreading	O
across	O
the	O
continent	O
and	O
eating	O
the	O
local	O
fauna	O
(except	O
for	O
,	O
ironically	O
,	O
the	O
cane	O
beetle)	O
.	O

It	O
was	O
a	O
trial	O
run	O
for	O
a	O
proposed	O
later	O
attack	O
.	O

If	O
you're	O
thoroughly	O
grossed	O
out	O
by	O
this	O
,	O
don't	O
worry:	O
The	O
food	O
won't	O
actually	O
be	O
eaten	O
-	O
this	O
"	O
bioart"	O
project	O
is	O
meant	O
more	O
as	O
a	O
thought	O
experiment	O
than	O
as	O
dinner	O
.	O

The	O
authors	O
indicated	O
that	O
lack	O
of	O
food	O
and	O
other	O
economic	O
effects	O
would	O
probably	O
continue	O
in	O
the	O
rural	O
population	O
long	O
after	O
the	O
Ebola	B-Incident
outbreak	E-Incident
had	O
ended	O
.	O

Furthermore	O
,	O
19(10%)	O
laboratories	O
had	O
hepatitis	B-Pathogen
B	I-Pathogen
virus	E-Pathogen
vaccination	O
programme	O
,	O
5	O
(6.	O
2%)	O
applied	O
BCG	B-Vaccine
vaccine	E-Vaccine
,	O
and	O
2	O
(1.	O
1%)	O
vaccinated	O
the	O
staff	O
against	O
.	O

The	O
intermediate	O
b	O
is	O
then	O
added	O
to	O
a	O
solution	O
containing	O
intermediate	O
c	O
dropwise	O
.	O

On	O
22	O
March	O
,	O
it	O
was	O
reported	O
that	O
Russia	S-Location
had	O
sent	O
nine	O
military	O
planes	O
with	O
medical	O
equipment	O
to	O
Italy	S-Organization
.	O
,	O
there	O
were	O
217,185	O
confirmed	O
cases	O
,	O
30,201	O
deaths	O
,	O
and	O
99,023	O
recoveries	O
in	O
Italy	S-Location
,	O
with	O
the	O
majority	O
of	O
those	O
cases	O
occurring	O
in	O
the	O
Lombardy	S-Location
region	O
.	O

"	O
Many	O
of	O
us	O
think	O
that's	O
really	O
a	O
matter	O
of	O
good	O
fortune,	O
"	O
said	O
Beth	B-Person
Willis	E-Person
who	O
chairs	O
a	O
citizen	B-Organization
lab	I-Organization
advisory	I-Organization
panel	E-Organization
in	O
Frederick,	B-Location
Md	E-Location
.	O
,	O
home	O
to	O
one	O
of	O
the	O
nation's	O
largest	O
high-containment	O
research	O
campuses	O
at	O
the	O
Army's	O
.	O

Benefits:	O
Simply	O
put	O
,	O
our	O
world	O
has	O
been	O
reshaped	O
by	O
rDNA	O
.	O

In	O
2014	O
,	O
historian	O
Mark	B-Person
Humphries	E-Person
argued	O
that	O
the	O
mobilization	O
of	O
96,000	O
Chinese	O
laborers	O
to	O
work	O
behind	O
the	O
British	O
and	O
French	O
lines	O
might	O
have	O
been	O
the	O
source	O
of	O
the	O
pandemic	O
.	O

A	O
typical	O
crRNA	O
array	O
has	O
multiple	O
unique	O
target	O
sequences	O
.	O

Only	O
,	O
ten	O
(5.	O
2%)	O
participated	O
in	O
training	O
about	O
response	O
to	O
fire	O
emergency	O
,	O
and	O
28	O
(14.	O
7%)	O
reported	O
the	O
laboratory	O
accident	O
occurred	O
during	O
work.45	O
(23.	O
7%)	O
laboratories	O
had	O
a	O
written	O
standard	O
operation	O
procedures	O
(SOPs)	O
,	O
and	O
35	O
(18.	O
4%)	O
had	O
written	O
procedures	O
for	O
the	O
lean-up	O
of	O
spills	O
.	O

Science	O
Vol.	O
310(5745):77–80	O
The	O
CRISPR/Cas	B-Technology
system	E-Technology
has	O
emerged	O
as	O
a	O
promising	O
technique	O
for	O
gene	O
editing	O
.	O

On	O
July	O
11	O
,	O
2014	O
,	O
Dr	O
.	O

We're	O
still	O
just	O
beginning	O
the	O
investigation	O
to	O
determine	O
how	O
this	O
happened	O
.	O

The	O
recommendations	O
included	O
prioritizing	O
research	O
and	O
development	O
(R&amp;D)	O
related	O
to	O
overwhelmingly	O
infectious	O
Type	O
III	O
diseases	O
and	O
supporting	O
collaboration	O
between	O
internationally	O
recognized	O
R&amp;D	O
and	O
institutions	O
in	O
developing	O
nations	O
.	O

Water	O
has	O
an	O
attenuation	O
of	O
0	O
Hounsfield	O
units	O
(HU)	O
,	O
while	O
air	O
is	O
−1,000 HU	O
,	O
cancellous	O
bone	O
is	O
typically	O
+400 HU	O
,	O
and	O
cranial	O
bone	O
can	O
reach	O
2,000 HU	O
or	O
more	O
(os	O
temporale)	O
and	O
can	O
cause	O
artifacts	O
.	O

On	O
19	O
March	O
,	O
it	O
was	O
also	O
reported	O
by	O
the	O
media	O
that	O
another	O
individual	O
had	O
died	O
due	O
to	O
the	O
virus	O
at	O
the	O
treatment	O
centre	O
in	O
Nzerekore	S-Location
,	O
consequently	O
,	O
the	O
country's	O
government	O
quarantined	O
an	O
area	O
around	O
the	O
home	O
where	O
the	O
cases	O
took	O
place	O
.	O

Next	O
question	O
on	O
the	O
phone	O
.	O

The	O
appointment	O
address	O
praised	O
Mugabe	S-Person
for	O
his	O
commitment	O
to	O
public	O
health	O
in	O
.	O

The	O
DoD	S-Organization
selected	O
GlobalMed	S-Organization
for	O
its	O
that	O
seamlessly	O
and	O
securely	O
connects	O
healthcare	O
professionals	O
and	O
patients	O
,	O
regardless	O
of	O
location	O
.	O

The	O
lab	O
technician	O
of	O
this	O
ship	O
took	O
samples	O
of	O
plankton	O
twice	O
a	O
day	O
from	O
the	O
top	O
deck	O
.	O

Part	O
of	O
that	O
innovation	O
investment	O
could	O
come	O
in	O
tandem	O
with	O
New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
BioInc@NYMC	B-Platform
life	I-Platform
sciences	I-Platform
incubator	E-Platform
,	O
which	O
occupies	O
a	O
portion	O
of	O
the	O
120,000-square-foot	O
building	O
at	O
7	O
Dana	O
Road	O
that	O
will	O
primarily	O
be	O
used	O
for	O
Center	B-Organization
of	I-Organization
Excellence	E-Organization
training.	O
explained	O
that	O
the	O
center's	O
research	O
on	O
strategies	O
to	O
combat	O
biological	O
and	O
chemical	O
threats	O
could	O
come	O
from	O
or	O
help	O
advance	O
products	O
from	O
companies	O
based	O
at	O
the	O
incubator	O
.	O

Another	O
trend	O
noticeable	O
from	O
the	O
desktop	O
review	O
was	O
that	O
countries	O
with	O
actively	O
functional	O
NGOs	O
working	O
as	O
Biosafety	O
Associations	O
,	O
and/or	O
those	O
with	O
institutes	O
with	O
biosafety	O
missions	O
,	O
had	O
far	O
more	O
initiatives	O
on	O
general	O
awareness	O
of	O
biosafety-related	O
issues	O
than	O
those	O
without	O
such	O
associations	O
.	O

Screening	O
for	O
COVID-19	S-Disease
in	O
pregnant	O
women	O
in	O
New	B-Location
York	I-Location
City	E-Location
,	O
and	O
blood	O
donors	O
in	O
the	O
Netherlands	S-Location
,	O
has	O
also	O
found	O
rates	O
of	O
positive	O
antibody	O
tests	O
that	O
may	O
indicate	O
more	O
infections	O
than	O
reported	O
.	O

The	O
author	O
Seiichi	B-Person
Morimura	E-Person
published	O
The	O
Devil's	O
Gluttony	O
(悪魔の飽食)	O
in	O
1981	O
,	O
followed	O
by	O
The	O
Devil's	O
Gluttony:	O
A	O
Sequel	O
in	O
1983	O
.	O

It	O
has	O
been	O
documented	O
that	O
blaNDM-5	O
,	O
ST167	O
,	O
and	O
carbapenem-resistant	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
can	O
infect	O
humans	O
and	O
animals	O
(4)	O
.	O

One	O
of	O
the	O
goals	O
of	O
the	O
lab	O
is	O
to	O
teach	O
students	O
molecular	O
diagnostics	O
methods	O
(serological	O
methods	O
for	O
viral	O
analysis	O
are	O
taught	O
in	O
a	O
preceding	O
immunology	O
lab)	O
.	O

In	O
1997	O
,	O
the	O
international	O
lawyer	O
Kōnen	B-Person
Tsuchiya	E-Person
filed	O
a	O
class	O
action	O
suit	O
against	O
the	O
Japanese	O
government	O
,	O
demanding	O
reparations	O
for	O
the	O
actions	O
of	O
Unit	B-Organization
731	E-Organization
,	O
using	O
evidence	O
filed	O
by	O
Professor	O
Makoto	B-Person
Ueda	E-Person
of	O
.	O
All	O
Japanese	O
court	O
levels	O
found	O
that	O
the	O
suit	O
was	O
baseless	O
.	O

Cells	O
of	O
interest	O
can	O
be	O
consequentially	O
infected	O
by	O
the	O
library	O
and	O
then	O
selected	O
according	O
to	O
the	O
phenotype	O
.	O

The	O
conditions	O
used	O
to	O
decide	O
when	O
the	O
fund	O
should	O
pay	O
out	O
to	O
disease-affected	O
countries	O
were	O
criticised	O
as	O
too	O
stringent	O
.	O

Afterward	O
,	O
he	O
claimed	O
the	O
experiment	O
left	O
him	O
feeling	O
better	O
.	O

New	O
technological	O
possibilities	O
met	O
new	O
military	O
concepts	O
in	O
the	O
USA	S-Location
and	O
led	O
to	O
a	O
renewed	O
interest	O
in	O
weapons	O
that	O
,	O
until	O
recently	O
,	O
had	O
been	O
banned	O
and	O
rejected	O
.	O

DARPA	S-Organization
program	O
seeks	O
to	O
prevent	O
these	O
cross-species	O
jumps	O
by	O
predicting	O
viral	O
evolution	O
and	O
transmission	O
pathways	O
and	O
proactively	O
intervening	O
to	O
prevent	O
the	O
jump	O
to	O
humans	O
.	O

In	O
a	O
November	O
2017	O
JAMA	O
article	O
,	O
Center	O
authors	O
outlined	O
why	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)-a	O
formal	O
,	O
international	O
initiative	O
launched	O
in	O
2014	O
to	O
keep	O
the	O
world	O
safe	O
from	O
infectious	O
disease	O
threats-needed	O
additional	O
U.S.	S-Location
funding	O
to	O
ensure	O
its	O
long-term	O
sustainability	O
beyond	O
the	O
approaching	O
expiration	O
of	O
an	O
initial	O
$1	O
billion	O
U.S.	S-Location
investment	O
.	O

While	O
it	O
might	O
be	O
capable	O
of	O
infecting	O
goats	O
,	O
and	O
could	O
potentially	O
cause	O
disease	O
,	O
this	O
has	O
not	O
been	O
tested	O
.	O

The	O
plan	O
submitted	O
by	O
the	O
TB	S-Disease
lab	O
to	O
the	O
internal	O
working	O
group	O
details	O
safety	O
procedures	O
for	O
each	O
step	O
of	O
the	O
TB	S-Disease
inactivation	O
process	O
.	O

Anthrax	S-Pathogen
letter	O
When	O
these	O
letters	O
were	O
opened	O
,	O
the	O
fine-grained	O
within	O
them	O
misted	O
into	O
the	O
air	O
.	O


A	O
June	O
2014	O
potential	O
exposure	O
happened	O
when	O
a	O
lab	O
worker	O
didn't	O
wear	O
appropriate	O
personal	O
protective	O
equipment	O
and	O
was	O
working	O
with	O
the	O
pathogen	O
on	O
a	O
benchtop	S-Equipment
instead	O
of	O
inside	O
a	O
.	O

Controversies	O
have	O
erupted	O
multiple	O
times	O
when	O
the	O
IARC	S-Organization
has	O
classified	O
many	O
things	O
as	O
Class	O
2a	O
(probable	O
carcinogens)	O
or	O
2b	O
(possible	O
carcinogen)	O
,	O
including	O
cell	O
phone	O
signals	O
,	O
glyphosate	O
,	O
drinking	O
hot	O
beverages	O
,	O
and	O
working	O
as	O
a	O
barber	O
.	O

The	O
isolates	O
from	O
Finland	S-Location
were	O
also	O
ST167	O
;	O
the	O
isolates	O
from	O
South	B-Location
Korea	E-Location
and	O
Algeria	S-Location
were	O
obtained	O
from	O
canine	O
feces	O
and	O
identified	O
as	O
ST410	O
and	O
ST1284	O
.	O

To	O
reduce	O
health	O
security	O
risks	O
around	O
the	O
world	O
,	O
CDC	S-Organization
and	O
its	O
partners	O
are	O
building	O
capabilities	O
to	O
prevent	O
,	O
detect	O
and	O
contain	O
disease	O
outbreaks	O
through	O
GHSA	S-International_exchange_and_cooperation
.	O
CDC	S-Organization
works	O
to	O
advance	O
global	O
health	O
security	O
in	O
49	O
countries	O
where	O
there	O
is	O
risk	O
for	O
disease	O
outbreaks	O
,	O
and	O
these	O
countries	O
collectively	O
represent	O
$300	O
billion	O
in	O
exports	O
and	O
support	O
1.6	O
million	O
American	O
jobs	O
across	O
50	O
states	O
.	O

As	O
a	O
founding	O
director	O
of	O
the	O
nation's	O
first	O
bioterrorism	O
preparedness	O
program	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
in	O
1999	O
,	O
Dr	O
.	O

These	O
precautions	O
included	O
the	O
practices	O
,	O
safe	O
equipment	O
and	O
facility	O
,	O
protection	O
of	O
laboratory	O
staff	O
and	O
public	O
environment	O
from	O
exposure	O
to	O
infectious	O
substances	O
.	O

The	O
Tanzanian	B-Person
Health	I-Person
Minister	I-Person
Ummy	I-Person
Mwalimu	E-Person
stated	O
on	O
3	O
October	O
2019	O
that	O
there	O
was	O
no	O
Ebola	B-Incident
outbreak	E-Incident
in	O
Tanzania	S-Location
.	O
The	O
WHO	S-Organization
were	O
provided	O
with	O
a	O
preparedness	O
update	O
on	O
18	O
October	O
which	O
outlined	O
a	O
range	O
of	O
actions	O
,	O
and	O
included	O
commentary	O
that	O
since	O
the	O
outbreak	O
commenced	O
,	O
there	O
had	O
been	O
"	O
29	O
alerts	O
of	O
Ebola	S-Disease
suspect	O
cases	O
reported	O
,	O
17	O
samples	O
tested	O
and	O
were	O
negative	O
for	O
(including	O
2	O
in	O
September	O
2019)"	O
.	O

The	O
death	O
toll	O
was	O
at	O
least	O
105	O
,	O
but	O
no	O
one	O
knows	O
the	O
exact	O
number	O
,	O
because	O
all	O
hospital	O
records	O
and	O
other	O
evidence	O
were	O
destroyed	O
by	O
the	O
KGB	S-Organization
,	O
according	O
to	O
former	O
Biopreparat	S-Organization
deputy	O
director	O
.	O

On	O
11	O
August	O
1978	O
,	O
Parker	S-Person
(who	O
had	O
been	O
vaccinated	O
against	O
smallpox	S-Disease
in	O
1966	O
,	O
but	O
not	O
since)	O
fell	O
ill	O
;	O
she	O
had	O
a	O
headache	S-Phenotype
and	O
pains	B-Phenotype
in	I-Phenotype
her	I-Phenotype
muscles	E-Phenotype
.	O
She	O
developed	O
spots	S-Phenotype
that	O
were	O
thought	O
to	O
be	O
a	O
benign	O
rash	S-Disease
,	O
or	O
chickenpox	S-Disease
.	O
On	O
20	O
August	O
at	O
3pm	O
,	O
she	O
was	O
admitted	O
to	O
East	B-Location
Birmingham	E-Location
(now	O
Heartlands	S-Location
)	O
Hospital	O
and	O
a	O
clinical	O
diagnosis	O
of	O
Variola	B-Disease
major	E-Disease
,	O
the	O
most	O
serious	O
type	O
of	O
smallpox	S-Disease
,	O
was	O
made	O
by	O
consultant	O
.	O

Several	O
immediate	O
steps	O
have	O
already	O
been	O
implemented	O
and	O
reported	O
by	O
CDC	S-Organization
including	O
the	O
institution	O
of	O
a	O
moratorium	O
on	O
the	O
movement	O
(i.e.	O
,	O
transfer	O
inside	O
or	O
outside	O
the	O
agency)	O
of	O
biological	O
materials	O
from	O
BSL-3	S-Platform
or	O
facilities	O
.	O

Photon	B-Equipment
counting	I-Equipment
detectors	E-Equipment
(	O
PCDs	S-Equipment
)	O
are	O
still	O
affected	O
by	O
noise	O
but	O
it	O
does	O
not	O
change	O
the	O
measured	O
counts	O
of	O
photons	O
.	O

This	O
plan	O
outlines	O
steps	O
taken	O
by	O
the	O
Federal	O
government	O
over	O
the	O
next	O
five	O
years	O
needed	O
in	O
order	O
to	O
prevent	O
and	O
contain	O
outbreaks	O
of	O
antibiotic-resistant	O
infections	O
;	O
maintain	O
the	O
efficacy	O
of	O
antibiotics	O
already	O
on	O
the	O
market	O
;	O
and	O
to	O
help	O
to	O
develop	O
future	O
diagnostics	O
,	O
antibiotics	O
,	O
and	O
vaccines	O
.	O

Sure	O
,	O
the	O
hero	O
has	O
done	O
what	O
he	O
set	O
out	O
to	O
do	O
and	O
solved	O
whatever	O
crisis	O
he	O
faced	O
,	O
but	O
in	O
real	O
life	O
that	O
would	O
only	O
be	O
a	O
small	O
part	O
of	O
the	O
story	O
,	O
said	O
Amler	S-Person
After	O
all	O
,	O
plenty	O
of	O
people	O
may	O
have	O
been	O
harmed	O
before	O
our	O
hero	O
finally	O
resolved	O
or	O
prevented	O
the	O
calamity	O
.	O

It	O
occurs	O
because	O
conventional	O
sources	O
,	O
like	O
X-ray	B-Equipment
tubes	E-Equipment
emit	O
a	O
polychromatic	O
spectrum	O
.	O

Some	O
materials	O
found	O
in	O
PPE	S-Equipment
may	O
contain	O
allergens	O
,	O
such	O
as	O
latex	O
,	O
that	O
can	O
stimulate	O
health	O
problems	O
for	O
allergic	O
personnel	O
.	O

Travel	O
to	O
and	O
from	O
Aralsk	S-Location
was	O
stopped	O
,	O
and	O
many	O
homes	O
were	O
disinfected	O
,	O
along	O
with	O
18	O
metric	O
tons	O
of	O
household	O
goods	O
.	O

Using	O
state	O
money	O
,	O
Reilly	S-Person
said	O
the	O
center	O
will	O
be	O
able	O
to	O
purchase	O
more	O
of	O
the	O
simulators	O
.	O

WHO	S-Organization
Director-General	O
Margaret	B-Person
Chan	E-Person
appointed	O
29	O
flu	O
experts	O
from	O
outside	O
the	O
organization	O
to	O
conduct	O
a	O
review	O
of	O
WHO	S-Organization
's	O
handling	O
of	O
the	O
.	O
She	O
told	O
them	O
,	O
"	O
We	O
want	O
a	O
frank	O
,	O
critical	O
,	O
transparent	O
,	O
credible	O
and	O
independent	O
review	O
of	O
our	O
performance.	O
"	O

The	O
general	O
population	O
was	O
familiar	O
with	O
patterns	O
of	O
pandemic	O
disease	O
in	O
the	O
late	O
19th	O
and	O
early	O
20th	O
centuries:	O
typhoid	S-Disease
,	O
yellow	B-Disease
fever	E-Disease
,	O
diphtheria	S-Disease
and	O
cholera	S-Disease
all	O
occurred	O
near	O
the	O
same	O
time	O
.	O

According	O
to	O
mask	O
manufacturer	O
3M	S-Organization
masks	S-Equipment
will	O
filter	O
out	O
particles	O
in	O
industrial	O
settings	O
,	O
but	O
"	O
there	O
are	O
no	O
established	O
exposure	O
limits	O
for	O
biological	O
agents	O
such	O
as	O
swine	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
"	O
.	O
However	O
,	O
despite	O
the	O
lack	O
of	O
evidence	O
of	O
effectiveness	O
,	O
the	O
use	O
of	O
such	O
masks	O
is	O
common	O
in	O
Asia	S-Location
.	O
They	O
are	O
particularly	O
popular	O
in	O
Japan	S-Location
,	O
where	O
cleanliness	O
and	O
hygiene	O
are	O
highly	O
valued	O
and	O
where	O
etiquette	O
obligates	O
those	O
who	O
are	O
sick	O
to	O
wear	O
to	O
avoid	O
spreading	O
disease	O
.	O

The	O
Global	B-Organization
Health	I-Organization
Observatory	E-Organization
(	O
GHO	S-Organization
)	O
has	O
been	O
the	O
's	O
main	O
portal	O
which	O
provides	O
access	O
to	O
data	O
and	O
analyses	O
for	O
key	O
health	O
themes	O
by	O
monitoring	O
health	O
situations	O
around	O
the	O
globe	O
.	O

According	O
to	O
Giorgadze	S-Person
,	O
the	O
documents	O
include	O
a	O
list	O
of	O
30	O
individuals	O
who	O
allegedly	O
died	O
in	O
the	O
facility	O
from	O
Hepatitis	B-Disease
C	E-Disease
in	O
December	O
2014	O
,	O
24	O
of	O
them	O
on	O
the	O
same	O
day	O
.	O

We	O
believe	O
that	O
the	O
key	O
factors	O
in	O
building	O
trust	O
among	O
FBD	S-Platform
network	O
members	O
have	O
been	O
joint	O
work	O
on	O
the	O
part	O
of	O
laboratory	O
personnel	O
,	O
significant	O
contribution	O
by	O
each	O
of	O
the	O
participating	O
agencies	O
,	O
and	O
common	O
ownership	O
of	O
results	O
.	O

The	O
figure	O
to	O
the	O
right	O
is	O
one	O
of	O
the	O
synthesis	O
routes	O
of	O
remdesivir	S-Drug
invented	O
by	O
Chun	S-Person
and	O
coauthors	O
from	O
.	O
In	O
this	O
method	O
,	O
intermediate	O
a	O
is	O
firstly	O
prepared	O
from	O
L-alanine	O
and	O
phenyl	O
phosphorodichloridate	O
in	O
presence	O
of	O
triethylamine	O
and	O
dichloromethane	O
;	O
triple	O
benzyl-protected	O
ribose	O
is	O
oxidized	O
by	O
dimethyl	O
sulfoxide	O
with	O
acetic	O
anhydride	O
and	O
give	O
the	O
lactone	O
intermediate	O
b	O
;	O
pyrrolo[2,1-f]	O
[1,2,4]triazin-4-amine	O
is	O
brominated	O
,	O
and	O
the	O
amine	O
group	O
is	O
protected	O
by	O
excess	O
trimethylsilyl	O
chloride.	O
n-Butyllithium	O
undergoes	O
a	O
halogen-lithium	O
exchange	O
reaction	O
with	O
the	O
bromide	O
at	O
to	O
yield	O
the	O
intermediate	O
c	O
.	O

That	O
incident	O
remains	O
shrouded	O
in	O
secrecy	O
.	O

According	O
to	O
the	O
authorities	O
,	O
some	O
patients	O
were	O
operating	O
dealers	O
or	O
vendors	O
in	O
the	O
Huanan	B-Location
Seafood	I-Location
market	E-Location
Based	O
on	O
the	O
preliminary	O
information	O
from	O
the	O
,	O
no	O
evidence	O
of	O
significant	O
human-to-human	O
transmission	O
and	O
no	O
health	O
care	O
worker	O
infections	O
have	O
been	O
reported	O
.	O

Emergent	B-Organization
BioSolutions	E-Organization
developed	O
VIGIV	S-Vaccine
,	O
the	O
FDA	S-Organization
's	O
only	O
licensed	O
therapeutic	O
for	O
the	O
treatment	O
of	O
smallpox	B-Disease
vaccination	I-Disease
complications	E-Disease
,	O
on	O
the	O
company's	O
hyperimmune	O
platform	O
and	O
has	O
delivered	O
it	O
to	O
SNS	S-Organization
since	O
2002	O
.	O

And	O
we	O
do	O
have	O
a	O
question	O
from	O
Miriam	B-Person
Falco	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
inspectors	O
and	O
University	B-Organization
of	I-Organization
Michigan	E-Organization
officials	O
found	O
materials	O
labeled	O
as	O
Brucella	S-Pathogen
,	O
a	O
select	O
agent	O
,	O
outside	O
the	O
containment	O
area	O
in	O
April	O
2012	O
.	O

So	O
for	O
example	O
,	O
in	O
the	O
anthrax	S-Pathogen
episode	O
,	O
they	O
could	O
have	O
used	O
a	O
harmless	O
form	O
of	O
what's	O
called	O
bacillus	O
,	O
the	O
same	O
genus	O
but	O
a	O
different	O
species	O
for	O
that	O
experiment	O
.	O

The	O
World	B-Organization
Bank	E-Organization
was	O
criticised	O
when	O
its	O
Pandemic	O
Emergency	O
Financing	O
Facility	O
,	O
a	O
fund	O
backed	O
by	O
private	O
finance	O
intended	O
to	O
support	O
countries	O
affected	O
by	O
pandemic	O
diseases	O
,	O
had	O
only	O
paid	O
out	O
$31 million	O
of	O
a	O
potential	O
total	O
of	O
$425 million	O
by	O
August	O
2019	O
,	O
while	O
generating	O
substantial	O
returns	O
for	O
investors	O
.	O

The	O
clinical	O
isolates	O
were	O
collected	O
from	O
infected	O
patients	O
located	O
in	O
Bhutan	S-Location
,	O
Cambodia	S-Location
,	O
Nepal	S-Location
and	O
Thailand	S-Location
between	O
1993	O
and	O
2016	O
,	O
allowing	O
researchers	O
to	O
measure	O
the	O
impact	O
of	O
Travelan®	S-Drug
antibodies	O
on	O
recent	O
infectious	O
bacterial	O
strains	O
in	O
the	O
field	O
.	O

If	O
the	O
attack	O
were	O
not	O
detected	O
by	O
one	O
of	O
the	O
monitoring	O
systems	O
in	O
place	O
in	O
the	O
,	O
it	O
might	O
go	O
unnoticed	O
until	O
doctors	O
begin	O
to	O
see	O
unusual	O
patterns	O
of	O
illness	O
among	O
sick	O
people	O
showing	O
up	O
at	O
emergency	O
rooms	O
.	O

At	O
Karlstein	S-Location
in	O
,	O
attacking	O
forces	O
launched	O
the	O
decaying	O
cadavers	O
of	O
men	O
killed	O
in	O
battle	O
over	O
the	O
castle	O
walls	O
.	O

US	S-Location
civilian	O
personnel	O
performing	O
work	O
at	O
The	O
Lugar	B-Organization
Center	E-Organization
have	O
also	O
been	O
given	O
diplomatic	O
immunity	O
,	O
although	O
they	O
are	O
not	O
diplomats	O
.	O

The	O
monitoring	O
data	O
provides	O
evidence	O
to	O
assess	O
policies	O
,	O
set	O
priorities	O
and	O
determine	O
where	O
to	O
act	O
immediately	O
and	O
where	O
resources	O
need	O
to	O
be	O
addressed	O
.	O

Both	O
the	O
fish	O
and	O
the	O
cyanobacteria	O
grew	O
well	O
in	O
the	O
experiment	O
.	O

Based	O
on	O
In	O
a	O
simple	O
model	O
needs	O
on	O
average	O
over	O
time	O
be	O
kept	O
at	O
or	O
below	O
zero	O
to	O
avoid	O
exponential	O
growth	O
.	O

All	O
these	O
possibilities	O
can	O
be	O
pursued	O
mainly	O
to	O
the	O
presence	O
of	O
the	O
Cas9	O
targeting	O
signal	O
(PAM)	O
in	O
the	O
DNA	O
of	O
most	O
of	O
cell	O
types	O
and	O
organisms	O
.	O

On	O
13	O
March	O
,	O
Prime	O
Minister	O
Édouard	B-Person
Philippe	E-Person
ordered	O
the	O
closure	O
of	O
all	O
non-essential	O
public	O
places	O
,	O
and	O
on	O
16	O
March	O
,	O
French	O
President	O
Emmanuel	B-Person
Macron	E-Person
announced	O
mandatory	O
home	O
confinement	O
,	O
a	O
policy	O
which	O
was	O
extended	O
at	O
least	O
until	O
11	O
May.	O
,	O
France	S-Location
has	O
reported	O
more	O
than	O
120,804	O
confirmed	O
cases	O
,	O
21,856	O
deaths	O
,	O
and	O
42,088	O
recoveries	O
,	O
ranking	O
fourth	O
in	O
number	O
of	O
confirmed	O
cases	O
.	O

CDC	S-Organization
will	O
also	O
report	O
this	O
event	O
to	O
its	O
which	O
provides	O
ongoing	O
advice	O
and	O
direction	O
for	O
laboratory	O
science	O
and	O
safety	O
.	O

The	O
outbreak	O
struck	O
Aralsk	S-Location
a	O
port	O
on	O
the	O
Aral	B-Location
sea	E-Location
in	O
what	O
was	O
then	O
the	O
Kazakh	B-Location
Republic	E-Location
.	O
The	O
report	O
says	O
a	O
ship	O
doing	O
ecological	O
research	O
sailed	O
too	O
close	O
to	O
a	O
military	O
test	O
that	O
sent	O
out	O
a	O
deadly	O
plume	O
of	O
germs	O
,	O
infecting	O
a	O
crew	O
member	O
who	O
carried	O
the	O
virus	O
back	O
to	O
the	O
city	O
.	O

In	O
January	O
1919	O
a	O
third	O
wave	O
of	O
the	O
Spanish	B-Disease
Flu	E-Disease
hit	O
Australia	S-Location
,	O
then	O
spread	O
quickly	O
through	O
Europe	S-Location
and	O
the	O
United	B-Location
States	E-Location
,	O
where	O
it	O
lingered	O
through	O
the	O
Spring	O
and	O
until	O
June	O
1919	O
.	O

Wondering	O
whether	O
de	O
Grey	S-Person
goals	O
are	O
realistic	O
,	O
I	O
reached	O
out	O
to	O
Genspace	S-Organization
co-founder	O
Oliver	B-Person
Medvedik	E-Person
,	O
who	O
earned	O
his	O
PhD	O
at	O
Harvard	B-Organization
Medical	I-Organization
School	E-Organization
and	O
now	O
directs	O
the	O
Kanbar	B-Organization
Center	I-Organization
for	I-Organization
Biomedical	I-Organization
Engineering	E-Organization
at	O
.	O
"	O
Living	O
to	O
1,000?	O
It's	O
definitely	O
within	O
our	O
realm	O
of	O
possibility	O
if	O
we	O
as	O
a	O
society	O
that	O
doles	O
out	O
money	O
[to	O
fund	O
research	O
we	O
deem	O
worthy]	O
decide	O
we	O
want	O
to	O
do	O
it,	O
"	O
he	O
told	O
me	O
.	O

In	O
fact	O
,	O
they	O
come	O
with	O
the	O
date	O
of	O
February	O
10th	O
of	O
1954	O
.	O

Thank	O
you	O
very	O
much	O
.	O

It	O
was	O
suspected	O
that	O
the	O
two	O
viruses	O
mixed	O
while	O
he	O
was	O
doing	O
his	O
research	O
.	O

The	O
DRC	B-Organization
Ministry	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
reported	O
on	O
16	O
August	O
2018	O
that	O
316	O
individuals	O
had	O
been	O
vaccinated	O
.	O

David	B-Person
Beasley	E-Person
head	O
of	O
the	O
World	B-Organization
Food	I-Organization
Programme	E-Organization
()	O
,	O
said	O
"	O
we	O
could	O
be	O
facing	O
multiple	O
famines	O
of	O
biblical	O
proportions	O
within	O
a	O
short	O
few	O
months.	O
"	O

Hands-on	O
training	O
accounted	O
for	O
2.67%	O
(n = 49)	O
of	O
initiatives	O
.	O

During	O
World	O
War	O
II	O
,	O
Joseph	B-Person
Stalin	E-Person
was	O
forced	O
to	O
move	O
his	O
biological	O
warfare	O
(BW)	O
operations	O
out	O
of	O
the	O
path	O
of	O
advancing	O
German	B-Organization
forces	E-Organization
and	O
may	O
have	O
used	O
tularemia	S-Pathogen
against	O
German	O
troops	O
in	O
1942	O
near	O
.	O

As	O
part	O
of	O
its	O
effort	O
,	O
the	O
Commission	O
was	O
tasked	O
with	O
developing	O
lists	O
of	O
agents	O
for	O
which	O
specific	O
activities	O
should	O
be	O
undertaken	O
to	O
improve	O
preparedness	O
in	O
the	O
EU	S-Location
,	O
as	O
a	O
result	O
two	O
groups	O
of	O
potential	O
bioterrorism	O
biological	O
agents	O
were	O
defined	O
[13]	O
,	O
[14]	O
.	O

However	O
,	O
due	O
to	O
its	O
ease	O
of	O
use	O
and	O
accessibility	O
,	O
it	O
has	O
raised	O
a	O
number	O
of	O
ethical	O
concerns	O
,	O
especially	O
surrounding	O
its	O
use	O
in	O
the	O
biohacking	O
space	O
.	O

Assistant	O
Minister	O
Wesseh	S-Person
who	O
officially	O
opened	O
the	O
workshop	O
on	O
behalf	O
of	O
Agriculture	O
Minister	O
Mogana	B-Person
S.	I-Person
Flomo	E-Person
,	O
added	O
that	O
the	O
one	O
week	O
sitting	O
by	O
stakeholders	O
is	O
an	O
opportunity	O
to	O
put	O
in	O
place	O
an	O
Integrated	O
National	B-Document
Rabies	I-Document
Elimination	I-Document
Plan	E-Document
by	O
using	O
the	O
"	O
One	O
Health	O
"	O
Approach	O
that	O
will	O
be	O
in	O
the	O
heart	O
of	O
our	O
.	O

Their	O
work	O
contributes	O
new	O
ideas	O
to	O
a	O
field	O
in	O
need	O
of	O
innovation	O
despite	O
important	O
,	O
ongoing	O
progress	O
in	O
both	O
the	O
public	O
and	O
private	O
sectors	O
to	O
address	O
pandemic	O
risk	O
.	O

That	O
should	O
have	O
happened	O
,	O
and	O
it	O
didn't	O
.	O

JULIE	B-Person
STEENHUYSEN	E-Person
Hi	O
.	O

But	O
the	O
fact	O
is	O
that	O
anthrax	S-Pathogen
has	O
been	O
used	O
as	O
a	O
weapon	O
,	O
and	O
there's	O
a	O
risk	O
it	O
will	O
be	O
used	O
as	O
a	O
weapon	O
.	O

Adalja	S-Person
said	O
there	O
is	O
evidence	O
that	O
a	O
shortened	O
course	O
of	O
treatment	O
works	O
,	O
and	O
it	O
may	O
be	O
more	O
effective	O
in	O
the	O
long	O
run	O
because	O
"	O
it's	O
very	O
hard	O
for	O
people	O
to	O
comply	O
"	O
with	O
a	O
full	O
60	O
days	O
of	O
antibiotics	O
that	O
can	O
cause	O
unpleasant	O
side	O
effects	O
.	O

Freckle-like	O
spots	O
and	O
rashes	O
,	O
D.	B-Person
Herlihy	E-Person
,	O
The	O
Black	B-Disease
Death	E-Disease
and	O
the	O
Transformation	O
of	O
the	O
West	O
(	O
Harvard	B-Organization
University	I-Organization
Press	E-Organization
:	O
Cambridge	S-Location
,	O
Massachusetts	S-Location
,	O
1997)	O
,	O
p.29.	O
which	O
could	O
have	O
been	O
caused	O
by	O
flea-bites	O
,	O
were	O
identified	O
as	O
another	O
potential	O
sign	O
of	O
the	O
.	O

Researchers	O
thus	O
can	O
control	O
if	O
they	O
want	O
to	O
keep	O
their	O
data	O
private	O
or	O
with	O
whom	O
they	O
want	O
to	O
share	O
it	O
.	O

The	O
accident	O
is	O
sometimes	O
referred	O
to	O
as	O
"	O
biological	O
Chernobyl"	O
.	O

Whether	O
either	O
of	O
these	O
two	O
leads	O
to	O
the	O
same	O
benefit	O
for	O
people	O
who	O
are	O
critically	O
ill	O
is	O
not	O
known	O
.	O

&quot;This	O
is	O
a	O
large-scale	O
operation	O
so	O
five-	O
or	O
10-year	O
programs	O
are	O
going	O
to	O
be	O
need	O
ed,&quot;	B-Person
L	E-Person
said	O
.	O

Since	O
that	O
time	O
,	O
the	O
outbreak	O
turned	O
into	O
the	O
largest	O
Ebola	S-Disease
epidemic	O
in	O
recorded	O
history	O
,	O
with	O
over	O
22,000	O
cases	O
and	O
nearly	O
9,000	O
deaths	O
.	O

With	O
the	O
support	O
of	O
international	O
organizations	O
that	O
focus	O
on	O
biosafety	O
and	O
biosecurity	O
,	O
a	O
number	O
of	O
biosafety	O
initiatives	O
took	O
place	O
after	O
2000	O
in	O
the	O
scientific	O
community	O
of	O
the	O
region	O
.	O

While	O
the	O
article	O
did	O
not	O
claim	O
that	O
such	O
a	O
scenario	O
was	O
possible	O
,	O
it	O
did	O
use	O
the	O
popular	O
culture	O
appeal	O
as	O
a	O
means	O
of	O
urging	O
citizens	O
to	O
prepare	O
for	O
all	O
potential	O
hazards	O
,	O
such	O
as	O
earthquakes	O
,	O
tornadoes	O
,	O
and	O
floods	O
.	O

Because	O
of	O
this	O
,	O
the	O
mean	O
energy	O
of	O
the	O
spectrum	O
increases	O
when	O
passing	O
the	O
object	O
,	O
often	O
described	O
as	O
getting	O
"	O
harder".	O
This	O
leads	O
to	O
an	O
effect	O
increasingly	O
underestimating	O
material	O
thickness	O
,	O
if	O
not	O
corrected	O
.	O

United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Health	E-Organization
,	O
Education	B-Organization
and	I-Organization
Welfare	E-Organization
,	O
)	O
.	O

The	O
air	O
flow	O
in	O
laboratory	O
is	O
also	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

Many	O
algorithms	O
exist	O
to	O
correct	O
for	O
this	O
artifact	O
.	O

The	O
drug	O
prevents	O
this	O
exit	O
,	O
stopping	O
the	O
virus'	O
spread	O
.	O

On	O
8	O
April	O
,	O
a	O
new	O
health	O
minister	O
was	O
named	O
in	O
an	O
effort	O
to	O
end	O
Ebola	S-Disease
in	O
the	O
country	O
and	O
on	O
26	O
April	O
,	O
MSF	S-Organization
handed	O
the	O
Ebola	S-Disease
treatment	O
facility	O
,	O
ELWA-3	S-Organization
,	O
over	O
to	O
the	O
government	O
.	O

The	O
then-Soviet	B-Organization
Union	E-Organization
-	O
in	O
competition	O
with	O
the	O
-	O
had	O
large-scale	O
nuclear	O
,	O
biological	O
and	O
chemical	O
warfare	O
research	O
programmes	O
.	O

The	O
Soviet	B-Organization
government	E-Organization
publicly	O
blamed	O
contaminated	O
meat	O
,	O
but	O
intelligence	O
sources	O
suspected	O
the	O
outbreak	O
was	O
linked	O
to	O
secret	O
weapons	O
work	O
at	O
a	O
nearby	O
army	O
lab	O
.	O

Real-time	B-Technology
RT-PCR	E-Technology
is	O
the	O
recommended	O
test	O
as	O
others	O
are	O
unable	O
to	O
differentiate	O
between	O
pandemic	B-Disease
H1N1	E-Disease
and	O
regular	O
seasonal	B-Disease
flu	E-Disease
.	O
However	O
,	O
most	O
people	O
with	O
flu	B-Disease
symptoms	E-Disease
do	O
not	O
need	O
a	O
test	O
for	O
pandemic	B-Disease
H1N1	I-Disease
flu	E-Disease
specifically	O
,	O
because	O
the	O
test	O
results	O
usually	O
do	O
not	O
affect	O
the	O
recommended	O
course	O
of	O
treatment.The	O
U.S.	B-Organization
CDC	E-Organization
recommend	O
testing	O
only	O
for	O
people	O
who	O
are	O
hospitalized	O
with	O
suspected	O
flu	S-Disease
,	O
pregnant	O
women	O
,	O
and	O
people	O
with	O
weakened	O
immune	O
systems	O
.	O

Social	O
distancing	O
strategies	O
aim	O
to	O
reduce	O
contact	O
of	O
infected	O
persons	O
with	O
large	O
groups	O
by	O
closing	O
schools	O
and	O
workplaces	O
,	O
restricting	O
travel	O
,	O
and	O
cancelling	O
large	O
public	O
gatherings	O
.	O

To	O
maintain	O
morale	O
,	O
World	B-Incident
War	I-Incident
I	E-Incident
censors	O
minimized	O
early	O
reports	O
of	O
illness	O
and	O
mortality	O
in	O
Germany	S-Location
,	O
the	O
United	B-Location
Kingdom	E-Location
,	O
France	S-Location
,	O
and	O
the	O
United	B-Location
States	E-Location
.	O
Newspapers	O
were	O
free	O
to	O
report	O
the	O
epidemic's	O
effects	O
in	O
neutral	O
Spain	S-Location
,	O
such	O
as	O
the	O
grave	O
illness	O
of	O
King	B-Person
Alfonso	I-Person
XIII	E-Person
,	O
and	O
these	O
stories	O
created	O
a	O
false	O
impression	O
of	O
Spain	S-Location
as	O
especially	O
hard	O
hit	O
.	O

Stericycle	S-Organization
and	O
are	O
two	O
national	O
leaders	O
in	O
medical	O
waste	O
and	O
pharmaceutical	O
disposal	O
in	O
the	O
United	O
States	O
.	O

On	O
9	O
December	O
2014	O
news	O
reports	O
described	O
the	O
discovery	O
of	O
"	O
a	O
grim	O
scene"-piles	O
of	O
bodies	O
,	O
overwhelmed	O
medical	O
personnel	O
and	O
exhausted	O
burial	O
teams-in	O
the	O
remote	O
eastern	O
Kono	B-Location
District	E-Location
On	O
15	O
December	O
the	O
CDC	S-Organization
indicated	O
that	O
their	O
main	O
concern	O
was	O
Sierra	B-Location
Leone	E-Location
,	O
where	O
the	O
epidemic	O
had	O
shown	O
no	O
signs	O
of	O
abating	O
as	O
cases	O
continued	O
to	O
rise	O
exponentially	O
;	O
by	O
the	O
second	O
week	O
of	O
December	O
,	O
Sierra	B-Location
Leone	E-Location
had	O
reported	O
nearly	O
400 cases-more	O
than	O
three	O
times	O
the	O
number	O
reported	O
by	O
Guinea	S-Location
and	O
Liberia	S-Location
combined	O
.	O

The	O
other	O
close	O
contacts	O
,	O
which	O
included	O
two	O
biomedical	O
scientists	O
from	O
the	O
Regional	B-Organization
Virus	I-Organization
Laboratory	E-Organization
,	O
were	O
released	O
from	O
quarantine	O
in	O
on	O
10	O
October	O
1978	O
.	O

Aside	O
from	O
his	O
comments	O
,	O
no	O
details	O
of	O
the	O
putative	O
test	O
are	O
known	O
publicly	O
.	O

These	O
biting	O
insects	O
live	O
indoors	O
,	O
in	O
bathrooms	O
,	O
all	O
year	O
long	O
,	O
which	O
was	O
not	O
the	O
typical	O
behaviour	O
of	O
these	O
species	O
in	O
Georgia	S-Location
previously	O
(normally	O
the	O
Phlebotomine	O
fly	O
season	O
in	O
is	O
exceptionally	O
short	O
–	O
from	O
June	O
to	O
September)	O
.	O

Peter	B-Person
Salama	E-Person
,	O
who	O
is	O
Deputy	O
Director-General	O
of	O
Emergency	O
Preparedness	O
and	O
Response	O
for	O
WHO	S-Organization
,	O
reported	O
that	O
the	O
current	O
300,000	O
vaccine	O
stockpile	O
may	O
not	O
be	O
enough	O
to	O
contain	O
this	O
EVD	S-Disease
outbreak	O
;	O
additionally	O
it	O
takes	O
several	O
months	O
to	O
make	O
more	O
of	O
the	O
Zaire	B-Vaccine
EVD	I-Vaccine
vaccine	E-Vaccine
(	O
rVSV-ZEBOV	S-Vaccine
)	O
.	O

The	O
first	O
self-replicating	O
synthetic	O
bacteria	O
cell	O
constructed	O
by	O
scientists	O
at	O
the	O
has	O
more	O
than	O
1	O
million	O
base	O
pairs	O
of	O
DNA	O
,	O
almost	O
1,000	O
genes	O
,	O
and	O
involved	O
the	O
complete	O
replacement	O
of	O
genetic	O
material	O
in	O
the	O
cell	O
.	O

"	O
The	O
way	O
that	O
people	O
think	O
about	O
[nuclear	O
weapons]	O
is	O
on	O
a	O
much	O
,	O
much	O
grander	O
scale	O
than	O
biological	O
weapons	O
,	O
and	O
I	O
think	O
that's	O
a	O
misperception,	O
"	O
said	O
Dr	O
.	O

Following	O
the	O
2014	B-Incident
Ebola	I-Incident
outbreak	I-Incident
in	I-Incident
West	I-Incident
Africa	E-Incident
the	O
organization	O
was	O
heavily	O
criticized	O
for	O
its	O
bureaucracy	O
,	O
insufficient	O
financing	O
,	O
regional	O
structure	O
,	O
and	O
staffing	O
profile	O
.	O

Also	O
,	O
CDC	S-Organization
has	O
reported	O
the	O
incident	O
to	O
the	O
Federal	O
Select	O
Agent	O
Program	O
.	O

The	O
STCU	S-Organization
officially	O
supports	O
projects	O
of	O
scientists	O
previously	O
involved	O
in	O
the	O
Soviet	B-Scientific_research_project
biological	I-Scientific_research_project
weapons	I-Scientific_research_project
program	E-Scientific_research_project
.	O
Over	O
the	O
past	O
20	O
years	O
the	O
has	O
invested	O
over	O
$285	O
million	O
in	O
funding	O
and	O
managing	O
some	O
1,850	O
projects	O
of	O
scientists	O
who	O
previously	O
worked	O
on	O
the	O
development	O
of	O
weapons	O
of	O
mass	O
destruction	O
.	O

It	O
involved	O
removing	O
immune	O
cells	O
from	O
people	O
with	O
lung	B-Disease
cancer	E-Disease
,	O
using	O
CRISPR	S-Disease
to	O
edit	O
out	O
the	O
gene	O
expressed	O
PD-1	O
,	O
then	O
administrating	O
the	O
altered	O
cells	O
back	O
to	O
the	O
same	O
person.	O
20	O
other	O
trials	O
were	O
under	O
way	O
or	O
nearly	O
ready	O
,	O
mostly	O
in	O
,	O
.	O

Cam­bridge	S-Location
Mass­a­chu­setts	S-Location
start­up	O
is	O
join­ing	O
forces	O
with	O
US	O
de­fense	O
or­ga­ni­za­tions	O
to	O
see	O
if	O
their	O
in­ves­ti­ga­tion­al	O
an­tibi­ot­ic	O
could	O
be	O
use­ful	O
against	O
biode­fense	O
threats	O
.	O

The	O
is	O
in	O
current	O
use	O
worldwide	O
in	O
the	O
effort	O
to	O
improve	O
patient	O
safety	O
.	O

In	O
public	O
health	O
,	O
there	O
are	O
often	O
no	O
quick	O
solutions	O
.	O

They	O
used	O
a	O
process	O
that	O
they	O
thought	O
would	O
kill	O
the	O
anthrax	S-Pathogen
bacteria	O
,	O
and	O
it	O
may	O
not	O
have	O
.	O

The	O
CDC	S-Organization
response	O
to	O
has	O
been	O
criticized	O
for	O
promoting	O
some	O
public	O
health	O
policies	O
that	O
harmed	O
HIV+	O
people	O
and	O
for	O
providing	O
ineffective	O
public	O
education	O
.	O

For	O
a	O
start	O
,	O
there	O
are	O
few	O
large-scale	O
pharmaceutical	O
campaigns	O
.	O

Biological	O
Warfare	O
and	O
Biological	O
Defense	O
Programs	O
,	O
(PDF:	O
p.430	O
[p.	O
6	O
in	O
PDF])	O
,	O
Borden	O
Institute	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Air	O
University	O
.	O

The	O
hypothetical	O
possibility	O
of	O
vertical	O
transmission	O
(from	O
mother	O
to	O
child)	O
of	O
diseases	O
,	O
particularly	O
syphilis	S-Disease
was	O
the	O
stated	O
reason	O
for	O
the	O
torture	O
.	O

Numerous	O
studies	O
have	O
been	O
performed	O
under	O
the	O
DTRA	B-Scientific_research_project
Cooperative	I-Scientific_research_project
Biological	I-Scientific_research_project
Engagement	I-Scientific_research_project
Program	E-Scientific_research_project
()	O
in	O
a	O
search	O
for	O
deadly	O
pathogens	O
of	O
military	O
importance	O
in	O
bats	O
.	O

Symptoms	O
include	O
fever	S-Phenotype
,	O
cough	S-Phenotype
,	O
and	O
blood-tinged	B-Phenotype
sputum	E-Phenotype
.	O
As	O
the	O
disease	O
progresses	O
,	O
sputum	O
becomes	O
free-flowing	O
and	O
bright	O
red.	O
has	O
a	O
mortality	O
rate	O
of	O
90	O
to	O
95	O
percent	O
.	O

Smallpox	S-Disease
is	O
an	O
infectious	O
disease	O
unique	O
to	O
humans	O
,	O
caused	O
by	O
either	O
of	O
two	O
virus	O
variants	O
named	O
Variola	B-Pathogen
major	E-Pathogen
and	O
Variola	B-Pathogen
minor	E-Pathogen
.	O
The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
had	O
established	O
a	O
smallpox	B-Scientific_research_project
eradication	I-Scientific_research_project
programme	E-Scientific_research_project
and	O
,	O
by	O
1978	O
,	O
was	O
close	O
to	O
declaring	O
that	O
the	O
disease	O
had	O
been	O
eradicated	O
globally	O
.	O

Army	O
Engineer	O
Hisato	B-Person
Yoshimura	E-Person
conducted	O
experiments	O
by	O
taking	O
captives	O
outside	O
,	O
dipping	O
various	O
appendages	O
into	O
water	O
,	O
and	O
allowing	O
the	O
limb	O
to	O
freeze	O
.	O

This	O
technique	O
produces	O
membranes	O
with	O
uniform	O
pore	O
sizes	O
and	O
minimal	O
defects	O
,	O
creating	O
a	O
more	O
reliable	O
product	O
.	O

Anthrax	S-Pathogen
was	O
used	O
in	O
a	O
series	O
of	O
attacks	O
by	O
a	O
microbiologist	O
at	O
the	O
US	B-Organization
Army	I-Organization
Medical	I-Organization
Research	I-Organization
Institute	I-Organization
of	I-Organization
Infection	I-Organization
Disease	E-Organization
on	O
the	O
offices	O
of	O
several	O
United	B-Location
States	E-Location
Senators	O
in	O
late	O
2001	O
.	O

On	O
19	O
May	O
2020	O
,	O
Australia	S-Organization
filed	O
a	O
motion	O
with	O
the	O
UN	S-Organization
for	O
an	O
inquiry	O
into	O
the	O
origins	O
of	O
the	O
virus	O
,	O
and	O
the	O
response	O
of	O
the	O
and	O
governments	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	I-Organization
and	I-Organization
the	I-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
said	O
those	O
agencies	O
have	O
been	O
acting	O
for	O
weeks	O
as	O
if	O
Phase	O
6	O
were	O
already	O
in	O
effect	O
and	O
no	O
additional	O
measures	O
would	O
be	O
put	O
into	O
effect	O
.	O

In	O
the	O
1918–1919	B-Incident
pandemic	E-Incident
a	O
first	O
or	O
spring	O
wave	O
began	O
in	O
March	O
1918	O
and	O
spread	O
unevenly	O
through	O
the	O
United	B-Location
States	E-Location
,	O
Europe	S-Location
,	O
and	O
possibly	O
Asia	S-Location
over	O
the	O
next	O
6	O
months	O
(Figure	O
1)	O
.	O

People	O
&amp	O
;	O
Power:	O
Dirty	O
little	O
sec	O
rets	B-Person
by	I-Person
Diarmuid	E-Person
Al	O
Jazeera	O
English	O
,	O
2010-03-10	O
In	O
this	O
program	O
,	O
Pr	O
ofessor	B-Person
Mori	E-Person
Masataka	O
investigated	O
historical	O
artifacts	O
in	O
the	O
form	O
of	O
bomb	O
casin	O
gs	S-Organization
from	O
US	O
biological	O
weapons	O
,	O
contemporary	O
documentary	O
evidence	O
and	O
eyewitness	O
testimonies	O
.	O

That	O
same	O
day	O
,	O
Chinese	B-Organization
Communist	I-Organization
Party	E-Organization
general	O
secretary	O
Xi	B-Person
Jinping	E-Person
and	O
State	B-Organization
Council	E-Organization
premier	O
Li	B-Person
Keqiang	E-Person
issued	O
their	O
first	O
public	O
comments	O
about	O
the	O
virus	O
,	O
telling	O
people	O
in	O
infected	O
areas	O
to	O
practice	O
social	O
distancing	O
and	O
avoid	O
travel	O
.	O

MRI	S-Technology
for	O
imaging	O
anatomical	O
structures	O
or	O
blood	O
flow	O
do	O
not	O
require	O
contrast	O
agents	O
since	O
the	O
varying	O
properties	O
of	O
the	O
tissues	O
or	O
blood	O
provide	O
natural	O
contrasts	O
.	O

This	O
review	O
introduces	O
the	O
classification	O
and	O
characterization	O
of	O
IAVs	S-Pathogen
,	O
pinpoints	O
historic	O
pandemics	O
and	O
epidemics	O
caused	O
by	O
IAVs	S-Pathogen
,	O
emphasizes	O
the	O
significance	O
and	O
necessity	O
of	O
biosafety	O
,	O
summarizes	O
currently	O
established	O
biosafety-related	O
protocols	O
for	O
research	O
,	O
and	O
provides	O
potential	O
strategies	O
to	O
improve	O
biosafety	O
protocols	O
for	O
dual-use	O
research	O
on	O
the	O
highly	O
pathogenic	O
avian	O
influenza	O
viruses	O
and	O
other	O
emerging	O
infectious	O
agents	O
.	O

Per	O
media	O
reports	O
on	O
1April	O
,	O
has	O
received	O
requests	O
for	O
virus	O
testing	O
assistance	O
from	O
121	O
different	O
countries	O
.	O

Chinese	O
officials	O
also	O
admitted	O
to	O
major	O
underreporting	O
of	O
cases	O
,	O
which	O
were	O
attributed	O
to	O
bureaucratic	O
ineptitude	O
.	O

The	O
WHO	S-Organization
estimates	O
that	O
12.	O
6 million	O
people	O
died	O
as	O
a	O
result	O
of	O
living	O
or	O
working	O
in	O
an	O
unhealthy	O
environment	O
in	O
2012	O
–	O
this	O
accounts	O
for	O
nearly	O
1	O
in	O
4	O
of	O
total	O
global	O
deaths	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
estimated	O
that	O
the	O
total	O
number	O
of	O
deaths	O
in	O
was	O
12,469	O
.	O

Biosecurity	O
has	O
also	O
been	O
raised	O
to	O
a	O
place	O
of	O
prominence	O
in	O
security	O
discussions	O
throughout	O
much	O
of	O
the	O
rest	O
of	O
the	O
globe	O
,	O
largely	O
through	O
the	O
mechanisms	O
of	O
the	O
Biological	B-Document
and	I-Document
Toxin	I-Document
Weapons	I-Document
Convention	E-Document
and	O
related	O
groups	O
,	O
but	O
also	O
through	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
and	O
the	O
implementation	O
of	O
the	O
,	O
which	O
is	O
scheduled	O
for	O
2012	O
.	O

Under	O
suspicion	O
since	O
the	O
release	O
of	O
the	O
prior	O
suspect	O
,	O
Dutschke	S-Person
denied	O
the	O
allegations	O
through	O
his	O
lawyer	O
.	O

Traditionally	O
,	O
cardiac	O
CT	S-Equipment
scans	O
are	O
used	O
to	O
detect	O
,	O
diagnose	O
,	O
or	O
follow	O
up	O
coronary	B-Disease
artery	I-Disease
disease	E-Disease
.	O
More	O
recently	O
CT	S-Technology
has	O
played	O
a	O
key	O
role	O
in	O
the	O
fast	O
evolving	O
field	O
of	O
transcatheter	O
structural	O
heart	O
interventions	O
,	O
more	O
specifically	O
in	O
the	O
.	O

But	O
as	O
de	B-Person
Bretton-Gordon	E-Person
explained	O
,	O
that's	O
not	O
how	O
works	O
.	O

The	O
team	O
used	O
a	O
modified	O
version	O
of	O
DARPA	S-Organization
Heilmeier	O
Catechism	O
to	O
standardize	O
the	O
process	O
of	O
evaluating	O
each	O
technology	O
and	O
formulating	O
guidance	O
for	O
funding	O
decisions	O
.	O

A	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
report	O
is	O
touting	O
the	O
benefits	O
of	O
a	O
program	O
credited	O
with	O
expediting	O
detection	O
.	O

As	O
a	O
contributor	O
to	O
the	O
Global	B-International_exchange_and_cooperation
Health	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
Agenda	E-International_exchange_and_cooperation
(	O
GHSA	S-International_exchange_and_cooperation
)	O
,	O
a	O
multilateral	O
,	O
multisector	O
effort	O
that	O
includes	O
60	O
participating	O
countries	O
and	O
numerous	O
private	O
and	O
public	O
international	O
organizations	O
focused	O
on	O
building	O
up	O
worldwide	O
health	O
security	O
capabilities	O
toward	O
meeting	O
such	O
threats	O
,	O
has	O
committed	O
to	O
improving	O
its	O
own	O
preparedness	O
,	O
as	O
well	O
as	O
that	O
of	O
other	O
nations	O
.	O

On	O
29	O
July	O
,	O
a	O
sharp	O
decline	O
in	O
cases	O
was	O
reported	O
,	O
with	O
only	O
a	O
single	O
case	O
,	O
per	O
media	O
reports	O
left	O
by	O
the	O
end	O
of	O
the	O
week	O
,	O
the	O
number	O
of	O
cases	O
eventually	O
plateaued	O
at	O
1	O
or	O
2	O
cases	O
per	O
week	O
after	O
the	O
beginning	O
of	O
August	O
.	O

Since	O
then	O
,	O
it	O
has	O
jumped	O
from	O
radical	O
personal	O
experimentation	O
to	O
TED	O
st	S-Organization
to	O
everyday	O
lifestyle	O
products	O
,	O
including	O
coffee	O
.	O

It	O
includes	O
an	O
understanding	O
of	O
the	O
chain	O
of	O
communication	O
and	O
who	O
you	O
tell	O
when	O
.	O

The	O
current	O
pandemic	O
of	O
coronavirus	B-Disease
disease	I-Disease
2019	E-Disease
(	O
COVID-19	S-Disease
)	O
is	O
not	O
caused	O
by	O
an	O
influenza	O
virus	O
but	O
,	O
a	O
coronavirus	O
which	O
also	O
primarily	O
affects	O
the	O
respiratory	O
system	O
.	O

Presently	O
the	O
Pentagon	S-Organization
produces	O
and	O
tests	O
live	O
bio-	O
agents	O
at	O
the	O
same	O
military	O
facility	O
as	O
it	O
did	O
in	O
the	O
past	O
–	O
.	O

The	O
situation	O
is	O
already	O
being	O
reflected	O
in	O
the	O
financial	O
markets	O
-	O
US	S-Location
lean-hog	O
futures	O
on	O
the	O
have	O
risen	O
around	O
60%	O
over	O
the	O
last	O
month	O
.	O

Bayles	S-Person
said	O
the	O
Los	B-Location
Alamos	E-Location
program	O
would	O
complement	O
an	O
existing	O
educational	O
pipeline	O
previously	O
established	O
between	O
other	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
laboratories	O
,	O
UNMC	S-Organization
and	O
the	O
University	B-Organization
of	I-Organization
Nebraska	E-Organization
at	O
.	O

When	O
the	O
WHO	S-Organization
released	O
these	O
estimates	O
,	O
a	O
number	O
of	O
epidemiologists	O
presented	O
data	O
to	O
show	O
that	O
the	O
WHO	S-Organization
projection	O
of	O
a	O
total	O
of	O
20,000	O
cases	O
was	O
likely	O
an	O
underestimate	O
.	O

The	O
goal	O
to	O
end	O
BioWatch	S-Document
he	O
said	O
,	O
is	O
part	O
of	O
a	O
bigger	O
administration	O
revamp	O
for	O
how	O
collects	O
,	O
uses	O
,	O
monitors	O
and	O
distributes	O
information	O
for	O
fighting	O
biological	O
threats	O
,	O
and	O
to	O
do	O
it	O
with	O
more	O
speed	O
so	O
that	O
a	O
pathogen	O
doesn't	O
have	O
time	O
to	O
morph	O
into	O
a	O
full-blown	O
pandemic	O
.	O

The	O
primary	O
data	O
from	O
the	O
above	O
studies	O
(–)	O
and	O
a	O
number	O
of	O
reviews	O
covering	O
different	O
aspects	O
of	O
the	O
1918	B-Incident
pandemic	E-Incident
have	O
recently	O
been	O
published	O
(–)	O
and	O
confirm	O
that	O
the	O
1918	B-Pathogen
virus	E-Pathogen
is	O
the	O
likely	O
ancestor	O
of	O
all	O
4	O
of	O
the	O
human	O
and	O
swine	O
H1N1	S-Pathogen
and	O
H3N2	S-Pathogen
lineages	O
,	O
as	O
well	O
as	O
the	O
"	O
extinct"	O
H2N2	S-Pathogen
lineage	O
.	O

The	O
head	O
of	O
Unit	B-Organization
731	E-Organization
,	O
Shiro	B-Person
Ishii	E-Person
,	O
was	O
granted	O
immunity	O
from	O
war	O
crimes	O
prosecution	O
in	O
exchange	O
for	O
providing	O
information	O
to	O
the	O
United	B-Location
States	E-Location
on	O
the	O
Unit's	O
activities	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
isolate	O
,	O
complete	O
genome	O
,	O
GenBank	O
The	O
3′	O
terminus	O
is	O
not	O
polyadenylated	O
and	O
the	O
5′	O
end	O
is	O
not	O
capped	O
.	O

He	O
asked	O
volunteers	O
to	O
fill	O
out	O
a	O
brief	O
questionnaire	O
and	O
give	O
blood	O
samples	O
at	O
the	O
beginning	O
of	O
their	O
deployment	O
,	O
mid-deployment	O
,	O
and	O
again	O
post-deployment	O
.	O

Sweden	S-Organization
differed	O
from	O
most	O
other	O
European	O
countries	O
in	O
that	O
it	O
mostly	O
remained	O
open	O
.	O

Problems	O
he	O
was	O
seeing	O
included	O
chronic	B-Phenotype
pain	E-Phenotype
,	O
sometimes	O
so	O
severe	O
that	O
walking	O
was	O
difficult	O
;	O
eye	O
problems	O
,	O
including	O
uveitis	S-Disease
;	O
and	O
headaches	S-Phenotype
as	O
the	O
most	O
common	O
physical	O
symptoms.	O
"	O
They're	O
still	O
very	O
severe	O
and	O
impacting	O
their	O
life	O
every	O
day	O
.	O

In	O
August	O
1918	O
,	O
a	O
more	O
virulent	O
strain	O
appeared	O
simultaneously	O
in	O
Brest	S-Location
France	S-Location
;	O
in	O
Freetown	S-Location
,	O
Sierra	B-Location
Leone	E-Location
;	O
and	O
in	O
the	O
U.S.	S-Location
,	O
in	O
September	O
,	O
at	O
the	O
Boston	B-Location
Navy	I-Location
Yard	E-Location
and	O
Camp	B-Location
Devens	E-Location
(later	O
renamed	O
Fort	B-Location
Devens	E-Location
)	O
,	O
about	O
30	O
miles	O
west	O
of	O
Boston	S-Location
.Other	O
U.S.	S-Location
military	O
sites	O
were	O
soon	O
afflicted	O
,	O
as	O
were	O
troops	O
being	O
transported	O
to	O
Europe	S-Location
.	O
The	O
Spanish	B-Disease
flu	E-Disease
also	O
spread	O
through	O
,	O
carried	O
there	O
by	O
returning	O
Irish	O
soldiers	O
.	O

Continuing	O
such	O
cross-party	O
work	O
will	O
be	O
tantamount	O
to	O
ensuring	O
Americans	O
are	O
protected	O
against	O
these	O
increasing	O
and	O
evolving	O
threats	O
,	O
said	O
members	O
of	O
the	O
Senate	B-Organization
Health,	I-Organization
Education,	I-Organization
Labor,	I-Organization
and	I-Organization
Pensions	I-Organization
(HELP)	I-Organization
Committee	E-Organization
during	O
a	O
Jan.	O
17	O
hearing	O
that	O
kickstarted	O
the	O
reauthorization	B-Document
process	I-Document
for	I-Document
the	I-Document
Pandemic	I-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
Act	E-Document
()	O
.	O

Real-time	B-Technology
MRI	E-Technology
is	O
likely	O
to	O
add	O
important	O
information	O
on	O
diseases	O
of	O
the	O
heart	O
and	O
the	O
joints	O
,	O
and	O
in	O
many	O
cases	O
may	O
make	O
MRI	S-Technology
examinations	O
easier	O
and	O
more	O
comfortable	O
for	O
patients	O
,	O
especially	O
for	O
the	O
patients	O
who	O
cannot	O
hold	O
their	O
breathings	O
or	O
who	O
have	O
.	O

Virus	O
sequencing	O
from	O
78	O
patients	O
with	O
confirmed	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
representing	O
more	O
than	O
70%	O
of	O
cases	O
diagnosed	O
in	O
Sierra	B-Location
Leone	E-Location
from	O
late	O
May	O
to	O
mid-June	O
2014	O
,	O
provided	O
evidence	O
that	O
the	O
2014	O
outbreak	O
was	O
no	O
longer	O
being	O
fed	O
by	O
new	O
contacts	O
with	O
its	O
natural	O
reservoir	O
.	O

The	O
plan	O
includes	O
risk	O
assessment	O
;	O
rules	O
for	O
personal	O
protective	O
equipment	O
;	O
validation	O
(including	O
observation	O
of	O
key	O
steps	O
by	O
a	O
second	O
,	O
highly	O
trained	O
and	O
certified	O
lab	O
technician)	O
that	O
the	O
heat-kill	S-Technology
process	O
was	O
conducted	O
correctly	O
and	O
that	O
any	O
living	O
organisms	O
were	O
killed	O
;	O
strict	O
limits	O
on	O
lab	O
access	O
;	O
medical	O
monitoring	O
of	O
lab	O
personnel	O
;	O
and	O
back-up	O
tests	O
.	O

But	O
because	O
of	O
that	O
,	O
workers	O
in	O
other	O
laboratories	O
who	O
received	O
materials	O
that	O
that	O
laboratory	O
prepared	O
may	O
have	O
been	O
exposed	O
to	O
.	O
While	O
we've	O
assessed	O
the	O
event	O
,	O
we've	O
learned	O
more	O
about	O
what	O
happened	O
.	O

The	O
period	O
of	O
infestation	O
stretched	O
from	O
July	O
1989	O
through	O
November	O
1990	O
.	O

Follow	O
all	O
appropriate	O
guidelines	O
and	O
regulations	O
for	O
the	O
use	O
and	O
handling	O
of	O
pathogenic	O
microorganisms	O
.	O

New	O
viruses	O
are	O
also	O
emerging	O
each	O
year	O
to	O
threaten	O
the	O
lives	O
of	O
both	O
humans	O
and	O
animals	O
.	O

Frank	B-Person
Pallone	E-Person
(D-NJ)	O
,	O
ranking	O
member	O
of	O
the	O
full	O
House	B-Organization
Energy	I-Organization
and	I-Organization
Commerce	I-Organization
Committee	E-Organization
,	O
voiced	O
concern	O
with	O
the	O
inclusion	O
of	O
the	O
control	O
shift	O
item	O
in	O
the	O
discussion	O
draft	O
,	O
though	O
he	O
said	O
generally	O
he	O
was	O
supportive	O
of	O
the	O
overall	O
document	O
.	O

Bioterrorism	O
Agent.B	O
.	O

It	O
is	O
generally	O
believed	O
that	O
a	O
one	O
or	O
two-year-old	O
boy	O
,	O
later	O
identified	O
as	O
Emile	B-Person
Ouamouno	E-Person
who	O
died	O
in	O
December	O
2013	O
in	O
the	O
village	O
of	O
Méliandou	S-Location
,	O
Guéckédou	B-Location
Prefecture	E-Location
,	O
Guinea	S-Location
,	O
was	O
the	O
index	O
case	O
of	O
the	O
Western	B-Disease
African	I-Disease
epidemic	E-Disease
.	O
Scientists	O
have	O
deduced	O
that	O
bats	O
are	O
involved	O
in	O
the	O
spread	O
of	O
the	O
virus	O
,	O
and	O
,	O
incidentally	O
,	O
the	O
boy's	O
home	O
was	O
in	O
the	O
vicinity	O
of	O
a	O
large	O
colony	O
of	O
Angolan	O
free-tailed	O
bats	O
,	O
according	O
to	O
media	O
reports	O
.	O

Thousands	O
of	O
men	O
,	O
women	O
,	O
children	O
and	O
infants	O
interned	O
at	O
prisoner	O
of	O
war	O
camps	O
were	O
subjected	O
to	O
vivisection	O
,	O
often	O
without	O
anesthesia	O
and	O
usually	O
ending	O
with	O
the	O
death	O
of	O
the	O
victim	O
.	O

"	O
Chronology	O
of	O
CBW	O
Incidents	O
Targeting	O
Agriculture	O
1915-2008	O
"	O
,	O
James	B-Organization
Martin	I-Organization
Center	I-Organization
for	I-Organization
Nonproliferation	I-Organization
Studies	E-Organization
Monterey	B-Organization
Institute	I-Organization
of	I-Organization
International	I-Organization
Studies	E-Organization
,	O
Middlebury	B-Organization
College	E-Organization
,	O
March	O
2009	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

Chen	S-Person
,	O
H	S-Person
,	O
D	B-Person
Zeng	E-Person
,	O
and	O
Y	B-Person
Pan	E-Person
.	O
"	O
"	O
20120	O
,	O
XXII	O
,	O
209p.	O
68	O
illus..	O
,	O
Hardcover	O
.	O

The	O
programs	O
aim	O
to	O
save	O
lives	O
by	O
detecting	O
outbreaks	O
more	O
quickly	O
,	O
but	O
flagging	O
non-outbreaks	O
can	O
waste	O
resources	O
.	O

The	O
letter	O
,	O
which	O
contained	O
contingencies	O
that	O
USAMRIID	S-Organization
still	O
needs	O
to	O
meet	O
,	O
allows	O
scientists	O
to	O
resume	O
working	O
on	O
five	O
studies	O
.	O

This	O
will	O
allow	O
active	O
duty	O
members	O
of	O
the	O
military	O
and	O
their	O
dependents	O
,	O
wherever	O
they	O
may	O
be	O
working	O
around	O
the	O
globe	O
,	O
to	O
access	O
the	O
same	O
quality	O
care	O
as	O
they	O
would	O
at	O
home	O
.	O

Officials	O
in	O
Taiwan	S-Location
suggested	O
use	O
of	O
the	O
names	O
"	O
H1N1	B-Disease
flu	E-Disease
"	O
or	O
"	O
new	B-Disease
flu	E-Disease
"	O
.	O
The	O
World	B-Organization
Organization	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
,	O
an	O
IGO	O
based	O
in	O
Europe	S-Location
,	O
proposed	O
the	O
name	O
"	O
North	B-Disease
American	I-Disease
influenza	E-Disease
"	O
.	O
The	O
European	B-Organization
Commission	E-Organization
adopted	O
the	O
term	O
"	O
novel	B-Pathogen
flu	I-Pathogen
virus	E-Pathogen
"	O
.	O
Officials	O
in	O
Israel	S-Location
and	O
South	B-Location
Korea	E-Location
briefly	O
considered	O
adoption	O
of	O
the	O
name	O
"	O
Mexican	B-Pathogen
virus	E-Pathogen
"	O
due	O
to	O
concern	O
about	O
the	O
use	O
of	O
the	O
word	O
"	O
swine".	O
In	O
Israel	S-Location
,	O
objections	O
stemmed	O
from	O
sensitivity	O
to	O
religious	O
restrictions	O
on	O
eating	O
pork	O
in	O
the	O
Jewish	O
and	O
Muslim	O
populations	O
,	O
in	O
,	O
concerns	O
were	O
influenced	O
by	O
the	O
importance	O
of	O
pork	O
and	O
domestic	O
pigs	O
.	O

An	O
envelope	O
that	O
tested	O
positive	O
for	O
the	O
deadly	O
poison	O
ricin	S-Pathogen
was	O
intercepted	O
Tuesday	O
afternoon	O
at	O
the	O
U.S.	B-Organization
Capitol's	I-Organization
off-site	I-Organization
mail	I-Organization
facility	E-Organization
in	O
,	O
congressional	O
and	O
law	O
enforcement	O
sources	O
tell	O
CNN	O
.	O

On	O
12	O
June	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
the	O
5-year-old	O
patient	O
had	O
died	O
,	O
while	O
2	O
more	O
cases	O
of	O
Ebola	S-Pathogen
infection	O
within	O
the	O
same	O
family	O
were	O
also	O
confirmed	O
.	O

Information	O
has	O
also	O
been	O
made	O
available	O
on	O
the	O
relevant	O
authorities'	O
websites	O
,	O
and	O
a	O
leaflet	O
has	O
been	O
produced	O
and	O
distributed	O
.	O

To	O
explore	O
how	O
the	O
problem	O
of	O
antibiotic	O
resistance	O
might	O
best	O
be	O
addressed	O
,	O
a	O
group	O
of	O
thirty	O
scientists	O
from	O
academia	O
and	O
industry	O
gathered	O
at	O
the	O
Banbury	B-Location
Conference	I-Location
Centre	E-Location
in	O
Cold	B-Location
Spring	I-Location
Harbor	E-Location
,	O
,	O
May	O
16-18	O
,	O
2011	O
.	O

These	O
international	O
concerns	O
,	O
at	O
the	O
forefront	O
in	O
the	O
United	B-Activity
Nations	I-Activity
Conference	I-Activity
on	I-Activity
Environment	I-Activity
and	I-Activity
Development	E-Activity
(	O
UNCED	S-Activity
)	O
,	O
were	O
formally	O
recognized	O
in	O
what	O
became	O
the	O
first	O
Earth	B-Activity
Summit	E-Activity
,	O
held	O
in	O
Rio	B-Location
de	I-Location
Janeiro	E-Location
in	O
June	O
1992	O
.	O

The	O
FDA	S-Organization
first	O
determined	O
in	O
1977	O
that	O
there	O
is	O
evidence	O
of	O
emergence	O
of	O
antibiotic-resistant	O
bacterial	O
strains	O
in	O
livestock	O
.	O

Among	O
the	O
set	O
of	O
bilateral	O
agreements	O
between	O
the	O
US	S-Location
and	O
Ukraine	S-Organization
is	O
the	O
establishment	O
of	O
the	O
Science	B-Organization
and	I-Organization
Technology	I-Organization
Center	I-Organization
in	I-Organization
Ukraine	E-Organization
(	O
STCU	S-Organization
)	O
–	O
an	O
International	O
organization	O
funded	O
mainly	O
by	O
the	O
US	B-Organization
government	E-Organization
which	O
has	O
been	O
accorded	O
diplomatic	O
status	O
.	O

During	O
the	O
same	O
period	O
,	O
1,642	O
deaths	O
were	O
officially	O
confirmed	O
as	O
caused	O
by	O
H1N1	B-Disease
flu	E-Disease
.	O
The	O
WHO	S-Organization
stated	O
in	O
2010	O
that	O
total	O
mortality	O
(including	O
unconfirmed	O
or	O
unreported	O
deaths)	O
from	O
was	O
"	O
unquestionably	O
higher	O
"	O
than	O
their	O
own	O
confirmed	O
death	O
statistics	O
.	O

So	O
far	O
,	O
the	O
focus	O
has	O
been	O
on	O
real-time	O
PCR	S-Technology
analyses	O
and	O
cultivation	O
methods	O
of	O
the	O
high-consequence	O
pathogens	O
Bacillus	B-Pathogen
anthracis	E-Pathogen
,	O
Brucella	B-Pathogen
spp	E-Pathogen
.	O
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
,	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
,	O
Francisella	B-Pathogen
tularensis	E-Pathogen
,	O
Yersinia	B-Pathogen
pestis	E-Pathogen
,	O
and	O
.	O

This	O
interview	O
was	O
conducted	O
by	O
Zipporah	B-Person
Nyambura	E-Person
It	O
has	O
been	O
edited	O
for	O
clarity	O
.	O

To	O
date	O
,	O
the	O
network's	O
activities	O
have	O
focused	O
primarily	O
on	O
high-consequence	O
bacteria	O
,	O
and	O
only	O
a	O
few	O
projects	O
have	O
involved	O
emerging	O
viruses	O
.	O

There	O
has	O
been	O
a	O
concerted	O
effort	O
to	O
enhance	O
the	O
general	O
awareness	O
of	O
biosafety	O
and	O
biosecurity	O
in	O
the	O
life	O
sciences	O
in	O
the	O
BMENA	S-Location
region	O
over	O
the	O
last	O
decade	O
.	O

However	O
,	O
one	O
aspect	O
of	O
defense	O
would	O
receive	O
less	O
money:	O
"	O
protecting	O
the	O
nation	O
from	O
deadly	O
pathogens	O
,	O
man-made	O
or	O
natural,	O
"	O
according	O
to	O
The	O
New	O
York	O
Times	O
.	O

In	O
2014	O
The	O
Lugar	B-Organization
Center	E-Organization
was	O
equipped	O
with	O
an	O
insect	B-Equipment
facility	E-Equipment
and	O
launched	O
a	O
project	O
"	O
Raising	B-Scientific_research_project
Awareness	I-Scientific_research_project
about	I-Scientific_research_project
Barcoding	I-Scientific_research_project
of	I-Scientific_research_project
Sand	I-Scientific_research_project
Flies	I-Scientific_research_project
in	I-Scientific_research_project
Georgia	I-Scientific_research_project
and	I-Scientific_research_project
Caucasus	E-Scientific_research_project
"	O
.	O
The	O
project	O
covered	O
a	O
larger	O
geographic	O
area	O
outside	O
of	O
Georgia	S-Location
–	O
Caucasus	S-Location
.	O
In	O
2014-2015	O
Phlebotomine	O
sand	O
fly	O
species	O
were	O
collected	O
under	O
another	O
project	O
"	O
"	O
and	O
all	O
(female)	O
sand	O
flies	O
were	O
tested	O
to	O
determine	O
their	O
infectivity	O
rate	O
.	O

In	O
2016	O
,	O
the	O
first	O
conference	O
to	O
focus	O
specifically	O
on	O
biohacking	O
was	O
announced	O
to	O
take	O
place	O
in	O
September	O
in	O
Oakland	S-Location
.	O

For	O
example	O
,	O
sending	O
samples	O
and	O
metadata	O
requires	O
a	O
system	O
that	O
ensures	O
confidentiality	O
in	O
the	O
laboratory	O
receiving	O
it	O
.	O

The	O
first	O
confirmed	O
H1N1/09	B-Disease
pandemic	I-Disease
flu	E-Disease
death	O
,	O
which	O
occurred	O
at	O
Texas	B-Organization
Children's	I-Organization
Hospital	E-Organization
in	O
Houston	S-Location
,	O
Texas	S-Location
,	O
was	O
of	O
a	O
toddler	O
from	O
Mexico	B-Location
City	E-Location
who	O
was	O
visiting	O
family	O
in	O
Brownsville	S-Location
,	O
Texas	S-Location
,	O
before	O
being	O
air-lifted	O
to	O
Houston	S-Location
for	O
treatment	O
.	O

The	O
team	O
at	O
JCVI	S-Organization
has	O
learned	O
a	O
lot	O
from	O
the	O
nearly	O
15	O
years	O
it	O
has	O
taken	O
to	O
get	O
to	O
this	O
successful	O
stage	O
.	O

DNA	B-Technology
sequencing	E-Technology
showed	O
that	O
Sonia	S-Person
carried	O
the	O
fatal	O
mutation	O
as	O
well	O
.	O

The	O
CDC	S-Organization
"	O
Biosafety	O
in	O
Microbiological	O
and	O
Biomedical	O
Laboratories.	O
"	O

Yambuku	S-Location
is	O
a	O
small	O
village	O
in	O
Mongala	B-Location
Province	E-Location
in	O
northern	B-Location
Democratic	I-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
,	O
best	O
known	O
as	O
the	O
center	O
of	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
.	O
It	O
is	O
northeast	O
of	O
the	O
capital	O
city	O
of	O
.	O

On	O
1	O
January	O
2020	O
,	O
WHO	S-Organization
requested	O
further	O
information	O
from	O
national	O
authorities	O
to	O
assess	O
the	O
risk	O
.	O

The	O
country	O
office	O
is	O
headed	O
by	O
a	O
WHO	S-Organization
Representative	O
(WR).	O
,	O
the	O
only	O
WHO	S-Organization
Representative	O
outside	O
Europe	S-Location
to	O
be	O
a	O
national	O
of	O
that	O
country	O
was	O
for	O
the	O
Libyan	B-Location
Arab	I-Location
Jamahiriya	E-Location
(	O
"	O
Libya	S-Location
"	O
);	O
all	O
other	O
staff	O
were	O
international	O
.	O

Wuhan	S-Location
,	O
)	O
,	O
animal	O
species	O
or	O
groups	O
of	O
people	O
in	O
disease	O
and	O
virus	O
names	O
to	O
prevent	O
social	O
stigma	O
.	O

This	O
viral	O
genome	O
codes	O
for	O
seven	O
structural	O
proteins	O
and	O
one	O
non-structural	O
protein	O
.	O

Genetic	O
analysis	O
has	O
revealed	O
that	O
the	O
coronavirus	S-Pathogen
genetically	O
clusters	O
with	O
the	O
genus	B-Pathogen
Betacoronavirus	E-Pathogen
,	O
in	O
subgenus	O
Sarbecovirus	O
(lineage	O
B)	O
together	O
with	O
two	O
bat-derived	O
strains	O
.	O

Other	O
experiments	O
that	O
have	O
involved	O
medical	O
treatments	O
include	O
a	O
whole	O
body	O
microbiome	B-Technology
transplant	E-Technology
and	O
the	O
creation	O
of	O
for	O
diabetics	O
.	O

The	O
Greenville	B-Location
facility	E-Location
where	O
the	O
letter	O
was	O
found	O
was	O
also	O
declared	O
ricin-free	O
in	O
the	O
ensuing	O
weeks.	O
"	O
CDC	S-Organization
warns	O
of	O
potential	O
for	O
ricin	O
poisoning"	O
,	O
Center	B-Organization
for	I-Organization
Infectious	I-Organization
Disease	I-Organization
Research	I-Organization
and	I-Organization
Policy	E-Organization
,	O
University	B-Organization
of	I-Organization
Minnesota	E-Organization
,	O
November	O
20	O
,	O
2003	O
,	O
accessed	O
May	O
6	O
,	O
2009	O
.	O

Some	O
of	O
the	O
Unit	B-Organization
731	E-Organization
personnel	O
were	O
imprisoned	O
by	O
the	O
Soviets	O
,	O
and	O
may	O
have	O
been	O
a	O
potential	O
source	O
of	O
information	O
on	O
Japanese	O
weaponization	O
.	O

The	O
procedure	O
used	O
by	O
CDC	S-Organization
to	O
deactivate	O
the	O
bacteria	O
in	O
this	O
incident	O
had	O
been	O
examined	O
previously	O
for	O
effectiveness	O
.	O

The	O
virus	O
was	O
found	O
to	O
be	O
a	O
novel	O
strain	B-Pathogen
of	I-Pathogen
influenza	E-Pathogen
for	O
which	O
extant	O
vaccines	O
against	O
seasonal	B-Disease
flu	E-Disease
provided	O
little	O
protection	O
.	O

The	O
event	O
was	O
discovered	O
by	O
the	O
laboratory	O
scientists	O
yesterday	O
,	O
December	O
23	O
,	O
and	O
reported	O
to	O
leadership	O
within	O
an	O
hour	O
of	O
the	O
discovery	O
.	O

Since	O
the	O
mid-1980s	O
pharmaceutical	O
companies	O
have	O
invested	O
in	O
medications	O
for	O
cancer	O
or	O
chronic	O
disease	O
that	O
have	O
greater	O
potential	O
to	O
make	O
money	O
and	O
have	O
"	O
de-emphasized	O
or	O
dropped	O
development	O
of	O
antibiotics"	O
.	O

But	O
we	O
will	O
not	O
give	O
up	O
.	O

Nixon	O
noted	O
that	O
biological	O
weapons	O
were	O
unreliableGraham	O
,	O
Thomas	S-Person
.	O
Disarmament	O
Sketches:	O
Three	O
Decades	O
of	O
Arms	O
Control	O
and	O
International	O
Law	O
,	O
(Google	O
Books)	O
,	O
University	O
of	O
Washington	S-Location
Press	O
,	O
2002	O
,	O
pp.	O
21–30	O
,	O
().	O
and	O
stated:	O
,	O
pp.	O
61–64	O
.	O

Men	O
Behind	O
the	O
Sun	O
(1988)	O
,	O
China	S-Location
directed	O
by	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
was	O
first	O
identified	O
as	O
a	O
possible	O
new	O
"	O
strain"	O
of	O
Marburg	B-Pathogen
virus	E-Pathogen
in	O
1976	O
.	O

Corina	B-Person
Ingram-Noehr	E-Person
33	O
,	O
an	O
American	O
events	O
organiser	O
living	O
in	O
Berlin	S-Location
,	O
has	O
a	O
daily	O
ritual	O
involving	O
technology	O
,	O
diet	O
and	O
more	O
than	O
20	O
different	O
supplements	O
to	O
try	O
to	O
keep	O
in	O
peak	O
physical	O
condition	O
.	O

People	O
in	O
at-risk	O
groups	O
should	O
be	O
treated	O
with	O
antivirals	O
(	O
oseltamivir	S-Drug
or	O
zanamivir	S-Drug
)	O
as	O
soon	O
as	O
possible	O
when	O
they	O
first	O
experience	O
flu	O
symptoms	O
.	O

The	O
infected	O
researcher	O
wasn't	O
working	O
on	O
B.	B-Pathogen
cereus	E-Pathogen
but	O
may	O
have	O
touched	O
her	O
gloved	O
hand	O
to	O
a	O
drop	O
of	O
inoculant	O
spilled	O
by	O
another	O
researcher	O
,	O
then	O
touched	O
a	O
wound	O
on	O
her	O
skin	O
that	O
wasn't	O
properly	O
covered	O
,	O
Gilliam	S-Person
said	O
.	O

Howard	S-Person
,	O
Russell	B-Person
D	E-Person
.	O
et	O
al	O
.	O

Operations	O
and	O
experiments	O
continued	O
until	O
the	O
end	O
of	O
the	O
war	O
.	O

In	O
treating	O
such	O
individuals	O
,	O
the	O
WHO	S-Organization
recommends	O
urgent	O
intervention	O
if	O
uveitis	S-Disease
is	O
suspected	O
;	O
this	O
consists	O
mainly	O
of	O
prednisone	S-Drug
(a	O
corticosteroid)	O
.	O

Next	O
question	O
comes	O
from	O
Eui	B-Person
Hoai-Tran	E-Person
with	O
.	O
You	O
may	O
ask	O
your	O
question	O
.	O

The	O
toggle	O
switch	O
and	O
other	O
early	O
examples	O
of	O
engineered	O
circuits	O
showed	O
that	O
the	O
cut-and-paste	B-Technology
genetic	I-Technology
technology	E-Technology
that	O
had	O
been	O
around	O
for	O
almost	O
three	O
decades	O
could	O
be	O
used	O
to	O
give	O
cells	O
functions	O
that	O
hadn't	O
previously	O
existed	O
in	O
any	O
cell	O
.	O

Each	O
time	O
,	O
samples	O
were	O
screened	O
for	O
serological	O
evidence	O
of	O
infection	O
and	O
then	O
compared	O
to	O
the	O
questionnaire	O
responses	O
to	O
identify	O
potential	O
risk	O
factors	O
.	O

Redd	S-Person
noting	O
that	O
there	O
were	O
delays	O
in	O
both	O
U.S.	S-Location
responses	O
to	O
recent	O
that	O
hindered	O
efforts.	O
"	O
Something	O
along	O
those	O
lines	O
would	O
be	O
quite	O
helpful,	O
"	O
he	O
said	O
,	O
adding	O
that	O
an	O
expedited	O
or	O
streamlined	O
funding	O
approval	O
process	O
also	O
would	O
ensure	O
that	O
the	O
funds	O
were	O
used	O
more	O
quickly	O
.	O

Three	O
private	O
American	O
companies	O
work	O
at	O
the	O
US	S-Location
bio-laboratory	O
in	O
Tbilisi	S-Location
–	O
CH2M	B-Organization
Hill	E-Organization
,	O
Battelle	S-Organization
and	O
Metabiota	S-Organization
.	O
In	O
addition	O
to	O
the	O
Pentagon	S-Organization
,	O
these	O
private	O
contractors	O
perform	O
biological	O
research	O
for	O
the	O
and	O
various	O
other	O
government	O
agencies	O
.	O

Both	O
al-Taha	S-Person
and	O
Ammash	S-Person
were	O
captured	O
by	O
U.S.	B-Organization
forces	E-Organization
after	O
the	O
2003	O
invasion	O
of	O
,	O
but	O
both	O
were	O
released	O
in	O
2005	O
after	O
they	O
were	O
among	O
those	O
an	O
American-Iraqi	O
board	O
found	O
to	O
be	O
no	O
longer	O
security	O
threats	O
.	O

However	O
,	O
today	O
what	O
I	O
want	O
to	O
talk	O
about	O
are	O
three	O
laboratory	O
incidents	O
that	O
raise	O
serious	O
and	O
troubling	O
questions	O
.	O

A	O
domestic	O
cat	O
in	O
Liège,	B-Location
Belgium	E-Location
tested	O
positive	O
after	O
it	O
started	O
showing	O
symptoms	O
(diarrhoea	O
,	O
vomiting	O
,	O
shortness	O
of	O
breath)	O
a	O
week	O
later	O
than	O
its	O
owner	O
,	O
who	O
was	O
also	O
positive	O
.	O

After	O
the	O
Soviet	B-Organization
Union	E-Organization
ceased	O
to	O
exist	O
,	O
the	O
island	O
became	O
joint	O
territory	O
of	O
Kazakhstan	S-Location
and	O
.	O

To	O
ensure	O
the	O
UK	S-Organization
health	O
services	O
had	O
sufficient	O
capacity	O
to	O
treat	O
people	O
with	O
COVID-19	S-Disease
,	O
a	O
number	O
of	O
temporary	O
critical	O
care	O
hospitals	O
were	O
built	O
.	O

In	O
2014	O
,	O
historian	O
Mark	B-Person
Humphries	E-Person
argued	O
that	O
the	O
mobilization	O
of	O
96,000	O
Chinese	O
laborers	O
to	O
work	O
behind	O
the	O
British	O
and	O
French	O
lines	O
might	O
have	O
been	O
the	O
source	O
of	O
the	O
pandemic	O
.	O

CRISPR	S-Technology
had	O
been	O
studied	O
in	O
animal	O
models	O
and	O
cancer	S-Disease
cell	O
lines	O
,	O
to	O
learn	O
if	O
it	O
can	O
be	O
used	O
to	O
repair	O
or	O
thwart	O
mutated	O
genes	O
that	O
cause	O
.	O

The	O
general	O
population	O
was	O
familiar	O
with	O
patterns	O
of	O
pandemic	O
disease	O
in	O
the	O
late	O
19th	O
and	O
early	O
20th	O
centuries:	O
typhoid	S-Disease
,	O
yellow	B-Disease
fever	E-Disease
,	O
diphtheria	S-Disease
and	O
cholera	S-Disease
all	O
occurred	O
near	O
the	O
same	O
time	O
.	O

Engineering	O
inexpensive	O
plants	O
to	O
include	O
these	O
nutrients	O
could	O
save	O
millions	O
of	O
lives	O
.	O

According	O
to	O
the	O
CDC	S-Organization
,	O
"	O
the	O
risk	O
we	O
face	O
now	O
[is]	O
that	O
Ebola	S-Disease
will	O
simmer	O
along	O
,	O
become	O
native	O
and	O
be	O
a	O
problem	O
for	O
Africa	S-Location
and	O
the	O
world	O
,	O
for	O
years	O
to	O
come"	O
.	O

Comparison	O
of	O
the	O
biological	B-Document
agent	I-Document
category	I-Document
lists	E-Document
revealed	O
that	O
the	O
laboratory	O
biosafety	O
risk	O
groups	O
of	O
most	O
biological	O
agents	O
in	O
NIH	S-Organization
,	O
EU	S-Location
and	O
China	S-Location
are	O
consistent	O
,	O
although	O
some	O
inconsistencies	O
were	O
identified	O
(Table	O
2	O
,	O
Table	O
3)	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S	O
.	O

The	O
WHO	S-Organization
has	O
published	O
biological	O
agent	O
laboratory	O
biosafety	O
risk	O
group	O
classification	O
criteria	O
,	O
but	O
has	O
not	O
published	O
the	O
category	O
list	O
based	O
on	O
this	O
classification	O
.	O

"	O
This	O
is	O
an	O
important	O
and	O
challenging	O
day	O
for	O
all	O
of	O
us,	O
"	O
WHO	S-Organization
Director	O
General	O
Margaret	B-Person
Chan	E-Person
said	O
in	O
a	O
briefing	O
with	O
reporters.	O
"	O
We	O
are	O
moving	O
into	O
the	O
early	O
days	O
of	O
the	O
first	O
pandemic	O
of	O
the	O
21st	O
century.	O
"	O

Due	O
to	O
pressure	O
from	O
numerous	O
accounts	O
of	O
the	O
bio-warfare	O
attacks	O
,	O
Chiang	B-Person
Kai-shek	E-Person
sent	O
a	O
delegation	O
of	O
army	O
and	O
foreign	O
medical	O
personnel	O
in	O
November	O
1941	O
to	O
document	O
evidence	O
and	O
treat	O
the	O
afflicted	O
.	O

But	O
there	O
is	O
a	O
small	O
fraction	O
that	O
uses	O
live	O
pathogens	O
of	O
kinds	O
that	O
are	O
known	O
to	O
threaten	O
global	O
harm	O
.	O

Egypt	S-Location
–	O
Major	O
Cities	O
,	O
U.S.	B-Organization
Library	I-Organization
of	I-Organization
Congress	E-Organization
In	O
Cairo	S-Location
,	O
with	O
a	O
population	O
numbering	O
as	O
many	O
as	O
600,000	O
,	O
and	O
possibly	O
the	O
largest	O
city	O
west	O
of	O
,	O
between	O
one	O
third	O
and	O
40%	O
of	O
the	O
inhabitants	O
died	O
inside	O
of	O
eight	O
months	O
.	O

How	O
Well	O
Is	O
Environmental	O
Biosafety	O
Research	O
Supporting	O
the	O
Scientific	O
Debate	O
on	O
the	O
Biosafety	O
of	O
Genetically	B-Technology
Modified	I-Technology
Organisms	E-Technology
()?	O

Yet	O
no	O
clear	O
mechanisms	O
to	O
enforce	O
the	O
treaty	O
existed	O
.	O

"	O
This	O
type	O
of	O
manufacturing	O
is	O
new	O
,	O
pharmacy	O
on	O
demand,	O
"	O
Dr	O
.	O

In	O
2016	O
,	O
Jennifer	B-Person
Doudna	E-Person
and	O
Emmanuelle	B-Person
Charpentier	E-Person
,	O
along	O
with	O
Rudolph	B-Person
Barrangou	E-Person
,	O
Philippe	B-Person
Horvath	E-Person
,	O
and	O
Feng	B-Person
Zhang	E-Person
won	O
the	O
Gairdner	O
International	O
award	O
.	O

By	O
late	O
summer	O
1348	O
it	O
reached	O
Cairo	S-Location
,	O
capital	O
of	O
the	O
Mamluk	B-Location
Sultanate	E-Location
,	O
cultural	O
centre	O
of	O
the	O
Islamic	O
world	O
,	O
and	O
the	O
largest	O
city	O
in	O
the	O
Mediterranean	B-Location
Basin	E-Location
;	O
the	O
Bahriyya	S-Location
child	O
sultan	O
an-Nasir	B-Person
Hasan	E-Person
fled	O
and	O
more	O
than	O
a	O
third	O
of	O
the	O
600,000	O
residents	O
died	O
.	O

An	O
inherent	O
challenge	O
of	O
biopreparedness	O
diagnostics	O
is	O
to	O
gather	O
expertise	O
covering	O
all	O
groups	O
of	O
high-consequence	O
pathogens	O
(ie	O
,	O
bacteria	O
,	O
viruses	O
,	O
RNA	O
viruses	O
,	O
and	O
toxins)	O
.	O

The	O
pixel	O
itself	O
is	O
displayed	O
according	O
to	O
the	O
mean	O
attenuation	O
of	O
the	O
tissue(s)	O
that	O
it	O
corresponds	O
to	O
on	O
a	O
scale	O
from	O
+3,071	O
(most	O
attenuating)	O
to	O
−1,024	O
(least	O
attenuating)	O
on	O
the	O
Hounsfield	O
scale	O
.	O

Later	O
,	O
South	B-Organization
Dakota	E-Organization
reported	O
that	O
a	O
similar	O
attack	O
with	O
a	O
corn	O
or	O
soybean	O
pest	O
could	O
devastate	O
their	O
agriculture	O
industry.The	O
threat	O
of	O
agricultural	O
terrorism	O
South	B-Organization
Dakota	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
In	O
May	O
2001	O
,	O
Mark	B-Person
Urlaub	E-Person
,	O
the	O
Department	B-Organization
of	I-Organization
Agriculture	E-Organization
's	O
biosecurity	O
program	O
director	O
,	O
announced	O
that	O
investigators	O
were	O
"	O
taking	O
another	O
look	O
at	O
"	O
the	O
1989	O
attack	O
.	O

The	O
flu	S-Disease
has	O
been	O
linked	O
to	O
the	O
in	O
the	O
1920s	O
.	O

Why	O
the	O
Second	O
Wave	O
of	O
the	O
1918	B-Disease
Spanish	I-Disease
Flu	E-Disease
Was	O
So	O
Deadly	O
History.	O
com	O
-	O
Retrieved	O
8	O
May	O
2020	O
It	O
primarily	O
affected	O
Spain	S-Location
,	O
Serbia	S-Location
,	O
Mexico	S-Location
and	O
Great	B-Location
Britain	E-Location
,	O
resulting	O
in	O
hundreds	O
of	O
thousands	O
of	O
deaths	O
.	O

His	O
attitude	O
towards	O
the	O
outbreak	O
has	O
so	O
closely	O
matched	O
that	O
of	O
U.S.	S-Location
president	O
Donald	B-Person
Trump	E-Person
that	O
he	O
has	O
been	O
called	O
the	O
"	O
of	O
the	O
Tropics"	O
.	O

This	O
page	O
provides	O
links	O
to	O
international	O
biosafety	O
guidelines	O
and	O
websites	O
.	O

In	O
their	O
latest	O
investigation	O
,	O
GAO	S-Organization
professionals	O
interviewed	O
department	O
officials	O
,	O
analyzed	O
agency	O
data	O
,	O
and	O
made	O
field	O
visits	O
to	O
the	O
three	O
affected	O
countries	O
.	O

The	O
biochemical	O
and	O
protein	O
structure	O
analyses	O
will	O
be	O
published	O
by	O
and	O
his	O
colleagues	O
in	O
the	O
journal	O
Angewandte	O
Chemie	O
,	O
also	O
providing	O
insight	O
into	O
the	O
molecular	O
mechanisms	O
.	O

One	O
of	O
the	O
big	O
picture	O
challenges	O
associated	O
with	O
pandemic	O
preparedness	O
that	O
this	O
platform	O
could	O
help	O
solve	O
,	O
in	O
fact	O
,	O
"	O
is	O
how	O
quickly	O
you	O
are	O
able	O
to	O
respond	O
to	O
contain	O
and	O
stop	O
the	O
spread	O
of	O
disease	O
and	O
to	O
treat	O
those	O
infected,	O
"	O
said	O
Saward	S-Person

Two	O
visiting	O
Wasco	B-Location
County	E-Location
commissioners	O
were	O
infected	O
via	O
glasses	O
of	O
water	O
containing	O
Salmonella	S-Pathogen
bacteria	O
during	O
a	O
visit	O
to	O
Rajneeshpuram	S-Location
on	O
August	O
29	O
,	O
1984	O
.	O

Bacillus	B-Pathogen
anthracis	E-Pathogen
was	O
included	O
in	O
NIH	S-Organization
biosafety	O
category	O
risk	O
group	O
2	O
,	O
but	O
was	O
included	O
in	O
risk	O
group	O
3	O
according	O
to	O
the	O
EU	S-Location
categorization	O
.	O

The	O
genetic	O
diversity	O
of	O
Ebolavirus	S-Pathogen
remained	O
constant	O
before	O
1900	O
.	O

Fourth	O
,	O
I've	O
begun	O
the	O
process	O
of	O
establishing	O
an	O
external	O
advisory	O
group	O
that	O
will	O
be	O
part	O
of	O
the	O
advisory	O
committee	O
to	O
the	O
director	O
,	O
and	O
I	O
will	O
issue	O
invitations	O
to	O
the	O
leading	O
scientists	O
of	O
that	O
group	O
by	O
the	O
end	O
of	O
next	O
week	O
.	O

Numerous	O
airlines	O
have	O
cancelled	O
flights	O
due	O
to	O
lower	O
demand	O
,	O
and	O
British	S-Organization
regional	O
airline	O
collapsed	O
.	O

Early	O
in	O
the	O
epidemic	O
,	O
the	O
Chinese	B-Organization
government	E-Organization
discouraged	O
its	O
press	O
from	O
reporting	O
on	O
SARS	S-Disease
,	O
delayed	O
reporting	O
to	O
WHO	S-Organization
,	O
and	O
initially	O
did	O
not	O
provide	O
information	O
to	O
Chinese	O
outside	O
Guangdong	B-Location
province	E-Location
,	O
where	O
the	O
disease	O
is	O
believed	O
to	O
have	O
originated	O
.	O

All	O
of	O
them	O
died	O
.	O

A	O
second	O
or	O
fall	O
wave	O
spread	O
globally	O
from	O
September	O
to	O
November	O
1918	O
and	O
was	O
highly	O
fatal	O
.	O

World	B-Activity
Antibiotic	I-Activity
Awareness	I-Activity
Week	E-Activity
has	O
been	O
held	O
every	O
November	O
since	O
2015	O
.	O

Mathematical	O
models	O
have	O
raised	O
the	O
possibility	O
that	O
anthrax	B-Pathogen
spores	E-Pathogen
if	O
aerosolized	O
,	O
can	O
spread	O
over	O
big	O
cities	O
and	O
"	O
result	O
in	O
a	O
mass-casualty	O
incident	O
involving	O
hundreds	O
of	O
thousands	O
of	O
illnesses	O
and	O
deaths,	O
"	O
according	O
to	O
previous	O
guidance	O
.	O

Zayner	S-Person
also	O
popularized	O
the	O
notion	O
that	O
you	O
can	O
edit	O
your	O
own	O
DNA	O
with	O
CRISPR	S-Technology
.	O
In	O
2017	O
,	O
he	O
injected	O
himself	O
with	O
CRISPR	S-Technology
DNA	O
at	O
a	O
biotech	O
conference	O
,	O
live-streaming	O
the	O
experiment	O
.	O

For	O
example	O
,	O
clinical	O
trials	O
have	O
shown	O
that	O
mindfulness	O
meditation	O
can	O
help	O
reduce	O
anxiety	S-Phenotype
and	O
.	O

They	O
can	O
cause	O
diseases	O
of	O
plague	S-Disease
dimensions	O
with	O
serious	O
economic	O
and	O
environmental	O
consequences	O
.	O

The	O
system	O
will	O
rely	O
on	O
big-data	O
analytics	O
to	O
determine	O
whether	O
further	O
inspection	O
is	O
warranted	O
.	O

Due	O
to	O
current	O
advances	O
in	O
genetics	O
and	O
biotechnology	O
these	O
bacteriophages	O
can	O
possibly	O
be	O
manufactured	O
to	O
treat	O
specific	O
infections	O
.	O

And	O
it	O
may	O
have	O
also	O
laid	O
waste	O
to	O
parts	O
of	O
central	B-Location
Asia	E-Location
,	O
India	S-Location
and	O
.	O
Due	O
to	O
the	O
scant	O
records	O
of	O
the	O
14th	O
century	O
,	O
we	O
will	O
never	O
know	O
the	O
true	O
toll	O
,	O
but	O
our	O
best	O
estimates	O
are	O
that	O
somewhere	O
between	O
5%	O
and	O
14%	O
of	O
all	O
the	O
world's	O
people	O
were	O
killed	O
,	O
in	O
what	O
may	O
have	O
been	O
the	O
greatest	O
catastrophe	O
humanity	O
has	O
seen	O
.	O

In	O
a	O
previous	O
study	O
,	O
based	O
on	O
experiences	O
gained	O
during	O
46	O
years	O
of	O
collaborative	O
work	O
,	O
performed	O
across	O
diverse	O
laboratory	O
cultures	O
,	O
the	O
value	O
of	O
networks	O
has	O
been	O
summarized	O
as	O
having	O
achieved	O
enhanced	O
productivity	O
and	O
trust-greater	O
than	O
any	O
single	O
laboratory	O
could	O
achieve	O
.	O

While	O
no	O
DIYbio	B-Scientific_research_project
project	E-Scientific_research_project
to	O
date	O
has	O
involved	O
harmful	O
agents	O
,	O
the	O
fear	O
remains	O
in	O
the	O
minds	O
of	O
both	O
regulators	O
and	O
laypersons	O
.	O

Bell	S-Person
and	O
his	O
working	O
group	O
will	O
look	O
at	O
is	O
exactly	O
that	O
.	O

PREEMPT	S-Scientific_research_project
will	O
have	O
two	O
technical	O
thrusts:	O
development	O
of	O
multiscale	O
models	O
and	O
test	O
beds	O
to	O
quantify	O
the	O
imminent	O
emergence	O
and	O
reemergence	O
of	O
human	O
pathogens	O
;	O
and	O
development	O
of	O
new	O
,	O
scalable	O
approaches	O
to	O
preventing	O
pathogen	O
spillover	O
and	O
transmission	O
from	O
animals	O
and	O
vectors	O
into	O
humans	O
.	O

Due	O
to	O
fears	O
of	O
the	O
MERS	B-Pathogen
virus	E-Pathogen
attendance	O
in	O
the	O
hajj	S-Activity
in	O
2013	O
was	O
lower	O
than	O
the	O
previous	O
year	O
.	O

Applications	O
must	O
be	O
received	O
by	O
Feb.22	O
,	O
2018	O
.	O

An	O
electron	B-Equipment
microscope	E-Equipment
image	O
of	O
coronavirus	O
particles	O
,	O
colorized	O
in	O
yellow	O
.	O

A	O
single	O
source	O
may	O
report	O
statistics	O
for	O
multiple	O
"	O
as	O
of	O
"	O
dates	O
.	O

The	O
CDC	S-Organization
outlines	O
the	O
guidelines	O
for	O
the	O
use	O
of	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
during	O
the	O
pandemic	O
.	O

To	O
maximize	O
efficiency	O
,	O
the	O
lab	O
is	O
divided	O
into	O
four	O
posts-three	O
work	O
stations	O
and	O
a	O
lecture	O
area	O
.	O

The	O
three	O
victims	O
who	O
died	O
in	O
Aralsk	S-Location
Dr	O
.	O

All	O
of	O
these	O
technologies	O
combine	O
to	O
form	O
what	O
seems	O
like	O
a	O
relatively	O
strong	O
deterrent	O
to	O
bioterrorism	O
.	O

Contrary	O
to	O
the	O
official	O
Soviet	S-Organization
report	O
,	O
he	O
said	O
,	O
she	O
told	O
him	O
that	O
she	O
never	O
disembarked	O
from	O
the	O
ship	O
,	O
the	O
Lev	O
Berg	O
,	O
before	O
returning	O
to	O
the	O
home	B-Location
port	I-Location
of	I-Location
Aralsk	E-Location
.	O

The	O
study	O
was	O
commissioned	O
by	O
the	O
Defense	B-Organization
Department	E-Organization
with	O
the	O
aim	O
of	O
developing	O
a	O
framework	O
to	O
guide	O
an	O
assessment	O
of	O
the	O
security	O
concerns	O
related	O
to	O
advances	O
in	O
synthetic	O
biology	O
,	O
evaluate	O
the	O
levels	O
of	O
concern	O
warranted	O
for	O
such	O
advances	O
and	O
identify	O
options	O
to	O
mitigate	O
threats	O
.	O

Old	O
and	O
discarded	O
,	O
or	O
even	O
rejected	O
,	O
antibiotics	O
should	O
be	O
re-investigated	O
,	O
re-purposed	O
and	O
used	O
as	O
needed	O
.	O

Understanding	O
the	O
and	O
its	O
implications	O
for	O
future	O
pandemics	O
requires	O
careful	O
experimentation	O
and	O
in-depth	O
historical	O
analysis	O
.	O

It	O
replaced	O
a	O
CDC	S-Organization
lab	O
that	O
had	O
operated	O
for	O
20	O
years	O
.	O

And	O
each	O
program	O
devised	O
sophisticated	O
ways	O
to	O
disperse	O
these	O
agents	O
in	O
fine-mist	O
aerosols	O
,	O
to	O
package	O
them	O
in	O
bombs	O
,	O
and	O
to	O
launch	O
them	O
on	O
missiles	O
.	O

Practically	O
,	O
preparation	O
of	O
a	O
national	O
biotechnology	O
strategic	O
plan	O
in	O
the	O
country	O
coincided	O
with	O
development	O
of	O
a	O
national	O
biosafety	O
framework	O
that	O
was	O
the	O
basis	O
for	O
the	O
drafted	O
biosafety	O
law	O
.	O

29	O
cases	O
of	O
Hepatitis	B-Disease
A	E-Disease
were	O
reported	O
in	O
Kharkiv	S-Location
in	O
November	O
2017	O
.	O

Finally	O
,	O
they	O
would	O
like	O
to	O
see	O
the	O
development	O
of	O
an	O
international	O
response	O
framework	O
that	O
maps	O
gaps	O
in	O
the	O
response	O
architecture	O
for	O
biological	O
weapons	O
events	O
.	O

Among	O
the	O
expected	O
outcomes	O
from	O
the	O
meeting	O
,	O
GHSA	B-Person
Georgia	I-Person
Team	E-Person
members	O
hope	O
to	O
gain	O
insights	O
into	O
disease	O
surveillance	O
,	O
update	O
best	O
practices	O
,	O
develop	O
recommendations	O
for	O
better	O
planning	O
and	O
operationalization	O
of	O
disease	O
surveillance	O
systems	O
,	O
and	O
define	O
their	O
next	O
steps	O
for	O
the	O
.	O

The	O
ISA	O
software	O
suite	O
has	O
been	O
employed	O
in	O
several	O
projects	O
and	O
integrated	O
into	O
other	O
data	O
management	O
systems	O
,	O
e.g.	O
the	O
Harvard	B-Platform
stem	I-Platform
cell	I-Platform
discovery	I-Platform
engine	E-Platform
Installation	O
of	O
the	O
Java	O
applications	O
of	O
the	O
software	O
suite	O
is	O
simple	O
.	O

What	O
are	O
the	O
risks	O
associated	O
with	O
synthetic	B-Technology
organisms	E-Technology
Do	O
the	O
risks	O
of	O
these	O
technologies	O
overshadow	O
the	O
potential	O
benefits?	O

Other	O
factors	O
,	O
per	O
media	O
reports	O
,	O
included	O
local	O
burial	O
customs	O
of	O
washing	O
the	O
body	O
and	O
the	O
unprecedented	O
spread	O
of	O
to	O
densely	O
populated	O
cities	O
.	O

Military	O
service	O
members	O
are	O
called	O
upon	O
to	O
operate	O
virtually	O
anywhere	O
in	O
the	O
world	O
,	O
often	O
on	O
short	O
notice	O
,	O
and	O
the	O
locations	O
to	O
which	O
they	O
deploy	O
frequently	O
lack	O
the	O
robust	O
public	O
health	O
infrastructure	O
to	O
identify	O
and	O
contain	O
the	O
spread	O
of	O
new	O
viral	O
infectious	O
diseases	O
.	O

Most	O
people	O
who	O
contract	O
COVID-19	S-Disease
recover	O
.	O

But	O
the	O
revolution	O
in	O
biotechnology	O
,	O
namely	O
the	O
new	O
tools	O
for	O
analysing	O
and	O
specifically	O
changing	O
an	O
organism's	O
genetic	O
material	O
,	O
has	O
led	O
to	O
an	O
increased	O
risk	O
of	O
biowarfare	O
due	O
to	O
several	O
factors	O
.	O

Prime	B-Technology
editing	E-Technology
was	O
developed	O
by	O
researchers	O
at	O
the	O
Broad	B-Organization
Institute	I-Organization
of	I-Organization
MIT	E-Organization
and	O
Harvard	B-Organization
in	I-Organization
Massachusetts	E-Organization
.	O
More	O
work	O
is	O
needed	O
to	O
optimize	O
the	O
methods.Prime	O
editing:	O
DNA	O
tool	O
could	O
correct	O
89%	O
of	O
genetic	O
defects.	O
,	O
BBC	O
News.	O
21	O
October	O
2019	O
.	O

However	O
,	O
John	B-Person
Barry	E-Person
stated	O
in	O
his	O
2004	O
book	O
The	O
Great	O
Influenza	S-Disease
:	O
The	O
Epic	O
Story	O
of	O
the	O
Deadliest	O
Plague	O
In	O
History	O
that	O
researchers	O
have	O
found	O
no	O
evidence	O
to	O
support	O
this	O
position	O
.	O

The	O
Bio-safety	O
Level	O
3	O
Laboratory	O
is	O
accessible	O
only	O
to	O
US	S-Location
citizens	O
with	O
security	O
clearance	O
.	O

The	O
integration	O
of	O
resources	O
can	O
be	O
handled	O
in	O
manifold	O
ways	O
.	O

Australian	O
Government	O
has	O
aligned	O
with	O
the	O
Global	B-Organization
Action	I-Organization
Plan	E-Organization
(	O
GAP	S-Organization
)	O
,	O
World	B-Organization
Health	I-Organization
Organisation	E-Organization
(	O
WHO	S-Organization
)	O
,	O
World	B-Organization
Organisation	I-Organization
for	I-Organization
Animal	I-Organization
Health	E-Organization
(	O
OIE	S-Organization
)	O
,	O
and	O
the	O
Food	B-Organization
and	I-Organization
Agriculture	I-Organization
Organisation	I-Organization
of	I-Organization
the	I-Organization
United	I-Organization
Nations	E-Organization
()	O
on	O
responding	O
to	O
antimicrobial	O
resistance	O
.	O

As	O
part	O
of	O
an	O
in­ter-agency	O
col­lab­o­ra­tion	O
,	O
the	O
US	B-Organization
Army	E-Organization
is	O
step­ping	O
up	O
to	O
test	O
Spero's	B-Drug
an­tibi­ot­ic	E-Drug
,	O
SPR994	S-Drug
,	O
to	O
see	O
how	O
it	O
works	O
against	O
biode­fense	O
threats	O
like	O
an­thrax	S-Disease
,	O
plague	S-Disease
,	O
and	O
me­lioi­do­sis	S-Disease
.	O
Those	O
stud­ies	O
will	O
be	O
con­duct­ed	O
by	O
the	O
.	O

In	O
Oregon	S-Location
in	O
1984	O
,	O
followers	O
of	O
the	O
Bhagwan	B-Person
Shree	I-Person
Rajneesh	E-Person
attempted	O
to	O
control	O
a	O
local	O
election	O
by	O
incapacitating	O
the	O
local	O
population	O
.	O

Although	O
academic	O
debate	O
continues	O
,	O
no	O
single	O
alternative	O
solution	O
has	O
achieved	O
widespread	O
acceptance	O
.	O

Many	O
believed	O
the	O
epidemic	O
was	O
a	O
punishment	O
by	O
God	O
for	O
their	O
sins	O
,	O
and	O
could	O
be	O
relieved	O
by	O
winning	O
God's	O
forgiveness	O
.	O

The	O
views	O
expressed	O
here	O
are	O
those	O
of	O
the	O
authors	O
and	O
do	O
not	O
necessarily	O
represent	O
the	O
position	O
of	O
the	O
.	O

The	O
Office	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
would	O
be	O
cut	O
by	O
$136	O
million	O
,	O
or	O
9.7	O
percent	O
.	O

Studies	O
have	O
found	O
that	O
bacteria	O
that	O
evolve	O
antibiotic	O
resistance	O
towards	O
one	O
group	O
of	O
antibiotic	O
may	O
become	O
more	O
sensitive	O
to	O
others	O
.	O

The	O
United	B-Organization
States	I-Organization
Government	E-Organization
remains	O
a	O
strong	O
supporter	O
of	O
GHSA	S-International_exchange_and_cooperation
and	O
continues	O
to	O
demonstrate	O
leadership	O
through	O
our	O
engagement	O
in	O
multilateral	O
efforts	O
and	O
bilateral	O
capacity	O
building	O
programs	O
.	O

Further	O
development	O
of	O
the	O
disease	O
can	O
lead	O
to	O
complications	O
including	O
pneumonia	S-Disease
,	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
,	O
sepsis	S-Disease
,	O
septic	B-Disease
shock	E-Disease
,	O
and	O
.	O

In	O
late	O
June	O
2015	O
,	O
the	O
WHO	S-Organization
reported	O
that	O
"	O
weekly	O
case	O
incidence	O
has	O
stalled	O
at	O
between	O
20	O
and	O
27	O
cases	O
since	O
the	O
end	O
of	O
May	O
,	O
whilst	O
cases	O
continue	O
to	O
arise	O
from	O
unknown	O
sources	O
of	O
infection	O
,	O
and	O
to	O
be	O
detected	O
only	O
after	O
post-mortem	O
testing	O
of	O
community	O
deaths"	O
.	O

"	O
If	O
it	O
can	O
be	O
put	O
under	O
control	O
,	O
it	O
should	O
not	O
be	O
a	O
problem	O
…	O
but	O
we	O
have	O
to	O
watch	O
the	O
developments	O
very	O
carefully,	O
"	O
said	O
Yao	B-Person
Guiling	E-Person
an	O
analyst	O
with	O
consultancy	O
.	O

The	O
development	O
of	O
Biological	B-Document
Agent	I-Document
Biodefense	I-Document
Category	I-Document
Lists	E-Document
generally	O
takes	O
into	O
account	O
characteristics	O
of	O
individual	O
biological	O
agent	O
,	O
such	O
as	O
their	O
acquisition	O
,	O
production	O
and	O
dissemination	O
capabilities	O
,	O
results	O
of	O
deliberate	O
release	O
and	O
response	O
measures	O
.	O

The	O
Guardian	O
2012]	O
.	O

Thomas	B-Person
Inglesby	E-Person
,	O
a	O
biosecurity	O
expert	O
at	O
the	O
UPMC	B-Organization
Center	I-Organization
for	I-Organization
Health	I-Organization
Security	E-Organization
in	O
Baltimore	S-Location
,	O
Maryland	S-Location
,	O
calls	O
the	O
"	O
a	O
welcome	O
development	O
…	O
the	O
memo	O
should	O
prompt	O
a	O
lot	O
of	O
activity	O
that	O
can	O
improve	O
safety	O
"	O
at	O
both	O
government	O
and	O
extramural	O
labs	O
.	O

Rep	O
.	O

For	O
example	O
,	O
Colorado	B-Organization
State	I-Organization
University	E-Organization
biologist	O
is	O
using	O
engineered	O
circuits	O
in	O
plants	O
to	O
detect	O
explosives	O
.	O

On	O
February	O
28	O
,	O
1985	O
,	O
Congressman	O
James	B-Person
H.	I-Person
Weaver	E-Person
gave	O
a	O
speech	O
in	O
the	O
United	B-Organization
States	I-Organization
House	I-Organization
of	I-Organization
Representatives	E-Organization
in	O
which	O
he	O
"	O
accused	O
the	O
Rajneeshees	O
of	O
sprinkling	O
culture	O
on	O
salad	O
bar	O
ingredients	O
in	O
eight	O
restaurants"	O
.	O

On	O
14	O
June	O
it	O
was	O
reported	O
that	O
there	O
were	O
112	O
contacts	O
since	O
EVD	S-Disease
was	O
first	O
detected	O
in	O
Uganda	S-Location
.	O
Ring	O
vaccination	O
of	O
Ugandan	O
contacts	O
was	O
scheduled	O
to	O
start	O
on	O
15	O
June	O
.	O

If	O
F.	B-Pathogen
tularensis	E-Pathogen
were	O
used	O
as	O
a	O
weapon	O
,	O
the	O
bacteria	O
would	O
likely	O
be	O
made	O
airborne	O
for	O
exposure	O
by	O
inhalation	O
.	O

However	O
,	O
the	O
current	O
higher-levels	O
of	O
antibiotic-resistant	O
bacteria	O
are	O
attributed	O
to	O
the	O
overuse	O
and	O
abuse	O
of	O
antibiotics	O
.	O

Such	O
individuals	O
are	O
monitored	O
for	O
up	O
to	O
21	O
days	O
in	O
the	O
case	O
of	O
EVD	S-Disease

On	O
29	O
December	O
2018	O
,	O
Oxfam	S-Organization
said	O
it	O
would	O
suspend	O
its	O
work	O
due	O
to	O
the	O
ongoing	O
violence	O
in	O
the	O
DRC	S-Location
;	O
on	O
the	O
same	O
day	O
,	O
the	O
International	B-Organization
Rescue	I-Organization
Committee	E-Organization
suspended	O
their	O
Ebola	S-Pathogen
support	O
efforts	O
as	O
well	O
.	O

I'm	O
Associate	O
Director	O
for	O
Communication	O
at	O
CDC	S-Organization
.	O
Welcome	O
to	O
our	O
guests	O
in	O
the	O
room	O
,	O
to	O
those	O
watching	O
on	O
IPTV	S-Platform
,	O
on	O
satellite	S-Platform
.	O
Today's	O
briefing	O
from	O
CDC	S-Organization
highlights	O
steps	O
to	O
improve	O
laboratory	O
safety	O
after	O
several	O
recent	O
laboratory	O
incidents	O
.	O

Some	O
notable	O
points	O
made	O
in	O
the	O
draft	O
include	O
addressing	O
gender	O
inequity	O
where	O
females	O
are	O
nearly	O
twice	O
as	O
likely	O
as	O
men	O
to	O
get	O
infected	O
with	O
HIV	S-Pathogen
and	O
tailoring	O
resources	O
to	O
mobilized	O
regions	O
where	O
the	O
health	O
system	O
may	O
be	O
compromised	O
due	O
to	O
natural	O
disasters	O
,	O
etc	O
.	O

In	O
2007	O
,	O
the	O
WHO	S-Organization
organized	O
work	O
on	O
pandemic	O
influenza	O
vaccine	O
development	O
through	O
clinical	O
trials	O
in	O
collaboration	O
with	O
many	O
experts	O
and	O
health	O
officials	O
.	O

The	O
UN	B-Organization
food	I-Organization
body	E-Organization
furthered	O
,	O
that	O
in	O
addition	O
to	O
the	O
thousands	O
of	O
human	O
deaths	O
,	O
millions	O
of	O
dogs	O
die	O
each	O
year	O
due	O
to	O
.	O

The	O
WHA	S-Organization
convenes	O
annually	O
and	O
is	O
responsible	O
for	O
selecting	O
the	O
Director-General	O
,	O
setting	O
goals	O
and	O
priorities	O
,	O
and	O
approving	O
the	O
WHO	S-Organization
's	O
budget	O
and	O
activities	O
.	O

An	O
MRI	S-Technology
may	O
yield	O
different	O
information	O
compared	O
with	O
CT	S-Technology
.	O
Risks	O
and	O
discomfort	O
may	O
be	O
associated	O
with	O
MRI	B-Technology
scans	E-Technology
.	O
Compared	O
with	O
CT	B-Technology
scans	E-Technology
,	O
MRI	B-Technology
scans	E-Technology
typically	O
take	O
longer	O
and	O
are	O
louder	O
,	O
and	O
they	O
usually	O
need	O
the	O
subject	O
to	O
enter	O
a	O
narrow	O
,	O
confining	O
tube	O
.	O

Bats	O
have	O
been	O
blamed	O
for	O
the	O
deadly	O
Ebola	B-Incident
outbreak	E-Incident
in	O
(2014-2016)	O
.	O

More	O
than	O
ten	O
countries	O
had	O
traced	O
their	O
cases	O
back	O
to	O
Iran	S-Location
by	O
28	O
February	O
,	O
indicating	O
the	O
outbreak	O
may	O
have	O
been	O
more	O
severe	O
than	O
the	O
388	O
cases	O
reported	O
by	O
the	O
Iranian	B-Organization
government	E-Organization
by	O
that	O
date	O
.	O

Zelicoff	S-Person
said.	O
"	O
But	O
it	O
at	O
least	O
makes	O
the	O
questions	O
legitimate.	O
"	O

This	O
was	O
done	O
by	O
infecting	O
salad	O
bars	O
in	O
11	O
restaurants	O
,	O
produce	O
in	O
grocery	O
stores	O
,	O
doorknobs	O
,	O
and	O
other	O
public	O
domains	O
with	O
Salmonella	B-Pathogen
typhimurium	I-Pathogen
bacteria	E-Pathogen
in	O
the	O
city	O
of	O
The	O
Dalles	S-Location
,	O
Oregon	S-Location
.	O
The	O
attack	O
infected	O
751	O
people	O
with	O
severe	O
food	B-Disease
poisoning	E-Disease
.	O
There	O
were	O
no	O
fatalities	O
.	O

In	O
the	O
last	O
lab	O
,	O
students	O
receive	O
a	O
calculation	O
assignment	O
related	O
to	O
viral	B-Disease
infection	E-Disease
in	O
culture	O
(supplementary	O
material)	O
.	O

For	O
example	O
,	O
imposed	O
a	O
14-day	O
mandatory	O
quarantine	O
for	O
all	O
international	O
travellers	O
entering	O
the	O
city	O
.	O

For	O
instance	O
,	O
the	O
US	B-Organization
Marine	I-Organization
Corps	E-Organization
recently	O
investigated	O
the	O
potential	O
military	O
usefulness	O
of	O
calmatives	O
such	O
as	O
benzodiazepines	S-Drug
and	O
α2-adrenoreceptor	B-Drug
agonists	E-Drug
.	O
However	O
,	O
the	O
identification	O
of	O
suitable	O
substances	O
is	O
only	O
one	O
part	O
of	O
the	O
renewed	O
chemical	O
weapons	O
research	O
in	O
the	O
USA	S-Location
.	O
Recently	O
published	O
documents	O
show	O
that	O
the	O
US	O
military	O
forces	O
are	O
also	O
developing	O
new	O
delivery	O
devices	O
for	O
chemicals	O
with	O
a	O
range	O
of	O
more	O
than	O
2.	O
5	O
km-a	O
distance	O
that	O
makes	O
sense	O
only	O
for	O
warfare	O
scenarios	O
as	O
opposed	O
to	O
police	O
operations	O
,	O
in	O
which	O
ranges	O
from	O
10	O
to	O
50	O
m	O
for	O
tear	O
gas	O
grenades	O
are	O
common.	O
prohibits	O
any	O
use	O
of	O
chemicals	O
,	O
including	O
'non-lethal'	O
chemicals	O
,	O
in	O
warfare	O
situations	O
.	O

"	O
My	O
version	O
of	O
biohacking	O
is	O
unexpected	O
people	O
in	O
unexpected	O
places	O
doing	O
biotechnology,	O
"	O
Jorgensen	S-Person
told	O
me	O
.	O

PCDs	S-Equipment
have	O
several	O
potential	O
advantages	O
,	O
including	O
improving	O
signal	O
(and	O
contrast)	O
to	O
noise	O
ratios	O
,	O
reducing	O
doses	O
,	O
improving	O
spatial	O
resolution	O
,	O
and	O
through	O
use	O
of	O
several	O
energies	O
,	O
distinguishing	O
multiple	O
contrast	O
agents	O
.	O

On	O
2	O
May	O
2014	O
,	O
the	O
United	B-Organization
States	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	E-Organization
(	O
CDC	S-Organization
)	O
confirmed	O
the	O
first	O
diagnosis	O
of	O
MERS-CoV	S-Pathogen
in	O
the	O
United	B-Location
States	E-Location
in	O
Indiana	S-Location
.	O
The	O
man	O
diagnosed	O
was	O
a	O
healthcare	O
worker	O
who	O
had	O
been	O
in	O
Saudi	B-Location
Arabia	E-Location
a	O
week	O
earlier	O
,	O
and	O
was	O
reported	O
to	O
be	O
in	O
good	O
condition	O
.	O

An	O
inspection	O
of	O
each	O
involved	O
laboratory	O
was	O
also	O
conducted	O
by	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
Animal	B-Organization
and	I-Organization
Plant	I-Organization
Health	I-Organization
Inspection	I-Organization
Service	E-Organization
()	O
Agricultural	O
Select	O
Agent	O
Services	O
.	O

A	O
report	O
of	O
the	O
provides	O
an	O
explanation	O
for	O
the	O
culture	O
of	O
non-sharing	O
as	O
due	O
to	O
the	O
pressure	O
for	O
commercialization	O
and	O
competition	O
even	O
between	O
academic	O
groups	O
.	O

A	O
summary	O
of	O
joint	O
projects	O
,	O
each	O
lasting	O
between	O
1	O
and	O
3	O
years	O
,	O
is	O
listed	O
in	O
Table	O
2	O
.	O

When	O
biological	O
warfare	O
or	O
new	O
,	O
currently	O
hypothetical	O
,	O
threats	O
(i.e.	O
,	O
robots	O
,	O
new	O
artificial	O
bacteria)	O
are	O
considered	O
,	O
biosafety	O
precautions	O
are	O
generally	O
not	O
sufficient.	O
(link	O
to	O
incident	O
report	O
,	O
i.e.	O
such	O
as	O
problems	O
with	O
CDC	B-Organization
research	I-Organization
labs	E-Organization
in	O
2014)The	O
new	O
field	O
of	O
biosecurity	O
addresses	O
these	O
complex	O
threats	O
.	O

The	O
Assembly	O
elects	O
34	O
members	O
,	O
technically	O
qualified	O
in	O
the	O
field	O
of	O
health	O
,	O
to	O
the	O
Executive	O
Board	O
for	O
three-year	O
terms	O
.	O

"	O
You're	O
talking	O
about	O
the	O
use	O
of	O
antibiotics	O
in	O
the	O
absence	O
of	O
disease,	O
"	O
Kar	S-Person
said.	O
"	O
I	O
think	O
there's	O
very	O
little	O
justification	O
for	O
calling	O
that	O
therapeutic	O
,	O
and	O
there's	O
a	O
lot	O
of	O
overlap	O
between	O
growth	O
promotion	O
and	O
disease	O
prevention	O
in	O
that	O
context.	O
"	O

In	O
cases	O
of	O
influenza	O
outbreaks	O
,	O
WHO	S-Organization
and	O
associated	O
agencies	O
have	O
moved	O
rapidly	O
to	O
isolate	O
and	O
eliminate	O
new	O
outbreaks	O
of	O
infection	O
.	O

The	O
Soviet	S-Organization
program	O
was	O
spread	O
over	O
dozens	O
of	O
facilities	O
and	O
involved	O
tens	O
of	O
thousands	O
of	O
specialists	O
.	O

Enhanced	O
equipment	O
for	O
first	O
responders	O
.	O

Yet	O
another	O
attack	O
reported	O
on	O
17	O
November	O
,	O
in	O
Beni	S-Location
by	O
an	O
armed	O
rebel	O
group	O
forced	O
the	O
cessation	O
of	O
EVD	S-Disease
containment	O
efforts	O
and	O
WHO	S-Organization
staff	O
to	O
evacuate	O
to	O
another	O
DRC	O
city	O
for	O
the	O
time	O
being.	O
continues	O
to	O
be	O
the	O
site	O
of	O
attacks	O
by	O
militant	O
groups	O
as	O
18	O
civilians	O
were	O
killed	O
on	O
6	O
December	O
.	O

In	O
the	O
second	O
week	O
of	O
September	O
2016	O
,	O
the	O
state	O
of	O
New	B-Location
York	E-Location
held	O
a	O
large	O
emergency	O
response	O
training	O
exercise	O
called	O
the	O
Excelsior	B-Activity
Challenge	E-Activity
,	O
with	O
over	O
100	O
emergency	O
responders	O
participating	O
.	O

Ring	O
artifact	O
Probably	O
the	O
most	O
common	O
mechanical	O
artifact	O
,	O
the	O
image	O
of	O
one	O
or	O
many	O
"	O
rings"	O
appears	O
within	O
an	O
image	O
.	O

NTI	S-Organization
was	O
founded	O
in	O
2001	O
by	O
former	O
U.S.Sen	O
.	O

Nevertheless	O
,	O
adaptation	O
of	O
the	O
technology	O
to	O
plant	O
biology	O
requires	O
further	O
investigation	O
since	O
the	O
efficiency	O
of	O
targeted	O
editing	O
remains	O
at	O
low	O
frequency	O
while	O
off-target	O
effect	O
have	O
been	O
reported	O
to	O
remain	O
very	O
high	O
.	O

After	O
the	O
DoD	S-Organization
halted	O
efforts	O
to	O
find	O
those	O
who	O
may	O
have	O
been	O
affected	O
by	O
the	O
tests	O
,	O
veteran	O
health	O
activists	O
and	O
others	O
identified	O
approximately	O
600	O
additional	O
individuals	O
who	O
were	O
potentially	O
exposed	O
during	O
Project	B-Scientific_research_project
112	E-Scientific_research_project
.	O
Some	O
of	O
the	O
individuals	O
were	O
identified	O
after	O
the	O
GAO	S-Organization
reviewed	O
records	O
stored	O
at	O
the	O
Dugway	B-Location
Proving	I-Location
Ground	E-Location
,	O
others	O
were	O
identified	O
by	O
the	O
.	O
Many	O
of	O
the	O
newly	O
identified	O
suffer	O
from	O
long	O
term	O
illnesses	O
that	O
may	O
have	O
been	O
caused	O
by	O
the	O
biological	O
or	O
chemical	O
testing	O
.	O

Gaggle	S-Platform
is	O
now	O
employed	O
in	O
the	O
integration	O
of	O
databases	O
over	O
the	O
Internet	O
in	O
the	O
to	O
build	O
up	O
a	O
systems	O
biology	O
knowledgebase	O
.	O

There	O
was	O
no	O
major	O
structural	O
damage	O
in	O
the	O
incident	O
and	O
"	O
no	O
work	O
with	O
biological	O
materials	O
was	O
going	O
on	O
there"	O
,	O
the	O
Vektor	S-Organization
statement	O
said	O
.	O

The	O
bill	O
also	O
would	O
renew	O
these	O
health-readiness	O
programs	O
but	O
would	O
change	O
how	O
some	O
of	O
the	O
federal	O
funds	O
get	O
spent	O
,	O
according	O
to	O
a	O
summary	O
provided	O
by	O
Rep	O
.	O

In	O
January	O
2010	O
,	O
Wolfgang	B-Person
Wodarg	E-Person
a	O
German	O
deputy	O
who	O
trained	O
as	O
a	O
physician	O
and	O
now	O
chairs	O
the	O
health	B-Organization
committee	I-Organization
at	I-Organization
the	I-Organization
Council	I-Organization
of	I-Organization
Europe	E-Organization
,	O
claimed	O
major	O
firms	O
had	O
organized	O
a	O
"	O
campaign	O
of	O
panic	O
"	O
to	O
put	O
pressure	O
on	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
to	O
declare	O
a	O
"	O
false	O
pandemic	O
"	O
to	O
sell	O
vaccines	O
.	O

Months	O
later	O
,	O
starting	O
on	O
September	O
16	O
,	O
1985	O
,	O
Rajneesh	S-Person
who	O
had	O
recently	O
emerged	O
from	O
a	O
four-year	O
period	O
of	O
public	O
silence	O
and	O
self-imposed	O
isolation	O
(although	O
he	O
had	O
continued	O
to	O
meet	O
with	O
his	O
assistant)	O
at	O
the	O
commune	O
,	O
convened	O
press	O
conferences:	O
he	O
stated	O
that	O
Sheela	S-Person
and	O
19	O
other	O
commune	O
leaders	O
,	O
including	O
Puja	S-Person
,	O
had	O
left	O
Rajneeshpuram	S-Location
over	O
the	O
weekend	O
and	O
gone	O
to	O
Europe	S-Location
.	O
He	O
said	O
that	O
he	O
had	O
received	O
information	O
from	O
commune	O
residents	O
that	O
Sheela	S-Person
and	O
her	O
team	O
had	O
committed	O
a	O
number	O
of	O
serious	O
crimes	O
.	O

Ameyo	B-Person
Stella	I-Person
Adadevoh	E-Person
at	O
First	B-Organization
Consultants	I-Organization
Medical	I-Organization
Centre	E-Organization
in	O
.	O

Chinese	O
biological	O
material	O
has	O
been	O
collected	O
under	O
a	O
series	O
of	O
federal	O
projects	O
including	O
saliva	O
and	O
cancer	S-Disease
tissue	O
.	O

The	O
GAO	S-Organization
scolded	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense's	E-Organization
(	O
DOD	S-Organization
)	O
2003	O
decision	O
to	O
stop	O
searching	O
for	O
people	O
affected	O
by	O
the	O
tests	O
was	O
premature	O
.	O

One	O
of	O
the	O
most	O
direct	O
routes	O
to	O
informing	O
scientific	O
debates	O
is	O
through	O
the	O
timely	O
publication	O
of	O
relevant	O
research	O
results	O
.	O

Viral	O
infectious	O
diseases	O
often	O
arise	O
in	O
animals	O
.	O

Again	O
,	O
the	O
delivery	O
system	O
is	O
a	O
key	O
stem	O
to	O
overcome	O
before	O
it	O
can	O
be	O
used	O
in	O
oncologic	O
patients	O
.	O

Several	O
other	O
studies	O
,	O
using	O
a	O
variety	O
of	O
methods	O
,	O
have	O
estimated	O
that	O
numbers	O
of	O
infections	O
in	O
many	O
countries	O
are	O
likely	O
to	O
be	O
considerably	O
greater	O
than	O
the	O
reported	O
cases	O
.	O

Because	O
of	O
Schully's	O
findings	O
,	O
the	O
U.S.	B-Organization
Indo-Pacific	I-Organization
Command	E-Organization
(	O
PACOM	S-Organization
)	O
has	O
requested	O
that	O
the	O
same	O
forces	O
serving	O
in	O
Darwin	S-Location
be	O
screened	O
for	O
the	O
mosquito-borne	O
Ross	B-Pathogen
River	I-Pathogen
Virus	E-Pathogen
,	O
and	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center	I-Organization
Asia	E-Organization
is	O
using	O
the	O
study	O
to	O
provide	O
additional	O
surveillance	O
of	O
diseases	O
endemic	O
to	O
and	O
the	O
risks	O
they	O
present	O
to	O
the	O
servicemembers	O
.	O

The	O
standard	O
test	O
for	O
current	O
infection	O
with	O
SARS-CoV-2	S-Pathogen
uses	O
RNA	B-Technology
testing	E-Technology
of	O
respiratory	O
secretions	O
collected	O
using	O
a	O
nasopharyngeal	O
swab	O
,	O
though	O
it	O
is	O
possible	O
to	O
test	O
other	O
samples	O
.	O

NIAID	S-Organization
oversees	O
responses	O
to	O
Zika	S-Pathogen
,	O
Ebola	S-Pathogen
and	O
vaccine	O
research	O
.	O

Anne	B-Person
Schuchat	E-Person
acting	O
director	O
of	O
the	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
,	O
said	O
last	O
week.	O
"	O
Just	O
ask	O
South	B-Location
Korea	E-Location
about	O
MERS	S-Disease
;	O
just	O
ask	O
Canada	S-Location
and	O
Singapore	S-Organization
about	O
SARS	S-Disease
;	O
just	O
ask	O
Brazil	S-Organization
about	O
yellow	B-Disease
fever	E-Disease
and	O
.	O

Inactive	O
dCas9	O
protein	O
modulate	O
gene	O
expression	O
by	O
targeting	O
dCas9-repressors	O
or	O
activators	O
toward	O
promoter	O
or	O
transcriptional	O
start	O
sites	O
of	O
target	O
genes	O
.	O

However	O
,	O
it	O
is	O
often	O
pointed	O
out	O
that	O
Dis	O
at	O
too	O
early	O
a	O
stage	O
to	O
consider	O
such	O
advanced	O
projects	O
feasible	O
,	O
as	O
few	O
successful	O
transformative	O
genetics	O
projects	O
have	O
been	O
undertaken	O
yet	O
.	O

Research	O
on	O
coronavirus	O
genomes	O
indicates	O
the	O
majority	O
of	O
COVID-19	S-Disease
cases	O
in	O
New	B-Location
York	E-Location
came	O
from	O
European	O
travellers	O
,	O
rather	O
than	O
directly	O
from	O
China	S-Location
or	O
any	O
other	O
Asian	S-Location
country	O
.	O

In	O
addition	O
to	O
its	O
Atlanta	S-Location
headquarters	O
,	O
CDC	S-Organization
's	O
other	O
domestic	O
locations	O
are	O
Anchorage	S-Location
,	O
Fort	B-Location
Collins	E-Location
,	O
Hyattsville	S-Location
,	O
Research	B-Location
Triangle	I-Location
Park	E-Location
,	O
San	B-Location
Juan	I-Location
(Puerto	I-Location
Rico	E-Location
)	O
,	O
and	O
Washington	S-Location
,	O
D.C.	S-Location
,	O
while	O
NIOSH	S-Organization
operates	O
its	O
own	O
facilities	O
in	O
Cincinnati	S-Location
,	O
Morgantown	S-Location
,	O
Pittsburgh	S-Location
,	O
Spokane	S-Location
,	O
Denver	S-Location
,	O
and	O
Anchorage	S-Location
.	O
In	O
addition	O
,	O
CDC	S-Organization
operates	O
quarantine	O
facilities	O
in	O
20	O
cities	O
in	O
.	O

In	O
clinical	O
and	O
research	O
MRI	S-Technology
,	O
hydrogen	O
atoms	O
are	O
most	O
often	O
used	O
to	O
generate	O
a	O
macroscopic	O
polarization	O
that	O
is	O
detected	O
by	O
antennas	O
close	O
to	O
the	O
subject	O
being	O
examined	O
.	O

The	O
lower	O
value	O
of	O
700	O
million	O
is	O
more	O
than	O
the	O
500	O
million	O
people	O
estimated	O
to	O
have	O
been	O
infected	O
by	O
the	O
Spanish	B-Incident
flu	I-Incident
pandemic	E-Incident

The	O
WHO	S-Organization
representative	O
in	O
Nigeria	S-Location
officially	O
declared	O
the	O
country	O
Ebola	S-Disease
-free	O
on	O
20	O
October	O
2014	O
,	O
after	O
no	O
new	O
active	O
cases	O
were	O
reported	O
in	O
the	O
follow	O
up	O
contacts	O
,	O
stating	O
it	O
was	O
a	O
"	O
spectacular	O
success	O
story"	O
.	O

The	O
Swedish	B-Platform
Forum	I-Platform
for	I-Platform
Biopreparedness	I-Platform
Diagnostics	E-Platform
(	O
FBD	S-Platform
)	O
is	O
a	O
network	O
that	O
fosters	O
collaboration	O
among	O
the	O
4	O
agencies	O
with	O
responsibility	O
for	O
the	O
laboratory	O
diagnostics	O
of	O
high-consequence	O
pathogens	O
,	O
covering	O
animal	O
health	O
and	O
feed	O
safety	O
,	O
food	O
safety	O
,	O
public	O
health	O
and	O
biodefense	O
,	O
and	O
security	O
.	O

The	O
first	O
2	O
waves	O
occurred	O
at	O
a	O
time	O
of	O
year	O
normally	O
unfavorable	O
to	O
influenza	S-Disease
virus	O
spread	O
.	O

In	O
November	O
,	O
WHO	S-Organization
released	O
a	O
protocol	O
for	O
the	O
safe	O
and	O
dignified	O
burial	O
of	O
people	O
who	O
die	O
from	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
It	O
encouraged	O
the	O
inclusion	O
of	O
family	O
and	O
clergy	O
,	O
and	O
gave	O
specific	O
instructions	O
for	O
Muslim	O
and	O
Christian	O
burials	O
.	O

Legal	O
challenges	O
from	O
the	O
food	O
animal	O
and	O
pharmaceutical	O
industries	O
delayed	O
the	O
final	O
decision	O
to	O
do	O
so	O
until	O
2006	O
.	O

Although	O
Britain	O
never	O
offensively	O
used	O
the	O
biological	O
weapons	O
it	O
developed	O
,	O
its	O
program	O
was	O
the	O
first	O
to	O
successfully	O
weaponize	O
a	O
variety	O
of	O
deadly	O
pathogens	O
and	O
bring	O
them	O
into	O
industrial	O
production	O
.	O

A	O
spokesperson	O
for	O
the	O
hospital	O
stated	O
that	O
"	O
Guys	B-Organization
and	I-Organization
St	I-Organization
Thomas	E-Organization
can	O
confirm	O
that	O
the	O
patient	O
with	O
severe	O
respiratory	O
illness	O
due	O
to	O
novel	O
coronavirus	O
()	O
died	O
on	O
Friday	O
28	O
June	O
,	O
after	O
his	O
condition	O
deteriorated	O
despite	O
every	O
effort	O
and	O
full	O
supportive	O
treatment.	O
"	O

At	O
the	O
same	O
time	O
,	O
other	O
,	O
more	O
benign	O
scenarios	O
are	O
being	O
circulated	O
in	O
an	O
attempt	O
to	O
explain	O
the	O
infestation's	O
quirks	O
.	O

The	O
pandemic	O
began	O
to	O
taper	O
off	O
in	O
November	O
2009	O
,	O
and	O
by	O
May	O
2010	O
,	O
the	O
number	O
of	O
cases	O
was	O
in	O
steep	O
decline	O
.	O

Chinese	O
aid	O
was	O
well-received	O
in	O
parts	O
of	O
Latin	B-Location
America	E-Location
and	O
Africa	S-Location
.	O
On	O
2April	O
,	O
the	O
launched	O
emergency	O
support	O
operations	O
for	O
developing	O
countries	O
.	O

Berkeley	S-Location
,	O
Calif.:	O
University	O
of	O
California	O
Press	O
,	O
1992	O
;	O
Patel,	B-Person
Kant	E-Person
;	O
Rushefsky	S-Person
,	O
Mark	B-Person
E	E-Person
.	O
;	O
and	O
McFarlane	S-Person
,	O
.	O
The	O
Politics	O
of	O
Public	O
Health	O
in	O
the	O
United	O
States	O
.	O

Both	O
MERS-CoV	S-Pathogen
and	O
SARS-CoV	S-Pathogen
()	O
are	O
betacoronaviruses	O
.	O

In	O
Spain	S-Location
sources	O
from	O
the	O
period	O
explicitly	O
linked	O
the	O
Spanish	B-Disease
flu	E-Disease
to	O
the	O
cultural	O
figure	O
of	O
Don	B-Person
Juan	E-Person
.	O
The	O
nickname	O
for	O
the	O
flu	S-Disease
,	O
the	O
"	O
Naples	O
Soldier"	O
,	O
was	O
adopted	O
from	O
Federico	B-Person
Romero	E-Person
and	O
Guillermo	B-Person
Fernández	I-Person
Shaw	E-Person
's	O
1916	O
operetta	O
,	O
The	O
Song	O
of	O
Forgetting	O
(La	O
canción	O
del	O
olvido)	O
.	O

The	O
City	B-Location
of	I-Location
Atlanta	E-Location
annexed	O
the	O
CDC	S-Organization
headquarters	O
effective	O
January	O
1	O
,	O
2018	O
,	O
a	O
part	O
of	O
the	O
city's	O
largest	O
annexation	O
within	O
a	O
period	O
of	O
65	O
years	O
;	O
the	O
Atlanta	B-Organization
City	I-Organization
Council	E-Organization
voted	O
to	O
do	O
so	O
the	O
prior	O
December	O
.	O

CDC	S-Organization
believes	O
that	O
other	O
staff	O
,	O
family	O
and	O
friends	O
are	O
not	O
at	O
risk	O
.	O

Scientists	O
who	O
work	O
on	O
have	O
performed	O
risk	O
assessments	O
and	O
equipped	O
them	O
with	O
safeguards	O
to	O
make	O
the	O
trials	O
as	O
safe	O
as	O
possible	O
.	O

By	O
May	O
2013	O
,	O
10	O
of	O
the	O
22	O
people	O
who	O
died	O
and	O
22	O
of	O
44	O
cases	O
reported	O
were	O
in	O
Saudi	B-Location
Arabia	E-Location
and	O
over	O
80%	O
were	O
male	O
.	O

Many	O
important	O
crops	O
have	O
been	O
genetically	O
modified	O
to	O
produce	O
higher	O
yields	O
,	O
withstand	O
environmental	O
stress	O
,	O
or	O
grow	O
without	O
pesticides	O
.	O

For	O
this	O
particular	O
purpose	O
,	O
the	O
development	O
of	O
tools	O
for	O
high-throughput	B-Technology
genome	I-Technology
editing	E-Technology
is	O
a	O
growing	O
need	O
for	O
the	O
pharma	O
companies.	O
will	O
drive	O
to	O
more	O
cost-effective	O
biological	O
therapies	O
and	O
most-likely	O
to	O
the	O
generalisation	O
of	O
better	O
patient-based	O
therapies	O
.	O

In	O
2005	O
,	O
the	O
Iraq	B-Organization
Survey	I-Organization
Group	E-Organization
-	O
an	O
international	O
group	O
composed	O
of	O
civilian	O
and	O
military	O
experts	O
-	O
concluded	O
that	O
the	O
Iraqi	B-Scientific_research_project
military	I-Scientific_research_project
BW	I-Scientific_research_project
program	E-Scientific_research_project
had	O
been	O
abandoned	O
during	O
1995	O
and	O
1996	O
because	O
of	O
fear	O
that	O
discovery	O
of	O
continued	O
activity	O
would	O
result	O
in	O
severe	O
political	O
repercussions	O
including	O
the	O
extension	O
of	O
UN	S-Organization
sanctions	O
.	O

Control	O
measures	O
in	O
human	O
healthcare	O
settings	O
include	O
strict	O
hand	O
hygiene	O
,	O
use	O
of	O
personal	O
protective	O
equipment	O
,	O
and	O
environmental	O
decontamination	O
(10)	O
.	O

In	O
the	O
event	O
of	O
a	O
crisis	O
,	O
network	O
activation	O
relies	O
on	O
a	O
request	O
of	O
assistance	O
from	O
any	O
of	O
the	O
network	O
agencies	O
.	O

She	O
herself	O
has	O
had	O
a	O
working	O
relationship	O
with	O
law	O
enforcement	O
since	O
the	O
early	O
2000s	O
.	O

Since	O
its	O
development	O
in	O
the	O
1970s	O
and	O
1980s	O
,	O
MRI	S-Technology
has	O
proven	O
to	O
be	O
a	O
versatile	O
imaging	O
technique	O
.	O

Representative	O
results	O
are	O
shown	O
in	O
Fig.2	O
.	O

In	O
November	O
2018	O
,	O
Jiankui	B-Person
He	E-Person
announced	O
that	O
he	O
had	O
edited	O
two	O
human	O
embryos	O
to	O
attempt	O
to	O
disable	O
the	O
gene	O
for	O
CCR5	O
,	O
which	O
codes	O
for	O
a	O
receptor	O
that	O
HIV	S-Disease
uses	O
to	O
enter	O
cells	O
.	O

I	O
was	O
just	O
wondering	O
how	O
that	O
impacts	O
the	O
other	O
things	O
that	O
you're	O
doing	O
.	O

In	O
December	O
2016	O
,	O
the	O
results	O
of	O
the	O
two-year	O
Guinea	S-Location
trial	O
were	O
published	O
announcing	O
that	O
rVSV-ZEBOV	S-Vaccine
had	O
been	O
found	O
to	O
protect	O
people	O
who	O
had	O
been	O
exposed	O
to	O
cases	O
of	O
.	O

But	O
after	O
the	O
2006	O
episode	O
,	O
what	O
they	O
did	O
was	O
implement	O
a	O
procedure	O
for	O
one	O
particular	O
type	O
of	O
specimen	O
.	O

SARS-CoV-2	S-Pathogen
is	O
closely	O
related	O
to	O
the	O
original	O
SARS-CoV	S-Pathogen
.	O
It	O
is	O
thought	O
to	O
have	O
an	O
animal	O
(zoonotic)	O
origin	O
.	O

The	O
partnership	O
with	O
the	O
University	B-Organization
of	I-Organization
Nebraska	I-Organization
and	I-Organization
Los	I-Organization
Alamos	E-Organization
is	O
specifically	O
looking	O
into	O
the	O
diagnosis	O
and	O
detection	O
of	O
infectious	O
disease	O
agents	O
through	O
the	O
use	O
of	O
biosensors	O
,	O
analytical	O
devices	O
that	O
convert	O
a	O
biological	O
response	O
into	O
an	O
electrical	O
signal	O
.	O

Glenn	B-Person
Cross	E-Person
.	O
Dirty	O
War:	O
Rhodesia	O
and	O
Chemical	O
Biological	O
Warfare	O
,	O
1975	O
to	O
1980.	O
:	O
Helion	O
&amp	O
;	O
Company	O
(2017)	O
.	O

There	O
was	O
a	O
brief	O
respite	O
from	O
these	O
charges	O
between	O
1987	O
and	O
1992	O
,	O
but	O
after	O
that	O
former	O
Soviet	S-Organization
military	O
officials	O
who	O
were	O
part	O
of	O
the	O
Soviet	B-Organization
Union	E-Organization
's	O
own	O
BW	O
program	O
once	O
again	O
began	O
to	O
repeat	O
the	O
same	O
discredited	O
charges	O
.	O

Neither	O
delivery	O
method	O
was	O
perfected	O
before	O
the	O
war	O
in	O
Europe	S-Location
ended	O
.	O

Calling	O
the	O
measure	O
"	O
critical	O
to	O
our	O
national	O
security,	O
"	O
Rep	O
.	O

Comparison	O
of	O
statistics	O
for	O
deaths	O
for	O
all	O
causes	O
versus	O
the	O
seasonal	O
average	O
indicates	O
excess	O
mortality	O
in	O
many	O
countries	O
.	O

The	O
company	O
was	O
also	O
a	O
prime	O
Pentagon	S-Organization
contractor	O
in	O
the	O
past	O
under	O
the	O
for	O
research	O
and	O
development	O
of	O
bio-agents	O
with	O
16	O
contracts	O
between	O
1951	O
and	O
1962	O
.	O

All	O
workers	O
of	O
a	O
ceramic	O
plant	O
across	O
the	O
street	O
fell	O
ill	O
during	O
the	O
next	O
few	O
days	O
.	O

After	O
over	O
two	O
decades	O
of	O
fighting	O
smallpox	S-Disease
,	O
the	O
declared	O
in	O
1979	O
that	O
the	O
disease	O
had	O
been	O
eradicated	O
–	O
the	O
first	O
disease	O
in	O
history	O
to	O
be	O
eliminated	O
by	O
human	O
effort	O
.	O

Shooter	S-Organization
's	O
enquiry	O
discovered	O
that	O
the	O
Dangerous	B-Organization
Pathogens	I-Organization
Advisory	I-Organization
Group	E-Organization
had	O
inspected	O
the	O
laboratory	O
on	O
two	O
occasions	O
and	O
each	O
time	O
recommended	O
that	O
the	O
smallpox	S-Disease
research	O
be	O
continued	O
there	O
,	O
even	O
though	O
the	O
facilities	O
at	O
the	O
laboratory	O
fell	O
far	O
short	O
of	O
those	O
required	O
by	O
law	O
.	O

Besides	O
standard	O
data	O
formats	O
'ontologies'	O
are	O
frameworks	O
to	O
standardize	O
the	O
knowledge	O
representation	O
in	O
a	O
domain	O
.	O

The	O
old	O
radiocontrast	O
agents	O
caused	O
anaphylaxis	S-Phenotype
in	O
1%	O
of	O
cases	O
while	O
the	O
newer	O
,	O
lower-osmolar	O
agents	O
cause	O
reactions	O
in	O
0.01–0.	O
04%	O
of	O
cases	O
.	O

Both	O
Ebola	S-Pathogen
and	O
are	O
part	O
of	O
the	O
Filoviridae	O
family	O
.	O

As	O
a	O
follow-on	O
effort	O
,	O
DARPA	S-Organization
funded	O
research	O
into	O
genetic	O
constructs	O
that	O
can	O
directly	O
stimulate	O
production	O
of	O
antibodies	O
in	O
the	O
body	O
.	O

One	O
study	O
yielded	O
results	O
of	O
the	O
spatio-temporal	O
evolution	O
of	O
the	O
viral	O
outbreak	O
.	O

Read	O
more:	O
What	O
if	O
the	O
Ebola	S-Disease
epidemic	O
returns?	O

Deadly	O
Arsenals	O
,	O
p.	O
35	O
.	O

In	O
addition	O
,	O
these	O
bodies	O
synergize	O
and	O
harmonize	O
the	O
ethical	O
issues	O
related	O
to	O
the	O
release	O
and	O
use	O
of	O
GM	S-Technology
products	O
.	O

Other	O
delivery	O
systems	O
researched	O
and	O
at	O
least	O
partially	O
developed	O
during	O
the	O
1950s	O
included	O
the	O
E77	O
balloon	O
bomb	O
and	O
the	O
E86	O
cluster	O
bomb	O
.	O

According	O
to	O
the	O
local	O
health	O
authorities	O
,	O
the	O
cause	O
of	O
the	O
outbreak	O
was	O
into	O
which	O
police	O
launched	O
an	O
investigation	O
.	O

These	O
findings	O
wouldn't	O
be	O
generalizable	O
to	O
the	O
rest	O
of	O
us	O
.	O

In	O
2005	O
,	O
influenza	O
only	O
appeared	O
on	O
the	O
death	O
certificates	O
of	O
1,812	O
people	O
in	O
the	O
US	S-Location
The	O
average	O
annual	O
US	O
death	O
toll	O
from	O
flu	O
is	O
,	O
however	O
,	O
estimated	O
to	O
be	O
36,000	O
.	O

Every	O
five	O
years	O
,	O
the	O
States	O
Parties	O
meet	O
in	O
Geneva	S-Location
to	O
participate	O
in	O
a	O
Review	O
Conference	O
(RevCon)	O
that	O
is	O
the	O
culmination	O
of	O
the	O
last	O
five	O
years	O
of	O
efforts	O
to	O
strengthen	O
the	O
Convention	O
.	O

Altering	O
of	O
gametocytes	O
and	O
embryos	O
to	O
generate	O
heritable	O
changes	O
in	O
humans	O
was	O
defined	O
to	O
be	O
irresponsible	O
.	O

The	O
international	O
community	O
cannot	O
wait	O
to	O
provide	O
the	O
necessary	O
assistance	O
while	O
investigations	O
on	O
the	O
cause	O
of	O
an	O
outbreak	O
are	O
carried	O
out	O
.	O

Work	O
on	O
delivery	O
systems	O
for	O
the	O
U.S.	S-Location
bioweapons	O
arsenal	O
led	O
to	O
the	O
first	O
mass-produced	O
biological	O
weapon	O
in	O
1952	O
,	O
the	O
M33	O
cluster	O
bomb.Croddy	O
,	O
Weapons	O
of	O
Mass	O
Destruction	O
,	O
p.	O
75	O
.	O

The	O
process	O
,	O
she	O
explained	O
,	O
relies	O
on	O
plasma	O
donors	O
who	O
have	O
been	O
stimulated	O
to	O
have	O
an	O
immune	O
response	O
and	O
develop	O
antibodies	O
to	O
fight	O
specific	O
diseases	O
.	O

The	O
ad	O
stated:	O
"	O
Breeders	O
if	O
you're	O
for	O
real	O
send	O
one	O
of	O
your	O
little	O
friends	O
.	O

But	O
how	O
do	O
you	O
change	O
the	O
culture?	O
I	O
mean	O
,	O
this	O
administration	O
has	O
been	O
here	O
since	O
2009	O
at	O
the	O
.	O
Obviously	O
this	O
is	O
an	O
ingrained	O
culture	O
.	O

In	O
Boston	S-Location
the	O
mission	O
seems	O
to	O
have	O
failed	O
;	O
the	O
infected	O
civilians	O
were	O
quarantined	O
and	O
thus	O
kept	O
from	O
Continental	O
soldiers	O
.	O

Perhaps	O
persuaded	O
by	O
fear	O
,	O
patients	O
and	O
doctors	O
sometimes	O
agree	O
to	O
an	O
intensive	O
schedule	O
of	O
CT	S-Equipment
scans	O
,	O
sometimes	O
up	O
to	O
every	O
three	O
months	O
and	O
beyond	O
the	O
recommended	O
guidelines	O
,	O
in	O
an	O
attempt	O
to	O
do	O
surveillance	O
on	O
the	O
nodules.	O
,	O
which	O
cites	O
However	O
,	O
established	O
guidelines	O
advise	O
that	O
patients	O
without	O
a	O
prior	O
history	O
of	O
cancer	O
and	O
whose	O
solid	O
nodules	O
have	O
not	O
grown	O
over	O
a	O
two-year	O
period	O
are	O
unlikely	O
to	O
have	O
any	O
malignant	O
cancer	O
.	O

Successful	O
public/private	O
partnership	O
models	O
that	O
currently	O
exist	O
include	O
the	O
International	B-Organization
Council	I-Organization
for	I-Organization
the	I-Organization
Life	I-Organization
Sciences	E-Organization
(a	O
U.S.	S-Location
-based	O
non-profit	O
agency)	O
,	O
working	O
in	O
collaboration	O
with	O
the	O
Royal	B-Organization
Scientific	I-Organization
Society	I-Organization
of	I-Organization
Jordan	E-Organization
(	O
RSS	S-Organization
)	O
,	O
the	O
Biosafety	B-Organization
and	I-Organization
Biosecurity	I-Organization
International	I-Organization
Consortium	E-Organization
(	O
BBIC	S-Organization
,	O
a	O
network	O
of	O
concerned	O
individuals	O
from	O
22	O
countries	O
in	O
the	O
region)	O
,	O
and	O
the	O
Moroccan	B-Organization
Biosafety	I-Organization
Association	E-Organization
()	O
that	O
have	O
developed	O
successful	O
sustainable	O
projects	O
since	O
2005	O
.	O

Loss	B-Phenotype
of	I-Phenotype
smell	E-Phenotype
was	O
a	O
presenting	O
symptom	O
in	O
30%	O
of	O
confirmed	O
cases	O
in	O
.	O

One	O
of	O
those	O
DHS	S-Organization
partners	O
,	O
for	O
instance	O
,	O
is	O
the	O
,	O
which	O
has	O
been	O
realigned	O
to	O
focus	O
on	O
top	O
modernization	O
priorities	O
such	O
as	O
building	O
stronger	O
tactical	O
cyber	O
teams	O
.	O

As	O
a	O
note	O
,	O
the	O
use	O
of	O
biological	O
weapons	O
was	O
banned	O
by	O
the	O
1925	O
.	O
My	O
team	O
at	O
State	O
has	O
led	O
outreach	O
to	O
expand	O
the	O
convention's	O
membership	O
,	O
and	O
today	O
there	O
are	O
172	O
States	O
Parties	O
.	O

It	O
acknowledges	O
that	O
the	O
aggregate	O
case	O
load	O
of	O
could	O
exceed	O
20,000	O
over	O
the	O
course	O
of	O
this	O
emergency	O
.	O

Several	O
have	O
been	O
evaluated	O
by	O
Public	B-Organization
Health	I-Organization
England	E-Organization
and	O
approved	O
for	O
use	O
in	O
.	O

The	O
first	O
of	O
these	O
strategies	O
was	O
developed	O
by	O
the	O
Science	B-Organization
and	I-Organization
Technology	I-Organization
Directorate	E-Organization
(	O
S&a	O
mp;T)	O
of	O
DHS	O
to	O
ensure	O
that	O
the	O
danger	O
of	O
suspicious	O
powders	O
could	O
be	O
effectively	O
assessed	O
,	O
(as	O
many	O
dangerous	O
biological	O
agents	O
such	O
as	O
anthrax	S-Pathogen
exist	O
as	O
a	O
white	O
powder)	O
.	O

Such	O
organisms	O
are	O
not	O
known	O
to	O
consistently	O
cause	O
disease	O
in	O
healthy	O
adult	O
humans	O
,	O
and	O
are	O
of	O
minimal	O
potential	O
hazard	O
to	O
laboratory	O
personnel	O
and	O
the	O
environment	O
.	O

Work	O
with	O
CDC	S-Organization
scientists	O
from	O
to	O
establish	O
a	O
peer-review	O
system	O
of	O
written	O
research	O
plans	O
to	O
foster	O
critical	O
thinking	O
on	O
how	O
to	O
optimize	O
workflows	O
in	O
protocols	O
and	O
minimize	O
error	O
.	O

Another	O
powerful	O
tool	O
developed	O
within	O
New	B-Location
York	I-Location
City	E-Location
for	O
use	O
in	O
countering	O
bioterrorism	O
is	O
the	O
development	O
of	O
the	O
New	B-Platform
York	I-Platform
City	I-Platform
Syndromic	I-Platform
Surveillance	I-Platform
System	E-Platform
.	O
This	O
system	O
is	O
essentially	O
a	O
way	O
of	O
tracking	O
disease	O
progression	O
throughout	O
New	B-Location
York	I-Location
City	E-Location
,	O
and	O
was	O
developed	O
by	O
the	O
New	B-Organization
York	I-Organization
City	I-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Mental	I-Organization
Hygiene	E-Organization
(	O
NYC	B-Organization
DOHMH	E-Organization
)	O
in	O
the	O
wake	O
of	O
the	O
9/11	O
attacks	O
.	O

Senators	O
were	O
told	O
the	O
post	O
office	O
would	O
be	O
temporarily	O
shut	O
down	O
"	O
to	O
make	O
sure	O
they	O
get	O
everything	O
squared	O
away,	O
"	O
McCaskill	S-Person
,	O
,	O
said	O
Tuesday	O
afternoon	O
.	O

Diagnostic	O
guidelines	O
released	O
by	O
Zhongnan	B-Organization
Hospital	I-Organization
of	I-Organization
Wuhan	I-Organization
University	E-Organization
suggested	O
methods	O
for	O
detecting	O
infections	O
based	O
upon	O
clinical	O
features	O
and	O
epidemiological	O
risk	O
.	O

Once	O
the	O
move	O
and	O
decontamination	O
of	O
Cummings	O
labs	O
are	O
complete	O
,	O
"	O
We'll	O
seriously	O
sit	O
down	O
to	O
retraining	O
,	O
retooling	O
,	O
rethinking	O
"	O
biosafety	O
procedures	O
,	O
Gilliam	S-Person
says	O
.	O

Eitzen	S-Person
Edward	B-Person
M	E-Person
.	O
Medical	O
Aspects	O
of	O
Chemical	O
and	O
Biological	O
Warfare:	O
Chapter	O
20	O
–	O
Use	O
of	O
Biological	O
Weapons	O
,	O
(PDF:	O
p.	O
6)	O
,	O
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
Maxwell-Gunter	O
Air	O
Force	O
Base	O
.	O

This	O
approach	O
allows	O
for	O
working	O
under	O
BSL2	S-Platform
conditions	O
in	O
parallel	O
with	O
laboratories	O
and	O
makes	O
maximum	O
use	O
of	O
teaching	O
resources	O
and	O
professional	O
staff	O
to	O
enhance	O
the	O
learning	O
experience	O
of	O
life‐science	O
undergraduates	O
.	O

Advocates	O
for	O
gun	O
control	O
oppose	O
the	O
amendment	O
and	O
have	O
tried	O
to	O
overturn	O
it	O
.	O

A	O
reduction	O
of	O
the	O
diarrhea	S-Phenotype
disease	O
burden	O
through	O
improved	O
infrastructure	O
would	O
result	O
in	O
large	O
decreases	O
in	O
the	O
number	O
of	O
diarrhea	S-Phenotype
cases	O
treated	O
with	O
antibiotics	O
.	O

Further	O
,	O
the	O
Africa	B-Organization
CDC	I-Organization
Central	I-Organization
Africa	I-Organization
Regional	I-Organization
Collaborating	I-Organization
Centre	E-Organization
pledged	O
to	O
fill	O
recognized	O
biosecurity	O
training	O
gaps	O
by	O
coordinating	O
a	O
regional	O
effort	O
,	O
through	O
partnerships	O
with	O
Africa	B-Organization
CDC's	I-Organization
Institute	I-Organization
for	I-Organization
Workforce	I-Organization
Development	E-Organization
,	O
Columbia	B-Organization
University	E-Organization
,	O
and	O
the	O
Association	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Laboratories	E-Organization
.	O
The	O
idea	O
is	O
to	O
adapt	O
existing	O
biosecurity	O
and	O
biosafety	O
training	O
curricula	O
to	O
the	O
Central	O
African	O
Member	O
States	O
.	O

More	O
than	O
40	O
experts	O
from	O
nine	O
Central	O
African	O
nations	O
met	O
in	O
October	O
at	O
an	O
event	O
hosted	O
by	O
the	O
Nuclear	B-Organization
Threat	I-Organization
Initiative	E-Organization
(	O
NTI	S-Organization
)	O
and	O
the	O
Africa	B-Organization
Centres	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
to	O
advance	O
biosafety	O
and	O
biosecurity	O
in	O
the	O
region	O
.	O

BARDA	S-Organization
is	O
sponsoring	O
the	O
development	O
of	O
two	O
test	O
systems	O
from	O
.	O
The	O
company's	O
first-generation	O
test	O
system	O
may	O
be	O
able	O
to	O
provide	O
results	O
using	O
bacteria	O
isolated	O
from	O
patient	O
samples	O
24	O
hours	O
faster	O
than	O
current	O
state-of-the-art	O
methods	O
and	O
may	O
be	O
able	O
to	O
provide	O
results	O
from	O
blood	O
samples	O
three	O
days	O
faster	O
than	O
the	O
current	O
methods	O
.	O

First	O
,	O
the	O
US	B-Organization
national	I-Organization
council	E-Organization
on	O
research	O
requested	O
full	O
and	O
open	O
access	O
to	O
publicly	O
funded	O
research	O
data	O
.	O

As	O
an	O
example	O
,	O
in	O
1910	O
,	O
Dr	O
.	O

This	O
may	O
ignore	O
deaths	O
of	O
people	O
who	O
die	O
without	O
testing	O
,	O
e.g.	O
at	O
home	O
or	O
in	O
nursing	O
homes	O
.	O

On	O
29	O
March	O
,	O
Urbani	S-Person
died	O
in	O
Bangkok	S-Location
of	O
a	O
.	O

Melioidosis	S-Pathogen
has	O
the	O
potential	O
to	O
be	O
developed	O
as	O
a	O
biological	O
weapon	O
,	O
hence	O
,	O
it	O
is	O
classed	O
as	O
a	O
category	O
B	O
.	O

The	O
N95	B-Equipment
mask	E-Equipment
disposable	B-Equipment
hat	E-Equipment
,	O
overshoes	S-Equipment
and	O
inner-layer	B-Equipment
gloves	E-Equipment
should	O
be	O
removed	O
in	O
the	O
shower	O
room	O
.	O

The	O
Chinese	B-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
published	O
the	O
"	O
"	O
in	O
2006	O
[8]	O
,	O
which	O
identified	O
harmful	O
levels	O
of	O
each	O
pathogenic	O
microorganism	O
and	O
the	O
laboratory	O
BSL	O
at	O
which	O
they	O
should	O
be	O
handled	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Thank	O
you	O
.	O

Many	O
dioceses	O
have	O
recommended	O
older	O
Christians	O
stay	O
home	O
rather	O
than	O
attend	O
Mass	O
on	O
Sundays.	O
(Services	O
are	O
available	O
via	O
radio	O
,	O
online	O
live	O
streaming	O
and	O
television.	O
)	O
With	O
the	O
Roman	B-Organization
Catholic	I-Organization
Diocese	E-Organization
of	O
Rome	O
closing	O
its	O
churches	O
and	O
chapels	O
and	O
St.	B-Location
Peter's	I-Location
Square	E-Location
emptied	O
of	O
,	O
other	O
religious	O
bodies	O
also	O
cancelled	O
services	O
and	O
limited	O
public	O
gatherings	O
in	O
churches	O
,	O
mosques	O
,	O
synagogues	O
,	O
temples	O
and	O
gurdwaras	O
.	O

Government	O
laboratories	O
were	O
more	O
likely	O
to	O
train	O
their	O
staff	O
when	O
compared	O
to	O
other	O
private	O
and	O
health	O
organization	O
laboratories	O
,	O
still	O
this	O
different	O
was	O
not	O
significant	O
(P=	O
0.145)	O
.	O

"	O
I	O
think	O
much	O
more	O
emphasis	O
needs	O
to	O
be	O
placed	O
on	O
developing	O
'pull'	O
incentives,	O
"	O
Gottlieb	S-Person
said.	O
"	O
I'm	O
deeply	O
concerned	O
that	O
without	O
stronger	O
'pull'	O
incentives	O
that	O
encourage	O
more	O
research	O
and	O
development	O
,	O
we'll	O
see	O
a	O
far	O
less	O
robust	O
pipeline	O
of	O
products	O
than	O
we	O
need	O
to	O
address	O
antimicrobial	O
resistance.	O
"	O

Central	O
authorities	O
confirmed	O
the	O
devastating	O
illness	O
in	O
a	O
pig	O
on	O
Friday	O
in	O
a	O
community	O
in	O
Shenyang	S-Location
Shenbei	B-Location
New	I-Location
Area	E-Location
,	O
before	O
killing	O
all	O
the	O
pigs	O
there	O
that	O
were	O
thought	O
to	O
be	O
affected	O
and	O
launching	O
tests	O
on	O
others	O
in	O
the	O
area	O
that	O
might	O
be	O
threatened	O
,	O
reported	O
.	O

On	O
31	O
October	O
,	O
it	O
was	O
reported	O
that	O
an	O
EVD	S-Disease
survivor	O
who	O
had	O
been	O
assisting	O
at	O
a	O
treatment	O
center	O
in	O
Beni	S-Location
had	O
been	O
reinfected	O
with	O
and	O
died	O
;	O
such	O
an	O
incident	O
is	O
unprecedented	O
.	O

According	O
to	O
the	O
WHO	S-Organization
the	O
use	O
of	O
masks	O
is	O
recommended	O
only	O
if	O
a	O
person	O
is	O
coughing	O
or	O
sneezing	O
or	O
when	O
one	O
is	O
taking	O
care	O
of	O
someone	O
with	O
a	O
suspected	O
infection	O
.	O

They	O
believe	O
this	O
because	O
larvae	O
were	O
detected	O
there	O
,	O
indicating	O
the	O
existence	O
of	O
a	O
breeding	O
population	O
.	O

We	O
cannot	O
rule	O
out	O
possible	O
exposure	O
of	O
the	O
one	O
laboratory	O
technician	O
who	O
worked	O
with	O
the	O
material	O
in	O
the	O
laboratory	O
.	O

Photons	O
of	O
higher	O
photon	O
energy	O
levels	O
are	O
typically	O
attenuated	O
less	O
.	O

On	O
6	O
March	O
,	O
President	O
Trump	S-Person
signed	O
the	O
,	O
which	O
provided	O
$8.	O
3 billion	O
in	O
emergency	O
funding	O
for	O
federal	O
agencies	O
to	O
respond	O
to	O
the	O
outbreak	O
.	O

The	O
Eurovision	O
Song	O
Contest	O
,	O
which	O
was	O
due	O
to	O
be	O
held	O
in	O
the	O
Netherlands	S-Location
in	O
May	O
,	O
was	O
postponed	O
until	O
2021	O
.	O

Enhance	O
international	O
partnerships	O
and	O
cooperation	O
on	O
regional	O
and	O
global	O
efforts	O
to	O
respond	O
to	O
AMR	O
.	O

At	O
the	O
same	O
time	O
,	O
other	O
,	O
more	O
benign	O
scenarios	O
are	O
being	O
circulated	O
in	O
an	O
attempt	O
to	O
explain	O
the	O
infestation's	O
quirks	O
.	O

The	O
authors	O
thank	O
all	O
the	O
present	O
and	O
previous	O
staff	O
and	O
members	O
of	O
the	O
FBD	S-Platform
network	O
and	O
Mr	O
.	O

The	O
study	O
found	O
that	O
laboratory	O
staff	O
did	O
not	O
wear	O
lab-coat	O
and	O
gloves	O
in	O
all	O
laboratory	O
procedures	O
as	O
the	O
percentage	O
was	O
very	O
low	O
.	O

In	O
May	O
2014	O
,	O
an	O
animal	O
caretaker	O
also	O
was	O
potentially	O
exposed	O
to	O
leptospira	S-Pathogen
when	O
the	O
person	O
removed	O
their	O
and	O
rubbed	O
an	O
eye	O
prior	O
to	O
washing	O
their	O
hands	O
.	O

Most	O
of	O
the	O
cases	O
were	O
linked	O
to	O
apartments	O
with	O
a	O
north-western	O
orientation	O
which	O
shared	O
the	O
same	O
sewage	O
pipe	O
.	O

GHSA	S-International_exchange_and_cooperation
funding	O
enables	O
CDC	S-Organization
to	O
partner	O
with	O
countries	O
to	O
stop	O
infectious	O
disease	O
outbreaks	O
where	O
they	O
occur.	O
is	O
thus	O
able	O
to	O
use	O
its	O
expertise	O
and	O
technology	O
to	O
support	O
countries	O
in	O
preventing	O
known	O
infectious	O
diseases	O
and	O
to	O
recognize	O
and	O
control	O
rare	O
,	O
highly	O
dangerous	O
and	O
newly	O
emerging	O
threats	O
.	O

For	O
example	O
,	O
less	O
than	O
5	O
months	O
after	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
declared	O
a	O
public	O
health	O
emergency	O
,	O
researchers	O
got	O
approval	O
to	O
enroll	O
patients	O
in	O
trials	O
for	O
a	O
DNA	O
vaccine	O
.	O

The	O
CDC	S-Organization
also	O
operates	O
a	O
number	O
of	O
notable	O
training	O
and	O
fellowship	O
programs	O
,	O
including	O
those	O
indicated	O
below	O
.	O

As	O
to	O
how	O
you	O
feel	O
about	O
this	O
happening	O
at	O
this	O
place	O
.	O

And	O
I	O
don't	O
think	O
it's	O
an	O
issue	O
across	O
all	O
CDC	S-Organization
laboratories	O
.	O

After	O
having	O
completed	O
the	O
42-day	O
time	O
period	O
,	O
Liberia	S-Location
was	O
declared	O
free	O
from	O
the	O
virus	O
on	O
14	O
January	O
2016	O
,	O
effectively	O
ending	O
the	O
outbreak	O
that	O
had	O
started	O
in	O
neighbouring	O
Guinea	S-Location
2	O
years	O
earlier	O
.	O

Escapes	O
occurred	O
in	O
a	O
variety	O
of	O
scenarios	O
,	O
including	O
mice	O
jumping	O
onto	O
researchers	O
and	O
running	O
under	O
freezers	S-Equipment
incident	O
records	O
show	O
.	O

Initially	O
,	O
biosafety	O
was	O
essentially	O
a	O
technical	O
term	O
related	O
to	O
the	O
risks	O
of	O
contamination	O
in	O
laboratories	O
or	O
food	O
industry	O
and	O
then	O
be	O
used	O
to	O
protect	O
biodiversity	O
against	O
the	O
spread	O
of	O
genetically	B-Technology
modified	I-Technology
organisms	E-Technology
()	O
into	O
the	O
environment	O
.	O

,	O
remdesivir	S-Drug
was	O
viewed	O
as	O
the	O
most	O
promising	O
treatment	O
for	O
COVID-19	S-Disease
,	O
and	O
was	O
included	O
among	O
four	O
treatments	O
under	O
evaluation	O
in	O
the	O
international	O
Solidarity	O
trial	O
and	O
European	O
Discovery	O
trial	O
.	O

A	O
CT	B-Technology
scan	E-Technology
or	O
computed	B-Technology
tomography	I-Technology
scan	E-Technology
(formerly	O
computerized	B-Technology
axial	I-Technology
tomography	I-Technology
scan	E-Technology
,	O
or	O
CAT	B-Technology
scan	E-Technology
)	O
is	O
a	O
medical	O
imaging	O
procedure	O
that	O
uses	O
computer-processed	O
combinations	O
of	O
many	O
X-ray	O
measurements	O
taken	O
from	O
different	O
angles	O
to	O
produce	O
cross-sectional	O
(tomographic)	O
images	O
(virtual	O
"	O
slices")	O
of	O
specific	O
areas	O
of	O
a	O
scanned	O
object	O
,	O
allowing	O
the	O
user	O
to	O
see	O
inside	O
the	O
object	O
without	O
cutting	O
.	O

In	O
FY	O
2017	O
,	O
a	O
total	O
of	O
42	O
proposals	O
were	O
submitted	O
to	O
the	O
BRAG	S-Document
program	O
requesting	O
a	O
total	O
of	O
$19,129,634	O
.	O

The	O
majority	O
of	O
adverse	O
events	O
were	O
deemed	O
to	O
be	O
nonserious	O
by	O
the	O
investigators.	O
"	O
Adverse	O
events	O
of	O
grade	O
3	O
or	O
higher	O
occurred	O
or	O
worsened	O
during	O
treatment	O
at	O
a	O
frequency	O
of	O
1.	O
1%	O
in	O
both	O
the	O
tecovirimat	S-Drug
group	O
and	O
the	O
placebo	S-Drug
group	O
and	O
included	O
headache	S-Disease
,	O
osteoarthritis	S-Disease
,	O
and	O
hidradenitis	S-Disease
,	O
"	O
study	O
authors	O
write	O
.	O

Using	O
the	O
technique	O
pioneered	O
by	O
Boyer	S-Person
and	O
Cohen	S-Person
,	O
scientists	O
at	O
the	O
pharmaceutical	B-Organization
company	I-Organization
Eli	I-Organization
Lilly	E-Organization
figured	O
out	O
how	O
to	O
insert	O
the	O
human	O
gene	O
for	O
producing	O
into	O
bacterial	O
cells	O
.	O

The	O
anticipated	O
global	O
eradication	O
of	O
wild	O
poliovirus	S-Pathogen
has	O
prompted	O
the	O
promulgation	O
of	O
new	O
biosafety	O
guidelines	O
for	O
future	O
laboratory	O
and	O
animal	O
work	O
.	O

On	O
22	O
January	O
it	O
was	O
reported	O
that	O
this	O
patient	O
was	O
responding	O
to	O
treatment	O
.	O

Here	O
weapons	O
are	O
being	O
tested	O
,	O
meaning	O
that	O
the	O
field	O
tests	O
with	O
biological	O
simulants	O
(bacteria)	O
also	O
fall	O
into	O
this	O
group	O
.	O

He	O
says	O
that	O
the	O
is	O
unlikely	O
to	O
affect	O
their	O
activities	O
because	O
the	O
actions	O
are	O
recommendations	O
,	O
not	O
requirements	O
.	O

The	O
fourth	O
case	O
,	O
another	O
traveler	O
to	O
Guangdong	S-Location
,	O
was	O
identified	O
in	O
Chiayi	S-Location
on	O
18	O
March	O
,	O
after	O
he	O
sought	O
treatment	O
at	O
a	O
hospital	O
the	O
previous	O
day	O
.	O

All	O
traffic	O
in	O
and	O
out	O
of	O
the	O
city	O
was	O
stopped	O
,	O
and	O
approximately	O
5.000	O
sq.meter	O
(54.000	O
sq.ft.	O
)	O
of	O
living	O
space	O
and	O
18	O
metric	O
tons	O
of	O
household	O
goods	O
were	O
incinerated	O
by	O
health	O
officials.	O
(2002)	O
,	O
Op.cit	O
.	O

The	O
initial	O
step	O
in	O
a	O
biosafety	O
program	O
is	O
the	O
assessment	O
of	O
risk	O
to	O
the	O
employee	O
.	O

Hydrogen	O
peroxide	O
is	O
used	O
to	O
help	O
eliminate	O
bacterial	O
spores	O
in	O
the	O
alcohol	O
;	O
it	O
is	O
"	O
not	O
an	O
active	O
substance	O
for	O
hand	O
antisepsis".	O
is	O
added	O
as	O
a	O
humectant	O
.	O

According	O
to	O
FRONTLINE	S-Organization
interview	O
with	O
Dr	O
.	O

In	O
1992	O
,	O
Russia	S-Location
allowed	O
a	O
U.S.	S-Location
team	O
to	O
visit	O
Sverdlovsk	S-Location
.	O
The	O
team's	O
investigation	O
turned	O
up	O
telltale	O
evidence	O
in	O
the	O
lungs	O
of	O
victims	O
that	O
many	O
died	O
from	O
inhalation	O
anthrax	S-Pathogen
,	O
likely	O
caused	O
by	O
the	O
accidental	O
release	O
of	O
aerosolized	O
anthrax	B-Pathogen
spores	E-Pathogen
from	O
the	O
military	O
base	O
.	O

According	O
to	O
WHO	S-Organization
statistics	O
(as	O
of	O
July	O
2010)	O
,	O
the	O
virus	O
had	O
killed	O
more	O
than	O
18,000	O
people	O
since	O
it	O
appeared	O
in	O
April	O
2009	O
;	O
however	O
,	O
they	O
state	O
that	O
the	O
total	O
mortality	O
(including	O
deaths	O
unconfirmed	O
or	O
unreported)	O
from	O
the	O
H1N1	S-Pathogen
strain	O
is	O
"	O
unquestionably	O
higher"	O
.	O

"	O
Creating	O
new	O
demands	O
for	O
plant	O
materials	O
will	O
never	O
solve	O
the	O
problem	O
of	O
climate	O
change	O
"	O
stated	O
Rachel	B-Person
Smolker	E-Person
from	O
.	O
"	O
Incredibly,	O
some	O
are	O
now	O
advocating	O
that	O
we	O
burn	O
massive	O
quantities	O
of	O
plant	O
material	O
to	O
make	O
charcoal	O
(aka	O
biochar)	O
and	O
bury	O
it	O
in	O
soils	O
.	O

Kanabrocki	S-Person
serves	O
as	O
Select	O
Agent	O
Responsible	O
Official	O
,	O
University	O
Biosafety	O
Officer	O
,	O
and	O
Director	O
of	O
the	O
Biosafety	O
programs	O
at	O
the	O
University	B-Organization
of	I-Organization
Chicago's	I-Organization
Ricketts	I-Organization
Regional	I-Organization
Biocontainment	I-Organization
Laboratory	E-Organization
and	O
the	O
Great	B-Organization
Lakes	I-Organization
Regional	I-Organization
Center	I-Organization
of	I-Organization
Excellence	I-Organization
for	I-Organization
Biodefense	I-Organization
and	I-Organization
Emerging	I-Organization
Infectious	I-Organization
Diseases	I-Organization
Research	E-Organization
.Dr	O
.	O

That	O
evolutionary	O
process	O
contains	O
natural	O
bottlenecks	O
that	O
could	O
be	O
exploited	O
to	O
impede	O
dangerous	O
mutations	O
.	O

It	O
was	O
found	O
that	O
472	O
nucleotides	O
from	O
the	O
3'	O
end	O
and	O
731	O
nucleotides	O
from	O
the	O
5'	O
end	O
are	O
sufficient	O
for	O
replication	O
of	O
a	O
viral	O
"	O
minigenome",	O
though	O
not	O
sufficient	O
for	O
infection	O
.	O

This	O
left-right	O
interchange	O
corresponds	O
to	O
the	O
view	O
that	O
physicians	O
generally	O
have	O
in	O
reality	O
when	O
positioned	O
in	O
front	O
of	O
patients	O
.	O

So	O
can	O
going	O
to	O
a	O
spin	O
class	O
or	O
taking	O
antidepressants	S-Drug

In	O
September	O
and	O
December	O
2014	O
,	O
the	O
released	O
revised	O
and	O
more	O
accurate	O
CFR	O
figures	O
of	O
70.8%	O
and	O
71%	O
respectively	O
,	O
using	O
data	O
from	O
patients	O
with	O
definitive	O
clinical	O
outcomes	O
.	O

Knock-in	O
mutations	O
,	O
facilitated	O
via	O
homology	B-Technology
directed	I-Technology
repair	E-Technology
(	O
HDR	S-Technology
)	O
,	O
is	O
the	O
traditional	O
pathway	O
of	O
targeted	O
.	O

In	O
light	O
of	O
the	O
likely	O
multiple	O
calls	O
for	O
a	O
stand-down	O
,	O
we	O
encourage	O
institutions	O
to	O
coordinate	O
the	O
activity	O
on	O
campus	O
to	O
avoid	O
miscommunications.	O
*Does	O
this	O
only	O
apply	O
to	O
Select	O
Agents*?	O
No	O
,	O
because	O
all	O
institutions	O
using	O
Select	O
Agents	O
and	O
Toxins	O
should	O
already	O
be	O
keeping	O
track	O
of	O
those	O
pathogens	O
.	O

Since	O
,	O
the	O
cost	O
of	O
DNA	O
sequencing	O
has	O
dropped	O
dramatically	O
,	O
making	O
it	O
a	O
simple	O
and	O
widespread	O
research	O
tool	O
.	O

In	O
1970	O
and	O
1972	O
,	O
Sand	B-Scientific_research_project
Fly	I-Scientific_research_project
Fever	E-Scientific_research_project
tests	O
were	O
performed	O
on	O
humans	O
according	O
to	O
a	O
declassified	O
US	B-Organization
Army	E-Organization
report	O
–	O
US	B-Organization
Army	E-Organization
Activities	O
in	O
the	O
US	S-Location
,	O
Biological	O
Warfare	O
Programs	O
,	O
1977	O
,	O
vol.II	O
,	O
p.	O
203	O
During	O
operation	O
Whitecoat	O
volunteers	O
were	O
exposed	O
to	O
bites	O
by	O
infected	O
sand	O
flies	O
.	O

On	O
4	O
August	O
,	O
the	O
WHO	S-Organization
indicated	O
that	O
the	O
current	O
situation	O
in	O
the	O
,	O
due	O
to	O
several	O
factors	O
,	O
warranted	O
a	O
"	O
high	O
risk	O
assessment	O
"	O
at	O
the	O
national	O
and	O
regional	O
level	O
for	O
public	O
health	O
.	O

The	O
testing	O
of	O
one	O
,	O
Pleospora	B-Pathogen
papaveracea	E-Pathogen
,	O
against	O
opium	O
poppy	O
,	O
was	O
conducted	O
in	O
Tashkent,	B-Location
Uzbekistan	E-Location
,	O
with	O
financial	O
and	O
scientific	O
support	O
from	O
the	O
USA	S-Location
,	O
and	O
was	O
completed	O
in	O
2001	O
.	O

On	O
14	O
September	O
2015	O
Sierra	B-Location
Leone	E-Location
National	B-Organization
Ebola	I-Organization
Response	I-Organization
Centre	E-Organization
confirmed	O
the	O
death	O
of	O
a	O
16-year-old	O
in	O
a	O
village	O
in	O
the	O
Bombali	B-Location
District	E-Location
.	O
It	O
is	O
suspected	O
that	O
she	O
contracted	O
the	O
disease	O
from	O
the	O
semen	O
of	O
an	O
Ebola	S-Disease
survivor	O
who	O
had	O
been	O
discharged	O
in	O
March	O
2015	O
.	O

Insulin	S-Drug
doesn't	O
cost	O
much	O
to	O
produce	O
,	O
but	O
as	O
a	O
society	O
we've	O
allowed	O
companies	O
to	O
jack	O
up	O
the	O
price	O
so	O
high	O
that	O
many	O
people	O
with	O
are	O
now	O
skipping	O
lifesaving	O
doses	O
.	O

These	O
techniques	O
depend	O
on	O
the	O
availability	O
of	O
web	O
services	O
,	O
which	O
are	O
rapidly	O
spreading	O
and	O
can	O
be	O
retrieved	O
from	O
collections	O
like	O
.	O

In	O
March	O
2017	O
,	O
the	O
European	B-Organization
Patent	I-Organization
Office	E-Organization
(	O
EPO	S-Organization
)	O
announced	O
its	O
intention	O
to	O
allow	O
broad	O
claims	O
for	O
editing	O
all	O
kinds	O
of	O
cells	O
to	O
Max-Planck	B-Organization
Institute	I-Organization
in	I-Organization
Berlin	E-Organization
,	O
University	B-Organization
of	I-Organization
California	E-Organization
,	O
and	O
University	B-Organization
of	I-Organization
Vienna	E-Organization
,	O
and	O
in	O
August	O
2017	O
,	O
the	O
EPO	S-Organization
announced	O
its	O
intention	O
to	O
allow	O
CRISPR	S-Technology
claims	O
in	O
a	O
patent	O
application	O
that	O
had	O
filed	O
.	O

TOM	B-Person
FRIEDEN	E-Person
For	O
the	O
nonpathogenic	O
avian	O
influenza	O
was	O
h7	O
-	O
sorry	O
,	O
h9n2?	O
H9n2	S-Pathogen
,	O
sorry	O
.	O

Through	O
8August	O
2009	O
,	O
the	O
CDC	S-Organization
had	O
received	O
36	O
reports	O
of	O
paediatric	O
deaths	O
with	O
associated	O
influenza	O
symptoms	O
and	O
laboratory-confirmed	O
pandemic	O
H1N1	S-Pathogen
from	O
state	O
and	O
local	O
health	O
authorities	O
within	O
the	O
United	B-Location
States	E-Location
,	O
with	O
22	O
of	O
these	O
children	O
having	O
neurodevelopmental	O
conditions	O
such	O
as	O
cerebral	B-Disease
palsy	E-Disease
,	O
muscular	B-Disease
dystrophy	E-Disease
,	O
or	O
developmental	B-Disease
delays	E-Disease
.	O
"	O
Children	O
with	O
nerve	O
and	O
muscle	O
problems	O
may	O
be	O
at	O
especially	O
high	O
risk	O
for	O
complications	O
because	O
they	O
cannot	O
cough	O
hard	O
enough	O
to	O
clear	O
their	O
airways"	O
.	O

This	O
study	O
involved	O
a	O
total	O
of	O
272	O
patients	O
,	O
which	O
represents	O
approximately	O
25%	O
of	O
US	O
hospitalized	O
patients	O
with	O
lab-confirmed	O
H1N1	S-Pathogen
whose	O
cases	O
were	O
reported	O
to	O
the	O
US	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
()	O
from	O
1May	O
to	O
9June	O
2009	O
.	O

This	O
review	O
examines	O
the	O
history	O
,	O
the	O
causes	O
,	O
and	O
the	O
methods	O
for	O
prevention	O
of	O
laboratory-associated	O
infections	O
.	O

Yeltsin	S-Person
acknowledged	O
the	O
existence	O
of	O
an	O
illegal	O
BW	O
program	O
in	O
the	O
former	O
Soviet	B-Organization
Union	E-Organization
and	O
ordered	O
it	O
to	O
be	O
dissolved	O
.	O

,	O
also	O
referred	O
to	O
as	O
Detachment	B-Organization
731	E-Organization
the	O
731	B-Organization
Regiment	E-Organization
,	O
Manshu	B-Organization
Detachment	I-Organization
731	E-Organization
,	O
The	O
Kamo	B-Organization
Detachment	E-Organization
,	O
Ishii	B-Organization
Unit	E-Organization
,	O
Ishii	B-Organization
Detachment	E-Organization
or	O
the	O
Ishii	B-Organization
Company	E-Organization
,	O
was	O
a	O
covert	O
biological	O
and	O
chemical	O
warfare	O
research	O
and	O
development	O
unit	O
of	O
the	O
Imperial	B-Organization
Japanese	I-Organization
Army	E-Organization
that	O
undertook	O
lethal	O
human	O
experimentation	O
during	O
the	O
Second	O
Sino-Japanese	O
War	O
(1937–1945)	O
of	O
World	O
War	O
II	O
.	O

Accessed	O
November	O
18	O
,	O
2008	O
.	O

Some	O
Chinese	O
students	O
at	O
American	O
universities	O
sent	O
aid	O
,	O
including	O
50,000	O
N95	B-Equipment
masks	E-Equipment
on	O
30	O
January	O
.	O

CT	S-Technology
produces	O
data	O
that	O
can	O
be	O
manipulated	O
in	O
order	O
to	O
demonstrate	O
various	O
bodily	O
structures	O
based	O
on	O
their	O
ability	O
to	O
absorb	O
the	O
X-ray	O
beam	O
.	O

The	O
war	O
also	O
enabled	O
the	O
virus	O
to	O
spread	O
and	O
diffuse	O
.	O

The	O
European	B-Organization
Parliament	I-Organization
and	I-Organization
the	I-Organization
Council	E-Organization
have	O
published	O
in	O
2000	O
on	O
the	O
protection	O
of	O
workers	O
from	O
risks	O
related	O
to	O
exposure	O
to	O
biological	O
agents	O
at	O
work	O
.	O

Multiple	O
donor	O
agencies	O
from	O
around	O
the	O
globe	O
either	O
funded	O
or	O
collaborated	O
with	O
the	O
biosafety	O
initiatives	O
in	O
the	O
region	O
.	O

On	O
23	O
August	O
,	O
he	O
sought	O
medical	O
care	O
for	O
symptoms	O
including	O
diarrhoea	S-Phenotype
,	O
and	O
vomiting	S-Phenotype
plus	O
signs	B-Phenotype
of	I-Phenotype
fever	E-Phenotype
.	O
He	O
received	O
treatment	O
for	O
but	O
did	O
not	O
improve	O
and	O
left	O
the	O
facility	O
.	O

In	O
study	O
conducted	O
in	O
laboratories	O
across	O
Canada	S-Location
to	O
determine	O
rates	O
of	O
compliance	O
with	O
recommended	O
safety	O
precautions	O
against	O
exposure	O
to	O
blood	O
borne	O
pathogens	O
.	O

"	O
What	O
the	O
CDC	S-Organization
incidents	O
showed	O
us	O
...	O
is	O
that	O
the	O
very	O
best	O
labs	O
are	O
not	O
perfectly	O
safe,	O
"	O
says	O
Marc	B-Person
Lipsitch	E-Person
,	O
a	O
professor	O
of	O
epidemiology.	O
"	O
If	O
it	O
can	O
happen	O
there	O
,	O
it	O
certainly	O
can	O
happen	O
anywhere.	O
"	O

Additionally	O
,	O
the	O
bill	O
would	O
direct	O
the	O
HHS	B-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
to	O
convene	O
a	O
meeting	O
within	O
a	O
year	O
of	O
the	O
measure's	O
enactment	O
to	O
determine	O
"	O
how	O
genomic	O
engineering	O
can	O
be	O
used	O
both	O
in	O
countermeasures	O
and	O
in	O
national	O
security	O
threats,	O
"	O
she	O
said	O
.	O

The	O
microscopic	O
spores	O
could	O
be	O
put	O
into	O
powders	O
,	O
sprays	O
,	O
food	O
,	O
and	O
water	O
.	O

The	O
key	O
questions	O
for	O
researchers	O
to	O
address	O
are	O
therefore:	O
These	O
questions	O
are	O
priorities	O
for	O
the	O
prevention	O
of	O
antibiotic	O
resistance	O
development	O
worldwide	O
;	O
in	O
order	O
to	O
support	O
the	O
research	O
necessary	O
to	O
track	O
new	O
threats	O
on	O
a	O
global	O
scale	O
,	O
international	O
funding	O
is	O
indispensable	O
.	O

The	O
clerk	O
countered	O
this	O
attempt	O
by	O
enforcing	O
a	O
regulation	O
that	O
required	O
all	O
new	O
voters	O
to	O
submit	O
their	O
qualifications	O
when	O
registering	O
to	O
vote	O
.	O

The	O
pandemic	O
affected	O
everyone	O
.	O

But	O
some	O
of	O
the	O
memo	O
is	O
incorrect	O
,	O
the	O
source	O
says	O
.	O

Although	O
publicly	O
silent	O
on	O
the	O
issue	O
at	O
the	O
Tokyo	O
Trials	O
,	O
the	O
Soviet	B-Organization
Union	E-Organization
pursued	O
the	O
case	O
and	O
prosecuted	O
twelve	O
top	O
military	O
leaders	O
and	O
scientists	O
from	O
Unit	B-Person
731	E-Person
and	O
its	O
affiliated	O
biological-war	O
prisons	O
Unit	B-Person
1644	E-Person
in	O
Nanjing	S-Location
,	O
and	O
Unit	B-Person
100	E-Person
in	O
Changchun	S-Location
,	O
in	O
the	O
Khabarovsk	O
War	O
Crime	O
Trials	O
.	O

Other	O
anthrax	O
vaccines	O
also	O
exist	O
.	O

The	O
Japanese	O
army	O
never	O
succeeded	O
,	O
though	O
,	O
in	O
producing	O
advanced	O
biological	O
munitions	O
,	O
such	O
as	O
pathogen-laced	O
bombs	O
.	O

I	O
can	O
later	O
go	O
into	O
some	O
details	O
about	O
this	O
,	O
but	O
as	O
I	O
think	O
about	O
it	O
,	O
what	O
we	O
learned	O
made	O
us	O
more	O
reassured	O
about	O
the	O
likelihood	O
that	O
people	O
were	O
actually	O
exposed	O
,	O
which	O
now	O
looks	O
very	O
,	O
very	O
unlikely	O
.	O

The	O
same	O
year	O
,	O
workers	O
at	O
the	O
Norfolk	B-Location
Supply	I-Location
Center	E-Location
in	O
Norfolk	S-Location
,	O
Virginia	S-Location
,	O
were	O
unknowingly	O
exposed	O
to	O
Aspergillus	B-Pathogen
fumigatus	I-Pathogen
spores	E-Pathogen
.	O
Another	O
case	O
of	O
human	O
research	O
was	O
the	O
biodefense	O
medical	O
research	O
program	O
,	O
.	O

In	O
addition	O
,	O
resources	O
for	O
more	O
information	O
are	O
provided	O
in	O
the	O
Literature	O
Cited	O
and	O
Key	O
References	O
sections	O
and	O
in	O
URLs	O
given	O
within	O
the	O
text	O
,	O
as	O
well	O
as	O
the	O
Internet	O
Resources	O
section.Curr.Protoc.Microbiol.13:1A.1.1‐1A.1.14.	O
©	O
2009	O
by	O
Inc	O
.	O

As	O
of	O
17	O
May	O
,	O
the	O
U.S.	S-Location
,	O
which	O
accounts	O
for	O
about	O
4.	O
25%	O
of	O
the	O
world's	O
population	O
,	O
had	O
about	O
29%	O
of	O
the	O
confirmed	O
deaths	O
.	O

Many	O
areas	O
are	O
still	O
in	O
need	O
of	O
clarification	O
and	O
elaboration	O
.	O

It	O
wasn't	O
until	O
thirteen	O
years	O
later	O
-	O
1992-	O
that	O
President	O
Boris	B-Person
Yeltsin	E-Person
admitted	O
,	O
without	O
going	O
into	O
details	O
,	O
that	O
the	O
anthrax	S-Pathogen
outbreak	O
was	O
the	O
result	O
of	O
military	O
activity	O
at	O
the	O
facility	O
.	O

He	O
explained	O
that	O
HLI	S-Organization
has	O
new	O
and	O
advanced	O
techniques	O
for	O
early	O
detection	O
.	O

The	O
study	O
found	O
that	O
laboratory	O
personnel	O
are	O
highly	O
exposure	O
to	O
body	O
fluids	O
and	O
poor	O
rate	O
compliance	O
with	O
personal	O
protective	O
behaviors	O
,	O
this	O
finding	O
is	O
similar	O
to	O
our	O
study	O
results	O
.	O

They	O
also	O
urged	O
schools	O
to	O
suspend	O
rules	O
,	O
such	O
as	O
penalties	O
for	O
late	O
papers	O
or	O
missed	O
classes	O
or	O
requirements	O
for	O
a	O
doctor's	O
note	O
,	O
to	O
enforce	O
"	O
self-isolation"	O
and	O
prevent	O
students	O
from	O
venturing	O
out	O
while	O
ill	O
;	O
schools	O
were	O
advised	O
to	O
set	O
aside	O
a	O
room	O
for	O
people	O
developing	O
flu-like	O
symptoms	O
while	O
they	O
waited	O
to	O
go	O
home	O
and	O
to	O
have	O
ill	O
students	O
or	O
staff	O
and	O
those	O
caring	O
for	O
them	O
use	O
.	O

In	O
the	O
United	B-Location
States	E-Location
drug	O
companies	O
and	O
the	O
administration	O
of	O
President	O
Barack	B-Person
Obama	E-Person
had	O
been	O
proposing	O
changing	O
the	O
standards	O
by	O
which	O
the	O
approves	O
antibiotics	O
targeted	O
at	O
resistant	O
organisms	O
.	O

William	B-Person
Close	E-Person
1995	O
Ebola	S-Pathogen
:	O
A	O
Documentary	O
Novel	O
of	O
Its	O
First	O
Explosion	O
and	O
2002	O
Ebola	S-Pathogen
:	O
Through	O
the	O
Eyes	O
of	O
the	O
People	O
focused	O
on	O
individuals'	O
reactions	O
to	O
the	O
1976	B-Incident
Ebola	I-Incident
outbreak	E-Incident
in	O
.	O
At	O
Google	O
Books	O
.	O

Epidemics	O
ravaged	O
cities	O
,	O
particularly	O
children.	O
Plagues	B-Disease
easily	O
spread	O
by	O
lice	O
,	O
unsanitary	O
drinking	O
water	O
,	O
armies	O
,	O
or	O
by	O
poor	O
sanitation	O
.	O

The	O
act	O
regulates	O
any	O
genetically	O
modified	O
organism	O
that	O
utilizes	O
the	O
genome	O
of	O
a	O
predefined	O
"	O
plant	O
pest	O
"	O
or	O
any	O
plant	O
not	O
previously	O
categorized	O
.	O

The	O
synthetic	B-Pathogen
M.	I-Pathogen
mycoides	I-Pathogen
organism	E-Pathogen
has	O
14	O
genes	O
deleted	O
or	O
inactivated	O
,	O
including	O
genes	O
that	O
are	O
predicted	O
to	O
be	O
critical	O
to	O
virulence	O
.	O

As	O
engineers	O
began	O
to	O
see	O
the	O
potential	O
in	O
biology	O
,	O
their	O
desire	O
to	O
design	O
things	O
from	O
scratch	O
and	O
build	O
complex	O
devices	O
would	O
revolutionize	O
the	O
field	O
once	O
more	O
.	O

All	O
comments	O
must	O
be	O
submitted	O
electronically	O
on	O
the	O
submission	O
website	O
.	O

The	O
use	O
of	O
these	O
items	O
is	O
appropriate	O
even	O
during	O
research	O
of	O
minimal	O
biosafety	O
concern	O
.	O

Biohackers	O
congregate	O
in	O
dedicated	O
online	O
networks	O
,	O
in	O
Sl	O
ack	B-Platform
a	E-Platform
Wh	O
atsApp	B-Platform
g	E-Platform
roups	O
-	O
Wefor	O
example	O
,	O
is	O
for	O
intermittent	O
fasters	O
.	O

G.P.O.	O
,	O
2012	O
.	O

The	O
death	O
toll	O
in	O
the	O
United	B-Location
Kingdom	E-Location
was	O
nearly	O
29,427	O
for	O
those	O
tested	O
positive	O
for	O
the	O
virus	O
.	O

Their	O
labs	O
will	O
inventory	O
their	O
collections	O
of	O
infectious	O
agents	O
and	O
toxins	O
and	O
review	O
biosafety	O
protocols	O
and	O
training	O
procedures.	O
's	O
grantee	O
institutions	O
"	O
are	O
encouraged	O
"	O
to	O
do	O
the	O
same	O
.	O

In	O
February	O
2018	O
,	O
a	O
CNN	S-Organization
employee	O
discovered	O
on	O
an	O
airplane	O
a	O
"	O
sensitive,	O
top-secret	O
document	O
in	O
the	O
seatback	O
pouch	O
explaining	O
how	O
the	O
would	O
respond	O
to	O
a	O
bioterrorism	O
attack	O
at	O
the	O
Super	O
Bowl.	O
"	O

He	O
was	O
flown	O
privately	O
by	O
air	O
ambulance	O
from	O
Doha	S-Location
to	O
London	S-Location
on	O
11	O
September	O
where	O
he	O
was	O
admitted	O
to	O
St	B-Organization
Mary's	I-Organization
Hospital	E-Organization
and	O
later	O
was	O
transferred	O
to	O
St	B-Organization
Thomas's	I-Organization
Hospital	E-Organization
.	O
As	O
a	O
result	O
of	O
Dr	O
Zaki	S-Person
's	O
post	O
on	O
Pro-MED	S-Organization
,	O
the	O
novel	O
coronavirus	O
was	O
quickly	O
identified	O
.	O

On	O
21	O
February	O
,	O
Liu	S-Person
and	O
his	O
wife	O
checked	O
into	O
room	O
911	O
on	O
the	O
ninth	O
floor	O
of	O
the	O
Metropole	B-Organization
Hotel	E-Organization
.	O
Despite	O
feeling	O
ill	O
he	O
visited	O
with	O
his	O
family	O
and	O
they	O
traveled	O
around	O
Hong	B-Location
Kong	E-Location
.	O
By	O
the	O
morning	O
of	O
22	O
February	O
,	O
he	O
knew	O
he	O
was	O
very	O
sick	O
and	O
walked	O
to	O
nearby	O
to	O
seek	O
treatment	O
.	O

The	O
would	O
be	O
scalable	O
to	O
cover	O
a	O
major	O
metropolitan	O
city	O
and	O
its	O
surrounding	O
region	O
.	O

All	O
these	O
diseases	O
are	O
notifiable	O
to	O
the	O
.	O

Successfully	O
developing	O
scalable	O
,	O
long-range	O
chemical	O
sensors	O
would	O
help	O
enable	O
interdiction	O
of	O
improvised	O
chemical	O
and	O
explosive	O
threats	O
or	O
their	O
constituent	O
materials	O
before	O
an	O
attack	O
occurs	O
.	O

What	O
are	O
the	O
next	O
steps	O
for	O
this	O
research	O
at	O
JCVI	S-Organization

On	O
28	O
January	O
,	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	I-Organization
(CDC	E-Organization
announced	O
they	O
had	O
developed	O
their	O
own	O
testing	O
kit	O
.	O

One	O
letter	O
was	O
mailed	O
to	O
the	O
White	B-Organization
House	E-Organization
and	O
intercepted	O
at	O
a	O
processing	O
facility	O
;	O
another	O
was	O
discovered	O
with	O
no	O
address	O
in	O
South	B-Location
Carolina	E-Location
.	O
A	O
February	B-Incident
2004	I-Incident
ricin	I-Incident
incident	E-Incident
at	O
the	O
Dirksen	B-Location
Senate	I-Location
Office	I-Location
Building	E-Location
was	O
initially	O
connected	O
to	O
the	O
as	O
well	O
.	O

In	O
particular	O
,	O
it	O
is	O
a	O
warning	O
sign	O
if	O
a	O
child	O
seems	O
to	O
be	O
getting	O
better	O
and	O
then	O
relapses	O
with	O
high	B-Phenotype
fever	E-Phenotype
as	O
this	O
relapse	O
may	O
be	O
.	O

But	O
we	O
have	O
to	O
do	O
it	O
safely	O
.	O

In	O
this	O
day	O
and	O
age	O
current	O
antimicrobial	O
resistance	O
leads	O
to	O
longer	O
hospital	O
stays	O
,	O
higher	O
medical	O
costs	O
,	O
and	O
increased	O
mortality	O
.	O

You	O
don't	O
need	O
nootropics	S-Drug
to	O
biohack	O
.	O

The	O
FBD	B-Document
QA	I-Document
manual	E-Document
has	O
gradually	O
been	O
revised	O
and	O
now	O
covers	O
network	O
organization	O
,	O
project	O
management	O
,	O
implementation	O
planning	O
,	O
communicating	O
project	O
results	O
,	O
recommendations	O
on	O
quality	O
assurance	O
of	O
diagnostics	O
at	O
BSL-3	S-Platform
laboratories	O
,	O
and	O
protocols	O
for	O
the	O
validation	O
of	O
diagnostic	B-Equipment
PCR	E-Equipment
methods	O
.	O

US	S-Location
pork	O
exports	O
to	O
are	O
currently	O
facing	O
tariffs	O
of	O
62%	O
because	O
of	O
the	O
continuing	O
trade	O
dispute	O
between	O
both	O
countries	O
.	O

After	O
48	O
hr	O
,	O
Vero	O
cells	O
were	O
fixed	O
using	O
100 μl	O
3.	O
8%	O
formaldehyde	O
in	O
PBS	O
,	O
for	O
10	O
min	O
at	O
room	O
temperature	O
,	O
washed	O
three	O
times	O
with	O
1×	O
PBS	O
and	O
blocked	O
for	O
30	O
min	O
at	O
room	O
temperature	O
with	O
100 μl	O
1%	O
BSA	O
in	O
PBS	O
(blocking	O
solution)	O
.	O

The	O
new	O
agency	O
was	O
a	O
branch	O
of	O
the	O
U.S.	B-Organization
Public	I-Organization
Health	I-Organization
Service	E-Organization
was	O
chosen	O
as	O
the	O
location	O
because	O
malaria	O
was	O
endemic	O
in	O
the	O
Southern	O
United	O
States	O
.	O

These	O
samples	O
had	O
appeared	O
to	O
be	O
negative	O
for	O
anthrax	S-Pathogen
at	O
the	O
time	O
the	O
samples	O
were	O
distributed	O
to	O
the	O
other	O
laboratories	O
.	O

Of	O
these	O
41%	O
died	O
,	O
according	O
to	O
one	O
study	O
in	O
the	O
.	O

The	O
authors	O
went	O
on	O
to	O
state	O
that	O
social	O
vulnerability	O
has	O
multiple	O
factors	O
and	O
proposed	O
a	O
classification	O
based	O
on	O
multiple	O
variables	O
instead	O
of	O
single	O
indicators	O
such	O
as	O
food	O
insecurity	O
or	O
lack	O
of	O
hospitals	O
,	O
which	O
were	O
problems	O
faced	O
by	O
rural	O
Liberians	O
.	O

Developed	O
nations	O
,	O
and	O
even	O
impoverished	O
ones	O
,	O
have	O
the	O
resources	O
and	O
know-how	O
to	O
produce	O
bioweapons	O
.	O

Rapid	O
progress	O
in	O
the	O
application	O
of	O
biotechnological	O
methodologies	O
and	O
development	O
of	O
genetically	O
modified	O
crops	O
in	O
Iran	S-Location
necessitated	O
intensive	O
efforts	O
to	O
establish	O
proper	O
organizations	O
and	O
prepare	O
required	O
rules	O
and	O
regulations	O
at	O
the	O
national	O
level	O
to	O
ensure	O
safe	O
application	O
of	O
biotechnology	O
in	O
all	O
pertinent	O
aspects	O
.	O

The	O
implications	O
for	O
the	O
use	O
of	O
select	O
agents	O
,	O
including	O
for	O
CDC	S-Organization
regulatory	O
functions	O
through	O
's	O
Division	O
of	O
Select	O
Agents	O
and	O
Toxins	O
will	O
be	O
carefully	O
reviewed	O
to	O
incorporate	O
any	O
lessons	O
learned	O
.	O

Now	O
,	O
though	O
,	O
some	O
agencies	O
seem	O
to	O
think	O
they	O
ought	O
to	O
take	O
action	O
.	O

Certain	O
characteristics	O
of	O
the	O
1989	O
medfly	O
infestation	O
led	O
investigators	O
to	O
the	O
conclusion	O
that	O
someone	O
was	O
responsible	O
for	O
deliberately	O
releasing	O
medflies	O
.	O

Many	O
newspaper	O
agencies	O
removed	O
their	O
online	O
paywalls	O
for	O
some	O
or	O
all	O
of	O
their	O
coronavirus-related	O
articles	O
and	O
posts	O
,	O
while	O
scientific	O
publishers	O
made	O
scientific	O
papers	O
related	O
to	O
the	O
outbreak	O
available	O
with	O
open	O
access	O
.	O

Among	O
the	O
points	O
made	O
,	O
it	O
seems	O
clear	O
that	O
although	O
the	O
prevalence	O
of	O
transmission	O
is	O
declining	O
,	O
there	O
is	O
still	O
a	O
need	O
for	O
resources	O
,	O
health	O
education	O
,	O
and	O
global	O
efforts	O
to	O
end	O
this	O
epidemic	O
.	O

Fourteen	O
companion	O
dogs	O
and	O
one	O
cat	O
that	O
had	O
been	O
infected	O
with	O
carbapenem-resistant	B-Pathogen
E.	I-Pathogen
coli	E-Pathogen
(	O
CRE	S-Pathogen
)	O
were	O
treated	O
at	O
the	O
teaching	O
hospital.	O
is	O
a	O
family	O
of	O
bacteria	O
that	O
can	O
cause	O
difficult-to-treat	O
infections	O
.	O

On	O
Vozrozhdeniya	B-Location
Island	E-Location
in	O
the	O
Aral	B-Location
Sea	E-Location
,	O
the	O
strongest	O
recipes	O
of	O
smallpox	S-Pathogen
were	O
tested	O
.	O

By	O
September	O
,	O
treatment	O
for	O
Ebola	S-Disease
patients	O
had	O
become	O
unavailable	O
in	O
some	O
areas	O
.	O

Cas3	S-Technology
is	O
more	O
destructive	O
than	O
the	O
better	O
known	O
.	O

WHO	S-Organization
has	O
been	O
moving	O
toward	O
acceptance	O
and	O
integration	O
of	O
traditional	O
medicine	O
and	O
traditional	O
Chinese	O
medicine	O
.	O

The	O
aid	O
included	O
establishment	O
of	O
a	O
fixed	O
Biosafety	B-Platform
Level	I-Platform
3	E-Platform
(	O
BSL-3	S-Platform
)	O
laboratory	O
in	O
Freetown	S-Location
,	O
the	O
capital	O
city	O
of	O
Sierra	B-Location
Leone	E-Location
.	O
The	O
project	O
began	O
on	O
20	O
November	O
2014	O
and	O
construction	O
was	O
completed	O
on	O
31	O
January	O
2015	O
.	O

One	O
example	O
occurred	O
in	O
2009	O
during	O
the	O
first	O
herd	O
in	O
27	O
years	O
.	O

Medvedik	S-Person
calls	O
that	O
the	O
"	O
low-hanging	O
fruit.	O
"	O
He	O
spoke	O
excitedly	O
about	O
the	O
possibility	O
of	O
creating	O
a	O
supplement	O
from	O
a	O
plant	O
compound	O
called	O
fisetin	O
,	O
noting	O
that	O
a	O
recent	O
(small)	O
trial	O
suggests	O
high	O
concentrations	O
of	O
fisetin	O
can	O
clear	O
out	O
senescent	O
cells	O
in	O
humans	O
-	O
cells	O
that	O
have	O
stopped	O
dividing	O
and	O
that	O
contribute	O
to	O
aging	O
.	O

In	O
March	O
2014	O
,	O
the	O
Senegal	B-Organization
Ministry	I-Organization
of	I-Organization
Interior	E-Organization
closed	O
its	O
southern	O
border	O
with	O
Guinea	S-Location
,	O
but	O
on	O
29	O
August	O
,	O
the	O
health	O
minister	O
announced	O
the	O
country's	O
first	O
case	O
–	O
a	O
university	O
student	O
from	O
Guinea	S-Location
who	O
was	O
being	O
treated	O
in	O
a	O
Dakar	B-Organization
hospital	E-Organization
.	O
The	O
patient	O
was	O
a	O
native	O
of	O
Guinea	S-Location
who	O
had	O
travelled	O
to	O
Dakar	S-Location
,	O
arriving	O
on	O
20	O
August	O
.	O

Ricin	S-Pathogen
is	O
a	O
highly	O
toxic	O
substance	O
derived	O
from	O
castor	O
beans	O
.	O

Some	O
18	O
million	O
kilos	O
of	O
ground	O
turkey	O
product	O
have	O
been	O
recalled	O
to	O
date	O
.	O

For	O
the	O
RNA-Dependent	O
RNA	O
Polymerase	O
of	O
MERS-CoV	S-Pathogen
,	O
SARS-CoV-1	S-Pathogen
,	O
and	O
SARS-CoV-2	S-Pathogen
arrest	O
of	O
RNA	O
synthesis	O
occurs	O
after	O
incorporation	O
of	O
three	O
additional	O
nucleotides	O
.	O

Using	O
three	O
or	O
more	O
drugs	O
together	O
,	O
termed	O
combination	O
therapy	O
,	O
has	O
helped	O
to	O
control	O
this	O
problem	O
,	O
but	O
new	O
drugs	O
are	O
needed	O
because	O
of	O
the	O
continuing	O
emergence	O
of	O
drug-resistant	O
strains	O
.	O

Sputum	O
and	O
saliva	O
carry	O
large	O
amounts	O
of	O
virus	O
.	O

Traps	O
caught	O
14	O
rats	O
before	O
the	O
nest	O
was	O
dismantled	O
and	O
disinfected	O
with	O
bleach	O
.	O

for	O
required	O
precautions	O
.	O

"	O
If	O
we	O
are	O
able	O
to	O
predict	O
how	O
viruses	O
might	O
mutate	O
and	O
spread	O
,	O
and	O
take	O
steps	O
to	O
prevent	O
those	O
mutations	O
from	O
impacting	O
humans	O
,	O
then	O
we'll	O
vastly	O
diminish	O
the	O
possibility	O
of	O
future	O
viral	O
pandemics,	O
"	O
said	O
Gimlett	S-Person

A	O
β-lactam	O
was	O
given	O
to	O
5/6	O
animal	O
s,	B-Drug
azithromy	E-Drug
to	O
5/6	O
animal	O
s,	B-Drug
metronidaz	E-Drug
ole	O
to	O
4/6	O
animals	O
,	O
acin	O
to	O
4/6	O
animals	O
(Table)	O
.	O

&quot;I	O
don't	O
think	O
we've	O
done	O
anywhere	O
near	O
the	O
amount	O
of	O
work	O
necessary	O
to	O
create	O
the	O
medical	O
understanding	O
,	O
the	O
psychological	O
understanding	O
,	O
and	O
maybe	O
even	O
the	O
genetic	O
understanding	O
of	O
what	O
happens	O
to	O
people	O
who	O
are	O
exposed,&quot	O
;	O
said	O
Blue	O
Ribbon	O
Study	O
Pan	O
el	B-Person
member	I-Person
T	E-Person
Daschle	O
,	O
a	O
former	O
majority	O
leadU.S.Senate	O
.	O

It	O
can	O
also	O
cause	O
infertility	O
in	O
animals	O
and	O
humans	O
.	O

In	O
addition	O
,	O
the	O
lab	O
added	O
a	O
clear	O
hose	O
cover	O
to	O
the	O
tubes	O
for	O
extra	O
protection	O
,	O
and	O
latches	O
on	O
50	O
poultry	O
cages	O
were	O
replaced	O
after	O
the	O
lab	O
looked	O
for	O
possible	O
snag	O
hazards	O
.	O

As	O
the	O
alveolar	O
disease	O
progresses	O
,	O
respiratory	O
failure	O
might	O
develop	O
and	O
death	O
may	O
follow	O
.	O

An	O
act	O
of	O
the	O
United	O
States	O
Congress	O
appended	O
the	O
words	O
"	O
and	O
Prevention	O
"	O
to	O
the	O
name	O
effective	O
October	O
27	O
,	O
1992	O
.	O

Smart	S-Person
,	O
Jeffery	B-Person
K	E-Person
.	O
Medical	B-Document
Aspects	I-Document
of	I-Document
Chemical	I-Document
and	I-Document
Biological	I-Document
Warfare:	I-Document
Chapter	I-Document
2	I-Document
–	I-Document
History	I-Document
of	I-Document
Chemical	I-Document
and	I-Document
Biological	I-Document
Warfare:	I-Document
An	I-Document
American	I-Document
Perspective	E-Document
,	O
(PDF:	O
p.	O
14)	O
,	O
Borden	B-Organization
Institute	E-Organization
,	O
Textbooks	O
of	O
Military	O
Medicine	O
,	O
PDF	O
via	O
.	O
Retrieved	O
January	O
3	O
,	O
2009	O
.	O

Of	O
these	O
,	O
three-	O
anthrax	S-Pathogen
,	O
botulinum	S-Pathogen
and	O
aflatoxin	S-Pathogen
-had	O
proceeded	O
to	O
weaponization	O
for	O
deployment.	O
(1999)	O
,	O
Op.	O
cit.	O
,	O
pg	O
143	O
.	O

The	O
equivalent	O
dose	O
is	O
the	O
effective	O
dose	O
of	O
a	O
case	O
,	O
in	O
which	O
the	O
whole	O
body	O
would	O
actually	O
absorb	O
the	O
same	O
radiation	O
dose	O
,	O
and	O
the	O
sievert	O
unit	O
is	O
used	O
in	O
its	O
report	O
.	O

It	O
first	O
arrived	O
in	O
in	O
September	O
of	O
1918	O
through	O
the	O
port	O
busy	O
with	O
war	O
shipments	O
of	O
machinery	O
and	O
supplies	O
.	O

TOM	B-Person
FRIEDEN	E-Person
Good	O
morning	O
,	O
everyone	O
.	O

The	O
pathogen	O
was	O
manufactured	O
and	O
stockpiled	O
in	O
large	O
quantities	O
throughout	O
the	O
1970s	O
and	O
1980s	O
.	O

According	O
to	O
government	O
officials	O
,	O
the	O
virus	O
was	O
brought	O
into	O
the	O
estate	O
by	O
an	O
infected	O
kidney	O
patient	O
(the	O
type	O
of	O
kidney	O
illness	O
was	O
not	O
specified)	O
after	O
discharge	O
from	O
Prince	B-Organization
of	I-Organization
Wales	I-Organization
Hospital	E-Organization
who	O
visited	O
his	O
elder	O
brother	O
living	O
on	O
the	O
seventh	O
floor	O
.	O

In	O
addition	O
,	O
the	O
network	O
has	O
a	O
steering	O
committee	O
,	O
which	O
consists	O
of	O
members	O
who	O
have	O
authority	O
to	O
influence	O
the	O
work	O
in	O
each	O
agency	O
and	O
which	O
is	O
responsible	O
for	O
coordinating	O
the	O
network	O
and	O
ensuring	O
a	O
balance	O
in	O
the	O
type	O
of	O
projects	O
run	O
.	O

On	O
21	O
January	O
2020	O
,	O
the	O
Wuhan	B-Organization
Institute	I-Organization
of	I-Organization
Virology	E-Organization
applied	O
for	O
a	O
Chinese	O
"	O
use	O
patent"	O
,	O
for	O
treating	O
.	O

Many	O
informal	O
horizontal	O
links	O
have	O
been	O
created	O
,	O
and	O
this	O
has	O
expanded	O
the	O
communication	O
between	O
agencies	O
at	O
all	O
levels	O
.	O

The	O
tragic	O
2014-16	O
West	B-Incident
Africa	I-Incident
Ebola	I-Incident
epidemic	E-Incident
exposed	O
crucial	O
gaps	O
in	O
the	O
global	O
emergency	O
response	O
network	O
.	O

Developing	O
such	O
a	O
platform	O
will	O
require	O
overcoming	O
numerous	O
engineering	O
challenges	O
.	O

On	O
21	O
April	O
2014	O
,	O
the	O
Health	B-Organization
Ministry	I-Organization
of	I-Organization
UAE	E-Organization
reported	O
an	O
additional	O
9	O
cases	O
.	O

Of	O
the	O
four	O
disease-causing	O
viruses	O
,	O
Ebola	B-Pathogen
virus	E-Pathogen
(formerly	O
and	O
often	O
still	O
called	O
the	O
Zaire	B-Pathogen
Ebola	I-Pathogen
virus	E-Pathogen
)	O
is	O
dangerous	O
and	O
is	O
the	O
virus	O
responsible	O
for	O
the	O
epidemic	O
in	O
.	O

The	O
basic	O
reproduction	O
number	O
,	O
R0	O
,	O
is	O
a	O
statistical	O
measure	O
of	O
the	O
average	O
number	O
of	O
people	O
expected	O
to	O
be	O
infected	O
by	O
one	O
person	O
who	O
has	O
a	O
disease	O
.	O

Including	O
responsibility	O
not	O
only	O
for	O
the	O
individuals	O
who	O
may	O
have	O
personally	O
carried	O
out	O
the	O
experiments	O
,	O
but	O
for	O
those	O
who	O
set	O
up	O
a	O
system	O
for	O
them	O
to	O
do	O
those	O
experiments	O
within	O
.	O

The	O
letters	O
tested	O
positive	O
for	O
ricin	S-Pathogen
during	O
testing	O
.	O

A	O
lab	O
worker	O
at	O
the	O
University	B-Organization
of	I-Organization
Pittsburgh	E-Organization
became	O
infected	O
with	O
Zika	B-Pathogen
virus	E-Pathogen
last	O
month	O
(May	O
23)	O
after	O
accidentally	O
sticking	O
herself	O
with	O
a	O
needle	O
.	O

CT	B-Technology
colonography	E-Technology
(also	O
known	O
as	O
virtual	O
colonoscopy	O
or	O
VC	O
for	O
short)	O
is	O
far	O
more	O
accurate	O
than	O
a	O
barium	O
enema	O
for	O
detection	O
of	O
tumors	O
,	O
and	O
uses	O
a	O
lower	O
radiation	O
dose	O
.	O

As	O
of	O
mid-October	O
the	O
transmission	O
of	O
the	O
virus	O
had	O
significantly	O
reduced	O
;	O
it	O
was	O
by	O
then	O
confined	O
to	O
the	O
Mandima	S-Location
region	O
near	O
where	O
the	O
outbreak	O
began	O
,	O
and	O
was	O
only	O
affecting	O
27	O
health	O
zones	O
in	O
the	O
(down	O
from	O
a	O
peak	O
of	O
207)	O
.	O

This	O
same	O
year	O
,	O
issued	O
a	O
case	O
study	O
report	O
including	O
reviews	O
of	O
ten	O
different	O
nations’	O
current	O
biosafety	O
regulations	O
,	O
including	O
the	O
United	O
States	O
.	O

This	O
new	O
device	O
allows	O
for	O
the	O
use	O
of	O
portable	O
instruments	O
that	O
can	O
provide	O
immediate	O
diagnosis	O
.	O

Hadassah	B-Organization
Academic	I-Organization
College	E-Organization
relies	O
on	O
graduate	O
students	O
from	O
nearby	O
universities	O
and	O
medical	O
centers	O
as	O
teaching	O
assistants	O
for	O
the	O
course	O
.	O

Bacteria	O
were	O
the	O
perfect	O
choice	O
because	O
they	O
are	O
prokaryotic	O
cells	O
.	O

Unprecedented	O
heavy	O
rainfall	O
in	O
the	O
Fort	B-Location
Detrick	E-Location
area	O
created	O
flooding	O
issues	O
in	O
the	O
Steam	B-Equipment
Sterilization	I-Equipment
Plant	E-Equipment
()	O
.	O

According	O
to	O
the	O
California	B-Organization
Department	I-Organization
of	I-Organization
Food	I-Organization
and	I-Organization
Agriculture	E-Organization
,	O
"	O
California	S-Location
agriculture	O
is	O
nearly	O
a	O
$36.6	O
billion	O
dollar	O
industry	O
that	O
generates	O
$100	O
billion	O
in	O
related	O
economic	O
activity.	O
"	O
The	O
state's	O
agricultural	O
sales	O
first	O
exceeded	O
$30	O
billion	O
in	O
2004	O
,	O
Since	O
1975	O
,	O
California	S-Location
had	O
seen	O
small	O
annual	O
infestations	O
of	O
the	O
medfly	O
,	O
typically	O
ascribing	O
their	O
appearance	O
to	O
the	O
casual	O
shipping	O
of	O
fruit	O
,	O
and	O
visits	O
,	O
between	O
relatives	O
and	O
friends	O
in	O
California	S-Location
and	O
.	O

The	O
selected	O
contractor	O
,	O
working	O
directly	O
with	O
the	O
state	O
or	O
local	O
Laboratory	O
Directors	O
in	O
each	O
BioWatch	S-Document
jurisdiction	O
,	O
shall	O
provide	O
qualified	O
laboratory	O
personnel	O
to	O
conduct	O
BioWatch	S-Document
analysis	O
activities	O
at	O
state	O
and	O
municipal	O
public	O
health	O
laboratories	O
.	O

This	O
was	O
due	O
in	O
part	O
to	O
the	O
failure	O
of	O
medical	O
doctors	O
,	O
who	O
were	O
predominantly	O
men	O
,	O
to	O
contain	O
and	O
prevent	O
the	O
illness	O
.	O

Three	O
Hong	B-Location
Kong	E-Location
television	O
reporters	O
who	O
visited	O
SARS	S-Location
-related	O
sites	O
in	O
Guangzhou	S-Location
were	O
declared	O
free	O
of	O
the	O
disease	O
.	O

Rep	O
.	O

The	O
Pentagon	S-Organization
has	O
a	O
long	O
history	O
in	O
using	O
insects	O
as	O
vectors	O
for	O
diseases	O
.	O

The	O
WHO	S-Organization
and	O
NIH	S-Organization
do	O
not	O
oppose	O
the	O
use	O
of	O
non-steroidal	B-Drug
anti-inflammatory	I-Drug
drugs	E-Drug
(	O
NSAIDs	S-Drug
)	O
such	O
as	O
ibuprofen	S-Drug
for	O
symptoms	O
,	O
and	O
the	O
FDA	S-Organization
says	O
currently	O
there	O
is	O
no	O
evidence	O
that	O
NSAIDs	S-Drug
worsen	O
symptoms	O
.	O

The	O
OFW	O
,	O
who	O
was	O
working	O
as	O
a	O
nurse	O
in	O
the	O
UAE	S-Location
,	O
had	O
contact	O
with	O
a	O
Filipino	O
paramedic	O
who	O
had	O
died	O
recently	O
in	O
the	O
said	O
country	O
.	O

The	O
capital	O
city	O
suffered	O
construction	O
and	O
restaurant	O
unemployment	O
the	O
most	O
,	O
while	O
outside	O
the	O
capital	O
,	O
the	O
food	O
and	O
beverage	O
sectors	O
suffered	O
economically	O
.	O

Anthrax	S-Pathogen
is	O
of	O
course	O
the	O
first	O
choice	O
because	O
the	O
causative	O
agent	O
,	O
B.	B-Pathogen
anthracis	E-Pathogen
,	O
fulfils	O
nearly	O
all	O
of	O
these	O
specifications	O
(Fig.3)	O
.	O

On	O
22	O
August	O
2019	O
,	O
Nyiragongo	B-Location
Health	I-Location
Zone	E-Location
,	O
the	O
affected	O
area	O
on	O
the	O
outskirts	O
of	O
,	O
reached	O
21	O
days	O
without	O
further	O
cases	O
being	O
confirmed	O
.	O

External	O
test	O
panels	O
for	O
such	O
pathogens	O
are	O
generally	O
not	O
commercially	O
available	O
,	O
but	O
capability	O
testing	O
has	O
been	O
made	O
possible	O
in	O
the	O
FBD	S-Platform
network	O
projects	O
through	O
in-house	O
ring	O
trials	O
that	O
are	O
performed	O
annually	O
in	O
the	O
network	O
.	O

Committee	B-Organization
on	I-Organization
Homeland	I-Organization
Security	E-Organization
Taking	O
Measure	O
of	O
Countermeasures	O
.	O

On	O
22	O
December	O
,	O
it	O
was	O
reported	O
that	O
the	O
IMF	S-Organization
had	O
given	O
Liberia	S-Location
an	O
additional	O
$10	O
million	O
due	O
to	O
the	O
economic	O
impact	O
of	O
the	O
.	O

And	O
number	O
two	O
,	O
you've	O
talked	O
a	O
lot	O
about	O
putting	O
new	O
procedures	O
in	O
place	O
.	O

CDC	S-Organization
continues	O
to	O
take	O
multiple	O
steps	O
toward	O
preventing	O
something	O
like	O
this	O
from	O
happening	O
in	O
the	O
future	O
.	O

Kenneth	B-Person
Berns	E-Person
MD	O
,	O
PhD	O
,	O
is	O
Distinguished	O
Professor	O
Emeritus	O
of	O
Molecular	O
Genetics	O
and	O
Microbiology	O
,	O
College	B-Organization
of	I-Organization
Medicine	E-Organization
,	O
University	B-Organization
of	I-Organization
Florida	E-Organization
.	O
He	O
recently	O
retired	O
as	O
Director	O
of	O
the	O
Genetics	B-Organization
Institute	E-Organization
at	O
the	O
university	O
,	O
and	O
he	O
served	O
as	O
Dean	O
of	O
the	O
College	B-Organization
of	I-Organization
Medicine	E-Organization
and	O
Vice	O
President	O
for	O
Health	B-Organization
Affairs	E-Organization
.Dr	O
.	O

Operation	B-Activity
Big	I-Activity
Itch	E-Activity
Field	O
tests	O
were	O
performed	O
to	O
determine	O
coverage	O
patterns	O
and	O
survivability	O
of	O
the	O
tropical	O
rat	O
flea	O
for	O
use	O
as	O
a	O
disease	O
vector	O
in	O
biological	O
warfare	O
.	O

There	O
has	O
been	O
no	O
further	O
evidence	O
of	O
rodent	O
entry	O
into	O
the	O
barrels	O
,	O
the	O
university	O
said	O
.	O

The	O
FBD	S-Platform
network	O
is	O
coordinated	O
by	O
a	O
steering	O
committee	O
that	O
consists	O
of	O
2	O
representatives	O
from	O
each	O
of	O
the	O
4	O
agencies	O
,	O
and	O
the	O
presidency	O
of	O
the	O
committee	O
is	O
rotating	O
.	O

Takeda	S-Organization
Zika	B-Vaccine
vaccine	E-Vaccine
candidate	O
is	O
currently	O
being	O
studied	O
in	O
a	O
Phase	O
1	O
trial	O
(	O
ZIK-101	S-Drug
)	O
under	O
a	O
U.S.	S-Location
Investigational	O
New	O
Drug	O
(IND)	O
application	O
.	O

On	O
Monday	O
night	O
,	O
they	O
worked	O
through	O
the	O
night	O
to	O
confirm	O
that	O
the	O
DNA	O
was	O
present	O
by	O
PCR	B-Technology
testing	E-Technology
they	O
then	O
injected	O
the	O
material	O
into	O
special	O
materials	O
to	O
see	O
if	O
it	O
was	O
alive	O
.	O

EW	O
is	O
a	O
specific	O
type	O
of	O
biological	O
warfare	O
which	O
aims	O
to	O
use	O
insects	O
as	O
weapon	O
,	O
either	O
directly	O
or	O
through	O
their	O
potential	O
to	O
act	O
as	O
vectors	O
.	O

To	O
minimise	O
the	O
harm	O
from	O
misinformation	O
,	O
medical	O
professionals	O
and	O
the	O
public	O
are	O
advised	O
to	O
expect	O
rapid	O
changes	O
to	O
available	O
information	O
,	O
and	O
to	O
be	O
attentive	O
to	O
retractions	O
and	O
other	O
updates	O
.	O

Fortunately	O
antibiotic	O
resistance	O
was	O
not	O
an	O
issue	O
in	O
this	O
case	O
.	O

In	O
addition	O
,	O
a	O
bilateral	O
collaboration	O
between	O
Sweden	S-Location
and	O
has	O
resulted	O
in	O
joint	O
ring	O
trials	O
for	O
analysis	O
of	O
spiked	O
samples	O
for	O
detecting	O
high-consequence	O
bacteria	O
.	O

The	O
most	O
widely	O
accepted	O
estimate	O
for	O
the	O
Middle	B-Location
East	E-Location
including	O
Iraq	S-Location
,	O
Iran	S-Location
,	O
and	O
Syria	S-Location
,	O
during	O
this	O
time	O
,	O
is	O
for	O
a	O
death	O
toll	O
of	O
about	O
a	O
third	O
of	O
the	O
population	O
.	O

EIS	S-Scientific_research_project
is	O
a	O
two-year	O
fellowship	O
program	O
within	O
CDC	S-Organization
first	O
created	O
in	O
the	O
1950s	O
in	O
response	O
to	O
the	O
threat	O
of	O
bioterror	O
during	O
the	O
,	O
providing	O
on-the-job	O
training	O
to	O
equip	O
physicians	O
and	O
other	O
health	O
professionals	O
in	O
responding	O
to	O
public	O
health	O
emergencies	O
.	O

They	O
stitched	O
those	O
pieces	O
together	O
to	O
make	O
a	O
synthetic	O
copy	O
of	O
the	O
bacteria's	O
genome	O
,	O
with	O
a	O
few	O
small	O
changes	O
,	O
and	O
inserted	O
it	O
into	O
a	O
different	O
bacterial	O
cell	O
.	O

WHO	S-Organization
also	O
recommends	O
the	O
use	O
of	O
a	O
coverall	O
,	O
which	O
is	O
generally	O
appraised	O
in	O
terms	O
of	O
its	O
resistance	O
to	O
non-enveloped	O
DNA	O
virus	O
.	O

Building	O
on	O
the	O
longstanding	O
and	O
successful	O
history	O
in	O
molecular	O
biology	O
of	O
millions	O
of	O
experiments	O
engineering	O
and	O
using	O
organisms	O
like	O
E.	O
coli	O
to	O
conduct	O
research	O
,	O
JCVI	S-Organization
and	O
researchers	O
will	O
be	O
able	O
to	O
engineer	O
synthetic	O
bacterial	O
cells	O
so	O
they	O
cannot	O
live	O
outside	O
of	O
the	O
lab	O
or	O
other	O
production	O
environments	O
.	O

The	O
way	O
that	O
this	O
research	O
will	O
impact	O
human	O
lives	O
is	O
through	O
the	O
numerous	O
applications	O
such	O
as	O
new	O
vaccines	O
,	O
pharmaceuticals	O
,	O
biofuels	O
,	O
etc	O
.	O

And	O
while	O
leadership	O
on	O
the	O
issue	O
is	O
needed	O
,	O
he	O
thinks	O
the	O
solution	O
is	O
organization	O
rather	O
than	O
whomever	O
mans	O
it	O
.	O

August	O
2018	O
–	O
presentWidespread:Limited	O
and	O
local:	O
EBOV	S-Pathogen
1	O
August	O
2018	O
,	O
the	O
Democratic	B-Organization
Republic	I-Organization
of	I-Organization
the	I-Organization
Congo	I-Organization
Ministry	I-Organization
of	I-Organization
Health	E-Organization
declared	O
an	O
outbreak	O
when	O
4	O
individuals	O
tested	O
positive	O
for	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
.	O
the	O
outbreak	O
is	O
still	O
ongoing	O
.	O

All	O
three	O
examples	O
have	O
been	O
researched	O
and	O
extensively	O
published	O
by	O
the	O
(further	O
reading	O
is	O
available	O
at	O
sunshine-project.org)	O
.	O

In	O
the	O
years	O
since	O
medflies	O
were	O
discovered	O
in	O
California	S-Location
an	O
average	O
of	O
$26	O
million	O
was	O
spent	O
annually	O
to	O
control	O
them	O
;	O
but	O
1989's	O
attack	O
was	O
estimated	O
to	O
have	O
cost	O
$60	O
million	O
in	O
eradication	O
efforts	O
,	O
making	O
1989	O
the	O
second-most	O
expensive	O
year	O
in	O
the	O
state's	O
program.	O
"	O
Palo	O
Alto	O
Pests:	O
The	O
1981	B-Incident
Medfly	I-Incident
Invasion	E-Incident
"	O
,	O
paloaltohistory.com	O
,	O
accessed	O
February	O
23	O
,	O
2012	O
.	O

These	O
agents	O
are	O
typically	O
found	O
in	O
nature	O
,	O
but	O
could	O
be	O
mutated	O
or	O
altered	O
to	O
increase	O
their	O
ability	O
to	O
cause	O
disease	O
,	O
make	O
them	O
resistant	O
to	O
current	O
medicines	O
,	O
or	O
to	O
increase	O
their	O
ability	O
to	O
be	O
spread	O
into	O
the	O
environment	O
.	O

In	O
principle	O
,	O
rather	O
than	O
transporting	O
samples	O
to	O
a	O
different	O
laboratory	O
in	O
the	O
network	O
,	O
an	O
alternative	O
would	O
be	O
to	O
exchange	O
staff	O
,	O
as	O
the	O
network	O
members'	O
staff	O
are	O
now	O
familiar	O
with	O
the	O
methods	O
and	O
practices	O
used	O
in	O
the	O
other	O
laboratories	O
.	O

The	O
moratorium	O
on	O
biological	O
material	O
leaving	O
all	O
CDC	S-Organization
BSL-3	S-Platform
and	O
labs	O
.	O

Most	O
steps	O
are	O
to	O
be	O
completed	O
within	O
the	O
next	O
year	O
or	O
two	O
.	O

But	O
until	O
the	O
African	B-Disease
swine	I-Disease
fever	E-Disease
epidemic	O
is	O
brought	O
under	O
control	O
,	O
there	O
is	O
clearly	O
little	O
to	O
celebrate	O
.	O

On	O
17	O
March	O
2020	O
,	O
the	O
drug	O
was	O
provisionally	O
approved	O
for	O
use	O
for	O
COVID‑19	S-Disease
patients	O
in	O
a	O
serious	O
condition	O
as	O
a	O
result	O
of	O
the	O
outbreak	O
in	O
the	O
Czech	B-Location
Republic	E-Location
.	O
HTML	O
Version	O
On	O
20	O
March	O
2020	O
,	O
United	B-Location
States	E-Location
President	O
Donald	B-Person
Trump	E-Person
announced	O
that	O
remdesivir	S-Drug
was	O
available	O
for	O
"	O
compassionate	O
use	O
"	O
for	O
people	O
with	O
COVID‑19	S-Disease
;	O
FDA	S-Organization
Commissioner	O
Stephen	B-Person
Hahn	E-Person
confirmed	O
the	O
statement	O
at	O
the	O
same	O
press	O
conference	O
.	O

Laboratories	O
are	O
working	O
on	O
advanced	O
detection	O
systems	O
to	O
provide	O
early	O
warning	O
,	O
identify	O
contaminated	O
areas	O
and	O
populations	O
at	O
risk	O
,	O
and	O
to	O
facilitate	O
prompt	O
treatment	O
.	O

In	O
Japan	S-Location
257,363 deaths	O
were	O
attributed	O
to	O
by	O
July	O
1919	O
,	O
giving	O
an	O
estimated	O
0.	O
4%	O
mortality	O
rate	O
,	O
much	O
lower	O
than	O
nearly	O
all	O
other	O
Asian	O
countries	O
for	O
which	O
data	O
are	O
available	O
.	O

Battelle	S-Organization
has	O
operated	O
a	O
Top	O
Secret	O
Bio	O
laboratory	O
(	O
National	B-Organization
Biodefense	I-Organization
Analysis	I-Organization
and	I-Organization
Countermeasures	I-Organization
Center	E-Organization
–	O
NBACC	S-Organization
)	O
at	O
Fort	B-Location
Detrick	E-Location
,	O
Maryland	S-Location
under	O
a	O
US	B-Organization
Department	I-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
(	O
DHS	S-Organization
)	O
contract	O
for	O
the	O
last	O
decade	O
.	O

I'd	O
like	O
to	O
really	O
outline	O
what	O
has	O
happened	O
in	O
recent	O
months	O
,	O
give	O
the	O
details	O
,	O
give	O
what	O
happened	O
,	O
why	O
it	O
happened	O
and	O
what	O
we	O
are	O
doing	O
about	O
it	O
.	O

Since	O
the	O
insertion	O
of	O
a	O
gene	O
into	O
the	O
host	O
genome	O
may	O
even	O
cause	O
copy	O
number	O
variation	O
,	O
this	O
may	O
be	O
uncovered	O
using	O
real	B-Equipment
time	I-Equipment
PCR	E-Equipment
Besides	O
,	O
assessing	O
the	O
exact	O
number	O
of	O
mRNA	O
transcripts	O
of	O
a	O
gene	O
,	O
correlation	O
between	O
the	O
template	O
activity	O
and	O
expressed	O
protein	O
may	O
be	O
established	O
.	O

Bell	S-Person
is	O
going	O
to	O
look	O
at	O
every	O
way	O
we	O
can	O
to	O
enhance	O
the	O
culture	O
of	O
safety	O
so	O
we	O
have	O
-	O
we're	O
not	O
relying	O
on	O
people	O
to	O
do	O
the	O
right	O
thing	O
,	O
though	O
we	O
want	O
them	O
to	O
do	O
that	O
,	O
we're	O
relying	O
on	O
systems	O
so	O
that	O
even	O
if	O
someone	O
makes	O
a	O
mistake	O
,	O
there	O
will	O
not	O
be	O
a	O
risk	O
to	O
people	O
.	O

Black	B-Disease
Death	E-Disease
,	O
Jewishencyclopedia.com	O
In	O
the	O
Strasbourg	S-Location
massacre	O
of	O
February	O
1349	O
,	O
about	O
2,000	O
Jews	O
were	O
murdered	O
.	O

This	O
not	O
only	O
takes	O
a	O
great	O
deal	O
of	O
time	O
but	O
also	O
exposes	O
them	O
to	O
the	O
virus	O
because	O
,	O
for	O
those	O
wearing	O
protective	B-Equipment
clothing	E-Equipment
,	O
one	O
of	O
the	O
most	O
dangerous	O
moments	O
for	O
contracting	O
is	O
while	O
suits	O
are	O
being	O
removed	O
.	O

*Update	O
,	O
27	O
August	O
,	O
3:18	O
p.m.	O
:	O
This	O
article	O
was	O
updated	O
to	O
include	O
a	O
comment	O
from	O
Ron	B-Person
Atlas	E-Person
and	O
to	O
clarify	O
the	O
source	O
of	O
today's	O
memo	O
.	O

There	O
were	O
also	O
reports	O
that	O
adequate	O
personal	B-Equipment
protection	I-Equipment
equipment	E-Equipment
was	O
not	O
being	O
provided	O
for	O
medical	O
personnel	O
.	O

The	O
Action	O
Packages	O
have	O
been	O
identified	O
and	O
agreed	O
upon	O
by	O
GHSA	S-International_exchange_and_cooperation
member	O
countries	O
to	O
provide	O
focus	O
and	O
structure	O
to	O
priority	O
technical	O
areas	O
that	O
will	O
help	O
achieve	O
the	O
overall	O
GHSA	S-International_exchange_and_cooperation
goal	O
to	O
prevent	O
,	O
detect	O
and	O
respond	O
to	O
infectious	O
disease	O
outbreaks	O
.	O

In	O
April	O
2019	O
,	O
the	O
WHO	S-Organization
released	O
new	O
recommendations	O
stating	O
that	O
children	O
between	O
the	O
ages	O
of	O
two	O
and	O
five	O
should	O
spend	O
no	O
more	O
than	O
one	O
hour	O
per	O
day	O
engaging	O
in	O
sedentary	O
behavior	O
in	O
front	O
of	O
a	O
screen	O
and	O
that	O
children	O
under	O
two	O
should	O
not	O
be	O
permitted	O
any	O
sedentary	O
screen	O
time	O
.	O

The	O
bacteria	O
that	O
cause	O
tularemia	O
occur	O
widely	O
in	O
nature	O
and	O
could	O
be	O
isolated	O
and	O
grown	O
in	O
quantity	O
in	O
a	O
laboratory	O
,	O
although	O
manufacturing	O
an	O
effective	O
aerosol	O
weapon	O
would	O
require	O
considerable	O
sophistication	O
.	O

In	O
2014	O
,	O
incidents	O
with	O
Anthrax	O
and	O
Ebola	O
pathogens	O
in	O
CDC	O
laboratories	O
()	O
,	O
prompted	O
the	O
CDC	S-Organization
director	O
to	O
issue	O
a	O
moratorium	O
for	O
research	O
with	O
these	O
types	O
of	O
select	O
agents	O
.	O

The	O
second	O
lab	O
poses	O
an	O
organizational	O
challenge:	O
Each	O
pair	O
of	O
students	O
works	O
in	O
a	O
sterile	O
biological	O
hood	O
for	O
15–20	O
min	O
,	O
under	O
personal	O
supervision	O
.	O

But	O
,	O
he	O
did	O
not	O
infect	O
his	O
family	O
.	O

Usually	O
in-house	O
solutions	O
are	O
developed	O
,	O
and	O
the	O
total	O
number	O
of	O
staff	O
working	O
in	O
this	O
field	O
is	O
limited	O
.	O

In	O
the	O
hands	O
of	O
terrorists	O
and	O
rogue	O
nation	O
states	O
,	O
however	O
,	O
these	O
capabilities	O
could	O
be	O
misused	O
to	O
concoct	O
chemical	O
,	O
biological	O
,	O
radiological	O
,	O
nuclear	O
,	O
and	O
high-yield	O
explosive	O
(CBRNE)	O
weapons	O
of	O
mass	O
destruction	O
(WMD)	O
in	O
small	O
quantities	O
and	O
in	O
form	O
factors	O
that	O
are	O
hard	O
to	O
detect	O
.	O

In	O
addition	O
,	O
the	O
costs	O
of	O
employing	O
are	O
relatively	O
low	O
.	O

PPE	S-Equipment
removal	O
in	O
the	O
region	O
and	O
the	O
2nd	O
changing	O
room	O
should	O
be	O
carefully	O
monitored	O
by	O
a	O
working	O
partner	O
or	O
by	O
the	O
staffs	O
in	O
the	O
central	O
control	O
room	O
through	O
the	O
emergency	O
window	O
(Fig.1)	O
.	O

In	O
2015	O
,	O
between	O
11	O
March	O
and	O
20	O
April	O
,	O
a	O
total	O
of	O
913	O
specimens	O
were	O
received	O
in	O
the	O
SLE-CHN	B-Organization
Biosafety	I-Organization
Lab	E-Organization
including	O
350	O
blood	O
specimens	O
and	O
563	O
throat	O
swabs	O
.	O

Margret	B-Person
Chan	E-Person
declared	O
in	O
2010	O
that	O
the	O
has	O
moved	O
into	O
the	O
post-pandemic	O
period	O
.	O

A	O
field	O
experiment	O
in	O
the	O
West	B-Location
Nile	E-Location
district	O
allowed	O
researchers	O
to	O
take	O
blood	O
from	O
children	O
3	O
times	O
a	O
day	O
,	O
to	O
allegedly	O
study	O
a	O
local	O
disease	O
causing	O
mononucleosis	S-Disease
.	O
It	O
has	O
been	O
alleged	O
they	O
were	O
actually	O
being	O
infected	O
with	O
contaminated	O
and	O
their	O
antibodies	O
were	O
being	O
studied	O
.	O

Prime	O
editingSearch-and-replace	O
genome	B-Technology
editing	E-Technology
without	O
double-strand	O
breaks	O
or	O
donor	O
DNA	O
.	O

On	O
11	O
June	O
Sierra	B-Location
Leone	E-Location
shut	O
its	O
borders	O
for	O
trade	O
with	O
Guinea	S-Location
and	O
Liberia	S-Location
and	O
closed	O
some	O
schools	O
in	O
an	O
attempt	O
to	O
slow	O
the	O
spread	O
of	O
the	O
virus	O
;	O
on	O
30	O
July	O
the	O
government	O
began	O
to	O
deploy	O
troops	O
to	O
enforce	O
quarantines	O
,	O
and	O
by	O
15	O
October	O
the	O
last	O
district	O
in	O
Sierra	B-Location
Leone	E-Location
previously	O
untouched	O
by	O
the	O
disease	O
had	O
declared	O
cases	O
.	O

Research	O
suggests	O
that	O
CRISPR	S-Technology
is	O
an	O
effective	O
way	O
to	O
limit	O
replication	O
of	O
multiple	O
herpesviruses	O
.	O

It	O
was	O
encouraging	O
to	O
note	O
that	O
every	O
country	O
listed	O
in	O
the	O
BMENA	S-Location
region	O
had	O
some	O
initiatives	O
related	O
to	O
biosafety/biosecurity	O
between	O
2001	O
and	O
2013	O
(Figure	O
1)	O
.	O

If	O
you	O
don't	O
know	O
enough	O
biology	O
to	O
take	O
part	O
at	O
first	O
,	O
you	O
learn	O
it	O
along	O
the	O
way	O
.	O

The	O
anticipated	O
global	O
eradication	O
of	O
has	O
prompted	O
the	O
promulgation	O
of	O
new	O
biosafety	O
guidelines	O
for	O
future	O
laboratory	O
and	O
animal	O
work	O
.	O

For	O
instance	O
,	O
Spain	S-Organization
withdrew	O
58,000	O
Chinese-made	O
coronavirus	B-Equipment
testing	I-Equipment
kits	E-Equipment
with	O
an	O
accuracy	O
rate	O
of	O
30	O
percent	O
,	O
while	O
the	O
Netherlands	S-Organization
recalled	O
600,000	O
Chinese	O
face	O
masks	O
which	O
were	O
said	O
to	O
be	O
defective	O
,	O
yet	O
this	O
could	O
have	O
been	O
due	O
to	O
product	O
misuse	O
.	O

Often	O
the	O
willingness	O
to	O
share	O
biological	O
data	O
is	O
limited	O
and	O
it	O
is	O
difficult	O
to	O
convince	O
researchers	O
to	O
share	O
raw	O
data	O
even	O
after	O
publication	O
.	O

The	O
Office	B-Organization
of	I-Organization
Public	I-Organization
Health	I-Organization
Preparedness	E-Organization
was	O
created	O
during	O
the	O
2001	B-Incident
anthrax	I-Incident
attacks	E-Incident
shortly	O
after	O
.	O
Its	O
purpose	O
was	O
to	O
coordinate	O
among	O
the	O
government	O
the	O
response	O
to	O
a	O
range	O
of	O
biological	O
terrorism	O
threats	O
.	O

Agencies	O
involved	O
in	O
producing	O
policies	O
surrounding	O
biosafety	O
within	O
a	O
hospital	O
,	O
pharmacy	O
or	O
clinical	O
research	O
laboratory	O
include:	O
the	O
CDC	S-Organization
FDA	O
,	O
USDA	O
,	O
,	O
DoT	O
,	O
EPA	O
and	O
potentially	O
other	O
local	O
organizations	O
including	O
public	O
health	O
departments	O
.	O

The	O
origins	O
of	O
this	O
influenza	O
variant	O
is	O
not	O
precisely	O
known	O
.	O

In	O
the	O
fifth	O
lab	O
restriction	O
enzyme	O
analysis	O
of	O
the	O
hCMV	S-Pathogen
DNA	O
is	O
conducted	O
based	O
on	O
a	O
paper	O
by	O
Chou	S-Person
and	O
Dennison	S-Person
9	O
.	O

In	O
September	O
2015	O
,	O
a	O
new	O
chip-based	O
testing	O
method	O
that	O
can	O
detect	O
accurately	O
was	O
reported	O
.	O

Semi-automated	O
approaches	O
are	O
dropboxes	O
of	O
and	O
batch	O
import	O
facilities	O
in	O
most	O
other	O
systems	O
.	O

He	O
claims	O
there	O
has	O
not	O
been	O
a	O
serious	O
plan	O
of	O
action	O
since	O
2004	O
during	O
George	B-Person
W.	I-Person
Bush'	E-Person
s	O
presidency	O
,	O
in	O
which	O
he	O
issued	O
a	O
Homeland	O
Security	O
directive	O
delegating	O
responsibilities	O
among	O
various	O
federal	O
agencies	O
.	O

Their	O
1992	O
findings	O
tallied	O
with	O
a	O
release	O
of	O
downwind	O
from	O
the	O
site	O
.	O

After	O
mutating	O
,	O
the	O
viruses	O
became	O
capable	O
of	O
infecting	O
humans.	O
"	O

Between	O
2009	O
and	O
2016	O
Taiwan	S-Location
was	O
allowed	O
to	O
attend	O
WHO	S-Organization
meetings	O
and	O
events	O
as	O
an	O
observer	O
but	O
was	O
forced	O
to	O
stop	O
due	O
to	O
renewed	O
pressure	O
from	O
.	O

In	O
October	O
2014	O
,	O
a	O
safety	O
worker	O
at	O
Colorado	B-Organization
State	I-Organization
University	I-Organization
in	I-Organization
Fort	I-Organization
Collins	E-Organization
discovered	O
an	O
insect	O
bite	O
after	O
a	O
shift	O
in	O
a	O
laboratory	O
.	O

The	O
companies	O
,	O
involved	O
in	O
the	O
project	O
,	O
are	O
owned	O
by	O
the	O
biggest	O
American	O
tobacco	O
companies	O
–	O
Mediacago	B-Organization
Inc	E-Organization
is	O
co-owned	O
by	O
Philip	B-Organization
Morris	E-Organization
and	O
Kentucky	B-Organization
BioProcessing	E-Organization
,	O
a	O
subsidiary	O
of	O
Reynolds	B-Organization
American	E-Organization
which	O
is	O
owned	O
by	O
British	B-Organization
American	I-Organization
Tobacco	E-Organization
.	O
Currently	O
they	O
are	O
producing	O
from	O
tobacco	O
plants	O
.	O

The	O
lower	O
estimates	O
of	O
the	O
Chinese	O
death	O
toll	O
are	O
based	O
on	O
the	O
low	O
mortality	O
rates	O
that	O
were	O
found	O
in	O
Chinese	O
port	O
cities	O
(for	O
example	O
,	O
Hong	B-Location
Kong	E-Location
and	O
on	O
the	O
assumption	O
that	O
poor	O
communications	O
prevented	O
the	O
flu	S-Disease
from	O
penetrating	O
the	O
interior	O
of	O
China	S-Location
.	O
However	O
,	O
some	O
contemporary	O
newspaper	O
and	O
post	O
office	O
reports	O
,	O
as	O
well	O
as	O
reports	O
from	O
missionary	O
doctors	O
,	O
suggest	O
that	O
the	O
flu	S-Disease
did	O
penetrate	O
the	O
Chinese	O
interior	O
and	O
that	O
influenza	S-Disease
was	O
severe	O
in	O
at	O
least	O
some	O
locations	O
in	O
the	O
countryside	O
of	O
.	O

Previously	O
the	O
headquarters	O
were	O
in	O
an	O
unincorporated	O
area	O
,	O
statistically	O
in	O
the	O
Druid	B-Location
Hills	I-Location
census-designated	I-Location
place	E-Location
.CDC	O
Home	O
Page	O
,	O
cdc.gov	O
;	O
retrieved	O
November	O
19	O
,	O
2008.	O
"	O
1600	O
Clifton	O
Rd	O
.	O

Their	O
modeling	O
results	O
showed	O
that	O
all	O
three	O
factors	O
are	O
important	O
,	O
but	O
human	O
behavioral	O
responses	O
showed	O
the	O
most	O
significant	O
effects	O
.	O

Bio	O
warfare	O
scientists	O
using	O
diplomatic	O
cover	O
test	O
man-made	O
viruses	O
at	O
Pentagon	B-Organization
bio	I-Organization
laboratories	E-Organization
in	O
25	O
countries	O
across	O
the	O
world	O
.	O

In	O
December	O
2014	O
,	O
a	O
Cambridge	B-Organization
University	E-Organization
study	O
linked	O
IMF	S-Organization
policies	O
with	O
the	O
financial	O
difficulties	O
that	O
prevented	O
a	O
strong	O
Ebola	S-Disease
response	O
in	O
the	O
three	O
most	O
heavily	O
affected	O
countries	O
,	O
and	O
they	O
were	O
urged	O
by	O
both	O
the	O
UN	S-Organization
and	O
NGOs	S-Organization
who	O
had	O
worked	O
in	O
the	O
affected	O
countries	O
to	O
grant	O
debt	O
relief	O
rather	O
than	O
low-interest	O
loans	O
.	O

Such	O
procedures	O
use	O
no	O
ferromagnetic	O
instruments	O
.	O

There	O
are	O
antibiotics	O
,	O
including	O
the	O
powerful	O
medication	O
Ciprofloxacin	S-Drug
,	O
vaccines	O
for	O
smallpox	S-Disease
and	O
and	O
antivirals	O
for	O
a	O
deadly	O
influenza	O
pandemic	O
.	O

Call	O
John	S-Person
at	O
.	O
"	O

On	O
1May	O
the	O
CDC	S-Organization
presented	O
a	O
17-page	O
report	O
titled	O
"	O
Guidance	B-Document
for	I-Document
Implementing	I-Document
the	I-Document
Opening	I-Document
Up	I-Document
America	I-Document
Again	I-Document
Framework	E-Document
"	O
to	O
the	O
administration	O
.	O

The	O
pressure	O
in	O
the	O
BSL-3	S-Platform
laboratory	O
is	O
recorded	O
by	O
checking	O
the	O
pressure	O
gauge	O
in	O
the	O
lab	O
every	O
day	O
,	O
and	O
it	O
was	O
also	O
real-time	O
monitored	O
in	O
the	O
central	O
control	O
room	O
.	O

Entire	O
Inuit	O
and	O
Alaskan	O
Native	O
village	O
communities	O
died	O
in	O
Al	O
as	O
ka	O
.	O

Bacillus	B-Pathogen
anthracis	E-Pathogen
is	O
a	O
Tier	O
1	O
agent	O
.	O

The	O
European	B-Organization
Union	E-Organization
rejected	O
the	O
idea	O
of	O
suspending	O
the	O
Schengen	S-Location
free	O
travel	O
zone	O
and	O
introducing	O
border	O
controls	O
with	O
,	O
a	O
decision	O
which	O
has	O
been	O
criticised	O
by	O
some	O
European	O
politicians	O
.	O

Zebrafish	O
are	O
perfect	O
for	O
this	O
study	O
because	O
they	O
are	O
transparent	O
,	O
and	O
the	O
cyanobacteria	O
were	O
made	O
fluorescent	O
to	O
make	O
it	O
easier	O
for	O
the	O
scientists	O
to	O
see	O
where	O
they	O
were	O
growing	O
.	O

Such	O
species	O
of	O
mosquitoes	O
and	O
fleas	O
(studied	O
in	O
the	O
past	O
under	O
the	O
US	S-Location
Entomological	O
Warfare	O
Program)	O
have	O
also	O
been	O
collected	O
in	O
Georgia	S-Location
and	O
tested	O
at	O
The	O
.	O

However	O
,	O
the	O
fact	O
that	O
deaths	O
are	O
the	O
result	O
of	O
cases	O
contracted	O
in	O
the	O
past	O
can	O
mean	O
the	O
current	O
mortality	O
rate	O
is	O
underestimated	O
.	O

Reevaluation	O
and	O
improvement	O
of	O
inactivation	O
procedures	O
in	O
all	O
BSL-3	S-Platform
and	O
labs	O
.	O

The	O
Pentagon	S-Organization
has	O
a	O
long	O
history	O
in	O
using	O
insects	O
as	O
vectors	O
for	O
diseases	O
.	O

The	O
key	O
questions	O
for	O
researchers	O
to	O
address	O
are	O
therefore:	O
These	O
questions	O
are	O
priorities	O
for	O
the	O
prevention	O
of	O
antibiotic	O
resistance	O
development	O
worldwide	O
;	O
in	O
order	O
to	O
support	O
the	O
research	O
necessary	O
to	O
track	O
new	O
threats	O
on	O
a	O
global	O
scale	O
,	O
international	O
funding	O
is	O
indispensable	O
.	O

Ecuador	S-Organization
's	O
vice	O
president	O
,	O
,	O
apologised	O
to	O
the	O
nation	O
saying	O
,	O
"	O
We	O
have	O
seen	O
images	O
that	O
should	O
never	O
have	O
happened	O
,	O
and	O
as	O
your	O
public	O
servant	O
I	O
apologise.	O
"	O

Going	O
forward	O
,	O
the	O
CDC	S-Organization
will	O
continue	O
to	O
approve	O
the	O
studies	O
that	O
USAMRIID	S-Organization
scientists	O
wish	O
to	O
do	O
.	O

Developing	O
countermeasures	O
should	O
be	O
"	O
top	O
of	O
mind,	O
"	O
Burr	S-Person
added	O
,	O
saying	O
lawmakers	O
need	O
to	O
ensure	O
that	O
the	O
responsible	O
agencies	O
have	O
what	O
they	O
need	O
to	O
keep	O
pace	O
with	O
rapidly	O
changing	O
and	O
evolving	O
threats	O
.	O

An	O
internal	O
WHO	S-Organization
report	O
on	O
the	O
Ebola	S-Pathogen
response	O
pointed	O
to	O
underfunding	O
and	O
the	O
lack	O
of	O
"	O
core	O
capacity	O
"	O
in	O
health	O
systems	O
in	O
developing	O
countries	O
as	O
the	O
primary	O
weaknesses	O
of	O
the	O
existing	O
system	O
.	O

A	O
biohazard	B-Equipment
container	E-Equipment
is	O
used	O
for	O
the	O
temporary	O
disposal	O
of	O
needles	O
and	O
other	O
sharp	O
objects	O
.	O

Each	O
regional	O
office	O
is	O
headed	O
by	O
a	O
director	O
,	O
who	O
is	O
elected	O
by	O
the	O
Regional	O
Committee	O
.	O

The	O
failed	O
disinfections	O
resulted	O
in	O
the	O
bacteria	O
entering	O
the	O
exhaust	O
emitted	O
by	O
the	O
factory	O
,	O
which	O
infected	O
students	O
and	O
faculty	O
members	O
of	O
the	O
Lanzhou	B-Organization
Veterinary	I-Organization
Research	I-Organization
Institute	E-Organization
of	O
the	O
,	O
said	O
the	O
report	O
.	O

Many	O
questions	O
about	O
its	O
origins	O
,	O
its	O
unusual	O
epidemiologic	O
features	O
,	O
and	O
the	O
basis	O
of	O
its	O
pathogenicity	O
remain	O
unanswered	O
.	O

CNNW	O
.	O

No	O
findings	O
of	O
fact	O
were	O
made	O
about	O
the	O
existence	O
of	O
human	O
experimentation	O
,	O
but	O
the	O
decision	O
of	O
the	O
court	O
was	O
that	O
reparations	O
are	O
determined	O
by	O
international	O
treaties	O
and	O
not	O
by	O
national	O
court	O
cases	O
.	O

This	O
study	O
was	O
supported	O
in	O
part	O
by	O
grant	O
FOA	O
PAR-17-141	O
and	O
performed	O
in	O
collaboration	O
with	O
the	O
US	B-Platform
Food	I-Platform
and	I-Platform
Drug	I-Platform
Administration	I-Platform
Veterinary	I-Platform
Laboratory	I-Platform
Investigation	I-Platform
and	I-Platform
Response	I-Platform
Network	E-Platform
(	O
FDA	B-Platform
Vet-LIRN	E-Platform
)	O
under	O
grant	O
1	O
U18	O
FD006669-01	O
.	O

These	O
were	O
conducted	O
while	O
the	O
patients	O
were	O
alive	O
because	O
it	O
was	O
thought	O
that	O
the	O
death	O
of	O
the	O
subject	O
would	O
affect	O
the	O
results	O
.	O

While	O
in	O
Darwin	S-Location
Schully	S-Person
used	O
a	O
tool	O
he	O
developed	O
with	O
colleagues	O
to	O
continuously	O
screen	O
U.S.	O
forces	O
serving	O
in	O
endemic	O
areas	O
.	O

The	O
Solomon	O
Curse	O
,	O
a	O
novel	O
in	O
the	O
Fargo	O
Adventures	O
series	O
by	O
Clive	B-Person
Cussler	E-Person
and	O
Russell	B-Person
Blake	E-Person
,	O
involves	O
this	O
unit	O
in	O
its	O
plot	O
,	O
around	O
secret	O
human	O
experimentation	O
on	O
the	O
island	O
of	O
.	O

Even	O
with	O
Roosevelt	S-Person
's	O
declaration	O
opposition	O
to	O
the	O
Protocol	O
remained	O
strong	O
;	O
in	O
1949	O
the	O
Protocol	O
was	O
among	O
several	O
old	O
treaties	O
returned	O
to	O
President	O
unratified	O
.	O

This	O
review	O
will	O
give	O
us	O
a	O
clear	O
understanding	O
of	O
what	O
happened	O
in	O
this	O
case	O
and	O
what	O
can	O
be	O
done	O
to	O
further	O
improve	O
laboratory	O
safety	O
.	O

Current	O
approaches	O
for	O
recent	O
public	O
health	O
emergencies	O
due	O
to	O
infectious	O
diseases	O
have	O
not	O
produced	O
effective	O
preventive	O
or	O
therapeutic	O
solutions	O
in	O
a	O
relevant	O
timescale	O
.	O

All	O
died	O
painfully	O
from	O
internal	O
haemorrhaging	O
.	O

The	O
coffin	O
was	O
found	O
to	O
be	O
split	O
and	O
the	O
cadaver	O
badly	O
decomposed	O
;	O
nonetheless	O
,	O
samples	O
of	O
lung	O
and	O
brain	O
tissue	O
were	O
taken	O
.	O

Concerns	O
have	O
been	O
raised	O
over	O
the	O
effectiveness	O
of	O
travel	O
restrictions	O
to	O
contain	O
the	O
spread	O
of	O
COVID-19	S-Disease
A	O
study	O
in	O
Science	O
found	O
that	O
travel	O
restrictions	O
had	O
only	O
modest	O
effects	O
delaying	O
the	O
initial	O
spread	O
of	O
COVID-19	S-Disease
,	O
unless	O
combined	O
with	O
infection	O
prevention	O
and	O
control	O
measures	O
to	O
considerably	O
reduce	O
transmissions	O
.	O

It	O
can	O
also	O
occur	O
when	O
the	O
power	O
supplied	O
to	O
the	O
X-ray	B-Equipment
tube	E-Equipment
is	O
insufficient	O
to	O
penetrate	O
the	O
anatomy	O
.	O

However	O
,	O
in	O
late	O
August	O
,	O
according	O
to	O
media	O
reports	O
,	O
large	O
numbers	O
of	O
new	O
cases	O
reappeared	O
in	O
the	O
region	O
.	O

On	O
1	O
November	O
2013	O
,	O
a	O
woman	O
who	O
had	O
recently	O
traveled	O
to	O
Saudi	B-Location
Arabia	E-Location
for	O
the	O
Hajj	S-Activity
,	O
contracted	O
the	O
disease	O
.	O

Usually	O
in-house	O
solutions	O
are	O
developed	O
,	O
and	O
the	O
total	O
number	O
of	O
staff	O
working	O
in	O
this	O
field	O
is	O
limited	O
.	O

Dense	O
minerals	O
such	O
as	O
pyrite	O
and	O
barite	O
appear	O
brighter	O
and	O
less	O
dense	O
components	O
such	O
as	O
clay	O
appear	O
dull	O
in	O
.	O

Unit	O
members	O
orchestrated	O
forced	O
sex	O
acts	O
between	O
infected	O
and	O
non-infected	O
prisoners	O
to	O
transmit	O
the	O
disease	O
,	O
as	O
the	O
testimony	O
of	O
a	O
prison	O
guard	O
on	O
the	O
subject	O
of	O
devising	O
a	O
method	O
for	O
transmission	O
of	O
syphilis	S-Disease
between	O
patients	O
shows:"Infection	O
of	O
venereal	O
disease	O
by	O
injection	O
was	O
abandoned	O
,	O
and	O
the	O
researchers	O
started	O
forcing	O
the	O
prisoners	O
into	O
sexual	O
acts	O
with	O
each	O
other	O
.	O

The	O
CRISPR	S-Technology
and	O
Cas9	S-Technology
revolution	O
in	O
genomic	O
modeling	O
does	O
not	O
extend	O
only	O
to	O
mammals	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
1918	O
sequences	O
have	O
too	O
few	O
amino	O
acid	O
differences	O
from	O
those	O
of	O
wild-bird	B-Pathogen
strains	E-Pathogen
to	O
have	O
spent	O
many	O
years	O
adapting	O
only	O
in	O
a	O
human	O
or	O
swine	O
intermediate	O
host	O
.	O

Kirby	S-Person
,	O
.	O
"	O
The	O
CB	O
Battlefield	O
Legacy:	O
Understanding	O
the	O
Potential	O
Problem	O
of	O
Clustered	O
CB	O
Weapons	O
"	O
,	O
Army	O
Chemical	O
Review	O
,	O
pp.	O
25–29	O
,	O
July–December	O
2006	O
,	O
accessed	O
November	O
16	O
,	O
2008	O
.	O

From	O
August	O
through	O
December	O
2014	O
,	O
a	O
total	O
of	O
10	O
patients	O
with	O
Ebola	S-Disease
were	O
treated	O
in	O
US	O
hospitals	O
;	O
of	O
these	O
patients	O
,	O
8	O
survived	O
.	O

Root-Bernstein	S-Person
Robert	B-Person
S	E-Person
.	O
"	O
Infectious	O
Terrorism"	O
,	O
The	O
Atlantic	O
,	O
May	O
1991	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

The	O
results	O
were	O
slower	O
but	O
the	O
test	O
was	O
judged	O
a	O
success	O
;	O
the	O
prisoners	O
fell	O
ill	O
within	O
a	O
week	O
.	O

In	O
,	O
the	O
death	O
rate	O
was	O
2.	O
8	O
percent	O
for	O
men	O
and	O
1.	O
7	O
percent	O
for	O
women	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
asking	O
Congress	S-Organization
for	O
money	O
for	O
a	O
new	O
building	O
to	O
house	O
the	O
laboratories	O
that	O
work	O
on	O
the	O
deadliest	O
pathogens	O
known	O
to	O
humankind	O
.	O

WHO	S-Organization
	S-Organization
the	O
,	O
targeted	O
at	O
improving	O
health	O
policy	O
and	O
systems	O
.	O

Cuba	S-Organization
also	O
accused	O
the	O
of	O
spreading	O
human	O
and	O
animal	O
disease	O
on	O
their	O
island	O
nation	O
.	O

President	O
Hassan	B-Person
Rouhani	E-Person
said	O
on	O
26	O
February	O
there	O
were	O
no	O
plans	O
to	O
quarantine	O
areas	O
affected	O
by	O
the	O
outbreak	O
,	O
and	O
only	O
individuals	O
would	O
be	O
quarantined	O
.	O

The	O
WHO	S-Organization
publishes	O
the	O
"	O
Laboratory	B-Document
Biosafety	I-Document
Manual	E-Document
"	O
[4]	O
.	O

The	O
team	O
at	O
Emory	B-Organization
University	E-Organization
has	O
been	O
working	O
hard	O
to	O
find	O
a	O
way	O
to	O
use	O
existing	O
antibiotics	O
more	O
effectively	O
in	O
order	O
to	O
fight	O
off	O
superbugs	O
.	O

The	O
Al	B-Drug
Hakum	E-Drug
facility	O
began	O
mass	O
production	O
of	O
weapons-grade	O
anthrax	S-Pathogen
in	O
1989	O
,	O
eventually	O
producing	O
8,000	O
liters	O
or	O
more	O
(the	O
8,000	O
liter	O
figure	O
is	O
based	O
on	O
declared	O
amounts)	O
.	O

Since	O
its	O
development	O
in	O
the	O
1970s	O
and	O
1980s	O
,	O
MRI	S-Technology
has	O
proven	O
to	O
be	O
a	O
versatile	O
imaging	O
technique	O
.	O

If	O
I	O
could	O
start	O
,	O
doctor	O
,	O
you	O
said	O
that	O
the	O
was	O
the	O
most	O
distressing	O
.	O

Dunn	S-Person
,	O
.	O
"	O
State	O
Gambles	O
That	O
Sterile	O
Flies	O
Can	O
Do	O
the	O
Job:	O
Medfly:	O
Agriculture	O
officials	O
are	O
about	O
to	O
attempt	O
a	O
tactical	O
shift	O
in	O
the	O
battle	O
,	O
replacing	O
the	O
aerial	O
spraying	O
of	O
malathion"	O
,	O
Los	O
Angeles	O
Times	O
,	O
May	O
16	O
,	O
1990	O
,	O
accessed	O
February	O
23	O
,	O
2012	O
.	O

In	O
Guinea	S-Location
,	O
a	O
total	O
of	O
86	O
suspected	O
cases	O
,	O
including	O
59	O
deaths	O
,	O
had	O
been	O
reported	O
as	O
of	O
24	O
March	O
.	O

Many	O
large	O
theatres	O
such	O
as	O
those	O
on	O
Broadway	S-Organization
also	O
suspended	O
all	O
performances	O
.	O

Fifteen	O
cases	O
of	O
a	O
rare	O
antibiotic-resistant	O
bacteria	O
have	O
been	O
identified	O
in	O
animal	O
patients	O
at	O
the	O
University	B-Organization
of	I-Organization
Pennsylvania	I-Organization
Matthew	I-Organization
J.	I-Organization
Ryan	I-Organization
Veterinary	I-Organization
Hospital	E-Organization
the	O
last	O
year	O
,	O
the	O
facility	O
announced	O
Tuesday	O
.	O

If	O
it	O
should	O
become	O
possible	O
to	O
rebuild	O
variola	O
major	O
,	O
the	O
smallpox	B-Pathogen
virus	E-Pathogen
,	O
in	O
the	O
laboratory	O
from	O
scratch-and	O
the	O
virus's	O
genome	O
sequence	O
is	O
available	O
from	O
biological	O
databases-this	O
risk	O
could	O
change	O
greatly.	O
is	O
an	O
ideal	O
biological	O
weapon	O
,	O
particularly	O
for	O
terrorist	O
groups	O
,	O
because	O
it	O
is	O
highly	O
infectious	O
and	O
lethal	O
and	O
there	O
is	O
no	O
effective	O
treatment	O
available	O
.	O

ResistanceOpen	S-Platform
is	O
an	O
online	O
global	O
map	O
of	O
antimicrobial	O
resistance	O
developed	O
by	O
HealthMap	S-Platform
which	O
displays	O
aggregated	O
data	O
on	O
antimicrobial	O
resistance	O
from	O
publicly	O
available	O
and	O
user	O
submitted	O
data	O
.	O

Richard	B-Person
Burr	E-Person
(R-NC)	O
introduced	O
both	O
Senate	O
versions	O
of	O
PAHPA	S-Document
;	O
the	O
original	O
bill	O
,	O
S.	O
3678	O
,	O
which	O
became	O
law	O
in	O
2006	O
,	O
and	O
the	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
Reauthorization	I-Document
Act	E-Document
()	O
of	O
2013	O
,	O
S.	O
242	O
,	O
which	O
became	O
law	O
that	O
same	O
year	O
.	O

The	O
window	O
used	O
for	O
display	O
must	O
be	O
matched	O
to	O
the	O
X-ray	O
density	O
of	O
the	O
object	O
of	O
interest	O
,	O
in	O
order	O
to	O
optimize	O
the	O
visible	O
detail	O
.	O

Travis	B-Person
Warren	E-Person
,	O
who	O
has	O
been	O
a	O
USAMRIID	S-Organization
principal	O
investigator	O
since	O
2007	O
,	O
said	O
that	O
the	O
"	O
work	O
is	O
a	O
result	O
of	O
the	O
continuing	O
collaboration	O
between	O
USAMRIID	S-Organization
and	O
Gilead	B-Organization
Sciences	E-Organization
"	O
.	O
The	O
"	O
initial	O
screening	O
"	O
of	O
the	O
"	O
Gilead	B-Platform
Sciences	I-Platform
compound	I-Platform
library	E-Platform
to	O
find	O
molecules	O
with	O
promising	O
antiviral	O
activity	O
"	O
was	O
performed	O
by	O
scientists	O
at	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
.	O

If	O
viable	O
smallpox	S-Pathogen
is	O
present	O
,	O
WHO	S-Organization
will	O
be	O
invited	O
to	O
witness	O
the	O
destruction	O
of	O
these	O
smallpox	S-Pathogen
materials	O
,	O
as	O
has	O
been	O
the	O
precedent	O
for	O
other	O
cases	O
where	O
samples	O
have	O
been	O
found	O
outside	O
of	O
the	O
two	O
official	O
repositories	O
.	O

Laboratories	O
are	O
working	O
on	O
advanced	O
detection	O
systems	O
to	O
provide	O
early	O
warning	O
,	O
identify	O
contaminated	O
areas	O
and	O
populations	O
at	O
risk	O
,	O
and	O
to	O
facilitate	O
prompt	O
treatment	O
.	O

Zelicoff	S-Person
reassured	O
health	O
and	O
military	O
officials	O
that	O
he	O
would	O
recommend	O
more	O
research	O
rather	O
than	O
changes	O
in	O
vaccine	O
production	O
.	O

Biological	O
agents	O
pose	O
a	O
serious	O
threat	O
to	O
human	O
health	O
,	O
economic	O
development	O
,	O
social	O
stability	O
and	O
even	O
national	O
security	O
.	O

In	O
a	O
2009	O
paper	O
published	O
in	O
the	O
journal	O
Clinical	O
Infectious	O
Diseases	O
,	O
Karen	B-Person
Starko	E-Person
proposed	O
that	O
aspirin	S-Drug
poisoning	O
contributed	O
substantially	O
to	O
the	O
fatalities	O
.	O

In	O
this	O
animal	O
study	O
,	O
the	O
virus	O
became	O
practically	O
non-viable	O
,	O
consequently	O
increasing	O
survival	O
.	O

And	O
I've	O
established	O
a	O
high-level	O
working	O
group	O
chaired	O
by	O
Dr	O
.	O

Catherine	B-Person
Wilhemson	E-Person
biosecurity	O
manager	O
for	O
USAMRIID	S-Organization
,	O
demonstrates	O
how	O
a	O
BSL-4	S-Platform
positive-pressure	O
suit	O
works	O
on	O
March	O
15	O
,	O
2004	O
.	O

Researchers	O
continue	O
working	O
on	O
more	O
effective	O
treatments	O
and	O
many	O
vaccine	O
candidates	O
are	O
in	O
development	O
or	O
testing	O
phases	O
.	O

"	O
I	O
look	O
forward	O
to	O
a	O
timely	O
,	O
bipartisan	O
reauthorization	O
of	O
this	O
crucial	O
legislation	O
to	O
ensure	O
we	O
are	O
prepared	O
to	O
respond	O
to	O
natural	O
disasters	O
like	O
hurricanes	O
,	O
and	O
protect	O
Americans	O
against	O
bioterror	O
attacks	O
and	O
infectious	O
disease	O
outbreaks	O
,	O
like	O
the	O
Zika	B-Pathogen
virus	E-Pathogen
or	O
a	O
pandemic	O
influenza,	O
"	O
said	O
U.S.Sen	O
.	O

Although	O
it	O
would	O
be	O
comforting	O
to	O
consider	O
laboratory‐acquired	O
infection	O
an	O
artifact	O
of	O
a	O
less	O
sophisticated	O
time	O
in	O
biomedical	O
research	O
,	O
recent	O
examples	O
refute	O
this	O
.	O

The	O
most	O
notorious	O
of	O
these	O
were	O
the	O
allegations	O
made	O
by	O
the	O
Soviet	B-Organization
Union	E-Organization
,	O
the	O
People's	B-Organization
Republic	I-Organization
of	I-Organization
China	E-Organization
,	O
and	O
North	B-Location
Korea	E-Location
,	O
charging	O
that	O
the	O
United	B-Location
States	E-Location
used	O
biological	O
weapons	O
during	O
the	O
1950-1953	O
Korean	O
War	O
.	O

Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
.	O

The	O
situation	O
is	O
already	O
being	O
reflected	O
in	O
the	O
financial	O
markets	O
-	O
US	S-Location
lean-hog	O
futures	O
on	O
the	O
have	O
risen	O
around	O
60%	O
over	O
the	O
last	O
month	O
.	O

Russia	S-Location
also	O
sent	O
a	O
cargo	O
plane	O
with	O
medical	O
aid	O
to	O
the	O
United	B-Location
States	E-Location
.	O
Kremlin	S-Organization
spokesman	O
Dmitry	B-Person
Peskov	E-Person
said	O
"	O
when	O
offering	O
assistance	O
to	O
U.S.	S-Location
colleagues	O
,	O
[	O
Putin	S-Person
]	O
assumes	O
that	O
when	O
manufacturers	O
of	O
medical	O
equipment	O
and	O
materials	O
gain	O
momentum	O
,	O
they	O
will	O
also	O
be	O
able	O
to	O
reciprocate	O
if	O
necessary.	O
"	O

Tularemia	S-Disease
or	O
"	O
rabbit	B-Disease
fever	E-Disease
"	O
:	O
Tularemia	S-Disease
has	O
a	O
very	O
low	O
fatality	O
rate	O
if	O
treated	O
,	O
but	O
can	O
severely	O
incapacitate	O
.	O

The	O
U.S.	B-Organization
Government	I-Organization
Accountability	I-Organization
Office	E-Organization
(	O
GAO	S-Organization
)	O
has	O
recommended	O
that	O
the	O
Department	B-Organization
of	I-Organization
Homeland	I-Organization
Security	E-Organization
's	O
Countering	B-Organization
Weapons	I-Organization
of	I-Organization
Mass	I-Organization
Destruction	I-Organization
Office	E-Organization
develop	O
a	O
plan	O
to	O
help	O
coordinate	O
chemical	O
defense	O
programs	O
and	O
activities	O
.	O

Standard	O
microbiological	O
practices	O
should	O
be	O
followed	O
when	O
working	O
with	O
these	O
organisms	O
.	O

Partners	O
include	O
the	O
Bill	B-Organization
and	I-Organization
Melinda	I-Organization
Gates	I-Organization
Foundation	E-Organization
and	O
the	O
.	O

A	O
research	O
ship	O
[the	O
Lev	O
Berg]	O
of	O
the	O
Aral	S-Location
fleet	O
came	O
to	O
within	O
15	O
km	O
of	O
the	O
island	O
(it	O
was	O
forbidden	O
to	O
come	O
any	O
closer	O
than	O
40 km)	O
.	O

The	O
virus	O
has	O
been	O
found	O
in	O
American	O
hogs	O
,	O
and	O
Canadian	O
as	O
well	O
as	O
in	O
hogs	O
in	O
Northern	B-Location
Ireland	E-Location
,	O
Argentina	S-Location
,	O
and	O
Norway	S-Location
.	O
Leading	O
health	O
agencies	O
and	O
the	O
have	O
stressed	O
that	O
eating	O
properly	O
cooked	O
pork	O
or	O
other	O
food	O
products	O
derived	O
from	O
pigs	O
will	O
not	O
cause	O
flu	O
.	O

Rickettsia	B-Pathogen
prowazekii	E-Pathogen
,	O
Coxiella	B-Pathogen
burnetii	E-Pathogen
were	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
Russian	O
biodefense	O
categorization	O
,	O
but	O
was	O
included	O
in	O
the	O
second	O
highest	O
category	O
by	O
the	O
US	B-Organization
CDC	E-Organization
and	O
the	O
EU	S-Location
.	O
Influenza	O
virus	O
was	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
Russian	O
biodefense	O
categorization	O
,	O
but	O
was	O
included	O
in	O
the	O
second	O
highest	O
category	O
by	O
the	O
EU	S-Location
,	O
and	O
was	O
not	O
specifically	O
listed	O
by	O
.	O

Initial	O
interest	O
in	O
any	O
form	O
of	O
biological	O
warfare	O
came	O
at	O
the	O
close	O
of	O
World	O
War	O
I	O
.	O

In	O
large-scale	O
projects	O
,	O
often	O
heterogeneous	O
data	O
management	O
solutions	O
have	O
to	O
be	O
brought	O
together	O
.	O

The	O
Center	O
is	O
part	O
of	O
the	O
Johns	B-Organization
Hopkins	I-Organization
Bloomberg	I-Organization
School	I-Organization
of	I-Organization
Public	I-Organization
Health	E-Organization
and	O
is	O
located	O
in	O
.	O

In	O
addition	O
,	O
as	O
of	O
December	O
2017	O
has	O
not	O
ensured	O
that	O
the	O
contractor	O
has	O
a	O
complete	O
and	O
accurate	O
inventory	O
,	O
which	O
it	O
said	O
is	O
also	O
useful	O
for	O
informing	O
and	O
improving	O
its	O
ability	O
to	O
respond	O
to	O
future	O
global	O
health	O
emergencies	O
.	O

The	O
DIYbio	B-Activity
movement	E-Activity
seeks	O
to	O
revise	O
the	O
notion	O
that	O
one	O
must	O
be	O
an	O
academic	O
with	O
an	O
advanced	O
degree	O
to	O
make	O
any	O
significant	O
contribution	O
to	O
the	O
biology	O
community	O
.	O

But	O
often	O
,	O
these	O
data	O
are	O
inaccessible	O
for	O
future	O
research	O
projects	O
or	O
data	O
are	O
stored	O
in	O
proprietary	O
data	O
formats	O
that	O
are	O
not	O
interoperable	O
standard	O
formats	O
.	O

The	O
economic	O
effects	O
were	O
being	O
felt	O
nationwide	O
in	O
Liberia	S-Location
,	O
such	O
as	O
the	O
termination	O
of	O
expansions	O
in	O
the	O
mining	O
business	O
.	O

When	O
the	O
full	O
suspension	O
is	O
lifted	O
,	O
USAMRIID	S-Organization
will	O
not	O
need	O
approval	O
for	O
the	O
studies	O
it	O
wishes	O
to	O
perform	O
.	O

Many	O
believed	O
the	O
epidemic	O
was	O
a	O
punishment	O
by	O
God	O
for	O
their	O
sins	O
,	O
and	O
could	O
be	O
relieved	O
by	O
winning	O
God's	O
forgiveness	O
.	O

When	O
the	O
two	O
scientists	O
began	O
sharing	O
their	O
work	O
,	O
they	O
realized	O
that	O
they	O
could	O
use	O
the	O
sticky	O
ends	O
to	O
put	O
new	O
pieces	O
of	O
DNA	O
into	O
the	O
plasmids	O
that	O
Cohen	S-Person
was	O
studying	O
.	O

Wheeler	S-Person
,	O
Mark	S-Person
.	O
"	O
Fly	O
Wars"	O
,	O
Discovery	O
Magazine	O
,	O
February	O
1993	O
,	O
accessed	O
February	O
19	O
,	O
2012	O
.	O

Many	O
developed	O
countries	O
do	O
not	O
have	O
enough	O
hospital	O
beds	O
per	O
capita	O
,	O
which	O
limits	O
a	O
health	O
system's	O
capacity	O
to	O
handle	O
a	O
sudden	O
spike	O
in	O
the	O
number	O
of	O
COVID‑19	S-Disease
cases	O
severe	O
enough	O
to	O
require	O
hospitalisation	O
.	O

The	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
(	O
CDC	S-Organization
is	O
the	O
leading	O
national	O
public	O
health	O
institute	O
of	O
the	O
.	O

This	O
turned	O
the	O
bacteria	O
into	O
tiny	O
insulin	O
factories	O
.	O

A	O
case-study	O
of	O
the	O
preparation	O
,	O
planning	O
,	O
mitigation	O
,	O
and	O
response	O
efforts	O
during	O
the	O
fall	O
of	O
2009	O
is	O
that	O
of	O
the	O
Children's	B-Organization
Hospital	I-Organization
of	I-Organization
Philadelphia	E-Organization
()	O
which	O
took	O
several	O
steps	O
to	O
increase	O
the	O
emergency	O
department	O
(ED)	O
surge	O
capacity	O
response	O
.	O

PlasmidFinder	O
(https://cge.cbs.dtu.dk/services/PlasmidFinderExternal	O
Link)	O
analysis	O
confirmed	O
the	O
presence	O
of	O
an	O
IncFII	O
plasmid	O
in	O
all	O
isolates	O
.	O

The	O
medical	O
director	O
of	O
a	O
hospital	O
in	O
Liberia	S-Location
reported	O
that	O
he	O
was	O
seeing	O
health	O
problems	O
in	O
patients	O
who	O
had	O
been	O
in	O
recovery	O
for	O
as	O
long	O
as	O
nine	O
months	O
.	O

Many	O
others	O
lie	O
somewhere	O
in	O
between	O
.	O

Training	O
at	O
EIS	S-Scientific_research_project
also	O
is	O
a	O
great	O
lead	O
in	O
to	O
public	O
service	O
,	O
Redd	S-Person
said	O
,	O
a	O
comment	O
backed	O
by	O
Schakowsky	S-Person
,	O
who	O
said	O
85	O
percent	O
of	O
grads	O
enter	O
the	O
public	O
workforce	O
,	O
"	O
so	O
it	O
acts	O
as	O
a	O
pipeline	O
for	O
the	O
next	O
generation	O
of	O
public	O
health	O
professionals,	O
"	O
she	O
said	O
.	O

On	O
the	O
phone	O
?	O

Recent	O
genetic	O
analysis	O
has	O
revealed	O
that	O
three-quarters	O
,	O
or	O
six	O
out	O
of	O
the	O
eight	O
genetic	O
segments	O
,	O
of	O
the	O
2009	B-Pathogen
flu	I-Pathogen
pandemic	I-Pathogen
strain	E-Pathogen
arose	O
from	O
the	O
North	B-Pathogen
American	I-Pathogen
swine	I-Pathogen
flu	I-Pathogen
strains	E-Pathogen
circulating	O
since	O
1998	O
,	O
when	O
a	O
new	O
strain	O
was	O
first	O
identified	O
on	O
a	O
factory	O
farm	O
in	O
,	O
and	O
which	O
was	O
the	O
first-ever	O
reported	O
triple-hybrid	O
flu	O
virus	O
.	O

Tens	O
of	O
millions	O
fell	O
gravely	O
ill	O
,	O
their	O
bodies	O
succumbing	O
to	O
the	O
disease	O
in	O
different	O
ways	O
.	O

A	O
number	O
of	O
methods	O
have	O
been	O
recommended	O
to	O
help	O
ease	O
symptoms	O
,	O
including	O
adequate	O
liquid	O
intake	O
and	O
rest	O
.	O

Shortly	O
after	O
the	O
start	O
of	O
World	O
War	O
I	O
,	O
Germany	S-Location
launched	O
a	O
biological	O
sabotage	O
campaign	O
in	O
the	O
United	B-Location
States	E-Location
,	O
Russia	S-Location
,	O
Romania	S-Location
,	O
and	O
France	S-Location
.	O
At	O
that	O
time	O
,	O
Anton	B-Person
Dilger	E-Person
lived	O
in	O
Germany	S-Location
,	O
but	O
in	O
1915	O
he	O
was	O
sent	O
to	O
the	O
United	B-Location
States	E-Location
carrying	O
cultures	O
of	O
glanders	S-Disease
,	O
a	O
virulent	B-Disease
disease	E-Disease
of	O
horses	O
and	O
mules	O
.	O

Safety	O
officials	O
found	O
its	O
latch	O
was	O
broken	O
-	O
as	O
were	O
those	O
on	O
about	O
30%	O
of	O
the	O
barrels	O
,	O
records	O
say	O
.	O

Some	O
estimates	O
place	O
this	O
number	O
at	O
30%	O
.	O

Remaining	O
rings	O
can	O
be	O
suppressed	O
by	O
a	O
transformation	O
to	O
polar	O
space	O
,	O
where	O
they	O
become	O
linear	O
stripes	O
.	O

Men	O
across	O
the	O
nation	O
were	O
mobilizing	O
to	O
join	O
the	O
military	O
and	O
the	O
cause	O
.	O

Some	O
developing	O
countries	O
are	O
densely	O
populous	O
,	O
with	O
scant	O
biodefense	O
budgets	O
,	O
and	O
bioterrorism	O
would	O
be	O
even	O
more	O
effective	O
in	O
low	O
resourced	O
regions	O
.	O

MERS-CoV	S-Pathogen
is	O
thought	O
to	O
originate	O
from	O
bats	O
and	O
spread	O
directly	O
to	O
humans	O
and/or	O
camels	O
.	O

The	O
impact	O
of	O
the	O
pandemic	O
and	O
its	O
mortality	O
rate	O
are	O
different	O
for	O
men	O
and	O
women	O
.	O

In	O
October	O
2014	O
,	O
a	O
safety	O
worker	O
at	O
Colorado	B-Organization
State	I-Organization
University	I-Organization
in	I-Organization
Fort	I-Organization
Collins	E-Organization
discovered	O
an	O
insect	O
bite	O
after	O
completing	O
a	O
laboratory	O
shift	O
.	O

The	O
number	O
of	O
extra	O
hospital	O
days	O
was	O
2.5	O
million	O
.	O

Since	O
Monday	O
,	O
December	O
3	O
,	O
2018	O
Cameroon	S-Organization
is	O
endowed	O
with	O
a	O
FCFA	O
2	O
billion	O
(about	O
3.	O
5	O
million	O
US	S-Location
Dollars)	O
Public	B-Organization
Health	I-Organization
Emergency	I-Organization
Operations	I-Organization
Centre	E-Organization
located	O
at	O
the	O
Messa	B-Location
neighbourhood	E-Location
in	O
the	O
capital	O
city	O
.	O

Infectious	O
disease	O
control	O
through	O
improved	O
water	O
,	O
sanitation	O
and	O
hygiene	O
(WASH)	O
infrastructure	O
needs	O
to	O
be	O
included	O
in	O
the	O
antimicrobial	O
resistance	O
(AMR)	O
agenda	O
.	O

These	O
aspects	O
relate	O
not	O
only	O
to	O
human	O
health	O
,	O
but	O
also	O
to	O
the	O
potential	O
for	O
environmental	O
damage	O
(animals	O
and	O
plants)	O
.	O

The	O
office	O
tracks	O
outbreaks	O
of	O
disease	O
.	O

But	O
he's	O
also	O
motivated	O
in	O
large	O
part	O
by	O
frustration	O
.	O

Woodruff	S-Person
had	O
a	O
long-time	O
interest	O
in	O
malaria	O
control	O
,	O
which	O
had	O
been	O
a	O
problem	O
in	O
areas	O
where	O
he	O
went	O
hunting	O
.	O

The	O
goal	O
for	O
2050	O
is	O
a	O
27%	O
share	O
of	O
the	O
fuel	O
for	O
transport	O
.	O

In	O
a	O
September	O
2016	O
interview	O
conducted	O
by	O
Homeland	O
Preparedness	O
News	O
,	O
Daniel	B-Person
Gerstein	E-Person
a	O
senior	O
policy	O
researcher	O
for	O
the	O
RAND	B-Organization
Corporation	E-Organization
,	O
stresses	O
the	O
importance	O
in	O
preparing	O
for	O
potential	O
bioterrorist	O
attacks	O
on	O
the	O
nation	O
.	O

These	O
plates	O
had	O
appeared	O
negative	O
for	O
B.	B-Pathogen
anthracis	E-Pathogen
at	O
the	O
time	O
samples	O
were	O
distributed	O
to	O
the	O
other	O
laboratories	O
.	O

The	O
Infectious	B-Organization
Diseases	I-Organization
Society	I-Organization
of	I-Organization
America	E-Organization
has	O
proposed	O
a	O
goal	O
of	O
"	O
10	O
new	O
antibiotics	O
for	O
2020	O
"	O
(Ref)	O
.	O

The	O
center	O
is	O
a	O
branch	O
of	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
that	O
fights	O
threats	O
like	O
anthrax	S-Pathogen
and	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
and	O
additionally	O
towards	O
research	O
on	O
.	O

However	O
,	O
are	O
freestanding	O
organizational	O
units	O
and	O
do	O
not	O
belong	O
to	O
a	O
parent	O
Office	O
.	O

Visual	O
inspection	O
of	O
incidence	O
curves	O
alone	O
could	O
not	O
render	O
the	O
needed	O
results	O
or	O
data	O
;	O
growth	O
rates	O
with	O
a	O
two-dimensional	O
heat	O
map	O
were	O
used	O
.	O

Hence	O
,	O
private	O
companies	O
can	O
perform	O
work	O
,	O
under	O
diplomatic	O
cover	O
,	O
for	O
the	O
US	B-Organization
government	E-Organization
without	O
being	O
under	O
the	O
direct	O
control	O
of	O
the	O
host	O
state	O
–	O
in	O
this	O
case	O
the	O
Republic	B-Organization
of	I-Organization
Georgia	E-Organization
.	O
This	O
practice	O
is	O
often	O
used	O
by	O
the	O
to	O
provide	O
cover	O
for	O
its	O
agents	O
.	O

This	O
is	O
something	O
that	O
Dr	O
.	O

The	O
public	O
forum	O
where	O
Dr	O
.	O

Only	O
the	O
United	B-Location
States	E-Location
and	O
now	O
keep	O
publicly	O
declared	O
stocks	O
of	O
the	O
virus	O
.	O

They	O
concluded	O
that	O
"	O
the	O
salicylate	O
[	O
aspirin	S-Drug
poisoning	O
hypothesis	O
[was]	O
difficult	O
to	O
sustain	O
as	O
the	O
primary	O
explanation	O
for	O
the	O
unusual	O
virulence	O
of	O
the	O
1918–1919	B-Incident
influenza	I-Incident
pandemic	E-Incident
"	O
.	O
In	O
response	O
,	O
Starko	S-Person
said	O
there	O
was	O
anecdotal	O
evidence	O
of	O
aspirin	S-Drug
use	O
in	O
India	S-Location
and	O
argued	O
that	O
even	O
if	O
aspirin	S-Drug
over-prescription	O
had	O
not	O
contributed	O
to	O
the	O
high	O
Indian	O
mortality	O
rate	O
,	O
it	O
could	O
still	O
have	O
been	O
a	O
factor	O
for	O
high	O
rates	O
in	O
areas	O
where	O
other	O
exacerbating	O
factors	O
present	O
in	O
played	O
less	O
of	O
a	O
role	O
.	O

Nationalism	O
pervaded	O
as	O
people	O
accepted	O
government	O
authority	O
.	O

For	O
instance	O
,	O
an	O
envelope	O
with	O
powder	O
in	O
it	O
that	O
says	O
,	O
"	O
You've	O
just	O
been	O
exposed	O
to	O
anthrax	S-Pathogen
"	O
Such	O
hoaxes	O
already	O
showed	O
to	O
produce	O
a	O
large	O
psychological	O
impact	O
on	O
the	O
population	O
.	O

Because	O
they	O
are	O
so	O
small	O
,	O
you	O
may	O
not	O
be	O
able	O
to	O
see	O
,	O
smell	O
,	O
or	O
taste	O
them	O
.	O

CT	B-Technology
scans	E-Technology
can	O
be	O
performed	O
with	O
different	O
settings	O
for	O
lower	O
exposure	O
in	O
children	O
with	O
most	O
manufacturers	O
of	O
CT	B-Technology
scans	E-Technology
as	O
of	O
2007	O
having	O
this	O
function	O
built	O
in	O
.	O

Whereas	O
methods	O
such	O
as	O
RNA	O
interference	O
(RNAi)	O
do	O
not	O
fully	O
suppress	O
gene	O
function	O
,	O
CRISPR	S-Technology
ZFNs	S-Technology
,	O
and	O
TALENs	S-Technology
provide	O
full	O
irreversible	O
gene	B-Technology
knockout	E-Technology
.	O
CRISPR	S-Technology
can	O
also	O
target	O
several	O
DNA	O
sites	O
simultaneously	O
simply	O
by	O
introducing	O
different	O
gRNAs	O
.	O

Preston	S-Person
,	O
Richard	S-Person
(2002)	O
.	O

According	O
to	O
the	O
International	B-Organization
Red	I-Organization
Cross	E-Organization
a	O
"	O
most	O
likely	O
scenario	O
"	O
entails	O
an	O
asymptomatic	O
case	O
will	O
at	O
some	O
point	O
enter	O
the	O
country	O
of	O
Uganda	S-Location
undetected	O
among	O
the	O
numerous	O
refugees	O
coming	O
from	O
the	O
DRC	S-Location
.	O
On	O
20	O
September	O
,	O
Uganda	S-Location
indicated	O
it	O
was	O
ready	O
for	O
immediate	O
vaccination	O
,	O
should	O
the	O
be	O
detected	O
in	O
any	O
individual	O
.	O

So	O
many	O
questions	O
I'd	O
like	O
to	O
ask	O
.	O

"	O
The	O
idea	O
is	O
to	O
combine	O
surveillance	O
and	O
diagnostics,	O
"	O
said	O
Sokurenko	S-Person
"	O
Surveillance	O
works	O
for	O
diagnostics	O
,	O
and	O
diagnostics	O
feeds	O
back	O
to	O
surveillance.	O
"	O

Tick-borne	O
diseases	O
have	O
become	O
a	O
serious	O
,	O
potentially	O
deadly	O
,	O
and	O
rapidly	O
growing	O
threat	O
to	O
public	O
health	O
.	O

"	O
Chemical	O
and	O
Biological	O
Weapons:	O
Possession	O
and	O
Programs	O
Past	O
and	O
Present"	O
,	O
James	B-Organization
Martin	I-Organization
Center	I-Organization
for	I-Organization
Nonproliferation	I-Organization
Studies	E-Organization
Middlebury	O
College	O
,	O
April	O
9	O
,	O
2002	O
.	O

He	O
has	O
been	O
chair	O
or	O
a	O
member	O
of	O
several	O
National	B-Organization
Academy	I-Organization
of	I-Organization
Sciences	I-Organization
committees	E-Organization
,	O
and	O
he	O
has	O
served	O
in	O
an	O
advisory	O
capacity	O
to	O
the	O
Defense	B-Organization
Science	I-Organization
Board	E-Organization
,	O
the	O
Departments	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
and	O
Homeland	B-Organization
Security	E-Organization
,	O
and	O
the	O
National	B-Organization
Institutes	I-Organization
of	I-Organization
Health	E-Organization
.Dr	O
.	O

Health	O
officials	O
worldwide	O
were	O
also	O
concerned	O
because	O
the	O
virus	O
was	O
new	O
and	O
could	O
easily	O
mutate	O
and	O
become	O
more	O
virulent	O
,	O
even	O
though	O
most	O
flu	O
symptoms	O
were	O
mild	O
and	O
lasted	O
only	O
a	O
few	O
days	O
without	O
treatment	O
.	O

There's	O
a	O
mic	O
over	O
here	O
,	O
please	O
.	O

In	O
the	O
process	O
,	O
unknowingly	O
,	O
they	O
cross-contaminated	O
that	O
strain	O
with	O
highly	O
pathogenic	O
H5N1	B-Disease
influenza	E-Disease
.	O
As	O
a	O
result	O
when	O
they	O
sent	O
it	O
to	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	I-Organization
laboratory	E-Organization
to	O
see	O
for	O
the	O
research	O
that	O
they	O
were	O
doing	O
on	O
the	O
low	O
pathogenic	O
,	O
the	O
relatively	O
safe	O
influenza	O
strain	O
,	O
that	O
laboratory	O
saw	O
that	O
it	O
was	O
not	O
behaving	O
as	O
a	O
low	O
pathogenic	O
strain	O
would	O
behave	O
.	O

These	O
Muslim	O
doctors	O
also	O
depended	O
on	O
the	O
writings	O
of	O
the	O
ancient	O
Greeks	O
.	O

(1995)	O
.	O

Influenza	S-Disease
and	O
pneumonia	S-Disease
death	O
rates	O
for	O
those	O
15–34	O
years	O
of	O
age	O
in	O
1918–1919	O
,	O
for	O
example	O
,	O
were	O
&gt;20	O
times	O
higher	O
than	O
in	O
previous	O
years	O
.	O

After	O
three	O
washes	O
with	O
1×	O
PBS	O
0.	O
05%	O
Tween	O
20	O
,	O
cells	O
were	O
treated	O
for	O
30	O
min	O
with	O
50 μl	O
goat	O
anti	O
rabbit	O
IgG	O
HRP	O
conjugated	O
(Biotest)	O
,	O
and	O
washed	O
again	O
.	O

His	O
wife	O
became	O
ill	O
after	O
caring	O
for	O
him	O
,	O
and	O
both	O
were	O
admitted	O
to	O
National	B-Organization
Taiwan	I-Organization
University	I-Organization
Hospital	E-Organization
.	O
Taiwan	S-Location
's	O
third	O
case	O
of	O
the	O
disease	O
was	O
identified	O
in	O
a	O
Yilan	O
hospital	O
on	O
15	O
March	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
Web	O
site	O
.	O

Owing	O
to	O
the	O
effective	O
quarantine	O
of	O
public	O
transport	O
in	O
Wuhan	S-Location
and	O
Hubei	S-Location
,	O
several	O
countries	O
evacuated	O
their	O
citizens	O
and	O
diplomatic	O
staff	O
from	O
the	O
area	O
,	O
primarily	O
through	O
chartered	O
flights	O
of	O
the	O
home	O
nation	O
,	O
with	O
Chinese	O
authorities	O
providing	O
clearance	O
.	O

The	O
event	O
,	O
held	O
in	O
Libreville	S-Location
Gabon	S-Location
,	O
was	O
the	O
second	O
in	O
a	O
series	O
of	O
workshops	O
to	O
advance	O
Africa	B-Organization
CDC	E-Organization
's	O
Initiative	O
to	O
Strengthen	O
Biosecurity	O
and	O
Biosafety	O
,	O
launched	O
during	O
the	O
Nuclear	B-Activity
Threat	I-Activity
Initiative's	I-Activity
NTI	I-Activity
Global	I-Activity
Biosecurity	I-Activity
Dialogue	I-Activity
at	I-Activity
the	I-Activity
African	I-Activity
Union	E-Activity
in	O
Addis	B-Location
Ababa	E-Location
,	O
.	O

The	O
FBI	S-Organization
became	O
involved	O
in	O
the	O
investigation	O
and	O
the	O
letters	O
were	O
turned	O
over	O
to	O
the	O
Los	B-Organization
Angeles	I-Organization
Police	I-Organization
Department's	I-Organization
Criminal	I-Organization
Conspiracy	I-Organization
Section	E-Organization
.	O
During	O
the	O
course	O
of	O
the	O
investigation	O
,	O
the	O
United	B-Organization
States	I-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
attempted	O
to	O
contact	O
The	O
Breeders	O
through	O
a	O
classified	O
ad	O
placed	O
in	O
the	O
Los	B-Location
Angeles	E-Location
Times	O
.	O

In	O
remarks	O
,	O
both	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
and	O
the	O
United	B-Organization
States	I-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
assured	O
the	O
Government	B-Organization
of	I-Organization
Liberia	E-Organization
of	O
their	O
commitment	O
in	O
supporting	O
the	O
"	O
One	O
Health	O
"	O
Approach	O
geared	O
towards	O
preventing	O
rabies	S-Disease
in	O
.	O

In	O
early	O
and	O
mid-January	O
2020	O
,	O
the	O
virus	O
spread	O
to	O
other	O
Chinese	O
provinces	O
,	O
helped	O
by	O
the	O
Chinese	B-Activity
New	I-Activity
Year	I-Activity
migration	E-Activity
and	O
Wuhan	S-Location
being	O
a	O
transport	O
hub	O
and	O
major	O
rail	O
interchange	O
.	O

Lastly	O
,	O
we're	O
really	O
pushing	O
our	O
colleagues	O
working	O
in	O
the	O
international	O
space	O
.	O

The	O
COVID-19	B-Incident
pandemic	E-Incident
also	O
known	O
as	O
the	O
coronavirus	O
pandemic	O
,	O
is	O
an	O
ongoing	O
pandemic	O
of	O
coronavirus	B-Disease
disease	I-Disease
2019	E-Disease
(	O
COVID‑19	S-Disease
)	O
,	O
caused	O
by	O
severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus	I-Pathogen
2	E-Pathogen
(	O
SARS‑CoV‑2	S-Pathogen
)	O
.	O

Both	O
chambers	O
of	O
Congress	S-Organization
now	O
are	O
working	O
to	O
fast	O
track	O
revamps	O
to	O
the	O
2006	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
Act	E-Document
()	O
,	O
first	O
reauthorized	O
in	O
2013	O
,	O
and	O
which	O
is	O
now	O
due	O
to	O
expire	O
Sept.	O
30	O
.	O

The	O
memo	O
was	O
based	O
on	O
conversations	O
between	O
officials	O
from	O
the	O
university	O
groups	O
and	O
officials	O
within	O
the	O
administration	O
,	O
the	O
memo	O
said	O
.	O

DARPA	S-Organization
anticipates	O
that	O
will	O
be	O
a	O
four-year	O
,	O
fundamental	O
research	O
program	O
requiring	O
contributions	O
in	O
the	O
areas	O
of	O
biology	O
,	O
chemistry	O
,	O
physics	O
,	O
machine	O
learning	O
,	O
analytics	O
,	O
oceanography	O
,	O
mechanical	O
and	O
electrical	O
engineering	O
,	O
and	O
weak	O
signals	O
detection	O
.	O

Whether	O
the	O
viruses	O
were	O
equally	O
transmissible	O
in	O
1918	O
,	O
whether	O
they	O
had	O
identical	O
patterns	O
of	O
replication	O
in	O
the	O
respiratory	O
tree	O
,	O
and	O
whether	O
one	O
or	O
both	O
also	O
circulated	O
in	O
the	O
first	O
and	O
third	O
pandemic	O
waves	O
,	O
are	O
unknown	O
.	O

To	O
explain	O
the	O
situations	O
that	O
New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
Center	B-Organization
of	I-Organization
Excellence	I-Organization
in	I-Organization
Precision	I-Organization
Responses	I-Organization
to	I-Organization
Bioterrorism	I-Organization
and	I-Organization
Disasters	E-Organization
will	O
help	O
address	O
,	O
Dr.	O
said	O
to	O
picture	O
the	O
final	O
scene	O
of	O
an	O
action	O
or	O
disaster	O
movie	O
.	O

Because	O
these	O
patients	O
were	O
apparently	O
healthy	O
in	O
the	O
absence	O
of	O
the	O
protein	O
,	O
researchers	O
reasoned	O
that	O
deleting	O
its	O
gene	O
in	O
the	O
cells	O
of	O
infected	O
or	O
at-risk	O
patients	O
could	O
be	O
a	O
permanent	O
cure	O
for	O
HIV	S-Pathogen
and	O
AIDS	S-Pathogen
.	O
With	O
the	O
arrival	O
of	O
the	O
new	O
tool	O
,	O
a	O
set	O
of	O
'DNA	O
scissors'	O
called	O
CRISPR/Cas9	S-Technology
,	O
that	O
holds	O
the	O
promise	O
of	O
simple	O
gene	O
surgery	O
for	O
HIV	S-Technology
,	O
cancer	O
,	O
and	O
many	O
other	O
genetic	O
diseases	O
,	O
the	O
scientific	O
world	O
started	O
to	O
imagine	O
nearly	O
infinite	O
possibilities	O
.	O

All	O
synthetic	B-Technology
genomics	E-Technology
work	O
to	O
date	O
,	O
both	O
at	O
the	O
and	O
elsewhere	O
has	O
focused	O
on	O
microorganisms	O
.	O

House	O
.	O

Geneticists	O
quickly	O
picked	O
up	O
on	O
the	O
technique	O
,	O
transferring	B-Technology
animal	I-Technology
and	I-Technology
plant	I-Technology
genes	I-Technology
into	I-Technology
bacteria	I-Technology
using	I-Technology
plasmids	I-Technology
and	I-Technology
restriction	I-Technology
enzymes	E-Technology
.	O
This	O
was	O
the	O
beginning	O
of	O
.	O

A	O
second	O
new	O
case-confirmed	O
by	O
WHO	S-Organization
spokesman	O
Tarik	B-Person
Jasarevic	E-Person
to	O
involve	O
a	O
38-year-old	O
relative	O
and	O
caregiver	O
of	O
the	O
aforementioned	O
Ebola	S-Disease
victim-had	O
become	O
symptomatic	O
on	O
20	O
Jan	O
while	O
under	O
observation	O
at	O
a	O
quarantine	O
centre	O
.	O

On	O
7	O
May	O
2020	O
,	O
Japan's	B-Organization
Ministry	I-Organization
of	I-Organization
Health,	I-Organization
Labour	I-Organization
and	I-Organization
Welfare	E-Organization
approved	O
the	O
drug	O
for	O
use	O
in	O
Japan	S-Location
,	O
in	O
a	O
fast-tracked	O
process	O
based	O
on	O
emergency	O
authorization	O
.	O

As	O
of	O
2008	O
,	O
no	O
connection	O
between	O
the	O
Fallen	B-Incident
Angel	I-Incident
letters	E-Incident
and	O
the	O
Dirksen	B-Incident
building	I-Incident
incident	E-Incident
has	O
been	O
established	O
.	O

Considering	O
the	O
implications	O
of	O
these	O
events	O
for	O
the	O
handling	O
of	O
select	O
agents	O
and	O
virulent	O
pathogens	O
more	O
broadly	O
,	O
not	O
just	O
within	O
CDC	S-Organization
but	O
throughout	O
the	O
scientific	O
community	O
.	O

Remdesivir	S-Drug
can	O
be	O
synthesized	O
in	O
multiple	O
steps	O
from	O
ribose	O
derivatives	O
.	O

The	O
first	O
question	O
I	O
heard	O
from	O
my	O
colleagues	O
was	O
if	O
it	O
could	O
be	O
used	O
to	O
"	O
cure"	O
genetic	O
disorders	O
in	O
human	O
embryos	O
.	O

Based	O
on	O
In	O
a	O
simple	O
model	O
needs	O
on	O
average	O
over	O
time	O
be	O
kept	O
at	O
or	O
below	O
zero	O
to	O
avoid	O
exponential	O
growth	O
.	O

One	O
case	O
of	O
a	O
drug-resistant	O
form	O
of	O
the	O
bacterium	O
was	O
found	O
in	O
Madagascar	S-Location
in	O
1995	O
.	O

And	O
that's	O
what	O
I	O
want	O
to	O
ensure	O
happens	O
.	O

A	O
monoclonal	O
antibody	O
against	O
the	O
IgV	O
domain	O
of	O
TIM-1	O
,	O
ARD5	O
,	O
blocked	O
binding	O
and	O
infection	O
.	O

We	O
reviewed	O
research	O
contents	O
,	O
evaluated	O
principles	O
,	O
policies	O
and	O
procedures	O
for	O
biosafety	O
of	O
GEAs	S-Technology
,	O
also	O
enumerated	O
upcoming	O
approved	O
products	O
of	O
GEAs	S-Technology
.	O
Finally	O
,	O
we	O
suggested	O
perspectives	O
of	O
research	O
and	O
application	O
of	O
or	O
their	O
derived	O
products	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
deputy	O
health	O
minister	O
was	O
fired	O
,	O
the	O
second	O
high	O
level	O
health	O
official	O
fired	O
within	O
two	O
months	O
.	O

Her	O
father	O
had	O
worked	O
for	O
the	O
Red	B-Organization
Cross	I-Organization
in	I-Organization
Guinea	E-Organization
and	O
also	O
in	O
a	O
private	O
health	O
clinic	O
;	O
he	O
had	O
died	O
earlier	O
in	O
the	O
month	O
,	O
likely	O
from	O
an	O
Ebola	S-Disease
infection	O
contracted	O
in	O
the	O
private	O
clinic	O
.	O

In	O
February	O
2018	O
,	O
three	O
isolates	O
of	O
NDM-5–positive	B-Pathogen
E.	I-Pathogen
coli	I-Pathogen
(ST43)	E-Pathogen
were	O
isolated	O
from	O
2	O
patients	O
in	O
a	O
skilled	O
nursing	O
facility	O
in	O
New	B-Location
York	E-Location
,	O
New	B-Location
York	E-Location
(7)	O
.	O

Strategies	O
for	O
preventing	O
transmission	O
of	O
the	O
disease	O
include	O
maintaining	O
overall	O
good	O
personal	O
hygiene	O
,	O
washing	O
hands	O
,	O
avoiding	O
touching	O
the	O
eyes	O
,	O
nose	O
,	O
or	O
mouth	O
with	O
unwashed	O
hands	O
,	O
and	O
coughing	O
or	O
sneezing	O
into	O
a	O
tissue	O
,	O
and	O
putting	O
the	O
tissue	O
directly	O
into	O
a	O
waste	O
container	O
.	O

The	O
Netherlands	S-Organization
Spain	S-Organization
,	O
Turkey	S-Organization
,	O
Georgia	S-Organization
,	O
and	O
the	O
Czech	B-Organization
Republic	E-Organization
expressed	O
concerns	O
over	O
Chinese-made	O
masks	O
and	O
test	O
kits	O
.	O

The	O
Beijing	B-Organization
News	E-Organization
also	O
reported	O
that	O
students	O
at	O
the	O
institute	O
often	O
forgo	O
wearing	O
masks	O
and	O
taking	O
other	O
precautions	O
.	O

While	O
virus	O
has	O
been	O
detected	O
in	O
cerebrospinal	O
fluid	O
of	O
autopsies	O
,	O
the	O
exact	O
mechanism	O
by	O
which	O
it	O
invades	O
the	O
CNS	O
remains	O
unclear	O
and	O
may	O
first	O
involve	O
invasion	O
of	O
peripheral	O
nerves	O
given	O
the	O
low	O
levels	O
of	O
ACE2	O
in	O
the	O
brain	O
.	O

The	O
eleven	O
miscellaneous	O
pathogens	O
were:	O
Blue	B-Pathogen
tongue	I-Pathogen
virus	E-Pathogen
,	O
bovine	B-Pathogen
influenza	E-Pathogen
,	O
bovine	B-Pathogen
virus	I-Pathogen
diarrhea	E-Pathogen
(	O
BVD	S-Pathogen
)	O
,	O
fowl	B-Pathogen
plague	E-Pathogen
,	O
goat	B-Pathogen
pneumonitis	E-Pathogen
,	O
mycobacteria	S-Pathogen
,	O
"	O
N"	B-Pathogen
virus	E-Pathogen
,	O
Newcastle	B-Pathogen
disease	E-Pathogen
,	O
sheep	B-Pathogen
pox	E-Pathogen
,	O
Teschers	B-Pathogen
disease	E-Pathogen
,	O
and	O
.	O

Zelicoff	O
(2002)	O
,	O
Op.cit	O
.	O

It	O
can	O
be	O
produced	O
easily	O
and	O
cheaply	O
,	O
and	O
authorities	O
in	O
several	O
countries	O
have	O
investigated	O
links	O
between	O
suspect	O
extremists	O
and	O
ricin	S-Pathogen
But	O
experts	O
say	O
it	O
is	O
more	O
effective	O
on	O
individuals	O
than	O
as	O
a	O
weapon	O
of	O
mass	O
destruction	O
.	O

Global	O
health	O
security	O
issues	O
will	O
continue	O
to	O
challenge	O
collaboration	O
between	O
sectors	O
,	O
laboratory	O
activities	O
,	O
and	O
technologies	O
in	O
the	O
coming	O
years	O
.	O

The	O
virus	O
has	O
also	O
been	O
associated	O
with	O
neurological	B-Disease
complications	E-Disease
,	O
including	O
Guillain-Barre	B-Disease
Syndrome	E-Disease
(	O
GBS	S-Disease
)	O
,	O
in	O
the	O
general	O
population	O
.	O

In	O
person	O
,	O
they	O
run	O
experiments	O
and	O
take	O
classes	O
at	O
"	O
hacklabs,"	O
improvised	O
laboratories	O
that	O
are	O
open	O
to	O
the	O
public	O
,	O
and	O
attend	O
any	O
one	O
of	O
the	O
dozens	O
of	O
biohacking	O
conferences	O
put	O
on	O
each	O
year	O
.	O

Project	B-Scientific_research_project
BioShield	E-Scientific_research_project
The	O
accrual	O
of	O
vaccines	O
and	O
treatments	O
for	O
potential	O
biological	O
threats	O
,	O
also	O
known	O
as	O
medical	O
countermeasures	O
has	O
been	O
an	O
important	O
aspect	O
in	O
preparing	O
for	O
a	O
potential	O
bioterrorist	O
attack	O
;	O
this	O
took	O
the	O
form	O
of	O
a	O
program	O
beginning	O
in	O
2004	O
,	O
referred	O
to	O
as	O
Project	B-Scientific_research_project
BioShield	E-Scientific_research_project
.	O
Hylton	S-Person
,	O
Wil	B-Person
S	E-Person
.	O
"	O
How	O
Ready	O
Are	O
We	O
for	O
Bioterrorism?	O
"	O
The	O
New	O
York	O
Times	O
.	O

Antibiotic	O
resistance	O
is	O
rising	O
to	O
dangerously	O
high	O
levels	O
in	O
all	O
parts	O
of	O
the	O
world	O
.	O

In	O
August	O
2018	O
a	O
UN	S-Organization
agency	O
indicated	O
that	O
steps	O
were	O
being	O
taken	O
to	O
ensure	O
that	O
those	O
leaving	O
the	O
DRC	S-Location
into	O
Uganda	S-Location
were	O
not	O
infected	O
with	O
Ebola	S-Pathogen
,	O
which	O
was	O
being	O
done	O
via	O
active	O
screening	O
.	O

The	O
BSL‐2	S-Platform
laboratory	O
area	O
had	O
already	O
been	O
decontaminated	O
and	O
the	O
material	O
destroyed	O
as	O
a	O
routine	O
procedure	O
before	O
the	O
error	O
was	O
identified	O
.	O

There's	O
also	O
the	O
avian	B-Disease
flu	E-Disease
that	O
emerged	O
in	O
china	S-Location
a	O
few	O
years	O
ago	O
.	O

In	O
the	O
United	B-Location
States	E-Location
the	O
disease	O
was	O
first	O
observed	O
in	O
Haskell	B-Location
County	E-Location
,	O
Kansas	S-Location
,	O
in	O
January	O
1918	O
,	O
prompting	O
local	O
doctor	O
Loring	B-Person
Miner	E-Person
to	O
warn	O
the	O
US	B-Organization
Public	I-Organization
Health	I-Organization
Service's	I-Organization
academic	I-Organization
journal	E-Organization
.	O
On	O
4 March	O
1918	O
,	O
company	O
cook	O
Albert	B-Person
Gitchell	E-Person
,	O
from	O
Haskell	B-Location
County	E-Location
,	O
reported	O
sick	O
at	O
Fort	B-Location
Riley	E-Location
,	O
a	O
US	O
military	O
facility	O
that	O
at	O
the	O
time	O
was	O
training	O
American	O
troops	O
during	O
World	B-Incident
War	I-Incident
I	E-Incident
,	O
making	O
him	O
the	O
first	O
recorded	O
victim	O
of	O
the	O
flu	O
.	O

Initiatives	O
to	O
foster	O
open	O
accessibility	O
of	O
publicly	O
funded	O
research	O
data	O
are	O
now	O
put	O
into	O
practice	O
by	O
compilation	O
of	O
data	O
sharing	O
policies	O
and	O
mandatory	O
professional	O
data	O
management	O
strategies	O
in	O
application	O
calls	O
.	O

Among	O
the	O
set	O
of	O
bilateral	O
agreements	O
between	O
the	O
US	S-Location
and	O
Ukraine	S-Organization
is	O
the	O
establishment	O
of	O
the	O
Science	B-Organization
and	I-Organization
Technology	I-Organization
Center	I-Organization
in	I-Organization
Ukraine	E-Organization
(	O
STCU	S-Organization
)	O
–	O
an	O
International	O
organization	O
funded	O
mainly	O
by	O
the	O
US	B-Organization
government	E-Organization
which	O
has	O
been	O
accorded	O
diplomatic	O
status	O
.	O

They've	O
even	O
generated	O
and	O
adopted	O
their	O
own	O
codes	O
of	O
ethics	O
.	O

This	O
means	O
they	O
don't	O
have	O
a	O
membrane-bound	O
nucleus	O
;	O
instead	O
of	O
having	O
chromosomal	O
DNA	O
,	O
their	O
genetic	O
information	O
is	O
maintained	O
in	O
a	O
circular	O
plasmid	O
like	O
the	O
ones	O
Cohen	S-Person
studied	O
.	O

Furthermore	O
,	O
30.	O
7%	O
of	O
the	O
respondents	O
said	O
they	O
discard	O
used	O
syringes	O
directly	O
into	O
municipal	O
dustbins	O
.	O

Doctor	O
Zhang	B-Person
Jixian	E-Person
observed	O
a	O
cluster	O
of	O
pneumonia	S-Disease
cases	O
of	O
unknown	O
cause	O
on	O
26	O
December	O
,	O
upon	O
which	O
her	O
hospital	O
informed	O
Wuhan	B-Organization
Jianghan	I-Organization
CDC	E-Organization
on	O
27	O
December	O
.	O

Such	O
measures	O
may	O
include:	O
prophylaxis	O
by	O
vaccination	O
or	O
antisera	S-Drug
sanitary	O
measures	O
,	O
e.g.	O
,	O
food	O
and	O
water	O
hygiene	O
;	O
the	O
control	O
of	O
animal	O
reservoirs	O
or	O
arthropod	O
vectors	O
;	O
the	O
movement	O
of	O
people	O
or	O
animals	O
;	O
and	O
the	O
importation	O
of	O
infected	O
animals	O
or	O
animal	O
products	O
.	O

It	O
is	O
undergoing	O
a	O
phase2	B-Activity
non-randomised	I-Activity
trial	E-Activity
at	O
the	O
national	O
level	O
in	O
after	O
showing	O
positive	O
results	O
in	O
people	O
with	O
severe	O
disease	O
.	O

The	O
historian	O
al-Maqrizi	S-Person
described	O
the	O
abundant	O
work	O
for	O
grave-diggers	O
and	O
practitioners	O
of	O
funeral	O
rites	O
,	O
and	O
the	O
plague	S-Disease
recurred	O
in	O
more	O
than	O
fifty	O
times	O
over	O
the	O
following	O
century	O
and	O
half	O
.	O

In	O
another	O
experiment	O
,	O
15	O
Kurdish	O
prisoners	O
were	O
tied	O
up	O
in	O
a	O
field	O
while	O
shells	O
containing	O
,	O
a	O
mild	O
virus	O
,	O
were	O
dropped	O
from	O
a	O
light	O
aircraft	O
.	O

In	O
fact	O
,	O
there	O
are	O
less	O
than	O
two	O
dozen	O
Category	O
4	O
laboratories	O
in	O
the	O
world	O
,	O
according	O
to	O
the	O
Federation	B-Organization
of	I-Organization
American	I-Organization
Scientists	E-Organization
Failure	O
to	O
work	O
inside	O
one	O
of	O
these	O
labs	O
when	O
handling	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
would	O
likely	O
result	O
in	O
the	O
death	O
of	O
whoever	O
is	O
doing	O
the	O
weaponizing	O
,	O
said	O
.	O

Chen	S-Person
,	O
H	S-Person
,	O
D	B-Person
Zeng	E-Person
,	O
and	O
Y	B-Person
Pan	E-Person
.	O
"	O
"	O
20120	O
,	O
XXII	O
,	O
209p.	O
68	O
illus..	O
,	O
Hardcover	O
.	O

There	O
has	O
also	O
been	O
a	O
new	O
generation	O
of	O
Self-Contained	B-Equipment
Breathing	I-Equipment
Apparatuses	E-Equipment
(	O
SCBA	S-Equipment
)	O
which	O
has	O
been	O
recently	O
made	O
more	O
robust	O
against	O
bioterrorism	O
agents	O
.	O

Biological	O
agents	O
include	O
bacteria	O
,	O
viruses	O
,	O
fungi	O
and	O
toxins	O
that	O
cause	O
infection	O
,	O
allergy	S-Phenotype
toxicity	O
or	O
other	O
hazards	O
to	O
human	O
health	O
,	O
and	O
also	O
pose	O
a	O
serious	O
threat	O
to	O
economic	O
development	O
,	O
social	O
stability	O
and	O
even	O
national	O
security	O
.	O

In	O
December	O
2016	O
,	O
a	O
study	O
found	O
the	O
VSV-EBOV	B-Vaccine
vaccine	E-Vaccine
to	O
be	O
70–100%	O
effective	O
against	O
the	O
Ebola	B-Pathogen
virus	E-Pathogen
,	O
making	O
it	O
the	O
first	O
vaccine	O
against	O
the	O
disease	O
.	O

It	O
has	O
done	O
this	O
mainly	O
through	O
carrying	O
out	O
joint	O
projects	O
,	O
which	O
have	O
included	O
activities	O
such	O
as	O
ring	O
trials	O
(analysis	O
of	O
spiked	O
samples	O
for	O
detection	O
of	O
high-consequence	O
pathogens)	O
,	O
exercises	O
,	O
and	O
audits	O
.	O

J.	B-Person
Craig	I-Person
Venter	E-Person
.	O
Since	O
2005	O
,	O
SGI	S-Organization
has	O
funded	O
approximately	O
$30	O
million	O
of	O
synthetic	O
genomics	O
basic	O
science	O
research	O
at	O
the	O
JCVI	S-Organization
.	O
has	O
exclusive	O
assignment	O
of	O
intellectual	O
property	O
rights	O
on	O
this	O
work	O
and	O
has	O
filed	O
approximately	O
13	O
patent	O
application	O
families	O
to	O
date	O
.	O

When	O
BSL‐2	S-Platform
conditions	O
are	O
appropriate	O
due	O
to	O
the	O
use	O
of	O
human‐derived	O
materials	O
,	O
the	O
following	O
note	O
is	O
included	O
in	O
the	O
introduction	O
.	O

The	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Allergy	I-Organization
and	I-Organization
Infectious	I-Organization
Diseases	I-Organization
(NIAID)	I-Organization
Integrated	I-Organization
Research	I-Organization
Facility	E-Organization
(	O
IRF	S-Organization
)	O
is	O
part	O
of	O
the	O
National	B-Organization
Interagency	I-Organization
Biodefense	I-Organization
Campus	E-Organization
based	O
at	O
Fort	B-Location
Detrick	E-Location
,	O
.	O

Salisbury	S-Person
's	O
death	O
led	O
to	O
more	O
open	O
admissions	O
by	O
the	O
Chinese	B-Organization
government	E-Organization
about	O
the	O
spread	O
of	O
.	O

Even	O
though	O
the	O
Soviet	B-Organization
Union	E-Organization
is	O
no	O
more	O
,	O
one	O
of	O
its	O
KGB	S-Organization
lieutenant	O
colonels	O
is	O
now	O
Russia	S-Location
's	O
president	O
,	O
and	O
authorizes	O
continued	O
work	O
on	O
internationally	O
banned	O
biological	O
agents	O
.	O

In	O
fact	O
,	O
the	O
CDC	S-Organization
mission	O
was	O
set	O
under	O
PAHPRA	S-Document
,	O
said	O
,	O
and	O
includes	O
laboratory	O
testing	O
,	O
surveillance	O
(for	O
disease	O
detection)	O
,	O
epidemiology	O
,	O
guidance	O
to	O
healthcare	O
providers	O
,	O
incident	O
management	O
,	O
logistics	O
,	O
emergency	O
risk	O
communication	O
,	O
disease	O
control	O
programs	O
,	O
distribution	O
of	O
medical	O
countermeasures	O
,	O
responder	O
health	O
and	O
well-being	O
,	O
and	O
human	O
and	O
animal	O
medicine	O
.	O

The	O
initial	O
step	O
in	O
a	O
biosafety	O
program	O
is	O
the	O
assessment	O
of	O
risk	O
to	O
the	O
employee	O
.	O

But	O
I	O
think	O
absolutely	O
,	O
we're	O
going	O
to	O
look	O
at	O
this	O
experience	O
and	O
these	O
two	O
incidents	O
or	O
three	O
incidents	O
in	O
particular	O
and	O
more	O
broadly	O
at	O
a	O
culture	O
of	O
lab	O
safety	O
to	O
see	O
what	O
we	O
can	O
do	O
to	O
ensure	O
that	O
work	O
that's	O
done	O
with	O
either	O
select	O
agents	O
or	O
other	O
dangerous	O
microbes	O
is	O
done	O
safely	O
.	O

A	O
scientist	O
at	O
Texas	B-Organization
A&amp;M	I-Organization
in	I-Organization
College	I-Organization
Station-B	E-Organization
stuck	O
himself	O
with	O
a	O
needle	O
while	O
injecting	O
a	O
mouse	O
that	O
was	O
previously	O
infected	O
wit	O
h	B-Pathogen
a	I-Pathogen
recombinant	I-Pathogen
strain	I-Pathogen
of	I-Pathogen
Borrelia	I-Pathogen
burgdor	E-Pathogen
feri	O
,	O
the	O
bacteria	O
that	O
cauease	O
,	O
in	O
February	O
2014	O
.	O

"	O
It's	O
our	O
honor	O
and	O
duty	O
to	O
support	O
our	O
military	O
personnel	O
by	O
ensuring	O
they	O
have	O
access	O
to	O
safe	O
and	O
effective	O
medical	O
products	O
–	O
especially	O
products	O
that	O
meet	O
the	O
unique	O
needs	O
and	O
settings	O
in	O
which	O
soldiers	O
may	O
require	O
medical	O
treatment,	O
"	O
said	O
FDA	S-Organization
Commissioner	O
.	O

Distancing	O
guidelines	O
also	O
include	O
that	O
people	O
stay	O
at	O
least	O
apart	O
.	O

Similarly	O
,	O
in	O
Western	O
22%	O
of	O
the	O
population	O
of	O
38,000	O
died	O
within	O
two	O
months	O
.	O

Those	O
who	O
may	O
have	O
been	O
exposed	O
to	O
someone	O
with	O
COVID-19	S-Disease
and	O
those	O
who	O
have	O
recently	O
travelled	O
to	O
a	O
country	O
or	O
region	O
with	O
widespread	O
transmission	O
have	O
been	O
advised	O
to	O
self-quarantine	O
for	O
14	O
days	O
from	O
the	O
time	O
of	O
last	O
possible	O
exposure	O
.	O

The	O
Japanese	O
wanted	O
to	O
avoid	O
prosecution	O
under	O
the	O
Soviet	S-Organization
legal	O
system	O
,	O
so	O
the	O
next	O
morning	O
after	O
he	O
made	O
his	O
threat	O
,	O
Sanders	S-Person
received	O
a	O
manuscript	O
describing	O
Japan	S-Location
's	O
involvement	O
in	O
biological	O
warfare	O
.	O

The	O
same	O
researcher	O
was	O
bitten	O
through	O
a	O
glove	O
by	O
a	O
mouse	O
infected	O
with	O
B.	B-Disease
burgdorferi	E-Disease
just	O
a	O
week	O
later	O
.	O

What	O
matters	O
is	O
the	O
poor	O
track	O
record	O
in	O
the	O
field	O
,	O
made	O
worse	O
by	O
a	O
lack	O
of	O
transparency	O
and	O
accountability	O
.	O

ACE2	O
receptors	O
are	O
highly	O
expressed	O
in	O
the	O
heart	O
and	O
are	O
involved	O
in	O
heart	O
function	O
.	O

The	O
most	O
commonly	O
used	O
intravenous	O
contrast	O
agents	O
are	O
based	O
on	O
chelates	O
of	O
gadolinium	O
.	O

Academic	O
Andrew	B-Person
Price-Smith	E-Person
has	O
made	O
the	O
argument	O
that	O
the	O
virus	O
helped	O
tip	O
the	O
balance	O
of	O
power	O
in	O
the	O
latter	O
days	O
of	O
the	O
war	O
towards	O
the	O
Allied	O
cause	O
.	O

The	O
study	O
was	O
part	O
of	O
a	O
larger	O
project	O
titled	O
"	O
Scientific	B-International_exchange_and_cooperation
Engagement:	I-International_exchange_and_cooperation
Defining	I-International_exchange_and_cooperation
Gaps	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Creating	I-International_exchange_and_cooperation
Opportunities	I-International_exchange_and_cooperation
for	I-International_exchange_and_cooperation
Cooperative	I-International_exchange_and_cooperation
Research	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
Global	I-International_exchange_and_cooperation
Security	I-International_exchange_and_cooperation
in	I-International_exchange_and_cooperation
the	I-International_exchange_and_cooperation
Broader	I-International_exchange_and_cooperation
Middle	I-International_exchange_and_cooperation
East	I-International_exchange_and_cooperation
and	I-International_exchange_and_cooperation
North	I-International_exchange_and_cooperation
Africa	I-International_exchange_and_cooperation
(BMENA)	I-International_exchange_and_cooperation
Region	E-International_exchange_and_cooperation
and	O
was	O
funded	O
by	O
the	O
American	B-Organization
Association	I-Organization
for	I-Organization
the	I-Organization
Advancement	I-Organization
of	I-Organization
Science	E-Organization
()	O
Grant	O
#	O
2492	O
–	O
Pat	O
–	O
ERC	O
.	O

The	O
CDC	S-Organization
recommends	O
those	O
who	O
suspect	O
they	O
carry	O
the	O
virus	O
wear	O
a	O
simple	O
face	B-Equipment
mask	E-Equipment
.	O
Extracorporeal	B-Equipment
membrane	I-Equipment
oxygenation	E-Equipment
(	O
ECMO	S-Equipment
)	O
has	O
been	O
used	O
to	O
address	O
the	O
issue	O
of	O
,	O
but	O
its	O
benefits	O
are	O
still	O
under	O
consideration	O
.	O

Four	O
companies	O
have	O
each	O
won	O
a	O
potential	O
five-year	O
,	O
$75M	O
contract	O
to	O
provide	O
the	O
Food	B-Organization
and	I-Organization
Drug	I-Organization
Administration	E-Organization
center	O
for	O
biologics	O
evaluation	O
and	O
research	O
with	O
data	O
,	O
tools	O
and	O
infrastructure	O
for	O
use	O
in	O
the	O
surveillance	O
of	O
vaccines	O
,	O
tissues	O
,	O
blood	O
products	O
and	O
other	O
biologics	O
.	O

Thus	O
,	O
they	O
could	O
open	O
the	O
survey	O
,	O
agree	O
to	O
the	O
human	O
ethics	O
considerations	O
,	O
and	O
then	O
view	O
the	O
remaining	O
questions	O
.	O

The	O
mid-level	O
in	O
this	O
range	O
is	O
about	O
12,470	O
-related	O
deaths	O
.	O

the	O
patent	O
situation	O
in	O
Europe	S-Location
was	O
complex	O
,	O
with	O
MilliporeSigma	S-Organization
,	O
ToolGen	S-Organization
,	O
Vilnius	B-Organization
University	E-Organization
,	O
and	O
Harvard	S-Organization
contending	O
for	O
claims	O
,	O
along	O
with	O
.	O

Zebrafish	O
are	O
perfect	O
for	O
this	O
study	O
because	O
they	O
are	O
transparent	O
,	O
and	O
the	O
cyanobacteria	O
were	O
made	O
fluorescent	O
to	O
make	O
it	O
easier	O
for	O
the	O
scientists	O
to	O
see	O
where	O
they	O
were	O
growing	O
.	O

1,980	O
cases	O
with	O
699	O
deaths	O
were	O
reported	O
in	O
15	O
countries	O
across	O
the	O
world	O
(as	O
of	O
June	O
2017)	O
caused	O
by	O
MERS-CoV	S-Pathogen

Mycoplasma	B-Pathogen
genitalium	E-Pathogen
the	O
species	O
whose	O
genome	O
we	O
previously	O
synthesized	O
is	O
a	O
sexually	O
transmitted	O
parasite	O
of	O
the	O
human	O
urogenital	O
tract	O
that	O
causes	O
urethritis	S-Disease
and	O
is	O
implicated	O
in	O
adverse	B-Disease
pregnancy	E-Disease
outcomes	O
.	O
Perhaps	O
as	O
much	O
as	O
1%	O
of	O
adults	O
may	O
be	O
infected	O
,	O
often	O
asymptomatically	O
.	O

Al	B-Organization
Jazeera	E-Organization
website	O
Retrieved	O
12	O
April	O
2020	O
.	O

They	O
use	O
to	O
tie	O
the	O
body	O
along	O
with	O
the	O
canon	O
balls	O
and	O
use	O
to	O
shoot	O
them	O
towards	O
the	O
city	O
area	O
.	O

Merck.Covert	O
,	O
Norman	O
M.	O
(2000)	O
,	O
"	O
A	O
History	O
of	O
Fort	O
Detrick	O
,	O
Maryland"	O
,	O
4th	O
Edition:	O
2000	O
.	O

In	O
March	O
2020	O
,	O
researchers	O
from	O
the	O
University	B-Organization
of	I-Organization
Hong	I-Organization
Kong	E-Organization
have	O
shown	O
that	O
Syrian	O
hamsters	O
could	O
be	O
a	O
model	O
organism	O
for	O
research	O
.	O

When	O
Europeans	O
reached	O
the	O
Americas	S-Location
in	O
1492	O
,	O
the	O
two	O
populations	O
exposed	O
each	O
other	O
to	O
completely	O
novel	O
diseases	O
.	O

GlobalMed	S-Organization
powers	O
the	O
world's	O
largest	O
,	O
most	O
advanced	O
telehealth	O
programs	O
and	O
is	O
honored	O
to	O
be	O
the	O
telehealth	O
provider	O
to	O
the	O
White	B-Organization
House	E-Organization
,	O
Dept.	B-Organization
of	I-Organization
Veterans	I-Organization
Affairs	E-Organization
and	O
Defense	B-Organization
Health	I-Organization
Agency	E-Organization
.	O
More	O
than	O
4,000	O
organizations	O
have	O
trusted	O
GlobalMed	S-Organization
to	O
power	O
over	O
15	O
million	O
consults	O
,	O
improving	O
access	O
to	O
care	O
in	O
55	O
countries	O
.	O

The	O
war	O
may	O
also	O
have	O
reduced	O
people's	O
resistance	O
to	O
the	O
virus	O
.	O

During	O
the	O
height	O
of	O
the	O
epidemic	O
,	O
most	O
schools	O
in	O
the	O
three	O
most	O
affected	O
countries	O
were	O
shut	O
down	O
and	O
remained	O
closed	O
for	O
several	O
months	O
.	O

And	O
if	O
you	O
remember	O
nothing	O
else	O
from	O
what	O
I	O
say	O
this	O
morning	O
,	O
I	O
want	O
you	O
to	O
remember	O
three	O
things	O
.	O

The	O
virus	O
was	O
carried	O
to	O
Hanoi	S-Location
Vietnam	S-Location
,	O
by	O
Chinese-American	O
Johnny	B-Person
Chen	E-Person
,	O
a	O
resident	O
of	O
Shanghai	S-Location
who	O
had	O
roomed	O
across	O
the	O
hall	O
from	O
Liu	S-Person
at	O
the	O
Metropole	S-Organization
.	O
He	O
was	O
admitted	O
to	O
the	O
French	B-Organization
Hospital	I-Organization
of	I-Organization
Hanoi	E-Organization
on	O
26	O
February	O
,	O
where	O
he	O
infected	O
at	O
least	O
38	O
members	O
of	O
the	O
staff	O
.	O

Since	O
1999	O
,	O
Regional	O
directors	O
serve	O
for	O
a	O
once-renewable	O
five-year	O
term	O
,	O
and	O
typically	O
take	O
their	O
position	O
on	O
1	O
February	O
.	O

However	O
,	O
a	O
new	O
case	O
emerged	O
on	O
1	O
September	O
,	O
when	O
a	O
patient	O
from	O
Sella	B-Location
Kafta	I-Location
village	E-Location
in	O
tested	O
positive	O
for	O
the	O
disease	O
after	O
her	O
death	O
;	O
her	O
case	O
eventually	O
resulted	O
in	O
3	O
other	O
infections	O
among	O
her	O
contacts	O
.	O

By	O
the	O
post-pandemic	O
period	O
critics	O
claimed	O
the	O
WHO	S-Organization
had	O
exaggerated	O
the	O
danger	O
,	O
spreading	O
"	O
fear	O
and	O
confusion	O
"	O
rather	O
than	O
"	O
immediate	O
information".	O
admits	O
errors	O
in	O
handling	O
flu	O
pandemic:	O
Agency	O
accused	O
of	O
overplaying	O
danger	O
of	O
the	O
virus	O
as	O
it	O
swept	O
the	O
globe	O
.	O

The	O
Spanish	B-Disease
flu	E-Disease
pandemic	O
was	O
remarkable	O
in	O
having	O
very	O
little	O
apparent	O
effect	O
on	O
the	O
world's	O
development	O
,	O
despite	O
its	O
global	O
reach	O
.	O

The	O
blast	O
occurred	O
Monday	O
during	O
repair	O
work	O
of	O
a	O
sanitary	O
inspection	O
room	O
at	O
the	O
Russian	B-Organization
State	I-Organization
Centre	I-Organization
for	I-Organization
Research	I-Organization
on	I-Organization
Virology	I-Organization
and	I-Organization
Biotechnology	E-Organization
known	O
as	O
Vector	S-Organization
,	O
near	O
the	O
Russian	O
city	O
of	O
Novosibirsk	S-Location
in	O
,	O
the	O
center	O
said	O
in	O
a	O
statement	O
.	O

The	O
risk	O
was	O
low	O
,	O
but	O
the	O
researcher	O
was	O
referred	O
to	O
a	O
physician	O
and	O
started	O
post-exposure	O
prophylaxis	O
and	O
a	O
Tdap	B-Vaccine
vaccination	E-Vaccine

The	O
is	O
in	O
current	O
use	O
worldwide	O
in	O
the	O
effort	O
to	O
improve	O
patient	O
safety	O
.	O

In	O
a	O
14	O
January	O
conference	O
call	O
,	O
Chinese	O
officials	O
said	O
privately	O
that	O
human-to-human	O
transmission	O
was	O
a	O
possibility	O
,	O
and	O
pandemic	O
preparations	O
were	O
needed	O
.	O

Characterization	O
of	O
CRE	O
isolates	O
from	O
animals	O
is	O
needed	O
to	O
build	O
a	O
knowledge	O
base	O
and	O
provide	O
guidance	O
for	O
future	O
studies	O
because	O
CRE	O
will	O
continue	O
to	O
emerge	O
in	O
veterinary	O
medical	O
settings	O
.	O

Saudi	S-Organization
officials	O
expressed	O
great	O
concern	O
that	O
millions	O
of	O
Muslims	O
from	O
around	O
the	O
world	O
would	O
potentially	O
be	O
exposed	O
to	O
the	O
virus	O
during	O
the	O
autumn	O
Hajj	S-Activity
,	O
or	O
pilgrimage	O
to	O
.	O

Hal	O
Gold	O
,	O
Unit	O
731	O
testimony	O
,	O
1996	O
,	O
p.	O
64-66	O
In	O
1940	O
,	O
the	O
Imperial	O
Japanese	O
Army	O
Air	O
Force	O
bombed	O
Ningbo	O
with	O
ceramic	O
bombs	O
full	O
of	O
fleas	O
carrying	O
the	O
.	O

On	O
4	O
April	O
,	O
the	O
WHO	O
team	O
inspected	O
the	O
first	O
infection	O
case	O
in	O
Foshan	B-Location
County	E-Location
The	O
male	O
infected	O
four	O
people	O
.	O

One	O
such	O
pathogen	O
is	O
the	O
foot-and-mouth	B-Disease
disease	E-Disease
(	O
FMD	S-Disease
)	O
virus	O
,	O
which	O
is	O
capable	O
of	O
causing	O
widespread	O
economic	O
damage	O
and	O
public	O
concern	O
(as	O
witnessed	O
in	O
the	O
2001	B-Incident
and	I-Incident
2007	I-Incident
FMD	I-Incident
outbreaks	E-Incident
in	O
the	O
)	O
,	O
while	O
having	O
almost	O
no	O
capacity	O
to	O
infect	O
humans	O
.	O

Thirty-three	O
individuals	O
taking	O
antibiotics	S-Drug
in	O
group	O
two	O
are	O
being	O
advised	O
that	O
they	O
can	O
discontinue	O
.	O

Severe	B-Pathogen
acute	I-Pathogen
respiratory	I-Pathogen
syndrome	I-Pathogen
coronavirus	I-Pathogen
2	E-Pathogen
(	O
SARS‑CoV‑2	S-Pathogen
)	O
is	O
a	O
novel	O
virus	O
,	O
first	O
isolated	O
from	O
three	O
people	O
with	O
pneumonia	S-Disease
connected	O
to	O
the	O
cluster	O
of	O
acute	B-Disease
respiratory	I-Disease
illness	E-Disease
cases	O
in	O
Wuhan	S-Location
.	O
All	O
features	O
of	O
the	O
novel	O
virus	O
occur	O
in	O
related	O
coronaviruses	O
in	O
nature	O
.	O

It	O
made	O
CRISPR/Cas9	B-Technology
system	E-Technology
even	O
more	O
interesting	O
in	O
gene	O
editing	O
.	O

Pharmaceutical	O
companies	O
should	O
provide	O
their	O
stocks	O
for	O
this	O
purpose	O
(retaining	O
rights	O
to	O
other	O
applications)	O
.	O

WardEnvironment	S-Organization
time	O
since	O
the	O
initial	O
outbreak	O
,	O
and	O
population	O
characteristics	O
,	O
such	O
as	O
age	O
,	O
sex	O
,	O
and	O
overall	O
health	O
.	O

One	O
of	O
the	O
most	O
direct	O
routes	O
to	O
informing	O
scientific	O
debates	O
is	O
through	O
the	O
timely	O
publication	O
of	O
relevant	O
research	O
results	O
.	O

JOHN	B-Person
ROBERTS	E-Person
Everybody	O
on	O
the	O
phone	O
was	O
asking	O
two	O
questions	O
so	O
i	O
thought	O
I	O
might	O
try	O
to	O
get	O
a	O
second	O
one	O
in	O
.	O

The	O
most	O
common	O
mechanism	O
of	O
horizontal	O
gene	O
transfer	O
is	O
the	O
transferring	O
of	O
plasmids	O
carrying	O
antibiotic	O
resistance	O
genes	O
between	O
bacteria	O
of	O
the	O
same	O
or	O
different	O
species	O
via	O
conjugation	O
.	O

Suddenly	O
I	O
was	O
informed	O
that	O
there	O
were	O
mysterious	O
cases	O
of	O
mortalities	O
in	O
Aralsk	S-Location
(	O
Aral	S-Location
)	O
.	O

Because	O
of	O
Schully's	O
findings	O
,	O
the	O
U.S.	B-Organization
Indo-Pacific	I-Organization
Command	E-Organization
(	O
PACOM	S-Organization
)	O
has	O
requested	O
that	O
the	O
same	O
forces	O
serving	O
in	O
Darwin	S-Location
be	O
screened	O
for	O
the	O
mosquito-borne	O
Ross	B-Pathogen
River	I-Pathogen
Virus	E-Pathogen
,	O
and	O
Naval	B-Organization
Medical	I-Organization
Research	I-Organization
Center	I-Organization
Asia	E-Organization
is	O
using	O
the	O
study	O
to	O
provide	O
additional	O
surveillance	O
of	O
diseases	O
endemic	O
to	O
and	O
the	O
risks	O
they	O
present	O
to	O
the	O
servicemembers	O
.	O

So	O
the	O
NIH	S-Organization
and	O
FDA	S-Organization
are	O
both	O
scouring	O
their	O
campuses	O
to	O
see	O
if	O
there	O
are	O
other	O
examples	O
.	O

If	O
the	O
rate	O
is	O
less	O
than	O
1	O
,	O
the	O
infection	O
dies	O
out	O
;	O
if	O
it	O
is	O
greater	O
than	O
1	O
,	O
the	O
infection	O
continues	O
to	O
spread-with	O
exponential	O
growth	O
in	O
the	O
number	O
of	O
cases	O
.	O

Advanced	O
commercially	O
available	O
technologies-such	O
as	O
additive	O
manufacturing	O
(3-D	O
printing)	O
,	O
small-scale	O
chemical	O
reactors	O
for	O
pharmaceuticals	O
,	O
and	O
CRISPR	B-Technology
gene-manipulation	E-Technology
tools-have	O
opened	O
wide	O
access	O
to	O
scientific	O
exploration	O
and	O
discovery	O
.	O

Staff	O
entering	O
the	O
yellow	O
zone	O
must	O
wear	O
at	O
least	O
disposable	O
protective	B-Equipment
clothing	E-Equipment
a	O
disposable	O
medical	B-Equipment
protective	I-Equipment
mask	E-Equipment
,	O
a	O
disposable	O
hat	O
,	O
long-sleeved	O
medical	B-Equipment
rubber	I-Equipment
gloves	I-Equipment
and	I-Equipment
overshoes	E-Equipment
.	O
Staff	O
entering	O
the	O
BSL-3	S-Platform
lab	O
must	O
wear	O
a	O
long-sleeved	O
inner	O
gown	O
,	O
a	O
disposable	O
hat	O
,	O
lab	O
stockings	O
,	O
an	O
N95	B-Equipment
mask	E-Equipment
,	O
inner-layer	O
gloves	O
,	O
medical	B-Equipment
protective	I-Equipment
clothing	E-Equipment
,	O
long-sleeved	O
medical	B-Equipment
outer	I-Equipment
gloves	I-Equipment
and	I-Equipment
lab	I-Equipment
shoes	E-Equipment
in	O
the	O
1st	O
changing	O
room	O
,	O
and	O
overshoes	O
and	O
long	O
waterproof	O
boots	O
covers	O
in	O
the	O
shower	O
room	O
,	O
a	O
positive-pressure	O
breathing	B-Equipment
protection	I-Equipment
device	E-Equipment
and	O
disposable	O
waterproof	O
clothing	O
in	O
the	O
2nd	O
changing	O
room	O
.	O

"	O
The	O
process	O
to	O
weaponize	O
a	O
biological	O
agent	O
is	O
complex	O
and	O
multi-staged	O
,	O
involving	O
enrichment	O
,	O
refining	O
,	O
toughening	O
,	O
milling	O
and	O
preparation,	O
"	O
de	B-Person
Bretton-Gordon	E-Person
said	O
.	O

On	O
31	O
July	O
2015	O
,	O
the	O
WHO	S-Organization
announced	O
"	O
an	O
extremely	O
promising	O
development	O
"	O
in	O
the	O
search	O
for	O
an	O
effective	O
vaccine	O
for	O
Ebola	B-Disease
virus	I-Disease
disease	E-Disease
.	O
While	O
the	O
vaccine	O
had	O
shown	O
high	O
efficacy	O
in	O
individuals	O
,	O
more	O
conclusive	O
evidence	O
was	O
needed	O
regarding	O
its	O
capacity	O
to	O
protect	O
populations	O
through	O
herd	O
immunity	O
.	O

A	O
review	O
is	O
"	O
crucial"	O
and	O
"	O
a	O
decade-and-a-half	O
overdue,	O
"	O
says	O
.	O

The	O
terms	O
biohacking	O
and	O
wetware	O
hacking	O
emphasize	O
the	O
connection	O
to	O
hacker	O
culture	O
and	O
the	O
hacker	O
ethic	O
.	O

He	O
claims	O
there	O
has	O
not	O
been	O
a	O
serious	O
plan	O
of	O
action	O
since	O
2004	O
during	O
George	B-Person
W.	I-Person
Bush'	E-Person
s	O
presidency	O
,	O
in	O
which	O
he	O
issued	O
a	O
Homeland	O
Security	O
directive	O
delegating	O
responsibilities	O
among	O
various	O
federal	O
agencies	O
.	O

Zaire	B-Pathogen
ebolavirus	E-Pathogen
–	O
Makona	O
variant	O
caused	O
the	O
.	O
The	O
outbreak	O
was	O
characterized	O
by	O
the	O
longest	O
instance	O
of	O
human-to-human	O
transmission	O
of	O
the	O
viral	O
species	O
.	O

Ebola	B-Pathogen
virus	E-Pathogen
has	O
caused	O
the	O
majority	O
of	O
human	O
deaths	O
from	O
EVD	S-Disease
,	O
and	O
was	O
the	O
cause	O
of	O
the	O
,	O
which	O
resulted	O
in	O
at	O
least	O
suspected	O
cases	O
and	O
confirmed	O
deaths	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Agriculture	E-Organization
(	O
USDA	S-Organization
)	O
National	B-Organization
Institute	I-Organization
of	I-Organization
Food	I-Organization
and	I-Organization
Agriculture	E-Organization
(	O
NIFA	S-Organization
)	O
has	O
announced	O
a	O
competitive	O
opportunity	O
to	O
conduct	O
research	O
on	O
the	O
environmental	O
effects	O
of	O
genetically	O
engineered	O
(GE)	O
organisms	O
,	O
including	O
plants	O
,	O
animals	O
,	O
insects	O
,	O
and	O
microorganisms	O
.	O

It	O
has	O
also	O
recognized	O
the	O
vulnerability	O
of	O
victims	O
of	O
HIV/AIDS	S-Disease
to	O
.	O

Thus	O
,	O
one	O
major	O
reason	O
for	O
the	O
reluctance	O
to	O
share	O
data	O
before	O
publication	O
is	O
that	O
researchers	O
want	O
to	O
prevent	O
competitors	O
from	O
anticipating	O
publications	O
based	O
upon	O
their	O
data	O
.	O

After	O
several	O
cases	O
of	O
SARS	S-Disease
were	O
diagnosed	O
in	O
Taiwan	S-Location
throughout	O
the	O
month	O
of	O
April	O
,	O
including	O
a	O
cluster	O
at	O
Taipei	B-Organization
Municipal	I-Organization
Hospital's	I-Organization
Hoping	I-Organization
branch	E-Organization
,	O
the	O
closed	O
that	O
hospital	O
and	O
quarantined	O
its	O
930	O
staff	O
and	O
240	O
patients	O
for	O
two	O
weeks	O
.	O

In	O
January	O
and	O
February	O
2020	O
,	O
during	O
the	O
height	O
of	O
the	O
epidemic	O
in	O
Wuhan	S-Location
,	O
about	O
5 million	O
people	O
lost	O
their	O
jobs	O
.	O

These	O
experts	O
pointed	O
to	O
three	O
main	O
reasons	O
why	O
Ebola	S-Disease
isn't	O
likely	O
to	O
be	O
used	O
as	O
a	O
bioterrorism	O
agent	O
anytime	O
in	O
the	O
near	O
future	O
.	O

The	O
FDA	S-Organization
has	O
granted	O
temporary	O
authorisation	O
to	O
convalescent	O
plasma	O
as	O
an	O
experimental	O
treatment	O
in	O
cases	O
where	O
the	O
person's	O
life	O
is	O
seriously	O
or	O
immediately	O
threatened	O
.	O

I	O
dare	O
to	O
suspect	O
that	O
direct	O
therapeutic	O
approaches	O
of	O
CRISPR/Cas9	S-Technology
are	O
probably	O
the	O
mainstream	O
of	O
investment	O
in	O
gene	O
therapy	O
,	O
especially	O
in	O
academia	O
.	O

The	O
CDC	S-Organization
publication	O
,	O
"	O
"	O

Agents	O
questioned	O
various	O
individuals	O
during	O
their	O
probe	O
,	O
such	O
as	O
one	O
vocal	O
former	O
trucker	O
in	O
Florida	S-Location
.	O
Appelbaum	S-Person
,	O
Binyamin	S-Person
.	O
"	O
Ricin	S-Pathogen
probe	O
targets	O
man	O
on	O
Southside"	O
,	O
Florida	S-Location
Times	O
Union	O
,	O
February	O
15	O
,	O
2004	O
,	O
accessed	O
May	O
5	O
,	O
2009	O
.	O

Sharp	B-Equipment
disposable	I-Equipment
containers	E-Equipment
were	O
found	O
in	O
84	O
(44.	O
2%)	O
labs	O
,	O
but	O
the	O
difference	O
between	O
government	O
,	O
private	O
and	O
organization	O
laboratories	O
was	O
not	O
significant	O
(P=0.149)	O
.	O

Some	O
biohacks	O
are	O
backed	O
by	O
strong	O
scientific	O
evidence	O
and	O
are	O
likely	O
to	O
be	O
beneficial	O
.	O

But	O
they	O
also	O
rely	O
on	O
being	O
able	O
to	O
make	O
as	O
many	O
copies	O
of	O
a	O
particular	O
gene	O
as	O
a	O
scientist	O
needs	O
.	O

Lodewijk	B-Person
Heyligen	E-Person
whose	O
master	O
the	O
Cardinal	O
Colonna	S-Person
died	O
of	O
the	O
plague	S-Disease
in	O
1348	O
,	O
noted	O
a	O
distinct	O
form	O
of	O
the	O
disease	O
,	O
pneumonic	B-Disease
plague	E-Disease
,	O
that	O
infected	O
the	O
lungs	O
and	O
led	O
to	O
respiratory	O
problems	O
.	O

Thank	O
you	O
very	O
much	O
.	O

Dr	O
.	O

I	O
just	O
want	O
to	O
get	O
a	O
personal	O
reaction	O
here	O
,	O
Dr	O
.	O

New	B-Organization
York	I-Organization
Medical	I-Organization
College	E-Organization
will	O
also	O
develop	O
a	O
full-time	O
"	O
austere	O
medicine	O
"	O
training	O
facility	O
for	O
training	O
first	O
responders	O
.	O

The	O
WHO	S-Organization
has	O
commended	O
the	O
Chinese	O
authorities	O
for	O
providing	O
"	O
regular	O
updates"	O
,	O
contrasting	O
it	O
to	O
the	O
2002–2004	B-Incident
SARS	I-Incident
outbreak	E-Incident
when	O
they	O
were	O
accused	O
of	O
secrecy	O
.	O

Across	O
the	O
federal	O
government	O
,	O
there	O
is	O
a	O
growing	O
consensus	O
around	O
the	O
value	O
of	O
data	O
governance	O
to	O
minimize	O
costs	O
and	O
maximize	O
efficiency	O
.	O

"	O
Antibiotic	O
resistance	O
is	O
not	O
only	O
a	O
U.S.	S-Location
problem	O
-	O
it	O
is	O
a	O
global	O
crisis,	O
"	O
the	O
recent	O
report	O
states	O
.	O

They	O
also	O
have	O
a	O
strong	O
resistance	O
to	O
cold	O
and	O
can	O
survive	O
even	O
in	O
the	O
sub-zero	O
temperatures	O
in	O
the	O
mountains	O
.	O

On	O
5	O
May	O
2014	O
,	O
WHO	S-Organization
announced	O
that	O
the	O
spread	O
of	O
polio	S-Disease
was	O
a	O
world	O
health	O
emergency	O
–	O
outbreaks	O
of	O
the	O
disease	O
in	O
Asia	S-Location
,	O
Africa	S-Location
,	O
and	O
the	O
were	O
considered	O
"	O
extraordinary".	O

Calls	O
to	O
close	O
the	O
border	O
to	O
contain	O
the	O
spread	O
were	O
rejected	O
.	O

Students	O
from	O
SUNY	B-Organization
Albany's	I-Organization
College	I-Organization
of	I-Organization
Emergency	I-Organization
Preparedness	E-Organization
,	O
Homeland	B-Organization
Security	I-Organization
and	I-Organization
Cybersecurity	E-Organization
,	O
were	O
able	O
to	O
participate	O
in	O
this	O
year's	O
exercise	O
and	O
learn	O
how	O
"	O
supports	O
law	O
enforcement	O
specialty	O
teams.	O
"	O

On	O
30	O
December	O
,	O
a	O
test	O
report	O
addressed	O
to	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
,	O
from	O
company	O
CapitalBio	B-Organization
Medlab	E-Organization
,	O
stated	O
an	O
erroneous	O
positive	O
result	O
for	O
SARS	S-Disease
,	O
causing	O
a	O
group	O
of	O
doctors	O
at	O
Wuhan	B-Organization
Central	I-Organization
Hospital	E-Organization
to	O
alert	O
their	O
colleagues	O
and	O
relevant	O
hospital	O
authorities	O
of	O
the	O
result	O
.	O

Retrieved	O
January	O
5	O
,	O
2009	O
.	O

Work	O
on	O
delivery	O
systems	O
for	O
the	O
U.S.	S-Location
bioweapons	O
arsenal	O
led	O
to	O
the	O
first	O
mass-produced	O
biological	O
weapon	O
in	O
1952	O
,	O
the	O
M33	O
cluster	O
bomb.Croddy	O
,	O
Weapons	O
of	O
Mass	O
Destruction	O
,	O
p.	O
75	O
.	O

I'm	O
really	O
glad	O
you	O
asked	O
that	O
.	O

Although	O
tularemia	S-Pathogen
is	O
treatable	O
by	O
antibiotics	S-Drug
,	O
treatment	O
does	O
not	O
shorten	O
the	O
course	O
of	O
the	O
disease	O
.	O

The	O
discussion	O
draft	O
,	O
which	O
Rep	O
.	O

"	O
The	O
two	O
biggest	O
reasons	O
why	O
people	O
past	O
the	O
age	O
of	O
50	O
don't	O
live	O
past	O
74	O
are	O
heart	B-Disease
disease	E-Disease
and	O
cancer	S-Disease
.	O
In	O
modern	O
medicine	O
,	O
you	O
only	O
go	O
to	O
get	O
yourself	O
checked	O
if	O
you	O
show	O
symptoms,	O
"	O
said	O
Venter	S-Person
,	O
but	O
added	O
that	O
an	O
estimated	O
five	O
percent	O
of	O
people	O
have	O
that	O
they	O
are	O
not	O
aware	O
of	O
and	O
would	O
only	O
be	O
alerted	O
to	O
once	O
they	O
metastasize	O
or	O
grow	O
big	O
enough	O
.	O

A	O
2017	O
report	O
from	O
the	O
Brookings	B-Organization
Institute	E-Organization
cautions	O
that	O
biohacking	O
simultaneously	O
makes	O
science	O
available	O
to	O
everyone	O
while	O
also	O
introducing	O
countless	O
new	O
safety	O
concerns	O
.	O

On	O
21	O
January	O
2020	O
,	O
the	O
Wuhan	B-Organization
Institute	I-Organization
of	I-Organization
Virology	E-Organization
applied	O
for	O
a	O
Chinese	O
"	O
use	O
patent"	O
,	O
for	O
treating	O
.	O

The	O
U.S.	B-Organization
Centers	I-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
;	O
see	O
Internet	O
Resources)	O
defines	O
four	O
levels	O
of	O
biosafety	O
,	O
which	O
are	O
outlined	O
below	O
.	O

Chavez	S-Person
Stephanie	S-Person
and	O
Simon	S-Person
,	O
Richard	S-Person
.	O
"	O
State	O
Launches	O
New	O
Offensive	O
Against	O
Medfly"	O
,	O
Los	B-Location
Angeles	E-Location
Times	O
,	O
December	O
8	O
,	O
1989	O
,	O
accessed	O
February	O
21	O
,	O
2012	O
.	O

They	O
had	O
found	O
a	O
way	O
to	O
cut	O
and	O
paste	O
DNA	O
between	O
different	O
organisms	O
.	O

According	O
to	O
some	O
news	O
reports	O
,	O
a	O
new	O
study	O
to	O
be	O
published	O
in	O
the	O
New	B-Organization
England	I-Organization
Journal	I-Organization
of	I-Organization
Medicine	E-Organization
indicated	O
that	O
the	O
RNA	O
virus	O
could	O
remain	O
in	O
the	O
semen	O
of	O
survivors	O
for	O
up	O
to	O
six	O
months	O
,	O
and	O
according	O
to	O
other	O
researchers	O
,	O
the	O
RNA	O
virus	O
could	O
continue	O
in	O
semen	O
for	O
82	O
days	O
and	O
maybe	O
longer	O
.	O

By	O
the	O
late	O
1950s	O
the	O
4.5	O
"	O
E120	O
spraying	O
spherical	O
bomblet	O
was	O
developed	O
;	O
a	O
B-47	O
bomber	O
with	O
a	O
SUU-24/A	O
dispenser	O
could	O
infect	O
50%	O
or	O
more	O
of	O
the	O
population	O
of	O
a	O
area	O
with	O
tularemia	S-Pathogen
with	O
the	O
E120	O
.	O

However	O
some	O
analysts	O
believe	O
that	O
China	S-Location
has	O
been	O
under-reporting	O
the	O
situation	O
,	O
partly	O
due	O
to	O
local	O
farmers	O
withholding	O
information	O
about	O
outbreaks	O
.	O

Some	O
of	O
the	O
research	O
undertaken	O
or	O
supported	O
by	O
WHO	S-Organization
to	O
determine	O
how	O
people's	O
lifestyles	O
and	O
environments	O
are	O
influencing	O
whether	O
they	O
live	O
in	O
better	O
or	O
worse	O
health	O
can	O
be	O
controversial	O
,	O
as	O
illustrated	O
by	O
a	O
2003	O
joint	O
WHO	S-Organization
/	O
FAO	S-Organization
report	O
on	O
nutrition	O
and	O
the	O
prevention	O
of	O
chronic	O
non-communicable	O
disease,Report	O
of	O
a	O
Joint	O
FAO	S-Organization
/	O
WHO	S-Organization
Consultation	O
.	O

The	O
combined	O
2012–2013	O
budget	O
has	O
proposed	O
a	O
total	O
expenditure	O
of	O
$3,959 million	O
,	O
of	O
which	O
$944 million	O
(24%)	O
will	O
come	O
from	O
assessed	O
contributions	O
.	O

In	O
2007	O
despite	O
the	O
anthrax	B-Incident
outbreak	E-Incident
the	O
Georgian	B-Organization
government	E-Organization
terminated	O
the	O
compulsory	O
vaccination	O
for	O
7	O
years	O
,	O
2013	O
saw	O
NATO	S-Organization
start	O
human	O
trials	O
on	O
a	O
new	O
anthrax	B-Vaccine
vaccine	E-Vaccine
in	O
.	O

The	O
prime	O
contractor	O
being	O
Advanced	B-Organization
Biosystems	E-Organization
,	O
whose	O
president	O
at	O
that	O
time	O
was	O
Ken	B-Person
Alibek	E-Person
(a	O
former	O
Soviet	O
microbiologist	O
and	O
biological	O
warfare	O
expert	O
from	O
Kazakhstan	S-Location
who	O
defected	O
to	O
the	O
in	O
1992)	O
.	O

Howitt	S-Person
,	O
Arnold	B-Person
M.	E-Person
and	O
Pangi	S-Person
,	O
Countering	O
Terrorism:	O
Dimensions	O
of	O
Preparedness	O
,	O
(Google	O
Books	O
link)	O
,	O
MIT	O
Press	O
,	O
2003	O
,	O
pp.	O
202-03	O
,	O
()	O
.	O

The	O
Demon	O
in	O
the	O
Freezer	O
,	O
Ballantine	O
Books	O
,	O
.	O
.	O

The	O
potential	O
crisis	O
at	O
hand	O
is	O
the	O
result	O
of	O
a	O
marked	O
decrease	O
in	O
industry	O
R&amp;D	O
.	O

Further	O
development	O
of	O
the	O
disease	O
can	O
lead	O
to	O
complications	O
including	O
pneumonia	S-Disease
,	O
acute	B-Disease
respiratory	I-Disease
distress	I-Disease
syndrome	E-Disease
,	O
sepsis	S-Disease
,	O
septic	B-Disease
shock	E-Disease
,	O
and	O
.	O

In	O
1997	O
,	O
European	B-Organization
Union	E-Organization
health	O
ministers	O
voted	O
to	O
ban	O
avoparcin	S-Drug
and	O
four	O
additional	O
antibiotics	O
used	O
to	O
promote	O
animal	O
growth	O
in	O
1999	O
.	O

Prime	O
editing	O
does	O
not	O
cut	O
the	O
double-stranded	O
DNA	O
but	O
instead	O
uses	O
the	O
CRISPR	S-Technology
targeting	O
apparatus	O
to	O
shuttle	O
an	O
additional	O
enzyme	O
to	O
a	O
desired	O
sequence	O
,	O
where	O
it	O
converts	O
a	O
single	O
nucleotide	O
into	O
another	O
.	O

The	O
repair	O
template	O
is	O
also	O
uniquely	O
designed	O
for	O
each	O
application	O
,	O
as	O
it	O
must	O
complement	O
to	O
some	O
degree	O
the	O
DNA	O
sequences	O
on	O
either	O
side	O
of	O
the	O
cut	O
and	O
also	O
contain	O
whatever	O
sequence	O
is	O
desired	O
for	O
insertion	O
into	O
the	O
host	O
genome	O
.	O

This	O
resulted	O
in	O
the	O
Convention	B-Document
on	I-Document
Biological	I-Document
Diversity	E-Document
,	O
from	O
which	O
originated	O
the	O
1993	O
.	O
The	O
terms	O
biosafety	O
and	O
biosecurity	O
,	O
thereafter	O
,	O
gained	O
much	O
popularity	O
and	O
focus	O
among	O
the	O
scientists	O
and	O
policy	O
makers	O
globally	O
.	O

The	O
report	O
identified	O
seven	O
experiments	O
of	O
concern	O
,	O
including	O
those	O
that	O
would	O
enhance	O
the	O
virulence	O
of	O
a	O
pathogen	O
and	O
demonstrate	O
how	O
to	O
render	O
a	O
vaccine	O
ineffective	O
.	O

•	O
Understand	O
immunological	O
mechanism	O
(for	O
example	O
,	O
pathogen-host	O
interaction)	O
of	O
immune	O
protection	O
for	O
Lyme	B-Pathogen
disease	E-Pathogen
and	O
other	O
tick-borne	O
diseases	O
.	O

Standard	O
operating	O
procedures	O
were	O
not	O
available	O
in	O
67.	O
2%	O
labs	O
,	O
and	O
accident	O
records	O
were	O
not	O
maintained	O
in	O
83.4%	O
.	O

Curt	B-Person
Frodlund	E-Person
at	O
Utvecklingsprojekt	B-Organization
AB	E-Organization
for	O
his	O
inputs	O
on	O
project	O
management	O
.	O

That	O
means	O
that	O
a	O
big	O
amount	O
of	O
cartilage	O
and	O
a	O
thin	O
layer	O
of	O
compact	O
bone	O
can	O
cause	O
the	O
same	O
attenuation	O
in	O
a	O
voxel	O
as	O
hyperdense	O
cartilage	O
alone	O
.	O

The	O
media	O
reported	O
that	O
then	O
entered	O
a	O
90-day	O
period	O
of	O
heightened	O
surveillance	O
,	O
which	O
concluded	O
on	O
15	O
June	O
2016	O
,	O
and	O
it	O
was	O
reported	O
that	O
by	O
15	O
July	O
the	O
country	O
had	O
discontinued	O
testing	O
corpses	O
for	O
the	O
virus	O
.	O

Examples	O
include	O
HIV	S-Pathogen
(chimpanzees)	O
,	O
Ebola	S-Pathogen
(bats)	O
,	O
Sars	S-Pathogen
(probably	O
civets	O
or	O
bats)	O
and	O
influenza	S-Pathogen
(usually	O
pigs	O
or	O
birds)	O
.	O

As	O
a	O
world	O
leader	O
,	O
the	O
United	B-Location
States	E-Location
should	O
also	O
encourage	O
other	O
nations	O
to	O
adopt	O
sound	O
biosecurity	O
governance	O
systems	O
.	O

It	O
was	O
a	O
request	O
"	O
which	O
we	O
were	O
obligated	O
to	O
fulfill,	O
"	O
as	O
described	O
in	O
WHO	S-Organization
and	O
treaties	O
.	O

Jordan	S-Person
showed	O
that	O
from	O
1900	O
to	O
1917	O
,	O
the	O
5-	O
to	O
15-year	O
age	O
group	O
accounted	O
for	O
11%	O
of	O
total	O
influenza	S-Disease
cases	O
,	O
while	O
the	O
&gt;65-year	O
age	O
group	O
accounted	O
for	O
6%	O
of	B-Disease
influe	E-Disease
nza	O
cases	O
.	O

A	O
third	O
project	O
,	O
also	O
including	O
sand	O
flies	O
collection	O
,	O
studied	O
the	O
characteristics	O
of	O
their	O
salivary	O
glands	O
.	O

SCOTTSDALE	S-Location
Ariz	S-Location
.	O
,	O
Jan.	O
9	O
,	O
2018	O
/PRNewswire/	O
--	O
GlobalMed	S-Organization
,	O
an	O
international	O
provider	O
of	O
telehealth	O
solutions	O
,	O
today	O
announced	O
that	O
its	O
industry	O
leading	O
virtual	B-Platform
health	I-Platform
platform	E-Platform
has	O
earned	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)	O
Authority	O
to	O
Operate	O
(ATO)	O
on	O
DoD	S-Organization
networks	O
.	O

The	O
populations	O
of	O
some	O
Italian	O
cities	O
,	O
notably	O
,	O
did	O
not	O
regain	O
their	O
pre-14th	O
century	O
size	O
until	O
the	O
19th	O
century	O
.	O

Milton	B-Person
Leitenberg	E-Person
noted	O
in	O
the	O
2005	O
work	O
Assessing	B-Scientific_research_project
the	I-Scientific_research_project
Biological	I-Scientific_research_project
Weapons	I-Scientific_research_project
and	I-Scientific_research_project
Bioterrorism	I-Scientific_research_project
Threat	E-Scientific_research_project
,	O
"	O
there	O
is	O
apparently	O
no	O
other	O
'terrorist'	O
group	O
that	O
is	O
known	O
to	O
have	O
successfully	O
cultured	O
any	O
pathogen.	O
"	O
Federal	O
and	O
state	O
investigators	O
requested	O
that	O
details	O
of	O
the	O
incident	O
not	O
be	O
published	O
in	O
the	O
Journal	B-Organization
of	I-Organization
the	I-Organization
American	I-Organization
Medical	I-Organization
Association	E-Organization
(	O
JAMA	S-Organization
)	O
for	O
12	O
years	O
,	O
for	O
they	O
feared	O
a	O
description	O
of	O
the	O
events	O
could	O
spark	O
copycat	O
crimes	O
,	O
and	O
JAMA	S-Organization
complied	O
.	O

However	O
,	O
I	O
would	O
not	O
like	O
to	O
finish	O
this	O
post	O
without	O
a	O
bit	O
of	O
autocritics	O
in	O
what	O
I	O
think	O
will	O
become	O
one	O
of	O
the	O
most	O
revolutionary	O
innovations	O
of	O
the	O
21st	O
century	O
.	O

For	O
example	O
,	O
a	O
recently	O
announced	O
initiative	O
called	O
GP-Write	S-Activity
has	O
the	O
goal	O
of	O
synthesizing	O
an	O
entire	O
human	O
genome	O
from	O
chemical	O
building	O
blocks	O
within	O
the	O
next	O
10	O
years	O
.	O

Materials	O
on	O
the	O
Trial	O
of	O
Former	O
Servicemen	O
of	O
the	O
Japanese	B-Organization
Army	E-Organization
Charged	O
with	O
Manufacturing	O
and	O
Employing	O
Bacteriological	O
Weapons	O
(Moscow:	O
Foreign	O
Languages	O
Publishing	O
House	O
,	O
1950).	O
(French	O
language:	O
Documents	O
relatifs	O
au	O
procès	O
des	O
anciens	O
Militaires	O
de	O
l'Armée	O
Japonaise	O
accusés	O
d'avoir	O
préparé	O
et	O
employé	O
l'Arme	O
Bactériologique	O
/	O
Japanese	O
language:	O
細菌戦用兵器ノ準備及ビ使用ノ廉デ起訴サレタ元日本軍軍人ノ事件ニ関スル公判書類	O
/	O
Chinese	O
language:	O
前日本陸軍軍人因準備和使用細菌武器被控案審判材料)	O
The	O
lead	O
prosecuting	O
attorney	O
at	O
the	O
Khabarovsk	S-Location
trial	O
was	O
Lev	B-Person
Smirnov	E-Person
,	O
who	O
had	O
been	O
one	O
of	O
the	O
top	O
Soviet	S-Location
prosecutors	O
at	O
the	O
Trials	O
.	O

Children	O
make	O
up	O
a	O
small	O
proportion	O
of	O
reported	O
cases	O
,	O
with	O
about	O
1%	O
of	O
cases	O
being	O
under	O
10	O
years	O
and	O
4%	O
aged	O
10–19	O
years	O
.	O

Earlier	O
today	O
,	O
a	O
memo	O
distributed	O
by	O
groups	O
that	O
represent	O
research	O
universities	O
reported	O
that	O
White	B-Organization
House	E-Organization
officials	O
would	O
call	O
for	O
a	O
24-hour	O
pause	O
in	O
government-funded	O
research	O
involving	O
the	O
most	O
dangerous	O
agents	O
.	O

In	O
the	O
September	O
2014	O
incident	O
,	O
an	O
animal	O
caretaker	O
in	O
a	O
BSL-3	S-Platform
lab	O
noticed	O
decreased	O
airflow	O
to	O
their	O
respirator	O
and	O
discovered	O
that	O
a	O
hose	O
had	O
separated	O
from	O
its	O
coupling	O
.	O

Sara	B-Person
Roszak	E-Person
senior	O
director	O
of	O
research	O
programs	O
of	O
the	O
National	B-Organization
Association	I-Organization
of	I-Organization
Chain	I-Organization
Drug	I-Organization
Stores	E-Organization
,	O
gave	O
the	O
example	O
of	O
the	O
.	O
When	O
the	O
outbreak	O
occurred	O
,	O
she	O
said	O
her	O
organization	O
was	O
able	O
to	O
pull	O
together	O
a	O
network	O
of	O
pharmacies	O
to	O
initiate	O
a	O
nationwide	O
vaccination	O
campaign	O
"	O
on	O
a	O
drop	O
of	O
a	O
dime	O
"	O
primarily	O
because	O
there	O
were	O
existing	O
relationships	O
within	O
this	O
pharmacy	O
system	O
.	O

Anthrax	S-Pathogen
makes	O
a	O
good	O
weapon	O
because	O
it	O
can	O
be	O
released	O
quietly	O
and	O
without	O
anyone	O
knowing	O
.	O

Selection	O
of	O
an	O
appropriate	O
biosafety	O
level	O
for	O
work	O
with	O
a	O
particular	O
agent	O
or	O
animal	O
study	O
(see	O
Animal	O
Facilities)	O
depends	O
upon	O
a	O
number	O
of	O
factors	O
.	O

It	O
was	O
made	O
clear	O
that	O
anyone	O
resisting	O
would	O
be	O
shot.	O
"	O
After	O
victims	O
were	O
infected	O
,	O
they	O
were	O
vivisected	O
at	O
different	O
stages	O
of	O
infection	O
,	O
so	O
that	O
internal	O
and	O
external	O
organs	O
could	O
be	O
observed	O
as	O
the	O
disease	O
progressed	O
.	O

On	O
June	O
5th	O
of	O
this	O
year	O
,	O
a	O
laboratory	O
scientist	O
working	O
in	O
one	O
of	O
our	O
bioterrorism	O
response	O
laboratories	O
made	O
a	O
mistake	O
.	O

Second	O
,	O
the	O
system	O
must	O
sustain	O
the	O
bacteria	O
in	O
simulated	O
host	O
environments	O
long	O
enough	O
to	O
conduct	O
testing	O
.	O

The	O
first	O
medical	O
worker	O
infected	O
with	O
SARS	S-Disease
died	O
in	O
Hong	B-Location
Kong	E-Location
.	O
The	O
doctor's	O
daughter	O
and	O
infected	O
wife	O
survived	O
his	O
illness	O
,	O
even	O
though	O
the	O
wife	O
was	O
also	O
among	O
the	O
quarantined	O
medical	O
workers	O
under	O
intensive	O
care.	O
school	O
closures	O
were	O
extended	O
by	O
two	O
weeks	O
to	O
21	O
April	O
.	O

Countries	O
across	O
the	O
region	O
,	O
especially	O
those	O
around	O
the	O
Mediterranean	B-Location
Sea	E-Location
which	O
are	O
highly	O
dependent	O
on	O
agriculture	O
,	O
are	O
tempted	O
to	O
use	O
to	O
meet	O
consumer	O
food	O
demand	O
.	O

Kioyashi	B-Person
Mineoi	E-Person
"	O
civilian	O
employee	O
"	O

In	O
December	O
2015	O
,	O
during	O
the	O
8th	O
meeting	O
of	O
WHO	S-Organization
"	O
IHR	B-Organization
Emergency	I-Organization
Committee	I-Organization
regarding	I-Organization
Ebola	E-Organization
"	O
,	O
it	O
spoke	O
out	O
against	O
further	O
travel	O
restrictions	O
saying:	O
"	O
The	O
Committee	O
remains	O
deeply	O
concerned	O
that	O
34	O
countries	O
still	O
enact	O
inappropriate	O
travel	O
and	O
transport	O
measures	O
and	O
highlights	O
the	O
need	O
to	O
immediately	O
terminate	O
any	O
such	O
measures	O
due	O
to	O
their	O
negative	O
impact	O
,	O
particularly	O
on	O
recovery	O
efforts.	O
"	O
In	O
December	O
2015	O
,	O
the	O
CDC	S-Organization
indicated	O
that	O
it	O
would	O
no	O
longer	O
make	O
the	O
recommendation	O
for	O
US	O
citizens	O
going	O
to	O
Sierra	B-Location
Leone	E-Location
to	O
be	O
extra	O
careful	O
.	O

On	O
28	O
August	O
,	O
a	O
second	O
man	O
presented	O
symptoms	O
,	O
claiming	O
he	O
was	O
from	O
the	O
nearby	O
village	O
of	O
Yandongi	S-Location
.	O
He	O
left	O
the	O
hospital	O
on	O
30	O
August	O
,	O
as	O
no	O
clear	O
cause	O
could	O
be	O
identified	O
from	O
his	O
symptoms	O
,	O
and	O
was	O
not	O
seen	O
again	O
.	O

Work	O
with	O
or	O
potential	O
exposure	O
to	O
biological	O
materials	O
in	O
the	O
course	O
of	O
performing	O
research	O
or	O
other	O
work	O
activities	O
at	O
Lawrence	B-Organization
Berkeley	I-Organization
National	I-Organization
Laboratory	E-Organization
(	O
LBNL	S-Organization
)	O
must	O
be	O
conducted	O
in	O
a	O
safe	O
,	O
ethical	O
,	O
environmentally	O
sound	O
,	O
and	O
compliant	O
manner	O
.	O

Fortunately	O
antibiotic	O
resistance	O
was	O
not	O
an	O
issue	O
in	O
this	O
case	O
.	O

The	O
USPTO	S-Organization
granted	O
two	O
patents	O
on	O
remdesivir	S-Drug
to	O
Gilead	B-Organization
Sciences	E-Organization
on	O
April	O
9	O
,	O
2019:	O
one	O
for	O
filoviruses	S-Pathogen
,	O
and	O
one	O
which	O
covered	O
both	O
arenaviruses	S-Pathogen
and	O
.	O

Children	O
showed	O
no	O
cross-reactive	O
antibody	O
reaction	O
to	O
the	O
new	O
strain	O
,	O
adults	O
aged	O
18	O
to	O
60	O
had	O
6–9%	O
,	O
and	O
older	O
adults	O
33%	O
.	O

Sam	B-Person
Nunn	E-Person
and	O
philanthropist	O
who	O
continue	O
to	O
serve	O
as	O
co-chairs	O
.	O

The	O
BRM	S-Platform
is	O
a	O
freely	O
distributed	O
data	O
management	O
system	O
connected	O
to	O
Gaggle	S-Platform
.	O
The	O
system	O
is	O
designed	O
as	O
client	O
server	O
architecture	O
containing	O
a	O
PostgreSQL	O
database	O
storing	O
project	O
data	O
,	O
external	O
data	O
and	O
metadata	O
,	O
a	O
server	O
providing	O
access	O
to	O
the	O
database	O
and	O
a	O
Java	O
front-end	O
to	O
the	O
server	O
to	O
let	O
the	O
user	O
manage	O
projects	O
and	O
analyze	O
data	O
.	O

Many	O
thought	O
it	O
was	O
a	O
result	O
of	O
the	O
trench	O
warfare	O
,	O
the	O
use	O
of	O
mustard	O
gases	O
and	O
the	O
generated	O
"	O
smoke	O
and	O
fumes	O
"	O
of	O
the	O
war	O
.	O

The	O
strongest	O
self-quarantine	O
instructions	O
have	O
been	O
issued	O
to	O
those	O
in	O
high	O
risk	O
groups	O
.	O

An	O
investigation	O
by	O
the	O
Korean	B-Organization
CDC	E-Organization
of	O
285	O
individuals	O
who	O
tested	O
positive	O
for	O
SARS-CoV-2	S-Pathogen
in	O
PCR	B-Technology
tests	E-Technology
administered	O
days	O
or	O
weeks	O
after	O
recovery	O
from	O
found	O
no	O
evidence	O
that	O
these	O
individuals	O
were	O
contagious	O
at	O
this	O
later	O
time	O
.	O

For	O
joint	O
European	O
research	O
projects	O
,	O
harmonization	O
is	O
already	O
recommended	O
in	O
the	O
report	O
of	O
the	O
EU	S-Location
and	O
funded	O
project	O
'	O
PARSE.	B-International_exchange_and_cooperation
Insight	E-International_exchange_and_cooperation
':	O
'An	O
integrated	O
and	O
international	O
approach	O
is	O
desired	O
,	O
in	O
which	O
policies	O
are	O
geared	O
to	O
one	O
another	O
to	O
ensure	O
efficiency	O
and	O
rapid	O
development	O
of	O
policies'	O
.	O

The	O
CDC	S-Organization
outlines	O
the	O
guidelines	O
for	O
the	O
use	O
of	O
personal	B-Equipment
protective	I-Equipment
equipment	E-Equipment
(	O
PPE	S-Equipment
)	O
during	O
the	O
pandemic	O
.	O

Along	O
with	O
Southern	B-Organization
Research	I-Organization
Institute	E-Organization
two	O
other	O
private	O
American	O
companies	O
operate	O
military	O
bio-labs	O
in	O
Ukraine	S-Location
–	O
Black&amp;Ve	S-Organization
atch	O
iota	O
.	O

Here	O
,	O
we	O
present	O
an	O
overview	O
on	O
the	O
production	O
of	O
crops	O
,	O
their	O
acceptabilities	O
,	O
detection	O
strategies	O
,	O
biosafety	O
issues	O
and	O
potential	O
impact	O
on	O
society	O
.	O

An	O
International	B-Organization
Council	I-Organization
for	I-Organization
Science	E-Organization
report	O
detects	O
additional	O
impediments	O
in	O
'trends	O
toward	O
the	O
appropriation	O
of	O
data	O
,	O
such	O
as	O
genetic	O
information	O
and	O
the	O
protection	O
of	O
databases'	O
.	O

In	O
April	O
,	O
there	O
were	O
riots	O
in	O
some	O
Paris	S-Location
suburbs	O
.	O

The	O
Zika	B-Pathogen
virus	E-Pathogen
has	O
spread	O
in	O
recent	O
years	O
to	O
more	O
than	O
84	O
countries	O
,	O
territories	O
or	O
subnational	O
areas	O
,	O
including	O
the	O
U.S	S-Location
.	O
There	O
is	O
currently	O
no	O
vaccine	O
or	O
medicine	O
for	O
.	O

GlobalMed	S-Organization
is	O
also	O
the	O
telehealth	O
provider	O
for	O
the	O
.	O

He	O
said	O
that	O
the	O
girls	O
still	O
carried	O
functional	O
copies	O
of	O
CCR5	O
along	O
with	O
disabled	O
CCR5	O
(mosaicism)	O
and	O
were	O
still	O
vulnerable	O
to	O
.	O
The	O
work	O
was	O
widely	O
condemned	O
as	O
unethical	O
,	O
dangerous	O
,	O
and	O
premature	O
.	O

On	O
22	O
March	O
,	O
the	O
media	O
reported	O
that	O
medical	O
authorities	O
in	O
Guinea	S-Location
had	O
quarantined	O
816	O
suspected	O
contacts	O
of	O
the	O
prior	O
cases	O
(more	O
than	O
100	O
individuals	O
were	O
considered	O
high-risk)	O
;	O
the	O
same	O
day	O
,	O
Liberia	S-Organization
ordered	O
its	O
border	O
with	O
Guinea	S-Location
closed	O
.	O

For	O
a	O
10-year	O
period	O
(2006-2016)	O
Southern	B-Organization
Research	I-Organization
Institute	E-Organization
paid	O
$1.	O
28	O
million	O
for	O
lobbying	O
the	O
US	B-Organization
Senate	E-Organization
,	O
House	B-Organization
of	I-Organization
Representatives	E-Organization
,	O
the	O
State	B-Organization
Department	E-Organization
and	O
the	O
Department	B-Organization
of	I-Organization
Defense	E-Organization
(	O
DoD	S-Organization
)	O
.	O

The	O
current	O
chairman	O
of	O
the	O
executive	O
board	O
is	O
Dr.	O
.	O

There	O
is	O
high	O
mortality	O
in	O
people	O
ventilated	O
with	O
COVID-19	S-Pathogen
thought	O
to	O
be	O
due	O
to	O
cytokine	B-Phenotype
storm	E-Phenotype
.	O
Blockade	B-Equipment
of	I-Equipment
the	I-Equipment
IL-6	I-Equipment
system	E-Equipment
is	O
recommended	O
by	O
and	O
Allergy	O
to	O
be	O
considered	O
early	O
in	O
severe	O
disease	O
,	O
and	O
is	O
included	O
for	O
consideration	O
in	O
a	O
number	O
of	O
national	O
guidelines	O
.	O

The	O
also	O
just	O
released	O
a	O
new	O
special	O
report	O
on	O
biodefense	O
preparedness	O
at	O
the	O
local	O
level	O
.	O

Work	O
must	O
be	O
conducted	O
in	O
accordance	O
with	O
established	O
biosafety	O
standards	O
,	O
the	O
principles	O
and	O
functions	O
of	O
Integrated	B-Document
Safety	I-Document
Management	E-Document
(	O
ISM	S-Document
)	O
,	O
this	O
Biosafety	O
Manual	O
,	O
Chapter	O
26	O
(Biosafety)	O
of	O
the	O
Health	B-Document
and	I-Document
Safety	I-Document
Manual	E-Document
(PUB-3000)	O
,	O
and	O
applicable	O
standards	O
and	O
policies	O
.	O

"	O
State	O
officials	O
have	O
probably	O
noticed	O
an	O
increase	O
as	O
well	O
as	O
an	O
unusual	O
distribution	O
of	O
Medfly	O
infestation	O
in	O
Los	B-Location
Angeles	I-Location
County	E-Location
since	O
March	O
,	O
1989,	O
"	O
the	O
letter	O
stated	O
.	O

It	O
is	O
transmitted	O
by	O
ticks	O
and	O
direct	O
contact	O
between	O
animals	O
and	O
there	O
is	O
no	O
vaccine	O
.	O

Production	O
potential	O
includes	O
the	O
acquisition	O
of	O
potential	O
pathogens	O
,	O
stability	O
,	O
and	O
potential	O
production	O
capacity	O
[14]	O
.	O

For	O
example	O
,	O
Burkholderia	B-Pathogen
mallei	E-Pathogen
was	O
listed	O
in	O
the	O
highest	O
threat	O
group	O
according	O
to	O
the	O
biodefense	O
categorization	O
of	O
the	O
EU	S-Location
and	O
Russia	S-Location
,	O
while	O
the	O
US	B-Organization
CDC	E-Organization
listed	O
this	O
agent	O
in	O
the	O
second	O
highest	O
category	O
.	O

The	O
lungs	O
are	O
the	O
organs	O
most	O
affected	O
by	O
COVID‑19	S-Disease
because	O
the	O
virus	O
accesses	O
host	O
cells	O
via	O
the	O
enzyme	O
angiotensin-converting	O
enzyme	O
2	O
(ACE2)	O
,	O
which	O
is	O
most	O
abundant	O
in	O
type	O
II	O
alveolar	O
cells	O
of	O
the	O
lungs	O
.	O

The	O
CDC	S-Organization
goal	O
is	O
to	O
have	O
the	O
new	O
facility	O
built	O
in	O
time	O
to	O
ensure	O
the	O
transition	O
from	O
the	O
current	O
labs	O
to	O
the	O
new	O
ones	O
is	O
seamless	O
,	O
said	O
.	O

Tailoring	O
these	O
genes	O
opened	O
any	O
RNA	O
molecule	O
to	O
editing	O
.	O

The	O
initially	O
said	O
there	O
was	O
no	O
"	O
clear	O
evidence	O
"	O
of	O
human-to-human	O
transmission	O
.	O

Other	O
basic	O
steps	O
to	O
mastering	O
this	O
biohack:	O
no	O
phones	O
in	O
bed	O
,	O
no	O
caffeine	O
or	O
prescription	O
amphetamines	S-Drug
before	O
bed	O
,	O
no	O
alcohol	O
before	O
bed	O
because	O
it	O
messes	O
with	O
sleep	O
cycles	O
.	O

The	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
is	O
asking	O
Congress	S-Organization
for	O
money	O
for	O
a	O
new	O
building	O
to	O
house	O
the	O
laboratories	O
that	O
work	O
on	O
the	O
deadliest	O
pathogens	O
known	O
to	O
humankind	O
.	O

Registration	O
is	O
available	O
at:	O

The	O
report	O
concludes	O
that	O
the	O
critical	O
nature	O
of	O
investigations	O
to	O
detect	O
and	O
respond	O
to	O
naturally	O
occurring	O
and	O
man-made	O
events	O
with	O
select	O
agents	O
while	O
ensuring	O
the	O
safety	O
of	O
staff	O
are	O
paramount	O
and	O
should	O
be	O
guided	O
by	O
the	O
highest	O
standards	O
.	O

The	O
T1	O
and	O
T2	O
weighting	O
can	O
also	O
be	O
described	O
as	O
sequences	O
.	O

A	O
study	O
estimated	O
that	O
there	O
were	O
110	O
incidents	O
of	O
preventable	O
cardiac	O
death	O
as	O
compared	O
to	O
86	O
confirmed	O
deaths	O
from	O
as	O
of	O
March	O
29	O
.	O

We	O
describe	O
a	O
unique	O
cluster	O
of	O
blaNDM-5–producing	O
E.	O
coli	O
in	O
a	O
veterinary	O
hospital	O
.	O

Bioterrorism	O
Agent.B	O
.	O

Walden	S-Person
,	O
chairman	O
of	O
the	O
U.S.	B-Organization
House	I-Organization
Energy	I-Organization
and	I-Organization
Commerce	I-Organization
Committee	E-Organization
,	O
who	O
initially	O
asked	O
Rep.	O
to	O
lead	O
on	O
the	O
reauthorization	O
effort	O
for	O
the	O
committee	O
.	O

Based	O
on	O
Johns	B-Organization
Hopkins	I-Organization
University	E-Organization
statistics	O
,	O
the	O
global	O
death-to-case	O
ratio	O
is	O
(/)	O
as	O
of	O
.	O
The	O
number	O
varies	O
by	O
region	O
.	O

These	O
bio-weapons	O
were	O
deployed	O
but	O
never	O
used	O
.	O

This	O
chain	O
of	O
events	O
forms	O
a	O
possible	O
indirect	O
means	O
of	O
transmission	O
from	O
the	O
natural	O
host	O
to	O
animal	O
populations	O
.	O

Melioidosis	S-Disease
also	O
called	O
Whitmore's	B-Disease
disease	E-Disease
,	O
is	O
an	O
infectious	O
disease	O
that	O
can	O
infect	O
humans	O
or	O
animals	O
,	O
caused	O
by	O
the	O
bacterium	O
Burkholderia	B-Pathogen
pseudomallei	E-Pathogen
()	O
.	O

The	O
World	B-Organization
Health	I-Organization
Assembly	E-Organization
(	O
WHA	S-Organization
)	O
is	O
the	O
legislative	O
and	O
supreme	O
body	O
of	O
WHO	S-Organization
.	O
Based	O
in	O
Geneva	S-Location
,	O
it	O
typically	O
meets	O
yearly	O
in	O
May	O
.	O

By	O
the	O
late	O
1950s	O
the	O
4.5	O
"	O
E120	O
spraying	O
spherical	O
bomblet	O
was	O
developed	O
;	O
a	O
B-47	O
bomber	O
with	O
a	O
SUU-24/A	O
dispenser	O
could	O
infect	O
50%	O
or	O
more	O
of	O
the	O
population	O
of	O
a	O
area	O
with	O
tularemia	S-Pathogen
with	O
the	O
E120	O
.	O

These	O
experiments	O
may	O
help	O
define	O
the	O
viral	O
component	O
to	O
the	O
unusual	O
pathogenicity	O
of	O
the	O
1918	B-Pathogen
virus	E-Pathogen
but	O
cannot	O
address	O
whether	O
specific	O
host	O
factors	O
in	O
1918	O
accounted	O
for	O
unique	O
mortality	O
patterns	O
.	O

The	O
institute	O
says	O
it	O
has	O
closed	O
its	O
labs	O
following	O
the	O
outbreak	O
.	O

It's	O
not	O
unreasonable	O
to	O
assume	O
that	O
terrorists	O
or	O
other	O
groups	O
are	O
trying	O
to	O
get	O
their	O
hands	O
on	O
bioweapons	O
as	O
well	O
.	O

Sanjay	B-Person
Gupta	E-Person
weighed	O
in	O
on	O
the	O
American	O
government's	O
recent	O
approach	O
to	O
bioterrorist	O
threats	O
.	O

Before	O
synthetic	B-Technology
biology	E-Technology
genetic	O
engineering	O
was	O
largely	O
just	O
genetics	O
.	O

Although	O
it	O
was	O
originally	O
thought	O
the	O
pandemic	O
reached	O
France	S-Location
on	O
24	O
January	O
2020	O
,	O
when	O
the	O
first	O
COVID-19	S-Disease
case	O
in	O
Europe	S-Location
was	O
confirmed	O
in	O
Bordeaux	S-Location
,	O
it	O
was	O
later	O
discovered	O
that	O
a	O
person	O
near	O
Paris	S-Location
had	O
tested	O
positive	O
for	O
the	O
virus	O
on	O
27	O
December	O
2019	O
after	O
retesting	O
old	O
samples	O
.	O

Mecca	S-Location
became	O
infected	O
in	O
1348	O
by	O
pilgrims	O
performing	O
the	O
Hajj	O
.	O

Global	O
health	O
and	O
nonproliferation	O
may	O
seem	O
like	O
distinct	O
missions	O
,	O
but	O
they	O
overlap	O
in	O
important	O
ways	O
,	O
and	O
we	O
can	O
accomplish	O
more	O
by	O
working	O
together	O
.	O

According	O
to	O
a	O
1994	O
study	O
published	O
in	O
the	O
journal	O
Sociology	O
of	O
Religion	O
,	O
"	O
[m]ost	O
sannyasins	S-Person
indicated	O
that	O
they	O
believed	O
that	O
[Rajneesh]	O
knew	O
about	O
Ma	O
Anand	O
Sheela's	O
illegal	O
activities.	O
"	O
Frances	B-Person
FitzGerald	E-Person
writes	O
in	O
Cities	O
on	O
a	O
Hill	O
that	O
most	O
of	O
Rajneesh's	O
followers	O
"	O
believed	O
[him]	O
incapable	O
of	O
doing	O
,	O
or	O
willing	O
,	O
violence	O
against	O
another	O
person"	O
,	O
and	O
that	O
almost	O
all	O
thought	O
the	O
responsibility	O
for	O
the	O
criminality	O
was	O
Sheela's	O
–	O
according	O
to	O
FitzGerald	S-Person
,	O
the	O
followers	O
believed	O
the	O
guru	O
had	O
not	O
known	O
anything	O
about	O
it	O
.	O

Category:Medical	O
and	O
health	O
organizations	O
based	O
in	O
Washington,	B-Location
D.C	E-Location

With	O
regards	O
to	O
biodefense	O
,	O
international	O
cooperation	O
is	O
even	O
more	O
absent	O
.	O

Follow	O
all	O
appropriate	O
guidelines	O
and	O
regulations	O
for	O
the	O
use	O
and	O
handling	O
of	O
pathogenic	O
microorganisms	O
.	O

The	O
Occupational	O
Safety	O
and	O
Health	O
Administration	O
(	O
OSHA	S-Organization
regulations	O
in	O
.	O

Sections	O
of	O
the	O
NP	O
,	O
VP35	O
and	O
the	O
L	O
genes	O
from	O
filoviruses	O
have	O
been	O
identified	O
as	O
endogenous	O
in	O
the	O
genomes	O
of	O
several	O
groups	O
of	O
small	O
mammals	O
.	O

Phage	B-Technology
therapy	E-Technology
relies	O
on	O
the	O
use	O
of	O
naturally-occurring	O
bacteriophages	O
to	O
infect	O
and	O
lyse	O
bacteria	O
at	O
the	O
site	O
of	O
infection	O
in	O
a	O
host	O
.	O

Since	O
the	O
start	O
of	O
the	O
outbreak	O
,	O
heightened	O
prejudice	O
,	O
xenophobia	O
,	O
and	O
racism	O
have	O
been	O
documented	O
around	O
the	O
world	O
toward	O
people	O
of	O
Chinese	O
and	O
East	O
Asian	O
descent	O
,	O
Reports	O
from	O
February	O
(when	O
most	O
cases	O
were	O
confined	O
to	O
China	S-Location
documented	O
racist	O
sentiments	O
expressed	O
in	O
groups	O
worldwide	O
about	O
Chinese	O
people	O
deserving	O
the	O
virus	O
.	O

In	O
January	O
2015	O
,	O
a	O
new	O
treatment	O
and	O
research	O
centre	O
was	O
built	O
by	O
Rusal	S-Organization
and	O
Russia	S-Location
in	O
the	O
city	O
of	O
Kindia	S-Location
in	O
Guinea	S-Location
.	O
It	O
is	O
one	O
of	O
the	O
most	O
modern	O
medical	O
centres	O
in	O
Guinea	S-Location
.	O
Also	O
in	O
January	O
,	O
MSF	S-Organization
admitted	O
its	O
first	O
patients	O
to	O
a	O
new	O
treatment	O
centre	O
in	O
Kissy	S-Location
,	O
an	O
Ebola	S-Disease
hotspot	O
on	O
the	O
outskirts	O
of	O
Freetown	S-Location
,	O
.	O
The	O
centre	O
has	O
a	O
maternity	O
unit	O
for	O
pregnant	O
women	O
with	O
the	O
virus	O
.	O

The	O
laboratory	O
worker's	O
complete	O
isolation	O
from	O
aerosolized	O
infectious	O
materials	O
is	O
accomplished	O
primarily	O
by	O
working	O
in	O
a	O
Class	B-Equipment
III	I-Equipment
BSC	E-Equipment
or	O
in	O
a	O
full‐body	O
,	O
air‐supplied	O
,	O
positive‐pressure	O
personnel	O
suit	O
.	O

The	O
plan	O
includes	O
public	O
disclosure	O
of	O
lab	O
accidents	O
,	O
a	O
new	O
system	O
for	O
reporting	O
mishaps	O
,	O
and	O
a	O
review	O
of	O
the	O
large	O
number	O
of	O
high-containment	O
labs	O
in	O
the	O
country	O
.	O

Representative	O
results	O
are	O
shown	O
in	O
Fig.1	O
.	O

Enormous	O
additional	O
knowledge	O
and	O
insights	O
could	O
be	O
extracted	O
from	O
existing	O
projects	O
if	O
their	O
data	O
were	O
publicly	O
available	O
.	O

Harold	B-Person
Jaffe	E-Person
is	O
leading	O
an	O
internal	O
investigation	O
into	O
the	O
circumstances	O
surrounding	O
this	O
incident	O
.	O

Often	O
,	O
pathogens	O
are	O
left	O
behind	O
for	O
the	O
use	O
of	O
post-doctoral	O
fellows	O
and	O
graduates	O
to	O
complete	O
work	O
in	O
progress	O
.	O

However	O
,	O
in	O
October	O
2015	O
,	O
she	O
again	O
became	O
critically	O
ill	O
and	O
was	O
diagnosed	O
with	O
meningitis	S-Disease
.	O
In	O
this	O
unprecedented	O
case	O
it	O
is	O
thought	O
that	O
the	O
virus	O
remained	O
in	O
her	O
brain	O
replicating	O
at	O
a	O
very	O
low	O
level	O
until	O
it	O
had	O
replicated	O
to	O
a	O
degree	O
capable	O
of	O
causing	O
.	O
The	O
woman	O
was	O
treated	O
and	O
in	O
November	O
2015	O
it	O
was	O
reported	O
that	O
she	O
had	O
recovered	O
.	O

To	O
comply	O
with	O
these	O
regulations	O
,	O
several	O
European	O
laboratory	O
networks	O
have	O
been	O
established	O
.	O

The	O
RD	O
manages	O
and/or	O
supervises	O
a	O
staff	O
of	O
health	O
and	O
other	O
experts	O
at	O
the	O
regional	O
offices	O
and	O
in	O
specialized	O
centres	O
.	O

As	O
the	O
number	O
of	O
susceptible	O
hosts	O
declines	O
,	O
so	O
does	O
the	O
effective	O
population	O
size	O
and	O
its	O
genetic	O
diversity	O
.	O

Holy	O
Week	O
observances	O
in	O
Rome	S-Location
which	O
occur	O
during	O
the	O
last	O
week	O
of	O
the	O
Christian	O
penitential	O
season	O
of	O
Lent	O
,	O
were	O
cancelled	O
.	O

As	O
a	O
refresher	O
,	O
that's	O
when	O
an	O
older	O
person	O
pays	O
for	O
a	O
young	O
person's	O
blood	O
and	O
has	O
it	O
pumped	O
into	O
their	O
veins	O
in	O
the	O
hope	O
that	O
it'll	O
fight	O
aging	O
.	O

The	O
death	O
toll	O
is	O
claimed	O
to	O
be	O
at	O
least	O
105	O
,	O
but	O
the	O
exact	O
number	O
is	O
unknown	O
,	O
as	O
all	O
hospital	O
records	O
and	O
other	O
evidence	O
were	O
destroyed	O
by	O
the	O
KGB	S-Organization
according	O
to	O
former	O
Biopreparat	S-Scientific_research_project
deputy	O
director	O
.	O

EBOV	S-Pathogen
RNA	O
in	O
semen	O
is	O
not	O
the	O
same	O
situation	O
as	O
perseverance	O
of	O
in	O
semen	O
,	O
however	O
the	O
"	O
clinical	O
significance	O
of	O
low	O
levels	O
of	O
virus	O
RNA	O
in	O
convalescent	O
"	O
individuals	O
who	O
are	O
healthy	O
is	O
unknown	O
.	O

Yuri	B-Person
OvchinnikovBirstein	E-Person
Vadim	B-Person
J	E-Person
.	O
(2004)	O
,	O
The	O
Perversion	O
Of	O
Knowledge:	O
The	O
True	O
Story	O
of	O
Science	O
,	O
Westview	O
Press	O
.	O

Slovenia	S-Location
is	O
a	O
small	O
country	O
and	O
a	O
new	O
Member	O
State	O
.	O

This	O
map	O
shows	O
previous	O
EVD	S-Disease
outbreaks	O
in	O
the	O
area	O
of	O
central	O
Africa	S-Location
,	O
which	O
includes	O
the	O
Democratic	B-Location
Republic	I-Location
of	I-Location
the	I-Location
Congo	E-Location
.	O
This	O
outbreak	O
is	O
the	O
biggest	O
of	O
the	O
ten	O
recorded	O
outbreaks	O
that	O
have	O
occurred	O
in	O
the	O
.	O

By	O
reformatting	O
the	O
volume	O
,	O
it	O
becomes	O
much	O
easier	O
to	O
visualise	O
the	O
position	O
of	O
one	O
vertebral	O
body	O
in	O
relation	O
to	O
the	O
others	O
.	O

The	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
uses	O
the	O
term	O
"	O
(H1N1)	B-Incident
2009	I-Incident
pandemic	E-Incident
"	O
when	O
referring	O
to	O
the	O
event	O
,	O
and	O
officially	O
adopted	O
the	O
name	O
"	O
"	O
for	O
the	O
virus	O
in	O
2010	O
,	O
after	O
the	O
conclusion	O
of	O
the	O
pandemic	O
.	O

In	O
1977	O
,	O
the	O
World	B-Organization
Health	I-Organization
Organization	E-Organization
(	O
WHO	S-Organization
)	O
had	O
told	O
Henry	B-Person
Bedson	E-Person
that	O
his	O
application	O
for	O
his	O
laboratory	O
to	O
become	O
a	O
Smallpox	B-Organization
Collaborating	I-Organization
Centre	E-Organization
had	O
been	O
rejected	O
.	O

Appropriate	O
and	O
approved	O
inactivation	O
procedures	O
,	O
consistent	O
with	O
recently	O
implemented	O
laboratory	O
safety	O
improvements	O
,	O
were	O
used	O
.	O

Or	O
they	O
might	O
take	O
a	O
Gen	O
space	B-Organization
cl	E-Organization
on	O
how	O
to	O
make	O
furniture	O
out	O
of	O
fungi	O
or	O
paper	O
out	O
of	O
kombucha	O
.	O

He	O
received	O
a	O
ten-year	O
suspended	O
sentence	O
and	O
a	O
fine	O
of	O
US$400,000	O
,	O
and	O
was	O
deported	O
and	O
barred	O
from	O
reentering	O
the	O
United	B-Location
States	E-Location
for	O
a	O
period	O
of	O
five	O
years	O
.	O

When	O
a	O
gown	O
(or	O
coverall)	O
is	O
worn	O
,	O
it	O
should	O
continue	O
beyond	O
the	O
shoe	O
covers	O
.	O

The	O
new	O
strain	O
was	O
first	O
identified	O
by	O
the	O
CDC	S-Organization
in	O
two	O
children	O
,	O
neither	O
of	O
whom	O
had	O
been	O
in	O
contact	O
with	O
pigs	O
.	O

On	O
2	O
May	O
,	O
China	S-Location
announced	O
the	O
three	O
suspected	O
cases	O
as	O
genuine	O
cases	O
of	O
SARS	S-Disease
,	O
bringing	O
the	O
total	O
cases	O
in	O
a	O
recent	O
outbreak	O
to	O
nine.	O
189	O
people	O
were	O
released	O
from	O
quarantine	O
.	O

He	O
,	O
did	O
,	O
however	O
,	O
accept	O
that	O
more	O
had	O
to	O
be	O
done	O
to	O
assist	O
maternal	O
health	O
and	O
that	O
progress	O
in	O
this	O
area	O
had	O
been	O
slow	O
.	O

Zelicoff	S-Person
reassured	O
health	O
and	O
military	O
officials	O
that	O
he	O
would	O
recommend	O
more	O
research	O
rather	O
than	O
changes	O
in	O
vaccine	O
production	O
.	O

Enhance	O
international	O
partnerships	O
and	O
cooperation	O
on	O
regional	O
and	O
global	O
efforts	O
to	O
respond	O
to	O
AMR	O
.	O

Of	O
the	O
initiatives	O
reviewed	O
,	O
2.67%	O
(n = 49)	O
were	O
in	O
the	O
category	O
of	O
hands-on	O
training	O
.	O

A	O
benzyl-free	O
intermediate	O
was	O
obtained	O
.	O

Church	S-Person
used	O
the	O
method	O
to	O
find	O
versions	O
of	O
the	O
bacteria	O
Escherichia	O
coli	O
that	O
produce	O
higher	O
than	O
normal	O
levels	O
of	O
a	O
chemical	O
called	O
lycopene	O
.	O

The	O
researchers	O
stress	O
that	O
any	O
biosecurity	O
policies	O
must	O
take	O
a	O
"	O
bottom	O
up	O
"	O
approach	O
by	O
including	O
direct	O
involvement	O
from	O
working	O
scientists	O
.	O

Finally	O
,	O
data	O
from	O
a	O
single	O
imaging	O
procedure	O
consisting	O
of	O
either	O
multiple	O
contiguous	O
or	O
one	O
helical	O
scan	O
can	O
be	O
viewed	O
as	O
images	O
in	O
the	O
axial	O
,	O
coronal	O
,	O
or	O
sagittal	O
planes	O
,	O
depending	O
on	O
the	O
diagnostic	O
task	O
.	O

The	O
FDA	S-Organization
	S-Organization
stated	O
on	O
1	O
May	O
2020	O
,	O
that	O
it	O
is	O
"	O
reasonable	O
to	O
believe	O
"	O
that	O
known	O
and	O
potential	O
benefits	O
of	O
remdesivir	S-Drug
outweigh	O
its	O
known	O
and	O
potential	O
risks	O
,	O
in	O
some	O
specific	O
populations	O
hospitalized	O
with	O
severe	O
COVID‑19	S-Disease
.	O
As	O
of	O
May	O
2020	O
,	O
there	O
was	O
no	O
good	O
evidence	O
that	O
remdesivir	S-Drug
reduced	O
mortality	O
in	O
people	O
with	O
.	O

Remdesivir	S-Drug
is	O
a	O
ProTide	O
(Prodrug	O
of	O
nucleoTide)	O
that	O
is	O
able	O
to	O
diffuse	O
into	O
cells	O
where	O
it	O
is	O
converted	O
to	O
GS-441524	O
mono-phosphate	O
via	O
the	O
actions	O
of	O
esterases	O
and	O
a	O
phosphoramidase	O
;	O
this	O
in	O
turn	O
is	O
further	O
phosphorylated	O
to	O
its	O
active	O
metabolite	O
triphosphate	O
by	O
nucleoside-phosphate	O
kinases	O
.	O

This	O
is	O
most	O
commonly	O
seen	O
in	O
the	O
z-direction	O
,	O
due	O
to	O
the	O
conventional	O
use	O
of	O
highly	O
anisotropic	O
voxels	O
,	O
which	O
have	O
a	O
much	O
lower	O
out-of-plane	O
resolution	O
,	O
than	O
in-plane	O
resolution	O
.	O

At	O
least	O
12	O
large-scale	O
field	O
trials	O
of	O
biological	O
weapons	O
were	O
performed	O
,	O
and	O
at	O
least	O
11	O
Chinese	O
cities	O
were	O
attacked	O
with	O
biological	O
agents	O
.	O

Some	O
experts	O
project	O
that	O
in	O
the	O
future	O
,	O
between	O
three	O
and	O
five	O
percent	O
of	O
all	O
cancers	S-Disease
would	O
result	O
from	O
.	O

Several	O
internationally	O
recognised	O
experts	O
produced	O
evidence	O
during	O
the	O
prosecution	O
to	O
show	O
that	O
it	O
was	O
unlikely	O
that	O
Parker	S-Person
was	O
infected	O
by	O
airborne	O
transmission	O
in	O
this	O
way	O
.	O

Ricin	S-Pathogen
is	O
a	O
white	O
powder	O
that	O
can	O
be	O
produced	O
as	O
a	O
liquid	O
or	O
a	O
crystal	O
.	O

The	O
WHO	S-Organization
based	O
their	O
new	O
recommendations	O
on	O
a	O
March	O
2015	O
case	O
,	O
in	O
which	O
a	O
Liberian	O
woman	O
who	O
had	O
no	O
contact	O
with	O
the	O
disease	O
other	O
than	O
having	O
had	O
unprotected	O
sex	O
with	O
a	O
man	O
who	O
had	O
had	O
the	O
disease	O
in	O
October	O
2014	O
,	O
was	O
diagnosed	O
with	O
Ebola	S-Disease
.	O
While	O
no	O
evidence	O
of	O
the	O
virus	O
was	O
found	O
in	O
his	O
blood	O
,	O
his	O
semen	O
revealed	O
RNA	O
closely	O
matching	O
the	O
variant	O
that	O
infected	O
the	O
woman	O
.	O

Biological	O
weapons	O
were	O
used	O
against	O
both	O
Chinese	O
soldiers	O
and	O
civilians	O
in	O
several	O
military	O
campaigns	O
.	O

Malarial	O
parasites	O
that	O
are	O
resistant	O
to	O
the	O
drugs	O
that	O
are	O
currently	O
available	O
to	O
infections	O
are	O
common	O
and	O
this	O
has	O
led	O
to	O
increased	O
efforts	O
to	O
develop	O
new	O
drugs	O
.	O

During	O
the	O
exercises	O
,	O
both	O
groups	O
were	O
charged	O
with	O
providing	O
humanitarian	O
assistance	O
to	O
simulated	O
survivors	O
of	O
an	O
earthquake	O
,	O
with	O
Marines	S-Organization
in	O
the	O
unit	O
presented	O
with	O
situations	O
they	O
do	O
not	O
normally	O
train	O
for	O
,	O
testing	O
the	O
versatility	O
inherent	O
within	O
the	O
unit	O
,	O
according	O
to	O
officials	O
.	O

Two	O
instances	O
of	O
documents	O
discussing	O
the	O
use	O
of	O
biological	O
disease	O
by	O
the	O
British	O
against	O
North	O
American	O
Indians	O
during	O
Pontiac's	O
Rebellion	O
(1763–66)	O
have	O
been	O
examined	O
by	O
historians	O
,	O
but	O
the	O
actual	O
effectiveness	O
is	O
unknown	O
.	O

Both	O
chambers	O
of	O
Congress	S-Organization
now	O
are	O
working	O
to	O
fast	O
track	O
revamps	O
to	O
the	O
2006	O
Pandemic	B-Document
and	I-Document
All-Hazards	I-Document
Preparedness	I-Document
Act	E-Document
()	O
,	O
first	O
reauthorized	O
in	O
2013	O
,	O
and	O
which	O
is	O
now	O
due	O
to	O
expire	O
Sept.	O
30	O
.	O

Egyptian	O
Muslims	O
who	O
went	O
on	O
the	O
annual	O
to	O
Mecca	S-Location
risked	O
being	O
quarantined	O
upon	O
their	O
return	O
.	O

By	O
24	O
April	O
,	O
889,309	O
cases	O
had	O
been	O
confirmed	O
and	O
50,256	O
people	O
had	O
died	O
.	O

Iran	S-Location
reported	O
its	O
first	O
confirmed	O
cases	O
of	O
SARS‑CoV‑2	S-Pathogen
infections	O
on	O
19	O
February	O
in	O
Qom	S-Location
,	O
where	O
,	O
according	O
to	O
the	O
Ministry	B-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Medical	I-Organization
Education	E-Organization
,	O
two	O
people	O
died	O
on	O
that	O
day	O
.	O

Research	O
in	O
2018	O
found	O
evidence	O
of	O
Yersinia	B-Pathogen
pestis	E-Pathogen
in	O
an	O
ancient	O
Swedish	S-Location
tomb	O
,	O
which	O
may	O
have	O
been	O
associated	O
with	O
the	O
"	O
Neolithic	O
decline	O
"	O
around	O
3000	O
BC	O
,	O
in	O
which	O
European	S-Location
populations	O
fell	O
significantly	O
.	O

This	O
project	O
was	O
supported	O
by	O
funding	O
from	O
the	O
Open	B-Organization
Philanthropy	I-Organization
Project	E-Organization
and	O
is	O
the	O
most	O
recent	O
addition	O
to	O
the	O
Center's	O
leading	O
research	O
and	O
scholarship	O
on	O
GCBRs	O
.	O

Is	O
there	O
some	O
sort	O
of	O
-	O
when	O
you	O
talk	O
about	O
culture	O
,	O
is	O
there	O
some	O
sort	O
of	O
culture	O
of	O
fear	O
that	O
people	O
who	O
worked	O
at	O
the	O
were	O
afraid	O
to	O
tell	O
upper	O
management?	O

The	O
employee	O
was	O
given	O
an	O
antiviral	O
medication	O
;	O
no	O
infection	O
resulted	O
,	O
the	O
records	O
say	O
.	O

The	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services'	I-Organization
(HHS)	I-Organization
Office	I-Organization
of	I-Organization
the	I-Organization
Assistant	I-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
,	O
Biomedical	B-Organization
Advanced	I-Organization
Research	I-Organization
and	I-Organization
Development	I-Organization
Authority	E-Organization
(	O
BARDA	S-Organization
)	O
will	O
sponsor	O
the	O
advanced	O
development	O
of	O
the	O
new	O
testing	O
technology	O
under	O
an	O
18-month	O
,	O
approximately	O
$9.3	O
million	O
contract	O
with	O
SeLux	B-Organization
Diagnostic,	I-Organization
Inc	E-Organization
of	O
Charlestown	S-Location
,	O
.	O

A	O
NHK	O
Documentary	O
broadcast	O
in	O
2017	O
,	O
including	O
paper	O
materials	O
,	O
recording	O
tapes	O
,	O
and	O
interviews	O
to	O
former	O
members	O
and	O
doctors	O
who	O
have	O
implemented	O
experiments	O
in	O
.	O

Transfer	O
materials	O
to	O
other	O
facilities	O
according	O
to	O
federal	B-Document
and	I-Document
international	I-Document
regulations	E-Document

In	O
addition	O
,	O
a	O
Japanese	O
journalist	O
claims	O
to	O
have	O
seen	O
similar	O
evidence	O
of	O
a	O
Soviet	O
disinformation	O
campaign	O
and	O
that	O
the	O
evidence	O
supporting	O
its	O
occurrence	O
was	O
faked	O
.	O

Montserrado	S-Location
saw	O
a	O
47%	O
decline	O
in	O
employment	O
per	O
firm	O
in	O
contrast	O
to	O
what	O
was	O
obtained	O
prior	O
to	O
the	O
.	O

According	O
to	O
an	O
April	O
2017	O
KPMG	O
survey	O
conducted	O
by	O
HIMSS	B-Organization
Analytics	E-Organization
31	O
percent	O
of	O
healthcare	O
organizations	O
currently	O
use	O
video-based	O
telemedicine	O
services	O
and	O
another	O
44	O
percent	O
of	O
healthcare	O
organizations	O
are	O
considering	O
implementing	O
video-based	O
telemedicine	O
services	O
in	O
the	O
near	O
future	O
.	O

News	O
of	O
the	O
immensity	O
of	O
the	O
Soviets	S-Organization
biological	O
weapons	O
program	O
began	O
to	O
reach	O
the	O
West	O
in	O
1989	O
,	O
when	O
biologist	O
Vladimir	B-Person
Pasechnik	E-Person
defected	O
to	O
Britain	S-Location
.	O
The	O
stories	O
he	O
told-of	O
genetically	O
altered	O
"	O
superplague	S-Pathogen
,	O
"	O
antibiotic-resistant	O
anthrax	S-Pathogen
,	O
and	O
long-range	O
missiles	O
designed	O
to	O
spread	O
disease-were	O
confirmed	O
by	O
later	O
defectors	O
like	O
Ken	B-Person
Alibek	E-Person
and	O
.	O

Key	O
players	O
with	O
a	O
biopreparedness	O
perspective	O
in	O
were	O
identified	O
,	O
including	O
county	O
veterinarians	O
,	O
veterinarians	O
in	O
clinical	O
practice	O
,	O
food	O
inspectors	O
at	O
the	O
local	O
level	O
,	O
and	O
relevant	O
personnel	O
in	O
the	O
healthcare	O
sector	O
.	O

We're	O
very	O
concerned	O
about	O
the	O
health	O
and	O
well-being	O
of	O
our	O
own	O
staff	O
.	O

For	O
example	O
,	O
they	O
feared	O
that	O
rDNA	O
derived	O
from	O
drug-resistant	O
bacteria	O
could	O
escape	O
from	O
the	O
lab	O
,	O
threatening	O
the	O
public	O
with	O
infectious	O
superbugs	O
.	O

When	O
scientists	O
went	O
digging	O
for	O
clues	O
in	O
the	O
DNA	O
of	O
people	O
who	O
are	O
apparently	O
immune	O
to	O
HIV	S-Disease
they	O
found	O
that	O
the	O
resistant	O
individuals	O
had	O
mutated	O
a	O
protein	O
that	O
serves	O
as	O
the	O
landing	O
pad	O
for	O
HIV	S-Pathogen
on	O
the	O
surface	O
of	O
blood	O
cells	O
.	O

technological	O
basis	O
to	O
change	O
natural	O
microorganisms	O
into	O
anti-material	O
microbes	O
.	O

One	O
of	O
the	O
things	O
that	O
we've	O
learned	O
in	O
public	O
health	O
is	O
in	O
any	O
procedure	O
,	O
there	O
may	O
be	O
-	O
or	O
process	O
-	O
there	O
may	O
be	O
certain	O
points	O
that	O
are	O
particularly	O
high	O
risk	O
,	O
critical	O
control	O
points	O
.	O

The	O
researcher	O
,	O
Stanley	B-Person
Perlman	E-Person
was	O
put	O
on	O
probation	O
for	O
a	O
year	O
and	O
received	O
additional	O
monitoring	O
from	O
the	O
university	O
.	O

The	O
Middle	B-Location
East	E-Location
was	O
ravaged	O
,	O
too	O
,	O
with	O
the	O
plague	O
killing	O
about	O
one	O
in	O
three	O
Egyptians	O
and	O
Syrians	O
.	O

This	O
can	O
result	O
in	O
a	O
number	O
of	O
pollution-related	O
diseases	O
.	O

Robert	B-Person
Kadlec	E-Person
Assistant	B-Organization
Secretary	I-Organization
for	I-Organization
Preparedness	I-Organization
and	I-Organization
Response	E-Organization
(	O
ASPR	S-Organization
)	O
at	O
the	O
U.S.	B-Organization
Department	I-Organization
of	I-Organization
Health	I-Organization
and	I-Organization
Human	I-Organization
Services	E-Organization
()	O
,	O
for	O
instance	O
,	O
said	O
the	O
office	O
has	O
enough	O
domestic	O
vaccine	O
manufacturing	O
capacity	O
to	O
produce	O
bulk	O
vaccines	O
for	O
each	O
American	O
within	O
six	O
months	O
.	O

MIKE	B-Person
STOBBE	E-Person
Thank	O
you	O
.	O

The	O
papal	O
doctor	O
recognised	O
that	O
bloodletting	O
was	O
ineffective	O
(though	O
he	O
continued	O
to	O
prescribe	O
bleeding	O
for	O
members	O
of	O
the	O
Roman	B-Organization
Curia	E-Organization
,	O
whom	O
he	O
disliked)	O
,	O
and	O
claimed	O
that	O
all	O
true	O
cases	O
of	O
the	O
were	O
caused	O
by	O
astrological	O
factors	O
and	O
were	O
incurable	O
;	O
he	O
himself	O
was	O
never	O
able	O
to	O
effect	O
a	O
cure	O
.	O

"	O
Those	O
investments	O
are	O
paying	O
dividends	O
,	O
as	O
this	O
information	B-Platform
technology	I-Platform
system	E-Platform
now	O
allows	O
officials	O
to	O
detect	O
a	O
wide	O
range	O
of	O
health	O
threats	O
beyond	O
biological	O
attacks	O
,	O
from	O
opioid	O
overdoses	O
to	O
chemical	O
exposures	O
to	O
disease	O
outbreaks,	O
"	O
Dr	O
.	O

In	O
another	O
study	O
done	O
in	O
an	O
intensive	O
care	O
unit	O
in	O
a	O
major	O
hospital	O
in	O
,	O
it	O
was	O
shown	O
that	O
30%	O
to	O
60%	O
of	O
prescribed	O
antibiotics	O
were	O
unnecessary	O
.	O

In	O
the	O
trenches	O
,	O
natural	O
selection	O
was	O
reversed	O
.	O

It	O
was	O
revealed	O
that	O
the	O
Iraqi	O
program	O
conducted	O
basic	O
research	O
on	O
B.	B-Pathogen
anthracis	E-Pathogen
,	O
rotavirus	S-Pathogen
,	O
camelpox	B-Pathogen
virus	E-Pathogen
,	O
aflatoxin	S-Pathogen
,	O
botulinum	B-Pathogen
toxins	E-Pathogen
,	O
,	O
and	O
an	O
anticrop	O
agent	O
(wheat	O
cover	O
smut)	O
.	O

Like	O
Scythian	O
archers	O
,	O
Roman	O
soldiers	O
dipped	O
their	O
swords	O
into	O
excrements	O
and	O
cadavers	O
too	O
-	O
victims	O
were	O
commonly	O
infected	O
by	O
as	O
result	O
.	O

The	O
inquiry's	O
report	O
noted	O
that	O
Bedson	S-Person
had	O
failed	O
to	O
inform	O
the	O
authorities	O
of	O
changes	O
in	O
his	O
research	O
that	O
could	O
have	O
affected	O
safety	O
.	O

Igor	B-Person
DomaradskijDomaradskij,	I-Person
Igor	I-Person
V.	E-Person
and	O
(2003)	O
,	O
Biowarrior:	O
Inside	O
the	O
Soviet/Russian	O
Biological	O
War	O
Machine	O
;	O
Prometheus	O
Books	O
.	O

U.S.	B-Organization
government	E-Organization
officials	O
were	O
especially	O
concerned	O
about	O
schools	O
because	O
the	O
appears	O
to	O
disproportionately	O
affect	O
young	O
and	O
school-age	O
people	O
,	O
between	O
six	O
months	O
and	O
24	O
years	O
of	O
age	O
.	O

Many	O
are	O
represented	O
in	O
the	O
International	B-Organization
Association	I-Organization
of	I-Organization
National	I-Organization
Public	I-Organization
Health	I-Organization
Institutes	E-Organization
and	O
discussed	O
at	O
.	O

Zelicoff	S-Person
of	O
the	O
was	O
able	O
to	O
track	O
down	O
and	O
interview	O
the	O
outbreak's	O
first	O
case	O
,	O
who	O
was	O
then	O
a	O
young	O
fisheries	O
expert	O
,	O
as	O
well	O
as	O
the	O
second	O
patient	O
,	O
her	O
9-year-old	O
brother	O
.	O

In	O
those	O
beyond	O
48	O
hours	O
who	O
are	O
moderately	O
or	O
severely	O
ill	O
,	O
antivirals	O
may	O
still	O
be	O
beneficial	O
.	O

No	O
formal	O
biosafety	O
training	O
had	O
been	O
provided	O
to	O
84.	O
2%	O
of	O
the	O
respondents	O
.	O

In	O
essence	O
,	O
the	O
Insect	B-Scientific_research_project
Allies	E-Scientific_research_project
Program	O
seeks	O
to	O
speed	O
the	O
genetic	O
modification	O
process	O
.	O

Characteristic	O
imaging	O
features	O
on	O
chest	B-Equipment
radiographs	E-Equipment
and	O
computed	B-Equipment
tomography	E-Equipment
(	O
CT	S-Equipment
)	O
of	O
people	O
who	O
are	O
symptomatic	O
include	O
asymmetric	O
peripheral	O
ground-glass	O
opacities	O
without	O
pleural	B-Disease
effusions	E-Disease
.	O
The	O
Italian	O
Radiological	B-Organization
Society	E-Organization
is	O
compiling	O
an	O
international	O
online	O
database	O
of	O
imaging	O
findings	O
for	O
confirmed	O
cases	O
.	O

Do	O
you	O
mind	O
clarifying	O
why	O
and	O
also	O
addressing	O
-	O
did	O
the	O
sample	O
end	O
up	O
mutating	O
or	O
changing	O
as	O
a	O
result	O
of	O
-	O
is	O
there	O
some	O
ongoing	O
concern	O
regarding	O
the	O
results	O
of	O
that	O
cross-contamination?	O

Sanders	S-Person
took	O
this	O
information	O
to	O
General	O
Douglas	B-Person
MacArthur	E-Person
,	O
who	O
was	O
the	O
Supreme	O
Commander	O
of	O
the	O
Allied	B-Organization
Powers	E-Organization
responsible	O
for	O
rebuilding	O
during	O
the	O
Allied	O
occupations	O
.	O

School	O
closures	O
,	O
lockdowns	O
,	O
and	O
reduced	O
access	O
to	O
healthcare	O
following	O
the	O
COVID-19	S-Pathogen
pandemic	O
may	O
differentially	O
affect	O
the	O
genders	O
and	O
possibly	O
exaggerate	O
existing	O
gender	O
disparity	O
.	O

Among	O
them	O
,	O
insertional	O
mutagenesis	O
by	O
enhancer	O
mediated	O
dysregulation	O
of	O
neighboring	O
genes	O
or	O
aberrant	O
splicing	O
is	O
still	O
the	O
biggest	O
concern	O
.	O

While	O
this	O
practice	O
does	O
result	O
in	O
better	O
yields	O
and	O
meat	O
products	O
,	O
it	O
is	O
a	O
major	O
issue	O
in	O
terms	O
of	O
preventing	O
antimicrobial	O
resistance	O
.	O

These	O
are	O
wake-up	O
calls	O
.	O

Lillibridge	S-Person
who	O
experienced	O
firsthand	O
the	O
anthrax	S-Pathogen
events	O
of	O
2001	O
,	O
addressed	O
these	O
and	O
other	O
future	O
biological	O
challenges	O
during	O
one	O
of	O
several	O
panels	O
held	O
during	O
Tuesday's	O
meeting	O
to	O
review	O
the	O
state	O
of	O
biodefense	O
.	O

But	O
how	O
do	O
you	O
change	O
the	O
culture?	O
I	O
mean	O
,	O
this	O
administration	O
has	O
been	O
here	O
since	O
2009	O
at	O
the	O
.	O
Obviously	O
this	O
is	O
an	O
ingrained	O
culture	O
.	O

Stating	O
that	O
"	O
the	O
Ebola	B-Incident
outbreak	E-Incident
has	O
decimated	O
families	O
,	O
health	O
systems	O
,	O
economies	O
,	O
and	O
social	O
structures"	O
,	O
the	O
WHO	S-Organization
called	O
the	O
aftermath	O
of	O
the	O
epidemic	O
"	O
an	O
emergency	O
within	O
an	O
emergency.	O
"	O
Of	O
special	O
concern	O
is	O
recent	O
research	O
that	O
shows	O
some	O
Ebola	S-Disease
survivors	O
experience	O
a	O
so-called	O
"	O
",	O
with	O
symptoms	O
so	O
severe	O
that	O
survivors	O
may	O
require	O
medical	O
care	O
for	O
months	O
and	O
even	O
years	O
.	O

Later	O
,	O
it	O
was	O
calculated	O
at	O
32,313	O
,	O
after	O
taking	O
the	O
official	O
death	O
count	O
for	O
Scotland	S-Organization
and	O
into	O
account	O
.	O

The	O
incident	O
comes	O
just	O
weeks	O
after	O
an	O
explosion	O
near	O
the	O
site	O
of	O
a	O
suspected	O
failed	O
missile	O
test	O
in	O
northern	O
Russia	S-Location
that	O
killed	O
at	O
least	O
five	O
nuclear	O
specialists	O
and	O
caused	O
radiation	O
levels	O
to	O
spike	O
.	O

Application	O
of	O
these	O
principles	O
to	O
animals	O
retained	O
in	O
outdoor	O
environments	O
has	O
been	O
a	O
consequence	O
of	O
disease	O
eradication	O
programs	O
.	O

"	O
We	O
recognized	O
this	O
strain	O
by	O
using	O
its	O
fingerprints	O
,	O
and	O
we	O
realized	O
there's	O
been	O
a	O
significant	O
shift	O
in	O
its	O
prevalence,	O
"	O
Sokurenko	S-Person
said	O
.	O

Antonina	B-Person
Presnyakova	E-Person
was	O
an	O
experienced	O
researcher	O
,	O
who	O
was	O
doing	O
tests	O
on	O
guinea	O
pigs	O
at	O
the	O
time	O
,	O
daily	O
reported	O
.	O

Equally	O
vital	O
in	O
making	O
this	O
progress	O
,	O
he	O
added	O
,	O
has	O
been	O
the	O
close	O
collaboration	O
between	O
the	O
Centers	B-Organization
for	I-Organization
Disease	I-Organization
Control	I-Organization
and	I-Organization
Prevention	E-Organization
(	O
CDC	S-Organization
)	O
,	O
,	O
and	O
the	O
nation's	O
state	O
,	O
local	O
,	O
tribal	O
,	O
and	O
territorial	O
public	O
health	O
departments	O
.	O

TOM	B-Person
FRIEDEN	E-Person
I	O
think	O
if	O
we	O
look	O
at	O
laboratory	O
science	O
overall	O
,	O
there's	O
been	O
a	O
lot	O
of	O
change	O
in	O
recent	O
decades	O
.	O

I	O
was	O
just	O
wondering	O
how	O
that	O
impacts	O
the	O
other	O
things	O
that	O
you're	O
doing	O
.	O

On	O
28	O
August	O
2014	O
,	O
authorities	B-Organization
in	I-Organization
Guinea	E-Organization
issued	O
an	O
alert	O
informing	O
their	O
medical	O
services	O
and	O
neighbouring	O
countries	O
that	O
a	O
person	O
who	O
had	O
been	O
in	O
close	O
contact	O
with	O
an	O
Ebola	S-Disease
-infected	O
patient	O
had	O
escaped	O
their	O
surveillance	O
system	O
.	O

The	O
letters	O
were	O
sent	O
by	O
an	O
individual	O
who	O
referred	O
to	O
themselves	O
as	O
"	O
Fallen	B-Person
Angel	E-Person
The	O
sender	O
,	O
who	O
claimed	O
to	O
own	O
a	O
trucking	O
company	O
,	O
expressed	O
anger	O
over	O
changes	O
in	O
federal	O
trucking	O
regulations	O
.	O

With	O
the	O
coming	O
of	O
the	O
Red	B-Organization
Army	E-Organization
in	O
August	O
1945	O
,	O
the	O
unit	O
had	O
to	O
abandon	O
their	O
work	O
in	O
haste	O
.	O

The	O
CDC	S-Organization
had	O
requested	O
that	O
the	O
Atlanta	O
city	O
government	O
annex	O
the	O
area	O
.	O

